word,frequency,log frequency
the,275442,12.526132359095541
of,271999,12.513553668800787
and,211545,12.26219302079445
in,150182,11.91960317091771
to,125980,11.74387844317592
a,87382,11.378044590776334
with,78871,11.275568885403835
for,60231,11.005942448921688
is,56513,10.94222597916381
patients,48173,10.782553977112013
The,46387,10.74477452654493
was,40646,10.612655709150252
that,37613,10.535105014302918
were,32990,10.403959764222627
asthma,32608,10.392312936022451
are,30713,10.332441296713197
on,29906,10.305814408143789
as,29741,10.300281844196661
by,29447,10.290347316318723
be,27487,10.221468444611173
influenza,27368,10.21712972665744
stroke,26703,10.19253119762704
from,23414,10.061089413039618
an,23322,10.057152400080279
or,22124,10.004418271114568
this,20991,9.951849053414007
have,20503,9.928326495883047
infarction,19994,9.903187507527125
myocardial,19240,9.864746724219698
acute,18920,9.847974842605868
disease,18140,9.805874723669127
COVID-19,17041,9.743377484107393
In,16635,9.719264188452577
has,16363,9.702777967428895
SARS-CoV-2,16186,9.691901950055648
at,15653,9.658417870888224
clinical,15148,9.625623789021686
study,14867,9.60689927061335
been,14840,9.605081516721372
not,14480,9.580523665939708
risk,14264,9.565494159542977
after,14206,9.561419689557756
treatment,13721,9.526682784921174
We,13453,9.506957408485542
A,13156,9.484633207308947
virus,12301,9.417435838868785
may,12288,9.416378455387454
than,12076,9.39897529082673
This,12033,9.395408154438163
pandemic,11931,9.3868953338758
which,11814,9.37704054786718
between,11451,9.34583234141334
can,10872,9.29394595583098
infection,10669,9.275097619191461
we,10640,9.272375762895635
these,10635,9.271905727634337
during,10546,9.263501920090414
more,10065,9.216819338073892
respiratory,9890,9.199279424616758
severe,9776,9.187685681411377
Background,9694,9.17926241640532
had,9549,9.164191715950203
but,9530,9.162199996648248
children,8936,9.097843340749037
studies,8893,9.09301972939964
their,8809,9.083529205109796
associated,8777,9.079889942592118
2,8776,9.079776001955066
vaccine,8774,9.07954808172616
mortality,8678,9.068546366358296
cases,8620,9.061840363657739
also,8186,9.010180657052349
data,8182,9.009691898489343
coronary,8176,9.008958312443486
health,8138,9.004299728561636
factors,8067,8.995536944936974
therapy,7853,8.968650903374874
group,7846,8.967759126769497
years,7773,8.958411469230219
who,7689,8.94754601503218
symptoms,7651,8.942591637231851
care,7527,8.926251835034533
coronavirus,7477,8.919586920999915
it,7469,8.918516400357067
most,7287,8.893847217670283
use,7167,8.877242435993919
control,7135,8.872767529910936
other,7008,8.854807632616227
used,6947,8.846065190692881
results,6885,8.837100411162755
all,6879,8.836228571526014
such,6660,8.803874763534434
diagnosis,6412,8.765926513729443
high,6405,8.764834214330834
patient,6386,8.761863373274727
among,6275,8.744328763999984
its,6241,8.738895704934043
both,6238,8.738414897167749
review,6186,8.730043953245016
first,6105,8.716863386544805
management,6089,8.714239143608575
ischemic,5988,8.69751274553952
age,5977,8.695674048824253
using,5891,8.681181041521688
vaccination,5844,8.67317077287059
significant,5753,8.657476736863293
no,5746,8.656259239539235
time,5742,8.655562860681009
However,5731,8.653645314551737
increased,5722,8.652073673610056
early,5630,8.635864721133736
two,5598,8.630164670075398
viral,5573,8.625688787569537
should,5521,8.616314282284044
those,5515,8.615226931687603
one,5499,8.612321536507814
syndrome,5466,8.606302366488013
important,5449,8.603187384583098
new,5426,8.598957493218878
population,5424,8.598588829620232
compared,5365,8.587651655064798
well,5298,8.575084669832014
different,5296,8.574707097616844
To,5286,8.572817095164234
including,5246,8.56522116042682
there,5111,8.53915035876828
only,5104,8.537779825024625
left,5091,8.535229553902337
viruses,5030,8.523175263093785
potential,5008,8.518791912779934
1,5007,8.518592212329946
ventricular,5002,8.517593111437565
rate,4959,8.508959386489133
against,4943,8.505727713306959
vaccines,4839,8.48446336679332
will,4767,8.469472455204826
development,4732,8.462103225098277
less,4706,8.456593569287309
present,4685,8.452121194672523
reported,4604,8.434680769841773
higher,4594,8.432506383249043
response,4591,8.431853144249223
evidence,4583,8.430109084509125
p,4574,8.428143374582726
function,4565,8.426173793029069
analysis,4530,8.41847721847708
artery,4507,8.413387022690648
significantly,4455,8.40178233990491
role,4450,8.400659375160286
human,4448,8.400209835930418
number,4444,8.39931015075952
case,4439,8.398184404834035
about,4431,8.39638057119949
could,4429,8.395929103923198
effective,4367,8.381831553485561
3,4338,8.37516869138682
test,4331,8.373553741214627
found,4326,8.372398606513004
testing,4304,8.36730010184162
into,4283,8.36240897761537
current,4227,8.34924780056679
It,4221,8.347827345782498
hospital,4172,8.336150816120663
cardiac,4162,8.33375100695358
days,4149,8.330622620332868
groups,4141,8.328692583545568
when,4070,8.311398278436641
positive,4068,8.31090675716845
showed,4061,8.309184527686298
effects,4034,8.302513718514158
within,4034,8.302513718514158
cause,4024,8.300031711779575
due,3967,8.28576542051433
our,3925,8.275121630216509
severity,3921,8.27410200229233
H1N1,3912,8.271804031154709
strokes,3911,8.271548374755515
changes,3909,8.271036865792954
outcomes,3906,8.270269111436624
transmission,3906,8.270269111436624
death,3895,8.267448958304849
incidence,3874,8.262042843966942
These,3847,8.255048902752295
over,3806,8.244334047856094
prevention,3769,8.234564993267135
infections,3756,8.231109840328154
medical,3724,8.222553638396958
available,3716,8.22040309993373
cells,3697,8.215276958936633
common,3696,8.215006432761575
2019,3686,8.212297138229768
airway,3671,8.208219383496834
-,3663,8.206037762778815
without,3660,8.205218426395412
based,3647,8.20166019080868
effect,3641,8.200013648175434
heart,3637,8.19891444498699
increase,3588,8.185350223178686
95,3584,8.18423477409482
There,3572,8.18088094199639
diagnostic,3571,8.18060094759445
blood,3571,8.18060094759445
tests,3555,8.176110342237342
chronic,3545,8.173293438966228
some,3537,8.17103418920548
public,3508,8.162801353492073
AMI,3496,8.159374736775426
impact,3477,8.153925132007862
caused,3466,8.150756470275551
outcome,3459,8.148734808937169
prevalence,3459,8.148734808937169
performed,3452,8.146709052203319
MI,3440,8.143226750367445
levels,3421,8.137688184977605
onset,3412,8.13505390861157
system,3406,8.133293861222633
novel,3405,8.133000218583613
model,3404,8.132706489693264
research,3399,8.131236549696116
rates,3397,8.130647968160584
detection,3379,8.12533508671429
developed,3357,8.118802996980035
2009,3352,8.117312461601975
diseases,3331,8.11102783819368
therapeutic,3327,8.109826276018477
specific,3316,8.106514516255185
related,3306,8.10349427838097
major,3305,8.103191752285786
trials,3299,8.101374671228582
provide,3277,8.094683648698815
strategies,3266,8.09132127353041
findings,3265,8.09101504171053
period,3261,8.089789175789319
whether,3238,8.08271113423758
identified,3228,8.07961802938984
primary,3207,8.073091199693154
observed,3151,8.055475141757274
many,3150,8.055157731819678
information,3143,8.052933036797567
following,3139,8.051659556841953
months,3136,8.0507033814703
spread,3104,8.04044688130311
three,3096,8.037866234709618
need,3095,8.037543185118697
recent,3092,8.036573409707312
possible,3082,8.033334015880062
individuals,3082,8.033334015880062
morbidity,3070,8.029432840581244
through,3065,8.027802848370312
lower,3057,8.025189321890835
low,3035,8.017966703493599
immune,3026,8.014996894348302
total,3023,8.014004994779459
countries,3008,8.00903068506973
they,2968,7.995643604287271
mechanisms,2957,7.9919305198524775
Asthma,2953,7.990576881743923
CI,2938,7.9854843567338225
Although,2921,7.979681302387741
subjects,2917,7.978310969867722
determine,2911,7.976251943745623
aim,2883,7.9665866976384025
level,2881,7.9658927350845286
bronchial,2859,7.958227192322312
drugs,2855,7.956827122090111
complications,2851,7.955425088912672
activity,2844,7.952966790923131
measures,2807,7.939871576361883
cell,2803,7.938445551164788
report,2798,7.936660155225426
samples,2782,7.930925372483388
before,2781,7.930565854233965
large,2781,7.930565854233965
10,2768,7.92588031673756
Objective,2768,7.92588031673756
several,2768,7.92588031673756
global,2712,7.905441649060286
illness,2708,7.903965634032166
assess,2695,7.899153483343097
identify,2688,7.89655270164304
lung,2682,7.894318063841624
adults,2679,7.893198869544609
rapid,2675,7.891704659330107
year,2672,7.890582534656536
people,2664,7.88758403166028
efficacy,2658,7.885329239273191
women,2645,7.8804263442924
protein,2642,7.879291485082271
approach,2641,7.878912912297133
characteristics,2601,7.8636512654486515
further,2594,7.860956364876389
treated,2592,7.860185057472165
outbreak,2567,7.8504931808711405
6,2565,7.84971375760487
epidemic,2554,7.845416036592485
infarct,2552,7.844632644464681
evaluate,2549,7.8434564043761155
history,2549,7.8434564043761155
known,2538,7.839131648274333
improve,2529,7.835579246669965
reduce,2529,7.835579246669965
intervention,2515,7.83002808253384
suggest,2512,7.828834527588089
events,2512,7.828834527588089
association,2493,7.821242083523558
5,2481,7.816416983691801
imaging,2479,7.8156105320351905
emergency,2477,7.814803429489359
considered,2477,7.814803429489359
type,2471,7.81237820598861
inflammation,2468,7.811163385025279
4,2466,7.81035268372429
if,2464,7.80954132465341
B,2451,7.804251383528112
differences,2441,7.80016307039296
shown,2438,7.798933310041217
failure,2436,7.798112628829788
how,2426,7.793999089503996
methods,2421,7.791935956938058
life,2412,7.788211557847076
being,2407,7.786136437783072
each,2406,7.785720896534624
often,2401,7.783640596221253
purpose,2400,7.783224016336037
asthmatic,2394,7.780720886117918
article,2380,7.77485576666552
hours,2366,7.768956044538332
future,2360,7.7664168980196555
Influenza,2359,7.765993079407675
method,2355,7.764296006450518
similar,2352,7.763021309018518
Stroke,2351,7.762596048540069
respectively,2345,7.76004068088038
flow,2338,7.757051142032013
anterior,2331,7.754052639035757
infected,2330,7.753623546559746
limited,2325,7.751475318021456
antibodies,2325,7.751475318021456
evaluated,2321,7.749753406274437
studied,2313,7.746300662231439
Our,2298,7.739794458408701
knowledge,2296,7.738923757439457
confirmed,2281,7.732369222284388
better,2275,7.729735331385051
exercise,2267,7.726212650507529
remains,2266,7.725771441587952
reperfusion,2263,7.724446645633537
mean,2262,7.724004656676065
sensitivity,2259,7.7226775164680035
likely,2255,7.720905251936779
while,2254,7.720461694599722
general,2252,7.719573989259581
understanding,2248,7.717796211013582
right,2248,7.717796211013582
surveillance,2242,7.715123603632105
because,2238,7.71333788887187
size,2236,7.71244383427499
demonstrated,2235,7.711996507047669
deaths,2234,7.711548979629146
presence,2224,7.707062655370473
included,2221,7.7057128238944275
factor,2214,7.7025561132685825
responses,2214,7.7025561132685825
worldwide,2213,7.70210434005105
did,2213,7.70210434005105
exposure,2201,7.696667081526462
conditions,2199,7.695757990554761
greater,2183,7.688455356549944
normal,2182,7.687997166393016
any,2182,7.687997166393016
long-term,2173,7.6838639802564295
vs,2145,7.6708948313621175
antiviral,2135,7.666221925662725
addition,2118,7.658227526161352
aimed,2117,7.6577552711348655
per,2116,7.65728279297819
12,2115,7.656810091480378
still,2112,7.655390644826152
brain,2103,7.6511201757027
models,2097,7.64826303090192
P,2091,7.645397699428633
out,2089,7.644440761556566
various,2087,7.643482907077201
causes,2082,7.641084249174914
pulmonary,2078,7.639161171659173
reduced,2078,7.639161171659173
assessment,2066,7.633369649679584
negative,2062,7.631431664576906
RNA,2055,7.628031126930335
describe,2055,7.628031126930335
would,2053,7.627057417018934
inflammatory,2043,7.622174594817622
quality,2041,7.621195162809845
especially,2031,7.616283561580385
guidelines,2030,7.615791072035833
20,2020,7.61085279039525
antibody,2020,7.61085279039525
Health,2014,7.607878073278507
result,2013,7.607381425639791
highly,2010,7.605890001053122
value,2005,7.60339933974067
functional,2000,7.600902459542082
strains,1998,7.599901959208498
cerebral,1994,7.597897950521784
2020,1993,7.597396320212795
work,1993,7.597396320212795
however,1980,7.590852123688581
interventions,1972,7.586803535162581
assessed,1971,7.58629630715272
agents,1969,7.585281078639126
support,1964,7.582738488914411
very,1960,7.580699752224563
effectiveness,1954,7.577633832602728
might,1949,7.575071699507561
drug,1940,7.570443252057374
secondary,1937,7.5688956634069955
Patients,1935,7.5678626054638825
seasonal,1934,7.56734567601324
relationship,1924,7.562161631225652
pressure,1922,7.561121589530238
phase,1896,7.547501682814967
wall,1893,7.545918151209323
n,1891,7.544861068658458
improved,1890,7.5443321080536885
prognosis,1888,7.543273346705446
include,1874,7.535830462798367
course,1870,7.533693709848633
presented,1859,7.527793987721444
features,1855,7.5256399750415355
increasing,1855,7.5256399750415355
previous,1853,7.52456122628536
regarding,1851,7.523481312573497
admission,1849,7.522400231387125
literature,1842,7.518607216815252
chest,1842,7.518607216815252
conducted,1840,7.517520850603031
multiple,1837,7.515889085215125
investigated,1836,7.515344571180436
30,1830,7.512071245835466
world,1828,7.510977752014095
pneumonia,1824,7.508787170634276
elderly,1820,7.506591780070841
investigate,1819,7.506042178518122
evaluation,1819,7.506042178518122
cardiovascular,1815,7.503840746698951
under,1815,7.503840746698951
particularly,1812,7.502186486602924
revealed,1789,7.489412083508719
initial,1787,7.488293515159428
tested,1783,7.48605261786314
needed,1781,7.484930283289661
obtained,1781,7.484930283289661
detected,1776,7.4821189235521155
young,1775,7.4815557019095165
prevent,1774,7.480992162869525
show,1771,7.479299637782834
burden,1770,7.478734825567875
reduction,1768,7.477604243197589
up,1767,7.4770384723196965
status,1763,7.47477218239787
As,1763,7.47477218239787
recovery,1756,7.470793774195062
15,1753,7.469083884921234
mild,1753,7.469083884921234
examined,1753,7.469083884921234
peak,1751,7.467942332285852
Here,1750,7.4673710669175595
occurred,1744,7.463936604468925
area,1743,7.463363045520021
community,1741,7.462214939768189
main,1734,7.458186157340487
China,1731,7.456454555176209
thrombolysis,1730,7.455876687491824
even,1729,7.455298485683291
social,1726,7.453561871643373
weeks,1721,7.450660796211539
healthcare,1720,7.450079569807499
occlusion,1715,7.44716835960004
second,1713,7.44600149832412
50,1697,7.436617265234227
follow-up,1694,7.434847875211999
tissue,1694,7.434847875211999
develop,1692,7.433666540166168
strategy,1690,7.432483807917119
leading,1689,7.4318919168078
monitoring,1688,7.431299675155903
them,1683,7.428333194190806
aged,1676,7.424165281042028
help,1672,7.421775793644647
practice,1667,7.418780882750794
therapies,1667,7.418780882750794
host,1666,7.418180822726788
critical,1661,7.415175109613295
allergic,1657,7.4127640174265625
underlying,1650,7.408530566894626
laboratory,1648,7.4073177104694174
lead,1641,7.403061091090091
importance,1641,7.403061091090091
elevation,1630,7.396335293800808
day,1630,7.396335293800808
assay,1628,7.395107546562485
made,1626,7.3938782901077555
currently,1623,7.392031567514591
molecular,1620,7.3901814282264295
humans,1612,7.385230923066573
serum,1610,7.383989457978509
standard,1605,7.380879035564116
small,1601,7.3783837129967145
older,1601,7.3783837129967145
United,1596,7.3752557780097545
process,1592,7.3727463664043285
For,1588,7.370230641807081
genetic,1581,7.365812837209472
safety,1576,7.362645270417825
infectious,1576,7.362645270417825
order,1575,7.362010551259734
useful,1572,7.360103972989152
same,1566,7.356279876550748
established,1562,7.3537223303996315
key,1559,7.351799869057777
objective,1554,7.348587530927593
four,1553,7.347943823148687
physical,1549,7.3453648404168685
admitted,1546,7.343426229147367
atrial,1544,7.342131730584722
appropriate,1544,7.342131730584722
discussed,1537,7.337587743538596
ratio,1535,7.336285660021297
season,1533,7.334981878871814
either,1529,7.332369205929062
avian,1528,7.331714969726466
ST,1524,7.329093736246592
late,1522,7.3277805384216315
decreased,1511,7.32052696227274
described,1510,7.31986492980897
24,1510,7.31986492980897
persons,1507,7.317876198626496
poor,1506,7.317212408359839
recurrent,1501,7.313886831633462
populations,1499,7.312553498102598
asymptomatic,1491,7.307202314764738
childhood,1489,7.305860032684009
symptom,1489,7.305860032684009
criteria,1489,7.305860032684009
benefit,1488,7.305188215393037
since,1484,7.302496423727326
approaches,1483,7.301822342137932
few,1482,7.301147805856032
areas,1482,7.301147805856032
frequency,1480,7.299797366758161
required,1479,7.2991214627108
complex,1473,7.29505641646263
performance,1472,7.294377299288821
ECG,1471,7.293697720601438
challenge,1467,7.2909747781429814
values,1466,7.290292882446597
range,1465,7.289610521451167
immunity,1465,7.289610521451167
received,1464,7.288927694521257
rehabilitation,1463,7.288244401020124
improvement,1461,7.2868764117507
RT-PCR,1456,7.283448228756631
An,1454,7.282073658093465
assays,1454,7.282073658093465
reaction,1446,7.27655640271871
injury,1445,7.275864600546533
thrombolytic,1444,7.275172319452771
7,1433,7.267525427828172
across,1431,7.266128779556451
pathogenesis,1428,7.2640301428995295
healthy,1426,7.262628600974241
followed,1426,7.262628600974241
score,1424,7.261225091971921
parameters,1423,7.260522598089852
provides,1421,7.259116128097101
States,1421,7.259116128097101
discuss,1421,7.259116128097101
epidemiological,1417,7.256297239690681
During,1413,7.253470382684528
influence,1409,7.25063551189868
outbreaks,1404,7.247080584585756
fibrillation,1403,7.246368080102461
developing,1399,7.243512974665482
affected,1399,7.243512974665482
individual,1397,7.242082359256962
ischemia,1390,7.237059026124737
change,1390,7.237059026124737
All,1388,7.23561914106675
Objectives,1387,7.234898420314831
recommendations,1386,7.234177179749849
Therefore,1385,7.233455418621439
occur,1383,7.232010331664759
100,1382,7.231287004327616
given,1382,7.231287004327616
experience,1380,7.22983877815125
systems,1379,7.229113877793302
determined,1376,7.226936018493289
strain,1374,7.2254814727822945
protection,1369,7.221835825288449
least,1368,7.221105098182496
diagnosed,1366,7.2196420401307355
depression,1364,7.218176838403408
rapidly,1361,7.215975002651466
specificity,1353,7.210079628170788
recommended,1353,7.210079628170788
must,1353,7.210079628170788
difference,1352,7.20934025660291
direct,1351,7.208600337960199
collected,1350,7.2078598714324755
attack,1350,7.2078598714324755
target,1349,7.207118856207756
essential,1348,7.206377291472252
frequent,1348,7.206377291472252
condition,1347,7.205635176410364
according,1347,7.205635176410364
men,1342,7.201916317531627
trial,1339,7.199678345691172
analyzed,1339,7.199678345691172
workers,1335,7.19668657083435
14,1334,7.195937226475569
defined,1334,7.195937226475569
single,1332,7.194436851100335
0001,1329,7.192182058713246
involved,1325,7.1891677384203225
part,1324,7.188412736496954
hospitalization,1322,7.186901020411631
variants,1321,7.186144304522325
acid,1317,7.183111701743281
duration,1316,7.182352111885263
paper,1316,7.182352111885263
index,1315,7.181591944611865
25,1315,7.181591944611865
angioplasty,1313,7.180069874302796
million,1313,7.180069874302796
damage,1312,7.179307969504034
measured,1311,7.1785454837637
Despite,1309,7.1770187659099
vascular,1307,7.175489713624222
decrease,1305,7.173958319756794
where,1305,7.173958319756794
treatments,1302,7.171656822768514
controls,1301,7.170888478512505
survival,1301,7.170888478512505
Introduction,1299,7.1693500166706
shock,1299,7.1693500166706
environmental,1298,7.168579897264035
become,1298,7.168579897264035
now,1297,7.167809184316444
pain,1296,7.16703787691222
frequently,1287,7.160069207596127
exacerbations,1287,7.160069207596127
sample,1284,7.157735484249907
gene,1281,7.155396301896734
estimated,1278,7.15305163493748
dose,1276,7.151485463904735
previously,1276,7.151485463904735
dysfunction,1276,7.151485463904735
inhaled,1273,7.149131598557407
11,1270,7.146772179452637
andor,1266,7.143617602704121
ischaemic,1262,7.140453043101158
CT,1262,7.140453043101158
versus,1260,7.138866999945524
although,1259,7.138073034044347
volume,1259,7.138073034044347
Of,1258,7.1372784372603855
inferior,1257,7.136483208590247
do,1257,7.136483208590247
suggested,1255,7.134890851565884
particular,1255,7.134890851565884
hypertension,1253,7.133295954896068
adverse,1247,7.1284959456800365
Thus,1244,7.126087273299125
setting,1238,7.121252453244542
surgery,1235,7.118826249062078
H5N1,1235,7.118826249062078
published,1232,7.116394144093465
proteins,1228,7.113142108707088
best,1225,7.110696122978827
types,1224,7.1098794630722715
wave,1224,7.1098794630722715
ability,1223,7.109062135687172
suggests,1222,7.108244139731541
techniques,1221,7.107425474110705
correlation,1220,7.106606137727303
overall,1218,7.1049654482698426
family,1217,7.104144092987527
controlled,1217,7.104144092987527
disorders,1213,7.10085190894405
recently,1212,7.10002716662926
therefore,1211,7.099201743553092
stress,1209,7.097548850614793
additional,1205,7.094234845924755
induced,1200,7.090076835776092
past,1198,7.088408778675395
Acute,1196,7.086737934510577
reports,1194,7.085064293952548
identification,1192,7.083387847625295
screening,1192,7.083387847625295
provided,1191,7.0825485693553
subsequent,1191,7.0825485693553
potentially,1190,7.081708586105575
obstruction,1190,7.081708586105575
prior,1189,7.080867896690782
airways,1188,7.080026499922591
remain,1188,7.080026499922591
challenges,1188,7.080026499922591
administration,1188,7.080026499922591
school,1183,7.075808863978387
fraction,1180,7.07326971745971
unit,1177,7.0707241072602764
After,1176,7.069874128458572
40,1174,7.068172000388042
hospitalized,1174,7.068172000388042
good,1173,7.067319848653476
cohort,1170,7.064759027791802
patterns,1169,7.063903961472068
neurological,1169,7.063903961472068
8,1167,7.062191632286556
medication,1165,7.060476365999801
mechanism,1164,7.059617628291383
epidemics,1164,7.059617628291383
state,1160,7.05617528410041
receptor,1160,7.05617528410041
seen,1160,7.05617528410041
so,1159,7.055312843339752
focus,1158,7.05444965813294
optimal,1158,7.05444965813294
animal,1156,7.052721049232323
OR,1153,7.050122520269059
basis,1152,7.049254841255837
interval,1152,7.049254841255837
angiography,1152,7.049254841255837
extent,1149,7.046647277848756
lack,1149,7.046647277848756
adult,1148,7.045776576879511
education,1148,7.045776576879511
costs,1147,7.044905117129371
spike,1146,7.044032897274685
five,1143,7.04141166379481
percutaneous,1140,7.038783541388542
characterized,1139,7.037905963447182
daily,1137,7.036148493750536
necessary,1134,7.033506484287697
whereas,1133,7.0326242610280065
13,1132,7.0317412587631285
local,1132,7.0317412587631285
lesions,1125,7.025538314638521
plasma,1124,7.024649030453636
protective,1124,7.024649030453636
yet,1124,7.024649030453636
capacity,1122,7.022868086082641
program,1122,7.022868086082641
authors,1122,7.022868086082641
symptomatic,1118,7.0192966537150445
reviewed,1118,7.0192966537150445
examine,1114,7.01571242048723
unknown,1113,7.014814351275545
16,1113,7.014814351275545
indicate,1111,7.01301578963963
proportion,1111,7.01301578963963
last,1110,7.01211529430638
suspected,1109,7.011213987350367
relative,1108,7.010311867307229
flu,1108,7.010311867307229
inhibitors,1107,7.009408932708637
leads,1107,7.009408932708637
oral,1107,7.009408932708637
expression,1106,7.00850518208228
AF,1106,7.00850518208228
persistent,1106,7.00850518208228
myocardium,1105,7.007600613951853
occupational,1104,7.00669522683704
despite,1104,7.00669522683704
smoking,1103,7.005789019253503
efforts,1102,7.004881989712859
regions,1102,7.004881989712859
genes,1101,7.00397413672268
randomized,1100,7.003065458786462
US,1099,7.002155954403621
Among,1095,6.9985096422506015
hospitals,1094,6.9975959829819265
18,1093,6.996681488176539
combination,1092,6.9957661563048505
then,1091,6.994849985833071
rare,1090,6.993932975223189
physicians,1090,6.993932975223189
independent,1089,6.9930151229329605
experimental,1087,6.99117688712121
reducing,1086,6.990256500493881
pediatric,1084,6.988413181999592
national,1083,6.9874902470009905
Coronavirus,1083,6.9874902470009905
asthmatics,1082,6.9865664594064265
proposed,1082,6.9865664594064265
carotid,1082,6.9865664594064265
serious,1080,6.984716320118266
later,1080,6.984716320118266
contribute,1079,6.983789965258135
resulting,1078,6.982862751468942
participants,1076,6.98100574072173
National,1076,6.98100574072173
compare,1075,6.980075940561763
IgG,1073,6.9782137426306985
play,1072,6.977281341630747
died,1071,6.976348070447749
isolated,1069,6.974478911025045
diabetes,1068,6.97354301952014
PCR,1068,6.97354301952014
001,1067,6.9726062513017535
specimens,1065,6.970730078143525
60,1065,6.970730078143525
successful,1063,6.968850378341948
contact,1062,6.967909201801884
air,1062,6.967909201801884
understand,1062,6.967909201801884
thus,1060,6.966024187106113
detect,1060,6.966024187106113
chain,1060,6.966024187106113
December,1059,6.9650803456014065
benefits,1058,6.964135612418245
occurrence,1057,6.963189985870238
005,1056,6.962243464266207
ejection,1056,6.962243464266207
emerging,1055,6.961296045910167
At,1053,6.959398512133975
estimate,1049,6.955592608396297
Since,1046,6.952728644624869
Severe,1045,6.951772164398911
signs,1045,6.951772164398911
prognostic,1044,6.950814768442584
STEMI,1041,6.947937068614969
event,1041,6.947937068614969
pattern,1038,6.945051063725834
With,1036,6.943122422819428
mechanical,1035,6.942156705699469
highest,1035,6.942156705699469
region,1034,6.9411900550683745
variables,1031,6.93828448401696
little,1027,6.934397209928558
baseline,1026,6.933423025730715
responsible,1026,6.933423025730715
h,1024,6.931471805599453
corticosteroids,1022,6.92951677076365
perfusion,1021,6.928537818164665
One,1019,6.926577033222725
ongoing,1019,6.926577033222725
discharge,1018,6.925595197110468
vaccinated,1014,6.921658184151129
training,1012,6.919683849847411
distribution,1011,6.918695219020472
I,1010,6.917705609835305
average,1006,6.913737350659685
moderate,1004,6.911747300251674
times,1003,6.910750787961936
While,1002,6.90975328164481
disability,1002,6.90975328164481
difficult,1001,6.90875477931522
mainly,999,6.906754778648554
arterial,994,6.901737206656574
relevant,993,6.900730664045173
T,993,6.900730664045173
underwent,991,6.898714534329988
combined,990,6.897704943128636
Purpose,989,6.8966943316227125
indicated,989,6.8966943316227125
presentation,988,6.895682697747868
production,986,6.893656354602635
problem,985,6.892641641172089
contrast,984,6.891625897052253
via,982,6.889591308354466
binding,982,6.889591308354466
affect,979,6.88653164253051
selected,978,6.885509670034818
end,977,6.884486652042782
degree,975,6.882437470997847
aspects,974,6.881411303642535
survey,974,6.881411303642535
having,973,6.880384082186005
pandemics,973,6.880384082186005
Furthermore,972,6.879355804460439
old,971,6.878326468291325
9,971,6.878326468291325
tract,967,6.874198495453294
terms,965,6.872128101338986
correlated,964,6.871091294610546
On,964,6.871091294610546
attention,963,6.870053411798126
economic,963,6.870053411798126
medications,961,6.8679744089702925
six,959,6.8658910748834385
investigation,957,6.863803391452954
cost,955,6.86171134048073
analyses,954,6.860663671448287
relation,953,6.859614903654202
regional,952,6.858565034791365
measure,951,6.85751406254539
systemic,950,6.856461984594587
absence,949,6.855408798609928
predictive,948,6.854354502255021
design,948,6.854354502255021
cardiogenic,945,6.851184927493743
17,945,6.851184927493743
percent,945,6.851184927493743
tool,944,6.8501261661455
emergence,943,6.849066282633458
segment,942,6.848005274576363
unclear,941,6.846943139585379
alternative,941,6.846943139585379
fatal,941,6.846943139585379
clinically,939,6.844815479208263
does,935,6.840546529288687
active,935,6.840546529288687
conclusion,933,6.838405200847344
circulation,932,6.837332814685591
confidence,931,6.836259277277067
cognitive,930,6.835184586147301
cellular,929,6.834108738813838
applied,926,6.8308742346461795
No,924,6.828712071641684
usually,922,6.826545223556594
resulted,922,6.826545223556594
evolution,922,6.826545223556594
vessel,919,6.823286122355687
stenosis,918,6.822197390620491
presenting,918,6.822197390620491
approximately,917,6.821107472256465
intensive,917,6.821107472256465
pathophysiology,916,6.82001636467413
intravenous,912,6.815639990074331
65,911,6.814542897259958
around,910,6.813444599510896
predict,910,6.813444599510896
antigen,908,6.811244378601294
relatively,907,6.810142450115136
concern,905,6.807934943699926
epidemiology,905,6.807934943699926
much,904,6.806829360392176
regression,903,6.805722553416985
majority,903,6.805722553416985
muscle,902,6.804614520062624
Most,901,6.803505257608338
19,899,6.80128303447162
activation,898,6.8001700683022
pregnancy,896,6.79794041297493
long,896,6.79794041297493
increases,895,6.796823718274855
survivors,894,6.795705775173514
Group,892,6.79346613258001
natural,892,6.79346613258001
led,889,6.790097235513905
sensitive,884,6.784457062637643
cough,884,6.784457062637643
resistance,884,6.784457062637643
complete,883,6.78332520060396
attacks,882,6.782192056006791
mutations,882,6.782192056006791
remodeling,881,6.78105762593618
angina,880,6.779921907472252
manifestations,879,6.778784897685177
home,878,6.777646593635117
require,876,6.775366090936392
fever,874,6.773080375655535
commonly,873,6.771935555839602
problems,873,6.771935555839602
median,872,6.77078942390898
activities,872,6.77078942390898
II,872,6.77078942390898
widely,872,6.77078942390898
reverse,871,6.769641976852503
March,871,6.769641976852503
explore,867,6.7650389767805414
subtypes,866,6.763884908562435
enzyme,866,6.763884908562435
processes,865,6.762729506931879
requires,864,6.761572768804055
examination,861,6.7580945044277305
cancer,860,6.756932389247553
ST-segment,859,6.755768921984255
substantial,859,6.755768921984255
accurate,858,6.754604099487962
COPD,858,6.754604099487962
routine,857,6.75343791859778
issues,855,6.75110146893676
Moreover,855,6.75110146893676
treat,854,6.74993119378857
polymerase,854,6.74993119378857
implications,852,6.747586526829315
circulating,851,6.7464121285733745
mass,849,6.744059186311348
safe,848,6.742880635791903
lesion,846,6.740519359606223
demonstrate,846,6.740519359606223
S,846,6.740519359606223
aims,845,6.739336627357174
whom,845,6.739336627357174
means,844,6.738152494595957
high-risk,843,6.736966958001855
stage,842,6.7357800142423265
settings,842,6.7357800142423265
systematic,842,6.7357800142423265
dynamics,842,6.7357800142423265
New,841,6.734591659972948
Recent,841,6.734591659972948
comparison,841,6.734591659972948
animals,840,6.733401891837359
surgical,839,6.732210706467206
prospective,839,6.732210706467206
week,837,6.729824070489475
action,836,6.728628613084702
context,829,6.720220155135295
preventive,827,6.717804695023691
PCI,826,6.716594773520978
needs,826,6.716594773520978
body,821,6.710523109452428
delay,820,6.709304340258298
arteries,820,6.709304340258298
advances,819,6.70808408385307
Several,818,6.706862336602747
targets,818,6.706862336602747
occurs,818,6.706862336602747
younger,818,6.706862336602747
carried,817,6.705639094860003
promising,817,6.705639094860003
questionnaire,815,6.703188113240863
application,815,6.703188113240863
impairment,814,6.70196036600254
pregnant,814,6.70196036600254
80,813,6.70073110954781
male,813,6.70073110954781
Clinical,813,6.70073110954781
technique,813,6.70073110954781
22,812,6.699500340161678
comprehensive,812,6.699500340161678
clear,810,6.697034247666484
central,808,6.694562058521095
transient,807,6.693323668269949
MRI,806,6.692083742506628
ie,805,6.690842277418564
tools,805,6.690842277418564
preventing,802,6.687108607866515
international,801,6.68586094706836
procedures,800,6.684611727667927
pathways,798,6.682108597449809
achieved,798,6.682108597449809
emerged,798,6.682108597449809
posterior,796,6.679599185844383
loss,796,6.679599185844383
site,795,6.678342114654332
mice,795,6.678342114654332
antigenic,795,6.678342114654332
consecutive,795,6.678342114654332
scores,795,6.678342114654332
what,794,6.677083461247136
threat,793,6.675823221634848
21,792,6.674561391814426
magnetic,791,6.673297967767654
point,791,6.673297967767654
risks,789,6.670766320845874
existing,789,6.670766320845874
certain,789,6.670766320845874
sex,789,6.670766320845874
replication,788,6.669498089857879
FEV1,786,6.666956792429207
predictors,785,6.665683717782408
administered,784,6.664409020350408
alone,784,6.664409020350408
recorded,784,6.664409020350408
third,783,6.663132695990803
designed,783,6.663132695990803
programs,782,6.661854740545311
taken,781,6.660575149839686
access,781,6.660575149839686
make,779,6.658011045870748
oxygen,779,6.658011045870748
causing,779,6.658011045870748
revascularization,779,6.658011045870748
April,778,6.656726524178391
experienced,777,6.655440350367647
70,777,6.655440350367647
implementation,777,6.655440350367647
form,775,6.652863029353347
AH1N1,775,6.652863029353347
elevated,775,6.652863029353347
tomography,774,6.651571873589727
upper,774,6.651571873589727
genome,773,6.650279048587422
World,773,6.650279048587422
beneficial,771,6.647688373563329
appears,770,6.646390514847729
They,770,6.646390514847729
28,769,6.645090969505644
receiving,769,6.645090969505644
doses,768,6.643789733147672
variation,767,6.642486801367256
questions,767,6.642486801367256
Myocardial,767,6.642486801367256
network,766,6.641182169740591
echocardiography,765,6.639875833826536
Data,765,6.639875833826536
agent,763,6.637258031284457
45,763,6.637258031284457
date,763,6.637258031284457
suggesting,762,6.635946555686647
swabs,761,6.634633357861686
series,761,6.634633357861686
48,759,6.63200177739563
conventional,758,6.630683385642372
infarcts,758,6.630683385642372
services,757,6.6293632534374485
January,757,6.6293632534374485
delivery,757,6.6293632534374485
variant,756,6.628041376179533
90,755,6.626717749249025
subtype,754,6.625392368007956
nasopharyngeal,753,6.6240652277998935
interactions,752,6.62273632394984
complication,752,6.62273632394984
ventilation,751,6.621405651764134
isolation,750,6.620073206530356
Results,750,6.620073206530356
immunization,750,6.620073206530356
strong,749,6.618738983517219
WHO,749,6.618738983517219
accuracy,748,6.617402977974478
cerebrovascular,748,6.617402977974478
crucial,747,6.616065185132817
23,746,6.61472560020376
estimates,744,6.612041034833092
resonance,744,6.612041034833092
motion,744,6.612041034833092
scientific,744,6.612041034833092
expected,742,6.60934924316738
way,741,6.608000625296087
Two,741,6.608000625296087
consequences,741,6.608000625296087
account,740,6.606650186198215
medicine,738,6.6039438246004725
European,738,6.6039438246004725
department,738,6.6039438246004725
exacerbation,738,6.6039438246004725
ACE2,737,6.602587892189336
swine,737,6.602587892189336
complicated,735,6.5998704992128365
expiratory,734,6.598509028614515
recognized,734,6.598509028614515
pathogenic,732,6.595780513961311
receive,731,6.594413459749778
progression,729,6.591673732008658
involvement,728,6.590301048196686
hypothesis,728,6.590301048196686
interaction,728,6.590301048196686
field,726,6.587550014824796
psychological,725,6.586171654854675
H3N2,724,6.584791392385716
measurements,721,6.580639137284949
Using,721,6.580639137284949
predicted,721,6.580639137284949
abnormalities,720,6.579251212010101
eg,719,6.577861357721047
real-time,719,6.577861357721047
Respiratory,719,6.577861357721047
thrombosis,718,6.576469569048224
like,717,6.57507584059962
significance,716,6.573680166960646
When,716,6.573680166960646
biomarkers,715,6.5722825426940075
child,710,6.565264970035361
markers,710,6.565264970035361
great,705,6.558197802812269
documented,704,6.556778356158042
hemorrhagic,702,6.553933404025811
resources,702,6.553933404025811
generally,701,6.55250788703459
selection,700,6.551080335043404
motor,698,6.548219102762372
LV,698,6.548219102762372
options,697,6.546785410760524
short,697,6.546785410760524
obstructive,697,6.546785410760524
variability,696,6.54534966033442
26,695,6.543911845564792
structure,693,6.541029999189903
describes,692,6.539585955617669
uptake,692,6.539585955617669
unique,692,6.539585955617669
biological,692,6.539585955617669
able,692,6.539585955617669
wheezing,690,6.536691597591305
country,688,6.5337888379333435
female,687,6.532334292222349
staff,687,6.532334292222349
sought,686,6.530877627725885
visits,686,6.530877627725885
Many,686,6.530877627725885
oseltamivir,682,6.525029657843462
every,682,6.525029657843462
episodes,682,6.525029657843462
directly,681,6.523562306149512
throughout,681,6.523562306149512
recognition,681,6.523562306149512
rather,680,6.522092798170152
necrosis,679,6.520621127558696
surface,678,6.519147287940395
simple,678,6.519147287940395
implemented,677,6.517671272912275
address,677,6.517671272912275
extensive,677,6.517671272912275
75,677,6.517671272912275
sudden,677,6.517671272912275
reliable,676,6.516193076042964
Both,675,6.51471269087253
source,674,6.513230110912307
improving,673,6.511745329644728
far,672,6.51025834052315
Further,672,6.51025834052315
swab,672,6.51025834052315
environment,670,6.507277712385012
bypass,669,6.505784060128229
structural,669,6.505784060128229
35,668,6.504288173536645
odds,668,6.504288173536645
procedure,667,6.502790045915623
interest,666,6.501289670540389
ILI,666,6.501289670540389
limitations,665,6.499787040655854
infarctions,665,6.499787040655854
in-hospital,662,6.495265555937008
close,661,6.493753839851686
electrocardiographic,660,6.492239835020471
policy,659,6.490723534502507
27,658,6.489204931325317
31,657,6.48768401848461
annual,657,6.48768401848461
side,656,6.486160788944089
classification,656,6.486160788944089
1918,656,6.486160788944089
set,656,6.486160788944089
By,656,6.486160788944089
quantitative,655,6.484635235635252
focused,655,6.484635235635252
disorder,655,6.484635235635252
seems,655,6.484635235635252
phenotypes,654,6.483107351457199
variable,654,6.483107351457199
percentage,653,6.481577129276431
min,653,6.481577129276431
coverage,653,6.481577129276431
identifying,652,6.480044561926653
influenza-like,652,6.480044561926653
hyperresponsiveness,652,6.480044561926653
shows,651,6.478509642208569
represent,649,6.47543271670409
month,648,6.473890696352274
etiology,648,6.473890696352274
possibility,648,6.473890696352274
consistent,647,6.472346294500901
placebo,647,6.472346294500901
limit,646,6.470799503782602
basic,645,6.4692503167957724
coronaviruses,644,6.467698726104354
together,643,6.466144724237619
considerable,643,6.466144724237619
waves,643,6.466144724237619
Organization,643,6.466144724237619
location,643,6.466144724237619
providing,642,6.464588303689961
allow,642,6.464588303689961
progress,641,6.46302945692067
treating,641,6.46302945692067
goal,640,6.461468176353717
Finally,639,6.459904454377535
man,639,6.459904454377535
±,639,6.459904454377535
recurrence,638,6.45833828334479
conclude,638,6.45833828334479
Early,637,6.456769655572163
reviews,636,6.455198563340122
computed,631,6.447305862541213
components,631,6.447305862541213
stable,630,6.4457198193855785
scale,628,6.4425401664681985
Hospital,628,6.4425401664681985
fully,628,6.4425401664681985
origin,627,6.440946540632921
Disease,626,6.439350371100098
measurement,626,6.439350371100098
Because,626,6.439350371100098
produced,623,6.434546518787453
ventricle,623,6.434546518787453
reactions,622,6.432940092739179
arrhythmias,621,6.431331081933479
reference,619,6.428105272684596
decision,619,6.428105272684596
targeted,618,6.42648845745769
allergen,618,6.42648845745769
along,618,6.42648845745769
poorly,616,6.423246963533519
units,616,6.423246963533519
concerns,616,6.423246963533519
availability,616,6.423246963533519
abnormal,613,6.418364935936212
American,613,6.418364935936212
understood,613,6.418364935936212
adherence,613,6.418364935936212
others,612,6.416732282512326
growth,612,6.416732282512326
find,611,6.415096959171596
presents,611,6.415096959171596
occurring,610,6.413458957167357
adequate,609,6.411818267709897
urgent,609,6.411818267709897
hand,609,6.411818267709897
upon,608,6.410174881966167
29,608,6.410174881966167
timely,607,6.408528791059498
immediate,607,6.408528791059498
seasons,606,6.406879986069314
includes,606,6.406879986069314
living,606,6.406879986069314
variety,603,6.401917196727186
larger,603,6.401917196727186
nature,602,6.400257445308821
concentration,601,6.398594934535208
reasons,601,6.398594934535208
remained,601,6.398594934535208
parents,600,6.396929655216146
hemorrhage,600,6.396929655216146
bacterial,600,6.396929655216146
C,599,6.395261598115449
situation,598,6.393590753950631
successfully,598,6.393590753950631
susceptibility,597,6.391917113392602
probably,597,6.391917113392602
appear,597,6.391917113392602
nucleic,597,6.391917113392602
involving,596,6.39024066706535
neutralizing,596,6.39024066706535
minutes,596,6.39024066706535
working,596,6.39024066706535
half,596,6.39024066706535
approved,595,6.38856140554563
making,595,6.38856140554563
From,594,6.386879319362645
stem,593,6.385194398997726
decades,593,6.385194398997726
serological,593,6.385194398997726
physician,592,6.3835066348840055
allergy,591,6.3818160174060985
longer,591,6.3818160174060985
efficient,591,6.3818160174060985
sites,591,6.3818160174060985
term,590,6.380122536899765
whole,589,6.3784261836515865
analyze,589,6.3784261836515865
nasal,588,6.376726947898627
mRNA,588,6.376726947898627
post-stroke,587,6.375024819828097
differ,587,6.375024819828097
sequences,587,6.375024819828097
continue,587,6.375024819828097
release,586,6.373319789577012
numbers,585,6.371611847231857
toward,585,6.371611847231857
search,584,6.369900982828227
retrospective,584,6.369900982828227
widespread,584,6.369900982828227
block,583,6.368187186350492
already,583,6.368187186350492
hospitalizations,582,6.366470447731438
highlight,582,6.366470447731438
prophylaxis,581,6.364750756851911
saliva,581,6.364750756851911
take,580,6.363028103540465
another,580,6.363028103540465
preparedness,578,6.359573868672378
seven,578,6.359573868672378
largely,577,6.3578422665081
concerning,577,6.3578422665081
nursing,577,6.3578422665081
systolic,577,6.3578422665081
load,576,6.3561076606958915
allergens,575,6.354370040797351
prediction,575,6.354370040797351
almost,575,6.354370040797351
thrombectomy,575,6.354370040797351
inhalation,574,6.352629396319567
May,574,6.352629396319567
electrocardiogram,574,6.352629396319567
N,574,6.352629396319567
investigations,574,6.352629396319567
towards,573,6.35088571671474
establish,572,6.349138991379798
clinicians,572,6.349138991379798
atopic,571,6.3473892096560105
plan,571,6.3473892096560105
Wuhan,570,6.345636360828596
poultry,570,6.345636360828596
Based,568,6.342121418721152
until,567,6.340359303727752
undergoing,567,6.340359303727752
facilities,567,6.340359303727752
represents,567,6.340359303727752
hemodynamic,567,6.340359303727752
affects,566,6.338594078203183
points,566,6.338594078203183
anxiety,566,6.338594078203183
statistically,565,6.336825731146441
assessing,565,6.336825731146441
species,565,6.336825731146441
Q,564,6.335054251498059
delayed,564,6.335054251498059
modified,562,6.331501849893691
associations,560,6.327936783729195
achieve,560,6.327936783729195
Study,559,6.326149473155099
entry,559,6.326149473155099
overview,559,6.326149473155099
students,559,6.326149473155099
rats,557,6.322565239927284
strongly,557,6.322565239927284
behavior,557,6.322565239927284
distress,556,6.320768294250582
targeting,555,6.318968113746434
wide,555,6.318968113746434
planning,555,6.318968113746434
rupture,555,6.318968113746434
thrombus,555,6.318968113746434
aspirin,553,6.315358001522335
pathogens,553,6.315358001522335
trends,553,6.315358001522335
members,553,6.315358001522335
prolonged,553,6.315358001522335
earlier,551,6.311734809152915
mm,551,6.311734809152915
36,550,6.309918278226516
increasingly,550,6.309918278226516
professionals,550,6.309918278226516
profile,549,6.3080984415095305
distinct,549,6.3080984415095305
periods,548,6.306275286948016
residents,548,6.306275286948016
cannot,546,6.302618975744905
affecting,546,6.302618975744905
r,545,6.300785794663244
gender,545,6.300785794663244
guide,544,6.298949246855942
Japan,544,6.298949246855942
enhanced,543,6.297109319933935
practices,542,6.295266001439646
Some,542,6.295266001439646
contacts,542,6.295266001439646
traditional,541,6.293419278846481
classified,541,6.293419278846481
exposed,541,6.293419278846481
properties,541,6.293419278846481
rise,541,6.293419278846481
collection,540,6.29156913955832
sequence,539,6.289715570908998
timing,539,6.289715570908998
segments,537,6.285998094508865
Overall,536,6.284134161070802
personal,535,6.282266746896006
anticoagulation,535,6.282266746896006
pathology,534,6.280395838960195
SARS-CoV,533,6.278521424165844
above,533,6.278521424165844
comorbidities,533,6.278521424165844
summarize,532,6.2766434893416445
awareness,532,6.2766434893416445
component,531,6.274762021241939
Europe,530,6.272877006546167
plans,530,6.272877006546167
concentrations,529,6.270988431858299
primarily,529,6.270988431858299
centers,528,6.269096283706261
adolescents,528,6.269096283706261
communication,527,6.267200548541362
eight,527,6.267200548541362
his,527,6.267200548541362
consider,527,6.267200548541362
candidates,526,6.26530121273771
airflow,526,6.26530121273771
June,526,6.26530121273771
definition,525,6.263398262591624
calculated,525,6.263398262591624
If,525,6.263398262591624
peripheral,525,6.263398262591624
finding,524,6.261491684321042
proven,524,6.261491684321042
derived,524,6.261491684321042
skin,524,6.261491684321042
PTCA,524,6.261491684321042
Control,523,6.259581464064923
cent,523,6.259581464064923
impaired,521,6.255750041753367
free,521,6.255750041753367
devices,521,6.255750041753367
protocol,520,6.253828811575473
functions,520,6.253828811575473
cytokines,519,6.251903883165888
SARS,518,6.249975242259483
domain,518,6.249975242259483
worse,518,6.249975242259483
admissions,517,6.248042874508429
anti-inflammatory,517,6.248042874508429
Coronary,517,6.248042874508429
pharmacological,517,6.248042874508429
effectively,517,6.248042874508429
globally,516,6.246106765481563
ill,516,6.246106765481563
More,516,6.246106765481563
comparable,516,6.246106765481563
issue,515,6.244166900663736
cytokine,515,6.244166900663736
vitro,514,6.2422232654551655
view,514,6.2422232654551655
32,513,6.240275845170769
facilitate,512,6.238324625039508
descending,512,6.238324625039508
noted,512,6.238324625039508
neuraminidase,512,6.238324625039508
detecting,512,6.238324625039508
class,512,6.238324625039508
stages,512,6.238324625039508
inhibition,511,6.236369590203704
33,510,6.234410725718371
formation,509,6.2324480165505225
membrane,508,6.230481447578482
forms,508,6.230481447578482
fact,507,6.2285110035911835
compounds,507,6.2285110035911835
whose,506,6.226536669287466
Treatment,506,6.226536669287466
temperature,505,6.22455842927536
typical,505,6.22455842927536
rhinitis,504,6.222576268071369
transmural,504,6.222576268071369
indicates,503,6.220590170099739
suffering,503,6.220590170099739
place,503,6.220590170099739
mutation,502,6.218600119691729
induce,502,6.218600119691729
inactivated,501,6.2166061010848646
detailed,500,6.214608098422191
technology,500,6.214608098422191
reduces,499,6.212606095751519
explored,499,6.212606095751519
explain,498,6.210600077024653
linked,498,6.210600077024653
adjusted,498,6.210600077024653
convalescent,498,6.210600077024653
reporting,497,6.208590026096629
laboratories,496,6.206575926724928
divided,496,6.206575926724928
2019-nCoV,496,6.206575926724928
Scale,495,6.20455776256869
discusses,494,6.202535517187923
Prevention,494,6.202535517187923
sources,493,6.20050917404269
completed,492,6.198478716492308
define,491,6.19644412779452
offer,491,6.19644412779452
validated,490,6.194405391104672
success,490,6.194405391104672
beginning,489,6.192362489474872
infarcted,488,6.1903154058531475
live,487,6.18826412308259
pathway,487,6.18826412308259
nurses,487,6.18826412308259
H7N9,487,6.18826412308259
South,487,6.18826412308259
2010,487,6.18826412308259
sleep,486,6.186208623900494
innate,486,6.186208623900494
communities,486,6.186208623900494
UK,485,6.184148890937483
winter,484,6.182084906716632
us,484,6.182084906716632
thoracic,484,6.182084906716632
prevalent,483,6.180016653652572
decisions,482,6.1779441140506
Current,481,6.175867270105761
families,481,6.175867270105761
variations,480,6.173786103901937
Chinese,480,6.173786103901937
infarct-related,479,6.171700597410915
evaluating,479,6.171700597410915
next,479,6.171700597410915
done,478,6.169610732491456
predicting,478,6.169610732491456
special,478,6.169610732491456
propose,478,6.169610732491456
specifically,478,6.169610732491456
Studies,477,6.1675164908883415
endovascular,476,6.16541785423142
receptors,476,6.16541785423142
38,476,6.16541785423142
introduction,475,6.163314804034641
decline,475,6.163314804034641
growing,475,6.163314804034641
continuous,474,6.161207321695077
regard,474,6.161207321695077
exist,473,6.159095388491933
marked,472,6.156978985585555
34,472,6.156978985585555
February,472,6.156978985585555
maximum,471,6.154858094016418
susceptible,471,6.154858094016418
Only,471,6.154858094016418
providers,470,6.152732694704104
Three,470,6.152732694704104
sputum,470,6.152732694704104
records,470,6.152732694704104
suitable,469,6.150602768446279
respect,469,6.150602768446279
pathological,468,6.148468295917647
continues,468,6.148468295917647
supply,467,6.1463292576688975
infants,467,6.1463292576688975
37,466,6.144185634125646
55,466,6.144185634125646
ED,466,6.144185634125646
regular,465,6.142037405587356
challenging,465,6.142037405587356
highlights,464,6.139884552226255
middle,464,6.139884552226255
residual,464,6.139884552226255
controlling,464,6.139884552226255
threshold,464,6.139884552226255
advanced,464,6.139884552226255
continued,464,6.139884552226255
statistical,464,6.139884552226255
appeared,463,6.137727054086234
allows,463,6.137727054086234
final,462,6.135564891081739
meta-analysis,462,6.135564891081739
media,461,6.133398042996649
recanalization,461,6.133398042996649
compliance,461,6.133398042996649
plays,460,6.131226489483141
equal,460,6.131226489483141
sufficient,460,6.131226489483141
started,459,6.129050210060545
insights,458,6.126869184114185
suffered,458,6.126869184114185
deficits,458,6.126869184114185
choice,458,6.126869184114185
42,458,6.126869184114185
concluded,458,6.126869184114185
immunological,457,6.124683390894205
differential,457,6.124683390894205
predictor,456,6.1224928095143865
indicating,456,6.1224928095143865
taking,456,6.1224928095143865
transcription,456,6.1224928095143865
sustained,455,6.12029741895095
IgE,454,6.118097198041348
requiring,454,6.118097198041348
Currently,454,6.118097198041348
isolates,453,6.115892125483034
beta,453,6.115892125483034
summarizes,453,6.115892125483034
agreement,452,6.113682179832232
vessels,452,6.113682179832232
personnel,451,6.111467339502679
D,450,6.1092475827643655
enhance,450,6.1092475827643655
enrolled,450,6.1092475827643655
device,449,6.1070228877422545
AH1N1pdm09,449,6.1070228877422545
objectives,448,6.104793232414985
cycle,448,6.104793232414985
III,448,6.104793232414985
ensure,447,6.102558594613569
mg,447,6.102558594613569
RBD,447,6.102558594613569
technologies,446,6.100318952020064
heterogeneous,446,6.100318952020064
characterize,446,6.100318952020064
atherosclerosis,446,6.100318952020064
antigens,446,6.100318952020064
produce,446,6.100318952020064
2021,444,6.095824562432225
discharged,444,6.095824562432225
HA,444,6.095824562432225
post,443,6.093569770045136
males,443,6.093569770045136
mediators,442,6.091309882077698
intensity,442,6.091309882077698
immediately,441,6.089044875446846
determining,441,6.089044875446846
41,440,6.0867747269123065
perform,439,6.0844994130751715
vulnerable,438,6.082218910376446
responsiveness,438,6.082218910376446
effort,438,6.082218910376446
phenomenon,438,6.082218910376446
concept,438,6.082218910376446
household,438,6.082218910376446
exhaled,437,6.07993319509559
excess,437,6.07993319509559
urban,437,6.07993319509559
candidate,437,6.07993319509559
protocols,437,6.07993319509559
titers,437,6.07993319509559
diagnostics,436,6.077642243349034
sera,436,6.077642243349034
clinic,436,6.077642243349034
angiographic,435,6.075346031088684
epithelial,435,6.075346031088684
woman,435,6.075346031088684
here,435,6.075346031088684
spectrum,435,6.075346031088684
Medical,435,6.075346031088684
QRS,433,6.07073772800249
observational,432,6.068425588244111
roles,432,6.068425588244111
question,432,6.068425588244111
images,431,6.066108090103747
mostly,431,6.066108090103747
showing,431,6.066108090103747
marker,431,6.066108090103747
states,431,6.066108090103747
possibly,431,6.066108090103747
recovered,430,6.063785208687608
framework,430,6.063785208687608
VE,430,6.063785208687608
programme,429,6.061456918928017
mellitus,428,6.059123195581797
repeated,428,6.059123195581797
vivo,428,6.059123195581797
socioeconomic,427,6.056784013228625
illnesses,427,6.056784013228625
initially,427,6.056784013228625
amount,427,6.056784013228625
clearly,427,6.056784013228625
Recently,427,6.056784013228625
controversial,426,6.054439346269371
always,426,6.054439346269371
0,426,6.054439346269371
analysed,426,6.054439346269371
perspective,425,6.052089168924417
generated,425,6.052089168924417
fall,425,6.052089168924417
smooth,424,6.049733455231958
proved,424,6.049733455231958
utility,423,6.0473721790462776
sequencing,423,6.0473721790462776
depends,423,6.0473721790462776
pathogen,423,6.0473721790462776
example,423,6.0473721790462776
July,423,6.0473721790462776
IgM,423,6.0473721790462776
comparing,422,6.045005314036012
39,421,6.042632833682381
Aim,421,6.042632833682381
stay,421,6.042632833682381
TIA,420,6.040254711277414
center,420,6.040254711277414
closure,420,6.040254711277414
outpatient,420,6.040254711277414
stimulation,420,6.040254711277414
logistic,420,6.040254711277414
fatality,420,6.040254711277414
protect,420,6.040254711277414
though,419,6.037870919922137
avoid,419,6.037870919922137
monitor,419,6.037870919922137
laboratory-confirmed,419,6.037870919922137
efficiency,418,6.035481432524756
became,418,6.035481432524756
inform,418,6.035481432524756
AH3N2,417,6.0330862217988015
matter,417,6.0330862217988015
inhibitor,417,6.0330862217988015
43,417,6.0330862217988015
Africa,417,6.0330862217988015
HCWs,417,6.0330862217988015
perception,416,6.030685260261263
newly,416,6.030685260261263
fluid,416,6.030685260261263
syndromes,415,6.028278520230698
exposures,414,6.025865973825314
light,414,6.025865973825314
consumption,414,6.025865973825314
culture,414,6.025865973825314
epidemiologic,414,6.025865973825314
bleeding,414,6.025865973825314
maternal,413,6.023447592961033
dogs,413,6.023447592961033
repair,413,6.023447592961033
ST-elevation,413,6.023447592961033
October,413,6.023447592961033
44,412,6.021023349349527
Children,412,6.021023349349527
practical,412,6.021023349349527
females,411,6.018593214496234
expressed,411,6.018593214496234
lungs,411,6.018593214496234
consideration,411,6.018593214496234
Given,411,6.018593214496234
invasive,411,6.018593214496234
dynamic,410,6.016157159698354
containing,410,6.016157159698354
real,410,6.016157159698354
employed,410,6.016157159698354
spreading,410,6.016157159698354
vital,410,6.016157159698354
recipients,409,6.013715156042802
intracranial,408,6.0112671744041615
cross-sectional,408,6.0112671744041615
72,408,6.0112671744041615
perceived,408,6.0112671744041615
dependent,408,6.0112671744041615
determinants,408,6.0112671744041615
rural,407,6.008813185442595
behavioral,407,6.008813185442595
nine,407,6.008813185442595
consensus,406,6.0063531596017325
internal,406,6.0063531596017325
vitamin,405,6.003887067106539
transplantation,405,6.003887067106539
critically,405,6.003887067106539
numerous,404,6.0014148779611505
sampling,404,6.0014148779611505
therapeutics,404,6.0014148779611505
failed,404,6.0014148779611505
observations,404,6.0014148779611505
closely,403,5.998936561946683
influenced,403,5.998936561946683
networks,402,5.996452088619021
triggers,402,5.996452088619021
250,401,5.993961427306569
promote,401,5.993961427306569
trend,401,5.993961427306569
probability,401,5.993961427306569
thought,400,5.991464547107982
weight,400,5.991464547107982
platelet,400,5.991464547107982
antiplatelet,399,5.988961416889864
room,399,5.988961416889864
confirm,398,5.986452005284438
stenting,398,5.986452005284438
Additionally,398,5.986452005284438
PEF,398,5.986452005284438
white,398,5.986452005284438
reinfarction,398,5.986452005284438
valuable,397,5.983936280687191
heterogeneity,397,5.983936280687191
evidence-based,397,5.983936280687191
phenotype,396,5.981414211254481
recommend,396,5.981414211254481
crisis,396,5.981414211254481
stent,396,5.981414211254481
substantially,396,5.981414211254481
indirect,396,5.981414211254481
breathing,395,5.978885764901122
ICU,395,5.978885764901122
CDC,395,5.978885764901122
called,395,5.978885764901122
introduced,394,5.976350909297934
RT-qPCR,394,5.976350909297934
46,393,5.973809611869261
Australia,393,5.973809611869261
schools,392,5.971261839790462
E,392,5.971261839790462
embolism,392,5.971261839790462
full,391,5.968707559985366
standardized,391,5.968707559985366
Syndrome,391,5.968707559985366
contribution,391,5.968707559985366
depending,390,5.966146739123692
zone,390,5.966146739123692
hemisphere,389,5.963579343618446
remaining,389,5.963579343618446
length,389,5.963579343618446
emotional,389,5.963579343618446
metabolic,389,5.963579343618446
barriers,389,5.963579343618446
addressed,389,5.963579343618446
assist,388,5.961005339623274
perioperative,388,5.961005339623274
demographic,388,5.961005339623274
serial,387,5.958424693029782
Italy,386,5.955837369464831
creatine,386,5.955837369464831
researchers,385,5.953243334287785
oxide,385,5.953243334287785
atherosclerotic,385,5.953243334287785
prehospital,385,5.953243334287785
Such,385,5.953243334287785
reversible,385,5.953243334287785
plaque,384,5.950642552587727
educational,384,5.950642552587727
corticosteroid,384,5.950642552587727
balloon,384,5.950642552587727
BP,383,5.948034989180646
demand,383,5.948034989180646
improvements,383,5.948034989180646
service,382,5.945420608606575
DNA,382,5.945420608606575
cryptogenic,382,5.945420608606575
improves,381,5.942799375126701
beyond,381,5.942799375126701
collateral,381,5.942799375126701
observation,381,5.942799375126701
obesity,380,5.940171252720432
forced,380,5.940171252720432
plasminogen,380,5.940171252720432
manage,380,5.940171252720432
wheeze,380,5.940171252720432
ages,379,5.937536205082426
broad,379,5.937536205082426
relationships,379,5.937536205082426
characteristic,379,5.937536205082426
acceptance,378,5.934894195619588
dyspnea,378,5.934894195619588
reactivity,378,5.934894195619588
initiated,378,5.934894195619588
activator,377,5.932245187448011
amplification,377,5.932245187448011
independently,377,5.932245187448011
kinase,376,5.929589143389895
rest,376,5.929589143389895
count,375,5.926926025970411
steroids,375,5.926926025970411
self-management,375,5.926926025970411
hundred,374,5.924255797414532
advantages,374,5.924255797414532
47,374,5.924255797414532
resolution,374,5.924255797414532
practitioners,374,5.924255797414532
subject,374,5.924255797414532
corresponding,374,5.924255797414532
initiation,373,5.921578419643816
focuses,372,5.918893854273146
dementia,371,5.916202062607435
policies,371,5.916202062607435
temporal,371,5.916202062607435
short-term,371,5.916202062607435
grade,371,5.916202062607435
spontaneous,371,5.916202062607435
venous,369,5.910796644040527
population-based,369,5.910796644040527
kidney,368,5.908082938168931
articles,368,5.908082938168931
serve,368,5.908082938168931
AT,368,5.908082938168931
rarely,368,5.908082938168931
prospectively,368,5.908082938168931
varied,368,5.908082938168931
Other,368,5.908082938168931
evolving,367,5.905361848054571
physiological,367,5.905361848054571
aortic,367,5.905361848054571
transplant,367,5.905361848054571
51,367,5.905361848054571
September,367,5.905361848054571
opportunity,367,5.905361848054571
organ,367,5.905361848054571
neurologic,366,5.902633333401366
renal,366,5.902633333401366
guidance,365,5.8998973535824915
universal,365,5.8998973535824915
referred,365,5.8998973535824915
November,365,5.8998973535824915
Research,365,5.8998973535824915
cavity,365,5.8998973535824915
generation,365,5.8998973535824915
pathophysiological,365,5.8998973535824915
subsequently,365,5.8998973535824915
interpretation,364,5.8971538676367405
potent,364,5.8971538676367405
priority,364,5.8971538676367405
gold,364,5.8971538676367405
raised,364,5.8971538676367405
maximal,364,5.8971538676367405
liver,363,5.8944028342648505
latter,363,5.8944028342648505
antivirals,363,5.8944028342648505
52,362,5.8916442118257715
progressive,362,5.8916442118257715
prophylactic,362,5.8916442118257715
completely,361,5.8888779583328805
altered,360,5.886104031450156
decade,359,5.883322388488279
undertaken,359,5.883322388488279
life-threatening,359,5.883322388488279
experiences,358,5.8805329864007
he,358,5.8805329864007
psychosocial,358,5.8805329864007
century,358,5.8805329864007
R,358,5.8805329864007
ways,358,5.8805329864007
recombinant,358,5.8805329864007
greatest,358,5.8805329864007
seem,358,5.8805329864007
minor,357,5.877735781779639
rhythm,357,5.877735781779639
city,357,5.877735781779639
multivariate,357,5.877735781779639
nocturnal,357,5.877735781779639
signaling,357,5.877735781779639
genomic,357,5.877735781779639
pH1N1,356,5.87493073085203
robust,356,5.87493073085203
below,356,5.87493073085203
structures,356,5.87493073085203
intervals,356,5.87493073085203
Kong,356,5.87493073085203
open,355,5.872117789475416
true,355,5.872117789475416
equipment,355,5.872117789475416
easily,355,5.872117789475416
Covid-19,355,5.872117789475416
enable,355,5.872117789475416
epitopes,354,5.869296913133774
Asia,354,5.869296913133774
embolic,354,5.869296913133774
antagonists,354,5.869296913133774
magnitude,354,5.869296913133774
attitudes,353,5.8664680569332965
step,353,5.8664680569332965
pigs,353,5.8664680569332965
reflect,352,5.863631175598097
Compared,352,5.863631175598097
According,352,5.863631175598097
diagnose,352,5.863631175598097
pollution,351,5.860786223465865
degrees,351,5.860786223465865
face,351,5.860786223465865
proper,351,5.860786223465865
tissues,350,5.857933154483459
unprecedented,350,5.857933154483459
64,350,5.857933154483459
quarantine,350,5.857933154483459
acquired,350,5.857933154483459
TIMI,349,5.855071922202427
immunotherapy,348,5.8522024797744745
Hong,348,5.8522024797744745
Due,348,5.8522024797744745
branch,348,5.8522024797744745
atopy,347,5.849324779946859
database,347,5.849324779946859
Nevertheless,347,5.849324779946859
injection,347,5.849324779946859
transmissibility,346,5.846438775057725
indicators,346,5.846438775057725
emphasis,345,5.84354441703136
methacholine,345,5.84354441703136
Over,345,5.84354441703136
reason,345,5.84354441703136
nitric,345,5.84354441703136
African,345,5.84354441703136
nervous,345,5.84354441703136
uncontrolled,344,5.840641657373398
septal,344,5.840641657373398
highlighted,344,5.840641657373398
excluded,344,5.840641657373398
diverse,344,5.840641657373398
distal,344,5.840641657373398
subgroups,344,5.840641657373398
distancing,344,5.840641657373398
hypothesized,343,5.8377304471659395
vary,343,5.8377304471659395
mental,343,5.8377304471659395
stratification,343,5.8377304471659395
aid,343,5.8377304471659395
Heart,342,5.834810737062605
Infarction,342,5.834810737062605
Vaccination,341,5.831882477283517
trigger,341,5.831882477283517
offers,340,5.8289456176102075
Department,340,5.8289456176102075
respond,340,5.8289456176102075
University,340,5.8289456176102075
exists,340,5.8289456176102075
products,339,5.82600010738045
transport,339,5.82600010738045
none,339,5.82600010738045
alterations,339,5.82600010738045
preclinical,339,5.82600010738045
immunogenicity,338,5.823045895483019
viable,338,5.823045895483019
team,338,5.823045895483019
56,338,5.823045895483019
modalities,338,5.823045895483019
causative,338,5.823045895483019
attenuated,338,5.823045895483019
IAV,338,5.823045895483019
managed,338,5.823045895483019
limitation,338,5.823045895483019
August,337,5.820082930352362
lacking,337,5.820082930352362
hesitancy,337,5.820082930352362
particles,337,5.820082930352362
positivity,336,5.817111159963204
bronchoconstriction,336,5.817111159963204
follow,336,5.817111159963204
lateral,336,5.817111159963204
questionnaires,336,5.817111159963204
superior,336,5.817111159963204
pleural,336,5.817111159963204
platform,336,5.817111159963204
utilization,335,5.814130531825066
learning,335,5.814130531825066
stability,335,5.814130531825066
East,335,5.814130531825066
proximal,334,5.811140992976701
2013,334,5.811140992976701
lives,333,5.808142489980444
aggressive,333,5.808142489980444
changed,332,5.805134968916488
nor,332,5.805134968916488
India,331,5.802118375377063
commercial,331,5.802118375377063
00001,331,5.802118375377063
attributed,330,5.799092654460526
likelihood,330,5.799092654460526
extremely,330,5.799092654460526
occluded,330,5.799092654460526
poststroke,329,5.796057750765372
society,329,5.796057750765372
background,329,5.796057750765372
nearly,329,5.796057750765372
algorithm,329,5.796057750765372
apparent,329,5.796057750765372
dissection,328,5.793013608384144
USA,328,5.793013608384144
adaptive,328,5.793013608384144
accompanied,328,5.793013608384144
diastolic,328,5.793013608384144
longitudinal,327,5.7899601708972535
hosts,326,5.786897381366708
indices,326,5.786897381366708
International,326,5.786897381366708
obtain,326,5.786897381366708
eosinophils,326,5.786897381366708
shedding,326,5.786897381366708
resistant,325,5.783825182329737
Also,325,5.783825182329737
Global,325,5.783825182329737
molecules,325,5.783825182329737
induction,325,5.783825182329737
postoperative,325,5.783825182329737
PFO,325,5.783825182329737
infectivity,325,5.783825182329737
feature,325,5.783825182329737
Rapid,325,5.783825182329737
angiotensin-converting,325,5.783825182329737
unstable,324,5.780743515792329
lineage,324,5.780743515792329
managing,324,5.780743515792329
give,323,5.777652323222656
2003,323,5.777652323222656
start,323,5.777652323222656
explained,323,5.777652323222656
prescribed,323,5.777652323222656
53,323,5.777652323222656
diagnoses,322,5.7745515455444085
quickly,322,5.7745515455444085
goals,322,5.7745515455444085
entire,322,5.7745515455444085
correlate,322,5.7745515455444085
Previous,322,5.7745515455444085
Emergency,322,5.7745515455444085
spatial,322,5.7745515455444085
Institute,321,5.771441123130016
TRUNCATED,321,5.771441123130016
WORDS,321,5.771441123130016
noninvasive,321,5.771441123130016
platforms,320,5.768320995793772
involves,320,5.768320995793772
amino,320,5.768320995793772
directed,320,5.768320995793772
cold,319,5.765191102784844
relevance,319,5.765191102784844
54,319,5.765191102784844
endothelial,319,5.765191102784844
considering,319,5.765191102784844
government,318,5.762051382780177
summary,318,5.762051382780177
lacunar,318,5.762051382780177
reached,318,5.762051382780177
supporting,317,5.75890177387728
transmitted,317,5.75890177387728
sensitization,317,5.75890177387728
fast,316,5.755742213586912
AIS,316,5.755742213586912
neutralization,316,5.755742213586912
person,316,5.755742213586912
smaller,316,5.755742213586912
fatigue,316,5.755742213586912
59,316,5.755742213586912
defect,316,5.755742213586912
patent,315,5.752572638825633
discovery,315,5.752572638825633
subgroup,315,5.752572638825633
congestive,315,5.752572638825633
dust,314,5.749392985908253
warfarin,314,5.749392985908253
severely,314,5.749392985908253
travel,314,5.749392985908253
ELISA,314,5.749392985908253
CK,314,5.749392985908253
breath,314,5.749392985908253
49,314,5.749392985908253
line,314,5.749392985908253
Germany,314,5.749392985908253
Methods,314,5.749392985908253
ranged,313,5.746203190540153
extraction,313,5.746203190540153
minimal,313,5.746203190540153
Cardiac,313,5.746203190540153
hemagglutinin,312,5.7430031878094825
63,312,5.7430031878094825
edema,312,5.7430031878094825
validity,312,5.7430031878094825
Mexico,312,5.7430031878094825
link,312,5.7430031878094825
actions,312,5.7430031878094825
patency,311,5.739792912179234
thereby,311,5.739792912179234
matched,311,5.739792912179234
catheterization,311,5.739792912179234
ranging,311,5.739792912179234
ischaemia,311,5.739792912179234
itself,311,5.739792912179234
helpful,310,5.736572297479192
supported,310,5.736572297479192
capable,310,5.736572297479192
behaviors,310,5.736572297479192
hyperreactivity,310,5.736572297479192
persistence,310,5.736572297479192
her,309,5.733341276897746
integrated,309,5.733341276897746
insight,309,5.733341276897746
false,309,5.733341276897746
signal,308,5.730099782973574
streptokinase,308,5.730099782973574
America,308,5.730099782973574
cardioembolic,308,5.730099782973574
uncertain,308,5.730099782973574
85,308,5.730099782973574
birds,308,5.730099782973574
He,307,5.726847747587197
authorities,307,5.726847747587197
large-scale,306,5.723585101952381
declared,306,5.723585101952381
water,306,5.723585101952381
prompt,306,5.723585101952381
North,305,5.720311776607412
58,305,5.720311776607412
outside,305,5.720311776607412
intracoronary,304,5.717027701406222
maintenance,304,5.717027701406222
mitigate,304,5.717027701406222
ones,304,5.717027701406222
influences,304,5.717027701406222
67,303,5.713732805509369
contain,303,5.713732805509369
fewer,303,5.713732805509369
exercise-induced,303,5.713732805509369
transfer,302,5.71042701737487
window,302,5.71042701737487
typically,302,5.71042701737487
suffer,301,5.707110264748875
ICS,301,5.707110264748875
Understanding,301,5.707110264748875
Canada,301,5.707110264748875
profiles,300,5.703782474656201
registered,300,5.703782474656201
spirometry,300,5.703782474656201
return,300,5.703782474656201
millions,299,5.700443573390687
indications,299,5.700443573390687
inadequate,299,5.700443573390687
demonstrates,299,5.700443573390687
viability,299,5.700443573390687
Aims,299,5.700443573390687
curve,298,5.697093486505405
modern,298,5.697093486505405
coronavirus-2,298,5.697093486505405
IV,297,5.6937321388027
correct,297,5.6937321388027
57,297,5.6937321388027
RR,297,5.6937321388027
shift,297,5.6937321388027
diversity,296,5.69035945432406
Four,296,5.69035945432406
humoral,295,5.68697535633982
biology,295,5.68697535633982
favorable,295,5.68697535633982
steroid,295,5.68697535633982
steps,295,5.68697535633982
IS,295,5.68697535633982
content,295,5.68697535633982
deterioration,295,5.68697535633982
consequence,294,5.683579767338681
soon,294,5.683579767338681
concomitant,294,5.683579767338681
lifestyle,294,5.683579767338681
volumes,294,5.683579767338681
inclusion,293,5.680172609017068
silent,293,5.680172609017068
greatly,293,5.680172609017068
62,293,5.680172609017068
reveal,293,5.680172609017068
updated,293,5.680172609017068
ratios,293,5.680172609017068
Risk,293,5.680172609017068
anticoagulants,293,5.680172609017068
FeNO,293,5.680172609017068
bias,293,5.680172609017068
contributing,293,5.680172609017068
predominantly,293,5.680172609017068
accepted,292,5.676753802268282
difficulties,292,5.676753802268282
et,292,5.676753802268282
departments,292,5.676753802268282
databases,291,5.673323267171493
option,291,5.673323267171493
worsening,291,5.673323267171493
lipid,291,5.673323267171493
NIHSS,290,5.66988092298052
genomes,290,5.66988092298052
contributes,290,5.66988092298052
kits,290,5.66988092298052
SD,290,5.66988092298052
language,289,5.666426688112432
histamine,289,5.666426688112432
devastating,289,5.666426688112432
remote,289,5.666426688112432
applications,289,5.666426688112432
NA,289,5.666426688112432
specimen,289,5.666426688112432
examines,289,5.666426688112432
core,289,5.666426688112432
predominant,288,5.662960480135946
accurately,288,5.662960480135946
focusing,288,5.662960480135946
MERS-CoV,288,5.662960480135946
peptide,288,5.662960480135946
birth,288,5.662960480135946
disparities,288,5.662960480135946
barrier,288,5.662960480135946
food,287,5.659482215759621
decreasing,287,5.659482215759621
thrombotic,287,5.659482215759621
manner,287,5.659482215759621
retrospectively,287,5.659482215759621
absolute,287,5.659482215759621
cluster,286,5.655991810819852
74,286,5.655991810819852
episode,286,5.655991810819852
excellent,286,5.655991810819852
1997,286,5.655991810819852
fibrosis,286,5.655991810819852
monitored,285,5.652489180268651
Following,285,5.652489180268651
allowed,285,5.652489180268651
impacts,285,5.652489180268651
lineages,284,5.648974238161206
mediated,284,5.648974238161206
virulence,284,5.648974238161206
77,284,5.648974238161206
correlates,284,5.648974238161206
bronchodilator,284,5.648974238161206
insufficient,284,5.648974238161206
respondents,284,5.648974238161206
throat,284,5.648974238161206
intracerebral,283,5.645446897643238
own,283,5.645446897643238
resource,282,5.641907070938114
aerosol,282,5.641907070938114
causal,282,5.641907070938114
RV,282,5.641907070938114
200,281,5.638354669333745
minority,281,5.638354669333745
consisted,281,5.638354669333745
bilateral,281,5.638354669333745
Care,281,5.638354669333745
validation,281,5.638354669333745
68,280,5.634789603169249
limits,280,5.634789603169249
precise,280,5.634789603169249
functioning,280,5.634789603169249
discussion,280,5.634789603169249
69,280,5.634789603169249
balance,280,5.634789603169249
uncertainty,280,5.634789603169249
qualitative,279,5.631211781821365
categories,279,5.631211781821365
varying,279,5.631211781821365
reach,279,5.631211781821365
wastewater,279,5.631211781821365
exhibited,279,5.631211781821365
regulation,278,5.627621113690637
reactive,278,5.627621113690637
feasible,278,5.627621113690637
quantify,278,5.627621113690637
ARDS,277,5.6240175061873385
hour,277,5.6240175061873385
blockers,277,5.6240175061873385
ACE,277,5.6240175061873385
twice,277,5.6240175061873385
feasibility,277,5.6240175061873385
vaccinations,277,5.6240175061873385
linear,276,5.62040086571715
metabolism,276,5.62040086571715
Spanish,276,5.62040086571715
eligible,276,5.62040086571715
gaps,276,5.62040086571715
operation,276,5.62040086571715
Society,276,5.62040086571715
regulatory,276,5.62040086571715
71,275,5.616771097666572
near,275,5.616771097666572
characterization,275,5.616771097666572
remodelling,275,5.616771097666572
measuring,274,5.6131281063880705
neural,274,5.6131281063880705
perceptions,274,5.6131281063880705
NO,274,5.6131281063880705
selective,274,5.6131281063880705
opportunities,274,5.6131281063880705
brief,274,5.6131281063880705
speed,273,5.60947179518496
visual,273,5.60947179518496
maintain,273,5.60947179518496
estimation,273,5.60947179518496
monoclonal,273,5.60947179518496
generate,273,5.60947179518496
contributed,273,5.60947179518496
lowest,273,5.60947179518496
CS,272,5.605802066295998
antithrombotic,272,5.605802066295998
decreases,272,5.605802066295998
intermittent,272,5.605802066295998
aneurysm,272,5.605802066295998
phases,271,5.602118820879701
inpatient,271,5.602118820879701
cholesterol,271,5.602118820879701
protease,271,5.602118820879701
sometimes,271,5.602118820879701
considerations,271,5.602118820879701
France,271,5.602118820879701
uncomplicated,271,5.602118820879701
actual,271,5.602118820879701
scan,271,5.602118820879701
disturbances,271,5.602118820879701
too,270,5.598421958998375
heparin,270,5.598421958998375
mathematical,270,5.598421958998375
cumulative,270,5.598421958998375
seizures,270,5.598421958998375
lethal,270,5.598421958998375
document,270,5.598421958998375
attributable,270,5.598421958998375
precordial,270,5.598421958998375
just,269,5.594711379601839
prevented,269,5.594711379601839
diagnosing,269,5.594711379601839
randomly,269,5.594711379601839
atypical,269,5.594711379601839
allowing,269,5.594711379601839
uses,269,5.594711379601839
markedly,269,5.594711379601839
hazard,269,5.594711379601839
began,268,5.5909869805108565
MR,268,5.5909869805108565
guideline,268,5.5909869805108565
point-of-care,267,5.58724865840025
NP,267,5.58724865840025
cortical,267,5.58724865840025
clarify,267,5.58724865840025
Asian,267,5.58724865840025
implicated,267,5.58724865840025
usefulness,266,5.583496308781699
Pandemic,266,5.583496308781699
zoonotic,266,5.583496308781699
pooled,266,5.583496308781699
cities,266,5.583496308781699
determination,265,5.579729825986222
immunoglobulin,265,5.579729825986222
correlations,265,5.579729825986222
incident,265,5.579729825986222
calcium,265,5.579729825986222
Ischemic,265,5.579729825986222
chemical,265,5.579729825986222
73,265,5.579729825986222
combat,265,5.579729825986222
regimens,265,5.579729825986222
reproduction,265,5.579729825986222
radionuclide,265,5.579729825986222
modeling,265,5.579729825986222
adopted,265,5.579729825986222
methodology,265,5.579729825986222
fundamental,265,5.579729825986222
urgently,265,5.579729825986222
systematically,265,5.579729825986222
headache,265,5.579729825986222
airborne,264,5.575949103146316
Center,264,5.575949103146316
recognize,264,5.575949103146316
Herein,264,5.575949103146316
96,264,5.575949103146316
adjustment,264,5.575949103146316
why,264,5.575949103146316
geographic,264,5.575949103146316
plus,264,5.575949103146316
simulation,264,5.575949103146316
diabetic,264,5.575949103146316
met,264,5.575949103146316
experts,263,5.572154032177765
asthma-related,263,5.572154032177765
panel,263,5.572154032177765
tachycardia,263,5.572154032177765
BNT162b2,263,5.572154032177765
experiments,263,5.572154032177765
except,263,5.572154032177765
Bronchial,263,5.572154032177765
trauma,262,5.568344503761097
Management,262,5.568344503761097
Left,262,5.568344503761097
manifestation,262,5.568344503761097
002,262,5.568344503761097
apoptosis,261,5.564520407322694
hygiene,261,5.564520407322694
Brazil,261,5.564520407322694
Its,261,5.564520407322694
overcome,261,5.564520407322694
anti-SARS-CoV-2,261,5.564520407322694
minimize,261,5.564520407322694
principles,261,5.564520407322694
professional,261,5.564520407322694
makes,260,5.560681631015528
transluminal,260,5.560681631015528
mixed,260,5.560681631015528
HR,260,5.560681631015528
evident,260,5.560681631015528
adaptation,260,5.560681631015528
66,260,5.560681631015528
cost-effectiveness,259,5.556828061699537
power,259,5.556828061699537
Western,259,5.556828061699537
tolerance,259,5.556828061699537
78,259,5.556828061699537
act,259,5.556828061699537
uncommon,259,5.556828061699537
doctors,258,5.552959584921617
once,258,5.552959584921617
expansion,258,5.552959584921617
surveys,258,5.552959584921617
cost-effective,258,5.552959584921617
elements,257,5.54907608489522
readily,257,5.54907608489522
involve,257,5.54907608489522
2011,257,5.54907608489522
peptides,257,5.54907608489522
oxidative,257,5.54907608489522
caregivers,257,5.54907608489522
Ct,257,5.54907608489522
microvascular,257,5.54907608489522
homes,257,5.54907608489522
glucose,257,5.54907608489522
presentations,257,5.54907608489522
appearance,257,5.54907608489522
definitions,257,5.54907608489522
developments,256,5.545177444479562
76,256,5.545177444479562
86,256,5.545177444479562
definite,256,5.545177444479562
route,256,5.545177444479562
2012,255,5.541263545158426
movement,255,5.541263545158426
infect,255,5.541263545158426
recruited,255,5.541263545158426
anticoagulant,255,5.541263545158426
placed,255,5.541263545158426
memory,254,5.537334267018537
permanent,254,5.537334267018537
enzymes,254,5.537334267018537
changing,254,5.537334267018537
random,254,5.537334267018537
94,254,5.537334267018537
2015,254,5.537334267018537
LAD,254,5.537334267018537
behaviour,254,5.537334267018537
Test,254,5.537334267018537
05,254,5.537334267018537
delays,254,5.537334267018537
non-invasive,253,5.53338948872752
households,253,5.53338948872752
Human,253,5.53338948872752
biomarker,253,5.53338948872752
autopsy,253,5.53338948872752
1000,253,5.53338948872752
participation,252,5.529429087511423
focal,252,5.529429087511423
conserved,252,5.529429087511423
globe,252,5.529429087511423
surfaces,252,5.529429087511423
parts,252,5.529429087511423
2005,252,5.529429087511423
LVEF,252,5.529429087511423
usual,251,5.5254529391317835
echocardiographic,251,5.5254529391317835
reliability,251,5.5254529391317835
79,251,5.5254529391317835
diet,251,5.5254529391317835
representative,251,5.5254529391317835
facility,251,5.5254529391317835
mouse,251,5.5254529391317835
position,251,5.5254529391317835
arrhythmia,250,5.521460917862246
weekly,250,5.521460917862246
starting,250,5.521460917862246
partial,250,5.521460917862246
organs,250,5.521460917862246
material,250,5.521460917862246
seroprevalence,249,5.517452896464707
clinics,249,5.517452896464707
containment,249,5.517452896464707
annually,249,5.517452896464707
online,249,5.517452896464707
workplace,249,5.517452896464707
inhibit,248,5.5134287461649825
Each,248,5.5134287461649825
created,248,5.5134287461649825
unusual,248,5.5134287461649825
2008,248,5.5134287461649825
get,248,5.5134287461649825
update,248,5.5134287461649825
61,248,5.5134287461649825
attempt,247,5.5093883366279774
statins,247,5.5093883366279774
analytical,247,5.5093883366279774
Public,247,5.5093883366279774
tertiary,247,5.5093883366279774
beliefs,247,5.5093883366279774
B117,246,5.5053315359323625
eosinophilic,246,5.5053315359323625
supports,246,5.5053315359323625
survived,246,5.5053315359323625
composition,246,5.5053315359323625
triggered,246,5.5053315359323625
careful,246,5.5053315359323625
meet,246,5.5053315359323625
2007,245,5.501258210544727
ten,245,5.501258210544727
al,245,5.501258210544727
83,245,5.501258210544727
believed,245,5.501258210544727
Vaccine,245,5.501258210544727
glycoprotein,245,5.501258210544727
neuroimaging,245,5.501258210544727
smoke,245,5.501258210544727
pharmacologic,244,5.497168225293202
distributed,244,5.497168225293202
preparation,244,5.497168225293202
varies,244,5.497168225293202
energy,244,5.497168225293202
ultrasound,244,5.497168225293202
electrical,244,5.497168225293202
preliminary,243,5.493061443340548
scintigraphy,243,5.493061443340548
mode,243,5.493061443340548
implement,243,5.493061443340548
salvage,243,5.493061443340548
decision-making,243,5.493061443340548
easy,243,5.493061443340548
sodium,242,5.488937726156687
solution,242,5.488937726156687
avoidance,242,5.488937726156687
neuroprotective,242,5.488937726156687
hypertensive,242,5.488937726156687
refractory,242,5.488937726156687
deep,242,5.488937726156687
extension,241,5.484796933490655
gain,241,5.484796933490655
utilized,241,5.484796933490655
91,241,5.484796933490655
volunteers,241,5.484796933490655
interventional,241,5.484796933490655
institutions,241,5.484796933490655
provocation,240,5.480638923341991
Administration,240,5.480638923341991
deficiency,240,5.480638923341991
largest,240,5.480638923341991
diffusion,240,5.480638923341991
Even,240,5.480638923341991
technical,240,5.480638923341991
82,239,5.476463551931511
extended,239,5.476463551931511
processing,239,5.476463551931511
becoming,239,5.476463551931511
territory,239,5.476463551931511
titer,239,5.476463551931511
programmes,239,5.476463551931511
elucidate,239,5.476463551931511
≥,239,5.476463551931511
subset,239,5.476463551931511
drift,238,5.472270673671475
located,238,5.472270673671475
Doppler,238,5.472270673671475
density,238,5.472270673671475
Primary,238,5.472270673671475
indoor,238,5.472270673671475
era,238,5.472270673671475
offered,238,5.472270673671475
simultaneously,238,5.472270673671475
NSTEMI,238,5.472270673671475
pectoris,237,5.4680601411351315
arrest,237,5.4680601411351315
Middle,236,5.4638318050256105
febrile,236,5.4638318050256105
neonatal,236,5.4638318050256105
summarized,236,5.4638318050256105
task,236,5.4638318050256105
massive,236,5.4638318050256105
87,236,5.4638318050256105
88,236,5.4638318050256105
scenarios,235,5.459585514144159
perinatal,235,5.459585514144159
medium,235,5.459585514144159
insufficiency,235,5.459585514144159
she,235,5.459585514144159
influenza-related,235,5.459585514144159
arrival,235,5.459585514144159
2006,235,5.459585514144159
clusters,235,5.459585514144159
dominant,235,5.459585514144159
slow,235,5.459585514144159
trivalent,234,5.455321115357702
2000,234,5.455321115357702
Analysis,234,5.455321115357702
overlap,234,5.455321115357702
eosinophil,233,5.4510384535657
scarce,233,5.4510384535657
vector,233,5.4510384535657
separate,233,5.4510384535657
registry,233,5.4510384535657
Drug,233,5.4510384535657
latest,233,5.4510384535657
electronic,233,5.4510384535657
space,233,5.4510384535657
Korea,233,5.4510384535657
regardless,233,5.4510384535657
situations,233,5.4510384535657
undergo,233,5.4510384535657
81,232,5.44673737166631
share,232,5.44673737166631
automated,232,5.44673737166631
Viral,232,5.44673737166631
distinguish,232,5.44673737166631
biochemical,232,5.44673737166631
pre-existing,232,5.44673737166631
otherwise,232,5.44673737166631
coagulation,231,5.442417710521793
Surveillance,231,5.442417710521793
prepared,231,5.442417710521793
High,231,5.442417710521793
reductions,231,5.442417710521793
84,231,5.442417710521793
historical,231,5.442417710521793
indication,230,5.438079308923196
external,230,5.438079308923196
routinely,230,5.438079308923196
influenza-associated,230,5.438079308923196
synthesis,229,5.43372200355424
base,229,5.43372200355424
donors,229,5.43372200355424
Program,229,5.43372200355424
parameter,229,5.43372200355424
ECMO,229,5.43372200355424
Atrial,229,5.43372200355424
tracing,229,5.43372200355424
gastrointestinal,229,5.43372200355424
PSD,229,5.43372200355424
01,229,5.43372200355424
modification,229,5.43372200355424
nucleocapsid,228,5.429345628954441
mast,228,5.429345628954441
2014,228,5.429345628954441
Centers,228,5.429345628954441
neuronal,228,5.429345628954441
detail,228,5.429345628954441
collaboration,228,5.429345628954441
case-control,228,5.429345628954441
endarterectomy,228,5.429345628954441
circumstances,227,5.424950017481403
bronchodilators,227,5.424950017481403
stimuli,227,5.424950017481403
added,227,5.424950017481403
antibiotics,227,5.424950017481403
hope,227,5.424950017481403
concepts,227,5.424950017481403
comparative,227,5.424950017481403
Association,226,5.420534999272286
120,226,5.420534999272286
intrinsic,226,5.420534999272286
intake,226,5.420534999272286
infusion,226,5.420534999272286
lost,226,5.420534999272286
postinfarction,226,5.420534999272286
etc,226,5.420534999272286
hearts,225,5.41610040220442
pump,225,5.41610040220442
minimum,225,5.41610040220442
indicator,225,5.41610040220442
irreversible,225,5.41610040220442
complexity,225,5.41610040220442
believe,225,5.41610040220442
slightly,225,5.41610040220442
nonspecific,224,5.4116460518550396
M,224,5.4116460518550396
troponin,224,5.4116460518550396
nurse,224,5.4116460518550396
92,224,5.4116460518550396
kit,224,5.4116460518550396
assessments,224,5.4116460518550396
First,224,5.4116460518550396
depend,224,5.4116460518550396
implantation,224,5.4116460518550396
smokers,223,5.407171771460119
sinus,223,5.407171771460119
named,223,5.407171771460119
probable,223,5.407171771460119
shared,223,5.407171771460119
campaigns,223,5.407171771460119
activated,223,5.407171771460119
EF,223,5.407171771460119
evolutionary,223,5.407171771460119
validate,222,5.402677381872279
replacement,222,5.402677381872279
accounts,222,5.402677381872279
science,222,5.402677381872279
matrix,222,5.402677381872279
Whether,222,5.402677381872279
participated,222,5.402677381872279
original,221,5.3981627015177525
intermediate,221,5.3981627015177525
Hence,221,5.3981627015177525
requirements,221,5.3981627015177525
oxygenation,221,5.3981627015177525
1-year,221,5.3981627015177525
Multiple,221,5.3981627015177525
advantage,221,5.3981627015177525
entity,221,5.3981627015177525
exhibit,221,5.3981627015177525
paediatric,221,5.3981627015177525
droplets,221,5.3981627015177525
exact,221,5.3981627015177525
complement,220,5.393627546352362
cohorts,220,5.393627546352362
examinations,220,5.393627546352362
domestic,219,5.389071729816501
Five,219,5.389071729816501
99,219,5.389071729816501
limiting,219,5.389071729816501
warranted,219,5.389071729816501
differentiate,219,5.389071729816501
themselves,219,5.389071729816501
theory,218,5.384495062789089
aware,218,5.384495062789089
Within,218,5.384495062789089
Evidence,218,5.384495062789089
domains,218,5.384495062789089
regimen,218,5.384495062789089
89,218,5.384495062789089
poses,218,5.384495062789089
bone,218,5.384495062789089
preferred,218,5.384495062789089
becomes,217,5.37989735354046
consistently,217,5.37989735354046
reflux,217,5.37989735354046
screened,217,5.37989735354046
dental,217,5.37989735354046
know,217,5.37989735354046
implementing,216,5.375278407684165
never,216,5.375278407684165
tobacco,216,5.375278407684165
catheter,216,5.375278407684165
bronchitis,216,5.375278407684165
mothers,216,5.375278407684165
turn,216,5.375278407684165
surrounding,216,5.375278407684165
pathogenicity,216,5.375278407684165
England,216,5.375278407684165
all-cause,215,5.3706380281276624
Thrombolysis,215,5.3706380281276624
Spain,215,5.3706380281276624
apply,215,5.3706380281276624
theoretical,215,5.3706380281276624
visit,215,5.3706380281276624
achieving,215,5.3706380281276624
adapted,215,5.3706380281276624
Japanese,214,5.365976015021851
simultaneous,214,5.365976015021851
City,214,5.365976015021851
counts,214,5.365976015021851
scenario,214,5.365976015021851
serology,214,5.365976015021851
93,214,5.365976015021851
prominent,214,5.365976015021851
enough,214,5.365976015021851
defects,214,5.365976015021851
constant,214,5.365976015021851
mitigation,213,5.3612921657094255
multidisciplinary,213,5.3612921657094255
Little,213,5.3612921657094255
restricted,213,5.3612921657094255
Guidelines,213,5.3612921657094255
encountered,213,5.3612921657094255
accounted,213,5.3612921657094255
campaign,213,5.3612921657094255
excessive,213,5.3612921657094255
BHR,212,5.356586274672012
HIV,212,5.356586274672012
97,212,5.356586274672012
picture,212,5.356586274672012
angiotensin,212,5.356586274672012
deviation,212,5.356586274672012
performing,212,5.356586274672012
investigating,212,5.356586274672012
scientists,212,5.356586274672012
optimize,212,5.356586274672012
considerably,211,5.351858133476067
phylogenetic,211,5.351858133476067
experiencing,211,5.351858133476067
mapping,211,5.351858133476067
bronchospasm,211,5.351858133476067
penumbra,211,5.351858133476067
follows,211,5.351858133476067
acupuncture,211,5.351858133476067
informed,210,5.3471075307174685
discovered,210,5.3471075307174685
briefly,210,5.3471075307174685
encephalopathy,210,5.3471075307174685
sequelae,209,5.342334251964811
subjective,209,5.342334251964811
classes,209,5.342334251964811
neither,209,5.342334251964811
expert,209,5.342334251964811
maintained,209,5.342334251964811
locations,209,5.342334251964811
poorer,209,5.342334251964811
storm,209,5.342334251964811
scales,209,5.342334251964811
mismatch,209,5.342334251964811
sentinel,209,5.342334251964811
partially,209,5.342334251964811
Between,209,5.342334251964811
debate,208,5.337538079701318
contagious,208,5.337538079701318
promise,208,5.337538079701318
Zealand,208,5.337538079701318
nationwide,208,5.337538079701318
valve,208,5.337538079701318
CoV,207,5.332718793265369
agonists,207,5.332718793265369
health-care,207,5.332718793265369
Americans,207,5.332718793265369
carefully,207,5.332718793265369
circumflex,207,5.332718793265369
Hg,207,5.332718793265369
bundle,207,5.332718793265369
Trial,207,5.332718793265369
usage,206,5.327876168789581
difficulty,206,5.327876168789581
suggestive,206,5.327876168789581
Few,206,5.327876168789581
i,206,5.327876168789581
Their,205,5.3230099791384085
depressive,205,5.3230099791384085
clearance,205,5.3230099791384085
ventriculography,205,5.3230099791384085
accelerated,205,5.3230099791384085
parallel,205,5.3230099791384085
Institutes,204,5.318119993844216
see,204,5.318119993844216
IgA,204,5.318119993844216
confirmation,204,5.318119993844216
ethnic,204,5.318119993844216
alter,204,5.318119993844216
Future,204,5.318119993844216
CPK,204,5.318119993844216
differentiation,204,5.318119993844216
dietary,204,5.318119993844216
PEFR,204,5.318119993844216
trained,204,5.318119993844216
skills,204,5.318119993844216
grafting,203,5.313205979041787
specialist,203,5.313205979041787
myocarditis,203,5.313205979041787
output,203,5.313205979041787
emergent,203,5.313205979041787
mitral,203,5.313205979041787
b,203,5.313205979041787
parental,203,5.313205979041787
Kingdom,203,5.313205979041787
released,203,5.313205979041787
shorter,203,5.313205979041787
positively,202,5.308267697401205
missed,202,5.308267697401205
acids,202,5.308267697401205
project,202,5.308267697401205
topic,202,5.308267697401205
Blood,202,5.308267697401205
lavage,202,5.308267697401205
CABG,202,5.308267697401205
migraine,202,5.308267697401205
NS,201,5.303304908059076
epithelium,201,5.303304908059076
efficacious,201,5.303304908059076
fear,201,5.303304908059076
subacute,201,5.303304908059076
product,201,5.303304908059076
2004,201,5.303304908059076
supportive,201,5.303304908059076
fetal,201,5.303304908059076
Approximately,201,5.303304908059076
differed,201,5.303304908059076
first-ever,200,5.298317366548036
ovale,200,5.298317366548036
efficiently,200,5.298317366548036
specialists,200,5.298317366548036
powerful,200,5.298317366548036
She,200,5.298317366548036
haemorrhagic,200,5.298317366548036
polymorphisms,200,5.298317366548036
organizations,200,5.298317366548036
fitness,200,5.298317366548036
gas,200,5.298317366548036
2016,199,5.293304824724492
self-reported,199,5.293304824724492
maintaining,199,5.293304824724492
alveolar,199,5.293304824724492
abnormality,199,5.293304824724492
ICH,199,5.293304824724492
complementary,199,5.293304824724492
receptor-binding,199,5.293304824724492
Assessment,199,5.293304824724492
ACS,199,5.293304824724492
influencing,199,5.293304824724492
circulatory,199,5.293304824724492
virological,199,5.293304824724492
adjusting,199,5.293304824724492
lockdown,199,5.293304824724492
end-diastolic,199,5.293304824724492
emphasize,198,5.288267030694535
lowering,198,5.288267030694535
30-day,198,5.288267030694535
lessons,198,5.288267030694535
image,198,5.288267030694535
York,198,5.288267030694535
physiologic,198,5.288267030694535
yielded,198,5.288267030694535
existence,198,5.288267030694535
namely,197,5.2832037287379885
attempts,197,5.2832037287379885
warning,197,5.2832037287379885
disruption,197,5.2832037287379885
localization,197,5.2832037287379885
magnesium,197,5.2832037287379885
deficit,197,5.2832037287379885
triage,197,5.2832037287379885
antigenically,197,5.2832037287379885
Lung,197,5.2832037287379885
gained,197,5.2832037287379885
humidity,197,5.2832037287379885
assigned,196,5.278114659230517
fusion,196,5.278114659230517
SPECT,196,5.278114659230517
foramen,196,5.278114659230517
childrens,196,5.278114659230517
Mortality,196,5.278114659230517
immunocompromised,196,5.278114659230517
100000,196,5.278114659230517
multicenter,196,5.278114659230517
industry,195,5.272999558563747
masks,195,5.272999558563747
coefficient,195,5.272999558563747
materials,195,5.272999558563747
recommendation,195,5.272999558563747
signals,195,5.272999558563747
Medicine,195,5.272999558563747
COVID,195,5.272999558563747
Information,194,5.267858159063328
distance,194,5.267858159063328
de,194,5.267858159063328
aging,194,5.267858159063328
pool,194,5.267858159063328
organization,194,5.267858159063328
alcohol,194,5.267858159063328
potentials,194,5.267858159063328
Significant,194,5.267858159063328
prescription,194,5.267858159063328
sets,194,5.267858159063328
dry,194,5.267858159063328
subjected,194,5.267858159063328
force,193,5.262690188904886
rescue,193,5.262690188904886
CEA,193,5.262690188904886
removal,193,5.262690188904886
aetiology,192,5.2574953720277815
addressing,192,5.2574953720277815
describing,192,5.2574953720277815
loads,192,5.2574953720277815
T-cell,192,5.2574953720277815
circadian,192,5.2574953720277815
classical,192,5.2574953720277815
aspiration,192,5.2574953720277815
lines,192,5.2574953720277815
tumor,191,5.25227342804663
ideal,191,5.25227342804663
OA,191,5.25227342804663
BA,191,5.25227342804663
RSV,191,5.25227342804663
serologic,191,5.25227342804663
hospitalisation,191,5.25227342804663
Italian,191,5.25227342804663
zanamivir,191,5.25227342804663
98,191,5.25227342804663
institution,191,5.25227342804663
summer,190,5.247024072160486
race,190,5.247024072160486
Mean,190,5.247024072160486
come,190,5.247024072160486
contraction,190,5.247024072160486
unlikely,190,5.247024072160486
PubMed,190,5.247024072160486
velocity,190,5.247024072160486
Six,190,5.247024072160486
highlighting,190,5.247024072160486
extracted,190,5.247024072160486
continuing,190,5.247024072160486
bacteria,190,5.247024072160486
double,189,5.241747015059643
pathologic,189,5.241747015059643
enhancement,189,5.241747015059643
head,189,5.241747015059643
put,189,5.241747015059643
safely,189,5.241747015059643
diffuse,189,5.241747015059643
Food,189,5.241747015059643
took,189,5.241747015059643
thromboembolic,189,5.241747015059643
immunoassay,189,5.241747015059643
create,188,5.236441962829949
declined,188,5.236441962829949
scans,188,5.236441962829949
Quality,188,5.236441962829949
publications,188,5.236441962829949
cigarette,188,5.236441962829949
standards,188,5.236441962829949
95CI,188,5.236441962829949
axis,188,5.236441962829949
quantification,188,5.236441962829949
geographical,188,5.236441962829949
Use,188,5.236441962829949
Diagnosis,187,5.231108616854587
herd,187,5.231108616854587
unvaccinated,187,5.231108616854587
solutions,187,5.231108616854587
Unit,187,5.231108616854587
again,187,5.231108616854587
fight,187,5.231108616854587
extensively,187,5.231108616854587
cardiopulmonary,186,5.225746673713202
suspicion,186,5.225746673713202
specialized,186,5.225746673713202
ethical,186,5.225746673713202
intention,186,5.225746673713202
What,186,5.225746673713202
modelling,186,5.225746673713202
premature,186,5.225746673713202
contained,186,5.225746673713202
tendency,186,5.225746673713202
fixed,186,5.225746673713202
pronounced,186,5.225746673713202
negatively,185,5.220355825078324
haemorrhage,185,5.220355825078324
identical,185,5.220355825078324
Besides,185,5.220355825078324
lymphocytes,185,5.220355825078324
health-related,185,5.220355825078324
ligation,185,5.220355825078324
subunit,185,5.220355825078324
antibiotic,185,5.220355825078324
affinity,185,5.220355825078324
multivessel,184,5.214935757608986
principal,184,5.214935757608986
restoration,184,5.214935757608986
pose,184,5.214935757608986
valid,184,5.214935757608986
suboptimal,184,5.214935757608986
equivalent,184,5.214935757608986
Conclusions,184,5.214935757608986
representing,184,5.214935757608986
sickle,184,5.214935757608986
demonstrating,184,5.214935757608986
B1351,184,5.214935757608986
brought,183,5.209486152841421
randomised,183,5.209486152841421
description,183,5.209486152841421
Type,183,5.209486152841421
spring,183,5.209486152841421
Australian,183,5.209486152841421
quantified,183,5.209486152841421
comparisons,183,5.209486152841421
human-to-human,183,5.209486152841421
comorbid,183,5.209486152841421
similarities,182,5.204006687076795
boys,182,5.204006687076795
searched,182,5.204006687076795
opinion,182,5.204006687076795
Initiative,182,5.204006687076795
HI,182,5.204006687076795
algorithms,182,5.204006687076795
represented,182,5.204006687076795
conduction,182,5.204006687076795
Q-wave,182,5.204006687076795
2002,182,5.204006687076795
seeking,182,5.204006687076795
thickening,182,5.204006687076795
General,181,5.198497031265826
System,181,5.198497031265826
Taiwan,181,5.198497031265826
detectable,181,5.198497031265826
reassortment,181,5.198497031265826
purposes,181,5.198497031265826
SCD,181,5.198497031265826
nonfatal,181,5.198497031265826
wild,181,5.198497031265826
mucosal,180,5.19295685089021
environments,180,5.19295685089021
absenteeism,180,5.19295685089021
Rankin,180,5.19295685089021
hence,180,5.19295685089021
radiological,180,5.19295685089021
passive,180,5.19295685089021
theophylline,180,5.19295685089021
ever,180,5.19295685089021
Unfortunately,179,5.187385805840755
QT,179,5.187385805840755
quite,179,5.187385805840755
0005,179,5.187385805840755
coupled,179,5.187385805840755
coping,179,5.187385805840755
select,179,5.187385805840755
estimating,179,5.187385805840755
routes,178,5.181783550292085
2017,178,5.181783550292085
ultimately,178,5.181783550292085
conclusions,178,5.181783550292085
ambulatory,178,5.181783550292085
record,178,5.181783550292085
partly,178,5.181783550292085
aerosols,178,5.181783550292085
AH7N9,178,5.181783550292085
schoolchildren,178,5.181783550292085
maps,178,5.181783550292085
conduct,178,5.181783550292085
nosocomial,178,5.181783550292085
delivered,178,5.181783550292085
FDA,178,5.181783550292085
GINA,177,5.176149732573829
ii,177,5.176149732573829
hypoxia,177,5.176149732573829
Various,177,5.176149732573829
province,177,5.176149732573829
outpatients,177,5.176149732573829
evolved,177,5.176149732573829
preceding,177,5.176149732573829
played,177,5.176149732573829
complicating,177,5.176149732573829
assumed,177,5.176149732573829
non,177,5.176149732573829
antihypertensive,176,5.170483995038151
conflicting,176,5.170483995038151
MSCs,176,5.170483995038151
exclusion,176,5.170483995038151
strict,176,5.170483995038151
call,176,5.170483995038151
DWI,176,5.170483995038151
rat,176,5.170483995038151
psychiatric,176,5.170483995038151
non-Q-wave,176,5.170483995038151
participate,176,5.170483995038151
autonomic,176,5.170483995038151
Netherlands,176,5.170483995038151
modifications,175,5.1647859739235145
Laboratory,175,5.1647859739235145
pharmaceutical,175,5.1647859739235145
proliferation,175,5.1647859739235145
simulations,175,5.1647859739235145
AH5N1,175,5.1647859739235145
advice,175,5.1647859739235145
etiologies,175,5.1647859739235145
owing,175,5.1647859739235145
absent,175,5.1647859739235145
substances,175,5.1647859739235145
covered,175,5.1647859739235145
transition,175,5.1647859739235145
filling,175,5.1647859739235145
Increased,174,5.159055299214529
escape,174,5.159055299214529
Committee,174,5.159055299214529
emission,174,5.159055299214529
tasks,174,5.159055299214529
dramatically,174,5.159055299214529
curves,174,5.159055299214529
modifiable,174,5.159055299214529
genetics,174,5.159055299214529
displayed,174,5.159055299214529
yr,173,5.153291594497779
spasm,173,5.153291594497779
huge,173,5.153291594497779
cats,173,5.153291594497779
rule,173,5.153291594497779
enables,173,5.153291594497779
amantadine,173,5.153291594497779
000,173,5.153291594497779
narrowing,173,5.153291594497779
attempted,173,5.153291594497779
mmHg,172,5.147494476813453
perhaps,172,5.147494476813453
contemporary,172,5.147494476813453
users,172,5.147494476813453
nucleotide,172,5.147494476813453
surrogate,172,5.147494476813453
reflects,172,5.147494476813453
syncytial,172,5.147494476813453
transfusion,172,5.147494476813453
acceptable,172,5.147494476813453
regularly,172,5.147494476813453
details,172,5.147494476813453
combinations,172,5.147494476813453
rising,172,5.147494476813453
limb,172,5.147494476813453
stratified,172,5.147494476813453
aphasia,172,5.147494476813453
K,172,5.147494476813453
sign,172,5.147494476813453
immunologic,171,5.14166355650266
kinetics,171,5.14166355650266
version,171,5.14166355650266
fibrinolytic,171,5.14166355650266
EIA,171,5.14166355650266
restrictions,171,5.14166355650266
advance,171,5.14166355650266
adequately,171,5.14166355650266
HF,171,5.14166355650266
correctly,171,5.14166355650266
referral,171,5.14166355650266
reversibility,170,5.135798437050262
emerge,170,5.135798437050262
expensive,170,5.135798437050262
thickness,170,5.135798437050262
ward,170,5.135798437050262
comprised,170,5.135798437050262
C-reactive,170,5.135798437050262
reproductive,170,5.135798437050262
yield,170,5.135798437050262
So,170,5.135798437050262
French,170,5.135798437050262
equally,170,5.135798437050262
returned,170,5.135798437050262
Chronic,170,5.135798437050262
examining,170,5.135798437050262
strength,169,5.1298987149230735
gap,169,5.1298987149230735
intense,169,5.1298987149230735
willingness,169,5.1298987149230735
induces,169,5.1298987149230735
house,169,5.1298987149230735
repeat,169,5.1298987149230735
prove,169,5.1298987149230735
SARS-COV-2,169,5.1298987149230735
pathophysiologic,168,5.123963979403259
arteriography,168,5.123963979403259
perspectives,168,5.123963979403259
behind,168,5.123963979403259
300,168,5.123963979403259
promoting,168,5.123963979403259
former,168,5.123963979403259
undergone,168,5.123963979403259
Northern,168,5.123963979403259
defining,168,5.123963979403259
×,167,5.117993812416755
undetermined,167,5.117993812416755
relating,167,5.117993812416755
Those,167,5.117993812416755
establishing,167,5.117993812416755
dissemination,167,5.117993812416755
analyse,167,5.117993812416755
003,167,5.117993812416755
Questionnaire,167,5.117993812416755
etiological,167,5.117993812416755
ESUS,167,5.117993812416755
economy,167,5.117993812416755
saline,167,5.117993812416755
modality,167,5.117993812416755
ACT,167,5.117993812416755
rationale,167,5.117993812416755
applying,167,5.117993812416755
concurrent,167,5.117993812416755
mandatory,167,5.117993812416755
unchanged,166,5.111987788356544
attitude,166,5.111987788356544
income,166,5.111987788356544
infrastructure,166,5.111987788356544
abdominal,166,5.111987788356544
contains,166,5.111987788356544
thrombi,166,5.111987788356544
expanded,166,5.111987788356544
evaluations,166,5.111987788356544
polymorphism,166,5.111987788356544
high-throughput,166,5.111987788356544
confounding,166,5.111987788356544
diameter,166,5.111987788356544
leukotriene,165,5.10594547390058
Occupational,165,5.10594547390058
interferon,165,5.10594547390058
inhaler,165,5.10594547390058
fibrinolysis,165,5.10594547390058
morning,165,5.10594547390058
Network,165,5.10594547390058
dual,164,5.099866427824199
asked,164,5.099866427824199
operating,164,5.099866427824199
mask,164,5.099866427824199
X-ray,164,5.099866427824199
producing,164,5.099866427824199
hypotension,164,5.099866427824199
community-based,164,5.099866427824199
interviews,164,5.099866427824199
102,164,5.099866427824199
military,164,5.099866427824199
College,164,5.099866427824199
items,164,5.099866427824199
preoperative,164,5.099866427824199
portion,164,5.099866427824199
Strokes,164,5.099866427824199
mucus,164,5.099866427824199
anatomical,164,5.099866427824199
post-MI,164,5.099866427824199
closed,164,5.099866427824199
dilatation,164,5.099866427824199
reagents,164,5.099866427824199
epicardial,164,5.099866427824199
p0001,163,5.093750200806762
gives,163,5.093750200806762
Consequently,163,5.093750200806762
CRP,163,5.093750200806762
precision,163,5.093750200806762
anti-influenza,163,5.093750200806762
consists,163,5.093750200806762
screen,163,5.093750200806762
emphasized,163,5.093750200806762
papers,163,5.093750200806762
biopsy,163,5.093750200806762
culprit,163,5.093750200806762
southern,162,5.087596335232384
reperfused,162,5.087596335232384
attending,162,5.087596335232384
complexes,162,5.087596335232384
neutrophils,162,5.087596335232384
die,162,5.087596335232384
carry,162,5.087596335232384
pro-inflammatory,162,5.087596335232384
driven,162,5.087596335232384
12-lead,162,5.087596335232384
structured,162,5.087596335232384
biologic,162,5.087596335232384
approval,162,5.087596335232384
formed,162,5.087596335232384
But,162,5.087596335232384
rational,161,5.081404364984463
Education,161,5.081404364984463
accumulation,161,5.081404364984463
elicited,161,5.081404364984463
basal,161,5.081404364984463
learned,161,5.081404364984463
eventually,161,5.081404364984463
allergies,161,5.081404364984463
105,161,5.081404364984463
Abbott,161,5.081404364984463
genetically,161,5.081404364984463
occlusions,161,5.081404364984463
identifies,161,5.081404364984463
faster,160,5.075173815233827
Poland,160,5.075173815233827
NPS,160,5.075173815233827
CHD,160,5.075173815233827
mechanistic,160,5.075173815233827
mobile,160,5.075173815233827
posed,160,5.075173815233827
anatomy,160,5.075173815233827
ago,160,5.075173815233827
necessity,160,5.075173815233827
definitive,160,5.075173815233827
night,160,5.075173815233827
predicts,160,5.075173815233827
interact,160,5.075173815233827
inducing,160,5.075173815233827
northern,160,5.075173815233827
infiltration,160,5.075173815233827
Patient,159,5.0689042022202315
multifactorial,159,5.0689042022202315
impairments,159,5.0689042022202315
favourable,159,5.0689042022202315
raise,159,5.0689042022202315
list,159,5.0689042022202315
non-specific,159,5.0689042022202315
MT,159,5.0689042022202315
centres,159,5.0689042022202315
remission,159,5.0689042022202315
athletes,159,5.0689042022202315
EMS,159,5.0689042022202315
transcranial,159,5.0689042022202315
regarded,159,5.0689042022202315
commercially,159,5.0689042022202315
precautions,159,5.0689042022202315
S1,159,5.0689042022202315
contractility,158,5.062595033026967
elective,158,5.062595033026967
statistics,158,5.062595033026967
arm,158,5.062595033026967
G,158,5.062595033026967
cessation,158,5.062595033026967
tPA,157,5.056245805348308
innovative,157,5.056245805348308
gradually,157,5.056245805348308
financial,157,5.056245805348308
endogenous,157,5.056245805348308
1998,157,5.056245805348308
intended,157,5.056245805348308
newer,157,5.056245805348308
spite,157,5.056245805348308
hypertrophy,157,5.056245805348308
antioxidant,157,5.056245805348308
responded,157,5.056245805348308
electrocardiograms,157,5.056245805348308
seek,157,5.056245805348308
criterion,156,5.049856007249537
150,156,5.049856007249537
2018,156,5.049856007249537
101,156,5.049856007249537
determinant,156,5.049856007249537
Virus,156,5.049856007249537
extracorporeal,156,5.049856007249537
down,156,5.049856007249537
aspect,156,5.049856007249537
construct,156,5.049856007249537
004,156,5.049856007249537
assistance,156,5.049856007249537
enhancing,156,5.049856007249537
practitioner,156,5.049856007249537
characterised,156,5.049856007249537
interesting,156,5.049856007249537
Airway,156,5.049856007249537
CNS,156,5.049856007249537
cortex,156,5.049856007249537
apparently,156,5.049856007249537
written,156,5.049856007249537
adjuvant,156,5.049856007249537
academic,156,5.049856007249537
multiplex,155,5.043425116919247
takes,155,5.043425116919247
amplitude,155,5.043425116919247
instrument,155,5.043425116919247
participating,155,5.043425116919247
reinfection,155,5.043425116919247
prepare,155,5.043425116919247
teaching,155,5.043425116919247
dosage,155,5.043425116919247
mutant,155,5.043425116919247
avoided,154,5.0369526024136295
appropriately,154,5.0369526024136295
thrombocytopenia,154,5.0369526024136295
beta-blockers,154,5.0369526024136295
black,154,5.0369526024136295
effusion,154,5.0369526024136295
comorbidity,154,5.0369526024136295
agencies,154,5.0369526024136295
sexual,154,5.0369526024136295
broadly,154,5.0369526024136295
collect,154,5.0369526024136295
MERS,154,5.0369526024136295
clot,153,5.030437921392435
1999,153,5.030437921392435
RT-LAMP,153,5.030437921392435
organized,153,5.030437921392435
CVD,153,5.030437921392435
provision,153,5.030437921392435
constructed,153,5.030437921392435
examples,153,5.030437921392435
benign,153,5.030437921392435
Evaluation,153,5.030437921392435
staining,153,5.030437921392435
double-blind,153,5.030437921392435
pollutants,152,5.0238805208462765
enzymatic,152,5.0238805208462765
immunized,152,5.0238805208462765
instead,152,5.0238805208462765
septum,152,5.0238805208462765
reflected,152,5.0238805208462765
pacing,152,5.0238805208462765
doctor,152,5.0238805208462765
marrow,152,5.0238805208462765
directions,152,5.0238805208462765
illustrate,152,5.0238805208462765
None,152,5.0238805208462765
incomplete,152,5.0238805208462765
observe,152,5.0238805208462765
territories,152,5.0238805208462765
dispersion,152,5.0238805208462765
category,152,5.0238805208462765
medicines,152,5.0238805208462765
malignant,152,5.0238805208462765
analyzing,151,5.017279836814924
satisfactory,151,5.017279836814924
arise,151,5.017279836814924
hospitalised,151,5.017279836814924
Eight,151,5.017279836814924
giving,151,5.017279836814924
thromboembolism,151,5.017279836814924
Conclusion,151,5.017279836814924
back,151,5.017279836814924
western,151,5.017279836814924
isolate,151,5.017279836814924
injuries,151,5.017279836814924
asynergy,151,5.017279836814924
graft,151,5.017279836814924
macrophages,151,5.017279836814924
chance,151,5.017279836814924
Diseases,151,5.017279836814924
Considering,151,5.017279836814924
mucosa,150,5.0106352940962555
inpatients,150,5.0106352940962555
Childhood,150,5.0106352940962555
combining,150,5.0106352940962555
Additional,150,5.0106352940962555
Vaccines,150,5.0106352940962555
investigators,150,5.0106352940962555
capability,150,5.0106352940962555
sense,150,5.0106352940962555
untreated,150,5.0106352940962555
faced,150,5.0106352940962555
bind,150,5.0106352940962555
sizes,150,5.0106352940962555
protected,150,5.0106352940962555
Similarly,150,5.0106352940962555
localized,150,5.0106352940962555
modify,150,5.0106352940962555
resolved,150,5.0106352940962555
born,150,5.0106352940962555
hypothermia,150,5.0106352940962555
Province,149,5.003946305945459
border,149,5.003946305945459
pilot,149,5.003946305945459
recording,149,5.003946305945459
thousands,149,5.003946305945459
125,149,5.003946305945459
weak,149,5.003946305945459
hypotheses,149,5.003946305945459
Allergy,149,5.003946305945459
extracellular,149,5.003946305945459
addresses,149,5.003946305945459
meeting,149,5.003946305945459
infant,148,4.997212273764115
studying,148,4.997212273764115
profound,148,4.997212273764115
long-acting,148,4.997212273764115
secretion,148,4.997212273764115
tree,148,4.997212273764115
dramatic,148,4.997212273764115
proportions,148,4.997212273764115
Importantly,148,4.997212273764115
sufficiently,148,4.997212273764115
reveals,148,4.997212273764115
centre,148,4.997212273764115
university,148,4.997212273764115
explanation,148,4.997212273764115
Chest,148,4.997212273764115
autoimmune,147,4.990432586778736
MB,147,4.990432586778736
ferrets,147,4.990432586778736
categorized,147,4.990432586778736
Registry,147,4.990432586778736
explores,147,4.990432586778736
congenital,147,4.990432586778736
healing,147,4.990432586778736
deal,147,4.990432586778736
relaxation,147,4.990432586778736
x,147,4.990432586778736
introduce,147,4.990432586778736
donor,147,4.990432586778736
Seasonal,147,4.990432586778736
CD4,147,4.990432586778736
Novel,147,4.990432586778736
elucidated,147,4.990432586778736
1996,146,4.983606621708336
mobility,146,4.983606621708336
cord,146,4.983606621708336
clinician,146,4.983606621708336
threats,146,4.983606621708336
Healthcare,146,4.983606621708336
contraindications,146,4.983606621708336
IVT,146,4.983606621708336
lymphocyte,146,4.983606621708336
electrocardiography,146,4.983606621708336
solid,146,4.983606621708336
avoiding,146,4.983606621708336
integration,146,4.983606621708336
eosinophilia,146,4.983606621708336
licensed,146,4.983606621708336
enabled,146,4.983606621708336
interviewed,146,4.983606621708336
endemic,146,4.983606621708336
acting,146,4.983606621708336
inconsistent,146,4.983606621708336
Spike,146,4.983606621708336
post-infarction,146,4.983606621708336
tolerated,145,4.976733742420574
recognised,145,4.976733742420574
carriers,145,4.976733742420574
embolization,145,4.976733742420574
two-dimensional,145,4.976733742420574
Serum,145,4.976733742420574
modes,145,4.976733742420574
Epidemiological,145,4.976733742420574
docking,145,4.976733742420574
possibilities,145,4.976733742420574
cure,145,4.976733742420574
modulate,145,4.976733742420574
consisting,145,4.976733742420574
author,145,4.976733742420574
imperative,145,4.976733742420574
Carotid,145,4.976733742420574
CK-MB,145,4.976733742420574
necrotic,145,4.976733742420574
tended,145,4.976733742420574
translation,145,4.976733742420574
titres,145,4.976733742420574
CMR,145,4.976733742420574
dependence,145,4.976733742420574
IABP,144,4.969813299576001
originated,144,4.969813299576001
rt-PA,144,4.969813299576001
Cox,144,4.969813299576001
400,144,4.969813299576001
pulse,144,4.969813299576001
Numerous,144,4.969813299576001
computational,144,4.969813299576001
inhibited,144,4.969813299576001
QoL,144,4.969813299576001
at-risk,144,4.969813299576001
presumed,144,4.969813299576001
establishment,144,4.969813299576001
mood,144,4.969813299576001
methodological,144,4.969813299576001
Seven,144,4.969813299576001
ECGs,144,4.969813299576001
employees,144,4.969813299576001
Central,143,4.962844630259907
channel,143,4.962844630259907
market,143,4.962844630259907
top,143,4.962844630259907
stronger,143,4.962844630259907
pressures,143,4.962844630259907
Knowledge,143,4.962844630259907
adjunctive,143,4.962844630259907
surviving,143,4.962844630259907
repurposing,143,4.962844630259907
conservative,143,4.962844630259907
Indeed,143,4.962844630259907
scar,143,4.962844630259907
Survey,143,4.962844630259907
relate,143,4.962844630259907
mammalian,143,4.962844630259907
medically,143,4.962844630259907
shortness,143,4.962844630259907
supplies,143,4.962844630259907
tailored,143,4.962844630259907
scoring,143,4.962844630259907
dedicated,143,4.962844630259907
girls,142,4.955827057601261
instruments,142,4.955827057601261
EVT,142,4.955827057601261
Changes,142,4.955827057601261
challenged,142,4.955827057601261
CP,142,4.955827057601261
remarkable,142,4.955827057601261
consultation,142,4.955827057601261
103,142,4.955827057601261
heat,142,4.955827057601261
shed,142,4.955827057601261
rely,142,4.955827057601261
outline,142,4.955827057601261
map,142,4.955827057601261
platelets,142,4.955827057601261
computer,142,4.955827057601261
104,142,4.955827057601261
pollen,141,4.948759890378168
herein,141,4.948759890378168
transferred,141,4.948759890378168
transportation,141,4.948759890378168
pericardial,141,4.948759890378168
seroconversion,141,4.948759890378168
Pediatric,141,4.948759890378168
disproportionately,141,4.948759890378168
CD8,141,4.948759890378168
relief,141,4.948759890378168
Israel,141,4.948759890378168
1968,141,4.948759890378168
anticipated,141,4.948759890378168
instability,141,4.948759890378168
incubation,141,4.948759890378168
copies,141,4.948759890378168
reaching,141,4.948759890378168
California,141,4.948759890378168
classic,141,4.948759890378168
Specific,141,4.948759890378168
broader,140,4.941642422609304
MCA,140,4.941642422609304
unilateral,140,4.941642422609304
billion,140,4.941642422609304
attractive,140,4.941642422609304
mimic,140,4.941642422609304
transmissible,140,4.941642422609304
Thailand,140,4.941642422609304
triggering,140,4.941642422609304
obvious,140,4.941642422609304
utilizing,140,4.941642422609304
proinflammatory,140,4.941642422609304
terminal,140,4.941642422609304
pooling,140,4.941642422609304
digital,139,4.9344739331306915
H,139,4.9344739331306915
Different,139,4.9344739331306915
tend,139,4.9344739331306915
pivotal,139,4.9344739331306915
bronchoalveolar,139,4.9344739331306915
miRNAs,139,4.9344739331306915
ambulance,139,4.9344739331306915
exclude,139,4.9344739331306915
optimized,139,4.9344739331306915
damaged,139,4.9344739331306915
reasonable,139,4.9344739331306915
mite,139,4.9344739331306915
Through,139,4.9344739331306915
Immunization,139,4.9344739331306915
attended,139,4.9344739331306915
cascade,139,4.9344739331306915
teams,139,4.9344739331306915
relies,139,4.9344739331306915
verified,139,4.9344739331306915
thorough,139,4.9344739331306915
lesser,139,4.9344739331306915
CCU,139,4.9344739331306915
mother,139,4.9344739331306915
member,138,4.927253685157205
Secondary,138,4.927253685157205
optimization,138,4.927253685157205
alert,138,4.927253685157205
sick,138,4.927253685157205
FENO,138,4.927253685157205
LAA,138,4.927253685157205
forward,138,4.927253685157205
sent,138,4.927253685157205
predictions,138,4.927253685157205
synthetic,138,4.927253685157205
cultures,138,4.927253685157205
Interestingly,138,4.927253685157205
Cardiovascular,138,4.927253685157205
P0001,138,4.927253685157205
haemodynamic,137,4.919980925828125
106,137,4.919980925828125
governments,137,4.919980925828125
driving,137,4.919980925828125
well-being,137,4.919980925828125
societal,137,4.919980925828125
nerve,137,4.919980925828125
topics,137,4.919980925828125
worker,137,4.919980925828125
Participants,137,4.919980925828125
LVO,137,4.919980925828125
gave,137,4.919980925828125
differs,137,4.919980925828125
HCP,137,4.919980925828125
finally,137,4.919980925828125
off,136,4.912654885736052
Subjects,136,4.912654885736052
migration,136,4.912654885736052
defense,136,4.912654885736052
D614G,136,4.912654885736052
neutrophil,136,4.912654885736052
placebo-controlled,136,4.912654885736052
resuscitation,136,4.912654885736052
German,136,4.912654885736052
mediastinal,136,4.912654885736052
red,136,4.912654885736052
non-Q,136,4.912654885736052
wild-type,136,4.912654885736052
neonates,136,4.912654885736052
segmental,136,4.912654885736052
requirement,136,4.912654885736052
antagonist,135,4.90527477843843
consultations,135,4.90527477843843
intubation,135,4.90527477843843
section,135,4.90527477843843
preexisting,135,4.90527477843843
isothermal,135,4.90527477843843
transcription-polymerase,135,4.90527477843843
Effective,135,4.90527477843843
preventable,135,4.90527477843843
Accordingly,135,4.90527477843843
served,135,4.90527477843843
exchange,135,4.90527477843843
moderately,135,4.90527477843843
machine,135,4.90527477843843
constitute,135,4.90527477843843
Ten,135,4.90527477843843
publication,135,4.90527477843843
cardiomyopathy,135,4.90527477843843
reservoir,135,4.90527477843843
subcortical,135,4.90527477843843
submitted,134,4.897839799950911
bedside,134,4.897839799950911
Hypertension,134,4.897839799950911
L,134,4.897839799950911
accounting,134,4.897839799950911
fail,134,4.897839799950911
recruitment,134,4.897839799950911
Total,134,4.897839799950911
trust,134,4.897839799950911
endpoint,134,4.897839799950911
hemispheric,134,4.897839799950911
04,134,4.897839799950911
State,134,4.897839799950911
epilepsy,134,4.897839799950911
rRT-PCR,134,4.897839799950911
Yet,134,4.897839799950911
AHR,134,4.897839799950911
climate,133,4.890349128221754
thallium,133,4.890349128221754
tracking,133,4.890349128221754
echo,133,4.890349128221754
demands,133,4.890349128221754
stents,133,4.890349128221754
stroke-related,133,4.890349128221754
immunoassays,133,4.890349128221754
adulthood,133,4.890349128221754
ml,133,4.890349128221754
Cerebral,133,4.890349128221754
ms,133,4.890349128221754
Singapore,132,4.882801922586371
concerned,132,4.882801922586371
direction,132,4.882801922586371
prone,132,4.882801922586371
adoption,132,4.882801922586371
resting,132,4.882801922586371
Science,132,4.882801922586371
allocation,132,4.882801922586371
About,132,4.882801922586371
properly,132,4.882801922586371
HCW,132,4.882801922586371
1st,132,4.882801922586371
blocking,132,4.882801922586371
preparations,132,4.882801922586371
elevations,132,4.882801922586371
nations,132,4.882801922586371
cross,132,4.882801922586371
code,131,4.875197323201151
contractile,131,4.875197323201151
initiate,131,4.875197323201151
treadmill,131,4.875197323201151
coordination,131,4.875197323201151
apical,131,4.875197323201151
comprising,131,4.875197323201151
personality,131,4.875197323201151
actually,131,4.875197323201151
childs,131,4.875197323201151
horses,131,4.875197323201151
acutely,131,4.875197323201151
weakness,131,4.875197323201151
paired,131,4.875197323201151
vein,131,4.875197323201151
amongst,131,4.875197323201151
removed,131,4.875197323201151
encourage,130,4.867534450455582
hr,130,4.867534450455582
error,130,4.867534450455582
importantly,130,4.867534450455582
controversy,130,4.867534450455582
ranges,130,4.867534450455582
2001,130,4.867534450455582
1993,130,4.867534450455582
continuously,130,4.867534450455582
modulation,130,4.867534450455582
fourth,130,4.867534450455582
Diagnostic,130,4.867534450455582
empirical,130,4.867534450455582
sessions,130,4.867534450455582
walking,130,4.867534450455582
match,130,4.867534450455582
heavy,130,4.867534450455582
110,130,4.867534450455582
proportional,130,4.867534450455582
surveyed,130,4.867534450455582
fractional,129,4.859812404361672
lasting,129,4.859812404361672
joint,129,4.859812404361672
helps,129,4.859812404361672
persist,129,4.859812404361672
coming,129,4.859812404361672
virulent,129,4.859812404361672
held,129,4.859812404361672
statin,129,4.859812404361672
drawn,129,4.859812404361672
answer,129,4.859812404361672
neglect,129,4.859812404361672
inhibiting,129,4.859812404361672
inhibitory,129,4.859812404361672
applicable,129,4.859812404361672
reocclusion,128,4.852030263919617
detrimental,128,4.852030263919617
cornerstone,128,4.852030263919617
anatomic,128,4.852030263919617
deadly,128,4.852030263919617
scheme,128,4.852030263919617
capture,128,4.852030263919617
protecting,128,4.852030263919617
sensory,128,4.852030263919617
hemodynamics,128,4.852030263919617
real-world,128,4.852030263919617
reserve,128,4.852030263919617
CoV-2,128,4.852030263919617
QOL,128,4.852030263919617
500,128,4.852030263919617
1990,128,4.852030263919617
expertise,127,4.844187086458591
seropositive,127,4.844187086458591
calls,127,4.844187086458591
generalized,127,4.844187086458591
vulnerability,127,4.844187086458591
Review,127,4.844187086458591
plaques,127,4.844187086458591
modest,127,4.844187086458591
02,127,4.844187086458591
coordinated,127,4.844187086458591
ethnicity,127,4.844187086458591
ineffective,127,4.844187086458591
so-called,127,4.844187086458591
elicit,127,4.844187086458591
intracellular,127,4.844187086458591
promptly,127,4.844187086458591
116,127,4.844187086458591
anteroseptal,127,4.844187086458591
COVID‐19,127,4.844187086458591
immunomodulatory,127,4.844187086458591
pneumothorax,127,4.844187086458591
encouraging,127,4.844187086458591
alternatives,127,4.844187086458591
shape,127,4.844187086458591
officials,127,4.844187086458591
wards,127,4.844187086458591
designs,127,4.844187086458591
Canadian,127,4.844187086458591
manifested,127,4.844187086458591
epitope,127,4.844187086458591
facilitated,127,4.844187086458591
capabilities,127,4.844187086458591
interview,127,4.844187086458591
peaked,126,4.836281906951478
irrespective,126,4.836281906951478
persisted,126,4.836281906951478
lactate,126,4.836281906951478
DM,126,4.836281906951478
drive,126,4.836281906951478
inappropriate,126,4.836281906951478
nuclear,126,4.836281906951478
scanning,126,4.836281906951478
recordings,126,4.836281906951478
raises,126,4.836281906951478
CoVs,126,4.836281906951478
EIB,126,4.836281906951478
complaints,126,4.836281906951478
pig,126,4.836281906951478
appendage,126,4.836281906951478
paradigm,125,4.8283137373023015
subarachnoid,125,4.8283137373023015
dyspnoea,125,4.8283137373023015
drainage,125,4.8283137373023015
Expert,125,4.8283137373023015
dimensions,125,4.8283137373023015
planned,125,4.8283137373023015
facing,125,4.8283137373023015
0002,125,4.8283137373023015
termed,125,4.8283137373023015
Second,125,4.8283137373023015
mimics,125,4.8283137373023015
extreme,125,4.8283137373023015
preconditioning,125,4.8283137373023015
courses,125,4.8283137373023015
vaccinate,125,4.8283137373023015
SARS-CoV2,125,4.8283137373023015
nitroglycerin,125,4.8283137373023015
seasonality,125,4.8283137373023015
peaks,125,4.8283137373023015
designing,125,4.8283137373023015
Multivariate,125,4.8283137373023015
phenotypic,124,4.820281565605037
accessible,124,4.820281565605037
individualized,124,4.820281565605037
stepwise,124,4.820281565605037
Until,124,4.820281565605037
ipsilateral,124,4.820281565605037
molecule,124,4.820281565605037
anesthesia,124,4.820281565605037
deliver,124,4.820281565605037
vomiting,124,4.820281565605037
correction,124,4.820281565605037
frame,124,4.820281565605037
integrity,124,4.820281565605037
racial,124,4.820281565605037
c,124,4.820281565605037
yrs,124,4.820281565605037
angiogenesis,124,4.820281565605037
CAD,123,4.812184355372417
Rationale,123,4.812184355372417
supplementation,123,4.812184355372417
Hubei,123,4.812184355372417
neurons,123,4.812184355372417
reliably,123,4.812184355372417
Another,123,4.812184355372417
glucocorticoids,123,4.812184355372417
1995,123,4.812184355372417
composite,123,4.812184355372417
sequential,123,4.812184355372417
entities,123,4.812184355372417
03,123,4.812184355372417
Initial,123,4.812184355372417
accordance,123,4.812184355372417
extrinsic,123,4.812184355372417
POC,123,4.812184355372417
extract,123,4.812184355372417
HRV,123,4.812184355372417
School,123,4.812184355372417
coding,123,4.812184355372417
Limited,123,4.812184355372417
AI,123,4.812184355372417
aggregation,123,4.812184355372417
translational,123,4.812184355372417
chosen,122,4.804021044733257
multivariable,122,4.804021044733257
separately,122,4.804021044733257
aneurysms,122,4.804021044733257
concordance,122,4.804021044733257
manufacturing,122,4.804021044733257
plasticity,122,4.804021044733257
shortening,122,4.804021044733257
Long-term,122,4.804021044733257
impacted,122,4.804021044733257
Inhaled,122,4.804021044733257
similarity,122,4.804021044733257
ascertain,122,4.804021044733257
storage,122,4.804021044733257
imbalance,122,4.804021044733257
physiology,122,4.804021044733257
oropharyngeal,122,4.804021044733257
morphology,122,4.804021044733257
pneumoniae,122,4.804021044733257
remdesivir,122,4.804021044733257
demographics,122,4.804021044733257
suppression,122,4.804021044733257
VOC,122,4.804021044733257
predischarge,122,4.804021044733257
pharmacotherapy,122,4.804021044733257
1957,122,4.804021044733257
1994,122,4.804021044733257
Development,121,4.795790545596741
anemia,121,4.795790545596741
09,121,4.795790545596741
occlusive,121,4.795790545596741
respective,121,4.795790545596741
actively,121,4.795790545596741
killed,121,4.795790545596741
Physicians,121,4.795790545596741
temperate,121,4.795790545596741
Infarct,121,4.795790545596741
histological,121,4.795790545596741
simulated,121,4.795790545596741
1988,121,4.795790545596741
zones,121,4.795790545596741
gait,121,4.795790545596741
distinguished,121,4.795790545596741
variance,121,4.795790545596741
traits,121,4.795790545596741
Factors,121,4.795790545596741
Nine,121,4.795790545596741
vast,121,4.795790545596741
Pulmonary,121,4.795790545596741
one-third,121,4.795790545596741
PA,121,4.795790545596741
high-dose,120,4.787491742782046
mediator,120,4.787491742782046
hormone,120,4.787491742782046
Life,120,4.787491742782046
Infection,120,4.787491742782046
immunosuppressive,120,4.787491742782046
views,120,4.787491742782046
preschool,120,4.787491742782046
today,120,4.787491742782046
collaterals,120,4.787491742782046
bring,120,4.787491742782046
Prior,120,4.787491742782046
endpoints,120,4.787491742782046
chapter,120,4.787491742782046
incorporated,120,4.787491742782046
principle,120,4.787491742782046
minimizing,120,4.787491742782046
alteration,120,4.787491742782046
pH,120,4.787491742782046
societies,120,4.787491742782046
107,120,4.787491742782046
Low,120,4.787491742782046
Women,120,4.787491742782046
How,120,4.787491742782046
expand,119,4.77912349311153
disease-2019,119,4.77912349311153
Republic,119,4.77912349311153
West,119,4.77912349311153
Saudi,119,4.77912349311153
endotypes,119,4.77912349311153
no-reflow,119,4.77912349311153
Community,119,4.77912349311153
intra-arterial,119,4.77912349311153
Age,119,4.77912349311153
T2,119,4.77912349311153
s,119,4.77912349311153
accident,119,4.77912349311153
advent,119,4.77912349311153
conjunction,119,4.77912349311153
conducting,119,4.77912349311153
Similar,119,4.77912349311153
Roche,119,4.77912349311153
manufacturers,119,4.77912349311153
d,119,4.77912349311153
tropical,119,4.77912349311153
evolve,119,4.77912349311153
silico,119,4.77912349311153
stop,119,4.77912349311153
shortly,119,4.77912349311153
extend,119,4.77912349311153
exert,118,4.770684624465665
Though,118,4.770684624465665
preserved,118,4.770684624465665
sporadic,118,4.770684624465665
responsibility,118,4.770684624465665
keep,118,4.770684624465665
TCD,118,4.770684624465665
adenosine,118,4.770684624465665
1992,118,4.770684624465665
habits,118,4.770684624465665
IQR,118,4.770684624465665
quick,118,4.770684624465665
pairs,118,4.770684624465665
CAS,118,4.770684624465665
Index,118,4.770684624465665
transcriptase,118,4.770684624465665
Direct,118,4.770684624465665
lobe,118,4.770684624465665
unable,118,4.770684624465665
placement,118,4.770684624465665
06,118,4.770684624465665
reflecting,118,4.770684624465665
vectors,118,4.770684624465665
eye,118,4.770684624465665
covering,118,4.770684624465665
immunosorbent,118,4.770684624465665
pathogenetic,118,4.770684624465665
microbial,118,4.770684624465665
112,118,4.770684624465665
compromise,118,4.770684624465665
deployment,118,4.770684624465665
genotype,118,4.770684624465665
LAIV,118,4.770684624465665
Experimental,118,4.770684624465665
intra-aortic,117,4.762173934797756
acquisition,117,4.762173934797756
unexpected,117,4.762173934797756
Phase,117,4.762173934797756
pneumococcal,117,4.762173934797756
intact,117,4.762173934797756
behavioural,117,4.762173934797756
unrecognized,117,4.762173934797756
intranasal,117,4.762173934797756
short-,117,4.762173934797756
Depression,117,4.762173934797756
harmful,117,4.762173934797756
coughing,117,4.762173934797756
Regional,117,4.762173934797756
constitutes,117,4.762173934797756
assumptions,117,4.762173934797756
thalamic,117,4.762173934797756
initiatives,117,4.762173934797756
begin,117,4.762173934797756
Killip,117,4.762173934797756
muscles,117,4.762173934797756
makers,117,4.762173934797756
enormous,116,4.7535901911063645
prescribing,116,4.7535901911063645
wider,116,4.7535901911063645
Indian,116,4.7535901911063645
qRT-PCR,116,4.7535901911063645
subclinical,116,4.7535901911063645
illustrates,116,4.7535901911063645
IL-6,116,4.7535901911063645
contamination,116,4.7535901911063645
Time,116,4.7535901911063645
111,116,4.7535901911063645
morphological,116,4.7535901911063645
fashion,116,4.7535901911063645
commentary,116,4.7535901911063645
inactivation,116,4.7535901911063645
glucocorticoid,116,4.7535901911063645
immunogenic,116,4.7535901911063645
redistribution,116,4.7535901911063645
paid,116,4.7535901911063645
permeability,116,4.7535901911063645
fatty,116,4.7535901911063645
cerebellar,116,4.7535901911063645
unnecessary,116,4.7535901911063645
sensitivities,116,4.7535901911063645
surge,116,4.7535901911063645
distributions,116,4.7535901911063645
haemagglutinin,116,4.7535901911063645
speech,115,4.74493212836325
carries,115,4.74493212836325
LA,115,4.74493212836325
BAL,115,4.74493212836325
interpreted,115,4.74493212836325
County,115,4.74493212836325
nanoparticles,115,4.74493212836325
missing,115,4.74493212836325
unsuccessful,115,4.74493212836325
similarly,115,4.74493212836325
display,115,4.74493212836325
descriptive,115,4.74493212836325
shortage,115,4.74493212836325
Sweden,115,4.74493212836325
OAC,115,4.74493212836325
depressed,115,4.74493212836325
learn,115,4.74493212836325
integral,115,4.74493212836325
telephone,114,4.736198448394496
etiologic,114,4.736198448394496
mentioned,114,4.736198448394496
dehydrogenase,114,4.736198448394496
designated,114,4.736198448394496
Wales,114,4.736198448394496
bat,114,4.736198448394496
pretreatment,114,4.736198448394496
milk,114,4.736198448394496
preceded,114,4.736198448394496
inexpensive,114,4.736198448394496
consciousness,114,4.736198448394496
diffusion-weighted,114,4.736198448394496
bicycle,114,4.736198448394496
fit,114,4.736198448394496
unless,113,4.727387818712341
frequencies,113,4.727387818712341
administrative,113,4.727387818712341
108,113,4.727387818712341
microscopy,113,4.727387818712341
necessarily,113,4.727387818712341
cooperation,113,4.727387818712341
connectivity,113,4.727387818712341
BMI,113,4.727387818712341
temporary,113,4.727387818712341
substitution,113,4.727387818712341
180,113,4.727387818712341
personalized,113,4.727387818712341
insurance,113,4.727387818712341
survive,113,4.727387818712341
autophagy,113,4.727387818712341
1980,113,4.727387818712341
1991,113,4.727387818712341
contributions,113,4.727387818712341
emphasizes,113,4.727387818712341
Avian,113,4.727387818712341
private,113,4.727387818712341
contaminated,113,4.727387818712341
away,113,4.727387818712341
experimentally,113,4.727387818712341
British,113,4.727387818712341
vertical,112,4.718498871295094
software,112,4.718498871295094
blockade,112,4.718498871295094
stenoses,112,4.718498871295094
indirectly,112,4.718498871295094
myoglobin,112,4.718498871295094
victims,112,4.718498871295094
restriction,112,4.718498871295094
Once,112,4.718498871295094
evidenced,112,4.718498871295094
toxicity,112,4.718498871295094
amounts,112,4.718498871295094
prick,112,4.718498871295094
socio-economic,112,4.718498871295094
slight,112,4.718498871295094
mainstay,112,4.718498871295094
case-fatality,112,4.718498871295094
clade,112,4.718498871295094
PET,112,4.718498871295094
reassortant,112,4.718498871295094
adolescent,112,4.718498871295094
composed,112,4.718498871295094
infective,112,4.718498871295094
political,112,4.718498871295094
consequently,112,4.718498871295094
gut,112,4.718498871295094
disturbance,112,4.718498871295094
115,112,4.718498871295094
fractions,112,4.718498871295094
weather,112,4.718498871295094
119,112,4.718498871295094
fifth,111,4.709530201312334
regeneration,111,4.709530201312334
interplay,111,4.709530201312334
artificial,111,4.709530201312334
cleavage,111,4.709530201312334
pathologies,111,4.709530201312334
droplet,111,4.709530201312334
corrected,111,4.709530201312334
track,111,4.709530201312334
Delta,111,4.709530201312334
rimantadine,111,4.709530201312334
predisposing,111,4.709530201312334
revascularisation,111,4.709530201312334
residues,111,4.709530201312334
140,111,4.709530201312334
compromised,111,4.709530201312334
autumn,111,4.709530201312334
produces,111,4.709530201312334
VF,111,4.709530201312334
PI,111,4.709530201312334
expanding,111,4.709530201312334
AB,111,4.709530201312334
exclusively,111,4.709530201312334
fields,111,4.709530201312334
ventilatory,111,4.709530201312334
His,111,4.709530201312334
repetitive,111,4.709530201312334
underestimated,111,4.709530201312334
Allergic,111,4.709530201312334
neurovascular,111,4.709530201312334
caring,110,4.700480365792417
arising,110,4.700480365792417
verapamil,110,4.700480365792417
ARI,110,4.700480365792417
ambient,110,4.700480365792417
develops,110,4.700480365792417
cross-reactivity,110,4.700480365792417
MS,110,4.700480365792417
underway,110,4.700480365792417
Specifically,110,4.700480365792417
fatalities,110,4.700480365792417
instances,110,4.700480365792417
particulate,110,4.700480365792417
restore,110,4.700480365792417
closures,110,4.700480365792417
109,110,4.700480365792417
TIV,110,4.700480365792417
21st,110,4.700480365792417
secretions,110,4.700480365792417
V,110,4.700480365792417
Therapy,109,4.6913478822291435
Cardiology,109,4.6913478822291435
chemotherapy,109,4.6913478822291435
subendocardial,109,4.6913478822291435
operations,109,4.6913478822291435
compatible,109,4.6913478822291435
portable,109,4.6913478822291435
Percutaneous,109,4.6913478822291435
contralateral,109,4.6913478822291435
institutional,109,4.6913478822291435
Exercise,109,4.6913478822291435
begins,109,4.6913478822291435
hospital-based,109,4.6913478822291435
compound,109,4.6913478822291435
middle-aged,109,4.6913478822291435
dangerous,109,4.6913478822291435
converting,109,4.6913478822291435
adapt,109,4.6913478822291435
formulation,109,4.6913478822291435
H1,109,4.6913478822291435
transmit,109,4.6913478822291435
came,109,4.6913478822291435
infecting,109,4.6913478822291435
links,108,4.68213122712422
aiming,108,4.68213122712422
exploring,108,4.68213122712422
obtaining,108,4.68213122712422
atrioventricular,108,4.68213122712422
claims,108,4.68213122712422
Infectious,108,4.68213122712422
angiogram,108,4.68213122712422
calculate,108,4.68213122712422
Intravenous,108,4.68213122712422
panic,108,4.68213122712422
enabling,108,4.68213122712422
Th2,108,4.68213122712422
pericarditis,108,4.68213122712422
counterpulsation,108,4.68213122712422
microbiota,108,4.68213122712422
VOCs,108,4.68213122712422
regards,108,4.68213122712422
fell,108,4.68213122712422
raising,108,4.68213122712422
yearly,108,4.68213122712422
Then,108,4.68213122712422
homeostasis,108,4.68213122712422
fibrinogen,108,4.68213122712422
Sensitivity,108,4.68213122712422
diminished,108,4.68213122712422
symptomatology,108,4.68213122712422
interference,108,4.68213122712422
bird,107,4.672828834461906
Accurate,107,4.672828834461906
Neurological,107,4.672828834461906
phenomena,107,4.672828834461906
trunk,107,4.672828834461906
carrying,107,4.672828834461906
considers,107,4.672828834461906
co-infection,107,4.672828834461906
procedural,107,4.672828834461906
vaccinating,107,4.672828834461906
office,107,4.672828834461906
connected,107,4.672828834461906
Molecular,107,4.672828834461906
generating,107,4.672828834461906
collagen,107,4.672828834461906
Eastern,107,4.672828834461906
weighted,107,4.672828834461906
mesenchymal,107,4.672828834461906
English,106,4.663439094112067
parent,106,4.663439094112067
dying,106,4.663439094112067
cycles,106,4.663439094112067
encouraged,106,4.663439094112067
y,106,4.663439094112067
132,106,4.663439094112067
thallium-201,106,4.663439094112067
IRA,106,4.663439094112067
fluorescence,106,4.663439094112067
outlined,106,4.663439094112067
sum,106,4.663439094112067
registries,106,4.663439094112067
tube,106,4.663439094112067
seropositivity,106,4.663439094112067
Symptoms,106,4.663439094112067
minute,106,4.663439094112067
scope,106,4.663439094112067
immunosuppression,106,4.663439094112067
operative,106,4.663439094112067
mammals,106,4.663439094112067
costly,106,4.663439094112067
low-dose,106,4.663439094112067
Victoria,106,4.663439094112067
prompted,106,4.663439094112067
kept,106,4.663439094112067
non-fatal,106,4.663439094112067
Antiviral,106,4.663439094112067
GPs,105,4.653960350157523
occasionally,105,4.653960350157523
demonstration,105,4.653960350157523
encephalitis,105,4.653960350157523
potency,105,4.653960350157523
enzyme-linked,105,4.653960350157523
pre-,105,4.653960350157523
injected,105,4.653960350157523
g,105,4.653960350157523
text,105,4.653960350157523
movements,105,4.653960350157523
incorporate,105,4.653960350157523
R0,105,4.653960350157523
errors,105,4.653960350157523
helped,105,4.653960350157523
belonging,105,4.653960350157523
boy,105,4.653960350157523
P1,105,4.653960350157523
collaborative,105,4.653960350157523
normalized,105,4.653960350157523
well-known,105,4.653960350157523
outlines,105,4.653960350157523
cardiomyocytes,105,4.653960350157523
°C,105,4.653960350157523
stated,105,4.653960350157523
prevents,105,4.653960350157523
intravascular,105,4.653960350157523
realistic,105,4.653960350157523
facilitating,105,4.653960350157523
statement,105,4.653960350157523
constraints,105,4.653960350157523
getting,105,4.653960350157523
middle-income,105,4.653960350157523
mutants,105,4.653960350157523
SBP,105,4.653960350157523
strongest,104,4.6443908991413725
Cochrane,104,4.6443908991413725
accelerate,104,4.6443908991413725
datasets,104,4.6443908991413725
creating,104,4.6443908991413725
Out,104,4.6443908991413725
blunt,104,4.6443908991413725
relatives,104,4.6443908991413725
alpha,104,4.6443908991413725
117,104,4.6443908991413725
disabling,104,4.6443908991413725
fetus,104,4.6443908991413725
documents,104,4.6443908991413725
bats,104,4.6443908991413725
People,104,4.6443908991413725
imported,104,4.6443908991413725
compares,104,4.6443908991413725
ASM,104,4.6443908991413725
Increasing,104,4.6443908991413725
GP,104,4.6443908991413725
intentions,104,4.6443908991413725
caregiver,104,4.6443908991413725
lethality,104,4.6443908991413725
work-related,104,4.6443908991413725
Follow-up,104,4.6443908991413725
serves,104,4.6443908991413725
manifest,104,4.6443908991413725
swine-origin,104,4.6443908991413725
false-negative,104,4.6443908991413725
ease,104,4.6443908991413725
mediastinum,104,4.6443908991413725
updates,103,4.634728988229636
confirms,103,4.634728988229636
Hispanic,103,4.634728988229636
predisposition,103,4.634728988229636
mixing,103,4.634728988229636
metropolitan,103,4.634728988229636
job,103,4.634728988229636
relapse,103,4.634728988229636
128,103,4.634728988229636
RCTs,103,4.634728988229636
Testing,103,4.634728988229636
methodologies,103,4.634728988229636
Flu,103,4.634728988229636
argue,103,4.634728988229636
hydroxychloroquine,103,4.634728988229636
false-positive,103,4.634728988229636
nutritional,103,4.634728988229636
diarrhea,103,4.634728988229636
hyperventilation,103,4.634728988229636
Twenty,103,4.634728988229636
hemagglutination,103,4.634728988229636
RdRp,103,4.634728988229636
1985,103,4.634728988229636
Therapeutic,103,4.634728988229636
coinfection,103,4.634728988229636
controller,103,4.634728988229636
neuroprotection,103,4.634728988229636
Before,103,4.634728988229636
restenosis,103,4.634728988229636
paradoxical,103,4.634728988229636
familial,103,4.634728988229636
dialysis,103,4.634728988229636
pre-hospital,103,4.634728988229636
confer,103,4.634728988229636
predominance,103,4.634728988229636
adjuvants,103,4.634728988229636
places,103,4.634728988229636
SARS-CoV-2-specific,102,4.624972813284271
EEG,102,4.624972813284271
MD,102,4.624972813284271
voluntary,102,4.624972813284271
tuberculosis,102,4.624972813284271
breastfeeding,102,4.624972813284271
soluble,102,4.624972813284271
dog,102,4.624972813284271
handling,102,4.624972813284271
propagation,102,4.624972813284271
worsen,102,4.624972813284271
breast,102,4.624972813284271
everyday,102,4.624972813284271
register,102,4.624972813284271
high-quality,102,4.624972813284271
Panel,102,4.624972813284271
Thrombolytic,102,4.624972813284271
cardiologists,102,4.624972813284271
J,102,4.624972813284271
1989,102,4.624972813284271
126,102,4.624972813284271
recover,102,4.624972813284271
go,102,4.624972813284271
aOR,102,4.624972813284271
notably,102,4.624972813284271
stakeholders,101,4.61512051684126
element,101,4.61512051684126
Black,101,4.61512051684126
retrieved,101,4.61512051684126
iv,101,4.61512051684126
apnea,101,4.61512051684126
adjunct,101,4.61512051684126
inconclusive,101,4.61512051684126
intestinal,101,4.61512051684126
indicative,101,4.61512051684126
probe,101,4.61512051684126
mgkg,101,4.61512051684126
1986,101,4.61512051684126
figures,101,4.61512051684126
manual,101,4.61512051684126
begun,101,4.61512051684126
Ministry,101,4.61512051684126
transformation,101,4.61512051684126
radiation,101,4.61512051684126
undiagnosed,101,4.61512051684126
131,101,4.61512051684126
breathlessness,101,4.61512051684126
pts,101,4.61512051684126
themes,101,4.61512051684126
Right,101,4.61512051684126
dysphagia,101,4.61512051684126
array,101,4.61512051684126
sampled,101,4.61512051684126
tumors,101,4.61512051684126
D-dimer,101,4.61512051684126
connection,101,4.61512051684126
anti-viral,101,4.61512051684126
AUC,101,4.61512051684126
RNAs,101,4.61512051684126
disinfection,100,4.605170185988092
NS1,100,4.605170185988092
GER,100,4.605170185988092
ACOS,100,4.605170185988092
inhabitants,100,4.605170185988092
gradual,100,4.605170185988092
unrelated,100,4.605170185988092
Serological,100,4.605170185988092
dealing,100,4.605170185988092
employing,100,4.605170185988092
applicability,100,4.605170185988092
net,100,4.605170185988092
companies,100,4.605170185988092
infancy,100,4.605170185988092
nose,100,4.605170185988092
cultural,100,4.605170185988092
sparse,100,4.605170185988092
hypersensitivity,100,4.605170185988092
documentation,100,4.605170185988092
clarified,100,4.605170185988092
provider,100,4.605170185988092
MINOCA,100,4.605170185988092
H9N2,100,4.605170185988092
adolescence,100,4.605170185988092
Environmental,100,4.605170185988092
130,100,4.605170185988092
naturally,100,4.605170185988092
Peak,100,4.605170185988092
threatening,100,4.605170185988092
elimination,100,4.605170185988092
V1,100,4.605170185988092
regulate,100,4.605170185988092
vasospasm,99,4.59511985013459
carbon,99,4.59511985013459
iii,99,4.59511985013459
beats,99,4.59511985013459
operated,99,4.59511985013459
urine,99,4.59511985013459
1976,99,4.59511985013459
debated,99,4.59511985013459
mitigating,99,4.59511985013459
cat,99,4.59511985013459
cover,99,4.59511985013459
postulated,99,4.59511985013459
ensuring,99,4.59511985013459
extracranial,99,4.59511985013459
FVC,99,4.59511985013459
problematic,99,4.59511985013459
run,99,4.59511985013459
corona,99,4.59511985013459
HPAI,99,4.59511985013459
Recurrent,99,4.59511985013459
disseminated,99,4.59511985013459
Centre,99,4.59511985013459
tone,99,4.59511985013459
sharing,99,4.59511985013459
daytime,99,4.59511985013459
cardiology,99,4.59511985013459
sensitized,98,4.584967478670572
mind,98,4.584967478670572
add,98,4.584967478670572
M2,98,4.584967478670572
productivity,98,4.584967478670572
inoculation,98,4.584967478670572
agreed,98,4.584967478670572
first-line,98,4.584967478670572
alive,98,4.584967478670572
TCM,98,4.584967478670572
immunisation,98,4.584967478670572
expectations,98,4.584967478670572
hazards,98,4.584967478670572
apart,98,4.584967478670572
chemokines,98,4.584967478670572
Cases,98,4.584967478670572
adjacent,98,4.584967478670572
Case,98,4.584967478670572
derive,98,4.584967478670572
sections,98,4.584967478670572
clades,98,4.584967478670572
Differences,98,4.584967478670572
papillary,98,4.584967478670572
10000,98,4.584967478670572
Holter,98,4.584967478670572
look,98,4.584967478670572
interface,98,4.584967478670572
cope,98,4.584967478670572
angiographically,98,4.584967478670572
reciprocal,98,4.584967478670572
capillary,98,4.584967478670572
postmortem,98,4.584967478670572
ER,97,4.574710978503383
MIs,97,4.574710978503383
feedback,97,4.574710978503383
6-month,97,4.574710978503383
quarter,97,4.574710978503383
2009-2010,97,4.574710978503383
consistency,97,4.574710978503383
satisfaction,97,4.574710978503383
fluids,97,4.574710978503383
cervical,97,4.574710978503383
selecting,97,4.574710978503383
Individuals,97,4.574710978503383
responding,97,4.574710978503383
tightness,97,4.574710978503383
thereafter,97,4.574710978503383
short-acting,97,4.574710978503383
121,97,4.574710978503383
substitutions,97,4.574710978503383
Oseltamivir,97,4.574710978503383
Functional,97,4.574710978503383
foreign,97,4.574710978503383
Importance,97,4.574710978503383
regulating,97,4.574710978503383
sympathetic,97,4.574710978503383
mRS,97,4.574710978503383
build,97,4.574710978503383
origins,97,4.574710978503383
Serial,97,4.574710978503383
neurologists,97,4.574710978503383
putative,96,4.564348191467836
OSA,96,4.564348191467836
subsets,96,4.564348191467836
reverse-transcription,96,4.564348191467836
channels,96,4.564348191467836
118,96,4.564348191467836
workflow,96,4.564348191467836
Southern,96,4.564348191467836
substrate,96,4.564348191467836
preventative,96,4.564348191467836
emphasizing,96,4.564348191467836
sepsis,96,4.564348191467836
Annual,96,4.564348191467836
progressed,96,4.564348191467836
Korean,96,4.564348191467836
incorporating,96,4.564348191467836
nitrates,96,4.564348191467836
expressing,96,4.564348191467836
IFN,96,4.564348191467836
eliminate,96,4.564348191467836
rhinovirus,96,4.564348191467836
reviewing,96,4.564348191467836
IL-5,96,4.564348191467836
consolidation,96,4.564348191467836
sexes,96,4.564348191467836
1978,96,4.564348191467836
08,96,4.564348191467836
SARS-CoV‑2,96,4.564348191467836
cutaneous,96,4.564348191467836
thrombolytics,96,4.564348191467836
propensity,96,4.564348191467836
dysregulation,96,4.564348191467836
ID,96,4.564348191467836
entered,96,4.564348191467836
convenient,96,4.564348191467836
delta,96,4.564348191467836
gastroesophageal,96,4.564348191467836
adenovirus,96,4.564348191467836
desirable,96,4.564348191467836
Genetic,96,4.564348191467836
spreads,96,4.564348191467836
kind,96,4.564348191467836
Google,95,4.553876891600541
exploration,95,4.553876891600541
Indonesia,95,4.553876891600541
dioxide,95,4.553876891600541
deposition,95,4.553876891600541
recommends,95,4.553876891600541
overlooked,95,4.553876891600541
Classification,95,4.553876891600541
sore,95,4.553876891600541
deployed,95,4.553876891600541
disadvantages,95,4.553876891600541
Large,95,4.553876891600541
135,95,4.553876891600541
antiarrhythmic,95,4.553876891600541
Physical,95,4.553876891600541
Findings,95,4.553876891600541
seizure,95,4.553876891600541
provinces,95,4.553876891600541
cutoff,95,4.553876891600541
emphysema,95,4.553876891600541
dataset,95,4.553876891600541
CKD,95,4.553876891600541
strategic,95,4.553876891600541
P005,95,4.553876891600541
guiding,95,4.553876891600541
SARS-CoV-1,95,4.553876891600541
0003,95,4.553876891600541
district,95,4.553876891600541
contracting,95,4.553876891600541
hemiparesis,95,4.553876891600541
inherent,95,4.553876891600541
evaluates,94,4.543294782270004
deleterious,94,4.543294782270004
sound,94,4.543294782270004
traditionally,94,4.543294782270004
building,94,4.543294782270004
clopidogrel,94,4.543294782270004
Russia,94,4.543294782270004
enter,94,4.543294782270004
developmental,94,4.543294782270004
issued,94,4.543294782270004
virology,94,4.543294782270004
vaccine-induced,94,4.543294782270004
regulated,94,4.543294782270004
sociodemographic,94,4.543294782270004
interfere,94,4.543294782270004
authorization,94,4.543294782270004
ocular,94,4.543294782270004
accompanying,94,4.543294782270004
AH1N1v,94,4.543294782270004
toxic,94,4.543294782270004
residence,94,4.543294782270004
heightened,94,4.543294782270004
employment,94,4.543294782270004
shunt,94,4.543294782270004
official,94,4.543294782270004
tried,94,4.543294782270004
resident,94,4.543294782270004
114,94,4.543294782270004
1977,94,4.543294782270004
seemed,94,4.543294782270004
Web,93,4.532599493153256
industrialized,93,4.532599493153256
meaningful,93,4.532599493153256
oedema,93,4.532599493153256
technological,93,4.532599493153256
NPIs,93,4.532599493153256
Latin,93,4.532599493153256
tremendous,93,4.532599493153256
Up,93,4.532599493153256
fat,93,4.532599493153256
enhances,93,4.532599493153256
neuropsychological,93,4.532599493153256
Family,93,4.532599493153256
m,93,4.532599493153256
plants,93,4.532599493153256
promoted,93,4.532599493153256
hundreds,93,4.532599493153256
permit,93,4.532599493153256
classify,93,4.532599493153256
Comparison,93,4.532599493153256
moment,93,4.532599493153256
histories,93,4.532599493153256
unexplained,93,4.532599493153256
fungal,93,4.532599493153256
ASA,93,4.532599493153256
assumption,93,4.532599493153256
treatable,93,4.532599493153256
AR,93,4.532599493153256
122,93,4.532599493153256
Switzerland,93,4.532599493153256
cocaine,93,4.532599493153256
messages,93,4.532599493153256
explanations,93,4.532599493153256
confined,93,4.532599493153256
responsive,93,4.532599493153256
HRQoL,93,4.532599493153256
Mpro,92,4.5217885770490405
Social,92,4.5217885770490405
monthly,92,4.5217885770490405
Advisory,92,4.5217885770490405
frontal,92,4.5217885770490405
cerebrospinal,92,4.5217885770490405
milder,92,4.5217885770490405
H5,92,4.5217885770490405
thousand,92,4.5217885770490405
natriuretic,92,4.5217885770490405
grouped,92,4.5217885770490405
differing,92,4.5217885770490405
relations,92,4.5217885770490405
probes,92,4.5217885770490405
nodes,92,4.5217885770490405
moving,92,4.5217885770490405
Conversely,92,4.5217885770490405
dilution,92,4.5217885770490405
immunodeficiency,92,4.5217885770490405
IL-4,92,4.5217885770490405
emergencies,92,4.5217885770490405
neck,92,4.5217885770490405
Monitoring,92,4.5217885770490405
injured,92,4.5217885770490405
travelers,92,4.5217885770490405
combating,92,4.5217885770490405
Nonetheless,92,4.5217885770490405
works,92,4.5217885770490405
favor,92,4.5217885770490405
paucity,92,4.5217885770490405
residential,92,4.5217885770490405
preservation,92,4.5217885770490405
belief,92,4.5217885770490405
reading,92,4.5217885770490405
non-pharmaceutical,92,4.5217885770490405
asthma-like,92,4.5217885770490405
promotion,92,4.5217885770490405
repeatedly,92,4.5217885770490405
assesses,91,4.51085950651685
distinguishing,91,4.51085950651685
caution,91,4.51085950651685
laser,91,4.51085950651685
quantitatively,91,4.51085950651685
5-year,91,4.51085950651685
AD,91,4.51085950651685
questioned,91,4.51085950651685
spontaneously,91,4.51085950651685
antioxidants,91,4.51085950651685
organic,91,4.51085950651685
acceptability,91,4.51085950651685
declining,91,4.51085950651685
computerized,91,4.51085950651685
Cardiogenic,91,4.51085950651685
opening,91,4.51085950651685
IL-13,91,4.51085950651685
girl,91,4.51085950651685
virtual,91,4.51085950651685
saturation,91,4.51085950651685
inversely,91,4.51085950651685
≤,91,4.51085950651685
sports,91,4.51085950651685
proteases,91,4.51085950651685
echocardiogram,91,4.51085950651685
134,91,4.51085950651685
stabilization,91,4.51085950651685
revised,91,4.51085950651685
hold,90,4.499809670330265
Positive,90,4.499809670330265
idea,90,4.499809670330265
EUA,90,4.499809670330265
capacities,90,4.499809670330265
behaviours,90,4.499809670330265
normally,90,4.499809670330265
LAMP,90,4.499809670330265
Intensive,90,4.499809670330265
outdoor,90,4.499809670330265
returning,90,4.499809670330265
cut-off,90,4.499809670330265
county,90,4.499809670330265
low-income,90,4.499809670330265
genotypes,90,4.499809670330265
paramount,90,4.499809670330265
dilation,90,4.499809670330265
phosphokinase,90,4.499809670330265
differentiated,90,4.499809670330265
somewhat,90,4.499809670330265
inner-city,90,4.499809670330265
mediate,90,4.499809670330265
Service,90,4.499809670330265
theories,90,4.499809670330265
initiating,90,4.499809670330265
offering,90,4.499809670330265
sigma,90,4.499809670330265
inhalers,90,4.499809670330265
recovering,90,4.499809670330265
adhesion,90,4.499809670330265
thresholds,90,4.499809670330265
COVID-19-related,90,4.499809670330265
sector,90,4.499809670330265
CVA,90,4.499809670330265
visible,90,4.499809670330265
PPE,90,4.499809670330265
influenzae,90,4.499809670330265
Model,90,4.499809670330265
160,90,4.499809670330265
comprises,90,4.499809670330265
cell-based,90,4.499809670330265
Emerging,90,4.499809670330265
Identification,90,4.499809670330265
exhibits,90,4.499809670330265
myalgia,90,4.499809670330265
cognition,90,4.499809670330265
brainstem,89,4.48863636973214
readmission,89,4.48863636973214
lifetime,89,4.48863636973214
reproducibility,89,4.48863636973214
sequenced,89,4.48863636973214
pools,89,4.48863636973214
optical,89,4.48863636973214
Region,89,4.48863636973214
exception,89,4.48863636973214
dobutamine,89,4.48863636973214
bed,89,4.48863636973214
clustering,89,4.48863636973214
infrequent,89,4.48863636973214
Pfizer-BioNTech,89,4.48863636973214
ET,89,4.48863636973214
bridge,89,4.48863636973214
PC20,89,4.48863636973214
allocated,89,4.48863636973214
blocks,89,4.48863636973214
Not,89,4.48863636973214
Real-time,89,4.48863636973214
proposes,89,4.48863636973214
visited,89,4.48863636973214
suppress,89,4.48863636973214
Clinicians,89,4.48863636973214
visualization,89,4.48863636973214
operational,89,4.48863636973214
hyperglycemia,89,4.48863636973214
ChAdOx1,89,4.48863636973214
test-negative,89,4.48863636973214
ultimate,89,4.48863636973214
rigorous,89,4.48863636973214
funding,89,4.48863636973214
endocarditis,89,4.48863636973214
beds,89,4.48863636973214
obese,89,4.48863636973214
priorities,89,4.48863636973214
biomedical,88,4.477336814478207
co-morbidities,88,4.477336814478207
dosing,88,4.477336814478207
Iran,88,4.477336814478207
progenitor,88,4.477336814478207
3D,88,4.477336814478207
informative,88,4.477336814478207
implies,88,4.477336814478207
formulated,88,4.477336814478207
1987,88,4.477336814478207
progressively,88,4.477336814478207
exacerbate,88,4.477336814478207
running,88,4.477336814478207
Identifying,88,4.477336814478207
near-fatal,88,4.477336814478207
linkage,88,4.477336814478207
lipoprotein,88,4.477336814478207
1981,88,4.477336814478207
counseling,88,4.477336814478207
epigenetic,88,4.477336814478207
entirely,88,4.477336814478207
accidents,88,4.477336814478207
Successful,88,4.477336814478207
postpartum,88,4.477336814478207
rabbits,88,4.477336814478207
Detection,88,4.477336814478207
Thoracic,88,4.477336814478207
Subsequently,88,4.477336814478207
Context,88,4.477336814478207
metabolites,88,4.477336814478207
Hz,88,4.477336814478207
mites,88,4.477336814478207
individually,88,4.477336814478207
1918-1919,88,4.477336814478207
self-efficacy,88,4.477336814478207
narrow,88,4.477336814478207
biopsies,88,4.477336814478207
CCP,87,4.465908118654584
linking,87,4.465908118654584
24-hour,87,4.465908118654584
uncertainties,87,4.465908118654584
worlds,87,4.465908118654584
antiinflammatory,87,4.465908118654584
lumen,87,4.465908118654584
episodic,87,4.465908118654584
post-myocardial,87,4.465908118654584
leave,87,4.465908118654584
hypoxemia,87,4.465908118654584
illustrated,87,4.465908118654584
optimum,87,4.465908118654584
urinary,87,4.465908118654584
uniform,87,4.465908118654584
spirometric,87,4.465908118654584
analyzes,87,4.465908118654584
grafts,87,4.465908118654584
partners,87,4.465908118654584
low-risk,87,4.465908118654584
RCA,87,4.465908118654584
generic,87,4.465908118654584
virtually,87,4.465908118654584
counties,87,4.465908118654584
curative,87,4.465908118654584
incremental,87,4.465908118654584
suggestions,87,4.465908118654584
lymph,87,4.465908118654584
gathered,87,4.465908118654584
overt,87,4.465908118654584
reorganization,87,4.465908118654584
Arabia,87,4.465908118654584
H1N1pdm,87,4.465908118654584
H1N1pdm09,87,4.465908118654584
envelope,87,4.465908118654584
mobilization,87,4.465908118654584
asthmaticus,86,4.454347296253507
A2,86,4.454347296253507
popular,86,4.454347296253507
adversely,86,4.454347296253507
disabilities,86,4.454347296253507
effector,86,4.454347296253507
GERD,86,4.454347296253507
recognizing,86,4.454347296253507
matching,86,4.454347296253507
easier,86,4.454347296253507
registration,86,4.454347296253507
exercises,86,4.454347296253507
agonist,86,4.454347296253507
H3,86,4.454347296253507
inability,86,4.454347296253507
consent,86,4.454347296253507
excluding,86,4.454347296253507
wearing,86,4.454347296253507
manuscript,86,4.454347296253507
instance,86,4.454347296253507
worst,86,4.454347296253507
Recommendations,86,4.454347296253507
tomographic,86,4.454347296253507
Taken,86,4.454347296253507
CV,86,4.454347296253507
Late,86,4.454347296253507
persists,86,4.454347296253507
disappeared,86,4.454347296253507
Antibody,86,4.454347296253507
stimulate,86,4.454347296253507
ground,86,4.454347296253507
Score,86,4.454347296253507
Medicare,86,4.454347296253507
responders,86,4.454347296253507
Hemisphere,86,4.454347296253507
170,86,4.454347296253507
Finland,86,4.454347296253507
emboli,86,4.454347296253507
interstitial,86,4.454347296253507
129,86,4.454347296253507
work-up,86,4.454347296253507
meaning,86,4.454347296253507
t-PA,85,4.442651256490317
rose,85,4.442651256490317
Bayesian,85,4.442651256490317
periodic,85,4.442651256490317
narrative,85,4.442651256490317
Under,85,4.442651256490317
verify,85,4.442651256490317
height,85,4.442651256490317
instituted,85,4.442651256490317
heavily,85,4.442651256490317
savings,85,4.442651256490317
biosensors,85,4.442651256490317
confounders,85,4.442651256490317
predispose,85,4.442651256490317
save,85,4.442651256490317
meta-analyses,85,4.442651256490317
Higher,85,4.442651256490317
anaphylaxis,85,4.442651256490317
answers,85,4.442651256490317
workup,85,4.442651256490317
stochastic,85,4.442651256490317
indexes,85,4.442651256490317
indeed,85,4.442651256490317
low-,85,4.442651256490317
prescriptions,85,4.442651256490317
PC,85,4.442651256490317
salbutamol,85,4.442651256490317
unmet,85,4.442651256490317
dead,85,4.442651256490317
formulations,85,4.442651256490317
performances,85,4.442651256490317
vertebral,85,4.442651256490317
totally,85,4.442651256490317
unfavorable,85,4.442651256490317
translate,85,4.442651256490317
contributor,85,4.442651256490317
engagement,85,4.442651256490317
shortages,85,4.442651256490317
Reverse,85,4.442651256490317
flu-like,85,4.442651256490317
Ag,85,4.442651256490317
transplanted,84,4.430816798843313
DBS,84,4.430816798843313
127,84,4.430816798843313
Much,84,4.430816798843313
triple,84,4.430816798843313
1975,84,4.430816798843313
felt,84,4.430816798843313
new-onset,84,4.430816798843313
Advances,84,4.430816798843313
Beijing,84,4.430816798843313
175,84,4.430816798843313
swallowing,84,4.430816798843313
inverse,84,4.430816798843313
suddenly,84,4.430816798843313
136,84,4.430816798843313
leukocyte,84,4.430816798843313
Special,84,4.430816798843313
ecological,84,4.430816798843313
Childrens,84,4.430816798843313
chemoprophylaxis,84,4.430816798843313
reproducible,84,4.430816798843313
experiment,84,4.430816798843313
refers,84,4.430816798843313
139,84,4.430816798843313
radiographic,84,4.430816798843313
Older,84,4.430816798843313
atrium,84,4.430816798843313
Brain,84,4.430816798843313
interleukin,84,4.430816798843313
maximize,84,4.430816798843313
guided,84,4.430816798843313
paroxysmal,84,4.430816798843313
spinal,84,4.430816798843313
Outcomes,84,4.430816798843313
drop,84,4.430816798843313
circulate,84,4.430816798843313
Norway,84,4.430816798843313
Ontario,84,4.430816798843313
147,84,4.430816798843313
toll,83,4.418840607796598
Results-,83,4.418840607796598
tension,83,4.418840607796598
microcirculation,83,4.418840607796598
stimulated,83,4.418840607796598
White,83,4.418840607796598
input,83,4.418840607796598
activate,83,4.418840607796598
PSF,83,4.418840607796598
1984,83,4.418840607796598
biologics,83,4.418840607796598
QTc,83,4.418840607796598
Thirty,83,4.418840607796598
in-house,83,4.418840607796598
insulin,83,4.418840607796598
shifts,83,4.418840607796598
Regarding,83,4.418840607796598
possess,83,4.418840607796598
ozone,83,4.418840607796598
foundation,83,4.418840607796598
time-dependent,83,4.418840607796598
lowered,83,4.418840607796598
lupus,83,4.418840607796598
20th,83,4.418840607796598
consecutively,83,4.418840607796598
modulating,83,4.418840607796598
Echocardiography,83,4.418840607796598
113,83,4.418840607796598
aorta,83,4.418840607796598
Preliminary,83,4.418840607796598
contrary,83,4.418840607796598
autologous,83,4.418840607796598
accept,83,4.418840607796598
Endovascular,82,4.406719247264253
Mechanical,82,4.406719247264253
constantly,82,4.406719247264253
Vietnam,82,4.406719247264253
newborn,82,4.406719247264253
depth,82,4.406719247264253
seriously,82,4.406719247264253
besides,82,4.406719247264253
quadrivalent,82,4.406719247264253
achievement,82,4.406719247264253
Cerebrovascular,82,4.406719247264253
VA,82,4.406719247264253
falls,82,4.406719247264253
CHF,82,4.406719247264253
CBF,82,4.406719247264253
solely,82,4.406719247264253
resolve,82,4.406719247264253
positives,82,4.406719247264253
thalamus,82,4.406719247264253
feeding,82,4.406719247264253
industrial,82,4.406719247264253
Purpose-,82,4.406719247264253
reflow,82,4.406719247264253
Academy,82,4.406719247264253
unselected,82,4.406719247264253
replicate,82,4.406719247264253
bridging,82,4.406719247264253
Oral,82,4.406719247264253
overwhelming,82,4.406719247264253
Conclusions-,82,4.406719247264253
chains,82,4.406719247264253
depletion,82,4.406719247264253
essentially,82,4.406719247264253
N2,82,4.406719247264253
separated,82,4.406719247264253
comes,82,4.406719247264253
leukocytes,82,4.406719247264253
immunofluorescence,82,4.406719247264253
SARS‐CoV‐2,82,4.406719247264253
potassium,82,4.406719247264253
circulated,82,4.406719247264253
SES,82,4.406719247264253
Methods-,82,4.406719247264253
abilities,82,4.406719247264253
142,82,4.406719247264253
liquid,81,4.394449154672439
3rd,81,4.394449154672439
cardioprotective,81,4.394449154672439
lasted,81,4.394449154672439
one-year,81,4.394449154672439
undertook,81,4.394449154672439
atherothrombotic,81,4.394449154672439
Major,81,4.394449154672439
investigates,81,4.394449154672439
PPCI,81,4.394449154672439
news,81,4.394449154672439
sport,81,4.394449154672439
cross-reactive,81,4.394449154672439
Eleven,81,4.394449154672439
CHA2DS2-VASc,81,4.394449154672439
simply,81,4.394449154672439
nifedipine,81,4.394449154672439
univariate,81,4.394449154672439
quantity,81,4.394449154672439
cromolyn,81,4.394449154672439
BBB,81,4.394449154672439
independence,81,4.394449154672439
AIV,81,4.394449154672439
encoding,81,4.394449154672439
discover,81,4.394449154672439
instrumental,81,4.394449154672439
judged,81,4.394449154672439
AV,81,4.394449154672439
RVI,81,4.394449154672439
dose-response,81,4.394449154672439
explains,81,4.394449154672439
Twelve,81,4.394449154672439
144,81,4.394449154672439
TMPRSS2,81,4.394449154672439
partnership,81,4.394449154672439
Possible,81,4.394449154672439
latent,81,4.394449154672439
Poor,81,4.394449154672439
hemorrhages,81,4.394449154672439
worsened,80,4.382026634673881
lipids,80,4.382026634673881
Services,80,4.382026634673881
HIV-infected,80,4.382026634673881
nausea,80,4.382026634673881
school-based,80,4.382026634673881
draw,80,4.382026634673881
201,80,4.382026634673881
Optimal,80,4.382026634673881
nontransmural,80,4.382026634673881
Ventricular,80,4.382026634673881
spent,80,4.382026634673881
TDI,80,4.382026634673881
whites,80,4.382026634673881
willing,80,4.382026634673881
albumin,80,4.382026634673881
turned,80,4.382026634673881
flexible,80,4.382026634673881
CA,80,4.382026634673881
temperatures,80,4.382026634673881
overlapping,80,4.382026634673881
vaccinees,80,4.382026634673881
throughput,80,4.382026634673881
age-specific,80,4.382026634673881
124,80,4.382026634673881
characterizing,80,4.382026634673881
unpredictable,80,4.382026634673881
student,80,4.382026634673881
catastrophic,80,4.382026634673881
completion,80,4.382026634673881
end-systolic,80,4.382026634673881
Coronaviruses,80,4.382026634673881
profiling,80,4.382026634673881
session,80,4.382026634673881
commonest,80,4.382026634673881
native,80,4.382026634673881
acquire,80,4.382026634673881
worked,80,4.382026634673881
ICA,80,4.382026634673881
Report,80,4.382026634673881
discrimination,80,4.382026634673881
justified,80,4.382026634673881
consequent,79,4.3694478524670215
Imaging,79,4.3694478524670215
equilibrium,79,4.3694478524670215
histologic,79,4.3694478524670215
In-hospital,79,4.3694478524670215
dexamethasone,79,4.3694478524670215
audit,79,4.3694478524670215
133,79,4.3694478524670215
07,79,4.3694478524670215
losses,79,4.3694478524670215
equine,79,4.3694478524670215
isoproterenol,79,4.3694478524670215
codes,79,4.3694478524670215
Project,79,4.3694478524670215
remarkably,79,4.3694478524670215
devoted,79,4.3694478524670215
plausible,79,4.3694478524670215
abuse,79,4.3694478524670215
Nurses,79,4.3694478524670215
extracts,79,4.3694478524670215
hospitalisations,79,4.3694478524670215
elusive,79,4.3694478524670215
Moderna,79,4.3694478524670215
purified,79,4.3694478524670215
assisted,79,4.3694478524670215
alteplase,79,4.3694478524670215
peoples,79,4.3694478524670215
bodies,79,4.3694478524670215
Plasma,79,4.3694478524670215
mitochondrial,79,4.3694478524670215
virions,79,4.3694478524670215
antiphospholipid,79,4.3694478524670215
implanted,79,4.3694478524670215
till,79,4.3694478524670215
143,79,4.3694478524670215
advised,79,4.3694478524670215
Turkey,79,4.3694478524670215
normalization,79,4.3694478524670215
inoculated,79,4.3694478524670215
meteorological,79,4.3694478524670215
proximity,79,4.3694478524670215
preferences,79,4.3694478524670215
protects,79,4.3694478524670215
comprehensively,79,4.3694478524670215
137,79,4.3694478524670215
Southeast,79,4.3694478524670215
collapse,79,4.3694478524670215
PMI,78,4.356708826689592
low-cost,78,4.356708826689592
creation,78,4.356708826689592
discriminant,78,4.356708826689592
keeping,78,4.356708826689592
CF,78,4.356708826689592
eczema,78,4.356708826689592
counterparts,78,4.356708826689592
ultrasonography,78,4.356708826689592
comprise,78,4.356708826689592
hyper-responsiveness,78,4.356708826689592
strengthen,78,4.356708826689592
helping,78,4.356708826689592
stopped,78,4.356708826689592
administer,78,4.356708826689592
electron,78,4.356708826689592
helper,78,4.356708826689592
165,78,4.356708826689592
confirming,78,4.356708826689592
conference,78,4.356708826689592
Improved,78,4.356708826689592
hard,78,4.356708826689592
particle,78,4.356708826689592
hormones,78,4.356708826689592
123,78,4.356708826689592
hyperacute,78,4.356708826689592
dependency,78,4.356708826689592
whilst,78,4.356708826689592
S2,78,4.356708826689592
diseased,78,4.356708826689592
cromoglycate,78,4.356708826689592
conceptual,78,4.356708826689592
185,78,4.356708826689592
discriminate,78,4.356708826689592
Whereas,78,4.356708826689592
cytotoxic,77,4.343805421853684
164,77,4.343805421853684
Apart,77,4.343805421853684
striking,77,4.343805421853684
interdisciplinary,77,4.343805421853684
foods,77,4.343805421853684
sewage,77,4.343805421853684
ideas,77,4.343805421853684
mV,77,4.343805421853684
distinction,77,4.343805421853684
recombination,77,4.343805421853684
rhinosinusitis,77,4.343805421853684
isoenzyme,77,4.343805421853684
sinusitis,77,4.343805421853684
time-consuming,77,4.343805421853684
Notably,77,4.343805421853684
Traditional,77,4.343805421853684
immunology,77,4.343805421853684
neglected,77,4.343805421853684
advocated,77,4.343805421853684
inner,77,4.343805421853684
creatinine,77,4.343805421853684
primers,77,4.343805421853684
regurgitation,77,4.343805421853684
successive,77,4.343805421853684
Meanwhile,77,4.343805421853684
biosafety,77,4.343805421853684
olfactory,77,4.343805421853684
diuretics,77,4.343805421853684
school-aged,77,4.343805421853684
radiography,77,4.343805421853684
F,77,4.343805421853684
viewed,77,4.343805421853684
Every,77,4.343805421853684
covers,77,4.343805421853684
exacerbated,77,4.343805421853684
conditioning,77,4.343805421853684
deceased,77,4.343805421853684
murine,77,4.343805421853684
federal,77,4.343805421853684
confusion,77,4.343805421853684
invasion,77,4.343805421853684
Key,77,4.343805421853684
Computed,77,4.343805421853684
congestion,77,4.343805421853684
anterolateral,76,4.330733340286331
adding,76,4.330733340286331
somatic,76,4.330733340286331
SARI,76,4.330733340286331
passengers,76,4.330733340286331
binds,76,4.330733340286331
emotions,76,4.330733340286331
attendance,76,4.330733340286331
opinions,76,4.330733340286331
replaced,76,4.330733340286331
Incidence,76,4.330733340286331
choices,76,4.330733340286331
well-established,76,4.330733340286331
geometric,76,4.330733340286331
Statistical,76,4.330733340286331
basilar,76,4.330733340286331
claimed,76,4.330733340286331
age-matched,76,4.330733340286331
replace,76,4.330733340286331
hypothesize,76,4.330733340286331
hypothetical,76,4.330733340286331
apex,76,4.330733340286331
precisely,76,4.330733340286331
simulate,76,4.330733340286331
ventilated,76,4.330733340286331
hypoperfusion,76,4.330733340286331
interquartile,76,4.330733340286331
additive,76,4.330733340286331
notable,76,4.330733340286331
explaining,76,4.330733340286331
chronically,76,4.330733340286331
plastic,76,4.330733340286331
stool,76,4.330733340286331
malignancies,76,4.330733340286331
diabetics,76,4.330733340286331
Diabetes,76,4.330733340286331
doing,76,4.330733340286331
VT,76,4.330733340286331
v,76,4.330733340286331
differently,76,4.330733340286331
pets,76,4.330733340286331
downstream,76,4.330733340286331
degradation,76,4.330733340286331
substance,76,4.330733340286331
formal,76,4.330733340286331
stimulus,76,4.330733340286331
pumping,76,4.330733340286331
persisting,76,4.330733340286331
publicly,76,4.330733340286331
dermatitis,76,4.330733340286331
warrant,76,4.330733340286331
2-3,75,4.31748811353631
mRNA-1273,75,4.31748811353631
guinea,75,4.31748811353631
authorized,75,4.31748811353631
saved,75,4.31748811353631
teachers,75,4.31748811353631
reversed,75,4.31748811353631
Better,75,4.31748811353631
grades,75,4.31748811353631
registers,75,4.31748811353631
unanswered,75,4.31748811353631
membranes,75,4.31748811353631
leukotrienes,75,4.31748811353631
irritants,75,4.31748811353631
prioritized,75,4.31748811353631
Prospective,75,4.31748811353631
reconstruction,75,4.31748811353631
3-month,75,4.31748811353631
hemoglobin,75,4.31748811353631
dominated,75,4.31748811353631
LDH,75,4.31748811353631
rules,75,4.31748811353631
facilitates,75,4.31748811353631
ANew,75,4.31748811353631
web,75,4.31748811353631
allele,75,4.31748811353631
pertinent,75,4.31748811353631
originating,75,4.31748811353631
Animal,75,4.31748811353631
Dutch,75,4.31748811353631
Important,75,4.31748811353631
note,75,4.31748811353631
immunosuppressed,75,4.31748811353631
600,75,4.31748811353631
201Tl,74,4.30406509320417
pyrophosphate,74,4.30406509320417
virus-induced,74,4.30406509320417
optimizing,74,4.30406509320417
PM,74,4.30406509320417
Quantitative,74,4.30406509320417
interpret,74,4.30406509320417
subcutaneous,74,4.30406509320417
mixture,74,4.30406509320417
locally,74,4.30406509320417
discussions,74,4.30406509320417
supplement,74,4.30406509320417
intravenously,74,4.30406509320417
ACO,74,4.30406509320417
clustered,74,4.30406509320417
157,74,4.30406509320417
sensor,74,4.30406509320417
elsewhere,74,4.30406509320417
herbal,74,4.30406509320417
Pakistan,74,4.30406509320417
answered,74,4.30406509320417
transported,74,4.30406509320417
CFR,74,4.30406509320417
homocysteine,74,4.30406509320417
big,74,4.30406509320417
ablation,74,4.30406509320417
mononuclear,74,4.30406509320417
LBBB,74,4.30406509320417
translated,74,4.30406509320417
concentrated,74,4.30406509320417
parietal,74,4.30406509320417
pharyngeal,74,4.30406509320417
wk,74,4.30406509320417
S-OIV,74,4.30406509320417
presently,74,4.30406509320417
ACE-2,74,4.30406509320417
districts,74,4.30406509320417
continents,74,4.30406509320417
ascertained,74,4.30406509320417
evidences,74,4.30406509320417
frontline,74,4.30406509320417
security,74,4.30406509320417
determines,74,4.30406509320417
pre-pandemic,74,4.30406509320417
inside,74,4.30406509320417
integrate,74,4.30406509320417
harm,74,4.30406509320417
earliest,74,4.30406509320417
recipient,73,4.290459441148391
justify,73,4.290459441148391
coexisting,73,4.290459441148391
arrived,73,4.290459441148391
syndromic,73,4.290459441148391
pharmacists,73,4.290459441148391
TOAST,73,4.290459441148391
EBC,73,4.290459441148391
acts,73,4.290459441148391
promotes,73,4.290459441148391
diurnal,73,4.290459441148391
projects,73,4.290459441148391
derivatives,73,4.290459441148391
SR,73,4.290459441148391
WUS,73,4.290459441148391
exceeding,73,4.290459441148391
additionally,73,4.290459441148391
Recognition,73,4.290459441148391
Thirteen,73,4.290459441148391
broad-spectrum,73,4.290459441148391
strengths,73,4.290459441148391
162,73,4.290459441148391
interventricular,73,4.290459441148391
collective,73,4.290459441148391
Union,73,4.290459441148391
diary,73,4.290459441148391
inversion,73,4.290459441148391
HS,73,4.290459441148391
executive,73,4.290459441148391
B-cell,73,4.290459441148391
dyslipidemia,73,4.290459441148391
said,73,4.290459441148391
pointed,73,4.290459441148391
drivers,73,4.290459441148391
MEDLINE,73,4.290459441148391
large-vessel,73,4.290459441148391
T-wave,73,4.290459441148391
homogeneous,73,4.290459441148391
inspiratory,73,4.290459441148391
separation,73,4.290459441148391
regenerative,73,4.290459441148391
unlike,73,4.290459441148391
impending,72,4.276666119016055
dimension,72,4.276666119016055
histopathological,72,4.276666119016055
And,72,4.276666119016055
CAM,72,4.276666119016055
AH1N12009,72,4.276666119016055
enlargement,72,4.276666119016055
schemes,72,4.276666119016055
occasions,72,4.276666119016055
Randomized,72,4.276666119016055
processed,72,4.276666119016055
bronchi,72,4.276666119016055
esophageal,72,4.276666119016055
msec,72,4.276666119016055
familiar,72,4.276666119016055
rooms,72,4.276666119016055
Scientific,72,4.276666119016055
Fourteen,72,4.276666119016055
Efforts,72,4.276666119016055
Groups,72,4.276666119016055
attachment,72,4.276666119016055
in-depth,72,4.276666119016055
Register,72,4.276666119016055
exertion,72,4.276666119016055
Clinic,72,4.276666119016055
naïve,72,4.276666119016055
trimester,72,4.276666119016055
insult,72,4.276666119016055
telemedicine,72,4.276666119016055
warrants,72,4.276666119016055
Potential,72,4.276666119016055
Together,72,4.276666119016055
141,72,4.276666119016055
intrathoracic,72,4.276666119016055
certainly,72,4.276666119016055
workshop,72,4.276666119016055
lysis,72,4.276666119016055
mildly,72,4.276666119016055
radiographs,72,4.276666119016055
Baseline,72,4.276666119016055
resection,72,4.276666119016055
Swine,72,4.276666119016055
calculation,72,4.276666119016055
interim,72,4.276666119016055
signalling,72,4.276666119016055
Exposure,72,4.276666119016055
mucous,71,4.2626798770413155
revealing,71,4.2626798770413155
ROS,71,4.2626798770413155
parenchyma,71,4.2626798770413155
Phylogenetic,71,4.2626798770413155
expectancy,71,4.2626798770413155
failures,71,4.2626798770413155
character,71,4.2626798770413155
preparing,71,4.2626798770413155
Aspirin,71,4.2626798770413155
M1,71,4.2626798770413155
thrombin,71,4.2626798770413155
kappa,71,4.2626798770413155
Neither,71,4.2626798770413155
forces,71,4.2626798770413155
hit,71,4.2626798770413155
PD,71,4.2626798770413155
microbiome,71,4.2626798770413155
long-lasting,71,4.2626798770413155
nationally,71,4.2626798770413155
166,71,4.2626798770413155
Reperfusion,71,4.2626798770413155
Cognitive,71,4.2626798770413155
fluorescent,71,4.2626798770413155
Survival,71,4.2626798770413155
scintigraphic,71,4.2626798770413155
mainland,71,4.2626798770413155
NIH,71,4.2626798770413155
aerobic,71,4.2626798770413155
words,71,4.2626798770413155
prime,71,4.2626798770413155
summarises,71,4.2626798770413155
AKI,71,4.2626798770413155
predominated,71,4.2626798770413155
format,71,4.2626798770413155
manipulation,71,4.2626798770413155
impossible,71,4.2626798770413155
stockpiling,71,4.2626798770413155
qPCR,71,4.2626798770413155
citizens,71,4.2626798770413155
intraaortic,71,4.2626798770413155
permits,71,4.2626798770413155
traffic,71,4.2626798770413155
145,71,4.2626798770413155
crude,71,4.2626798770413155
stimulating,71,4.2626798770413155
wood,71,4.2626798770413155
spectrometry,71,4.2626798770413155
try,71,4.2626798770413155
parainfluenza,71,4.2626798770413155
self,71,4.2626798770413155
prodromal,71,4.2626798770413155
distinctive,71,4.2626798770413155
trajectory,71,4.2626798770413155
Strategies,71,4.2626798770413155
layer,70,4.248495242049359
aureus,70,4.248495242049359
arguments,70,4.248495242049359
Air,70,4.248495242049359
built,70,4.248495242049359
averaged,70,4.248495242049359
high-resolution,70,4.248495242049359
fine,70,4.248495242049359
youth,70,4.248495242049359
accumulated,70,4.248495242049359
GI,70,4.248495242049359
Practices,70,4.248495242049359
iron,70,4.248495242049359
landscape,70,4.248495242049359
up-to-date,70,4.248495242049359
prospects,70,4.248495242049359
1983,70,4.248495242049359
modeled,70,4.248495242049359
transmembrane,70,4.248495242049359
advancing,70,4.248495242049359
organisms,70,4.248495242049359
S-T,70,4.248495242049359
reversal,70,4.248495242049359
intraoperative,70,4.248495242049359
holds,70,4.248495242049359
3CLpro,70,4.248495242049359
astrocytes,70,4.248495242049359
facial,70,4.248495242049359
obstacles,70,4.248495242049359
sectors,70,4.248495242049359
172,70,4.248495242049359
inhibits,70,4.248495242049359
resultant,70,4.248495242049359
misinformation,70,4.248495242049359
thoroughly,70,4.248495242049359
Plan,70,4.248495242049359
supplied,70,4.248495242049359
injections,70,4.248495242049359
upregulated,70,4.248495242049359
stressed,70,4.248495242049359
vasculopathy,70,4.248495242049359
exceeded,70,4.248495242049359
incidences,70,4.248495242049359
240,70,4.248495242049359
delivering,70,4.248495242049359
SCA,70,4.248495242049359
bronchoscopy,70,4.248495242049359
H7,70,4.248495242049359
Swedish,70,4.248495242049359
sham,70,4.248495242049359
side-effects,69,4.23410650459726
originally,69,4.23410650459726
169,69,4.23410650459726
nonallergic,69,4.23410650459726
homologous,69,4.23410650459726
orally,69,4.23410650459726
CE,69,4.23410650459726
transesophageal,69,4.23410650459726
signature,69,4.23410650459726
convincing,69,4.23410650459726
preserve,69,4.23410650459726
RT,69,4.23410650459726
transthoracic,69,4.23410650459726
colleagues,69,4.23410650459726
repurposed,69,4.23410650459726
beta-blocker,69,4.23410650459726
SA,69,4.23410650459726
expect,69,4.23410650459726
restored,69,4.23410650459726
loop,69,4.23410650459726
stored,69,4.23410650459726
covariates,69,4.23410650459726
minimally,69,4.23410650459726
listed,69,4.23410650459726
primer,69,4.23410650459726
initiative,69,4.23410650459726
opposed,69,4.23410650459726
mediating,69,4.23410650459726
boost,69,4.23410650459726
newborns,69,4.23410650459726
asthmas,69,4.23410650459726
IgE-mediated,69,4.23410650459726
az,69,4.23410650459726
pass,69,4.23410650459726
neurogenesis,69,4.23410650459726
MACE,69,4.23410650459726
conversion,69,4.23410650459726
exhibiting,69,4.23410650459726
p005,69,4.23410650459726
safer,69,4.23410650459726
Small,69,4.23410650459726
combine,69,4.23410650459726
pay,69,4.23410650459726
affordable,69,4.23410650459726
Nasopharyngeal,69,4.23410650459726
hematological,68,4.219507705176107
Cell,68,4.219507705176107
crises,68,4.219507705176107
PAF,68,4.219507705176107
radical,68,4.219507705176107
p001,68,4.219507705176107
opacities,68,4.219507705176107
skilled,68,4.219507705176107
signatures,68,4.219507705176107
U,68,4.219507705176107
chicken,68,4.219507705176107
153,68,4.219507705176107
extremity,68,4.219507705176107
nonatopic,68,4.219507705176107
Unlike,68,4.219507705176107
dengue,68,4.219507705176107
express,68,4.219507705176107
optimally,68,4.219507705176107
SS,68,4.219507705176107
existed,68,4.219507705176107
motivation,68,4.219507705176107
NAIs,68,4.219507705176107
estrogen,68,4.219507705176107
metoprolol,68,4.219507705176107
stiffness,68,4.219507705176107
glycoproteins,68,4.219507705176107
dipyridamole,68,4.219507705176107
difficult-to-treat,68,4.219507705176107
167,68,4.219507705176107
Dr,68,4.219507705176107
lot,68,4.219507705176107
Improvement,68,4.219507705176107
attenuation,68,4.219507705176107
accomplished,68,4.219507705176107
ship,68,4.219507705176107
serine,68,4.219507705176107
Prevalence,68,4.219507705176107
bronchiolitis,68,4.219507705176107
anticipate,68,4.219507705176107
span,68,4.219507705176107
disease-19,68,4.219507705176107
V4R,68,4.219507705176107
ECP,67,4.204692619390966
ground-glass,67,4.204692619390966
fairly,67,4.204692619390966
extra,67,4.204692619390966
choose,67,4.204692619390966
proof,67,4.204692619390966
multifaceted,67,4.204692619390966
path,67,4.204692619390966
fish,67,4.204692619390966
216,67,4.204692619390966
fragments,67,4.204692619390966
valvular,67,4.204692619390966
left-ventricular,67,4.204692619390966
prerequisite,67,4.204692619390966
geriatric,67,4.204692619390966
nitrogen,67,4.204692619390966
sensors,67,4.204692619390966
Standard,67,4.204692619390966
waste,67,4.204692619390966
Medline,67,4.204692619390966
assume,67,4.204692619390966
uneventful,67,4.204692619390966
nucleoprotein,67,4.204692619390966
opposite,67,4.204692619390966
workload,67,4.204692619390966
occasional,67,4.204692619390966
detects,67,4.204692619390966
149,67,4.204692619390966
encounter,67,4.204692619390966
compensation,67,4.204692619390966
sophisticated,67,4.204692619390966
1982,67,4.204692619390966
Chile,67,4.204692619390966
bronchiectasis,67,4.204692619390966
abundant,67,4.204692619390966
gross,67,4.204692619390966
RH,67,4.204692619390966
Median,67,4.204692619390966
Council,67,4.204692619390966
Brazilian,67,4.204692619390966
tackle,67,4.204692619390966
alarming,67,4.204692619390966
self-care,67,4.204692619390966
encounters,67,4.204692619390966
clues,66,4.189654742026425
•,66,4.189654742026425
148,66,4.189654742026425
pertaining,66,4.189654742026425
occupation,66,4.189654742026425
elementary,66,4.189654742026425
nonpharmaceutical,66,4.189654742026425
interactive,66,4.189654742026425
traumatic,66,4.189654742026425
preference,66,4.189654742026425
mouth,66,4.189654742026425
respiration,66,4.189654742026425
whereby,66,4.189654742026425
Exhaled,66,4.189654742026425
Eighteen,66,4.189654742026425
discomfort,66,4.189654742026425
synergistic,66,4.189654742026425
branches,66,4.189654742026425
onto,66,4.189654742026425
és,66,4.189654742026425
156,66,4.189654742026425
underlie,66,4.189654742026425
enrollment,66,4.189654742026425
PB2,66,4.189654742026425
hamsters,66,4.189654742026425
Samples,66,4.189654742026425
provoked,66,4.189654742026425
referring,66,4.189654742026425
entering,66,4.189654742026425
identity,66,4.189654742026425
SNPs,66,4.189654742026425
irradiation,66,4.189654742026425
vocal,66,4.189654742026425
HRQL,66,4.189654742026425
ppb,66,4.189654742026425
IR,66,4.189654742026425
nutrition,66,4.189654742026425
salt,66,4.189654742026425
transcriptase-polymerase,66,4.189654742026425
prothrombotic,66,4.189654742026425
shortcomings,66,4.189654742026425
adult-onset,66,4.189654742026425
standardised,66,4.189654742026425
gradient,66,4.189654742026425
PR,66,4.189654742026425
Appropriate,66,4.189654742026425
0004,66,4.189654742026425
community-acquired,66,4.189654742026425
glutathione,66,4.189654742026425
inducible,66,4.189654742026425
confirmatory,66,4.189654742026425
H2N2,66,4.189654742026425
egg,66,4.189654742026425
mutational,66,4.189654742026425
think,66,4.189654742026425
utilize,66,4.189654742026425
Anxiety,66,4.189654742026425
synthesized,66,4.189654742026425
Rehabilitation,65,4.174387269895637
Magnetic,65,4.174387269895637
doubt,65,4.174387269895637
hepatitis,65,4.174387269895637
identifiable,65,4.174387269895637
152,65,4.174387269895637
urgency,65,4.174387269895637
walls,65,4.174387269895637
positions,65,4.174387269895637
cell-mediated,65,4.174387269895637
activating,65,4.174387269895637
tropism,65,4.174387269895637
discussing,65,4.174387269895637
1979,65,4.174387269895637
merits,65,4.174387269895637
Vero,65,4.174387269895637
Database,65,4.174387269895637
Th1,65,4.174387269895637
arch,65,4.174387269895637
adopt,65,4.174387269895637
gestation,65,4.174387269895637
203,65,4.174387269895637
infects,65,4.174387269895637
suppressed,65,4.174387269895637
Safety,65,4.174387269895637
disrupted,65,4.174387269895637
HT,65,4.174387269895637
lymphopenia,65,4.174387269895637
imply,65,4.174387269895637
noticed,65,4.174387269895637
192,65,4.174387269895637
hyperplasia,65,4.174387269895637
phenotyping,65,4.174387269895637
QIV,65,4.174387269895637
forecast,65,4.174387269895637
12-month,65,4.174387269895637
randomization,65,4.174387269895637
IU,65,4.174387269895637
engaged,65,4.174387269895637
exponential,65,4.174387269895637
blood-brain,65,4.174387269895637
looking,65,4.174387269895637
delirium,65,4.174387269895637
scheduled,65,4.174387269895637
differentially,65,4.174387269895637
San,65,4.174387269895637
regulators,65,4.174387269895637
SU,65,4.174387269895637
pure,65,4.174387269895637
hypoxic,65,4.174387269895637
Xpress,65,4.174387269895637
filtration,65,4.174387269895637
Less,65,4.174387269895637
bound,65,4.174387269895637
age-,65,4.174387269895637
geographically,65,4.174387269895637
205,65,4.174387269895637
accessibility,65,4.174387269895637
nCoV-19,65,4.174387269895637
1990s,64,4.1588830833596715
Mexican,64,4.1588830833596715
imposed,64,4.1588830833596715
Antigen,64,4.1588830833596715
visualized,64,4.1588830833596715
chloroquine,64,4.1588830833596715
eNO,64,4.1588830833596715
instructions,64,4.1588830833596715
radiologic,64,4.1588830833596715
Nineteen,64,4.1588830833596715
006,64,4.1588830833596715
schizophrenia,64,4.1588830833596715
ferret,64,4.1588830833596715
move,64,4.1588830833596715
advancements,64,4.1588830833596715
mechanics,64,4.1588830833596715
displacement,64,4.1588830833596715
sensing,64,4.1588830833596715
age-related,64,4.1588830833596715
hampered,64,4.1588830833596715
hyperlipidemia,64,4.1588830833596715
AA,64,4.1588830833596715
hemodialysis,64,4.1588830833596715
percentages,64,4.1588830833596715
biosensor,64,4.1588830833596715
presumably,64,4.1588830833596715
hallmark,64,4.1588830833596715
alleviate,64,4.1588830833596715
enrichment,64,4.1588830833596715
angiograms,64,4.1588830833596715
eligibility,64,4.1588830833596715
markets,64,4.1588830833596715
174,64,4.1588830833596715
modifiers,64,4.1588830833596715
cm,64,4.1588830833596715
tends,64,4.1588830833596715
radial,64,4.1588830833596715
SARS-Cov-2,64,4.1588830833596715
Post-stroke,64,4.1588830833596715
arrhythmic,64,4.1588830833596715
Subsequent,64,4.1588830833596715
conformational,64,4.1588830833596715
333,64,4.1588830833596715
vestibular,64,4.1588830833596715
Xpert,64,4.1588830833596715
hypersecretion,64,4.1588830833596715
t,64,4.1588830833596715
canine,64,4.1588830833596715
Systematic,64,4.1588830833596715
Asthmatic,64,4.1588830833596715
hematologic,64,4.1588830833596715
next-generation,64,4.1588830833596715
turnaround,64,4.1588830833596715
Complications,64,4.1588830833596715
Intervention,64,4.1588830833596715
determinations,64,4.1588830833596715
SE,64,4.1588830833596715
video,64,4.1588830833596715
Immunology,64,4.1588830833596715
hyperinflation,64,4.1588830833596715
saving,64,4.1588830833596715
Vascular,64,4.1588830833596715
proteomics,63,4.143134726391533
recall,63,4.143134726391533
RNA-dependent,63,4.143134726391533
proxy,63,4.143134726391533
pace,63,4.143134726391533
unaffected,63,4.143134726391533
veterinary,63,4.143134726391533
Elderly,63,4.143134726391533
delaying,63,4.143134726391533
Fifty,63,4.143134726391533
monovalent,63,4.143134726391533
replicated,63,4.143134726391533
171,63,4.143134726391533
Journal,63,4.143134726391533
graded,63,4.143134726391533
ligand,63,4.143134726391533
eggs,63,4.143134726391533
receipt,63,4.143134726391533
GR,63,4.143134726391533
Shanghai,63,4.143134726391533
Egypt,63,4.143134726391533
misdiagnosed,63,4.143134726391533
chart,63,4.143134726391533
Infections,63,4.143134726391533
antimicrobial,63,4.143134726391533
Lastly,63,4.143134726391533
1-2,63,4.143134726391533
138,63,4.143134726391533
151,63,4.143134726391533
recurrences,63,4.143134726391533
preterm,63,4.143134726391533
Any,63,4.143134726391533
three-dimensional,63,4.143134726391533
cruise,63,4.143134726391533
log10,63,4.143134726391533
London,63,4.143134726391533
RAS,63,4.143134726391533
extending,63,4.143134726391533
decided,63,4.143134726391533
Streptococcus,63,4.143134726391533
administering,63,4.143134726391533
chemicals,63,4.143134726391533
Almost,63,4.143134726391533
alongside,63,4.143134726391533
T1,63,4.143134726391533
Sixteen,63,4.143134726391533
incorporates,63,4.143134726391533
sclerosis,63,4.143134726391533
biases,63,4.143134726391533
post-pandemic,63,4.143134726391533
feelings,63,4.143134726391533
delineate,63,4.143134726391533
reservoirs,63,4.143134726391533
β,63,4.143134726391533
10-year,63,4.143134726391533
modifying,63,4.143134726391533
St,63,4.143134726391533
virus-specific,63,4.143134726391533
albeit,63,4.143134726391533
Protection,63,4.143134726391533
tracheal,63,4.143134726391533
hypercholesterolemia,63,4.143134726391533
relates,63,4.143134726391533
N501Y,63,4.143134726391533
X,63,4.143134726391533
omalizumab,63,4.143134726391533
classifications,63,4.143134726391533
quantifying,63,4.143134726391533
organism,63,4.143134726391533
endocardial,63,4.143134726391533
high-income,63,4.143134726391533
incompletely,63,4.143134726391533
exceed,63,4.143134726391533
single-stranded,63,4.143134726391533
late-onset,63,4.143134726391533
zero,63,4.143134726391533
destruction,63,4.143134726391533
wound,63,4.143134726391533
rated,62,4.127134385045092
PPV,62,4.127134385045092
real-life,62,4.127134385045092
antigenicity,62,4.127134385045092
Is,62,4.127134385045092
precipitating,62,4.127134385045092
wedge,62,4.127134385045092
RIDT,62,4.127134385045092
Pregnant,62,4.127134385045092
carrier,62,4.127134385045092
coefficients,62,4.127134385045092
medicinal,62,4.127134385045092
intramuscular,62,4.127134385045092
TIAs,62,4.127134385045092
shorten,62,4.127134385045092
specificities,62,4.127134385045092
NAEPP,62,4.127134385045092
ARD,62,4.127134385045092
state-of-the-art,62,4.127134385045092
capital,62,4.127134385045092
maturation,62,4.127134385045092
Denmark,62,4.127134385045092
Extensive,62,4.127134385045092
launched,62,4.127134385045092
playing,62,4.127134385045092
oncology,62,4.127134385045092
combines,62,4.127134385045092
tracts,62,4.127134385045092
spaces,62,4.127134385045092
thorax,62,4.127134385045092
Chicago,62,4.127134385045092
168,62,4.127134385045092
diaphragm,62,4.127134385045092
stockpile,62,4.127134385045092
avenues,62,4.127134385045092
statements,62,4.127134385045092
ready,62,4.127134385045092
hematopoietic,62,4.127134385045092
HLA,62,4.127134385045092
cardiomyocyte,62,4.127134385045092
hepatic,62,4.127134385045092
CR,62,4.127134385045092
EMBASE,62,4.127134385045092
style,62,4.127134385045092
endothelium,62,4.127134385045092
lab,62,4.127134385045092
rehabilitative,62,4.127134385045092
posing,62,4.127134385045092
hormonal,62,4.127134385045092
beta-agonists,62,4.127134385045092
Russian,62,4.127134385045092
perfect,62,4.127134385045092
atmospheric,62,4.127134385045092
differentiating,62,4.127134385045092
beta2-agonists,62,4.127134385045092
Forty,62,4.127134385045092
schedule,62,4.127134385045092
2nd,62,4.127134385045092
rollout,62,4.127134385045092
countermeasures,62,4.127134385045092
policymakers,62,4.127134385045092
ageing,62,4.127134385045092
cardioembolism,62,4.127134385045092
dizziness,62,4.127134385045092
shortened,61,4.110873864173311
labeled,61,4.110873864173311
burdens,61,4.110873864173311
relieve,61,4.110873864173311
008,61,4.110873864173311
90-day,61,4.110873864173311
farms,61,4.110873864173311
T2-weighted,61,4.110873864173311
2-year,61,4.110873864173311
multicentre,61,4.110873864173311
glycosylation,61,4.110873864173311
climatic,61,4.110873864173311
postural,61,4.110873864173311
Yamagata,61,4.110873864173311
ahead,61,4.110873864173311
microscopic,61,4.110873864173311
5-10,61,4.110873864173311
oseltamivir-resistant,61,4.110873864173311
wake-up,61,4.110873864173311
fighting,61,4.110873864173311
lay,61,4.110873864173311
Elevated,61,4.110873864173311
vehicle,61,4.110873864173311
AND,61,4.110873864173311
reality,61,4.110873864173311
210,61,4.110873864173311
enveloped,61,4.110873864173311
psychosomatic,61,4.110873864173311
beta-adrenergic,61,4.110873864173311
condensate,61,4.110873864173311
spectral,61,4.110873864173311
notified,61,4.110873864173311
reserved,61,4.110873864173311
gamma,61,4.110873864173311
ventricles,61,4.110873864173311
mgml,61,4.110873864173311
ORF1ab,61,4.110873864173311
chances,61,4.110873864173311
infectiousness,61,4.110873864173311
pediatricians,61,4.110873864173311
introducing,61,4.110873864173311
discrete,61,4.110873864173311
Argentina,61,4.110873864173311
anomalies,61,4.110873864173311
anosmia,61,4.110873864173311
genesis,61,4.110873864173311
legal,61,4.110873864173311
impair,61,4.110873864173311
scored,61,4.110873864173311
qualified,61,4.110873864173311
Adult,61,4.110873864173311
labor,61,4.110873864173311
ganglia,61,4.110873864173311
implication,61,4.110873864173311
stresses,61,4.110873864173311
complicate,61,4.110873864173311
posterolateral,61,4.110873864173311
insertion,61,4.110873864173311
literacy,61,4.110873864173311
Cancer,61,4.110873864173311
disabled,61,4.110873864173311
contraindicated,61,4.110873864173311
Surgical,61,4.110873864173311
school-age,61,4.110873864173311
representation,61,4.110873864173311
159,61,4.110873864173311
metrics,61,4.110873864173311
closer,60,4.0943445622221
Previously,60,4.0943445622221
anomaly,60,4.0943445622221
radiologists,60,4.0943445622221
SARS-CoV-2-infected,60,4.0943445622221
refer,60,4.0943445622221
pacemaker,60,4.0943445622221
electrochemical,60,4.0943445622221
symptom-free,60,4.0943445622221
158,60,4.0943445622221
dysfunctional,60,4.0943445622221
exogenous,60,4.0943445622221
abundance,60,4.0943445622221
MCAO,60,4.0943445622221
altering,60,4.0943445622221
194,60,4.0943445622221
pdm09,60,4.0943445622221
NVAF,60,4.0943445622221
superiority,60,4.0943445622221
Trials,60,4.0943445622221
belonged,60,4.0943445622221
parenchymal,60,4.0943445622221
Greece,60,4.0943445622221
SLE,60,4.0943445622221
compression,60,4.0943445622221
attributes,60,4.0943445622221
212,60,4.0943445622221
equation,60,4.0943445622221
Now,60,4.0943445622221
SC,60,4.0943445622221
withdrawal,60,4.0943445622221
PCS,60,4.0943445622221
automatic,60,4.0943445622221
multidimensional,60,4.0943445622221
organizational,60,4.0943445622221
right-sided,60,4.0943445622221
Measurement,60,4.0943445622221
subdivided,60,4.0943445622221
FDA-approved,60,4.0943445622221
BT,60,4.0943445622221
plant,60,4.0943445622221
washing,60,4.0943445622221
213,60,4.0943445622221
disaster,60,4.0943445622221
engineering,60,4.0943445622221
pitfalls,60,4.0943445622221
standardization,60,4.0943445622221
sialic,60,4.0943445622221
1974,60,4.0943445622221
IAVs,60,4.0943445622221
constructs,60,4.0943445622221
intractable,60,4.0943445622221
Viruses,60,4.0943445622221
Common,60,4.0943445622221
thyroid,60,4.0943445622221
intraventricular,60,4.0943445622221
blind,60,4.0943445622221
RAST,60,4.0943445622221
ruled,60,4.0943445622221
ending,59,4.07753744390572
mL,59,4.07753744390572
summarise,59,4.07753744390572
075,59,4.07753744390572
educate,59,4.07753744390572
rTMS,59,4.07753744390572
Seventeen,59,4.07753744390572
2D,59,4.07753744390572
renewed,59,4.07753744390572
neutrophilic,59,4.07753744390572
leaders,59,4.07753744390572
messenger,59,4.07753744390572
sedentary,59,4.07753744390572
Vitamin,59,4.07753744390572
numerical,59,4.07753744390572
bioinformatics,59,4.07753744390572
Ischaemic,59,4.07753744390572
slowly,59,4.07753744390572
intelligence,59,4.07753744390572
Transient,59,4.07753744390572
reopening,59,4.07753744390572
tissue-type,59,4.07753744390572
permitted,59,4.07753744390572
surgically,59,4.07753744390572
reflex,59,4.07753744390572
interacting,59,4.07753744390572
inception,59,4.07753744390572
necessitates,59,4.07753744390572
CSF,59,4.07753744390572
RD,59,4.07753744390572
trait,59,4.07753744390572
Nearly,59,4.07753744390572
accessory,59,4.07753744390572
introductions,59,4.07753744390572
kinds,59,4.07753744390572
unfavourable,59,4.07753744390572
lymphatic,59,4.07753744390572
Examination,59,4.07753744390572
discoveries,59,4.07753744390572
loop-mediated,59,4.07753744390572
receiver,59,4.07753744390572
telestroke,59,4.07753744390572
neurology,59,4.07753744390572
ruptured,59,4.07753744390572
duty,59,4.07753744390572
gaining,59,4.07753744390572
disproportionate,59,4.07753744390572
hemispheres,59,4.07753744390572
brings,59,4.07753744390572
incorporation,59,4.07753744390572
Available,59,4.07753744390572
inferred,59,4.07753744390572
accumulating,59,4.07753744390572
163,59,4.07753744390572
mAbs,59,4.07753744390572
leaving,59,4.07753744390572
bowel,59,4.07753744390572
acquiring,59,4.07753744390572
Local,59,4.07753744390572
contagion,59,4.07753744390572
Authors,59,4.07753744390572
Asymptomatic,59,4.07753744390572
fracture,59,4.07753744390572
convened,59,4.07753744390572
meter,58,4.060443010546419
Young,58,4.060443010546419
certificates,58,4.060443010546419
apathy,58,4.060443010546419
PP,58,4.060443010546419
decide,58,4.060443010546419
paretic,58,4.060443010546419
Smoking,58,4.060443010546419
moyamoya,58,4.060443010546419
competition,58,4.060443010546419
atrophy,58,4.060443010546419
IFN-γ,58,4.060443010546419
fulfilled,58,4.060443010546419
Systemic,58,4.060443010546419
176,58,4.060443010546419
eventual,58,4.060443010546419
omics,58,4.060443010546419
multisystem,58,4.060443010546419
powder,58,4.060443010546419
breakthrough,58,4.060443010546419
voltage,58,4.060443010546419
preferentially,58,4.060443010546419
inference,58,4.060443010546419
cross-immunity,58,4.060443010546419
Embase,58,4.060443010546419
aggravate,58,4.060443010546419
non-Hispanic,58,4.060443010546419
146,58,4.060443010546419
Next,58,4.060443010546419
cystic,58,4.060443010546419
Prompt,58,4.060443010546419
178,58,4.060443010546419
overweight,58,4.060443010546419
workplaces,58,4.060443010546419
strictly,58,4.060443010546419
gastric,58,4.060443010546419
macaques,58,4.060443010546419
COVID‑19,58,4.060443010546419
3-4,58,4.060443010546419
positron,58,4.060443010546419
Hajj,58,4.060443010546419
Greater,58,4.060443010546419
defines,58,4.060443010546419
Nigeria,58,4.060443010546419
multimodal,58,4.060443010546419
rich,58,4.060443010546419
marginal,58,4.060443010546419
steadily,58,4.060443010546419
discrepancy,58,4.060443010546419
genome-wide,58,4.060443010546419
INR,58,4.060443010546419
web-based,58,4.060443010546419
unresolved,58,4.060443010546419
intolerance,58,4.060443010546419
N95,58,4.060443010546419
long-standing,58,4.060443010546419
compensatory,58,4.060443010546419
drug-resistant,58,4.060443010546419
Force,58,4.060443010546419
virion,58,4.060443010546419
BNP,58,4.060443010546419
players,58,4.060443010546419
lies,58,4.060443010546419
colorimetric,58,4.060443010546419
contexts,58,4.060443010546419
dendritic,58,4.060443010546419
case-patients,58,4.060443010546419
glass,57,4.04305126783455
affective,57,4.04305126783455
pharmacy,57,4.04305126783455
H1N109,57,4.04305126783455
disappearance,57,4.04305126783455
Clinically,57,4.04305126783455
Factor,57,4.04305126783455
well-defined,57,4.04305126783455
inequities,57,4.04305126783455
revision,57,4.04305126783455
trajectories,57,4.04305126783455
serially,57,4.04305126783455
contradictory,57,4.04305126783455
person-to-person,57,4.04305126783455
discrepancies,57,4.04305126783455
retained,57,4.04305126783455
conferred,57,4.04305126783455
self-administered,57,4.04305126783455
179,57,4.04305126783455
aVF,57,4.04305126783455
pipeline,57,4.04305126783455
209,57,4.04305126783455
IBD,57,4.04305126783455
MDCK,57,4.04305126783455
waning,57,4.04305126783455
universally,57,4.04305126783455
renin-angiotensin,57,4.04305126783455
architecture,57,4.04305126783455
EU,57,4.04305126783455
upcoming,57,4.04305126783455
steady,57,4.04305126783455
IgGIgM,57,4.04305126783455
preinfarction,57,4.04305126783455
comparatively,57,4.04305126783455
non-ST,57,4.04305126783455
cooling,57,4.04305126783455
MIS-C,57,4.04305126783455
hypercoagulable,57,4.04305126783455
logical,57,4.04305126783455
arteriopathy,57,4.04305126783455
danger,57,4.04305126783455
swimming,57,4.04305126783455
remove,57,4.04305126783455
Ireland,57,4.04305126783455
writing,57,4.04305126783455
District,57,4.04305126783455
electric,57,4.04305126783455
190,57,4.04305126783455
EVs,57,4.04305126783455
nerves,57,4.04305126783455
188,57,4.04305126783455
214,57,4.04305126783455
suppressing,57,4.04305126783455
codon,57,4.04305126783455
residing,57,4.04305126783455
MRA,56,4.02535169073515
ascertainment,56,4.02535169073515
primates,56,4.02535169073515
integrative,56,4.02535169073515
malignancy,56,4.02535169073515
exerts,56,4.02535169073515
latency,56,4.02535169073515
Response,56,4.02535169073515
respirators,56,4.02535169073515
ns,56,4.02535169073515
appreciation,56,4.02535169073515
multi-organ,56,4.02535169073515
contraindication,56,4.02535169073515
GC,56,4.02535169073515
provoke,56,4.02535169073515
perennial,56,4.02535169073515
island,56,4.02535169073515
feeling,56,4.02535169073515
prioritize,56,4.02535169073515
neutralize,56,4.02535169073515
SAH,56,4.02535169073515
enriched,56,4.02535169073515
237,56,4.02535169073515
quantities,56,4.02535169073515
inferoposterior,56,4.02535169073515
Barthel,56,4.02535169073515
submaximal,56,4.02535169073515
stabilized,56,4.02535169073515
negatives,56,4.02535169073515
expenditure,56,4.02535169073515
refined,56,4.02535169073515
alleles,56,4.02535169073515
inotropic,56,4.02535169073515
impedance,56,4.02535169073515
acidosis,56,4.02535169073515
realized,56,4.02535169073515
sub-Saharan,56,4.02535169073515
POCT,56,4.02535169073515
smoked,56,4.02535169073515
cedar,56,4.02535169073515
Exercise-induced,56,4.02535169073515
debilitating,56,4.02535169073515
pre-clinical,56,4.02535169073515
Alberta,56,4.02535169073515
chickens,56,4.02535169073515
compelling,56,4.02535169073515
stratify,56,4.02535169073515
surgeries,56,4.02535169073515
contraceptives,56,4.02535169073515
drinking,56,4.02535169073515
offspring,56,4.02535169073515
retention,56,4.02535169073515
Estimates,56,4.02535169073515
monotherapy,56,4.02535169073515
hydrochloride,56,4.02535169073515
engage,56,4.02535169073515
MVO,56,4.02535169073515
weaknesses,56,4.02535169073515
Interventions,56,4.02535169073515
sensitisation,56,4.02535169073515
Malaysia,56,4.02535169073515
favipiravir,56,4.02535169073515
band,56,4.02535169073515
conformation,56,4.02535169073515
hoped,56,4.02535169073515
197,56,4.02535169073515
septic,56,4.02535169073515
hot,56,4.02535169073515
154,56,4.02535169073515
postconditioning,56,4.02535169073515
amplified,56,4.02535169073515
375,56,4.02535169073515
Latino,56,4.02535169073515
microarray,56,4.02535169073515
passed,56,4.02535169073515
attenuate,56,4.02535169073515
LVAD,56,4.02535169073515
tidal,56,4.02535169073515
myositis,55,4.007333185232471
accordingly,55,4.007333185232471
IHD,55,4.007333185232471
198,55,4.007333185232471
competitive,55,4.007333185232471
blocker,55,4.007333185232471
transmissions,55,4.007333185232471
Areas,55,4.007333185232471
anti-asthma,55,4.007333185232471
masking,55,4.007333185232471
twenty,55,4.007333185232471
Bangladesh,55,4.007333185232471
aetiological,55,4.007333185232471
college,55,4.007333185232471
mo,55,4.007333185232471
excretion,55,4.007333185232471
deficiencies,55,4.007333185232471
non-ST-segment,55,4.007333185232471
mild-to-moderate,55,4.007333185232471
serologically,55,4.007333185232471
dollars,55,4.007333185232471
215,55,4.007333185232471
favour,55,4.007333185232471
shifted,55,4.007333185232471
titre,55,4.007333185232471
Government,55,4.007333185232471
virologic,55,4.007333185232471
underdiagnosed,55,4.007333185232471
waiting,55,4.007333185232471
aggravation,55,4.007333185232471
advancement,55,4.007333185232471
otitis,55,4.007333185232471
Coronavirus-2,55,4.007333185232471
shares,55,4.007333185232471
inequalities,55,4.007333185232471
counter,55,4.007333185232471
unusually,55,4.007333185232471
classifying,55,4.007333185232471
gated,55,4.007333185232471
charge,55,4.007333185232471
vagal,55,4.007333185232471
184,55,4.007333185232471
HRCT,55,4.007333185232471
E484K,55,4.007333185232471
belong,55,4.007333185232471
195,55,4.007333185232471
VCD,55,4.007333185232471
restrictive,55,4.007333185232471
deemed,55,4.007333185232471
non-allergic,55,4.007333185232471
thoracotomy,55,4.007333185232471
dabigatran,55,4.007333185232471
integrating,55,4.007333185232471
V2,55,4.007333185232471
palsy,55,4.007333185232471
2-D,55,4.007333185232471
am,55,4.007333185232471
prolongation,55,4.007333185232471
progressing,55,4.007333185232471
Complete,55,4.007333185232471
postmyocardial,55,4.007333185232471
stressors,55,4.007333185232471
correspond,55,4.007333185232471
Ab,55,4.007333185232471
eastern,55,4.007333185232471
VTM,55,4.007333185232471
conscious,55,4.007333185232471
flexibility,55,4.007333185232471
functionality,55,4.007333185232471
extraordinary,55,4.007333185232471
Outcome,55,4.007333185232471
Minnesota,55,4.007333185232471
kg,55,4.007333185232471
prestroke,55,4.007333185232471
passage,55,4.007333185232471
spatiotemporal,55,4.007333185232471
Day,55,4.007333185232471
photon,55,4.007333185232471
AM,54,3.9889840465642745
155,54,3.9889840465642745
217,54,3.9889840465642745
prednisolone,54,3.9889840465642745
log,54,3.9889840465642745
tamponade,54,3.9889840465642745
exciting,54,3.9889840465642745
0007,54,3.9889840465642745
regulations,54,3.9889840465642745
rejection,54,3.9889840465642745
thermal,54,3.9889840465642745
Scholar,54,3.9889840465642745
internationally,54,3.9889840465642745
Her,54,3.9889840465642745
007,54,3.9889840465642745
distant,54,3.9889840465642745
minorities,54,3.9889840465642745
static,54,3.9889840465642745
logistical,54,3.9889840465642745
neighborhood,54,3.9889840465642745
perceive,54,3.9889840465642745
vertigo,54,3.9889840465642745
fibers,54,3.9889840465642745
discontinued,54,3.9889840465642745
vision,54,3.9889840465642745
adjuvanted,54,3.9889840465642745
prioritization,54,3.9889840465642745
porcine,54,3.9889840465642745
pet,54,3.9889840465642745
abrupt,54,3.9889840465642745
analysing,54,3.9889840465642745
remainder,54,3.9889840465642745
supplemented,54,3.9889840465642745
DC,54,3.9889840465642745
fluctuations,54,3.9889840465642745
front,54,3.9889840465642745
purification,54,3.9889840465642745
idiopathic,54,3.9889840465642745
aberrant,54,3.9889840465642745
193,54,3.9889840465642745
rhythms,54,3.9889840465642745
skeletal,54,3.9889840465642745
ergometer,54,3.9889840465642745
confers,54,3.9889840465642745
door-to-balloon,54,3.9889840465642745
inevitable,54,3.9889840465642745
objectively,54,3.9889840465642745
TT,54,3.9889840465642745
1-3,54,3.9889840465642745
concludes,54,3.9889840465642745
rises,54,3.9889840465642745
vasculitis,54,3.9889840465642745
Very,54,3.9889840465642745
curb,54,3.9889840465642745
hands,54,3.9889840465642745
root,54,3.9889840465642745
subtle,54,3.9889840465642745
AHong,54,3.9889840465642745
reaches,54,3.9889840465642745
read,54,3.9889840465642745
nonasthmatic,54,3.9889840465642745
expenditures,54,3.9889840465642745
fibrin,54,3.9889840465642745
091,54,3.9889840465642745
Agency,54,3.9889840465642745
noncardiac,54,3.9889840465642745
going,54,3.9889840465642745
disturbed,54,3.9889840465642745
se,54,3.9889840465642745
Poisson,54,3.9889840465642745
announced,54,3.9889840465642745
Altogether,54,3.9889840465642745
Regular,54,3.9889840465642745
infiltrates,53,3.970291913552122
publics,53,3.970291913552122
asthma-specific,53,3.970291913552122
PD20,53,3.970291913552122
parenteral,53,3.970291913552122
selectively,53,3.970291913552122
situ,53,3.970291913552122
rheumatic,53,3.970291913552122
theoretically,53,3.970291913552122
177,53,3.970291913552122
hemiblock,53,3.970291913552122
placental,53,3.970291913552122
functionally,53,3.970291913552122
IA,53,3.970291913552122
012,53,3.970291913552122
searching,53,3.970291913552122
Continuous,53,3.970291913552122
mimicking,53,3.970291913552122
split,53,3.970291913552122
Certain,53,3.970291913552122
salivary,53,3.970291913552122
filter,53,3.970291913552122
witnessed,53,3.970291913552122
aminotransferase,53,3.970291913552122
Transmission,53,3.970291913552122
scalable,53,3.970291913552122
Dermatophagoides,53,3.970291913552122
Comprehensive,53,3.970291913552122
siblings,53,3.970291913552122
Failure,53,3.970291913552122
methylation,53,3.970291913552122
1980s,53,3.970291913552122
economies,53,3.970291913552122
fungi,53,3.970291913552122
swelling,53,3.970291913552122
surgeons,53,3.970291913552122
leukemia,53,3.970291913552122
balanced,53,3.970291913552122
TLRs,53,3.970291913552122
222,53,3.970291913552122
AQLQ,53,3.970291913552122
lag,53,3.970291913552122
biologically,53,3.970291913552122
ICD,53,3.970291913552122
pharmacies,53,3.970291913552122
LCX,53,3.970291913552122
interfering,53,3.970291913552122
specified,53,3.970291913552122
neuroplasticity,53,3.970291913552122
ADC,53,3.970291913552122
186,53,3.970291913552122
aura,53,3.970291913552122
construction,53,3.970291913552122
irritant,53,3.970291913552122
deterministic,53,3.970291913552122
IIbIIIa,53,3.970291913552122
jurisdictions,53,3.970291913552122
PB1,53,3.970291913552122
1972,53,3.970291913552122
tolerability,53,3.970291913552122
thoracoscopic,53,3.970291913552122
vigorous,53,3.970291913552122
Combined,53,3.970291913552122
gains,53,3.970291913552122
atheroma,53,3.970291913552122
person-years,53,3.970291913552122
seronegative,53,3.970291913552122
MPV,53,3.970291913552122
reinforce,53,3.970291913552122
advantageous,53,3.970291913552122
beclomethasone,53,3.970291913552122
consist,53,3.970291913552122
deletion,53,3.970291913552122
diaphragmatic,53,3.970291913552122
physically,53,3.970291913552122
node,52,3.9512437185814275
projected,52,3.9512437185814275
Highly,52,3.9512437185814275
subpopulations,52,3.9512437185814275
arises,52,3.9512437185814275
color,52,3.9512437185814275
non-valvular,52,3.9512437185814275
conjunctivitis,52,3.9512437185814275
pilgrims,52,3.9512437185814275
microg,52,3.9512437185814275
aeroallergens,52,3.9512437185814275
3-5,52,3.9512437185814275
immunopathology,52,3.9512437185814275
repolarization,52,3.9512437185814275
chloride,52,3.9512437185814275
Fever,52,3.9512437185814275
utmost,52,3.9512437185814275
supplements,52,3.9512437185814275
trace,52,3.9512437185814275
soldiers,52,3.9512437185814275
Danish,52,3.9512437185814275
183,52,3.9512437185814275
I2,52,3.9512437185814275
MCE,52,3.9512437185814275
H275Y,52,3.9512437185814275
ngml,52,3.9512437185814275
acetylsalicylic,52,3.9512437185814275
Staphylococcus,52,3.9512437185814275
copiesmL,52,3.9512437185814275
altitude,52,3.9512437185814275
indispensable,52,3.9512437185814275
ACIP,52,3.9512437185814275
NAI,52,3.9512437185814275
VEGF,52,3.9512437185814275
AstraZeneca,52,3.9512437185814275
exosomes,52,3.9512437185814275
round,52,3.9512437185814275
hematoma,52,3.9512437185814275
well-controlled,52,3.9512437185814275
Gene,52,3.9512437185814275
intercostal,52,3.9512437185814275
Commission,52,3.9512437185814275
Ongoing,52,3.9512437185814275
housing,52,3.9512437185814275
poverty,52,3.9512437185814275
physician-diagnosed,52,3.9512437185814275
thermoplasty,52,3.9512437185814275
instruction,52,3.9512437185814275
early-onset,52,3.9512437185814275
captured,52,3.9512437185814275
property,52,3.9512437185814275
exceptional,52,3.9512437185814275
switch,52,3.9512437185814275
Inc,52,3.9512437185814275
malformations,52,3.9512437185814275
EDs,52,3.9512437185814275
principally,52,3.9512437185814275
vasculature,52,3.9512437185814275
Scotland,52,3.9512437185814275
W,52,3.9512437185814275
FEV1FVC,52,3.9512437185814275
disparity,52,3.9512437185814275
nevertheless,52,3.9512437185814275
nonvalvular,52,3.9512437185814275
stromal,52,3.9512437185814275
impacting,52,3.9512437185814275
Severity,52,3.9512437185814275
infiltrate,52,3.9512437185814275
provocative,52,3.9512437185814275
suspect,52,3.9512437185814275
user,52,3.9512437185814275
hip,52,3.9512437185814275
ROC,52,3.9512437185814275
negligible,51,3.9318256327243257
nebulized,51,3.9318256327243257
Conventional,51,3.9318256327243257
imminent,51,3.9318256327243257
underused,51,3.9318256327243257
undertreatment,51,3.9318256327243257
187,51,3.9318256327243257
fill,51,3.9318256327243257
manifests,51,3.9318256327243257
descriptions,51,3.9318256327243257
macrophage,51,3.9318256327243257
hemiplegia,51,3.9318256327243257
neutral,51,3.9318256327243257
year-old,51,3.9318256327243257
mRNA-based,51,3.9318256327243257
moderate-to-severe,51,3.9318256327243257
Likewise,51,3.9318256327243257
vesicles,51,3.9318256327243257
indigenous,51,3.9318256327243257
LUS,51,3.9318256327243257
CD,51,3.9318256327243257
exhaustion,51,3.9318256327243257
Psychological,51,3.9318256327243257
miRNA,51,3.9318256327243257
Nowadays,51,3.9318256327243257
fMRI,51,3.9318256327243257
beta-agonist,51,3.9318256327243257
medial,51,3.9318256327243257
PTSD,51,3.9318256327243257
anginal,51,3.9318256327243257
healed,51,3.9318256327243257
equitable,51,3.9318256327243257
PPA,51,3.9318256327243257
belongs,51,3.9318256327243257
189,51,3.9318256327243257
averted,51,3.9318256327243257
creates,51,3.9318256327243257
suggestion,51,3.9318256327243257
B16172,51,3.9318256327243257
panels,51,3.9318256327243257
connections,51,3.9318256327243257
motif,51,3.9318256327243257
Universal,51,3.9318256327243257
Antigenic,51,3.9318256327243257
UL,51,3.9318256327243257
gases,51,3.9318256327243257
SF-36,51,3.9318256327243257
Hospitals,51,3.9318256327243257
disciplines,51,3.9318256327243257
investigational,51,3.9318256327243257
atheromatous,51,3.9318256327243257
delineated,51,3.9318256327243257
tachyarrhythmias,51,3.9318256327243257
urokinase,51,3.9318256327243257
patch,51,3.9318256327243257
bad,51,3.9318256327243257
prototype,51,3.9318256327243257
fails,51,3.9318256327243257
basement,51,3.9318256327243257
Lower,51,3.9318256327243257
multiorgan,51,3.9318256327243257
Logistic,51,3.9318256327243257
officially,51,3.9318256327243257
Part,51,3.9318256327243257
Critical,51,3.9318256327243257
novo,51,3.9318256327243257
Lack,51,3.9318256327243257
farm,51,3.9318256327243257
Timely,51,3.9318256327243257
keywords,51,3.9318256327243257
choosing,51,3.9318256327243257
loci,51,3.9318256327243257
neuropsychiatric,51,3.9318256327243257
ignored,51,3.9318256327243257
eliminated,51,3.9318256327243257
specialty,51,3.9318256327243257
interruption,51,3.9318256327243257
assembly,50,3.912023005428146
oil,50,3.912023005428146
ribavirin,50,3.912023005428146
ion,50,3.912023005428146
METHODS,50,3.912023005428146
BD,50,3.912023005428146
Symptomatic,50,3.912023005428146
minimise,50,3.912023005428146
gatherings,50,3.912023005428146
periprocedural,50,3.912023005428146
nighttime,50,3.912023005428146
011,50,3.912023005428146
adjust,50,3.912023005428146
residue,50,3.912023005428146
088,50,3.912023005428146
compiled,50,3.912023005428146
starts,50,3.912023005428146
Owing,50,3.912023005428146
underscores,50,3.912023005428146
bearing,50,3.912023005428146
stressful,50,3.912023005428146
vaccine-related,50,3.912023005428146
hay,50,3.912023005428146
truly,50,3.912023005428146
deteriorated,50,3.912023005428146
2010-2011,50,3.912023005428146
decisive,50,3.912023005428146
strengthening,50,3.912023005428146
farmers,50,3.912023005428146
VITT,50,3.912023005428146
left-sided,50,3.912023005428146
communicable,50,3.912023005428146
economical,50,3.912023005428146
accelerating,50,3.912023005428146
PCR-confirmed,50,3.912023005428146
Office,50,3.912023005428146
cerebellum,50,3.912023005428146
Practice,50,3.912023005428146
dilated,50,3.912023005428146
antiasthmatic,50,3.912023005428146
Caucasian,50,3.912023005428146
chemokine,50,3.912023005428146
Main,50,3.912023005428146
feces,50,3.912023005428146
moved,50,3.912023005428146
forecasting,50,3.912023005428146
grown,50,3.912023005428146
preferably,50,3.912023005428146
Sentinel,50,3.912023005428146
cultured,50,3.912023005428146
Prehospital,50,3.912023005428146
electrophysiological,50,3.912023005428146
inherited,50,3.912023005428146
psychologic,50,3.912023005428146
bolus,50,3.912023005428146
NOACs,50,3.912023005428146
engineered,50,3.912023005428146
Today,50,3.912023005428146
Worldwide,50,3.912023005428146
fair,50,3.912023005428146
salvageable,50,3.912023005428146
orientation,50,3.912023005428146
Arterial,50,3.912023005428146
Nepal,50,3.912023005428146
N-terminal,50,3.912023005428146
eliminating,50,3.912023005428146
mutated,50,3.912023005428146
Having,50,3.912023005428146
Texas,50,3.912023005428146
retinal,50,3.912023005428146
laboratory-based,50,3.912023005428146
full-length,50,3.912023005428146
trade,50,3.912023005428146
digestive,50,3.912023005428146
Anterior,50,3.912023005428146
subunits,50,3.912023005428146
yields,50,3.912023005428146
erythematosus,50,3.912023005428146
rating,50,3.912023005428146
forming,50,3.912023005428146
lived,50,3.912023005428146
notion,50,3.912023005428146
formulate,50,3.912023005428146
fecal,50,3.912023005428146
trying,50,3.912023005428146
peer,50,3.912023005428146
161,50,3.912023005428146
235,50,3.912023005428146
Screening,50,3.912023005428146
feline,50,3.912023005428146
ameliorate,50,3.912023005428146
booster,50,3.912023005428146
dropped,50,3.912023005428146
Fortunately,50,3.912023005428146
Fifteen,50,3.912023005428146
cited,50,3.912023005428146
IM,50,3.912023005428146
Mg,50,3.912023005428146
immunoglobulins,50,3.912023005428146
augment,50,3.912023005428146
intent,50,3.912023005428146
suitability,50,3.912023005428146
N1,50,3.912023005428146
fitted,50,3.912023005428146
Convalescent,50,3.912023005428146
characterizes,49,3.8918202981106265
went,49,3.8918202981106265
SARS-CoV-2-positive,49,3.8918202981106265
BHong,49,3.8918202981106265
extends,49,3.8918202981106265
subtropical,49,3.8918202981106265
contents,49,3.8918202981106265
controversies,49,3.8918202981106265
microorganisms,49,3.8918202981106265
one-step,49,3.8918202981106265
inspired,49,3.8918202981106265
yielding,49,3.8918202981106265
P001,49,3.8918202981106265
0025,49,3.8918202981106265
CO,49,3.8918202981106265
resource-limited,49,3.8918202981106265
disappointing,49,3.8918202981106265
SSA,49,3.8918202981106265
continually,49,3.8918202981106265
Preparedness,49,3.8918202981106265
coincided,49,3.8918202981106265
expressions,49,3.8918202981106265
vasoconstriction,49,3.8918202981106265
nowadays,49,3.8918202981106265
SI,49,3.8918202981106265
Daily,49,3.8918202981106265
Swiss,49,3.8918202981106265
causality,49,3.8918202981106265
CRISPR,49,3.8918202981106265
augmented,49,3.8918202981106265
non-structural,49,3.8918202981106265
muscular,49,3.8918202981106265
Anti-SARS-CoV-2,49,3.8918202981106265
prevalences,49,3.8918202981106265
velocities,49,3.8918202981106265
visiting,49,3.8918202981106265
4-6,49,3.8918202981106265
220,49,3.8918202981106265
2-4,49,3.8918202981106265
non-asthmatic,49,3.8918202981106265
grow,49,3.8918202981106265
H2,49,3.8918202981106265
biased,49,3.8918202981106265
CXR,49,3.8918202981106265
hyperthyroidism,49,3.8918202981106265
Like,49,3.8918202981106265
interpreting,49,3.8918202981106265
references,49,3.8918202981106265
minimized,49,3.8918202981106265
Still,49,3.8918202981106265
173,49,3.8918202981106265
fragment,49,3.8918202981106265
3-year,49,3.8918202981106265
grading,49,3.8918202981106265
amenable,49,3.8918202981106265
dilemma,49,3.8918202981106265
ovalbumin,49,3.8918202981106265
fixation,49,3.8918202981106265
seeks,49,3.8918202981106265
check,49,3.8918202981106265
Taking,49,3.8918202981106265
disclosed,49,3.8918202981106265
e,49,3.8918202981106265
misdiagnosis,49,3.8918202981106265
ISAAC,49,3.8918202981106265
dysregulated,49,3.8918202981106265
junction,49,3.8918202981106265
Good,49,3.8918202981106265
killer,49,3.8918202981106265
postoperatively,49,3.8918202981106265
smell,49,3.8918202981106265
vertebrobasilar,49,3.8918202981106265
WT,49,3.8918202981106265
230,49,3.8918202981106265
ischemia-reperfusion,49,3.8918202981106265
blocked,49,3.8918202981106265
outweigh,49,3.8918202981106265
OD,49,3.8918202981106265
cortisol,49,3.8918202981106265
flows,49,3.8918202981106265
progresses,49,3.8918202981106265
RdRP,49,3.8918202981106265
microglia,49,3.8918202981106265
rtPA,49,3.8918202981106265
Antibodies,49,3.8918202981106265
4th,49,3.8918202981106265
ARBs,49,3.8918202981106265
fiber,49,3.8918202981106265
NAAT,49,3.8918202981106265
preferable,49,3.8918202981106265
Epidemiologic,49,3.8918202981106265
on-site,49,3.8918202981106265
deficient,48,3.871201010907891
Multivariable,48,3.871201010907891
convenience,48,3.871201010907891
modulated,48,3.871201010907891
G-CSF,48,3.871201010907891
innovation,48,3.871201010907891
FA,48,3.871201010907891
suited,48,3.871201010907891
investment,48,3.871201010907891
post-mortem,48,3.871201010907891
scintigrams,48,3.871201010907891
alternate,48,3.871201010907891
Organisation,48,3.871201010907891
monocytes,48,3.871201010907891
ectopic,48,3.871201010907891
attained,48,3.871201010907891
discontinuation,48,3.871201010907891
filled,48,3.871201010907891
nuclei,48,3.871201010907891
logistics,48,3.871201010907891
add-on,48,3.871201010907891
IL-8,48,3.871201010907891
possesses,48,3.871201010907891
counselling,48,3.871201010907891
dysfunctions,48,3.871201010907891
conflict,48,3.871201010907891
echocardiograms,48,3.871201010907891
182,48,3.871201010907891
explicit,48,3.871201010907891
reagent,48,3.871201010907891
325,48,3.871201010907891
Negative,48,3.871201010907891
low-density,48,3.871201010907891
temporarily,48,3.871201010907891
HDM,48,3.871201010907891
deciding,48,3.871201010907891
nondiabetic,48,3.871201010907891
Working,48,3.871201010907891
ipsilesional,48,3.871201010907891
allergenic,48,3.871201010907891
comprehension,48,3.871201010907891
item,48,3.871201010907891
cut,48,3.871201010907891
presymptomatic,48,3.871201010907891
Materials,48,3.871201010907891
093,48,3.871201010907891
readings,48,3.871201010907891
HA1,48,3.871201010907891
sole,48,3.871201010907891
nedocromil,48,3.871201010907891
mix,48,3.871201010907891
transcatheter,48,3.871201010907891
mgL,48,3.871201010907891
opened,48,3.871201010907891
frailty,48,3.871201010907891
affection,48,3.871201010907891
radiograph,48,3.871201010907891
certification,48,3.871201010907891
predictable,48,3.871201010907891
aquatic,48,3.871201010907891
adrenal,48,3.871201010907891
acknowledged,48,3.871201010907891
1970,48,3.871201010907891
SIR,48,3.871201010907891
corresponded,48,3.871201010907891
expiration,48,3.871201010907891
C-ACT,48,3.871201010907891
programmed,48,3.871201010907891
deeper,48,3.871201010907891
authority,48,3.871201010907891
non-pharmacological,48,3.871201010907891
181,48,3.871201010907891
Observational,48,3.871201010907891
VCG,48,3.871201010907891
winters,48,3.871201010907891
bronchodilation,48,3.871201010907891
fresh,48,3.871201010907891
genomics,48,3.871201010907891
advocate,48,3.871201010907891
aspergillosis,48,3.871201010907891
Without,48,3.871201010907891
Researchers,48,3.871201010907891
Chain,48,3.871201010907891
foci,48,3.871201010907891
myocytes,48,3.871201010907891
Inventory,48,3.871201010907891
prepandemic,48,3.871201010907891
co-infections,48,3.871201010907891
windows,48,3.871201010907891
continent,48,3.871201010907891
Amantadine,48,3.871201010907891
underestimate,48,3.871201010907891
art,48,3.871201010907891
cleaning,48,3.871201010907891
Basic,48,3.871201010907891
fibrous,48,3.871201010907891
Individual,48,3.871201010907891
Associations,48,3.871201010907891
persistently,47,3.8501476017100584
lacks,47,3.8501476017100584
2-agonists,47,3.8501476017100584
sustain,47,3.8501476017100584
Ebola,47,3.8501476017100584
peer-reviewed,47,3.8501476017100584
Diagnostics,47,3.8501476017100584
exceeds,47,3.8501476017100584
DES,47,3.8501476017100584
065,47,3.8501476017100584
implantable,47,3.8501476017100584
compartments,47,3.8501476017100584
unavailable,47,3.8501476017100584
co-circulation,47,3.8501476017100584
comments,47,3.8501476017100584
catheters,47,3.8501476017100584
aortocoronary,47,3.8501476017100584
sharp,47,3.8501476017100584
world-wide,47,3.8501476017100584
recurring,47,3.8501476017100584
AC,47,3.8501476017100584
deserves,47,3.8501476017100584
researches,47,3.8501476017100584
matrices,47,3.8501476017100584
adds,47,3.8501476017100584
coded,47,3.8501476017100584
Improvements,47,3.8501476017100584
exploratory,47,3.8501476017100584
transverse,47,3.8501476017100584
hoc,47,3.8501476017100584
contralesional,47,3.8501476017100584
acetylcholine,47,3.8501476017100584
Jersey,47,3.8501476017100584
business,47,3.8501476017100584
Angioplasty,47,3.8501476017100584
Antiplatelet,47,3.8501476017100584
insular,47,3.8501476017100584
Elecsys,47,3.8501476017100584
Spontaneous,47,3.8501476017100584
Measures,47,3.8501476017100584
009,47,3.8501476017100584
sufferers,47,3.8501476017100584
leakage,47,3.8501476017100584
cranial,47,3.8501476017100584
upregulation,47,3.8501476017100584
causation,47,3.8501476017100584
War,47,3.8501476017100584
Island,47,3.8501476017100584
encompasses,47,3.8501476017100584
CONCLUSIONS,47,3.8501476017100584
Michigan,47,3.8501476017100584
message,47,3.8501476017100584
Great,47,3.8501476017100584
betacoronavirus,47,3.8501476017100584
carers,47,3.8501476017100584
Formula,47,3.8501476017100584
TEE,47,3.8501476017100584
stroke-induced,47,3.8501476017100584
226,47,3.8501476017100584
misclassification,47,3.8501476017100584
Puerto,47,3.8501476017100584
probabilities,47,3.8501476017100584
pupils,47,3.8501476017100584
want,47,3.8501476017100584
015,47,3.8501476017100584
246,47,3.8501476017100584
necropsy,47,3.8501476017100584
hesitant,47,3.8501476017100584
lymphadenopathy,47,3.8501476017100584
regulates,47,3.8501476017100584
pressing,47,3.8501476017100584
underscore,47,3.8501476017100584
signal-averaged,47,3.8501476017100584
occupations,47,3.8501476017100584
Hemodynamic,47,3.8501476017100584
intranasally,47,3.8501476017100584
Belgium,47,3.8501476017100584
constriction,47,3.8501476017100584
COVID19,47,3.8501476017100584
transcriptional,47,3.8501476017100584
tandem,47,3.8501476017100584
serving,47,3.8501476017100584
Death,47,3.8501476017100584
interested,47,3.8501476017100584
beings,47,3.8501476017100584
undetected,47,3.8501476017100584
blacks,47,3.8501476017100584
Haemophilus,47,3.8501476017100584
stringent,47,3.8501476017100584
virus-host,47,3.8501476017100584
simplified,47,3.8501476017100584
continuity,46,3.828641396489095
prednisone,46,3.828641396489095
whole-genome,46,3.828641396489095
weakly,46,3.828641396489095
population-level,46,3.828641396489095
045,46,3.828641396489095
228,46,3.828641396489095
readers,46,3.828641396489095
faces,46,3.828641396489095
pharmacology,46,3.828641396489095
CTA,46,3.828641396489095
proteolytic,46,3.828641396489095
mgday,46,3.828641396489095
press,46,3.828641396489095
intracardiac,46,3.828641396489095
denial,46,3.828641396489095
intensified,46,3.828641396489095
PCR-based,46,3.828641396489095
akinetic,46,3.828641396489095
Adverse,46,3.828641396489095
nanoparticle,46,3.828641396489095
copy,46,3.828641396489095
microRNAs,46,3.828641396489095
CAP,46,3.828641396489095
exclusive,46,3.828641396489095
fibroblasts,46,3.828641396489095
histology,46,3.828641396489095
forecasts,46,3.828641396489095
Authorization,46,3.828641396489095
204,46,3.828641396489095
homology,46,3.828641396489095
library,46,3.828641396489095
declines,46,3.828641396489095
Existing,46,3.828641396489095
virus-infected,46,3.828641396489095
223,46,3.828641396489095
borderline,46,3.828641396489095
adopting,46,3.828641396489095
theme,46,3.828641396489095
immunologically,46,3.828641396489095
object,46,3.828641396489095
NI,46,3.828641396489095
aggravated,46,3.828641396489095
24-h,46,3.828641396489095
fomites,46,3.828641396489095
deals,46,3.828641396489095
nested,46,3.828641396489095
dates,46,3.828641396489095
loading,46,3.828641396489095
pregnancies,46,3.828641396489095
PM25,46,3.828641396489095
conservatively,46,3.828641396489095
hierarchical,46,3.828641396489095
Electrocardiographic,46,3.828641396489095
HCoV,46,3.828641396489095
reimbursement,46,3.828641396489095
Whilst,46,3.828641396489095
journals,46,3.828641396489095
Reaction,46,3.828641396489095
module,46,3.828641396489095
analogue,46,3.828641396489095
supervised,46,3.828641396489095
equations,46,3.828641396489095
racialethnic,46,3.828641396489095
distances,46,3.828641396489095
well-designed,46,3.828641396489095
evasion,46,3.828641396489095
awakening,46,3.828641396489095
CHADS2,46,3.828641396489095
qualitatively,46,3.828641396489095
two-dose,46,3.828641396489095
resumption,46,3.828641396489095
post-vaccination,46,3.828641396489095
two-thirds,46,3.828641396489095
bronchoprovocation,46,3.828641396489095
recanalisation,46,3.828641396489095
Tokyo,46,3.828641396489095
projections,46,3.828641396489095
isocyanates,46,3.828641396489095
IgMIgG,46,3.828641396489095
Odds,46,3.828641396489095
website,46,3.828641396489095
desired,46,3.828641396489095
800,46,3.828641396489095
removing,46,3.828641396489095
nation,46,3.828641396489095
coupling,46,3.828641396489095
convalescence,46,3.828641396489095
thinking,46,3.828641396489095
constituted,46,3.828641396489095
informing,46,3.828641396489095
formally,46,3.828641396489095
sensorimotor,46,3.828641396489095
Alzheimers,46,3.828641396489095
Female,46,3.828641396489095
neutralising,46,3.828641396489095
074,46,3.828641396489095
radicals,46,3.828641396489095
Adherence,46,3.828641396489095
spleen,46,3.828641396489095
digitalis,46,3.828641396489095
backgrounds,45,3.8066624897703196
LMICs,45,3.8066624897703196
standing,45,3.8066624897703196
zinc,45,3.8066624897703196
counteract,45,3.8066624897703196
234,45,3.8066624897703196
metal,45,3.8066624897703196
adjustments,45,3.8066624897703196
interspecies,45,3.8066624897703196
doubled,45,3.8066624897703196
286,45,3.8066624897703196
084,45,3.8066624897703196
aVL,45,3.8066624897703196
NAbs,45,3.8066624897703196
facts,45,3.8066624897703196
cured,45,3.8066624897703196
Impact,45,3.8066624897703196
IT,45,3.8066624897703196
Retrospective,45,3.8066624897703196
reacted,45,3.8066624897703196
pseudovirus,45,3.8066624897703196
collecting,45,3.8066624897703196
mural,45,3.8066624897703196
physiotherapy,45,3.8066624897703196
nm,45,3.8066624897703196
opacity,45,3.8066624897703196
mink,45,3.8066624897703196
Scopus,45,3.8066624897703196
orders,45,3.8066624897703196
Preventive,45,3.8066624897703196
beta2-agonist,45,3.8066624897703196
Guangdong,45,3.8066624897703196
seldom,45,3.8066624897703196
emerges,45,3.8066624897703196
IL-10,45,3.8066624897703196
electrodes,45,3.8066624897703196
connective,45,3.8066624897703196
horizontal,45,3.8066624897703196
fulminant,45,3.8066624897703196
pseudotyped,45,3.8066624897703196
1973,45,3.8066624897703196
eleven,45,3.8066624897703196
town,45,3.8066624897703196
LOS,45,3.8066624897703196
insults,45,3.8066624897703196
requested,45,3.8066624897703196
098,45,3.8066624897703196
ICSs,45,3.8066624897703196
Collectively,45,3.8066624897703196
searches,45,3.8066624897703196
whenever,45,3.8066624897703196
straightforward,45,3.8066624897703196
BACKGROUND,45,3.8066624897703196
O,45,3.8066624897703196
washout,45,3.8066624897703196
Kit,45,3.8066624897703196
therapeutically,45,3.8066624897703196
Method,45,3.8066624897703196
Initially,45,3.8066624897703196
charts,45,3.8066624897703196
endurance,45,3.8066624897703196
asthma-COPD,45,3.8066624897703196
Polish,45,3.8066624897703196
break,45,3.8066624897703196
mechanically,45,3.8066624897703196
MIBI,45,3.8066624897703196
insula,45,3.8066624897703196
womens,45,3.8066624897703196
hyper-reactivity,45,3.8066624897703196
high-sensitivity,45,3.8066624897703196
favorably,45,3.8066624897703196
calculations,45,3.8066624897703196
proactive,45,3.8066624897703196
eating,45,3.8066624897703196
reinfarctions,45,3.8066624897703196
pair,45,3.8066624897703196
incorrect,45,3.8066624897703196
south,45,3.8066624897703196
GBS,45,3.8066624897703196
fate,45,3.8066624897703196
CRS,45,3.8066624897703196
Persistent,45,3.8066624897703196
predisposed,45,3.8066624897703196
Mild,45,3.8066624897703196
trachea,45,3.8066624897703196
NOW,45,3.8066624897703196
sustainable,45,3.8066624897703196
STR,45,3.8066624897703196
WRA,45,3.8066624897703196
AMP,45,3.8066624897703196
supposed,45,3.8066624897703196
undoubtedly,45,3.8066624897703196
relying,45,3.8066624897703196
Inflammation,45,3.8066624897703196
ethics,45,3.8066624897703196
participant,45,3.8066624897703196
leak,45,3.8066624897703196
isocyanate,45,3.8066624897703196
Allergies,45,3.8066624897703196
That,45,3.8066624897703196
pre-stroke,45,3.8066624897703196
anomalous,45,3.8066624897703196
Morbidity,45,3.8066624897703196
you,45,3.8066624897703196
Outbreaks,45,3.8066624897703196
kinetic,45,3.8066624897703196
BALBc,44,3.784189633918261
predisposes,44,3.784189633918261
Immune,44,3.784189633918261
Implementation,44,3.784189633918261
elapsed,44,3.784189633918261
implying,44,3.784189633918261
attracted,44,3.784189633918261
025,44,3.784189633918261
allogeneic,44,3.784189633918261
limbs,44,3.784189633918261
temporally,44,3.784189633918261
infrequently,44,3.784189633918261
Protein,44,3.784189633918261
reliever,44,3.784189633918261
5000,44,3.784189633918261
Disorders,44,3.784189633918261
Pneumonia,44,3.784189633918261
latex,44,3.784189633918261
Insurance,44,3.784189633918261
reductase,44,3.784189633918261
intervene,44,3.784189633918261
tubes,44,3.784189633918261
template,44,3.784189633918261
Epidemiology,44,3.784189633918261
diltiazem,44,3.784189633918261
wash,44,3.784189633918261
ergometry,44,3.784189633918261
ducks,44,3.784189633918261
Isolated,44,3.784189633918261
hereditary,44,3.784189633918261
Mathematical,44,3.784189633918261
6th,44,3.784189633918261
010,44,3.784189633918261
Repeated,44,3.784189633918261
Routine,44,3.784189633918261
African-American,44,3.784189633918261
Deaths,44,3.784189633918261
proteome,44,3.784189633918261
glutamate,44,3.784189633918261
preserving,44,3.784189633918261
Kawasaki,44,3.784189633918261
twelve,44,3.784189633918261
chromatography,44,3.784189633918261
thinning,44,3.784189633918261
overload,44,3.784189633918261
SK,44,3.784189633918261
tracer,44,3.784189633918261
227,44,3.784189633918261
inadequately,44,3.784189633918261
insignificant,44,3.784189633918261
neonate,44,3.784189633918261
protein-protein,44,3.784189633918261
Beta,44,3.784189633918261
soft,44,3.784189633918261
A1,44,3.784189633918261
Reduction,44,3.784189633918261
MSC,44,3.784189633918261
AP,44,3.784189633918261
productive,44,3.784189633918261
holistic,44,3.784189633918261
chamber,44,3.784189633918261
Efficacy,44,3.784189633918261
224,44,3.784189633918261
documenting,44,3.784189633918261
width,44,3.784189633918261
operate,44,3.784189633918261
hazardous,44,3.784189633918261
objects,44,3.784189633918261
complicates,44,3.784189633918261
plane,44,3.784189633918261
A549,44,3.784189633918261
interacts,44,3.784189633918261
Developing,44,3.784189633918261
092,44,3.784189633918261
2011-2012,44,3.784189633918261
bronchopulmonary,44,3.784189633918261
reassortants,44,3.784189633918261
Coronaviridae,44,3.784189633918261
surprising,44,3.784189633918261
competing,44,3.784189633918261
therapeutical,44,3.784189633918261
decompensation,44,3.784189633918261
generates,44,3.784189633918261
rabbit,44,3.784189633918261
Paediatric,44,3.784189633918261
ddPCR,44,3.784189633918261
chemiluminescence,44,3.784189633918261
transformed,44,3.784189633918261
ideally,44,3.784189633918261
specially,44,3.784189633918261
periodically,44,3.784189633918261
Active,44,3.784189633918261
intubated,44,3.784189633918261
formula,44,3.784189633918261
dyskinesis,44,3.784189633918261
checked,44,3.784189633918261
tight,44,3.784189633918261
mediates,44,3.784189633918261
Pfizer,44,3.784189633918261
RCT,44,3.784189633918261
drug-eluting,44,3.784189633918261
reader,43,3.7612001156935624
DE,43,3.7612001156935624
seemingly,43,3.7612001156935624
geometry,43,3.7612001156935624
endotracheal,43,3.7612001156935624
transcription-PCR,43,3.7612001156935624
Polymerase,43,3.7612001156935624
219,43,3.7612001156935624
reasonably,43,3.7612001156935624
influx,43,3.7612001156935624
aspartate,43,3.7612001156935624
rivaroxaban,43,3.7612001156935624
microfluidic,43,3.7612001156935624
lymphoid,43,3.7612001156935624
merely,43,3.7612001156935624
precautionary,43,3.7612001156935624
culturally,43,3.7612001156935624
Twenty-one,43,3.7612001156935624
10-fold,43,3.7612001156935624
serotonin,43,3.7612001156935624
postmenopausal,43,3.7612001156935624
durations,43,3.7612001156935624
Careful,43,3.7612001156935624
Neuraminidase,43,3.7612001156935624
transgenic,43,3.7612001156935624
camp,43,3.7612001156935624
Especially,43,3.7612001156935624
slowing,43,3.7612001156935624
neuromuscular,43,3.7612001156935624
ventilator,43,3.7612001156935624
Half,43,3.7612001156935624
082,43,3.7612001156935624
sex-specific,43,3.7612001156935624
notification,43,3.7612001156935624
immense,43,3.7612001156935624
readmissions,43,3.7612001156935624
urticaria,43,3.7612001156935624
AH,43,3.7612001156935624
Third,43,3.7612001156935624
LDT,43,3.7612001156935624
empiric,43,3.7612001156935624
supervision,43,3.7612001156935624
continuum,43,3.7612001156935624
Recovery,43,3.7612001156935624
Czech,43,3.7612001156935624
naive,43,3.7612001156935624
proof-of-concept,43,3.7612001156935624
spectra,43,3.7612001156935624
proposal,43,3.7612001156935624
uninfected,43,3.7612001156935624
HCoVs,43,3.7612001156935624
Task,43,3.7612001156935624
well-documented,43,3.7612001156935624
NQMI,43,3.7612001156935624
fears,43,3.7612001156935624
necrotizing,43,3.7612001156935624
undetectable,43,3.7612001156935624
binary,43,3.7612001156935624
wind,43,3.7612001156935624
199,43,3.7612001156935624
diminish,43,3.7612001156935624
Relative,43,3.7612001156935624
206,43,3.7612001156935624
heterologous,43,3.7612001156935624
paralysis,43,3.7612001156935624
autonomy,43,3.7612001156935624
claim,43,3.7612001156935624
entropy,43,3.7612001156935624
anti-COVID-19,43,3.7612001156935624
Assay,43,3.7612001156935624
achievable,43,3.7612001156935624
terminology,43,3.7612001156935624
communicate,43,3.7612001156935624
leg,43,3.7612001156935624
rash,43,3.7612001156935624
macrofocal,43,3.7612001156935624
threatened,43,3.7612001156935624
P00001,43,3.7612001156935624
080,43,3.7612001156935624
non-diabetic,43,3.7612001156935624
218,43,3.7612001156935624
underline,43,3.7612001156935624
NHS,43,3.7612001156935624
luminal,43,3.7612001156935624
blinded,43,3.7612001156935624
utero,43,3.7612001156935624
hindered,43,3.7612001156935624
relied,43,3.7612001156935624
Saliva,43,3.7612001156935624
consulted,43,3.7612001156935624
restoring,43,3.7612001156935624
Comparing,43,3.7612001156935624
cigarettes,43,3.7612001156935624
Training,43,3.7612001156935624
meters,43,3.7612001156935624
drastically,43,3.7612001156935624
haemagglutination,43,3.7612001156935624
figure,43,3.7612001156935624
deviations,43,3.7612001156935624
explicitly,43,3.7612001156935624
≥65,43,3.7612001156935624
evolves,43,3.7612001156935624
agency,43,3.7612001156935624
communications,43,3.7612001156935624
spared,43,3.7612001156935624
educated,43,3.7612001156935624
AE,43,3.7612001156935624
Instead,43,3.7612001156935624
OS,43,3.7612001156935624
penumbral,43,3.7612001156935624
bioactive,43,3.7612001156935624
invaluable,43,3.7612001156935624
drawing,43,3.7612001156935624
spectroscopy,42,3.7376696182833684
078,42,3.7376696182833684
exam,42,3.7376696182833684
first-time,42,3.7376696182833684
Access,42,3.7376696182833684
invited,42,3.7376696182833684
standardize,42,3.7376696182833684
PE,42,3.7376696182833684
Royal,42,3.7376696182833684
undertreated,42,3.7376696182833684
pursued,42,3.7376696182833684
Independent,42,3.7376696182833684
underdiagnosis,42,3.7376696182833684
prenatal,42,3.7376696182833684
halt,42,3.7376696182833684
definitely,42,3.7376696182833684
bringing,42,3.7376696182833684
blue,42,3.7376696182833684
intrauterine,42,3.7376696182833684
acid-based,42,3.7376696182833684
Modern,42,3.7376696182833684
augmentation,42,3.7376696182833684
in-person,42,3.7376696182833684
HRQOL,42,3.7376696182833684
sixth,42,3.7376696182833684
neurodegenerative,42,3.7376696182833684
28-day,42,3.7376696182833684
forth,42,3.7376696182833684
boosting,42,3.7376696182833684
contracted,42,3.7376696182833684
abnormally,42,3.7376696182833684
elite,42,3.7376696182833684
20-30,42,3.7376696182833684
Illness,42,3.7376696182833684
community-dwelling,42,3.7376696182833684
RS,42,3.7376696182833684
afforded,42,3.7376696182833684
propranolol,42,3.7376696182833684
wait,42,3.7376696182833684
Application,42,3.7376696182833684
micrograms,42,3.7376696182833684
262,42,3.7376696182833684
gland,42,3.7376696182833684
BCG,42,3.7376696182833684
analytic,42,3.7376696182833684
large-artery,42,3.7376696182833684
CPR,42,3.7376696182833684
socio-demographic,42,3.7376696182833684
ASPECTS,42,3.7376696182833684
208,42,3.7376696182833684
frail,42,3.7376696182833684
argues,42,3.7376696182833684
AAR,42,3.7376696182833684
MDI,42,3.7376696182833684
attempting,42,3.7376696182833684
solve,42,3.7376696182833684
superoxide,42,3.7376696182833684
Rates,42,3.7376696182833684
originate,42,3.7376696182833684
measurable,42,3.7376696182833684
cyclic,42,3.7376696182833684
p00001,42,3.7376696182833684
Reporting,42,3.7376696182833684
Corona,42,3.7376696182833684
ecology,42,3.7376696182833684
196,42,3.7376696182833684
Mediterranean,42,3.7376696182833684
nanotechnology,42,3.7376696182833684
SEM,42,3.7376696182833684
parasympathetic,42,3.7376696182833684
ascending,42,3.7376696182833684
625,42,3.7376696182833684
Poststroke,42,3.7376696182833684
master,42,3.7376696182833684
Surgery,42,3.7376696182833684
slower,42,3.7376696182833684
Hispanics,42,3.7376696182833684
handicap,42,3.7376696182833684
outstanding,42,3.7376696182833684
HCoV-OC43,42,3.7376696182833684
MA,42,3.7376696182833684
elicits,42,3.7376696182833684
LR,42,3.7376696182833684
Atherosclerosis,42,3.7376696182833684
nucleus,42,3.7376696182833684
VAS,42,3.7376696182833684
Consensus,42,3.7376696182833684
H1N1v,42,3.7376696182833684
equipped,42,3.7376696182833684
ST-T,42,3.7376696182833684
practically,42,3.7376696182833684
complained,42,3.7376696182833684
migratory,42,3.7376696182833684
255,42,3.7376696182833684
GISAID,42,3.7376696182833684
202,42,3.7376696182833684
segmentation,42,3.7376696182833684
7th,42,3.7376696182833684
immunizations,42,3.7376696182833684
fold,42,3.7376696182833684
mapped,42,3.7376696182833684
10th,42,3.7376696182833684
notes,42,3.7376696182833684
191,42,3.7376696182833684
peers,42,3.7376696182833684
quartile,42,3.7376696182833684
departure,42,3.7376696182833684
MBG,42,3.7376696182833684
tocilizumab,42,3.7376696182833684
258,42,3.7376696182833684
ITP,41,3.713572066704308
post-acute,41,3.713572066704308
precipitation,41,3.713572066704308
Veterans,41,3.713572066704308
contacted,41,3.713572066704308
twin,41,3.713572066704308
Adults,41,3.713572066704308
pathobiology,41,3.713572066704308
sulfate,41,3.713572066704308
evening,41,3.713572066704308
RVMI,41,3.713572066704308
package,41,3.713572066704308
obscure,41,3.713572066704308
Washington,41,3.713572066704308
syndrome-coronavirus-2,41,3.713572066704308
END,41,3.713572066704308
surprisingly,41,3.713572066704308
centuries,41,3.713572066704308
HCQ,41,3.713572066704308
EA,41,3.713572066704308
Reports,41,3.713572066704308
complexities,41,3.713572066704308
crossed,41,3.713572066704308
TB,41,3.713572066704308
244,41,3.713572066704308
conditional,41,3.713572066704308
LT,41,3.713572066704308
reflection,41,3.713572066704308
necessitating,41,3.713572066704308
damaging,41,3.713572066704308
high-grade,41,3.713572066704308
meningitis,41,3.713572066704308
supplemental,41,3.713572066704308
225,41,3.713572066704308
twofold,41,3.713572066704308
Measurements,41,3.713572066704308
positioning,41,3.713572066704308
P2,41,3.713572066704308
phosphate,41,3.713572066704308
overseas,41,3.713572066704308
noninfarcted,41,3.713572066704308
war,41,3.713572066704308
modules,41,3.713572066704308
puberty,41,3.713572066704308
Federal,41,3.713572066704308
displaying,41,3.713572066704308
raceethnicity,41,3.713572066704308
dosages,41,3.713572066704308
peroxidation,41,3.713572066704308
enlarged,41,3.713572066704308
obstetric,41,3.713572066704308
norms,41,3.713572066704308
seventh,41,3.713572066704308
MM,41,3.713572066704308
displays,41,3.713572066704308
pleura,41,3.713572066704308
glial,41,3.713572066704308
prospect,41,3.713572066704308
207,41,3.713572066704308
buffer,41,3.713572066704308
276,41,3.713572066704308
Upon,41,3.713572066704308
083,41,3.713572066704308
wealth,41,3.713572066704308
transfusions,41,3.713572066704308
age-adjusted,41,3.713572066704308
hybridization,41,3.713572066704308
dose-dependent,41,3.713572066704308
collectively,41,3.713572066704308
speculated,41,3.713572066704308
cross-protection,41,3.713572066704308
rhabdomyolysis,41,3.713572066704308
countrys,41,3.713572066704308
law,41,3.713572066704308
interpandemic,41,3.713572066704308
020,41,3.713572066704308
worry,41,3.713572066704308
falling,41,3.713572066704308
synthesize,41,3.713572066704308
Cough,41,3.713572066704308
refusal,41,3.713572066704308
endothelin-1,41,3.713572066704308
concordant,41,3.713572066704308
manufacture,41,3.713572066704308
ended,41,3.713572066704308
Complex,41,3.713572066704308
recognise,41,3.713572066704308
non-smokers,41,3.713572066704308
self-report,41,3.713572066704308
247,41,3.713572066704308
certainty,41,3.713572066704308
battle,41,3.713572066704308
robustness,41,3.713572066704308
allergen-induced,41,3.713572066704308
CL,41,3.713572066704308
Sixty,41,3.713572066704308
contributors,41,3.713572066704308
OP,41,3.713572066704308
FDG,41,3.713572066704308
LTCFs,41,3.713572066704308
LOD,41,3.713572066704308
workforce,41,3.713572066704308
risk-benefit,41,3.713572066704308
simpler,41,3.713572066704308
rank,41,3.713572066704308
slope,41,3.713572066704308
interferons,41,3.713572066704308
electrode,41,3.713572066704308
IE,41,3.713572066704308
275,41,3.713572066704308
sales,41,3.713572066704308
tDCS,41,3.713572066704308
out-of-hospital,41,3.713572066704308
Guideline,41,3.713572066704308
229,40,3.6888794541139363
endocrine,40,3.6888794541139363
closing,40,3.6888794541139363
layers,40,3.6888794541139363
085,40,3.6888794541139363
volatile,40,3.6888794541139363
precipitated,40,3.6888794541139363
ICUs,40,3.6888794541139363
advisable,40,3.6888794541139363
264,40,3.6888794541139363
Abnormal,40,3.6888794541139363
Obstructive,40,3.6888794541139363
TNF-alpha,40,3.6888794541139363
non-human,40,3.6888794541139363
mid,40,3.6888794541139363
DSE,40,3.6888794541139363
Cambodia,40,3.6888794541139363
Peoples,40,3.6888794541139363
microbiological,40,3.6888794541139363
survivor,40,3.6888794541139363
bottleneck,40,3.6888794541139363
supplying,40,3.6888794541139363
DEGs,40,3.6888794541139363
shot,40,3.6888794541139363
Asians,40,3.6888794541139363
endoscopic,40,3.6888794541139363
anaerobic,40,3.6888794541139363
looked,40,3.6888794541139363
ngmL,40,3.6888794541139363
neutralized,40,3.6888794541139363
taste,40,3.6888794541139363
damages,40,3.6888794541139363
supplementary,40,3.6888794541139363
Symptom,40,3.6888794541139363
durability,40,3.6888794541139363
00002,40,3.6888794541139363
jeopardized,40,3.6888794541139363
jobs,40,3.6888794541139363
pave,40,3.6888794541139363
lobes,40,3.6888794541139363
react,40,3.6888794541139363
apoptotic,40,3.6888794541139363
Countries,40,3.6888794541139363
handle,40,3.6888794541139363
eyes,40,3.6888794541139363
2013-2014,40,3.6888794541139363
responds,40,3.6888794541139363
ligands,40,3.6888794541139363
schedules,40,3.6888794541139363
CTP,40,3.6888794541139363
ABCD2,40,3.6888794541139363
non-atopic,40,3.6888794541139363
0000,40,3.6888794541139363
1969,40,3.6888794541139363
degeneration,40,3.6888794541139363
uniquely,40,3.6888794541139363
extrapolated,40,3.6888794541139363
consuming,40,3.6888794541139363
projection,40,3.6888794541139363
utilizes,40,3.6888794541139363
morphologic,40,3.6888794541139363
influential,40,3.6888794541139363
characterisation,40,3.6888794541139363
Parents,40,3.6888794541139363
amplify,40,3.6888794541139363
Silent,40,3.6888794541139363
Significantly,40,3.6888794541139363
ranked,40,3.6888794541139363
epidemiologically,40,3.6888794541139363
pragmatic,40,3.6888794541139363
diaries,40,3.6888794541139363
SP,40,3.6888794541139363
Average,40,3.6888794541139363
aggregated,40,3.6888794541139363
employ,40,3.6888794541139363
ACQ,40,3.6888794541139363
NO2,40,3.6888794541139363
overcoming,40,3.6888794541139363
cardiological,40,3.6888794541139363
commenced,40,3.6888794541139363
Toll-like,40,3.6888794541139363
PCA,40,3.6888794541139363
243,40,3.6888794541139363
Practitioners,40,3.6888794541139363
Turkish,40,3.6888794541139363
OC43,40,3.6888794541139363
flight,40,3.6888794541139363
1919,40,3.6888794541139363
233,40,3.6888794541139363
acceleration,40,3.6888794541139363
Demographic,40,3.6888794541139363
Interview,40,3.6888794541139363
USSR,40,3.6888794541139363
worsens,40,3.6888794541139363
Intracoronary,40,3.6888794541139363
Foundation,40,3.6888794541139363
single-vessel,40,3.6888794541139363
Nursing,40,3.6888794541139363
Persons,40,3.6888794541139363
0008,40,3.6888794541139363
Generally,40,3.6888794541139363
3-6,40,3.6888794541139363
dorsal,40,3.6888794541139363
adenoviral,40,3.6888794541139363
friends,40,3.6888794541139363
saw,40,3.6888794541139363
cold-adapted,40,3.6888794541139363
applies,40,3.6888794541139363
aerosolized,40,3.6888794541139363
rhesus,40,3.6888794541139363
slices,40,3.6888794541139363
precursor,40,3.6888794541139363
pteronyssinus,40,3.6888794541139363
hypokinesia,40,3.6888794541139363
035,40,3.6888794541139363
colds,40,3.6888794541139363
precipitate,40,3.6888794541139363
Analyses,40,3.6888794541139363
Johnson,40,3.6888794541139363
ESC,40,3.6888794541139363
arthritis,39,3.6635616461296463
4-year,39,3.6635616461296463
needle,39,3.6635616461296463
UV,39,3.6635616461296463
arms,39,3.6635616461296463
appreciated,39,3.6635616461296463
psychometric,39,3.6635616461296463
timolol,39,3.6635616461296463
arisen,39,3.6635616461296463
Longitudinal,39,3.6635616461296463
basophils,39,3.6635616461296463
brittle,39,3.6635616461296463
furin,39,3.6635616461296463
hypokinesis,39,3.6635616461296463
Inflammatory,39,3.6635616461296463
ineligible,39,3.6635616461296463
cardiorespiratory,39,3.6635616461296463
longest,39,3.6635616461296463
immune-mediated,39,3.6635616461296463
bronchoconstrictor,39,3.6635616461296463
Adequate,39,3.6635616461296463
kidneys,39,3.6635616461296463
teenagers,39,3.6635616461296463
037,39,3.6635616461296463
somatosensory,39,3.6635616461296463
specialised,39,3.6635616461296463
Globally,39,3.6635616461296463
glycans,39,3.6635616461296463
day-to-day,39,3.6635616461296463
journal,39,3.6635616461296463
autopsies,39,3.6635616461296463
Controlled,39,3.6635616461296463
Along,39,3.6635616461296463
spray,39,3.6635616461296463
walk,39,3.6635616461296463
gestational,39,3.6635616461296463
deprivation,39,3.6635616461296463
glands,39,3.6635616461296463
221,39,3.6635616461296463
perfused,39,3.6635616461296463
Where,39,3.6635616461296463
tropics,39,3.6635616461296463
NMR,39,3.6635616461296463
aggravating,39,3.6635616461296463
mgdL,39,3.6635616461296463
speculate,39,3.6635616461296463
births,39,3.6635616461296463
inserted,39,3.6635616461296463
frames,39,3.6635616461296463
von,39,3.6635616461296463
Tamiflu,39,3.6635616461296463
roughly,39,3.6635616461296463
Motor,39,3.6635616461296463
Auckland,39,3.6635616461296463
ratings,39,3.6635616461296463
non-ST-elevation,39,3.6635616461296463
shunting,39,3.6635616461296463
hinder,39,3.6635616461296463
095,39,3.6635616461296463
topical,39,3.6635616461296463
1970s,39,3.6635616461296463
wheezy,39,3.6635616461296463
hidden,39,3.6635616461296463
practicing,39,3.6635616461296463
informal,39,3.6635616461296463
vasodilator,39,3.6635616461296463
pneumonias,39,3.6635616461296463
hACE2,39,3.6635616461296463
lacked,39,3.6635616461296463
Perioperative,39,3.6635616461296463
Neurology,39,3.6635616461296463
agree,39,3.6635616461296463
antibody-dependent,39,3.6635616461296463
Internet,39,3.6635616461296463
AH3,39,3.6635616461296463
unbiased,39,3.6635616461296463
viewpoint,39,3.6635616461296463
expired,39,3.6635616461296463
bundle-branch,39,3.6635616461296463
disadvantaged,39,3.6635616461296463
menopause,39,3.6635616461296463
ordinary,39,3.6635616461296463
TTE,39,3.6635616461296463
Olympic,39,3.6635616461296463
079,39,3.6635616461296463
occipital,39,3.6635616461296463
corticospinal,39,3.6635616461296463
nonstructural,39,3.6635616461296463
compromising,39,3.6635616461296463
nonhuman,39,3.6635616461296463
Pacific,39,3.6635616461296463
elucidating,39,3.6635616461296463
bifurcation,39,3.6635616461296463
Advanced,39,3.6635616461296463
secretory,39,3.6635616461296463
stockpiles,39,3.6635616461296463
holidays,39,3.6635616461296463
NF-κB,39,3.6635616461296463
tertile,39,3.6635616461296463
worth,39,3.6635616461296463
Reported,39,3.6635616461296463
judgment,39,3.6635616461296463
chief,39,3.6635616461296463
placenta,39,3.6635616461296463
corresponds,39,3.6635616461296463
056,39,3.6635616461296463
appraisal,39,3.6635616461296463
difficult-to-control,39,3.6635616461296463
malaise,39,3.6635616461296463
SM,39,3.6635616461296463
la,39,3.6635616461296463
green,39,3.6635616461296463
NK,38,3.6375861597263857
fruit,38,3.6375861597263857
disposition,38,3.6375861597263857
plateau,38,3.6375861597263857
hybrid,38,3.6375861597263857
centralized,38,3.6375861597263857
reactivation,38,3.6375861597263857
adrenergic,38,3.6375861597263857
elaborate,38,3.6375861597263857
lessen,38,3.6375861597263857
253,38,3.6375861597263857
brains,38,3.6375861597263857
calcification,38,3.6375861597263857
stations,38,3.6375861597263857
Pharmacological,38,3.6375861597263857
Laboratories,38,3.6375861597263857
encompassing,38,3.6375861597263857
commitment,38,3.6375861597263857
Prolonged,38,3.6375861597263857
Aboriginal,38,3.6375861597263857
hopefully,38,3.6375861597263857
biggest,38,3.6375861597263857
CRISPR-based,38,3.6375861597263857
neuroinflammation,38,3.6375861597263857
palliative,38,3.6375861597263857
paradox,38,3.6375861597263857
lifelong,38,3.6375861597263857
priming,38,3.6375861597263857
lists,38,3.6375861597263857
confused,38,3.6375861597263857
endorsed,38,3.6375861597263857
postdischarge,38,3.6375861597263857
Tissue,38,3.6375861597263857
neurogenic,38,3.6375861597263857
knew,38,3.6375861597263857
evoked,38,3.6375861597263857
exaggerated,38,3.6375861597263857
beta-2,38,3.6375861597263857
OMI,38,3.6375861597263857
coagulopathy,38,3.6375861597263857
circuit,38,3.6375861597263857
Nasal,38,3.6375861597263857
co-morbid,38,3.6375861597263857
elastic,38,3.6375861597263857
T-cells,38,3.6375861597263857
Child,38,3.6375861597263857
0006,38,3.6375861597263857
Twenty-four,38,3.6375861597263857
physiopathology,38,3.6375861597263857
AIT,38,3.6375861597263857
241,38,3.6375861597263857
sickness,38,3.6375861597263857
disrupt,38,3.6375861597263857
deteriorating,38,3.6375861597263857
unexplored,38,3.6375861597263857
coexistence,38,3.6375861597263857
structure-based,38,3.6375861597263857
sneezing,38,3.6375861597263857
depended,38,3.6375861597263857
selectivity,38,3.6375861597263857
peculiar,38,3.6375861597263857
autoantibodies,38,3.6375861597263857
O2,38,3.6375861597263857
divergence,38,3.6375861597263857
tea,38,3.6375861597263857
Comparisons,38,3.6375861597263857
intimal,38,3.6375861597263857
tracheostomy,38,3.6375861597263857
captopril,38,3.6375861597263857
hemostasis,38,3.6375861597263857
Army,38,3.6375861597263857
259,38,3.6375861597263857
GA,38,3.6375861597263857
azithromycin,38,3.6375861597263857
face-to-face,38,3.6375861597263857
Decoction,38,3.6375861597263857
hemagglutination-inhibition,38,3.6375861597263857
exacerbating,38,3.6375861597263857
restorative,38,3.6375861597263857
humanity,38,3.6375861597263857
simplicity,38,3.6375861597263857
infer,38,3.6375861597263857
isolating,38,3.6375861597263857
funded,38,3.6375861597263857
systole,38,3.6375861597263857
meetings,38,3.6375861597263857
μM,38,3.6375861597263857
Effectiveness,38,3.6375861597263857
appearing,38,3.6375861597263857
265,38,3.6375861597263857
Kong68,38,3.6375861597263857
rodents,38,3.6375861597263857
Oxford,38,3.6375861597263857
conclusive,38,3.6375861597263857
reporter,38,3.6375861597263857
masses,38,3.6375861597263857
visualize,38,3.6375861597263857
LFIA,38,3.6375861597263857
assuming,38,3.6375861597263857
reverse-transcriptase,38,3.6375861597263857
ML,38,3.6375861597263857
epileptic,38,3.6375861597263857
00005,38,3.6375861597263857
ships,38,3.6375861597263857
Detailed,38,3.6375861597263857
hemodynamically,38,3.6375861597263857
V6,38,3.6375861597263857
timeline,38,3.6375861597263857
NPV,38,3.6375861597263857
name,38,3.6375861597263857
Internal,38,3.6375861597263857
mlm2,38,3.6375861597263857
032,38,3.6375861597263857
≥1,38,3.6375861597263857
successes,38,3.6375861597263857
Population,38,3.6375861597263857
impression,38,3.6375861597263857
self-collected,38,3.6375861597263857
ingestion,38,3.6375861597263857
071,38,3.6375861597263857
sparing,38,3.6375861597263857
Med,38,3.6375861597263857
extrapulmonary,38,3.6375861597263857
Lombardy,38,3.6375861597263857
Investigation,38,3.6375861597263857
099,38,3.6375861597263857
measles,38,3.6375861597263857
ambiguous,38,3.6375861597263857
beneficiaries,38,3.6375861597263857
microenvironment,38,3.6375861597263857
Maryland,38,3.6375861597263857
Z,38,3.6375861597263857
penetration,38,3.6375861597263857
baby,37,3.6109179126442243
QS,37,3.6109179126442243
profession,37,3.6109179126442243
high-frequency,37,3.6109179126442243
reasoning,37,3.6109179126442243
life-saving,37,3.6109179126442243
frameworks,37,3.6109179126442243
NGS,37,3.6109179126442243
suspended,37,3.6109179126442243
TNF-α,37,3.6109179126442243
null,37,3.6109179126442243
Specificity,37,3.6109179126442243
arriving,37,3.6109179126442243
warm,37,3.6109179126442243
axillary,37,3.6109179126442243
trapping,37,3.6109179126442243
self-limited,37,3.6109179126442243
2017-2018,37,3.6109179126442243
adamantanes,37,3.6109179126442243
regimes,37,3.6109179126442243
calibrated,37,3.6109179126442243
OCS,37,3.6109179126442243
personalised,37,3.6109179126442243
exerted,37,3.6109179126442243
RIDTs,37,3.6109179126442243
086,37,3.6109179126442243
plethysmography,37,3.6109179126442243
2-dimensional,37,3.6109179126442243
declaration,37,3.6109179126442243
cost-benefit,37,3.6109179126442243
Consecutive,37,3.6109179126442243
700,37,3.6109179126442243
retrieval,37,3.6109179126442243
FP,37,3.6109179126442243
disease-specific,37,3.6109179126442243
Thirty-five,37,3.6109179126442243
ORF,37,3.6109179126442243
your,37,3.6109179126442243
Awareness,37,3.6109179126442243
vitamins,37,3.6109179126442243
Mycoplasma,37,3.6109179126442243
T-helper,37,3.6109179126442243
PICU,37,3.6109179126442243
giant,37,3.6109179126442243
Cohort,37,3.6109179126442243
donation,37,3.6109179126442243
Kaplan-Meier,37,3.6109179126442243
campus,37,3.6109179126442243
Paulo,37,3.6109179126442243
anti-IgE,37,3.6109179126442243
technetium-99m,37,3.6109179126442243
single-dose,37,3.6109179126442243
capillaries,37,3.6109179126442243
bases,37,3.6109179126442243
Newer,37,3.6109179126442243
placing,37,3.6109179126442243
impede,37,3.6109179126442243
histopathology,37,3.6109179126442243
myriad,37,3.6109179126442243
activates,37,3.6109179126442243
quarantined,37,3.6109179126442243
sporadically,37,3.6109179126442243
monkeys,37,3.6109179126442243
thirds,37,3.6109179126442243
IL-17,37,3.6109179126442243
neurodegeneration,37,3.6109179126442243
repercussions,37,3.6109179126442243
Australians,37,3.6109179126442243
interrupt,37,3.6109179126442243
Pregnancy,37,3.6109179126442243
Federation,37,3.6109179126442243
ST-segment-elevation,37,3.6109179126442243
versions,37,3.6109179126442243
antiasthma,37,3.6109179126442243
immunocompetent,37,3.6109179126442243
vaccine-preventable,37,3.6109179126442243
influenzas,37,3.6109179126442243
1918-19,37,3.6109179126442243
obstacle,37,3.6109179126442243
severities,37,3.6109179126442243
backscatter,37,3.6109179126442243
irregular,37,3.6109179126442243
10-15,37,3.6109179126442243
087,37,3.6109179126442243
Class,37,3.6109179126442243
evade,37,3.6109179126442243
influenzal,37,3.6109179126442243
tailor,37,3.6109179126442243
explanatory,37,3.6109179126442243
depolarization,37,3.6109179126442243
clots,37,3.6109179126442243
NLRP3,37,3.6109179126442243
imposes,37,3.6109179126442243
firm,37,3.6109179126442243
institute,37,3.6109179126442243
Spirometry,37,3.6109179126442243
historically,37,3.6109179126442243
IHS,37,3.6109179126442243
microbiology,37,3.6109179126442243
cared,37,3.6109179126442243
000001,37,3.6109179126442243
innovations,37,3.6109179126442243
Natural,37,3.6109179126442243
coherence,37,3.6109179126442243
314,37,3.6109179126442243
conjunctival,37,3.6109179126442243
representations,37,3.6109179126442243
calculating,37,3.6109179126442243
guarantee,37,3.6109179126442243
STE,37,3.6109179126442243
stays,37,3.6109179126442243
offices,37,3.6109179126442243
ρ,37,3.6109179126442243
neurologist,37,3.6109179126442243
coexist,37,3.6109179126442243
eliciting,37,3.6109179126442243
render,37,3.6109179126442243
procurement,37,3.6109179126442243
AIA,37,3.6109179126442243
Colorado,37,3.6109179126442243
equivocal,37,3.6109179126442243
fitting,37,3.6109179126442243
Statins,37,3.6109179126442243
spouses,37,3.6109179126442243
specialties,37,3.6109179126442243
youngest,37,3.6109179126442243
hopes,37,3.6109179126442243
ketotifen,37,3.6109179126442243
Austria,37,3.6109179126442243
Twenty-five,37,3.6109179126442243
Structural,37,3.6109179126442243
SNP,37,3.6109179126442243
aggregate,37,3.6109179126442243
875,37,3.6109179126442243
scant,37,3.6109179126442243
mold,37,3.6109179126442243
097,37,3.6109179126442243
impulse,37,3.6109179126442243
Area,37,3.6109179126442243
Reliable,37,3.6109179126442243
arteriovenous,37,3.6109179126442243
inactivate,37,3.6109179126442243
intensively,36,3.58351893845611
inflammasome,36,3.58351893845611
overwhelmed,36,3.58351893845611
card,36,3.58351893845611
History,36,3.58351893845611
Sciences,36,3.58351893845611
Attack,36,3.58351893845611
occasion,36,3.58351893845611
recreational,36,3.58351893845611
nitrate,36,3.58351893845611
Guangzhou,36,3.58351893845611
prognoses,36,3.58351893845611
Stress,36,3.58351893845611
Economic,36,3.58351893845611
electrolyte,36,3.58351893845611
notifications,36,3.58351893845611
correlating,36,3.58351893845611
273,36,3.58351893845611
arose,36,3.58351893845611
collaborating,36,3.58351893845611
dynamical,36,3.58351893845611
discriminating,36,3.58351893845611
066,36,3.58351893845611
table,36,3.58351893845611
verbal,36,3.58351893845611
PLpro,36,3.58351893845611
263,36,3.58351893845611
messaging,36,3.58351893845611
284,36,3.58351893845611
alignment,36,3.58351893845611
Particular,36,3.58351893845611
HCoV-229E,36,3.58351893845611
rhinoviruses,36,3.58351893845611
antecedent,36,3.58351893845611
operators,36,3.58351893845611
conservation,36,3.58351893845611
ABI,36,3.58351893845611
thanks,36,3.58351893845611
013,36,3.58351893845611
devised,36,3.58351893845611
continuation,36,3.58351893845611
multitude,36,3.58351893845611
protracted,36,3.58351893845611
non-cardiac,36,3.58351893845611
RBBB,36,3.58351893845611
Fractional,36,3.58351893845611
desensitization,36,3.58351893845611
Prognosis,36,3.58351893845611
Skin,36,3.58351893845611
DiaSorin,36,3.58351893845611
modelled,36,3.58351893845611
Euroimmun,36,3.58351893845611
religious,36,3.58351893845611
inspiration,36,3.58351893845611
Alternative,36,3.58351893845611
Univariate,36,3.58351893845611
poisoning,36,3.58351893845611
patient-reported,36,3.58351893845611
Portugal,36,3.58351893845611
5th,36,3.58351893845611
BinaxNOW,36,3.58351893845611
quality-of-life,36,3.58351893845611
BMSCs,36,3.58351893845611
Transcranial,36,3.58351893845611
recommending,36,3.58351893845611
gathering,36,3.58351893845611
bradycardia,36,3.58351893845611
Ag-RDTs,36,3.58351893845611
HD,36,3.58351893845611
Programme,36,3.58351893845611
advise,36,3.58351893845611
statistic,36,3.58351893845611
Posterior,36,3.58351893845611
oblique,36,3.58351893845611
genus,36,3.58351893845611
exploited,36,3.58351893845611
094,36,3.58351893845611
dye,36,3.58351893845611
mutate,36,3.58351893845611
amounted,36,3.58351893845611
film,36,3.58351893845611
Melbourne,36,3.58351893845611
downregulated,36,3.58351893845611
empirically,36,3.58351893845611
enters,36,3.58351893845611
mRNAs,36,3.58351893845611
obstructed,36,3.58351893845611
occurrences,36,3.58351893845611
321,36,3.58351893845611
SVD,36,3.58351893845611
stopping,36,3.58351893845611
eradication,36,3.58351893845611
word,36,3.58351893845611
committee,36,3.58351893845611
plethora,36,3.58351893845611
headaches,36,3.58351893845611
impressive,36,3.58351893845611
sensitizing,36,3.58351893845611
RA,36,3.58351893845611
Tomography,36,3.58351893845611
angiopathy,36,3.58351893845611
BPV,36,3.58351893845611
endoscopy,36,3.58351893845611
approached,36,3.58351893845611
prevailing,36,3.58351893845611
mature,36,3.58351893845611
inactivity,36,3.58351893845611
board,36,3.58351893845611
paracrine,36,3.58351893845611
appreciate,36,3.58351893845611
Correlation,36,3.58351893845611
yoga,36,3.58351893845611
appropriateness,36,3.58351893845611
abciximab,36,3.58351893845611
multifocal,36,3.58351893845611
undertake,36,3.58351893845611
ORF3a,36,3.58351893845611
secreted,36,3.58351893845611
adequacy,36,3.58351893845611
defence,36,3.58351893845611
substrates,36,3.58351893845611
distortion,36,3.58351893845611
achievements,36,3.58351893845611
Implications,36,3.58351893845611
reliance,36,3.58351893845611
insensitive,36,3.58351893845611
senior,36,3.58351893845611
incentives,36,3.58351893845611
thematic,36,3.58351893845611
PCT,36,3.58351893845611
245,36,3.58351893845611
Reasons,36,3.58351893845611
laboratory-developed,36,3.58351893845611
replicating,36,3.58351893845611
Post,36,3.58351893845611
uncover,36,3.58351893845611
compartmental,35,3.5553480614894135
troponins,35,3.5553480614894135
immunochromatographic,35,3.5553480614894135
calling,35,3.5553480614894135
260,35,3.5553480614894135
reinforced,35,3.5553480614894135
transcriptomic,35,3.5553480614894135
Pooled,35,3.5553480614894135
pollens,35,3.5553480614894135
apps,35,3.5553480614894135
deposited,35,3.5553480614894135
AH1N1pdm,35,3.5553480614894135
211,35,3.5553480614894135
305,35,3.5553480614894135
RESULTS,35,3.5553480614894135
patchy,35,3.5553480614894135
inaccurate,35,3.5553480614894135
overestimated,35,3.5553480614894135
epidemiologists,35,3.5553480614894135
Being,35,3.5553480614894135
demanding,35,3.5553480614894135
Summary,35,3.5553480614894135
microspheres,35,3.5553480614894135
anaesthesia,35,3.5553480614894135
resume,35,3.5553480614894135
prioritizing,35,3.5553480614894135
blush,35,3.5553480614894135
2014-2015,35,3.5553480614894135
peculiarities,35,3.5553480614894135
prudent,35,3.5553480614894135
relieved,35,3.5553480614894135
Surprisingly,35,3.5553480614894135
AZD1222,35,3.5553480614894135
melatonin,35,3.5553480614894135
attenuating,35,3.5553480614894135
Healthy,35,3.5553480614894135
cross-species,35,3.5553480614894135
Immediate,35,3.5553480614894135
256,35,3.5553480614894135
siRNA,35,3.5553480614894135
noise,35,3.5553480614894135
easy-to-use,35,3.5553480614894135
Toronto,35,3.5553480614894135
inheritance,35,3.5553480614894135
IMPORTANCE,35,3.5553480614894135
violence,35,3.5553480614894135
superimposed,35,3.5553480614894135
possessed,35,3.5553480614894135
Substantial,35,3.5553480614894135
anti-platelet,35,3.5553480614894135
SIT,35,3.5553480614894135
contraceptive,35,3.5553480614894135
lability,35,3.5553480614894135
technically,35,3.5553480614894135
352,35,3.5553480614894135
mannitol,35,3.5553480614894135
V3,35,3.5553480614894135
Nations,35,3.5553480614894135
capsule,35,3.5553480614894135
Bacterial,35,3.5553480614894135
intradermal,35,3.5553480614894135
Cepheid,35,3.5553480614894135
peaking,35,3.5553480614894135
059,35,3.5553480614894135
emotion,35,3.5553480614894135
putting,35,3.5553480614894135
MVD,35,3.5553480614894135
associate,35,3.5553480614894135
LP,35,3.5553480614894135
raw,35,3.5553480614894135
aldosterone,35,3.5553480614894135
rodent,35,3.5553480614894135
respirator,35,3.5553480614894135
necessitated,35,3.5553480614894135
dealt,35,3.5553480614894135
Questionnaires,35,3.5553480614894135
030,35,3.5553480614894135
shaped,35,3.5553480614894135
releasing,35,3.5553480614894135
myocyte,35,3.5553480614894135
utilisation,35,3.5553480614894135
Finnish,35,3.5553480614894135
durable,35,3.5553480614894135
single-center,35,3.5553480614894135
280,35,3.5553480614894135
protein-based,35,3.5553480614894135
adaptations,35,3.5553480614894135
him,35,3.5553480614894135
interrupted,35,3.5553480614894135
Zhejiang,35,3.5553480614894135
noncompliance,35,3.5553480614894135
discordant,35,3.5553480614894135
veins,35,3.5553480614894135
ELISAs,35,3.5553480614894135
301,35,3.5553480614894135
perfusion-weighted,35,3.5553480614894135
wire,35,3.5553480614894135
335,35,3.5553480614894135
Learning,35,3.5553480614894135
waterfowl,35,3.5553480614894135
encodes,35,3.5553480614894135
representatives,35,3.5553480614894135
physiologically,35,3.5553480614894135
dissociation,35,3.5553480614894135
certified,35,3.5553480614894135
Models,35,3.5553480614894135
VL,35,3.5553480614894135
retrograde,35,3.5553480614894135
sectional,35,3.5553480614894135
transform,35,3.5553480614894135
bilirubin,35,3.5553480614894135
re-infection,35,3.5553480614894135
Units,35,3.5553480614894135
ethanol,35,3.5553480614894135
WBC,35,3.5553480614894135
spots,35,3.5553480614894135
subepithelial,35,3.5553480614894135
Live,35,3.5553480614894135
postnatal,35,3.5553480614894135
cytometry,35,3.5553480614894135
295,35,3.5553480614894135
043,35,3.5553480614894135
vigilant,35,3.5553480614894135
olds,35,3.5553480614894135
arachidonic,35,3.5553480614894135
Library,35,3.5553480614894135
Presently,35,3.5553480614894135
077,35,3.5553480614894135
TLR,35,3.5553480614894135
strengthened,35,3.5553480614894135
Across,35,3.5553480614894135
TH2,35,3.5553480614894135
Mass,35,3.5553480614894135
Exacerbations,34,3.5263605246161616
empyema,34,3.5263605246161616
Louisiana,34,3.5263605246161616
modulators,34,3.5263605246161616
sedation,34,3.5263605246161616
transiently,34,3.5263605246161616
beta2,34,3.5263605246161616
nutrients,34,3.5263605246161616
mounting,34,3.5263605246161616
270,34,3.5263605246161616
dried,34,3.5263605246161616
remedies,34,3.5263605246161616
antenatal,34,3.5263605246161616
NAT,34,3.5263605246161616
NFA,34,3.5263605246161616
categorization,34,3.5263605246161616
underutilized,34,3.5263605246161616
chemiluminescent,34,3.5263605246161616
mixtures,34,3.5263605246161616
antiplatelets,34,3.5263605246161616
337,34,3.5263605246161616
regulator,34,3.5263605246161616
calendar,34,3.5263605246161616
avoidable,34,3.5263605246161616
SEIR,34,3.5263605246161616
locus,34,3.5263605246161616
Israeli,34,3.5263605246161616
manufactured,34,3.5263605246161616
anger,34,3.5263605246161616
pPCI,34,3.5263605246161616
Literature,34,3.5263605246161616
census,34,3.5263605246161616
tackling,34,3.5263605246161616
supraventricular,34,3.5263605246161616
glomerular,34,3.5263605246161616
348,34,3.5263605246161616
dominance,34,3.5263605246161616
opens,34,3.5263605246161616
rehospitalization,34,3.5263605246161616
insufficiently,34,3.5263605246161616
aspirin-induced,34,3.5263605246161616
concise,34,3.5263605246161616
cockroach,34,3.5263605246161616
confronted,34,3.5263605246161616
Drugs,34,3.5263605246161616
Excess,34,3.5263605246161616
VO2,34,3.5263605246161616
sec,34,3.5263605246161616
underserved,34,3.5263605246161616
akinesis,34,3.5263605246161616
1971,34,3.5263605246161616
attend,34,3.5263605246161616
274,34,3.5263605246161616
PM10,34,3.5263605246161616
gray,34,3.5263605246161616
Angiotensin-converting,34,3.5263605246161616
Corticosteroids,34,3.5263605246161616
demonstrable,34,3.5263605246161616
risen,34,3.5263605246161616
unravel,34,3.5263605246161616
Adjusted,34,3.5263605246161616
hypoxaemia,34,3.5263605246161616
semi-structured,34,3.5263605246161616
Ig,34,3.5263605246161616
Depending,34,3.5263605246161616
histopathologic,34,3.5263605246161616
294,34,3.5263605246161616
Comparative,34,3.5263605246161616
automatically,34,3.5263605246161616
Fatigue,34,3.5263605246161616
Nucleic,34,3.5263605246161616
substantiated,34,3.5263605246161616
Published,34,3.5263605246161616
boundaries,34,3.5263605246161616
grounds,34,3.5263605246161616
Integrated,34,3.5263605246161616
agricultural,34,3.5263605246161616
Single,34,3.5263605246161616
CBV,34,3.5263605246161616
Urgent,34,3.5263605246161616
Combining,34,3.5263605246161616
perforation,34,3.5263605246161616
midbrain,34,3.5263605246161616
meant,34,3.5263605246161616
gravity,34,3.5263605246161616
PI3K,34,3.5263605246161616
HAI,34,3.5263605246161616
BVictoria,34,3.5263605246161616
mortalities,34,3.5263605246161616
Mental,34,3.5263605246161616
320,34,3.5263605246161616
068,34,3.5263605246161616
unsatisfactory,34,3.5263605246161616
309,34,3.5263605246161616
FD,34,3.5263605246161616
motivated,34,3.5263605246161616
avidity,34,3.5263605246161616
anticholinergic,34,3.5263605246161616
NYHA,34,3.5263605246161616
CO2,34,3.5263605246161616
073,34,3.5263605246161616
nonlinear,34,3.5263605246161616
managers,34,3.5263605246161616
co-circulating,34,3.5263605246161616
vectorcardiography,34,3.5263605246161616
secure,34,3.5263605246161616
304,34,3.5263605246161616
substitute,34,3.5263605246161616
characterise,34,3.5263605246161616
breadth,34,3.5263605246161616
alters,34,3.5263605246161616
carcinoma,34,3.5263605246161616
lactic,34,3.5263605246161616
HBO,34,3.5263605246161616
345,34,3.5263605246161616
low-molecular-weight,34,3.5263605246161616
gene-environment,34,3.5263605246161616
classifier,34,3.5263605246161616
239,34,3.5263605246161616
Aspergillus,34,3.5263605246161616
Atopy,34,3.5263605246161616
072,34,3.5263605246161616
skill,34,3.5263605246161616
rendered,34,3.5263605246161616
employers,34,3.5263605246161616
reportedly,34,3.5263605246161616
MONICA,34,3.5263605246161616
verification,34,3.5263605246161616
microbleeds,34,3.5263605246161616
exponentially,34,3.5263605246161616
immunohistochemistry,34,3.5263605246161616
Maternal,34,3.5263605246161616
nasopharynx,34,3.5263605246161616
crew,34,3.5263605246161616
pre-treatment,34,3.5263605246161616
circle,34,3.5263605246161616
confounded,34,3.5263605246161616
syndrome-coronavirus,34,3.5263605246161616
312,34,3.5263605246161616
SERS,34,3.5263605246161616
awake,34,3.5263605246161616
immunohistochemical,34,3.5263605246161616
seriousness,34,3.5263605246161616
economics,34,3.5263605246161616
COVID-19-associated,34,3.5263605246161616
possessing,34,3.5263605246161616
spikes,34,3.5263605246161616
derivative,34,3.5263605246161616
towns,34,3.5263605246161616
0-2,34,3.5263605246161616
wanted,34,3.5263605246161616
Aggressive,34,3.5263605246161616
Alpha,34,3.5263605246161616
convulsions,34,3.5263605246161616
Wheezing,34,3.5263605246161616
AF-related,34,3.5263605246161616
forest,34,3.5263605246161616
reconstruct,34,3.5263605246161616
fractures,34,3.5263605246161616
232,34,3.5263605246161616
timeliness,34,3.5263605246161616
350,34,3.5263605246161616
non-transmural,34,3.5263605246161616
022,34,3.5263605246161616
BALF,33,3.4965075614664802
division,33,3.4965075614664802
everyone,33,3.4965075614664802
Twenty-eight,33,3.4965075614664802
apparatus,33,3.4965075614664802
argument,33,3.4965075614664802
cavities,33,3.4965075614664802
Levels,33,3.4965075614664802
digoxin,33,3.4965075614664802
unexposed,33,3.4965075614664802
imperfect,33,3.4965075614664802
urbanization,33,3.4965075614664802
leukoaraiosis,33,3.4965075614664802
Moscow,33,3.4965075614664802
DS,33,3.4965075614664802
discordance,33,3.4965075614664802
269,33,3.4965075614664802
sounds,33,3.4965075614664802
IVE,33,3.4965075614664802
aligned,33,3.4965075614664802
ICD-9,33,3.4965075614664802
shaping,33,3.4965075614664802
Ultimately,33,3.4965075614664802
performs,33,3.4965075614664802
hardly,33,3.4965075614664802
concurrently,33,3.4965075614664802
reconstructed,33,3.4965075614664802
embolus,33,3.4965075614664802
900,33,3.4965075614664802
MV,33,3.4965075614664802
bear,33,3.4965075614664802
clotting,33,3.4965075614664802
stained,33,3.4965075614664802
neighboring,33,3.4965075614664802
gloves,33,3.4965075614664802
instrumentation,33,3.4965075614664802
spasticity,33,3.4965075614664802
longer-term,33,3.4965075614664802
DBP,33,3.4965075614664802
microbes,33,3.4965075614664802
667,33,3.4965075614664802
2012-2013,33,3.4965075614664802
public-health,33,3.4965075614664802
hemostatic,33,3.4965075614664802
cardiothoracic,33,3.4965075614664802
coil,33,3.4965075614664802
hyperinflammatory,33,3.4965075614664802
Perinatal,33,3.4965075614664802
crystal,33,3.4965075614664802
Proper,33,3.4965075614664802
dander,33,3.4965075614664802
Beyond,33,3.4965075614664802
2010-11,33,3.4965075614664802
062,33,3.4965075614664802
dyskinesia,33,3.4965075614664802
hub,33,3.4965075614664802
expense,33,3.4965075614664802
NPA,33,3.4965075614664802
APS,33,3.4965075614664802
rib,33,3.4965075614664802
076,33,3.4965075614664802
hydrogen,33,3.4965075614664802
Systems,33,3.4965075614664802
socially,33,3.4965075614664802
frozen,33,3.4965075614664802
Secondly,33,3.4965075614664802
live-attenuated,33,3.4965075614664802
favored,33,3.4965075614664802
immigrants,33,3.4965075614664802
transaminase,33,3.4965075614664802
flutter,33,3.4965075614664802
reviewers,33,3.4965075614664802
hypercoagulability,33,3.4965075614664802
Norwegian,33,3.4965075614664802
painful,33,3.4965075614664802
019,33,3.4965075614664802
stockpiled,33,3.4965075614664802
Sequencing,33,3.4965075614664802
anaphylactic,33,3.4965075614664802
feel,33,3.4965075614664802
Twenty-two,33,3.4965075614664802
Stem,33,3.4965075614664802
waking,33,3.4965075614664802
averaging,33,3.4965075614664802
complaint,33,3.4965075614664802
oxidation,33,3.4965075614664802
adhere,33,3.4965075614664802
driver,33,3.4965075614664802
AVictoria375,33,3.4965075614664802
governmental,33,3.4965075614664802
three-vessel,33,3.4965075614664802
NHLBI,33,3.4965075614664802
anamnesis,33,3.4965075614664802
alike,33,3.4965075614664802
Americas,33,3.4965075614664802
methylprednisolone,33,3.4965075614664802
machinery,33,3.4965075614664802
450,33,3.4965075614664802
Neurologic,33,3.4965075614664802
antibody-based,33,3.4965075614664802
biosecurity,33,3.4965075614664802
outer,33,3.4965075614664802
universities,33,3.4965075614664802
Investigations,33,3.4965075614664802
IL-1β,33,3.4965075614664802
precursors,33,3.4965075614664802
hs-CRP,33,3.4965075614664802
battery,33,3.4965075614664802
genotyping,33,3.4965075614664802
inhalant,33,3.4965075614664802
fasting,33,3.4965075614664802
TH,33,3.4965075614664802
disposable,33,3.4965075614664802
understudied,33,3.4965075614664802
threatens,33,3.4965075614664802
epicenter,33,3.4965075614664802
leaves,33,3.4965075614664802
hypoperfused,33,3.4965075614664802
ethically,33,3.4965075614664802
restricting,33,3.4965075614664802
Anticoagulation,33,3.4965075614664802
symptom-limited,33,3.4965075614664802
Columbia,33,3.4965075614664802
psychotherapy,33,3.4965075614664802
competent,33,3.4965075614664802
purely,33,3.4965075614664802
post-exposure,33,3.4965075614664802
NYC,33,3.4965075614664802
283,33,3.4965075614664802
vigilance,33,3.4965075614664802
hyperintensity,33,3.4965075614664802
attentional,33,3.4965075614664802
beatsmin,33,3.4965075614664802
Particularly,33,3.4965075614664802
TAVR,33,3.4965075614664802
Tl-201,33,3.4965075614664802
monocyte,33,3.4965075614664802
re-infarction,33,3.4965075614664802
label,33,3.4965075614664802
armamentarium,33,3.4965075614664802
covid-19,33,3.4965075614664802
Determining,33,3.4965075614664802
278,33,3.4965075614664802
visually,33,3.4965075614664802
postal,33,3.4965075614664802
doubling,33,3.4965075614664802
NAC,33,3.4965075614664802
encoded,33,3.4965075614664802
Flow,33,3.4965075614664802
Impella,33,3.4965075614664802
hypertonic,33,3.4965075614664802
HMGB1,33,3.4965075614664802
272,33,3.4965075614664802
transcriptome,33,3.4965075614664802
Carolina,33,3.4965075614664802
Subgroup,33,3.4965075614664802
revolutionized,33,3.4965075614664802
IC50,33,3.4965075614664802
segmented,33,3.4965075614664802
economically,33,3.4965075614664802
lipid-lowering,33,3.4965075614664802
EC,33,3.4965075614664802
switching,33,3.4965075614664802
radiology,33,3.4965075614664802
ADL,32,3.4657359027997265
V5,32,3.4657359027997265
ES,32,3.4657359027997265
fistula,32,3.4657359027997265
anti-spike,32,3.4657359027997265
HBOT,32,3.4657359027997265
714,32,3.4657359027997265
SAR,32,3.4657359027997265
operator,32,3.4657359027997265
influenza-specific,32,3.4657359027997265
ppm,32,3.4657359027997265
in-patient,32,3.4657359027997265
Inhalation,32,3.4657359027997265
integrates,32,3.4657359027997265
CADASIL,32,3.4657359027997265
observers,32,3.4657359027997265
São,32,3.4657359027997265
antigen-specific,32,3.4657359027997265
optimise,32,3.4657359027997265
viremia,32,3.4657359027997265
nonsmoking,32,3.4657359027997265
RBM,32,3.4657359027997265
mutually,32,3.4657359027997265
Improving,32,3.4657359027997265
coinfections,32,3.4657359027997265
Guillain-Barré,32,3.4657359027997265
recanalized,32,3.4657359027997265
climates,32,3.4657359027997265
296,32,3.4657359027997265
dipropionate,32,3.4657359027997265
antireflux,32,3.4657359027997265
324,32,3.4657359027997265
Year,32,3.4657359027997265
topography,32,3.4657359027997265
Statistics,32,3.4657359027997265
transitory,32,3.4657359027997265
254,32,3.4657359027997265
readiness,32,3.4657359027997265
hyperimmune,32,3.4657359027997265
therapists,32,3.4657359027997265
Frequent,32,3.4657359027997265
deserve,32,3.4657359027997265
arrive,32,3.4657359027997265
Sickle,32,3.4657359027997265
municipal,32,3.4657359027997265
scientifically,32,3.4657359027997265
polyclonal,32,3.4657359027997265
mankind,32,3.4657359027997265
afford,32,3.4657359027997265
laryngeal,32,3.4657359027997265
376,32,3.4657359027997265
uniformly,32,3.4657359027997265
SIV,32,3.4657359027997265
completing,32,3.4657359027997265
travellers,32,3.4657359027997265
oldest,32,3.4657359027997265
pneumonitis,32,3.4657359027997265
steel,32,3.4657359027997265
RI,32,3.4657359027997265
AS,32,3.4657359027997265
tumour,32,3.4657359027997265
wear,32,3.4657359027997265
milieu,32,3.4657359027997265
vaccinology,32,3.4657359027997265
biventricular,32,3.4657359027997265
096,32,3.4657359027997265
resembled,32,3.4657359027997265
ATP,32,3.4657359027997265
perceptual,32,3.4657359027997265
organisation,32,3.4657359027997265
sestamibi,32,3.4657359027997265
H1N12009,32,3.4657359027997265
cesarean,32,3.4657359027997265
289,32,3.4657359027997265
PETCT,32,3.4657359027997265
underpinning,32,3.4657359027997265
coordinate,32,3.4657359027997265
CC,32,3.4657359027997265
catecholamines,32,3.4657359027997265
292,32,3.4657359027997265
VSR,32,3.4657359027997265
post-infection,32,3.4657359027997265
chimeric,32,3.4657359027997265
SOT,32,3.4657359027997265
Criteria,32,3.4657359027997265
OSAS,32,3.4657359027997265
metric,32,3.4657359027997265
rights,32,3.4657359027997265
RP,32,3.4657359027997265
furthermore,32,3.4657359027997265
040,32,3.4657359027997265
outflow,32,3.4657359027997265
permanently,32,3.4657359027997265
Conference,32,3.4657359027997265
myeloid,32,3.4657359027997265
Trends,32,3.4657359027997265
382,32,3.4657359027997265
execution,32,3.4657359027997265
killing,32,3.4657359027997265
18F-FDG,32,3.4657359027997265
AH1,32,3.4657359027997265
purpura,32,3.4657359027997265
overexpression,32,3.4657359027997265
restrict,32,3.4657359027997265
stunning,32,3.4657359027997265
nM,32,3.4657359027997265
prescribe,32,3.4657359027997265
spot,32,3.4657359027997265
069,32,3.4657359027997265
Tests,32,3.4657359027997265
titration,32,3.4657359027997265
individualised,32,3.4657359027997265
visitors,32,3.4657359027997265
virologically,32,3.4657359027997265
2009-10,32,3.4657359027997265
Later,32,3.4657359027997265
penetrating,32,3.4657359027997265
1960s,32,3.4657359027997265
ISH,32,3.4657359027997265
suffers,32,3.4657359027997265
HCPs,32,3.4657359027997265
responsibilities,32,3.4657359027997265
diisocyanate,32,3.4657359027997265
380,32,3.4657359027997265
444,32,3.4657359027997265
Remdesivir,32,3.4657359027997265
company,32,3.4657359027997265
T-,32,3.4657359027997265
Oxygen,32,3.4657359027997265
Are,32,3.4657359027997265
alexithymia,32,3.4657359027997265
happen,32,3.4657359027997265
Work,32,3.4657359027997265
non-significant,32,3.4657359027997265
Florida,32,3.4657359027997265
twins,32,3.4657359027997265
followed-up,32,3.4657359027997265
Measure,32,3.4657359027997265
anxious,32,3.4657359027997265
granted,32,3.4657359027997265
half-life,32,3.4657359027997265
glycan,32,3.4657359027997265
Enhanced,32,3.4657359027997265
industries,32,3.4657359027997265
APort,32,3.4657359027997265
CpG,32,3.4657359027997265
configuration,32,3.4657359027997265
RDT,32,3.4657359027997265
Body,32,3.4657359027997265
GWAS,32,3.4657359027997265
cascades,32,3.4657359027997265
within-host,32,3.4657359027997265
287,32,3.4657359027997265
B1,32,3.4657359027997265
undertaking,32,3.4657359027997265
translating,32,3.4657359027997265
ordered,32,3.4657359027997265
metabolomics,32,3.4657359027997265
Obesity,32,3.4657359027997265
Radix,32,3.4657359027997265
non-lacunar,32,3.4657359027997265
antegrade,32,3.4657359027997265
returns,32,3.4657359027997265
ETS,31,3.4339872044851463
11th,31,3.4339872044851463
monitors,31,3.4339872044851463
Massachusetts,31,3.4339872044851463
236,31,3.4339872044851463
024,31,3.4339872044851463
got,31,3.4339872044851463
pericardium,31,3.4339872044851463
Ib,31,3.4339872044851463
labelled,31,3.4339872044851463
post-AMI,31,3.4339872044851463
duplex,31,3.4339872044851463
populated,31,3.4339872044851463
puncture,31,3.4339872044851463
practiced,31,3.4339872044851463
thirteen,31,3.4339872044851463
061,31,3.4339872044851463
internet,31,3.4339872044851463
Clin,31,3.4339872044851463
Indigenous,31,3.4339872044851463
home-based,31,3.4339872044851463
intensities,31,3.4339872044851463
comply,31,3.4339872044851463
shifting,31,3.4339872044851463
monoxide,31,3.4339872044851463
PFT,31,3.4339872044851463
postponed,31,3.4339872044851463
imagery,31,3.4339872044851463
hotspots,31,3.4339872044851463
price,31,3.4339872044851463
minks,31,3.4339872044851463
appreciable,31,3.4339872044851463
stabilize,31,3.4339872044851463
patents,31,3.4339872044851463
needing,31,3.4339872044851463
Arab,31,3.4339872044851463
038,31,3.4339872044851463
grew,31,3.4339872044851463
Reduced,31,3.4339872044851463
synonymous,31,3.4339872044851463
north,31,3.4339872044851463
sustaining,31,3.4339872044851463
hypertensives,31,3.4339872044851463
Sera,31,3.4339872044851463
malaria,31,3.4339872044851463
forefront,31,3.4339872044851463
inputs,31,3.4339872044851463
drawbacks,31,3.4339872044851463
self-collection,31,3.4339872044851463
akinesia,31,3.4339872044851463
withdrawn,31,3.4339872044851463
014,31,3.4339872044851463
concomitantly,31,3.4339872044851463
pre-symptomatic,31,3.4339872044851463
arteritis,31,3.4339872044851463
sharply,31,3.4339872044851463
unreliable,31,3.4339872044851463
Concern,31,3.4339872044851463
IIV4,31,3.4339872044851463
circumferential,31,3.4339872044851463
HCT,31,3.4339872044851463
divergent,31,3.4339872044851463
285,31,3.4339872044851463
immunomodulators,31,3.4339872044851463
mark,31,3.4339872044851463
businesses,31,3.4339872044851463
misleading,31,3.4339872044851463
sugar,31,3.4339872044851463
290,31,3.4339872044851463
refine,31,3.4339872044851463
peri-infarct,31,3.4339872044851463
Magnesium,31,3.4339872044851463
reactogenicity,31,3.4339872044851463
tailoring,31,3.4339872044851463
342,31,3.4339872044851463
nearest,31,3.4339872044851463
Typically,31,3.4339872044851463
Joint,31,3.4339872044851463
patient-centered,31,3.4339872044851463
Hungary,31,3.4339872044851463
erythrocyte,31,3.4339872044851463
LABA,31,3.4339872044851463
post-COVID,31,3.4339872044851463
contrast-enhanced,31,3.4339872044851463
Romania,31,3.4339872044851463
SABA,31,3.4339872044851463
chemistry,31,3.4339872044851463
preload,31,3.4339872044851463
oscillation,31,3.4339872044851463
Virology,31,3.4339872044851463
goblet,31,3.4339872044851463
traced,31,3.4339872044851463
049,31,3.4339872044851463
entitled,31,3.4339872044851463
aggressively,31,3.4339872044851463
underestimation,31,3.4339872044851463
concentrate,31,3.4339872044851463
cage,31,3.4339872044851463
resurgence,31,3.4339872044851463
indistinguishable,31,3.4339872044851463
aspirate,31,3.4339872044851463
doubts,31,3.4339872044851463
Short,31,3.4339872044851463
VTE,31,3.4339872044851463
ENO,31,3.4339872044851463
hypercapnia,31,3.4339872044851463
accepting,31,3.4339872044851463
FEF25-75,31,3.4339872044851463
stasis,31,3.4339872044851463
contract,31,3.4339872044851463
symptom-based,31,3.4339872044851463
aptamer,31,3.4339872044851463
scarcity,31,3.4339872044851463
cleared,31,3.4339872044851463
AST,31,3.4339872044851463
HRT,31,3.4339872044851463
assembled,31,3.4339872044851463
Patent,31,3.4339872044851463
wearable,31,3.4339872044851463
CIs,31,3.4339872044851463
dysplasia,31,3.4339872044851463
covert,31,3.4339872044851463
Regardless,31,3.4339872044851463
competence,31,3.4339872044851463
struck,31,3.4339872044851463
cannabis,31,3.4339872044851463
pangolin,31,3.4339872044851463
mgdl,31,3.4339872044851463
convincingly,31,3.4339872044851463
effusions,31,3.4339872044851463
destructive,31,3.4339872044851463
wake,31,3.4339872044851463
048,31,3.4339872044851463
PT,31,3.4339872044851463
weekends,31,3.4339872044851463
firstly,31,3.4339872044851463
Allergen,31,3.4339872044851463
Continued,31,3.4339872044851463
pre-school,31,3.4339872044851463
femoral,31,3.4339872044851463
progeny,31,3.4339872044851463
denied,31,3.4339872044851463
V3R,31,3.4339872044851463
cationic,31,3.4339872044851463
044,31,3.4339872044851463
Seventy,31,3.4339872044851463
antisera,31,3.4339872044851463
smart,31,3.4339872044851463
anterograde,31,3.4339872044851463
educating,31,3.4339872044851463
ancestral,31,3.4339872044851463
©,31,3.4339872044851463
heterosubtypic,31,3.4339872044851463
nCoV,31,3.4339872044851463
gadolinium,31,3.4339872044851463
ORs,31,3.4339872044851463
immunopathogenesis,31,3.4339872044851463
dehydration,31,3.4339872044851463
excitability,31,3.4339872044851463
339,31,3.4339872044851463
sciences,31,3.4339872044851463
sludge,31,3.4339872044851463
LAR,31,3.4339872044851463
learnt,31,3.4339872044851463
subtyping,31,3.4339872044851463
apixaban,31,3.4339872044851463
sublingual,31,3.4339872044851463
labeling,31,3.4339872044851463
Stockholm,31,3.4339872044851463
Responses,31,3.4339872044851463
statewide,31,3.4339872044851463
paradigms,31,3.4339872044851463
lockdowns,31,3.4339872044851463
oriented,31,3.4339872044851463
gel,31,3.4339872044851463
inactive,31,3.4339872044851463
drain,31,3.4339872044851463
incurred,31,3.4339872044851463
Willebrand,31,3.4339872044851463
herpes,31,3.4339872044851463
clean,31,3.4339872044851463
specify,31,3.4339872044851463
SARS‑CoV‑2,31,3.4339872044851463
Fugl-Meyer,30,3.4011973816621555
031,30,3.4011973816621555
on-going,30,3.4011973816621555
360,30,3.4011973816621555
decompressive,30,3.4011973816621555
bulk,30,3.4011973816621555
054,30,3.4011973816621555
atherothrombosis,30,3.4011973816621555
absorption,30,3.4011973816621555
nonsteroidal,30,3.4011973816621555
sensitizers,30,3.4011973816621555
undesirable,30,3.4011973816621555
two-year,30,3.4011973816621555
metered-dose,30,3.4011973816621555
suspension,30,3.4011973816621555
bromide,30,3.4011973816621555
succumbed,30,3.4011973816621555
absences,30,3.4011973816621555
2004-2005,30,3.4011973816621555
prolong,30,3.4011973816621555
Borg,30,3.4011973816621555
genders,30,3.4011973816621555
Scottish,30,3.4011973816621555
wildlife,30,3.4011973816621555
permissive,30,3.4011973816621555
noninvasively,30,3.4011973816621555
2005-2006,30,3.4011973816621555
Zanamivir,30,3.4011973816621555
vectorcardiographic,30,3.4011973816621555
PTCR,30,3.4011973816621555
say,30,3.4011973816621555
knowing,30,3.4011973816621555
unified,30,3.4011973816621555
238,30,3.4011973816621555
313,30,3.4011973816621555
298,30,3.4011973816621555
Activity,30,3.4011973816621555
immunomodulation,30,3.4011973816621555
316,30,3.4011973816621555
exacerbates,30,3.4011973816621555
Histological,30,3.4011973816621555
Stent,30,3.4011973816621555
prompting,30,3.4011973816621555
Except,30,3.4011973816621555
Male,30,3.4011973816621555
Cardioembolic,30,3.4011973816621555
047,30,3.4011973816621555
endotype,30,3.4011973816621555
IFA,30,3.4011973816621555
importation,30,3.4011973816621555
well-characterized,30,3.4011973816621555
synthase,30,3.4011973816621555
electrocardiographically,30,3.4011973816621555
Kenya,30,3.4011973816621555
Croatia,30,3.4011973816621555
pharmacokinetics,30,3.4011973816621555
patches,30,3.4011973816621555
communicating,30,3.4011973816621555
rapidity,30,3.4011973816621555
996,30,3.4011973816621555
BMT,30,3.4011973816621555
constrained,30,3.4011973816621555
irreversibly,30,3.4011973816621555
framing,30,3.4011973816621555
allergen-specific,30,3.4011973816621555
percentile,30,3.4011973816621555
haemodynamics,30,3.4011973816621555
Sequence,30,3.4011973816621555
endotoxin,30,3.4011973816621555
paramedics,30,3.4011973816621555
misconceptions,30,3.4011973816621555
probiotics,30,3.4011973816621555
Targeted,30,3.4011973816621555
MDA,30,3.4011973816621555
Rt,30,3.4011973816621555
reproduced,30,3.4011973816621555
Abstract,30,3.4011973816621555
non-medical,30,3.4011973816621555
MACEs,30,3.4011973816621555
stroke-like,30,3.4011973816621555
stimulates,30,3.4011973816621555
--,30,3.4011973816621555
Lacunar,30,3.4011973816621555
cheap,30,3.4011973816621555
sure,30,3.4011973816621555
Progress,30,3.4011973816621555
Two-dimensional,30,3.4011973816621555
organizing,30,3.4011973816621555
urea,30,3.4011973816621555
stress-induced,30,3.4011973816621555
249,30,3.4011973816621555
filters,30,3.4011973816621555
physiopathological,30,3.4011973816621555
grave,30,3.4011973816621555
looks,30,3.4011973816621555
inspection,30,3.4011973816621555
transduction,30,3.4011973816621555
assure,30,3.4011973816621555
Consistent,30,3.4011973816621555
introduces,30,3.4011973816621555
resilience,30,3.4011973816621555
plague,30,3.4011973816621555
017,30,3.4011973816621555
proton,30,3.4011973816621555
staffing,30,3.4011973816621555
hurdles,30,3.4011973816621555
2008-2009,30,3.4011973816621555
instructed,30,3.4011973816621555
non-COVID-19,30,3.4011973816621555
perturbations,30,3.4011973816621555
seconds,30,3.4011973816621555
Biomarkers,30,3.4011973816621555
catalytic,30,3.4011973816621555
248,30,3.4011973816621555
Pediatrics,30,3.4011973816621555
resembling,30,3.4011973816621555
328,30,3.4011973816621555
heating,30,3.4011973816621555
eGFR,30,3.4011973816621555
Ethiopia,30,3.4011973816621555
387,30,3.4011973816621555
subtotal,30,3.4011973816621555
manufacturer,30,3.4011973816621555
Activation,30,3.4011973816621555
comment,30,3.4011973816621555
Performance,30,3.4011973816621555
phone,30,3.4011973816621555
epinephrine,30,3.4011973816621555
realize,30,3.4011973816621555
089,30,3.4011973816621555
constituents,30,3.4011973816621555
Whites,30,3.4011973816621555
nonsmokers,30,3.4011973816621555
S1S2,30,3.4011973816621555
thin,30,3.4011973816621555
drifted,30,3.4011973816621555
population-wide,30,3.4011973816621555
argued,30,3.4011973816621555
kinase-MB,30,3.4011973816621555
immunodepression,30,3.4011973816621555
assisting,30,3.4011973816621555
dentists,30,3.4011973816621555
miss,30,3.4011973816621555
mount,30,3.4011973816621555
Ad26COV2S,30,3.4011973816621555
dPCR,30,3.4011973816621555
BM,30,3.4011973816621555
cancers,30,3.4011973816621555
accumulate,30,3.4011973816621555
versatile,30,3.4011973816621555
Medicines,30,3.4011973816621555
RAT,30,3.4011973816621555
aforementioned,30,3.4011973816621555
anonymous,30,3.4011973816621555
AMIs,30,3.4011973816621555
dismutase,30,3.4011973816621555
adapting,30,3.4011973816621555
co-morbidity,30,3.4011973816621555
planar,30,3.4011973816621555
Organizations,30,3.4011973816621555
thrombophilia,30,3.4011973816621555
MHC,30,3.4011973816621555
impairs,30,3.4011973816621555
leadership,30,3.4011973816621555
assurance,30,3.4011973816621555
structurally,30,3.4011973816621555
p-value,30,3.4011973816621555
10172,30,3.4011973816621555
Prefecture,30,3.4011973816621555
inhospital,30,3.4011973816621555
self-monitoring,30,3.4011973816621555
chemotactic,30,3.4011973816621555
low-level,30,3.4011973816621555
2-week,30,3.4011973816621555
peramivir,30,3.4011973816621555
pharmacokinetic,30,3.4011973816621555
extraction-free,30,3.4011973816621555
probabilistic,30,3.4011973816621555
mining,30,3.4011973816621555
failing,30,3.4011973816621555
puerperium,30,3.4011973816621555
auditory,30,3.4011973816621555
Mechanisms,30,3.4011973816621555
km,30,3.4011973816621555
phosphorylation,30,3.4011973816621555
Eighty,30,3.4011973816621555
margin,30,3.4011973816621555
five-year,30,3.4011973816621555
historic,30,3.4011973816621555
disadvantage,30,3.4011973816621555
Caucasians,30,3.4011973816621555
intriguing,30,3.4011973816621555
κ,30,3.4011973816621555
versa,30,3.4011973816621555
341,29,3.367295829986474
harms,29,3.367295829986474
reproduce,29,3.367295829986474
inevitably,29,3.367295829986474
solved,29,3.367295829986474
058,29,3.367295829986474
dissections,29,3.367295829986474
morbid,29,3.367295829986474
exploit,29,3.367295829986474
30th,29,3.367295829986474
permitting,29,3.367295829986474
IL-1,29,3.367295829986474
non-stroke,29,3.367295829986474
Raman,29,3.367295829986474
regime,29,3.367295829986474
Medicaid,29,3.367295829986474
houses,29,3.367295829986474
happens,29,3.367295829986474
subtraction,29,3.367295829986474
puts,29,3.367295829986474
Support,29,3.367295829986474
Ia,29,3.367295829986474
aided,29,3.367295829986474
968,29,3.367295829986474
fertility,29,3.367295829986474
310,29,3.367295829986474
resuscitated,29,3.367295829986474
peroxidase,29,3.367295829986474
ferritin,29,3.367295829986474
alleviation,29,3.367295829986474
allied,29,3.367295829986474
Autopsy,29,3.367295829986474
employee,29,3.367295829986474
approximate,29,3.367295829986474
METs,29,3.367295829986474
nAbs,29,3.367295829986474
≥6,29,3.367295829986474
Twenty-three,29,3.367295829986474
MoCA,29,3.367295829986474
croup,29,3.367295829986474
gather,29,3.367295829986474
090,29,3.367295829986474
diagonal,29,3.367295829986474
433,29,3.367295829986474
analogous,29,3.367295829986474
7-day,29,3.367295829986474
compartment,29,3.367295829986474
IL-2,29,3.367295829986474
ancient,29,3.367295829986474
769,29,3.367295829986474
abolished,29,3.367295829986474
discharges,29,3.367295829986474
sub-acute,29,3.367295829986474
predominate,29,3.367295829986474
partnerships,29,3.367295829986474
axial,29,3.367295829986474
LDL,29,3.367295829986474
resumed,29,3.367295829986474
Pathological,29,3.367295829986474
marketing,29,3.367295829986474
lie,29,3.367295829986474
WM,29,3.367295829986474
lidocaine,29,3.367295829986474
flour,29,3.367295829986474
microneutralization,29,3.367295829986474
ART,29,3.367295829986474
Short-term,29,3.367295829986474
transcripts,29,3.367295829986474
Educational,29,3.367295829986474
MMPs,29,3.367295829986474
single-photon,29,3.367295829986474
reminders,29,3.367295829986474
Hemorrhagic,29,3.367295829986474
definitively,29,3.367295829986474
Sample,29,3.367295829986474
attain,29,3.367295829986474
feared,29,3.367295829986474
Predictors,29,3.367295829986474
correspondence,29,3.367295829986474
Sydney,29,3.367295829986474
G614,29,3.367295829986474
fibrotic,29,3.367295829986474
TICI,29,3.367295829986474
freely,29,3.367295829986474
302,29,3.367295829986474
cycling,29,3.367295829986474
dysarthria,29,3.367295829986474
252,29,3.367295829986474
Collaboration,29,3.367295829986474
Iranian,29,3.367295829986474
Upper,29,3.367295829986474
PSCI,29,3.367295829986474
agenda,29,3.367295829986474
intra-,29,3.367295829986474
SGOT,29,3.367295829986474
intramyocardial,29,3.367295829986474
Preclinical,29,3.367295829986474
029,29,3.367295829986474
centered,29,3.367295829986474
318,29,3.367295829986474
achieves,29,3.367295829986474
kinases,29,3.367295829986474
317,29,3.367295829986474
500000,29,3.367295829986474
road,29,3.367295829986474
NSCs,29,3.367295829986474
readout,29,3.367295829986474
315,29,3.367295829986474
Personal,29,3.367295829986474
lifesaving,29,3.367295829986474
pandemia,29,3.367295829986474
decision-makers,29,3.367295829986474
PF,29,3.367295829986474
201011,29,3.367295829986474
strain-specific,29,3.367295829986474
uncovered,29,3.367295829986474
Göteborg,29,3.367295829986474
noteworthy,29,3.367295829986474
peritoneal,29,3.367295829986474
Present,29,3.367295829986474
MN,29,3.367295829986474
5-7,29,3.367295829986474
longevity,29,3.367295829986474
small-vessel,29,3.367295829986474
accomplish,29,3.367295829986474
2006-2007,29,3.367295829986474
afflicted,29,3.367295829986474
malnutrition,29,3.367295829986474
BYamagata,29,3.367295829986474
deploy,29,3.367295829986474
acidic,29,3.367295829986474
biofeedback,29,3.367295829986474
Act,29,3.367295829986474
Paris,29,3.367295829986474
questionable,29,3.367295829986474
diluted,29,3.367295829986474
farming,29,3.367295829986474
trees,29,3.367295829986474
RF,29,3.367295829986474
PaCO2,29,3.367295829986474
NTD,29,3.367295829986474
manifesting,29,3.367295829986474
admitting,29,3.367295829986474
Cluster,29,3.367295829986474
catheter-based,29,3.367295829986474
Dynamic,29,3.367295829986474
1-5,29,3.367295829986474
FC,29,3.367295829986474
haplotype,29,3.367295829986474
PCR-positive,29,3.367295829986474
438,29,3.367295829986474
websites,29,3.367295829986474
Traditionally,29,3.367295829986474
H3N2v,29,3.367295829986474
summed,29,3.367295829986474
decay,29,3.367295829986474
catheterisation,29,3.367295829986474
participates,29,3.367295829986474
alleviating,29,3.367295829986474
unexpectedly,29,3.367295829986474
Cape,29,3.367295829986474
resemble,29,3.367295829986474
optimism,29,3.367295829986474
hypokinetic,29,3.367295829986474
bipolar,29,3.367295829986474
positioned,29,3.367295829986474
suburban,29,3.367295829986474
TTC,29,3.367295829986474
editorial,29,3.367295829986474
cytotoxicity,29,3.367295829986474
mention,29,3.367295829986474
horse,29,3.367295829986474
swabbing,29,3.367295829986474
airports,29,3.367295829986474
346,29,3.367295829986474
Embolic,29,3.367295829986474
Rats,29,3.367295829986474
PSE,29,3.367295829986474
end-stage,29,3.367295829986474
Iceland,29,3.367295829986474
estimations,29,3.367295829986474
7-10,29,3.367295829986474
welfare,29,3.367295829986474
364,29,3.367295829986474
H1N2,29,3.367295829986474
right-to-left,29,3.367295829986474
exceptionally,29,3.367295829986474
high-level,29,3.367295829986474
IC,29,3.367295829986474
non-severe,29,3.367295829986474
marrow-derived,29,3.367295829986474
borders,29,3.367295829986474
ergometric,29,3.367295829986474
diving,29,3.367295829986474
nystagmus,29,3.367295829986474
Wistar,29,3.367295829986474
IP,29,3.367295829986474
slowed,29,3.367295829986474
P50,29,3.367295829986474
6-12,29,3.367295829986474
nights,29,3.367295829986474
sanitation,29,3.367295829986474
RNase,29,3.367295829986474
transit,29,3.367295829986474
physicochemical,29,3.367295829986474
Technology,29,3.367295829986474
ORF8,29,3.367295829986474
goes,29,3.367295829986474
IOS,29,3.367295829986474
jointly,29,3.367295829986474
incidents,29,3.367295829986474
vice,29,3.367295829986474
Essential,29,3.367295829986474
H9,29,3.367295829986474
Georgia,29,3.367295829986474
exercised,29,3.367295829986474
endobronchial,29,3.367295829986474
embedded,29,3.367295829986474
hypothesised,29,3.367295829986474
Amongst,29,3.367295829986474
taught,29,3.367295829986474
copiesml,29,3.367295829986474
AIM,28,3.332204510175204
mitigated,28,3.332204510175204
20102011,28,3.332204510175204
preponderance,28,3.332204510175204
purchase,28,3.332204510175204
stratifying,28,3.332204510175204
ataxia,28,3.332204510175204
midst,28,3.332204510175204
IN,28,3.332204510175204
429,28,3.332204510175204
mutual,28,3.332204510175204
chambers,28,3.332204510175204
PaO2,28,3.332204510175204
SPSS,28,3.332204510175204
rheumatoid,28,3.332204510175204
grass,28,3.332204510175204
conjugate,28,3.332204510175204
autosomal,28,3.332204510175204
4-week,28,3.332204510175204
pancreatic,28,3.332204510175204
unacceptably,28,3.332204510175204
VLPs,28,3.332204510175204
ultrasonic,28,3.332204510175204
tear,28,3.332204510175204
Thirty-one,28,3.332204510175204
afterwards,28,3.332204510175204
Sudden,28,3.332204510175204
surfactant,28,3.332204510175204
angiogenic,28,3.332204510175204
Level,28,3.332204510175204
SARS-like,28,3.332204510175204
Cohens,28,3.332204510175204
1966,28,3.332204510175204
HSCT,28,3.332204510175204
GM-CSF,28,3.332204510175204
fits,28,3.332204510175204
categorical,28,3.332204510175204
Protocol,28,3.332204510175204
Ramaswamy,28,3.332204510175204
NPI,28,3.332204510175204
Whole,28,3.332204510175204
overestimate,28,3.332204510175204
ensuing,28,3.332204510175204
superinfection,28,3.332204510175204
hyperbaric,28,3.332204510175204
modestly,28,3.332204510175204
cAMP,28,3.332204510175204
tactics,28,3.332204510175204
obviously,28,3.332204510175204
preclude,28,3.332204510175204
sunlight,28,3.332204510175204
CPSP,28,3.332204510175204
281,28,3.332204510175204
bronchiale,28,3.332204510175204
Normal,28,3.332204510175204
supratentorial,28,3.332204510175204
cysteine,28,3.332204510175204
conflicts,28,3.332204510175204
8th,28,3.332204510175204
factory,28,3.332204510175204
alanine,28,3.332204510175204
aluminum,28,3.332204510175204
251,28,3.332204510175204
Twitter,28,3.332204510175204
Events,28,3.332204510175204
231,28,3.332204510175204
teach,28,3.332204510175204
compensate,28,3.332204510175204
343,28,3.332204510175204
Alternatively,28,3.332204510175204
CAT,28,3.332204510175204
475,28,3.332204510175204
phytochemicals,28,3.332204510175204
isoforms,28,3.332204510175204
sitting,28,3.332204510175204
weights,28,3.332204510175204
Concerns,28,3.332204510175204
attribute,28,3.332204510175204
disparate,28,3.332204510175204
arteriogram,28,3.332204510175204
Platelet,28,3.332204510175204
277,28,3.332204510175204
bioavailability,28,3.332204510175204
deceleration,28,3.332204510175204
non-paretic,28,3.332204510175204
expedite,28,3.332204510175204
267,28,3.332204510175204
FEV10,28,3.332204510175204
circuits,28,3.332204510175204
282,28,3.332204510175204
PWI,28,3.332204510175204
Britain,28,3.332204510175204
onward,28,3.332204510175204
elucidation,28,3.332204510175204
anticoagulated,28,3.332204510175204
fragmentation,28,3.332204510175204
undergoes,28,3.332204510175204
drives,28,3.332204510175204
opportunistic,28,3.332204510175204
inflation,28,3.332204510175204
camps,28,3.332204510175204
weaker,28,3.332204510175204
updating,28,3.332204510175204
AIVs,28,3.332204510175204
busy,28,3.332204510175204
contiguous,28,3.332204510175204
Sex,28,3.332204510175204
painless,28,3.332204510175204
455,28,3.332204510175204
Typical,28,3.332204510175204
Chloroquine,28,3.332204510175204
818,28,3.332204510175204
transparent,28,3.332204510175204
311,28,3.332204510175204
alarm,28,3.332204510175204
sides,28,3.332204510175204
prognostication,28,3.332204510175204
381,28,3.332204510175204
unspecific,28,3.332204510175204
formerly,28,3.332204510175204
overnight,28,3.332204510175204
13-14,28,3.332204510175204
exhaustive,28,3.332204510175204
non-pregnant,28,3.332204510175204
marketed,28,3.332204510175204
041,28,3.332204510175204
NSW,28,3.332204510175204
accompany,28,3.332204510175204
leisure,28,3.332204510175204
Serology,28,3.332204510175204
autoimmunity,28,3.332204510175204
ventilators,28,3.332204510175204
CSC,28,3.332204510175204
tens,28,3.332204510175204
ribonucleic,28,3.332204510175204
018,28,3.332204510175204
equity,28,3.332204510175204
Close,28,3.332204510175204
favourably,28,3.332204510175204
Neuroimaging,28,3.332204510175204
community-wide,28,3.332204510175204
scrutiny,28,3.332204510175204
Defense,28,3.332204510175204
stabilizing,28,3.332204510175204
iatrogenic,28,3.332204510175204
happened,28,3.332204510175204
PCPS,28,3.332204510175204
histone,28,3.332204510175204
descriptors,28,3.332204510175204
transparency,28,3.332204510175204
Emergent,28,3.332204510175204
Considerable,28,3.332204510175204
forthcoming,28,3.332204510175204
2002-2003,28,3.332204510175204
civilian,28,3.332204510175204
Intracranial,28,3.332204510175204
engaging,28,3.332204510175204
proceed,28,3.332204510175204
continual,28,3.332204510175204
proving,28,3.332204510175204
interleukin-6,28,3.332204510175204
Microbiology,28,3.332204510175204
Presence,28,3.332204510175204
defective,28,3.332204510175204
Francisco,28,3.332204510175204
postvaccination,28,3.332204510175204
caliber,28,3.332204510175204
Affairs,28,3.332204510175204
localities,28,3.332204510175204
retriever,28,3.332204510175204
Decreased,28,3.332204510175204
afferent,28,3.332204510175204
Takotsubo,28,3.332204510175204
2003-2004,28,3.332204510175204
metabolite,28,3.332204510175204
Neutralizing,28,3.332204510175204
random-effects,28,3.332204510175204
escalation,28,3.332204510175204
399,28,3.332204510175204
021,28,3.332204510175204
suspicious,28,3.332204510175204
Prediction,28,3.332204510175204
disruptions,28,3.332204510175204
organised,28,3.332204510175204
thirty,28,3.332204510175204
disability-adjusted,28,3.332204510175204
2-5,28,3.332204510175204
sternal,28,3.332204510175204
lymphoma,28,3.332204510175204
eighth,28,3.332204510175204
conferring,28,3.332204510175204
isoenzymes,28,3.332204510175204
recruit,28,3.332204510175204
ubiquitous,28,3.332204510175204
merit,28,3.332204510175204
reversing,28,3.332204510175204
extinction,28,3.332204510175204
alerts,28,3.332204510175204
catecholamine,27,3.295836866004329
365,27,3.295836866004329
wrong,27,3.295836866004329
conductance,27,3.295836866004329
ET-1,27,3.295836866004329
storms,27,3.295836866004329
angle,27,3.295836866004329
technetium,27,3.295836866004329
enalapril,27,3.295836866004329
predictability,27,3.295836866004329
WTP,27,3.295836866004329
CTL,27,3.295836866004329
parasitic,27,3.295836866004329
stand,27,3.295836866004329
door,27,3.295836866004329
smallest,27,3.295836866004329
Plus,27,3.295836866004329
spouse,27,3.295836866004329
expectoration,27,3.295836866004329
Lpa,27,3.295836866004329
DTI,27,3.295836866004329
425,27,3.295836866004329
workflows,27,3.295836866004329
moreover,27,3.295836866004329
016,27,3.295836866004329
credible,27,3.295836866004329
hypertrophic,27,3.295836866004329
capsular,27,3.295836866004329
VD,27,3.295836866004329
378,27,3.295836866004329
chills,27,3.295836866004329
positive-sense,27,3.295836866004329
dilemmas,27,3.295836866004329
inferences,27,3.295836866004329
Immunotherapy,27,3.295836866004329
really,27,3.295836866004329
village,27,3.295836866004329
ostium,27,3.295836866004329
CLIA,27,3.295836866004329
transmitting,27,3.295836866004329
NLR,27,3.295836866004329
monogenic,27,3.295836866004329
sanitary,27,3.295836866004329
planners,27,3.295836866004329
Fisher,27,3.295836866004329
Hydroxychloroquine,27,3.295836866004329
intellectual,27,3.295836866004329
ask,27,3.295836866004329
unresponsive,27,3.295836866004329
323,27,3.295836866004329
strenuous,27,3.295836866004329
low-resource,27,3.295836866004329
Genome,27,3.295836866004329
concerted,27,3.295836866004329
BMC,27,3.295836866004329
406,27,3.295836866004329
Repeat,27,3.295836866004329
skin-prick,27,3.295836866004329
396,27,3.295836866004329
Qualitative,27,3.295836866004329
033,27,3.295836866004329
tetrazolium,27,3.295836866004329
agent-based,27,3.295836866004329
selenium,27,3.295836866004329
scoping,27,3.295836866004329
OVA,27,3.295836866004329
smoker,27,3.295836866004329
unscheduled,27,3.295836866004329
time-series,27,3.295836866004329
satisfied,27,3.295836866004329
reinjection,27,3.295836866004329
unaware,27,3.295836866004329
Queensland,27,3.295836866004329
staged,27,3.295836866004329
384,27,3.295836866004329
underlines,27,3.295836866004329
retinopathy,27,3.295836866004329
deteriorate,27,3.295836866004329
door-to-needle,27,3.295836866004329
Moyamoya,27,3.295836866004329
closest,27,3.295836866004329
governing,27,3.295836866004329
questioning,27,3.295836866004329
Code,27,3.295836866004329
Agreement,27,3.295836866004329
Planning,27,3.295836866004329
ipratropium,27,3.295836866004329
SDB,27,3.295836866004329
Warsaw,27,3.295836866004329
haematological,27,3.295836866004329
aeroallergen,27,3.295836866004329
293,27,3.295836866004329
subpopulation,27,3.295836866004329
intramural,27,3.295836866004329
predefined,27,3.295836866004329
localize,27,3.295836866004329
powered,27,3.295836866004329
activations,27,3.295836866004329
year-round,27,3.295836866004329
osteoporosis,27,3.295836866004329
non-linear,27,3.295836866004329
validating,27,3.295836866004329
suite,27,3.295836866004329
nanomedicine,27,3.295836866004329
cardinal,27,3.295836866004329
neurotrophic,27,3.295836866004329
Living,27,3.295836866004329
Angiotensin,27,3.295836866004329
collaborations,27,3.295836866004329
Cryptogenic,27,3.295836866004329
MDCT,27,3.295836866004329
0-4,27,3.295836866004329
interests,27,3.295836866004329
sequentially,27,3.295836866004329
lengths,27,3.295836866004329
exactly,27,3.295836866004329
spatio-temporal,27,3.295836866004329
271,27,3.295836866004329
Selective,27,3.295836866004329
premorbid,27,3.295836866004329
Ltd,27,3.295836866004329
conventionally,27,3.295836866004329
Blacks,27,3.295836866004329
etiopathogenesis,27,3.295836866004329
judicious,27,3.295836866004329
340,27,3.295836866004329
triglycerides,27,3.295836866004329
irritability,27,3.295836866004329
Eurasian,27,3.295836866004329
crossing,27,3.295836866004329
ultraviolet,27,3.295836866004329
deeply,27,3.295836866004329
asynergic,27,3.295836866004329
Contact,27,3.295836866004329
correctional,27,3.295836866004329
CPAP,27,3.295836866004329
multiplicity,27,3.295836866004329
hemiplegic,27,3.295836866004329
proteomic,27,3.295836866004329
Large-scale,27,3.295836866004329
Reducing,27,3.295836866004329
morbidities,27,3.295836866004329
rigorously,27,3.295836866004329
staging,27,3.295836866004329
suicidal,27,3.295836866004329
Widespread,27,3.295836866004329
322,27,3.295836866004329
onwards,27,3.295836866004329
disappear,27,3.295836866004329
Los,27,3.295836866004329
Experience,27,3.295836866004329
Angeles,27,3.295836866004329
post-exercise,27,3.295836866004329
fulfill,27,3.295836866004329
435,27,3.295836866004329
IFNs,27,3.295836866004329
turning,27,3.295836866004329
concrete,27,3.295836866004329
ownership,27,3.295836866004329
orthogonal,27,3.295836866004329
Historically,27,3.295836866004329
COVID-19-positive,27,3.295836866004329
201112,27,3.295836866004329
Breathing,27,3.295836866004329
relapses,27,3.295836866004329
high-density,27,3.295836866004329
neuropathy,27,3.295836866004329
gold-standard,27,3.295836866004329
sibling,27,3.295836866004329
investigative,27,3.295836866004329
disinfectants,27,3.295836866004329
insensitivity,27,3.295836866004329
347,27,3.295836866004329
Mutations,27,3.295836866004329
MAPK,27,3.295836866004329
antibacterial,27,3.295836866004329
DOAC,27,3.295836866004329
viscosity,27,3.295836866004329
attainment,27,3.295836866004329
profoundly,27,3.295836866004329
summarised,27,3.295836866004329
tweets,27,3.295836866004329
albuterol,27,3.295836866004329
elaboration,27,3.295836866004329
pulsed,27,3.295836866004329
sensation,27,3.295836866004329
chromosome,27,3.295836866004329
fumes,27,3.295836866004329
age-group,27,3.295836866004329
Extracorporeal,27,3.295836866004329
Last,27,3.295836866004329
308,27,3.295836866004329
Attention,27,3.295836866004329
fifty,27,3.295836866004329
aetiologies,27,3.295836866004329
metapneumovirus,27,3.295836866004329
Diffusion-weighted,27,3.295836866004329
scanner,27,3.295836866004329
Action,27,3.295836866004329
underuse,27,3.295836866004329
post-operative,27,3.295836866004329
Thai,27,3.295836866004329
TTS,27,3.295836866004329
herald,27,3.295836866004329
Reviews,27,3.295836866004329
cyst,27,3.295836866004329
ascribed,27,3.295836866004329
gone,27,3.295836866004329
prophylactically,27,3.295836866004329
non-vaccinated,27,3.295836866004329
contributory,27,3.295836866004329
Infected,27,3.295836866004329
cirrhosis,27,3.295836866004329
deformation,27,3.295836866004329
hyposensitization,27,3.295836866004329
utilised,27,3.295836866004329
offending,27,3.295836866004329
sensations,27,3.295836866004329
viruss,27,3.295836866004329
rhinorrhea,27,3.295836866004329
fourfold,27,3.295836866004329
afterload,27,3.295836866004329
aqueous,27,3.295836866004329
preeclampsia,27,3.295836866004329
firmly,26,3.258096538021482
Centres,26,3.258096538021482
diarrhoea,26,3.258096538021482
leukocytosis,26,3.258096538021482
data-driven,26,3.258096538021482
mailed,26,3.258096538021482
erectile,26,3.258096538021482
age-dependent,26,3.258096538021482
Twenty-nine,26,3.258096538021482
replacing,26,3.258096538021482
fecal-oral,26,3.258096538021482
Simple,26,3.258096538021482
pleiotropic,26,3.258096538021482
defibrillation,26,3.258096538021482
307,26,3.258096538021482
NIs,26,3.258096538021482
edition,26,3.258096538021482
Full,26,3.258096538021482
KD,26,3.258096538021482
chi,26,3.258096538021482
parasite,26,3.258096538021482
governance,26,3.258096538021482
Establishing,26,3.258096538021482
extremities,26,3.258096538021482
Intracerebral,26,3.258096538021482
holiday,26,3.258096538021482
transcribed,26,3.258096538021482
outreach,26,3.258096538021482
non-adherence,26,3.258096538021482
Psychosocial,26,3.258096538021482
thromboses,26,3.258096538021482
Emphasis,26,3.258096538021482
hypotensive,26,3.258096538021482
drops,26,3.258096538021482
0015,26,3.258096538021482
pneumomediastinum,26,3.258096538021482
HCoV-NL63,26,3.258096538021482
Angiographic,26,3.258096538021482
runs,26,3.258096538021482
4-5,26,3.258096538021482
2DE,26,3.258096538021482
normotensive,26,3.258096538021482
globulin,26,3.258096538021482
train,26,3.258096538021482
Noninvasive,26,3.258096538021482
Around,26,3.258096538021482
Oxidative,26,3.258096538021482
HIT,26,3.258096538021482
fifteen,26,3.258096538021482
6-8,26,3.258096538021482
retain,26,3.258096538021482
pointing,26,3.258096538021482
judgement,26,3.258096538021482
degenerative,26,3.258096538021482
288,26,3.258096538021482
42-year-old,26,3.258096538021482
modulates,26,3.258096538021482
Ohio,26,3.258096538021482
EI,26,3.258096538021482
non-coding,26,3.258096538021482
amyloid,26,3.258096538021482
coma,26,3.258096538021482
attached,26,3.258096538021482
patient-specific,26,3.258096538021482
mTOR,26,3.258096538021482
Students,26,3.258096538021482
Fabry,26,3.258096538021482
zoster,26,3.258096538021482
HAs,26,3.258096538021482
hygienic,26,3.258096538021482
anecdotal,26,3.258096538021482
termination,26,3.258096538021482
Contrary,26,3.258096538021482
anatomically,26,3.258096538021482
Wisconsin,26,3.258096538021482
beta-blockade,26,3.258096538021482
lymphocytic,26,3.258096538021482
manually,26,3.258096538021482
LC,26,3.258096538021482
havoc,26,3.258096538021482
585,26,3.258096538021482
coronarography,26,3.258096538021482
368,26,3.258096538021482
hostility,26,3.258096538021482
ClinicalTrialsgov,26,3.258096538021482
326,26,3.258096538021482
one-half,26,3.258096538021482
Perceived,26,3.258096538021482
pathologically,26,3.258096538021482
stigma,26,3.258096538021482
Scientists,26,3.258096538021482
consulting,26,3.258096538021482
receives,26,3.258096538021482
opacification,26,3.258096538021482
SMI,26,3.258096538021482
BI,26,3.258096538021482
cholinergic,26,3.258096538021482
Past,26,3.258096538021482
Definition,26,3.258096538021482
shoulder,26,3.258096538021482
242,26,3.258096538021482
467,26,3.258096538021482
Ninety,26,3.258096538021482
023,26,3.258096538021482
escalating,26,3.258096538021482
noncoding,26,3.258096538021482
AOR,26,3.258096538021482
Forced,26,3.258096538021482
app,26,3.258096538021482
785,26,3.258096538021482
self-isolation,26,3.258096538021482
SCT,26,3.258096538021482
preferential,26,3.258096538021482
maladaptive,26,3.258096538021482
game,26,3.258096538021482
unadjusted,26,3.258096538021482
unavailability,26,3.258096538021482
chiefly,26,3.258096538021482
unloading,26,3.258096538021482
extrasystoles,26,3.258096538021482
T2MI,26,3.258096538021482
out-patient,26,3.258096538021482
Raw,26,3.258096538021482
summarizing,26,3.258096538021482
steroid-resistant,26,3.258096538021482
Echocardiographic,26,3.258096538021482
priori,26,3.258096538021482
RNAi,26,3.258096538021482
non-influenza,26,3.258096538021482
SOD,26,3.258096538021482
arrhythmogenic,26,3.258096538021482
absolutely,26,3.258096538021482
V4,26,3.258096538021482
broke,26,3.258096538021482
case-based,26,3.258096538021482
NF,26,3.258096538021482
MetS,26,3.258096538021482
Characteristics,26,3.258096538021482
coinciding,26,3.258096538021482
contractions,26,3.258096538021482
PLR,26,3.258096538021482
ex,26,3.258096538021482
therapy-resistant,26,3.258096538021482
immunoinformatics,26,3.258096538021482
transitions,26,3.258096538021482
swift,26,3.258096538021482
late-phase,26,3.258096538021482
polyps,26,3.258096538021482
avenue,26,3.258096538021482
Figure,26,3.258096538021482
incidental,26,3.258096538021482
isolations,26,3.258096538021482
counting,26,3.258096538021482
IMI,26,3.258096538021482
Recanalization,26,3.258096538021482
CCA,26,3.258096538021482
accessed,26,3.258096538021482
1920,26,3.258096538021482
20092010,26,3.258096538021482
audience,26,3.258096538021482
immunize,26,3.258096538021482
homozygous,26,3.258096538021482
psychic,26,3.258096538021482
misuse,26,3.258096538021482
VKAs,26,3.258096538021482
pharmacologically,26,3.258096538021482
299,26,3.258096538021482
anesthetic,26,3.258096538021482
steroid-dependent,26,3.258096538021482
Population-based,26,3.258096538021482
385,26,3.258096538021482
incarcerated,26,3.258096538021482
hemicraniectomy,26,3.258096538021482
heterogenous,26,3.258096538021482
Peripheral,26,3.258096538021482
Caribbean,26,3.258096538021482
046,26,3.258096538021482
dispensing,26,3.258096538021482
ear,26,3.258096538021482
consumed,26,3.258096538021482
biomaterials,26,3.258096538021482
falsely,26,3.258096538021482
prefectures,26,3.258096538021482
retrievers,26,3.258096538021482
cysteinyl,26,3.258096538021482
30-40,26,3.258096538021482
PAT,26,3.258096538021482
adipose,26,3.258096538021482
vegetables,26,3.258096538021482
increment,26,3.258096538021482
primate,26,3.258096538021482
triad,26,3.258096538021482
hrs,26,3.258096538021482
intend,26,3.258096538021482
influenza-positive,26,3.258096538021482
actors,26,3.258096538021482
individual-level,26,3.258096538021482
200910,26,3.258096538021482
noncardioembolic,26,3.258096538021482
Serologic,26,3.258096538021482
freedom,26,3.258096538021482
cardioprotection,26,3.258096538021482
blockage,26,3.258096538021482
DRG,26,3.258096538021482
Wall,26,3.258096538021482
Wiley,26,3.258096538021482
D222G,26,3.258096538021482
Against,26,3.258096538021482
spacer,26,3.258096538021482
replicates,26,3.258096538021482
discovering,26,3.258096538021482
glucocorticosteroids,26,3.258096538021482
lifespan,26,3.258096538021482
0016,26,3.258096538021482
CBT,26,3.258096538021482
2-agonist,26,3.258096538021482
Hygiene,26,3.258096538021482
longitudinally,26,3.258096538021482
contextual,26,3.258096538021482
appraise,26,3.258096538021482
Delayed,26,3.258096538021482
inhalations,26,3.258096538021482
fourteen,26,3.258096538021482
crossover,26,3.258096538021482
outlook,26,3.258096538021482
Prophylactic,26,3.258096538021482
microangiopathy,26,3.258096538021482
my,26,3.258096538021482
Perfusion,26,3.258096538021482
myxoma,26,3.258096538021482
3000,26,3.258096538021482
scintigram,26,3.258096538021482
humid,26,3.258096538021482
tricuspid,26,3.258096538021482
bidirectional,26,3.258096538021482
fibrinolytics,26,3.258096538021482
disagreement,26,3.258096538021482
Admission,26,3.258096538021482
defibrillator,26,3.258096538021482
encompass,26,3.258096538021482
sheep,26,3.258096538021482
CDCs,26,3.258096538021482
Nocturnal,26,3.258096538021482
ventriculograms,26,3.258096538021482
progesterone,26,3.258096538021482
prison,26,3.258096538021482
401,26,3.258096538021482
spatially,26,3.258096538021482
proposals,26,3.258096538021482
stenotic,26,3.258096538021482
nucleoside,26,3.258096538021482
PAI-1,26,3.258096538021482
Angiography,26,3.258096538021482
unfortunately,26,3.258096538021482
thick,26,3.258096538021482
Concerning,26,3.258096538021482
oscillations,26,3.258096538021482
assayed,26,3.258096538021482
Communication,26,3.258096538021482
contingent,26,3.258096538021482
mortem,26,3.258096538021482
multilevel,26,3.258096538021482
conductivity,26,3.258096538021482
M-mode,26,3.258096538021482
unequivocally,26,3.258096538021482
dyssynergy,26,3.258096538021482
paramedian,26,3.258096538021482
inferolateral,25,3.2188758248682006
ECR,25,3.2188758248682006
Quebec,25,3.2188758248682006
pre-COVID-19,25,3.2188758248682006
seeing,25,3.2188758248682006
retested,25,3.2188758248682006
immunopathological,25,3.2188758248682006
Sarma,25,3.2188758248682006
surgeon,25,3.2188758248682006
seasonally,25,3.2188758248682006
benchmark,25,3.2188758248682006
east,25,3.2188758248682006
proposing,25,3.2188758248682006
rotation,25,3.2188758248682006
convergence,25,3.2188758248682006
redox,25,3.2188758248682006
Throughout,25,3.2188758248682006
mobilized,25,3.2188758248682006
Differential,25,3.2188758248682006
291,25,3.2188758248682006
subclavian,25,3.2188758248682006
procalcitonin,25,3.2188758248682006
Household,25,3.2188758248682006
thoracoscopy,25,3.2188758248682006
upright,25,3.2188758248682006
5-14,25,3.2188758248682006
neovascularization,25,3.2188758248682006
calibration,25,3.2188758248682006
SF,25,3.2188758248682006
Hospitalization,25,3.2188758248682006
pre-epidemic,25,3.2188758248682006
leukoencephalopathy,25,3.2188758248682006
sex-matched,25,3.2188758248682006
camera,25,3.2188758248682006
SARS-CoV-2-induced,25,3.2188758248682006
Fort,25,3.2188758248682006
EPCs,25,3.2188758248682006
institutes,25,3.2188758248682006
rendering,25,3.2188758248682006
omega-3,25,3.2188758248682006
downward,25,3.2188758248682006
911,25,3.2188758248682006
abstract,25,3.2188758248682006
ARVI,25,3.2188758248682006
351,25,3.2188758248682006
Regression,25,3.2188758248682006
ventral,25,3.2188758248682006
partner,25,3.2188758248682006
worthwhile,25,3.2188758248682006
n-3,25,3.2188758248682006
nonischemic,25,3.2188758248682006
embryonated,25,3.2188758248682006
quality-adjusted,25,3.2188758248682006
disseminate,25,3.2188758248682006
Met,25,3.2188758248682006
Behavioral,25,3.2188758248682006
PAD,25,3.2188758248682006
non-compliance,25,3.2188758248682006
Taiwanese,25,3.2188758248682006
neurosurgical,25,3.2188758248682006
Costs,25,3.2188758248682006
ad,25,3.2188758248682006
Carlo,25,3.2188758248682006
IB,25,3.2188758248682006
31st,25,3.2188758248682006
knee,25,3.2188758248682006
cautious,25,3.2188758248682006
Sleep,25,3.2188758248682006
Do,25,3.2188758248682006
lopinavirritonavir,25,3.2188758248682006
square,25,3.2188758248682006
Houston,25,3.2188758248682006
Open,25,3.2188758248682006
facemasks,25,3.2188758248682006
Features,25,3.2188758248682006
Younger,25,3.2188758248682006
labs,25,3.2188758248682006
upstream,25,3.2188758248682006
448,25,3.2188758248682006
sinovenous,25,3.2188758248682006
isometric,25,3.2188758248682006
murmur,25,3.2188758248682006
graph,25,3.2188758248682006
distribute,25,3.2188758248682006
valves,25,3.2188758248682006
crowded,25,3.2188758248682006
IMT,25,3.2188758248682006
Genomic,25,3.2188758248682006
Belgian,25,3.2188758248682006
aspirates,25,3.2188758248682006
vasoactive,25,3.2188758248682006
STAT3,25,3.2188758248682006
Thirty-four,25,3.2188758248682006
stock,25,3.2188758248682006
toluene,25,3.2188758248682006
cutting,25,3.2188758248682006
Stenting,25,3.2188758248682006
industrialised,25,3.2188758248682006
deduced,25,3.2188758248682006
353,25,3.2188758248682006
clarification,25,3.2188758248682006
Reactive,25,3.2188758248682006
stoke,25,3.2188758248682006
localised,25,3.2188758248682006
epilepticus,25,3.2188758248682006
334,25,3.2188758248682006
intraarterial,25,3.2188758248682006
rales,25,3.2188758248682006
Mice,25,3.2188758248682006
sea,25,3.2188758248682006
eradicate,25,3.2188758248682006
researched,25,3.2188758248682006
marital,25,3.2188758248682006
solitary,25,3.2188758248682006
Starting,25,3.2188758248682006
VC,25,3.2188758248682006
occupied,25,3.2188758248682006
cytomegalovirus,25,3.2188758248682006
laws,25,3.2188758248682006
20000,25,3.2188758248682006
Aphasia,25,3.2188758248682006
clarity,25,3.2188758248682006
blunted,25,3.2188758248682006
well-recognized,25,3.2188758248682006
explosive,25,3.2188758248682006
BDNF,25,3.2188758248682006
909,25,3.2188758248682006
dysgeusia,25,3.2188758248682006
extremes,25,3.2188758248682006
Greek,25,3.2188758248682006
abstracts,25,3.2188758248682006
compounded,25,3.2188758248682006
paralleled,25,3.2188758248682006
TTP,25,3.2188758248682006
4-fold,25,3.2188758248682006
tumours,25,3.2188758248682006
354,25,3.2188758248682006
quantitation,25,3.2188758248682006
Reference,25,3.2188758248682006
331,25,3.2188758248682006
303,25,3.2188758248682006
Grade,25,3.2188758248682006
OEF,25,3.2188758248682006
networking,25,3.2188758248682006
lasts,25,3.2188758248682006
charges,25,3.2188758248682006
chronicity,25,3.2188758248682006
transcriptomics,25,3.2188758248682006
357,25,3.2188758248682006
IIV,25,3.2188758248682006
co-circulated,25,3.2188758248682006
Function,25,3.2188758248682006
indeterminate,25,3.2188758248682006
incision,25,3.2188758248682006
open-label,25,3.2188758248682006
acupoints,25,3.2188758248682006
mepolizumab,25,3.2188758248682006
positional,25,3.2188758248682006
struggle,25,3.2188758248682006
optimistic,25,3.2188758248682006
licensure,25,3.2188758248682006
515,25,3.2188758248682006
AAA,25,3.2188758248682006
causally,25,3.2188758248682006
LGE,25,3.2188758248682006
blot,25,3.2188758248682006
15-20,25,3.2188758248682006
labour,25,3.2188758248682006
computationally,25,3.2188758248682006
hospital-acquired,25,3.2188758248682006
salient,25,3.2188758248682006
hyperactivity,25,3.2188758248682006
phylogeny,25,3.2188758248682006
inquiry,25,3.2188758248682006
arbitrary,25,3.2188758248682006
contingency,25,3.2188758248682006
RTW,25,3.2188758248682006
pieces,25,3.2188758248682006
endoplasmic,25,3.2188758248682006
533,25,3.2188758248682006
scaffold,25,3.2188758248682006
judge,25,3.2188758248682006
downregulation,25,3.2188758248682006
MAP,25,3.2188758248682006
Occlusion,25,3.2188758248682006
x-ray,25,3.2188758248682006
regressions,25,3.2188758248682006
IBV,25,3.2188758248682006
decontamination,25,3.2188758248682006
football,25,3.2188758248682006
SGaw,25,3.2188758248682006
Treatments,25,3.2188758248682006
Respondents,25,3.2188758248682006
052,25,3.2188758248682006
Can,25,3.2188758248682006
dense,25,3.2188758248682006
allergists,25,3.2188758248682006
syncope,25,3.2188758248682006
microRNA,25,3.2188758248682006
Resistance,25,3.2188758248682006
Why,25,3.2188758248682006
081,25,3.2188758248682006
conception,25,3.2188758248682006
Evidence-based,25,3.2188758248682006
0014,25,3.2188758248682006
inefficient,25,3.2188758248682006
10-20,25,3.2188758248682006
self-limiting,25,3.2188758248682006
unprotected,25,3.2188758248682006
completeness,25,3.2188758248682006
pontine,25,3.2188758248682006
Cumulative,25,3.2188758248682006
Knowing,25,3.2188758248682006
0009,25,3.2188758248682006
wish,25,3.2188758248682006
Postoperative,25,3.2188758248682006
immunosenescence,25,3.2188758248682006
strip,25,3.2188758248682006
congregate,25,3.2188758248682006
menstrual,25,3.2188758248682006
Selected,25,3.2188758248682006
lactating,25,3.2188758248682006
virus-like,25,3.2188758248682006
aVR,25,3.2188758248682006
PRISMA,25,3.2188758248682006
subgenomic,25,3.2188758248682006
convalescents,25,3.2188758248682006
KAMIR,25,3.2188758248682006
renin-angiotensin-aldosterone,25,3.2188758248682006
Asthmatics,25,3.2188758248682006
umbilical,25,3.2188758248682006
042,25,3.2188758248682006
uric,25,3.2188758248682006
057,25,3.2188758248682006
narrowed,25,3.2188758248682006
nonpharmacological,25,3.2188758248682006
refused,25,3.2188758248682006
EL,25,3.2188758248682006
Maximum,25,3.2188758248682006
conspiracy,25,3.2188758248682006
multivalent,25,3.2188758248682006
tyrosine,25,3.2188758248682006
Thereafter,25,3.2188758248682006
necessitate,25,3.2188758248682006
24-48,25,3.2188758248682006
053,24,3.1780538303479458
Tc-99m,24,3.1780538303479458
fulfilling,24,3.1780538303479458
situated,24,3.1780538303479458
forcing,24,3.1780538303479458
IQ,24,3.1780538303479458
Moderate,24,3.1780538303479458
Cigarette,24,3.1780538303479458
spores,24,3.1780538303479458
hamper,24,3.1780538303479458
disrupting,24,3.1780538303479458
cobas,24,3.1780538303479458
ACA,24,3.1780538303479458
Experts,24,3.1780538303479458
Seroprevalence,24,3.1780538303479458
observing,24,3.1780538303479458
fowl,24,3.1780538303479458
framed,24,3.1780538303479458
Ratio,24,3.1780538303479458
discriminative,24,3.1780538303479458
breakthroughs,24,3.1780538303479458
bovine,24,3.1780538303479458
supine,24,3.1780538303479458
Strategy,24,3.1780538303479458
multiplexed,24,3.1780538303479458
765,24,3.1780538303479458
2019-2020,24,3.1780538303479458
contrasting,24,3.1780538303479458
330,24,3.1780538303479458
exercising,24,3.1780538303479458
Soon,24,3.1780538303479458
LMCA,24,3.1780538303479458
423,24,3.1780538303479458
Majority,24,3.1780538303479458
budesonide,24,3.1780538303479458
Chinas,24,3.1780538303479458
corpus,24,3.1780538303479458
polyunsaturated,24,3.1780538303479458
sub-optimal,24,3.1780538303479458
Austrian,24,3.1780538303479458
pharmaceuticals,24,3.1780538303479458
Racial,24,3.1780538303479458
Measuring,24,3.1780538303479458
marine,24,3.1780538303479458
T2DM,24,3.1780538303479458
interrelated,24,3.1780538303479458
Long,24,3.1780538303479458
acted,24,3.1780538303479458
speaking,24,3.1780538303479458
suppresses,24,3.1780538303479458
1999-2000,24,3.1780538303479458
EKG,24,3.1780538303479458
Interventional,24,3.1780538303479458
constellation,24,3.1780538303479458
064,24,3.1780538303479458
cardiomegaly,24,3.1780538303479458
unreported,24,3.1780538303479458
converted,24,3.1780538303479458
discriminatory,24,3.1780538303479458
malformation,24,3.1780538303479458
MTHFR,24,3.1780538303479458
allergological,24,3.1780538303479458
rigid,24,3.1780538303479458
overestimation,24,3.1780538303479458
observable,24,3.1780538303479458
Questions,24,3.1780538303479458
benefited,24,3.1780538303479458
bears,24,3.1780538303479458
Directigen,24,3.1780538303479458
Work-related,24,3.1780538303479458
musculoskeletal,24,3.1780538303479458
occult,24,3.1780538303479458
paediatricians,24,3.1780538303479458
431,24,3.1780538303479458
bodily,24,3.1780538303479458
spiked,24,3.1780538303479458
Xa,24,3.1780538303479458
Board,24,3.1780538303479458
basically,24,3.1780538303479458
biosensing,24,3.1780538303479458
Uncontrolled,24,3.1780538303479458
phylogeographic,24,3.1780538303479458
Lmin,24,3.1780538303479458
interpersonal,24,3.1780538303479458
344,24,3.1780538303479458
promoter,24,3.1780538303479458
re-emerging,24,3.1780538303479458
chemotaxis,24,3.1780538303479458
FIM,24,3.1780538303479458
Attempts,24,3.1780538303479458
employer,24,3.1780538303479458
lifestyles,24,3.1780538303479458
NAb,24,3.1780538303479458
ceased,24,3.1780538303479458
meets,24,3.1780538303479458
Safe,24,3.1780538303479458
micro,24,3.1780538303479458
Best,24,3.1780538303479458
1500,24,3.1780538303479458
X-rays,24,3.1780538303479458
hypercholesterolaemia,24,3.1780538303479458
nonsignificant,24,3.1780538303479458
stroke-specific,24,3.1780538303479458
Y,24,3.1780538303479458
rho,24,3.1780538303479458
Philippines,24,3.1780538303479458
S-protein,24,3.1780538303479458
non-invasively,24,3.1780538303479458
virus-associated,24,3.1780538303479458
CM,24,3.1780538303479458
flights,24,3.1780538303479458
immunochromatography,24,3.1780538303479458
listening,24,3.1780538303479458
reminder,24,3.1780538303479458
posture,24,3.1780538303479458
TNF,24,3.1780538303479458
invade,24,3.1780538303479458
piece,24,3.1780538303479458
unfractionated,24,3.1780538303479458
cardiologic,24,3.1780538303479458
Angina,24,3.1780538303479458
Biochemical,24,3.1780538303479458
densely,24,3.1780538303479458
vector-based,24,3.1780538303479458
autonomous,24,3.1780538303479458
Inhibition,24,3.1780538303479458
hypercoagulation,24,3.1780538303479458
exceptions,24,3.1780538303479458
571,24,3.1780538303479458
hisher,24,3.1780538303479458
haplotypes,24,3.1780538303479458
Portuguese,24,3.1780538303479458
seed,24,3.1780538303479458
Host,24,3.1780538303479458
realization,24,3.1780538303479458
travelling,24,3.1780538303479458
TAVI,24,3.1780538303479458
intraluminal,24,3.1780538303479458
establishes,24,3.1780538303479458
conducts,24,3.1780538303479458
Hetil,24,3.1780538303479458
Orv,24,3.1780538303479458
Simultaneous,24,3.1780538303479458
guides,24,3.1780538303479458
isotope,24,3.1780538303479458
2007-2008,24,3.1780538303479458
delivers,24,3.1780538303479458
synergy,24,3.1780538303479458
atelectasis,24,3.1780538303479458
infraction,24,3.1780538303479458
postinfection,24,3.1780538303479458
266,24,3.1780538303479458
Weekly,24,3.1780538303479458
periphery,24,3.1780538303479458
homeostatic,24,3.1780538303479458
NIV,24,3.1780538303479458
405,24,3.1780538303479458
ions,24,3.1780538303479458
recognizes,24,3.1780538303479458
struggling,24,3.1780538303479458
non-communicable,24,3.1780538303479458
HKU1,24,3.1780538303479458
horizon,24,3.1780538303479458
933,24,3.1780538303479458
bronchospastic,24,3.1780538303479458
aerosol-generating,24,3.1780538303479458
intima-media,24,3.1780538303479458
vicious,24,3.1780538303479458
antihistamines,24,3.1780538303479458
compliant,24,3.1780538303479458
babies,24,3.1780538303479458
machines,24,3.1780538303479458
as-needed,24,3.1780538303479458
commuting,24,3.1780538303479458
297,24,3.1780538303479458
Revascularization,24,3.1780538303479458
disasters,24,3.1780538303479458
libraries,24,3.1780538303479458
Backgroundaims,24,3.1780538303479458
Home,24,3.1780538303479458
box,24,3.1780538303479458
transducer,24,3.1780538303479458
contrasted,24,3.1780538303479458
duck,24,3.1780538303479458
hematocrit,24,3.1780538303479458
user-friendly,24,3.1780538303479458
sRaw,24,3.1780538303479458
Framework,24,3.1780538303479458
Controls,24,3.1780538303479458
screens,24,3.1780538303479458
clock,24,3.1780538303479458
unipolar,24,3.1780538303479458
PSO,24,3.1780538303479458
Cellular,24,3.1780538303479458
catastrophe,24,3.1780538303479458
noticeable,24,3.1780538303479458
1-4,24,3.1780538303479458
elaborated,24,3.1780538303479458
something,24,3.1780538303479458
accidental,24,3.1780538303479458
anticipation,24,3.1780538303479458
anti-RBD,24,3.1780538303479458
stunned,24,3.1780538303479458
Compliance,24,3.1780538303479458
donations,24,3.1780538303479458
single-nucleotide,24,3.1780538303479458
budget,24,3.1780538303479458
flux,24,3.1780538303479458
analgesia,24,3.1780538303479458
CINAHL,24,3.1780538303479458
correcting,24,3.1780538303479458
microcirculatory,24,3.1780538303479458
staying,24,3.1780538303479458
traveling,24,3.1780538303479458
improper,24,3.1780538303479458
wellbeing,24,3.1780538303479458
foot,24,3.1780538303479458
hitherto,24,3.1780538303479458
R2,24,3.1780538303479458
draws,24,3.1780538303479458
FLAIR,24,3.1780538303479458
diastole,24,3.1780538303479458
resuming,24,3.1780538303479458
ranking,24,3.1780538303479458
Consortium,24,3.1780538303479458
abscess,24,3.1780538303479458
irrigation,24,3.1780538303479458
typing,24,3.1780538303479458
ionic,24,3.1780538303479458
2018-2019,24,3.1780538303479458
RT-ddPCR,24,3.1780538303479458
degranulation,24,3.1780538303479458
261,24,3.1780538303479458
solving,24,3.1780538303479458
p38,24,3.1780538303479458
pgml,24,3.1780538303479458
319,24,3.1780538303479458
dispersal,24,3.1780538303479458
on-line,24,3.1780538303479458
readmitted,24,3.1780538303479458
revascularized,24,3.1780538303479458
thrombocytopenic,24,3.1780538303479458
arginine,24,3.1780538303479458
Accumulating,24,3.1780538303479458
336,24,3.1780538303479458
306,24,3.1780538303479458
RAD,24,3.1780538303479458
senescence,24,3.1780538303479458
portal,24,3.1780538303479458
412,24,3.1780538303479458
PBS,24,3.1780538303479458
RDTs,24,3.1780538303479458
Warfarin,24,3.1780538303479458
Issue,24,3.1780538303479458
STING,24,3.1780538303479458
trainees,24,3.1780538303479458
metalloproteinases,24,3.1780538303479458
Sputum,24,3.1780538303479458
referrals,24,3.1780538303479458
metabolomic,24,3.1780538303479458
meningococcal,24,3.1780538303479458
IPC,24,3.1780538303479458
hyperlipidaemia,24,3.1780538303479458
lytic,24,3.1780538303479458
371,23,3.1354942159291497
approximation,23,3.1354942159291497
enzymatically,23,3.1354942159291497
relieving,23,3.1354942159291497
anamnestic,23,3.1354942159291497
pocket,23,3.1354942159291497
individual-based,23,3.1354942159291497
Nucleocapsid,23,3.1354942159291497
counterpart,23,3.1354942159291497
postpandemic,23,3.1354942159291497
PCPs,23,3.1354942159291497
copper,23,3.1354942159291497
categorize,23,3.1354942159291497
alleviated,23,3.1354942159291497
histologically,23,3.1354942159291497
6-7,23,3.1354942159291497
country-specific,23,3.1354942159291497
swallow,23,3.1354942159291497
shelters,23,3.1354942159291497
Rhinitis,23,3.1354942159291497
pancreatitis,23,3.1354942159291497
407,23,3.1354942159291497
respects,23,3.1354942159291497
Boston,23,3.1354942159291497
Collateral,23,3.1354942159291497
comparator,23,3.1354942159291497
victim,23,3.1354942159291497
WBE,23,3.1354942159291497
player,23,3.1354942159291497
antagonism,23,3.1354942159291497
99mTc-sestamibi,23,3.1354942159291497
nonadherence,23,3.1354942159291497
cleaved,23,3.1354942159291497
hair,23,3.1354942159291497
SLIT,23,3.1354942159291497
todays,23,3.1354942159291497
ophthalmic,23,3.1354942159291497
Historical,23,3.1354942159291497
200000,23,3.1354942159291497
ordinal,23,3.1354942159291497
nonreperfused,23,3.1354942159291497
emphasised,23,3.1354942159291497
radiotherapy,23,3.1354942159291497
music,23,3.1354942159291497
coordinating,23,3.1354942159291497
E-gene,23,3.1354942159291497
isoprenaline,23,3.1354942159291497
506,23,3.1354942159291497
awaited,23,3.1354942159291497
Linear,23,3.1354942159291497
LTCF,23,3.1354942159291497
Peru,23,3.1354942159291497
MG,23,3.1354942159291497
investments,23,3.1354942159291497
high-intensity,23,3.1354942159291497
χ2,23,3.1354942159291497
clue,23,3.1354942159291497
Treating,23,3.1354942159291497
linearly,23,3.1354942159291497
charged,23,3.1354942159291497
visceral,23,3.1354942159291497
363,23,3.1354942159291497
Emotional,23,3.1354942159291497
tongue,23,3.1354942159291497
impose,23,3.1354942159291497
plate,23,3.1354942159291497
ALT,23,3.1354942159291497
clarifying,23,3.1354942159291497
dynamically,23,3.1354942159291497
alternatively,23,3.1354942159291497
syndrome-related,23,3.1354942159291497
semiquantitative,23,3.1354942159291497
anticholinergics,23,3.1354942159291497
mismatches,23,3.1354942159291497
-2,23,3.1354942159291497
9th,23,3.1354942159291497
jugular,23,3.1354942159291497
incidentally,23,3.1354942159291497
antidepressants,23,3.1354942159291497
High-risk,23,3.1354942159291497
ISO,23,3.1354942159291497
dysbiosis,23,3.1354942159291497
Twenty-six,23,3.1354942159291497
Glasgow,23,3.1354942159291497
associates,23,3.1354942159291497
PPI,23,3.1354942159291497
981,23,3.1354942159291497
rarity,23,3.1354942159291497
neurorehabilitation,23,3.1354942159291497
deletions,23,3.1354942159291497
sanatorium,23,3.1354942159291497
minus,23,3.1354942159291497
473,23,3.1354942159291497
executed,23,3.1354942159291497
Colombia,23,3.1354942159291497
precede,23,3.1354942159291497
approaching,23,3.1354942159291497
childhood-onset,23,3.1354942159291497
spa,23,3.1354942159291497
simulating,23,3.1354942159291497
629,23,3.1354942159291497
NCP,23,3.1354942159291497
sternotomy,23,3.1354942159291497
two-fold,23,3.1354942159291497
attendant,23,3.1354942159291497
athlete,23,3.1354942159291497
laid,23,3.1354942159291497
touched,23,3.1354942159291497
ancestor,23,3.1354942159291497
Applying,23,3.1354942159291497
insomnia,23,3.1354942159291497
meat,23,3.1354942159291497
CTFC,23,3.1354942159291497
k,23,3.1354942159291497
analog,23,3.1354942159291497
Form,23,3.1354942159291497
chi-square,23,3.1354942159291497
DD,23,3.1354942159291497
ca,23,3.1354942159291497
pulmonologists,23,3.1354942159291497
327,23,3.1354942159291497
haemorrhages,23,3.1354942159291497
saphenous,23,3.1354942159291497
Impaired,23,3.1354942159291497
cardioversion,23,3.1354942159291497
Utah,23,3.1354942159291497
shadow,23,3.1354942159291497
Berlin,23,3.1354942159291497
cytopathic,23,3.1354942159291497
paths,23,3.1354942159291497
islands,23,3.1354942159291497
Favipiravir,23,3.1354942159291497
imaged,23,3.1354942159291497
Thirty-three,23,3.1354942159291497
seniors,23,3.1354942159291497
launch,23,3.1354942159291497
repertoire,23,3.1354942159291497
entails,23,3.1354942159291497
acoustic,23,3.1354942159291497
Excellence,23,3.1354942159291497
focussed,23,3.1354942159291497
fragmented,23,3.1354942159291497
060,23,3.1354942159291497
IVIG,23,3.1354942159291497
≥2,23,3.1354942159291497
niche,23,3.1354942159291497
desire,23,3.1354942159291497
Estimating,23,3.1354942159291497
carriage,23,3.1354942159291497
Professor,23,3.1354942159291497
exhaust,23,3.1354942159291497
NPs,23,3.1354942159291497
retraining,23,3.1354942159291497
comparability,23,3.1354942159291497
IFITM3,23,3.1354942159291497
TP,23,3.1354942159291497
H7N7,23,3.1354942159291497
erythema,23,3.1354942159291497
fibroblast,23,3.1354942159291497
ensures,23,3.1354942159291497
phagocytosis,23,3.1354942159291497
reentry,23,3.1354942159291497
070,23,3.1354942159291497
interepidemic,23,3.1354942159291497
up-regulated,23,3.1354942159291497
unacceptable,23,3.1354942159291497
cross-validation,23,3.1354942159291497
LAAO,23,3.1354942159291497
0-1,23,3.1354942159291497
unequivocal,23,3.1354942159291497
bradykinin,23,3.1354942159291497
Monte,23,3.1354942159291497
974,23,3.1354942159291497
subepicardial,23,3.1354942159291497
narratives,23,3.1354942159291497
Postmortem,23,3.1354942159291497
Clearly,23,3.1354942159291497
vena,23,3.1354942159291497
FRC,23,3.1354942159291497
050,23,3.1354942159291497
anesthetized,23,3.1354942159291497
027,23,3.1354942159291497
99m,23,3.1354942159291497
farinae,23,3.1354942159291497
microvasculature,23,3.1354942159291497
junctional,23,3.1354942159291497
Does,23,3.1354942159291497
366,23,3.1354942159291497
polygenic,23,3.1354942159291497
depict,23,3.1354942159291497
liability,23,3.1354942159291497
confront,23,3.1354942159291497
ample,23,3.1354942159291497
enoxaparin,23,3.1354942159291497
consult,23,3.1354942159291497
hits,23,3.1354942159291497
intercellular,23,3.1354942159291497
anaemia,23,3.1354942159291497
ADE,23,3.1354942159291497
risky,23,3.1354942159291497
diminution,23,3.1354942159291497
Transcription,23,3.1354942159291497
unproven,23,3.1354942159291497
Flutracking,23,3.1354942159291497
SAP,23,3.1354942159291497
466,23,3.1354942159291497
Systolic,23,3.1354942159291497
CG,23,3.1354942159291497
DSCG,23,3.1354942159291497
artifacts,23,3.1354942159291497
shortest,23,3.1354942159291497
Tl,23,3.1354942159291497
mucociliary,23,3.1354942159291497
mandates,23,3.1354942159291497
487,23,3.1354942159291497
50-64,23,3.1354942159291497
Forty-eight,23,3.1354942159291497
parasites,23,3.1354942159291497
beta-blocking,23,3.1354942159291497
relatedness,23,3.1354942159291497
B1526,23,3.1354942159291497
RATs,23,3.1354942159291497
539,23,3.1354942159291497
implicating,23,3.1354942159291497
paper-based,23,3.1354942159291497
asking,23,3.1354942159291497
faecal,23,3.1354942159291497
biphasic,23,3.1354942159291497
things,23,3.1354942159291497
adaptability,23,3.1354942159291497
sacrificed,23,3.1354942159291497
spillover,23,3.1354942159291497
prothrombin,23,3.1354942159291497
neurocognitive,23,3.1354942159291497
Design,23,3.1354942159291497
592,23,3.1354942159291497
445,23,3.1354942159291497
984,23,3.1354942159291497
prostate,23,3.1354942159291497
occluding,23,3.1354942159291497
Adolescents,23,3.1354942159291497
Challenges,23,3.1354942159291497
facets,23,3.1354942159291497
Rescue,23,3.1354942159291497
efficacies,23,3.1354942159291497
diuretic,23,3.1354942159291497
nonlacunar,23,3.1354942159291497
395,23,3.1354942159291497
barotrauma,23,3.1354942159291497
Table,23,3.1354942159291497
intoxication,23,3.1354942159291497
PSA,23,3.1354942159291497
Influenza-like,23,3.1354942159291497
C3,23,3.1354942159291497
aminophylline,23,3.1354942159291497
geography,23,3.1354942159291497
ICP,23,3.1354942159291497
virucidal,23,3.1354942159291497
someone,23,3.1354942159291497
symposium,23,3.1354942159291497
tracked,23,3.1354942159291497
upward,23,3.1354942159291497
NL63,23,3.1354942159291497
shapes,23,3.1354942159291497
wheezers,23,3.1354942159291497
372,23,3.1354942159291497
60-year-old,23,3.1354942159291497
antithrombin,23,3.1354942159291497
herds,23,3.1354942159291497
ruling,23,3.1354942159291497
autopsied,23,3.1354942159291497
embryonic,23,3.1354942159291497
neuroscience,23,3.1354942159291497
municipalities,23,3.1354942159291497
390,23,3.1354942159291497
398,23,3.1354942159291497
034,23,3.1354942159291497
livestock,23,3.1354942159291497
2500,23,3.1354942159291497
sporting,23,3.1354942159291497
up-regulation,23,3.1354942159291497
conferences,23,3.1354942159291497
LFA,23,3.1354942159291497
Medication,23,3.1354942159291497
molds,23,3.1354942159291497
quintiles,23,3.1354942159291497
361,23,3.1354942159291497
Thirty-nine,23,3.1354942159291497
Genes,23,3.1354942159291497
279,23,3.1354942159291497
fallen,23,3.1354942159291497
420,23,3.1354942159291497
cytoplasmic,23,3.1354942159291497
Survivors,23,3.1354942159291497
cTnT,23,3.1354942159291497
conducive,23,3.1354942159291497
story,23,3.1354942159291497
energies,23,3.1354942159291497
CPT,23,3.1354942159291497
distrust,23,3.1354942159291497
toll-like,22,3.091042453358316
interhemispheric,22,3.091042453358316
PV,22,3.091042453358316
non-infectious,22,3.091042453358316
incontinence,22,3.091042453358316
Ghana,22,3.091042453358316
post-ischemic,22,3.091042453358316
underpin,22,3.091042453358316
Schools,22,3.091042453358316
229E,22,3.091042453358316
C4,22,3.091042453358316
thrombogenic,22,3.091042453358316
Usually,22,3.091042453358316
Deep,22,3.091042453358316
coffee,22,3.091042453358316
SSS,22,3.091042453358316
550,22,3.091042453358316
cava,22,3.091042453358316
19th,22,3.091042453358316
Earlier,22,3.091042453358316
416,22,3.091042453358316
Maori,22,3.091042453358316
harboring,22,3.091042453358316
tensor,22,3.091042453358316
Bilateral,22,3.091042453358316
depicted,22,3.091042453358316
Paired,22,3.091042453358316
mandate,22,3.091042453358316
EMT,22,3.091042453358316
father,22,3.091042453358316
063,22,3.091042453358316
boosted,22,3.091042453358316
watershed,22,3.091042453358316
high-affinity,22,3.091042453358316
retardation,22,3.091042453358316
soil,22,3.091042453358316
myelitis,22,3.091042453358316
SMS,22,3.091042453358316
389,22,3.091042453358316
presumptive,22,3.091042453358316
off-pump,22,3.091042453358316
resolving,22,3.091042453358316
432,22,3.091042453358316
H1N1-2009,22,3.091042453358316
longstanding,22,3.091042453358316
accessing,22,3.091042453358316
Technical,22,3.091042453358316
proteinuria,22,3.091042453358316
CMV,22,3.091042453358316
FG,22,3.091042453358316
repositioning,22,3.091042453358316
ANP,22,3.091042453358316
489,22,3.091042453358316
early-life,22,3.091042453358316
ABPM,22,3.091042453358316
short-lived,22,3.091042453358316
plugging,22,3.091042453358316
FIA,22,3.091042453358316
infrastructures,22,3.091042453358316
participatory,22,3.091042453358316
submucosal,22,3.091042453358316
Mini,22,3.091042453358316
TA,22,3.091042453358316
IWMI,22,3.091042453358316
post-influenza,22,3.091042453358316
muscarinic,22,3.091042453358316
HE,22,3.091042453358316
IL-18,22,3.091042453358316
inventory,22,3.091042453358316
spine,22,3.091042453358316
glycol,22,3.091042453358316
gender-specific,22,3.091042453358316
Difficult,22,3.091042453358316
419,22,3.091042453358316
Immediately,22,3.091042453358316
stridor,22,3.091042453358316
bench,22,3.091042453358316
neuron,22,3.091042453358316
548,22,3.091042453358316
motivate,22,3.091042453358316
370,22,3.091042453358316
Increases,22,3.091042453358316
Statistically,22,3.091042453358316
ticlopidine,22,3.091042453358316
interobserver,22,3.091042453358316
Forty-one,22,3.091042453358316
adenocarcinoma,22,3.091042453358316
Nitric,22,3.091042453358316
Telemedicine,22,3.091042453358316
controllers,22,3.091042453358316
maintains,22,3.091042453358316
9-1-1,22,3.091042453358316
1-month,22,3.091042453358316
favors,22,3.091042453358316
quest,22,3.091042453358316
low-frequency,22,3.091042453358316
intricate,22,3.091042453358316
discrepant,22,3.091042453358316
LVT,22,3.091042453358316
ECRHS,22,3.091042453358316
corneal,22,3.091042453358316
Dix,22,3.091042453358316
cautiously,22,3.091042453358316
hyperinflammation,22,3.091042453358316
Jordan,22,3.091042453358316
designation,22,3.091042453358316
triaging,22,3.091042453358316
non-STEMI,22,3.091042453358316
2015-2016,22,3.091042453358316
dinitrate,22,3.091042453358316
server,22,3.091042453358316
CAIV-T,22,3.091042453358316
provoking,22,3.091042453358316
intestine,22,3.091042453358316
psychogenic,22,3.091042453358316
mmolL,22,3.091042453358316
GSTM1,22,3.091042453358316
homing,22,3.091042453358316
028,22,3.091042453358316
Quick,22,3.091042453358316
cheaper,22,3.091042453358316
581,22,3.091042453358316
lose,22,3.091042453358316
marginally,22,3.091042453358316
maybe,22,3.091042453358316
cardiopathy,22,3.091042453358316
apnoea,22,3.091042453358316
labels,22,3.091042453358316
Changing,22,3.091042453358316
414,22,3.091042453358316
billions,22,3.091042453358316
distinctly,22,3.091042453358316
intends,22,3.091042453358316
LoD,22,3.091042453358316
unidentified,22,3.091042453358316
usability,22,3.091042453358316
392,22,3.091042453358316
Checklist,22,3.091042453358316
host-virus,22,3.091042453358316
Passive,22,3.091042453358316
Animals,22,3.091042453358316
Migraine,22,3.091042453358316
OC,22,3.091042453358316
invalid,22,3.091042453358316
sinuses,22,3.091042453358316
diisocyanates,22,3.091042453358316
communicated,22,3.091042453358316
Field,22,3.091042453358316
stainless,22,3.091042453358316
contrasts,22,3.091042453358316
Growth,22,3.091042453358316
Eosinophils,22,3.091042453358316
companion,22,3.091042453358316
beta-adrenoceptor,22,3.091042453358316
metaplasia,22,3.091042453358316
fragile,22,3.091042453358316
label-free,22,3.091042453358316
988,22,3.091042453358316
Sexual,22,3.091042453358316
files,22,3.091042453358316
610,22,3.091042453358316
Rio,22,3.091042453358316
LTs,22,3.091042453358316
overuse,22,3.091042453358316
expose,22,3.091042453358316
postprocedural,22,3.091042453358316
implant,22,3.091042453358316
conditioned,22,3.091042453358316
enteral,22,3.091042453358316
localisation,22,3.091042453358316
postero-inferior,22,3.091042453358316
couple,22,3.091042453358316
reinforcing,22,3.091042453358316
Real,22,3.091042453358316
host-pathogen,22,3.091042453358316
coating,22,3.091042453358316
GSTT1,22,3.091042453358316
vague,22,3.091042453358316
voluntarily,22,3.091042453358316
026,22,3.091042453358316
recruiting,22,3.091042453358316
inactivating,22,3.091042453358316
kill,22,3.091042453358316
34-year-old,22,3.091042453358316
Circulating,22,3.091042453358316
emphasise,22,3.091042453358316
exit,22,3.091042453358316
discern,22,3.091042453358316
IFN-α,22,3.091042453358316
hemophagocytic,22,3.091042453358316
appointments,22,3.091042453358316
unremarkable,22,3.091042453358316
refinement,22,3.091042453358316
Lessons,22,3.091042453358316
stream,22,3.091042453358316
Gender,22,3.091042453358316
awaiting,22,3.091042453358316
prisons,22,3.091042453358316
DP,22,3.091042453358316
reticulum,22,3.091042453358316
administrators,22,3.091042453358316
GSH,22,3.091042453358316
RADS,22,3.091042453358316
potently,22,3.091042453358316
KO,22,3.091042453358316
NILT,22,3.091042453358316
A2Hong,22,3.091042453358316
devise,22,3.091042453358316
night-time,22,3.091042453358316
reassessment,22,3.091042453358316
procedure-related,22,3.091042453358316
disordered,22,3.091042453358316
pretest,22,3.091042453358316
researcher,22,3.091042453358316
sooner,22,3.091042453358316
semi-quantitative,22,3.091042453358316
411,22,3.091042453358316
NOAC,22,3.091042453358316
HC,22,3.091042453358316
Health-related,22,3.091042453358316
clearer,22,3.091042453358316
fQRS,22,3.091042453358316
mistaken,22,3.091042453358316
Avoidance,22,3.091042453358316
Disability,22,3.091042453358316
15th,22,3.091042453358316
485,22,3.091042453358316
mini-review,22,3.091042453358316
fastest,22,3.091042453358316
SCG,22,3.091042453358316
debris,22,3.091042453358316
facilitators,22,3.091042453358316
peroxide,22,3.091042453358316
Calu-3,22,3.091042453358316
anti-coronavirus,22,3.091042453358316
quantifies,22,3.091042453358316
12th,22,3.091042453358316
strokeTIA,22,3.091042453358316
ACP,22,3.091042453358316
moral,22,3.091042453358316
faculty,22,3.091042453358316
Rather,22,3.091042453358316
normalize,22,3.091042453358316
Status,22,3.091042453358316
owners,22,3.091042453358316
bronchus,22,3.091042453358316
influenza-like-illness,22,3.091042453358316
Headache,22,3.091042453358316
PFA,22,3.091042453358316
passages,22,3.091042453358316
413,22,3.091042453358316
bivariate,22,3.091042453358316
Infants,22,3.091042453358316
roll-out,22,3.091042453358316
tip,22,3.091042453358316
6-week,22,3.091042453358316
grafted,22,3.091042453358316
Influenza-associated,22,3.091042453358316
1200,22,3.091042453358316
PEEP,22,3.091042453358316
B2,22,3.091042453358316
pathologists,22,3.091042453358316
067,22,3.091042453358316
pneumocytes,22,3.091042453358316
formaldehyde,22,3.091042453358316
857,22,3.091042453358316
excised,22,3.091042453358316
Sofia,22,3.091042453358316
Cameroon,22,3.091042453358316
chi2,22,3.091042453358316
unavoidable,22,3.091042453358316
pursue,22,3.091042453358316
auxiliary,22,3.091042453358316
biomolecules,22,3.091042453358316
Achieving,22,3.091042453358316
Acceptance,22,3.091042453358316
ischemiareperfusion,22,3.091042453358316
Consideration,22,3.091042453358316
antidepressant,22,3.091042453358316
0018,22,3.091042453358316
cardiologist,22,3.091042453358316
secondly,22,3.091042453358316
5-fold,22,3.091042453358316
Pandemics,22,3.091042453358316
trimeric,22,3.091042453358316
standardizing,22,3.091042453358316
404,22,3.091042453358316
steady-state,22,3.091042453358316
aids,22,3.091042453358316
disposal,22,3.091042453358316
645,22,3.091042453358316
cytoplasm,22,3.091042453358316
burst,22,3.091042453358316
attributions,22,3.091042453358316
anti-asthmatic,22,3.091042453358316
Invasive,22,3.091042453358316
Th17,22,3.091042453358316
Fusion,22,3.091042453358316
maximizing,22,3.091042453358316
accommodate,22,3.091042453358316
video-assisted,22,3.091042453358316
homeless,22,3.091042453358316
post-treatment,22,3.091042453358316
polymorphic,22,3.091042453358316
501,22,3.091042453358316
359,22,3.091042453358316
BS,22,3.091042453358316
time-sensitive,22,3.091042453358316
vegetable,22,3.091042453358316
multi-center,22,3.091042453358316
simplify,22,3.091042453358316
routines,22,3.091042453358316
styles,22,3.091042453358316
multinational,21,3.044522437723423
adaptable,21,3.044522437723423
59-year-old,21,3.044522437723423
delineation,21,3.044522437723423
trafficking,21,3.044522437723423
invading,21,3.044522437723423
peripartum,21,3.044522437723423
Electronic,21,3.044522437723423
re-positive,21,3.044522437723423
0043,21,3.044522437723423
antimalarial,21,3.044522437723423
nonsurvivors,21,3.044522437723423
influenza-attributable,21,3.044522437723423
trivial,21,3.044522437723423
distressing,21,3.044522437723423
transplants,21,3.044522437723423
Alternaria,21,3.044522437723423
50-year-old,21,3.044522437723423
gyrus,21,3.044522437723423
≥18,21,3.044522437723423
washings,21,3.044522437723423
ABO,21,3.044522437723423
mildmoderate,21,3.044522437723423
obstructions,21,3.044522437723423
OF,21,3.044522437723423
spanning,21,3.044522437723423
Leiden,21,3.044522437723423
analogues,21,3.044522437723423
expectation,21,3.044522437723423
Behavior,21,3.044522437723423
conjunctiva,21,3.044522437723423
ligated,21,3.044522437723423
employs,21,3.044522437723423
conversely,21,3.044522437723423
connecting,21,3.044522437723423
column,21,3.044522437723423
WMSI,21,3.044522437723423
356,21,3.044522437723423
Diffusion,21,3.044522437723423
383,21,3.044522437723423
delineating,21,3.044522437723423
Intal,21,3.044522437723423
concert,21,3.044522437723423
couples,21,3.044522437723423
thymic,21,3.044522437723423
subscales,21,3.044522437723423
fuzzy,21,3.044522437723423
VPBs,21,3.044522437723423
Should,21,3.044522437723423
HDL,21,3.044522437723423
house-dust,21,3.044522437723423
NR,21,3.044522437723423
2-,21,3.044522437723423
reflections,21,3.044522437723423
525,21,3.044522437723423
money,21,3.044522437723423
prognostically,21,3.044522437723423
TaqPath,21,3.044522437723423
reparative,21,3.044522437723423
Predicting,21,3.044522437723423
051,21,3.044522437723423
humanized,21,3.044522437723423
417,21,3.044522437723423
substudy,21,3.044522437723423
268,21,3.044522437723423
Analytical,21,3.044522437723423
hydrogel,21,3.044522437723423
Head,21,3.044522437723423
backbone,21,3.044522437723423
Often,21,3.044522437723423
8-week,21,3.044522437723423
GOR,21,3.044522437723423
heard,21,3.044522437723423
Markov,21,3.044522437723423
resected,21,3.044522437723423
myopathy,21,3.044522437723423
Egyptian,21,3.044522437723423
SAECG,21,3.044522437723423
Programs,21,3.044522437723423
chose,21,3.044522437723423
SNF,21,3.044522437723423
t-test,21,3.044522437723423
OPCAB,21,3.044522437723423
initiates,21,3.044522437723423
Estimated,21,3.044522437723423
Acupuncture,21,3.044522437723423
r2,21,3.044522437723423
undefined,21,3.044522437723423
seroconverted,21,3.044522437723423
oils,21,3.044522437723423
Biotech,21,3.044522437723423
nurse-led,21,3.044522437723423
neutralisation,21,3.044522437723423
Recombinant,21,3.044522437723423
resembles,21,3.044522437723423
μm,21,3.044522437723423
paced,21,3.044522437723423
arteriopathies,21,3.044522437723423
tolerate,21,3.044522437723423
DoD,21,3.044522437723423
rounds,21,3.044522437723423
varicella,21,3.044522437723423
allocating,21,3.044522437723423
masked,21,3.044522437723423
Problems,21,3.044522437723423
academia,21,3.044522437723423
idioventricular,21,3.044522437723423
cohorting,21,3.044522437723423
organize,21,3.044522437723423
Beginning,21,3.044522437723423
assumes,21,3.044522437723423
speckle,21,3.044522437723423
Kaunas,21,3.044522437723423
Virginia,21,3.044522437723423
bronchodilating,21,3.044522437723423
betablockers,21,3.044522437723423
ASC,21,3.044522437723423
833,21,3.044522437723423
proliferative,21,3.044522437723423
RAAS,21,3.044522437723423
Epidemic,21,3.044522437723423
fundamentally,21,3.044522437723423
Lesion,21,3.044522437723423
1950s,21,3.044522437723423
sheets,21,3.044522437723423
NC,21,3.044522437723423
Hsw1N1,21,3.044522437723423
mirror,21,3.044522437723423
flocked,21,3.044522437723423
laninamivir,21,3.044522437723423
ADAM33,21,3.044522437723423
latitude,21,3.044522437723423
sponsored,21,3.044522437723423
quantitate,21,3.044522437723423
nanomaterials,21,3.044522437723423
HSP,21,3.044522437723423
NSBR,21,3.044522437723423
excitotoxicity,21,3.044522437723423
organisations,21,3.044522437723423
succeeded,21,3.044522437723423
vesicular,21,3.044522437723423
cons,21,3.044522437723423
VN,21,3.044522437723423
nebulization,21,3.044522437723423
precedes,21,3.044522437723423
convey,21,3.044522437723423
Targeting,21,3.044522437723423
thromboprophylaxis,21,3.044522437723423
deprived,21,3.044522437723423
in-vitro,21,3.044522437723423
Teaching,21,3.044522437723423
yellow,21,3.044522437723423
epizootic,21,3.044522437723423
lecture,21,3.044522437723423
export,21,3.044522437723423
Building,21,3.044522437723423
504,21,3.044522437723423
herniation,21,3.044522437723423
hsCRP,21,3.044522437723423
unsupervised,21,3.044522437723423
Airways,21,3.044522437723423
Plaque,21,3.044522437723423
55-year-old,21,3.044522437723423
Guinea,21,3.044522437723423
subsided,21,3.044522437723423
thromboxane,21,3.044522437723423
Delhi,21,3.044522437723423
satisfactorily,21,3.044522437723423
57-year-old,21,3.044522437723423
macrolides,21,3.044522437723423
provincial,21,3.044522437723423
WMH,21,3.044522437723423
EC50,21,3.044522437723423
Croatian,21,3.044522437723423
TC,21,3.044522437723423
vaccine-elicited,21,3.044522437723423
37-year-old,21,3.044522437723423
Manitoba,21,3.044522437723423
Seizures,21,3.044522437723423
Parkinsons,21,3.044522437723423
bands,21,3.044522437723423
auscultation,21,3.044522437723423
349,21,3.044522437723423
Abs,21,3.044522437723423
roadmap,21,3.044522437723423
reuptake,21,3.044522437723423
reticular,21,3.044522437723423
biotechnology,21,3.044522437723423
Pennsylvania,21,3.044522437723423
stenosed,21,3.044522437723423
ECHO,21,3.044522437723423
loops,21,3.044522437723423
ventriculographic,21,3.044522437723423
Outpatient,21,3.044522437723423
FEV,21,3.044522437723423
426,21,3.044522437723423
Induced,21,3.044522437723423
kcalmol,21,3.044522437723423
cc,21,3.044522437723423
foreseeable,21,3.044522437723423
troublesome,21,3.044522437723423
cues,21,3.044522437723423
RRs,21,3.044522437723423
Items,21,3.044522437723423
non-vitamin,21,3.044522437723423
Spearman,21,3.044522437723423
Lake,21,3.044522437723423
engraftment,21,3.044522437723423
Hawaii,21,3.044522437723423
recoil,21,3.044522437723423
generations,21,3.044522437723423
Age-specific,21,3.044522437723423
ECM,21,3.044522437723423
collections,21,3.044522437723423
TLR4,21,3.044522437723423
Innovative,21,3.044522437723423
VATS,21,3.044522437723423
R-wave,21,3.044522437723423
medicolegal,21,3.044522437723423
Belief,21,3.044522437723423
diminishing,21,3.044522437723423
confident,21,3.044522437723423
dyskinetic,21,3.044522437723423
522,21,3.044522437723423
passenger,21,3.044522437723423
rectal,21,3.044522437723423
breakdown,21,3.044522437723423
wet,21,3.044522437723423
simplex,21,3.044522437723423
2016-2017,21,3.044522437723423
Validation,21,3.044522437723423
Methacholine,21,3.044522437723423
finds,21,3.044522437723423
evacuation,21,3.044522437723423
habit,21,3.044522437723423
salvaged,21,3.044522437723423
750,21,3.044522437723423
VI,21,3.044522437723423
abdomen,21,3.044522437723423
worrying,21,3.044522437723423
gradients,21,3.044522437723423
Atlanta,21,3.044522437723423
microglial,21,3.044522437723423
Cyprus,21,3.044522437723423
tears,21,3.044522437723423
advocates,21,3.044522437723423
classically,21,3.044522437723423
life-years,21,3.044522437723423
max,21,3.044522437723423
Executive,21,3.044522437723423
post-PCI,21,3.044522437723423
ARIA,21,3.044522437723423
MMSE,21,3.044522437723423
greenhouse,21,3.044522437723423
stocks,21,3.044522437723423
accompanies,21,3.044522437723423
avian-origin,21,3.044522437723423
surges,21,3.044522437723423
427,21,3.044522437723423
BVictoria287,21,3.044522437723423
hibernating,21,3.044522437723423
Unique,21,3.044522437723423
dangers,21,3.044522437723423
GUSTO,21,3.044522437723423
volunteer,21,3.044522437723423
Gamma,21,3.044522437723423
Copenhagen,21,3.044522437723423
Predictive,21,3.044522437723423
stakeholder,21,3.044522437723423
recapitulate,21,3.044522437723423
Serious,21,3.044522437723423
Native,21,3.044522437723423
posted,21,3.044522437723423
inclusive,21,3.044522437723423
hyperglycaemia,21,3.044522437723423
HIV-1,21,3.044522437723423
≥12,21,3.044522437723423
Spatial,21,3.044522437723423
cobalt,21,3.044522437723423
plugs,21,3.044522437723423
Generalized,21,3.044522437723423
Controversy,21,3.044522437723423
424,21,3.044522437723423
insecurity,21,3.044522437723423
553,21,3.044522437723423
Birmingham,21,3.044522437723423
hourly,21,3.044522437723423
NT-proBNP,21,3.044522437723423
self-esteem,21,3.044522437723423
Free,21,3.044522437723423
copiesreaction,21,3.044522437723423
64-year-old,21,3.044522437723423
Forty-three,21,3.044522437723423
career,21,3.044522437723423
aviation,21,3.044522437723423
NCBI,21,3.044522437723423
displaced,21,3.044522437723423
copiesμL,21,3.044522437723423
14-day,21,3.044522437723423
cTnI,21,3.044522437723423
smartphone,21,3.044522437723423
remind,21,3.044522437723423
Inactivated,21,3.044522437723423
anisotropy,21,3.044522437723423
L452R,21,3.044522437723423
497,21,3.044522437723423
excursion,21,3.044522437723423
reinforcement,21,3.044522437723423
Non-invasive,21,3.044522437723423
trans,21,3.044522437723423
printed,21,3.044522437723423
diversification,21,3.044522437723423
B12,21,3.044522437723423
Alaska,21,3.044522437723423
Twenty-seven,21,3.044522437723423
575,21,3.044522437723423
analgesics,21,3.044522437723423
infusions,21,3.044522437723423
nonetheless,21,3.044522437723423
preserves,21,3.044522437723423
nineteen,21,3.044522437723423
cross-over,21,3.044522437723423
408,21,3.044522437723423
hyperkinetic,21,3.044522437723423
asymmetry,21,3.044522437723423
obtainable,21,3.044522437723423
coincide,20,2.995732273553991
LAC,20,2.995732273553991
formulating,20,2.995732273553991
acknowledge,20,2.995732273553991
serotype,20,2.995732273553991
regionally,20,2.995732273553991
MEF50,20,2.995732273553991
Asia-Pacific,20,2.995732273553991
centrifugal,20,2.995732273553991
refractoriness,20,2.995732273553991
antiepileptic,20,2.995732273553991
hyperintensities,20,2.995732273553991
AHA,20,2.995732273553991
perfectly,20,2.995732273553991
riskbenefit,20,2.995732273553991
capita,20,2.995732273553991
MC,20,2.995732273553991
fluctuation,20,2.995732273553991
Multicenter,20,2.995732273553991
judgments,20,2.995732273553991
mmoll,20,2.995732273553991
lobar,20,2.995732273553991
touch,20,2.995732273553991
fruits,20,2.995732273553991
distributing,20,2.995732273553991
Excessive,20,2.995732273553991
antisense,20,2.995732273553991
promises,20,2.995732273553991
myths,20,2.995732273553991
influenza-infected,20,2.995732273553991
synopsis,20,2.995732273553991
aborted,20,2.995732273553991
microm,20,2.995732273553991
identifier,20,2.995732273553991
cross-protective,20,2.995732273553991
nicorandil,20,2.995732273553991
laterality,20,2.995732273553991
matters,20,2.995732273553991
Military,20,2.995732273553991
attribution,20,2.995732273553991
RAO,20,2.995732273553991
Town,20,2.995732273553991
Immunisation,20,2.995732273553991
case-patient,20,2.995732273553991
300000,20,2.995732273553991
ruptures,20,2.995732273553991
UA,20,2.995732273553991
402,20,2.995732273553991
meantime,20,2.995732273553991
contagiousness,20,2.995732273553991
CRT,20,2.995732273553991
phylodynamic,20,2.995732273553991
intakes,20,2.995732273553991
Workers,20,2.995732273553991
QL,20,2.995732273553991
Absolute,20,2.995732273553991
dopamine,20,2.995732273553991
Pharmacists,20,2.995732273553991
fetuses,20,2.995732273553991
implied,20,2.995732273553991
reserves,20,2.995732273553991
quintile,20,2.995732273553991
colophony,20,2.995732273553991
electrophysiologic,20,2.995732273553991
holding,20,2.995732273553991
cancellation,20,2.995732273553991
Sustained,20,2.995732273553991
4000,20,2.995732273553991
905,20,2.995732273553991
CLD,20,2.995732273553991
civil,20,2.995732273553991
scaling,20,2.995732273553991
followup,20,2.995732273553991
golden,20,2.995732273553991
underscored,20,2.995732273553991
polymers,20,2.995732273553991
carbohydrate,20,2.995732273553991
descent,20,2.995732273553991
35-year-old,20,2.995732273553991
plots,20,2.995732273553991
Calcium,20,2.995732273553991
TO,20,2.995732273553991
densities,20,2.995732273553991
47-year-old,20,2.995732273553991
Mb,20,2.995732273553991
lining,20,2.995732273553991
thrombolysed,20,2.995732273553991
sympathomimetic,20,2.995732273553991
contusion,20,2.995732273553991
obstetrical,20,2.995732273553991
RBD-specific,20,2.995732273553991
989,20,2.995732273553991
Inadequate,20,2.995732273553991
landmark,20,2.995732273553991
endocytosis,20,2.995732273553991
HPA,20,2.995732273553991
approvals,20,2.995732273553991
LABAs,20,2.995732273553991
517,20,2.995732273553991
anti-CD20,20,2.995732273553991
GO,20,2.995732273553991
597,20,2.995732273553991
Louis,20,2.995732273553991
cards,20,2.995732273553991
prerequisites,20,2.995732273553991
962,20,2.995732273553991
725,20,2.995732273553991
threaten,20,2.995732273553991
voxels,20,2.995732273553991
obstetricians,20,2.995732273553991
conjugated,20,2.995732273553991
Epidemics,20,2.995732273553991
rests,20,2.995732273553991
478,20,2.995732273553991
ageusia,20,2.995732273553991
cTn,20,2.995732273553991
WHOs,20,2.995732273553991
Receiver,20,2.995732273553991
POCTs,20,2.995732273553991
Setting,20,2.995732273553991
amiodarone,20,2.995732273553991
TMS,20,2.995732273553991
antiinfluenza,20,2.995732273553991
Kappa,20,2.995732273553991
25th,20,2.995732273553991
Pooling,20,2.995732273553991
diminishes,20,2.995732273553991
panic-fear,20,2.995732273553991
procoagulant,20,2.995732273553991
siRNAs,20,2.995732273553991
duct,20,2.995732273553991
SP-D,20,2.995732273553991
awakenings,20,2.995732273553991
NOS,20,2.995732273553991
1-7,20,2.995732273553991
novelty,20,2.995732273553991
patient-years,20,2.995732273553991
replication-competent,20,2.995732273553991
sustainability,20,2.995732273553991
CH,20,2.995732273553991
PBC,20,2.995732273553991
635,20,2.995732273553991
institutionalized,20,2.995732273553991
TFC,20,2.995732273553991
BMSC,20,2.995732273553991
countermeasure,20,2.995732273553991
founded,20,2.995732273553991
Ejection,20,2.995732273553991
Indirect,20,2.995732273553991
balancing,20,2.995732273553991
year-olds,20,2.995732273553991
encapsulated,20,2.995732273553991
plausibility,20,2.995732273553991
portions,20,2.995732273553991
allograft,20,2.995732273553991
369,20,2.995732273553991
capturing,20,2.995732273553991
exudate,20,2.995732273553991
Records,20,2.995732273553991
thyroiditis,20,2.995732273553991
sixteen,20,2.995732273553991
CCS,20,2.995732273553991
affordability,20,2.995732273553991
trusted,20,2.995732273553991
ameliorated,20,2.995732273553991
501YV2,20,2.995732273553991
452,20,2.995732273553991
440,20,2.995732273553991
post-COVID-19,20,2.995732273553991
pursuit,20,2.995732273553991
letter,20,2.995732273553991
obligations,20,2.995732273553991
moxibustion,20,2.995732273553991
transmits,20,2.995732273553991
antecedents,20,2.995732273553991
arrangements,20,2.995732273553991
Chlamydia,20,2.995732273553991
Intraoperative,20,2.995732273553991
Jiangsu,20,2.995732273553991
Cells,20,2.995732273553991
exertional,20,2.995732273553991
Thirty-six,20,2.995732273553991
callosum,20,2.995732273553991
myalgias,20,2.995732273553991
Biological,20,2.995732273553991
immunizing,20,2.995732273553991
altogether,20,2.995732273553991
neighborhoods,20,2.995732273553991
494,20,2.995732273553991
disseminating,20,2.995732273553991
en,20,2.995732273553991
hippocampal,20,2.995732273553991
967,20,2.995732273553991
IHC,20,2.995732273553991
Controlling,20,2.995732273553991
metered,20,2.995732273553991
LI,20,2.995732273553991
translates,20,2.995732273553991
above-mentioned,20,2.995732273553991
Neonatal,20,2.995732273553991
Member,20,2.995732273553991
seroprotection,20,2.995732273553991
Caledonia2099,20,2.995732273553991
955,20,2.995732273553991
speeds,20,2.995732273553991
LF,20,2.995732273553991
GTN,20,2.995732273553991
chemically,20,2.995732273553991
non-infarcted,20,2.995732273553991
sickle-cell,20,2.995732273553991
vasodilators,20,2.995732273553991
036,20,2.995732273553991
nonpharmacologic,20,2.995732273553991
30000,20,2.995732273553991
mineral,20,2.995732273553991
Rhizoma,20,2.995732273553991
WGS,20,2.995732273553991
psychosis,20,2.995732273553991
imprinting,20,2.995732273553991
await,20,2.995732273553991
Underlying,20,2.995732273553991
Womens,20,2.995732273553991
batch,20,2.995732273553991
SIC,20,2.995732273553991
by-pass,20,2.995732273553991
inconsistently,20,2.995732273553991
583,20,2.995732273553991
605,20,2.995732273553991
dusts,20,2.995732273553991
Perhaps,20,2.995732273553991
Uncertainty,20,2.995732273553991
two-stage,20,2.995732273553991
5-15,20,2.995732273553991
maneuvers,20,2.995732273553991
foam,20,2.995732273553991
caretakers,20,2.995732273553991
west,20,2.995732273553991
Confidence,20,2.995732273553991
Brocas,20,2.995732273553991
362,20,2.995732273553991
counted,20,2.995732273553991
traveled,20,2.995732273553991
prototypes,20,2.995732273553991
cut-offs,20,2.995732273553991
chick,20,2.995732273553991
Theophylline,20,2.995732273553991
tracheobronchial,20,2.995732273553991
fasciculus,20,2.995732273553991
embryos,20,2.995732273553991
FS,20,2.995732273553991
fast-track,20,2.995732273553991
Solitaire,20,2.995732273553991
faeces,20,2.995732273553991
Collaborative,20,2.995732273553991
reteplase,20,2.995732273553991
IIV3,20,2.995732273553991
Determination,20,2.995732273553991
Mobile,20,2.995732273553991
hernia,20,2.995732273553991
hemolytic,20,2.995732273553991
plasmapheresis,20,2.995732273553991
catalase,20,2.995732273553991
MCP-1,20,2.995732273553991
Males,20,2.995732273553991
unsuitable,20,2.995732273553991
short-axis,20,2.995732273553991
ORMDL3,20,2.995732273553991
drastic,20,2.995732273553991
grouping,20,2.995732273553991
medullary,20,2.995732273553991
port,20,2.995732273553991
asymmetric,20,2.995732273553991
HBV,20,2.995732273553991
bailout,20,2.995732273553991
EBV,20,2.995732273553991
409,20,2.995732273553991
pros,20,2.995732273553991
PS,20,2.995732273553991
conformations,20,2.995732273553991
Abnormalities,20,2.995732273553991
SaO2,20,2.995732273553991
NHP,20,2.995732273553991
adjuncts,20,2.995732273553991
biosynthesis,20,2.995732273553991
neoplastic,20,2.995732273553991
topology,20,2.995732273553991
inhaling,20,2.995732273553991
consortium,20,2.995732273553991
dictate,20,2.995732273553991
Larger,20,2.995732273553991
Language,20,2.995732273553991
arithmetic,20,2.995732273553991
IAE,20,2.995732273553991
stain,20,2.995732273553991
MCS,20,2.995732273553991
extra-pulmonary,20,2.995732273553991
switched,20,2.995732273553991
licensing,20,2.995732273553991
EPR-3,20,2.995732273553991
Device,20,2.995732273553991
radioactive,20,2.995732273553991
synergistically,20,2.995732273553991
packaging,20,2.995732273553991
CW,20,2.995732273553991
interpretations,20,2.995732273553991
Surveys,20,2.995732273553991
terbutaline,20,2.995732273553991
disodium,20,2.995732273553991
CST,19,2.9444389791664403
nucleotides,19,2.9444389791664403
herbs,19,2.9444389791664403
parties,19,2.9444389791664403
hereby,19,2.9444389791664403
suture,19,2.9444389791664403
nitroprusside,19,2.9444389791664403
disease-related,19,2.9444389791664403
ancillary,19,2.9444389791664403
coincident,19,2.9444389791664403
anti-ischemic,19,2.9444389791664403
PLWH,19,2.9444389791664403
ILIs,19,2.9444389791664403
La,19,2.9444389791664403
filament,19,2.9444389791664403
coincidence,19,2.9444389791664403
Which,19,2.9444389791664403
LMT,19,2.9444389791664403
spasms,19,2.9444389791664403
mistrust,19,2.9444389791664403
post-symptom,19,2.9444389791664403
oligonucleotides,19,2.9444389791664403
perforating,19,2.9444389791664403
853,19,2.9444389791664403
Bank,19,2.9444389791664403
Physiological,19,2.9444389791664403
NXY-059,19,2.9444389791664403
immunosensor,19,2.9444389791664403
MHz,19,2.9444389791664403
PVC,19,2.9444389791664403
enteric,19,2.9444389791664403
dont,19,2.9444389791664403
Frequency,19,2.9444389791664403
neuroendocrine,19,2.9444389791664403
IUliter,19,2.9444389791664403
swept,19,2.9444389791664403
866,19,2.9444389791664403
DA,19,2.9444389791664403
silencing,19,2.9444389791664403
HDL-C,19,2.9444389791664403
proficiency,19,2.9444389791664403
GH,19,2.9444389791664403
Marked,19,2.9444389791664403
ribs,19,2.9444389791664403
tables,19,2.9444389791664403
polyethylene,19,2.9444389791664403
infused,19,2.9444389791664403
checklist,19,2.9444389791664403
foster,19,2.9444389791664403
Standardized,19,2.9444389791664403
Cooperative,19,2.9444389791664403
cms,19,2.9444389791664403
default,19,2.9444389791664403
Salt,19,2.9444389791664403
periostin,19,2.9444389791664403
monkey,19,2.9444389791664403
quasispecies,19,2.9444389791664403
instantaneous,19,2.9444389791664403
505,19,2.9444389791664403
heparins,19,2.9444389791664403
veterans,19,2.9444389791664403
493,19,2.9444389791664403
OACs,19,2.9444389791664403
collaborate,19,2.9444389791664403
amplitudes,19,2.9444389791664403
forensic,19,2.9444389791664403
trimer,19,2.9444389791664403
superficial,19,2.9444389791664403
norm,19,2.9444389791664403
CAE,19,2.9444389791664403
T-lymphocytes,19,2.9444389791664403
aptamers,19,2.9444389791664403
computerised,19,2.9444389791664403
potentiation,19,2.9444389791664403
electrophoresis,19,2.9444389791664403
enclosed,19,2.9444389791664403
misinterpretation,19,2.9444389791664403
Absence,19,2.9444389791664403
alveoli,19,2.9444389791664403
excision,19,2.9444389791664403
nonpregnant,19,2.9444389791664403
Rate,19,2.9444389791664403
discourse,19,2.9444389791664403
debatable,19,2.9444389791664403
cap,19,2.9444389791664403
pork,19,2.9444389791664403
Visual,19,2.9444389791664403
Step,19,2.9444389791664403
task-specific,19,2.9444389791664403
421,19,2.9444389791664403
knockout,19,2.9444389791664403
interconnected,19,2.9444389791664403
Ag-RDT,19,2.9444389791664403
filtered,19,2.9444389791664403
curbing,19,2.9444389791664403
reluctance,19,2.9444389791664403
polymer,19,2.9444389791664403
hypoventilation,19,2.9444389791664403
naming,19,2.9444389791664403
align,19,2.9444389791664403
recessive,19,2.9444389791664403
atmosphere,19,2.9444389791664403
TV,19,2.9444389791664403
rhinoconjunctivitis,19,2.9444389791664403
leverage,19,2.9444389791664403
MBL,19,2.9444389791664403
Thrombectomy,19,2.9444389791664403
Fewer,19,2.9444389791664403
hippocampus,19,2.9444389791664403
External,19,2.9444389791664403
arteriographic,19,2.9444389791664403
urge,19,2.9444389791664403
stepping,19,2.9444389791664403
Contemporary,19,2.9444389791664403
C-terminal,19,2.9444389791664403
Virtual,19,2.9444389791664403
30-year-old,19,2.9444389791664403
second-generation,19,2.9444389791664403
Alinity,19,2.9444389791664403
breaks,19,2.9444389791664403
viz,19,2.9444389791664403
three-year,19,2.9444389791664403
confinement,19,2.9444389791664403
noncontrast,19,2.9444389791664403
childcare,19,2.9444389791664403
Chalmers,19,2.9444389791664403
moon,19,2.9444389791664403
Enzyme,19,2.9444389791664403
bronchoscopic,19,2.9444389791664403
one-month,19,2.9444389791664403
destination,19,2.9444389791664403
lectin,19,2.9444389791664403
rolled,19,2.9444389791664403
521,19,2.9444389791664403
spike-specific,19,2.9444389791664403
dysrhythmias,19,2.9444389791664403
hyperkalemia,19,2.9444389791664403
QMI,19,2.9444389791664403
Chi-square,19,2.9444389791664403
62-year-old,19,2.9444389791664403
preoperatively,19,2.9444389791664403
LVH,19,2.9444389791664403
391,19,2.9444389791664403
Pharmacologic,19,2.9444389791664403
aneurysmal,19,2.9444389791664403
Clade,19,2.9444389791664403
616,19,2.9444389791664403
Pearson,19,2.9444389791664403
intensification,19,2.9444389791664403
twenty-first,19,2.9444389791664403
druggable,19,2.9444389791664403
dearth,19,2.9444389791664403
multicentric,19,2.9444389791664403
536,19,2.9444389791664403
β-blockers,19,2.9444389791664403
mounted,19,2.9444389791664403
maximise,19,2.9444389791664403
multifunctional,19,2.9444389791664403
immunogens,19,2.9444389791664403
proxies,19,2.9444389791664403
E6,19,2.9444389791664403
invariably,19,2.9444389791664403
H3N2-like,19,2.9444389791664403
solar,19,2.9444389791664403
antiretroviral,19,2.9444389791664403
infrared,19,2.9444389791664403
STK,19,2.9444389791664403
reinfections,19,2.9444389791664403
salts,19,2.9444389791664403
hypoglycemia,19,2.9444389791664403
sex-related,19,2.9444389791664403
pending,19,2.9444389791664403
SARS-CoV-2-related,19,2.9444389791664403
polysaccharides,19,2.9444389791664403
leptin,19,2.9444389791664403
broaden,19,2.9444389791664403
three-fold,19,2.9444389791664403
Approaches,19,2.9444389791664403
Sprague-Dawley,19,2.9444389791664403
A-V,19,2.9444389791664403
bFGF,19,2.9444389791664403
alternating,19,2.9444389791664403
generalizability,19,2.9444389791664403
prime-boost,19,2.9444389791664403
high-volume,19,2.9444389791664403
pseudoviruses,19,2.9444389791664403
CMIA,19,2.9444389791664403
Cost,19,2.9444389791664403
understandings,19,2.9444389791664403
injectable,19,2.9444389791664403
torso,19,2.9444389791664403
deliberate,19,2.9444389791664403
subscale,19,2.9444389791664403
Preventing,19,2.9444389791664403
anorexia,19,2.9444389791664403
GRADE,19,2.9444389791664403
multiplication,19,2.9444389791664403
gustatory,19,2.9444389791664403
far-reaching,19,2.9444389791664403
substantiate,19,2.9444389791664403
oximetry,19,2.9444389791664403
Thirty-seven,19,2.9444389791664403
MicroRNAs,19,2.9444389791664403
vegetative,19,2.9444389791664403
junior,19,2.9444389791664403
excitatory,19,2.9444389791664403
defenses,19,2.9444389791664403
Transplantation,19,2.9444389791664403
implicit,19,2.9444389791664403
CardiologyAmerican,19,2.9444389791664403
983,19,2.9444389791664403
des,19,2.9444389791664403
ensemble,19,2.9444389791664403
Selvester,19,2.9444389791664403
465,19,2.9444389791664403
twentieth,19,2.9444389791664403
popularity,19,2.9444389791664403
hyaluronidase,19,2.9444389791664403
finite,19,2.9444389791664403
erroneous,19,2.9444389791664403
accelerates,19,2.9444389791664403
686,19,2.9444389791664403
VSD,19,2.9444389791664403
Cobas,19,2.9444389791664403
justifies,19,2.9444389791664403
plot,19,2.9444389791664403
unifying,19,2.9444389791664403
underlies,19,2.9444389791664403
Policy,19,2.9444389791664403
513,19,2.9444389791664403
HP,19,2.9444389791664403
offset,19,2.9444389791664403
Rico,19,2.9444389791664403
transitional,19,2.9444389791664403
T0,19,2.9444389791664403
reevaluated,19,2.9444389791664403
415,19,2.9444389791664403
secondarily,19,2.9444389791664403
510,19,2.9444389791664403
Aging,19,2.9444389791664403
worthy,19,2.9444389791664403
Reyes,19,2.9444389791664403
NIBS,19,2.9444389791664403
advising,19,2.9444389791664403
compromises,19,2.9444389791664403
527,19,2.9444389791664403
pollutant,19,2.9444389791664403
synaptic,19,2.9444389791664403
circumference,19,2.9444389791664403
458,19,2.9444389791664403
drying,19,2.9444389791664403
Immunological,19,2.9444389791664403
uncomfortable,19,2.9444389791664403
right-hemisphere,19,2.9444389791664403
MPro,19,2.9444389791664403
graphene,19,2.9444389791664403
FAST,19,2.9444389791664403
vectorcardiogram,19,2.9444389791664403
Indians,19,2.9444389791664403
coastal,19,2.9444389791664403
Applied,19,2.9444389791664403
sedimentation,19,2.9444389791664403
Euros,19,2.9444389791664403
transoesophageal,19,2.9444389791664403
774,19,2.9444389791664403
461,19,2.9444389791664403
Audit,19,2.9444389791664403
ICAS,19,2.9444389791664403
co-existing,19,2.9444389791664403
Diabetic,19,2.9444389791664403
committed,19,2.9444389791664403
immigrant,19,2.9444389791664403
montelukast,19,2.9444389791664403
colchicine,19,2.9444389791664403
JPGL,19,2.9444389791664403
606,19,2.9444389791664403
Inpatient,19,2.9444389791664403
pertussis,19,2.9444389791664403
20-25,19,2.9444389791664403
LM,19,2.9444389791664403
influenzavirus,19,2.9444389791664403
exploiting,19,2.9444389791664403
ventriculogram,19,2.9444389791664403
confusing,19,2.9444389791664403
PEP,19,2.9444389791664403
LPS,19,2.9444389791664403
EIT,19,2.9444389791664403
tertiles,19,2.9444389791664403
mesothelial,19,2.9444389791664403
LTRAs,19,2.9444389791664403
lens,19,2.9444389791664403
isocyanate-induced,19,2.9444389791664403
KNa,19,2.9444389791664403
worn,19,2.9444389791664403
AUmL,19,2.9444389791664403
Notch3,19,2.9444389791664403
oesophageal,19,2.9444389791664403
miRs,19,2.9444389791664403
Gastrointestinal,19,2.9444389791664403
myeloma,19,2.9444389791664403
477,19,2.9444389791664403
Gastroesophageal,19,2.9444389791664403
heritable,19,2.9444389791664403
hierarchy,19,2.9444389791664403
phosphatase,19,2.9444389791664403
isosorbide,19,2.9444389791664403
translocation,19,2.9444389791664403
inmates,19,2.9444389791664403
expands,19,2.9444389791664403
Division,19,2.9444389791664403
swimmers,19,2.9444389791664403
Innate,19,2.9444389791664403
asthmaCOPD,19,2.9444389791664403
25-30,19,2.9444389791664403
synchronized,19,2.9444389791664403
RaTG13,19,2.9444389791664403
immunodominant,19,2.9444389791664403
bronchopneumonia,19,2.9444389791664403
appreciably,19,2.9444389791664403
recruits,19,2.9444389791664403
weighed,19,2.9444389791664403
Fast,19,2.9444389791664403
Emergence,19,2.9444389791664403
metagenomic,19,2.9444389791664403
equivalents,19,2.9444389791664403
PEG,19,2.9444389791664403
Montreal,19,2.9444389791664403
recurred,19,2.9444389791664403
pediatrics,19,2.9444389791664403
ANS,19,2.9444389791664403
betacoronaviruses,19,2.9444389791664403
Evaluating,19,2.9444389791664403
fossa,19,2.9444389791664403
Indiana,19,2.9444389791664403
14th,19,2.9444389791664403
stepped,19,2.9444389791664403
enthusiasm,19,2.9444389791664403
Artery,19,2.9444389791664403
6-,19,2.9444389791664403
zip,19,2.9444389791664403
1918-1920,19,2.9444389791664403
underreporting,19,2.9444389791664403
257,19,2.9444389791664403
373,19,2.9444389791664403
cocaine-induced,19,2.9444389791664403
sequela,19,2.9444389791664403
bodys,19,2.9444389791664403
ESA,19,2.9444389791664403
Inclusion,19,2.9444389791664403
Effects,19,2.9444389791664403
devising,19,2.9444389791664403
affluent,19,2.9444389791664403
expenses,19,2.9444389791664403
filtering,19,2.9444389791664403
15-30,19,2.9444389791664403
Norris,19,2.9444389791664403
Relevant,19,2.9444389791664403
Nationwide,19,2.9444389791664403
Security,19,2.9444389791664403
Metabolic,19,2.9444389791664403
Reinfarction,19,2.9444389791664403
ssRNA,19,2.9444389791664403
Framingham,19,2.9444389791664403
nearby,19,2.9444389791664403
332,19,2.9444389791664403
metastatic,19,2.9444389791664403
authentic,19,2.9444389791664403
VKA,19,2.9444389791664403
Heterogeneity,19,2.9444389791664403
99th,19,2.9444389791664403
developers,19,2.9444389791664403
abroad,19,2.9444389791664403
Streptokinase,19,2.9444389791664403
Anti-inflammatory,19,2.9444389791664403
neurotrophins,19,2.9444389791664403
Lp-PLA2,19,2.9444389791664403
expedited,19,2.9444389791664403
Indications,19,2.9444389791664403
sleepiness,19,2.9444389791664403
post-discharge,19,2.9444389791664403
AHT,19,2.9444389791664403
D614,19,2.9444389791664403
entrance,19,2.9444389791664403
enforced,19,2.9444389791664403
reflective,19,2.9444389791664403
Telestroke,19,2.9444389791664403
00,19,2.9444389791664403
curtail,19,2.9444389791664403
edge,19,2.9444389791664403
seroepidemiological,19,2.9444389791664403
Transmural,19,2.9444389791664403
fire,19,2.9444389791664403
planimetry,19,2.9444389791664403
Fig,19,2.9444389791664403
large-focal,19,2.9444389791664403
Variations,19,2.9444389791664403
RDV,19,2.9444389791664403
551,19,2.9444389791664403
Section,19,2.9444389791664403
passes,19,2.9444389791664403
WE,19,2.9444389791664403
extrapolation,19,2.9444389791664403
worried,19,2.9444389791664403
Alteplase,19,2.9444389791664403
PROGRESS,19,2.9444389791664403
waters,19,2.9444389791664403
792,19,2.9444389791664403
WHAT,19,2.9444389791664403
Randomised,19,2.9444389791664403
gauge,19,2.9444389791664403
geomagnetic,19,2.9444389791664403
Red,19,2.9444389791664403
388,19,2.9444389791664403
Subjective,18,2.8903717578961645
classifiers,18,2.8903717578961645
cilostazol,18,2.8903717578961645
avian-like,18,2.8903717578961645
normative,18,2.8903717578961645
cumbersome,18,2.8903717578961645
biomass,18,2.8903717578961645
BZ,18,2.8903717578961645
nothing,18,2.8903717578961645
non-epidemic,18,2.8903717578961645
AMI-CS,18,2.8903717578961645
exposing,18,2.8903717578961645
IgG1,18,2.8903717578961645
Hopefully,18,2.8903717578961645
TMA,18,2.8903717578961645
strive,18,2.8903717578961645
442,18,2.8903717578961645
mission,18,2.8903717578961645
GFT,18,2.8903717578961645
Dental,18,2.8903717578961645
479,18,2.8903717578961645
BRE,18,2.8903717578961645
61-year-old,18,2.8903717578961645
Perception,18,2.8903717578961645
cDNA,18,2.8903717578961645
activators,18,2.8903717578961645
work-exacerbated,18,2.8903717578961645
Urban,18,2.8903717578961645
Seattle,18,2.8903717578961645
STOP,18,2.8903717578961645
macroscopic,18,2.8903717578961645
Tfh,18,2.8903717578961645
culminating,18,2.8903717578961645
Experiments,18,2.8903717578961645
Omalizumab,18,2.8903717578961645
CES,18,2.8903717578961645
Aortic,18,2.8903717578961645
unparalleled,18,2.8903717578961645
Barcelona,18,2.8903717578961645
cryo-EM,18,2.8903717578961645
locate,18,2.8903717578961645
Parental,18,2.8903717578961645
Europeans,18,2.8903717578961645
responder,18,2.8903717578961645
prevailed,18,2.8903717578961645
step-wise,18,2.8903717578961645
Triage,18,2.8903717578961645
scalp,18,2.8903717578961645
age-structured,18,2.8903717578961645
missense,18,2.8903717578961645
ensured,18,2.8903717578961645
355,18,2.8903717578961645
transforming,18,2.8903717578961645
morphometric,18,2.8903717578961645
community-level,18,2.8903717578961645
thickened,18,2.8903717578961645
destabilization,18,2.8903717578961645
1950,18,2.8903717578961645
Ideally,18,2.8903717578961645
DVT,18,2.8903717578961645
fascicular,18,2.8903717578961645
547,18,2.8903717578961645
characters,18,2.8903717578961645
finger,18,2.8903717578961645
nondiagnostic,18,2.8903717578961645
virtue,18,2.8903717578961645
Munich,18,2.8903717578961645
endothelin,18,2.8903717578961645
advocacy,18,2.8903717578961645
occupationally,18,2.8903717578961645
6MWT,18,2.8903717578961645
nAb,18,2.8903717578961645
Receptor,18,2.8903717578961645
cannula,18,2.8903717578961645
ameliorating,18,2.8903717578961645
uremic,18,2.8903717578961645
nebulised,18,2.8903717578961645
Signs,18,2.8903717578961645
postulate,18,2.8903717578961645
EISS,18,2.8903717578961645
Barriers,18,2.8903717578961645
RSS,18,2.8903717578961645
Binding,18,2.8903717578961645
speak,18,2.8903717578961645
FluMist,18,2.8903717578961645
CCBs,18,2.8903717578961645
Treg,18,2.8903717578961645
tightly,18,2.8903717578961645
tachypnea,18,2.8903717578961645
Endarterectomy,18,2.8903717578961645
611,18,2.8903717578961645
Investigators,18,2.8903717578961645
proteolysis,18,2.8903717578961645
educators,18,2.8903717578961645
CoronaVac,18,2.8903717578961645
NPWT,18,2.8903717578961645
952,18,2.8903717578961645
zoonosis,18,2.8903717578961645
scarring,18,2.8903717578961645
threefold,18,2.8903717578961645
polarization,18,2.8903717578961645
atropine,18,2.8903717578961645
coexistent,18,2.8903717578961645
mutating,18,2.8903717578961645
conclusively,18,2.8903717578961645
Slovakia,18,2.8903717578961645
low-grade,18,2.8903717578961645
letters,18,2.8903717578961645
extrapolate,18,2.8903717578961645
cost-saving,18,2.8903717578961645
pituitary,18,2.8903717578961645
parallels,18,2.8903717578961645
Simultaneously,18,2.8903717578961645
moderate-severe,18,2.8903717578961645
039,18,2.8903717578961645
2-6,18,2.8903717578961645
GCA,18,2.8903717578961645
naked,18,2.8903717578961645
immunogen,18,2.8903717578961645
523,18,2.8903717578961645
valuation,18,2.8903717578961645
Practical,18,2.8903717578961645
bottom,18,2.8903717578961645
Tenecteplase,18,2.8903717578961645
UAE,18,2.8903717578961645
psychologically,18,2.8903717578961645
medulla,18,2.8903717578961645
491,18,2.8903717578961645
relaxing,18,2.8903717578961645
event-free,18,2.8903717578961645
builds,18,2.8903717578961645
gets,18,2.8903717578961645
flora,18,2.8903717578961645
forty,18,2.8903717578961645
Digital,18,2.8903717578961645
812,18,2.8903717578961645
illustrating,18,2.8903717578961645
disclose,18,2.8903717578961645
weigh,18,2.8903717578961645
tendencies,18,2.8903717578961645
Panther,18,2.8903717578961645
Hologic,18,2.8903717578961645
QALY,18,2.8903717578961645
Canadians,18,2.8903717578961645
payer,18,2.8903717578961645
craniectomy,18,2.8903717578961645
0011,18,2.8903717578961645
healthier,18,2.8903717578961645
sexuality,18,2.8903717578961645
Thallium,18,2.8903717578961645
multi-epitope,18,2.8903717578961645
MxA,18,2.8903717578961645
Aspiration,18,2.8903717578961645
DFA,18,2.8903717578961645
weighting,18,2.8903717578961645
Forty-four,18,2.8903717578961645
RWM,18,2.8903717578961645
917,18,2.8903717578961645
detections,18,2.8903717578961645
NH,18,2.8903717578961645
continental,18,2.8903717578961645
18-49,18,2.8903717578961645
pregnancy-related,18,2.8903717578961645
under-recognized,18,2.8903717578961645
APT,18,2.8903717578961645
coated,18,2.8903717578961645
extracting,18,2.8903717578961645
duties,18,2.8903717578961645
ultrastructural,18,2.8903717578961645
cysts,18,2.8903717578961645
0048,18,2.8903717578961645
878,18,2.8903717578961645
graphs,18,2.8903717578961645
corroborated,18,2.8903717578961645
dialogue,18,2.8903717578961645
front-line,18,2.8903717578961645
Expression,18,2.8903717578961645
diagram,18,2.8903717578961645
step-up,18,2.8903717578961645
eruptions,18,2.8903717578961645
ESD,18,2.8903717578961645
Statin,18,2.8903717578961645
TS,18,2.8903717578961645
496,18,2.8903717578961645
inciting,18,2.8903717578961645
055,18,2.8903717578961645
explosion,18,2.8903717578961645
Examples,18,2.8903717578961645
MATERIAL,18,2.8903717578961645
DWI-FLAIR,18,2.8903717578961645
cyclooxygenase,18,2.8903717578961645
ectasia,18,2.8903717578961645
parenting,18,2.8903717578961645
confronting,18,2.8903717578961645
glycemic,18,2.8903717578961645
Movement,18,2.8903717578961645
undermine,18,2.8903717578961645
CoV2,18,2.8903717578961645
primed,18,2.8903717578961645
head-to-head,18,2.8903717578961645
plasmid,18,2.8903717578961645
38-year-old,18,2.8903717578961645
millennium,18,2.8903717578961645
puzzling,18,2.8903717578961645
SNVs,18,2.8903717578961645
full-time,18,2.8903717578961645
remedy,18,2.8903717578961645
esophagectomy,18,2.8903717578961645
revolution,18,2.8903717578961645
haematoma,18,2.8903717578961645
anywhere,18,2.8903717578961645
perivascular,18,2.8903717578961645
nonobstructive,18,2.8903717578961645
Games,18,2.8903717578961645
effectors,18,2.8903717578961645
thereof,18,2.8903717578961645
Complementary,18,2.8903717578961645
erythropoietin,18,2.8903717578961645
dire,18,2.8903717578961645
attracting,18,2.8903717578961645
justifying,18,2.8903717578961645
grains,18,2.8903717578961645
tracings,18,2.8903717578961645
993,18,2.8903717578961645
Preoperative,18,2.8903717578961645
VS,18,2.8903717578961645
Oxfordshire,18,2.8903717578961645
Transesophageal,18,2.8903717578961645
hinders,18,2.8903717578961645
folding,18,2.8903717578961645
594,18,2.8903717578961645
578,18,2.8903717578961645
spurred,18,2.8903717578961645
HA2,18,2.8903717578961645
CCUs,18,2.8903717578961645
DCA,18,2.8903717578961645
inconsistencies,18,2.8903717578961645
NAATs,18,2.8903717578961645
co-occurrence,18,2.8903717578961645
unhealthy,18,2.8903717578961645
5-lipoxygenase,18,2.8903717578961645
immobilized,18,2.8903717578961645
Kentucky,18,2.8903717578961645
549,18,2.8903717578961645
P002,18,2.8903717578961645
wished,18,2.8903717578961645
Nosocomial,18,2.8903717578961645
ACC,18,2.8903717578961645
influenza-A,18,2.8903717578961645
distinctions,18,2.8903717578961645
EMG,18,2.8903717578961645
Syrian,18,2.8903717578961645
Efficient,18,2.8903717578961645
reintegration,18,2.8903717578961645
NEED,18,2.8903717578961645
Newly,18,2.8903717578961645
430,18,2.8903717578961645
proves,18,2.8903717578961645
dysrhythmia,18,2.8903717578961645
-1,18,2.8903717578961645
small-scale,18,2.8903717578961645
4-8,18,2.8903717578961645
Bacillus,18,2.8903717578961645
over-the-counter,18,2.8903717578961645
Machine,18,2.8903717578961645
videos,18,2.8903717578961645
timeframe,18,2.8903717578961645
genuine,18,2.8903717578961645
NPPV,18,2.8903717578961645
topographical,18,2.8903717578961645
0047,18,2.8903717578961645
asthma-associated,18,2.8903717578961645
binomial,18,2.8903717578961645
Estonia,18,2.8903717578961645
multi-disciplinary,18,2.8903717578961645
consumer,18,2.8903717578961645
Point-of-care,18,2.8903717578961645
DB,18,2.8903717578961645
alum,18,2.8903717578961645
978,18,2.8903717578961645
ran,18,2.8903717578961645
TBI,18,2.8903717578961645
umbrella,18,2.8903717578961645
Frank,18,2.8903717578961645
rarer,18,2.8903717578961645
cobas®,18,2.8903717578961645
65-year-old,18,2.8903717578961645
harmless,18,2.8903717578961645
p002,18,2.8903717578961645
Xpert®,18,2.8903717578961645
underutilization,18,2.8903717578961645
inducers,18,2.8903717578961645
721,18,2.8903717578961645
paresis,18,2.8903717578961645
MNPs,18,2.8903717578961645
six-month,18,2.8903717578961645
14-year-old,18,2.8903717578961645
dismissal,18,2.8903717578961645
684,18,2.8903717578961645
B-type,18,2.8903717578961645
evolutionarily,18,2.8903717578961645
GISSI,18,2.8903717578961645
5-9,18,2.8903717578961645
policy-makers,18,2.8903717578961645
m-2,18,2.8903717578961645
36-year-old,18,2.8903717578961645
chilblains,18,2.8903717578961645
Staff,18,2.8903717578961645
Atopic,18,2.8903717578961645
neurotropic,18,2.8903717578961645
dividing,18,2.8903717578961645
norepinephrine,18,2.8903717578961645
glycosylated,18,2.8903717578961645
IAV-infected,18,2.8903717578961645
dissect,18,2.8903717578961645
notice,18,2.8903717578961645
topographic,18,2.8903717578961645
strand,18,2.8903717578961645
nephropathy,18,2.8903717578961645
whatever,18,2.8903717578961645
backward,18,2.8903717578961645
Providing,18,2.8903717578961645
oscillometry,18,2.8903717578961645
nodal,18,2.8903717578961645
Disease-2019,18,2.8903717578961645
summaries,18,2.8903717578961645
mgmL,18,2.8903717578961645
HV,18,2.8903717578961645
thoughts,18,2.8903717578961645
complemented,18,2.8903717578961645
Thrombus,18,2.8903717578961645
Partial,18,2.8903717578961645
absorbed,18,2.8903717578961645
traveler,18,2.8903717578961645
gastro-oesophageal,18,2.8903717578961645
cooperative,18,2.8903717578961645
interatrial,18,2.8903717578961645
advisory,18,2.8903717578961645
H5N6,18,2.8903717578961645
casualties,18,2.8903717578961645
wherein,18,2.8903717578961645
adhered,18,2.8903717578961645
52-year-old,18,2.8903717578961645
813,18,2.8903717578961645
rituximab,18,2.8903717578961645
infection-induced,18,2.8903717578961645
didnt,18,2.8903717578961645
Hungarian,18,2.8903717578961645
Rural,18,2.8903717578961645
Prognostic,18,2.8903717578961645
374,18,2.8903717578961645
995,18,2.8903717578961645
Immunocompromised,18,2.8903717578961645
Rome,18,2.8903717578961645
neighbouring,18,2.8903717578961645
Der,18,2.8903717578961645
virus-laden,18,2.8903717578961645
cholesterol-lowering,18,2.8903717578961645
afebrile,18,2.8903717578961645
perceivers,18,2.8903717578961645
TLT,18,2.8903717578961645
end-expiratory,18,2.8903717578961645
hallmarks,18,2.8903717578961645
amid,18,2.8903717578961645
DSA,18,2.8903717578961645
28-year-old,18,2.8903717578961645
married,18,2.8903717578961645
linearity,18,2.8903717578961645
proceeded,18,2.8903717578961645
antibody-mediated,18,2.8903717578961645
486,18,2.8903717578961645
anti-severe,18,2.8903717578961645
John,18,2.8903717578961645
Allplex,18,2.8903717578961645
municipality,18,2.8903717578961645
depressions,18,2.8903717578961645
TLR3,18,2.8903717578961645
HL,18,2.8903717578961645
appearances,18,2.8903717578961645
fivefold,18,2.8903717578961645
anastomosis,18,2.8903717578961645
Meta-analysis,18,2.8903717578961645
early-stage,18,2.8903717578961645
Activities,18,2.8903717578961645
heated,18,2.8903717578961645
aggregates,18,2.8903717578961645
Jersey76,18,2.8903717578961645
drive-through,18,2.8903717578961645
arsenal,18,2.8903717578961645
SAI,18,2.8903717578961645
diets,18,2.8903717578961645
AED,18,2.8903717578961645
Utilization,18,2.8903717578961645
pharmacogenetics,18,2.8903717578961645
bottlenecks,18,2.8903717578961645
Kuwait,18,2.8903717578961645
arena,18,2.8903717578961645
gargle,18,2.8903717578961645
two-step,18,2.8903717578961645
437,18,2.8903717578961645
dispensed,18,2.8903717578961645
Atypical,18,2.8903717578961645
LD,18,2.8903717578961645
credit,18,2.8903717578961645
circular,18,2.8903717578961645
≥3,18,2.8903717578961645
stroke-free,18,2.8903717578961645
109L,18,2.8903717578961645
anticancer,18,2.8903717578961645
quarantining,18,2.8903717578961645
Ischemia,18,2.8903717578961645
opposing,18,2.8903717578961645
stands,18,2.8903717578961645
V50,18,2.8903717578961645
397,18,2.8903717578961645
Finding,18,2.8903717578961645
394,18,2.8903717578961645
normalcy,18,2.8903717578961645
Cross,18,2.8903717578961645
payment,18,2.8903717578961645
HM,18,2.8903717578961645
disruptive,18,2.8903717578961645
449,18,2.8903717578961645
decrement,18,2.8903717578961645
hamster,18,2.8903717578961645
LPs,18,2.8903717578961645
coincidental,18,2.8903717578961645
Midlands,18,2.8903717578961645
marks,18,2.8903717578961645
queries,18,2.8903717578961645
Heparin,18,2.8903717578961645
technicians,18,2.8903717578961645
Discussion,18,2.8903717578961645
doctor-diagnosed,18,2.8903717578961645
201213,18,2.8903717578961645
adenoviruses,18,2.8903717578961645
dichotomized,18,2.8903717578961645
Killips,18,2.8903717578961645
V25,18,2.8903717578961645
lengthy,18,2.8903717578961645
516,18,2.8903717578961645
MBs,18,2.8903717578961645
gL,18,2.8903717578961645
vocational,17,2.833213344056216
545,17,2.833213344056216
NBT,17,2.833213344056216
misery,17,2.833213344056216
PVCs,17,2.833213344056216
bronchiolar,17,2.833213344056216
Others,17,2.833213344056216
re-evaluation,17,2.833213344056216
Diet,17,2.833213344056216
semen,17,2.833213344056216
resting-state,17,2.833213344056216
aside,17,2.833213344056216
polluted,17,2.833213344056216
Men,17,2.833213344056216
IRDT,17,2.833213344056216
OBJECTIVE,17,2.833213344056216
Pathologic,17,2.833213344056216
shall,17,2.833213344056216
unknowns,17,2.833213344056216
settled,17,2.833213344056216
pons,17,2.833213344056216
isopotential,17,2.833213344056216
563,17,2.833213344056216
surrounds,17,2.833213344056216
Delay,17,2.833213344056216
biplane,17,2.833213344056216
Tool,17,2.833213344056216
intervening,17,2.833213344056216
SRI,17,2.833213344056216
peri-infarction,17,2.833213344056216
repetition,17,2.833213344056216
smallpox,17,2.833213344056216
myosin,17,2.833213344056216
constituting,17,2.833213344056216
SO2,17,2.833213344056216
speculation,17,2.833213344056216
topological,17,2.833213344056216
chip,17,2.833213344056216
Betacoronavirus,17,2.833213344056216
strips,17,2.833213344056216
anyone,17,2.833213344056216
poorest,17,2.833213344056216
IRI,17,2.833213344056216
renin,17,2.833213344056216
metacholine,17,2.833213344056216
Minor,17,2.833213344056216
Coalition,17,2.833213344056216
radiologist,17,2.833213344056216
answering,17,2.833213344056216
lethargica,17,2.833213344056216
loaded,17,2.833213344056216
adamantane,17,2.833213344056216
enzyme-2,17,2.833213344056216
neurorestorative,17,2.833213344056216
Forty-two,17,2.833213344056216
Authorities,17,2.833213344056216
7-year,17,2.833213344056216
LMIC,17,2.833213344056216
655,17,2.833213344056216
re-emergence,17,2.833213344056216
Core,17,2.833213344056216
erythrocytes,17,2.833213344056216
P-value,17,2.833213344056216
coherent,17,2.833213344056216
reassuring,17,2.833213344056216
singular,17,2.833213344056216
3-,17,2.833213344056216
electronically,17,2.833213344056216
Sixty-five,17,2.833213344056216
floor,17,2.833213344056216
HPAIV,17,2.833213344056216
reconstructions,17,2.833213344056216
venom,17,2.833213344056216
hydroxyurea,17,2.833213344056216
linkages,17,2.833213344056216
Modified,17,2.833213344056216
guideline-recommended,17,2.833213344056216
FT,17,2.833213344056216
Volume,17,2.833213344056216
repository,17,2.833213344056216
assignment,17,2.833213344056216
hyperreactive,17,2.833213344056216
open-ended,17,2.833213344056216
Thirty-two,17,2.833213344056216
BMCs,17,2.833213344056216
actuarial,17,2.833213344056216
biologicals,17,2.833213344056216
Indoor,17,2.833213344056216
clearing,17,2.833213344056216
vectored,17,2.833213344056216
artificially,17,2.833213344056216
RT-PCR-positive,17,2.833213344056216
mediation,17,2.833213344056216
microscope,17,2.833213344056216
Computerized,17,2.833213344056216
inherently,17,2.833213344056216
CKMB,17,2.833213344056216
386,17,2.833213344056216
guideline-based,17,2.833213344056216
pretreated,17,2.833213344056216
undifferentiated,17,2.833213344056216
0013,17,2.833213344056216
harbor,17,2.833213344056216
lopinavir,17,2.833213344056216
stemming,17,2.833213344056216
biochemistry,17,2.833213344056216
AOP,17,2.833213344056216
phospholipase,17,2.833213344056216
inverted,17,2.833213344056216
Diego,17,2.833213344056216
428,17,2.833213344056216
Philadelphia,17,2.833213344056216
607,17,2.833213344056216
41-year-old,17,2.833213344056216
TGV,17,2.833213344056216
releases,17,2.833213344056216
metformin,17,2.833213344056216
329,17,2.833213344056216
indoors,17,2.833213344056216
SVV,17,2.833213344056216
Backgroundaim,17,2.833213344056216
clones,17,2.833213344056216
notions,17,2.833213344056216
AUml,17,2.833213344056216
unspecified,17,2.833213344056216
spin,17,2.833213344056216
Anemia,17,2.833213344056216
imposing,17,2.833213344056216
999,17,2.833213344056216
40000,17,2.833213344056216
0017,17,2.833213344056216
intrapleural,17,2.833213344056216
King,17,2.833213344056216
intrahospital,17,2.833213344056216
1900,17,2.833213344056216
dreaded,17,2.833213344056216
543,17,2.833213344056216
territorial,17,2.833213344056216
944,17,2.833213344056216
ASI,17,2.833213344056216
flow-volume,17,2.833213344056216
Pretreatment,17,2.833213344056216
MVL,17,2.833213344056216
problem-solving,17,2.833213344056216
varieties,17,2.833213344056216
prefer,17,2.833213344056216
511,17,2.833213344056216
650,17,2.833213344056216
query,17,2.833213344056216
anti-S,17,2.833213344056216
encourages,17,2.833213344056216
≥80,17,2.833213344056216
ranks,17,2.833213344056216
coli,17,2.833213344056216
UTM,17,2.833213344056216
encode,17,2.833213344056216
sparked,17,2.833213344056216
RVEF,17,2.833213344056216
BDI,17,2.833213344056216
quarters,17,2.833213344056216
NaCl,17,2.833213344056216
sonography,17,2.833213344056216
welding,17,2.833213344056216
56-year-old,17,2.833213344056216
GCR,17,2.833213344056216
LDL-cholesterol,17,2.833213344056216
newspaper,17,2.833213344056216
Strong,17,2.833213344056216
appetite,17,2.833213344056216
Electrical,17,2.833213344056216
occupancy,17,2.833213344056216
Architect,17,2.833213344056216
TLC,17,2.833213344056216
bronchodilatation,17,2.833213344056216
sixty,17,2.833213344056216
Keywords,17,2.833213344056216
Assessing,17,2.833213344056216
essay,17,2.833213344056216
systemically,17,2.833213344056216
Backgroundpurpose,17,2.833213344056216
justification,17,2.833213344056216
constructing,17,2.833213344056216
Regulatory,17,2.833213344056216
Islands,17,2.833213344056216
Sri,17,2.833213344056216
producers,17,2.833213344056216
touching,17,2.833213344056216
analgesic,17,2.833213344056216
discipline,17,2.833213344056216
visuospatial,17,2.833213344056216
intensive-care,17,2.833213344056216
Mymensingh,17,2.833213344056216
disease-modifying,17,2.833213344056216
pre-exercise,17,2.833213344056216
adenopathy,17,2.833213344056216
cloning,17,2.833213344056216
roll,17,2.833213344056216
SUs,17,2.833213344056216
Pigs,17,2.833213344056216
sphingolipid,17,2.833213344056216
503,17,2.833213344056216
ambulation,17,2.833213344056216
Periodicals,17,2.833213344056216
8-10,17,2.833213344056216
proceeding,17,2.833213344056216
arbidol,17,2.833213344056216
Manual,17,2.833213344056216
IF,17,2.833213344056216
macrolide,17,2.833213344056216
astrocyte,17,2.833213344056216
diagnostically,17,2.833213344056216
time-course,17,2.833213344056216
inappropriately,17,2.833213344056216
scheduling,17,2.833213344056216
AWM,17,2.833213344056216
fM,17,2.833213344056216
newest,17,2.833213344056216
MK,17,2.833213344056216
pumps,17,2.833213344056216
sub-group,17,2.833213344056216
pharynx,17,2.833213344056216
pangolins,17,2.833213344056216
overcrowding,17,2.833213344056216
aboard,17,2.833213344056216
operates,17,2.833213344056216
behalf,17,2.833213344056216
films,17,2.833213344056216
Congress,17,2.833213344056216
succeed,17,2.833213344056216
isoelectric,17,2.833213344056216
560,17,2.833213344056216
immunised,17,2.833213344056216
646,17,2.833213344056216
chameleons,17,2.833213344056216
Paul,17,2.833213344056216
renders,17,2.833213344056216
Thanks,17,2.833213344056216
Myocarditis,17,2.833213344056216
analyzer,17,2.833213344056216
TUS,17,2.833213344056216
infantile,17,2.833213344056216
Room,17,2.833213344056216
monomer,17,2.833213344056216
Fc,17,2.833213344056216
backyard,17,2.833213344056216
ancestors,17,2.833213344056216
Antivirals,17,2.833213344056216
fibromuscular,17,2.833213344056216
scale-up,17,2.833213344056216
hemiparetic,17,2.833213344056216
NBTE,17,2.833213344056216
associating,17,2.833213344056216
pulsus,17,2.833213344056216
Fishers,17,2.833213344056216
propagate,17,2.833213344056216
529,17,2.833213344056216
28th,17,2.833213344056216
Lab,17,2.833213344056216
request,17,2.833213344056216
CNN,17,2.833213344056216
474,17,2.833213344056216
oxidants,17,2.833213344056216
≥40,17,2.833213344056216
Occluded,17,2.833213344056216
734,17,2.833213344056216
sd,17,2.833213344056216
Seventy-five,17,2.833213344056216
penetrate,17,2.833213344056216
precipitants,17,2.833213344056216
Valsalva,17,2.833213344056216
controllable,17,2.833213344056216
hypoxemic,17,2.833213344056216
handwashing,17,2.833213344056216
NY,17,2.833213344056216
367,17,2.833213344056216
editing,17,2.833213344056216
Electrocardiogram,17,2.833213344056216
arousal,17,2.833213344056216
EE,17,2.833213344056216
502,17,2.833213344056216
SSRIs,17,2.833213344056216
2-fold,17,2.833213344056216
caregiving,17,2.833213344056216
Nature,17,2.833213344056216
perimeter,17,2.833213344056216
Impairment,17,2.833213344056216
polymorphonuclear,17,2.833213344056216
self-rated,17,2.833213344056216
609,17,2.833213344056216
mitochondria,17,2.833213344056216
risk-based,17,2.833213344056216
SGRQ,17,2.833213344056216
radioactivity,17,2.833213344056216
cell-derived,17,2.833213344056216
Focusing,17,2.833213344056216
computer-aided,17,2.833213344056216
FDP,17,2.833213344056216
normality,17,2.833213344056216
VIII,17,2.833213344056216
Jan,17,2.833213344056216
IAT,17,2.833213344056216
stems,17,2.833213344056216
dispersed,17,2.833213344056216
Orleans,17,2.833213344056216
Microvascular,17,2.833213344056216
692,17,2.833213344056216
sensitizations,17,2.833213344056216
multi-vessel,17,2.833213344056216
Spring,17,2.833213344056216
hand-washing,17,2.833213344056216
Transcatheter,17,2.833213344056216
spending,17,2.833213344056216
neutrophilia,17,2.833213344056216
Characterization,17,2.833213344056216
radiofrequency,17,2.833213344056216
ancestry,17,2.833213344056216
programming,17,2.833213344056216
grey,17,2.833213344056216
Making,17,2.833213344056216
ROI,17,2.833213344056216
noneosinophilic,17,2.833213344056216
Eosinophilic,17,2.833213344056216
891,17,2.833213344056216
intimately,17,2.833213344056216
Lesions,17,2.833213344056216
tachyarrhythmia,17,2.833213344056216
cell-cell,17,2.833213344056216
colloidal,17,2.833213344056216
maximally,17,2.833213344056216
bedding,17,2.833213344056216
generalised,17,2.833213344056216
587,17,2.833213344056216
658,17,2.833213344056216
201819,17,2.833213344056216
Firstly,17,2.833213344056216
bank,17,2.833213344056216
handled,17,2.833213344056216
calibre,17,2.833213344056216
Variants,17,2.833213344056216
volumetric,17,2.833213344056216
Event,17,2.833213344056216
combinatorial,17,2.833213344056216
557,17,2.833213344056216
705,17,2.833213344056216
Communities,17,2.833213344056216
μg,17,2.833213344056216
honey,17,2.833213344056216
migrainous,17,2.833213344056216
photothrombotic,17,2.833213344056216
flocks,17,2.833213344056216
NICU,17,2.833213344056216
telmisartan,17,2.833213344056216
telehealth,17,2.833213344056216
emulsion,17,2.833213344056216
358,17,2.833213344056216
pdmH1N1,17,2.833213344056216
µg,17,2.833213344056216
streamlined,17,2.833213344056216
consolidate,17,2.833213344056216
postero,17,2.833213344056216
interactome,17,2.833213344056216
polypill,17,2.833213344056216
439,17,2.833213344056216
Vital,17,2.833213344056216
Beck,17,2.833213344056216
quotient,17,2.833213344056216
Fatal,17,2.833213344056216
ill-defined,17,2.833213344056216
lncRNAs,17,2.833213344056216
bamlanivimab,17,2.833213344056216
30-50,17,2.833213344056216
PA-X,17,2.833213344056216
underestimates,17,2.833213344056216
Forum,17,2.833213344056216
prefusion,17,2.833213344056216
Illumina,17,2.833213344056216
ARB,17,2.833213344056216
codons,17,2.833213344056216
Promising,17,2.833213344056216
observer,17,2.833213344056216
thunderstorm,17,2.833213344056216
TGF-beta1,17,2.833213344056216
fluctuating,17,2.833213344056216
commencement,17,2.833213344056216
legislation,17,2.833213344056216
Leukotrienes,17,2.833213344056216
post-infarct,17,2.833213344056216
pseudoaneurysm,17,2.833213344056216
culling,17,2.833213344056216
rescued,17,2.833213344056216
favoring,17,2.833213344056216
922,17,2.833213344056216
BAO,17,2.833213344056216
anosognosia,17,2.833213344056216
papain-like,17,2.833213344056216
self-assessment,17,2.833213344056216
Lebanon,17,2.833213344056216
LAAC,17,2.833213344056216
organisational,17,2.833213344056216
aftermath,17,2.833213344056216
refute,17,2.833213344056216
PF4,17,2.833213344056216
inanimate,17,2.833213344056216
neurodevelopmental,17,2.833213344056216
categorised,17,2.833213344056216
519,17,2.833213344056216
Side,17,2.833213344056216
Correlations,17,2.833213344056216
Difficulties,17,2.833213344056216
remotely,17,2.833213344056216
436,17,2.833213344056216
metalloproteinase,17,2.833213344056216
affords,17,2.833213344056216
attenuates,17,2.833213344056216
698,17,2.833213344056216
URL,17,2.833213344056216
unemployment,17,2.833213344056216
562,17,2.833213344056216
PD15,17,2.833213344056216
antiarrhythmics,17,2.833213344056216
acupoint,17,2.833213344056216
cynomolgus,17,2.833213344056216
ALI,17,2.833213344056216
cardiosclerosis,17,2.833213344056216
TD,17,2.833213344056216
63-year-old,17,2.833213344056216
Insights,17,2.833213344056216
mm2,17,2.833213344056216
under-diagnosed,17,2.833213344056216
incubated,17,2.833213344056216
exudation,17,2.833213344056216
18-64,17,2.833213344056216
POD,17,2.833213344056216
motifs,17,2.833213344056216
mid-term,17,2.833213344056216
irritation,17,2.833213344056216
688,17,2.833213344056216
guidewire,17,2.833213344056216
nomenclature,17,2.833213344056216
externally,17,2.833213344056216
transcutaneous,17,2.833213344056216
polyposis,17,2.833213344056216
IPA,17,2.833213344056216
elastase,17,2.833213344056216
cooking,17,2.833213344056216
genera,17,2.833213344056216
log-rank,17,2.833213344056216
electroencephalography,17,2.833213344056216
flap,17,2.833213344056216
False,17,2.833213344056216
mould,17,2.833213344056216
Catalonia,17,2.833213344056216
mid-March,17,2.833213344056216
unfolding,17,2.833213344056216
ANE,17,2.833213344056216
Rhode,17,2.833213344056216
MIBG,17,2.833213344056216
QALYs,17,2.833213344056216
1-,17,2.833213344056216
beta-coronavirus,17,2.833213344056216
555,17,2.833213344056216
72-year-old,17,2.833213344056216
SPT,17,2.833213344056216
338,17,2.833213344056216
Coma,17,2.833213344056216
implicates,17,2.833213344056216
lateralization,17,2.833213344056216
adsorption,17,2.833213344056216
815,17,2.833213344056216
vastly,17,2.833213344056216
insect,17,2.833213344056216
BYamagata1688,17,2.833213344056216
mandated,16,2.772588722239781
confound,16,2.772588722239781
conceptions,16,2.772588722239781
microvessels,16,2.772588722239781
DCs,16,2.772588722239781
Az,16,2.772588722239781
higher-risk,16,2.772588722239781
configurations,16,2.772588722239781
scattered,16,2.772588722239781
Meta-analyses,16,2.772588722239781
528,16,2.772588722239781
GLS,16,2.772588722239781
WMI,16,2.772588722239781
epicardium,16,2.772588722239781
Sequential,16,2.772588722239781
appealing,16,2.772588722239781
377,16,2.772588722239781
formats,16,2.772588722239781
proportionally,16,2.772588722239781
Panbio,16,2.772588722239781
anti-vaccine,16,2.772588722239781
leader,16,2.772588722239781
pages,16,2.772588722239781
normals,16,2.772588722239781
Departments,16,2.772588722239781
oligonucleotide,16,2.772588722239781
dozens,16,2.772588722239781
HeartMate,16,2.772588722239781
evoke,16,2.772588722239781
haemoglobin,16,2.772588722239781
morphine,16,2.772588722239781
emissions,16,2.772588722239781
sort,16,2.772588722239781
STI,16,2.772588722239781
ingredients,16,2.772588722239781
471,16,2.772588722239781
TR,16,2.772588722239781
bloodstream,16,2.772588722239781
39-year-old,16,2.772588722239781
kgm2,16,2.772588722239781
AssociationAmerican,16,2.772588722239781
Thirty-eight,16,2.772588722239781
erroneously,16,2.772588722239781
pains,16,2.772588722239781
ICCU,16,2.772588722239781
unintended,16,2.772588722239781
Authority,16,2.772588722239781
sulphate,16,2.772588722239781
bead,16,2.772588722239781
aiding,16,2.772588722239781
anal,16,2.772588722239781
Technological,16,2.772588722239781
lifting,16,2.772588722239781
GGOs,16,2.772588722239781
haemodynamically,16,2.772588722239781
modifies,16,2.772588722239781
IUml,16,2.772588722239781
DUS,16,2.772588722239781
atlas,16,2.772588722239781
926,16,2.772588722239781
aroused,16,2.772588722239781
scene,16,2.772588722239781
southeast,16,2.772588722239781
amlodipine,16,2.772588722239781
premenstrual,16,2.772588722239781
methodologic,16,2.772588722239781
peptide-based,16,2.772588722239781
552,16,2.772588722239781
antimyosin,16,2.772588722239781
politics,16,2.772588722239781
791,16,2.772588722239781
cohesion,16,2.772588722239781
Valley,16,2.772588722239781
Scheme,16,2.772588722239781
μL,16,2.772588722239781
Disruption,16,2.772588722239781
southeastern,16,2.772588722239781
Co,16,2.772588722239781
vasospastic,16,2.772588722239781
caesarean,16,2.772588722239781
motivational,16,2.772588722239781
uninsured,16,2.772588722239781
rehabilitated,16,2.772588722239781
ISDN,16,2.772588722239781
Corticosteroid,16,2.772588722239781
potentiate,16,2.772588722239781
Allplex™,16,2.772588722239781
trophic,16,2.772588722239781
lipoproteins,16,2.772588722239781
knowledgeable,16,2.772588722239781
ecg,16,2.772588722239781
debates,16,2.772588722239781
autoregulation,16,2.772588722239781
massage,16,2.772588722239781
Congestive,16,2.772588722239781
nomogram,16,2.772588722239781
cotton,16,2.772588722239781
dominate,16,2.772588722239781
Q-waves,16,2.772588722239781
newspapers,16,2.772588722239781
ORG,16,2.772588722239781
L-1,16,2.772588722239781
QTd,16,2.772588722239781
Problem,16,2.772588722239781
fed,16,2.772588722239781
441,16,2.772588722239781
non-synonymous,16,2.772588722239781
100-fold,16,2.772588722239781
matches,16,2.772588722239781
Duration,16,2.772588722239781
RPA,16,2.772588722239781
methotrexate,16,2.772588722239781
MAC,16,2.772588722239781
Th1Th2,16,2.772588722239781
quercetin,16,2.772588722239781
meticulous,16,2.772588722239781
intramuscularly,16,2.772588722239781
DI,16,2.772588722239781
warranting,16,2.772588722239781
automation,16,2.772588722239781
committees,16,2.772588722239781
STRA,16,2.772588722239781
Brief,16,2.772588722239781
Administrative,16,2.772588722239781
Set,16,2.772588722239781
vera,16,2.772588722239781
573,16,2.772588722239781
anterior-wall,16,2.772588722239781
knockdown,16,2.772588722239781
immunosuppressants,16,2.772588722239781
amplicons,16,2.772588722239781
Pakistani,16,2.772588722239781
434,16,2.772588722239781
ankle,16,2.772588722239781
480,16,2.772588722239781
pharmacogenomics,16,2.772588722239781
network-based,16,2.772588722239781
asphyxia,16,2.772588722239781
mid-February,16,2.772588722239781
SBR,16,2.772588722239781
transfers,16,2.772588722239781
arteriosclerotic,16,2.772588722239781
contrived,16,2.772588722239781
Wild,16,2.772588722239781
Islander,16,2.772588722239781
care-seeking,16,2.772588722239781
coworkers,16,2.772588722239781
ophthalmologists,16,2.772588722239781
460,16,2.772588722239781
ring,16,2.772588722239781
2001-2002,16,2.772588722239781
surpassed,16,2.772588722239781
Vaxzevria,16,2.772588722239781
literatures,16,2.772588722239781
cardio-embolic,16,2.772588722239781
impeded,16,2.772588722239781
races,16,2.772588722239781
acetate,16,2.772588722239781
migrated,16,2.772588722239781
instituting,16,2.772588722239781
recesses,16,2.772588722239781
dichotomous,16,2.772588722239781
venovenous,16,2.772588722239781
clear-cut,16,2.772588722239781
Clopidogrel,16,2.772588722239781
IVF,16,2.772588722239781
asystole,16,2.772588722239781
scaffolds,16,2.772588722239781
sight,16,2.772588722239781
676,16,2.772588722239781
grain,16,2.772588722239781
0012,16,2.772588722239781
basics,16,2.772588722239781
rationally,16,2.772588722239781
2019COVID-19,16,2.772588722239781
reinforces,16,2.772588722239781
comfort,16,2.772588722239781
Rint,16,2.772588722239781
00003,16,2.772588722239781
transferring,16,2.772588722239781
asymptomatically,16,2.772588722239781
NF-kappaB,16,2.772588722239781
conduit,16,2.772588722239781
535,16,2.772588722239781
deliveries,16,2.772588722239781
0026,16,2.772588722239781
surrounded,16,2.772588722239781
defend,16,2.772588722239781
circulates,16,2.772588722239781
African-Americans,16,2.772588722239781
arranged,16,2.772588722239781
LTE4,16,2.772588722239781
AIs,16,2.772588722239781
outweighs,16,2.772588722239781
faecal-oral,16,2.772588722239781
roots,16,2.772588722239781
ONPS,16,2.772588722239781
IABC,16,2.772588722239781
captures,16,2.772588722239781
Intra-aortic,16,2.772588722239781
hyperthermia,16,2.772588722239781
FFPE,16,2.772588722239781
consultant,16,2.772588722239781
hemagglutinins,16,2.772588722239781
717,16,2.772588722239781
covalent,16,2.772588722239781
two-part,16,2.772588722239781
CVAs,16,2.772588722239781
proportionate,16,2.772588722239781
hubs,16,2.772588722239781
down-regulated,16,2.772588722239781
docked,16,2.772588722239781
IACP,16,2.772588722239781
abruptly,16,2.772588722239781
intrinsically,16,2.772588722239781
migrate,16,2.772588722239781
diesel,16,2.772588722239781
allocate,16,2.772588722239781
REPORT,16,2.772588722239781
WMS,16,2.772588722239781
Variation,16,2.772588722239781
luciferase,16,2.772588722239781
adrenaline,16,2.772588722239781
immunotherapies,16,2.772588722239781
patient-level,16,2.772588722239781
Ukraine,16,2.772588722239781
compositions,16,2.772588722239781
cytoprotective,16,2.772588722239781
RAGE,16,2.772588722239781
Defining,16,2.772588722239781
fabricated,16,2.772588722239781
testosterone,16,2.772588722239781
well-developed,16,2.772588722239781
Mesenchymal,16,2.772588722239781
tremendously,16,2.772588722239781
Adjunctive,16,2.772588722239781
Th2-type,16,2.772588722239781
angiocardiography,16,2.772588722239781
Ca,16,2.772588722239781
Suggestions,16,2.772588722239781
lethargy,16,2.772588722239781
stores,16,2.772588722239781
deacetylase,16,2.772588722239781
denominator,16,2.772588722239781
540,16,2.772588722239781
minimizes,16,2.772588722239781
Bone,16,2.772588722239781
Protective,16,2.772588722239781
TaqMan,16,2.772588722239781
well-tolerated,16,2.772588722239781
Thermo,16,2.772588722239781
pharmacovigilance,16,2.772588722239781
FH,16,2.772588722239781
Tobacco,16,2.772588722239781
shots,16,2.772588722239781
871,16,2.772588722239781
conscripts,16,2.772588722239781
4-month,16,2.772588722239781
neutropenia,16,2.772588722239781
Leukotriene,16,2.772588722239781
covariate,16,2.772588722239781
truncated,16,2.772588722239781
476,16,2.772588722239781
CVT,16,2.772588722239781
consumers,16,2.772588722239781
interindividual,16,2.772588722239781
epidural,16,2.772588722239781
ibuprofen,16,2.772588722239781
778,16,2.772588722239781
familiarity,16,2.772588722239781
Profile,16,2.772588722239781
ASMCs,16,2.772588722239781
compensated,16,2.772588722239781
migrating,16,2.772588722239781
purity,16,2.772588722239781
Detecting,16,2.772588722239781
Cycle,16,2.772588722239781
GRACE,16,2.772588722239781
20-40,16,2.772588722239781
Attitudes,16,2.772588722239781
Congenital,16,2.772588722239781
leaks,16,2.772588722239781
contemporaneous,16,2.772588722239781
abbreviated,16,2.772588722239781
indomethacin,16,2.772588722239781
reluctant,16,2.772588722239781
PAIS,16,2.772588722239781
featured,16,2.772588722239781
Caregivers,16,2.772588722239781
24h,16,2.772588722239781
Dietary,16,2.772588722239781
cine,16,2.772588722239781
Environment,16,2.772588722239781
564,16,2.772588722239781
intercourse,16,2.772588722239781
underpinned,16,2.772588722239781
plasmonic,16,2.772588722239781
OTC,16,2.772588722239781
Selection,16,2.772588722239781
6800,16,2.772588722239781
tenecteplase,16,2.772588722239781
archived,16,2.772588722239781
TPA,16,2.772588722239781
irritant-induced,16,2.772588722239781
authorisation,16,2.772588722239781
N-protein,16,2.772588722239781
nonclinical,16,2.772588722239781
recycling,16,2.772588722239781
client,16,2.772588722239781
talk,16,2.772588722239781
neuroradiological,16,2.772588722239781
asses,16,2.772588722239781
pi,16,2.772588722239781
yen,16,2.772588722239781
strata,16,2.772588722239781
chylothorax,16,2.772588722239781
Resting,16,2.772588722239781
Delays,16,2.772588722239781
nonsynonymous,16,2.772588722239781
structure-function,16,2.772588722239781
post-traumatic,16,2.772588722239781
chromosomal,16,2.772588722239781
Subject,16,2.772588722239781
0-3,16,2.772588722239781
life-style,16,2.772588722239781
teens,16,2.772588722239781
Swan-Ganz,16,2.772588722239781
Milan,16,2.772588722239781
implicate,16,2.772588722239781
affinities,16,2.772588722239781
serosurveys,16,2.772588722239781
CASE,16,2.772588722239781
prespecified,16,2.772588722239781
Registration,16,2.772588722239781
934,16,2.772588722239781
recur,16,2.772588722239781
ordering,16,2.772588722239781
Content,16,2.772588722239781
nonvaccinated,16,2.772588722239781
triple-reassortant,16,2.772588722239781
913,16,2.772588722239781
CD34,16,2.772588722239781
NSAID,16,2.772588722239781
468,16,2.772588722239781
hCoV,16,2.772588722239781
ragweed,16,2.772588722239781
postexercise,16,2.772588722239781
organelles,16,2.772588722239781
Pain,16,2.772588722239781
Ang,16,2.772588722239781
planes,16,2.772588722239781
runny,16,2.772588722239781
complaining,16,2.772588722239781
PG,16,2.772588722239781
blotting,16,2.772588722239781
nonusers,16,2.772588722239781
outlining,16,2.772588722239781
rationing,16,2.772588722239781
cardiography,16,2.772588722239781
pm,16,2.772588722239781
neuroinvasive,16,2.772588722239781
multi-faceted,16,2.772588722239781
Functioning,16,2.772588722239781
trigeminal,16,2.772588722239781
inter-pandemic,16,2.772588722239781
extracardiac,16,2.772588722239781
redefined,16,2.772588722239781
hyponatremia,16,2.772588722239781
influenzalike,16,2.772588722239781
standpoint,16,2.772588722239781
Change,16,2.772588722239781
Ecuador,16,2.772588722239781
thrombocythemia,16,2.772588722239781
HSP70,16,2.772588722239781
619,16,2.772588722239781
PCP,16,2.772588722239781
732,16,2.772588722239781
optimisation,16,2.772588722239781
intimate,16,2.772588722239781
propagated,16,2.772588722239781
Kidney,16,2.772588722239781
ribonucleoprotein,16,2.772588722239781
hydrophobic,16,2.772588722239781
CAG,16,2.772588722239781
apoplexy,16,2.772588722239781
Spearmans,16,2.772588722239781
mgkgday,16,2.772588722239781
reelevation,16,2.772588722239781
Translational,16,2.772588722239781
Precordial,16,2.772588722239781
chronological,16,2.772588722239781
767,16,2.772588722239781
hyperglycemic,16,2.772588722239781
consumables,16,2.772588722239781
701,16,2.772588722239781
paying,16,2.772588722239781
954,16,2.772588722239781
tHcy,16,2.772588722239781
attract,16,2.772588722239781
haemagglutination-inhibition,16,2.772588722239781
Fibrillation,16,2.772588722239781
repairing,16,2.772588722239781
antigen-presenting,16,2.772588722239781
49-year-old,16,2.772588722239781
JAGL,16,2.772588722239781
Madrid,16,2.772588722239781
wives,16,2.772588722239781
remediation,16,2.772588722239781
MIF,16,2.772588722239781
ACE-inhibitors,16,2.772588722239781
non-cardioembolic,16,2.772588722239781
SRA,16,2.772588722239781
acute-phase,16,2.772588722239781
613,16,2.772588722239781
splenic,16,2.772588722239781
immature,16,2.772588722239781
Cross-sectional,16,2.772588722239781
neurohormonal,16,2.772588722239781
derangement,16,2.772588722239781
high-,16,2.772588722239781
Symposium,16,2.772588722239781
placebo-treated,16,2.772588722239781
CAO,16,2.772588722239781
NSAIDs,16,2.772588722239781
Renal,16,2.772588722239781
595,16,2.772588722239781
scholars,16,2.772588722239781
Africans,16,2.772588722239781
daunting,16,2.772588722239781
divide,16,2.772588722239781
lymphocytopenia,16,2.772588722239781
1889,16,2.772588722239781
URTI,16,2.772588722239781
f,16,2.772588722239781
momentum,16,2.772588722239781
Issues,16,2.772588722239781
investigator,16,2.772588722239781
pillars,16,2.772588722239781
empathy,16,2.772588722239781
997,16,2.772588722239781
seeded,16,2.772588722239781
intra-hospital,16,2.772588722239781
reopen,16,2.772588722239781
IHH,16,2.772588722239781
colonization,16,2.772588722239781
acinar,16,2.772588722239781
prematurely,16,2.772588722239781
q,16,2.772588722239781
810,16,2.772588722239781
GGO,16,2.772588722239781
LVD,16,2.772588722239781
sensible,16,2.772588722239781
DAWN,16,2.772588722239781
Memory,16,2.772588722239781
respirable,16,2.772588722239781
off-label,16,2.772588722239781
NSBH,16,2.772588722239781
passing,16,2.772588722239781
games,16,2.772588722239781
Oxford-AstraZeneca,16,2.772588722239781
ml-1,16,2.772588722239781
914,16,2.772588722239781
Self-management,16,2.772588722239781
buildings,16,2.772588722239781
MPO,16,2.772588722239781
metals,16,2.772588722239781
614,16,2.772588722239781
vegetation,16,2.772588722239781
0019,16,2.772588722239781
Multiplex,16,2.772588722239781
consume,16,2.772588722239781
harvested,16,2.772588722239781
electrically,16,2.772588722239781
mid-December,16,2.772588722239781
ICF,16,2.772588722239781
logic,16,2.772588722239781
well-studied,16,2.772588722239781
parametric,16,2.772588722239781
Physician,16,2.772588722239781
heliox,16,2.772588722239781
994,16,2.772588722239781
AEs,16,2.772588722239781
Zika,16,2.772588722239781
443,16,2.772588722239781
567,16,2.772588722239781
bioinformatic,16,2.772588722239781
Ketotifen,16,2.772588722239781
anti-thrombotic,16,2.772588722239781
TLR2,16,2.772588722239781
endotyping,16,2.772588722239781
emotionally,16,2.772588722239781
762,16,2.772588722239781
beat,16,2.772588722239781
itching,16,2.772588722239781
PRP,16,2.772588722239781
cords,16,2.772588722239781
cocktail,16,2.772588722239781
RT-PCR-based,16,2.772588722239781
Interval,15,2.70805020110221
weighing,15,2.70805020110221
empower,15,2.70805020110221
Causes,15,2.70805020110221
tachycardias,15,2.70805020110221
checkpoint,15,2.70805020110221
CSS,15,2.70805020110221
disclosure,15,2.70805020110221
unfolds,15,2.70805020110221
inlet,15,2.70805020110221
superinfections,15,2.70805020110221
circumvent,15,2.70805020110221
680,15,2.70805020110221
O3,15,2.70805020110221
rubber,15,2.70805020110221
vials,15,2.70805020110221
antileukotrienes,15,2.70805020110221
alkaline,15,2.70805020110221
silver,15,2.70805020110221
Janeiro,15,2.70805020110221
BTS,15,2.70805020110221
grossly,15,2.70805020110221
soap,15,2.70805020110221
Utilizing,15,2.70805020110221
discarded,15,2.70805020110221
craniotomy,15,2.70805020110221
PUFA,15,2.70805020110221
creative,15,2.70805020110221
556,15,2.70805020110221
H1N1-infected,15,2.70805020110221
specifications,15,2.70805020110221
Discharge,15,2.70805020110221
incorrectly,15,2.70805020110221
Disparities,15,2.70805020110221
draft,15,2.70805020110221
attendees,15,2.70805020110221
Muscle,15,2.70805020110221
LCI,15,2.70805020110221
colour,15,2.70805020110221
Strikingly,15,2.70805020110221
northeastern,15,2.70805020110221
541,15,2.70805020110221
ritonavir,15,2.70805020110221
successively,15,2.70805020110221
polar,15,2.70805020110221
Fund,15,2.70805020110221
CLL,15,2.70805020110221
antero-septal,15,2.70805020110221
illustration,15,2.70805020110221
aircraft,15,2.70805020110221
938,15,2.70805020110221
vaccine-associated,15,2.70805020110221
arteriosclerosis,15,2.70805020110221
LS,15,2.70805020110221
redundancy,15,2.70805020110221
Org,15,2.70805020110221
≥70,15,2.70805020110221
prosody,15,2.70805020110221
Tecumseh,15,2.70805020110221
progenitors,15,2.70805020110221
nonculprit,15,2.70805020110221
531,15,2.70805020110221
currents,15,2.70805020110221
repositories,15,2.70805020110221
Either,15,2.70805020110221
Accuracy,15,2.70805020110221
decentralized,15,2.70805020110221
Sensitive,15,2.70805020110221
individualize,15,2.70805020110221
subcellular,15,2.70805020110221
pushed,15,2.70805020110221
realities,15,2.70805020110221
corrective,15,2.70805020110221
sternum,15,2.70805020110221
Highlights,15,2.70805020110221
weakened,15,2.70805020110221
Residual,15,2.70805020110221
ISI,15,2.70805020110221
artifact,15,2.70805020110221
shear,15,2.70805020110221
vasopressor,15,2.70805020110221
stemprogenitor,15,2.70805020110221
moulds,15,2.70805020110221
tablet,15,2.70805020110221
looming,15,2.70805020110221
atherogenic,15,2.70805020110221
ramifications,15,2.70805020110221
frustration,15,2.70805020110221
RBDs,15,2.70805020110221
anti-allergic,15,2.70805020110221
PGE2,15,2.70805020110221
Scandinavian,15,2.70805020110221
innocuous,15,2.70805020110221
bare,15,2.70805020110221
coagulopathies,15,2.70805020110221
Geneva,15,2.70805020110221
Personality,15,2.70805020110221
incompetence,15,2.70805020110221
manuscripts,15,2.70805020110221
DEFUSE,15,2.70805020110221
inflow,15,2.70805020110221
618,15,2.70805020110221
consolidated,15,2.70805020110221
co-infected,15,2.70805020110221
PAO,15,2.70805020110221
handles,15,2.70805020110221
under-treated,15,2.70805020110221
let,15,2.70805020110221
Hospitalized,15,2.70805020110221
Helsinki,15,2.70805020110221
877,15,2.70805020110221
assets,15,2.70805020110221
periodicity,15,2.70805020110221
Arm,15,2.70805020110221
compulsory,15,2.70805020110221
cockroaches,15,2.70805020110221
institutionalization,15,2.70805020110221
navigate,15,2.70805020110221
funds,15,2.70805020110221
µM,15,2.70805020110221
SV,15,2.70805020110221
mutagenesis,15,2.70805020110221
distinguishes,15,2.70805020110221
Dhaka,15,2.70805020110221
phosphate-buffered,15,2.70805020110221
AWSN33,15,2.70805020110221
700000,15,2.70805020110221
co-ordinated,15,2.70805020110221
deflection,15,2.70805020110221
constituent,15,2.70805020110221
nascent,15,2.70805020110221
Random,15,2.70805020110221
MIC,15,2.70805020110221
sweating,15,2.70805020110221
villages,15,2.70805020110221
530,15,2.70805020110221
polio,15,2.70805020110221
compute,15,2.70805020110221
mediastinitis,15,2.70805020110221
decomposition,15,2.70805020110221
athletic,15,2.70805020110221
mongrel,15,2.70805020110221
noninfectious,15,2.70805020110221
lactation,15,2.70805020110221
resort,15,2.70805020110221
Illinois,15,2.70805020110221
dictates,15,2.70805020110221
encephalomyelitis,15,2.70805020110221
neighbourhood,15,2.70805020110221
wholly,15,2.70805020110221
questionnaire-based,15,2.70805020110221
excreta,15,2.70805020110221
impetus,15,2.70805020110221
oculomotor,15,2.70805020110221
-19,15,2.70805020110221
multiplexing,15,2.70805020110221
814,15,2.70805020110221
trade-off,15,2.70805020110221
one-,15,2.70805020110221
sVNT,15,2.70805020110221
amelioration,15,2.70805020110221
pre-discharge,15,2.70805020110221
postexposure,15,2.70805020110221
0042,15,2.70805020110221
Balance,15,2.70805020110221
958,15,2.70805020110221
B-lines,15,2.70805020110221
Regulations,15,2.70805020110221
curriculum,15,2.70805020110221
Eighty-one,15,2.70805020110221
genotyped,15,2.70805020110221
transplacental,15,2.70805020110221
Arteries,15,2.70805020110221
age-standardized,15,2.70805020110221
nonatherosclerotic,15,2.70805020110221
functionalized,15,2.70805020110221
743,15,2.70805020110221
740,15,2.70805020110221
anti-flu,15,2.70805020110221
URT,15,2.70805020110221
Hopkins,15,2.70805020110221
Se,15,2.70805020110221
sandwich,15,2.70805020110221
juvenile,15,2.70805020110221
infratentorial,15,2.70805020110221
760,15,2.70805020110221
cornerstones,15,2.70805020110221
rhythmic,15,2.70805020110221
skewed,15,2.70805020110221
711,15,2.70805020110221
immunoregulatory,15,2.70805020110221
saves,15,2.70805020110221
overproduction,15,2.70805020110221
stented,15,2.70805020110221
steep,15,2.70805020110221
≥60,15,2.70805020110221
ulcers,15,2.70805020110221
AEngland4272,15,2.70805020110221
small-molecule,15,2.70805020110221
stroketransient,15,2.70805020110221
discernible,15,2.70805020110221
chlorine,15,2.70805020110221
quartiles,15,2.70805020110221
Proposed,15,2.70805020110221
nonoccupational,15,2.70805020110221
dating,15,2.70805020110221
indexed,15,2.70805020110221
derives,15,2.70805020110221
16-year-old,15,2.70805020110221
first-pass,15,2.70805020110221
990,15,2.70805020110221
tilt,15,2.70805020110221
lateropulsion,15,2.70805020110221
encouragement,15,2.70805020110221
appointment,15,2.70805020110221
vasculopathies,15,2.70805020110221
oncological,15,2.70805020110221
DAD,15,2.70805020110221
deposits,15,2.70805020110221
Simulations,15,2.70805020110221
helium,15,2.70805020110221
phosphodiesterase,15,2.70805020110221
justice,15,2.70805020110221
autocorrelation,15,2.70805020110221
borne,15,2.70805020110221
CRISPR-Cas,15,2.70805020110221
premise,15,2.70805020110221
PfizerBioNTech,15,2.70805020110221
Web-based,15,2.70805020110221
RSI,15,2.70805020110221
customized,15,2.70805020110221
SB,15,2.70805020110221
excitation,15,2.70805020110221
DEX,15,2.70805020110221
suppressive,15,2.70805020110221
Tropical,15,2.70805020110221
malefemale,15,2.70805020110221
946,15,2.70805020110221
rate-pressure,15,2.70805020110221
Loss,15,2.70805020110221
enrolling,15,2.70805020110221
distinguishable,15,2.70805020110221
isocapnic,15,2.70805020110221
non-obstructive,15,2.70805020110221
ignore,15,2.70805020110221
neurobehavioral,15,2.70805020110221
commencing,15,2.70805020110221
repeats,15,2.70805020110221
20022003,15,2.70805020110221
773,15,2.70805020110221
Histamine,15,2.70805020110221
733,15,2.70805020110221
postbronchodilator,15,2.70805020110221
PR8,15,2.70805020110221
benefiting,15,2.70805020110221
Recognizing,15,2.70805020110221
0028,15,2.70805020110221
998,15,2.70805020110221
imbalances,15,2.70805020110221
470,15,2.70805020110221
Pearsons,15,2.70805020110221
reception,15,2.70805020110221
infection-related,15,2.70805020110221
828,15,2.70805020110221
cumulated,15,2.70805020110221
Governments,15,2.70805020110221
agglutination,15,2.70805020110221
doubtful,15,2.70805020110221
755,15,2.70805020110221
NRL,15,2.70805020110221
analogs,15,2.70805020110221
zafirlukast,15,2.70805020110221
569,15,2.70805020110221
TPP,15,2.70805020110221
scanty,15,2.70805020110221
Articles,15,2.70805020110221
78-year-old,15,2.70805020110221
foremost,15,2.70805020110221
BF,15,2.70805020110221
longterm,15,2.70805020110221
Diltiazem,15,2.70805020110221
osmotic,15,2.70805020110221
Annually,15,2.70805020110221
subendocardium,15,2.70805020110221
32-year-old,15,2.70805020110221
exhausted,15,2.70805020110221
thunderstorms,15,2.70805020110221
qualify,15,2.70805020110221
lumbar,15,2.70805020110221
dissecting,15,2.70805020110221
490,15,2.70805020110221
spend,15,2.70805020110221
α,15,2.70805020110221
Missouri,15,2.70805020110221
Theory,15,2.70805020110221
purchased,15,2.70805020110221
demanded,15,2.70805020110221
Princess,15,2.70805020110221
warnings,15,2.70805020110221
SIVs,15,2.70805020110221
mini,15,2.70805020110221
Hearts,15,2.70805020110221
hypokalemia,15,2.70805020110221
Managing,15,2.70805020110221
heath,15,2.70805020110221
602,15,2.70805020110221
745,15,2.70805020110221
Antithrombotic,15,2.70805020110221
aluminium,15,2.70805020110221
swiftly,15,2.70805020110221
disease-free,15,2.70805020110221
internalization,15,2.70805020110221
convert,15,2.70805020110221
C57BL6,15,2.70805020110221
Antihypertensive,15,2.70805020110221
LMWH,15,2.70805020110221
nicotine,15,2.70805020110221
diameters,15,2.70805020110221
EZ,15,2.70805020110221
7-8,15,2.70805020110221
weapon,15,2.70805020110221
WATCHMAN,15,2.70805020110221
compile,15,2.70805020110221
bronchodilatory,15,2.70805020110221
untoward,15,2.70805020110221
convolutional,15,2.70805020110221
surrogates,15,2.70805020110221
step-down,15,2.70805020110221
disinfecting,15,2.70805020110221
Remote,15,2.70805020110221
checking,15,2.70805020110221
postischemic,15,2.70805020110221
786,15,2.70805020110221
weaned,15,2.70805020110221
manipulated,15,2.70805020110221
pranlukast,15,2.70805020110221
subtyped,15,2.70805020110221
NOTCH3,15,2.70805020110221
airline,15,2.70805020110221
immunopathologic,15,2.70805020110221
31-year-old,15,2.70805020110221
2000-2001,15,2.70805020110221
stains,15,2.70805020110221
≤2,15,2.70805020110221
665,15,2.70805020110221
atenolol,15,2.70805020110221
neuraminidases,15,2.70805020110221
overwhelm,15,2.70805020110221
overdiagnosis,15,2.70805020110221
excreted,15,2.70805020110221
GORD,15,2.70805020110221
slides,15,2.70805020110221
925,15,2.70805020110221
maneuver,15,2.70805020110221
strikingly,15,2.70805020110221
QR,15,2.70805020110221
883,15,2.70805020110221
semester,15,2.70805020110221
dilutions,15,2.70805020110221
HbA1c,15,2.70805020110221
Distress,15,2.70805020110221
One-hundred,15,2.70805020110221
united,15,2.70805020110221
17-year-old,15,2.70805020110221
chapters,15,2.70805020110221
CIMT,15,2.70805020110221
racing,15,2.70805020110221
AIDS,15,2.70805020110221
K18-hACE2,15,2.70805020110221
Forty-six,15,2.70805020110221
Intense,15,2.70805020110221
evenly,15,2.70805020110221
forum,15,2.70805020110221
SARS-CoV-2-associated,15,2.70805020110221
embolized,15,2.70805020110221
Chalmers173,15,2.70805020110221
201415,15,2.70805020110221
965,15,2.70805020110221
FVE,15,2.70805020110221
inaccessible,15,2.70805020110221
Confirmation,15,2.70805020110221
medium-term,15,2.70805020110221
Isolation,15,2.70805020110221
m2,15,2.70805020110221
divers,15,2.70805020110221
English-language,15,2.70805020110221
unpredictability,15,2.70805020110221
plasmon,15,2.70805020110221
posthospital,15,2.70805020110221
affiliated,15,2.70805020110221
67-year-old,15,2.70805020110221
Electrocardiography,15,2.70805020110221
inapparent,15,2.70805020110221
boundary,15,2.70805020110221
SAVE,15,2.70805020110221
embolisation,15,2.70805020110221
School-based,15,2.70805020110221
stomach,15,2.70805020110221
0-14,15,2.70805020110221
Qatar,15,2.70805020110221
retrieve,15,2.70805020110221
Related,15,2.70805020110221
age-stratified,15,2.70805020110221
tabulated,15,2.70805020110221
Epitope,15,2.70805020110221
outgrow,15,2.70805020110221
Gross,15,2.70805020110221
underlined,15,2.70805020110221
immunotherapeutic,15,2.70805020110221
CSVD,15,2.70805020110221
46-year-old,15,2.70805020110221
Cytokine,15,2.70805020110221
transdermal,15,2.70805020110221
SARS-CoV-2COVID-19,15,2.70805020110221
WEA,15,2.70805020110221
triphenyltetrazolium,15,2.70805020110221
Contrast,15,2.70805020110221
microemboli,15,2.70805020110221
curated,15,2.70805020110221
nonepidemic,15,2.70805020110221
casual,15,2.70805020110221
HU,15,2.70805020110221
admittance,15,2.70805020110221
601,15,2.70805020110221
unsolved,15,2.70805020110221
mobilisation,15,2.70805020110221
Bedside,15,2.70805020110221
MP,15,2.70805020110221
lowers,15,2.70805020110221
populous,15,2.70805020110221
linguistic,15,2.70805020110221
Computational,15,2.70805020110221
exams,15,2.70805020110221
pyroptosis,15,2.70805020110221
MMP,15,2.70805020110221
interferes,15,2.70805020110221
benralizumab,15,2.70805020110221
phased,15,2.70805020110221
mixes,15,2.70805020110221
Cq,15,2.70805020110221
lobectomy,15,2.70805020110221
Ambulatory,15,2.70805020110221
579,15,2.70805020110221
streams,15,2.70805020110221
FluNet,15,2.70805020110221
pre,15,2.70805020110221
TAT,15,2.70805020110221
Veneto,15,2.70805020110221
dampen,15,2.70805020110221
≥4,15,2.70805020110221
Interviews,15,2.70805020110221
727,15,2.70805020110221
replicative,15,2.70805020110221
ciliary,15,2.70805020110221
Fifty-three,15,2.70805020110221
Cl,15,2.70805020110221
intensely,15,2.70805020110221
interacted,15,2.70805020110221
Madin-Darby,15,2.70805020110221
Seventy-eight,15,2.70805020110221
phylogenetically,15,2.70805020110221
neurophysiological,15,2.70805020110221
Distinct,15,2.70805020110221
les,15,2.70805020110221
Diagnosing,15,2.70805020110221
TM,15,2.70805020110221
58-year-old,15,2.70805020110221
elbow,15,2.70805020110221
Surface,15,2.70805020110221
Assays,15,2.70805020110221
nonsevere,15,2.70805020110221
Trust,15,2.70805020110221
Period,15,2.70805020110221
phlegm,15,2.70805020110221
201516,15,2.70805020110221
aa,15,2.70805020110221
space-time,15,2.70805020110221
conversations,15,2.70805020110221
HWs,15,2.70805020110221
2b,15,2.70805020110221
end-organ,15,2.70805020110221
myoblast,15,2.70805020110221
IVUS,15,2.70805020110221
Doctors,15,2.70805020110221
anti,15,2.70805020110221
z,15,2.70805020110221
Willis,15,2.70805020110221
maternity,15,2.70805020110221
PAQLQ,15,2.70805020110221
decoction,15,2.70805020110221
Orthomyxoviridae,15,2.70805020110221
wavelet,15,2.70805020110221
mere,15,2.70805020110221
coughs,15,2.70805020110221
hypothermic,15,2.70805020110221
aorto-coronary,15,2.70805020110221
rewarming,15,2.70805020110221
generalization,15,2.70805020110221
Arizona,15,2.70805020110221
upset,15,2.70805020110221
EDWT,15,2.70805020110221
Intravascular,15,2.70805020110221
0021,15,2.70805020110221
SCS,15,2.70805020110221
MMD,15,2.70805020110221
leukopenia,15,2.70805020110221
garnered,15,2.70805020110221
branching,15,2.70805020110221
19992000,15,2.70805020110221
Geographic,15,2.70805020110221
turnover,15,2.70805020110221
illustrative,15,2.70805020110221
tenth,15,2.70805020110221
amounting,15,2.70805020110221
WA12020,15,2.70805020110221
Relenza,15,2.70805020110221
Medications,15,2.70805020110221
computer-assisted,15,2.70805020110221
Navy,15,2.70805020110221
sociocultural,15,2.70805020110221
Estimation,15,2.70805020110221
hyaline,15,2.70805020110221
Stimulation,15,2.70805020110221
N-glycosylation,15,2.70805020110221
24th,15,2.70805020110221
lags,15,2.70805020110221
FAK,15,2.70805020110221
decipher,15,2.70805020110221
mumol,15,2.70805020110221
bakers,15,2.70805020110221
MIS,15,2.70805020110221
excludes,15,2.70805020110221
76-year-old,15,2.70805020110221
situational,15,2.70805020110221
3-day,15,2.70805020110221
perturbation,15,2.70805020110221
ideation,15,2.70805020110221
953,15,2.70805020110221
AH3N2v,15,2.70805020110221
homogenous,15,2.70805020110221
Ref,15,2.70805020110221
sleep-disordered,14,2.6390573296152584
announcement,14,2.6390573296152584
Tmax,14,2.6390573296152584
HIA,14,2.6390573296152584
5-8,14,2.6390573296152584
PEA,14,2.6390573296152584
uncontrollable,14,2.6390573296152584
Wastewater,14,2.6390573296152584
NTG,14,2.6390573296152584
Rigorous,14,2.6390573296152584
remembered,14,2.6390573296152584
459,14,2.6390573296152584
lend,14,2.6390573296152584
PB1-F2,14,2.6390573296152584
BRFSS,14,2.6390573296152584
SARP,14,2.6390573296152584
demise,14,2.6390573296152584
509,14,2.6390573296152584
archival,14,2.6390573296152584
orchestrated,14,2.6390573296152584
18th,14,2.6390573296152584
motions,14,2.6390573296152584
non-eosinophilic,14,2.6390573296152584
humanistic,14,2.6390573296152584
efficiencies,14,2.6390573296152584
Trevo,14,2.6390573296152584
fenoterol,14,2.6390573296152584
non-respiratory,14,2.6390573296152584
epithelia,14,2.6390573296152584
Fifty-four,14,2.6390573296152584
2030,14,2.6390573296152584
shield,14,2.6390573296152584
LDL-C,14,2.6390573296152584
Pubmed,14,2.6390573296152584
entail,14,2.6390573296152584
diaschisis,14,2.6390573296152584
crucially,14,2.6390573296152584
unfamiliar,14,2.6390573296152584
HIS,14,2.6390573296152584
underrepresented,14,2.6390573296152584
correctable,14,2.6390573296152584
unity,14,2.6390573296152584
QI,14,2.6390573296152584
Distribution,14,2.6390573296152584
excessively,14,2.6390573296152584
manpower,14,2.6390573296152584
977,14,2.6390573296152584
200405,14,2.6390573296152584
typesubtype,14,2.6390573296152584
biophysical,14,2.6390573296152584
pathomechanism,14,2.6390573296152584
AAI,14,2.6390573296152584
polyprotein,14,2.6390573296152584
GDR,14,2.6390573296152584
three-month,14,2.6390573296152584
hypothyroidism,14,2.6390573296152584
isotype,14,2.6390573296152584
≥50,14,2.6390573296152584
clients,14,2.6390573296152584
intra,14,2.6390573296152584
blindness,14,2.6390573296152584
Rican,14,2.6390573296152584
credibility,14,2.6390573296152584
sagittal,14,2.6390573296152584
538,14,2.6390573296152584
losartan,14,2.6390573296152584
percutaneously,14,2.6390573296152584
Excluding,14,2.6390573296152584
impairing,14,2.6390573296152584
neurosurgery,14,2.6390573296152584
Immunity,14,2.6390573296152584
Mounting,14,2.6390573296152584
stranded,14,2.6390573296152584
559,14,2.6390573296152584
refuse,14,2.6390573296152584
PaO2FiO2,14,2.6390573296152584
1960,14,2.6390573296152584
toddlers,14,2.6390573296152584
symmetrical,14,2.6390573296152584
purported,14,2.6390573296152584
Values,14,2.6390573296152584
24-year-old,14,2.6390573296152584
one-quarter,14,2.6390573296152584
streamline,14,2.6390573296152584
predetermined,14,2.6390573296152584
adiponectin,14,2.6390573296152584
atomic,14,2.6390573296152584
MRC,14,2.6390573296152584
segregation,14,2.6390573296152584
secular,14,2.6390573296152584
Sixty-three,14,2.6390573296152584
multiethnic,14,2.6390573296152584
multidetector,14,2.6390573296152584
therapist,14,2.6390573296152584
hydrocephalus,14,2.6390573296152584
483,14,2.6390573296152584
Motivation,14,2.6390573296152584
socioeconomically,14,2.6390573296152584
H6,14,2.6390573296152584
nsp1,14,2.6390573296152584
inferring,14,2.6390573296152584
incriminated,14,2.6390573296152584
reflexes,14,2.6390573296152584
non-steroidal,14,2.6390573296152584
Transplant,14,2.6390573296152584
SLPs,14,2.6390573296152584
unfolded,14,2.6390573296152584
aches,14,2.6390573296152584
201314,14,2.6390573296152584
relapsing,14,2.6390573296152584
tail,14,2.6390573296152584
456,14,2.6390573296152584
hotspot,14,2.6390573296152584
synchronous,14,2.6390573296152584
738,14,2.6390573296152584
lately,14,2.6390573296152584
membership,14,2.6390573296152584
end-point,14,2.6390573296152584
essence,14,2.6390573296152584
centred,14,2.6390573296152584
influent,14,2.6390573296152584
separating,14,2.6390573296152584
Relatively,14,2.6390573296152584
Shock,14,2.6390573296152584
Exacerbation,14,2.6390573296152584
Variables,14,2.6390573296152584
doubles,14,2.6390573296152584
elected,14,2.6390573296152584
foetus,14,2.6390573296152584
army,14,2.6390573296152584
attacked,14,2.6390573296152584
ex-smokers,14,2.6390573296152584
aHR,14,2.6390573296152584
Kong168,14,2.6390573296152584
kindergarten,14,2.6390573296152584
interrelationships,14,2.6390573296152584
allergist,14,2.6390573296152584
SARSCoV-2,14,2.6390573296152584
MMF,14,2.6390573296152584
chemoattractant,14,2.6390573296152584
dyslipidaemia,14,2.6390573296152584
nonrespiratory,14,2.6390573296152584
mammary,14,2.6390573296152584
Recommended,14,2.6390573296152584
mathematically,14,2.6390573296152584
robustly,14,2.6390573296152584
HDAC1,14,2.6390573296152584
201718,14,2.6390573296152584
Droplet,14,2.6390573296152584
granzyme,14,2.6390573296152584
paraclinical,14,2.6390573296152584
polypeptide,14,2.6390573296152584
expressive,14,2.6390573296152584
prematurity,14,2.6390573296152584
ACEIs,14,2.6390573296152584
disequilibrium,14,2.6390573296152584
568,14,2.6390573296152584
Mood,14,2.6390573296152584
admit,14,2.6390573296152584
liter,14,2.6390573296152584
Zagreb,14,2.6390573296152584
IL-37,14,2.6390573296152584
safest,14,2.6390573296152584
heterozygous,14,2.6390573296152584
ST-depression,14,2.6390573296152584
Adding,14,2.6390573296152584
endosomal,14,2.6390573296152584
lentiviral,14,2.6390573296152584
monetary,14,2.6390573296152584
10-12,14,2.6390573296152584
Specimens,14,2.6390573296152584
Adjustment,14,2.6390573296152584
3-fold,14,2.6390573296152584
Damage,14,2.6390573296152584
pictures,14,2.6390573296152584
enquiry,14,2.6390573296152584
Regions,14,2.6390573296152584
warming,14,2.6390573296152584
Injury,14,2.6390573296152584
DNT,14,2.6390573296152584
daycare,14,2.6390573296152584
SAVR,14,2.6390573296152584
suicide,14,2.6390573296152584
l,14,2.6390573296152584
Meeting,14,2.6390573296152584
multiscale,14,2.6390573296152584
Intranasal,14,2.6390573296152584
fulfil,14,2.6390573296152584
MRI-based,14,2.6390573296152584
827,14,2.6390573296152584
attach,14,2.6390573296152584
Expiratory,14,2.6390573296152584
Shenzhen,14,2.6390573296152584
synergies,14,2.6390573296152584
single-cell,14,2.6390573296152584
underlining,14,2.6390573296152584
Descriptive,14,2.6390573296152584
855,14,2.6390573296152584
LVADs,14,2.6390573296152584
CHIM,14,2.6390573296152584
da,14,2.6390573296152584
extant,14,2.6390573296152584
60-80,14,2.6390573296152584
H2O2,14,2.6390573296152584
TE,14,2.6390573296152584
acknowledging,14,2.6390573296152584
parkinsonism,14,2.6390573296152584
commoner,14,2.6390573296152584
BR,14,2.6390573296152584
DDA,14,2.6390573296152584
LTC4,14,2.6390573296152584
AAV,14,2.6390573296152584
rs12252,14,2.6390573296152584
SW,14,2.6390573296152584
Mast,14,2.6390573296152584
1890,14,2.6390573296152584
bimodal,14,2.6390573296152584
utilities,14,2.6390573296152584
sterile,14,2.6390573296152584
metapopulation,14,2.6390573296152584
subphenotypes,14,2.6390573296152584
bivalent,14,2.6390573296152584
534,14,2.6390573296152584
radius,14,2.6390573296152584
interrupting,14,2.6390573296152584
stimulants,14,2.6390573296152584
pred,14,2.6390573296152584
quit,14,2.6390573296152584
IDV,14,2.6390573296152584
Sixty-two,14,2.6390573296152584
702,14,2.6390573296152584
Assuming,14,2.6390573296152584
APSAC,14,2.6390573296152584
subjectively,14,2.6390573296152584
recovers,14,2.6390573296152584
subcutaneously,14,2.6390573296152584
epigenetics,14,2.6390573296152584
histochemical,14,2.6390573296152584
dimer,14,2.6390573296152584
neighbor,14,2.6390573296152584
ICV,14,2.6390573296152584
Quadrivalent,14,2.6390573296152584
IPD,14,2.6390573296152584
accommodation,14,2.6390573296152584
setup,14,2.6390573296152584
AUCs,14,2.6390573296152584
calf,14,2.6390573296152584
Progressive,14,2.6390573296152584
840,14,2.6390573296152584
Emirates,14,2.6390573296152584
Known,14,2.6390573296152584
TCA,14,2.6390573296152584
boarding,14,2.6390573296152584
screenings,14,2.6390573296152584
MHV,14,2.6390573296152584
injecting,14,2.6390573296152584
≤5,14,2.6390573296152584
FBG,14,2.6390573296152584
393,14,2.6390573296152584
1400,14,2.6390573296152584
scars,14,2.6390573296152584
418,14,2.6390573296152584
trade-offs,14,2.6390573296152584
underappreciated,14,2.6390573296152584
pharmacogenetic,14,2.6390573296152584
lymphopoietin,14,2.6390573296152584
alkaloids,14,2.6390573296152584
mesothelioma,14,2.6390573296152584
buffers,14,2.6390573296152584
Circadian,14,2.6390573296152584
joined,14,2.6390573296152584
simulator,14,2.6390573296152584
hopeful,14,2.6390573296152584
Zn,14,2.6390573296152584
ADAMTS13,14,2.6390573296152584
Genetics,14,2.6390573296152584
Robert,14,2.6390573296152584
Lifestyle,14,2.6390573296152584
paradoxus,14,2.6390573296152584
favoured,14,2.6390573296152584
stannous,14,2.6390573296152584
elders,14,2.6390573296152584
dissected,14,2.6390573296152584
spirometer,14,2.6390573296152584
draining,14,2.6390573296152584
sequel,14,2.6390573296152584
Ca2,14,2.6390573296152584
TPE,14,2.6390573296152584
conceivable,14,2.6390573296152584
claiming,14,2.6390573296152584
mainstream,14,2.6390573296152584
methylene,14,2.6390573296152584
963,14,2.6390573296152584
immune-related,14,2.6390573296152584
lesioned,14,2.6390573296152584
variably,14,2.6390573296152584
embrace,14,2.6390573296152584
Transthoracic,14,2.6390573296152584
hyperresponsive,14,2.6390573296152584
nebulizers,14,2.6390573296152584
jet,14,2.6390573296152584
widened,14,2.6390573296152584
primer-probe,14,2.6390573296152584
593,14,2.6390573296152584
reconsidered,14,2.6390573296152584
neuropathological,14,2.6390573296152584
sex-based,14,2.6390573296152584
remnant,14,2.6390573296152584
nonrandomized,14,2.6390573296152584
Delphi,14,2.6390573296152584
inhomogeneity,14,2.6390573296152584
0031,14,2.6390573296152584
spoke,14,2.6390573296152584
amplifies,14,2.6390573296152584
synthesise,14,2.6390573296152584
unpublished,14,2.6390573296152584
bridges,14,2.6390573296152584
Theoretically,14,2.6390573296152584
LAH,14,2.6390573296152584
earthquake,14,2.6390573296152584
prostaglandin,14,2.6390573296152584
Drawing,14,2.6390573296152584
Neutralization,14,2.6390573296152584
misperceptions,14,2.6390573296152584
Challenge,14,2.6390573296152584
756,14,2.6390573296152584
≥75,14,2.6390573296152584
partitioning,14,2.6390573296152584
USD,14,2.6390573296152584
CAA,14,2.6390573296152584
537,14,2.6390573296152584
DW,14,2.6390573296152584
SRC,14,2.6390573296152584
bypassing,14,2.6390573296152584
neurotransmitters,14,2.6390573296152584
IL,14,2.6390573296152584
Dyspnea,14,2.6390573296152584
Technologies,14,2.6390573296152584
denervation,14,2.6390573296152584
AEFI,14,2.6390573296152584
Rotterdam,14,2.6390573296152584
grant,14,2.6390573296152584
overlay,14,2.6390573296152584
ought,14,2.6390573296152584
sheet,14,2.6390573296152584
50000,14,2.6390573296152584
ACEI,14,2.6390573296152584
shelter,14,2.6390573296152584
Societies,14,2.6390573296152584
intersection,14,2.6390573296152584
pulmonologist,14,2.6390573296152584
Editorial,14,2.6390573296152584
cardioplegic,14,2.6390573296152584
grounded,14,2.6390573296152584
assigning,14,2.6390573296152584
Zinc,14,2.6390573296152584
invested,14,2.6390573296152584
quantum,14,2.6390573296152584
TW,14,2.6390573296152584
Atherosclerotic,14,2.6390573296152584
habitual,14,2.6390573296152584
attitudinal,14,2.6390573296152584
coronaviral,14,2.6390573296152584
ESWI,14,2.6390573296152584
Totally,14,2.6390573296152584
Northeast,14,2.6390573296152584
20I501YV1,14,2.6390573296152584
Dementia,14,2.6390573296152584
876,14,2.6390573296152584
spastic,14,2.6390573296152584
cross-react,14,2.6390573296152584
factor-α,14,2.6390573296152584
Dysphagia,14,2.6390573296152584
regenerate,14,2.6390573296152584
posttreatment,14,2.6390573296152584
whole-virion,14,2.6390573296152584
transvenous,14,2.6390573296152584
IVD,14,2.6390573296152584
echoes,14,2.6390573296152584
Nitrates,14,2.6390573296152584
supernatant,14,2.6390573296152584
806,14,2.6390573296152584
two-vessel,14,2.6390573296152584
Strategic,14,2.6390573296152584
SVO,14,2.6390573296152584
tubular,14,2.6390573296152584
jurisdiction,14,2.6390573296152584
timelines,14,2.6390573296152584
glycine,14,2.6390573296152584
granular,14,2.6390573296152584
realm,14,2.6390573296152584
mlmin,14,2.6390573296152584
neurohumoral,14,2.6390573296152584
Included,14,2.6390573296152584
2-adrenergic,14,2.6390573296152584
vasodilatation,14,2.6390573296152584
ORF7a,14,2.6390573296152584
ORF6,14,2.6390573296152584
wastewater-based,14,2.6390573296152584
consultants,14,2.6390573296152584
attendances,14,2.6390573296152584
pixel,14,2.6390573296152584
25-64,14,2.6390573296152584
Tanzania,14,2.6390573296152584
Siriraj,14,2.6390573296152584
872,14,2.6390573296152584
burdened,14,2.6390573296152584
hereafter,14,2.6390573296152584
Families,14,2.6390573296152584
localizing,14,2.6390573296152584
site-specific,14,2.6390573296152584
inadvertently,14,2.6390573296152584
dipping,14,2.6390573296152584
6-10,14,2.6390573296152584
KEGG,14,2.6390573296152584
granulocyte,14,2.6390573296152584
hMPV,14,2.6390573296152584
colony,14,2.6390573296152584
INF,14,2.6390573296152584
emphasises,14,2.6390573296152584
Welfare,14,2.6390573296152584
54-year-old,14,2.6390573296152584
Hyperglycemia,14,2.6390573296152584
fluticasone,14,2.6390573296152584
Low-dose,14,2.6390573296152584
resided,14,2.6390573296152584
512,14,2.6390573296152584
prioritisation,14,2.6390573296152584
digestion,14,2.6390573296152584
certificate,14,2.6390573296152584
Structured,14,2.6390573296152584
CVEs,14,2.6390573296152584
finished,14,2.6390573296152584
arrays,14,2.6390573296152584
pinpoint,14,2.6390573296152584
arteriolar,14,2.6390573296152584
EX,14,2.6390573296152584
engineers,14,2.6390573296152584
solidarity,14,2.6390573296152584
vWF,14,2.6390573296152584
outperforms,14,2.6390573296152584
Academic,14,2.6390573296152584
stories,14,2.6390573296152584
illuminate,14,2.6390573296152584
anastomotic,14,2.6390573296152584
interhospital,14,2.6390573296152584
Perspective,14,2.6390573296152584
satisfying,14,2.6390573296152584
remedial,14,2.6390573296152584
ectodomain,14,2.6390573296152584
mHealth,14,2.6390573296152584
cattle,14,2.6390573296152584
anaesthetic,14,2.6390573296152584
commented,14,2.6390573296152584
plotted,14,2.6390573296152584
believing,14,2.6390573296152584
AHRE,14,2.6390573296152584
laparoscopic,14,2.6390573296152584
DT,14,2.6390573296152584
EPO,14,2.6390573296152584
Belt,14,2.6390573296152584
elder,14,2.6390573296152584
curcumin,14,2.6390573296152584
TDC,14,2.6390573296152584
CCC,14,2.6390573296152584
UE,14,2.6390573296152584
Millions,14,2.6390573296152584
two-,14,2.6390573296152584
inhalative,14,2.6390573296152584
discontinue,14,2.6390573296152584
Cytokines,14,2.6390573296152584
mid-October,14,2.6390573296152584
WA,14,2.6390573296152584
VO2max,14,2.6390573296152584
0-6,14,2.6390573296152584
inducer,14,2.6390573296152584
land,14,2.6390573296152584
molecularly,14,2.6390573296152584
prevail,14,2.6390573296152584
post-infectious,14,2.6390573296152584
overlapped,14,2.6390573296152584
microV,14,2.6390573296152584
CQ,14,2.6390573296152584
Pleural,14,2.6390573296152584
GMT,14,2.6390573296152584
Modification,14,2.6390573296152584
heme,14,2.6390573296152584
Preferred,14,2.6390573296152584
ambulances,14,2.6390573296152584
owned,14,2.6390573296152584
collects,14,2.6390573296152584
arrests,14,2.6390573296152584
requests,14,2.6390573296152584
811,14,2.6390573296152584
weapons,14,2.6390573296152584
ports,14,2.6390573296152584
nonsustained,14,2.6390573296152584
COVID-,14,2.6390573296152584
Lancet,14,2.6390573296152584
colon,14,2.6390573296152584
caudate,14,2.6390573296152584
studys,14,2.6390573296152584
anistreplase,14,2.6390573296152584
wrist,14,2.6390573296152584
Studying,14,2.6390573296152584
negativity,14,2.6390573296152584
RealTime,14,2.6390573296152584
pectus,14,2.6390573296152584
contacting,14,2.6390573296152584
ANOVA,14,2.6390573296152584
Implementing,14,2.6390573296152584
decompression,14,2.6390573296152584
Mann-Whitney,14,2.6390573296152584
helicase,14,2.6390573296152584
sprays,14,2.6390573296152584
atresia,14,2.6390573296152584
Towards,14,2.6390573296152584
Epstein-Barr,14,2.6390573296152584
perforator,14,2.6390573296152584
mRNA-LNP,14,2.6390573296152584
sensibility,14,2.6390573296152584
antioxidative,14,2.6390573296152584
CPPs,14,2.6390573296152584
ovarian,14,2.6390573296152584
Remarkably,14,2.6390573296152584
generalizable,14,2.6390573296152584
additives,14,2.6390573296152584
Nigerian,14,2.6390573296152584
miles,14,2.6390573296152584
re-evaluated,14,2.6390573296152584
parsimonious,14,2.6390573296152584
capsules,14,2.6390573296152584
45-year-old,14,2.6390573296152584
pgmL,14,2.6390573296152584
RLS,14,2.6390573296152584
Matrix,14,2.6390573296152584
compete,14,2.6390573296152584
swabbed,14,2.6390573296152584
APA,14,2.6390573296152584
956,14,2.6390573296152584
myofibroblasts,14,2.6390573296152584
tell,14,2.6390573296152584
fiberoptic,14,2.6390573296152584
ILS,14,2.6390573296152584
hemithorax,14,2.6390573296152584
overrepresented,14,2.6390573296152584
Nanopore,14,2.6390573296152584
trimers,14,2.6390573296152584
IL-33,14,2.6390573296152584
carbachol,14,2.6390573296152584
underrecognized,14,2.6390573296152584
computer-based,14,2.6390573296152584
524,14,2.6390573296152584
infarctionABSTRACT,14,2.6390573296152584
MAb,14,2.6390573296152584
anticipating,14,2.6390573296152584
directing,14,2.6390573296152584
estrogens,14,2.6390573296152584
Diamond,14,2.6390573296152584
EP,14,2.6390573296152584
43-year-old,14,2.6390573296152584
interspaced,14,2.6390573296152584
vaginal,14,2.6390573296152584
foetal,14,2.6390573296152584
HbSS,14,2.6390573296152584
under-,14,2.6390573296152584
long-lived,14,2.6390573296152584
hearing,14,2.6390573296152584
Hand,14,2.6390573296152584
ICD-10,14,2.6390573296152584
APR834,14,2.6390573296152584
ignoring,14,2.6390573296152584
Length,14,2.6390573296152584
B-,14,2.6390573296152584
867,14,2.6390573296152584
brachial,14,2.6390573296152584
846,14,2.6390573296152584
submaximum,14,2.6390573296152584
666,14,2.6390573296152584
hemolysis,14,2.6390573296152584
scarcely,14,2.6390573296152584
singing,14,2.6390573296152584
exposition,14,2.6390573296152584
Chilean,14,2.6390573296152584
milestone,14,2.6390573296152584
Forty-seven,14,2.6390573296152584
Georges,14,2.6390573296152584
Resources,14,2.6390573296152584
blood-based,14,2.6390573296152584
912,14,2.6390573296152584
992,14,2.6390573296152584
NAG,14,2.6390573296152584
tour,14,2.6390573296152584
noon,14,2.6390573296152584
Two-thirds,14,2.6390573296152584
palindromic,14,2.6390573296152584
closed-chest,14,2.6390573296152584
wane,14,2.6390573296152584
TVR,14,2.6390573296152584
unwillingness,14,2.6390573296152584
kg-1,14,2.6390573296152584
inequality,14,2.6390573296152584
588,14,2.6390573296152584
resides,14,2.6390573296152584
Guidance,14,2.6390573296152584
HLH,14,2.6390573296152584
plain,14,2.6390573296152584
ends,14,2.6390573296152584
TIVs,13,2.5649493574615367
Laboratory-based,13,2.5649493574615367
EGFR,13,2.5649493574615367
inconsistency,13,2.5649493574615367
544,13,2.5649493574615367
2019-novel,13,2.5649493574615367
SPR,13,2.5649493574615367
633,13,2.5649493574615367
Growing,13,2.5649493574615367
Mycobacterium,13,2.5649493574615367
719,13,2.5649493574615367
virus-neutralizing,13,2.5649493574615367
vaccinee,13,2.5649493574615367
Limitations,13,2.5649493574615367
neurotransmitter,13,2.5649493574615367
Santa,13,2.5649493574615367
Cocaine,13,2.5649493574615367
derangements,13,2.5649493574615367
Avoiding,13,2.5649493574615367
antipyretic,13,2.5649493574615367
spiral,13,2.5649493574615367
senile,13,2.5649493574615367
D3,13,2.5649493574615367
n11,13,2.5649493574615367
Faculty,13,2.5649493574615367
clinicopathological,13,2.5649493574615367
neurologically,13,2.5649493574615367
EPI,13,2.5649493574615367
507,13,2.5649493574615367
1917,13,2.5649493574615367
bar,13,2.5649493574615367
burning,13,2.5649493574615367
Volunteers,13,2.5649493574615367
nodules,13,2.5649493574615367
frontier,13,2.5649493574615367
Alliance,13,2.5649493574615367
praecordial,13,2.5649493574615367
596,13,2.5649493574615367
uncovering,13,2.5649493574615367
min-1,13,2.5649493574615367
genotypic,13,2.5649493574615367
out-patients,13,2.5649493574615367
endocardium,13,2.5649493574615367
claudication,13,2.5649493574615367
interestingly,13,2.5649493574615367
annotated,13,2.5649493574615367
purifying,13,2.5649493574615367
test-positive,13,2.5649493574615367
relaxed,13,2.5649493574615367
PEDV,13,2.5649493574615367
lymphoblastic,13,2.5649493574615367
neuroinflammatory,13,2.5649493574615367
PMN,13,2.5649493574615367
hijack,13,2.5649493574615367
non-asthmatics,13,2.5649493574615367
sudden-onset,13,2.5649493574615367
923,13,2.5649493574615367
842,13,2.5649493574615367
excellence,13,2.5649493574615367
blinding,13,2.5649493574615367
lifted,13,2.5649493574615367
488,13,2.5649493574615367
Thrombotic,13,2.5649493574615367
Tc,13,2.5649493574615367
TPB,13,2.5649493574615367
atorvastatin,13,2.5649493574615367
eighteen,13,2.5649493574615367
dupilumab,13,2.5649493574615367
depicts,13,2.5649493574615367
838,13,2.5649493574615367
medium-sized,13,2.5649493574615367
7-14,13,2.5649493574615367
eclampsia,13,2.5649493574615367
rotational,13,2.5649493574615367
Jewish,13,2.5649493574615367
683,13,2.5649493574615367
numbness,13,2.5649493574615367
COVID-19-infected,13,2.5649493574615367
PRoFESS,13,2.5649493574615367
MF,13,2.5649493574615367
O-glycosylation,13,2.5649493574615367
leveraging,13,2.5649493574615367
accuracies,13,2.5649493574615367
Fifty-seven,13,2.5649493574615367
MMS,13,2.5649493574615367
facile,13,2.5649493574615367
bronchoconstrictive,13,2.5649493574615367
nonasthmatics,13,2.5649493574615367
fueled,13,2.5649493574615367
snapshot,13,2.5649493574615367
arrangement,13,2.5649493574615367
VWF,13,2.5649493574615367
919,13,2.5649493574615367
Clusters,13,2.5649493574615367
purchasing,13,2.5649493574615367
MCAo,13,2.5649493574615367
weaken,13,2.5649493574615367
infarction-related,13,2.5649493574615367
Supplemental,13,2.5649493574615367
drug-induced,13,2.5649493574615367
professions,13,2.5649493574615367
26-year-old,13,2.5649493574615367
polymeric,13,2.5649493574615367
Edinburgh,13,2.5649493574615367
transcription-quantitative,13,2.5649493574615367
averages,13,2.5649493574615367
584,13,2.5649493574615367
redundant,13,2.5649493574615367
69-year-old,13,2.5649493574615367
catchment,13,2.5649493574615367
apolipoprotein,13,2.5649493574615367
722,13,2.5649493574615367
NOx,13,2.5649493574615367
predilection,13,2.5649493574615367
CSOE,13,2.5649493574615367
multisystemic,13,2.5649493574615367
weekdays,13,2.5649493574615367
Self-reported,13,2.5649493574615367
signify,13,2.5649493574615367
1600,13,2.5649493574615367
n10,13,2.5649493574615367
662,13,2.5649493574615367
QuickVue,13,2.5649493574615367
K417N,13,2.5649493574615367
speculative,13,2.5649493574615367
clamping,13,2.5649493574615367
Ultrasound,13,2.5649493574615367
river,13,2.5649493574615367
NHPs,13,2.5649493574615367
ray,13,2.5649493574615367
ascites,13,2.5649493574615367
sided,13,2.5649493574615367
Uptake,13,2.5649493574615367
commercialized,13,2.5649493574615367
glycogen,13,2.5649493574615367
14090,13,2.5649493574615367
MSCT,13,2.5649493574615367
Fifty-two,13,2.5649493574615367
RealStar,13,2.5649493574615367
isotypes,13,2.5649493574615367
≥14,13,2.5649493574615367
Feline,13,2.5649493574615367
trypsin,13,2.5649493574615367
VADs,13,2.5649493574615367
sBPT,13,2.5649493574615367
migrant,13,2.5649493574615367
anti-,13,2.5649493574615367
15-year-old,13,2.5649493574615367
weekday,13,2.5649493574615367
actin,13,2.5649493574615367
resistive,13,2.5649493574615367
APN,13,2.5649493574615367
641,13,2.5649493574615367
Decision,13,2.5649493574615367
characteristically,13,2.5649493574615367
amplifying,13,2.5649493574615367
accidentally,13,2.5649493574615367
frustrating,13,2.5649493574615367
6-23,13,2.5649493574615367
586,13,2.5649493574615367
recognizable,13,2.5649493574615367
bond,13,2.5649493574615367
prefecture,13,2.5649493574615367
age-associated,13,2.5649493574615367
S3,13,2.5649493574615367
incapacity,13,2.5649493574615367
at-home,13,2.5649493574615367
cool,13,2.5649493574615367
psychomotor,13,2.5649493574615367
electrophysiology,13,2.5649493574615367
graphical,13,2.5649493574615367
nuanced,13,2.5649493574615367
SDH,13,2.5649493574615367
dPdt,13,2.5649493574615367
IUl,13,2.5649493574615367
coronaries,13,2.5649493574615367
Multisystem,13,2.5649493574615367
weekend,13,2.5649493574615367
feet,13,2.5649493574615367
Sharing,13,2.5649493574615367
lessening,13,2.5649493574615367
succumb,13,2.5649493574615367
Mx1,13,2.5649493574615367
deadliest,13,2.5649493574615367
Intra-arterial,13,2.5649493574615367
fabrication,13,2.5649493574615367
jump,13,2.5649493574615367
vicinity,13,2.5649493574615367
suboptimally,13,2.5649493574615367
abstracted,13,2.5649493574615367
964,13,2.5649493574615367
predominately,13,2.5649493574615367
Th,13,2.5649493574615367
disturb,13,2.5649493574615367
caffeine,13,2.5649493574615367
622,13,2.5649493574615367
12-week,13,2.5649493574615367
Concomitant,13,2.5649493574615367
627,13,2.5649493574615367
MMEF,13,2.5649493574615367
Neural,13,2.5649493574615367
visibility,13,2.5649493574615367
bird-to-human,13,2.5649493574615367
profiled,13,2.5649493574615367
Clear,13,2.5649493574615367
experimentation,13,2.5649493574615367
Endothelial,13,2.5649493574615367
603,13,2.5649493574615367
Fifty-one,13,2.5649493574615367
repeatability,13,2.5649493574615367
868,13,2.5649493574615367
January-March,13,2.5649493574615367
SHRSPIzm,13,2.5649493574615367
QRST,13,2.5649493574615367
IQRST,13,2.5649493574615367
CPA,13,2.5649493574615367
GCS,13,2.5649493574615367
PSS,13,2.5649493574615367
Analyzing,13,2.5649493574615367
MMWR,13,2.5649493574615367
1010,13,2.5649493574615367
exhalation,13,2.5649493574615367
pancreas,13,2.5649493574615367
antithrombotics,13,2.5649493574615367
years-old,13,2.5649493574615367
V1-V3,13,2.5649493574615367
allergenicity,13,2.5649493574615367
LH,13,2.5649493574615367
peri-procedural,13,2.5649493574615367
514,13,2.5649493574615367
Director,13,2.5649493574615367
regionalization,13,2.5649493574615367
451,13,2.5649493574615367
Circulation,13,2.5649493574615367
vapor,13,2.5649493574615367
hemagglutination-inhibiting,13,2.5649493574615367
zileuton,13,2.5649493574615367
pore,13,2.5649493574615367
regain,13,2.5649493574615367
religion,13,2.5649493574615367
MF59-adjuvanted,13,2.5649493574615367
traces,13,2.5649493574615367
453,13,2.5649493574615367
allergologic,13,2.5649493574615367
Multimodal,13,2.5649493574615367
peak-flow,13,2.5649493574615367
communitys,13,2.5649493574615367
Availability,13,2.5649493574615367
postures,13,2.5649493574615367
overarching,13,2.5649493574615367
membranous,13,2.5649493574615367
demography,13,2.5649493574615367
puzzle,13,2.5649493574615367
10-14,13,2.5649493574615367
T2-high,13,2.5649493574615367
life-year,13,2.5649493574615367
971,13,2.5649493574615367
598,13,2.5649493574615367
junctions,13,2.5649493574615367
GA2LEN,13,2.5649493574615367
non-healthcare,13,2.5649493574615367
HHT,13,2.5649493574615367
hyaluronic,13,2.5649493574615367
platinum,13,2.5649493574615367
deriving,13,2.5649493574615367
IAM,13,2.5649493574615367
ulcer,13,2.5649493574615367
ecologic,13,2.5649493574615367
vegetations,13,2.5649493574615367
sized,13,2.5649493574615367
prices,13,2.5649493574615367
SAF,13,2.5649493574615367
ADP,13,2.5649493574615367
dated,13,2.5649493574615367
BOLD,13,2.5649493574615367
assistant,13,2.5649493574615367
695,13,2.5649493574615367
self-regulation,13,2.5649493574615367
628,13,2.5649493574615367
nonhemorrhagic,13,2.5649493574615367
10-day,13,2.5649493574615367
Insight,13,2.5649493574615367
fog,13,2.5649493574615367
dark,13,2.5649493574615367
Antibiotics,13,2.5649493574615367
PTB,13,2.5649493574615367
sizable,13,2.5649493574615367
Referral,13,2.5649493574615367
PAMI,13,2.5649493574615367
angiographies,13,2.5649493574615367
remember,13,2.5649493574615367
isoform,13,2.5649493574615367
EHR,13,2.5649493574615367
Seegene,13,2.5649493574615367
vasomotor,13,2.5649493574615367
Brugada,13,2.5649493574615367
reevaluation,13,2.5649493574615367
accelerometers,13,2.5649493574615367
anteriorly,13,2.5649493574615367
triglyceride,13,2.5649493574615367
27-year-old,13,2.5649493574615367
S477N,13,2.5649493574615367
ticagrelor,13,2.5649493574615367
perindopril,13,2.5649493574615367
governed,13,2.5649493574615367
Youdens,13,2.5649493574615367
Distal,13,2.5649493574615367
mild-moderate,13,2.5649493574615367
927,13,2.5649493574615367
747,13,2.5649493574615367
PBM,13,2.5649493574615367
glutamic,13,2.5649493574615367
ALP,13,2.5649493574615367
stayed,13,2.5649493574615367
witnessing,13,2.5649493574615367
Anticoagulant,13,2.5649493574615367
premenopausal,13,2.5649493574615367
Speed,13,2.5649493574615367
histocompatibility,13,2.5649493574615367
withholding,13,2.5649493574615367
864,13,2.5649493574615367
Aptima,13,2.5649493574615367
PEPLVET,13,2.5649493574615367
MH,13,2.5649493574615367
cardioverter-defibrillator,13,2.5649493574615367
unconventional,13,2.5649493574615367
THE,13,2.5649493574615367
Inner-City,13,2.5649493574615367
631,13,2.5649493574615367
stroke-associated,13,2.5649493574615367
seventy,13,2.5649493574615367
2-month,13,2.5649493574615367
one-vessel,13,2.5649493574615367
PubChem,13,2.5649493574615367
20032004,13,2.5649493574615367
fare,13,2.5649493574615367
thrombocytosis,13,2.5649493574615367
paving,13,2.5649493574615367
pressurized,13,2.5649493574615367
epicentre,13,2.5649493574615367
723,13,2.5649493574615367
converge,13,2.5649493574615367
annotation,13,2.5649493574615367
H4,13,2.5649493574615367
rainy,13,2.5649493574615367
resist,13,2.5649493574615367
UVC,13,2.5649493574615367
needling,13,2.5649493574615367
provisions,13,2.5649493574615367
banding,13,2.5649493574615367
timepoints,13,2.5649493574615367
VLSM,13,2.5649493574615367
NICE,13,2.5649493574615367
3CL,13,2.5649493574615367
99mTc,13,2.5649493574615367
48-year-old,13,2.5649493574615367
page,13,2.5649493574615367
migraines,13,2.5649493574615367
convulsion,13,2.5649493574615367
originates,13,2.5649493574615367
celiac,13,2.5649493574615367
AIANs,13,2.5649493574615367
cutoffs,13,2.5649493574615367
697,13,2.5649493574615367
agreements,13,2.5649493574615367
Artemisia,13,2.5649493574615367
paravertebral,13,2.5649493574615367
aspirated,13,2.5649493574615367
climbing,13,2.5649493574615367
MB-CK,13,2.5649493574615367
facilitation,13,2.5649493574615367
3-year-old,13,2.5649493574615367
Lanka,13,2.5649493574615367
UAP,13,2.5649493574615367
1918-20,13,2.5649493574615367
recalled,13,2.5649493574615367
Madagascar,13,2.5649493574615367
Interest,13,2.5649493574615367
pneumonectomy,13,2.5649493574615367
930,13,2.5649493574615367
nem,13,2.5649493574615367
volt,13,2.5649493574615367
dinucleotide,13,2.5649493574615367
instable,13,2.5649493574615367
hyperperfusion,13,2.5649493574615367
sphincter,13,2.5649493574615367
Final,13,2.5649493574615367
yes,13,2.5649493574615367
Java,13,2.5649493574615367
BrdU,13,2.5649493574615367
757,13,2.5649493574615367
deploying,13,2.5649493574615367
curtailing,13,2.5649493574615367
Multivessel,13,2.5649493574615367
885,13,2.5649493574615367
paternal,13,2.5649493574615367
soy,13,2.5649493574615367
alcoholic,13,2.5649493574615367
repurpose,13,2.5649493574615367
exploitation,13,2.5649493574615367
LDTs,13,2.5649493574615367
basophil,13,2.5649493574615367
Nln,13,2.5649493574615367
basing,13,2.5649493574615367
Sodium,13,2.5649493574615367
time-varying,13,2.5649493574615367
gastroenteritis,13,2.5649493574615367
Covishield,13,2.5649493574615367
CPK-MB,13,2.5649493574615367
892,13,2.5649493574615367
ethnicities,13,2.5649493574615367
NETs,13,2.5649493574615367
p003,13,2.5649493574615367
embolectomy,13,2.5649493574615367
permission,13,2.5649493574615367
tonsillectomy,13,2.5649493574615367
serous,13,2.5649493574615367
LCL,13,2.5649493574615367
463,13,2.5649493574615367
stimulator,13,2.5649493574615367
NINDS,13,2.5649493574615367
symptomology,13,2.5649493574615367
COVID-19-like,13,2.5649493574615367
stockings,13,2.5649493574615367
gender-related,13,2.5649493574615367
cineangiography,13,2.5649493574615367
periodontal,13,2.5649493574615367
methacholine-induced,13,2.5649493574615367
hyperhomocysteinemia,13,2.5649493574615367
post-bronchodilator,13,2.5649493574615367
561,13,2.5649493574615367
pluripotent,13,2.5649493574615367
pharmacodynamic,13,2.5649493574615367
vitality,13,2.5649493574615367
ICC,13,2.5649493574615367
asthenia,13,2.5649493574615367
Recurrence,13,2.5649493574615367
19-year-old,13,2.5649493574615367
mystery,13,2.5649493574615367
peanut,13,2.5649493574615367
vulnerabilities,13,2.5649493574615367
B6,13,2.5649493574615367
921,13,2.5649493574615367
sigmaST,13,2.5649493574615367
open-source,13,2.5649493574615367
environmentally,13,2.5649493574615367
Janssen,13,2.5649493574615367
commuter,13,2.5649493574615367
H10N8,13,2.5649493574615367
0046,13,2.5649493574615367
Census,13,2.5649493574615367
Rasch,13,2.5649493574615367
voice,13,2.5649493574615367
Postinfarction,13,2.5649493574615367
inflamed,13,2.5649493574615367
House,13,2.5649493574615367
reactors,13,2.5649493574615367
eruption,13,2.5649493574615367
germ,13,2.5649493574615367
0035,13,2.5649493574615367
hyperactive,13,2.5649493574615367
seafood,13,2.5649493574615367
bilaterally,13,2.5649493574615367
Forces,13,2.5649493574615367
non-selective,13,2.5649493574615367
Cities,13,2.5649493574615367
tape,13,2.5649493574615367
internalizing,13,2.5649493574615367
vaccinal,13,2.5649493574615367
4-,13,2.5649493574615367
pro-,13,2.5649493574615367
optimised,13,2.5649493574615367
constitutional,13,2.5649493574615367
SPET,13,2.5649493574615367
post-translational,13,2.5649493574615367
cocirculating,13,2.5649493574615367
P0003,13,2.5649493574615367
AH1N109,13,2.5649493574615367
automobile,13,2.5649493574615367
hindering,13,2.5649493574615367
allelic,13,2.5649493574615367
446,13,2.5649493574615367
glucose-lowering,13,2.5649493574615367
electroencephalogram,13,2.5649493574615367
antigen-based,13,2.5649493574615367
prostaglandins,13,2.5649493574615367
Online,13,2.5649493574615367
707,13,2.5649493574615367
photographs,13,2.5649493574615367
bladder,13,2.5649493574615367
706,13,2.5649493574615367
plateaued,13,2.5649493574615367
Seroconversion,13,2.5649493574615367
spherical,13,2.5649493574615367
myeloproliferative,13,2.5649493574615367
motivating,13,2.5649493574615367
ADRs,13,2.5649493574615367
Sgarbossa,13,2.5649493574615367
410,13,2.5649493574615367
periventricular,13,2.5649493574615367
cloned,13,2.5649493574615367
IVS,13,2.5649493574615367
574,13,2.5649493574615367
tall,13,2.5649493574615367
crosstalk,13,2.5649493574615367
Combination,13,2.5649493574615367
syringe,13,2.5649493574615367
IgE-dependent,13,2.5649493574615367
calcified,13,2.5649493574615367
labile,13,2.5649493574615367
scavenger,13,2.5649493574615367
cross-reaction,13,2.5649493574615367
rs,13,2.5649493574615367
underscoring,13,2.5649493574615367
age-appropriate,13,2.5649493574615367
Point,13,2.5649493574615367
mid-January,13,2.5649493574615367
aerodynamic,13,2.5649493574615367
MTX,13,2.5649493574615367
anti-arrhythmic,13,2.5649493574615367
EIS,13,2.5649493574615367
Stepwise,13,2.5649493574615367
discriminated,13,2.5649493574615367
etiologically,13,2.5649493574615367
PFR,13,2.5649493574615367
902,13,2.5649493574615367
complements,13,2.5649493574615367
NAIS,13,2.5649493574615367
30-minute,13,2.5649493574615367
housed,13,2.5649493574615367
Rarely,13,2.5649493574615367
937,13,2.5649493574615367
Wake-up,13,2.5649493574615367
457,13,2.5649493574615367
Pharmaceutical,13,2.5649493574615367
eosinopenia,13,2.5649493574615367
Backgroundobjectives,13,2.5649493574615367
tryptophan,13,2.5649493574615367
703,13,2.5649493574615367
unclassified,13,2.5649493574615367
parent-child,13,2.5649493574615367
Cholesterol,13,2.5649493574615367
impeding,13,2.5649493574615367
IL-12,13,2.5649493574615367
777,13,2.5649493574615367
199697,13,2.5649493574615367
Radionuclide,13,2.5649493574615367
Fourth,13,2.5649493574615367
CaW,13,2.5649493574615367
autophagic,13,2.5649493574615367
RT-RPA,13,2.5649493574615367
PAEDP,13,2.5649493574615367
OCT,13,2.5649493574615367
DH,13,2.5649493574615367
ARS,13,2.5649493574615367
hemoptysis,13,2.5649493574615367
Blue,13,2.5649493574615367
Senegal,13,2.5649493574615367
MBF,13,2.5649493574615367
quiet,13,2.5649493574615367
abortion,13,2.5649493574615367
00004,13,2.5649493574615367
718,13,2.5649493574615367
non-asthma,13,2.5649493574615367
Cronbachs,13,2.5649493574615367
manipulate,13,2.5649493574615367
liberation,13,2.5649493574615367
987,13,2.5649493574615367
elution,13,2.5649493574615367
amniotic,13,2.5649493574615367
Transport,13,2.5649493574615367
anti-infective,13,2.5649493574615367
Autophagy,13,2.5649493574615367
70-year-old,13,2.5649493574615367
compatibility,13,2.5649493574615367
paracetamol,13,2.5649493574615367
PD20FEV1,13,2.5649493574615367
Ann,13,2.5649493574615367
Adaptive,13,2.5649493574615367
dismissals,13,2.5649493574615367
ingredient,13,2.5649493574615367
axonal,13,2.5649493574615367
vRNA,13,2.5649493574615367
ivermectin,13,2.5649493574615367
euro,13,2.5649493574615367
avert,13,2.5649493574615367
virus-positive,13,2.5649493574615367
Shortly,13,2.5649493574615367
Insulin,13,2.5649493574615367
exceedingly,13,2.5649493574615367
phagocytic,13,2.5649493574615367
IP-10,13,2.5649493574615367
1996-1997,13,2.5649493574615367
uneven,13,2.5649493574615367
versatility,13,2.5649493574615367
co-circulate,13,2.5649493574615367
44-year-old,13,2.5649493574615367
cost-of-illness,13,2.5649493574615367
OCSP,13,2.5649493574615367
hypnosis,13,2.5649493574615367
Venous,13,2.5649493574615367
inhalational,13,2.5649493574615367
CMBs,13,2.5649493574615367
anastomoses,13,2.5649493574615367
IL-25,13,2.5649493574615367
superspreading,13,2.5649493574615367
ash,13,2.5649493574615367
wheezes,13,2.5649493574615367
Residents,13,2.5649493574615367
Green,13,2.5649493574615367
SNFs,13,2.5649493574615367
ulceration,13,2.5649493574615367
workdays,13,2.5649493574615367
929,13,2.5649493574615367
NVX-CoV2373,13,2.5649493574615367
South-East,13,2.5649493574615367
hypoplasia,13,2.5649493574615367
Cincinnati,13,2.5649493574615367
foremen,13,2.5649493574615367
379,13,2.5649493574615367
647,13,2.5649493574615367
469,13,2.5649493574615367
acid-base,13,2.5649493574615367
stalk,13,2.5649493574615367
599,13,2.5649493574615367
70-80,13,2.5649493574615367
hydrocortisone,13,2.5649493574615367
usefully,13,2.5649493574615367
Arabic,13,2.5649493574615367
0029,13,2.5649493574615367
reversibly,13,2.5649493574615367
cyanosis,13,2.5649493574615367
sting,13,2.5649493574615367
bigger,13,2.5649493574615367
painters,13,2.5649493574615367
Internet-based,13,2.5649493574615367
thyrotoxicosis,13,2.5649493574615367
ANFIS,13,2.5649493574615367
crowding,13,2.5649493574615367
halted,13,2.5649493574615367
trouble,13,2.5649493574615367
941,13,2.5649493574615367
import,13,2.5649493574615367
Pre-existing,13,2.5649493574615367
paradoxically,13,2.5649493574615367
Troponin,13,2.5649493574615367
201T1,13,2.5649493574615367
imprecise,13,2.5649493574615367
obscured,13,2.5649493574615367
Connecticut,13,2.5649493574615367
polybasic,13,2.5649493574615367
HCoV-HKU1,13,2.5649493574615367
reads,13,2.5649493574615367
citations,13,2.5649493574615367
tough,13,2.5649493574615367
cytological,13,2.5649493574615367
vigorously,13,2.5649493574615367
SVM,13,2.5649493574615367
serotypes,13,2.5649493574615367
Occasionally,13,2.5649493574615367
30-min,13,2.5649493574615367
ICIs,13,2.5649493574615367
MPS,13,2.5649493574615367
variously,13,2.5649493574615367
peribronchial,13,2.5649493574615367
interviewing,13,2.5649493574615367
protections,13,2.5649493574615367
immunofluorescent,13,2.5649493574615367
pylori,13,2.5649493574615367
dots,12,2.4849066497880004
RM,12,2.4849066497880004
amplicon,12,2.4849066497880004
halting,12,2.4849066497880004
Seoul,12,2.4849066497880004
Irrespective,12,2.4849066497880004
IFNγ,12,2.4849066497880004
HIV-negative,12,2.4849066497880004
RNA-based,12,2.4849066497880004
strike,12,2.4849066497880004
Assessments,12,2.4849066497880004
high-performance,12,2.4849066497880004
SIRS,12,2.4849066497880004
moderatesevere,12,2.4849066497880004
replies,12,2.4849066497880004
phenotype-specific,12,2.4849066497880004
gaseous,12,2.4849066497880004
human-like,12,2.4849066497880004
2019-nCOV,12,2.4849066497880004
posttraumatic,12,2.4849066497880004
impractical,12,2.4849066497880004
NSE,12,2.4849066497880004
necroses,12,2.4849066497880004
regenerating,12,2.4849066497880004
wheat,12,2.4849066497880004
emergently,12,2.4849066497880004
self-control,12,2.4849066497880004
ganglion,12,2.4849066497880004
886,12,2.4849066497880004
6-year,12,2.4849066497880004
posteroinferior,12,2.4849066497880004
PTFV1,12,2.4849066497880004
660,12,2.4849066497880004
835,12,2.4849066497880004
Lowering,12,2.4849066497880004
cognate,12,2.4849066497880004
Sv-O2,12,2.4849066497880004
delicate,12,2.4849066497880004
concluding,12,2.4849066497880004
MCI,12,2.4849066497880004
AIIRD,12,2.4849066497880004
stand-alone,12,2.4849066497880004
Rwanda,12,2.4849066497880004
640,12,2.4849066497880004
labelling,12,2.4849066497880004
Th2-mediated,12,2.4849066497880004
viral-induced,12,2.4849066497880004
detoxification,12,2.4849066497880004
36000,12,2.4849066497880004
Long-acting,12,2.4849066497880004
Eosinophilia,12,2.4849066497880004
contact-tracing,12,2.4849066497880004
drained,12,2.4849066497880004
ninth,12,2.4849066497880004
fluorescence-based,12,2.4849066497880004
electromechanical,12,2.4849066497880004
UC,12,2.4849066497880004
germinal,12,2.4849066497880004
Maintaining,12,2.4849066497880004
Bangladeshi,12,2.4849066497880004
adjudicated,12,2.4849066497880004
809,12,2.4849066497880004
vibration,12,2.4849066497880004
ATS,12,2.4849066497880004
SHOCK,12,2.4849066497880004
sympathomimetics,12,2.4849066497880004
TH1,12,2.4849066497880004
hMSCs,12,2.4849066497880004
lithium,12,2.4849066497880004
umifenovir,12,2.4849066497880004
tactile,12,2.4849066497880004
GCVF,12,2.4849066497880004
healthcare-associated,12,2.4849066497880004
safeguard,12,2.4849066497880004
lipoproteina,12,2.4849066497880004
outperform,12,2.4849066497880004
recursive,12,2.4849066497880004
FluCAN,12,2.4849066497880004
RGD,12,2.4849066497880004
host-cell,12,2.4849066497880004
Monoclonal,12,2.4849066497880004
1967,12,2.4849066497880004
repeating,12,2.4849066497880004
repeatable,12,2.4849066497880004
morphogenesis,12,2.4849066497880004
12-year-old,12,2.4849066497880004
Bronchoconstriction,12,2.4849066497880004
adherent,12,2.4849066497880004
psoriasis,12,2.4849066497880004
philosophy,12,2.4849066497880004
rheography,12,2.4849066497880004
BV,12,2.4849066497880004
chromatographic,12,2.4849066497880004
Iowa,12,2.4849066497880004
-10,12,2.4849066497880004
inter-rater,12,2.4849066497880004
foundations,12,2.4849066497880004
Antibiotic,12,2.4849066497880004
deferred,12,2.4849066497880004
-11,12,2.4849066497880004
imitation,12,2.4849066497880004
non-AMI,12,2.4849066497880004
Alterations,12,2.4849066497880004
liposarcoma,12,2.4849066497880004
voivodeship,12,2.4849066497880004
0049,12,2.4849066497880004
smear,12,2.4849066497880004
DTD,12,2.4849066497880004
LVOT,12,2.4849066497880004
bathing,12,2.4849066497880004
widening,12,2.4849066497880004
preschool-aged,12,2.4849066497880004
polyproteins,12,2.4849066497880004
undocumented,12,2.4849066497880004
0034,12,2.4849066497880004
sensitively,12,2.4849066497880004
beta-2-agonists,12,2.4849066497880004
642,12,2.4849066497880004
CMI,12,2.4849066497880004
Dabigatran,12,2.4849066497880004
competency,12,2.4849066497880004
ILC2s,12,2.4849066497880004
SPAF,12,2.4849066497880004
patented,12,2.4849066497880004
ARIC,12,2.4849066497880004
LVOs,12,2.4849066497880004
tablets,12,2.4849066497880004
Increasingly,12,2.4849066497880004
IAS,12,2.4849066497880004
toolkit,12,2.4849066497880004
cell-free,12,2.4849066497880004
Paroxysmal,12,2.4849066497880004
Leningrad,12,2.4849066497880004
immunomodulating,12,2.4849066497880004
PAC,12,2.4849066497880004
robotic,12,2.4849066497880004
SABAs,12,2.4849066497880004
gadolinium-DTPA,12,2.4849066497880004
augmenting,12,2.4849066497880004
P0002,12,2.4849066497880004
synchrony,12,2.4849066497880004
clonal,12,2.4849066497880004
DO,12,2.4849066497880004
637,12,2.4849066497880004
dispatch,12,2.4849066497880004
A-S-C-O,12,2.4849066497880004
constraint,12,2.4849066497880004
secrete,12,2.4849066497880004
Esophageal,12,2.4849066497880004
Associated,12,2.4849066497880004
Subcortical,12,2.4849066497880004
increments,12,2.4849066497880004
DAPT,12,2.4849066497880004
696,12,2.4849066497880004
ostial,12,2.4849066497880004
in-situ,12,2.4849066497880004
Nifedipine,12,2.4849066497880004
BCVI,12,2.4849066497880004
evolutive,12,2.4849066497880004
845,12,2.4849066497880004
ontology,12,2.4849066497880004
848,12,2.4849066497880004
UKs,12,2.4849066497880004
queried,12,2.4849066497880004
agriculture,12,2.4849066497880004
says,12,2.4849066497880004
sST2,12,2.4849066497880004
emitted,12,2.4849066497880004
mins,12,2.4849066497880004
PFOs,12,2.4849066497880004
mTICI,12,2.4849066497880004
peri-operative,12,2.4849066497880004
test-retest,12,2.4849066497880004
ophthalmology,12,2.4849066497880004
immunotherapeutics,12,2.4849066497880004
Quidel,12,2.4849066497880004
U-shaped,12,2.4849066497880004
2019-nCov,12,2.4849066497880004
retrosternal,12,2.4849066497880004
placentas,12,2.4849066497880004
Nuss,12,2.4849066497880004
malfunction,12,2.4849066497880004
2013-14,12,2.4849066497880004
folic,12,2.4849066497880004
withheld,12,2.4849066497880004
case-by-case,12,2.4849066497880004
Brighton,12,2.4849066497880004
moderating,12,2.4849066497880004
humankind,12,2.4849066497880004
TG,12,2.4849066497880004
Empirical,12,2.4849066497880004
discharging,12,2.4849066497880004
EUSI,12,2.4849066497880004
calcium-channel,12,2.4849066497880004
strands,12,2.4849066497880004
Sporadic,12,2.4849066497880004
cooperate,12,2.4849066497880004
cross-correlation,12,2.4849066497880004
682,12,2.4849066497880004
reappeared,12,2.4849066497880004
appraised,12,2.4849066497880004
Observed,12,2.4849066497880004
internists,12,2.4849066497880004
Paradoxical,12,2.4849066497880004
EUROIMMUN,12,2.4849066497880004
p0002,12,2.4849066497880004
MMP-9,12,2.4849066497880004
biopsychosocial,12,2.4849066497880004
resveratrol,12,2.4849066497880004
DBH,12,2.4849066497880004
Increase,12,2.4849066497880004
Sub-Saharan,12,2.4849066497880004
in-,12,2.4849066497880004
indium-111,12,2.4849066497880004
dips,12,2.4849066497880004
VLP,12,2.4849066497880004
cofactor,12,2.4849066497880004
difficult-to-manage,12,2.4849066497880004
keeps,12,2.4849066497880004
axons,12,2.4849066497880004
re-opening,12,2.4849066497880004
Parent,12,2.4849066497880004
piloted,12,2.4849066497880004
low-intensity,12,2.4849066497880004
viewpoints,12,2.4849066497880004
unwell,12,2.4849066497880004
MAARI,12,2.4849066497880004
HRB,12,2.4849066497880004
wounds,12,2.4849066497880004
overlaps,12,2.4849066497880004
824,12,2.4849066497880004
unfounded,12,2.4849066497880004
PESP,12,2.4849066497880004
β-blocker,12,2.4849066497880004
urged,12,2.4849066497880004
Caregiver,12,2.4849066497880004
planet,12,2.4849066497880004
eagerly,12,2.4849066497880004
60-90,12,2.4849066497880004
exhibition,12,2.4849066497880004
fuel,12,2.4849066497880004
coronarographic,12,2.4849066497880004
isointegral,12,2.4849066497880004
William,12,2.4849066497880004
pericytes,12,2.4849066497880004
854,12,2.4849066497880004
open-chest,12,2.4849066497880004
coordinators,12,2.4849066497880004
virus-related,12,2.4849066497880004
Malaysian,12,2.4849066497880004
lavages,12,2.4849066497880004
CBS,12,2.4849066497880004
compassionate,12,2.4849066497880004
bag,12,2.4849066497880004
Caco-2,12,2.4849066497880004
arteriograms,12,2.4849066497880004
Osaka,12,2.4849066497880004
IAP,12,2.4849066497880004
22-year-old,12,2.4849066497880004
vehicles,12,2.4849066497880004
dystrophy,12,2.4849066497880004
reassessed,12,2.4849066497880004
40-50,12,2.4849066497880004
SGTF,12,2.4849066497880004
HCTs,12,2.4849066497880004
895,12,2.4849066497880004
Asari,12,2.4849066497880004
cm3,12,2.4849066497880004
recapitulates,12,2.4849066497880004
5-day,12,2.4849066497880004
gEq,12,2.4849066497880004
bile,12,2.4849066497880004
bibliographic,12,2.4849066497880004
EMI,12,2.4849066497880004
cow,12,2.4849066497880004
thalami,12,2.4849066497880004
Probably,12,2.4849066497880004
armed,12,2.4849066497880004
anesthesiologists,12,2.4849066497880004
Uganda,12,2.4849066497880004
plexus,12,2.4849066497880004
tradition,12,2.4849066497880004
mobilize,12,2.4849066497880004
endeavor,12,2.4849066497880004
mNIHSS,12,2.4849066497880004
unnecessarily,12,2.4849066497880004
C57BL6J,12,2.4849066497880004
occupying,12,2.4849066497880004
Pneumococcal,12,2.4849066497880004
microsphere,12,2.4849066497880004
H1N1-related,12,2.4849066497880004
symptomless,12,2.4849066497880004
Search,12,2.4849066497880004
Sars-CoV-2,12,2.4849066497880004
bystander,12,2.4849066497880004
949,12,2.4849066497880004
1920s,12,2.4849066497880004
TMI,12,2.4849066497880004
peptidase,12,2.4849066497880004
LRE,12,2.4849066497880004
Fall,12,2.4849066497880004
Pediatr,12,2.4849066497880004
709,12,2.4849066497880004
collaborated,12,2.4849066497880004
5-6,12,2.4849066497880004
BNT,12,2.4849066497880004
frightening,12,2.4849066497880004
quick-relief,12,2.4849066497880004
Facing,12,2.4849066497880004
monozygotic,12,2.4849066497880004
dispatchers,12,2.4849066497880004
13-year-old,12,2.4849066497880004
ChAd,12,2.4849066497880004
498,12,2.4849066497880004
Chagas,12,2.4849066497880004
exudative,12,2.4849066497880004
Orf8,12,2.4849066497880004
SDIA,12,2.4849066497880004
compact,12,2.4849066497880004
643,12,2.4849066497880004
SAO,12,2.4849066497880004
co-exist,12,2.4849066497880004
oncologic,12,2.4849066497880004
WC,12,2.4849066497880004
Observations,12,2.4849066497880004
RC,12,2.4849066497880004
decompensated,12,2.4849066497880004
afterward,12,2.4849066497880004
Adolescent,12,2.4849066497880004
beverages,12,2.4849066497880004
ectopy,12,2.4849066497880004
practise,12,2.4849066497880004
Jordanian,12,2.4849066497880004
SCAD,12,2.4849066497880004
baths,12,2.4849066497880004
corrections,12,2.4849066497880004
psychotic,12,2.4849066497880004
Strait,12,2.4849066497880004
march,12,2.4849066497880004
pindolol,12,2.4849066497880004
succeeding,12,2.4849066497880004
0010,12,2.4849066497880004
Context—,12,2.4849066497880004
Sixty-seven,12,2.4849066497880004
five-fold,12,2.4849066497880004
magnitudes,12,2.4849066497880004
wine,12,2.4849066497880004
imaging-based,12,2.4849066497880004
454,12,2.4849066497880004
colleges,12,2.4849066497880004
636,12,2.4849066497880004
20112012,12,2.4849066497880004
WMLs,12,2.4849066497880004
hospitalists,12,2.4849066497880004
voxel-based,12,2.4849066497880004
IUL,12,2.4849066497880004
blueprint,12,2.4849066497880004
Rimantadine,12,2.4849066497880004
542,12,2.4849066497880004
outputs,12,2.4849066497880004
Apoptosis,12,2.4849066497880004
Fengxiao,12,2.4849066497880004
high-altitude,12,2.4849066497880004
Ankara,12,2.4849066497880004
reslizumab,12,2.4849066497880004
outperformed,12,2.4849066497880004
awakened,12,2.4849066497880004
ballooning,12,2.4849066497880004
DTB,12,2.4849066497880004
NSP16,12,2.4849066497880004
disturbing,12,2.4849066497880004
oneself,12,2.4849066497880004
ICI,12,2.4849066497880004
disfunction,12,2.4849066497880004
appraisals,12,2.4849066497880004
10-4,12,2.4849066497880004
silhouette,12,2.4849066497880004
DPI,12,2.4849066497880004
CRISPR-Cas12a,12,2.4849066497880004
LRTI,12,2.4849066497880004
infiltrating,12,2.4849066497880004
691,12,2.4849066497880004
893,12,2.4849066497880004
long-chain,12,2.4849066497880004
T1-201,12,2.4849066497880004
bedrooms,12,2.4849066497880004
referenced,12,2.4849066497880004
AMoscow1099,12,2.4849066497880004
Agenda,12,2.4849066497880004
pravastatin,12,2.4849066497880004
ngL,12,2.4849066497880004
CHI,12,2.4849066497880004
AFib,12,2.4849066497880004
746,12,2.4849066497880004
Real-Time,12,2.4849066497880004
benefitrisk,12,2.4849066497880004
624,12,2.4849066497880004
ABC,12,2.4849066497880004
embryo,12,2.4849066497880004
pushing,12,2.4849066497880004
palpable,12,2.4849066497880004
29-year-old,12,2.4849066497880004
P0004,12,2.4849066497880004
nephrotic,12,2.4849066497880004
disopyramide,12,2.4849066497880004
migraineurs,12,2.4849066497880004
biomolecular,12,2.4849066497880004
maleate,12,2.4849066497880004
3-7,12,2.4849066497880004
VNS,12,2.4849066497880004
nebulizer,12,2.4849066497880004
15-64,12,2.4849066497880004
MCH,12,2.4849066497880004
metadata,12,2.4849066497880004
attaining,12,2.4849066497880004
everything,12,2.4849066497880004
antimicrobials,12,2.4849066497880004
premotor,12,2.4849066497880004
Fifty-six,12,2.4849066497880004
obliterans,12,2.4849066497880004
cortices,12,2.4849066497880004
Benefits,12,2.4849066497880004
multi-factorial,12,2.4849066497880004
15-fold,12,2.4849066497880004
CD25,12,2.4849066497880004
relax,12,2.4849066497880004
SCIT,12,2.4849066497880004
drawback,12,2.4849066497880004
775,12,2.4849066497880004
intelligent,12,2.4849066497880004
Mendelian,12,2.4849066497880004
inborn,12,2.4849066497880004
CysLT1,12,2.4849066497880004
25-75,12,2.4849066497880004
SG,12,2.4849066497880004
NHIS,12,2.4849066497880004
cross-neutralizing,12,2.4849066497880004
Variant,12,2.4849066497880004
scatter,12,2.4849066497880004
poised,12,2.4849066497880004
reassure,12,2.4849066497880004
welders,12,2.4849066497880004
jeopardize,12,2.4849066497880004
diagrams,12,2.4849066497880004
assured,12,2.4849066497880004
enrich,12,2.4849066497880004
Fibrinolytic,12,2.4849066497880004
influenza-induced,12,2.4849066497880004
untranslated,12,2.4849066497880004
nutrient,12,2.4849066497880004
z-score,12,2.4849066497880004
B4,12,2.4849066497880004
non-ICU,12,2.4849066497880004
sweat,12,2.4849066497880004
780,12,2.4849066497880004
6-year-old,12,2.4849066497880004
Perth,12,2.4849066497880004
Permanent,12,2.4849066497880004
stools,12,2.4849066497880004
2014-15,12,2.4849066497880004
unwanted,12,2.4849066497880004
df,12,2.4849066497880004
telemonitoring,12,2.4849066497880004
corroborate,12,2.4849066497880004
SCLS,12,2.4849066497880004
Rrs,12,2.4849066497880004
784,12,2.4849066497880004
soccer,12,2.4849066497880004
Nutrition,12,2.4849066497880004
cause-specific,12,2.4849066497880004
eosin,12,2.4849066497880004
Infarcts,12,2.4849066497880004
intensify,12,2.4849066497880004
dictated,12,2.4849066497880004
abolish,12,2.4849066497880004
Speech,12,2.4849066497880004
lessened,12,2.4849066497880004
ophthalmological,12,2.4849066497880004
bid,12,2.4849066497880004
UEMI,12,2.4849066497880004
1-10,12,2.4849066497880004
Modeling,12,2.4849066497880004
practicable,12,2.4849066497880004
1958,12,2.4849066497880004
capsid,12,2.4849066497880004
revaccination,12,2.4849066497880004
enigma,12,2.4849066497880004
prioritising,12,2.4849066497880004
UV-C,12,2.4849066497880004
mandating,12,2.4849066497880004
childbearing,12,2.4849066497880004
age-groups,12,2.4849066497880004
nonbacterial,12,2.4849066497880004
post-partum,12,2.4849066497880004
comfortable,12,2.4849066497880004
Thrombosis,12,2.4849066497880004
cytology,12,2.4849066497880004
VITROS,12,2.4849066497880004
982,12,2.4849066497880004
B16171,12,2.4849066497880004
bacillus,12,2.4849066497880004
AAT,12,2.4849066497880004
specification,12,2.4849066497880004
flaws,12,2.4849066497880004
envisaged,12,2.4849066497880004
esophagus,12,2.4849066497880004
LOA,12,2.4849066497880004
pharmacist,12,2.4849066497880004
subclasses,12,2.4849066497880004
SAR-CoV-2,12,2.4849066497880004
revolutionize,12,2.4849066497880004
probands,12,2.4849066497880004
rCBF,12,2.4849066497880004
1-vessel,12,2.4849066497880004
Australias,12,2.4849066497880004
medium-,12,2.4849066497880004
pandemic-related,12,2.4849066497880004
Danshen,12,2.4849066497880004
Christmas,12,2.4849066497880004
thing,12,2.4849066497880004
JNK,12,2.4849066497880004
Expansion,12,2.4849066497880004
LTD4,12,2.4849066497880004
Papua,12,2.4849066497880004
multi-strain,12,2.4849066497880004
self-testing,12,2.4849066497880004
Histopathological,12,2.4849066497880004
anti-apoptotic,12,2.4849066497880004
-75,12,2.4849066497880004
prosthetic,12,2.4849066497880004
critique,12,2.4849066497880004
eighty,12,2.4849066497880004
non-parametric,12,2.4849066497880004
RMI,12,2.4849066497880004
budding,12,2.4849066497880004
forelimb,12,2.4849066497880004
contentious,12,2.4849066497880004
MEM,12,2.4849066497880004
896,12,2.4849066497880004
H1N1-associated,12,2.4849066497880004
939,12,2.4849066497880004
Commercial,12,2.4849066497880004
Alzheimer,12,2.4849066497880004
significative,12,2.4849066497880004
Involvement,12,2.4849066497880004
three-quarters,12,2.4849066497880004
convexity,12,2.4849066497880004
heterotypic,12,2.4849066497880004
Independence,12,2.4849066497880004
Uml,12,2.4849066497880004
n6,12,2.4849066497880004
T3,12,2.4849066497880004
1964,12,2.4849066497880004
leaflet,12,2.4849066497880004
908,12,2.4849066497880004
linker,12,2.4849066497880004
1-6,12,2.4849066497880004
CEAs,12,2.4849066497880004
Sham,12,2.4849066497880004
ENT,12,2.4849066497880004
3-vessel,12,2.4849066497880004
BC,12,2.4849066497880004
Vitros,12,2.4849066497880004
Southeastern,12,2.4849066497880004
Siemens,12,2.4849066497880004
N-linked,12,2.4849066497880004
ICAM-1,12,2.4849066497880004
mismatched,12,2.4849066497880004
folate,12,2.4849066497880004
divisions,12,2.4849066497880004
716,12,2.4849066497880004
728,12,2.4849066497880004
harmonization,12,2.4849066497880004
dyads,12,2.4849066497880004
QIVs,12,2.4849066497880004
IFN-I,12,2.4849066497880004
psychophysiological,12,2.4849066497880004
cavitations,12,2.4849066497880004
NST,12,2.4849066497880004
MCDA,12,2.4849066497880004
biomaterial,12,2.4849066497880004
unconfirmed,12,2.4849066497880004
correlative,12,2.4849066497880004
Collaborating,12,2.4849066497880004
likewise,12,2.4849066497880004
polypharmacy,12,2.4849066497880004
Elevation,12,2.4849066497880004
multiepitope,12,2.4849066497880004
retaining,12,2.4849066497880004
lingering,12,2.4849066497880004
precludes,12,2.4849066497880004
plug,12,2.4849066497880004
patient-centred,12,2.4849066497880004
anti-hypertensive,12,2.4849066497880004
Eighty-five,12,2.4849066497880004
Coping,12,2.4849066497880004
electrochemiluminescence,12,2.4849066497880004
templates,12,2.4849066497880004
985,12,2.4849066497880004
outset,12,2.4849066497880004
843,12,2.4849066497880004
cytochrome,12,2.4849066497880004
faith,12,2.4849066497880004
avoids,12,2.4849066497880004
590,12,2.4849066497880004
arrives,12,2.4849066497880004
PWE,12,2.4849066497880004
edoxaban,12,2.4849066497880004
pseudoaneurysms,12,2.4849066497880004
fevers,12,2.4849066497880004
Old,12,2.4849066497880004
nonresponders,12,2.4849066497880004
disrupts,12,2.4849066497880004
sphere,12,2.4849066497880004
DSM-IV,12,2.4849066497880004
PHAC,12,2.4849066497880004
6h,12,2.4849066497880004
Memorial,12,2.4849066497880004
weaning,12,2.4849066497880004
SQ,12,2.4849066497880004
seeding,12,2.4849066497880004
P003,12,2.4849066497880004
underpowered,12,2.4849066497880004
arrhythmogenesis,12,2.4849066497880004
Optical,12,2.4849066497880004
stressing,12,2.4849066497880004
BioNTech,12,2.4849066497880004
affliction,12,2.4849066497880004
Artificial,12,2.4849066497880004
defensive,12,2.4849066497880004
6-minute,12,2.4849066497880004
fomite,12,2.4849066497880004
chord,12,2.4849066497880004
leveraged,12,2.4849066497880004
0020,12,2.4849066497880004
Kounis,12,2.4849066497880004
lift,12,2.4849066497880004
sub-types,12,2.4849066497880004
Instrument,12,2.4849066497880004
believes,12,2.4849066497880004
RIS,12,2.4849066497880004
pathomechanisms,12,2.4849066497880004
officers,12,2.4849066497880004
vasopressors,12,2.4849066497880004
rooted,12,2.4849066497880004
strained,12,2.4849066497880004
DENV,12,2.4849066497880004
612,12,2.4849066497880004
IMR,12,2.4849066497880004
652,12,2.4849066497880004
hGBP1,12,2.4849066497880004
SpO2,12,2.4849066497880004
salmeterol,12,2.4849066497880004
guaranteed,12,2.4849066497880004
restructuring,12,2.4849066497880004
dairy,12,2.4849066497880004
thoracic-abdominal,12,2.4849066497880004
legs,12,2.4849066497880004
482,12,2.4849066497880004
Integration,12,2.4849066497880004
yogurt,12,2.4849066497880004
pneumococci,12,2.4849066497880004
99mTc-pyrophosphate,12,2.4849066497880004
microarrays,12,2.4849066497880004
TSLP,12,2.4849066497880004
fiscal,12,2.4849066497880004
Transfer,12,2.4849066497880004
opted,12,2.4849066497880004
Mini-Mental,12,2.4849066497880004
dermatology,12,2.4849066497880004
20012002,12,2.4849066497880004
psychology,12,2.4849066497880004
microneutralisation,12,2.4849066497880004
dermatologists,12,2.4849066497880004
guinea-pigs,12,2.4849066497880004
inferiorposterior,12,2.4849066497880004
1-8,12,2.4849066497880004
devastated,12,2.4849066497880004
Trivalent,12,2.4849066497880004
redefinition,12,2.4849066497880004
hampering,12,2.4849066497880004
postacute,12,2.4849066497880004
GFR,12,2.4849066497880004
consults,12,2.4849066497880004
instillation,12,2.4849066497880004
obtuse,12,2.4849066497880004
handheld,12,2.4849066497880004
2009H1N1,12,2.4849066497880004
scanned,12,2.4849066497880004
diathesis,12,2.4849066497880004
657,12,2.4849066497880004
prosthesis,12,2.4849066497880004
criticized,12,2.4849066497880004
Reversible,12,2.4849066497880004
Taiwans,12,2.4849066497880004
smartphones,12,2.4849066497880004
Effectively,12,2.4849066497880004
Scores,12,2.4849066497880004
Thirty-day,12,2.4849066497880004
CAL,12,2.4849066497880004
Sansure,12,2.4849066497880004
Precision,12,2.4849066497880004
cholera,12,2.4849066497880004
analytes,12,2.4849066497880004
restores,12,2.4849066497880004
cows,12,2.4849066497880004
Anhui,12,2.4849066497880004
Therapies,12,2.4849066497880004
Radiological,12,2.4849066497880004
Ad,12,2.4849066497880004
Power,12,2.4849066497880004
Vocal,12,2.4849066497880004
cadavers,12,2.4849066497880004
AVS,12,2.4849066497880004
654,12,2.4849066497880004
makeup,12,2.4849066497880004
formidable,12,2.4849066497880004
neuritis,12,2.4849066497880004
November-December,12,2.4849066497880004
dimensional,12,2.4849066497880004
wheezed,12,2.4849066497880004
2011-12,12,2.4849066497880004
torque,12,2.4849066497880004
hyperkinesis,12,2.4849066497880004
struggled,12,2.4849066497880004
illicit,12,2.4849066497880004
wall-motion,12,2.4849066497880004
non-atherosclerotic,12,2.4849066497880004
scaled,12,2.4849066497880004
R5,12,2.4849066497880004
Size,12,2.4849066497880004
resource-poor,12,2.4849066497880004
Resonance,12,2.4849066497880004
transmitral,12,2.4849066497880004
16S,12,2.4849066497880004
PsycINFO,12,2.4849066497880004
IFR,12,2.4849066497880004
commissioned,12,2.4849066497880004
CrI,12,2.4849066497880004
Conditions,12,2.4849066497880004
unjustified,12,2.4849066497880004
LVEDP,12,2.4849066497880004
SVS,12,2.4849066497880004
conversation,12,2.4849066497880004
milestones,12,2.4849066497880004
President,12,2.4849066497880004
Unexpectedly,12,2.4849066497880004
ETT,12,2.4849066497880004
P0005,12,2.4849066497880004
graphic,12,2.4849066497880004
silica,12,2.4849066497880004
emptying,12,2.4849066497880004
PNC,12,2.4849066497880004
NSP3,12,2.4849066497880004
pneumophila,12,2.4849066497880004
oestrogen,12,2.4849066497880004
raters,12,2.4849066497880004
Rhinolophus,12,2.4849066497880004
mid-,12,2.4849066497880004
rheolytic,12,2.4849066497880004
Faced,12,2.4849066497880004
detachment,12,2.4849066497880004
particularities,12,2.4849066497880004
occlude,12,2.4849066497880004
joints,12,2.4849066497880004
relapsed,12,2.4849066497880004
first-generation,12,2.4849066497880004
justifiable,12,2.4849066497880004
X-linked,12,2.4849066497880004
pre-infarction,12,2.4849066497880004
Interactions,12,2.4849066497880004
GV,12,2.4849066497880004
481,12,2.4849066497880004
numbering,12,2.4849066497880004
retains,12,2.4849066497880004
estimator,12,2.4849066497880004
encompassed,12,2.4849066497880004
Vaccinating,12,2.4849066497880004
Laos,12,2.4849066497880004
FIP,12,2.4849066497880004
editors,12,2.4849066497880004
AW,12,2.4849066497880004
commence,12,2.4849066497880004
glioma,12,2.4849066497880004
terminated,12,2.4849066497880004
Beside,12,2.4849066497880004
820,12,2.4849066497880004
enroll,12,2.4849066497880004
insufflation,12,2.4849066497880004
prolongs,12,2.4849066497880004
adhering,12,2.4849066497880004
potentiating,12,2.4849066497880004
HMG-CoA,12,2.4849066497880004
cross-infection,12,2.4849066497880004
SICH,12,2.4849066497880004
Pts,12,2.4849066497880004
Exploring,12,2.4849066497880004
Intermittent,12,2.4849066497880004
Myoglobin,12,2.4849066497880004
worries,12,2.4849066497880004
fathers,12,2.4849066497880004
33-year-old,12,2.4849066497880004
ASCO,12,2.4849066497880004
dissatisfaction,12,2.4849066497880004
Onset,12,2.4849066497880004
costing,12,2.4849066497880004
sialidase,12,2.4849066497880004
ARIMA,12,2.4849066497880004
1951,12,2.4849066497880004
neoplasms,12,2.4849066497880004
scientist,12,2.4849066497880004
ensue,12,2.4849066497880004
toilet,12,2.4849066497880004
pediatrician,12,2.4849066497880004
Spanish-speaking,12,2.4849066497880004
cannulation,12,2.4849066497880004
arthroplasty,12,2.4849066497880004
8-12,12,2.4849066497880004
Vienna,12,2.4849066497880004
incipient,12,2.4849066497880004
SRBD,12,2.4849066497880004
663,12,2.4849066497880004
ng,12,2.4849066497880004
laboratory-proven,12,2.4849066497880004
566,12,2.4849066497880004
kPa,12,2.4849066497880004
10-year-old,12,2.4849066497880004
PSR,12,2.4849066497880004
ultrasensitive,12,2.4849066497880004
pleurodesis,12,2.4849066497880004
spiritual,12,2.4849066497880004
financing,12,2.4849066497880004
LTA,12,2.4849066497880004
culture-confirmed,12,2.4849066497880004
restricts,12,2.4849066497880004
meanwhile,12,2.4849066497880004
psychopathology,12,2.4849066497880004
minday,12,2.4849066497880004
standard-dose,12,2.4849066497880004
Instituto,12,2.4849066497880004
erosion,12,2.4849066497880004
sequels,12,2.4849066497880004
PWIDWI,12,2.4849066497880004
afternoon,12,2.4849066497880004
704,12,2.4849066497880004
transcript,12,2.4849066497880004
Cerebrolysin,12,2.4849066497880004
Solid,12,2.4849066497880004
macaque,11,2.3978952727983707
DEP,11,2.3978952727983707
LTC4S,11,2.3978952727983707
quoted,11,2.3978952727983707
mitogen-activated,11,2.3978952727983707
Version,11,2.3978952727983707
CN,11,2.3978952727983707
within-subject,11,2.3978952727983707
caudal,11,2.3978952727983707
Participation,11,2.3978952727983707
d-dimer,11,2.3978952727983707
adenovirus-vectored,11,2.3978952727983707
minors,11,2.3978952727983707
Nrf2,11,2.3978952727983707
ictus,11,2.3978952727983707
shipping,11,2.3978952727983707
PUFAs,11,2.3978952727983707
12000,11,2.3978952727983707
1997-1998,11,2.3978952727983707
reuse,11,2.3978952727983707
alerted,11,2.3978952727983707
FFR,11,2.3978952727983707
psychical,11,2.3978952727983707
PAP,11,2.3978952727983707
DTEC,11,2.3978952727983707
ME,11,2.3978952727983707
angular,11,2.3978952727983707
Depressive,11,2.3978952727983707
enrolment,11,2.3978952727983707
streptomycin,11,2.3978952727983707
UmL,11,2.3978952727983707
n19,11,2.3978952727983707
importations,11,2.3978952727983707
832,11,2.3978952727983707
mgd,11,2.3978952727983707
CD147,11,2.3978952727983707
Pericardial,11,2.3978952727983707
SH,11,2.3978952727983707
invest,11,2.3978952727983707
Automated,11,2.3978952727983707
SOD1,11,2.3978952727983707
mumps,11,2.3978952727983707
constitutive,11,2.3978952727983707
pacemakers,11,2.3978952727983707
Walking,11,2.3978952727983707
918,11,2.3978952727983707
Swab,11,2.3978952727983707
grows,11,2.3978952727983707
consolidations,11,2.3978952727983707
psychotherapeutic,11,2.3978952727983707
hyperintense,11,2.3978952727983707
Creatine,11,2.3978952727983707
ORF1a,11,2.3978952727983707
arguably,11,2.3978952727983707
AO,11,2.3978952727983707
strain-transcending,11,2.3978952727983707
PFTs,11,2.3978952727983707
preadmission,11,2.3978952727983707
795,11,2.3978952727983707
interrelation,11,2.3978952727983707
pneumonic,11,2.3978952727983707
tracks,11,2.3978952727983707
Addition,11,2.3978952727983707
super,11,2.3978952727983707
495,11,2.3978952727983707
dB,11,2.3978952727983707
differentiates,11,2.3978952727983707
payers,11,2.3978952727983707
n16,11,2.3978952727983707
Feb,11,2.3978952727983707
tiredness,11,2.3978952727983707
LVEDV,11,2.3978952727983707
H1N1-like,11,2.3978952727983707
Bronchoalveolar,11,2.3978952727983707
marking,11,2.3978952727983707
HDAC2,11,2.3978952727983707
Nurse,11,2.3978952727983707
transfused,11,2.3978952727983707
Amp,11,2.3978952727983707
Vaccine-induced,11,2.3978952727983707
repression,11,2.3978952727983707
teenager,11,2.3978952727983707
Mechanistically,11,2.3978952727983707
816,11,2.3978952727983707
Principal,11,2.3978952727983707
qualifying,11,2.3978952727983707
transitioning,11,2.3978952727983707
648,11,2.3978952727983707
10-19,11,2.3978952727983707
Hazard,11,2.3978952727983707
Soviet,11,2.3978952727983707
Value,11,2.3978952727983707
long-distance,11,2.3978952727983707
CVST,11,2.3978952727983707
Pasteur,11,2.3978952727983707
AIAN,11,2.3978952727983707
enormously,11,2.3978952727983707
Reunion,11,2.3978952727983707
encephalitisencephalopathy,11,2.3978952727983707
packaged,11,2.3978952727983707
disastrous,11,2.3978952727983707
practicality,11,2.3978952727983707
aphasic,11,2.3978952727983707
connect,11,2.3978952727983707
well-described,11,2.3978952727983707
implementations,11,2.3978952727983707
sanitizer,11,2.3978952727983707
eukaryotic,11,2.3978952727983707
LAS,11,2.3978952727983707
reconstitution,11,2.3978952727983707
FluRSV,11,2.3978952727983707
maxillofacial,11,2.3978952727983707
mentally,11,2.3978952727983707
Fluarix,11,2.3978952727983707
QTcrest,11,2.3978952727983707
aggression,11,2.3978952727983707
revisited,11,2.3978952727983707
pre-PCI,11,2.3978952727983707
Balloon,11,2.3978952727983707
politicians,11,2.3978952727983707
radiographically,11,2.3978952727983707
refusing,11,2.3978952727983707
WV,11,2.3978952727983707
Blunt,11,2.3978952727983707
823,11,2.3978952727983707
754,11,2.3978952727983707
20201201,11,2.3978952727983707
661,11,2.3978952727983707
detailing,11,2.3978952727983707
neuroanatomical,11,2.3978952727983707
methodologically,11,2.3978952727983707
Lateral,11,2.3978952727983707
epsilon,11,2.3978952727983707
demographically,11,2.3978952727983707
niches,11,2.3978952727983707
HBM,11,2.3978952727983707
Extracranial,11,2.3978952727983707
bimanual,11,2.3978952727983707
undergraduate,11,2.3978952727983707
migrants,11,2.3978952727983707
folds,11,2.3978952727983707
prophylactics,11,2.3978952727983707
690,11,2.3978952727983707
1998-1999,11,2.3978952727983707
Torres,11,2.3978952727983707
accentuated,11,2.3978952727983707
coat,11,2.3978952727983707
expresses,11,2.3978952727983707
homogeneity,11,2.3978952727983707
morphologically,11,2.3978952727983707
biodegradable,11,2.3978952727983707
60-69,11,2.3978952727983707
Seventy-four,11,2.3978952727983707
stably,11,2.3978952727983707
Details,11,2.3978952727983707
doppler,11,2.3978952727983707
Outbreak,11,2.3978952727983707
ACCP,11,2.3978952727983707
qualities,11,2.3978952727983707
invasively,11,2.3978952727983707
910,11,2.3978952727983707
576,11,2.3978952727983707
antihistamine,11,2.3978952727983707
Irish,11,2.3978952727983707
reprogramming,11,2.3978952727983707
I-MOVE,11,2.3978952727983707
neurointerventional,11,2.3978952727983707
51-year-old,11,2.3978952727983707
coronavirus-related,11,2.3978952727983707
efferent,11,2.3978952727983707
462,11,2.3978952727983707
multislice,11,2.3978952727983707
G1,11,2.3978952727983707
non-contrast,11,2.3978952727983707
flawed,11,2.3978952727983707
pricing,11,2.3978952727983707
exotic,11,2.3978952727983707
882,11,2.3978952727983707
pervasive,11,2.3978952727983707
cyclosporine,11,2.3978952727983707
misclassified,11,2.3978952727983707
Paradoxically,11,2.3978952727983707
ligations,11,2.3978952727983707
robots,11,2.3978952727983707
Panama,11,2.3978952727983707
ab,11,2.3978952727983707
elevate,11,2.3978952727983707
Detroit,11,2.3978952727983707
bp,11,2.3978952727983707
B1525,11,2.3978952727983707
3D-printed,11,2.3978952727983707
decoy,11,2.3978952727983707
PTX3,11,2.3978952727983707
EAACI,11,2.3978952727983707
Wright,11,2.3978952727983707
rationales,11,2.3978952727983707
7-17,11,2.3978952727983707
Innovations,11,2.3978952727983707
win,11,2.3978952727983707
fluoxetine,11,2.3978952727983707
mL-1,11,2.3978952727983707
anti-NP,11,2.3978952727983707
Ipratropium,11,2.3978952727983707
ambitious,11,2.3978952727983707
SN,11,2.3978952727983707
Ul,11,2.3978952727983707
locally-acquired,11,2.3978952727983707
903,11,2.3978952727983707
consenting,11,2.3978952727983707
uncommonly,11,2.3978952727983707
narcolepsy,11,2.3978952727983707
B1427,11,2.3978952727983707
day-1,11,2.3978952727983707
Addressing,11,2.3978952727983707
passively,11,2.3978952727983707
restitution,11,2.3978952727983707
low-prevalence,11,2.3978952727983707
PACS,11,2.3978952727983707
allosteric,11,2.3978952727983707
B1429,11,2.3978952727983707
526,11,2.3978952727983707
Pattern,11,2.3978952727983707
FM,11,2.3978952727983707
non-toxic,11,2.3978952727983707
truth,11,2.3978952727983707
replacements,11,2.3978952727983707
Heat,11,2.3978952727983707
beads,11,2.3978952727983707
pre-admission,11,2.3978952727983707
Penicillium,11,2.3978952727983707
Benefit,11,2.3978952727983707
pursuing,11,2.3978952727983707
P323L,11,2.3978952727983707
3-chymotrypsin-like,11,2.3978952727983707
farmworkers,11,2.3978952727983707
Eurasia,11,2.3978952727983707
15-25,11,2.3978952727983707
Sensitization,11,2.3978952727983707
type-2,11,2.3978952727983707
angiotensin-converting-enzyme,11,2.3978952727983707
IRR,11,2.3978952727983707
grip,11,2.3978952727983707
arc,11,2.3978952727983707
Hib,11,2.3978952727983707
bedroom,11,2.3978952727983707
alternans,11,2.3978952727983707
rainfall,11,2.3978952727983707
time-,11,2.3978952727983707
dropout,11,2.3978952727983707
Versus,11,2.3978952727983707
741,11,2.3978952727983707
IPPV,11,2.3978952727983707
hs-cTnI,11,2.3978952727983707
distilled,11,2.3978952727983707
710,11,2.3978952727983707
AH10N8,11,2.3978952727983707
0037,11,2.3978952727983707
LAIV4,11,2.3978952727983707
high-prevalence,11,2.3978952727983707
CCD,11,2.3978952727983707
Incorporating,11,2.3978952727983707
Maximal,11,2.3978952727983707
Assess,11,2.3978952727983707
626,11,2.3978952727983707
cannabinoids,11,2.3978952727983707
WMA,11,2.3978952727983707
40-year-old,11,2.3978952727983707
OAS,11,2.3978952727983707
intraplaque,11,2.3978952727983707
ACSs,11,2.3978952727983707
disc,11,2.3978952727983707
percentiles,11,2.3978952727983707
zoonoses,11,2.3978952727983707
dystonia,11,2.3978952727983707
897,11,2.3978952727983707
sterilization,11,2.3978952727983707
BH,11,2.3978952727983707
Behaviour,11,2.3978952727983707
unmeasured,11,2.3978952727983707
maritime,11,2.3978952727983707
factual,11,2.3978952727983707
anti-inflammation,11,2.3978952727983707
send,11,2.3978952727983707
WML,11,2.3978952727983707
impaction,11,2.3978952727983707
Indonesian,11,2.3978952727983707
miscellaneous,11,2.3978952727983707
Veritor,11,2.3978952727983707
Just,11,2.3978952727983707
overlying,11,2.3978952727983707
Hypertensive,11,2.3978952727983707
201617,11,2.3978952727983707
889,11,2.3978952727983707
30-60,11,2.3978952727983707
TMP,11,2.3978952727983707
dentistry,11,2.3978952727983707
à,11,2.3978952727983707
indapamide,11,2.3978952727983707
Gal-3,11,2.3978952727983707
copeptin,11,2.3978952727983707
cellsμL,11,2.3978952727983707
rule-out,11,2.3978952727983707
caveats,11,2.3978952727983707
air-flow,11,2.3978952727983707
self-confidence,11,2.3978952727983707
Maintenance,11,2.3978952727983707
vaccine-hesitant,11,2.3978952727983707
impedes,11,2.3978952727983707
le,11,2.3978952727983707
Determinants,11,2.3978952727983707
1989-90,11,2.3978952727983707
harbored,11,2.3978952727983707
angles,11,2.3978952727983707
1a,11,2.3978952727983707
pulsatile,11,2.3978952727983707
dyes,11,2.3978952727983707
asthmonia,11,2.3978952727983707
owner,11,2.3978952727983707
subventricular,11,2.3978952727983707
polyfunctional,11,2.3978952727983707
ICT,11,2.3978952727983707
PCAQ,11,2.3978952727983707
beta2-adrenoceptor,11,2.3978952727983707
care-associated,11,2.3978952727983707
chromatin,11,2.3978952727983707
voxel,11,2.3978952727983707
cargo,11,2.3978952727983707
SARS-,11,2.3978952727983707
639,11,2.3978952727983707
vectorcardiograms,11,2.3978952727983707
708,11,2.3978952727983707
appendicitis,11,2.3978952727983707
viewing,11,2.3978952727983707
anti-ischaemic,11,2.3978952727983707
prolonging,11,2.3978952727983707
Latinx,11,2.3978952727983707
Hospital-based,11,2.3978952727983707
membrane-bound,11,2.3978952727983707
symmetric,11,2.3978952727983707
preformed,11,2.3978952727983707
753,11,2.3978952727983707
spreaders,11,2.3978952727983707
supplementing,11,2.3978952727983707
etiquette,11,2.3978952727983707
platelet-activating,11,2.3978952727983707
Corporation,11,2.3978952727983707
Theoretical,11,2.3978952727983707
exerting,11,2.3978952727983707
arginase,11,2.3978952727983707
unrealistic,11,2.3978952727983707
CVE,11,2.3978952727983707
CI95,11,2.3978952727983707
Tumor,11,2.3978952727983707
derivation,11,2.3978952727983707
discontinuing,11,2.3978952727983707
grams,11,2.3978952727983707
centerline,11,2.3978952727983707
funders,11,2.3978952727983707
told,11,2.3978952727983707
methicillin-resistant,11,2.3978952727983707
self-perceived,11,2.3978952727983707
multiplied,11,2.3978952727983707
AG,11,2.3978952727983707
Nacional,11,2.3978952727983707
peroxynitrite,11,2.3978952727983707
groundwork,11,2.3978952727983707
T2D,11,2.3978952727983707
centrifugation,11,2.3978952727983707
curing,11,2.3978952727983707
Variability,11,2.3978952727983707
informs,11,2.3978952727983707
Stratified,11,2.3978952727983707
subtype-specific,11,2.3978952727983707
DALYs,11,2.3978952727983707
Years,11,2.3978952727983707
standard-of-care,11,2.3978952727983707
spacers,11,2.3978952727983707
subpleural,11,2.3978952727983707
insist,11,2.3978952727983707
N-acetylcysteine,11,2.3978952727983707
Pathophysiological,11,2.3978952727983707
Cp,11,2.3978952727983707
ALL,11,2.3978952727983707
ATexas,11,2.3978952727983707
Stratification,11,2.3978952727983707
UFH,11,2.3978952727983707
convergent,11,2.3978952727983707
Effect,11,2.3978952727983707
SARS-related,11,2.3978952727983707
unimproved,11,2.3978952727983707
effected,11,2.3978952727983707
1977-78,11,2.3978952727983707
dormitory,11,2.3978952727983707
Inhibitors,11,2.3978952727983707
MCT,11,2.3978952727983707
3-kinase,11,2.3978952727983707
CTO,11,2.3978952727983707
Loop-mediated,11,2.3978952727983707
inoculum,11,2.3978952727983707
News,11,2.3978952727983707
7-12,11,2.3978952727983707
conspicuous,11,2.3978952727983707
Frequently,11,2.3978952727983707
broken,11,2.3978952727983707
favours,11,2.3978952727983707
methyl,11,2.3978952727983707
forceps,11,2.3978952727983707
diffusion-,11,2.3978952727983707
particulates,11,2.3978952727983707
push,11,2.3978952727983707
reassorted,11,2.3978952727983707
catabolism,11,2.3978952727983707
deny,11,2.3978952727983707
nonpathogenic,11,2.3978952727983707
Latinos,11,2.3978952727983707
Containment,11,2.3978952727983707
corticosteroid-resistant,11,2.3978952727983707
748,11,2.3978952727983707
ascertaining,11,2.3978952727983707
Cuba,11,2.3978952727983707
Campaign,11,2.3978952727983707
indefinitely,11,2.3978952727983707
concentrating,11,2.3978952727983707
IBS,11,2.3978952727983707
mm3,11,2.3978952727983707
1968-1969,11,2.3978952727983707
MPM,11,2.3978952727983707
Sputnik,11,2.3978952727983707
govern,11,2.3978952727983707
Partnership,11,2.3978952727983707
electively,11,2.3978952727983707
Anesthesia,11,2.3978952727983707
ultracentrifugation,11,2.3978952727983707
TF,11,2.3978952727983707
partum,11,2.3978952727983707
snow,11,2.3978952727983707
multicomponent,11,2.3978952727983707
terminate,11,2.3978952727983707
species-specific,11,2.3978952727983707
CD46,11,2.3978952727983707
cost-efficient,11,2.3978952727983707
adenovirus-based,11,2.3978952727983707
autoregressive,11,2.3978952727983707
veloergometry,11,2.3978952727983707
PPIs,11,2.3978952727983707
oscillatory,11,2.3978952727983707
hypoplastic,11,2.3978952727983707
dextrocardia,11,2.3978952727983707
ACTIV,11,2.3978952727983707
scalability,11,2.3978952727983707
spike-based,11,2.3978952727983707
putamen,11,2.3978952727983707
inter-individual,11,2.3978952727983707
Premature,11,2.3978952727983707
interrogate,11,2.3978952727983707
Temporal,11,2.3978952727983707
sterilizing,11,2.3978952727983707
officer,11,2.3978952727983707
prodrome,11,2.3978952727983707
TIPE2,11,2.3978952727983707
IIb,11,2.3978952727983707
nontraditional,11,2.3978952727983707
posts,11,2.3978952727983707
reassurance,11,2.3978952727983707
community-onset,11,2.3978952727983707
sleep-related,11,2.3978952727983707
H5N2,11,2.3978952727983707
larvae,11,2.3978952727983707
Burden,11,2.3978952727983707
LIFE,11,2.3978952727983707
cast,11,2.3978952727983707
long-range,11,2.3978952727983707
Budapest,11,2.3978952727983707
unpleasant,11,2.3978952727983707
Biosafety,11,2.3978952727983707
HTN,11,2.3978952727983707
organoids,11,2.3978952727983707
centrally,11,2.3978952727983707
Updated,11,2.3978952727983707
7500,11,2.3978952727983707
CHA2DS2VASc,11,2.3978952727983707
Arrhythmias,11,2.3978952727983707
Johns,11,2.3978952727983707
intraparenchymal,11,2.3978952727983707
T1-weighted,11,2.3978952727983707
delineates,11,2.3978952727983707
wavelength,11,2.3978952727983707
Agents,11,2.3978952727983707
821,11,2.3978952727983707
672,11,2.3978952727983707
interfered,11,2.3978952727983707
outward,11,2.3978952727983707
devoid,11,2.3978952727983707
Examinations,11,2.3978952727983707
951,11,2.3978952727983707
Evaluate,11,2.3978952727983707
LPMs,11,2.3978952727983707
Hypothesis,11,2.3978952727983707
Parameters,11,2.3978952727983707
synthesizes,11,2.3978952727983707
CIND,11,2.3978952727983707
optic,11,2.3978952727983707
822,11,2.3978952727983707
720,11,2.3978952727983707
potroom,11,2.3978952727983707
β-coronavirus,11,2.3978952727983707
pauci-symptomatic,11,2.3978952727983707
50-60,11,2.3978952727983707
685,11,2.3978952727983707
appeal,11,2.3978952727983707
four-fold,11,2.3978952727983707
tiotropium,11,2.3978952727983707
neurotic,11,2.3978952727983707
altitudes,11,2.3978952727983707
lminm2,11,2.3978952727983707
PACs,11,2.3978952727983707
20162017,11,2.3978952727983707
Mexicos,11,2.3978952727983707
65-74,11,2.3978952727983707
protein-specific,11,2.3978952727983707
dies,11,2.3978952727983707
English-speaking,11,2.3978952727983707
Platelets,11,2.3978952727983707
opioid,11,2.3978952727983707
CT-based,11,2.3978952727983707
SLV-I,11,2.3978952727983707
depicting,11,2.3978952727983707
factorial,11,2.3978952727983707
amyloidosis,11,2.3978952727983707
portability,11,2.3978952727983707
Seropositivity,11,2.3978952727983707
0024,11,2.3978952727983707
bleedings,11,2.3978952727983707
BB,11,2.3978952727983707
satisfy,11,2.3978952727983707
adhesive,11,2.3978952727983707
recorder,11,2.3978952727983707
coast,11,2.3978952727983707
Temporary,11,2.3978952727983707
PCRs,11,2.3978952727983707
transports,11,2.3978952727983707
PFM,11,2.3978952727983707
9000,11,2.3978952727983707
interprofessional,11,2.3978952727983707
Conservative,11,2.3978952727983707
Tregs,11,2.3978952727983707
GICA,11,2.3978952727983707
fungus,11,2.3978952727983707
Hcy,11,2.3978952727983707
Opinion,11,2.3978952727983707
coenzyme,11,2.3978952727983707
averting,11,2.3978952727983707
intal,11,2.3978952727983707
radiologically,11,2.3978952727983707
Focal,11,2.3978952727983707
bivalirudin,11,2.3978952727983707
Susceptibility,11,2.3978952727983707
Tennessee,11,2.3978952727983707
hypereosinophilic,11,2.3978952727983707
smears,11,2.3978952727983707
autophagosomes,11,2.3978952727983707
confocal,11,2.3978952727983707
leucocytes,11,2.3978952727983707
self-reports,11,2.3978952727983707
Nordic,11,2.3978952727983707
cryopreservation,11,2.3978952727983707
Monday,11,2.3978952727983707
C1,11,2.3978952727983707
famotidine,11,2.3978952727983707
565,11,2.3978952727983707
demyelinating,11,2.3978952727983707
Operation,11,2.3978952727983707
rejected,11,2.3978952727983707
contra-indications,11,2.3978952727983707
mlday,11,2.3978952727983707
CPB,11,2.3978952727983707
generalize,11,2.3978952727983707
baicalein,11,2.3978952727983707
once-daily,11,2.3978952727983707
assuring,11,2.3978952727983707
provisional,11,2.3978952727983707
directional,11,2.3978952727983707
PSC,11,2.3978952727983707
decedents,11,2.3978952727983707
prelude,11,2.3978952727983707
β-agonists,11,2.3978952727983707
ligament,11,2.3978952727983707
inactivates,11,2.3978952727983707
Penumbra,11,2.3978952727983707
-omics,11,2.3978952727983707
NRP-1,11,2.3978952727983707
mphi,11,2.3978952727983707
webs,11,2.3978952727983707
mammal,11,2.3978952727983707
PECAM-1,11,2.3978952727983707
death-rate,11,2.3978952727983707
testis,11,2.3978952727983707
enzymic,11,2.3978952727983707
FPE,11,2.3978952727983707
Travel,11,2.3978952727983707
mgm3,11,2.3978952727983707
Cladosporium,11,2.3978952727983707
restarting,11,2.3978952727983707
Mayo,11,2.3978952727983707
sp,11,2.3978952727983707
minimising,11,2.3978952727983707
Port,11,2.3978952727983707
RIG-I,11,2.3978952727983707
26th,11,2.3978952727983707
WBV,11,2.3978952727983707
SMD,11,2.3978952727983707
tier,11,2.3978952727983707
K-12,11,2.3978952727983707
1963,11,2.3978952727983707
downloaded,11,2.3978952727983707
Radiology,11,2.3978952727983707
precious,11,2.3978952727983707
antifungal,11,2.3978952727983707
store,11,2.3978952727983707
acuteness,11,2.3978952727983707
birch,11,2.3978952727983707
ominous,11,2.3978952727983707
unsure,11,2.3978952727983707
Oncology,11,2.3978952727983707
PIP,11,2.3978952727983707
Biology,11,2.3978952727983707
non-replicating,11,2.3978952727983707
coronal,11,2.3978952727983707
TX,11,2.3978952727983707
tourism,11,2.3978952727983707
EPR,11,2.3978952727983707
20-44,11,2.3978952727983707
case-crossover,11,2.3978952727983707
serosurveillance,11,2.3978952727983707
egg-based,11,2.3978952727983707
P-selectin,11,2.3978952727983707
donated,11,2.3978952727983707
18-year-old,11,2.3978952727983707
taxonomy,11,2.3978952727983707
Wondfo,11,2.3978952727983707
epitope-based,11,2.3978952727983707
self-sampling,11,2.3978952727983707
Restoration,11,2.3978952727983707
rigor,11,2.3978952727983707
Envelope,11,2.3978952727983707
Cx,11,2.3978952727983707
non-pandemic,11,2.3978952727983707
faulty,11,2.3978952727983707
P004,11,2.3978952727983707
seals,11,2.3978952727983707
hint,11,2.3978952727983707
in-patients,11,2.3978952727983707
purulent,11,2.3978952727983707
dual-use,11,2.3978952727983707
conceptualization,11,2.3978952727983707
nebulisers,11,2.3978952727983707
one-fifth,11,2.3978952727983707
postinfarct,11,2.3978952727983707
Quarantine,11,2.3978952727983707
pI,11,2.3978952727983707
quantitated,11,2.3978952727983707
plicatic,11,2.3978952727983707
oropharynx,11,2.3978952727983707
Seventy-two,11,2.3978952727983707
stomatitis,11,2.3978952727983707
malondialdehyde,11,2.3978952727983707
mLm2,11,2.3978952727983707
Rapidly,11,2.3978952727983707
BSL-2,11,2.3978952727983707
PCG,11,2.3978952727983707
Statement,11,2.3978952727983707
sustained-release,11,2.3978952727983707
side-effect,11,2.3978952727983707
PIMS-TS,11,2.3978952727983707
972,11,2.3978952727983707
NHBE,11,2.3978952727983707
obligatory,11,2.3978952727983707
Humans,11,2.3978952727983707
proteinase,11,2.3978952727983707
hyper-acute,11,2.3978952727983707
693,11,2.3978952727983707
Pediatricians,11,2.3978952727983707
fibrillation-related,11,2.3978952727983707
Modelling,11,2.3978952727983707
mesenteric,11,2.3978952727983707
One-year,11,2.3978952727983707
COVID-19-specific,11,2.3978952727983707
mAb,11,2.3978952727983707
bouts,11,2.3978952727983707
oesophagus,11,2.3978952727983707
synergism,11,2.3978952727983707
non-responders,11,2.3978952727983707
catch,11,2.3978952727983707
Mount,11,2.3978952727983707
ADs,11,2.3978952727983707
epithelial-mesenchymal,11,2.3978952727983707
preventer,11,2.3978952727983707
ACFs,11,2.3978952727983707
spare,11,2.3978952727983707
sizing,11,2.3978952727983707
Sixty-four,11,2.3978952727983707
865,11,2.3978952727983707
Mutation,11,2.3978952727983707
routing,11,2.3978952727983707
orthostatic,11,2.3978952727983707
thermodilution,11,2.3978952727983707
car,11,2.3978952727983707
Siberia,11,2.3978952727983707
Alert,11,2.3978952727983707
del,11,2.3978952727983707
shunts,11,2.3978952727983707
973,11,2.3978952727983707
semantic,11,2.3978952727983707
759,11,2.3978952727983707
WWTP,11,2.3978952727983707
Corresponding,11,2.3978952727983707
bronchioles,11,2.3978952727983707
expeditious,11,2.3978952727983707
addiction,11,2.3978952727983707
IFN-β,11,2.3978952727983707
microgramsl,11,2.3978952727983707
neurotoxic,11,2.3978952727983707
634,11,2.3978952727983707
2-17,11,2.3978952727983707
surroundings,11,2.3978952727983707
CPC,11,2.3978952727983707
textile,11,2.3978952727983707
PIV,11,2.3978952727983707
979,11,2.3978952727983707
replicon,11,2.3978952727983707
RAP,11,2.3978952727983707
99mTc-PYP,11,2.3978952727983707
spp,11,2.3978952727983707
VR,11,2.3978952727983707
Assembly,11,2.3978952727983707
Computer,11,2.3978952727983707
cite,11,2.3978952727983707
or65,11,2.3978952727983707
Maine,11,2.3978952727983707
liposomes,11,2.3978952727983707
teacher,11,2.3978952727983707
respondent,11,2.3978952727983707
Pressure,11,2.3978952727983707
manipulating,11,2.3978952727983707
Bells,11,2.3978952727983707
peritonitis,11,2.3978952727983707
glycemia,11,2.3978952727983707
Ninety-four,11,2.3978952727983707
occured,11,2.3978952727983707
glycopeptide,11,2.3978952727983707
ACI,11,2.3978952727983707
heparin-induced,11,2.3978952727983707
Dysfunction,11,2.3978952727983707
Insufficient,11,2.3978952727983707
reemergence,11,2.3978952727983707
DL,11,2.3978952727983707
Activated,11,2.3978952727983707
PBMCs,11,2.3978952727983707
SESs,11,2.3978952727983707
Ferrets,11,2.3978952727983707
COVID-19-recovered,11,2.3978952727983707
776,11,2.3978952727983707
CAR,11,2.3978952727983707
957,11,2.3978952727983707
embolisms,11,2.3978952727983707
Map,11,2.3978952727983707
ACalifornia72009,11,2.3978952727983707
Mainland,11,2.3978952727983707
Eighty-three,11,2.3978952727983707
non-clinical,11,2.3978952727983707
1930s,11,2.3978952727983707
helminths,11,2.3978952727983707
constrictive,11,2.3978952727983707
INDICAID,11,2.3978952727983707
651,11,2.3978952727983707
≥20,11,2.3978952727983707
antidiabetic,11,2.3978952727983707
nitazoxanide,11,2.3978952727983707
0-5,11,2.3978952727983707
epizootics,11,2.3978952727983707
journey,11,2.3978952727983707
evaluable,11,2.3978952727983707
transmitters,11,2.3978952727983707
imprecision,11,2.3978952727983707
opioids,11,2.3978952727983707
neurotrophin,11,2.3978952727983707
lying,11,2.3978952727983707
Conduct,11,2.3978952727983707
schooling,11,2.3978952727983707
sexually,11,2.3978952727983707
inorganic,11,2.3978952727983707
Numerical,11,2.3978952727983707
breakfast,11,2.3978952727983707
endomyocardial,11,2.3978952727983707
proliferate,11,2.3978952727983707
520,11,2.3978952727983707
tap,11,2.3978952727983707
sleeping,11,2.3978952727983707
928,11,2.3978952727983707
n23,11,2.3978952727983707
656,11,2.3978952727983707
flu-related,11,2.3978952727983707
MAbs,11,2.3978952727983707
regularity,11,2.3978952727983707
pharmacotherapies,11,2.3978952727983707
826,11,2.3978952727983707
audits,11,2.3978952727983707
β2-agonists,11,2.3978952727983707
SRH,11,2.3978952727983707
small-artery,11,2.3978952727983707
heaves,11,2.3978952727983707
ADCC,11,2.3978952727983707
969,11,2.3978952727983707
aerosolization,11,2.3978952727983707
givers,11,2.3978952727983707
awaits,11,2.3978952727983707
Altered,11,2.3978952727983707
P0006,11,2.3978952727983707
PRNT90,11,2.3978952727983707
dismal,11,2.3978952727983707
GDP,11,2.3978952727983707
Interim,11,2.3978952727983707
proceeds,11,2.3978952727983707
transfection,11,2.3978952727983707
675,11,2.3978952727983707
916,11,2.3978952727983707
insidious,11,2.3978952727983707
BioFire,11,2.3978952727983707
Steroid,11,2.3978952727983707
olfaction,11,2.3978952727983707
outgrown,11,2.3978952727983707
MHC-I,11,2.3978952727983707
suitably,11,2.3978952727983707
Risks,11,2.3978952727983707
preprocedural,11,2.3978952727983707
860,11,2.3978952727983707
EVH,11,2.3978952727983707
antiischemic,11,2.3978952727983707
furosemide,11,2.3978952727983707
networked,11,2.3978952727983707
tertiary-care,11,2.3978952727983707
744,11,2.3978952727983707
fur,11,2.3978952727983707
25-50,11,2.3978952727983707
615,11,2.3978952727983707
1965,11,2.3978952727983707
LKN,11,2.3978952727983707
ultrasonographic,11,2.3978952727983707
sever,11,2.3978952727983707
neuroprotectants,11,2.3978952727983707
leather,11,2.3978952727983707
uniformity,11,2.3978952727983707
medRxiv,11,2.3978952727983707
0038,11,2.3978952727983707
unsuspected,11,2.3978952727983707
citizen,11,2.3978952727983707
neurosurgeons,11,2.3978952727983707
phenomenological,11,2.3978952727983707
psychiatrists,11,2.3978952727983707
editor,11,2.3978952727983707
myopericarditis,11,2.3978952727983707
10-5,11,2.3978952727983707
Industrial,11,2.3978952727983707
Newcastle,11,2.3978952727983707
one-fourth,11,2.3978952727983707
77-year-old,11,2.3978952727983707
superfamily,11,2.3978952727983707
Hamilton,11,2.3978952727983707
IVA,11,2.3978952727983707
Vaxigrip,11,2.3978952727983707
Alcohol,11,2.3978952727983707
850,11,2.3978952727983707
Yoga,11,2.3978952727983707
first-degree,11,2.3978952727983707
16-64,11,2.3978952727983707
570,11,2.3978952727983707
plates,11,2.3978952727983707
abreast,10,2.302585092994046
high-speed,10,2.302585092994046
617,10,2.302585092994046
seroepidemiologic,10,2.302585092994046
steroid-sparing,10,2.302585092994046
Ml,10,2.302585092994046
Presentation,10,2.302585092994046
time-resolved,10,2.302585092994046
follow-ups,10,2.302585092994046
badly,10,2.302585092994046
lyophilized,10,2.302585092994046
refining,10,2.302585092994046
MFEIT,10,2.302585092994046
larynx,10,2.302585092994046
instigated,10,2.302585092994046
punctuated,10,2.302585092994046
recanalize,10,2.302585092994046
danders,10,2.302585092994046
TAQLQ,10,2.302585092994046
M2e,10,2.302585092994046
Novosibirsk,10,2.302585092994046
outdoors,10,2.302585092994046
980,10,2.302585092994046
Sometimes,10,2.302585092994046
199899,10,2.302585092994046
predominating,10,2.302585092994046
stiffening,10,2.302585092994046
allantoic,10,2.302585092994046
comparably,10,2.302585092994046
SGA,10,2.302585092994046
Throat,10,2.302585092994046
856,10,2.302585092994046
GL,10,2.302585092994046
suction,10,2.302585092994046
0-19,10,2.302585092994046
Confirmed,10,2.302585092994046
fractured,10,2.302585092994046
Grading,10,2.302585092994046
aprotinin,10,2.302585092994046
interleukin-1,10,2.302585092994046
CGA,10,2.302585092994046
liberal,10,2.302585092994046
Ad26,10,2.302585092994046
Actually,10,2.302585092994046
noradrenaline,10,2.302585092994046
essentials,10,2.302585092994046
simplest,10,2.302585092994046
20B,10,2.302585092994046
1213,10,2.302585092994046
Nitroglycerin,10,2.302585092994046
broadening,10,2.302585092994046
midnight,10,2.302585092994046
TI,10,2.302585092994046
Products,10,2.302585092994046
one-way,10,2.302585092994046
discontinuous,10,2.302585092994046
Topics,10,2.302585092994046
maternal-fetal,10,2.302585092994046
manifold,10,2.302585092994046
Coxs,10,2.302585092994046
TGF-beta,10,2.302585092994046
Ensuring,10,2.302585092994046
H2O,10,2.302585092994046
GWASs,10,2.302585092994046
veno-arterial,10,2.302585092994046
Intrinsic,10,2.302585092994046
Perindopril,10,2.302585092994046
J-shaped,10,2.302585092994046
SEP,10,2.302585092994046
stroke-prone,10,2.302585092994046
propagating,10,2.302585092994046
headings,10,2.302585092994046
patient-related,10,2.302585092994046
Yearly,10,2.302585092994046
7-9,10,2.302585092994046
flare,10,2.302585092994046
nitroglycerine,10,2.302585092994046
congruence,10,2.302585092994046
ninety,10,2.302585092994046
aspirin-sensitive,10,2.302585092994046
industrialization,10,2.302585092994046
Gulf,10,2.302585092994046
Mothers,10,2.302585092994046
underreported,10,2.302585092994046
cardial,10,2.302585092994046
Rupture,10,2.302585092994046
predicated,10,2.302585092994046
Urinary,10,2.302585092994046
autoantibody,10,2.302585092994046
4°C,10,2.302585092994046
in-silico,10,2.302585092994046
tooth,10,2.302585092994046
Tools,10,2.302585092994046
batches,10,2.302585092994046
6-14,10,2.302585092994046
integrins,10,2.302585092994046
noticeably,10,2.302585092994046
Rare,10,2.302585092994046
dominating,10,2.302585092994046
Pradesh,10,2.302585092994046
non-randomized,10,2.302585092994046
AOM,10,2.302585092994046
kinematic,10,2.302585092994046
11-15,10,2.302585092994046
probiotic,10,2.302585092994046
extravasation,10,2.302585092994046
20-year,10,2.302585092994046
pelvic,10,2.302585092994046
desquamation,10,2.302585092994046
CRPS,10,2.302585092994046
splenial,10,2.302585092994046
conjugates,10,2.302585092994046
mimicked,10,2.302585092994046
re-examined,10,2.302585092994046
invades,10,2.302585092994046
Re,10,2.302585092994046
Winnipeg,10,2.302585092994046
philosophical,10,2.302585092994046
Communicated,10,2.302585092994046
RSCEM,10,2.302585092994046
biogenesis,10,2.302585092994046
cleaners,10,2.302585092994046
668,10,2.302585092994046
PU,10,2.302585092994046
midturbinate,10,2.302585092994046
administrations,10,2.302585092994046
splanchnic,10,2.302585092994046
nonproductive,10,2.302585092994046
mask-wearing,10,2.302585092994046
unambiguous,10,2.302585092994046
RG-rescued,10,2.302585092994046
ischemia-induced,10,2.302585092994046
CRF,10,2.302585092994046
orchestrate,10,2.302585092994046
antiaggregant,10,2.302585092994046
timed,10,2.302585092994046
oxidized,10,2.302585092994046
Allergology,10,2.302585092994046
hypnotic,10,2.302585092994046
elongation,10,2.302585092994046
recognising,10,2.302585092994046
subdural,10,2.302585092994046
nanopore,10,2.302585092994046
Standards,10,2.302585092994046
pension,10,2.302585092994046
PC-ASPECTS,10,2.302585092994046
parasternal,10,2.302585092994046
Presenting,10,2.302585092994046
self-quarantine,10,2.302585092994046
Virological,10,2.302585092994046
oro-nasopharyngeal,10,2.302585092994046
Wide,10,2.302585092994046
Minimal,10,2.302585092994046
Bax,10,2.302585092994046
VNT,10,2.302585092994046
25-year-old,10,2.302585092994046
LRI,10,2.302585092994046
vaccine-resistant,10,2.302585092994046
reminds,10,2.302585092994046
Similarities,10,2.302585092994046
seal,10,2.302585092994046
403,10,2.302585092994046
Uruguay,10,2.302585092994046
midwives,10,2.302585092994046
Vaccinated,10,2.302585092994046
Coordination,10,2.302585092994046
Verapamil,10,2.302585092994046
anti-neuraminidase,10,2.302585092994046
antivirus,10,2.302585092994046
931,10,2.302585092994046
polarized,10,2.302585092994046
direct-acting,10,2.302585092994046
EAP,10,2.302585092994046
vertically,10,2.302585092994046
Immunohistochemistry,10,2.302585092994046
reopened,10,2.302585092994046
sentiment,10,2.302585092994046
nasopharyngealoropharyngeal,10,2.302585092994046
E2,10,2.302585092994046
RNAaemia,10,2.302585092994046
RANTES,10,2.302585092994046
clinic-based,10,2.302585092994046
SMC,10,2.302585092994046
neuropeptides,10,2.302585092994046
sulfur,10,2.302585092994046
pfu,10,2.302585092994046
osmolarity,10,2.302585092994046
system-wide,10,2.302585092994046
Start,10,2.302585092994046
phasic,10,2.302585092994046
Repurposing,10,2.302585092994046
amidst,10,2.302585092994046
pubertal,10,2.302585092994046
ignorance,10,2.302585092994046
AIMI,10,2.302585092994046
cardiac-related,10,2.302585092994046
T2WI,10,2.302585092994046
succinct,10,2.302585092994046
settlements,10,2.302585092994046
reliant,10,2.302585092994046
sizeable,10,2.302585092994046
Potentially,10,2.302585092994046
talks,10,2.302585092994046
GenBank,10,2.302585092994046
interdependence,10,2.302585092994046
unremitting,10,2.302585092994046
AP-1,10,2.302585092994046
AH1N1pdm2009,10,2.302585092994046
metallic,10,2.302585092994046
httpswwwclinicaltrialsgov,10,2.302585092994046
Week,10,2.302585092994046
Delivery,10,2.302585092994046
Or,10,2.302585092994046
implants,10,2.302585092994046
incoming,10,2.302585092994046
Zol,10,2.302585092994046
re-evaluate,10,2.302585092994046
precedent,10,2.302585092994046
VPS,10,2.302585092994046
vascularity,10,2.302585092994046
Multidimensional,10,2.302585092994046
paucigranulocytic,10,2.302585092994046
frontiers,10,2.302585092994046
Bonferroni,10,2.302585092994046
dipeptidyl,10,2.302585092994046
hosted,10,2.302585092994046
abstinence,10,2.302585092994046
CBD,10,2.302585092994046
taxa,10,2.302585092994046
Target,10,2.302585092994046
Northwestern,10,2.302585092994046
tentative,10,2.302585092994046
817,10,2.302585092994046
Klebsiella,10,2.302585092994046
PBMC,10,2.302585092994046
parallel-group,10,2.302585092994046
liposomal,10,2.302585092994046
snoring,10,2.302585092994046
ever-increasing,10,2.302585092994046
coordinator,10,2.302585092994046
pre-eclampsia,10,2.302585092994046
EuroImmun,10,2.302585092994046
ONT,10,2.302585092994046
remit,10,2.302585092994046
U-BIOPRED,10,2.302585092994046
noninfarct,10,2.302585092994046
miR-1,10,2.302585092994046
844,10,2.302585092994046
Technetium,10,2.302585092994046
CT-scan,10,2.302585092994046
midlife,10,2.302585092994046
AU,10,2.302585092994046
schema,10,2.302585092994046
modular,10,2.302585092994046
benzodiazepine,10,2.302585092994046
names,10,2.302585092994046
Seventy-six,10,2.302585092994046
multimodality,10,2.302585092994046
meta-regression,10,2.302585092994046
Pittsburgh,10,2.302585092994046
Ninety-five,10,2.302585092994046
non-inferiority,10,2.302585092994046
Lead,10,2.302585092994046
public-private,10,2.302585092994046
depolarizations,10,2.302585092994046
Biotechnology,10,2.302585092994046
revisions,10,2.302585092994046
PES,10,2.302585092994046
ABeijing26295,10,2.302585092994046
GFP,10,2.302585092994046
corticoids,10,2.302585092994046
awoke,10,2.302585092994046
benefit-risk,10,2.302585092994046
oil-in-water,10,2.302585092994046
non-dominant,10,2.302585092994046
breathe,10,2.302585092994046
insightful,10,2.302585092994046
lends,10,2.302585092994046
mail,10,2.302585092994046
urticarial,10,2.302585092994046
immunologists,10,2.302585092994046
tragic,10,2.302585092994046
taxonomic,10,2.302585092994046
MVO2,10,2.302585092994046
richness,10,2.302585092994046
retail,10,2.302585092994046
inspire,10,2.302585092994046
full-term,10,2.302585092994046
commensal,10,2.302585092994046
Return,10,2.302585092994046
Comorbidities,10,2.302585092994046
796,10,2.302585092994046
transfected,10,2.302585092994046
doesnt,10,2.302585092994046
malperfusion,10,2.302585092994046
radioisotope,10,2.302585092994046
POEMS,10,2.302585092994046
heralded,10,2.302585092994046
prominence,10,2.302585092994046
Obtaining,10,2.302585092994046
warn,10,2.302585092994046
needles,10,2.302585092994046
whole-body,10,2.302585092994046
co-workers,10,2.302585092994046
hurdle,10,2.302585092994046
hypothalamic-pituitary-adrenal,10,2.302585092994046
exploits,10,2.302585092994046
suffice,10,2.302585092994046
Signal,10,2.302585092994046
839,10,2.302585092994046
6-18,10,2.302585092994046
spirit,10,2.302585092994046
Zoonotic,10,2.302585092994046
Backgrounds,10,2.302585092994046
Southwest,10,2.302585092994046
PMA,10,2.302585092994046
mid-turbinate,10,2.302585092994046
Montelukast,10,2.302585092994046
incentive,10,2.302585092994046
first-dose,10,2.302585092994046
internet-based,10,2.302585092994046
exposes,10,2.302585092994046
See,10,2.302585092994046
2-dose,10,2.302585092994046
announcements,10,2.302585092994046
elicitation,10,2.302585092994046
CSR,10,2.302585092994046
decrements,10,2.302585092994046
unwarranted,10,2.302585092994046
Too,10,2.302585092994046
Changsha,10,2.302585092994046
Arbidol,10,2.302585092994046
grippe,10,2.302585092994046
albino,10,2.302585092994046
pre-test,10,2.302585092994046
AEP,10,2.302585092994046
966,10,2.302585092994046
Zimbabwe,10,2.302585092994046
Bay,10,2.302585092994046
904,10,2.302585092994046
analytically,10,2.302585092994046
cardioverter,10,2.302585092994046
Robust,10,2.302585092994046
caseload,10,2.302585092994046
anti-S1,10,2.302585092994046
sialylated,10,2.302585092994046
modifier,10,2.302585092994046
damp,10,2.302585092994046
H1N1-induced,10,2.302585092994046
Observation,10,2.302585092994046
Concordance,10,2.302585092994046
duplicate,10,2.302585092994046
Nonspecific,10,2.302585092994046
dimensionality,10,2.302585092994046
GPX-1,10,2.302585092994046
physiotherapists,10,2.302585092994046
prejudice,10,2.302585092994046
MSU,10,2.302585092994046
Zambia,10,2.302585092994046
breastfeed,10,2.302585092994046
effluent,10,2.302585092994046
hopelessness,10,2.302585092994046
dot,10,2.302585092994046
PMWs,10,2.302585092994046
Patterns,10,2.302585092994046
unraveled,10,2.302585092994046
pseudoviral,10,2.302585092994046
rewarding,10,2.302585092994046
anti-IL-5,10,2.302585092994046
ARIs,10,2.302585092994046
Kong873,10,2.302585092994046
subclass,10,2.302585092994046
substantive,10,2.302585092994046
cocaine-associated,10,2.302585092994046
MTT,10,2.302585092994046
life-long,10,2.302585092994046
stricter,10,2.302585092994046
Basel,10,2.302585092994046
resp,10,2.302585092994046
Genomics,10,2.302585092994046
treatment-seeking,10,2.302585092994046
selects,10,2.302585092994046
analytics,10,2.302585092994046
inter-,10,2.302585092994046
Ricans,10,2.302585092994046
enzootic,10,2.302585092994046
modulator,10,2.302585092994046
AUSSR,10,2.302585092994046
PRNT50,10,2.302585092994046
orthopedic,10,2.302585092994046
Devices,10,2.302585092994046
proprietary,10,2.302585092994046
scratch,10,2.302585092994046
lady,10,2.302585092994046
monographs,10,2.302585092994046
Evolution,10,2.302585092994046
brisk,10,2.302585092994046
campuses,10,2.302585092994046
authorised,10,2.302585092994046
MCCD,10,2.302585092994046
DET,10,2.302585092994046
ADAPT,10,2.302585092994046
858,10,2.302585092994046
RVP,10,2.302585092994046
contend,10,2.302585092994046
under-diagnosis,10,2.302585092994046
sufficiency,10,2.302585092994046
cue,10,2.302585092994046
cocaine-related,10,2.302585092994046
etiopathogenetic,10,2.302585092994046
RNA-Seq,10,2.302585092994046
practolol,10,2.302585092994046
inductive,10,2.302585092994046
enacted,10,2.302585092994046
Falls,10,2.302585092994046
colony-stimulating,10,2.302585092994046
exposome,10,2.302585092994046
HCs,10,2.302585092994046
Remodeling,10,2.302585092994046
dsDNA,10,2.302585092994046
COS,10,2.302585092994046
four-year,10,2.302585092994046
deciphering,10,2.302585092994046
ligating,10,2.302585092994046
TI-201,10,2.302585092994046
SHA,10,2.302585092994046
drinks,10,2.302585092994046
623,10,2.302585092994046
cost-utility,10,2.302585092994046
961,10,2.302585092994046
mA,10,2.302585092994046
Lactobacillus,10,2.302585092994046
HSPA12A,10,2.302585092994046
moves,10,2.302585092994046
B11,10,2.302585092994046
1947,10,2.302585092994046
KATP,10,2.302585092994046
practicability,10,2.302585092994046
reside,10,2.302585092994046
Predischarge,10,2.302585092994046
prominently,10,2.302585092994046
MID,10,2.302585092994046
post-hoc,10,2.302585092994046
understandable,10,2.302585092994046
unstructured,10,2.302585092994046
neurobiology,10,2.302585092994046
two-way,10,2.302585092994046
illegal,10,2.302585092994046
occupants,10,2.302585092994046
hemispatial,10,2.302585092994046
choroidal,10,2.302585092994046
amnesia,10,2.302585092994046
Lymphopenia,10,2.302585092994046
oxygenator,10,2.302585092994046
SUA,10,2.302585092994046
Intraaortic,10,2.302585092994046
Am,10,2.302585092994046
HEDIS,10,2.302585092994046
party,10,2.302585092994046
tacrolimus,10,2.302585092994046
standstill,10,2.302585092994046
BSPM,10,2.302585092994046
HCRU,10,2.302585092994046
intentional,10,2.302585092994046
wireless,10,2.302585092994046
engine,10,2.302585092994046
Carefully,10,2.302585092994046
hypothetically,10,2.302585092994046
intermittently,10,2.302585092994046
eliminates,10,2.302585092994046
Eighty-eight,10,2.302585092994046
pharmacogenomic,10,2.302585092994046
residency,10,2.302585092994046
LSA,10,2.302585092994046
neglecting,10,2.302585092994046
Mismatch,10,2.302585092994046
749,10,2.302585092994046
s-Se,10,2.302585092994046
AHAASA,10,2.302585092994046
annum,10,2.302585092994046
15-24,10,2.302585092994046
FluA,10,2.302585092994046
H7N2,10,2.302585092994046
type-specific,10,2.302585092994046
menstruation,10,2.302585092994046
non-smoking,10,2.302585092994046
retraction,10,2.302585092994046
TIM-1,10,2.302585092994046
915,10,2.302585092994046
metastasis,10,2.302585092994046
nanobiosensors,10,2.302585092994046
Non-Q,10,2.302585092994046
Ascaris,10,2.302585092994046
specifying,10,2.302585092994046
NMDA,10,2.302585092994046
skepticism,10,2.302585092994046
bites,10,2.302585092994046
Patency,10,2.302585092994046
serosurvey,10,2.302585092994046
contemplated,10,2.302585092994046
catching,10,2.302585092994046
lacunes,10,2.302585092994046
locomotor,10,2.302585092994046
rearrangement,10,2.302585092994046
Looking,10,2.302585092994046
condensates,10,2.302585092994046
antianginal,10,2.302585092994046
1115,10,2.302585092994046
diffusing,10,2.302585092994046
urban-rural,10,2.302585092994046
Pathway,10,2.302585092994046
Cystic,10,2.302585092994046
elastance,10,2.302585092994046
SCIs,10,2.302585092994046
SPS3,10,2.302585092994046
transradial,10,2.302585092994046
infestation,10,2.302585092994046
dollar,10,2.302585092994046
Mondays,10,2.302585092994046
mastocytes,10,2.302585092994046
chemistries,10,2.302585092994046
anoxia,10,2.302585092994046
bradyarrhythmias,10,2.302585092994046
hemodialyzed,10,2.302585092994046
COVID-19s,10,2.302585092994046
Reading,10,2.302585092994046
0022,10,2.302585092994046
rheology,10,2.302585092994046
collated,10,2.302585092994046
lysosomal,10,2.302585092994046
tenfold,10,2.302585092994046
Standardization,10,2.302585092994046
conceptualized,10,2.302585092994046
hepatocytes,10,2.302585092994046
latitudes,10,2.302585092994046
Trade,10,2.302585092994046
vial,10,2.302585092994046
EMA,10,2.302585092994046
influenza-negative,10,2.302585092994046
differentials,10,2.302585092994046
VV-ECMO,10,2.302585092994046
808,10,2.302585092994046
RTI,10,2.302585092994046
Mixed,10,2.302585092994046
hand-held,10,2.302585092994046
laborious,10,2.302585092994046
authorizations,10,2.302585092994046
anticardiolipin,10,2.302585092994046
linkers,10,2.302585092994046
asymmetrical,10,2.302585092994046
plastics,10,2.302585092994046
multi-centre,10,2.302585092994046
reappraisal,10,2.302585092994046
interrelationship,10,2.302585092994046
incredible,10,2.302585092994046
6-35,10,2.302585092994046
flying,10,2.302585092994046
irrelevant,10,2.302585092994046
deteriorates,10,2.302585092994046
re-elevation,10,2.302585092994046
Extracellular,10,2.302585092994046
download,10,2.302585092994046
CHO,10,2.302585092994046
Members,10,2.302585092994046
Pandemrix,10,2.302585092994046
nares,10,2.302585092994046
protein-1,10,2.302585092994046
acute-onset,10,2.302585092994046
radically,10,2.302585092994046
Team,10,2.302585092994046
nonagenarians,10,2.302585092994046
bioaerosols,10,2.302585092994046
C-STAT,10,2.302585092994046
fewest,10,2.302585092994046
861,10,2.302585092994046
unveiled,10,2.302585092994046
Informed,10,2.302585092994046
microgramskg,10,2.302585092994046
breeding,10,2.302585092994046
polycythemia,10,2.302585092994046
758,10,2.302585092994046
n5,10,2.302585092994046
electrostatic,10,2.302585092994046
Nonpharmacologic,10,2.302585092994046
679,10,2.302585092994046
intuitive,10,2.302585092994046
follicular,10,2.302585092994046
Pan,10,2.302585092994046
ramipril,10,2.302585092994046
ECLIA,10,2.302585092994046
20172018,10,2.302585092994046
Betacoronaviruses,10,2.302585092994046
blogs,10,2.302585092994046
grasp,10,2.302585092994046
gastro-esophageal,10,2.302585092994046
medicaments,10,2.302585092994046
9-10,10,2.302585092994046
co-existence,10,2.302585092994046
6-24,10,2.302585092994046
substituted,10,2.302585092994046
SAD,10,2.302585092994046
Age-adjusted,10,2.302585092994046
DUSP4,10,2.302585092994046
noxious,10,2.302585092994046
allopurinol,10,2.302585092994046
BUN,10,2.302585092994046
18-59,10,2.302585092994046
Seventy-one,10,2.302585092994046
H2S,10,2.302585092994046
harnessing,10,2.302585092994046
Regulation,10,2.302585092994046
3C2a,10,2.302585092994046
work-relatedness,10,2.302585092994046
canonical,10,2.302585092994046
affairs,10,2.302585092994046
Light,10,2.302585092994046
-8,10,2.302585092994046
reassort,10,2.302585092994046
Escherichia,10,2.302585092994046
BLL,10,2.302585092994046
infectives,10,2.302585092994046
stochasticity,10,2.302585092994046
SUD,10,2.302585092994046
mLmin,10,2.302585092994046
heterogeneities,10,2.302585092994046
890,10,2.302585092994046
tracers,10,2.302585092994046
post-transplantation,10,2.302585092994046
FET,10,2.302585092994046
Suppression,10,2.302585092994046
breastfed,10,2.302585092994046
Wilcoxon,10,2.302585092994046
Ninety-two,10,2.302585092994046
715,10,2.302585092994046
eradicating,10,2.302585092994046
Dual,10,2.302585092994046
Romanian,10,2.302585092994046
echocardiographically,10,2.302585092994046
lysine,10,2.302585092994046
687,10,2.302585092994046
H5N8,10,2.302585092994046
Eventually,10,2.302585092994046
amino-acid,10,2.302585092994046
evaluative,10,2.302585092994046
942,10,2.302585092994046
happening,10,2.302585092994046
early-,10,2.302585092994046
558,10,2.302585092994046
straight,10,2.302585092994046
Simplexa,10,2.302585092994046
concurrence,10,2.302585092994046
reticularis,10,2.302585092994046
ciliated,10,2.302585092994046
intra-thoracic,10,2.302585092994046
retirement,10,2.302585092994046
buying,10,2.302585092994046
print,10,2.302585092994046
iterative,10,2.302585092994046
NET,10,2.302585092994046
aggravates,10,2.302585092994046
Options,10,2.302585092994046
862,10,2.302585092994046
stress-related,10,2.302585092994046
ACVS,10,2.302585092994046
intestines,10,2.302585092994046
Electron,10,2.302585092994046
742,10,2.302585092994046
1962,10,2.302585092994046
5-,10,2.302585092994046
1935,10,2.302585092994046
invasiveness,10,2.302585092994046
DE-MRI,10,2.302585092994046
equilibria,10,2.302585092994046
REM,10,2.302585092994046
immune-based,10,2.302585092994046
mutism,10,2.302585092994046
Module,10,2.302585092994046
Characteristic,10,2.302585092994046
Surgeons,10,2.302585092994046
Cath,10,2.302585092994046
NT,10,2.302585092994046
Municipal,10,2.302585092994046
roentgenogram,10,2.302585092994046
late-stage,10,2.302585092994046
End,10,2.302585092994046
447,10,2.302585092994046
2005-06,10,2.302585092994046
heritability,10,2.302585092994046
motives,10,2.302585092994046
correspondingly,10,2.302585092994046
airspace,10,2.302585092994046
unemployed,10,2.302585092994046
Winter,10,2.302585092994046
inotropes,10,2.302585092994046
dermatologic,10,2.302585092994046
colitis,10,2.302585092994046
Segmental,10,2.302585092994046
bacteriological,10,2.302585092994046
belt,10,2.302585092994046
OPN,10,2.302585092994046
Anticoagulants,10,2.302585092994046
marriage,10,2.302585092994046
in-vivo,10,2.302585092994046
himself,10,2.302585092994046
adhesions,10,2.302585092994046
Histologic,10,2.302585092994046
heredity,10,2.302585092994046
2-day,10,2.302585092994046
day-care,10,2.302585092994046
Words,10,2.302585092994046
Kaiser,10,2.302585092994046
double-membrane,10,2.302585092994046
harnessed,10,2.302585092994046
perpetuate,10,2.302585092994046
desaturation,10,2.302585092994046
renamed,10,2.302585092994046
Amazon,10,2.302585092994046
671,10,2.302585092994046
endangered,10,2.302585092994046
famous,10,2.302585092994046
HWM,10,2.302585092994046
flooding,10,2.302585092994046
Extreme,10,2.302585092994046
prioritised,10,2.302585092994046
Pollen,10,2.302585092994046
pesticides,10,2.302585092994046
Century,10,2.302585092994046
conform,10,2.302585092994046
Alongside,10,2.302585092994046
atria,10,2.302585092994046
high-touch,10,2.302585092994046
Ventilation,10,2.302585092994046
4G5G,10,2.302585092994046
Caution,10,2.302585092994046
destroyed,10,2.302585092994046
bystanders,10,2.302585092994046
abandoned,10,2.302585092994046
brain-derived,10,2.302585092994046
Simulation,10,2.302585092994046
regaining,10,2.302585092994046
trainings,10,2.302585092994046
Minority,10,2.302585092994046
optional,10,2.302585092994046
LVR,10,2.302585092994046
April-June,10,2.302585092994046
powerlessness,10,2.302585092994046
methylenetetrahydrofolate,10,2.302585092994046
608,10,2.302585092994046
granules,10,2.302585092994046
under-treatment,10,2.302585092994046
Baltimore,10,2.302585092994046
cathepsin,10,2.302585092994046
Conflicting,10,2.302585092994046
excavatum,10,2.302585092994046
GAP,10,2.302585092994046
RSD,10,2.302585092994046
twenty-nine,10,2.302585092994046
David,10,2.302585092994046
overtreatment,10,2.302585092994046
feed,10,2.302585092994046
prompts,10,2.302585092994046
woods,10,2.302585092994046
Dysregulation,10,2.302585092994046
full-text,10,2.302585092994046
19B,10,2.302585092994046
visualizing,10,2.302585092994046
usable,10,2.302585092994046
GST,10,2.302585092994046
promoters,10,2.302585092994046
HDAC11,10,2.302585092994046
toxin,10,2.302585092994046
communal,10,2.302585092994046
EMs,10,2.302585092994046
enterocytes,10,2.302585092994046
BCT,10,2.302585092994046
molecular-based,10,2.302585092994046
interferon-γ,10,2.302585092994046
aVE,10,2.302585092994046
neuroendovascular,10,2.302585092994046
beta2-adrenergic,10,2.302585092994046
perceiving,10,2.302585092994046
cloth,10,2.302585092994046
greenspace,10,2.302585092994046
crying,10,2.302585092994046
S1P,10,2.302585092994046
arthralgia,10,2.302585092994046
BID,10,2.302585092994046
cofactors,10,2.302585092994046
EDV,10,2.302585092994046
ICER,10,2.302585092994046
GSK,10,2.302585092994046
talking,10,2.302585092994046
join,10,2.302585092994046
macroscopically,10,2.302585092994046
far-UVC,10,2.302585092994046
keys,10,2.302585092994046
Saint,10,2.302585092994046
NIOX,10,2.302585092994046
tempered,10,2.302585092994046
MODS,10,2.302585092994046
veterinarians,10,2.302585092994046
bronchomotor,10,2.302585092994046
shop,10,2.302585092994046
863,10,2.302585092994046
Malignant,10,2.302585092994046
Face,10,2.302585092994046
Pbm,10,2.302585092994046
IL-22,10,2.302585092994046
68-year-old,10,2.302585092994046
drawings,10,2.302585092994046
25000,10,2.302585092994046
tRNA,10,2.302585092994046
SVT,10,2.302585092994046
cross-talk,10,2.302585092994046
712,10,2.302585092994046
granulocytes,10,2.302585092994046
osmolality,10,2.302585092994046
triamcinolone,10,2.302585092994046
Notifiable,10,2.302585092994046
Thromboembolic,10,2.302585092994046
Percent,10,2.302585092994046
Alexithymia,10,2.302585092994046
No-reflow,10,2.302585092994046
6-17,10,2.302585092994046
workshops,10,2.302585092994046
Ribavirin,10,2.302585092994046
1999-2008,10,2.302585092994046
772,10,2.302585092994046
Virtually,10,2.302585092994046
Decisions,10,2.302585092994046
MEV,10,2.302585092994046
Fourier,10,2.302585092994046
hampers,10,2.302585092994046
hematomas,10,2.302585092994046
insured,10,2.302585092994046
GlaxoSmithKline,10,2.302585092994046
alleged,10,2.302585092994046
Wastewater-based,10,2.302585092994046
Delirium,10,2.302585092994046
circumstance,10,2.302585092994046
Relationships,10,2.302585092994046
Simpsons,10,2.302585092994046
Taxonomy,10,2.302585092994046
LNP,10,2.302585092994046
immune-modulating,10,2.302585092994046
bare-metal,10,2.302585092994046
NSSTTAs,10,2.302585092994046
cell-specific,10,2.302585092994046
724,10,2.302585092994046
altruism,10,2.302585092994046
MET,10,2.302585092994046
High-throughput,10,2.302585092994046
paediatrics,10,2.302585092994046
Sanger,10,2.302585092994046
Alternate,10,2.302585092994046
interleukins,10,2.302585092994046
Embolism,10,2.302585092994046
APhilippines282,10,2.302585092994046
CTLs,10,2.302585092994046
postintervention,10,2.302585092994046
accountable,10,2.302585092994046
Acid,10,2.302585092994046
εs,10,2.302585092994046
Interferon,10,2.302585092994046
lymphohistiocytosis,10,2.302585092994046
4-7,10,2.302585092994046
spin-echo,10,2.302585092994046
Luminex,10,2.302585092994046
polyphenols,10,2.302585092994046
depleted,10,2.302585092994046
tryptase,10,2.302585092994046
lagged,10,2.302585092994046
Comorbid,10,2.302585092994046
academics,10,2.302585092994046
retired,10,2.302585092994046
naturalistic,10,2.302585092994046
unrecognised,10,2.302585092994046
hardest,10,2.302585092994046
Synthetic,10,2.302585092994046
supposedly,10,2.302585092994046
small-,10,2.302585092994046
s-1,10,2.302585092994046
PRV,10,2.302585092994046
REVASCAT,10,2.302585092994046
nationalism,10,2.302585092994046
bore,10,2.302585092994046
posttest,10,2.302585092994046
modulatory,10,2.302585092994046
737,10,2.302585092994046
150000,10,2.302585092994046
Occurrence,10,2.302585092994046
securing,10,2.302585092994046
pilgrimage,10,2.302585092994046
EchoCG,10,2.302585092994046
Split,10,2.302585092994046
TLR7,10,2.302585092994046
numerically,10,2.302585092994046
internally,10,2.302585092994046
1014,10,2.302585092994046
Protocols,10,2.302585092994046
8000,10,2.302585092994046
drip,10,2.302585092994046
SMB,10,2.302585092994046
mg100,10,2.302585092994046
hesitation,10,2.302585092994046
Commentary,10,2.302585092994046
travel-related,10,2.302585092994046
P2Y12,10,2.302585092994046
SPMA,10,2.302585092994046
ESR,10,2.302585092994046
Immunoglobulin,10,2.302585092994046
pericardiocentesis,10,2.302585092994046
downregulate,10,2.302585092994046
659,10,2.302585092994046
Self-Efficacy,10,2.302585092994046
expanders,10,2.302585092994046
uneventfully,10,2.302585092994046
growers,10,2.302585092994046
906,10,2.302585092994046
935,10,2.302585092994046
PCV,10,2.302585092994046
Immunofluorescence,10,2.302585092994046
SDchord,10,2.302585092994046
NOW®,10,2.302585092994046
lncRNA,10,2.302585092994046
MB-CPK,10,2.302585092994046
survivorship,10,2.302585092994046
Covid,10,2.302585092994046
deformity,10,2.302585092994046
-20,10,2.302585092994046
SCF,10,2.302585092994046
basketball,10,2.302585092994046
benidipine,10,2.302585092994046
Fontan,10,2.302585092994046
1957-58,10,2.302585092994046
placebos,10,2.302585092994046
denervated,10,2.302585092994046
excitement,10,2.302585092994046
sinonasal,10,2.302585092994046
precaution,10,2.302585092994046
Bangkok,10,2.302585092994046
ICSLABA,10,2.302585092994046
retard,10,2.302585092994046
normalisation,10,2.302585092994046
dsRNA,10,2.302585092994046
ketoacidosis,10,2.302585092994046
hyperkinesia,10,2.302585092994046
Skills,10,2.302585092994046
crews,10,2.302585092994046
preprint,10,2.302585092994046
Hill,10,2.302585092994046
scanners,10,2.302585092994046
po,10,2.302585092994046
bee,10,2.302585092994046
Bureau,10,2.302585092994046
2a,10,2.302585092994046
1800,10,2.302585092994046
alien,10,2.302585092994046
C677T,10,2.302585092994046
sneezes,10,2.302585092994046
COVID-19-induced,10,2.302585092994046
striatum,10,2.302585092994046
PO2,10,2.302585092994046
LTB4,10,2.302585092994046
TEC,10,2.302585092994046
reemerging,10,2.302585092994046
10-3,10,2.302585092994046
perilesional,10,2.302585092994046
AUFVC,10,2.302585092994046
18-item,10,2.302585092994046
covariance,10,2.302585092994046
convinced,10,2.302585092994046
combatting,10,2.302585092994046
Responsiveness,10,2.302585092994046
IIa,10,2.302585092994046
12-18,10,2.302585092994046
psychoemotional,10,2.302585092994046
deleted,10,2.302585092994046
manager,10,2.302585092994046
0600,10,2.302585092994046
SYBR,10,2.302585092994046
cease,10,2.302585092994046
Proust,10,2.302585092994046
Isothermal,10,2.302585092994046
SOFIA,10,2.302585092994046
0-10,10,2.302585092994046
10-13,10,2.302585092994046
MU,10,2.302585092994046
hyperemia,10,2.302585092994046
Incident,10,2.302585092994046
exchanges,10,2.302585092994046
PRNT,10,2.302585092994046
CNKI,10,2.302585092994046
Ceará,10,2.302585092994046
IG,10,2.302585092994046
occluder,10,2.302585092994046
valued,10,2.302585092994046
betegek,10,2.302585092994046
propelled,10,2.302585092994046
single-blind,10,2.302585092994046
endeavors,10,2.302585092994046
degraded,10,2.302585092994046
bursts,10,2.302585092994046
deconditioning,10,2.302585092994046
iCR,10,2.302585092994046
interleukin-4,10,2.302585092994046
Sinai,10,2.302585092994046
high-efficiency,10,2.302585092994046
non-culprit,10,2.302585092994046
5-11,10,2.302585092994046
harness,10,2.302585092994046
sicker,10,2.302585092994046
mutates,10,2.302585092994046
dimerization,10,2.302585092994046
posit,10,2.302585092994046
stray,10,2.302585092994046
primerprobe,10,2.302585092994046
brother,10,2.302585092994046
Midwest,10,2.302585092994046
EQA,10,2.302585092994046
mucoid,10,2.302585092994046
FES,10,2.302585092994046
non-exposed,10,2.302585092994046
counsel,10,2.302585092994046
phospholipid,10,2.302585092994046
0027,10,2.302585092994046
Összefoglaló,10,2.302585092994046
computation,10,2.302585092994046
ailments,10,2.302585092994046
dependents,10,2.302585092994046
0023,10,2.302585092994046
long-term-care,10,2.302585092994046
736,10,2.302585092994046
steal,10,2.302585092994046
son,10,2.302585092994046
0032,10,2.302585092994046
surprise,10,2.302585092994046
stone,10,2.302585092994046
16th,10,2.302585092994046
653,10,2.302585092994046
CSA,10,2.302585092994046
Health-care,10,2.302585092994046
premises,10,2.302585092994046
Edition,10,2.302585092994046
undue,10,2.302585092994046
epidermal,10,2.302585092994046
deposit,10,2.302585092994046
sample-to-answer,10,2.302585092994046
VOIs,10,2.302585092994046
532,10,2.302585092994046
751,10,2.302585092994046
vitreous,10,2.302585092994046
disconnection,10,2.302585092994046
hydrophilic,10,2.302585092994046
diphtheria,10,2.302585092994046
HPS,10,2.302585092994046
Ever,10,2.302585092994046
DRGs,10,2.302585092994046
Tunisian,10,2.302585092994046
M2SR,10,2.302585092994046
wintertime,10,2.302585092994046
entailing,10,2.302585092994046
prisoners,10,2.302585092994046
Ortho,10,2.302585092994046
non-seasonal,10,2.302585092994046
MOI,10,2.302585092994046
adduction,10,2.302585092994046
Who,10,2.302585092994046
neurobiological,10,2.302585092994046
sin,10,2.302585092994046
DOACs,10,2.302585092994046
Liaison,10,2.302585092994046
BSL-3,10,2.302585092994046
declare,10,2.302585092994046
incubating,10,2.302585092994046
Communicable,10,2.302585092994046
best-practice,10,2.302585092994046
n25,10,2.302585092994046
hiccups,9,2.1972245773362196
1041,9,2.1972245773362196
Vs,9,2.1972245773362196
BBS,9,2.1972245773362196
CPI,9,2.1972245773362196
Harlem,9,2.1972245773362196
Rhinovirus,9,2.1972245773362196
shopping,9,2.1972245773362196
non-hospitalized,9,2.1972245773362196
ensued,9,2.1972245773362196
2007-08,9,2.1972245773362196
paramedic,9,2.1972245773362196
PB,9,2.1972245773362196
Denver,9,2.1972245773362196
colored,9,2.1972245773362196
bleeds,9,2.1972245773362196
Arabian,9,2.1972245773362196
464,9,2.1972245773362196
edges,9,2.1972245773362196
hypoalbuminemia,9,2.1972245773362196
voivodship,9,2.1972245773362196
overly,9,2.1972245773362196
797,9,2.1972245773362196
UDMI,9,2.1972245773362196
mimicry,9,2.1972245773362196
powers,9,2.1972245773362196
ambiguity,9,2.1972245773362196
endorse,9,2.1972245773362196
unenhanced,9,2.1972245773362196
fortunately,9,2.1972245773362196
COMPASS,9,2.1972245773362196
Episodes,9,2.1972245773362196
interior,9,2.1972245773362196
terrestrial,9,2.1972245773362196
Intelligence,9,2.1972245773362196
unplanned,9,2.1972245773362196
lateral-flow,9,2.1972245773362196
centrilobular,9,2.1972245773362196
enrollees,9,2.1972245773362196
embodiment,9,2.1972245773362196
consensus-based,9,2.1972245773362196
dilating,9,2.1972245773362196
hardship,9,2.1972245773362196
GOLD,9,2.1972245773362196
flare-up,9,2.1972245773362196
SCCAN,9,2.1972245773362196
baboons,9,2.1972245773362196
MNT,9,2.1972245773362196
tolerable,9,2.1972245773362196
DPP4,9,2.1972245773362196
Coxsackie,9,2.1972245773362196
Hb,9,2.1972245773362196
ADRB2,9,2.1972245773362196
SDM,9,2.1972245773362196
disinfectant,9,2.1972245773362196
dilate,9,2.1972245773362196
Joinville,9,2.1972245773362196
region-specific,9,2.1972245773362196
bakery,9,2.1972245773362196
television,9,2.1972245773362196
FXIII,9,2.1972245773362196
nondominant,9,2.1972245773362196
helicopter,9,2.1972245773362196
univariable,9,2.1972245773362196
IST-3,9,2.1972245773362196
aromatic,9,2.1972245773362196
UNDW,9,2.1972245773362196
Park,9,2.1972245773362196
ginseng,9,2.1972245773362196
pneumonia-like,9,2.1972245773362196
Joseph,9,2.1972245773362196
RMS,9,2.1972245773362196
irritating,9,2.1972245773362196
artery-to-artery,9,2.1972245773362196
sorting,9,2.1972245773362196
trimesters,9,2.1972245773362196
Peel,9,2.1972245773362196
pathophysiologically,9,2.1972245773362196
TWA,9,2.1972245773362196
reverses,9,2.1972245773362196
LFAs,9,2.1972245773362196
perfume,9,2.1972245773362196
hypothesise,9,2.1972245773362196
mid-April,9,2.1972245773362196
musical,9,2.1972245773362196
BNT162b1,9,2.1972245773362196
1931,9,2.1972245773362196
SOFA,9,2.1972245773362196
hydrolysis,9,2.1972245773362196
neuropathic,9,2.1972245773362196
discouraged,9,2.1972245773362196
languages,9,2.1972245773362196
reconstructive,9,2.1972245773362196
Plasminogen,9,2.1972245773362196
RPDs,9,2.1972245773362196
879,9,2.1972245773362196
petrochemical,9,2.1972245773362196
NAs,9,2.1972245773362196
HR1,9,2.1972245773362196
Editor,9,2.1972245773362196
El,9,2.1972245773362196
sequence-specific,9,2.1972245773362196
Keeping,9,2.1972245773362196
binders,9,2.1972245773362196
carnosine,9,2.1972245773362196
remarks,9,2.1972245773362196
individualization,9,2.1972245773362196
BSA,9,2.1972245773362196
dissimilar,9,2.1972245773362196
non-ischemic,9,2.1972245773362196
AQLQS,9,2.1972245773362196
violation,9,2.1972245773362196
COVAX,9,2.1972245773362196
manoeuvres,9,2.1972245773362196
£,9,2.1972245773362196
HIN1,9,2.1972245773362196
bn,9,2.1972245773362196
3-D,9,2.1972245773362196
unanticipated,9,2.1972245773362196
EAS,9,2.1972245773362196
curvature,9,2.1972245773362196
jeopardy,9,2.1972245773362196
polyurethane,9,2.1972245773362196
AH1pdm09,9,2.1972245773362196
Reocclusion,9,2.1972245773362196
DESIGN,9,2.1972245773362196
seeds,9,2.1972245773362196
B1427B1429,9,2.1972245773362196
Pontryagins,9,2.1972245773362196
MCG,9,2.1972245773362196
787,9,2.1972245773362196
takotsubo,9,2.1972245773362196
sex-,9,2.1972245773362196
pertains,9,2.1972245773362196
18-month,9,2.1972245773362196
empowering,9,2.1972245773362196
Base,9,2.1972245773362196
sur,9,2.1972245773362196
halves,9,2.1972245773362196
CCF,9,2.1972245773362196
liable,9,2.1972245773362196
Epidemiologists,9,2.1972245773362196
carer,9,2.1972245773362196
granulocytic,9,2.1972245773362196
antiserum,9,2.1972245773362196
Nogo-C,9,2.1972245773362196
dermal,9,2.1972245773362196
AMPs,9,2.1972245773362196
IVEB,9,2.1972245773362196
Ethical,9,2.1972245773362196
STA,9,2.1972245773362196
RT-PCR-confirmed,9,2.1972245773362196
end-points,9,2.1972245773362196
omitted,9,2.1972245773362196
cath,9,2.1972245773362196
astrogliosis,9,2.1972245773362196
turns,9,2.1972245773362196
Student,9,2.1972245773362196
youngsters,9,2.1972245773362196
IV-tPA,9,2.1972245773362196
non-infected,9,2.1972245773362196
Mesa,9,2.1972245773362196
undesired,9,2.1972245773362196
speech-language,9,2.1972245773362196
roads,9,2.1972245773362196
PK,9,2.1972245773362196
chronobiological,9,2.1972245773362196
pre-vaccination,9,2.1972245773362196
FHS,9,2.1972245773362196
ONP,9,2.1972245773362196
hACE-2,9,2.1972245773362196
expeditiously,9,2.1972245773362196
HEM,9,2.1972245773362196
Okinawa,9,2.1972245773362196
struggles,9,2.1972245773362196
BSingapore22279,9,2.1972245773362196
drug-resistance,9,2.1972245773362196
Neurovascular,9,2.1972245773362196
cyclophosphamide,9,2.1972245773362196
Result,9,2.1972245773362196
one-pot,9,2.1972245773362196
NCPAP,9,2.1972245773362196
non-WUS,9,2.1972245773362196
Periodic,9,2.1972245773362196
Providers,9,2.1972245773362196
Dresslers,9,2.1972245773362196
aggregability,9,2.1972245773362196
simulation-based,9,2.1972245773362196
AAD,9,2.1972245773362196
livedo,9,2.1972245773362196
beam,9,2.1972245773362196
Chi,9,2.1972245773362196
reusable,9,2.1972245773362196
Nijmegen,9,2.1972245773362196
accredited,9,2.1972245773362196
Diastolic,9,2.1972245773362196
726,9,2.1972245773362196
12-24,9,2.1972245773362196
621,9,2.1972245773362196
KAP,9,2.1972245773362196
recombinase,9,2.1972245773362196
Pure,9,2.1972245773362196
privacy,9,2.1972245773362196
250000,9,2.1972245773362196
empowerment,9,2.1972245773362196
ACalifornia042009,9,2.1972245773362196
AAEMI,9,2.1972245773362196
Non,9,2.1972245773362196
checks,9,2.1972245773362196
Human-to-human,9,2.1972245773362196
Steps,9,2.1972245773362196
precipitant,9,2.1972245773362196
assign,9,2.1972245773362196
HADS,9,2.1972245773362196
kindergartens,9,2.1972245773362196
Anatomic,9,2.1972245773362196
implicitly,9,2.1972245773362196
deviate,9,2.1972245773362196
flexion,9,2.1972245773362196
SEA,9,2.1972245773362196
pre-term,9,2.1972245773362196
dysosmia,9,2.1972245773362196
collaborators,9,2.1972245773362196
thalassemia,9,2.1972245773362196
Hospitalizations,9,2.1972245773362196
TDCS,9,2.1972245773362196
else,9,2.1972245773362196
impart,9,2.1972245773362196
Initiation,9,2.1972245773362196
breaking,9,2.1972245773362196
Organ,9,2.1972245773362196
focussing,9,2.1972245773362196
shocks,9,2.1972245773362196
intuitively,9,2.1972245773362196
computing,9,2.1972245773362196
DNARNA,9,2.1972245773362196
ADHD,9,2.1972245773362196
800000,9,2.1972245773362196
Gd-DTPA-enhanced,9,2.1972245773362196
wt,9,2.1972245773362196
norovirus,9,2.1972245773362196
non-survivors,9,2.1972245773362196
Legionella,9,2.1972245773362196
n1,9,2.1972245773362196
n3,9,2.1972245773362196
Fear,9,2.1972245773362196
LTC,9,2.1972245773362196
Persistence,9,2.1972245773362196
transmurality,9,2.1972245773362196
SPM,9,2.1972245773362196
PROSPERO,9,2.1972245773362196
Age-related,9,2.1972245773362196
n13,9,2.1972245773362196
rolling,9,2.1972245773362196
turkeys,9,2.1972245773362196
Positron,9,2.1972245773362196
Developed,9,2.1972245773362196
Capacity,9,2.1972245773362196
MRs,9,2.1972245773362196
729,9,2.1972245773362196
hepatobiliary,9,2.1972245773362196
CD66c,9,2.1972245773362196
insects,9,2.1972245773362196
CAC,9,2.1972245773362196
AVR,9,2.1972245773362196
elucidates,9,2.1972245773362196
hygienists,9,2.1972245773362196
Cat,9,2.1972245773362196
0033,9,2.1972245773362196
intraclass,9,2.1972245773362196
PHA,9,2.1972245773362196
eradicated,9,2.1972245773362196
Lausanne,9,2.1972245773362196
PGA,9,2.1972245773362196
hyperdynamic,9,2.1972245773362196
3C3a,9,2.1972245773362196
AIRE,9,2.1972245773362196
LBP,9,2.1972245773362196
TSS,9,2.1972245773362196
solid-organ,9,2.1972245773362196
JCI,9,2.1972245773362196
write,9,2.1972245773362196
Periprocedural,9,2.1972245773362196
perpetuation,9,2.1972245773362196
53-year-old,9,2.1972245773362196
lengthening,9,2.1972245773362196
commensurate,9,2.1972245773362196
Workshop,9,2.1972245773362196
renewal,9,2.1972245773362196
ergonovine,9,2.1972245773362196
chilblain-like,9,2.1972245773362196
tissue-level,9,2.1972245773362196
rtRT-PCR,9,2.1972245773362196
host-directed,9,2.1972245773362196
591,9,2.1972245773362196
554,9,2.1972245773362196
3-8,9,2.1972245773362196
STD,9,2.1972245773362196
reperfuse,9,2.1972245773362196
ELVO,9,2.1972245773362196
MENA,9,2.1972245773362196
handicapped,9,2.1972245773362196
deformities,9,2.1972245773362196
thromboplastin,9,2.1972245773362196
Moving,9,2.1972245773362196
twice-daily,9,2.1972245773362196
inclination,9,2.1972245773362196
solicited,9,2.1972245773362196
globalization,9,2.1972245773362196
dizygotic,9,2.1972245773362196
SARS-CoV-2s,9,2.1972245773362196
preschoolers,9,2.1972245773362196
harbors,9,2.1972245773362196
Fibrinolysis,9,2.1972245773362196
Buenos,9,2.1972245773362196
multipotent,9,2.1972245773362196
Aires,9,2.1972245773362196
Semen,9,2.1972245773362196
rheumatology,9,2.1972245773362196
ligature,9,2.1972245773362196
conceptually,9,2.1972245773362196
eCO,9,2.1972245773362196
registrars,9,2.1972245773362196
cyclosporin,9,2.1972245773362196
798,9,2.1972245773362196
immobilization,9,2.1972245773362196
Simplexa™,9,2.1972245773362196
Confirmatory,9,2.1972245773362196
Definitive,9,2.1972245773362196
Palestine,9,2.1972245773362196
microscopically,9,2.1972245773362196
nigra,9,2.1972245773362196
ND,9,2.1972245773362196
aetiologic,9,2.1972245773362196
Automatic,9,2.1972245773362196
minimization,9,2.1972245773362196
Pulsed,9,2.1972245773362196
Adolescence,9,2.1972245773362196
full-blown,9,2.1972245773362196
dimeric,9,2.1972245773362196
p53,9,2.1972245773362196
fruitful,9,2.1972245773362196
convince,9,2.1972245773362196
Hundreds,9,2.1972245773362196
quicker,9,2.1972245773362196
succession,9,2.1972245773362196
Mechanistic,9,2.1972245773362196
Cardiopulmonary,9,2.1972245773362196
12-14,9,2.1972245773362196
pressor,9,2.1972245773362196
LU,9,2.1972245773362196
TCID50,9,2.1972245773362196
Innovation,9,2.1972245773362196
PDE,9,2.1972245773362196
PFO-related,9,2.1972245773362196
meningoencephalitis,9,2.1972245773362196
5C,9,2.1972245773362196
file,9,2.1972245773362196
GLP-1,9,2.1972245773362196
twenty-five,9,2.1972245773362196
gingival,9,2.1972245773362196
optimising,9,2.1972245773362196
lots,9,2.1972245773362196
Tesla,9,2.1972245773362196
detention,9,2.1972245773362196
Thomas,9,2.1972245773362196
classed,9,2.1972245773362196
intrapulmonary,9,2.1972245773362196
single-molecule,9,2.1972245773362196
AEngland,9,2.1972245773362196
coronary-care,9,2.1972245773362196
bibliometric,9,2.1972245773362196
noncompliant,9,2.1972245773362196
state-based,9,2.1972245773362196
nCov-19,9,2.1972245773362196
urbanized,9,2.1972245773362196
River,9,2.1972245773362196
LHS,9,2.1972245773362196
debridement,9,2.1972245773362196
HAT,9,2.1972245773362196
Sestamibi,9,2.1972245773362196
HMO,9,2.1972245773362196
shortens,9,2.1972245773362196
arcuate,9,2.1972245773362196
AT1,9,2.1972245773362196
1ab,9,2.1972245773362196
thoracoabdominal,9,2.1972245773362196
Parallel,9,2.1972245773362196
Supportive,9,2.1972245773362196
treatment-related,9,2.1972245773362196
WWTPs,9,2.1972245773362196
dasatinib,9,2.1972245773362196
ASD,9,2.1972245773362196
4D,9,2.1972245773362196
battling,9,2.1972245773362196
registrations,9,2.1972245773362196
Cutaneous,9,2.1972245773362196
472,9,2.1972245773362196
74-year-old,9,2.1972245773362196
p0004,9,2.1972245773362196
GFAP,9,2.1972245773362196
seroreactivity,9,2.1972245773362196
homoeopathic,9,2.1972245773362196
exempt,9,2.1972245773362196
enteroviruses,9,2.1972245773362196
pre-fusion,9,2.1972245773362196
pyothorax,9,2.1972245773362196
11-year-old,9,2.1972245773362196
optimizes,9,2.1972245773362196
20A,9,2.1972245773362196
ESCAPE,9,2.1972245773362196
existential,9,2.1972245773362196
Israels,9,2.1972245773362196
unnoticed,9,2.1972245773362196
sanitization,9,2.1972245773362196
adenine,9,2.1972245773362196
Tongluo,9,2.1972245773362196
Carbon,9,2.1972245773362196
borderzone,9,2.1972245773362196
factor-alpha,9,2.1972245773362196
EBM,9,2.1972245773362196
appropriated,9,2.1972245773362196
warm-up,9,2.1972245773362196
hypertriglyceridemia,9,2.1972245773362196
inconvenience,9,2.1972245773362196
actionable,9,2.1972245773362196
HH,9,2.1972245773362196
discretion,9,2.1972245773362196
RNAemia,9,2.1972245773362196
UCA1,9,2.1972245773362196
standardisation,9,2.1972245773362196
self-reporting,9,2.1972245773362196
TISMO,9,2.1972245773362196
neuropsychologic,9,2.1972245773362196
p0005,9,2.1972245773362196
delusion,9,2.1972245773362196
PPARgamma,9,2.1972245773362196
1-day,9,2.1972245773362196
annua,9,2.1972245773362196
VEI,9,2.1972245773362196
relational,9,2.1972245773362196
contagions,9,2.1972245773362196
swing,9,2.1972245773362196
informational,9,2.1972245773362196
Conditional,9,2.1972245773362196
unwilling,9,2.1972245773362196
ECA,9,2.1972245773362196
Harvard,9,2.1972245773362196
escalated,9,2.1972245773362196
coldflu,9,2.1972245773362196
acute-care,9,2.1972245773362196
Epithelial,9,2.1972245773362196
unwitnessed,9,2.1972245773362196
RE-LY,9,2.1972245773362196
fronts,9,2.1972245773362196
unimmunized,9,2.1972245773362196
phenytoin,9,2.1972245773362196
Reye,9,2.1972245773362196
accord,9,2.1972245773362196
lmin,9,2.1972245773362196
Prevent,9,2.1972245773362196
TCS,9,2.1972245773362196
mid-November,9,2.1972245773362196
DKA,9,2.1972245773362196
brand,9,2.1972245773362196
phantom,9,2.1972245773362196
Unless,9,2.1972245773362196
Beneficial,9,2.1972245773362196
anulus,9,2.1972245773362196
GDF-15,9,2.1972245773362196
OCS-dependent,9,2.1972245773362196
PCR-negative,9,2.1972245773362196
underpinnings,9,2.1972245773362196
AN,9,2.1972245773362196
polysaccharide,9,2.1972245773362196
multi-component,9,2.1972245773362196
Refractory,9,2.1972245773362196
sale,9,2.1972245773362196
INCS,9,2.1972245773362196
nonmodifiable,9,2.1972245773362196
771,9,2.1972245773362196
cocktails,9,2.1972245773362196
Grippol,9,2.1972245773362196
Ba598Br,9,2.1972245773362196
aspergillus,9,2.1972245773362196
trips,9,2.1972245773362196
seventeen,9,2.1972245773362196
easy-to-implement,9,2.1972245773362196
toxicities,9,2.1972245773362196
Differentiation,9,2.1972245773362196
LVET,9,2.1972245773362196
classifies,9,2.1972245773362196
VPD,9,2.1972245773362196
alliance,9,2.1972245773362196
microalbuminuria,9,2.1972245773362196
monomorphic,9,2.1972245773362196
HAL,9,2.1972245773362196
patient-focused,9,2.1972245773362196
ABangkok179,9,2.1972245773362196
heptad,9,2.1972245773362196
suit,9,2.1972245773362196
apnea-hypopnea,9,2.1972245773362196
glycosides,9,2.1972245773362196
caspase,9,2.1972245773362196
glycaemic,9,2.1972245773362196
concealed,9,2.1972245773362196
re-assortment,9,2.1972245773362196
Cromolyn,9,2.1972245773362196
infection-control,9,2.1972245773362196
valvuloplasty,9,2.1972245773362196
repaired,9,2.1972245773362196
Platform,9,2.1972245773362196
MEPs,9,2.1972245773362196
Intriguingly,9,2.1972245773362196
70000,9,2.1972245773362196
miniaturization,9,2.1972245773362196
2-8,9,2.1972245773362196
Christian,9,2.1972245773362196
849,9,2.1972245773362196
21th,9,2.1972245773362196
beside,9,2.1972245773362196
Focused,9,2.1972245773362196
intertwined,9,2.1972245773362196
speculations,9,2.1972245773362196
phrenic,9,2.1972245773362196
783,9,2.1972245773362196
leaf,9,2.1972245773362196
anteroposterior,9,2.1972245773362196
hasten,9,2.1972245773362196
UI,9,2.1972245773362196
exemplified,9,2.1972245773362196
scavengers,9,2.1972245773362196
6000,9,2.1972245773362196
varicella-zoster,9,2.1972245773362196
flat,9,2.1972245773362196
10-11,9,2.1972245773362196
TMR,9,2.1972245773362196
patient-year,9,2.1972245773362196
LFHF,9,2.1972245773362196
-9,9,2.1972245773362196
2001-02,9,2.1972245773362196
stenocardia,9,2.1972245773362196
engrafted,9,2.1972245773362196
lifecycle,9,2.1972245773362196
susceptibles,9,2.1972245773362196
adaption,9,2.1972245773362196
nicotinamide,9,2.1972245773362196
Dec,9,2.1972245773362196
Singapores,9,2.1972245773362196
MMPI,9,2.1972245773362196
featuring,9,2.1972245773362196
gleaned,9,2.1972245773362196
chronotherapy,9,2.1972245773362196
CAB,9,2.1972245773362196
Labour,9,2.1972245773362196
Non-Q-wave,9,2.1972245773362196
00009,9,2.1972245773362196
ORFs,9,2.1972245773362196
contention,9,2.1972245773362196
steeply,9,2.1972245773362196
mainstays,9,2.1972245773362196
biocides,9,2.1972245773362196
Geriatric,9,2.1972245773362196
TMPG,9,2.1972245773362196
LMWHs,9,2.1972245773362196
reverse-genetics,9,2.1972245773362196
N-glycans,9,2.1972245773362196
dislodgement,9,2.1972245773362196
Beta-blockers,9,2.1972245773362196
confidential,9,2.1972245773362196
flu-p,9,2.1972245773362196
3061,9,2.1972245773362196
Vaccinations,9,2.1972245773362196
SNAP,9,2.1972245773362196
AT1R,9,2.1972245773362196
Evans,9,2.1972245773362196
Biomedical,9,2.1972245773362196
IH,9,2.1972245773362196
audited,9,2.1972245773362196
relaxin,9,2.1972245773362196
MCAv,9,2.1972245773362196
chaotic,9,2.1972245773362196
UPR,9,2.1972245773362196
barely,9,2.1972245773362196
wise,9,2.1972245773362196
goal-directed,9,2.1972245773362196
V1-V4,9,2.1972245773362196
CTRL,9,2.1972245773362196
chi-squared,9,2.1972245773362196
ramp,9,2.1972245773362196
SWT,9,2.1972245773362196
isonitrile,9,2.1972245773362196
Grail,9,2.1972245773362196
Therapeutics,9,2.1972245773362196
Gansu,9,2.1972245773362196
trough,9,2.1972245773362196
chimpanzee,9,2.1972245773362196
Multidisciplinary,9,2.1972245773362196
pathophysiologies,9,2.1972245773362196
Institutions,9,2.1972245773362196
thermometer,9,2.1972245773362196
GAD,9,2.1972245773362196
symptomatically,9,2.1972245773362196
Diabetics,9,2.1972245773362196
book,9,2.1972245773362196
intentionally,9,2.1972245773362196
Quercetin,9,2.1972245773362196
nonselected,9,2.1972245773362196
HG,9,2.1972245773362196
colonies,9,2.1972245773362196
magnified,9,2.1972245773362196
assignments,9,2.1972245773362196
make-up,9,2.1972245773362196
inbred,9,2.1972245773362196
gene-gene,9,2.1972245773362196
Metropolitan,9,2.1972245773362196
galectin-3,9,2.1972245773362196
streptokinase-treated,9,2.1972245773362196
illuminated,9,2.1972245773362196
worsenings,9,2.1972245773362196
asks,9,2.1972245773362196
uninterrupted,9,2.1972245773362196
Established,9,2.1972245773362196
pharmacotherapeutic,9,2.1972245773362196
adopts,9,2.1972245773362196
Al,9,2.1972245773362196
centralised,9,2.1972245773362196
PROTECT,9,2.1972245773362196
PCO2,9,2.1972245773362196
Toward,9,2.1972245773362196
AOA,9,2.1972245773362196
tegmentum,9,2.1972245773362196
Eosinophil,9,2.1972245773362196
nonsudden,9,2.1972245773362196
affectivity,9,2.1972245773362196
COX-2,9,2.1972245773362196
Transcriptase,9,2.1972245773362196
cGAMP,9,2.1972245773362196
non-haemorrhagic,9,2.1972245773362196
bioterrorist,9,2.1972245773362196
518,9,2.1972245773362196
Watchman,9,2.1972245773362196
Media,9,2.1972245773362196
frusemide,9,2.1972245773362196
realised,9,2.1972245773362196
working-age,9,2.1972245773362196
severecritical,9,2.1972245773362196
metastases,9,2.1972245773362196
E484Q,9,2.1972245773362196
Extending,9,2.1972245773362196
Professional,9,2.1972245773362196
flocking,9,2.1972245773362196
Diary,9,2.1972245773362196
199495,9,2.1972245773362196
Thallium-201,9,2.1972245773362196
billing,9,2.1972245773362196
0-17,9,2.1972245773362196
PETh,9,2.1972245773362196
Sixty-one,9,2.1972245773362196
misinterpreted,9,2.1972245773362196
endured,9,2.1972245773362196
hypereosinophilia,9,2.1972245773362196
B1617,9,2.1972245773362196
Object,9,2.1972245773362196
OAT,9,2.1972245773362196
Focus,9,2.1972245773362196
baloxavir,9,2.1972245773362196
50-70,9,2.1972245773362196
raceethnic,9,2.1972245773362196
demented,9,2.1972245773362196
MEP,9,2.1972245773362196
dyad,9,2.1972245773362196
TNFα,9,2.1972245773362196
Abdominal,9,2.1972245773362196
splenectomy,9,2.1972245773362196
turbulence,9,2.1972245773362196
Were,9,2.1972245773362196
sirolimus-eluting,9,2.1972245773362196
immunostaining,9,2.1972245773362196
IST,9,2.1972245773362196
scapular,9,2.1972245773362196
Source,9,2.1972245773362196
commercialization,9,2.1972245773362196
ASydney597,9,2.1972245773362196
biologists,9,2.1972245773362196
MO,9,2.1972245773362196
James,9,2.1972245773362196
10-7,9,2.1972245773362196
revolutionised,9,2.1972245773362196
SPARCL,9,2.1972245773362196
PGI2,9,2.1972245773362196
ambulant,9,2.1972245773362196
double-blinded,9,2.1972245773362196
nitrites,9,2.1972245773362196
AT2,9,2.1972245773362196
LE,9,2.1972245773362196
garlic,9,2.1972245773362196
943,9,2.1972245773362196
upgrade,9,2.1972245773362196
Territory,9,2.1972245773362196
censoring,9,2.1972245773362196
FEV1VC,9,2.1972245773362196
PUIs,9,2.1972245773362196
Decompressive,9,2.1972245773362196
Californians,9,2.1972245773362196
wakefulness,9,2.1972245773362196
Satisfaction,9,2.1972245773362196
ribosomal,9,2.1972245773362196
simplifying,9,2.1972245773362196
multi-omics,9,2.1972245773362196
marijuana,9,2.1972245773362196
POBA,9,2.1972245773362196
Crude,9,2.1972245773362196
Nucleotide,9,2.1972245773362196
superspreaders,9,2.1972245773362196
Expanded,9,2.1972245773362196
ACCAHA,9,2.1972245773362196
Alere,9,2.1972245773362196
OPG,9,2.1972245773362196
scalar,9,2.1972245773362196
hematology,9,2.1972245773362196
MW06,9,2.1972245773362196
violations,9,2.1972245773362196
etexilate,9,2.1972245773362196
microcantilever,9,2.1972245773362196
Forty-nine,9,2.1972245773362196
Cost-effectiveness,9,2.1972245773362196
MFT,9,2.1972245773362196
unequal,9,2.1972245773362196
energetic,9,2.1972245773362196
947,9,2.1972245773362196
GII,9,2.1972245773362196
left-hemisphere,9,2.1972245773362196
fishers,9,2.1972245773362196
unconscious,9,2.1972245773362196
tympanostomy,9,2.1972245773362196
802,9,2.1972245773362196
WMHI,9,2.1972245773362196
Occlusive,9,2.1972245773362196
789,9,2.1972245773362196
LoC,9,2.1972245773362196
MAX,9,2.1972245773362196
CONCLUSION,9,2.1972245773362196
C-3,9,2.1972245773362196
nondiabetics,9,2.1972245773362196
isoproterenol-induced,9,2.1972245773362196
után,9,2.1972245773362196
NSP6,9,2.1972245773362196
esetén,9,2.1972245773362196
907,9,2.1972245773362196
Manufacturers,9,2.1972245773362196
stark,9,2.1972245773362196
turn-around,9,2.1972245773362196
informants,9,2.1972245773362196
scale-free,9,2.1972245773362196
miR-20a-5p,9,2.1972245773362196
waveform,9,2.1972245773362196
small-world,9,2.1972245773362196
Oxide,9,2.1972245773362196
P-R,9,2.1972245773362196
beta2-glycoprotein,9,2.1972245773362196
macro,9,2.1972245773362196
25OHD,9,2.1972245773362196
time-based,9,2.1972245773362196
wide-ranging,9,2.1972245773362196
octogenarians,9,2.1972245773362196
adjusted-dose,9,2.1972245773362196
Acetylsalicylic,9,2.1972245773362196
fibres,9,2.1972245773362196
nitrite,9,2.1972245773362196
Syndromic,9,2.1972245773362196
terpenoids,9,2.1972245773362196
misconception,9,2.1972245773362196
5-HT,9,2.1972245773362196
founder,9,2.1972245773362196
nsp12,9,2.1972245773362196
Reversibility,9,2.1972245773362196
nonanterior,9,2.1972245773362196
illness-related,9,2.1972245773362196
Operations,9,2.1972245773362196
hematoxylin,9,2.1972245773362196
cytosolic,9,2.1972245773362196
RHD,9,2.1972245773362196
Ki-67,9,2.1972245773362196
bounds,9,2.1972245773362196
nondisabling,9,2.1972245773362196
ePlex,9,2.1972245773362196
803,9,2.1972245773362196
knows,9,2.1972245773362196
Democratic,9,2.1972245773362196
climatotherapy,9,2.1972245773362196
Gaining,9,2.1972245773362196
non-adjuvanted,9,2.1972245773362196
slow-release,9,2.1972245773362196
Subarachnoid,9,2.1972245773362196
mistake,9,2.1972245773362196
odd,9,2.1972245773362196
disregarding,9,2.1972245773362196
coalescent,9,2.1972245773362196
rabies,9,2.1972245773362196
multiform,9,2.1972245773362196
MMA,9,2.1972245773362196
19A,9,2.1972245773362196
confluent,9,2.1972245773362196
biliary,9,2.1972245773362196
radioallergosorbent,9,2.1972245773362196
uterine,9,2.1972245773362196
distally,9,2.1972245773362196
Ramadan,9,2.1972245773362196
Eligible,9,2.1972245773362196
71-year-old,9,2.1972245773362196
immunodeficient,9,2.1972245773362196
VRI,9,2.1972245773362196
mycoplasma,9,2.1972245773362196
Olomouc,9,2.1972245773362196
SD-Biosensor,9,2.1972245773362196
echo-planar,9,2.1972245773362196
Beckman,9,2.1972245773362196
meridian,9,2.1972245773362196
suburbs,9,2.1972245773362196
sleep-wake,9,2.1972245773362196
post-hospital,9,2.1972245773362196
sc,9,2.1972245773362196
1995-1996,9,2.1972245773362196
aspirations,9,2.1972245773362196
slide,9,2.1972245773362196
thoracentesis,9,2.1972245773362196
NIAID,9,2.1972245773362196
margins,9,2.1972245773362196
NCF,9,2.1972245773362196
eccentric,9,2.1972245773362196
Percheron,9,2.1972245773362196
disproportionally,9,2.1972245773362196
ST-elevated,9,2.1972245773362196
Tracking,9,2.1972245773362196
Binax,9,2.1972245773362196
afflicting,9,2.1972245773362196
vacation,9,2.1972245773362196
10-30,9,2.1972245773362196
coincides,9,2.1972245773362196
immunodiffusion,9,2.1972245773362196
log-linear,9,2.1972245773362196
Limitation,9,2.1972245773362196
829,9,2.1972245773362196
fund,9,2.1972245773362196
sarcoidosis,9,2.1972245773362196
self-assembly,9,2.1972245773362196
FCS,9,2.1972245773362196
HTS,9,2.1972245773362196
evokes,9,2.1972245773362196
tapering,9,2.1972245773362196
ISIS-4,9,2.1972245773362196
situs,9,2.1972245773362196
quail,9,2.1972245773362196
678,9,2.1972245773362196
cross-reacting,9,2.1972245773362196
IHEs,9,2.1972245773362196
steeper,9,2.1972245773362196
bathroom,9,2.1972245773362196
yeast,9,2.1972245773362196
Kyoto,9,2.1972245773362196
MRSA,9,2.1972245773362196
clipping,9,2.1972245773362196
Northeastern,9,2.1972245773362196
Aerosol,9,2.1972245773362196
paramedical,9,2.1972245773362196
GT,9,2.1972245773362196
hypercytokinemia,9,2.1972245773362196
per-capita,9,2.1972245773362196
pressure-volume,9,2.1972245773362196
traffic-related,9,2.1972245773362196
chiropractic,9,2.1972245773362196
IZ,9,2.1972245773362196
staggering,9,2.1972245773362196
Interpretation,9,2.1972245773362196
Engineering,9,2.1972245773362196
CBC,9,2.1972245773362196
diffusivity,9,2.1972245773362196
RMBF,9,2.1972245773362196
Socioeconomic,9,2.1972245773362196
ip,9,2.1972245773362196
546,9,2.1972245773362196
antineoplastic,9,2.1972245773362196
APs,9,2.1972245773362196
Hemagglutinin,9,2.1972245773362196
travels,9,2.1972245773362196
Undoubtedly,9,2.1972245773362196
intrahost,9,2.1972245773362196
animal-to-human,9,2.1972245773362196
paramagnetic,9,2.1972245773362196
TND,9,2.1972245773362196
Reinfection,9,2.1972245773362196
pancytopenia,9,2.1972245773362196
amantadine-resistant,9,2.1972245773362196
991,9,2.1972245773362196
postulates,9,2.1972245773362196
Neuroprotection,9,2.1972245773362196
G6PDd,9,2.1972245773362196
airport,9,2.1972245773362196
exemplify,9,2.1972245773362196
mock,9,2.1972245773362196
IgM-IgG,9,2.1972245773362196
depleting,9,2.1972245773362196
laughter,9,2.1972245773362196
MCs,9,2.1972245773362196
notching,9,2.1972245773362196
582,9,2.1972245773362196
DMS,9,2.1972245773362196
Swimming,9,2.1972245773362196
200809,9,2.1972245773362196
Charcot,9,2.1972245773362196
irregularity,9,2.1972245773362196
exemplar,9,2.1972245773362196
Differentiating,9,2.1972245773362196
Adelaide,9,2.1972245773362196
venue,9,2.1972245773362196
transfemoral,9,2.1972245773362196
reappearance,9,2.1972245773362196
countrywide,9,2.1972245773362196
Tianjin,9,2.1972245773362196
Fab,9,2.1972245773362196
sociological,9,2.1972245773362196
hinges,9,2.1972245773362196
pneumococcus,9,2.1972245773362196
sparsely,9,2.1972245773362196
preconditioned,9,2.1972245773362196
2300,9,2.1972245773362196
pre-specified,9,2.1972245773362196
informations,9,2.1972245773362196
conceived,9,2.1972245773362196
Correct,9,2.1972245773362196
Ninety-six,9,2.1972245773362196
transducers,9,2.1972245773362196
cross-section,9,2.1972245773362196
Tertiary,9,2.1972245773362196
resolves,9,2.1972245773362196
post-,9,2.1972245773362196
Interleukin,9,2.1972245773362196
nonrheumatic,9,2.1972245773362196
Sensitivities,9,2.1972245773362196
slopes,9,2.1972245773362196
conveyed,9,2.1972245773362196
Dobutamine,9,2.1972245773362196
β2,9,2.1972245773362196
bright,9,2.1972245773362196
JAK,9,2.1972245773362196
CTS,9,2.1972245773362196
defeat,9,2.1972245773362196
Hunan,9,2.1972245773362196
opposition,9,2.1972245773362196
12-15,9,2.1972245773362196
subclade,9,2.1972245773362196
classroom,9,2.1972245773362196
Qiagen,9,2.1972245773362196
assists,9,2.1972245773362196
PTFE,9,2.1972245773362196
COVID-positive,9,2.1972245773362196
neoplasm,9,2.1972245773362196
post-marketing,9,2.1972245773362196
Vietnamese,9,2.1972245773362196
Plans,9,2.1972245773362196
leukaemia,9,2.1972245773362196
3-week,9,2.1972245773362196
interstitium,9,2.1972245773362196
secured,9,2.1972245773362196
Procedural,9,2.1972245773362196
MIS-A,9,2.1972245773362196
puffs,9,2.1972245773362196
myeloperoxidase,9,2.1972245773362196
iso,9,2.1972245773362196
theory-based,9,2.1972245773362196
4G4G,9,2.1972245773362196
t-tests,9,2.1972245773362196
Disease-19,9,2.1972245773362196
meaningfully,9,2.1972245773362196
reminiscent,9,2.1972245773362196
colorectal,9,2.1972245773362196
CKmax,9,2.1972245773362196
gastrostomy,9,2.1972245773362196
bilayer,9,2.1972245773362196
curricula,9,2.1972245773362196
cardiorrhexis,9,2.1972245773362196
μgmL,9,2.1972245773362196
ECT,9,2.1972245773362196
C2,9,2.1972245773362196
stimulant,9,2.1972245773362196
culminated,9,2.1972245773362196
BMD,9,2.1972245773362196
CiC,9,2.1972245773362196
EDS,9,2.1972245773362196
antipyretics,9,2.1972245773362196
interferon-induced,9,2.1972245773362196
classrooms,9,2.1972245773362196
spectrometer,9,2.1972245773362196
1997-98,9,2.1972245773362196
Elimination,9,2.1972245773362196
accrued,9,2.1972245773362196
Pulse,9,2.1972245773362196
profit,9,2.1972245773362196
Regimen,9,2.1972245773362196
telephone-based,9,2.1972245773362196
CLEAN,9,2.1972245773362196
nonstroke,9,2.1972245773362196
EV,9,2.1972245773362196
Closure,9,2.1972245773362196
Trained,9,2.1972245773362196
drug-drug,9,2.1972245773362196
Sufficient,9,2.1972245773362196
mens,9,2.1972245773362196
Equine,9,2.1972245773362196
detectability,9,2.1972245773362196
1b,9,2.1972245773362196
Repetitive,9,2.1972245773362196
A4,9,2.1972245773362196
960,9,2.1972245773362196
Liver,9,2.1972245773362196
DMP,9,2.1972245773362196
eucapnic,9,2.1972245773362196
Berg,9,2.1972245773362196
GRK2,9,2.1972245773362196
work-aggravated,9,2.1972245773362196
Dengue,9,2.1972245773362196
VP,9,2.1972245773362196
stabilisation,9,2.1972245773362196
PCW,9,2.1972245773362196
Types,9,2.1972245773362196
synthesised,9,2.1972245773362196
PMNs,9,2.1972245773362196
meditation,9,2.1972245773362196
casualty,9,2.1972245773362196
hypodensity,9,2.1972245773362196
Gait,9,2.1972245773362196
12-hour,9,2.1972245773362196
unstudied,9,2.1972245773362196
Poorly,9,2.1972245773362196
alternation,9,2.1972245773362196
near-patient,9,2.1972245773362196
atherogenesis,9,2.1972245773362196
hibernation,9,2.1972245773362196
Markers,9,2.1972245773362196
burns,9,2.1972245773362196
N3,9,2.1972245773362196
831,9,2.1972245773362196
baroreflex,9,2.1972245773362196
Asthma-related,9,2.1972245773362196
URI,9,2.1972245773362196
Battery,9,2.1972245773362196
electrographic,9,2.1972245773362196
MLA,9,2.1972245773362196
NAFLD,9,2.1972245773362196
EC90,9,2.1972245773362196
FiO2,9,2.1972245773362196
IEI,9,2.1972245773362196
lysate,9,2.1972245773362196
739,9,2.1972245773362196
guardians,9,2.1972245773362196
PTE,9,2.1972245773362196
LRT,9,2.1972245773362196
HeLa,9,2.1972245773362196
intra-host,9,2.1972245773362196
deregulation,9,2.1972245773362196
mercury,9,2.1972245773362196
acetaminophen,9,2.1972245773362196
90000,9,2.1972245773362196
immigration,9,2.1972245773362196
669,9,2.1972245773362196
scattering,9,2.1972245773362196
Bayes,9,2.1972245773362196
orthopaedic,9,2.1972245773362196
circulations,9,2.1972245773362196
Inferior,9,2.1972245773362196
GCF,9,2.1972245773362196
Community-acquired,9,2.1972245773362196
p004,9,2.1972245773362196
vaccine-specific,9,2.1972245773362196
508,9,2.1972245773362196
structure-activity,9,2.1972245773362196
20142015,9,2.1972245773362196
gm,9,2.1972245773362196
non-SARS-CoV-2,9,2.1972245773362196
inocula,9,2.1972245773362196
E4,9,2.1972245773362196
Graphical,9,2.1972245773362196
double-stranded,9,2.1972245773362196
station,9,2.1972245773362196
conjugation,9,2.1972245773362196
Daylight,9,2.1972245773362196
bronchoconstrictors,9,2.1972245773362196
unabated,9,2.1972245773362196
prodromes,9,2.1972245773362196
oxidant,9,2.1972245773362196
Bland-Altman,9,2.1972245773362196
cross-reacted,9,2.1972245773362196
899,9,2.1972245773362196
drew,9,2.1972245773362196
healers,9,2.1972245773362196
judging,9,2.1972245773362196
toxicological,9,2.1972245773362196
chemotherapeutic,9,2.1972245773362196
RRST,9,2.1972245773362196
segmentations,9,2.1972245773362196
chronology,9,2.1972245773362196
o,9,2.1972245773362196
sham-operated,9,2.1972245773362196
14000,9,2.1972245773362196
transferase,9,2.1972245773362196
Anderson,9,2.1972245773362196
servers,9,2.1972245773362196
trapped,9,2.1972245773362196
Swallowing,9,2.1972245773362196
ΔP,9,2.1972245773362196
cardioplegia,9,2.1972245773362196
874,9,2.1972245773362196
stem-cell,9,2.1972245773362196
G-quadruplex,9,2.1972245773362196
orand,9,2.1972245773362196
geopolitical,9,2.1972245773362196
narrowings,9,2.1972245773362196
state-level,9,2.1972245773362196
complain,9,2.1972245773362196
Chief,9,2.1972245773362196
imagined,9,2.1972245773362196
precluded,9,2.1972245773362196
VII,9,2.1972245773362196
BCI,9,2.1972245773362196
2020-2021,9,2.1972245773362196
NPOP,9,2.1972245773362196
calibrate,9,2.1972245773362196
bioanalytical,9,2.1972245773362196
helical,9,2.1972245773362196
20-fold,9,2.1972245773362196
ambivalence,9,2.1972245773362196
telemetry,9,2.1972245773362196
Forty-five,9,2.1972245773362196
miniaturized,9,2.1972245773362196
macromolecules,9,2.1972245773362196
S-100B,9,2.1972245773362196
Bivariate,9,2.1972245773362196
flare-ups,9,2.1972245773362196
patient-based,9,2.1972245773362196
dreadful,9,2.1972245773362196
locality,9,2.1972245773362196
gaze,9,2.1972245773362196
IL6,9,2.1972245773362196
·,9,2.1972245773362196
untrained,9,2.1972245773362196
Internationally,9,2.1972245773362196
painting,9,2.1972245773362196
986,9,2.1972245773362196
499,9,2.1972245773362196
00007,9,2.1972245773362196
Image,9,2.1972245773362196
revise,9,2.1972245773362196
exercise-related,9,2.1972245773362196
benchmarks,9,2.1972245773362196
ZIP,9,2.1972245773362196
iNKT,9,2.1972245773362196
post-intervention,9,2.1972245773362196
μl,9,2.1972245773362196
neurofibromatosis,9,2.1972245773362196
concussion,9,2.1972245773362196
bioRxiv,9,2.1972245773362196
influenzaviruses,9,2.1972245773362196
VaD,9,2.1972245773362196
melting,9,2.1972245773362196
circumstantial,9,2.1972245773362196
Malays,9,2.1972245773362196
anesthetics,9,2.1972245773362196
Diffuse,9,2.1972245773362196
Prophylaxis,9,2.1972245773362196
interferon-gamma,9,2.1972245773362196
glutaraldehyde,9,2.1972245773362196
644,9,2.1972245773362196
x-rays,9,2.1972245773362196
help-seeking,9,2.1972245773362196
cardio-respiratory,9,2.1972245773362196
long-time,9,2.1972245773362196
pillar,9,2.1972245773362196
alertness,9,2.1972245773362196
morbidly,9,2.1972245773362196
Cooperation,9,2.1972245773362196
foundational,9,2.1972245773362196
practising,9,2.1972245773362196
Fifty-eight,9,2.1972245773362196
protein-ligand,9,2.1972245773362196
CHB,9,2.1972245773362196
kin,9,2.1972245773362196
AVictoria75,9,2.1972245773362196
Revision,9,2.1972245773362196
830,9,2.1972245773362196
Hangzhou,9,2.1972245773362196
EDVI,9,2.1972245773362196
listing,9,2.1972245773362196
annealing,9,2.1972245773362196
hydrogels,9,2.1972245773362196
pVAD,9,2.1972245773362196
high-priority,9,2.1972245773362196
SBI,9,2.1972245773362196
amphetamine,9,2.1972245773362196
supply-demand,9,2.1972245773362196
antihypertensives,9,2.1972245773362196
non-neutralizing,9,2.1972245773362196
haemolysis,9,2.1972245773362196
floating,9,2.1972245773362196
Maoris,9,2.1972245773362196
Practitioner,9,2.1972245773362196
1911,9,2.1972245773362196
practised,9,2.1972245773362196
helium-oxygen,9,2.1972245773362196
defences,9,2.1972245773362196
anemic,9,2.1972245773362196
tetravalent,9,2.1972245773362196
categorizing,9,2.1972245773362196
Saskatchewan,9,2.1972245773362196
NL,9,2.1972245773362196
KNOW,9,2.1972245773362196
638,9,2.1972245773362196
Ninety-eight,9,2.1972245773362196
Pre-hospital,9,2.1972245773362196
irregularities,9,2.1972245773362196
meanings,9,2.1972245773362196
STAIR,9,2.1972245773362196
policymaking,8,2.0794415416798357
AEDT,8,2.0794415416798357
inattention,8,2.0794415416798357
copiesμl,8,2.0794415416798357
goods,8,2.0794415416798357
Sensory,8,2.0794415416798357
teratoma,8,2.0794415416798357
Pathogenic,8,2.0794415416798357
inflammasomes,8,2.0794415416798357
laminar,8,2.0794415416798357
re-emerged,8,2.0794415416798357
prioritise,8,2.0794415416798357
gain-of-function,8,2.0794415416798357
PRE-hospital,8,2.0794415416798357
man-made,8,2.0794415416798357
Syndrome-Coronavirus,8,2.0794415416798357
mentioning,8,2.0794415416798357
fluid-attenuated,8,2.0794415416798357
quitting,8,2.0794415416798357
Orf7a,8,2.0794415416798357
Armed,8,2.0794415416798357
MIP,8,2.0794415416798357
Sheva,8,2.0794415416798357
Atlantic,8,2.0794415416798357
Decades,8,2.0794415416798357
deglutition,8,2.0794415416798357
Preschool,8,2.0794415416798357
SARs-CoV-2,8,2.0794415416798357
proactively,8,2.0794415416798357
Compelling,8,2.0794415416798357
OIDA,8,2.0794415416798357
RT-dPCR,8,2.0794415416798357
microstructural,8,2.0794415416798357
inter-hemispheric,8,2.0794415416798357
assemble,8,2.0794415416798357
unambiguously,8,2.0794415416798357
pre-screening,8,2.0794415416798357
Beer,8,2.0794415416798357
PAS,8,2.0794415416798357
2015-16,8,2.0794415416798357
spotlight,8,2.0794415416798357
Stanford,8,2.0794415416798357
thymus,8,2.0794415416798357
antiaggregants,8,2.0794415416798357
complementing,8,2.0794415416798357
blank,8,2.0794415416798357
sonographic,8,2.0794415416798357
Wolf,8,2.0794415416798357
short-time,8,2.0794415416798357
artefacts,8,2.0794415416798357
Wantai,8,2.0794415416798357
cures,8,2.0794415416798357
syndemic,8,2.0794415416798357
Pharmacogenetics,8,2.0794415416798357
prosodic,8,2.0794415416798357
PTD,8,2.0794415416798357
Gadolinium-DTPA,8,2.0794415416798357
freshly,8,2.0794415416798357
PH,8,2.0794415416798357
RV15,8,2.0794415416798357
AGP,8,2.0794415416798357
TN,8,2.0794415416798357
equated,8,2.0794415416798357
dislocation,8,2.0794415416798357
tonic,8,2.0794415416798357
copiescm2,8,2.0794415416798357
nondipping,8,2.0794415416798357
wore,8,2.0794415416798357
hypoxic-ischemic,8,2.0794415416798357
OM,8,2.0794415416798357
Allen,8,2.0794415416798357
polarity,8,2.0794415416798357
overshadowed,8,2.0794415416798357
split-virion,8,2.0794415416798357
SFR,8,2.0794415416798357
Process,8,2.0794415416798357
enforcement,8,2.0794415416798357
pathognomonic,8,2.0794415416798357
pertain,8,2.0794415416798357
Trusts,8,2.0794415416798357
fermentation,8,2.0794415416798357
mucolytics,8,2.0794415416798357
nanoscale,8,2.0794415416798357
Thrombocytopenia,8,2.0794415416798357
DDT,8,2.0794415416798357
geospatial,8,2.0794415416798357
non-,8,2.0794415416798357
groupings,8,2.0794415416798357
Pa,8,2.0794415416798357
proximally,8,2.0794415416798357
VPCs,8,2.0794415416798357
MIH,8,2.0794415416798357
intensifying,8,2.0794415416798357
Written,8,2.0794415416798357
vitally,8,2.0794415416798357
LWH,8,2.0794415416798357
non-immune,8,2.0794415416798357
tigers,8,2.0794415416798357
Stage,8,2.0794415416798357
demyelination,8,2.0794415416798357
MCM,8,2.0794415416798357
ELISA-based,8,2.0794415416798357
Pharmacogenomics,8,2.0794415416798357
triiodothyronine,8,2.0794415416798357
fibrates,8,2.0794415416798357
AGPs,8,2.0794415416798357
hypo-perfused,8,2.0794415416798357
crosses,8,2.0794415416798357
constants,8,2.0794415416798357
February-March,8,2.0794415416798357
openness,8,2.0794415416798357
Selecting,8,2.0794415416798357
myofibroblast,8,2.0794415416798357
IIalpha,8,2.0794415416798357
desmoteplase,8,2.0794415416798357
radioimmunoassay,8,2.0794415416798357
RBD219-N1C1,8,2.0794415416798357
Wnt,8,2.0794415416798357
receptor-mediated,8,2.0794415416798357
moderated,8,2.0794415416798357
SAT,8,2.0794415416798357
Hsp90,8,2.0794415416798357
Notch,8,2.0794415416798357
HFQE,8,2.0794415416798357
Hemagglutination,8,2.0794415416798357
Nuclear,8,2.0794415416798357
perturbed,8,2.0794415416798357
EW,8,2.0794415416798357
FV,8,2.0794415416798357
post-menopausal,8,2.0794415416798357
400000,8,2.0794415416798357
discouraging,8,2.0794415416798357
Go,8,2.0794415416798357
HRs,8,2.0794415416798357
antero-lateral,8,2.0794415416798357
ICCI,8,2.0794415416798357
mono-,8,2.0794415416798357
reactivities,8,2.0794415416798357
Panic,8,2.0794415416798357
Campylobacter,8,2.0794415416798357
AGI,8,2.0794415416798357
generalist,8,2.0794415416798357
17th,8,2.0794415416798357
recoveries,8,2.0794415416798357
parent-reported,8,2.0794415416798357
rightward,8,2.0794415416798357
breaths,8,2.0794415416798357
Weighted,8,2.0794415416798357
prohibited,8,2.0794415416798357
Sinus,8,2.0794415416798357
nail,8,2.0794415416798357
rhinorrhoea,8,2.0794415416798357
SSN,8,2.0794415416798357
MPCL,8,2.0794415416798357
24-month,8,2.0794415416798357
Worsening,8,2.0794415416798357
testicular,8,2.0794415416798357
Histologically,8,2.0794415416798357
ATE,8,2.0794415416798357
Post-MI,8,2.0794415416798357
Facilitated,8,2.0794415416798357
P-wave,8,2.0794415416798357
Smokers,8,2.0794415416798357
high-sensitive,8,2.0794415416798357
husbands,8,2.0794415416798357
TcPPi,8,2.0794415416798357
attributing,8,2.0794415416798357
MCh,8,2.0794415416798357
Sixty-six,8,2.0794415416798357
abandon,8,2.0794415416798357
Hypotension,8,2.0794415416798357
630,8,2.0794415416798357
humanitarian,8,2.0794415416798357
preservative,8,2.0794415416798357
immunoprophylaxis,8,2.0794415416798357
ADP-ribose,8,2.0794415416798357
FLU-v,8,2.0794415416798357
periinfarct,8,2.0794415416798357
infarcting,8,2.0794415416798357
Preexisting,8,2.0794415416798357
poly,8,2.0794415416798357
ice,8,2.0794415416798357
Warp,8,2.0794415416798357
hemichorea,8,2.0794415416798357
PHC,8,2.0794415416798357
occupy,8,2.0794415416798357
ellagic,8,2.0794415416798357
generator,8,2.0794415416798357
8-year-old,8,2.0794415416798357
flavonoids,8,2.0794415416798357
P3,8,2.0794415416798357
ammonia,8,2.0794415416798357
SACE2,8,2.0794415416798357
5-17,8,2.0794415416798357
transformations,8,2.0794415416798357
MAPCs,8,2.0794415416798357
11-year,8,2.0794415416798357
tetrapolar,8,2.0794415416798357
EH,8,2.0794415416798357
1880,8,2.0794415416798357
candesartan,8,2.0794415416798357
preclinically,8,2.0794415416798357
LLC,8,2.0794415416798357
obligation,8,2.0794415416798357
Morocco,8,2.0794415416798357
MgSO4,8,2.0794415416798357
paraffin-embedded,8,2.0794415416798357
hemineglect,8,2.0794415416798357
antileukotriene,8,2.0794415416798357
tau,8,2.0794415416798357
coronavirus-19,8,2.0794415416798357
KAF,8,2.0794415416798357
precipitates,8,2.0794415416798357
BMIPP,8,2.0794415416798357
thesis,8,2.0794415416798357
AS03,8,2.0794415416798357
DHL,8,2.0794415416798357
eTCB,8,2.0794415416798357
congruent,8,2.0794415416798357
Pseudomonas,8,2.0794415416798357
3-45,8,2.0794415416798357
tragedy,8,2.0794415416798357
Ageing,8,2.0794415416798357
FL,8,2.0794415416798357
Exclusion,8,2.0794415416798357
gdL,8,2.0794415416798357
Fifty-nine,8,2.0794415416798357
enactment,8,2.0794415416798357
SAC,8,2.0794415416798357
oncologists,8,2.0794415416798357
AOS,8,2.0794415416798357
BB536,8,2.0794415416798357
GAOF,8,2.0794415416798357
post-vaccine,8,2.0794415416798357
AFDAS,8,2.0794415416798357
rheumatologic,8,2.0794415416798357
APuerto,8,2.0794415416798357
LCX-related,8,2.0794415416798357
anti-immunoglobulin,8,2.0794415416798357
appointed,8,2.0794415416798357
Alveolar,8,2.0794415416798357
Discriminant,8,2.0794415416798357
grandparents,8,2.0794415416798357
cooperativity,8,2.0794415416798357
AII,8,2.0794415416798357
Membrane,8,2.0794415416798357
hands-on,8,2.0794415416798357
perioperatively,8,2.0794415416798357
maximizes,8,2.0794415416798357
disintegrin,8,2.0794415416798357
mgml-1,8,2.0794415416798357
case-finding,8,2.0794415416798357
Hereditary,8,2.0794415416798357
Diarrhea,8,2.0794415416798357
aesthetic,8,2.0794415416798357
haemagglutination-inhibiting,8,2.0794415416798357
sub-phenotypes,8,2.0794415416798357
super-spreading,8,2.0794415416798357
Protecting,8,2.0794415416798357
1-week,8,2.0794415416798357
ChAdOx1-S,8,2.0794415416798357
early-warning,8,2.0794415416798357
basin,8,2.0794415416798357
AVL,8,2.0794415416798357
20-year-old,8,2.0794415416798357
Spirometric,8,2.0794415416798357
mean-field,8,2.0794415416798357
electrocardiograph,8,2.0794415416798357
NCX,8,2.0794415416798357
SCID,8,2.0794415416798357
pesticide,8,2.0794415416798357
Ability,8,2.0794415416798357
Costa,8,2.0794415416798357
LD1,8,2.0794415416798357
APOE,8,2.0794415416798357
pleocytosis,8,2.0794415416798357
hydrochloric,8,2.0794415416798357
bacteriology,8,2.0794415416798357
cytologic,8,2.0794415416798357
PSCs,8,2.0794415416798357
sarcomere,8,2.0794415416798357
2005-2007,8,2.0794415416798357
interfaces,8,2.0794415416798357
Vertebral,8,2.0794415416798357
Adjuvants,8,2.0794415416798357
myasthenia,8,2.0794415416798357
Adaptation,8,2.0794415416798357
1980-81,8,2.0794415416798357
cytosol,8,2.0794415416798357
envision,8,2.0794415416798357
microangiopathic,8,2.0794415416798357
Highest,8,2.0794415416798357
Utility,8,2.0794415416798357
bioterrorism,8,2.0794415416798357
Well,8,2.0794415416798357
OH,8,2.0794415416798357
Chair,8,2.0794415416798357
Ambulance,8,2.0794415416798357
852,8,2.0794415416798357
Nose,8,2.0794415416798357
countless,8,2.0794415416798357
MBP,8,2.0794415416798357
cMyBP-C,8,2.0794415416798357
precondition,8,2.0794415416798357
LAAc,8,2.0794415416798357
Abundant,8,2.0794415416798357
PCM,8,2.0794415416798357
RP21,8,2.0794415416798357
sweep,8,2.0794415416798357
SITS,8,2.0794415416798357
putatively,8,2.0794415416798357
time-to-treatment,8,2.0794415416798357
semi-automated,8,2.0794415416798357
fast-tracked,8,2.0794415416798357
haematopoietic,8,2.0794415416798357
effecting,8,2.0794415416798357
940,8,2.0794415416798357
sperm,8,2.0794415416798357
notwithstanding,8,2.0794415416798357
microfocal,8,2.0794415416798357
harvest,8,2.0794415416798357
LDI,8,2.0794415416798357
Ecological,8,2.0794415416798357
criticism,8,2.0794415416798357
Viable,8,2.0794415416798357
drug-related,8,2.0794415416798357
neoplasia,8,2.0794415416798357
975,8,2.0794415416798357
miR-29c,8,2.0794415416798357
sirtuin,8,2.0794415416798357
neuromodulation,8,2.0794415416798357
coagulative,8,2.0794415416798357
oligomers,8,2.0794415416798357
denoted,8,2.0794415416798357
IADL,8,2.0794415416798357
Causative,8,2.0794415416798357
hallucinations,8,2.0794415416798357
recapitulated,8,2.0794415416798357
innervation,8,2.0794415416798357
purine,8,2.0794415416798357
urges,8,2.0794415416798357
microbiomes,8,2.0794415416798357
Pilot,8,2.0794415416798357
inhale,8,2.0794415416798357
BDP,8,2.0794415416798357
ST-Elevation,8,2.0794415416798357
CIIS,8,2.0794415416798357
Probable,8,2.0794415416798357
80-year-old,8,2.0794415416798357
myoclonus,8,2.0794415416798357
Pathophysiologic,8,2.0794415416798357
bath,8,2.0794415416798357
terrain,8,2.0794415416798357
H10,8,2.0794415416798357
nosological,8,2.0794415416798357
Goals,8,2.0794415416798357
work-release,8,2.0794415416798357
aRR,8,2.0794415416798357
nonspecialists,8,2.0794415416798357
EFNS,8,2.0794415416798357
WMHV,8,2.0794415416798357
Endogenous,8,2.0794415416798357
inhibitor-1,8,2.0794415416798357
inaccuracy,8,2.0794415416798357
SVI,8,2.0794415416798357
maturity,8,2.0794415416798357
pharmacodynamics,8,2.0794415416798357
LIAISON,8,2.0794415416798357
Disturbances,8,2.0794415416798357
Biosensor,8,2.0794415416798357
Omnibus,8,2.0794415416798357
Cranial,8,2.0794415416798357
Elucidation,8,2.0794415416798357
attainable,8,2.0794415416798357
Highlands,8,2.0794415416798357
EIAs,8,2.0794415416798357
QuSAGE,8,2.0794415416798357
restructured,8,2.0794415416798357
EDI,8,2.0794415416798357
Chemical,8,2.0794415416798357
2022,8,2.0794415416798357
GISRS,8,2.0794415416798357
noninflammatory,8,2.0794415416798357
8-9,8,2.0794415416798357
hepatocellular,8,2.0794415416798357
RPD,8,2.0794415416798357
SWEDEHEART,8,2.0794415416798357
paranasal,8,2.0794415416798357
anthrax,8,2.0794415416798357
Rational,8,2.0794415416798357
strangulation,8,2.0794415416798357
TNFA,8,2.0794415416798357
Mazowieckie,8,2.0794415416798357
phylodynamics,8,2.0794415416798357
LACS,8,2.0794415416798357
perpetuating,8,2.0794415416798357
immune-modulatory,8,2.0794415416798357
expediting,8,2.0794415416798357
bays,8,2.0794415416798357
ecosystem,8,2.0794415416798357
Error,8,2.0794415416798357
CSVT,8,2.0794415416798357
habitat,8,2.0794415416798357
Colleges,8,2.0794415416798357
insurers,8,2.0794415416798357
750000,8,2.0794415416798357
well-validated,8,2.0794415416798357
phylogenetics,8,2.0794415416798357
enjoy,8,2.0794415416798357
stay-at-home,8,2.0794415416798357
normothermic,8,2.0794415416798357
Lean,8,2.0794415416798357
shell,8,2.0794415416798357
non-EVT,8,2.0794415416798357
1221,8,2.0794415416798357
neurotropism,8,2.0794415416798357
VOI,8,2.0794415416798357
NIA,8,2.0794415416798357
antiallergic,8,2.0794415416798357
Policies,8,2.0794415416798357
exacerbators,8,2.0794415416798357
BSPMs,8,2.0794415416798357
free-radical,8,2.0794415416798357
venues,8,2.0794415416798357
seamless,8,2.0794415416798357
levalbuterol,8,2.0794415416798357
Your,8,2.0794415416798357
wildfire,8,2.0794415416798357
Smith,8,2.0794415416798357
drifts,8,2.0794415416798357
self-,8,2.0794415416798357
texture,8,2.0794415416798357
mucolytic,8,2.0794415416798357
second-,8,2.0794415416798357
spans,8,2.0794415416798357
aseptic,8,2.0794415416798357
1032,8,2.0794415416798357
convalescent-phase,8,2.0794415416798357
praxis,8,2.0794415416798357
Tehran,8,2.0794415416798357
USS,8,2.0794415416798357
handgrip,8,2.0794415416798357
CRISPR-Cas13,8,2.0794415416798357
rEF,8,2.0794415416798357
HSAP-NP,8,2.0794415416798357
multipronged,8,2.0794415416798357
bypasses,8,2.0794415416798357
multiply,8,2.0794415416798357
Inf,8,2.0794415416798357
rRNA,8,2.0794415416798357
1100,8,2.0794415416798357
electrograms,8,2.0794415416798357
prodrug,8,2.0794415416798357
pt,8,2.0794415416798357
stroke-unit,8,2.0794415416798357
Medtronic,8,2.0794415416798357
parameterized,8,2.0794415416798357
bottom-up,8,2.0794415416798357
non-infarct,8,2.0794415416798357
alerting,8,2.0794415416798357
quantifiable,8,2.0794415416798357
impediments,8,2.0794415416798357
event-related,8,2.0794415416798357
exercise-based,8,2.0794415416798357
Co-infection,8,2.0794415416798357
Aerobic,8,2.0794415416798357
OVID,8,2.0794415416798357
PD40,8,2.0794415416798357
EM,8,2.0794415416798357
Angiotensin-Converting,8,2.0794415416798357
CSE,8,2.0794415416798357
Delaware,8,2.0794415416798357
biomechanical,8,2.0794415416798357
Spike-specific,8,2.0794415416798357
migraine-related,8,2.0794415416798357
endowed,8,2.0794415416798357
1002,8,2.0794415416798357
micro-albuminuria,8,2.0794415416798357
time-of-flight,8,2.0794415416798357
IgGs,8,2.0794415416798357
mNGS,8,2.0794415416798357
mechanistically,8,2.0794415416798357
MPs,8,2.0794415416798357
inter-hospital,8,2.0794415416798357
Behavioural,8,2.0794415416798357
packages,8,2.0794415416798357
RPE,8,2.0794415416798357
electroencephalographic,8,2.0794415416798357
APTT,8,2.0794415416798357
1075,8,2.0794415416798357
exome,8,2.0794415416798357
USA-WA12020,8,2.0794415416798357
futile,8,2.0794415416798357
LBMs,8,2.0794415416798357
cleaned,8,2.0794415416798357
Diasorin,8,2.0794415416798357
in-flight,8,2.0794415416798357
ROIs,8,2.0794415416798357
rethrombosis,8,2.0794415416798357
Nebraska,8,2.0794415416798357
contaminate,8,2.0794415416798357
Energy,8,2.0794415416798357
March-April,8,2.0794415416798357
locomotion,8,2.0794415416798357
BPD,8,2.0794415416798357
signal-to-noise,8,2.0794415416798357
string,8,2.0794415416798357
well-conducted,8,2.0794415416798357
haemodialysis,8,2.0794415416798357
extubation,8,2.0794415416798357
Otherwise,8,2.0794415416798357
S128P,8,2.0794415416798357
antibody-positive,8,2.0794415416798357
judiciously,8,2.0794415416798357
T-lymphocyte,8,2.0794415416798357
Capillary,8,2.0794415416798357
non-modifiable,8,2.0794415416798357
ASU,8,2.0794415416798357
FR,8,2.0794415416798357
hyposmia,8,2.0794415416798357
curvilinear,8,2.0794415416798357
Comirnaty,8,2.0794415416798357
CoV2T,8,2.0794415416798357
IAV-induced,8,2.0794415416798357
2004-05,8,2.0794415416798357
intolerant,8,2.0794415416798357
frank,8,2.0794415416798357
1011,8,2.0794415416798357
non-elective,8,2.0794415416798357
replication-incompetent,8,2.0794415416798357
RNP,8,2.0794415416798357
myxomas,8,2.0794415416798357
cubic,8,2.0794415416798357
productively,8,2.0794415416798357
data-based,8,2.0794415416798357
Ta,8,2.0794415416798357
broadened,8,2.0794415416798357
risk-factor,8,2.0794415416798357
complacency,8,2.0794415416798357
LIPUS,8,2.0794415416798357
fluctuated,8,2.0794415416798357
multi-target,8,2.0794415416798357
Sublingual,8,2.0794415416798357
11-16,8,2.0794415416798357
cheapest,8,2.0794415416798357
slice,8,2.0794415416798357
antiparasitic,8,2.0794415416798357
minocycline,8,2.0794415416798357
stewardship,8,2.0794415416798357
multiparametric,8,2.0794415416798357
HAW,8,2.0794415416798357
Charlson,8,2.0794415416798357
PrPSc,8,2.0794415416798357
Reviewers,8,2.0794415416798357
anti-virus,8,2.0794415416798357
pro-thrombotic,8,2.0794415416798357
microorganism,8,2.0794415416798357
homogeneously,8,2.0794415416798357
aldehydes,8,2.0794415416798357
cause-effect,8,2.0794415416798357
dronedarone,8,2.0794415416798357
III-IV,8,2.0794415416798357
delusional,8,2.0794415416798357
Neglect,8,2.0794415416798357
CSCs,8,2.0794415416798357
VAD,8,2.0794415416798357
disentangle,8,2.0794415416798357
traps,8,2.0794415416798357
NVU,8,2.0794415416798357
-7,8,2.0794415416798357
18-55,8,2.0794415416798357
du,8,2.0794415416798357
Papers,8,2.0794415416798357
weakens,8,2.0794415416798357
dose-related,8,2.0794415416798357
Discrepancies,8,2.0794415416798357
Bulgaria,8,2.0794415416798357
adjudication,8,2.0794415416798357
guaranteeing,8,2.0794415416798357
fibre,8,2.0794415416798357
patient-derived,8,2.0794415416798357
mMSCs,8,2.0794415416798357
hemoglobinuria,8,2.0794415416798357
PNH,8,2.0794415416798357
in-school,8,2.0794415416798357
EFg,8,2.0794415416798357
Screen,8,2.0794415416798357
580,8,2.0794415416798357
Rating,8,2.0794415416798357
Roberts,8,2.0794415416798357
Dogs,8,2.0794415416798357
suspensions,8,2.0794415416798357
antigen-detection,8,2.0794415416798357
void,8,2.0794415416798357
upwards,8,2.0794415416798357
myogenic,8,2.0794415416798357
anchor,8,2.0794415416798357
UTR,8,2.0794415416798357
bacilli,8,2.0794415416798357
fractal,8,2.0794415416798357
RPP,8,2.0794415416798357
automaticity,8,2.0794415416798357
meridians,8,2.0794415416798357
landmarks,8,2.0794415416798357
missions,8,2.0794415416798357
farmer,8,2.0794415416798357
pre-dispensing,8,2.0794415416798357
mildest,8,2.0794415416798357
teamwork,8,2.0794415416798357
melanoma,8,2.0794415416798357
9-year-old,8,2.0794415416798357
columns,8,2.0794415416798357
impediment,8,2.0794415416798357
nonmedical,8,2.0794415416798357
201TI,8,2.0794415416798357
squatting,8,2.0794415416798357
GB,8,2.0794415416798357
beverage,8,2.0794415416798357
QP2,8,2.0794415416798357
virologists,8,2.0794415416798357
Accident,8,2.0794415416798357
Mecca,8,2.0794415416798357
Chapter,8,2.0794415416798357
Orf1ab,8,2.0794415416798357
nursery,8,2.0794415416798357
self-medication,8,2.0794415416798357
alcoholism,8,2.0794415416798357
oblongata,8,2.0794415416798357
cryo-electron,8,2.0794415416798357
cold-chain,8,2.0794415416798357
vasodilation,8,2.0794415416798357
Institut,8,2.0794415416798357
1-2-0,8,2.0794415416798357
miscarriage,8,2.0794415416798357
Databases,8,2.0794415416798357
Dissection,8,2.0794415416798357
Easy,8,2.0794415416798357
postinfluenzal,8,2.0794415416798357
interferon-stimulated,8,2.0794415416798357
command,8,2.0794415416798357
NDs,8,2.0794415416798357
collate,8,2.0794415416798357
fishing,8,2.0794415416798357
immunoreactivity,8,2.0794415416798357
thirty-eight,8,2.0794415416798357
dwelling,8,2.0794415416798357
Hurricane,8,2.0794415416798357
overexpressed,8,2.0794415416798357
gestures,8,2.0794415416798357
IOTEE,8,2.0794415416798357
sphingolipids,8,2.0794415416798357
Benign,8,2.0794415416798357
Inappropriate,8,2.0794415416798357
non-neurological,8,2.0794415416798357
pill,8,2.0794415416798357
co-ordination,8,2.0794415416798357
hemophilia,8,2.0794415416798357
Nor,8,2.0794415416798357
biracial,8,2.0794415416798357
TAMI,8,2.0794415416798357
jumped,8,2.0794415416798357
animal-human,8,2.0794415416798357
chromosomes,8,2.0794415416798357
human-to-animal,8,2.0794415416798357
RAPID,8,2.0794415416798357
abscesses,8,2.0794415416798357
disturbs,8,2.0794415416798357
viperin,8,2.0794415416798357
excrescences,8,2.0794415416798357
Affected,8,2.0794415416798357
inhalants,8,2.0794415416798357
Smyd1,8,2.0794415416798357
Ninety-one,8,2.0794415416798357
Pharmaceuticals,8,2.0794415416798357
glomerulonephritis,8,2.0794415416798357
installed,8,2.0794415416798357
cough-variant,8,2.0794415416798357
IFN-gamma,8,2.0794415416798357
propionate,8,2.0794415416798357
SARS-COV2,8,2.0794415416798357
CD163,8,2.0794415416798357
centrality,8,2.0794415416798357
blood-pressure,8,2.0794415416798357
insertable,8,2.0794415416798357
ICM,8,2.0794415416798357
IL10,8,2.0794415416798357
under-reporting,8,2.0794415416798357
ADEM,8,2.0794415416798357
post-transcriptional,8,2.0794415416798357
stretched,8,2.0794415416798357
HOMA-IR,8,2.0794415416798357
Sul,8,2.0794415416798357
Optimizing,8,2.0794415416798357
drains,8,2.0794415416798357
flatten,8,2.0794415416798357
chaperone,8,2.0794415416798357
remissions,8,2.0794415416798357
Remission,8,2.0794415416798357
thrombophilic,8,2.0794415416798357
ache,8,2.0794415416798357
Subcommittee,8,2.0794415416798357
menarche,8,2.0794415416798357
3C-like,8,2.0794415416798357
interruptions,8,2.0794415416798357
1232,8,2.0794415416798357
reestablishing,8,2.0794415416798357
Distinguishing,8,2.0794415416798357
Drs,8,2.0794415416798357
crepitations,8,2.0794415416798357
collector,8,2.0794415416798357
MSX,8,2.0794415416798357
refrain,8,2.0794415416798357
humidified,8,2.0794415416798357
Equally,8,2.0794415416798357
avian-to-human,8,2.0794415416798357
shaking,8,2.0794415416798357
inducibility,8,2.0794415416798357
20-60,8,2.0794415416798357
Duke,8,2.0794415416798357
11000,8,2.0794415416798357
kinematics,8,2.0794415416798357
HSPs,8,2.0794415416798357
1016,8,2.0794415416798357
incapable,8,2.0794415416798357
110000,8,2.0794415416798357
scintillation,8,2.0794415416798357
familys,8,2.0794415416798357
WMHs,8,2.0794415416798357
quadratic,8,2.0794415416798357
wreaked,8,2.0794415416798357
Debate,8,2.0794415416798357
cross-neutralization,8,2.0794415416798357
wholesale,8,2.0794415416798357
Prism,8,2.0794415416798357
pars,8,2.0794415416798357
sneeze,8,2.0794415416798357
rudimentary,8,2.0794415416798357
cheese,8,2.0794415416798357
GCs,8,2.0794415416798357
ABrisbane592007,8,2.0794415416798357
bundles,8,2.0794415416798357
Breastfeeding,8,2.0794415416798357
retrotracheal,8,2.0794415416798357
upgraded,8,2.0794415416798357
484,8,2.0794415416798357
instruct,8,2.0794415416798357
inferoseptal,8,2.0794415416798357
wastewaters,8,2.0794415416798357
Subclinical,8,2.0794415416798357
unsafe,8,2.0794415416798357
paediatrician,8,2.0794415416798357
kd,8,2.0794415416798357
polyvalent,8,2.0794415416798357
IIIII,8,2.0794415416798357
nonimmunologic,8,2.0794415416798357
model-based,8,2.0794415416798357
nearing,8,2.0794415416798357
-30,8,2.0794415416798357
Nonvalvular,8,2.0794415416798357
pseudotype,8,2.0794415416798357
Actual,8,2.0794415416798357
high-molecular-weight,8,2.0794415416798357
Translating,8,2.0794415416798357
S-,8,2.0794415416798357
non-diabetics,8,2.0794415416798357
ECG-gated,8,2.0794415416798357
monophosphate,8,2.0794415416798357
POS,8,2.0794415416798357
836,8,2.0794415416798357
interlobular,8,2.0794415416798357
Eighty-nine,8,2.0794415416798357
entries,8,2.0794415416798357
Resuscitation,8,2.0794415416798357
PLC,8,2.0794415416798357
Adenosine,8,2.0794415416798357
antagonize,8,2.0794415416798357
massively,8,2.0794415416798357
ADME,8,2.0794415416798357
sprouting,8,2.0794415416798357
extensions,8,2.0794415416798357
Including,8,2.0794415416798357
STEAMI,8,2.0794415416798357
non-obese,8,2.0794415416798357
RMSD,8,2.0794415416798357
totaling,8,2.0794415416798357
disulfide,8,2.0794415416798357
pre-exposure,8,2.0794415416798357
577,8,2.0794415416798357
harmonized,8,2.0794415416798357
statutory,8,2.0794415416798357
0030,8,2.0794415416798357
LitCovid,8,2.0794415416798357
Presumably,8,2.0794415416798357
EOC,8,2.0794415416798357
serotonergic,8,2.0794415416798357
AMR,8,2.0794415416798357
doping,8,2.0794415416798357
p0003,8,2.0794415416798357
DHC,8,2.0794415416798357
nCPAP,8,2.0794415416798357
pulsation,8,2.0794415416798357
Performing,8,2.0794415416798357
asynchrony,8,2.0794415416798357
baselines,8,2.0794415416798357
exitialis,8,2.0794415416798357
Elecsys®,8,2.0794415416798357
CFAF,8,2.0794415416798357
Concurrently,8,2.0794415416798357
OPs,8,2.0794415416798357
AS03-adjuvanted,8,2.0794415416798357
acuity,8,2.0794415416798357
asthma-chronic,8,2.0794415416798357
ZNF,8,2.0794415416798357
Get,8,2.0794415416798357
unanimous,8,2.0794415416798357
whole-brain,8,2.0794415416798357
CFA,8,2.0794415416798357
AZ,8,2.0794415416798357
25-hydroxyvitamin,8,2.0794415416798357
appliances,8,2.0794415416798357
anti-CoV,8,2.0794415416798357
Thromboembolism,8,2.0794415416798357
strengthens,8,2.0794415416798357
Electrocardiograms,8,2.0794415416798357
foreseen,8,2.0794415416798357
comprehend,8,2.0794415416798357
OVA-induced,8,2.0794415416798357
ILD,8,2.0794415416798357
autogenic,8,2.0794415416798357
TTI,8,2.0794415416798357
patient-oriented,8,2.0794415416798357
paraplegia,8,2.0794415416798357
sedatives,8,2.0794415416798357
club,8,2.0794415416798357
replicase,8,2.0794415416798357
SARSCoV-,8,2.0794415416798357
on-call,8,2.0794415416798357
2009-2011,8,2.0794415416798357
commonplace,8,2.0794415416798357
Optimum,8,2.0794415416798357
LDH1,8,2.0794415416798357
Perceptions,8,2.0794415416798357
Accumulated,8,2.0794415416798357
Again,8,2.0794415416798357
hardware,8,2.0794415416798357
normalised,8,2.0794415416798357
STEMIs,8,2.0794415416798357
administrated,8,2.0794415416798357
noninfected,8,2.0794415416798357
pulmonale,8,2.0794415416798357
Hemorrhage,8,2.0794415416798357
cor,8,2.0794415416798357
Genome-wide,8,2.0794415416798357
SF-12,8,2.0794415416798357
minima,8,2.0794415416798357
LAB,8,2.0794415416798357
confounds,8,2.0794415416798357
Lyra,8,2.0794415416798357
lacunae,8,2.0794415416798357
Amid,8,2.0794415416798357
palpitations,8,2.0794415416798357
Umbria,8,2.0794415416798357
L84S,8,2.0794415416798357
echography,8,2.0794415416798357
IRT,8,2.0794415416798357
corticosteroid-dependent,8,2.0794415416798357
domiciliary,8,2.0794415416798357
High-dose,8,2.0794415416798357
Nedocromil,8,2.0794415416798357
first-,8,2.0794415416798357
STANDARD,8,2.0794415416798357
steno-occlusive,8,2.0794415416798357
ADMA,8,2.0794415416798357
radiomics,8,2.0794415416798357
Archive,8,2.0794415416798357
6-11,8,2.0794415416798357
hospice,8,2.0794415416798357
PrI,8,2.0794415416798357
haloperidol,8,2.0794415416798357
1020,8,2.0794415416798357
Commonly,8,2.0794415416798357
0036,8,2.0794415416798357
E-selectin,8,2.0794415416798357
FEF,8,2.0794415416798357
Ritonavir,8,2.0794415416798357
OGT,8,2.0794415416798357
Benin,8,2.0794415416798357
COVI-VAC,8,2.0794415416798357
M-S,8,2.0794415416798357
761,8,2.0794415416798357
expended,8,2.0794415416798357
20C,8,2.0794415416798357
NAWM,8,2.0794415416798357
examiners,8,2.0794415416798357
ORF10,8,2.0794415416798357
779,8,2.0794415416798357
pH1N1-associated,8,2.0794415416798357
co-twin,8,2.0794415416798357
osteoprotegerin,8,2.0794415416798357
bottle,8,2.0794415416798357
satisfies,8,2.0794415416798357
intermediary,8,2.0794415416798357
Q57H,8,2.0794415416798357
wavefront,8,2.0794415416798357
programmatic,8,2.0794415416798357
endeavour,8,2.0794415416798357
co-expression,8,2.0794415416798357
001ABSTRACT,8,2.0794415416798357
CD4CD8,8,2.0794415416798357
non-occupational,8,2.0794415416798357
transporting,8,2.0794415416798357
Mediastinal,8,2.0794415416798357
MPE,8,2.0794415416798357
96-well,8,2.0794415416798357
Timing,8,2.0794415416798357
necroptosis,8,2.0794415416798357
IRs,8,2.0794415416798357
involuntary,8,2.0794415416798357
liters,8,2.0794415416798357
976,8,2.0794415416798357
under-resourced,8,2.0794415416798357
Concurrent,8,2.0794415416798357
myoglobinuria,8,2.0794415416798357
neurorepair,8,2.0794415416798357
lamina,8,2.0794415416798357
exuberant,8,2.0794415416798357
847,8,2.0794415416798357
radio,8,2.0794415416798357
infero-posterior,8,2.0794415416798357
HRM,8,2.0794415416798357
contrapulsation,8,2.0794415416798357
brain-damaged,8,2.0794415416798357
Capital,8,2.0794415416798357
heads,8,2.0794415416798357
794,8,2.0794415416798357
V6R,8,2.0794415416798357
nightly,8,2.0794415416798357
wide-scale,8,2.0794415416798357
422,8,2.0794415416798357
gallbladder,8,2.0794415416798357
facepiece,8,2.0794415416798357
rt-PCR,8,2.0794415416798357
tentatively,8,2.0794415416798357
Inner,8,2.0794415416798357
Variable,8,2.0794415416798357
hypovolemia,8,2.0794415416798357
Implantation,8,2.0794415416798357
Fifty-five,8,2.0794415416798357
discourage,8,2.0794415416798357
anxieties,8,2.0794415416798357
Oceania,8,2.0794415416798357
trading,8,2.0794415416798357
acaricides,8,2.0794415416798357
dormitories,8,2.0794415416798357
assertion,8,2.0794415416798357
dampness,8,2.0794415416798357
Thorough,8,2.0794415416798357
redesign,8,2.0794415416798357
Consumption,8,2.0794415416798357
CIN,8,2.0794415416798357
nARS,8,2.0794415416798357
virome,8,2.0794415416798357
664,8,2.0794415416798357
IPS,8,2.0794415416798357
IFVA,8,2.0794415416798357
1977-1978,8,2.0794415416798357
Generation,8,2.0794415416798357
non-enzymatic,8,2.0794415416798357
BSichuan37999,8,2.0794415416798357
persuasive,8,2.0794415416798357
15-44,8,2.0794415416798357
SARS-2,8,2.0794415416798357
moiety,8,2.0794415416798357
timepoint,8,2.0794415416798357
directors,8,2.0794415416798357
paves,8,2.0794415416798357
LCx,8,2.0794415416798357
seawater,8,2.0794415416798357
anything,8,2.0794415416798357
distorted,8,2.0794415416798357
triple-vessel,8,2.0794415416798357
realtime,8,2.0794415416798357
aeromedical,8,2.0794415416798357
viral-host,8,2.0794415416798357
down-regulation,8,2.0794415416798357
miR-155,8,2.0794415416798357
Townsend,8,2.0794415416798357
BB-EPI,8,2.0794415416798357
LCPUFA,8,2.0794415416798357
Epigenetic,8,2.0794415416798357
801,8,2.0794415416798357
neuroprotectant,8,2.0794415416798357
ST-,8,2.0794415416798357
synaptogenesis,8,2.0794415416798357
southwest,8,2.0794415416798357
serodiagnosis,8,2.0794415416798357
proteomes,8,2.0794415416798357
obstructing,8,2.0794415416798357
32-item,8,2.0794415416798357
tercile,8,2.0794415416798357
biannual,8,2.0794415416798357
FINMONICA,8,2.0794415416798357
polyneuropathy,8,2.0794415416798357
Pathogens,8,2.0794415416798357
outlet,8,2.0794415416798357
terminus,8,2.0794415416798357
n26,8,2.0794415416798357
AH1N2,8,2.0794415416798357
substernal,8,2.0794415416798357
Pune,8,2.0794415416798357
Longer,8,2.0794415416798357
herb,8,2.0794415416798357
H7N3,8,2.0794415416798357
pressure-lowering,8,2.0794415416798357
Investigational,8,2.0794415416798357
PBL,8,2.0794415416798357
MTM,8,2.0794415416798357
DDAH1,8,2.0794415416798357
27-item,8,2.0794415416798357
convalescing,8,2.0794415416798357
deliberately,8,2.0794415416798357
chitosan,8,2.0794415416798357
intraperitoneal,8,2.0794415416798357
PQ,8,2.0794415416798357
transmittable,8,2.0794415416798357
fill-in,8,2.0794415416798357
visualisation,8,2.0794415416798357
saliva-based,8,2.0794415416798357
pathogenetically,8,2.0794415416798357
Eighty-seven,8,2.0794415416798357
qualification,8,2.0794415416798357
deduce,8,2.0794415416798357
Sir,8,2.0794415416798357
Real-world,8,2.0794415416798357
motivations,8,2.0794415416798357
paved,8,2.0794415416798357
PW,8,2.0794415416798357
respiratory-related,8,2.0794415416798357
10h,8,2.0794415416798357
shadows,8,2.0794415416798357
7-year-old,8,2.0794415416798357
PubMedMEDLINE,8,2.0794415416798357
fluctuates,8,2.0794415416798357
preventions,8,2.0794415416798357
imputation,8,2.0794415416798357
TKA,8,2.0794415416798357
southwestern,8,2.0794415416798357
prions,8,2.0794415416798357
thermostable,8,2.0794415416798357
antihemagglutinin,8,2.0794415416798357
cerebro-vascular,8,2.0794415416798357
northeast,8,2.0794415416798357
staffs,8,2.0794415416798357
Prospectively,8,2.0794415416798357
Cas13,8,2.0794415416798357
Reductions,8,2.0794415416798357
citicoline,8,2.0794415416798357
E627K,8,2.0794415416798357
treats,8,2.0794415416798357
cytoskeleton,8,2.0794415416798357
CD200,8,2.0794415416798357
consumable,8,2.0794415416798357
cryptic,8,2.0794415416798357
SCUBA,8,2.0794415416798357
hypothalamic,8,2.0794415416798357
symbolic,8,2.0794415416798357
Macaca,8,2.0794415416798357
azelastine,8,2.0794415416798357
lesion-symptom,8,2.0794415416798357
20-64,8,2.0794415416798357
Metoprolol,8,2.0794415416798357
pO2,8,2.0794415416798357
dissolve,8,2.0794415416798357
KNN,8,2.0794415416798357
plasmin,8,2.0794415416798357
Predominant,8,2.0794415416798357
anti-nucleocapsid,8,2.0794415416798357
Å,8,2.0794415416798357
200708,8,2.0794415416798357
Demographics,8,2.0794415416798357
Smart,8,2.0794415416798357
digitized,8,2.0794415416798357
ChA,8,2.0794415416798357
FEF25,8,2.0794415416798357
forskolin,8,2.0794415416798357
alignments,8,2.0794415416798357
neuroinvasion,8,2.0794415416798357
825,8,2.0794415416798357
revisit,8,2.0794415416798357
Lately,8,2.0794415416798357
pairwise,8,2.0794415416798357
Intrathoracic,8,2.0794415416798357
Laboratory-confirmed,8,2.0794415416798357
seroprotective,8,2.0794415416798357
necrotising,8,2.0794415416798357
nonreversible,8,2.0794415416798357
prostacyclin,8,2.0794415416798357
Soluble,8,2.0794415416798357
nonocclusive,8,2.0794415416798357
biosolids,8,2.0794415416798357
subway,8,2.0794415416798357
favouring,8,2.0794415416798357
macular,8,2.0794415416798357
DAMPs,8,2.0794415416798357
BMS,8,2.0794415416798357
Autoimmune,8,2.0794415416798357
salvaging,8,2.0794415416798357
Neurologists,8,2.0794415416798357
haemostatic,8,2.0794415416798357
whole-virus,8,2.0794415416798357
apneas,8,2.0794415416798357
interferon-inducible,8,2.0794415416798357
succinate,8,2.0794415416798357
PoC,8,2.0794415416798357
collateralization,8,2.0794415416798357
chords,8,2.0794415416798357
nation-wide,8,2.0794415416798357
AASMC,8,2.0794415416798357
7-16,8,2.0794415416798357
tilts,8,2.0794415416798357
jaundice,8,2.0794415416798357
HDI,8,2.0794415416798357
RRx-001,8,2.0794415416798357
antibody-antigen,8,2.0794415416798357
indecision,8,2.0794415416798357
in-stent,8,2.0794415416798357
irreplaceable,8,2.0794415416798357
post-PTCA,8,2.0794415416798357
Essen,8,2.0794415416798357
preschool-age,8,2.0794415416798357
postinfectious,8,2.0794415416798357
N-specific,8,2.0794415416798357
Allergists,8,2.0794415416798357
Thrombolytics,8,2.0794415416798357
ravaging,8,2.0794415416798357
prioritizes,8,2.0794415416798357
1H,8,2.0794415416798357
Favorable,8,2.0794415416798357
SpikeD614G,8,2.0794415416798357
reassortments,8,2.0794415416798357
Salvador,8,2.0794415416798357
callers,8,2.0794415416798357
752,8,2.0794415416798357
constructive,8,2.0794415416798357
enduring,8,2.0794415416798357
Mucosal,8,2.0794415416798357
wildtype,8,2.0794415416798357
FVIII,8,2.0794415416798357
Evaluations,8,2.0794415416798357
provokes,8,2.0794415416798357
LPL,8,2.0794415416798357
apo,8,2.0794415416798357
Preventions,8,2.0794415416798357
verticality,8,2.0794415416798357
unchecked,8,2.0794415416798357
submission,8,2.0794415416798357
R₀,8,2.0794415416798357
heights,8,2.0794415416798357
sheds,8,2.0794415416798357
950,8,2.0794415416798357
non-CE,8,2.0794415416798357
RBC,8,2.0794415416798357
context-specific,8,2.0794415416798357
Minimum,8,2.0794415416798357
PCC,8,2.0794415416798357
warned,8,2.0794415416798357
Females,8,2.0794415416798357
959,8,2.0794415416798357
time-related,8,2.0794415416798357
Ethnic,8,2.0794415416798357
third-generation,8,2.0794415416798357
LSTM,8,2.0794415416798357
Navarre,8,2.0794415416798357
radon,8,2.0794415416798357
bacterium,8,2.0794415416798357
unprepared,8,2.0794415416798357
Cog-4,8,2.0794415416798357
utilising,8,2.0794415416798357
Registration-,8,2.0794415416798357
nanobodies,8,2.0794415416798357
multigated,8,2.0794415416798357
P-RDT,8,2.0794415416798357
PRRs,8,2.0794415416798357
Dialysis,8,2.0794415416798357
algae,8,2.0794415416798357
seminal,8,2.0794415416798357
non-pharmacologic,8,2.0794415416798357
skeptical,8,2.0794415416798357
ionizing,8,2.0794415416798357
Thrombi,8,2.0794415416798357
763,8,2.0794415416798357
Sicily,8,2.0794415416798357
apheresis,8,2.0794415416798357
casts,8,2.0794415416798357
freezing,8,2.0794415416798357
pregnancy-induced,8,2.0794415416798357
caught,8,2.0794415416798357
assistants,8,2.0794415416798357
presenters,8,2.0794415416798357
Calmette-Guérin,8,2.0794415416798357
FA-2,8,2.0794415416798357
Neutrophil,8,2.0794415416798357
educator,8,2.0794415416798357
1959,8,2.0794415416798357
heat-inactivated,8,2.0794415416798357
wrote,8,2.0794415416798357
Exploration,8,2.0794415416798357
globular,8,2.0794415416798357
graying,8,2.0794415416798357
56°C,8,2.0794415416798357
mid-August,8,2.0794415416798357
n8,8,2.0794415416798357
daysweek,8,2.0794415416798357
tries,8,2.0794415416798357
Roosevelt,8,2.0794415416798357
asset,8,2.0794415416798357
regress,8,2.0794415416798357
7-15,8,2.0794415416798357
881,8,2.0794415416798357
telocytes,8,2.0794415416798357
reacting,8,2.0794415416798357
1050,8,2.0794415416798357
hajj,8,2.0794415416798357
negotiating,8,2.0794415416798357
614G,8,2.0794415416798357
837,8,2.0794415416798357
guanidine,8,2.0794415416798357
Cold,8,2.0794415416798357
toxicology,8,2.0794415416798357
electrolytes,8,2.0794415416798357
salutary,8,2.0794415416798357
Universities,8,2.0794415416798357
serumplasma,8,2.0794415416798357
illustrations,8,2.0794415416798357
között,8,2.0794415416798357
nitrotyrosine,8,2.0794415416798357
March-June,8,2.0794415416798357
649,8,2.0794415416798357
beteg,8,2.0794415416798357
forceful,8,2.0794415416798357
Steroids,8,2.0794415416798357
FNS,8,2.0794415416798357
Victorian,8,2.0794415416798357
MF59,8,2.0794415416798357
pre-defined,8,2.0794415416798357
marginalized,8,2.0794415416798357
gram-negative,8,2.0794415416798357
AESI,8,2.0794415416798357
periodontitis,8,2.0794415416798357
Co-circulation,8,2.0794415416798357
posteromedial,8,2.0794415416798357
drafted,8,2.0794415416798357
GPS,8,2.0794415416798357
inequity,8,2.0794415416798357
sGaw,8,2.0794415416798357
-3,8,2.0794415416798357
co-contraction,8,2.0794415416798357
WHO-recommended,8,2.0794415416798357
subsample,8,2.0794415416798357
h-1,8,2.0794415416798357
declaring,8,2.0794415416798357
731,8,2.0794415416798357
Réunion,8,2.0794415416798357
MIBI-SPECT,8,2.0794415416798357
pores,8,2.0794415416798357
immunodeficiencies,8,2.0794415416798357
20192020,8,2.0794415416798357
pial,8,2.0794415416798357
police,8,2.0794415416798357
887,8,2.0794415416798357
674,8,2.0794415416798357
AFOs,8,2.0794415416798357
learning-based,8,2.0794415416798357
sway,8,2.0794415416798357
pheochromocytoma,8,2.0794415416798357
non-acute,8,2.0794415416798357
Nonfatal,8,2.0794415416798357
fi,8,2.0794415416798357
Resistant,8,2.0794415416798357
Isocyanates,8,2.0794415416798357
rst,8,2.0794415416798357
inversions,8,2.0794415416798357
pro,8,2.0794415416798357
homeopathy,8,2.0794415416798357
E75,8,2.0794415416798357
laughing,8,2.0794415416798357
Florence,8,2.0794415416798357
pyogenes,8,2.0794415416798357
palsies,8,2.0794415416798357
traders,8,2.0794415416798357
anti-oxidative,8,2.0794415416798357
luminescence,8,2.0794415416798357
ANN,8,2.0794415416798357
IL-17A,8,2.0794415416798357
preparatory,8,2.0794415416798357
electrophoretic,8,2.0794415416798357
II-IV,8,2.0794415416798357
901,8,2.0794415416798357
EET,8,2.0794415416798357
destabilize,8,2.0794415416798357
myofibrils,8,2.0794415416798357
bat-derived,8,2.0794415416798357
envenomation,8,2.0794415416798357
obviate,8,2.0794415416798357
equivalence,8,2.0794415416798357
van,8,2.0794415416798357
fL,8,2.0794415416798357
Days,8,2.0794415416798357
plausibly,8,2.0794415416798357
Suggested,8,2.0794415416798357
arterioles,8,2.0794415416798357
30-35,8,2.0794415416798357
sub-clade,8,2.0794415416798357
Helicobacter,8,2.0794415416798357
604,8,2.0794415416798357
DNAm,8,2.0794415416798357
Andalusia,8,2.0794415416798357
Necropsy,8,2.0794415416798357
plasmas,8,2.0794415416798357
annulus,8,2.0794415416798357
contaminants,8,2.0794415416798357
NSPs,8,2.0794415416798357
60-70,8,2.0794415416798357
booklet,8,2.0794415416798357
GISSI-2,8,2.0794415416798357
Bologna,8,2.0794415416798357
burn,8,2.0794415416798357
≥15,8,2.0794415416798357
undermined,8,2.0794415416798357
5-12,8,2.0794415416798357
reaction-based,8,2.0794415416798357
stretching,8,2.0794415416798357
IMS,8,2.0794415416798357
replied,8,2.0794415416798357
narrower,8,2.0794415416798357
etiopathogenic,8,2.0794415416798357
EPR-2,8,2.0794415416798357
rows,8,2.0794415416798357
equals,8,2.0794415416798357
atherectomy,8,2.0794415416798357
civilization,8,2.0794415416798357
thrombo-embolic,8,2.0794415416798357
nickel,8,2.0794415416798357
reorganize,8,2.0794415416798357
needle-free,8,2.0794415416798357
PAM,8,2.0794415416798357
Varying,8,2.0794415416798357
fused,8,2.0794415416798357
buccal,8,2.0794415416798357
ETA,8,2.0794415416798357
oxLDL,8,2.0794415416798357
APanama200799,8,2.0794415416798357
anti-coagulation,8,2.0794415416798357
IAA,8,2.0794415416798357
mJcm2,8,2.0794415416798357
5-year-old,8,2.0794415416798357
reactance,8,2.0794415416798357
seated,8,2.0794415416798357
rehospitalized,8,2.0794415416798357
Engl,8,2.0794415416798357
drowsiness,8,2.0794415416798357
2-7,8,2.0794415416798357
white-matter,8,2.0794415416798357
self-interest,8,2.0794415416798357
collaboratively,8,2.0794415416798357
CRRT,8,2.0794415416798357
EPA,8,2.0794415416798357
typed,8,2.0794415416798357
eosinophil-derived,8,2.0794415416798357
suppressor,8,2.0794415416798357
Ao-CBCT,8,2.0794415416798357
single-,8,2.0794415416798357
elderberry,8,2.0794415416798357
cancelled,8,2.0794415416798357
PWP,8,2.0794415416798357
Predisposing,8,2.0794415416798357
secreting,8,2.0794415416798357
Attitude,8,2.0794415416798357
microgramsmin,8,2.0794415416798357
plant-based,8,2.0794415416798357
tasked,8,2.0794415416798357
Law,8,2.0794415416798357
8-14,8,2.0794415416798357
alcohol-based,8,2.0794415416798357
p0008,8,2.0794415416798357
SOA,8,2.0794415416798357
hyper-inflammatory,8,2.0794415416798357
folk,8,2.0794415416798357
grid,8,2.0794415416798357
washes,8,2.0794415416798357
RAPvO2,8,2.0794415416798357
pyrexia,8,2.0794415416798357
leukemias,8,2.0794415416798357
traumas,8,2.0794415416798357
CPRS,7,1.9459101490553132
arrythmias,7,1.9459101490553132
23rd,7,1.9459101490553132
DEC,7,1.9459101490553132
ergot,7,1.9459101490553132
thrombolyzed,7,1.9459101490553132
ignited,7,1.9459101490553132
Gastro-oesophageal,7,1.9459101490553132
coaching,7,1.9459101490553132
HGF,7,1.9459101490553132
ethnically,7,1.9459101490553132
struts,7,1.9459101490553132
germs,7,1.9459101490553132
NANC,7,1.9459101490553132
SDS,7,1.9459101490553132
womans,7,1.9459101490553132
CHS,7,1.9459101490553132
2p,7,1.9459101490553132
lesson,7,1.9459101490553132
extensor,7,1.9459101490553132
redness,7,1.9459101490553132
transcardiac,7,1.9459101490553132
Short-acting,7,1.9459101490553132
Da,7,1.9459101490553132
spells,7,1.9459101490553132
tenderness,7,1.9459101490553132
Evolutionary,7,1.9459101490553132
destined,7,1.9459101490553132
nonalcoholic,7,1.9459101490553132
873,7,1.9459101490553132
LFRET,7,1.9459101490553132
pulses,7,1.9459101490553132
Fibrosis,7,1.9459101490553132
Luxembourg,7,1.9459101490553132
reestablishment,7,1.9459101490553132
incur,7,1.9459101490553132
2000s,7,1.9459101490553132
psycho-social,7,1.9459101490553132
Q1,7,1.9459101490553132
neuropathies,7,1.9459101490553132
analogy,7,1.9459101490553132
83-year-old,7,1.9459101490553132
Disorder,7,1.9459101490553132
characterises,7,1.9459101490553132
steroidal,7,1.9459101490553132
definable,7,1.9459101490553132
Associate,7,1.9459101490553132
Dissemination,7,1.9459101490553132
culture-derived,7,1.9459101490553132
Bergamo,7,1.9459101490553132
492,7,1.9459101490553132
Midwestern,7,1.9459101490553132
cloud,7,1.9459101490553132
IIS,7,1.9459101490553132
66-year-old,7,1.9459101490553132
Adult-onset,7,1.9459101490553132
Athletes,7,1.9459101490553132
epigenomics,7,1.9459101490553132
spirituality,7,1.9459101490553132
SLIV,7,1.9459101490553132
Hepatitis,7,1.9459101490553132
IIB,7,1.9459101490553132
folded,7,1.9459101490553132
formulae,7,1.9459101490553132
NSC,7,1.9459101490553132
Albeit,7,1.9459101490553132
CD55,7,1.9459101490553132
Product,7,1.9459101490553132
Phenotypes,7,1.9459101490553132
personally,7,1.9459101490553132
MMR,7,1.9459101490553132
Voluntary,7,1.9459101490553132
confidently,7,1.9459101490553132
transporters,7,1.9459101490553132
LIA,7,1.9459101490553132
FHMI,7,1.9459101490553132
l-arginine,7,1.9459101490553132
AH9N2,7,1.9459101490553132
CIRI,7,1.9459101490553132
clumping,7,1.9459101490553132
resource-constrained,7,1.9459101490553132
fragility,7,1.9459101490553132
amplification-based,7,1.9459101490553132
cytokine-mediated,7,1.9459101490553132
wasp,7,1.9459101490553132
Henry,7,1.9459101490553132
Ventriculography,7,1.9459101490553132
sphericity,7,1.9459101490553132
attachments,7,1.9459101490553132
willingness-to-pay,7,1.9459101490553132
CAMP,7,1.9459101490553132
fills,7,1.9459101490553132
exclusions,7,1.9459101490553132
vagus,7,1.9459101490553132
Administration-approved,7,1.9459101490553132
BLAST,7,1.9459101490553132
pessimistic,7,1.9459101490553132
PQLQ,7,1.9459101490553132
quaternary,7,1.9459101490553132
MCO,7,1.9459101490553132
artists,7,1.9459101490553132
589,7,1.9459101490553132
inquiries,7,1.9459101490553132
wherever,7,1.9459101490553132
APPs,7,1.9459101490553132
HEPA,7,1.9459101490553132
Post-myocardial,7,1.9459101490553132
neuropathology,7,1.9459101490553132
Concepts,7,1.9459101490553132
Hspa12a--,7,1.9459101490553132
199596,7,1.9459101490553132
openings,7,1.9459101490553132
CA521FALA,7,1.9459101490553132
macrodomains,7,1.9459101490553132
organizes,7,1.9459101490553132
MEF25,7,1.9459101490553132
cross-country,7,1.9459101490553132
Till,7,1.9459101490553132
antineuraminidase,7,1.9459101490553132
adiastole,7,1.9459101490553132
SGPT,7,1.9459101490553132
sold,7,1.9459101490553132
computers,7,1.9459101490553132
RBCs,7,1.9459101490553132
incurring,7,1.9459101490553132
Trauma,7,1.9459101490553132
naproxen,7,1.9459101490553132
Eighty-four,7,1.9459101490553132
Continuing,7,1.9459101490553132
cartilage,7,1.9459101490553132
sub-strains,7,1.9459101490553132
orofacial,7,1.9459101490553132
corporate,7,1.9459101490553132
pollinosis,7,1.9459101490553132
Physiologic,7,1.9459101490553132
efflux,7,1.9459101490553132
pre-analytical,7,1.9459101490553132
sanitizers,7,1.9459101490553132
β-agonist,7,1.9459101490553132
hemopericardium,7,1.9459101490553132
tempo,7,1.9459101490553132
near-normal,7,1.9459101490553132
typhoid,7,1.9459101490553132
faith-based,7,1.9459101490553132
Constant,7,1.9459101490553132
HDM-induced,7,1.9459101490553132
winning,7,1.9459101490553132
OPS,7,1.9459101490553132
hydration,7,1.9459101490553132
Outside,7,1.9459101490553132
1350,7,1.9459101490553132
psychometrically,7,1.9459101490553132
reverted,7,1.9459101490553132
malpractice,7,1.9459101490553132
n60,7,1.9459101490553132
catalyzed,7,1.9459101490553132
Guide,7,1.9459101490553132
BBT,7,1.9459101490553132
double-edged,7,1.9459101490553132
HCW-collected,7,1.9459101490553132
pictorial,7,1.9459101490553132
intercurrent,7,1.9459101490553132
FilterWire,7,1.9459101490553132
hemophagocytosis,7,1.9459101490553132
Sheffield,7,1.9459101490553132
200001,7,1.9459101490553132
algorithmic,7,1.9459101490553132
Airport,7,1.9459101490553132
externalizing,7,1.9459101490553132
Kirschner,7,1.9459101490553132
FLU,7,1.9459101490553132
rhinomanometry,7,1.9459101490553132
Million,7,1.9459101490553132
6-hour,7,1.9459101490553132
leucocyte,7,1.9459101490553132
nanoparticle-based,7,1.9459101490553132
milliliter,7,1.9459101490553132
hCoVs,7,1.9459101490553132
CYP,7,1.9459101490553132
sulphasalazine,7,1.9459101490553132
FMD,7,1.9459101490553132
MHC-II,7,1.9459101490553132
trainee,7,1.9459101490553132
nonselective,7,1.9459101490553132
YouTube,7,1.9459101490553132
IHCA,7,1.9459101490553132
Please,7,1.9459101490553132
Probabilistic,7,1.9459101490553132
Bioinformatics,7,1.9459101490553132
practicalities,7,1.9459101490553132
AAs,7,1.9459101490553132
social-distancing,7,1.9459101490553132
instructive,7,1.9459101490553132
alpha-1-AT,7,1.9459101490553132
200506,7,1.9459101490553132
Scales,7,1.9459101490553132
FVL,7,1.9459101490553132
Regionally,7,1.9459101490553132
enforcing,7,1.9459101490553132
keen,7,1.9459101490553132
leverages,7,1.9459101490553132
Athens,7,1.9459101490553132
discount,7,1.9459101490553132
heshe,7,1.9459101490553132
forget,7,1.9459101490553132
1961,7,1.9459101490553132
October-November,7,1.9459101490553132
Swabs,7,1.9459101490553132
dipole,7,1.9459101490553132
Kazakhstan,7,1.9459101490553132
cathodal,7,1.9459101490553132
mid-expiratory,7,1.9459101490553132
surface-enhanced,7,1.9459101490553132
Microarray,7,1.9459101490553132
cell-surface,7,1.9459101490553132
CAT-FAS,7,1.9459101490553132
chitosomes,7,1.9459101490553132
NIP,7,1.9459101490553132
scrutinised,7,1.9459101490553132
farmed,7,1.9459101490553132
treatment-resistant,7,1.9459101490553132
aggressiveness,7,1.9459101490553132
biofluid,7,1.9459101490553132
minireview,7,1.9459101490553132
anabolic,7,1.9459101490553132
tolls,7,1.9459101490553132
PMCT,7,1.9459101490553132
Psychiatric,7,1.9459101490553132
receptive,7,1.9459101490553132
solid-phase,7,1.9459101490553132
Block,7,1.9459101490553132
UL1,7,1.9459101490553132
hernias,7,1.9459101490553132
contracts,7,1.9459101490553132
hemagglutinating,7,1.9459101490553132
primum,7,1.9459101490553132
alkaloid,7,1.9459101490553132
interchangeable,7,1.9459101490553132
SLS,7,1.9459101490553132
0041,7,1.9459101490553132
USPS,7,1.9459101490553132
RSP,7,1.9459101490553132
coined,7,1.9459101490553132
PPUs,7,1.9459101490553132
ESV,7,1.9459101490553132
graphically,7,1.9459101490553132
metagenomics,7,1.9459101490553132
oatmeal,7,1.9459101490553132
Cervical,7,1.9459101490553132
thrombogenesis,7,1.9459101490553132
UCB,7,1.9459101490553132
solubility,7,1.9459101490553132
hyperosmolar,7,1.9459101490553132
valamint,7,1.9459101490553132
HCR,7,1.9459101490553132
interstate,7,1.9459101490553132
Occluder,7,1.9459101490553132
labetalol,7,1.9459101490553132
antemortem,7,1.9459101490553132
Sinovac,7,1.9459101490553132
anteroapical,7,1.9459101490553132
legally,7,1.9459101490553132
device-based,7,1.9459101490553132
scoliosis,7,1.9459101490553132
0045,7,1.9459101490553132
neuroradiology,7,1.9459101490553132
Elective,7,1.9459101490553132
Accula,7,1.9459101490553132
LabChip,7,1.9459101490553132
enigmatic,7,1.9459101490553132
Confounding,7,1.9459101490553132
molecule-1,7,1.9459101490553132
Untreated,7,1.9459101490553132
ACE2-RBD,7,1.9459101490553132
Educating,7,1.9459101490553132
disagreements,7,1.9459101490553132
FELUDA,7,1.9459101490553132
unlimited,7,1.9459101490553132
degrades,7,1.9459101490553132
Resveratrol,7,1.9459101490553132
PMT,7,1.9459101490553132
influenza-B,7,1.9459101490553132
spectrometry-based,7,1.9459101490553132
834,7,1.9459101490553132
INTRODUCTION,7,1.9459101490553132
cycloergometer,7,1.9459101490553132
latrines,7,1.9459101490553132
B19,7,1.9459101490553132
chair,7,1.9459101490553132
Description,7,1.9459101490553132
anniversary,7,1.9459101490553132
NMDs,7,1.9459101490553132
launching,7,1.9459101490553132
examinees,7,1.9459101490553132
hypercholesteremia,7,1.9459101490553132
music-supported,7,1.9459101490553132
disregarded,7,1.9459101490553132
seroepidemiology,7,1.9459101490553132
deflections,7,1.9459101490553132
clinicaltrialsgov,7,1.9459101490553132
post-training,7,1.9459101490553132
overrisk,7,1.9459101490553132
lactoferrin,7,1.9459101490553132
≥8,7,1.9459101490553132
consumes,7,1.9459101490553132
ataxic,7,1.9459101490553132
6B1,7,1.9459101490553132
BK,7,1.9459101490553132
Prominent,7,1.9459101490553132
transferable,7,1.9459101490553132
ultrafast,7,1.9459101490553132
gmm2,7,1.9459101490553132
1013,7,1.9459101490553132
nuances,7,1.9459101490553132
bpm,7,1.9459101490553132
Cardioembolism,7,1.9459101490553132
PARP-1,7,1.9459101490553132
funnel,7,1.9459101490553132
Incremental,7,1.9459101490553132
SRs,7,1.9459101490553132
ovalbumin-induced,7,1.9459101490553132
≤10,7,1.9459101490553132
AVMU,7,1.9459101490553132
serosal,7,1.9459101490553132
VPDs,7,1.9459101490553132
R-waves,7,1.9459101490553132
cancer-associated,7,1.9459101490553132
polysymptomatic,7,1.9459101490553132
adapts,7,1.9459101490553132
Neuropsychological,7,1.9459101490553132
omission,7,1.9459101490553132
Pulmonology,7,1.9459101490553132
neuroradiologists,7,1.9459101490553132
dip,7,1.9459101490553132
PMNL,7,1.9459101490553132
GMTs,7,1.9459101490553132
consented,7,1.9459101490553132
mucin,7,1.9459101490553132
epigenome,7,1.9459101490553132
apraxia,7,1.9459101490553132
QIVe,7,1.9459101490553132
QIVc,7,1.9459101490553132
anodal,7,1.9459101490553132
Clungene,7,1.9459101490553132
Cerebrospinal,7,1.9459101490553132
bereavement,7,1.9459101490553132
SDOH,7,1.9459101490553132
Cannabis,7,1.9459101490553132
Impulse,7,1.9459101490553132
human-animal,7,1.9459101490553132
mountain,7,1.9459101490553132
SIPA,7,1.9459101490553132
1118,7,1.9459101490553132
-14,7,1.9459101490553132
PMM,7,1.9459101490553132
788,7,1.9459101490553132
Registers,7,1.9459101490553132
ineffectiveness,7,1.9459101490553132
AML,7,1.9459101490553132
concisely,7,1.9459101490553132
proliferating,7,1.9459101490553132
primersprobe,7,1.9459101490553132
non-ST-segment-elevation,7,1.9459101490553132
Underdiagnosis,7,1.9459101490553132
Katrina,7,1.9459101490553132
mycotic,7,1.9459101490553132
moments,7,1.9459101490553132
engines,7,1.9459101490553132
non-governmental,7,1.9459101490553132
expectancies,7,1.9459101490553132
Haemagglutination,7,1.9459101490553132
Verona,7,1.9459101490553132
requesting,7,1.9459101490553132
dihydropyridine,7,1.9459101490553132
AVC,7,1.9459101490553132
waist,7,1.9459101490553132
diisocyanate-induced,7,1.9459101490553132
flowers,7,1.9459101490553132
replaces,7,1.9459101490553132
R20,7,1.9459101490553132
fraught,7,1.9459101490553132
retina,7,1.9459101490553132
PIF,7,1.9459101490553132
Bali,7,1.9459101490553132
toxicants,7,1.9459101490553132
aneurysmectomy,7,1.9459101490553132
council,7,1.9459101490553132
GIS,7,1.9459101490553132
interdependent,7,1.9459101490553132
preferring,7,1.9459101490553132
counterclockwise,7,1.9459101490553132
corticotherapy,7,1.9459101490553132
109l,7,1.9459101490553132
Treated,7,1.9459101490553132
strategically,7,1.9459101490553132
congress,7,1.9459101490553132
dalteparin,7,1.9459101490553132
scavenging,7,1.9459101490553132
prevaccination,7,1.9459101490553132
non-specialist,7,1.9459101490553132
undecided,7,1.9459101490553132
hyperuricemia,7,1.9459101490553132
anti-N,7,1.9459101490553132
R1,7,1.9459101490553132
DPSO,7,1.9459101490553132
LVESV,7,1.9459101490553132
DM2,7,1.9459101490553132
workplace-related,7,1.9459101490553132
ordinarily,7,1.9459101490553132
formazan,7,1.9459101490553132
1892,7,1.9459101490553132
Domestic,7,1.9459101490553132
Influence,7,1.9459101490553132
ATexas177,7,1.9459101490553132
Antonio,7,1.9459101490553132
catheterized,7,1.9459101490553132
Ambient,7,1.9459101490553132
dwellers,7,1.9459101490553132
Gensini,7,1.9459101490553132
whistling,7,1.9459101490553132
cognitions,7,1.9459101490553132
darkness,7,1.9459101490553132
RGT,7,1.9459101490553132
NIID,7,1.9459101490553132
NIID-N2,7,1.9459101490553132
endure,7,1.9459101490553132
phosphoprotein,7,1.9459101490553132
Tremendous,7,1.9459101490553132
imitate,7,1.9459101490553132
coronavirus-2019,7,1.9459101490553132
SAQ,7,1.9459101490553132
thrice,7,1.9459101490553132
Workplace,7,1.9459101490553132
vapors,7,1.9459101490553132
unraveling,7,1.9459101490553132
tourist,7,1.9459101490553132
six-year,7,1.9459101490553132
thoughtful,7,1.9459101490553132
82-year-old,7,1.9459101490553132
Needs,7,1.9459101490553132
ant,7,1.9459101490553132
shielding,7,1.9459101490553132
avian-human,7,1.9459101490553132
V1-V6,7,1.9459101490553132
corner,7,1.9459101490553132
vehicle-treated,7,1.9459101490553132
corpses,7,1.9459101490553132
ERV,7,1.9459101490553132
symmetry,7,1.9459101490553132
n9,7,1.9459101490553132
signssymptoms,7,1.9459101490553132
unprimed,7,1.9459101490553132
Azithromycin,7,1.9459101490553132
impoverished,7,1.9459101490553132
drug-sensitive,7,1.9459101490553132
decongestants,7,1.9459101490553132
panzootic,7,1.9459101490553132
Diurnal,7,1.9459101490553132
Calculation,7,1.9459101490553132
IL-2R,7,1.9459101490553132
Nanchang,7,1.9459101490553132
Aged,7,1.9459101490553132
large-sized,7,1.9459101490553132
rumors,7,1.9459101490553132
recourse,7,1.9459101490553132
retinoic,7,1.9459101490553132
quinapril,7,1.9459101490553132
hydrochlorothiazide,7,1.9459101490553132
non-ischaemic,7,1.9459101490553132
Olfactory,7,1.9459101490553132
Minister,7,1.9459101490553132
781,7,1.9459101490553132
mindset,7,1.9459101490553132
choroid,7,1.9459101490553132
drove,7,1.9459101490553132
mesylate,7,1.9459101490553132
CAPA,7,1.9459101490553132
ZstatFlu-II,7,1.9459101490553132
rBO,7,1.9459101490553132
Wanfang,7,1.9459101490553132
geometrical,7,1.9459101490553132
logistically,7,1.9459101490553132
AIE,7,1.9459101490553132
high-degree,7,1.9459101490553132
non-type,7,1.9459101490553132
VH,7,1.9459101490553132
IFN-alpha,7,1.9459101490553132
Shorter,7,1.9459101490553132
uncharacterized,7,1.9459101490553132
N-methyl-D-aspartate,7,1.9459101490553132
phospholipids,7,1.9459101490553132
Nationally,7,1.9459101490553132
pipe,7,1.9459101490553132
flowing,7,1.9459101490553132
intracutaneous,7,1.9459101490553132
FTN,7,1.9459101490553132
transbronchial,7,1.9459101490553132
SWIFT,7,1.9459101490553132
autopsy-proven,7,1.9459101490553132
hub-and-spoke,7,1.9459101490553132
realism,7,1.9459101490553132
IBM,7,1.9459101490553132
DTC,7,1.9459101490553132
eluates,7,1.9459101490553132
Update,7,1.9459101490553132
aeruginosa,7,1.9459101490553132
All-cause,7,1.9459101490553132
DCI,7,1.9459101490553132
mosaic,7,1.9459101490553132
culminate,7,1.9459101490553132
CdM,7,1.9459101490553132
low-pH,7,1.9459101490553132
Circulatory,7,1.9459101490553132
3-hour,7,1.9459101490553132
ailment,7,1.9459101490553132
diverge,7,1.9459101490553132
autoregulatory,7,1.9459101490553132
reproducibly,7,1.9459101490553132
H1N1-positive,7,1.9459101490553132
rebound,7,1.9459101490553132
BBrisbane602008-like,7,1.9459101490553132
ISA,7,1.9459101490553132
statuses,7,1.9459101490553132
herpesvirus,7,1.9459101490553132
iPSc,7,1.9459101490553132
election,7,1.9459101490553132
breathomics,7,1.9459101490553132
PDB,7,1.9459101490553132
CRTH2,7,1.9459101490553132
interval-censored,7,1.9459101490553132
27th,7,1.9459101490553132
logically,7,1.9459101490553132
ascorbic,7,1.9459101490553132
PESs,7,1.9459101490553132
endosomes,7,1.9459101490553132
destroy,7,1.9459101490553132
UH,7,1.9459101490553132
timings,7,1.9459101490553132
Elsevier,7,1.9459101490553132
layered,7,1.9459101490553132
Coordinated,7,1.9459101490553132
Neuroprotective,7,1.9459101490553132
vv,7,1.9459101490553132
S-100β,7,1.9459101490553132
hypothalamus,7,1.9459101490553132
shops,7,1.9459101490553132
dementias,7,1.9459101490553132
Retinal,7,1.9459101490553132
inert,7,1.9459101490553132
Techniques,7,1.9459101490553132
BPhuket30732013-like,7,1.9459101490553132
restraint,7,1.9459101490553132
flares,7,1.9459101490553132
tuberculous,7,1.9459101490553132
run-in,7,1.9459101490553132
crRNA,7,1.9459101490553132
stripe,7,1.9459101490553132
vanished,7,1.9459101490553132
pneumologists,7,1.9459101490553132
phase-SD,7,1.9459101490553132
Number,7,1.9459101490553132
Oman,7,1.9459101490553132
AVictoria,7,1.9459101490553132
actuation,7,1.9459101490553132
neoton,7,1.9459101490553132
CFD,7,1.9459101490553132
OSHA,7,1.9459101490553132
RIC,7,1.9459101490553132
autism,7,1.9459101490553132
mist,7,1.9459101490553132
4-11,7,1.9459101490553132
interpretive,7,1.9459101490553132
verbatim,7,1.9459101490553132
Fukuoka,7,1.9459101490553132
CARDS,7,1.9459101490553132
HOPE,7,1.9459101490553132
orchestrating,7,1.9459101490553132
aftercare,7,1.9459101490553132
hospital-level,7,1.9459101490553132
Searches,7,1.9459101490553132
spices,7,1.9459101490553132
cleaves,7,1.9459101490553132
Airborne,7,1.9459101490553132
effectivity,7,1.9459101490553132
mast-cell,7,1.9459101490553132
antigen-induced,7,1.9459101490553132
Chemoprophylaxis,7,1.9459101490553132
rotating,7,1.9459101490553132
bother,7,1.9459101490553132
physiopathologic,7,1.9459101490553132
fusiform,7,1.9459101490553132
chronotype,7,1.9459101490553132
Mongolia,7,1.9459101490553132
in-field,7,1.9459101490553132
exchanged,7,1.9459101490553132
Modular,7,1.9459101490553132
preprocedure,7,1.9459101490553132
two-wave,7,1.9459101490553132
right-handed,7,1.9459101490553132
ball,7,1.9459101490553132
counterproductive,7,1.9459101490553132
sphingosine-1-phosphate,7,1.9459101490553132
shutdown,7,1.9459101490553132
Tajimas,7,1.9459101490553132
1030,7,1.9459101490553132
Dramatic,7,1.9459101490553132
Slovenia,7,1.9459101490553132
tortuosity,7,1.9459101490553132
spectacular,7,1.9459101490553132
alternata,7,1.9459101490553132
orthodontic,7,1.9459101490553132
halved,7,1.9459101490553132
γ,7,1.9459101490553132
SVR,7,1.9459101490553132
reconcile,7,1.9459101490553132
prohibition,7,1.9459101490553132
Endpoint,7,1.9459101490553132
burdensome,7,1.9459101490553132
Gram,7,1.9459101490553132
perforators,7,1.9459101490553132
11-13,7,1.9459101490553132
Undetermined,7,1.9459101490553132
arthropod,7,1.9459101490553132
677,7,1.9459101490553132
Miami,7,1.9459101490553132
coryza,7,1.9459101490553132
Koch,7,1.9459101490553132
MVA,7,1.9459101490553132
IFN-beta,7,1.9459101490553132
biobanks,7,1.9459101490553132
biobanking,7,1.9459101490553132
BioNTechPfizer,7,1.9459101490553132
2732,7,1.9459101490553132
fatigability,7,1.9459101490553132
FLD,7,1.9459101490553132
nebulisation,7,1.9459101490553132
complying,7,1.9459101490553132
invariant,7,1.9459101490553132
nanostructures,7,1.9459101490553132
694,7,1.9459101490553132
PTMC,7,1.9459101490553132
Assistant,7,1.9459101490553132
hypermetabolic,7,1.9459101490553132
overriding,7,1.9459101490553132
NSP15,7,1.9459101490553132
Influenza-related,7,1.9459101490553132
Isoproterenol,7,1.9459101490553132
booths,7,1.9459101490553132
multiplier,7,1.9459101490553132
FluSurv-NET,7,1.9459101490553132
Affiliated,7,1.9459101490553132
alarms,7,1.9459101490553132
Briefly,7,1.9459101490553132
Ischaemia,7,1.9459101490553132
activization,7,1.9459101490553132
IBA,7,1.9459101490553132
T1MI,7,1.9459101490553132
Company,7,1.9459101490553132
confrontation,7,1.9459101490553132
regressed,7,1.9459101490553132
theophyllines,7,1.9459101490553132
Mitochondrial,7,1.9459101490553132
TFA,7,1.9459101490553132
Programmed,7,1.9459101490553132
professor,7,1.9459101490553132
Induction,7,1.9459101490553132
UMCs,7,1.9459101490553132
start-up,7,1.9459101490553132
SIADH,7,1.9459101490553132
speeding,7,1.9459101490553132
81mKr,7,1.9459101490553132
N-acetyl,7,1.9459101490553132
Linkage,7,1.9459101490553132
bullous,7,1.9459101490553132
jails,7,1.9459101490553132
multisite,7,1.9459101490553132
VITROS®,7,1.9459101490553132
Mgl,7,1.9459101490553132
naked-eye,7,1.9459101490553132
heal,7,1.9459101490553132
joining,7,1.9459101490553132
egress,7,1.9459101490553132
goodness,7,1.9459101490553132
JawNO,7,1.9459101490553132
switches,7,1.9459101490553132
onslaught,7,1.9459101490553132
Press,7,1.9459101490553132
HIVAIDS,7,1.9459101490553132
BBC,7,1.9459101490553132
distressed,7,1.9459101490553132
Tab,7,1.9459101490553132
mint,7,1.9459101490553132
APL,7,1.9459101490553132
infertility,7,1.9459101490553132
mgh,7,1.9459101490553132
terfenadine,7,1.9459101490553132
NeuroFlo,7,1.9459101490553132
alveolar-capillary,7,1.9459101490553132
Cur,7,1.9459101490553132
nadir,7,1.9459101490553132
PP2A,7,1.9459101490553132
post-surgery,7,1.9459101490553132
IEDB,7,1.9459101490553132
untargeted,7,1.9459101490553132
Timolol,7,1.9459101490553132
shams,7,1.9459101490553132
integrals,7,1.9459101490553132
Laser,7,1.9459101490553132
2002-03,7,1.9459101490553132
hyperdense,7,1.9459101490553132
interrogation,7,1.9459101490553132
polymerases,7,1.9459101490553132
agitation,7,1.9459101490553132
ms2,7,1.9459101490553132
FIV,7,1.9459101490553132
CypA,7,1.9459101490553132
Qm,7,1.9459101490553132
R-R,7,1.9459101490553132
ECG-LVH,7,1.9459101490553132
fluency,7,1.9459101490553132
Summer,7,1.9459101490553132
Foxp3,7,1.9459101490553132
Endothelin-1,7,1.9459101490553132
RNV,7,1.9459101490553132
noting,7,1.9459101490553132
Aside,7,1.9459101490553132
Colombian,7,1.9459101490553132
13th,7,1.9459101490553132
acetaldehyde,7,1.9459101490553132
navigation,7,1.9459101490553132
sex-adjusted,7,1.9459101490553132
SPs,7,1.9459101490553132
menopausal,7,1.9459101490553132
exacts,7,1.9459101490553132
fix,7,1.9459101490553132
shADSC,7,1.9459101490553132
Resource,7,1.9459101490553132
stress-redistribution,7,1.9459101490553132
pp,7,1.9459101490553132
premonitory,7,1.9459101490553132
sensitizer,7,1.9459101490553132
small-airways,7,1.9459101490553132
SWI,7,1.9459101490553132
Richard,7,1.9459101490553132
CAF,7,1.9459101490553132
hemosorption,7,1.9459101490553132
Per,7,1.9459101490553132
dentist,7,1.9459101490553132
Beta-adrenergic,7,1.9459101490553132
tetramer,7,1.9459101490553132
nontraumatic,7,1.9459101490553132
gabapentin,7,1.9459101490553132
Encephalitis,7,1.9459101490553132
chips,7,1.9459101490553132
free-wall,7,1.9459101490553132
Expanding,7,1.9459101490553132
Ds,7,1.9459101490553132
Acquired,7,1.9459101490553132
Bronchoscopy,7,1.9459101490553132
footprint,7,1.9459101490553132
20-29,7,1.9459101490553132
stimulus-response,7,1.9459101490553132
Dendritic,7,1.9459101490553132
alarmingly,7,1.9459101490553132
spheres,7,1.9459101490553132
setups,7,1.9459101490553132
BPSA,7,1.9459101490553132
patient-provider,7,1.9459101490553132
functioned,7,1.9459101490553132
extracranial-intracranial,7,1.9459101490553132
Policymakers,7,1.9459101490553132
CHU,7,1.9459101490553132
Broad,7,1.9459101490553132
Discussions,7,1.9459101490553132
Vancouver,7,1.9459101490553132
G4,7,1.9459101490553132
cooled,7,1.9459101490553132
Fibromuscular,7,1.9459101490553132
Develop,7,1.9459101490553132
fibrodysplasia,7,1.9459101490553132
ossificans,7,1.9459101490553132
progressiva,7,1.9459101490553132
notifiable,7,1.9459101490553132
etiotropic,7,1.9459101490553132
authoritative,7,1.9459101490553132
MSI,7,1.9459101490553132
symptom-to-balloon,7,1.9459101490553132
KHR,7,1.9459101490553132
entirety,7,1.9459101490553132
CFRs,7,1.9459101490553132
LNPs,7,1.9459101490553132
RVAD,7,1.9459101490553132
inflict,7,1.9459101490553132
pregnancy-associated,7,1.9459101490553132
nonexistent,7,1.9459101490553132
805,7,1.9459101490553132
autophagy-related,7,1.9459101490553132
ATHR,7,1.9459101490553132
Boys,7,1.9459101490553132
Origin,7,1.9459101490553132
non-infarct-related,7,1.9459101490553132
Crohns,7,1.9459101490553132
naval,7,1.9459101490553132
Pharmacotherapy,7,1.9459101490553132
insofar,7,1.9459101490553132
archives,7,1.9459101490553132
COVAM,7,1.9459101490553132
FEV₁,7,1.9459101490553132
bulb,7,1.9459101490553132
CARAT10,7,1.9459101490553132
natto,7,1.9459101490553132
timescale,7,1.9459101490553132
LTAs,7,1.9459101490553132
m2000,7,1.9459101490553132
influenza-,7,1.9459101490553132
HO-1,7,1.9459101490553132
pre-emptive,7,1.9459101490553132
inflammation-related,7,1.9459101490553132
REGEN-COV,7,1.9459101490553132
LAIV-T,7,1.9459101490553132
INASC,7,1.9459101490553132
Vulnerable,7,1.9459101490553132
wheal,7,1.9459101490553132
restart,7,1.9459101490553132
pre-determined,7,1.9459101490553132
arrivals,7,1.9459101490553132
Atmospheric,7,1.9459101490553132
voxel-wise,7,1.9459101490553132
Sports,7,1.9459101490553132
Lambls,7,1.9459101490553132
7-point,7,1.9459101490553132
legislative,7,1.9459101490553132
RHS,7,1.9459101490553132
BSCs,7,1.9459101490553132
shotgun,7,1.9459101490553132
immune-compromised,7,1.9459101490553132
arranging,7,1.9459101490553132
protrusion,7,1.9459101490553132
Weight,7,1.9459101490553132
NJ,7,1.9459101490553132
privileged,7,1.9459101490553132
humor,7,1.9459101490553132
overlook,7,1.9459101490553132
analyzers,7,1.9459101490553132
odor,7,1.9459101490553132
Bahrain,7,1.9459101490553132
expedient,7,1.9459101490553132
non-uniform,7,1.9459101490553132
Biomeme,7,1.9459101490553132
concentrates,7,1.9459101490553132
reclassification,7,1.9459101490553132
haemolytic,7,1.9459101490553132
biocontainment,7,1.9459101490553132
dissolved,7,1.9459101490553132
Efficiency,7,1.9459101490553132
well-trained,7,1.9459101490553132
culture-positive,7,1.9459101490553132
somehow,7,1.9459101490553132
ultrafiltration,7,1.9459101490553132
gender-matched,7,1.9459101490553132
Formal,7,1.9459101490553132
medically-attended,7,1.9459101490553132
RT‐PCR,7,1.9459101490553132
unobserved,7,1.9459101490553132
Plasmodium,7,1.9459101490553132
hydrolase,7,1.9459101490553132
self-assembled,7,1.9459101490553132
materially,7,1.9459101490553132
rubella,7,1.9459101490553132
IVB,7,1.9459101490553132
syphilis,7,1.9459101490553132
reinfected,7,1.9459101490553132
revising,7,1.9459101490553132
CDT,7,1.9459101490553132
traditions,7,1.9459101490553132
subgenus,7,1.9459101490553132
Sarbecovirus,7,1.9459101490553132
operationalized,7,1.9459101490553132
pathogen-associated,7,1.9459101490553132
homolog,7,1.9459101490553132
heretofore,7,1.9459101490553132
abrogated,7,1.9459101490553132
dysphagic,7,1.9459101490553132
parishes,7,1.9459101490553132
non-additive,7,1.9459101490553132
knob,7,1.9459101490553132
APC,7,1.9459101490553132
713,7,1.9459101490553132
Maebashi,7,1.9459101490553132
Optimization,7,1.9459101490553132
antipsychotic,7,1.9459101490553132
Vaxign2,7,1.9459101490553132
Dublin,7,1.9459101490553132
mesh,7,1.9459101490553132
0-9,7,1.9459101490553132
N156K,7,1.9459101490553132
CPD,7,1.9459101490553132
petechial,7,1.9459101490553132
IL-4IL-13,7,1.9459101490553132
biomimetic,7,1.9459101490553132
Ventilatory,7,1.9459101490553132
ACEis,7,1.9459101490553132
hunting,7,1.9459101490553132
RE,7,1.9459101490553132
200607,7,1.9459101490553132
nonimmunological,7,1.9459101490553132
furniture,7,1.9459101490553132
skull,7,1.9459101490553132
Will,7,1.9459101490553132
PHEIC,7,1.9459101490553132
NASCET,7,1.9459101490553132
undermining,7,1.9459101490553132
MDS,7,1.9459101490553132
MHD,7,1.9459101490553132
Editors,7,1.9459101490553132
westernized,7,1.9459101490553132
SCOPUS,7,1.9459101490553132
unforeseen,7,1.9459101490553132
elevating,7,1.9459101490553132
Industry,7,1.9459101490553132
RT-RAA,7,1.9459101490553132
Jr,7,1.9459101490553132
Enzymatic,7,1.9459101490553132
viscous,7,1.9459101490553132
PRM,7,1.9459101490553132
Ethiopians,7,1.9459101490553132
Investigating,7,1.9459101490553132
permutation,7,1.9459101490553132
logs,7,1.9459101490553132
A27,7,1.9459101490553132
n14,7,1.9459101490553132
DOR,7,1.9459101490553132
salvages,7,1.9459101490553132
noisy,7,1.9459101490553132
fared,7,1.9459101490553132
Passengers,7,1.9459101490553132
titled,7,1.9459101490553132
separates,7,1.9459101490553132
designate,7,1.9459101490553132
-6,7,1.9459101490553132
anti-virals,7,1.9459101490553132
housekeeping,7,1.9459101490553132
Useful,7,1.9459101490553132
Brisbane,7,1.9459101490553132
LAO,7,1.9459101490553132
Eighty-two,7,1.9459101490553132
scrutinized,7,1.9459101490553132
20H501YV2,7,1.9459101490553132
villitis,7,1.9459101490553132
ultrastructure,7,1.9459101490553132
annexin,7,1.9459101490553132
careers,7,1.9459101490553132
disconnections,7,1.9459101490553132
FRAST,7,1.9459101490553132
Beliefs,7,1.9459101490553132
4-year-old,7,1.9459101490553132
ties,7,1.9459101490553132
multi-ethnic,7,1.9459101490553132
multicellular,7,1.9459101490553132
Far,7,1.9459101490553132
PAPR,7,1.9459101490553132
ankle-brachial,7,1.9459101490553132
surging,7,1.9459101490553132
Clara,7,1.9459101490553132
NBO,7,1.9459101490553132
bedtime,7,1.9459101490553132
Preparation,7,1.9459101490553132
defer,7,1.9459101490553132
SARS-CoV-2-mediated,7,1.9459101490553132
moisture,7,1.9459101490553132
counteracting,7,1.9459101490553132
aPL,7,1.9459101490553132
expecting,7,1.9459101490553132
labor-intensive,7,1.9459101490553132
Hierarchical,7,1.9459101490553132
Thereby,7,1.9459101490553132
reorganisation,7,1.9459101490553132
Whatever,7,1.9459101490553132
Behcets,7,1.9459101490553132
gripped,7,1.9459101490553132
graduated,7,1.9459101490553132
exanthem,7,1.9459101490553132
rush,7,1.9459101490553132
isozymes,7,1.9459101490553132
HDAC,7,1.9459101490553132
tachyphylaxis,7,1.9459101490553132
1819,7,1.9459101490553132
Pathology,7,1.9459101490553132
auspices,7,1.9459101490553132
neointimal,7,1.9459101490553132
agrees,7,1.9459101490553132
tighter,7,1.9459101490553132
neuralgia,7,1.9459101490553132
rs1800896,7,1.9459101490553132
Islamic,7,1.9459101490553132
29th,7,1.9459101490553132
obliteration,7,1.9459101490553132
Bradford,7,1.9459101490553132
GOT,7,1.9459101490553132
inclined,7,1.9459101490553132
Peruvian,7,1.9459101490553132
yolk,7,1.9459101490553132
CECs,7,1.9459101490553132
1112,7,1.9459101490553132
ZESs,7,1.9459101490553132
plaque-forming,7,1.9459101490553132
ERPs,7,1.9459101490553132
Incomplete,7,1.9459101490553132
invoke,7,1.9459101490553132
SHRSP,7,1.9459101490553132
PAHO,7,1.9459101490553132
hyper,7,1.9459101490553132
Hokkaido,7,1.9459101490553132
installation,7,1.9459101490553132
NIRV,7,1.9459101490553132
Lazio,7,1.9459101490553132
-15,7,1.9459101490553132
pre-procedural,7,1.9459101490553132
unethical,7,1.9459101490553132
intra-abdominal,7,1.9459101490553132
689,7,1.9459101490553132
interviewees,7,1.9459101490553132
reoccurrence,7,1.9459101490553132
formoterol,7,1.9459101490553132
non-perfused,7,1.9459101490553132
Ge,7,1.9459101490553132
stationary,7,1.9459101490553132
devastation,7,1.9459101490553132
immunoinformatic,7,1.9459101490553132
pro-BNP,7,1.9459101490553132
sunspot,7,1.9459101490553132
thigh,7,1.9459101490553132
Disaster,7,1.9459101490553132
hs,7,1.9459101490553132
forgotten,7,1.9459101490553132
troponin-I,7,1.9459101490553132
Apical,7,1.9459101490553132
gating,7,1.9459101490553132
PD35,7,1.9459101490553132
palate,7,1.9459101490553132
5-34,7,1.9459101490553132
acellular,7,1.9459101490553132
Macau,7,1.9459101490553132
omitting,7,1.9459101490553132
MINCA,7,1.9459101490553132
hints,7,1.9459101490553132
clone,7,1.9459101490553132
cleft,7,1.9459101490553132
sister,7,1.9459101490553132
isotonic,7,1.9459101490553132
WMC,7,1.9459101490553132
stood,7,1.9459101490553132
≤30,7,1.9459101490553132
osteopathic,7,1.9459101490553132
HBFP,7,1.9459101490553132
overactivity,7,1.9459101490553132
CML,7,1.9459101490553132
SAA,7,1.9459101490553132
anti-coronaviral,7,1.9459101490553132
proof-of-principle,7,1.9459101490553132
malapposition,7,1.9459101490553132
Hartford,7,1.9459101490553132
microaspiration,7,1.9459101490553132
infection-associated,7,1.9459101490553132
22nd,7,1.9459101490553132
Mitigation,7,1.9459101490553132
FilmArray,7,1.9459101490553132
B-NHL,7,1.9459101490553132
intima,7,1.9459101490553132
1918-like,7,1.9459101490553132
Interferons,7,1.9459101490553132
bonds,7,1.9459101490553132
notorious,7,1.9459101490553132
inserting,7,1.9459101490553132
sub-type,7,1.9459101490553132
CPSS,7,1.9459101490553132
execute,7,1.9459101490553132
Appraisal,7,1.9459101490553132
gynecologic,7,1.9459101490553132
APP,7,1.9459101490553132
cingulate,7,1.9459101490553132
epitope-specific,7,1.9459101490553132
nominal,7,1.9459101490553132
DIDO,7,1.9459101490553132
titrated,7,1.9459101490553132
Component,7,1.9459101490553132
Recovered,7,1.9459101490553132
Susceptible,7,1.9459101490553132
20082009,7,1.9459101490553132
Coagulation,7,1.9459101490553132
one-second,7,1.9459101490553132
CCIS,7,1.9459101490553132
ADAM17,7,1.9459101490553132
Czechoslovakia,7,1.9459101490553132
One-third,7,1.9459101490553132
mCi,7,1.9459101490553132
Consider,7,1.9459101490553132
noninferior,7,1.9459101490553132
resource-intensive,7,1.9459101490553132
Unrecognized,7,1.9459101490553132
apprehension,7,1.9459101490553132
790,7,1.9459101490553132
subspecialty,7,1.9459101490553132
Dijon,7,1.9459101490553132
sacrifice,7,1.9459101490553132
microparticle,7,1.9459101490553132
co-activation,7,1.9459101490553132
re-established,7,1.9459101490553132
neurosurgeon,7,1.9459101490553132
rLMC,7,1.9459101490553132
Regeneron,7,1.9459101490553132
cavitary,7,1.9459101490553132
conus,7,1.9459101490553132
782,7,1.9459101490553132
husband,7,1.9459101490553132
bloc,7,1.9459101490553132
DESs,7,1.9459101490553132
population-scale,7,1.9459101490553132
TDA,7,1.9459101490553132
Unified,7,1.9459101490553132
LDKT,7,1.9459101490553132
dizzinessvertigo,7,1.9459101490553132
microM,7,1.9459101490553132
AMPK,7,1.9459101490553132
Subunit,7,1.9459101490553132
eNOS,7,1.9459101490553132
bout,7,1.9459101490553132
vison,7,1.9459101490553132
W-shaped,7,1.9459101490553132
acutesubacute,7,1.9459101490553132
RHA,7,1.9459101490553132
unseen,7,1.9459101490553132
unmodified,7,1.9459101490553132
potentiated,7,1.9459101490553132
CVR,7,1.9459101490553132
DFCN,7,1.9459101490553132
AMs,7,1.9459101490553132
formalin-fixed,7,1.9459101490553132
rethink,7,1.9459101490553132
post-thrombolytic,7,1.9459101490553132
corporations,7,1.9459101490553132
commonalities,7,1.9459101490553132
Liguria,7,1.9459101490553132
n12,7,1.9459101490553132
Approach,7,1.9459101490553132
hemisensory,7,1.9459101490553132
turbinates,7,1.9459101490553132
Schedule,7,1.9459101490553132
cocirculated,7,1.9459101490553132
Lifetime,7,1.9459101490553132
staffed,7,1.9459101490553132
WCH,7,1.9459101490553132
Networks,7,1.9459101490553132
retesting,7,1.9459101490553132
textbooks,7,1.9459101490553132
misses,7,1.9459101490553132
Cockcroft,7,1.9459101490553132
health-seeking,7,1.9459101490553132
occurence,7,1.9459101490553132
anti-hemagglutinin,7,1.9459101490553132
crystallography,7,1.9459101490553132
Virologic,7,1.9459101490553132
2012-13,7,1.9459101490553132
Households,7,1.9459101490553132
Porto,7,1.9459101490553132
opponents,7,1.9459101490553132
FE,7,1.9459101490553132
Hereby,7,1.9459101490553132
full-dose,7,1.9459101490553132
GATA3,7,1.9459101490553132
Spinal,7,1.9459101490553132
1-antitrypsin,7,1.9459101490553132
inhabited,7,1.9459101490553132
Cause,7,1.9459101490553132
protean,7,1.9459101490553132
2013-2015,7,1.9459101490553132
920,7,1.9459101490553132
advocating,7,1.9459101490553132
fertilization,7,1.9459101490553132
Sarbecoviruses,7,1.9459101490553132
SSEPs,7,1.9459101490553132
mu,7,1.9459101490553132
Agent-based,7,1.9459101490553132
Integrating,7,1.9459101490553132
Tc2,7,1.9459101490553132
noninfarct-related,7,1.9459101490553132
rashes,7,1.9459101490553132
lightning,7,1.9459101490553132
Dyskinesis,7,1.9459101490553132
Lown,7,1.9459101490553132
di,7,1.9459101490553132
abduction,7,1.9459101490553132
eNAT,7,1.9459101490553132
transposition,7,1.9459101490553132
thromboemboli,7,1.9459101490553132
ST12,7,1.9459101490553132
unintentional,7,1.9459101490553132
Pertinent,7,1.9459101490553132
T478K,7,1.9459101490553132
NG-Test®,7,1.9459101490553132
colonic,7,1.9459101490553132
670,7,1.9459101490553132
nationals,7,1.9459101490553132
nut,7,1.9459101490553132
Canadas,7,1.9459101490553132
revascularize,7,1.9459101490553132
inadvertent,7,1.9459101490553132
irregularly,7,1.9459101490553132
Dried,7,1.9459101490553132
CUSUM,7,1.9459101490553132
preasthma,7,1.9459101490553132
Localization,7,1.9459101490553132
glia,7,1.9459101490553132
RPP30,7,1.9459101490553132
GeneXpert,7,1.9459101490553132
relievers,7,1.9459101490553132
loneliness,7,1.9459101490553132
glycolysis,7,1.9459101490553132
ORF7b,7,1.9459101490553132
mixed-methods,7,1.9459101490553132
rod,7,1.9459101490553132
minwk,7,1.9459101490553132
NFT,7,1.9459101490553132
Specialist,7,1.9459101490553132
AVF,7,1.9459101490553132
infarction-associated,7,1.9459101490553132
meta-population,7,1.9459101490553132
toxins,7,1.9459101490553132
off-site,7,1.9459101490553132
Verbal,7,1.9459101490553132
ISAR,7,1.9459101490553132
acral,7,1.9459101490553132
roommates,7,1.9459101490553132
understands,7,1.9459101490553132
PTF,7,1.9459101490553132
presumption,7,1.9459101490553132
Exosomes,7,1.9459101490553132
Unusual,7,1.9459101490553132
Septal,7,1.9459101490553132
esterase,7,1.9459101490553132
JRF,7,1.9459101490553132
doctor-patient,7,1.9459101490553132
Meta-Analyses,7,1.9459101490553132
re-entry,7,1.9459101490553132
75-year-old,7,1.9459101490553132
par,7,1.9459101490553132
HAY,7,1.9459101490553132
Syndromes,7,1.9459101490553132
S-specific,7,1.9459101490553132
Aerosolized,7,1.9459101490553132
laypeople,7,1.9459101490553132
sub-populations,7,1.9459101490553132
Collection,7,1.9459101490553132
2004-2006,7,1.9459101490553132
hday,7,1.9459101490553132
sublineages,7,1.9459101490553132
sorely,7,1.9459101490553132
PRA,7,1.9459101490553132
intraoperatively,7,1.9459101490553132
glycyrrhizin,7,1.9459101490553132
sympathovagal,7,1.9459101490553132
Twin,7,1.9459101490553132
bacteremia,7,1.9459101490553132
dysphasia,7,1.9459101490553132
rs12252-C,7,1.9459101490553132
807,7,1.9459101490553132
fidelity,7,1.9459101490553132
polymerase-chain-reaction,7,1.9459101490553132
AMI-patients,7,1.9459101490553132
audible,7,1.9459101490553132
subcategories,7,1.9459101490553132
Activator,7,1.9459101490553132
Mel,7,1.9459101490553132
cavernous,7,1.9459101490553132
Expeditionary,7,1.9459101490553132
p0006,7,1.9459101490553132
spironolactone,7,1.9459101490553132
surely,7,1.9459101490553132
hepatectomy,7,1.9459101490553132
wloss,7,1.9459101490553132
squared,7,1.9459101490553132
long-axis,7,1.9459101490553132
Cortical,7,1.9459101490553132
Saitama,7,1.9459101490553132
cardio-,7,1.9459101490553132
formalin,7,1.9459101490553132
ACE2s,7,1.9459101490553132
VB,7,1.9459101490553132
mPOCT,7,1.9459101490553132
dozen,7,1.9459101490553132
therein,7,1.9459101490553132
kHz,7,1.9459101490553132
Apathy,7,1.9459101490553132
plenty,7,1.9459101490553132
7-18,7,1.9459101490553132
helpers,7,1.9459101490553132
drug-likeness,7,1.9459101490553132
RTPCR,7,1.9459101490553132
overstated,7,1.9459101490553132
haemostasis,7,1.9459101490553132
Reactions,7,1.9459101490553132
stance,7,1.9459101490553132
strikes,7,1.9459101490553132
oxyhemoglobin,7,1.9459101490553132
AMN,7,1.9459101490553132
HIV-positive,7,1.9459101490553132
1048,7,1.9459101490553132
IMC,7,1.9459101490553132
D4,7,1.9459101490553132
clinicopathologic,7,1.9459101490553132
FAO,7,1.9459101490553132
Neurosurgery,7,1.9459101490553132
vakcina,7,1.9459101490553132
unifocal,7,1.9459101490553132
rehabilitants,7,1.9459101490553132
NIRS,7,1.9459101490553132
improbable,7,1.9459101490553132
plethysmographic,7,1.9459101490553132
OxfordAstraZeneca,7,1.9459101490553132
horizons,7,1.9459101490553132
helplessness,7,1.9459101490553132
post-reperfusion,7,1.9459101490553132
Instrumental,7,1.9459101490553132
BioGerm,7,1.9459101490553132
food-induced,7,1.9459101490553132
Interaction,7,1.9459101490553132
tuning,7,1.9459101490553132
Non-pharmaceutical,7,1.9459101490553132
Sinopharm,7,1.9459101490553132
skin-to-skin,7,1.9459101490553132
voltages,7,1.9459101490553132
IIV4s,7,1.9459101490553132
1361,7,1.9459101490553132
publishes,7,1.9459101490553132
saccular,7,1.9459101490553132
rub,7,1.9459101490553132
nauseavomiting,7,1.9459101490553132
affections,7,1.9459101490553132
LPAI,7,1.9459101490553132
Combinations,7,1.9459101490553132
stops,7,1.9459101490553132
Oropharyngeal,7,1.9459101490553132
COVID-VIRO®,7,1.9459101490553132
vis-à-vis,7,1.9459101490553132
diverted,7,1.9459101490553132
transcriptase-PCR,7,1.9459101490553132
waterborne,7,1.9459101490553132
Describe,7,1.9459101490553132
Vue,7,1.9459101490553132
fume,7,1.9459101490553132
immunochemical,7,1.9459101490553132
fixed-dose,7,1.9459101490553132
LFIAs,7,1.9459101490553132
Inconsistent,7,1.9459101490553132
LAMP-based,7,1.9459101490553132
IC-LAA,7,1.9459101490553132
10-item,7,1.9459101490553132
851,7,1.9459101490553132
CPM,7,1.9459101490553132
majorly,7,1.9459101490553132
systems-level,7,1.9459101490553132
physician-patient,7,1.9459101490553132
CTT,7,1.9459101490553132
intratracheal,7,1.9459101490553132
Sociodemographic,7,1.9459101490553132
fairs,7,1.9459101490553132
antiquity,7,1.9459101490553132
microembolic,7,1.9459101490553132
aligning,7,1.9459101490553132
sulphur,7,1.9459101490553132
Congo,7,1.9459101490553132
Vmax,7,1.9459101490553132
Brussels,7,1.9459101490553132
Westernized,7,1.9459101490553132
45-64,7,1.9459101490553132
Schrodinger,7,1.9459101490553132
35°C,7,1.9459101490553132
equipoise,7,1.9459101490553132
A-associated,7,1.9459101490553132
TRAS,7,1.9459101490553132
querying,7,1.9459101490553132
ts,7,1.9459101490553132
VZV,7,1.9459101490553132
fabric,7,1.9459101490553132
straining,7,1.9459101490553132
incomes,7,1.9459101490553132
1979-1980,7,1.9459101490553132
transventricular,7,1.9459101490553132
carboxylate,7,1.9459101490553132
2050,7,1.9459101490553132
LPV,7,1.9459101490553132
BMJ,7,1.9459101490553132
nebuliser,7,1.9459101490553132
sgRNAs,7,1.9459101490553132
legacy,7,1.9459101490553132
1068,7,1.9459101490553132
satellite,7,1.9459101490553132
captive,7,1.9459101490553132
NAB,7,1.9459101490553132
Suzuki,7,1.9459101490553132
GISSI-3,7,1.9459101490553132
≥30,7,1.9459101490553132
pounds,7,1.9459101490553132
connects,7,1.9459101490553132
sentiments,7,1.9459101490553132
inferiorly,7,1.9459101490553132
572,7,1.9459101490553132
kPas,7,1.9459101490553132
crippling,7,1.9459101490553132
1933,7,1.9459101490553132
VAERS,7,1.9459101490553132
over-reliance,7,1.9459101490553132
ISO-induced,7,1.9459101490553132
resorption,7,1.9459101490553132
CLCG,7,1.9459101490553132
FN,7,1.9459101490553132
VSV-GFP,7,1.9459101490553132
unrestricted,7,1.9459101490553132
endogenously,7,1.9459101490553132
historians,7,1.9459101490553132
RNA-seq,7,1.9459101490553132
virosomal,7,1.9459101490553132
un,7,1.9459101490553132
solids,7,1.9459101490553132
Docking,7,1.9459101490553132
Q-Tc,7,1.9459101490553132
typessubtypes,7,1.9459101490553132
Identify,7,1.9459101490553132
diffused,7,1.9459101490553132
noncholinergic,7,1.9459101490553132
LACA,7,1.9459101490553132
neurofeedback,7,1.9459101490553132
894,7,1.9459101490553132
erratic,7,1.9459101490553132
asthma-control,7,1.9459101490553132
16-20,7,1.9459101490553132
restrain,7,1.9459101490553132
underestimating,7,1.9459101490553132
Feno,7,1.9459101490553132
group-specific,7,1.9459101490553132
truncatus,7,1.9459101490553132
certifying,7,1.9459101490553132
earnings,7,1.9459101490553132
Djibouti,7,1.9459101490553132
asynergies,7,1.9459101490553132
augments,7,1.9459101490553132
DSW,7,1.9459101490553132
HeO2,7,1.9459101490553132
interpretable,7,1.9459101490553132
NAS,7,1.9459101490553132
sweeping,7,1.9459101490553132
Aiming,7,1.9459101490553132
colder,7,1.9459101490553132
inversus,7,1.9459101490553132
PWV,7,1.9459101490553132
1239,7,1.9459101490553132
que,7,1.9459101490553132
repositive,7,1.9459101490553132
00006,7,1.9459101490553132
mgm,7,1.9459101490553132
negative-sense,7,1.9459101490553132
monitorization,7,1.9459101490553132
imagings,7,1.9459101490553132
Resolution,7,1.9459101490553132
prosocial,7,1.9459101490553132
Pathogenesis,7,1.9459101490553132
632,7,1.9459101490553132
reformulated,7,1.9459101490553132
Etiology,7,1.9459101490553132
3300,7,1.9459101490553132
1996-97,7,1.9459101490553132
FSM,7,1.9459101490553132
beating,7,1.9459101490553132
eviction,7,1.9459101490553132
EPOMI,7,1.9459101490553132
ΔN-NP,7,1.9459101490553132
MCCU,7,1.9459101490553132
vasoconstrictor,7,1.9459101490553132
Bahia,7,1.9459101490553132
13000,7,1.9459101490553132
1991-92,7,1.9459101490553132
Palermo,7,1.9459101490553132
180-day,7,1.9459101490553132
AS-STEMI,7,1.9459101490553132
set-up,7,1.9459101490553132
IIB4,7,1.9459101490553132
lean,7,1.9459101490553132
Ligation,7,1.9459101490553132
Iscom,7,1.9459101490553132
B1128,7,1.9459101490553132
agitated,7,1.9459101490553132
Altona,7,1.9459101490553132
nongenomic,7,1.9459101490553132
μgml,7,1.9459101490553132
Wheeze,7,1.9459101490553132
Reality,7,1.9459101490553132
organelle,7,1.9459101490553132
one-size-fits-all,7,1.9459101490553132
932,7,1.9459101490553132
Discovery,7,1.9459101490553132
PAR,7,1.9459101490553132
preoccupation,7,1.9459101490553132
Cambridge,7,1.9459101490553132
Akt,7,1.9459101490553132
KIM1,7,1.9459101490553132
self-expanding,7,1.9459101490553132
disclosing,7,1.9459101490553132
simvastatin,7,1.9459101490553132
AIVR,7,1.9459101490553132
CrB,7,1.9459101490553132
CLMN,7,1.9459101490553132
soft-tissue,7,1.9459101490553132
T-waves,7,1.9459101490553132
constrain,7,1.9459101490553132
NOX2,7,1.9459101490553132
musculature,7,1.9459101490553132
MCD,7,1.9459101490553132
PPS,7,1.9459101490553132
vocabulary,7,1.9459101490553132
oxidase,7,1.9459101490553132
ischemia-related,7,1.9459101490553132
subtended,7,1.9459101490553132
third-party,7,1.9459101490553132
wellness,7,1.9459101490553132
diversified,7,1.9459101490553132
13-17,7,1.9459101490553132
Autopsies,7,1.9459101490553132
complied,7,1.9459101490553132
normalizing,7,1.9459101490553132
KEY,7,1.9459101490553132
regained,7,1.9459101490553132
DVD,7,1.9459101490553132
Sources,7,1.9459101490553132
twenty-three,7,1.9459101490553132
sarcoma,7,1.9459101490553132
H274Y,7,1.9459101490553132
2019nCoVR,7,1.9459101490553132
hinge,7,1.9459101490553132
MMPi,7,1.9459101490553132
ELF-EMF,7,1.9459101490553132
informatics,7,1.9459101490553132
risk-factors,7,1.9459101490553132
PEL,7,1.9459101490553132
lateralized,7,1.9459101490553132
Achievement,7,1.9459101490553132
grapple,7,1.9459101490553132
disputed,7,1.9459101490553132
well-matched,7,1.9459101490553132
deviated,7,1.9459101490553132
ceruloplasmin,7,1.9459101490553132
otolaryngologists,7,1.9459101490553132
NK-cells,7,1.9459101490553132
conserve,7,1.9459101490553132
infarctectomy,7,1.9459101490553132
DPIs,7,1.9459101490553132
asthma-affected,7,1.9459101490553132
facilitator,7,1.9459101490553132
upgrading,7,1.9459101490553132
diffusion-perfusion,7,1.9459101490553132
logarithmic,7,1.9459101490553132
Ayous,7,1.9459101490553132
Epilepsy,7,1.9459101490553132
5-UTR,7,1.9459101490553132
unaltered,7,1.9459101490553132
hydatid,7,1.9459101490553132
axon,7,1.9459101490553132
TAH,7,1.9459101490553132
Albuterol,7,1.9459101490553132
mASC,7,1.9459101490553132
fostering,7,1.9459101490553132
tide,7,1.9459101490553132
household-based,7,1.9459101490553132
Math,7,1.9459101490553132
reconsider,7,1.9459101490553132
authorize,7,1.9459101490553132
sewer,7,1.9459101490553132
Influenzavirus,7,1.9459101490553132
exogenously,7,1.9459101490553132
comatose,7,1.9459101490553132
Peter,7,1.9459101490553132
STATEMENT,7,1.9459101490553132
discounted,7,1.9459101490553132
cimetidine,7,1.9459101490553132
GINAq,7,1.9459101490553132
terminals,7,1.9459101490553132
Already,7,1.9459101490553132
Ninety-three,7,1.9459101490553132
PDT,7,1.9459101490553132
cellulose,7,1.9459101490553132
Malta,7,1.9459101490553132
manages,7,1.9459101490553132
immunostimulatory,7,1.9459101490553132
888,7,1.9459101490553132
lessens,7,1.9459101490553132
sub,7,1.9459101490553132
revenue,7,1.9459101490553132
Adenovirus,7,1.9459101490553132
Febrile,7,1.9459101490553132
SBPV,7,1.9459101490553132
CDPH,7,1.9459101490553132
Corrected,7,1.9459101490553132
heparan,7,1.9459101490553132
dream,7,1.9459101490553132
nanomedicines,7,1.9459101490553132
dermatomyositis,7,1.9459101490553132
MRS,7,1.9459101490553132
cations,7,1.9459101490553132
Bypass,7,1.9459101490553132
Ninth,7,1.9459101490553132
Metabolomics,7,1.9459101490553132
family-based,7,1.9459101490553132
underdeveloped,7,1.9459101490553132
Pre-,7,1.9459101490553132
correlational,7,1.9459101490553132
exhibitors,7,1.9459101490553132
73-year-old,7,1.9459101490553132
liquids,7,1.9459101490553132
gastrocnemius,7,1.9459101490553132
K699R,7,1.9459101490553132
aspirin-exacerbated,7,1.9459101490553132
neurotransmission,7,1.9459101490553132
766,7,1.9459101490553132
764,7,1.9459101490553132
insert,7,1.9459101490553132
Controversies,7,1.9459101490553132
SARS-CoV-,7,1.9459101490553132
ILCs,7,1.9459101490553132
N-,7,1.9459101490553132
Stockpile,7,1.9459101490553132
subclassification,7,1.9459101490553132
TENS,7,1.9459101490553132
behaves,7,1.9459101490553132
outburst,7,1.9459101490553132
higher-order,7,1.9459101490553132
alveolitis,7,1.9459101490553132
variances,7,1.9459101490553132
CPET,7,1.9459101490553132
title,7,1.9459101490553132
Definite,7,1.9459101490553132
LMT-AMI,7,1.9459101490553132
Pathways,7,1.9459101490553132
0-7,7,1.9459101490553132
mimetics,7,1.9459101490553132
macrovascular,7,1.9459101490553132
proofreading,7,1.9459101490553132
Users,7,1.9459101490553132
PCWP,7,1.9459101490553132
antitussives,7,1.9459101490553132
self-referred,7,1.9459101490553132
post-coronary,7,1.9459101490553132
under-recognised,7,1.9459101490553132
highvery,7,1.9459101490553132
submit,7,1.9459101490553132
seroprevalences,7,1.9459101490553132
unmatched,7,1.9459101490553132
egg-derived,7,1.9459101490553132
useless,7,1.9459101490553132
niILI,7,1.9459101490553132
dyssynergic,7,1.9459101490553132
Takayasus,7,1.9459101490553132
Methodological,7,1.9459101490553132
Mexicans,7,1.9459101490553132
Greeks,7,1.9459101490553132
tracheotomy,7,1.9459101490553132
Thermoplasty,7,1.9459101490553132
Injection,7,1.9459101490553132
leucocytosis,7,1.9459101490553132
harsh,7,1.9459101490553132
24-72,7,1.9459101490553132
TGFβ1,7,1.9459101490553132
soreness,7,1.9459101490553132
texts,7,1.9459101490553132
rampant,7,1.9459101490553132
paucisymptomatic,7,1.9459101490553132
reoperation,7,1.9459101490553132
mouse-adapted,7,1.9459101490553132
RNS,7,1.9459101490553132
os,7,1.9459101490553132
silence,7,1.9459101490553132
accommodated,7,1.9459101490553132
corollary,7,1.9459101490553132
nudges,7,1.9459101490553132
mtDNA,7,1.9459101490553132
compressed,7,1.9459101490553132
Composite,7,1.9459101490553132
psychopathological,7,1.9459101490553132
PEGs,7,1.9459101490553132
chronologically,7,1.9459101490553132
host-specific,7,1.9459101490553132
Eighty-six,7,1.9459101490553132
ISIS,7,1.9459101490553132
Lipid,7,1.9459101490553132
oligosaccharide,7,1.9459101490553132
HFR,7,1.9459101490553132
NATs,7,1.9459101490553132
hypothyroid,7,1.9459101490553132
CME,7,1.9459101490553132
mineralizing,7,1.9459101490553132
Down,7,1.9459101490553132
gastro-intestinal,7,1.9459101490553132
neuroanatomy,7,1.9459101490553132
Record,7,1.9459101490553132
NMOSD,7,1.9459101490553132
QTcD,7,1.9459101490553132
trinitrate,7,1.9459101490553132
Transfusion,7,1.9459101490553132
coalition,7,1.9459101490553132
arsenic,7,1.9459101490553132
on-demand,7,1.9459101490553132
mirrored,7,1.9459101490553132
De,7,1.9459101490553132
dyspneic,7,1.9459101490553132
admixture,7,1.9459101490553132
axes,7,1.9459101490553132
FACA,7,1.9459101490553132
CALIBURN,7,1.9459101490553132
human-human,7,1.9459101490553132
first-year,7,1.9459101490553132
AL,7,1.9459101490553132
80-90,7,1.9459101490553132
PLS,7,1.9459101490553132
HM3,7,1.9459101490553132
directs,7,1.9459101490553132
ANG,7,1.9459101490553132
cartography,7,1.9459101490553132
HVAD,7,1.9459101490553132
PS20,7,1.9459101490553132
alternately,7,1.9459101490553132
crRNAs,7,1.9459101490553132
FFO,7,1.9459101490553132
cerebroprotective,7,1.9459101490553132
heighten,7,1.9459101490553132
CoronaVirus,7,1.9459101490553132
tissue-derived,7,1.9459101490553132
anti-reflux,7,1.9459101490553132
Utrecht,7,1.9459101490553132
controllability,7,1.9459101490553132
ATaiwan186,7,1.9459101490553132
onsets,7,1.9459101490553132
Runx3,7,1.9459101490553132
VCI,7,1.9459101490553132
1025,7,1.9459101490553132
myoblasts,7,1.9459101490553132
restless,7,1.9459101490553132
microcatheter,7,1.9459101490553132
dominantly,7,1.9459101490553132
president,7,1.9459101490553132
nonprofit,7,1.9459101490553132
thicker,7,1.9459101490553132
coarse,7,1.9459101490553132
keystone,7,1.9459101490553132
loved,7,1.9459101490553132
6-fold,7,1.9459101490553132
QEEG,7,1.9459101490553132
SPE,7,1.9459101490553132
ERF,7,1.9459101490553132
Specialized,7,1.9459101490553132
Murine,7,1.9459101490553132
MRC-5,7,1.9459101490553132
TFIIB,7,1.9459101490553132
bibliographies,7,1.9459101490553132
ECASS,7,1.9459101490553132
Hyperbaric,7,1.9459101490553132
acknowledges,7,1.9459101490553132
e-cigarettes,7,1.9459101490553132
ApoE,7,1.9459101490553132
VoC,7,1.9459101490553132
enterovirus,7,1.9459101490553132
Corps,7,1.9459101490553132
tips,7,1.9459101490553132
orifice,7,1.9459101490553132
D1,7,1.9459101490553132
Cambodian,7,1.9459101490553132
Forrester,7,1.9459101490553132
supraclavicular,7,1.9459101490553132
Mitral,7,1.9459101490553132
digit,7,1.9459101490553132
managements,7,1.9459101490553132
detergent,7,1.9459101490553132
adrenals,7,1.9459101490553132
graft-versus-host,7,1.9459101490553132
technologic,7,1.9459101490553132
metacognition,7,1.9459101490553132
mutagenic,7,1.9459101490553132
EsA,7,1.9459101490553132
Mapping,7,1.9459101490553132
aHUS,7,1.9459101490553132
EVLW,7,1.9459101490553132
quarantines,7,1.9459101490553132
Sao,7,1.9459101490553132
overwhelmingly,7,1.9459101490553132
HIV-uninfected,7,1.9459101490553132
triplex,7,1.9459101490553132
pwMS,7,1.9459101490553132
symptom-driven,7,1.9459101490553132
mines,7,1.9459101490553132
AGT,7,1.9459101490553132
MBCK,7,1.9459101490553132
AIRD,7,1.9459101490553132
cadaveric,7,1.9459101490553132
Progression,7,1.9459101490553132
neuroimmune,7,1.9459101490553132
Festival,7,1.9459101490553132
prevails,7,1.9459101490553132
Meteorological,7,1.9459101490553132
ECDC,7,1.9459101490553132
LOC,7,1.9459101490553132
purines,7,1.9459101490553132
recrudescence,7,1.9459101490553132
Unilateral,7,1.9459101490553132
1018,7,1.9459101490553132
multimorbidity,7,1.9459101490553132
developmentally,7,1.9459101490553132
FIPV,7,1.9459101490553132
exhale,7,1.9459101490553132
turmoil,7,1.9459101490553132
dismissed,7,1.9459101490553132
vitD3,7,1.9459101490553132
Sendai,7,1.9459101490553132
realistically,7,1.9459101490553132
ourselves,7,1.9459101490553132
B-mode,7,1.9459101490553132
2c,7,1.9459101490553132
Entry,7,1.9459101490553132
Correction,7,1.9459101490553132
two-week,7,1.9459101490553132
MAS,7,1.9459101490553132
PrPC,7,1.9459101490553132
15-2,7,1.9459101490553132
re-examination,7,1.9459101490553132
673,7,1.9459101490553132
Receiving,7,1.9459101490553132
pest,7,1.9459101490553132
accomplishments,7,1.9459101490553132
Participating,7,1.9459101490553132
case-controlled,7,1.9459101490553132
manipulations,7,1.9459101490553132
Raised,7,1.9459101490553132
Endobronchial,7,1.9459101490553132
respected,7,1.9459101490553132
Denial,7,1.9459101490553132
workloads,7,1.9459101490553132
198990,7,1.9459101490553132
urodynamic,7,1.9459101490553132
air-borne,7,1.9459101490553132
HES,7,1.9459101490553132
Consultation,7,1.9459101490553132
envisage,7,1.9459101490553132
Necrosis,7,1.9459101490553132
urological,7,1.9459101490553132
cardio-pulmonary,7,1.9459101490553132
cerebrum,7,1.9459101490553132
tungsten,7,1.9459101490553132
backed,7,1.9459101490553132
involvements,7,1.9459101490553132
GOF,7,1.9459101490553132
NKp46,7,1.9459101490553132
HispanicLatino,7,1.9459101490553132
fundamentals,7,1.9459101490553132
MaR,7,1.9459101490553132
Degree,7,1.9459101490553132
E3,7,1.9459101490553132
open-heart,7,1.9459101490553132
recurrently,7,1.9459101490553132
image-based,7,1.9459101490553132
Restenosis,7,1.9459101490553132
maxima,7,1.9459101490553132
AUD,7,1.9459101490553132
Tuberculosis,7,1.9459101490553132
nucleoproteins,7,1.9459101490553132
Fluorescent,7,1.9459101490553132
electromagnetic,7,1.9459101490553132
NSM,7,1.9459101490553132
Petersburg,7,1.9459101490553132
debut,7,1.9459101490553132
1099,7,1.9459101490553132
exercise-,7,1.9459101490553132
metasurface,7,1.9459101490553132
non-COVID,7,1.9459101490553132
Oregon,7,1.9459101490553132
TABP,7,1.9459101490553132
cross-sectionally,7,1.9459101490553132
MM-GBSA,7,1.9459101490553132
ENaC,7,1.9459101490553132
21-day,7,1.9459101490553132
SCAF,7,1.9459101490553132
readaptation,7,1.9459101490553132
Selenium,7,1.9459101490553132
PVA,7,1.9459101490553132
non-transplant,7,1.9459101490553132
architectures,7,1.9459101490553132
ISG15,7,1.9459101490553132
informativeness,7,1.9459101490553132
levosimendan,7,1.9459101490553132
insignificantly,6,1.791759469228055
customary,6,1.791759469228055
oversight,6,1.791759469228055
Churg-Strauss,6,1.791759469228055
xenon,6,1.791759469228055
visuomotor,6,1.791759469228055
paramyxoviruses,6,1.791759469228055
non-Aboriginal,6,1.791759469228055
extracurricular,6,1.791759469228055
Immunosenescence,6,1.791759469228055
gunshot,6,1.791759469228055
NGF,6,1.791759469228055
potentiality,6,1.791759469228055
Notwithstanding,6,1.791759469228055
pharmacoeconomic,6,1.791759469228055
SARS-CoV-2-negative,6,1.791759469228055
paused,6,1.791759469228055
maternal-neonatal,6,1.791759469228055
apposition,6,1.791759469228055
GBD,6,1.791759469228055
apico-septo-lateral,6,1.791759469228055
Marseille,6,1.791759469228055
Stalin,6,1.791759469228055
quasi-experimental,6,1.791759469228055
Melatonin,6,1.791759469228055
936,6,1.791759469228055
anti-stroke,6,1.791759469228055
outbreak-associated,6,1.791759469228055
Amsterdam,6,1.791759469228055
Overuse,6,1.791759469228055
FRG,6,1.791759469228055
Collective,6,1.791759469228055
sCD40L,6,1.791759469228055
acronym,6,1.791759469228055
Mac1,6,1.791759469228055
Boards,6,1.791759469228055
comprehensiveness,6,1.791759469228055
simulates,6,1.791759469228055
RBD-,6,1.791759469228055
enterprises,6,1.791759469228055
Nov,6,1.791759469228055
Tandem,6,1.791759469228055
mmol,6,1.791759469228055
tiered,6,1.791759469228055
non-surgical,6,1.791759469228055
atheromatosis,6,1.791759469228055
subsamples,6,1.791759469228055
vasodilating,6,1.791759469228055
validations,6,1.791759469228055
Plain,6,1.791759469228055
linoleic,6,1.791759469228055
negotiation,6,1.791759469228055
time-point,6,1.791759469228055
DVA,6,1.791759469228055
embedding,6,1.791759469228055
spasmodic,6,1.791759469228055
teenage,6,1.791759469228055
avirulent,6,1.791759469228055
ACE2-expressing,6,1.791759469228055
mediums,6,1.791759469228055
Scoring,6,1.791759469228055
segregated,6,1.791759469228055
diagnosis-related,6,1.791759469228055
-063,6,1.791759469228055
antechamber,6,1.791759469228055
RWMA,6,1.791759469228055
welcome,6,1.791759469228055
CoVLP,6,1.791759469228055
validates,6,1.791759469228055
Intensified,6,1.791759469228055
ICSO,6,1.791759469228055
Converting,6,1.791759469228055
140000,6,1.791759469228055
Provision,6,1.791759469228055
agarose,6,1.791759469228055
orthotopic,6,1.791759469228055
amply,6,1.791759469228055
Hospitalists,6,1.791759469228055
IRD,6,1.791759469228055
realizing,6,1.791759469228055
Ghent,6,1.791759469228055
COLD,6,1.791759469228055
MUGA,6,1.791759469228055
Nara,6,1.791759469228055
visuo-spatial,6,1.791759469228055
sorted,6,1.791759469228055
BChE,6,1.791759469228055
Vessel,6,1.791759469228055
self-protection,6,1.791759469228055
Islanders,6,1.791759469228055
H₂S,6,1.791759469228055
truncation,6,1.791759469228055
ligase,6,1.791759469228055
carinatum,6,1.791759469228055
ITS,6,1.791759469228055
0-100,6,1.791759469228055
Capilia,6,1.791759469228055
hypnotherapy,6,1.791759469228055
mobilised,6,1.791759469228055
aM,6,1.791759469228055
alpha2-6,6,1.791759469228055
electroporation,6,1.791759469228055
cytometric,6,1.791759469228055
two-strain,6,1.791759469228055
spreadsheet,6,1.791759469228055
removes,6,1.791759469228055
ADP-ribosylation,6,1.791759469228055
sub-epithelial,6,1.791759469228055
Immunogenicity,6,1.791759469228055
GUSTO-I,6,1.791759469228055
wanes,6,1.791759469228055
theatre,6,1.791759469228055
kgm,6,1.791759469228055
DockCoV2,6,1.791759469228055
rectus,6,1.791759469228055
HFD,6,1.791759469228055
immune-modulators,6,1.791759469228055
invaded,6,1.791759469228055
uptakes,6,1.791759469228055
slower-onset,6,1.791759469228055
morphologies,6,1.791759469228055
GEIG,6,1.791759469228055
cutting-edge,6,1.791759469228055
nonwhite,6,1.791759469228055
Mar,6,1.791759469228055
OHSS,6,1.791759469228055
Adrenal,6,1.791759469228055
phylogenies,6,1.791759469228055
WTO,6,1.791759469228055
Infarto,6,1.791759469228055
Pharyngeal,6,1.791759469228055
841,6,1.791759469228055
Prodromal,6,1.791759469228055
contraception,6,1.791759469228055
Cessation,6,1.791759469228055
ACTH,6,1.791759469228055
V1-6,6,1.791759469228055
inflammations,6,1.791759469228055
photodynamic,6,1.791759469228055
constellations,6,1.791759469228055
Plant,6,1.791759469228055
clusterin,6,1.791759469228055
moieties,6,1.791759469228055
non-enhanced,6,1.791759469228055
Undergoing,6,1.791759469228055
Nonallergic,6,1.791759469228055
Neurointervention,6,1.791759469228055
strides,6,1.791759469228055
nano-based,6,1.791759469228055
drop-out,6,1.791759469228055
1954,6,1.791759469228055
downtown,6,1.791759469228055
Seventy-nine,6,1.791759469228055
DU,6,1.791759469228055
Cassette,6,1.791759469228055
intrabronchial,6,1.791759469228055
Jones,6,1.791759469228055
inadequacies,6,1.791759469228055
nodular,6,1.791759469228055
3h,6,1.791759469228055
applicants,6,1.791759469228055
HZ,6,1.791759469228055
NEDDylation,6,1.791759469228055
RSV-associated,6,1.791759469228055
prasugrel,6,1.791759469228055
18F-fluorodeoxyglucose,6,1.791759469228055
Undiagnosed,6,1.791759469228055
banning,6,1.791759469228055
multi-infarct,6,1.791759469228055
biosocial,6,1.791759469228055
LSM,6,1.791759469228055
48-72,6,1.791759469228055
Kenyan,6,1.791759469228055
1940s,6,1.791759469228055
survey-based,6,1.791759469228055
Polymorphisms,6,1.791759469228055
cmsec,6,1.791759469228055
Tongji,6,1.791759469228055
HF-QRS,6,1.791759469228055
Next-generation,6,1.791759469228055
AATD,6,1.791759469228055
closings,6,1.791759469228055
ERs,6,1.791759469228055
erythroid,6,1.791759469228055
capitals,6,1.791759469228055
coronary-prone,6,1.791759469228055
Dexamethasone,6,1.791759469228055
prolactin,6,1.791759469228055
referent,6,1.791759469228055
IgGSP,6,1.791759469228055
attraction,6,1.791759469228055
valley,6,1.791759469228055
assert,6,1.791759469228055
end-tidal,6,1.791759469228055
harder,6,1.791759469228055
Becks,6,1.791759469228055
Fundamental,6,1.791759469228055
inferiority,6,1.791759469228055
hiring,6,1.791759469228055
201Tl-defect,6,1.791759469228055
OIFIs,6,1.791759469228055
Usual,6,1.791759469228055
resuscitative,6,1.791759469228055
IL-37tg,6,1.791759469228055
exudates,6,1.791759469228055
Supply,6,1.791759469228055
cortisone,6,1.791759469228055
Ontarios,6,1.791759469228055
cautionary,6,1.791759469228055
embarking,6,1.791759469228055
flexors,6,1.791759469228055
alpine,6,1.791759469228055
consequential,6,1.791759469228055
lipoprotein-associated,6,1.791759469228055
gday,6,1.791759469228055
noses,6,1.791759469228055
Hydroxyurea,6,1.791759469228055
DRUL,6,1.791759469228055
adsorption-extraction,6,1.791759469228055
quo,6,1.791759469228055
rethinking,6,1.791759469228055
eplerenone,6,1.791759469228055
681,6,1.791759469228055
macromolecular,6,1.791759469228055
Sustainable,6,1.791759469228055
MMP-1,6,1.791759469228055
PASP,6,1.791759469228055
interferon-inducing,6,1.791759469228055
easiest,6,1.791759469228055
exogenic,6,1.791759469228055
coliphages,6,1.791759469228055
1921,6,1.791759469228055
glutathionylation,6,1.791759469228055
constipation,6,1.791759469228055
FCoV,6,1.791759469228055
geared,6,1.791759469228055
hemadsorption,6,1.791759469228055
Determine,6,1.791759469228055
ABCD,6,1.791759469228055
May-June,6,1.791759469228055
CBA,6,1.791759469228055
bicarbonate,6,1.791759469228055
AWuhan35995,6,1.791759469228055
tonsillitis,6,1.791759469228055
re-purposed,6,1.791759469228055
AGE,6,1.791759469228055
multinomial,6,1.791759469228055
PUE,6,1.791759469228055
unlock,6,1.791759469228055
schoolboys,6,1.791759469228055
allergologists,6,1.791759469228055
2273,6,1.791759469228055
770,6,1.791759469228055
phenotypically,6,1.791759469228055
microgramsml,6,1.791759469228055
radiopharmaceuticals,6,1.791759469228055
TIMI-3,6,1.791759469228055
subnormal,6,1.791759469228055
decellularized,6,1.791759469228055
ABangkok,6,1.791759469228055
sorbent,6,1.791759469228055
RWT,6,1.791759469228055
hot-spot,6,1.791759469228055
NSABSTRACT,6,1.791759469228055
cadets,6,1.791759469228055
501YV1,6,1.791759469228055
mattress,6,1.791759469228055
Forest,6,1.791759469228055
70-90,6,1.791759469228055
laypersons,6,1.791759469228055
AQLQ-M,6,1.791759469228055
manufacturer-independent,6,1.791759469228055
live-poultry,6,1.791759469228055
12-year,6,1.791759469228055
Success,6,1.791759469228055
elaborates,6,1.791759469228055
w,6,1.791759469228055
timesday,6,1.791759469228055
Motivated,6,1.791759469228055
neighbors,6,1.791759469228055
multilayered,6,1.791759469228055
fluorogenic,6,1.791759469228055
epithelium-derived,6,1.791759469228055
Cefuroxime,6,1.791759469228055
commitments,6,1.791759469228055
Bio-Rad,6,1.791759469228055
dilator,6,1.791759469228055
Employing,6,1.791759469228055
Allied,6,1.791759469228055
register-based,6,1.791759469228055
Heavy,6,1.791759469228055
soybean,6,1.791759469228055
schoolteachers,6,1.791759469228055
stenosisocclusion,6,1.791759469228055
ACalifornia072009,6,1.791759469228055
CARAT,6,1.791759469228055
Thousands,6,1.791759469228055
sickled,6,1.791759469228055
spike-ACE2,6,1.791759469228055
ENOS,6,1.791759469228055
ten-year,6,1.791759469228055
burnetii,6,1.791759469228055
inter,6,1.791759469228055
thirty-six,6,1.791759469228055
Sepsis,6,1.791759469228055
Hoc,6,1.791759469228055
IPSS,6,1.791759469228055
sadness,6,1.791759469228055
field-deployable,6,1.791759469228055
Sars-Cov-2,6,1.791759469228055
diuresis,6,1.791759469228055
fires,6,1.791759469228055
microthrombosis,6,1.791759469228055
CHR,6,1.791759469228055
reject,6,1.791759469228055
Arctic,6,1.791759469228055
passport,6,1.791759469228055
cyclical,6,1.791759469228055
LHD,6,1.791759469228055
pasture,6,1.791759469228055
Depletion,6,1.791759469228055
Candida,6,1.791759469228055
Diagnoses,6,1.791759469228055
rheological,6,1.791759469228055
rotavirus,6,1.791759469228055
non-depressed,6,1.791759469228055
High-frequency,6,1.791759469228055
wasted,6,1.791759469228055
disorganization,6,1.791759469228055
heterozygote,6,1.791759469228055
ANY,6,1.791759469228055
m6A,6,1.791759469228055
endorsing,6,1.791759469228055
adipose-derived,6,1.791759469228055
standpoints,6,1.791759469228055
S100,6,1.791759469228055
User,6,1.791759469228055
lays,6,1.791759469228055
pioneering,6,1.791759469228055
SRID,6,1.791759469228055
rebuilding,6,1.791759469228055
AS-IV,6,1.791759469228055
Examining,6,1.791759469228055
UT,6,1.791759469228055
FEV1pred,6,1.791759469228055
reconstituted,6,1.791759469228055
daylight,6,1.791759469228055
epistaxis,6,1.791759469228055
interleukin-5,6,1.791759469228055
inhalable,6,1.791759469228055
oldest-old,6,1.791759469228055
toilets,6,1.791759469228055
ACEi,6,1.791759469228055
endorses,6,1.791759469228055
IFAA,6,1.791759469228055
nonhospitalized,6,1.791759469228055
CENTRAL,6,1.791759469228055
PPAR-γ,6,1.791759469228055
co-delivery,6,1.791759469228055
proliferator-activated,6,1.791759469228055
seminar,6,1.791759469228055
peroxisome,6,1.791759469228055
ATPase,6,1.791759469228055
Need,6,1.791759469228055
Anger,6,1.791759469228055
prostanoid,6,1.791759469228055
PID,6,1.791759469228055
Registered,6,1.791759469228055
breast-feeding,6,1.791759469228055
rHA,6,1.791759469228055
CCA-IMT,6,1.791759469228055
apoptosis-related,6,1.791759469228055
Guiana,6,1.791759469228055
DIF,6,1.791759469228055
Item,6,1.791759469228055
AHMPPI,6,1.791759469228055
haematocrit,6,1.791759469228055
PA-EA,6,1.791759469228055
Northwest,6,1.791759469228055
degrade,6,1.791759469228055
non-productive,6,1.791759469228055
virally,6,1.791759469228055
Liverpool,6,1.791759469228055
1957-1958,6,1.791759469228055
tailor-made,6,1.791759469228055
reintroduction,6,1.791759469228055
gracile,6,1.791759469228055
Zhuyu,6,1.791759469228055
neuroregeneration,6,1.791759469228055
SDNN,6,1.791759469228055
Sacin,6,1.791759469228055
dippers,6,1.791759469228055
Exposures,6,1.791759469228055
guarantees,6,1.791759469228055
Antileukotrienes,6,1.791759469228055
PVL,6,1.791759469228055
dropping,6,1.791759469228055
normothermia,6,1.791759469228055
vaccination-related,6,1.791759469228055
Todds,6,1.791759469228055
preconditions,6,1.791759469228055
Retriever,6,1.791759469228055
filarial,6,1.791759469228055
cathepsins,6,1.791759469228055
Oklahoma,6,1.791759469228055
atomistic,6,1.791759469228055
SSEs,6,1.791759469228055
Austin,6,1.791759469228055
prescribers,6,1.791759469228055
eustachian,6,1.791759469228055
IgG-positive,6,1.791759469228055
Basal,6,1.791759469228055
Nam,6,1.791759469228055
Viet,6,1.791759469228055
Gsk-3,6,1.791759469228055
babys,6,1.791759469228055
high-flow,6,1.791759469228055
trustworthy,6,1.791759469228055
abachi,6,1.791759469228055
self-evaluation,6,1.791759469228055
Fatality,6,1.791759469228055
stretch,6,1.791759469228055
≥7,6,1.791759469228055
3CLPRO,6,1.791759469228055
co-culture,6,1.791759469228055
half-lives,6,1.791759469228055
multi-system,6,1.791759469228055
fluorescent-antibody,6,1.791759469228055
anterior-posterior,6,1.791759469228055
capsaicin,6,1.791759469228055
thrombosed,6,1.791759469228055
H5N1-induced,6,1.791759469228055
REC,6,1.791759469228055
1-July,6,1.791759469228055
p-values,6,1.791759469228055
perimenstrual,6,1.791759469228055
noncompaction,6,1.791759469228055
Thames,6,1.791759469228055
camels,6,1.791759469228055
Trait,6,1.791759469228055
aspartic,6,1.791759469228055
hematogenous,6,1.791759469228055
PROMIS,6,1.791759469228055
catheterizations,6,1.791759469228055
reestablish,6,1.791759469228055
July-August,6,1.791759469228055
Shaanxi,6,1.791759469228055
Deployment,6,1.791759469228055
Translation,6,1.791759469228055
non-treated,6,1.791759469228055
LAVs,6,1.791759469228055
amines,6,1.791759469228055
scourge,6,1.791759469228055
confirmations,6,1.791759469228055
gravis,6,1.791759469228055
topo,6,1.791759469228055
Physiologically,6,1.791759469228055
n17,6,1.791759469228055
impactful,6,1.791759469228055
thrombocytes,6,1.791759469228055
non-urgent,6,1.791759469228055
Gynecology,6,1.791759469228055
precarious,6,1.791759469228055
remodel,6,1.791759469228055
Order,6,1.791759469228055
interrelations,6,1.791759469228055
Subgroups,6,1.791759469228055
motivates,6,1.791759469228055
Migrainous,6,1.791759469228055
Oslo,6,1.791759469228055
bone-marrow,6,1.791759469228055
AT-527,6,1.791759469228055
HIIT,6,1.791759469228055
triphosphate,6,1.791759469228055
cant,6,1.791759469228055
tissue-specific,6,1.791759469228055
RVAMI,6,1.791759469228055
New-onset,6,1.791759469228055
1512,6,1.791759469228055
fluence,6,1.791759469228055
angioscopy,6,1.791759469228055
Relying,6,1.791759469228055
1922,6,1.791759469228055
torques,6,1.791759469228055
Institutional,6,1.791759469228055
ban,6,1.791759469228055
DEPs,6,1.791759469228055
likes,6,1.791759469228055
14-year,6,1.791759469228055
LUMIPULSE,6,1.791759469228055
Personalized,6,1.791759469228055
thrombocyte,6,1.791759469228055
parotitis,6,1.791759469228055
Pharmacogenetic,6,1.791759469228055
peritoneum,6,1.791759469228055
HCl,6,1.791759469228055
acquaintances,6,1.791759469228055
Obstetrics,6,1.791759469228055
Virocult,6,1.791759469228055
Fecal,6,1.791759469228055
livelihoods,6,1.791759469228055
signed,6,1.791759469228055
pick,6,1.791759469228055
clockwise,6,1.791759469228055
digitoxin,6,1.791759469228055
exported,6,1.791759469228055
license,6,1.791759469228055
Accounting,6,1.791759469228055
VAs,6,1.791759469228055
ChAdPd,6,1.791759469228055
generative,6,1.791759469228055
antagonized,6,1.791759469228055
heterogeneously,6,1.791759469228055
Classic,6,1.791759469228055
p38MAPK,6,1.791759469228055
VBHC,6,1.791759469228055
qi,6,1.791759469228055
1925,6,1.791759469228055
10-40,6,1.791759469228055
finishing,6,1.791759469228055
clot-busting,6,1.791759469228055
Protease,6,1.791759469228055
remembering,6,1.791759469228055
raging,6,1.791759469228055
June-August,6,1.791759469228055
ERM,6,1.791759469228055
replications,6,1.791759469228055
A3,6,1.791759469228055
time-points,6,1.791759469228055
BSS,6,1.791759469228055
reservations,6,1.791759469228055
myocardiac,6,1.791759469228055
potentiates,6,1.791759469228055
BGI,6,1.791759469228055
easing,6,1.791759469228055
homotypic,6,1.791759469228055
imADSC,6,1.791759469228055
EUA-approved,6,1.791759469228055
plasmids,6,1.791759469228055
XRCC1,6,1.791759469228055
MPVplatelet,6,1.791759469228055
TIS,6,1.791759469228055
percolation,6,1.791759469228055
INRs,6,1.791759469228055
PUUV,6,1.791759469228055
18-60,6,1.791759469228055
domestically,6,1.791759469228055
FSO,6,1.791759469228055
elapsing,6,1.791759469228055
80s,6,1.791759469228055
V5R,6,1.791759469228055
emanating,6,1.791759469228055
limbic,6,1.791759469228055
RTA,6,1.791759469228055
Saline,6,1.791759469228055
clamp,6,1.791759469228055
P0015,6,1.791759469228055
screw,6,1.791759469228055
Low-level,6,1.791759469228055
cuff,6,1.791759469228055
instrumented,6,1.791759469228055
FDR,6,1.791759469228055
sRAGE,6,1.791759469228055
slow-flow,6,1.791759469228055
curtailed,6,1.791759469228055
clinical-epidemiological,6,1.791759469228055
unmitigated,6,1.791759469228055
spitting,6,1.791759469228055
pessimism,6,1.791759469228055
multiplying,6,1.791759469228055
immersion,6,1.791759469228055
tobacco-related,6,1.791759469228055
depolarized,6,1.791759469228055
toolbox,6,1.791759469228055
abortive,6,1.791759469228055
DPP-4,6,1.791759469228055
HBDT,6,1.791759469228055
betaine,6,1.791759469228055
methionine,6,1.791759469228055
rinsegargle,6,1.791759469228055
PLHIV,6,1.791759469228055
pre-event,6,1.791759469228055
bronchogenic,6,1.791759469228055
broad-based,6,1.791759469228055
grasping,6,1.791759469228055
AEDs,6,1.791759469228055
BSL3,6,1.791759469228055
CDF,6,1.791759469228055
unsuccessfully,6,1.791759469228055
5-monophosphate,6,1.791759469228055
woken,6,1.791759469228055
MDT,6,1.791759469228055
pharmacoinvasive,6,1.791759469228055
Haemodynamic,6,1.791759469228055
20002001,6,1.791759469228055
BHAT,6,1.791759469228055
choking,6,1.791759469228055
TSA,6,1.791759469228055
SC75741,6,1.791759469228055
fibrin-specific,6,1.791759469228055
cosinor,6,1.791759469228055
Integrative,6,1.791759469228055
Leukocyte,6,1.791759469228055
extraordinarily,6,1.791759469228055
Indinavir,6,1.791759469228055
n-IRA,6,1.791759469228055
IMH,6,1.791759469228055
COCOA,6,1.791759469228055
flattening,6,1.791759469228055
Influenza-Like,6,1.791759469228055
burials,6,1.791759469228055
cross-neutralize,6,1.791759469228055
CARETCTI,6,1.791759469228055
street,6,1.791759469228055
amantadin,6,1.791759469228055
vi,6,1.791759469228055
HW,6,1.791759469228055
DAH,6,1.791759469228055
AYA,6,1.791759469228055
non-VOC,6,1.791759469228055
Karachi,6,1.791759469228055
reappear,6,1.791759469228055
1min,6,1.791759469228055
efferocytosis,6,1.791759469228055
TRP,6,1.791759469228055
PVS,6,1.791759469228055
Trails,6,1.791759469228055
extravascular,6,1.791759469228055
visualised,6,1.791759469228055
smoothly,6,1.791759469228055
Digits,6,1.791759469228055
≥5,6,1.791759469228055
Sa,6,1.791759469228055
under-estimated,6,1.791759469228055
1899,6,1.791759469228055
pipelines,6,1.791759469228055
emphasising,6,1.791759469228055
IEM,6,1.791759469228055
MiniAQLQ,6,1.791759469228055
Chan,6,1.791759469228055
metabolome,6,1.791759469228055
antagonistic,6,1.791759469228055
emboligenic,6,1.791759469228055
culture-based,6,1.791759469228055
second-order,6,1.791759469228055
IL-7,6,1.791759469228055
parasitized,6,1.791759469228055
Ch,6,1.791759469228055
fibrinous,6,1.791759469228055
coronavirus-induced,6,1.791759469228055
Europes,6,1.791759469228055
pale,6,1.791759469228055
HTPR,6,1.791759469228055
Hesitancy,6,1.791759469228055
escalate,6,1.791759469228055
Hemophilus,6,1.791759469228055
eager,6,1.791759469228055
reactively,6,1.791759469228055
dashboard,6,1.791759469228055
anonymously,6,1.791759469228055
Bronchospasm,6,1.791759469228055
Minimizing,6,1.791759469228055
packing,6,1.791759469228055
Swietokrzyskie,6,1.791759469228055
Taipei,6,1.791759469228055
FPs,6,1.791759469228055
Humidity,6,1.791759469228055
RSNA,6,1.791759469228055
guilt,6,1.791759469228055
RIDT-positive,6,1.791759469228055
első,6,1.791759469228055
IgM-positive,6,1.791759469228055
2009-2012,6,1.791759469228055
genealogical,6,1.791759469228055
extubated,6,1.791759469228055
multi-dimensional,6,1.791759469228055
high-fidelity,6,1.791759469228055
Sixty-eight,6,1.791759469228055
sildenafil,6,1.791759469228055
Neuroradiology,6,1.791759469228055
13080,6,1.791759469228055
tagged,6,1.791759469228055
summertime,6,1.791759469228055
hypercholesterolemic,6,1.791759469228055
intraperitoneally,6,1.791759469228055
Adjusting,6,1.791759469228055
Bleeding,6,1.791759469228055
in-home,6,1.791759469228055
consciously,6,1.791759469228055
lenses,6,1.791759469228055
nanomolar,6,1.791759469228055
Jews,6,1.791759469228055
upregulating,6,1.791759469228055
Antiphospholipid,6,1.791759469228055
Hyperglycaemia,6,1.791759469228055
CAIV,6,1.791759469228055
Brown,6,1.791759469228055
Amino,6,1.791759469228055
RRref,6,1.791759469228055
Kd,6,1.791759469228055
fertile,6,1.791759469228055
spinothalamic,6,1.791759469228055
angiotensinogen-TT,6,1.791759469228055
iNOS,6,1.791759469228055
Afghanistan,6,1.791759469228055
intramyocardially,6,1.791759469228055
DNAs,6,1.791759469228055
receptivity,6,1.791759469228055
methylxanthines,6,1.791759469228055
TKM,6,1.791759469228055
CBCL,6,1.791759469228055
Procedures,6,1.791759469228055
spatial-temporal,6,1.791759469228055
HACWs,6,1.791759469228055
RV3,6,1.791759469228055
titrate,6,1.791759469228055
20132014,6,1.791759469228055
retrievable,6,1.791759469228055
BECH,6,1.791759469228055
Suzhou,6,1.791759469228055
Dermatology,6,1.791759469228055
evidenced-based,6,1.791759469228055
ESRD,6,1.791759469228055
CD45,6,1.791759469228055
EIP,6,1.791759469228055
left-side,6,1.791759469228055
AstraZenecas,6,1.791759469228055
Original,6,1.791759469228055
≤3,6,1.791759469228055
control-based,6,1.791759469228055
T2-low,6,1.791759469228055
roentgenography,6,1.791759469228055
kDa,6,1.791759469228055
infarctionaortic,6,1.791759469228055
multidrug-resistant,6,1.791759469228055
left-to-right,6,1.791759469228055
coaches,6,1.791759469228055
dependant,6,1.791759469228055
WAMP,6,1.791759469228055
Jima,6,1.791759469228055
polysensitization,6,1.791759469228055
ACE-DD,6,1.791759469228055
readability,6,1.791759469228055
arteriogenesis,6,1.791759469228055
signifies,6,1.791759469228055
contour,6,1.791759469228055
Depressed,6,1.791759469228055
granulation,6,1.791759469228055
drink,6,1.791759469228055
MPI,6,1.791759469228055
volunteered,6,1.791759469228055
Castlemans,6,1.791759469228055
negotiate,6,1.791759469228055
945,6,1.791759469228055
periinfarction,6,1.791759469228055
δ,6,1.791759469228055
2000-01,6,1.791759469228055
1978-1979,6,1.791759469228055
Mr,6,1.791759469228055
SNS,6,1.791759469228055
Coverdell,6,1.791759469228055
beforehand,6,1.791759469228055
dive,6,1.791759469228055
5-19,6,1.791759469228055
compilation,6,1.791759469228055
Pathogenicity,6,1.791759469228055
Orange,6,1.791759469228055
Quantification,6,1.791759469228055
stroke-affected,6,1.791759469228055
Nation,6,1.791759469228055
premedication,6,1.791759469228055
kills,6,1.791759469228055
staphylococcal,6,1.791759469228055
exemption,6,1.791759469228055
custom,6,1.791759469228055
motive,6,1.791759469228055
Gaps,6,1.791759469228055
watts,6,1.791759469228055
onset-to-treatment,6,1.791759469228055
Sixty-nine,6,1.791759469228055
ata,6,1.791759469228055
Discordance,6,1.791759469228055
erythematous,6,1.791759469228055
notoriously,6,1.791759469228055
broncho-alveolar,6,1.791759469228055
cusp,6,1.791759469228055
nanosensor,6,1.791759469228055
Advice,6,1.791759469228055
galactose,6,1.791759469228055
interfacial,6,1.791759469228055
sensitivityspecificity,6,1.791759469228055
Likelihood,6,1.791759469228055
abstraction,6,1.791759469228055
resource-rich,6,1.791759469228055
extrapleural,6,1.791759469228055
1521,6,1.791759469228055
crescendo,6,1.791759469228055
TIAminor,6,1.791759469228055
four-week,6,1.791759469228055
YO,6,1.791759469228055
CADD,6,1.791759469228055
explorations,6,1.791759469228055
Age-,6,1.791759469228055
endothelium-derived,6,1.791759469228055
non-institutionalized,6,1.791759469228055
purposive,6,1.791759469228055
vasculome,6,1.791759469228055
sewing,6,1.791759469228055
bigeminy,6,1.791759469228055
ICR,6,1.791759469228055
genuinely,6,1.791759469228055
K09,6,1.791759469228055
apathetic,6,1.791759469228055
microwave,6,1.791759469228055
oncohematological,6,1.791759469228055
abort,6,1.791759469228055
PNS,6,1.791759469228055
ASIA,6,1.791759469228055
autoinflammatory,6,1.791759469228055
EGEA,6,1.791759469228055
incredibly,6,1.791759469228055
calculator,6,1.791759469228055
804,6,1.791759469228055
PSAs,6,1.791759469228055
intraoral,6,1.791759469228055
Th1-type,6,1.791759469228055
CANP,6,1.791759469228055
Admissions,6,1.791759469228055
samplers,6,1.791759469228055
sampler,6,1.791759469228055
multiyear,6,1.791759469228055
syndrome-associated,6,1.791759469228055
continuous-flow,6,1.791759469228055
Financing,6,1.791759469228055
B-cells,6,1.791759469228055
dose-dependently,6,1.791759469228055
PON,6,1.791759469228055
PFU,6,1.791759469228055
watch,6,1.791759469228055
exemplary,6,1.791759469228055
TWLD,6,1.791759469228055
3-10,6,1.791759469228055
Bcl-2,6,1.791759469228055
Promoting,6,1.791759469228055
striatal,6,1.791759469228055
Muslims,6,1.791759469228055
apelin‑13,6,1.791759469228055
1062,6,1.791759469228055
customize,6,1.791759469228055
contours,6,1.791759469228055
biodiversity,6,1.791759469228055
paratracheal,6,1.791759469228055
drinkers,6,1.791759469228055
disappears,6,1.791759469228055
Asthmas,6,1.791759469228055
vertebra,6,1.791759469228055
isotopes,6,1.791759469228055
Saturdays,6,1.791759469228055
NOMAS,6,1.791759469228055
skiing,6,1.791759469228055
sociodemographics,6,1.791759469228055
envisioned,6,1.791759469228055
onboard,6,1.791759469228055
mitogen,6,1.791759469228055
attested,6,1.791759469228055
cores,6,1.791759469228055
1-hour,6,1.791759469228055
infrequency,6,1.791759469228055
pound,6,1.791759469228055
twenty-fifth,6,1.791759469228055
myocardiocyte,6,1.791759469228055
AAP,6,1.791759469228055
fascicularis,6,1.791759469228055
90th,6,1.791759469228055
Replication,6,1.791759469228055
post-embolization,6,1.791759469228055
anthropogenic,6,1.791759469228055
Images,6,1.791759469228055
conductive,6,1.791759469228055
Removal,6,1.791759469228055
non-vascular,6,1.791759469228055
two-group,6,1.791759469228055
right-hemispheric,6,1.791759469228055
GC5131,6,1.791759469228055
repressed,6,1.791759469228055
bleed,6,1.791759469228055
multiple-organ,6,1.791759469228055
RWE,6,1.791759469228055
homonymous,6,1.791759469228055
instructional,6,1.791759469228055
voices,6,1.791759469228055
gliomas,6,1.791759469228055
ALC,6,1.791759469228055
VPC,6,1.791759469228055
passaging,6,1.791759469228055
I-II,6,1.791759469228055
crime,6,1.791759469228055
Positivity,6,1.791759469228055
Test™,6,1.791759469228055
consultative,6,1.791759469228055
Non-An,6,1.791759469228055
Broadly,6,1.791759469228055
fuels,6,1.791759469228055
735,6,1.791759469228055
Dentists,6,1.791759469228055
frictional,6,1.791759469228055
nsp13,6,1.791759469228055
bridged,6,1.791759469228055
birthweight,6,1.791759469228055
fluidic,6,1.791759469228055
ACBG,6,1.791759469228055
entrusted,6,1.791759469228055
posthospitalization,6,1.791759469228055
p04,6,1.791759469228055
handful,6,1.791759469228055
Considered,6,1.791759469228055
short-duration,6,1.791759469228055
rationalize,6,1.791759469228055
onset-to-balloon,6,1.791759469228055
polylysine,6,1.791759469228055
EPSS,6,1.791759469228055
day-night,6,1.791759469228055
mid-portion,6,1.791759469228055
saturated,6,1.791759469228055
connectome,6,1.791759469228055
Ethics,6,1.791759469228055
D2,6,1.791759469228055
anyway,6,1.791759469228055
AMayo,6,1.791759469228055
Transportation,6,1.791759469228055
overviews,6,1.791759469228055
co-occurring,6,1.791759469228055
helix,6,1.791759469228055
Afterwards,6,1.791759469228055
6-19,6,1.791759469228055
penetrated,6,1.791759469228055
observance,6,1.791759469228055
HFJV,6,1.791759469228055
23Na,6,1.791759469228055
one-day,6,1.791759469228055
George,6,1.791759469228055
SPC,6,1.791759469228055
PMR,6,1.791759469228055
COVID-2019,6,1.791759469228055
fragmentary,6,1.791759469228055
SHARP,6,1.791759469228055
cfDNA,6,1.791759469228055
Lagos,6,1.791759469228055
FDG-PET,6,1.791759469228055
compiles,6,1.791759469228055
cross-reactions,6,1.791759469228055
antinuclear,6,1.791759469228055
balances,6,1.791759469228055
sheath,6,1.791759469228055
CZ,6,1.791759469228055
brunt,6,1.791759469228055
tiny,6,1.791759469228055
drafting,6,1.791759469228055
self-quarantined,6,1.791759469228055
catalyze,6,1.791759469228055
ambroxol,6,1.791759469228055
ncRNAs,6,1.791759469228055
hindsight,6,1.791759469228055
transistor,6,1.791759469228055
field-effect,6,1.791759469228055
Purposes,6,1.791759469228055
upscaling,6,1.791759469228055
tonsils,6,1.791759469228055
boards,6,1.791759469228055
coated-platelet,6,1.791759469228055
inferior-posterior,6,1.791759469228055
microliter,6,1.791759469228055
witnesses,6,1.791759469228055
P0037,6,1.791759469228055
Compounds,6,1.791759469228055
Have,6,1.791759469228055
henceforth,6,1.791759469228055
azathioprine,6,1.791759469228055
floating-reference,6,1.791759469228055
intercalating,6,1.791759469228055
12-months,6,1.791759469228055
DLV,6,1.791759469228055
S-transferase,6,1.791759469228055
biomedicine,6,1.791759469228055
VLM,6,1.791759469228055
nNO,6,1.791759469228055
detector,6,1.791759469228055
PPCM,6,1.791759469228055
Digit,6,1.791759469228055
Span,6,1.791759469228055
left-,6,1.791759469228055
TWN,6,1.791759469228055
demarcated,6,1.791759469228055
herpesviruses,6,1.791759469228055
Release,6,1.791759469228055
cornea,6,1.791759469228055
sometime,6,1.791759469228055
Lymphocyte,6,1.791759469228055
antigen-independent,6,1.791759469228055
turkey,6,1.791759469228055
NtAb,6,1.791759469228055
régióban,6,1.791759469228055
cognitive-behavioral,6,1.791759469228055
1986-1987,6,1.791759469228055
Acinetobacter,6,1.791759469228055
granule,6,1.791759469228055
gender-based,6,1.791759469228055
e-mail,6,1.791759469228055
RIPerC,6,1.791759469228055
Subacute,6,1.791759469228055
biosynthetic,6,1.791759469228055
Pathophysiology,6,1.791759469228055
meg,6,1.791759469228055
UME,6,1.791759469228055
mycophenolate,6,1.791759469228055
crossroads,6,1.791759469228055
walked,6,1.791759469228055
constraint-induced,6,1.791759469228055
5-LO,6,1.791759469228055
F12,6,1.791759469228055
ulcerative,6,1.791759469228055
lysozyme,6,1.791759469228055
MI-patients,6,1.791759469228055
complimentary,6,1.791759469228055
Lithuania,6,1.791759469228055
camostat,6,1.791759469228055
mobilizing,6,1.791759469228055
flow-limiting,6,1.791759469228055
infection-dependent,6,1.791759469228055
hyaluronan,6,1.791759469228055
low-energy,6,1.791759469228055
clefts,6,1.791759469228055
Sons,6,1.791759469228055
Abciximab,6,1.791759469228055
Oxy,6,1.791759469228055
blue-collar,6,1.791759469228055
white-collar,6,1.791759469228055
sutures,6,1.791759469228055
desperately,6,1.791759469228055
banks,6,1.791759469228055
sink,6,1.791759469228055
advices,6,1.791759469228055
laceration,6,1.791759469228055
anion,6,1.791759469228055
directive,6,1.791759469228055
fertilizer,6,1.791759469228055
sponges,6,1.791759469228055
Phenotyping,6,1.791759469228055
deliberations,6,1.791759469228055
endeavours,6,1.791759469228055
Mab,6,1.791759469228055
canton,6,1.791759469228055
vertebrates,6,1.791759469228055
Ace2,6,1.791759469228055
choline,6,1.791759469228055
PD-,6,1.791759469228055
neurorestoration,6,1.791759469228055
Decreases,6,1.791759469228055
IAD,6,1.791759469228055
STEP,6,1.791759469228055
MRCA,6,1.791759469228055
disperse,6,1.791759469228055
Biol,6,1.791759469228055
reporters,6,1.791759469228055
DDF,6,1.791759469228055
LAs,6,1.791759469228055
httpwwwcdcgovflu,6,1.791759469228055
MCP,6,1.791759469228055
peduncle,6,1.791759469228055
CFC-free,6,1.791759469228055
NWC,6,1.791759469228055
CIC,6,1.791759469228055
SIGNIFICANCE,6,1.791759469228055
Amplification,6,1.791759469228055
genome-scale,6,1.791759469228055
leukemic,6,1.791759469228055
Tomographic,6,1.791759469228055
landscapes,6,1.791759469228055
domesticated,6,1.791759469228055
Kurume,6,1.791759469228055
Tokai,6,1.791759469228055
2013-2017,6,1.791759469228055
portrait,6,1.791759469228055
DWT,6,1.791759469228055
vignettes,6,1.791759469228055
CD68,6,1.791759469228055
Leukoaraiosis,6,1.791759469228055
Thematic,6,1.791759469228055
prebronchodilator,6,1.791759469228055
2070,6,1.791759469228055
microparticles,6,1.791759469228055
Commercially,6,1.791759469228055
-22,6,1.791759469228055
amplifications,6,1.791759469228055
eNose,6,1.791759469228055
micro-,6,1.791759469228055
overcame,6,1.791759469228055
Shock-STEMI,6,1.791759469228055
trip,6,1.791759469228055
intercontinental,6,1.791759469228055
psychiatrist,6,1.791759469228055
FSC,6,1.791759469228055
ATR-FTIR,6,1.791759469228055
Video,6,1.791759469228055
professionally,6,1.791759469228055
omnipresent,6,1.791759469228055
foregoing,6,1.791759469228055
CLOTS,6,1.791759469228055
touches,6,1.791759469228055
snake,6,1.791759469228055
Geographical,6,1.791759469228055
Precautions,6,1.791759469228055
plenary,6,1.791759469228055
post-transplant,6,1.791759469228055
Schofield,6,1.791759469228055
neutrophil-to-lymphocyte,6,1.791759469228055
Preparing,6,1.791759469228055
ASL,6,1.791759469228055
nihilism,6,1.791759469228055
17q21,6,1.791759469228055
non-optimal,6,1.791759469228055
SARS-CoVs,6,1.791759469228055
polysomnography,6,1.791759469228055
fumigatus,6,1.791759469228055
Liat,6,1.791759469228055
intensifies,6,1.791759469228055
Rab11,6,1.791759469228055
LIS,6,1.791759469228055
non-existent,6,1.791759469228055
1008,6,1.791759469228055
IL-15,6,1.791759469228055
seat,6,1.791759469228055
Nottingham,6,1.791759469228055
symbol,6,1.791759469228055
canines,6,1.791759469228055
DHCWs,6,1.791759469228055
Fbn,6,1.791759469228055
Neovastat,6,1.791759469228055
enteritis,6,1.791759469228055
Aosta,6,1.791759469228055
Commissioning,6,1.791759469228055
affirm,6,1.791759469228055
subtests,6,1.791759469228055
prognosing,6,1.791759469228055
Wechsler,6,1.791759469228055
DTS,6,1.791759469228055
Normalization,6,1.791759469228055
lectins,6,1.791759469228055
TJ,6,1.791759469228055
Vircell,6,1.791759469228055
phylum,6,1.791759469228055
adaptative,6,1.791759469228055
Mouse,6,1.791759469228055
resemblance,6,1.791759469228055
SQ-RAT,6,1.791759469228055
Outpatients,6,1.791759469228055
Emilia-Romagna,6,1.791759469228055
non-complicated,6,1.791759469228055
leaky,6,1.791759469228055
uninterpretable,6,1.791759469228055
venules,6,1.791759469228055
Norfolk,6,1.791759469228055
Kussmauls,6,1.791759469228055
absorbance,6,1.791759469228055
2D-ECHO,6,1.791759469228055
Vero-CCL81,6,1.791759469228055
Near-fatal,6,1.791759469228055
receiver-operating,6,1.791759469228055
BDR,6,1.791759469228055
hotels,6,1.791759469228055
RTIs,6,1.791759469228055
anecdotally,6,1.791759469228055
near-complete,6,1.791759469228055
P05,6,1.791759469228055
1128,6,1.791759469228055
exacerbation-prone,6,1.791759469228055
prion,6,1.791759469228055
streamlining,6,1.791759469228055
880,6,1.791759469228055
Bio,6,1.791759469228055
desirability,6,1.791759469228055
Curcumin,6,1.791759469228055
My,6,1.791759469228055
BZDR,6,1.791759469228055
wife,6,1.791759469228055
anti-SARS-COV-2,6,1.791759469228055
TGF-β,6,1.791759469228055
CCL,6,1.791759469228055
00008,6,1.791759469228055
multiparous,6,1.791759469228055
SARS-2-S,6,1.791759469228055
MESs,6,1.791759469228055
slit-based,6,1.791759469228055
perfusion-diffusion,6,1.791759469228055
HIV-associated,6,1.791759469228055
textbook,6,1.791759469228055
spurious,6,1.791759469228055
adiposity,6,1.791759469228055
NOS1,6,1.791759469228055
heat-inactivation,6,1.791759469228055
UOS,6,1.791759469228055
Weeks,6,1.791759469228055
Critically,6,1.791759469228055
60000,6,1.791759469228055
auscultatory,6,1.791759469228055
bACE2-Rm,6,1.791759469228055
4-10,6,1.791759469228055
BOP,6,1.791759469228055
laryngitis,6,1.791759469228055
A-H1N1,6,1.791759469228055
р,6,1.791759469228055
fellow,6,1.791759469228055
mini-mental,6,1.791759469228055
DDFPe,6,1.791759469228055
stigmatization,6,1.791759469228055
nCOV,6,1.791759469228055
Rh,6,1.791759469228055
constitution,6,1.791759469228055
Intercollegiate,6,1.791759469228055
1004,6,1.791759469228055
12-17,6,1.791759469228055
ROA,6,1.791759469228055
pro-resolving,6,1.791759469228055
sequalae,6,1.791759469228055
conservancy,6,1.791759469228055
waned,6,1.791759469228055
non-covalent,6,1.791759469228055
streptokinase-induced,6,1.791759469228055
standalone,6,1.791759469228055
VEDIS,6,1.791759469228055
LAIVs,6,1.791759469228055
9-12,6,1.791759469228055
full-scale,6,1.791759469228055
MS-based,6,1.791759469228055
obstruct,6,1.791759469228055
revolutionary,6,1.791759469228055
cultivated,6,1.791759469228055
broncho-obstruction,6,1.791759469228055
3D8,6,1.791759469228055
guarded,6,1.791759469228055
IPL,6,1.791759469228055
gradings,6,1.791759469228055
trimetazidine,6,1.791759469228055
Scarce,6,1.791759469228055
1005,6,1.791759469228055
HHS,6,1.791759469228055
1908,6,1.791759469228055
DOC,6,1.791759469228055
Ortho-Clinical,6,1.791759469228055
EMR,6,1.791759469228055
Documentation,6,1.791759469228055
micronutrient,6,1.791759469228055
probed,6,1.791759469228055
K417NT,6,1.791759469228055
Biologics,6,1.791759469228055
proprioception,6,1.791759469228055
dogma,6,1.791759469228055
prethrombolytic,6,1.791759469228055
Radial,6,1.791759469228055
rule-in,6,1.791759469228055
Responding,6,1.791759469228055
flock,6,1.791759469228055
P0024,6,1.791759469228055
Dynamics,6,1.791759469228055
3-h,6,1.791759469228055
atrio-ventricular,6,1.791759469228055
Aid,6,1.791759469228055
contra-indication,6,1.791759469228055
40-60,6,1.791759469228055
PLEX-ID,6,1.791759469228055
stasis-dissolving,6,1.791759469228055
autolysis,6,1.791759469228055
Qi,6,1.791759469228055
EUEEA,6,1.791759469228055
anti-HA,6,1.791759469228055
2008-09,6,1.791759469228055
PISA,6,1.791759469228055
exquisitely,6,1.791759469228055
kinesis,6,1.791759469228055
broadband,6,1.791759469228055
VSDs,6,1.791759469228055
Basing,6,1.791759469228055
cardiomyoplasty,6,1.791759469228055
bags,6,1.791759469228055
DETECTR,6,1.791759469228055
patient-physician,6,1.791759469228055
glimpse,6,1.791759469228055
aspecific,6,1.791759469228055
Amplatzer,6,1.791759469228055
platelet-rich,6,1.791759469228055
POCUS,6,1.791759469228055
IVIg,6,1.791759469228055
NxTAG,6,1.791759469228055
populace,6,1.791759469228055
thermocyclers,6,1.791759469228055
lectures,6,1.791759469228055
thoracocentesis,6,1.791759469228055
WMD,6,1.791759469228055
Question,6,1.791759469228055
Cairo,6,1.791759469228055
phagocyte,6,1.791759469228055
atheromas,6,1.791759469228055
JCM5805,6,1.791759469228055
legislators,6,1.791759469228055
2-year-old,6,1.791759469228055
thrombocytopaenia,6,1.791759469228055
NDDS,6,1.791759469228055
irritable,6,1.791759469228055
Valid,6,1.791759469228055
picking,6,1.791759469228055
time-activity,6,1.791759469228055
requisite,6,1.791759469228055
Loop,6,1.791759469228055
SMA,6,1.791759469228055
CVDs,6,1.791759469228055
SARS-coronavirus,6,1.791759469228055
risking,6,1.791759469228055
flexor,6,1.791759469228055
Ultraviolet,6,1.791759469228055
1260,6,1.791759469228055
CADILLAC,6,1.791759469228055
pollen-sensitive,6,1.791759469228055
Xiangya,6,1.791759469228055
anginous,6,1.791759469228055
balloons,6,1.791759469228055
e-cigarette,6,1.791759469228055
co-pathogens,6,1.791759469228055
Augsburg,6,1.791759469228055
veterinarian,6,1.791759469228055
propolis,6,1.791759469228055
Card,6,1.791759469228055
perseveration,6,1.791759469228055
kinin,6,1.791759469228055
CF-LVAD,6,1.791759469228055
vaso-occlusive,6,1.791759469228055
AAnhui12013,6,1.791759469228055
LRD,6,1.791759469228055
scepticism,6,1.791759469228055
0053,6,1.791759469228055
10-6,6,1.791759469228055
5-18,6,1.791759469228055
coronavirus2019-nCoV,6,1.791759469228055
UGC,6,1.791759469228055
DMD,6,1.791759469228055
20122013,6,1.791759469228055
Non-specific,6,1.791759469228055
Aspects,6,1.791759469228055
AspAT,6,1.791759469228055
Makkah,6,1.791759469228055
hijacks,6,1.791759469228055
jaw,6,1.791759469228055
CAI,6,1.791759469228055
HAPs,6,1.791759469228055
CHIS,6,1.791759469228055
corporation,6,1.791759469228055
lower-income,6,1.791759469228055
lysates,6,1.791759469228055
supernatants,6,1.791759469228055
prolapse,6,1.791759469228055
visitation,6,1.791759469228055
hypo-,6,1.791759469228055
Mozambique,6,1.791759469228055
1084,6,1.791759469228055
Madhya,6,1.791759469228055
radicular,6,1.791759469228055
Long-Term,6,1.791759469228055
portray,6,1.791759469228055
dose-sparing,6,1.791759469228055
10-16,6,1.791759469228055
hydroxyproline,6,1.791759469228055
cross-linking,6,1.791759469228055
DSRS,6,1.791759469228055
AIOD-CRISPR,6,1.791759469228055
embarked,6,1.791759469228055
leukocytic,6,1.791759469228055
proline,6,1.791759469228055
interleukin-2,6,1.791759469228055
facility-wide,6,1.791759469228055
Facilities,6,1.791759469228055
modernization,6,1.791759469228055
TLR78,6,1.791759469228055
re-detectable,6,1.791759469228055
singleplex,6,1.791759469228055
post-epidemic,6,1.791759469228055
redirected,6,1.791759469228055
prism,6,1.791759469228055
envelopes,6,1.791759469228055
self-treatment,6,1.791759469228055
FACS,6,1.791759469228055
Eggers,6,1.791759469228055
gene-based,6,1.791759469228055
11-12,6,1.791759469228055
MMGBSA,6,1.791759469228055
sub-clinical,6,1.791759469228055
base-line,6,1.791759469228055
Vit,6,1.791759469228055
toxoid,6,1.791759469228055
Ivanovsky,6,1.791759469228055
Incorrect,6,1.791759469228055
meningitidis,6,1.791759469228055
PERK,6,1.791759469228055
n28,6,1.791759469228055
Nutritional,6,1.791759469228055
splenium,6,1.791759469228055
remnants,6,1.791759469228055
1300,6,1.791759469228055
Bengal,6,1.791759469228055
WKYIzm,6,1.791759469228055
stressor,6,1.791759469228055
multiple-wave,6,1.791759469228055
AH5N8,6,1.791759469228055
Fletcher,6,1.791759469228055
ABrazil1178,6,1.791759469228055
NSP,6,1.791759469228055
cytokineschemokines,6,1.791759469228055
combustion,6,1.791759469228055
Mepolizumab,6,1.791759469228055
rADC,6,1.791759469228055
Postdischarge,6,1.791759469228055
bans,6,1.791759469228055
Angiographically,6,1.791759469228055
glucocorticosteroid,6,1.791759469228055
Coverage,6,1.791759469228055
NRC,6,1.791759469228055
establishments,6,1.791759469228055
heavier,6,1.791759469228055
AgPOCT,6,1.791759469228055
Peaks,6,1.791759469228055
Residential,6,1.791759469228055
Lysis,6,1.791759469228055
finalized,6,1.791759469228055
Classically,6,1.791759469228055
CPX,6,1.791759469228055
inaugural,6,1.791759469228055
pVNT,6,1.791759469228055
microchip,6,1.791759469228055
compressive,6,1.791759469228055
COE,6,1.791759469228055
meal,6,1.791759469228055
Infarctions,6,1.791759469228055
microchips,6,1.791759469228055
protruding,6,1.791759469228055
IABCP,6,1.791759469228055
high-yield,6,1.791759469228055
-035,6,1.791759469228055
Hyperacute,6,1.791759469228055
test-based,6,1.791759469228055
EID50,6,1.791759469228055
capnogram,6,1.791759469228055
cluster-randomized,6,1.791759469228055
2-14,6,1.791759469228055
glutathione-S-transferase,6,1.791759469228055
00013,6,1.791759469228055
ammonium,6,1.791759469228055
non-reactive,6,1.791759469228055
snakebite,6,1.791759469228055
anti-IAV,6,1.791759469228055
Titers,6,1.791759469228055
Yan,6,1.791759469228055
immunosensors,6,1.791759469228055
one-dose,6,1.791759469228055
substantiates,6,1.791759469228055
scarred,6,1.791759469228055
orphan,6,1.791759469228055
PHLS,6,1.791759469228055
Symptom-based,6,1.791759469228055
Ros,6,1.791759469228055
smoke-free,6,1.791759469228055
advection,6,1.791759469228055
phosphatidylserine,6,1.791759469228055
Minneapolis,6,1.791759469228055
plasmatic,6,1.791759469228055
cation,6,1.791759469228055
Familiarity,6,1.791759469228055
fifths,6,1.791759469228055
16-fold,6,1.791759469228055
CREG-ESC,6,1.791759469228055
IFV,6,1.791759469228055
midpoint,6,1.791759469228055
unpredictably,6,1.791759469228055
precardial,6,1.791759469228055
L-type,6,1.791759469228055
FVH-DWI,6,1.791759469228055
reinnervation,6,1.791759469228055
CTL-inducing,6,1.791759469228055
polyamines,6,1.791759469228055
non-negligible,6,1.791759469228055
Alone,6,1.791759469228055
tolerant,6,1.791759469228055
adsorbed,6,1.791759469228055
coalitions,6,1.791759469228055
EPI-2010,6,1.791759469228055
Afro-Caribbean,6,1.791759469228055
p05,6,1.791759469228055
Pathogen,6,1.791759469228055
flipping,6,1.791759469228055
unravelled,6,1.791759469228055
factories,6,1.791759469228055
candidacy,6,1.791759469228055
Jeddah,6,1.791759469228055
Phenotypic,6,1.791759469228055
presenceabsence,6,1.791759469228055
festival,6,1.791759469228055
founding,6,1.791759469228055
NWCA,6,1.791759469228055
Successive,6,1.791759469228055
Publications,6,1.791759469228055
LED,6,1.791759469228055
a2AP,6,1.791759469228055
pathogen-specific,6,1.791759469228055
Clot,6,1.791759469228055
Mold,6,1.791759469228055
re-establishment,6,1.791759469228055
colostrum,6,1.791759469228055
monolayer,6,1.791759469228055
Grande,6,1.791759469228055
Descriptions,6,1.791759469228055
invite,6,1.791759469228055
ductal,6,1.791759469228055
IRMA,6,1.791759469228055
travelled,6,1.791759469228055
Multiphasic,6,1.791759469228055
Problematic,6,1.791759469228055
pit,6,1.791759469228055
TTR,6,1.791759469228055
RCDM,6,1.791759469228055
harvesting,6,1.791759469228055
asymptotic,6,1.791759469228055
multilobar,6,1.791759469228055
incapacitated,6,1.791759469228055
SEEKING,6,1.791759469228055
BFstroke,6,1.791759469228055
23-year-old,6,1.791759469228055
anti-cancer,6,1.791759469228055
self-help,6,1.791759469228055
maze,6,1.791759469228055
VirusViz,6,1.791759469228055
Dissections,6,1.791759469228055
invalidity,6,1.791759469228055
OCSs,6,1.791759469228055
encountering,6,1.791759469228055
decisional,6,1.791759469228055
SPRG,6,1.791759469228055
hypoallergenic,6,1.791759469228055
entailed,6,1.791759469228055
Veterinary,6,1.791759469228055
0·0001,6,1.791759469228055
Fortitude,6,1.791759469228055
post-test,6,1.791759469228055
shipment,6,1.791759469228055
rewards,6,1.791759469228055
same-day,6,1.791759469228055
SacubitrilValsartan,6,1.791759469228055
β2-agonist,6,1.791759469228055
endorsement,6,1.791759469228055
second-trimester,6,1.791759469228055
psychologists,6,1.791759469228055
hyperactivation,6,1.791759469228055
firefighters,6,1.791759469228055
Col,6,1.791759469228055
cross-validated,6,1.791759469228055
liberated,6,1.791759469228055
Developments,6,1.791759469228055
LVF,6,1.791759469228055
e-Nose,6,1.791759469228055
coinfected,6,1.791759469228055
Haven,6,1.791759469228055
non-reperfused,6,1.791759469228055
prearrest,6,1.791759469228055
nodule,6,1.791759469228055
NEJM,6,1.791759469228055
∼30,6,1.791759469228055
science-based,6,1.791759469228055
75-80,6,1.791759469228055
Domain,6,1.791759469228055
Idaho,6,1.791759469228055
calcific,6,1.791759469228055
extraluminal,6,1.791759469228055
ATII,6,1.791759469228055
45-6h,6,1.791759469228055
Misdiagnosis,6,1.791759469228055
Equity,6,1.791759469228055
Wilson,6,1.791759469228055
quiescent,6,1.791759469228055
CCT,6,1.791759469228055
space-occupying,6,1.791759469228055
Anatomical,6,1.791759469228055
ephedrine,6,1.791759469228055
Satisfactory,6,1.791759469228055
intrapopulation,6,1.791759469228055
ITGV,6,1.791759469228055
Amidst,6,1.791759469228055
naso-esophageal,6,1.791759469228055
attracts,6,1.791759469228055
Early-life,6,1.791759469228055
monophasic,6,1.791759469228055
pinpointed,6,1.791759469228055
und,6,1.791759469228055
PUBMED,6,1.791759469228055
Sp,6,1.791759469228055
paraspinal,6,1.791759469228055
oxaloacetic,6,1.791759469228055
brackets,6,1.791759469228055
anchored,6,1.791759469228055
RNA-binding,6,1.791759469228055
CCH,6,1.791759469228055
tenet,6,1.791759469228055
Elucidating,6,1.791759469228055
equip,6,1.791759469228055
VFibCA,6,1.791759469228055
AngioJet,6,1.791759469228055
specializing,6,1.791759469228055
imagine,6,1.791759469228055
skiers,6,1.791759469228055
rapamycin,6,1.791759469228055
Consequences,6,1.791759469228055
financially,6,1.791759469228055
cellsµl,6,1.791759469228055
intercept,6,1.791759469228055
washed,6,1.791759469228055
earthquakes,6,1.791759469228055
Echocardiograms,6,1.791759469228055
radiopharmaceutical,6,1.791759469228055
repatriation,6,1.791759469228055
Classifying,6,1.791759469228055
1994-1995,6,1.791759469228055
ODD,6,1.791759469228055
COP,6,1.791759469228055
trending,6,1.791759469228055
Immunoassay,6,1.791759469228055
DTA,6,1.791759469228055
hypodense,6,1.791759469228055
color-coded,6,1.791759469228055
eluting,6,1.791759469228055
Cardil,6,1.791759469228055
nucleoside-modified,6,1.791759469228055
BL,6,1.791759469228055
extended-release,6,1.791759469228055
CARD,6,1.791759469228055
1141,6,1.791759469228055
quota,6,1.791759469228055
Infusion,6,1.791759469228055
telomere,6,1.791759469228055
defibrillators,6,1.791759469228055
consortia,6,1.791759469228055
FEVI,6,1.791759469228055
burnout,6,1.791759469228055
county-level,6,1.791759469228055
larger-scale,6,1.791759469228055
vectorial,6,1.791759469228055
Iron,6,1.791759469228055
CPF,6,1.791759469228055
Measured,6,1.791759469228055
postprandial,6,1.791759469228055
gelatin,6,1.791759469228055
C0C1f,6,1.791759469228055
iqr,6,1.791759469228055
di-isocyanate,6,1.791759469228055
Conclusively,6,1.791759469228055
drug-delivery,6,1.791759469228055
C5a,6,1.791759469228055
bread,6,1.791759469228055
deltoid,6,1.791759469228055
Gd-DTPA,6,1.791759469228055
CT-P59,6,1.791759469228055
GER-related,6,1.791759469228055
-27,6,1.791759469228055
sectioned,6,1.791759469228055
nitroblue,6,1.791759469228055
stoves,6,1.791759469228055
husbandry,6,1.791759469228055
motility,6,1.791759469228055
transcriptomes,6,1.791759469228055
surpass,6,1.791759469228055
acidification,6,1.791759469228055
internalized,6,1.791759469228055
X-Ray,6,1.791759469228055
CTs,6,1.791759469228055
mSOAR,6,1.791759469228055
venography,6,1.791759469228055
Iraq,6,1.791759469228055
trialled,6,1.791759469228055
postpone,6,1.791759469228055
chromium,6,1.791759469228055
PHS,6,1.791759469228055
squares,6,1.791759469228055
Optimized,6,1.791759469228055
CART,6,1.791759469228055
islanders,6,1.791759469228055
arguing,6,1.791759469228055
theses,6,1.791759469228055
rough,6,1.791759469228055
1-9,6,1.791759469228055
sword,6,1.791759469228055
phosphatidylinositol,6,1.791759469228055
retrospect,6,1.791759469228055
Turbuhaler,6,1.791759469228055
Seeking,6,1.791759469228055
Fortaleza,6,1.791759469228055
SCI,6,1.791759469228055
re-tested,6,1.791759469228055
anhydride,6,1.791759469228055
Permanente,6,1.791759469228055
Thorax,6,1.791759469228055
midline,6,1.791759469228055
Reed,6,1.791759469228055
Antarctica,6,1.791759469228055
Na,6,1.791759469228055
BEC,6,1.791759469228055
Saxony,6,1.791759469228055
union,6,1.791759469228055
interleukin-13,6,1.791759469228055
antigen-detecting,6,1.791759469228055
LAVI,6,1.791759469228055
irritative,6,1.791759469228055
summation,6,1.791759469228055
frequentist,6,1.791759469228055
Ibadan,6,1.791759469228055
≤50,6,1.791759469228055
He-Ne,6,1.791759469228055
ab1,6,1.791759469228055
NCSE,6,1.791759469228055
Planned,6,1.791759469228055
misunderstanding,6,1.791759469228055
Defence,6,1.791759469228055
lone,6,1.791759469228055
microbiologically,6,1.791759469228055
transplantations,6,1.791759469228055
cuts,6,1.791759469228055
Hunter,6,1.791759469228055
berberine,6,1.791759469228055
AHF,6,1.791759469228055
hyperpnea,6,1.791759469228055
RFS,6,1.791759469228055
inoculations,6,1.791759469228055
Massive,6,1.791759469228055
office-based,6,1.791759469228055
1035,6,1.791759469228055
MERS‐CoV,6,1.791759469228055
porous,6,1.791759469228055
SEC,6,1.791759469228055
COVID-19-RdRpHel,6,1.791759469228055
ICG,6,1.791759469228055
hASCs,6,1.791759469228055
plagued,6,1.791759469228055
risk-reduction,6,1.791759469228055
well-organized,6,1.791759469228055
polyester,6,1.791759469228055
antiaggregation,6,1.791759469228055
galectins,6,1.791759469228055
IAV-S,6,1.791759469228055
neglects,6,1.791759469228055
concur,6,1.791759469228055
3-12,6,1.791759469228055
noncardiovascular,6,1.791759469228055
Caledonia2099-like,6,1.791759469228055
2-12,6,1.791759469228055
pad,6,1.791759469228055
1215-LOX,6,1.791759469228055
MBPT,6,1.791759469228055
legitimacy,6,1.791759469228055
policy-making,6,1.791759469228055
FXIII-A,6,1.791759469228055
Rochester,6,1.791759469228055
violent,6,1.791759469228055
moderate-,6,1.791759469228055
juncture,6,1.791759469228055
printing,6,1.791759469228055
reformulation,6,1.791759469228055
glyceryl,6,1.791759469228055
Advantages,6,1.791759469228055
innumerable,6,1.791759469228055
dysgraphia,6,1.791759469228055
thiobarbituric,6,1.791759469228055
oliguria,6,1.791759469228055
co-occur,6,1.791759469228055
UN,6,1.791759469228055
worrisome,6,1.791759469228055
nonallergenic,6,1.791759469228055
infamous,6,1.791759469228055
lactate-dehydrogenase,6,1.791759469228055
THC-MIST,6,1.791759469228055
device-related,6,1.791759469228055
G6PD,6,1.791759469228055
Revascularisation,6,1.791759469228055
eminent,6,1.791759469228055
PACQLQ,6,1.791759469228055
wells,6,1.791759469228055
EXTEND,6,1.791759469228055
apt,6,1.791759469228055
brands,6,1.791759469228055
rigidity,6,1.791759469228055
Maharashtra,6,1.791759469228055
microcomputer,6,1.791759469228055
epigastric,6,1.791759469228055
β-coronaviruses,6,1.791759469228055
heading,6,1.791759469228055
eventuality,6,1.791759469228055
underweight,6,1.791759469228055
synthetase,6,1.791759469228055
Ktrans,6,1.791759469228055
chromatography-mass,6,1.791759469228055
nontoxic,6,1.791759469228055
VIP,6,1.791759469228055
Stenosis,6,1.791759469228055
accumulates,6,1.791759469228055
worksite,6,1.791759469228055
Prescription,6,1.791759469228055
conundrum,6,1.791759469228055
IPCs,6,1.791759469228055
dissociated,6,1.791759469228055
sIgA,6,1.791759469228055
alizarin,6,1.791759469228055
soils,6,1.791759469228055
OI,6,1.791759469228055
catalogued,6,1.791759469228055
anti-leukotrienes,6,1.791759469228055
quenched,6,1.791759469228055
NCA,6,1.791759469228055
spit,6,1.791759469228055
hemispace,6,1.791759469228055
Supporting,6,1.791759469228055
Sex-specific,6,1.791759469228055
Liat®,6,1.791759469228055
Kobe,6,1.791759469228055
Malawi,6,1.791759469228055
step-by-step,6,1.791759469228055
ORL,6,1.791759469228055
purposeful,6,1.791759469228055
bradyarrhythmia,6,1.791759469228055
Probability,6,1.791759469228055
AQLQ-S,6,1.791759469228055
SOV,6,1.791759469228055
Nanomaterials,6,1.791759469228055
FFRs,6,1.791759469228055
circles,6,1.791759469228055
IHME,6,1.791759469228055
antidoping,6,1.791759469228055
CSPPC,6,1.791759469228055
bronchovascular,6,1.791759469228055
DIPs,6,1.791759469228055
multistage,6,1.791759469228055
moist,6,1.791759469228055
ITB,6,1.791759469228055
Mongolian,6,1.791759469228055
Long-standing,6,1.791759469228055
disinformation,6,1.791759469228055
invented,6,1.791759469228055
sIL-6R,6,1.791759469228055
vacuum,6,1.791759469228055
equatorial,6,1.791759469228055
IGF-1,6,1.791759469228055
unfold,6,1.791759469228055
decontaminate,6,1.791759469228055
masquerade,6,1.791759469228055
Paidu,6,1.791759469228055
crown,6,1.791759469228055
Trail,6,1.791759469228055
post-contrast,6,1.791759469228055
Arabs,6,1.791759469228055
telangiectasia,6,1.791759469228055
boroughs,6,1.791759469228055
IPH,6,1.791759469228055
Category,6,1.791759469228055
RICU,6,1.791759469228055
BTT,6,1.791759469228055
Peptide,6,1.791759469228055
synchronization,6,1.791759469228055
acetylcholinesterase,6,1.791759469228055
second-hand,6,1.791759469228055
ageism,6,1.791759469228055
speaks,6,1.791759469228055
799,6,1.791759469228055
fortnight,6,1.791759469228055
benchmarking,6,1.791759469228055
glycated,6,1.791759469228055
publicized,6,1.791759469228055
astemizole,6,1.791759469228055
restrained,6,1.791759469228055
executing,6,1.791759469228055
10-25,6,1.791759469228055
lisinopril,6,1.791759469228055
20-59,6,1.791759469228055
egg-allergic,6,1.791759469228055
refugees,6,1.791759469228055
MAPKs,6,1.791759469228055
pharmacy-based,6,1.791759469228055
1313,6,1.791759469228055
Geometric,6,1.791759469228055
forums,6,1.791759469228055
miR‑125a,6,1.791759469228055
50-75,6,1.791759469228055
religiosity,6,1.791759469228055
NBP,6,1.791759469228055
outgrowth,6,1.791759469228055
Series,6,1.791759469228055
Ang-1-7,6,1.791759469228055
T1D,6,1.791759469228055
Aichi,6,1.791759469228055
cytopathogenic,6,1.791759469228055
im,6,1.791759469228055
time-critical,6,1.791759469228055
childbirth,6,1.791759469228055
PAV,6,1.791759469228055
CysLTs,6,1.791759469228055
severer,6,1.791759469228055
ASS,6,1.791759469228055
sub-sample,6,1.791759469228055
Seeplex,6,1.791759469228055
institutionalised,6,1.791759469228055
preintervention,6,1.791759469228055
RIA,6,1.791759469228055
peace,6,1.791759469228055
IHR,6,1.791759469228055
freshmen,6,1.791759469228055
scintigraphically,6,1.791759469228055
Grant,6,1.791759469228055
additions,6,1.791759469228055
neuropsychology,6,1.791759469228055
target-specific,6,1.791759469228055
diagnostic-therapeutic,6,1.791759469228055
virus-based,6,1.791759469228055
Enrichment,6,1.791759469228055
non-vaccine,6,1.791759469228055
lignocaine,6,1.791759469228055
counterbalanced,6,1.791759469228055
Seafood,6,1.791759469228055
HIF-1,6,1.791759469228055
submitting,6,1.791759469228055
LC-MSMS,6,1.791759469228055
869,6,1.791759469228055
sending,6,1.791759469228055
Olympics,6,1.791759469228055
DNIC-GS,6,1.791759469228055
characterising,6,1.791759469228055
1415,6,1.791759469228055
overactivation,6,1.791759469228055
Operative,6,1.791759469228055
homogenization,6,1.791759469228055
scFv,6,1.791759469228055
Healths,6,1.791759469228055
instigating,6,1.791759469228055
electromyogram,6,1.791759469228055
formulas,6,1.791759469228055
fascinating,6,1.791759469228055
coexists,6,1.791759469228055
wonder,6,1.791759469228055
stump,6,1.791759469228055
Gated,6,1.791759469228055
toxicologic,6,1.791759469228055
ADR,6,1.791759469228055
AMCase,6,1.791759469228055
wheelchair,6,1.791759469228055
unevenly,6,1.791759469228055
Subcutaneous,6,1.791759469228055
cath-lab,6,1.791759469228055
Prp18,6,1.791759469228055
problem-focused,6,1.791759469228055
µm,6,1.791759469228055
Pivotal,6,1.791759469228055
1968-69,6,1.791759469228055
pMI,6,1.791759469228055
shipped,6,1.791759469228055
virus-cell,6,1.791759469228055
bars,6,1.791759469228055
phobia,6,1.791759469228055
B11248,6,1.791759469228055
Adjuvant,6,1.791759469228055
dermatological,6,1.791759469228055
transrepression,6,1.791759469228055
EK1,6,1.791759469228055
ERS,6,1.791759469228055
Enoxaparin,6,1.791759469228055
tedious,6,1.791759469228055
viral-bacterial,6,1.791759469228055
overexpressing,6,1.791759469228055
interferences,6,1.791759469228055
epileptiform,6,1.791759469228055
Qingfei,6,1.791759469228055
KAESP,6,1.791759469228055
repolarisation,6,1.791759469228055
Thirdly,6,1.791759469228055
Dakar,6,1.791759469228055
super-infection,6,1.791759469228055
V9,6,1.791759469228055
V7,6,1.791759469228055
IoMT,6,1.791759469228055
Radiologists,6,1.791759469228055
sticking,6,1.791759469228055
paper-and-pencil,6,1.791759469228055
imports,6,1.791759469228055
neuroticism,6,1.791759469228055
Culprit,6,1.791759469228055
host-related,6,1.791759469228055
DASH,6,1.791759469228055
sero-surveillance,6,1.791759469228055
galvanization,6,1.791759469228055
COX2,6,1.791759469228055
rollouts,6,1.791759469228055
re-emergent,6,1.791759469228055
Neutrophilic,6,1.791759469228055
Latex,6,1.791759469228055
immunocompetence,6,1.791759469228055
Multilevel,6,1.791759469228055
graphics,6,1.791759469228055
arbitrarily,6,1.791759469228055
Certified,6,1.791759469228055
GPIAG,6,1.791759469228055
RRT,6,1.791759469228055
immunogenetic,6,1.791759469228055
affiliation,6,1.791759469228055
effluents,6,1.791759469228055
EGF,6,1.791759469228055
tetanus,6,1.791759469228055
self-assembling,6,1.791759469228055
LVED,6,1.791759469228055
Emission,6,1.791759469228055
whichever,6,1.791759469228055
myth,6,1.791759469228055
auto-PEEP,6,1.791759469228055
MAPE,6,1.791759469228055
cloacal,6,1.791759469228055
glandular,6,1.791759469228055
immunoprecipitation,6,1.791759469228055
SPIO,6,1.791759469228055
Sigma,6,1.791759469228055
Campania,6,1.791759469228055
myoepithelioma,6,1.791759469228055
phones,6,1.791759469228055
copiesL,6,1.791759469228055
upto,6,1.791759469228055
WW,6,1.791759469228055
contracture,6,1.791759469228055
mixed-effects,6,1.791759469228055
Relaxation,6,1.791759469228055
paradoxes,6,1.791759469228055
recess,6,1.791759469228055
commodities,6,1.791759469228055
L-arginine,6,1.791759469228055
bone-marrow-derived,6,1.791759469228055
bubbles,6,1.791759469228055
breastmilk,6,1.791759469228055
Src,6,1.791759469228055
Turin,6,1.791759469228055
INFVA,6,1.791759469228055
duplicates,6,1.791759469228055
IAs,6,1.791759469228055
allergology,6,1.791759469228055
AVN,6,1.791759469228055
granulosus,6,1.791759469228055
miR-149,6,1.791759469228055
enjoyed,6,1.791759469228055
arduous,6,1.791759469228055
TrueNat,6,1.791759469228055
mastery,6,1.791759469228055
Asthmaticus,6,1.791759469228055
miR-146a,6,1.791759469228055
mysterious,6,1.791759469228055
12-13,6,1.791759469228055
maximized,6,1.791759469228055
Rituximab,6,1.791759469228055
Abstracts,6,1.791759469228055
freeze-thaw,6,1.791759469228055
wide-spread,6,1.791759469228055
≥21,6,1.791759469228055
pyogenic,6,1.791759469228055
SHS,6,1.791759469228055
collision,6,1.791759469228055
plantar,6,1.791759469228055
budgets,6,1.791759469228055
Publication,6,1.791759469228055
twenty-two,6,1.791759469228055
organizers,6,1.791759469228055
phagocytes,6,1.791759469228055
LAmax,6,1.791759469228055
top-down,6,1.791759469228055
semi-closed,6,1.791759469228055
Leading,6,1.791759469228055
immunising,6,1.791759469228055
MCSA,6,1.791759469228055
Reviewing,6,1.791759469228055
Presented,6,1.791759469228055
Initiatives,6,1.791759469228055
Racialethnic,6,1.791759469228055
Recipients,6,1.791759469228055
potentialities,6,1.791759469228055
co-administration,6,1.791759469228055
Trigger,6,1.791759469228055
Canine,6,1.791759469228055
CMCT,6,1.791759469228055
coarctation,6,1.791759469228055
disease-associated,6,1.791759469228055
virus-,6,1.791759469228055
EIPH,6,1.791759469228055
off-target,6,1.791759469228055
IABPA,6,1.791759469228055
≤7,6,1.791759469228055
Candidate,6,1.791759469228055
20-HETE,6,1.791759469228055
15000,6,1.791759469228055
falciparum,6,1.791759469228055
epilepsies,6,1.791759469228055
PTCRPTCA,6,1.791759469228055
pockets,6,1.791759469228055
raced,6,1.791759469228055
hoping,6,1.791759469228055
Bordeaux,6,1.791759469228055
2-ClHDA,6,1.791759469228055
VIDAS,6,1.791759469228055
specialities,6,1.791759469228055
frontoparietal,6,1.791759469228055
Michael,6,1.791759469228055
NMT,6,1.791759469228055
spline,6,1.791759469228055
organ-specific,6,1.791759469228055
IgMIgA,6,1.791759469228055
inaccuracies,6,1.791759469228055
post-inoculation,6,1.791759469228055
substantiation,6,1.791759469228055
exon,6,1.791759469228055
probing,6,1.791759469228055
P681H,6,1.791759469228055
retest,6,1.791759469228055
Jilin,6,1.791759469228055
melioidosis,6,1.791759469228055
hepatocyte,6,1.791759469228055
Janus,6,1.791759469228055
palladium,6,1.791759469228055
powdered,6,1.791759469228055
WHI,6,1.791759469228055
coumarin,6,1.791759469228055
TUG,6,1.791759469228055
PRS,6,1.791759469228055
MMIA,6,1.791759469228055
ill-health,6,1.791759469228055
regressive,6,1.791759469228055
Vector,6,1.791759469228055
auricle,6,1.791759469228055
bubble,6,1.791759469228055
870,6,1.791759469228055
Bronchodilators,6,1.791759469228055
incompatible,6,1.791759469228055
oligodendrocytes,6,1.791759469228055
cleave,6,1.791759469228055
hyperemic,6,1.791759469228055
NAT2,6,1.791759469228055
ATP-sensitive,6,1.791759469228055
Mississippi,6,1.791759469228055
hyperplastic,6,1.791759469228055
noncommunicable,6,1.791759469228055
dressing,6,1.791759469228055
non-availability,6,1.791759469228055
Roughly,6,1.791759469228055
Meta-regression,6,1.791759469228055
SIAS,6,1.791759469228055
laparotomy,6,1.791759469228055
IRF,6,1.791759469228055
Bronchodilator,6,1.791759469228055
anticipatory,6,1.791759469228055
Deterioration,6,1.791759469228055
integrin,6,1.791759469228055
Antiarrhythmic,6,1.791759469228055
c-fos,6,1.791759469228055
glycaemia,6,1.791759469228055
BWST,6,1.791759469228055
samba,6,1.791759469228055
end-of-life,6,1.791759469228055
Fifth,6,1.791759469228055
DexAide,6,1.791759469228055
1989-1990,6,1.791759469228055
Contrast-enhanced,6,1.791759469228055
ciclesonide,6,1.791759469228055
Bradykinin,6,1.791759469228055
Karvonens,6,1.791759469228055
AuNPs,6,1.791759469228055
implements,6,1.791759469228055
PPN,6,1.791759469228055
ADSC,6,1.791759469228055
Objectiveshypothesis,6,1.791759469228055
annualized,6,1.791759469228055
summing,6,1.791759469228055
school-closure,6,1.791759469228055
Herpes,6,1.791759469228055
harmonize,6,1.791759469228055
craniocervical,6,1.791759469228055
gyrencephalic,6,1.791759469228055
allergy-related,6,1.791759469228055
resourced,6,1.791759469228055
24000,6,1.791759469228055
Methodology,6,1.791759469228055
Check,6,1.791759469228055
specifics,6,1.791759469228055
veno-venous,6,1.791759469228055
single-arm,6,1.791759469228055
Aberrant,6,1.791759469228055
stagnation,6,1.791759469228055
ULN,6,1.791759469228055
avascular,6,1.791759469228055
dislodged,6,1.791759469228055
inclusivity,6,1.791759469228055
adhesiveness,6,1.791759469228055
citys,6,1.791759469228055
carboxyhemoglobin,6,1.791759469228055
1000-fold,6,1.791759469228055
Brittle,6,1.791759469228055
13NH3,6,1.791759469228055
ALIARDS,6,1.791759469228055
4-weekly,6,1.791759469228055
ICAD,6,1.791759469228055
Cuban,6,1.791759469228055
time-period,6,1.791759469228055
VEM,6,1.791759469228055
April-May,6,1.791759469228055
MCDM,6,1.791759469228055
9-11,6,1.791759469228055
RQ,6,1.791759469228055
enolase,6,1.791759469228055
neuron-specific,6,1.791759469228055
extra-cardiac,6,1.791759469228055
microbubbles,6,1.791759469228055
identities,6,1.791759469228055
yang,6,1.791759469228055
leap,6,1.791759469228055
homeopathic,6,1.791759469228055
Antwerp,6,1.791759469228055
antispike,6,1.791759469228055
AHEI-2010,6,1.791759469228055
CABS,6,1.791759469228055
random-effect,6,1.791759469228055
FRPs,6,1.791759469228055
pre-requisite,6,1.791759469228055
mega,6,1.791759469228055
Inspiratory,6,1.791759469228055
Low-income,6,1.791759469228055
Q-QS,6,1.791759469228055
cardiotoxicity,6,1.791759469228055
Post-infarction,6,1.791759469228055
Apulia,6,1.791759469228055
cmH2O,6,1.791759469228055
UDA,6,1.791759469228055
onsite,6,1.791759469228055
6-59,6,1.791759469228055
Cardiologists,6,1.791759469228055
Hormone,6,1.791759469228055
accelerometer,6,1.791759469228055
VBM,6,1.791759469228055
TSTEMI,6,1.791759469228055
Triple,6,1.791759469228055
dispute,6,1.791759469228055
bruising,6,1.791759469228055
helmet,6,1.791759469228055
Scott,6,1.791759469228055
HBR,6,1.791759469228055
antigen-binding,6,1.791759469228055
HTR,6,1.791759469228055
Lu,6,1.791759469228055
splitting,6,1.791759469228055
slurred,6,1.791759469228055
Venezuela,6,1.791759469228055
HUS,6,1.791759469228055
proceedings,6,1.791759469228055
EWI,6,1.791759469228055
Priorities,6,1.791759469228055
Middle-East,6,1.791759469228055
IDA,6,1.791759469228055
primary-care,6,1.791759469228055
fixed-axis,6,1.791759469228055
1992-93,6,1.791759469228055
dislike,6,1.791759469228055
everywhere,6,1.791759469228055
Newborns,6,1.791759469228055
lions,6,1.791759469228055
adenoidectomy,6,1.791759469228055
deltaFEV1year,6,1.791759469228055
Asian-Indian,6,1.791759469228055
Gothenburg,6,1.791759469228055
single-gene,6,1.791759469228055
banking,6,1.791759469228055
dexterity,6,1.791759469228055
Foreign,6,1.791759469228055
untested,6,1.791759469228055
Impedance,6,1.791759469228055
robotics,6,1.791759469228055
V7R,6,1.791759469228055
isovolumic,6,1.791759469228055
Employees,6,1.791759469228055
BCL2L2,6,1.791759469228055
Brixton,6,1.791759469228055
sees,6,1.791759469228055
postbypass,6,1.791759469228055
STRE,6,1.791759469228055
Bird,6,1.791759469228055
dialyzed,6,1.791759469228055
WGA,6,1.791759469228055
coronary-artery,6,1.791759469228055
Dubai,6,1.791759469228055
WASH,6,1.791759469228055
70-79,6,1.791759469228055
Q677H,6,1.791759469228055
3200,6,1.791759469228055
saRNA,6,1.791759469228055
pangolin-CoV,6,1.791759469228055
Australasia,6,1.791759469228055
deter,6,1.791759469228055
3-9,6,1.791759469228055
biocompatibility,6,1.791759469228055
PLAATO,6,1.791759469228055
Exact,6,1.791759469228055
LEAD,6,1.791759469228055
Establishment,6,1.791759469228055
0·05,6,1.791759469228055
LVWMA,5,1.6094379124341003
non-affected,5,1.6094379124341003
NDDCT,5,1.6094379124341003
Todays,5,1.6094379124341003
initiators,5,1.6094379124341003
machine-learning,5,1.6094379124341003
focusses,5,1.6094379124341003
accesses,5,1.6094379124341003
aversion,5,1.6094379124341003
pretransplant,5,1.6094379124341003
K562-S,5,1.6094379124341003
cryopreserved,5,1.6094379124341003
YAP,5,1.6094379124341003
curation,5,1.6094379124341003
SO,5,1.6094379124341003
ICPs,5,1.6094379124341003
0001ABSTRACT,5,1.6094379124341003
February-April,5,1.6094379124341003
SiNW,5,1.6094379124341003
cavitation,5,1.6094379124341003
subsidy,5,1.6094379124341003
0-15,5,1.6094379124341003
Provocation,5,1.6094379124341003
Ω-3,5,1.6094379124341003
licorice,5,1.6094379124341003
condensation,5,1.6094379124341003
εa,5,1.6094379124341003
RGO,5,1.6094379124341003
Highland,5,1.6094379124341003
inflicted,5,1.6094379124341003
uni-,5,1.6094379124341003
Virus-CKB,5,1.6094379124341003
Milwaukee,5,1.6094379124341003
48th,5,1.6094379124341003
1930,5,1.6094379124341003
necrotization,5,1.6094379124341003
Square,5,1.6094379124341003
2019-nCoVrecurrentgroup,5,1.6094379124341003
Pfeiffers,5,1.6094379124341003
swollen,5,1.6094379124341003
Self-report,5,1.6094379124341003
penicillin,5,1.6094379124341003
Analyze,5,1.6094379124341003
Guatemala,5,1.6094379124341003
collation,5,1.6094379124341003
stickiness,5,1.6094379124341003
prohibitively,5,1.6094379124341003
lipidomic,5,1.6094379124341003
6-h,5,1.6094379124341003
reply,5,1.6094379124341003
1042,5,1.6094379124341003
Panic-Fear,5,1.6094379124341003
1436,5,1.6094379124341003
Heterogeneous,5,1.6094379124341003
auricular,5,1.6094379124341003
1276,5,1.6094379124341003
debilitated,5,1.6094379124341003
sorption,5,1.6094379124341003
REGN10933,5,1.6094379124341003
Professionals,5,1.6094379124341003
tinnitus,5,1.6094379124341003
AGEP,5,1.6094379124341003
susceptibility-weighted,5,1.6094379124341003
Sea,5,1.6094379124341003
HCLs,5,1.6094379124341003
CAVB,5,1.6094379124341003
AHL,5,1.6094379124341003
gearing,5,1.6094379124341003
W6,5,1.6094379124341003
NMI,5,1.6094379124341003
cocirculation,5,1.6094379124341003
buffered,5,1.6094379124341003
cloprednol,5,1.6094379124341003
buy,5,1.6094379124341003
Psychologic,5,1.6094379124341003
revive,5,1.6094379124341003
dyssynchrony,5,1.6094379124341003
CAL20C,5,1.6094379124341003
groin,5,1.6094379124341003
poster,5,1.6094379124341003
dichotomy,5,1.6094379124341003
globalized,5,1.6094379124341003
Lacking,5,1.6094379124341003
ISIS-2,5,1.6094379124341003
analyte,5,1.6094379124341003
1939,5,1.6094379124341003
revelation,5,1.6094379124341003
NAD,5,1.6094379124341003
present-day,5,1.6094379124341003
ATG7,5,1.6094379124341003
MZ,5,1.6094379124341003
Talpha1,5,1.6094379124341003
scenes,5,1.6094379124341003
monomeric,5,1.6094379124341003
1070,5,1.6094379124341003
Smaller,5,1.6094379124341003
Choosing,5,1.6094379124341003
2012-2014,5,1.6094379124341003
between-group,5,1.6094379124341003
Turku,5,1.6094379124341003
infiltrative,5,1.6094379124341003
4500,5,1.6094379124341003
remodeled,5,1.6094379124341003
HIMM,5,1.6094379124341003
ECL,5,1.6094379124341003
Chutse,5,1.6094379124341003
caveat,5,1.6094379124341003
dispersing,5,1.6094379124341003
hypertrophied,5,1.6094379124341003
Ninety-seven,5,1.6094379124341003
pioglitazone,5,1.6094379124341003
Postconditioning,5,1.6094379124341003
evenings,5,1.6094379124341003
Ad26-based,5,1.6094379124341003
Contamination,5,1.6094379124341003
conveniently,5,1.6094379124341003
MOH,5,1.6094379124341003
asthmaMethods,5,1.6094379124341003
photothrombosis,5,1.6094379124341003
paraffin,5,1.6094379124341003
bioelectrical,5,1.6094379124341003
shocked,5,1.6094379124341003
HSPCs,5,1.6094379124341003
HOCl,5,1.6094379124341003
E1,5,1.6094379124341003
gene-sets,5,1.6094379124341003
spore,5,1.6094379124341003
Amiodarone,5,1.6094379124341003
zero-vessel,5,1.6094379124341003
1937,5,1.6094379124341003
lentivirus,5,1.6094379124341003
ODI,5,1.6094379124341003
gallisepticum,5,1.6094379124341003
15-19,5,1.6094379124341003
CMIRLV,5,1.6094379124341003
rail,5,1.6094379124341003
SIS,5,1.6094379124341003
SWiTCH,5,1.6094379124341003
Emirate,5,1.6094379124341003
edaravone,5,1.6094379124341003
steroid-sensitive,5,1.6094379124341003
Extended,5,1.6094379124341003
backup,5,1.6094379124341003
SUVmax,5,1.6094379124341003
miR-451a,5,1.6094379124341003
diphosphate,5,1.6094379124341003
unmarried,5,1.6094379124341003
Arkansas,5,1.6094379124341003
rt-pa,5,1.6094379124341003
demographical,5,1.6094379124341003
QC,5,1.6094379124341003
pyrin,5,1.6094379124341003
breeder,5,1.6094379124341003
Chemotherapy,5,1.6094379124341003
Alegre,5,1.6094379124341003
androgen,5,1.6094379124341003
ameliorative,5,1.6094379124341003
Christchurch,5,1.6094379124341003
BAME,5,1.6094379124341003
Decrease,5,1.6094379124341003
mesenchyme,5,1.6094379124341003
Expectations,5,1.6094379124341003
tranquilizers,5,1.6094379124341003
loosely,5,1.6094379124341003
thicknesses,5,1.6094379124341003
sanitizing,5,1.6094379124341003
crazy,5,1.6094379124341003
Monovalent,5,1.6094379124341003
eighty-four,5,1.6094379124341003
2006-07,5,1.6094379124341003
Hirulog,5,1.6094379124341003
Nontransmural,5,1.6094379124341003
May-July,5,1.6094379124341003
veloergometric,5,1.6094379124341003
C-X-C,5,1.6094379124341003
RBD-ferritin,5,1.6094379124341003
1993-1994,5,1.6094379124341003
post-onset,5,1.6094379124341003
co-operation,5,1.6094379124341003
backdrop,5,1.6094379124341003
2010-2013,5,1.6094379124341003
ISGs,5,1.6094379124341003
Kyushu-Okinawa,5,1.6094379124341003
simplistic,5,1.6094379124341003
CCR5,5,1.6094379124341003
Site,5,1.6094379124341003
DDSP,5,1.6094379124341003
Extra,5,1.6094379124341003
T2-MI,5,1.6094379124341003
cigars,5,1.6094379124341003
Visits,5,1.6094379124341003
transaminases,5,1.6094379124341003
banknotes,5,1.6094379124341003
speculates,5,1.6094379124341003
scare,5,1.6094379124341003
post-processing,5,1.6094379124341003
KP,5,1.6094379124341003
Anecdotal,5,1.6094379124341003
ORF1b,5,1.6094379124341003
Exploratory,5,1.6094379124341003
Hutt,5,1.6094379124341003
0-18,5,1.6094379124341003
16-year,5,1.6094379124341003
aberrations,5,1.6094379124341003
0400,5,1.6094379124341003
Co-infections,5,1.6094379124341003
JMI,5,1.6094379124341003
turn-around-time,5,1.6094379124341003
IVI,5,1.6094379124341003
burgeoning,5,1.6094379124341003
non-MVO,5,1.6094379124341003
waveforms,5,1.6094379124341003
wage,5,1.6094379124341003
sophistication,5,1.6094379124341003
leftward,5,1.6094379124341003
9-week,5,1.6094379124341003
indisputable,5,1.6094379124341003
twenty-eight,5,1.6094379124341003
P0008,5,1.6094379124341003
shrink,5,1.6094379124341003
ESVI,5,1.6094379124341003
RDMS,5,1.6094379124341003
anxiolytic,5,1.6094379124341003
ministry,5,1.6094379124341003
partitioned,5,1.6094379124341003
IPP,5,1.6094379124341003
FX,5,1.6094379124341003
multispecialty,5,1.6094379124341003
2009-January,5,1.6094379124341003
interwoven,5,1.6094379124341003
Cytoscape,5,1.6094379124341003
roentgenograms,5,1.6094379124341003
biospecimens,5,1.6094379124341003
calcifications,5,1.6094379124341003
DR,5,1.6094379124341003
notify,5,1.6094379124341003
unclassifiable,5,1.6094379124341003
UTI,5,1.6094379124341003
rationality,5,1.6094379124341003
conceivably,5,1.6094379124341003
APACHE,5,1.6094379124341003
Elements,5,1.6094379124341003
RObi,5,1.6094379124341003
non-pathogenic,5,1.6094379124341003
alarmins,5,1.6094379124341003
non-essential,5,1.6094379124341003
iteratively,5,1.6094379124341003
propellants,5,1.6094379124341003
shut,5,1.6094379124341003
reminded,5,1.6094379124341003
suspects,5,1.6094379124341003
ASP,5,1.6094379124341003
SVC-RA,5,1.6094379124341003
sweetened,5,1.6094379124341003
HRSA,5,1.6094379124341003
BICV,5,1.6094379124341003
446-480,5,1.6094379124341003
typhus,5,1.6094379124341003
health-promoting,5,1.6094379124341003
age-based,5,1.6094379124341003
representativeness,5,1.6094379124341003
IN-AMI,5,1.6094379124341003
atopics,5,1.6094379124341003
I-123,5,1.6094379124341003
pAsp,5,1.6094379124341003
tricyclic,5,1.6094379124341003
multichannel,5,1.6094379124341003
Stroop,5,1.6094379124341003
cancelling,5,1.6094379124341003
SW0123,5,1.6094379124341003
Equipment,5,1.6094379124341003
HTL,5,1.6094379124341003
VAHL,5,1.6094379124341003
atlantoaxial,5,1.6094379124341003
3d,5,1.6094379124341003
septa,5,1.6094379124341003
RO,5,1.6094379124341003
Decree,5,1.6094379124341003
tracheostomies,5,1.6094379124341003
annular,5,1.6094379124341003
alternate-day,5,1.6094379124341003
0039,5,1.6094379124341003
3-dimensional,5,1.6094379124341003
FunCoup,5,1.6094379124341003
compensating,5,1.6094379124341003
PanbioTM,5,1.6094379124341003
birthday,5,1.6094379124341003
three-step,5,1.6094379124341003
Preceding,5,1.6094379124341003
RNaseP,5,1.6094379124341003
housework,5,1.6094379124341003
11-21,5,1.6094379124341003
VLCKD,5,1.6094379124341003
group-level,5,1.6094379124341003
Bakers,5,1.6094379124341003
adrenoceptor,5,1.6094379124341003
rhonchi,5,1.6094379124341003
Fabrys,5,1.6094379124341003
engineer,5,1.6094379124341003
compelled,5,1.6094379124341003
well-timed,5,1.6094379124341003
Poly,5,1.6094379124341003
1000000,5,1.6094379124341003
fifty-one,5,1.6094379124341003
nursed,5,1.6094379124341003
caudispina,5,1.6094379124341003
Interdisciplinary,5,1.6094379124341003
17000,5,1.6094379124341003
Cas12a,5,1.6094379124341003
heterotopic,5,1.6094379124341003
BMTs,5,1.6094379124341003
serum-specific,5,1.6094379124341003
5-week,5,1.6094379124341003
off-season,5,1.6094379124341003
INO-4800,5,1.6094379124341003
cataract,5,1.6094379124341003
subthalamic,5,1.6094379124341003
recession,5,1.6094379124341003
aperture,5,1.6094379124341003
hyper-,5,1.6094379124341003
Springer,5,1.6094379124341003
molar,5,1.6094379124341003
bariatric,5,1.6094379124341003
evidencing,5,1.6094379124341003
PWUD,5,1.6094379124341003
secundum,5,1.6094379124341003
recanalizing,5,1.6094379124341003
ubiquitin,5,1.6094379124341003
hypotonic,5,1.6094379124341003
Columbus,5,1.6094379124341003
AgNPs,5,1.6094379124341003
N20,5,1.6094379124341003
uPAR,5,1.6094379124341003
vaccine-based,5,1.6094379124341003
Q-MI,5,1.6094379124341003
non-hypertensive,5,1.6094379124341003
2010-2012,5,1.6094379124341003
Dipyridamole,5,1.6094379124341003
lobule,5,1.6094379124341003
RPV,5,1.6094379124341003
tractable,5,1.6094379124341003
Strain,5,1.6094379124341003
FMA,5,1.6094379124341003
constraining,5,1.6094379124341003
hemoperfusion,5,1.6094379124341003
Counterpulsation,5,1.6094379124341003
breathed,5,1.6094379124341003
Humoral,5,1.6094379124341003
Modifiable,5,1.6094379124341003
OSCN-,5,1.6094379124341003
n4,5,1.6094379124341003
prechallenge,5,1.6094379124341003
architectural,5,1.6094379124341003
exonuclease,5,1.6094379124341003
editorials,5,1.6094379124341003
alpha-,5,1.6094379124341003
Lyo-CRISPR,5,1.6094379124341003
cares,5,1.6094379124341003
Tei,5,1.6094379124341003
invalidism,5,1.6094379124341003
MCOs,5,1.6094379124341003
endangering,5,1.6094379124341003
SISSS,5,1.6094379124341003
Astrocytes,5,1.6094379124341003
PEMFs,5,1.6094379124341003
dpdt,5,1.6094379124341003
cruzi,5,1.6094379124341003
pleurisy,5,1.6094379124341003
trandolapril,5,1.6094379124341003
SVG,5,1.6094379124341003
TNP,5,1.6094379124341003
RKI,5,1.6094379124341003
duodenal,5,1.6094379124341003
1205,5,1.6094379124341003
wealthy,5,1.6094379124341003
sealed,5,1.6094379124341003
ingested,5,1.6094379124341003
Inhaler,5,1.6094379124341003
elemental,5,1.6094379124341003
Kiruna,5,1.6094379124341003
net-present,5,1.6094379124341003
cost-savings,5,1.6094379124341003
redo,5,1.6094379124341003
Late-onset,5,1.6094379124341003
Campus,5,1.6094379124341003
muscle-specific,5,1.6094379124341003
quarterly,5,1.6094379124341003
time-window,5,1.6094379124341003
abundances,5,1.6094379124341003
20-,5,1.6094379124341003
Amiens,5,1.6094379124341003
380°C,5,1.6094379124341003
BMM,5,1.6094379124341003
222G,5,1.6094379124341003
CoVdb,5,1.6094379124341003
1249,5,1.6094379124341003
non-professional,5,1.6094379124341003
actualbest,5,1.6094379124341003
ANA,5,1.6094379124341003
Rheumatology,5,1.6094379124341003
angioplasties,5,1.6094379124341003
PSC-17,5,1.6094379124341003
1160,5,1.6094379124341003
reuteri,5,1.6094379124341003
1320,5,1.6094379124341003
ENA,5,1.6094379124341003
Nonadherence,5,1.6094379124341003
expansive,5,1.6094379124341003
second-line,5,1.6094379124341003
IVR,5,1.6094379124341003
retarded,5,1.6094379124341003
Disabilities,5,1.6094379124341003
Daytime,5,1.6094379124341003
precociously,5,1.6094379124341003
RT-,5,1.6094379124341003
ReA,5,1.6094379124341003
influenza-coded,5,1.6094379124341003
898,5,1.6094379124341003
Chorus,5,1.6094379124341003
exemplifies,5,1.6094379124341003
PI3Ks,5,1.6094379124341003
Measles,5,1.6094379124341003
clips,5,1.6094379124341003
facilitys,5,1.6094379124341003
saga,5,1.6094379124341003
under-utilization,5,1.6094379124341003
copiesµl,5,1.6094379124341003
asthmaallergy,5,1.6094379124341003
HSES,5,1.6094379124341003
hemorheological,5,1.6094379124341003
cocirculate,5,1.6094379124341003
July-December,5,1.6094379124341003
Algeria,5,1.6094379124341003
ceiling,5,1.6094379124341003
HSV,5,1.6094379124341003
ximelagatran,5,1.6094379124341003
Documents,5,1.6094379124341003
trap,5,1.6094379124341003
flowchart,5,1.6094379124341003
approve,5,1.6094379124341003
hyperphosphatasemia,5,1.6094379124341003
Hepatic,5,1.6094379124341003
covariation,5,1.6094379124341003
IgG-IgM,5,1.6094379124341003
teratogenic,5,1.6094379124341003
MS2,5,1.6094379124341003
PKR,5,1.6094379124341003
1minute,5,1.6094379124341003
3C2a1b,5,1.6094379124341003
FebriDx,5,1.6094379124341003
T-cell-mediated,5,1.6094379124341003
1976-1977,5,1.6094379124341003
directives,5,1.6094379124341003
anti-anginal,5,1.6094379124341003
⩾,5,1.6094379124341003
immunoprivilege,5,1.6094379124341003
baricitinib,5,1.6094379124341003
glass-fiber,5,1.6094379124341003
nvAF,5,1.6094379124341003
DHSS,5,1.6094379124341003
fingerstick,5,1.6094379124341003
arthralgias,5,1.6094379124341003
shields,5,1.6094379124341003
ARCHITECT™,5,1.6094379124341003
calculates,5,1.6094379124341003
squadron,5,1.6094379124341003
refrigerator,5,1.6094379124341003
Community-based,5,1.6094379124341003
syringes,5,1.6094379124341003
managerial,5,1.6094379124341003
Syncytial,5,1.6094379124341003
ΔPRRA,5,1.6094379124341003
unresponsiveness,5,1.6094379124341003
granulomatosis,5,1.6094379124341003
federally,5,1.6094379124341003
predilation,5,1.6094379124341003
NAMPT,5,1.6094379124341003
pays,5,1.6094379124341003
accrue,5,1.6094379124341003
euthyroid,5,1.6094379124341003
Mali,5,1.6094379124341003
SCoV-2,5,1.6094379124341003
Confusion,5,1.6094379124341003
turbine,5,1.6094379124341003
NhPV,5,1.6094379124341003
subintimal,5,1.6094379124341003
cellsmm3,5,1.6094379124341003
Resident,5,1.6094379124341003
FLUA,5,1.6094379124341003
thread,5,1.6094379124341003
glance,5,1.6094379124341003
Kardiomobil,5,1.6094379124341003
1-15,5,1.6094379124341003
chloroplast,5,1.6094379124341003
imatinib,5,1.6094379124341003
non-active,5,1.6094379124341003
Pericarditis,5,1.6094379124341003
7030,5,1.6094379124341003
erythromycin,5,1.6094379124341003
Rica,5,1.6094379124341003
railway,5,1.6094379124341003
Th1-biased,5,1.6094379124341003
root-mean-square,5,1.6094379124341003
CCAS-32,5,1.6094379124341003
Histopathologic,5,1.6094379124341003
QTd1,5,1.6094379124341003
reproduces,5,1.6094379124341003
Anti-Doping,5,1.6094379124341003
hUTC,5,1.6094379124341003
pBECs,5,1.6094379124341003
gently,5,1.6094379124341003
Stronger,5,1.6094379124341003
Physiotherapy,5,1.6094379124341003
odors,5,1.6094379124341003
Istanbul,5,1.6094379124341003
guideline-directed,5,1.6094379124341003
beneath,5,1.6094379124341003
no-ST,5,1.6094379124341003
selections,5,1.6094379124341003
Portland,5,1.6094379124341003
forty-nine,5,1.6094379124341003
swl,5,1.6094379124341003
doughnut,5,1.6094379124341003
PTG,5,1.6094379124341003
Cys300,5,1.6094379124341003
CDGSF,5,1.6094379124341003
subcostal,5,1.6094379124341003
vapours,5,1.6094379124341003
year-to-year,5,1.6094379124341003
non-cancer,5,1.6094379124341003
hypersecretory,5,1.6094379124341003
lapses,5,1.6094379124341003
post-CABS,5,1.6094379124341003
Fasting,5,1.6094379124341003
CoViD-19,5,1.6094379124341003
contradiction,5,1.6094379124341003
immunoglobulin-like,5,1.6094379124341003
reinfect,5,1.6094379124341003
phosphorothioate,5,1.6094379124341003
circumscribed,5,1.6094379124341003
DRS,5,1.6094379124341003
r-tPA,5,1.6094379124341003
witness,5,1.6094379124341003
immunostimulants,5,1.6094379124341003
IAR,5,1.6094379124341003
fermented,5,1.6094379124341003
Cw,5,1.6094379124341003
Neretva,5,1.6094379124341003
Likert,5,1.6094379124341003
MDH,5,1.6094379124341003
120000,5,1.6094379124341003
1528,5,1.6094379124341003
EBCT,5,1.6094379124341003
MAQLQ-M,5,1.6094379124341003
SOC,5,1.6094379124341003
RVLV,5,1.6094379124341003
Händel,5,1.6094379124341003
Cas9,5,1.6094379124341003
NCE,5,1.6094379124341003
Minneapolis-St,5,1.6094379124341003
phosphokinase-MB,5,1.6094379124341003
Loccus,5,1.6094379124341003
well-differentiated,5,1.6094379124341003
STUDY,5,1.6094379124341003
LVG,5,1.6094379124341003
normobaric,5,1.6094379124341003
poliovirus,5,1.6094379124341003
Genotyping,5,1.6094379124341003
CSD,5,1.6094379124341003
ILC2,5,1.6094379124341003
α-glucosidase,5,1.6094379124341003
Bruce,5,1.6094379124341003
EB-PM,5,1.6094379124341003
VPR,5,1.6094379124341003
asbestos,5,1.6094379124341003
BAPE,5,1.6094379124341003
ASolomon,5,1.6094379124341003
stenosing,5,1.6094379124341003
blend,5,1.6094379124341003
viralbacterial,5,1.6094379124341003
RCP,5,1.6094379124341003
AH1N1v2009,5,1.6094379124341003
-17,5,1.6094379124341003
subnational,5,1.6094379124341003
L-DOPS,5,1.6094379124341003
CPP,5,1.6094379124341003
unmasking,5,1.6094379124341003
monocentric,5,1.6094379124341003
36-48,5,1.6094379124341003
1038,5,1.6094379124341003
Net,5,1.6094379124341003
super-spreaders,5,1.6094379124341003
over-treatment,5,1.6094379124341003
suramin,5,1.6094379124341003
COVD-19,5,1.6094379124341003
self-enzyme,5,1.6094379124341003
Kong3302001-like,5,1.6094379124341003
rheopheresis,5,1.6094379124341003
kb,5,1.6094379124341003
anti-fibrotic,5,1.6094379124341003
Saxony-Anhalt,5,1.6094379124341003
articulate,5,1.6094379124341003
RGS,5,1.6094379124341003
VOP,5,1.6094379124341003
homozygotes,5,1.6094379124341003
MOD,5,1.6094379124341003
phyla,5,1.6094379124341003
Physiology,5,1.6094379124341003
2011-2015,5,1.6094379124341003
Malayan,5,1.6094379124341003
non-participants,5,1.6094379124341003
SCC,5,1.6094379124341003
ovary,5,1.6094379124341003
air-liquid,5,1.6094379124341003
FDA-authorized,5,1.6094379124341003
acute-PTCA,5,1.6094379124341003
Kuala,5,1.6094379124341003
incl,5,1.6094379124341003
YGW,5,1.6094379124341003
practice-based,5,1.6094379124341003
Ninety-nine,5,1.6094379124341003
replicable,5,1.6094379124341003
H9N2G1,5,1.6094379124341003
Hypothermia,5,1.6094379124341003
subarachnoidal,5,1.6094379124341003
gamma-irradiated,5,1.6094379124341003
lieu,5,1.6094379124341003
pathobiological,5,1.6094379124341003
Papillary,5,1.6094379124341003
3-months,5,1.6094379124341003
5G,5,1.6094379124341003
commerce,5,1.6094379124341003
iENA,5,1.6094379124341003
TRH,5,1.6094379124341003
heaviest,5,1.6094379124341003
LLNs,5,1.6094379124341003
Things,5,1.6094379124341003
1116,5,1.6094379124341003
infodemic,5,1.6094379124341003
PIDIRAC,5,1.6094379124341003
IDNOW,5,1.6094379124341003
coronavirus-specific,5,1.6094379124341003
Douglas,5,1.6094379124341003
MJ,5,1.6094379124341003
steroid-naive,5,1.6094379124341003
TDI-induced,5,1.6094379124341003
citing,5,1.6094379124341003
LTCU,5,1.6094379124341003
single-shot,5,1.6094379124341003
Abbreviations,5,1.6094379124341003
recipes,5,1.6094379124341003
decubitus,5,1.6094379124341003
WSN-PB2,5,1.6094379124341003
H1NI,5,1.6094379124341003
Epsilon,5,1.6094379124341003
MOS-SSS,5,1.6094379124341003
Missing,5,1.6094379124341003
amantadine-treated,5,1.6094379124341003
resolutions,5,1.6094379124341003
transpulmonary,5,1.6094379124341003
Affordable,5,1.6094379124341003
Biosystems,5,1.6094379124341003
Phosphatase,5,1.6094379124341003
subdivisions,5,1.6094379124341003
carnitine,5,1.6094379124341003
Anaphylaxis,5,1.6094379124341003
819,5,1.6094379124341003
FVH,5,1.6094379124341003
Frame,5,1.6094379124341003
diverged,5,1.6094379124341003
Overlap,5,1.6094379124341003
Hematopoietic,5,1.6094379124341003
vaso-occlusion,5,1.6094379124341003
PoS,5,1.6094379124341003
Brunswick,5,1.6094379124341003
Seasonality,5,1.6094379124341003
≥16,5,1.6094379124341003
NMP,5,1.6094379124341003
amodiaquine,5,1.6094379124341003
meteorologic,5,1.6094379124341003
HLAs,5,1.6094379124341003
bifurcations,5,1.6094379124341003
rotations,5,1.6094379124341003
packed,5,1.6094379124341003
Think,5,1.6094379124341003
accountability,5,1.6094379124341003
GM,5,1.6094379124341003
friction,5,1.6094379124341003
gemcitabine,5,1.6094379124341003
CCs,5,1.6094379124341003
exploded,5,1.6094379124341003
Glucocorticoids,5,1.6094379124341003
Cys145,5,1.6094379124341003
CREST,5,1.6094379124341003
curable,5,1.6094379124341003
overreliance,5,1.6094379124341003
cohesive,5,1.6094379124341003
Guided,5,1.6094379124341003
Situation,5,1.6094379124341003
nonintervention,5,1.6094379124341003
fasted,5,1.6094379124341003
disconnected,5,1.6094379124341003
single-blinded,5,1.6094379124341003
CCDC,5,1.6094379124341003
lipoprotein-cholesterol,5,1.6094379124341003
IPBCAMS,5,1.6094379124341003
toco,5,1.6094379124341003
Demonstrating,5,1.6094379124341003
FPCA,5,1.6094379124341003
extensors,5,1.6094379124341003
Fungal,5,1.6094379124341003
SIs,5,1.6094379124341003
Hyponatremia,5,1.6094379124341003
planimetric,5,1.6094379124341003
SITS-MOST,5,1.6094379124341003
1-17,5,1.6094379124341003
PCoA,5,1.6094379124341003
IIR,5,1.6094379124341003
aortal,5,1.6094379124341003
self-selected,5,1.6094379124341003
S1P1R,5,1.6094379124341003
flail,5,1.6094379124341003
NIVGRIP,5,1.6094379124341003
Disodium,5,1.6094379124341003
Familial,5,1.6094379124341003
subglottic,5,1.6094379124341003
re-admission,5,1.6094379124341003
QTcd,5,1.6094379124341003
nRIC,5,1.6094379124341003
agreeing,5,1.6094379124341003
portfolio,5,1.6094379124341003
Bioclin,5,1.6094379124341003
nonteaching,5,1.6094379124341003
synchronised,5,1.6094379124341003
servicemen,5,1.6094379124341003
warfare,5,1.6094379124341003
EOs,5,1.6094379124341003
BioGene,5,1.6094379124341003
Lymphocytes,5,1.6094379124341003
vaccine-mediated,5,1.6094379124341003
modelers,5,1.6094379124341003
Oscillococcinum,5,1.6094379124341003
00017,5,1.6094379124341003
graduate,5,1.6094379124341003
DAR,5,1.6094379124341003
Mexican-Americans,5,1.6094379124341003
G3,5,1.6094379124341003
APGAR,5,1.6094379124341003
CMRO2,5,1.6094379124341003
complement-fixation,5,1.6094379124341003
BPanama4590,5,1.6094379124341003
V8,5,1.6094379124341003
publicised,5,1.6094379124341003
pulvinar,5,1.6094379124341003
lined,5,1.6094379124341003
HIG,5,1.6094379124341003
trans-system,5,1.6094379124341003
endings,5,1.6094379124341003
Kruskal-Wallis,5,1.6094379124341003
wishing,5,1.6094379124341003
N2-positive,5,1.6094379124341003
StriFK-FH002C,5,1.6094379124341003
immunomodulator,5,1.6094379124341003
electromyography,5,1.6094379124341003
encapsulation,5,1.6094379124341003
Properly,5,1.6094379124341003
1071,5,1.6094379124341003
core-shell,5,1.6094379124341003
nongenetic,5,1.6094379124341003
Guillain-Barre,5,1.6094379124341003
hypochondriac,5,1.6094379124341003
Preconditioning,5,1.6094379124341003
hostile,5,1.6094379124341003
pre-existent,5,1.6094379124341003
E-negative,5,1.6094379124341003
succumbing,5,1.6094379124341003
ESG,5,1.6094379124341003
non-elderly,5,1.6094379124341003
asthma-induced,5,1.6094379124341003
reactivated,5,1.6094379124341003
pH1N12009,5,1.6094379124341003
Consistently,5,1.6094379124341003
Internists,5,1.6094379124341003
couplets,5,1.6094379124341003
R-on-T,5,1.6094379124341003
CAPS,5,1.6094379124341003
éves,5,1.6094379124341003
platelet-derived,5,1.6094379124341003
HCV,5,1.6094379124341003
seroconversions,5,1.6094379124341003
pre-morbid,5,1.6094379124341003
Ephedra,5,1.6094379124341003
phosphoinositide,5,1.6094379124341003
Galway,5,1.6094379124341003
AAsian,5,1.6094379124341003
Célkitűzés,5,1.6094379124341003
G20210A,5,1.6094379124341003
waiver,5,1.6094379124341003
passports,5,1.6094379124341003
watt,5,1.6094379124341003
Viremia,5,1.6094379124341003
PAedP,5,1.6094379124341003
socio-cultural,5,1.6094379124341003
Seroepidemiological,5,1.6094379124341003
nonviable,5,1.6094379124341003
chaos,5,1.6094379124341003
Arrhythmia,5,1.6094379124341003
post-thrombolysis,5,1.6094379124341003
nonimmunized,5,1.6094379124341003
quality-improvement,5,1.6094379124341003
Managed,5,1.6094379124341003
hymenoptera,5,1.6094379124341003
supposition,5,1.6094379124341003
járó,5,1.6094379124341003
interpretative,5,1.6094379124341003
asterixis,5,1.6094379124341003
McNemar,5,1.6094379124341003
household-level,5,1.6094379124341003
morbimortality,5,1.6094379124341003
1065,5,1.6094379124341003
tremor,5,1.6094379124341003
Infrastructure,5,1.6094379124341003
amygdala,5,1.6094379124341003
remits,5,1.6094379124341003
Confocal,5,1.6094379124341003
Advancing,5,1.6094379124341003
bordering,5,1.6094379124341003
polyarteritis,5,1.6094379124341003
nodosa,5,1.6094379124341003
GPIIbIIIa,5,1.6094379124341003
COronaVIrus,5,1.6094379124341003
autochthonous,5,1.6094379124341003
EPR3,5,1.6094379124341003
racial-ethnic,5,1.6094379124341003
incurable,5,1.6094379124341003
publish,5,1.6094379124341003
nonmyocardial,5,1.6094379124341003
Barbados,5,1.6094379124341003
Tucson,5,1.6094379124341003
Fraction,5,1.6094379124341003
SAEC,5,1.6094379124341003
post-bypass,5,1.6094379124341003
ssDNA,5,1.6094379124341003
incessant,5,1.6094379124341003
ONO-1301MS,5,1.6094379124341003
aneurysmatic,5,1.6094379124341003
heralds,5,1.6094379124341003
swH1N1,5,1.6094379124341003
barracks,5,1.6094379124341003
NeuMoDx,5,1.6094379124341003
16-24,5,1.6094379124341003
LPZ,5,1.6094379124341003
interns,5,1.6094379124341003
naso-pharyngeal,5,1.6094379124341003
reportable,5,1.6094379124341003
OPZ,5,1.6094379124341003
gram,5,1.6094379124341003
time-limited,5,1.6094379124341003
fibrillations,5,1.6094379124341003
trended,5,1.6094379124341003
patient-collected,5,1.6094379124341003
non-MI,5,1.6094379124341003
heat-RNA,5,1.6094379124341003
hAd5,5,1.6094379124341003
coloured,5,1.6094379124341003
BPhuket30732013,5,1.6094379124341003
equator,5,1.6094379124341003
unadjuvanted,5,1.6094379124341003
apico-septal,5,1.6094379124341003
hyperlipemia,5,1.6094379124341003
litersmin,5,1.6094379124341003
miatt,5,1.6094379124341003
adventitial,5,1.6094379124341003
Single-cell,5,1.6094379124341003
szívinfarktus,5,1.6094379124341003
time-domain,5,1.6094379124341003
intraabdominal,5,1.6094379124341003
GIR,5,1.6094379124341003
1207,5,1.6094379124341003
ET-related,5,1.6094379124341003
Polycythemia,5,1.6094379124341003
shoe,5,1.6094379124341003
piracetam,5,1.6094379124341003
Postprocedural,5,1.6094379124341003
antidote,5,1.6094379124341003
Deficiencies,5,1.6094379124341003
LD-1,5,1.6094379124341003
riboxin,5,1.6094379124341003
Aneurysms,5,1.6094379124341003
housewives,5,1.6094379124341003
LMI,5,1.6094379124341003
n22,5,1.6094379124341003
stereotaxic,5,1.6094379124341003
pallidus,5,1.6094379124341003
Fox,5,1.6094379124341003
globus,5,1.6094379124341003
SUS,5,1.6094379124341003
VHD,5,1.6094379124341003
selinexor,5,1.6094379124341003
fibrobronchoscopy,5,1.6094379124341003
shutoff,5,1.6094379124341003
XPO1,5,1.6094379124341003
EDP,5,1.6094379124341003
hypertonia,5,1.6094379124341003
morbiditymortality,5,1.6094379124341003
Rhinostic,5,1.6094379124341003
NQO1,5,1.6094379124341003
echographic,5,1.6094379124341003
chaperones,5,1.6094379124341003
personalities,5,1.6094379124341003
Kathmandu,5,1.6094379124341003
mv,5,1.6094379124341003
rMpg-RBD-7,5,1.6094379124341003
35000,5,1.6094379124341003
salicylates,5,1.6094379124341003
limelight,5,1.6094379124341003
Separate,5,1.6094379124341003
Dox,5,1.6094379124341003
l-thyroxine,5,1.6094379124341003
Poultry,5,1.6094379124341003
Chalmers73,5,1.6094379124341003
wax,5,1.6094379124341003
hyperviscosity,5,1.6094379124341003
blood-pool,5,1.6094379124341003
inefficiency,5,1.6094379124341003
McNemars,5,1.6094379124341003
pilgrimages,5,1.6094379124341003
30days,5,1.6094379124341003
obatoclax,5,1.6094379124341003
opt,5,1.6094379124341003
PRES,5,1.6094379124341003
vasculatures,5,1.6094379124341003
adrenocortical,5,1.6094379124341003
polypropylene,5,1.6094379124341003
hyperdiagnosis,5,1.6094379124341003
posttranslational,5,1.6094379124341003
organising,5,1.6094379124341003
DIC,5,1.6094379124341003
false-negatives,5,1.6094379124341003
Taleum,5,1.6094379124341003
endoscopically,5,1.6094379124341003
Hodgkins,5,1.6094379124341003
complement-mediated,5,1.6094379124341003
individualizing,5,1.6094379124341003
socioemotional,5,1.6094379124341003
candidiasis,5,1.6094379124341003
195K,5,1.6094379124341003
minden,5,1.6094379124341003
nonstenosing,5,1.6094379124341003
rhinovirusenterovirus,5,1.6094379124341003
twenty-seven,5,1.6094379124341003
során,5,1.6094379124341003
sarbecovirus,5,1.6094379124341003
napon,5,1.6094379124341003
SAMPPs,5,1.6094379124341003
bioaerosol,5,1.6094379124341003
invoked,5,1.6094379124341003
BRQ,5,1.6094379124341003
non-inflammatory,5,1.6094379124341003
SRT,5,1.6094379124341003
Tl-uptake,5,1.6094379124341003
barometric,5,1.6094379124341003
rays,5,1.6094379124341003
stagnant,5,1.6094379124341003
Gubler,5,1.6094379124341003
Immunosuppressed,5,1.6094379124341003
pharmacophore,5,1.6094379124341003
League,5,1.6094379124341003
Eredmények,5,1.6094379124341003
Experiences,5,1.6094379124341003
Numbers,5,1.6094379124341003
Stroke-induced,5,1.6094379124341003
Henan,5,1.6094379124341003
enact,5,1.6094379124341003
cadence,5,1.6094379124341003
invitation,5,1.6094379124341003
UPE,5,1.6094379124341003
stimulators,5,1.6094379124341003
Charles,5,1.6094379124341003
undamaged,5,1.6094379124341003
filaggrin,5,1.6094379124341003
kD,5,1.6094379124341003
Categories,5,1.6094379124341003
Suspected,5,1.6094379124341003
STe,5,1.6094379124341003
DST,5,1.6094379124341003
nonverbal,5,1.6094379124341003
supra-aortic,5,1.6094379124341003
interviewer-administered,5,1.6094379124341003
ever-present,5,1.6094379124341003
transdisciplinary,5,1.6094379124341003
tenets,5,1.6094379124341003
AGIM,5,1.6094379124341003
seroresponse,5,1.6094379124341003
fitness-to-fly,5,1.6094379124341003
reclassified,5,1.6094379124341003
spark,5,1.6094379124341003
distorting,5,1.6094379124341003
RB,5,1.6094379124341003
finish,5,1.6094379124341003
GW,5,1.6094379124341003
inserts,5,1.6094379124341003
factor-beta,5,1.6094379124341003
EA-STEMI,5,1.6094379124341003
resistances,5,1.6094379124341003
coatings,5,1.6094379124341003
Palestinian,5,1.6094379124341003
-65,5,1.6094379124341003
Diyarbakir,5,1.6094379124341003
severe-to-critical,5,1.6094379124341003
Boolean,5,1.6094379124341003
2B,5,1.6094379124341003
isozyme,5,1.6094379124341003
ARCHITECT,5,1.6094379124341003
batteries,5,1.6094379124341003
anti-cytokine,5,1.6094379124341003
downgraded,5,1.6094379124341003
sad,5,1.6094379124341003
CDI,5,1.6094379124341003
four-month,5,1.6094379124341003
DC-T-cell,5,1.6094379124341003
basigin,5,1.6094379124341003
1463,5,1.6094379124341003
near-term,5,1.6094379124341003
survivals,5,1.6094379124341003
900000,5,1.6094379124341003
mucocutaneous,5,1.6094379124341003
negate,5,1.6094379124341003
Euclidean,5,1.6094379124341003
contributive,5,1.6094379124341003
inflated,5,1.6094379124341003
sTNFR1,5,1.6094379124341003
angioedema,5,1.6094379124341003
intermolecular,5,1.6094379124341003
bullet,5,1.6094379124341003
fearful,5,1.6094379124341003
Xuefu,5,1.6094379124341003
walnut,5,1.6094379124341003
Dis,5,1.6094379124341003
Threshold,5,1.6094379124341003
conjecture,5,1.6094379124341003
unquestionable,5,1.6094379124341003
Mn-SOD,5,1.6094379124341003
Weather,5,1.6094379124341003
cupping,5,1.6094379124341003
seroma,5,1.6094379124341003
State-Trait,5,1.6094379124341003
10-week,5,1.6094379124341003
Gambia,5,1.6094379124341003
neoformans,5,1.6094379124341003
Cochran-Mantel-Haenszel,5,1.6094379124341003
Epigenetics,5,1.6094379124341003
1929,5,1.6094379124341003
cardiotoxic,5,1.6094379124341003
wrist-worn,5,1.6094379124341003
HBE,5,1.6094379124341003
extrasystole,5,1.6094379124341003
outlets,5,1.6094379124341003
vaccination-induced,5,1.6094379124341003
mine,5,1.6094379124341003
partnering,5,1.6094379124341003
endocytic,5,1.6094379124341003
nitrosative,5,1.6094379124341003
14-16,5,1.6094379124341003
tPA-treated,5,1.6094379124341003
Autonomous,5,1.6094379124341003
behave,5,1.6094379124341003
lodge,5,1.6094379124341003
photocatalyst,5,1.6094379124341003
Remaining,5,1.6094379124341003
translatable,5,1.6094379124341003
polycythaemia,5,1.6094379124341003
ODPs,5,1.6094379124341003
nonadrenergic,5,1.6094379124341003
Nepalese,5,1.6094379124341003
nontreated,5,1.6094379124341003
NN,5,1.6094379124341003
preference-based,5,1.6094379124341003
cytarabine,5,1.6094379124341003
Amazonas,5,1.6094379124341003
amphetamines,5,1.6094379124341003
Singaporean,5,1.6094379124341003
Assisted,5,1.6094379124341003
One-step,5,1.6094379124341003
Zealands,5,1.6094379124341003
milligrams,5,1.6094379124341003
settlement,5,1.6094379124341003
patient’s,5,1.6094379124341003
cell-to-cell,5,1.6094379124341003
hypercytokinaemia,5,1.6094379124341003
Tl-ECT,5,1.6094379124341003
1003,5,1.6094379124341003
operationally,5,1.6094379124341003
1043,5,1.6094379124341003
Follow,5,1.6094379124341003
surprised,5,1.6094379124341003
Peninsula,5,1.6094379124341003
ST-depr,5,1.6094379124341003
Goal,5,1.6094379124341003
Scintigrams,5,1.6094379124341003
iodinated,5,1.6094379124341003
isnt,5,1.6094379124341003
1972-1973,5,1.6094379124341003
nowcasting,5,1.6094379124341003
RMSV,5,1.6094379124341003
oligomerization,5,1.6094379124341003
olive,5,1.6094379124341003
CK2,5,1.6094379124341003
-069,5,1.6094379124341003
anticytokine,5,1.6094379124341003
QSAR,5,1.6094379124341003
RMHC,5,1.6094379124341003
NEP,5,1.6094379124341003
MNA,5,1.6094379124341003
fulfills,5,1.6094379124341003
SCH,5,1.6094379124341003
IL1B,5,1.6094379124341003
anti-human,5,1.6094379124341003
unregulated,5,1.6094379124341003
Trialists,5,1.6094379124341003
Conducting,5,1.6094379124341003
1982-1983,5,1.6094379124341003
hydroxide,5,1.6094379124341003
purify,5,1.6094379124341003
single-particle,5,1.6094379124341003
desorptionionization,5,1.6094379124341003
October-December,5,1.6094379124341003
dispensable,5,1.6094379124341003
LIPID,5,1.6094379124341003
sons,5,1.6094379124341003
personalization,5,1.6094379124341003
Riyadh,5,1.6094379124341003
Tarnobrzeg,5,1.6094379124341003
human-adapted,5,1.6094379124341003
multiplanar,5,1.6094379124341003
coevolution,5,1.6094379124341003
FWR,5,1.6094379124341003
1975-1979,5,1.6094379124341003
anti-ADAMTS13,5,1.6094379124341003
SEE,5,1.6094379124341003
Radiologic,5,1.6094379124341003
Franks,5,1.6094379124341003
escaping,5,1.6094379124341003
Assistance,5,1.6094379124341003
non-compliant,5,1.6094379124341003
transferrin,5,1.6094379124341003
OEFR,5,1.6094379124341003
colors,5,1.6094379124341003
outlier,5,1.6094379124341003
DLE,5,1.6094379124341003
48-h,5,1.6094379124341003
pan-European,5,1.6094379124341003
longitude,5,1.6094379124341003
NSF,5,1.6094379124341003
96-98,5,1.6094379124341003
citation,5,1.6094379124341003
preset,5,1.6094379124341003
CRSwNP,5,1.6094379124341003
casirivimab,5,1.6094379124341003
Antidepressants,5,1.6094379124341003
IVs,5,1.6094379124341003
Myalgia,5,1.6094379124341003
nozzles,5,1.6094379124341003
Intradermal,5,1.6094379124341003
HA-LCI,5,1.6094379124341003
theorized,5,1.6094379124341003
1061,5,1.6094379124341003
p0026,5,1.6094379124341003
disease-causing,5,1.6094379124341003
Readmissions,5,1.6094379124341003
1533,5,1.6094379124341003
IPPA,5,1.6094379124341003
Calcutta,5,1.6094379124341003
meticulously,5,1.6094379124341003
Conduction,5,1.6094379124341003
healthcare-seeking,5,1.6094379124341003
TRS,5,1.6094379124341003
2019-nCoV-infected,5,1.6094379124341003
SDN,5,1.6094379124341003
middle-,5,1.6094379124341003
MSUs,5,1.6094379124341003
mates,5,1.6094379124341003
IIV3s,5,1.6094379124341003
manipulative,5,1.6094379124341003
electrostimulation,5,1.6094379124341003
-21,5,1.6094379124341003
v21,5,1.6094379124341003
parity,5,1.6094379124341003
Sudden-onset,5,1.6094379124341003
Lebanese,5,1.6094379124341003
stature,5,1.6094379124341003
ptosis,5,1.6094379124341003
pioneered,5,1.6094379124341003
nonstenotic,5,1.6094379124341003
cardiac-specific,5,1.6094379124341003
awaken,5,1.6094379124341003
loratadine,5,1.6094379124341003
gynecologists,5,1.6094379124341003
semistructured,5,1.6094379124341003
patho-physiological,5,1.6094379124341003
thirdly,5,1.6094379124341003
Anti-IgE,5,1.6094379124341003
provocations,5,1.6094379124341003
gargles,5,1.6094379124341003
NSP1,5,1.6094379124341003
osseous,5,1.6094379124341003
projecting,5,1.6094379124341003
Calculations,5,1.6094379124341003
Documented,5,1.6094379124341003
Brazils,5,1.6094379124341003
confuse,5,1.6094379124341003
concentration-time,5,1.6094379124341003
Portable,5,1.6094379124341003
geese,5,1.6094379124341003
Herbal,5,1.6094379124341003
calories,5,1.6094379124341003
perceiver,5,1.6094379124341003
electrogram,5,1.6094379124341003
intangible,5,1.6094379124341003
LIMIT-2,5,1.6094379124341003
T‑cell,5,1.6094379124341003
shaken,5,1.6094379124341003
MLD,5,1.6094379124341003
sealing,5,1.6094379124341003
1355,5,1.6094379124341003
whole-blood,5,1.6094379124341003
Private,5,1.6094379124341003
Tamiflu®,5,1.6094379124341003
30-days,5,1.6094379124341003
watched,5,1.6094379124341003
WD,5,1.6094379124341003
MIT,5,1.6094379124341003
euthanized,5,1.6094379124341003
6B,5,1.6094379124341003
regularities,5,1.6094379124341003
Serbia,5,1.6094379124341003
Life-threatening,5,1.6094379124341003
psychopathologies,5,1.6094379124341003
cohabiting,5,1.6094379124341003
Spectroscopy,5,1.6094379124341003
7000,5,1.6094379124341003
90-minute,5,1.6094379124341003
Article,5,1.6094379124341003
NoV,5,1.6094379124341003
Cornell,5,1.6094379124341003
Coast,5,1.6094379124341003
Memphis,5,1.6094379124341003
-24,5,1.6094379124341003
leptomeningeal,5,1.6094379124341003
multistate,5,1.6094379124341003
calprotectin,5,1.6094379124341003
mns,5,1.6094379124341003
gd,5,1.6094379124341003
hyperstimulation,5,1.6094379124341003
herniated,5,1.6094379124341003
conformity,5,1.6094379124341003
OME,5,1.6094379124341003
lysosomes,5,1.6094379124341003
sAA,5,1.6094379124341003
by-products,5,1.6094379124341003
albuminuria,5,1.6094379124341003
teratogenicity,5,1.6094379124341003
non-health,5,1.6094379124341003
stacked,5,1.6094379124341003
lamotrigine,5,1.6094379124341003
nobody,5,1.6094379124341003
adenotonsillectomy,5,1.6094379124341003
Sickness,5,1.6094379124341003
Plug,5,1.6094379124341003
QRS-,5,1.6094379124341003
Nanjing,5,1.6094379124341003
cys-LT,5,1.6094379124341003
locating,5,1.6094379124341003
P22,5,1.6094379124341003
1218,5,1.6094379124341003
GPR,5,1.6094379124341003
Rev,5,1.6094379124341003
NNDSS,5,1.6094379124341003
legitimate,5,1.6094379124341003
utilise,5,1.6094379124341003
501Y,5,1.6094379124341003
end-users,5,1.6094379124341003
sequence-based,5,1.6094379124341003
Lewis,5,1.6094379124341003
divorced,5,1.6094379124341003
stringency,5,1.6094379124341003
nasally,5,1.6094379124341003
seamlessly,5,1.6094379124341003
extraction-based,5,1.6094379124341003
mentality,5,1.6094379124341003
masters,5,1.6094379124341003
thromboembolus,5,1.6094379124341003
200102,5,1.6094379124341003
bioassays,5,1.6094379124341003
VCGs,5,1.6094379124341003
packet,5,1.6094379124341003
cordialin,5,1.6094379124341003
smartphone-based,5,1.6094379124341003
ISR,5,1.6094379124341003
Atorvastatin,5,1.6094379124341003
Running,5,1.6094379124341003
bocavirus,5,1.6094379124341003
loud,5,1.6094379124341003
racism,5,1.6094379124341003
ODT,5,1.6094379124341003
self-concept,5,1.6094379124341003
SVA,5,1.6094379124341003
PIBD,5,1.6094379124341003
Hedmark,5,1.6094379124341003
single-stage,5,1.6094379124341003
city-level,5,1.6094379124341003
duplicated,5,1.6094379124341003
Rest,5,1.6094379124341003
esophagitis,5,1.6094379124341003
harbour,5,1.6094379124341003
recuperation,5,1.6094379124341003
homemade,5,1.6094379124341003
minimised,5,1.6094379124341003
DNA-based,5,1.6094379124341003
testable,5,1.6094379124341003
inspected,5,1.6094379124341003
human-origin,5,1.6094379124341003
Hamsters,5,1.6094379124341003
n18,5,1.6094379124341003
730,5,1.6094379124341003
commission,5,1.6094379124341003
Tibet,5,1.6094379124341003
Q-T,5,1.6094379124341003
losing,5,1.6094379124341003
plasmablasts,5,1.6094379124341003
illness-specific,5,1.6094379124341003
wisdom,5,1.6094379124341003
Radiographic,5,1.6094379124341003
Difference,5,1.6094379124341003
Warning,5,1.6094379124341003
UVA,5,1.6094379124341003
cineangiographic,5,1.6094379124341003
UVB,5,1.6094379124341003
non-operative,5,1.6094379124341003
sac,5,1.6094379124341003
purchases,5,1.6094379124341003
vignette,5,1.6094379124341003
multilead,5,1.6094379124341003
asleep,5,1.6094379124341003
reanalyzed,5,1.6094379124341003
creatine-kinase,5,1.6094379124341003
phase-III,5,1.6094379124341003
OT,5,1.6094379124341003
Caroline,5,1.6094379124341003
Directions,5,1.6094379124341003
scent,5,1.6094379124341003
Officer,5,1.6094379124341003
Obstetricians,5,1.6094379124341003
ration,5,1.6094379124341003
ATG5,5,1.6094379124341003
anti-vaccination,5,1.6094379124341003
keyword,5,1.6094379124341003
Correcting,5,1.6094379124341003
Atrioventricular,5,1.6094379124341003
kefir,5,1.6094379124341003
undoubted,5,1.6094379124341003
theorem,5,1.6094379124341003
NACI,5,1.6094379124341003
pan-coronavirus,5,1.6094379124341003
CEPI,5,1.6094379124341003
C-11,5,1.6094379124341003
high-titer,5,1.6094379124341003
85-90,5,1.6094379124341003
Guidelines-Stroke,5,1.6094379124341003
denotes,5,1.6094379124341003
1028,5,1.6094379124341003
≈5,5,1.6094379124341003
columnar,5,1.6094379124341003
DOHMH,5,1.6094379124341003
beneficiary,5,1.6094379124341003
portrayal,5,1.6094379124341003
solutes,5,1.6094379124341003
haematoxylin,5,1.6094379124341003
NSTE-ACS,5,1.6094379124341003
ACF,5,1.6094379124341003
permeation,5,1.6094379124341003
watching,5,1.6094379124341003
composer,5,1.6094379124341003
thermally,5,1.6094379124341003
invalidate,5,1.6094379124341003
pMDIs,5,1.6094379124341003
neu,5,1.6094379124341003
AFPCs,5,1.6094379124341003
radionuclear,5,1.6094379124341003
gateway,5,1.6094379124341003
extractions,5,1.6094379124341003
Opinions,5,1.6094379124341003
12h,5,1.6094379124341003
Sets,5,1.6094379124341003
Cobas®,5,1.6094379124341003
blindly,5,1.6094379124341003
AFIAS,5,1.6094379124341003
hemogram,5,1.6094379124341003
Impulsin,5,1.6094379124341003
civets,5,1.6094379124341003
sub-groups,5,1.6094379124341003
resuscitate,5,1.6094379124341003
positive-stranded,5,1.6094379124341003
TnI,5,1.6094379124341003
n21,5,1.6094379124341003
NCICAS,5,1.6094379124341003
enlisted,5,1.6094379124341003
CIT,5,1.6094379124341003
LDSE,5,1.6094379124341003
CAFO,5,1.6094379124341003
enhancements,5,1.6094379124341003
Widely,5,1.6094379124341003
30-,5,1.6094379124341003
IDDM,5,1.6094379124341003
gesture,5,1.6094379124341003
2132,5,1.6094379124341003
-072,5,1.6094379124341003
49-57,5,1.6094379124341003
singularly,5,1.6094379124341003
hemofiltration,5,1.6094379124341003
Spider,5,1.6094379124341003
DPS,5,1.6094379124341003
non-imaging,5,1.6094379124341003
contra-indicated,5,1.6094379124341003
vasopressin,5,1.6094379124341003
urticarias,5,1.6094379124341003
dose-finding,5,1.6094379124341003
1609,5,1.6094379124341003
1135,5,1.6094379124341003
dosed,5,1.6094379124341003
1982-84,5,1.6094379124341003
Breath,5,1.6094379124341003
creativity,5,1.6094379124341003
HAbg,5,1.6094379124341003
haematologic,5,1.6094379124341003
C3PA,5,1.6094379124341003
approx,5,1.6094379124341003
1998-2000,5,1.6094379124341003
endoventricular,5,1.6094379124341003
Aneurysm,5,1.6094379124341003
Immunomodulatory,5,1.6094379124341003
crystallographic,5,1.6094379124341003
gallopamil,5,1.6094379124341003
foreign-born,5,1.6094379124341003
STF,5,1.6094379124341003
Ovid,5,1.6094379124341003
carriership,5,1.6094379124341003
PLPRO,5,1.6094379124341003
InAc-NPs,5,1.6094379124341003
neuraminidase-inhibiting,5,1.6094379124341003
RAND-ACM,5,1.6094379124341003
FENO₀₀₅,5,1.6094379124341003
PPG,5,1.6094379124341003
ST-VM,5,1.6094379124341003
vasogenic,5,1.6094379124341003
Telmisartan,5,1.6094379124341003
Neuropsychiatric,5,1.6094379124341003
Uncertainties,5,1.6094379124341003
extrasystolic,5,1.6094379124341003
Inactivation,5,1.6094379124341003
16000,5,1.6094379124341003
RAND,5,1.6094379124341003
repress,5,1.6094379124341003
possession,5,1.6094379124341003
terrible,5,1.6094379124341003
dyspepsia,5,1.6094379124341003
auto,5,1.6094379124341003
ncovNP,5,1.6094379124341003
infarct-dependent,5,1.6094379124341003
homologue,5,1.6094379124341003
parameterization,5,1.6094379124341003
literary,5,1.6094379124341003
interleukin-10,5,1.6094379124341003
cm2,5,1.6094379124341003
Predicted,5,1.6094379124341003
otolith,5,1.6094379124341003
SRD,5,1.6094379124341003
PWI-DWI,5,1.6094379124341003
Ppl,5,1.6094379124341003
Covasim,5,1.6094379124341003
LightMix,5,1.6094379124341003
2016-17,5,1.6094379124341003
family-centered,5,1.6094379124341003
two-day,5,1.6094379124341003
iota-carrageenan,5,1.6094379124341003
Inuit,5,1.6094379124341003
1021,5,1.6094379124341003
AH5,5,1.6094379124341003
TST,5,1.6094379124341003
Pneumology,5,1.6094379124341003
IMA,5,1.6094379124341003
evidence-practice,5,1.6094379124341003
single-use,5,1.6094379124341003
Episodic,5,1.6094379124341003
Territorial,5,1.6094379124341003
Semi-structured,5,1.6094379124341003
6-months,5,1.6094379124341003
alpha-tocopherol,5,1.6094379124341003
transversal,5,1.6094379124341003
thiazide,5,1.6094379124341003
Naval,5,1.6094379124341003
Somatic,5,1.6094379124341003
discordantly,5,1.6094379124341003
35-40,5,1.6094379124341003
Unprecedented,5,1.6094379124341003
non-DAWN,5,1.6094379124341003
sums,5,1.6094379124341003
ItOSS,5,1.6094379124341003
abrogation,5,1.6094379124341003
tabletop,5,1.6094379124341003
DO2,5,1.6094379124341003
924,5,1.6094379124341003
Strengths,5,1.6094379124341003
multimers,5,1.6094379124341003
LVHT,5,1.6094379124341003
recrudescent,5,1.6094379124341003
LVETI,5,1.6094379124341003
geriatricians,5,1.6094379124341003
affording,5,1.6094379124341003
Ground-glass,5,1.6094379124341003
upslope,5,1.6094379124341003
credited,5,1.6094379124341003
Complement,5,1.6094379124341003
hypobaric,5,1.6094379124341003
Fibrinogen,5,1.6094379124341003
Validated,5,1.6094379124341003
non-sudden,5,1.6094379124341003
Salivary,5,1.6094379124341003
Experimentally,5,1.6094379124341003
Declaration,5,1.6094379124341003
Panbio™,5,1.6094379124341003
altruistic,5,1.6094379124341003
quadrant,5,1.6094379124341003
high-confidence,5,1.6094379124341003
Cleaning,5,1.6094379124341003
≤25,5,1.6094379124341003
IFF,5,1.6094379124341003
drug-food,5,1.6094379124341003
frequency-matched,5,1.6094379124341003
10-100,5,1.6094379124341003
subluxation,5,1.6094379124341003
postponing,5,1.6094379124341003
IL-12A,5,1.6094379124341003
operculum,5,1.6094379124341003
OPHL,5,1.6094379124341003
communicators,5,1.6094379124341003
SAMBA,5,1.6094379124341003
ossification,5,1.6094379124341003
technologists,5,1.6094379124341003
mth,5,1.6094379124341003
cilazapril,5,1.6094379124341003
microbiologists,5,1.6094379124341003
meta-analyzed,5,1.6094379124341003
pathogen-host,5,1.6094379124341003
wisely,5,1.6094379124341003
webinar,5,1.6094379124341003
SARS‐COV‐2,5,1.6094379124341003
undeniable,5,1.6094379124341003
resynchronization,5,1.6094379124341003
MRT,5,1.6094379124341003
built-in,5,1.6094379124341003
soaring,5,1.6094379124341003
overcomes,5,1.6094379124341003
thrust,5,1.6094379124341003
SHR-SP,5,1.6094379124341003
innocent,5,1.6094379124341003
CPK-peak,5,1.6094379124341003
assemblies,5,1.6094379124341003
EZ-SARS-CoV-2,5,1.6094379124341003
side-by-side,5,1.6094379124341003
chimpanzees,5,1.6094379124341003
halls,5,1.6094379124341003
moderators,5,1.6094379124341003
scaled-up,5,1.6094379124341003
mets,5,1.6094379124341003
BMP-7,5,1.6094379124341003
wrestling,5,1.6094379124341003
edited,5,1.6094379124341003
one-stop,5,1.6094379124341003
peroxides,5,1.6094379124341003
normal-weight,5,1.6094379124341003
cortical-subcortical,5,1.6094379124341003
prognosticating,5,1.6094379124341003
Facebook,5,1.6094379124341003
idiosyncratic,5,1.6094379124341003
asthma-only,5,1.6094379124341003
Malay,5,1.6094379124341003
Theories,5,1.6094379124341003
medicineTCM,5,1.6094379124341003
PEH,5,1.6094379124341003
roommate,5,1.6094379124341003
Hypercholesterolaemia,5,1.6094379124341003
escaped,5,1.6094379124341003
loose,5,1.6094379124341003
TF-RBD,5,1.6094379124341003
Intestinal,5,1.6094379124341003
atomization,5,1.6094379124341003
80000,5,1.6094379124341003
VSV,5,1.6094379124341003
Reliability,5,1.6094379124341003
low-amplitude,5,1.6094379124341003
wreak,5,1.6094379124341003
westward,5,1.6094379124341003
SAGE,5,1.6094379124341003
plasma-based,5,1.6094379124341003
subdivision,5,1.6094379124341003
RFCA,5,1.6094379124341003
PASC,5,1.6094379124341003
coronarosclerosis,5,1.6094379124341003
remantadin,5,1.6094379124341003
cromones,5,1.6094379124341003
Cohorts,5,1.6094379124341003
multimorbidity-related,5,1.6094379124341003
neonatologists,5,1.6094379124341003
capnography,5,1.6094379124341003
mucosae,5,1.6094379124341003
T4,5,1.6094379124341003
delusions,5,1.6094379124341003
explantation,5,1.6094379124341003
OU,5,1.6094379124341003
promotional,5,1.6094379124341003
6-13,5,1.6094379124341003
1105,5,1.6094379124341003
Goretex,5,1.6094379124341003
thrombolitic,5,1.6094379124341003
9-,5,1.6094379124341003
saturations,5,1.6094379124341003
Pk,5,1.6094379124341003
confine,5,1.6094379124341003
mid-May,5,1.6094379124341003
MMIS,5,1.6094379124341003
2b-3,5,1.6094379124341003
e-learning,5,1.6094379124341003
interrater,5,1.6094379124341003
P0039,5,1.6094379124341003
anchoring,5,1.6094379124341003
Paramedics,5,1.6094379124341003
HTx,5,1.6094379124341003
capitalize,5,1.6094379124341003
ANEC,5,1.6094379124341003
Attachment,5,1.6094379124341003
asynchronous,5,1.6094379124341003
ATI,5,1.6094379124341003
oriental,5,1.6094379124341003
APPROACH-score,5,1.6094379124341003
pg,5,1.6094379124341003
judgements,5,1.6094379124341003
Neuromuscular,5,1.6094379124341003
dissolution,5,1.6094379124341003
EUR,5,1.6094379124341003
wean,5,1.6094379124341003
Predictions,5,1.6094379124341003
n33,5,1.6094379124341003
refinements,5,1.6094379124341003
negotiated,5,1.6094379124341003
API,5,1.6094379124341003
type-2eosinophilic,5,1.6094379124341003
precocious,5,1.6094379124341003
economists,5,1.6094379124341003
wash-out,5,1.6094379124341003
subtotally,5,1.6094379124341003
Subtypes,5,1.6094379124341003
In-depth,5,1.6094379124341003
Document,5,1.6094379124341003
Dry,5,1.6094379124341003
A1298C,5,1.6094379124341003
inadequacy,5,1.6094379124341003
insolation,5,1.6094379124341003
aliquots,5,1.6094379124341003
MiSeq,5,1.6094379124341003
LWAQ,5,1.6094379124341003
5-month,5,1.6094379124341003
tirofiban,5,1.6094379124341003
25-40,5,1.6094379124341003
mitotic,5,1.6094379124341003
Bats,5,1.6094379124341003
exposure-response,5,1.6094379124341003
disappointingly,5,1.6094379124341003
predominates,5,1.6094379124341003
enemy,5,1.6094379124341003
2010-2014,5,1.6094379124341003
irradiated,5,1.6094379124341003
bony,5,1.6094379124341003
walled,5,1.6094379124341003
PAI-2,5,1.6094379124341003
evades,5,1.6094379124341003
35-64,5,1.6094379124341003
Opportunities,5,1.6094379124341003
PFV,5,1.6094379124341003
kurtosis,5,1.6094379124341003
hypovolemic,5,1.6094379124341003
earning,5,1.6094379124341003
salicylate,5,1.6094379124341003
attaching,5,1.6094379124341003
sputa,5,1.6094379124341003
Haj,5,1.6094379124341003
fallacy,5,1.6094379124341003
tent,5,1.6094379124341003
low-pH-stable,5,1.6094379124341003
exaggerate,5,1.6094379124341003
Sn,5,1.6094379124341003
Home-based,5,1.6094379124341003
reach-to-grasp,5,1.6094379124341003
estimators,5,1.6094379124341003
tackled,5,1.6094379124341003
BPT,5,1.6094379124341003
otorhinolaryngological,5,1.6094379124341003
santé,5,1.6094379124341003
SIA,5,1.6094379124341003
ultraorthodox,5,1.6094379124341003
shoulders,5,1.6094379124341003
005ABSTRACT,5,1.6094379124341003
residences,5,1.6094379124341003
mechanic,5,1.6094379124341003
Tr,5,1.6094379124341003
IND,5,1.6094379124341003
CovTI,5,1.6094379124341003
crops,5,1.6094379124341003
Mark,5,1.6094379124341003
multilateral,5,1.6094379124341003
AIM-BP,5,1.6094379124341003
gymnasium,5,1.6094379124341003
incursion,5,1.6094379124341003
Twenty-four-hour,5,1.6094379124341003
multi-step,5,1.6094379124341003
guinea-pig,5,1.6094379124341003
BVic,5,1.6094379124341003
AH2N2,5,1.6094379124341003
Antioxidant,5,1.6094379124341003
attractor,5,1.6094379124341003
Naples,5,1.6094379124341003
LACN,5,1.6094379124341003
Hemiplegia,5,1.6094379124341003
Filipinos,5,1.6094379124341003
970,5,1.6094379124341003
preexistent,5,1.6094379124341003
NHFS,5,1.6094379124341003
newcomers,5,1.6094379124341003
heparinoids,5,1.6094379124341003
leisure-time,5,1.6094379124341003
une,5,1.6094379124341003
donate,5,1.6094379124341003
HAART,5,1.6094379124341003
unveil,5,1.6094379124341003
infectors,5,1.6094379124341003
beta-defensin,5,1.6094379124341003
two-phase,5,1.6094379124341003
HEX,5,1.6094379124341003
mcg,5,1.6094379124341003
timeframes,5,1.6094379124341003
Covaxin,5,1.6094379124341003
insecure,5,1.6094379124341003
invisible,5,1.6094379124341003
FURIN,5,1.6094379124341003
NS2,5,1.6094379124341003
HDPCR,5,1.6094379124341003
MSC-based,5,1.6094379124341003
Hormonal,5,1.6094379124341003
pfumL,5,1.6094379124341003
singled,5,1.6094379124341003
RASSF1,5,1.6094379124341003
Han,5,1.6094379124341003
ushered,5,1.6094379124341003
serum-based,5,1.6094379124341003
Scale-16,5,1.6094379124341003
1649,5,1.6094379124341003
NT-020,5,1.6094379124341003
Lay,5,1.6094379124341003
CTSL,5,1.6094379124341003
normoxia,5,1.6094379124341003
confidentiality,5,1.6094379124341003
ETB,5,1.6094379124341003
sensory-motor,5,1.6094379124341003
NOTEWORTHY,5,1.6094379124341003
recalling,5,1.6094379124341003
TENOR,5,1.6094379124341003
A1c,5,1.6094379124341003
low-molecular,5,1.6094379124341003
denaturation,5,1.6094379124341003
BMS‑345541,5,1.6094379124341003
KI,5,1.6094379124341003
countering,5,1.6094379124341003
postcapillary,5,1.6094379124341003
diversion,5,1.6094379124341003
self-amplifying,5,1.6094379124341003
physio-pathological,5,1.6094379124341003
inter-species,5,1.6094379124341003
Strict,5,1.6094379124341003
fixed-reference,5,1.6094379124341003
TLP,5,1.6094379124341003
neutralizes,5,1.6094379124341003
DNB,5,1.6094379124341003
case-series,5,1.6094379124341003
1992-1993,5,1.6094379124341003
List,5,1.6094379124341003
self-manage,5,1.6094379124341003
sunshine,5,1.6094379124341003
MELAS,5,1.6094379124341003
Facility,5,1.6094379124341003
EIW,5,1.6094379124341003
aplastic,5,1.6094379124341003
diligent,5,1.6094379124341003
Wolff-Parkinson-White,5,1.6094379124341003
µL,5,1.6094379124341003
Salmonella,5,1.6094379124341003
counselled,5,1.6094379124341003
MPSS,5,1.6094379124341003
Rs,5,1.6094379124341003
65°C,5,1.6094379124341003
paratope,5,1.6094379124341003
RCC,5,1.6094379124341003
DAVIT,5,1.6094379124341003
pulled,5,1.6094379124341003
Role,5,1.6094379124341003
LFDs,5,1.6094379124341003
substantia,5,1.6094379124341003
Supervised,5,1.6094379124341003
cyclooxygenase-2,5,1.6094379124341003
merited,5,1.6094379124341003
Compliant,5,1.6094379124341003
bones,5,1.6094379124341003
subtracting,5,1.6094379124341003
third-degree,5,1.6094379124341003
low-volume,5,1.6094379124341003
Evidences,5,1.6094379124341003
electromotive,5,1.6094379124341003
3T,5,1.6094379124341003
rewiring,5,1.6094379124341003
H3N8,5,1.6094379124341003
SLI,5,1.6094379124341003
Rajasthan,5,1.6094379124341003
revert,5,1.6094379124341003
dimethylarginine,5,1.6094379124341003
approximated,5,1.6094379124341003
fingers,5,1.6094379124341003
Reciprocal,5,1.6094379124341003
Fore,5,1.6094379124341003
Fluzone,5,1.6094379124341003
engender,5,1.6094379124341003
biodistribution,5,1.6094379124341003
UIIP,5,1.6094379124341003
Pool,5,1.6094379124341003
conveying,5,1.6094379124341003
conserving,5,1.6094379124341003
cardiosurgical,5,1.6094379124341003
rCBV,5,1.6094379124341003
Rhabdomyolysis,5,1.6094379124341003
non-vaccinees,5,1.6094379124341003
RNEF,5,1.6094379124341003
near-future,5,1.6094379124341003
cardiomyopathies,5,1.6094379124341003
-16,5,1.6094379124341003
1288,5,1.6094379124341003
FIRST,5,1.6094379124341003
B1258,5,1.6094379124341003
TNC,5,1.6094379124341003
AAQOL,5,1.6094379124341003
Principles,5,1.6094379124341003
GPT,5,1.6094379124341003
multi,5,1.6094379124341003
birth-death,5,1.6094379124341003
unclarified,5,1.6094379124341003
SMASH-U,5,1.6094379124341003
concave,5,1.6094379124341003
2-20,5,1.6094379124341003
small-bore,5,1.6094379124341003
anhydrides,5,1.6094379124341003
neurocritical,5,1.6094379124341003
Companies,5,1.6094379124341003
non-pH1N1,5,1.6094379124341003
Skeletal,5,1.6094379124341003
harbinger,5,1.6094379124341003
Hyland,5,1.6094379124341003
1055,5,1.6094379124341003
trackers,5,1.6094379124341003
grasses,5,1.6094379124341003
LCA,5,1.6094379124341003
small-focal,5,1.6094379124341003
catastrophes,5,1.6094379124341003
human-avian,5,1.6094379124341003
postponement,5,1.6094379124341003
tubercular,5,1.6094379124341003
20045,5,1.6094379124341003
chronobiology,5,1.6094379124341003
RVD,5,1.6094379124341003
AFL,5,1.6094379124341003
Sci,5,1.6094379124341003
20056,5,1.6094379124341003
miR-4485,5,1.6094379124341003
Dibasol,5,1.6094379124341003
memo,5,1.6094379124341003
inferential,5,1.6094379124341003
societys,5,1.6094379124341003
repertoires,5,1.6094379124341003
Limb,5,1.6094379124341003
intermediate-term,5,1.6094379124341003
reperfusing,5,1.6094379124341003
Age-standardized,5,1.6094379124341003
Hybrid,5,1.6094379124341003
Amr,5,1.6094379124341003
Ipsilateral,5,1.6094379124341003
Ultrasonography,5,1.6094379124341003
GR-Ser226,5,1.6094379124341003
c-Met,5,1.6094379124341003
neuroimmunological,5,1.6094379124341003
JNK1,5,1.6094379124341003
radiata,5,1.6094379124341003
1809,5,1.6094379124341003
childrenadolescents,5,1.6094379124341003
embodied,5,1.6094379124341003
BEpCs,5,1.6094379124341003
MAGLUMI,5,1.6094379124341003
non-adherent,5,1.6094379124341003
host-based,5,1.6094379124341003
onset-to-door,5,1.6094379124341003
high-pathogenicity,5,1.6094379124341003
senses,5,1.6094379124341003
SECP,5,1.6094379124341003
remantadine,5,1.6094379124341003
nanotubes,5,1.6094379124341003
third-leading,5,1.6094379124341003
lower-middle-income,5,1.6094379124341003
-12,5,1.6094379124341003
objection,5,1.6094379124341003
1159,5,1.6094379124341003
Breathlessness,5,1.6094379124341003
polytrauma,5,1.6094379124341003
extractable,5,1.6094379124341003
4-18,5,1.6094379124341003
µgm3,5,1.6094379124341003
kogiids,5,1.6094379124341003
reorganized,5,1.6094379124341003
constrains,5,1.6094379124341003
-18,5,1.6094379124341003
Microscopically,5,1.6094379124341003
8-fold,5,1.6094379124341003
ecosystems,5,1.6094379124341003
Matched,5,1.6094379124341003
22-month-old,5,1.6094379124341003
COR,5,1.6094379124341003
non-smoker,5,1.6094379124341003
high-mannose,5,1.6094379124341003
maximization,5,1.6094379124341003
pathogeneses,5,1.6094379124341003
Self-monitoring,5,1.6094379124341003
sterling,5,1.6094379124341003
CACS,5,1.6094379124341003
guidelines-based,5,1.6094379124341003
livelihood,5,1.6094379124341003
BYam,5,1.6094379124341003
AKS-452,5,1.6094379124341003
DRs,5,1.6094379124341003
Herd,5,1.6094379124341003
assigns,5,1.6094379124341003
1878,5,1.6094379124341003
civic,5,1.6094379124341003
detriment,5,1.6094379124341003
XX,5,1.6094379124341003
Adopting,5,1.6094379124341003
prohibitive,5,1.6094379124341003
population-specific,5,1.6094379124341003
human-derived,5,1.6094379124341003
carryover,5,1.6094379124341003
Algerian,5,1.6094379124341003
Solutions,5,1.6094379124341003
life-table,5,1.6094379124341003
8-11,5,1.6094379124341003
maxillary,5,1.6094379124341003
polyclinics,5,1.6094379124341003
orthognathic,5,1.6094379124341003
dichotomies,5,1.6094379124341003
stereotypes,5,1.6094379124341003
AIIRDs,5,1.6094379124341003
deconvolution,5,1.6094379124341003
recalls,5,1.6094379124341003
Quickvue,5,1.6094379124341003
neuroradiologist,5,1.6094379124341003
RIT,5,1.6094379124341003
test-of-skew,5,1.6094379124341003
destroys,5,1.6094379124341003
generality,5,1.6094379124341003
CFTAH,5,1.6094379124341003
HIF-1α,5,1.6094379124341003
Updates,5,1.6094379124341003
S-RBD,5,1.6094379124341003
reoccluded,5,1.6094379124341003
Thyroid,5,1.6094379124341003
prepaid,5,1.6094379124341003
D21,5,1.6094379124341003
HINTS,5,1.6094379124341003
indolent,5,1.6094379124341003
EQ-5D,5,1.6094379124341003
GSTT1--,5,1.6094379124341003
provisionally,5,1.6094379124341003
Nanotechnology,5,1.6094379124341003
mouthrinses,5,1.6094379124341003
multi-level,5,1.6094379124341003
tangible,5,1.6094379124341003
excesses,5,1.6094379124341003
NHC,5,1.6094379124341003
allergyimmunology,5,1.6094379124341003
StO2,5,1.6094379124341003
proviral,5,1.6094379124341003
immune-regulatory,5,1.6094379124341003
BHRwork,5,1.6094379124341003
hydroxyl,5,1.6094379124341003
LBD,5,1.6094379124341003
Lethal,5,1.6094379124341003
CASP,5,1.6094379124341003
hypogeusia,5,1.6094379124341003
Autonomic,5,1.6094379124341003
interpretability,5,1.6094379124341003
Non-vitamin,5,1.6094379124341003
competitions,5,1.6094379124341003
SCoVaG,5,1.6094379124341003
≤40,5,1.6094379124341003
psychotropic,5,1.6094379124341003
traceable,5,1.6094379124341003
dehydrated,5,1.6094379124341003
registering,5,1.6094379124341003
Short-Form,5,1.6094379124341003
shelter-in-place,5,1.6094379124341003
pause,5,1.6094379124341003
beta-receptor,5,1.6094379124341003
disagree,5,1.6094379124341003
cadaver,5,1.6094379124341003
Difficulty,5,1.6094379124341003
Fujian,5,1.6094379124341003
SEIAR,5,1.6094379124341003
2344,5,1.6094379124341003
sliding,5,1.6094379124341003
co-cultured,5,1.6094379124341003
neuroprotectors,5,1.6094379124341003
twist,5,1.6094379124341003
Rules,5,1.6094379124341003
MOF,5,1.6094379124341003
Latvia,5,1.6094379124341003
BioS,5,1.6094379124341003
stating,5,1.6094379124341003
corticobulbar,5,1.6094379124341003
triangulation,5,1.6094379124341003
Tailored,5,1.6094379124341003
preliminarily,5,1.6094379124341003
BLTS,5,1.6094379124341003
Euro,5,1.6094379124341003
AChA,5,1.6094379124341003
interactomes,5,1.6094379124341003
withwithout,5,1.6094379124341003
ASCT,5,1.6094379124341003
neuro-imaging,5,1.6094379124341003
Jaccard,5,1.6094379124341003
Q4,5,1.6094379124341003
NIID-S2,5,1.6094379124341003
Q3,5,1.6094379124341003
treadmill-running,5,1.6094379124341003
temperature-sensitive,5,1.6094379124341003
mitigates,5,1.6094379124341003
nonpenetrating,5,1.6094379124341003
racially,5,1.6094379124341003
forty-one,5,1.6094379124341003
litre,5,1.6094379124341003
Manaus,5,1.6094379124341003
GN,5,1.6094379124341003
Charité,5,1.6094379124341003
photochemical,5,1.6094379124341003
-079,5,1.6094379124341003
PCTs,5,1.6094379124341003
2003-04,5,1.6094379124341003
BHRlab,5,1.6094379124341003
Endotoxin,5,1.6094379124341003
diet-induced,5,1.6094379124341003
engenders,5,1.6094379124341003
acetyl,5,1.6094379124341003
Methylprednisolone,5,1.6094379124341003
Stenotrophomonas,5,1.6094379124341003
Brunei,5,1.6094379124341003
TCMs,5,1.6094379124341003
RT-PCRs,5,1.6094379124341003
maltophilia,5,1.6094379124341003
permeable,5,1.6094379124341003
metalloprotease,5,1.6094379124341003
corpuscular,5,1.6094379124341003
DSS,5,1.6094379124341003
imparts,5,1.6094379124341003
immunoblotting,5,1.6094379124341003
hysteria,5,1.6094379124341003
keratinocytes,5,1.6094379124341003
twenty-six,5,1.6094379124341003
AH7N7,5,1.6094379124341003
MLRM,5,1.6094379124341003
CICU,5,1.6094379124341003
Excellent,5,1.6094379124341003
multistep,5,1.6094379124341003
anatomic-pathology,5,1.6094379124341003
six-week,5,1.6094379124341003
co-factor,5,1.6094379124341003
manageable,5,1.6094379124341003
UANSTEMI,5,1.6094379124341003
17q12-21,5,1.6094379124341003
unhelpful,5,1.6094379124341003
n29,5,1.6094379124341003
RVPNT,5,1.6094379124341003
Mch,5,1.6094379124341003
ARVDC,5,1.6094379124341003
Nonpharmaceutical,5,1.6094379124341003
PBV,5,1.6094379124341003
-4,5,1.6094379124341003
gathers,5,1.6094379124341003
22-28,5,1.6094379124341003
visit-to-visit,5,1.6094379124341003
tipped,5,1.6094379124341003
spirometers,5,1.6094379124341003
Af,5,1.6094379124341003
cancer-related,5,1.6094379124341003
diverging,5,1.6094379124341003
hinting,5,1.6094379124341003
Pin1,5,1.6094379124341003
gowns,5,1.6094379124341003
spawned,5,1.6094379124341003
Zhou,5,1.6094379124341003
GHSA,5,1.6094379124341003
Patch,5,1.6094379124341003
striving,5,1.6094379124341003
hitting,5,1.6094379124341003
publishing,5,1.6094379124341003
robot,5,1.6094379124341003
foresee,5,1.6094379124341003
posteriori,5,1.6094379124341003
lipase,5,1.6094379124341003
constrictor,5,1.6094379124341003
reverse-mode,5,1.6094379124341003
ABP,5,1.6094379124341003
ID50,5,1.6094379124341003
operability,5,1.6094379124341003
Sichuan,5,1.6094379124341003
niacin,5,1.6094379124341003
wastes,5,1.6094379124341003
tomograms,5,1.6094379124341003
miR-30a,5,1.6094379124341003
Ion,5,1.6094379124341003
invention,5,1.6094379124341003
resin,5,1.6094379124341003
Modifications,5,1.6094379124341003
biosurveillance,5,1.6094379124341003
breach,5,1.6094379124341003
IMD,5,1.6094379124341003
sat,5,1.6094379124341003
CalvNO,5,1.6094379124341003
SAB,5,1.6094379124341003
domain-containing,5,1.6094379124341003
glycan-based,5,1.6094379124341003
day-time,5,1.6094379124341003
momentary,5,1.6094379124341003
sponsors,5,1.6094379124341003
proofs,5,1.6094379124341003
leathers,5,1.6094379124341003
synapses,5,1.6094379124341003
carbohydrates,5,1.6094379124341003
germicidal,5,1.6094379124341003
Coinfection,5,1.6094379124341003
haploidentical,5,1.6094379124341003
mattresses,5,1.6094379124341003
infarct-limiting,5,1.6094379124341003
tsunami,5,1.6094379124341003
catamenial,5,1.6094379124341003
199798,5,1.6094379124341003
RPT,5,1.6094379124341003
NK-1R,5,1.6094379124341003
pleurectomy,5,1.6094379124341003
Ca2i,5,1.6094379124341003
Validity,5,1.6094379124341003
coverings,5,1.6094379124341003
mole,5,1.6094379124341003
finger-prick,5,1.6094379124341003
angiocardiographic,5,1.6094379124341003
hydrofluoroalkane,5,1.6094379124341003
redeployment,5,1.6094379124341003
phytotherapy,5,1.6094379124341003
juice,5,1.6094379124341003
humidifier,5,1.6094379124341003
interleukin-1β,5,1.6094379124341003
fortnightly,5,1.6094379124341003
2017-18,5,1.6094379124341003
ZAP,5,1.6094379124341003
foodborne,5,1.6094379124341003
NCs,5,1.6094379124341003
Segments,5,1.6094379124341003
megakaryocytes,5,1.6094379124341003
moderator,5,1.6094379124341003
epiphenomenon,5,1.6094379124341003
Gypsum,5,1.6094379124341003
Hyposensitization,5,1.6094379124341003
GRE,5,1.6094379124341003
H6N1,5,1.6094379124341003
hall,5,1.6094379124341003
tied,5,1.6094379124341003
rectum,5,1.6094379124341003
evaporation,5,1.6094379124341003
warmer,5,1.6094379124341003
fibronectin,5,1.6094379124341003
Mother,5,1.6094379124341003
Charleroi,5,1.6094379124341003
imperfectly,5,1.6094379124341003
clothing,5,1.6094379124341003
1938,5,1.6094379124341003
acetylation,5,1.6094379124341003
Flemish,5,1.6094379124341003
P0DTC4,5,1.6094379124341003
leaflets,5,1.6094379124341003
viroporin,5,1.6094379124341003
ACE-inhibitor,5,1.6094379124341003
S-wave,5,1.6094379124341003
APOBEC3,5,1.6094379124341003
voxelwise,5,1.6094379124341003
HDL-cholesterol,5,1.6094379124341003
pharyngitis,5,1.6094379124341003
unawareness,5,1.6094379124341003
underrepresentation,5,1.6094379124341003
bedridden,5,1.6094379124341003
LPM,5,1.6094379124341003
CD19,5,1.6094379124341003
Fructus,5,1.6094379124341003
Haemorrhagic,5,1.6094379124341003
sensitised,5,1.6094379124341003
albicans,5,1.6094379124341003
shaft,5,1.6094379124341003
haptic,5,1.6094379124341003
EMDs,5,1.6094379124341003
-25,5,1.6094379124341003
hesperidin,5,1.6094379124341003
Greenland,5,1.6094379124341003
RPA-LF,5,1.6094379124341003
IADC,5,1.6094379124341003
non-cavitary,5,1.6094379124341003
Material,5,1.6094379124341003
summated,5,1.6094379124341003
LHDs,5,1.6094379124341003
anOPCAB,5,1.6094379124341003
ACR,5,1.6094379124341003
Adoption,5,1.6094379124341003
Worcester,5,1.6094379124341003
luteolin,5,1.6094379124341003
1-1,5,1.6094379124341003
Collaterals,5,1.6094379124341003
untreatable,5,1.6094379124341003
webinars,5,1.6094379124341003
migraineous,5,1.6094379124341003
cross-clamping,5,1.6094379124341003
ELF-MF,5,1.6094379124341003
EOA,5,1.6094379124341003
pathologist,5,1.6094379124341003
ZINC,5,1.6094379124341003
tracheobronchitis,5,1.6094379124341003
assessable,5,1.6094379124341003
STS,5,1.6094379124341003
99mTc-TBI,5,1.6094379124341003
reallocation,5,1.6094379124341003
Nsp3,5,1.6094379124341003
GenMark,5,1.6094379124341003
misperception,5,1.6094379124341003
TAb,5,1.6094379124341003
IDS,5,1.6094379124341003
rafts,5,1.6094379124341003
FQHC,5,1.6094379124341003
exchanger,5,1.6094379124341003
mortality-rate,5,1.6094379124341003
within-country,5,1.6094379124341003
1884,5,1.6094379124341003
gender-,5,1.6094379124341003
exchangers,5,1.6094379124341003
IVUS-VH,5,1.6094379124341003
microscopical,5,1.6094379124341003
facemask,5,1.6094379124341003
mouthpiece,5,1.6094379124341003
denoting,5,1.6094379124341003
SNAb,5,1.6094379124341003
pinpointing,5,1.6094379124341003
deranged,5,1.6094379124341003
5778,5,1.6094379124341003
Race,5,1.6094379124341003
aptamer-nucleoprotein,5,1.6094379124341003
nationality,5,1.6094379124341003
idiosyncrasy,5,1.6094379124341003
Sheikh,5,1.6094379124341003
RSC,5,1.6094379124341003
Lumbricus,5,1.6094379124341003
AC-EIA,5,1.6094379124341003
enddiastolic,5,1.6094379124341003
curse,5,1.6094379124341003
solvent,5,1.6094379124341003
singly,5,1.6094379124341003
Secretary,5,1.6094379124341003
EFs,5,1.6094379124341003
suspicions,5,1.6094379124341003
spencer,5,1.6094379124341003
inoculate,5,1.6094379124341003
descendants,5,1.6094379124341003
necrosed,5,1.6094379124341003
1136,5,1.6094379124341003
amended,5,1.6094379124341003
trail,5,1.6094379124341003
disagreed,5,1.6094379124341003
–,5,1.6094379124341003
laying,5,1.6094379124341003
Headings,5,1.6094379124341003
Ectopic,5,1.6094379124341003
titles,5,1.6094379124341003
Astra,5,1.6094379124341003
functionalities,5,1.6094379124341003
AVM,5,1.6094379124341003
hospitalist,5,1.6094379124341003
mutability,5,1.6094379124341003
electromyographic,5,1.6094379124341003
abundantly,5,1.6094379124341003
Intra,5,1.6094379124341003
colloid,5,1.6094379124341003
SOPs,5,1.6094379124341003
DNM,5,1.6094379124341003
tipping,5,1.6094379124341003
friendly,5,1.6094379124341003
electronegative,5,1.6094379124341003
high-dimensional,5,1.6094379124341003
wrongly,5,1.6094379124341003
Case-fatality,5,1.6094379124341003
rostral,5,1.6094379124341003
low-power,5,1.6094379124341003
disorientation,5,1.6094379124341003
HAS-BLED,5,1.6094379124341003
anoxic,5,1.6094379124341003
Reproduction,5,1.6094379124341003
Self-collection,5,1.6094379124341003
1326,5,1.6094379124341003
non-R,5,1.6094379124341003
Estonian,5,1.6094379124341003
attentive,5,1.6094379124341003
Percentage,5,1.6094379124341003
sarbecoviruses,5,1.6094379124341003
noncomplicated,5,1.6094379124341003
Cardiología,5,1.6094379124341003
ours,5,1.6094379124341003
ovariectomized,5,1.6094379124341003
biography,5,1.6094379124341003
≤6,5,1.6094379124341003
SRS,5,1.6094379124341003
ketamine,5,1.6094379124341003
CRISPRCas13,5,1.6094379124341003
Cytomegalovirus,5,1.6094379124341003
CIB,5,1.6094379124341003
xanthines,5,1.6094379124341003
stabilised,5,1.6094379124341003
refuting,5,1.6094379124341003
envelop,5,1.6094379124341003
redefine,5,1.6094379124341003
Anti,5,1.6094379124341003
mexidol,5,1.6094379124341003
enoxacin,5,1.6094379124341003
NSA,5,1.6094379124341003
peculiarity,5,1.6094379124341003
Replacement,5,1.6094379124341003
3-UTR,5,1.6094379124341003
Mg2,5,1.6094379124341003
eicosapentaenoic,5,1.6094379124341003
Wuxi,5,1.6094379124341003
DHA,5,1.6094379124341003
IgG2a,5,1.6094379124341003
tells,5,1.6094379124341003
videoconferencing,5,1.6094379124341003
RDN,5,1.6094379124341003
irreversibility,5,1.6094379124341003
0125,5,1.6094379124341003
Incubation,5,1.6094379124341003
nylon,5,1.6094379124341003
20152016,5,1.6094379124341003
AECs,5,1.6094379124341003
PARP,5,1.6094379124341003
Herzegovina,5,1.6094379124341003
Bosnia,5,1.6094379124341003
MEG,5,1.6094379124341003
B-lymphocytes,5,1.6094379124341003
Enlargement,5,1.6094379124341003
deepened,5,1.6094379124341003
rinse,5,1.6094379124341003
2019-20,5,1.6094379124341003
VES,5,1.6094379124341003
SAS,5,1.6094379124341003
ipsi-,5,1.6094379124341003
QRS-complex,5,1.6094379124341003
Antioxidants,5,1.6094379124341003
O-linked,5,1.6094379124341003
avid,5,1.6094379124341003
Wearing,5,1.6094379124341003
approximations,5,1.6094379124341003
DANAMI-2,5,1.6094379124341003
Exogenous,5,1.6094379124341003
bed-ridden,5,1.6094379124341003
APerth162009,5,1.6094379124341003
Ramipril,5,1.6094379124341003
human-type,5,1.6094379124341003
VRTI,5,1.6094379124341003
20-39,5,1.6094379124341003
40th,5,1.6094379124341003
thoracostomy,5,1.6094379124341003
personalize,5,1.6094379124341003
abolishing,5,1.6094379124341003
lipidomics,5,1.6094379124341003
REINJ,5,1.6094379124341003
realise,5,1.6094379124341003
CEHC,5,1.6094379124341003
sympathoadrenal,5,1.6094379124341003
anti-allergy,5,1.6094379124341003
CrBs,5,1.6094379124341003
dysfunctioning,5,1.6094379124341003
VO2peak,5,1.6094379124341003
localizable,5,1.6094379124341003
HPD,5,1.6094379124341003
stuttering,5,1.6094379124341003
AMA,5,1.6094379124341003
person-months,5,1.6094379124341003
Blockade,5,1.6094379124341003
secondhand,5,1.6094379124341003
STEPS,5,1.6094379124341003
least-squares,5,1.6094379124341003
1140,5,1.6094379124341003
Strains,5,1.6094379124341003
raloxifene,5,1.6094379124341003
IIV3LAIV3,5,1.6094379124341003
anti-H5,5,1.6094379124341003
labored,5,1.6094379124341003
haemagglutinins,5,1.6094379124341003
unmasked,5,1.6094379124341003
p01,5,1.6094379124341003
Populations,5,1.6094379124341003
quantitating,5,1.6094379124341003
DITPA,5,1.6094379124341003
thyroxine,5,1.6094379124341003
CARE,5,1.6094379124341003
60-min,5,1.6094379124341003
depot,5,1.6094379124341003
1993-94,5,1.6094379124341003
mistakenly,5,1.6094379124341003
9-month,5,1.6094379124341003
nt,5,1.6094379124341003
type-I,5,1.6094379124341003
spoken,5,1.6094379124341003
freeze-thawing,5,1.6094379124341003
inter-patient,5,1.6094379124341003
JS7,5,1.6094379124341003
annotations,5,1.6094379124341003
1h,5,1.6094379124341003
shrinkage,5,1.6094379124341003
México,5,1.6094379124341003
1848,5,1.6094379124341003
unbalanced,5,1.6094379124341003
delayed-enhancement,5,1.6094379124341003
Metis,5,1.6094379124341003
proarrhythmic,5,1.6094379124341003
T2-AAR,5,1.6094379124341003
supervising,5,1.6094379124341003
interviewers,5,1.6094379124341003
nonresponder,5,1.6094379124341003
reanalysis,5,1.6094379124341003
Rg2,5,1.6094379124341003
worst-case,5,1.6094379124341003
relay,5,1.6094379124341003
CTPpost,5,1.6094379124341003
anesthetist,5,1.6094379124341003
DIT,5,1.6094379124341003
Lopinavir,5,1.6094379124341003
ameliorates,5,1.6094379124341003
psychodiagnostic,5,1.6094379124341003
GGT,5,1.6094379124341003
necrotized,5,1.6094379124341003
DBA2,5,1.6094379124341003
Non-ST,5,1.6094379124341003
microscopes,5,1.6094379124341003
Normalized,5,1.6094379124341003
charitable,5,1.6094379124341003
ginsenoside,5,1.6094379124341003
amplification-free,5,1.6094379124341003
digits,5,1.6094379124341003
rehabilitating,5,1.6094379124341003
Prime,5,1.6094379124341003
Amarum,5,1.6094379124341003
Mortagy,5,1.6094379124341003
Reproducibility,5,1.6094379124341003
POINTS,5,1.6094379124341003
DLS,5,1.6094379124341003
Armeniacae,5,1.6094379124341003
Ill,5,1.6094379124341003
Gd-DOTA,5,1.6094379124341003
microgram,5,1.6094379124341003
polyclinic,5,1.6094379124341003
imprinted,5,1.6094379124341003
beta-receptors,5,1.6094379124341003
sentence,5,1.6094379124341003
recombinants,5,1.6094379124341003
Connections,5,1.6094379124341003
IPPE,5,1.6094379124341003
distension,5,1.6094379124341003
theatres,5,1.6094379124341003
prognosticate,5,1.6094379124341003
Schoolchildren,5,1.6094379124341003
MTC,5,1.6094379124341003
costal,5,1.6094379124341003
reversion,5,1.6094379124341003
GEMA,5,1.6094379124341003
dural,5,1.6094379124341003
2035,5,1.6094379124341003
immunosuppressant,5,1.6094379124341003
IV-t-PA,5,1.6094379124341003
ADCR,5,1.6094379124341003
SARS-CoV-2-encoded,5,1.6094379124341003
V1-V2,5,1.6094379124341003
closeness,5,1.6094379124341003
first-onset,5,1.6094379124341003
precedents,5,1.6094379124341003
obligate,5,1.6094379124341003
Perspectives,5,1.6094379124341003
KTR,5,1.6094379124341003
Parkinson,5,1.6094379124341003
shelf,5,1.6094379124341003
domain-binding,5,1.6094379124341003
repositioned,5,1.6094379124341003
bus,5,1.6094379124341003
Self-collected,5,1.6094379124341003
48-hour,5,1.6094379124341003
saponins,5,1.6094379124341003
BRBV,5,1.6094379124341003
HFREF,5,1.6094379124341003
well-coordinated,5,1.6094379124341003
UL2,5,1.6094379124341003
GSTTF,5,1.6094379124341003
SHR-A3,5,1.6094379124341003
Nagasaki,5,1.6094379124341003
PROs,5,1.6094379124341003
768,5,1.6094379124341003
Root,5,1.6094379124341003
GP1R-binding,5,1.6094379124341003
-13,5,1.6094379124341003
localizes,5,1.6094379124341003
Diisocyanates,5,1.6094379124341003
-23,5,1.6094379124341003
H5N1-infected,5,1.6094379124341003
uninfarcted,5,1.6094379124341003
hs-cTnT,5,1.6094379124341003
vasodilatory,5,1.6094379124341003
Indicators,5,1.6094379124341003
deregulated,5,1.6094379124341003
Davis,5,1.6094379124341003
germane,5,1.6094379124341003
NPP,5,1.6094379124341003
interchangeably,5,1.6094379124341003
3-hydroxy-3-methylglutaryl,5,1.6094379124341003
ASUI,5,1.6094379124341003
talked,5,1.6094379124341003
Brescia,5,1.6094379124341003
1450,5,1.6094379124341003
SPSN,5,1.6094379124341003
radionuclides,5,1.6094379124341003
attack-rate,5,1.6094379124341003
SHR,5,1.6094379124341003
unanimously,5,1.6094379124341003
bizarre,5,1.6094379124341003
periodicity-2,5,1.6094379124341003
HepG2,5,1.6094379124341003
HFABP,5,1.6094379124341003
OHCA,5,1.6094379124341003
EGCG,5,1.6094379124341003
J-point,5,1.6094379124341003
Modernas,5,1.6094379124341003
competencies,5,1.6094379124341003
upsurge,5,1.6094379124341003
para,5,1.6094379124341003
glycation,5,1.6094379124341003
MSICH,5,1.6094379124341003
migraine-induced,5,1.6094379124341003
lastly,5,1.6094379124341003
3015,5,1.6094379124341003
Santiago,5,1.6094379124341003
grants,5,1.6094379124341003
Word,5,1.6094379124341003
0075,5,1.6094379124341003
ultra-fast,5,1.6094379124341003
Underuse,5,1.6094379124341003
AQL,5,1.6094379124341003
city-specific,5,1.6094379124341003
PRED,5,1.6094379124341003
Cu,5,1.6094379124341003
delirious,5,1.6094379124341003
nitrative,5,1.6094379124341003
nasalnasopharyngeal,5,1.6094379124341003
mirrors,5,1.6094379124341003
tMCAO,5,1.6094379124341003
centurys,5,1.6094379124341003
derivations,5,1.6094379124341003
chemoprophylactic,5,1.6094379124341003
nontotal,5,1.6094379124341003
TimeSpan,5,1.6094379124341003
travel-associated,5,1.6094379124341003
AFujian4112002,5,1.6094379124341003
seventy-nine,5,1.6094379124341003
Oxygenation,5,1.6094379124341003
desaturations,5,1.6094379124341003
Pathologically,5,1.6094379124341003
skeleton,5,1.6094379124341003
1810,5,1.6094379124341003
BICV-F,5,1.6094379124341003
immunodiagnostic,5,1.6094379124341003
engraft,5,1.6094379124341003
PFUmL,5,1.6094379124341003
affirmed,5,1.6094379124341003
Dacron,5,1.6094379124341003
SEAMI,5,1.6094379124341003
CPs,5,1.6094379124341003
Roundtable,5,1.6094379124341003
anti-tumor,5,1.6094379124341003
photocatalytic,5,1.6094379124341003
sigmoid,5,1.6094379124341003
LSS,5,1.6094379124341003
bay,5,1.6094379124341003
Punjab,5,1.6094379124341003
1901,5,1.6094379124341003
Selvesters,5,1.6094379124341003
Microbiological,5,1.6094379124341003
mHla-RBD,5,1.6094379124341003
NSTND,5,1.6094379124341003
sulfonylureas,5,1.6094379124341003
Redistribution,5,1.6094379124341003
post-SARS,5,1.6094379124341003
urogenital,5,1.6094379124341003
Rabbits,5,1.6094379124341003
NC-CT,5,1.6094379124341003
conveys,5,1.6094379124341003
Ancillary,5,1.6094379124341003
Kansai,5,1.6094379124341003
Alternatives,5,1.6094379124341003
SMART,5,1.6094379124341003
1·1,5,1.6094379124341003
1086,5,1.6094379124341003
MCID,5,1.6094379124341003
LLEx,5,1.6094379124341003
Veracruz,5,1.6094379124341003
ProFlu,5,1.6094379124341003
case-history,5,1.6094379124341003
inventories,5,1.6094379124341003
multiple-choice,5,1.6094379124341003
HCTCAR-T,5,1.6094379124341003
RT-qPCR-based,5,1.6094379124341003
1932,5,1.6094379124341003
totalling,5,1.6094379124341003
SVGs,5,1.6094379124341003
lyse,5,1.6094379124341003
near-infrared,5,1.6094379124341003
Yes,5,1.6094379124341003
inward,5,1.6094379124341003
MICAD,5,1.6094379124341003
cleaner,5,1.6094379124341003
1-30,5,1.6094379124341003
colocalization,5,1.6094379124341003
sponge,5,1.6094379124341003
Neutrophils,5,1.6094379124341003
MgIG,5,1.6094379124341003
ISUC,5,1.6094379124341003
seats,5,1.6094379124341003
UP,5,1.6094379124341003
≥10,5,1.6094379124341003
cold-induced,5,1.6094379124341003
midway,5,1.6094379124341003
Sahlgrenska,5,1.6094379124341003
introductory,5,1.6094379124341003
Migration,5,1.6094379124341003
Accelerated,5,1.6094379124341003
neurosyphilis,5,1.6094379124341003
NSCH,5,1.6094379124341003
Above,5,1.6094379124341003
troubling,5,1.6094379124341003
occluders,5,1.6094379124341003
Calgary,5,1.6094379124341003
single-centre,5,1.6094379124341003
thrombo-embolism,5,1.6094379124341003
Daegu,5,1.6094379124341003
coils,5,1.6094379124341003
land-based,5,1.6094379124341003
PSV,5,1.6094379124341003
pour,5,1.6094379124341003
Classical,5,1.6094379124341003
13-22,5,1.6094379124341003
granularity,5,1.6094379124341003
Martinique,5,1.6094379124341003
Estrogen,5,1.6094379124341003
CCTA,5,1.6094379124341003
empyemas,5,1.6094379124341003
PVSA,5,1.6094379124341003
euros,5,1.6094379124341003
intrapartum,5,1.6094379124341003
mfEMT,5,1.6094379124341003
covalently,5,1.6094379124341003
Bronx,5,1.6094379124341003
worker-collected,5,1.6094379124341003
portends,5,1.6094379124341003
hyperenhancement,5,1.6094379124341003
fgmL,5,1.6094379124341003
60-day,5,1.6094379124341003
Analogous,5,1.6094379124341003
Unbiased,5,1.6094379124341003
ln,5,1.6094379124341003
€,5,1.6094379124341003
Hippocratic,5,1.6094379124341003
Susceptible-Infected-Recovered,5,1.6094379124341003
mentions,5,1.6094379124341003
peroxidative,5,1.6094379124341003
TBGS,5,1.6094379124341003
excitotoxic,5,1.6094379124341003
VDR,5,1.6094379124341003
thrombectomies,5,1.6094379124341003
significantABSTRACT,5,1.6094379124341003
racemic,5,1.6094379124341003
contagiosity,5,1.6094379124341003
thrown,5,1.6094379124341003
between-visit,5,1.6094379124341003
epileptogenesis,5,1.6094379124341003
impossibility,5,1.6094379124341003
Miyazaki,5,1.6094379124341003
lab-based,5,1.6094379124341003
cholecystectomy,5,1.6094379124341003
ORF9b,5,1.6094379124341003
tradeoffs,5,1.6094379124341003
extents,5,1.6094379124341003
on-board,5,1.6094379124341003
Bronchoprovocation,5,1.6094379124341003
flushing,5,1.6094379124341003
Accessory,5,1.6094379124341003
terrifying,5,1.6094379124341003
BioFire®,5,1.6094379124341003
u,5,1.6094379124341003
fractionated,5,1.6094379124341003
half-maximal,5,1.6094379124341003
Propylamylatin,5,1.6094379124341003
low-pathogenic,5,1.6094379124341003
ORF3b,5,1.6094379124341003
youths,5,1.6094379124341003
TGF-β-mediated,5,1.6094379124341003
QASC,5,1.6094379124341003
GEO,5,1.6094379124341003
EPR2,5,1.6094379124341003
male-female,5,1.6094379124341003
phenotypical,5,1.6094379124341003
histograms,5,1.6094379124341003
Ex-Echo,5,1.6094379124341003
continuance,5,1.6094379124341003
új,5,1.6094379124341003
Jersey876,5,1.6094379124341003
June-September,5,1.6094379124341003
confusional,5,1.6094379124341003
desperate,5,1.6094379124341003
4-day,5,1.6094379124341003
Controversial,5,1.6094379124341003
eminently,5,1.6094379124341003
mania,5,1.6094379124341003
5-point,5,1.6094379124341003
Station,5,1.6094379124341003
litigation,5,1.6094379124341003
week-1,5,1.6094379124341003
musculocutaneous,5,1.6094379124341003
ARF,5,1.6094379124341003
hypochondriasis,5,1.6094379124341003
PD20C,5,1.6094379124341003
-308,5,1.6094379124341003
criticisms,5,1.6094379124341003
eluted,5,1.6094379124341003
Marine,5,1.6094379124341003
EMAs,5,1.6094379124341003
1976-77,5,1.6094379124341003
AMAT,5,1.6094379124341003
parameterize,5,1.6094379124341003
activity-related,5,1.6094379124341003
shedders,5,1.6094379124341003
ADSCs,5,1.6094379124341003
MFI-20,5,1.6094379124341003
Peculiarities,5,1.6094379124341003
Mage,5,1.6094379124341003
HMW,5,1.6094379124341003
apolipoproteins,5,1.6094379124341003
true-positive,5,1.6094379124341003
Evolving,5,1.6094379124341003
17-28,5,1.6094379124341003
55-64,5,1.6094379124341003
venoarterial,5,1.6094379124341003
deactivation,5,1.6094379124341003
Interstitial,5,1.6094379124341003
GmbH,5,1.6094379124341003
depopulation,5,1.6094379124341003
ose-R,5,1.6094379124341003
microvessel,5,1.6094379124341003
nonparametric,5,1.6094379124341003
deferral,5,1.6094379124341003
reperfusion-induced,5,1.6094379124341003
Shell,5,1.6094379124341003
IIb-IIIa,5,1.6094379124341003
animal-derived,5,1.6094379124341003
circuitry,5,1.6094379124341003
pearls,5,1.6094379124341003
nST,5,1.6094379124341003
Exposed,5,1.6094379124341003
uncoating,5,1.6094379124341003
Jakarta,5,1.6094379124341003
CAMI,5,1.6094379124341003
pneumothoraces,5,1.6094379124341003
Bat,5,1.6094379124341003
venepuncture,5,1.6094379124341003
thermodynamic,5,1.6094379124341003
VQ,5,1.6094379124341003
fQRSD,5,1.6094379124341003
eight-year,5,1.6094379124341003
uremia,5,1.6094379124341003
flow-based,5,1.6094379124341003
abated,5,1.6094379124341003
Aas,5,1.6094379124341003
suspecting,5,1.6094379124341003
Authorizations,5,1.6094379124341003
rurality,5,1.6094379124341003
Returning,5,1.6094379124341003
caseloads,5,1.6094379124341003
második,5,1.6094379124341003
Cross-reactivity,5,1.6094379124341003
CRISPRCas,5,1.6094379124341003
dual-task,5,1.6094379124341003
IgG2,5,1.6094379124341003
PSD-95,5,1.6094379124341003
inter-assay,5,1.6094379124341003
hotel,5,1.6094379124341003
overflow,5,1.6094379124341003
dependencies,5,1.6094379124341003
attrition,5,1.6094379124341003
medical-surgical,5,1.6094379124341003
Cronbach,5,1.6094379124341003
MI-NCA,5,1.6094379124341003
portend,5,1.6094379124341003
posteriorly,5,1.6094379124341003
new-generation,5,1.6094379124341003
impulses,5,1.6094379124341003
dispatcher,5,1.6094379124341003
E-protein,5,1.6094379124341003
pili,5,1.6094379124341003
perpetuated,5,1.6094379124341003
oxygenated,5,1.6094379124341003
1-11,5,1.6094379124341003
obtains,5,1.6094379124341003
BCDT,5,1.6094379124341003
ILINet,5,1.6094379124341003
pre-operative,5,1.6094379124341003
condition-specific,5,1.6094379124341003
vaccine-type,5,1.6094379124341003
subtest,5,1.6094379124341003
ventilation-perfusion,5,1.6094379124341003
hemianopia,5,1.6094379124341003
RCVS,5,1.6094379124341003
START,5,1.6094379124341003
Nausea,5,1.6094379124341003
Postural,5,1.6094379124341003
obliged,5,1.6094379124341003
collapsed,5,1.6094379124341003
evacuees,5,1.6094379124341003
Stop,5,1.6094379124341003
decortication,5,1.6094379124341003
Abeta1-40,5,1.6094379124341003
csoportban,5,1.6094379124341003
VitaPCR™,5,1.6094379124341003
-047,5,1.6094379124341003
1732,5,1.6094379124341003
4-hour,5,1.6094379124341003
ISB6,5,1.6094379124341003
expelled,5,1.6094379124341003
ISTLR4--,5,1.6094379124341003
Tc-PYP,5,1.6094379124341003
settling,5,1.6094379124341003
methylergometrine,5,1.6094379124341003
pensioners,5,1.6094379124341003
explainable,5,1.6094379124341003
slow-onset,5,1.6094379124341003
ethnicracial,5,1.6094379124341003
safeguarding,5,1.6094379124341003
Aggregation,5,1.6094379124341003
Learn,5,1.6094379124341003
inland,5,1.6094379124341003
merging,5,1.6094379124341003
1525,5,1.6094379124341003
low-dosage,5,1.6094379124341003
Readers,5,1.6094379124341003
1984-85,5,1.6094379124341003
proximate,5,1.6094379124341003
metabolizing,5,1.6094379124341003
ASOs,5,1.6094379124341003
nanoagent,5,1.6094379124341003
OPV1,5,1.6094379124341003
characterizations,5,1.6094379124341003
bacteriophage,5,1.6094379124341003
ref,5,1.6094379124341003
MoH,5,1.6094379124341003
IUdL,5,1.6094379124341003
parturition,5,1.6094379124341003
predispositions,5,1.6094379124341003
MDCK-SIAT1,5,1.6094379124341003
compendium,5,1.6094379124341003
daughter,5,1.6094379124341003
triaged,5,1.6094379124341003
Visit,5,1.6094379124341003
synthetized,5,1.6094379124341003
fifty-two,5,1.6094379124341003
reshaped,5,1.6094379124341003
Below,5,1.6094379124341003
dreams,5,1.6094379124341003
AQP4,5,1.6094379124341003
SET,5,1.6094379124341003
antioxidant-rich,5,1.6094379124341003
ELA,5,1.6094379124341003
liquid-handling,5,1.6094379124341003
over-expression,5,1.6094379124341003
obviating,5,1.6094379124341003
eicosanoids,5,1.6094379124341003
3500,5,1.6094379124341003
mn,5,1.6094379124341003
15-month,5,1.6094379124341003
Intramyocardial,5,1.6094379124341003
cleaving,5,1.6094379124341003
oxygenase-1,5,1.6094379124341003
Intrauterine,5,1.6094379124341003
-004,5,1.6094379124341003
non-traditional,5,1.6094379124341003
R292K,5,1.6094379124341003
incurs,5,1.6094379124341003
79-year-old,5,1.6094379124341003
Misconceptions,5,1.6094379124341003
stethoscope,5,1.6094379124341003
Ep,5,1.6094379124341003
Reproductive,5,1.6094379124341003
poll,5,1.6094379124341003
1425,5,1.6094379124341003
AMICS,5,1.6094379124341003
serodiagnostic,5,1.6094379124341003
Cue,5,1.6094379124341003
betablocker,5,1.6094379124341003
Tang,5,1.6094379124341003
Nash,5,1.6094379124341003
Wang,5,1.6094379124341003
perturb,5,1.6094379124341003
Assurance,5,1.6094379124341003
sequestration,5,1.6094379124341003
incontinentia,5,1.6094379124341003
fingerprint,5,1.6094379124341003
Tozinameran,5,1.6094379124341003
miR-133a,5,1.6094379124341003
pigmenti,5,1.6094379124341003
inferiorlateral,5,1.6094379124341003
Gujarat,5,1.6094379124341003
Fine,5,1.6094379124341003
C-C,5,1.6094379124341003
II-III,5,1.6094379124341003
Chart,5,1.6094379124341003
multiplicative,5,1.6094379124341003
DANAMI,5,1.6094379124341003
nonvascular,5,1.6094379124341003
nSTEMI,5,1.6094379124341003
Appreciation,5,1.6094379124341003
myofibril,5,1.6094379124341003
stride,5,1.6094379124341003
country-level,5,1.6094379124341003
undeveloped,5,1.6094379124341003
OHNS,5,1.6094379124341003
dissimilarities,5,1.6094379124341003
homozygote,5,1.6094379124341003
ploidy,5,1.6094379124341003
multiomics,5,1.6094379124341003
golf,5,1.6094379124341003
laterally,5,1.6094379124341003
substantiating,5,1.6094379124341003
overburdened,5,1.6094379124341003
cancerous,5,1.6094379124341003
infiltrated,5,1.6094379124341003
ProQuest,5,1.6094379124341003
submucosa,5,1.6094379124341003
check-ups,5,1.6094379124341003
Piedmont,5,1.6094379124341003
orderly,5,1.6094379124341003
accepts,5,1.6094379124341003
20-50,5,1.6094379124341003
microgL,5,1.6094379124341003
Backgroundobjective,5,1.6094379124341003
Immunol,5,1.6094379124341003
WindSock,5,1.6094379124341003
Addisons,5,1.6094379124341003
Backward,5,1.6094379124341003
alleviates,5,1.6094379124341003
RT-PCR-negative,5,1.6094379124341003
specialization,5,1.6094379124341003
EGFP,5,1.6094379124341003
Sequences,5,1.6094379124341003
Yangtze,5,1.6094379124341003
feels,5,1.6094379124341003
neuroplastic,5,1.6094379124341003
heel,5,1.6094379124341003
relocation,5,1.6094379124341003
Jenkins,5,1.6094379124341003
Overcoming,5,1.6094379124341003
self-assessed,5,1.6094379124341003
assistive,5,1.6094379124341003
Wearable,5,1.6094379124341003
recommendable,5,1.6094379124341003
composing,5,1.6094379124341003
1117,5,1.6094379124341003
Journals,5,1.6094379124341003
sham-controlled,5,1.6094379124341003
PVI,5,1.6094379124341003
minerals,5,1.6094379124341003
20089,5,1.6094379124341003
crab,5,1.6094379124341003
antiflu,5,1.6094379124341003
SARS-Co-V-2,5,1.6094379124341003
Obstacles,5,1.6094379124341003
three-week,5,1.6094379124341003
Immunosuppression,5,1.6094379124341003
Home-time,5,1.6094379124341003
attack-rates,5,1.6094379124341003
home-time,5,1.6094379124341003
SPRINT,5,1.6094379124341003
endophenotypes,5,1.6094379124341003
Designing,5,1.6094379124341003
0·001,5,1.6094379124341003
right-posterior-inferior,5,1.6094379124341003
SCOVAM,5,1.6094379124341003
19181919,5,1.6094379124341003
interspace,5,1.6094379124341003
deformations,5,1.6094379124341003
SERPINE1,5,1.6094379124341003
MeSH,5,1.6094379124341003
24-hr,5,1.6094379124341003
Ironically,5,1.6094379124341003
distraction,5,1.6094379124341003
Ukrainian,5,1.6094379124341003
pathomorphological,5,1.6094379124341003
verifying,5,1.6094379124341003
metaphors,5,1.6094379124341003
H5N6GZ14,5,1.6094379124341003
Parkinsonism,5,1.6094379124341003
acebutolol,5,1.6094379124341003
Achilles,5,1.6094379124341003
upper-limb,5,1.6094379124341003
nutraceuticals,5,1.6094379124341003
Non-valvular,5,1.6094379124341003
post-conditioning,5,1.6094379124341003
advises,5,1.6094379124341003
multi-scale,5,1.6094379124341003
pregabalin,5,1.6094379124341003
area-at-risk,5,1.6094379124341003
hide,5,1.6094379124341003
nondippers,5,1.6094379124341003
quadriplegic,5,1.6094379124341003
streptococcal,5,1.6094379124341003
ultrafine,5,1.6094379124341003
Enteric,5,1.6094379124341003
guideline-driven,5,1.6094379124341003
reoxygenation,5,1.6094379124341003
powders,5,1.6094379124341003
Unexplained,5,1.6094379124341003
penetrates,5,1.6094379124341003
Batumi,5,1.6094379124341003
Asian-Pacific,5,1.6094379124341003
hypercapnic,4,1.3862943611198906
Stroke-related,4,1.3862943611198906
14-3-3,4,1.3862943611198906
Takayasu,4,1.3862943611198906
Manager,4,1.3862943611198906
retrieving,4,1.3862943611198906
Concomitantly,4,1.3862943611198906
door-to-door,4,1.3862943611198906
Barnes,4,1.3862943611198906
1234,4,1.3862943611198906
nanocarriers,4,1.3862943611198906
1818,4,1.3862943611198906
identifications,4,1.3862943611198906
Vessels,4,1.3862943611198906
Huanan,4,1.3862943611198906
-061,4,1.3862943611198906
shelf-life,4,1.3862943611198906
DrugBank,4,1.3862943611198906
Murray,4,1.3862943611198906
contaminations,4,1.3862943611198906
MagNA,4,1.3862943611198906
phobic,4,1.3862943611198906
HSV-1,4,1.3862943611198906
rationed,4,1.3862943611198906
22-fold,4,1.3862943611198906
invalidated,4,1.3862943611198906
WQ,4,1.3862943611198906
autosomal-dominant,4,1.3862943611198906
publishers,4,1.3862943611198906
1981-1983,4,1.3862943611198906
Mostly,4,1.3862943611198906
anticardiac,4,1.3862943611198906
pre-dispensed,4,1.3862943611198906
multipurpose,4,1.3862943611198906
person-fit,4,1.3862943611198906
translations,4,1.3862943611198906
48h,4,1.3862943611198906
hurricanes,4,1.3862943611198906
mentoring,4,1.3862943611198906
kpmmin,4,1.3862943611198906
Plg--,4,1.3862943611198906
n35,4,1.3862943611198906
legion,4,1.3862943611198906
xenogeneic,4,1.3862943611198906
221minm2,4,1.3862943611198906
exercise-provoked,4,1.3862943611198906
1023,4,1.3862943611198906
toddler,4,1.3862943611198906
CZ-MD,4,1.3862943611198906
misfolding,4,1.3862943611198906
Ghanaian,4,1.3862943611198906
CDPHE,4,1.3862943611198906
biofluids,4,1.3862943611198906
calves,4,1.3862943611198906
Reminder,4,1.3862943611198906
Prinzmetals,4,1.3862943611198906
11-20,4,1.3862943611198906
rinses,4,1.3862943611198906
oxides,4,1.3862943611198906
VRF,4,1.3862943611198906
overconsumption,4,1.3862943611198906
Gruppo,4,1.3862943611198906
Tristan,4,1.3862943611198906
microgkg,4,1.3862943611198906
Italiano,4,1.3862943611198906
lo,4,1.3862943611198906
Studio,4,1.3862943611198906
Cunha,4,1.3862943611198906
empty,4,1.3862943611198906
COVID‐19‐associated,4,1.3862943611198906
chicks,4,1.3862943611198906
rhythm-control,4,1.3862943611198906
OBJECTIVES,4,1.3862943611198906
leucotrienes,4,1.3862943611198906
Azerbaijan,4,1.3862943611198906
shipboard,4,1.3862943611198906
phthalic,4,1.3862943611198906
co-operative,4,1.3862943611198906
pyramidal,4,1.3862943611198906
schematic,4,1.3862943611198906
MPT,4,1.3862943611198906
fronto-temporal,4,1.3862943611198906
HPV,4,1.3862943611198906
S-2P,4,1.3862943611198906
pM,4,1.3862943611198906
bending,4,1.3862943611198906
analyser,4,1.3862943611198906
Thalamic,4,1.3862943611198906
cyanotic,4,1.3862943611198906
SRCs,4,1.3862943611198906
operant,4,1.3862943611198906
immortalized,4,1.3862943611198906
flow-mediated,4,1.3862943611198906
damage-associated,4,1.3862943611198906
DV,4,1.3862943611198906
re-admitted,4,1.3862943611198906
dismiss,4,1.3862943611198906
BioSpeedia,4,1.3862943611198906
1019,4,1.3862943611198906
CVLT-II,4,1.3862943611198906
SHUTi,4,1.3862943611198906
negative-pressure,4,1.3862943611198906
old-age,4,1.3862943611198906
Gaussian,4,1.3862943611198906
6LU7,4,1.3862943611198906
ESHRE,4,1.3862943611198906
performance-based,4,1.3862943611198906
chorea,4,1.3862943611198906
plasmablast,4,1.3862943611198906
GsGd,4,1.3862943611198906
COVID-19-,4,1.3862943611198906
thoracoamniotic,4,1.3862943611198906
3020,4,1.3862943611198906
TCCS,4,1.3862943611198906
asth,4,1.3862943611198906
10-min,4,1.3862943611198906
pulseless,4,1.3862943611198906
Disposable,4,1.3862943611198906
benzodiazepines,4,1.3862943611198906
endeavoring,4,1.3862943611198906
GeneXpert®,4,1.3862943611198906
1A,4,1.3862943611198906
18-30,4,1.3862943611198906
glycerol,4,1.3862943611198906
DMN,4,1.3862943611198906
iliac,4,1.3862943611198906
200203,4,1.3862943611198906
voles,4,1.3862943611198906
5-20,4,1.3862943611198906
confluence,4,1.3862943611198906
ECD,4,1.3862943611198906
blamed,4,1.3862943611198906
Unemployment,4,1.3862943611198906
40-70,4,1.3862943611198906
1752,4,1.3862943611198906
Reassortment,4,1.3862943611198906
contra,4,1.3862943611198906
Manifestations,4,1.3862943611198906
plt0001,4,1.3862943611198906
centipede,4,1.3862943611198906
YES,4,1.3862943611198906
unbound,4,1.3862943611198906
RMSF,4,1.3862943611198906
AFM,4,1.3862943611198906
hypogammaglobulinemia,4,1.3862943611198906
Respir,4,1.3862943611198906
liver-transplant,4,1.3862943611198906
tempting,4,1.3862943611198906
post-viral,4,1.3862943611198906
casting,4,1.3862943611198906
complementarity,4,1.3862943611198906
-82,4,1.3862943611198906
fuelled,4,1.3862943611198906
entrenched,4,1.3862943611198906
One-Pot,4,1.3862943611198906
unverified,4,1.3862943611198906
intelligible,4,1.3862943611198906
storing,4,1.3862943611198906
blast,4,1.3862943611198906
fifty-four,4,1.3862943611198906
migraine-like,4,1.3862943611198906
bioresorbable,4,1.3862943611198906
AVI,4,1.3862943611198906
≥300,4,1.3862943611198906
Muslim,4,1.3862943611198906
BVictoria287-lineage,4,1.3862943611198906
factor-based,4,1.3862943611198906
tcPo2,4,1.3862943611198906
P0013,4,1.3862943611198906
monocytosis,4,1.3862943611198906
acutechronic,4,1.3862943611198906
HEK293,4,1.3862943611198906
SGs,4,1.3862943611198906
Proportional,4,1.3862943611198906
high-mobility,4,1.3862943611198906
complement-fixing,4,1.3862943611198906
iodine,4,1.3862943611198906
rumor,4,1.3862943611198906
SARS-CoV-2-S,4,1.3862943611198906
Approved,4,1.3862943611198906
non-approved,4,1.3862943611198906
Hazards,4,1.3862943611198906
CoV2-S,4,1.3862943611198906
VCV,4,1.3862943611198906
TBS,4,1.3862943611198906
cav-1,4,1.3862943611198906
cotinine,4,1.3862943611198906
CIS,4,1.3862943611198906
samplings,4,1.3862943611198906
AAS,4,1.3862943611198906
202021,4,1.3862943611198906
marathon,4,1.3862943611198906
MHV-A59,4,1.3862943611198906
Microalbuminuria,4,1.3862943611198906
90-120,4,1.3862943611198906
VK,4,1.3862943611198906
concentric,4,1.3862943611198906
thematically,4,1.3862943611198906
telematic,4,1.3862943611198906
transcytosis,4,1.3862943611198906
humidifiers,4,1.3862943611198906
dictating,4,1.3862943611198906
non-Asian,4,1.3862943611198906
123IMIBG,4,1.3862943611198906
serostatus,4,1.3862943611198906
ECG-12,4,1.3862943611198906
pads,4,1.3862943611198906
stent-assisted,4,1.3862943611198906
15-minute,4,1.3862943611198906
XeCT,4,1.3862943611198906
lips,4,1.3862943611198906
Milton,4,1.3862943611198906
VA-ECMO,4,1.3862943611198906
pc-,4,1.3862943611198906
Lodz,4,1.3862943611198906
vagy,4,1.3862943611198906
goggles,4,1.3862943611198906
der,4,1.3862943611198906
Fas,4,1.3862943611198906
glasses,4,1.3862943611198906
Procalcitonin,4,1.3862943611198906
glove,4,1.3862943611198906
NRAD,4,1.3862943611198906
UET,4,1.3862943611198906
CO-VID-19,4,1.3862943611198906
onset-to-needle,4,1.3862943611198906
sub-endocardial,4,1.3862943611198906
oppose,4,1.3862943611198906
middle-ear,4,1.3862943611198906
Comparable,4,1.3862943611198906
Ramin,4,1.3862943611198906
7-,4,1.3862943611198906
SARS--CoV--2,4,1.3862943611198906
WHotLAMP,4,1.3862943611198906
stings,4,1.3862943611198906
≥13,4,1.3862943611198906
enlarge,4,1.3862943611198906
benchmarked,4,1.3862943611198906
stung,4,1.3862943611198906
Excel,4,1.3862943611198906
pop,4,1.3862943611198906
re-infections,4,1.3862943611198906
Misinformation,4,1.3862943611198906
chronic-care,4,1.3862943611198906
late-presenting,4,1.3862943611198906
RVs,4,1.3862943611198906
CawNO,4,1.3862943611198906
bidentata,4,1.3862943611198906
Postoperatively,4,1.3862943611198906
Undertreatment,4,1.3862943611198906
1820,4,1.3862943611198906
COSS,4,1.3862943611198906
yellow-gold,4,1.3862943611198906
deepen,4,1.3862943611198906
schizophrenic,4,1.3862943611198906
xenobiotics,4,1.3862943611198906
hUC-MSCs,4,1.3862943611198906
omega-6,4,1.3862943611198906
Vaccine-associated,4,1.3862943611198906
AVs,4,1.3862943611198906
May-August,4,1.3862943611198906
Mumbai,4,1.3862943611198906
sensibilization,4,1.3862943611198906
onkológiai,4,1.3862943611198906
1376,4,1.3862943611198906
ABrisbane5907,4,1.3862943611198906
chlorofluorocarbons,4,1.3862943611198906
RASTs,4,1.3862943611198906
single-domain,4,1.3862943611198906
wetlands,4,1.3862943611198906
LVA,4,1.3862943611198906
viral-infected,4,1.3862943611198906
rhinocerotis,4,1.3862943611198906
fuelling,4,1.3862943611198906
RTKs,4,1.3862943611198906
pineal,4,1.3862943611198906
Tulsa,4,1.3862943611198906
-33,4,1.3862943611198906
chromogranin,4,1.3862943611198906
DBHM,4,1.3862943611198906
anti-S-RBD,4,1.3862943611198906
1941,4,1.3862943611198906
articulation,4,1.3862943611198906
Transforming,4,1.3862943611198906
fundoplication,4,1.3862943611198906
SORT,4,1.3862943611198906
MHV-68,4,1.3862943611198906
Shoulder,4,1.3862943611198906
Exaggerated,4,1.3862943611198906
Guideline-based,4,1.3862943611198906
FFM,4,1.3862943611198906
Extremely,4,1.3862943611198906
nonvitamin,4,1.3862943611198906
Dor,4,1.3862943611198906
Reactogenicity,4,1.3862943611198906
Matrix-M,4,1.3862943611198906
PHI,4,1.3862943611198906
multi-year,4,1.3862943611198906
2009-2013,4,1.3862943611198906
FAM,4,1.3862943611198906
-5,4,1.3862943611198906
phlegm-heat,4,1.3862943611198906
prefrontal,4,1.3862943611198906
non-ischemized,4,1.3862943611198906
water-soluble,4,1.3862943611198906
RVsZO,4,1.3862943611198906
MCDPH,4,1.3862943611198906
6-20,4,1.3862943611198906
forty-five,4,1.3862943611198906
Titer,4,1.3862943611198906
cosmetic,4,1.3862943611198906
broncholytics,4,1.3862943611198906
rejecting,4,1.3862943611198906
patients’,4,1.3862943611198906
dayswk,4,1.3862943611198906
decelerating,4,1.3862943611198906
cTns,4,1.3862943611198906
zonal,4,1.3862943611198906
Cordafen,4,1.3862943611198906
astounding,4,1.3862943611198906
evidently,4,1.3862943611198906
12-16,4,1.3862943611198906
INS,4,1.3862943611198906
CD3,4,1.3862943611198906
GLaMOR,4,1.3862943611198906
virus-encoded,4,1.3862943611198906
TAPAS,4,1.3862943611198906
non-corticosteroids,4,1.3862943611198906
compositional,4,1.3862943611198906
N-IRA,4,1.3862943611198906
MTS,4,1.3862943611198906
accomplishing,4,1.3862943611198906
subspecialists,4,1.3862943611198906
oclock,4,1.3862943611198906
subcohort,4,1.3862943611198906
subunit-based,4,1.3862943611198906
EVT-access,4,1.3862943611198906
gammaherpesvirus,4,1.3862943611198906
utilitarian,4,1.3862943611198906
antero,4,1.3862943611198906
pyruvate,4,1.3862943611198906
self-imposed,4,1.3862943611198906
699,4,1.3862943611198906
XII,4,1.3862943611198906
adipokines,4,1.3862943611198906
Myxovirus,4,1.3862943611198906
41-50,4,1.3862943611198906
virosomes,4,1.3862943611198906
itchy,4,1.3862943611198906
acquisitions,4,1.3862943611198906
autofluorescence,4,1.3862943611198906
ponds,4,1.3862943611198906
Fibrosum,4,1.3862943611198906
methylated,4,1.3862943611198906
sensitizer-induced,4,1.3862943611198906
9-15,4,1.3862943611198906
mimetic,4,1.3862943611198906
macrolevel,4,1.3862943611198906
high-precision,4,1.3862943611198906
Age-matched,4,1.3862943611198906
Estimate,4,1.3862943611198906
MALDI-TOF,4,1.3862943611198906
EMPs,4,1.3862943611198906
catarrhalis,4,1.3862943611198906
corridor,4,1.3862943611198906
Principle,4,1.3862943611198906
WMFT-IT,4,1.3862943611198906
dentate,4,1.3862943611198906
Music,4,1.3862943611198906
PMPs,4,1.3862943611198906
cages,4,1.3862943611198906
immunise,4,1.3862943611198906
kallikrein,4,1.3862943611198906
Non-compliance,4,1.3862943611198906
bifid,4,1.3862943611198906
ICHD,4,1.3862943611198906
peroxidase-antiperoxidase,4,1.3862943611198906
overcrowded,4,1.3862943611198906
skipped,4,1.3862943611198906
FI,4,1.3862943611198906
induration,4,1.3862943611198906
marmosets,4,1.3862943611198906
PDGF-AB,4,1.3862943611198906
knowledge-based,4,1.3862943611198906
afflictions,4,1.3862943611198906
earth,4,1.3862943611198906
4200,4,1.3862943611198906
Rhinoviruses,4,1.3862943611198906
MSMS,4,1.3862943611198906
Allopurinol,4,1.3862943611198906
lowest-income,4,1.3862943611198906
00035,4,1.3862943611198906
Judging,4,1.3862943611198906
trinitrin,4,1.3862943611198906
announcing,4,1.3862943611198906
insertions,4,1.3862943611198906
naturopathy,4,1.3862943611198906
cluster-randomised,4,1.3862943611198906
ectatic,4,1.3862943611198906
Dallas,4,1.3862943611198906
non-cerebrovascular,4,1.3862943611198906
self-independent,4,1.3862943611198906
preejection,4,1.3862943611198906
coordinates,4,1.3862943611198906
split-virus,4,1.3862943611198906
detergents,4,1.3862943611198906
painter,4,1.3862943611198906
MVA-SARS-2-S,4,1.3862943611198906
BRM,4,1.3862943611198906
best-fit,4,1.3862943611198906
HbS,4,1.3862943611198906
purchasers,4,1.3862943611198906
disintegration,4,1.3862943611198906
every-day,4,1.3862943611198906
inotropy,4,1.3862943611198906
survivable,4,1.3862943611198906
Profound,4,1.3862943611198906
coiling,4,1.3862943611198906
CR3022,4,1.3862943611198906
perseverance,4,1.3862943611198906
halfway,4,1.3862943611198906
pituitary-adrenal,4,1.3862943611198906
neuromodulatory,4,1.3862943611198906
Datalink,4,1.3862943611198906
reexamined,4,1.3862943611198906
Homeland,4,1.3862943611198906
Event-free,4,1.3862943611198906
millió,4,1.3862943611198906
Pounds,4,1.3862943611198906
heuristic,4,1.3862943611198906
corticosterone,4,1.3862943611198906
T1DM,4,1.3862943611198906
Market,4,1.3862943611198906
emigrants,4,1.3862943611198906
salicylic,4,1.3862943611198906
Aspergillosis,4,1.3862943611198906
1984-1985,4,1.3862943611198906
BEAS-2B,4,1.3862943611198906
nonmigrants,4,1.3862943611198906
soldier,4,1.3862943611198906
meals,4,1.3862943611198906
probit,4,1.3862943611198906
IIIa,4,1.3862943611198906
cross-border,4,1.3862943611198906
mid-July,4,1.3862943611198906
HASBLED,4,1.3862943611198906
SARS-CoV-2-PCR,4,1.3862943611198906
artistic,4,1.3862943611198906
G-protein-coupled,4,1.3862943611198906
CPHL,4,1.3862943611198906
Suboptimal,4,1.3862943611198906
Ethnopharmacological,4,1.3862943611198906
log-binomial,4,1.3862943611198906
anti-2GPI,4,1.3862943611198906
spacing,4,1.3862943611198906
MMP-2,4,1.3862943611198906
Stents,4,1.3862943611198906
embryological,4,1.3862943611198906
settle,4,1.3862943611198906
cell-,4,1.3862943611198906
Position,4,1.3862943611198906
Chennai,4,1.3862943611198906
mass-action,4,1.3862943611198906
termtime,4,1.3862943611198906
reexamine,4,1.3862943611198906
pCO2,4,1.3862943611198906
HLA-A,4,1.3862943611198906
Localized,4,1.3862943611198906
Allogeneic,4,1.3862943611198906
apraxic,4,1.3862943611198906
temporoparietal,4,1.3862943611198906
superiorly,4,1.3862943611198906
AcHERV-VLP,4,1.3862943611198906
cars,4,1.3862943611198906
neurite,4,1.3862943611198906
haematology,4,1.3862943611198906
nonlethal,4,1.3862943611198906
CoVID-19,4,1.3862943611198906
sympathectomy,4,1.3862943611198906
meaningless,4,1.3862943611198906
NIH-SS,4,1.3862943611198906
18449,4,1.3862943611198906
contradict,4,1.3862943611198906
representational,4,1.3862943611198906
transactional,4,1.3862943611198906
Neonatology,4,1.3862943611198906
feral,4,1.3862943611198906
acenocoumarol,4,1.3862943611198906
peptidomimetic,4,1.3862943611198906
perorally,4,1.3862943611198906
Overexpression,4,1.3862943611198906
EVW,4,1.3862943611198906
Cadm2,4,1.3862943611198906
hydralazine,4,1.3862943611198906
Seminar,4,1.3862943611198906
Dosing,4,1.3862943611198906
3608,4,1.3862943611198906
up-regulate,4,1.3862943611198906
nitrendipine,4,1.3862943611198906
Coupled,4,1.3862943611198906
μ,4,1.3862943611198906
ICE,4,1.3862943611198906
no-ER,4,1.3862943611198906
197980,4,1.3862943611198906
Florianopolis,4,1.3862943611198906
Hospitalised,4,1.3862943611198906
Düsseldorf,4,1.3862943611198906
lg,4,1.3862943611198906
winter-spring,4,1.3862943611198906
vectorcardiogramme,4,1.3862943611198906
Triazavirin,4,1.3862943611198906
1012,4,1.3862943611198906
CMILRV,4,1.3862943611198906
FPA,4,1.3862943611198906
ETIS,4,1.3862943611198906
neuropilin-1,4,1.3862943611198906
ASTER,4,1.3862943611198906
Post-hoc,4,1.3862943611198906
Serotonin,4,1.3862943611198906
thrombo-aspiration,4,1.3862943611198906
HR096,4,1.3862943611198906
AHINI,4,1.3862943611198906
endoscope,4,1.3862943611198906
heat-treated,4,1.3862943611198906
small-sized,4,1.3862943611198906
ASMareaPBM,4,1.3862943611198906
1-12,4,1.3862943611198906
4DCT,4,1.3862943611198906
MM-A,4,1.3862943611198906
Sneddon,4,1.3862943611198906
CD14,4,1.3862943611198906
randomisation,4,1.3862943611198906
refrigerated,4,1.3862943611198906
JAKSTAT,4,1.3862943611198906
PI3KAKT,4,1.3862943611198906
Multicentre,4,1.3862943611198906
lactis,4,1.3862943611198906
CYP2C19,4,1.3862943611198906
clot-dissolving,4,1.3862943611198906
SOS,4,1.3862943611198906
excipients,4,1.3862943611198906
MOLLI,4,1.3862943611198906
paper-pencil,4,1.3862943611198906
advisors,4,1.3862943611198906
Wi-N,4,1.3862943611198906
Sphingolipids,4,1.3862943611198906
S-CRISPR,4,1.3862943611198906
S-gene,4,1.3862943611198906
Cancellation,4,1.3862943611198906
affordance,4,1.3862943611198906
S-myoglobin,4,1.3862943611198906
PROMs,4,1.3862943611198906
Star,4,1.3862943611198906
RCGP,4,1.3862943611198906
pre-DOAC,4,1.3862943611198906
Ischgl,4,1.3862943611198906
Digitalis,4,1.3862943611198906
bemiparin,4,1.3862943611198906
maker,4,1.3862943611198906
SSEP,4,1.3862943611198906
Bevezetés,4,1.3862943611198906
Policlinico,4,1.3862943611198906
illuminance,4,1.3862943611198906
ESwab,4,1.3862943611198906
pharma,4,1.3862943611198906
Specimen,4,1.3862943611198906
proponents,4,1.3862943611198906
GIH,4,1.3862943611198906
CDS,4,1.3862943611198906
kinesio,4,1.3862943611198906
taping,4,1.3862943611198906
overdispersion,4,1.3862943611198906
FAST-MI,4,1.3862943611198906
Allergist,4,1.3862943611198906
leukosis,4,1.3862943611198906
structuring,4,1.3862943611198906
Kolkata,4,1.3862943611198906
T2-mapping,4,1.3862943611198906
Leicestershire,4,1.3862943611198906
SACS,4,1.3862943611198906
PVP-I,4,1.3862943611198906
nanobiodevice,4,1.3862943611198906
PCF,4,1.3862943611198906
anti-inflammatories,4,1.3862943611198906
nonsurgical,4,1.3862943611198906
18-50,4,1.3862943611198906
1882,4,1.3862943611198906
compiling,4,1.3862943611198906
VKHD,4,1.3862943611198906
empowered,4,1.3862943611198906
co-administered,4,1.3862943611198906
bioclimatic,4,1.3862943611198906
yesno,4,1.3862943611198906
60-140,4,1.3862943611198906
transseptal,4,1.3862943611198906
Warburg,4,1.3862943611198906
Consolidation,4,1.3862943611198906
Box,4,1.3862943611198906
Non-contrast,4,1.3862943611198906
CDR,4,1.3862943611198906
two-test,4,1.3862943611198906
2162,4,1.3862943611198906
Dickinson,4,1.3862943611198906
periciliary,4,1.3862943611198906
SARS-CoV-2-RNA,4,1.3862943611198906
untimely,4,1.3862943611198906
Uhl-1,4,1.3862943611198906
MDC,4,1.3862943611198906
Becton,4,1.3862943611198906
-053,4,1.3862943611198906
-029,4,1.3862943611198906
multi-feature,4,1.3862943611198906
ATM,4,1.3862943611198906
Color,4,1.3862943611198906
CDSC,4,1.3862943611198906
50-59,4,1.3862943611198906
clinico-epidemiological,4,1.3862943611198906
parent-report,4,1.3862943611198906
Intraventricular,4,1.3862943611198906
Catheter,4,1.3862943611198906
initiator,4,1.3862943611198906
Ontology,4,1.3862943611198906
Zurich,4,1.3862943611198906
Brazilians,4,1.3862943611198906
prostatic,4,1.3862943611198906
instantaneously,4,1.3862943611198906
capnograms,4,1.3862943611198906
PMIP,4,1.3862943611198906
IIABSTRACT,4,1.3862943611198906
potencies,4,1.3862943611198906
-56,4,1.3862943611198906
proteasome,4,1.3862943611198906
Dupilumab,4,1.3862943611198906
DTPA,4,1.3862943611198906
January-February,4,1.3862943611198906
elasticity,4,1.3862943611198906
D-type,4,1.3862943611198906
104353,4,1.3862943611198906
BKg,4,1.3862943611198906
counterbalancing,4,1.3862943611198906
pro-urokinase,4,1.3862943611198906
cardiometabolic,4,1.3862943611198906
unsustained,4,1.3862943611198906
1176,4,1.3862943611198906
ALRI,4,1.3862943611198906
monocytesmacrophages,4,1.3862943611198906
90-95,4,1.3862943611198906
-63,4,1.3862943611198906
desensitizing,4,1.3862943611198906
cichoriin,4,1.3862943611198906
PGRN,4,1.3862943611198906
preeminent,4,1.3862943611198906
SKF,4,1.3862943611198906
9-13,4,1.3862943611198906
approximates,4,1.3862943611198906
Surface-enhanced,4,1.3862943611198906
learns,4,1.3862943611198906
heveny,4,1.3862943611198906
Extent,4,1.3862943611198906
Bistriţa,4,1.3862943611198906
subsidized,4,1.3862943611198906
halálozás,4,1.3862943611198906
subtracted,4,1.3862943611198906
radiocardiography,4,1.3862943611198906
PEDro,4,1.3862943611198906
time-efficient,4,1.3862943611198906
hypertriglyceridaemia,4,1.3862943611198906
de-novo,4,1.3862943611198906
machineries,4,1.3862943611198906
15-16,4,1.3862943611198906
live-virus,4,1.3862943611198906
parvovirus,4,1.3862943611198906
EA-H1N1,4,1.3862943611198906
AVB,4,1.3862943611198906
organise,4,1.3862943611198906
robot-assisted,4,1.3862943611198906
n75,4,1.3862943611198906
transcortical,4,1.3862943611198906
BZI,4,1.3862943611198906
mmolkg,4,1.3862943611198906
PTA,4,1.3862943611198906
Chlorpromazine,4,1.3862943611198906
Reperfused,4,1.3862943611198906
evidence-base,4,1.3862943611198906
CAPE,4,1.3862943611198906
non-occlusive,4,1.3862943611198906
Syncope,4,1.3862943611198906
nanomaterial,4,1.3862943611198906
A2a,4,1.3862943611198906
CVnCoV,4,1.3862943611198906
1987-1988,4,1.3862943611198906
collagenous,4,1.3862943611198906
mink-associated,4,1.3862943611198906
20052006,4,1.3862943611198906
-065,4,1.3862943611198906
thirty-nine,4,1.3862943611198906
inaction,4,1.3862943611198906
qualifications,4,1.3862943611198906
Precise,4,1.3862943611198906
Basically,4,1.3862943611198906
nasalthroat,4,1.3862943611198906
unknowingly,4,1.3862943611198906
predecessors,4,1.3862943611198906
categorisation,4,1.3862943611198906
onion,4,1.3862943611198906
ambitions,4,1.3862943611198906
rIC,4,1.3862943611198906
under-represented,4,1.3862943611198906
2200,4,1.3862943611198906
Solas,4,1.3862943611198906
whales,4,1.3862943611198906
ovine,4,1.3862943611198906
Similarity,4,1.3862943611198906
2-9,4,1.3862943611198906
antiapoptosis,4,1.3862943611198906
undergraduates,4,1.3862943611198906
tachypnoea,4,1.3862943611198906
Qigong,4,1.3862943611198906
microgliamacrophages,4,1.3862943611198906
FPI,4,1.3862943611198906
purposively,4,1.3862943611198906
DMPs,4,1.3862943611198906
microthrombi,4,1.3862943611198906
hBMSCs,4,1.3862943611198906
torsion,4,1.3862943611198906
IDOC,4,1.3862943611198906
packs,4,1.3862943611198906
PEARL,4,1.3862943611198906
QFP,4,1.3862943611198906
LIAISON®SARS-CoV-2,4,1.3862943611198906
noises,4,1.3862943611198906
culturing,4,1.3862943611198906
AH1N1p,4,1.3862943611198906
2196,4,1.3862943611198906
SBO,4,1.3862943611198906
EAU,4,1.3862943611198906
agenesis,4,1.3862943611198906
work-place,4,1.3862943611198906
following-up,4,1.3862943611198906
ependymal,4,1.3862943611198906
Iscomatrix,4,1.3862943611198906
motor-related,4,1.3862943611198906
201920,4,1.3862943611198906
fatality-prone,4,1.3862943611198906
Addis,4,1.3862943611198906
Ababa,4,1.3862943611198906
rs16986718G,4,1.3862943611198906
paint,4,1.3862943611198906
oppression,4,1.3862943611198906
striate,4,1.3862943611198906
COVID-19-affected,4,1.3862943611198906
ABSTRACT,4,1.3862943611198906
K-means,4,1.3862943611198906
d42,4,1.3862943611198906
CRD,4,1.3862943611198906
abdominoplasty,4,1.3862943611198906
like-illness,4,1.3862943611198906
Cognition,4,1.3862943611198906
Well-designed,4,1.3862943611198906
RmYN02,4,1.3862943611198906
AUSSR77,4,1.3862943611198906
malabsorption,4,1.3862943611198906
Wikipedia,4,1.3862943611198906
protocol-driven,4,1.3862943611198906
nuclease,4,1.3862943611198906
25-250,4,1.3862943611198906
replenishment,4,1.3862943611198906
pterostilbene,4,1.3862943611198906
2SF,4,1.3862943611198906
orciprenaline,4,1.3862943611198906
taller,4,1.3862943611198906
emergency-use,4,1.3862943611198906
hypolipidemic,4,1.3862943611198906
Beirut,4,1.3862943611198906
kerosene,4,1.3862943611198906
reentrant,4,1.3862943611198906
co-detection,4,1.3862943611198906
nonemergency,4,1.3862943611198906
transmission-based,4,1.3862943611198906
-05,4,1.3862943611198906
downloadable,4,1.3862943611198906
etoposide,4,1.3862943611198906
00025,4,1.3862943611198906
anaphylactoid,4,1.3862943611198906
bypassed,4,1.3862943611198906
bioscience,4,1.3862943611198906
ternary,4,1.3862943611198906
reconciled,4,1.3862943611198906
Venezuelan,4,1.3862943611198906
OCI,4,1.3862943611198906
Hgsec,4,1.3862943611198906
19951996,4,1.3862943611198906
Anesthetized,4,1.3862943611198906
subdivide,4,1.3862943611198906
propel,4,1.3862943611198906
otologic,4,1.3862943611198906
mycosis,4,1.3862943611198906
PIC,4,1.3862943611198906
nonfocal,4,1.3862943611198906
back-up,4,1.3862943611198906
ASTHMA,4,1.3862943611198906
afibrinogenaemia,4,1.3862943611198906
bothered,4,1.3862943611198906
God,4,1.3862943611198906
65-85,4,1.3862943611198906
non-allergenic,4,1.3862943611198906
Dog,4,1.3862943611198906
amoxicillin,4,1.3862943611198906
MatMaCorp,4,1.3862943611198906
non-immediate,4,1.3862943611198906
objectified,4,1.3862943611198906
dispensary,4,1.3862943611198906
medium-risk,4,1.3862943611198906
haplogroups,4,1.3862943611198906
Command,4,1.3862943611198906
manuals,4,1.3862943611198906
self-isolate,4,1.3862943611198906
Durham,4,1.3862943611198906
recognises,4,1.3862943611198906
impinge,4,1.3862943611198906
1210,4,1.3862943611198906
α-Klotho,4,1.3862943611198906
Statewide,4,1.3862943611198906
ASCs,4,1.3862943611198906
SFS,4,1.3862943611198906
Usefulness,4,1.3862943611198906
converts,4,1.3862943611198906
Pairwise,4,1.3862943611198906
nephrology,4,1.3862943611198906
Dysfunctional,4,1.3862943611198906
Collecting,4,1.3862943611198906
PTT,4,1.3862943611198906
ScienceDirect,4,1.3862943611198906
ICTV,4,1.3862943611198906
piglets,4,1.3862943611198906
Heidelberg,4,1.3862943611198906
unchanging,4,1.3862943611198906
A2B,4,1.3862943611198906
hypochlorite,4,1.3862943611198906
HaNDL,4,1.3862943611198906
Hematology,4,1.3862943611198906
ASydney,4,1.3862943611198906
multi-parameter,4,1.3862943611198906
unconsciousness,4,1.3862943611198906
Marburg,4,1.3862943611198906
microbiologic,4,1.3862943611198906
SSRN,4,1.3862943611198906
echocardiograph,4,1.3862943611198906
inter-personal,4,1.3862943611198906
dawn,4,1.3862943611198906
life-altering,4,1.3862943611198906
perindopril-based,4,1.3862943611198906
1s,4,1.3862943611198906
anthropometric,4,1.3862943611198906
II-B,4,1.3862943611198906
Toxicology,4,1.3862943611198906
RVG-Exo,4,1.3862943611198906
p0011,4,1.3862943611198906
PPU,4,1.3862943611198906
≤35,4,1.3862943611198906
Telehealth,4,1.3862943611198906
RBD-conjugated,4,1.3862943611198906
latex-induced,4,1.3862943611198906
co-twins,4,1.3862943611198906
tozinameran,4,1.3862943611198906
mid-June,4,1.3862943611198906
APTIMA,4,1.3862943611198906
supermarket,4,1.3862943611198906
spm,4,1.3862943611198906
REALFLU,4,1.3862943611198906
4-MU,4,1.3862943611198906
oxygenase,4,1.3862943611198906
AEM,4,1.3862943611198906
TDI-asthma,4,1.3862943611198906
neurosciences,4,1.3862943611198906
unduly,4,1.3862943611198906
row,4,1.3862943611198906
steering,4,1.3862943611198906
dependable,4,1.3862943611198906
MPVP,4,1.3862943611198906
skewing,4,1.3862943611198906
posterior-circulation,4,1.3862943611198906
ichromaTM,4,1.3862943611198906
Athenian,4,1.3862943611198906
coexisted,4,1.3862943611198906
Thucydides,4,1.3862943611198906
Compound,4,1.3862943611198906
light-chain,4,1.3862943611198906
counteracted,4,1.3862943611198906
devote,4,1.3862943611198906
medians,4,1.3862943611198906
gemL,4,1.3862943611198906
re-estimation,4,1.3862943611198906
I-A,4,1.3862943611198906
ischaemia-reperfusion,4,1.3862943611198906
enterprise,4,1.3862943611198906
Official,4,1.3862943611198906
strut,4,1.3862943611198906
embraced,4,1.3862943611198906
Trump,4,1.3862943611198906
phynoptin,4,1.3862943611198906
Margaret,4,1.3862943611198906
1700,4,1.3862943611198906
exchanging,4,1.3862943611198906
2514,4,1.3862943611198906
carina,4,1.3862943611198906
Consult,4,1.3862943611198906
sonomicrometry,4,1.3862943611198906
heroic,4,1.3862943611198906
Obtained,4,1.3862943611198906
nonhealthcare,4,1.3862943611198906
microbiologist,4,1.3862943611198906
electro-,4,1.3862943611198906
Panton-Valentine,4,1.3862943611198906
biotech,4,1.3862943611198906
neurotoxicity,4,1.3862943611198906
recoding,4,1.3862943611198906
revascularizations,4,1.3862943611198906
seventy-five,4,1.3862943611198906
Maastricht,4,1.3862943611198906
2215,4,1.3862943611198906
Infectivity,4,1.3862943611198906
soleus,4,1.3862943611198906
MCAo-PBS,4,1.3862943611198906
sibutramine,4,1.3862943611198906
interactive-critical,4,1.3862943611198906
troubled,4,1.3862943611198906
BMPAQ,4,1.3862943611198906
nonparticipation,4,1.3862943611198906
hayfever,4,1.3862943611198906
corroborating,4,1.3862943611198906
A222V,4,1.3862943611198906
won,4,1.3862943611198906
Angiograms,4,1.3862943611198906
pneumatic,4,1.3862943611198906
heterozygosity,4,1.3862943611198906
uld,4,1.3862943611198906
L18F,4,1.3862943611198906
playgrounds,4,1.3862943611198906
Charcots,4,1.3862943611198906
hard-to-reach,4,1.3862943611198906
re-uptake,4,1.3862943611198906
ready-to-use,4,1.3862943611198906
biosurfactants,4,1.3862943611198906
Lumpur,4,1.3862943611198906
theres,4,1.3862943611198906
-075,4,1.3862943611198906
App,4,1.3862943611198906
suppliers,4,1.3862943611198906
RVG-ExoHMGB1-siRNA,4,1.3862943611198906
airplane,4,1.3862943611198906
reintervention,4,1.3862943611198906
VPDI,4,1.3862943611198906
Biopsy,4,1.3862943611198906
educative,4,1.3862943611198906
Raynauds,4,1.3862943611198906
ISMs,4,1.3862943611198906
Nanomedicine,4,1.3862943611198906
LTRA,4,1.3862943611198906
ms12,4,1.3862943611198906
p0028,4,1.3862943611198906
MCAo-hMSC,4,1.3862943611198906
stair,4,1.3862943611198906
Indexes,4,1.3862943611198906
re-analysis,4,1.3862943611198906
asparagine,4,1.3862943611198906
SARS-Cov2,4,1.3862943611198906
Perugia,4,1.3862943611198906
danoprevir,4,1.3862943611198906
1952,4,1.3862943611198906
sensorineural,4,1.3862943611198906
self-monitor,4,1.3862943611198906
ad-hoc,4,1.3862943611198906
GRMD,4,1.3862943611198906
Aptima™,4,1.3862943611198906
biothreat,4,1.3862943611198906
PTZ,4,1.3862943611198906
IGT,4,1.3862943611198906
Maria,4,1.3862943611198906
commentaries,4,1.3862943611198906
Odisha,4,1.3862943611198906
nanobiomaterials,4,1.3862943611198906
reassured,4,1.3862943611198906
Narrative,4,1.3862943611198906
multifactor,4,1.3862943611198906
pre-designed,4,1.3862943611198906
References,4,1.3862943611198906
abrogate,4,1.3862943611198906
advertising,4,1.3862943611198906
ensues,4,1.3862943611198906
Baranya,4,1.3862943611198906
1972-73,4,1.3862943611198906
multi-drug,4,1.3862943611198906
do-it-yourself,4,1.3862943611198906
interlinked,4,1.3862943611198906
sensed,4,1.3862943611198906
stroke-prevention,4,1.3862943611198906
Afterward,4,1.3862943611198906
IAB,4,1.3862943611198906
IκB,4,1.3862943611198906
mindkét,4,1.3862943611198906
Memorandum,4,1.3862943611198906
MPSI15,4,1.3862943611198906
MPSIor15,4,1.3862943611198906
gender-dependent,4,1.3862943611198906
MPSI,4,1.3862943611198906
armoury,4,1.3862943611198906
twenty-four,4,1.3862943611198906
post-operatively,4,1.3862943611198906
IPVD,4,1.3862943611198906
Neurogenic,4,1.3862943611198906
2053,4,1.3862943611198906
AOSD,4,1.3862943611198906
Insular,4,1.3862943611198906
Ibn,4,1.3862943611198906
Taubenberger,4,1.3862943611198906
E125,4,1.3862943611198906
logOR,4,1.3862943611198906
Következtetés,4,1.3862943611198906
SARSr-CoVs,4,1.3862943611198906
3600,4,1.3862943611198906
medico-social,4,1.3862943611198906
DeltaLVEF,4,1.3862943611198906
adversity,4,1.3862943611198906
LFIC,4,1.3862943611198906
sex-dependent,4,1.3862943611198906
ASTRAL,4,1.3862943611198906
GK-7,4,1.3862943611198906
one-and-a-half,4,1.3862943611198906
Analyse,4,1.3862943611198906
WHS,4,1.3862943611198906
Flu-like,4,1.3862943611198906
IMSS,4,1.3862943611198906
corticodependent,4,1.3862943611198906
IFN-αβ,4,1.3862943611198906
Prompted,4,1.3862943611198906
Antigens,4,1.3862943611198906
corticodependence,4,1.3862943611198906
DeltaLVEDV,4,1.3862943611198906
COVID-19-convalescent,4,1.3862943611198906
slant,4,1.3862943611198906
39°C,4,1.3862943611198906
pre-thrombolysis,4,1.3862943611198906
self-competence,4,1.3862943611198906
walks,4,1.3862943611198906
Stool,4,1.3862943611198906
contemporaneously,4,1.3862943611198906
inhomogeneous,4,1.3862943611198906
Undertake,4,1.3862943611198906
akut,4,1.3862943611198906
ALB,4,1.3862943611198906
MMs,4,1.3862943611198906
ST-elevációval,4,1.3862943611198906
19-related,4,1.3862943611198906
mitosis,4,1.3862943611198906
sixth-generation,4,1.3862943611198906
guess,4,1.3862943611198906
ACH,4,1.3862943611198906
Infarcted,4,1.3862943611198906
human-to-swine,4,1.3862943611198906
Dressler,4,1.3862943611198906
LVMI,4,1.3862943611198906
CRISPRCas12a,4,1.3862943611198906
N-gene,4,1.3862943611198906
BCoV,4,1.3862943611198906
Módszer,4,1.3862943611198906
relentlessly,4,1.3862943611198906
Predominantly,4,1.3862943611198906
hibernated,4,1.3862943611198906
droperidol,4,1.3862943611198906
MDTT,4,1.3862943611198906
depiction,4,1.3862943611198906
lumensmm2,4,1.3862943611198906
DHs,4,1.3862943611198906
Creatinine,4,1.3862943611198906
PWD,4,1.3862943611198906
Ad-based,4,1.3862943611198906
subsides,4,1.3862943611198906
censored,4,1.3862943611198906
alatt,4,1.3862943611198906
microbiotic,4,1.3862943611198906
advisor,4,1.3862943611198906
intrapericardial,4,1.3862943611198906
bronchoprovocant,4,1.3862943611198906
eIF4A,4,1.3862943611198906
hatching,4,1.3862943611198906
Nyugat-Magyarország,4,1.3862943611198906
NtAb50,4,1.3862943611198906
chasm,4,1.3862943611198906
non-selected,4,1.3862943611198906
2400,4,1.3862943611198906
198081,4,1.3862943611198906
caretaker,4,1.3862943611198906
EHRs,4,1.3862943611198906
coughed,4,1.3862943611198906
placentae,4,1.3862943611198906
aMI,4,1.3862943611198906
proportionately,4,1.3862943611198906
platoons,4,1.3862943611198906
Micronutrients,4,1.3862943611198906
SARS-CoV-2-laden,4,1.3862943611198906
CRISPR-associated,4,1.3862943611198906
inflammometry,4,1.3862943611198906
Cas,4,1.3862943611198906
pseudotypes,4,1.3862943611198906
FluoroSpot,4,1.3862943611198906
Applications,4,1.3862943611198906
VESUSC,4,1.3862943611198906
Severodvinsk,4,1.3862943611198906
rapid-onset,4,1.3862943611198906
non-slit-based,4,1.3862943611198906
resonance-based,4,1.3862943611198906
3067,4,1.3862943611198906
Xinjiang,4,1.3862943611198906
Lymph,4,1.3862943611198906
Utilising,4,1.3862943611198906
strokesyear,4,1.3862943611198906
cyanocobalamin,4,1.3862943611198906
Vitamins,4,1.3862943611198906
TLTs,4,1.3862943611198906
rehospitalizations,4,1.3862943611198906
PROVE,4,1.3862943611198906
SND,4,1.3862943611198906
high-growth,4,1.3862943611198906
SHERLOCK,4,1.3862943611198906
cas,4,1.3862943611198906
CMSDA,4,1.3862943611198906
qui,4,1.3862943611198906
hypocalcemia,4,1.3862943611198906
pre-season,4,1.3862943611198906
pull,4,1.3862943611198906
paralyzed,4,1.3862943611198906
micronutrients,4,1.3862943611198906
Case-control,4,1.3862943611198906
adsorb,4,1.3862943611198906
VGG,4,1.3862943611198906
Convolutional,4,1.3862943611198906
a-,4,1.3862943611198906
AWMI,4,1.3862943611198906
postictal,4,1.3862943611198906
imitating,4,1.3862943611198906
infection-age,4,1.3862943611198906
F-18-FDG-uptake,4,1.3862943611198906
PS-LPFG,4,1.3862943611198906
Overweight,4,1.3862943611198906
myelin,4,1.3862943611198906
mgmin,4,1.3862943611198906
Nsp6L37F,4,1.3862943611198906
underperfused,4,1.3862943611198906
Requests,4,1.3862943611198906
summarising,4,1.3862943611198906
Underestimation,4,1.3862943611198906
non-attendance,4,1.3862943611198906
Unstable,4,1.3862943611198906
Mask,4,1.3862943611198906
South-east,4,1.3862943611198906
MRA-DWI,4,1.3862943611198906
ft,4,1.3862943611198906
negated,4,1.3862943611198906
Nsp12P323L,4,1.3862943611198906
ICUS,4,1.3862943611198906
H18N11,4,1.3862943611198906
buildup,4,1.3862943611198906
ORF3aG251V,4,1.3862943611198906
compel,4,1.3862943611198906
sub-clades,4,1.3862943611198906
right-anterior-inferior,4,1.3862943611198906
iMI,4,1.3862943611198906
Covid-Presto®,4,1.3862943611198906
1332,4,1.3862943611198906
Szabolcs-Szatmár-Bereg,4,1.3862943611198906
IAVIBV,4,1.3862943611198906
systematize,4,1.3862943611198906
Homocysteine,4,1.3862943611198906
malarial,4,1.3862943611198906
deferring,4,1.3862943611198906
P18,4,1.3862943611198906
LDL-c,4,1.3862943611198906
runners,4,1.3862943611198906
w3,4,1.3862943611198906
seventy-fifth,4,1.3862943611198906
homelessness,4,1.3862943611198906
hematologyoncology,4,1.3862943611198906
Did,4,1.3862943611198906
contextualized,4,1.3862943611198906
metro,4,1.3862943611198906
deep-learning,4,1.3862943611198906
posited,4,1.3862943611198906
Hemopump,4,1.3862943611198906
echo-free,4,1.3862943611198906
catalogue,4,1.3862943611198906
IEA,4,1.3862943611198906
taper,4,1.3862943611198906
CDTT,4,1.3862943611198906
Circle,4,1.3862943611198906
vagueness,4,1.3862943611198906
NVP,4,1.3862943611198906
day-of-week,4,1.3862943611198906
oseltamivir-treated,4,1.3862943611198906
MNS,4,1.3862943611198906
E119V,4,1.3862943611198906
Asthma-COPD,4,1.3862943611198906
VLP-based,4,1.3862943611198906
electrophilic,4,1.3862943611198906
riders,4,1.3862943611198906
defibrillated,4,1.3862943611198906
FSSs,4,1.3862943611198906
in-office,4,1.3862943611198906
glycosaminoglycans,4,1.3862943611198906
baculovirus,4,1.3862943611198906
Nigerians,4,1.3862943611198906
feathers,4,1.3862943611198906
glycosite,4,1.3862943611198906
cabin,4,1.3862943611198906
nCoV-2,4,1.3862943611198906
tonic-clonic,4,1.3862943611198906
Medically,4,1.3862943611198906
paraviral,4,1.3862943611198906
cell-treated,4,1.3862943611198906
GPBB,4,1.3862943611198906
Lyapunov,4,1.3862943611198906
tibialis,4,1.3862943611198906
3400,4,1.3862943611198906
non-effective,4,1.3862943611198906
mgg,4,1.3862943611198906
Valencia,4,1.3862943611198906
multi-professional,4,1.3862943611198906
JAMA,4,1.3862943611198906
oronasopharyngeal,4,1.3862943611198906
femoris,4,1.3862943611198906
hexon,4,1.3862943611198906
j,4,1.3862943611198906
neurointerventionalists,4,1.3862943611198906
Creating,4,1.3862943611198906
16-30,4,1.3862943611198906
anti-microbial,4,1.3862943611198906
monospecific,4,1.3862943611198906
Unadjusted,4,1.3862943611198906
between-host,4,1.3862943611198906
distended,4,1.3862943611198906
29000,4,1.3862943611198906
caspase-3,4,1.3862943611198906
PRIME,4,1.3862943611198906
neuroleptic,4,1.3862943611198906
CIDP,4,1.3862943611198906
1422,4,1.3862943611198906
hydrophobicity,4,1.3862943611198906
peribronchiolar,4,1.3862943611198906
Historic,4,1.3862943611198906
RWA,4,1.3862943611198906
Regimens,4,1.3862943611198906
build-up,4,1.3862943611198906
hemorheology,4,1.3862943611198906
strokespatient-year,4,1.3862943611198906
Newborn,4,1.3862943611198906
easy-to-perform,4,1.3862943611198906
ultrasonically,4,1.3862943611198906
n50,4,1.3862943611198906
nanofiber,4,1.3862943611198906
n15,4,1.3862943611198906
p00005,4,1.3862943611198906
MDVs,4,1.3862943611198906
3WJ,4,1.3862943611198906
Court,4,1.3862943611198906
univocal,4,1.3862943611198906
spirographic,4,1.3862943611198906
viscoelastic,4,1.3862943611198906
well-child,4,1.3862943611198906
calamity,4,1.3862943611198906
dubbed,4,1.3862943611198906
CMD20,4,1.3862943611198906
cannulae,4,1.3862943611198906
interrupts,4,1.3862943611198906
stent-like,4,1.3862943611198906
ROTEM,4,1.3862943611198906
TDCs,4,1.3862943611198906
spasmogens,4,1.3862943611198906
reverse-dippers,4,1.3862943611198906
nCoV-DK,4,1.3862943611198906
FamHC,4,1.3862943611198906
Acetylcholine,4,1.3862943611198906
self-sustaining,4,1.3862943611198906
syntheses,4,1.3862943611198906
socioprofessional,4,1.3862943611198906
Employer,4,1.3862943611198906
unimmunised,4,1.3862943611198906
bactericidal,4,1.3862943611198906
RT-Ach,4,1.3862943611198906
LD2,4,1.3862943611198906
overestimating,4,1.3862943611198906
HAdV-D,4,1.3862943611198906
foe,4,1.3862943611198906
RS-T,4,1.3862943611198906
syncopal,4,1.3862943611198906
Account,4,1.3862943611198906
Spasm,4,1.3862943611198906
BShanghai3612002-like,4,1.3862943611198906
acetazolamide,4,1.3862943611198906
Sweat,4,1.3862943611198906
CTA-SI,4,1.3862943611198906
respirologists,4,1.3862943611198906
2000000,4,1.3862943611198906
cartridge,4,1.3862943611198906
WBA,4,1.3862943611198906
hyper-enhancement,4,1.3862943611198906
Monthly,4,1.3862943611198906
end-diastole,4,1.3862943611198906
ODE,4,1.3862943611198906
videofluorographic,4,1.3862943611198906
Bangalore,4,1.3862943611198906
bite,4,1.3862943611198906
sanitiser,4,1.3862943611198906
Permissive,4,1.3862943611198906
adamantane-resistant,4,1.3862943611198906
Zero,4,1.3862943611198906
vasoconstricting,4,1.3862943611198906
H0N1,4,1.3862943611198906
Netrin-1,4,1.3862943611198906
RAPBC,4,1.3862943611198906
brown,4,1.3862943611198906
ellátásának,4,1.3862943611198906
PolyECG-S,4,1.3862943611198906
hypomagnesaemia,4,1.3862943611198906
mean-SD,4,1.3862943611198906
PWP-GT,4,1.3862943611198906
nucleosides,4,1.3862943611198906
fluxes,4,1.3862943611198906
Jamaica,4,1.3862943611198906
hypercube,4,1.3862943611198906
Missed,4,1.3862943611198906
Hydrogen,4,1.3862943611198906
autumnwinter,4,1.3862943611198906
sulfide,4,1.3862943611198906
immunoreactive,4,1.3862943611198906
re-testing,4,1.3862943611198906
marantic,4,1.3862943611198906
anti-proliferative,4,1.3862943611198906
Grippe,4,1.3862943611198906
shearwaters,4,1.3862943611198906
2020-March,4,1.3862943611198906
CX,4,1.3862943611198906
curious,4,1.3862943611198906
40-64,4,1.3862943611198906
inflating,4,1.3862943611198906
sectioning,4,1.3862943611198906
convex,4,1.3862943611198906
IABP-SHOCK,4,1.3862943611198906
polypragmasy,4,1.3862943611198906
neopterin,4,1.3862943611198906
NCT,4,1.3862943611198906
SARS-CoV-2ACE2,4,1.3862943611198906
redefining,4,1.3862943611198906
near-occlusion,4,1.3862943611198906
antimalarials,4,1.3862943611198906
Ps,4,1.3862943611198906
pipes,4,1.3862943611198906
Appropriately,4,1.3862943611198906
kgmmin,4,1.3862943611198906
instant,4,1.3862943611198906
4-day-old,4,1.3862943611198906
MI-MMPi,4,1.3862943611198906
fluctuate,4,1.3862943611198906
transcallosal,4,1.3862943611198906
2006-2009,4,1.3862943611198906
Avicel,4,1.3862943611198906
NaH,4,1.3862943611198906
non-Latino,4,1.3862943611198906
orthomyxoviruses,4,1.3862943611198906
low-fat,4,1.3862943611198906
10-24,4,1.3862943611198906
LIAISON®,4,1.3862943611198906
bitten,4,1.3862943611198906
Fg,4,1.3862943611198906
ROCs,4,1.3862943611198906
polynuclear,4,1.3862943611198906
Large-artery,4,1.3862943611198906
Consultant,4,1.3862943611198906
disinhibition,4,1.3862943611198906
Steering,4,1.3862943611198906
urging,4,1.3862943611198906
toxicant,4,1.3862943611198906
NT-3,4,1.3862943611198906
non-S,4,1.3862943611198906
grandchildren,4,1.3862943611198906
rH1N1,4,1.3862943611198906
replicability,4,1.3862943611198906
2019‐nCoV,4,1.3862943611198906
TDM,4,1.3862943611198906
ASRH,4,1.3862943611198906
high-energy,4,1.3862943611198906
misunderstandings,4,1.3862943611198906
rs3025020,4,1.3862943611198906
Kemeny,4,1.3862943611198906
costimulatory,4,1.3862943611198906
EpiRank,4,1.3862943611198906
stylized,4,1.3862943611198906
pre-trained,4,1.3862943611198906
paradoxic,4,1.3862943611198906
Mouth,4,1.3862943611198906
SARSr-CoV,4,1.3862943611198906
Contractile,4,1.3862943611198906
furry,4,1.3862943611198906
stereotyped,4,1.3862943611198906
neutropenic,4,1.3862943611198906
mislabeling,4,1.3862943611198906
MCMC,4,1.3862943611198906
Anosmia,4,1.3862943611198906
postextrasystolic,4,1.3862943611198906
mRNA-,4,1.3862943611198906
Twice,4,1.3862943611198906
GISN,4,1.3862943611198906
triphenyl,4,1.3862943611198906
MM-PBSA,4,1.3862943611198906
Mitigating,4,1.3862943611198906
non-response,4,1.3862943611198906
Explanations,4,1.3862943611198906
delayed-onset,4,1.3862943611198906
tank,4,1.3862943611198906
advisability,4,1.3862943611198906
Reagent,4,1.3862943611198906
1033,4,1.3862943611198906
humid-rainy,4,1.3862943611198906
Double,4,1.3862943611198906
diamond,4,1.3862943611198906
antitrypsin,4,1.3862943611198906
sub-themes,4,1.3862943611198906
FlOPs,4,1.3862943611198906
chlorhexidine,4,1.3862943611198906
Low-,4,1.3862943611198906
culture-proven,4,1.3862943611198906
continence,4,1.3862943611198906
weakening,4,1.3862943611198906
bolstering,4,1.3862943611198906
Club,4,1.3862943611198906
Up-to-date,4,1.3862943611198906
2025,4,1.3862943611198906
PIRH,4,1.3862943611198906
Identical,4,1.3862943611198906
vasoreactivity,4,1.3862943611198906
deaminase,4,1.3862943611198906
Regularly,4,1.3862943611198906
peri-,4,1.3862943611198906
SLP,4,1.3862943611198906
vagally,4,1.3862943611198906
GLA-SE,4,1.3862943611198906
e-cigs,4,1.3862943611198906
XL,4,1.3862943611198906
Labor,4,1.3862943611198906
unpaired,4,1.3862943611198906
silicon,4,1.3862943611198906
b2,4,1.3862943611198906
C-terminus,4,1.3862943611198906
2020-April,4,1.3862943611198906
très,4,1.3862943611198906
maladjustment,4,1.3862943611198906
Informing,4,1.3862943611198906
maladaptation,4,1.3862943611198906
wording,4,1.3862943611198906
1536,4,1.3862943611198906
articulated,4,1.3862943611198906
ki,4,1.3862943611198906
Randomization,4,1.3862943611198906
JGL,4,1.3862943611198906
32000,4,1.3862943611198906
20-OH-LTB4,4,1.3862943611198906
mixed-effect,4,1.3862943611198906
Treadmill,4,1.3862943611198906
stroke-protective,4,1.3862943611198906
-40,4,1.3862943611198906
hyperoxia,4,1.3862943611198906
catalog,4,1.3862943611198906
DPT,4,1.3862943611198906
reperfusionABSTRACT,4,1.3862943611198906
HBDH,4,1.3862943611198906
yin,4,1.3862943611198906
collar,4,1.3862943611198906
P450,4,1.3862943611198906
subfamily,4,1.3862943611198906
Methyltransferase,4,1.3862943611198906
A-20,4,1.3862943611198906
fosamil,4,1.3862943611198906
dpo,4,1.3862943611198906
Ceftaroline,4,1.3862943611198906
fifty-five,4,1.3862943611198906
IUmL,4,1.3862943611198906
half-dose,4,1.3862943611198906
hemothorax,4,1.3862943611198906
Voxel-based,4,1.3862943611198906
Video-assisted,4,1.3862943611198906
departing,4,1.3862943611198906
Side-effects,4,1.3862943611198906
illiterate,4,1.3862943611198906
fugax,4,1.3862943611198906
inter-observer,4,1.3862943611198906
amaurosis,4,1.3862943611198906
Mixing,4,1.3862943611198906
Biomics,4,1.3862943611198906
KSA,4,1.3862943611198906
dispelling,4,1.3862943611198906
MIA,4,1.3862943611198906
immunobinding,4,1.3862943611198906
pre-nARS,4,1.3862943611198906
inclusionexclusion,4,1.3862943611198906
SNCP,4,1.3862943611198906
echocardiographical,4,1.3862943611198906
filed,4,1.3862943611198906
admixed,4,1.3862943611198906
ascribes,4,1.3862943611198906
RTR,4,1.3862943611198906
ODN,4,1.3862943611198906
IRME,4,1.3862943611198906
endocrinopathy,4,1.3862943611198906
gammopathy,4,1.3862943611198906
coronary-surgical,4,1.3862943611198906
Queens,4,1.3862943611198906
ARTIC,4,1.3862943611198906
VCAM-1,4,1.3862943611198906
Farma,4,1.3862943611198906
vulgaris,4,1.3862943611198906
PAMBA,4,1.3862943611198906
Ⅱ,4,1.3862943611198906
mLmin173,4,1.3862943611198906
Suramin,4,1.3862943611198906
vaccine-mismatched,4,1.3862943611198906
8-13,4,1.3862943611198906
arachidonate,4,1.3862943611198906
O-deacylated,4,1.3862943611198906
sibships,4,1.3862943611198906
Tunisia,4,1.3862943611198906
Fc-mediated,4,1.3862943611198906
lymphoproliferative,4,1.3862943611198906
non-ischemia,4,1.3862943611198906
cost-free,4,1.3862943611198906
RML,4,1.3862943611198906
theirs,4,1.3862943611198906
hPMSCs,4,1.3862943611198906
de-stiffening,4,1.3862943611198906
P323L-RdRp,4,1.3862943611198906
mASCmEC,4,1.3862943611198906
life-sustaining,4,1.3862943611198906
Cilostazol,4,1.3862943611198906
single-strand,4,1.3862943611198906
lifestyle-related,4,1.3862943611198906
NMAD,4,1.3862943611198906
LQC,4,1.3862943611198906
restudy,4,1.3862943611198906
PAGs,4,1.3862943611198906
imposition,4,1.3862943611198906
vivid,4,1.3862943611198906
PRN,4,1.3862943611198906
sorts,4,1.3862943611198906
sentences,4,1.3862943611198906
Eleutherococcus,4,1.3862943611198906
spaced,4,1.3862943611198906
HFOV,4,1.3862943611198906
prairie,4,1.3862943611198906
sero-epidemiological,4,1.3862943611198906
cosine,4,1.3862943611198906
Mirror,4,1.3862943611198906
SRPs,4,1.3862943611198906
sacrificing,4,1.3862943611198906
X2,4,1.3862943611198906
marred,4,1.3862943611198906
CRY,4,1.3862943611198906
PSP,4,1.3862943611198906
hotly,4,1.3862943611198906
Speaking,4,1.3862943611198906
cysLTs,4,1.3862943611198906
bioNexia,4,1.3862943611198906
moderation,4,1.3862943611198906
Oasys,4,1.3862943611198906
Static,4,1.3862943611198906
Immunologic,4,1.3862943611198906
affair,4,1.3862943611198906
natives,4,1.3862943611198906
subtherapeutic,4,1.3862943611198906
Ad-synd4,4,1.3862943611198906
neurotics,4,1.3862943611198906
absorb,4,1.3862943611198906
lumens,4,1.3862943611198906
synd4,4,1.3862943611198906
on-campus,4,1.3862943611198906
-005,4,1.3862943611198906
dual-energy,4,1.3862943611198906
mimickers,4,1.3862943611198906
tutorial,4,1.3862943611198906
agendas,4,1.3862943611198906
omic,4,1.3862943611198906
heels,4,1.3862943611198906
spill,4,1.3862943611198906
RT-SIBA,4,1.3862943611198906
Cysteinyl,4,1.3862943611198906
PPAR,4,1.3862943611198906
counter-narrative,4,1.3862943611198906
spiraling,4,1.3862943611198906
pressurised,4,1.3862943611198906
Genalyte,4,1.3862943611198906
ATF6,4,1.3862943611198906
or2,4,1.3862943611198906
or5,4,1.3862943611198906
DWIs,4,1.3862943611198906
bronchospasm-hypersecretion,4,1.3862943611198906
lambda,4,1.3862943611198906
You,4,1.3862943611198906
µgmL,4,1.3862943611198906
MEDLINEPubMed,4,1.3862943611198906
workgroup,4,1.3862943611198906
miR-21,4,1.3862943611198906
CoV3D,4,1.3862943611198906
diaphoresis,4,1.3862943611198906
furnished,4,1.3862943611198906
sub-network,4,1.3862943611198906
Southwestern,4,1.3862943611198906
orienting,4,1.3862943611198906
QIAstat-SARS,4,1.3862943611198906
blow,4,1.3862943611198906
paracellular,4,1.3862943611198906
multitrigger,4,1.3862943611198906
pretested,4,1.3862943611198906
hypothesizes,4,1.3862943611198906
footing,4,1.3862943611198906
intensivist,4,1.3862943611198906
df1,4,1.3862943611198906
pneumoconiosis,4,1.3862943611198906
pride,4,1.3862943611198906
BKCa,4,1.3862943611198906
NeuN,4,1.3862943611198906
FeSS,4,1.3862943611198906
Hyperthyroidism,4,1.3862943611198906
MiRNAs,4,1.3862943611198906
postinjury,4,1.3862943611198906
Antenatal,4,1.3862943611198906
lipid-rich,4,1.3862943611198906
EDTA,4,1.3862943611198906
intermediates,4,1.3862943611198906
14-25,4,1.3862943611198906
electrocution,4,1.3862943611198906
Immunodeficiency,4,1.3862943611198906
patient-facing,4,1.3862943611198906
infarct-artery,4,1.3862943611198906
TZV,4,1.3862943611198906
MRIMRA,4,1.3862943611198906
RBD-based,4,1.3862943611198906
μmolL,4,1.3862943611198906
AIIDs,4,1.3862943611198906
organoid,4,1.3862943611198906
coolant,4,1.3862943611198906
pelvis,4,1.3862943611198906
Ibsen,4,1.3862943611198906
non-DSW,4,1.3862943611198906
Faso,4,1.3862943611198906
soldering,4,1.3862943611198906
00016,4,1.3862943611198906
5-24,4,1.3862943611198906
Burkina,4,1.3862943611198906
immunoinhibition,4,1.3862943611198906
OM-b,4,1.3862943611198906
amitriptyline,4,1.3862943611198906
AY-2C2,4,1.3862943611198906
newly-developed,4,1.3862943611198906
reallocate,4,1.3862943611198906
Zeneca,4,1.3862943611198906
Circumstantial,4,1.3862943611198906
endocrinological,4,1.3862943611198906
Italians,4,1.3862943611198906
opacified,4,1.3862943611198906
electronics,4,1.3862943611198906
Modulation,4,1.3862943611198906
P0016,4,1.3862943611198906
point-prevalence,4,1.3862943611198906
YH-1A1,4,1.3862943611198906
neurotoxin,4,1.3862943611198906
EDN,4,1.3862943611198906
PAMPs,4,1.3862943611198906
FDEIA,4,1.3862943611198906
Varicella,4,1.3862943611198906
unassociated,4,1.3862943611198906
Ro,4,1.3862943611198906
fosters,4,1.3862943611198906
Kong3302001,4,1.3862943611198906
tanks,4,1.3862943611198906
K417T,4,1.3862943611198906
opolskie,4,1.3862943611198906
Spielberger,4,1.3862943611198906
under-utilized,4,1.3862943611198906
parenterally,4,1.3862943611198906
hMAPCs,4,1.3862943611198906
widen,4,1.3862943611198906
PRG,4,1.3862943611198906
anymore,4,1.3862943611198906
Ocular,4,1.3862943611198906
5th-7th,4,1.3862943611198906
country-wide,4,1.3862943611198906
angiotensinogen,4,1.3862943611198906
triplicate,4,1.3862943611198906
Ottawa,4,1.3862943611198906
pallidum,4,1.3862943611198906
psychoeducational,4,1.3862943611198906
LVEFs,4,1.3862943611198906
postprocedure,4,1.3862943611198906
rightly,4,1.3862943611198906
risk-standardized,4,1.3862943611198906
wild-silk,4,1.3862943611198906
spokes,4,1.3862943611198906
fibrillary,4,1.3862943611198906
bioengineering,4,1.3862943611198906
1173,4,1.3862943611198906
Analogue,4,1.3862943611198906
Promotion,4,1.3862943611198906
Omics,4,1.3862943611198906
1546,4,1.3862943611198906
notch,4,1.3862943611198906
IUI,4,1.3862943611198906
3-14,4,1.3862943611198906
anteflexion,4,1.3862943611198906
expound,4,1.3862943611198906
MEA,4,1.3862943611198906
mABs,4,1.3862943611198906
G222,4,1.3862943611198906
Gamaleya,4,1.3862943611198906
resisted,4,1.3862943611198906
mentors,4,1.3862943611198906
simplifies,4,1.3862943611198906
griffithsin,4,1.3862943611198906
Virol,4,1.3862943611198906
magasabb,4,1.3862943611198906
COVID-19-negatív,4,1.3862943611198906
sulfated,4,1.3862943611198906
0085,4,1.3862943611198906
sublethal,4,1.3862943611198906
cooked,4,1.3862943611198906
Morisky,4,1.3862943611198906
second-dose,4,1.3862943611198906
TRAIL,4,1.3862943611198906
biochemically,4,1.3862943611198906
ACQ-7,4,1.3862943611198906
Exciting,4,1.3862943611198906
competitively,4,1.3862943611198906
≥090,4,1.3862943611198906
CTP-derived,4,1.3862943611198906
readouts,4,1.3862943611198906
case-ascertained,4,1.3862943611198906
Full-length,4,1.3862943611198906
octant,4,1.3862943611198906
p0025,4,1.3862943611198906
Non-fatal,4,1.3862943611198906
sluggish,4,1.3862943611198906
≥05,4,1.3862943611198906
Definitions,4,1.3862943611198906
nonoperative,4,1.3862943611198906
specter,4,1.3862943611198906
evading,4,1.3862943611198906
opponent,4,1.3862943611198906
fine-grained,4,1.3862943611198906
Funding,4,1.3862943611198906
v-miRNAs,4,1.3862943611198906
hydrate,4,1.3862943611198906
IVL,4,1.3862943611198906
lymphomatosis,4,1.3862943611198906
Temperature,4,1.3862943611198906
CCR5-Δ32,4,1.3862943611198906
MFI,4,1.3862943611198906
Conscious,4,1.3862943611198906
forehead,4,1.3862943611198906
Leu,4,1.3862943611198906
13b,4,1.3862943611198906
oncologist,4,1.3862943611198906
endoluminal,4,1.3862943611198906
Khomeini,4,1.3862943611198906
affirms,4,1.3862943611198906
sheer,4,1.3862943611198906
pessimists,4,1.3862943611198906
neat,4,1.3862943611198906
β-CoV,4,1.3862943611198906
RTMM,4,1.3862943611198906
viral-vectored,4,1.3862943611198906
Galectin-3,4,1.3862943611198906
Fenoterol,4,1.3862943611198906
AT-511,4,1.3862943611198906
crevicular,4,1.3862943611198906
1956,4,1.3862943611198906
12-item,4,1.3862943611198906
asserted,4,1.3862943611198906
Nicolau,4,1.3862943611198906
Stefan,4,1.3862943611198906
undiluted,4,1.3862943611198906
MVAS,4,1.3862943611198906
curiosity,4,1.3862943611198906
Elite,4,1.3862943611198906
EPR-Update,4,1.3862943611198906
Considerations,4,1.3862943611198906
Airflow,4,1.3862943611198906
SEI,4,1.3862943611198906
biotechnological,4,1.3862943611198906
HIF-1alpha,4,1.3862943611198906
Targets,4,1.3862943611198906
antiinfluenzal,4,1.3862943611198906
APPE,4,1.3862943611198906
pedagogical,4,1.3862943611198906
dinucleotides,4,1.3862943611198906
R101S-R105S,4,1.3862943611198906
pre-hospitalization,4,1.3862943611198906
opiate,4,1.3862943611198906
anteromedian,4,1.3862943611198906
disability-free,4,1.3862943611198906
accelerometry,4,1.3862943611198906
Citys,4,1.3862943611198906
physics,4,1.3862943611198906
1928,4,1.3862943611198906
steric,4,1.3862943611198906
Medicinal,4,1.3862943611198906
postmyocardial-infarction,4,1.3862943611198906
short-lasting,4,1.3862943611198906
NHI,4,1.3862943611198906
hindrance,4,1.3862943611198906
faint,4,1.3862943611198906
cardiospecific,4,1.3862943611198906
SCPS,4,1.3862943611198906
reconsideration,4,1.3862943611198906
COVseq,4,1.3862943611198906
quadruplex,4,1.3862943611198906
logarithm,4,1.3862943611198906
tako-tsubo,4,1.3862943611198906
Fire,4,1.3862943611198906
Pair,4,1.3862943611198906
hyperventilation-induced,4,1.3862943611198906
Rentrop,4,1.3862943611198906
Blood-brain,4,1.3862943611198906
MLP,4,1.3862943611198906
PVP,4,1.3862943611198906
aged-matched,4,1.3862943611198906
MATERIALS,4,1.3862943611198906
hPAF1C,4,1.3862943611198906
HAMA,4,1.3862943611198906
self-diagnosis,4,1.3862943611198906
TMLR,4,1.3862943611198906
tensions,4,1.3862943611198906
sliced,4,1.3862943611198906
methodically,4,1.3862943611198906
sustains,4,1.3862943611198906
hypomagnesemia,4,1.3862943611198906
three-wave,4,1.3862943611198906
microsphere-based,4,1.3862943611198906
fluorescently,4,1.3862943611198906
lower-,4,1.3862943611198906
rage,4,1.3862943611198906
macroeconomic,4,1.3862943611198906
high-cost,4,1.3862943611198906
LDF,4,1.3862943611198906
cisplatin,4,1.3862943611198906
Otitis,4,1.3862943611198906
second-leading,4,1.3862943611198906
Ningbo,4,1.3862943611198906
—,4,1.3862943611198906
AdviseDx,4,1.3862943611198906
revived,4,1.3862943611198906
Rheolytic,4,1.3862943611198906
Haramaya,4,1.3862943611198906
unregistered,4,1.3862943611198906
T95I,4,1.3862943611198906
Alhydrogel®,4,1.3862943611198906
Morphological,4,1.3862943611198906
fruition,4,1.3862943611198906
NCCT,4,1.3862943611198906
hepatotoxic,4,1.3862943611198906
PDMS,4,1.3862943611198906
meningoceles,4,1.3862943611198906
round-the-clock,4,1.3862943611198906
12-fold,4,1.3862943611198906
methylcellulose,4,1.3862943611198906
µENIA,4,1.3862943611198906
speleotherapy,4,1.3862943611198906
bonding,4,1.3862943611198906
intervened,4,1.3862943611198906
Appendage,4,1.3862943611198906
unidimensional,4,1.3862943611198906
unproved,4,1.3862943611198906
non-insulin-dependent,4,1.3862943611198906
CIM,4,1.3862943611198906
MMC,4,1.3862943611198906
Gowanda,4,1.3862943611198906
pre-formed,4,1.3862943611198906
vorapaxar,4,1.3862943611198906
eotaxin,4,1.3862943611198906
populate,4,1.3862943611198906
beta-glucuronidase,4,1.3862943611198906
epistatic,4,1.3862943611198906
Simoa,4,1.3862943611198906
Alfred,4,1.3862943611198906
Two-hundred,4,1.3862943611198906
documentary,4,1.3862943611198906
occupies,4,1.3862943611198906
RDW,4,1.3862943611198906
finer,4,1.3862943611198906
AAOHN,4,1.3862943611198906
ducts,4,1.3862943611198906
debt,4,1.3862943611198906
Immunoassays,4,1.3862943611198906
MADIT-II,4,1.3862943611198906
FYMS,4,1.3862943611198906
000000,4,1.3862943611198906
neurokinin,4,1.3862943611198906
Macrolides,4,1.3862943611198906
1707,4,1.3862943611198906
dilutional,4,1.3862943611198906
Master,4,1.3862943611198906
rs3815188,4,1.3862943611198906
live-alone,4,1.3862943611198906
SOMAscan,4,1.3862943611198906
intention-to-treat,4,1.3862943611198906
venipuncture,4,1.3862943611198906
Flu-V,4,1.3862943611198906
nonresponse,4,1.3862943611198906
Lancaster,4,1.3862943611198906
cPass,4,1.3862943611198906
relieves,4,1.3862943611198906
molsidomine,4,1.3862943611198906
Recruitment,4,1.3862943611198906
E-64c,4,1.3862943611198906
hindlimb,4,1.3862943611198906
neointima,4,1.3862943611198906
OCD,4,1.3862943611198906
polarizing,4,1.3862943611198906
derivates,4,1.3862943611198906
1617,4,1.3862943611198906
20202021,4,1.3862943611198906
reductionist,4,1.3862943611198906
Bahraini,4,1.3862943611198906
EudraVigilance,4,1.3862943611198906
rain,4,1.3862943611198906
wasnt,4,1.3862943611198906
attaches,4,1.3862943611198906
STd,4,1.3862943611198906
shellfish,4,1.3862943611198906
SSC,4,1.3862943611198906
Th-2,4,1.3862943611198906
N-terminus,4,1.3862943611198906
thirty-two,4,1.3862943611198906
Ia-1,4,1.3862943611198906
IFN-induced,4,1.3862943611198906
primers-probe,4,1.3862943611198906
Kyushu,4,1.3862943611198906
1846,4,1.3862943611198906
K-dependent,4,1.3862943611198906
HR-QoL,4,1.3862943611198906
COVA1-16,4,1.3862943611198906
Havana,4,1.3862943611198906
Cubas,4,1.3862943611198906
Chang,4,1.3862943611198906
calorie,4,1.3862943611198906
cytolytic,4,1.3862943611198906
free-floating,4,1.3862943611198906
anti-malarial,4,1.3862943611198906
menace,4,1.3862943611198906
HINI,4,1.3862943611198906
phenotyped,4,1.3862943611198906
re-education,4,1.3862943611198906
lodged,4,1.3862943611198906
Attenuation,4,1.3862943611198906
imprint,4,1.3862943611198906
Buteyko,4,1.3862943611198906
abating,4,1.3862943611198906
first-hour,4,1.3862943611198906
Successfully,4,1.3862943611198906
subcomponents,4,1.3862943611198906
MHLW,4,1.3862943611198906
cabinet,4,1.3862943611198906
unpaid,4,1.3862943611198906
relayed,4,1.3862943611198906
superseded,4,1.3862943611198906
VTVD,4,1.3862943611198906
PCV7,4,1.3862943611198906
exhaustively,4,1.3862943611198906
breathless,4,1.3862943611198906
cervicocerebral,4,1.3862943611198906
n7,4,1.3862943611198906
Rondônia,4,1.3862943611198906
V2-V6,4,1.3862943611198906
population-adjusted,4,1.3862943611198906
18FFDG,4,1.3862943611198906
PET-CT,4,1.3862943611198906
S-ID,4,1.3862943611198906
compose,4,1.3862943611198906
uniqueness,4,1.3862943611198906
covid19,4,1.3862943611198906
mottle,4,1.3862943611198906
pepper,4,1.3862943611198906
Interactive,4,1.3862943611198906
kingdom,4,1.3862943611198906
ventriculopleural,4,1.3862943611198906
secondary-treated,4,1.3862943611198906
MAX™,4,1.3862943611198906
Dust,4,1.3862943611198906
chameleon,4,1.3862943611198906
granulocyte-colony,4,1.3862943611198906
RN,4,1.3862943611198906
hematoxylin-eosin,4,1.3862943611198906
nanotechnology-based,4,1.3862943611198906
state-reproduction,4,1.3862943611198906
tending,4,1.3862943611198906
positive-pressure,4,1.3862943611198906
Chiropractic,4,1.3862943611198906
Enterprise,4,1.3862943611198906
Endotracheal,4,1.3862943611198906
superparamagnetic,4,1.3862943611198906
Birds,4,1.3862943611198906
AIH,4,1.3862943611198906
SPIO-labeled,4,1.3862943611198906
s-K1,4,1.3862943611198906
thalassaemia,4,1.3862943611198906
within-,4,1.3862943611198906
nonreactive,4,1.3862943611198906
MSDs,4,1.3862943611198906
Antigen-based,4,1.3862943611198906
withhold,4,1.3862943611198906
Microbial,4,1.3862943611198906
interleukin-8,4,1.3862943611198906
s-Mg1,4,1.3862943611198906
bifidum,4,1.3862943611198906
serology-based,4,1.3862943611198906
stipulated,4,1.3862943611198906
3819,4,1.3862943611198906
mismatching,4,1.3862943611198906
Construct,4,1.3862943611198906
opportune,4,1.3862943611198906
ICDs,4,1.3862943611198906
200304,4,1.3862943611198906
Mite,4,1.3862943611198906
ACE2-Fc-TD,4,1.3862943611198906
disappointments,4,1.3862943611198906
Erie,4,1.3862943611198906
Experiment,4,1.3862943611198906
0-,4,1.3862943611198906
Buffalo,4,1.3862943611198906
re-emphasize,4,1.3862943611198906
mite-sensitive,4,1.3862943611198906
AURSS9077,4,1.3862943611198906
Inhibiting,4,1.3862943611198906
GIK,4,1.3862943611198906
Post-mortem,4,1.3862943611198906
stratum,4,1.3862943611198906
hemiblocks,4,1.3862943611198906
Maeurer,4,1.3862943611198906
SSMI,4,1.3862943611198906
Spread,4,1.3862943611198906
microfiber,4,1.3862943611198906
AGTR2,4,1.3862943611198906
2c-3,4,1.3862943611198906
12-20,4,1.3862943611198906
Epileptic,4,1.3862943611198906
ethnic-specific,4,1.3862943611198906
0050,4,1.3862943611198906
artesunate,4,1.3862943611198906
paracentral,4,1.3862943611198906
yo,4,1.3862943611198906
phenolic,4,1.3862943611198906
understated,4,1.3862943611198906
Inference,4,1.3862943611198906
viro-neutralization,4,1.3862943611198906
sonicated,4,1.3862943611198906
disconnectome,4,1.3862943611198906
anticonvulsant,4,1.3862943611198906
µg108,4,1.3862943611198906
haematomas,4,1.3862943611198906
CRR,4,1.3862943611198906
wave-like,4,1.3862943611198906
tanshinone,4,1.3862943611198906
fascicle,4,1.3862943611198906
SC2,4,1.3862943611198906
misplacement,4,1.3862943611198906
SARS-CoV-2-exposed,4,1.3862943611198906
bead-based,4,1.3862943611198906
full-genome,4,1.3862943611198906
SARS-CoV-2-reactive,4,1.3862943611198906
sweats,4,1.3862943611198906
Abu,4,1.3862943611198906
manoeuvre,4,1.3862943611198906
exanthema,4,1.3862943611198906
microtubule,4,1.3862943611198906
sulfinpyrazone,4,1.3862943611198906
gift,4,1.3862943611198906
Tel,4,1.3862943611198906
2531,4,1.3862943611198906
admittances,4,1.3862943611198906
reconciling,4,1.3862943611198906
doors,4,1.3862943611198906
ECG-4,4,1.3862943611198906
mediastinoscopy,4,1.3862943611198906
MBCS,4,1.3862943611198906
ignores,4,1.3862943611198906
insistence,4,1.3862943611198906
Sections,4,1.3862943611198906
ABMs,4,1.3862943611198906
susceptibilities,4,1.3862943611198906
1949,4,1.3862943611198906
Dhabi,4,1.3862943611198906
membrane-associated,4,1.3862943611198906
chordae,4,1.3862943611198906
5G5G,4,1.3862943611198906
NRP1,4,1.3862943611198906
self-renewing,4,1.3862943611198906
Undetected,4,1.3862943611198906
2001-2009,4,1.3862943611198906
Flex,4,1.3862943611198906
reintroduced,4,1.3862943611198906
procaterol,4,1.3862943611198906
HRA,4,1.3862943611198906
A2Japan,4,1.3862943611198906
Sabah,4,1.3862943611198906
unrevealing,4,1.3862943611198906
forwarded,4,1.3862943611198906
mindful,4,1.3862943611198906
beset,4,1.3862943611198906
unidirectional,4,1.3862943611198906
psychoneuroimmunology,4,1.3862943611198906
PNI,4,1.3862943611198906
normoxemic,4,1.3862943611198906
bits,4,1.3862943611198906
ESO,4,1.3862943611198906
immensely,4,1.3862943611198906
Swan,4,1.3862943611198906
PI3K-δ,4,1.3862943611198906
polarcardiographic,4,1.3862943611198906
tethering,4,1.3862943611198906
prehospitalization,4,1.3862943611198906
HTRA1,4,1.3862943611198906
imager,4,1.3862943611198906
cognitively,4,1.3862943611198906
NZ,4,1.3862943611198906
NOK,4,1.3862943611198906
PAVMs,4,1.3862943611198906
seaweed,4,1.3862943611198906
Autologous,4,1.3862943611198906
18-24,4,1.3862943611198906
lacrimal,4,1.3862943611198906
rsEEG,4,1.3862943611198906
merged,4,1.3862943611198906
Difficult-to-treat,4,1.3862943611198906
COX-1,4,1.3862943611198906
treatment-refractory,4,1.3862943611198906
VV,4,1.3862943611198906
uncoupling,4,1.3862943611198906
MBTE,4,1.3862943611198906
MMP9,4,1.3862943611198906
Rat,4,1.3862943611198906
P0012,4,1.3862943611198906
FXIII-Ad5,4,1.3862943611198906
mUml,4,1.3862943611198906
contradictions,4,1.3862943611198906
SympAsth,4,1.3862943611198906
14-18,4,1.3862943611198906
≥45,4,1.3862943611198906
Symp0,4,1.3862943611198906
Latin-America,4,1.3862943611198906
GRL0617,4,1.3862943611198906
intending,4,1.3862943611198906
videofluoroscopy,4,1.3862943611198906
miR-221,4,1.3862943611198906
fibrinoid,4,1.3862943611198906
Ctrl,4,1.3862943611198906
SPEC,4,1.3862943611198906
accession,4,1.3862943611198906
Retrieval,4,1.3862943611198906
Annotation,4,1.3862943611198906
Visualization,4,1.3862943611198906
Unsurprisingly,4,1.3862943611198906
outliers,4,1.3862943611198906
culturable,4,1.3862943611198906
HERS,4,1.3862943611198906
NQWI,4,1.3862943611198906
exponent,4,1.3862943611198906
spinning,4,1.3862943611198906
magnifying,4,1.3862943611198906
VEF1,4,1.3862943611198906
excursions,4,1.3862943611198906
under-recognition,4,1.3862943611198906
quinacrine,4,1.3862943611198906
Dentistry,4,1.3862943611198906
minigenome,4,1.3862943611198906
double-vessel,4,1.3862943611198906
equidistant,4,1.3862943611198906
ascaris,4,1.3862943611198906
nurseries,4,1.3862943611198906
outnumber,4,1.3862943611198906
pills,4,1.3862943611198906
middle-age,4,1.3862943611198906
scFv-Fc,4,1.3862943611198906
3611,4,1.3862943611198906
Contribution,4,1.3862943611198906
201thallium,4,1.3862943611198906
Kawasaki-like,4,1.3862943611198906
ESWIs,4,1.3862943611198906
informant,4,1.3862943611198906
fluorophore,4,1.3862943611198906
I223R,4,1.3862943611198906
sick-leave,4,1.3862943611198906
SIS-16,4,1.3862943611198906
Forms,4,1.3862943611198906
-038,4,1.3862943611198906
Facial,4,1.3862943611198906
broncholytic,4,1.3862943611198906
specialize,4,1.3862943611198906
transaminitis,4,1.3862943611198906
Bursa,4,1.3862943611198906
HDM2,4,1.3862943611198906
constrict,4,1.3862943611198906
NL2631-R223,4,1.3862943611198906
DMEM,4,1.3862943611198906
5-25,4,1.3862943611198906
amine,4,1.3862943611198906
changeability,4,1.3862943611198906
panuveitis,4,1.3862943611198906
hypoechoic,4,1.3862943611198906
isoechoic,4,1.3862943611198906
WSN,4,1.3862943611198906
NL602,4,1.3862943611198906
paroxystic,4,1.3862943611198906
LW,4,1.3862943611198906
malign,4,1.3862943611198906
Atahualpa,4,1.3862943611198906
rescuing,4,1.3862943611198906
vasculogenesis,4,1.3862943611198906
immunobiology,4,1.3862943611198906
community-engaged,4,1.3862943611198906
alteplasetPA,4,1.3862943611198906
TLR9,4,1.3862943611198906
NSP10,4,1.3862943611198906
mistreated,4,1.3862943611198906
2145,4,1.3862943611198906
bloodletting,4,1.3862943611198906
T24,4,1.3862943611198906
Discordant,4,1.3862943611198906
9999,4,1.3862943611198906
descend,4,1.3862943611198906
ALS,4,1.3862943611198906
Endoscopy,4,1.3862943611198906
modal,4,1.3862943611198906
steer,4,1.3862943611198906
nitinol,4,1.3862943611198906
KCl,4,1.3862943611198906
LVSD,4,1.3862943611198906
insurmountable,4,1.3862943611198906
pollen-induced,4,1.3862943611198906
p0016,4,1.3862943611198906
non-detectable,4,1.3862943611198906
1349,4,1.3862943611198906
Angola,4,1.3862943611198906
cytogenetic,4,1.3862943611198906
karyotype,4,1.3862943611198906
Basilar,4,1.3862943611198906
TRPV3,4,1.3862943611198906
SARS-CoV-2-contaminated,4,1.3862943611198906
boxes,4,1.3862943611198906
DALY,4,1.3862943611198906
13-15,4,1.3862943611198906
radiolabeled,4,1.3862943611198906
GG,4,1.3862943611198906
1209,4,1.3862943611198906
detached,4,1.3862943611198906
substratum,4,1.3862943611198906
accommodating,4,1.3862943611198906
Lowns,4,1.3862943611198906
RCM,4,1.3862943611198906
spasmolytic,4,1.3862943611198906
fee,4,1.3862943611198906
SISS,4,1.3862943611198906
20-75,4,1.3862943611198906
CDC-based,4,1.3862943611198906
1746,4,1.3862943611198906
elude,4,1.3862943611198906
Refined,4,1.3862943611198906
oocyte,4,1.3862943611198906
mid-1990s,4,1.3862943611198906
psoriatic,4,1.3862943611198906
pulmonology,4,1.3862943611198906
checklists,4,1.3862943611198906
Jadad,4,1.3862943611198906
low-pathogenicity,4,1.3862943611198906
redirect,4,1.3862943611198906
well-equipped,4,1.3862943611198906
Simulated,4,1.3862943611198906
Mellitus,4,1.3862943611198906
family-related,4,1.3862943611198906
Expressed,4,1.3862943611198906
anhedonia,4,1.3862943611198906
border-zone,4,1.3862943611198906
surfacing,4,1.3862943611198906
outdated,4,1.3862943611198906
Patient-Reported,4,1.3862943611198906
α26-linked,4,1.3862943611198906
clinical-radiological,4,1.3862943611198906
Acutely,4,1.3862943611198906
dogmas,4,1.3862943611198906
unleashed,4,1.3862943611198906
adaptively,4,1.3862943611198906
Agent,4,1.3862943611198906
reflexive,4,1.3862943611198906
magnet,4,1.3862943611198906
up-,4,1.3862943611198906
tagging,4,1.3862943611198906
10W,4,1.3862943611198906
Purified,4,1.3862943611198906
imidazole,4,1.3862943611198906
Accreditation,4,1.3862943611198906
shrew,4,1.3862943611198906
defecation,4,1.3862943611198906
859,4,1.3862943611198906
BNS1,4,1.3862943611198906
canceling,4,1.3862943611198906
preregistered,4,1.3862943611198906
3917,4,1.3862943611198906
or380,4,1.3862943611198906
immunoperoxidase,4,1.3862943611198906
RU,4,1.3862943611198906
stimulatory,4,1.3862943611198906
insulin-like,4,1.3862943611198906
21-year-old,4,1.3862943611198906
tapered,4,1.3862943611198906
Hawaiis,4,1.3862943611198906
Yale,4,1.3862943611198906
recruitable,4,1.3862943611198906
disinfect,4,1.3862943611198906
cMRI,4,1.3862943611198906
antigen-positive,4,1.3862943611198906
rifampicin,4,1.3862943611198906
tournaments,4,1.3862943611198906
acid-fast,4,1.3862943611198906
Côte,4,1.3862943611198906
initio,4,1.3862943611198906
LF-sVNT,4,1.3862943611198906
bi-directional,4,1.3862943611198906
alpha-1-antitrypsin,4,1.3862943611198906
marboxil,4,1.3862943611198906
pre-treated,4,1.3862943611198906
precipitin,4,1.3862943611198906
inquiring,4,1.3862943611198906
toroidal,4,1.3862943611198906
ADP-induced,4,1.3862943611198906
pointes,4,1.3862943611198906
uncinate,4,1.3862943611198906
parametrization,4,1.3862943611198906
Anonymous,4,1.3862943611198906
Lao,4,1.3862943611198906
deoxyhemoglobin,4,1.3862943611198906
meshwork,4,1.3862943611198906
Relapse,4,1.3862943611198906
pasteurization,4,1.3862943611198906
ears,4,1.3862943611198906
BBFM,4,1.3862943611198906
11-OCS,4,1.3862943611198906
Mix,4,1.3862943611198906
PrimeDirect,4,1.3862943611198906
uterus,4,1.3862943611198906
releasability,4,1.3862943611198906
movie,4,1.3862943611198906
theranostic,4,1.3862943611198906
bioanalysis,4,1.3862943611198906
Modest,4,1.3862943611198906
Communications,4,1.3862943611198906
lipoma,4,1.3862943611198906
EMPRES-i,4,1.3862943611198906
herhis,4,1.3862943611198906
mid-ventricular,4,1.3862943611198906
outweighed,4,1.3862943611198906
racist,4,1.3862943611198906
undermines,4,1.3862943611198906
ERK12,4,1.3862943611198906
PDF,4,1.3862943611198906
factor-kappa,4,1.3862943611198906
Declining,4,1.3862943611198906
Shanxi,4,1.3862943611198906
CBDM,4,1.3862943611198906
harmonic,4,1.3862943611198906
HPC,4,1.3862943611198906
AIS-LVO,4,1.3862943611198906
offline,4,1.3862943611198906
galvanized,4,1.3862943611198906
OK-432,4,1.3862943611198906
FSMs,4,1.3862943611198906
OD450,4,1.3862943611198906
anti-S1RBD,4,1.3862943611198906
slurry,4,1.3862943611198906
2-way,4,1.3862943611198906
Qβ,4,1.3862943611198906
fee-for-service,4,1.3862943611198906
AKorea82,4,1.3862943611198906
Examine,4,1.3862943611198906
Infant,4,1.3862943611198906
April-July,4,1.3862943611198906
VDBWST,4,1.3862943611198906
TLR-related,4,1.3862943611198906
DCVMN,4,1.3862943611198906
apnoeas,4,1.3862943611198906
embolizations,4,1.3862943611198906
15100,4,1.3862943611198906
inoperable,4,1.3862943611198906
BWT,4,1.3862943611198906
shivering,4,1.3862943611198906
Allegheny,4,1.3862943611198906
0300,4,1.3862943611198906
self-completed,4,1.3862943611198906
450000,4,1.3862943611198906
sCFR,4,1.3862943611198906
pulsatility,4,1.3862943611198906
Q12,4,1.3862943611198906
risk-stratification,4,1.3862943611198906
testkits,4,1.3862943611198906
Notifications,4,1.3862943611198906
LMS,4,1.3862943611198906
HA-pep25,4,1.3862943611198906
overseas-acquired,4,1.3862943611198906
Noncompliance,4,1.3862943611198906
Flu-B,4,1.3862943611198906
high-coverage,4,1.3862943611198906
T-SFDOSM,4,1.3862943611198906
APCs,4,1.3862943611198906
existent,4,1.3862943611198906
PMP,4,1.3862943611198906
neuraminidase-inhibitor,4,1.3862943611198906
Country,4,1.3862943611198906
dobutamine-induced,4,1.3862943611198906
well-localized,4,1.3862943611198906
Fourfold,4,1.3862943611198906
factored,4,1.3862943611198906
40-59,4,1.3862943611198906
ionization,4,1.3862943611198906
cfa-miR-197,4,1.3862943611198906
Kong33001,4,1.3862943611198906
acid-,4,1.3862943611198906
cardboard,4,1.3862943611198906
futility,4,1.3862943611198906
docosahexaenoic,4,1.3862943611198906
wildland,4,1.3862943611198906
preinfection,4,1.3862943611198906
CONTENT,4,1.3862943611198906
LINKED,4,1.3862943611198906
Leydig,4,1.3862943611198906
LB,4,1.3862943611198906
disablement,4,1.3862943611198906
returnees,4,1.3862943611198906
Liege,4,1.3862943611198906
1523,4,1.3862943611198906
tha,4,1.3862943611198906
glymphatic,4,1.3862943611198906
TCID50mL,4,1.3862943611198906
Anomalous,4,1.3862943611198906
liabilities,4,1.3862943611198906
ultra,4,1.3862943611198906
07-08,4,1.3862943611198906
tonsil,4,1.3862943611198906
SWD,4,1.3862943611198906
disarray,4,1.3862943611198906
VPW,4,1.3862943611198906
CTR,4,1.3862943611198906
high-threat,4,1.3862943611198906
lawsuits,4,1.3862943611198906
email,4,1.3862943611198906
hyperthermic,4,1.3862943611198906
lingual,4,1.3862943611198906
-58,4,1.3862943611198906
fibromyalgia,4,1.3862943611198906
sourced,4,1.3862943611198906
waitlist,4,1.3862943611198906
publicity,4,1.3862943611198906
injurious,4,1.3862943611198906
setback,4,1.3862943611198906
≥160,4,1.3862943611198906
PKC,4,1.3862943611198906
Projects,4,1.3862943611198906
Reaferon,4,1.3862943611198906
Asthma-chronic,4,1.3862943611198906
hydrophilicity,4,1.3862943611198906
wary,4,1.3862943611198906
RdPR,4,1.3862943611198906
Standardised,4,1.3862943611198906
NY18,4,1.3862943611198906
Readiness,4,1.3862943611198906
able-bodied,4,1.3862943611198906
68Ga-NODAGA-RGD,4,1.3862943611198906
Angiogenesis,4,1.3862943611198906
forgetting,4,1.3862943611198906
forestall,4,1.3862943611198906
lipoxygenase,4,1.3862943611198906
1395,4,1.3862943611198906
Cleveland,4,1.3862943611198906
embraces,4,1.3862943611198906
encephalopathyencephalitis,4,1.3862943611198906
deltaFVC,4,1.3862943611198906
highlow,4,1.3862943611198906
mastocytosis,4,1.3862943611198906
continuous-time,4,1.3862943611198906
hydrocarbons,4,1.3862943611198906
HD-CEC,4,1.3862943611198906
B1129,4,1.3862943611198906
fluoride,4,1.3862943611198906
N439K,4,1.3862943611198906
intracavitary,4,1.3862943611198906
Echinococcus,4,1.3862943611198906
terminating,4,1.3862943611198906
CD11bbright,4,1.3862943611198906
messengers,4,1.3862943611198906
0972,4,1.3862943611198906
non-infarction,4,1.3862943611198906
PROM,4,1.3862943611198906
life-change,4,1.3862943611198906
Neurol,4,1.3862943611198906
Simplified,4,1.3862943611198906
fNLF,4,1.3862943611198906
III-A,4,1.3862943611198906
SWA,4,1.3862943611198906
Myomo,4,1.3862943611198906
2006-2014,4,1.3862943611198906
individual-specific,4,1.3862943611198906
matricellular,4,1.3862943611198906
fixed-,4,1.3862943611198906
mycardial,4,1.3862943611198906
susceptible-exposed-infectious-removed,4,1.3862943611198906
Abruzzo,4,1.3862943611198906
DTR,4,1.3862943611198906
SWMAs,4,1.3862943611198906
aprosodia,4,1.3862943611198906
mucormycosis,4,1.3862943611198906
795000,4,1.3862943611198906
fibrofatty,4,1.3862943611198906
IVRT,4,1.3862943611198906
tirelessly,4,1.3862943611198906
predisease,4,1.3862943611198906
SVZ,4,1.3862943611198906
GDG,4,1.3862943611198906
apoptosis-associated,4,1.3862943611198906
AVQ,4,1.3862943611198906
Electroencephalography,4,1.3862943611198906
Annals,4,1.3862943611198906
nonlocalizable,4,1.3862943611198906
Lyme,4,1.3862943611198906
scaling-up,4,1.3862943611198906
FMSCA,4,1.3862943611198906
swine-related,4,1.3862943611198906
IL-4Ralpha,4,1.3862943611198906
multi-slice,4,1.3862943611198906
ICS-containing,4,1.3862943611198906
SORP,4,1.3862943611198906
adj,4,1.3862943611198906
endotype-specific,4,1.3862943611198906
rs2910164,4,1.3862943611198906
r-TPA,4,1.3862943611198906
bodyweight,4,1.3862943611198906
Bazetts,4,1.3862943611198906
withdrawing,4,1.3862943611198906
kilogram,4,1.3862943611198906
progestin,4,1.3862943611198906
Revised,4,1.3862943611198906
comparators,4,1.3862943611198906
self-renewal,4,1.3862943611198906
injury-induced,4,1.3862943611198906
proportional-hazards,4,1.3862943611198906
LDA,4,1.3862943611198906
cm2m2,4,1.3862943611198906
TGF-β1,4,1.3862943611198906
Fc-effector,4,1.3862943611198906
LTR,4,1.3862943611198906
Oscillation,4,1.3862943611198906
1291,4,1.3862943611198906
NASBA,4,1.3862943611198906
Obviously,4,1.3862943611198906
upregulates,4,1.3862943611198906
Edwards,4,1.3862943611198906
FOT,4,1.3862943611198906
postsynaptic,4,1.3862943611198906
hairdressers,4,1.3862943611198906
CADs,4,1.3862943611198906
Drug-eluting,4,1.3862943611198906
asthma-PD,4,1.3862943611198906
laminectomy,4,1.3862943611198906
Define,4,1.3862943611198906
WeChat,4,1.3862943611198906
microacupuncture,4,1.3862943611198906
TLR8,4,1.3862943611198906
B-lineage,4,1.3862943611198906
1-SD,4,1.3862943611198906
fast-spreading,4,1.3862943611198906
palmitoyltransferase,4,1.3862943611198906
Udine,4,1.3862943611198906
1924,4,1.3862943611198906
GAM,4,1.3862943611198906
gamma-globulin,4,1.3862943611198906
n70,4,1.3862943611198906
Marcel,4,1.3862943611198906
NSG,4,1.3862943611198906
appreciating,4,1.3862943611198906
IHV,4,1.3862943611198906
determinate,4,1.3862943611198906
CASSPIT,4,1.3862943611198906
n31,4,1.3862943611198906
diverticulous,4,1.3862943611198906
pneumoconioses,4,1.3862943611198906
BXM,4,1.3862943611198906
assembling,4,1.3862943611198906
Isc,4,1.3862943611198906
left-atrial,4,1.3862943611198906
microeconomic,4,1.3862943611198906
EUROSTROKE,4,1.3862943611198906
UCLA,4,1.3862943611198906
TRACE,4,1.3862943611198906
BIOSYNEX®,4,1.3862943611198906
respecting,4,1.3862943611198906
nonconventional,4,1.3862943611198906
kinins,4,1.3862943611198906
sinusoidal,4,1.3862943611198906
lipomatous,4,1.3862943611198906
β2-adrenergic,4,1.3862943611198906
35-fold,4,1.3862943611198906
H11,4,1.3862943611198906
Virus-specific,4,1.3862943611198906
Handwashing,4,1.3862943611198906
jumping,4,1.3862943611198906
COPD-related,4,1.3862943611198906
UK-38485,4,1.3862943611198906
Dmin,4,1.3862943611198906
acariens,4,1.3862943611198906
midterm,4,1.3862943611198906
Institution,4,1.3862943611198906
NMRs,4,1.3862943611198906
n24,4,1.3862943611198906
Analyzed,4,1.3862943611198906
preprocessing,4,1.3862943611198906
phenotypesendotypes,4,1.3862943611198906
groupABSTRACT,4,1.3862943611198906
obturation,4,1.3862943611198906
typified,4,1.3862943611198906
indefinite,4,1.3862943611198906
reproducing,4,1.3862943611198906
HALex,4,1.3862943611198906
Actions,4,1.3862943611198906
LCMV,4,1.3862943611198906
HB,4,1.3862943611198906
ISB,4,1.3862943611198906
mycophenolic,4,1.3862943611198906
clofazimine,4,1.3862943611198906
isotopic,4,1.3862943611198906
Jun,4,1.3862943611198906
I-IV,4,1.3862943611198906
fluoroscopic,4,1.3862943611198906
cardioactive,4,1.3862943611198906
clot-retrieval,4,1.3862943611198906
Forresters,4,1.3862943611198906
streptodecase,4,1.3862943611198906
PVADs,4,1.3862943611198906
MBC,4,1.3862943611198906
congregations,4,1.3862943611198906
floors,4,1.3862943611198906
small-particle,4,1.3862943611198906
superspreader,4,1.3862943611198906
Identified,4,1.3862943611198906
Maps,4,1.3862943611198906
flight-related,4,1.3862943611198906
DLVSP,4,1.3862943611198906
teen,4,1.3862943611198906
F-FDG,4,1.3862943611198906
VTG,4,1.3862943611198906
inferoapical,4,1.3862943611198906
Nanyang,4,1.3862943611198906
dual-target,4,1.3862943611198906
obstetrician,4,1.3862943611198906
noninstitutionalized,4,1.3862943611198906
Dependent,4,1.3862943611198906
Hanoi,4,1.3862943611198906
Fragmented,4,1.3862943611198906
pioneer,4,1.3862943611198906
≥90,4,1.3862943611198906
L-carnitine,4,1.3862943611198906
sample-specific,4,1.3862943611198906
PDA,4,1.3862943611198906
Endoscopic,4,1.3862943611198906
overemphasized,4,1.3862943611198906
barcodes,4,1.3862943611198906
comprehending,4,1.3862943611198906
1137,4,1.3862943611198906
bioreporter,4,1.3862943611198906
haptens,4,1.3862943611198906
fenoptosys,4,1.3862943611198906
OIE,4,1.3862943611198906
AMM,4,1.3862943611198906
intermingled,4,1.3862943611198906
cryoinjury,4,1.3862943611198906
Extension,4,1.3862943611198906
cassette,4,1.3862943611198906
mofetil,4,1.3862943611198906
Ingavirin,4,1.3862943611198906
colloquially,4,1.3862943611198906
ingesting,4,1.3862943611198906
1058,4,1.3862943611198906
insecticide,4,1.3862943611198906
1256,4,1.3862943611198906
MIP-1α,4,1.3862943611198906
1155,4,1.3862943611198906
Eligibility,4,1.3862943611198906
doxycycline,4,1.3862943611198906
-074,4,1.3862943611198906
VSI,4,1.3862943611198906
HIV-related,4,1.3862943611198906
negligence,4,1.3862943611198906
MRI-BAS,4,1.3862943611198906
mgkg-1,4,1.3862943611198906
HRV-BF,4,1.3862943611198906
RESCUE,4,1.3862943611198906
interregional,4,1.3862943611198906
Data-driven,4,1.3862943611198906
alpha-hydroxybutyrate,4,1.3862943611198906
Clínicas,4,1.3862943611198906
NRHOSP,4,1.3862943611198906
fortunate,4,1.3862943611198906
ELISPOT,4,1.3862943611198906
Nakhon,4,1.3862943611198906
Histology,4,1.3862943611198906
Provinces,4,1.3862943611198906
εe,4,1.3862943611198906
serum-free,4,1.3862943611198906
D399N,4,1.3862943611198906
sustentacular,4,1.3862943611198906
ISC,4,1.3862943611198906
IL-4RαIL-5--,4,1.3862943611198906
aVHS,4,1.3862943611198906
tiers,4,1.3862943611198906
CincinnatiNorthern,4,1.3862943611198906
inexperience,4,1.3862943611198906
phlebotomy,4,1.3862943611198906
1916,4,1.3862943611198906
cellsmL,4,1.3862943611198906
hunters,4,1.3862943611198906
ARTI,4,1.3862943611198906
heartburn,4,1.3862943611198906
excimer,4,1.3862943611198906
BACE1,4,1.3862943611198906
ITZs,4,1.3862943611198906
non-cardiovascular,4,1.3862943611198906
NMDA-receptors,4,1.3862943611198906
CASI,4,1.3862943611198906
asystolia,4,1.3862943611198906
rerouting,4,1.3862943611198906
two-shot,4,1.3862943611198906
1007,4,1.3862943611198906
Copyright,4,1.3862943611198906
SENTIS,4,1.3862943611198906
BIPQ,4,1.3862943611198906
alcohol-induced,4,1.3862943611198906
bioelectric,4,1.3862943611198906
7-13,4,1.3862943611198906
Notable,4,1.3862943611198906
Note,4,1.3862943611198906
preemptively,4,1.3862943611198906
teicoplanin,4,1.3862943611198906
LPVr,4,1.3862943611198906
Anticholinergic,4,1.3862943611198906
undulating,4,1.3862943611198906
denote,4,1.3862943611198906
inferobasal,4,1.3862943611198906
Tdap,4,1.3862943611198906
39-year,4,1.3862943611198906
interventionalists,4,1.3862943611198906
resilient,4,1.3862943611198906
Orally,4,1.3862943611198906
dpi,4,1.3862943611198906
RMD,4,1.3862943611198906
SCN,4,1.3862943611198906
anti-atherosclerotic,4,1.3862943611198906
DSP,4,1.3862943611198906
sero-epidemiologic,4,1.3862943611198906
explanted,4,1.3862943611198906
BW,4,1.3862943611198906
polytetrafluoroethylene,4,1.3862943611198906
KCNN4,4,1.3862943611198906
Bern,4,1.3862943611198906
campers,4,1.3862943611198906
catalyzes,4,1.3862943611198906
Al-adjuvanted,4,1.3862943611198906
BCL0,4,1.3862943611198906
G0,4,1.3862943611198906
BCL,4,1.3862943611198906
EFA,4,1.3862943611198906
Sanitation,4,1.3862943611198906
habitation,4,1.3862943611198906
DBE,4,1.3862943611198906
DBNE,4,1.3862943611198906
arent,4,1.3862943611198906
computations,4,1.3862943611198906
Jefferson,4,1.3862943611198906
thinner,4,1.3862943611198906
GSD,4,1.3862943611198906
selling,4,1.3862943611198906
non-White,4,1.3862943611198906
NovaGen,4,1.3862943611198906
6×30,4,1.3862943611198906
Seventh,4,1.3862943611198906
GPCRs,4,1.3862943611198906
Genomes,4,1.3862943611198906
smokeless,4,1.3862943611198906
odours,4,1.3862943611198906
p008,4,1.3862943611198906
reassess,4,1.3862943611198906
ST-VD,4,1.3862943611198906
NECs,4,1.3862943611198906
Allergen-induced,4,1.3862943611198906
sigmodontis,4,1.3862943611198906
LTS,4,1.3862943611198906
ST3GAL1,4,1.3862943611198906
oximeter,4,1.3862943611198906
Aβ1-40,4,1.3862943611198906
Aβ1-42,4,1.3862943611198906
AVietnam12032004,4,1.3862943611198906
S1-4,4,1.3862943611198906
Decline,4,1.3862943611198906
antigen-antibody,4,1.3862943611198906
odour,4,1.3862943611198906
Gastroenterology,4,1.3862943611198906
GESS,4,1.3862943611198906
2018-19,4,1.3862943611198906
homocystinuria,4,1.3862943611198906
angiitis,4,1.3862943611198906
gonadal,4,1.3862943611198906
4×40,4,1.3862943611198906
Neonates,4,1.3862943611198906
high-incidence,4,1.3862943611198906
roundtable,4,1.3862943611198906
K627E,4,1.3862943611198906
screen-printed,4,1.3862943611198906
vented,4,1.3862943611198906
15-18,4,1.3862943611198906
punctate,4,1.3862943611198906
Preference,4,1.3862943611198906
PURPOSE,4,1.3862943611198906
dyskinesias,4,1.3862943611198906
pleasant,4,1.3862943611198906
G2,4,1.3862943611198906
fortification,4,1.3862943611198906
scuba,4,1.3862943611198906
38th,4,1.3862943611198906
A3243G,4,1.3862943611198906
deductive,4,1.3862943611198906
45th,4,1.3862943611198906
15-45,4,1.3862943611198906
CPCC,4,1.3862943611198906
Hong-Kong,4,1.3862943611198906
compartmentalization,4,1.3862943611198906
unblinded,4,1.3862943611198906
isovolumetric,4,1.3862943611198906
p02,4,1.3862943611198906
under-representation,4,1.3862943611198906
cART,4,1.3862943611198906
north-western,4,1.3862943611198906
cuticles,4,1.3862943611198906
sp-A,4,1.3862943611198906
insertiondeletion,4,1.3862943611198906
80-85,4,1.3862943611198906
CLINICAL,4,1.3862943611198906
Macaé,4,1.3862943611198906
hogy,4,1.3862943611198906
CMTF,4,1.3862943611198906
airlines,4,1.3862943611198906
biennial,4,1.3862943611198906
Methylene,4,1.3862943611198906
IRAO,4,1.3862943611198906
detained,4,1.3862943611198906
fabrics,4,1.3862943611198906
skew,4,1.3862943611198906
ETCO2,4,1.3862943611198906
14-21,4,1.3862943611198906
FRS,4,1.3862943611198906
modellers,4,1.3862943611198906
enumerated,4,1.3862943611198906
ALWC,4,1.3862943611198906
frequency-domain,4,1.3862943611198906
immunities,4,1.3862943611198906
propranolol-treated,4,1.3862943611198906
decade-long,4,1.3862943611198906
upregulate,4,1.3862943611198906
mosaicism,4,1.3862943611198906
nonagenarian,4,1.3862943611198906
allergyasthma,4,1.3862943611198906
manufactures,4,1.3862943611198906
immobility,4,1.3862943611198906
Clostridium,4,1.3862943611198906
cereal,4,1.3862943611198906
COV-2,4,1.3862943611198906
Seventy-three,4,1.3862943611198906
IL-1beta,4,1.3862943611198906
Walker,4,1.3862943611198906
alpha-amylase,4,1.3862943611198906
Beta-blocker,4,1.3862943611198906
two-third,4,1.3862943611198906
ubiquity,4,1.3862943611198906
fallwinter,4,1.3862943611198906
hsa-miR-1307-3p,4,1.3862943611198906
thermostability,4,1.3862943611198906
CHA2DS2-VASc-CF,4,1.3862943611198906
Morris,4,1.3862943611198906
PvuII,4,1.3862943611198906
pejorative,4,1.3862943611198906
epistasis,4,1.3862943611198906
atenolol-based,4,1.3862943611198906
nsp5,4,1.3862943611198906
AH7,4,1.3862943611198906
re-occlusion,4,1.3862943611198906
REGN10987,4,1.3862943611198906
S-Trimer,4,1.3862943611198906
garrison,4,1.3862943611198906
attentions,4,1.3862943611198906
Components,4,1.3862943611198906
Impairments,4,1.3862943611198906
Fluorescence,4,1.3862943611198906
ASydney597-like,4,1.3862943611198906
recent-onset,4,1.3862943611198906
Diagnosed,4,1.3862943611198906
latecomers,4,1.3862943611198906
pH1N1-related,4,1.3862943611198906
gauged,4,1.3862943611198906
thermometers,4,1.3862943611198906
reset,4,1.3862943611198906
Glostrup,4,1.3862943611198906
non-contact,4,1.3862943611198906
non-young,4,1.3862943611198906
adeno-associated,4,1.3862943611198906
ACOV,4,1.3862943611198906
0089,4,1.3862943611198906
alpha-1,4,1.3862943611198906
14-31,4,1.3862943611198906
hemispherical,4,1.3862943611198906
Spike-protein,4,1.3862943611198906
takeoff,4,1.3862943611198906
medico-legal,4,1.3862943611198906
Socialist,4,1.3862943611198906
south-east,4,1.3862943611198906
pro-brain,4,1.3862943611198906
ventilationperfusion,4,1.3862943611198906
bihemispheric,4,1.3862943611198906
hottest,4,1.3862943611198906
incompetent,4,1.3862943611198906
hantavirus,4,1.3862943611198906
bio-safety,4,1.3862943611198906
transcendental,4,1.3862943611198906
2010-2015,4,1.3862943611198906
Z0,4,1.3862943611198906
bifascicular,4,1.3862943611198906
antibiotic-resistant,4,1.3862943611198906
GPIbα,4,1.3862943611198906
equipotent,4,1.3862943611198906
technics,4,1.3862943611198906
micromolar,4,1.3862943611198906
Xiaodu,4,1.3862943611198906
Losartan,4,1.3862943611198906
Ganlu,4,1.3862943611198906
LEW,4,1.3862943611198906
late-type,4,1.3862943611198906
S31N,4,1.3862943611198906
estradiol,4,1.3862943611198906
nvH1N1,4,1.3862943611198906
or1,4,1.3862943611198906
theaters,4,1.3862943611198906
losartan-based,4,1.3862943611198906
LOAD,4,1.3862943611198906
post-PET,4,1.3862943611198906
Apparently,4,1.3862943611198906
vertex,4,1.3862943611198906
QWB,4,1.3862943611198906
prototypical,4,1.3862943611198906
footprints,4,1.3862943611198906
Off-pump,4,1.3862943611198906
formulates,4,1.3862943611198906
several-fold,4,1.3862943611198906
hyper-inflammation,4,1.3862943611198906
AAAAI,4,1.3862943611198906
lactose,4,1.3862943611198906
86-year-old,4,1.3862943611198906
competes,4,1.3862943611198906
chloramphenicol,4,1.3862943611198906
SARS-CoV-22019-nCoV,4,1.3862943611198906
IFN-stimulated,4,1.3862943611198906
pain-free,4,1.3862943611198906
A2-RP,4,1.3862943611198906
short-read,4,1.3862943611198906
phosphatases,4,1.3862943611198906
subclades,4,1.3862943611198906
off-the-shelf,4,1.3862943611198906
unproductive,4,1.3862943611198906
anonymized,4,1.3862943611198906
Directorate,4,1.3862943611198906
acid-induced,4,1.3862943611198906
IFN-λ3,4,1.3862943611198906
IFN-λ2,4,1.3862943611198906
IFN-λ,4,1.3862943611198906
High-sensitivity,4,1.3862943611198906
CEE,4,1.3862943611198906
Foucaults,4,1.3862943611198906
moderate-to-high,4,1.3862943611198906
»,4,1.3862943611198906
preexcitation,4,1.3862943611198906
subgenomes,4,1.3862943611198906
lipohyalinosis,4,1.3862943611198906
Ifanadiana,4,1.3862943611198906
Biologic,4,1.3862943611198906
High-quality,4,1.3862943611198906
≤1,4,1.3862943611198906
elliptical,4,1.3862943611198906
ST-elevations,4,1.3862943611198906
basins,4,1.3862943611198906
felines,4,1.3862943611198906
geographies,4,1.3862943611198906
-CI,4,1.3862943611198906
Mustela,4,1.3862943611198906
QMRA,4,1.3862943611198906
mosquito,4,1.3862943611198906
75000,4,1.3862943611198906
isopropanol,4,1.3862943611198906
IgMSP,4,1.3862943611198906
asymptotically,4,1.3862943611198906
35-44,4,1.3862943611198906
unforeseeable,4,1.3862943611198906
meningeal,4,1.3862943611198906
Código,4,1.3862943611198906
peri-index,4,1.3862943611198906
Matthew,4,1.3862943611198906
transposon,4,1.3862943611198906
Completed,4,1.3862943611198906
fine-tune,4,1.3862943611198906
SIMID,4,1.3862943611198906
1051,4,1.3862943611198906
mitophagy,4,1.3862943611198906
PBMac,4,1.3862943611198906
P0009,4,1.3862943611198906
≤19,4,1.3862943611198906
human-specific,4,1.3862943611198906
radiating,4,1.3862943611198906
5-item,4,1.3862943611198906
transcriptions,4,1.3862943611198906
kernel,4,1.3862943611198906
professors,4,1.3862943611198906
ultra-early,4,1.3862943611198906
connexin-43,4,1.3862943611198906
HM-γ-PGA,4,1.3862943611198906
SJVO2,4,1.3862943611198906
neuroepidemiology,4,1.3862943611198906
suppressant,4,1.3862943611198906
CPIs,4,1.3862943611198906
Fazekas,4,1.3862943611198906
1029,4,1.3862943611198906
CNV,4,1.3862943611198906
MRI-guided,4,1.3862943611198906
carvedilol,4,1.3862943611198906
end-to-end,4,1.3862943611198906
suppressants,4,1.3862943611198906
ethnographic,4,1.3862943611198906
LICH,4,1.3862943611198906
Miller,4,1.3862943611198906
2-hour,4,1.3862943611198906
calcium-antagonists,4,1.3862943611198906
nonvaccinees,4,1.3862943611198906
prefectural,4,1.3862943611198906
hesitance,4,1.3862943611198906
13-19,4,1.3862943611198906
reexamination,4,1.3862943611198906
Indias,4,1.3862943611198906
bi-ethnic,4,1.3862943611198906
locale,4,1.3862943611198906
Erectile,4,1.3862943611198906
orbital,4,1.3862943611198906
aides,4,1.3862943611198906
Transfusions,4,1.3862943611198906
Cardiomyocyte,4,1.3862943611198906
small-airway,4,1.3862943611198906
kJ,4,1.3862943611198906
ionized,4,1.3862943611198906
Wake-Up,4,1.3862943611198906
Comorbidity,4,1.3862943611198906
ILI-related,4,1.3862943611198906
CEC,4,1.3862943611198906
B117775,4,1.3862943611198906
Branch,4,1.3862943611198906
High-resolution,4,1.3862943611198906
vesicle,4,1.3862943611198906
task-oriented,4,1.3862943611198906
NFL,4,1.3862943611198906
2-related,4,1.3862943611198906
ImunoAce,4,1.3862943611198906
1879,4,1.3862943611198906
videofluoroscopic,4,1.3862943611198906
vaccinia,4,1.3862943611198906
phylogeography,4,1.3862943611198906
Uliter,4,1.3862943611198906
arterio-venous,4,1.3862943611198906
CORAVAX,4,1.3862943611198906
GHS,4,1.3862943611198906
Corman,4,1.3862943611198906
phenotype-targeted,4,1.3862943611198906
sIgE,4,1.3862943611198906
Dpt,4,1.3862943611198906
Provider,4,1.3862943611198906
superensemble,4,1.3862943611198906
illiteracy,4,1.3862943611198906
Tuscany,4,1.3862943611198906
adage,4,1.3862943611198906
Tc-PPi,4,1.3862943611198906
time-lags,4,1.3862943611198906
meta-analytical,4,1.3862943611198906
intolerable,4,1.3862943611198906
revascularised,4,1.3862943611198906
functionalization,4,1.3862943611198906
microarchitecture,4,1.3862943611198906
tissuesorgans,4,1.3862943611198906
0-30,4,1.3862943611198906
stairs,4,1.3862943611198906
NKT,4,1.3862943611198906
endarterectomies,4,1.3862943611198906
predictably,4,1.3862943611198906
MEF,4,1.3862943611198906
7666,4,1.3862943611198906
lower-limb,4,1.3862943611198906
1847,4,1.3862943611198906
Links,4,1.3862943611198906
Salvia,4,1.3862943611198906
2477,4,1.3862943611198906
NERD,4,1.3862943611198906
cerevisiae,4,1.3862943611198906
non-NA,4,1.3862943611198906
Hypokinesis,4,1.3862943611198906
HLP,4,1.3862943611198906
Saccharomyces,4,1.3862943611198906
wont,4,1.3862943611198906
CCAAP,4,1.3862943611198906
surged,4,1.3862943611198906
vírus,4,1.3862943611198906
Trousseau,4,1.3862943611198906
angor,4,1.3862943611198906
2005-2008,4,1.3862943611198906
antidiuretic,4,1.3862943611198906
Prespecified,4,1.3862943611198906
undiscovered,4,1.3862943611198906
biocompatible,4,1.3862943611198906
transformative,4,1.3862943611198906
Δ382,4,1.3862943611198906
Anat,4,1.3862943611198906
nuts,4,1.3862943611198906
Extrapolating,4,1.3862943611198906
3884,4,1.3862943611198906
short-range,4,1.3862943611198906
TRUPCR,4,1.3862943611198906
amyotrophic,4,1.3862943611198906
BI-RADS,4,1.3862943611198906
Blockers,4,1.3862943611198906
4-sample,4,1.3862943611198906
inertia,4,1.3862943611198906
Characterizing,4,1.3862943611198906
bisection,4,1.3862943611198906
hypofixation,4,1.3862943611198906
1889-1890,4,1.3862943611198906
Hebei,4,1.3862943611198906
neurothrombectomy,4,1.3862943611198906
unprocessed,4,1.3862943611198906
ventriculoperitoneal,4,1.3862943611198906
pain-relieving,4,1.3862943611198906
eightfold,4,1.3862943611198906
Tested,4,1.3862943611198906
methyltransferase,4,1.3862943611198906
CULPRIT-SHOCK,4,1.3862943611198906
plea,4,1.3862943611198906
hyperpnoea,4,1.3862943611198906
thrombolytic-treated,4,1.3862943611198906
Psychosomatic,4,1.3862943611198906
nonimmune,4,1.3862943611198906
della,4,1.3862943611198906
syndrome-CoV,4,1.3862943611198906
2009-June,4,1.3862943611198906
nonuse,4,1.3862943611198906
recanalised,4,1.3862943611198906
weight-adjusted,4,1.3862943611198906
G-protein,4,1.3862943611198906
canceled,4,1.3862943611198906
revival,4,1.3862943611198906
FNE,4,1.3862943611198906
sulpyrine,4,1.3862943611198906
TDS,4,1.3862943611198906
counseled,4,1.3862943611198906
Priority,4,1.3862943611198906
Antegrade,4,1.3862943611198906
PPSs,4,1.3862943611198906
Vigilance,4,1.3862943611198906
LMC,4,1.3862943611198906
Providence,4,1.3862943611198906
ratiometric,4,1.3862943611198906
Anisotropy,4,1.3862943611198906
metachromatic,4,1.3862943611198906
Paper,4,1.3862943611198906
place-based,4,1.3862943611198906
risk-of-infection,4,1.3862943611198906
gradient-echo,4,1.3862943611198906
lenticulostriate,4,1.3862943611198906
ARIES,4,1.3862943611198906
docking-based,4,1.3862943611198906
LVFP,4,1.3862943611198906
non-segmented,4,1.3862943611198906
TNFalpha,4,1.3862943611198906
posttransplant,4,1.3862943611198906
lambda-like,4,1.3862943611198906
inexorable,4,1.3862943611198906
EVALI,4,1.3862943611198906
positivenegative,4,1.3862943611198906
outcompeted,4,1.3862943611198906
host-mediated,4,1.3862943611198906
AWisconsin672005,4,1.3862943611198906
postchallenge,4,1.3862943611198906
endocrinology,4,1.3862943611198906
NHANES,4,1.3862943611198906
harmonics,4,1.3862943611198906
NOD2,4,1.3862943611198906
MNP,4,1.3862943611198906
Hip,4,1.3862943611198906
off-hours,4,1.3862943611198906
serinethreonine,4,1.3862943611198906
948,4,1.3862943611198906
rides,4,1.3862943611198906
parasitosis,4,1.3862943611198906
researching,4,1.3862943611198906
catastrophizing,4,1.3862943611198906
MRg-HIFU,4,1.3862943611198906
EOS,4,1.3862943611198906
LAD2,4,1.3862943611198906
centimeters,4,1.3862943611198906
rushed,4,1.3862943611198906
BAE,4,1.3862943611198906
hypopituitarism,4,1.3862943611198906
TVAC,4,1.3862943611198906
pseudoknot,4,1.3862943611198906
relegated,4,1.3862943611198906
brachiocephalic,4,1.3862943611198906
glioblastoma,4,1.3862943611198906
twenty-one,4,1.3862943611198906
within-household,4,1.3862943611198906
diffusional,4,1.3862943611198906
exocrine,4,1.3862943611198906
jail,4,1.3862943611198906
deer,4,1.3862943611198906
squamous,4,1.3862943611198906
iPSC-derived,4,1.3862943611198906
indigent,4,1.3862943611198906
40-year,4,1.3862943611198906
ESS,4,1.3862943611198906
videoconference,4,1.3862943611198906
graver,4,1.3862943611198906
overinflation,4,1.3862943611198906
diphosphonate,4,1.3862943611198906
brain-heart,4,1.3862943611198906
Alma-Ata,4,1.3862943611198906
team-based,4,1.3862943611198906
NHs,4,1.3862943611198906
ACE2h,4,1.3862943611198906
broadest,4,1.3862943611198906
sonothrombolysis,4,1.3862943611198906
1241,4,1.3862943611198906
flexibly,4,1.3862943611198906
T85I,4,1.3862943611198906
incited,4,1.3862943611198906
nsp2,4,1.3862943611198906
HNC,4,1.3862943611198906
divides,4,1.3862943611198906
K18,4,1.3862943611198906
cocoon,4,1.3862943611198906
post-procedural,4,1.3862943611198906
Lineage,4,1.3862943611198906
Anticipating,4,1.3862943611198906
tomorrow,4,1.3862943611198906
wishes,4,1.3862943611198906
mannose-binding,4,1.3862943611198906
Three-quarters,4,1.3862943611198906
Ca04,4,1.3862943611198906
sutured,4,1.3862943611198906
ECHO-LVEF,4,1.3862943611198906
fellows,4,1.3862943611198906
hoursABSTRACT,4,1.3862943611198906
Reykjavik,4,1.3862943611198906
SubMF59,4,1.3862943611198906
antiepidemic,4,1.3862943611198906
PRF,4,1.3862943611198906
enthusiastic,4,1.3862943611198906
anxietydepression,4,1.3862943611198906
Probiotics,4,1.3862943611198906
Responsibility,4,1.3862943611198906
biomechanics,4,1.3862943611198906
disentangling,4,1.3862943611198906
instigate,4,1.3862943611198906
undernutrition,4,1.3862943611198906
PoST,4,1.3862943611198906
meta-analytic,4,1.3862943611198906
intercritical,4,1.3862943611198906
C-acetate,4,1.3862943611198906
-07,4,1.3862943611198906
Wyoming,4,1.3862943611198906
ischaemiareperfusion,4,1.3862943611198906
Additive,4,1.3862943611198906
ADIS-IV,4,1.3862943611198906
vowel,4,1.3862943611198906
trains,4,1.3862943611198906
host-environment,4,1.3862943611198906
manubrium,4,1.3862943611198906
False-negative,4,1.3862943611198906
orange,4,1.3862943611198906
cellsml,4,1.3862943611198906
non-nocturnal,4,1.3862943611198906
patterning,4,1.3862943611198906
glucose-insulin-potassium,4,1.3862943611198906
extramural,4,1.3862943611198906
eigenvalues,4,1.3862943611198906
jerseys,4,1.3862943611198906
1284,4,1.3862943611198906
2006-7,4,1.3862943611198906
fuchsin,4,1.3862943611198906
VSGs,4,1.3862943611198906
19891990,4,1.3862943611198906
Humphreys,4,1.3862943611198906
LHI,4,1.3862943611198906
Calmette-Guerin,4,1.3862943611198906
IVNTG,4,1.3862943611198906
fibrocytes,4,1.3862943611198906
2007-8,4,1.3862943611198906
Operational,4,1.3862943611198906
Tetanus,4,1.3862943611198906
Camp,4,1.3862943611198906
Beta-13-glucan,4,1.3862943611198906
flowmetry,4,1.3862943611198906
papaverine,4,1.3862943611198906
medicamentous,4,1.3862943611198906
MASL,4,1.3862943611198906
type-A,4,1.3862943611198906
two-color,4,1.3862943611198906
milliseconds,4,1.3862943611198906
sponsor,4,1.3862943611198906
non-viable,4,1.3862943611198906
THPA,4,1.3862943611198906
cECG,4,1.3862943611198906
VCIND,4,1.3862943611198906
miR-101,4,1.3862943611198906
downregulates,4,1.3862943611198906
medicated,4,1.3862943611198906
Focetria,4,1.3862943611198906
penalty,4,1.3862943611198906
centimeter,4,1.3862943611198906
precocity,4,1.3862943611198906
non-TCM,4,1.3862943611198906
papillomavirus,4,1.3862943611198906
COVID-19-suspected,4,1.3862943611198906
NIOSH,4,1.3862943611198906
Nile,4,1.3862943611198906
Consent,4,1.3862943611198906
Probe,4,1.3862943611198906
restrains,4,1.3862943611198906
11-28,4,1.3862943611198906
telephonic,4,1.3862943611198906
Torrent,4,1.3862943611198906
neurovirulent,4,1.3862943611198906
pink,4,1.3862943611198906
non-specialists,4,1.3862943611198906
sH1N1,4,1.3862943611198906
standby,4,1.3862943611198906
rotigaptide,4,1.3862943611198906
buried,4,1.3862943611198906
threads,4,1.3862943611198906
all-atom,4,1.3862943611198906
SJS,4,1.3862943611198906
skeptics,4,1.3862943611198906
booth,4,1.3862943611198906
IIVs,4,1.3862943611198906
ROM,4,1.3862943611198906
70-99,4,1.3862943611198906
hyper-reactive,4,1.3862943611198906
immersive,4,1.3862943611198906
subepicardium,4,1.3862943611198906
aplasia,4,1.3862943611198906
elaborating,4,1.3862943611198906
person-days,4,1.3862943611198906
Robot-assisted,4,1.3862943611198906
oval,4,1.3862943611198906
GHD,4,1.3862943611198906
BAD,4,1.3862943611198906
Messenger,4,1.3862943611198906
ambivalent,4,1.3862943611198906
boosts,4,1.3862943611198906
ELVs,4,1.3862943611198906
fixed-effects,4,1.3862943611198906
1114,4,1.3862943611198906
coccidioidomycosis,4,1.3862943611198906
tracheo-bronchial,4,1.3862943611198906
outright,4,1.3862943611198906
cartilaginous,4,1.3862943611198906
bulletins,4,1.3862943611198906
TRA,4,1.3862943611198906
Advancements,4,1.3862943611198906
roadway,4,1.3862943611198906
3100000,4,1.3862943611198906
popularly,4,1.3862943611198906
separable,4,1.3862943611198906
mislead,4,1.3862943611198906
transmission-reducing,4,1.3862943611198906
µgml,4,1.3862943611198906
immersed,4,1.3862943611198906
astrocytic,4,1.3862943611198906
tactical,4,1.3862943611198906
AVPs,4,1.3862943611198906
Slow,4,1.3862943611198906
spectrogram,4,1.3862943611198906
prebiotics,4,1.3862943611198906
formative,4,1.3862943611198906
AM-SdenseNet,4,1.3862943611198906
1940,4,1.3862943611198906
neurosis,4,1.3862943611198906
aliphatic,4,1.3862943611198906
solder,4,1.3862943611198906
surveillances,4,1.3862943611198906
dominates,4,1.3862943611198906
fillers,4,1.3862943611198906
inoperability,4,1.3862943611198906
kUL,4,1.3862943611198906
7-fold,4,1.3862943611198906
panicfear,4,1.3862943611198906
1994-99,4,1.3862943611198906
influenza-virus,4,1.3862943611198906
1983-88,4,1.3862943611198906
1081,4,1.3862943611198906
adoptive,4,1.3862943611198906
constancy,4,1.3862943611198906
forty-four,4,1.3862943611198906
incrementally,4,1.3862943611198906
2h,4,1.3862943611198906
1122,4,1.3862943611198906
Neovison,4,1.3862943611198906
bit,4,1.3862943611198906
20-minute,4,1.3862943611198906
STM,4,1.3862943611198906
mefloquine,4,1.3862943611198906
small-size,4,1.3862943611198906
cyanorona-20,4,1.3862943611198906
Telfer,4,1.3862943611198906
RIDT-negative,4,1.3862943611198906
Malmö,4,1.3862943611198906
REGARDS,4,1.3862943611198906
fissure,4,1.3862943611198906
engages,4,1.3862943611198906
divergences,4,1.3862943611198906
shuttle,4,1.3862943611198906
well-informed,4,1.3862943611198906
rationalized,4,1.3862943611198906
throat-swab,4,1.3862943611198906
biliverdin,4,1.3862943611198906
susceptible-exposed-infectious-recovered,4,1.3862943611198906
SARS-CoV-2-RBD,4,1.3862943611198906
Seroprotection,4,1.3862943611198906
MFC,4,1.3862943611198906
ADAP,4,1.3862943611198906
all-encompassing,4,1.3862943611198906
780000,4,1.3862943611198906
error-prone,4,1.3862943611198906
immunotolerance,4,1.3862943611198906
Scond,4,1.3862943611198906
reasoned,4,1.3862943611198906
Zealanders,4,1.3862943611198906
colloids,4,1.3862943611198906
Toolkit,4,1.3862943611198906
dummy,4,1.3862943611198906
LVS,4,1.3862943611198906
perforations,4,1.3862943611198906
pioneers,4,1.3862943611198906
university-affiliated,4,1.3862943611198906
ulcerated,4,1.3862943611198906
chaired,4,1.3862943611198906
DREP,4,1.3862943611198906
diplomacy,4,1.3862943611198906
unused,4,1.3862943611198906
PTMs,4,1.3862943611198906
Whole-genome,4,1.3862943611198906
cardialgia,4,1.3862943611198906
fees,4,1.3862943611198906
defeated,4,1.3862943611198906
bloody,4,1.3862943611198906
B1133,4,1.3862943611198906
polarimetry,4,1.3862943611198906
elastase-induced,4,1.3862943611198906
uveitis,4,1.3862943611198906
regenerated,4,1.3862943611198906
p85β,4,1.3862943611198906
CRK,4,1.3862943611198906
illuminates,4,1.3862943611198906
ventriculotomy,4,1.3862943611198906
refocusing,4,1.3862943611198906
12-25,4,1.3862943611198906
Repair,4,1.3862943611198906
Near,4,1.3862943611198906
cruises,4,1.3862943611198906
door-to-imaging,4,1.3862943611198906
disseminates,4,1.3862943611198906
unilaterally,4,1.3862943611198906
mouthwash,4,1.3862943611198906
1412,4,1.3862943611198906
over-estimate,4,1.3862943611198906
commissions,4,1.3862943611198906
flaccid,4,1.3862943611198906
bloodflow,4,1.3862943611198906
shortlisted,4,1.3862943611198906
Arteriopathy,4,1.3862943611198906
CP-based,4,1.3862943611198906
GenScript,4,1.3862943611198906
HTP,4,1.3862943611198906
Transcriptase-Polymerase,4,1.3862943611198906
ABPA,4,1.3862943611198906
flood,4,1.3862943611198906
decode,4,1.3862943611198906
asthmawheeze,4,1.3862943611198906
therapyABSTRACT,4,1.3862943611198906
portrayed,4,1.3862943611198906
attest,4,1.3862943611198906
HRBNS,4,1.3862943611198906
6-16,4,1.3862943611198906
eighty-nine,4,1.3862943611198906
vii,4,1.3862943611198906
anesthesiologist,4,1.3862943611198906
pyrosequencing,4,1.3862943611198906
infarctionMI,4,1.3862943611198906
LD-1LD-4,4,1.3862943611198906
alpha-smooth,4,1.3862943611198906
exiting,4,1.3862943611198906
worms,4,1.3862943611198906
combo,4,1.3862943611198906
motoric,4,1.3862943611198906
unconditional,4,1.3862943611198906
surmount,4,1.3862943611198906
South-Eastern,4,1.3862943611198906
ERP,4,1.3862943611198906
PCIs,4,1.3862943611198906
Bronchiectasis,4,1.3862943611198906
CODA,4,1.3862943611198906
Valencian,4,1.3862943611198906
β-blockade,4,1.3862943611198906
Giant,4,1.3862943611198906
nonarteriosclerotic,4,1.3862943611198906
glomus,4,1.3862943611198906
ZES,4,1.3862943611198906
1037,4,1.3862943611198906
stereotype,4,1.3862943611198906
prenotification,4,1.3862943611198906
pairing,4,1.3862943611198906
1164,4,1.3862943611198906
transitioned,4,1.3862943611198906
DoDGRS,4,1.3862943611198906
Wernickes,4,1.3862943611198906
dispel,4,1.3862943611198906
Immunohistochemical,4,1.3862943611198906
surround,4,1.3862943611198906
TRANSCEND,4,1.3862943611198906
depressant,4,1.3862943611198906
akin,4,1.3862943611198906
AQ,4,1.3862943611198906
miR,4,1.3862943611198906
EAR,4,1.3862943611198906
TTs,4,1.3862943611198906
AMIS,4,1.3862943611198906
2600,4,1.3862943611198906
Surviving,4,1.3862943611198906
1199,4,1.3862943611198906
proton-pump,4,1.3862943611198906
Sergipe,4,1.3862943611198906
Secondarily,4,1.3862943611198906
Neuroscience,4,1.3862943611198906
ASMC,4,1.3862943611198906
RCPP,4,1.3862943611198906
heroin,4,1.3862943611198906
HYP144,4,1.3862943611198906
AP-PCR,4,1.3862943611198906
AV-P,4,1.3862943611198906
retroviral,4,1.3862943611198906
fibrillationflutter,4,1.3862943611198906
EMRs,4,1.3862943611198906
ORMDL,4,1.3862943611198906
interspersed,4,1.3862943611198906
mismanagement,4,1.3862943611198906
duo,4,1.3862943611198906
Sex-related,4,1.3862943611198906
H5N104,4,1.3862943611198906
nsp14-ExoN,4,1.3862943611198906
transdiaphragmatic,4,1.3862943611198906
EMH,4,1.3862943611198906
Namely,4,1.3862943611198906
splicing,4,1.3862943611198906
thigh-level,4,1.3862943611198906
arouses,4,1.3862943611198906
Substance,4,1.3862943611198906
Soldiers,4,1.3862943611198906
south-west,4,1.3862943611198906
Defect,4,1.3862943611198906
hematopoiesis,4,1.3862943611198906
SWOP,4,1.3862943611198906
VAH,4,1.3862943611198906
progeria,4,1.3862943611198906
race-ethnicity,4,1.3862943611198906
HTRR,4,1.3862943611198906
ValVal,4,1.3862943611198906
SRM,4,1.3862943611198906
2007-2009,4,1.3862943611198906
ileum,4,1.3862943611198906
Symptom-limited,4,1.3862943611198906
PLT,4,1.3862943611198906
PC20M,4,1.3862943611198906
RNLI,4,1.3862943611198906
sapiens,4,1.3862943611198906
conceive,4,1.3862943611198906
non-bacterial,4,1.3862943611198906
noninferiority,4,1.3862943611198906
CrCl,4,1.3862943611198906
A-positive,4,1.3862943611198906
AV-L,4,1.3862943611198906
finance,4,1.3862943611198906
Jerusalem,4,1.3862943611198906
HERO-2,4,1.3862943611198906
CD40,4,1.3862943611198906
identifiability,4,1.3862943611198906
abolishes,4,1.3862943611198906
13-24,4,1.3862943611198906
inspiring,4,1.3862943611198906
low-middle,4,1.3862943611198906
filler,4,1.3862943611198906
enforce,4,1.3862943611198906
harmed,4,1.3862943611198906
parks,4,1.3862943611198906
cellulitis,4,1.3862943611198906
ma-Ca04,4,1.3862943611198906
PHSM,4,1.3862943611198906
epidemy,4,1.3862943611198906
acute-stage,4,1.3862943611198906
CVDC,4,1.3862943611198906
half-year,4,1.3862943611198906
cardiocirculatory,4,1.3862943611198906
life-changing,4,1.3862943611198906
Remodelling,4,1.3862943611198906
2701,4,1.3862943611198906
dysregulations,4,1.3862943611198906
syntropy,4,1.3862943611198906
Gray,4,1.3862943611198906
CalEnviroScreen,4,1.3862943611198906
Formulation,4,1.3862943611198906
stretches,4,1.3862943611198906
≤15,4,1.3862943611198906
Mexican-American,4,1.3862943611198906
Ischemia-induced,4,1.3862943611198906
Leveraging,4,1.3862943611198906
HDT,4,1.3862943611198906
colonial,4,1.3862943611198906
Whenever,4,1.3862943611198906
opvCRISPR,4,1.3862943611198906
Luminex-based,4,1.3862943611198906
severity-appropriate,4,1.3862943611198906
door-to-reperfusion,4,1.3862943611198906
Ramuz,4,1.3862943611198906
intermediate-,4,1.3862943611198906
re-establish,4,1.3862943611198906
antigen-dependent,4,1.3862943611198906
EX-AMI,4,1.3862943611198906
Baden-Wuerttemberg,4,1.3862943611198906
nucleozin,4,1.3862943611198906
cylinder,4,1.3862943611198906
deoxyribonucleic,4,1.3862943611198906
CPK-g-equ,4,1.3862943611198906
mallards,4,1.3862943611198906
headneck,4,1.3862943611198906
competitiveness,4,1.3862943611198906
probability-based,4,1.3862943611198906
Intention,4,1.3862943611198906
30s,4,1.3862943611198906
spongiosis,4,1.3862943611198906
vWD,4,1.3862943611198906
rs34481144,4,1.3862943611198906
Consumer,4,1.3862943611198906
ceftriaxone,4,1.3862943611198906
n2,4,1.3862943611198906
cribriform,4,1.3862943611198906
unextracted,4,1.3862943611198906
hens,4,1.3862943611198906
district-level,4,1.3862943611198906
thirty-seven,4,1.3862943611198906
RAb,4,1.3862943611198906
ten-fold,4,1.3862943611198906
Hodgkin,4,1.3862943611198906
descended,4,1.3862943611198906
YLSA,4,1.3862943611198906
sulfonylurea,4,1.3862943611198906
MBS-Lab,4,1.3862943611198906
non-A,4,1.3862943611198906
Cultural,4,1.3862943611198906
fSC,4,1.3862943611198906
Indices,4,1.3862943611198906
PRIMA,4,1.3862943611198906
1046,4,1.3862943611198906
hemoglobinopathies,4,1.3862943611198906
SMN,4,1.3862943611198906
DTCA,4,1.3862943611198906
Summarize,4,1.3862943611198906
Aurora,4,1.3862943611198906
epiphysis,4,1.3862943611198906
somnolence,4,1.3862943611198906
whatsoever,4,1.3862943611198906
paresthesias,4,1.3862943611198906
Tropic,4,1.3862943611198906
diisocyanate-occupational,4,1.3862943611198906
4-13,4,1.3862943611198906
pre-reperfusion,4,1.3862943611198906
premium,4,1.3862943611198906
horseshoe,4,1.3862943611198906
seventy-two,4,1.3862943611198906
contextualize,4,1.3862943611198906
narrated,4,1.3862943611198906
fibrogenesis,4,1.3862943611198906
Mariupol,4,1.3862943611198906
lethally,4,1.3862943611198906
Switching,4,1.3862943611198906
applicators,4,1.3862943611198906
inter-host,4,1.3862943611198906
subsidence,4,1.3862943611198906
afflict,4,1.3862943611198906
1318,4,1.3862943611198906
nonexpanders,4,1.3862943611198906
Clock,4,1.3862943611198906
deaths1000,4,1.3862943611198906
25-,4,1.3862943611198906
11-,4,1.3862943611198906
Chimeric,4,1.3862943611198906
Metformin,4,1.3862943611198906
anti-A,4,1.3862943611198906
eight-week,4,1.3862943611198906
coronary-arterial,4,1.3862943611198906
optimizations,4,1.3862943611198906
severity-based,4,1.3862943611198906
Faster,4,1.3862943611198906
A-H3N2,4,1.3862943611198906
beta-adrenoreceptor,4,1.3862943611198906
Provocative,4,1.3862943611198906
Adderall,4,1.3862943611198906
antiseizure,4,1.3862943611198906
mLkg,4,1.3862943611198906
close-contact,4,1.3862943611198906
microfluidics,4,1.3862943611198906
slaughter,4,1.3862943611198906
re-assessment,4,1.3862943611198906
hPa,4,1.3862943611198906
TAS-20,4,1.3862943611198906
2177,4,1.3862943611198906
CK-MM3CK-MM1,4,1.3862943611198906
trialed,4,1.3862943611198906
post-immunization,4,1.3862943611198906
know-how,4,1.3862943611198906
director,4,1.3862943611198906
intra-assay,4,1.3862943611198906
psychologist,4,1.3862943611198906
APV,4,1.3862943611198906
nanosized,4,1.3862943611198906
mysteries,4,1.3862943611198906
51-,4,1.3862943611198906
mSC,4,1.3862943611198906
sake,4,1.3862943611198906
ENS,4,1.3862943611198906
operable,4,1.3862943611198906
dorsolateral,4,1.3862943611198906
targetable,4,1.3862943611198906
WHOQOL,4,1.3862943611198906
⩽19,4,1.3862943611198906
tid,4,1.3862943611198906
watery,4,1.3862943611198906
NCDs,4,1.3862943611198906
briefing,4,1.3862943611198906
forty-two,4,1.3862943611198906
Approval,4,1.3862943611198906
SARS-coronavirus-2,4,1.3862943611198906
M40,4,1.3862943611198906
BYamagata1688-like,4,1.3862943611198906
tortuous,4,1.3862943611198906
Tasmania,4,1.3862943611198906
LBM,4,1.3862943611198906
Springfield,4,1.3862943611198906
1454,4,1.3862943611198906
deployable,4,1.3862943611198906
GPI,4,1.3862943611198906
never-smokers,4,1.3862943611198906
promised,4,1.3862943611198906
phosphorylated,4,1.3862943611198906
blood-activating,4,1.3862943611198906
sentinels,4,1.3862943611198906
nCOV-19,4,1.3862943611198906
Wallenberg,4,1.3862943611198906
heat-treatment,4,1.3862943611198906
pp1ab,4,1.3862943611198906
Inhibitor,4,1.3862943611198906
co-receptors,4,1.3862943611198906
HDAC6,4,1.3862943611198906
1995-96,4,1.3862943611198906
Rico81934,4,1.3862943611198906
Edward,4,1.3862943611198906
FLAIR-DWI,4,1.3862943611198906
socializing,4,1.3862943611198906
converse,4,1.3862943611198906
endonuclease,4,1.3862943611198906
immunity-based,4,1.3862943611198906
Chongqing,4,1.3862943611198906
CD20,4,1.3862943611198906
bidimensional,4,1.3862943611198906
diplopia,4,1.3862943611198906
bioengineered,4,1.3862943611198906
seventy-eight,4,1.3862943611198906
piecewise,4,1.3862943611198906
microsimulation,4,1.3862943611198906
Vice,4,1.3862943611198906
Forensic,4,1.3862943611198906
quitters,4,1.3862943611198906
planetary,4,1.3862943611198906
Containing,4,1.3862943611198906
scotoma,4,1.3862943611198906
1333,4,1.3862943611198906
Umifenovir,4,1.3862943611198906
OLYMPUS,4,1.3862943611198906
ocrelizumab,4,1.3862943611198906
Personalised,4,1.3862943611198906
succeeds,4,1.3862943611198906
illumination,4,1.3862943611198906
HGPS,4,1.3862943611198906
DRC,4,1.3862943611198906
N7-MTase,4,1.3862943611198906
fulfillment,4,1.3862943611198906
non-white,4,1.3862943611198906
polyurethanes,4,1.3862943611198906
Linked,4,1.3862943611198906
Clots,4,1.3862943611198906
familiarize,4,1.3862943611198906
Potent,4,1.3862943611198906
symptom-to-door,4,1.3862943611198906
Air-MSU,4,1.3862943611198906
CNSLD,4,1.3862943611198906
phrases,4,1.3862943611198906
Ski,4,1.3862943611198906
phenomenology,4,1.3862943611198906
indiscriminately,4,1.3862943611198906
hoarseness,4,1.3862943611198906
secret,4,1.3862943611198906
VPB,4,1.3862943611198906
Aquatic,4,1.3862943611198906
BCBSM,4,1.3862943611198906
cytoskeletal,4,1.3862943611198906
subthemes,4,1.3862943611198906
Speleotherapy,4,1.3862943611198906
PharMetrics,4,1.3862943611198906
benchtop,4,1.3862943611198906
Gut,4,1.3862943611198906
abs,4,1.3862943611198906
heralding,4,1.3862943611198906
post-infected,4,1.3862943611198906
Pools,4,1.3862943611198906
Baltic,4,1.3862943611198906
MGB,4,1.3862943611198906
Formulating,4,1.3862943611198906
Package,4,1.3862943611198906
CoP,4,1.3862943611198906
Kartagener,4,1.3862943611198906
havent,4,1.3862943611198906
prepares,4,1.3862943611198906
U-wave,4,1.3862943611198906
Ad5,4,1.3862943611198906
Inducible,4,1.3862943611198906
trochlear,4,1.3862943611198906
1720,4,1.3862943611198906
Doppler-derived,4,1.3862943611198906
SAEs,4,1.3862943611198906
Hemispheres,4,1.3862943611198906
individual-,4,1.3862943611198906
sufferings,4,1.3862943611198906
consonant,4,1.3862943611198906
brain-computer,4,1.3862943611198906
Acting,4,1.3862943611198906
biofeedback-assisted,4,1.3862943611198906
15D,4,1.3862943611198906
reexposure,4,1.3862943611198906
OVA-treated,4,1.3862943611198906
phrase,4,1.3862943611198906
cytopathology,4,1.3862943611198906
installment,4,1.3862943611198906
outbred,4,1.3862943611198906
tracheas,4,1.3862943611198906
TRs,4,1.3862943611198906
Viewpoint,4,1.3862943611198906
pandemic1,4,1.3862943611198906
Beggs,4,1.3862943611198906
intervillositis,4,1.3862943611198906
long-haulers,4,1.3862943611198906
191819,4,1.3862943611198906
LTRs,4,1.3862943611198906
parturient,4,1.3862943611198906
hs-cTn,4,1.3862943611198906
ECG-MI,4,1.3862943611198906
UFPs,4,1.3862943611198906
advertisement,4,1.3862943611198906
neighborhood-level,4,1.3862943611198906
p-ANCA,4,1.3862943611198906
Rising,4,1.3862943611198906
sumatriptan,4,1.3862943611198906
Bergen,4,1.3862943611198906
CHW,4,1.3862943611198906
GLP-1R,4,1.3862943611198906
subjacent,4,1.3862943611198906
Salud,4,1.3862943611198906
antibody-secreting,4,1.3862943611198906
Li,4,1.3862943611198906
mid-season,4,1.3862943611198906
Tayside,4,1.3862943611198906
APEC,4,1.3862943611198906
Fish,4,1.3862943611198906
AdC68-19S,4,1.3862943611198906
East-Southeast,4,1.3862943611198906
tributaries,4,1.3862943611198906
mined,4,1.3862943611198906
Delaying,4,1.3862943611198906
reaction-confirmed,4,1.3862943611198906
CRAO,4,1.3862943611198906
history-taking,4,1.3862943611198906
Q-,4,1.3862943611198906
stove,4,1.3862943611198906
0993,4,1.3862943611198906
DISBAR,4,1.3862943611198906
Qingwen,4,1.3862943611198906
unaddressed,4,1.3862943611198906
Lianhua,4,1.3862943611198906
BMalaysia25062004-like,4,1.3862943611198906
UFP,4,1.3862943611198906
substitutes,4,1.3862943611198906
Bochdalek,4,1.3862943611198906
Pao,4,1.3862943611198906
royal,4,1.3862943611198906
Horses,4,1.3862943611198906
expectorants,4,1.3862943611198906
carotid-related,4,1.3862943611198906
vascularization,4,1.3862943611198906
MBCK-IG,4,1.3862943611198906
eCoV,4,1.3862943611198906
Algo,4,1.3862943611198906
pneumoallergens,4,1.3862943611198906
gymnastics,4,1.3862943611198906
Farmers,4,1.3862943611198906
solvents,4,1.3862943611198906
walk-in,4,1.3862943611198906
Contrast-induced,4,1.3862943611198906
fostered,4,1.3862943611198906
Quanty,4,1.3862943611198906
Kung,4,1.3862943611198906
Cardiological,4,1.3862943611198906
surfaced,4,1.3862943611198906
short-stay,4,1.3862943611198906
AdC7-RBD-tr2,4,1.3862943611198906
Hiroshima,4,1.3862943611198906
RBD-ACE2,4,1.3862943611198906
P01,4,1.3862943611198906
TATs,4,1.3862943611198906
RGGI,4,1.3862943611198906
OLL1073R-1,4,1.3862943611198906
infectious-allergic,4,1.3862943611198906
BromAc,4,1.3862943611198906
co-ordinating,4,1.3862943611198906
45000,4,1.3862943611198906
hAECs,4,1.3862943611198906
PCSK9,4,1.3862943611198906
cross-cultural,4,1.3862943611198906
Kanagawa,4,1.3862943611198906
Specificities,4,1.3862943611198906
CoQ10,4,1.3862943611198906
Cocaine-induced,4,1.3862943611198906
DIST,4,1.3862943611198906
Health-Related,4,1.3862943611198906
clavicular,4,1.3862943611198906
tick,4,1.3862943611198906
CSG,4,1.3862943611198906
unifies,4,1.3862943611198906
hCSCs,4,1.3862943611198906
zanamavir,4,1.3862943611198906
Compensatory,4,1.3862943611198906
weal,4,1.3862943611198906
outbroke,4,1.3862943611198906
eighteenth,4,1.3862943611198906
fairness,4,1.3862943611198906
carpets,4,1.3862943611198906
commissurotomy,4,1.3862943611198906
Ground,4,1.3862943611198906
catarrhal,4,1.3862943611198906
Telephone,4,1.3862943611198906
traveller,4,1.3862943611198906
Crete,4,1.3862943611198906
unify,4,1.3862943611198906
hastens,4,1.3862943611198906
Originating,4,1.3862943611198906
HLHCSS,4,1.3862943611198906
ECST,4,1.3862943611198906
Nanoparticles,4,1.3862943611198906
H1N1-LCI,4,1.3862943611198906
ISIS-3,4,1.3862943611198906
30c,4,1.3862943611198906
wedge-shaped,4,1.3862943611198906
pusher,4,1.3862943611198906
GVHD,4,1.3862943611198906
DLCO,4,1.3862943611198906
atypically,4,1.3862943611198906
ATAQ,4,1.3862943611198906
helminth,4,1.3862943611198906
aGVHD,4,1.3862943611198906
time-to-peak,4,1.3862943611198906
Frankfurt,4,1.3862943611198906
trunks,4,1.3862943611198906
micro-focal,4,1.3862943611198906
Employers,4,1.3862943611198906
abolition,4,1.3862943611198906
macro-focal,4,1.3862943611198906
fHg,4,1.3862943611198906
3136,4,1.3862943611198906
DDR,4,1.3862943611198906
antagonizing,4,1.3862943611198906
ultrasound-guided,4,1.3862943611198906
authored,4,1.3862943611198906
adipokine,4,1.3862943611198906
origination,4,1.3862943611198906
insecticides,4,1.3862943611198906
lineage-specific,4,1.3862943611198906
AUTO12,4,1.3862943611198906
dihydropyridines,4,1.3862943611198906
textiles,4,1.3862943611198906
EoSC,4,1.3862943611198906
reserving,4,1.3862943611198906
stricken,4,1.3862943611198906
DENSE,4,1.3862943611198906
ranitidine,4,1.3862943611198906
Ecc,4,1.3862943611198906
contemporarily,4,1.3862943611198906
heart-brain,4,1.3862943611198906
ISTIA,4,1.3862943611198906
porcupine,4,1.3862943611198906
boar,4,1.3862943611198906
scholarly,4,1.3862943611198906
petroleum,4,1.3862943611198906
PNS-CT,4,1.3862943611198906
2001-2003,4,1.3862943611198906
redistribute,4,1.3862943611198906
1979-80,4,1.3862943611198906
telemedical,4,1.3862943611198906
11C-methionine,4,1.3862943611198906
SCFAs,4,1.3862943611198906
v2,4,1.3862943611198906
SBE,4,1.3862943611198906
caspase-1,4,1.3862943611198906
hesitated,4,1.3862943611198906
multi-sectoral,4,1.3862943611198906
Acknowledging,4,1.3862943611198906
True,4,1.3862943611198906
Summit,4,1.3862943611198906
equality,4,1.3862943611198906
polygraphic,4,1.3862943611198906
9167,4,1.3862943611198906
immunoassay-based,4,1.3862943611198906
3336,4,1.3862943611198906
FC-SBL,4,1.3862943611198906
vasoconstrictors,4,1.3862943611198906
destabilizing,4,1.3862943611198906
CYP4F2,4,1.3862943611198906
vertebrate,4,1.3862943611198906
hematuria,4,1.3862943611198906
fascia,4,1.3862943611198906
Serfling,4,1.3862943611198906
autoradiography,4,1.3862943611198906
jogging,4,1.3862943611198906
Vertical,4,1.3862943611198906
rs275653,4,1.3862943611198906
α-23-,4,1.3862943611198906
Bioline,4,1.3862943611198906
infero-lateral,4,1.3862943611198906
omeprazole,4,1.3862943611198906
mind-body,4,1.3862943611198906
discs,4,1.3862943611198906
nCoV-19AZD1222,4,1.3862943611198906
PERC6,4,1.3862943611198906
CAR-T,4,1.3862943611198906
faithfully,4,1.3862943611198906
Archives,4,1.3862943611198906
ER-DP,4,1.3862943611198906
multi-protein,4,1.3862943611198906
Colophony,4,1.3862943611198906
S-I,4,1.3862943611198906
-36,4,1.3862943611198906
Kansas,4,1.3862943611198906
rs1492099,4,1.3862943611198906
friend,4,1.3862943611198906
NYS,4,1.3862943611198906
EMTU,4,1.3862943611198906
Monogenic,4,1.3862943611198906
His-tag,4,1.3862943611198906
adjustable,4,1.3862943611198906
1967-68,4,1.3862943611198906
biostatistics,4,1.3862943611198906
Willingness,4,1.3862943611198906
Attacks,4,1.3862943611198906
nonacademic,4,1.3862943611198906
Sclerosis,4,1.3862943611198906
V4-V6,4,1.3862943611198906
ASCOD,4,1.3862943611198906
Leipzig,4,1.3862943611198906
inspections,4,1.3862943611198906
postgraduate,4,1.3862943611198906
Difficult-to-control,4,1.3862943611198906
pp1a,4,1.3862943611198906
Assertive,4,1.3862943611198906
-200,4,1.3862943611198906
convulsive,4,1.3862943611198906
sample-to-result,4,1.3862943611198906
felids,4,1.3862943611198906
M158-66,4,1.3862943611198906
orientated,4,1.3862943611198906
dipyridamole-thallium,4,1.3862943611198906
instantly,4,1.3862943611198906
post-infarcted,4,1.3862943611198906
amolmm2,4,1.3862943611198906
T-helper-2,4,1.3862943611198906
CMS,4,1.3862943611198906
alphacoronavirus,4,1.3862943611198906
125ISar1Ile8angiotensin,4,1.3862943611198906
ANOVAs,4,1.3862943611198906
anserine,4,1.3862943611198906
gentleman,4,1.3862943611198906
Shope,4,1.3862943611198906
Leishmania,4,1.3862943611198906
CFI,4,1.3862943611198906
Busselton,4,1.3862943611198906
Aetiological,4,1.3862943611198906
PGD2,4,1.3862943611198906
appeals,4,1.3862943611198906
TNG,4,1.3862943611198906
IgAIgG,4,1.3862943611198906
p300,4,1.3862943611198906
formations,4,1.3862943611198906
steepness,4,1.3862943611198906
quadriplegia,4,1.3862943611198906
leaps,4,1.3862943611198906
inaccessibility,4,1.3862943611198906
hypocontractile,4,1.3862943611198906
VEMS,4,1.3862943611198906
nelfinavir,4,1.3862943611198906
sulphites,4,1.3862943611198906
Goldman,4,1.3862943611198906
Unvaccinated,4,1.3862943611198906
national-level,4,1.3862943611198906
A23403G,4,1.3862943611198906
Smell,4,1.3862943611198906
sulphite,4,1.3862943611198906
villagers,4,1.3862943611198906
codominant,4,1.3862943611198906
occupational-type,4,1.3862943611198906
independency,4,1.3862943611198906
PACIFIC,4,1.3862943611198906
propionic,4,1.3862943611198906
pathognomic,4,1.3862943611198906
migraine-stroke,4,1.3862943611198906
Etude,4,1.3862943611198906
hypo,4,1.3862943611198906
TCRT,4,1.3862943611198906
abortions,4,1.3862943611198906
FLOQSwabs,4,1.3862943611198906
PMC,4,1.3862943611198906
1017,4,1.3862943611198906
amp,4,1.3862943611198906
unfortunate,4,1.3862943611198906
ALOX5,4,1.3862943611198906
nonparetic,4,1.3862943611198906
two-component,4,1.3862943611198906
paclitaxel-eluting,4,1.3862943611198906
saruplase,4,1.3862943611198906
sawmill,4,1.3862943611198906
lipoxin,4,1.3862943611198906
heroes,4,1.3862943611198906
rs568408,4,1.3862943611198906
deciphered,4,1.3862943611198906
examiner,4,1.3862943611198906
RNA-ISH,4,1.3862943611198906
D222E,4,1.3862943611198906
ELISpot,4,1.3862943611198906
Neuronal,4,1.3862943611198906
collectives,4,1.3862943611198906
bloods,4,1.3862943611198906
ninety-seven,4,1.3862943611198906
Back-shu,4,1.3862943611198906
BC01,4,1.3862943611198906
non-registered,4,1.3862943611198906
counters,4,1.3862943611198906
NDA,4,1.3862943611198906
anticoronavirus,4,1.3862943611198906
perceives,4,1.3862943611198906
SPLPO,4,1.3862943611198906
2434,4,1.3862943611198906
non-enveloped,4,1.3862943611198906
Occipital,4,1.3862943611198906
gastrooesophageal,4,1.3862943611198906
3Cpro,4,1.3862943611198906
NSTE,4,1.3862943611198906
self-rating,4,1.3862943611198906
microflora,4,1.3862943611198906
Agricultural,4,1.3862943611198906
pneumocyte,4,1.3862943611198906
95th,4,1.3862943611198906
Test-retest,4,1.3862943611198906
School-aged,4,1.3862943611198906
transporter,4,1.3862943611198906
egg-adapted,4,1.3862943611198906
armies,4,1.3862943611198906
Deciding,4,1.3862943611198906
1109,4,1.3862943611198906
deltavariability,4,1.3862943611198906
avoidant,4,1.3862943611198906
case-report,4,1.3862943611198906
1226,4,1.3862943611198906
hypoglycaemic,4,1.3862943611198906
synapse,4,1.3862943611198906
1120,4,1.3862943611198906
Be,4,1.3862943611198906
in-line,4,1.3862943611198906
risk-free,4,1.3862943611198906
intra-coronary,4,1.3862943611198906
miniature,4,1.3862943611198906
autumn-winter,4,1.3862943611198906
theoretic,4,1.3862943611198906
60s,4,1.3862943611198906
histidine,4,1.3862943611198906
Hypnosis,4,1.3862943611198906
PVES,4,1.3862943611198906
stabilise,4,1.3862943611198906
C-statistic,4,1.3862943611198906
cup,4,1.3862943611198906
defending,4,1.3862943611198906
1519,4,1.3862943611198906
beneficially,4,1.3862943611198906
CoV-19,4,1.3862943611198906
Influenzanet,4,1.3862943611198906
SCOPE,4,1.3862943611198906
ALLHAT,4,1.3862943611198906
NBHR,4,1.3862943611198906
US-Mexico,4,1.3862943611198906
shower,4,1.3862943611198906
miR-5197,4,1.3862943611198906
distantly,4,1.3862943611198906
TBM,4,1.3862943611198906
TERT,4,1.3862943611198906
disconcerting,4,1.3862943611198906
PEI,4,1.3862943611198906
Emotion,4,1.3862943611198906
one-to-one,4,1.3862943611198906
Labeling,4,1.3862943611198906
RBDhACE2,4,1.3862943611198906
Caused,4,1.3862943611198906
cerebroprotection,4,1.3862943611198906
intraocular,4,1.3862943611198906
machinists,4,1.3862943611198906
Antigenically,4,1.3862943611198906
125I-labelled,4,1.3862943611198906
DSO,4,1.3862943611198906
COV,4,1.3862943611198906
orthodox,4,1.3862943611198906
three-fourths,4,1.3862943611198906
logarithmically,4,1.3862943611198906
KIV-2,4,1.3862943611198906
normotension,4,1.3862943611198906
allopathic,4,1.3862943611198906
LPA,4,1.3862943611198906
50-,4,1.3862943611198906
Orgogozo,4,1.3862943611198906
Andalusian,4,1.3862943611198906
SWHP,4,1.3862943611198906
BHV-1,4,1.3862943611198906
Photovoice,4,1.3862943611198906
neuropeptide,4,1.3862943611198906
slows,4,1.3862943611198906
warns,4,1.3862943611198906
anti-PD-1,4,1.3862943611198906
Democrats,4,1.3862943611198906
return-to-work,4,1.3862943611198906
preemptive,4,1.3862943611198906
Intermediate,4,1.3862943611198906
nonpandemic,4,1.3862943611198906
14-20,4,1.3862943611198906
thrive,4,1.3862943611198906
Republicans,4,1.3862943611198906
gravida,4,1.3862943611198906
por,4,1.3862943611198906
Solitary,4,1.3862943611198906
Pr,4,1.3862943611198906
TLR-4,4,1.3862943611198906
Shortening,4,1.3862943611198906
1150,4,1.3862943611198906
disregard,4,1.3862943611198906
SARS-CoV-2-neutralizing,4,1.3862943611198906
ICTs,4,1.3862943611198906
non-randomised,4,1.3862943611198906
implanting,4,1.3862943611198906
2011-2016,4,1.3862943611198906
hyperpermeability,4,1.3862943611198906
H3N1,4,1.3862943611198906
Log-Quality,4,1.3862943611198906
RNA-,4,1.3862943611198906
SFTs,4,1.3862943611198906
complexed,4,1.3862943611198906
inflammation-associated,4,1.3862943611198906
destroying,4,1.3862943611198906
assimilation,4,1.3862943611198906
post-fusion,4,1.3862943611198906
Nicaragua,4,1.3862943611198906
IL8,4,1.3862943611198906
hypovolaemia,4,1.3862943611198906
metabolically,4,1.3862943611198906
radiosurgery,4,1.3862943611198906
repurposable,4,1.3862943611198906
CCL2,4,1.3862943611198906
BOOP,4,1.3862943611198906
WG,4,1.3862943611198906
stemmed,4,1.3862943611198906
Contagion,4,1.3862943611198906
anti-infarct,4,1.3862943611198906
41071,4,1.3862943611198906
IPOC,4,1.3862943611198906
65-79,4,1.3862943611198906
Latent,4,1.3862943611198906
bioactivity,4,1.3862943611198906
lung-cancer,4,1.3862943611198906
NSTEMIs,4,1.3862943611198906
2-adrenoceptor,4,1.3862943611198906
postinfluenza,4,1.3862943611198906
ICVT,4,1.3862943611198906
tribal,4,1.3862943611198906
navigating,4,1.3862943611198906
Turner,4,1.3862943611198906
Prioritizing,4,1.3862943611198906
teasoda,4,1.3862943611198906
pauci-immune,4,1.3862943611198906
8-hour,4,1.3862943611198906
Accelerating,4,1.3862943611198906
totaled,4,1.3862943611198906
TLR6,4,1.3862943611198906
licenced,4,1.3862943611198906
doubly,4,1.3862943611198906
SEOS,4,1.3862943611198906
Infect,4,1.3862943611198906
wastage,4,1.3862943611198906
L-NNA,4,1.3862943611198906
HIV-1-infected,4,1.3862943611198906
partnered,4,1.3862943611198906
S2GΔHR2,4,1.3862943611198906
cycEVA,4,1.3862943611198906
miR-133,4,1.3862943611198906
CSs,4,1.3862943611198906
generators,4,1.3862943611198906
NA-based,4,1.3862943611198906
finely,4,1.3862943611198906
diffusive,4,1.3862943611198906
Agencies,4,1.3862943611198906
tuned,4,1.3862943611198906
welcomed,4,1.3862943611198906
Dapex,4,1.3862943611198906
ASAT,4,1.3862943611198906
F₂-isoP,4,1.3862943611198906
Dbase,4,1.3862943611198906
single-base,4,1.3862943611198906
CHA,4,1.3862943611198906
dermatophagoides,4,1.3862943611198906
TXA2,4,1.3862943611198906
8-18,4,1.3862943611198906
Ex,4,1.3862943611198906
March-May,4,1.3862943611198906
SARS-COV,4,1.3862943611198906
psychophysical,4,1.3862943611198906
Yin,4,1.3862943611198906
deficiency，,4,1.3862943611198906
IBI,4,1.3862943611198906
inclusions,4,1.3862943611198906
PD50Rrs,4,1.3862943611198906
survivability,4,1.3862943611198906
micron,4,1.3862943611198906
LQ,4,1.3862943611198906
lysing,4,1.3862943611198906
1142,4,1.3862943611198906
heart-rate,4,1.3862943611198906
Huo-Yan,4,1.3862943611198906
isoprostanes,4,1.3862943611198906
BPL,4,1.3862943611198906
non-AF,4,1.3862943611198906
interfaced,4,1.3862943611198906
5234,4,1.3862943611198906
Greenwich,4,1.3862943611198906
620,4,1.3862943611198906
culmination,4,1.3862943611198906
decision-analytic,4,1.3862943611198906
nonoverlapping,4,1.3862943611198906
cerebrolysin,4,1.3862943611198906
live-bird,4,1.3862943611198906
HSAP,4,1.3862943611198906
smoothing,4,1.3862943611198906
mlkgmin,4,1.3862943611198906
90-min,4,1.3862943611198906
inter-related,4,1.3862943611198906
liaison,4,1.3862943611198906
self-expandable,4,1.3862943611198906
Dozens,4,1.3862943611198906
shingles,4,1.3862943611198906
HOI,4,1.3862943611198906
SVC,4,1.3862943611198906
Hospitalisation,4,1.3862943611198906
84-year-old,4,1.3862943611198906
ascent,4,1.3862943611198906
DMTs,4,1.3862943611198906
Dominican,4,1.3862943611198906
plagues,4,1.3862943611198906
Intraoperatively,4,1.3862943611198906
inequitable,4,1.3862943611198906
metabonomic,4,1.3862943611198906
ECGraphic,4,1.3862943611198906
winterspring,4,1.3862943611198906
LCV,4,1.3862943611198906
PPh,4,1.3862943611198906
innovate,4,1.3862943611198906
photonic,4,1.3862943611198906
2077,4,1.3862943611198906
traceability,4,1.3862943611198906
endemicity,4,1.3862943611198906
CPE,4,1.3862943611198906
deterrent,4,1.3862943611198906
I117M,4,1.3862943611198906
teachings,4,1.3862943611198906
photonics,4,1.3862943611198906
pine,4,1.3862943611198906
influenza-certified,4,1.3862943611198906
mRNA-RBD,4,1.3862943611198906
VR-based,4,1.3862943611198906
non-endemic,4,1.3862943611198906
CPS,4,1.3862943611198906
cycler,4,1.3862943611198906
non-serious,4,1.3862943611198906
toucans,4,1.3862943611198906
post-PCR,4,1.3862943611198906
n32,4,1.3862943611198906
PRiOR,4,1.3862943611198906
disaggregated,4,1.3862943611198906
H456P,4,1.3862943611198906
experimenting,4,1.3862943611198906
Causal,4,1.3862943611198906
Gam-COVID-Vac,4,1.3862943611198906
1107,4,1.3862943611198906
whole-cell,4,1.3862943611198906
1893,4,1.3862943611198906
identically,4,1.3862943611198906
intra-alveolar,4,1.3862943611198906
Normally,4,1.3862943611198906
optica,4,1.3862943611198906
signifying,4,1.3862943611198906
clarifies,4,1.3862943611198906
1170,4,1.3862943611198906
globulins,4,1.3862943611198906
Seventy-seven,4,1.3862943611198906
MI-1,4,1.3862943611198906
nanostructured,4,1.3862943611198906
Procedure-related,4,1.3862943611198906
common-cold,4,1.3862943611198906
neuromyelitis,4,1.3862943611198906
Wider,4,1.3862943611198906
proportionality,4,1.3862943611198906
commentators,4,1.3862943611198906
FFA,4,1.3862943611198906
pdmH1,4,1.3862943611198906
Particulate,4,1.3862943611198906
constricted,4,1.3862943611198906
countriesregions,4,1.3862943611198906
antiseptics,4,1.3862943611198906
6400,4,1.3862943611198906
aligns,4,1.3862943611198906
Stevens-Johnson,4,1.3862943611198906
9565,4,1.3862943611198906
occuring,4,1.3862943611198906
multiple-vessel,4,1.3862943611198906
ACCESS,4,1.3862943611198906
Monitor,4,1.3862943611198906
25-45,4,1.3862943611198906
phenylephrine,4,1.3862943611198906
rotated,4,1.3862943611198906
asthma-predictive,4,1.3862943611198906
lagging,4,1.3862943611198906
flowmeters,4,1.3862943611198906
17-year,4,1.3862943611198906
squeezing,4,1.3862943611198906
technetium-99,4,1.3862943611198906
Richmond,4,1.3862943611198906
Xrs5,4,1.3862943611198906
diazepam,4,1.3862943611198906
bipartite,4,1.3862943611198906
Rrs5,4,1.3862943611198906
Drawings,4,1.3862943611198906
European-wide,4,1.3862943611198906
microfibrillar,4,1.3862943611198906
MARK-B,4,1.3862943611198906
GInPipe,4,1.3862943611198906
ma,4,1.3862943611198906
Stigma,4,1.3862943611198906
-054,4,1.3862943611198906
neurilemmomas,4,1.3862943611198906
Intraplaque,4,1.3862943611198906
dichotomizing,4,1.3862943611198906
I-TVR,4,1.3862943611198906
SARS‐CoV,4,1.3862943611198906
residuals,4,1.3862943611198906
repairs,4,1.3862943611198906
Catholic,4,1.3862943611198906
Rapitex,4,1.3862943611198906
irreparable,4,1.3862943611198906
Separately,4,1.3862943611198906
saparal,4,1.3862943611198906
ARC,4,1.3862943611198906
Covid‐19,4,1.3862943611198906
Involuntary,4,1.3862943611198906
S-proteins,4,1.3862943611198906
μV,4,1.3862943611198906
CMN,4,1.3862943611198906
cadet,4,1.3862943611198906
RVC,4,1.3862943611198906
unnatural,4,1.3862943611198906
eicosanoid,4,1.3862943611198906
LMW,4,1.3862943611198906
Sacks,4,1.3862943611198906
ablate,4,1.3862943611198906
Individualized,4,1.3862943611198906
minds,4,1.3862943611198906
interactors,4,1.3862943611198906
sequester,4,1.3862943611198906
HMII,4,1.3862943611198906
thresholding,4,1.3862943611198906
non-diagnostic,4,1.3862943611198906
JJ,4,1.3862943611198906
AAichi268,4,1.3862943611198906
repressive,4,1.3862943611198906
Might,4,1.3862943611198906
subjecting,4,1.3862943611198906
KTRs,4,1.3862943611198906
decides,4,1.3862943611198906
Amendments,4,1.3862943611198906
filaments,4,1.3862943611198906
pH1N109,4,1.3862943611198906
Max,4,1.3862943611198906
accessory-muscle,4,1.3862943611198906
TH2-type,4,1.3862943611198906
Oldenburg,4,1.3862943611198906
1912,4,1.3862943611198906
Theradiag,4,1.3862943611198906
1980-1981,4,1.3862943611198906
noncases,4,1.3862943611198906
spanned,4,1.3862943611198906
cataracts,4,1.3862943611198906
sorbents,4,1.3862943611198906
academies,4,1.3862943611198906
inventory-20,4,1.3862943611198906
sub-study,4,1.3862943611198906
ARE,3,1.0986122886681098
-39,3,1.0986122886681098
Huazhong,3,1.0986122886681098
PKHID,3,1.0986122886681098
Tainan,3,1.0986122886681098
overactive,3,1.0986122886681098
TSP,3,1.0986122886681098
Hyperinflation,3,1.0986122886681098
CE-IVD,3,1.0986122886681098
informatic,3,1.0986122886681098
3153,3,1.0986122886681098
Duplex,3,1.0986122886681098
reactant,3,1.0986122886681098
D-R,3,1.0986122886681098
QTcwork,3,1.0986122886681098
antero-septo-apical,3,1.0986122886681098
terápiás,3,1.0986122886681098
ultrasonography-guided,3,1.0986122886681098
N-13,3,1.0986122886681098
SH2,3,1.0986122886681098
Physician-diagnosed,3,1.0986122886681098
pNN50,3,1.0986122886681098
Kapβ2,3,1.0986122886681098
eukaryotes,3,1.0986122886681098
Amlodipine,3,1.0986122886681098
SSP,3,1.0986122886681098
adenosine-induced,3,1.0986122886681098
kinetocardiography,3,1.0986122886681098
Fosun,3,1.0986122886681098
Antithrombin,3,1.0986122886681098
cyanobacteria,3,1.0986122886681098
Q226L,3,1.0986122886681098
predecessor,3,1.0986122886681098
tethered,3,1.0986122886681098
hypogonadism,3,1.0986122886681098
Inability,3,1.0986122886681098
Arbeitsgemeinschaft,3,1.0986122886681098
dedication,3,1.0986122886681098
MSSD,3,1.0986122886681098
Zusanli,3,1.0986122886681098
safety-net,3,1.0986122886681098
endemicseasonal,3,1.0986122886681098
hyponatraemia,3,1.0986122886681098
headquarters,3,1.0986122886681098
split-product,3,1.0986122886681098
HDACs,3,1.0986122886681098
vote,3,1.0986122886681098
RealStar®,3,1.0986122886681098
Merci,3,1.0986122886681098
environment-,3,1.0986122886681098
Avoidable,3,1.0986122886681098
2947,3,1.0986122886681098
ITU,3,1.0986122886681098
ulcerations,3,1.0986122886681098
high-rate,3,1.0986122886681098
eV,3,1.0986122886681098
982-100,3,1.0986122886681098
railways,3,1.0986122886681098
E119I,3,1.0986122886681098
fibrocystic,3,1.0986122886681098
chloroplasts,3,1.0986122886681098
renovation,3,1.0986122886681098
prereperfusion,3,1.0986122886681098
accentuation,3,1.0986122886681098
suspend,3,1.0986122886681098
MMB,3,1.0986122886681098
Hai,3,1.0986122886681098
eVLPs,3,1.0986122886681098
league,3,1.0986122886681098
cinetocardiograms,3,1.0986122886681098
nondrinkers,3,1.0986122886681098
1776,3,1.0986122886681098
MBNW,3,1.0986122886681098
HPI,3,1.0986122886681098
protein-encoding,3,1.0986122886681098
MB-creatine,3,1.0986122886681098
1403,3,1.0986122886681098
poultry-to-human,3,1.0986122886681098
NFs,3,1.0986122886681098
precipitously,3,1.0986122886681098
kaempferol,3,1.0986122886681098
sweet,3,1.0986122886681098
resurgent,3,1.0986122886681098
hospitalize,3,1.0986122886681098
symptomssigns,3,1.0986122886681098
TAM,3,1.0986122886681098
ICAA,3,1.0986122886681098
intron,3,1.0986122886681098
ACAAI,3,1.0986122886681098
NEDD8,3,1.0986122886681098
lightweight,3,1.0986122886681098
unconcentrated,3,1.0986122886681098
Second-generation,3,1.0986122886681098
co,3,1.0986122886681098
Telecommunications,3,1.0986122886681098
anti-SARS,3,1.0986122886681098
NCT04743388,3,1.0986122886681098
OBE,3,1.0986122886681098
1910,3,1.0986122886681098
Bian,3,1.0986122886681098
suspending,3,1.0986122886681098
miR-208a,3,1.0986122886681098
BBIBP-CorV,3,1.0986122886681098
CE-CMR,3,1.0986122886681098
TFT-DMF,3,1.0986122886681098
thirty-three,3,1.0986122886681098
betulinic,3,1.0986122886681098
Rheumatic,3,1.0986122886681098
QIAGEN,3,1.0986122886681098
mid-anterior,3,1.0986122886681098
point-of-need,3,1.0986122886681098
Pushkarmula,3,1.0986122886681098
auspicious,3,1.0986122886681098
Humboldt,3,1.0986122886681098
staggered,3,1.0986122886681098
12-,3,1.0986122886681098
agencys,3,1.0986122886681098
gun,3,1.0986122886681098
counter-intuitive,3,1.0986122886681098
anti-NA,3,1.0986122886681098
antipsychotics,3,1.0986122886681098
Unites,3,1.0986122886681098
politically,3,1.0986122886681098
gas-diffuser,3,1.0986122886681098
Catecholamine,3,1.0986122886681098
Bethesda,3,1.0986122886681098
checkpoints,3,1.0986122886681098
secretes,3,1.0986122886681098
rosiglitazone,3,1.0986122886681098
exclusivity,3,1.0986122886681098
n81,3,1.0986122886681098
underling,3,1.0986122886681098
16-week,3,1.0986122886681098
ΔG,3,1.0986122886681098
Restrictive,3,1.0986122886681098
γδT,3,1.0986122886681098
DPA,3,1.0986122886681098
Limiting,3,1.0986122886681098
Kcal,3,1.0986122886681098
microprocessor,3,1.0986122886681098
SOL,3,1.0986122886681098
swab-negative,3,1.0986122886681098
Quality-of-Life,3,1.0986122886681098
plasmacytoid,3,1.0986122886681098
catheterised,3,1.0986122886681098
8-day,3,1.0986122886681098
beta-lactoglobulin,3,1.0986122886681098
Asinex,3,1.0986122886681098
Vaccinology,3,1.0986122886681098
Consolidated,3,1.0986122886681098
MCBN,3,1.0986122886681098
Lankan,3,1.0986122886681098
Medium,3,1.0986122886681098
tan,3,1.0986122886681098
drank,3,1.0986122886681098
interjoint,3,1.0986122886681098
n78,3,1.0986122886681098
grim,3,1.0986122886681098
effort-independent,3,1.0986122886681098
pre-interventional,3,1.0986122886681098
Extrapulmonary,3,1.0986122886681098
subside,3,1.0986122886681098
loses,3,1.0986122886681098
NRMI-2,3,1.0986122886681098
drowning,3,1.0986122886681098
remitted,3,1.0986122886681098
certify,3,1.0986122886681098
alkyl,3,1.0986122886681098
GWTG,3,1.0986122886681098
BAnn,3,1.0986122886681098
NMES,3,1.0986122886681098
SARS-nCoV-2,3,1.0986122886681098
topologically,3,1.0986122886681098
1001,3,1.0986122886681098
18-34,3,1.0986122886681098
Correctional,3,1.0986122886681098
Susceptible-Infected-Removed,3,1.0986122886681098
1969-70,3,1.0986122886681098
ACalifornia0709,3,1.0986122886681098
1427,3,1.0986122886681098
non-immunogenic,3,1.0986122886681098
torsade,3,1.0986122886681098
impurities,3,1.0986122886681098
Osterholm,3,1.0986122886681098
insemination,3,1.0986122886681098
H1-,3,1.0986122886681098
1331,3,1.0986122886681098
seven-day,3,1.0986122886681098
pharmacoeconomics,3,1.0986122886681098
Objectively,3,1.0986122886681098
imdevimab,3,1.0986122886681098
cellsmicroliter,3,1.0986122886681098
TEG®,3,1.0986122886681098
Wavelet,3,1.0986122886681098
18-23,3,1.0986122886681098
súlyos,3,1.0986122886681098
disaggregation,3,1.0986122886681098
18-21,3,1.0986122886681098
non-PAF,3,1.0986122886681098
szindrómát,3,1.0986122886681098
SBPpos,3,1.0986122886681098
russelii,3,1.0986122886681098
jury,3,1.0986122886681098
pupillary,3,1.0986122886681098
Holidays,3,1.0986122886681098
Transform,3,1.0986122886681098
Ppos,3,1.0986122886681098
Rankins,3,1.0986122886681098
nondysphoric,3,1.0986122886681098
Pneg,3,1.0986122886681098
Erlangen,3,1.0986122886681098
postinoculation,3,1.0986122886681098
TAC,3,1.0986122886681098
UVC-LED,3,1.0986122886681098
NHANESI,3,1.0986122886681098
30-59,3,1.0986122886681098
ACPAnnals,3,1.0986122886681098
ECLS,3,1.0986122886681098
CysLT,3,1.0986122886681098
Antalya,3,1.0986122886681098
Appendix,3,1.0986122886681098
IL-21,3,1.0986122886681098
thio-NAD,3,1.0986122886681098
sporesm3,3,1.0986122886681098
HFQRS,3,1.0986122886681098
extreme-dippers,3,1.0986122886681098
reagent-free,3,1.0986122886681098
Heger,3,1.0986122886681098
conventional-discharge,3,1.0986122886681098
5-lipoxygenase-activating,3,1.0986122886681098
log-log,3,1.0986122886681098
early-discharge,3,1.0986122886681098
Low-risk,3,1.0986122886681098
glucocorticoid-dependent,3,1.0986122886681098
anti-neutrophil,3,1.0986122886681098
revisits,3,1.0986122886681098
CNPF,3,1.0986122886681098
forty-eight,3,1.0986122886681098
under-estimation,3,1.0986122886681098
misalignment,3,1.0986122886681098
pregnancy-specific,3,1.0986122886681098
provocable,3,1.0986122886681098
FOV,3,1.0986122886681098
abide,3,1.0986122886681098
40-48,3,1.0986122886681098
1279,3,1.0986122886681098
coverages,3,1.0986122886681098
Hologic®,3,1.0986122886681098
CTP-SI,3,1.0986122886681098
Neisseria,3,1.0986122886681098
centroid,3,1.0986122886681098
aneurism,3,1.0986122886681098
Quantitatively,3,1.0986122886681098
fear-avoidance,3,1.0986122886681098
gradation,3,1.0986122886681098
supplydemand,3,1.0986122886681098
sparser,3,1.0986122886681098
Clark,3,1.0986122886681098
chlorpheniramine,3,1.0986122886681098
8-24,3,1.0986122886681098
H1-receptor,3,1.0986122886681098
Optimising,3,1.0986122886681098
beta2-mimetics,3,1.0986122886681098
subdiaphragmatic,3,1.0986122886681098
1339,3,1.0986122886681098
Fluid,3,1.0986122886681098
GTD,3,1.0986122886681098
suum,3,1.0986122886681098
20078,3,1.0986122886681098
1015,3,1.0986122886681098
obviated,3,1.0986122886681098
60-64,3,1.0986122886681098
Housing,3,1.0986122886681098
COPDasthma,3,1.0986122886681098
WIR,3,1.0986122886681098
interankle,3,1.0986122886681098
incapacitating,3,1.0986122886681098
Wald,3,1.0986122886681098
tunicamycin,3,1.0986122886681098
status-quo,3,1.0986122886681098
unsteady,3,1.0986122886681098
Oriental,3,1.0986122886681098
health-oriented,3,1.0986122886681098
sow,3,1.0986122886681098
MLS,3,1.0986122886681098
A549-ACE2,3,1.0986122886681098
Vero-E6,3,1.0986122886681098
broncho-constriction,3,1.0986122886681098
non-NFA,3,1.0986122886681098
LAPSS,3,1.0986122886681098
alexithymic,3,1.0986122886681098
Sterling,3,1.0986122886681098
polling,3,1.0986122886681098
2043,3,1.0986122886681098
hemiballismus,3,1.0986122886681098
szerepét,3,1.0986122886681098
M1NL,3,1.0986122886681098
sped,3,1.0986122886681098
ACE-II,3,1.0986122886681098
Spine,3,1.0986122886681098
Pulmonologists,3,1.0986122886681098
modernized,3,1.0986122886681098
inflicting,3,1.0986122886681098
Pm,3,1.0986122886681098
SPRAS,3,1.0986122886681098
type-II,3,1.0986122886681098
electrophiles,3,1.0986122886681098
orf8,3,1.0986122886681098
akinetic-dyskinetic,3,1.0986122886681098
activity-based,3,1.0986122886681098
Horizontal,3,1.0986122886681098
Neoton,3,1.0986122886681098
sulfoxide,3,1.0986122886681098
dimethyl,3,1.0986122886681098
netizens,3,1.0986122886681098
open-state,3,1.0986122886681098
HutterSidel,3,1.0986122886681098
circumferences,3,1.0986122886681098
Forecasts,3,1.0986122886681098
Hitachi,3,1.0986122886681098
1192,3,1.0986122886681098
stochastically,3,1.0986122886681098
undistinguished,3,1.0986122886681098
venostasis,3,1.0986122886681098
hypernatremia,3,1.0986122886681098
Muse,3,1.0986122886681098
PROSIT,3,1.0986122886681098
trichrome,3,1.0986122886681098
Conferences,3,1.0986122886681098
periprocedure,3,1.0986122886681098
converging,3,1.0986122886681098
EEG-based,3,1.0986122886681098
acetylsalicyclic,3,1.0986122886681098
Boehringer,3,1.0986122886681098
1089,3,1.0986122886681098
USEPA,3,1.0986122886681098
FNs,3,1.0986122886681098
viral-associated,3,1.0986122886681098
replication-defective,3,1.0986122886681098
NB-UVA,3,1.0986122886681098
Reaching,3,1.0986122886681098
1220,3,1.0986122886681098
orifices,3,1.0986122886681098
1620,3,1.0986122886681098
cytokine-based,3,1.0986122886681098
LAmbre,3,1.0986122886681098
pSV10-SARS-CoV-2,3,1.0986122886681098
microsampling,3,1.0986122886681098
physiotherapeutic,3,1.0986122886681098
Mitra,3,1.0986122886681098
Extracts,3,1.0986122886681098
GraphPad,3,1.0986122886681098
CFT,3,1.0986122886681098
optimists,3,1.0986122886681098
cystatin,3,1.0986122886681098
ECRS,3,1.0986122886681098
2-10,3,1.0986122886681098
Canterbury,3,1.0986122886681098
nonsignificantly,3,1.0986122886681098
fistulas,3,1.0986122886681098
WHO-RT-PCR,3,1.0986122886681098
MK-4482,3,1.0986122886681098
denatured,3,1.0986122886681098
descendent,3,1.0986122886681098
asthma-pneumonia,3,1.0986122886681098
EVAR,3,1.0986122886681098
Alhydrogel,3,1.0986122886681098
May-November,3,1.0986122886681098
tuberculoma,3,1.0986122886681098
periodontopathic,3,1.0986122886681098
orthopnea,3,1.0986122886681098
antibiotherapy,3,1.0986122886681098
Feeling,3,1.0986122886681098
Haemostasis,3,1.0986122886681098
medián,3,1.0986122886681098
Hippo,3,1.0986122886681098
indica,3,1.0986122886681098
Azadirachta,3,1.0986122886681098
SINAP,3,1.0986122886681098
DSC-PWI,3,1.0986122886681098
asserts,3,1.0986122886681098
level-dependent,3,1.0986122886681098
körében,3,1.0986122886681098
BBeijing18493,3,1.0986122886681098
Crow,3,1.0986122886681098
lacrimation,3,1.0986122886681098
ruminants,3,1.0986122886681098
decisively,3,1.0986122886681098
forego,3,1.0986122886681098
profuse,3,1.0986122886681098
re-establishing,3,1.0986122886681098
enterosorption,3,1.0986122886681098
hyperchrloridemia,3,1.0986122886681098
hypochrloridemia,3,1.0986122886681098
biobridge,3,1.0986122886681098
Spatiotemporal,3,1.0986122886681098
parameterizations,3,1.0986122886681098
infarction‑induced,3,1.0986122886681098
apelin,3,1.0986122886681098
receptor-like,3,1.0986122886681098
gear,3,1.0986122886681098
posits,3,1.0986122886681098
personnels,3,1.0986122886681098
Kong572,3,1.0986122886681098
premortem,3,1.0986122886681098
Apelin,3,1.0986122886681098
SM-MIT,3,1.0986122886681098
heparinization,3,1.0986122886681098
szignifikáns,3,1.0986122886681098
Suspicion,3,1.0986122886681098
vált,3,1.0986122886681098
PACD,3,1.0986122886681098
rotarod,3,1.0986122886681098
neuroblasts,3,1.0986122886681098
intra-household,3,1.0986122886681098
multiphase,3,1.0986122886681098
3360,3,1.0986122886681098
Egy,3,1.0986122886681098
Novavax,3,1.0986122886681098
rapid-response,3,1.0986122886681098
oxidizing,3,1.0986122886681098
purposed,3,1.0986122886681098
Fei,3,1.0986122886681098
Glycosylation,3,1.0986122886681098
LKW,3,1.0986122886681098
gdl,3,1.0986122886681098
alacsonyabb,3,1.0986122886681098
hétvégén,3,1.0986122886681098
seafarers,3,1.0986122886681098
egy,3,1.0986122886681098
six-year-old,3,1.0986122886681098
inexplicable,3,1.0986122886681098
1090,3,1.0986122886681098
197879,3,1.0986122886681098
1914,3,1.0986122886681098
Age-stratified,3,1.0986122886681098
pharmacist-provided,3,1.0986122886681098
MHCs,3,1.0986122886681098
laudable,3,1.0986122886681098
RANKL,3,1.0986122886681098
glycoside,3,1.0986122886681098
fevereczema,3,1.0986122886681098
0066,3,1.0986122886681098
Republican,3,1.0986122886681098
Iota,3,1.0986122886681098
electro-anatomical,3,1.0986122886681098
antifibrinolytic,3,1.0986122886681098
transparently,3,1.0986122886681098
Danes,3,1.0986122886681098
hypermetabolism,3,1.0986122886681098
inflight,3,1.0986122886681098
QIAstat-Dx,3,1.0986122886681098
anti-cytokine-based,3,1.0986122886681098
abatement,3,1.0986122886681098
installing,3,1.0986122886681098
paraganglioma,3,1.0986122886681098
difficile,3,1.0986122886681098
PPP,3,1.0986122886681098
Sero-surveys,3,1.0986122886681098
shikimic,3,1.0986122886681098
phosphorus,3,1.0986122886681098
metaphor,3,1.0986122886681098
sem,3,1.0986122886681098
-independent,3,1.0986122886681098
non-ambulatory,3,1.0986122886681098
criterium,3,1.0986122886681098
anticipates,3,1.0986122886681098
youngster,3,1.0986122886681098
CVVH,3,1.0986122886681098
igazolódott,3,1.0986122886681098
00053,3,1.0986122886681098
fluctuation-robust,3,1.0986122886681098
GPVI,3,1.0986122886681098
HDM-driven,3,1.0986122886681098
abusive,3,1.0986122886681098
low-quality,3,1.0986122886681098
gRNA,3,1.0986122886681098
NPW,3,1.0986122886681098
collectin,3,1.0986122886681098
GEN,3,1.0986122886681098
AEngland86475,3,1.0986122886681098
anti-IV,3,1.0986122886681098
Shannon,3,1.0986122886681098
temper,3,1.0986122886681098
contact-adjusted,3,1.0986122886681098
pan,3,1.0986122886681098
vaccine-enhanced,3,1.0986122886681098
anti-haemagglutinin,3,1.0986122886681098
IFN-γ-producing,3,1.0986122886681098
fist,3,1.0986122886681098
Charité-Berlin,3,1.0986122886681098
thin-section,3,1.0986122886681098
dispositional,3,1.0986122886681098
proposition,3,1.0986122886681098
GRMs,3,1.0986122886681098
ose-S,3,1.0986122886681098
42000,3,1.0986122886681098
by-product,3,1.0986122886681098
colonoscope,3,1.0986122886681098
recurrencies,3,1.0986122886681098
Kong73,3,1.0986122886681098
COVID-dedicated,3,1.0986122886681098
ion-channel,3,1.0986122886681098
centerpiece,3,1.0986122886681098
virus-1,3,1.0986122886681098
amphotericin,3,1.0986122886681098
inferior-wall,3,1.0986122886681098
recurs,3,1.0986122886681098
w-COVID19,3,1.0986122886681098
Xolair,3,1.0986122886681098
ORT,3,1.0986122886681098
AQRS,3,1.0986122886681098
antibodyantigen,3,1.0986122886681098
assortment,3,1.0986122886681098
trocar,3,1.0986122886681098
LNs,3,1.0986122886681098
Actuarial,3,1.0986122886681098
gene-specific,3,1.0986122886681098
one-dimensional,3,1.0986122886681098
1612,3,1.0986122886681098
Preservation,3,1.0986122886681098
RdRp-P2,3,1.0986122886681098
quotes,3,1.0986122886681098
pustules,3,1.0986122886681098
InstituteNational,3,1.0986122886681098
EXCELS,3,1.0986122886681098
Therapeutics-Clinical,3,1.0986122886681098
exanthematous,3,1.0986122886681098
othering,3,1.0986122886681098
TIVE,3,1.0986122886681098
in-group,3,1.0986122886681098
Characteristically,3,1.0986122886681098
blaming,3,1.0986122886681098
i-COVID19,3,1.0986122886681098
skillful,3,1.0986122886681098
11-item,3,1.0986122886681098
expandable,3,1.0986122886681098
conforming,3,1.0986122886681098
25-48,3,1.0986122886681098
NEM,3,1.0986122886681098
ventilator-associated,3,1.0986122886681098
boluses,3,1.0986122886681098
COHb,3,1.0986122886681098
nineteenth,3,1.0986122886681098
chronical,3,1.0986122886681098
upbringing,3,1.0986122886681098
fraternity,3,1.0986122886681098
ILISARI,3,1.0986122886681098
hRSV,3,1.0986122886681098
Pharmacy,3,1.0986122886681098
justifications,3,1.0986122886681098
operationalize,3,1.0986122886681098
1894,3,1.0986122886681098
enhancer,3,1.0986122886681098
2a-3,3,1.0986122886681098
alpha-mangostin,3,1.0986122886681098
Linearity,3,1.0986122886681098
Irvine,3,1.0986122886681098
PMs,3,1.0986122886681098
ARNTL,3,1.0986122886681098
deepening,3,1.0986122886681098
Programmes,3,1.0986122886681098
NICs,3,1.0986122886681098
Supplementation,3,1.0986122886681098
cleavable,3,1.0986122886681098
160000,3,1.0986122886681098
piperine,3,1.0986122886681098
GSEA,3,1.0986122886681098
non-residential,3,1.0986122886681098
triptan,3,1.0986122886681098
astute,3,1.0986122886681098
open-artery,3,1.0986122886681098
brain-spleen,3,1.0986122886681098
Wood,3,1.0986122886681098
PAGER-CoV,3,1.0986122886681098
brain-immune,3,1.0986122886681098
NCIP,3,1.0986122886681098
cysLT,3,1.0986122886681098
Intuitively,3,1.0986122886681098
physiotherapist,3,1.0986122886681098
Preventable,3,1.0986122886681098
Graft,3,1.0986122886681098
sewersheds,3,1.0986122886681098
chemists,3,1.0986122886681098
undeniably,3,1.0986122886681098
conviction,3,1.0986122886681098
recollection,3,1.0986122886681098
mEC,3,1.0986122886681098
nanocarrier,3,1.0986122886681098
dreaming,3,1.0986122886681098
ECI,3,1.0986122886681098
immunocompromising,3,1.0986122886681098
Coefficient,3,1.0986122886681098
avec,3,1.0986122886681098
enterosorbent,3,1.0986122886681098
pre-COVID,3,1.0986122886681098
FEBS,3,1.0986122886681098
CorvGenSurv,3,1.0986122886681098
abate,3,1.0986122886681098
Montt,3,1.0986122886681098
30-80,3,1.0986122886681098
improperly,3,1.0986122886681098
anthropological,3,1.0986122886681098
LGE-CMR,3,1.0986122886681098
lab-confirmed,3,1.0986122886681098
Secretory,3,1.0986122886681098
dilatations,3,1.0986122886681098
G9,3,1.0986122886681098
telephoning,3,1.0986122886681098
ws,3,1.0986122886681098
miR-8066,3,1.0986122886681098
outnumbered,3,1.0986122886681098
0959,3,1.0986122886681098
1453,3,1.0986122886681098
proliferated,3,1.0986122886681098
contested,3,1.0986122886681098
CD31,3,1.0986122886681098
unrest,3,1.0986122886681098
R203KG204R,3,1.0986122886681098
amplicon-based,3,1.0986122886681098
GC3,3,1.0986122886681098
LIs,3,1.0986122886681098
pneumonia-associated,3,1.0986122886681098
non-conventional,3,1.0986122886681098
gyakori,3,1.0986122886681098
non-adaptive,3,1.0986122886681098
per-pass,3,1.0986122886681098
half-century,3,1.0986122886681098
dance,3,1.0986122886681098
sixty-two,3,1.0986122886681098
fleet,3,1.0986122886681098
midwestern,3,1.0986122886681098
Bedouin-Arab,3,1.0986122886681098
ANCOVA,3,1.0986122886681098
10-minute,3,1.0986122886681098
Paso,3,1.0986122886681098
MERCI,3,1.0986122886681098
Cutting-edge,3,1.0986122886681098
genomewide,3,1.0986122886681098
1119,3,1.0986122886681098
JR-NET,3,1.0986122886681098
HOMA,3,1.0986122886681098
deteriorations,3,1.0986122886681098
hyperlipidemic,3,1.0986122886681098
open-labeled,3,1.0986122886681098
oropharyngealnasopharyngeal,3,1.0986122886681098
Receipt,3,1.0986122886681098
cm-2,3,1.0986122886681098
megfelelő,3,1.0986122886681098
Isparta,3,1.0986122886681098
chlorpromazine,3,1.0986122886681098
Plastic,3,1.0986122886681098
mass-screening,3,1.0986122886681098
1Lsec,3,1.0986122886681098
Hemodialysis,3,1.0986122886681098
Asma,3,1.0986122886681098
multiracial,3,1.0986122886681098
1410,3,1.0986122886681098
Restoring,3,1.0986122886681098
1252,3,1.0986122886681098
p006,3,1.0986122886681098
1998-99,3,1.0986122886681098
swab-independent,3,1.0986122886681098
trainers,3,1.0986122886681098
1472,3,1.0986122886681098
1187,3,1.0986122886681098
APOBEC,3,1.0986122886681098
lab-developed,3,1.0986122886681098
PAR1,3,1.0986122886681098
scrub,3,1.0986122886681098
allies,3,1.0986122886681098
inactive-phase,3,1.0986122886681098
bed-1,3,1.0986122886681098
fluorescein,3,1.0986122886681098
-03,3,1.0986122886681098
neuron-generated,3,1.0986122886681098
Art,3,1.0986122886681098
infection-mediated,3,1.0986122886681098
chordal,3,1.0986122886681098
annuloplasty,3,1.0986122886681098
1215,3,1.0986122886681098
NF-kB,3,1.0986122886681098
oltás,3,1.0986122886681098
companions,3,1.0986122886681098
multisectoral,3,1.0986122886681098
cold-weather,3,1.0986122886681098
EAFT,3,1.0986122886681098
COVID-19-pozitív,3,1.0986122886681098
cognitivebehavioral,3,1.0986122886681098
utáni,3,1.0986122886681098
COVID-19-fertőzés,3,1.0986122886681098
Ƙ,3,1.0986122886681098
CLCE-24,3,1.0986122886681098
Lsec,3,1.0986122886681098
averse,3,1.0986122886681098
Proteins,3,1.0986122886681098
KPK,3,1.0986122886681098
stamping,3,1.0986122886681098
coronavirus-associated,3,1.0986122886681098
RT-fLAMP,3,1.0986122886681098
Maestro,3,1.0986122886681098
ribose,3,1.0986122886681098
Pre-clinical,3,1.0986122886681098
-066,3,1.0986122886681098
P0067,3,1.0986122886681098
neurodevelopment,3,1.0986122886681098
Langendorff,3,1.0986122886681098
lapse,3,1.0986122886681098
Teams,3,1.0986122886681098
tolerogenic,3,1.0986122886681098
chemically-synthesised,3,1.0986122886681098
double-,3,1.0986122886681098
ragweed-allergic,3,1.0986122886681098
beta-adrenergic-blocking,3,1.0986122886681098
enzyme-immunoassay,3,1.0986122886681098
counter-pulsation,3,1.0986122886681098
non-progressive,3,1.0986122886681098
600000,3,1.0986122886681098
calcineurin,3,1.0986122886681098
Oct,3,1.0986122886681098
PPH,3,1.0986122886681098
rs34481144-A,3,1.0986122886681098
psychoses,3,1.0986122886681098
α-26-sialic,3,1.0986122886681098
reflux-associated,3,1.0986122886681098
Responsible,3,1.0986122886681098
non-atheromatous,3,1.0986122886681098
Comirnaty®,3,1.0986122886681098
Thymic,3,1.0986122886681098
multi-detector,3,1.0986122886681098
transudative,3,1.0986122886681098
abiotic,3,1.0986122886681098
MCC,3,1.0986122886681098
tápláltsági,3,1.0986122886681098
cost-related,3,1.0986122886681098
reallocated,3,1.0986122886681098
O-glycosites,3,1.0986122886681098
inscription,3,1.0986122886681098
inhabitant,3,1.0986122886681098
3579,3,1.0986122886681098
BUSSR10083,3,1.0986122886681098
bioluminescence,3,1.0986122886681098
pre-eminent,3,1.0986122886681098
hydroxymethylglutaryl,3,1.0986122886681098
TLA,3,1.0986122886681098
Nova,3,1.0986122886681098
Braunwald,3,1.0986122886681098
narcotic,3,1.0986122886681098
Direction,3,1.0986122886681098
methadone,3,1.0986122886681098
-078,3,1.0986122886681098
translocator,3,1.0986122886681098
non-emergency,3,1.0986122886681098
Scotia,3,1.0986122886681098
softwares,3,1.0986122886681098
COVID-19SARS-CoV-2,3,1.0986122886681098
GenBody™,3,1.0986122886681098
rs3025039,3,1.0986122886681098
Sixth,3,1.0986122886681098
NCO-700,3,1.0986122886681098
COVAG025,3,1.0986122886681098
-081,3,1.0986122886681098
Propranolol,3,1.0986122886681098
Infertility,3,1.0986122886681098
Cockroach,3,1.0986122886681098
CATCH,3,1.0986122886681098
NT3,3,1.0986122886681098
inflations,3,1.0986122886681098
CMB,3,1.0986122886681098
Dx,3,1.0986122886681098
antivaccination,3,1.0986122886681098
scavenge,3,1.0986122886681098
DWIPWI,3,1.0986122886681098
1293,3,1.0986122886681098
all-or-nothing,3,1.0986122886681098
Extrapolated,3,1.0986122886681098
FluSurge,3,1.0986122886681098
INT-reductase,3,1.0986122886681098
polymorphs,3,1.0986122886681098
New•,3,1.0986122886681098
composes,3,1.0986122886681098
Echoscan,3,1.0986122886681098
parameterised,3,1.0986122886681098
absentee,3,1.0986122886681098
taskforce,3,1.0986122886681098
PIPDeploy,3,1.0986122886681098
Known•,3,1.0986122886681098
RHL,3,1.0986122886681098
chocolate,3,1.0986122886681098
adjunction,3,1.0986122886681098
1309,3,1.0986122886681098
EpiSims,3,1.0986122886681098
Paediatrics,3,1.0986122886681098
vaccine-matched,3,1.0986122886681098
PTX,3,1.0986122886681098
steroid-naïve,3,1.0986122886681098
GUSB,3,1.0986122886681098
Questionnaire-9,3,1.0986122886681098
Dilution,3,1.0986122886681098
natality,3,1.0986122886681098
infectiveness,3,1.0986122886681098
mid-2009,3,1.0986122886681098
reocclusions,3,1.0986122886681098
end-systole,3,1.0986122886681098
NT-4,3,1.0986122886681098
Vcf,3,1.0986122886681098
imaginary,3,1.0986122886681098
reform,3,1.0986122886681098
cross-clamp,3,1.0986122886681098
deltaD,3,1.0986122886681098
metaregression,3,1.0986122886681098
flanking,3,1.0986122886681098
Breast-feeding,3,1.0986122886681098
superselective,3,1.0986122886681098
polarize,3,1.0986122886681098
OpenABM-Covid19,3,1.0986122886681098
stigmatized,3,1.0986122886681098
self-stereotypes,3,1.0986122886681098
1366,3,1.0986122886681098
dining,3,1.0986122886681098
OIL-TAS,3,1.0986122886681098
FFP3,3,1.0986122886681098
slept,3,1.0986122886681098
chromogenic,3,1.0986122886681098
postocclusive,3,1.0986122886681098
2125,3,1.0986122886681098
prehabilitation,3,1.0986122886681098
epidemicspandemics,3,1.0986122886681098
perfusion-,3,1.0986122886681098
First-pass,3,1.0986122886681098
1625,3,1.0986122886681098
Fresh,3,1.0986122886681098
Betablockers,3,1.0986122886681098
egocentric,3,1.0986122886681098
Pravastatin,3,1.0986122886681098
parasitological,3,1.0986122886681098
PCR-tested,3,1.0986122886681098
feed-forward,3,1.0986122886681098
TestNorm,3,1.0986122886681098
20-100,3,1.0986122886681098
crowds,3,1.0986122886681098
Leukopenia,3,1.0986122886681098
PR834,3,1.0986122886681098
double-dose,3,1.0986122886681098
Clearance,3,1.0986122886681098
Estimations,3,1.0986122886681098
nonrelaxing,3,1.0986122886681098
PPIS,3,1.0986122886681098
CeAD,3,1.0986122886681098
cardiodynamic,3,1.0986122886681098
CHC,3,1.0986122886681098
sessionsweek,3,1.0986122886681098
aminoadamantane,3,1.0986122886681098
vp,3,1.0986122886681098
⩽48,3,1.0986122886681098
MSCT-64,3,1.0986122886681098
hospital-related,3,1.0986122886681098
intensivists,3,1.0986122886681098
nematode,3,1.0986122886681098
asthmaasthma-like,3,1.0986122886681098
Ruptured,3,1.0986122886681098
ACEs,3,1.0986122886681098
factor-kappaB,3,1.0986122886681098
invokes,3,1.0986122886681098
glitazones,3,1.0986122886681098
Obese,3,1.0986122886681098
DTC-speed,3,1.0986122886681098
ATIV,3,1.0986122886681098
V367F,3,1.0986122886681098
6-72,3,1.0986122886681098
unsolicited,3,1.0986122886681098
ALERT,3,1.0986122886681098
mixed-breed,3,1.0986122886681098
cognitive-motor,3,1.0986122886681098
Influences,3,1.0986122886681098
asphyxic,3,1.0986122886681098
IFN-sensitive,3,1.0986122886681098
KwaZulu,3,1.0986122886681098
rpm,3,1.0986122886681098
to-and-fro,3,1.0986122886681098
universality,3,1.0986122886681098
17-21,3,1.0986122886681098
Becker,3,1.0986122886681098
spectrums,3,1.0986122886681098
NAEP,3,1.0986122886681098
reticuloendothelial,3,1.0986122886681098
Krahn,3,1.0986122886681098
amenorrhea,3,1.0986122886681098
brushing,3,1.0986122886681098
signal-to-cutoff,3,1.0986122886681098
Conversion,3,1.0986122886681098
βt,3,1.0986122886681098
2593,3,1.0986122886681098
Meyer,3,1.0986122886681098
fibreoptic,3,1.0986122886681098
craniofacial,3,1.0986122886681098
D2B,3,1.0986122886681098
metaanalyses,3,1.0986122886681098
ICAMCA,3,1.0986122886681098
pre-challenge,3,1.0986122886681098
HRCA,3,1.0986122886681098
Fugl,3,1.0986122886681098
Timed,3,1.0986122886681098
Contralateral,3,1.0986122886681098
30-36,3,1.0986122886681098
Foremost,3,1.0986122886681098
Neighborhood,3,1.0986122886681098
AIURT,3,1.0986122886681098
modularity,3,1.0986122886681098
F-18,3,1.0986122886681098
D131E,3,1.0986122886681098
S186P,3,1.0986122886681098
MINO,3,1.0986122886681098
cRASL-seq,3,1.0986122886681098
RCSN,3,1.0986122886681098
intrathecal,3,1.0986122886681098
dolgozó,3,1.0986122886681098
Cxcr4,3,1.0986122886681098
deluge,3,1.0986122886681098
automatable,3,1.0986122886681098
Themes,3,1.0986122886681098
Edgar,3,1.0986122886681098
cardiomyogenesis,3,1.0986122886681098
D-,3,1.0986122886681098
BMMSC,3,1.0986122886681098
Season,3,1.0986122886681098
sommeil,3,1.0986122886681098
dietetic,3,1.0986122886681098
thirty-four,3,1.0986122886681098
morphometrical,3,1.0986122886681098
monograph,3,1.0986122886681098
virus-derived,3,1.0986122886681098
intervention-capable,3,1.0986122886681098
oseltamivir-resistance,3,1.0986122886681098
hooked,3,1.0986122886681098
transyears,3,1.0986122886681098
profibrotic,3,1.0986122886681098
base-case,3,1.0986122886681098
six-minute,3,1.0986122886681098
Television,3,1.0986122886681098
0696,3,1.0986122886681098
OSACO,3,1.0986122886681098
Crescent,3,1.0986122886681098
stabilizes,3,1.0986122886681098
sows,3,1.0986122886681098
ICD-9-CM,3,1.0986122886681098
nifedipine-treated,3,1.0986122886681098
Liferiver,3,1.0986122886681098
2312,3,1.0986122886681098
BEAST,3,1.0986122886681098
Pig,3,1.0986122886681098
health-system,3,1.0986122886681098
-0036,3,1.0986122886681098
time-trend,3,1.0986122886681098
multihospital,3,1.0986122886681098
PCE,3,1.0986122886681098
LMCA-AMI,3,1.0986122886681098
2-18,3,1.0986122886681098
onset-to-door-time,3,1.0986122886681098
generalizing,3,1.0986122886681098
LHN,3,1.0986122886681098
TMRCA,3,1.0986122886681098
CTMRI,3,1.0986122886681098
manned,3,1.0986122886681098
arteritic,3,1.0986122886681098
unofficial,3,1.0986122886681098
SCD-associated,3,1.0986122886681098
Phi29,3,1.0986122886681098
low-and,3,1.0986122886681098
SoC,3,1.0986122886681098
WBC-C,3,1.0986122886681098
nonfrontal,3,1.0986122886681098
Heightened,3,1.0986122886681098
Payment,3,1.0986122886681098
JNC,3,1.0986122886681098
polyphenol,3,1.0986122886681098
BSM,3,1.0986122886681098
Sahlgrens,3,1.0986122886681098
mangiferin,3,1.0986122886681098
extensibility,3,1.0986122886681098
double-antigen,3,1.0986122886681098
Coimbra,3,1.0986122886681098
emotional-painful,3,1.0986122886681098
1127,3,1.0986122886681098
perfusing,3,1.0986122886681098
IPPB,3,1.0986122886681098
dissolving,3,1.0986122886681098
over-estimated,3,1.0986122886681098
SHEP,3,1.0986122886681098
ASouth,3,1.0986122886681098
factor-β,3,1.0986122886681098
myocellular,3,1.0986122886681098
risk-stratifying,3,1.0986122886681098
ArcGIS,3,1.0986122886681098
Species,3,1.0986122886681098
1022,3,1.0986122886681098
nasobronchial,3,1.0986122886681098
rt-PA-treated,3,1.0986122886681098
1974-1975,3,1.0986122886681098
XS,3,1.0986122886681098
ramped,3,1.0986122886681098
Salbutamol,3,1.0986122886681098
bait,3,1.0986122886681098
hijacked,3,1.0986122886681098
relentless,3,1.0986122886681098
-0009,3,1.0986122886681098
FluAB,3,1.0986122886681098
Emergencies,3,1.0986122886681098
tastesmell,3,1.0986122886681098
glucoside,3,1.0986122886681098
SARS-CoV-2-S1-binding,3,1.0986122886681098
cardioverter-defibrillators,3,1.0986122886681098
Reservists,3,1.0986122886681098
conquering,3,1.0986122886681098
ointment,3,1.0986122886681098
refractive,3,1.0986122886681098
hygiene-related,3,1.0986122886681098
overused,3,1.0986122886681098
RDIAHI,3,1.0986122886681098
pigtail,3,1.0986122886681098
310000,3,1.0986122886681098
drug-target,3,1.0986122886681098
subtilis,3,1.0986122886681098
gravitational,3,1.0986122886681098
Efficacious,3,1.0986122886681098
1158,3,1.0986122886681098
neuroanatomic,3,1.0986122886681098
abandonment,3,1.0986122886681098
fastidious,3,1.0986122886681098
f-5-HT,3,1.0986122886681098
®,3,1.0986122886681098
strings,3,1.0986122886681098
Intracardiac,3,1.0986122886681098
Carney,3,1.0986122886681098
prostheses,3,1.0986122886681098
Rt-PCR,3,1.0986122886681098
drainages,3,1.0986122886681098
asthma--in,3,1.0986122886681098
case–control,3,1.0986122886681098
ECG-abnormalities,3,1.0986122886681098
mid-left,3,1.0986122886681098
risk-to-benefit,3,1.0986122886681098
4293,3,1.0986122886681098
Macroscopic,3,1.0986122886681098
Ultrastructural,3,1.0986122886681098
nano-luciferase,3,1.0986122886681098
NDT,3,1.0986122886681098
ACT-J,3,1.0986122886681098
cm-1,3,1.0986122886681098
2009-March,3,1.0986122886681098
EAWMI,3,1.0986122886681098
pleuropulmonary,3,1.0986122886681098
aspergilloma,3,1.0986122886681098
ACCs,3,1.0986122886681098
on-scene,3,1.0986122886681098
Mesocestoides,3,1.0986122886681098
Eyes,3,1.0986122886681098
PA-aO2,3,1.0986122886681098
Mild-to-moderate,3,1.0986122886681098
celebration,3,1.0986122886681098
valine,3,1.0986122886681098
PxAF,3,1.0986122886681098
transients,3,1.0986122886681098
BCAA,3,1.0986122886681098
istological,3,1.0986122886681098
larval,3,1.0986122886681098
pseudonormalization,3,1.0986122886681098
23-24,3,1.0986122886681098
E-,3,1.0986122886681098
autres,3,1.0986122886681098
Precisely,3,1.0986122886681098
hectic,3,1.0986122886681098
Jönköping,3,1.0986122886681098
Olympus,3,1.0986122886681098
Flavivirus,3,1.0986122886681098
incisions,3,1.0986122886681098
two-month,3,1.0986122886681098
DMV,3,1.0986122886681098
HR-CT,3,1.0986122886681098
cusps,3,1.0986122886681098
de-identified,3,1.0986122886681098
declarations,3,1.0986122886681098
1182,3,1.0986122886681098
ED-based,3,1.0986122886681098
AMP-activated,3,1.0986122886681098
LETM,3,1.0986122886681098
Polymorphism,3,1.0986122886681098
260000,3,1.0986122886681098
spectroscopic,3,1.0986122886681098
8-19,3,1.0986122886681098
Mainly,3,1.0986122886681098
UPF,3,1.0986122886681098
Arginase,3,1.0986122886681098
nonneuronal,3,1.0986122886681098
immeasurable,3,1.0986122886681098
peacefully,3,1.0986122886681098
xenobiotic,3,1.0986122886681098
2254,3,1.0986122886681098
viscera,3,1.0986122886681098
booklets,3,1.0986122886681098
RSST,3,1.0986122886681098
brigade,3,1.0986122886681098
SCD-MMS,3,1.0986122886681098
Ibsens,3,1.0986122886681098
end-on,3,1.0986122886681098
donningdoffing,3,1.0986122886681098
DEL,3,1.0986122886681098
NLI,3,1.0986122886681098
nCoV-2019,3,1.0986122886681098
accruing,3,1.0986122886681098
cross-national,3,1.0986122886681098
6-week-old,3,1.0986122886681098
precancerous,3,1.0986122886681098
JAK-STAT,3,1.0986122886681098
allele-specific,3,1.0986122886681098
inquire,3,1.0986122886681098
S100B,3,1.0986122886681098
AAPs,3,1.0986122886681098
Imperial,3,1.0986122886681098
CerTest,3,1.0986122886681098
Consultants,3,1.0986122886681098
RT-MCE,3,1.0986122886681098
enlarging,3,1.0986122886681098
precluding,3,1.0986122886681098
Biotec,3,1.0986122886681098
rRTPCR,3,1.0986122886681098
mathematic,3,1.0986122886681098
affirming,3,1.0986122886681098
Medicina,3,1.0986122886681098
signalled,3,1.0986122886681098
bulla,3,1.0986122886681098
scrutinise,3,1.0986122886681098
transplanting,3,1.0986122886681098
modification-based,3,1.0986122886681098
HHG,3,1.0986122886681098
21-50,3,1.0986122886681098
vector-host,3,1.0986122886681098
Tc-Sestamibi,3,1.0986122886681098
18-48,3,1.0986122886681098
Anti-influenza,3,1.0986122886681098
Summarizing,3,1.0986122886681098
B-scan,3,1.0986122886681098
0044,3,1.0986122886681098
Cutoff,3,1.0986122886681098
perforated,3,1.0986122886681098
HEAL,3,1.0986122886681098
Encounters,3,1.0986122886681098
RFP,3,1.0986122886681098
Prisons,3,1.0986122886681098
hilar,3,1.0986122886681098
S1Q3T3,3,1.0986122886681098
suturing,3,1.0986122886681098
Otolaryngology,3,1.0986122886681098
Ashworth,3,1.0986122886681098
1404,3,1.0986122886681098
self-managed,3,1.0986122886681098
breathsmin,3,1.0986122886681098
unite,3,1.0986122886681098
placebo-TENS,3,1.0986122886681098
PLEDs,3,1.0986122886681098
allowance,3,1.0986122886681098
37°C,3,1.0986122886681098
displacements,3,1.0986122886681098
ABPL,3,1.0986122886681098
pneumology,3,1.0986122886681098
low-resourced,3,1.0986122886681098
restaging,3,1.0986122886681098
17025,3,1.0986122886681098
RFN,3,1.0986122886681098
ASSURED,3,1.0986122886681098
ringing,3,1.0986122886681098
confabulation,3,1.0986122886681098
breakdowns,3,1.0986122886681098
DEI,3,1.0986122886681098
explosively,3,1.0986122886681098
SIRIO,3,1.0986122886681098
neurovisualization,3,1.0986122886681098
learnings,3,1.0986122886681098
S13I,3,1.0986122886681098
neo-angiogenesis,3,1.0986122886681098
W152C,3,1.0986122886681098
pitfall,3,1.0986122886681098
long-held,3,1.0986122886681098
ASSENT,3,1.0986122886681098
Enumeration,3,1.0986122886681098
BPTs,3,1.0986122886681098
lip,3,1.0986122886681098
Parameter,3,1.0986122886681098
ABM,3,1.0986122886681098
Virgin,3,1.0986122886681098
mesial,3,1.0986122886681098
DeltaLVESV,3,1.0986122886681098
honor,3,1.0986122886681098
hypometabolism,3,1.0986122886681098
Urine,3,1.0986122886681098
diversify,3,1.0986122886681098
Gadchiroli,3,1.0986122886681098
RNA-virus,3,1.0986122886681098
conformed,3,1.0986122886681098
3275,3,1.0986122886681098
fats,3,1.0986122886681098
synchronize,3,1.0986122886681098
checkup,3,1.0986122886681098
ABGL,3,1.0986122886681098
crossreactive,3,1.0986122886681098
oxidation-reduction,3,1.0986122886681098
hematology-oncology,3,1.0986122886681098
metalloproteins,3,1.0986122886681098
calcitonin,3,1.0986122886681098
PBS-treated,3,1.0986122886681098
CGRP,3,1.0986122886681098
PTEN,3,1.0986122886681098
acute-stroke,3,1.0986122886681098
Religious,3,1.0986122886681098
one-page,3,1.0986122886681098
Nondipping,3,1.0986122886681098
lymphomas,3,1.0986122886681098
Viability,3,1.0986122886681098
anti-PF4,3,1.0986122886681098
hydrostatic,3,1.0986122886681098
1728,3,1.0986122886681098
ADCA,3,1.0986122886681098
sero-conversion,3,1.0986122886681098
COVID-19Communicated,3,1.0986122886681098
Post-discharge,3,1.0986122886681098
post-licensure,3,1.0986122886681098
unmask,3,1.0986122886681098
APhil82,3,1.0986122886681098
lifetimes,3,1.0986122886681098
ISS,3,1.0986122886681098
nondipolarity,3,1.0986122886681098
sub-score,3,1.0986122886681098
Riggs,3,1.0986122886681098
Herschler,3,1.0986122886681098
area-length,3,1.0986122886681098
Piedra,3,1.0986122886681098
subsensitivity,3,1.0986122886681098
self-determination,3,1.0986122886681098
SHC-LDT,3,1.0986122886681098
neuro-,3,1.0986122886681098
penal,3,1.0986122886681098
AgaA,3,1.0986122886681098
Duchenne,3,1.0986122886681098
Striking,3,1.0986122886681098
Gaglani,3,1.0986122886681098
Q-code,3,1.0986122886681098
strived,3,1.0986122886681098
vasculitic,3,1.0986122886681098
1321,3,1.0986122886681098
α26-SA,3,1.0986122886681098
uploaded,3,1.0986122886681098
HBP,3,1.0986122886681098
Cholera,3,1.0986122886681098
hemangioblastoma,3,1.0986122886681098
Dice,3,1.0986122886681098
autosegmentation,3,1.0986122886681098
Metrics,3,1.0986122886681098
DASS-21,3,1.0986122886681098
Oulu,3,1.0986122886681098
1516,3,1.0986122886681098
enumerating,3,1.0986122886681098
Neutropenia,3,1.0986122886681098
alia,3,1.0986122886681098
DPH,3,1.0986122886681098
anxiety-depression,3,1.0986122886681098
Removing,3,1.0986122886681098
consumptive,3,1.0986122886681098
Scalable,3,1.0986122886681098
OXVASC,3,1.0986122886681098
irrigated,3,1.0986122886681098
HN,3,1.0986122886681098
cardio-vascular,3,1.0986122886681098
postepidemic,3,1.0986122886681098
72nd,3,1.0986122886681098
pneumopathies,3,1.0986122886681098
excel,3,1.0986122886681098
refill,3,1.0986122886681098
Dataset,3,1.0986122886681098
cSVD,3,1.0986122886681098
2530,3,1.0986122886681098
DBCOVP,3,1.0986122886681098
verses,3,1.0986122886681098
heaviness,3,1.0986122886681098
cDNAs,3,1.0986122886681098
raccoon,3,1.0986122886681098
fatally,3,1.0986122886681098
Aironet,3,1.0986122886681098
Cell-based,3,1.0986122886681098
P007,3,1.0986122886681098
GE,3,1.0986122886681098
minute-ventilation,3,1.0986122886681098
nonurban,3,1.0986122886681098
AM3,3,1.0986122886681098
microns,3,1.0986122886681098
alarmed,3,1.0986122886681098
birefringence,3,1.0986122886681098
B-associated,3,1.0986122886681098
LTT,3,1.0986122886681098
Charts,3,1.0986122886681098
non-hydrolyzed,3,1.0986122886681098
IDRI,3,1.0986122886681098
Proinflammatory,3,1.0986122886681098
dissociate,3,1.0986122886681098
Syndrome-CoronaVirus-2,3,1.0986122886681098
invertebrate,3,1.0986122886681098
amnesic,3,1.0986122886681098
disproven,3,1.0986122886681098
METS,3,1.0986122886681098
Inverness,3,1.0986122886681098
cartogram,3,1.0986122886681098
E‑cadherin,3,1.0986122886681098
cold-season-AMIs,3,1.0986122886681098
thrombospondin-1,3,1.0986122886681098
10-1,3,1.0986122886681098
material-enhanced,3,1.0986122886681098
emotion-focused,3,1.0986122886681098
latitudinal,3,1.0986122886681098
NM,3,1.0986122886681098
perturbance,3,1.0986122886681098
APHC,3,1.0986122886681098
AbC-19,3,1.0986122886681098
GO-reflux,3,1.0986122886681098
magnetocardiogram,3,1.0986122886681098
APHL,3,1.0986122886681098
hECs,3,1.0986122886681098
hPSC-CMs,3,1.0986122886681098
futuristic,3,1.0986122886681098
District-8,3,1.0986122886681098
IKKβ,3,1.0986122886681098
Neuro-occupation,3,1.0986122886681098
cardio,3,1.0986122886681098
age-structure,3,1.0986122886681098
ATET,3,1.0986122886681098
outflows,3,1.0986122886681098
Added,3,1.0986122886681098
Egg,3,1.0986122886681098
carnivores,3,1.0986122886681098
manufacturability,3,1.0986122886681098
state-specific,3,1.0986122886681098
glycoconjugates,3,1.0986122886681098
Leaving,3,1.0986122886681098
discerning,3,1.0986122886681098
diethylenetriaminepentaacetic,3,1.0986122886681098
prudence,3,1.0986122886681098
15-November,3,1.0986122886681098
-001,3,1.0986122886681098
renew,3,1.0986122886681098
nVAF,3,1.0986122886681098
CONSENSUS,3,1.0986122886681098
poliomyelitis,3,1.0986122886681098
Winnebago,3,1.0986122886681098
WAPs,3,1.0986122886681098
Crucial,3,1.0986122886681098
CPGs,3,1.0986122886681098
Québec,3,1.0986122886681098
plight,3,1.0986122886681098
communicative,3,1.0986122886681098
LesionD0,3,1.0986122886681098
medium-treated,3,1.0986122886681098
perfusiondiffusion,3,1.0986122886681098
villains,3,1.0986122886681098
dystypia,3,1.0986122886681098
3900,3,1.0986122886681098
Archival,3,1.0986122886681098
aspirin-intolerant,3,1.0986122886681098
instilled,3,1.0986122886681098
coffins,3,1.0986122886681098
bacteriologic,3,1.0986122886681098
micro-organisms,3,1.0986122886681098
acyclic,3,1.0986122886681098
Personnel,3,1.0986122886681098
productions,3,1.0986122886681098
Cord,3,1.0986122886681098
duplexes,3,1.0986122886681098
Penglai,3,1.0986122886681098
dengue-endemic,3,1.0986122886681098
zonulin,3,1.0986122886681098
bisphosphonates,3,1.0986122886681098
VAL,3,1.0986122886681098
nanoliter,3,1.0986122886681098
reshape,3,1.0986122886681098
Evidence-Based,3,1.0986122886681098
UND,3,1.0986122886681098
inosine,3,1.0986122886681098
renowned,3,1.0986122886681098
electrocardiographical,3,1.0986122886681098
1273,3,1.0986122886681098
GIP,3,1.0986122886681098
hardness,3,1.0986122886681098
coxibs,3,1.0986122886681098
BMP,3,1.0986122886681098
PEmax,3,1.0986122886681098
Curiously,3,1.0986122886681098
PImax,3,1.0986122886681098
Nashville,3,1.0986122886681098
iRMDs,3,1.0986122886681098
CD163high,3,1.0986122886681098
PRACTICAL,3,1.0986122886681098
post-DOAC,3,1.0986122886681098
24-36,3,1.0986122886681098
gravimetric,3,1.0986122886681098
VAOS,3,1.0986122886681098
Premorbid,3,1.0986122886681098
cross-ventilation,3,1.0986122886681098
Eur,3,1.0986122886681098
rescinded,3,1.0986122886681098
Benralizumab,3,1.0986122886681098
vacuoles,3,1.0986122886681098
normalizes,3,1.0986122886681098
mock-infected,3,1.0986122886681098
ANanchang93395,3,1.0986122886681098
non-peer-reviewed,3,1.0986122886681098
gerontology,3,1.0986122886681098
significances,3,1.0986122886681098
Aggregated,3,1.0986122886681098
mitochondria-targeted,3,1.0986122886681098
RNA-sequencing,3,1.0986122886681098
non-intensive,3,1.0986122886681098
infectionreplication,3,1.0986122886681098
dipstick,3,1.0986122886681098
Seroreactivity,3,1.0986122886681098
Ingenuity,3,1.0986122886681098
hypersensitive,3,1.0986122886681098
concentration-PM25,3,1.0986122886681098
Electric,3,1.0986122886681098
sero-prevalence,3,1.0986122886681098
privately,3,1.0986122886681098
high-impact,3,1.0986122886681098
supranational,3,1.0986122886681098
Months,3,1.0986122886681098
16-18,3,1.0986122886681098
Recombination,3,1.0986122886681098
telling,3,1.0986122886681098
immunohistochemically,3,1.0986122886681098
M4,3,1.0986122886681098
Possibly,3,1.0986122886681098
Peg,3,1.0986122886681098
Wallerian,3,1.0986122886681098
rostrum,3,1.0986122886681098
ERMANCIA,3,1.0986122886681098
haemopericardium,3,1.0986122886681098
AHunan424432015H1N1,3,1.0986122886681098
Ovalbumin,3,1.0986122886681098
locales,3,1.0986122886681098
long-awaited,3,1.0986122886681098
paralleling,3,1.0986122886681098
Cardiorespiratory,3,1.0986122886681098
Conceptually,3,1.0986122886681098
induced-sputum,3,1.0986122886681098
schoolsworkplaces,3,1.0986122886681098
-125,3,1.0986122886681098
FUNDING,3,1.0986122886681098
Edema,3,1.0986122886681098
isothiocyanate,3,1.0986122886681098
glossary,3,1.0986122886681098
antagonizes,3,1.0986122886681098
F1,3,1.0986122886681098
SaW,3,1.0986122886681098
breakpoint,3,1.0986122886681098
manometry,3,1.0986122886681098
ASydney0597,3,1.0986122886681098
IBAE,3,1.0986122886681098
4-12,3,1.0986122886681098
Zhu,3,1.0986122886681098
fault,3,1.0986122886681098
sequencing-based,3,1.0986122886681098
waveguides,3,1.0986122886681098
thermolabile,3,1.0986122886681098
1990-91,3,1.0986122886681098
17-18,3,1.0986122886681098
MET-Home,3,1.0986122886681098
videotape,3,1.0986122886681098
pretreatments,3,1.0986122886681098
IL17A,3,1.0986122886681098
Hypoperfusion,3,1.0986122886681098
radiolabelled,3,1.0986122886681098
Peptides,3,1.0986122886681098
lymphocytosis,3,1.0986122886681098
Encephalopathy,3,1.0986122886681098
postbronchiolitis,3,1.0986122886681098
Proposals,3,1.0986122886681098
I-ILI,3,1.0986122886681098
6-15,3,1.0986122886681098
vrs,3,1.0986122886681098
INSIGHT,3,1.0986122886681098
Nevada,3,1.0986122886681098
justifiability,3,1.0986122886681098
1197,3,1.0986122886681098
Has,3,1.0986122886681098
infarctional,3,1.0986122886681098
2431,3,1.0986122886681098
RBD219-WT,3,1.0986122886681098
zinc-metalloprotease,3,1.0986122886681098
budgetary,3,1.0986122886681098
Accompanying,3,1.0986122886681098
obstructs,3,1.0986122886681098
Porter,3,1.0986122886681098
Caesarean,3,1.0986122886681098
documentations,3,1.0986122886681098
congested,3,1.0986122886681098
eat,3,1.0986122886681098
ramping,3,1.0986122886681098
realisation,3,1.0986122886681098
location-specific,3,1.0986122886681098
65-69,3,1.0986122886681098
healthcare-related,3,1.0986122886681098
Cerebellar,3,1.0986122886681098
D225G,3,1.0986122886681098
expCFR,3,1.0986122886681098
Vina,3,1.0986122886681098
WES,3,1.0986122886681098
1167,3,1.0986122886681098
usefull,3,1.0986122886681098
Soc,3,1.0986122886681098
0924,3,1.0986122886681098
invites,3,1.0986122886681098
2700,3,1.0986122886681098
barcoded,3,1.0986122886681098
Universitys,3,1.0986122886681098
SYNTAX,3,1.0986122886681098
Deciphering,3,1.0986122886681098
mild-intermittent,3,1.0986122886681098
Closed,3,1.0986122886681098
immuno-epidemiological,3,1.0986122886681098
Woll,3,1.0986122886681098
Legal,3,1.0986122886681098
Hypercholesterolemia,3,1.0986122886681098
Communicating,3,1.0986122886681098
2650,3,1.0986122886681098
aberrancy,3,1.0986122886681098
14-year-olds,3,1.0986122886681098
EULAR,3,1.0986122886681098
boomers,3,1.0986122886681098
Natives,3,1.0986122886681098
222D,3,1.0986122886681098
0973,3,1.0986122886681098
avian-,3,1.0986122886681098
wet-lab,3,1.0986122886681098
analyst,3,1.0986122886681098
18-20,3,1.0986122886681098
Self-Rating,3,1.0986122886681098
MCAO-induced,3,1.0986122886681098
∼100,3,1.0986122886681098
CRISPR-Cas13a,3,1.0986122886681098
Identifier,3,1.0986122886681098
flue,3,1.0986122886681098
breached,3,1.0986122886681098
illuminating,3,1.0986122886681098
pack-years,3,1.0986122886681098
CGATSE,3,1.0986122886681098
primordial,3,1.0986122886681098
Aβ,3,1.0986122886681098
overdue,3,1.0986122886681098
Castilla,3,1.0986122886681098
freedoms,3,1.0986122886681098
Sobel,3,1.0986122886681098
Thacker,3,1.0986122886681098
Marshall,3,1.0986122886681098
20-24,3,1.0986122886681098
pCT,3,1.0986122886681098
Etiologies,3,1.0986122886681098
picornaviruses,3,1.0986122886681098
petechiae,3,1.0986122886681098
Atkinson,3,1.0986122886681098
genosensor,3,1.0986122886681098
Egger,3,1.0986122886681098
iTTP,3,1.0986122886681098
Bearing,3,1.0986122886681098
S-trimer,3,1.0986122886681098
voltammetry,3,1.0986122886681098
Immune-mediated,3,1.0986122886681098
1359,3,1.0986122886681098
pathobiologic,3,1.0986122886681098
distensibility,3,1.0986122886681098
multigravida,3,1.0986122886681098
groundwater,3,1.0986122886681098
Visible,3,1.0986122886681098
IRV,3,1.0986122886681098
co-registration,3,1.0986122886681098
planimetrically,3,1.0986122886681098
geodesic,3,1.0986122886681098
polyetiological,3,1.0986122886681098
mycoplasmas,3,1.0986122886681098
3083,3,1.0986122886681098
6565,3,1.0986122886681098
promulgation,3,1.0986122886681098
SIENNA™,3,1.0986122886681098
LIPS,3,1.0986122886681098
flow-directed,3,1.0986122886681098
SSNHL,3,1.0986122886681098
cross-referenced,3,1.0986122886681098
praw,3,1.0986122886681098
EMERALD,3,1.0986122886681098
PCAF,3,1.0986122886681098
1431,3,1.0986122886681098
COVID-19-free,3,1.0986122886681098
1082,3,1.0986122886681098
8-,3,1.0986122886681098
Prevailing,3,1.0986122886681098
TLR-10,3,1.0986122886681098
Crystal,3,1.0986122886681098
equivalently,3,1.0986122886681098
Tensor,3,1.0986122886681098
cross-strain,3,1.0986122886681098
Silesian,3,1.0986122886681098
objectivity,3,1.0986122886681098
dithiothreitol,3,1.0986122886681098
Submaximal,3,1.0986122886681098
kinking,3,1.0986122886681098
H5N3,3,1.0986122886681098
HL-1,3,1.0986122886681098
Phylodynamic,3,1.0986122886681098
FMO,3,1.0986122886681098
NCU,3,1.0986122886681098
non-lipid,3,1.0986122886681098
alveolar-arterial,3,1.0986122886681098
one-tenth,3,1.0986122886681098
NEA,3,1.0986122886681098
Asynergies,3,1.0986122886681098
sixty-three,3,1.0986122886681098
inferiolateral,3,1.0986122886681098
impinging,3,1.0986122886681098
TAS2Rs,3,1.0986122886681098
nanomaterial-based,3,1.0986122886681098
AV-block,3,1.0986122886681098
UVGI,3,1.0986122886681098
chewing,3,1.0986122886681098
inspite,3,1.0986122886681098
nihilistic,3,1.0986122886681098
invariance,3,1.0986122886681098
before-after,3,1.0986122886681098
intricacies,3,1.0986122886681098
biomolecule,3,1.0986122886681098
24-mer,3,1.0986122886681098
acid-related,3,1.0986122886681098
principled,3,1.0986122886681098
non-Type,3,1.0986122886681098
2009-H1N1,3,1.0986122886681098
nonreactors,3,1.0986122886681098
blood-borne,3,1.0986122886681098
ANSM,3,1.0986122886681098
als,3,1.0986122886681098
100-year-old,3,1.0986122886681098
BinaxNOW-positive,3,1.0986122886681098
Pelotas,3,1.0986122886681098
sling,3,1.0986122886681098
intraobserver,3,1.0986122886681098
analysts,3,1.0986122886681098
methodologists,3,1.0986122886681098
EEI,3,1.0986122886681098
subitems,3,1.0986122886681098
misdiagnoses,3,1.0986122886681098
Shedding,3,1.0986122886681098
Koreas,3,1.0986122886681098
Gliomas,3,1.0986122886681098
citywide,3,1.0986122886681098
Au-Fe3O4,3,1.0986122886681098
Diminished,3,1.0986122886681098
TSoccupational,3,1.0986122886681098
hysterectomy,3,1.0986122886681098
methandrostenolone,3,1.0986122886681098
Belo,3,1.0986122886681098
PEFM,3,1.0986122886681098
1743,3,1.0986122886681098
Employment,3,1.0986122886681098
poor-quality,3,1.0986122886681098
MPP,3,1.0986122886681098
MP789,3,1.0986122886681098
aPWA,3,1.0986122886681098
venting,3,1.0986122886681098
cross-subtype,3,1.0986122886681098
DHMH,3,1.0986122886681098
Dilazep,3,1.0986122886681098
10MWT,3,1.0986122886681098
semaphorin3E,3,1.0986122886681098
revolutions,3,1.0986122886681098
ever-evolving,3,1.0986122886681098
case-referent,3,1.0986122886681098
CEA-related,3,1.0986122886681098
peripostoperative,3,1.0986122886681098
Three-hundred,3,1.0986122886681098
GMOs,3,1.0986122886681098
Phylogeographic,3,1.0986122886681098
IgG-,3,1.0986122886681098
60-65,3,1.0986122886681098
CDNF,3,1.0986122886681098
BACKGROUNDThe,3,1.0986122886681098
35-69,3,1.0986122886681098
centric,3,1.0986122886681098
nanomedicine-based,3,1.0986122886681098
Shared,3,1.0986122886681098
MANF,3,1.0986122886681098
MTBTs,3,1.0986122886681098
genu,3,1.0986122886681098
deceptive,3,1.0986122886681098
Conceivably,3,1.0986122886681098
referents,3,1.0986122886681098
uLTE4,3,1.0986122886681098
3044,3,1.0986122886681098
engorgement,3,1.0986122886681098
technology-based,3,1.0986122886681098
champions,3,1.0986122886681098
consumer-level,3,1.0986122886681098
Sambucus,3,1.0986122886681098
PANGO,3,1.0986122886681098
Assignment,3,1.0986122886681098
latencies,3,1.0986122886681098
IC50-spr,3,1.0986122886681098
paradigmatic,3,1.0986122886681098
FCP-Flu,3,1.0986122886681098
riding,3,1.0986122886681098
Cut-off,3,1.0986122886681098
cineventriculography,3,1.0986122886681098
grass-pollen,3,1.0986122886681098
symptomatics,3,1.0986122886681098
halitosis,3,1.0986122886681098
NSP-RDT,3,1.0986122886681098
Typing,3,1.0986122886681098
hypercontractile,3,1.0986122886681098
gold-based,3,1.0986122886681098
sociology,3,1.0986122886681098
s-IGF1,3,1.0986122886681098
mm2s,3,1.0986122886681098
IGF1,3,1.0986122886681098
multiplicities,3,1.0986122886681098
NOA,3,1.0986122886681098
neuro-COVID,3,1.0986122886681098
age-distribution,3,1.0986122886681098
information-sharing,3,1.0986122886681098
HISS,3,1.0986122886681098
subnetwork,3,1.0986122886681098
Influenza-A,3,1.0986122886681098
randomized-controlled,3,1.0986122886681098
bacteremic,3,1.0986122886681098
pre-processed,3,1.0986122886681098
1724,3,1.0986122886681098
Poverty,3,1.0986122886681098
870000,3,1.0986122886681098
thunderstorm-related,3,1.0986122886681098
FOXP3,3,1.0986122886681098
RSNs,3,1.0986122886681098
quote,3,1.0986122886681098
pneumo-allergens,3,1.0986122886681098
virostatic,3,1.0986122886681098
rapid-acting,3,1.0986122886681098
microgl,3,1.0986122886681098
polyclinical,3,1.0986122886681098
Case-patients,3,1.0986122886681098
staphylococci,3,1.0986122886681098
paralyses,3,1.0986122886681098
43000,3,1.0986122886681098
placebo-,3,1.0986122886681098
polymorph,3,1.0986122886681098
neuramidase,3,1.0986122886681098
incompatibility,3,1.0986122886681098
≥32,3,1.0986122886681098
maynei,3,1.0986122886681098
resource-consuming,3,1.0986122886681098
single-task,3,1.0986122886681098
mediolateral,3,1.0986122886681098
Tracker,3,1.0986122886681098
Euroglyphus,3,1.0986122886681098
43-K,3,1.0986122886681098
grass-treated,3,1.0986122886681098
anti-diabetic,3,1.0986122886681098
nonfasting,3,1.0986122886681098
cerebellitis,3,1.0986122886681098
opiates,3,1.0986122886681098
consensus-negative,3,1.0986122886681098
EC-IC,3,1.0986122886681098
Adjuvanted,3,1.0986122886681098
codified,3,1.0986122886681098
STIKO,3,1.0986122886681098
Travelers,3,1.0986122886681098
angiotension,3,1.0986122886681098
BAU,3,1.0986122886681098
Apgar,3,1.0986122886681098
argumentation,3,1.0986122886681098
CMVR,3,1.0986122886681098
multimode,3,1.0986122886681098
preoccupied,3,1.0986122886681098
Aequine,3,1.0986122886681098
thermography,3,1.0986122886681098
absorbing,3,1.0986122886681098
glycopeptides,3,1.0986122886681098
ISs,3,1.0986122886681098
Brodmann,3,1.0986122886681098
μgL,3,1.0986122886681098
hypopigmented,3,1.0986122886681098
bruit,3,1.0986122886681098
Ray,3,1.0986122886681098
3546,3,1.0986122886681098
musculoaponeurotic,3,1.0986122886681098
WEs,3,1.0986122886681098
stricture,3,1.0986122886681098
host-interacting,3,1.0986122886681098
saquinavir,3,1.0986122886681098
self-acting,3,1.0986122886681098
SPX,3,1.0986122886681098
fingerprinting,3,1.0986122886681098
ribosomes,3,1.0986122886681098
trades,3,1.0986122886681098
optometrists,3,1.0986122886681098
CYamagata2681,3,1.0986122886681098
squalene,3,1.0986122886681098
25-5,3,1.0986122886681098
Wenckebach,3,1.0986122886681098
regression-based,3,1.0986122886681098
IILI,3,1.0986122886681098
rSP,3,1.0986122886681098
Periostin,3,1.0986122886681098
RMs,3,1.0986122886681098
Baduanjin,3,1.0986122886681098
VRS,3,1.0986122886681098
2681,3,1.0986122886681098
SILI,3,1.0986122886681098
antiphlogistic,3,1.0986122886681098
AL-Flu,3,1.0986122886681098
hMDM,3,1.0986122886681098
plication,3,1.0986122886681098
Correspondingly,3,1.0986122886681098
MassARRAY®,3,1.0986122886681098
Lecture,3,1.0986122886681098
2-person,3,1.0986122886681098
working-aged,3,1.0986122886681098
RMSEA,3,1.0986122886681098
soften,3,1.0986122886681098
out-of-home,3,1.0986122886681098
B-infected,3,1.0986122886681098
Soft,3,1.0986122886681098
typesubtype-specific,3,1.0986122886681098
Motif,3,1.0986122886681098
demarcation,3,1.0986122886681098
ASRM,3,1.0986122886681098
Fears,3,1.0986122886681098
psychoactive,3,1.0986122886681098
IRDTs,3,1.0986122886681098
1327,3,1.0986122886681098
transcription-mediated,3,1.0986122886681098
Bolus,3,1.0986122886681098
self-preservation,3,1.0986122886681098
multidose,3,1.0986122886681098
coreceptor,3,1.0986122886681098
gamma-glutamyl,3,1.0986122886681098
ALOX5AP,3,1.0986122886681098
Basigin,3,1.0986122886681098
Isfahan,3,1.0986122886681098
wrapped,3,1.0986122886681098
cohorted,3,1.0986122886681098
D111,3,1.0986122886681098
equates,3,1.0986122886681098
D36,3,1.0986122886681098
SARS-Cov-1,3,1.0986122886681098
multi-systemic,3,1.0986122886681098
6-SOMT,3,1.0986122886681098
arrythmia,3,1.0986122886681098
double-basket,3,1.0986122886681098
samplespool,3,1.0986122886681098
Chemokine,3,1.0986122886681098
Noncontrast,3,1.0986122886681098
-100,3,1.0986122886681098
il,3,1.0986122886681098
PAL,3,1.0986122886681098
250-500,3,1.0986122886681098
Reversal,3,1.0986122886681098
non-hemodialyzed,3,1.0986122886681098
19-21,3,1.0986122886681098
thermotherapy,3,1.0986122886681098
Element,3,1.0986122886681098
SMRs,3,1.0986122886681098
Standing,3,1.0986122886681098
MAR,3,1.0986122886681098
2-18Ffluoro-2-deoxy-D-glucose,3,1.0986122886681098
demarcate,3,1.0986122886681098
Multinational,3,1.0986122886681098
Fertility,3,1.0986122886681098
microembolism,3,1.0986122886681098
1280,3,1.0986122886681098
dual-track,3,1.0986122886681098
1085,3,1.0986122886681098
CVC,3,1.0986122886681098
recombinantly,3,1.0986122886681098
ebony,3,1.0986122886681098
ergometrine,3,1.0986122886681098
Milk,3,1.0986122886681098
cb-CoV2-6C3,3,1.0986122886681098
AmericansBlacks,3,1.0986122886681098
HispanicsLatinos,3,1.0986122886681098
Antibody-based,3,1.0986122886681098
Two-third,3,1.0986122886681098
V2-6,3,1.0986122886681098
myelopathy,3,1.0986122886681098
mlh,3,1.0986122886681098
1229,3,1.0986122886681098
WRL,3,1.0986122886681098
enquiries,3,1.0986122886681098
burial,3,1.0986122886681098
AHK868,3,1.0986122886681098
rhinopharyngeal,3,1.0986122886681098
Sophisticated,3,1.0986122886681098
positive-strand,3,1.0986122886681098
CT-angiography,3,1.0986122886681098
HDMs,3,1.0986122886681098
Gloucestershire,3,1.0986122886681098
Leukocytes,3,1.0986122886681098
uBLU,3,1.0986122886681098
non-users,3,1.0986122886681098
multi-dose,3,1.0986122886681098
non-disabling,3,1.0986122886681098
Bmax,3,1.0986122886681098
fmolmg,3,1.0986122886681098
Hyaluronidase,3,1.0986122886681098
sICH,3,1.0986122886681098
cont,3,1.0986122886681098
DPs,3,1.0986122886681098
hypersomnia,3,1.0986122886681098
Haute-Garonne,3,1.0986122886681098
chess,3,1.0986122886681098
orthosis,3,1.0986122886681098
south-western,3,1.0986122886681098
anaplastic,3,1.0986122886681098
Periods,3,1.0986122886681098
ASHD,3,1.0986122886681098
transcoronary,3,1.0986122886681098
UKPDS,3,1.0986122886681098
Girls,3,1.0986122886681098
biceps,3,1.0986122886681098
5×,3,1.0986122886681098
DNCG,3,1.0986122886681098
futures,3,1.0986122886681098
radiographers,3,1.0986122886681098
Kent,3,1.0986122886681098
ún,3,1.0986122886681098
Statistic,3,1.0986122886681098
barcoding,3,1.0986122886681098
MTD,3,1.0986122886681098
influenza-bacterial,3,1.0986122886681098
mgkgd,3,1.0986122886681098
10-21,3,1.0986122886681098
after-care,3,1.0986122886681098
haemagglutinating,3,1.0986122886681098
Zymo,3,1.0986122886681098
Central-Eastern,3,1.0986122886681098
post-epilepsy,3,1.0986122886681098
warp,3,1.0986122886681098
virus-free,3,1.0986122886681098
ski,3,1.0986122886681098
actor,3,1.0986122886681098
N-lineage,3,1.0986122886681098
Frontal,3,1.0986122886681098
Pending,3,1.0986122886681098
Citations,3,1.0986122886681098
Text,3,1.0986122886681098
vLAB,3,1.0986122886681098
everyones,3,1.0986122886681098
brochure,3,1.0986122886681098
strain-dependent,3,1.0986122886681098
Glycoprotein,3,1.0986122886681098
kórházi,3,1.0986122886681098
-015,3,1.0986122886681098
decoding,3,1.0986122886681098
cut-score,3,1.0986122886681098
cut-point,3,1.0986122886681098
cut-points,3,1.0986122886681098
NRL-induced,3,1.0986122886681098
FOR,3,1.0986122886681098
facet,3,1.0986122886681098
non-conservative,3,1.0986122886681098
Structures,3,1.0986122886681098
dividends,3,1.0986122886681098
insulin-dependent,3,1.0986122886681098
Russians,3,1.0986122886681098
Ft,3,1.0986122886681098
simian,3,1.0986122886681098
freight,3,1.0986122886681098
YKL-40,3,1.0986122886681098
CLPs,3,1.0986122886681098
Guan,3,1.0986122886681098
co-infecting,3,1.0986122886681098
simplification,3,1.0986122886681098
flipped,3,1.0986122886681098
life-history,3,1.0986122886681098
One-way,3,1.0986122886681098
SEPAR,3,1.0986122886681098
paroxysm,3,1.0986122886681098
insoluble,3,1.0986122886681098
demand-supply,3,1.0986122886681098
centennial,3,1.0986122886681098
sportsman,3,1.0986122886681098
-064,3,1.0986122886681098
Awake,3,1.0986122886681098
endotheliopathy,3,1.0986122886681098
capitalizing,3,1.0986122886681098
Distance,3,1.0986122886681098
writer,3,1.0986122886681098
meta-synthesis,3,1.0986122886681098
FSB,3,1.0986122886681098
MEDLINER,3,1.0986122886681098
overestimates,3,1.0986122886681098
single-city,3,1.0986122886681098
through-and-through,3,1.0986122886681098
25-35,3,1.0986122886681098
chloroquinehydroxychloroquine,3,1.0986122886681098
Epub,3,1.0986122886681098
non-traumatic,3,1.0986122886681098
age-old,3,1.0986122886681098
archaea,3,1.0986122886681098
looms,3,1.0986122886681098
Vertebrobasilar,3,1.0986122886681098
Reteplase,3,1.0986122886681098
ceCMR,3,1.0986122886681098
okozta,3,1.0986122886681098
mls,3,1.0986122886681098
grasped,3,1.0986122886681098
micromol,3,1.0986122886681098
nonionic,3,1.0986122886681098
Post-Infarction,3,1.0986122886681098
druggability,3,1.0986122886681098
Tocilizumab,3,1.0986122886681098
83000,3,1.0986122886681098
non-immunocompromised,3,1.0986122886681098
naso-oropharyngeal,3,1.0986122886681098
virosome,3,1.0986122886681098
ci,3,1.0986122886681098
transcervical,3,1.0986122886681098
SRC-fix,3,1.0986122886681098
FTT,3,1.0986122886681098
GRAd-COV2,3,1.0986122886681098
dampening,3,1.0986122886681098
Jiangxi,3,1.0986122886681098
Astragalus,3,1.0986122886681098
remark,3,1.0986122886681098
tofacitinib,3,1.0986122886681098
-weighted,3,1.0986122886681098
Points•,3,1.0986122886681098
Retrospectively,3,1.0986122886681098
Huzhu,3,1.0986122886681098
epidemiológiai,3,1.0986122886681098
VAMLA,3,1.0986122886681098
WNT,3,1.0986122886681098
aktívfekvőbeteg-szakellátás,3,1.0986122886681098
chitinases,3,1.0986122886681098
alapján,3,1.0986122886681098
polyplexes,3,1.0986122886681098
Feasibility,3,1.0986122886681098
leucopenia,3,1.0986122886681098
204219,3,1.0986122886681098
myocardia,3,1.0986122886681098
-036,3,1.0986122886681098
peer-led,3,1.0986122886681098
Accolate,3,1.0986122886681098
Singulair,3,1.0986122886681098
Onon,3,1.0986122886681098
homogenized,3,1.0986122886681098
champion,3,1.0986122886681098
Kampo,3,1.0986122886681098
ellátási,3,1.0986122886681098
time-independent,3,1.0986122886681098
-024,3,1.0986122886681098
ceases,3,1.0986122886681098
prenecrotic,3,1.0986122886681098
acetic,3,1.0986122886681098
AVietnam120304,3,1.0986122886681098
resistance-associated,3,1.0986122886681098
Hotez,3,1.0986122886681098
Dean,3,1.0986122886681098
books,3,1.0986122886681098
Velocity,3,1.0986122886681098
Discrimination,3,1.0986122886681098
RBD-hFc,3,1.0986122886681098
RSCU-based,3,1.0986122886681098
Shifts,3,1.0986122886681098
ADCD-P,3,1.0986122886681098
Exercising,3,1.0986122886681098
Match,3,1.0986122886681098
Kyiv,3,1.0986122886681098
unmanageable,3,1.0986122886681098
transportations,3,1.0986122886681098
Tflex,3,1.0986122886681098
TiO2,3,1.0986122886681098
CCR5Δ32,3,1.0986122886681098
8-17,3,1.0986122886681098
Deviation,3,1.0986122886681098
DOE,3,1.0986122886681098
trucks,3,1.0986122886681098
acrophase,3,1.0986122886681098
commences,3,1.0986122886681098
financed,3,1.0986122886681098
hedonic,3,1.0986122886681098
Atomic,3,1.0986122886681098
MBW,3,1.0986122886681098
railroad,3,1.0986122886681098
CT6,3,1.0986122886681098
deviating,3,1.0986122886681098
FRET-PCRs,3,1.0986122886681098
self-protective,3,1.0986122886681098
self-antigens,3,1.0986122886681098
Climatic,3,1.0986122886681098
psychotherapies,3,1.0986122886681098
sceptical,3,1.0986122886681098
controversially,3,1.0986122886681098
laboratorial,3,1.0986122886681098
long‑term,3,1.0986122886681098
ionizable,3,1.0986122886681098
0200,3,1.0986122886681098
non-sentinel,3,1.0986122886681098
bioreactors,3,1.0986122886681098
testimony,3,1.0986122886681098
Intramuscular,3,1.0986122886681098
agronomic,3,1.0986122886681098
virus-exposed,3,1.0986122886681098
μPADs,3,1.0986122886681098
phytochemical,3,1.0986122886681098
quills,3,1.0986122886681098
tripled,3,1.0986122886681098
arts,3,1.0986122886681098
Duchennes,3,1.0986122886681098
coincidentally,3,1.0986122886681098
quill,3,1.0986122886681098
PRNs,3,1.0986122886681098
conceptualize,3,1.0986122886681098
Generator,3,1.0986122886681098
Errands,3,1.0986122886681098
CLOCK,3,1.0986122886681098
One-Step,3,1.0986122886681098
Balbc,3,1.0986122886681098
Dniprodzerzhinsk,3,1.0986122886681098
variant-specific,3,1.0986122886681098
glycolytic,3,1.0986122886681098
Defined,3,1.0986122886681098
self-monitored,3,1.0986122886681098
discloses,3,1.0986122886681098
2252,3,1.0986122886681098
intra-individual,3,1.0986122886681098
Orthocoronavirinae,3,1.0986122886681098
nsp14,3,1.0986122886681098
hypodynamic,3,1.0986122886681098
Overview,3,1.0986122886681098
INTERACT,3,1.0986122886681098
20042005,3,1.0986122886681098
mothership,3,1.0986122886681098
12400,3,1.0986122886681098
Spike-RBD,3,1.0986122886681098
CAPRIE,3,1.0986122886681098
Oversight,3,1.0986122886681098
UK-based,3,1.0986122886681098
transapical,3,1.0986122886681098
1227,3,1.0986122886681098
mlminkg,3,1.0986122886681098
18-,3,1.0986122886681098
chagasic,3,1.0986122886681098
91-year-old,3,1.0986122886681098
ILO,3,1.0986122886681098
nontreatment,3,1.0986122886681098
reward,3,1.0986122886681098
ONTARGET,3,1.0986122886681098
multi-territory,3,1.0986122886681098
Pregnancy-associated,3,1.0986122886681098
1091,3,1.0986122886681098
epistemological,3,1.0986122886681098
CT17,3,1.0986122886681098
applicant,3,1.0986122886681098
copiesPCR,3,1.0986122886681098
texting,3,1.0986122886681098
Golden,3,1.0986122886681098
complains,3,1.0986122886681098
ensembles,3,1.0986122886681098
1795,3,1.0986122886681098
prohormone,3,1.0986122886681098
hyperechoic,3,1.0986122886681098
adjuvant-containing,3,1.0986122886681098
on-pump,3,1.0986122886681098
MMCT,3,1.0986122886681098
metamorphosis,3,1.0986122886681098
asthma-inducing,3,1.0986122886681098
1417,3,1.0986122886681098
YHSA,3,1.0986122886681098
impressions,3,1.0986122886681098
forty-seven,3,1.0986122886681098
post-IS,3,1.0986122886681098
I-B,3,1.0986122886681098
2833,3,1.0986122886681098
II-A,3,1.0986122886681098
virus-vaccine,3,1.0986122886681098
colour-naming,3,1.0986122886681098
whole-lesion,3,1.0986122886681098
buy-in,3,1.0986122886681098
post-first,3,1.0986122886681098
Smartphone,3,1.0986122886681098
intercoronary,3,1.0986122886681098
nonembolic,3,1.0986122886681098
destructor,3,1.0986122886681098
premier,3,1.0986122886681098
demoralization,3,1.0986122886681098
score-matched,3,1.0986122886681098
PCI-treated,3,1.0986122886681098
Stroke-prone,3,1.0986122886681098
Gung,3,1.0986122886681098
scholarship,3,1.0986122886681098
X-SCID,3,1.0986122886681098
host-targeting,3,1.0986122886681098
n59,3,1.0986122886681098
speedy,3,1.0986122886681098
tomographically,3,1.0986122886681098
mMoles,3,1.0986122886681098
HPLC,3,1.0986122886681098
IIBIIIA,3,1.0986122886681098
experiential,3,1.0986122886681098
WMAI,3,1.0986122886681098
Drug-resistant,3,1.0986122886681098
Separation,3,1.0986122886681098
hugely,3,1.0986122886681098
elegantly,3,1.0986122886681098
Belfast,3,1.0986122886681098
non-HCWs,3,1.0986122886681098
MMF-treated,3,1.0986122886681098
MIMIC,3,1.0986122886681098
Northwell,3,1.0986122886681098
non-controlled,3,1.0986122886681098
TBIs,3,1.0986122886681098
nonmechanical,3,1.0986122886681098
allergen-,3,1.0986122886681098
N-IgG,3,1.0986122886681098
fasciitis,3,1.0986122886681098
gene-environmental,3,1.0986122886681098
tilade,3,1.0986122886681098
Pronto,3,1.0986122886681098
vertebrae,3,1.0986122886681098
azygos,3,1.0986122886681098
atherothromboembolism,3,1.0986122886681098
σ,3,1.0986122886681098
non-vaccination,3,1.0986122886681098
0v,3,1.0986122886681098
MBCs,3,1.0986122886681098
traversed,3,1.0986122886681098
molded,3,1.0986122886681098
cephalosporins,3,1.0986122886681098
RHR,3,1.0986122886681098
1547,3,1.0986122886681098
sizeABSTRACT,3,1.0986122886681098
subsinuosal,3,1.0986122886681098
sterilized,3,1.0986122886681098
2-vessel,3,1.0986122886681098
weve,3,1.0986122886681098
floods,3,1.0986122886681098
18F-FDG-PET,3,1.0986122886681098
halofuginone,3,1.0986122886681098
mw,3,1.0986122886681098
mitogens,3,1.0986122886681098
trabeculae,3,1.0986122886681098
chelation,3,1.0986122886681098
2207,3,1.0986122886681098
LDR,3,1.0986122886681098
Infarction-2,3,1.0986122886681098
1026,3,1.0986122886681098
self-practice,3,1.0986122886681098
IL-23,3,1.0986122886681098
Baloxavir,3,1.0986122886681098
NSI-566RSC,3,1.0986122886681098
-26,3,1.0986122886681098
dysregulate,3,1.0986122886681098
competences,3,1.0986122886681098
tachykinins,3,1.0986122886681098
pruritus,3,1.0986122886681098
cupsday,3,1.0986122886681098
overloaded,3,1.0986122886681098
18-40,3,1.0986122886681098
bimodality,3,1.0986122886681098
∆C,3,1.0986122886681098
≤4,3,1.0986122886681098
lesion-induced,3,1.0986122886681098
Stern,3,1.0986122886681098
Kcalmol,3,1.0986122886681098
ATexas3691,3,1.0986122886681098
50-80,3,1.0986122886681098
50VC,3,1.0986122886681098
psycho-emotional,3,1.0986122886681098
rs1043994,3,1.0986122886681098
asthenic,3,1.0986122886681098
Mode,3,1.0986122886681098
Ad5SARS-CoV-2-S1,3,1.0986122886681098
agile,3,1.0986122886681098
pigment,3,1.0986122886681098
trVLP,3,1.0986122886681098
Antimyosin,3,1.0986122886681098
repressor,3,1.0986122886681098
long-read,3,1.0986122886681098
RNA-RNA,3,1.0986122886681098
diligently,3,1.0986122886681098
Placental,3,1.0986122886681098
SARS-CoV-2-N,3,1.0986122886681098
1744,3,1.0986122886681098
subgenome,3,1.0986122886681098
1750,3,1.0986122886681098
dysregulates,3,1.0986122886681098
trillion,3,1.0986122886681098
neutrality,3,1.0986122886681098
RBD-62,3,1.0986122886681098
80-100,3,1.0986122886681098
harmonisation,3,1.0986122886681098
pipetting-based,3,1.0986122886681098
Marylands,3,1.0986122886681098
signalment,3,1.0986122886681098
EE-mediated,3,1.0986122886681098
Bavaria,3,1.0986122886681098
programmable,3,1.0986122886681098
PIA,3,1.0986122886681098
n36,3,1.0986122886681098
zebrafish,3,1.0986122886681098
Asthma-like,3,1.0986122886681098
thoracis,3,1.0986122886681098
me,3,1.0986122886681098
Martin,3,1.0986122886681098
reinvestment,3,1.0986122886681098
AQL-5D,3,1.0986122886681098
customization,3,1.0986122886681098
unimaginable,3,1.0986122886681098
host-range,3,1.0986122886681098
parathyroid,3,1.0986122886681098
Rhesus,3,1.0986122886681098
beta-stimulants,3,1.0986122886681098
Mubarak,3,1.0986122886681098
Messages,3,1.0986122886681098
cerebrolysate,3,1.0986122886681098
dueling,3,1.0986122886681098
inefficacy,3,1.0986122886681098
ASMR,3,1.0986122886681098
overprotection,3,1.0986122886681098
1047,3,1.0986122886681098
FluB,3,1.0986122886681098
theranostics,3,1.0986122886681098
inordinately,3,1.0986122886681098
microgday,3,1.0986122886681098
Disabling,3,1.0986122886681098
prourokinase,3,1.0986122886681098
lymph-node,3,1.0986122886681098
ISIAH,3,1.0986122886681098
pushes,3,1.0986122886681098
Pets,3,1.0986122886681098
mummified,3,1.0986122886681098
bold,3,1.0986122886681098
Mext,3,1.0986122886681098
step-care,3,1.0986122886681098
non-monetary,3,1.0986122886681098
ischemias,3,1.0986122886681098
adaptational,3,1.0986122886681098
eGLIA,3,1.0986122886681098
scintigraphies,3,1.0986122886681098
UAml,3,1.0986122886681098
OIT,3,1.0986122886681098
autoblood,3,1.0986122886681098
nondepressed,3,1.0986122886681098
deleteriously,3,1.0986122886681098
V2-V4,3,1.0986122886681098
reexpansion,3,1.0986122886681098
CRISPR-Cas12a-based,3,1.0986122886681098
Pro-inflammatory,3,1.0986122886681098
gender-adjusted,3,1.0986122886681098
copyμL,3,1.0986122886681098
Six-year,3,1.0986122886681098
RT-MCDA,3,1.0986122886681098
ischaemia-induced,3,1.0986122886681098
patient-doctor,3,1.0986122886681098
CRISPR-Cas12aCrRNA,3,1.0986122886681098
ultralow,3,1.0986122886681098
18000,3,1.0986122886681098
variabilities,3,1.0986122886681098
Ad26COV2,3,1.0986122886681098
rfNP,3,1.0986122886681098
Mannitol,3,1.0986122886681098
gum,3,1.0986122886681098
corroboration,3,1.0986122886681098
harboured,3,1.0986122886681098
detoxifying,3,1.0986122886681098
SPEED,3,1.0986122886681098
happy,3,1.0986122886681098
sparking,3,1.0986122886681098
1823,3,1.0986122886681098
healthiness,3,1.0986122886681098
darunavir,3,1.0986122886681098
byproduct,3,1.0986122886681098
0872,3,1.0986122886681098
re-opened,3,1.0986122886681098
snuff,3,1.0986122886681098
boon,3,1.0986122886681098
Homeopathy,3,1.0986122886681098
AIEgens,3,1.0986122886681098
value-based,3,1.0986122886681098
socio-environmental,3,1.0986122886681098
eptifibatide,3,1.0986122886681098
entrapped,3,1.0986122886681098
tuberothalamic,3,1.0986122886681098
4-chamber,3,1.0986122886681098
Fudan,3,1.0986122886681098
SCoV-DP15,3,1.0986122886681098
P0000,3,1.0986122886681098
-41,3,1.0986122886681098
aAbs,3,1.0986122886681098
instructor,3,1.0986122886681098
over-represented,3,1.0986122886681098
immunoregulation,3,1.0986122886681098
Heliox,3,1.0986122886681098
Film,3,1.0986122886681098
infero-apical,3,1.0986122886681098
pgmg,3,1.0986122886681098
infero-apico-septal,3,1.0986122886681098
antero-inferior,3,1.0986122886681098
bleach,3,1.0986122886681098
0480,3,1.0986122886681098
MCAs,3,1.0986122886681098
non-Indigenous,3,1.0986122886681098
Togo,3,1.0986122886681098
AV-S,3,1.0986122886681098
risk-assessment,3,1.0986122886681098
-70°C,3,1.0986122886681098
AFD,3,1.0986122886681098
GIST,3,1.0986122886681098
1540,3,1.0986122886681098
subsegmental,3,1.0986122886681098
baicalensis,3,1.0986122886681098
AV-A,3,1.0986122886681098
Technically,3,1.0986122886681098
commune,3,1.0986122886681098
Pre-pandemic,3,1.0986122886681098
indigenously,3,1.0986122886681098
≥140,3,1.0986122886681098
Call,3,1.0986122886681098
callback,3,1.0986122886681098
engulfed,3,1.0986122886681098
ramus,3,1.0986122886681098
IDRs,3,1.0986122886681098
CXRs,3,1.0986122886681098
polymorphous,3,1.0986122886681098
uncorrelated,3,1.0986122886681098
swine-like,3,1.0986122886681098
SPIKE,3,1.0986122886681098
Nebulized,3,1.0986122886681098
MDIS,3,1.0986122886681098
gametes,3,1.0986122886681098
Furin,3,1.0986122886681098
neovascular,3,1.0986122886681098
AMD,3,1.0986122886681098
AMHS,3,1.0986122886681098
RBD-immunized,3,1.0986122886681098
suppose,3,1.0986122886681098
MarketScan,3,1.0986122886681098
arteryABSTRACT,3,1.0986122886681098
wanting,3,1.0986122886681098
TCMS,3,1.0986122886681098
COL4A1,3,1.0986122886681098
RtR,3,1.0986122886681098
Marfan,3,1.0986122886681098
conditionally,3,1.0986122886681098
park,3,1.0986122886681098
Provincial,3,1.0986122886681098
Ehlers-Danlos,3,1.0986122886681098
SOTR,3,1.0986122886681098
corticoid,3,1.0986122886681098
thyroid-stimulating,3,1.0986122886681098
IMTX,3,1.0986122886681098
sixty-four,3,1.0986122886681098
TiterScape,3,1.0986122886681098
month-6,3,1.0986122886681098
exitus,3,1.0986122886681098
RevMan,3,1.0986122886681098
perilous,3,1.0986122886681098
55Co-PET,3,1.0986122886681098
hBC,3,1.0986122886681098
chronopathological,3,1.0986122886681098
hyperexcitability,3,1.0986122886681098
i2000,3,1.0986122886681098
IVD-labeled,3,1.0986122886681098
celastrol,3,1.0986122886681098
non-demented,3,1.0986122886681098
CLS,3,1.0986122886681098
corticosteroid-sensitive,3,1.0986122886681098
amplifiable,3,1.0986122886681098
Defective,3,1.0986122886681098
locked,3,1.0986122886681098
disulphide,3,1.0986122886681098
NIBRG-14,3,1.0986122886681098
circannual,3,1.0986122886681098
entrances,3,1.0986122886681098
herbals,3,1.0986122886681098
sticker,3,1.0986122886681098
chests,3,1.0986122886681098
Innumerable,3,1.0986122886681098
mid-September,3,1.0986122886681098
aerodigestive,3,1.0986122886681098
STATA,3,1.0986122886681098
amphiphilic,3,1.0986122886681098
single-plane,3,1.0986122886681098
USP,3,1.0986122886681098
lipopeptides,3,1.0986122886681098
000005,3,1.0986122886681098
objectify,3,1.0986122886681098
underutilised,3,1.0986122886681098
nNOS,3,1.0986122886681098
structure-guided,3,1.0986122886681098
withstand,3,1.0986122886681098
4G,3,1.0986122886681098
1966-7,3,1.0986122886681098
lever,3,1.0986122886681098
1981-2,3,1.0986122886681098
Hippocampal,3,1.0986122886681098
ipsi-lesional,3,1.0986122886681098
Walter,3,1.0986122886681098
contra-lesional,3,1.0986122886681098
20182019,3,1.0986122886681098
subtrees,3,1.0986122886681098
Subfields,3,1.0986122886681098
Polymorphonuclear,3,1.0986122886681098
free-running,3,1.0986122886681098
Carnosine,3,1.0986122886681098
endograft,3,1.0986122886681098
confining,3,1.0986122886681098
10-point,3,1.0986122886681098
unappreciated,3,1.0986122886681098
UIV,3,1.0986122886681098
UIVs,3,1.0986122886681098
WU,3,1.0986122886681098
trans-species,3,1.0986122886681098
4221,3,1.0986122886681098
1189,3,1.0986122886681098
EEm,3,1.0986122886681098
Bcg,3,1.0986122886681098
MBq,3,1.0986122886681098
Mucoid,3,1.0986122886681098
41-year,3,1.0986122886681098
IL-4R,3,1.0986122886681098
stabilising,3,1.0986122886681098
Maputo,3,1.0986122886681098
peroxiredoxin,3,1.0986122886681098
2116,3,1.0986122886681098
incursions,3,1.0986122886681098
rested,3,1.0986122886681098
precipitous,3,1.0986122886681098
glucose-loaded,3,1.0986122886681098
denying,3,1.0986122886681098
nasal-swab,3,1.0986122886681098
SC18,3,1.0986122886681098
tissue-based,3,1.0986122886681098
anti-TNF,3,1.0986122886681098
SETTING,3,1.0986122886681098
CRPs,3,1.0986122886681098
CNPs,3,1.0986122886681098
inefficiently,3,1.0986122886681098
Post-Acute,3,1.0986122886681098
flaps,3,1.0986122886681098
HA-glycan,3,1.0986122886681098
tubules,3,1.0986122886681098
supply-chain,3,1.0986122886681098
technic,3,1.0986122886681098
≤30s,3,1.0986122886681098
G614-bearing,3,1.0986122886681098
HBC,3,1.0986122886681098
sICAM-1,3,1.0986122886681098
EGF-induced,3,1.0986122886681098
anastomosed,3,1.0986122886681098
Set-4,3,1.0986122886681098
Set-10,3,1.0986122886681098
Set-11,3,1.0986122886681098
1641,3,1.0986122886681098
Set-13,3,1.0986122886681098
WCST,3,1.0986122886681098
hides,3,1.0986122886681098
Set-17,3,1.0986122886681098
multi-trigger,3,1.0986122886681098
Weibull,3,1.0986122886681098
Set-14,3,1.0986122886681098
Offering,3,1.0986122886681098
prodromi,3,1.0986122886681098
SDF-1α,3,1.0986122886681098
fluorodeoxyglucose,3,1.0986122886681098
Lupus,3,1.0986122886681098
neuroadrenergic,3,1.0986122886681098
1-odds,3,1.0986122886681098
MRCG,3,1.0986122886681098
25HC,3,1.0986122886681098
Investigative,3,1.0986122886681098
conduction-heterogeneity,3,1.0986122886681098
LVEDD,3,1.0986122886681098
iPS,3,1.0986122886681098
GPx,3,1.0986122886681098
presidential,3,1.0986122886681098
p＜005,3,1.0986122886681098
CCL5,3,1.0986122886681098
Closing,3,1.0986122886681098
renin-angiotensin-system,3,1.0986122886681098
teleconferences,3,1.0986122886681098
arouse,3,1.0986122886681098
immuno-assays,3,1.0986122886681098
posterobasal,3,1.0986122886681098
1451,3,1.0986122886681098
plaque-purified,3,1.0986122886681098
cumulate,3,1.0986122886681098
3-16,3,1.0986122886681098
LAMS,3,1.0986122886681098
ajmaline,3,1.0986122886681098
ethyl,3,1.0986122886681098
IGFBP1,3,1.0986122886681098
inviting,3,1.0986122886681098
high-resource,3,1.0986122886681098
pests,3,1.0986122886681098
Piacenza,3,1.0986122886681098
PsychInfo,3,1.0986122886681098
yak,3,1.0986122886681098
mid-20th,3,1.0986122886681098
PanBio,3,1.0986122886681098
enthusiastically,3,1.0986122886681098
nonlesioned,3,1.0986122886681098
month-old,3,1.0986122886681098
IMCI,3,1.0986122886681098
stroke-based,3,1.0986122886681098
coroners,3,1.0986122886681098
Complicated,3,1.0986122886681098
categorically,3,1.0986122886681098
alarmin,3,1.0986122886681098
NEST,3,1.0986122886681098
oversees,3,1.0986122886681098
75-84,3,1.0986122886681098
ST-asymmetry,3,1.0986122886681098
Faroe,3,1.0986122886681098
D-Dimer,3,1.0986122886681098
TSCM,3,1.0986122886681098
Biomolecular,3,1.0986122886681098
platelet-to-lymphocyte,3,1.0986122886681098
VIM,3,1.0986122886681098
debating,3,1.0986122886681098
RT‑qPCR,3,1.0986122886681098
unvalidated,3,1.0986122886681098
upscale,3,1.0986122886681098
cellularmolecular,3,1.0986122886681098
3302,3,1.0986122886681098
AECOPD,3,1.0986122886681098
STA-MCA,3,1.0986122886681098
Bharat,3,1.0986122886681098
Hgmm,3,1.0986122886681098
levelled,3,1.0986122886681098
Catastrophic,3,1.0986122886681098
13-18,3,1.0986122886681098
helices,3,1.0986122886681098
hyperlucency,3,1.0986122886681098
standardise,3,1.0986122886681098
displace,3,1.0986122886681098
Software,3,1.0986122886681098
1723,3,1.0986122886681098
protrudes,3,1.0986122886681098
cross-reactivities,3,1.0986122886681098
proangiogenic,3,1.0986122886681098
Shandong,3,1.0986122886681098
iPSCs,3,1.0986122886681098
bona,3,1.0986122886681098
gt180,3,1.0986122886681098
T-SFWZIC,3,1.0986122886681098
Signal-averaged,3,1.0986122886681098
antiproliferative,3,1.0986122886681098
AMIABSTRACT,3,1.0986122886681098
fide,3,1.0986122886681098
or13,3,1.0986122886681098
nonperfused,3,1.0986122886681098
Westernization,3,1.0986122886681098
lower-risk,3,1.0986122886681098
tht,3,1.0986122886681098
partisanship,3,1.0986122886681098
PTCP,3,1.0986122886681098
Nerve,3,1.0986122886681098
young-adult,3,1.0986122886681098
45-54,3,1.0986122886681098
Listening,3,1.0986122886681098
Mollet,3,1.0986122886681098
mSv,3,1.0986122886681098
Hamadan,3,1.0986122886681098
15-min,3,1.0986122886681098
polytherapy,3,1.0986122886681098
multi-society,3,1.0986122886681098
UCD,3,1.0986122886681098
rS1,3,1.0986122886681098
whale,3,1.0986122886681098
HypR,3,1.0986122886681098
swarm,3,1.0986122886681098
-54,3,1.0986122886681098
2256,3,1.0986122886681098
TMBIM6,3,1.0986122886681098
S4,3,1.0986122886681098
APF,3,1.0986122886681098
extramedullary,3,1.0986122886681098
VET,3,1.0986122886681098
facility-based,3,1.0986122886681098
phenotype-based,3,1.0986122886681098
maple,3,1.0986122886681098
extrathoracic,3,1.0986122886681098
IMV,3,1.0986122886681098
dormant,3,1.0986122886681098
exacerbator,3,1.0986122886681098
rS-RBD-mFc,3,1.0986122886681098
lending,3,1.0986122886681098
non-lethal,3,1.0986122886681098
Psychotherapy,3,1.0986122886681098
neutrophil-derived,3,1.0986122886681098
SIM,3,1.0986122886681098
rig,3,1.0986122886681098
LAP,3,1.0986122886681098
bilayers,3,1.0986122886681098
Incidences,3,1.0986122886681098
lipopolysaccharide,3,1.0986122886681098
Prenatal,3,1.0986122886681098
Disinfection,3,1.0986122886681098
bullae,3,1.0986122886681098
PPARγ,3,1.0986122886681098
LLCMK2,3,1.0986122886681098
Pathogenetic,3,1.0986122886681098
GLM,3,1.0986122886681098
cultivation,3,1.0986122886681098
SEAS,3,1.0986122886681098
99-m,3,1.0986122886681098
40-49,3,1.0986122886681098
immunocapture,3,1.0986122886681098
methoxyisobutyl,3,1.0986122886681098
1423,3,1.0986122886681098
Was,3,1.0986122886681098
French-speaking,3,1.0986122886681098
annoying,3,1.0986122886681098
non-HIV,3,1.0986122886681098
pulmonogenic,3,1.0986122886681098
AH7N2,3,1.0986122886681098
Orthotopic,3,1.0986122886681098
isokinetic,3,1.0986122886681098
summarization,3,1.0986122886681098
transcribe,3,1.0986122886681098
densitometry,3,1.0986122886681098
IgE-,3,1.0986122886681098
culture-independent,3,1.0986122886681098
Facility-wide,3,1.0986122886681098
topologies,3,1.0986122886681098
ILRs,3,1.0986122886681098
clinical-infarct,3,1.0986122886681098
multi-site,3,1.0986122886681098
intubations,3,1.0986122886681098
Tigsun,3,1.0986122886681098
survives,3,1.0986122886681098
HLA-DR,3,1.0986122886681098
FDA-EUA,3,1.0986122886681098
brachii,3,1.0986122886681098
Captopril,3,1.0986122886681098
iChroma,3,1.0986122886681098
GPA,3,1.0986122886681098
Volumetric,3,1.0986122886681098
Haryana,3,1.0986122886681098
gadolinium-enhanced,3,1.0986122886681098
rheumatological,3,1.0986122886681098
1977-1982,3,1.0986122886681098
Baidu,3,1.0986122886681098
DMARDs,3,1.0986122886681098
H7N9-related,3,1.0986122886681098
Back,3,1.0986122886681098
Anxious,3,1.0986122886681098
Paediatricians,3,1.0986122886681098
Th2Th1,3,1.0986122886681098
postsymptom,3,1.0986122886681098
2-sympathomimetics,3,1.0986122886681098
Lille,3,1.0986122886681098
X-31,3,1.0986122886681098
centrifuge,3,1.0986122886681098
TEM,3,1.0986122886681098
seroincidence,3,1.0986122886681098
contraindicate,3,1.0986122886681098
PICUs,3,1.0986122886681098
Governmental,3,1.0986122886681098
upheaval,3,1.0986122886681098
behaviour-incidence,3,1.0986122886681098
SGM,3,1.0986122886681098
cestode,3,1.0986122886681098
kinesitherapy,3,1.0986122886681098
intersex,3,1.0986122886681098
non-SARI,3,1.0986122886681098
biovolume,3,1.0986122886681098
cisgender,3,1.0986122886681098
transgender,3,1.0986122886681098
Molecules,3,1.0986122886681098
Michel,3,1.0986122886681098
rs1800872,3,1.0986122886681098
bursitis,3,1.0986122886681098
ACE2-NPs,3,1.0986122886681098
rs1800871,3,1.0986122886681098
Homo,3,1.0986122886681098
detract,3,1.0986122886681098
1891,3,1.0986122886681098
Culture,3,1.0986122886681098
severest,3,1.0986122886681098
PNA,3,1.0986122886681098
rimantadine-resistant,3,1.0986122886681098
roadblocks,3,1.0986122886681098
CD200R,3,1.0986122886681098
ayurvedic,3,1.0986122886681098
Deficits,3,1.0986122886681098
BVS,3,1.0986122886681098
noncoronary,3,1.0986122886681098
IGF-I,3,1.0986122886681098
FWER,3,1.0986122886681098
atheroembolic,3,1.0986122886681098
game-changing,3,1.0986122886681098
social-contextual,3,1.0986122886681098
1541,3,1.0986122886681098
aTIV,3,1.0986122886681098
PANGOLIN,3,1.0986122886681098
transcription-loop-mediated,3,1.0986122886681098
1251,3,1.0986122886681098
Aotearoa,3,1.0986122886681098
intellect,3,1.0986122886681098
0058,3,1.0986122886681098
k-nearest,3,1.0986122886681098
LUNAR-COV19,3,1.0986122886681098
00036,3,1.0986122886681098
allay,3,1.0986122886681098
3I,3,1.0986122886681098
Monroe,3,1.0986122886681098
Dates,3,1.0986122886681098
CGKD,3,1.0986122886681098
classics,3,1.0986122886681098
EIPA,3,1.0986122886681098
rMTT,3,1.0986122886681098
canvas,3,1.0986122886681098
psi,3,1.0986122886681098
APIC,3,1.0986122886681098
rhetorical,3,1.0986122886681098
well-recognised,3,1.0986122886681098
2800,3,1.0986122886681098
mass-univariate,3,1.0986122886681098
sylvian,3,1.0986122886681098
reiterates,3,1.0986122886681098
betweenness,3,1.0986122886681098
OPA,3,1.0986122886681098
2021Results,3,1.0986122886681098
cepheid®,3,1.0986122886681098
tabulate,3,1.0986122886681098
MIQ,3,1.0986122886681098
polymerase-chain,3,1.0986122886681098
sonolysis,3,1.0986122886681098
р005,3,1.0986122886681098
asthma-management,3,1.0986122886681098
theta,3,1.0986122886681098
1918-type,3,1.0986122886681098
nanovaccines,3,1.0986122886681098
STATs,3,1.0986122886681098
Dox-,3,1.0986122886681098
STAR,3,1.0986122886681098
Fully,3,1.0986122886681098
under-fives,3,1.0986122886681098
PMX-DHP,3,1.0986122886681098
validly,3,1.0986122886681098
SCs,3,1.0986122886681098
end-user,3,1.0986122886681098
Patient-centered,3,1.0986122886681098
time-to-event,3,1.0986122886681098
brain-behavior,3,1.0986122886681098
Propensity,3,1.0986122886681098
Problemcondition,3,1.0986122886681098
discernable,3,1.0986122886681098
ERK,3,1.0986122886681098
sMAC,3,1.0986122886681098
trauma-induced,3,1.0986122886681098
palm,3,1.0986122886681098
Controller,3,1.0986122886681098
14-month-old,3,1.0986122886681098
constrictions,3,1.0986122886681098
msmmHg,3,1.0986122886681098
intergroup,3,1.0986122886681098
underprivileged,3,1.0986122886681098
FEV1height2,3,1.0986122886681098
school-located,3,1.0986122886681098
Mitogen-activated,3,1.0986122886681098
non-PHOFS,3,1.0986122886681098
antifibrotics,3,1.0986122886681098
WMG,3,1.0986122886681098
PHOFS,3,1.0986122886681098
2·20,3,1.0986122886681098
postganglionic,3,1.0986122886681098
AMISTAD,3,1.0986122886681098
dual-antigen,3,1.0986122886681098
blebs,3,1.0986122886681098
s-IGF-I,3,1.0986122886681098
N-ETSD,3,1.0986122886681098
S-Fusion,3,1.0986122886681098
endemically,3,1.0986122886681098
post-receptor,3,1.0986122886681098
91-100,3,1.0986122886681098
mnemonic,3,1.0986122886681098
pericardiectomy,3,1.0986122886681098
Polynesia,3,1.0986122886681098
forever,3,1.0986122886681098
Pharmacies,3,1.0986122886681098
LDG,3,1.0986122886681098
nonfunctional,3,1.0986122886681098
HITT,3,1.0986122886681098
over-diagnose,3,1.0986122886681098
deathABSTRACT,3,1.0986122886681098
antiseptic,3,1.0986122886681098
teboroxime,3,1.0986122886681098
PCOM,3,1.0986122886681098
quinine,3,1.0986122886681098
postcoronary,3,1.0986122886681098
lengthened,3,1.0986122886681098
Ignacio,3,1.0986122886681098
over-representation,3,1.0986122886681098
rhetorics,3,1.0986122886681098
1401,3,1.0986122886681098
MW,3,1.0986122886681098
tetracycline,3,1.0986122886681098
nonhospital,3,1.0986122886681098
congregation,3,1.0986122886681098
extra-fine,3,1.0986122886681098
Quito,3,1.0986122886681098
Chávez,3,1.0986122886681098
community-residing,3,1.0986122886681098
Antiinflammatory,3,1.0986122886681098
re-open,3,1.0986122886681098
25-year,3,1.0986122886681098
Normalized-Uncertainty,3,1.0986122886681098
cost-,3,1.0986122886681098
orosomucoid,3,1.0986122886681098
gyri,3,1.0986122886681098
RdRpHel,3,1.0986122886681098
vaccine-advocacy,3,1.0986122886681098
Hemodynamically,3,1.0986122886681098
GABA,3,1.0986122886681098
DisGeNET,3,1.0986122886681098
elasticum,3,1.0986122886681098
anti-apoptosis,3,1.0986122886681098
QaHKG197,3,1.0986122886681098
pre-established,3,1.0986122886681098
sECP,3,1.0986122886681098
inevitability,3,1.0986122886681098
s-Mg2,3,1.0986122886681098
ABCC6,3,1.0986122886681098
pre-revascularization,3,1.0986122886681098
30-fold,3,1.0986122886681098
preventively,3,1.0986122886681098
Natriuretic,3,1.0986122886681098
cGAS-independent,3,1.0986122886681098
IgG3,3,1.0986122886681098
ACE-I,3,1.0986122886681098
salvianolic,3,1.0986122886681098
ligand-based,3,1.0986122886681098
Quality-of-life,3,1.0986122886681098
AHW,3,1.0986122886681098
ALMS1,3,1.0986122886681098
multi-modal,3,1.0986122886681098
North-East,3,1.0986122886681098
non-T2,3,1.0986122886681098
ASQ,3,1.0986122886681098
arteriole,3,1.0986122886681098
infantis,3,1.0986122886681098
alpaca,3,1.0986122886681098
Copan,3,1.0986122886681098
medium-size,3,1.0986122886681098
DPOS,3,1.0986122886681098
transmission-blocking,3,1.0986122886681098
cupric,3,1.0986122886681098
overdrive,3,1.0986122886681098
mm-3,3,1.0986122886681098
HFCWO,3,1.0986122886681098
Hefei,3,1.0986122886681098
ANPS,3,1.0986122886681098
TMGW,3,1.0986122886681098
jungle,3,1.0986122886681098
Affective,3,1.0986122886681098
anti-interleukin,3,1.0986122886681098
Co-expression,3,1.0986122886681098
NOLC1,3,1.0986122886681098
septomarginal,3,1.0986122886681098
Calabria,3,1.0986122886681098
2222,3,1.0986122886681098
refrained,3,1.0986122886681098
Transluminal,3,1.0986122886681098
health-protective,3,1.0986122886681098
1919-1920,3,1.0986122886681098
DNA-modifying,3,1.0986122886681098
18-31,3,1.0986122886681098
webpage,3,1.0986122886681098
pre-decontamination,3,1.0986122886681098
Rosen,3,1.0986122886681098
hollow,3,1.0986122886681098
endonasal,3,1.0986122886681098
coagulability,3,1.0986122886681098
neurocardiogenic,3,1.0986122886681098
nose-lung,3,1.0986122886681098
IN-HD,3,1.0986122886681098
nonuremic,3,1.0986122886681098
dishes,3,1.0986122886681098
Aviv,3,1.0986122886681098
2729,3,1.0986122886681098
utterances,3,1.0986122886681098
mengovirus,3,1.0986122886681098
anti-COVID,3,1.0986122886681098
noninvasiveness,3,1.0986122886681098
Spirituality,3,1.0986122886681098
abovementioned,3,1.0986122886681098
AUSSR9077,3,1.0986122886681098
iAVS,3,1.0986122886681098
adjunctively,3,1.0986122886681098
neuromotor,3,1.0986122886681098
EPD,3,1.0986122886681098
1796,3,1.0986122886681098
LPC,3,1.0986122886681098
biopolymers,3,1.0986122886681098
tendineae,3,1.0986122886681098
1661,3,1.0986122886681098
airwall,3,1.0986122886681098
CSF3R,3,1.0986122886681098
KOLs,3,1.0986122886681098
CCR10,3,1.0986122886681098
CCR1,3,1.0986122886681098
Japans,3,1.0986122886681098
RAC1,3,1.0986122886681098
rKa,3,1.0986122886681098
GSE34198,3,1.0986122886681098
MRC5ACE2,3,1.0986122886681098
half-saturation,3,1.0986122886681098
5-projection,3,1.0986122886681098
resource-efficient,3,1.0986122886681098
adrenocorticosteroids,3,1.0986122886681098
AF-associated,3,1.0986122886681098
transduced,3,1.0986122886681098
humerus,3,1.0986122886681098
unapproved,3,1.0986122886681098
traction,3,1.0986122886681098
RESPECT,3,1.0986122886681098
Coupling,3,1.0986122886681098
Overcrowding,3,1.0986122886681098
1701,3,1.0986122886681098
propofol,3,1.0986122886681098
ruxolitinib,3,1.0986122886681098
game-changer,3,1.0986122886681098
SATORI,3,1.0986122886681098
CRISPR-Cas13-based,3,1.0986122886681098
2182,3,1.0986122886681098
MPZs,3,1.0986122886681098
Folic,3,1.0986122886681098
CCL-81,3,1.0986122886681098
Apparent,3,1.0986122886681098
TOP,3,1.0986122886681098
CSNAT,3,1.0986122886681098
dubious,3,1.0986122886681098
hyper-immune,3,1.0986122886681098
OSDH,3,1.0986122886681098
13-fold,3,1.0986122886681098
Epidemiologically,3,1.0986122886681098
microgramsliter,3,1.0986122886681098
microarray-based,3,1.0986122886681098
Supported,3,1.0986122886681098
PHL,3,1.0986122886681098
FLU-v-specific,3,1.0986122886681098
otolaryngologist,3,1.0986122886681098
-77,3,1.0986122886681098
1982-83,3,1.0986122886681098
protein-coupled,3,1.0986122886681098
mono,3,1.0986122886681098
IIA,3,1.0986122886681098
SENTINEL,3,1.0986122886681098
IGR,3,1.0986122886681098
corticosteroidslong-acting,3,1.0986122886681098
non-lesioned,3,1.0986122886681098
pdm,3,1.0986122886681098
following1,3,1.0986122886681098
miltiorrhiza,3,1.0986122886681098
CU,3,1.0986122886681098
oxidantantioxidant,3,1.0986122886681098
Crl,3,1.0986122886681098
LifeGene,3,1.0986122886681098
posterior-wall,3,1.0986122886681098
P0038,3,1.0986122886681098
TMM,3,1.0986122886681098
Transitional,3,1.0986122886681098
mum,3,1.0986122886681098
SSRI,3,1.0986122886681098
Urinothorax,3,1.0986122886681098
non-necrotic,3,1.0986122886681098
urinothorax,3,1.0986122886681098
mT,3,1.0986122886681098
smelltaste,3,1.0986122886681098
infection-blocking,3,1.0986122886681098
troponin-only-positive,3,1.0986122886681098
nonparticipants,3,1.0986122886681098
Relatives,3,1.0986122886681098
subsectors,3,1.0986122886681098
Proportion,3,1.0986122886681098
IgMA,3,1.0986122886681098
1715,3,1.0986122886681098
Kr,3,1.0986122886681098
transactions,3,1.0986122886681098
Reconstruction,3,1.0986122886681098
Inoculation,3,1.0986122886681098
re-hospitalized,3,1.0986122886681098
skin-test,3,1.0986122886681098
empagliflozin,3,1.0986122886681098
1247,3,1.0986122886681098
MINC,3,1.0986122886681098
patching,3,1.0986122886681098
primacy,3,1.0986122886681098
HA-targeted,3,1.0986122886681098
VBIS,3,1.0986122886681098
symptom-reporting,3,1.0986122886681098
Self-concept,3,1.0986122886681098
Tier,3,1.0986122886681098
non-immigrant,3,1.0986122886681098
Grades,3,1.0986122886681098
Fogarty,3,1.0986122886681098
bGGO,3,1.0986122886681098
1328,3,1.0986122886681098
depressor,3,1.0986122886681098
tapped,3,1.0986122886681098
Hamburg,3,1.0986122886681098
microembolisation,3,1.0986122886681098
BIOSIS,3,1.0986122886681098
Dyspnoea,3,1.0986122886681098
well-characterised,3,1.0986122886681098
ELI,3,1.0986122886681098
non-destructive,3,1.0986122886681098
Orient,3,1.0986122886681098
multi-objective,3,1.0986122886681098
COPD-only,3,1.0986122886681098
nitrous,3,1.0986122886681098
R-FSRS,3,1.0986122886681098
substrate-binding,3,1.0986122886681098
Pereire,3,1.0986122886681098
Minas,3,1.0986122886681098
Gerais,3,1.0986122886681098
assay-based,3,1.0986122886681098
DECREASE,3,1.0986122886681098
1294,3,1.0986122886681098
flu-vaccination,3,1.0986122886681098
CSWS,3,1.0986122886681098
Cor,3,1.0986122886681098
EDACP,3,1.0986122886681098
Sagrat,3,1.0986122886681098
fatalism,3,1.0986122886681098
smooth-muscle,3,1.0986122886681098
carboxypeptidase,3,1.0986122886681098
Export,3,1.0986122886681098
Akita,3,1.0986122886681098
strophanthin,3,1.0986122886681098
CRISPR-Cas12,3,1.0986122886681098
ESKD,3,1.0986122886681098
LINH,3,1.0986122886681098
pre-PDT,3,1.0986122886681098
ESSENCE,3,1.0986122886681098
within-pair,3,1.0986122886681098
Citation,3,1.0986122886681098
ovariectomy,3,1.0986122886681098
Self,3,1.0986122886681098
Handicap,3,1.0986122886681098
untyped,3,1.0986122886681098
NITAGs,3,1.0986122886681098
QSR,3,1.0986122886681098
northwest,3,1.0986122886681098
smilies,3,1.0986122886681098
REVIVAL-2,3,1.0986122886681098
tropicity,3,1.0986122886681098
masqueraders,3,1.0986122886681098
222GN,3,1.0986122886681098
Operating,3,1.0986122886681098
embark,3,1.0986122886681098
Ticlopidine,3,1.0986122886681098
video-oculography,3,1.0986122886681098
gl-1,3,1.0986122886681098
Catherine,3,1.0986122886681098
T200A,3,1.0986122886681098
immortal,3,1.0986122886681098
Line,3,1.0986122886681098
Infective,3,1.0986122886681098
after-load,3,1.0986122886681098
caudodorsal,3,1.0986122886681098
16-,3,1.0986122886681098
Engraftment,3,1.0986122886681098
pleuritic,3,1.0986122886681098
1485,3,1.0986122886681098
T2-MAP,3,1.0986122886681098
under-reported,3,1.0986122886681098
unimodally,3,1.0986122886681098
spirography,3,1.0986122886681098
preceeding,3,1.0986122886681098
alpha-galactosidase,3,1.0986122886681098
Officers,3,1.0986122886681098
high-end,3,1.0986122886681098
Federally,3,1.0986122886681098
T1-mapping,3,1.0986122886681098
VAT-LA,3,1.0986122886681098
33-36,3,1.0986122886681098
2010-2019,3,1.0986122886681098
1980-1984,3,1.0986122886681098
inconstant,3,1.0986122886681098
chemotherapeutics,3,1.0986122886681098
Superior,3,1.0986122886681098
Cantabria,3,1.0986122886681098
1H-NMR,3,1.0986122886681098
NAM,3,1.0986122886681098
customizable,3,1.0986122886681098
supplier,3,1.0986122886681098
Psoriasis,3,1.0986122886681098
talent,3,1.0986122886681098
NSI,3,1.0986122886681098
Ophthalmologists,3,1.0986122886681098
promulgated,3,1.0986122886681098
piezoelectric,3,1.0986122886681098
fifty-six,3,1.0986122886681098
Invest,3,1.0986122886681098
Purulent,3,1.0986122886681098
FRISC,3,1.0986122886681098
Glycyrrhizae,3,1.0986122886681098
EDL,3,1.0986122886681098
Echocardiogram,3,1.0986122886681098
Gargle,3,1.0986122886681098
Density,3,1.0986122886681098
unbalance,3,1.0986122886681098
handwriting,3,1.0986122886681098
Idiopathic,3,1.0986122886681098
≤55,3,1.0986122886681098
under-use,3,1.0986122886681098
Non-atopic,3,1.0986122886681098
α-smooth,3,1.0986122886681098
CuZn,3,1.0986122886681098
Sundays,3,1.0986122886681098
Lipoprotein,3,1.0986122886681098
corticosteroid-treated,3,1.0986122886681098
Corpus,3,1.0986122886681098
Kendall,3,1.0986122886681098
Atherothrombosis,3,1.0986122886681098
Aug,3,1.0986122886681098
polyADP-ribose,3,1.0986122886681098
PSs,3,1.0986122886681098
one-on-one,3,1.0986122886681098
Exploiting,3,1.0986122886681098
Handling,3,1.0986122886681098
IFI,3,1.0986122886681098
Sport,3,1.0986122886681098
sport-specific,3,1.0986122886681098
quenching,3,1.0986122886681098
mefenamic,3,1.0986122886681098
slum,3,1.0986122886681098
16-segment,3,1.0986122886681098
hHIT,3,1.0986122886681098
ventricule,3,1.0986122886681098
unborn,3,1.0986122886681098
Cohen,3,1.0986122886681098
r-LVR,3,1.0986122886681098
arrange,3,1.0986122886681098
TRPM2,3,1.0986122886681098
poly-YE,3,1.0986122886681098
reactivate,3,1.0986122886681098
RBCT,3,1.0986122886681098
supplanted,3,1.0986122886681098
1902,3,1.0986122886681098
hadnt,3,1.0986122886681098
dysautonomia,3,1.0986122886681098
brilliant,3,1.0986122886681098
embracing,3,1.0986122886681098
Fleet,3,1.0986122886681098
thefts,3,1.0986122886681098
immune-competent,3,1.0986122886681098
Transcriptomic,3,1.0986122886681098
Countermeasures,3,1.0986122886681098
syndrome-like,3,1.0986122886681098
45-minute,3,1.0986122886681098
Police,3,1.0986122886681098
uroperitoneum,3,1.0986122886681098
PARG,3,1.0986122886681098
minithoracotomy,3,1.0986122886681098
45min,3,1.0986122886681098
Meningococcal,3,1.0986122886681098
byproducts,3,1.0986122886681098
hemichorea-hemiballism,3,1.0986122886681098
miRNA-based,3,1.0986122886681098
OSD,3,1.0986122886681098
Isolations,3,1.0986122886681098
β₂,3,1.0986122886681098
HRV-induced,3,1.0986122886681098
enhancers,3,1.0986122886681098
antiapoptotic,3,1.0986122886681098
Well-established,3,1.0986122886681098
infection-,3,1.0986122886681098
Shiga,3,1.0986122886681098
Censuses,3,1.0986122886681098
trans-complementation,3,1.0986122886681098
heaves-affected,3,1.0986122886681098
-030,3,1.0986122886681098
macrodomain,3,1.0986122886681098
glucocorticoid-resistant,3,1.0986122886681098
polymerase-1,3,1.0986122886681098
Wallstent,3,1.0986122886681098
9988,3,1.0986122886681098
testify,3,1.0986122886681098
ICHs,3,1.0986122886681098
run-out,3,1.0986122886681098
-agonists,3,1.0986122886681098
-042,3,1.0986122886681098
NGS-based,3,1.0986122886681098
HUMIR,3,1.0986122886681098
subregions,3,1.0986122886681098
Immunizations,3,1.0986122886681098
Cathepsin,3,1.0986122886681098
Describing,3,1.0986122886681098
macroangiopathy,3,1.0986122886681098
AstraZenecaOxford,3,1.0986122886681098
Univariable,3,1.0986122886681098
cycle-based,3,1.0986122886681098
benefit-cost,3,1.0986122886681098
cautions,3,1.0986122886681098
leucoencephalopathy,3,1.0986122886681098
Toshiba,3,1.0986122886681098
costbenefit,3,1.0986122886681098
VeroE6,3,1.0986122886681098
protein-mediated,3,1.0986122886681098
vendor,3,1.0986122886681098
DawNO,3,1.0986122886681098
all-inclusive,3,1.0986122886681098
coexpression,3,1.0986122886681098
DOI,3,1.0986122886681098
procordial,3,1.0986122886681098
reexpression,3,1.0986122886681098
compensations,3,1.0986122886681098
Cross-reactive,3,1.0986122886681098
postresuscitation,3,1.0986122886681098
non-commercial,3,1.0986122886681098
openly,3,1.0986122886681098
Mathematically,3,1.0986122886681098
spotter,3,1.0986122886681098
1094,3,1.0986122886681098
LODs,3,1.0986122886681098
≤20,3,1.0986122886681098
ACST,3,1.0986122886681098
AKS,3,1.0986122886681098
steam,3,1.0986122886681098
VAI,3,1.0986122886681098
IL-32,3,1.0986122886681098
atomic-level,3,1.0986122886681098
non-stationary,3,1.0986122886681098
Alsace,3,1.0986122886681098
upper-,3,1.0986122886681098
alum-adjuvanted,3,1.0986122886681098
transversely,3,1.0986122886681098
0800,3,1.0986122886681098
cytoflavin,3,1.0986122886681098
spirometrically,3,1.0986122886681098
calorimetry,3,1.0986122886681098
7415,3,1.0986122886681098
3498,3,1.0986122886681098
all-causes,3,1.0986122886681098
recalculated,3,1.0986122886681098
portrays,3,1.0986122886681098
matured,3,1.0986122886681098
PPEs,3,1.0986122886681098
Thresholds,3,1.0986122886681098
leukocidin,3,1.0986122886681098
landscaping,3,1.0986122886681098
oligemia,3,1.0986122886681098
Lombardia,3,1.0986122886681098
MinION,3,1.0986122886681098
Covert,3,1.0986122886681098
cups,3,1.0986122886681098
Methylation,3,1.0986122886681098
MS023,3,1.0986122886681098
point-of-use,3,1.0986122886681098
PRMT,3,1.0986122886681098
subnet,3,1.0986122886681098
Cochran,3,1.0986122886681098
mLs,3,1.0986122886681098
to-date,3,1.0986122886681098
cannulations,3,1.0986122886681098
WR-SiO2,3,1.0986122886681098
R95,3,1.0986122886681098
-175,3,1.0986122886681098
ashfall,3,1.0986122886681098
rear,3,1.0986122886681098
stickers,3,1.0986122886681098
contradicting,3,1.0986122886681098
Informal,3,1.0986122886681098
Dresden,3,1.0986122886681098
MITI,3,1.0986122886681098
underdevelopment,3,1.0986122886681098
craniocerebral,3,1.0986122886681098
Berardinelli-Seip,3,1.0986122886681098
lipodystrophy,3,1.0986122886681098
two-period,3,1.0986122886681098
Stephen,3,1.0986122886681098
streets,3,1.0986122886681098
fibrin-rich,3,1.0986122886681098
metabolized,3,1.0986122886681098
Giulia,3,1.0986122886681098
pneumonia-related,3,1.0986122886681098
spiramycin,3,1.0986122886681098
Ophiopogonis,3,1.0986122886681098
below-knee,3,1.0986122886681098
impingement,3,1.0986122886681098
Tracheal,3,1.0986122886681098
well-researched,3,1.0986122886681098
VIDISCA-454,3,1.0986122886681098
time-frame,3,1.0986122886681098
nonfluent,3,1.0986122886681098
fluent,3,1.0986122886681098
agnosia,3,1.0986122886681098
enterotoxin,3,1.0986122886681098
Ward,3,1.0986122886681098
3750,3,1.0986122886681098
23-29,3,1.0986122886681098
SARIARDS,3,1.0986122886681098
intrafamilial,3,1.0986122886681098
0056,3,1.0986122886681098
psychiatry,3,1.0986122886681098
postnasal,3,1.0986122886681098
occludes,3,1.0986122886681098
pressure-controlled,3,1.0986122886681098
angulation,3,1.0986122886681098
narcosis,3,1.0986122886681098
CPRD,3,1.0986122886681098
Prime-boost,3,1.0986122886681098
saprophytes,3,1.0986122886681098
RNA-extraction,3,1.0986122886681098
ACIS,3,1.0986122886681098
expansions,3,1.0986122886681098
b-agonists,3,1.0986122886681098
Herba,3,1.0986122886681098
≤48,3,1.0986122886681098
miocardial,3,1.0986122886681098
Wellington,3,1.0986122886681098
BRMs,3,1.0986122886681098
DockThor-VS,3,1.0986122886681098
coarse-grained,3,1.0986122886681098
innocuity,3,1.0986122886681098
non-corticosteroid,3,1.0986122886681098
mgl,3,1.0986122886681098
1749,3,1.0986122886681098
LumiraDx,3,1.0986122886681098
Friuli,3,1.0986122886681098
Lachnospiraceae,3,1.0986122886681098
Venezia,3,1.0986122886681098
noncontact,3,1.0986122886681098
NISDA,3,1.0986122886681098
4180,3,1.0986122886681098
microgdL,3,1.0986122886681098
adjHR,3,1.0986122886681098
PFE,3,1.0986122886681098
sub-divided,3,1.0986122886681098
Scutellariae,3,1.0986122886681098
9677,3,1.0986122886681098
shuttle-running,3,1.0986122886681098
Semantic,3,1.0986122886681098
miscommunication,3,1.0986122886681098
annoyances,3,1.0986122886681098
103-122,3,1.0986122886681098
Homer,3,1.0986122886681098
1864,3,1.0986122886681098
tapes,3,1.0986122886681098
STroke,3,1.0986122886681098
Lloyd,3,1.0986122886681098
monokine,3,1.0986122886681098
OSEs,3,1.0986122886681098
interectopic,3,1.0986122886681098
synergize,3,1.0986122886681098
Gilbert,3,1.0986122886681098
1853,3,1.0986122886681098
negotiations,3,1.0986122886681098
admissionseparation,3,1.0986122886681098
cell-in-cell,3,1.0986122886681098
virion-PM,3,1.0986122886681098
predesigned,3,1.0986122886681098
tablet-based,3,1.0986122886681098
BM-derived,3,1.0986122886681098
issuing,3,1.0986122886681098
Supplement,3,1.0986122886681098
CONSISE,3,1.0986122886681098
inject,3,1.0986122886681098
cognitive-behavioural,3,1.0986122886681098
self-perpetuating,3,1.0986122886681098
gut-lung,3,1.0986122886681098
mol,3,1.0986122886681098
rigour,3,1.0986122886681098
ocean,3,1.0986122886681098
escalates,3,1.0986122886681098
socialeconomic,3,1.0986122886681098
Dose-response,3,1.0986122886681098
1464,3,1.0986122886681098
juxtaposition,3,1.0986122886681098
IVNC,3,1.0986122886681098
pre-and,3,1.0986122886681098
1080,3,1.0986122886681098
RT‑PCR,3,1.0986122886681098
Orthostatic,3,1.0986122886681098
E-I,3,1.0986122886681098
accustomed,3,1.0986122886681098
immune-inflammatory,3,1.0986122886681098
gastroduodenal,3,1.0986122886681098
Thunderstorms,3,1.0986122886681098
7-days,3,1.0986122886681098
assaying,3,1.0986122886681098
PANBIO,3,1.0986122886681098
long-run,3,1.0986122886681098
Neuroplasticity,3,1.0986122886681098
principals,3,1.0986122886681098
CO-RADS,3,1.0986122886681098
RBB,3,1.0986122886681098
epidemicpandemic,3,1.0986122886681098
flavonols,3,1.0986122886681098
lifes,3,1.0986122886681098
Reflecting,3,1.0986122886681098
self-controlled,3,1.0986122886681098
ASAP,3,1.0986122886681098
Babinski,3,1.0986122886681098
RNA-dependent-RNA-polymerase,3,1.0986122886681098
SUE,3,1.0986122886681098
1468,3,1.0986122886681098
eNoses,3,1.0986122886681098
contractures,3,1.0986122886681098
Single-photon,3,1.0986122886681098
1088,3,1.0986122886681098
Sterile,3,1.0986122886681098
fountains,3,1.0986122886681098
FADD,3,1.0986122886681098
gp,3,1.0986122886681098
Fluency,3,1.0986122886681098
recalcitrant,3,1.0986122886681098
el,3,1.0986122886681098
nellInfarto,3,1.0986122886681098
preemergent,3,1.0986122886681098
Grippovak,3,1.0986122886681098
non-compliers,3,1.0986122886681098
funnel-freezing,3,1.0986122886681098
SINAN,3,1.0986122886681098
diphenylmethane,3,1.0986122886681098
discriminator,3,1.0986122886681098
PIPM,3,1.0986122886681098
Cas12,3,1.0986122886681098
catalysis,3,1.0986122886681098
Maurice,3,1.0986122886681098
BCE,3,1.0986122886681098
MSCs-based,3,1.0986122886681098
sulfidopeptide,3,1.0986122886681098
Osteoprotegerin,3,1.0986122886681098
sham-operation,3,1.0986122886681098
pristimerin,3,1.0986122886681098
FRNA,3,1.0986122886681098
high-content,3,1.0986122886681098
MLV,3,1.0986122886681098
15-day,3,1.0986122886681098
rate-limiting,3,1.0986122886681098
tilting,3,1.0986122886681098
catalysed,3,1.0986122886681098
DARB,3,1.0986122886681098
apelin-APJ,3,1.0986122886681098
ILK-MSCs,3,1.0986122886681098
tease,3,1.0986122886681098
ΔS,3,1.0986122886681098
signpost,3,1.0986122886681098
solidify,3,1.0986122886681098
1797,3,1.0986122886681098
EHA2,3,1.0986122886681098
Locus,3,1.0986122886681098
DDB,3,1.0986122886681098
NOD-like,3,1.0986122886681098
Spacer,3,1.0986122886681098
Nutr,3,1.0986122886681098
ANRIL,3,1.0986122886681098
Isosorbide,3,1.0986122886681098
HDAC9,3,1.0986122886681098
NHCU,3,1.0986122886681098
3-11,3,1.0986122886681098
CD36,3,1.0986122886681098
LD50,3,1.0986122886681098
pro-oxidant,3,1.0986122886681098
transglutaminase,3,1.0986122886681098
recede,3,1.0986122886681098
inter-regional,3,1.0986122886681098
grainsm3,3,1.0986122886681098
fibroblastic,3,1.0986122886681098
SPME,3,1.0986122886681098
re-infect,3,1.0986122886681098
fuller,3,1.0986122886681098
30-year,3,1.0986122886681098
GAPP,3,1.0986122886681098
Altering,3,1.0986122886681098
2-49,3,1.0986122886681098
ophthalmoplegia,3,1.0986122886681098
literate,3,1.0986122886681098
56000,3,1.0986122886681098
weeds,3,1.0986122886681098
time-stratified,3,1.0986122886681098
antifibrotic,3,1.0986122886681098
3090,3,1.0986122886681098
minimally-invasive,3,1.0986122886681098
ISM,3,1.0986122886681098
Walk,3,1.0986122886681098
fetuin,3,1.0986122886681098
tracheomalacia,3,1.0986122886681098
Tokelauan,3,1.0986122886681098
POPs,3,1.0986122886681098
AF-SCREEN,3,1.0986122886681098
Hp,3,1.0986122886681098
25-49,3,1.0986122886681098
Breakthrough,3,1.0986122886681098
zest,3,1.0986122886681098
THH,3,1.0986122886681098
microbiome-mediated,3,1.0986122886681098
hyperphosphorylation,3,1.0986122886681098
Enzyme-linked,3,1.0986122886681098
2318,3,1.0986122886681098
isoniazid,3,1.0986122886681098
AF-unrelated,3,1.0986122886681098
9085,3,1.0986122886681098
verifiable,3,1.0986122886681098
nonsecreting,3,1.0986122886681098
teeth,3,1.0986122886681098
benefitted,3,1.0986122886681098
incoordination,3,1.0986122886681098
pigmentation,3,1.0986122886681098
Samara,3,1.0986122886681098
honeybee,3,1.0986122886681098
MALDI-MS,3,1.0986122886681098
0051,3,1.0986122886681098
Syst,3,1.0986122886681098
americana,3,1.0986122886681098
Bla,3,1.0986122886681098
equipments,3,1.0986122886681098
troop,3,1.0986122886681098
tauopathy,3,1.0986122886681098
hole,3,1.0986122886681098
1729,3,1.0986122886681098
MedlinePubMed,3,1.0986122886681098
Wellcome,3,1.0986122886681098
embed,3,1.0986122886681098
Acetylcysteine,3,1.0986122886681098
1517,3,1.0986122886681098
Banks,3,1.0986122886681098
carbonic,3,1.0986122886681098
rate-systolic,3,1.0986122886681098
punctures,3,1.0986122886681098
evanescent,3,1.0986122886681098
facility-level,3,1.0986122886681098
RNA-mediated,3,1.0986122886681098
enzyme-free,3,1.0986122886681098
abnormally-contracting,3,1.0986122886681098
QUEST,3,1.0986122886681098
twenty-metre,3,1.0986122886681098
RBF,3,1.0986122886681098
within-week,3,1.0986122886681098
Stable,3,1.0986122886681098
Mountain,3,1.0986122886681098
genotypephenotype,3,1.0986122886681098
Serologically,3,1.0986122886681098
Surg,3,1.0986122886681098
carcasses,3,1.0986122886681098
TMDE,3,1.0986122886681098
multimedication,3,1.0986122886681098
1896,3,1.0986122886681098
nuisance,3,1.0986122886681098
amplifiers,3,1.0986122886681098
early-phase,3,1.0986122886681098
modus,3,1.0986122886681098
UW,3,1.0986122886681098
Ho,3,1.0986122886681098
perinecrotic,3,1.0986122886681098
Unipolar,3,1.0986122886681098
syndrome，,3,1.0986122886681098
enteroviral,3,1.0986122886681098
MTs,3,1.0986122886681098
unlabeled,3,1.0986122886681098
Manufacturer,3,1.0986122886681098
ASEAN,3,1.0986122886681098
ECOWAS,3,1.0986122886681098
desquamated,3,1.0986122886681098
endotheliocytes,3,1.0986122886681098
digested,3,1.0986122886681098
tachyarrythmias,3,1.0986122886681098
atlases,3,1.0986122886681098
dialdehyde,3,1.0986122886681098
CVL218,3,1.0986122886681098
32nd,3,1.0986122886681098
perplexing,3,1.0986122886681098
BRS,3,1.0986122886681098
stratifications,3,1.0986122886681098
HTCC,3,1.0986122886681098
well-maintained,3,1.0986122886681098
double-bounded,3,1.0986122886681098
hypercalcemia,3,1.0986122886681098
Boyacá,3,1.0986122886681098
Yokohama,3,1.0986122886681098
CDK2,3,1.0986122886681098
Iwate,3,1.0986122886681098
PBI,3,1.0986122886681098
ofa,3,1.0986122886681098
currency,3,1.0986122886681098
DOH,3,1.0986122886681098
diversities,3,1.0986122886681098
Game,3,1.0986122886681098
1988-1989,3,1.0986122886681098
self-initiative,3,1.0986122886681098
Endotypes,3,1.0986122886681098
KCNMB1,3,1.0986122886681098
Tsp45I,3,1.0986122886681098
Bobo-Dioulasso,3,1.0986122886681098
75mg,3,1.0986122886681098
sited,3,1.0986122886681098
1183,3,1.0986122886681098
Noteworthy,3,1.0986122886681098
Penn-RAMP,3,1.0986122886681098
unopsonized,3,1.0986122886681098
re-infected,3,1.0986122886681098
separations,3,1.0986122886681098
Errors,3,1.0986122886681098
infuenza,3,1.0986122886681098
inpatient-rehabilitation,3,1.0986122886681098
videotapes,3,1.0986122886681098
ia,3,1.0986122886681098
schistosomiasis,3,1.0986122886681098
Hypotheses,3,1.0986122886681098
compacta,3,1.0986122886681098
plethysmograph,3,1.0986122886681098
affirmative,3,1.0986122886681098
redressing,3,1.0986122886681098
Enrolled,3,1.0986122886681098
Pulsus,3,1.0986122886681098
anti-Spike,3,1.0986122886681098
APanama200799-like,3,1.0986122886681098
August-September,3,1.0986122886681098
apneic,3,1.0986122886681098
Queen,3,1.0986122886681098
ASMarea,3,1.0986122886681098
Elizabeth,3,1.0986122886681098
ENFUMOSA,3,1.0986122886681098
videotracking,3,1.0986122886681098
cartograms,3,1.0986122886681098
seventy-four,3,1.0986122886681098
818T,3,1.0986122886681098
discriminates,3,1.0986122886681098
Sapporo,3,1.0986122886681098
Necrotic,3,1.0986122886681098
WHR,3,1.0986122886681098
Y839,3,1.0986122886681098
350000,3,1.0986122886681098
unpartnered,3,1.0986122886681098
Erfurt,3,1.0986122886681098
MuLBSTA,3,1.0986122886681098
unicentric,3,1.0986122886681098
80J,3,1.0986122886681098
CTGA,3,1.0986122886681098
PFS,3,1.0986122886681098
Detrimental,3,1.0986122886681098
0052,3,1.0986122886681098
MOSES,3,1.0986122886681098
hypoglycaemia,3,1.0986122886681098
Channel,3,1.0986122886681098
non-dipping,3,1.0986122886681098
oligoadenylate,3,1.0986122886681098
PTF-V1,3,1.0986122886681098
Revolution,3,1.0986122886681098
imbalanced,3,1.0986122886681098
IFN-alphabeta,3,1.0986122886681098
under-explored,3,1.0986122886681098
NF-kappa,3,1.0986122886681098
pulp,3,1.0986122886681098
Albert,3,1.0986122886681098
omega-63,3,1.0986122886681098
preselection,3,1.0986122886681098
CFCs,3,1.0986122886681098
pMDI,3,1.0986122886681098
Door-to-Balloon,3,1.0986122886681098
hyperthyroid,3,1.0986122886681098
0-89,3,1.0986122886681098
parturients,3,1.0986122886681098
CAIMI,3,1.0986122886681098
disaster-response,3,1.0986122886681098
rationalization,3,1.0986122886681098
cell-associated,3,1.0986122886681098
bizonyos,3,1.0986122886681098
Intractable,3,1.0986122886681098
unreasonable,3,1.0986122886681098
anastomosing,3,1.0986122886681098
alprenolol,3,1.0986122886681098
EBUS,3,1.0986122886681098
sequellae,3,1.0986122886681098
Wseg,3,1.0986122886681098
70-95,3,1.0986122886681098
3111,3,1.0986122886681098
ethylene,3,1.0986122886681098
faults,3,1.0986122886681098
Silesia,3,1.0986122886681098
Aprotinin,3,1.0986122886681098
melyek,3,1.0986122886681098
thinned,3,1.0986122886681098
Reserve,3,1.0986122886681098
posters,3,1.0986122886681098
venular,3,1.0986122886681098
nonexposed,3,1.0986122886681098
MoS2,3,1.0986122886681098
formalized,3,1.0986122886681098
trisomy,3,1.0986122886681098
recreate,3,1.0986122886681098
guilty,3,1.0986122886681098
1134,3,1.0986122886681098
ACOEM,3,1.0986122886681098
homoplasies,3,1.0986122886681098
lh,3,1.0986122886681098
forty-three,3,1.0986122886681098
assortativity,3,1.0986122886681098
assortative,3,1.0986122886681098
depressing,3,1.0986122886681098
MAVS,3,1.0986122886681098
somatoparaphrenia,3,1.0986122886681098
httpscoronavirusjhuedumaphtml,3,1.0986122886681098
June-July,3,1.0986122886681098
Anosognosia,3,1.0986122886681098
flooded,3,1.0986122886681098
5-hydroxytryptamine,3,1.0986122886681098
enablers,3,1.0986122886681098
1665,3,1.0986122886681098
WCB,3,1.0986122886681098
ether-treated,3,1.0986122886681098
high-accuracy,3,1.0986122886681098
Infarct-related,3,1.0986122886681098
ARs,3,1.0986122886681098
AVictoria375-like,3,1.0986122886681098
lands,3,1.0986122886681098
1098,3,1.0986122886681098
artwork,3,1.0986122886681098
summoned,3,1.0986122886681098
Endemic,3,1.0986122886681098
vaccine-producing,3,1.0986122886681098
tb,3,1.0986122886681098
hyperirritability,3,1.0986122886681098
tuberculin,3,1.0986122886681098
sero-neutralization,3,1.0986122886681098
anti-remodelling,3,1.0986122886681098
thromboaspiration,3,1.0986122886681098
EDD,3,1.0986122886681098
intra-atrial,3,1.0986122886681098
changeable,3,1.0986122886681098
TGF-b,3,1.0986122886681098
reaccumulation,3,1.0986122886681098
Neuroendocrine,3,1.0986122886681098
∼50,3,1.0986122886681098
liberty,3,1.0986122886681098
31-40,3,1.0986122886681098
Lumipulse,3,1.0986122886681098
IPV,3,1.0986122886681098
GPSPE,3,1.0986122886681098
NIC,3,1.0986122886681098
unleashing,3,1.0986122886681098
cornstarch,3,1.0986122886681098
IVET,3,1.0986122886681098
ecchymosis,3,1.0986122886681098
respectivelyABSTRACT,3,1.0986122886681098
lipid-based,3,1.0986122886681098
Hyperhomocysteinemia,3,1.0986122886681098
Wellbeing,3,1.0986122886681098
bibliography,3,1.0986122886681098
Illnesses,3,1.0986122886681098
sphingomyelin,3,1.0986122886681098
AH1N1p2009,3,1.0986122886681098
IABA,3,1.0986122886681098
light-to-moderate,3,1.0986122886681098
non-seniors,3,1.0986122886681098
fisher,3,1.0986122886681098
RTs,3,1.0986122886681098
lymphatics,3,1.0986122886681098
forearm,3,1.0986122886681098
1-14,3,1.0986122886681098
inter-laboratory,3,1.0986122886681098
MWM,3,1.0986122886681098
OTV-resistant,3,1.0986122886681098
Validating,3,1.0986122886681098
Cyclic,3,1.0986122886681098
bled,3,1.0986122886681098
shrinks,3,1.0986122886681098
exempted,3,1.0986122886681098
RRsigma,3,1.0986122886681098
O-glycans,3,1.0986122886681098
5-minute,3,1.0986122886681098
person-month,3,1.0986122886681098
edentulism,3,1.0986122886681098
supreme,3,1.0986122886681098
multimeric,3,1.0986122886681098
PPO,3,1.0986122886681098
99mTc-glucarate,3,1.0986122886681098
mastered,3,1.0986122886681098
MRI-FT,3,1.0986122886681098
thienopyridines,3,1.0986122886681098
caries,3,1.0986122886681098
ORF1,3,1.0986122886681098
catabolic,3,1.0986122886681098
H7N9-infected,3,1.0986122886681098
disconnectivity,3,1.0986122886681098
Premier,3,1.0986122886681098
lumina,3,1.0986122886681098
Sandy,3,1.0986122886681098
P042,3,1.0986122886681098
nVATS,3,1.0986122886681098
decoupling,3,1.0986122886681098
1a-2,3,1.0986122886681098
non-receptor,3,1.0986122886681098
Transplanted,3,1.0986122886681098
PBonferroni,3,1.0986122886681098
accumulative,3,1.0986122886681098
endoribonuclease,3,1.0986122886681098
macrohistological,3,1.0986122886681098
co‐infections,3,1.0986122886681098
biomarker-driven,3,1.0986122886681098
18FDG,3,1.0986122886681098
MOHME,3,1.0986122886681098
1066,3,1.0986122886681098
asthmagens,3,1.0986122886681098
ECMOnet,3,1.0986122886681098
Feature,3,1.0986122886681098
install,3,1.0986122886681098
predicament,3,1.0986122886681098
n30,3,1.0986122886681098
court,3,1.0986122886681098
assuage,3,1.0986122886681098
test-positives,3,1.0986122886681098
Wingspan,3,1.0986122886681098
MERS-COV,3,1.0986122886681098
type-1,3,1.0986122886681098
risk-taking,3,1.0986122886681098
Britains,3,1.0986122886681098
Crisis,3,1.0986122886681098
CAST,3,1.0986122886681098
cMCAO,3,1.0986122886681098
Strengthening,3,1.0986122886681098
LGALS1,3,1.0986122886681098
4040,3,1.0986122886681098
IPECFIOCRUZ,3,1.0986122886681098
1172,3,1.0986122886681098
test-negatives,3,1.0986122886681098
intra-operatively,3,1.0986122886681098
n66,3,1.0986122886681098
infaction,3,1.0986122886681098
45h,3,1.0986122886681098
hybrids,3,1.0986122886681098
goodness-of-fit,3,1.0986122886681098
1955,3,1.0986122886681098
Yalta,3,1.0986122886681098
ninety-two,3,1.0986122886681098
Kendalls,3,1.0986122886681098
cholecystitis,3,1.0986122886681098
OMS,3,1.0986122886681098
≥005,3,1.0986122886681098
OWS,3,1.0986122886681098
OLT,3,1.0986122886681098
Leicester,3,1.0986122886681098
RW,3,1.0986122886681098
Saikosaponins,3,1.0986122886681098
DSMI,3,1.0986122886681098
Pheochromocytomas,3,1.0986122886681098
picomolar,3,1.0986122886681098
Jebsen-Taylor,3,1.0986122886681098
AFK,3,1.0986122886681098
PC35sGaw,3,1.0986122886681098
epi-aortic,3,1.0986122886681098
Foramen,3,1.0986122886681098
Ovale,3,1.0986122886681098
neuroradiologic,3,1.0986122886681098
Production,3,1.0986122886681098
budgeting,3,1.0986122886681098
closes,3,1.0986122886681098
0498,3,1.0986122886681098
epistemic,3,1.0986122886681098
interconnections,3,1.0986122886681098
a-priori,3,1.0986122886681098
intra-class,3,1.0986122886681098
psychometrics,3,1.0986122886681098
plasmid-based,3,1.0986122886681098
Bovine,3,1.0986122886681098
Intraperitoneal,3,1.0986122886681098
Patrick,3,1.0986122886681098
99Tcm-Sestamibi,3,1.0986122886681098
plead,3,1.0986122886681098
cabins,3,1.0986122886681098
MICS,3,1.0986122886681098
neutered,3,1.0986122886681098
WMFT,3,1.0986122886681098
vice-versa,3,1.0986122886681098
0919,3,1.0986122886681098
Standardizing,3,1.0986122886681098
Interferon-gamma,3,1.0986122886681098
Locations,3,1.0986122886681098
pro-fibrotic,3,1.0986122886681098
turbulent,3,1.0986122886681098
ubiquitously,3,1.0986122886681098
Brdu,3,1.0986122886681098
irrespectively,3,1.0986122886681098
kell,3,1.0986122886681098
summers,3,1.0986122886681098
H-bond,3,1.0986122886681098
acid-containing,3,1.0986122886681098
CR4R,3,1.0986122886681098
bioenergetic,3,1.0986122886681098
coldest,3,1.0986122886681098
Uveitis,3,1.0986122886681098
coalescence,3,1.0986122886681098
VSN,3,1.0986122886681098
histones,3,1.0986122886681098
IPRs,3,1.0986122886681098
Darunavir,3,1.0986122886681098
1106,3,1.0986122886681098
nonelderly,3,1.0986122886681098
offensive,3,1.0986122886681098
co-crystal,3,1.0986122886681098
protrude,3,1.0986122886681098
crown-like,3,1.0986122886681098
Wuhan-Hu-1,3,1.0986122886681098
ASSURED-SQVM,3,1.0986122886681098
wildfires,3,1.0986122886681098
diversifying,3,1.0986122886681098
time-bound,3,1.0986122886681098
Gossypiboma,3,1.0986122886681098
p0000,3,1.0986122886681098
ResNet,3,1.0986122886681098
dietdietary,3,1.0986122886681098
phlebothrombosis,3,1.0986122886681098
C-ACTM,3,1.0986122886681098
Samsun,3,1.0986122886681098
XXI,3,1.0986122886681098
hAOs,3,1.0986122886681098
syncytia,3,1.0986122886681098
sustainably,3,1.0986122886681098
ultra-low,3,1.0986122886681098
double-strand,3,1.0986122886681098
NLRP4,3,1.0986122886681098
indecisive,3,1.0986122886681098
cohosh,3,1.0986122886681098
traumatism,3,1.0986122886681098
AlPO4,3,1.0986122886681098
Explore,3,1.0986122886681098
protuberance,3,1.0986122886681098
AHFCHF,3,1.0986122886681098
CSL,3,1.0986122886681098
rSARS-CoV-2,3,1.0986122886681098
chymase,3,1.0986122886681098
faculties,3,1.0986122886681098
communitywide,3,1.0986122886681098
Experiencing,3,1.0986122886681098
sausage,3,1.0986122886681098
brain-injured,3,1.0986122886681098
cladosporium,3,1.0986122886681098
SLNTG,3,1.0986122886681098
countered,3,1.0986122886681098
pansystolic,3,1.0986122886681098
IoT,3,1.0986122886681098
epsilon-aminocapronic,3,1.0986122886681098
2014-2016,3,1.0986122886681098
±SD,3,1.0986122886681098
severerefractory,3,1.0986122886681098
thrombolyse,3,1.0986122886681098
post-hospitalization,3,1.0986122886681098
Skye,3,1.0986122886681098
Jaeger,3,1.0986122886681098
11575,3,1.0986122886681098
EIDs,3,1.0986122886681098
hypervirulent,3,1.0986122886681098
self-criticism,3,1.0986122886681098
chlorination,3,1.0986122886681098
gonadotrophin-releasing,3,1.0986122886681098
Instructions,3,1.0986122886681098
cargoes,3,1.0986122886681098
hemopneumothorax,3,1.0986122886681098
elapses,3,1.0986122886681098
underexplored,3,1.0986122886681098
non-indigenous,3,1.0986122886681098
objections,3,1.0986122886681098
Restorative,3,1.0986122886681098
Chronically,3,1.0986122886681098
end-of-season,3,1.0986122886681098
Thermal,3,1.0986122886681098
EMV,3,1.0986122886681098
Broadcasting,3,1.0986122886681098
VEGF-A,3,1.0986122886681098
subnetworks,3,1.0986122886681098
HR2,3,1.0986122886681098
Diarrhoea,3,1.0986122886681098
savvy,3,1.0986122886681098
non-immunological,3,1.0986122886681098
non-EUA,3,1.0986122886681098
IVDs,3,1.0986122886681098
Histopathology,3,1.0986122886681098
Bangabandhu,3,1.0986122886681098
cephalalgia,3,1.0986122886681098
aspirin-like,3,1.0986122886681098
uraemia,3,1.0986122886681098
digests,3,1.0986122886681098
handedness,3,1.0986122886681098
catabolites,3,1.0986122886681098
Mujib,3,1.0986122886681098
0496,3,1.0986122886681098
renewing,3,1.0986122886681098
physiochemical,3,1.0986122886681098
chimera,3,1.0986122886681098
qd,3,1.0986122886681098
SAM,3,1.0986122886681098
RVEV,3,1.0986122886681098
colorimetry,3,1.0986122886681098
third-line,3,1.0986122886681098
regionalized,3,1.0986122886681098
extrusion,3,1.0986122886681098
CBT-I,3,1.0986122886681098
18-25,3,1.0986122886681098
metacognitive,3,1.0986122886681098
supersite,3,1.0986122886681098
-232,3,1.0986122886681098
carinii,3,1.0986122886681098
Alagoas,3,1.0986122886681098
mesencephalic,3,1.0986122886681098
ARG1,3,1.0986122886681098
protruded,3,1.0986122886681098
throws,3,1.0986122886681098
Valve,3,1.0986122886681098
Kigali,3,1.0986122886681098
Osterhaus,3,1.0986122886681098
Times,3,1.0986122886681098
2009-pandemic,3,1.0986122886681098
Española,3,1.0986122886681098
ZF2001,3,1.0986122886681098
suites,3,1.0986122886681098
Districts,3,1.0986122886681098
V3R-V5R,3,1.0986122886681098
juxtaposed,3,1.0986122886681098
SLU,3,1.0986122886681098
Silver,3,1.0986122886681098
N-3,3,1.0986122886681098
ACSS,3,1.0986122886681098
Madinah,3,1.0986122886681098
adjuvantation,3,1.0986122886681098
HT™,3,1.0986122886681098
Niger,3,1.0986122886681098
Litomosoides,3,1.0986122886681098
Serbian,3,1.0986122886681098
VMX,3,1.0986122886681098
myofibrillar,3,1.0986122886681098
frustratingly,3,1.0986122886681098
dangerously,3,1.0986122886681098
MT-I,3,1.0986122886681098
Wayne,3,1.0986122886681098
record-breaking,3,1.0986122886681098
Independently,3,1.0986122886681098
salivas,3,1.0986122886681098
Thymoquinone,3,1.0986122886681098
pharmaco-economic,3,1.0986122886681098
SXS,3,1.0986122886681098
2788,3,1.0986122886681098
1638,3,1.0986122886681098
Evolutionarily,3,1.0986122886681098
product-based,3,1.0986122886681098
SSR,3,1.0986122886681098
Juniper,3,1.0986122886681098
0072,3,1.0986122886681098
goal-setting,3,1.0986122886681098
Armband,3,1.0986122886681098
1344,3,1.0986122886681098
2651,3,1.0986122886681098
s-ASAT,3,1.0986122886681098
nucleinas,3,1.0986122886681098
Natrii,3,1.0986122886681098
2121,3,1.0986122886681098
rainforest,3,1.0986122886681098
CoVaccine,3,1.0986122886681098
ofpatients,3,1.0986122886681098
Approximate,3,1.0986122886681098
SITS-technology,3,1.0986122886681098
non-canonical,3,1.0986122886681098
AKT,3,1.0986122886681098
Abiomed,3,1.0986122886681098
3-methyladenine,3,1.0986122886681098
3-MA,3,1.0986122886681098
castrated,3,1.0986122886681098
artefactual,3,1.0986122886681098
usurp,3,1.0986122886681098
ERAD,3,1.0986122886681098
orchitis,3,1.0986122886681098
high-order,3,1.0986122886681098
Multiorgan,3,1.0986122886681098
revascularizing,3,1.0986122886681098
C57Bl6,3,1.0986122886681098
epiaortic,3,1.0986122886681098
rehabilitate,3,1.0986122886681098
tendon,3,1.0986122886681098
ECN,3,1.0986122886681098
re-investigated,3,1.0986122886681098
reappraise,3,1.0986122886681098
continuing-care,3,1.0986122886681098
cryoablation,3,1.0986122886681098
octogenarian,3,1.0986122886681098
gene-expression,3,1.0986122886681098
Regionalization,3,1.0986122886681098
mitesg,3,1.0986122886681098
NBR1,3,1.0986122886681098
mlmin100,3,1.0986122886681098
197374,3,1.0986122886681098
creatinophosphokinase,3,1.0986122886681098
mLgmin,3,1.0986122886681098
Phosphoinositide,3,1.0986122886681098
colossal,3,1.0986122886681098
commonality,3,1.0986122886681098
inter-network,3,1.0986122886681098
Romed,3,1.0986122886681098
dashboards,3,1.0986122886681098
COVID-eVax,3,1.0986122886681098
Ratings,3,1.0986122886681098
super-spreader,3,1.0986122886681098
57-day,3,1.0986122886681098
Thromboprophylaxis,3,1.0986122886681098
VOR,3,1.0986122886681098
psychosocially,3,1.0986122886681098
Bris59,3,1.0986122886681098
pomegranate,3,1.0986122886681098
Priming,3,1.0986122886681098
Insulin-like,3,1.0986122886681098
factor-1,3,1.0986122886681098
receptor-blocking,3,1.0986122886681098
Blocking,3,1.0986122886681098
post-challenge,3,1.0986122886681098
hyposensitized,3,1.0986122886681098
schoolschildcare,3,1.0986122886681098
osteosynthesis,3,1.0986122886681098
Supplementary,3,1.0986122886681098
Readmission,3,1.0986122886681098
exhausts,3,1.0986122886681098
1402,3,1.0986122886681098
ophthalmologist,3,1.0986122886681098
cell-type-specific,3,1.0986122886681098
particlescough,3,1.0986122886681098
ABrisbane102007,3,1.0986122886681098
last-seen-well,3,1.0986122886681098
SalivaAll,3,1.0986122886681098
pre-infected,3,1.0986122886681098
SBT,3,1.0986122886681098
cogent,3,1.0986122886681098
NPSs,3,1.0986122886681098
stress-reinjection,3,1.0986122886681098
drum,3,1.0986122886681098
MSAGR,3,1.0986122886681098
M3,3,1.0986122886681098
perforin,3,1.0986122886681098
Differing,3,1.0986122886681098
MPA-ANFIS,3,1.0986122886681098
Directed,3,1.0986122886681098
retrogradely,3,1.0986122886681098
medicalization,3,1.0986122886681098
End-of-season,3,1.0986122886681098
intuition,3,1.0986122886681098
nanobubbles,3,1.0986122886681098
1890-1892,3,1.0986122886681098
responsivness,3,1.0986122886681098
HRI,3,1.0986122886681098
Tallinn,3,1.0986122886681098
0673,3,1.0986122886681098
leveled,3,1.0986122886681098
CAGE,3,1.0986122886681098
Wight,3,1.0986122886681098
homeownership,3,1.0986122886681098
wrapping,3,1.0986122886681098
ICS-formoterol,3,1.0986122886681098
human-pathogenic,3,1.0986122886681098
collates,3,1.0986122886681098
hpi,3,1.0986122886681098
Hypercoagulable,3,1.0986122886681098
Fetal,3,1.0986122886681098
CCI,3,1.0986122886681098
pulmonic,3,1.0986122886681098
polymerized,3,1.0986122886681098
OMT,3,1.0986122886681098
brain-specific,3,1.0986122886681098
discerned,3,1.0986122886681098
high-exposure,3,1.0986122886681098
Routinely,3,1.0986122886681098
Watch,3,1.0986122886681098
GBM-C,3,1.0986122886681098
transmodal,3,1.0986122886681098
impedimetric,3,1.0986122886681098
MAE,3,1.0986122886681098
obsolete,3,1.0986122886681098
frustrations,3,1.0986122886681098
judo,3,1.0986122886681098
Myeloperoxidase,3,1.0986122886681098
charity,3,1.0986122886681098
novice,3,1.0986122886681098
LP-EM,3,1.0986122886681098
1997-1999,3,1.0986122886681098
dextromethorphan,3,1.0986122886681098
sublineage,3,1.0986122886681098
brothers,3,1.0986122886681098
cycloferon,3,1.0986122886681098
1718,3,1.0986122886681098
four-phase,3,1.0986122886681098
M-CDC,3,1.0986122886681098
HUCBCs,3,1.0986122886681098
erythrocytic,3,1.0986122886681098
13-20,3,1.0986122886681098
Hybridization,3,1.0986122886681098
Glutathione,3,1.0986122886681098
self-reliance,3,1.0986122886681098
forge,3,1.0986122886681098
biopsied,3,1.0986122886681098
Maxwell,3,1.0986122886681098
DMVAC,3,1.0986122886681098
streptococcus,3,1.0986122886681098
adversities,3,1.0986122886681098
Technetium-99m,3,1.0986122886681098
Englands,3,1.0986122886681098
OVA-specific,3,1.0986122886681098
toxicosis,3,1.0986122886681098
decoded,3,1.0986122886681098
Di-Tan,3,1.0986122886681098
mlkg,3,1.0986122886681098
XI,3,1.0986122886681098
Polynesian,3,1.0986122886681098
hypercontraction,3,1.0986122886681098
MECC,3,1.0986122886681098
A-CPR,3,1.0986122886681098
overweightobese,3,1.0986122886681098
interconnection,3,1.0986122886681098
fcMRI,3,1.0986122886681098
single-walled,3,1.0986122886681098
thrombophilias,3,1.0986122886681098
Dividing,3,1.0986122886681098
homozonal,3,1.0986122886681098
deem,3,1.0986122886681098
desorption,3,1.0986122886681098
glycobiological,3,1.0986122886681098
3472,3,1.0986122886681098
instrument-free,3,1.0986122886681098
non-interventional,3,1.0986122886681098
mass-vaccination,3,1.0986122886681098
cyclodextrin,3,1.0986122886681098
N4-8,3,1.0986122886681098
hypoxia-inducible,3,1.0986122886681098
three-day,3,1.0986122886681098
amputation,3,1.0986122886681098
6-sulfatoxymelatonin,3,1.0986122886681098
rMVAs,3,1.0986122886681098
rMVA,3,1.0986122886681098
Teresina,3,1.0986122886681098
intrusion,3,1.0986122886681098
box-1,3,1.0986122886681098
MALDI-TOF-MS,3,1.0986122886681098
tumultuous,3,1.0986122886681098
coronavirus‐2,3,1.0986122886681098
AfricanAfrican-American,3,1.0986122886681098
sACE2,3,1.0986122886681098
immuno,3,1.0986122886681098
Mucus,3,1.0986122886681098
5900,3,1.0986122886681098
LD-1LD-5,3,1.0986122886681098
HTA,3,1.0986122886681098
synchronously,3,1.0986122886681098
Overt,3,1.0986122886681098
Ginseng,3,1.0986122886681098
Propolis,3,1.0986122886681098
pinnipeds,3,1.0986122886681098
detrimentally,3,1.0986122886681098
hypercarbia,3,1.0986122886681098
2016-February,3,1.0986122886681098
full-process,3,1.0986122886681098
BSichuan37999-like,3,1.0986122886681098
Chlamydophila,3,1.0986122886681098
extra-hospital,3,1.0986122886681098
customisation,3,1.0986122886681098
1100000,3,1.0986122886681098
girdle,3,1.0986122886681098
narratively,3,1.0986122886681098
inhalatory,3,1.0986122886681098
Gy,3,1.0986122886681098
negating,3,1.0986122886681098
BoNTA,3,1.0986122886681098
pneumonia-causing,3,1.0986122886681098
Cactus,3,1.0986122886681098
GEIs,3,1.0986122886681098
task-based,3,1.0986122886681098
iCaPPS©,3,1.0986122886681098
Bhutan,3,1.0986122886681098
LICs,3,1.0986122886681098
1-mm,3,1.0986122886681098
thank,3,1.0986122886681098
IBM-Bonner,3,1.0986122886681098
January-April,3,1.0986122886681098
≥100,3,1.0986122886681098
dichotomised,3,1.0986122886681098
SDs,3,1.0986122886681098
pseudobulbar,3,1.0986122886681098
n39,3,1.0986122886681098
multimer,3,1.0986122886681098
after-effects,3,1.0986122886681098
Vocational,3,1.0986122886681098
1330,3,1.0986122886681098
p0019,3,1.0986122886681098
IUAT,3,1.0986122886681098
LopinavirRitonavir,3,1.0986122886681098
IL-35,3,1.0986122886681098
KT,3,1.0986122886681098
deputising,3,1.0986122886681098
top-ranked,3,1.0986122886681098
Ferret,3,1.0986122886681098
20072008,3,1.0986122886681098
Montana,3,1.0986122886681098
re-hospitalization,3,1.0986122886681098
seroconverting,3,1.0986122886681098
evidence-,3,1.0986122886681098
Remantadin,3,1.0986122886681098
Concluding,3,1.0986122886681098
Abeta,3,1.0986122886681098
1202,3,1.0986122886681098
Undernutrition,3,1.0986122886681098
1975-76,3,1.0986122886681098
WB,3,1.0986122886681098
Etiologic,3,1.0986122886681098
36-Item,3,1.0986122886681098
ed,3,1.0986122886681098
16-34,3,1.0986122886681098
PC20H,3,1.0986122886681098
fuses,3,1.0986122886681098
temperament,3,1.0986122886681098
vaccineexcipient,3,1.0986122886681098
9901,3,1.0986122886681098
1480,3,1.0986122886681098
hsTn,3,1.0986122886681098
Demonstration,3,1.0986122886681098
Hounsfield,3,1.0986122886681098
Used,3,1.0986122886681098
cell-H,3,1.0986122886681098
multiplies,3,1.0986122886681098
literature-based,3,1.0986122886681098
recoverable,3,1.0986122886681098
adduce,3,1.0986122886681098
2063,3,1.0986122886681098
rent,3,1.0986122886681098
Case-based,3,1.0986122886681098
cell-M,3,1.0986122886681098
destinations,3,1.0986122886681098
ubiquitination,3,1.0986122886681098
nonresponsive,3,1.0986122886681098
Yazd,3,1.0986122886681098
mineralocorticoid,3,1.0986122886681098
non-residents,3,1.0986122886681098
Sickle-cell,3,1.0986122886681098
Breakdown,3,1.0986122886681098
springsummer,3,1.0986122886681098
67Ga,3,1.0986122886681098
Neurorehabilitation,3,1.0986122886681098
dust-induced,3,1.0986122886681098
closed-loop,3,1.0986122886681098
SNSSs,3,1.0986122886681098
fourth-grade,3,1.0986122886681098
subsidies,3,1.0986122886681098
methacoline,3,1.0986122886681098
pressure-derived,3,1.0986122886681098
interview-based,3,1.0986122886681098
PAN,3,1.0986122886681098
AtriClip,3,1.0986122886681098
Waals,3,1.0986122886681098
radical-induced,3,1.0986122886681098
multidirectional,3,1.0986122886681098
sauna,3,1.0986122886681098
suddenness,3,1.0986122886681098
tissue-resident,3,1.0986122886681098
insulation,3,1.0986122886681098
vasospasms,3,1.0986122886681098
D936Y,3,1.0986122886681098
Cardio,3,1.0986122886681098
multi-stakeholder,3,1.0986122886681098
650000,3,1.0986122886681098
orchestration,3,1.0986122886681098
three-level,3,1.0986122886681098
21-30,3,1.0986122886681098
7157,3,1.0986122886681098
Lipinski,3,1.0986122886681098
0063,3,1.0986122886681098
aORs,3,1.0986122886681098
CES-D,3,1.0986122886681098
ne,3,1.0986122886681098
two-photon,3,1.0986122886681098
TVs,3,1.0986122886681098
hamming,3,1.0986122886681098
WTC,3,1.0986122886681098
Gloria,3,1.0986122886681098
misusers,3,1.0986122886681098
less-severe,3,1.0986122886681098
drug-like,3,1.0986122886681098
coffeegreen,3,1.0986122886681098
precipitator,3,1.0986122886681098
health-economic,3,1.0986122886681098
acknowledgement,3,1.0986122886681098
1108,3,1.0986122886681098
scrambling,3,1.0986122886681098
1396,3,1.0986122886681098
Seraph100,3,1.0986122886681098
Tracing,3,1.0986122886681098
IMP,3,1.0986122886681098
vasoconstrictive,3,1.0986122886681098
Des,3,1.0986122886681098
glutathionylated,3,1.0986122886681098
Elevations,3,1.0986122886681098
transnational,3,1.0986122886681098
Concentration,3,1.0986122886681098
vaccineMethods,3,1.0986122886681098
uncorrected,3,1.0986122886681098
deplete,3,1.0986122886681098
BICV-SP,3,1.0986122886681098
hálózat,3,1.0986122886681098
hobbies,3,1.0986122886681098
xenon-enhanced,3,1.0986122886681098
myocutaneous,3,1.0986122886681098
Diverse,3,1.0986122886681098
engendered,3,1.0986122886681098
Okapa,3,1.0986122886681098
V1-2,3,1.0986122886681098
ivIg,3,1.0986122886681098
ischemic-like,3,1.0986122886681098
HFA-MDI,3,1.0986122886681098
unsuppressed,3,1.0986122886681098
beclometasoneformoterol,3,1.0986122886681098
surpassing,3,1.0986122886681098
steatohepatitis,3,1.0986122886681098
nitrocellulose,3,1.0986122886681098
reposition,3,1.0986122886681098
sewage-based,3,1.0986122886681098
infographics,3,1.0986122886681098
TPE-TR,3,1.0986122886681098
Nonhuman,3,1.0986122886681098
inter-seasonal,3,1.0986122886681098
AYp28,3,1.0986122886681098
pruning,3,1.0986122886681098
unrepresentative,3,1.0986122886681098
p0012,3,1.0986122886681098
flags,3,1.0986122886681098
ISDs,3,1.0986122886681098
Five-year,3,1.0986122886681098
Storage,3,1.0986122886681098
MERS-,3,1.0986122886681098
non-anterior,3,1.0986122886681098
intelligence-based,3,1.0986122886681098
second-highest,3,1.0986122886681098
TnT,3,1.0986122886681098
extensiveness,3,1.0986122886681098
alimentary,3,1.0986122886681098
0997,3,1.0986122886681098
GWA,3,1.0986122886681098
KCDC,3,1.0986122886681098
LD-1LD-2,3,1.0986122886681098
litonit,3,1.0986122886681098
p0017,3,1.0986122886681098
speakers,3,1.0986122886681098
CHA₂DS₂-VASc,3,1.0986122886681098
spraying,3,1.0986122886681098
Worth,3,1.0986122886681098
µl,3,1.0986122886681098
Hypoxic,3,1.0986122886681098
prayer,3,1.0986122886681098
0-12,3,1.0986122886681098
textLVEF,3,1.0986122886681098
emergences,3,1.0986122886681098
brompheniramine,3,1.0986122886681098
methimazole,3,1.0986122886681098
IL13,3,1.0986122886681098
IIV3-HD,3,1.0986122886681098
Campinas,3,1.0986122886681098
RS0,3,1.0986122886681098
reciprocity,3,1.0986122886681098
CBM-assisted,3,1.0986122886681098
2281,3,1.0986122886681098
vol,3,1.0986122886681098
visual-spatial,3,1.0986122886681098
ministers,3,1.0986122886681098
bioMérieux,3,1.0986122886681098
peptidase-4,3,1.0986122886681098
perivenous,3,1.0986122886681098
inbound,3,1.0986122886681098
Vaxign-ML,3,1.0986122886681098
EIATS,3,1.0986122886681098
copolymer,3,1.0986122886681098
AJ,3,1.0986122886681098
Lminm2,3,1.0986122886681098
cryosupernatant,3,1.0986122886681098
volatility,3,1.0986122886681098
FSS,3,1.0986122886681098
postnatally,3,1.0986122886681098
RICT,3,1.0986122886681098
protein-water,3,1.0986122886681098
corticosteroidlong-acting,3,1.0986122886681098
pro-apoptotic,3,1.0986122886681098
Longer-term,3,1.0986122886681098
Ca-patients,3,1.0986122886681098
upper-respiratory-tract,3,1.0986122886681098
Wild-type,3,1.0986122886681098
TBXA2R,3,1.0986122886681098
EtOH,3,1.0986122886681098
Deutsche,3,1.0986122886681098
1885,3,1.0986122886681098
S1-based,3,1.0986122886681098
AAMI,3,1.0986122886681098
Modulating,3,1.0986122886681098
Bedouins,3,1.0986122886681098
AJN,3,1.0986122886681098
cardioselective,3,1.0986122886681098
eIF4G,3,1.0986122886681098
protein-mapping,3,1.0986122886681098
Amman,3,1.0986122886681098
faecium,3,1.0986122886681098
Adjacent,3,1.0986122886681098
30-45,3,1.0986122886681098
patient-clinician,3,1.0986122886681098
interpolated,3,1.0986122886681098
NeuGcalpha23Gal,3,1.0986122886681098
FACES,3,1.0986122886681098
reaffirms,3,1.0986122886681098
Hypoxaemia,3,1.0986122886681098
dually,3,1.0986122886681098
citrate,3,1.0986122886681098
graftable,3,1.0986122886681098
narrowly,3,1.0986122886681098
8333,3,1.0986122886681098
Pathologists,3,1.0986122886681098
plant-derived,3,1.0986122886681098
Cats,3,1.0986122886681098
bronchiole,3,1.0986122886681098
medium-dose,3,1.0986122886681098
Deming,3,1.0986122886681098
sol-gel,3,1.0986122886681098
Bedouin,3,1.0986122886681098
Interpandemic,3,1.0986122886681098
interpolation,3,1.0986122886681098
accretion,3,1.0986122886681098
hypothesizing,3,1.0986122886681098
Airports,3,1.0986122886681098
bonaphthone,3,1.0986122886681098
syndrome-2,3,1.0986122886681098
learners,3,1.0986122886681098
ravage,3,1.0986122886681098
ether,3,1.0986122886681098
Taylor,3,1.0986122886681098
gastroenterologists,3,1.0986122886681098
picric,3,1.0986122886681098
reactogenic,3,1.0986122886681098
forged,3,1.0986122886681098
Cutler,3,1.0986122886681098
FMT,3,1.0986122886681098
Pertussis,3,1.0986122886681098
PDK1-PKBAkt,3,1.0986122886681098
adventitia,3,1.0986122886681098
Rc,3,1.0986122886681098
prohibit,3,1.0986122886681098
hypoparathyroidism,3,1.0986122886681098
configured,3,1.0986122886681098
luck,3,1.0986122886681098
nonautopsied,3,1.0986122886681098
nanocage,3,1.0986122886681098
Time-frequency,3,1.0986122886681098
constitutively,3,1.0986122886681098
CF-LVAS,3,1.0986122886681098
anti-IL-4,3,1.0986122886681098
Tmprss2--,3,1.0986122886681098
MDIs,3,1.0986122886681098
MDCH,3,1.0986122886681098
2000-2005,3,1.0986122886681098
sisters,3,1.0986122886681098
nitrogenous,3,1.0986122886681098
fg,3,1.0986122886681098
secretome,3,1.0986122886681098
dampened,3,1.0986122886681098
genome-reduced,3,1.0986122886681098
popularized,3,1.0986122886681098
2953,3,1.0986122886681098
Hi1a,3,1.0986122886681098
handrails,3,1.0986122886681098
testicles,3,1.0986122886681098
1805,3,1.0986122886681098
glomangiosarcoma,3,1.0986122886681098
Incidentally,3,1.0986122886681098
anhidrosis,3,1.0986122886681098
likelihood-based,3,1.0986122886681098
kyphosis,3,1.0986122886681098
Oakland,3,1.0986122886681098
intercepting,3,1.0986122886681098
human-virus,3,1.0986122886681098
algorithm-based,3,1.0986122886681098
unfeasible,3,1.0986122886681098
Indies,3,1.0986122886681098
0542,3,1.0986122886681098
Temple,3,1.0986122886681098
Papain-like,3,1.0986122886681098
MwoA,3,1.0986122886681098
iteration,3,1.0986122886681098
MWA,3,1.0986122886681098
View,3,1.0986122886681098
PolyVD,3,1.0986122886681098
polyvascular,3,1.0986122886681098
Yorkshire,3,1.0986122886681098
iMRI,3,1.0986122886681098
Baylor,3,1.0986122886681098
compounding,3,1.0986122886681098
aetiopathogenesis,3,1.0986122886681098
Mayotte,3,1.0986122886681098
children’s,3,1.0986122886681098
protagonists,3,1.0986122886681098
re-organization,3,1.0986122886681098
Resection,3,1.0986122886681098
stuffy,3,1.0986122886681098
rheologic,3,1.0986122886681098
right-side,3,1.0986122886681098
patient-relevant,3,1.0986122886681098
Prospects,3,1.0986122886681098
bench-to-bedside,3,1.0986122886681098
Absent,3,1.0986122886681098
FEV1forced,3,1.0986122886681098
HiBiT-RBD,3,1.0986122886681098
re-purposing,3,1.0986122886681098
uncrossed,3,1.0986122886681098
certifications,3,1.0986122886681098
ultra-acute,3,1.0986122886681098
audio-recorded,3,1.0986122886681098
orientations,3,1.0986122886681098
pleomorphic,3,1.0986122886681098
RNA-containing,3,1.0986122886681098
cannabidiol,3,1.0986122886681098
3-DE,3,1.0986122886681098
phytocompounds,3,1.0986122886681098
1927,3,1.0986122886681098
noninterventional,3,1.0986122886681098
freitasi,3,1.0986122886681098
bullets,3,1.0986122886681098
neuro-psychiatric,3,1.0986122886681098
Methodist,3,1.0986122886681098
Donor,3,1.0986122886681098
PSOTRs,3,1.0986122886681098
Dipetalonema,3,1.0986122886681098
chaperoning,3,1.0986122886681098
sulcus,3,1.0986122886681098
nematodes,3,1.0986122886681098
supporters,3,1.0986122886681098
rooming-in,3,1.0986122886681098
forebrain,3,1.0986122886681098
femalemale,3,1.0986122886681098
S1-S2,3,1.0986122886681098
plasmic,3,1.0986122886681098
ESCC,3,1.0986122886681098
balloon-expandable,3,1.0986122886681098
serviced,3,1.0986122886681098
evaluator,3,1.0986122886681098
mastectomy,3,1.0986122886681098
N9,3,1.0986122886681098
Macroscopically,3,1.0986122886681098
rs1048479,3,1.0986122886681098
prokaryotic,3,1.0986122886681098
Postpartum,3,1.0986122886681098
food-frequency,3,1.0986122886681098
ever-expanding,3,1.0986122886681098
Palliative,3,1.0986122886681098
mexicor,3,1.0986122886681098
Fragile,3,1.0986122886681098
Fluctuations,3,1.0986122886681098
Portal,3,1.0986122886681098
Optimally,3,1.0986122886681098
coconut,3,1.0986122886681098
climb,3,1.0986122886681098
intra-cardiac,3,1.0986122886681098
stainless-steel,3,1.0986122886681098
cross-disciplinary,3,1.0986122886681098
ontogeny,3,1.0986122886681098
dasatinib-induced,3,1.0986122886681098
occulusion,3,1.0986122886681098
high-functioning,3,1.0986122886681098
PfzierBioNTech,3,1.0986122886681098
rs113350588,3,1.0986122886681098
Epidemiol,3,1.0986122886681098
7-month,3,1.0986122886681098
centenary,3,1.0986122886681098
TripleLock,3,1.0986122886681098
Jinhua,3,1.0986122886681098
hyperfunction,3,1.0986122886681098
villi,3,1.0986122886681098
1219,3,1.0986122886681098
1171,3,1.0986122886681098
microdroplets,3,1.0986122886681098
EMM,3,1.0986122886681098
Paramedian,3,1.0986122886681098
volitional,3,1.0986122886681098
hematologists,3,1.0986122886681098
1549,3,1.0986122886681098
months-17,3,1.0986122886681098
S-group,3,1.0986122886681098
T-group,3,1.0986122886681098
HK213,3,1.0986122886681098
1983-1984,3,1.0986122886681098
1479,3,1.0986122886681098
Unsupervised,3,1.0986122886681098
PANAS,3,1.0986122886681098
Biomonitoring,3,1.0986122886681098
E-AP-CeO2,3,1.0986122886681098
angiotensin‑converting,3,1.0986122886681098
four-part,3,1.0986122886681098
Shigan,3,1.0986122886681098
Maxing,3,1.0986122886681098
PRAM,3,1.0986122886681098
post-CAS,3,1.0986122886681098
Ximelagatran,3,1.0986122886681098
RV-induced,3,1.0986122886681098
Jiedu,3,1.0986122886681098
Asthma-PD,3,1.0986122886681098
Irreversible,3,1.0986122886681098
instructors,3,1.0986122886681098
CQHCQ,3,1.0986122886681098
layperson,3,1.0986122886681098
emotionalism,3,1.0986122886681098
STAI,3,1.0986122886681098
ΔORF,3,1.0986122886681098
close-ended,3,1.0986122886681098
1083,3,1.0986122886681098
SNAP1,3,1.0986122886681098
BackgroundIn,3,1.0986122886681098
HMs,3,1.0986122886681098
CMD,3,1.0986122886681098
Examiner,3,1.0986122886681098
reoperations,3,1.0986122886681098
restraints,3,1.0986122886681098
assessors,3,1.0986122886681098
ethic,3,1.0986122886681098
expressivity,3,1.0986122886681098
dysmorphic,3,1.0986122886681098
virus-receptor,3,1.0986122886681098
PLOS,3,1.0986122886681098
social-economic,3,1.0986122886681098
NADPH,3,1.0986122886681098
Hepatology,3,1.0986122886681098
rESV,3,1.0986122886681098
deviant,3,1.0986122886681098
impotence,3,1.0986122886681098
nasaloropharyngeal,3,1.0986122886681098
Aerosol-generating,3,1.0986122886681098
DHCPs,3,1.0986122886681098
luxury,3,1.0986122886681098
deviance,3,1.0986122886681098
Rag2--,3,1.0986122886681098
Harmonizing,3,1.0986122886681098
inextricably,3,1.0986122886681098
mesencephalon,3,1.0986122886681098
Indonesias,3,1.0986122886681098
non-wind,3,1.0986122886681098
1990-1991,3,1.0986122886681098
blockades,3,1.0986122886681098
peninsula,3,1.0986122886681098
injuring,3,1.0986122886681098
sibs,3,1.0986122886681098
OCR,3,1.0986122886681098
misidentification,3,1.0986122886681098
scholastic,3,1.0986122886681098
treatment-based,3,1.0986122886681098
coracoid,3,1.0986122886681098
rSARS-CoV-2WT,3,1.0986122886681098
widths,3,1.0986122886681098
thrombophlebitis,3,1.0986122886681098
GV20,3,1.0986122886681098
athymhormia,3,1.0986122886681098
SLT,3,1.0986122886681098
fulfils,3,1.0986122886681098
diffusely,3,1.0986122886681098
Ukg,3,1.0986122886681098
30-69,3,1.0986122886681098
ACAS,3,1.0986122886681098
efficaciously,3,1.0986122886681098
helpline,3,1.0986122886681098
subdistribution,3,1.0986122886681098
MLT,3,1.0986122886681098
dpso,3,1.0986122886681098
CXCL12,3,1.0986122886681098
partitions,3,1.0986122886681098
Vol,3,1.0986122886681098
L5,3,1.0986122886681098
time-span,3,1.0986122886681098
C14408T,3,1.0986122886681098
Aminophylline,3,1.0986122886681098
SICI,3,1.0986122886681098
Discriminating,3,1.0986122886681098
east-west,3,1.0986122886681098
19-20,3,1.0986122886681098
goal-oriented,3,1.0986122886681098
2277,3,1.0986122886681098
door-to-CT,3,1.0986122886681098
self-treat,3,1.0986122886681098
Electrochemical,3,1.0986122886681098
interfacility,3,1.0986122886681098
11127,3,1.0986122886681098
Problem-solving,3,1.0986122886681098
1370,3,1.0986122886681098
much-needed,3,1.0986122886681098
lesional,3,1.0986122886681098
Readily,3,1.0986122886681098
TRIM25,3,1.0986122886681098
9-year,3,1.0986122886681098
dynamism,3,1.0986122886681098
MAptapro-IR1,3,1.0986122886681098
motivators,3,1.0986122886681098
clinicoradiological,3,1.0986122886681098
sweeps,3,1.0986122886681098
FGF21,3,1.0986122886681098
Severely,3,1.0986122886681098
condensed,3,1.0986122886681098
510-methylenetetrahydrofolate,3,1.0986122886681098
RSCU,3,1.0986122886681098
proteome-wide,3,1.0986122886681098
bevacizumab,3,1.0986122886681098
Followup,3,1.0986122886681098
kezelés,3,1.0986122886681098
zymosan,3,1.0986122886681098
blame,3,1.0986122886681098
6065,3,1.0986122886681098
bronchospasms,3,1.0986122886681098
conveyance,3,1.0986122886681098
CREG,3,1.0986122886681098
Balancing,3,1.0986122886681098
GDNF,3,1.0986122886681098
1200000,3,1.0986122886681098
lymphadenectomy,3,1.0986122886681098
GenePro,3,1.0986122886681098
3143,3,1.0986122886681098
fourth-generation,3,1.0986122886681098
splenectomized,3,1.0986122886681098
depletion-of-susceptibles,3,1.0986122886681098
BEST,3,1.0986122886681098
Cts,3,1.0986122886681098
Viasure,3,1.0986122886681098
blurred,3,1.0986122886681098
mM,3,1.0986122886681098
75-85,3,1.0986122886681098
pharmaceutics,3,1.0986122886681098
nanomicroarray,3,1.0986122886681098
P⩽0001,3,1.0986122886681098
low-educated,3,1.0986122886681098
accomplishment,3,1.0986122886681098
DAVID,3,1.0986122886681098
ANPNPRA,3,1.0986122886681098
1034,3,1.0986122886681098
desk,3,1.0986122886681098
nanomixing,3,1.0986122886681098
Nitazoxanide,3,1.0986122886681098
re-presented,3,1.0986122886681098
microassay,3,1.0986122886681098
multiple-segment,3,1.0986122886681098
STRING,3,1.0986122886681098
China-Japan,3,1.0986122886681098
cis-acting,3,1.0986122886681098
Thoratec,3,1.0986122886681098
medication-class,3,1.0986122886681098
19-25,3,1.0986122886681098
21-month,3,1.0986122886681098
Friendship,3,1.0986122886681098
3C,3,1.0986122886681098
system-level,3,1.0986122886681098
Letter,3,1.0986122886681098
discounting,3,1.0986122886681098
church,3,1.0986122886681098
Orientation,3,1.0986122886681098
unfavorably,3,1.0986122886681098
0783,3,1.0986122886681098
ISAM,3,1.0986122886681098
13N-ammonia,3,1.0986122886681098
EuroSCORE,3,1.0986122886681098
redress,3,1.0986122886681098
PtcO2,3,1.0986122886681098
Stata,3,1.0986122886681098
APRV,3,1.0986122886681098
DNA-,3,1.0986122886681098
tetrahydrofolate,3,1.0986122886681098
WIV-1,3,1.0986122886681098
ruralurban,3,1.0986122886681098
12-mo,3,1.0986122886681098
SAMMPRIS,3,1.0986122886681098
Th1Th17,3,1.0986122886681098
postero-basal,3,1.0986122886681098
susceptible-infectious-recovered,3,1.0986122886681098
Stroke--5th,3,1.0986122886681098
BBs,3,1.0986122886681098
EDCs,3,1.0986122886681098
deoxynucleotidyl,3,1.0986122886681098
nick,3,1.0986122886681098
Viewing,3,1.0986122886681098
caspases,3,1.0986122886681098
RRR,3,1.0986122886681098
chromaffin,3,1.0986122886681098
VCAR,3,1.0986122886681098
accommodations,3,1.0986122886681098
1602,3,1.0986122886681098
fowls,3,1.0986122886681098
waited,3,1.0986122886681098
BVictoria287-like,3,1.0986122886681098
monolayers,3,1.0986122886681098
RAPPID,3,1.0986122886681098
Encyclopedia,3,1.0986122886681098
Placebo-controlled,3,1.0986122886681098
apogeotropic,3,1.0986122886681098
2-adrenoreceptor,3,1.0986122886681098
GAIN,3,1.0986122886681098
Abana,3,1.0986122886681098
SApNP,3,1.0986122886681098
tünetek,3,1.0986122886681098
lengthen,3,1.0986122886681098
physician-confirmed,3,1.0986122886681098
enyhe,3,1.0986122886681098
Uniphyl,3,1.0986122886681098
V-lineage,3,1.0986122886681098
terminologies,3,1.0986122886681098
Caspian,3,1.0986122886681098
Presidents,3,1.0986122886681098
laboratory-tested,3,1.0986122886681098
attends,3,1.0986122886681098
EFPT-BR,3,1.0986122886681098
infection-naïve,3,1.0986122886681098
Persuasive,3,1.0986122886681098
reacts,3,1.0986122886681098
libido,3,1.0986122886681098
Light-to-moderate,3,1.0986122886681098
elderlies,3,1.0986122886681098
eculizumab,3,1.0986122886681098
Autoantibodies,3,1.0986122886681098
HPT,3,1.0986122886681098
DIS,3,1.0986122886681098
Usage,3,1.0986122886681098
haemorheology,3,1.0986122886681098
perfection,3,1.0986122886681098
GHGs,3,1.0986122886681098
8-12Hz,3,1.0986122886681098
Babies,3,1.0986122886681098
semi-annual,3,1.0986122886681098
Phytochemicals,3,1.0986122886681098
Reuptake,3,1.0986122886681098
morphed,3,1.0986122886681098
upper-extremity,3,1.0986122886681098
S-WMFT,3,1.0986122886681098
1362,3,1.0986122886681098
intraseasonal,3,1.0986122886681098
immitis,3,1.0986122886681098
sedated,3,1.0986122886681098
aliskiren,3,1.0986122886681098
1--2,3,1.0986122886681098
aspirin-resistant,3,1.0986122886681098
Heinsberg,3,1.0986122886681098
1560,3,1.0986122886681098
cohabitant,3,1.0986122886681098
univentricular,3,1.0986122886681098
Mladá,3,1.0986122886681098
α1-helix,3,1.0986122886681098
IRF7,3,1.0986122886681098
Assist,3,1.0986122886681098
CCM,3,1.0986122886681098
daganatos,3,1.0986122886681098
Fahd,3,1.0986122886681098
coronavirus‑2,3,1.0986122886681098
North-Eastern,3,1.0986122886681098
disproportional,3,1.0986122886681098
Kingston,3,1.0986122886681098
single-chain,3,1.0986122886681098
hemianopsia,3,1.0986122886681098
RFA,3,1.0986122886681098
B6-CH1-RBD,3,1.0986122886681098
matrix-assisted,3,1.0986122886681098
979-1000,3,1.0986122886681098
35-59,3,1.0986122886681098
WTT,3,1.0986122886681098
PYP,3,1.0986122886681098
gauges,3,1.0986122886681098
Th2-driven,3,1.0986122886681098
conformationally,3,1.0986122886681098
immunoprivileged,3,1.0986122886681098
AcHERV-HA,3,1.0986122886681098
allogenic,3,1.0986122886681098
OLCA-stroke,3,1.0986122886681098
dysmetria,3,1.0986122886681098
overemphasizing,3,1.0986122886681098
transcription‑quantitative,3,1.0986122886681098
cumulation,3,1.0986122886681098
bronchoprotection,3,1.0986122886681098
fructose-16-diphosphate,3,1.0986122886681098
multitype,3,1.0986122886681098
TEI,3,1.0986122886681098
edits,3,1.0986122886681098
gagging,3,1.0986122886681098
economization,3,1.0986122886681098
enlighten,3,1.0986122886681098
V7-V9,3,1.0986122886681098
re-contacted,3,1.0986122886681098
Naturally,3,1.0986122886681098
more-severe,3,1.0986122886681098
tissue-plasminogen,3,1.0986122886681098
hemiaxial,3,1.0986122886681098
AMCAS,3,1.0986122886681098
MCAS,3,1.0986122886681098
1440,3,1.0986122886681098
splenocytes,3,1.0986122886681098
Unequal,3,1.0986122886681098
coronavirus-like,3,1.0986122886681098
digitalisation,3,1.0986122886681098
dismally,3,1.0986122886681098
G614D,3,1.0986122886681098
emit,3,1.0986122886681098
Non-pharmacological,3,1.0986122886681098
Sinusitis,3,1.0986122886681098
1671,3,1.0986122886681098
Bypassing,3,1.0986122886681098
schistosome,3,1.0986122886681098
HFNC,3,1.0986122886681098
2006-2008,3,1.0986122886681098
japonicum,3,1.0986122886681098
-57,3,1.0986122886681098
treatmentprophylaxis,3,1.0986122886681098
Post-E2,3,1.0986122886681098
Post-E1,3,1.0986122886681098
-49,3,1.0986122886681098
198384,3,1.0986122886681098
‐,3,1.0986122886681098
acculturation,3,1.0986122886681098
Boleslav,3,1.0986122886681098
post-injury,3,1.0986122886681098
μgm3,3,1.0986122886681098
ATRIA,3,1.0986122886681098
CO2e,3,1.0986122886681098
unmonitored,3,1.0986122886681098
mLh,3,1.0986122886681098
RTK,3,1.0986122886681098
Fr,3,1.0986122886681098
2014-2019,3,1.0986122886681098
PTXs,3,1.0986122886681098
wasting,3,1.0986122886681098
misunderstood,3,1.0986122886681098
pepitope,3,1.0986122886681098
αOX40,3,1.0986122886681098
SVSpike,3,1.0986122886681098
Pre-E,3,1.0986122886681098
-70,3,1.0986122886681098
1261,3,1.0986122886681098
Descending,3,1.0986122886681098
intercostals,3,1.0986122886681098
IFAST,3,1.0986122886681098
Essentially,3,1.0986122886681098
elastosis,3,1.0986122886681098
FNMI,3,1.0986122886681098
Doubling,3,1.0986122886681098
15-85,3,1.0986122886681098
1269,3,1.0986122886681098
Interruption,3,1.0986122886681098
trusts,3,1.0986122886681098
Laplace,3,1.0986122886681098
visuoperceptual,3,1.0986122886681098
Hs-CRP,3,1.0986122886681098
Inattention,3,1.0986122886681098
DFSA,3,1.0986122886681098
Implantable,3,1.0986122886681098
contact-to-balloon,3,1.0986122886681098
breathprints,3,1.0986122886681098
stillbirths,3,1.0986122886681098
Proportions,3,1.0986122886681098
well-suited,3,1.0986122886681098
ANC,3,1.0986122886681098
osteomuscular,3,1.0986122886681098
low-output,3,1.0986122886681098
well-phenotyped,3,1.0986122886681098
reshaping,3,1.0986122886681098
PrEP,3,1.0986122886681098
secondforced,3,1.0986122886681098
Parenchymal,3,1.0986122886681098
3434,3,1.0986122886681098
1977-1979,3,1.0986122886681098
radii,3,1.0986122886681098
HYVET,3,1.0986122886681098
nonhypotensive,3,1.0986122886681098
afflicts,3,1.0986122886681098
consensual,3,1.0986122886681098
MI-2,3,1.0986122886681098
MBBA,3,1.0986122886681098
nsp3,3,1.0986122886681098
TCID50ml,3,1.0986122886681098
PATIENTS,3,1.0986122886681098
epidemicity,3,1.0986122886681098
2715,3,1.0986122886681098
DEFUSE-3,3,1.0986122886681098
drill,3,1.0986122886681098
entertainment,3,1.0986122886681098
crowd,3,1.0986122886681098
one-time,3,1.0986122886681098
fast-paced,3,1.0986122886681098
love,3,1.0986122886681098
NHG,3,1.0986122886681098
grappling,3,1.0986122886681098
northwestern,3,1.0986122886681098
FLG-associated,3,1.0986122886681098
cranioplasty,3,1.0986122886681098
halo,3,1.0986122886681098
knockouts,3,1.0986122886681098
influenza-pneumonia,3,1.0986122886681098
hypercoaguable,3,1.0986122886681098
non-cocaine-related,3,1.0986122886681098
one-size,3,1.0986122886681098
ninety-five,3,1.0986122886681098
theorizing,3,1.0986122886681098
neoadjuvant,3,1.0986122886681098
PVD,3,1.0986122886681098
TIMI-III,3,1.0986122886681098
phage,3,1.0986122886681098
100-year,3,1.0986122886681098
Okayama,3,1.0986122886681098
COX,3,1.0986122886681098
Reorganization,3,1.0986122886681098
titrating,3,1.0986122886681098
cineangiogram,3,1.0986122886681098
clerks,3,1.0986122886681098
pranayama,3,1.0986122886681098
077-098,3,1.0986122886681098
RBP4,3,1.0986122886681098
minimisation,3,1.0986122886681098
infers,3,1.0986122886681098
swietokrzyskie,3,1.0986122886681098
Lincoln,3,1.0986122886681098
trypsin-like,3,1.0986122886681098
endometriosis,3,1.0986122886681098
Carbohydrate,3,1.0986122886681098
60--90,3,1.0986122886681098
Glial,3,1.0986122886681098
Via,3,1.0986122886681098
-043,3,1.0986122886681098
18-35,3,1.0986122886681098
pluralism,3,1.0986122886681098
paints,3,1.0986122886681098
learner,3,1.0986122886681098
atypia,3,1.0986122886681098
outbreak-related,3,1.0986122886681098
HEK,3,1.0986122886681098
real‐time,3,1.0986122886681098
utóbbi,3,1.0986122886681098
non-symptomatic,3,1.0986122886681098
unsatisfied,3,1.0986122886681098
23-,3,1.0986122886681098
primarysecondary,3,1.0986122886681098
protector,3,1.0986122886681098
HO,3,1.0986122886681098
cell-cultured,3,1.0986122886681098
AFO,3,1.0986122886681098
FLG,3,1.0986122886681098
FCFA,3,1.0986122886681098
Triggering,3,1.0986122886681098
agglomeration,3,1.0986122886681098
Xiamen,3,1.0986122886681098
first-hand,3,1.0986122886681098
histopathologically,3,1.0986122886681098
low-titre,3,1.0986122886681098
procured,3,1.0986122886681098
CARMERTK,3,1.0986122886681098
EUROS,3,1.0986122886681098
micro-NT,3,1.0986122886681098
ResNet101,3,1.0986122886681098
CA1,3,1.0986122886681098
ResNet50,3,1.0986122886681098
ResNet18,3,1.0986122886681098
x2,3,1.0986122886681098
ozagrel,3,1.0986122886681098
alternated,3,1.0986122886681098
Aerospace,3,1.0986122886681098
Least,3,1.0986122886681098
teleradiológiai,3,1.0986122886681098
bachelor,3,1.0986122886681098
Marks,3,1.0986122886681098
4×20,3,1.0986122886681098
non-reperfusion,3,1.0986122886681098
heparinized,3,1.0986122886681098
CARs,3,1.0986122886681098
autonomously,3,1.0986122886681098
noninfluenza,3,1.0986122886681098
PTAH,3,1.0986122886681098
Emory,3,1.0986122886681098
Provide,3,1.0986122886681098
non-PTCA,3,1.0986122886681098
AESD,3,1.0986122886681098
evolutions,3,1.0986122886681098
sex-ratio,3,1.0986122886681098
benzoyl,3,1.0986122886681098
0978,3,1.0986122886681098
Wegeners,3,1.0986122886681098
effacement,3,1.0986122886681098
PD35SGaw,3,1.0986122886681098
halogenated,3,1.0986122886681098
microcatheterization,3,1.0986122886681098
alpha-adrenergic,3,1.0986122886681098
peribronchovascular,3,1.0986122886681098
T2-type,3,1.0986122886681098
beta-Adrenergic,3,1.0986122886681098
fallsnear,3,1.0986122886681098
VCPbSAg2,3,1.0986122886681098
2426,3,1.0986122886681098
TCR,3,1.0986122886681098
PRACTALL,3,1.0986122886681098
nominated,3,1.0986122886681098
prostatectomy,3,1.0986122886681098
DSe,3,1.0986122886681098
nanoprobes,3,1.0986122886681098
unpacking,3,1.0986122886681098
Organizational,3,1.0986122886681098
lake,3,1.0986122886681098
baumannii,3,1.0986122886681098
less-invasive,3,1.0986122886681098
gangrene,3,1.0986122886681098
hyporeactive,3,1.0986122886681098
bupivacaine,3,1.0986122886681098
succinctly,3,1.0986122886681098
hyperpyrexia,3,1.0986122886681098
higher-than-expected,3,1.0986122886681098
1595,3,1.0986122886681098
35-74,3,1.0986122886681098
Bd,3,1.0986122886681098
meriting,3,1.0986122886681098
mesalazine,3,1.0986122886681098
OLS,3,1.0986122886681098
Progenitor,3,1.0986122886681098
Vestibular,3,1.0986122886681098
patient-,3,1.0986122886681098
H5N1-positive,3,1.0986122886681098
glucagon-like,3,1.0986122886681098
mellett,3,1.0986122886681098
subfertile,3,1.0986122886681098
transendothelial,3,1.0986122886681098
Multifaceted,3,1.0986122886681098
Syria,3,1.0986122886681098
polymicrobial,3,1.0986122886681098
H5N1-negative,3,1.0986122886681098
non-targeted,3,1.0986122886681098
LoS,3,1.0986122886681098
Mallorca,3,1.0986122886681098
A5,3,1.0986122886681098
Thoracoscopic,3,1.0986122886681098
unload,3,1.0986122886681098
prehypertension,3,1.0986122886681098
radar,3,1.0986122886681098
2956,3,1.0986122886681098
qSAT,3,1.0986122886681098
recombinase-aided,3,1.0986122886681098
fibrinopurulent,3,1.0986122886681098
chronologic,3,1.0986122886681098
G186V,3,1.0986122886681098
L194P,3,1.0986122886681098
1681,3,1.0986122886681098
theyre,3,1.0986122886681098
fulfilment,3,1.0986122886681098
99mTc-MIBI,3,1.0986122886681098
b-value,3,1.0986122886681098
nephrologists,3,1.0986122886681098
wearers,3,1.0986122886681098
catalyst,3,1.0986122886681098
clearest,3,1.0986122886681098
40EF,3,1.0986122886681098
noncarriers,3,1.0986122886681098
shut-off,3,1.0986122886681098
primigravida,3,1.0986122886681098
RT-LAMP-based,3,1.0986122886681098
Notice,3,1.0986122886681098
preexercise,3,1.0986122886681098
1788,3,1.0986122886681098
unveiling,3,1.0986122886681098
deformable,3,1.0986122886681098
microvascularization,3,1.0986122886681098
CK-IG,3,1.0986122886681098
Anti-interleukin,3,1.0986122886681098
Capsule,3,1.0986122886681098
DIL,3,1.0986122886681098
nonspecialized,3,1.0986122886681098
feverishness,3,1.0986122886681098
quickest,3,1.0986122886681098
Exercise-Heart,3,1.0986122886681098
investing,3,1.0986122886681098
schoolworkplace,3,1.0986122886681098
Contributors,3,1.0986122886681098
Buergers,3,1.0986122886681098
eased,3,1.0986122886681098
REG,3,1.0986122886681098
hCSC,3,1.0986122886681098
preconditioned-hCSC,3,1.0986122886681098
extra-corporeal,3,1.0986122886681098
heterosexual,3,1.0986122886681098
75th,3,1.0986122886681098
balloon-dependent,3,1.0986122886681098
measureable,3,1.0986122886681098
adenoma,3,1.0986122886681098
noncardiogenic,3,1.0986122886681098
chungpyesagan-tang,3,1.0986122886681098
donating,3,1.0986122886681098
Plasmapheresis,3,1.0986122886681098
spirals,3,1.0986122886681098
SERS-based,3,1.0986122886681098
co-operate,3,1.0986122886681098
Au,3,1.0986122886681098
macro-,3,1.0986122886681098
Out-patient,3,1.0986122886681098
sun,3,1.0986122886681098
ABeijing3292,3,1.0986122886681098
dice,3,1.0986122886681098
199394,3,1.0986122886681098
entrapment,3,1.0986122886681098
Aberdeen,3,1.0986122886681098
droop,3,1.0986122886681098
Meuse-Argonne,3,1.0986122886681098
ground-breaking,3,1.0986122886681098
treatment-subgroup,3,1.0986122886681098
≥71,3,1.0986122886681098
midexpiratory,3,1.0986122886681098
Electrophysiologic,3,1.0986122886681098
40-250,3,1.0986122886681098
Consultations,3,1.0986122886681098
self-directed,3,1.0986122886681098
n40,3,1.0986122886681098
sociopolitical,3,1.0986122886681098
Model-based,3,1.0986122886681098
4400,3,1.0986122886681098
Macrophages,3,1.0986122886681098
PNU,3,1.0986122886681098
confounder,3,1.0986122886681098
posteroanterior,3,1.0986122886681098
emitters,3,1.0986122886681098
infarct-avid,3,1.0986122886681098
OM-group,3,1.0986122886681098
Processes,3,1.0986122886681098
lung-function,3,1.0986122886681098
Assessed,3,1.0986122886681098
2630,3,1.0986122886681098
descriptor,3,1.0986122886681098
non-Emiratis,3,1.0986122886681098
visualise,3,1.0986122886681098
immunoglobin,3,1.0986122886681098
NCIT,3,1.0986122886681098
meso,3,1.0986122886681098
RIRR,3,1.0986122886681098
kr,3,1.0986122886681098
PSRH,3,1.0986122886681098
non-rheumatic,3,1.0986122886681098
clears,3,1.0986122886681098
CRISPR-augmented,3,1.0986122886681098
unification,3,1.0986122886681098
Ondines,3,1.0986122886681098
Blocker,3,1.0986122886681098
clothes,3,1.0986122886681098
loss-of-function,3,1.0986122886681098
1614,3,1.0986122886681098
MBI,3,1.0986122886681098
high-use,3,1.0986122886681098
WM-group,3,1.0986122886681098
SARS-CoV-2-CMI,3,1.0986122886681098
Chin,3,1.0986122886681098
614D,3,1.0986122886681098
confirmative,3,1.0986122886681098
COVID-19-compatible,3,1.0986122886681098
stylistic,3,1.0986122886681098
adherers,3,1.0986122886681098
fluctuation-very,3,1.0986122886681098
PGM,3,1.0986122886681098
IC95,3,1.0986122886681098
Equitable,3,1.0986122886681098
chance-corrected,3,1.0986122886681098
deformed,3,1.0986122886681098
Academies,3,1.0986122886681098
RIM,3,1.0986122886681098
AT1001,3,1.0986122886681098
strategys,3,1.0986122886681098
four-fifths,3,1.0986122886681098
mortalityABSTRACT,3,1.0986122886681098
recalculate,3,1.0986122886681098
Intracellular,3,1.0986122886681098
viper,3,1.0986122886681098
hinterland,3,1.0986122886681098
Wistar-Kyoto,3,1.0986122886681098
large-bore,3,1.0986122886681098
CPK-MM,3,1.0986122886681098
RWMSI,3,1.0986122886681098
extra-oesophageal,3,1.0986122886681098
Hospital-acquired,3,1.0986122886681098
1759,3,1.0986122886681098
CGHA,3,1.0986122886681098
1253,3,1.0986122886681098
authenticated,3,1.0986122886681098
2187,3,1.0986122886681098
Abrupt,3,1.0986122886681098
study-specific,3,1.0986122886681098
Directional,3,1.0986122886681098
071-094,3,1.0986122886681098
90-days,3,1.0986122886681098
uncovers,3,1.0986122886681098
inter-subject,3,1.0986122886681098
Olmsted,3,1.0986122886681098
inconveniences,3,1.0986122886681098
dual-criterion,3,1.0986122886681098
publically,3,1.0986122886681098
everybody,3,1.0986122886681098
pandemic-media-fatigue,3,1.0986122886681098
CP®,3,1.0986122886681098
convertase,3,1.0986122886681098
nonsystematic,3,1.0986122886681098
corticoid-resistant,3,1.0986122886681098
A57,3,1.0986122886681098
AOntario12522007,3,1.0986122886681098
AFM147,3,1.0986122886681098
Y41,3,1.0986122886681098
Wells-Riley,3,1.0986122886681098
medication-related,3,1.0986122886681098
Anti-CoV2,3,1.0986122886681098
Koreans,3,1.0986122886681098
hardships,3,1.0986122886681098
immunocytochemical,3,1.0986122886681098
life-span,3,1.0986122886681098
Vigorous,3,1.0986122886681098
Avidity,3,1.0986122886681098
Friedman,3,1.0986122886681098
disinfected,3,1.0986122886681098
CRCT,3,1.0986122886681098
ITA,3,1.0986122886681098
Telemonitoring,3,1.0986122886681098
ECs,3,1.0986122886681098
Whichever,3,1.0986122886681098
Disturbed,3,1.0986122886681098
PrimeScript,3,1.0986122886681098
imaging-guided,3,1.0986122886681098
nullified,3,1.0986122886681098
string-of-beads,3,1.0986122886681098
virus-2,3,1.0986122886681098
astonishing,3,1.0986122886681098
1976-1981,3,1.0986122886681098
1834,3,1.0986122886681098
VISP,3,1.0986122886681098
nmol,3,1.0986122886681098
tNLuc,3,1.0986122886681098
DWI-MRI,3,1.0986122886681098
CoronaVirus-2,3,1.0986122886681098
flower,3,1.0986122886681098
lump,3,1.0986122886681098
polypeptides,3,1.0986122886681098
snowball,3,1.0986122886681098
infiltrations,3,1.0986122886681098
contingents,3,1.0986122886681098
alemtuzumab,3,1.0986122886681098
Virchow,3,1.0986122886681098
NAION,3,1.0986122886681098
cognizant,3,1.0986122886681098
dysplasias,3,1.0986122886681098
non-narrative,3,1.0986122886681098
Molnupiravir,3,1.0986122886681098
cladribine,3,1.0986122886681098
Rx,3,1.0986122886681098
subdue,3,1.0986122886681098
Takara,3,1.0986122886681098
S-antigen,3,1.0986122886681098
sub-networks,3,1.0986122886681098
05-5,3,1.0986122886681098
Differentially,3,1.0986122886681098
BASIS,3,1.0986122886681098
intra-arrest,3,1.0986122886681098
workable,3,1.0986122886681098
multifarious,3,1.0986122886681098
Roadmap,3,1.0986122886681098
cultivate,3,1.0986122886681098
one-arm,3,1.0986122886681098
PDR,3,1.0986122886681098
Gordon,3,1.0986122886681098
Verden,3,1.0986122886681098
Reinforcement,3,1.0986122886681098
CCC19,3,1.0986122886681098
Mannose-binding,3,1.0986122886681098
Hanover,3,1.0986122886681098
Inspired,3,1.0986122886681098
inductors,3,1.0986122886681098
AFC,3,1.0986122886681098
hemoglobinopathy,3,1.0986122886681098
Karolinska,3,1.0986122886681098
Lumipulse®,3,1.0986122886681098
Biochemistry,3,1.0986122886681098
fibroplasia,3,1.0986122886681098
omit,3,1.0986122886681098
Ingestion,3,1.0986122886681098
extention,3,1.0986122886681098
reliabilities,3,1.0986122886681098
grand,3,1.0986122886681098
proprotein,3,1.0986122886681098
corneas,3,1.0986122886681098
Virus-like,3,1.0986122886681098
mWcm2,3,1.0986122886681098
1027,3,1.0986122886681098
FDasy,3,1.0986122886681098
GSTs,3,1.0986122886681098
785000,3,1.0986122886681098
ACalifornia72004,3,1.0986122886681098
antibody-binding,3,1.0986122886681098
AJapan30557,3,1.0986122886681098
pollution-to-human,3,1.0986122886681098
self-organizing,3,1.0986122886681098
redirecting,3,1.0986122886681098
PVCM,3,1.0986122886681098
radiopaque,3,1.0986122886681098
extinct,3,1.0986122886681098
Ma,3,1.0986122886681098
concordantly,3,1.0986122886681098
QIAamp,3,1.0986122886681098
customised,3,1.0986122886681098
january,3,1.0986122886681098
december,3,1.0986122886681098
perish,3,1.0986122886681098
pro-B-type,3,1.0986122886681098
dissonant,3,1.0986122886681098
conA,3,1.0986122886681098
EXTEND-IA,3,1.0986122886681098
QuantStudio,3,1.0986122886681098
encephalopathic,3,1.0986122886681098
shortfall,3,1.0986122886681098
non-organic,3,1.0986122886681098
TBil,3,1.0986122886681098
ungated,3,1.0986122886681098
reanimation,3,1.0986122886681098
neurointerventionists,3,1.0986122886681098
blistering,3,1.0986122886681098
126000,3,1.0986122886681098
crudely,3,1.0986122886681098
Bordetella,3,1.0986122886681098
anakinra,3,1.0986122886681098
post-MCAo,3,1.0986122886681098
constricting,3,1.0986122886681098
surfactants,3,1.0986122886681098
spherocytosis,3,1.0986122886681098
Extramedullary,3,1.0986122886681098
hosting,3,1.0986122886681098
FANA,3,1.0986122886681098
Eskimo,3,1.0986122886681098
Scintigraphy,3,1.0986122886681098
non-drug,3,1.0986122886681098
disease-induced,3,1.0986122886681098
Defibrillator,3,1.0986122886681098
single-strain,3,1.0986122886681098
MA-ILI,3,1.0986122886681098
attenders,3,1.0986122886681098
mildasymptomatic,3,1.0986122886681098
insure,3,1.0986122886681098
1994-2004,3,1.0986122886681098
AFCA,3,1.0986122886681098
2011-September,3,1.0986122886681098
Imam,3,1.0986122886681098
overflows,3,1.0986122886681098
AXL,3,1.0986122886681098
nesting,3,1.0986122886681098
PED,3,1.0986122886681098
Moya-Moya,3,1.0986122886681098
Unexpected,3,1.0986122886681098
1966-67,3,1.0986122886681098
breeds,3,1.0986122886681098
1097,3,1.0986122886681098
aftereffects,3,1.0986122886681098
1382,3,1.0986122886681098
intent-to-treat,3,1.0986122886681098
p0018,3,1.0986122886681098
restaurants,3,1.0986122886681098
terns,3,1.0986122886681098
2042,3,1.0986122886681098
neurovirulence,3,1.0986122886681098
valvulopathy,3,1.0986122886681098
Department-based,3,1.0986122886681098
noncomplex,3,1.0986122886681098
P006,3,1.0986122886681098
1-16,3,1.0986122886681098
THA,3,1.0986122886681098
closed-cell,3,1.0986122886681098
bACE2,3,1.0986122886681098
ΔNIHSS,3,1.0986122886681098
Puffinus,3,1.0986122886681098
2443,3,1.0986122886681098
registry-based,3,1.0986122886681098
north-east,3,1.0986122886681098
degrading,3,1.0986122886681098
glaucoma,3,1.0986122886681098
post-HSCT,3,1.0986122886681098
3-19,3,1.0986122886681098
Substantially,3,1.0986122886681098
refrigeration,3,1.0986122886681098
Caretakers,3,1.0986122886681098
Prioritization,3,1.0986122886681098
2677,3,1.0986122886681098
PVTP,3,1.0986122886681098
RNADNA,3,1.0986122886681098
furthered,3,1.0986122886681098
spills,3,1.0986122886681098
Conversations,3,1.0986122886681098
TND-IVE,3,1.0986122886681098
herb-derived,3,1.0986122886681098
protagonist,3,1.0986122886681098
editions,3,1.0986122886681098
2068,3,1.0986122886681098
Slovenian,3,1.0986122886681098
gastroenterology,3,1.0986122886681098
purposefully,3,1.0986122886681098
AIC,3,1.0986122886681098
n41,3,1.0986122886681098
FOXC1,3,1.0986122886681098
multicrystal,3,1.0986122886681098
beforeafter,3,1.0986122886681098
Reverse-transcription,3,1.0986122886681098
maternally,3,1.0986122886681098
sinister,3,1.0986122886681098
C3a,3,1.0986122886681098
valuations,3,1.0986122886681098
BBV152,3,1.0986122886681098
ORF9,3,1.0986122886681098
asymptomatics,3,1.0986122886681098
CVHI,3,1.0986122886681098
ex-smoker,3,1.0986122886681098
Aerocrine,3,1.0986122886681098
LHospitalet,3,1.0986122886681098
re-MI,3,1.0986122886681098
4-PL,3,1.0986122886681098
charities,3,1.0986122886681098
skews,3,1.0986122886681098
sE-selectin,3,1.0986122886681098
cp,3,1.0986122886681098
exhaling,3,1.0986122886681098
dusty,3,1.0986122886681098
hijacking,3,1.0986122886681098
undercooked,3,1.0986122886681098
asthmaConclusions,3,1.0986122886681098
NHC-TP,3,1.0986122886681098
bracket,3,1.0986122886681098
nanocages,3,1.0986122886681098
Sumatra,3,1.0986122886681098
KTA,3,1.0986122886681098
helium-neon,3,1.0986122886681098
sima,3,1.0986122886681098
1991-1995,3,1.0986122886681098
generalists,3,1.0986122886681098
Prothrombotic,3,1.0986122886681098
sturdy,3,1.0986122886681098
nanophotonic,3,1.0986122886681098
value-added,3,1.0986122886681098
cereals,3,1.0986122886681098
5-45,3,1.0986122886681098
1356,3,1.0986122886681098
Corp,3,1.0986122886681098
B11281,3,1.0986122886681098
cost-reimbursement,3,1.0986122886681098
GPIbalpha,3,1.0986122886681098
19-fold,3,1.0986122886681098
Autogenic,3,1.0986122886681098
urokinase-type,3,1.0986122886681098
2632,3,1.0986122886681098
clinicallaboratory,3,1.0986122886681098
Enalapril,3,1.0986122886681098
piA,3,1.0986122886681098
1265,3,1.0986122886681098
panting,3,1.0986122886681098
knock-out,3,1.0986122886681098
hood,3,1.0986122886681098
capillary--fiber,3,1.0986122886681098
no-RVD,3,1.0986122886681098
Nitrite,3,1.0986122886681098
CRM,3,1.0986122886681098
reevaluate,3,1.0986122886681098
subconjunctival,3,1.0986122886681098
Morphologic,3,1.0986122886681098
reaction-restriction,3,1.0986122886681098
preshock,3,1.0986122886681098
SFTP,3,1.0986122886681098
algal,3,1.0986122886681098
1992-1996,3,1.0986122886681098
UHPLC-MS,3,1.0986122886681098
chilling,3,1.0986122886681098
stirred,3,1.0986122886681098
contest,3,1.0986122886681098
moderate-intensity,3,1.0986122886681098
JMB2002,3,1.0986122886681098
1163,3,1.0986122886681098
Intervening,3,1.0986122886681098
Paracetamol,3,1.0986122886681098
trans-thoracic,3,1.0986122886681098
Benfords,3,1.0986122886681098
calendars,3,1.0986122886681098
rescinding,3,1.0986122886681098
Tokyo-Yokohama,3,1.0986122886681098
multiforme,3,1.0986122886681098
thyrotoxic,3,1.0986122886681098
reemerge,3,1.0986122886681098
intricately,3,1.0986122886681098
barrel,3,1.0986122886681098
palmitoleic,3,1.0986122886681098
SwIN,3,1.0986122886681098
technologically,3,1.0986122886681098
grocery,3,1.0986122886681098
recirculation,3,1.0986122886681098
stroke-units,3,1.0986122886681098
Anamnestic,3,1.0986122886681098
large-size,3,1.0986122886681098
Wkg,3,1.0986122886681098
distractor,3,1.0986122886681098
2538,3,1.0986122886681098
self-powered,3,1.0986122886681098
NSET,3,1.0986122886681098
PHD,3,1.0986122886681098
nondrug,3,1.0986122886681098
27000,3,1.0986122886681098
MIAMI,3,1.0986122886681098
CRVs,3,1.0986122886681098
6-SMT,3,1.0986122886681098
obesity-asthma,3,1.0986122886681098
Wepfer,3,1.0986122886681098
referable,3,1.0986122886681098
NPR3,3,1.0986122886681098
Jakob,3,1.0986122886681098
∼15,3,1.0986122886681098
bromocriptine,3,1.0986122886681098
Oct4,3,1.0986122886681098
Niue,3,1.0986122886681098
Hippocrates,3,1.0986122886681098
Irans,3,1.0986122886681098
Mechanism,3,1.0986122886681098
-060,3,1.0986122886681098
PEG-mediated,3,1.0986122886681098
CPU,3,1.0986122886681098
motorcycle,3,1.0986122886681098
slowdown,3,1.0986122886681098
Binfluenza,3,1.0986122886681098
Restored,3,1.0986122886681098
hesitancyresistance,3,1.0986122886681098
MRAPPCWP,3,1.0986122886681098
climbed,3,1.0986122886681098
radiotracers,3,1.0986122886681098
APSU,3,1.0986122886681098
3b,3,1.0986122886681098
humidification,3,1.0986122886681098
hemopoietic,3,1.0986122886681098
severitycontrol,3,1.0986122886681098
non-spatial,3,1.0986122886681098
SLTA,3,1.0986122886681098
2931,3,1.0986122886681098
long-stay,3,1.0986122886681098
first-stroke,3,1.0986122886681098
1162,3,1.0986122886681098
non-ST--segment,3,1.0986122886681098
pyramids,3,1.0986122886681098
GISSI-1,3,1.0986122886681098
Saiboku-to,3,1.0986122886681098
Infantile,3,1.0986122886681098
15-21,3,1.0986122886681098
ssp,3,1.0986122886681098
purview,3,1.0986122886681098
2-3rd,3,1.0986122886681098
Morozov,3,1.0986122886681098
Gastric,3,1.0986122886681098
Ophthalmol,3,1.0986122886681098
IL-26,3,1.0986122886681098
Stroke-associated,3,1.0986122886681098
bandwidth,3,1.0986122886681098
epiglottis,3,1.0986122886681098
Wiktor,3,1.0986122886681098
immaturity,3,1.0986122886681098
cognitiveaffective,3,1.0986122886681098
DCN2,3,1.0986122886681098
cine-MRI,3,1.0986122886681098
debilitation,3,1.0986122886681098
1432,3,1.0986122886681098
VHA,3,1.0986122886681098
Petri,3,1.0986122886681098
diverting,3,1.0986122886681098
sub-population,3,1.0986122886681098
AFujian41102,3,1.0986122886681098
Hostility,3,1.0986122886681098
broncho-pulmonary,3,1.0986122886681098
Outreach,3,1.0986122886681098
roentgenological,3,1.0986122886681098
guarding,3,1.0986122886681098
attack-related,3,1.0986122886681098
probe-based,3,1.0986122886681098
cost-analysis,3,1.0986122886681098
rs767649,3,1.0986122886681098
habitats,3,1.0986122886681098
Orf3a,3,1.0986122886681098
0086,3,1.0986122886681098
EXE,3,1.0986122886681098
Ophthalmology,3,1.0986122886681098
glycomics,3,1.0986122886681098
recombine,3,1.0986122886681098
anti-tuberculosis,3,1.0986122886681098
veritable,3,1.0986122886681098
lire,3,1.0986122886681098
higher-level,3,1.0986122886681098
cytokinechemokine,3,1.0986122886681098
countryside,3,1.0986122886681098
Cook,3,1.0986122886681098
CatWalk,3,1.0986122886681098
low-passage,3,1.0986122886681098
low-flow,3,1.0986122886681098
PAVs,3,1.0986122886681098
Tl201,3,1.0986122886681098
ganglioside,3,1.0986122886681098
mentorship,3,1.0986122886681098
Maricopa,3,1.0986122886681098
direct-writing,3,1.0986122886681098
photographic,3,1.0986122886681098
enquiring,3,1.0986122886681098
MGEs,3,1.0986122886681098
macroaggregated,3,1.0986122886681098
2862,3,1.0986122886681098
MASS,3,1.0986122886681098
60°,3,1.0986122886681098
single-tube,3,1.0986122886681098
Porcine,3,1.0986122886681098
D222,3,1.0986122886681098
Baicalin,3,1.0986122886681098
NSP4,3,1.0986122886681098
RG,3,1.0986122886681098
1342,3,1.0986122886681098
Neuropeptides,3,1.0986122886681098
dilute,3,1.0986122886681098
Ninety-day,3,1.0986122886681098
hydrodynamic,3,1.0986122886681098
biobank,3,1.0986122886681098
Unmet,3,1.0986122886681098
SXscore,3,1.0986122886681098
Ratchaburi,3,1.0986122886681098
consolidates,3,1.0986122886681098
AIMS,3,1.0986122886681098
pre-immune,3,1.0986122886681098
1297,3,1.0986122886681098
Phenotype,3,1.0986122886681098
dandruff,3,1.0986122886681098
viral-specific,3,1.0986122886681098
non-dengue,3,1.0986122886681098
braincognitive,3,1.0986122886681098
polycations,3,1.0986122886681098
viremic,3,1.0986122886681098
impingers,3,1.0986122886681098
Feedback,3,1.0986122886681098
BE,3,1.0986122886681098
Aimed,3,1.0986122886681098
α2-6,3,1.0986122886681098
MarchApril,3,1.0986122886681098
VESP,3,1.0986122886681098
Limonin,3,1.0986122886681098
VEP,3,1.0986122886681098
isoleucine,3,1.0986122886681098
stir,3,1.0986122886681098
ravaged,3,1.0986122886681098
87-lead,3,1.0986122886681098
cross-resistance,3,1.0986122886681098
Genesee,3,1.0986122886681098
amrinone,3,1.0986122886681098
2-part,3,1.0986122886681098
HAdV-D56,3,1.0986122886681098
Dawley,3,1.0986122886681098
Sprague,3,1.0986122886681098
YHPG,3,1.0986122886681098
stepped-wedge,3,1.0986122886681098
Prefectural,3,1.0986122886681098
drugvaccine,3,1.0986122886681098
four-point,3,1.0986122886681098
Bivalirudin,3,1.0986122886681098
disseminators,3,1.0986122886681098
intractability,3,1.0986122886681098
1998-2008,3,1.0986122886681098
Clarifying,3,1.0986122886681098
30-49,3,1.0986122886681098
job-related,3,1.0986122886681098
mcgl,3,1.0986122886681098
personnes,3,1.0986122886681098
Explicit,3,1.0986122886681098
Cabrol,3,1.0986122886681098
concerts,3,1.0986122886681098
usher,3,1.0986122886681098
1144,3,1.0986122886681098
1310,3,1.0986122886681098
Hosmer-Lemeshow,3,1.0986122886681098
TL,3,1.0986122886681098
Amrita,3,1.0986122886681098
owe,3,1.0986122886681098
reprocessing,3,1.0986122886681098
arteriotomy,3,1.0986122886681098
Bindu,3,1.0986122886681098
2·9,3,1.0986122886681098
Ayurvedic,3,1.0986122886681098
Re-analysis,3,1.0986122886681098
interrupter,3,1.0986122886681098
18-54,3,1.0986122886681098
esophageal-pleural,3,1.0986122886681098
outstrips,3,1.0986122886681098
cysteinyl-leukotrienes,3,1.0986122886681098
refolded,3,1.0986122886681098
reestablished,3,1.0986122886681098
ST-segments,3,1.0986122886681098
fingerprints,3,1.0986122886681098
overloading,3,1.0986122886681098
Persian,3,1.0986122886681098
httpwwwcdcgovncidoddiseasesflufluvirushtm,3,1.0986122886681098
cysLT1,3,1.0986122886681098
Democracy,3,1.0986122886681098
vapour,3,1.0986122886681098
democracy,3,1.0986122886681098
thirty-one,3,1.0986122886681098
promyelocytic,3,1.0986122886681098
CeVD,3,1.0986122886681098
Highlighting,3,1.0986122886681098
swH1,3,1.0986122886681098
compassionate-use,3,1.0986122886681098
peri-Fontan,3,1.0986122886681098
Python,3,1.0986122886681098
hyperimmunoglobulin,3,1.0986122886681098
four-,3,1.0986122886681098
overdiagnosed,3,1.0986122886681098
G204R,3,1.0986122886681098
hormone-dependent,3,1.0986122886681098
ORF8L84S,3,1.0986122886681098
Penh,3,1.0986122886681098
radical-mediated,3,1.0986122886681098
bronchoconstricting,3,1.0986122886681098
DRAGON,3,1.0986122886681098
INNOVITA,3,1.0986122886681098
Krasnodar,3,1.0986122886681098
ANT6068,3,1.0986122886681098
fictitious,3,1.0986122886681098
attendants,3,1.0986122886681098
inspirable,3,1.0986122886681098
corona-virus,3,1.0986122886681098
míg,3,1.0986122886681098
crop,3,1.0986122886681098
socio-ecological,3,1.0986122886681098
Porirua,3,1.0986122886681098
Fe,3,1.0986122886681098
ΔNWU,3,1.0986122886681098
antidysrhythmic,3,1.0986122886681098
prostanoids,3,1.0986122886681098
Angiogram,3,1.0986122886681098
1C,3,1.0986122886681098
TLC-XR,3,1.0986122886681098
tryptic,3,1.0986122886681098
1640,3,1.0986122886681098
NWU,3,1.0986122886681098
férfiak,3,1.0986122886681098
CDB,3,1.0986122886681098
év,3,1.0986122886681098
szignifikánsan,3,1.0986122886681098
perfusional,3,1.0986122886681098
MSSP,3,1.0986122886681098
SARS-Cov,3,1.0986122886681098
under-five,3,1.0986122886681098
misconstrued,3,1.0986122886681098
Tea,3,1.0986122886681098
handy,3,1.0986122886681098
per-,3,1.0986122886681098
antiangiogenic,3,1.0986122886681098
SestaMIBI,3,1.0986122886681098
insurer,3,1.0986122886681098
submissions,3,1.0986122886681098
antitumor,3,1.0986122886681098
LPO,3,1.0986122886681098
homological,3,1.0986122886681098
nonstandard,3,1.0986122886681098
STND,3,1.0986122886681098
Imbalance,3,1.0986122886681098
C-type,3,1.0986122886681098
neuroimaging-based,3,1.0986122886681098
non-therapeutic,3,1.0986122886681098
saccades,3,1.0986122886681098
peri-operatively,3,1.0986122886681098
H1N1California,3,1.0986122886681098
holes,3,1.0986122886681098
GRWs,3,1.0986122886681098
proteoglycans,3,1.0986122886681098
influenza-confirmed,3,1.0986122886681098
simplifications,3,1.0986122886681098
hospital-treated,3,1.0986122886681098
malades,3,1.0986122886681098
obstetrics,3,1.0986122886681098
xanthine,3,1.0986122886681098
ICVL,3,1.0986122886681098
infection-triggered,3,1.0986122886681098
hexanoates,3,1.0986122886681098
AHIT,3,1.0986122886681098
reticulate,3,1.0986122886681098
Quantitation,3,1.0986122886681098
12q24,3,1.0986122886681098
headlines,3,1.0986122886681098
ww,3,1.0986122886681098
12q,3,1.0986122886681098
synthases,3,1.0986122886681098
therapy-induced,3,1.0986122886681098
Discontinuance,3,1.0986122886681098
Dextrocardia,3,1.0986122886681098
FOD-based,3,1.0986122886681098
Catarina,3,1.0986122886681098
FLUAV,3,1.0986122886681098
Infrared,3,1.0986122886681098
privilege,3,1.0986122886681098
reflexology,3,1.0986122886681098
0985,3,1.0986122886681098
FA-based,3,1.0986122886681098
sensitizes,3,1.0986122886681098
Apr,3,1.0986122886681098
tension-type,3,1.0986122886681098
Strongyloides,3,1.0986122886681098
co-housed,3,1.0986122886681098
Les,3,1.0986122886681098
MyD88-dependent,3,1.0986122886681098
non-TM,3,1.0986122886681098
IT-TIMI,3,1.0986122886681098
2S-SPLPO,3,1.0986122886681098
Erythropoietin,3,1.0986122886681098
Ad49L-nCoV-S,3,1.0986122886681098
Vectorcardiograms,3,1.0986122886681098
Lipoprotein-associated,3,1.0986122886681098
PRE,3,1.0986122886681098
BN,3,1.0986122886681098
14-fold,3,1.0986122886681098
vindicate,3,1.0986122886681098
hastened,3,1.0986122886681098
hemagglutinin-specific,3,1.0986122886681098
IUkg,3,1.0986122886681098
damping,3,1.0986122886681098
clinico-instrumental,3,1.0986122886681098
NZiS,3,1.0986122886681098
mathematics,3,1.0986122886681098
SDC,3,1.0986122886681098
knowns,3,1.0986122886681098
PD10T,3,1.0986122886681098
COVID-associated,3,1.0986122886681098
PD10,3,1.0986122886681098
Antireflux,3,1.0986122886681098
dystrophic,3,1.0986122886681098
mesothelium,3,1.0986122886681098
IDDVT,3,1.0986122886681098
neurones,3,1.0986122886681098
Post-operative,3,1.0986122886681098
sixfold,3,1.0986122886681098
spike-S-protein,3,1.0986122886681098
NFκB,3,1.0986122886681098
prepost,3,1.0986122886681098
MyD88,3,1.0986122886681098
Scenario,3,1.0986122886681098
non-IgE,3,1.0986122886681098
fundus,3,1.0986122886681098
PMS,3,1.0986122886681098
isoamyl,3,1.0986122886681098
THD,3,1.0986122886681098
CHQ,3,1.0986122886681098
16-28,3,1.0986122886681098
PRAMI,3,1.0986122886681098
Australia-New,3,1.0986122886681098
Topical,3,1.0986122886681098
deairing,3,1.0986122886681098
time-volume,3,1.0986122886681098
localising,3,1.0986122886681098
stillbirth,3,1.0986122886681098
self-administration,3,1.0986122886681098
centering,3,1.0986122886681098
Sad23L-nCoV-S,3,1.0986122886681098
pro-rata,3,1.0986122886681098
Orlando,3,1.0986122886681098
Arguments,3,1.0986122886681098
Facilitating,3,1.0986122886681098
idarucizumab,3,1.0986122886681098
bioethicists,3,1.0986122886681098
unhygienic,3,1.0986122886681098
MES,3,1.0986122886681098
Ear,3,1.0986122886681098
40-80,3,1.0986122886681098
acromegalic,3,1.0986122886681098
AYG,3,1.0986122886681098
county-wide,3,1.0986122886681098
ABrazil,3,1.0986122886681098
BAC,3,1.0986122886681098
Renin-angiotensin,3,1.0986122886681098
extinguished,3,1.0986122886681098
Introducing,3,1.0986122886681098
populaces,3,1.0986122886681098
1301,3,1.0986122886681098
Aga,3,1.0986122886681098
Plymouth,3,1.0986122886681098
Range,3,1.0986122886681098
compressions,3,1.0986122886681098
non-irrigation,3,1.0986122886681098
atelectatic,3,1.0986122886681098
pair-wise,3,1.0986122886681098
carcinogenic,3,1.0986122886681098
hiatus,3,1.0986122886681098
t-peak,3,1.0986122886681098
octanoate,3,1.0986122886681098
Pneumothorax,3,1.0986122886681098
tale,3,1.0986122886681098
Intraclass,3,1.0986122886681098
K51,3,1.0986122886681098
Sorting,3,1.0986122886681098
Financial,3,1.0986122886681098
religation,3,1.0986122886681098
histogram,3,1.0986122886681098
Interobserver,3,1.0986122886681098
M-distance,3,1.0986122886681098
soles,3,1.0986122886681098
highest-risk,3,1.0986122886681098
resurgences,3,1.0986122886681098
bachelors,3,1.0986122886681098
Syst-Eur,3,1.0986122886681098
2017-2019,3,1.0986122886681098
introducers,3,1.0986122886681098
mid-to-high-level-RF-IgM-positive,3,1.0986122886681098
ELCA,3,1.0986122886681098
transfect,3,1.0986122886681098
cargos,3,1.0986122886681098
microgm3,3,1.0986122886681098
shRNA,3,1.0986122886681098
olfactorygustatory,3,1.0986122886681098
Nasarawa,3,1.0986122886681098
non-fluent,3,1.0986122886681098
athletics,3,1.0986122886681098
19-year,3,1.0986122886681098
QLD15162021,3,1.0986122886681098
readjustment,3,1.0986122886681098
VIRCLIA®,3,1.0986122886681098
Analysing,3,1.0986122886681098
Wondfo®,3,1.0986122886681098
COV-19,3,1.0986122886681098
AllTest,3,1.0986122886681098
corrosive,3,1.0986122886681098
non-coronary,3,1.0986122886681098
RELY,3,1.0986122886681098
MIE,3,1.0986122886681098
L-shaped,3,1.0986122886681098
E-mediated,3,1.0986122886681098
WUIS,3,1.0986122886681098
CVRFs,3,1.0986122886681098
Honolulu,3,1.0986122886681098
A-like,3,1.0986122886681098
inertial,3,1.0986122886681098
surveying,3,1.0986122886681098
self-image,3,1.0986122886681098
HEK293T,3,1.0986122886681098
pre-PTCA,3,1.0986122886681098
Obstruction,3,1.0986122886681098
LATEF,3,1.0986122886681098
RBBBLAH,3,1.0986122886681098
readministration,3,1.0986122886681098
Designed,3,1.0986122886681098
pc-ASPECTS,3,1.0986122886681098
Proven,3,1.0986122886681098
non-Maori,3,1.0986122886681098
invasions,3,1.0986122886681098
chronotypes,3,1.0986122886681098
taux,3,1.0986122886681098
thromboembolectomy,3,1.0986122886681098
spike-S1,3,1.0986122886681098
OverCOVID,3,1.0986122886681098
ASCOT,3,1.0986122886681098
distributive,3,1.0986122886681098
4S,3,1.0986122886681098
Committees,3,1.0986122886681098
urban-industrial,3,1.0986122886681098
summit,3,1.0986122886681098
vestibulo-ocular,3,1.0986122886681098
ADD,3,1.0986122886681098
CEI,3,1.0986122886681098
three-plane,3,1.0986122886681098
non-experimental,3,1.0986122886681098
multilayer,3,1.0986122886681098
diluting,3,1.0986122886681098
MI-only,3,1.0986122886681098
microl,3,1.0986122886681098
solid-liquid,3,1.0986122886681098
Stroke-like,3,1.0986122886681098
litters,3,1.0986122886681098
Cornwall,3,1.0986122886681098
spectre,3,1.0986122886681098
delimit,3,1.0986122886681098
anti-coagulant,3,1.0986122886681098
culled,3,1.0986122886681098
Computerised,3,1.0986122886681098
Possibilities,3,1.0986122886681098
synthesizing,3,1.0986122886681098
laryngoscopy,3,1.0986122886681098
MLC601,3,1.0986122886681098
cardiotonic,3,1.0986122886681098
MPH,3,1.0986122886681098
Warner,3,1.0986122886681098
polynomial,3,1.0986122886681098
Mex09-S,3,1.0986122886681098
CLN,3,1.0986122886681098
ou,3,1.0986122886681098
Comparatively,3,1.0986122886681098
Tiotropium,3,1.0986122886681098
noticing,3,1.0986122886681098
asthma-friendly,3,1.0986122886681098
Justification,3,1.0986122886681098
OUTCOME,3,1.0986122886681098
Swedes,3,1.0986122886681098
rubs,3,1.0986122886681098
paraesophageal,3,1.0986122886681098
veteran,3,1.0986122886681098
NEW,3,1.0986122886681098
Pfeiffer,3,1.0986122886681098
Flutter,3,1.0986122886681098
VRP1,3,1.0986122886681098
MACCE,3,1.0986122886681098
visualizes,3,1.0986122886681098
non-hemorrhagic,3,1.0986122886681098
levelling,3,1.0986122886681098
LCPUFAs,3,1.0986122886681098
DMCs,3,1.0986122886681098
post-percutaneous,3,1.0986122886681098
RBD-HR,3,1.0986122886681098
3845,3,1.0986122886681098
POMS,3,1.0986122886681098
CTMC,3,1.0986122886681098
on-road,3,1.0986122886681098
pan-CoV,3,1.0986122886681098
NCS,3,1.0986122886681098
2036,3,1.0986122886681098
late-life,3,1.0986122886681098
supraclinoid,3,1.0986122886681098
thymuses,3,1.0986122886681098
Equation,3,1.0986122886681098
poison,3,1.0986122886681098
NLA,3,1.0986122886681098
Algorithms,3,1.0986122886681098
carnival,3,1.0986122886681098
19971998,3,1.0986122886681098
35th,3,1.0986122886681098
Collgroup,3,1.0986122886681098
countriesterritories,3,1.0986122886681098
60th,3,1.0986122886681098
post-PSA,3,1.0986122886681098
AiBSA,3,1.0986122886681098
Funded,3,1.0986122886681098
ImpellaCP,3,1.0986122886681098
WABSA,3,1.0986122886681098
pan-sarbecovirus,3,1.0986122886681098
10-90,3,1.0986122886681098
intraprocedural,3,1.0986122886681098
dMRI,3,1.0986122886681098
HSS,3,1.0986122886681098
adatait,3,1.0986122886681098
Rickettsial,3,1.0986122886681098
risk-stratify,3,1.0986122886681098
pedigree,3,1.0986122886681098
TSH,3,1.0986122886681098
Nemzeti,3,1.0986122886681098
embarrassment,3,1.0986122886681098
infracted,3,1.0986122886681098
sub-haplotypes,3,1.0986122886681098
spillage,3,1.0986122886681098
elemzése,3,1.0986122886681098
reproductive-aged,3,1.0986122886681098
túlélés,3,1.0986122886681098
ellátás,3,1.0986122886681098
Rentrops,3,1.0986122886681098
prototypic,3,1.0986122886681098
Objectivebackground,3,1.0986122886681098
disputes,3,1.0986122886681098
PfizerBioNTechs,3,1.0986122886681098
Stockpiling,3,1.0986122886681098
VESYMP,3,1.0986122886681098
Eurosurveillance,3,1.0986122886681098
D-HFUF,3,1.0986122886681098
activist,3,1.0986122886681098
IDD,3,1.0986122886681098
VALs,3,1.0986122886681098
rugs,3,1.0986122886681098
student-directed,3,1.0986122886681098
STEMI-betegek,3,1.0986122886681098
model-free,3,1.0986122886681098
Kelet-Magyarország,3,1.0986122886681098
antispastic,3,1.0986122886681098
Marrow,3,1.0986122886681098
5-min,3,1.0986122886681098
0601,3,1.0986122886681098
non-neurologic,3,1.0986122886681098
SARIMA,3,1.0986122886681098
Oslers,3,1.0986122886681098
Verde,3,1.0986122886681098
Mauritania,3,1.0986122886681098
17-fold,3,1.0986122886681098
NSP12P323L,3,1.0986122886681098
dyslipidemias,3,1.0986122886681098
Osler,3,1.0986122886681098
vizsgált,3,1.0986122886681098
ASO,3,1.0986122886681098
Grounded,3,1.0986122886681098
Goblet,3,1.0986122886681098
EBA,3,1.0986122886681098
nine-year,3,1.0986122886681098
self-awareness,3,1.0986122886681098
20-month,3,1.0986122886681098
I63,3,1.0986122886681098
seroconvert,3,1.0986122886681098
Ineffective,3,1.0986122886681098
SARS-CoV-2-host,3,1.0986122886681098
bronchography,3,1.0986122886681098
Chance,3,1.0986122886681098
Reopening,3,1.0986122886681098
Trinidad,3,1.0986122886681098
myxoviruses,3,1.0986122886681098
EPHX2,3,1.0986122886681098
post-cardiac,3,1.0986122886681098
Toulouse,3,1.0986122886681098
6-21,3,1.0986122886681098
crystallization,3,1.0986122886681098
school-associated,3,1.0986122886681098
Specially,3,1.0986122886681098
1-proteinase,3,1.0986122886681098
preanalytical,3,1.0986122886681098
normal-appearing,3,1.0986122886681098
Interpretive,3,1.0986122886681098
blood-derived,3,1.0986122886681098
OSAHS,3,1.0986122886681098
antivirally,3,1.0986122886681098
scorpion,3,1.0986122886681098
2330,3,1.0986122886681098
membrane-derived,3,1.0986122886681098
23403AG,3,1.0986122886681098
regiments,3,1.0986122886681098
Regiszter,3,1.0986122886681098
DPD,3,1.0986122886681098
Select™,3,1.0986122886681098
epicenters,3,1.0986122886681098
Inefficient,3,1.0986122886681098
Quartile,3,1.0986122886681098
P00004,3,1.0986122886681098
célja,3,1.0986122886681098
hypointense,3,1.0986122886681098
vizsgálat,3,1.0986122886681098
Vo2max,3,1.0986122886681098
történt,3,1.0986122886681098
Dominant,3,1.0986122886681098
NFZ,3,1.0986122886681098
famotine,3,1.0986122886681098
anti-receptor,3,1.0986122886681098
Pilgrims,3,1.0986122886681098
p0048,3,1.0986122886681098
1148-1159,3,1.0986122886681098
immunosurveillance,3,1.0986122886681098
amendments,3,1.0986122886681098
tumor-bearing,3,1.0986122886681098
ISLV,3,1.0986122886681098
Binax-CoV2,3,1.0986122886681098
MSA,3,1.0986122886681098
drowsy,3,1.0986122886681098
sanatorial,3,1.0986122886681098
tIgE,3,1.0986122886681098
99mTc-PPi,3,1.0986122886681098
EB,3,1.0986122886681098
icELISA,3,1.0986122886681098
DISP,3,1.0986122886681098
paralytic,3,1.0986122886681098
Notch‑4,3,1.0986122886681098
emotive,3,1.0986122886681098
1511,3,1.0986122886681098
Hsp70,3,1.0986122886681098
Wt,3,1.0986122886681098
1520,3,1.0986122886681098
multiples,3,1.0986122886681098
cardioverted,3,1.0986122886681098
ARRISA,3,1.0986122886681098
jagged‑1,3,1.0986122886681098
delta‑4,3,1.0986122886681098
ISSS,3,1.0986122886681098
leptinergic,3,1.0986122886681098
Genechecker,3,1.0986122886681098
turmeric,3,1.0986122886681098
labour-intensive,3,1.0986122886681098
Notch‑2,3,1.0986122886681098
energetically,3,1.0986122886681098
antiviral-resistant,3,1.0986122886681098
biotherapeutics,3,1.0986122886681098
EPX,3,1.0986122886681098
four-chamber,3,1.0986122886681098
supposing,3,1.0986122886681098
n158,3,1.0986122886681098
rs2292832,3,1.0986122886681098
non-pulmonary,3,1.0986122886681098
exploding,3,1.0986122886681098
Semax,3,1.0986122886681098
Travellers,3,1.0986122886681098
littermates,3,1.0986122886681098
45-year,3,1.0986122886681098
First-ever,3,1.0986122886681098
S-ACE,3,1.0986122886681098
1-59,3,1.0986122886681098
LCB1v13,3,1.0986122886681098
1721,3,1.0986122886681098
PIRA,3,1.0986122886681098
non-inferior,3,1.0986122886681098
self-contained,3,1.0986122886681098
Expected,3,1.0986122886681098
slot,3,1.0986122886681098
ICTG,3,1.0986122886681098
≤18,3,1.0986122886681098
LightCycler,3,1.0986122886681098
OVA‑treated,3,1.0986122886681098
manners,3,1.0986122886681098
sarcolemma,3,1.0986122886681098
Loefflers,3,1.0986122886681098
galvanic,3,1.0986122886681098
501N,3,1.0986122886681098
Hypereosinophilic,3,1.0986122886681098
perceptible,3,1.0986122886681098
mg2,3,1.0986122886681098
neurointensive,3,1.0986122886681098
neurohormone,3,1.0986122886681098
Qingdao,3,1.0986122886681098
Regenerative,3,1.0986122886681098
InfAH1N1,3,1.0986122886681098
IRAT,3,1.0986122886681098
perpendicular,3,1.0986122886681098
stabilities,3,1.0986122886681098
Combating,3,1.0986122886681098
downsloping,3,1.0986122886681098
NFS,3,1.0986122886681098
spirometries,3,1.0986122886681098
Low-frequency,3,1.0986122886681098
adaptor,3,1.0986122886681098
cineangiograms,3,1.0986122886681098
swim,3,1.0986122886681098
triple-layer,3,1.0986122886681098
tonicity,3,1.0986122886681098
1104,3,1.0986122886681098
cytometer,3,1.0986122886681098
Laguna,3,1.0986122886681098
RNAi-based,3,1.0986122886681098
AprilMay,3,1.0986122886681098
thumb,3,1.0986122886681098
3637,3,1.0986122886681098
thermocycler,3,1.0986122886681098
Zafirlukast,3,1.0986122886681098
fixing,3,1.0986122886681098
Inputs,3,1.0986122886681098
laboratory-positive,3,1.0986122886681098
wearer,3,1.0986122886681098
Fiji,3,1.0986122886681098
intraindividual,3,1.0986122886681098
ribonuclease,3,1.0986122886681098
129Xe,3,1.0986122886681098
asymptomaticmild,3,1.0986122886681098
Bias,3,1.0986122886681098
470000,3,1.0986122886681098
hirudin,3,1.0986122886681098
Stochastic,3,1.0986122886681098
threonine,3,1.0986122886681098
Notch‑1,3,1.0986122886681098
eras,3,1.0986122886681098
XII-dependent,3,1.0986122886681098
aero-allergens,3,1.0986122886681098
1052,3,1.0986122886681098
AUROC,3,1.0986122886681098
RdRPE,3,1.0986122886681098
vascularisation,3,1.0986122886681098
bio-affinitive,3,1.0986122886681098
faithful,3,1.0986122886681098
diluent,3,1.0986122886681098
1095,3,1.0986122886681098
Stoke,3,1.0986122886681098
fearing,3,1.0986122886681098
AEC,3,1.0986122886681098
μmol,3,1.0986122886681098
SKN,3,1.0986122886681098
Trypanosoma,3,1.0986122886681098
C5,3,1.0986122886681098
Cruz,3,1.0986122886681098
3492,3,1.0986122886681098
LightMix®,3,1.0986122886681098
unintentionally,3,1.0986122886681098
ATG,3,1.0986122886681098
visuo-motor,3,1.0986122886681098
well-accepted,3,1.0986122886681098
symmetrically,3,1.0986122886681098
redemption,3,1.0986122886681098
cylindrical,3,1.0986122886681098
Amies,3,1.0986122886681098
extinguish,3,1.0986122886681098
rival,3,1.0986122886681098
Boerhaave,3,1.0986122886681098
Wilsons,3,1.0986122886681098
local-level,3,1.0986122886681098
fine-tuning,3,1.0986122886681098
Grayson,3,1.0986122886681098
malposition,3,1.0986122886681098
Anon-H1N1,3,1.0986122886681098
asthmoid,3,1.0986122886681098
15-May,3,1.0986122886681098
proteoglycan,3,1.0986122886681098
brain-wide,3,1.0986122886681098
plateau-like,3,1.0986122886681098
socio-professional,3,1.0986122886681098
endless,3,1.0986122886681098
tunnel,3,1.0986122886681098
BShanghai193,3,1.0986122886681098
needless,3,1.0986122886681098
≈,3,1.0986122886681098
stroke-survivors,3,1.0986122886681098
Capoten,3,1.0986122886681098
vaccae,3,1.0986122886681098
bronchogram,3,1.0986122886681098
high-pressure,3,1.0986122886681098
Tech,3,1.0986122886681098
IgE-independent,3,1.0986122886681098
showcases,3,1.0986122886681098
Promega,3,1.0986122886681098
Party,3,1.0986122886681098
gravidas,3,1.0986122886681098
intra-operative,3,1.0986122886681098
P0017,3,1.0986122886681098
SIgMIgM,3,1.0986122886681098
stick,3,1.0986122886681098
low-perfusion,3,1.0986122886681098
antero-apical,3,1.0986122886681098
structural-functional,3,1.0986122886681098
ridge,3,1.0986122886681098
SIgAIgA,3,1.0986122886681098
8-year,3,1.0986122886681098
pre-MI,3,1.0986122886681098
COREA,3,1.0986122886681098
holy,3,1.0986122886681098
Mashhad,3,1.0986122886681098
Angiotensin-converting-enzyme,3,1.0986122886681098
Woodrow,3,1.0986122886681098
Accumulation,3,1.0986122886681098
edge-network,3,1.0986122886681098
resourceful,3,1.0986122886681098
1-yr,3,1.0986122886681098
Everest,3,1.0986122886681098
Crossed,3,1.0986122886681098
extrapolations,3,1.0986122886681098
Month,3,1.0986122886681098
hardiness,3,1.0986122886681098
showcasing,3,1.0986122886681098
En,3,1.0986122886681098
α-SMA,3,1.0986122886681098
three-,3,1.0986122886681098
3924,3,1.0986122886681098
hereinafter,3,1.0986122886681098
lethargic,3,1.0986122886681098
End-point,3,1.0986122886681098
toileting,3,1.0986122886681098
Iamandescu,3,1.0986122886681098
alphaconstr,3,1.0986122886681098
interdepartmental,3,1.0986122886681098
Mammalian,3,1.0986122886681098
Bacteria,3,1.0986122886681098
-057,3,1.0986122886681098
Oswaldo,3,1.0986122886681098
curfews,3,1.0986122886681098
anionic,3,1.0986122886681098
AUDIT-positive,3,1.0986122886681098
please,3,1.0986122886681098
binge,3,1.0986122886681098
cell-limited,3,1.0986122886681098
aspiring,3,1.0986122886681098
EPPY,3,1.0986122886681098
telomerase,3,1.0986122886681098
non-focal,3,1.0986122886681098
molecular-weight,3,1.0986122886681098
EVD,3,1.0986122886681098
months--8,3,1.0986122886681098
cross-contamination,3,1.0986122886681098
nonlinearity,3,1.0986122886681098
TPO,3,1.0986122886681098
Victoria-lineage,3,1.0986122886681098
overabundance,3,1.0986122886681098
Yamagata-lineage,3,1.0986122886681098
three-part,3,1.0986122886681098
supratherapeutic,3,1.0986122886681098
Neutralising,3,1.0986122886681098
RR-8,3,1.0986122886681098
Neurofibromatosis,3,1.0986122886681098
resolvins,3,1.0986122886681098
IVSK,3,1.0986122886681098
RVEDVI,3,1.0986122886681098
200958No,3,1.0986122886681098
SHP,3,1.0986122886681098
SOBERANA,3,1.0986122886681098
N-methyl-d-aspartate,3,1.0986122886681098
H69V70,3,1.0986122886681098
echinococcosis,3,1.0986122886681098
alphadilat,3,1.0986122886681098
Omega-3,3,1.0986122886681098
protectins,3,1.0986122886681098
Ad-null,3,1.0986122886681098
second-degree,3,1.0986122886681098
pyramid,3,1.0986122886681098
Antananarivo,3,1.0986122886681098
Cleavage,3,1.0986122886681098
prescriptive,3,1.0986122886681098
Handgrip,3,1.0986122886681098
single-breath,3,1.0986122886681098
3466,3,1.0986122886681098
furnish,3,1.0986122886681098
Manchester,3,1.0986122886681098
virus-mediated,3,1.0986122886681098
perifocal,3,1.0986122886681098
truncal,3,1.0986122886681098
orthogonally,3,1.0986122886681098
logged,3,1.0986122886681098
fro,3,1.0986122886681098
TIM1,3,1.0986122886681098
Fresnel,3,1.0986122886681098
open-access,3,1.0986122886681098
6-bed,3,1.0986122886681098
negative-strand,3,1.0986122886681098
CMCs,3,1.0986122886681098
FM1,3,1.0986122886681098
diving-related,3,1.0986122886681098
MedRxiv,3,1.0986122886681098
electrospray,3,1.0986122886681098
-052,3,1.0986122886681098
WCA,3,1.0986122886681098
Vaxzevria®,3,1.0986122886681098
rapport,3,1.0986122886681098
nationalist,3,1.0986122886681098
Mikołajki,3,1.0986122886681098
TeleStroke,3,1.0986122886681098
⩽,3,1.0986122886681098
Hematological,3,1.0986122886681098
systematized,3,1.0986122886681098
Procurement,3,1.0986122886681098
entropy-driven,3,1.0986122886681098
AAC,3,1.0986122886681098
glycosaminoglycan,3,1.0986122886681098
phylogeographies,3,1.0986122886681098
pendulum,3,1.0986122886681098
ophthalmoparesis,3,1.0986122886681098
vit,3,1.0986122886681098
CApH1N1,3,1.0986122886681098
strives,3,1.0986122886681098
beta-coronaviruses,3,1.0986122886681098
arenavirus,3,1.0986122886681098
Virchows,3,1.0986122886681098
decoys,3,1.0986122886681098
chromones,3,1.0986122886681098
2-low,3,1.0986122886681098
igniting,3,1.0986122886681098
Olten,3,1.0986122886681098
Misclassification,3,1.0986122886681098
Somatosensory,3,1.0986122886681098
KPNA6,3,1.0986122886681098
integer,3,1.0986122886681098
gauging,3,1.0986122886681098
off-labeled,3,1.0986122886681098
propensity-score,3,1.0986122886681098
mountains,3,1.0986122886681098
conduits,3,1.0986122886681098
PIDs,3,1.0986122886681098
1006,3,1.0986122886681098
Prousts,3,1.0986122886681098
FRMB,3,1.0986122886681098
Cap-iLAMP,3,1.0986122886681098
de-escalation,3,1.0986122886681098
nucleocapsid-specific,3,1.0986122886681098
MUC1,3,1.0986122886681098
Surrey,3,1.0986122886681098
exaggeration,3,1.0986122886681098
virgin,3,1.0986122886681098
uncontrollably,3,1.0986122886681098
ESH,3,1.0986122886681098
nexus,3,1.0986122886681098
fuse,3,1.0986122886681098
RMZ,3,1.0986122886681098
Tmax6,3,1.0986122886681098
Moroccan,3,1.0986122886681098
arenas,3,1.0986122886681098
85000,3,1.0986122886681098
designating,3,1.0986122886681098
Sarajevo,3,1.0986122886681098
Saurashtra,3,1.0986122886681098
1375,3,1.0986122886681098
MUC1-C,3,1.0986122886681098
miR-488,3,1.0986122886681098
reconstructing,3,1.0986122886681098
Genetically,3,1.0986122886681098
DCR,3,1.0986122886681098
Liège,3,1.0986122886681098
sloughing,3,1.0986122886681098
thyme,3,1.0986122886681098
nonrandom,3,1.0986122886681098
fibrosing,3,1.0986122886681098
migrations,3,1.0986122886681098
001The,3,1.0986122886681098
GSPECT,3,1.0986122886681098
interrogated,3,1.0986122886681098
Anti-platelet,3,1.0986122886681098
groundbreaking,3,1.0986122886681098
peri-interventional,3,1.0986122886681098
PCDH-based,3,1.0986122886681098
Three-dimensional,3,1.0986122886681098
anti-epileptic,3,1.0986122886681098
reprogram,3,1.0986122886681098
emulation,3,1.0986122886681098
extrafine,3,1.0986122886681098
Yale-New,3,1.0986122886681098
CCL20,3,1.0986122886681098
LCN2,3,1.0986122886681098
Niagara,3,1.0986122886681098
Uhr,3,1.0986122886681098
glycolipids,3,1.0986122886681098
Titres,3,1.0986122886681098
PLAAO,3,1.0986122886681098
HPIV-3,3,1.0986122886681098
SPOT,3,1.0986122886681098
phenomenons,3,1.0986122886681098
widowers,3,1.0986122886681098
n20,3,1.0986122886681098
Collagen,3,1.0986122886681098
proteolytically,3,1.0986122886681098
atraumatic,3,1.0986122886681098
MAP1LC3,3,1.0986122886681098
Junior,3,1.0986122886681098
genitourinary,3,1.0986122886681098
incisive,3,1.0986122886681098
Trunk,3,1.0986122886681098
microneedle,3,1.0986122886681098
nervosa,3,1.0986122886681098
-negative,3,1.0986122886681098
SPETT,3,1.0986122886681098
28000,3,1.0986122886681098
caregiver-reported,3,1.0986122886681098
unaided,3,1.0986122886681098
periodical,3,1.0986122886681098
lactosamine,3,1.0986122886681098
L2,3,1.0986122886681098
Educate,3,1.0986122886681098
plotting,3,1.0986122886681098
predictivity,3,1.0986122886681098
Fibroblast,3,1.0986122886681098
face-mask,3,1.0986122886681098
dispatches,3,1.0986122886681098
FGF23,3,1.0986122886681098
Newcastle-Ottawa,3,1.0986122886681098
Recording,3,1.0986122886681098
WARS,3,1.0986122886681098
Bronchiolitis,3,1.0986122886681098
SQNP-adjuvanted,3,1.0986122886681098
Celiac,3,1.0986122886681098
overtly,3,1.0986122886681098
intermixed,3,1.0986122886681098
Baricitinib,3,1.0986122886681098
Glide,3,1.0986122886681098
AutoDock,3,1.0986122886681098
minimises,3,1.0986122886681098
3477,3,1.0986122886681098
extracerebral,3,1.0986122886681098
Seropositive,3,1.0986122886681098
SARS-CoV-2-RdRp,3,1.0986122886681098
Mandatory,3,1.0986122886681098
1130,3,1.0986122886681098
artery-related,3,1.0986122886681098
Dealing,3,1.0986122886681098
reproducibilities,3,1.0986122886681098
non-RVI,3,1.0986122886681098
clonidine,3,1.0986122886681098
HSBC,3,1.0986122886681098
Anesthesiologists,3,1.0986122886681098
Means,3,1.0986122886681098
Bhopal,3,1.0986122886681098
1888,3,1.0986122886681098
JGL2015,3,1.0986122886681098
MEFs,3,1.0986122886681098
CBSAs,3,1.0986122886681098
Scandinavia,3,1.0986122886681098
13-,3,1.0986122886681098
CUT-OFF,3,1.0986122886681098
ACVA,3,1.0986122886681098
8-15,3,1.0986122886681098
culprit-only,3,1.0986122886681098
1725,3,1.0986122886681098
1125,3,1.0986122886681098
NLW,3,1.0986122886681098
Matching,3,1.0986122886681098
unwise,3,1.0986122886681098
CAACP,3,1.0986122886681098
Cox-proportional,3,1.0986122886681098
on-farm,3,1.0986122886681098
electoral,3,1.0986122886681098
fifty-three,3,1.0986122886681098
Sleep-disordered,3,1.0986122886681098
oligosaccharides,3,1.0986122886681098
antirheumatic,3,1.0986122886681098
prazosin,3,1.0986122886681098
Biotherapies,3,1.0986122886681098
acid-binding,3,1.0986122886681098
conservatism,3,1.0986122886681098
Inter-observer,3,1.0986122886681098
priority-setting,3,1.0986122886681098
SARS-CoV-19,3,1.0986122886681098
stentriever,3,1.0986122886681098
Veritor™,3,1.0986122886681098
submodalities,3,1.0986122886681098
electricity,3,1.0986122886681098
EMS-reported,3,1.0986122886681098
deltaLKN,3,1.0986122886681098
pedicle,3,1.0986122886681098
Operator,3,1.0986122886681098
1285,3,1.0986122886681098
Methotrexate,3,1.0986122886681098
single-step,3,1.0986122886681098
transaxial,3,1.0986122886681098
vendor-specific,3,1.0986122886681098
binding-induced,3,1.0986122886681098
IL-6R,3,1.0986122886681098
75-95,3,1.0986122886681098
clinico-pathogenetic,3,1.0986122886681098
reconstructs,3,1.0986122886681098
anticoagulative,3,1.0986122886681098
Potassium,3,1.0986122886681098
25°C,3,1.0986122886681098
Mutual,3,1.0986122886681098
coitus,3,1.0986122886681098
ESCACC,3,1.0986122886681098
first-aid,3,1.0986122886681098
2A,3,1.0986122886681098
Aggregate,3,1.0986122886681098
Dont,3,1.0986122886681098
Iwo,3,1.0986122886681098
1722,3,1.0986122886681098
radiotracer,3,1.0986122886681098
pemphigoid,3,1.0986122886681098
hesitate,3,1.0986122886681098
Cardiff,3,1.0986122886681098
Youth,3,1.0986122886681098
dryness,3,1.0986122886681098
-delta,3,1.0986122886681098
HT22,3,1.0986122886681098
Cheyne-Stokes,3,1.0986122886681098
Flu-A,3,1.0986122886681098
positron-emission,3,1.0986122886681098
DSM,3,1.0986122886681098
neprilysin,3,1.0986122886681098
rechallenged,3,1.0986122886681098
OZG-38613,3,1.0986122886681098
stentrievers,3,1.0986122886681098
reengagement,3,1.0986122886681098
imparting,3,1.0986122886681098
Krakow,3,1.0986122886681098
15-17,3,1.0986122886681098
poultries,3,1.0986122886681098
GIHSN,3,1.0986122886681098
misattributions,3,1.0986122886681098
Lazarus,3,1.0986122886681098
GOs,3,1.0986122886681098
1268,3,1.0986122886681098
patient-to-patient,3,1.0986122886681098
unhoused,3,1.0986122886681098
Calibration,3,1.0986122886681098
2337,3,1.0986122886681098
Encouragingly,3,1.0986122886681098
rollercoaster,3,1.0986122886681098
Covid‑19,3,1.0986122886681098
univariately,3,1.0986122886681098
flu-associated,3,1.0986122886681098
Hydrocortisone,3,1.0986122886681098
carcinogenicity,3,1.0986122886681098
NWHL,3,1.0986122886681098
Nebulizer,3,1.0986122886681098
sings,3,1.0986122886681098
non-competitive,3,1.0986122886681098
KDPH,3,1.0986122886681098
eosinophil-associated,3,1.0986122886681098
Gene-environment,3,1.0986122886681098
amnestic,3,1.0986122886681098
nonuniform,3,1.0986122886681098
osteosarcoma,3,1.0986122886681098
pathogenicities,3,1.0986122886681098
singleton,3,1.0986122886681098
audiovisual,3,1.0986122886681098
intravital,3,1.0986122886681098
silently,3,1.0986122886681098
Bad,3,1.0986122886681098
black-blood,3,1.0986122886681098
audiences,3,1.0986122886681098
four-step,3,1.0986122886681098
Door-to-balloon,3,1.0986122886681098
dielectric,3,1.0986122886681098
beta-thalassemia,3,1.0986122886681098
HPA1,3,1.0986122886681098
70s,3,1.0986122886681098
DF,3,1.0986122886681098
TNK-tPA,3,1.0986122886681098
fibrin-specificity,3,1.0986122886681098
PANDEMIC,3,1.0986122886681098
pedAIS,3,1.0986122886681098
dehumidifier,3,1.0986122886681098
pectoral,3,1.0986122886681098
community-,3,1.0986122886681098
payout,3,1.0986122886681098
Luan,3,1.0986122886681098
Limit,3,1.0986122886681098
Isolates,3,1.0986122886681098
emoxipin,3,1.0986122886681098
immunocytes,3,1.0986122886681098
PGWB,3,1.0986122886681098
derail,3,1.0986122886681098
flourishing,3,1.0986122886681098
high-definition,3,1.0986122886681098
shRNAs,3,1.0986122886681098
Minute,3,1.0986122886681098
metasensors,3,1.0986122886681098
hypertention,3,1.0986122886681098
biographical,3,1.0986122886681098
non-WRA,3,1.0986122886681098
non-high-risk,3,1.0986122886681098
accreditation,3,1.0986122886681098
Space,3,1.0986122886681098
I-converting,3,1.0986122886681098
season-to-season,3,1.0986122886681098
anxiety-depressive,3,1.0986122886681098
nineteenth-century,3,1.0986122886681098
JTotal,3,1.0986122886681098
nicotinic,3,1.0986122886681098
Clinics,3,1.0986122886681098
DhsLLL,3,1.0986122886681098
Changhwa,3,1.0986122886681098
immunocomplexes,3,1.0986122886681098
bothersome,3,1.0986122886681098
Brugada-type,3,1.0986122886681098
1175,3,1.0986122886681098
connectedness,3,1.0986122886681098
21-25,3,1.0986122886681098
torque-angle,3,1.0986122886681098
oSC,3,1.0986122886681098
N-CTD,3,1.0986122886681098
Subclade,3,1.0986122886681098
096-098,3,1.0986122886681098
astronomical,3,1.0986122886681098
hydric,3,1.0986122886681098
ampicillin,3,1.0986122886681098
roentgenographic,3,1.0986122886681098
bat-CoVs,3,1.0986122886681098
Glutamate,3,1.0986122886681098
dura,3,1.0986122886681098
Anaphylactic,3,1.0986122886681098
copious,3,1.0986122886681098
p65,3,1.0986122886681098
Smad,3,1.0986122886681098
peptic,3,1.0986122886681098
COVID-19-mediated,3,1.0986122886681098
paraneoplastic,3,1.0986122886681098
p0045,3,1.0986122886681098
intertrabecular,3,1.0986122886681098
alliances,3,1.0986122886681098
suppurative,3,1.0986122886681098
crushing,3,1.0986122886681098
1322,3,1.0986122886681098
RPS3,3,1.0986122886681098
cardioaortic,3,1.0986122886681098
affinis,3,1.0986122886681098
stress-autophagy,3,1.0986122886681098
Kong48012014,3,1.0986122886681098
Juan,3,1.0986122886681098
Worse,3,1.0986122886681098
wwwclinicaltrialsgov,3,1.0986122886681098
intimacy,3,1.0986122886681098
vaccine2,3,1.0986122886681098
sacs,3,1.0986122886681098
1329,3,1.0986122886681098
echo-Doppler,3,1.0986122886681098
384-well,3,1.0986122886681098
membrane-based,3,1.0986122886681098
low-voltage,3,1.0986122886681098
Samters,3,1.0986122886681098
non-medicated,3,1.0986122886681098
LAV,3,1.0986122886681098
Neurophysiological,3,1.0986122886681098
RMB,3,1.0986122886681098
furthers,3,1.0986122886681098
M2-3,3,1.0986122886681098
midwife,3,1.0986122886681098
50-fold,3,1.0986122886681098
assorted,3,1.0986122886681098
PAC-MAN,3,1.0986122886681098
Psychogenic,3,1.0986122886681098
Kefir,3,1.0986122886681098
Bubble,3,1.0986122886681098
forensics,3,1.0986122886681098
extra-,3,1.0986122886681098
2046,3,1.0986122886681098
cell-death,3,1.0986122886681098
parsimony,3,1.0986122886681098
ITIH-5,3,1.0986122886681098
antigen-sparing,3,1.0986122886681098
Yunnan,3,1.0986122886681098
-60,3,1.0986122886681098
00000,3,1.0986122886681098
crippled,3,1.0986122886681098
Cys-LTs,3,1.0986122886681098
Quantal,3,1.0986122886681098
β-propiolactone,3,1.0986122886681098
convolution,3,1.0986122886681098
Alabama,3,1.0986122886681098
neurorecovery,3,1.0986122886681098
Improve,3,1.0986122886681098
1737,3,1.0986122886681098
anti-leucocyte,3,1.0986122886681098
symRNA-Cas12a,3,1.0986122886681098
eighty-three,3,1.0986122886681098
scintiscans,3,1.0986122886681098
homogenate,3,1.0986122886681098
OGD,3,1.0986122886681098
chip-based,3,1.0986122886681098
extraversion,3,1.0986122886681098
urticariaangioedema,3,1.0986122886681098
Clusterin,3,1.0986122886681098
target-based,3,1.0986122886681098
p-interaction,3,1.0986122886681098
VFT,3,1.0986122886681098
nH1N1,3,1.0986122886681098
excited,3,1.0986122886681098
Eplerenone,3,1.0986122886681098
fl,3,1.0986122886681098
5500,3,1.0986122886681098
immunoenzymometric,3,1.0986122886681098
Prescribing,3,1.0986122886681098
Diving,3,1.0986122886681098
MEGA,3,1.0986122886681098
11-14,3,1.0986122886681098
ARDs,3,1.0986122886681098
MDD,3,1.0986122886681098
School-age,3,1.0986122886681098
LAT,3,1.0986122886681098
∼3,3,1.0986122886681098
single-sample,3,1.0986122886681098
forecasted,3,1.0986122886681098
accentuate,3,1.0986122886681098
hierarchically,3,1.0986122886681098
native-like,3,1.0986122886681098
SIAM,3,1.0986122886681098
non-allergen,3,1.0986122886681098
interconnectivity,3,1.0986122886681098
23000,3,1.0986122886681098
Appl,3,1.0986122886681098
resiliency,3,1.0986122886681098
asthmogenic,3,1.0986122886681098
random-digit,3,1.0986122886681098
das,3,1.0986122886681098
CXCL10,3,1.0986122886681098
incapacitation,3,1.0986122886681098
fibroelastosis,3,1.0986122886681098
18-month-old,3,1.0986122886681098
cool-dry,3,1.0986122886681098
FDT,3,1.0986122886681098
emotion-induced,3,1.0986122886681098
anew,3,1.0986122886681098
well-managed,3,1.0986122886681098
1-Step,3,1.0986122886681098
cellshour,3,1.0986122886681098
GTNN,3,1.0986122886681098
Failing,3,1.0986122886681098
severefatal,3,1.0986122886681098
delegated,3,1.0986122886681098
CC16,3,1.0986122886681098
metaphorical,3,1.0986122886681098
pre-disease,3,1.0986122886681098
Inspection,3,1.0986122886681098
regret,3,1.0986122886681098
PsycInfo,3,1.0986122886681098
Médica,3,1.0986122886681098
ecotoxicological,3,1.0986122886681098
GENI,3,1.0986122886681098
pseudo-chilblains,3,1.0986122886681098
shorted,3,1.0986122886681098
live-alones,3,1.0986122886681098
abstain,3,1.0986122886681098
treatment-induced,3,1.0986122886681098
encephalopathies,3,1.0986122886681098
harnesses,3,1.0986122886681098
Immunomodulation,3,1.0986122886681098
CTSB,3,1.0986122886681098
Propofol,3,1.0986122886681098
128x,3,1.0986122886681098
dialing,3,1.0986122886681098
NGNN,3,1.0986122886681098
deferrals,3,1.0986122886681098
accelerations,3,1.0986122886681098
autobiographical,3,1.0986122886681098
UGRP1,3,1.0986122886681098
Taihu,3,1.0986122886681098
wavelengths,3,1.0986122886681098
nil,3,1.0986122886681098
lights,3,1.0986122886681098
neurilemmoma,3,1.0986122886681098
bulge,3,1.0986122886681098
histamine-induced,3,1.0986122886681098
Ivano-Frankivsk,3,1.0986122886681098
Crosby,3,1.0986122886681098
HBSS,3,1.0986122886681098
coumarins,3,1.0986122886681098
CK-activity,3,1.0986122886681098
HMCAS,3,1.0986122886681098
n72,3,1.0986122886681098
downregulating,3,1.0986122886681098
MCVs,3,1.0986122886681098
2457,3,1.0986122886681098
ASITN,3,1.0986122886681098
1031,3,1.0986122886681098
DUV-LED,3,1.0986122886681098
resect,3,1.0986122886681098
0539,3,1.0986122886681098
non-thrombolysed,3,1.0986122886681098
latters,3,1.0986122886681098
Colostrum,3,1.0986122886681098
Wu,3,1.0986122886681098
TKIs,3,1.0986122886681098
lateralis,3,1.0986122886681098
speaker,3,1.0986122886681098
tomogram,3,1.0986122886681098
turbinate,3,1.0986122886681098
stage-wise,3,1.0986122886681098
selffamily,3,1.0986122886681098
thiol,3,1.0986122886681098
geo-social,3,1.0986122886681098
beginnings,3,1.0986122886681098
-020,3,1.0986122886681098
Preventative,3,1.0986122886681098
casually,3,1.0986122886681098
Antibody-dependent,3,1.0986122886681098
12-41,3,1.0986122886681098
wealthiest,3,1.0986122886681098
betadrenergic,3,1.0986122886681098
Covered,3,1.0986122886681098
terrorist,3,1.0986122886681098
Rickettsia,3,1.0986122886681098
tcPO2,3,1.0986122886681098
three-way,3,1.0986122886681098
Quite,3,1.0986122886681098
Intraarterial,3,1.0986122886681098
Collected,3,1.0986122886681098
non-admitted,3,1.0986122886681098
nsp8,3,1.0986122886681098
Galuteolin,3,1.0986122886681098
scientifi,3,1.0986122886681098
6-9,3,1.0986122886681098
hiding,3,1.0986122886681098
Foxf1,3,1.0986122886681098
S08,3,1.0986122886681098
1190,3,1.0986122886681098
Zymosan,3,1.0986122886681098
biometric,3,1.0986122886681098
preservatives,3,1.0986122886681098
Inversion,3,1.0986122886681098
lighting,3,1.0986122886681098
post-extrasystolic,3,1.0986122886681098
mastocyte,3,1.0986122886681098
wants,3,1.0986122886681098
crustaceans,3,1.0986122886681098
Nontraumatic,3,1.0986122886681098
hydrolyzes,3,1.0986122886681098
≈7,3,1.0986122886681098
influenza-experienced,3,1.0986122886681098
NVivo,3,1.0986122886681098
burgdorferi,3,1.0986122886681098
ACD,3,1.0986122886681098
co-ordinate,3,1.0986122886681098
crustacean,3,1.0986122886681098
tracheitis,3,1.0986122886681098
PAQL,3,1.0986122886681098
Locally,3,1.0986122886681098
Post-influenza,3,1.0986122886681098
Could,3,1.0986122886681098
dedifferentiation,3,1.0986122886681098
RCVA,3,1.0986122886681098
venture,3,1.0986122886681098
Adamantanes,3,1.0986122886681098
Aspergillus-sensitive,3,1.0986122886681098
near-real-time,3,1.0986122886681098
PGF,3,1.0986122886681098
otolaryngology,3,1.0986122886681098
centralization,3,1.0986122886681098
NNMF,3,1.0986122886681098
externalization,3,1.0986122886681098
Combo,3,1.0986122886681098
TaqPath™,3,1.0986122886681098
R80-coded,3,1.0986122886681098
wildfowl,3,1.0986122886681098
potential-like,3,1.0986122886681098
retarding,3,1.0986122886681098
expedition,3,1.0986122886681098
sialyl,3,1.0986122886681098
twelve-lead,3,1.0986122886681098
Volatile,3,1.0986122886681098
Borrelia,3,1.0986122886681098
nmol5,3,1.0986122886681098
aptitude,3,1.0986122886681098
CASA,3,1.0986122886681098
Allbutt,3,1.0986122886681098
Ga-BNOTA-PRGD2,2,0.6931471805599453
2Decho,2,0.6931471805599453
Isatidis,2,0.6931471805599453
Cost-effective,2,0.6931471805599453
mononuclears,2,0.6931471805599453
Anesthesiology,2,0.6931471805599453
Anti-flu,2,0.6931471805599453
1548,2,0.6931471805599453
filterable,2,0.6931471805599453
2003-2009,2,0.6931471805599453
already-immune,2,0.6931471805599453
Facklamia,2,0.6931471805599453
icNT,2,0.6931471805599453
QtC,2,0.6931471805599453
5-sample,2,0.6931471805599453
Distinctive,2,0.6931471805599453
M-MAT,2,0.6931471805599453
succumbs,2,0.6931471805599453
Uniform,2,0.6931471805599453
testifying,2,0.6931471805599453
SLCVA,2,0.6931471805599453
78418,2,0.6931471805599453
barn,2,0.6931471805599453
Enzyme-2,2,0.6931471805599453
H1-like,2,0.6931471805599453
statelocal,2,0.6931471805599453
gallium-68,2,0.6931471805599453
Nanog,2,0.6931471805599453
in-service,2,0.6931471805599453
Forward,2,0.6931471805599453
-76,2,0.6931471805599453
anecdotes,2,0.6931471805599453
peek,2,0.6931471805599453
exertions,2,0.6931471805599453
Ag-specific,2,0.6931471805599453
Shortage,2,0.6931471805599453
Retractor,2,0.6931471805599453
1683,2,0.6931471805599453
SFT,2,0.6931471805599453
Amulet,2,0.6931471805599453
fucoidan,2,0.6931471805599453
COMPARE,2,0.6931471805599453
feverseasonal,2,0.6931471805599453
stent-trievers,2,0.6931471805599453
chronicles,2,0.6931471805599453
non-penetrating,2,0.6931471805599453
Beta-2-agonists,2,0.6931471805599453
Time-to-treatment,2,0.6931471805599453
destabilized,2,0.6931471805599453
1559,2,0.6931471805599453
drift-related,2,0.6931471805599453
30-second,2,0.6931471805599453
colleague,2,0.6931471805599453
GROUP,2,0.6931471805599453
Lithium,2,0.6931471805599453
SDL,2,0.6931471805599453
TTV,2,0.6931471805599453
blank-control,2,0.6931471805599453
httpwwwclinicaltrialsgov,2,0.6931471805599453
granulo-,2,0.6931471805599453
homotrimeric,2,0.6931471805599453
p-selectin,2,0.6931471805599453
6444,2,0.6931471805599453
AUSSR77-like,2,0.6931471805599453
preexistence,2,0.6931471805599453
Tasso-SST,2,0.6931471805599453
out-hospital,2,0.6931471805599453
nano-2D-LC,2,0.6931471805599453
work-days,2,0.6931471805599453
non-statin,2,0.6931471805599453
GWUMC,2,0.6931471805599453
NREVSS,2,0.6931471805599453
complexation,2,0.6931471805599453
Genoa,2,0.6931471805599453
A-type,2,0.6931471805599453
Electrophysiological,2,0.6931471805599453
self-completion,2,0.6931471805599453
SEIMC,2,0.6931471805599453
secondary-stroke-prevention,2,0.6931471805599453
Arogh,2,0.6931471805599453
glutathione-s-transferase,2,0.6931471805599453
sell,2,0.6931471805599453
Frail,2,0.6931471805599453
Vero-cell-derived,2,0.6931471805599453
1518,2,0.6931471805599453
maintainance,2,0.6931471805599453
restraining,2,0.6931471805599453
infection-allergic,2,0.6931471805599453
anti-HIV,2,0.6931471805599453
transduce,2,0.6931471805599453
carbohydrate-binding,2,0.6931471805599453
gallstones,2,0.6931471805599453
Fiber,2,0.6931471805599453
behaviorally,2,0.6931471805599453
turbo,2,0.6931471805599453
hs-troponin,2,0.6931471805599453
6767,2,0.6931471805599453
EIBs,2,0.6931471805599453
6-month-old,2,0.6931471805599453
Toxic,2,0.6931471805599453
pSEP,2,0.6931471805599453
Applicability,2,0.6931471805599453
12700,2,0.6931471805599453
two-and-a-half,2,0.6931471805599453
28-fold,2,0.6931471805599453
198788,2,0.6931471805599453
giants,2,0.6931471805599453
errorless,2,0.6931471805599453
AAV25-CAG-Nln,2,0.6931471805599453
ladder-like,2,0.6931471805599453
Apnea,2,0.6931471805599453
Rico834,2,0.6931471805599453
phthalates,2,0.6931471805599453
post-strokes,2,0.6931471805599453
Asthograph,2,0.6931471805599453
adjuvanticity,2,0.6931471805599453
3362,2,0.6931471805599453
overviewed,2,0.6931471805599453
Trimer-Tag,2,0.6931471805599453
skinprick,2,0.6931471805599453
goose,2,0.6931471805599453
mannose-specific,2,0.6931471805599453
hasty,2,0.6931471805599453
7250,2,0.6931471805599453
metres,2,0.6931471805599453
Hardiness,2,0.6931471805599453
LVCT,2,0.6931471805599453
Cough-CPR,2,0.6931471805599453
1915,2,0.6931471805599453
upperbound,2,0.6931471805599453
BPC,2,0.6931471805599453
V1-3,2,0.6931471805599453
b2MGCr,2,0.6931471805599453
MSR1,2,0.6931471805599453
widescale,2,0.6931471805599453
pentadecanoic,2,0.6931471805599453
voiced,2,0.6931471805599453
antibody-,2,0.6931471805599453
asthma-symptom,2,0.6931471805599453
Buddhist,2,0.6931471805599453
-122,2,0.6931471805599453
T1BMIPP,2,0.6931471805599453
reversions,2,0.6931471805599453
subdominant,2,0.6931471805599453
videoconferences,2,0.6931471805599453
revertant,2,0.6931471805599453
group-based,2,0.6931471805599453
NIVEL,2,0.6931471805599453
nondisease,2,0.6931471805599453
Viral-induced,2,0.6931471805599453
EoB-CFU,2,0.6931471805599453
-omic,2,0.6931471805599453
journalists,2,0.6931471805599453
closely-related,2,0.6931471805599453
CIAT,2,0.6931471805599453
tradeoff,2,0.6931471805599453
IMAI,2,0.6931471805599453
05-16,2,0.6931471805599453
cmsec2,2,0.6931471805599453
claims-based,2,0.6931471805599453
7-25,2,0.6931471805599453
throw,2,0.6931471805599453
uncouple,2,0.6931471805599453
Hypothetically,2,0.6931471805599453
HFrEF,2,0.6931471805599453
context-sensitive,2,0.6931471805599453
diseaseABSTRACT,2,0.6931471805599453
system-related,2,0.6931471805599453
cobas®6800,2,0.6931471805599453
knocking,2,0.6931471805599453
french,2,0.6931471805599453
postero-lateral,2,0.6931471805599453
Glycated,2,0.6931471805599453
Indefinite,2,0.6931471805599453
103ml,2,0.6931471805599453
DUSPs,2,0.6931471805599453
PRNTs,2,0.6931471805599453
inapplicable,2,0.6931471805599453
MBS,2,0.6931471805599453
mollified,2,0.6931471805599453
suspense,2,0.6931471805599453
physician-less,2,0.6931471805599453
PHCs,2,0.6931471805599453
P0018,2,0.6931471805599453
hypothymia,2,0.6931471805599453
IVTMT,2,0.6931471805599453
influenza-contaminated,2,0.6931471805599453
asthmaCOPD-related,2,0.6931471805599453
broadcasting,2,0.6931471805599453
lacuna,2,0.6931471805599453
respirometer,2,0.6931471805599453
bi-level,2,0.6931471805599453
1973-74,2,0.6931471805599453
air-purifying,2,0.6931471805599453
DNA-seq,2,0.6931471805599453
mutationsvariants,2,0.6931471805599453
newly-diagnosed,2,0.6931471805599453
ANCA-associated,2,0.6931471805599453
ACh,2,0.6931471805599453
Hastings,2,0.6931471805599453
Decellularized,2,0.6931471805599453
headline,2,0.6931471805599453
TBG,2,0.6931471805599453
AJohannesburg8296,2,0.6931471805599453
Church,2,0.6931471805599453
neuroses,2,0.6931471805599453
nondifferential,2,0.6931471805599453
PEVPKRKRTARGL,2,0.6931471805599453
80533,2,0.6931471805599453
crescents,2,0.6931471805599453
RCOG,2,0.6931471805599453
neuro-inflammation,2,0.6931471805599453
rhino-pharyngeal,2,0.6931471805599453
SBPT,2,0.6931471805599453
N-antigen,2,0.6931471805599453
dysmenorrhea,2,0.6931471805599453
invalids,2,0.6931471805599453
half-face,2,0.6931471805599453
-0015,2,0.6931471805599453
18-84,2,0.6931471805599453
south-central,2,0.6931471805599453
KISS,2,0.6931471805599453
Antagonists,2,0.6931471805599453
FAB,2,0.6931471805599453
UV-based,2,0.6931471805599453
-0042,2,0.6931471805599453
forgoing,2,0.6931471805599453
960000,2,0.6931471805599453
MOGAD,2,0.6931471805599453
negative-result,2,0.6931471805599453
IL4RA,2,0.6931471805599453
non-institutionalised,2,0.6931471805599453
outpouring,2,0.6931471805599453
LUMIPULSE®,2,0.6931471805599453
Crystallography,2,0.6931471805599453
overperception,2,0.6931471805599453
stey-by-step,2,0.6931471805599453
IL-9,2,0.6931471805599453
4-28,2,0.6931471805599453
ABCC1,2,0.6931471805599453
VEs,2,0.6931471805599453
valence,2,0.6931471805599453
pSEPs,2,0.6931471805599453
Oro-,2,0.6931471805599453
spillback,2,0.6931471805599453
sandwich-like,2,0.6931471805599453
IIFT,2,0.6931471805599453
hypoesthesia,2,0.6931471805599453
multidrug,2,0.6931471805599453
-66,2,0.6931471805599453
Lawson,2,0.6931471805599453
Empiric,2,0.6931471805599453
progenies,2,0.6931471805599453
self-Ag-RDT,2,0.6931471805599453
-675,2,0.6931471805599453
operationalizing,2,0.6931471805599453
CO1,2,0.6931471805599453
7368,2,0.6931471805599453
Β117alpha,2,0.6931471805599453
goiter,2,0.6931471805599453
O2-·,2,0.6931471805599453
dependently,2,0.6931471805599453
particulary,2,0.6931471805599453
clorhidric,2,0.6931471805599453
prehospital-treated,2,0.6931471805599453
Planck,2,0.6931471805599453
Tetra®,2,0.6931471805599453
1983-84,2,0.6931471805599453
Australasian,2,0.6931471805599453
scrupulous,2,0.6931471805599453
nonvasospastic,2,0.6931471805599453
198889,2,0.6931471805599453
millimetric,2,0.6931471805599453
Avigan,2,0.6931471805599453
LTA4H,2,0.6931471805599453
AAnn,2,0.6931471805599453
52000,2,0.6931471805599453
ALDH2,2,0.6931471805599453
6676,2,0.6931471805599453
innovating,2,0.6931471805599453
1474,2,0.6931471805599453
entangled,2,0.6931471805599453
anaesthetized,2,0.6931471805599453
CISDCP,2,0.6931471805599453
sojourn,2,0.6931471805599453
dual-tasks,2,0.6931471805599453
ResultsA,2,0.6931471805599453
vesselABSTRACT,2,0.6931471805599453
200809-201112,2,0.6931471805599453
leptomeninges,2,0.6931471805599453
Infirmary,2,0.6931471805599453
NCCP,2,0.6931471805599453
immunocorrection,2,0.6931471805599453
post-implant,2,0.6931471805599453
age-standardised,2,0.6931471805599453
homologies,2,0.6931471805599453
nicely,2,0.6931471805599453
cocci,2,0.6931471805599453
SvO2,2,0.6931471805599453
Methamphetamine,2,0.6931471805599453
in-ICCU,2,0.6931471805599453
leaning,2,0.6931471805599453
5-49,2,0.6931471805599453
viscus,2,0.6931471805599453
H1N109-positive,2,0.6931471805599453
immuno-modulating,2,0.6931471805599453
unfair,2,0.6931471805599453
idealistic,2,0.6931471805599453
anchors,2,0.6931471805599453
3553,2,0.6931471805599453
furred,2,0.6931471805599453
unweighted,2,0.6931471805599453
sceletal,2,0.6931471805599453
Probing,2,0.6931471805599453
short-interval,2,0.6931471805599453
non-aura,2,0.6931471805599453
schoolchildrens,2,0.6931471805599453
preimaging,2,0.6931471805599453
Realizing,2,0.6931471805599453
well-,2,0.6931471805599453
javanica,2,0.6931471805599453
self-fulfilling,2,0.6931471805599453
granuloma,2,0.6931471805599453
Manis,2,0.6931471805599453
commuters,2,0.6931471805599453
sub-national,2,0.6931471805599453
decidedly,2,0.6931471805599453
BioRad,2,0.6931471805599453
7-24,2,0.6931471805599453
r082,2,0.6931471805599453
no-flow,2,0.6931471805599453
canisters,2,0.6931471805599453
postviral,2,0.6931471805599453
HAD,2,0.6931471805599453
41st,2,0.6931471805599453
food-derived,2,0.6931471805599453
Advancement,2,0.6931471805599453
scraping,2,0.6931471805599453
1392,2,0.6931471805599453
lymphohistiocytic,2,0.6931471805599453
large-animal,2,0.6931471805599453
GBM,2,0.6931471805599453
risk-related,2,0.6931471805599453
DCLV,2,0.6931471805599453
Taq,2,0.6931471805599453
Resulting,2,0.6931471805599453
relevancy,2,0.6931471805599453
nuevo,2,0.6931471805599453
cortico-steroids,2,0.6931471805599453
orf7a,2,0.6931471805599453
Beta2-adrenergic,2,0.6931471805599453
audiovestibular,2,0.6931471805599453
ACTEI,2,0.6931471805599453
Small-vessel,2,0.6931471805599453
miniproteins,2,0.6931471805599453
CISS,2,0.6931471805599453
baroreceptor,2,0.6931471805599453
136-349,2,0.6931471805599453
Glomerular,2,0.6931471805599453
1570,2,0.6931471805599453
220120,2,0.6931471805599453
RMS40,2,0.6931471805599453
PIAMA,2,0.6931471805599453
practice-related,2,0.6931471805599453
Sick,2,0.6931471805599453
Hemophagocytic,2,0.6931471805599453
acclimatization,2,0.6931471805599453
10-50,2,0.6931471805599453
ICAM1,2,0.6931471805599453
OSN-qRT-PCR,2,0.6931471805599453
Marines,2,0.6931471805599453
Twins,2,0.6931471805599453
emoxypine,2,0.6931471805599453
mononucleosis,2,0.6931471805599453
Proprietary,2,0.6931471805599453
SCFA,2,0.6931471805599453
parental-reported,2,0.6931471805599453
stereotypies,2,0.6931471805599453
FDR-P,2,0.6931471805599453
Corynebacterium,2,0.6931471805599453
clonic,2,0.6931471805599453
Agathobacter,2,0.6931471805599453
Good-quality,2,0.6931471805599453
MTST,2,0.6931471805599453
bronchoscopies,2,0.6931471805599453
reorganizational,2,0.6931471805599453
2999,2,0.6931471805599453
central-chest,2,0.6931471805599453
3M,2,0.6931471805599453
dermis,2,0.6931471805599453
intraepidermal,2,0.6931471805599453
expert-annotated,2,0.6931471805599453
CPMP,2,0.6931471805599453
nmolml,2,0.6931471805599453
scribbling,2,0.6931471805599453
PERMANOVA,2,0.6931471805599453
consequentially,2,0.6931471805599453
Il,2,0.6931471805599453
K-nearest,2,0.6931471805599453
1644,2,0.6931471805599453
reactivating,2,0.6931471805599453
11-oxycorticosteroids,2,0.6931471805599453
TWI,2,0.6931471805599453
PRX,2,0.6931471805599453
3033,2,0.6931471805599453
Preoperatively,2,0.6931471805599453
unknown-onset,2,0.6931471805599453
FENO-ACQ,2,0.6931471805599453
Markovian,2,0.6931471805599453
Telerehabilitation,2,0.6931471805599453
anti-pandemic,2,0.6931471805599453
powerfully,2,0.6931471805599453
2452,2,0.6931471805599453
tonus,2,0.6931471805599453
Caffeic,2,0.6931471805599453
scribblings,2,0.6931471805599453
re-occurrence,2,0.6931471805599453
strokestransient,2,0.6931471805599453
eight-month,2,0.6931471805599453
cherry,2,0.6931471805599453
long-duration,2,0.6931471805599453
fermentate,2,0.6931471805599453
Lactate,2,0.6931471805599453
yeast-based,2,0.6931471805599453
vasoplegic,2,0.6931471805599453
EpiCor,2,0.6931471805599453
reconsidering,2,0.6931471805599453
IMDQ-PEG-CHOL,2,0.6931471805599453
NeuroInterventional,2,0.6931471805599453
inhibitorangiotensin,2,0.6931471805599453
unfairly,2,0.6931471805599453
3VD,2,0.6931471805599453
PRISMS,2,0.6931471805599453
buzz,2,0.6931471805599453
functionally-conserved,2,0.6931471805599453
in-clinic,2,0.6931471805599453
Moraxella,2,0.6931471805599453
Firmicutes,2,0.6931471805599453
Overdiagnosis,2,0.6931471805599453
24-30,2,0.6931471805599453
LMTD,2,0.6931471805599453
Dephedrin,2,0.6931471805599453
cortico-cerebellar,2,0.6931471805599453
Juss,2,0.6931471805599453
2019-nCoV-related,2,0.6931471805599453
adhesives,2,0.6931471805599453
pleuropneumonia,2,0.6931471805599453
ther,2,0.6931471805599453
b2-agonists,2,0.6931471805599453
dosimetry,2,0.6931471805599453
polysomnographic,2,0.6931471805599453
secrecy,2,0.6931471805599453
Lone,2,0.6931471805599453
TREVO2,2,0.6931471805599453
commensals,2,0.6931471805599453
liberating,2,0.6931471805599453
pre-asthma,2,0.6931471805599453
Utilisation,2,0.6931471805599453
majors,2,0.6931471805599453
Marzano,2,0.6931471805599453
developmentalbiopsychosocial,2,0.6931471805599453
cardiogemic,2,0.6931471805599453
imidazoquinoline,2,0.6931471805599453
Intubation,2,0.6931471805599453
tricks,2,0.6931471805599453
aliquot,2,0.6931471805599453
meninges,2,0.6931471805599453
enfermedad,2,0.6931471805599453
NCT04368988,2,0.6931471805599453
posthumous,2,0.6931471805599453
CON-A,2,0.6931471805599453
negates,2,0.6931471805599453
binned,2,0.6931471805599453
saponin-based,2,0.6931471805599453
oscillating,2,0.6931471805599453
1628,2,0.6931471805599453
all-fiber,2,0.6931471805599453
self-assemblies,2,0.6931471805599453
UKROC,2,0.6931471805599453
SPG-Stim,2,0.6931471805599453
Re-evaluation,2,0.6931471805599453
pmole,2,0.6931471805599453
miR-182,2,0.6931471805599453
T205I,2,0.6931471805599453
non-paired,2,0.6931471805599453
three-factor,2,0.6931471805599453
Fit,2,0.6931471805599453
hypoxia-induced,2,0.6931471805599453
favorite,2,0.6931471805599453
Momentum,2,0.6931471805599453
B-mismatched,2,0.6931471805599453
BiT,2,0.6931471805599453
complementation,2,0.6931471805599453
O-800,2,0.6931471805599453
backflow,2,0.6931471805599453
peakflow,2,0.6931471805599453
2188,2,0.6931471805599453
Walloon,2,0.6931471805599453
A-40,2,0.6931471805599453
Macroautophagy,2,0.6931471805599453
tightening,2,0.6931471805599453
retrofitting,2,0.6931471805599453
-128,2,0.6931471805599453
cross-site,2,0.6931471805599453
inclement,2,0.6931471805599453
large-volume,2,0.6931471805599453
2393,2,0.6931471805599453
hypoxicischemic,2,0.6931471805599453
ACOs,2,0.6931471805599453
strokeESUS,2,0.6931471805599453
exertion-related,2,0.6931471805599453
anteromedial,2,0.6931471805599453
4-14,2,0.6931471805599453
S2-78,2,0.6931471805599453
Annexin,2,0.6931471805599453
HAdV,2,0.6931471805599453
uORF,2,0.6931471805599453
nonallergicnonatopic,2,0.6931471805599453
sojourns,2,0.6931471805599453
antibody-targeted,2,0.6931471805599453
Noymer,2,0.6931471805599453
Commitment,2,0.6931471805599453
shapers,2,0.6931471805599453
situon-site,2,0.6931471805599453
0-56,2,0.6931471805599453
0-13,2,0.6931471805599453
protein-derived,2,0.6931471805599453
anticoagulant-associated,2,0.6931471805599453
0-25,2,0.6931471805599453
courageous,2,0.6931471805599453
Transporting,2,0.6931471805599453
Miocardico,2,0.6931471805599453
reentered,2,0.6931471805599453
unmistakable,2,0.6931471805599453
HSBDF,2,0.6931471805599453
bio-probe,2,0.6931471805599453
TAMM,2,0.6931471805599453
time-averaged,2,0.6931471805599453
Scenarios,2,0.6931471805599453
leucosis,2,0.6931471805599453
xylosoxidans,2,0.6931471805599453
decorated,2,0.6931471805599453
WGM,2,0.6931471805599453
VASchildren,2,0.6931471805599453
isotretinoin,2,0.6931471805599453
MF59-like,2,0.6931471805599453
TRIPS,2,0.6931471805599453
wash-free,2,0.6931471805599453
lm,2,0.6931471805599453
TS-19,2,0.6931471805599453
LLPCs,2,0.6931471805599453
10-60,2,0.6931471805599453
non-COPD,2,0.6931471805599453
ORF3c,2,0.6931471805599453
allergicatopic,2,0.6931471805599453
striatocapsular,2,0.6931471805599453
bruises,2,0.6931471805599453
warships,2,0.6931471805599453
HVAC,2,0.6931471805599453
shehe,2,0.6931471805599453
Archivos,2,0.6931471805599453
beta-13-glucan,2,0.6931471805599453
Dp-sensitivity,2,0.6931471805599453
Streptococci,2,0.6931471805599453
Guadalajara,2,0.6931471805599453
4885,2,0.6931471805599453
One-month,2,0.6931471805599453
MGUS,2,0.6931471805599453
antedated,2,0.6931471805599453
serologies,2,0.6931471805599453
Herpesviruses,2,0.6931471805599453
chemometric,2,0.6931471805599453
Ephedrae,2,0.6931471805599453
vowels,2,0.6931471805599453
anti-CD38,2,0.6931471805599453
USSR77,2,0.6931471805599453
-37,2,0.6931471805599453
herba,2,0.6931471805599453
Dp,2,0.6931471805599453
nonreplicating,2,0.6931471805599453
mVhr,2,0.6931471805599453
Cognitive-behavioral,2,0.6931471805599453
cumulating,2,0.6931471805599453
ReLEG,2,0.6931471805599453
bispecific,2,0.6931471805599453
15-59,2,0.6931471805599453
branched,2,0.6931471805599453
amnio,2,0.6931471805599453
gentle,2,0.6931471805599453
Marie,2,0.6931471805599453
1153,2,0.6931471805599453
1315,2,0.6931471805599453
AEFIs,2,0.6931471805599453
P0028,2,0.6931471805599453
2556,2,0.6931471805599453
GBM-A,2,0.6931471805599453
20A-Sp1,2,0.6931471805599453
20A-Sp2,2,0.6931471805599453
2‑driven,2,0.6931471805599453
Arrhythmic,2,0.6931471805599453
2-15,2,0.6931471805599453
tumoral,2,0.6931471805599453
DNA-sensors,2,0.6931471805599453
postcardiac,2,0.6931471805599453
prescreening,2,0.6931471805599453
Prestroke,2,0.6931471805599453
Rotters,2,0.6931471805599453
sought-after,2,0.6931471805599453
ATN,2,0.6931471805599453
patients-year,2,0.6931471805599453
month-1,2,0.6931471805599453
N-95,2,0.6931471805599453
Paradigm,2,0.6931471805599453
TDIMDI,2,0.6931471805599453
O-600,2,0.6931471805599453
Santander,2,0.6931471805599453
Uremic,2,0.6931471805599453
Q677PH,2,0.6931471805599453
16-month-old,2,0.6931471805599453
gradations,2,0.6931471805599453
Pan99,2,0.6931471805599453
SDc,2,0.6931471805599453
vexing,2,0.6931471805599453
transistor-based,2,0.6931471805599453
framessec,2,0.6931471805599453
democratic,2,0.6931471805599453
LPCW,2,0.6931471805599453
SPPA,2,0.6931471805599453
myelomonocytic,2,0.6931471805599453
Tachyarrhythmias,2,0.6931471805599453
1626,2,0.6931471805599453
TIN,2,0.6931471805599453
MM3MM1,2,0.6931471805599453
Goodpastures,2,0.6931471805599453
9544,2,0.6931471805599453
IUweek,2,0.6931471805599453
AGN,2,0.6931471805599453
pro-con,2,0.6931471805599453
high-dependency,2,0.6931471805599453
CRM197,2,0.6931471805599453
Unresolved,2,0.6931471805599453
Th2-directed,2,0.6931471805599453
hovering,2,0.6931471805599453
NHWS,2,0.6931471805599453
CB,2,0.6931471805599453
Dystrophic,2,0.6931471805599453
bio-sensing,2,0.6931471805599453
Oaxaca,2,0.6931471805599453
inconstantly,2,0.6931471805599453
Thats,2,0.6931471805599453
P079,2,0.6931471805599453
swine-derived,2,0.6931471805599453
symptoms1‐3,2,0.6931471805599453
MEES,2,0.6931471805599453
Minh,2,0.6931471805599453
Coll-group,2,0.6931471805599453
TRR,2,0.6931471805599453
Dermatological,2,0.6931471805599453
χ22,2,0.6931471805599453
pertained,2,0.6931471805599453
anatomies,2,0.6931471805599453
rRT-PCRs,2,0.6931471805599453
totalled,2,0.6931471805599453
disembarked,2,0.6931471805599453
RV7,2,0.6931471805599453
ºC,2,0.6931471805599453
Harters,2,0.6931471805599453
intercrisis,2,0.6931471805599453
front-loaded,2,0.6931471805599453
sphenopalatine,2,0.6931471805599453
gram-positive,2,0.6931471805599453
white-coat,2,0.6931471805599453
illusion,2,0.6931471805599453
authorship,2,0.6931471805599453
myeloperoxidases,2,0.6931471805599453
P0014,2,0.6931471805599453
Saliva-based,2,0.6931471805599453
Allocation,2,0.6931471805599453
Angiographical,2,0.6931471805599453
Individual-based,2,0.6931471805599453
HUNT,2,0.6931471805599453
FIP3,2,0.6931471805599453
Neuropathological,2,0.6931471805599453
postnitroglycerin,2,0.6931471805599453
uninoculated,2,0.6931471805599453
myocard,2,0.6931471805599453
nervous-anxious,2,0.6931471805599453
Familiarize,2,0.6931471805599453
buds,2,0.6931471805599453
non-ILI,2,0.6931471805599453
hospitalABSTRACT,2,0.6931471805599453
totals,2,0.6931471805599453
Exercise-Induced,2,0.6931471805599453
EuroMOMO,2,0.6931471805599453
688800,2,0.6931471805599453
LIDAR,2,0.6931471805599453
VEVO2-1,2,0.6931471805599453
Far-East,2,0.6931471805599453
Sarbeco-N,2,0.6931471805599453
Se-RNA,2,0.6931471805599453
navy,2,0.6931471805599453
Progressively,2,0.6931471805599453
0772,2,0.6931471805599453
TMJ,2,0.6931471805599453
manual-based,2,0.6931471805599453
puberal,2,0.6931471805599453
plasmacytosis,2,0.6931471805599453
Mutant,2,0.6931471805599453
congregant,2,0.6931471805599453
S186I,2,0.6931471805599453
ligaments,2,0.6931471805599453
Patient-based,2,0.6931471805599453
LDPM,2,0.6931471805599453
Compartmental,2,0.6931471805599453
multi-locus,2,0.6931471805599453
SPS,2,0.6931471805599453
Corrections,2,0.6931471805599453
Infinium,2,0.6931471805599453
Listing,2,0.6931471805599453
BeadChip,2,0.6931471805599453
25-34,2,0.6931471805599453
area-under-the-curve,2,0.6931471805599453
first-in-life,2,0.6931471805599453
Coll-groupp,2,0.6931471805599453
SARS-CoV-2-derived,2,0.6931471805599453
conscientiously,2,0.6931471805599453
2534,2,0.6931471805599453
NHWs,2,0.6931471805599453
S-RNA,2,0.6931471805599453
cRT-PCR,2,0.6931471805599453
quadrupole,2,0.6931471805599453
self-healing,2,0.6931471805599453
goat,2,0.6931471805599453
Grand,2,0.6931471805599453
05-20,2,0.6931471805599453
Allplex-nCoV,2,0.6931471805599453
Borgs,2,0.6931471805599453
S-type,2,0.6931471805599453
dissatisfied,2,0.6931471805599453
Apdm09,2,0.6931471805599453
embeddings,2,0.6931471805599453
1760,2,0.6931471805599453
tourist-recreational,2,0.6931471805599453
intraalveolar,2,0.6931471805599453
COBALT,2,0.6931471805599453
organogenesis,2,0.6931471805599453
2175,2,0.6931471805599453
Alum,2,0.6931471805599453
airplanes,2,0.6931471805599453
japonica,2,0.6931471805599453
Turners,2,0.6931471805599453
Co-operative,2,0.6931471805599453
Scratch,2,0.6931471805599453
Cupressaceae,2,0.6931471805599453
FTIR,2,0.6931471805599453
Histocompatibility,2,0.6931471805599453
amide,2,0.6931471805599453
thalamotuberal,2,0.6931471805599453
juniper,2,0.6931471805599453
GTPase,2,0.6931471805599453
S1-5,2,0.6931471805599453
exsmokers,2,0.6931471805599453
Cryptomeria,2,0.6931471805599453
thalamostriate,2,0.6931471805599453
dissonance,2,0.6931471805599453
Taxodiaceae,2,0.6931471805599453
flashes,2,0.6931471805599453
antitubercular,2,0.6931471805599453
Eczema,2,0.6931471805599453
LogIgE,2,0.6931471805599453
FMODB,2,0.6931471805599453
Severance,2,0.6931471805599453
interferon-α,2,0.6931471805599453
39-45,2,0.6931471805599453
SARS-CoV-2-inactivating,2,0.6931471805599453
EBV-associated,2,0.6931471805599453
opsonization,2,0.6931471805599453
ASSESSMENT,2,0.6931471805599453
ictal,2,0.6931471805599453
unclear-onset,2,0.6931471805599453
Relationship,2,0.6931471805599453
honesty,2,0.6931471805599453
microbalance,2,0.6931471805599453
Gazeta,2,0.6931471805599453
99mTc-pertechnetate,2,0.6931471805599453
DSp,2,0.6931471805599453
30-msec,2,0.6931471805599453
empathetic,2,0.6931471805599453
foamy,2,0.6931471805599453
generational,2,0.6931471805599453
1610,2,0.6931471805599453
Asystole,2,0.6931471805599453
Coulter,2,0.6931471805599453
ODFs,2,0.6931471805599453
unknownObjectives,2,0.6931471805599453
holographic,2,0.6931471805599453
pre-menopausal,2,0.6931471805599453
Tunicamycin,2,0.6931471805599453
postthrombolysis,2,0.6931471805599453
wer,2,0.6931471805599453
IL-4RA,2,0.6931471805599453
CVS,2,0.6931471805599453
nondemented,2,0.6931471805599453
TMT,2,0.6931471805599453
rightfully,2,0.6931471805599453
cleansing,2,0.6931471805599453
HAR,2,0.6931471805599453
stroke-diagnosis,2,0.6931471805599453
Fuzzy,2,0.6931471805599453
Finite,2,0.6931471805599453
anti-aggregant,2,0.6931471805599453
in-host,2,0.6931471805599453
side-clamping,2,0.6931471805599453
betamimetic,2,0.6931471805599453
collectors,2,0.6931471805599453
avian-derived,2,0.6931471805599453
Cross-immunity,2,0.6931471805599453
trenches,2,0.6931471805599453
Horizonte,2,0.6931471805599453
Chronological,2,0.6931471805599453
metal-chelating,2,0.6931471805599453
vibrational,2,0.6931471805599453
pathologicoanatomical,2,0.6931471805599453
cross-immune,2,0.6931471805599453
LS7,2,0.6931471805599453
sub-tropical,2,0.6931471805599453
nimodipine,2,0.6931471805599453
geriatric-specific,2,0.6931471805599453
surgeryprocedures,2,0.6931471805599453
2875,2,0.6931471805599453
-103,2,0.6931471805599453
sub-unit,2,0.6931471805599453
feedbacks,2,0.6931471805599453
RACE,2,0.6931471805599453
CXCR5,2,0.6931471805599453
biopharmaceutical,2,0.6931471805599453
18-65,2,0.6931471805599453
S84N,2,0.6931471805599453
follicles,2,0.6931471805599453
02-06,2,0.6931471805599453
0-3Hz,2,0.6931471805599453
pseudo-infarction,2,0.6931471805599453
3--5,2,0.6931471805599453
misfolded,2,0.6931471805599453
ecstasy,2,0.6931471805599453
Nestin,2,0.6931471805599453
resorted,2,0.6931471805599453
exercise-tests,2,0.6931471805599453
CSM,2,0.6931471805599453
underpins,2,0.6931471805599453
11600,2,0.6931471805599453
importin,2,0.6931471805599453
oseltamivir-sensitive,2,0.6931471805599453
adventure,2,0.6931471805599453
millimeters,2,0.6931471805599453
Echoing,2,0.6931471805599453
asthma-causing,2,0.6931471805599453
duodenum,2,0.6931471805599453
auscultative,2,0.6931471805599453
one-minute,2,0.6931471805599453
slanting,2,0.6931471805599453
fourths,2,0.6931471805599453
17-25,2,0.6931471805599453
PSA-NCAM,2,0.6931471805599453
phase-contrast,2,0.6931471805599453
importing,2,0.6931471805599453
pensions,2,0.6931471805599453
pinpoints,2,0.6931471805599453
1996-2005,2,0.6931471805599453
Economies,2,0.6931471805599453
SPF,2,0.6931471805599453
Transcripts,2,0.6931471805599453
toes,2,0.6931471805599453
reassessing,2,0.6931471805599453
TAB,2,0.6931471805599453
Alameda,2,0.6931471805599453
Quest,2,0.6931471805599453
Q493R,2,0.6931471805599453
RMSSD,2,0.6931471805599453
capture-recapture,2,0.6931471805599453
I117V,2,0.6931471805599453
sevenfold,2,0.6931471805599453
in-kind,2,0.6931471805599453
Savulescu,2,0.6931471805599453
2060,2,0.6931471805599453
job-centered,2,0.6931471805599453
epicentres,2,0.6931471805599453
BNT162B2,2,0.6931471805599453
carotidcerebral,2,0.6931471805599453
immunoadsorption,2,0.6931471805599453
osteoblastic,2,0.6931471805599453
Nepals,2,0.6931471805599453
BCCAo,2,0.6931471805599453
electrostimulator,2,0.6931471805599453
osteogenic,2,0.6931471805599453
-018,2,0.6931471805599453
sixty-nine,2,0.6931471805599453
magnetometers,2,0.6931471805599453
Once-daily,2,0.6931471805599453
16095,2,0.6931471805599453
aneurismal,2,0.6931471805599453
1113,2,0.6931471805599453
Syst-China,2,0.6931471805599453
10000mm3,2,0.6931471805599453
morbilliform,2,0.6931471805599453
re-resection,2,0.6931471805599453
aerosol-producing,2,0.6931471805599453
imperceptible,2,0.6931471805599453
RIVM,2,0.6931471805599453
orthotic,2,0.6931471805599453
Figures,2,0.6931471805599453
GoN,2,0.6931471805599453
Medscape,2,0.6931471805599453
-033,2,0.6931471805599453
type-D,2,0.6931471805599453
witch,2,0.6931471805599453
5120,2,0.6931471805599453
Wallonia,2,0.6931471805599453
Pensions,2,0.6931471805599453
ait,2,0.6931471805599453
chrysophylla,2,0.6931471805599453
Sophora,2,0.6931471805599453
4422,2,0.6931471805599453
FRCpleth,2,0.6931471805599453
0467,2,0.6931471805599453
daysThis,2,0.6931471805599453
LAMA,2,0.6931471805599453
httpwwwcrdyorkacukPROSPERO,2,0.6931471805599453
Tauopathy,2,0.6931471805599453
non-persistent,2,0.6931471805599453
crescent,2,0.6931471805599453
nonpersistent,2,0.6931471805599453
fibrate,2,0.6931471805599453
labyrinthitis,2,0.6931471805599453
nomenclatures,2,0.6931471805599453
flank,2,0.6931471805599453
bAb,2,0.6931471805599453
force-assisted,2,0.6931471805599453
Serra,2,0.6931471805599453
IO,2,0.6931471805599453
school-related,2,0.6931471805599453
2446,2,0.6931471805599453
30-100,2,0.6931471805599453
8e,2,0.6931471805599453
SA-ECG,2,0.6931471805599453
Troughs,2,0.6931471805599453
Centanni,2,0.6931471805599453
urology,2,0.6931471805599453
three-item,2,0.6931471805599453
delle,2,0.6931471805599453
0-50,2,0.6931471805599453
actuated,2,0.6931471805599453
nonthrombolyzed,2,0.6931471805599453
depolarisation,2,0.6931471805599453
banana,2,0.6931471805599453
felt-temperature,2,0.6931471805599453
JUMC,2,0.6931471805599453
micro-scale,2,0.6931471805599453
Modes,2,0.6931471805599453
radiate,2,0.6931471805599453
h-HIT,2,0.6931471805599453
inmate,2,0.6931471805599453
extrapolating,2,0.6931471805599453
lungworms,2,0.6931471805599453
lungworm,2,0.6931471805599453
LPAIV,2,0.6931471805599453
gallinaceous,2,0.6931471805599453
3837,2,0.6931471805599453
ARMS-PCR,2,0.6931471805599453
Perroncito,2,0.6931471805599453
Clinician,2,0.6931471805599453
Edmonton,2,0.6931471805599453
steadiness,2,0.6931471805599453
spatium,2,0.6931471805599453
unpleasantness,2,0.6931471805599453
TCG,2,0.6931471805599453
whooping,2,0.6931471805599453
H1-H3,2,0.6931471805599453
lobular,2,0.6931471805599453
late-term,2,0.6931471805599453
potato,2,0.6931471805599453
2735,2,0.6931471805599453
legumes,2,0.6931471805599453
masquerades,2,0.6931471805599453
ERASE,2,0.6931471805599453
earned,2,0.6931471805599453
Kitami,2,0.6931471805599453
NHPSS,2,0.6931471805599453
0790,2,0.6931471805599453
hill,2,0.6931471805599453
p38α,2,0.6931471805599453
between-country,2,0.6931471805599453
0736,2,0.6931471805599453
Bcl-XL,2,0.6931471805599453
2646,2,0.6931471805599453
FLIP,2,0.6931471805599453
Apixaban,2,0.6931471805599453
2164,2,0.6931471805599453
Normative,2,0.6931471805599453
Tension,2,0.6931471805599453
HD-IIV,2,0.6931471805599453
caspase-8,2,0.6931471805599453
Dane,2,0.6931471805599453
Parasites,2,0.6931471805599453
cable,2,0.6931471805599453
miR-125b,2,0.6931471805599453
carcass,2,0.6931471805599453
infarction-induced,2,0.6931471805599453
Transmembrane,2,0.6931471805599453
CAs,2,0.6931471805599453
37-54,2,0.6931471805599453
Jimma,2,0.6931471805599453
gesturing,2,0.6931471805599453
Hiccups,2,0.6931471805599453
LTD-IDMS,2,0.6931471805599453
Shield,2,0.6931471805599453
short-exhaustive,2,0.6931471805599453
Tweetable,2,0.6931471805599453
cinnamon,2,0.6931471805599453
tarsal,2,0.6931471805599453
non-natural,2,0.6931471805599453
n87,2,0.6931471805599453
Bos,2,0.6931471805599453
fibroelastoma,2,0.6931471805599453
LTD,2,0.6931471805599453
IL-3,2,0.6931471805599453
29891,2,0.6931471805599453
AuNP,2,0.6931471805599453
HTE,2,0.6931471805599453
unthout,2,0.6931471805599453
subcomponent,2,0.6931471805599453
turn-over,2,0.6931471805599453
neurokinins,2,0.6931471805599453
continental-scale,2,0.6931471805599453
AATD-related,2,0.6931471805599453
Generative,2,0.6931471805599453
nonrecipients,2,0.6931471805599453
3096626,2,0.6931471805599453
asthma-equivalent,2,0.6931471805599453
reconfirmed,2,0.6931471805599453
aerosolizing,2,0.6931471805599453
NGAL,2,0.6931471805599453
osteopontin,2,0.6931471805599453
4260,2,0.6931471805599453
FMSS,2,0.6931471805599453
217896,2,0.6931471805599453
OpenfluDB,2,0.6931471805599453
non-use,2,0.6931471805599453
Deeper,2,0.6931471805599453
Glucocorticosteroids,2,0.6931471805599453
VBI-2902a,2,0.6931471805599453
Technegas,2,0.6931471805599453
philosopher,2,0.6931471805599453
Coccidioides,2,0.6931471805599453
Generalization,2,0.6931471805599453
Nancy,2,0.6931471805599453
Jecker,2,0.6931471805599453
H3Nx,2,0.6931471805599453
Keys,2,0.6931471805599453
midscapular,2,0.6931471805599453
MMPBSA,2,0.6931471805599453
RDB,2,0.6931471805599453
13899,2,0.6931471805599453
miR21,2,0.6931471805599453
4878,2,0.6931471805599453
Biobehavioral,2,0.6931471805599453
aminotransferases,2,0.6931471805599453
normodynamic,2,0.6931471805599453
1228,2,0.6931471805599453
telemanagement,2,0.6931471805599453
biobehavioral,2,0.6931471805599453
3029,2,0.6931471805599453
Oxidants,2,0.6931471805599453
Hypothyroid,2,0.6931471805599453
cyanoacrylate,2,0.6931471805599453
fast-evolving,2,0.6931471805599453
1905,2,0.6931471805599453
1979-86,2,0.6931471805599453
1049,2,0.6931471805599453
STUFFS,2,0.6931471805599453
Affymetrix,2,0.6931471805599453
father-child,2,0.6931471805599453
mother-child,2,0.6931471805599453
mid-gestation,2,0.6931471805599453
Postextrasystolic,2,0.6931471805599453
4394,2,0.6931471805599453
IFN-αγ,2,0.6931471805599453
ostensibly,2,0.6931471805599453
3-weeks,2,0.6931471805599453
LVDF,2,0.6931471805599453
miR29,2,0.6931471805599453
School-located,2,0.6931471805599453
45-years,2,0.6931471805599453
graduation,2,0.6931471805599453
1611,2,0.6931471805599453
Lublin,2,0.6931471805599453
impulsive,2,0.6931471805599453
1998-2015,2,0.6931471805599453
surpasses,2,0.6931471805599453
antibody-producing,2,0.6931471805599453
8343,2,0.6931471805599453
Bosch,2,0.6931471805599453
Innova,2,0.6931471805599453
Non-O,2,0.6931471805599453
mistreatment,2,0.6931471805599453
case-reports,2,0.6931471805599453
locals,2,0.6931471805599453
6263,2,0.6931471805599453
INSTAND,2,0.6931471805599453
notches,2,0.6931471805599453
defeating,2,0.6931471805599453
αGal,2,0.6931471805599453
anti-Gal,2,0.6931471805599453
α-Gal,2,0.6931471805599453
nonprimate,2,0.6931471805599453
altona,2,0.6931471805599453
exemplars,2,0.6931471805599453
injustices,2,0.6931471805599453
thinks,2,0.6931471805599453
inhales,2,0.6931471805599453
FreeSurferv53,2,0.6931471805599453
Victoria-,2,0.6931471805599453
AdaBoost,2,0.6931471805599453
Yamagata-,2,0.6931471805599453
polycyclic,2,0.6931471805599453
remyelination,2,0.6931471805599453
ANMCO,2,0.6931471805599453
vagi,2,0.6931471805599453
allergization,2,0.6931471805599453
non-adrenergic,2,0.6931471805599453
family-history,2,0.6931471805599453
right-hand,2,0.6931471805599453
AShangdong993,2,0.6931471805599453
cold-dry,2,0.6931471805599453
Fluosol,2,0.6931471805599453
AVERROES,2,0.6931471805599453
teleconsultation,2,0.6931471805599453
PD-1,2,0.6931471805599453
Visit-to-visit,2,0.6931471805599453
polyfunctionality,2,0.6931471805599453
-OC43,2,0.6931471805599453
OPNS,2,0.6931471805599453
teleradiology,2,0.6931471805599453
Contributions,2,0.6931471805599453
ICSS,2,0.6931471805599453
H2-receptors,2,0.6931471805599453
Faculdade,2,0.6931471805599453
alternative-specimen,2,0.6931471805599453
accompaniment,2,0.6931471805599453
AST-negative,2,0.6931471805599453
beta-fibrinogen,2,0.6931471805599453
Macrophage,2,0.6931471805599453
six-gene,2,0.6931471805599453
PLE,2,0.6931471805599453
Luanda,2,0.6931471805599453
RR112,2,0.6931471805599453
non-urbanized,2,0.6931471805599453
reputable,2,0.6931471805599453
Hip-fracture,2,0.6931471805599453
micro-ADAPT,2,0.6931471805599453
Phylogenomic,2,0.6931471805599453
22-year,2,0.6931471805599453
flurry,2,0.6931471805599453
DVO,2,0.6931471805599453
Angolan,2,0.6931471805599453
Incidental,2,0.6931471805599453
ANAR,2,0.6931471805599453
nonshared,2,0.6931471805599453
accommodates,2,0.6931471805599453
ROC-AUC,2,0.6931471805599453
inter-reader,2,0.6931471805599453
Serca2a,2,0.6931471805599453
Profiler,2,0.6931471805599453
NEC,2,0.6931471805599453
host-infected,2,0.6931471805599453
reflexion,2,0.6931471805599453
noncanonical,2,0.6931471805599453
CollA1,2,0.6931471805599453
contractibility,2,0.6931471805599453
beta-mimetic,2,0.6931471805599453
Biofire,2,0.6931471805599453
Sdf1,2,0.6931471805599453
2504,2,0.6931471805599453
I300F,2,0.6931471805599453
SAMU,2,0.6931471805599453
R203K,2,0.6931471805599453
60-fold,2,0.6931471805599453
incriminate,2,0.6931471805599453
FoxOs,2,0.6931471805599453
Beagle,2,0.6931471805599453
chorionic,2,0.6931471805599453
Pexelizumab,2,0.6931471805599453
thoraxes,2,0.6931471805599453
45-74,2,0.6931471805599453
5742,2,0.6931471805599453
influenza-inactivated,2,0.6931471805599453
re-appraisal,2,0.6931471805599453
furthering,2,0.6931471805599453
endophthalmitis,2,0.6931471805599453
delphinids,2,0.6931471805599453
1132,2,0.6931471805599453
phocoenids,2,0.6931471805599453
shallow,2,0.6931471805599453
1238,2,0.6931471805599453
Hours,2,0.6931471805599453
burdening,2,0.6931471805599453
2014H3N2,2,0.6931471805599453
infit,2,0.6931471805599453
non-LAD-related,2,0.6931471805599453
corticomotor,2,0.6931471805599453
GPL,2,0.6931471805599453
FSMAP,2,0.6931471805599453
unorthodox,2,0.6931471805599453
mgL-1,2,0.6931471805599453
outfit,2,0.6931471805599453
e-smRSq,2,0.6931471805599453
Srmax,2,0.6931471805599453
fabricate,2,0.6931471805599453
pre-tested,2,0.6931471805599453
disqualifying,2,0.6931471805599453
logits,2,0.6931471805599453
sinicus,2,0.6931471805599453
stimulation-induced,2,0.6931471805599453
Inhalational,2,0.6931471805599453
Printzmetal,2,0.6931471805599453
Detectable,2,0.6931471805599453
Sra,2,0.6931471805599453
Remarkable,2,0.6931471805599453
francs,2,0.6931471805599453
slippery,2,0.6931471805599453
lyophilization,2,0.6931471805599453
encapsulating,2,0.6931471805599453
mRNA-LNPs,2,0.6931471805599453
nonclassical,2,0.6931471805599453
Hope-Simpson,2,0.6931471805599453
125OH2D,2,0.6931471805599453
Cryoelectron,2,0.6931471805599453
4604,2,0.6931471805599453
smRSq,2,0.6931471805599453
Excised,2,0.6931471805599453
aptamer-attached,2,0.6931471805599453
Yam88,2,0.6931471805599453
polyethyleneimine,2,0.6931471805599453
transmanubrial,2,0.6931471805599453
Pancoast,2,0.6931471805599453
agnostic,2,0.6931471805599453
numeric,2,0.6931471805599453
objetive,2,0.6931471805599453
crura,2,0.6931471805599453
ascitic,2,0.6931471805599453
battlefield,2,0.6931471805599453
SCN5A,2,0.6931471805599453
triangular,2,0.6931471805599453
mass-vaccinate,2,0.6931471805599453
Livzon,2,0.6931471805599453
vagolithic,2,0.6931471805599453
HSP90β,2,0.6931471805599453
triterpene,2,0.6931471805599453
rightward-shifting,2,0.6931471805599453
ursolic,2,0.6931471805599453
maslinic,2,0.6931471805599453
betulin,2,0.6931471805599453
prisms,2,0.6931471805599453
TACI,2,0.6931471805599453
cervico-thoracic,2,0.6931471805599453
POCI,2,0.6931471805599453
HUVEC,2,0.6931471805599453
45-fold,2,0.6931471805599453
wheezing-associated,2,0.6931471805599453
G142D,2,0.6931471805599453
IL-13-producing,2,0.6931471805599453
suprainfection,2,0.6931471805599453
schizotypy,2,0.6931471805599453
Mauritius,2,0.6931471805599453
-112A,2,0.6931471805599453
interchange,2,0.6931471805599453
Vic87,2,0.6931471805599453
segmet,2,0.6931471805599453
-073,2,0.6931471805599453
for-profit,2,0.6931471805599453
IQRS,2,0.6931471805599453
TIB,2,0.6931471805599453
Q-tips,2,0.6931471805599453
Warm-up,2,0.6931471805599453
5571,2,0.6931471805599453
70-85,2,0.6931471805599453
careoutpatient,2,0.6931471805599453
re-assessed,2,0.6931471805599453
dye-based,2,0.6931471805599453
thrombolysis-induced,2,0.6931471805599453
deep-diving,2,0.6931471805599453
75-99,2,0.6931471805599453
-084,2,0.6931471805599453
-085,2,0.6931471805599453
artefact,2,0.6931471805599453
SD-FD,2,0.6931471805599453
subject-specific,2,0.6931471805599453
conductivities,2,0.6931471805599453
thrombosuction,2,0.6931471805599453
multi-sensor,2,0.6931471805599453
Novacor,2,0.6931471805599453
reorganizes,2,0.6931471805599453
antidepressive,2,0.6931471805599453
non-IgE-mediated,2,0.6931471805599453
electrospun,2,0.6931471805599453
Sicilian,2,0.6931471805599453
TDT,2,0.6931471805599453
GSMDB,2,0.6931471805599453
Single-nucleotide,2,0.6931471805599453
case-study,2,0.6931471805599453
hippocampi,2,0.6931471805599453
counter-regulate,2,0.6931471805599453
disease-based,2,0.6931471805599453
Post-ischemic,2,0.6931471805599453
m-1,2,0.6931471805599453
postcode,2,0.6931471805599453
Astograph,2,0.6931471805599453
read-out,2,0.6931471805599453
unsettled,2,0.6931471805599453
RNAi-sensitive,2,0.6931471805599453
5060,2,0.6931471805599453
host-jumping,2,0.6931471805599453
Bill,2,0.6931471805599453
legislatures,2,0.6931471805599453
CL-900i,2,0.6931471805599453
VidasIII,2,0.6931471805599453
BMB,2,0.6931471805599453
anions,2,0.6931471805599453
exposuretravel,2,0.6931471805599453
Ptrend00001,2,0.6931471805599453
mEqL,2,0.6931471805599453
3-mm,2,0.6931471805599453
beta-hydroxybutyrate,2,0.6931471805599453
mini-AQLQ,2,0.6931471805599453
resections,2,0.6931471805599453
αCD40RBD,2,0.6931471805599453
101-111,2,0.6931471805599453
anti-drug,2,0.6931471805599453
H4N6,2,0.6931471805599453
21-days,2,0.6931471805599453
ate,2,0.6931471805599453
0-49,2,0.6931471805599453
Ia-2,2,0.6931471805599453
squirrel,2,0.6931471805599453
soundly,2,0.6931471805599453
bunching,2,0.6931471805599453
phase-3,2,0.6931471805599453
UHWI,2,0.6931471805599453
0738,2,0.6931471805599453
caval,2,0.6931471805599453
thrombocytemia,2,0.6931471805599453
1801,2,0.6931471805599453
3-6-year-old,2,0.6931471805599453
granulomatous,2,0.6931471805599453
AlOH3,2,0.6931471805599453
48-hours,2,0.6931471805599453
rs1800629,2,0.6931471805599453
Honey,2,0.6931471805599453
intemperance,2,0.6931471805599453
4-bed,2,0.6931471805599453
1024,2,0.6931471805599453
safeguards,2,0.6931471805599453
1968-1998,2,0.6931471805599453
13-item,2,0.6931471805599453
Iroquois,2,0.6931471805599453
1756,2,0.6931471805599453
Zung,2,0.6931471805599453
Q498R,2,0.6931471805599453
heritage,2,0.6931471805599453
dynasties,2,0.6931471805599453
Yuan,2,0.6931471805599453
Qing,2,0.6931471805599453
neurocentric,2,0.6931471805599453
weeksPatients,2,0.6931471805599453
3364,2,0.6931471805599453
materia,2,0.6931471805599453
medica,2,0.6931471805599453
1590,2,0.6931471805599453
5897,2,0.6931471805599453
TDI-sensitized,2,0.6931471805599453
acrolein,2,0.6931471805599453
contact-reducing,2,0.6931471805599453
HAP,2,0.6931471805599453
radio-immunoassay,2,0.6931471805599453
JANSSEN,2,0.6931471805599453
socio-psychological,2,0.6931471805599453
HI-,2,0.6931471805599453
strangers,2,0.6931471805599453
Solid-phase,2,0.6931471805599453
enlightenment,2,0.6931471805599453
generalizations,2,0.6931471805599453
hispanic,2,0.6931471805599453
Du,2,0.6931471805599453
balloon-tipped,2,0.6931471805599453
1378,2,0.6931471805599453
Multifactor,2,0.6931471805599453
mid-life,2,0.6931471805599453
4-A,2,0.6931471805599453
epoxide,2,0.6931471805599453
Caerphilly,2,0.6931471805599453
rhinitic,2,0.6931471805599453
five-factor,2,0.6931471805599453
Miss,2,0.6931471805599453
all-night,2,0.6931471805599453
standardising,2,0.6931471805599453
Repeatability,2,0.6931471805599453
autovaccines,2,0.6931471805599453
pareses,2,0.6931471805599453
Callous,2,0.6931471805599453
punched,2,0.6931471805599453
ses,2,0.6931471805599453
virus-containing,2,0.6931471805599453
1972-1981,2,0.6931471805599453
AMPLATZER,2,0.6931471805599453
Karelia,2,0.6931471805599453
DhC,2,0.6931471805599453
IRB,2,0.6931471805599453
temporospatial,2,0.6931471805599453
livedoid,2,0.6931471805599453
Strachan,2,0.6931471805599453
tako-tsubo-like,2,0.6931471805599453
11q13,2,0.6931471805599453
subarctic,2,0.6931471805599453
Cone,2,0.6931471805599453
inter-relationships,2,0.6931471805599453
acro-papular,2,0.6931471805599453
nationalities,2,0.6931471805599453
ve,2,0.6931471805599453
Jang,2,0.6931471805599453
spinner,2,0.6931471805599453
fidget,2,0.6931471805599453
Houttuynia,2,0.6931471805599453
cordata,2,0.6931471805599453
Predi-COVID,2,0.6931471805599453
Ontarians,2,0.6931471805599453
NYSDOH,2,0.6931471805599453
PAMS,2,0.6931471805599453
Hypercytokinemia,2,0.6931471805599453
Sanitec,2,0.6931471805599453
excellently,2,0.6931471805599453
waterfowls,2,0.6931471805599453
thalamogeniculate,2,0.6931471805599453
RASP-UK,2,0.6931471805599453
500100000,2,0.6931471805599453
PHQ-2,2,0.6931471805599453
cross-tabulation,2,0.6931471805599453
RIAT,2,0.6931471805599453
End-systolic,2,0.6931471805599453
0097,2,0.6931471805599453
non-UAE,2,0.6931471805599453
A2England72,2,0.6931471805599453
Diisocyanate,2,0.6931471805599453
case-targeted,2,0.6931471805599453
degree--in,2,0.6931471805599453
instigates,2,0.6931471805599453
investigator-initiated,2,0.6931471805599453
pDC,2,0.6931471805599453
ERASER,2,0.6931471805599453
relocated,2,0.6931471805599453
Gibbs,2,0.6931471805599453
violated,2,0.6931471805599453
anaplasmosis,2,0.6931471805599453
subsection,2,0.6931471805599453
582000,2,0.6931471805599453
1807,2,0.6931471805599453
ICr,2,0.6931471805599453
neuroscientist,2,0.6931471805599453
nanotherapeutics,2,0.6931471805599453
5982,2,0.6931471805599453
oocytes,2,0.6931471805599453
FMMLT,2,0.6931471805599453
UNICEF,2,0.6931471805599453
distinctively,2,0.6931471805599453
locally-circulating,2,0.6931471805599453
42nd,2,0.6931471805599453
Strangulation,2,0.6931471805599453
1244,2,0.6931471805599453
post-negative,2,0.6931471805599453
transcription-3,2,0.6931471805599453
neuro-endocrine,2,0.6931471805599453
S1-RBD,2,0.6931471805599453
high-transmission,2,0.6931471805599453
E119,2,0.6931471805599453
stabile,2,0.6931471805599453
horrors,2,0.6931471805599453
Ginkgo,2,0.6931471805599453
NTPs,2,0.6931471805599453
photobleaching,2,0.6931471805599453
photoactivation,2,0.6931471805599453
systematization,2,0.6931471805599453
crewmember,2,0.6931471805599453
preprints,2,0.6931471805599453
defervescence,2,0.6931471805599453
pruritic,2,0.6931471805599453
mass-scale,2,0.6931471805599453
Agilent,2,0.6931471805599453
CD11b,2,0.6931471805599453
anti-H1N1,2,0.6931471805599453
Eliciting,2,0.6931471805599453
on-chip,2,0.6931471805599453
client-centeredness,2,0.6931471805599453
3506,2,0.6931471805599453
non-unique,2,0.6931471805599453
PAH,2,0.6931471805599453
Acad,2,0.6931471805599453
partialgradual,2,0.6931471805599453
inflammometer,2,0.6931471805599453
underlay,2,0.6931471805599453
interne,2,0.6931471805599453
dopplerography,2,0.6931471805599453
10-month,2,0.6931471805599453
Rhythms,2,0.6931471805599453
heaters,2,0.6931471805599453
chronotherapeutics,2,0.6931471805599453
in-country,2,0.6931471805599453
rs3746444,2,0.6931471805599453
rhythmicity,2,0.6931471805599453
Retrograde,2,0.6931471805599453
mycobacterial,2,0.6931471805599453
miR-499,2,0.6931471805599453
epifluorescence,2,0.6931471805599453
hyperosmolarity,2,0.6931471805599453
Hernández,2,0.6931471805599453
Mismatches,2,0.6931471805599453
Frailty,2,0.6931471805599453
SDIs,2,0.6931471805599453
sternocostal,2,0.6931471805599453
Sanitary,2,0.6931471805599453
Stations,2,0.6931471805599453
non-live,2,0.6931471805599453
preeclampsia-eclampsia,2,0.6931471805599453
sleepwake,2,0.6931471805599453
churches,2,0.6931471805599453
lakh,2,0.6931471805599453
DPP-4i,2,0.6931471805599453
pre-asthmatic,2,0.6931471805599453
Glucose,2,0.6931471805599453
ELSI-Brazil,2,0.6931471805599453
bronchospam,2,0.6931471805599453
adjusted-VE,2,0.6931471805599453
indice,2,0.6931471805599453
B-LiFe,2,0.6931471805599453
1736,2,0.6931471805599453
family-wide,2,0.6931471805599453
irradiating,2,0.6931471805599453
cfa-miR-215,2,0.6931471805599453
sheltered,2,0.6931471805599453
adenosine-mediated,2,0.6931471805599453
ticagrelor-involving,2,0.6931471805599453
overturn,2,0.6931471805599453
middle-class,2,0.6931471805599453
aneurismatic,2,0.6931471805599453
1079,2,0.6931471805599453
WEST,2,0.6931471805599453
immunosystem,2,0.6931471805599453
improvisation,2,0.6931471805599453
DMSA,2,0.6931471805599453
anisotropic,2,0.6931471805599453
WMHLs,2,0.6931471805599453
camel,2,0.6931471805599453
SLA,2,0.6931471805599453
vaccination-specific,2,0.6931471805599453
E‑cad,2,0.6931471805599453
single-subject,2,0.6931471805599453
Comparability,2,0.6931471805599453
sub-categories,2,0.6931471805599453
WP,2,0.6931471805599453
9794,2,0.6931471805599453
Weissler,2,0.6931471805599453
Kashmir,2,0.6931471805599453
beluga,2,0.6931471805599453
leucas,2,0.6931471805599453
Delphinapterus,2,0.6931471805599453
ELISACLIA,2,0.6931471805599453
SLN,2,0.6931471805599453
SL-asymmetry,2,0.6931471805599453
vaccine-,2,0.6931471805599453
VHM,2,0.6931471805599453
SLDM,2,0.6931471805599453
Mus,2,0.6931471805599453
contact-balloon,2,0.6931471805599453
VPN,2,0.6931471805599453
musculus,2,0.6931471805599453
CCMV,2,0.6931471805599453
16163,2,0.6931471805599453
cowpea,2,0.6931471805599453
2241,2,0.6931471805599453
CRP-mediated,2,0.6931471805599453
IgE-IgG-dependent,2,0.6931471805599453
PTS,2,0.6931471805599453
wandering,2,0.6931471805599453
nanovaccine,2,0.6931471805599453
propensity-matched,2,0.6931471805599453
pursed-lip,2,0.6931471805599453
felmérésben,2,0.6931471805599453
COVID-19-fertőzésen,2,0.6931471805599453
STEAM-DWI,2,0.6931471805599453
át,2,0.6931471805599453
esett,2,0.6931471805599453
vevő,2,0.6931471805599453
részt,2,0.6931471805599453
NRs,2,0.6931471805599453
csoport,2,0.6931471805599453
±2,2,0.6931471805599453
b1,2,0.6931471805599453
3350,2,0.6931471805599453
plegia,2,0.6931471805599453
SAINT,2,0.6931471805599453
elő,2,0.6931471805599453
sCoVs,2,0.6931471805599453
faible,2,0.6931471805599453
értéke,2,0.6931471805599453
SRS2,2,0.6931471805599453
molliter,2,0.6931471805599453
03-05,2,0.6931471805599453
ISDNI,2,0.6931471805599453
pourraient,2,0.6931471805599453
antiprotozoal,2,0.6931471805599453
héttel,2,0.6931471805599453
mAB,2,0.6931471805599453
valsartan,2,0.6931471805599453
dolgozók,2,0.6931471805599453
oltott,2,0.6931471805599453
polluting,2,0.6931471805599453
Chairman,2,0.6931471805599453
három,2,0.6931471805599453
megfigyelési,2,0.6931471805599453
e-cig,2,0.6931471805599453
virus-centric,2,0.6931471805599453
inter-atrial,2,0.6931471805599453
1059,2,0.6931471805599453
congressionally,2,0.6931471805599453
HCFA,2,0.6931471805599453
refusalhesitancy,2,0.6931471805599453
3-Chymotrypsin,2,0.6931471805599453
Cardiomegaly,2,0.6931471805599453
thorny,2,0.6931471805599453
spurt,2,0.6931471805599453
nonstenosed,2,0.6931471805599453
corroborates,2,0.6931471805599453
CCUI,2,0.6931471805599453
diffusionperfusion,2,0.6931471805599453
transport-related,2,0.6931471805599453
détection,2,0.6931471805599453
tracheostomized,2,0.6931471805599453
1988-1992,2,0.6931471805599453
Irbesartan,2,0.6931471805599453
fifty-eight,2,0.6931471805599453
siesta,2,0.6931471805599453
0417,2,0.6931471805599453
symptômes,2,0.6931471805599453
blocs,2,0.6931471805599453
BA-ELISA,2,0.6931471805599453
rôle,2,0.6931471805599453
locates,2,0.6931471805599453
commended,2,0.6931471805599453
plural,2,0.6931471805599453
recatheterization,2,0.6931471805599453
tels,2,0.6931471805599453
Lotka-Euler,2,0.6931471805599453
time-effect,2,0.6931471805599453
facteurs,2,0.6931471805599453
socio,2,0.6931471805599453
1-hr,2,0.6931471805599453
exosome,2,0.6931471805599453
CTBG,2,0.6931471805599453
respiratoires,2,0.6931471805599453
laryngopharyngeal,2,0.6931471805599453
Rhythmic,2,0.6931471805599453
sports-related,2,0.6931471805599453
post-GMT,2,0.6931471805599453
mute,2,0.6931471805599453
222-nm,2,0.6931471805599453
localisations,2,0.6931471805599453
1978-79,2,0.6931471805599453
retrained,2,0.6931471805599453
Sénégal,2,0.6931471805599453
periinterventional,2,0.6931471805599453
Intervent,2,0.6931471805599453
concordances,2,0.6931471805599453
ligand-protein,2,0.6931471805599453
IDPs,2,0.6931471805599453
guérison,2,0.6931471805599453
hyperlactacidemia,2,0.6931471805599453
ketogenic,2,0.6931471805599453
Enveloped,2,0.6931471805599453
colonoscopy,2,0.6931471805599453
PDMS-TEOS,2,0.6931471805599453
1565,2,0.6931471805599453
untangle,2,0.6931471805599453
MRI-DWI,2,0.6931471805599453
oestro-progestational,2,0.6931471805599453
Discovering,2,0.6931471805599453
Specialty,2,0.6931471805599453
Accra,2,0.6931471805599453
parent-version,2,0.6931471805599453
antithymocyte,2,0.6931471805599453
8-12-year-old,2,0.6931471805599453
CK-MB-estimated,2,0.6931471805599453
Cardiovasc,2,0.6931471805599453
Cathet,2,0.6931471805599453
kayak,2,0.6931471805599453
MoyaMoya,2,0.6931471805599453
Arteriopathies,2,0.6931471805599453
FCA,2,0.6931471805599453
unproper,2,0.6931471805599453
már,2,0.6931471805599453
canoe,2,0.6931471805599453
lényegesen,2,0.6931471805599453
4757,2,0.6931471805599453
egyének,2,0.6931471805599453
résultats,2,0.6931471805599453
Topographic,2,0.6931471805599453
fertőzések,2,0.6931471805599453
MCQ,2,0.6931471805599453
élevé,2,0.6931471805599453
craniocaudal,2,0.6931471805599453
non-small-cell,2,0.6931471805599453
entonox,2,0.6931471805599453
pain-relief,2,0.6931471805599453
Hypoperfused,2,0.6931471805599453
HL-A,2,0.6931471805599453
4738,2,0.6931471805599453
NS8L84S,2,0.6931471805599453
solicit,2,0.6931471805599453
Bihar,2,0.6931471805599453
Arepanrix,2,0.6931471805599453
Herrick,2,0.6931471805599453
PTFA,2,0.6931471805599453
NSP12A97V,2,0.6931471805599453
graft-coronary,2,0.6931471805599453
Ingelheim,2,0.6931471805599453
étroit,2,0.6931471805599453
post-infective,2,0.6931471805599453
être,2,0.6931471805599453
17-20,2,0.6931471805599453
19901991,2,0.6931471805599453
adjectives,2,0.6931471805599453
Microbiol,2,0.6931471805599453
Notch‑3,2,0.6931471805599453
10-17,2,0.6931471805599453
0289,2,0.6931471805599453
Veteran,2,0.6931471805599453
electroconductive,2,0.6931471805599453
7142,2,0.6931471805599453
adrenomimetic,2,0.6931471805599453
nanogold,2,0.6931471805599453
Dopamine,2,0.6931471805599453
repressing,2,0.6931471805599453
unheralded,2,0.6931471805599453
BCP,2,0.6931471805599453
Thankfully,2,0.6931471805599453
7857,2,0.6931471805599453
V3R-V6R,2,0.6931471805599453
vehicular,2,0.6931471805599453
cannabinoids-related,2,0.6931471805599453
legalization,2,0.6931471805599453
publicize,2,0.6931471805599453
1-RBD,2,0.6931471805599453
0882,2,0.6931471805599453
pan-epidemic,2,0.6931471805599453
preconditioning-mimetic,2,0.6931471805599453
flecainide,2,0.6931471805599453
Fundação,2,0.6931471805599453
Periodically,2,0.6931471805599453
room-air,2,0.6931471805599453
hematologist,2,0.6931471805599453
Reims,2,0.6931471805599453
5686,2,0.6931471805599453
comfortably,2,0.6931471805599453
Neuroendovascular,2,0.6931471805599453
RBD219-N1,2,0.6931471805599453
five-item,2,0.6931471805599453
Shore,2,0.6931471805599453
BUNCr,2,0.6931471805599453
pollutant-induced,2,0.6931471805599453
Instruments,2,0.6931471805599453
upper-airways,2,0.6931471805599453
particle-based,2,0.6931471805599453
17-24,2,0.6931471805599453
nonbridged,2,0.6931471805599453
Out-of-season,2,0.6931471805599453
1975-1976,2,0.6931471805599453
cataplexy,2,0.6931471805599453
ischaemically,2,0.6931471805599453
Gade,2,0.6931471805599453
Overdosage,2,0.6931471805599453
score-matching,2,0.6931471805599453
Quervains,2,0.6931471805599453
biovars,2,0.6931471805599453
2·4,2,0.6931471805599453
staircase,2,0.6931471805599453
part-time,2,0.6931471805599453
health-care-seeking,2,0.6931471805599453
Microneutralization,2,0.6931471805599453
Sopravvivenza,2,0.6931471805599453
agglutinating,2,0.6931471805599453
nonsteroid-dependent,2,0.6931471805599453
serovar,2,0.6931471805599453
Darby,2,0.6931471805599453
Timeliness,2,0.6931471805599453
Vehicle,2,0.6931471805599453
innovated,2,0.6931471805599453
Homeostatic,2,0.6931471805599453
15-63,2,0.6931471805599453
Poincaré,2,0.6931471805599453
multivitamin,2,0.6931471805599453
radionuclide-determined,2,0.6931471805599453
Extracranial-intracranial,2,0.6931471805599453
Seprafilm,2,0.6931471805599453
glycerin,2,0.6931471805599453
Paradox,2,0.6931471805599453
STLF,2,0.6931471805599453
promiscuity,2,0.6931471805599453
deforestation,2,0.6931471805599453
D56,2,0.6931471805599453
nontransferred,2,0.6931471805599453
bushmeat,2,0.6931471805599453
FLAP,2,0.6931471805599453
impactors,2,0.6931471805599453
anti-IL-13,2,0.6931471805599453
ACQ-6,2,0.6931471805599453
extraskeletal,2,0.6931471805599453
Malaysians,2,0.6931471805599453
chylous,2,0.6931471805599453
CD93,2,0.6931471805599453
biosensor-based,2,0.6931471805599453
contre,2,0.6931471805599453
dehumidifiers,2,0.6931471805599453
Nsp12,2,0.6931471805599453
nsp10,2,0.6931471805599453
27-fold,2,0.6931471805599453
α2-3,2,0.6931471805599453
Coughing,2,0.6931471805599453
just-in-time,2,0.6931471805599453
lakhs,2,0.6931471805599453
STC,2,0.6931471805599453
T-piece,2,0.6931471805599453
extubations,2,0.6931471805599453
6-item,2,0.6931471805599453
furin-like,2,0.6931471805599453
Plot,2,0.6931471805599453
PBB,2,0.6931471805599453
varicose,2,0.6931471805599453
mouse-adaptive,2,0.6931471805599453
mouse-specific,2,0.6931471805599453
attendee,2,0.6931471805599453
WT-,2,0.6931471805599453
destabilised,2,0.6931471805599453
1PI,2,0.6931471805599453
SDSD,2,0.6931471805599453
4-class,2,0.6931471805599453
NPC1,2,0.6931471805599453
reproterol,2,0.6931471805599453
A97V,2,0.6931471805599453
thromboembolization,2,0.6931471805599453
5776,2,0.6931471805599453
Post-translational,2,0.6931471805599453
WT-RdRp,2,0.6931471805599453
Malloch,2,0.6931471805599453
DFT,2,0.6931471805599453
quercetin-treated,2,0.6931471805599453
Schatz,2,0.6931471805599453
Palmaz,2,0.6931471805599453
LVAD-related,2,0.6931471805599453
Subsets,2,0.6931471805599453
cascade-forward,2,0.6931471805599453
0830,2,0.6931471805599453
0846,2,0.6931471805599453
Kimchi,2,0.6931471805599453
ISOIEC,2,0.6931471805599453
9889,2,0.6931471805599453
pre-treatments,2,0.6931471805599453
9834,2,0.6931471805599453
ERAsthma,2,0.6931471805599453
r065,2,0.6931471805599453
non-contracting,2,0.6931471805599453
MoA,2,0.6931471805599453
14-37,2,0.6931471805599453
0100,2,0.6931471805599453
trader,2,0.6931471805599453
curtailment,2,0.6931471805599453
99mTc-Trend,2,0.6931471805599453
FAST-based,2,0.6931471805599453
non-ST-elevated,2,0.6931471805599453
swell,2,0.6931471805599453
Glucocorticoid,2,0.6931471805599453
anticytoplasmic,2,0.6931471805599453
CFC-BDP,2,0.6931471805599453
Malnutrition,2,0.6931471805599453
virotherapy,2,0.6931471805599453
n130,2,0.6931471805599453
postembolization,2,0.6931471805599453
Rheumatoid,2,0.6931471805599453
assessor,2,0.6931471805599453
6825,2,0.6931471805599453
4981,2,0.6931471805599453
disregulation,2,0.6931471805599453
RPArkDNA-GO,2,0.6931471805599453
Presuming,2,0.6931471805599453
vagotonia,2,0.6931471805599453
proneness,2,0.6931471805599453
stalk-based,2,0.6931471805599453
iodide,2,0.6931471805599453
inosculation,2,0.6931471805599453
two-chamber,2,0.6931471805599453
RPA-amplified,2,0.6931471805599453
rkDNA,2,0.6931471805599453
cereton,2,0.6931471805599453
wires,2,0.6931471805599453
palmar,2,0.6931471805599453
Adenovirus-based,2,0.6931471805599453
Placentae,2,0.6931471805599453
reminderrecall,2,0.6931471805599453
utterly,2,0.6931471805599453
Two-sample,2,0.6931471805599453
1275,2,0.6931471805599453
PLase,2,0.6931471805599453
REACT,2,0.6931471805599453
conceptualise,2,0.6931471805599453
Stringent,2,0.6931471805599453
Colombo,2,0.6931471805599453
pseudocorticodependence,2,0.6931471805599453
REGISTRATION,2,0.6931471805599453
sevrage,2,0.6931471805599453
transosseous,2,0.6931471805599453
Pragmatic,2,0.6931471805599453
cholesterol-containing,2,0.6931471805599453
politicized,2,0.6931471805599453
E35,2,0.6931471805599453
Ordinal,2,0.6931471805599453
parent-rated,2,0.6931471805599453
Freedom,2,0.6931471805599453
Ethos,2,0.6931471805599453
CV2CoV,2,0.6931471805599453
VOSviewer,2,0.6931471805599453
11-yr-old,2,0.6931471805599453
ethnicityrace,2,0.6931471805599453
reagins,2,0.6931471805599453
Neurobehavioral,2,0.6931471805599453
Intact,2,0.6931471805599453
clinician-diagnosed,2,0.6931471805599453
non-LAC,2,0.6931471805599453
conveyances,2,0.6931471805599453
attendanceadmission,2,0.6931471805599453
convoluted,2,0.6931471805599453
palivizumab,2,0.6931471805599453
log-likelihood,2,0.6931471805599453
verbalized,2,0.6931471805599453
20191,2,0.6931471805599453
mPCR,2,0.6931471805599453
city-to-city,2,0.6931471805599453
clinician-assessed,2,0.6931471805599453
molnupiravir-induced,2,0.6931471805599453
COVID-19-patients,2,0.6931471805599453
not-for-profit,2,0.6931471805599453
chemo,2,0.6931471805599453
philanthropic,2,0.6931471805599453
encephaloduroarteriosynangiosis,2,0.6931471805599453
WVs,2,0.6931471805599453
molnupiravir,2,0.6931471805599453
Adj,2,0.6931471805599453
hitrate,2,0.6931471805599453
GSTM1--,2,0.6931471805599453
vWf,2,0.6931471805599453
non-genetic,2,0.6931471805599453
stemstromal,2,0.6931471805599453
1635,2,0.6931471805599453
VAHS,2,0.6931471805599453
0055,2,0.6931471805599453
programe,2,0.6931471805599453
darunavirritonavir,2,0.6931471805599453
ASPECTs,2,0.6931471805599453
dysautonomic,2,0.6931471805599453
pulling,2,0.6931471805599453
β-D-N4-hydroxycytidine,2,0.6931471805599453
InfarctionArterial,2,0.6931471805599453
TICI2CAOL3,2,0.6931471805599453
co-primary,2,0.6931471805599453
Virosome,2,0.6931471805599453
co-existent,2,0.6931471805599453
HIV-seronegative,2,0.6931471805599453
anaesthetised,2,0.6931471805599453
proband,2,0.6931471805599453
locum,2,0.6931471805599453
allo-HSCTs,2,0.6931471805599453
relaxant,2,0.6931471805599453
v3,2,0.6931471805599453
STAT,2,0.6931471805599453
transgastric,2,0.6931471805599453
Prentice,2,0.6931471805599453
Natal,2,0.6931471805599453
Rivaroxaban,2,0.6931471805599453
behavior-related,2,0.6931471805599453
NAVIGATE,2,0.6931471805599453
radioisotopic,2,0.6931471805599453
entertained,2,0.6931471805599453
Anticipated,2,0.6931471805599453
allo-HSCT,2,0.6931471805599453
density-dependent,2,0.6931471805599453
megacity,2,0.6931471805599453
ACalifornia72004-like,2,0.6931471805599453
non-vitamin-K,2,0.6931471805599453
surplus,2,0.6931471805599453
extirpation,2,0.6931471805599453
9190,2,0.6931471805599453
Ethanol,2,0.6931471805599453
sub-analysis,2,0.6931471805599453
I-SPY,2,0.6931471805599453
HICs,2,0.6931471805599453
etiopathological,2,0.6931471805599453
Kits,2,0.6931471805599453
iGAS,2,0.6931471805599453
α23-,2,0.6931471805599453
DSDB,2,0.6931471805599453
Purely,2,0.6931471805599453
cytopathy,2,0.6931471805599453
knock,2,0.6931471805599453
pNAb,2,0.6931471805599453
non-household,2,0.6931471805599453
hypocaloric,2,0.6931471805599453
non-patient-facing,2,0.6931471805599453
SFCs106,2,0.6931471805599453
saliva-positive,2,0.6931471805599453
transcription--polymerase,2,0.6931471805599453
Method-,2,0.6931471805599453
handouts,2,0.6931471805599453
T-bet,2,0.6931471805599453
underexpressed,2,0.6931471805599453
postherpes,2,0.6931471805599453
shorebirds,2,0.6931471805599453
runner,2,0.6931471805599453
Nagano,2,0.6931471805599453
Yardstick,2,0.6931471805599453
particularity,2,0.6931471805599453
FLAARDS,2,0.6931471805599453
TikTok,2,0.6931471805599453
Anti-vaccination,2,0.6931471805599453
SARSMERS,2,0.6931471805599453
hashtag,2,0.6931471805599453
cordis,2,0.6931471805599453
2005a,2,0.6931471805599453
1903,2,0.6931471805599453
asthmaABSTRACT,2,0.6931471805599453
sixty-six,2,0.6931471805599453
DDFPe-STND,2,0.6931471805599453
DDFPe-NSTND,2,0.6931471805599453
drama,2,0.6931471805599453
forme,2,0.6931471805599453
careproviders,2,0.6931471805599453
hear,2,0.6931471805599453
anti-CD4,2,0.6931471805599453
infector-infectee,2,0.6931471805599453
delete,2,0.6931471805599453
gasometric,2,0.6931471805599453
monoclones,2,0.6931471805599453
SAMPs,2,0.6931471805599453
1979--January,2,0.6931471805599453
07-10,2,0.6931471805599453
stem-specific,2,0.6931471805599453
stabbing,2,0.6931471805599453
pdm09-associated,2,0.6931471805599453
mVE,2,0.6931471805599453
anatomopathologic,2,0.6931471805599453
orient,2,0.6931471805599453
Yentl,2,0.6931471805599453
quinone,2,0.6931471805599453
Ex-ECG,2,0.6931471805599453
pencil,2,0.6931471805599453
sub-arachnoid,2,0.6931471805599453
Wildlife,2,0.6931471805599453
bNEA,2,0.6931471805599453
Spilberger,2,0.6931471805599453
charted,2,0.6931471805599453
cigar,2,0.6931471805599453
purpuric,2,0.6931471805599453
VDAART,2,0.6931471805599453
ceramides,2,0.6931471805599453
4q25,2,0.6931471805599453
Oxford-Astra,2,0.6931471805599453
administrating,2,0.6931471805599453
IgE-antibodies,2,0.6931471805599453
BDSD,2,0.6931471805599453
phosphosphingolipid,2,0.6931471805599453
fluctuation-sensitive,2,0.6931471805599453
prepayment,2,0.6931471805599453
ALOS,2,0.6931471805599453
Notification,2,0.6931471805599453
Corona-virus,2,0.6931471805599453
3548,2,0.6931471805599453
naphazoline,2,0.6931471805599453
outweighing,2,0.6931471805599453
nanotechnologies,2,0.6931471805599453
orthomyxoviridae,2,0.6931471805599453
IFT,2,0.6931471805599453
HGM,2,0.6931471805599453
nucleoprotein-based,2,0.6931471805599453
patient-dependent,2,0.6931471805599453
antigen-negative,2,0.6931471805599453
briefings,2,0.6931471805599453
QNU,2,0.6931471805599453
restarted,2,0.6931471805599453
AFort,2,0.6931471805599453
non-CPR,2,0.6931471805599453
aneurisms,2,0.6931471805599453
menacing,2,0.6931471805599453
lodges,2,0.6931471805599453
food-production,2,0.6931471805599453
well-reported,2,0.6931471805599453
himher,2,0.6931471805599453
schizotypal,2,0.6931471805599453
dyspeptic,2,0.6931471805599453
preadaptation,2,0.6931471805599453
abietic,2,0.6931471805599453
4143,2,0.6931471805599453
periodMethods,2,0.6931471805599453
Windows,2,0.6931471805599453
Hemolysis,2,0.6931471805599453
resectable,2,0.6931471805599453
touted,2,0.6931471805599453
abstention,2,0.6931471805599453
postrehabilitation,2,0.6931471805599453
w-6w-3,2,0.6931471805599453
n53,2,0.6931471805599453
reservation,2,0.6931471805599453
Bouaké,2,0.6931471805599453
ARCOS,2,0.6931471805599453
2640,2,0.6931471805599453
Preserved,2,0.6931471805599453
Protein-protein,2,0.6931471805599453
FCT,2,0.6931471805599453
camelid,2,0.6931471805599453
Atg5,2,0.6931471805599453
coupled-diffusion,2,0.6931471805599453
Cardiolin,2,0.6931471805599453
F-18-FDG-PET,2,0.6931471805599453
lantan,2,0.6931471805599453
sdAbs,2,0.6931471805599453
SENSOR,2,0.6931471805599453
10527,2,0.6931471805599453
Anti-viral,2,0.6931471805599453
mobilizes,2,0.6931471805599453
informally,2,0.6931471805599453
rMSSD,2,0.6931471805599453
SDNNi,2,0.6931471805599453
publicly-available,2,0.6931471805599453
46-64,2,0.6931471805599453
Lampang,2,0.6931471805599453
quinidine,2,0.6931471805599453
coronaropathy,2,0.6931471805599453
impermeable,2,0.6931471805599453
easiness,2,0.6931471805599453
L-VAD,2,0.6931471805599453
8097,2,0.6931471805599453
underrating,2,0.6931471805599453
disease-dependent,2,0.6931471805599453
tones,2,0.6931471805599453
happiness,2,0.6931471805599453
non-steroid,2,0.6931471805599453
activatable,2,0.6931471805599453
snowfall,2,0.6931471805599453
gout,2,0.6931471805599453
Luna,2,0.6931471805599453
redilated,2,0.6931471805599453
OVA-challenged,2,0.6931471805599453
Cy75,2,0.6931471805599453
stratifies,2,0.6931471805599453
matched-cohort,2,0.6931471805599453
Finnmark,2,0.6931471805599453
pretransfusion,2,0.6931471805599453
Underrepresentation,2,0.6931471805599453
Short-,2,0.6931471805599453
ridged,2,0.6931471805599453
IH-induced,2,0.6931471805599453
ThermoFisher,2,0.6931471805599453
fluorophores,2,0.6931471805599453
quotients,2,0.6931471805599453
perieccrine,2,0.6931471805599453
IRT-model,2,0.6931471805599453
varicella-like,2,0.6931471805599453
JASDF,2,0.6931471805599453
Self-Defense,2,0.6931471805599453
Precipitin,2,0.6931471805599453
erased,2,0.6931471805599453
027-092,2,0.6931471805599453
vision-based,2,0.6931471805599453
perampanel,2,0.6931471805599453
short-bore,2,0.6931471805599453
Moss,2,0.6931471805599453
microcircuits,2,0.6931471805599453
non-Qwave,2,0.6931471805599453
Omega,2,0.6931471805599453
epithelial-to-mesenchymal,2,0.6931471805599453
prediabetic,2,0.6931471805599453
1995-2000,2,0.6931471805599453
793,2,0.6931471805599453
ORA,2,0.6931471805599453
B02,2,0.6931471805599453
Incarcerated,2,0.6931471805599453
N-glycosylated,2,0.6931471805599453
shipyard,2,0.6931471805599453
67000,2,0.6931471805599453
-089,2,0.6931471805599453
woven,2,0.6931471805599453
068-094,2,0.6931471805599453
disfavor,2,0.6931471805599453
Unravelling,2,0.6931471805599453
1069,2,0.6931471805599453
paratopes,2,0.6931471805599453
atheroscrelotic,2,0.6931471805599453
nephrologist,2,0.6931471805599453
lug,2,0.6931471805599453
2730,2,0.6931471805599453
Deficient,2,0.6931471805599453
Gironde,2,0.6931471805599453
Lot,2,0.6931471805599453
vasculaires,2,0.6931471805599453
Garonne,2,0.6931471805599453
COMPASS-TC,2,0.6931471805599453
nonrecovered,2,0.6931471805599453
tents,2,0.6931471805599453
3M-052,2,0.6931471805599453
27-June,2,0.6931471805599453
proof-of,2,0.6931471805599453
unloads,2,0.6931471805599453
intubate,2,0.6931471805599453
1-person,2,0.6931471805599453
disqualification,2,0.6931471805599453
medium-field,2,0.6931471805599453
mistakes,2,0.6931471805599453
post-prediction,2,0.6931471805599453
restudied,2,0.6931471805599453
Vaxign,2,0.6931471805599453
Normandy,2,0.6931471805599453
Beta-Blocker,2,0.6931471805599453
22-Hydroxyhopan-3-one,2,0.6931471805599453
6-Oxoisoiguesterin,2,0.6931471805599453
Cryptoquindoline,2,0.6931471805599453
shortcut,2,0.6931471805599453
10-Hydroxyusambarensine,2,0.6931471805599453
resins,2,0.6931471805599453
2205,2,0.6931471805599453
TNT,2,0.6931471805599453
NT-pro,2,0.6931471805599453
1072,2,0.6931471805599453
breed,2,0.6931471805599453
LPXRBD-mRNA,2,0.6931471805599453
echoplanar,2,0.6931471805599453
PADOH,2,0.6931471805599453
inter-professional,2,0.6931471805599453
Embryology,2,0.6931471805599453
1772,2,0.6931471805599453
Lehigh,2,0.6931471805599453
14-17,2,0.6931471805599453
unifactorial,2,0.6931471805599453
Agriculture,2,0.6931471805599453
well-understood,2,0.6931471805599453
CFQ,2,0.6931471805599453
inventions,2,0.6931471805599453
RBD-mRNA,2,0.6931471805599453
multipolar,2,0.6931471805599453
immunohistologic,2,0.6931471805599453
downloading,2,0.6931471805599453
brain-type,2,0.6931471805599453
terminally,2,0.6931471805599453
Schematically,2,0.6931471805599453
CXCL1,2,0.6931471805599453
distention,2,0.6931471805599453
Reliever,2,0.6931471805599453
malpositioning,2,0.6931471805599453
Solving,2,0.6931471805599453
GSK-3βmTORp70S6K,2,0.6931471805599453
Yamagata-like,2,0.6931471805599453
E-Sarbeco,2,0.6931471805599453
meconium,2,0.6931471805599453
benefitting,2,0.6931471805599453
microbiomics,2,0.6931471805599453
Nang,2,0.6931471805599453
active-site,2,0.6931471805599453
lucrative,2,0.6931471805599453
frequence,2,0.6931471805599453
35S-methionine,2,0.6931471805599453
budesonideformoterol,2,0.6931471805599453
Drainage,2,0.6931471805599453
autoimmune-mediated,2,0.6931471805599453
projectile,2,0.6931471805599453
Mimicking,2,0.6931471805599453
PDGF-AB-based,2,0.6931471805599453
COBRA,2,0.6931471805599453
influenza-naive,2,0.6931471805599453
age-targeted,2,0.6931471805599453
hematologystem,2,0.6931471805599453
remarked,2,0.6931471805599453
Hyaluronic,2,0.6931471805599453
precoronary,2,0.6931471805599453
B0AT1ACE2,2,0.6931471805599453
Rule,2,0.6931471805599453
X77-mimetic,2,0.6931471805599453
cerebrovasuclar,2,0.6931471805599453
IgA-specific,2,0.6931471805599453
NE,2,0.6931471805599453
slim,2,0.6931471805599453
2-peak,2,0.6931471805599453
megakaryocyte,2,0.6931471805599453
thermotolerant,2,0.6931471805599453
directionality,2,0.6931471805599453
enumerate,2,0.6931471805599453
RCSB,2,0.6931471805599453
reticulated,2,0.6931471805599453
10056,2,0.6931471805599453
-114,2,0.6931471805599453
MKs,2,0.6931471805599453
Superimposed,2,0.6931471805599453
rank-sum,2,0.6931471805599453
H5-specific,2,0.6931471805599453
hyposensitisation,2,0.6931471805599453
reconfiguring,2,0.6931471805599453
plasmacryosupernatant,2,0.6931471805599453
Researches,2,0.6931471805599453
blanket,2,0.6931471805599453
Four-dimensional,2,0.6931471805599453
invent,2,0.6931471805599453
health-insurance,2,0.6931471805599453
6-60,2,0.6931471805599453
Meticulous,2,0.6931471805599453
StatesMethods,2,0.6931471805599453
VIASURE,2,0.6931471805599453
plasmapheresis-based,2,0.6931471805599453
11071,2,0.6931471805599453
ADPN,2,0.6931471805599453
C18,2,0.6931471805599453
dRT-PCR,2,0.6931471805599453
k-21,2,0.6931471805599453
EPVS,2,0.6931471805599453
-119,2,0.6931471805599453
plateletfibrin,2,0.6931471805599453
OWOH,2,0.6931471805599453
cilia,2,0.6931471805599453
tinctoria,2,0.6931471805599453
EGFP-ESC,2,0.6931471805599453
3132,2,0.6931471805599453
1632,2,0.6931471805599453
hyperproduction,2,0.6931471805599453
sterility,2,0.6931471805599453
rVE,2,0.6931471805599453
reframed,2,0.6931471805599453
N75,2,0.6931471805599453
low-micromolar,2,0.6931471805599453
JUN,2,0.6931471805599453
single-segment,2,0.6931471805599453
BCL2,2,0.6931471805599453
telerehabilitation,2,0.6931471805599453
quinquefolium,2,0.6931471805599453
cyclo-oxygenase,2,0.6931471805599453
HFNEF,2,0.6931471805599453
dependants,2,0.6931471805599453
Isatis,2,0.6931471805599453
whey,2,0.6931471805599453
Quantifying,2,0.6931471805599453
p00,2,0.6931471805599453
Seasons,2,0.6931471805599453
FF100,2,0.6931471805599453
Hundred,2,0.6931471805599453
Editor-in-Chief,2,0.6931471805599453
TOS,2,0.6931471805599453
quadrate,2,0.6931471805599453
0314,2,0.6931471805599453
non-obstructed,2,0.6931471805599453
WWI,2,0.6931471805599453
ketones,2,0.6931471805599453
substitutionssiteyear,2,0.6931471805599453
phenolics,2,0.6931471805599453
Unfavorable,2,0.6931471805599453
SURA,2,0.6931471805599453
Aragon,2,0.6931471805599453
infarction-limiting,2,0.6931471805599453
Paraguay,2,0.6931471805599453
OST-resistant,2,0.6931471805599453
OST,2,0.6931471805599453
flagging,2,0.6931471805599453
FOIS,2,0.6931471805599453
MI-CAD,2,0.6931471805599453
post-procedure,2,0.6931471805599453
gall,2,0.6931471805599453
adsorption-elution,2,0.6931471805599453
Cell-free,2,0.6931471805599453
Log-transformed,2,0.6931471805599453
dyspnoeic,2,0.6931471805599453
monofaceted,2,0.6931471805599453
doxantrazole,2,0.6931471805599453
2649,2,0.6931471805599453
Kong16816235,2,0.6931471805599453
2351,2,0.6931471805599453
4·71,2,0.6931471805599453
Sunnyvale,2,0.6931471805599453
diarrheal,2,0.6931471805599453
handlers,2,0.6931471805599453
drip-and-ship,2,0.6931471805599453
Prescribed,2,0.6931471805599453
daysyear,2,0.6931471805599453
shelf-stable,2,0.6931471805599453
23-diphosphoglycerate,2,0.6931471805599453
Accidents,2,0.6931471805599453
lab-in-a-box,2,0.6931471805599453
Checking,2,0.6931471805599453
89-100,2,0.6931471805599453
CWS,2,0.6931471805599453
HR095,2,0.6931471805599453
mcgday,2,0.6931471805599453
covariables,2,0.6931471805599453
Réalisée,2,0.6931471805599453
Height,2,0.6931471805599453
6-methylprednisolone,2,0.6931471805599453
data-collection,2,0.6931471805599453
compliance-improving,2,0.6931471805599453
Therapists,2,0.6931471805599453
cement,2,0.6931471805599453
Lactococcus,2,0.6931471805599453
093-098,2,0.6931471805599453
IFN-α-mediated,2,0.6931471805599453
Transmissibility,2,0.6931471805599453
Heubner,2,0.6931471805599453
attesting,2,0.6931471805599453
RV1,2,0.6931471805599453
celecoxib,2,0.6931471805599453
Completeness,2,0.6931471805599453
basiliximab,2,0.6931471805599453
Centrée,2,0.6931471805599453
lIncidence,2,0.6931471805599453
thymoglobulin,2,0.6931471805599453
gammaglobulin,2,0.6931471805599453
inactivable,2,0.6931471805599453
Conditioning,2,0.6931471805599453
ACalifornia,2,0.6931471805599453
pancreas-kidney,2,0.6931471805599453
ventilator-induced,2,0.6931471805599453
7960,2,0.6931471805599453
Statutory,2,0.6931471805599453
log-transformed,2,0.6931471805599453
cell-dependent,2,0.6931471805599453
pedalling,2,0.6931471805599453
Embryo,2,0.6931471805599453
AKAP12,2,0.6931471805599453
appositional,2,0.6931471805599453
insertional,2,0.6931471805599453
-SMA,2,0.6931471805599453
X-gal,2,0.6931471805599453
GLRA2,2,0.6931471805599453
α2,2,0.6931471805599453
15x106,2,0.6931471805599453
anti-inflammatoryimmunomodulatory,2,0.6931471805599453
vector-ECG,2,0.6931471805599453
non-AKI,2,0.6931471805599453
Post-traumatic,2,0.6931471805599453
TiO2-mediated,2,0.6931471805599453
unsusceptible,2,0.6931471805599453
iPSC,2,0.6931471805599453
serovariant,2,0.6931471805599453
99mTc-albumin,2,0.6931471805599453
periplasmic,2,0.6931471805599453
Yuji,2,0.6931471805599453
actigraphy,2,0.6931471805599453
Y414A,2,0.6931471805599453
D330A,2,0.6931471805599453
urologic,2,0.6931471805599453
HA0,2,0.6931471805599453
tumorous,2,0.6931471805599453
IAV-,2,0.6931471805599453
Gal,2,0.6931471805599453
angiosarcoma,2,0.6931471805599453
CT-perfusion,2,0.6931471805599453
Smolensk,2,0.6931471805599453
aPTT,2,0.6931471805599453
Titles,2,0.6931471805599453
radioimmunological,2,0.6931471805599453
monolithic,2,0.6931471805599453
slowness,2,0.6931471805599453
inflection,2,0.6931471805599453
myelodysplastic,2,0.6931471805599453
HINT,2,0.6931471805599453
Man-to-man,2,0.6931471805599453
sm,2,0.6931471805599453
141293,2,0.6931471805599453
H4-H15,2,0.6931471805599453
preflight,2,0.6931471805599453
combinatory,2,0.6931471805599453
septicemia,2,0.6931471805599453
rSARS-CoV-2s,2,0.6931471805599453
downhill,2,0.6931471805599453
NAD-dependent,2,0.6931471805599453
practice-dependent,2,0.6931471805599453
Personally,2,0.6931471805599453
HifA,2,0.6931471805599453
RRmax,2,0.6931471805599453
pre-print,2,0.6931471805599453
-II,2,0.6931471805599453
m-3,2,0.6931471805599453
laboratory-documented,2,0.6931471805599453
Sense,2,0.6931471805599453
integrum,2,0.6931471805599453
Discharged,2,0.6931471805599453
basophilic,2,0.6931471805599453
Gram-negative,2,0.6931471805599453
perpostoperative,2,0.6931471805599453
multifield,2,0.6931471805599453
serogroup,2,0.6931471805599453
RFE,2,0.6931471805599453
AHDRA,2,0.6931471805599453
007-097,2,0.6931471805599453
GSE61144,2,0.6931471805599453
capsulated,2,0.6931471805599453
emphysematicus,2,0.6931471805599453
Histone,2,0.6931471805599453
100-104,2,0.6931471805599453
LCL-related,2,0.6931471805599453
3-d,2,0.6931471805599453
Caesar,2,0.6931471805599453
bone-avid,2,0.6931471805599453
aminopeptidase,2,0.6931471805599453
thermoregulatory,2,0.6931471805599453
NoFAS,2,0.6931471805599453
gym,2,0.6931471805599453
swap,2,0.6931471805599453
subspecialist,2,0.6931471805599453
Non-,2,0.6931471805599453
AHRF,2,0.6931471805599453
Explanatory,2,0.6931471805599453
lmm2,2,0.6931471805599453
Proceedings,2,0.6931471805599453
spasmogen,2,0.6931471805599453
12-h,2,0.6931471805599453
spermatogenesis,2,0.6931471805599453
LCL-IgE,2,0.6931471805599453
WF10att,2,0.6931471805599453
withdraw,2,0.6931471805599453
civilized,2,0.6931471805599453
super-resolution,2,0.6931471805599453
PAC-CVD,2,0.6931471805599453
milliliters,2,0.6931471805599453
AID,2,0.6931471805599453
HCE,2,0.6931471805599453
Fukuda,2,0.6931471805599453
adjunctiverescue,2,0.6931471805599453
Integrilin,2,0.6931471805599453
microgd,2,0.6931471805599453
Ahead,2,0.6931471805599453
multi-drug-resistant,2,0.6931471805599453
reinvestigation,2,0.6931471805599453
958-100,2,0.6931471805599453
Replacing,2,0.6931471805599453
biology-based,2,0.6931471805599453
97-100,2,0.6931471805599453
B-mismatch,2,0.6931471805599453
1064,2,0.6931471805599453
Societal,2,0.6931471805599453
H1N1-,2,0.6931471805599453
Arksey,2,0.6931471805599453
PICO,2,0.6931471805599453
time-of-day,2,0.6931471805599453
glycyrrhizic,2,0.6931471805599453
anti-oxidation,2,0.6931471805599453
thrombolyses,2,0.6931471805599453
hepatoprotective,2,0.6931471805599453
Cross-protection,2,0.6931471805599453
1982-1992,2,0.6931471805599453
prolaps,2,0.6931471805599453
annuas,2,0.6931471805599453
ACCULINKACCUNET,2,0.6931471805599453
Uncover,2,0.6931471805599453
Unanticipated,2,0.6931471805599453
evidence-informed,2,0.6931471805599453
CAPTURE,2,0.6931471805599453
yearscycle,2,0.6931471805599453
extranodal,2,0.6931471805599453
poststroketransient,2,0.6931471805599453
chemotherapies,2,0.6931471805599453
shutter,2,0.6931471805599453
VIRO®,2,0.6931471805599453
coronavirus-host,2,0.6931471805599453
-002,2,0.6931471805599453
nitroprusside-induced,2,0.6931471805599453
Unreported,2,0.6931471805599453
Stimulating,2,0.6931471805599453
Kessler,2,0.6931471805599453
Replicate,2,0.6931471805599453
microvolt,2,0.6931471805599453
1970-72,2,0.6931471805599453
re-admissions,2,0.6931471805599453
obliquus,2,0.6931471805599453
CauliFlower,2,0.6931471805599453
anguish,2,0.6931471805599453
LE-FMA,2,0.6931471805599453
pH1N1-infected,2,0.6931471805599453
repressors,2,0.6931471805599453
Blush,2,0.6931471805599453
semiaquatic,2,0.6931471805599453
carrier-host,2,0.6931471805599453
asthma-controlling,2,0.6931471805599453
single-lobed,2,0.6931471805599453
carbonyl,2,0.6931471805599453
bi-fascicular,2,0.6931471805599453
150150,2,0.6931471805599453
phthalate,2,0.6931471805599453
AUC0-30,2,0.6931471805599453
dioctyl-phthalate,2,0.6931471805599453
impairment-oriented,2,0.6931471805599453
SP-IgM,2,0.6931471805599453
SP-IgG,2,0.6931471805599453
harming,2,0.6931471805599453
push-off,2,0.6931471805599453
simulators,2,0.6931471805599453
testbed,2,0.6931471805599453
MBPS,2,0.6931471805599453
GSH-Px,2,0.6931471805599453
farrow-to-finish,2,0.6931471805599453
carrier-hosts,2,0.6931471805599453
ChickenWing,2,0.6931471805599453
trigeminy,2,0.6931471805599453
gradient-recalled,2,0.6931471805599453
encapsidated,2,0.6931471805599453
8-h,2,0.6931471805599453
conforms,2,0.6931471805599453
yawning,2,0.6931471805599453
0·043,2,0.6931471805599453
JB,2,0.6931471805599453
COU,2,0.6931471805599453
rampiril,2,0.6931471805599453
non-contractile,2,0.6931471805599453
troopship,2,0.6931471805599453
Cardiac-specific,2,0.6931471805599453
PWC,2,0.6931471805599453
whole-of-government,2,0.6931471805599453
ABBREVIATIONS,2,0.6931471805599453
assesment,2,0.6931471805599453
reinvestigated,2,0.6931471805599453
laboratorians,2,0.6931471805599453
amylase,2,0.6931471805599453
healthcentres,2,0.6931471805599453
loculation,2,0.6931471805599453
MVO-,2,0.6931471805599453
shared-care,2,0.6931471805599453
6049,2,0.6931471805599453
common-goal,2,0.6931471805599453
20002001-winter,2,0.6931471805599453
Cytochrome,2,0.6931471805599453
hypoperfusive,2,0.6931471805599453
low-prevalent,2,0.6931471805599453
headway,2,0.6931471805599453
200-500,2,0.6931471805599453
vaccineantiviral,2,0.6931471805599453
recuperated,2,0.6931471805599453
swine-human,2,0.6931471805599453
Ring,2,0.6931471805599453
Bel,2,0.6931471805599453
Wesel,2,0.6931471805599453
50th,2,0.6931471805599453
centrum,2,0.6931471805599453
revamped,2,0.6931471805599453
histiocytic,2,0.6931471805599453
1212,2,0.6931471805599453
3567,2,0.6931471805599453
laboratory-related,2,0.6931471805599453
ACalifornia72004H3N2-like,2,0.6931471805599453
Subbarao,2,0.6931471805599453
Anti‑SARS‑CoV‑2,2,0.6931471805599453
“The,2,0.6931471805599453
birth-cohorts,2,0.6931471805599453
explosiveness,2,0.6931471805599453
AJT,2,0.6931471805599453
SALT,2,0.6931471805599453
radionecrosis,2,0.6931471805599453
overeating,2,0.6931471805599453
48-96,2,0.6931471805599453
take-home,2,0.6931471805599453
ACCC,2,0.6931471805599453
0991,2,0.6931471805599453
Well-controlled,2,0.6931471805599453
-0062,2,0.6931471805599453
5472,2,0.6931471805599453
Alexandria,2,0.6931471805599453
Governorate,2,0.6931471805599453
time-matched,2,0.6931471805599453
3925,2,0.6931471805599453
2740,2,0.6931471805599453
inter-parental,2,0.6931471805599453
HifB,2,0.6931471805599453
symptomfree,2,0.6931471805599453
Report”,2,0.6931471805599453
NPVs,2,0.6931471805599453
Strenuous,2,0.6931471805599453
1972-1975,2,0.6931471805599453
HSP27,2,0.6931471805599453
Incidents,2,0.6931471805599453
Surabaya,2,0.6931471805599453
1973-1974,2,0.6931471805599453
childrenABSTRACT,2,0.6931471805599453
DIC-syndrome,2,0.6931471805599453
Backgroud,2,0.6931471805599453
obliterating,2,0.6931471805599453
tube-MDCK,2,0.6931471805599453
tube-A549,2,0.6931471805599453
TOSs,2,0.6931471805599453
FERV,2,0.6931471805599453
SV-MDCK,2,0.6931471805599453
SNSs,2,0.6931471805599453
rhinovirusesenteroviruses,2,0.6931471805599453
4347,2,0.6931471805599453
post-event,2,0.6931471805599453
1346,2,0.6931471805599453
Partnering,2,0.6931471805599453
nursesmidwives,2,0.6931471805599453
reprogrammed,2,0.6931471805599453
anti-Mix,2,0.6931471805599453
hypertrophyhyperplasia,2,0.6931471805599453
envenomations,2,0.6931471805599453
25000000,2,0.6931471805599453
cantons,2,0.6931471805599453
CArdiovascular,2,0.6931471805599453
MMLS,2,0.6931471805599453
Organizing,2,0.6931471805599453
call-outs,2,0.6931471805599453
dystextia,2,0.6931471805599453
2°C,2,0.6931471805599453
age-gender,2,0.6931471805599453
spike-IgG,2,0.6931471805599453
microRNA-223,2,0.6931471805599453
pre-sternotomy,2,0.6931471805599453
scleroxylon,2,0.6931471805599453
MIABSTRACT,2,0.6931471805599453
felodipine,2,0.6931471805599453
subdomains,2,0.6931471805599453
Chicago-area,2,0.6931471805599453
Triplochiton,2,0.6931471805599453
markings,2,0.6931471805599453
pathogenetical,2,0.6931471805599453
61-80,2,0.6931471805599453
demonstrations,2,0.6931471805599453
emits,2,0.6931471805599453
RSIs,2,0.6931471805599453
Megacare,2,0.6931471805599453
sternotomised,2,0.6931471805599453
early-open,2,0.6931471805599453
compartmentalized,2,0.6931471805599453
ERNA,2,0.6931471805599453
Px,2,0.6931471805599453
carpenter,2,0.6931471805599453
hypothetic,2,0.6931471805599453
1-29,2,0.6931471805599453
first-step,2,0.6931471805599453
gloomy,2,0.6931471805599453
reviewer,2,0.6931471805599453
immuno-system,2,0.6931471805599453
Nanotechnology-based,2,0.6931471805599453
highly-vaccinated,2,0.6931471805599453
PCR-restriction,2,0.6931471805599453
stu-dies,2,0.6931471805599453
ARISTOTLE,2,0.6931471805599453
merchant,2,0.6931471805599453
RV6,2,0.6931471805599453
Antigen-specific,2,0.6931471805599453
1493,2,0.6931471805599453
egg-grown,2,0.6931471805599453
excrete,2,0.6931471805599453
fibrynolysis,2,0.6931471805599453
psycho-geriatric,2,0.6931471805599453
PF-,2,0.6931471805599453
NMCTH,2,0.6931471805599453
Nitroglycerinheparin,2,0.6931471805599453
Transcription-Polymerase,2,0.6931471805599453
High-molecular-weight,2,0.6931471805599453
100-120,2,0.6931471805599453
MCSFR,2,0.6931471805599453
Hisayama,2,0.6931471805599453
high-filtration,2,0.6931471805599453
T1a,2,0.6931471805599453
worded,2,0.6931471805599453
obeying,2,0.6931471805599453
104-140,2,0.6931471805599453
over-diagnosed,2,0.6931471805599453
supercomputer,2,0.6931471805599453
Inflammasome,2,0.6931471805599453
160100,2,0.6931471805599453
calisthenics,2,0.6931471805599453
NRTW,2,0.6931471805599453
work-flow,2,0.6931471805599453
Transradial,2,0.6931471805599453
heterozygotic,2,0.6931471805599453
QDS,2,0.6931471805599453
PCR-screening,2,0.6931471805599453
secrets,2,0.6931471805599453
1977-2009,2,0.6931471805599453
provasopressin,2,0.6931471805599453
6W01,2,0.6931471805599453
metropolis,2,0.6931471805599453
micro-contact,2,0.6931471805599453
interferon-alpha,2,0.6931471805599453
ACE2-binding,2,0.6931471805599453
PLK1,2,0.6931471805599453
xenograft,2,0.6931471805599453
Luckily,2,0.6931471805599453
PARPs,2,0.6931471805599453
tastes,2,0.6931471805599453
ptiO2,2,0.6931471805599453
first-day,2,0.6931471805599453
N2l,2,0.6931471805599453
slightest,2,0.6931471805599453
nebulizing,2,0.6931471805599453
1897,2,0.6931471805599453
Vo,2,0.6931471805599453
phenotype-driven,2,0.6931471805599453
trimethylamine,2,0.6931471805599453
microembolization,2,0.6931471805599453
fat-free,2,0.6931471805599453
leucine,2,0.6931471805599453
RPPG,2,0.6931471805599453
anti-fungal,2,0.6931471805599453
Galactomannan,2,0.6931471805599453
Prone,2,0.6931471805599453
2C08-like,2,0.6931471805599453
MCMS,2,0.6931471805599453
10100,2,0.6931471805599453
ribcage,2,0.6931471805599453
Berkeley,2,0.6931471805599453
Clonal,2,0.6931471805599453
glucans,2,0.6931471805599453
post-amplification,2,0.6931471805599453
Subspecialty,2,0.6931471805599453
Reed-Frost,2,0.6931471805599453
Receptor-binding,2,0.6931471805599453
Westernised,2,0.6931471805599453
Th2-skewed,2,0.6931471805599453
Hematoxylin,2,0.6931471805599453
butyric,2,0.6931471805599453
butyrate,2,0.6931471805599453
30-46,2,0.6931471805599453
interplaying,2,0.6931471805599453
one-off,2,0.6931471805599453
research-grade,2,0.6931471805599453
2870,2,0.6931471805599453
VOC-20201201,2,0.6931471805599453
haemiballism,2,0.6931471805599453
sCR1,2,0.6931471805599453
or3,2,0.6931471805599453
CoV-1,2,0.6931471805599453
Term,2,0.6931471805599453
Schisandrae,2,0.6931471805599453
GCC,2,0.6931471805599453
expatriates,2,0.6931471805599453
nourishing,2,0.6931471805599453
Cortex,2,0.6931471805599453
Yangqin,2,0.6931471805599453
Sanzi,2,0.6931471805599453
3287,2,0.6931471805599453
Tolerance,2,0.6931471805599453
Officinalis,2,0.6931471805599453
thrombocythaemia,2,0.6931471805599453
Pogostemonis,2,0.6931471805599453
nonprobability,2,0.6931471805599453
Lepidii,2,0.6931471805599453
revascularisations,2,0.6931471805599453
hemiaxes,2,0.6931471805599453
cTFC,2,0.6931471805599453
T1b,2,0.6931471805599453
gallic,2,0.6931471805599453
fit-for-purpose,2,0.6931471805599453
recreation,2,0.6931471805599453
3672,2,0.6931471805599453
divine,2,0.6931471805599453
Postpandemic,2,0.6931471805599453
s-K,2,0.6931471805599453
PCoVGX,2,0.6931471805599453
nonreferred,2,0.6931471805599453
recreationally,2,0.6931471805599453
culprits,2,0.6931471805599453
Compensation,2,0.6931471805599453
groupP,2,0.6931471805599453
SARS-CoV-2-,2,0.6931471805599453
periodThe,2,0.6931471805599453
0853,2,0.6931471805599453
28-days,2,0.6931471805599453
viruseshour,2,0.6931471805599453
armament,2,0.6931471805599453
Biopsies,2,0.6931471805599453
quasi-stationary,2,0.6931471805599453
terrier,2,0.6931471805599453
spayed,2,0.6931471805599453
0900,2,0.6931471805599453
COVID-specific,2,0.6931471805599453
1-projection,2,0.6931471805599453
3-projection,2,0.6931471805599453
--in,2,0.6931471805599453
89-98,2,0.6931471805599453
adheres,2,0.6931471805599453
19-24,2,0.6931471805599453
regrowth,2,0.6931471805599453
129Xe-MRI,2,0.6931471805599453
0077,2,0.6931471805599453
18-44,2,0.6931471805599453
1246,2,0.6931471805599453
2210,2,0.6931471805599453
immunoallergological,2,0.6931471805599453
1351,2,0.6931471805599453
TMEM41B,2,0.6931471805599453
euthanasia,2,0.6931471805599453
IV-infected,2,0.6931471805599453
Putative,2,0.6931471805599453
assemblers,2,0.6931471805599453
47000,2,0.6931471805599453
Sedation,2,0.6931471805599453
lymphagogues,2,0.6931471805599453
LBDs,2,0.6931471805599453
50-99,2,0.6931471805599453
Nighttime,2,0.6931471805599453
inter-dependent,2,0.6931471805599453
zero-inflated,2,0.6931471805599453
propria,2,0.6931471805599453
LC-MS,2,0.6931471805599453
notices,2,0.6931471805599453
splenosis,2,0.6931471805599453
4-wk,2,0.6931471805599453
T3-treated,2,0.6931471805599453
T3-induced,2,0.6931471805599453
65-84,2,0.6931471805599453
0974,2,0.6931471805599453
2013-2018,2,0.6931471805599453
2009-2014,2,0.6931471805599453
25-44,2,0.6931471805599453
51000,2,0.6931471805599453
two-years,2,0.6931471805599453
nomadic,2,0.6931471805599453
Task-specific,2,0.6931471805599453
BIII,2,0.6931471805599453
Somewhat,2,0.6931471805599453
s-Mg,2,0.6931471805599453
Mobility,2,0.6931471805599453
PI3K-dependent,2,0.6931471805599453
city-wide,2,0.6931471805599453
transactivation,2,0.6931471805599453
rice,2,0.6931471805599453
Falling,2,0.6931471805599453
prostration,2,0.6931471805599453
93-year-old,2,0.6931471805599453
Pnky,2,0.6931471805599453
RBD-ID,2,0.6931471805599453
Squared,2,0.6931471805599453
ASISTASTM,2,0.6931471805599453
8846,2,0.6931471805599453
Destructive,2,0.6931471805599453
nanorobots,2,0.6931471805599453
associationConclusion,2,0.6931471805599453
9648,2,0.6931471805599453
Failures,2,0.6931471805599453
Concentrations,2,0.6931471805599453
seven-year,2,0.6931471805599453
Host-virus,2,0.6931471805599453
Chaldeans,2,0.6931471805599453
activitieslevels,2,0.6931471805599453
2494,2,0.6931471805599453
desktop,2,0.6931471805599453
succesfully,2,0.6931471805599453
angiotensinconverting,2,0.6931471805599453
ACEACE-2,2,0.6931471805599453
pharmaco-invasive,2,0.6931471805599453
Artesunate,2,0.6931471805599453
2353,2,0.6931471805599453
energy-yielding,2,0.6931471805599453
Rhizopus,2,0.6931471805599453
neighbourhood-level,2,0.6931471805599453
streptozotocin,2,0.6931471805599453
fashionable,2,0.6931471805599453
immunostimulating,2,0.6931471805599453
1435,2,0.6931471805599453
unease,2,0.6931471805599453
postsurgical,2,0.6931471805599453
countershock,2,0.6931471805599453
prefusion-stabilized,2,0.6931471805599453
Beaumont,2,0.6931471805599453
acetone,2,0.6931471805599453
phenols,2,0.6931471805599453
myopathies,2,0.6931471805599453
encasings,2,0.6931471805599453
sous-vide,2,0.6931471805599453
quadrupling,2,0.6931471805599453
s-K2,2,0.6931471805599453
Chunghyul-dan,2,0.6931471805599453
BZs,2,0.6931471805599453
Glaxo-Wellcome,2,0.6931471805599453
azelnidipine,2,0.6931471805599453
adventitious,2,0.6931471805599453
Kelantan,2,0.6931471805599453
Modifying,2,0.6931471805599453
substudies,2,0.6931471805599453
osteoarthritis,2,0.6931471805599453
Boost,2,0.6931471805599453
2X2,2,0.6931471805599453
4230,2,0.6931471805599453
mlm-2,2,0.6931471805599453
apoA-I,2,0.6931471805599453
MPA,2,0.6931471805599453
yet-unidentified,2,0.6931471805599453
apoB,2,0.6931471805599453
Novartis,2,0.6931471805599453
proatherogenic,2,0.6931471805599453
exercisers,2,0.6931471805599453
2C08,2,0.6931471805599453
1076,2,0.6931471805599453
pontocerebellar,2,0.6931471805599453
RCCVC,2,0.6931471805599453
filtrates,2,0.6931471805599453
17-23,2,0.6931471805599453
normoxic,2,0.6931471805599453
caverns,2,0.6931471805599453
CSN5,2,0.6931471805599453
T4SS,2,0.6931471805599453
cardiocerebrovascular,2,0.6931471805599453
12-yr,2,0.6931471805599453
perimeters,2,0.6931471805599453
Para-clinical,2,0.6931471805599453
pontis,2,0.6931471805599453
Influenced,2,0.6931471805599453
Basis,2,0.6931471805599453
Desensitization,2,0.6931471805599453
proteasome-mediated,2,0.6931471805599453
compress,2,0.6931471805599453
pulsating,2,0.6931471805599453
pre-bronchodilator,2,0.6931471805599453
Latvian,2,0.6931471805599453
1216,2,0.6931471805599453
unpredicted,2,0.6931471805599453
oseltamavir,2,0.6931471805599453
αβ,2,0.6931471805599453
Deliberately,2,0.6931471805599453
impoverishment,2,0.6931471805599453
-0,2,0.6931471805599453
Mas,2,0.6931471805599453
octapeptide,2,0.6931471805599453
1573,2,0.6931471805599453
celebrating,2,0.6931471805599453
free-range,2,0.6931471805599453
APSI,2,0.6931471805599453
106-190,2,0.6931471805599453
hypoplasic,2,0.6931471805599453
easy-to-access,2,0.6931471805599453
Boushey,2,0.6931471805599453
Warnock,2,0.6931471805599453
Mayer,2,0.6931471805599453
IBAs,2,0.6931471805599453
reprints,2,0.6931471805599453
94143,2,0.6931471805599453
Situations,2,0.6931471805599453
Occupations,2,0.6931471805599453
Pathologies,2,0.6931471805599453
teammates,2,0.6931471805599453
navigated,2,0.6931471805599453
Garmin,2,0.6931471805599453
post-SARS-CoV-2,2,0.6931471805599453
HRG-enriched,2,0.6931471805599453
μgkgh,2,0.6931471805599453
motivator,2,0.6931471805599453
ALVI,2,0.6931471805599453
23-25,2,0.6931471805599453
2371,2,0.6931471805599453
arm-ergometry,2,0.6931471805599453
well-preserved,2,0.6931471805599453
CTFCP,2,0.6931471805599453
Harris,2,0.6931471805599453
unlagged,2,0.6931471805599453
european,2,0.6931471805599453
yourself,2,0.6931471805599453
good-quality,2,0.6931471805599453
laryngospasm,2,0.6931471805599453
entry-blocking,2,0.6931471805599453
CHOP,2,0.6931471805599453
n448,2,0.6931471805599453
Virus-host,2,0.6931471805599453
HBAE,2,0.6931471805599453
inter-disciplinary,2,0.6931471805599453
pre-mRNA,2,0.6931471805599453
shore-based,2,0.6931471805599453
pilots,2,0.6931471805599453
cluster-based,2,0.6931471805599453
Neutrostim,2,0.6931471805599453
functionalizing,2,0.6931471805599453
PPAs,2,0.6931471805599453
cytokine-driven,2,0.6931471805599453
psychoneurosis,2,0.6931471805599453
-174,2,0.6931471805599453
AH6N1,2,0.6931471805599453
MPIV,2,0.6931471805599453
pAH1N1,2,0.6931471805599453
PRD,2,0.6931471805599453
BPH,2,0.6931471805599453
personalise,2,0.6931471805599453
dermatoglyphics,2,0.6931471805599453
Umeå,2,0.6931471805599453
perfluorocarbon,2,0.6931471805599453
kt,2,0.6931471805599453
Mt,2,0.6931471805599453
Assistive,2,0.6931471805599453
somatotype,2,0.6931471805599453
high-educated,2,0.6931471805599453
ΔFA,2,0.6931471805599453
Brooklyn,2,0.6931471805599453
risk-specific,2,0.6931471805599453
dacryoadenitis,2,0.6931471805599453
UTM-RT,2,0.6931471805599453
nervousness,2,0.6931471805599453
above-named,2,0.6931471805599453
encyclopedia,2,0.6931471805599453
hairdressing,2,0.6931471805599453
Nichol,2,0.6931471805599453
in-solution,2,0.6931471805599453
SARS-CoV-specific,2,0.6931471805599453
rumours,2,0.6931471805599453
ERVL,2,0.6931471805599453
Hyperactivations,2,0.6931471805599453
alpha-mediated,2,0.6931471805599453
Al-Khobar,2,0.6931471805599453
HCM,2,0.6931471805599453
crafted,2,0.6931471805599453
radiologys,2,0.6931471805599453
≥85,2,0.6931471805599453
psychostimulants,2,0.6931471805599453
per-person,2,0.6931471805599453
SILAC,2,0.6931471805599453
NASIS,2,0.6931471805599453
frontrunners,2,0.6931471805599453
tabular,2,0.6931471805599453
HMSAs,2,0.6931471805599453
instilling,2,0.6931471805599453
Pollutants,2,0.6931471805599453
auratus,2,0.6931471805599453
carp,2,0.6931471805599453
fat-soluble,2,0.6931471805599453
sib,2,0.6931471805599453
ß2-agonists,2,0.6931471805599453
FEB,2,0.6931471805599453
r059,2,0.6931471805599453
microgml,2,0.6931471805599453
80min,2,0.6931471805599453
PakistaniBangladeshi,2,0.6931471805599453
sickness-related,2,0.6931471805599453
measurably,2,0.6931471805599453
presidents,2,0.6931471805599453
readily-available,2,0.6931471805599453
ECG-monitoring,2,0.6931471805599453
1981-1982,2,0.6931471805599453
79000,2,0.6931471805599453
Peer,2,0.6931471805599453
post-CABG,2,0.6931471805599453
generous,2,0.6931471805599453
right-atrial,2,0.6931471805599453
cDSP,2,0.6931471805599453
door-to-angiography,2,0.6931471805599453
betwen,2,0.6931471805599453
B-system,2,0.6931471805599453
2820,2,0.6931471805599453
jurisdictional,2,0.6931471805599453
non-IP,2,0.6931471805599453
Antipyretics,2,0.6931471805599453
single-drug,2,0.6931471805599453
COVID-19Areas,2,0.6931471805599453
strain-derived,2,0.6931471805599453
9017,2,0.6931471805599453
Sclarovsky-Birnbaum,2,0.6931471805599453
modified-SOAR,2,0.6931471805599453
Hemodynamics,2,0.6931471805599453
mRS≤2,2,0.6931471805599453
IFN-1,2,0.6931471805599453
3000000,2,0.6931471805599453
Tie-2,2,0.6931471805599453
Angiogenic,2,0.6931471805599453
19881989,2,0.6931471805599453
9249,2,0.6931471805599453
combinationABSTRACT,2,0.6931471805599453
hCoV-229E,2,0.6931471805599453
MIDITPA,2,0.6931471805599453
Goyal,2,0.6931471805599453
hCoV-OC43,2,0.6931471805599453
130-149,2,0.6931471805599453
isomer,2,0.6931471805599453
totality,2,0.6931471805599453
maculopapular,2,0.6931471805599453
miR-155-5p,2,0.6931471805599453
Mauk,2,0.6931471805599453
leadsABSTRACT,2,0.6931471805599453
Nouakchott,2,0.6931471805599453
2176,2,0.6931471805599453
cameras,2,0.6931471805599453
Granzyme,2,0.6931471805599453
Kremsner,2,0.6931471805599453
wetdry,2,0.6931471805599453
Yazdanbakhsh,2,0.6931471805599453
nucleated,2,0.6931471805599453
miR-126-3p,2,0.6931471805599453
donning,2,0.6931471805599453
Director-General,2,0.6931471805599453
practitioners-based,2,0.6931471805599453
predeparture,2,0.6931471805599453
Cienfuegos,2,0.6931471805599453
Pulmicort,2,0.6931471805599453
rye,2,0.6931471805599453
220000,2,0.6931471805599453
2158,2,0.6931471805599453
Myocardium,2,0.6931471805599453
Markedly,2,0.6931471805599453
paroxysms,2,0.6931471805599453
promotions,2,0.6931471805599453
150-200,2,0.6931471805599453
signal-averaging,2,0.6931471805599453
Colchicine,2,0.6931471805599453
exhalation-to-inhalation,2,0.6931471805599453
Steven,2,0.6931471805599453
postloading,2,0.6931471805599453
n48,2,0.6931471805599453
lenient,2,0.6931471805599453
bronchiectasia,2,0.6931471805599453
PFO-stroke,2,0.6931471805599453
Inquiry,2,0.6931471805599453
intracardial,2,0.6931471805599453
Two-year,2,0.6931471805599453
colonize,2,0.6931471805599453
UMAP,2,0.6931471805599453
RPRIT,2,0.6931471805599453
disability-perception,2,0.6931471805599453
meta-ORs,2,0.6931471805599453
hybridizing,2,0.6931471805599453
UAmL,2,0.6931471805599453
≥3100,2,0.6931471805599453
RFLP,2,0.6931471805599453
2247,2,0.6931471805599453
LEOPARD,2,0.6931471805599453
tracrRNAs,2,0.6931471805599453
MAUDE,2,0.6931471805599453
heat-shock,2,0.6931471805599453
laboratory-acquired,2,0.6931471805599453
2-test,2,0.6931471805599453
Stunned,2,0.6931471805599453
Biopharmaceutical,2,0.6931471805599453
nanovesicles,2,0.6931471805599453
Glaxo,2,0.6931471805599453
71000,2,0.6931471805599453
IMUH,2,0.6931471805599453
Farmed,2,0.6931471805599453
MI-normoxic,2,0.6931471805599453
Atrovent,2,0.6931471805599453
S-G614,2,0.6931471805599453
S-D614,2,0.6931471805599453
ATACH,2,0.6931471805599453
ARG,2,0.6931471805599453
2263,2,0.6931471805599453
etesevimab,2,0.6931471805599453
immediate-type,2,0.6931471805599453
zinc-chelating,2,0.6931471805599453
IAnH1N1,2,0.6931471805599453
fatter,2,0.6931471805599453
Behçets,2,0.6931471805599453
CG-1A,2,0.6931471805599453
Conscripts,2,0.6931471805599453
deterministically,2,0.6931471805599453
target-cell,2,0.6931471805599453
jejuni,2,0.6931471805599453
HVFDs,2,0.6931471805599453
velocimetry,2,0.6931471805599453
allergizing,2,0.6931471805599453
1986-1990,2,0.6931471805599453
VirScan,2,0.6931471805599453
AF-stroke,2,0.6931471805599453
Chicken,2,0.6931471805599453
0999,2,0.6931471805599453
Perseveration,2,0.6931471805599453
truthful,2,0.6931471805599453
5-year-olds,2,0.6931471805599453
153×103µL,2,0.6931471805599453
tracrRNA,2,0.6931471805599453
LAICOD,2,0.6931471805599453
commissioners,2,0.6931471805599453
uncharacterised,2,0.6931471805599453
sheltering,2,0.6931471805599453
toluidine,2,0.6931471805599453
latent-class,2,0.6931471805599453
federations,2,0.6931471805599453
carotid-artery,2,0.6931471805599453
factor-4,2,0.6931471805599453
Macedonia,2,0.6931471805599453
cholesterols,2,0.6931471805599453
heed,2,0.6931471805599453
-64,2,0.6931471805599453
AKawasaki86,2,0.6931471805599453
0867,2,0.6931471805599453
severing,2,0.6931471805599453
Motors,2,0.6931471805599453
StatFlu,2,0.6931471805599453
Maassab,2,0.6931471805599453
LGB,2,0.6931471805599453
JS,2,0.6931471805599453
AKawasaki,2,0.6931471805599453
LVDd,2,0.6931471805599453
phantoms,2,0.6931471805599453
diligence,2,0.6931471805599453
microhabitats,2,0.6931471805599453
Remantadine,2,0.6931471805599453
2095,2,0.6931471805599453
microhabitat,2,0.6931471805599453
1147,2,0.6931471805599453
CoroAnnoter,2,0.6931471805599453
COVID-Pred,2,0.6931471805599453
C-lobe,2,0.6931471805599453
anti-Influenza,2,0.6931471805599453
SMs,2,0.6931471805599453
drug-discovery,2,0.6931471805599453
ALXFPR2,2,0.6931471805599453
PCR-diagnosed,2,0.6931471805599453
steroid-non-dependent,2,0.6931471805599453
intraepidemic,2,0.6931471805599453
Low-degree,2,0.6931471805599453
HBPC,2,0.6931471805599453
approximating,2,0.6931471805599453
Faridabad,2,0.6931471805599453
autoimmuneautoinflammatory,2,0.6931471805599453
gastro,2,0.6931471805599453
luminol-dependent,2,0.6931471805599453
9953,2,0.6931471805599453
PLO,2,0.6931471805599453
reminding,2,0.6931471805599453
homocystein,2,0.6931471805599453
18-fold,2,0.6931471805599453
Subtraction,2,0.6931471805599453
-205,2,0.6931471805599453
-378,2,0.6931471805599453
fluorography,2,0.6931471805599453
dolphin,2,0.6931471805599453
EEL,2,0.6931471805599453
infarctual,2,0.6931471805599453
TLR4-TRIF,2,0.6931471805599453
Mx,2,0.6931471805599453
glucocorticoid-induced,2,0.6931471805599453
Microcirculatory,2,0.6931471805599453
autosomal-recessive,2,0.6931471805599453
immune‐mediated,2,0.6931471805599453
W4,2,0.6931471805599453
infecteds,2,0.6931471805599453
Fingerstick,2,0.6931471805599453
PANBIO™,2,0.6931471805599453
Grippferon,2,0.6931471805599453
biomicroscopy,2,0.6931471805599453
-266,2,0.6931471805599453
mal,2,0.6931471805599453
A-specific,2,0.6931471805599453
melanocortin,2,0.6931471805599453
mitigationcontainment,2,0.6931471805599453
reanalyze,2,0.6931471805599453
ripple,2,0.6931471805599453
i-NANC,2,0.6931471805599453
drugsvaccines,2,0.6931471805599453
Pyrophosphate,2,0.6931471805599453
biohazardous,2,0.6931471805599453
DHHS,2,0.6931471805599453
reticulum-Golgi,2,0.6931471805599453
8384,2,0.6931471805599453
QTd2,2,0.6931471805599453
Unexposed,2,0.6931471805599453
avidly,2,0.6931471805599453
intakebaseline,2,0.6931471805599453
correspondences,2,0.6931471805599453
Freiburg,2,0.6931471805599453
permutation-based,2,0.6931471805599453
PROACT,2,0.6931471805599453
PSSE,2,0.6931471805599453
1650,2,0.6931471805599453
Zwolle,2,0.6931471805599453
Counterintuitively,2,0.6931471805599453
ninety-four,2,0.6931471805599453
semi-alignment,2,0.6931471805599453
CNSPNS,2,0.6931471805599453
Flocked,2,0.6931471805599453
postulation,2,0.6931471805599453
northernmost,2,0.6931471805599453
copyreaction,2,0.6931471805599453
Parietaria,2,0.6931471805599453
OR206,2,0.6931471805599453
Bermuda,2,0.6931471805599453
mucins,2,0.6931471805599453
foodstuffs,2,0.6931471805599453
NIOM,2,0.6931471805599453
JPGL2017,2,0.6931471805599453
STEMI-patients,2,0.6931471805599453
Gazi,2,0.6931471805599453
rs4820294,2,0.6931471805599453
WHODAS,2,0.6931471805599453
agreeability,2,0.6931471805599453
nonspecifically,2,0.6931471805599453
ORper,2,0.6931471805599453
aggregometry,2,0.6931471805599453
ergogenic,2,0.6931471805599453
REAMI,2,0.6931471805599453
transmittance,2,0.6931471805599453
clinico-anatomical,2,0.6931471805599453
maladies,2,0.6931471805599453
COLADP,2,0.6931471805599453
tamponnade,2,0.6931471805599453
TIMI-flow,2,0.6931471805599453
trend00001,2,0.6931471805599453
-0067,2,0.6931471805599453
dyspneas,2,0.6931471805599453
cystectomy,2,0.6931471805599453
technician-paramedics,2,0.6931471805599453
Nice,2,0.6931471805599453
predating,2,0.6931471805599453
Q-wave-T-wave,2,0.6931471805599453
loosened,2,0.6931471805599453
adamantane-sensitive,2,0.6931471805599453
Hydatid,2,0.6931471805599453
Sigmodon,2,0.6931471805599453
Multicomponent,2,0.6931471805599453
PBT,2,0.6931471805599453
EMC,2,0.6931471805599453
No-Uncertainty,2,0.6931471805599453
Strauss,2,0.6931471805599453
Churg,2,0.6931471805599453
IRRs,2,0.6931471805599453
pseudo-asthma,2,0.6931471805599453
GCSE,2,0.6931471805599453
AswineLondon,2,0.6931471805599453
UK-variant,2,0.6931471805599453
SARS-1,2,0.6931471805599453
5-58,2,0.6931471805599453
TNCCS,2,0.6931471805599453
-1202,2,0.6931471805599453
extractionless,2,0.6931471805599453
100100000,2,0.6931471805599453
1215-lipoxygenase,2,0.6931471805599453
ADS,2,0.6931471805599453
radio-opaque,2,0.6931471805599453
summative,2,0.6931471805599453
19-52,2,0.6931471805599453
2-25,2,0.6931471805599453
6-hourly,2,0.6931471805599453
morbidity-mortality,2,0.6931471805599453
Aldrich,2,0.6931471805599453
inheritable,2,0.6931471805599453
Microtainer,2,0.6931471805599453
omega-3s,2,0.6931471805599453
pro-allergic,2,0.6931471805599453
five-month,2,0.6931471805599453
reaction-positive,2,0.6931471805599453
anti-cytokines,2,0.6931471805599453
cardio-metabolic,2,0.6931471805599453
20-49,2,0.6931471805599453
non-DM,2,0.6931471805599453
later-diagnosed,2,0.6931471805599453
engendering,2,0.6931471805599453
OS9,2,0.6931471805599453
sPTSD,2,0.6931471805599453
2558,2,0.6931471805599453
Viennese,2,0.6931471805599453
S-phase,2,0.6931471805599453
SCOPES,2,0.6931471805599453
Fluad,2,0.6931471805599453
BVictoria0288,2,0.6931471805599453
RBD-Fc,2,0.6931471805599453
disks,2,0.6931471805599453
Hyperosmolar,2,0.6931471805599453
γ-globulin,2,0.6931471805599453
FPN,2,0.6931471805599453
LYM,2,0.6931471805599453
pL,2,0.6931471805599453
signers,2,0.6931471805599453
Improper,2,0.6931471805599453
sub-optimally,2,0.6931471805599453
0835,2,0.6931471805599453
0735,2,0.6931471805599453
early-diagnosed,2,0.6931471805599453
prey,2,0.6931471805599453
IAAR,2,0.6931471805599453
97300,2,0.6931471805599453
10-sec,2,0.6931471805599453
reperfusions,2,0.6931471805599453
reconfirm,2,0.6931471805599453
DAN,2,0.6931471805599453
PH-Covid19,2,0.6931471805599453
fdPTSD,2,0.6931471805599453
MCP-3,2,0.6931471805599453
housewife,2,0.6931471805599453
hexathia-18-crown-6,2,0.6931471805599453
winter--a,2,0.6931471805599453
8461,2,0.6931471805599453
0605,2,0.6931471805599453
voltammetric,2,0.6931471805599453
medium-volume,2,0.6931471805599453
left-hemispheric,2,0.6931471805599453
right-left,2,0.6931471805599453
dinatriumcromoglycate,2,0.6931471805599453
3063,2,0.6931471805599453
clinicofunctional,2,0.6931471805599453
Suggestion,2,0.6931471805599453
systemwide,2,0.6931471805599453
Crosse,2,0.6931471805599453
histiocytoma,2,0.6931471805599453
mucoprotein,2,0.6931471805599453
0897,2,0.6931471805599453
smFISH,2,0.6931471805599453
T1-,2,0.6931471805599453
ASMI,2,0.6931471805599453
unrestrained,2,0.6931471805599453
Parts,2,0.6931471805599453
locative,2,0.6931471805599453
chitin,2,0.6931471805599453
infero-posterolateral,2,0.6931471805599453
99Tcm-ECD,2,0.6931471805599453
hyperenzymia,2,0.6931471805599453
Eucapnic,2,0.6931471805599453
life-time,2,0.6931471805599453
μA,2,0.6931471805599453
99Tcm-HMPAO,2,0.6931471805599453
alpha-LA,2,0.6931471805599453
arthropods,2,0.6931471805599453
extra-cranial,2,0.6931471805599453
antagonised,2,0.6931471805599453
Eltrombopag,2,0.6931471805599453
iconicity,2,0.6931471805599453
gynecological,2,0.6931471805599453
urbanisation,2,0.6931471805599453
membrane-stabilizing,2,0.6931471805599453
mlyear,2,0.6931471805599453
th,2,0.6931471805599453
SIGNOR,2,0.6931471805599453
annotate,2,0.6931471805599453
TMB,2,0.6931471805599453
disconnect,2,0.6931471805599453
Vitesse,2,0.6931471805599453
NEU,2,0.6931471805599453
semiconducting,2,0.6931471805599453
Mean±SD,2,0.6931471805599453
IPR,2,0.6931471805599453
Sunamganj,2,0.6931471805599453
Netrokona,2,0.6931471805599453
Sherpur,2,0.6931471805599453
Jamalpur,2,0.6931471805599453
Painters,2,0.6931471805599453
2-to,2,0.6931471805599453
NovemberDecember,2,0.6931471805599453
2850,2,0.6931471805599453
MVO2satPCW,2,0.6931471805599453
MVO2sat,2,0.6931471805599453
Taser,2,0.6931471805599453
non-HT,2,0.6931471805599453
SUSs,2,0.6931471805599453
entry-associated,2,0.6931471805599453
perfluorane,2,0.6931471805599453
finite-element,2,0.6931471805599453
qRT-PCR-testing,2,0.6931471805599453
autoreceptor,2,0.6931471805599453
stroma,2,0.6931471805599453
deadlier,2,0.6931471805599453
ARIILI,2,0.6931471805599453
mucosoadhesive,2,0.6931471805599453
Laboratory-supported,2,0.6931471805599453
second-wave,2,0.6931471805599453
cost-effect,2,0.6931471805599453
Nippon,2,0.6931471805599453
subclassify,2,0.6931471805599453
pin-point,2,0.6931471805599453
p0046,2,0.6931471805599453
injustice,2,0.6931471805599453
marginalised,2,0.6931471805599453
Fruit,2,0.6931471805599453
1-year-old,2,0.6931471805599453
pauci-,2,0.6931471805599453
ESR1,2,0.6931471805599453
emphysemas,2,0.6931471805599453
eltrombopag,2,0.6931471805599453
kinasesignal,2,0.6931471805599453
ABCD-score,2,0.6931471805599453
hemoconcentration,2,0.6931471805599453
protectivity,2,0.6931471805599453
2324,2,0.6931471805599453
precision-based,2,0.6931471805599453
Klima,2,0.6931471805599453
Carriers,2,0.6931471805599453
coercion,2,0.6931471805599453
75-89,2,0.6931471805599453
5-80,2,0.6931471805599453
abbreviation,2,0.6931471805599453
Hickok,2,0.6931471805599453
0-8,2,0.6931471805599453
Chil,2,0.6931471805599453
Artron,2,0.6931471805599453
nanopores,2,0.6931471805599453
rs2564978,2,0.6931471805599453
r-022,2,0.6931471805599453
CDM,2,0.6931471805599453
censuses,2,0.6931471805599453
15-65,2,0.6931471805599453
20-34,2,0.6931471805599453
independents,2,0.6931471805599453
photophobia,2,0.6931471805599453
Haplotype,2,0.6931471805599453
-86,2,0.6931471805599453
120-min,2,0.6931471805599453
DCM,2,0.6931471805599453
Consciousness,2,0.6931471805599453
cholangiocytes,2,0.6931471805599453
Palsy,2,0.6931471805599453
Dysarthria,2,0.6931471805599453
meningo-encephalitis,2,0.6931471805599453
Levosimendan,2,0.6931471805599453
histiocytes,2,0.6931471805599453
compressing,2,0.6931471805599453
timetable,2,0.6931471805599453
hyperpolarized,2,0.6931471805599453
DBPs,2,0.6931471805599453
Turn,2,0.6931471805599453
1994-2017,2,0.6931471805599453
silos,2,0.6931471805599453
pre-summer,2,0.6931471805599453
62-88,2,0.6931471805599453
pneumonitisatelectasis,2,0.6931471805599453
AQ-TOP,2,0.6931471805599453
unheeded,2,0.6931471805599453
4104,2,0.6931471805599453
7663,2,0.6931471805599453
afraid,2,0.6931471805599453
vendors,2,0.6931471805599453
IBTO,2,0.6931471805599453
101RKLKR105,2,0.6931471805599453
R101S,2,0.6931471805599453
R105S,2,0.6931471805599453
noncritical,2,0.6931471805599453
irbesartan,2,0.6931471805599453
truer,2,0.6931471805599453
MISS,2,0.6931471805599453
POCKIT,2,0.6931471805599453
Abbot,2,0.6931471805599453
VDB,2,0.6931471805599453
universitys,2,0.6931471805599453
Al-Kabeer,2,0.6931471805599453
embodies,2,0.6931471805599453
self-selection,2,0.6931471805599453
hypoinflation,2,0.6931471805599453
nineties,2,0.6931471805599453
Neurosurgeons,2,0.6931471805599453
Vigilant,2,0.6931471805599453
Jordanovac,2,0.6931471805599453
psychobiological,2,0.6931471805599453
maximum-likelihood,2,0.6931471805599453
1870,2,0.6931471805599453
polytetrafluoroethylene-covered,2,0.6931471805599453
area-wide,2,0.6931471805599453
PICHs,2,0.6931471805599453
instill,2,0.6931471805599453
obviates,2,0.6931471805599453
heparinisation,2,0.6931471805599453
Competition,2,0.6931471805599453
Functions,2,0.6931471805599453
acupuncture-moxibustion,2,0.6931471805599453
ASIT,2,0.6931471805599453
bleomycin,2,0.6931471805599453
LRTCs,2,0.6931471805599453
PAF1,2,0.6931471805599453
-02,2,0.6931471805599453
nQMI,2,0.6931471805599453
Ethnographic,2,0.6931471805599453
TMLR-MI,2,0.6931471805599453
overburden,2,0.6931471805599453
neovascularisation,2,0.6931471805599453
H1N1-specific,2,0.6931471805599453
adult-type,2,0.6931471805599453
fronto-parietal,2,0.6931471805599453
B-specific,2,0.6931471805599453
multiparameter,2,0.6931471805599453
RIST,2,0.6931471805599453
Albania,2,0.6931471805599453
2454,2,0.6931471805599453
PM-523,2,0.6931471805599453
electrocardiotopography,2,0.6931471805599453
re-analysed,2,0.6931471805599453
obliterate,2,0.6931471805599453
pathogenesismechanisms,2,0.6931471805599453
-844,2,0.6931471805599453
-52,2,0.6931471805599453
itolizumab,2,0.6931471805599453
Waiting,2,0.6931471805599453
upper-middle-income,2,0.6931471805599453
advertisements,2,0.6931471805599453
CSUA,2,0.6931471805599453
Pill,2,0.6931471805599453
T-440,2,0.6931471805599453
cumRHR,2,0.6931471805599453
Exchange,2,0.6931471805599453
Engagement,2,0.6931471805599453
30-74,2,0.6931471805599453
Offices,2,0.6931471805599453
vRIC-seq,2,0.6931471805599453
11053,2,0.6931471805599453
ChadOx1,2,0.6931471805599453
ISTH,2,0.6931471805599453
FEIA,2,0.6931471805599453
noncovalent,2,0.6931471805599453
powerless,2,0.6931471805599453
information-seeking,2,0.6931471805599453
inhibitor-bound,2,0.6931471805599453
non-intentional,2,0.6931471805599453
Cotonou,2,0.6931471805599453
reduced-cost,2,0.6931471805599453
1msec,2,0.6931471805599453
Parakou,2,0.6931471805599453
interlaboratory,2,0.6931471805599453
Intentional,2,0.6931471805599453
GS-441524,2,0.6931471805599453
bronchofibroscopy,2,0.6931471805599453
Foods,2,0.6931471805599453
smelling,2,0.6931471805599453
avalanche,2,0.6931471805599453
cholangiopathy,2,0.6931471805599453
disposed,2,0.6931471805599453
M1-MCA,2,0.6931471805599453
Saver,2,0.6931471805599453
seventy-seven,2,0.6931471805599453
2032,2,0.6931471805599453
86-95,2,0.6931471805599453
SARS-CoV-2-seronegative,2,0.6931471805599453
adenoids,2,0.6931471805599453
use-authorized,2,0.6931471805599453
ministries,2,0.6931471805599453
4787,2,0.6931471805599453
hemtetradecapeptide,2,0.6931471805599453
expulsion,2,0.6931471805599453
05-15,2,0.6931471805599453
9974,2,0.6931471805599453
4476,2,0.6931471805599453
4298,2,0.6931471805599453
cardiogenesis,2,0.6931471805599453
management-related,2,0.6931471805599453
skillfully,2,0.6931471805599453
patients--with,2,0.6931471805599453
irritations,2,0.6931471805599453
APeking279H3N2,2,0.6931471805599453
017-085,2,0.6931471805599453
028-206,2,0.6931471805599453
8571,2,0.6931471805599453
009-147,2,0.6931471805599453
HID50,2,0.6931471805599453
075-1812,2,0.6931471805599453
26-44,2,0.6931471805599453
hypertrophia,2,0.6931471805599453
abusers,2,0.6931471805599453
XLA,2,0.6931471805599453
MLD50,2,0.6931471805599453
builder,2,0.6931471805599453
Murcia,2,0.6931471805599453
1168,2,0.6931471805599453
handbook,2,0.6931471805599453
filamentous,2,0.6931471805599453
finishers,2,0.6931471805599453
rosemary,2,0.6931471805599453
antibody-guided,2,0.6931471805599453
Kehua,2,0.6931471805599453
prevaccine,2,0.6931471805599453
stranger,2,0.6931471805599453
nociceptive,2,0.6931471805599453
butyrate-producing,2,0.6931471805599453
PerkinElmer,2,0.6931471805599453
6-day,2,0.6931471805599453
stimulus-induced,2,0.6931471805599453
MS2-based,2,0.6931471805599453
Q-and,2,0.6931471805599453
Ecology,2,0.6931471805599453
departmental,2,0.6931471805599453
Pangolin,2,0.6931471805599453
Contingency,2,0.6931471805599453
psychobiologic,2,0.6931471805599453
Infectiousness,2,0.6931471805599453
hyperbilirubinemia,2,0.6931471805599453
Involving,2,0.6931471805599453
Bio-Engineering,2,0.6931471805599453
allergen-reducing,2,0.6931471805599453
low-medium,2,0.6931471805599453
NZ393,2,0.6931471805599453
protein-chemical,2,0.6931471805599453
oligomer,2,0.6931471805599453
tremens,2,0.6931471805599453
Immigration,2,0.6931471805599453
nightmare,2,0.6931471805599453
gasdermin,2,0.6931471805599453
170000,2,0.6931471805599453
1161,2,0.6931471805599453
MMRT,2,0.6931471805599453
nonenveloped,2,0.6931471805599453
angiospasm,2,0.6931471805599453
shelflike,2,0.6931471805599453
Failed,2,0.6931471805599453
socio-demographics,2,0.6931471805599453
astenoneurotic,2,0.6931471805599453
semiannual,2,0.6931471805599453
levitation,2,0.6931471805599453
multi-stage,2,0.6931471805599453
clinicoepidemiological,2,0.6931471805599453
reverse-transcribed,2,0.6931471805599453
100-110,2,0.6931471805599453
Influenza-induced,2,0.6931471805599453
100-109,2,0.6931471805599453
9688,2,0.6931471805599453
cuprous,2,0.6931471805599453
cerebello-cerebral,2,0.6931471805599453
iSeq,2,0.6931471805599453
ECABS,2,0.6931471805599453
gated-SPECT,2,0.6931471805599453
rs4820294rs2899292,2,0.6931471805599453
OHS,2,0.6931471805599453
cerebellar-cerebral,2,0.6931471805599453
sulcal,2,0.6931471805599453
Coronarography,2,0.6931471805599453
cytokine-storm,2,0.6931471805599453
Organization-recommended,2,0.6931471805599453
CuO,2,0.6931471805599453
contact-cases,2,0.6931471805599453
type-reproduction,2,0.6931471805599453
3464,2,0.6931471805599453
JAP,2,0.6931471805599453
Grid,2,0.6931471805599453
Heesterbeek,2,0.6931471805599453
ORF2S,2,0.6931471805599453
Proc,2,0.6931471805599453
Triphenyltetrazolium,2,0.6931471805599453
CLIAs,2,0.6931471805599453
COPDACO,2,0.6931471805599453
signaled,2,0.6931471805599453
min-delayed,2,0.6931471805599453
00022,2,0.6931471805599453
wipes,2,0.6931471805599453
relaxometry,2,0.6931471805599453
hemophiliac,2,0.6931471805599453
counterattack,2,0.6931471805599453
CNCB,2,0.6931471805599453
antibody-negative,2,0.6931471805599453
ACGIH,2,0.6931471805599453
HESA-A,2,0.6931471805599453
TLV,2,0.6931471805599453
35-day,2,0.6931471805599453
1850,2,0.6931471805599453
PI-HD,2,0.6931471805599453
mixed-type,2,0.6931471805599453
Ensure,2,0.6931471805599453
nonhigh,2,0.6931471805599453
1682,2,0.6931471805599453
050-054,2,0.6931471805599453
HD-ICS,2,0.6931471805599453
responsibly,2,0.6931471805599453
CtCq,2,0.6931471805599453
non-SARS-COV-2,2,0.6931471805599453
2-months,2,0.6931471805599453
CH50,2,0.6931471805599453
radiograms,2,0.6931471805599453
KIADYNYKL,2,0.6931471805599453
immunodetection,2,0.6931471805599453
Sympathomimetic,2,0.6931471805599453
NoInh-kit,2,0.6931471805599453
×g,2,0.6931471805599453
SENS-kit,2,0.6931471805599453
self-consciousness,2,0.6931471805599453
scholar,2,0.6931471805599453
PGE,2,0.6931471805599453
Spiking,2,0.6931471805599453
NP-based,2,0.6931471805599453
3738,2,0.6931471805599453
tubercle,2,0.6931471805599453
STE-ACS,2,0.6931471805599453
Sokolow,2,0.6931471805599453
sEA,2,0.6931471805599453
equilibrium-gated,2,0.6931471805599453
Morphology,2,0.6931471805599453
HRSA-funded,2,0.6931471805599453
star,2,0.6931471805599453
dissociations,2,0.6931471805599453
SFMPQ,2,0.6931471805599453
CAIF,2,0.6931471805599453
nano,2,0.6931471805599453
oxygen-derived,2,0.6931471805599453
H3N2-predominant,2,0.6931471805599453
Miyagi,2,0.6931471805599453
2013-May,2,0.6931471805599453
BM-MNC,2,0.6931471805599453
cobalt-sensitized,2,0.6931471805599453
STING-dependent,2,0.6931471805599453
navigator,2,0.6931471805599453
Stimulator,2,0.6931471805599453
hemianesthesia,2,0.6931471805599453
unitary,2,0.6931471805599453
12500,2,0.6931471805599453
aorta-coronary,2,0.6931471805599453
draconian,2,0.6931471805599453
FAST-ED,2,0.6931471805599453
MedImmune,2,0.6931471805599453
Synergium,2,0.6931471805599453
Maintain,2,0.6931471805599453
Destination,2,0.6931471805599453
prestigious,2,0.6931471805599453
Millennium,2,0.6931471805599453
Kennedy,2,0.6931471805599453
Coastal,2,0.6931471805599453
APM,2,0.6931471805599453
buckle,2,0.6931471805599453
finger-stick,2,0.6931471805599453
RSTD,2,0.6931471805599453
pollution-mediated,2,0.6931471805599453
Humasis,2,0.6931471805599453
pf,2,0.6931471805599453
cranio-caudal,2,0.6931471805599453
tegus,2,0.6931471805599453
system-specific,2,0.6931471805599453
222DG,2,0.6931471805599453
-67,2,0.6931471805599453
104-109,2,0.6931471805599453
diary-based,2,0.6931471805599453
Dilated,2,0.6931471805599453
country-,2,0.6931471805599453
22-38,2,0.6931471805599453
Repoxteine,2,0.6931471805599453
WASID,2,0.6931471805599453
002ABSTRACT,2,0.6931471805599453
intracorporeal,2,0.6931471805599453
NS-AF,2,0.6931471805599453
gravest,2,0.6931471805599453
followers,2,0.6931471805599453
ASPECT,2,0.6931471805599453
Democrat,2,0.6931471805599453
PSQ,2,0.6931471805599453
6years,2,0.6931471805599453
HA-222,2,0.6931471805599453
inconvenient,2,0.6931471805599453
Molecular-based,2,0.6931471805599453
Teachers,2,0.6931471805599453
mocks,2,0.6931471805599453
IL1RL1,2,0.6931471805599453
IL33,2,0.6931471805599453
pyrophosphates,2,0.6931471805599453
95-CI,2,0.6931471805599453
cones,2,0.6931471805599453
BrS,2,0.6931471805599453
indictors,2,0.6931471805599453
Leukemia,2,0.6931471805599453
Théo,2,0.6931471805599453
Enormous,2,0.6931471805599453
FH-LPH,2,0.6931471805599453
infarction--the,2,0.6931471805599453
TVPS-3,2,0.6931471805599453
Warfarin-Aspirin,2,0.6931471805599453
Over-representation,2,0.6931471805599453
0376,2,0.6931471805599453
2013-March,2,0.6931471805599453
holistically,2,0.6931471805599453
Wellens,2,0.6931471805599453
undisturbed,2,0.6931471805599453
ONgoing,2,0.6931471805599453
bracing,2,0.6931471805599453
coin,2,0.6931471805599453
myotonic,2,0.6931471805599453
SCU,2,0.6931471805599453
MOrbidity,2,0.6931471805599453
Welsh,2,0.6931471805599453
Gyrus,2,0.6931471805599453
non-HDM,2,0.6931471805599453
Neurofeedback,2,0.6931471805599453
proficient,2,0.6931471805599453
myoelectric,2,0.6931471805599453
weight-based,2,0.6931471805599453
2015-2017,2,0.6931471805599453
sphygmomanometer,2,0.6931471805599453
laparoscopy,2,0.6931471805599453
angiotensine,2,0.6931471805599453
58-76,2,0.6931471805599453
2491,2,0.6931471805599453
decaying,2,0.6931471805599453
SW-E,2,0.6931471805599453
3416,2,0.6931471805599453
time-lag,2,0.6931471805599453
44-69,2,0.6931471805599453
Adapting,2,0.6931471805599453
genotype-guided,2,0.6931471805599453
Haemorrhage,2,0.6931471805599453
MIV,2,0.6931471805599453
introverted,2,0.6931471805599453
Dronedarone,2,0.6931471805599453
85-96,2,0.6931471805599453
handler,2,0.6931471805599453
gerontological,2,0.6931471805599453
ADP-receptor,2,0.6931471805599453
1358,2,0.6931471805599453
ITaly,2,0.6931471805599453
PROject,2,0.6931471805599453
data-base,2,0.6931471805599453
commissioning,2,0.6931471805599453
SELDI-TOF,2,0.6931471805599453
Novgorod,2,0.6931471805599453
post-AIS,2,0.6931471805599453
JC,2,0.6931471805599453
ADCw,2,0.6931471805599453
2276,2,0.6931471805599453
gastroenteric,2,0.6931471805599453
Treviso,2,0.6931471805599453
resourcing,2,0.6931471805599453
35-45,2,0.6931471805599453
bur,2,0.6931471805599453
weariness,2,0.6931471805599453
unjustly,2,0.6931471805599453
WH1,2,0.6931471805599453
ethers,2,0.6931471805599453
arterialization,2,0.6931471805599453
SJP-002C,2,0.6931471805599453
non-perioperative,2,0.6931471805599453
untold,2,0.6931471805599453
widowed,2,0.6931471805599453
Post-partum,2,0.6931471805599453
SMR,2,0.6931471805599453
emigrated,2,0.6931471805599453
4249,2,0.6931471805599453
diver,2,0.6931471805599453
four-day,2,0.6931471805599453
Reduce,2,0.6931471805599453
2011-March,2,0.6931471805599453
08-10,2,0.6931471805599453
haemocoagulation,2,0.6931471805599453
Scuba,2,0.6931471805599453
2100,2,0.6931471805599453
geocoded,2,0.6931471805599453
S1-IgG,2,0.6931471805599453
1308,2,0.6931471805599453
-145,2,0.6931471805599453
K417TN,2,0.6931471805599453
wrong-way,2,0.6931471805599453
PIV3,2,0.6931471805599453
lysosomotropic,2,0.6931471805599453
strophanthanin,2,0.6931471805599453
artemisinins,2,0.6931471805599453
PLCL,2,0.6931471805599453
Bod,2,0.6931471805599453
6254,2,0.6931471805599453
GOAL,2,0.6931471805599453
homologs,2,0.6931471805599453
taxon,2,0.6931471805599453
5127,2,0.6931471805599453
evidence-based-medicine,2,0.6931471805599453
RBD-IgG,2,0.6931471805599453
Chitinases,2,0.6931471805599453
cysteinyl-LTs,2,0.6931471805599453
cysteinyl-LT,2,0.6931471805599453
198615,2,0.6931471805599453
Pod,2,0.6931471805599453
Tyrol,2,0.6931471805599453
COVID-19-naive,2,0.6931471805599453
four-hour,2,0.6931471805599453
Large-vessel,2,0.6931471805599453
1976-1979,2,0.6931471805599453
FFT,2,0.6931471805599453
Nine-hundred,2,0.6931471805599453
LTD4-induced,2,0.6931471805599453
ONO-1078,2,0.6931471805599453
Kjekshus,2,0.6931471805599453
underly,2,0.6931471805599453
MK-476,2,0.6931471805599453
intercritic,2,0.6931471805599453
20J501YV3,2,0.6931471805599453
precentral,2,0.6931471805599453
ill-prepared,2,0.6931471805599453
UNSP,2,0.6931471805599453
superclade,2,0.6931471805599453
Continuously,2,0.6931471805599453
drier,2,0.6931471805599453
2011-2013,2,0.6931471805599453
significatively,2,0.6931471805599453
p0021,2,0.6931471805599453
1990-2002,2,0.6931471805599453
regimental,2,0.6931471805599453
praised,2,0.6931471805599453
RNA-targeting,2,0.6931471805599453
rimantadine-sensitive,2,0.6931471805599453
cloistered,2,0.6931471805599453
gestations,2,0.6931471805599453
acutely-infected,2,0.6931471805599453
licenses,2,0.6931471805599453
aka,2,0.6931471805599453
pandemicCommunicated,2,0.6931471805599453
bolster,2,0.6931471805599453
4634,2,0.6931471805599453
relaxants,2,0.6931471805599453
2136,2,0.6931471805599453
inroads,2,0.6931471805599453
non-immunized,2,0.6931471805599453
70-100,2,0.6931471805599453
duality,2,0.6931471805599453
exposure-outcome,2,0.6931471805599453
018-085,2,0.6931471805599453
Finklea,2,0.6931471805599453
enlarges,2,0.6931471805599453
asymmetrically,2,0.6931471805599453
smoldering,2,0.6931471805599453
Overwhelming,2,0.6931471805599453
miR-155-knockout,2,0.6931471805599453
Cox-regression,2,0.6931471805599453
NC0455122,2,0.6931471805599453
1663,2,0.6931471805599453
velpatasvir,2,0.6931471805599453
m1A,2,0.6931471805599453
28-35,2,0.6931471805599453
3540,2,0.6931471805599453
n38,2,0.6931471805599453
betacoronaviridae,2,0.6931471805599453
Buffer,2,0.6931471805599453
hyalinized,2,0.6931471805599453
Frenchay,2,0.6931471805599453
in-contact,2,0.6931471805599453
lansoprazole,2,0.6931471805599453
CE-MRI,2,0.6931471805599453
developmentIMPORTANCE,2,0.6931471805599453
multilineage,2,0.6931471805599453
nozzle,2,0.6931471805599453
ineffectively,2,0.6931471805599453
QUADAS-2,2,0.6931471805599453
posturing,2,0.6931471805599453
FP6,2,0.6931471805599453
98-100,2,0.6931471805599453
cardiotrophin-1,2,0.6931471805599453
2595,2,0.6931471805599453
In-patient,2,0.6931471805599453
non-HCW,2,0.6931471805599453
GER-induced,2,0.6931471805599453
1785,2,0.6931471805599453
1869,2,0.6931471805599453
inactiveactive,2,0.6931471805599453
NLP,2,0.6931471805599453
self-transport,2,0.6931471805599453
angiotensin-like,2,0.6931471805599453
short-course,2,0.6931471805599453
aTRH,2,0.6931471805599453
90-100,2,0.6931471805599453
better-educated,2,0.6931471805599453
TR-FRET,2,0.6931471805599453
occupation-related,2,0.6931471805599453
Förster,2,0.6931471805599453
4094,2,0.6931471805599453
Adv,2,0.6931471805599453
20112244-253,2,0.6931471805599453
3066,2,0.6931471805599453
8235,2,0.6931471805599453
colonising,2,0.6931471805599453
vRNP,2,0.6931471805599453
1778,2,0.6931471805599453
selves,2,0.6931471805599453
7-month-old,2,0.6931471805599453
healthful,2,0.6931471805599453
GINA-based,2,0.6931471805599453
displacing,2,0.6931471805599453
physiologist,2,0.6931471805599453
Originally,2,0.6931471805599453
Burn,2,0.6931471805599453
lap,2,0.6931471805599453
college-level,2,0.6931471805599453
subconsensus,2,0.6931471805599453
Carolinas,2,0.6931471805599453
reemphasize,2,0.6931471805599453
pursuant,2,0.6931471805599453
York552004,2,0.6931471805599453
heterotrimeric,2,0.6931471805599453
Cardioprotection,2,0.6931471805599453
north-west,2,0.6931471805599453
1556,2,0.6931471805599453
alloxan,2,0.6931471805599453
involution,2,0.6931471805599453
pyruvic,2,0.6931471805599453
Fat,2,0.6931471805599453
7553,2,0.6931471805599453
0290,2,0.6931471805599453
10-18,2,0.6931471805599453
PEPI,2,0.6931471805599453
BJiangsu102003,2,0.6931471805599453
non-proprietary,2,0.6931471805599453
mobile-based,2,0.6931471805599453
wears,2,0.6931471805599453
cf-DNA,2,0.6931471805599453
anencephaly,2,0.6931471805599453
myocarditispericarditis,2,0.6931471805599453
Instituting,2,0.6931471805599453
ANP32A,2,0.6931471805599453
Bundle-branch,2,0.6931471805599453
throwing,2,0.6931471805599453
Jean-Martin,2,0.6931471805599453
replicationinfection,2,0.6931471805599453
ATexas77,2,0.6931471805599453
Salpêtrière,2,0.6931471805599453
1292,2,0.6931471805599453
Vanderbilt,2,0.6931471805599453
caffeic,2,0.6931471805599453
motto,2,0.6931471805599453
ENIA,2,0.6931471805599453
rhexis,2,0.6931471805599453
Baillie,2,0.6931471805599453
PWID,2,0.6931471805599453
4353,2,0.6931471805599453
apoplectic,2,0.6931471805599453
anti-leukotriens,2,0.6931471805599453
mitoses,2,0.6931471805599453
cortico-dependent,2,0.6931471805599453
self-sampled,2,0.6931471805599453
trailers,2,0.6931471805599453
BCVIs,2,0.6931471805599453
1851,2,0.6931471805599453
sociologists,2,0.6931471805599453
VMT,2,0.6931471805599453
1825-1893,2,0.6931471805599453
Gerhardt,2,0.6931471805599453
relapse-free,2,0.6931471805599453
mantle,2,0.6931471805599453
IIE,2,0.6931471805599453
Cookes,2,0.6931471805599453
Widal,2,0.6931471805599453
Hsps,2,0.6931471805599453
aspirin-associated,2,0.6931471805599453
pectoralis,2,0.6931471805599453
exosomal,2,0.6931471805599453
arresting,2,0.6931471805599453
NRZ,2,0.6931471805599453
Hoffmann-La,2,0.6931471805599453
AVietnam119404,2,0.6931471805599453
anti-N1,2,0.6931471805599453
139100000,2,0.6931471805599453
apartments,2,0.6931471805599453
hCoV-reactive,2,0.6931471805599453
BU,2,0.6931471805599453
1973-1980,2,0.6931471805599453
administers,2,0.6931471805599453
Post-acute,2,0.6931471805599453
N-oxide,2,0.6931471805599453
TMAO,2,0.6931471805599453
25-69,2,0.6931471805599453
permanence,2,0.6931471805599453
forwards,2,0.6931471805599453
uphold,2,0.6931471805599453
Fluoxetine,2,0.6931471805599453
Nitro-BT,2,0.6931471805599453
post-randomization,2,0.6931471805599453
preplanned,2,0.6931471805599453
fixel-based,2,0.6931471805599453
seasoned,2,0.6931471805599453
Emodin,2,0.6931471805599453
Haplotype-based,2,0.6931471805599453
chitinase,2,0.6931471805599453
anticoronaviral,2,0.6931471805599453
ankles,2,0.6931471805599453
MUNANA,2,0.6931471805599453
tip-toe,2,0.6931471805599453
fiber-specific,2,0.6931471805599453
Caco2,2,0.6931471805599453
plasticity-related,2,0.6931471805599453
T1-uptakes,2,0.6931471805599453
morbi-mortality,2,0.6931471805599453
two-gene,2,0.6931471805599453
K166Q,2,0.6931471805599453
nonimmunosuppressed,2,0.6931471805599453
livers,2,0.6931471805599453
thalamo-capsular,2,0.6931471805599453
1735,2,0.6931471805599453
2-point,2,0.6931471805599453
1093,2,0.6931471805599453
∼8,2,0.6931471805599453
25-65,2,0.6931471805599453
293T-ACE2,2,0.6931471805599453
rcVSV-CoV2-S,2,0.6931471805599453
volcanic,2,0.6931471805599453
CNRL,2,0.6931471805599453
bigeminal,2,0.6931471805599453
100gm2,2,0.6931471805599453
re-permeabilization,2,0.6931471805599453
corrects,2,0.6931471805599453
IgG4,2,0.6931471805599453
FHx,2,0.6931471805599453
middle-cerebral,2,0.6931471805599453
metaplastic,2,0.6931471805599453
elevates,2,0.6931471805599453
VMR,2,0.6931471805599453
MMc,2,0.6931471805599453
focus-group,2,0.6931471805599453
Xiaogan,2,0.6931471805599453
Leads,2,0.6931471805599453
SPUL,2,0.6931471805599453
V2-V1,2,0.6931471805599453
TASK-CBT,2,0.6931471805599453
non-lactating,2,0.6931471805599453
fixations,2,0.6931471805599453
Kazakh,2,0.6931471805599453
meticillin-resistant,2,0.6931471805599453
pre-set,2,0.6931471805599453
Benzonal,2,0.6931471805599453
PFOA,2,0.6931471805599453
Minsk,2,0.6931471805599453
Ephedrine,2,0.6931471805599453
Myricetin,2,0.6931471805599453
Whole-brain,2,0.6931471805599453
ruling-out,2,0.6931471805599453
75-79,2,0.6931471805599453
extracted-RNA,2,0.6931471805599453
mass-testing,2,0.6931471805599453
post-insult,2,0.6931471805599453
G1691A,2,0.6931471805599453
isomerism,2,0.6931471805599453
2120,2,0.6931471805599453
trusting,2,0.6931471805599453
VEGF-ANRP-1,2,0.6931471805599453
antibody-independent,2,0.6931471805599453
cardiopathic,2,0.6931471805599453
Kenyatta,2,0.6931471805599453
Ive,2,0.6931471805599453
Boman,2,0.6931471805599453
Didnt,2,0.6931471805599453
Everyone,2,0.6931471805599453
amazing,2,0.6931471805599453
ABT,2,0.6931471805599453
88-year-old,2,0.6931471805599453
frankness,2,0.6931471805599453
wrap,2,0.6931471805599453
Tupinambis,2,0.6931471805599453
covid,2,0.6931471805599453
CEACAS,2,0.6931471805599453
Occams,2,0.6931471805599453
chitosome,2,0.6931471805599453
razor,2,0.6931471805599453
cardiocerebral,2,0.6931471805599453
sharper,2,0.6931471805599453
Two-week,2,0.6931471805599453
Post-AMI,2,0.6931471805599453
Multi-pronged,2,0.6931471805599453
Buying,2,0.6931471805599453
BHarbin794,2,0.6931471805599453
COVID-19-nsp2,2,0.6931471805599453
polyvinyl,2,0.6931471805599453
ticket,2,0.6931471805599453
40-42,2,0.6931471805599453
NLS,2,0.6931471805599453
tumorectomy,2,0.6931471805599453
nanocomposites,2,0.6931471805599453
Unmod-Exo,2,0.6931471805599453
Retraining,2,0.6931471805599453
Polymeric,2,0.6931471805599453
Fourthly,2,0.6931471805599453
metalloproteases,2,0.6931471805599453
pumpIABP,2,0.6931471805599453
CMEA,2,0.6931471805599453
Cancers,2,0.6931471805599453
hyperalgesia,2,0.6931471805599453
Osogbo,2,0.6931471805599453
EWSR1,2,0.6931471805599453
SXS22,2,0.6931471805599453
Enhancement,2,0.6931471805599453
PIDAC,2,0.6931471805599453
epoprostenol,2,0.6931471805599453
EMRGQ,2,0.6931471805599453
Fatty,2,0.6931471805599453
HMGB1-siRNA,2,0.6931471805599453
RVG,2,0.6931471805599453
cardio-selective,2,0.6931471805599453
Non-selective,2,0.6931471805599453
rescues,2,0.6931471805599453
population-representative,2,0.6931471805599453
Lamp2b,2,0.6931471805599453
noncontraceptive,2,0.6931471805599453
ODI-CL,2,0.6931471805599453
Alanine,2,0.6931471805599453
Jaundice,2,0.6931471805599453
indisputably,2,0.6931471805599453
Periodical,2,0.6931471805599453
fine-scale,2,0.6931471805599453
KingFisher,2,0.6931471805599453
NSIP,2,0.6931471805599453
oligaemia,2,0.6931471805599453
access-related,2,0.6931471805599453
non-sequence-specific,2,0.6931471805599453
baicalin,2,0.6931471805599453
Electromechanical,2,0.6931471805599453
6523,2,0.6931471805599453
11020,2,0.6931471805599453
2297,2,0.6931471805599453
Christi,2,0.6931471805599453
4231,2,0.6931471805599453
superoxides,2,0.6931471805599453
Superoxide,2,0.6931471805599453
OR12-month,2,0.6931471805599453
shuts,2,0.6931471805599453
urate,2,0.6931471805599453
OLAB,2,0.6931471805599453
antihemagglutinins,2,0.6931471805599453
SBPLVEDP,2,0.6931471805599453
phosphates,2,0.6931471805599453
32-34°C,2,0.6931471805599453
Clustering,2,0.6931471805599453
Creactive,2,0.6931471805599453
Categorization,2,0.6931471805599453
TPC,2,0.6931471805599453
pericardiotomy,2,0.6931471805599453
85-95,2,0.6931471805599453
disorganized,2,0.6931471805599453
immunoprotection,2,0.6931471805599453
indexing,2,0.6931471805599453
high-surgical-risk,2,0.6931471805599453
critiqued,2,0.6931471805599453
Corinfar,2,0.6931471805599453
20°C,2,0.6931471805599453
Retard,2,0.6931471805599453
DS14,2,0.6931471805599453
sub-intensive,2,0.6931471805599453
HPP,2,0.6931471805599453
Tri-County,2,0.6931471805599453
BZIs,2,0.6931471805599453
alkaline-reacting,2,0.6931471805599453
excavation,2,0.6931471805599453
non-transplanted,2,0.6931471805599453
overstretched,2,0.6931471805599453
Hyperresponsiveness,2,0.6931471805599453
AUC-CK,2,0.6931471805599453
fondaparinux,2,0.6931471805599453
structuralnon-structural,2,0.6931471805599453
115000,2,0.6931471805599453
non-H1N1,2,0.6931471805599453
conjunctively,2,0.6931471805599453
spheric,2,0.6931471805599453
40-52,2,0.6931471805599453
AUC-MB,2,0.6931471805599453
sevoflurane,2,0.6931471805599453
SBA,2,0.6931471805599453
epiphenomena,2,0.6931471805599453
iNATs,2,0.6931471805599453
APPLICATIONS,2,0.6931471805599453
photography,2,0.6931471805599453
QRS-score,2,0.6931471805599453
QRS-estimated,2,0.6931471805599453
ST-predicted,2,0.6931471805599453
Addenbrookes,2,0.6931471805599453
klx,2,0.6931471805599453
farther,2,0.6931471805599453
interred,2,0.6931471805599453
complicity,2,0.6931471805599453
Bergego,2,0.6931471805599453
BMSC-treated,2,0.6931471805599453
area-level,2,0.6931471805599453
mirroring,2,0.6931471805599453
Shape,2,0.6931471805599453
1·4,2,0.6931471805599453
Bisection,2,0.6931471805599453
groupism,2,0.6931471805599453
seniority,2,0.6931471805599453
perished,2,0.6931471805599453
non-ipsilateral,2,0.6931471805599453
FMRI,2,0.6931471805599453
Tat-NR2B9c,2,0.6931471805599453
edematous,2,0.6931471805599453
httpeducationamjmedcomvideophpeventid445stageid5vcs1,2,0.6931471805599453
unmanaged,2,0.6931471805599453
non-ST-,2,0.6931471805599453
fast-acting,2,0.6931471805599453
medics,2,0.6931471805599453
Decompensated,2,0.6931471805599453
notifies,2,0.6931471805599453
adipocytokines,2,0.6931471805599453
depress,2,0.6931471805599453
near-simultaneous,2,0.6931471805599453
neutrophillymphocyte,2,0.6931471805599453
pseudoappendicitis,2,0.6931471805599453
steroid-insensitive,2,0.6931471805599453
Nsp5,2,0.6931471805599453
004ABSTRACT,2,0.6931471805599453
analyzable,2,0.6931471805599453
timescales,2,0.6931471805599453
battery-powered,2,0.6931471805599453
non-interacting,2,0.6931471805599453
unheated,2,0.6931471805599453
Brownian,2,0.6931471805599453
centenarians,2,0.6931471805599453
reaginic,2,0.6931471805599453
1255,2,0.6931471805599453
lower-respiratory-tract,2,0.6931471805599453
tie-breaker,2,0.6931471805599453
dipoles,2,0.6931471805599453
anti-cholinergic,2,0.6931471805599453
ClyA-RBD,2,0.6931471805599453
antihistaminics,2,0.6931471805599453
One-,2,0.6931471805599453
Aquilion,2,0.6931471805599453
aorto,2,0.6931471805599453
proprioceptive,2,0.6931471805599453
kit-free,2,0.6931471805599453
MINS,2,0.6931471805599453
image-guided,2,0.6931471805599453
appendix,2,0.6931471805599453
1469,2,0.6931471805599453
FASTER,2,0.6931471805599453
diamniotic,2,0.6931471805599453
comorbilities,2,0.6931471805599453
11094,2,0.6931471805599453
Autism,2,0.6931471805599453
1126,2,0.6931471805599453
bronchoconstricted,2,0.6931471805599453
ENTIRE,2,0.6931471805599453
deconstructive,2,0.6931471805599453
MIG,2,0.6931471805599453
protein-10,2,0.6931471805599453
Jack,2,0.6931471805599453
workstations,2,0.6931471805599453
anti-dengue,2,0.6931471805599453
ethnicity-specific,2,0.6931471805599453
E-rosette,2,0.6931471805599453
liveborn,2,0.6931471805599453
0·01,2,0.6931471805599453
Amersham,2,0.6931471805599453
lyses,2,0.6931471805599453
Double-blind,2,0.6931471805599453
L226,2,0.6931471805599453
G228,2,0.6931471805599453
VZ,2,0.6931471805599453
Microsoft,2,0.6931471805599453
Subgenomic,2,0.6931471805599453
entrainment,2,0.6931471805599453
biweekly,2,0.6931471805599453
subadditive,2,0.6931471805599453
RDP4,2,0.6931471805599453
Bat-SARS-CoVs,2,0.6931471805599453
nosebleeds,2,0.6931471805599453
telangiectases,2,0.6931471805599453
microng,2,0.6931471805599453
E-induced,2,0.6931471805599453
friendship,2,0.6931471805599453
circRNAs,2,0.6931471805599453
reconvalescence,2,0.6931471805599453
Advance,2,0.6931471805599453
Interference,2,0.6931471805599453
Chukyo,2,0.6931471805599453
4379,2,0.6931471805599453
GSTM100,2,0.6931471805599453
Compilation,2,0.6931471805599453
GSTT100,2,0.6931471805599453
Suitable,2,0.6931471805599453
Hot,2,0.6931471805599453
27-63,2,0.6931471805599453
ALDH3A1,2,0.6931471805599453
USSR9077,2,0.6931471805599453
ribm,2,0.6931471805599453
pre-vaccine,2,0.6931471805599453
flow-dependent,2,0.6931471805599453
indurated,2,0.6931471805599453
EWS,2,0.6931471805599453
Hot-pattern,2,0.6931471805599453
Cold-,2,0.6931471805599453
glutathione-,2,0.6931471805599453
NDMA,2,0.6931471805599453
Nitrogen,2,0.6931471805599453
markedness,2,0.6931471805599453
Ouedraogo,2,0.6931471805599453
4800,2,0.6931471805599453
Yalgado,2,0.6931471805599453
ATSM,2,0.6931471805599453
offsite,2,0.6931471805599453
Accidental,2,0.6931471805599453
322000,2,0.6931471805599453
Tray,2,0.6931471805599453
Baking,2,0.6931471805599453
SHCLCI,2,0.6931471805599453
1371,2,0.6931471805599453
3979,2,0.6931471805599453
4318,2,0.6931471805599453
host-response,2,0.6931471805599453
supravalvular,2,0.6931471805599453
rotary,2,0.6931471805599453
PACF,2,0.6931471805599453
dysexecutive,2,0.6931471805599453
Slit-based,2,0.6931471805599453
requisites,2,0.6931471805599453
myocardial-infarction,2,0.6931471805599453
interspecific,2,0.6931471805599453
shore,2,0.6931471805599453
CSPPT,2,0.6931471805599453
wistar,2,0.6931471805599453
DEFUSE3,2,0.6931471805599453
cyanide,2,0.6931471805599453
tender,2,0.6931471805599453
All-Drug,2,0.6931471805599453
Clinical-Drug,2,0.6931471805599453
61-yr-old,2,0.6931471805599453
prepolymers,2,0.6931471805599453
Covid-Drug,2,0.6931471805599453
1539,2,0.6931471805599453
sinobronchial,2,0.6931471805599453
variants-of-concern,2,0.6931471805599453
non-prevalence,2,0.6931471805599453
Salzburg,2,0.6931471805599453
polycystic,2,0.6931471805599453
drug-likeliness,2,0.6931471805599453
RIG-I-like,2,0.6931471805599453
2003-2012,2,0.6931471805599453
λD,2,0.6931471805599453
inscribed,2,0.6931471805599453
long-period,2,0.6931471805599453
Therapy-Thrombolysis,2,0.6931471805599453
ACCI,2,0.6931471805599453
pre-entry,2,0.6931471805599453
1968-1970,2,0.6931471805599453
counter-measures,2,0.6931471805599453
LVMD,2,0.6931471805599453
staff-patient,2,0.6931471805599453
multiregional,2,0.6931471805599453
burr-to-tooth,2,0.6931471805599453
retirees,2,0.6931471805599453
Belshe,2,0.6931471805599453
USOPTFs,2,0.6931471805599453
MAD,2,0.6931471805599453
viewers,2,0.6931471805599453
60-year,2,0.6931471805599453
figured,2,0.6931471805599453
activists,2,0.6931471805599453
activism,2,0.6931471805599453
F490S,2,0.6931471805599453
2009AH1N1,2,0.6931471805599453
49000,2,0.6931471805599453
Proteomic,2,0.6931471805599453
realignment,2,0.6931471805599453
smoking-related,2,0.6931471805599453
criminal,2,0.6931471805599453
S494P,2,0.6931471805599453
script,2,0.6931471805599453
cross-clade,2,0.6931471805599453
HAS,2,0.6931471805599453
globally-reported,2,0.6931471805599453
P00002,2,0.6931471805599453
anticonvulsants,2,0.6931471805599453
Nicaraguan,2,0.6931471805599453
LSTD-,2,0.6931471805599453
15-51,2,0.6931471805599453
Ege,2,0.6931471805599453
LSTD,2,0.6931471805599453
forearms,2,0.6931471805599453
Proteobacteria,2,0.6931471805599453
Rees,2,0.6931471805599453
backlash,2,0.6931471805599453
meteorology,2,0.6931471805599453
Complaints,2,0.6931471805599453
proBNP,2,0.6931471805599453
lipidic,2,0.6931471805599453
nosocomially,2,0.6931471805599453
Achievements,2,0.6931471805599453
dyslipidemic,2,0.6931471805599453
Augmented,2,0.6931471805599453
Nucleoprotein-,2,0.6931471805599453
Virotech,2,0.6931471805599453
counselor,2,0.6931471805599453
G46,2,0.6931471805599453
D43,2,0.6931471805599453
-080,2,0.6931471805599453
4652,2,0.6931471805599453
siting,2,0.6931471805599453
3059,2,0.6931471805599453
sniffer,2,0.6931471805599453
nucleoprotein-,2,0.6931471805599453
2007-2012,2,0.6931471805599453
synonyms,2,0.6931471805599453
Fulminant,2,0.6931471805599453
glycoprotein-based,2,0.6931471805599453
rotatory,2,0.6931471805599453
premisting,2,0.6931471805599453
1993-95,2,0.6931471805599453
2321,2,0.6931471805599453
1248,2,0.6931471805599453
197273,2,0.6931471805599453
1531,2,0.6931471805599453
TGA,2,0.6931471805599453
ss,2,0.6931471805599453
tirilazad,2,0.6931471805599453
fraternal,2,0.6931471805599453
3782,2,0.6931471805599453
airway-unrelated,2,0.6931471805599453
9976,2,0.6931471805599453
TMC,2,0.6931471805599453
caudoventral,2,0.6931471805599453
medicalsocial,2,0.6931471805599453
Kochi,2,0.6931471805599453
Control-based,2,0.6931471805599453
care-givers,2,0.6931471805599453
pandemic-2009-H1N1,2,0.6931471805599453
contradicts,2,0.6931471805599453
Euclidian,2,0.6931471805599453
multimorbidities,2,0.6931471805599453
0360,2,0.6931471805599453
S-nitroso-N-acetylpenicillamine,2,0.6931471805599453
eponymous,2,0.6931471805599453
Traumatic,2,0.6931471805599453
diplomas,2,0.6931471805599453
EC200Raw,2,0.6931471805599453
IES-R,2,0.6931471805599453
hyperlipoproteinaemia,2,0.6931471805599453
subtropics,2,0.6931471805599453
third-,2,0.6931471805599453
Vaccine-preventable,2,0.6931471805599453
May-October,2,0.6931471805599453
1676,2,0.6931471805599453
lidocaine-induced,2,0.6931471805599453
15-49,2,0.6931471805599453
11816,2,0.6931471805599453
fourth-,2,0.6931471805599453
WTh,2,0.6931471805599453
n27,2,0.6931471805599453
0929,2,0.6931471805599453
misallocation,2,0.6931471805599453
SocietyAmerican,2,0.6931471805599453
1D,2,0.6931471805599453
Antinuclear,2,0.6931471805599453
ANCA,2,0.6931471805599453
Fitness-to-fly,2,0.6931471805599453
unsurprisingly,2,0.6931471805599453
expectant,2,0.6931471805599453
cross-transmission,2,0.6931471805599453
Denying,2,0.6931471805599453
electrocardiological,2,0.6931471805599453
adrenalin,2,0.6931471805599453
Uncomplicated,2,0.6931471805599453
Nonatopic,2,0.6931471805599453
symptom-,2,0.6931471805599453
ROSIER,2,0.6931471805599453
myelogenous,2,0.6931471805599453
1985-1989,2,0.6931471805599453
permissible,2,0.6931471805599453
Mustard,2,0.6931471805599453
ECG-based,2,0.6931471805599453
ASwitzerland97152932013H3N2,2,0.6931471805599453
intersecting,2,0.6931471805599453
2685,2,0.6931471805599453
haptoglobin,2,0.6931471805599453
nidus,2,0.6931471805599453
Akaike,2,0.6931471805599453
PVT,2,0.6931471805599453
1970-1975,2,0.6931471805599453
10-29,2,0.6931471805599453
UWI,2,0.6931471805599453
Mona,2,0.6931471805599453
Tobago,2,0.6931471805599453
Pleso,2,0.6931471805599453
Strbské,2,0.6931471805599453
infective-allergic,2,0.6931471805599453
HPAA,2,0.6931471805599453
AEqui-2Miami63,2,0.6931471805599453
ponies,2,0.6931471805599453
re-intervention,2,0.6931471805599453
hyperactivated,2,0.6931471805599453
Q-40,2,0.6931471805599453
H5N1-affected,2,0.6931471805599453
miR-126,2,0.6931471805599453
polarised,2,0.6931471805599453
aerosolised,2,0.6931471805599453
5x106,2,0.6931471805599453
fibrinolitic,2,0.6931471805599453
Eotaxin,2,0.6931471805599453
Avon,2,0.6931471805599453
Medina,2,0.6931471805599453
2024,2,0.6931471805599453
Hôtel-Dieu,2,0.6931471805599453
p0047,2,0.6931471805599453
Asthmaexpert,2,0.6931471805599453
stage-by-stage,2,0.6931471805599453
egg-independent,2,0.6931471805599453
hourday,2,0.6931471805599453
proteinR203K,2,0.6931471805599453
episodically,2,0.6931471805599453
Nsp13,2,0.6931471805599453
HDP,2,0.6931471805599453
terrorism,2,0.6931471805599453
Downs,2,0.6931471805599453
MobilDNA,2,0.6931471805599453
ORF3aQ57H,2,0.6931471805599453
Short-stay,2,0.6931471805599453
underassessment,2,0.6931471805599453
lumped,2,0.6931471805599453
Nationale,2,0.6931471805599453
UAD,2,0.6931471805599453
haemoptysis,2,0.6931471805599453
Contrasted,2,0.6931471805599453
Panhuysen,2,0.6931471805599453
post-Fontan,2,0.6931471805599453
IAV-positive,2,0.6931471805599453
picrosirius,2,0.6931471805599453
in-frame,2,0.6931471805599453
bat-CoV,2,0.6931471805599453
Detroiters,2,0.6931471805599453
Nox4,2,0.6931471805599453
jeopardizes,2,0.6931471805599453
Nox2,2,0.6931471805599453
NOX‑derived,2,0.6931471805599453
0937,2,0.6931471805599453
165000,2,0.6931471805599453
mall,2,0.6931471805599453
2292,2,0.6931471805599453
AUCμg,2,0.6931471805599453
lest,2,0.6931471805599453
overloads,2,0.6931471805599453
NGTest,2,0.6931471805599453
0936,2,0.6931471805599453
0947,2,0.6931471805599453
3355-tetramethylbenzidine,2,0.6931471805599453
NormNet,2,0.6931471805599453
Fe2O3,2,0.6931471805599453
2238,2,0.6931471805599453
programmatically,2,0.6931471805599453
Shunt,2,0.6931471805599453
segmenting,2,0.6931471805599453
unopposed,2,0.6931471805599453
Compulsive,2,0.6931471805599453
thrombus-guided,2,0.6931471805599453
nonneurosurgical,2,0.6931471805599453
out-of,2,0.6931471805599453
PL16T,2,0.6931471805599453
progestogen,2,0.6931471805599453
epic,2,0.6931471805599453
Sinas,2,0.6931471805599453
Sina,2,0.6931471805599453
angioplastic,2,0.6931471805599453
non-state,2,0.6931471805599453
tamoxifen,2,0.6931471805599453
cutpoints,2,0.6931471805599453
1193,2,0.6931471805599453
R-Biopharm,2,0.6931471805599453
2315,2,0.6931471805599453
WHO-based,2,0.6931471805599453
GSK-3β,2,0.6931471805599453
Quicker,2,0.6931471805599453
Contrarily,2,0.6931471805599453
sub-lethal,2,0.6931471805599453
antiperoxide,2,0.6931471805599453
vermis,2,0.6931471805599453
2625,2,0.6931471805599453
3742,2,0.6931471805599453
water-based,2,0.6931471805599453
corollaries,2,0.6931471805599453
AMI-free,2,0.6931471805599453
Sanofi,2,0.6931471805599453
LOD95,2,0.6931471805599453
RADT,2,0.6931471805599453
APR8,2,0.6931471805599453
4727,2,0.6931471805599453
C135,2,0.6931471805599453
aerosol-mediated,2,0.6931471805599453
recumbent,2,0.6931471805599453
stem-loop,2,0.6931471805599453
Vermont,2,0.6931471805599453
DiaPro,2,0.6931471805599453
HIC,2,0.6931471805599453
rearrangements,2,0.6931471805599453
non-academic,2,0.6931471805599453
allocations,2,0.6931471805599453
Ctl1-2018,2,0.6931471805599453
C144,2,0.6931471805599453
0040,2,0.6931471805599453
math,2,0.6931471805599453
THP-1,2,0.6931471805599453
SIgA,2,0.6931471805599453
intra-cranial,2,0.6931471805599453
cryostorage,2,0.6931471805599453
Catecholamines,2,0.6931471805599453
pIE,2,0.6931471805599453
stakes,2,0.6931471805599453
pausing,2,0.6931471805599453
commend,2,0.6931471805599453
case-level,2,0.6931471805599453
attains,2,0.6931471805599453
biophysics,2,0.6931471805599453
decompensate,2,0.6931471805599453
psychiatrically,2,0.6931471805599453
2019-related,2,0.6931471805599453
hygienist,2,0.6931471805599453
sen,2,0.6931471805599453
acc,2,0.6931471805599453
Kunjal,2,0.6931471805599453
yogic,2,0.6931471805599453
enjoying,2,0.6931471805599453
renaissance,2,0.6931471805599453
radiations,2,0.6931471805599453
serologically-confirmed,2,0.6931471805599453
non-manual,2,0.6931471805599453
Zhengzhou,2,0.6931471805599453
Accessibility,2,0.6931471805599453
001-037,2,0.6931471805599453
treatmentand,2,0.6931471805599453
Silymarin,2,0.6931471805599453
silymarin,2,0.6931471805599453
bioactivities,2,0.6931471805599453
unoccupied,2,0.6931471805599453
dress,2,0.6931471805599453
Cobalt,2,0.6931471805599453
2316,2,0.6931471805599453
Prepandemic,2,0.6931471805599453
flulike,2,0.6931471805599453
Tripler,2,0.6931471805599453
inter-group,2,0.6931471805599453
semisynthetic,2,0.6931471805599453
CovXNet,2,0.6931471805599453
heroine,2,0.6931471805599453
ectodomains,2,0.6931471805599453
mevalonate,2,0.6931471805599453
Antigen-detecting,2,0.6931471805599453
carbide,2,0.6931471805599453
RfH,2,0.6931471805599453
mmol1,2,0.6931471805599453
C1q,2,0.6931471805599453
4832,2,0.6931471805599453
neuro-fuzzy,2,0.6931471805599453
nonnegative,2,0.6931471805599453
factorization,2,0.6931471805599453
addicts,2,0.6931471805599453
Self-sampling,2,0.6931471805599453
oxemia,2,0.6931471805599453
miraculous,2,0.6931471805599453
Carba-nicotinamide-adenine-dinucleotide,2,0.6931471805599453
DB02498,2,0.6931471805599453
culminates,2,0.6931471805599453
Δ69Δ70,2,0.6931471805599453
Fel,2,0.6931471805599453
9-month-old,2,0.6931471805599453
28±35,2,0.6931471805599453
fMRT,2,0.6931471805599453
reinvent,2,0.6931471805599453
Compare,2,0.6931471805599453
Morphologically,2,0.6931471805599453
supraspinal,2,0.6931471805599453
preemployment,2,0.6931471805599453
44±54,2,0.6931471805599453
…,2,0.6931471805599453
teledentistry,2,0.6931471805599453
ideology,2,0.6931471805599453
Histochemical,2,0.6931471805599453
converting-enzyme,2,0.6931471805599453
eH,2,0.6931471805599453
eI,2,0.6931471805599453
eL,2,0.6931471805599453
reciprocating-flowing,2,0.6931471805599453
time-frequency,2,0.6931471805599453
nitro,2,0.6931471805599453
5613,2,0.6931471805599453
Vid,2,0.6931471805599453
Sfax,2,0.6931471805599453
Opuzen,2,0.6931471805599453
2-diethylaminoethanol,2,0.6931471805599453
unbridled,2,0.6931471805599453
nation-state,2,0.6931471805599453
rejects,2,0.6931471805599453
Sibling,2,0.6931471805599453
honest,2,0.6931471805599453
cosmopolitan,2,0.6931471805599453
middle-ground,2,0.6931471805599453
CEIRS,2,0.6931471805599453
Contrived,2,0.6931471805599453
vagina,2,0.6931471805599453
SEIR-type,2,0.6931471805599453
unascertained,2,0.6931471805599453
RF-immunobinding,2,0.6931471805599453
deciduous,2,0.6931471805599453
momentous,2,0.6931471805599453
trypanosomiasis,2,0.6931471805599453
protozoan,2,0.6931471805599453
hemiparesia,2,0.6931471805599453
sensori-motor,2,0.6931471805599453
mTICI3,2,0.6931471805599453
mTICI2b,2,0.6931471805599453
Particle,2,0.6931471805599453
056-090,2,0.6931471805599453
re-inhalation,2,0.6931471805599453
microinfarcts,2,0.6931471805599453
Pregnancy-related,2,0.6931471805599453
flip,2,0.6931471805599453
chlorogenic,2,0.6931471805599453
95000,2,0.6931471805599453
plant-made,2,0.6931471805599453
SRP,2,0.6931471805599453
anthropozoonosis,2,0.6931471805599453
beta-adrenoblockers,2,0.6931471805599453
cryogenic,2,0.6931471805599453
discontinuity,2,0.6931471805599453
immunosorption,2,0.6931471805599453
Vidonje,2,0.6931471805599453
delagil,2,0.6931471805599453
inter-batch,2,0.6931471805599453
intra-and,2,0.6931471805599453
anti-interference,2,0.6931471805599453
obsidan,2,0.6931471805599453
imagistic,2,0.6931471805599453
antihyperlipidaemic,2,0.6931471805599453
3488,2,0.6931471805599453
Irene,2,0.6931471805599453
IL-27,2,0.6931471805599453
226000,2,0.6931471805599453
deviates,2,0.6931471805599453
nourishment,2,0.6931471805599453
depthwise,2,0.6931471805599453
stacking,2,0.6931471805599453
Had,2,0.6931471805599453
AAC-508,2,0.6931471805599453
INN,2,0.6931471805599453
Detoxifying,2,0.6931471805599453
Kone,2,0.6931471805599453
Microlyte,2,0.6931471805599453
Cleansing,2,0.6931471805599453
6months,2,0.6931471805599453
spectrophotometer,2,0.6931471805599453
associative,2,0.6931471805599453
4Ps,2,0.6931471805599453
corticoid-dependent,2,0.6931471805599453
imitated,2,0.6931471805599453
BColorado062017,2,0.6931471805599453
Seldom,2,0.6931471805599453
government-led,2,0.6931471805599453
pledged,2,0.6931471805599453
interfer,2,0.6931471805599453
risk-adjusted,2,0.6931471805599453
inactivated-virus,2,0.6931471805599453
Polysaccharides,2,0.6931471805599453
Legitimate,2,0.6931471805599453
7052,2,0.6931471805599453
MultiCoV-Ab,2,0.6931471805599453
-212,2,0.6931471805599453
vinyl,2,0.6931471805599453
subtypeslineages,2,0.6931471805599453
intrinsec,2,0.6931471805599453
metaiodobenzylguanidine,2,0.6931471805599453
-like,2,0.6931471805599453
SATiN,2,0.6931471805599453
QS-complex,2,0.6931471805599453
extrinsec,2,0.6931471805599453
guanidinium,2,0.6931471805599453
co-diagnosis,2,0.6931471805599453
circumvents,2,0.6931471805599453
5018,2,0.6931471805599453
typesubtypes,2,0.6931471805599453
Intermountain,2,0.6931471805599453
Boceprevir,2,0.6931471805599453
cerebrovasculature,2,0.6931471805599453
Morrison,2,0.6931471805599453
Inconsistencies,2,0.6931471805599453
beta-adrenergic-antagonist,2,0.6931471805599453
Toxin,2,0.6931471805599453
non-convulsive,2,0.6931471805599453
fast-growing,2,0.6931471805599453
transmurally,2,0.6931471805599453
105-150,2,0.6931471805599453
Lifelong,2,0.6931471805599453
bu,2,0.6931471805599453
deactivate,2,0.6931471805599453
EAAAK,2,0.6931471805599453
A-C,2,0.6931471805599453
behaving,2,0.6931471805599453
diseasedisability,2,0.6931471805599453
accusations,2,0.6931471805599453
coldness,2,0.6931471805599453
tunable,2,0.6931471805599453
pleural-based,2,0.6931471805599453
A-lines,2,0.6931471805599453
superimposition,2,0.6931471805599453
PEACE,2,0.6931471805599453
Patient-Centered,2,0.6931471805599453
electrotherapy,2,0.6931471805599453
COPD-6,2,0.6931471805599453
sedentarism,2,0.6931471805599453
random-access,2,0.6931471805599453
under-utilised,2,0.6931471805599453
GPGPG,2,0.6931471805599453
CXCL8,2,0.6931471805599453
excepted,2,0.6931471805599453
IP10,2,0.6931471805599453
-0442,2,0.6931471805599453
generalizes,2,0.6931471805599453
Anakinra,2,0.6931471805599453
Ampicillin,2,0.6931471805599453
3165,2,0.6931471805599453
reimbursements,2,0.6931471805599453
Nonimmunologic,2,0.6931471805599453
atriotomy,2,0.6931471805599453
MCAORNSC,2,0.6931471805599453
oligogenic,2,0.6931471805599453
later-life,2,0.6931471805599453
MCAORmedium,2,0.6931471805599453
Cα,2,0.6931471805599453
echo-pacing,2,0.6931471805599453
SARSCoV2,2,0.6931471805599453
HLA-I,2,0.6931471805599453
NanoAct™,2,0.6931471805599453
non-sterile,2,0.6931471805599453
Variance,2,0.6931471805599453
1250,2,0.6931471805599453
ASHG,2,0.6931471805599453
audio,2,0.6931471805599453
Akinesis,2,0.6931471805599453
MCAOR,2,0.6931471805599453
MOCs,2,0.6931471805599453
game-theoretic,2,0.6931471805599453
H3N2-subtype,2,0.6931471805599453
multiclass,2,0.6931471805599453
endangers,2,0.6931471805599453
-048,2,0.6931471805599453
gl,2,0.6931471805599453
Night-time,2,0.6931471805599453
User-friendly,2,0.6931471805599453
72-h,2,0.6931471805599453
WVU,2,0.6931471805599453
Equipment-free,2,0.6931471805599453
psychotraumatic,2,0.6931471805599453
Deliverable,2,0.6931471805599453
stroke-ready,2,0.6931471805599453
desert,2,0.6931471805599453
multimorbid,2,0.6931471805599453
Lp,2,0.6931471805599453
fissured,2,0.6931471805599453
post-administration,2,0.6931471805599453
CEF,2,0.6931471805599453
Chapmans,2,0.6931471805599453
multifragmentary,2,0.6931471805599453
0976,2,0.6931471805599453
infection-elicited,2,0.6931471805599453
inaccurately,2,0.6931471805599453
TAI,2,0.6931471805599453
FSI-10,2,0.6931471805599453
multivesicular,2,0.6931471805599453
oxytocin,2,0.6931471805599453
0°,2,0.6931471805599453
EVIDENCE,2,0.6931471805599453
Broader,2,0.6931471805599453
high-activity,2,0.6931471805599453
Palmaz-Schatz,2,0.6931471805599453
120°,2,0.6931471805599453
NALT,2,0.6931471805599453
unattainable,2,0.6931471805599453
anomia,2,0.6931471805599453
radiocardiographically,2,0.6931471805599453
Causality,2,0.6931471805599453
TCO,2,0.6931471805599453
pre-requisites,2,0.6931471805599453
chlorinated,2,0.6931471805599453
contaminating,2,0.6931471805599453
sub-arctic,2,0.6931471805599453
pragmatically,2,0.6931471805599453
Discuss,2,0.6931471805599453
NHATS,2,0.6931471805599453
psychopharmacological,2,0.6931471805599453
Kumamoto,2,0.6931471805599453
7280,2,0.6931471805599453
Scapular,2,0.6931471805599453
sprint,2,0.6931471805599453
1056,2,0.6931471805599453
Promote,2,0.6931471805599453
prophylactictherapeutic,2,0.6931471805599453
titin,2,0.6931471805599453
healths,2,0.6931471805599453
restenoses,2,0.6931471805599453
township,2,0.6931471805599453
12-54,2,0.6931471805599453
locatability,2,0.6931471805599453
in-laboratory,2,0.6931471805599453
thrombolytic-related,2,0.6931471805599453
mile,2,0.6931471805599453
0367,2,0.6931471805599453
coronarogenic,2,0.6931471805599453
BTEE,2,0.6931471805599453
Aldosterone,2,0.6931471805599453
mb,2,0.6931471805599453
10-64,2,0.6931471805599453
archetype,2,0.6931471805599453
proclivity,2,0.6931471805599453
non-coronaviruses,2,0.6931471805599453
midpapillary,2,0.6931471805599453
fascinated,2,0.6931471805599453
vasoregulatory,2,0.6931471805599453
discriminators,2,0.6931471805599453
A-IQOLS,2,0.6931471805599453
neutrophil-lymphocyte,2,0.6931471805599453
576RR,2,0.6931471805599453
1304,2,0.6931471805599453
split-half,2,0.6931471805599453
34076,2,0.6931471805599453
C-590T,2,0.6931471805599453
zygosity,2,0.6931471805599453
pneumonia-complicated,2,0.6931471805599453
infarctionand,2,0.6931471805599453
rebreathing,2,0.6931471805599453
3441,2,0.6931471805599453
Style,2,0.6931471805599453
ng·mL-1,2,0.6931471805599453
crewmembers,2,0.6931471805599453
H5N1-HPAIV,2,0.6931471805599453
rescue-PTCA,2,0.6931471805599453
Ashwagandha,2,0.6931471805599453
mould-derived,2,0.6931471805599453
0909,2,0.6931471805599453
Alveolospheres,2,0.6931471805599453
coculture,2,0.6931471805599453
peak-to-peak,2,0.6931471805599453
co-expressed,2,0.6931471805599453
host-,2,0.6931471805599453
Documenting,2,0.6931471805599453
0758,2,0.6931471805599453
artery-middle,2,0.6931471805599453
cardiocentre,2,0.6931471805599453
0782,2,0.6931471805599453
stunting,2,0.6931471805599453
denudation,2,0.6931471805599453
localise,2,0.6931471805599453
lemurs,2,0.6931471805599453
ring-tailed,2,0.6931471805599453
erupt,2,0.6931471805599453
Sum,2,0.6931471805599453
alveolosphere,2,0.6931471805599453
Hubs,2,0.6931471805599453
RBDACE2,2,0.6931471805599453
11-month-old,2,0.6931471805599453
185000,2,0.6931471805599453
Transfection,2,0.6931471805599453
Lassa,2,0.6931471805599453
ACE-Is,2,0.6931471805599453
editorialist,2,0.6931471805599453
den,2,0.6931471805599453
Killip-Scheidt,2,0.6931471805599453
VOG,2,0.6931471805599453
warmed,2,0.6931471805599453
2580,2,0.6931471805599453
dyssomnia,2,0.6931471805599453
PLUS,2,0.6931471805599453
hypofunction,2,0.6931471805599453
5619,2,0.6931471805599453
supraregional,2,0.6931471805599453
mouldy,2,0.6931471805599453
Toll,2,0.6931471805599453
Bateman,2,0.6931471805599453
S-Mg,2,0.6931471805599453
Immunophenotyping,2,0.6931471805599453
HNL,2,0.6931471805599453
bioavailable,2,0.6931471805599453
4037,2,0.6931471805599453
5839,2,0.6931471805599453
SIZ,2,0.6931471805599453
thromboembolisms,2,0.6931471805599453
plastid,2,0.6931471805599453
self-evident,2,0.6931471805599453
OTS,2,0.6931471805599453
ICERs,2,0.6931471805599453
dollarsQALY,2,0.6931471805599453
winter-time,2,0.6931471805599453
ablactation,2,0.6931471805599453
Vojvodina,2,0.6931471805599453
5-triphosphate,2,0.6931471805599453
non-European,2,0.6931471805599453
p0013,2,0.6931471805599453
NHCG,2,0.6931471805599453
telecommunication,2,0.6931471805599453
1918-21,2,0.6931471805599453
Caledonia,2,0.6931471805599453
STEMI-equivalent,2,0.6931471805599453
Commonest,2,0.6931471805599453
Dysgeusia,2,0.6931471805599453
Samoa,2,0.6931471805599453
uprise,2,0.6931471805599453
patientscaregivers,2,0.6931471805599453
UCCs,2,0.6931471805599453
stabilizers,2,0.6931471805599453
Hyperintense,2,0.6931471805599453
Yanbu,2,0.6931471805599453
NHCA,2,0.6931471805599453
EPC,2,0.6931471805599453
transneuronal,2,0.6931471805599453
biotic,2,0.6931471805599453
Esculentoside,2,0.6931471805599453
pre-ejection,2,0.6931471805599453
PMA-stimulated,2,0.6931471805599453
groups--group,2,0.6931471805599453
descriptively,2,0.6931471805599453
system-based,2,0.6931471805599453
carcinoids,2,0.6931471805599453
nongovernment,2,0.6931471805599453
6-43,2,0.6931471805599453
non-operated,2,0.6931471805599453
Silas,2,0.6931471805599453
225000,2,0.6931471805599453
grey-zone,2,0.6931471805599453
viraemia,2,0.6931471805599453
Ecg,2,0.6931471805599453
edge-biomarkers,2,0.6931471805599453
PVAVO2,2,0.6931471805599453
PVAMVO2,2,0.6931471805599453
shortlong-term,2,0.6931471805599453
Sacramento,2,0.6931471805599453
Tinospora,2,0.6931471805599453
ISWT,2,0.6931471805599453
RRHS,2,0.6931471805599453
cordifolia,2,0.6931471805599453
Urbana-Champaign,2,0.6931471805599453
fortuitous,2,0.6931471805599453
reused,2,0.6931471805599453
Reversed,2,0.6931471805599453
immuno-allergic,2,0.6931471805599453
aetiopathogenetic,2,0.6931471805599453
CCQ,2,0.6931471805599453
8mmolL,2,0.6931471805599453
Non-Achievers,2,0.6931471805599453
Achievers,2,0.6931471805599453
uninjured,2,0.6931471805599453
modernizing,2,0.6931471805599453
PHQ-9,2,0.6931471805599453
L1,2,0.6931471805599453
rigidly,2,0.6931471805599453
prestudy,2,0.6931471805599453
hNSE,2,0.6931471805599453
I₂,2,0.6931471805599453
Bifivir,2,0.6931471805599453
vaccinationimmunomodulators,2,0.6931471805599453
DUV,2,0.6931471805599453
HuNu,2,0.6931471805599453
DUV-LEDs,2,0.6931471805599453
Lorcainide,2,0.6931471805599453
ligatures,2,0.6931471805599453
SP2,2,0.6931471805599453
RBD-foldon,2,0.6931471805599453
VCP,2,0.6931471805599453
Crosbys,2,0.6931471805599453
self-identified,2,0.6931471805599453
clinically-relevant,2,0.6931471805599453
Ours,2,0.6931471805599453
misdirected,2,0.6931471805599453
VERO,2,0.6931471805599453
RENAAL,2,0.6931471805599453
differentially-expressed,2,0.6931471805599453
tunica,2,0.6931471805599453
setbacks,2,0.6931471805599453
Purposeful,2,0.6931471805599453
extra-corporal,2,0.6931471805599453
IBAD,2,0.6931471805599453
cruel,2,0.6931471805599453
eosinophil-related,2,0.6931471805599453
readjusted,2,0.6931471805599453
replication-deficient,2,0.6931471805599453
co-efficient,2,0.6931471805599453
non-live-alones,2,0.6931471805599453
AMSTAR,2,0.6931471805599453
chymotrypsin,2,0.6931471805599453
micro-proteomic,2,0.6931471805599453
clinician-based,2,0.6931471805599453
IDNT,2,0.6931471805599453
salience,2,0.6931471805599453
BNT162b,2,0.6931471805599453
Saddle,2,0.6931471805599453
negativepositive,2,0.6931471805599453
patient-perceived,2,0.6931471805599453
Chapman-Gray,2,0.6931471805599453
speech-limiting,2,0.6931471805599453
reemerged,2,0.6931471805599453
4307,2,0.6931471805599453
noncontracting,2,0.6931471805599453
catapulted,2,0.6931471805599453
nasopharyngeal-swab,2,0.6931471805599453
PEF-based,2,0.6931471805599453
rending,2,0.6931471805599453
Lomir,2,0.6931471805599453
rework,2,0.6931471805599453
loyalty,2,0.6931471805599453
nucleases,2,0.6931471805599453
assemblage,2,0.6931471805599453
reworked,2,0.6931471805599453
rTBMD,2,0.6931471805599453
CTCs,2,0.6931471805599453
vTBMD,2,0.6931471805599453
Rabbit,2,0.6931471805599453
micrometer,2,0.6931471805599453
hemi-inattention,2,0.6931471805599453
13ABSTRACT,2,0.6931471805599453
immunisations,2,0.6931471805599453
23-month-old,2,0.6931471805599453
MolBiol,2,0.6931471805599453
1968-1976,2,0.6931471805599453
Healgen,2,0.6931471805599453
Greenlandic,2,0.6931471805599453
Imprecision,2,0.6931471805599453
Minimization,2,0.6931471805599453
2280,2,0.6931471805599453
Scintigraphic,2,0.6931471805599453
30-d,2,0.6931471805599453
lenticulocapsular,2,0.6931471805599453
pseudo-Wellens,2,0.6931471805599453
Tartu,2,0.6931471805599453
Kong135102-like,2,0.6931471805599453
GNB2L1,2,0.6931471805599453
cardiographic,2,0.6931471805599453
cloaca,2,0.6931471805599453
O2-,2,0.6931471805599453
ROSRNS,2,0.6931471805599453
calorie-free,2,0.6931471805599453
BRCA1,2,0.6931471805599453
L-GO,2,0.6931471805599453
NCEs,2,0.6931471805599453
Kong33001-like,2,0.6931471805599453
≈500,2,0.6931471805599453
physico-chemical,2,0.6931471805599453
endanger,2,0.6931471805599453
reductioncessation,2,0.6931471805599453
Zhongnan,2,0.6931471805599453
3155,2,0.6931471805599453
virus-negative,2,0.6931471805599453
Gorham-Stout,2,0.6931471805599453
thioredoxin,2,0.6931471805599453
non-laboratory,2,0.6931471805599453
CT-guided,2,0.6931471805599453
saddle,2,0.6931471805599453
Lockdown,2,0.6931471805599453
iceberg,2,0.6931471805599453
Percentages,2,0.6931471805599453
Compounding,2,0.6931471805599453
months-9,2,0.6931471805599453
PLA2,2,0.6931471805599453
tracker,2,0.6931471805599453
14080,2,0.6931471805599453
Vtg,2,0.6931471805599453
influenzanovel,2,0.6931471805599453
epidemical,2,0.6931471805599453
prelicensure,2,0.6931471805599453
10mg,2,0.6931471805599453
Diskhaler,2,0.6931471805599453
mid-to-high,2,0.6931471805599453
lesion-based,2,0.6931471805599453
PCCs,2,0.6931471805599453
Sertoli,2,0.6931471805599453
anti-H1N1v,2,0.6931471805599453
follicle,2,0.6931471805599453
anti-SARS-Cov-2,2,0.6931471805599453
terror,2,0.6931471805599453
Zhongshan,2,0.6931471805599453
Self-care,2,0.6931471805599453
nefarious,2,0.6931471805599453
operandi,2,0.6931471805599453
Expenditure,2,0.6931471805599453
ICAC,2,0.6931471805599453
complete-genome,2,0.6931471805599453
Kong135102,2,0.6931471805599453
1505,2,0.6931471805599453
Attainment,2,0.6931471805599453
vis,2,0.6931471805599453
lead-in,2,0.6931471805599453
Fridays,2,0.6931471805599453
con,2,0.6931471805599453
phosphorylase,2,0.6931471805599453
-146,2,0.6931471805599453
kilometer,2,0.6931471805599453
plantsherbs,2,0.6931471805599453
towers,2,0.6931471805599453
clip,2,0.6931471805599453
inoculating,2,0.6931471805599453
Cal,2,0.6931471805599453
Well-organized,2,0.6931471805599453
nanosheets,2,0.6931471805599453
Tt,2,0.6931471805599453
enlightened,2,0.6931471805599453
childrenyear,2,0.6931471805599453
PedAIS,2,0.6931471805599453
45-57,2,0.6931471805599453
2015-2019,2,0.6931471805599453
B40,2,0.6931471805599453
B7,2,0.6931471805599453
time-invariant,2,0.6931471805599453
strokecerebrovascular,2,0.6931471805599453
-077,2,0.6931471805599453
-082,2,0.6931471805599453
toddler-aged,2,0.6931471805599453
MRV,2,0.6931471805599453
Hunt,2,0.6931471805599453
Clarkson,2,0.6931471805599453
T-regulatory,2,0.6931471805599453
tasking,2,0.6931471805599453
intercollegiate,2,0.6931471805599453
Productivity,2,0.6931471805599453
fluoroscopy,2,0.6931471805599453
privileging,2,0.6931471805599453
LCBF,2,0.6931471805599453
CT-CBF,2,0.6931471805599453
hypereactivity,2,0.6931471805599453
Basophil,2,0.6931471805599453
embryology,2,0.6931471805599453
prongs,2,0.6931471805599453
familyfriends,2,0.6931471805599453
26-year,2,0.6931471805599453
nc-sgRNAs,2,0.6931471805599453
cine-global,2,0.6931471805599453
-105,2,0.6931471805599453
childhood-,2,0.6931471805599453
Healthcare-associated,2,0.6931471805599453
non-linearity,2,0.6931471805599453
CSBPR,2,0.6931471805599453
Collaborations,2,0.6931471805599453
privileges,2,0.6931471805599453
lows,2,0.6931471805599453
highs,2,0.6931471805599453
WRF,2,0.6931471805599453
over-diagnosis,2,0.6931471805599453
P02,2,0.6931471805599453
JCAHO,2,0.6931471805599453
Chronobiology,2,0.6931471805599453
autoreactive,2,0.6931471805599453
guanosine,2,0.6931471805599453
GEQ,2,0.6931471805599453
horizontally,2,0.6931471805599453
Conjunctivitis,2,0.6931471805599453
Troponin-T,2,0.6931471805599453
strategize,2,0.6931471805599453
spousal,2,0.6931471805599453
replicon-based,2,0.6931471805599453
Th9,2,0.6931471805599453
Hairdressers,2,0.6931471805599453
rivers,2,0.6931471805599453
TAS,2,0.6931471805599453
DoHA,2,0.6931471805599453
GDS,2,0.6931471805599453
Sore,2,0.6931471805599453
AT-9010,2,0.6931471805599453
self-focused,2,0.6931471805599453
EGID,2,0.6931471805599453
cross-functional,2,0.6931471805599453
CPSSS,2,0.6931471805599453
Computer-assisted,2,0.6931471805599453
translocating,2,0.6931471805599453
sAXL,2,0.6931471805599453
GAS6,2,0.6931471805599453
neurodynamic,2,0.6931471805599453
thromboelastometry,2,0.6931471805599453
PA-NEA,2,0.6931471805599453
snakes,2,0.6931471805599453
pre-HSCT,2,0.6931471805599453
Internalizing,2,0.6931471805599453
warmth,2,0.6931471805599453
PVL-positive,2,0.6931471805599453
picture-to-puncture,2,0.6931471805599453
Hel,2,0.6931471805599453
polyadenylation,2,0.6931471805599453
00066,2,0.6931471805599453
polyphosphate,2,0.6931471805599453
cine-ventriculography,2,0.6931471805599453
intra-family,2,0.6931471805599453
prejudices,2,0.6931471805599453
Injured,2,0.6931471805599453
naturally-acquired,2,0.6931471805599453
exhaustiveness,2,0.6931471805599453
nonpneumonia,2,0.6931471805599453
self-perception,2,0.6931471805599453
SARS-CoV-2-S-IgG,2,0.6931471805599453
DESTRO,2,0.6931471805599453
pentapeptides,2,0.6931471805599453
Geqml,2,0.6931471805599453
crest,2,0.6931471805599453
iu,2,0.6931471805599453
RfEs,2,0.6931471805599453
Never,2,0.6931471805599453
1074,2,0.6931471805599453
LAD-stent,2,0.6931471805599453
nowhere,2,0.6931471805599453
illness-severity,2,0.6931471805599453
Ser,2,0.6931471805599453
Asp,2,0.6931471805599453
hyperendemic,2,0.6931471805599453
ZFAS1,2,0.6931471805599453
9926,2,0.6931471805599453
allergiceosinophilic,2,0.6931471805599453
AEngland42788,2,0.6931471805599453
iuL,2,0.6931471805599453
Symmetrical,2,0.6931471805599453
bat-borne,2,0.6931471805599453
sibilant,2,0.6931471805599453
Transdermal,2,0.6931471805599453
afferents,2,0.6931471805599453
EPP,2,0.6931471805599453
sensitivity-physical,2,0.6931471805599453
LINE1,2,0.6931471805599453
straw-breathing,2,0.6931471805599453
pressure-independent,2,0.6931471805599453
reoviruses,2,0.6931471805599453
non-isolated,2,0.6931471805599453
11-25,2,0.6931471805599453
ROCKET-AF,2,0.6931471805599453
VMC,2,0.6931471805599453
roster,2,0.6931471805599453
Howard,2,0.6931471805599453
Bioengineering,2,0.6931471805599453
3013,2,0.6931471805599453
padlock,2,0.6931471805599453
mappings,2,0.6931471805599453
TURP,2,0.6931471805599453
infrastructural,2,0.6931471805599453
gelatinase,2,0.6931471805599453
tetrachloroisophthalonitrile,2,0.6931471805599453
countywide,2,0.6931471805599453
sulci,2,0.6931471805599453
mirror-inverted,2,0.6931471805599453
5319,2,0.6931471805599453
tombstoning,2,0.6931471805599453
environment-affected,2,0.6931471805599453
15-39,2,0.6931471805599453
flavivirus,2,0.6931471805599453
SARS-CoV-2FluRSV,2,0.6931471805599453
550000,2,0.6931471805599453
undernourished,2,0.6931471805599453
NewYork-Presbyterian,2,0.6931471805599453
41000,2,0.6931471805599453
8169,2,0.6931471805599453
APS-related,2,0.6931471805599453
MCC-containing,2,0.6931471805599453
intra-pandemic,2,0.6931471805599453
neuro-logical,2,0.6931471805599453
κ091,2,0.6931471805599453
magnetization,2,0.6931471805599453
SPAMM,2,0.6931471805599453
PWT,2,0.6931471805599453
FLU-AH3,2,0.6931471805599453
r-gene®,2,0.6931471805599453
Continuation,2,0.6931471805599453
Irritant-induced,2,0.6931471805599453
Immunocompetent,2,0.6931471805599453
over-expressing,2,0.6931471805599453
Retention,2,0.6931471805599453
compliers,2,0.6931471805599453
reparatory,2,0.6931471805599453
NC-derived,2,0.6931471805599453
alveolocytes,2,0.6931471805599453
photo-irradiation,2,0.6931471805599453
（COVID-19）,2,0.6931471805599453
incite,2,0.6931471805599453
4142,2,0.6931471805599453
years，,2,0.6931471805599453
piano,2,0.6931471805599453
unsuited,2,0.6931471805599453
organometallic,2,0.6931471805599453
hGH,2,0.6931471805599453
skip,2,0.6931471805599453
Postmyocardial,2,0.6931471805599453
high-shear,2,0.6931471805599453
smoothness,2,0.6931471805599453
June-November,2,0.6931471805599453
non-NAbs,2,0.6931471805599453
Valsartan,2,0.6931471805599453
within-trial,2,0.6931471805599453
Frank-Starling,2,0.6931471805599453
deltaS,2,0.6931471805599453
gulls,2,0.6931471805599453
Synthesis,2,0.6931471805599453
Pathogenetically,2,0.6931471805599453
proclivities,2,0.6931471805599453
annoyance,2,0.6931471805599453
wrestlers,2,0.6931471805599453
tournament,2,0.6931471805599453
9198,2,0.6931471805599453
opined,2,0.6931471805599453
of--and,2,0.6931471805599453
19961997,2,0.6931471805599453
dropletsaerosols,2,0.6931471805599453
VEC,2,0.6931471805599453
Metrology,2,0.6931471805599453
Vincents,2,0.6931471805599453
131Cs,2,0.6931471805599453
nonhypercapnic,2,0.6931471805599453
three-phase,2,0.6931471805599453
incubator,2,0.6931471805599453
3115‰,2,0.6931471805599453
sub-cortical,2,0.6931471805599453
var,2,0.6931471805599453
emodin,2,0.6931471805599453
myocardiumABSTRACT,2,0.6931471805599453
state-of-art,2,0.6931471805599453
EURO,2,0.6931471805599453
Bites,2,0.6931471805599453
subject-oriented,2,0.6931471805599453
sacrococcygeal,2,0.6931471805599453
non-febrile,2,0.6931471805599453
B35,2,0.6931471805599453
RTC,2,0.6931471805599453
NP-specific,2,0.6931471805599453
cholesterol-independent,2,0.6931471805599453
prealbumin,2,0.6931471805599453
RDI,2,0.6931471805599453
cyclase,2,0.6931471805599453
assay-specific,2,0.6931471805599453
∼2,2,0.6931471805599453
state-dependent,2,0.6931471805599453
2406,2,0.6931471805599453
CEP,2,0.6931471805599453
Cepharanthine,2,0.6931471805599453
IC-SK,2,0.6931471805599453
hypoactivation,2,0.6931471805599453
heliumoxygen,2,0.6931471805599453
5968,2,0.6931471805599453
MCV,2,0.6931471805599453
VAO,2,0.6931471805599453
lower-airway,2,0.6931471805599453
para-medical,2,0.6931471805599453
4550,2,0.6931471805599453
brain-supplying,2,0.6931471805599453
endothelin-A,2,0.6931471805599453
Maybridge,2,0.6931471805599453
reviving,2,0.6931471805599453
Spontaneously,2,0.6931471805599453
pre-hypertensive,2,0.6931471805599453
-444AC,2,0.6931471805599453
PwMS,2,0.6931471805599453
20500,2,0.6931471805599453
endothelin-B,2,0.6931471805599453
non-atrial,2,0.6931471805599453
Antisera,2,0.6931471805599453
multiphasic,2,0.6931471805599453
foresees,2,0.6931471805599453
17-27,2,0.6931471805599453
Inter-,2,0.6931471805599453
near-consecutive,2,0.6931471805599453
bistability,2,0.6931471805599453
Bemcentinib,2,0.6931471805599453
cavital,2,0.6931471805599453
Coruña,2,0.6931471805599453
AVD,2,0.6931471805599453
grain-dust-induced,2,0.6931471805599453
20ngml,2,0.6931471805599453
clade-G,2,0.6931471805599453
fully-automated,2,0.6931471805599453
Tergitol,2,0.6931471805599453
raciallyethnically,2,0.6931471805599453
53-yr-old,2,0.6931471805599453
15-S-9,2,0.6931471805599453
three-pronged,2,0.6931471805599453
Cardio-embolic,2,0.6931471805599453
WMT,2,0.6931471805599453
MFCD00832476,2,0.6931471805599453
200857No,2,0.6931471805599453
dual-chamber,2,0.6931471805599453
provable,2,0.6931471805599453
200-250,2,0.6931471805599453
Xian,2,0.6931471805599453
16-38,2,0.6931471805599453
3537,2,0.6931471805599453
D701N,2,0.6931471805599453
FND,2,0.6931471805599453
insulinml,2,0.6931471805599453
importin-α,2,0.6931471805599453
bronchospasmolytic,2,0.6931471805599453
pR544C,2,0.6931471805599453
Auricular,2,0.6931471805599453
ACBCD,2,0.6931471805599453
self-service,2,0.6931471805599453
psychodynamic,2,0.6931471805599453
amyloidogenic,2,0.6931471805599453
FMZ,2,0.6931471805599453
Prick,2,0.6931471805599453
15μUnits,2,0.6931471805599453
4790,2,0.6931471805599453
Authoritys,2,0.6931471805599453
Ct30,2,0.6931471805599453
1224,2,0.6931471805599453
AVictoria3612011,2,0.6931471805599453
pre-monitory,2,0.6931471805599453
1496,2,0.6931471805599453
fluenza,2,0.6931471805599453
nonsteroid,2,0.6931471805599453
Inter-University,2,0.6931471805599453
supposes,2,0.6931471805599453
π,2,0.6931471805599453
pIV,2,0.6931471805599453
nonprimary,2,0.6931471805599453
shortcoming,2,0.6931471805599453
concentration-dependent,2,0.6931471805599453
removable,2,0.6931471805599453
atheroembolism,2,0.6931471805599453
Twenty-eight-day,2,0.6931471805599453
Budesonide,2,0.6931471805599453
project-related,2,0.6931471805599453
Fuel,2,0.6931471805599453
IFG,2,0.6931471805599453
Industries,2,0.6931471805599453
Takotsubo-like,2,0.6931471805599453
oppressive,2,0.6931471805599453
OCPs,2,0.6931471805599453
Tbilisi,2,0.6931471805599453
Alice,2,0.6931471805599453
on-treatment,2,0.6931471805599453
Ki-67DNA,2,0.6931471805599453
Co-morbidity,2,0.6931471805599453
Seville,2,0.6931471805599453
inspect,2,0.6931471805599453
visitor,2,0.6931471805599453
perforin-mediated,2,0.6931471805599453
MEDALZ,2,0.6931471805599453
Pork,2,0.6931471805599453
July2020,2,0.6931471805599453
aprior,2,0.6931471805599453
apprised,2,0.6931471805599453
NON-SUD,2,0.6931471805599453
CANO,2,0.6931471805599453
generalisable,2,0.6931471805599453
Niamey,2,0.6931471805599453
180000,2,0.6931471805599453
post-authorization,2,0.6931471805599453
1969--71,2,0.6931471805599453
Ozone,2,0.6931471805599453
1825,2,0.6931471805599453
H292,2,0.6931471805599453
imperfection,2,0.6931471805599453
timothy,2,0.6931471805599453
deltaV50He,2,0.6931471805599453
interferon-beta,2,0.6931471805599453
rejuvenation,2,0.6931471805599453
fibrocyte,2,0.6931471805599453
lymphokines,2,0.6931471805599453
amplitude-phase,2,0.6931471805599453
socio-emotional,2,0.6931471805599453
IBiS,2,0.6931471805599453
non-aphasic,2,0.6931471805599453
troubles,2,0.6931471805599453
non-Western,2,0.6931471805599453
multi-national,2,0.6931471805599453
well-recovered,2,0.6931471805599453
organotypic,2,0.6931471805599453
apipuncture,2,0.6931471805599453
Charite,2,0.6931471805599453
pretest-posttest,2,0.6931471805599453
ERFs,2,0.6931471805599453
REI,2,0.6931471805599453
4895,2,0.6931471805599453
anti-epidemic,2,0.6931471805599453
mantra,2,0.6931471805599453
depictions,2,0.6931471805599453
seven-year-old,2,0.6931471805599453
2·22,2,0.6931471805599453
Oil,2,0.6931471805599453
DAC,2,0.6931471805599453
48hours,2,0.6931471805599453
MHCII,2,0.6931471805599453
4950,2,0.6931471805599453
PHE,2,0.6931471805599453
subfamilies,2,0.6931471805599453
Paralympic,2,0.6931471805599453
tympanic,2,0.6931471805599453
Tricuspid,2,0.6931471805599453
ATMs,2,0.6931471805599453
XIII,2,0.6931471805599453
chairs,2,0.6931471805599453
sinks,2,0.6931471805599453
phonopneumonography,2,0.6931471805599453
CDAP,2,0.6931471805599453
impinger,2,0.6931471805599453
1694,2,0.6931471805599453
age-gender-standardised,2,0.6931471805599453
Indonesians,2,0.6931471805599453
invariable,2,0.6931471805599453
methodical,2,0.6931471805599453
36-50,2,0.6931471805599453
filtrate,2,0.6931471805599453
NCR,2,0.6931471805599453
Ratios,2,0.6931471805599453
ultracold,2,0.6931471805599453
-20°C,2,0.6931471805599453
intracortical,2,0.6931471805599453
Peramivir,2,0.6931471805599453
telephone-delivered,2,0.6931471805599453
INTERSTROKE,2,0.6931471805599453
19981999,2,0.6931471805599453
Macaques,2,0.6931471805599453
Fitting,2,0.6931471805599453
AH5N6,2,0.6931471805599453
FoundationAmerican,2,0.6931471805599453
endlessly,2,0.6931471805599453
flavor,2,0.6931471805599453
1662,2,0.6931471805599453
rankings,2,0.6931471805599453
Legs,2,0.6931471805599453
140-character,2,0.6931471805599453
disturbingly,2,0.6931471805599453
clinical-diffusion,2,0.6931471805599453
Barkers,2,0.6931471805599453
605263,2,0.6931471805599453
antigen-antibody-based,2,0.6931471805599453
tween-ether-split-vaccine,2,0.6931471805599453
HWD,2,0.6931471805599453
social-mixing,2,0.6931471805599453
transnasal,2,0.6931471805599453
phenomics,2,0.6931471805599453
between-season,2,0.6931471805599453
GNRI,2,0.6931471805599453
casesday,2,0.6931471805599453
mallard,2,0.6931471805599453
ZAN,2,0.6931471805599453
academic-creative,2,0.6931471805599453
ALVF,2,0.6931471805599453
bowl,2,0.6931471805599453
North-America,2,0.6931471805599453
Curitiba,2,0.6931471805599453
PIMS,2,0.6931471805599453
Cov2,2,0.6931471805599453
V3-4R,2,0.6931471805599453
Wairoa,2,0.6931471805599453
plasmons,2,0.6931471805599453
177-Å,2,0.6931471805599453
Paraná,2,0.6931471805599453
3-July,2,0.6931471805599453
temporize,2,0.6931471805599453
carboxyl,2,0.6931471805599453
ovomucoid,2,0.6931471805599453
chemosensitivity,2,0.6931471805599453
conalbumin,2,0.6931471805599453
MMP8,2,0.6931471805599453
3396,2,0.6931471805599453
ELANE,2,0.6931471805599453
non-myocardial,2,0.6931471805599453
kinase-2,2,0.6931471805599453
scrupulously,2,0.6931471805599453
Primate,2,0.6931471805599453
neurohormones,2,0.6931471805599453
952-100,2,0.6931471805599453
DOD,2,0.6931471805599453
psychobehavioral,2,0.6931471805599453
subnets,2,0.6931471805599453
DeepSC-COVID,2,0.6931471805599453
maximised,2,0.6931471805599453
antibody-treated,2,0.6931471805599453
CrEDTA,2,0.6931471805599453
1580,2,0.6931471805599453
2091,2,0.6931471805599453
Representative,2,0.6931471805599453
monocytic,2,0.6931471805599453
blasts,2,0.6931471805599453
tranquilisers,2,0.6931471805599453
20-mg,2,0.6931471805599453
asthma--the,2,0.6931471805599453
qPCR-based,2,0.6931471805599453
H1N1-virus,2,0.6931471805599453
APE1,2,0.6931471805599453
neurasthenia,2,0.6931471805599453
ACh-induced,2,0.6931471805599453
presynaptic,2,0.6931471805599453
writers,2,0.6931471805599453
Non-COVID-19,2,0.6931471805599453
tianeptine,2,0.6931471805599453
best-characterized,2,0.6931471805599453
Lakes,2,0.6931471805599453
flowed,2,0.6931471805599453
bullectomy,2,0.6931471805599453
calcium-binding,2,0.6931471805599453
-34,2,0.6931471805599453
Left-ventricular,2,0.6931471805599453
plaque-reduction,2,0.6931471805599453
normo-,2,0.6931471805599453
2555,2,0.6931471805599453
Adrien,2,0.6931471805599453
COVID-ER,2,0.6931471805599453
moderate-to-strong,2,0.6931471805599453
2000-2019,2,0.6931471805599453
non-refractory,2,0.6931471805599453
Geography,2,0.6931471805599453
cascading,2,0.6931471805599453
trucking,2,0.6931471805599453
2550,2,0.6931471805599453
nonessential,2,0.6931471805599453
advertised,2,0.6931471805599453
SSSCCS,2,0.6931471805599453
Explicitly,2,0.6931471805599453
treatment-response,2,0.6931471805599453
STK-treated,2,0.6931471805599453
Brissaud,2,0.6931471805599453
Ethnicity,2,0.6931471805599453
non-homogenous,2,0.6931471805599453
chronicle,2,0.6931471805599453
walrus,2,0.6931471805599453
cromolyns,2,0.6931471805599453
SBC,2,0.6931471805599453
0821,2,0.6931471805599453
monocyte-derived,2,0.6931471805599453
presentedExpert,2,0.6931471805599453
lipid-like,2,0.6931471805599453
MAP1LC3LC3,2,0.6931471805599453
Value-Based,2,0.6931471805599453
putaminal,2,0.6931471805599453
1-h,2,0.6931471805599453
OCT-A,2,0.6931471805599453
homework,2,0.6931471805599453
cusums,2,0.6931471805599453
McMaster,2,0.6931471805599453
Hands,2,0.6931471805599453
PVN,2,0.6931471805599453
REFINE-ICD,2,0.6931471805599453
perpetually,2,0.6931471805599453
co-pathogenesis,2,0.6931471805599453
CASCL,2,0.6931471805599453
CARIH,2,0.6931471805599453
more-than-30-day,2,0.6931471805599453
14700,2,0.6931471805599453
Tn916,2,0.6931471805599453
long-haul,2,0.6931471805599453
Fréchet,2,0.6931471805599453
Johann,2,0.6931471805599453
1655,2,0.6931471805599453
OraSure,2,0.6931471805599453
tACE2v,2,0.6931471805599453
eosinophilia-associated,2,0.6931471805599453
drugsABSTRACT,2,0.6931471805599453
lung-specific,2,0.6931471805599453
less-than-30-day,2,0.6931471805599453
Pentoxifylline,2,0.6931471805599453
pentoxifylline,2,0.6931471805599453
determinism,2,0.6931471805599453
knit,2,0.6931471805599453
sub-regional,2,0.6931471805599453
incentivizes,2,0.6931471805599453
urethral,2,0.6931471805599453
óta,2,0.6931471805599453
egymással,2,0.6931471805599453
copied,2,0.6931471805599453
anti-NC,2,0.6931471805599453
3040,2,0.6931471805599453
200J,2,0.6931471805599453
D839Y,2,0.6931471805599453
00049,2,0.6931471805599453
Localised,2,0.6931471805599453
CBPR,2,0.6931471805599453
65J,2,0.6931471805599453
S-ICD,2,0.6931471805599453
Echographic,2,0.6931471805599453
közös,2,0.6931471805599453
UCKG,2,0.6931471805599453
UCTG,2,0.6931471805599453
sugar-sweetened,2,0.6931471805599453
somatopsychic,2,0.6931471805599453
servingsd,2,0.6931471805599453
post-radiotherapy,2,0.6931471805599453
thermotolerance,2,0.6931471805599453
trimerization,2,0.6931471805599453
Dorfman,2,0.6931471805599453
adherencecompliance,2,0.6931471805599453
UMEs,2,0.6931471805599453
Valvular,2,0.6931471805599453
unitarian,2,0.6931471805599453
Elementary,2,0.6931471805599453
pups,2,0.6931471805599453
Sperling,2,0.6931471805599453
Viagra,2,0.6931471805599453
dyspnea-fear,2,0.6931471805599453
Hospitalier,2,0.6931471805599453
self-conscious,2,0.6931471805599453
adjuvantdelivery,2,0.6931471805599453
MVC-COV1901,2,0.6931471805599453
ami,2,0.6931471805599453
transnasally,2,0.6931471805599453
Evidenced-based,2,0.6931471805599453
Population-level,2,0.6931471805599453
PC20histamine,2,0.6931471805599453
formalin-inactivated,2,0.6931471805599453
bat-virus,2,0.6931471805599453
történő,2,0.6931471805599453
ApdmH1N1,2,0.6931471805599453
azon,2,0.6931471805599453
amelyek,2,0.6931471805599453
előfordulása,2,0.6931471805599453
különböző,2,0.6931471805599453
non-immunosuppressed,2,0.6931471805599453
non-differentiated,2,0.6931471805599453
163-170,2,0.6931471805599453
unions,2,0.6931471805599453
Biologicals,2,0.6931471805599453
WEB,2,0.6931471805599453
point-by-point,2,0.6931471805599453
transoral,2,0.6931471805599453
annals,2,0.6931471805599453
Filipino,2,0.6931471805599453
webtool,2,0.6931471805599453
subthreshold,2,0.6931471805599453
user-provided,2,0.6931471805599453
pro-vaccine,2,0.6931471805599453
ez,2,0.6931471805599453
leucocytic,2,0.6931471805599453
AMP-CpG,2,0.6931471805599453
PC35,2,0.6931471805599453
18-29,2,0.6931471805599453
pandémia,2,0.6931471805599453
urinalysis,2,0.6931471805599453
25-fold,2,0.6931471805599453
trafficked,2,0.6931471805599453
mechanism-specific,2,0.6931471805599453
laryngopharingitis,2,0.6931471805599453
coadjutant,2,0.6931471805599453
Sympathetic,2,0.6931471805599453
Nat,2,0.6931471805599453
Y52H,2,0.6931471805599453
28600,2,0.6931471805599453
Biotechnol,2,0.6931471805599453
tailed,2,0.6931471805599453
RADx,2,0.6931471805599453
host-switch,2,0.6931471805599453
forte,2,0.6931471805599453
Point-of-Care,2,0.6931471805599453
size-matched,2,0.6931471805599453
Kao,2,0.6931471805599453
Y289H,2,0.6931471805599453
submicromolar,2,0.6931471805599453
ejaculation,2,0.6931471805599453
themMethods,2,0.6931471805599453
NIHSS-scores,2,0.6931471805599453
Intra-abdominal,2,0.6931471805599453
950000,2,0.6931471805599453
1341,2,0.6931471805599453
forerunner,2,0.6931471805599453
16-50,2,0.6931471805599453
April-September,2,0.6931471805599453
pre-percutaneous,2,0.6931471805599453
AF-induced,2,0.6931471805599453
SureScreen,2,0.6931471805599453
free-of-charge,2,0.6931471805599453
рlt0001,2,0.6931471805599453
unpurified,2,0.6931471805599453
CardioVision,2,0.6931471805599453
cannabis-induced,2,0.6931471805599453
Slight,2,0.6931471805599453
idealized,2,0.6931471805599453
needlessly,2,0.6931471805599453
AAM,2,0.6931471805599453
NMS,2,0.6931471805599453
overexertion,2,0.6931471805599453
Pes,2,0.6931471805599453
perturbing,2,0.6931471805599453
non-pilot,2,0.6931471805599453
hand-searched,2,0.6931471805599453
TRALI,2,0.6931471805599453
desynchronization,2,0.6931471805599453
≧,2,0.6931471805599453
non-guideline,2,0.6931471805599453
0907,2,0.6931471805599453
Kano,2,0.6931471805599453
reimplantation,2,0.6931471805599453
hexakis,2,0.6931471805599453
beta1,2,0.6931471805599453
MSC-derived,2,0.6931471805599453
20-July,2,0.6931471805599453
bracelet,2,0.6931471805599453
clavicle,2,0.6931471805599453
Ava,2,0.6931471805599453
all-individuals,2,0.6931471805599453
most-but,2,0.6931471805599453
≤23,2,0.6931471805599453
13-75,2,0.6931471805599453
Coffee,2,0.6931471805599453
Positions,2,0.6931471805599453
thrombusABSTRACT,2,0.6931471805599453
subcultures,2,0.6931471805599453
USEP,2,0.6931471805599453
Navigator,2,0.6931471805599453
rediscovered,2,0.6931471805599453
low‑flow,2,0.6931471805599453
GHSI,2,0.6931471805599453
Equator,2,0.6931471805599453
Capricorn,2,0.6931471805599453
Maladaptive,2,0.6931471805599453
pH-monitoring,2,0.6931471805599453
non-CCU,2,0.6931471805599453
lineage-defining,2,0.6931471805599453
nonindex,2,0.6931471805599453
atropine-like,2,0.6931471805599453
90°,2,0.6931471805599453
7667,2,0.6931471805599453
Duck,2,0.6931471805599453
2840,2,0.6931471805599453
decree,2,0.6931471805599453
pathogeny,2,0.6931471805599453
1-like,2,0.6931471805599453
MADIT,2,0.6931471805599453
TES,2,0.6931471805599453
self-determined,2,0.6931471805599453
temporopolar,2,0.6931471805599453
Revealing,2,0.6931471805599453
prednisolone-primed,2,0.6931471805599453
1-53,2,0.6931471805599453
2110,2,0.6931471805599453
Convalescence,2,0.6931471805599453
THR,2,0.6931471805599453
mutationally,2,0.6931471805599453
T-cell-based,2,0.6931471805599453
pPTCA,2,0.6931471805599453
T5,2,0.6931471805599453
alimentation,2,0.6931471805599453
ventricular-septal,2,0.6931471805599453
co-circulates,2,0.6931471805599453
parieto-temporal,2,0.6931471805599453
devitalized,2,0.6931471805599453
velocity-compensated,2,0.6931471805599453
HKU,2,0.6931471805599453
temporo-parietal,2,0.6931471805599453
randomize,2,0.6931471805599453
Cardiol,2,0.6931471805599453
08-14,2,0.6931471805599453
occipito-parietal,2,0.6931471805599453
Arteriography,2,0.6931471805599453
radiculopathy,2,0.6931471805599453
201314-201516,2,0.6931471805599453
Estrogens,2,0.6931471805599453
autonomy-supportive,2,0.6931471805599453
painstaking,2,0.6931471805599453
Uml-1,2,0.6931471805599453
ageist,2,0.6931471805599453
Interrater,2,0.6931471805599453
contestations,2,0.6931471805599453
AdipoR1,2,0.6931471805599453
IGFBP-1,2,0.6931471805599453
AJohannesburg3394,2,0.6931471805599453
mitogen-induced,2,0.6931471805599453
CDDP,2,0.6931471805599453
NASMC,2,0.6931471805599453
CREB,2,0.6931471805599453
multicentered,2,0.6931471805599453
childrenWhat,2,0.6931471805599453
Systematically,2,0.6931471805599453
Turnbull,2,0.6931471805599453
fgμL,2,0.6931471805599453
obliterative,2,0.6931471805599453
emigration,2,0.6931471805599453
p1-3lt0001,2,0.6931471805599453
Adhesion,2,0.6931471805599453
sarcoendoplasmic,2,0.6931471805599453
sub-micromolar,2,0.6931471805599453
AdipoR2,2,0.6931471805599453
β-CoVs,2,0.6931471805599453
OSs,2,0.6931471805599453
45-55,2,0.6931471805599453
living-donor,2,0.6931471805599453
nontransplant,2,0.6931471805599453
35-75,2,0.6931471805599453
Esteio,2,0.6931471805599453
ARTERIA,2,0.6931471805599453
seizure-like,2,0.6931471805599453
Placenta,2,0.6931471805599453
Nadal,2,0.6931471805599453
pro-vaccination,2,0.6931471805599453
proprieties,2,0.6931471805599453
optometrist,2,0.6931471805599453
anti-interleukin-5,2,0.6931471805599453
sewershed,2,0.6931471805599453
2-3-year-olds,2,0.6931471805599453
Hongkong,2,0.6931471805599453
bronchopneumopathies,2,0.6931471805599453
PEFs,2,0.6931471805599453
recapitulating,2,0.6931471805599453
post-spillover,2,0.6931471805599453
DSG,2,0.6931471805599453
00045,2,0.6931471805599453
5011,2,0.6931471805599453
clinic-epidemiological,2,0.6931471805599453
Eating,2,0.6931471805599453
stem-binding,2,0.6931471805599453
P0020,2,0.6931471805599453
multivessels,2,0.6931471805599453
ASao,2,0.6931471805599453
58-70,2,0.6931471805599453
Animal-based,2,0.6931471805599453
cause-and-effect,2,0.6931471805599453
non-life-threatening,2,0.6931471805599453
020-077,2,0.6931471805599453
Zeta,2,0.6931471805599453
overreaction,2,0.6931471805599453
stress-redistribution-reinjection,2,0.6931471805599453
mother-to-child,2,0.6931471805599453
ICOS1IL-21,2,0.6931471805599453
1654,2,0.6931471805599453
cheroot,2,0.6931471805599453
homogenates,2,0.6931471805599453
intimating,2,0.6931471805599453
MRI-positive,2,0.6931471805599453
MRI-negative,2,0.6931471805599453
Yemen,2,0.6931471805599453
Abnormally,2,0.6931471805599453
periorbital,2,0.6931471805599453
insulated,2,0.6931471805599453
hyperreflexia,2,0.6931471805599453
0412,2,0.6931471805599453
nasogastric,2,0.6931471805599453
long-term-control,2,0.6931471805599453
cineangiocardiograms,2,0.6931471805599453
SkodaAuto,2,0.6931471805599453
liquidation,2,0.6931471805599453
TTM,2,0.6931471805599453
PF4polyanion,2,0.6931471805599453
implementable,2,0.6931471805599453
racehorses,2,0.6931471805599453
impartial,2,0.6931471805599453
overcalled,2,0.6931471805599453
T6,2,0.6931471805599453
T0-T6,2,0.6931471805599453
Hills,2,0.6931471805599453
40-79,2,0.6931471805599453
RNase-free,2,0.6931471805599453
Immunochromatographic,2,0.6931471805599453
Residence,2,0.6931471805599453
agent-,2,0.6931471805599453
0461,2,0.6931471805599453
mouths,2,0.6931471805599453
1214,2,0.6931471805599453
chesty,2,0.6931471805599453
two-target,2,0.6931471805599453
mini-Asthma,2,0.6931471805599453
hypoxia-prestimulated,2,0.6931471805599453
Expired,2,0.6931471805599453
videothoracoscopies,2,0.6931471805599453
ischaemichypoxic,2,0.6931471805599453
paspat,2,0.6931471805599453
Nerima,2,0.6931471805599453
httpsdoiorg1028071560-7917ES20202532000045,2,0.6931471805599453
sanation,2,0.6931471805599453
Surveill,2,0.6931471805599453
Suginami,2,0.6931471805599453
Molenkamp,2,0.6931471805599453
Landt,2,0.6931471805599453
reinterventions,2,0.6931471805599453
WURSS-21,2,0.6931471805599453
mini-ACQ,2,0.6931471805599453
securely,2,0.6931471805599453
9-64,2,0.6931471805599453
contends,2,0.6931471805599453
fossil,2,0.6931471805599453
low-viral,2,0.6931471805599453
Theme,2,0.6931471805599453
CCVI,2,0.6931471805599453
Vulnerability,2,0.6931471805599453
post-lockdown,2,0.6931471805599453
alcohols,2,0.6931471805599453
thence,2,0.6931471805599453
Interpreting,2,0.6931471805599453
9-17,2,0.6931471805599453
Unpredictable,2,0.6931471805599453
1847-1848,2,0.6931471805599453
1836-1837,2,0.6931471805599453
1833,2,0.6931471805599453
1830-1831,2,0.6931471805599453
1830,2,0.6931471805599453
upper-middle,2,0.6931471805599453
transcription-droplet,2,0.6931471805599453
Nicole,2,0.6931471805599453
Neuman,2,0.6931471805599453
Tc-pyrophosphate,2,0.6931471805599453
1-81,2,0.6931471805599453
Equivalent,2,0.6931471805599453
glomeruli,2,0.6931471805599453
fecal-respiratory,2,0.6931471805599453
malesfemales,2,0.6931471805599453
F1-score,2,0.6931471805599453
UMI,2,0.6931471805599453
2466,2,0.6931471805599453
chlorofluorocarbon-beclomethasone,2,0.6931471805599453
Excerpts,2,0.6931471805599453
28609,2,0.6931471805599453
austere,2,0.6931471805599453
toolsdatabases,2,0.6931471805599453
1889-91,2,0.6931471805599453
isotropic,2,0.6931471805599453
occlusion-reperfusion,2,0.6931471805599453
Neuroinflammation,2,0.6931471805599453
orchestrates,2,0.6931471805599453
Nonsurvivors,2,0.6931471805599453
CXCR5-ICOS1,2,0.6931471805599453
Nobody,2,0.6931471805599453
1145,2,0.6931471805599453
receptor-bearing,2,0.6931471805599453
Apolipoprotein,2,0.6931471805599453
Lancsar,2,0.6931471805599453
Savage,2,0.6931471805599453
nonadjuvanted,2,0.6931471805599453
intra-vascular,2,0.6931471805599453
explorative,2,0.6931471805599453
NPcA,2,0.6931471805599453
Labeled,2,0.6931471805599453
1057,2,0.6931471805599453
Pinteraction,2,0.6931471805599453
4522,2,0.6931471805599453
∈2,2,0.6931471805599453
reperfusate,2,0.6931471805599453
Basilicata,2,0.6931471805599453
Influenzae,2,0.6931471805599453
neo-cavity,2,0.6931471805599453
∈4,2,0.6931471805599453
irrational,2,0.6931471805599453
evolutional,2,0.6931471805599453
1782,2,0.6931471805599453
TH2-driven,2,0.6931471805599453
Asthma-Full,2,0.6931471805599453
Q10,2,0.6931471805599453
dead-end,2,0.6931471805599453
León,2,0.6931471805599453
geriatrics,2,0.6931471805599453
g-mm2,2,0.6931471805599453
hunt,2,0.6931471805599453
Surat,2,0.6931471805599453
mph,2,0.6931471805599453
SMART-MI,2,0.6931471805599453
mCas13,2,0.6931471805599453
Lepidoglyphus,2,0.6931471805599453
3982,2,0.6931471805599453
rams,2,0.6931471805599453
school-free,2,0.6931471805599453
ileocecal,2,0.6931471805599453
non-B,2,0.6931471805599453
precariously,2,0.6931471805599453
Erythema,2,0.6931471805599453
easy-to-fabricate,2,0.6931471805599453
SDF,2,0.6931471805599453
kilograms,2,0.6931471805599453
insomniastress,2,0.6931471805599453
lenticulostriatal,2,0.6931471805599453
NMO,2,0.6931471805599453
ZO1,2,0.6931471805599453
101-109,2,0.6931471805599453
Tropics,2,0.6931471805599453
direly,2,0.6931471805599453
fomented,2,0.6931471805599453
ewes,2,0.6931471805599453
insisted,2,0.6931471805599453
≥3000,2,0.6931471805599453
MI-BCI,2,0.6931471805599453
Hutchinson-Gilford,2,0.6931471805599453
LMNA,2,0.6931471805599453
Patient-related,2,0.6931471805599453
pgmL-1,2,0.6931471805599453
collating,2,0.6931471805599453
four-year-old,2,0.6931471805599453
caseous,2,0.6931471805599453
single-parent,2,0.6931471805599453
onsetpotential,2,0.6931471805599453
easyMAG,2,0.6931471805599453
NucliSENS,2,0.6931471805599453
0456,2,0.6931471805599453
lymphadenitis,2,0.6931471805599453
≥3500,2,0.6931471805599453
OKY-046,2,0.6931471805599453
1·6,2,0.6931471805599453
flared,2,0.6931471805599453
ECTIM,2,0.6931471805599453
-0135,2,0.6931471805599453
pdmH1N1-infected,2,0.6931471805599453
custom-made,2,0.6931471805599453
HLA-A2,2,0.6931471805599453
grade-4,2,0.6931471805599453
17-30,2,0.6931471805599453
03-06,2,0.6931471805599453
paraoxonase,2,0.6931471805599453
biotin-labeled,2,0.6931471805599453
nonpolio,2,0.6931471805599453
Mini-Wright,2,0.6931471805599453
0145,2,0.6931471805599453
brilacidin,2,0.6931471805599453
µls,2,0.6931471805599453
physicans,2,0.6931471805599453
1618,2,0.6931471805599453
hysteresis,2,0.6931471805599453
infector,2,0.6931471805599453
0518,2,0.6931471805599453
acquainted,2,0.6931471805599453
MPCs,2,0.6931471805599453
1299,2,0.6931471805599453
PLoS,2,0.6931471805599453
chronometry,2,0.6931471805599453
Holosystolic,2,0.6931471805599453
Enzymatically,2,0.6931471805599453
age-sex,2,0.6931471805599453
21-28,2,0.6931471805599453
PC30,2,0.6931471805599453
3Flex,2,0.6931471805599453
antigens-spike,2,0.6931471805599453
anosmiaageusia,2,0.6931471805599453
Two-lowestmean,2,0.6931471805599453
Mahaim,2,0.6931471805599453
fasciculoventricular,2,0.6931471805599453
manure,2,0.6931471805599453
traded,2,0.6931471805599453
transcriptase–polymerase,2,0.6931471805599453
17-39,2,0.6931471805599453
Nottinghamshire,2,0.6931471805599453
approximatively,2,0.6931471805599453
toll-free,2,0.6931471805599453
Spanish-only,2,0.6931471805599453
hemodinamic,2,0.6931471805599453
Transit,2,0.6931471805599453
ever-employed,2,0.6931471805599453
19-33,2,0.6931471805599453
HLH-20042009,2,0.6931471805599453
Confining,2,0.6931471805599453
HDMpos,2,0.6931471805599453
spate,2,0.6931471805599453
receptor-engineered,2,0.6931471805599453
state-operated,2,0.6931471805599453
Visualizing,2,0.6931471805599453
HScore,2,0.6931471805599453
or60,2,0.6931471805599453
R02,2,0.6931471805599453
driving-related,2,0.6931471805599453
9789,2,0.6931471805599453
radio-isotopic,2,0.6931471805599453
monotherapies,2,0.6931471805599453
capnographic,2,0.6931471805599453
ControLAsma,2,0.6931471805599453
reappears,2,0.6931471805599453
8740,2,0.6931471805599453
10457,2,0.6931471805599453
SOM,2,0.6931471805599453
1987-88,2,0.6931471805599453
10years,2,0.6931471805599453
iuml,2,0.6931471805599453
stasis-precipitated,2,0.6931471805599453
cortexin,2,0.6931471805599453
StrongStep®,2,0.6931471805599453
workups,2,0.6931471805599453
metalloproteinase-9,2,0.6931471805599453
Mx1--,2,0.6931471805599453
TWO,2,0.6931471805599453
punicalagin,2,0.6931471805599453
→U,2,0.6931471805599453
surface-exposed,2,0.6931471805599453
allo-HCT,2,0.6931471805599453
Ultrafine,2,0.6931471805599453
Caledonia2099H1N1,2,0.6931471805599453
peel,2,0.6931471805599453
Reassortant,2,0.6931471805599453
unhindered,2,0.6931471805599453
speed-up,2,0.6931471805599453
Ancrod,2,0.6931471805599453
punicalin,2,0.6931471805599453
parities,2,0.6931471805599453
diseases--the,2,0.6931471805599453
corporal,2,0.6931471805599453
Iraqi,2,0.6931471805599453
No-ECP,2,0.6931471805599453
ancrod,2,0.6931471805599453
capped,2,0.6931471805599453
-067,2,0.6931471805599453
9067,2,0.6931471805599453
opt-out,2,0.6931471805599453
GMC,2,0.6931471805599453
March-August,2,0.6931471805599453
MAHS,2,0.6931471805599453
malignancy-associated,2,0.6931471805599453
air-space,2,0.6931471805599453
familialprimary,2,0.6931471805599453
9797,2,0.6931471805599453
9515,2,0.6931471805599453
Cn,2,0.6931471805599453
12-58,2,0.6931471805599453
1414,2,0.6931471805599453
signified,2,0.6931471805599453
Brain-computer,2,0.6931471805599453
Kilkenny,2,0.6931471805599453
german,2,0.6931471805599453
term-born,2,0.6931471805599453
deoptimization,2,0.6931471805599453
transpleural,2,0.6931471805599453
precision-medicine,2,0.6931471805599453
12‑lead,2,0.6931471805599453
95372568,2,0.6931471805599453
1776037,2,0.6931471805599453
14-week,2,0.6931471805599453
uteroplacental,2,0.6931471805599453
statutes,2,0.6931471805599453
retropleural,2,0.6931471805599453
1152,2,0.6931471805599453
FPD-CBCT,2,0.6931471805599453
MAGIC,2,0.6931471805599453
solstice,2,0.6931471805599453
3028,2,0.6931471805599453
Dedicated,2,0.6931471805599453
RHAS,2,0.6931471805599453
vent,2,0.6931471805599453
ABIOMED,2,0.6931471805599453
Danvers,2,0.6931471805599453
puma,2,0.6931471805599453
mink-to-human,2,0.6931471805599453
Subarachnoid-pleural,2,0.6931471805599453
symptoms1,2,0.6931471805599453
allosterically,2,0.6931471805599453
AC-service,2,0.6931471805599453
myelography,2,0.6931471805599453
5735,2,0.6931471805599453
Unfractionated,2,0.6931471805599453
ENM,2,0.6931471805599453
computer-processed,2,0.6931471805599453
Barry,2,0.6931471805599453
nonvented,2,0.6931471805599453
SCD-related,2,0.6931471805599453
echo-,2,0.6931471805599453
SWB,2,0.6931471805599453
kallikrein-kinin,2,0.6931471805599453
de-airing,2,0.6931471805599453
Westmead,2,0.6931471805599453
verdict,2,0.6931471805599453
RdRp-COVID,2,0.6931471805599453
decisionmaking,2,0.6931471805599453
wouldve,2,0.6931471805599453
decimate,2,0.6931471805599453
fourth-degree,2,0.6931471805599453
neurologist-determined,2,0.6931471805599453
recombinational,2,0.6931471805599453
hexosamine,2,0.6931471805599453
PSROP,2,0.6931471805599453
2881,2,0.6931471805599453
tetrahedron,2,0.6931471805599453
acquires,2,0.6931471805599453
Davies,2,0.6931471805599453
0915,2,0.6931471805599453
Flavonoids,2,0.6931471805599453
area-under-curve,2,0.6931471805599453
Adjudication,2,0.6931471805599453
non-systematic,2,0.6931471805599453
70-84,2,0.6931471805599453
minus-strand,2,0.6931471805599453
diffuses,2,0.6931471805599453
17-19,2,0.6931471805599453
2399,2,0.6931471805599453
4539,2,0.6931471805599453
rest-redistribution,2,0.6931471805599453
computer-generated,2,0.6931471805599453
criticised,2,0.6931471805599453
silicosis,2,0.6931471805599453
transmyocardial,2,0.6931471805599453
asbestosis,2,0.6931471805599453
Phoenix,2,0.6931471805599453
GAD-7,2,0.6931471805599453
Mites,2,0.6931471805599453
MAG,2,0.6931471805599453
near-zero,2,0.6931471805599453
BCG-induced,2,0.6931471805599453
fragment-based,2,0.6931471805599453
15167,2,0.6931471805599453
restlessness,2,0.6931471805599453
blood-flow,2,0.6931471805599453
conjugating,2,0.6931471805599453
sonogram,2,0.6931471805599453
kagocel,2,0.6931471805599453
Descemet,2,0.6931471805599453
canals,2,0.6931471805599453
shortcuts,2,0.6931471805599453
artemisinin-based,2,0.6931471805599453
n199,2,0.6931471805599453
sypmtoms,2,0.6931471805599453
foreigners,2,0.6931471805599453
Westerners,2,0.6931471805599453
artemisinin,2,0.6931471805599453
Sewage,2,0.6931471805599453
SAHS,2,0.6931471805599453
Neurogenesis,2,0.6931471805599453
1-way,2,0.6931471805599453
9065,2,0.6931471805599453
receptor-ligand,2,0.6931471805599453
equipping,2,0.6931471805599453
V470A,2,0.6931471805599453
flowering,2,0.6931471805599453
chitotriosidase,2,0.6931471805599453
punctual,2,0.6931471805599453
A-MUR,2,0.6931471805599453
L-MUR,2,0.6931471805599453
S-MUR,2,0.6931471805599453
multi-variate,2,0.6931471805599453
non-survival,2,0.6931471805599453
hpatient,2,0.6931471805599453
4989,2,0.6931471805599453
factor-κB,2,0.6931471805599453
left-superior,2,0.6931471805599453
7853,2,0.6931471805599453
etiopathology,2,0.6931471805599453
V354F,2,0.6931471805599453
uncompromised,2,0.6931471805599453
repurposingquot,2,0.6931471805599453
Chilblains,2,0.6931471805599453
two-compartment,2,0.6931471805599453
MD1,2,0.6931471805599453
pupil,2,0.6931471805599453
unventilated,2,0.6931471805599453
famine,2,0.6931471805599453
opium,2,0.6931471805599453
Wind,2,0.6931471805599453
cognitive-communication,2,0.6931471805599453
LMCA-MI,2,0.6931471805599453
comprehended,2,0.6931471805599453
allostery,2,0.6931471805599453
acidity,2,0.6931471805599453
glue,2,0.6931471805599453
1527,2,0.6931471805599453
128X,2,0.6931471805599453
4865,2,0.6931471805599453
Saturation,2,0.6931471805599453
One-Health,2,0.6931471805599453
dermatologist,2,0.6931471805599453
supplant,2,0.6931471805599453
thresholded,2,0.6931471805599453
quotdrug,2,0.6931471805599453
atheroemboli,2,0.6931471805599453
11-23,2,0.6931471805599453
SHEEP,2,0.6931471805599453
2CAN,2,0.6931471805599453
keratoplasty,2,0.6931471805599453
spice,2,0.6931471805599453
45-hour,2,0.6931471805599453
20-min,2,0.6931471805599453
acceptably,2,0.6931471805599453
20-54,2,0.6931471805599453
26-52,2,0.6931471805599453
misattributed,2,0.6931471805599453
translesional,2,0.6931471805599453
failings,2,0.6931471805599453
HFA,2,0.6931471805599453
unevenness,2,0.6931471805599453
BLeningrad86,2,0.6931471805599453
Absorption,2,0.6931471805599453
attests,2,0.6931471805599453
1753,2,0.6931471805599453
ccIIV4,2,0.6931471805599453
molt,2,0.6931471805599453
molting,2,0.6931471805599453
B712,2,0.6931471805599453
rim,2,0.6931471805599453
eyestalk,2,0.6931471805599453
Neurotrophic,2,0.6931471805599453
C7-T5,2,0.6931471805599453
Händels,2,0.6931471805599453
kit-based,2,0.6931471805599453
CHH,2,0.6931471805599453
ecdysis,2,0.6931471805599453
NSS,2,0.6931471805599453
Gairdner,2,0.6931471805599453
drifting,2,0.6931471805599453
ventrolateral,2,0.6931471805599453
southernmost,2,0.6931471805599453
polyangiitis,2,0.6931471805599453
Gibraltar,2,0.6931471805599453
nonrecurrence,2,0.6931471805599453
-155,2,0.6931471805599453
CE-marked,2,0.6931471805599453
042-097,2,0.6931471805599453
age-class,2,0.6931471805599453
BNPNT-proBNP,2,0.6931471805599453
neuroepidemiologic,2,0.6931471805599453
soy-based,2,0.6931471805599453
hemiataxia,2,0.6931471805599453
--CT,2,0.6931471805599453
--IT,2,0.6931471805599453
Gl-CHH,2,0.6931471805599453
Gl-MIH,2,0.6931471805599453
Montréal,2,0.6931471805599453
ratory,2,0.6931471805599453
Learned,2,0.6931471805599453
microclots,2,0.6931471805599453
agenesishypoplasia,2,0.6931471805599453
1-13,2,0.6931471805599453
apelin-13,2,0.6931471805599453
NF‑κB,2,0.6931471805599453
Massons,2,0.6931471805599453
muM,2,0.6931471805599453
iodoacetic,2,0.6931471805599453
Islands306,2,0.6931471805599453
prescreened,2,0.6931471805599453
APJ,2,0.6931471805599453
8367,2,0.6931471805599453
cyclothymia,2,0.6931471805599453
Multi-slice,2,0.6931471805599453
AWisconsin6705,2,0.6931471805599453
journalism,2,0.6931471805599453
biographies,2,0.6931471805599453
1824,2,0.6931471805599453
Lond,2,0.6931471805599453
polyphenolic,2,0.6931471805599453
EPITHET,2,0.6931471805599453
GHz,2,0.6931471805599453
disk,2,0.6931471805599453
Associates,2,0.6931471805599453
LES,2,0.6931471805599453
Gore,2,0.6931471805599453
esophagram,2,0.6931471805599453
Notified,2,0.6931471805599453
non-seropositive,2,0.6931471805599453
pseudo-occlusion,2,0.6931471805599453
Marrakesh,2,0.6931471805599453
coucher,2,0.6931471805599453
H5H1,2,0.6931471805599453
Sofia™,2,0.6931471805599453
stromalstem,2,0.6931471805599453
sEVs,2,0.6931471805599453
guerrilla,2,0.6931471805599453
Theophyllines,2,0.6931471805599453
Gender-specific,2,0.6931471805599453
33-63,2,0.6931471805599453
PO,2,0.6931471805599453
attacking,2,0.6931471805599453
Granulocyte-colony-stimulating,2,0.6931471805599453
36-54,2,0.6931471805599453
stigmatised,2,0.6931471805599453
kid,2,0.6931471805599453
évszakok,2,0.6931471805599453
hatásuk,2,0.6931471805599453
proteinprotein,2,0.6931471805599453
Described,2,0.6931471805599453
Whole-virus,2,0.6931471805599453
munkaszüneti,2,0.6931471805599453
RNA-guided,2,0.6931471805599453
n114,2,0.6931471805599453
coal,2,0.6931471805599453
incidencia,2,0.6931471805599453
Lunar,2,0.6931471805599453
Concealed,2,0.6931471805599453
saline-induced,2,0.6931471805599453
7028,2,0.6931471805599453
PermAF,2,0.6931471805599453
uncodable,2,0.6931471805599453
proning,2,0.6931471805599453
camouflage,2,0.6931471805599453
Mediterranean-style,2,0.6931471805599453
Unjustified,2,0.6931471805599453
Bulgarian,2,0.6931471805599453
Engine,2,0.6931471805599453
Bundle,2,0.6931471805599453
Possibility,2,0.6931471805599453
DIII,2,0.6931471805599453
Holters,2,0.6931471805599453
posterior-inferior,2,0.6931471805599453
RFTs,2,0.6931471805599453
EUAs,2,0.6931471805599453
Auditory,2,0.6931471805599453
GQL,2,0.6931471805599453
tavasszal,2,0.6931471805599453
Marfans,2,0.6931471805599453
Eye,2,0.6931471805599453
erinaceieuropaei,2,0.6931471805599453
infarktus,2,0.6931471805599453
Psychoneuroimmunology,2,0.6931471805599453
UCM,2,0.6931471805599453
NS1-defective,2,0.6931471805599453
Deletion,2,0.6931471805599453
fel,2,0.6931471805599453
MAV,2,0.6931471805599453
nagy,2,0.6931471805599453
szezonális,2,0.6931471805599453
gyakoriságának,2,0.6931471805599453
overreactive,2,0.6931471805599453
tapping,2,0.6931471805599453
IDR,2,0.6931471805599453
Spirometra,2,0.6931471805599453
tegmental,2,0.6931471805599453
methergine,2,0.6931471805599453
7162,2,0.6931471805599453
opener,2,0.6931471805599453
Estradiol,2,0.6931471805599453
Points,2,0.6931471805599453
hétfőn,2,0.6931471805599453
Overt-Stroke,2,0.6931471805599453
napjai,2,0.6931471805599453
hét,2,0.6931471805599453
TX98,2,0.6931471805599453
Pre-epidemic,2,0.6931471805599453
1916-1917,2,0.6931471805599453
este,2,0.6931471805599453
S-OtrH3N2,2,0.6931471805599453
óra,2,0.6931471805599453
infarktustípus,2,0.6931471805599453
16-month,2,0.6931471805599453
three-dimensionally,2,0.6931471805599453
ninety-three,2,0.6931471805599453
Emotionality,2,0.6931471805599453
-055,2,0.6931471805599453
pretherapy,2,0.6931471805599453
natriuresis,2,0.6931471805599453
30-64,2,0.6931471805599453
Médecins,2,0.6931471805599453
SARD,2,0.6931471805599453
abruption,2,0.6931471805599453
LTZs,2,0.6931471805599453
CHN,2,0.6931471805599453
miR-1468,2,0.6931471805599453
stipulate,2,0.6931471805599453
ngm3,2,0.6931471805599453
creatine-phosphokinase,2,0.6931471805599453
1-24,2,0.6931471805599453
STEMInon-STEMI,2,0.6931471805599453
NEMESIS,2,0.6931471805599453
co-evolution,2,0.6931471805599453
segment-specific,2,0.6931471805599453
T2-defined,2,0.6931471805599453
6B1A1,2,0.6931471805599453
steroid-treatment,2,0.6931471805599453
e411,2,0.6931471805599453
Antithrombotics,2,0.6931471805599453
229ENL63,2,0.6931471805599453
1992-3,2,0.6931471805599453
emotionalbehavioral,2,0.6931471805599453
Höhenried,2,0.6931471805599453
Contributing,2,0.6931471805599453
transpired,2,0.6931471805599453
unlinked,2,0.6931471805599453
vanquished,2,0.6931471805599453
Sb,2,0.6931471805599453
3C2a2,2,0.6931471805599453
minesweeper,2,0.6931471805599453
TIAstroke,2,0.6931471805599453
qLAIV,2,0.6931471805599453
FK506,2,0.6931471805599453
miR-1307,2,0.6931471805599453
infeasible,2,0.6931471805599453
impatience,2,0.6931471805599453
marine-derived,2,0.6931471805599453
syngeneic,2,0.6931471805599453
south-north,2,0.6931471805599453
1999-2007,2,0.6931471805599453
immune-suppression,2,0.6931471805599453
ROL,2,0.6931471805599453
KX,2,0.6931471805599453
neoangiogenesis,2,0.6931471805599453
1666,2,0.6931471805599453
100100,2,0.6931471805599453
1806,2,0.6931471805599453
2659,2,0.6931471805599453
9777,2,0.6931471805599453
2051,2,0.6931471805599453
haemothorax,2,0.6931471805599453
Administrations,2,0.6931471805599453
fortuitously,2,0.6931471805599453
Puritan,2,0.6931471805599453
α1-antitrypsin,2,0.6931471805599453
-induced,2,0.6931471805599453
demand-control,2,0.6931471805599453
SLL,2,0.6931471805599453
non-PCI,2,0.6931471805599453
miR-3611,2,0.6931471805599453
erection,2,0.6931471805599453
orientates,2,0.6931471805599453
replication-transcription,2,0.6931471805599453
unimpaired,2,0.6931471805599453
CDU,2,0.6931471805599453
ORF-1ab,2,0.6931471805599453
Biotime,2,0.6931471805599453
bat-SL-CoVZXC21,2,0.6931471805599453
EECP,2,0.6931471805599453
bat-SL-CoVZC45,2,0.6931471805599453
Endpoints,2,0.6931471805599453
Drivers,2,0.6931471805599453
Stunning,2,0.6931471805599453
TH2-,2,0.6931471805599453
Coherence,2,0.6931471805599453
13-86,2,0.6931471805599453
re-hospitalisation,2,0.6931471805599453
AA861,2,0.6931471805599453
hypothetized,2,0.6931471805599453
stapled,2,0.6931471805599453
quadriceps,2,0.6931471805599453
Pulsatile,2,0.6931471805599453
Strength,2,0.6931471805599453
wiht,2,0.6931471805599453
CMs,2,0.6931471805599453
1mm,2,0.6931471805599453
Analyzer,2,0.6931471805599453
Friedrich,2,0.6931471805599453
ingress,2,0.6931471805599453
z-scores,2,0.6931471805599453
NEBNext,2,0.6931471805599453
Lipoxygenase,2,0.6931471805599453
forskolin-treated,2,0.6931471805599453
beclomethasone-treated,2,0.6931471805599453
Difficult-to-Control,2,0.6931471805599453
drug-,2,0.6931471805599453
December-April,2,0.6931471805599453
HEN6,2,0.6931471805599453
York392012H3N2,2,0.6931471805599453
pre-processing,2,0.6931471805599453
self-screening,2,0.6931471805599453
Virulence,2,0.6931471805599453
BP-lowering,2,0.6931471805599453
Kaeo,2,0.6931471805599453
analogies,2,0.6931471805599453
baht,2,0.6931471805599453
under-report,2,0.6931471805599453
Done,2,0.6931471805599453
unnamed,2,0.6931471805599453
aspirin-DL-lysine,2,0.6931471805599453
motorcognitive,2,0.6931471805599453
Contacts,2,0.6931471805599453
Ultra,2,0.6931471805599453
ADP-ribosylhydrolases,2,0.6931471805599453
pre-purchase,2,0.6931471805599453
kPals,2,0.6931471805599453
Neuromedicine,2,0.6931471805599453
sl,2,0.6931471805599453
2-DG,2,0.6931471805599453
U937,2,0.6931471805599453
50mm,2,0.6931471805599453
EDF,2,0.6931471805599453
AP-1-dependent,2,0.6931471805599453
esteem,2,0.6931471805599453
haemofiltration,2,0.6931471805599453
GERD-associated,2,0.6931471805599453
240000,2,0.6931471805599453
Spleen,2,0.6931471805599453
underperfusion,2,0.6931471805599453
sub-region,2,0.6931471805599453
SpikeD614,2,0.6931471805599453
Dimensions,2,0.6931471805599453
6768,2,0.6931471805599453
asthmaThe,2,0.6931471805599453
sensu,2,0.6931471805599453
stricto,2,0.6931471805599453
Georg,2,0.6931471805599453
28-45,2,0.6931471805599453
PARs,2,0.6931471805599453
Border,2,0.6931471805599453
UnionEuropean,2,0.6931471805599453
NAEPPEPR-3,2,0.6931471805599453
responsive-purchase,2,0.6931471805599453
χ,2,0.6931471805599453
continent-specific,2,0.6931471805599453
phylogram,2,0.6931471805599453
ORF8L84,2,0.6931471805599453
3110,2,0.6931471805599453
hemorragic,2,0.6931471805599453
cavalry,2,0.6931471805599453
re-allocation,2,0.6931471805599453
non-mechanistic,2,0.6931471805599453
cubital,2,0.6931471805599453
Micron,2,0.6931471805599453
MSM,2,0.6931471805599453
interbeat,2,0.6931471805599453
unit-based,2,0.6931471805599453
squeeze-and-excitation,2,0.6931471805599453
intra-ventricular,2,0.6931471805599453
workhorse,2,0.6931471805599453
Farrar,2,0.6931471805599453
knife,2,0.6931471805599453
INSR,2,0.6931471805599453
presumptively,2,0.6931471805599453
SARS-CoV-2-naïve,2,0.6931471805599453
kidney-pancreas,2,0.6931471805599453
5046,2,0.6931471805599453
Schizophrenia,2,0.6931471805599453
6-segment,2,0.6931471805599453
hardening,2,0.6931471805599453
16813,2,0.6931471805599453
Hypercapnic,2,0.6931471805599453
Nassau,2,0.6931471805599453
évek,2,0.6931471805599453
VIIa,2,0.6931471805599453
fitters,2,0.6931471805599453
idraparinux,2,0.6931471805599453
areasneighborhoods,2,0.6931471805599453
PCTA,2,0.6931471805599453
semi-traveling,2,0.6931471805599453
ACanada11582006,2,0.6931471805599453
triple-mode,2,0.6931471805599453
bio-molecules,2,0.6931471805599453
voiding,2,0.6931471805599453
loomed,2,0.6931471805599453
upheld,2,0.6931471805599453
presage,2,0.6931471805599453
keyboards,2,0.6931471805599453
alpha-receptors,2,0.6931471805599453
nonhousehold,2,0.6931471805599453
9929,2,0.6931471805599453
cloud-based,2,0.6931471805599453
kiértékelési,2,0.6931471805599453
collagenase,2,0.6931471805599453
8020,2,0.6931471805599453
9767,2,0.6931471805599453
RTPL,2,0.6931471805599453
exacerbation-rate,2,0.6931471805599453
amalgamated,2,0.6931471805599453
trolley,2,0.6931471805599453
Yukon-Kuskokwim,2,0.6931471805599453
YKHC,2,0.6931471805599453
Yukon,2,0.6931471805599453
65-100,2,0.6931471805599453
lifespans,2,0.6931471805599453
unaccounted,2,0.6931471805599453
hat,2,0.6931471805599453
ischemia-alone,2,0.6931471805599453
-068,2,0.6931471805599453
Myoglobinuria,2,0.6931471805599453
zaditen,2,0.6931471805599453
Jeremy,2,0.6931471805599453
virus-contaminated,2,0.6931471805599453
pulmonary-function,2,0.6931471805599453
non-trivial,2,0.6931471805599453
Unrecognised,2,0.6931471805599453
kcal,2,0.6931471805599453
hinzii,2,0.6931471805599453
≤200,2,0.6931471805599453
mol-1,2,0.6931471805599453
homoeostasis,2,0.6931471805599453
courage,2,0.6931471805599453
Piot,2,0.6931471805599453
wartime,2,0.6931471805599453
prevaccinated,2,0.6931471805599453
bupivacaine-induced,2,0.6931471805599453
mechanikus,2,0.6931471805599453
orthologs,2,0.6931471805599453
iNO,2,0.6931471805599453
rs6598045,2,0.6931471805599453
1622,2,0.6931471805599453
VOIsVOCs,2,0.6931471805599453
bronchodilative,2,0.6931471805599453
-022,2,0.6931471805599453
-051,2,0.6931471805599453
non-validated,2,0.6931471805599453
fissuration,2,0.6931471805599453
surveyor,2,0.6931471805599453
Cytotoxic,2,0.6931471805599453
Placebo-Controlled,2,0.6931471805599453
cCFR,2,0.6931471805599453
Cost-of-illness,2,0.6931471805599453
widest,2,0.6931471805599453
Physiatric,2,0.6931471805599453
Self-Directed,2,0.6931471805599453
Glascow,2,0.6931471805599453
dispenses,2,0.6931471805599453
90-year-old,2,0.6931471805599453
lunch,2,0.6931471805599453
nanotechnology-enabled,2,0.6931471805599453
furlough,2,0.6931471805599453
demerits,2,0.6931471805599453
pediatric-specific,2,0.6931471805599453
Naha,2,0.6931471805599453
fought,2,0.6931471805599453
Charlottesville,2,0.6931471805599453
2924,2,0.6931471805599453
Va,2,0.6931471805599453
CDC-approved,2,0.6931471805599453
Vaccinees,2,0.6931471805599453
IBV-infected,2,0.6931471805599453
Île-de-France,2,0.6931471805599453
designates,2,0.6931471805599453
B-line,2,0.6931471805599453
38-40,2,0.6931471805599453
PDAs,2,0.6931471805599453
Statements,2,0.6931471805599453
ATP-dependent,2,0.6931471805599453
jelentősen,2,0.6931471805599453
AVT,2,0.6931471805599453
artifactual,2,0.6931471805599453
intentioned,2,0.6931471805599453
Influenza-attributable,2,0.6931471805599453
Graphic,2,0.6931471805599453
schemas,2,0.6931471805599453
identifiers,2,0.6931471805599453
Wikidata,2,0.6931471805599453
Councils,2,0.6931471805599453
Purification,2,0.6931471805599453
gene-set,2,0.6931471805599453
commons,2,0.6931471805599453
P-values,2,0.6931471805599453
CAMERA,2,0.6931471805599453
Knockdown,2,0.6931471805599453
inter-gene,2,0.6931471805599453
15-40,2,0.6931471805599453
IDH-1,2,0.6931471805599453
hormonally,2,0.6931471805599453
elegant,2,0.6931471805599453
problem-based,2,0.6931471805599453
MCFF-Net,2,0.6931471805599453
Occitania,2,0.6931471805599453
CorAide,2,0.6931471805599453
Closer,2,0.6931471805599453
Friuli-Venezia-Giulia,2,0.6931471805599453
slaughtering,2,0.6931471805599453
Random-effect,2,0.6931471805599453
region-,2,0.6931471805599453
ℜ₀,2,0.6931471805599453
Islands32006,2,0.6931471805599453
1690,2,0.6931471805599453
aneurysm-free,2,0.6931471805599453
4302,2,0.6931471805599453
NHLBINAEPP,2,0.6931471805599453
hypercapneic,2,0.6931471805599453
Regard,2,0.6931471805599453
dedikált,2,0.6931471805599453
p0035,2,0.6931471805599453
two-pore,2,0.6931471805599453
Temple-Belton,2,0.6931471805599453
Proposal,2,0.6931471805599453
p033,2,0.6931471805599453
spike-protein,2,0.6931471805599453
atenolol-treated,2,0.6931471805599453
p0022,2,0.6931471805599453
55-80,2,0.6931471805599453
taurine,2,0.6931471805599453
phenylpropanolamine,2,0.6931471805599453
decongestant-antihistamine,2,0.6931471805599453
nonadherent,2,0.6931471805599453
refills,2,0.6931471805599453
Nontraditional,2,0.6931471805599453
postcoital,2,0.6931471805599453
Post-PCI,2,0.6931471805599453
N69,2,0.6931471805599453
Re0,2,0.6931471805599453
renal-transplanted,2,0.6931471805599453
Generalised,2,0.6931471805599453
primary-school,2,0.6931471805599453
Albunex,2,0.6931471805599453
1706,2,0.6931471805599453
shine,2,0.6931471805599453
developped,2,0.6931471805599453
Watts,2,0.6931471805599453
gems,2,0.6931471805599453
patient-health,2,0.6931471805599453
Arch,2,0.6931471805599453
inasmuch,2,0.6931471805599453
sharps,2,0.6931471805599453
Kozinetz,2,0.6931471805599453
Griffith,2,0.6931471805599453
sibship,2,0.6931471805599453
bronchoprovocative,2,0.6931471805599453
High-performance,2,0.6931471805599453
Nuño,2,0.6931471805599453
letting,2,0.6931471805599453
Exacerbating,2,0.6931471805599453
miserable,2,0.6931471805599453
evacuated,2,0.6931471805599453
HP-LAMP,2,0.6931471805599453
bill,2,0.6931471805599453
Agreed,2,0.6931471805599453
wealthier,2,0.6931471805599453
Virus-2,2,0.6931471805599453
browse,2,0.6931471805599453
CHA2DS2-VASC,2,0.6931471805599453
MICs,2,0.6931471805599453
sequence-structural,2,0.6931471805599453
Nicotinamide,2,0.6931471805599453
GSDM,2,0.6931471805599453
randomised-controlled,2,0.6931471805599453
cholinolytics,2,0.6931471805599453
mlhr,2,0.6931471805599453
99mTc-labeled,2,0.6931471805599453
payments,2,0.6931471805599453
B136,2,0.6931471805599453
meta-analyze,2,0.6931471805599453
readership,2,0.6931471805599453
RNAseq,2,0.6931471805599453
six-point,2,0.6931471805599453
doctrines,2,0.6931471805599453
sarcopenia,2,0.6931471805599453
recidivism,2,0.6931471805599453
nanodiamonds,2,0.6931471805599453
2703,2,0.6931471805599453
furnace,2,0.6931471805599453
COVID-19Clinical,2,0.6931471805599453
Glycyrrhiza,2,0.6931471805599453
glabra,2,0.6931471805599453
180105,2,0.6931471805599453
IgG»,2,0.6931471805599453
P011,2,0.6931471805599453
Glucagon-like,2,0.6931471805599453
COVID-quick-DET,2,0.6931471805599453
time-effective,2,0.6931471805599453
Repolarization,2,0.6931471805599453
override,2,0.6931471805599453
43-61,2,0.6931471805599453
handout,2,0.6931471805599453
coloring,2,0.6931471805599453
Whats,2,0.6931471805599453
rhinovirus-induced,2,0.6931471805599453
kialakítása,2,0.6931471805599453
large-airway,2,0.6931471805599453
multiterritory,2,0.6931471805599453
mite-specific,2,0.6931471805599453
micromoll,2,0.6931471805599453
Kerala,2,0.6931471805599453
ISP,2,0.6931471805599453
bioenergetics,2,0.6931471805599453
antagonise,2,0.6931471805599453
USG,2,0.6931471805599453
FRs,2,0.6931471805599453
CPUs,2,0.6931471805599453
Filter,2,0.6931471805599453
retro-orbital,2,0.6931471805599453
self-initiated,2,0.6931471805599453
under-diagnosing,2,0.6931471805599453
PASSI,2,0.6931471805599453
anthropology,2,0.6931471805599453
third-wave,2,0.6931471805599453
MRI-confirmed,2,0.6931471805599453
pharmacoepidemiological,2,0.6931471805599453
FGID,2,0.6931471805599453
polyADP-ribosylation,2,0.6931471805599453
autologus,2,0.6931471805599453
epitome,2,0.6931471805599453
ECOSS,2,0.6931471805599453
well-folded,2,0.6931471805599453
dehiscence,2,0.6931471805599453
Injectable,2,0.6931471805599453
Hum,2,0.6931471805599453
cervico-mediastinal,2,0.6931471805599453
unmutated,2,0.6931471805599453
person-weeks,2,0.6931471805599453
city-basis,2,0.6931471805599453
offshore,2,0.6931471805599453
neurominidase,2,0.6931471805599453
Biomarker,2,0.6931471805599453
preepidemic,2,0.6931471805599453
endotypephenotype,2,0.6931471805599453
ECG-diagnosed,2,0.6931471805599453
arrested,2,0.6931471805599453
BA--in,2,0.6931471805599453
063-089,2,0.6931471805599453
appendages,2,0.6931471805599453
COB,2,0.6931471805599453
QGS,2,0.6931471805599453
losartan-,2,0.6931471805599453
aortogenic,2,0.6931471805599453
61000,2,0.6931471805599453
0094,2,0.6931471805599453
endovascularly,2,0.6931471805599453
PI3-K,2,0.6931471805599453
kilobases,2,0.6931471805599453
graft-coated,2,0.6931471805599453
facto,2,0.6931471805599453
mishaps,2,0.6931471805599453
skinny,2,0.6931471805599453
ProgramExpert,2,0.6931471805599453
two-sided,2,0.6931471805599453
DIA,2,0.6931471805599453
disputable,2,0.6931471805599453
2499,2,0.6931471805599453
Israelis,2,0.6931471805599453
MarchOctober,2,0.6931471805599453
consolidating,2,0.6931471805599453
panoply,2,0.6931471805599453
nanoscience,2,0.6931471805599453
100-200,2,0.6931471805599453
ASCVD,2,0.6931471805599453
VMET,2,0.6931471805599453
Bewick,2,0.6931471805599453
pneumopathy,2,0.6931471805599453
PLMS,2,0.6931471805599453
GEE,2,0.6931471805599453
109-131,2,0.6931471805599453
connexion,2,0.6931471805599453
Theodore,2,0.6931471805599453
filterability,2,0.6931471805599453
89000,2,0.6931471805599453
strugglers,2,0.6931471805599453
207000,2,0.6931471805599453
314000,2,0.6931471805599453
734000,2,0.6931471805599453
EpMotion,2,0.6931471805599453
46-83,2,0.6931471805599453
stent-retriever,2,0.6931471805599453
monocular,2,0.6931471805599453
Laura,2,0.6931471805599453
re-exposure,2,0.6931471805599453
D50,2,0.6931471805599453
alphavirus,2,0.6931471805599453
levers,2,0.6931471805599453
PEG-precipitation,2,0.6931471805599453
postencephalitic,2,0.6931471805599453
hidradenitis,2,0.6931471805599453
1997-2002,2,0.6931471805599453
embryologic,2,0.6931471805599453
A23404G,2,0.6931471805599453
23-fold,2,0.6931471805599453
hospital-centred,2,0.6931471805599453
Von,2,0.6931471805599453
STEPwise,2,0.6931471805599453
ATexas177H3N2,2,0.6931471805599453
Sindbis,2,0.6931471805599453
intra-tracheal,2,0.6931471805599453
ABangkok279,2,0.6931471805599453
silicone-coated,2,0.6931471805599453
GCN,2,0.6931471805599453
Anderson-Fabry,2,0.6931471805599453
Healing,2,0.6931471805599453
ISST,2,0.6931471805599453
hatred,2,0.6931471805599453
misoplegia,2,0.6931471805599453
1230,2,0.6931471805599453
self-isolating,2,0.6931471805599453
aloud,2,0.6931471805599453
mild-temperature,2,0.6931471805599453
MCPH,2,0.6931471805599453
BCVI4,2,0.6931471805599453
anginose,2,0.6931471805599453
heat-susceptible,2,0.6931471805599453
neuraminidase-inhibition,2,0.6931471805599453
DAPs,2,0.6931471805599453
solubilized,2,0.6931471805599453
Colmar,2,0.6931471805599453
sifting,2,0.6931471805599453
throatnose,2,0.6931471805599453
ix,2,0.6931471805599453
Pub,2,0.6931471805599453
viii,2,0.6931471805599453
postcardiotomy,2,0.6931471805599453
Empowered,2,0.6931471805599453
Doxycycline,2,0.6931471805599453
sift,2,0.6931471805599453
ABeijing3292-like,2,0.6931471805599453
endorgan,2,0.6931471805599453
drinker,2,0.6931471805599453
Distinguished,2,0.6931471805599453
Gable,2,0.6931471805599453
control-driven,2,0.6931471805599453
DMT,2,0.6931471805599453
Pleasanton,2,0.6931471805599453
clipped,2,0.6931471805599453
non-embolic,2,0.6931471805599453
diverter,2,0.6931471805599453
Cottbus,2,0.6931471805599453
long-,2,0.6931471805599453
droplet-nuclei,2,0.6931471805599453
9506,2,0.6931471805599453
sirolimus,2,0.6931471805599453
PCR-test,2,0.6931471805599453
Fixed,2,0.6931471805599453
Gran,2,0.6931471805599453
Canaria,2,0.6931471805599453
Cooke,2,0.6931471805599453
Canary,2,0.6931471805599453
pre-thrombolytic,2,0.6931471805599453
horizontally-directed,2,0.6931471805599453
imbedded,2,0.6931471805599453
111-232,2,0.6931471805599453
Canaries,2,0.6931471805599453
hemagglutinin-inhibition,2,0.6931471805599453
IACs,2,0.6931471805599453
water-borne,2,0.6931471805599453
air-,2,0.6931471805599453
monoparesis,2,0.6931471805599453
IFNG,2,0.6931471805599453
5700,2,0.6931471805599453
CCL17,2,0.6931471805599453
newly-discovered,2,0.6931471805599453
13652,2,0.6931471805599453
NFG,2,0.6931471805599453
10861,2,0.6931471805599453
eroded,2,0.6931471805599453
allergen-dependent,2,0.6931471805599453
affinity-capture,2,0.6931471805599453
2521,2,0.6931471805599453
post-peak,2,0.6931471805599453
1184,2,0.6931471805599453
1-65,2,0.6931471805599453
hypercapnoea,2,0.6931471805599453
-83,2,0.6931471805599453
co-worker,2,0.6931471805599453
CLCA1,2,0.6931471805599453
Lightning,2,0.6931471805599453
polycation,2,0.6931471805599453
procontractile,2,0.6931471805599453
2639,2,0.6931471805599453
Homecare,2,0.6931471805599453
prognosticated,2,0.6931471805599453
postischaemic,2,0.6931471805599453
FETP,2,0.6931471805599453
ACG,2,0.6931471805599453
HbF,2,0.6931471805599453
Agena,2,0.6931471805599453
HIHPCC,2,0.6931471805599453
Foley,2,0.6931471805599453
convection,2,0.6931471805599453
deferasirox,2,0.6931471805599453
hydroxyureaphlebotomy,2,0.6931471805599453
transfusionschelation,2,0.6931471805599453
oestrogens,2,0.6931471805599453
GDC,2,0.6931471805599453
különösen,2,0.6931471805599453
immiscible,2,0.6931471805599453
framings,2,0.6931471805599453
conventions,2,0.6931471805599453
recount,2,0.6931471805599453
l-citrulline,2,0.6931471805599453
l-proline,2,0.6931471805599453
cTCM,2,0.6931471805599453
CNIDRS,2,0.6931471805599453
PCR-,2,0.6931471805599453
CRISPR-Cas9,2,0.6931471805599453
INLA,2,0.6931471805599453
LRA,2,0.6931471805599453
microgmL,2,0.6931471805599453
ultrasound-enhanced,2,0.6931471805599453
sample-in,2,0.6931471805599453
P0048,2,0.6931471805599453
over-use,2,0.6931471805599453
over-users,2,0.6931471805599453
tolerances,2,0.6931471805599453
mulatta,2,0.6931471805599453
VSA,2,0.6931471805599453
1511-1519,2,0.6931471805599453
cleanliness,2,0.6931471805599453
epidemiologist,2,0.6931471805599453
2009–2010,2,0.6931471805599453
expediency,2,0.6931471805599453
16238,2,0.6931471805599453
steno-occlusion,2,0.6931471805599453
StentBoost,2,0.6931471805599453
disembarking,2,0.6931471805599453
LvRv,2,0.6931471805599453
So-called,2,0.6931471805599453
501V2,2,0.6931471805599453
seven-days,2,0.6931471805599453
peptide-1,2,0.6931471805599453
Shipping,2,0.6931471805599453
post-intensive,2,0.6931471805599453
0443,2,0.6931471805599453
gemfibrozil,2,0.6931471805599453
LDG1,2,0.6931471805599453
hexapeptide,2,0.6931471805599453
dalargin,2,0.6931471805599453
akár,2,0.6931471805599453
microgkgmin,2,0.6931471805599453
untapped,2,0.6931471805599453
ENDURANCE,2,0.6931471805599453
impactions,2,0.6931471805599453
masslike,2,0.6931471805599453
polyubiquitination,2,0.6931471805599453
transfusion-associated,2,0.6931471805599453
követő,2,0.6931471805599453
ever-growing,2,0.6931471805599453
0096,2,0.6931471805599453
caesarian,2,0.6931471805599453
beta-endorphin,2,0.6931471805599453
követően,2,0.6931471805599453
tetrapeptides,2,0.6931471805599453
heat-wave-related,2,0.6931471805599453
Capsular,2,0.6931471805599453
extrastimuli,2,0.6931471805599453
unsubstantiated,2,0.6931471805599453
CYC,2,0.6931471805599453
true-negative,2,0.6931471805599453
Vasospasm,2,0.6931471805599453
Feelings,2,0.6931471805599453
papain,2,0.6931471805599453
PODs,2,0.6931471805599453
tool--the,2,0.6931471805599453
aerated-saline,2,0.6931471805599453
LsRs,2,0.6931471805599453
myoendocarditis,2,0.6931471805599453
23-valent,2,0.6931471805599453
aerially,2,0.6931471805599453
16216,2,0.6931471805599453
611-614,2,0.6931471805599453
detach,2,0.6931471805599453
Inverse,2,0.6931471805599453
Organized,2,0.6931471805599453
infektológiai,2,0.6931471805599453
LDL-Chol,2,0.6931471805599453
Chol,2,0.6931471805599453
syrups,2,0.6931471805599453
Decision-makers,2,0.6931471805599453
0977,2,0.6931471805599453
under-appreciated,2,0.6931471805599453
anginanon-Q-wave,2,0.6931471805599453
commercially-available,2,0.6931471805599453
movens,2,0.6931471805599453
Interleukin-13,2,0.6931471805599453
Hemispheric,2,0.6931471805599453
veracity,2,0.6931471805599453
pointer,2,0.6931471805599453
subscribers,2,0.6931471805599453
giant-cell,2,0.6931471805599453
fake,2,0.6931471805599453
rheumatologists,2,0.6931471805599453
clinician-patient,2,0.6931471805599453
warming-up,2,0.6931471805599453
Acral,2,0.6931471805599453
SApNPs,2,0.6931471805599453
12-49,2,0.6931471805599453
LionHeart,2,0.6931471805599453
factitious,2,0.6931471805599453
1627,2,0.6931471805599453
pharyngalgia,2,0.6931471805599453
Emirati,2,0.6931471805599453
tampon,2,0.6931471805599453
IgG-S,2,0.6931471805599453
higher-dose,2,0.6931471805599453
S2P,2,0.6931471805599453
I3-01v9,2,0.6931471805599453
suburb,2,0.6931471805599453
preconception,2,0.6931471805599453
B-agonists,2,0.6931471805599453
SPECT-TI,2,0.6931471805599453
ECO,2,0.6931471805599453
13-year,2,0.6931471805599453
Coolidge,2,0.6931471805599453
brink,2,0.6931471805599453
WARSS,2,0.6931471805599453
ADSS,2,0.6931471805599453
Mind,2,0.6931471805599453
oseltamivir-susceptible,2,0.6931471805599453
influenza-vaccine,2,0.6931471805599453
Bioinformatic,2,0.6931471805599453
ground-truth,2,0.6931471805599453
suctioned,2,0.6931471805599453
DV-PEFR,2,0.6931471805599453
moistened,2,0.6931471805599453
postvaccinal,2,0.6931471805599453
Ages,2,0.6931471805599453
Linking,2,0.6931471805599453
three-miRNA,2,0.6931471805599453
ICRN,2,0.6931471805599453
675000,2,0.6931471805599453
Noticeably,2,0.6931471805599453
pteronissinus,2,0.6931471805599453
moulds--Dermatophagoides,2,0.6931471805599453
multidimensionality,2,0.6931471805599453
40-69,2,0.6931471805599453
Anti-thrombotic,2,0.6931471805599453
hormongátló,2,0.6931471805599453
x100,2,0.6931471805599453
betegség,2,0.6931471805599453
Institutionalization,2,0.6931471805599453
communicates,2,0.6931471805599453
deactivated,2,0.6931471805599453
transmissive,2,0.6931471805599453
intenzív,2,0.6931471805599453
time-scales,2,0.6931471805599453
áll,2,0.6931471805599453
boosters,2,0.6931471805599453
JEM,2,0.6931471805599453
exercise-thallium,2,0.6931471805599453
convening,2,0.6931471805599453
adrenocorticotrophic,2,0.6931471805599453
gyulladásos,2,0.6931471805599453
endotype-driven,2,0.6931471805599453
reclassify,2,0.6931471805599453
redesigned,2,0.6931471805599453
SHIPSAN,2,0.6931471805599453
hyperinflated,2,0.6931471805599453
socioecological,2,0.6931471805599453
traversing,2,0.6931471805599453
Angiotensin-II,2,0.6931471805599453
SARS-CoV-2-ACE2,2,0.6931471805599453
APC73,2,0.6931471805599453
non-attenders,2,0.6931471805599453
IntroductionThe,2,0.6931471805599453
daysseason,2,0.6931471805599453
one-health,2,0.6931471805599453
NAADSM,2,0.6931471805599453
dykinesia,2,0.6931471805599453
thrombectomy-capable,2,0.6931471805599453
MIND,2,0.6931471805599453
119-481,2,0.6931471805599453
asymptomatic-screened,2,0.6931471805599453
SRRS,2,0.6931471805599453
patientsThe,2,0.6931471805599453
05-08,2,0.6931471805599453
1393,2,0.6931471805599453
cryptococcal,2,0.6931471805599453
Lighthouse,2,0.6931471805599453
epigenetically,2,0.6931471805599453
Skilled,2,0.6931471805599453
eclipsed,2,0.6931471805599453
rung,2,0.6931471805599453
berotec,2,0.6931471805599453
infarction-like,2,0.6931471805599453
fetalis,2,0.6931471805599453
erythroblastosis,2,0.6931471805599453
talents,2,0.6931471805599453
NSI-566,2,0.6931471805599453
n37,2,0.6931471805599453
Lymphocytic,2,0.6931471805599453
At-risk,2,0.6931471805599453
polyuria,2,0.6931471805599453
8670,2,0.6931471805599453
motorway,2,0.6931471805599453
Chiles,2,0.6931471805599453
Climate,2,0.6931471805599453
remediate,2,0.6931471805599453
Ovarian,2,0.6931471805599453
-059,2,0.6931471805599453
NTC,2,0.6931471805599453
091-099,2,0.6931471805599453
Summed,2,0.6931471805599453
cross-linked,2,0.6931471805599453
0078,2,0.6931471805599453
glucometer,2,0.6931471805599453
129-136,2,0.6931471805599453
polydipsia,2,0.6931471805599453
proliferates,2,0.6931471805599453
Cryptococcus,2,0.6931471805599453
LCCA,2,0.6931471805599453
Thoracentesis,2,0.6931471805599453
antibody-escape,2,0.6931471805599453
4455,2,0.6931471805599453
LOTCA,2,0.6931471805599453
Loewenstein,2,0.6931471805599453
1786,2,0.6931471805599453
4014,2,0.6931471805599453
FDA‐approved,2,0.6931471805599453
milky,2,0.6931471805599453
-47,2,0.6931471805599453
Narrowing,2,0.6931471805599453
sickest,2,0.6931471805599453
gastrectomized,2,0.6931471805599453
m14846GA,2,0.6931471805599453
m12315GA,2,0.6931471805599453
-53,2,0.6931471805599453
SEARCH,2,0.6931471805599453
pig-human,2,0.6931471805599453
PEFRs,2,0.6931471805599453
intrastent,2,0.6931471805599453
anti-IL-5-receptor-alpha,2,0.6931471805599453
Prevention-Active,2,0.6931471805599453
Cambodians,2,0.6931471805599453
Versions,2,0.6931471805599453
Schedule-IV,2,0.6931471805599453
MASC,2,0.6931471805599453
STAI-C,2,0.6931471805599453
MTHFR-C677T,2,0.6931471805599453
peri-necrotic,2,0.6931471805599453
brain-behaviour,2,0.6931471805599453
7331,2,0.6931471805599453
thymosin,2,0.6931471805599453
fluconazole,2,0.6931471805599453
entanglement,2,0.6931471805599453
4729,2,0.6931471805599453
Scientist,2,0.6931471805599453
Parainfluenza,2,0.6931471805599453
Tyne,2,0.6931471805599453
Lethality,2,0.6931471805599453
influenza-type,2,0.6931471805599453
disulfide-linked,2,0.6931471805599453
AssessmeNt,2,0.6931471805599453
dignity,2,0.6931471805599453
816-855,2,0.6931471805599453
time-to-detection,2,0.6931471805599453
postmarketing,2,0.6931471805599453
EMS-transported,2,0.6931471805599453
ESEA,2,0.6931471805599453
onus,2,0.6931471805599453
AuNS,2,0.6931471805599453
medical-legal,2,0.6931471805599453
counteracts,2,0.6931471805599453
2004-2010,2,0.6931471805599453
57-89,2,0.6931471805599453
deep-sequencing,2,0.6931471805599453
P0042,2,0.6931471805599453
Reallocation,2,0.6931471805599453
EUROPA,2,0.6931471805599453
ESEA-LFIA,2,0.6931471805599453
seas,2,0.6931471805599453
9672,2,0.6931471805599453
elastography,2,0.6931471805599453
9933,2,0.6931471805599453
ExoN,2,0.6931471805599453
4106,2,0.6931471805599453
TaqMan-based,2,0.6931471805599453
Nervous,2,0.6931471805599453
TGFβ,2,0.6931471805599453
Paco2,2,0.6931471805599453
3802,2,0.6931471805599453
Pao2,2,0.6931471805599453
bronchoreactivity,2,0.6931471805599453
Interleukin-4,2,0.6931471805599453
break-even,2,0.6931471805599453
€20,2,0.6931471805599453
Candesartan,2,0.6931471805599453
Bender-Gestalt,2,0.6931471805599453
2532,2,0.6931471805599453
inter-relationship,2,0.6931471805599453
biopower,2,0.6931471805599453
flu-causing,2,0.6931471805599453
subjectivity,2,0.6931471805599453
specks,2,0.6931471805599453
PUI,2,0.6931471805599453
pericardectomy,2,0.6931471805599453
DNA-PK,2,0.6931471805599453
Mie,2,0.6931471805599453
Bender,2,0.6931471805599453
Peak-intensity,2,0.6931471805599453
Varese,2,0.6931471805599453
P0011,2,0.6931471805599453
Peak-timing,2,0.6931471805599453
simeprevir,2,0.6931471805599453
best-known,2,0.6931471805599453
30°,2,0.6931471805599453
2q,2,0.6931471805599453
5q,2,0.6931471805599453
11q,2,0.6931471805599453
hypotention,2,0.6931471805599453
care-based,2,0.6931471805599453
eLAMP,2,0.6931471805599453
emitter,2,0.6931471805599453
re-AMI,2,0.6931471805599453
EMPA-REG,2,0.6931471805599453
innovatively,2,0.6931471805599453
valproic,2,0.6931471805599453
antagomir,2,0.6931471805599453
H3N2s,2,0.6931471805599453
Intellectual,2,0.6931471805599453
urinestoolblood,2,0.6931471805599453
1651G,2,0.6931471805599453
PHF11,2,0.6931471805599453
epochal,2,0.6931471805599453
VAIs,2,0.6931471805599453
ASCEND,2,0.6931471805599453
D-deficient,2,0.6931471805599453
back-boosting,2,0.6931471805599453
Conceptual,2,0.6931471805599453
14-34,2,0.6931471805599453
032-075,2,0.6931471805599453
eosinophilicneutrophilic,2,0.6931471805599453
suicidality,2,0.6931471805599453
3123,2,0.6931471805599453
4560,2,0.6931471805599453
0061,2,0.6931471805599453
NeuroThera,2,0.6931471805599453
AAichi21968,2,0.6931471805599453
NEST-1,2,0.6931471805599453
triphosphates,2,0.6931471805599453
aerosoldroplet,2,0.6931471805599453
portals,2,0.6931471805599453
recorders,2,0.6931471805599453
Lummis,2,0.6931471805599453
out-of-season,2,0.6931471805599453
autobiographies,2,0.6931471805599453
IC50s,2,0.6931471805599453
EC50s,2,0.6931471805599453
rater,2,0.6931471805599453
293T,2,0.6931471805599453
LD-1LD-3,2,0.6931471805599453
off-hour,2,0.6931471805599453
cardiorenal,2,0.6931471805599453
Logistics,2,0.6931471805599453
Showing,2,0.6931471805599453
combinational,2,0.6931471805599453
n67,2,0.6931471805599453
Metered,2,0.6931471805599453
Dose,2,0.6931471805599453
n42,2,0.6931471805599453
histopathologies,2,0.6931471805599453
thermostabilizing,2,0.6931471805599453
WT-MtD,2,0.6931471805599453
fluidity,2,0.6931471805599453
apnoeahypopnoea,2,0.6931471805599453
Curve,2,0.6931471805599453
cueing,2,0.6931471805599453
8824,2,0.6931471805599453
Planners,2,0.6931471805599453
OND,2,0.6931471805599453
concealment,2,0.6931471805599453
ligand-,2,0.6931471805599453
1982-1986,2,0.6931471805599453
reverse-redistribution,2,0.6931471805599453
Ipom-F,2,0.6931471805599453
18F-2-deoxyglucose,2,0.6931471805599453
preanalytic,2,0.6931471805599453
eGFRs,2,0.6931471805599453
infected-removed,2,0.6931471805599453
Liquid,2,0.6931471805599453
AFO-provision,2,0.6931471805599453
clergy,2,0.6931471805599453
unquestionably,2,0.6931471805599453
9-52,2,0.6931471805599453
Augustów,2,0.6931471805599453
asexual,2,0.6931471805599453
1500000,2,0.6931471805599453
Well-developed,2,0.6931471805599453
postanalytic,2,0.6931471805599453
hypoenhanced,2,0.6931471805599453
Neto,2,0.6931471805599453
age-range,2,0.6931471805599453
self-assessments,2,0.6931471805599453
GVS,2,0.6931471805599453
DR-ELISA,2,0.6931471805599453
incoherent,2,0.6931471805599453
DR-LFA,2,0.6931471805599453
5379,2,0.6931471805599453
Pires,2,0.6931471805599453
FluAH1N109pdm,2,0.6931471805599453
2569,2,0.6931471805599453
40mgkg,2,0.6931471805599453
AH1N1pandemic,2,0.6931471805599453
lumbricoides,2,0.6931471805599453
de-isolation,2,0.6931471805599453
koff,2,0.6931471805599453
Lim,2,0.6931471805599453
view-point,2,0.6931471805599453
transferability,2,0.6931471805599453
Kc,2,0.6931471805599453
incising,2,0.6931471805599453
zoo,2,0.6931471805599453
glycolipid,2,0.6931471805599453
fades,2,0.6931471805599453
swinging,2,0.6931471805599453
neuropsychic,2,0.6931471805599453
post-decontamination,2,0.6931471805599453
Endothelin-1-induced,2,0.6931471805599453
time-saving,2,0.6931471805599453
Xe-CT,2,0.6931471805599453
IgM-A,2,0.6931471805599453
0571,2,0.6931471805599453
terminations,2,0.6931471805599453
Nocardiosis,2,0.6931471805599453
depositing,2,0.6931471805599453
Calcium-channel,2,0.6931471805599453
NIRV-associated,2,0.6931471805599453
Prognostication,2,0.6931471805599453
0-025,2,0.6931471805599453
originality,2,0.6931471805599453
cooks,2,0.6931471805599453
CLOSE,2,0.6931471805599453
m5178CA,2,0.6931471805599453
CARDIOFORM,2,0.6931471805599453
thrombospondin,2,0.6931471805599453
201Thallium,2,0.6931471805599453
GORE®,2,0.6931471805599453
REDUCE,2,0.6931471805599453
4345,2,0.6931471805599453
reabsorption,2,0.6931471805599453
frameshifting,2,0.6931471805599453
task-related,2,0.6931471805599453
2940,2,0.6931471805599453
0071,2,0.6931471805599453
experimentalists,2,0.6931471805599453
esterolytic,2,0.6931471805599453
crackles,2,0.6931471805599453
nanotube,2,0.6931471805599453
inventing,2,0.6931471805599453
SWCNT-based,2,0.6931471805599453
noncovalently,2,0.6931471805599453
heater,2,0.6931471805599453
famed,2,0.6931471805599453
optoelectronics,2,0.6931471805599453
ACE2-SWCNT,2,0.6931471805599453
ONO-1301,2,0.6931471805599453
nanosensors,2,0.6931471805599453
surge-capacity,2,0.6931471805599453
4328,2,0.6931471805599453
May-December,2,0.6931471805599453
55-60,2,0.6931471805599453
Funds,2,0.6931471805599453
NSQIP,2,0.6931471805599453
percents,2,0.6931471805599453
kaolin,2,0.6931471805599453
carotenoids,2,0.6931471805599453
Intake,2,0.6931471805599453
GM3,2,0.6931471805599453
Stroobandt,2,0.6931471805599453
2634,2,0.6931471805599453
cellcell,2,0.6931471805599453
19723,2,0.6931471805599453
corners,2,0.6931471805599453
E3N,2,0.6931471805599453
malpositioned,2,0.6931471805599453
kininogen,2,0.6931471805599453
Jugdutt,2,0.6931471805599453
misfortune,2,0.6931471805599453
GDL,2,0.6931471805599453
susceptible-infected-recovered,2,0.6931471805599453
bedside-back-to-bench,2,0.6931471805599453
NanoLuc,2,0.6931471805599453
fMV,2,0.6931471805599453
Argentine,2,0.6931471805599453
26133,2,0.6931471805599453
obtention,2,0.6931471805599453
Implanted,2,0.6931471805599453
Andong,2,0.6931471805599453
Seongbuk,2,0.6931471805599453
patient-initiated,2,0.6931471805599453
PFOc,2,0.6931471805599453
CORONA,2,0.6931471805599453
mediational,2,0.6931471805599453
large-focus,2,0.6931471805599453
day-to-night,2,0.6931471805599453
bioproducts,2,0.6931471805599453
air-conditioning,2,0.6931471805599453
intrahemispheric,2,0.6931471805599453
378°C,2,0.6931471805599453
stress-regulatory,2,0.6931471805599453
Dnepropetrovsk,2,0.6931471805599453
anti-aggregatory,2,0.6931471805599453
Moon,2,0.6931471805599453
Mgo,2,0.6931471805599453
tying,2,0.6931471805599453
postulating,2,0.6931471805599453
Preinfection,2,0.6931471805599453
Citizens,2,0.6931471805599453
body-plethysmography,2,0.6931471805599453
Manifestation,2,0.6931471805599453
mean-value,2,0.6931471805599453
fading,2,0.6931471805599453
A1C,2,0.6931471805599453
Recanalisation,2,0.6931471805599453
DWI-PWI,2,0.6931471805599453
person-centered,2,0.6931471805599453
CDHR3,2,0.6931471805599453
myAsthma,2,0.6931471805599453
redusome,2,0.6931471805599453
forty-year-old,2,0.6931471805599453
MAX-CPKr,2,0.6931471805599453
pandemic-strain,2,0.6931471805599453
Delirious,2,0.6931471805599453
1296,2,0.6931471805599453
GLMs,2,0.6931471805599453
launches,2,0.6931471805599453
Hemostasis,2,0.6931471805599453
pH1N1-2009,2,0.6931471805599453
binder,2,0.6931471805599453
tours,2,0.6931471805599453
Abbott´s,2,0.6931471805599453
Illness-specific,2,0.6931471805599453
B-Yamagata,2,0.6931471805599453
inferior-lateral,2,0.6931471805599453
arteriographically,2,0.6931471805599453
provenprobable,2,0.6931471805599453
Th2-high,2,0.6931471805599453
Grippovac,2,0.6931471805599453
aPLs,2,0.6931471805599453
Virions,2,0.6931471805599453
ZMDP,2,0.6931471805599453
coal-heating,2,0.6931471805599453
SEIQR,2,0.6931471805599453
Panic-fear,2,0.6931471805599453
BLAZE-2,2,0.6931471805599453
11174,2,0.6931471805599453
speckle-tracking,2,0.6931471805599453
worship,2,0.6931471805599453
pulling-force,2,0.6931471805599453
IgAIgMIgG,2,0.6931471805599453
4707,2,0.6931471805599453
Kiss,2,0.6931471805599453
944-998,2,0.6931471805599453
Vibo,2,0.6931471805599453
Valentia,2,0.6931471805599453
Aegle,2,0.6931471805599453
ubidecarenone,2,0.6931471805599453
multi-patch,2,0.6931471805599453
Goldstein,2,0.6931471805599453
10-2,2,0.6931471805599453
winner,2,0.6931471805599453
excruciating,2,0.6931471805599453
microgeometrical,2,0.6931471805599453
macrogeometrical,2,0.6931471805599453
dysbalance,2,0.6931471805599453
delimited,2,0.6931471805599453
Tactile,2,0.6931471805599453
O2-offer,2,0.6931471805599453
Hypercoagulation,2,0.6931471805599453
RNF213,2,0.6931471805599453
162744,2,0.6931471805599453
anxiousness,2,0.6931471805599453
GLA,2,0.6931471805599453
mans,2,0.6931471805599453
N-negative,2,0.6931471805599453
28948C,2,0.6931471805599453
all-round,2,0.6931471805599453
guidewires,2,0.6931471805599453
post-central,2,0.6931471805599453
WARIS,2,0.6931471805599453
disappearing,2,0.6931471805599453
Catalan,2,0.6931471805599453
50-69,2,0.6931471805599453
ROB,2,0.6931471805599453
1975-1977,2,0.6931471805599453
bursting,2,0.6931471805599453
Sacco,2,0.6931471805599453
1077,2,0.6931471805599453
1319,2,0.6931471805599453
1596,2,0.6931471805599453
BAIB,2,0.6931471805599453
psychomaintenance,2,0.6931471805599453
excipient,2,0.6931471805599453
clubs,2,0.6931471805599453
H1N1-09,2,0.6931471805599453
Players,2,0.6931471805599453
leave-one-subject-out,2,0.6931471805599453
non-Finnish,2,0.6931471805599453
1984-1986,2,0.6931471805599453
Provided,2,0.6931471805599453
interactively,2,0.6931471805599453
Thompson,2,0.6931471805599453
1934,2,0.6931471805599453
Slightly,2,0.6931471805599453
organs-on-chips,2,0.6931471805599453
14days,2,0.6931471805599453
Kermack,2,0.6931471805599453
postexertional,2,0.6931471805599453
hyperoxemic,2,0.6931471805599453
immunoglobulines,2,0.6931471805599453
McKendrick,2,0.6931471805599453
randomness,2,0.6931471805599453
PREVAIL,2,0.6931471805599453
voted,2,0.6931471805599453
exonerated,2,0.6931471805599453
BJamagata1688-like,2,0.6931471805599453
pAFPCs,2,0.6931471805599453
celebrated,2,0.6931471805599453
LatinoAdmixed,2,0.6931471805599453
hamstring,2,0.6931471805599453
understandably,2,0.6931471805599453
snags,2,0.6931471805599453
AwhalePacific,2,0.6931471805599453
W3,2,0.6931471805599453
CPER,2,0.6931471805599453
Luna®,2,0.6931471805599453
UGO-T,2,0.6931471805599453
convention,2,0.6931471805599453
catalysing,2,0.6931471805599453
AvWDacquired,2,0.6931471805599453
oxalacetic,2,0.6931471805599453
Structurally,2,0.6931471805599453
autoimmune-,2,0.6931471805599453
anti-RNA,2,0.6931471805599453
Provisional,2,0.6931471805599453
Medici,2,0.6931471805599453
SIMPeF,2,0.6931471805599453
borrowed,2,0.6931471805599453
medicalized,2,0.6931471805599453
gene-by-environment,2,0.6931471805599453
Blood-based,2,0.6931471805599453
H1H1,2,0.6931471805599453
Phenytoin,2,0.6931471805599453
deactivating,2,0.6931471805599453
p0032,2,0.6931471805599453
patient-performed,2,0.6931471805599453
precursory,2,0.6931471805599453
cap-binding,2,0.6931471805599453
UMVs,2,0.6931471805599453
beta-2-agonist,2,0.6931471805599453
bootstraps,2,0.6931471805599453
f1-score,2,0.6931471805599453
Clarification,2,0.6931471805599453
dictionary,2,0.6931471805599453
scaffolding,2,0.6931471805599453
Swine-Origin,2,0.6931471805599453
addendum,2,0.6931471805599453
Self-efficacy,2,0.6931471805599453
025-05,2,0.6931471805599453
ASE,2,0.6931471805599453
zip-code,2,0.6931471805599453
Realization,2,0.6931471805599453
Relevance,2,0.6931471805599453
2479,2,0.6931471805599453
antituberculous,2,0.6931471805599453
gamma-globulins,2,0.6931471805599453
7-27,2,0.6931471805599453
Haematological,2,0.6931471805599453
eldest,2,0.6931471805599453
Asynchrony,2,0.6931471805599453
ACE2-based,2,0.6931471805599453
110-143,2,0.6931471805599453
GERasthma,2,0.6931471805599453
JAK2,2,0.6931471805599453
don,2,0.6931471805599453
5698,2,0.6931471805599453
PCoI,2,0.6931471805599453
recirculated,2,0.6931471805599453
IPAT,2,0.6931471805599453
WCHT,2,0.6931471805599453
RVALVA,2,0.6931471805599453
L3,2,0.6931471805599453
non-TIAs,2,0.6931471805599453
1965-2005,2,0.6931471805599453
Eurasian-origin,2,0.6931471805599453
RASP,2,0.6931471805599453
multiple-breath,2,0.6931471805599453
1648,2,0.6931471805599453
2-stage,2,0.6931471805599453
passivity,2,0.6931471805599453
obesity-related,2,0.6931471805599453
Breast,2,0.6931471805599453
co-adjuvant,2,0.6931471805599453
O2-CryogelVAX,2,0.6931471805599453
sensitize,2,0.6931471805599453
Sick-role,2,0.6931471805599453
STsegment,2,0.6931471805599453
Voivodeship,2,0.6931471805599453
tomoscintigraphy,2,0.6931471805599453
Preeclampsia,2,0.6931471805599453
Virulent,2,0.6931471805599453
escapes,2,0.6931471805599453
landline,2,0.6931471805599453
sivelestat,2,0.6931471805599453
SASLT,2,0.6931471805599453
browser,2,0.6931471805599453
CCB,2,0.6931471805599453
Afriflu,2,0.6931471805599453
palmtop,2,0.6931471805599453
Middle-Eastern,2,0.6931471805599453
alpha-linolenic,2,0.6931471805599453
1510,2,0.6931471805599453
TELL,2,0.6931471805599453
1179,2,0.6931471805599453
1363,2,0.6931471805599453
Reticular,2,0.6931471805599453
Extrapolation,2,0.6931471805599453
time-controlled,2,0.6931471805599453
overconfident,2,0.6931471805599453
post-efficacy,2,0.6931471805599453
5251,2,0.6931471805599453
degradable,2,0.6931471805599453
ORPKI,2,0.6931471805599453
anosmiahyposmia,2,0.6931471805599453
Bonellis,2,0.6931471805599453
everolimus-eluting,2,0.6931471805599453
subphenotype,2,0.6931471805599453
shrapnel,2,0.6931471805599453
Water,2,0.6931471805599453
splinter,2,0.6931471805599453
CRISPR-mediated,2,0.6931471805599453
Convenient,2,0.6931471805599453
Allergens,2,0.6931471805599453
cochlear,2,0.6931471805599453
risk-discriminating,2,0.6931471805599453
hypercatabolism,2,0.6931471805599453
fibrogenic,2,0.6931471805599453
1240,2,0.6931471805599453
IQCODE,2,0.6931471805599453
unruptured,2,0.6931471805599453
workstation,2,0.6931471805599453
Informant,2,0.6931471805599453
Hess,2,0.6931471805599453
R-GENE,2,0.6931471805599453
seroarcheology,2,0.6931471805599453
speeded,2,0.6931471805599453
WIV1-CoV,2,0.6931471805599453
compactness,2,0.6931471805599453
Cushing,2,0.6931471805599453
AMED,2,0.6931471805599453
core-RBD,2,0.6931471805599453
IMIDs,2,0.6931471805599453
Iberian,2,0.6931471805599453
genital,2,0.6931471805599453
IgG2aIgG1,2,0.6931471805599453
SigmaSTe,2,0.6931471805599453
SIBI,2,0.6931471805599453
incidence-based,2,0.6931471805599453
Zaandam,2,0.6931471805599453
dextrorotation,2,0.6931471805599453
2013-2016,2,0.6931471805599453
clinical-grade,2,0.6931471805599453
asylums,2,0.6931471805599453
origin-independent,2,0.6931471805599453
hematemesis,2,0.6931471805599453
end-hole,2,0.6931471805599453
ST-Segment,2,0.6931471805599453
PVf,2,0.6931471805599453
Asahikawa,2,0.6931471805599453
out-of-pocket,2,0.6931471805599453
tunnels,2,0.6931471805599453
enacting,2,0.6931471805599453
supervisors,2,0.6931471805599453
pamphlets,2,0.6931471805599453
tourists,2,0.6931471805599453
1977--1978,2,0.6931471805599453
end-products,2,0.6931471805599453
cuffing,2,0.6931471805599453
amiloride,2,0.6931471805599453
privation,2,0.6931471805599453
Radiographs,2,0.6931471805599453
Cross-species,2,0.6931471805599453
Monagle,2,0.6931471805599453
Preischemic,2,0.6931471805599453
RdRPS,2,0.6931471805599453
lnc,2,0.6931471805599453
Kawasakis,2,0.6931471805599453
mushroom,2,0.6931471805599453
55-65,2,0.6931471805599453
carcinoma-associated,2,0.6931471805599453
HifD,2,0.6931471805599453
aldehyde,2,0.6931471805599453
mlbeat,2,0.6931471805599453
Amesh,2,0.6931471805599453
OC43-CoV,2,0.6931471805599453
patientsABSTRACT,2,0.6931471805599453
polynomials,2,0.6931471805599453
0-59,2,0.6931471805599453
labyrinth,2,0.6931471805599453
Brain-derived,2,0.6931471805599453
pomorskie,2,0.6931471805599453
nonsurvivor,2,0.6931471805599453
unexploited,2,0.6931471805599453
treasure,2,0.6931471805599453
faded,2,0.6931471805599453
AH5NI,2,0.6931471805599453
Adalja,2,0.6931471805599453
NBAAD,2,0.6931471805599453
pathogen-free,2,0.6931471805599453
ST-SD,2,0.6931471805599453
Ketorolac,2,0.6931471805599453
precuneus,2,0.6931471805599453
UAPs,2,0.6931471805599453
16117,2,0.6931471805599453
Monocyte,2,0.6931471805599453
under-detection,2,0.6931471805599453
Glycan,2,0.6931471805599453
“coronavirus,2,0.6931471805599453
Chemoattractant,2,0.6931471805599453
17-29,2,0.6931471805599453
2”,2,0.6931471805599453
ben,2,0.6931471805599453
1550,2,0.6931471805599453
Spectral,2,0.6931471805599453
Zamky,2,0.6931471805599453
US-licensed,2,0.6931471805599453
hunter-day,2,0.6931471805599453
Enterococcus,2,0.6931471805599453
household-to-household,2,0.6931471805599453
plaque-image,2,0.6931471805599453
symptoms-limited,2,0.6931471805599453
mmHgs,2,0.6931471805599453
RR-10,2,0.6931471805599453
BiomarkTM,2,0.6931471805599453
or6,2,0.6931471805599453
numerator,2,0.6931471805599453
4608,2,0.6931471805599453
bibula,2,0.6931471805599453
cost-effectively,2,0.6931471805599453
unloaded,2,0.6931471805599453
stigmasterol,2,0.6931471805599453
beta-sitosterol,2,0.6931471805599453
Counts,2,0.6931471805599453
HKU1-CoV,2,0.6931471805599453
strabismus,2,0.6931471805599453
0538,2,0.6931471805599453
outskirts,2,0.6931471805599453
Llobregat,2,0.6931471805599453
0180,2,0.6931471805599453
MB-CK-geqm2,2,0.6931471805599453
Prince,2,0.6931471805599453
Halifax,2,0.6931471805599453
Nové,2,0.6931471805599453
Boosting,2,0.6931471805599453
distributors,2,0.6931471805599453
instrumentalists,2,0.6931471805599453
adult-specific,2,0.6931471805599453
Semmelweis,2,0.6931471805599453
sociodemographical,2,0.6931471805599453
infinitely,2,0.6931471805599453
twisted,2,0.6931471805599453
otolaryngology-head,2,0.6931471805599453
prolapsing,2,0.6931471805599453
29-31,2,0.6931471805599453
38°C,2,0.6931471805599453
multi-domain,2,0.6931471805599453
granulomas,2,0.6931471805599453
ISRO,2,0.6931471805599453
foaming,2,0.6931471805599453
echoDoppler,2,0.6931471805599453
FRET-based,2,0.6931471805599453
WhatsApp,2,0.6931471805599453
VEH,2,0.6931471805599453
C0VID-19,2,0.6931471805599453
RS3PE,2,0.6931471805599453
botulinum,2,0.6931471805599453
pitting,2,0.6931471805599453
WAA,2,0.6931471805599453
non-alcoholic,2,0.6931471805599453
Franciscos,2,0.6931471805599453
coiled,2,0.6931471805599453
non-avian,2,0.6931471805599453
synovitis,2,0.6931471805599453
ambition,2,0.6931471805599453
Transplacental,2,0.6931471805599453
DCP,2,0.6931471805599453
054-089,2,0.6931471805599453
cms-1,2,0.6931471805599453
hypothalamus-pituitary-adrenal,2,0.6931471805599453
LRTIs,2,0.6931471805599453
loadings,2,0.6931471805599453
pathoanatomical,2,0.6931471805599453
Fusobacterium,2,0.6931471805599453
intergenerational,2,0.6931471805599453
odontogenic,2,0.6931471805599453
RUO,2,0.6931471805599453
renale,2,0.6931471805599453
orf1ab,2,0.6931471805599453
112-151,2,0.6931471805599453
101-129,2,0.6931471805599453
Ni2,2,0.6931471805599453
Yi,2,0.6931471805599453
cell-survival,2,0.6931471805599453
105-139,2,0.6931471805599453
AISP,2,0.6931471805599453
colloquial,2,0.6931471805599453
Craniocervical,2,0.6931471805599453
paraproteinemia,2,0.6931471805599453
Prep,2,0.6931471805599453
Threats,2,0.6931471805599453
Franklin,2,0.6931471805599453
sickened,2,0.6931471805599453
14-52,2,0.6931471805599453
clinico-radiological,2,0.6931471805599453
super-infections,2,0.6931471805599453
HAuCl4,2,0.6931471805599453
Gradient-echo,2,0.6931471805599453
chill,2,0.6931471805599453
FT3,2,0.6931471805599453
hips,2,0.6931471805599453
Rodent,2,0.6931471805599453
BVictoria-lineage,2,0.6931471805599453
pseudocyst,2,0.6931471805599453
14-yr-old,2,0.6931471805599453
liberties,2,0.6931471805599453
seronegativation,2,0.6931471805599453
tractography,2,0.6931471805599453
CPLNI,2,0.6931471805599453
feather,2,0.6931471805599453
Reverse-Transcription,2,0.6931471805599453
13426,2,0.6931471805599453
4373,2,0.6931471805599453
ascribe,2,0.6931471805599453
Renin,2,0.6931471805599453
91-99,2,0.6931471805599453
birthplace,2,0.6931471805599453
subsistence,2,0.6931471805599453
Neurosurgical,2,0.6931471805599453
WAO,2,0.6931471805599453
reperfusion-associated,2,0.6931471805599453
Minimally,2,0.6931471805599453
centromedian,2,0.6931471805599453
thalamotomy,2,0.6931471805599453
commenting,2,0.6931471805599453
recNL602-I223R,2,0.6931471805599453
preS,2,0.6931471805599453
compliment,2,0.6931471805599453
experimentations,2,0.6931471805599453
Croup,2,0.6931471805599453
post-market,2,0.6931471805599453
4359,2,0.6931471805599453
near-universal,2,0.6931471805599453
customers,2,0.6931471805599453
precipitins,2,0.6931471805599453
non-intervention,2,0.6931471805599453
QA,2,0.6931471805599453
reconditioning,2,0.6931471805599453
2-high,2,0.6931471805599453
Pupils,2,0.6931471805599453
PCR1100,2,0.6931471805599453
whole-school,2,0.6931471805599453
non-AA,2,0.6931471805599453
MRFIT,2,0.6931471805599453
paramivir,2,0.6931471805599453
onoff,2,0.6931471805599453
Susceptible-Exposed-Infected-Recovered,2,0.6931471805599453
Kissler,2,0.6931471805599453
disbalanced,2,0.6931471805599453
Czapek,2,0.6931471805599453
EDPRV,2,0.6931471805599453
circumventricular,2,0.6931471805599453
ATTP,2,0.6931471805599453
Lithuanian,2,0.6931471805599453
On-site,2,0.6931471805599453
pyrazinamide,2,0.6931471805599453
59000,2,0.6931471805599453
Parish,2,0.6931471805599453
52-month,2,0.6931471805599453
9403,2,0.6931471805599453
Na3Ct,2,0.6931471805599453
7729,2,0.6931471805599453
neuropsychiatry,2,0.6931471805599453
firmus,2,0.6931471805599453
intratracheally,2,0.6931471805599453
4A8,2,0.6931471805599453
congresses,2,0.6931471805599453
Patho,2,0.6931471805599453
LabGun,2,0.6931471805599453
bioelectronics,2,0.6931471805599453
beta-adrenoceptors,2,0.6931471805599453
liquefactive,2,0.6931471805599453
Chiapas,2,0.6931471805599453
pre-adolescent,2,0.6931471805599453
non-CIB,2,0.6931471805599453
catch-up,2,0.6931471805599453
Crucially,2,0.6931471805599453
volume-overload,2,0.6931471805599453
TdC,2,0.6931471805599453
NSP5,2,0.6931471805599453
anxious-depressive,2,0.6931471805599453
1102,2,0.6931471805599453
non-PCM,2,0.6931471805599453
mid-1960s,2,0.6931471805599453
downsides,2,0.6931471805599453
divisive,2,0.6931471805599453
FnCas9,2,0.6931471805599453
2305,2,0.6931471805599453
μL-1,2,0.6931471805599453
woke,2,0.6931471805599453
OM-85,2,0.6931471805599453
0661,2,0.6931471805599453
frontal-subcortical,2,0.6931471805599453
FokI,2,0.6931471805599453
ApaI,2,0.6931471805599453
dTM,2,0.6931471805599453
TaqI,2,0.6931471805599453
institutionalisation,2,0.6931471805599453
-42,2,0.6931471805599453
host-gene,2,0.6931471805599453
precisions,2,0.6931471805599453
Potentials,2,0.6931471805599453
-first,2,0.6931471805599453
regains,2,0.6931471805599453
4110,2,0.6931471805599453
Inhalative,2,0.6931471805599453
-related,2,0.6931471805599453
2737,2,0.6931471805599453
2601,2,0.6931471805599453
magnetoencephalography,2,0.6931471805599453
EBCA,2,0.6931471805599453
SDQ,2,0.6931471805599453
HArS,2,0.6931471805599453
one-sixth,2,0.6931471805599453
CYP4A11,2,0.6931471805599453
antihypoxic,2,0.6931471805599453
Qr,2,0.6931471805599453
hypertension-related,2,0.6931471805599453
α-tocopherol,2,0.6931471805599453
assimilated,2,0.6931471805599453
TGVp,2,0.6931471805599453
sediment,2,0.6931471805599453
-107,2,0.6931471805599453
Maybe,2,0.6931471805599453
remifentanil,2,0.6931471805599453
toxemia,2,0.6931471805599453
Jugular,2,0.6931471805599453
neuro,2,0.6931471805599453
mms,2,0.6931471805599453
dietitians,2,0.6931471805599453
UHF,2,0.6931471805599453
leishmaniasis,2,0.6931471805599453
TRIzol,2,0.6931471805599453
1601-1609,2,0.6931471805599453
16240,2,0.6931471805599453
nucleic-acid,2,0.6931471805599453
Chamber,2,0.6931471805599453
non-monotonic,2,0.6931471805599453
Coumadin,2,0.6931471805599453
WHA,2,0.6931471805599453
EU-25,2,0.6931471805599453
full-thickness,2,0.6931471805599453
1045,2,0.6931471805599453
tonsillar,2,0.6931471805599453
7th-10th,2,0.6931471805599453
orificium,2,0.6931471805599453
730000,2,0.6931471805599453
POC-test,2,0.6931471805599453
Drop,2,0.6931471805599453
Impulsive,2,0.6931471805599453
nephritis,2,0.6931471805599453
latissimus,2,0.6931471805599453
Multinomial,2,0.6931471805599453
noncore,2,0.6931471805599453
11-22,2,0.6931471805599453
Liberal,2,0.6931471805599453
Micro,2,0.6931471805599453
late-entry,2,0.6931471805599453
LPVs,2,0.6931471805599453
QLD15172021,2,0.6931471805599453
subdividing,2,0.6931471805599453
anatomists,2,0.6931471805599453
fascial,2,0.6931471805599453
slogan,2,0.6931471805599453
well-nourished,2,0.6931471805599453
memory-guided,2,0.6931471805599453
nubuck,2,0.6931471805599453
additive-coated,2,0.6931471805599453
MVC,2,0.6931471805599453
uncoated,2,0.6931471805599453
5-s,2,0.6931471805599453
meshes,2,0.6931471805599453
Leys,2,0.6931471805599453
steadier,2,0.6931471805599453
Werner,2,0.6931471805599453
chairman,2,0.6931471805599453
Divergent,2,0.6931471805599453
Biosecurity,2,0.6931471805599453
Spices,2,0.6931471805599453
PDCA,2,0.6931471805599453
Hyperinflammation,2,0.6931471805599453
fishbone,2,0.6931471805599453
Pound,2,0.6931471805599453
Gris,2,0.6931471805599453
dorsi,2,0.6931471805599453
Sensation,2,0.6931471805599453
4-17,2,0.6931471805599453
P-max,2,0.6931471805599453
anti-2019-nCoV,2,0.6931471805599453
shipments,2,0.6931471805599453
Arguably,2,0.6931471805599453
emulate,2,0.6931471805599453
pandemias,2,0.6931471805599453
sanatoria,2,0.6931471805599453
clinico-functional,2,0.6931471805599453
állapot,2,0.6931471805599453
uncharted,2,0.6931471805599453
Apache,2,0.6931471805599453
Pathophysiologically,2,0.6931471805599453
eco-environmental,2,0.6931471805599453
Co-occurrence,2,0.6931471805599453
unsupported,2,0.6931471805599453
Wildfire,2,0.6931471805599453
SAPS,2,0.6931471805599453
Breathmobile,2,0.6931471805599453
Budget,2,0.6931471805599453
KTx,2,0.6931471805599453
intercepts,2,0.6931471805599453
stroke-beteg,2,0.6931471805599453
conflated,2,0.6931471805599453
Proactive,2,0.6931471805599453
High-,2,0.6931471805599453
LF-rTMS,2,0.6931471805599453
absorptiometry,2,0.6931471805599453
72h,2,0.6931471805599453
63±2,2,0.6931471805599453
microvesicles,2,0.6931471805599453
energia-,2,0.6931471805599453
verdicts,2,0.6931471805599453
conjures,2,0.6931471805599453
allegation,2,0.6931471805599453
Na⁺,2,0.6931471805599453
telocyte,2,0.6931471805599453
plaintiff,2,0.6931471805599453
K⁺,2,0.6931471805599453
broach,2,0.6931471805599453
Cl⁻,2,0.6931471805599453
post-coronavirus,2,0.6931471805599453
microplates,2,0.6931471805599453
6109,2,0.6931471805599453
CVID,2,0.6931471805599453
2138,2,0.6931471805599453
1597,2,0.6931471805599453
SARS-CoV-2virus,2,0.6931471805599453
1584,2,0.6931471805599453
9796,2,0.6931471805599453
Allegations,2,0.6931471805599453
hyperchloredemia,2,0.6931471805599453
fMLP,2,0.6931471805599453
tápanyagbeviteli,2,0.6931471805599453
1323,2,0.6931471805599453
5560,2,0.6931471805599453
p025,2,0.6931471805599453
isoetharine,2,0.6931471805599453
mass-spectrometry-based,2,0.6931471805599453
bereaved,2,0.6931471805599453
SADP,2,0.6931471805599453
IDVet,2,0.6931471805599453
stamp,2,0.6931471805599453
reparation,2,0.6931471805599453
RII,2,0.6931471805599453
Adiponectin,2,0.6931471805599453
multi-agent,2,0.6931471805599453
BMC-derived,2,0.6931471805599453
cytopenias,2,0.6931471805599453
locked-in,2,0.6931471805599453
7-11,2,0.6931471805599453
adrenalectomy,2,0.6931471805599453
epicutaneous,2,0.6931471805599453
non-MENA,2,0.6931471805599453
XPAD3,2,0.6931471805599453
Concept,2,0.6931471805599453
3122,2,0.6931471805599453
Epworth,2,0.6931471805599453
thrombolysis-treated,2,0.6931471805599453
subscores,2,0.6931471805599453
Swinefords,2,0.6931471805599453
ith,2,0.6931471805599453
HeartWare,2,0.6931471805599453
9444,2,0.6931471805599453
CFAOS,2,0.6931471805599453
mite-induced,2,0.6931471805599453
Extract,2,0.6931471805599453
voluminous,2,0.6931471805599453
patently,2,0.6931471805599453
hypoxanthine,2,0.6931471805599453
revisiting,2,0.6931471805599453
Self-rated,2,0.6931471805599453
phenylalanine,2,0.6931471805599453
directionally,2,0.6931471805599453
TGVm,2,0.6931471805599453
CMEAnswers,2,0.6931471805599453
geneticists,2,0.6931471805599453
mechanism-based,2,0.6931471805599453
Sensing,2,0.6931471805599453
Ignoring,2,0.6931471805599453
reorganises,2,0.6931471805599453
Stabilization,2,0.6931471805599453
34840,2,0.6931471805599453
polypectomy,2,0.6931471805599453
phenotype-,2,0.6931471805599453
brush,2,0.6931471805599453
deep-sequenced,2,0.6931471805599453
NPFS,2,0.6931471805599453
immune-escape,2,0.6931471805599453
segregate,2,0.6931471805599453
Planar,2,0.6931471805599453
Automation,2,0.6931471805599453
AIF,2,0.6931471805599453
helpless,2,0.6931471805599453
Respirator,2,0.6931471805599453
Contemporaneous,2,0.6931471805599453
SWCM,2,0.6931471805599453
11-35,2,0.6931471805599453
oozing-type,2,0.6931471805599453
Sudan,2,0.6931471805599453
self-administer,2,0.6931471805599453
6986,2,0.6931471805599453
micro-strokes,2,0.6931471805599453
simple-to-use,2,0.6931471805599453
antigen-capture,2,0.6931471805599453
094-099,2,0.6931471805599453
non-malignant,2,0.6931471805599453
glutathione-ratio,2,0.6931471805599453
BMP-7-treated,2,0.6931471805599453
saline-treated,2,0.6931471805599453
five-,2,0.6931471805599453
disease-relevant,2,0.6931471805599453
adamantine,2,0.6931471805599453
Coexistence,2,0.6931471805599453
Person-to-person,2,0.6931471805599453
MTA,2,0.6931471805599453
aPL-,2,0.6931471805599453
Sneddons,2,0.6931471805599453
inflate,2,0.6931471805599453
Pfizer-BioNtech,2,0.6931471805599453
uncertain-AMI,2,0.6931471805599453
re-randomized,2,0.6931471805599453
Léa,2,0.6931471805599453
LMCAA,2,0.6931471805599453
198687,2,0.6931471805599453
pervasiveness,2,0.6931471805599453
unveils,2,0.6931471805599453
Preferential,2,0.6931471805599453
menses,2,0.6931471805599453
Proteinase,2,0.6931471805599453
58-80,2,0.6931471805599453
Left-sided,2,0.6931471805599453
non-tuberculous,2,0.6931471805599453
ChAd-primed,2,0.6931471805599453
Tabriz,2,0.6931471805599453
LRG1,2,0.6931471805599453
CCDs,2,0.6931471805599453
VAT,2,0.6931471805599453
sub-cohort,2,0.6931471805599453
backbones,2,0.6931471805599453
baculovirus-insect,2,0.6931471805599453
retractor,2,0.6931471805599453
Eliza,2,0.6931471805599453
J-hook,2,0.6931471805599453
Secretion,2,0.6931471805599453
ornamental,2,0.6931471805599453
beta-lactamase,2,0.6931471805599453
Clues,2,0.6931471805599453
BG,2,0.6931471805599453
swiftness,2,0.6931471805599453
Macao,2,0.6931471805599453
isomerase,2,0.6931471805599453
CVVs,2,0.6931471805599453
1258,2,0.6931471805599453
antidualist,2,0.6931471805599453
Benner,2,0.6931471805599453
civilians,2,0.6931471805599453
room-based,2,0.6931471805599453
MCF,2,0.6931471805599453
M4-5,2,0.6931471805599453
room-visiting,2,0.6931471805599453
broiler,2,0.6931471805599453
M0,2,0.6931471805599453
3259,2,0.6931471805599453
anti-H5N1,2,0.6931471805599453
pandemic-preparedness,2,0.6931471805599453
NCT02414854,2,0.6931471805599453
CIPOMO,2,0.6931471805599453
undervalued,2,0.6931471805599453
boredom,2,0.6931471805599453
V-01,2,0.6931471805599453
nonreceipt,2,0.6931471805599453
nine-segment,2,0.6931471805599453
haulers,2,0.6931471805599453
symptoms-the,2,0.6931471805599453
personalisation,2,0.6931471805599453
LAAS,2,0.6931471805599453
unconvincing,2,0.6931471805599453
3283,2,0.6931471805599453
2262,2,0.6931471805599453
LIBERTY,2,0.6931471805599453
Tien,2,0.6931471805599453
age-sex-matched,2,0.6931471805599453
Chuan,2,0.6931471805599453
60-85,2,0.6931471805599453
stat,2,0.6931471805599453
beatsminute,2,0.6931471805599453
Qualified,2,0.6931471805599453
011-084,2,0.6931471805599453
acid-challenged,2,0.6931471805599453
HINTS-plus,2,0.6931471805599453
well-conserved,2,0.6931471805599453
-Örebro,2,0.6931471805599453
narration,2,0.6931471805599453
SROC,2,0.6931471805599453
Simplifying,2,0.6931471805599453
non-major,2,0.6931471805599453
vagaries,2,0.6931471805599453
Doubled,2,0.6931471805599453
cassettes,2,0.6931471805599453
ofpecilomycotic,2,0.6931471805599453
morphofunctional,2,0.6931471805599453
pecilomycosis,2,0.6931471805599453
no-touch,2,0.6931471805599453
arguable,2,0.6931471805599453
hydrokinesitherapy,2,0.6931471805599453
Paecilomyces,2,0.6931471805599453
Lobar,2,0.6931471805599453
clouds,2,0.6931471805599453
Nonstructural,2,0.6931471805599453
nucleolar,2,0.6931471805599453
academy,2,0.6931471805599453
psycho-educational,2,0.6931471805599453
genotype-phenotype,2,0.6931471805599453
proteomics-based,2,0.6931471805599453
throatnasal,2,0.6931471805599453
2582,2,0.6931471805599453
doxepin,2,0.6931471805599453
bioaffinity,2,0.6931471805599453
cultivable,2,0.6931471805599453
defected,2,0.6931471805599453
MRIs,2,0.6931471805599453
Grafting,2,0.6931471805599453
CS-dependent,2,0.6931471805599453
2001-2014,2,0.6931471805599453
palpation,2,0.6931471805599453
lacunar-type,2,0.6931471805599453
gliosis,2,0.6931471805599453
managementtreatment,2,0.6931471805599453
TSCs,2,0.6931471805599453
RMSIP,2,0.6931471805599453
LVSWI,2,0.6931471805599453
conjunctive,2,0.6931471805599453
ASONs,2,0.6931471805599453
RASON,2,0.6931471805599453
MW05,2,0.6931471805599453
2080,2,0.6931471805599453
3145,2,0.6931471805599453
snare,2,0.6931471805599453
practice-level,2,0.6931471805599453
vaccinationMethods,2,0.6931471805599453
29-33,2,0.6931471805599453
downgrading,2,0.6931471805599453
RASONs,2,0.6931471805599453
Pump,2,0.6931471805599453
July-September,2,0.6931471805599453
5865,2,0.6931471805599453
Suwon,2,0.6931471805599453
CDTI,2,0.6931471805599453
Prediabetes,2,0.6931471805599453
cater,2,0.6931471805599453
divisional,2,0.6931471805599453
CCCs,2,0.6931471805599453
homologues,2,0.6931471805599453
24H,2,0.6931471805599453
BPM,2,0.6931471805599453
5years,2,0.6931471805599453
membranaceous,2,0.6931471805599453
UCBA,2,0.6931471805599453
valproate,2,0.6931471805599453
Consonant,2,0.6931471805599453
GABAergic,2,0.6931471805599453
underinsured,2,0.6931471805599453
④,2,0.6931471805599453
imaging-derived,2,0.6931471805599453
③,2,0.6931471805599453
ethnicity-related,2,0.6931471805599453
097-100,2,0.6931471805599453
rS,2,0.6931471805599453
re-infarctions,2,0.6931471805599453
②,2,0.6931471805599453
①,2,0.6931471805599453
abut,2,0.6931471805599453
abutting,2,0.6931471805599453
Biodefense,2,0.6931471805599453
subcommittees,2,0.6931471805599453
Veloergometry,2,0.6931471805599453
four-factor,2,0.6931471805599453
tenable,2,0.6931471805599453
Nigella,2,0.6931471805599453
sativa,2,0.6931471805599453
nonsedating,2,0.6931471805599453
15min,2,0.6931471805599453
unquestioned,2,0.6931471805599453
cancer-specific,2,0.6931471805599453
regularization,2,0.6931471805599453
perceptron,2,0.6931471805599453
anthracis,2,0.6931471805599453
in-center,2,0.6931471805599453
SAHPRA,2,0.6931471805599453
Boson,2,0.6931471805599453
correlograms,2,0.6931471805599453
educates,2,0.6931471805599453
ChI,2,0.6931471805599453
nők,2,0.6931471805599453
così,2,0.6931471805599453
nCil,2,0.6931471805599453
pretraining,2,0.6931471805599453
DAO,2,0.6931471805599453
championship,2,0.6931471805599453
fifty-nine,2,0.6931471805599453
utánkövetés,2,0.6931471805599453
gyakoribb,2,0.6931471805599453
reopenings,2,0.6931471805599453
beavatkozás,2,0.6931471805599453
vRNAs,2,0.6931471805599453
LCSC,2,0.6931471805599453
32-point,2,0.6931471805599453
régiókban,2,0.6931471805599453
Közép-Magyarország,2,0.6931471805599453
CRO-VAX,2,0.6931471805599453
speculating,2,0.6931471805599453
E484KN501Y,2,0.6931471805599453
Credible,2,0.6931471805599453
anti-NTD,2,0.6931471805599453
242-244Δ,2,0.6931471805599453
össze,2,0.6931471805599453
Milano,2,0.6931471805599453
2-family,2,0.6931471805599453
GOS,2,0.6931471805599453
BSMMU,2,0.6931471805599453
pathophysiology-based,2,0.6931471805599453
Mantel,2,0.6931471805599453
FNAB,2,0.6931471805599453
Pol,2,0.6931471805599453
assiduous,2,0.6931471805599453
Video-oculography,2,0.6931471805599453
DIP,2,0.6931471805599453
sIgG4,2,0.6931471805599453
Saud,2,0.6931471805599453
non-vaccine-controlled,2,0.6931471805599453
Privacy,2,0.6931471805599453
vaccine-controlled,2,0.6931471805599453
semi-automatic,2,0.6931471805599453
one-ported,2,0.6931471805599453
airspaces,2,0.6931471805599453
FARI,2,0.6931471805599453
handicaps,2,0.6931471805599453
Abbotts,2,0.6931471805599453
Engineered,2,0.6931471805599453
Longa,2,0.6931471805599453
adsorption-direct,2,0.6931471805599453
inhabit,2,0.6931471805599453
organotropism,2,0.6931471805599453
catechin,2,0.6931471805599453
cortico,2,0.6931471805599453
Yamanashi,2,0.6931471805599453
dissimilarity,2,0.6931471805599453
illetve,2,0.6931471805599453
avvenimenti,2,0.6931471805599453
K417NE484KN501Y,2,0.6931471805599453
RBD-subunit,2,0.6931471805599453
Biosynex,2,0.6931471805599453
Bunge,2,0.6931471805599453
Córdoba,2,0.6931471805599453
vaccinesdrugs,2,0.6931471805599453
tissueorgan,2,0.6931471805599453
magyarországi,2,0.6931471805599453
fatalistic,2,0.6931471805599453
misused,2,0.6931471805599453
stifle,2,0.6931471805599453
Qinhuangdao,2,0.6931471805599453
imperfections,2,0.6931471805599453
paraventricular,2,0.6931471805599453
SARs,2,0.6931471805599453
bisoprolol,2,0.6931471805599453
Infarktus,2,0.6931471805599453
Magyar,2,0.6931471805599453
kutatás,2,0.6931471805599453
recombined,2,0.6931471805599453
Anoop,2,0.6931471805599453
underassessed,2,0.6931471805599453
interposed,2,0.6931471805599453
2-wk,2,0.6931471805599453
Shah,2,0.6931471805599453
2007-2014,2,0.6931471805599453
tangential,2,0.6931471805599453
autoantigens,2,0.6931471805599453
regionális,2,0.6931471805599453
kezelt,2,0.6931471805599453
expander,2,0.6931471805599453
IFVB,2,0.6931471805599453
Szívinfarktus,2,0.6931471805599453
CD3CD1656,2,0.6931471805599453
Sloan-Kettering,2,0.6931471805599453
szerint,2,0.6931471805599453
Productive,2,0.6931471805599453
cellulo,2,0.6931471805599453
On-going,2,0.6931471805599453
groceries,2,0.6931471805599453
Shortness,2,0.6931471805599453
SJ,2,0.6931471805599453
nagyrégiók,2,0.6931471805599453
adatok,2,0.6931471805599453
Blueprint,2,0.6931471805599453
átesett,2,0.6931471805599453
infarctuson,2,0.6931471805599453
myocardialis,2,0.6931471805599453
denominators,2,0.6931471805599453
warehousing,2,0.6931471805599453
CY5,2,0.6931471805599453
nortriptyline,2,0.6931471805599453
egészségügyi,2,0.6931471805599453
overshadow,2,0.6931471805599453
PMMV,2,0.6931471805599453
methylphenidate,2,0.6931471805599453
rewarmed,2,0.6931471805599453
anti-SARS-CoV-2-antibodies,2,0.6931471805599453
young-onset,2,0.6931471805599453
részvételével,2,0.6931471805599453
CORONAPEP,2,0.6931471805599453
tolerates,2,0.6931471805599453
Disturbance,2,0.6931471805599453
05-25,2,0.6931471805599453
modern-day,2,0.6931471805599453
ans,2,0.6931471805599453
PICTs,2,0.6931471805599453
non-fitting,2,0.6931471805599453
RHRSP,2,0.6931471805599453
Nelfinavir,2,0.6931471805599453
relapsing-remitting,2,0.6931471805599453
Teicoplanin,2,0.6931471805599453
1945,2,0.6931471805599453
non-classical,2,0.6931471805599453
diphenhydramine,2,0.6931471805599453
Churchill,2,0.6931471805599453
Crimea,2,0.6931471805599453
Reform,2,0.6931471805599453
Gynaecologists,2,0.6931471805599453
post-World,2,0.6931471805599453
neuropathogenesis,2,0.6931471805599453
allergy-immunology,2,0.6931471805599453
SERPINB2,2,0.6931471805599453
B3,2,0.6931471805599453
WWII,2,0.6931471805599453
single-marker,2,0.6931471805599453
5507,2,0.6931471805599453
pain-causing,2,0.6931471805599453
faeco-oral,2,0.6931471805599453
resign,2,0.6931471805599453
well-selected,2,0.6931471805599453
Tenth,2,0.6931471805599453
VEMPs,2,0.6931471805599453
geostatistical,2,0.6931471805599453
log-normal,2,0.6931471805599453
06-09,2,0.6931471805599453
inflammatoryoxidative,2,0.6931471805599453
LCAIVs,2,0.6931471805599453
FLU-A,2,0.6931471805599453
Gestational,2,0.6931471805599453
DHCP,2,0.6931471805599453
Person,2,0.6931471805599453
Single-center,2,0.6931471805599453
early-vaccinated,2,0.6931471805599453
subcontinent,2,0.6931471805599453
phagocytosed,2,0.6931471805599453
caspase-dependent,2,0.6931471805599453
CMOS,2,0.6931471805599453
nitride,2,0.6931471805599453
spliceosome,2,0.6931471805599453
ribosome,2,0.6931471805599453
resonator,2,0.6931471805599453
ValMet,2,0.6931471805599453
micropillar,2,0.6931471805599453
Network-based,2,0.6931471805599453
single-level,2,0.6931471805599453
gadolinium-diethylenetriaminepentaacetic,2,0.6931471805599453
TMT-isobaric,2,0.6931471805599453
TIMPs,2,0.6931471805599453
clerical,2,0.6931471805599453
latrine,2,0.6931471805599453
Stingray™,2,0.6931471805599453
Carmichael,2,0.6931471805599453
Celastrol,2,0.6931471805599453
post-MT,2,0.6931471805599453
REGISTRATIONClinicalTrialsgov,2,0.6931471805599453
BCoM,2,0.6931471805599453
≥375°C,2,0.6931471805599453
Subendocardial,2,0.6931471805599453
Pyrexia,2,0.6931471805599453
mlming,2,0.6931471805599453
01ABSTRACT,2,0.6931471805599453
AVictoria208-clade,2,0.6931471805599453
cefuroxime,2,0.6931471805599453
2250,2,0.6931471805599453
invisibility,2,0.6931471805599453
antibacterials,2,0.6931471805599453
DDD,2,0.6931471805599453
racialized,2,0.6931471805599453
DDDs,2,0.6931471805599453
0299,2,0.6931471805599453
response-dose,2,0.6931471805599453
LLLI,2,0.6931471805599453
Dirichlet,2,0.6931471805599453
Killed,2,0.6931471805599453
reignited,2,0.6931471805599453
flow-independent,2,0.6931471805599453
hashtags,2,0.6931471805599453
non-tracheal,2,0.6931471805599453
non-immunologic,2,0.6931471805599453
SL-GXT,2,0.6931471805599453
sars-cov-2,2,0.6931471805599453
AlCl3,2,0.6931471805599453
Recalcati,2,0.6931471805599453
Shan,2,0.6931471805599453
Hgs,2,0.6931471805599453
cooperatively,2,0.6931471805599453
thoracoplasty,2,0.6931471805599453
biotherapeutic,2,0.6931471805599453
DT-MRI,2,0.6931471805599453
nondestructive,2,0.6931471805599453
complies,2,0.6931471805599453
not-well,2,0.6931471805599453
14-October,2,0.6931471805599453
PCNA,2,0.6931471805599453
TaqPathTM,2,0.6931471805599453
grandmother,2,0.6931471805599453
underrecognition,2,0.6931471805599453
nanopopcorn,2,0.6931471805599453
grapples,2,0.6931471805599453
β-alanyl-L-histidine,2,0.6931471805599453
Forel,2,0.6931471805599453
Auguste,2,0.6931471805599453
LPG,2,0.6931471805599453
aptasensor,2,0.6931471805599453
neutrophills,2,0.6931471805599453
αVβ3,2,0.6931471805599453
Integrin,2,0.6931471805599453
painted,2,0.6931471805599453
Kokoschka,2,0.6931471805599453
Z0IT,2,0.6931471805599453
connotation,2,0.6931471805599453
TFCTT,2,0.6931471805599453
neurorehabilitative,2,0.6931471805599453
re-hospitalizations,2,0.6931471805599453
bibasilar,2,0.6931471805599453
pendular,2,0.6931471805599453
Md,2,0.6931471805599453
paucimicronic,2,0.6931471805599453
FPV,2,0.6931471805599453
dosaged,2,0.6931471805599453
apices,2,0.6931471805599453
head-velocity,2,0.6931471805599453
papulovesicular,2,0.6931471805599453
LV-WMAI,2,0.6931471805599453
OPGTRAIL,2,0.6931471805599453
bronchoscope,2,0.6931471805599453
Creation,2,0.6931471805599453
pair-approximation,2,0.6931471805599453
RANK,2,0.6931471805599453
osteoclasts,2,0.6931471805599453
S-transferases,2,0.6931471805599453
Wellenss,2,0.6931471805599453
AWyoming32003,2,0.6931471805599453
Shizuoka,2,0.6931471805599453
refugee,2,0.6931471805599453
Linjudge,2,0.6931471805599453
FluApdm,2,0.6931471805599453
Bhutanese,2,0.6931471805599453
Seihoku,2,0.6931471805599453
Chunan,2,0.6931471805599453
arthropathy,2,0.6931471805599453
Montgomery,2,0.6931471805599453
RT-PCT,2,0.6931471805599453
dignitary,2,0.6931471805599453
1287,2,0.6931471805599453
angiotensin-1-converting,2,0.6931471805599453
haematopoiesis,2,0.6931471805599453
proportional-hazard,2,0.6931471805599453
105-170,2,0.6931471805599453
emphatically,2,0.6931471805599453
Wagga,2,0.6931471805599453
Napoli,2,0.6931471805599453
H7N1,2,0.6931471805599453
prevalently,2,0.6931471805599453
insulin-mediated,2,0.6931471805599453
inflammation-induced,2,0.6931471805599453
dl-1,2,0.6931471805599453
Infecting,2,0.6931471805599453
0325,2,0.6931471805599453
introducer,2,0.6931471805599453
clemastine,2,0.6931471805599453
exchangeable,2,0.6931471805599453
OSE,2,0.6931471805599453
I20,2,0.6931471805599453
bestowed,2,0.6931471805599453
SARS2,2,0.6931471805599453
SARS2-S,2,0.6931471805599453
MMT,2,0.6931471805599453
HBOCs,2,0.6931471805599453
1343,2,0.6931471805599453
PC-LDA,2,0.6931471805599453
HBOC,2,0.6931471805599453
infarctionIn,2,0.6931471805599453
4210,2,0.6931471805599453
intermedia,2,0.6931471805599453
externalities,2,0.6931471805599453
commodity,2,0.6931471805599453
Prinzmetal,2,0.6931471805599453
WISC-III,2,0.6931471805599453
gyms,2,0.6931471805599453
PAC-PB1N,2,0.6931471805599453
SARA,2,0.6931471805599453
12a,2,0.6931471805599453
SPD,2,0.6931471805599453
Prasugrel,2,0.6931471805599453
Ticagrelor,2,0.6931471805599453
1569,2,0.6931471805599453
validities,2,0.6931471805599453
CH25H,2,0.6931471805599453
63·3,2,0.6931471805599453
P0·001,2,0.6931471805599453
3C2a1,2,0.6931471805599453
halothane,2,0.6931471805599453
HSCs,2,0.6931471805599453
wheezing-related,2,0.6931471805599453
dystrophies,2,0.6931471805599453
73·8,2,0.6931471805599453
nonhomogeneous,2,0.6931471805599453
Baxter,2,0.6931471805599453
T705,2,0.6931471805599453
Tyumen,2,0.6931471805599453
CD3E,2,0.6931471805599453
DAS181,2,0.6931471805599453
CD3G,2,0.6931471805599453
Molecularly,2,0.6931471805599453
nonventilated,2,0.6931471805599453
Prima,2,0.6931471805599453
submicron,2,0.6931471805599453
test-trace-isolate,2,0.6931471805599453
Q-UEL,2,0.6931471805599453
00018,2,0.6931471805599453
utilises,2,0.6931471805599453
3057,2,0.6931471805599453
diathermy,2,0.6931471805599453
Right-sided,2,0.6931471805599453
eight-year-old,2,0.6931471805599453
workplace-associated,2,0.6931471805599453
Myopathy,2,0.6931471805599453
amd,2,0.6931471805599453
troponin-T,2,0.6931471805599453
hemangioendothelioma,2,0.6931471805599453
BTN162b2,2,0.6931471805599453
maoto,2,0.6931471805599453
Echinacea,2,0.6931471805599453
enumerates,2,0.6931471805599453
Encouraging,2,0.6931471805599453
ICS-treated,2,0.6931471805599453
Shao,2,0.6931471805599453
hospitalizations2,2,0.6931471805599453
Alkaline,2,0.6931471805599453
Endothelins,2,0.6931471805599453
testings,2,0.6931471805599453
Earthing,2,0.6931471805599453
misclassifications,2,0.6931471805599453
-0104,2,0.6931471805599453
Inhalers,2,0.6931471805599453
immunophenotyping,2,0.6931471805599453
Senior,2,0.6931471805599453
co-cultures,2,0.6931471805599453
gavage,2,0.6931471805599453
-008,2,0.6931471805599453
cardio-cerebral,2,0.6931471805599453
1181,2,0.6931471805599453
panning,2,0.6931471805599453
Recognising,2,0.6931471805599453
distort,2,0.6931471805599453
3298,2,0.6931471805599453
Interfering,2,0.6931471805599453
SARS‐CoV‐1,2,0.6931471805599453
2-skewed,2,0.6931471805599453
13-64,2,0.6931471805599453
RAPIDS,2,0.6931471805599453
Rudnick,2,0.6931471805599453
nurse-administered,2,0.6931471805599453
wait-list,2,0.6931471805599453
61-year,2,0.6931471805599453
resorbed,2,0.6931471805599453
unprofessional,2,0.6931471805599453
10-9,2,0.6931471805599453
antianxiety,2,0.6931471805599453
surface-to-volume,2,0.6931471805599453
Tube,2,0.6931471805599453
quanta,2,0.6931471805599453
acceptanceResults,2,0.6931471805599453
Binary,2,0.6931471805599453
preprinted,2,0.6931471805599453
intra-rater,2,0.6931471805599453
SIREN,2,0.6931471805599453
high-school,2,0.6931471805599453
Medica,2,0.6931471805599453
parent-adolescent,2,0.6931471805599453
tetramerization,2,0.6931471805599453
Ayurveda,2,0.6931471805599453
μl-1,2,0.6931471805599453
Co-Diagnostics,2,0.6931471805599453
BSL2,2,0.6931471805599453
CCL81,2,0.6931471805599453
testABSTRACT,2,0.6931471805599453
Phone,2,0.6931471805599453
Métis,2,0.6931471805599453
Antagonist,2,0.6931471805599453
Ciba,2,0.6931471805599453
over-activation,2,0.6931471805599453
GV150526,2,0.6931471805599453
Gavestinel,2,0.6931471805599453
D8,2,0.6931471805599453
self-ratings,2,0.6931471805599453
MI-associated,2,0.6931471805599453
lobby,2,0.6931471805599453
Azygos,2,0.6931471805599453
eventspatients,2,0.6931471805599453
multivariant,2,0.6931471805599453
VFWR,2,0.6931471805599453
Nihon,2,0.6931471805599453
para-aortic,2,0.6931471805599453
open-platform,2,0.6931471805599453
whereof,2,0.6931471805599453
Manhattan,2,0.6931471805599453
multiwave,2,0.6931471805599453
pre-trial,2,0.6931471805599453
Sustained-release,2,0.6931471805599453
tetrameric,2,0.6931471805599453
microwave-based,2,0.6931471805599453
cannabinoid,2,0.6931471805599453
Multi-vessel,2,0.6931471805599453
humidities,2,0.6931471805599453
leukocytopenia,2,0.6931471805599453
speckled,2,0.6931471805599453
Mino,2,0.6931471805599453
4-15,2,0.6931471805599453
well-organised,2,0.6931471805599453
sinopulmonary,2,0.6931471805599453
ALTE,2,0.6931471805599453
low-normal,2,0.6931471805599453
atoms,2,0.6931471805599453
81-year-old,2,0.6931471805599453
Vectorcardiographic,2,0.6931471805599453
crystallized,2,0.6931471805599453
pernio-like,2,0.6931471805599453
ADAPTE,2,0.6931471805599453
streptococci,2,0.6931471805599453
webservers,2,0.6931471805599453
quinolones,2,0.6931471805599453
Ready,2,0.6931471805599453
disbelief,2,0.6931471805599453
progressors,2,0.6931471805599453
Commissions,2,0.6931471805599453
myelinated,2,0.6931471805599453
averts,2,0.6931471805599453
httpbiszjueducnovercovid,2,0.6931471805599453
Angel,2,0.6931471805599453
CPMV,2,0.6931471805599453
IL-1b,2,0.6931471805599453
25-27,2,0.6931471805599453
Inter,2,0.6931471805599453
thermocycling,2,0.6931471805599453
compassion,2,0.6931471805599453
CB1,2,0.6931471805599453
CB2,2,0.6931471805599453
chemoreflex,2,0.6931471805599453
Complication,2,0.6931471805599453
dyscirculatory,2,0.6931471805599453
non-homologous,2,0.6931471805599453
His164,2,0.6931471805599453
∼99,2,0.6931471805599453
VEMSCV,2,0.6931471805599453
invoking,2,0.6931471805599453
severeness,2,0.6931471805599453
subgrouped,2,0.6931471805599453
urbanizing,2,0.6931471805599453
Spikevax,2,0.6931471805599453
fibrillating,2,0.6931471805599453
plug-and-play,2,0.6931471805599453
Emboli,2,0.6931471805599453
1411,2,0.6931471805599453
EE-dependent,2,0.6931471805599453
plume,2,0.6931471805599453
non-high,2,0.6931471805599453
3103,2,0.6931471805599453
Lowen,2,0.6931471805599453
redox-sensitive,2,0.6931471805599453
2019nCoVAS,2,0.6931471805599453
HDAC-2,2,0.6931471805599453
post-diagnosis,2,0.6931471805599453
Probit,2,0.6931471805599453
health-service,2,0.6931471805599453
cerebralsplanchnic,2,0.6931471805599453
Cold-adapted,2,0.6931471805599453
prediagnosis,2,0.6931471805599453
detachments,2,0.6931471805599453
parenthood,2,0.6931471805599453
non-disabled,2,0.6931471805599453
--when,2,0.6931471805599453
34-year,2,0.6931471805599453
CXCL5,2,0.6931471805599453
reportResults,2,0.6931471805599453
choroiditis,2,0.6931471805599453
Shenyang,2,0.6931471805599453
3634,2,0.6931471805599453
TFF3,2,0.6931471805599453
multi-factor,2,0.6931471805599453
2874,2,0.6931471805599453
prepublications,2,0.6931471805599453
NCAG,2,0.6931471805599453
hyperattenuated,2,0.6931471805599453
home-sampled,2,0.6931471805599453
WoE,2,0.6931471805599453
1658,2,0.6931471805599453
2000-2007,2,0.6931471805599453
decelerate,2,0.6931471805599453
upfront,2,0.6931471805599453
dpdtmax,2,0.6931471805599453
ultra-structure,2,0.6931471805599453
CAFOs,2,0.6931471805599453
non-IHD,2,0.6931471805599453
repolarizing,2,0.6931471805599453
CHI3L1,2,0.6931471805599453
-0006,2,0.6931471805599453
I-,2,0.6931471805599453
SARS-CoV-21,2,0.6931471805599453
squirrels,2,0.6931471805599453
Doubts,2,0.6931471805599453
Carrying,2,0.6931471805599453
calmodulin-active,2,0.6931471805599453
Madhi,2,0.6931471805599453
Telangana,2,0.6931471805599453
re-engineering,2,0.6931471805599453
more-effective,2,0.6931471805599453
C-Mill,2,0.6931471805599453
mutation-prone,2,0.6931471805599453
IAO,2,0.6931471805599453
MX1,2,0.6931471805599453
rupturing,2,0.6931471805599453
FALLS,2,0.6931471805599453
0942,2,0.6931471805599453
0408,2,0.6931471805599453
PSI,2,0.6931471805599453
0951,2,0.6931471805599453
Tc1,2,0.6931471805599453
haemoglobinopathy,2,0.6931471805599453
haemoglobinopathies,2,0.6931471805599453
0698,2,0.6931471805599453
12-month-old,2,0.6931471805599453
Deficiency,2,0.6931471805599453
hepatology,2,0.6931471805599453
decision-support,2,0.6931471805599453
≥998,2,0.6931471805599453
-0003,2,0.6931471805599453
TEF25PEF,2,0.6931471805599453
revalidation,2,0.6931471805599453
∼11,2,0.6931471805599453
re-extension,2,0.6931471805599453
triplet,2,0.6931471805599453
reinvigorated,2,0.6931471805599453
RFT,2,0.6931471805599453
Polycythaemia,2,0.6931471805599453
2528,2,0.6931471805599453
open-cell,2,0.6931471805599453
benefit-to-risk,2,0.6931471805599453
friable,2,0.6931471805599453
equating,2,0.6931471805599453
thromboatherosclerotic,2,0.6931471805599453
bronchologic,2,0.6931471805599453
tag,2,0.6931471805599453
well-circumscribed,2,0.6931471805599453
DDC,2,0.6931471805599453
impute,2,0.6931471805599453
Zn-SOD,2,0.6931471805599453
3539,2,0.6931471805599453
PMRs,2,0.6931471805599453
Oromia,2,0.6931471805599453
wayfinding,2,0.6931471805599453
purporting,2,0.6931471805599453
S1-RBD-protein,2,0.6931471805599453
TPEFTE,2,0.6931471805599453
VPEFVE,2,0.6931471805599453
2-mediated,2,0.6931471805599453
TIT,2,0.6931471805599453
neurotherapeutic,2,0.6931471805599453
gargling,2,0.6931471805599453
Nephrology,2,0.6931471805599453
CL-MIA,2,0.6931471805599453
3-tier,2,0.6931471805599453
cytometry-based,2,0.6931471805599453
CHAID,2,0.6931471805599453
Recursive,2,0.6931471805599453
Dinnes,2,0.6931471805599453
Deeks,2,0.6931471805599453
PL,2,0.6931471805599453
dienes,2,0.6931471805599453
malonic,2,0.6931471805599453
One-fifth,2,0.6931471805599453
Relations,2,0.6931471805599453
urbanrural,2,0.6931471805599453
3387,2,0.6931471805599453
ferulate,2,0.6931471805599453
Divided,2,0.6931471805599453
SocietyScottish,2,0.6931471805599453
SFG,2,0.6931471805599453
CVF,2,0.6931471805599453
GSH-px,2,0.6931471805599453
Christopher,2,0.6931471805599453
Way,2,0.6931471805599453
Symphony,2,0.6931471805599453
surface-antigen,2,0.6931471805599453
Tubarão,2,0.6931471805599453
pressure-generating,2,0.6931471805599453
Hypercoagulability,2,0.6931471805599453
55-85,2,0.6931471805599453
intra-His,2,0.6931471805599453
-096,2,0.6931471805599453
Lightmix®,2,0.6931471805599453
neuro-immune,2,0.6931471805599453
Scanty,2,0.6931471805599453
44-year,2,0.6931471805599453
Borderline,2,0.6931471805599453
Huelva,2,0.6931471805599453
reflector,2,0.6931471805599453
≥85-year,2,0.6931471805599453
alphabet,2,0.6931471805599453
24-lead,2,0.6931471805599453
pa,2,0.6931471805599453
heat-stable,2,0.6931471805599453
backscattered,2,0.6931471805599453
19931994,2,0.6931471805599453
Shot,2,0.6931471805599453
Osteopathic,2,0.6931471805599453
Out-of-hospital,2,0.6931471805599453
GCNKSS,2,0.6931471805599453
mis-diagnosed,2,0.6931471805599453
996-100,2,0.6931471805599453
GABAA,2,0.6931471805599453
30-339,2,0.6931471805599453
gamma-aminobutyric,2,0.6931471805599453
anti-SARS-CoV,2,0.6931471805599453
2157,2,0.6931471805599453
Branchburg,2,0.6931471805599453
Plaines,2,0.6931471805599453
styrene,2,0.6931471805599453
22-item,2,0.6931471805599453
B2M,2,0.6931471805599453
1368,2,0.6931471805599453
Coordinating,2,0.6931471805599453
3146,2,0.6931471805599453
Holter-recorded,2,0.6931471805599453
PETcomputed,2,0.6931471805599453
coregistered,2,0.6931471805599453
eluate,2,0.6931471805599453
Diuretic,2,0.6931471805599453
low-concentration,2,0.6931471805599453
rural-urban,2,0.6931471805599453
mW,2,0.6931471805599453
intersectoral,2,0.6931471805599453
Multisectoral,2,0.6931471805599453
microelecrostimulation,2,0.6931471805599453
treatment-averaged,2,0.6931471805599453
BIOVASC,2,0.6931471805599453
chorioamnionitis,2,0.6931471805599453
IgT,2,0.6931471805599453
AMichigan452015,2,0.6931471805599453
CBM-fused,2,0.6931471805599453
unprovoked,2,0.6931471805599453
seizuresepilepsy,2,0.6931471805599453
superstandard,2,0.6931471805599453
Indirectly,2,0.6931471805599453
Drinking,2,0.6931471805599453
glatiramer,2,0.6931471805599453
desialylated,2,0.6931471805599453
natalizumab,2,0.6931471805599453
pointers,2,0.6931471805599453
negative-control,2,0.6931471805599453
non-gated,2,0.6931471805599453
Sprint,2,0.6931471805599453
servant,2,0.6931471805599453
containers,2,0.6931471805599453
Dispatch,2,0.6931471805599453
homoarginine,2,0.6931471805599453
cases100,2,0.6931471805599453
hypothesis-driven,2,0.6931471805599453
virophagy,2,0.6931471805599453
macroautophagyautophagy,2,0.6931471805599453
Accomplishment,2,0.6931471805599453
symptom-to-reperfusion,2,0.6931471805599453
Hispanic-Mestizo,2,0.6931471805599453
Ergometrine,2,0.6931471805599453
VCRs,2,0.6931471805599453
off-work,2,0.6931471805599453
neurovisual,2,0.6931471805599453
fungicides,2,0.6931471805599453
techniques-rhinomanometry,2,0.6931471805599453
-003,2,0.6931471805599453
speedily,2,0.6931471805599453
AScotland74,2,0.6931471805599453
ACEIsARBs,2,0.6931471805599453
reticulum-associated,2,0.6931471805599453
2347,2,0.6931471805599453
1999-2009,2,0.6931471805599453
SARS-CoV-derived,2,0.6931471805599453
Mucor,2,0.6931471805599453
inquires,2,0.6931471805599453
preventers,2,0.6931471805599453
Verticillium,2,0.6931471805599453
Aracaju,2,0.6931471805599453
Meta-Analysis,2,0.6931471805599453
population-attributable,2,0.6931471805599453
implantations,2,0.6931471805599453
147000,2,0.6931471805599453
PhT,2,0.6931471805599453
B-eos,2,0.6931471805599453
2448,2,0.6931471805599453
five-week,2,0.6931471805599453
promptness,2,0.6931471805599453
ornithine,2,0.6931471805599453
CR7,2,0.6931471805599453
Bamako,2,0.6931471805599453
CR4,2,0.6931471805599453
supervise,2,0.6931471805599453
autologic,2,0.6931471805599453
NIID2019-nCOVN,2,0.6931471805599453
H1N1-NA,2,0.6931471805599453
laryngoscopic,2,0.6931471805599453
Laryngoscopic,2,0.6931471805599453
purpose-built,2,0.6931471805599453
prediction-based,2,0.6931471805599453
POU,2,0.6931471805599453
LIMS,2,0.6931471805599453
Birth,2,0.6931471805599453
Townsville,2,0.6931471805599453
post-outbreak,2,0.6931471805599453
Isle,2,0.6931471805599453
protein-3,2,0.6931471805599453
3C1,2,0.6931471805599453
nonstented,2,0.6931471805599453
contigs,2,0.6931471805599453
installations,2,0.6931471805599453
nonprocedural,2,0.6931471805599453
Continuum,2,0.6931471805599453
IDSA,2,0.6931471805599453
aortopulmonary,2,0.6931471805599453
nine-minute,2,0.6931471805599453
7407,2,0.6931471805599453
Ample,2,0.6931471805599453
within-flight,2,0.6931471805599453
rap,2,0.6931471805599453
LSG-based,2,0.6931471805599453
CPCSSN,2,0.6931471805599453
MI-CS,2,0.6931471805599453
lineage-mismatched,2,0.6931471805599453
pacemaker-induced,2,0.6931471805599453
SAPCReN-CPCSSN,2,0.6931471805599453
CHIMES,2,0.6931471805599453
NeuroAiD,2,0.6931471805599453
0344,2,0.6931471805599453
hemi-cord,2,0.6931471805599453
AWS33,2,0.6931471805599453
Non-adherence,2,0.6931471805599453
Bullous,2,0.6931471805599453
11-2012,2,0.6931471805599453
concurring,2,0.6931471805599453
wearables,2,0.6931471805599453
n44,2,0.6931471805599453
inhaler-based,2,0.6931471805599453
racesethnicities,2,0.6931471805599453
telecommunicators,2,0.6931471805599453
decent,2,0.6931471805599453
Indomethacin,2,0.6931471805599453
Merck,2,0.6931471805599453
obliges,2,0.6931471805599453
Headaches,2,0.6931471805599453
unrelenting,2,0.6931471805599453
sNIHSS-5,2,0.6931471805599453
VarsVID,2,0.6931471805599453
CK-BB,2,0.6931471805599453
Transverse,2,0.6931471805599453
ECQ,2,0.6931471805599453
BNT162b2-vaccinated,2,0.6931471805599453
MADE-DBM,2,0.6931471805599453
activation-induced,2,0.6931471805599453
unadvisable,2,0.6931471805599453
diamine,2,0.6931471805599453
post-inflammatory,2,0.6931471805599453
chest-CT,2,0.6931471805599453
well-rounded,2,0.6931471805599453
EEG-pattern,2,0.6931471805599453
miR-145,2,0.6931471805599453
lytic-eligible,2,0.6931471805599453
trombolytic,2,0.6931471805599453
aggregating,2,0.6931471805599453
antibioticsantivirals,2,0.6931471805599453
reduced-dose,2,0.6931471805599453
double-bolus,2,0.6931471805599453
intercountry,2,0.6931471805599453
Margarita,2,0.6931471805599453
DBM,2,0.6931471805599453
fold-increase,2,0.6931471805599453
light-sensitive,2,0.6931471805599453
pelt,2,0.6931471805599453
encumbered,2,0.6931471805599453
giver,2,0.6931471805599453
rapid-replicating,2,0.6931471805599453
prolines,2,0.6931471805599453
fusogenicity,2,0.6931471805599453
early-differentiated,2,0.6931471805599453
asthma”,2,0.6931471805599453
cursorily,2,0.6931471805599453
peptide-MHC,2,0.6931471805599453
cross-sectoral,2,0.6931471805599453
violate,2,0.6931471805599453
33-fold,2,0.6931471805599453
laboratorys,2,0.6931471805599453
COVID-191,2,0.6931471805599453
mast-cells,2,0.6931471805599453
Eysenck,2,0.6931471805599453
nocardiosis,2,0.6931471805599453
bronchiolo-alveolar,2,0.6931471805599453
pre-coating,2,0.6931471805599453
49-lead,2,0.6931471805599453
hyperglycosylation,2,0.6931471805599453
vitiate,2,0.6931471805599453
wholeness,2,0.6931471805599453
single-peak,2,0.6931471805599453
n52,2,0.6931471805599453
11-45,2,0.6931471805599453
myofiber,2,0.6931471805599453
7-60,2,0.6931471805599453
24-hours,2,0.6931471805599453
distorts,2,0.6931471805599453
Constraints,2,0.6931471805599453
0-16,2,0.6931471805599453
steered,2,0.6931471805599453
transfusionnal,2,0.6931471805599453
shrimp,2,0.6931471805599453
evoking,2,0.6931471805599453
conspecifics,2,0.6931471805599453
S-beta,2,0.6931471805599453
insufficiency-,2,0.6931471805599453
irritancy,2,0.6931471805599453
chemical-induced,2,0.6931471805599453
recesses--behind,2,0.6931471805599453
Gugging,2,0.6931471805599453
defends,2,0.6931471805599453
baseball,2,0.6931471805599453
hyperexpansion,2,0.6931471805599453
invests,2,0.6931471805599453
tennis,2,0.6931471805599453
Greatest,2,0.6931471805599453
BYamagata1688-lineage,2,0.6931471805599453
abrasion,2,0.6931471805599453
8°C,2,0.6931471805599453
Relating,2,0.6931471805599453
slow-reacting,2,0.6931471805599453
Compatibility,2,0.6931471805599453
executor,2,0.6931471805599453
therapy-related,2,0.6931471805599453
reaffirmed,2,0.6931471805599453
storks,2,0.6931471805599453
stork-derived,2,0.6931471805599453
MANOVA,2,0.6931471805599453
rinsing,2,0.6931471805599453
MNC,2,0.6931471805599453
10003,2,0.6931471805599453
culture-negative,2,0.6931471805599453
non-mucinous,2,0.6931471805599453
Sindh,2,0.6931471805599453
Genotypic,2,0.6931471805599453
TandemHeart,2,0.6931471805599453
feeble,2,0.6931471805599453
pressors,2,0.6931471805599453
ballon,2,0.6931471805599453
Balochistan,2,0.6931471805599453
asthmachronic,2,0.6931471805599453
PCR-RFLP,2,0.6931471805599453
onerous,2,0.6931471805599453
Caribbeans,2,0.6931471805599453
pre-selected,2,0.6931471805599453
SABA-only,2,0.6931471805599453
BYamanashi16698,2,0.6931471805599453
ABayern795,2,0.6931471805599453
arachnoiditis,2,0.6931471805599453
Centro,2,0.6931471805599453
Aided,2,0.6931471805599453
SARS-CoV-3,2,0.6931471805599453
topographies,2,0.6931471805599453
fellowship,2,0.6931471805599453
sterilants,2,0.6931471805599453
2148,2,0.6931471805599453
PAMI-2,2,0.6931471805599453
2115,2,0.6931471805599453
LMT-OMI,2,0.6931471805599453
GSTP1,2,0.6931471805599453
non-Bahraini,2,0.6931471805599453
Nonbacterial,2,0.6931471805599453
oxidoreductase,2,0.6931471805599453
irradiance,2,0.6931471805599453
IO-PDT,2,0.6931471805599453
ICMR,2,0.6931471805599453
14-session,2,0.6931471805599453
Barlows,2,0.6931471805599453
spilling,2,0.6931471805599453
emanate,2,0.6931471805599453
parsing,2,0.6931471805599453
topmost,2,0.6931471805599453
node-network,2,0.6931471805599453
aide,2,0.6931471805599453
1316,2,0.6931471805599453
1909,2,0.6931471805599453
0881,2,0.6931471805599453
c-index,2,0.6931471805599453
disutility,2,0.6931471805599453
monoplane,2,0.6931471805599453
8922,2,0.6931471805599453
mailout,2,0.6931471805599453
2003-2013,2,0.6931471805599453
GINA2015,2,0.6931471805599453
Zipfs,2,0.6931471805599453
Heaps,2,0.6931471805599453
1156,2,0.6931471805599453
Programa,2,0.6931471805599453
AH1N1sw1,2,0.6931471805599453
Serine128Arginine,2,0.6931471805599453
LMT-UAP,2,0.6931471805599453
civet,2,0.6931471805599453
Calvados,2,0.6931471805599453
D3Similarity,2,0.6931471805599453
0681,2,0.6931471805599453
0731,2,0.6931471805599453
cardiophrenic,2,0.6931471805599453
4-20,2,0.6931471805599453
age-demographic,2,0.6931471805599453
Immunodiagnostic,2,0.6931471805599453
drug-gene,2,0.6931471805599453
72-hour,2,0.6931471805599453
erythropoietic,2,0.6931471805599453
-thickening,2,0.6931471805599453
Intra-operative,2,0.6931471805599453
Reinvestment,2,0.6931471805599453
45-6,2,0.6931471805599453
disproving,2,0.6931471805599453
FXIIa,2,0.6931471805599453
nQS,2,0.6931471805599453
neuraminidase-inhibitors,2,0.6931471805599453
374-441,2,0.6931471805599453
Laparoscopic,2,0.6931471805599453
P031,2,0.6931471805599453
haematologist,2,0.6931471805599453
1985-1986,2,0.6931471805599453
Invariant,2,0.6931471805599453
BUT,2,0.6931471805599453
Tachycardia,2,0.6931471805599453
transendocardial,2,0.6931471805599453
smokelike,2,0.6931471805599453
Immunoinformatic,2,0.6931471805599453
SARS-Co,2,0.6931471805599453
cost-determining,2,0.6931471805599453
Isahaya,2,0.6931471805599453
aggravations,2,0.6931471805599453
-071,2,0.6931471805599453
hyperpolarizing,2,0.6931471805599453
unprecedentedly,2,0.6931471805599453
dispelled,2,0.6931471805599453
etanercept,2,0.6931471805599453
physical-chemical,2,0.6931471805599453
NS1-mediated,2,0.6931471805599453
Korczyński,2,0.6931471805599453
anesthetists,2,0.6931471805599453
1887,2,0.6931471805599453
Władysław,2,0.6931471805599453
15-year,2,0.6931471805599453
Józef,2,0.6931471805599453
reninhigh,2,0.6931471805599453
1437,2,0.6931471805599453
3444,2,0.6931471805599453
child-onset,2,0.6931471805599453
0687,2,0.6931471805599453
DINAMIT,2,0.6931471805599453
tranexamic,2,0.6931471805599453
ProtParam,2,0.6931471805599453
pack,2,0.6931471805599453
Napoleon,2,0.6931471805599453
intersectional,2,0.6931471805599453
r085,2,0.6931471805599453
Cybulski,2,0.6931471805599453
COLSARSPROT,2,0.6931471805599453
3365,2,0.6931471805599453
ACCA,2,0.6931471805599453
inter-country,2,0.6931471805599453
TRACER,2,0.6931471805599453
TRA2P,2,0.6931471805599453
protease-activated,2,0.6931471805599453
unconstrained,2,0.6931471805599453
Vorapaxar,2,0.6931471805599453
riddled,2,0.6931471805599453
Processing,2,0.6931471805599453
methosulphate,2,0.6931471805599453
resonate,2,0.6931471805599453
uninformed,2,0.6931471805599453
Arbor,2,0.6931471805599453
20-200,2,0.6931471805599453
Barrier,2,0.6931471805599453
θ,2,0.6931471805599453
7976,2,0.6931471805599453
12-30,2,0.6931471805599453
lehet,2,0.6931471805599453
non-shock,2,0.6931471805599453
self-terminating,2,0.6931471805599453
BBeijing18493-like,2,0.6931471805599453
Averaging,2,0.6931471805599453
BShandong797,2,0.6931471805599453
mammalian-adapted,2,0.6931471805599453
Intraparenchymal,2,0.6931471805599453
Fann,2,0.6931471805599453
noninfarction,2,0.6931471805599453
hematologic-metabolic,2,0.6931471805599453
phonological,2,0.6931471805599453
lexical,2,0.6931471805599453
10769,2,0.6931471805599453
peracute,2,0.6931471805599453
preventtreat,2,0.6931471805599453
-011,2,0.6931471805599453
-151,2,0.6931471805599453
infarct-size,2,0.6931471805599453
5136,2,0.6931471805599453
Dilation,2,0.6931471805599453
Herzinfarktverbund,2,0.6931471805599453
4643,2,0.6931471805599453
picked,2,0.6931471805599453
unsurprising,2,0.6931471805599453
HS-induced,2,0.6931471805599453
Sept,2,0.6931471805599453
sustenance,2,0.6931471805599453
Sigma-Virocult,2,0.6931471805599453
EMEM,2,0.6931471805599453
respiratorycirculatory-coded,2,0.6931471805599453
TmeTe,2,0.6931471805599453
VmaxFRC,2,0.6931471805599453
mists,2,0.6931471805599453
biorisk,2,0.6931471805599453
Believing,2,0.6931471805599453
presumes,2,0.6931471805599453
joules,2,0.6931471805599453
24-meric,2,0.6931471805599453
nyelészavar,2,0.6931471805599453
senators,2,0.6931471805599453
autistic,2,0.6931471805599453
nonexecutive,2,0.6931471805599453
HRSNs,2,0.6931471805599453
perforates,2,0.6931471805599453
Mazzoni,2,0.6931471805599453
Levi,2,0.6931471805599453
point-of-service,2,0.6931471805599453
dot-hybridization,2,0.6931471805599453
tragedies,2,0.6931471805599453
n-6,2,0.6931471805599453
50-100,2,0.6931471805599453
Realistic,2,0.6931471805599453
intersections,2,0.6931471805599453
Hyperuricemia,2,0.6931471805599453
thymectomy,2,0.6931471805599453
toolkits,2,0.6931471805599453
kmono,2,0.6931471805599453
short-sighted,2,0.6931471805599453
psychogenias,2,0.6931471805599453
cross-education,2,0.6931471805599453
PC20-HS,2,0.6931471805599453
Merely,2,0.6931471805599453
1243,2,0.6931471805599453
Pairs,2,0.6931471805599453
sialyltransferases,2,0.6931471805599453
Pacing,2,0.6931471805599453
Hap1,2,0.6931471805599453
isolate-specific,2,0.6931471805599453
sialyltransferase,2,0.6931471805599453
Hap4,2,0.6931471805599453
misplaced,2,0.6931471805599453
AEngland72,2,0.6931471805599453
Azzolini,2,0.6931471805599453
limb-shaking,2,0.6931471805599453
severevery,2,0.6931471805599453
Discoveries,2,0.6931471805599453
HYPOTHESIS,2,0.6931471805599453
wormwood-RAST,2,0.6931471805599453
mid-latitudes,2,0.6931471805599453
Otsu,2,0.6931471805599453
cyclically,2,0.6931471805599453
wv,2,0.6931471805599453
gm3,2,0.6931471805599453
dissipate,2,0.6931471805599453
1154,2,0.6931471805599453
commendable,2,0.6931471805599453
respectful,2,0.6931471805599453
emphysematous,2,0.6931471805599453
bronchitic,2,0.6931471805599453
közvetlen,2,0.6931471805599453
miR-133ab,2,0.6931471805599453
Canonical,2,0.6931471805599453
neurológiai,2,0.6931471805599453
20-37,2,0.6931471805599453
Initiating,2,0.6931471805599453
Lauria,2,0.6931471805599453
2008-9,2,0.6931471805599453
ACalifornia704,2,0.6931471805599453
Di,2,0.6931471805599453
23-71,2,0.6931471805599453
nasooropharyngeal,2,0.6931471805599453
BShanghai36102,2,0.6931471805599453
mvolt,2,0.6931471805599453
transected,2,0.6931471805599453
DiI,2,0.6931471805599453
misdiagnose,2,0.6931471805599453
EGR1,2,0.6931471805599453
OECG-F,2,0.6931471805599453
apatinib,2,0.6931471805599453
dabrafenib,2,0.6931471805599453
macroautophagy,2,0.6931471805599453
antiprotease,2,0.6931471805599453
non-psychiatric,2,0.6931471805599453
bills,2,0.6931471805599453
Prehosp,2,0.6931471805599453
PERK-mediated,2,0.6931471805599453
Spinhaler,2,0.6931471805599453
non-VKA,2,0.6931471805599453
54-100,2,0.6931471805599453
LRTH,2,0.6931471805599453
nemcsak,2,0.6931471805599453
AUSSR9277,2,0.6931471805599453
nucleocapsid-based,2,0.6931471805599453
brushes,2,0.6931471805599453
hanem,2,0.6931471805599453
eredmények,2,0.6931471805599453
sludging,2,0.6931471805599453
oligoallergenic,2,0.6931471805599453
PSDapathy,2,0.6931471805599453
kapcsolatos,2,0.6931471805599453
microbubble,2,0.6931471805599453
007-031,2,0.6931471805599453
subordinate,2,0.6931471805599453
phlegmy,2,0.6931471805599453
anti-LCMV,2,0.6931471805599453
microphones,2,0.6931471805599453
A177,2,0.6931471805599453
DMVs,2,0.6931471805599453
Johannesburg,2,0.6931471805599453
Durban,2,0.6931471805599453
patency-oriented,2,0.6931471805599453
patinets,2,0.6931471805599453
Adjustments,2,0.6931471805599453
tantamount,2,0.6931471805599453
125min,2,0.6931471805599453
CSSS,2,0.6931471805599453
well-identified,2,0.6931471805599453
lenticular,2,0.6931471805599453
fenestration,2,0.6931471805599453
non-Estonians,2,0.6931471805599453
2405,2,0.6931471805599453
Estonians,2,0.6931471805599453
CD44,2,0.6931471805599453
realist,2,0.6931471805599453
clinimetric,2,0.6931471805599453
LTF,2,0.6931471805599453
BOSS,2,0.6931471805599453
infarct-healing,2,0.6931471805599453
GTP,2,0.6931471805599453
MUC5B,2,0.6931471805599453
nephrolithiasis,2,0.6931471805599453
IL-413,2,0.6931471805599453
Katz,2,0.6931471805599453
PIFR,2,0.6931471805599453
Bacille,2,0.6931471805599453
Morning,2,0.6931471805599453
1947--1956,2,0.6931471805599453
self-admission,2,0.6931471805599453
koronavírus-2,2,0.6931471805599453
Goroka,2,0.6931471805599453
volumebody,2,0.6931471805599453
D-dimers,2,0.6931471805599453
vizsgálatára,2,0.6931471805599453
multilocular,2,0.6931471805599453
unilocular,2,0.6931471805599453
posttranscriptional,2,0.6931471805599453
szempontjait,2,0.6931471805599453
grating,2,0.6931471805599453
jelen,2,0.6931471805599453
Going,2,0.6931471805599453
16215,2,0.6931471805599453
563-570,2,0.6931471805599453
25-31,2,0.6931471805599453
Darussalam,2,0.6931471805599453
6748,2,0.6931471805599453
CGR,2,0.6931471805599453
af,2,0.6931471805599453
Madison,2,0.6931471805599453
1201,2,0.6931471805599453
antigen-naive,2,0.6931471805599453
reverse-transcriptase-polymerase-chain-reaction,2,0.6931471805599453
tragically,2,0.6931471805599453
CVIQ,2,0.6931471805599453
consonance,2,0.6931471805599453
transflection,2,0.6931471805599453
authoritarian,2,0.6931471805599453
cancel,2,0.6931471805599453
légzőszervi,2,0.6931471805599453
számos,2,0.6931471805599453
számára,2,0.6931471805599453
PFO-closure,2,0.6931471805599453
EAB,2,0.6931471805599453
aptamer-based,2,0.6931471805599453
post-resuscitation,2,0.6931471805599453
noncerebral,2,0.6931471805599453
gate,2,0.6931471805599453
való,2,0.6931471805599453
ACPK,2,0.6931471805599453
1277,2,0.6931471805599453
Bible,2,0.6931471805599453
non-cognitive,2,0.6931471805599453
fontos,2,0.6931471805599453
járvány,2,0.6931471805599453
azonban,2,0.6931471805599453
Keep,2,0.6931471805599453
0762,2,0.6931471805599453
Balanced,2,0.6931471805599453
piggeries,2,0.6931471805599453
trim,2,0.6931471805599453
szükséges,2,0.6931471805599453
slaughterhouses,2,0.6931471805599453
human-pig,2,0.6931471805599453
POE,2,0.6931471805599453
paindiscomfort,2,0.6931471805599453
bladeupper,2,0.6931471805599453
goitres,2,0.6931471805599453
PTAS,2,0.6931471805599453
earners,2,0.6931471805599453
woefully,2,0.6931471805599453
multilocation,2,0.6931471805599453
FEMA,2,0.6931471805599453
Ethiopian,2,0.6931471805599453
left-handed,2,0.6931471805599453
EPHI,2,0.6931471805599453
NMN,2,0.6931471805599453
062-084,2,0.6931471805599453
Malaria,2,0.6931471805599453
PVAD,2,0.6931471805599453
Middlesex,2,0.6931471805599453
ECG-defined,2,0.6931471805599453
evocative,2,0.6931471805599453
non-CIN,2,0.6931471805599453
Enhancing,2,0.6931471805599453
reprinted,2,0.6931471805599453
5719,2,0.6931471805599453
Investing,2,0.6931471805599453
anti-oxidant,2,0.6931471805599453
two-layer,2,0.6931471805599453
tw,2,0.6931471805599453
contrast-induced,2,0.6931471805599453
socio-economically,2,0.6931471805599453
95pcent,2,0.6931471805599453
Income,2,0.6931471805599453
hydrogen-bonding,2,0.6931471805599453
Thai-Myanmar,2,0.6931471805599453
CONTAIN,2,0.6931471805599453
DELAY,2,0.6931471805599453
OHPIP,2,0.6931471805599453
SGLT2,2,0.6931471805599453
1713,2,0.6931471805599453
ICHD-3,2,0.6931471805599453
sulphonylureas,2,0.6931471805599453
1-mg,2,0.6931471805599453
race-adjusted,2,0.6931471805599453
Aq,2,0.6931471805599453
2131,2,0.6931471805599453
drugs--neuraminidase,2,0.6931471805599453
“turn,2,0.6931471805599453
positive”,2,0.6931471805599453
Cine,2,0.6931471805599453
FLPRSR,2,0.6931471805599453
Hudsons,2,0.6931471805599453
data-sets,2,0.6931471805599453
26896,2,0.6931471805599453
3236,2,0.6931471805599453
IC-ECG,2,0.6931471805599453
103-104,2,0.6931471805599453
datehourminute,2,0.6931471805599453
MgV,2,0.6931471805599453
SARS-CoV-2-IgG,2,0.6931471805599453
titermL,2,0.6931471805599453
limit-of-detection,2,0.6931471805599453
11-18,2,0.6931471805599453
IGRA,2,0.6931471805599453
solves,2,0.6931471805599453
Pre-school,2,0.6931471805599453
Latest,2,0.6931471805599453
cm-5,2,0.6931471805599453
single-chamber,2,0.6931471805599453
nonpathological,2,0.6931471805599453
bacteriophages,2,0.6931471805599453
remedied,2,0.6931471805599453
coelomic,2,0.6931471805599453
phosphoribosyltransferase,2,0.6931471805599453
endo-,2,0.6931471805599453
airborne-transmissible,2,0.6931471805599453
ventrodorsal,2,0.6931471805599453
3639,2,0.6931471805599453
HA-specific,2,0.6931471805599453
flowmeter,2,0.6931471805599453
lapsed,2,0.6931471805599453
disciplining,2,0.6931471805599453
sub-scales,2,0.6931471805599453
FYN,2,0.6931471805599453
tocolytic,2,0.6931471805599453
Construction,2,0.6931471805599453
Reacting,2,0.6931471805599453
RTT,2,0.6931471805599453
desires,2,0.6931471805599453
sequellar,2,0.6931471805599453
acetonide,2,0.6931471805599453
ostia,2,0.6931471805599453
intra-operational,2,0.6931471805599453
-81,2,0.6931471805599453
test-and-isolate,2,0.6931471805599453
CSSR,2,0.6931471805599453
time-density,2,0.6931471805599453
ASSAM,2,0.6931471805599453
myography,2,0.6931471805599453
55-75,2,0.6931471805599453
testament,2,0.6931471805599453
syrinx,2,0.6931471805599453
KAU,2,0.6931471805599453
TCR-HA,2,0.6931471805599453
Genesis,2,0.6931471805599453
Graham,2,0.6931471805599453
11-54,2,0.6931471805599453
Diversity,2,0.6931471805599453
hemosorbents,2,0.6931471805599453
Gemosfer,2,0.6931471805599453
21000,2,0.6931471805599453
Cross-neutralization,2,0.6931471805599453
Files,2,0.6931471805599453
questionnaire-guided,2,0.6931471805599453
open-air,2,0.6931471805599453
DNA-containing,2,0.6931471805599453
non-professionals,2,0.6931471805599453
HPG,2,0.6931471805599453
buffalo,2,0.6931471805599453
myocytolysis,2,0.6931471805599453
dorm-style,2,0.6931471805599453
Carer,2,0.6931471805599453
person-centred,2,0.6931471805599453
High-level,2,0.6931471805599453
densest,2,0.6931471805599453
age10,2,0.6931471805599453
-041,2,0.6931471805599453
CFTR,2,0.6931471805599453
ventrally,2,0.6931471805599453
honeycomb-like,2,0.6931471805599453
2594,2,0.6931471805599453
virus-naive,2,0.6931471805599453
chlorofluorocarbon,2,0.6931471805599453
CFC-based,2,0.6931471805599453
22L,2,0.6931471805599453
macro-economic,2,0.6931471805599453
sectoral,2,0.6931471805599453
ceremony,2,0.6931471805599453
quantile,2,0.6931471805599453
deflation,2,0.6931471805599453
mJcm3,2,0.6931471805599453
Pablo,2,0.6931471805599453
weak-positive,2,0.6931471805599453
PAs,2,0.6931471805599453
metabolizes,2,0.6931471805599453
citrulline,2,0.6931471805599453
methylamine,2,0.6931471805599453
genome-based,2,0.6931471805599453
IAVWSN-induced,2,0.6931471805599453
Apoptotic,2,0.6931471805599453
Claims,2,0.6931471805599453
superdiffusive,2,0.6931471805599453
SCDs,2,0.6931471805599453
hydratation,2,0.6931471805599453
agencieshealth,2,0.6931471805599453
Likely,2,0.6931471805599453
BPND,2,0.6931471805599453
non-black,2,0.6931471805599453
Zn-binding,2,0.6931471805599453
nanoboxes,2,0.6931471805599453
receiptnon-receipt,2,0.6931471805599453
callosal,2,0.6931471805599453
Sapienza,2,0.6931471805599453
re-emerge,2,0.6931471805599453
Studied,2,0.6931471805599453
AH1N2v,2,0.6931471805599453
allergen-SIT,2,0.6931471805599453
Competitive,2,0.6931471805599453
Vincent,2,0.6931471805599453
195Aum,2,0.6931471805599453
Nelson,2,0.6931471805599453
riolozatrione,2,0.6931471805599453
free-ranging,2,0.6931471805599453
1730,2,0.6931471805599453
NO-parameters,2,0.6931471805599453
2167,2,0.6931471805599453
3394,2,0.6931471805599453
-50,2,0.6931471805599453
Dorfmans,2,0.6931471805599453
-72,2,0.6931471805599453
PEF-measurement,2,0.6931471805599453
17-26,2,0.6931471805599453
O2kg,2,0.6931471805599453
etesivimab,2,0.6931471805599453
6-min,2,0.6931471805599453
multijoint,2,0.6931471805599453
swineTaiwan69,2,0.6931471805599453
walkstand,2,0.6931471805599453
flown,2,0.6931471805599453
walkstair,2,0.6931471805599453
swineIowa1530,2,0.6931471805599453
H0,2,0.6931471805599453
efficacyeffectiveness,2,0.6931471805599453
anti-histamines,2,0.6931471805599453
stroke-risk,2,0.6931471805599453
tombstone,2,0.6931471805599453
Temporally,2,0.6931471805599453
physician-pharmacist,2,0.6931471805599453
paravalvular,2,0.6931471805599453
Wheeler,2,0.6931471805599453
PVE,2,0.6931471805599453
Qingjie,2,0.6931471805599453
Ensemble,2,0.6931471805599453
subanalyses,2,0.6931471805599453
promotors,2,0.6931471805599453
influenzainfluenza-like,2,0.6931471805599453
8-30,2,0.6931471805599453
cancellations,2,0.6931471805599453
100000000,2,0.6931471805599453
8089,2,0.6931471805599453
AHong-Kong,2,0.6931471805599453
Proton,2,0.6931471805599453
1971--1972,2,0.6931471805599453
BMMC,2,0.6931471805599453
REVEALR,2,0.6931471805599453
23--24,2,0.6931471805599453
door-to-needle-times,2,0.6931471805599453
AHong-KongI68,2,0.6931471805599453
IIV-HD,2,0.6931471805599453
IIV-SD,2,0.6931471805599453
chronopharmacology,2,0.6931471805599453
BMMCs,2,0.6931471805599453
counting-based,2,0.6931471805599453
Suppressing,2,0.6931471805599453
built-up,2,0.6931471805599453
infarct-free,2,0.6931471805599453
Injuries,2,0.6931471805599453
stroke-risk-reduction,2,0.6931471805599453
Scale-up,2,0.6931471805599453
Modem,2,0.6931471805599453
risk-reducing,2,0.6931471805599453
Uhls,2,0.6931471805599453
Replies,2,0.6931471805599453
0992,2,0.6931471805599453
NetMHC,2,0.6931471805599453
HLA-B2705,2,0.6931471805599453
0368,2,0.6931471805599453
mastering,2,0.6931471805599453
malnourishment,2,0.6931471805599453
Hsw1n1,2,0.6931471805599453
L5F,2,0.6931471805599453
Clinic10374,2,0.6931471805599453
foreshadow,2,0.6931471805599453
bland,2,0.6931471805599453
Business,2,0.6931471805599453
gonads,2,0.6931471805599453
Emphysema,2,0.6931471805599453
ascertains,2,0.6931471805599453
vaccinators,2,0.6931471805599453
Kinase,2,0.6931471805599453
HSA,2,0.6931471805599453
Cu2O,2,0.6931471805599453
geospatially,2,0.6931471805599453
ROSC,2,0.6931471805599453
ProtA,2,0.6931471805599453
off-campus,2,0.6931471805599453
rEJR,2,0.6931471805599453
interpatient,2,0.6931471805599453
FAT,2,0.6931471805599453
consortiums,2,0.6931471805599453
best-fitting,2,0.6931471805599453
resurrected,2,0.6931471805599453
cellularity,2,0.6931471805599453
historian,2,0.6931471805599453
thaw-mounting,2,0.6931471805599453
Confirming,2,0.6931471805599453
2099,2,0.6931471805599453
heat-stabilization,2,0.6931471805599453
ultra-rapid,2,0.6931471805599453
21-item,2,0.6931471805599453
ferumoxytol,2,0.6931471805599453
denser,2,0.6931471805599453
designations,2,0.6931471805599453
dragon,2,0.6931471805599453
PLL,2,0.6931471805599453
Galician,2,0.6931471805599453
Location,2,0.6931471805599453
vector-MSCs,2,0.6931471805599453
overstrained,2,0.6931471805599453
trabecular,2,0.6931471805599453
ILVNC,2,0.6931471805599453
aftermaths,2,0.6931471805599453
FGF-2,2,0.6931471805599453
repositivity,2,0.6931471805599453
87-year-old,2,0.6931471805599453
laundry,2,0.6931471805599453
carpeting,2,0.6931471805599453
NOFEF25-75,2,0.6931471805599453
openers,2,0.6931471805599453
Sexuality,2,0.6931471805599453
NOFEV1,2,0.6931471805599453
additively,2,0.6931471805599453
NEDS,2,0.6931471805599453
microgramsdl,2,0.6931471805599453
abound,2,0.6931471805599453
NRD,2,0.6931471805599453
retroviruses,2,0.6931471805599453
Muranga,2,0.6931471805599453
Nairobi,2,0.6931471805599453
Proelmed,2,0.6931471805599453
infectioninfluenza-like,2,0.6931471805599453
in-segment,2,0.6931471805599453
5862,2,0.6931471805599453
2005-2015,2,0.6931471805599453
Household-based,2,0.6931471805599453
hSAR,2,0.6931471805599453
exquisite,2,0.6931471805599453
abbreviating,2,0.6931471805599453
GC×GC-HRTOF-MS,2,0.6931471805599453
microextraction,2,0.6931471805599453
spirometry-adjusted,2,0.6931471805599453
analysisABSTRACT,2,0.6931471805599453
1843,2,0.6931471805599453
Malmberg,2,0.6931471805599453
carotids,2,0.6931471805599453
FKN,2,0.6931471805599453
persuasiveness,2,0.6931471805599453
Spirometry-adjusted,2,0.6931471805599453
factor-I,2,0.6931471805599453
trophoblasts,2,0.6931471805599453
rule-based,2,0.6931471805599453
2743,2,0.6931471805599453
HF-rTMS,2,0.6931471805599453
NK-1,2,0.6931471805599453
inositol,2,0.6931471805599453
H5N1AV,2,0.6931471805599453
de-,2,0.6931471805599453
LVI,2,0.6931471805599453
subjectsABSTRACT,2,0.6931471805599453
Restricting,2,0.6931471805599453
guano,2,0.6931471805599453
pyrimidine,2,0.6931471805599453
DP1,2,0.6931471805599453
pentose,2,0.6931471805599453
Refinement,2,0.6931471805599453
ADAM-33,2,0.6931471805599453
anatomopathological,2,0.6931471805599453
Codes,2,0.6931471805599453
Cumbria,2,0.6931471805599453
Ecuadorian,2,0.6931471805599453
HGSQ,2,0.6931471805599453
AI-assisted,2,0.6931471805599453
Devon,2,0.6931471805599453
serodiagnostics,2,0.6931471805599453
hydrolyze,2,0.6931471805599453
Logical,2,0.6931471805599453
tachycardiaventricular,2,0.6931471805599453
non-STE,2,0.6931471805599453
richer,2,0.6931471805599453
AMEI,2,0.6931471805599453
DHS,2,0.6931471805599453
VLP-forming,2,0.6931471805599453
GC-MSMS,2,0.6931471805599453
angioplasty-related,2,0.6931471805599453
1×107,2,0.6931471805599453
PCI-related,2,0.6931471805599453
Itk,2,0.6931471805599453
transversarium,2,0.6931471805599453
CD16,2,0.6931471805599453
EPM,2,0.6931471805599453
Syk,2,0.6931471805599453
Establish,2,0.6931471805599453
dictum,2,0.6931471805599453
20-yr,2,0.6931471805599453
right-anterior,2,0.6931471805599453
Benchmarking,2,0.6931471805599453
endosomeslysosomes,2,0.6931471805599453
NABL,2,0.6931471805599453
retards,2,0.6931471805599453
genic,2,0.6931471805599453
2429,2,0.6931471805599453
assures,2,0.6931471805599453
4000000,2,0.6931471805599453
Recorded,2,0.6931471805599453
Mantel-Haenszel,2,0.6931471805599453
chemo-radiotherapy,2,0.6931471805599453
mmsec,2,0.6931471805599453
100-102,2,0.6931471805599453
weeksmonths,2,0.6931471805599453
RBD-2E8,2,0.6931471805599453
PGF2,2,0.6931471805599453
prise,2,0.6931471805599453
THOV,2,0.6931471805599453
Elderberry,2,0.6931471805599453
multibiomarker,2,0.6931471805599453
theaflavin,2,0.6931471805599453
abstracting,2,0.6931471805599453
1443,2,0.6931471805599453
mayor,2,0.6931471805599453
sinensis,2,0.6931471805599453
Transcriptome,2,0.6931471805599453
T-and,2,0.6931471805599453
PON1,2,0.6931471805599453
CLC,2,0.6931471805599453
Flint,2,0.6931471805599453
K18-human,2,0.6931471805599453
syrup,2,0.6931471805599453
MI-SVO,2,0.6931471805599453
TDI-HSA,2,0.6931471805599453
beta-sympathomimetic,2,0.6931471805599453
Hyogo,2,0.6931471805599453
single-sided,2,0.6931471805599453
GPCR,2,0.6931471805599453
anti-SIV,2,0.6931471805599453
inhuman,2,0.6931471805599453
3-lead,2,0.6931471805599453
Reslizumab,2,0.6931471805599453
octants,2,0.6931471805599453
guardian,2,0.6931471805599453
Tooth,2,0.6931471805599453
under-18,2,0.6931471805599453
TN-based,2,0.6931471805599453
FIA-positive,2,0.6931471805599453
Interferon-induced,2,0.6931471805599453
unblocking,2,0.6931471805599453
Bagging,2,0.6931471805599453
onset-to-alarm,2,0.6931471805599453
out-groups,2,0.6931471805599453
parainfectious,2,0.6931471805599453
133xenon,2,0.6931471805599453
universe,2,0.6931471805599453
BNT162,2,0.6931471805599453
ACTION,2,0.6931471805599453
co-infect,2,0.6931471805599453
atheroembolization,2,0.6931471805599453
PercuSurge,2,0.6931471805599453
piglet,2,0.6931471805599453
degenerated,2,0.6931471805599453
Homologous,2,0.6931471805599453
HRVs,2,0.6931471805599453
2770,2,0.6931471805599453
00226,2,0.6931471805599453
Tc-99m-pyrophosphate,2,0.6931471805599453
CRISPR-Cas-based,2,0.6931471805599453
anorgasmia,2,0.6931471805599453
non-spreaders,2,0.6931471805599453
RNA-directed,2,0.6931471805599453
CRISPR-,2,0.6931471805599453
Cretan,2,0.6931471805599453
Surgeon,2,0.6931471805599453
cardia,2,0.6931471805599453
Repeats,2,0.6931471805599453
1-21,2,0.6931471805599453
18·1,2,0.6931471805599453
5444,2,0.6931471805599453
Radioallergosorbent,2,0.6931471805599453
bioprosthetic,2,0.6931471805599453
twice-weekly,2,0.6931471805599453
non-invasiveness,2,0.6931471805599453
AGTP,2,0.6931471805599453
three-hour,2,0.6931471805599453
RealOpt,2,0.6931471805599453
discontinuance,2,0.6931471805599453
ABG,2,0.6931471805599453
6225,2,0.6931471805599453
ecologically,2,0.6931471805599453
countys,2,0.6931471805599453
parameterizing,2,0.6931471805599453
Osnabrück,2,0.6931471805599453
drills,2,0.6931471805599453
trainer,2,0.6931471805599453
beta-2-adrenergic,2,0.6931471805599453
vaccinator,2,0.6931471805599453
shutting,2,0.6931471805599453
MMI,2,0.6931471805599453
Impression,2,0.6931471805599453
MDC80,2,0.6931471805599453
vpmL,2,0.6931471805599453
IMAC,2,0.6931471805599453
MBBAs,2,0.6931471805599453
2-targeted,2,0.6931471805599453
clinical-inflammatory,2,0.6931471805599453
Viperin,2,0.6931471805599453
functionABSTRACT,2,0.6931471805599453
gels,2,0.6931471805599453
Trillium,2,0.6931471805599453
Chi2,2,0.6931471805599453
THC,2,0.6931471805599453
gallop,2,0.6931471805599453
ESRS,2,0.6931471805599453
academically,2,0.6931471805599453
P0027,2,0.6931471805599453
10-,2,0.6931471805599453
pecularities,2,0.6931471805599453
17-year-olds,2,0.6931471805599453
bronchial-asthma,2,0.6931471805599453
comanagement,2,0.6931471805599453
4-26,2,0.6931471805599453
somatogenic,2,0.6931471805599453
QuickVue®,2,0.6931471805599453
92-100,2,0.6931471805599453
ITGV-Raw,2,0.6931471805599453
Influenza-B,2,0.6931471805599453
1-sec,2,0.6931471805599453
mild-persistent,2,0.6931471805599453
42-58,2,0.6931471805599453
Yijinjing,2,0.6931471805599453
IL4,2,0.6931471805599453
strokeMethods,2,0.6931471805599453
affected-side,2,0.6931471805599453
Essentials,2,0.6931471805599453
unaffected-side,2,0.6931471805599453
rehabilitationResults,2,0.6931471805599453
variablesConclusions,2,0.6931471805599453
hypoperceivers,2,0.6931471805599453
donepezil,2,0.6931471805599453
Acetylcholinesterase,2,0.6931471805599453
Schematic,2,0.6931471805599453
993-100,2,0.6931471805599453
TPLSM,2,0.6931471805599453
oligopeptides,2,0.6931471805599453
LSCI,2,0.6931471805599453
perconditioning,2,0.6931471805599453
HLVH,2,0.6931471805599453
est,2,0.6931471805599453
Inadequacies,2,0.6931471805599453
Ce,2,0.6931471805599453
MDCK-2,2,0.6931471805599453
MDCK-H,2,0.6931471805599453
well-targeted,2,0.6931471805599453
50min,2,0.6931471805599453
ENC,2,0.6931471805599453
non-paced,2,0.6931471805599453
2007-2010,2,0.6931471805599453
di-codons,2,0.6931471805599453
CHA₂DS₂VASC,2,0.6931471805599453
coved,2,0.6931471805599453
botanical,2,0.6931471805599453
OPNa,2,0.6931471805599453
SDMA,2,0.6931471805599453
rapidement,2,0.6931471805599453
1987-99,2,0.6931471805599453
3-17,2,0.6931471805599453
Coronoviridae,2,0.6931471805599453
January-May,2,0.6931471805599453
quasi-Poisson,2,0.6931471805599453
Nous,2,0.6931471805599453
Show,2,0.6931471805599453
1Hz,2,0.6931471805599453
amino-transferase,2,0.6931471805599453
otolaryngological,2,0.6931471805599453
6784,2,0.6931471805599453
Emilia,2,0.6931471805599453
AZD1222-dependent,2,0.6931471805599453
Behaviorally,2,0.6931471805599453
heartbeat,2,0.6931471805599453
5154,2,0.6931471805599453
mais,2,0.6931471805599453
CoronaVac®,2,0.6931471805599453
3650,2,0.6931471805599453
plusieurs,2,0.6931471805599453
isochronic,2,0.6931471805599453
IISs,2,0.6931471805599453
MHT,2,0.6931471805599453
Syndrome-CoV,2,0.6931471805599453
KwaZulu-Natal,2,0.6931471805599453
transplacentally,2,0.6931471805599453
1053,2,0.6931471805599453
été,2,0.6931471805599453
African-specific,2,0.6931471805599453
McAbs,2,0.6931471805599453
third-trimester,2,0.6931471805599453
ADVIA,2,0.6931471805599453
signes,2,0.6931471805599453
chez,2,0.6931471805599453
deux,2,0.6931471805599453
Storm,2,0.6931471805599453
fin,2,0.6931471805599453
maladie,2,0.6931471805599453
OTCA,2,0.6931471805599453
Coronary-prone,2,0.6931471805599453
jeopardise,2,0.6931471805599453
2020-January,2,0.6931471805599453
1-m,2,0.6931471805599453
encapsulate,2,0.6931471805599453
Door-to-needle,2,0.6931471805599453
Latinao,2,0.6931471805599453
crystalloid,2,0.6931471805599453
Commensal,2,0.6931471805599453
protein-expressing,2,0.6931471805599453
virus-immune,2,0.6931471805599453
p0029,2,0.6931471805599453
mail-based,2,0.6931471805599453
LVFWR,2,0.6931471805599453
HLA-identical,2,0.6931471805599453
-B,2,0.6931471805599453
para-clinical,2,0.6931471805599453
Murmansk,2,0.6931471805599453
Arkhangelsk,2,0.6931471805599453
ENSO,2,0.6931471805599453
Yichang,2,0.6931471805599453
P0007,2,0.6931471805599453
Sc,2,0.6931471805599453
Neutrophil-to-lymphocyte,2,0.6931471805599453
side‑effects,2,0.6931471805599453
118000,2,0.6931471805599453
vaccine‑induced,2,0.6931471805599453
AMI-BTT,2,0.6931471805599453
desensitizations,2,0.6931471805599453
season-related,2,0.6931471805599453
Cumulatively,2,0.6931471805599453
eighty-eight,2,0.6931471805599453
TAFI,2,0.6931471805599453
BHarbin0794,2,0.6931471805599453
interferon-y,2,0.6931471805599453
RATS,2,0.6931471805599453
4·72,2,0.6931471805599453
case-mix,2,0.6931471805599453
subxiphoid,2,0.6931471805599453
bictegravir,2,0.6931471805599453
divert,2,0.6931471805599453
cheat,2,0.6931471805599453
NAg,2,0.6931471805599453
SAg,2,0.6931471805599453
workings,2,0.6931471805599453
non-neurologists,2,0.6931471805599453
measles-mumps-rubella,2,0.6931471805599453
individualism,2,0.6931471805599453
N95s,2,0.6931471805599453
elastomeric,2,0.6931471805599453
MAST-I,2,0.6931471805599453
Discussed,2,0.6931471805599453
mouthwashes,2,0.6931471805599453
re-evaluating,2,0.6931471805599453
equaled,2,0.6931471805599453
cat-to-cat,2,0.6931471805599453
anthropologists,2,0.6931471805599453
leopards,2,0.6931471805599453
oversimplification,2,0.6931471805599453
Output,2,0.6931471805599453
granulocyte-macrophage,2,0.6931471805599453
lucky,2,0.6931471805599453
maturing,2,0.6931471805599453
beta2-AR,2,0.6931471805599453
radiomics-based,2,0.6931471805599453
treat-only,2,0.6931471805599453
cross-recognition,2,0.6931471805599453
3116,2,0.6931471805599453
leave-one-out,2,0.6931471805599453
β-weights,2,0.6931471805599453
1619,2,0.6931471805599453
0868,2,0.6931471805599453
texture-related,2,0.6931471805599453
HA-pseudoviruses,2,0.6931471805599453
Hallmarks,2,0.6931471805599453
schizophrenics,2,0.6931471805599453
trustworthiness,2,0.6931471805599453
05-1,2,0.6931471805599453
unjammed,2,0.6931471805599453
pastoris,2,0.6931471805599453
Pichia,2,0.6931471805599453
Wuchang,2,0.6931471805599453
rugosa,2,0.6931471805599453
38-54,2,0.6931471805599453
seven-valent,2,0.6931471805599453
walk-through,2,0.6931471805599453
solo,2,0.6931471805599453
masquerading,2,0.6931471805599453
knowledge-sharing,2,0.6931471805599453
stumbling,2,0.6931471805599453
macrocephalus,2,0.6931471805599453
Serfling-type,2,0.6931471805599453
minireplicon,2,0.6931471805599453
3-15,2,0.6931471805599453
rRBD,2,0.6931471805599453
myotubes,2,0.6931471805599453
rs1044009,2,0.6931471805599453
TEE-detected,2,0.6931471805599453
0903,2,0.6931471805599453
4538,2,0.6931471805599453
0502,2,0.6931471805599453
hippocampus-dependent,2,0.6931471805599453
CCS-1,2,0.6931471805599453
multinucleated,2,0.6931471805599453
non-first-line,2,0.6931471805599453
immunocytochemistry,2,0.6931471805599453
Lee,2,0.6931471805599453
1996-98,2,0.6931471805599453
incongruence,2,0.6931471805599453
13685,2,0.6931471805599453
severity-specific,2,0.6931471805599453
assurances,2,0.6931471805599453
S1-specific,2,0.6931471805599453
HIV-,2,0.6931471805599453
dipyridamol,2,0.6931471805599453
H1N1-influenza,2,0.6931471805599453
Industrialized,2,0.6931471805599453
coronaviridae,2,0.6931471805599453
2009-associated,2,0.6931471805599453
clinical-anamnestic,2,0.6931471805599453
rhythmogram,2,0.6931471805599453
Th2-associated,2,0.6931471805599453
neuro-ophthalmic,2,0.6931471805599453
campus-based,2,0.6931471805599453
filariae,2,0.6931471805599453
1985-1988,2,0.6931471805599453
NFkB,2,0.6931471805599453
JR-NET2,2,0.6931471805599453
MB-isoenzyme,2,0.6931471805599453
ALDH-2,2,0.6931471805599453
exonucleases,2,0.6931471805599453
forbidden,2,0.6931471805599453
one-group,2,0.6931471805599453
behaved,2,0.6931471805599453
2831,2,0.6931471805599453
bronchii,2,0.6931471805599453
Sollentuna,2,0.6931471805599453
resultsResults,2,0.6931471805599453
UniProtKB,2,0.6931471805599453
ORF14,2,0.6931471805599453
9b,2,0.6931471805599453
Round,2,0.6931471805599453
Hesse,2,0.6931471805599453
SAHE,2,0.6931471805599453
already-approved,2,0.6931471805599453
S-glycoprotein,2,0.6931471805599453
animal-free,2,0.6931471805599453
myocardiopathy,2,0.6931471805599453
virus-caused,2,0.6931471805599453
capsids,2,0.6931471805599453
liver-related,2,0.6931471805599453
HDLs,2,0.6931471805599453
leukotriene-receptor,2,0.6931471805599453
parent-completed,2,0.6931471805599453
Y15,2,0.6931471805599453
duplications,2,0.6931471805599453
commanding,2,0.6931471805599453
copying,2,0.6931471805599453
FluResearchNet,2,0.6931471805599453
N10,2,0.6931471805599453
3048,2,0.6931471805599453
N0,2,0.6931471805599453
unmasks,2,0.6931471805599453
LT-alpha,2,0.6931471805599453
AIRS,2,0.6931471805599453
Basedow,2,0.6931471805599453
Trace,2,0.6931471805599453
subendo-,2,0.6931471805599453
MI-induced,2,0.6931471805599453
anti-TSH,2,0.6931471805599453
membrane-engineered,2,0.6931471805599453
84-100,2,0.6931471805599453
iPhone,2,0.6931471805599453
bleak,2,0.6931471805599453
Hantavirus,2,0.6931471805599453
Zidovudine,2,0.6931471805599453
glibenclamide,2,0.6931471805599453
neuroborreliosis,2,0.6931471805599453
Economical,2,0.6931471805599453
11-yr,2,0.6931471805599453
FAK-KD,2,0.6931471805599453
kinase-dead,2,0.6931471805599453
Jules,2,0.6931471805599453
RSA,2,0.6931471805599453
0-22,2,0.6931471805599453
PFER,2,0.6931471805599453
51-66,2,0.6931471805599453
1110,2,0.6931471805599453
S100A1,2,0.6931471805599453
cannulated,2,0.6931471805599453
Insomnia,2,0.6931471805599453
PDE5,2,0.6931471805599453
H5N,2,0.6931471805599453
Gabon,2,0.6931471805599453
€15,2,0.6931471805599453
Asymmetry,2,0.6931471805599453
forepaw,2,0.6931471805599453
spike-in,2,0.6931471805599453
2008-2018,2,0.6931471805599453
19-37,2,0.6931471805599453
tract-level,2,0.6931471805599453
URIs,2,0.6931471805599453
Norrbotten,2,0.6931471805599453
Exhaustive,2,0.6931471805599453
COVID-19Results,2,0.6931471805599453
marijuana-associated,2,0.6931471805599453
platform-based,2,0.6931471805599453
WBCs,2,0.6931471805599453
rehab,2,0.6931471805599453
11100000,2,0.6931471805599453
390°C,2,0.6931471805599453
one-tube,2,0.6931471805599453
Verify,2,0.6931471805599453
-85,2,0.6931471805599453
-45,2,0.6931471805599453
nitrate-enhanced,2,0.6931471805599453
Mönkemüller,2,0.6931471805599453
G5,2,0.6931471805599453
semi-isolated,2,0.6931471805599453
15-mer,2,0.6931471805599453
microfluidics-based,2,0.6931471805599453
filiform,2,0.6931471805599453
Mini-Log,2,0.6931471805599453
2828,2,0.6931471805599453
80-95,2,0.6931471805599453
062-083,2,0.6931471805599453
IVO,2,0.6931471805599453
cysteines,2,0.6931471805599453
FHMC,2,0.6931471805599453
cicatricial,2,0.6931471805599453
FTY720,2,0.6931471805599453
MIDI-piano,2,0.6931471805599453
issuance,2,0.6931471805599453
punch,2,0.6931471805599453
1918-1921,2,0.6931471805599453
Employee,2,0.6931471805599453
weakest,2,0.6931471805599453
Architect™,2,0.6931471805599453
Hôpital,2,0.6931471805599453
Romagna,2,0.6931471805599453
á-2,2,0.6931471805599453
transpires,2,0.6931471805599453
end-inspiratory,2,0.6931471805599453
ectopics,2,0.6931471805599453
laboratory-defined,2,0.6931471805599453
somatization,2,0.6931471805599453
plateletpheresis,2,0.6931471805599453
3053,2,0.6931471805599453
Subdividing,2,0.6931471805599453
rest-injected,2,0.6931471805599453
1242,2,0.6931471805599453
epiglottitis,2,0.6931471805599453
mammal-infecting,2,0.6931471805599453
cardio-thoracic,2,0.6931471805599453
Hyderabad,2,0.6931471805599453
IL-25-induced,2,0.6931471805599453
4-PBA,2,0.6931471805599453
CysLT2,2,0.6931471805599453
pmoll,2,0.6931471805599453
non-First,2,0.6931471805599453
non-FN,2,0.6931471805599453
self-resolving,2,0.6931471805599453
hypocapnia,2,0.6931471805599453
YAG,2,0.6931471805599453
presupposes,2,0.6931471805599453
biocidal,2,0.6931471805599453
enumeration,2,0.6931471805599453
arthropod-borne,2,0.6931471805599453
survivor-caregiver,2,0.6931471805599453
Circular,2,0.6931471805599453
salmeterolfluticasone,2,0.6931471805599453
trialists,2,0.6931471805599453
judges,2,0.6931471805599453
-98,2,0.6931471805599453
-2SD,2,0.6931471805599453
WMAS,2,0.6931471805599453
pipetting,2,0.6931471805599453
EPRR,2,0.6931471805599453
Dispersion,2,0.6931471805599453
tilted,2,0.6931471805599453
Enigma,2,0.6931471805599453
moderate-grade,2,0.6931471805599453
trans-multi-disciplinary,2,0.6931471805599453
defibrillating,2,0.6931471805599453
195R,2,0.6931471805599453
drug-refractory,2,0.6931471805599453
austerity,2,0.6931471805599453
subcohorts,2,0.6931471805599453
polymer-based,2,0.6931471805599453
3a,2,0.6931471805599453
R195K,2,0.6931471805599453
open-reading,2,0.6931471805599453
revitalizing,2,0.6931471805599453
infarct100,2,0.6931471805599453
quantitates,2,0.6931471805599453
ATTICUS,2,0.6931471805599453
age-and-sex-specific,2,0.6931471805599453
heredity-related,2,0.6931471805599453
PRMT1,2,0.6931471805599453
methylates,2,0.6931471805599453
R177,2,0.6931471805599453
RGGRG,2,0.6931471805599453
releasable,2,0.6931471805599453
nasopharyngealmidturbinate,2,0.6931471805599453
Jenner,2,0.6931471805599453
eyection,2,0.6931471805599453
activation-recovery,2,0.6931471805599453
AQI,2,0.6931471805599453
transcriptionally,2,0.6931471805599453
bronchoprotective,2,0.6931471805599453
1000-1200,2,0.6931471805599453
plasma-fibrinogen,2,0.6931471805599453
0348,2,0.6931471805599453
AluI,2,0.6931471805599453
HTI,2,0.6931471805599453
1980-1999,2,0.6931471805599453
0504,2,0.6931471805599453
n139,2,0.6931471805599453
HARM,2,0.6931471805599453
0220,2,0.6931471805599453
premarket,2,0.6931471805599453
detritus,2,0.6931471805599453
Absenteeism,2,0.6931471805599453
C818T,2,0.6931471805599453
Tonsillectomy,2,0.6931471805599453
11B,2,0.6931471805599453
1148,2,0.6931471805599453
1501,2,0.6931471805599453
undigested,2,0.6931471805599453
beagles,2,0.6931471805599453
FebruaryMarch,2,0.6931471805599453
Allpyral,2,0.6931471805599453
hospital-wide,2,0.6931471805599453
misnomer,2,0.6931471805599453
antigenemiaviremia,2,0.6931471805599453
beta1-subunit,2,0.6931471805599453
14-44,2,0.6931471805599453
calcium-activated,2,0.6931471805599453
cardiomyocytic,2,0.6931471805599453
EcoRI,2,0.6931471805599453
angiographical,2,0.6931471805599453
AGA,2,0.6931471805599453
CCAM,2,0.6931471805599453
3100,2,0.6931471805599453
interconnectedness,2,0.6931471805599453
nonstatin,2,0.6931471805599453
11-19,2,0.6931471805599453
Postal,2,0.6931471805599453
pectinate,2,0.6931471805599453
Administration-cleared,2,0.6931471805599453
endsystolic,2,0.6931471805599453
Pro-ANP,2,0.6931471805599453
pro-ANP,2,0.6931471805599453
triennium,2,0.6931471805599453
chemoprevention,2,0.6931471805599453
AFP,2,0.6931471805599453
well-publicized,2,0.6931471805599453
Emile,2,0.6931471805599453
Picture,2,0.6931471805599453
HFAV,2,0.6931471805599453
NESID,2,0.6931471805599453
antioxidation,2,0.6931471805599453
under-vaccinated,2,0.6931471805599453
Protracted,2,0.6931471805599453
STEMI-equivalents,2,0.6931471805599453
2524,2,0.6931471805599453
ChAdOx1nCoV-19,2,0.6931471805599453
onsetoffset,2,0.6931471805599453
Root-mean-square,2,0.6931471805599453
Primers,2,0.6931471805599453
vaccins,2,0.6931471805599453
softening,2,0.6931471805599453
non-motor,2,0.6931471805599453
blood-air,2,0.6931471805599453
acrocentral,2,0.6931471805599453
nonwhites,2,0.6931471805599453
S982A,2,0.6931471805599453
thinners,2,0.6931471805599453
6610,2,0.6931471805599453
Institutet,2,0.6931471805599453
arterys,2,0.6931471805599453
PCBA,2,0.6931471805599453
McGill,2,0.6931471805599453
leveling,2,0.6931471805599453
rPCI,2,0.6931471805599453
modulations,2,0.6931471805599453
outspread,2,0.6931471805599453
ionol,2,0.6931471805599453
Spearman-rho,2,0.6931471805599453
Orthopedics,2,0.6931471805599453
LVOS,2,0.6931471805599453
2FdC,2,0.6931471805599453
WMCs,2,0.6931471805599453
Anzhen,2,0.6931471805599453
2-yr-old,2,0.6931471805599453
Della,2,0.6931471805599453
111In-antimyosin,2,0.6931471805599453
IVSPW,2,0.6931471805599453
inflicts,2,0.6931471805599453
horrendous,2,0.6931471805599453
cardiotropic,2,0.6931471805599453
21-22,2,0.6931471805599453
TTA,2,0.6931471805599453
Gastroenterological,2,0.6931471805599453
BIOMONITOR,2,0.6931471805599453
0489,2,0.6931471805599453
self-identity,2,0.6931471805599453
Pre-admission,2,0.6931471805599453
enlistment,2,0.6931471805599453
IV3,2,0.6931471805599453
eco-friendly,2,0.6931471805599453
RNA-vaccines,2,0.6931471805599453
aircrews,2,0.6931471805599453
Bronchodilatation,2,0.6931471805599453
20067,2,0.6931471805599453
-233,2,0.6931471805599453
20034,2,0.6931471805599453
-160,2,0.6931471805599453
dichorionic,2,0.6931471805599453
self-grounding,2,0.6931471805599453
Surfactant,2,0.6931471805599453
Bioactive,2,0.6931471805599453
rings,2,0.6931471805599453
explants,2,0.6931471805599453
-324,2,0.6931471805599453
Volunteer,2,0.6931471805599453
playground,2,0.6931471805599453
LFTs,2,0.6931471805599453
ALA-I,2,0.6931471805599453
rheumatologist,2,0.6931471805599453
ml3,2,0.6931471805599453
PN,2,0.6931471805599453
ICAI,2,0.6931471805599453
resampling,2,0.6931471805599453
spectrophotometrically,2,0.6931471805599453
re-vaccination,2,0.6931471805599453
LIN,2,0.6931471805599453
untenable,2,0.6931471805599453
mCANP,2,0.6931471805599453
SEIRA,2,0.6931471805599453
Lins,2,0.6931471805599453
Disposition,2,0.6931471805599453
Charlotte,2,0.6931471805599453
check-up,2,0.6931471805599453
EPDs,2,0.6931471805599453
nongravid,2,0.6931471805599453
1506,2,0.6931471805599453
2583,2,0.6931471805599453
1684,2,0.6931471805599453
31-57,2,0.6931471805599453
Las,2,0.6931471805599453
chyle,2,0.6931471805599453
intrapsychic,2,0.6931471805599453
likelihoods,2,0.6931471805599453
nose-to-brain,2,0.6931471805599453
raged,2,0.6931471805599453
1822,2,0.6931471805599453
23-31,2,0.6931471805599453
clinicopathogenetic,2,0.6931471805599453
Biffl,2,0.6931471805599453
9992,2,0.6931471805599453
HCL-based,2,0.6931471805599453
astma,2,0.6931471805599453
Uttar,2,0.6931471805599453
cold-,2,0.6931471805599453
Gary,2,0.6931471805599453
4-years-old,2,0.6931471805599453
self-test,2,0.6931471805599453
8-item,2,0.6931471805599453
8284,2,0.6931471805599453
rages,2,0.6931471805599453
Chittagong,2,0.6931471805599453
sMCAO,2,0.6931471805599453
nonsymptomatic,2,0.6931471805599453
CTPA,2,0.6931471805599453
imparted,2,0.6931471805599453
Caregiver-assisted,2,0.6931471805599453
2D-STE,2,0.6931471805599453
Preference-based,2,0.6931471805599453
community-scale,2,0.6931471805599453
EQ-5D-3L,2,0.6931471805599453
1714,2,0.6931471805599453
1103,2,0.6931471805599453
tannins,2,0.6931471805599453
urothorax,2,0.6931471805599453
reflectance,2,0.6931471805599453
2-min,2,0.6931471805599453
329-473,2,0.6931471805599453
1726,2,0.6931471805599453
Placing,2,0.6931471805599453
H6N2,2,0.6931471805599453
bioimpedance,2,0.6931471805599453
30-s,2,0.6931471805599453
vaccination-associated,2,0.6931471805599453
HCL,2,0.6931471805599453
ketotifene,2,0.6931471805599453
α-SYN,2,0.6931471805599453
JUST,2,0.6931471805599453
Saving,2,0.6931471805599453
Five-hundred,2,0.6931471805599453
10-23,2,0.6931471805599453
carcinomas,2,0.6931471805599453
URTIs,2,0.6931471805599453
substituting,2,0.6931471805599453
NNT,2,0.6931471805599453
immunes,2,0.6931471805599453
integrin-mediated,2,0.6931471805599453
bulbs,2,0.6931471805599453
bradycardiac,2,0.6931471805599453
metabolic-associated,2,0.6931471805599453
zeta,2,0.6931471805599453
antifibrillatory,2,0.6931471805599453
VeroE6TMPRSS2,2,0.6931471805599453
H-77,2,0.6931471805599453
teenaged,2,0.6931471805599453
1835,2,0.6931471805599453
dopaminergic,2,0.6931471805599453
C-D-T,2,0.6931471805599453
IUmlh,2,0.6931471805599453
discredit,2,0.6931471805599453
PTGS2,2,0.6931471805599453
2-mgm3,2,0.6931471805599453
Swine-origin,2,0.6931471805599453
α-synuclein,2,0.6931471805599453
synergetic,2,0.6931471805599453
2009-2016,2,0.6931471805599453
vectormRNA,2,0.6931471805599453
non-LVO,2,0.6931471805599453
metallopeptidase,2,0.6931471805599453
low-to-moderate,2,0.6931471805599453
diproprionate,2,0.6931471805599453
haphazard,2,0.6931471805599453
salbuthamol,2,0.6931471805599453
PHLs,2,0.6931471805599453
Multi-centre,2,0.6931471805599453
Yiqi,2,0.6931471805599453
AOT,2,0.6931471805599453
Favara,2,0.6931471805599453
Favignana,2,0.6931471805599453
CRV,2,0.6931471805599453
AIEOP,2,0.6931471805599453
prokinetic,2,0.6931471805599453
firms,2,0.6931471805599453
SQNP,2,0.6931471805599453
19471,2,0.6931471805599453
GSE97320,2,0.6931471805599453
protein‑protein,2,0.6931471805599453
Procedure,2,0.6931471805599453
feminist,2,0.6931471805599453
unfractioned,2,0.6931471805599453
99m-labeled,2,0.6931471805599453
oro-,2,0.6931471805599453
AWAD,2,0.6931471805599453
tetraparesis,2,0.6931471805599453
Disease-modifying,2,0.6931471805599453
1324,2,0.6931471805599453
multi-country,2,0.6931471805599453
WSN33,2,0.6931471805599453
AARs,2,0.6931471805599453
10-meter,2,0.6931471805599453
inductions,2,0.6931471805599453
miR-132,2,0.6931471805599453
≥11,2,0.6931471805599453
-102,2,0.6931471805599453
sucked,2,0.6931471805599453
objectivization,2,0.6931471805599453
prethrombolysis,2,0.6931471805599453
VSV-∆G-spike,2,0.6931471805599453
9813,2,0.6931471805599453
TRACK,2,0.6931471805599453
perpetual,2,0.6931471805599453
Barnett,2,0.6931471805599453
Gradually,2,0.6931471805599453
mFIM,2,0.6931471805599453
pacificus,2,0.6931471805599453
june,2,0.6931471805599453
immunotests,2,0.6931471805599453
Dissimilar,2,0.6931471805599453
cancelation,2,0.6931471805599453
long-COVID-19,2,0.6931471805599453
Isaacs,2,0.6931471805599453
midlevel,2,0.6931471805599453
monophyletic,2,0.6931471805599453
3D-STE,2,0.6931471805599453
15-120,2,0.6931471805599453
Mapp,2,0.6931471805599453
Discrete,2,0.6931471805599453
mobilises,2,0.6931471805599453
telediastolic,2,0.6931471805599453
QQS,2,0.6931471805599453
Self-administered,2,0.6931471805599453
NSFC,2,0.6931471805599453
Coronavirus-19,2,0.6931471805599453
butchering,2,0.6931471805599453
BACM,2,0.6931471805599453
Seroepidemiologic,2,0.6931471805599453
Hosp,2,0.6931471805599453
siRNA-mediated,2,0.6931471805599453
99mTc-DTPA,2,0.6931471805599453
HPB,2,0.6931471805599453
-cells,2,0.6931471805599453
multifold,2,0.6931471805599453
3-45h,2,0.6931471805599453
denuded,2,0.6931471805599453
entry-related,2,0.6931471805599453
CD163-macrophages,2,0.6931471805599453
Mex09,2,0.6931471805599453
neferine,2,0.6931471805599453
Neferine,2,0.6931471805599453
C-,2,0.6931471805599453
NIH50,2,0.6931471805599453
siRNA-MR,2,0.6931471805599453
quencher,2,0.6931471805599453
overtake,2,0.6931471805599453
dipeptide,2,0.6931471805599453
dipeptides,2,0.6931471805599453
FRET,2,0.6931471805599453
superhydrophobicity,2,0.6931471805599453
prooxidative,2,0.6931471805599453
twindemic,2,0.6931471805599453
jumps,2,0.6931471805599453
MISs,2,0.6931471805599453
VHH,2,0.6931471805599453
willingnessunwillingness,2,0.6931471805599453
αvβ3,2,0.6931471805599453
echocardiographies,2,0.6931471805599453
unsystematic,2,0.6931471805599453
shielded,2,0.6931471805599453
severity-of-asthma,2,0.6931471805599453
directindirect,2,0.6931471805599453
subtypical,2,0.6931471805599453
two-factor,2,0.6931471805599453
Gyeonggi-do,2,0.6931471805599453
1692,2,0.6931471805599453
1283,2,0.6931471805599453
Speed-Oligo,2,0.6931471805599453
GP-based,2,0.6931471805599453
unreliability,2,0.6931471805599453
conversions,2,0.6931471805599453
LC-MRM-MS,2,0.6931471805599453
Gold,2,0.6931471805599453
EIATS-GP,2,0.6931471805599453
chloramine-T,2,0.6931471805599453
FluShield,2,0.6931471805599453
EIATS-WV,2,0.6931471805599453
electrocardiographic-necropsy,2,0.6931471805599453
126-190,2,0.6931471805599453
maternities,2,0.6931471805599453
COVID-negative,2,0.6931471805599453
aldosteronism,2,0.6931471805599453
sub-scores,2,0.6931471805599453
zofenopril,2,0.6931471805599453
0728,2,0.6931471805599453
SMILE,2,0.6931471805599453
second-most,2,0.6931471805599453
-138,2,0.6931471805599453
riddle,2,0.6931471805599453
2849,2,0.6931471805599453
Hyperventilation,2,0.6931471805599453
IULm2,2,0.6931471805599453
Tai,2,0.6931471805599453
Metro,2,0.6931471805599453
vault,2,0.6931471805599453
exits,2,0.6931471805599453
Iba,2,0.6931471805599453
photobiomodulation,2,0.6931471805599453
Ecoli,2,0.6931471805599453
CIED,2,0.6931471805599453
non-Caucasians,2,0.6931471805599453
SM1,2,0.6931471805599453
near-deaths,2,0.6931471805599453
24-279,2,0.6931471805599453
conquer,2,0.6931471805599453
1490,2,0.6931471805599453
PRISMA-ScR,2,0.6931471805599453
RNAO,2,0.6931471805599453
Omsk,2,0.6931471805599453
1481,2,0.6931471805599453
high-mortality,2,0.6931471805599453
Biosensors,2,0.6931471805599453
Accommodations,2,0.6931471805599453
CD-sACE2,2,0.6931471805599453
laboratory-generated,2,0.6931471805599453
subserving,2,0.6931471805599453
immunostimulation,2,0.6931471805599453
upheavals,2,0.6931471805599453
020-098,2,0.6931471805599453
odynophagia,2,0.6931471805599453
alpha-actin,2,0.6931471805599453
cross-group,2,0.6931471805599453
alpha-MHC,2,0.6931471805599453
interactomics,2,0.6931471805599453
4741,2,0.6931471805599453
Traffic,2,0.6931471805599453
Hematologic,2,0.6931471805599453
thrombomodulin,2,0.6931471805599453
Syntax,2,0.6931471805599453
microgramskgmin,2,0.6931471805599453
25OH,2,0.6931471805599453
well-calibrated,2,0.6931471805599453
0918,2,0.6931471805599453
SARS-2-CoV,2,0.6931471805599453
Hannover,2,0.6931471805599453
inquired,2,0.6931471805599453
ghost,2,0.6931471805599453
disulfide-thiol,2,0.6931471805599453
re-PCI,2,0.6931471805599453
overlooking,2,0.6931471805599453
respectivelyConclusion,2,0.6931471805599453
assayResults,2,0.6931471805599453
n43,2,0.6931471805599453
acetylators,2,0.6931471805599453
12-60,2,0.6931471805599453
necessitans,2,0.6931471805599453
interconnecting,2,0.6931471805599453
roadblock,2,0.6931471805599453
-136,2,0.6931471805599453
2020b,2,0.6931471805599453
cellscollagen,2,0.6931471805599453
post-therapeutic,2,0.6931471805599453
cathelicidin,2,0.6931471805599453
Unequivocal,2,0.6931471805599453
attitudinally,2,0.6931471805599453
Pardi,2,0.6931471805599453
pelagic,2,0.6931471805599453
single-patient,2,0.6931471805599453
transferal,2,0.6931471805599453
Pharmacogenomic,2,0.6931471805599453
strictest,2,0.6931471805599453
AfSD,2,0.6931471805599453
mentor,2,0.6931471805599453
1918–19,2,0.6931471805599453
month-to-month,2,0.6931471805599453
GAVI,2,0.6931471805599453
Mossong,2,0.6931471805599453
Glasser,2,0.6931471805599453
extracutaneous,2,0.6931471805599453
dermatoses,2,0.6931471805599453
A570D,2,0.6931471805599453
tractability,2,0.6931471805599453
univariates,2,0.6931471805599453
BSWH,2,0.6931471805599453
to5,2,0.6931471805599453
nanoparticle-encapsulated,2,0.6931471805599453
33·3,2,0.6931471805599453
paste,2,0.6931471805599453
5880,2,0.6931471805599453
alpha-chloro,2,0.6931471805599453
pneumoperitoneum,2,0.6931471805599453
GdmCl,2,0.6931471805599453
107-149,2,0.6931471805599453
chlorinating,2,0.6931471805599453
090-095,2,0.6931471805599453
amendment,2,0.6931471805599453
nonsensitizing,2,0.6931471805599453
bend,2,0.6931471805599453
matched-pairs,2,0.6931471805599453
DM1,2,0.6931471805599453
Homeostasis,2,0.6931471805599453
S-Myoglobin,2,0.6931471805599453
NC045512,2,0.6931471805599453
Outline,2,0.6931471805599453
Dalbergia,2,0.6931471805599453
palisander,2,0.6931471805599453
FOUR,2,0.6931471805599453
fibrolipoma,2,0.6931471805599453
Ardabil,2,0.6931471805599453
nonimmediate,2,0.6931471805599453
anatomical-functional,2,0.6931471805599453
nQ30,2,0.6931471805599453
ghost-like,2,0.6931471805599453
nitro-blue,2,0.6931471805599453
MUR,2,0.6931471805599453
CQD15,2,0.6931471805599453
Fauci,2,0.6931471805599453
Woolhouse,2,0.6931471805599453
coatingbonding,2,0.6931471805599453
Liaoning,2,0.6931471805599453
SC2InflAInflB-UCT,2,0.6931471805599453
frontosubcortical,2,0.6931471805599453
0·03,2,0.6931471805599453
nSES,2,0.6931471805599453
Amendment,2,0.6931471805599453
SirRH,2,0.6931471805599453
sotalol,2,0.6931471805599453
ΔsirR,2,0.6931471805599453
waiving,2,0.6931471805599453
metatranscriptomic,2,0.6931471805599453
tPA-induced,2,0.6931471805599453
nafamostat,2,0.6931471805599453
treatment-time,2,0.6931471805599453
CBN,2,0.6931471805599453
elongated,2,0.6931471805599453
humanmouse,2,0.6931471805599453
104-fold,2,0.6931471805599453
SLIR,2,0.6931471805599453
23-SL,2,0.6931471805599453
cpn60,2,0.6931471805599453
freeze,2,0.6931471805599453
socialist,2,0.6931471805599453
quickness,2,0.6931471805599453
East-West,2,0.6931471805599453
resonant,2,0.6931471805599453
tesla,2,0.6931471805599453
hallways,2,0.6931471805599453
transgenes,2,0.6931471805599453
dead-volume,2,0.6931471805599453
transgene,2,0.6931471805599453
FCG,2,0.6931471805599453
XXF,2,0.6931471805599453
sideways,2,0.6931471805599453
XXM,2,0.6931471805599453
XYF,2,0.6931471805599453
XYM,2,0.6931471805599453
42-year,2,0.6931471805599453
INTERHEART,2,0.6931471805599453
Sarawak,2,0.6931471805599453
PEF-guided,2,0.6931471805599453
hyperreagibility,2,0.6931471805599453
55-year,2,0.6931471805599453
Wake,2,0.6931471805599453
core-too-large,2,0.6931471805599453
21-year,2,0.6931471805599453
DBPCOFC,2,0.6931471805599453
accorded,2,0.6931471805599453
right-censoring,2,0.6931471805599453
symptomsResults,2,0.6931471805599453
inductor,2,0.6931471805599453
Poludanum,2,0.6931471805599453
Altmetric,2,0.6931471805599453
Pharm,2,0.6931471805599453
coursing,2,0.6931471805599453
RSVC,2,0.6931471805599453
Haptoglobin,2,0.6931471805599453
27-day,2,0.6931471805599453
3-month-old,2,0.6931471805599453
sNMES,2,0.6931471805599453
historiography,2,0.6931471805599453
CTACTP,2,0.6931471805599453
XY,2,0.6931471805599453
FGF-23,2,0.6931471805599453
ACE2P1D1,2,0.6931471805599453
between-state,2,0.6931471805599453
ACE2P2D1,2,0.6931471805599453
distance-based,2,0.6931471805599453
self-gated,2,0.6931471805599453
protein-ACE2,2,0.6931471805599453
co-regulated,2,0.6931471805599453
IL-13-dependent,2,0.6931471805599453
distillation,2,0.6931471805599453
truths,2,0.6931471805599453
trim-and-fill,2,0.6931471805599453
2-Hi,2,0.6931471805599453
chi2-test,2,0.6931471805599453
Toyama,2,0.6931471805599453
attentionworking,2,0.6931471805599453
theory-informed,2,0.6931471805599453
landfall,2,0.6931471805599453
pinhole,2,0.6931471805599453
ozonation,2,0.6931471805599453
4-16,2,0.6931471805599453
non-normal,2,0.6931471805599453
fructose,2,0.6931471805599453
Bristol,2,0.6931471805599453
deiodinase,2,0.6931471805599453
Self-isolation,2,0.6931471805599453
dimorphic,2,0.6931471805599453
volume-weighted,2,0.6931471805599453
Pregnancies,2,0.6931471805599453
destabilisation,2,0.6931471805599453
n74,2,0.6931471805599453
CARISMA,2,0.6931471805599453
PU1,2,0.6931471805599453
HLA-B,2,0.6931471805599453
Bach2,2,0.6931471805599453
stentingangioplasty,2,0.6931471805599453
1486,2,0.6931471805599453
crystals,2,0.6931471805599453
4392,2,0.6931471805599453
RHC,2,0.6931471805599453
05-10,2,0.6931471805599453
departures,2,0.6931471805599453
I-TASSER,2,0.6931471805599453
randomForest,2,0.6931471805599453
UD,2,0.6931471805599453
1856,2,0.6931471805599453
infectious-related,2,0.6931471805599453
child-rearing,2,0.6931471805599453
nongovernmental,2,0.6931471805599453
Gas,2,0.6931471805599453
Virologically,2,0.6931471805599453
postfusion,2,0.6931471805599453
gmdL,2,0.6931471805599453
enrol,2,0.6931471805599453
orthomyxovirus,2,0.6931471805599453
imaging-defined,2,0.6931471805599453
Alutard,2,0.6931471805599453
headgroups,2,0.6931471805599453
Segregation,2,0.6931471805599453
3702,2,0.6931471805599453
fibrin-bound,2,0.6931471805599453
antigenantibody,2,0.6931471805599453
elapse,2,0.6931471805599453
microelement,2,0.6931471805599453
Counselling,2,0.6931471805599453
postocclusion,2,0.6931471805599453
colourful,2,0.6931471805599453
multisession,2,0.6931471805599453
50-74,2,0.6931471805599453
VIPIT,2,0.6931471805599453
EEG-fMRI,2,0.6931471805599453
acutest,2,0.6931471805599453
codeine,2,0.6931471805599453
pyrazine,2,0.6931471805599453
seaport,2,0.6931471805599453
calcium-dependent,2,0.6931471805599453
veiled,2,0.6931471805599453
depots,2,0.6931471805599453
LVEDd,2,0.6931471805599453
lung-centric,2,0.6931471805599453
immunothrombosis,2,0.6931471805599453
No-Reperfusion,2,0.6931471805599453
Kingfisher,2,0.6931471805599453
trans-acting,2,0.6931471805599453
disadvantageous,2,0.6931471805599453
signal-regulated,2,0.6931471805599453
c-Jun,2,0.6931471805599453
CpGs,2,0.6931471805599453
NH2-terminal,2,0.6931471805599453
Intensity,2,0.6931471805599453
Si3N4,2,0.6931471805599453
CIDS,2,0.6931471805599453
8108,2,0.6931471805599453
shortlist,2,0.6931471805599453
cumulatively,2,0.6931471805599453
M2del11HAavir,2,0.6931471805599453
prerolandic,2,0.6931471805599453
asthma-trained,2,0.6931471805599453
laminin,2,0.6931471805599453
negation,2,0.6931471805599453
A549-IFN-λ2,2,0.6931471805599453
colorectum,2,0.6931471805599453
headteachers,2,0.6931471805599453
kick,2,0.6931471805599453
Volumes,2,0.6931471805599453
plurality,2,0.6931471805599453
22·7,2,0.6931471805599453
interventionThe,2,0.6931471805599453
expelling,2,0.6931471805599453
viewer,2,0.6931471805599453
interconnects,2,0.6931471805599453
subserous,2,0.6931471805599453
1592,2,0.6931471805599453
NCT04746092,2,0.6931471805599453
IFPMA,2,0.6931471805599453
Middle-east,2,0.6931471805599453
Baye,2,0.6931471805599453
oropharyngealnasal,2,0.6931471805599453
false‐negative,2,0.6931471805599453
single-call,2,0.6931471805599453
complacent,2,0.6931471805599453
ethicists,2,0.6931471805599453
Swine1930,2,0.6931471805599453
extraoral,2,0.6931471805599453
Floating-axis,2,0.6931471805599453
114000,2,0.6931471805599453
Hmong,2,0.6931471805599453
floating-axis,2,0.6931471805599453
perimetric,2,0.6931471805599453
fissuring,2,0.6931471805599453
Arteriosclerosis,2,0.6931471805599453
beta-sympathicomimetics,2,0.6931471805599453
Galicia,2,0.6931471805599453
alkalosis,2,0.6931471805599453
Squares,2,0.6931471805599453
wages,2,0.6931471805599453
1111,2,0.6931471805599453
rightful,2,0.6931471805599453
105th,2,0.6931471805599453
Furanthril,2,0.6931471805599453
5414,2,0.6931471805599453
systematizes,2,0.6931471805599453
passerine,2,0.6931471805599453
suppositions,2,0.6931471805599453
Multivalent,2,0.6931471805599453
Essay,2,0.6931471805599453
participations,2,0.6931471805599453
hilus,2,0.6931471805599453
pharmacologists,2,0.6931471805599453
Montevideo,2,0.6931471805599453
1948,2,0.6931471805599453
i-B-NHL,2,0.6931471805599453
Contents,2,0.6931471805599453
anaphylatoxin,2,0.6931471805599453
HADS-A,2,0.6931471805599453
Dizziness,2,0.6931471805599453
N-acetylneuraminic,2,0.6931471805599453
HADS-D,2,0.6931471805599453
nandrolone,2,0.6931471805599453
Icelandic,2,0.6931471805599453
Metadata,2,0.6931471805599453
highjacks,2,0.6931471805599453
1976-1980,2,0.6931471805599453
--The,2,0.6931471805599453
pro-IL-1β,2,0.6931471805599453
hand-crafted,2,0.6931471805599453
autoencoder,2,0.6931471805599453
SSAE,2,0.6931471805599453
Segmentation,2,0.6931471805599453
waveguide,2,0.6931471805599453
0943,2,0.6931471805599453
obsessed,2,0.6931471805599453
0904,2,0.6931471805599453
3323,2,0.6931471805599453
femtoliter,2,0.6931471805599453
1696,2,0.6931471805599453
Proceeding,2,0.6931471805599453
102000,2,0.6931471805599453
dwindling,2,0.6931471805599453
TNE,2,0.6931471805599453
outcome-related,2,0.6931471805599453
pre-outbreak,2,0.6931471805599453
introversion,2,0.6931471805599453
71-81,2,0.6931471805599453
Pilsudski,2,0.6931471805599453
extroversion,2,0.6931471805599453
high-consequence,2,0.6931471805599453
a-B-NHL,2,0.6931471805599453
Teen-caregiver,2,0.6931471805599453
refuted,2,0.6931471805599453
Adequacy,2,0.6931471805599453
Demand,2,0.6931471805599453
FFPs,2,0.6931471805599453
HLN,2,0.6931471805599453
Suffering,2,0.6931471805599453
H2-receptor,2,0.6931471805599453
201Tl-scintigraphy,2,0.6931471805599453
polyp,2,0.6931471805599453
cooperating,2,0.6931471805599453
99mTc-gated,2,0.6931471805599453
intronic,2,0.6931471805599453
persuaded,2,0.6931471805599453
peak-CPK,2,0.6931471805599453
SARS1,2,0.6931471805599453
Danbury,2,0.6931471805599453
crystallograms,2,0.6931471805599453
distortions,2,0.6931471805599453
hyperinfection,2,0.6931471805599453
helminthic,2,0.6931471805599453
stercoralis,2,0.6931471805599453
subacute-chronic,2,0.6931471805599453
bioassay,2,0.6931471805599453
correspondent,2,0.6931471805599453
contusions,2,0.6931471805599453
tympanometric,2,0.6931471805599453
microelectrodes,2,0.6931471805599453
2326,2,0.6931471805599453
2019-2021,2,0.6931471805599453
infection-acquired,2,0.6931471805599453
6--8,2,0.6931471805599453
microbeads,2,0.6931471805599453
wind-heat,2,0.6931471805599453
NMPA,2,0.6931471805599453
RASi,2,0.6931471805599453
IAV-associated,2,0.6931471805599453
variables--age,2,0.6931471805599453
virus⋅⋅⋅cell,2,0.6931471805599453
7949,2,0.6931471805599453
2266,2,0.6931471805599453
3770,2,0.6931471805599453
B11222,2,0.6931471805599453
orcokinin,2,0.6931471805599453
1545,2,0.6931471805599453
273100000,2,0.6931471805599453
8615,2,0.6931471805599453
3r,2,0.6931471805599453
Heartware,2,0.6931471805599453
Oasys-2,2,0.6931471805599453
9538,2,0.6931471805599453
9231,2,0.6931471805599453
sarcoplasm,2,0.6931471805599453
2451,2,0.6931471805599453
9385,2,0.6931471805599453
2278,2,0.6931471805599453
Respi-Strip,2,0.6931471805599453
NetEpi,2,0.6931471805599453
Granulocyte,2,0.6931471805599453
excor,2,0.6931471805599453
miscarriages,2,0.6931471805599453
PAG-to-PAG,2,0.6931471805599453
ALVD,2,0.6931471805599453
beans,2,0.6931471805599453
light-dark,2,0.6931471805599453
DeepVacPred,2,0.6931471805599453
commonly-used,2,0.6931471805599453
apicoseptal,2,0.6931471805599453
1165,2,0.6931471805599453
hyperfibrinogenemia,2,0.6931471805599453
racemosa,2,0.6931471805599453
behooves,2,0.6931471805599453
01-04,2,0.6931471805599453
violaceous,2,0.6931471805599453
discoloration,2,0.6931471805599453
Review-,2,0.6931471805599453
entertain,2,0.6931471805599453
29043,2,0.6931471805599453
buttress,2,0.6931471805599453
IIIIV,2,0.6931471805599453
cause-of-death,2,0.6931471805599453
extraesophageal,2,0.6931471805599453
cod,2,0.6931471805599453
capsulitis,2,0.6931471805599453
8170,2,0.6931471805599453
Post-COVID-19,2,0.6931471805599453
LFA-based,2,0.6931471805599453
lesion-behavior,2,0.6931471805599453
Coris,2,0.6931471805599453
PowerChek™,2,0.6931471805599453
prescriber,2,0.6931471805599453
hexoses,2,0.6931471805599453
13639,2,0.6931471805599453
HIV-1-based,2,0.6931471805599453
SARS-CoV-2-naive,2,0.6931471805599453
071080,2,0.6931471805599453
persevere,2,0.6931471805599453
otorhinolaryngology,2,0.6931471805599453
analgesic-induced,2,0.6931471805599453
pacing-induced,2,0.6931471805599453
mottled,2,0.6931471805599453
hypoxia-specific,2,0.6931471805599453
under-used,2,0.6931471805599453
pHO1,2,0.6931471805599453
value-for-money,2,0.6931471805599453
BioRxiv,2,0.6931471805599453
PB-MNC-CD34,2,0.6931471805599453
organomegaly,2,0.6931471805599453
co-exposure,2,0.6931471805599453
APhilippines,2,0.6931471805599453
hemagglutinin-esterase,2,0.6931471805599453
glycan-binding,2,0.6931471805599453
chickenpox‐like,2,0.6931471805599453
ticking,2,0.6931471805599453
DP2k,2,0.6931471805599453
Peiris,2,0.6931471805599453
CYamagata1089,2,0.6931471805599453
Malik,2,0.6931471805599453
unsubtypeable,2,0.6931471805599453
multi-season,2,0.6931471805599453
14·0,2,0.6931471805599453
13217,2,0.6931471805599453
rank-based,2,0.6931471805599453
Matsumoto,2,0.6931471805599453
EN,2,0.6931471805599453
RdRPN,2,0.6931471805599453
microenvironments,2,0.6931471805599453
immuno-inflammatory,2,0.6931471805599453
metaanalysis,2,0.6931471805599453
medals,2,0.6931471805599453
backlogs,2,0.6931471805599453
IRB-approved,2,0.6931471805599453
AASM,2,0.6931471805599453
Geyer,2,0.6931471805599453
well-proven,2,0.6931471805599453
upended,2,0.6931471805599453
cellμl,2,0.6931471805599453
Black-blood,2,0.6931471805599453
CD3CD8,2,0.6931471805599453
cryoglobulinaemic,2,0.6931471805599453
cross-neutralized,2,0.6931471805599453
organstissues,2,0.6931471805599453
neuropathogenic,2,0.6931471805599453
virally-encoded,2,0.6931471805599453
outwith,2,0.6931471805599453
KDO,2,0.6931471805599453
diary-card,2,0.6931471805599453
prepregnancy,2,0.6931471805599453
iterations,2,0.6931471805599453
Kolmogorov-Smirnov,2,0.6931471805599453
illnessILI,2,0.6931471805599453
set-shifting,2,0.6931471805599453
HA2-76,2,0.6931471805599453
RCAP,2,0.6931471805599453
legnagyobb,2,0.6931471805599453
ill-effects,2,0.6931471805599453
over-all,2,0.6931471805599453
forma,2,0.6931471805599453
ARA,2,0.6931471805599453
Primer,2,0.6931471805599453
cirrhotic,2,0.6931471805599453
nemenkénti,2,0.6931471805599453
tube-type,2,0.6931471805599453
EndoribonucleaseendoU,2,0.6931471805599453
MTase,2,0.6931471805599453
0986,2,0.6931471805599453
sub-haplotype,2,0.6931471805599453
SARS-CoV-2In,2,0.6931471805599453
-601,2,0.6931471805599453
-730,2,0.6931471805599453
-748,2,0.6931471805599453
-863,2,0.6931471805599453
-680,2,0.6931471805599453
2790,2,0.6931471805599453
-842,2,0.6931471805599453
-797,2,0.6931471805599453
összesen,2,0.6931471805599453
16728,2,0.6931471805599453
-900,2,0.6931471805599453
milliárd,2,0.6931471805599453
waiting-list,2,0.6931471805599453
vonatkozóan,2,0.6931471805599453
immunopathogenic,2,0.6931471805599453
Afr,2,0.6931471805599453
gyration,2,0.6931471805599453
Lungs,2,0.6931471805599453
first-of-its-kind,2,0.6931471805599453
Non-adjuvanted,2,0.6931471805599453
reductive,2,0.6931471805599453
Consumers,2,0.6931471805599453
1-mediated,2,0.6931471805599453
phage-displayed,2,0.6931471805599453
rs-fMRI,2,0.6931471805599453
betegségek,2,0.6931471805599453
Persistently,2,0.6931471805599453
indifferent,2,0.6931471805599453
cautioned,2,0.6931471805599453
Laninamivir,2,0.6931471805599453
sub-tasks,2,0.6931471805599453
holoendemic,2,0.6931471805599453
Plasmosorption,2,0.6931471805599453
Shen,2,0.6931471805599453
LCOS,2,0.6931471805599453
Poorer,2,0.6931471805599453
CHQ-PF50,2,0.6931471805599453
egészségbiztosítási,2,0.6931471805599453
socioenvironmental,2,0.6931471805599453
NTHi,2,0.6931471805599453
year-by-year,2,0.6931471805599453
NEAK,2,0.6931471805599453
eloquent,2,0.6931471805599453
Atelectasis,2,0.6931471805599453
teljes,2,0.6931471805599453
Top,2,0.6931471805599453
yearsThe,2,0.6931471805599453
esetében,2,0.6931471805599453
Npro,2,0.6931471805599453
száma,2,0.6931471805599453
hemichorea-hemiballismus,2,0.6931471805599453
sub-strain,2,0.6931471805599453
125-500,2,0.6931471805599453
UDOs,2,0.6931471805599453
Unknown,2,0.6931471805599453
thwarted,2,0.6931471805599453
DSM-5,2,0.6931471805599453
sequestering,2,0.6931471805599453
perihaematomal,2,0.6931471805599453
polymersome,2,0.6931471805599453
authenticate,2,0.6931471805599453
misuses,2,0.6931471805599453
autogenes,2,0.6931471805599453
72-108,2,0.6931471805599453
cancels,2,0.6931471805599453
treatment-course,2,0.6931471805599453
sternoclavicular,2,0.6931471805599453
114-144,2,0.6931471805599453
Diaphragmatic,2,0.6931471805599453
Lilacs,2,0.6931471805599453
13010,2,0.6931471805599453
mPFC,2,0.6931471805599453
Kieny,2,0.6931471805599453
co-detected,2,0.6931471805599453
HA1-71,2,0.6931471805599453
aktívfekvőbeteg-szakellátásban,2,0.6931471805599453
Secreted,2,0.6931471805599453
induced-asthma,2,0.6931471805599453
Long-lasting,2,0.6931471805599453
experimenter,2,0.6931471805599453
adenoviral-based,2,0.6931471805599453
FSRP,2,0.6931471805599453
Endoribonuclease,2,0.6931471805599453
androgens,2,0.6931471805599453
22-23,2,0.6931471805599453
FluView,2,0.6931471805599453
peridural,2,0.6931471805599453
6753,2,0.6931471805599453
arterio-arterial,2,0.6931471805599453
K-antagonists,2,0.6931471805599453
rounded,2,0.6931471805599453
Zones,2,0.6931471805599453
leukocyte-erythrocyte,2,0.6931471805599453
RIB,2,0.6931471805599453
6619,2,0.6931471805599453
non-SDIA,2,0.6931471805599453
aggregations,2,0.6931471805599453
került,2,0.6931471805599453
NCCPHP,2,0.6931471805599453
0076,2,0.6931471805599453
Naïve,2,0.6931471805599453
valamennyi,2,0.6931471805599453
mVmsec,2,0.6931471805599453
számított,2,0.6931471805599453
inflammation-predominant,2,0.6931471805599453
RNA-negative,2,0.6931471805599453
over-expressed,2,0.6931471805599453
Luis,2,0.6931471805599453
9206,2,0.6931471805599453
well-positioned,2,0.6931471805599453
episodes100000,2,0.6931471805599453
tetrapeptide,2,0.6931471805599453
Hydrocarbon,2,0.6931471805599453
benzene,2,0.6931471805599453
differential-diagnostic,2,0.6931471805599453
Count,2,0.6931471805599453
otolaryngologic,2,0.6931471805599453
Asturias,2,0.6931471805599453
Microbe,2,0.6931471805599453
1733,2,0.6931471805599453
1803,2,0.6931471805599453
AOSs,2,0.6931471805599453
Davidson,2,0.6931471805599453
panorama,2,0.6931471805599453
2887,2,0.6931471805599453
lasers,2,0.6931471805599453
textilomas,2,0.6931471805599453
NNS,2,0.6931471805599453
co-medication,2,0.6931471805599453
board-certified,2,0.6931471805599453
1000mm3,2,0.6931471805599453
procoagulative,2,0.6931471805599453
non-lipid-lowering,2,0.6931471805599453
GxE,2,0.6931471805599453
north-central,2,0.6931471805599453
Natick,2,0.6931471805599453
exposure-disease,2,0.6931471805599453
18500,2,0.6931471805599453
ITF-1697,2,0.6931471805599453
antagonistically,2,0.6931471805599453
costed,2,0.6931471805599453
4300,2,0.6931471805599453
VLAs,2,0.6931471805599453
CoV2-6,2,0.6931471805599453
N66,2,0.6931471805599453
anasarca,2,0.6931471805599453
excuse,2,0.6931471805599453
rivaroxabanASA,2,0.6931471805599453
guanine,2,0.6931471805599453
improvised,2,0.6931471805599453
-308GA,2,0.6931471805599453
distresses,2,0.6931471805599453
ECMOs,2,0.6931471805599453
lymphotoxin-alpha,2,0.6931471805599453
client-centred,2,0.6931471805599453
Pollution,2,0.6931471805599453
Advantage,2,0.6931471805599453
Haemostatic,2,0.6931471805599453
Willebrands,2,0.6931471805599453
1970-1989,2,0.6931471805599453
Hyper,2,0.6931471805599453
Uni-,2,0.6931471805599453
forty-six,2,0.6931471805599453
Nonstenotic,2,0.6931471805599453
ISRCTN99414122,2,0.6931471805599453
naysayers,2,0.6931471805599453
hypercoagulative,2,0.6931471805599453
expectorant,2,0.6931471805599453
blunting,2,0.6931471805599453
dew,2,0.6931471805599453
miners,2,0.6931471805599453
dispositions,2,0.6931471805599453
tingling,2,0.6931471805599453
shooting,2,0.6931471805599453
0129,2,0.6931471805599453
diadochokinesis,2,0.6931471805599453
post-influenzal,2,0.6931471805599453
Varenicline,2,0.6931471805599453
credits,2,0.6931471805599453
criterias,2,0.6931471805599453
HDA-zanamivir,2,0.6931471805599453
dietnutrition,2,0.6931471805599453
PAFs,2,0.6931471805599453
guest,2,0.6931471805599453
Diver,2,0.6931471805599453
harbouring,2,0.6931471805599453
Invatec,2,0.6931471805599453
Realtime,2,0.6931471805599453
reverts,2,0.6931471805599453
Latency,2,0.6931471805599453
-009,2,0.6931471805599453
delighted,2,0.6931471805599453
foothold,2,0.6931471805599453
Xiuning,2,0.6931471805599453
Ocean,2,0.6931471805599453
Plenary,2,0.6931471805599453
hermeneutic,2,0.6931471805599453
outsiders,2,0.6931471805599453
Rhythm,2,0.6931471805599453
ligand-binding,2,0.6931471805599453
Habana,2,0.6931471805599453
indooroutdoor,2,0.6931471805599453
easy-to-produce,2,0.6931471805599453
sELISA,2,0.6931471805599453
nucleocapside,2,0.6931471805599453
H10-HA,2,0.6931471805599453
time-integral,2,0.6931471805599453
nQRST,2,0.6931471805599453
TBSS,2,0.6931471805599453
8s,2,0.6931471805599453
extended-care,2,0.6931471805599453
Tract,2,0.6931471805599453
pharmacology-based,2,0.6931471805599453
13NH3-PET,2,0.6931471805599453
SI-upslope,2,0.6931471805599453
GUSTO-IIb,2,0.6931471805599453
2002-2004,2,0.6931471805599453
Grampian,2,0.6931471805599453
Ciclesonide,2,0.6931471805599453
Cic2,2,0.6931471805599453
p000,2,0.6931471805599453
FcγR,2,0.6931471805599453
FcεRI,2,0.6931471805599453
hydroxy,2,0.6931471805599453
host-host,2,0.6931471805599453
BSPHU,2,0.6931471805599453
2633,2,0.6931471805599453
intradermally,2,0.6931471805599453
False-positive,2,0.6931471805599453
drainer,2,0.6931471805599453
Qinggan,2,0.6931471805599453
Yinqiao,2,0.6931471805599453
RAGE-mediated,2,0.6931471805599453
P0045,2,0.6931471805599453
MACE-free,2,0.6931471805599453
multi-frequency,2,0.6931471805599453
transtheoretical,2,0.6931471805599453
fulminating,2,0.6931471805599453
GER-,2,0.6931471805599453
NRE,2,0.6931471805599453
Electromagnetic,2,0.6931471805599453
Exponential,2,0.6931471805599453
61-70,2,0.6931471805599453
Dyslipidemia,2,0.6931471805599453
anonymised,2,0.6931471805599453
SELEX,2,0.6931471805599453
Hradec,2,0.6931471805599453
Králové,2,0.6931471805599453
meager,2,0.6931471805599453
4872,2,0.6931471805599453
1566,2,0.6931471805599453
TCDI,2,0.6931471805599453
NTZ,2,0.6931471805599453
Zone,2,0.6931471805599453
1430,2,0.6931471805599453
1993-1995,2,0.6931471805599453
VUI-NP13L,2,0.6931471805599453
Offspring,2,0.6931471805599453
Sparse,2,0.6931471805599453
B1195,2,0.6931471805599453
17-75,2,0.6931471805599453
V1-3QS,2,0.6931471805599453
V1-4QS,2,0.6931471805599453
lacune,2,0.6931471805599453
V1-5QS,2,0.6931471805599453
HSAP-NPpHO1,2,0.6931471805599453
19911993,2,0.6931471805599453
serum-ECP,2,0.6931471805599453
rubra,2,0.6931471805599453
interhuman,2,0.6931471805599453
Nicotine,2,0.6931471805599453
Zachodniopomorskie,2,0.6931471805599453
Multi-Tabs,2,0.6931471805599453
cross-city,2,0.6931471805599453
Podlaskie,2,0.6931471805599453
Intra-observer,2,0.6931471805599453
allege,2,0.6931471805599453
toe,2,0.6931471805599453
aortitis,2,0.6931471805599453
Functionally,2,0.6931471805599453
USFDA,2,0.6931471805599453
33000,2,0.6931471805599453
Lepu,2,0.6931471805599453
HITS,2,0.6931471805599453
PageRank,2,0.6931471805599453
Attributable,2,0.6931471805599453
eHCoV,2,0.6931471805599453
Kurdistan,2,0.6931471805599453
Artery-to-artery,2,0.6931471805599453
P0010,2,0.6931471805599453
belly,2,0.6931471805599453
Commuting,2,0.6931471805599453
lakes,2,0.6931471805599453
antithyroid,2,0.6931471805599453
autoimmuneinflammatory,2,0.6931471805599453
day-by-day,2,0.6931471805599453
sciatica,2,0.6931471805599453
Binge,2,0.6931471805599453
CHW-delivered,2,0.6931471805599453
hilum,2,0.6931471805599453
CT-scanner,2,0.6931471805599453
U-Net,2,0.6931471805599453
Radiomics,2,0.6931471805599453
radiographer,2,0.6931471805599453
CD5,2,0.6931471805599453
instructs,2,0.6931471805599453
NSCLC,2,0.6931471805599453
ex-vivo,2,0.6931471805599453
1·3,2,0.6931471805599453
Qwaves,2,0.6931471805599453
reassigned,2,0.6931471805599453
osteoclastic,2,0.6931471805599453
IIIA,2,0.6931471805599453
OVA-sensitized,2,0.6931471805599453
sits,2,0.6931471805599453
Fetour,2,0.6931471805599453
decidual,2,0.6931471805599453
Curcuma,2,0.6931471805599453
neurostimulation,2,0.6931471805599453
Trousseaus,2,0.6931471805599453
Shufeng,2,0.6931471805599453
admissionABSTRACT,2,0.6931471805599453
Enrollment,2,0.6931471805599453
20-35,2,0.6931471805599453
AUDIT-negative,2,0.6931471805599453
pond,2,0.6931471805599453
STN,2,0.6931471805599453
mini-Wright,2,0.6931471805599453
transfusing,2,0.6931471805599453
TLR4--,2,0.6931471805599453
spun,2,0.6931471805599453
McGoogan,2,0.6931471805599453
SCB6,2,0.6931471805599453
rock,2,0.6931471805599453
worst-hit,2,0.6931471805599453
SCTLR4--,2,0.6931471805599453
lingered,2,0.6931471805599453
Governor,2,0.6931471805599453
Polands,2,0.6931471805599453
SCN-,2,0.6931471805599453
High-altitude,2,0.6931471805599453
SJR,2,0.6931471805599453
D2BT,2,0.6931471805599453
thiocyanate,2,0.6931471805599453
RCHT,2,0.6931471805599453
liaisons,2,0.6931471805599453
MCIs,2,0.6931471805599453
workarounds,2,0.6931471805599453
pendrin,2,0.6931471805599453
approving,2,0.6931471805599453
110-190,2,0.6931471805599453
rug,2,0.6931471805599453
resonances,2,0.6931471805599453
silk,2,0.6931471805599453
sadly,2,0.6931471805599453
intra-orbital,2,0.6931471805599453
6-Ki,2,0.6931471805599453
unadapted,2,0.6931471805599453
Nonrandomized,2,0.6931471805599453
shareable,2,0.6931471805599453
explode,2,0.6931471805599453
co-localized,2,0.6931471805599453
Indication,2,0.6931471805599453
DLco,2,0.6931471805599453
EGIS,2,0.6931471805599453
sont,2,0.6931471805599453
MOA,2,0.6931471805599453
themed,2,0.6931471805599453
ABrevig,2,0.6931471805599453
self-damaging,2,0.6931471805599453
3862,2,0.6931471805599453
intermediate-risk,2,0.6931471805599453
pfuml,2,0.6931471805599453
vetting,2,0.6931471805599453
1-100,2,0.6931471805599453
AMI-RV,2,0.6931471805599453
RASL-seq,2,0.6931471805599453
1680,2,0.6931471805599453
Norilsk,2,0.6931471805599453
ic,2,0.6931471805599453
small-cell,2,0.6931471805599453
Venn,2,0.6931471805599453
1799,2,0.6931471805599453
interviewer,2,0.6931471805599453
1605,2,0.6931471805599453
pro-viral,2,0.6931471805599453
didactic,2,0.6931471805599453
teaches,2,0.6931471805599453
3235,2,0.6931471805599453
educed,2,0.6931471805599453
MESSAGES,2,0.6931471805599453
Bringing,2,0.6931471805599453
relatedly,2,0.6931471805599453
1298,2,0.6931471805599453
seminars,2,0.6931471805599453
half-day,2,0.6931471805599453
fecal-viral,2,0.6931471805599453
occupant,2,0.6931471805599453
-the,2,0.6931471805599453
caps,2,0.6931471805599453
pseudo-convolutional,2,0.6931471805599453
Mammography,2,0.6931471805599453
HLA-binding,2,0.6931471805599453
dietitian,2,0.6931471805599453
pyrophosphate-99mTc-Sn,2,0.6931471805599453
borough,2,0.6931471805599453
NRMI,2,0.6931471805599453
extrasynaptic,2,0.6931471805599453
neighbours,2,0.6931471805599453
Proving,2,0.6931471805599453
Evidently,2,0.6931471805599453
large-core,2,0.6931471805599453
bulging,2,0.6931471805599453
discernment,2,0.6931471805599453
microgramsday,2,0.6931471805599453
49-83,2,0.6931471805599453
nonintensive,2,0.6931471805599453
waviness,2,0.6931471805599453
conjectural,2,0.6931471805599453
resistivity,2,0.6931471805599453
Twelve-lead,2,0.6931471805599453
homotetramer,2,0.6931471805599453
epithelial‑mesenchymal,2,0.6931471805599453
SEIT,2,0.6931471805599453
DMSO,2,0.6931471805599453
dial,2,0.6931471805599453
coders,2,0.6931471805599453
Interhospital,2,0.6931471805599453
Prison,2,0.6931471805599453
Tilade,2,0.6931471805599453
Implemented,2,0.6931471805599453
fieldwork,2,0.6931471805599453
Non-smokers,2,0.6931471805599453
0163,2,0.6931471805599453
0331,2,0.6931471805599453
ANigeria174,2,0.6931471805599453
antifungals,2,0.6931471805599453
NETs-related,2,0.6931471805599453
BM1918,2,0.6931471805599453
citrullinated,2,0.6931471805599453
pandémie,2,0.6931471805599453
8600,2,0.6931471805599453
2415,2,0.6931471805599453
pre-Delta,2,0.6931471805599453
moyen,2,0.6931471805599453
Tomsk,2,0.6931471805599453
combinent,2,0.6931471805599453
gynecology,2,0.6931471805599453
Hoops,2,0.6931471805599453
race-ethnic,2,0.6931471805599453
ERICA,2,0.6931471805599453
chunk,2,0.6931471805599453
tenths,2,0.6931471805599453
postthrombolytic,2,0.6931471805599453
≥55,2,0.6931471805599453
logo,2,0.6931471805599453
divulge,2,0.6931471805599453
overdependence,2,0.6931471805599453
human-transmissible,2,0.6931471805599453
endothelium-dependent,2,0.6931471805599453
experimentally-induced,2,0.6931471805599453
nonenzymic,2,0.6931471805599453
institutionally,2,0.6931471805599453
1758,2,0.6931471805599453
hydroperoxides,2,0.6931471805599453
monument,2,0.6931471805599453
16-29,2,0.6931471805599453
ISO-treated,2,0.6931471805599453
first-ever-in-a-lifetime,2,0.6931471805599453
quadrupled,2,0.6931471805599453
caloric,2,0.6931471805599453
Ee,2,0.6931471805599453
Returns,2,0.6931471805599453
Simulating,2,0.6931471805599453
complementaryalternative,2,0.6931471805599453
PTINR,2,0.6931471805599453
humanised,2,0.6931471805599453
∼20,2,0.6931471805599453
3CLpro-Indinavir,2,0.6931471805599453
ISPH,2,0.6931471805599453
Diuretics,2,0.6931471805599453
Fibrous,2,0.6931471805599453
2SARS-CoV-2,2,0.6931471805599453
vulval,2,0.6931471805599453
Alicante,2,0.6931471805599453
150mg,2,0.6931471805599453
Miocardio,2,0.6931471805599453
densitometric,2,0.6931471805599453
agudo,2,0.6931471805599453
Registro,2,0.6931471805599453
hot-spots,2,0.6931471805599453
Proyecto,2,0.6931471805599453
CLSI,2,0.6931471805599453
re-attack,2,0.6931471805599453
prayers,2,0.6931471805599453
Hypoxia,2,0.6931471805599453
Anginal,2,0.6931471805599453
Dunedin,2,0.6931471805599453
phenytoin-treated,2,0.6931471805599453
C-Met,2,0.6931471805599453
1976--79,2,0.6931471805599453
cardiospinal,2,0.6931471805599453
SMuRFs,2,0.6931471805599453
1-December,2,0.6931471805599453
Play,2,0.6931471805599453
region-wide,2,0.6931471805599453
linguistically,2,0.6931471805599453
GITC,2,0.6931471805599453
Craniofacial,2,0.6931471805599453
Periodontitis,2,0.6931471805599453
hemagglutinin-inhibiting,2,0.6931471805599453
MMM,2,0.6931471805599453
Prevaccination,2,0.6931471805599453
castrates,2,0.6931471805599453
Wise,2,0.6931471805599453
sigma-1,2,0.6931471805599453
NYCDOH,2,0.6931471805599453
immunoenzymatic,2,0.6931471805599453
copiesswab,2,0.6931471805599453
n113,2,0.6931471805599453
VEGFA,2,0.6931471805599453
km2,2,0.6931471805599453
AJiangsu12011H1N1,2,0.6931471805599453
BMalaysia25062004,2,0.6931471805599453
midgestation,2,0.6931471805599453
antisclerotic,2,0.6931471805599453
Neurons,2,0.6931471805599453
Well-Integrated,2,0.6931471805599453
6601,2,0.6931471805599453
Dolichoectasia,2,0.6931471805599453
palliate,2,0.6931471805599453
PC20METH,2,0.6931471805599453
80-89,2,0.6931471805599453
within-season,2,0.6931471805599453
TESSy,2,0.6931471805599453
Stay,2,0.6931471805599453
fiber-shaped,2,0.6931471805599453
OVSARS2IgG,2,0.6931471805599453
HCQCQ,2,0.6931471805599453
Utahs,2,0.6931471805599453
1886,2,0.6931471805599453
MTHFRD,2,0.6931471805599453
packers,2,0.6931471805599453
β1,2,0.6931471805599453
enzyme‑linked,2,0.6931471805599453
fog-induced,2,0.6931471805599453
pokeweed,2,0.6931471805599453
late-August,2,0.6931471805599453
right-heart,2,0.6931471805599453
1408,2,0.6931471805599453
Proximal,2,0.6931471805599453
seize,2,0.6931471805599453
fo,2,0.6931471805599453
multiprofessional,2,0.6931471805599453
92-96,2,0.6931471805599453
holosystolic,2,0.6931471805599453
IWMLs,2,0.6931471805599453
single-well,2,0.6931471805599453
Rubella,2,0.6931471805599453
government-guided,2,0.6931471805599453
ZINC0000146942,2,0.6931471805599453
IV-rtPA,2,0.6931471805599453
H8,2,0.6931471805599453
Accurately,2,0.6931471805599453
ZINC00003118440,2,0.6931471805599453
flavus,2,0.6931471805599453
MFS,2,0.6931471805599453
host-targeted,2,0.6931471805599453
brewing,2,0.6931471805599453
19921993,2,0.6931471805599453
THERAPEUTIC,2,0.6931471805599453
Clínica,2,0.6931471805599453
plantarflexion,2,0.6931471805599453
4305,2,0.6931471805599453
AWenshan012009,2,0.6931471805599453
EIC,2,0.6931471805599453
AWenshan,2,0.6931471805599453
Thailands,2,0.6931471805599453
exports,2,0.6931471805599453
regionscountries,2,0.6931471805599453
TSNS,2,0.6931471805599453
Always,2,0.6931471805599453
SCW,2,0.6931471805599453
scrapings,2,0.6931471805599453
flunisolide,2,0.6931471805599453
35-65,2,0.6931471805599453
investigatory,2,0.6931471805599453
proapoptotic,2,0.6931471805599453
inlets,2,0.6931471805599453
energizing,2,0.6931471805599453
lysosome,2,0.6931471805599453
NIOSHCriteria,2,0.6931471805599453
calm,2,0.6931471805599453
Niigata,2,0.6931471805599453
Preferably,2,0.6931471805599453
impersistence,2,0.6931471805599453
work-induced,2,0.6931471805599453
coadministration,2,0.6931471805599453
Wisconsin01-like,2,0.6931471805599453
two-hourly,2,0.6931471805599453
ovales,2,0.6931471805599453
virtuous,2,0.6931471805599453
upperlower,2,0.6931471805599453
starvation,2,0.6931471805599453
Geriatr,2,0.6931471805599453
butter,2,0.6931471805599453
short-distance,2,0.6931471805599453
outwards,2,0.6931471805599453
YHLO,2,0.6931471805599453
CLIA-iFlash,2,0.6931471805599453
5-years,2,0.6931471805599453
3032,2,0.6931471805599453
00067,2,0.6931471805599453
Stockholm12-like,2,0.6931471805599453
PMO,2,0.6931471805599453
intra-clade,2,0.6931471805599453
für,2,0.6931471805599453
April-December,2,0.6931471805599453
immunometabolic,2,0.6931471805599453
p00000001,2,0.6931471805599453
peptidome,2,0.6931471805599453
autophagy-mediated,2,0.6931471805599453
7980,2,0.6931471805599453
serologic-based,2,0.6931471805599453
contemplating,2,0.6931471805599453
Insertion,2,0.6931471805599453
MeV-based,2,0.6931471805599453
electrodermal,2,0.6931471805599453
swept-source,2,0.6931471805599453
9-30,2,0.6931471805599453
disruptors,2,0.6931471805599453
p00046,2,0.6931471805599453
2OFZ,2,0.6931471805599453
VRFs,2,0.6931471805599453
repatriated,2,0.6931471805599453
epidrugs,2,0.6931471805599453
observant,2,0.6931471805599453
tissue-signature,2,0.6931471805599453
Lots,2,0.6931471805599453
pledge,2,0.6931471805599453
reutilization,2,0.6931471805599453
recency,2,0.6931471805599453
one-week,2,0.6931471805599453
EMCC,2,0.6931471805599453
appraises,2,0.6931471805599453
Lord,2,0.6931471805599453
in-hand,2,0.6931471805599453
Proof,2,0.6931471805599453
patient-orientated,2,0.6931471805599453
prescribes,2,0.6931471805599453
OIS,2,0.6931471805599453
bifrontal,2,0.6931471805599453
p0041,2,0.6931471805599453
thrombo-inflammatory,2,0.6931471805599453
CSI,2,0.6931471805599453
fluorometric,2,0.6931471805599453
1267,2,0.6931471805599453
ligand-receptor,2,0.6931471805599453
immuno-allergological,2,0.6931471805599453
gamma-interferon,2,0.6931471805599453
antedates,2,0.6931471805599453
D-VAMS,2,0.6931471805599453
MSW,2,0.6931471805599453
Pillar,2,0.6931471805599453
journeys,2,0.6931471805599453
vimentin,2,0.6931471805599453
Jean,2,0.6931471805599453
REL,2,0.6931471805599453
broncho-pleural,2,0.6931471805599453
NS2-knockout,2,0.6931471805599453
FT4,2,0.6931471805599453
camemberti,2,0.6931471805599453
Berberine,2,0.6931471805599453
Bacteroides,2,0.6931471805599453
Terminal,2,0.6931471805599453
Pre-stroke,2,0.6931471805599453
allergosorbent,2,0.6931471805599453
Keith,2,0.6931471805599453
mentale,2,0.6931471805599453
10664,2,0.6931471805599453
non-verbal,2,0.6931471805599453
Hamming,2,0.6931471805599453
BMRC,2,0.6931471805599453
rapid-eye-movement,2,0.6931471805599453
Hashimotos,2,0.6931471805599453
femoro-femoral,2,0.6931471805599453
2057,2,0.6931471805599453
Laterality,2,0.6931471805599453
9899,2,0.6931471805599453
Nickel,2,0.6931471805599453
SARS-CoV-2-LIPS-S,2,0.6931471805599453
PVV,2,0.6931471805599453
READII,2,0.6931471805599453
TAMI-6,2,0.6931471805599453
injector,2,0.6931471805599453
severe-persistent,2,0.6931471805599453
tenascin-C,2,0.6931471805599453
diagramming,2,0.6931471805599453
endo-systolic,2,0.6931471805599453
nominalist,2,0.6931471805599453
unites,2,0.6931471805599453
ΔH69V70,2,0.6931471805599453
19-,2,0.6931471805599453
20years,2,0.6931471805599453
España,2,0.6931471805599453
PCH,2,0.6931471805599453
sublingually,2,0.6931471805599453
4064,2,0.6931471805599453
BIOCREDIT,2,0.6931471805599453
stoma,2,0.6931471805599453
INK4,2,0.6931471805599453
51-74,2,0.6931471805599453
Bench,2,0.6931471805599453
university-based,2,0.6931471805599453
AC133,2,0.6931471805599453
IMRI,2,0.6931471805599453
Non-coding,2,0.6931471805599453
ZFHX3,2,0.6931471805599453
3068,2,0.6931471805599453
PITX2,2,0.6931471805599453
Seeing,2,0.6931471805599453
refusers,2,0.6931471805599453
NASH,2,0.6931471805599453
non-fasting,2,0.6931471805599453
occupation-specific,2,0.6931471805599453
E1-PWP,2,0.6931471805599453
Bradycardia,2,0.6931471805599453
syntactic,2,0.6931471805599453
oligo-asymptomatic,2,0.6931471805599453
Sakai,2,0.6931471805599453
0954,2,0.6931471805599453
ISPH-induced,2,0.6931471805599453
Neighbor-Joining,2,0.6931471805599453
Beard,2,0.6931471805599453
receiver-operator,2,0.6931471805599453
Prevención,2,0.6931471805599453
subtending,2,0.6931471805599453
mRT-LAMP-IRNH,2,0.6931471805599453
18-segment,2,0.6931471805599453
somatomotor,2,0.6931471805599453
directness,2,0.6931471805599453
Palmeri,2,0.6931471805599453
Victoria-related,2,0.6931471805599453
dread,2,0.6931471805599453
genetical,2,0.6931471805599453
0101,2,0.6931471805599453
unitcoronary,2,0.6931471805599453
pulsing,2,0.6931471805599453
nucleotidessiteyear,2,0.6931471805599453
P-BEST,2,0.6931471805599453
subforms,2,0.6931471805599453
Hyperactivity,2,0.6931471805599453
Optison,2,0.6931471805599453
2009AH1,2,0.6931471805599453
non-neuronal,2,0.6931471805599453
NCSVT,2,0.6931471805599453
explicate,2,0.6931471805599453
4053,2,0.6931471805599453
foot-strike,2,0.6931471805599453
angio-CT,2,0.6931471805599453
ARIMAX,2,0.6931471805599453
dichotic,2,0.6931471805599453
Owen,2,0.6931471805599453
Defects,2,0.6931471805599453
GSW,2,0.6931471805599453
Sphingosine-1-phosphate,2,0.6931471805599453
Choice,2,0.6931471805599453
2295,2,0.6931471805599453
GAN,2,0.6931471805599453
2078,2,0.6931471805599453
Northcliffe,2,0.6931471805599453
mastication,2,0.6931471805599453
post-revascularization,2,0.6931471805599453
macro-aggregation,2,0.6931471805599453
stoicism,2,0.6931471805599453
3120,2,0.6931471805599453
0081,2,0.6931471805599453
vasoconstrictory,2,0.6931471805599453
urinogenital,2,0.6931471805599453
archive,2,0.6931471805599453
community-derived,2,0.6931471805599453
hepatotoxicity,2,0.6931471805599453
μgkg,2,0.6931471805599453
thrombocytapheresis,2,0.6931471805599453
Ac,2,0.6931471805599453
nisoldipine,2,0.6931471805599453
SARS‐CoV‐2‐specific,2,0.6931471805599453
vegetal,2,0.6931471805599453
B18,2,0.6931471805599453
gums,2,0.6931471805599453
partisan,2,0.6931471805599453
barricade,2,0.6931471805599453
sub-haplogroup,2,0.6931471805599453
flours,2,0.6931471805599453
sesame,2,0.6931471805599453
confinements,2,0.6931471805599453
SARS-CoV-2019,2,0.6931471805599453
Khan,2,0.6931471805599453
Barnaul,2,0.6931471805599453
VMpo,2,0.6931471805599453
3757,2,0.6931471805599453
Observing,2,0.6931471805599453
non-mutagenic,2,0.6931471805599453
socio-economical,2,0.6931471805599453
100-162,2,0.6931471805599453
persuade,2,0.6931471805599453
PCKC,2,0.6931471805599453
6799,2,0.6931471805599453
dcAMP,2,0.6931471805599453
melt,2,0.6931471805599453
INAIL,2,0.6931471805599453
hominis,2,0.6931471805599453
LGG,2,0.6931471805599453
HGG,2,0.6931471805599453
Logistical,2,0.6931471805599453
Immunopathology,2,0.6931471805599453
free-text,2,0.6931471805599453
4146,2,0.6931471805599453
Scalp,2,0.6931471805599453
morphometrically,2,0.6931471805599453
tubulointerstitial,2,0.6931471805599453
6500,2,0.6931471805599453
protomers,2,0.6931471805599453
enjoyment,2,0.6931471805599453
leucine-rich,2,0.6931471805599453
frustrate,2,0.6931471805599453
IOP,2,0.6931471805599453
Penny,2,0.6931471805599453
meltdown,2,0.6931471805599453
NAMRU-3,2,0.6931471805599453
IOPs,2,0.6931471805599453
Cx3cr1,2,0.6931471805599453
3486,2,0.6931471805599453
NEMSIS,2,0.6931471805599453
TTETOE,2,0.6931471805599453
NOR,2,0.6931471805599453
TOE,2,0.6931471805599453
-058,2,0.6931471805599453
114-134,2,0.6931471805599453
KAPs,2,0.6931471805599453
bioperiodicities,2,0.6931471805599453
2248,2,0.6931471805599453
biohumoral,2,0.6931471805599453
producer,2,0.6931471805599453
XP,2,0.6931471805599453
equipment-free,2,0.6931471805599453
no-answers,2,0.6931471805599453
COVID-19-symptomatic,2,0.6931471805599453
within-patient,2,0.6931471805599453
pre-intervention,2,0.6931471805599453
290000,2,0.6931471805599453
v-NY,2,0.6931471805599453
precession,2,0.6931471805599453
LFC,2,0.6931471805599453
1582,2,0.6931471805599453
2773,2,0.6931471805599453
parentguardian,2,0.6931471805599453
strongyloidiasis,2,0.6931471805599453
filter-based,2,0.6931471805599453
000µL,2,0.6931471805599453
third-level,2,0.6931471805599453
Anticholinergics,2,0.6931471805599453
TSE,2,0.6931471805599453
Sanità,2,0.6931471805599453
ceria,2,0.6931471805599453
posttransplantation,2,0.6931471805599453
TACS,2,0.6931471805599453
POCS,2,0.6931471805599453
Tc99m-sestamibi-SPECT,2,0.6931471805599453
Chico,2,0.6931471805599453
One-quarter,2,0.6931471805599453
08-13,2,0.6931471805599453
subsystems,2,0.6931471805599453
life-threating,2,0.6931471805599453
60-78,2,0.6931471805599453
Path,2,0.6931471805599453
VerifyNow,2,0.6931471805599453
propaganda,2,0.6931471805599453
low-age,2,0.6931471805599453
Inherent,2,0.6931471805599453
isoprenoid,2,0.6931471805599453
0995,2,0.6931471805599453
4-4,2,0.6931471805599453
dolichol,2,0.6931471805599453
emotives,2,0.6931471805599453
2072,2,0.6931471805599453
PIMICS,2,0.6931471805599453
3877,2,0.6931471805599453
pleuritis,2,0.6931471805599453
discourses,2,0.6931471805599453
ubiquinone,2,0.6931471805599453
Vera,2,0.6931471805599453
glycoconjugate,2,0.6931471805599453
serogroups,2,0.6931471805599453
impressively,2,0.6931471805599453
Tailoring,2,0.6931471805599453
-508,2,0.6931471805599453
GRs,2,0.6931471805599453
know-answers,2,0.6931471805599453
Quantum,2,0.6931471805599453
Recoding,2,0.6931471805599453
Odate,2,0.6931471805599453
well-performing,2,0.6931471805599453
TCC,2,0.6931471805599453
35-50,2,0.6931471805599453
quinoline,2,0.6931471805599453
HEL,2,0.6931471805599453
already-existing,2,0.6931471805599453
VivaChek,2,0.6931471805599453
ferroquine,2,0.6931471805599453
single-round,2,0.6931471805599453
coxsackievirus,2,0.6931471805599453
AGTs,2,0.6931471805599453
tired,2,0.6931471805599453
cheating,2,0.6931471805599453
Taif,2,0.6931471805599453
step-like,2,0.6931471805599453
aviators,2,0.6931471805599453
normocholesterolemic,2,0.6931471805599453
chlamydia,2,0.6931471805599453
papilloma,2,0.6931471805599453
12-42,2,0.6931471805599453
embolic-appearing,2,0.6931471805599453
novelties,2,0.6931471805599453
pre-SARS,2,0.6931471805599453
primitive,2,0.6931471805599453
particulars,2,0.6931471805599453
interventionist,2,0.6931471805599453
LCBI,2,0.6931471805599453
multi-attribute,2,0.6931471805599453
rayon-bud,2,0.6931471805599453
backwards,2,0.6931471805599453
Ethiopias,2,0.6931471805599453
splenomegaly,2,0.6931471805599453
LCBIs,2,0.6931471805599453
HHI,2,0.6931471805599453
AHRR,2,0.6931471805599453
Marginalized,2,0.6931471805599453
hypomethylation,2,0.6931471805599453
cg05575921,2,0.6931471805599453
3-hydroxy-3,2,0.6931471805599453
axilla,2,0.6931471805599453
indicted,2,0.6931471805599453
xi2,2,0.6931471805599453
1429,2,0.6931471805599453
Prechallenge,2,0.6931471805599453
19-28,2,0.6931471805599453
dysphoric,2,0.6931471805599453
fmolml,2,0.6931471805599453
2027,2,0.6931471805599453
EMSA,2,0.6931471805599453
3181,2,0.6931471805599453
BDT,2,0.6931471805599453
intracranially,2,0.6931471805599453
dissipation,2,0.6931471805599453
meats,2,0.6931471805599453
Belonging,2,0.6931471805599453
owed,2,0.6931471805599453
bronchoprovokative,2,0.6931471805599453
deadline,2,0.6931471805599453
OTV,2,0.6931471805599453
SCGF-β,2,0.6931471805599453
stuffiness,2,0.6931471805599453
Headquarters,2,0.6931471805599453
274Y,2,0.6931471805599453
3254,2,0.6931471805599453
timesweek,2,0.6931471805599453
near-perfect,2,0.6931471805599453
Ancestor,2,0.6931471805599453
unannounced,2,0.6931471805599453
HRCurrent,2,0.6931471805599453
unsynchronized,2,0.6931471805599453
hermetization,2,0.6931471805599453
millimetres,2,0.6931471805599453
Former,2,0.6931471805599453
waist-to-hip,2,0.6931471805599453
Biology-Inspired,2,0.6931471805599453
Stratifying,2,0.6931471805599453
imputing,2,0.6931471805599453
hypocholesterolemic,2,0.6931471805599453
himselfherself,2,0.6931471805599453
SM-IVE,2,0.6931471805599453
hydrochlorotiazide,2,0.6931471805599453
Log,2,0.6931471805599453
spatter,2,0.6931471805599453
biopharmaceuticals,2,0.6931471805599453
sprints,2,0.6931471805599453
orf3a,2,0.6931471805599453
heparin-treated,2,0.6931471805599453
risk-groups,2,0.6931471805599453
self-collect,2,0.6931471805599453
tabulation,2,0.6931471805599453
code-level,2,0.6931471805599453
patterned,2,0.6931471805599453
16623,2,0.6931471805599453
31172,2,0.6931471805599453
UpToDate,2,0.6931471805599453
AMI-related,2,0.6931471805599453
ASLR,2,0.6931471805599453
aborting,2,0.6931471805599453
pentaacetic,2,0.6931471805599453
traumatized,2,0.6931471805599453
CLRD,2,0.6931471805599453
HPANHS,2,0.6931471805599453
inundated,2,0.6931471805599453
disease-severity,2,0.6931471805599453
best-studied,2,0.6931471805599453
HPAQSurveillance,2,0.6931471805599453
incinerated,2,0.6931471805599453
fastigial,2,0.6931471805599453
HAM,2,0.6931471805599453
dysesthesia,2,0.6931471805599453
⩽5,2,0.6931471805599453
N1N2N3,2,0.6931471805599453
AHIN1,2,0.6931471805599453
Civilian,2,0.6931471805599453
AChile183,2,0.6931471805599453
pneumonia-influenza,2,0.6931471805599453
qRT-PCR-based,2,0.6931471805599453
SendSS,2,0.6931471805599453
July-1,2,0.6931471805599453
moldy,2,0.6931471805599453
sprayed,2,0.6931471805599453
1777,2,0.6931471805599453
1977-1998,2,0.6931471805599453
ILs,2,0.6931471805599453
3876,2,0.6931471805599453
repulsion,2,0.6931471805599453
anthropomorphic,2,0.6931471805599453
controlquality,2,0.6931471805599453
UVDR,2,0.6931471805599453
PARP1,2,0.6931471805599453
ADMIRAL,2,0.6931471805599453
canopy,2,0.6931471805599453
after-school,2,0.6931471805599453
nano-amplified,2,0.6931471805599453
∼01,2,0.6931471805599453
RNA-extraction-free,2,0.6931471805599453
adsorbing,2,0.6931471805599453
hairpin,2,0.6931471805599453
BLF,2,0.6931471805599453
Laboratory-developed,2,0.6931471805599453
Cas13a,2,0.6931471805599453
orphanages,2,0.6931471805599453
VPL,2,0.6931471805599453
bioactivation,2,0.6931471805599453
ZnO-NW-enhanced,2,0.6931471805599453
CYP1A1,2,0.6931471805599453
NWs,2,0.6931471805599453
Peking,2,0.6931471805599453
ZnO,2,0.6931471805599453
beet,2,0.6931471805599453
ribavirin-treated,2,0.6931471805599453
I-III,2,0.6931471805599453
perpetuates,2,0.6931471805599453
Witwatersrand,2,0.6931471805599453
delayers,2,0.6931471805599453
TBPM,2,0.6931471805599453
preeclampsiaeclampsia,2,0.6931471805599453
supraazygos,2,0.6931471805599453
JanuaryFebruary,2,0.6931471805599453
echo-cardiography,2,0.6931471805599453
droppings,2,0.6931471805599453
POL-MONICA,2,0.6931471805599453
apitherapy,2,0.6931471805599453
Kraków,2,0.6931471805599453
downscaling,2,0.6931471805599453
R0s,2,0.6931471805599453
VTM-3840,2,0.6931471805599453
Moderna-vaccinated,2,0.6931471805599453
armhand,2,0.6931471805599453
FMA-UE,2,0.6931471805599453
⩽3,2,0.6931471805599453
NFEC,2,0.6931471805599453
Brigham,2,0.6931471805599453
1-18,2,0.6931471805599453
8-90,2,0.6931471805599453
r037,2,0.6931471805599453
ment,2,0.6931471805599453
PBS-glutamine,2,0.6931471805599453
nutraceutical,2,0.6931471805599453
subscribe,2,0.6931471805599453
beta-sympathomimetics,2,0.6931471805599453
minsession,2,0.6931471805599453
PREVESE,2,0.6931471805599453
host-microbiota,2,0.6931471805599453
pleuro-esophageal,2,0.6931471805599453
discarding,2,0.6931471805599453
⩾18,2,0.6931471805599453
Elsewhere,2,0.6931471805599453
3991,2,0.6931471805599453
4122,2,0.6931471805599453
Pisa,2,0.6931471805599453
EUs,2,0.6931471805599453
Metapneumovirus,2,0.6931471805599453
necroscopic,2,0.6931471805599453
radiogram,2,0.6931471805599453
Periplaneta,2,0.6931471805599453
securitised,2,0.6931471805599453
382000,2,0.6931471805599453
3481,2,0.6931471805599453
NIHWHO,2,0.6931471805599453
3725,2,0.6931471805599453
-IV,2,0.6931471805599453
unsuitability,2,0.6931471805599453
2202,2,0.6931471805599453
Transoesophageal,2,0.6931471805599453
systems-based,2,0.6931471805599453
meta-analyse,2,0.6931471805599453
groove,2,0.6931471805599453
CDC20,2,0.6931471805599453
appropriation,2,0.6931471805599453
SARS‑CoV,2,0.6931471805599453
BPs,2,0.6931471805599453
US-based,2,0.6931471805599453
Bt-CoV,2,0.6931471805599453
prodigious,2,0.6931471805599453
restimulation,2,0.6931471805599453
doi,2,0.6931471805599453
T1w-MRI,2,0.6931471805599453
51-60,2,0.6931471805599453
herniating,2,0.6931471805599453
2143,2,0.6931471805599453
expiry,2,0.6931471805599453
overmortality,2,0.6931471805599453
fireplaces,2,0.6931471805599453
semblance,2,0.6931471805599453
55Co,2,0.6931471805599453
transcription-Polymerase,2,0.6931471805599453
expert-based,2,0.6931471805599453
micro-embolization,2,0.6931471805599453
RNA‑dependent,2,0.6931471805599453
pseudoxanthoma,2,0.6931471805599453
PXE,2,0.6931471805599453
halts,2,0.6931471805599453
endogenic,2,0.6931471805599453
AHI,2,0.6931471805599453
2005-2009,2,0.6931471805599453
liquid-based,2,0.6931471805599453
Y-lineage,2,0.6931471805599453
WfMS,2,0.6931471805599453
addressability,2,0.6931471805599453
FeNo,2,0.6931471805599453
flus,2,0.6931471805599453
reconciliation,2,0.6931471805599453
In-house,2,0.6931471805599453
over-mortality,2,0.6931471805599453
LILACS,2,0.6931471805599453
OpenGrey,2,0.6931471805599453
cleavability,2,0.6931471805599453
cpmL,2,0.6931471805599453
confines,2,0.6931471805599453
trafermin,2,0.6931471805599453
Opportunity,2,0.6931471805599453
tyre,2,0.6931471805599453
0201,2,0.6931471805599453
unlicensed,2,0.6931471805599453
EBUS-TBNA,2,0.6931471805599453
Yangsheng,2,0.6931471805599453
BMass,2,0.6931471805599453
CoviVac,2,0.6931471805599453
true-positives,2,0.6931471805599453
MRFS,2,0.6931471805599453
multi-criteria,2,0.6931471805599453
mammary-coronary,2,0.6931471805599453
narcotics,2,0.6931471805599453
Urals,2,0.6931471805599453
iPad,2,0.6931471805599453
bilingual,2,0.6931471805599453
Mashad,2,0.6931471805599453
Giemsa,2,0.6931471805599453
well-received,2,0.6931471805599453
EDC,2,0.6931471805599453
peri-infarcted,2,0.6931471805599453
PHIs,2,0.6931471805599453
non-industrial,2,0.6931471805599453
26-28,2,0.6931471805599453
glues,2,0.6931471805599453
pedical,2,0.6931471805599453
nostril,2,0.6931471805599453
FP7,2,0.6931471805599453
Aurobindo,2,0.6931471805599453
blood-brain-barrier,2,0.6931471805599453
PHSMs,2,0.6931471805599453
C15O2-,2,0.6931471805599453
cardioversions,2,0.6931471805599453
cost-containment,2,0.6931471805599453
selectin,2,0.6931471805599453
anesthesiology,2,0.6931471805599453
fine-tuned,2,0.6931471805599453
26-45,2,0.6931471805599453
interposition,2,0.6931471805599453
Socorros,2,0.6931471805599453
Junta,2,0.6931471805599453
valinomycin,2,0.6931471805599453
reforms,2,0.6931471805599453
Bogota,2,0.6931471805599453
TEAM,2,0.6931471805599453
reimbursed,2,0.6931471805599453
dysbacteriosis,2,0.6931471805599453
11p13,2,0.6931471805599453
Build,2,0.6931471805599453
FREEDOM,2,0.6931471805599453
ce,2,0.6931471805599453
CMR-LGE,2,0.6931471805599453
wind，,2,0.6931471805599453
chromatographically,2,0.6931471805599453
CTFC14,2,0.6931471805599453
lacteal,2,0.6931471805599453
crash,2,0.6931471805599453
P022,2,0.6931471805599453
PDM09,2,0.6931471805599453
spearheaded,2,0.6931471805599453
Yang，,2,0.6931471805599453
liver，,2,0.6931471805599453
innominate,2,0.6931471805599453
p0049,2,0.6931471805599453
inherit,2,0.6931471805599453
Vf,2,0.6931471805599453
extra-respiratory,2,0.6931471805599453
cicatrices,2,0.6931471805599453
phlegm，,2,0.6931471805599453
Create,2,0.6931471805599453
resolutive,2,0.6931471805599453
kinship,2,0.6931471805599453
non-dentist,2,0.6931471805599453
Pranayama,2,0.6931471805599453
7200,2,0.6931471805599453
disorderly,2,0.6931471805599453
Clinicaltrialsgov,2,0.6931471805599453
neuro-interventional,2,0.6931471805599453
hyperreflective,2,0.6931471805599453
BE1-2G,2,0.6931471805599453
shadowing,2,0.6931471805599453
plexiform,2,0.6931471805599453
pole,2,0.6931471805599453
top-tier,2,0.6931471805599453
prescription，,2,0.6931471805599453
hyperaemia,2,0.6931471805599453
Hutterite,2,0.6931471805599453
PAMM,2,0.6931471805599453
neuroretinopathy,2,0.6931471805599453
Classified,2,0.6931471805599453
LAEF,2,0.6931471805599453
non-viral,2,0.6931471805599453
surveil,2,0.6931471805599453
inimitable,2,0.6931471805599453
nightmares,2,0.6931471805599453
PUVA,2,0.6931471805599453
GAPDH,2,0.6931471805599453
folklore,2,0.6931471805599453
electrocardiogrammes,2,0.6931471805599453
herbicide,2,0.6931471805599453
1616,2,0.6931471805599453
drug，,2,0.6931471805599453
82-96,2,0.6931471805599453
desserts,2,0.6931471805599453
MCTFEV1,2,0.6931471805599453
DAMP,2,0.6931471805599453
MCTWheeze,2,0.6931471805599453
aboriginal,2,0.6931471805599453
MCTFEV1Wheeze,2,0.6931471805599453
Psoralen,2,0.6931471805599453
phlegm-reducing,2,0.6931471805599453
selfcaregiver-administration,2,0.6931471805599453
rMSCs,2,0.6931471805599453
BVF,2,0.6931471805599453
Oesophageal,2,0.6931471805599453
82A6,2,0.6931471805599453
ABangkok179-like,2,0.6931471805599453
Blair,2,0.6931471805599453
Authorized,2,0.6931471805599453
FEVIdelta,2,0.6931471805599453
Bydgoszcz,2,0.6931471805599453
delegates,2,0.6931471805599453
helveticus,2,0.6931471805599453
P029,2,0.6931471805599453
circulation-improving,2,0.6931471805599453
medicineor,2,0.6931471805599453
P030,2,0.6931471805599453
Bifidobacterium,2,0.6931471805599453
incidenceprevalence,2,0.6931471805599453
anti-fibrinogen,2,0.6931471805599453
adept,2,0.6931471805599453
antiepileptics,2,0.6931471805599453
socioeconomical,2,0.6931471805599453
non-B117,2,0.6931471805599453
TNFi,2,0.6931471805599453
video-EEG,2,0.6931471805599453
Non-allergic,2,0.6931471805599453
Preadmission,2,0.6931471805599453
3950,2,0.6931471805599453
bioweapons,2,0.6931471805599453
PRECEDE-PROCEED,2,0.6931471805599453
tickborne,2,0.6931471805599453
no-template,2,0.6931471805599453
semantics,2,0.6931471805599453
VBDE,2,0.6931471805599453
49-54,2,0.6931471805599453
1768,2,0.6931471805599453
Uninfected,2,0.6931471805599453
homoharringtonine,2,0.6931471805599453
irresolvable,2,0.6931471805599453
CLBP,2,0.6931471805599453
-037,2,0.6931471805599453
Apulian,2,0.6931471805599453
A2009H1N1,2,0.6931471805599453
disagreeing,2,0.6931471805599453
controlsABSTRACT,2,0.6931471805599453
Mathematic,2,0.6931471805599453
mid-adult,2,0.6931471805599453
RIVA,2,0.6931471805599453
Preparations,2,0.6931471805599453
β-sheet,2,0.6931471805599453
IMPACT,2,0.6931471805599453
Multilayer,2,0.6931471805599453
preventingtreating,2,0.6931471805599453
Invalidism,2,0.6931471805599453
Ain,2,0.6931471805599453
-013,2,0.6931471805599453
sub-sets,2,0.6931471805599453
-012,2,0.6931471805599453
desquamating,2,0.6931471805599453
carcinomatosis,2,0.6931471805599453
coital,2,0.6931471805599453
Frankls,2,0.6931471805599453
Aeroallergen,2,0.6931471805599453
HITHOC,2,0.6931471805599453
ORMLD3,2,0.6931471805599453
time-out,2,0.6931471805599453
esters,2,0.6931471805599453
influenzapneumonia,2,0.6931471805599453
prevertebral,2,0.6931471805599453
layer-specific,2,0.6931471805599453
ridership,2,0.6931471805599453
clinicoeconomic,2,0.6931471805599453
refusals,2,0.6931471805599453
abnormalborderline,2,0.6931471805599453
-044,2,0.6931471805599453
Papanicolaous,2,0.6931471805599453
lycorine,2,0.6931471805599453
IUC,2,0.6931471805599453
ectopically,2,0.6931471805599453
vertebro-basilar,2,0.6931471805599453
mosquito-borne,2,0.6931471805599453
unimportant,2,0.6931471805599453
airtrapping,2,0.6931471805599453
IADLs,2,0.6931471805599453
interalveolar,2,0.6931471805599453
monensin,2,0.6931471805599453
P00000001,2,0.6931471805599453
fetusesnewborns,2,0.6931471805599453
BMAL1,2,0.6931471805599453
1458,2,0.6931471805599453
tubal,2,0.6931471805599453
11645,2,0.6931471805599453
distributed-lag,2,0.6931471805599453
Sam,2,0.6931471805599453
Feishu,2,0.6931471805599453
raphe,2,0.6931471805599453
DANish,2,0.6931471805599453
level-2,2,0.6931471805599453
level-3,2,0.6931471805599453
2-sample,2,0.6931471805599453
thrombin-antithrombin,2,0.6931471805599453
1157,2,0.6931471805599453
Binomial,2,0.6931471805599453
control-passengers,2,0.6931471805599453
locks,2,0.6931471805599453
case-passengers,2,0.6931471805599453
Raccoon,2,0.6931471805599453
E611,2,0.6931471805599453
Dosage,2,0.6931471805599453
Fuzhou,2,0.6931471805599453
beta-antagonists,2,0.6931471805599453
vagotomized,2,0.6931471805599453
H1N1S-OIV,2,0.6931471805599453
SASA,2,0.6931471805599453
HeadPoST,2,0.6931471805599453
pQTLs,2,0.6931471805599453
Positioning,2,0.6931471805599453
CI107-247,2,0.6931471805599453
PDBID,2,0.6931471805599453
enterovirushuman,2,0.6931471805599453
1633,2,0.6931471805599453
pocket-sized,2,0.6931471805599453
re-emphasized,2,0.6931471805599453
polysaccharide-based,2,0.6931471805599453
GeneScriptcPass,2,0.6931471805599453
adultchild,2,0.6931471805599453
n330,2,0.6931471805599453
typhi,2,0.6931471805599453
10-34,2,0.6931471805599453
T-SFSs,2,0.6931471805599453
postonset,2,0.6931471805599453
non-reversible,2,0.6931471805599453
1124,2,0.6931471805599453
6-54,2,0.6931471805599453
FVS,2,0.6931471805599453
nightclubs,2,0.6931471805599453
ninety-nine,2,0.6931471805599453
3485,2,0.6931471805599453
ASingaporeINFIMH-16-00192016,2,0.6931471805599453
countries--the,2,0.6931471805599453
Arrays,2,0.6931471805599453
betamethasone,2,0.6931471805599453
r069,2,0.6931471805599453
AddaVax,2,0.6931471805599453
virus-neutralisation,2,0.6931471805599453
GvHD,2,0.6931471805599453
biosciences,2,0.6931471805599453
FDOSM,2,0.6931471805599453
TUNEL,2,0.6931471805599453
SNF-associated,2,0.6931471805599453
prohibiting,2,0.6931471805599453
Thuringia,2,0.6931471805599453
disease-controlling,2,0.6931471805599453
user-generated,2,0.6931471805599453
mid-1970s,2,0.6931471805599453
mgkg-33,2,0.6931471805599453
Motivational,2,0.6931471805599453
Haematology,2,0.6931471805599453
twitching,2,0.6931471805599453
Radiating,2,0.6931471805599453
microliters,2,0.6931471805599453
T2-gradient,2,0.6931471805599453
FWZIC,2,0.6931471805599453
Host-directed,2,0.6931471805599453
articulating,2,0.6931471805599453
well-connected,2,0.6931471805599453
anti-infection,2,0.6931471805599453
r067,2,0.6931471805599453
laxatives,2,0.6931471805599453
LMCS50,2,0.6931471805599453
membrane-anchored,2,0.6931471805599453
hypercontractility,2,0.6931471805599453
susceptible-exposed-infected-recovered,2,0.6931471805599453
untypical,2,0.6931471805599453
Muscular,2,0.6931471805599453
InAc,2,0.6931471805599453
devascularization,2,0.6931471805599453
arsenic-induced,2,0.6931471805599453
Neutralisation,2,0.6931471805599453
dissociating,2,0.6931471805599453
mucinous,2,0.6931471805599453
APAs,2,0.6931471805599453
HispanicLatinx,2,0.6931471805599453
HIPEC,2,0.6931471805599453
Optimised,2,0.6931471805599453
analysisResults,2,0.6931471805599453
Sensitized,2,0.6931471805599453
mLμg,2,0.6931471805599453
Head-to-head,2,0.6931471805599453
1515,2,0.6931471805599453
cross-correlogram,2,0.6931471805599453
scenario-based,2,0.6931471805599453
Euroimmun-anti-S1-IgA,2,0.6931471805599453
Extraordinary,2,0.6931471805599453
decimated,2,0.6931471805599453
contextualizing,2,0.6931471805599453
Primarily,2,0.6931471805599453
uphill,2,0.6931471805599453
CoPP,2,0.6931471805599453
pleural-space-fluid,2,0.6931471805599453
CT-COVID-19,2,0.6931471805599453
Tissue-type,2,0.6931471805599453
underusing,2,0.6931471805599453
Roche-anti-N,2,0.6931471805599453
sepsis-like,2,0.6931471805599453
hCSCsGFP,2,0.6931471805599453
0809,2,0.6931471805599453
overusing,2,0.6931471805599453
MSCA,2,0.6931471805599453
annulocompression,2,0.6931471805599453
J-curve,2,0.6931471805599453
0765,2,0.6931471805599453
≤16,2,0.6931471805599453
post-recanalization,2,0.6931471805599453
widely-used,2,0.6931471805599453
subversion,2,0.6931471805599453
CHUV,2,0.6931471805599453
gait-training,2,0.6931471805599453
indels,2,0.6931471805599453
Abidjan,2,0.6931471805599453
nonambulatory,2,0.6931471805599453
dosimeter,2,0.6931471805599453
acid-hydrolyzing,2,0.6931471805599453
Ct-value,2,0.6931471805599453
Altman,2,0.6931471805599453
ECG-determined,2,0.6931471805599453
penetrance,2,0.6931471805599453
MACIs,2,0.6931471805599453
lysed,2,0.6931471805599453
8064,2,0.6931471805599453
IFN-mediated,2,0.6931471805599453
Rhinomanometry,2,0.6931471805599453
Kids,2,0.6931471805599453
violet,2,0.6931471805599453
ambulate,2,0.6931471805599453
VaccIntDesign,2,0.6931471805599453
non-chemical,2,0.6931471805599453
coeliac,2,0.6931471805599453
cued,2,0.6931471805599453
xi,2,0.6931471805599453
membranoproliferative,2,0.6931471805599453
TU,2,0.6931471805599453
3249,2,0.6931471805599453
pet-allergic,2,0.6931471805599453
2001-2007,2,0.6931471805599453
body-independent,2,0.6931471805599453
AFI,2,0.6931471805599453
smoking-induced,2,0.6931471805599453
layman,2,0.6931471805599453
RISK,2,0.6931471805599453
Junipers,2,0.6931471805599453
industrializing,2,0.6931471805599453
mesangial,2,0.6931471805599453
anti‑PD‑1,2,0.6931471805599453
dilative,2,0.6931471805599453
overrepresentation,2,0.6931471805599453
dIvoire,2,0.6931471805599453
201-Tl,2,0.6931471805599453
histomorphometry,2,0.6931471805599453
single-joint,2,0.6931471805599453
depresses,2,0.6931471805599453
pre-schoolers,2,0.6931471805599453
CMPHL,2,0.6931471805599453
Complicating,2,0.6931471805599453
AH1N1-2009,2,0.6931471805599453
4428,2,0.6931471805599453
brain-resident,2,0.6931471805599453
camping,2,0.6931471805599453
De-identified,2,0.6931471805599453
false-positives,2,0.6931471805599453
Investments,2,0.6931471805599453
Polynesians,2,0.6931471805599453
plasty,2,0.6931471805599453
LOH,2,0.6931471805599453
MicroRNA,2,0.6931471805599453
2-Deoxy-d-glucose,2,0.6931471805599453
peripherally,2,0.6931471805599453
Coloured,2,0.6931471805599453
OCTA,2,0.6931471805599453
UPTH,2,0.6931471805599453
Interpersonal,2,0.6931471805599453
soaps,2,0.6931471805599453
embarrassing,2,0.6931471805599453
tachycardic,2,0.6931471805599453
Sioux,2,0.6931471805599453
Copeptin,2,0.6931471805599453
recipe,2,0.6931471805599453
acid-inducible,2,0.6931471805599453
HSPC,2,0.6931471805599453
Cotton,2,0.6931471805599453
infinite,2,0.6931471805599453
nonmalignant,2,0.6931471805599453
Outdoor,2,0.6931471805599453
Schirmers,2,0.6931471805599453
Penetration,2,0.6931471805599453
nurse-delivered,2,0.6931471805599453
No1-9,2,0.6931471805599453
DRR,2,0.6931471805599453
recent-phase,2,0.6931471805599453
anti-Nogo,2,0.6931471805599453
estro-progestinic,2,0.6931471805599453
family-centred,2,0.6931471805599453
79130,2,0.6931471805599453
dual-marker,2,0.6931471805599453
human-related,2,0.6931471805599453
spectrophotometric,2,0.6931471805599453
Addison,2,0.6931471805599453
patientfamily,2,0.6931471805599453
Infantil,2,0.6931471805599453
diluents,2,0.6931471805599453
PW2,2,0.6931471805599453
consultation-oriented,2,0.6931471805599453
protonation,2,0.6931471805599453
LZTFL1,2,0.6931471805599453
MST,2,0.6931471805599453
SLC6A20,2,0.6931471805599453
Oldridge,2,0.6931471805599453
QLMI,2,0.6931471805599453
CCR9,2,0.6931471805599453
FYCO1,2,0.6931471805599453
CXCR6,2,0.6931471805599453
NOEs,2,0.6931471805599453
XCR1,2,0.6931471805599453
conformism,2,0.6931471805599453
HA1-H38,2,0.6931471805599453
digitally,2,0.6931471805599453
PW1,2,0.6931471805599453
A2H,2,0.6931471805599453
BFMI,2,0.6931471805599453
FFMI,2,0.6931471805599453
J45-J46,2,0.6931471805599453
n117,2,0.6931471805599453
exercise-test,2,0.6931471805599453
defects--VSDs,2,0.6931471805599453
defy,2,0.6931471805599453
VLDL-triglycerides,2,0.6931471805599453
china,2,0.6931471805599453
Nick,2,0.6931471805599453
2109,2,0.6931471805599453
pH-induced,2,0.6931471805599453
95CrI,2,0.6931471805599453
BABM,2,0.6931471805599453
stopgap,2,0.6931471805599453
8125,2,0.6931471805599453
self-generated,2,0.6931471805599453
n58,2,0.6931471805599453
pyelonephritis,2,0.6931471805599453
FLUBV,2,0.6931471805599453
FCGR2A,2,0.6931471805599453
Himalayas,2,0.6931471805599453
non-Stroke,2,0.6931471805599453
listeriosis,2,0.6931471805599453
P00005,2,0.6931471805599453
hml,2,0.6931471805599453
webcast,2,0.6931471805599453
hepatorenal,2,0.6931471805599453
quadruple,2,0.6931471805599453
causalities,2,0.6931471805599453
procure,2,0.6931471805599453
previously-infected,2,0.6931471805599453
deploys,2,0.6931471805599453
preparticipation,2,0.6931471805599453
tallies,2,0.6931471805599453
nonurgent,2,0.6931471805599453
pathoanatomy,2,0.6931471805599453
heparin-coated,2,0.6931471805599453
Le,2,0.6931471805599453
Mancha,2,0.6931471805599453
depletes,2,0.6931471805599453
histochemistry,2,0.6931471805599453
barns,2,0.6931471805599453
transforms,2,0.6931471805599453
CV07050101,2,0.6931471805599453
5197,2,0.6931471805599453
swineTaiwan,2,0.6931471805599453
CoA,2,0.6931471805599453
leukoareosis,2,0.6931471805599453
oncogenesis,2,0.6931471805599453
1972–1973,2,0.6931471805599453
Sales,2,0.6931471805599453
extended-stay,2,0.6931471805599453
multimedia,2,0.6931471805599453
Deepening,2,0.6931471805599453
endosome,2,0.6931471805599453
primersprobes,2,0.6931471805599453
multitarget,2,0.6931471805599453
Anderson-Wilkins,2,0.6931471805599453
single-primer,2,0.6931471805599453
WHtR,2,0.6931471805599453
1374,2,0.6931471805599453
5-44,2,0.6931471805599453
rearrange,2,0.6931471805599453
sequence-independent,2,0.6931471805599453
neighbour,2,0.6931471805599453
subcategory,2,0.6931471805599453
40-46,2,0.6931471805599453
host-associated,2,0.6931471805599453
duly,2,0.6931471805599453
inter-annual,2,0.6931471805599453
parametres,2,0.6931471805599453
never-smoking,2,0.6931471805599453
z-lead,2,0.6931471805599453
VLAD,2,0.6931471805599453
DNAzyme,2,0.6931471805599453
Vircell-IgG,2,0.6931471805599453
Euroimmun-IgG,2,0.6931471805599453
Zhongzhu,2,0.6931471805599453
NeuroIntervent,2,0.6931471805599453
Flk-1,2,0.6931471805599453
S-OIV-infected,2,0.6931471805599453
Waiguan,2,0.6931471805599453
heart-lung,2,0.6931471805599453
Beijings,2,0.6931471805599453
15T,2,0.6931471805599453
Chen,2,0.6931471805599453
Wherever,2,0.6931471805599453
Quchi,2,0.6931471805599453
Lkgh,2,0.6931471805599453
CD4LAPTreg,2,0.6931471805599453
Graves,2,0.6931471805599453
XFD,2,0.6931471805599453
Xinfadi,2,0.6931471805599453
28-,2,0.6931471805599453
Subtotal,2,0.6931471805599453
catherization,2,0.6931471805599453
Euroimmun-IgA,2,0.6931471805599453
CRISPRCas-based,2,0.6931471805599453
ESCs,2,0.6931471805599453
6079,2,0.6931471805599453
intern,2,0.6931471805599453
demons,2,0.6931471805599453
053-082,2,0.6931471805599453
subacromial-subdeltoid,2,0.6931471805599453
Hitherto,2,0.6931471805599453
antibody-avidity,2,0.6931471805599453
Taixi,2,0.6931471805599453
8159,2,0.6931471805599453
4286,2,0.6931471805599453
expert-reviewed,2,0.6931471805599453
COVID-19-negative,2,0.6931471805599453
Celvapan®,2,0.6931471805599453
ACalifornia72009H1N1pdm09,2,0.6931471805599453
Mesopotamia,2,0.6931471805599453
interleukin-18,2,0.6931471805599453
clearinghouse,2,0.6931471805599453
multi-burden,2,0.6931471805599453
Vein,2,0.6931471805599453
Prostaglandin,2,0.6931471805599453
Neurodegenerative,2,0.6931471805599453
cholesterin,2,0.6931471805599453
SKPTCA,2,0.6931471805599453
HexaPro,2,0.6931471805599453
metastable,2,0.6931471805599453
irrevocably,2,0.6931471805599453
semi-emergent,2,0.6931471805599453
hypervolemia,2,0.6931471805599453
fainting,2,0.6931471805599453
Publishing,2,0.6931471805599453
mite-free,2,0.6931471805599453
unyielding,2,0.6931471805599453
1063,2,0.6931471805599453
up-titration,2,0.6931471805599453
sensitivity-,2,0.6931471805599453
00041,2,0.6931471805599453
colonisation,2,0.6931471805599453
volunteering,2,0.6931471805599453
Su,2,0.6931471805599453
zymography,2,0.6931471805599453
Jok,2,0.6931471805599453
1060,2,0.6931471805599453
wwwnicdacza,2,0.6931471805599453
grief,2,0.6931471805599453
CVRF,2,0.6931471805599453
hypoglycemic,2,0.6931471805599453
PSH,2,0.6931471805599453
NICUs,2,0.6931471805599453
Random-effects,2,0.6931471805599453
sedimenting,2,0.6931471805599453
PdNH34Cl2,2,0.6931471805599453
Sarah,2,0.6931471805599453
Kaplan,2,0.6931471805599453
Distinction,2,0.6931471805599453
AOSC,2,0.6931471805599453
1143,2,0.6931471805599453
insulting,2,0.6931471805599453
33-day,2,0.6931471805599453
mutifactorial,2,0.6931471805599453
rhodium,2,0.6931471805599453
biorhythm,2,0.6931471805599453
cholangitis,2,0.6931471805599453
organismal,2,0.6931471805599453
SIDS,2,0.6931471805599453
SL,2,0.6931471805599453
APC-PCI,2,0.6931471805599453
embryogenesis,2,0.6931471805599453
ERIS,2,0.6931471805599453
incongruent,2,0.6931471805599453
solidity,2,0.6931471805599453
informationABSTRACT,2,0.6931471805599453
3761,2,0.6931471805599453
2408,2,0.6931471805599453
skewness,2,0.6931471805599453
waived,2,0.6931471805599453
one-year-beforeone-year-after,2,0.6931471805599453
PfAgo,2,0.6931471805599453
asthmatiform,2,0.6931471805599453
chronotropic,2,0.6931471805599453
Auscultation,2,0.6931471805599453
2904,2,0.6931471805599453
ivabradine,2,0.6931471805599453
anti-leucotrienes,2,0.6931471805599453
Chengdu,2,0.6931471805599453
Fibroblasts,2,0.6931471805599453
pneumotachometry,2,0.6931471805599453
mr,2,0.6931471805599453
dual-gene,2,0.6931471805599453
al1,2,0.6931471805599453
vasotherapeutics,2,0.6931471805599453
unravelling,2,0.6931471805599453
Min,2,0.6931471805599453
1981-82,2,0.6931471805599453
Droplets,2,0.6931471805599453
Brewers,2,0.6931471805599453
Fibrin,2,0.6931471805599453
persistency,2,0.6931471805599453
configurable,2,0.6931471805599453
Early-onset,2,0.6931471805599453
Youden,2,0.6931471805599453
pandemic-driven,2,0.6931471805599453
CON,2,0.6931471805599453
counterbalance,2,0.6931471805599453
Etiological,2,0.6931471805599453
GREAT,2,0.6931471805599453
8822,2,0.6931471805599453
9652,2,0.6931471805599453
penalized,2,0.6931471805599453
C-Reactive,2,0.6931471805599453
0117,2,0.6931471805599453
workschool,2,0.6931471805599453
Detections,2,0.6931471805599453
PAND,2,0.6931471805599453
brain-protective,2,0.6931471805599453
chemoradiotherapy,2,0.6931471805599453
overstate,2,0.6931471805599453
emulating,2,0.6931471805599453
textFormula,2,0.6931471805599453
season-year,2,0.6931471805599453
1918–1919,2,0.6931471805599453
textd,2,0.6931471805599453
2622,2,0.6931471805599453
microprobe,2,0.6931471805599453
9932,2,0.6931471805599453
9380,2,0.6931471805599453
9753,2,0.6931471805599453
Babol,2,0.6931471805599453
Dar-es-Salaam,2,0.6931471805599453
Dermatologists,2,0.6931471805599453
Fold,2,0.6931471805599453
56-7,2,0.6931471805599453
Colin,2,0.6931471805599453
witchcraft,2,0.6931471805599453
2857,2,0.6931471805599453
UL-VWFM,2,0.6931471805599453
influenza-mediated,2,0.6931471805599453
unsustainable,2,0.6931471805599453
optimistically,2,0.6931471805599453
COVID‐19”,2,0.6931471805599453
wit,2,0.6931471805599453
CRTx,2,0.6931471805599453
deoxyglucose,2,0.6931471805599453
ECSG,2,0.6931471805599453
vSP,2,0.6931471805599453
JES,2,0.6931471805599453
stand-by,2,0.6931471805599453
cochleovestibular,2,0.6931471805599453
cursor,2,0.6931471805599453
25-29,2,0.6931471805599453
brain-based,2,0.6931471805599453
dust-mite,2,0.6931471805599453
Non-Hispanic,2,0.6931471805599453
Norm-Activation,2,0.6931471805599453
lenvatinibremdesivir,2,0.6931471805599453
left-ventricular-assist,2,0.6931471805599453
Bonsai,2,0.6931471805599453
time-of-addition,2,0.6931471805599453
guideline-oriented,2,0.6931471805599453
SOTRs,2,0.6931471805599453
cinecoronariography,2,0.6931471805599453
proteinaceous,2,0.6931471805599453
nursing-home,2,0.6931471805599453
Inspite,2,0.6931471805599453
cardiac-embolic,2,0.6931471805599453
JH,2,0.6931471805599453
Anaesthetic,2,0.6931471805599453
Renin-Angiotensin-Aldosterone,2,0.6931471805599453
Integral,2,0.6931471805599453
cullers,2,0.6931471805599453
convulsant,2,0.6931471805599453
Negev,2,0.6931471805599453
patient-to-HCW,2,0.6931471805599453
PACSI,2,0.6931471805599453
Phosphate,2,0.6931471805599453
long-termresidential,2,0.6931471805599453
BioNTechs,2,0.6931471805599453
BackgroundThe,2,0.6931471805599453
1995-1998,2,0.6931471805599453
In-situ,2,0.6931471805599453
2325,2,0.6931471805599453
Nitrate,2,0.6931471805599453
post-IAV,2,0.6931471805599453
Bluetooth,2,0.6931471805599453
Chalmers74,2,0.6931471805599453
expediated,2,0.6931471805599453
broncho-obstructive,2,0.6931471805599453
bicycle-ergometric,2,0.6931471805599453
free-living,2,0.6931471805599453
ICMs,2,0.6931471805599453
semiology,2,0.6931471805599453
donor-derived,2,0.6931471805599453
homebound,2,0.6931471805599453
single-occupancy,2,0.6931471805599453
Alere™,2,0.6931471805599453
UK-RTC,2,0.6931471805599453
Athletic,2,0.6931471805599453
phylogenomics,2,0.6931471805599453
lock-down,2,0.6931471805599453
monachus,2,0.6931471805599453
cholestasis,2,0.6931471805599453
unlysed,2,0.6931471805599453
Limits,2,0.6931471805599453
degenerate,2,0.6931471805599453
grateful,2,0.6931471805599453
hemicranial,2,0.6931471805599453
noncirrhotic,2,0.6931471805599453
stroke-injured,2,0.6931471805599453
ascribable,2,0.6931471805599453
-090,2,0.6931471805599453
55-94,2,0.6931471805599453
sixteenth,2,0.6931471805599453
sclerosing,2,0.6931471805599453
model-inference,2,0.6931471805599453
DNA-binding,2,0.6931471805599453
Kong15697,2,0.6931471805599453
opposes,2,0.6931471805599453
geo-centroid,2,0.6931471805599453
HORIZONS-AMI,2,0.6931471805599453
Taskforce,2,0.6931471805599453
EIPs,2,0.6931471805599453
off-line,2,0.6931471805599453
β-carotene,2,0.6931471805599453
STIR,2,0.6931471805599453
1434,2,0.6931471805599453
inversion-recovery,2,0.6931471805599453
nontraining,2,0.6931471805599453
Qureshi,2,0.6931471805599453
nonwork-related,2,0.6931471805599453
Palestinians,2,0.6931471805599453
1816,2,0.6931471805599453
tranquillisers,2,0.6931471805599453
ASDs,2,0.6931471805599453
Ferrara,2,0.6931471805599453
coach,2,0.6931471805599453
246248,2,0.6931471805599453
Co-morbidities,2,0.6931471805599453
V-Chek,2,0.6931471805599453
publicly-funded,2,0.6931471805599453
damp-toxin,2,0.6931471805599453
micropores,2,0.6931471805599453
rechecked,2,0.6931471805599453
Pregnancy-induced,2,0.6931471805599453
Co-existing,2,0.6931471805599453
subanalysis,2,0.6931471805599453
CgA,2,0.6931471805599453
pus,2,0.6931471805599453
INJECT,2,0.6931471805599453
nonprescription,2,0.6931471805599453
NIPH-NIH,2,0.6931471805599453
Woven,2,0.6931471805599453
Andhra,2,0.6931471805599453
Rudolphi,2,0.6931471805599453
checkups,2,0.6931471805599453
nonpneumonic,2,0.6931471805599453
Biozek,2,0.6931471805599453
isoprenaline-induced,2,0.6931471805599453
4112,2,0.6931471805599453
10-22,2,0.6931471805599453
00015,2,0.6931471805599453
3-terminal,2,0.6931471805599453
immunosuppressiveimmunomodulating,2,0.6931471805599453
Chemistry,2,0.6931471805599453
huID,2,0.6931471805599453
pox,2,0.6931471805599453
10-mg,2,0.6931471805599453
AVP,2,0.6931471805599453
CSQ-8J,2,0.6931471805599453
infarct-like,2,0.6931471805599453
1623,2,0.6931471805599453
Rose,2,0.6931471805599453
Muller,2,0.6931471805599453
DAI-10,2,0.6931471805599453
non-LBBB,2,0.6931471805599453
≥38°C,2,0.6931471805599453
greedy,2,0.6931471805599453
EPICES,2,0.6931471805599453
Kunming,2,0.6931471805599453
triphosphatase,2,0.6931471805599453
Beta-blocking,2,0.6931471805599453
LD-A,2,0.6931471805599453
represses,2,0.6931471805599453
dewfrost,2,0.6931471805599453
overstrain,2,0.6931471805599453
0748,2,0.6931471805599453
Erasmus,2,0.6931471805599453
chemesthesis,2,0.6931471805599453
Horners,2,0.6931471805599453
mesoporous,2,0.6931471805599453
noncancer,2,0.6931471805599453
unsettling,2,0.6931471805599453
carrageenan,2,0.6931471805599453
UV-inactivated,2,0.6931471805599453
Waves,2,0.6931471805599453
under-ascertainment,2,0.6931471805599453
chemesthetic,2,0.6931471805599453
lactacidosis,2,0.6931471805599453
shoes,2,0.6931471805599453
constrictiva,2,0.6931471805599453
quartz,2,0.6931471805599453
Nord-Trøndelag,2,0.6931471805599453
socks,2,0.6931471805599453
GNI,2,0.6931471805599453
syndrome-induced,2,0.6931471805599453
B-C,2,0.6931471805599453
S1-S4,2,0.6931471805599453
CFU,2,0.6931471805599453
ketolide,2,0.6931471805599453
re-learning,2,0.6931471805599453
v1,2,0.6931471805599453
telithromycin,2,0.6931471805599453
aged-care,2,0.6931471805599453
Intraepidemic,2,0.6931471805599453
11-33,2,0.6931471805599453
-28,2,0.6931471805599453
Endomyocardial,2,0.6931471805599453
collapsibility,2,0.6931471805599453
medicinetherapies,2,0.6931471805599453
pre-empt,2,0.6931471805599453
Vasculitis,2,0.6931471805599453
CC50,2,0.6931471805599453
vaccine-modified,2,0.6931471805599453
Views,2,0.6931471805599453
CODU-INEM,2,0.6931471805599453
CC50EC50,2,0.6931471805599453
MET-hweek,2,0.6931471805599453
Monto,2,0.6931471805599453
non-PCR-trained,2,0.6931471805599453
iTRAQ,2,0.6931471805599453
Amperial™,2,0.6931471805599453
Africas,2,0.6931471805599453
greenspaces,2,0.6931471805599453
sertraline,2,0.6931471805599453
Primates,2,0.6931471805599453
SOIV,2,0.6931471805599453
2733,2,0.6931471805599453
dichotomizations,2,0.6931471805599453
individualistic,2,0.6931471805599453
Wigner,2,0.6931471805599453
ezrin,2,0.6931471805599453
CCoV,2,0.6931471805599453
eosinophil-driven,2,0.6931471805599453
anaclitic,2,0.6931471805599453
1191,2,0.6931471805599453
multi-day,2,0.6931471805599453
cine-magnetic,2,0.6931471805599453
collagens,2,0.6931471805599453
Antiplatelets,2,0.6931471805599453
first-wave,2,0.6931471805599453
PTKs,2,0.6931471805599453
precariousness,2,0.6931471805599453
cpreaction,2,0.6931471805599453
l-isoproterenol,2,0.6931471805599453
5467,2,0.6931471805599453
entrusting,2,0.6931471805599453
abandonic,2,0.6931471805599453
35326,2,0.6931471805599453
coimmunoprecipitation,2,0.6931471805599453
Organised,2,0.6931471805599453
monoaminergic,2,0.6931471805599453
Amplicons,2,0.6931471805599453
coreceptors,2,0.6931471805599453
Isocapnic,2,0.6931471805599453
colocalized,2,0.6931471805599453
Basement,2,0.6931471805599453
9995,2,0.6931471805599453
cartridges,2,0.6931471805599453
MSSCP,2,0.6931471805599453
incline,2,0.6931471805599453
36th,2,0.6931471805599453
PRB,2,0.6931471805599453
1413,2,0.6931471805599453
SWIFT-PRIME,2,0.6931471805599453
Work-Related,2,0.6931471805599453
steroidogenesis,2,0.6931471805599453
H1N1pdm09-like,2,0.6931471805599453
Alteration,2,0.6931471805599453
enflurane,2,0.6931471805599453
frontal-basal,2,0.6931471805599453
Dosages,2,0.6931471805599453
self-bath,2,0.6931471805599453
lineage3,2,0.6931471805599453
patient-days,2,0.6931471805599453
HRU,2,0.6931471805599453
moesin,2,0.6931471805599453
20-month-old,2,0.6931471805599453
knock-in,2,0.6931471805599453
Illustrative,2,0.6931471805599453
PTK,2,0.6931471805599453
GHQ-12,2,0.6931471805599453
Grotta,2,0.6931471805599453
interpleural,2,0.6931471805599453
thiopental,2,0.6931471805599453
LT-B,2,0.6931471805599453
Mutational,2,0.6931471805599453
vitamin-D-mediated,2,0.6931471805599453
2009-July,2,0.6931471805599453
021-024,2,0.6931471805599453
Ink4a,2,0.6931471805599453
amnion,2,0.6931471805599453
stalled,2,0.6931471805599453
ovalbumin-challenged,2,0.6931471805599453
roll-outs,2,0.6931471805599453
RHD-related,2,0.6931471805599453
medial-lateral,2,0.6931471805599453
fronto-temporo-parietal,2,0.6931471805599453
Tatum,2,0.6931471805599453
Salofa,2,0.6931471805599453
categorizes,2,0.6931471805599453
immigrated,2,0.6931471805599453
20062007,2,0.6931471805599453
46-fold,2,0.6931471805599453
Nf2p53,2,0.6931471805599453
AADs,2,0.6931471805599453
-056,2,0.6931471805599453
Workup,2,0.6931471805599453
Lesser,2,0.6931471805599453
Nf2Ink4aArf,2,0.6931471805599453
esteemed,2,0.6931471805599453
Influ,2,0.6931471805599453
heat-killed,2,0.6931471805599453
detracts,2,0.6931471805599453
AH3N2-related,2,0.6931471805599453
hydraulic,2,0.6931471805599453
Pap,2,0.6931471805599453
IL-1A,2,0.6931471805599453
01-05,2,0.6931471805599453
0000001,2,0.6931471805599453
clomethiazole,2,0.6931471805599453
AHKx31,2,0.6931471805599453
equivalentsmL,2,0.6931471805599453
phase-II,2,0.6931471805599453
Unacceptable,2,0.6931471805599453
low-threshold,2,0.6931471805599453
0786,2,0.6931471805599453
10hour,2,0.6931471805599453
nine-week,2,0.6931471805599453
hockey,2,0.6931471805599453
Seizure,2,0.6931471805599453
Postsurgical,2,0.6931471805599453
Acceptability,2,0.6931471805599453
Lingering,2,0.6931471805599453
Moloney,2,0.6931471805599453
triplets,2,0.6931471805599453
neuroaminidase,2,0.6931471805599453
sixty-five,2,0.6931471805599453
barcode,2,0.6931471805599453
Veille,2,0.6931471805599453
Sanitaire,2,0.6931471805599453
IL-1B,2,0.6931471805599453
indiscriminate,2,0.6931471805599453
postrema,2,0.6931471805599453
archetypes,2,0.6931471805599453
Examined,2,0.6931471805599453
2490,2,0.6931471805599453
Th2-cells,2,0.6931471805599453
2038,2,0.6931471805599453
center-stage,2,0.6931471805599453
cholinesterase,2,0.6931471805599453
cluster-specific,2,0.6931471805599453
spectrophotometry,2,0.6931471805599453
microvolts,2,0.6931471805599453
or--if,2,0.6931471805599453
host-switching,2,0.6931471805599453
neurointensivist,2,0.6931471805599453
unit-level,2,0.6931471805599453
sourcing,2,0.6931471805599453
3429,2,0.6931471805599453
thermophilus,2,0.6931471805599453
glomectomy,2,0.6931471805599453
decentralization,2,0.6931471805599453
school-year,2,0.6931471805599453
ZIKV,2,0.6931471805599453
p0036,2,0.6931471805599453
edvs,2,0.6931471805599453
Cross-clade,2,0.6931471805599453
nucleotide-binding,2,0.6931471805599453
hyperresponsivenss,2,0.6931471805599453
dorsally,2,0.6931471805599453
0691,2,0.6931471805599453
Transmissions,2,0.6931471805599453
intra-hemispheric,2,0.6931471805599453
sensitising,2,0.6931471805599453
underutilize,2,0.6931471805599453
Oy,2,0.6931471805599453
30-70,2,0.6931471805599453
eluded,2,0.6931471805599453
Salo,2,0.6931471805599453
Seed-based,2,0.6931471805599453
Onchocercidae,2,0.6931471805599453
p0015,2,0.6931471805599453
Actionable,2,0.6931471805599453
AVietnam11942004,2,0.6931471805599453
4535,2,0.6931471805599453
component-gene,2,0.6931471805599453
Pronounced,2,0.6931471805599453
sulfites,2,0.6931471805599453
cardiogram,2,0.6931471805599453
nonmetropolitan,2,0.6931471805599453
9944,2,0.6931471805599453
nanotechnological,2,0.6931471805599453
mini-thoracotomy,2,0.6931471805599453
1861,2,0.6931471805599453
maldistribution,2,0.6931471805599453
nodosome,2,0.6931471805599453
LacZ,2,0.6931471805599453
reap,2,0.6931471805599453
VISTA,2,0.6931471805599453
MATCH,2,0.6931471805599453
End-stage,2,0.6931471805599453
UIl,2,0.6931471805599453
non-sigmoidal,2,0.6931471805599453
n125,2,0.6931471805599453
Isoprenaline,2,0.6931471805599453
6656,2,0.6931471805599453
virulence-conferring,2,0.6931471805599453
Phadiatop,2,0.6931471805599453
non-novel,2,0.6931471805599453
infarct-associated,2,0.6931471805599453
Lodi,2,0.6931471805599453
Affect,2,0.6931471805599453
Evaluated,2,0.6931471805599453
3-24,2,0.6931471805599453
prefecture-level,2,0.6931471805599453
BDs,2,0.6931471805599453
re-enter,2,0.6931471805599453
c-ACT,2,0.6931471805599453
5200,2,0.6931471805599453
SkMs,2,0.6931471805599453
PTFE-covered,2,0.6931471805599453
semiclosed,2,0.6931471805599453
SARI-COVID,2,0.6931471805599453
demic,2,0.6931471805599453
CBO,2,0.6931471805599453
extraneous,2,0.6931471805599453
climatological,2,0.6931471805599453
non-COVID-19-related,2,0.6931471805599453
Paresis,2,0.6931471805599453
1-dose,2,0.6931471805599453
perihilar,2,0.6931471805599453
leucopoenia,2,0.6931471805599453
impalement,2,0.6931471805599453
OvRag,2,0.6931471805599453
invulnerability,2,0.6931471805599453
2661,2,0.6931471805599453
Existence,2,0.6931471805599453
Nueces,2,0.6931471805599453
Premenstrual,2,0.6931471805599453
1345,2,0.6931471805599453
40-100,2,0.6931471805599453
perimenstrually,2,0.6931471805599453
crise,2,0.6931471805599453
dPRP,2,0.6931471805599453
praying,2,0.6931471805599453
respite,2,0.6931471805599453
pressure-rate,2,0.6931471805599453
stressfulness,2,0.6931471805599453
T2W,2,0.6931471805599453
-SD,2,0.6931471805599453
nanoscopic,2,0.6931471805599453
Exercise-related,2,0.6931471805599453
premenstrually,2,0.6931471805599453
PFC,2,0.6931471805599453
Faecal,2,0.6931471805599453
1188,2,0.6931471805599453
15-,2,0.6931471805599453
LCxOM,2,0.6931471805599453
Campaigns,2,0.6931471805599453
royalblue,2,0.6931471805599453
24-,2,0.6931471805599453
Omani,2,0.6931471805599453
Cycler,2,0.6931471805599453
Dongchang,2,0.6931471805599453
MR-proANP,2,0.6931471805599453
NRSs,2,0.6931471805599453
NPEs,2,0.6931471805599453
74-87,2,0.6931471805599453
midregional,2,0.6931471805599453
NSP13,2,0.6931471805599453
self-replicating,2,0.6931471805599453
13-37,2,0.6931471805599453
dyskinesisakinesis,2,0.6931471805599453
Myanmar,2,0.6931471805599453
Wntβ-catenin,2,0.6931471805599453
Heredity,2,0.6931471805599453
sex-standardized,2,0.6931471805599453
Song,2,0.6931471805599453
theater,2,0.6931471805599453
hypobiotic,2,0.6931471805599453
sequestrations,2,0.6931471805599453
levity,2,0.6931471805599453
aspirin-intolerance,2,0.6931471805599453
IgGAM,2,0.6931471805599453
memantine,2,0.6931471805599453
MM4,2,0.6931471805599453
Mainz,2,0.6931471805599453
PDK1,2,0.6931471805599453
0798,2,0.6931471805599453
passive-immunotherapy,2,0.6931471805599453
TCs,2,0.6931471805599453
rp,2,0.6931471805599453
Pulmonol,2,0.6931471805599453
debaters,2,0.6931471805599453
Debates,2,0.6931471805599453
dispatched,2,0.6931471805599453
atrophic,2,0.6931471805599453
dWi,2,0.6931471805599453
geo-mapping,2,0.6931471805599453
care-dependent,2,0.6931471805599453
ARVD,2,0.6931471805599453
P014,2,0.6931471805599453
Ordinary,2,0.6931471805599453
Continual,2,0.6931471805599453
eversion,2,0.6931471805599453
Neotropical,2,0.6931471805599453
Tirofiban,2,0.6931471805599453
047-088,2,0.6931471805599453
I-123-MIBG,2,0.6931471805599453
greenyellow,2,0.6931471805599453
volunteerism,2,0.6931471805599453
unaccompanied,2,0.6931471805599453
Valsalvas,2,0.6931471805599453
Surrogate,2,0.6931471805599453
emails,2,0.6931471805599453
infectious-toxic,2,0.6931471805599453
alphavirus-based,2,0.6931471805599453
Bohemia,2,0.6931471805599453
heamodialyses,2,0.6931471805599453
Janet,2,0.6931471805599453
isoflurane,2,0.6931471805599453
Visiting,2,0.6931471805599453
consanguineous,2,0.6931471805599453
antiatherogenic,2,0.6931471805599453
cardiorhexis,2,0.6931471805599453
WSD,2,0.6931471805599453
swab-based,2,0.6931471805599453
prearrival,2,0.6931471805599453
anthropometrics,2,0.6931471805599453
dyscinesia,2,0.6931471805599453
single-target,2,0.6931471805599453
imperatives,2,0.6931471805599453
thrombohemorrhagic,2,0.6931471805599453
transurethral,2,0.6931471805599453
centralities,2,0.6931471805599453
atherogenicity,2,0.6931471805599453
STAT1,2,0.6931471805599453
chlorine-containing,2,0.6931471805599453
springboard,2,0.6931471805599453
F-M,2,0.6931471805599453
145-153,2,0.6931471805599453
GIT,2,0.6931471805599453
precedence,2,0.6931471805599453
Santo,2,0.6931471805599453
cocks,2,0.6931471805599453
PFUml,2,0.6931471805599453
Roma,2,0.6931471805599453
bifida,2,0.6931471805599453
spina,2,0.6931471805599453
cell-penetrating,2,0.6931471805599453
interplays,2,0.6931471805599453
rapid-turnaround,2,0.6931471805599453
down-regulating,2,0.6931471805599453
18F-FDGnitrogen-13-labelled,2,0.6931471805599453
lifeThe,2,0.6931471805599453
mumolmin,2,0.6931471805599453
CHAD,2,0.6931471805599453
nsp7-10,2,0.6931471805599453
R2375,2,0.6931471805599453
replicationtranscription,2,0.6931471805599453
F-actin,2,0.6931471805599453
nsp,2,0.6931471805599453
Hellenic,2,0.6931471805599453
ULM,2,0.6931471805599453
Fijians,2,0.6931471805599453
hyperuricaemia,2,0.6931471805599453
organssystems,2,0.6931471805599453
Colonial,2,0.6931471805599453
Buri,2,0.6931471805599453
dys-,2,0.6931471805599453
continous,2,0.6931471805599453
wakes,2,0.6931471805599453
Pathom,2,0.6931471805599453
FXIII-Ad0,2,0.6931471805599453
Seniors,2,0.6931471805599453
R1149,2,0.6931471805599453
siRNA-based,2,0.6931471805599453
neurotensin,2,0.6931471805599453
spawning,2,0.6931471805599453
newfound,2,0.6931471805599453
Rwandas,2,0.6931471805599453
2824,2,0.6931471805599453
abstinent,2,0.6931471805599453
AdC68-19RBD,2,0.6931471805599453
hypo-perfusion,2,0.6931471805599453
Photon,2,0.6931471805599453
LVES,2,0.6931471805599453
JVP,2,0.6931471805599453
IMIs,2,0.6931471805599453
10316,2,0.6931471805599453
30100000,2,0.6931471805599453
nutritious,2,0.6931471805599453
Work-exacerbated,2,0.6931471805599453
9550,2,0.6931471805599453
meningovascular,2,0.6931471805599453
MM-C,2,0.6931471805599453
Reviewed,2,0.6931471805599453
flagged,2,0.6931471805599453
Anatomically,2,0.6931471805599453
inconspicuous,2,0.6931471805599453
CPBS,2,0.6931471805599453
ambiguities,2,0.6931471805599453
MM-B,2,0.6931471805599453
clarithromycin,2,0.6931471805599453
Specialists,2,0.6931471805599453
Canton,2,0.6931471805599453
Metabolomic,2,0.6931471805599453
High-affinity,2,0.6931471805599453
gr,2,0.6931471805599453
Alberts,2,0.6931471805599453
nephroureterectomy,2,0.6931471805599453
AdC68-19RBDs,2,0.6931471805599453
235-triphenyltetrazolium,2,0.6931471805599453
HNE,2,0.6931471805599453
TARGET,2,0.6931471805599453
full-growns,2,0.6931471805599453
copyμl,2,0.6931471805599453
4744,2,0.6931471805599453
POPULATION,2,0.6931471805599453
next-of-kin,2,0.6931471805599453
expects,2,0.6931471805599453
2707,2,0.6931471805599453
24-26,2,0.6931471805599453
Calculated,2,0.6931471805599453
exerciseABSTRACT,2,0.6931471805599453
sub-pleural,2,0.6931471805599453
Zaria,2,0.6931471805599453
patientsyear,2,0.6931471805599453
clot-selective,2,0.6931471805599453
hierarchies,2,0.6931471805599453
Preanesthetic,2,0.6931471805599453
ascendant,2,0.6931471805599453
Kermanshah,2,0.6931471805599453
357-393,2,0.6931471805599453
conquest,2,0.6931471805599453
anti-B,2,0.6931471805599453
Nitroprusside,2,0.6931471805599453
otoscopic,2,0.6931471805599453
carpi,2,0.6931471805599453
35-39,2,0.6931471805599453
3D-echocardiography,2,0.6931471805599453
Moldavia,2,0.6931471805599453
asynchronism,2,0.6931471805599453
Granger,2,0.6931471805599453
HASUs,2,0.6931471805599453
390000,2,0.6931471805599453
2002-2017,2,0.6931471805599453
Radioimmunoassay,2,0.6931471805599453
Designated,2,0.6931471805599453
lecturers,2,0.6931471805599453
eCRF,2,0.6931471805599453
months-18,2,0.6931471805599453
Presentations,2,0.6931471805599453
SIRs,2,0.6931471805599453
right-brain,2,0.6931471805599453
SUMMARY,2,0.6931471805599453
gown,2,0.6931471805599453
25-3,2,0.6931471805599453
cohort-specific,2,0.6931471805599453
clinicolaboratory,2,0.6931471805599453
vRNPs,2,0.6931471805599453
Enzymes,2,0.6931471805599453
troops,2,0.6931471805599453
telemedically,2,0.6931471805599453
underperceivers,2,0.6931471805599453
2216,2,0.6931471805599453
Accessible,2,0.6931471805599453
genogroup,2,0.6931471805599453
concatenated,2,0.6931471805599453
2992,2,0.6931471805599453
throughly,2,0.6931471805599453
sixty-one,2,0.6931471805599453
FIM12,2,0.6931471805599453
FCR,2,0.6931471805599453
targetting,2,0.6931471805599453
50-54,2,0.6931471805599453
Reusable,2,0.6931471805599453
radialis,2,0.6931471805599453
AQLQ-J,2,0.6931471805599453
D225N,2,0.6931471805599453
αPBN,2,0.6931471805599453
1307,2,0.6931471805599453
kitchen,2,0.6931471805599453
conurbation,2,0.6931471805599453
serums,2,0.6931471805599453
hand-searching,2,0.6931471805599453
2045,2,0.6931471805599453
1840,2,0.6931471805599453
rhinobronchitis,2,0.6931471805599453
hyperstimulation-IVFICSI,2,0.6931471805599453
reverse-transcription-polymerase,2,0.6931471805599453
navies,2,0.6931471805599453
thoracolithiasis,2,0.6931471805599453
chain-reaction,2,0.6931471805599453
Turnaround,2,0.6931471805599453
mid-LAD,2,0.6931471805599453
002-005,2,0.6931471805599453
stroked,2,0.6931471805599453
ICD-10-coded,2,0.6931471805599453
alphabeta,2,0.6931471805599453
first-trimester,2,0.6931471805599453
1235,2,0.6931471805599453
7909,2,0.6931471805599453
active-phase,2,0.6931471805599453
singletons,2,0.6931471805599453
test-confirmed,2,0.6931471805599453
parapneumonic,2,0.6931471805599453
Suphan,2,0.6931471805599453
Onboard,2,0.6931471805599453
BYamagata-lineage,2,0.6931471805599453
nursings,2,0.6931471805599453
coronariography,2,0.6931471805599453
mlminm2,2,0.6931471805599453
2000-2004,2,0.6931471805599453
process-of-care,2,0.6931471805599453
30-90,2,0.6931471805599453
mortal,2,0.6931471805599453
stapling,2,0.6931471805599453
three-years,2,0.6931471805599453
strain-matched,2,0.6931471805599453
pillows,2,0.6931471805599453
Instability,2,0.6931471805599453
Same-day,2,0.6931471805599453
VLF,2,0.6931471805599453
arised,2,0.6931471805599453
facially,2,0.6931471805599453
left-brain,2,0.6931471805599453
or18,2,0.6931471805599453
Confirmative,2,0.6931471805599453
neuroepidemiological,2,0.6931471805599453
Gains,2,0.6931471805599453
Antibacterial,2,0.6931471805599453
FEEL,2,0.6931471805599453
cysteinyl-leukotriene,2,0.6931471805599453
Nonessential,2,0.6931471805599453
CeD,2,0.6931471805599453
Provoked,2,0.6931471805599453
outcomesExpert,2,0.6931471805599453
60-81,2,0.6931471805599453
attacksexacerbations,2,0.6931471805599453
chromatofocusing,2,0.6931471805599453
18-39,2,0.6931471805599453
nonshock,2,0.6931471805599453
SACs,2,0.6931471805599453
ASPIRE,2,0.6931471805599453
≥100°F,2,0.6931471805599453
Quant,2,0.6931471805599453
VISION,2,0.6931471805599453
25-37,2,0.6931471805599453
putorius,2,0.6931471805599453
conundrums,2,0.6931471805599453
roof,2,0.6931471805599453
parasomnias,2,0.6931471805599453
bedfellows,2,0.6931471805599453
litermin,2,0.6931471805599453
NeuMoDx™,2,0.6931471805599453
Johansen,2,0.6931471805599453
mustelids,2,0.6931471805599453
generalisability,2,0.6931471805599453
CKMB1,2,0.6931471805599453
replenishing,2,0.6931471805599453
high-profile,2,0.6931471805599453
cisatracurium,2,0.6931471805599453
Hans,2,0.6931471805599453
Wi-A,2,0.6931471805599453
Musteloidea,2,0.6931471805599453
6090,2,0.6931471805599453
nanobeads,2,0.6931471805599453
out-of-field,2,0.6931471805599453
S-mediated,2,0.6931471805599453
spirogram,2,0.6931471805599453
rheumatism,2,0.6931471805599453
workforces,2,0.6931471805599453
RRMS,2,0.6931471805599453
H1v,2,0.6931471805599453
tumorigenicity,2,0.6931471805599453
Urticaria,2,0.6931471805599453
monoform,2,0.6931471805599453
pancuronium,2,0.6931471805599453
dramatized,2,0.6931471805599453
pelleted,2,0.6931471805599453
DOPS,2,0.6931471805599453
gkg,2,0.6931471805599453
Sex-based,2,0.6931471805599453
electrolysis,2,0.6931471805599453
CORonavirus,2,0.6931471805599453
decision-tree,2,0.6931471805599453
250000-500000,2,0.6931471805599453
BEACH,2,0.6931471805599453
ACORN,2,0.6931471805599453
telenursing,2,0.6931471805599453
multi-parametric,2,0.6931471805599453
high-efficacy,2,0.6931471805599453
End-diastolic,2,0.6931471805599453
Bed,2,0.6931471805599453
diverges,2,0.6931471805599453
Non-Q-Wave,2,0.6931471805599453
Susceptible-Exposed-Infectious-Recovered,2,0.6931471805599453
responsively,2,0.6931471805599453
vanishing,2,0.6931471805599453
CKMB2,2,0.6931471805599453
htSNPs,2,0.6931471805599453
BXA,2,0.6931471805599453
cortico-subcortical,2,0.6931471805599453
2009-related,2,0.6931471805599453
Triggers,2,0.6931471805599453
Siberian,2,0.6931471805599453
TNPs,2,0.6931471805599453
herbarum,2,0.6931471805599453
SF-8,2,0.6931471805599453
quizzes,2,0.6931471805599453
articular,2,0.6931471805599453
0195,2,0.6931471805599453
MobileNet,2,0.6931471805599453
Amniotic,2,0.6931471805599453
mixture-model,2,0.6931471805599453
bimonthly,2,0.6931471805599453
certainties,2,0.6931471805599453
Schemes,2,0.6931471805599453
SocietyEuropean,2,0.6931471805599453
anti-CD-20,2,0.6931471805599453
UML,2,0.6931471805599453
cystoperitoneal,2,0.6931471805599453
atlas-assisted,2,0.6931471805599453
DAOS,2,0.6931471805599453
Registrar,2,0.6931471805599453
0-40,2,0.6931471805599453
GPC,2,0.6931471805599453
Gøtzsche,2,0.6931471805599453
-007,2,0.6931471805599453
manic,2,0.6931471805599453
exons,2,0.6931471805599453
FMS,2,0.6931471805599453
MYO1,2,0.6931471805599453
AX,2,0.6931471805599453
peg,2,0.6931471805599453
Reintegration,2,0.6931471805599453
low-efficacy,2,0.6931471805599453
Rotorod,2,0.6931471805599453
blowing,2,0.6931471805599453
computes,2,0.6931471805599453
Receptive,2,0.6931471805599453
monthsABSTRACT,2,0.6931471805599453
plasma-phase,2,0.6931471805599453
protein-bound,2,0.6931471805599453
abridged,2,0.6931471805599453
shrews,2,0.6931471805599453
-087,2,0.6931471805599453
first-in-human,2,0.6931471805599453
Enthusiasm,2,0.6931471805599453
precerebral,2,0.6931471805599453
deaths1,2,0.6931471805599453
15-item,2,0.6931471805599453
Climatologic,2,0.6931471805599453
affiliates,2,0.6931471805599453
prolific,2,0.6931471805599453
AEng42788,2,0.6931471805599453
pleomorphism,2,0.6931471805599453
interruptor,2,0.6931471805599453
HapMap,2,0.6931471805599453
NOW™,2,0.6931471805599453
SiO2AuQD,2,0.6931471805599453
studyResults,2,0.6931471805599453
Hypersensitivity,2,0.6931471805599453
autoptic,2,0.6931471805599453
Basidiomycetes,2,0.6931471805599453
steroid-phobia,2,0.6931471805599453
MYO2,2,0.6931471805599453
inorganic-,2,0.6931471805599453
RT-Proofman-LAMP,2,0.6931471805599453
Morphometric,2,0.6931471805599453
paraphenylpentadecanoic,2,0.6931471805599453
18-45,2,0.6931471805599453
Ag-T,2,0.6931471805599453
Jude,2,0.6931471805599453
atopyairway,1,0.0
unvealing,1,0.0
cur-,1,0.0
lacking2,1,0.0
near-road,1,0.0
1918–9,1,0.0
μ-,1,0.0
boots,1,0.0
CaWs,1,0.0
inventiveness,1,0.0
infarctionangina,1,0.0
32020,1,0.0
Th-2-mediated,1,0.0
-TH2,1,0.0
debunked,1,0.0
acute-to-subacute,1,0.0
Segovia,1,0.0
patchiness,1,0.0
Talavera,1,0.0
aisles,1,0.0
CD4LAPregulatory,1,0.0
busted,1,0.0
rhythmABSTRACT,1,0.0
pasture-associated,1,0.0
Reina,1,0.0
14262735,1,0.0
right-coronary-artery,1,0.0
Overlaying,1,0.0
tations,1,0.0
blade,1,0.0
comprehensibility,1,0.0
manifes-,1,0.0
jack-knife,1,0.0
parasympathetically,1,0.0
0–9,1,0.0
‘influenza’,1,0.0
flushed,1,0.0
bepossible,1,0.0
81718,1,0.0
reviewsmeta-analyses,1,0.0
sufficiencyResultsOf,1,0.0
hybridisation,1,0.0
171819,1,0.0
44454647,1,0.0
ROBIS-I,1,0.0
CHWs,1,0.0
Mviab,1,0.0
viralhost,1,0.0
patientsMethodsWe,1,0.0
indium-111thallium-201,1,0.0
matching-including,1,0.0
bronchiolitisbronchitis,1,0.0
Susceptible-Infected-Recovered-Vaccinated,1,0.0
REALISE,1,0.0
heat-,1,0.0
respirologist,1,0.0
enzymatic-mediated,1,0.0
ferric,1,0.0
biosecure,1,0.0
attributive,1,0.0
FRAP,1,0.0
direst,1,0.0
Hiles,1,0.0
3-cycle,1,0.0
upABSTRACT,1,0.0
bottle-feeding,1,0.0
suffocation,1,0.0
avR,1,0.0
3301,1,0.0
left-main,1,0.0
sub-occlusive,1,0.0
laryngotracheitis,1,0.0
treatise,1,0.0
VAMI,1,0.0
cohort-propensity,1,0.0
Sero,1,0.0
midthoracic,1,0.0
nondisposable,1,0.0
Almería,1,0.0
IX,1,0.0
testers,1,0.0
IκBNF-κB,1,0.0
Lugo,1,0.0
SIRV,1,0.0
Hoechst,1,0.0
unproportional,1,0.0
accumbens,1,0.0
777-782,1,0.0
Manipulation,1,0.0
BackgroundWe,1,0.0
815•,1,0.0
attempters,1,0.0
×2,1,0.0
schwannoma,1,0.0
Optimality,1,0.0
FSLs,1,0.0
H2O2-induced,1,0.0
7298,1,0.0
Mulago,1,0.0
activites,1,0.0
Venegas,1,0.0
Salter,1,0.0
windowsABSTRACT,1,0.0
AEng33380,1,0.0
Perforator,1,0.0
1916–7,1,0.0
neuroinvasiveness,1,0.0
naloxone,1,0.0
Substitutive,1,0.0
risk-score,1,0.0
Palese,1,0.0
pulsations,1,0.0
therapies-represent,1,0.0
Meter,1,0.0
Nauta,1,0.0
asthma-work,1,0.0
Madine-Darby,1,0.0
T-cadherin,1,0.0
strokeMI,1,0.0
centimetre,1,0.0
insulinsensitizing,1,0.0
glycosidases,1,0.0
anti-atherogenic,1,0.0
intraspinal,1,0.0
Angina--52,1,0.0
1915–6,1,0.0
T12,1,0.0
AD26COV2S,1,0.0
4063,1,0.0
Adams,1,0.0
2--12,1,0.0
Cambodge,1,0.0
WONDFO,1,0.0
Cineradiographic,1,0.0
cytoprotectors,1,0.0
Re-infarction--8,1,0.0
glycobiology,1,0.0
22-24th,1,0.0
6-12th,1,0.0
LFD,1,0.0
clinical-physiological,1,0.0
remapping,1,0.0
dimers,1,0.0
triptans,1,0.0
12087,1,0.0
±098,1,0.0
thrombinemia,1,0.0
summariesABSTRACT,1,0.0
cavitywhile,1,0.0
Progressive-care,1,0.0
supercomputing,1,0.0
2655,1,0.0
glycosidase,1,0.0
medium-income,1,0.0
carecoronary,1,0.0
mother-to-fetus,1,0.0
4573,1,0.0
anti-glycan,1,0.0
9412,1,0.0
099-142,1,0.0
supra-additive,1,0.0
Unit-,1,0.0
CHADOX1,1,0.0
atoll,1,0.0
pre-packed,1,0.0
Re-assessment,1,0.0
Thoracic-abdominal,1,0.0
n-benzyl-n-methylethanolamine,1,0.0
SVA549,1,0.0
but-alongside,1,0.0
idle,1,0.0
epinephryne,1,0.0
glycosyltransferases,1,0.0
33250,1,0.0
open-mouth,1,0.0
Arhus,1,0.0
coving,1,0.0
Tcadherin,1,0.0
DreamLab,1,0.0
retroperitonaeale,1,0.0
youger,1,0.0
2421,1,0.0
SV-A549,1,0.0
concealing,1,0.0
Osteoporosis,1,0.0
μmoll,1,0.0
less-anticipated,1,0.0
diene,1,0.0
schwannomas,1,0.0
attacks-are,1,0.0
cockroach-sensitive,1,0.0
chronorisk,1,0.0
psychomedical,1,0.0
NCOV-19,1,0.0
Death--10,1,0.0
subungual,1,0.0
surgeryABSTRACT,1,0.0
non-Th-2,1,0.0
surgery-related,1,0.0
Nunavut,1,0.0
BNT162b2-mRNA,1,0.0
forgetfulness,1,0.0
anti-Spike-Protein-Receptor-Binding-Domain,1,0.0
food-based,1,0.0
accidents-either,1,0.0
craniotomies,1,0.0
risk-laden,1,0.0
preinfarct,1,0.0
injury-limiting,1,0.0
aCL,1,0.0
costless,1,0.0
virus-3,1,0.0
7694,1,0.0
Non-brand-specific,1,0.0
maternalreproductive,1,0.0
locking,1,0.0
poststent,1,0.0
authors’,1,0.0
equine-derived,1,0.0
occiput,1,0.0
downright,1,0.0
semi-arid,1,0.0
Budd-Chiari,1,0.0
A-and,1,0.0
IgG7000AUmL,1,0.0
min⁻¹,1,0.0
microbe-immune,1,0.0
ASydney0597-like,1,0.0
822-999,1,0.0
patient-family,1,0.0
Uzbekistan,1,0.0
Opioids,1,0.0
≥61,1,0.0
m⁻²,1,0.0
Holstein,1,0.0
1591,1,0.0
101350,1,0.0
reachable,1,0.0
planningcoordination,1,0.0
Sample-to-answer,1,0.0
non-ionizing,1,0.0
school-day,1,0.0
IgG500AUmL,1,0.0
Morphine,1,0.0
3-20,1,0.0
scleroderma,1,0.0
micropopulation,1,0.0
7240,1,0.0
mite-,1,0.0
recumbency,1,0.0
400-1250,1,0.0
20961,1,0.0
pro-active,1,0.0
5658,1,0.0
-TH2-targeted,1,0.0
definitionPositive,1,0.0
vex,1,0.0
indoles,1,0.0
Sanikiluaq,1,0.0
oxygen-related,1,0.0
15-382,1,0.0
evolutionally,1,0.0
post-bifurcation,1,0.0
left-coronary,1,0.0
Tibetan,1,0.0
NOTES,1,0.0
VAQ,1,0.0
20-62,1,0.0
-ve,1,0.0
sero-positives,1,0.0
lymphopenic,1,0.0
8330±3308,1,0.0
MODE,1,0.0
hypotheticalWe,1,0.0
VCM-3000,1,0.0
Route,1,0.0
01-07,1,0.0
cruciate,1,0.0
immune-diagnostics,1,0.0
escape-mutants,1,0.0
22323,1,0.0
method-referred,1,0.0
result-reporting,1,0.0
laughter-induced,1,0.0
anti-N-terminal,1,0.0
Rae,1,0.0
Anti-RBD,1,0.0
perormed,1,0.0
STv,1,0.0
translumenal,1,0.0
1780,1,0.0
1647,1,0.0
hurting,1,0.0
unjust,1,0.0
moods,1,0.0
6410±3130,1,0.0
dichotomize,1,0.0
6-41,1,0.0
DeltavWF,1,0.0
precarotid,1,0.0
peripheralsmall,1,0.0
largecentral,1,0.0
large-airway-presumed,1,0.0
saharian,1,0.0
Ossmy,1,0.0
deveopped,1,0.0
inwardABSTRACT,1,0.0
-0210,1,0.0
stiffens,1,0.0
BackgroundObjective,1,0.0
20-day,1,0.0
-0109,1,0.0
Multi-disciplinary,1,0.0
24-69,1,0.0
eosinophilic-mediated,1,0.0
spearheading,1,0.0
commom,1,0.0
n2067,1,0.0
well-treated,1,0.0
Kurashiki,1,0.0
κ037,1,0.0
235-334,1,0.0
KPSS,1,0.0
02441556,1,0.0
1day,1,0.0
TFG,1,0.0
age600years,1,0.0
neurologygeriatric,1,0.0
Constitutional,1,0.0
nST-01,1,0.0
non-participation,1,0.0
antiNP,1,0.0
peripheralmicrovascular,1,0.0
anodic,1,0.0
cutoff-based,1,0.0
flaring,1,0.0
compresses,1,0.0
levalbuterol-treated,1,0.0
antiS,1,0.0
AAP-zymograms,1,0.0
AAP-activities,1,0.0
immunocompromise,1,0.0
PVCh,1,0.0
Apparantly,1,0.0
Ortomyxoviridae,1,0.0
precapillary,1,0.0
n2883,1,0.0
left-heart,1,0.0
type-2-mediated,1,0.0
hyper-responsive,1,0.0
LAP-values,1,0.0
rediscuss,1,0.0
8480325,1,0.0
time-eligible,1,0.0
anterior-septal,1,0.0
AN1H1v,1,0.0
coronavirus-mediated,1,0.0
6799800,1,0.0
sEMG,1,0.0
implemention,1,0.0
dysphonias,1,0.0
AAP-fraction,1,0.0
electro-chemiluminescent,1,0.0
rand,1,0.0
Irène,1,0.0
laughter-associated,1,0.0
ergomete,1,0.0
Sasaki,1,0.0
keenly,1,0.0
Guys,1,0.0
Besson,1,0.0
Laughter-induced,1,0.0
approach-for,1,0.0
livesickdead,1,0.0
large-cerebral-artery-occlusion,1,0.0
∼25,1,0.0
7th-14th,1,0.0
text-based,1,0.0
Chemotaxis,1,0.0
immunohistopathologic,1,0.0
nonextensive,1,0.0
cardiotomy,1,0.0
18356,1,0.0
acid-sensing,1,0.0
COPDemphysema,1,0.0
retractions,1,0.0
skyrocketed,1,0.0
IgGtotal,1,0.0
spider,1,0.0
disulfide-rich,1,0.0
R-package,1,0.0
antiS1S2,1,0.0
45428,1,0.0
Chassagnon,1,0.0
autoacoids,1,0.0
parasympatholytics,1,0.0
airwayalveolar,1,0.0
low-filtration,1,0.0
baptism,1,0.0
888000,1,0.0
Aborted,1,0.0
Anti-infectives,1,0.0
CKNAC,1,0.0
IDPH,1,0.0
days-,1,0.0
122-174,1,0.0
17-34,1,0.0
Physio-chemical,1,0.0
CYSLTR1,1,0.0
BPCAs,1,0.0
Deal-Making,1,0.0
MRP1,1,0.0
writes,1,0.0
T-Cells,1,0.0
BPCA,1,0.0
eerily,1,0.0
P792,1,0.0
ITThe,1,0.0
CK-MB-confirmed,1,0.0
ATP-binding,1,0.0
H1-δ1,1,0.0
secondarycritical,1,0.0
H1-δ2,1,0.0
Guerbet,1,0.0
characteristics1,1,0.0
protectors,1,0.0
North-western,1,0.0
3812,1,0.0
Vero-cell,1,0.0
bronchonstriction,1,0.0
GTCBio,1,0.0
Restarting,1,0.0
Elastic,1,0.0
unfitted,1,0.0
1991-2,1,0.0
hydroxy-methyl-coenzyme,1,0.0
003-400,1,0.0
haemaglutination,1,0.0
resuscitations,1,0.0
cough-CPR,1,0.0
PFO-associated,1,0.0
most-affected,1,0.0
Scars,1,0.0
C-CPR,1,0.0
anectodal,1,0.0
000-012,1,0.0
cough-cardiopulmonary,1,0.0
EADs,1,0.0
CRM197-RBD,1,0.0
IADs,1,0.0
wedged,1,0.0
222-1146,1,0.0
ConceptWAS,1,0.0
562-100,1,0.0
picornaviral,1,0.0
non-giant,1,0.0
reverse-transcriptase-loop,1,0.0
Pasewalk,1,0.0
Concept-Wide,1,0.0
046-191,1,0.0
ss2,1,0.0
zarfirlukast,1,0.0
multibranched,1,0.0
assiduity,1,0.0
macrofocal--70,1,0.0
acetyl-choline,1,0.0
Konzett-Rössler,1,0.0
12-47,1,0.0
heliocentric,1,0.0
quarternary,1,0.0
microfocal--65,1,0.0
Copernicus,1,0.0
demographicclinical,1,0.0
Questionnair-Marks,1,0.0
african,1,0.0
non-predictive,1,0.0
56748,1,0.0
Antecedent,1,0.0
4-limb,1,0.0
end-of-study,1,0.0
Non-parametric,1,0.0
drivingpropagating,1,0.0
18-75,1,0.0
non-datable,1,0.0
BioSense,1,0.0
Internet-source,1,0.0
estimand,1,0.0
Todd,1,0.0
single-group,1,0.0
Protien,1,0.0
Flutrackings,1,0.0
well-characterize,1,0.0
Mukamel,1,0.0
iv-evoked,1,0.0
two-hour,1,0.0
ago-marks,1,0.0
geocentric,1,0.0
Debrés,1,0.0
overreporting,1,0.0
ad-500,1,0.0
COVID-19-Betsy,1,0.0
tocopherol,1,0.0
Apexcardiography,1,0.0
Husbands,1,0.0
psycho-affective,1,0.0
amputated,1,0.0
H3-IVA,1,0.0
H3-IVB,1,0.0
honeybees,1,0.0
protein-homology,1,0.0
Salmon,1,0.0
iv-induced,1,0.0
6000-8000,1,0.0
Schrier,1,0.0
Professors,1,0.0
inflammation-dominated,1,0.0
Hist,1,0.0
Golgi,1,0.0
peroxisomes,1,0.0
H3-IVF,1,0.0
SPRs,1,0.0
3-36,1,0.0
neurobiologic,1,0.0
5-42,1,0.0
H1NA,1,0.0
4-November,1,0.0
roughness,1,0.0
based-models,1,0.0
1990-1993,1,0.0
AMINoC,1,0.0
nor-epinefrine,1,0.0
perianesthesia,1,0.0
vasopressine,1,0.0
1298C,1,0.0
101-149,1,0.0
sound--he,1,0.0
Underreporting,1,0.0
2-a,1,0.0
frequent-episodic,1,0.0
103-134,1,0.0
alpha070-090,1,0.0
Amiri,1,0.0
alpha093,1,0.0
premedullary,1,0.0
r076-085,1,0.0
Sequelae,1,0.0
oligohemic,1,0.0
r090,1,0.0
immunoprotein,1,0.0
supected,1,0.0
sweating--such,1,0.0
2660,1,0.0
EnviroX-Rv,1,0.0
livid,1,0.0
pallid,1,0.0
neuropathologic,1,0.0
PathogenDx,1,0.0
ischemic-hypoxic,1,0.0
disease-COVID-19,1,0.0
Perianesthesia,1,0.0
surgical-site,1,0.0
Marquette,1,0.0
Sinonasal,1,0.0
up-to-dated,1,0.0
hypokalemic,1,0.0
ROMI,1,0.0
Incineration,1,0.0
encircling,1,0.0
Recombinase,1,0.0
7659,1,0.0
proviso,1,0.0
transmembraneous,1,0.0
landfills,1,0.0
Hirschsprungs,1,0.0
host-cells,1,0.0
Moresby,1,0.0
observedConclusions,1,0.0
5-day-old,1,0.0
granting,1,0.0
perfusion-estimated,1,0.0
derailed,1,0.0
SERPINA1alpha-1,1,0.0
dual-pathway,1,0.0
disjunctive,1,0.0
«net,1,0.0
antidegenerative,1,0.0
benefit»,1,0.0
Sporting,1,0.0
translatome,1,0.0
care-quality,1,0.0
coact,1,0.0
amalgam,1,0.0
yogasanas,1,0.0
12SL,1,0.0
SYNergy,1,0.0
menstruation-associated,1,0.0
Kong26522006-like,1,0.0
BMC-2,1,0.0
14-60,1,0.0
ABrisbane592007-like,1,0.0
tightened,1,0.0
4769,1,0.0
throne,1,0.0
Ho-rizonte,1,0.0
copiesµL-1,1,0.0
intensest,1,0.0
dose-effect,1,0.0
acquiescence,1,0.0
volume-controlled,1,0.0
33-100,1,0.0
trigger-related,1,0.0
Six-minute,1,0.0
ImmunoStroke,1,0.0
controlAim,1,0.0
httpsimmunostrokede,1,0.0
multi-microelectrode,1,0.0
agonizing,1,0.0
left-circunflex,1,0.0
study-based,1,0.0
jailed,1,0.0
thiol-modified,1,0.0
symptomsawakenings,1,0.0
thermo-cycling,1,0.0
CHW-led,1,0.0
Unprotected,1,0.0
rods,1,0.0
Coincident,1,0.0
nonyoga,1,0.0
1-s,1,0.0
over-activity,1,0.0
rho081,1,0.0
province-scale,1,0.0
rho025-065,1,0.0
dimensionally,1,0.0
21-53,1,0.0
Redressing,1,0.0
IVS1-110,1,0.0
Programme--the,1,0.0
0864,1,0.0
0855,1,0.0
frailer,1,0.0
deflate,1,0.0
tugging,1,0.0
Kong21303,1,0.0
thalassemics,1,0.0
influenza-convalescent,1,0.0
ovulation,1,0.0
0425,1,0.0
3496,1,0.0
8844,1,0.0
jeopardizing,1,0.0
2008--on,1,0.0
flawless,1,0.0
severityactivity,1,0.0
assessmentfunctional,1,0.0
Sandwich-ELISA,1,0.0
HEI,1,0.0
OSASConclusions,1,0.0
recreations,1,0.0
neurogenerative,1,0.0
n7516,1,0.0
communicationpersuasion,1,0.0
Interlobular,1,0.0
Ground-grass,1,0.0
PREVENTION,1,0.0
Dried-blood-spots,1,0.0
all--Hispanics,1,0.0
intensive-dose,1,0.0
filter-cards,1,0.0
ventricular-assist,1,0.0
non-recovered,1,0.0
McGuires,1,0.0
STOKE,1,0.0
Most--but,1,0.0
6190,1,0.0
hypereosnophillia,1,0.0
cleverly,1,0.0
alpha-testing,1,0.0
8-wk,1,0.0
nurse-run,1,0.0
ADMIT,1,0.0
Thrombolysed,1,0.0
re-warming,1,0.0
4-192,1,0.0
3DE,1,0.0
alloxan-induced,1,0.0
subphenotype-specific,1,0.0
dreamed,1,0.0
etiology-based,1,0.0
architect,1,0.0
Rand,1,0.0
high‑flow,1,0.0
Amerindian,1,0.0
comb,1,0.0
Minn,1,0.0
16-slice,1,0.0
10994,1,0.0
community--both,1,0.0
creatinine-phosphokinase,1,0.0
MUs,1,0.0
breathiness,1,0.0
potentialitis,1,0.0
re-planned,1,0.0
richeness,1,0.0
3112,1,0.0
symptom‑based,1,0.0
ambulance-based,1,0.0
RBD-targeting,1,0.0
co-amplification,1,0.0
9606,1,0.0
randomizing,1,0.0
stress-limiting,1,0.0
non-silent,1,0.0
excessivedysregulated,1,0.0
pandemically,1,0.0
2·6,1,0.0
9108,1,0.0
cold-chains,1,0.0
swabssaliva,1,0.0
Th2-related,1,0.0
symptom-onset-to-balloon,1,0.0
first‑line,1,0.0
bioluminescent-tagged,1,0.0
-455GA,1,0.0
biologist,1,0.0
47241,1,0.0
hotlines,1,0.0
56-86,1,0.0
Havlí269k367v,1,0.0
Scale-20,1,0.0
Empathy,1,0.0
BES,1,0.0
Scales-21,1,0.0
Beach,1,0.0
Histopathologically,1,0.0
non‑infected,1,0.0
finality,1,0.0
1979-1983,1,0.0
Physically,1,0.0
enjoyments,1,0.0
mRNA‑based,1,0.0
TAXUS,1,0.0
Dade,1,0.0
Pneumocytes,1,0.0
tetrabenazine,1,0.0
PTCA-treated,1,0.0
heparin-binding,1,0.0
RRM,1,0.0
Thrombolysis-treated,1,0.0
SPAN-100,1,0.0
TDP-43,1,0.0
aggregation-prone,1,0.0
2-1-1,1,0.0
miR-133a-3p,1,0.0
H5N1-virus,1,0.0
fibrocellular,1,0.0
paucicellular,1,0.0
shRNA-mediated,1,0.0
sequencers,1,0.0
6567,1,0.0
Brod,1,0.0
peri-operation,1,0.0
pseudocolour,1,0.0
re-initiated,1,0.0
vaccinationsABSTRACT,1,0.0
Perhexiline,1,0.0
three-compartment,1,0.0
diostole,1,0.0
Hoovers,1,0.0
Maleate,1,0.0
internships,1,0.0
caudal-inward,1,0.0
Hypotron,1,0.0
oxygen-sparing,1,0.0
flowmetabolism,1,0.0
macrobeads,1,0.0
degenerating,1,0.0
31941,1,0.0
brutal,1,0.0
carbon-11,1,0.0
evocation,1,0.0
non-embolized,1,0.0
Exceptional,1,0.0
semiconductor,1,0.0
indulgences,1,0.0
micro-infarcted,1,0.0
hundred-thousand,1,0.0
sequencing-by-synthesis,1,0.0
Srinagar,1,0.0
36-87,1,0.0
Plains,1,0.0
83515,1,0.0
NSQIP-P,1,0.0
Moore,1,0.0
2-96,1,0.0
Demonstrate,1,0.0
physician-initiated,1,0.0
181000,1,0.0
2019-positive,1,0.0
procurements,1,0.0
myoglobinuric,1,0.0
hyposensitization-treatment,1,0.0
mysteriousness,1,0.0
US5000,1,0.0
anti-IL-5R,1,0.0
anti-IL-4Rα,1,0.0
TravMil,1,0.0
Polysensibilisation,1,0.0
2019-associated,1,0.0
30-93,1,0.0
asymptomaticpresymptomatic,1,0.0
Exogenously,1,0.0
Geant4-DNA,1,0.0
14792,1,0.0
auditing,1,0.0
1974-1980,1,0.0
CRISPR-Cas12-based,1,0.0
routeroutes,1,0.0
uprooted,1,0.0
hypoadiponectinemia,1,0.0
Q-type,1,0.0
base--has,1,0.0
754-110,1,0.0
high-priced,1,0.0
0790-0891,1,0.0
Subsidized,1,0.0
-containing,1,0.0
125-205,1,0.0
reverse-transcriptase-polymerase,1,0.0
1962-83,1,0.0
047100,1,0.0
unharmed,1,0.0
Reverse-genetics-based,1,0.0
laymen,1,0.0
108-h,1,0.0
Neck,1,0.0
traversal,1,0.0
80354,1,0.0
palatable,1,0.0
SCOT-Heart,1,0.0
Drive-through,1,0.0
otorhinolaryngologist,1,0.0
Trip,1,0.0
GoB,1,0.0
SCP,1,0.0
Morbidity-mortality,1,0.0
HCA,1,0.0
post-travel,1,0.0
31-36,1,0.0
31739,1,0.0
stenting-particularly,1,0.0
midadult,1,0.0
fastest-growing,1,0.0
Disodium-cromoglycate,1,0.0
asymptomaticpre-symptomatic,1,0.0
Mor,1,0.0
controled,1,0.0
Consecutively,1,0.0
84735,1,0.0
predeployment-screening,1,0.0
3836,1,0.0
404100,1,0.0
Biofeedback,1,0.0
H5-positive,1,0.0
stereotypical,1,0.0
Beneluxa,1,0.0
micro-atherosclerosis,1,0.0
agricultural-based,1,0.0
Knog,1,0.0
angiography-source,1,0.0
test--Killip,1,0.0
0840,1,0.0
variable--the,1,0.0
alteplaseplacebo,1,0.0
impairmentdisability,1,0.0
pre-pregnancy,1,0.0
ALERTA,1,0.0
x109l,1,0.0
asthmatogenic,1,0.0
Transcontinental,1,0.0
consultative-diagnostic,1,0.0
more-inclusive,1,0.0
hypoattenuation,1,0.0
remote-control,1,0.0
Asmática,1,0.0
prosperity,1,0.0
IVUS-guided,1,0.0
Exacerbación,1,0.0
24-25,1,0.0
high-pathogenic,1,0.0
H2O2Tetrametylbenzidine,1,0.0
eventuates,1,0.0
menstruations,1,0.0
Multi-colored,1,0.0
Tratamiento,1,0.0
alteplasePTCA,1,0.0
Famine,1,0.0
hyperresponsivenessABSTRACT,1,0.0
transabdominal,1,0.0
0778-0890,1,0.0
gene-directed,1,0.0
0834,1,0.0
4955,1,0.0
Cure,1,0.0
anulus--representing,1,0.0
adultelderly,1,0.0
Rudolph,1,0.0
gastropexy,1,0.0
smog,1,0.0
anti-TNF-alpha,1,0.0
Host-specific,1,0.0
euglycemia,1,0.0
MSE,1,0.0
Domi,1,0.0
1979-1988,1,0.0
intersubject,1,0.0
MPHA,1,0.0
quinine-labeled,1,0.0
straddled,1,0.0
ICD-8,1,0.0
BAEE,1,0.0
Hygienists,1,0.0
1969-1978,1,0.0
IL-5R,1,0.0
megakaryocyte-platelet-haemostatic,1,0.0
afucosylated,1,0.0
anti‒IL-5,1,0.0
Skin-prick,1,0.0
Nissen,1,0.0
airway-parenchyma,1,0.0
101-102,1,0.0
LLR,1,0.0
CT-value,1,0.0
anaesthetist,1,0.0
employer-based,1,0.0
North-American,1,0.0
Self-assessed,1,0.0
37-51,1,0.0
eases,1,0.0
54155642,1,0.0
strategy-also,1,0.0
SISAP,1,0.0
genotype-dependent,1,0.0
G-mutant,1,0.0
n393,1,0.0
shoe-integrated,1,0.0
Bioinformatically,1,0.0
antibiotic-induced,1,0.0
receptor-modified,1,0.0
BTSSIGN,1,0.0
VLA-1CD4,1,0.0
non-mutant,1,0.0
thirty-five-year-old,1,0.0
resequencing,1,0.0
Gunma,1,0.0
Premortem,1,0.0
Neurocognitive,1,0.0
neurologicalmedical,1,0.0
cIMT,1,0.0
Ekman,1,0.0
3652,1,0.0
Marcus,1,0.0
43802,1,0.0
posterir-low,1,0.0
Covariates,1,0.0
strategy-and,1,0.0
Low-fat,1,0.0
vagal-related,1,0.0
MUSCLE,1,0.0
MEGA6,1,0.0
n485,1,0.0
8·7,1,0.0
measure--forced,1,0.0
interdependency,1,0.0
apathogenic,1,0.0
AMoscow-like,1,0.0
chemioluminescent,1,0.0
22·2,1,0.0
Substernal,1,0.0
0·0404,1,0.0
beares,1,0.0
A-H,1,0.0
FMMS,1,0.0
virologist,1,0.0
DAdda,1,0.0
irreducible,1,0.0
vision-threatening,1,0.0
Castiglione,1,0.0
Sodi-Pallares,1,0.0
MRSs,1,0.0
branche,1,0.0
re-acquired,1,0.0
pharmacotheraphy,1,0.0
inadvisedly,1,0.0
R140W,1,0.0
48-50,1,0.0
Physiotherapy-based,1,0.0
single-site,1,0.0
ethnicityage,1,0.0
CK-values,1,0.0
Watchman-related,1,0.0
reactogenicityefficacy,1,0.0
Generalitat,1,0.0
578-36,1,0.0
vital-signs,1,0.0
325-23,1,0.0
thermopile,1,0.0
ischemia10,1,0.0
antigenadjuvant,1,0.0
24-GHz,1,0.0
anaesthetists,1,0.0
aphthae,1,0.0
435-31,1,0.0
Instrumented,1,0.0
ankle-arm,1,0.0
Isoenzyme,1,0.0
Lipschütz,1,0.0
593-44,1,0.0
0-275,1,0.0
Conserved,1,0.0
0-1257,1,0.0
Directigen®,1,0.0
dysfunctionAD,1,0.0
collimation,1,0.0
re-formulated,1,0.0
COmputed,1,0.0
HEART,1,0.0
Orems,1,0.0
IL-5-,1,0.0
SCOT-HEART,1,0.0
26p100,1,0.0
IL-4-,1,0.0
100-101,1,0.0
86942,1,0.0
no-screening,1,0.0
83rd,1,0.0
swine-to-human,1,0.0
reified,1,0.0
Friesens,1,0.0
Pictures,1,0.0
Merieux,1,0.0
1978-1987,1,0.0
COVID-19Conclusions,1,0.0
CD25CD4,1,0.0
Catala,1,0.0
MFV-Ject,1,0.0
c-reactive,1,0.0
fedratinib,1,0.0
iopinavir,1,0.0
CD8CD3,1,0.0
agerisk-structured,1,0.0
Salut,1,0.0
warbattle,1,0.0
GenXpert,1,0.0
beta2GP1,1,0.0
sectionResults,1,0.0
CD4CD3,1,0.0
METH,1,0.0
languagesData,1,0.0
studyStudy,1,0.0
government-issued,1,0.0
antisecretory,1,0.0
09-144,1,0.0
94515,1,0.0
Undertaking,1,0.0
003-256,1,0.0
006-124,1,0.0
HIGHLIGHTS,1,0.0
EUA-FDA,1,0.0
IL-5IL-5Rα,1,0.0
3–6,1,0.0
2000-2002,1,0.0
autophagyAbbreviation,1,0.0
molecularcellular,1,0.0
35-85,1,0.0
subcycle,1,0.0
A76,1,0.0
influenza-cases,1,0.0
RSCs,1,0.0
hyperreactivity-AH,1,0.0
HealthPartners,1,0.0
Flu-prompted,1,0.0
7442,1,0.0
7-F,1,0.0
Arterial-venous,1,0.0
reduceprevent,1,0.0
100-707,1,0.0
AVictoria72,1,0.0
2368,1,0.0
xg,1,0.0
12-2,1,0.0
multiple-targeting,1,0.0
lymphocyte-mediated,1,0.0
autoreactivity,1,0.0
aminoquinoline,1,0.0
m3256CT,1,0.0
leadlikeness,1,0.0
NZW,1,0.0
guaninecytosine,1,0.0
punching,1,0.0
heparin-like,1,0.0
8769,1,0.0
two-state,1,0.0
Splenectomized,1,0.0
1976-dubbed,1,0.0
plateaus,1,0.0
3250-4501,1,0.0
heterosexuals,1,0.0
parametersWe,1,0.0
virusμL,1,0.0
nanoyeast-scFv,1,0.0
collisions,1,0.0
trailing,1,0.0
Fraser,1,0.0
Chai,1,0.0
primase,1,0.0
nanoyeast-scFvs,1,0.0
5362,1,0.0
40-47,1,0.0
NPRA,1,0.0
transmission-especially,1,0.0
pleasure,1,0.0
prethrombotic,1,0.0
second-hit,1,0.0
93-points,1,0.0
educational-related,1,0.0
live-animal,1,0.0
SmithKline,1,0.0
Beecham,1,0.0
PreventionGlobal,1,0.0
Postvaccination,1,0.0
4134,1,0.0
60-61,1,0.0
100-in,1,0.0
Université,1,0.0
data--comments,1,0.0
Task-related,1,0.0
H1N1-RNA,1,0.0
consigned,1,0.0
exclusive-indeed,1,0.0
11328,1,0.0
monocaffeoyl,1,0.0
Angiopep-2,1,0.0
aucubin,1,0.0
collectins,1,0.0
002-03,1,0.0
tartaric,1,0.0
MBLs,1,0.0
as-designed,1,0.0
dilutes,1,0.0
hemohistocompatibility,1,0.0
8494,1,0.0
matricin,1,0.0
instabilities,1,0.0
re-audit,1,0.0
industrialisation,1,0.0
post-buckling,1,0.0
multigroup,1,0.0
conglutinin,1,0.0
m3336TC,1,0.0
m652delG,1,0.0
monodisperse,1,0.0
Mannan-binding,1,0.0
PBPK,1,0.0
mgKg,1,0.0
Ceria,1,0.0
AEngland87869,1,0.0
constant-stiffness,1,0.0
superposition,1,0.0
stiffnesses,1,0.0
recyclable,1,0.0
m652insG,1,0.0
Adsorbed,1,0.0
overproduced,1,0.0
aesculin,1,0.0
intracephalic,1,0.0
m1555AG,1,0.0
m15059GA,1,0.0
higheststrongest,1,0.0
groupsThis,1,0.0
peptidic,1,0.0
α1-based,1,0.0
Case-ascertained,1,0.0
dilitiazem,1,0.0
cardiodepressant,1,0.0
20-86y,1,0.0
Foucault,1,0.0
39d,1,0.0
IVIGs,1,0.0
unequally,1,0.0
α1,1,0.0
9959998,1,0.0
flourgrain,1,0.0
221-25374,1,0.0
Mauss,1,0.0
time-linked,1,0.0
non-IOP,1,0.0
18100,1,0.0
993999,1,0.0
host-jump,1,0.0
anthrone,1,0.0
989998,1,0.0
mixing-vessel,1,0.0
8896,1,0.0
Swine-to-human,1,0.0
esoenzyme,1,0.0
m13513GA,1,0.0
107-131,1,0.0
ACB,1,0.0
immnue,1,0.0
antepartum,1,0.0
or85,1,0.0
rescueadjunctive,1,0.0
blood-pressure-lowering,1,0.0
2746,1,0.0
12420,1,0.0
América,1,0.0
Zotarolimus-eluting,1,0.0
antigenicity--thereby,1,0.0
grievous,1,0.0
immuno-compromised,1,0.0
144-219,1,0.0
307-495,1,0.0
136-203,1,0.0
leukoyctes,1,0.0
CD36-ligand,1,0.0
8750,1,0.0
noble,1,0.0
14800,1,0.0
ALAT,1,0.0
decompensating,1,0.0
SERS-CRISPR,1,0.0
CRISPRCas12a-based,1,0.0
recommendedThe,1,0.0
Harmonisation,1,0.0
GrzB,1,0.0
pregnancyIf,1,0.0
IFN-γIL-10,1,0.0
interferon-γinterleukin-10,1,0.0
East-west,1,0.0
double-hit,1,0.0
α-crystallin,1,0.0
therefor,1,0.0
overexuberant,1,0.0
microaneurysmal,1,0.0
063-105,1,0.0
work-,1,0.0
alpha1,1,0.0
home-,1,0.0
Reinstatement,1,0.0
4546,1,0.0
Seroepidemiology,1,0.0
SRAS-CoV,1,0.0
Mould,1,0.0
Recomendaciones,1,0.0
SARC-CoV-2,1,0.0
threshold-tracking,1,0.0
fingerpick,1,0.0
Roches,1,0.0
064-099,1,0.0
pro-death,1,0.0
Autoregulatory,1,0.0
clout,1,0.0
0309,1,0.0
E--,1,0.0
ischaemicthrombotic,1,0.0
co-dominant,1,0.0
sub-totally,1,0.0
receptor--,1,0.0
Convergence,1,0.0
obligation--and,1,0.0
food-related,1,0.0
Resolved,1,0.0
Latina,1,0.0
cardiacsurgical,1,0.0
industry--to,1,0.0
ACALIFORNIA052009H1N1,1,0.0
subphenotyping,1,0.0
Floresta-MT,1,0.0
SCB-2019,1,0.0
l-serine,1,0.0
SHRSPIsm,1,0.0
97-103,1,0.0
brachium,1,0.0
Educación,1,0.0
coalescing,1,0.0
summits,1,0.0
HPETE,1,0.0
pinnacles,1,0.0
CFS,1,0.0
Rct,1,0.0
Guía,1,0.0
nanocubes,1,0.0
hemipons,1,0.0
decussating,1,0.0
114139,1,0.0
nanoyeast,1,0.0
line-derived,1,0.0
April-4,1,0.0
102-107,1,0.0
invigorated,1,0.0
antibodiesplasma,1,0.0
2010-April,1,0.0
2009-April,1,0.0
sputumtracheal,1,0.0
non-repositive,1,0.0
Alta,1,0.0
non‑repositives,1,0.0
repositives,1,0.0
single-chain-variable,1,0.0
nanobox-integrated,1,0.0
46114,1,0.0
Flu-Surge,1,0.0
inflamm-ageing,1,0.0
03-089,1,0.0
bronchomotoric,1,0.0
YORK152009H1N1,1,0.0
ANEW,1,0.0
celiase,1,0.0
iterated,1,0.0
Negatives,1,0.0
2475,1,0.0
4435-441,1,0.0
2275,1,0.0
sirolimus-eluding,1,0.0
4175,1,0.0
immunity--poses,1,0.0
magneto-laser,1,0.0
speciation,1,0.0
Rashidi,1,0.0
25139,1,0.0
Manejo,1,0.0
mutation--more,1,0.0
arbitrate,1,0.0
adolescentsadults,1,0.0
kappa057,1,0.0
39℃,1,0.0
84-,1,0.0
NLS-associated,1,0.0
avelysin,1,0.0
frequency-amplitude,1,0.0
monocyte-mediated,1,0.0
6775,1,0.0
fabricating,1,0.0
MALDI,1,0.0
avF,1,0.0
intranodal,1,0.0
miR-145-5p,1,0.0
Ministries,1,0.0
preoccupations,1,0.0
Z-score,1,0.0
hit-list,1,0.0
US643,1,0.0
pastoral,1,0.0
Sector,1,0.0
Yongin,1,0.0
3357,1,0.0
high-variability,1,0.0
low-variability,1,0.0
Religiously,1,0.0
laryngectomytracheοstomy,1,0.0
patient-exclusive,1,0.0
snapped,1,0.0
ADEMTox,1,0.0
religiously,1,0.0
semiautomatic,1,0.0
volumetry,1,0.0
US181,1,0.0
US4354,1,0.0
foolishness,1,0.0
2644,1,0.0
ANewCaledonia2099,1,0.0
APanama200199-like,1,0.0
3CLpro-referenced,1,0.0
97-124,1,0.0
Ferguson,1,0.0
68-94,1,0.0
91-110,1,0.0
83-99,1,0.0
enteralparenteral,1,0.0
stylet,1,0.0
RKAS-01,1,0.0
130309-313,1,0.0
4958188,1,0.0
hemoadsorption,1,0.0
Laryngoscope,1,0.0
ECCO2R,1,0.0
NCT02308605,1,0.0
sevier,1,0.0
sub-mucosal,1,0.0
tree-type,1,0.0
173396,1,0.0
22812491,1,0.0
Enlarged,1,0.0
NNF,1,0.0
overturned,1,0.0
Dumiak,1,0.0
SMARTCap,1,0.0
Regurgitation,1,0.0
ADMEtox,1,0.0
20-Epibryonolic,1,0.0
NNH147,1,0.0
0099,1,0.0
nonindigent,1,0.0
desiccation,1,0.0
aerosols-generating,1,0.0
Isoiguesterin,1,0.0
1552687,1,0.0
rhythmograms,1,0.0
paragraphs,1,0.0
Cryptospirolepine,1,0.0
animosity,1,0.0
m14459GA,1,0.0
specially-designed,1,0.0
susceptibly,1,0.0
US5178,1,0.0
180-365,1,0.0
neutrophil-driven,1,0.0
glaber,1,0.0
glycan-engineered,1,0.0
vasorum,1,0.0
146-28,1,0.0
nucleic-acid-based,1,0.0
crusade,1,0.0
Huanhu,1,0.0
Heterocephalus,1,0.0
feedforward,1,0.0
279-92,1,0.0
splashing,1,0.0
vasa,1,0.0
microgramsml-1,1,0.0
PDGF-AB-treated,1,0.0
ratio058,1,0.0
warhead,1,0.0
23-64,1,0.0
sulphonic,1,0.0
elevation-myocardial,1,0.0
2-oxopyrrolidine,1,0.0
ligand-bound,1,0.0
radecivir,1,0.0
24-month-old,1,0.0
baritinib,1,0.0
unoptimized,1,0.0
Channer,1,0.0
Hippocampus,1,0.0
primeboost,1,0.0
∼415,1,0.0
self-paid,1,0.0
6922,1,0.0
associationsmediations,1,0.0
273-37,1,0.0
control--167-41,1,0.0
near-miss,1,0.0
ETS-exposed,1,0.0
ASwEngland16326687,1,0.0
ASwWisconsin23897,1,0.0
polytetrafluoroethylene-coated,1,0.0
165-564,1,0.0
chemokine-driven,1,0.0
logrank,1,0.0
clip-and-loop,1,0.0
Alternations,1,0.0
141-4705,1,0.0
102-560,1,0.0
Bradyarrhythmias,1,0.0
pamphlet,1,0.0
001-052,1,0.0
B0AT1,1,0.0
doseduration,1,0.0
Host-response,1,0.0
Farms,1,0.0
revolves,1,0.0
cryo-apheresis,1,0.0
Multigene,1,0.0
100-1586,1,0.0
axon-glia,1,0.0
Cyanosis,1,0.0
ratio135,1,0.0
18138,1,0.0
r-084,1,0.0
m-068,1,0.0
microgramml-1,1,0.0
recently-identified,1,0.0
operation--345-67,1,0.0
Dpp4,1,0.0
8-isoprostanes,1,0.0
swallowing-induced,1,0.0
Horseshoe,1,0.0
interannual,1,0.0
Migraine-stroke,1,0.0
troopships,1,0.0
Mouse-adapted,1,0.0
Animal-to-human,1,0.0
71·5,1,0.0
hostsreservoirs,1,0.0
2181,1,0.0
2142,1,0.0
71·0,1,0.0
3124,1,0.0
Seminal,1,0.0
unstoppable,1,0.0
0·036,1,0.0
end-effector,1,0.0
anti-H,1,0.0
cardio-andor,1,0.0
cerebrovascular-disease,1,0.0
vaccine-altered,1,0.0
ward-by-ward,1,0.0
regionsAreas,1,0.0
WA-1,1,0.0
Goodness-of-fit,1,0.0
non-ill,1,0.0
passaged,1,0.0
2829,1,0.0
front-end,1,0.0
Estrogen-Progestin,1,0.0
080-122,1,0.0
62-fold,1,0.0
reportingExpert,1,0.0
cortexSIGNIFICANCE,1,0.0
maternofetal,1,0.0
Harm,1,0.0
miR-146-5p,1,0.0
genotoxicity,1,0.0
31-March,1,0.0
torsocardiac,1,0.0
063-088,1,0.0
3118,1,0.0
0·028,1,0.0
tribes,1,0.0
P194L,1,0.0
military-age,1,0.0
mortalityConclusionAge,1,0.0
clinico-epidemiologic,1,0.0
syndromecytokine,1,0.0
miR-21-5p,1,0.0
Program–Pediatric,1,0.0
immunocomprised,1,0.0
27·2,1,0.0
COVID-19-inducing,1,0.0
isolately,1,0.0
registryMethods,1,0.0
27·8,1,0.0
evocated,1,0.0
mid-1918,1,0.0
ResultsShiga,1,0.0
Disproportionately,1,0.0
068-092,1,0.0
27·0,1,0.0
commands,1,0.0
K140E,1,0.0
Fourty-four,1,0.0
3706,1,0.0
neurologyneurosurgery,1,0.0
oseltamivir-controlled,1,0.0
AM2,1,0.0
priorization,1,0.0
pre-a,1,0.0
NSAT,1,0.0
Graphs,1,0.0
Two-hundred-and-ninety-eight,1,0.0
Nonsustained,1,0.0
39769,1,0.0
Antisense,1,0.0
fact-finding,1,0.0
CGO,1,0.0
09-55,1,0.0
12-12,1,0.0
13-95,1,0.0
Computation,1,0.0
anticoagulantantithrombotic,1,0.0
phenomenologically,1,0.0
double-blindly,1,0.0
Needed,1,0.0
grossest,1,0.0
real-time-polymerase,1,0.0
infacts,1,0.0
795132,1,0.0
waveraised,1,0.0
prepubic,1,0.0
Consistencies,1,0.0
cheaply,1,0.0
echocontrast,1,0.0
ventriculostomy-associated,1,0.0
SEIR-TTI,1,0.0
urethra,1,0.0
contact-Tracing,1,0.0
poly-YE-treated,1,0.0
urethrography,1,0.0
post-a,1,0.0
acetateplacebo,1,0.0
badvery,1,0.0
three-arm,1,0.0
nonacclimatized,1,0.0
mgplacebo,1,0.0
Two-level,1,0.0
Bourbon,1,0.0
instructing,1,0.0
hydroxylases,1,0.0
Enugu,1,0.0
tick-transmitted,1,0.0
methylprednisolone-based,1,0.0
prolyl,1,0.0
sub-centimeter,1,0.0
28-127,1,0.0
histamines,1,0.0
Re-exposure,1,0.0
08-18,1,0.0
efegatran,1,0.0
beta2-sympathomimetics,1,0.0
hertofore,1,0.0
09-90,1,0.0
groomer,1,0.0
qualityquantity,1,0.0
hairdresser,1,0.0
predefinition,1,0.0
medroxyprogesterone,1,0.0
florist,1,0.0
CABS-dock,1,0.0
pharmacist-led,1,0.0
urethrostomy,1,0.0
Safery,1,0.0
FU,1,0.0
Lipids,1,0.0
Perturbations,1,0.0
Digitalized,1,0.0
odd-numbered,1,0.0
2-hypokinetic,1,0.0
1-normo,1,0.0
RAD51,1,0.0
TCD-based,1,0.0
trans-activating,1,0.0
xanthine-xanthine,1,0.0
9292,1,0.0
BFlorida42006-like,1,0.0
conditions-such,1,0.0
even-numbered,1,0.0
single-rescuer,1,0.0
Mouth-to-mouth,1,0.0
bronchospasmolysis,1,0.0
nMkg,1,0.0
3-akinetic,1,0.0
4-dyskinetic,1,0.0
Hits,1,0.0
hybridizes,1,0.0
H3N2-1968,1,0.0
NCT00361530,1,0.0
value0045,1,0.0
2488,1,0.0
115-7143,1,0.0
0812,1,0.0
Bartels,1,0.0
≥0931,1,0.0
Ball,1,0.0
H2N2-1957,1,0.0
Apnoeahypopnoea,1,0.0
pleiotrophic,1,0.0
episodeshr,1,0.0
098-245,1,0.0
obesity-experience,1,0.0
lipidome,1,0.0
9258,1,0.0
hyperinflatory,1,0.0
Baqiyatallah,1,0.0
body-growth,1,0.0
Interesting,1,0.0
interpopulation,1,0.0
Hyaluronan,1,0.0
Elastase,1,0.0
1834-3375,1,0.0
prostitutes,1,0.0
6020-14237,1,0.0
Post-varicella,1,0.0
homosexuals,1,0.0
19223,1,0.0
combinedRetinal,1,0.0
18×103µL,1,0.0
mg3,1,0.0
non-recanalized,1,0.0
147×103µL,1,0.0
B2-receptor,1,0.0
turn-around-times,1,0.0
technologist,1,0.0
084-216,1,0.0
HOE140,1,0.0
4801,1,0.0
1306-3174,1,0.0
coefficientof,1,0.0
vaping-product,1,0.0
176×103µL,1,0.0
transciptase-PCR,1,0.0
177×103µL,1,0.0
2019-nCoV-also,1,0.0
Echo,1,0.0
2·9-fold,1,0.0
1·5-fold,1,0.0
on-target,1,0.0
abattoirs,1,0.0
hundred-three,1,0.0
HR12,1,0.0
One-sample,1,0.0
HR13,1,0.0
pauses,1,0.0
5105,1,0.0
H1N1-1918,1,0.0
Pcombined,1,0.0
28258,1,0.0
140Trp,1,0.0
-echnetium,1,0.0
30-95,1,0.0
multiplexable,1,0.0
347363,1,0.0
cavity-filling,1,0.0
aspirin-accelerated,1,0.0
0·91,1,0.0
12421,1,0.0
0·0018,1,0.0
t-PA-heparin,1,0.0
Asp614→Gly,1,0.0
Covid-19s,1,0.0
hepatically,1,0.0
3D-STI,1,0.0
0·90,1,0.0
Therepautic,1,0.0
Non-response,1,0.0
subependymal,1,0.0
0·0046,1,0.0
5·66,1,0.0
1336,1,0.0
867256,1,0.0
radio-pharmaceutical,1,0.0
289-310,1,0.0
Kandy,1,0.0
instrumentalized,1,0.0
Psycho-social,1,0.0
J-STARS,1,0.0
bloodwork,1,0.0
M25,1,0.0
tiptoe,1,0.0
Cas9-RNA,1,0.0
intralaboratory,1,0.0
Answer,1,0.0
PSDs,1,0.0
re-employment,1,0.0
crawling,1,0.0
LLT,1,0.0
LLTs,1,0.0
20198999-1007,1,0.0
Bilevel,1,0.0
Theee,1,0.0
Geriatrics,1,0.0
levesl,1,0.0
Test-negative,1,0.0
subserved,1,0.0
estrogen-mediated,1,0.0
florid,1,0.0
one-tailed,1,0.0
sinotrial,1,0.0
CorkKerry,1,0.0
psycho-corporal,1,0.0
enormity,1,0.0
18--72,1,0.0
4491,1,0.0
use–associated,1,0.0
ACLVO,1,0.0
Hypoxemia,1,0.0
ACE2Ang-1-7Mas,1,0.0
HASSAN,1,0.0
9-37,1,0.0
Posteromedial,1,0.0
semi-quantitatively,1,0.0
endothelial-dependent,1,0.0
WHO-confirmed,1,0.0
2726,1,0.0
2943,1,0.0
BDI-data,1,0.0
Scintillation,1,0.0
item-response,1,0.0
moodcognition,1,0.0
Empirically,1,0.0
NCT02239640,1,0.0
≥2b,1,0.0
0183-0400,1,0.0
OSA-related,1,0.0
ruptureerosion,1,0.0
apically,1,0.0
0271,1,0.0
IH-aggravated,1,0.0
person-hours,1,0.0
22659,1,0.0
≥2c,1,0.0
A779,1,0.0
registry-a,1,0.0
40-minute,1,0.0
Ang-1-7-specific,1,0.0
five-phase,1,0.0
lipopolysaccharide-treated,1,0.0
ZINCPharmer,1,0.0
1968--1978,1,0.0
2015-February,1,0.0
ApH1N1,1,0.0
lncRNA-based,1,0.0
classification-based,1,0.0
01-Cubas,1,0.0
3CLproinhibitory,1,0.0
Seti,1,0.0
excepting,1,0.0
change--changes,1,0.0
senitization,1,0.0
33725432,1,0.0
Cutland,1,0.0
5h,1,0.0
quietly,1,0.0
Zonal,1,0.0
defects-none,1,0.0
PCR-verified,1,0.0
fragment-guided,1,0.0
113m-In,1,0.0
99m-Tc,1,0.0
CECMED,1,0.0
CIDI,1,0.0
malls,1,0.0
TYPE,1,0.0
authorial,1,0.0
recurrence-free,1,0.0
boiling,1,0.0
753090,1,0.0
3450,1,0.0
78492,1,0.0
moodcognitions,1,0.0
BO,1,0.0
care--is,1,0.0
TGF-βSmad,1,0.0
anti-tumour,1,0.0
Catalase,1,0.0
15x103,1,0.0
0092,1,0.0
13665-27042,1,0.0
nowcasted,1,0.0
nipping,1,0.0
youre,1,0.0
1573-546,1,0.0
0356-0709,1,0.0
0245,1,0.0
40919,1,0.0
0233-0607,1,0.0
non-cholinergic,1,0.0
up-dates,1,0.0
AnginaNon,1,0.0
WBC3,1,0.0
Detection-of-epidemic-start,1,0.0
modelThe,1,0.0
10-149,1,0.0
WBC2,1,0.0
WBC1,1,0.0
new-onsets,1,0.0
self-components,1,0.0
0896,1,0.0
neutrophil-associated,1,0.0
hyper-stimulate,1,0.0
2008-February,1,0.0
APerth162009-like,1,0.0
hyper-stimulated,1,0.0
Autoimmunity,1,0.0
0931,1,0.0
definitionssymptoms,1,0.0
NA1,1,0.0
140218,1,0.0
Includes,1,0.0
078-099,1,0.0
Neurothrombectomy,1,0.0
1399,1,0.0
STRATIS,1,0.0
7117,1,0.0
asystoly,1,0.0
desicion-making,1,0.0
Two-years,1,0.0
E-cadherin,1,0.0
PReventiOn,1,0.0
aCE-iNtolerant,1,0.0
Diffusion-weighted--DWI,1,0.0
Brisbane102007-like,1,0.0
person-time,1,0.0
086-104,1,0.0
079-105,1,0.0
8841,1,0.0
0405-0725,1,0.0
characteristicsA,1,0.0
photos,1,0.0
5926,1,0.0
builtFor,1,0.0
twisting,1,0.0
T1-weighted--T1WI,1,0.0
T2-weighted--T2WI,1,0.0
weighted--PDWI,1,0.0
ramp-up,1,0.0
085-098,1,0.0
Indicate,1,0.0
voxel-by-voxel,1,0.0
NA2,1,0.0
kVp,1,0.0
flowPEF,1,0.0
AswineEngland20163592,1,0.0
EGFP-transgenic,1,0.0
antgenic,1,0.0
asthmaAll,1,0.0
pneumoniamyocarditisencephalitis,1,0.0
aspirin-dipyridamole,1,0.0
HCoV-EMC,1,0.0
EMC2012,1,0.0
mineral-rich,1,0.0
30-90-day,1,0.0
Charlsons,1,0.0
immersions,1,0.0
morbidityAim,1,0.0
LOSMethodology,1,0.0
Dubois,1,0.0
Valmont,1,0.0
D3Docking,1,0.0
Branhamella,1,0.0
nonhypertensive,1,0.0
postmortal,1,0.0
residents--whether,1,0.0
Solliers,1,0.0
CVAIn,1,0.0
httpswwwd3pharmacomD3Targets-2019-nCoVD3Similarityindexphp,1,0.0
Speed-Impatience,1,0.0
braincomputer,1,0.0
Urut,1,0.0
Melayu,1,0.0
7·04,1,0.0
Hypovitaminosis,1,0.0
Boulogne-sur-Seine,1,0.0
tuberculosis-related,1,0.0
JAS,1,0.0
pin,1,0.0
counterfeit,1,0.0
fraternitys,1,0.0
cynicism,1,0.0
internalise,1,0.0
2971,1,0.0
bust,1,0.0
hypovitaminosis,1,0.0
chorioallantio,1,0.0
Ethylene,1,0.0
not--should,1,0.0
on-off,1,0.0
5-LOLTC4S,1,0.0
690-2663,1,0.0
aged≤13,1,0.0
Wujiang,1,0.0
Neurologique,1,0.0
4845,1,0.0
31239951,1,0.0
Revue,1,0.0
co-founder,1,0.0
35-,1,0.0
lineages†,1,0.0
Hubin,1,0.0
actinin,1,0.0
5010,1,0.0
cardiomyocyte-specific,1,0.0
clonally,1,0.0
Edouard,1,0.0
Th2-dominated,1,0.0
non-hematopoietic,1,0.0
Lymphocytemonocyte,1,0.0
foreword,1,0.0
1990-2001,1,0.0
on-period,1,0.0
Dejerine,1,0.0
LTA4,1,0.0
off-period,1,0.0
Rifle,1,0.0
X-mas,1,0.0
grand-glass,1,0.0
Widmer,1,0.0
Henry-Auguste,1,0.0
Scholars,1,0.0
Pathotechnical,1,0.0
pall,1,0.0
longlasting,1,0.0
nonsmoker,1,0.0
testingConclusion,1,0.0
synthetase-like,1,0.0
Atenolol,1,0.0
epidemio-surveillance,1,0.0
dibunol,1,0.0
dasyanthus,1,0.0
semi-isolation,1,0.0
Sollier,1,0.0
2·7,1,0.0
WAKE-UP,1,0.0
0951-0951,1,0.0
5-m,1,0.0
137-233,1,0.0
LFC281,1,0.0
Madin,1,0.0
viral-,1,0.0
review＞230,1,0.0
retransplantation,1,0.0
OR0973,1,0.0
Log2,1,0.0
00063,1,0.0
subcritical,1,0.0
1031-1031,1,0.0
BPIFA1,1,0.0
NCT01525290,1,0.0
httpswwwclinicaltrialsregistereu,1,0.0
ml100,1,0.0
2011-005906-32,1,0.0
Amsterdam-1,1,0.0
Nsp15NendoU,1,0.0
OR1196,1,0.0
50100000,1,0.0
uraemic,1,0.0
CLEIA-based,1,0.0
Non-survivors,1,0.0
96036,1,0.0
Norms,1,0.0
bioconductor,1,0.0
henipaviruses,1,0.0
Nipah-like,1,0.0
43-58,1,0.0
lyssaviruses,1,0.0
Hendra,1,0.0
filoviruses,1,0.0
analysis--as,1,0.0
Ebola-like,1,0.0
71-83,1,0.0
extension--cost-effectiveness,1,0.0
drug-binding,1,0.0
140181,1,0.0
LFC-145,1,0.0
partners-including,1,0.0
gifted,1,0.0
terrified,1,0.0
143251,1,0.0
5·00,1,0.0
PCR‐confirmed,1,0.0
roadside,1,0.0
heart-rate-limited,1,0.0
intactly,1,0.0
itinerary,1,0.0
5·88,1,0.0
4·11,1,0.0
anhelation,1,0.0
0·73,1,0.0
rollercoaster-evoked,1,0.0
2·51,1,0.0
underperception,1,0.0
Lost,1,0.0
magnum,1,0.0
opus,1,0.0
follower,1,0.0
Nsp13-Nsp16,1,0.0
20200404,1,0.0
Ml100,1,0.0
018-067,1,0.0
magnification,1,0.0
hospitals-are,1,0.0
para-nitrophenoltetrazolium,1,0.0
3381,1,0.0
1016-1016,1,0.0
OR1086,1,0.0
2·47,1,0.0
4·32,1,0.0
6·34,1,0.0
QVLP,1,0.0
averagely,1,0.0
6·86,1,0.0
hypoxiahypercapnia,1,0.0
20200304,1,0.0
2·82,1,0.0
0·78,1,0.0
20200317,1,0.0
2·62,1,0.0
cell-transplanted,1,0.0
radiographed,1,0.0
CNS-COVID19,1,0.0
1625-15445,1,0.0
442852,1,0.0
prednisonephobia,1,0.0
1999141049-54,1,0.0
Hoogen,1,0.0
Folgering,1,0.0
logit,1,0.0
antisocial,1,0.0
Bijl-Hofland,1,0.0
N25,1,0.0
piled,1,0.0
glossed,1,0.0
August09,1,0.0
diphenylcyclopropenone,1,0.0
respectively--p,1,0.0
14-27,1,0.0
ethno-medicines,1,0.0
Optimists,1,0.0
anterior-inferior,1,0.0
r092,1,0.0
antihyperglycemic,1,0.0
99398,1,0.0
500person,1,0.0
Meiklejohn,1,0.0
counsels,1,0.0
Meiklejohns,1,0.0
unbroken,1,0.0
superintendents,1,0.0
Polack,1,0.0
North-west,1,0.0
pursed,1,0.0
September-October09,1,0.0
settinggoal,1,0.0
N‑terminal,1,0.0
holidays--albeit,1,0.0
infringement,1,0.0
10185374,1,0.0
people--an,1,0.0
503862,1,0.0
mitigations,1,0.0
Bevacizumab,1,0.0
node-wise,1,0.0
Phytopharmaceuticals,1,0.0
Magnitudes,1,0.0
14071,1,0.0
cytospin-immunofluorescence,1,0.0
19953,1,0.0
Childhood-asthma,1,0.0
Confronted,1,0.0
asthma-therapy,1,0.0
Jixi,1,0.0
multi-family,1,0.0
NHBLI,1,0.0
NIHNHLBI,1,0.0
ethyl-cyanoacrylate,1,0.0
asthma1,1,0.0
peels,1,0.0
empyema--a,1,0.0
cyanoacrylates,1,0.0
3325606,1,0.0
1496639407,1,0.0
ALIS,1,0.0
ileum-colon,1,0.0
radiologist-approach,1,0.0
modified-for-children,1,0.0
PanicFear,1,0.0
17305,1,0.0
I--60,1,0.0
youdens,1,0.0
los,1,0.0
Banõs,1,0.0
3295,1,0.0
IV--76,1,0.0
III--111,1,0.0
subthalamus,1,0.0
II--114,1,0.0
learningperformance,1,0.0
HyperventilationIrritability,1,0.0
non-restricted,1,0.0
ethnopharmacological,1,0.0
5009,1,0.0
3046,1,0.0
edible,1,0.0
Toxicological,1,0.0
Asthma3,1,0.0
free-flowing,1,0.0
broadcast,1,0.0
Know,1,0.0
HCMV,1,0.0
83pcent,1,0.0
25pcent,1,0.0
1871-1922,1,0.0
19206,1,0.0
242100000Year,1,0.0
1032-3687,1,0.0
69372,1,0.0
00396,1,0.0
1015-1031,1,0.0
magnify,1,0.0
48207,1,0.0
≈10-fold,1,0.0
Pandemic-associated,1,0.0
76100000Year,1,0.0
47673,1,0.0
subhazard,1,0.0
0921-0954,1,0.0
Rumsfield,1,0.0
Afro-Caribbeans,1,0.0
41206,1,0.0
35pcent,1,0.0
stroke-subtype,1,0.0
Low-tidal,1,0.0
HealthNational,1,0.0
CD34-c-kitSca-1lineage-,1,0.0
Ballet,1,0.0
Research-funded,1,0.0
fever≥400°C,1,0.0
Greenspace,1,0.0
crimes,1,0.0
Afro-Carribeans,1,0.0
Socio-demographic,1,0.0
68pcent,1,0.0
280-1296,1,0.0
Unitary,1,0.0
imputed,1,0.0
Cost-utility,1,0.0
60pcent,1,0.0
67pcent,1,0.0
133pcent,1,0.0
613pcent,1,0.0
post-NSTMI,1,0.0
Organophosphate,1,0.0
timeprism,1,0.0
Glyciphagidae,1,0.0
14930,1,0.0
9580,1,0.0
Ussing,1,0.0
short-circuit,1,0.0
Calu3,1,0.0
Acaridae,1,0.0
pull-up,1,0.0
gastro-oesophegal,1,0.0
33301246,1,0.0
decortications,1,0.0
20203832603-15,1,0.0
Kitchin,1,0.0
in-fluences,1,0.0
Suddenly,1,0.0
retching,1,0.0
16998,1,0.0
11077,1,0.0
nonapproved,1,0.0
cAMP-,1,0.0
calcium-induced,1,0.0
flea,1,0.0
sphincteric,1,0.0
myosis,1,0.0
lesion-shape,1,0.0
now‐a‐days,1,0.0
hypersalivation,1,0.0
Endurance,1,0.0
Donald,1,0.0
cardio-protective,1,0.0
Declared,1,0.0
fasciculation,1,0.0
Pyroglyphidae,1,0.0
comprehensions,1,0.0
asynergia,1,0.0
TRAM-34,1,0.0
mos,1,0.0
May09,1,0.0
May10,1,0.0
KCNN4-stimulated,1,0.0
influence-indeed,1,0.0
48000000,1,0.0
5·4,1,0.0
HIV-specific,1,0.0
encephaloduroateriosynangiosis,1,0.0
β-defensin,1,0.0
radionuclide-ventriculography,1,0.0
pliability,1,0.0
ELISA-IgA,1,0.0
ITLCFTLKRK,1,0.0
KLNDLCFTNV,1,0.0
QLD15202020,1,0.0
GGDGKMKD,1,0.0
225-year,1,0.0
nsp-10,1,0.0
1967-1989,1,0.0
truncating,1,0.0
7a,1,0.0
7-nucleotide,1,0.0
re-defining,1,0.0
ELISA-IgG,1,0.0
long-estimated,1,0.0
vacancy,1,0.0
host’s,1,0.0
nonhomologous,1,0.0
nonallergenicity,1,0.0
promiscuousity,1,0.0
SCo,1,0.0
General-population,1,0.0
Directly,1,0.0
non-stimulated,1,0.0
exoribonuclease,1,0.0
Taraskul,1,0.0
propels,1,0.0
ESMA,1,0.0
monoventricular,1,0.0
RVPN,1,0.0
00059,1,0.0
596755,1,0.0
Delmarva,1,0.0
8-50,1,0.0
36-100,1,0.0
un-targeted,1,0.0
Lifetable,1,0.0
infarct-vessel,1,0.0
screened-out,1,0.0
GRAVY,1,0.0
5-terminus,1,0.0
electricity-free,1,0.0
Sweetened,1,0.0
lab-on-a-disc,1,0.0
opsonin-mediated,1,0.0
mLserving,1,0.0
silico-based,1,0.0
motor-perceptive,1,0.0
infrastructure-independent,1,0.0
easy-to-operate,1,0.0
sample-in-answer-out,1,0.0
wardsclinics,1,0.0
chronically-elevated,1,0.0
2588,1,0.0
inappropriatenon-adherence,1,0.0
1129,1,0.0
Time-averaged,1,0.0
1978-80,1,0.0
debarkation,1,0.0
1979-81,1,0.0
734-60,1,0.0
pump-based,1,0.0
Liposomes,1,0.0
arches,1,0.0
baboon,1,0.0
ectoenzyme,1,0.0
toy-inspired,1,0.0
micro-total-analysis,1,0.0
aliquoting,1,0.0
“S”,1,0.0
dumping,1,0.0
Long-COVID,1,0.0
decanting,1,0.0
IUmg,1,0.0
on-disc,1,0.0
septae,1,0.0
tented,1,0.0
cytomegaly,1,0.0
ulnar,1,0.0
whorls,1,0.0
unilobar,1,0.0
Dermatoglyphic,1,0.0
valving,1,0.0
non-contaminated,1,0.0
occupationals,1,0.0
age--30,1,0.0
NDAF,1,0.0
0186-039,1,0.0
Mottle,1,0.0
24884,1,0.0
PMMoV,1,0.0
sex-non-specific,1,0.0
springtime,1,0.0
exercise-sensitive,1,0.0
Endangered,1,0.0
altricial,1,0.0
chaotropic,1,0.0
or21,1,0.0
pegylated,1,0.0
85145,1,0.0
Trimeric,1,0.0
school-,1,0.0
morally,1,0.0
lymphocytic-eosinophilic,1,0.0
CAAs,1,0.0
Pepper,1,0.0
acidTNA,1,0.0
farm-reared,1,0.0
multiple-dose,1,0.0
methylenedioxymethamphetamine,1,0.0
MDMA,1,0.0
163-207,1,0.0
72·9,1,0.0
Czechoslovak,1,0.0
38·9,1,0.0
para-influenzas,1,0.0
46·5,1,0.0
165-264,1,0.0
pennanti,1,0.0
012-033,1,0.0
cerebral-renal,1,0.0
imagingangiography,1,0.0
019-052,1,0.0
009-019,1,0.0
12-dose,1,0.0
clinic-radiological,1,0.0
Intimal,1,0.0
Replicative,1,0.0
Msdps2,1,0.0
women--31,1,0.0
HRF,1,0.0
Oximetry,1,0.0
lifethreatening,1,0.0
cellsbasophils,1,0.0
multi-functionality,1,0.0
∼80-100,1,0.0
histamine-releasing,1,0.0
roadshows,1,0.0
particularily,1,0.0
histamine-release,1,0.0
antibody-related,1,0.0
bioanalytes,1,0.0
milling,1,0.0
goal-attainment-theory-based,1,0.0
HRIF,1,0.0
dose-free,1,0.0
preponderantly,1,0.0
employment--56,1,0.0
type-dependent,1,0.0
FSTS,1,0.0
Rockville,1,0.0
ferritin-like,1,0.0
devasting,1,0.0
∼3-fold,1,0.0
firmness,1,0.0
Viscoelastic,1,0.0
SWE,1,0.0
range045,1,0.0
VCDasthmapanic,1,0.0
mean119,1,0.0
PEG-IFN-beta,1,0.0
human-compatible,1,0.0
myxoid,1,0.0
RBD-trimer,1,0.0
synovial,1,0.0
Expi293,1,0.0
sheaths,1,0.0
carpal,1,0.0
httpbiosignalmedupatrasgrwordpressbiosignal,1,0.0
Manningham,1,0.0
Matlab,1,0.0
556-67,1,0.0
postpercutaneous,1,0.0
epigastralgia,1,0.0
Midline,1,0.0
aerosolic,1,0.0
anthroponosis,1,0.0
Vectors,1,0.0
DAN-MONICA,1,0.0
1982-1984,1,0.0
320000,1,0.0
58425681,1,0.0
H5N4,1,0.0
1385218,1,0.0
sanitary-and,1,0.0
physiotherapypsychotherapy,1,0.0
Horne-Östberg,1,0.0
evening-type,1,0.0
morning-,1,0.0
parentpatient,1,0.0
industrialists,1,0.0
eveningness,1,0.0
rapidly-growing,1,0.0
Morningness-Eveningness,1,0.0
MEQ,1,0.0
Intending,1,0.0
within-class,1,0.0
228-785,1,0.0
100th,1,0.0
255-793,1,0.0
post-TAVI,1,0.0
≥57,1,0.0
161-141,1,0.0
173-42,1,0.0
between-class,1,0.0
within-school,1,0.0
clock-hour,1,0.0
contact-based,1,0.0
6940,1,0.0
scleritis,1,0.0
similar-sized,1,0.0
chronometric,1,0.0
nonwake-up,1,0.0
therapiesstrategies,1,0.0
immunostimulators,1,0.0
Mobilization,1,0.0
0513,1,0.0
20--of,1,0.0
6636,1,0.0
1844,1,0.0
2044,1,0.0
00047,1,0.0
2066,1,0.0
areforyoungerpatients,1,0.0
Mosaicism,1,0.0
8278,1,0.0
-118,1,0.0
Acid-Schiff,1,0.0
epithelium-connective,1,0.0
usefulfor,1,0.0
Hematoxylin-Eosin,1,0.0
mortality-attributed,1,0.0
mitral-papillar,1,0.0
and÷or,1,0.0
wallABSTRACT,1,0.0
nonconfirmed,1,0.0
Tiantan,1,0.0
r-086,1,0.0
Bonaphthone,1,0.0
Dipstick,1,0.0
unsustainably,1,0.0
morningness,1,0.0
FEV1PC20FEV1,1,0.0
calculative,1,0.0
quantative,1,0.0
Bupleuri,1,0.0
sGaw--for,1,0.0
parameters--the,1,0.0
reinstating,1,0.0
Estrogen-progestin,1,0.0
4927,1,0.0
5044,1,0.0
Flusurge,1,0.0
32-old-man,1,0.0
447-664,1,0.0
5077,1,0.0
B11251,1,0.0
2736,1,0.0
non-Sentinel,1,0.0
PD20--the,1,0.0
mumoll,1,0.0
3510,1,0.0
herbal-based,1,0.0
Rab11-mediated,1,0.0
B111,1,0.0
B11161,1,0.0
recoverchange,1,0.0
Phage-DMS,1,0.0
interrogates,1,0.0
dose-titration,1,0.0
SNAPSHOT,1,0.0
two-signal,1,0.0
Rab11-depleted,1,0.0
out-dated,1,0.0
peer-reviewing,1,0.0
MPN,1,0.0
pathogen-based,1,0.0
ridgeline,1,0.0
10000-fold,1,0.0
104710,1,0.0
B39,1,0.0
pinch,1,0.0
Tygerberg,1,0.0
delayed-but-specific,1,0.0
emory,1,0.0
polyanions,1,0.0
C179,1,0.0
F49,1,0.0
bulls,1,0.0
non-spherical,1,0.0
170-320,1,0.0
45-79,1,0.0
QPS,1,0.0
autocardiac,1,0.0
Scanning,1,0.0
Tc-99m-Tetrofosmin,1,0.0
GTP-binding,1,0.0
Rab11-family,1,0.0
MPIMyocardial,1,0.0
35884,1,0.0
recoverychanges,1,0.0
GTP-cycling,1,0.0
32575,1,0.0
94888,1,0.0
25705,1,0.0
121-422,1,0.0
pharmacogenetically,1,0.0
Agreements,1,0.0
325627,1,0.0
days100,1,0.0
Beta-2-receptor,1,0.0
airminute,1,0.0
fiber-rich,1,0.0
theophilline,1,0.0
drug-metabolizing,1,0.0
13-44,1,0.0
omega-3-fatty,1,0.0
Cross-sectionally,1,0.0
height-adjusted,1,0.0
14-54,1,0.0
Longitudinally,1,0.0
443362,1,0.0
immunoregulants,1,0.0
≈US,1,0.0
R79805187,1,0.0
POCKITTM,1,0.0
sodiumchloride,1,0.0
8110,1,0.0
paraphasia,1,0.0
Homocysteinemia,1,0.0
14804,1,0.0
12396,1,0.0
5170,1,0.0
North-South,1,0.0
240578,1,0.0
dysfluency,1,0.0
16-82,1,0.0
5209AG,1,0.0
three-syllable,1,0.0
VOSL,1,0.0
23-86,1,0.0
phonemic,1,0.0
640785,1,0.0
S-2P-based,1,0.0
294000,1,0.0
675785,1,0.0
54785,1,0.0
LM-specific,1,0.0
Hope,1,0.0
∼60-70,1,0.0
armchair,1,0.0
west-east,1,0.0
5th15th,1,0.0
FAZ,1,0.0
doorknobs,1,0.0
dispensers,1,0.0
swallow-related,1,0.0
biodiverse,1,0.0
foveal,1,0.0
PC20AMP,1,0.0
industry-standard,1,0.0
273-876,1,0.0
spattered,1,0.0
Yarraman,1,0.0
TIMI-2,1,0.0
caveatsABSTRACT,1,0.0
designers,1,0.0
wicked,1,0.0
exotic-sounding,1,0.0
Reemergence,1,0.0
PDQeX,1,0.0
muscle-length,1,0.0
22643,1,0.0
3455,1,0.0
respired,1,0.0
pneumotachygraph,1,0.0
supersede,1,0.0
supercontractility,1,0.0
CEBP-alpha,1,0.0
Insufficiency,1,0.0
ABAH1N12009,1,0.0
Endoventricular,1,0.0
4622,1,0.0
non-vital,1,0.0
quasi-species,1,0.0
Throughput,1,0.0
mUmL,1,0.0
ischaemic-reperfusion,1,0.0
classschool,1,0.0
microscale,1,0.0
midrange,1,0.0
μRT-PCR,1,0.0
awarding,1,0.0
H11N3,1,0.0
Miocardico-2,1,0.0
Organization-region,1,0.0
drugsvasopressors,1,0.0
THL,1,0.0
qRT-,1,0.0
Jigüe,1,0.0
Batalla,1,0.0
Kimbal,1,0.0
80‐year‐old,1,0.0
chilblain‐like,1,0.0
PCR‐proven,1,0.0
H3N2--AKiev5979,1,0.0
NSTEMIPA,1,0.0
aproach,1,0.0
controversial1‐8,1,0.0
Stentrievers,1,0.0
chatter,1,0.0
classe,1,0.0
overcharge,1,0.0
ozonized,1,0.0
llbllla,1,0.0
C°,1,0.0
Tungsten,1,0.0
Stroke-SiGN,1,0.0
6-F,1,0.0
Incision,1,0.0
ORF-1a,1,0.0
Iso-SANP,1,0.0
AChickenKurgan305,1,0.0
protease-induced,1,0.0
501YV1V2,1,0.0
10746,1,0.0
7378,1,0.0
unitsoutpatient,1,0.0
plasm,1,0.0
papules,1,0.0
cell-matrix,1,0.0
project-based,1,0.0
81109,1,0.0
right‐sided,1,0.0
X‐ray,1,0.0
NSTEMIOA,1,0.0
phase-I,1,0.0
entrants,1,0.0
B-Eos,1,0.0
2-chamber,1,0.0
OR120,1,0.0
qualityof,1,0.0
asthratic,1,0.0
Y-organ,1,0.0
ecdysteroids,1,0.0
007-2,1,0.0
operationalization,1,0.0
Stroke-Specific,1,0.0
coincidently,1,0.0
Kinetocardiography,1,0.0
ACEP,1,0.0
29-75,1,0.0
bilateral-specific,1,0.0
9033,1,0.0
molt-inhibiting,1,0.0
39876,1,0.0
duped,1,0.0
8356,1,0.0
kinetocardiogram,1,0.0
Gecarcinus,1,0.0
normokinesishyperkinesis,1,0.0
Teach,1,0.0
4912,1,0.0
conditionality,1,0.0
Sep,1,0.0
Gl-elongation,1,0.0
branding,1,0.0
intra-immune,1,0.0
TNF-a,1,0.0
screen-and-test,1,0.0
patientswere,1,0.0
toxic-dust,1,0.0
post-MLA,1,0.0
12weeks,1,0.0
Educators,1,0.0
CAEs,1,0.0
62-,1,0.0
aerobiological,1,0.0
Symptomsdomain,1,0.0
inthe,1,0.0
autotomy,1,0.0
5-segment,1,0.0
simultaneity,1,0.0
crowdsourcing,1,0.0
243-2574,1,0.0
115-7347,1,0.0
Epitopes,1,0.0
microembolus,1,0.0
receptor-3,1,0.0
Lismore,1,0.0
RBD-simultaneously,1,0.0
pET-19b,1,0.0
interferon-γ-induced,1,0.0
australis,1,0.0
ADH,1,0.0
brevity,1,0.0
alloantigen,1,0.0
upscaled,1,0.0
cautiousness,1,0.0
visor,1,0.0
hypokaliemia,1,0.0
CFD-based,1,0.0
102-1505,1,0.0
Islamabad,1,0.0
decapod,1,0.0
22464,1,0.0
predatory,1,0.0
Anti-,1,0.0
Kinetocardiogram,1,0.0
Bootstrapping,1,0.0
Molting,1,0.0
semicontinuous,1,0.0
NIDCH,1,0.0
34588,1,0.0
34710,1,0.0
qds,1,0.0
target-sequences,1,0.0
no-opacified,1,0.0
fast-conventional,1,0.0
blessing,1,0.0
004-049,1,0.0
interferon-γ-inducing,1,0.0
Columbia-Presbyterian,1,0.0
100sec,1,0.0
rapidly-evolving,1,0.0
micro-blogging,1,0.0
Beta-defensins,1,0.0
magnesium-treated,1,0.0
head-impulse,1,0.0
40-56,1,0.0
10-15-yr-olds,1,0.0
EDFLDF,1,0.0
dec,1,0.0
cancer-form,1,0.0
histo-pathology,1,0.0
Equal,1,0.0
mutations-predictors,1,0.0
200720082009,1,0.0
Multisegment,1,0.0
piAseasonal,1,0.0
5579,1,0.0
AWI475794,1,0.0
AWI475594,1,0.0
AWI476094,1,0.0
non-risk,1,0.0
2533,1,0.0
8794,1,0.0
normograms,1,0.0
field-ready-it,1,0.0
boasts,1,0.0
Manufacture,1,0.0
self-limitation,1,0.0
Rc∗,1,0.0
64-κ,1,0.0
accountsfor,1,0.0
R-tubeVent®,1,0.0
XO,1,0.0
67-κ,1,0.0
11-day-old,1,0.0
anchorage-dependent,1,0.0
49-κ,1,0.0
Yields,1,0.0
spongiform,1,0.0
Andersen,1,0.0
micro-well,1,0.0
asthmaprone,1,0.0
portable-a,1,0.0
Sirikit,1,0.0
USD1694,1,0.0
purifier,1,0.0
INTACT,1,0.0
7886,1,0.0
factor-E2-related,1,0.0
neuroangiography,1,0.0
COVID-19-exposed,1,0.0
shortfalls,1,0.0
TCS-treated,1,0.0
vasoactive-inotroic,1,0.0
RNA-polymerase,1,0.0
ENCOURAGE,1,0.0
cathlab,1,0.0
unprompted,1,0.0
zebrawood,1,0.0
FNR,1,0.0
plasma-testing,1,0.0
R0170105,1,0.0
Threee,1,0.0
R0177123,1,0.0
acetolol,1,0.0
opisthotonos,1,0.0
methodAstograph,1,0.0
ASwIN172688,1,0.0
Microberlinia,1,0.0
AWI475894,1,0.0
blockages,1,0.0
hospitalisation-related,1,0.0
AWI475694,1,0.0
2021505e206-e213,1,0.0
7676,1,0.0
per-dose,1,0.0
virus-offer,1,0.0
vaccines-targeting,1,0.0
2613,1,0.0
6453,1,0.0
hemi-nested,1,0.0
time-to-result,1,0.0
Label-free,1,0.0
AWI475494,1,0.0
Lichtlen,1,0.0
allergo-sorbent,1,0.0
out-of-the-lab,1,0.0
SIgAimmunoglobulin,1,0.0
SIgMimmunoglobulin,1,0.0
6342,1,0.0
2856,1,0.0
AH3N2-dominated,1,0.0
endotoxin-contaminated,1,0.0
undisputed,1,0.0
ioxaglate,1,0.0
-396,1,0.0
-407,1,0.0
Contrast-deficit,1,0.0
032X2,1,0.0
contrast-filled,1,0.0
-492,1,0.0
dialysates,1,0.0
infirm,1,0.0
024X,1,0.0
-473,1,0.0
-528,1,0.0
effectsAreas,1,0.0
∆6970,1,0.0
-516,1,0.0
in-label,1,0.0
fibrosus,1,0.0
ultrahyperacute,1,0.0
proliferations,1,0.0
-536,1,0.0
overviewing,1,0.0
managemant,1,0.0
popuöation,1,0.0
TLVTWA,1,0.0
noxa,1,0.0
infarction-redistribution,1,0.0
Verified,1,0.0
danderurinary,1,0.0
458-462,1,0.0
MIS-CA,1,0.0
occurr,1,0.0
responsed,1,0.0
heightening,1,0.0
0-90,1,0.0
021X,1,0.0
ethnically-diverse,1,0.0
nonseroconversion,1,0.0
-062,1,0.0
electro-cauterization,1,0.0
endocarduim,1,0.0
imcomplete,1,0.0
CFK,1,0.0
entryway,1,0.0
immunolocalization,1,0.0
mast-cell-mediated,1,0.0
1999-2001,1,0.0
chemistry--will,1,0.0
RENASICA,1,0.0
sciences--for,1,0.0
Praecordial,1,0.0
saliva-negative,1,0.0
R-tube®,1,0.0
Furious,1,0.0
HADs,1,0.0
case-identification,1,0.0
700-bed,1,0.0
hypocortisolism,1,0.0
29972,1,0.0
TH2-weighted,1,0.0
non-TH2-weighted,1,0.0
allergologist,1,0.0
LAA-stroke,1,0.0
ionizer,1,0.0
lactationbreastfeeding,1,0.0
wide-band,1,0.0
BUSSR6069-based,1,0.0
RdRpS,1,0.0
assay-generated,1,0.0
areactogenic,1,0.0
Glyceryl,1,0.0
-525,1,0.0
neutralalkaline,1,0.0
degassed,1,0.0
concentrator,1,0.0
O2-H2On,1,0.0
log-S2S1,1,0.0
acreages,1,0.0
vasopermeability,1,0.0
iMLDR-TM,1,0.0
0515,1,0.0
HCO3-,1,0.0
treatment-mediated,1,0.0
0533,1,0.0
EF2,1,0.0
18F-FDG-PETCT,1,0.0
credential,1,0.0
BEAUti,1,0.0
middle-superior,1,0.0
left-middle,1,0.0
…might,1,0.0
x-TAG,1,0.0
diabets,1,0.0
ptaients,1,0.0
re-achieve,1,0.0
8521,1,0.0
acceptors,1,0.0
Abnormality,1,0.0
sympotomatic,1,0.0
202173,1,0.0
165-607,1,0.0
methane-rich,1,0.0
Methane,1,0.0
galactomanan,1,0.0
found-386,1,0.0
multiple-trigger,1,0.0
noxae,1,0.0
left-inferior,1,0.0
X-TAG,1,0.0
right-inferior,1,0.0
dacades,1,0.0
Theres,1,0.0
diesase,1,0.0
4254,1,0.0
2328,1,0.0
depertment,1,0.0
AFM-IR,1,0.0
03061,1,0.0
2471,1,0.0
synchrotron,1,0.0
right-superior,1,0.0
MM-3,1,0.0
Prevalance,1,0.0
metalloproteinase-3,1,0.0
1657,1,0.0
ß2-agonist,1,0.0
tightnes,1,0.0
outcome-modifying,1,0.0
Middle-aged,1,0.0
2028,1,0.0
384130,1,0.0
erogeneity,1,0.0
deficit--identification,1,0.0
adminstration,1,0.0
101086,1,0.0
virus-virus,1,0.0
Virus-virus,1,0.0
CT--determination,1,0.0
capsule-treated,1,0.0
myofilament,1,0.0
Cys-LT1,1,0.0
of--identification,1,0.0
of--the,1,0.0
2217,1,0.0
n1170,1,0.0
-994,1,0.0
clinic-friendly,1,0.0
sequencing-ready,1,0.0
≥98,1,0.0
n953,1,0.0
180dpos,1,0.0
allergies-are,1,0.0
allergies--particularly,1,0.0
bleakest,1,0.0
thrombectomy-the,1,0.0
tropicalsemi-arid,1,0.0
het-,1,0.0
adjuvent,1,0.0
222391,1,0.0
0913,1,0.0
NPSNSSS,1,0.0
techniques--restraint,1,0.0
1971-1988,1,0.0
capacities-laboratory,1,0.0
complications--decompressive,1,0.0
psychasthenia,1,0.0
on-were,1,0.0
9566,1,0.0
hypomania,1,0.0
critical-an,1,0.0
capital-enabled,1,0.0
DNA-array,1,0.0
neurostereology,1,0.0
cloudy,1,0.0
86582,1,0.0
multi-pathway,1,0.0
solution-based,1,0.0
influenzaStudies,1,0.0
NPR-C,1,0.0
Space-occupying,1,0.0
1950-78,1,0.0
Pepys,1,0.0
audiotapes,1,0.0
risk-prone,1,0.0
resonace,1,0.0
viro-immunologic,1,0.0
25Uml,1,0.0
meta-analysisThe,1,0.0
beyong,1,0.0
105-507,1,0.0
APGs,1,0.0
266-2831,1,0.0
Suppressed,1,0.0
matched-hospitalized,1,0.0
immunodominance,1,0.0
5p14-p13,1,0.0
drags,1,0.0
Consumer-resource,1,0.0
Themed,1,0.0
copy-number,1,0.0
Germany-wide,1,0.0
G20,1,0.0
diploid,1,0.0
Biotech-Pharma,1,0.0
informinfluence,1,0.0
DEFB103,1,0.0
high-DEFB103-expressing,1,0.0
multiorganic,1,0.0
Gastro-intestinal,1,0.0
nuchal,1,0.0
translucency,1,0.0
groundglass,1,0.0
H3-subtype,1,0.0
KAIMRC,1,0.0
susceptible-exposed-infected-removed,1,0.0
partially-effective,1,0.0
prefers,1,0.0
Multistrain,1,0.0
12vaccinee,1,0.0
jobsite,1,0.0
jobsites,1,0.0
Futures,1,0.0
tracing1-6,1,0.0
stormquot,1,0.0
086295,1,0.0
anti-arrhythmia,1,0.0
root-to-tip,1,0.0
mutationsgenomeday,1,0.0
Ongoings,1,0.0
Convulsions,1,0.0
VPObrazcov,1,0.0
autophagosome-lysosome,1,0.0
recycles,1,0.0
anti-myocardial,1,0.0
core-based,1,0.0
catalyzers,1,0.0
005526,1,0.0
anti-atherosclerosis,1,0.0
83688,1,0.0
quotcytokine,1,0.0
virusviral,1,0.0
405life-year,1,0.0
half-time,1,0.0
noninsignificant,1,0.0
chromium-51,1,0.0
166-169,1,0.0
37-59,1,0.0
episodeInfluenza,1,0.0
EIChazov,1,0.0
Morphol,1,0.0
Folia,1,0.0
iliofemoral,1,0.0
NDStrazhesko,1,0.0
goitre,1,0.0
anterosuperior,1,0.0
POA,1,0.0
098464,1,0.0
Two-dose,1,0.0
cat-derived,1,0.0
VIKolesov,1,0.0
Artemisinin,1,0.0
virus-enriched,1,0.0
high-depth,1,0.0
2023,1,0.0
selenite,1,0.0
FACTORS,1,0.0
membrane-fusion,1,0.0
signally,1,0.0
myocardial-lipids,1,0.0
overperceiver,1,0.0
Evening,1,0.0
overperceivers,1,0.0
chemofluorescent,1,0.0
Overperceivers,1,0.0
mutation-driven,1,0.0
sero-antibodies,1,0.0
VSOP,1,0.0
viruses--classical,1,0.0
seroreaction,1,0.0
CE-approved,1,0.0
26-50,1,0.0
gammakg,1,0.0
iron-oxide,1,0.0
NEGATIVE,1,0.0
avelysine,1,0.0
varnisher,1,0.0
8224,1,0.0
Swedish-born,1,0.0
arginine-metabolizing,1,0.0
voltammetry-based,1,0.0
11-mercaptoundecanoic,1,0.0
Arginine,1,0.0
strokeWe,1,0.0
MUA,1,0.0
Runge-Kutta,1,0.0
4029,1,0.0
monophosphate-adenosine,1,0.0
103-348,1,0.0
Cost-benefit,1,0.0
ngmL-1,1,0.0
13581,1,0.0
non-placebo-controlled,1,0.0
AchickenHenan12004,1,0.0
self-molecule,1,0.0
AIRI,1,0.0
distincly,1,0.0
FIND,1,0.0
40167,1,0.0
highly-contagious,1,0.0
0-23,1,0.0
HART,1,0.0
in-inducing,1,0.0
FRAXIS-fraxiparin,1,0.0
S2-epitope,1,0.0
7-component,1,0.0
community-driven,1,0.0
Isocyanate-induced,1,0.0
hospitalizationsdeaths,1,0.0
20-amino,1,0.0
04-14,1,0.0
bioviability,1,0.0
hospitalizationmortality,1,0.0
Gl-EF2,1,0.0
Yin-Deficiency,1,0.0
Dampness-Phlegm,1,0.0
Fire-Heat,1,0.0
Qi-Deficiency,1,0.0
6m,1,0.0
bronchopneumology,1,0.0
10060,1,0.0
thrombin-inhibitory,1,0.0
110min,1,0.0
bulge-like,1,0.0
-625,1,0.0
-Omics,1,0.0
-462,1,0.0
4852,1,0.0
tungal,1,0.0
discharge--namely,1,0.0
examiniation,1,0.0
host-cellular,1,0.0
new-found,1,0.0
laryngologic,1,0.0
pateints,1,0.0
peak-incidence,1,0.0
112×10⁹L,1,0.0
080×10⁹L,1,0.0
ABO-compatible,1,0.0
AMI-SK,1,0.0
7-18-y-old,1,0.0
6616,1,0.0
votings,1,0.0
Thromboxane,1,0.0
warehouse,1,0.0
unreleived,1,0.0
US15974,1,0.0
2362,1,0.0
Nicorandil,1,0.0
OUs,1,0.0
arteriolosclerosis,1,0.0
n235,1,0.0
severly,1,0.0
sensor-related,1,0.0
A2TXA2,1,0.0
L-threodops,1,0.0
aggregator,1,0.0
vasoconstricter,1,0.0
infleunza,1,0.0
AOkuda57xAFinland474,1,0.0
AScotland84074,1,0.0
basical,1,0.0
astmatic,1,0.0
fifty-eight-year-old,1,0.0
Nitrocellulose,1,0.0
non-preferred,1,0.0
2223,1,0.0
14dpos,1,0.0
metatranscriptomes,1,0.0
electro-aerosols,1,0.0
Assume,1,0.0
8-14dpos,1,0.0
brandslaboratories,1,0.0
glucose-consuming,1,0.0
plantcenter,1,0.0
micro-neutralisation,1,0.0
SPLP,1,0.0
less-known,1,0.0
dpos,1,0.0
3446,1,0.0
β-oxidation,1,0.0
days-post-onset,1,0.0
Lagrangian,1,0.0
4313,1,0.0
CBSL,1,0.0
Co-morbid,1,0.0
5749,1,0.0
2000-2999,1,0.0
Heroin,1,0.0
anti-CoViD-19,1,0.0
non-hospitalised,1,0.0
causeA,1,0.0
3027,1,0.0
317340,1,0.0
42167,1,0.0
82226,1,0.0
VLCAM,1,0.0
Opiate,1,0.0
85167,1,0.0
physician-assessed,1,0.0
1990-1994,1,0.0
5145,1,0.0
2-18-y-old,1,0.0
16167,1,0.0
2-6-,1,0.0
recuperating,1,0.0
123124,1,0.0
3642,1,0.0
two-sugar,1,0.0
DOPScontrol,1,0.0
HF120,1,0.0
15119,1,0.0
CoronavirusCoV,1,0.0
45–54,1,0.0
104552,1,0.0
Lubelskie,1,0.0
2636,1,0.0
easy-to-integrate,1,0.0
22975,1,0.0
non-contemporary,1,0.0
228055,1,0.0
SAEs1,1,0.0
Guadeloupe,1,0.0
three-weeks,1,0.0
killed-virus,1,0.0
alpha1-anti-trypsin,1,0.0
mild-to-substantial,1,0.0
voiceaudio,1,0.0
Ecstasy,1,0.0
obsolescence,1,0.0
AswineEngland19585292,1,0.0
six-well,1,0.0
hydrochephalus,1,0.0
phenotherol,1,0.0
tissuesConclusions,1,0.0
1943,1,0.0
493-502,1,0.0
Typhus,1,0.0
exudatious,1,0.0
iron-laden,1,0.0
macrophagemonocyte-lineage,1,0.0
gallinarum,1,0.0
monocytemyeloid-rich,1,0.0
beta-2adrenergics,1,0.0
Savunzzi,1,0.0
Savonuzzi,1,0.0
peste,1,0.0
aviaria,1,0.0
immunofluorescenceMeasurements,1,0.0
Communicazione,1,0.0
fatta,1,0.0
steadfast,1,0.0
Ames,1,0.0
thalamo-mesencephalic,1,0.0
EVD-group,1,0.0
18782187-126,1,0.0
virus-independent,1,0.0
septicemic,1,0.0
nonathletes,1,0.0
drain--EVD,1,0.0
Tissue-specific,1,0.0
viscometer,1,0.0
cone-plate,1,0.0
Rivolta,1,0.0
Devries,1,0.0
attitudinal-altered,1,0.0
phosphodiesterase-3,1,0.0
Delprato,1,0.0
Stubs,1,0.0
intra-familial,1,0.0
±153,1,0.0
Fowl,1,0.0
Biester,1,0.0
allaccademia,1,0.0
injuryMethods,1,0.0
scienze,1,0.0
Connected,1,0.0
195510b81-91,1,0.0
Beltsville,1,0.0
Duty,1,0.0
dayABSTRACT,1,0.0
Denoising,1,0.0
tottering-5J,1,0.0
Cav21,1,0.0
gamma-interferons,1,0.0
PQ-type,1,0.0
Naturf,1,0.0
trait-anger,1,0.0
anger-trait,1,0.0
pR1349Q,1,0.0
Sanok,1,0.0
2-27,1,0.0
c4046G→A,1,0.0
Sahaja,1,0.0
sensorimotor-right,1,0.0
simulator-based,1,0.0
Geflügelpest,1,0.0
mediche,1,0.0
Driving,1,0.0
naturali,1,0.0
Piglowski,1,0.0
Schäfer,1,0.0
Vergleichender,1,0.0
sero-immunologische,1,0.0
broncotest,1,0.0
Untersuchungen,1,0.0
ANetherlands24193,1,0.0
über,1,0.0
timolol-treated,1,0.0
Viren,1,0.0
klassischen,1,0.0
mRNA-vaccines,1,0.0
broncodynamic,1,0.0
Spirographic,1,0.0
adeno-vectored,1,0.0
single-construct,1,0.0
off-road,1,0.0
Torino,1,0.0
Agri,1,0.0
Accad,1,0.0
r072,1,0.0
4864,1,0.0
Lódź,1,0.0
8267,1,0.0
Lungene,1,0.0
1741129,1,0.0
-1317,1,0.0
Jan-March,1,0.0
1632167,1,0.0
757924,1,0.0
9993,1,0.0
revalidations,1,0.0
patient-completed,1,0.0
Immunologically,1,0.0
3210,1,0.0
4140,1,0.0
WITH,1,0.0
anklebrachial,1,0.0
device-implanted,1,0.0
7285,1,0.0
2333,1,0.0
26-February,1,0.0
9448,1,0.0
York-Presbyterian,1,0.0
Amphan,1,0.0
anti-IgM,1,0.0
Kelly,1,0.0
interventionsWe,1,0.0
clinicallylaboratory,1,0.0
sovereign,1,0.0
Westerdam,1,0.0
8502,1,0.0
9467,1,0.0
LFUS,1,0.0
declotting,1,0.0
deobstruction,1,0.0
stiffened,1,0.0
935000,1,0.0
halving,1,0.0
Stress-test-induced,1,0.0
4883,1,0.0
2767,1,0.0
RAS-modifying,1,0.0
Annali,1,0.0
clade-featured,1,0.0
open-,1,0.0
balloon-guided,1,0.0
non-emergent,1,0.0
ngµl,1,0.0
99633,1,0.0
23963,1,0.0
economic-mathematical,1,0.0
21303,1,0.0
alcohol-attributable,1,0.0
56-60°C,1,0.0
5335,1,0.0
asynchronicity,1,0.0
dander-induced,1,0.0
plasma-cell,1,0.0
Epizoozia,1,0.0
tifoide,1,0.0
nei,1,0.0
gallinacei,1,0.0
flow-reversal,1,0.0
hemorrhaging,1,0.0
Sort,1,0.0
43-71,1,0.0
iallergic,1,0.0
iichronic,1,0.0
decontrol,1,0.0
22-70,1,0.0
401072,1,0.0
Pneumomediastinum,1,0.0
83-86,1,0.0
52-58,1,0.0
communityhome,1,0.0
160482,1,0.0
30-44,1,0.0
importantclinical,1,0.0
ARMS-based,1,0.0
V-S,1,0.0
79780,1,0.0
G-GH-GR,1,0.0
pentaplex,1,0.0
308154,1,0.0
intraparietal,1,0.0
intraparietal-left,1,0.0
nonenzymatic,1,0.0
Anger-state,1,0.0
virosphere,1,0.0
p00017,1,0.0
stroke-alert,1,0.0
PIDIRAC-ILI,1,0.0
closuretotal,1,0.0
PIDIRAC-FLU,1,0.0
scarf,1,0.0
069-093,1,0.0
cold-related,1,0.0
1951-1980,1,0.0
Pyrococcus,1,0.0
Survey-21,1,0.0
furiosus,1,0.0
SHLCI,1,0.0
taxonomies,1,0.0
Argonaute,1,0.0
transgression,1,0.0
mortalitymyocardial,1,0.0
naturalization,1,0.0
11895,1,0.0
supergiant,1,0.0
cytotypes,1,0.0
Luries,1,0.0
24320,1,0.0
0828-0992,1,0.0
trans-cardiac,1,0.0
Scans,1,0.0
Ashkenazy,1,0.0
0968-0984,1,0.0
Jew,1,0.0
LCH,1,0.0
experienced-focused,1,0.0
dysphagiaswallowing,1,0.0
nasosinus,1,0.0
concensus,1,0.0
PRISMA-DTA,1,0.0
dpicardium,1,0.0
Handbook,1,0.0
PDU,1,0.0
deafness,1,0.0
Post-resuscitation,1,0.0
commits,1,0.0
SAP-E,1,0.0
transgressions,1,0.0
whole-class,1,0.0
septation,1,0.0
beacons,1,0.0
Penang,1,0.0
microthromboemboli,1,0.0
consistence,1,0.0
pre-VAT,1,0.0
asthma-training,1,0.0
ICH-as,1,0.0
Peptoniphilus,1,0.0
Everyday,1,0.0
fails-and,1,0.0
Actively,1,0.0
AIS-as,1,0.0
Nonintervention,1,0.0
misrepresentation,1,0.0
Faecalibacterium,1,0.0
dismutases,1,0.0
psychotropics,1,0.0
CSF3,1,0.0
Ⅰ,1,0.0
C-section,1,0.0
long-hauler,1,0.0
de-risked,1,0.0
myalgic,1,0.0
2018--2030,1,0.0
post-AZD1222,1,0.0
pandemic-COVID-19,1,0.0
inflammationomics,1,0.0
signature-based,1,0.0
Workbench,1,0.0
FDR005,1,0.0
99mm,1,0.0
log2FC1,1,0.0
despondency,1,0.0
Metacore,1,0.0
potential-novel,1,0.0
re-think,1,0.0
misbalance,1,0.0
diagnosticmanagement,1,0.0
ALPL,1,0.0
090-096,1,0.0
Sites,1,0.0
0079,1,0.0
Plaqueextension,1,0.0
LGVY,1,0.0
antirejection,1,0.0
regiment,1,0.0
mmoldL,1,0.0
nonhemostatic,1,0.0
nonnucleated,1,0.0
B1369,1,0.0
cariesincidence,1,0.0
Sulfurated,1,0.0
immunodot,1,0.0
Antiasthma,1,0.0
anticonoulsive,1,0.0
one-flow,1,0.0
magnesiumconcentration,1,0.0
Intrahost,1,0.0
calcium-concentrations,1,0.0
neuralsystem,1,0.0
ballistocardiography,1,0.0
cardiologically,1,0.0
tenuously,1,0.0
safety-tested,1,0.0
Inventory-2,1,0.0
visual-left,1,0.0
CACNA1A,1,0.0
Case-,1,0.0
student-focused,1,0.0
NaK-ATPse,1,0.0
virusSince,1,0.0
Adh-T,1,0.0
STAXI-2,1,0.0
HWs-related,1,0.0
irradiations,1,0.0
Plant-based,1,0.0
auto-inflammatory,1,0.0
75-108,1,0.0
microevolution,1,0.0
pan-IgG,1,0.0
75-20,1,0.0
Q493K,1,0.0
August-November,1,0.0
pharmaca,1,0.0
comparision,1,0.0
0016-0283,1,0.0
un-bias,1,0.0
aryepiglottic,1,0.0
EKGs,1,0.0
uninfluenced,1,0.0
metaproterenol,1,0.0
VIA,1,0.0
south-eastern,1,0.0
symptomssevere,1,0.0
InterventionPrevention,1,0.0
issuesdilemma,1,0.0
Oncologic,1,0.0
foxes,1,0.0
SAMBA-II,1,0.0
Vulpes,1,0.0
re-flux,1,0.0
Over-all,1,0.0
vulpes,1,0.0
personalising,1,0.0
065-087,1,0.0
health-in,1,0.0
subcategory-mobile,1,0.0
venoms,1,0.0
ballistocardiographic,1,0.0
NIH-guided,1,0.0
20198983988,1,0.0
Winston-Salem,1,0.0
Clinico-physiological,1,0.0
beta-2-stimulants,1,0.0
balneotherapy,1,0.0
occure,1,0.0
HTRR-induced,1,0.0
°C20,1,0.0
sometines,1,0.0
STmm,1,0.0
allergenicimmunogenic,1,0.0
AH1N109-10,1,0.0
post-nasal,1,0.0
Scrupulous,1,0.0
auxiliaries,1,0.0
Precodial,1,0.0
continuediscontinue,1,0.0
Cyclone,1,0.0
7277,1,0.0
anti-IgG,1,0.0
199293,1,0.0
Kgm2,1,0.0
A135T,1,0.0
S138AH3,1,0.0
Self-protective,1,0.0
case-mortality,1,0.0
Downstream,1,0.0
M1N30D,1,0.0
T215A,1,0.0
NS1P42S,1,0.0
EHOs,1,0.0
PB2E627K,1,0.0
AH567910,1,0.0
Physics,1,0.0
104-183,1,0.0
AH13,1,0.0
decreed,1,0.0
housemate,1,0.0
housemates,1,0.0
dehydrogenase-1,1,0.0
AH10N4,1,0.0
seasonal-flu-like,1,0.0
coalesced,1,0.0
49431,1,0.0
Multi-site,1,0.0
cross-correlations,1,0.0
010-091,1,0.0
020-076,1,0.0
In-vitro,1,0.0
scalescore,1,0.0
mid-level,1,0.0
hV4,1,0.0
23575,1,0.0
Severity-Based,1,0.0
pAbs,1,0.0
FEV1PEF,1,0.0
fmole,1,0.0
Instruction,1,0.0
clustering-based,1,0.0
agitate,1,0.0
Algorithm,1,0.0
poultry-to-person,1,0.0
11411,1,0.0
mission-oriented,1,0.0
Calculating,1,0.0
n467,1,0.0
indrawing,1,0.0
asthama,1,0.0
neurotic-functional,1,0.0
Höck,1,0.0
FEV₁FVC,1,0.0
rehabilitands,1,0.0
eosinphil,1,0.0
textCommunicated,1,0.0
n477,1,0.0
neuroadaptation,1,0.0
infrastructuresAimTo,1,0.0
ligandsS-protein,1,0.0
ICTRP,1,0.0
IntroductionAs,1,0.0
Epstein,1,0.0
Joshua,1,0.0
best-scored,1,0.0
scale--all,1,0.0
equivocation,1,0.0
Theorem,1,0.0
114-201,1,0.0
user-configurable,1,0.0
101-165,1,0.0
web-accessible,1,0.0
hACE2-transduced,1,0.0
binary-base,1,0.0
Euphoria,1,0.0
Redundancy,1,0.0
T-RBD,1,0.0
microgramsday15,1,0.0
Synchrodyn,1,0.0
StatesMethodsWe,1,0.0
ferritin-formed,1,0.0
installation-specific,1,0.0
propylthiouracil,1,0.0
Noisy,1,0.0
65-577DiscussionWorldwide,1,0.0
military-specific,1,0.0
socio-,1,0.0
themResultsOf,1,0.0
pharmacoinformatics,1,0.0
samplesensor,1,0.0
recently-developed,1,0.0
ofwhich,1,0.0
1gL,1,0.0
pneumotachographically,1,0.0
ventrial,1,0.0
Ambroxol,1,0.0
feed-back,1,0.0
14090mmHg,1,0.0
keratoconjunctvitis,1,0.0
tachycarrhythmias,1,0.0
Predict,1,0.0
ventriculo-aortic,1,0.0
cisplatin-based,1,0.0
519467,1,0.0
pseudo-resistance,1,0.0
four-time,1,0.0
78000-385000,1,0.0
10818005,1,0.0
pump-dependence,1,0.0
944-100,1,0.0
T-type,1,0.0
strokeAIShas,1,0.0
Na-nitroprusside,1,0.0
00042,1,0.0
underutilisation,1,0.0
hypertension-associated,1,0.0
acephalgic,1,0.0
diltiazem-related,1,0.0
atopical,1,0.0
282-236,1,0.0
34-3153,1,0.0
radiation-induced,1,0.0
rho0303,1,0.0
18-3,1,0.0
≈70,1,0.0
ethosuximide,1,0.0
p0298,1,0.0
voltage-activated,1,0.0
p099,1,0.0
Non-VKA,1,0.0
21-77,1,0.0
Accomplishing,1,0.0
phentolamine,1,0.0
Vasodilators,1,0.0
009-077,1,0.0
Minnesotas,1,0.0
50hm²,1,0.0
Mineralocorticoid,1,0.0
noncomplementary,1,0.0
blur,1,0.0
4534,1,0.0
5521,1,0.0
virusIt,1,0.0
co-creation,1,0.0
ATex77,1,0.0
Bcl-2Bax,1,0.0
AVic75,1,0.0
radio-immunoprecipitation,1,0.0
yearsAn,1,0.0
transformational,1,0.0
2303,1,0.0
yearsCharacterization,1,0.0
2617,1,0.0
fixed-effect,1,0.0
V7-AAD,1,0.0
Anti-hypertension,1,0.0
Angew,1,0.0
1minm2,1,0.0
h-occlusions,1,0.0
3-30,1,0.0
Mirroring,1,0.0
Mech,1,0.0
smallness,1,0.0
Alcohol-based,1,0.0
h-coronary,1,0.0
multi-compartment,1,0.0
under-representative,1,0.0
susceptive-infective-removal,1,0.0
Causation,1,0.0
Level-2,1,0.0
non-propagative,1,0.0
lipid-lowing,1,0.0
pentacetic,1,0.0
diethylenetriamine,1,0.0
technetium-labeled,1,0.0
Dysmenorrhea,1,0.0
heterogenicity,1,0.0
9091,1,0.0
Fighter,1,0.0
ClusterONE,1,0.0
affyPLM,1,0.0
hypodiagnosis,1,0.0
gastralgic,1,0.0
immuno-chromatography,1,0.0
friendlier,1,0.0
005-irreversible,1,0.0
dysfunction-partially,1,0.0
plugin,1,0.0
kids,1,0.0
testingself-isolation,1,0.0
dysfunction-completely,1,0.0
Subtype,1,0.0
ANXA1,1,0.0
experimented,1,0.0
AQP2,1,0.0
1978-1988,1,0.0
tick-borne,1,0.0
acyl-coenzyme,1,0.0
Bs,1,0.0
Ominibus,1,0.0
17110,1,0.0
strains-a,1,0.0
electron-dense,1,0.0
micrographs,1,0.0
569-781,1,0.0
intra-university,1,0.0
ICD-10I62,1,0.0
Loneliness,1,0.0
I65-I68,1,0.0
microscopists,1,0.0
Openness,1,0.0
GSE1957,1,0.0
Behaviours,1,0.0
20132014-20162017,1,0.0
httpscovid19whoint,1,0.0
252000045,1,0.0
httpswwwcdcgovcoronavirus2019-ncovdownloadsrt-pcr-panel-primer-probespdf,1,0.0
amenorrhoea,1,0.0
Worry,1,0.0
Term-time,1,0.0
SBIs,1,0.0
53-73,1,0.0
500-721,1,0.0
re-presentation,1,0.0
Smaller-sized,1,0.0
group-oriented,1,0.0
SARS-CoV2-originated,1,0.0
midaged,1,0.0
life-space,1,0.0
β‑CoVs,1,0.0
GUSS,1,0.0
Souro-Sanou,1,0.0
predivisional,1,0.0
well-know,1,0.0
cash,1,0.0
them--for,1,0.0
Desite,1,0.0
SARS‑CoV‑2‑causing,1,0.0
807-812,1,0.0
200-fold,1,0.0
post-TIAminor,1,0.0
16120,1,0.0
Virus2,1,0.0
AVANT,1,0.0
designee,1,0.0
RS-viruses,1,0.0
handoff,1,0.0
Waitlist,1,0.0
375-416,1,0.0
inactivations,1,0.0
normolipidemic,1,0.0
hyperlipedemic,1,0.0
DEG,1,0.0
hypertriglyceridemic,1,0.0
109-146,1,0.0
systemize,1,0.0
annual-update,1,0.0
AFukuokac798,1,0.0
fpund,1,0.0
coronavirus-Severe,1,0.0
Syndrome-Corona,1,0.0
Ulan-Ude,1,0.0
CHMP,1,0.0
ABern0795,1,0.0
582-715,1,0.0
COVID-risk,1,0.0
Roslagstull,1,0.0
athero-occlusive,1,0.0
netted,1,0.0
≤33,1,0.0
043-071,1,0.0
nationalglobal,1,0.0
swab-to-result,1,0.0
CHS-SCORE,1,0.0
n103,1,0.0
influenza-APort,1,0.0
ISPE,1,0.0
ASp,1,0.0
Pharmacoepidemiology,1,0.0
clinicalvirological,1,0.0
n212,1,0.0
respirology,1,0.0
immune-regulation,1,0.0
hogh-density,1,0.0
host-interactions,1,0.0
well-knownA,1,0.0
ASe,1,0.0
Laurentian,1,0.0
1794,1,0.0
ducklings,1,0.0
granulocytosis,1,0.0
GRY,1,0.0
n250,1,0.0
equilibrated,1,0.0
solvate,1,0.0
Encephalitisencephalopathy,1,0.0
Passerine,1,0.0
eosinophil-targeted,1,0.0
immunopotentiation,1,0.0
behavior-specific,1,0.0
today-the,1,0.0
caecum,1,0.0
nLBBB,1,0.0
gizzard,1,0.0
oLBBB,1,0.0
1-minute,1,0.0
vertigodizziness,1,0.0
that-without,1,0.0
Skin-to-skin,1,0.0
stealthy,1,0.0
536-672,1,0.0
variablesThe,1,0.0
post-reperfused,1,0.0
1B,1,0.0
HLD-C,1,0.0
2-79,1,0.0
proceduresother,1,0.0
ICD-10I60-I61,1,0.0
112-171,1,0.0
I63-I64,1,0.0
Calfornia,1,0.0
8132,1,0.0
271-402,1,0.0
210-415,1,0.0
272-442,1,0.0
Ptrend054,1,0.0
cross-sections,1,0.0
17233,1,0.0
enterocyte-expressed,1,0.0
49392,1,0.0
3011,1,0.0
Score≥5,1,0.0
isolette,1,0.0
RECORD,1,0.0
92-129,1,0.0
NRP,1,0.0
28357,1,0.0
Posttraumatic,1,0.0
23-39,1,0.0
2-year-increase,1,0.0
31419,1,0.0
159-323,1,0.0
allergen-antibody,1,0.0
Bloody,1,0.0
decomposing,1,0.0
talkingreading,1,0.0
CoQ10-treated,1,0.0
post-thrombolysed,1,0.0
proceduresconditions,1,0.0
3574,1,0.0
MACEsPatients,1,0.0
MalondialdehydeMDA,1,0.0
annotator,1,0.0
uResNet,1,0.0
enzyme-related,1,0.0
3988,1,0.0
hemmaglutination,1,0.0
bilingualism,1,0.0
Gene-based,1,0.0
tissuehost,1,0.0
usedABSTRACT,1,0.0
angioscintigraphy,1,0.0
real-time-reverse,1,0.0
fifth-day,1,0.0
1773086,1,0.0
111652,1,0.0
Saikosaponin,1,0.0
oleanane,1,0.0
antinephritis,1,0.0
aggregate-level,1,0.0
2018-1,1,0.0
Share,1,0.0
Prefusion,1,0.0
6VSB,1,0.0
7971,1,0.0
Low-grade,1,0.0
Saint-Etienne,1,0.0
Bilingualism,1,0.0
PROSPER,1,0.0
pheno-,1,0.0
Recognized,1,0.0
multi-morbidity,1,0.0
9998,1,0.0
Crossreactivity,1,0.0
beta-1,1,0.0
notatum,1,0.0
Methergin,1,0.0
ASCOT-LLA,1,0.0
Distancing,1,0.0
ACT-A,1,0.0
≥2-3,1,0.0
STDL,1,0.0
vs10,1,0.0
54-year,1,0.0
Kaletra,1,0.0
AbbVie,1,0.0
Accelerator,1,0.0
non-randomness,1,0.0
fourth-day,1,0.0
HBLB,1,0.0
22407,1,0.0
immunization--such,1,0.0
458-467,1,0.0
healthy-young-adults-first,1,0.0
16112,1,0.0
unfavourably,1,0.0
not-young,1,0.0
insulae,1,0.0
geniculate,1,0.0
inspi-,1,0.0
high--as,1,0.0
3614,1,0.0
31122018,1,0.0
01012017,1,0.0
6878,1,0.0
configuring,1,0.0
meningoencephalomyelitis,1,0.0
mixes-which,1,0.0
59083,1,0.0
1973-76,1,0.0
1957-62,1,0.0
CECT,1,0.0
PDs,1,0.0
148-50,1,0.0
4089,1,0.0
breathhold,1,0.0
15-T,1,0.0
GEEs,1,0.0
juvenilesadult,1,0.0
BAMSE,1,0.0
AQLQ12,1,0.0
Hunting,1,0.0
weighted-average,1,0.0
60-100,1,0.0
HaeIII,1,0.0
per-infection,1,0.0
BclI,1,0.0
86-92,1,0.0
Benefit-cost,1,0.0
0845,1,0.0
0301,1,0.0
3619,1,0.0
14210,1,0.0
productivityactivity,1,0.0
pre-mRNAs,1,0.0
Charite-E,1,0.0
mid-Atlantic,1,0.0
S1-101,1,0.0
601-612,1,0.0
Pasteur-RdRp-IP4,1,0.0
S1-105,1,0.0
625-636,1,0.0
Pasteur-RdRp-IP2,1,0.0
liquid-frozen,1,0.0
second-level,1,0.0
biocide,1,0.0
polyadenylation-site,1,0.0
TUBITAK,1,0.0
circumstantiated,1,0.0
OES,1,0.0
160-300,1,0.0
VSG,1,0.0
B-vitamins,1,0.0
Charite-RdRp,1,0.0
7534,1,0.0
pre-effort,1,0.0
S1-93,1,0.0
disease-Coronavirus,1,0.0
44-46,1,0.0
15-70,1,0.0
triangle,1,0.0
12-mer,1,0.0
Kong-N,1,0.0
937-969,1,0.0
948-980,1,0.0
553-564,1,0.0
577-588,1,0.0
Kong-ORF1b,1,0.0
ObjectiveTo,1,0.0
S1-97,1,0.0
CDC-N,1,0.0
CDC-ORF1ab,1,0.0
CDC-N2,1,0.0
acid-confirmed,1,0.0
CDC-N1,1,0.0
Substitution,1,0.0
micro-catheterisation,1,0.0
Form-12,1,0.0
2853,1,0.0
Predilection,1,0.0
1001836,1,0.0
20196,1,0.0
170±042,1,0.0
IUATLD,1,0.0
486±396,1,0.0
uHealth,1,0.0
36726,1,0.0
allergoses,1,0.0
107-325,1,0.0
621±101,1,0.0
multi-array,1,0.0
immuno-assay,1,0.0
M1-protein,1,0.0
Wellness,1,0.0
ImmunoCAP,1,0.0
QualityMetric,1,0.0
DataBase,1,0.0
Hawaiianother,1,0.0
NCI-H292,1,0.0
B-vitamin,1,0.0
Synchrotron-Fourier,1,0.0
on-duty,1,0.0
r083,1,0.0
“Severe,1,0.0
Hierarchy,1,0.0
mechanism1,1,0.0
infection2,1,0.0
leukocytoclastic,1,0.0
1-October,1,0.0
Synchrotron,1,0.0
AUdorn72H3N2,1,0.0
microspectroscopy,1,0.0
anomalously,1,0.0
packer,1,0.0
virus-stimulated,1,0.0
-treated,1,0.0
sausages,1,0.0
IndianAlaskan,1,0.0
P099,1,0.0
well-are,1,0.0
M-MLV,1,0.0
up-samples,1,0.0
0885,1,0.0
February2019,1,0.0
symptomresponse,1,0.0
enterica,1,0.0
Libraryand,1,0.0
Typhimurium,1,0.0
monochlorine-containing,1,0.0
CNKICBMVIPWanfangPubMedEmbaseCochrane,1,0.0
guts,1,0.0
Meditation,1,0.0
Nonlacunar,1,0.0
Blinded,1,0.0
29-48,1,0.0
triethnic,1,0.0
popularizing,1,0.0
regrets,1,0.0
perfluorinated,1,0.0
ninety-six,1,0.0
Bare-metal,1,0.0
V2-V5,1,0.0
nondependent,1,0.0
CHDM-programme,1,0.0
dextran,1,0.0
RR09995CI088-111,1,0.0
mmHgp,1,0.0
297p,1,0.0
IFN-r,1,0.0
per-swab,1,0.0
TNFs,1,0.0
sampling-,1,0.0
AShenzhen12011,1,0.0
Arg,1,0.0
CHDM,1,0.0
short-chain,1,0.0
1974-1993,1,0.0
burden-guided,1,0.0
RR09595CI082-111,1,0.0
P6,1,0.0
48005,1,0.0
RP8I,1,0.0
fermentative,1,0.0
microbiota-derived,1,0.0
drug-influenza,1,0.0
very-late-onset,1,0.0
Plugging,1,0.0
093-253,1,0.0
infectionexacerbation,1,0.0
moderate-to-good,1,0.0
ECFP,1,0.0
Shopes,1,0.0
0095,1,0.0
virus-not,1,0.0
cyan-fluorescent,1,0.0
Glia,1,0.0
believed-caused,1,0.0
fuiction,1,0.0
non-target,1,0.0
occlusion-model,1,0.0
2P-LSM,1,0.0
laser-scanning,1,0.0
retro-cardiac,1,0.0
Martes,1,0.0
13·5,1,0.0
Biased,1,0.0
red-fluorescent,1,0.0
101-286,1,0.0
interactomic,1,0.0
microstrokes,1,0.0
VLS,1,0.0
excitation-contraction,1,0.0
AIPMI,1,0.0
dysfunctionRVD,1,0.0
PAN-associated,1,0.0
Kusmauls,1,0.0
captation,1,0.0
balneologists,1,0.0
30-month,1,0.0
extremis,1,0.0
86Rb,1,0.0
lowlanders,1,0.0
nonemergent,1,0.0
multicolor,1,0.0
semiurgent,1,0.0
microCT,1,0.0
tdtomato,1,0.0
rodenticide,1,0.0
penicillins,1,0.0
00145,1,0.0
Howevermore,1,0.0
entrains,1,0.0
EsperanzaHope,1,0.0
poststreptokinase,1,0.0
waveform-based,1,0.0
annotatable,1,0.0
walk-up,1,0.0
Telecardiology,1,0.0
respirable-sized,1,0.0
AM-PAC,1,0.0
downdrafts,1,0.0
coronaroangiography,1,0.0
DIGE,1,0.0
ICU-acquired,1,0.0
COVID-19Furthermore,1,0.0
formalisation,1,0.0
COVID-19-asssociated,1,0.0
near-,1,0.0
dissertates,1,0.0
Dakota,1,0.0
RIDOH,1,0.0
asthma-management-education,1,0.0
willingness-to-travel,1,0.0
374042,1,0.0
vitro-transcribed,1,0.0
Decrements,1,0.0
20983,1,0.0
29571,1,0.0
multi-city,1,0.0
stabled,1,0.0
COPDHRCT,1,0.0
five-minute,1,0.0
Paw,1,0.0
Hoak,1,0.0
4020,1,0.0
Ig6,1,0.0
ACOSHRCT,1,0.0
ecohcardiogram,1,0.0
KFHU,1,0.0
diseaseimage,1,0.0
interpolative,1,0.0
pandemic-virus,1,0.0
nanoHPLC-nanoESI-MSMS,1,0.0
EHRA,1,0.0
160minp,1,0.0
HIA-,1,0.0
benzocycloheptathiophene,1,0.0
bd,1,0.0
sensationalism,1,0.0
sky,1,0.0
3244,1,0.0
literatureprobiotic,1,0.0
Moreoverfurther,1,0.0
EIA-,1,0.0
testMTST,1,0.0
thhe,1,0.0
trainingEx,1,0.0
45-208,1,0.0
trainingC,1,0.0
rateHR,1,0.0
pressureSBP,1,0.0
SBP10-2,1,0.0
15618,1,0.0
idiosyncrasyintolerance,1,0.0
Correspondence,1,0.0
deck,1,0.0
rhamnosus,1,0.0
parking,1,0.0
-17-fold,1,0.0
PIPs,1,0.0
PHUs,1,0.0
DACs,1,0.0
keratins,1,0.0
Hyperviscosity,1,0.0
macroglobulinemia,1,0.0
Nonsurviving,1,0.0
Waldenströms,1,0.0
inventoried,1,0.0
filing,1,0.0
Washout,1,0.0
garage,1,0.0
patientsalthough,1,0.0
Howeverit,1,0.0
immunoglobulinemia,1,0.0
not-too-distant,1,0.0
Puy-de-Dôme,1,0.0
31-289,1,0.0
holed,1,0.0
95-868,1,0.0
PVDF,1,0.0
non-safety,1,0.0
260-450ngL,1,0.0
non-bothersome,1,0.0
Yodo,1,0.0
asthmaPrevious,1,0.0
waivered,1,0.0
multi-sample,1,0.0
1841,1,0.0
ReDuNing,1,0.0
staffers,1,0.0
Apraxia,1,0.0
diplomats,1,0.0
S1-binding,1,0.0
internity,1,0.0
CKD-EPI,1,0.0
n379,1,0.0
combatant,1,0.0
paedagogical,1,0.0
multi-constituent,1,0.0
takenThe,1,0.0
1500-2600ngL,1,0.0
refluxes,1,0.0
088-097,1,0.0
pattern-detected,1,0.0
105-127,1,0.0
141-356,1,0.0
3938,1,0.0
Noting,1,0.0
myofibrotic,1,0.0
myoelastic,1,0.0
3598,1,0.0
22142,1,0.0
40-70ngL,1,0.0
rightleft-sided,1,0.0
170-1298,1,0.0
self-injurious,1,0.0
bio-behavioral,1,0.0
self-planning,1,0.0
19-59,1,0.0
refluxeshour,1,0.0
143-462,1,0.0
multi-effect,1,0.0
systems-pharmacology,1,0.0
n425,1,0.0
aureus-induced,1,0.0
triages,1,0.0
1503,1,0.0
NILT-treated,1,0.0
2089,1,0.0
lissencephalic,1,0.0
sham-treated,1,0.0
1551,1,0.0
womenABSTRACT,1,0.0
Suitably,1,0.0
zafirlucast,1,0.0
Nacetylcysteine,1,0.0
Embolization,1,0.0
syndromerelated,1,0.0
acidemia,1,0.0
glutaric,1,0.0
aciduria,1,0.0
SVIN,1,0.0
pre-ED,1,0.0
CHADS₂,1,0.0
luciferin-luciferase,1,0.0
fried,1,0.0
tolow,1,0.0
161-419,1,0.0
miltiorrhizae,1,0.0
MDRD,1,0.0
biloba,1,0.0
9224,1,0.0
germanium,1,0.0
140-15080-85,1,0.0
C-G,1,0.0
Cockcroft-Gault,1,0.0
Orpington,1,0.0
infections10000,1,0.0
16-July,1,0.0
Toreport,1,0.0
luckily,1,0.0
CVDstrokes,1,0.0
Ryan,1,0.0
strategic-infarct,1,0.0
44225,1,0.0
005-0001,1,0.0
CaF2,1,0.0
Rainfall,1,0.0
aortoarteritis,1,0.0
318--with,1,0.0
Stock,1,0.0
112-169,1,0.0
2547-53,1,0.0
Plenty,1,0.0
105micromolL,1,0.0
or153micromolL,1,0.0
ARDSTo,1,0.0
H7N9-associated,1,0.0
439--is,1,0.0
aneurysectomy,1,0.0
39242,1,0.0
retraining--the,1,0.0
McGowan,1,0.0
2021-2022,1,0.0
Jill,1,0.0
2-GPIaCL,1,0.0
2-IgG-glycoprotein,1,0.0
VRDLs,1,0.0
243--with,1,0.0
Actinobacteria,1,0.0
influenzae-infection,1,0.0
practitioner-prescribed,1,0.0
MR-guided,1,0.0
15-F2t-isoprostane,1,0.0
andrapid,1,0.0
accompaniedby,1,0.0
sympathicotonia,1,0.0
IWT,1,0.0
Kharkov,1,0.0
Kleinschmidts,1,0.0
117-986,1,0.0
100-132,1,0.0
121-335,1,0.0
101-218,1,0.0
BCC,1,0.0
B-infection-syndrome,1,0.0
KardyLab,1,0.0
5-micromolL,1,0.0
102-277,1,0.0
code-to-imaging,1,0.0
Saccharibacteria,1,0.0
glycosaminoglycans-like,1,0.0
5179,1,0.0
0734,1,0.0
00294,1,0.0
Residency,1,0.0
2529,1,0.0
00417,1,0.0
LOOCV,1,0.0
newly-replaced,1,0.0
Leave-one-out-cross-validation,1,0.0
trans-anal,1,0.0
Positivenegative,1,0.0
trans-oral,1,0.0
based-linear-discriminant,1,0.0
Principal-component,1,0.0
Principal-component-analysis,1,0.0
nonvolatile,1,0.0
30821-830,1,0.0
p-stroke,1,0.0
2017Wiley,1,0.0
calibrators,1,0.0
00209,1,0.0
CF-related,1,0.0
Sentinella,1,0.0
462801,1,0.0
20839,1,0.0
104microL,1,0.0
10098,1,0.0
Milder,1,0.0
JACC,1,0.0
behaviorA,1,0.0
Grs,1,0.0
scoreThis,1,0.0
cell-related,1,0.0
0671,1,0.0
3251436,1,0.0
ascertainability,1,0.0
3842,1,0.0
304599,1,0.0
pro-injury,1,0.0
pro-recovery,1,0.0
100993,1,0.0
httpswwwbiomedcentralcomcollectionsannualupdate2021,1,0.0
httpslinkspringercombookseries8901,1,0.0
AANSCNS,1,0.0
nano-differential,1,0.0
PPEylated,1,0.0
fluorometry,1,0.0
hypoperfusionmedian,1,0.0
56-117,1,0.0
12-28,1,0.0
derivaties,1,0.0
PMIS,1,0.0
Fluorescent-antibody,1,0.0
UV-vis,1,0.0
pyrimidone,1,0.0
protein-polymer,1,0.0
PEGylated,1,0.0
0-375,1,0.0
neural-tubal,1,0.0
1972--76,1,0.0
06-28,1,0.0
non-DCR,1,0.0
13-27,1,0.0
corrector,1,0.0
Ekmans,1,0.0
20-83,1,0.0
adenylate,1,0.0
9-19,1,0.0
AchickenVietnamC5804,1,0.0
AquailVietnam3604,1,0.0
Aswine,1,0.0
postendovascular,1,0.0
HswN1,1,0.0
supernates,1,0.0
Clinic74,1,0.0
non-rehabilitated,1,0.0
mTICI2a,1,0.0
british,1,0.0
flowcerebral,1,0.0
SwissADME,1,0.0
no-DCR,1,0.0
odorant,1,0.0
odorant-driven,1,0.0
34dihydropyrimidone,1,0.0
hospital-,1,0.0
09-33,1,0.0
16-78,1,0.0
diarrhea-related,1,0.0
2017-2036,1,0.0
initialization,1,0.0
1997-2016,1,0.0
Level-3,1,0.0
Rotorua,1,0.0
05-17-year-old,1,0.0
32778-782,1,0.0
7-23,1,0.0
COVID-19-which,1,0.0
218-1732,1,0.0
Inactivating,1,0.0
63-505,1,0.0
204-1961,1,0.0
34th,1,0.0
29-282,1,0.0
batch-related,1,0.0
2169,1,0.0
vinylidene,1,0.0
4746,1,0.0
cartilages,1,0.0
drug-treatment,1,0.0
21-42,1,0.0
≈13,1,0.0
nondilatable,1,0.0
peritracheal,1,0.0
Marketing,1,0.0
Neovascularization,1,0.0
18-69,1,0.0
marketable,1,0.0
Polyphosphoesters,1,0.0
Effector,1,0.0
bidding,1,0.0
cava-right,1,0.0
1981-1987,1,0.0
nooks,1,0.0
lymphangiogenic,1,0.0
hostel,1,0.0
dobutamine-atropine,1,0.0
biogerontological,1,0.0
4Flu,1,0.0
immunoprophylactic,1,0.0
Glucose-insulin-potassium,1,0.0
Althaus,1,0.0
tax,1,0.0
sleep-specific,1,0.0
upsets,1,0.0
rosa,1,0.0
Chao-Yang,1,0.0
reperfusion--called,1,0.0
Valleu,1,0.0
15-53,1,0.0
acumen,1,0.0
ValLeu,1,0.0
working-contact,1,0.0
000036,1,0.0
2012964,1,0.0
056-183,1,0.0
000031-00044,1,0.0
swans,1,0.0
Sacace,1,0.0
-polymerase,1,0.0
Trade-Related,1,0.0
Property,1,0.0
pellagra,1,0.0
Famous,1,0.0
notForty-five,1,0.0
dogmatism,1,0.0
Congenitally,1,0.0
SurgeonsCerebrovascular,1,0.0
AAN,1,0.0
SNIS,1,0.0
Illustration,1,0.0
p00032,1,0.0
foot-and-mouth,1,0.0
Sydenhams,1,0.0
genealogy,1,0.0
Principado,1,0.0
Galenism,1,0.0
Gaspar,1,0.0
Casal,1,0.0
stressdepression,1,0.0
Gerona,1,0.0
000096,1,0.0
Historia,1,0.0
000078-00012,1,0.0
Rights,1,0.0
112-30,1,0.0
51-labeled,1,0.0
cross-task,1,0.0
egalitarianism,1,0.0
vaccinestechnology,1,0.0
postured,1,0.0
task-aware,1,0.0
1SSK,1,0.0
strategizes,1,0.0
accessibilityaffordability,1,0.0
rejectedresisted,1,0.0
56079,1,0.0
vastity,1,0.0
Concentric,1,0.0
Pain-causing,1,0.0
Elutable,1,0.0
CPSP-associated,1,0.0
top-hits,1,0.0
Ares,1,0.0
QikProp,1,0.0
ethylenediaminetetraacetatic,1,0.0
ribonucleoprotien,1,0.0
technecium-99m-labeled,1,0.0
recenalization,1,0.0
00084,1,0.0
EGYPT,1,0.0
transmigration,1,0.0
enforcements,1,0.0
000091-00020,1,0.0
copyrights,1,0.0
trademarks,1,0.0
network-level,1,0.0
pain-alleviating,1,0.0
Gp,1,0.0
burn-injured,1,0.0
00028-0016,1,0.0
vaccinesmedicinestechnology,1,0.0
enoximone,1,0.0
29-82,1,0.0
thioflavin,1,0.0
anteriormiddle,1,0.0
developingleast,1,0.0
waive,1,0.0
waist-to-height,1,0.0
Right-hand,1,0.0
non-COVID-19-designated,1,0.0
Ugyanakkor,1,0.0
citrox,1,0.0
Łódź,1,0.0
proteostasis,1,0.0
achondroplasia,1,0.0
sheathless,1,0.0
Heat-Inactivation,1,0.0
PC20L,1,0.0
receptor-protein,1,0.0
reguirement,1,0.0
β-cyclodextrin,1,0.0
Stretching,1,0.0
GINAs,1,0.0
PUFFIN,1,0.0
medicine-guided,1,0.0
genotype-stratified,1,0.0
difficult-,1,0.0
-to-treat,1,0.0
all-approach,1,0.0
n254,1,0.0
SD18,1,0.0
thrombombolism,1,0.0
SD9,1,0.0
SD14,1,0.0
SD12,1,0.0
pilgrim,1,0.0
atheroscleroticintrinsic,1,0.0
bioflavonoids,1,0.0
lax,1,0.0
post-myocardyal,1,0.0
Skills-Third,1,0.0
MM-AMM-B,1,0.0
intravascularly,1,0.0
non-teaching,1,0.0
3397,1,0.0
stereocardia,1,0.0
signficant,1,0.0
di-sodium,1,0.0
percutan,1,0.0
Kielce,1,0.0
Dept,1,0.0
68287,1,0.0
Phytosanitary,1,0.0
557033,1,0.0
4084,1,0.0
value-at-risk,1,0.0
measure-general,1,0.0
1578494,1,0.0
surveillance-was,1,0.0
0808,1,0.0
all-regions,1,0.0
intra-bloc,1,0.0
extra-bloc,1,0.0
CDCM,1,0.0
hypothalamus-pituitary,1,0.0
time-honored,1,0.0
Maritime,1,0.0
IRI-based,1,0.0
3946,1,0.0
hyperhomocysteinaemia,1,0.0
4247,1,0.0
4447,1,0.0
focus-forming,1,0.0
4148,1,0.0
15-question,1,0.0
gammaherpes,1,0.0
-0261,1,0.0
contact-less,1,0.0
IRIs,1,0.0
Amount,1,0.0
497-524,1,0.0
mortalitását,1,0.0
társbetegségek,1,0.0
közöttük,1,0.0
ACE2-spike,1,0.0
növelik,1,0.0
Immunszuppresszív,1,0.0
felmerülhet,1,0.0
citotoxikus,1,0.0
kezelések,1,0.0
rizikónövelő,1,0.0
hatása,1,0.0
2233-619,1,0.0
electro,1,0.0
Exam,1,0.0
SCA-specific,1,0.0
Mohakhali,1,0.0
157969,1,0.0
Breslau,1,0.0
82506,1,0.0
Rosow,1,0.0
148914,1,0.0
145895,1,0.0
South-West,1,0.0
3777,1,0.0
Pharmacokinetic,1,0.0
SCA-associated,1,0.0
non-complying,1,0.0
7602,1,0.0
5441,1,0.0
super-predominant,1,0.0
15-times,1,0.0
RAPH,1,0.0
Banská,1,0.0
Bystrica,1,0.0
transfections,1,0.0
Gag-pol,1,0.0
SHAM,1,0.0
infarctus,1,0.0
7268,1,0.0
Perceptual,1,0.0
2010-2020,1,0.0
11-5,1,0.0
screening-examinations,1,0.0
CHIP-AE,1,0.0
oppositional,1,0.0
misrecognition,1,0.0
newsletters,1,0.0
Necroscopy,1,0.0
divisable,1,0.0
anarchy,1,0.0
RT-PCRPCR,1,0.0
IPE,1,0.0
penumbra-which,1,0.0
Cross-reactions,1,0.0
risk-the,1,0.0
1657-41440,1,0.0
Assemble,1,0.0
testsCommunicated,1,0.0
designingdevelopment,1,0.0
Ester,1,0.0
Phenethyl,1,0.0
cleanness,1,0.0
PREP,1,0.0
nine-question,1,0.0
unseasonal,1,0.0
withanolides,1,0.0
775000,1,0.0
needsThere,1,0.0
droplet-digital,1,0.0
well-replicating,1,0.0
calamitous,1,0.0
demoted,1,0.0
stoichiometry,1,0.0
sacubitrilvalsartan,1,0.0
Nonwhites,1,0.0
chemsex,1,0.0
NZACE2-Pātari,1,0.0
Intra-host,1,0.0
stalemate,1,0.0
chemo-resistance,1,0.0
HSP5A,1,0.0
GRP78,1,0.0
Bip,1,0.0
LumiraDx-results,1,0.0
cardioarticular,1,0.0
signaling-pathways,1,0.0
host-factors,1,0.0
mediocalcosis,1,0.0
population-76210007,1,0.0
NR2,1,0.0
factorshealthy,1,0.0
influenzaIn,1,0.0
precautious,1,0.0
mini-epidemics,1,0.0
82-89,1,0.0
Withanone,1,0.0
culture-adapted,1,0.0
1138,1,0.0
glimmers,1,0.0
IECAs,1,0.0
prognosisWe,1,0.0
ST-elevation-myocardial,1,0.0
sonomicrometers,1,0.0
nonpotentiated,1,0.0
Hobbesian,1,0.0
strangeness,1,0.0
wields,1,0.0
superhuman,1,0.0
mendacious,1,0.0
Multimedication,1,0.0
gloom,1,0.0
Asthma-E3N,1,0.0
gamma-Proteobacteria,1,0.0
urbansub,1,0.0
2777,1,0.0
ECIL-4,1,0.0
ECIL-4s,1,0.0
nucleocapid,1,0.0
771991,1,0.0
10761991,1,0.0
70-389,1,0.0
MM-AMM-C,1,0.0
rivaling,1,0.0
PI3KAKTmTOR,1,0.0
endolysosomal,1,0.0
cold-adaptedattenuated,1,0.0
EXEZ,1,0.0
wreaking,1,0.0
Withaferin-A,1,0.0
Slowing,1,0.0
adjustable-pressure,1,0.0
meningocele,1,0.0
Parry,1,0.0
Jane,1,0.0
phlebotomist,1,0.0
18195,1,0.0
EDSAB-HOME,1,0.0
keyworkers,1,0.0
Paracrine,1,0.0
alkalinizing,1,0.0
54-month,1,0.0
Neovessel,1,0.0
postendarterectomy,1,0.0
Postendarterectomy,1,0.0
self-injectable,1,0.0
Shepherd,1,0.0
immunoallergic,1,0.0
Foucard,1,0.0
dustmites,1,0.0
1-2-3-4,1,0.0
pindolol-treated,1,0.0
serum-antibody,1,0.0
antibody-affinity,1,0.0
cyanosispallor,1,0.0
hooks,1,0.0
lehetőségek,1,0.0
igényeket,1,0.0
K2,1,0.0
fogalmaztak,1,0.0
képalkotó,1,0.0
Orf1,1,0.0
diagnosztikával,1,0.0
10000000,1,0.0
orientate,1,0.0
szemben,1,0.0
morfológiai,1,0.0
elváltozások,1,0.0
artériás,1,0.0
INTEGRITI,1,0.0
kollaterális,1,0.0
rendszer,1,0.0
állapotát,1,0.0
esetekben,1,0.0
agy,1,0.0
szöveti,1,0.0
perfúzióját,1,0.0
meghatározni,1,0.0
Ezeket,1,0.0
komplex,1,0.0
NQWMI,1,0.0
Ezek,1,0.0
diagnosisexclusion,1,0.0
tanulmányai,1,0.0
kezelésének,1,0.0
loco-regionally,1,0.0
Antihormonal,1,0.0
MWU,1,0.0
httpgithubcomrarnaoutCovidswab,1,0.0
translational-research,1,0.0
Viewpoints,1,0.0
debunking,1,0.0
Post-extrasystolic,1,0.0
∼17,1,0.0
∼46,1,0.0
498400,1,0.0
SDxT,1,0.0
multicentrikus,1,0.0
MPDS,1,0.0
lehetőségei,1,0.0
években,1,0.0
scene-may,1,0.0
center-before,1,0.0
megváltoztak,1,0.0
bevezetésre,1,0.0
thrombectomia,1,0.0
időablak,1,0.0
kitágult,1,0.0
2SEM,1,0.0
Rumor,1,0.0
multiresistant,1,0.0
feladatokat,1,0.0
thrombectomiák,1,0.0
megjelenítése,1,0.0
contacts-a,1,0.0
valósult,1,0.0
egységesítette,1,0.0
nt-proBNP,1,0.0
stroke-CT-protokollok,1,0.0
beállításait,1,0.0
beutalási,1,0.0
n-,1,0.0
értékelési,1,0.0
stroke-CT-kiértékelések,1,0.0
emelkedett,1,0.0
academic-public,1,0.0
elmúlt,1,0.0
évben,1,0.0
stroke-hálózat,1,0.0
segítségével,1,0.0
MICA,1,0.0
optimalizálni,1,0.0
RCRI,1,0.0
kívánjuk,1,0.0
régió,1,0.0
stroke-ellátását,1,0.0
egyrészt,1,0.0
egységesítése,1,0.0
paramétereinek,1,0.0
confidence-building,1,0.0
originConclusion,1,0.0
mesterségesintelligencia-algoritmusok,1,0.0
támogathatják,1,0.0
kiértékelést,1,0.0
pár,1,0.0
perc,1,0.0
elvégezve,1,0.0
segítenek,1,0.0
döntés,1,0.0
kialakításában,1,0.0
Dél-,1,0.0
Nyugat-dunántúli,1,0.0
intézmény,1,0.0
non-VOCnon-VOI,1,0.0
2020Results,1,0.0
stroke-CT-kiértékelő,1,0.0
szoftver,1,0.0
factorsMethod,1,0.0
képkommunikáció,1,0.0
integrációja,1,0.0
vizsgálati,1,0.0
protokollok,1,0.0
state-to-state,1,0.0
Island-,1,0.0
technikai,1,0.0
httpprintedswabsorg,1,0.0
antimigratory,1,0.0
Deleterious,1,0.0
kezelését,1,0.0
ciklusa,1,0.0
Hearts™,1,0.0
légúti,1,0.0
Faxon,1,0.0
kapcsán,1,0.0
ambulancián,1,0.0
SARS-CoV-2-fertőzése,1,0.0
SCR,1,0.0
elderlyhigh-risk,1,0.0
Kemoterápiás,1,0.0
householdcommunity,1,0.0
felfüggesztettük,1,0.0
2008-September,1,0.0
diagnózistól,1,0.0
proffers,1,0.0
tünetmentessé,1,0.0
closely-monitored,1,0.0
ám,1,0.0
SARS-CoV-2-PCR-pozitivitása,1,0.0
még,1,0.0
fennállt,1,0.0
kezelést,1,0.0
indítottunk,1,0.0
CTFCs,1,0.0
részesült,1,0.0
appropriate-use,1,0.0
axillaris,1,0.0
ronthatja,1,0.0
terápia,1,0.0
megszakítása,1,0.0
halasztása,1,0.0
29-person,1,0.0
Assurances,1,0.0
agresszívebb,1,0.0
kiterjedtebb,1,0.0
fiatalkorban,1,0.0
jelentkező,1,0.0
daganatok,1,0.0
Reward,1,0.0
kórjóslatot,1,0.0
kemoterápiában,1,0.0
Trustees,1,0.0
nőbeteg,1,0.0
esetét,1,0.0
ismertetjük,1,0.0
késlekedve,1,0.0
felismert,1,0.0
lokoregionálisan,1,0.0
kiterjedt,1,0.0
Hospital-to-Home,1,0.0
emlődaganat,1,0.0
szisztémás,1,0.0
mastectomia,1,0.0
dissectio,1,0.0
tomographics,1,0.0
szorosabb,1,0.0
felszabadító,1,0.0
p0052In,1,0.0
nélkül,1,0.0
koronavírus-fertőzése,1,0.0
protokolltól,1,0.0
eltérés,1,0.0
egyénre,1,0.0
szabott,1,0.0
optimalizálásával,1,0.0
villa,1,0.0
multidiszciplináris,1,0.0
együttműködésével,1,0.0
virológiai,1,0.0
improvementnon-report,1,0.0
kockázat,1,0.0
areaA,1,0.0
együttes,1,0.0
alacsonyan,1,0.0
birth-year,1,0.0
tartása,1,0.0
retrospectivelyThe,1,0.0
megvalósítható,1,0.0
ISAAC-questionnaire,1,0.0
and-or,1,0.0
pozitivitás,1,0.0
elhúzódó,1,0.0
-206,1,0.0
fertőzéses,1,0.0
megszakított,1,0.0
kemoterápiát,1,0.0
leállítását,1,0.0
-251,1,0.0
HERO,1,0.0
579000,1,0.0
Spreading,1,0.0
CEAF,1,0.0
G-CSF-profilaxis,1,0.0
R03,1,0.0
újraindítottuk,1,0.0
Colony,1,0.0
salutogenetic,1,0.0
Granulocyte-Macrophage,1,0.0
szövődményt,1,0.0
észleltünk,1,0.0
Kemoterápia,1,0.0
műtét,1,0.0
SARS-CoV-2-fertőzött,1,0.0
tünetmentes,1,0.0
betegnél,1,0.0
szövődménymentesen,1,0.0
specialisations,1,0.0
végezhető,1,0.0
theophyllamine,1,0.0
recessions,1,0.0
120564-578,1,0.0
W6152R,1,0.0
16-44,1,0.0
notional,1,0.0
httpwwwnindsnihgovfindpeoplegroupsstrokeprgindexhtm,1,0.0
httpwwwnindsnihgovfindpeoplegroupsstrokeprg092006strokeprgreporthtm,1,0.0
NINDS-funded,1,0.0
Hypokalemia,1,0.0
generalise,1,0.0
≤71,1,0.0
cholesterolphospholipid,1,0.0
antigenically-matching,1,0.0
6-71,1,0.0
URTI-related,1,0.0
nosenasal,1,0.0
vaccine-naive,1,0.0
seroconversionseroresponse,1,0.0
micro-proteomics,1,0.0
sodium-potassium,1,0.0
metabolites--digoxin,1,0.0
clinical-and-functional,1,0.0
dietotherapy,1,0.0
quinolines,1,0.0
puncta,1,0.0
light-emitting,1,0.0
diode,1,0.0
LC3-positive,1,0.0
headrest,1,0.0
ivia,1,0.0
Silicone-coated,1,0.0
A-H5N1,1,0.0
pandemicsepidemics,1,0.0
preventionimmunization,1,0.0
INMA,1,0.0
Intra-gastric,1,0.0
2219,1,0.0
intra-gastric,1,0.0
SHS-exposed,1,0.0
-8876-2476,1,0.0
50mgkg,1,0.0
ASTEMI,1,0.0
A-H5N1-virus,1,0.0
neutraceutical,1,0.0
arterial-ischaemic,1,0.0
jelly-like,1,0.0
Sedatives,1,0.0
symbiont,1,0.0
Infrastructures,1,0.0
AMRI,1,0.0
nonselectively,1,0.0
macro-control,1,0.0
immobile,1,0.0
overweigh,1,0.0
challengeable,1,0.0
oxygenators,1,0.0
post-attachment,1,0.0
HCoV-229E-infected,1,0.0
RNA-spiked,1,0.0
DETermination,1,0.0
moped,1,0.0
Harar,1,0.0
Somali,1,0.0
Dire,1,0.0
Dawa,1,0.0
committing,1,0.0
artinemol,1,0.0
drug-escaping,1,0.0
sequence-structure-function-virulence,1,0.0
diabetes-specific,1,0.0
2838,1,0.0
stabilizingretaining,1,0.0
Ideas,1,0.0
DETO2X-AMI,1,0.0
GBRC239,1,0.0
well-powered,1,0.0
Gandhinagar,1,0.0
httpccsmghharvardedu,1,0.0
GBRC275b,1,0.0
inter-factor,1,0.0
H2Ol,1,0.0
gag,1,0.0
citric,1,0.0
N5928H,1,0.0
Lesson,1,0.0
Hararghe,1,0.0
Casual,1,0.0
‘allergy,1,0.0
aetiopathogenic,1,0.0
n57,1,0.0
n68,1,0.0
piperaquine,1,0.0
tafenoquine,1,0.0
Primaquine,1,0.0
012-12,1,0.0
Freebasing,1,0.0
02‐141,1,0.0
non‐White,1,0.0
snorting,1,0.0
mimic’,1,0.0
AsianPacific-Islander,1,0.0
freebase,1,0.0
non‐specific,1,0.0
non‐IgE‐mediated,1,0.0
2s,1,0.0
hemoglobins,1,0.0
sub-saharan,1,0.0
freebasing,1,0.0
addicted,1,0.0
33149,1,0.0
Desktop,1,0.0
13316,1,0.0
hyper-secretion,1,0.0
Percolation,1,0.0
2002-2012,1,0.0
wire-crossing,1,0.0
Cohorte,1,0.0
dExamens,1,0.0
Santé,1,0.0
COVID-2,1,0.0
2012-May,1,0.0
111-149,1,0.0
exeptional,1,0.0
schok,1,0.0
121-174,1,0.0
hyperiritability,1,0.0
sVNTs,1,0.0
tele-electrocardiography,1,0.0
CONSTANCES,1,0.0
intersubunit,1,0.0
Baxcaspase-dependent,1,0.0
point-to-point,1,0.0
site-independent,1,0.0
Atg3,1,0.0
TEMPiS,1,0.0
REACH,1,0.0
and-,1,0.0
No4,1,0.0
web-site,1,0.0
information-analytical,1,0.0
Duo,1,0.0
LWHs,1,0.0
bengal,1,0.0
dislipoproteinemia,1,0.0
ALIacute,1,0.0
AswineHeBei0122008,1,0.0
13886,1,0.0
blocker-induced,1,0.0
NAT-detectable,1,0.0
oxidase2,1,0.0
GEQmL,1,0.0
0755,1,0.0
LoDs,1,0.0
0702,1,0.0
erythropoiesis,1,0.0
0694,1,0.0
9962,1,0.0
-0571,1,0.0
0474,1,0.0
-0511,1,0.0
cholelithic,1,0.0
urolithiasis,1,0.0
fluorine-18,1,0.0
9887,1,0.0
tachogram,1,0.0
Bzip2,1,0.0
meanNN-normalized,1,0.0
standards-based,1,0.0
photochemically,1,0.0
autophagy-refractory,1,0.0
8136,1,0.0
-01-21,1,0.0
383201-203,1,0.0
httpsdoiorg101056NEJMp2012910,1,0.0
Itai,1,0.0
Yanai,1,0.0
Lercher,1,0.0
Feces,1,0.0
21231,1,0.0
httpsdoiorg101186s13059-020-02133-w,1,0.0
polarisation-sensitive,1,0.0
subtract,1,0.0
magnesium-deficient,1,0.0
57-96,1,0.0
Chowkwanyun,1,0.0
dilatory,1,0.0
ion-stabilizing,1,0.0
569-794,1,0.0
786-969,1,0.0
polyvinylidene,1,0.0
799-1037,1,0.0
pimelimidate,1,0.0
enriches,1,0.0
114667,1,0.0
8543,1,0.0
603-823,1,0.0
Adolph,1,0.0
Merlin,1,0.0
BaxBak-dependent,1,0.0
CXCL10IP10,1,0.0
BaxBak,1,0.0
270000,1,0.0
DACH,1,0.0
Bak,1,0.0
PR8-infected,1,0.0
Rico834H1N1,1,0.0
ATCC,1,0.0
profibrillatory,1,0.0
processes-which,1,0.0
cooperation-both,1,0.0
1β,1,0.0
IIangiotensin,1,0.0
mSphere,1,0.0
AT1R-mediated,1,0.0
ORF7,1,0.0
anti-cytokineanti-cytokine-signaling,1,0.0
312-597,1,0.0
anti-glutamic,1,0.0
58-498,1,0.0
CI1,1,0.0
decarboxylase,1,0.0
anti-GAD,1,0.0
antibody-associated,1,0.0
Kishana,1,0.0
Danger,1,0.0
stewards,1,0.0
Trp-Arg,1,0.0
9032,1,0.0
obliterated,1,0.0
4690,1,0.0
literatureWe,1,0.0
valved,1,0.0
isoperimetric,1,0.0
27-70,1,0.0
stress--a,1,0.0
valuepredicted,1,0.0
viralcellular,1,0.0
theme-centered,1,0.0
leat,1,0.0
lurking,1,0.0
solicitation,1,0.0
checkouts,1,0.0
scaled-determination,1,0.0
web-portal,1,0.0
Defeating,1,0.0
lesion-specific,1,0.0
Bodily,1,0.0
Västmanland,1,0.0
heterotaxy,1,0.0
mealtimes,1,0.0
hyperosmolality,1,0.0
security-provoking,1,0.0
IL-17-producing,1,0.0
Interviewing,1,0.0
Centipede,1,0.0
IMAGINE,1,0.0
gamma-herpesvirus,1,0.0
multiple-trial,1,0.0
Angiotensin-2,1,0.0
RBD-hACE2,1,0.0
hybridoma,1,0.0
017-073,1,0.0
nM-affinity,1,0.0
gliclazide,1,0.0
co-stimulatory,1,0.0
33441919,1,0.0
state-wide,1,0.0
1003497,1,0.0
Fogarty-Mexico,1,0.0
physiologically-based,1,0.0
freeing,1,0.0
serosignature,1,0.0
99mtechnetium,1,0.0
2-peptide,1,0.0
-397TC,1,0.0
rs2234693,1,0.0
-351AG,1,0.0
rs9340799,1,0.0
N295S,1,0.0
CT-Perfusion,1,0.0
n115,1,0.0
peptide-decorated,1,0.0
membrane-integral,1,0.0
RVG-Lamp2b,1,0.0
N-acetylneuramide,1,0.0
NP-RNA,1,0.0
processive,1,0.0
Relenza8482,1,0.0
NNT125,1,0.0
coenzymes,1,0.0
dehydrogenases,1,0.0
non-microbial,1,0.0
unstained,1,0.0
techniqueA,1,0.0
Inflammasomes,1,0.0
Trondheim,1,0.0
cone-beam,1,0.0
cRNA,1,0.0
4-methylumbelliferyl-alpha-ketoside,1,0.0
nationally-coordinated,1,0.0
CDNA,1,0.0
20-second,1,0.0
nonglycopeptides,1,0.0
monomer-grafted,1,0.0
4-Fr,1,0.0
othersunknown,1,0.0
WR,1,0.0
single-time,1,0.0
higly,1,0.0
dissociates,1,0.0
httpsdoiorg101073pnas0705856104,1,0.0
RVG-decorated,1,0.0
NP-vRNA,1,0.0
fatigue”,1,0.0
“pandemic,1,0.0
Effect”,1,0.0
Neuro2A,1,0.0
“Peltzman,1,0.0
Unmod-ExoHMGB1-siRNA,1,0.0
PEI25kHMGB1-siRNA,1,0.0
RVG-ExoHMGB1,1,0.0
distribution--especially,1,0.0
breaches,1,0.0
httpbitly2IgXcel,1,0.0
Naito,1,0.0
10418235-18240,1,0.0
Kiyasu,1,0.0
structurebased,1,0.0
Sugiyama,1,0.0
Kimura,1,0.0
Nakano,1,0.0
pharmacophore-based,1,0.0
Matsukage,1,0.0
Nagata,1,0.0
docking-,1,0.0
Natl,1,0.0
computer-,1,0.0
106-279,1,0.0
ON-hours,1,0.0
OFF-hours,1,0.0
361597-1616,1,0.0
Mucosalsubmucosal,1,0.0
113-144,1,0.0
109-138,1,0.0
113-126,1,0.0
Exuded,1,0.0
9373,1,0.0
reviewStudy,1,0.0
Wandsworth,1,0.0
SE120,1,0.0
2000-October,1,0.0
Notes,1,0.0
self-referral,1,0.0
cerebal,1,0.0
2833102-3109,1,0.0
to--objective,1,0.0
congregational,1,0.0
Voxel,1,0.0
bootstrapping,1,0.0
on-phone,1,0.0
IRCT,1,0.0
Base-case,1,0.0
flowcharts,1,0.0
85-year-old,1,0.0
control-they,1,0.0
101-133,1,0.0
150-200100000,1,0.0
McVicar,1,0.0
1968-1974,1,0.0
non-increasing,1,0.0
atopyallergic,1,0.0
47019,1,0.0
poly-sensitization,1,0.0
Multigeneration,1,0.0
1974-1981,1,0.0
States†,1,0.0
results§,1,0.0
centers¶,1,0.0
pandemic††,1,0.0
Survey§§,1,0.0
centers¶¶,1,0.0
Fiftytwo,1,0.0
5-October,1,0.0
7-week,1,0.0
Formulae,1,0.0
3194838,1,0.0
re-repair,1,0.0
308780,1,0.0
2506935,1,0.0
response-related,1,0.0
mediator-induced,1,0.0
non-metastatic,1,0.0
antileakage,1,0.0
Clancy,1,0.0
2011b,1,0.0
126-1518,1,0.0
corticofugal,1,0.0
gamma-,1,0.0
delta-coronaviruses,1,0.0
E-M,1,0.0
Laryngotracheobronchitis,1,0.0
lassitude,1,0.0
884,1,0.0
24-year,1,0.0
0651,1,0.0
eight-fold,1,0.0
high-signal,1,0.0
multilobe,1,0.0
neuromodulator,1,0.0
beta-,1,0.0
Kronach,1,0.0
genericspecific,1,0.0
Jackknife,1,0.0
001-092,1,0.0
014-080,1,0.0
001-082,1,0.0
001-083,1,0.0
steroid-containing,1,0.0
culprit-lesion-only,1,0.0
015-079,1,0.0
Gliclazide,1,0.0
heat-sensitive,1,0.0
inter-genus,1,0.0
treatment-in,1,0.0
nonrelapse,1,0.0
StrokeTIA,1,0.0
Innherred,1,0.0
Wernicke-Korsakoffs,1,0.0
non-drinkers,1,0.0
socio-familial,1,0.0
038-090,1,0.0
009-093,1,0.0
plummeted,1,0.0
Normothermic,1,0.0
heat-internal,1,0.0
non-SARS-related,1,0.0
cataloguing,1,0.0
intra-genus,1,0.0
133266,1,0.0
mail-in,1,0.0
pre-2019,1,0.0
Subpar,1,0.0
Okinawan,1,0.0
Make,1,0.0
inflammatory-based,1,0.0
Contraction,1,0.0
J-curve-shaped,1,0.0
Seretide,1,0.0
accessary,1,0.0
lehetőleg,1,0.0
maradjanak,1,0.0
CHDs,1,0.0
699-215,1,0.0
1543,1,0.0
Pso,1,0.0
beta2-,1,0.0
secvital,1,0.0
13-51,1,0.0
4-9,1,0.0
PsA,1,0.0
41-362,1,0.0
12-143,1,0.0
culture-documented,1,0.0
ABMS,1,0.0
vaccine–related,1,0.0
hemagglutinin-neuraminidase,1,0.0
perferred,1,0.0
stimulation-are,1,0.0
strategies-such,1,0.0
4311,1,0.0
intragraft,1,0.0
response-associated,1,0.0
P5315,1,0.0
coronavirus-infected,1,0.0
chr6,1,0.0
rs6924808,1,0.0
chr11,1,0.0
rs1353649,1,0.0
nonbinding,1,0.0
FDAs,1,0.0
mediators--cytokines,1,0.0
05092020,1,0.0
Odobenus,1,0.0
rosmarus,1,0.0
alphaTNF-alpha,1,0.0
divergens,1,0.0
Illiger,1,0.0
Bouts,1,0.0
01302020,1,0.0
03112020,1,0.0
04022020,1,0.0
04152020,1,0.0
04272020,1,0.0
1beta,1,0.0
1-type,1,0.0
4178346,1,0.0
1347936,1,0.0
227436,1,0.0
IL-,1,0.0
224422,1,0.0
gamma-induced,1,0.0
numbered,1,0.0
MIP-,1,0.0
-secreted,1,0.0
cell-expressed,1,0.0
6506,1,0.0
P6661,1,0.0
5670,1,0.0
needfor,1,0.0
124774,1,0.0
RECA1,1,0.0
IKB,1,0.0
PMCA2,1,0.0
EPC-transplanted,1,0.0
IAEA,1,0.0
Radiopharmacy,1,0.0
VIAs,1,0.0
inflammation-plagued,1,0.0
dlm2,1,0.0
penchant,1,0.0
405511,1,0.0
BHRPC20,1,0.0
scrambled,1,0.0
1798,1,0.0
non-q,1,0.0
prognosticator,1,0.0
rs2781666,1,0.0
thrombolytic-beta-blocker,1,0.0
conditons,1,0.0
619-188,1,0.0
805-205,1,0.0
CPB2,1,0.0
530-176,1,0.0
TAFIa,1,0.0
EPC-mediated,1,0.0
knockdownantisense,1,0.0
rachnoid,1,0.0
LAIVFluenz™,1,0.0
suba-,1,0.0
10671,1,0.0
physician-adjudicated,1,0.0
rous,1,0.0
Nume-,1,0.0
Anti-inflammation,1,0.0
anti-inflammation-induced,1,0.0
Ambulant,1,0.0
Laboratory-induced,1,0.0
covary,1,0.0
cylindric,1,0.0
breakouts,1,0.0
Cough-variant,1,0.0
pandemic2,1,0.0
host-immune,1,0.0
game-specific,1,0.0
7-week-old,1,0.0
clinically-accepted,1,0.0
Neuro-World,1,0.0
EPN,1,0.0
Contracture,1,0.0
Torque-angle,1,0.0
Weakness,1,0.0
ABO-incompatibility,1,0.0
dysfunctionalteration,1,0.0
25-yr-old,1,0.0
preventingcorrecting,1,0.0
Radiochemical,1,0.0
ALERTA-2,1,0.0
warfarinPatients,1,0.0
follow-upTwenty-nine,1,0.0
45-1575,1,0.0
stoppedThis,1,0.0
oblige,1,0.0
CIOMS-guidelines,1,0.0
HC-20511,1,0.0
Biblical,1,0.0
Luke,1,0.0
Gilmans,1,0.0
10427,1,0.0
Bronconeumología,1,0.0
gospels,1,0.0
Three-fourth,1,0.0
TPRs,1,0.0
TPR,1,0.0
192-259,1,0.0
143-224,1,0.0
116-199,1,0.0
Christ,1,0.0
Jesus,1,0.0
00257,1,0.0
non-vegetarian,1,0.0
zero-,1,0.0
planimetered,1,0.0
115-161,1,0.0
Sanguine,1,0.0
GSE101702,1,0.0
BPI,1,0.0
prevalence-based,1,0.0
stroke-admitting,1,0.0
evolvability,1,0.0
generally-held,1,0.0
058100-116100,1,0.0
67-89,1,0.0
S-G2M,1,0.0
49-88,1,0.0
cell-cycle,1,0.0
87-138,1,0.0
2934,1,0.0
alloys,1,0.0
snapshots,1,0.0
Stress-redistribution,1,0.0
widely-applicable,1,0.0
extra-lymphoid,1,0.0
long-sought,1,0.0
biosampler,1,0.0
oversampling,1,0.0
1668,1,0.0
humeroscapular,1,0.0
Stress-redistribution-reinjection,1,0.0
141-199,1,0.0
ECCC,1,0.0
httpswwwcdcgovnonpharmaceutical-interventions,1,0.0
Michigan-,1,0.0
Atellica,1,0.0
Vista,1,0.0
EuroimmunELISA,1,0.0
SOEP-CoV,1,0.0
Snibe,1,0.0
Maglumi,1,0.0
tourism-oriented,1,0.0
Sheets,1,0.0
nursenurses,1,0.0
border-reopening,1,0.0
janitorcleaners,1,0.0
Built,1,0.0
CUH-NOVO,1,0.0
9211,1,0.0
Massachusetts-,1,0.0
California-,1,0.0
domain-specific,1,0.0
Ligating,1,0.0
fourty,1,0.0
musculoutaneous,1,0.0
virusesThese,1,0.0
Layered,1,0.0
httpsstackscdcgovviewcdc11425,1,0.0
surfacesSeveral,1,0.0
iFlash,1,0.0
total-Ab,1,0.0
Red-Zone,1,0.0
CFUmL,1,0.0
antigenically-drifted,1,0.0
agent-host,1,0.0
substrate-based,1,0.0
nanogap,1,0.0
2D-MoS2,1,0.0
nano-spacing,1,0.0
freestanding,1,0.0
Hafnium,1,0.0
HfO2,1,0.0
mVdec,1,0.0
ONOFF,1,0.0
colony-forming,1,0.0
≥99,1,0.0
extened,1,0.0
37-770,1,0.0
xenosplenoperfusion,1,0.0
750-1334,1,0.0
1637-4203,1,0.0
reactivityABSTRACT,1,0.0
SOEP,1,0.0
0000024,1,0.0
helpfulness,1,0.0
Socio-Economic,1,0.0
Macroeconomic,1,0.0
collecton,1,0.0
HCC,1,0.0
DEFA4,1,0.0
proCPU,1,0.0
subarachnoidal-pleural,1,0.0
myeloscintigraphy,1,0.0
inguinal,1,0.0
r-0777,1,0.0
r-0291,1,0.0
r0803,1,0.0
Adipose-derived,1,0.0
r0326,1,0.0
r0306,1,0.0
vaporization,1,0.0
STEMINSTEMI,1,0.0
016-045,1,0.0
042-075,1,0.0
028-079,1,0.0
Transparietal,1,0.0
preconditioning-has,1,0.0
insult-ischemic,1,0.0
028-060,1,0.0
Cross-communication,1,0.0
AGuangzhou397152014,1,0.0
Vasculo-occlusive,1,0.0
thriving,1,0.0
autoantigen,1,0.0
Antiendomysial,1,0.0
antitransglutaminase,1,0.0
Koaguloscop-TC,1,0.0
hypolypidemic,1,0.0
extracavitary,1,0.0
B6A2G-Mx1,1,0.0
TMAD-adj,1,0.0
46100000,1,0.0
TMAD-adjusted,1,0.0
38100000,1,0.0
5747,1,0.0
Condensate,1,0.0
34506,1,0.0
oPLS,1,0.0
PLS-regression,1,0.0
stringencies,1,0.0
ninety-thousand,1,0.0
IFN-related,1,0.0
T7-8,1,0.0
chungkookjang,1,0.0
Amino-acid,1,0.0
Welchs,1,0.0
difficult-to-use,1,0.0
bio-security,1,0.0
poly-γ-glutamate,1,0.0
7900,1,0.0
food-safety,1,0.0
NOMI,1,0.0
nonocclusion,1,0.0
antiagragative,1,0.0
in-development,1,0.0
serology-specifically,1,0.0
containments,1,0.0
ten-node,1,0.0
someday,1,0.0
g-Eqm2,1,0.0
stenting-mechanical,1,0.0
listeners,1,0.0
lecture-like,1,0.0
non-citizens,1,0.0
well-curbed,1,0.0
Arbor660,1,0.0
edge-based,1,0.0
COrona,1,0.0
Immuno,1,0.0
Deficiency-2019,1,0.0
virtues,1,0.0
nonisomorphic,1,0.0
along-with,1,0.0
Pavia,1,0.0
unconjugated,1,0.0
884-100,1,0.0
Huge,1,0.0
QIAreach™,1,0.0
RH0,1,0.0
ZyCoV-D,1,0.0
Th-1,1,0.0
avirulence,1,0.0
first-order,1,0.0
stimultaneous,1,0.0
antitissue,1,0.0
16-August,1,0.0
antibodies-should,1,0.0
Administrators,1,0.0
vector-induced,1,0.0
Salinas,1,0.0
15146864,1,0.0
ity,1,0.0
12557305,1,0.0
120-137,1,0.0
285-606,1,0.0
60-184,1,0.0
sever-,1,0.0
166-274,1,0.0
inflammationfibrosis,1,0.0
nonsegmented,1,0.0
disguise,1,0.0
deductively,1,0.0
semi-allograft,1,0.0
6446,1,0.0
symptomsrelievers,1,0.0
2types,1,0.0
68Ga-Fucoidan,1,0.0
mation,1,0.0
inflam-,1,0.0
dyslipoproteinemia,1,0.0
104-121,1,0.0
trumpet,1,0.0
risk189,1,0.0
histopathophysiologic,1,0.0
bifurcate,1,0.0
mutant-line,1,0.0
antiemetics,1,0.0
slenderness,1,0.0
neuroleptanalgesia,1,0.0
504-536,1,0.0
teh,1,0.0
extra-infarction,1,0.0
immuno-selection,1,0.0
Macrophage-derived,1,0.0
egression,1,0.0
00014,1,0.0
27052020,1,0.0
Andreasen,1,0.0
00384,1,0.0
120-240,1,0.0
cysLT12,1,0.0
slender,1,0.0
standardizes,1,0.0
ONO-6950,1,0.0
Anaesthesia,1,0.0
24655,1,0.0
253775,1,0.0
Orthodontic,1,0.0
secretaries,1,0.0
20052020,1,0.0
Chronotype,1,0.0
monocytemacrophage,1,0.0
proCPB2,1,0.0
T2-sequences,1,0.0
cuspidate,1,0.0
bronchodilator-dependent,1,0.0
46-years-old,1,0.0
Hemiplegic,1,0.0
ECMOnetOur,1,0.0
technologySimulation,1,0.0
BeSD,1,0.0
IPF,1,0.0
Wait,1,0.0
5-lipoxygenase-activating-protein,1,0.0
visfatin,1,0.0
cold-air-induced,1,0.0
33100000,1,0.0
ECMOTo,1,0.0
SIRT,1,0.0
lounge,1,0.0
microgramsgm,1,0.0
peculiarly,1,0.0
rosaceae,1,0.0
umbelliferae,1,0.0
Bronchi,1,0.0
mononucleotide,1,0.0
KYRBWS,1,0.0
IL-7IL-7R,1,0.0
COID-19,1,0.0
beta2-receptor,1,0.0
interperson,1,0.0
Differentiate,1,0.0
epitomized,1,0.0
hencethe,1,0.0
pethidine,1,0.0
POST,1,0.0
hemicolectomy,1,0.0
expanse,1,0.0
ultrafilter,1,0.0
postbronchodilatator,1,0.0
mid-shaft,1,0.0
16x34,1,0.0
Cardiokymography,1,0.0
allocative,1,0.0
hand-driven,1,0.0
00299,1,0.0
selectsyringe,1,0.0
frameworksmechanisms,1,0.0
non-exercising,1,0.0
HR-based,1,0.0
Dysbiosis,1,0.0
164-218,1,0.0
microbiota-related,1,0.0
restaurant,1,0.0
Correlate,1,0.0
Cardiokymographic,1,0.0
glucocorticosteroid-insensitive,1,0.0
2559,1,0.0
Side-effect,1,0.0
Berodual,1,0.0
Fisons,1,0.0
MCTQ,1,0.0
chromoglycate,1,0.0
CD1d,1,0.0
Th17-related,1,0.0
4306,1,0.0
4335,1,0.0
lipid-reactive,1,0.0
MSF,1,0.0
SDW,1,0.0
Suxiao,1,0.0
exanthems,1,0.0
chemoluminescent,1,0.0
4002,1,0.0
understood--largely,1,0.0
5118,1,0.0
5167,1,0.0
health--air,1,0.0
quality--and,1,0.0
20148,1,0.0
Jiuxinwan,1,0.0
cardiokymography,1,0.0
diagnosisprognosis,1,0.0
MMEF25-75,1,0.0
ellátatlanul,1,0.0
homophilous,1,0.0
8935,1,0.0
AP-based,1,0.0
RNase-binding,1,0.0
4321116,1,0.0
11161271,1,0.0
CD28,1,0.0
both--are,1,0.0
degres,1,0.0
mediated--whether,1,0.0
lealing,1,0.0
bronchodilatators,1,0.0
cloud-native,1,0.0
tactically,1,0.0
shone,1,0.0
reorganising,1,0.0
Caffeine,1,0.0
class-switched,1,0.0
ACE2RBD,1,0.0
Tao-Yuan,1,0.0
water-oil,1,0.0
angle-dependent,1,0.0
NBO-studies,1,0.0
diameter-dependent,1,0.0
spectrophotometers,1,0.0
cables,1,0.0
254432,1,0.0
108432,1,0.0
10-step,1,0.0
Mekkah,1,0.0
pro-government,1,0.0
Bryan,1,0.0
slaughters,1,0.0
5150,1,0.0
international-that,1,0.0
factors-political,1,0.0
age-eligible,1,0.0
Leichter,1,0.0
300000-350000,1,0.0
AIndiana082011,1,0.0
ABeijing321992,1,0.0
Unal,1,0.0
120432,1,0.0
systemisation,1,0.0
nonlife,1,0.0
consequences-invalidity,1,0.0
fogging,1,0.0
9702,1,0.0
Croatian-specific,1,0.0
112005-112012,1,0.0
EBPH,1,0.0
1970-2011,1,0.0
17432,1,0.0
2778,1,0.0
ATA,1,0.0
ressortants,1,0.0
ANetherlands3593,1,0.0
rationalise,1,0.0
μs-long,1,0.0
nuclease-protection,1,0.0
rarely-seen,1,0.0
threading,1,0.0
dams,1,0.0
hemorrhagicischemic,1,0.0
PIVUS,1,0.0
eventuate,1,0.0
8-month-old,1,0.0
pseudo-myocardial,1,0.0
eludes,1,0.0
1H-MRS,1,0.0
effectors--local,1,0.0
VG,1,0.0
DWs,1,0.0
LAUP,1,0.0
BackgroundCohort,1,0.0
subjectsAimWe,1,0.0
lineage-associated,1,0.0
dataMethodsFor,1,0.0
httpwwwcombio-lezhangonline2019ncovhomehtml,1,0.0
outcomeResultsEach,1,0.0
12-19,1,0.0
41-54,1,0.0
3-stem,1,0.0
sheddase-induced,1,0.0
Scatter,1,0.0
pneumorrhagia,1,0.0
ANetherlands593,1,0.0
35338,1,0.0
fluorescence-labeled,1,0.0
times-to-detections,1,0.0
pre-influenza,1,0.0
Adaptability,1,0.0
Cohesion,1,0.0
TR-derived,1,0.0
PICUSeventy-seven,1,0.0
086-141,1,0.0
analyzedThe,1,0.0
137-212,1,0.0
non-American,1,0.0
087-145,1,0.0
129-201,1,0.0
VAP,1,0.0
hospitalizationA,1,0.0
AFDAS-related,1,0.0
failureCryptococcal,1,0.0
reinforcers,1,0.0
micromolds,1,0.0
guideline-adherent,1,0.0
trans-placental,1,0.0
123-155,1,0.0
Waco,1,0.0
Belton,1,0.0
Killing,1,0.0
Friend,1,0.0
136-276,1,0.0
cellulose-composed,1,0.0
enlargements,1,0.0
Consolidations,1,0.0
reticulation,1,0.0
Lymphadenopathy,1,0.0
non-biodegradable,1,0.0
oligomerized,1,0.0
4-37,1,0.0
polytraumatized,1,0.0
Nonviral,1,0.0
Creative,1,0.0
282-628,1,0.0
CHIP,1,0.0
Modeled,1,0.0
available--by,1,0.0
CVP,1,0.0
co-occurs,1,0.0
Decontamination,1,0.0
Intragroup,1,0.0
adult-age,1,0.0
Askoril,1,0.0
pre-export,1,0.0
Unmasked,1,0.0
040-079,1,0.0
0330-0734,1,0.0
pH1N1s,1,0.0
olyan,1,0.0
thrombectomiából,1,0.0
Botto,1,0.0
cellulose-based,1,0.0
valószínűleg,1,0.0
profitáló,1,0.0
hCG,1,0.0
gonadotropin,1,0.0
LFA-performance,1,0.0
másrészt,1,0.0
terheljük,1,0.0
ellátórendszert,1,0.0
esetekkel,1,0.0
0492,1,0.0
melyekről,1,0.0
dokumentáció,1,0.0
ismeretében,1,0.0
wash-off,1,0.0
derül,1,0.0
javasolt,1,0.0
16217,1,0.0
668-675,1,0.0
module-fused,1,0.0
4804,1,0.0
2579,1,0.0
subclinically,1,0.0
assignation,1,0.0
Abdullah,1,0.0
TAP,1,0.0
slow-replicating,1,0.0
stork,1,0.0
anti-RSV,1,0.0
Thais,1,0.0
pdmO9,1,0.0
child-to-parent,1,0.0
Child-Mediated,1,0.0
CMSC,1,0.0
open-bill,1,0.0
counteragents,1,0.0
Antigenicity,1,0.0
exhibitions,1,0.0
Th2-biased,1,0.0
photo-document,1,0.0
MHC-1,1,0.0
persecute,1,0.0
Steep,1,0.0
TLR2-epitope,1,0.0
El-Youssef,1,0.0
105-156,1,0.0
Kamal,1,0.0
239-254,1,0.0
Rg,1,0.0
nmS2N,1,0.0
uncured,1,0.0
dieticians,1,0.0
gluey,1,0.0
Grad,1,0.0
Ct-values,1,0.0
Hyperproduction,1,0.0
TRSs,1,0.0
hypermutation,1,0.0
alphacoronaviruses,1,0.0
Intracellularly,1,0.0
Goodwin,1,0.0
Verma,1,0.0
Arevalo,1,0.0
httpsdoiorg1011012020110620227215,1,0.0
Tedijanto,1,0.0
Lipsitch,1,0.0
TNFR,1,0.0
368860-868,1,0.0
httpsdoiorg101126scienceabb5793,1,0.0
enzyme-II,1,0.0
shock…,1,0.0
fraction…,1,0.0
function…,1,0.0
Digitized,1,0.0
Phonopneumography,1,0.0
baselineABSTRACT,1,0.0
GestIMA,1,0.0
AMAZES,1,0.0
094-105,1,0.0
101-115,1,0.0
miR-19a,1,0.0
negligibleConclusionSeasonal,1,0.0
paclitaxel,1,0.0
minimalise,1,0.0
40554,1,0.0
antioxygenation,1,0.0
Meleagris,1,0.0
MSG,1,0.0
gallopavo,1,0.0
coccyx,1,0.0
-NL63,1,0.0
-HKU1,1,0.0
HCoV-associated,1,0.0
5380,1,0.0
418448,1,0.0
Standard™,1,0.0
THM,1,0.0
12476,1,0.0
segmentallobar,1,0.0
non-B117-infected,1,0.0
HighWire,1,0.0
cryobiopsy,1,0.0
metroplex,1,0.0
Pneumologists,1,0.0
LABAinhaled,1,0.0
rate-blood,1,0.0
washout-rate,1,0.0
large-,1,0.0
COVID-19§§,1,0.0
centers††,1,0.0
ecometric,1,0.0
normoreactive,1,0.0
repeat-AMI,1,0.0
medicating,1,0.0
out-of-severity,1,0.0
non-severity-appropriate,1,0.0
Seinäjoki,1,0.0
311000,1,0.0
Tobit,1,0.0
35-J,1,0.0
Defibrillation,1,0.0
10-J,1,0.0
Ronald,1,0.0
2020-June,1,0.0
Reagan,1,0.0
adults†,1,0.0
prekindergarten,1,0.0
increasing§,1,0.0
fibrose,1,0.0
2019-Associated,1,0.0
COVID-NET¶,1,0.0
D222N,1,0.0
2020-August,1,0.0
E374K,1,0.0
diaphragm-intercostal,1,0.0
Carbon-11,1,0.0
mood-stabilizing,1,0.0
PCL,1,0.0
Developers,1,0.0
pseudo-bigeminy,1,0.0
succinylcholine,1,0.0
pseudo-arrhythmia,1,0.0
vaccine-effectiveness,1,0.0
Vaccine-hesitant,1,0.0
Encapsulating,1,0.0
per-contact,1,0.0
Ethiopian-Greek,1,0.0
5722,1,0.0
Anbessa,1,0.0
Tikur,1,0.0
bacille,1,0.0
posting,1,0.0
occupational-health,1,0.0
half-blooded,1,0.0
GSE111368,1,0.0
applet,1,0.0
5711,1,0.0
3393,1,0.0
TCN1,1,0.0
RETN,1,0.0
OLFM4,1,0.0
2495,1,0.0
Beta-Blockers,1,0.0
unconsciocus,1,0.0
primar-ily,1,0.0
IGDTBA,1,0.0
ACT-defined,1,0.0
prodigiosan,1,0.0
DIAGNOSIS,1,0.0
IgGIgM-,1,0.0
IABA-conditioned,1,0.0
103-147,1,0.0
reincorporation,1,0.0
B2AR,1,0.0
GR-α,1,0.0
pre-conception,1,0.0
clinicaltherapeutic,1,0.0
multianalyte,1,0.0
beta-lactam,1,0.0
lung-saving,1,0.0
Foreseeably,1,0.0
reassesses,1,0.0
assumable,1,0.0
immunoprotected,1,0.0
Coronavirinae,1,0.0
mitralic,1,0.0
diffusion-angiography,1,0.0
immunonephelometric,1,0.0
13-277,1,0.0
per-sons,1,0.0
non-hypercapnia,1,0.0
137040,1,0.0
premilitary,1,0.0
table-driven,1,0.0
statification,1,0.0
listen,1,0.0
pharmacist-patient,1,0.0
16-channel,1,0.0
cell-culture-generated,1,0.0
rogue,1,0.0
patient-friendly,1,0.0
1×,1,0.0
computerizing,1,0.0
Simsons,1,0.0
-91,1,0.0
dictors,1,0.0
beyound,1,0.0
MDI-sensitized,1,0.0
roll-to-roll,1,0.0
as-identified,1,0.0
COPSAC,1,0.0
vertical-flow,1,0.0
R501X,1,0.0
Del4,1,0.0
Filaggrin,1,0.0
106-312,1,0.0
metereologic,1,0.0
112-611,1,0.0
129-237,1,0.0
Non-structural,1,0.0
12-years,1,0.0
mediterranean,1,0.0
prophylaxis--an,1,0.0
41-46,1,0.0
Type-5,1,0.0
broncho-provocation,1,0.0
population-,1,0.0
healthenvironmental,1,0.0
CpHMD,1,0.0
pKa,1,0.0
His-106,1,0.0
well-tempered,1,0.0
COI,1,0.0
meta-dynamics,1,0.0
inquire--by,1,0.0
Sauna,1,0.0
gyr,1,0.0
Reclaiming,1,0.0
anti-host,1,0.0
Schoolwide,1,0.0
Attesting,1,0.0
affiliative,1,0.0
foundry,1,0.0
Etiquette,1,0.0
0005-ppm,1,0.0
HygieneCough,1,0.0
waterless,1,0.0
172-725,1,0.0
asymptomatic-and,1,0.0
Air-pollution,1,0.0
tolylene,1,0.0
aerosol-borne,1,0.0
jets,1,0.0
swine-influenza,1,0.0
ecobiological,1,0.0
outcomesCommunicated,1,0.0
Latitude,1,0.0
questions--of,1,0.0
literal,1,0.0
RL,1,0.0
Milner,1,0.0
260-261,1,0.0
67-133,1,0.0
Six-Foot,1,0.0
questions--was,1,0.0
stroke--ischemic,1,0.0
hemorrhage--have,1,0.0
supersedes,1,0.0
re-bleed,1,0.0
272-432,1,0.0
18-19,1,0.0
272-432µgm3,1,0.0
practitioner-reported,1,0.0
133-5927µgm3,1,0.0
curbside,1,0.0
pathogen-bearing,1,0.0
animal-related,1,0.0
23ABSTRACT,1,0.0
aluminium-based,1,0.0
1860,1,0.0
age-dependent-are,1,0.0
m--standard,1,0.0
dermatome,1,0.0
SBPDBP,1,0.0
M--mean,1,0.0
thigh-length,1,0.0
Neuroimmunology,1,0.0
M-m,1,0.0
Langerhans,1,0.0
25MHz,1,0.0
liposomesvirosomes,1,0.0
MR-proADM,1,0.0
G60,1,0.0
Contacting,1,0.0
SES-prestige,1,0.0
resources-and,1,0.0
steroid-responsive,1,0.0
Sonoline,1,0.0
Oilworkers,1,0.0
wwwcardiovision2020org,1,0.0
neutralizing-antibody,1,0.0
total-count,1,0.0
pro-adrenomedullin,1,0.0
translucent,1,0.0
large-dose,1,0.0
phosphocreatine,1,0.0
respiratory-borne,1,0.0
embellish,1,0.0
actuality,1,0.0
pathography,1,0.0
Attendees,1,0.0
executive-level,1,0.0
well-prepared,1,0.0
su-jok,1,0.0
surprises,1,0.0
McSweeney,1,0.0
impatiently,1,0.0
MAPMISS,1,0.0
inacceptable,1,0.0
corronavirus-19,1,0.0
Zwolle-6,1,0.0
SigmaSTD,1,0.0
therapeutic-driven,1,0.0
therapeutic-induced,1,0.0
pet-to-pet,1,0.0
pet-to-human,1,0.0
hyponatremic,1,0.0
symptomatologies,1,0.0
ATR,1,0.0
skin-fold,1,0.0
Perimenstrual,1,0.0
hormone-induced,1,0.0
appearence,1,0.0
17h,1,0.0
httpwwwfdagovbbstopicsNEWS2007NEW01611htm,1,0.0
Dilutions,1,0.0
similarity-based,1,0.0
hammer-screwdriver,1,0.0
concerninterest,1,0.0
event-based,1,0.0
hammer-nail,1,0.0
manipulable,1,0.0
human-made,1,0.0
artifact-related,1,0.0
Lesion-Symptom,1,0.0
LTO,1,0.0
hMT,1,0.0
nal,1,0.0
tranmission,1,0.0
RapiGEN,1,0.0
OMInon-OMI,1,0.0
Heterotrimeric,1,0.0
right-dominant,1,0.0
v5,1,0.0
waterbirds,1,0.0
Mekong,1,0.0
month-15,1,0.0
biscuit,1,0.0
mixer,1,0.0
obey,1,0.0
progestins,1,0.0
IHES,1,0.0
recitations,1,0.0
Unbeknown,1,0.0
Detrusor,1,0.0
co-administering,1,0.0
adjuvated,1,0.0
one-dimensionality,1,0.0
10692,1,0.0
two-time,1,0.0
coaxed,1,0.0
misfit,1,0.0
Antifibrinolytics,1,0.0
antifibrinolytics,1,0.0
Ad26-vector-based,1,0.0
asthmarefers,1,0.0
optimization-based,1,0.0
sedative,1,0.0
1976-1984,1,0.0
decreasingly,1,0.0
winded,1,0.0
essentialist,1,0.0
Addressed,1,0.0
neutrophil-recruiting,1,0.0
Kainov,1,0.0
influenza-COVID-19,1,0.0
finalization,1,0.0
trendy,1,0.0
Voiding,1,0.0
Thymosin,1,0.0
initiationHerein,1,0.0
knowing-doing,1,0.0
33-year,1,0.0
HES-associated,1,0.0
primerenzyme,1,0.0
TwoStep,1,0.0
PharmD,1,0.0
autoantibody-induced,1,0.0
rationalizing,1,0.0
1854,1,0.0
angioimmunoblastic,1,0.0
calcium-free,1,0.0
ametabolic,1,0.0
Madrids,1,0.0
divide-and-conquer,1,0.0
147114,1,0.0
Ageseropositivity,1,0.0
21235,1,0.0
17825,1,0.0
co-adjuvants,1,0.0
Spaniards,1,0.0
83121,1,0.0
redetectable,1,0.0
MILP,1,0.0
aptly,1,0.0
performanc,1,0.0
VOCI,1,0.0
neuroanatomically,1,0.0
Converging,1,0.0
PDAD,1,0.0
mishap,1,0.0
dashcam-captured,1,0.0
L37F,1,0.0
nsp6,1,0.0
G10818T,1,0.0
6354,1,0.0
Esophagus,1,0.0
A23138G,1,0.0
sub-phases,1,0.0
T27879C,1,0.0
Maximum-Parsimony,1,0.0
Psychopathological,1,0.0
IMTX-related,1,0.0
self-depreciation,1,0.0
vaccine-matching,1,0.0
157-127,1,0.0
TRIlatBB,1,0.0
TRIlatBR,1,0.0
003-006,1,0.0
Post-strokes,1,0.0
sub-phase,1,0.0
035-113,1,0.0
students´,1,0.0
left-appendage,1,0.0
Flu-p,1,0.0
receptor-T,1,0.0
pseudoinfluenza,1,0.0
2629,1,0.0
Intra-,1,0.0
ChalmersI73H3N2,1,0.0
BRoma167,1,0.0
AEngland4272H3N2,1,0.0
Herdimmunity,1,0.0
neededVaccines,1,0.0
haplotyping,1,0.0
peptide-,1,0.0
1T-helper,1,0.0
Life-saving,1,0.0
2972,1,0.0
P504L,1,0.0
Graft-versus-host,1,0.0
4581,1,0.0
vaccination-coverage,1,0.0
localizations,1,0.0
3621,1,0.0
V251F,1,0.0
G25879T,1,0.0
strokeClinical,1,0.0
500m,1,0.0
15-46,1,0.0
T442I,1,0.0
C14540T,1,0.0
demos,1,0.0
153517,1,0.0
9638,1,0.0
126-227,1,0.0
Postictal,1,0.0
289There,1,0.0
RIN,1,0.0
comedication,1,0.0
post-dynamic,1,0.0
Lamotrigine,1,0.0
His41-Cys145,1,0.0
nmol500K,1,0.0
cellsh,1,0.0
pharmacy-initiated,1,0.0
controverting,1,0.0
pre-examined,1,0.0
atients,1,0.0
7347,1,0.0
106-215,1,0.0
9800,1,0.0
98100,1,0.0
9296,1,0.0
109-186,1,0.0
9400,1,0.0
94100,1,0.0
117-269,1,0.0
3105,1,0.0
Endocardiac,1,0.0
Epilepsies,1,0.0
pwith,1,0.0
Wellknown,1,0.0
child-specific,1,0.0
E-RSCOPD,1,0.0
semi-emergency,1,0.0
144-135,1,0.0
monthsyears,1,0.0
Sparks,1,0.0
non-vaccinee,1,0.0
matchingmismatching,1,0.0
syndrome‐related,1,0.0
Baroyan-Rvachev,1,0.0
PSEEI2RF,1,0.0
calculation-theoretical,1,0.0
2-positive,1,0.0
Retest,1,0.0
B1128P1,1,0.0
Recordings,1,0.0
FNL,1,0.0
Speculation,1,0.0
Commission-certified,1,0.0
rostal,1,0.0
6352,1,0.0
737-54769,1,0.0
residue-residue,1,0.0
FEV10FVC,1,0.0
full-genomes,1,0.0
panacea,1,0.0
acquired-presumable,1,0.0
contused,1,0.0
N267,1,0.0
Th1Th2-bias,1,0.0
GSTM1-null,1,0.0
neo-Sumerian,1,0.0
turbidimetry,1,0.0
Mesopotamian,1,0.0
grew-up,1,0.0
opaque,1,0.0
cradle,1,0.0
p0087,1,0.0
n180,1,0.0
agglutination-PCR,1,0.0
n368,1,0.0
Fora,1,0.0
Juiz,1,0.0
agglutinate,1,0.0
DNA-barcoded,1,0.0
11051151-7,1,0.0
Microlab,1,0.0
Shiraz,1,0.0
Nemazee,1,0.0
5657,1,0.0
PIK3CG,1,0.0
IRAK2,1,0.0
9955,1,0.0
222223,1,0.0
evolvement,1,0.0
wrongfully,1,0.0
2112-2004,1,0.0
chronically-ill,1,0.0
elderies,1,0.0
ILVO,1,0.0
entryfusion,1,0.0
morbidity-diminishing,1,0.0
iNANC,1,0.0
bronchorelaxant,1,0.0
synonym,1,0.0
MVRR,1,0.0
BMVR,1,0.0
septic-shock,1,0.0
nanoshell,1,0.0
shells,1,0.0
clay,1,0.0
antitussive,1,0.0
nonvaccine-related,1,0.0
roaming,1,0.0
Physico-chemical,1,0.0
physician-priests,1,0.0
ašu,1,0.0
exorcists,1,0.0
4176,1,0.0
083-1,1,0.0
099-1,1,0.0
āšipu,1,0.0
CoV-NL63,1,0.0
RPAIN,1,0.0
CoV-HKU,1,0.0
ORF1b-nsp14,1,0.0
≥105,1,0.0
1264,1,0.0
7540,1,0.0
9603,1,0.0
CABG-treated,1,0.0
depression-anxiety,1,0.0
screen-and-consult,1,0.0
PICAI,1,0.0
factors--the,1,0.0
allergy--might,1,0.0
SYBR-Green,1,0.0
nonarrhythmic,1,0.0
glycoproteins--hemagglutinin,1,0.0
sinoventricular,1,0.0
sine-wave,1,0.0
1·37,1,0.0
1·18-1·60,1,0.0
3·10,1,0.0
2·13-4·52,1,0.0
Annapolis,1,0.0
2·03,1,0.0
1·65-2·50,1,0.0
Needlestick,1,0.0
supervenes,1,0.0
virus-A,1,0.0
preasthmatic,1,0.0
hands-free,1,0.0
ATIs,1,0.0
C1QBP,1,0.0
subgroups-negligible,1,0.0
CARe,1,0.0
197-249,1,0.0
106-146,1,0.0
Hypertrophic,1,0.0
leaver,1,0.0
ambient-,1,0.0
negligible-,1,0.0
924-989,1,0.0
apprenticeships,1,0.0
leavers,1,0.0
protein--M1,1,0.0
17-yr-old,1,0.0
27-yr-old,1,0.0
eggoals,1,0.0
20201201-lineage,1,0.0
analyzedResults,1,0.0
47-67,1,0.0
preschools,1,0.0
Inspiration,1,0.0
resultsConclusions,1,0.0
Spherical,1,0.0
80-120,1,0.0
old-peoples,1,0.0
paled,1,0.0
MiRXES,1,0.0
simulation‐based,1,0.0
ESCs-derived,1,0.0
animal-based,1,0.0
fledgling,1,0.0
non-conserved,1,0.0
human-based,1,0.0
anthropocentric,1,0.0
76421-428,1,0.0
HA1-H18,1,0.0
Monitored,1,0.0
cation-cation,1,0.0
on‐site,1,0.0
soaking,1,0.0
1528-127,1,0.0
distance‐learning,1,0.0
fourth‐year,1,0.0
cardio‐pulmonary,1,0.0
Hemagglutnin,1,0.0
seroarchaeology,1,0.0
seroarchaeological,1,0.0
1800s,1,0.0
28165,1,0.0
Intravenously,1,0.0
AnTicoagulation,1,0.0
anitibodies,1,0.0
changchun,1,0.0
95-15,1,0.0
HNA,1,0.0
ushering,1,0.0
httprimedorgrimedicaljournal-2017-11asp,1,0.0
732467,1,0.0
13-47,1,0.0
nasal-,1,0.0
confirmers,1,0.0
»35,1,0.0
11-37,1,0.0
13-46,1,0.0
B--,1,0.0
26-96,1,0.0
3cases,1,0.0
whiteout,1,0.0
828-081,1,0.0
149-242,1,0.0
ProActive,1,0.0
truck,1,0.0
TOBT,1,0.0
within-community,1,0.0
suppressible,1,0.0
contender,1,0.0
transference,1,0.0
25-03,1,0.0
-SEM,1,0.0
319-088,1,0.0
anti-leukocyte,1,0.0
pre-plasmapheresis,1,0.0
re-optimization,1,0.0
FDA-cleared,1,0.0
pro-regenerative,1,0.0
signalings,1,0.0
Lummiss,1,0.0
Immune-related,1,0.0
fourteenth,1,0.0
fronto-occipital,1,0.0
Desire,1,0.0
doctorpatient,1,0.0
ASH,1,0.0
counter-conditioning,1,0.0
menu,1,0.0
FSRS,1,0.0
Generations,1,0.0
PCOS,1,0.0
peal,1,0.0
asthmaMoreover,1,0.0
reconfirms,1,0.0
1996-2010,1,0.0
1996-2009,1,0.0
144-160,1,0.0
fertilized,1,0.0
0-96,1,0.0
0-104,1,0.0
go-live,1,0.0
Opposing,1,0.0
histoglobin,1,0.0
MB-izoenzyme,1,0.0
Kars,1,0.0
hydroxybutyrate,1,0.0
50567,1,0.0
68632,1,0.0
95724,1,0.0
TTE-detected,1,0.0
104-145,1,0.0
pertussis-induced,1,0.0
ovalbumin-specific,1,0.0
İstanbul,1,0.0
106-429,1,0.0
Southampton,1,0.0
Adıyaman,1,0.0
N3-forward,1,0.0
Erciyes,1,0.0
2503,1,0.0
Kocaeli,1,0.0
90300,1,0.0
17-September,1,0.0
NC0455121,1,0.0
MAFFT,1,0.0
AliView,1,0.0
Primer-probe,1,0.0
N-forward,1,0.0
endarterctomy,1,0.0
Intraobserver,1,0.0
50-150,1,0.0
resuLts,1,0.0
Hermansen,1,0.0
bwt,1,0.0
Werdnig-Hoffmann,1,0.0
amyotrophy,1,0.0
ischemiareperfusion-induced,1,0.0
Moderately,1,0.0
twofold--filling,1,0.0
hypophyseal,1,0.0
nanism,1,0.0
NFGamaleia,1,0.0
less-mutated,1,0.0
Respectively,1,0.0
reputed,1,0.0
gestion,1,0.0
coastlines,1,0.0
reputation,1,0.0
on-label,1,0.0
22-51,1,0.0
Wnt5aWnt11,1,0.0
httpsbitly3lxEGRA,1,0.0
knowledges,1,0.0
FXIII-A25th,1,0.0
1036,1,0.0
2702,1,0.0
Reach,1,0.0
7651,1,0.0
Relaxin,1,0.0
encephalomyelopathy,1,0.0
0004ABSTRACT,1,0.0
Trough,1,0.0
httpopenfluvital-itch,1,0.0
httpEMPRES-ifaoorg,1,0.0
droplet-generating,1,0.0
V4R-V7R,1,0.0
CoV-2019,1,0.0
Inferiorposterior,1,0.0
extra-cerebral,1,0.0
Concave,1,0.0
inflections,1,0.0
CACs,1,0.0
embolised,1,0.0
Smoking-induced,1,0.0
Tel-Aviv,1,0.0
ABrisbane,1,0.0
California709swine,1,0.0
mid-myocardial,1,0.0
-myocardial,1,0.0
over-reacted,1,0.0
holidaying,1,0.0
Diameter,1,0.0
fill-in-after,1,0.0
tribute,1,0.0
special-interest,1,0.0
Post-hospital,1,0.0
9948,1,0.0
d30,1,0.0
Russias,1,0.0
tensiontime,1,0.0
28±5,1,0.0
9±2,1,0.0
IBGP,1,0.0
Flixotide,1,0.0
Rotadisc,1,0.0
co-payment,1,0.0
77458,1,0.0
single-finger-typed,1,0.0
1946,1,0.0
1010634,1,0.0
33842281,1,0.0
REGN-Cov2,1,0.0
Hypotensive,1,0.0
DNBC,1,0.0
μT,1,0.0
Hypoplastic,1,0.0
athletically,1,0.0
ineffectual,1,0.0
httpwwwdiagnosticpathologydiagnomxeuvs1558483061962648,1,0.0
harmfully,1,0.0
n1536,1,0.0
cocooning,1,0.0
cμL,1,0.0
Kirchner,1,0.0
cytoplasma,1,0.0
Laser-facilitated,1,0.0
BBrisbene602008,1,0.0
13200,1,0.0
ARVIs,1,0.0
d0-d5,1,0.0
1377,1,0.0
Solomon,1,0.0
2561,1,0.0
7043,1,0.0
5052,1,0.0
7305,1,0.0
187256,1,0.0
8249,1,0.0
212257,1,0.0
«European,1,0.0
Tiffneaus,1,0.0
action»,1,0.0
receptor-specific,1,0.0
heat-labile,1,0.0
hedgehog-,1,0.0
CpG-ODN1826,1,0.0
raspberry-like,1,0.0
laser-generated,1,0.0
6712,1,0.0
danger-associated,1,0.0
obstruction--forced,1,0.0
volumemin,1,0.0
interconnect,1,0.0
Bremen,1,0.0
1998-updating,1,0.0
clerkship,1,0.0
36∶1,1,0.0
16∶1,1,0.0
18391,1,0.0
arenet,1,0.0
encephalon,1,0.0
slow-releasing,1,0.0
coverslips,1,0.0
photoactive,1,0.0
equalizing,1,0.0
physicians-in-training,1,0.0
stadiums,1,0.0
high-traffic,1,0.0
I60-I64,1,0.0
self-disinfectingcleaning,1,0.0
ARI-triggered,1,0.0
nonconductive,1,0.0
Ignorance,1,0.0
Multistage,1,0.0
436-1763,1,0.0
pre-strokes,1,0.0
3844,1,0.0
CDC-defined,1,0.0
swiss,1,0.0
GyneWeb,1,0.0
antithrombic,1,0.0
AGTEST,1,0.0
Singular,1,0.0
Polysorba,1,0.0
European-based,1,0.0
perforce,1,0.0
9627,1,0.0
doctor-prescribed,1,0.0
physician-prescribed,1,0.0
Pawtucket,1,0.0
non-English-speaking,1,0.0
microinfarction,1,0.0
serum-enzymes,1,0.0
delayed-type,1,0.0
silicic,1,0.0
polysorba,1,0.0
I461,1,0.0
bioassimilability,1,0.0
ThorUS,1,0.0
PleurEff,1,0.0
Judkins-catheter,1,0.0
open-chest-surgery,1,0.0
Altay,1,0.0
ARCHITECT®,1,0.0
hyperboles,1,0.0
infarctionICD-10,1,0.0
I21-I22,1,0.0
made-for-television-movie,1,0.0
helium-3,1,0.0
magazines,1,0.0
FAOs,1,0.0
12210,1,0.0
Electro,1,0.0
cardiographically,1,0.0
N1N1,1,0.0
bourgeoisies,1,0.0
late-gadolinium-enhancement,1,0.0
academic-industry,1,0.0
censuring,1,0.0
IIbIII,1,0.0
Misericórdia,1,0.0
1710,1,0.0
86-159,1,0.0
1991-2005,1,0.0
hirulog,1,0.0
exposureABSTRACT,1,0.0
19861987,1,0.0
geomapping,1,0.0
agroecological,1,0.0
pxAF,1,0.0
trace-and-track,1,0.0
ptAF,1,0.0
Hanbury,1,0.0
awakes,1,0.0
rescue-free,1,0.0
cromone,1,0.0
LGE-MRI,1,0.0
ESCACCAHA,1,0.0
Researh,1,0.0
sub-licensing,1,0.0
self-eating,1,0.0
Autophagys,1,0.0
PEGNaCl,1,0.0
Frunze,1,0.0
collectionGap,1,0.0
sizeAim,1,0.0
testingMethodology,1,0.0
expiring,1,0.0
geneResults,1,0.0
820-941,1,0.0
851-959,1,0.0
n62,1,0.0
Urmia,1,0.0
H5N1s,1,0.0
Reserves,1,0.0
nine-month,1,0.0
NF-AT,1,0.0
transduction-activated,1,0.0
co-activator,1,0.0
CREB-binding,1,0.0
CBP,1,0.0
2987,1,0.0
inundation,1,0.0
Q-TRAK,1,0.0
VivoFit,1,0.0
FitBit,1,0.0
spring-loaded,1,0.0
Jawbone,1,0.0
Trx1,1,0.0
10group,1,0.0
1040,1,0.0
intussusception,1,0.0
MYND,1,0.0
amassing,1,0.0
Overproduction,1,0.0
cytokine-secreting,1,0.0
calretinin,1,0.0
Turnbulls,1,0.0
3mg,1,0.0
Confluent,1,0.0
temperature-responsive,1,0.0
C3HHeN,1,0.0
GFP-positive,1,0.0
30min,1,0.0
GFP-staining,1,0.0
percussion,1,0.0
Hidaka,1,0.0
12070,1,0.0
124min,1,0.0
1988-90,1,0.0
AequineNewmarket177,1,0.0
AequineTokyo271,1,0.0
Self-medication,1,0.0
fussy,1,0.0
tired-appearing,1,0.0
α-actinin,1,0.0
daysmonth,1,0.0
1589,1,0.0
129–164,1,0.0
30-lead,1,0.0
0916,1,0.0
ROS-induced,1,0.0
245–316Of,1,0.0
AICAR,1,0.0
membranacea,1,0.0
Ganz,1,0.0
µmolL,1,0.0
cardiomyoblasts,1,0.0
seriate,1,0.0
clenched,1,0.0
vector-cardiography,1,0.0
non-Type-2,1,0.0
151300,1,0.0
34150,1,0.0
occupationally-acquired,1,0.0
H9C2,1,0.0
MuRF1,1,0.0
33-month-old,1,0.0
screaming,1,0.0
flexed,1,0.0
AMPKAMPK,1,0.0
AequineKentucky181,1,0.0
2-years-old,1,0.0
veinvenous,1,0.0
practice-by-practice,1,0.0
currentand,1,0.0
cerebellarataxia,1,0.0
appending,1,0.0
Hereinwe,1,0.0
infarctin,1,0.0
Possiblyin,1,0.0
beyond--providing,1,0.0
season--is,1,0.0
verge,1,0.0
medicinetreatment,1,0.0
vaccination-only,1,0.0
plentiful,1,0.0
accidentsVarious,1,0.0
98th,1,0.0
esophagogram,1,0.0
Suggesting,1,0.0
SGW,1,0.0
Pre-eclampsia,1,0.0
nonmonitored,1,0.0
Peritoneal,1,0.0
retroplacental,1,0.0
pre-eclamptic,1,0.0
anesthetised,1,0.0
Stab,1,0.0
amperage,1,0.0
--within,1,0.0
STO,1,0.0
0024-0066,1,0.0
nucleotidyl-transferases,1,0.0
albuminglobulin,1,0.0
schizonepetae,1,0.0
HA-Gag-VLPs,1,0.0
Electrostimulators,1,0.0
synocarotid,1,0.0
Disseminated,1,0.0
14·3,1,0.0
3·5,1,0.0
Amager-Hvidovre,1,0.0
01-08,1,0.0
attacks--35,1,0.0
vaccine-receptor,1,0.0
infarctABSTRACT,1,0.0
hypoglottis,1,0.0
suppuration,1,0.0
RV12,1,0.0
CS-AMI,1,0.0
cardio-specific,1,0.0
t-butylisonitrile,1,0.0
collagerogenesis,1,0.0
Rabep2,1,0.0
leptomenigeal,1,0.0
muscle--eg,1,0.0
diagnosistherapy,1,0.0
perinatology,1,0.0
Kalman,1,0.0
Limma,1,0.0
V13L,1,0.0
collection-February,1,0.0
databank,1,0.0
70752,1,0.0
Rhinobronchitis,1,0.0
sub-minute,1,0.0
cérébraux,1,0.0
2million,1,0.0
ILI-relevant,1,0.0
GSE7368,1,0.0
omnibus,1,0.0
Topological,1,0.0
G196V,1,0.0
Centiscape,1,0.0
ClusterOne,1,0.0
BINGO,1,0.0
text-mining,1,0.0
indentified,1,0.0
untractable,1,0.0
ESR2,1,0.0
PGR,1,0.0
hispidus,1,0.0
MYC,1,0.0
kineticssymptom,1,0.0
A99V,1,0.0
G252V,1,0.0
subvirion,1,0.0
nontransgenic,1,0.0
UP24,1,0.0
often-undiagnosed,1,0.0
wheeled,1,0.0
MPESD,1,0.0
≥4626,1,0.0
3-62-7,1,0.0
collectin-mediated,1,0.0
12-177-13,1,0.0
1-960-37,1,0.0
Fitbit,1,0.0
80rpm,1,0.0
accuracyprecision,1,0.0
Ulan,1,0.0
RIP-Kb,1,0.0
Businesses,1,0.0
r049,1,0.0
sigmaR,1,0.0
deltaR,1,0.0
r094,1,0.0
sanitary-polyclinic,1,0.0
cardioanalyzer,1,0.0
Kong10771,1,0.0
AMongolia01371,1,0.0
Bator,1,0.0
VKSD,1,0.0
best-fitted,1,0.0
enzymically,1,0.0
CD1d-restricted,1,0.0
CH6,1,0.0
gene-centered,1,0.0
RETIVAD,1,0.0
testing-induced,1,0.0
depopulate,1,0.0
non-negative,1,0.0
Carcasses,1,0.0
composted,1,0.0
1987-1993,1,0.0
outback,1,0.0
unmixing,1,0.0
receptor-positive,1,0.0
-274,1,0.0
4992,1,0.0
37722,1,0.0
overtime,1,0.0
redox-related,1,0.0
oxidationreduction,1,0.0
SuEIR,1,0.0
goblet-cell,1,0.0
Collinearity,1,0.0
0002†,1,0.0
Unscented,1,0.0
skiagraphic,1,0.0
sequencer,1,0.0
-108,1,0.0
sanitary-action,1,0.0
endoglycosidase,1,0.0
Hladovec,1,0.0
re-enactment,1,0.0
substitutive,1,0.0
subocclusive,1,0.0
Bioresorbable,1,0.0
single-antibody,1,0.0
multiantibody,1,0.0
nondifferentiated,1,0.0
PNGase,1,0.0
F-sensitive,1,0.0
2910,1,0.0
H-resistant,1,0.0
accomplishes,1,0.0
Furin-like,1,0.0
homodimerstrimers,1,0.0
post-translationally,1,0.0
bacterially-expressed,1,0.0
S-based,1,0.0
pulmonary-artery,1,0.0
Treat,1,0.0
race-sex,1,0.0
rate-pressure-product,1,0.0
CpG-ODNs,1,0.0
emergenceprogression,1,0.0
bloodborne,1,0.0
ever-decreasing,1,0.0
Seine-Saint-Denis,1,0.0
villag-es,1,0.0
bedevilled,1,0.0
doldrums,1,0.0
ARCOL,1,0.0
dozing,1,0.0
thyo-barbituric,1,0.0
nm-laser,1,0.0
pharmacoresistant,1,0.0
malonly,1,0.0
signification,1,0.0
dismethabolical,1,0.0
LDLc,1,0.0
IBV-associated,1,0.0
ICV-associated,1,0.0
Postma,1,0.0
Boezen,1,0.0
200412696S-104S,1,0.0
derailment,1,0.0
Relief,1,0.0
iPIT,1,0.0
1257,1,0.0
contemplate,1,0.0
mini-spirometer,1,0.0
Koko,1,0.0
redevelopment,1,0.0
AH7N9-negative,1,0.0
studies--that,1,0.0
19S,1,0.0
7S,1,0.0
Y453F,1,0.0
multi-reassortant,1,0.0
CR-was,1,0.0
populationTherefore,1,0.0
sensitivityThese,1,0.0
«Effectiveness,1,0.0
Sars-cov-2,1,0.0
Italy»,1,0.0
metabolism-related,1,0.0
33-50,1,0.0
Irritable,1,0.0
3561,1,0.0
N439KR,1,0.0
trial--we,1,0.0
flutterfibrillation,1,0.0
Δ242-244,1,0.0
socio-medical,1,0.0
dificult,1,0.0
Bifurcations,1,0.0
0969,1,0.0
Bajo,1,0.0
Aragón,1,0.0
massages,1,0.0
AISs,1,0.0
colic,1,0.0
mini-spirometry,1,0.0
neutrophil-related,1,0.0
OAD,1,0.0
Awakening,1,0.0
Adom,1,0.0
at-a-glance,1,0.0
table-can,1,0.0
Magen,1,0.0
face-arm-speech-time,1,0.0
22-month,1,0.0
Exceptions,1,0.0
VEDs,1,0.0
diedABSTRACT,1,0.0
capabilities-based,1,0.0
cen-sorships,1,0.0
O2kgmin,1,0.0
48643,1,0.0
Borovci-Nova,1,0.0
Selo,1,0.0
oxygen-uptake,1,0.0
VBA,1,0.0
Desne-Bagalovići,1,0.0
Dobranje,1,0.0
mid-70s,1,0.0
non-functioning,1,0.0
semesters,1,0.0
Metkovic,1,0.0
TOCC-based,1,0.0
review-augmented,1,0.0
49170,1,0.0
FEV1FEV6,1,0.0
1937-February,1,0.0
anti-thrombin,1,0.0
Mini-spirometers,1,0.0
Checklists,1,0.0
second-rate,1,0.0
1999-February,1,0.0
communityHere,1,0.0
DART,1,0.0
1600-February,1,0.0
casesAs,1,0.0
GSE115469,1,0.0
1946-February,1,0.0
1806-February,1,0.0
EDAS,1,0.0
1980-February,1,0.0
vocation,1,0.0
temperature-controlled,1,0.0
intelligentsia,1,0.0
sanitarians,1,0.0
reaffirmation,1,0.0
Janeiros,1,0.0
dissertations,1,0.0
Deputies,1,0.0
Mayors,1,0.0
seven-month-old,1,0.0
CR1,1,0.0
passive-elastic,1,0.0
1353,1,0.0
higher-than-average,1,0.0
Host-DNA,1,0.0
bance,1,0.0
reinclusion,1,0.0
distur-,1,0.0
thrombolysis--a,1,0.0
endsregions,1,0.0
103-151,1,0.0
utility-weighted,1,0.0
06-27,1,0.0
18148,1,0.0
11163,1,0.0
ROSY--80B,1,0.0
host-miRNA-related,1,0.0
-186,1,0.0
48--a,1,0.0
-202,1,0.0
alive--a,1,0.0
oC,1,0.0
2501516,1,0.0
49-149,1,0.0
AEqui-2,1,0.0
typesHuman,1,0.0
coxsackie,1,0.0
6When,1,0.0
comorbidi-,1,0.0
viral-microRNAs,1,0.0
httprimedorgrimedicaljournal-2017-05asp,1,0.0
stringently,1,0.0
Morse,1,0.0
diagnosisKey,1,0.0
COVID-19•,1,0.0
patients•,1,0.0
tape-recorded,1,0.0
structuralist,1,0.0
NCCTor,1,0.0
immune-system-modulating,1,0.0
pressure-length,1,0.0
clinical-enzimatic,1,0.0
medicalize,1,0.0
zumab,1,0.0
filtrations,1,0.0
anti-IgEomali-,1,0.0
re-thoracotomy,1,0.0
investigationABSTRACT,1,0.0
Needle-guided,1,0.0
non-palpable,1,0.0
peutic,1,0.0
VATSMethods,1,0.0
literatureResults,1,0.0
Hook,1,0.0
timingConclusion,1,0.0
thera-,1,0.0
Fibrillations,1,0.0
8992,1,0.0
1593,1,0.0
scFv-treated,1,0.0
1712-1899,1,0.0
4611-4956,1,0.0
TH2-mediated,1,0.0
Severedifficult-to-treat,1,0.0
revitalization,1,0.0
19010,1,0.0
GreedyAlloc,1,0.0
Low-amplitude,1,0.0
interbatch,1,0.0
50-times,1,0.0
xenophobia,1,0.0
stentriver,1,0.0
8532,1,0.0
Immunoblot,1,0.0
pterional,1,0.0
Sylvian,1,0.0
indocyanine,1,0.0
abzyme,1,0.0
video-angiography,1,0.0
2-mo,1,0.0
74100,1,0.0
Single-chain,1,0.0
echos,1,0.0
acenocumarol,1,0.0
186218,1,0.0
9713,1,0.0
9997,1,0.0
voxel-level,1,0.0
Nexpert,1,0.0
Hypercard,1,0.0
9383,1,0.0
MacIntosh,1,0.0
ratingABSTRACT,1,0.0
juxtacortical,1,0.0
delaypause,1,0.0
hemicomvulsions,1,0.0
nosethroat,1,0.0
hemiconvulsions,1,0.0
Scarcity,1,0.0
tracheae,1,0.0
widowhood,1,0.0
normalcy-recognizing,1,0.0
conspicuously,1,0.0
AMplification-Based,1,0.0
post-QRS,1,0.0
micropotentials,1,0.0
months--range,1,0.0
20-300,1,0.0
80-300,1,0.0
measures-national,1,0.0
spatiallyacross,1,0.0
aneurysmABSTRACT,1,0.0
Vidonjeand,1,0.0
Desne,1,0.0
twentieth-century,1,0.0
name-based,1,0.0
Visuospatial,1,0.0
chymotrypsin-,1,0.0
-412,1,0.0
36-58,1,0.0
8790,1,0.0
protein-inhibitor,1,0.0
sociological-demographic,1,0.0
121-1319,1,0.0
reporter-based,1,0.0
4-level,1,0.0
Reactivities,1,0.0
mg·L-1,1,0.0
≥1160,1,0.0
Tackling,1,0.0
110-1316,1,0.0
inter-sectoral,1,0.0
pan-African,1,0.0
four-pronged,1,0.0
people-focused,1,0.0
Ubuntu,1,0.0
207·103,1,0.0
inclusiveness,1,0.0
togetherness,1,0.0
ltbgtBackground,1,0.0
Objectiveltbgt,1,0.0
agrammatism,1,0.0
clinical-laboratory,1,0.0
Peri-Fontan,1,0.0
abolishment,1,0.0
Medleys,1,0.0
evo-epidemiological,1,0.0
sphygmomanometric,1,0.0
20-68,1,0.0
6-76,1,0.0
cross-amplification,1,0.0
outbursts,1,0.0
Pre-procedural,1,0.0
Globalisation,1,0.0
teary,1,0.0
fights,1,0.0
IAVhuman,1,0.0
⩾1,1,0.0
medical-hospital,1,0.0
476-636,1,0.0
150-172,1,0.0
IAV-diagnosed,1,0.0
140-150,1,0.0
IAVIBV-infected,1,0.0
79-86,1,0.0
1999-2016,1,0.0
1970-1971,1,0.0
pre-Fontan,1,0.0
System-II,1,0.0
average-,1,0.0
ltbgtMaterials,1,0.0
Methodsltbgt,1,0.0
3-open-complex,1,0.0
Hydration,1,0.0
AKI-related,1,0.0
IV-related,1,0.0
35·8,1,0.0
D614A-C,1,0.0
laboratory-quality,1,0.0
L455F,1,0.0
E-aminocaproic,1,0.0
F456L-RBD,1,0.0
Q787H-S2,1,0.0
ACE2-free,1,0.0
CT2,1,0.0
httpflupharmtaocom,1,0.0
open-complex,1,0.0
polymorphonuclears,1,0.0
TRS-L,1,0.0
TRS-B,1,0.0
Undesirable,1,0.0
ruffled,1,0.0
CASThe,1,0.0
60-99,1,0.0
realpolitik,1,0.0
scheduLed,1,0.0
medicaL,1,0.0
superimposing,1,0.0
host-virus-vaccine-drug-environment,1,0.0
average-altitude,1,0.0
multiple-location,1,0.0
Ahsa,1,0.0
ltbgtResultsltbgt,1,0.0
4016±1247,1,0.0
SpOltsubgt2ltsubgt,1,0.0
ltbgtConclusionltbgt,1,0.0
early-intervention,1,0.0
onset--the,1,0.0
003-081,1,0.0
fatiguemalaise,1,0.0
oral-pharyngeal,1,0.0
001-049,1,0.0
lower-respiratorytract,1,0.0
immunogenetics,1,0.0
063-1,1,0.0
KWB,1,0.0
Keith-Wagener-Barker,1,0.0
CVD-free,1,0.0
DNRP,1,0.0
low-osmolar,1,0.0
iso-,1,0.0
unfamiliarity,1,0.0
host-influenza,1,0.0
host-influenza-drug,1,0.0
host-influenza-vaccine,1,0.0
interlocked,1,0.0
outpatientsinpatients,1,0.0
multi-method,1,0.0
4143896,1,0.0
questionnaries,1,0.0
0990,1,0.0
0-21,1,0.0
308319,1,0.0
026-065,1,0.0
009-039,1,0.0
diary-obtained,1,0.0
sumscore,1,0.0
3896,1,0.0
bifactor,1,0.0
non-neuraminidase,1,0.0
Paying,1,0.0
traqueostomy,1,0.0
subsidize,1,0.0
bridge-related,1,0.0
55R2,1,0.0
alaryngeal,1,0.0
10week,1,0.0
tracheoesophageal,1,0.0
5week,1,0.0
furloughed,1,0.0
CiteSpace,1,0.0
end-result,1,0.0
laryngectomy,1,0.0
Tucker-Lewis,1,0.0
humidifications,1,0.0
SARS-CoV-2-purturbated,1,0.0
responsable,1,0.0
risk-communication,1,0.0
Landis,1,0.0
Leopold,1,0.0
salting,1,0.0
sweetening,1,0.0
6885,1,0.0
Optimisation,1,0.0
20p13,1,0.0
incriminating,1,0.0
inseparable,1,0.0
paralelism,1,0.0
hipperfusion,1,0.0
posenous,1,0.0
atelectasia,1,0.0
colapse,1,0.0
-0374,1,0.0
diseminated,1,0.0
0988,1,0.0
depurating,1,0.0
colaps,1,0.0
TLI,1,0.0
Mechanic,1,0.0
intermitent,1,0.0
possitive,1,0.0
shool-age,1,0.0
seizuresESs,1,0.0
electrogenic,1,0.0
ofneuraminidase,1,0.0
doctorsnurses,1,0.0
governmentalhospital,1,0.0
freeself-paid,1,0.0
alluded,1,0.0
effectivenesssafetycost,1,0.0
oseltamivirs,1,0.0
daldaghee,1,0.0
naswaar,1,0.0
virus-proven,1,0.0
paan,1,0.0
anechoichypoechoic,1,0.0
antibioticsantifungals,1,0.0
Embracing,1,0.0
Α,1,0.0
GENOMICA,1,0.0
PneumoVir,1,0.0
drugvaccinestrategy,1,0.0
Herculean,1,0.0
Chemo-diversity,1,0.0
Algae,1,0.0
benefitABSTRACT,1,0.0
CLART®,1,0.0
PR834-expressing,1,0.0
febrileafebrile,1,0.0
102020-112020,1,0.0
751680,1,0.0
optoelectronic,1,0.0
Alorbat,1,0.0
gene-to-gene,1,0.0
lymphopoietic,1,0.0
paracortical,1,0.0
carinal,1,0.0
soonest,1,0.0
governmenthospitals,1,0.0
protraction,1,0.0
727712,1,0.0
6-108,1,0.0
listeria,1,0.0
underdetection,1,0.0
aluminumoxide,1,0.0
blood-level-peak,1,0.0
5891,1,0.0
24848,1,0.0
USD90,1,0.0
646565,1,0.0
18484,1,0.0
25527,1,0.0
2721000,1,0.0
effectivenessrare,1,0.0
free80,1,0.0
nursesdoctors,1,0.0
level-forced,1,0.0
Srinagarind,1,0.0
non-classic,1,0.0
reticulocytes,1,0.0
RR-7,1,0.0
protein-oxygen,1,0.0
testee,1,0.0
4591,1,0.0
Bentalls,1,0.0
testees,1,0.0
twin-cartridge,1,0.0
Tentative,1,0.0
bronchoprovocationbronchodilator,1,0.0
Chuo,1,0.0
airstream,1,0.0
definte,1,0.0
Dinitrate,1,0.0
OAI,1,0.0
Intra-Aortic,1,0.0
NIHSSS,1,0.0
interactionist,1,0.0
ECGphic,1,0.0
NQ,1,0.0
2-the,1,0.0
SARS-CoV-2-was,1,0.0
spermatogonia,1,0.0
Pros,1,0.0
Kühtai,1,0.0
cases100000,1,0.0
Starnberg,1,0.0
sulpiride,1,0.0
MEGASTROKE,1,0.0
evacuatory,1,0.0
19214,1,0.0
6214mm3,1,0.0
HBs,1,0.0
ACAO,1,0.0
IntroductionEstimating,1,0.0
63811,1,0.0
Confidential,1,0.0
40453,1,0.0
3640,1,0.0
Th2Th17,1,0.0
neutrophilic-mediated,1,0.0
33918,1,0.0
hyphal,1,0.0
enzyme-producing,1,0.0
773234,1,0.0
P77×10-5,1,0.0
β0102,1,0.0
β0083,1,0.0
AHE,1,0.0
AHE-provoked,1,0.0
P5×10-8,1,0.0
110-187,1,0.0
1-ethyl-3-3-dimethylaminopropylcarbodiimide,1,0.0
ABIs,1,0.0
Maranhão,1,0.0
Innsbruck,1,0.0
26210,1,0.0
RT-q,1,0.0
trifurcations,1,0.0
hypercrinia,1,0.0
Bolivia,1,0.0
benevolent,1,0.0
GFTs,1,0.0
Freiburg-personality-inventory,1,0.0
Probiotic,1,0.0
braced,1,0.0
call-to-arms,1,0.0
diabetes-susceptible,1,0.0
829464,1,0.0
nonroutine,1,0.0
trifurcation,1,0.0
9615-10000,1,0.0
Trifurcating,1,0.0
506100000,1,0.0
trifurcartion,1,0.0
percutaneus,1,0.0
117100000,1,0.0
non-specific--dyspnea,1,0.0
problems--as,1,0.0
Myoepithelioma,1,0.0
pathogenicity--have,1,0.0
disease--the,1,0.0
Factor-Kappa,1,0.0
Benevolent,1,0.0
9185-9972,1,0.0
Poliovirus,1,0.0
2-O-MTase,1,0.0
autochthonously,1,0.0
n1431,1,0.0
25818,1,0.0
Islandic,1,0.0
39156,1,0.0
toothache,1,0.0
Pulmonary-Allergic,1,0.0
barkeeper,1,0.0
1381,1,0.0
Twentyfour,1,0.0
2073,1,0.0
9884,1,0.0
discrinia,1,0.0
9369-9997,1,0.0
9619-10000,1,0.0
9651,1,0.0
9014-9927,1,0.0
9260-9974,1,0.0
8488,1,0.0
7554-9170,1,0.0
9895,1,0.0
capping,1,0.0
5-end,1,0.0
9427-9997,1,0.0
8212,1,0.0
challengesAimIn,1,0.0
temperatureMethodsAssociations,1,0.0
AH1NI2009,1,0.0
NSTEMI-guidelines,1,0.0
STEMI-guidelines,1,0.0
Provence,1,0.0
Alpes,1,0.0
dAzur,1,0.0
PACA,1,0.0
Cardioversion,1,0.0
0652,1,0.0
0167,1,0.0
Hyperlipidemia,1,0.0
ever-widening,1,0.0
paperThese,1,0.0
retrotranscription,1,0.0
objectivizes,1,0.0
apparent-can,1,0.0
nor-owing,1,0.0
pulmonologist-confirmed,1,0.0
years-have,1,0.0
weeks-6,1,0.0
mortality-rates-both,1,0.0
condition-related,1,0.0
2-React,1,0.0
1920-51,1,0.0
stroke-mortality,1,0.0
TRANSIENT,1,0.0
IOM,1,0.0
startle,1,0.0
1013883,1,0.0
risk--children,1,0.0
Graded,1,0.0
before-PA,1,0.0
unsampled,1,0.0
no-early,1,0.0
Severe-acute-respiratory-syndrome-related,1,0.0
Rwandan,1,0.0
A231,1,0.0
347606,1,0.0
528394,1,0.0
507±167,1,0.0
sub-lineage,1,0.0
Backgrond,1,0.0
laparoscopic-assisted,1,0.0
6212,1,0.0
Laparoscopy,1,0.0
4331,1,0.0
6613,1,0.0
1792441,1,0.0
6669071,1,0.0
6318601,1,0.0
5046851,1,0.0
ORF1a-based,1,0.0
Viroselect,1,0.0
A2England11966,1,0.0
2Miami1963,1,0.0
shattering,1,0.0
menial,1,0.0
direct-care,1,0.0
299209,1,0.0
810-827,1,0.0
113-119,1,0.0
vaccinatedday,1,0.0
471-677,1,0.0
Funnel,1,0.0
733-903,1,0.0
Dogubeyazit-Van,1,0.0
179-305,1,0.0
Van-Dogubeyazit,1,0.0
stardom-his,1,0.0
registries-based,1,0.0
Gone,1,0.0
flew,1,0.0
gunner,1,0.0
179-290,1,0.0
258-399,1,0.0
mouth-to-mouth,1,0.0
MDI-aerosol,1,0.0
influenzaConclusionsStudies,1,0.0
mgdaily,1,0.0
calculatedResultsOverall,1,0.0
neurogliovascular,1,0.0
daily-varying,1,0.0
Parameterizing,1,0.0
A2Nederland1968,1,0.0
unitsliter,1,0.0
StartReact,1,0.0
Bulovce,1,0.0
Interpatient,1,0.0
Subnational,1,0.0
0ms,1,0.0
25s,1,0.0
80--85,1,0.0
club-like,1,0.0
ul,1,0.0
CDNANZ,1,0.0
uncoordinated,1,0.0
predominatedThis,1,0.0
consort,1,0.0
2001-May,1,0.0
October-May,1,0.0
preoperation,1,0.0
IcTn-I,1,0.0
HPLC-Q-TOFMS,1,0.0
1--64,1,0.0
GATM,1,0.0
NT5E,1,0.0
action-oriented,1,0.0
Sitting,1,0.0
Larger-scale,1,0.0
Ewing,1,0.0
region1,1,0.0
NF-B,1,0.0
disorderABSTRACT,1,0.0
3D-printing,1,0.0
Floridas,1,0.0
nontrivial,1,0.0
Media®,1,0.0
Indifference,1,0.0
rehearsals,1,0.0
dwell,1,0.0
0001Patients,1,0.0
analysisEighty,1,0.0
Singing,1,0.0
rehabilitationA,1,0.0
problemsWe,1,0.0
polybeta,1,0.0
Leukocytoclastic,1,0.0
US14,1,0.0
computerweb-based,1,0.0
Agastache,1,0.0
Deutschmarks,1,0.0
membranaceus,1,0.0
MDI-S,1,0.0
2009May,1,0.0
Cassia,1,0.0
alata,1,0.0
Ecklonia,1,0.0
aminoesters,1,0.0
WS,1,0.0
second-stage,1,0.0
2925,1,0.0
Hanege,1,0.0
Cerumen,1,0.0
wave-related,1,0.0
p0056,1,0.0
n3491,1,0.0
27351,1,0.0
28364,1,0.0
22286had,1,0.0
CLARITY-TIMI,1,0.0
non-pneumonia,1,0.0
Cardiomyopathy,1,0.0
18F-fluoro-2-deoxy-D-glucose,1,0.0
baPWV,1,0.0
peri-ischemic,1,0.0
14C-2-DG,1,0.0
2989,1,0.0
Next-morning,1,0.0
uncanny,1,0.0
Hemostatic,1,0.0
1968-77,1,0.0
Holmes,1,0.0
Rahes,1,0.0
alpha-blockers,1,0.0
brachial-ankle,1,0.0
Gymnema,1,0.0
Discovered,1,0.0
Chan-Yeung,1,0.0
taxifolin,1,0.0
herbacetin,1,0.0
Dar,1,0.0
hirsutenone,1,0.0
n80,1,0.0
iguesterin,1,0.0
jubanine,1,0.0
pectolinarin,1,0.0
textmgd,1,0.0
phloroeckol,1,0.0
silvestrol,1,0.0
text21Formula,1,0.0
rhoifolin,1,0.0
epigallocatechin-gallate,1,0.0
xanthoangelol,1,0.0
zingerol,1,0.0
influenza-parainfluenza,1,0.0
nasopharingeal,1,0.0
24-32,1,0.0
95IC,1,0.0
157-569,1,0.0
-RBD,1,0.0
beta-binomial,1,0.0
factorsIMPORTANCE,1,0.0
analogic,1,0.0
supernatural,1,0.0
diosmin,1,0.0
sylvestre,1,0.0
lingua,1,0.0
uralensis,1,0.0
decompose,1,0.0
Lindera,1,0.0
aggregata,1,0.0
Lycoris,1,0.0
INPS,1,0.0
Mollugo,1,0.0
cerviana,1,0.0
Polygonum,1,0.0
multiflorum,1,0.0
Pyrrosia,1,0.0
Saposhnikoviae,1,0.0
daidzein,1,0.0
divaricate,1,0.0
foult,1,0.0
pensioned,1,0.0
outlived,1,0.0
53269,1,0.0
acacetin,1,0.0
Shams,1,0.0
amentoflavone,1,0.0
allicin,1,0.0
blancoxanthone,1,0.0
cross-reference,1,0.0
Islamoglu,1,0.0
Moira,1,0.0
Toll-Like,1,0.0
differential-therapeutic,1,0.0
decadeIt,1,0.0
class-by-class,1,0.0
school-by-school,1,0.0
Trial-2,1,0.0
trialsEarly,1,0.0
bioequivalence,1,0.0
phonoelectrocardiography,1,0.0
2-24,1,0.0
halide,1,0.0
PGI2TxB2,1,0.0
retrofailure,1,0.0
O2-balance,1,0.0
NK1,1,0.0
proaggregants,1,0.0
carotid-femoral,1,0.0
dilatants,1,0.0
aldosteron-renin-angiotensin,1,0.0
TICI-2b-3,1,0.0
hypophyseoadrenocortical,1,0.0
2c3,1,0.0
radioimmunoassayed,1,0.0
RBD2,1,0.0
neurophysiologic,1,0.0
MR-angiography,1,0.0
Tachykinin,1,0.0
randomise,1,0.0
4314,1,0.0
inexcitability,1,0.0
immunohistological,1,0.0
microfold,1,0.0
Typhoid,1,0.0
fervescence,1,0.0
FPCAs,1,0.0
overall-state-of-the-patient,1,0.0
enprofylline,1,0.0
Tauzin,1,0.0
hyperkalemic,1,0.0
cystine-isoleucine-methionine,1,0.0
FVM-CIM,1,0.0
Phe352Cys-Val388Ile-Met647Met,1,0.0
staring,1,0.0
long-known,1,0.0
Cholinergic,1,0.0
Hemagglutination-inhibition,1,0.0
inspectors,1,0.0
slaughterersmeat,1,0.0
prejunctionally,1,0.0
IPTNFTISV,1,0.0
RLFRKSNLK,1,0.0
ASVYAWNRK,1,0.0
SGTNGTKRFDN,1,0.0
NK2,1,0.0
FLAIRDWI,1,0.0
seventies,1,0.0
Hyperemic,1,0.0
016-4583,1,0.0
hemophiliacs,1,0.0
l57,1,0.0
l2,1,0.0
criterion--rightward,1,0.0
QRS--occurred,1,0.0
underwhelming,1,0.0
13205,1,0.0
30-97,1,0.0
739-1079,1,0.0
7549,1,0.0
725-14032,1,0.0
α-amylase,1,0.0
risk--defined,1,0.0
32024,1,0.0
54069,1,0.0
r056,1,0.0
r075,1,0.0
r040,1,0.0
ΔR20439,1,0.0
1993-1997,1,0.0
F46314086,1,0.0
poisonings,1,0.0
carbamate,1,0.0
organophosphate,1,0.0
artery--was,1,0.0
antagomir-92a-based,1,0.0
noncarotid,1,0.0
Y453C,1,0.0
direct-to-PCR,1,0.0
YOLS,1,0.0
homogenization-based,1,0.0
15535,1,0.0
Probabilistically,1,0.0
probabilistically,1,0.0
risk-base,1,0.0
2421CT,1,0.0
5-untranslated,1,0.0
V111A,1,0.0
H133R,1,0.0
M626K,1,0.0
collateral-dependent,1,0.0
R995G,1,0.0
V1068L,1,0.0
antagomir-92a,1,0.0
B1136,1,0.0
cues-to-action,1,0.0
miR-targeted,1,0.0
misattributing,1,0.0
nonvectorized,1,0.0
miR-92a,1,0.0
ORMDL3-dysregulated,1,0.0
barium-gelatin,1,0.0
high-shedding,1,0.0
antipyretic-analgesic,1,0.0
VTR,1,0.0
first-approximation,1,0.0
behavioralpharmacologic,1,0.0
particle-related,1,0.0
cities-,1,0.0
-that,1,0.0
59-9,1,0.0
135-25,1,0.0
glial-scar,1,0.0
SSS2,1,0.0
64-31,1,0.0
43-40,1,0.0
hMAPC,1,0.0
hMSC,1,0.0
88-62,1,0.0
34-18,1,0.0
FeCl3,1,0.0
00-00,1,0.0
γC--,1,0.0
2--,1,0.0
BALBCa-RAG,1,0.0
103-fold,1,0.0
Chaparro,1,0.0
87738,1,0.0
C9994A,1,0.0
Fendrix,1,0.0
double-dosed,1,0.0
cell-size,1,0.0
Fgf2,1,0.0
Hgf,1,0.0
httpsgithubcomfindCPfindCPcli,1,0.0
ChristmasNew,1,0.0
plumes,1,0.0
pressurize,1,0.0
IDF,1,0.0
transductions,1,0.0
Smad3,1,0.0
3-April,1,0.0
BioModels,1,0.0
PKD,1,0.0
httpswwwebiacukbiomodelsMODEL2007210001,1,0.0
findCPcli,1,0.0
Timp4,1,0.0
Mmp2,1,0.0
small-intestinal,1,0.0
inter-relate,1,0.0
astrocytosis,1,0.0
glutamate-calcium,1,0.0
energy-dependent,1,0.0
aminoacidergic,1,0.0
phencyclidine-binding,1,0.0
astroglia,1,0.0
autoimplantation,1,0.0
geo-environmental,1,0.0
94470,1,0.0
Engerix-B,1,0.0
Northridge,1,0.0
30-day-mortality,1,0.0
performance-time,1,0.0
heterogenic,1,0.0
AR-a,1,0.0
Series-based,1,0.0
tralokinumab,1,0.0
34-69,1,0.0
517-290,1,0.0
170-774,1,0.0
116-433,1,0.0
133-418,1,0.0
Oriented,1,0.0
113-350,1,0.0
nonatopy,1,0.0
nontypeable,1,0.0
acid-nonsteroidal,1,0.0
690-914,1,0.0
Waning,1,0.0
PIF0035,1,0.0
atomic-resolution,1,0.0
-gender,1,0.0
DED,1,0.0
score-differences,1,0.0
child-version,1,0.0
keV,1,0.0
vitrified,1,0.0
receptor-2,1,0.0
Renin-sodium,1,0.0
4-dose,1,0.0
de-methylation,1,0.0
10-sample,1,0.0
553518,1,0.0
TLR2-mediated,1,0.0
NSP2T153M,1,0.0
NSP14I42V,1,0.0
Sp1-dependent,1,0.0
SpikeL18F,1,0.0
NSP13Y541C,1,0.0
NSP3T73I,1,0.0
NSP3Q180H,1,0.0
NSP3T1198K,1,0.0
15days,1,0.0
fracturing,1,0.0
Otorhinolaryngology,1,0.0
NTHi-induced,1,0.0
1-40,1,0.0
Galván,1,0.0
Casas,1,0.0
MKK36-p38αβ,1,0.0
cys,1,0.0
IKK-IκBα-dependent,1,0.0
MKK36-p38,1,0.0
NIK-IKKαβ-IκBα,1,0.0
cysLT2,1,0.0
258100000year,1,0.0
middle-to-low-income,1,0.0
bio‐aerosols,1,0.0
Alkinesia,1,0.0
feat,1,0.0
deputies,1,0.0
intermuscular,1,0.0
3-7-11,1,0.0
monosensitization,1,0.0
IgMIgG-positivity,1,0.0
PHN,1,0.0
healthy-travelers,1,0.0
Kostroma,1,0.0
strokes--15-18,1,0.0
strokes--02-04,1,0.0
Asynergy,1,0.0
1887-1953,1,0.0
NCT04324606,1,0.0
IQR12-28,1,0.0
IQR20-66,1,0.0
serum-antibodies,1,0.0
SDLD,1,0.0
28-d,1,0.0
D28,1,0.0
MenACWY,1,0.0
neutrophilmonocyte,1,0.0
preposition,1,0.0
IgE-activated,1,0.0
Allbutts,1,0.0
stress-attributable,1,0.0
Zyflo,1,0.0
syllabic,1,0.0
g24,1,0.0
nucleocapsid-antigens,1,0.0
BinaxNow,1,0.0
societyHuman-to-human,1,0.0
importanceIn,1,0.0
two-hand,1,0.0
CSD1,1,0.0
CSD2,1,0.0
CSDR,1,0.0
Cross-Correlation,1,0.0
C3M,1,0.0
anthroposophic,1,0.0
Bireme,1,0.0
3-class,1,0.0
Stent-protected,1,0.0
nonsurviving,1,0.0
Individualization,1,0.0
3409,1,0.0
non-metaphorical,1,0.0
Clifford,1,0.0
1836-1925,1,0.0
1849-1919,1,0.0
regius,1,0.0
Archibald,1,0.0
Pharmacologically,1,0.0
81-yr-old,1,0.0
138000,1,0.0
antibody-inducing,1,0.0
JCAAI,1,0.0
diferential,1,0.0
manqué,1,0.0
rendez-vous,1,0.0
gigantic,1,0.0
model-including,1,0.0
primates-for,1,0.0
Non-Structural,1,0.0
protection-obviating,1,0.0
Nucleoprotein,1,0.0
Plpro,1,0.0
Pública,1,0.0
isothernal,1,0.0
Darifenacin,1,0.0
Nebivolol,1,0.0
Bictegravir,1,0.0
Alvimopan,1,0.0
Epidemiología,1,0.0
0800-1000,1,0.0
CIBER,1,0.0
1600-1800,1,0.0
mobile-phone,1,0.0
Gupta,1,0.0
faeco‐oral,1,0.0
Gensinis,1,0.0
normoxemia,1,0.0
Indium-111-Fab,1,0.0
10-year-olds,1,0.0
Ultair,1,0.0
1977-1987,1,0.0
β2-Adrenergic,1,0.0
artery-to-middle,1,0.0
13-66,1,0.0
better-defined,1,0.0
4972,1,0.0
Lagging,1,0.0
FGD,1,0.0
Ramadhan,1,0.0
uncompensated,1,0.0
KCONVAC,1,0.0
pathogensis,1,0.0
Organs,1,0.0
out-,1,0.0
AH3Nx,1,0.0
15-year-olds,1,0.0
PWI–DWI,1,0.0
9½-year-old,1,0.0
HIVE,1,0.0
lymphoblastoid,1,0.0
IFN-,1,0.0
TNF-,1,0.0
friendsmicrobiota,1,0.0
Single-particle,1,0.0
Avants,1,0.0
hPMSC,1,0.0
highly-experienced,1,0.0
BMalaysia250604,1,0.0
cartographic,1,0.0
mghr,1,0.0
Supplements,1,0.0
psycho-physiological,1,0.0
HDL-c,1,0.0
signed-rank,1,0.0
Ubon-ratchathani,1,0.0
handcrafted,1,0.0
061-097,1,0.0
sedentarity,1,0.0
riskABSTRACT,1,0.0
067-098,1,0.0
Allergy-Immunology,1,0.0
22999,1,0.0
20639,1,0.0
068-099,1,0.0
survivorscaregivers,1,0.0
first-screening,1,0.0
715164,1,0.0
21-80,1,0.0
1451-25350,1,0.0
12-72,1,0.0
full-night,1,0.0
asthmagenicity,1,0.0
calory,1,0.0
overexposure,1,0.0
48397,1,0.0
transmissionAimWe,1,0.0
104-1025,1,0.0
bedrest,1,0.0
time-ultimately,1,0.0
005-045,1,0.0
138-1503,1,0.0
6021,1,0.0
mg-m3,1,0.0
trans-synapse-connected,1,0.0
Avian-origin,1,0.0
nitroglycerine-induced,1,0.0
BackgroundMany,1,0.0
casesMethodsWe,1,0.0
15697,1,0.0
2020ResultsIt,1,0.0
20-26,1,0.0
daysConclusionThe,1,0.0
acceleration-dependent,1,0.0
ECG-entity,1,0.0
lineagesclades,1,0.0
WGSs,1,0.0
Suriname,1,0.0
tract-derived,1,0.0
baculovirus-expressed,1,0.0
hemagglurinin,1,0.0
exemptions,1,0.0
Low-intensity,1,0.0
nonhormone,1,0.0
fibrinfibrinogen,1,0.0
80Twenty-one,1,0.0
Sixteenrefractory,1,0.0
Enhancements,1,0.0
Hyperimmune,1,0.0
flaplike,1,0.0
immortality,1,0.0
non-porous,1,0.0
280i,1,0.0
ECG-LAA,1,0.0
Echo-LAE,1,0.0
Sievers,1,0.0
occurhypercapnia,1,0.0
REPLATINUM,1,0.0
electroneuromyographic,1,0.0
small-for-gestational,1,0.0
breech,1,0.0
praevia,1,0.0
WAB,1,0.0
Formulated,1,0.0
nouns,1,0.0
propositional,1,0.0
brain-cortex,1,0.0
pathology-proven,1,0.0
bronchopleural,1,0.0
secondpredicted,1,0.0
NCT03699956,1,0.0
Monmouth,1,0.0
G-CSFAMD3100,1,0.0
FM147H1N1,1,0.0
1998-2011,1,0.0
CMDs,1,0.0
myocardial-perfusion,1,0.0
flow-on,1,0.0
Cesearean,1,0.0
non-surgically,1,0.0
peripartal,1,0.0
G-CSFPlerixafor,1,0.0
R287Q,1,0.0
AMD3100,1,0.0
K55R,1,0.0
143±136,1,0.0
first-test,1,0.0
1415-epoxyeicosatrienoic,1,0.0
Retesting,1,0.0
home-isolate,1,0.0
antigen-haploidentical,1,0.0
as-yet-undefined,1,0.0
RRx-001-mediated,1,0.0
Bosentan,1,0.0
post-injection,1,0.0
20-67,1,0.0
effectuality,1,0.0
post-ET,1,0.0
trec,1,0.0
Nonagenarians,1,0.0
Meat,1,0.0
immunotoxicity,1,0.0
Inferoposterior,1,0.0
third-grade,1,0.0
Gaseous,1,0.0
forth-coming,1,0.0
innervate,1,0.0
PCRisolation,1,0.0
andvia,1,0.0
RealFlu,1,0.0
autoinhibitory,1,0.0
organophosphorus,1,0.0
indicator-specific,1,0.0
sick-child,1,0.0
megakaryocytic,1,0.0
anagrelide,1,0.0
suggestively,1,0.0
b0,1,0.0
two-alternative-forced-choice,1,0.0
rs2200733,1,0.0
allergy-specific,1,0.0
Ascertaining,1,0.0
scratching,1,0.0
ACalifornia72009H1N1v,1,0.0
ABSTRACTCOVID-19,1,0.0
OP-induced,1,0.0
ALondon,1,0.0
Vision-based,1,0.0
-Gp,1,0.0
Arduino-based,1,0.0
Uncommon,1,0.0
CTP-predicted,1,0.0
0495-0797,1,0.0
0887,1,0.0
cardiembolic,1,0.0
0811-0935,1,0.0
anti-b2-glycoprotein,1,0.0
ANJ76-AVic75,1,0.0
PCIstill,1,0.0
minimalistic,1,0.0
indicence,1,0.0
CCDSS,1,0.0
cervicocephalic,1,0.0
Non-contracting,1,0.0
rhSP-D,1,0.0
anti-SP-D,1,0.0
L-I,1,0.0
L-II,1,0.0
Bartlett,1,0.0
inter-cohort,1,0.0
large-conductance,1,0.0
Ca2-activated,1,0.0
ts-1E,1,0.0
visit-based,1,0.0
107-128,1,0.0
-delivered,1,0.0
nucleotide-based,1,0.0
serology-informed,1,0.0
standard-based,1,0.0
fast-transmitting,1,0.0
Guarantee,1,0.0
GES,1,0.0
Welcome,1,0.0
sorrowful,1,0.0
etched,1,0.0
ponder,1,0.0
volumeflow,1,0.0
conductances,1,0.0
statics,1,0.0
quasi-randomized,1,0.0
056-10,1,0.0
106-141,1,0.0
pollinosics,1,0.0
healty,1,0.0
Pulmostar,1,0.0
Gutts,1,0.0
Fenyves,1,0.0
manicbipolar,1,0.0
Ekwo-Weiberger,1,0.0
EMS-identified,1,0.0
SHRs,1,0.0
53-71,1,0.0
fast-screening,1,0.0
119-134,1,0.0
737-812,1,0.0
169-189,1,0.0
10275,1,0.0
10238,1,0.0
190-216,1,0.0
214-232,1,0.0
131-147,1,0.0
146-156,1,0.0
138-147,1,0.0
10145,1,0.0
post-priming,1,0.0
7126,1,0.0
039055,1,0.0
Interferon-α,1,0.0
MONICA-Toulouse,1,0.0
€16,1,0.0
€2,1,0.0
€23426,1,0.0
€21096,1,0.0
€19170,1,0.0
€40000,1,0.0
21490,1,0.0
116539,1,0.0
Kamada,1,0.0
SERS-active,1,0.0
amoxycillin,1,0.0
Peribronchial,1,0.0
Abuja,1,0.0
18-306,1,0.0
evict,1,0.0
6·01000,1,0.0
evicted,1,0.0
1·84,1,0.0
Barts,1,0.0
1·39-2·54,1,0.0
2·08,1,0.0
1·49-2·91,1,0.0
receding,1,0.0
REGITELL,1,0.0
Bother,1,0.0
Psychometric,1,0.0
¿bother,1,0.0
¿management,1,0.0
PoC-RAT,1,0.0
back-to-work,1,0.0
V1A3,1,0.0
BTW,1,0.0
ATaiwan186-like,1,0.0
4338,1,0.0
monoplex,1,0.0
episodes1000,1,0.0
water-fowl,1,0.0
Trend,1,0.0
easternmost,1,0.0
10·51000,1,0.0
ANZPIC,1,0.0
ICU-setting,1,0.0
suctioning,1,0.0
parameterizes,1,0.0
5598,1,0.0
appropriate--aspirin,1,0.0
prevention--examples,1,0.0
1813,1,0.0
4-scenario,1,0.0
subphases,1,0.0
non-modifiable--these,1,0.0
ARG2,1,0.0
Arginases,1,0.0
aerosol-,1,0.0
inferiorly-located,1,0.0
ill-equipped,1,0.0
Abdul,1,0.0
Aziz,1,0.0
KAAI,1,0.0
proline-directed,1,0.0
serine-threonine,1,0.0
phosphorylate,1,0.0
mid-2012,1,0.0
COVID-19-if,1,0.0
epizoosis,1,0.0
enzooticity,1,0.0
development-orientated,1,0.0
geo-temporal,1,0.0
transmissability,1,0.0
highlands,1,0.0
dept,1,0.0
supportsstrategies,1,0.0
consumer-directed,1,0.0
x-axis,1,0.0
001-059,1,0.0
OR009,1,0.0
Pulsating,1,0.0
tension-like,1,0.0
Cranial-autonomic,1,0.0
007-030,1,0.0
agonal,1,0.0
OR014,1,0.0
025-093,1,0.0
027-100,1,0.0
p0039,1,0.0
p0145,1,0.0
OR048,1,0.0
Reticulate,1,0.0
011-098,1,0.0
OR033,1,0.0
401-220,1,0.0
Conformity,1,0.0
27405566-68,1,0.0
oscillated,1,0.0
483517,1,0.0
OR052,1,0.0
07-09,1,0.0
chilblains‐like,1,0.0
Maverick,1,0.0
macules,1,0.0
dusky,1,0.0
5·83-6·61,1,0.0
5·96,1,0.0
A-distance,1,0.0
sacked,1,0.0
Largest,1,0.0
L-distance,1,0.0
sLAE,1,0.0
Northshore,1,0.0
differentiations,1,0.0
Multi-Antigen,1,0.0
OR029,1,0.0
SM342,1,0.0
Fourteen-day,1,0.0
012-069,1,0.0
SM381,1,0.0
SM401,1,0.0
-0621,1,0.0
Maslow,1,0.0
datas,1,0.0
belongingness,1,0.0
P059,1,0.0
06-10,1,0.0
3-4-year,1,0.0
Tokyo-Narita,1,0.0
Mx3005,1,0.0
CCG,1,0.0
Val13-orcokinin,1,0.0
Ala13-orcokinin,1,0.0
FDAFTTGFGHS,1,0.0
H1H3,1,0.0
histopathologists,1,0.0
allatostatins,1,0.0
750-3000Da,1,0.0
ESI-Q-TOF,1,0.0
Fractions,1,0.0
borealis,1,0.0
Jonah,1,0.0
spectrometric,1,0.0
948-955,1,0.0
Recurrences,1,0.0
patientsHemorrhagic,1,0.0
multivisceral,1,0.0
Sickle-Cell,1,0.0
pluri-troncular,1,0.0
NGM,1,0.0
Daphne,1,0.0
Stannard,1,0.0
134a-beclomethasone,1,0.0
HFA-BDP,1,0.0
Qvar,1,0.0
tachykinin-related,1,0.0
946-981,1,0.0
Scadding,1,0.0
WeChatQQ,1,0.0
1248-55,1,0.0
best-placed,1,0.0
microRNA-mediated,1,0.0
swine-lineage,1,0.0
neuropeptidomic,1,0.0
limosus,1,0.0
Orconectes,1,0.0
NFDEIDRSSFGFV,1,0.0
NFDEIDRSGFA,1,0.0
FMRFamide,1,0.0
HCO,1,0.0
LRNLRFamide,1,0.0
50ml,1,0.0
DVRTPALRLRFamide,1,0.0
LNPFLRFamide,1,0.0
APQRNFLRFamide,1,0.0
dual-contact,1,0.0
EPLDHVFLRFamide,1,0.0
transmission-dominated,1,0.0
PELDHVFLRFamide,1,0.0
AYNRSFLRFamide,1,0.0
Q-TOF,1,0.0
FMRFamide-related,1,0.0
non-organicity,1,0.0
vaguer,1,0.0
6841,1,0.0
2-3-year,1,0.0
Guglielmo,1,0.0
volumetotal,1,0.0
thrombocytopeniableeding,1,0.0
Neighbourhood,1,0.0
Cocaine-associated,1,0.0
non-ISUC,1,0.0
arteriopathic,1,0.0
dysfunctioncytopathic,1,0.0
shortlong,1,0.0
pre-dilation,1,0.0
Dissatisfaction,1,0.0
Southside,1,0.0
Saliceto,1,0.0
infection-pneumonia,1,0.0
25-13911,1,0.0
MEF2A,1,0.0
volumeTmax,1,0.0
4s,1,0.0
sign-based,1,0.0
best-available,1,0.0
infusing,1,0.0
identifiedWe,1,0.0
immuno-double-diffusion,1,0.0
Rotor-Gene,1,0.0
3s,1,0.0
PCR-measured,1,0.0
lung-volume,1,0.0
±1334,1,0.0
mediastine,1,0.0
176-828,1,0.0
18-yr-olds,1,0.0
Prescriptions,1,0.0
659169,1,0.0
34950,1,0.0
2302,1,0.0
374068,1,0.0
Shibata,1,0.0
H1-antihistamines,1,0.0
8-yr,1,0.0
movable,1,0.0
exess,1,0.0
interfacing,1,0.0
Audience,1,0.0
namely-The,1,0.0
Wrap,1,0.0
IIIIII,1,0.0
ECFrom,1,0.0
irradicate,1,0.0
analysisThere,1,0.0
therapiesOn,1,0.0
Ministerial,1,0.0
chilled,1,0.0
phenomenographic,1,0.0
55-yr-old,1,0.0
OR940,1,0.0
interleukin‑4,1,0.0
hematopoetic,1,0.0
Anyone,1,0.0
prearranged,1,0.0
Co-exposure,1,0.0
Bandung,1,0.0
andasthma,1,0.0
hall-marks,1,0.0
Correctly,1,0.0
-polluted,1,0.0
21330,1,0.0
healthy-worker,1,0.0
infect-exacerbation,1,0.0
extinguishing,1,0.0
LIC,1,0.0
astaxanthin,1,0.0
ultrasonogram,1,0.0
Narcolepsy,1,0.0
Shaping,1,0.0
DQB10602,1,0.0
24308,1,0.0
Infraction,1,0.0
spike-to-actin,1,0.0
XLVII1997,1,0.0
intersample,1,0.0
discounts,1,0.0
Cardio-Neurology,1,0.0
Marker,1,0.0
malonaldehyde,1,0.0
markable,1,0.0
3-ppm,1,0.0
re-infarct,1,0.0
glycerol-containing,1,0.0
PBBs,1,0.0
Lipinski-Veber,1,0.0
proverbial,1,0.0
JNJ-78436735,1,0.0
β-Coronaviruses,1,0.0
8203,1,0.0
six-minute-walk-test,1,0.0
biannually,1,0.0
01-,1,0.0
visable,1,0.0
parameters--percentage,1,0.0
polaroid,1,0.0
httpsbitly2zfUZ1S,1,0.0
Nicotinic,1,0.0
Dynacalibrator,1,0.0
Cardiolog,1,0.0
ía,1,0.0
unappropriated,1,0.0
Nitroprusiate,1,0.0
casesABSTRACT,1,0.0
massABSTRACT,1,0.0
depth--significantly,1,0.0
Hyperreactivity,1,0.0
self-reinforcing,1,0.0
non-confirmation,1,0.0
Sprague‑Dawley,1,0.0
tissuescells,1,0.0
Runt-related,1,0.0
nonprescreened,1,0.0
implementimprove,1,0.0
Fitness,1,0.0
bargaining,1,0.0
RAPPCP,1,0.0
043x,1,0.0
non-SAD,1,0.0
0777,1,0.0
placenta‑deviated,1,0.0
OVA‑sensitized,1,0.0
genome-sequencing,1,0.0
calcium-channel-blocker,1,0.0
residually,1,0.0
delimitate,1,0.0
automates,1,0.0
particle-containing,1,0.0
Myco,1,0.0
Membrane-based,1,0.0
delta‑like,1,0.0
polysomes,1,0.0
hPMSC‑treated,1,0.0
interferon‑γ,1,0.0
hypermethylation,1,0.0
“On,1,0.0
trimester-60,1,0.0
stroke-accounting,1,0.0
patient-designed,1,0.0
laryngo-tracheobronchitis,1,0.0
article-specifically,1,0.0
parameters-can,1,0.0
Bioscientists,1,0.0
SCBA,1,0.0
hemocoagulative,1,0.0
pregnancy-owing,1,0.0
30-65,1,0.0
Ostergötland,1,0.0
Discontinuation,1,0.0
dehydroabietic,1,0.0
1510…in,1,0.0
56°S,1,0.0
17°S,1,0.0
6492,1,0.0
Madine,1,0.0
ED-ICU,1,0.0
perish”,1,0.0
rise…but,1,0.0
Modena,1,0.0
α-26,1,0.0
TCID50well,1,0.0
virus-antibody,1,0.0
non-mechanical,1,0.0
PBS-G,1,0.0
simulants,1,0.0
HMBG1TLR2TLR4MALMyD88RAM,1,0.0
testés,1,0.0
négatifs,1,0.0
CD14F4-88,1,0.0
DSRP1autophagy,1,0.0
Ccyclophilin,1,0.0
mitochondrial-damaged,1,0.0
Ces,1,0.0
NOX-1NOX-2ASK1p-MKK47p-JNKp-c-JUN,1,0.0
l´absence,1,0.0
sévère,1,0.0
TRIFTRAF6IKK-αp-NF-κBnuclear-NF-κBnuclear-IRF-37IL-1βIL-6TNF-αIFN-γ,1,0.0
négativité,1,0.0
MPOLy6CCD11bLy6GCD11b,1,0.0
s´expliquer,1,0.0
portage,1,0.0
virale,1,0.0
détectable,1,0.0
effet,1,0.0
certains,1,0.0
0630,1,0.0
events--that,1,0.0
IMM,1,0.0
201752129-138,1,0.0
climat,1,0.0
ont,1,0.0
signallings,1,0.0
génétiques,1,0.0
monde,1,0.0
112-401,1,0.0
n100,1,0.0
BinaxNOW®,1,0.0
OR212,1,0.0
133-108,1,0.0
particulièrement,1,0.0
problème,1,0.0
OR395,1,0.0
majeur,1,0.0
publique,1,0.0
dans,1,0.0
Varazdin,1,0.0
GROG,1,0.0
N751,1,0.0
Depuis,1,0.0
mars,1,0.0
enregistré,1,0.0
nanometer,1,0.0
guéris,1,0.0
seulement,1,0.0
sévères,1,0.0
Aussi,1,0.0
environ,1,0.0
Excimer,1,0.0
prédispositions,1,0.0
jouer,1,0.0
APEX-AMI,1,0.0
nonhierarchically,1,0.0
réorientés,1,0.0
Rhizonma,1,0.0
vers,1,0.0
prioritaires,1,0.0
sénégalais,1,0.0
Mahuang,1,0.0
Corydalis,1,0.0
Yanhusuo,1,0.0
Kansui,1,0.0
Gansui,1,0.0
Xixin,1,0.0
Boiss,1,0.0
epispastic,1,0.0
prohibitin,1,0.0
Terrestrial,1,0.0
enforceable,1,0.0
alba,1,0.0
hasnt,1,0.0
Brassica,1,0.0
physicians--eg,1,0.0
single-photon-emission,1,0.0
Baijiezi,1,0.0
mindfulness,1,0.0
periodicals,1,0.0
devraient,1,0.0
Shengjiang,1,0.0
viabilité,1,0.0
devrait,1,0.0
qu´Influenza,1,0.0
under-assessment,1,0.0
r0561,1,0.0
entérovirus,1,0.0
métapneumovirus,1,0.0
causant,1,0.0
mêmes,1,0.0
NRE15,1,0.0
r0983,1,0.0
leur,1,0.0
co-investigated,1,0.0
client-centered,1,0.0
déployés,1,0.0
faite,1,0.0
l´imputabilité,1,0.0
femaleswomen,1,0.0
tel,1,0.0
Malesmen,1,0.0
Influvac,1,0.0
respiratoire,1,0.0
au,1,0.0
nombre,1,0.0
supposées,1,0.0
Ainsi,1,0.0
NCDC,1,0.0
beta1-adrenergic-stimulation,1,0.0
Ningxia,1,0.0
3-40,1,0.0
neuroepithelial,1,0.0
marker-positive,1,0.0
plasticity-associated,1,0.0
MAP1B,1,0.0
Nogo,1,0.0
ephrin-A5,1,0.0
68-97,1,0.0
21-66,1,0.0
beta-amyloid,1,0.0
betaAPP,1,0.0
wks,1,0.0
43-72,1,0.0
cytoproliferative,1,0.0
n1055,1,0.0
WAP,1,0.0
costs-eg,1,0.0
Mamre,1,0.0
391000,1,0.0
Preschoolers,1,0.0
nursery-based,1,0.0
60535,1,0.0
wide-reaching,1,0.0
impasse,1,0.0
trans‑synaptic,1,0.0
6-30,1,0.0
Regeneration-associated,1,0.0
BrdU-positive,1,0.0
plasticity-promoting,1,0.0
transcriptase-loop-mediated,1,0.0
Blastomyces,1,0.0
stentreivers,1,0.0
dermatitidis,1,0.0
PCVs,1,0.0
7374,1,0.0
NPIs-strategies,1,0.0
2830,1,0.0
medications-to,1,0.0
virus-spiked,1,0.0
RFA-CI06-010,1,0.0
PfAgo-based,1,0.0
unencumbered,1,0.0
twenty-three-year-old,1,0.0
810000,1,0.0
970000,1,0.0
postcontrast,1,0.0
890000,1,0.0
activation-dependent,1,0.0
proliferation-related,1,0.0
pets-which,1,0.0
home-such,1,0.0
0-63,1,0.0
425-430,1,0.0
resurge,1,0.0
Hessian,1,0.0
15643,1,0.0
83650,1,0.0
bioCSL,1,0.0
Screener,1,0.0
deficits-are,1,0.0
polystyrene-toner,1,0.0
PS-T,1,0.0
deficits-anosognosia,1,0.0
3-50,1,0.0
microchamber,1,0.0
thermoblock,1,0.0
ASHA,1,0.0
26000,1,0.0
microdevice,1,0.0
Uhour,1,0.0
Swallow,1,0.0
100-5000,1,0.0
Wisdom,1,0.0
ratio--are,1,0.0
size--myocardial,1,0.0
Defy,1,0.0
transtracheal,1,0.0
Enemy,1,0.0
hIVIg,1,0.0
ISCOMATRIX™,1,0.0
antigen-formulated,1,0.0
echograms,1,0.0
pragmatics,1,0.0
DePaul,1,0.0
interviewsquestionnaire,1,0.0
RE-LYMP,1,0.0
5581,1,0.0
16267,1,0.0
wwwasmanetcom,1,0.0
189-577,1,0.0
receptors-dependent,1,0.0
crossovers,1,0.0
non-activated,1,0.0
Incessant,1,0.0
pseudovirus-based,1,0.0
late-activated,1,0.0
mongrels,1,0.0
XN,1,0.0
httpsdoiorg1023641asha12159597,1,0.0
ultrasound-based,1,0.0
Sysmex,1,0.0
Genoidentical,1,0.0
North-Africa,1,0.0
streptokinase-related,1,0.0
Sludge-induced,1,0.0
coliphage,1,0.0
CoV-Surv,1,0.0
dehydrogenase-2,1,0.0
ChinaLaboratory,1,0.0
XIa,1,0.0
histoplasmosis,1,0.0
perfuse,1,0.0
elucidatedABSTRACT,1,0.0
PCR-positivity,1,0.0
1forced,1,0.0
⩾35,1,0.0
n241,1,0.0
Pin1-similarly,1,0.0
13-100,1,0.0
ATRA-a,1,0.0
all-trans,1,0.0
anemias,1,0.0
exstrophy,1,0.0
vasculopothy,1,0.0
protein-based-assays,1,0.0
LIAISON®XL,1,0.0
PDmax,1,0.0
one-staged,1,0.0
ureteric,1,0.0
cobas™,1,0.0
4334,1,0.0
outmoded,1,0.0
overutilization,1,0.0
psyche,1,0.0
postive-pressure,1,0.0
developmentselection,1,0.0
137232,1,0.0
epitope-prediction,1,0.0
PDmaxlog,1,0.0
ratio070,1,0.0
IgG-reagins,1,0.0
portomesenteric,1,0.0
Subheading,1,0.0
autotransfusion,1,0.0
multi-functional,1,0.0
ST-dynamics,1,0.0
one-stop-shop,1,0.0
disconcordance,1,0.0
changer,1,0.0
hCoVs-229E,1,0.0
obesity-stroke,1,0.0
AAlma-Ata104483,1,0.0
OC43-circulate,1,0.0
examinedAbbreviations,1,0.0
3875,1,0.0
Thrombophilia,1,0.0
DOL,1,0.0
mid-superior,1,0.0
FibroScan,1,0.0
ACOS-,1,0.0
MEURI,1,0.0
Hyperosmolarity,1,0.0
n151,1,0.0
evaporative,1,0.0
n190,1,0.0
mll,1,0.0
pre-emptied,1,0.0
S-sequence,1,0.0
repectively,1,0.0
CASM,1,0.0
desaturated,1,0.0
oxymetry,1,0.0
cfa-miR361,1,0.0
repeats-CRISPR-associated,1,0.0
cfa-miR-1841,1,0.0
cfa-miR-1842,1,0.0
non-industry-sponsored,1,0.0
karyopherin,1,0.0
industry-sponsored,1,0.0
penetration-aspiration,1,0.0
covariant,1,0.0
biostimulation,1,0.0
non-HIV-infected,1,0.0
Low-power,1,0.0
SEIRA-based,1,0.0
Multichannel,1,0.0
Aculas-AM,1,0.0
Jcm2acupoint,1,0.0
post-laser,1,0.0
nano-island,1,0.0
evaporated,1,0.0
syndrome-corovavirus-2,1,0.0
lacation,1,0.0
Haitian,1,0.0
pre-6MWT,1,0.0
19691970,1,0.0
reconnected,1,0.0
scintigraph,1,0.0
andropause,1,0.0
centrestage,1,0.0
post-repolarization,1,0.0
structure-dynamics-energy,1,0.0
multi-microsecond,1,0.0
one-hundred,1,0.0
hand-hygiene,1,0.0
S-targeting,1,0.0
Tc-99m-labeled,1,0.0
23-dimercaptosuccinic,1,0.0
11-40,1,0.0
SARS-CoV-2-assocated,1,0.0
19681969,1,0.0
mCherry,1,0.0
SARS-CoV-2-mCherry,1,0.0
f1Allergen-f2AI,1,0.0
f3Allergen-f4BHR,1,0.0
f5AI,1,0.0
f6AI,1,0.0
006s,1,0.0
2-mimetic,1,0.0
effort-independence,1,0.0
ATaiwan179,1,0.0
re-actualized,1,0.0
10-38,1,0.0
oversite,1,0.0
LCB1,1,0.0
rerouted,1,0.0
non-cardiogenic,1,0.0
behavior-driven,1,0.0
semi-analytical,1,0.0
hypothalamic-pituitary-testicular,1,0.0
Hypothalamus,1,0.0
TTI-avoiders,1,0.0
gamma-variate,1,0.0
test-trace-and-isolate,1,0.0
reassumed,1,0.0
focalize,1,0.0
bindingneutralizing,1,0.0
cGMP,1,0.0
nicorandil-treated,1,0.0
wa,1,0.0
mistral,1,0.0
damming,1,0.0
environmental-to-human,1,0.0
susceptivity,1,0.0
018100000,1,0.0
x-rayABSTRACT,1,0.0
613780,1,0.0
3890250,1,0.0
RR-7This,1,0.0
201059No,1,0.0
elicitors,1,0.0
self-accelerating,1,0.0
fourth-worst,1,0.0
third-worst,1,0.0
120-200,1,0.0
dehydrate,1,0.0
humidify,1,0.0
Montpellier,1,0.0
Non-eosinophilic,1,0.0
normatively,1,0.0
scarves,1,0.0
anti-coagulationAdult,1,0.0
thromboprophylaxisDVT,1,0.0
085-097,1,0.0
68-99,1,0.0
75-88,1,0.0
073-086,1,0.0
re-start,1,0.0
postCOVID-19,1,0.0
impairment-no,1,0.0
53-90,1,0.0
incentivize,1,0.0
less-likely-to-call-911,1,0.0
Shelby,1,0.0
72-88,1,0.0
specificityD-dimer,1,0.0
faring,1,0.0
Lesioned,1,0.0
Exemplar,1,0.0
co-therapists,1,0.0
QAEN,1,0.0
regionalinternational,1,0.0
Fingolimod,1,0.0
r-043,1,0.0
Non-Middle,1,0.0
Chaldean,1,0.0
r-026,1,0.0
MET3-AE,1,0.0
ontology-driven,1,0.0
r-030,1,0.0
N85,1,0.0
Cermaide-1,1,0.0
B11241,1,0.0
BNT161b2,1,0.0
4562,1,0.0
nVNS,1,0.0
SPL,1,0.0
2017-February,1,0.0
27-44,1,0.0
Lyase,1,0.0
54-76,1,0.0
25-56,1,0.0
Ceramide,1,0.0
Viro-neutralization,1,0.0
linear-regression,1,0.0
inspires,1,0.0
iopamidol,1,0.0
disponibility,1,0.0
neurochemical,1,0.0
peak-flow-values,1,0.0
GileadRoche,1,0.0
multi-sector,1,0.0
patientsMethods,1,0.0
physiciansResults,1,0.0
128300,1,0.0
69128,1,0.0
antiobstructive,1,0.0
ashtma,1,0.0
53128,1,0.0
119128,1,0.0
125128,1,0.0
132-659,1,0.0
akineticdyskinetic,1,0.0
95CI067,1,0.0
akinesiadyskinesia,1,0.0
5-99,1,0.0
≥41,1,0.0
IRR118,1,0.0
β-043,1,0.0
95CI111,1,0.0
β-031,1,0.0
797051,1,0.0
r-025,1,0.0
r-039,1,0.0
IRR074,1,0.0
Interrelations,1,0.0
broncholability,1,0.0
provincialterritorial,1,0.0
Embasecom,1,0.0
phenotyp-specific,1,0.0
ischaemized,1,0.0
pneumologist,1,0.0
nonhyposensitized,1,0.0
pteronyssinus-specific,1,0.0
farinae-specific,1,0.0
1312,1,0.0
anti-SARS-CoV-2-S,1,0.0
VOSviewer1611,1,0.0
6568,1,0.0
Hartley,1,0.0
Hydroxypropyl,1,0.0
myocardiocytic,1,0.0
genomic-mediated,1,0.0
impulsivity,1,0.0
cell-evoking,1,0.0
Posed,1,0.0
test-treat,1,0.0
Posers,1,0.0
pound13700,1,0.0
neutral-content,1,0.0
pound1900-,1,0.0
vasorelaxation,1,0.0
Raters,1,0.0
Polarization,1,0.0
-578,1,0.0
recurrencing,1,0.0
re-extraction,1,0.0
Linster,1,0.0
Watanabe,1,0.0
4-AT,1,0.0
D40,1,0.0
V40,1,0.0
Coexisting,1,0.0
Cardiolite,1,0.0
Third-year,1,0.0
Pont,1,0.0
Kista,1,0.0
Bulls,1,0.0
2877,1,0.0
two-variable,1,0.0
spirometry-based,1,0.0
learning-derived,1,0.0
WhiteEuropean,1,0.0
groupsAmong,1,0.0
resolvedFinally,1,0.0
133-610,1,0.0
2C9,1,0.0
loosely-defined,1,0.0
over-anticoagulationIn,1,0.0
multiagent,1,0.0
pre-emptively,1,0.0
poser,1,0.0
deoxygenate,1,0.0
under-represent,1,0.0
Exanthema,1,0.0
lownegative,1,0.0
Ampofo,1,0.0
Ben,1,0.0
Platelet-activating,1,0.0
pityriasis,1,0.0
rosea,1,0.0
nodosum,1,0.0
Sweet’s,1,0.0
Drug‐Related,1,0.0
Intertriginous,1,0.0
Flexural,1,0.0
acro‐ischemianecrosis,1,0.0
multitemperature,1,0.0
chilblain,1,0.0
re-introducing,1,0.0
Citospyn,1,0.0
COV-CHECK,1,0.0
sprung,1,0.0
PORINETIA,1,0.0
59490,1,0.0
093-141,1,0.0
variants-specific,1,0.0
patient-caregiver-completed,1,0.0
2758,1,0.0
NPT,1,0.0
postlesional,1,0.0
NYEB,1,0.0
dendrites,1,0.0
36-159,1,0.0
re-fever,1,0.0
04-22,1,0.0
Comité,1,0.0
lutte,1,0.0
AHREs,1,0.0
Appointed,1,0.0
ex-officio,1,0.0
insuring,1,0.0
hippocampal-dependent,1,0.0
235724,1,0.0
525558,1,0.0
23710,1,0.0
Neurolucida,1,0.0
EdU,1,0.0
262917,1,0.0
analoque,1,0.0
lymphangiographic,1,0.0
lymphangiograms,1,0.0
incoagulable,1,0.0
thymidine,1,0.0
wheels,1,0.0
Pest,1,0.0
50910,1,0.0
miniprotein,1,0.0
LCB1-Fc,1,0.0
ischemia-dependent,1,0.0
≥323-log10,1,0.0
Glutathione-S-transferase,1,0.0
E-wave,1,0.0
5-9-year-old,1,0.0
countries3,1,0.0
infections12,1,0.0
228-fold,1,0.0
parchment,1,0.0
H1N1-virus-associated,1,0.0
parchmentlike,1,0.0
thickens,1,0.0
Pancytopenia,1,0.0
Epstein–Barr,1,0.0
52588,1,0.0
6490,1,0.0
160-325,1,0.0
46098,1,0.0
6895,1,0.0
32-39,1,0.0
286455,1,0.0
asthma--are,1,0.0
sown,1,0.0
COVID-19’s,1,0.0
bioinspiration,1,0.0
other’s,1,0.0
endocytosis-mediated,1,0.0
KAMI,1,0.0
imaging--has,1,0.0
MRI--using,1,0.0
Berman,1,0.0
myocyte-like,1,0.0
factor-positive,1,0.0
non-occluded,1,0.0
angioblasts,1,0.0
patch-based,1,0.0
gammagraphies,1,0.0
mtc,1,0.0
diphosphonates,1,0.0
LL,1,0.0
schoolConclusions,1,0.0
gammagraphy,1,0.0
enquired,1,0.0
intrafamily,1,0.0
Cols,1,0.0
schoolMethods,1,0.0
testPhadiotop,1,0.0
8393,1,0.0
post-defibrillation,1,0.0
1953-1962,1,0.0
refering,1,0.0
8539,1,0.0
Gabriels,1,0.0
Vp,1,0.0
GAPDS,1,0.0
clinico-biological,1,0.0
virosome-based,1,0.0
ventricularLA,1,0.0
Germicidal,1,0.0
Amazonian,1,0.0
diversifications,1,0.0
845-947,1,0.0
693-808,1,0.0
409-769,1,0.0
P4715L,1,0.0
039-118,1,0.0
cupweek,1,0.0
Vesicular,1,0.0
Super,1,0.0
Sani-Cloth,1,0.0
Wipes,1,0.0
Guillen-Barre,1,0.0
039-095,1,0.0
cupsweek,1,0.0
Oxivir,1,0.0
Tb,1,0.0
laminate,1,0.0
multivariable-adjusted,1,0.0
porcelain,1,0.0
post-disinfection,1,0.0
Kanto,1,0.0
non-disinfected,1,0.0
Disinfectants,1,0.0
Neurologic-associated,1,0.0
∼60000,1,0.0
Strainstrain,1,0.0
067-097,1,0.0
Reservoir,1,0.0
homogenize,1,0.0
Conductive,1,0.0
much-remains,1,0.0
Sr,1,0.0
Sre,1,0.0
efficacy-for,1,0.0
nine-year-old,1,0.0
millimeter,1,0.0
Х-ray,1,0.0
114-769,1,0.0
107-276,1,0.0
Tablighi,1,0.0
057-095,1,0.0
068-098,1,0.0
98-130,1,0.0
world1,1,0.0
published23,1,0.0
66‐year‐old,1,0.0
chest‐TC,1,0.0
lungs’,1,0.0
nasopharyngeal‐swab,1,0.0
erythematous‐pomphoid,1,0.0
Jamaat,1,0.0
RSV-lacZ,1,0.0
authenticative,1,0.0
X-gal-positive,1,0.0
mus,1,0.0
barriers-particularly,1,0.0
communities-pose,1,0.0
self-reflective,1,0.0
top-scoring,1,0.0
foreignness,1,0.0
reevaluating,1,0.0
9342,1,0.0
transcranially,1,0.0
ElliPro-a,1,0.0
Predictor,1,0.0
B-Cell,1,0.0
101-025,1,0.0
neuroimmunology,1,0.0
206-059,1,0.0
BepiPred-20,1,0.0
P0099,1,0.0
189-029,1,0.0
P00248,1,0.0
192-015,1,0.0
SWISS-MODEL,1,0.0
GalaxyRefine,1,0.0
P00024,1,0.0
Phyre2,1,0.0
289-176,1,0.0
peptide-binding,1,0.0
Sensitisation,1,0.0
240-099,1,0.0
ACA072009,1,0.0
bax,1,0.0
bcl-2,1,0.0
Chiayi,1,0.0
BioRendercom,1,0.0
TRF,1,0.0
previously-validated,1,0.0
120-542,1,0.0
non-flocked,1,0.0
138-768,1,0.0
oropharynxnares,1,0.0
124-1082,1,0.0
infundibular,1,0.0
Mal,1,0.0
available-are,1,0.0
E185,1,0.0
POCTs-when,1,0.0
CoV2-specific,1,0.0
litter,1,0.0
atrioventrcular,1,0.0
puzzles,1,0.0
program--is,1,0.0
150A,1,0.0
≥2-fold,1,0.0
self-management--the,1,0.0
P0279,1,0.0
apple,1,0.0
lacZ,1,0.0
profundity,1,0.0
mid-esophageal,1,0.0
interval219-441,1,0.0
Reflex,1,0.0
7002,1,0.0
4153,1,0.0
otolaryngology-for,1,0.0
chorda,1,0.0
specialties-including,1,0.0
tendinae,1,0.0
aspire,1,0.0
contestation,1,0.0
Replicability,1,0.0
antiatherosclerotic,1,0.0
steroid-free,1,0.0
re-docked,1,0.0
Denpasar,1,0.0
re-screened,1,0.0
Ergometric,1,0.0
work-load,1,0.0
anti-HIV1compounds,1,0.0
IDCRD42014013896,1,0.0
hangover,1,0.0
Larazotide,1,0.0
outbreak-turned-pandemic,1,0.0
metabolite-,1,0.0
symbiotic,1,0.0
P0134,1,0.0
Allergen-specific,1,0.0
CQI,1,0.0
numberpatients,1,0.0
vulvar,1,0.0
DRG14,1,0.0
strokesTIAs,1,0.0
225100000,1,0.0
tachyycardia,1,0.0
29169811,1,0.0
95-110,1,0.0
tachcardia,1,0.0
PIS,1,0.0
sublingual-specific,1,0.0
tetrachloride,1,0.0
Toscana,1,0.0
self-made,1,0.0
passion,1,0.0
Acquire,1,0.0
Chim,1,0.0
Acta,1,0.0
spasmolysis,1,0.0
Morley,1,0.0
Openers,1,0.0
antiemetic,1,0.0
Shinshu,1,0.0
≥3-log10,1,0.0
TVP,1,0.0
peripherals,1,0.0
UMV,1,0.0
AA-induced,1,0.0
33-36°C,1,0.0
famously,1,0.0
inhibitor-nimesulide,1,0.0
731238,1,0.0
779227,1,0.0
Ecotoxicological,1,0.0
682133,1,0.0
7402,1,0.0
743157,1,0.0
72-10,1,0.0
pathogenicityseverity,1,0.0
818-865,1,0.0
Teleradiology,1,0.0
504-583,1,0.0
606-682,1,0.0
170-274,1,0.0
5430,1,0.0
4204859,1,0.0
RR120,1,0.0
out-of-work,1,0.0
CI107-135,1,0.0
CI100-126,1,0.0
RR108,1,0.0
CI104-111,1,0.0
cardioischemic,1,0.0
Mesh,1,0.0
Multiphysics,1,0.0
6970-deletion,1,0.0
atheroscerosis,1,0.0
conflagrations,1,0.0
Vaccine-based,1,0.0
Asynergic,1,0.0
ovarian-induction,1,0.0
SARS‑,1,0.0
fickle,1,0.0
146-fold,1,0.0
immune-receptors,1,0.0
081-,1,0.0
molecular-level,1,0.0
Curious,1,0.0
Comsol,1,0.0
regrettably,1,0.0
missteps,1,0.0
186779,1,0.0
dark-coloured,1,0.0
Explant,1,0.0
skinning,1,0.0
POISE,1,0.0
multi-layer,1,0.0
ISchemic,1,0.0
eddy-current,1,0.0
PeriOperative,1,0.0
alveolus,1,0.0
age-dependency,1,0.0
information-rich,1,0.0
therapy-primary,1,0.0
21-34,1,0.0
rescuable,1,0.0
CellSearch®,1,0.0
CD146,1,0.0
DAPI,1,0.0
HD-CTC,1,0.0
disease-states,1,0.0
37-67100000,1,0.0
birth-prevalence,1,0.0
seroatopy,1,0.0
procedure-to-stroke,1,0.0
therapy-is,1,0.0
October-Italian,1,0.0
015-074,1,0.0
Intan,1,0.0
thermoplastic,1,0.0
Teluk,1,0.0
off-chip,1,0.0
Bioanalyzer,1,0.0
humoral-induced,1,0.0
panarteritic,1,0.0
panarteritis,1,0.0
14408CT,1,0.0
sKIDs,1,0.0
28-29,1,0.0
May-WHO,1,0.0
breaching,1,0.0
Helminths,1,0.0
hadn’t,1,0.0
Saffron,1,0.0
deworming,1,0.0
vaccinetherapy,1,0.0
264832,1,0.0
300832,1,0.0
Helminth-induced,1,0.0
134-172,1,0.0
Th2Th3,1,0.0
Helminth,1,0.0
Th3,1,0.0
Soil-transmitted,1,0.0
JIM,1,0.0
357-581,1,0.0
0003-008,1,0.0
de-escalate,1,0.0
Trento,1,0.0
moxibustion-massage,1,0.0
Therapy-resistant,1,0.0
vasocilator,1,0.0
Corticosteroid-induced,1,0.0
mean-reversion,1,0.0
March-September,1,0.0
Cautious,1,0.0
caroted,1,0.0
2159,1,0.0
inhaler-spacer,1,0.0
bisphophonate,1,0.0
NK-3,1,0.0
6475,1,0.0
uteroglobin-related,1,0.0
-112G,1,0.0
NK-2,1,0.0
trios,1,0.0
Tachykinins,1,0.0
macrophage-specific,1,0.0
-112,1,0.0
immunostained,1,0.0
-112GA,1,0.0
Zoledronate,1,0.0
maropitant,1,0.0
Pre-2013,1,0.0
Wonca,1,0.0
IPAG,1,0.0
IPCRG,1,0.0
V8R,1,0.0
distilling,1,0.0
Guides,1,0.0
leads--only,1,0.0
alpha-subunit,1,0.0
voltage-dependent,1,0.0
Nav15,1,0.0
Maropitant,1,0.0
236077,1,0.0
hyperattention,1,0.0
declination,1,0.0
overcleaning,1,0.0
laboratory-induced,1,0.0
Anglo-Scandinavian,1,0.0
HDFP,1,0.0
lowmiddle-income,1,0.0
00001-005,1,0.0
medicamental,1,0.0
barriersReperfusion,1,0.0
systematising,1,0.0
therapyIn,1,0.0
Randers,1,0.0
CR-non-attendees,1,0.0
out-of-school,1,0.0
obliquely,1,0.0
CR-attendees,1,0.0
multicystic,1,0.0
CR-attendance,1,0.0
Vagus,1,0.0
133816,1,0.0
httpsdoiorg1017605OSFIOBMJEK,1,0.0
Moderate-intensity,1,0.0
internationally-developed,1,0.0
ProvLab,1,0.0
detection-based,1,0.0
channel-blocking,1,0.0
asthma-safe,1,0.0
Kovesi,1,0.0
05-3,1,0.0
Barbeito-López,1,0.0
5201,1,0.0
Chance-orientated,1,0.0
Artificially,1,0.0
better-assessing,1,0.0
use-dependent,1,0.0
motor-predominant,1,0.0
kin-based,1,0.0
ppbLs,1,0.0
close-knit,1,0.0
ppbL,1,0.0
Heubners,1,0.0
Orthopaedic,1,0.0
Hypobulia,1,0.0
Transcortical,1,0.0
non-throbbing,1,0.0
double-bind,1,0.0
Trasylol-82,1,0.0
Trasylol,1,0.0
0701,1,0.0
0707,1,0.0
0712,1,0.0
0700,1,0.0
Buchvald,1,0.0
Telemanagement,1,0.0
BFP,1,0.0
Radiologist,1,0.0
ginkgo,1,0.0
4-24,1,0.0
temporal-parietal,1,0.0
non-spatially,1,0.0
overmedication,1,0.0
P13L,1,0.0
alveolization,1,0.0
time-lapse,1,0.0
Unveiling,1,0.0
1981-84,1,0.0
1979-84,1,0.0
1980-84,1,0.0
bioba,1,0.0
Sumatriptan,1,0.0
anti-ER,1,0.0
5HT-1,1,0.0
Col3a1,1,0.0
serotonin-1,1,0.0
Col1a2,1,0.0
BIPERP78,1,0.0
Beclin,1,0.0
Col4a3bp,1,0.0
MMPTIMP,1,0.0
apoptins,1,0.0
population-derived,1,0.0
hypostasis,1,0.0
point-interval,1,0.0
10⁻²,1,0.0
reanalysed,1,0.0
onsetAimTo,1,0.0
UK-TIA,1,0.0
BackgroundReverse-transcription,1,0.0
CATS,1,0.0
TASS,1,0.0
AAASPS,1,0.0
High-Risk,1,0.0
ESPS2,1,0.0
Triflusal,1,0.0
TACIP,1,0.0
revelant,1,0.0
15500-patient,1,0.0
respis,1,0.0
Uttara,1,0.0
Adhunik,1,0.0
UAMCH,1,0.0
5834±1290,1,0.0
Male-female,1,0.0
EWDs,1,0.0
veloergometer,1,0.0
postanesthetic,1,0.0
005-7,1,0.0
mepolizumb,1,0.0
omalizumb,1,0.0
PBA,1,0.0
typeMethodsWe,1,0.0
onceResultsThe,1,0.0
testsConclusionNP,1,0.0
114-person,1,0.0
improvisationsThe,1,0.0
irrecoverable,1,0.0
time-in,1,0.0
attacks-can,1,0.0
un-experienced,1,0.0
noncardiological,1,0.0
habilitatedThis,1,0.0
Mexicoan,1,0.0
thrombotic-like,1,0.0
ever-important,1,0.0
multi-disciplined,1,0.0
often-devastating,1,0.0
symbiotics,1,0.0
DC-9,1,0.0
Neuquén,1,0.0
D53,1,0.0
Postbronchodilator,1,0.0
41740,1,0.0
mLyear,1,0.0
0001year,1,0.0
Lysates,1,0.0
agents--aspirin,1,0.0
triflusal--have,1,0.0
Low-Dose,1,0.0
guidelines12,1,0.0
CSDs,1,0.0
connective-tissue,1,0.0
13h43,1,0.0
filtering-based,1,0.0
Trombocitopenia,1,0.0
Español,1,0.0
VaxignVaxign-ML,1,0.0
precomputed,1,0.0
httpwwwviolinetorgvaxign2,1,0.0
SEDAN,1,0.0
Grupo,1,0.0
atm,1,0.0
GRASPS,1,0.0
mm×14,1,0.0
V3-V4,1,0.0
GEPTI,1,0.0
near-by,1,0.0
28-month-old,1,0.0
kinasa,1,0.0
Samusocial,1,0.0
device-detected,1,0.0
COhort,1,0.0
BRonchial,1,0.0
non-structural-nuclear,1,0.0
thereafterOf,1,0.0
therapy-uncontrolled,1,0.0
300mm3,1,0.0
Inmune,1,0.0
RCAs,1,0.0
spin-labeling,1,0.0
Emphasized,1,0.0
nonvirologic,1,0.0
rallied,1,0.0
Canines,1,0.0
9986,1,0.0
9574,1,0.0
HKU-1,1,0.0
decreaseincrease,1,0.0
shoulderelbow,1,0.0
thelife,1,0.0
no-time-to-waste,1,0.0
noncurable,1,0.0
Pleurocath,1,0.0
LCXS,1,0.0
purse-string,1,0.0
Small-bore,1,0.0
infarction--a,1,0.0
infarction--had,1,0.0
1946-1947,1,0.0
dysaggregant,1,0.0
13-45,1,0.0
microflow,1,0.0
SARS‐CoV‐24‐5,1,0.0
delivery1‐3,1,0.0
immune-responses,1,0.0
habilitate,1,0.0
12470,1,0.0
NPR1,1,0.0
Kuiken,1,0.0
senzibilization,1,0.0
Playing,1,0.0
Banija,1,0.0
polysensibilization,1,0.0
allergometric,1,0.0
Rimmelzwaan,1,0.0
thymoma,1,0.0
multinodular,1,0.0
Guus,1,0.0
hydatic,1,0.0
chr9p21,1,0.0
Thijs,1,0.0
SOBERANA02,1,0.0
pericyte,1,0.0
FOXF2,1,0.0
HABP2,1,0.0
Fouchier,1,0.0
MMP12,1,0.0
Ron,1,0.0
within-subtype,1,0.0
TSPAN2,1,0.0
Likelihood-based,1,0.0
PMF1,1,0.0
sigle,1,0.0
6-62,1,0.0
B-memory,1,0.0
reponses,1,0.0
029-136,1,0.0
ECGABSTRACT,1,0.0
Subtle,1,0.0
care-certified,1,0.0
telemedicine-organized,1,0.0
C163T,1,0.0
201526,1,0.0
325526,1,0.0
188526,1,0.0
338526,1,0.0
vs70,1,0.0
vs4,1,0.0
029-171,1,0.0
RBD-TT,1,0.0
Endogeneity,1,0.0
AH3N23C2a,1,0.0
endogeneity,1,0.0
Reablement,1,0.0
home-reablement,1,0.0
3C3b,1,0.0
arginine-glycine-aspartic,1,0.0
elderly--a,1,0.0
Guizhou,1,0.0
Mérieux,1,0.0
Connaught,1,0.0
Bivalent,1,0.0
homosubtypic,1,0.0
hiPSCs,1,0.0
Self-initiated,1,0.0
p≅010,1,0.0
κ2≥094,1,0.0
cities-Kampala,1,0.0
Children’s,1,0.0
Entebbe,1,0.0
“A,1,0.0
Uganda-over,1,0.0
2008-2015,1,0.0
ca37,1,0.0
influence”,1,0.0
947-100,1,0.0
indecent,1,0.0
NOAAs,1,0.0
Critics,1,0.0
“homes,1,0.0
unwittingly,1,0.0
Zahra,1,0.0
versed,1,0.0
LUCKY,1,0.0
counterpulsation-related,1,0.0
incompleteness,1,0.0
-such,1,0.0
wittingly,1,0.0
G8,1,0.0
Action”,1,0.0
cross-sector,1,0.0
reponse,1,0.0
746816,1,0.0
Thicknesses,1,0.0
microscopy-which,1,0.0
SARS-CoV-2-are,1,0.0
baffle,1,0.0
orogastic,1,0.0
grkg,1,0.0
10-200,1,0.0
microvibration,1,0.0
five-stage,1,0.0
Service-National,1,0.0
NHIS-NSC,1,0.0
NL63-CoV,1,0.0
TNFSF10HDAC4HDAC5,1,0.0
complicationsmanifestations,1,0.0
immune-pathogenesis,1,0.0
229E-CoV,1,0.0
17-73,1,0.0
0≤2h,1,0.0
≤5h,1,0.0
5≤10h,1,0.0
-157,1,0.0
-101,1,0.0
-127,1,0.0
multistability,1,0.0
countsLongitudinal,1,0.0
scoreStudies,1,0.0
ELISACLIA-based,1,0.0
bird-infecting,1,0.0
44-73,1,0.0
pathogen-related,1,0.0
30-58,1,0.0
109000,1,0.0
15-22,1,0.0
50-325,1,0.0
Clopidgrel,1,0.0
67±20,1,0.0
CS-induced,1,0.0
Harstad,1,0.0
amantadanes,1,0.0
copiessample,1,0.0
amantadane,1,0.0
inventive,1,0.0
novel-coronavirus,1,0.0
MAptapro-IR2,1,0.0
Q-zone,1,0.0
ST-integral,1,0.0
entityABSTRACT,1,0.0
MAptapro,1,0.0
therapywith,1,0.0
elitist,1,0.0
ofinhalational,1,0.0
entropic,1,0.0
selfishness,1,0.0
34-57,1,0.0
2018-February,1,0.0
httpswwwcdcgovfluprotectwhoshouldvaxhtm,1,0.0
10-27,1,0.0
RST,1,0.0
K18-huACE2-Tg,1,0.0
Fundoplication,1,0.0
GER-associated,1,0.0
Plateletfibrin,1,0.0
Microemboli,1,0.0
reformations,1,0.0
ACE2-trangenic,1,0.0
Agonist,1,0.0
720-adjuvanted,1,0.0
VERO-E6,1,0.0
Montanide™,1,0.0
Customizing,1,0.0
fasudil,1,0.0
water-in-oil,1,0.0
full-proof,1,0.0
pluristems,1,0.0
SPRBD,1,0.0
FcRn,1,0.0
Ag-presenting,1,0.0
Fc-receptors,1,0.0
facor,1,0.0
SPRBD-Fc,1,0.0
biologically-engineered,1,0.0
databanks,1,0.0
cost-benefits,1,0.0
9575,1,0.0
trivalent-inactivated,1,0.0
omental,1,0.0
omentum,1,0.0
sociability,1,0.0
Re-adaptation,1,0.0
noninnervated,1,0.0
campaigning,1,0.0
FIGO,1,0.0
TDTE,1,0.0
20142015-20162017,1,0.0
HOPE-2,1,0.0
concentrations-has,1,0.0
058-069,1,0.0
Ugi-azide,1,0.0
081-091,1,0.0
≤74,1,0.0
thrombosis-which,1,0.0
years--conclusion,1,0.0
2004-December,1,0.0
Robotic,1,0.0
Antiasthmatic,1,0.0
programed,1,0.0
replenish,1,0.0
macrosocioeconomic,1,0.0
37th,1,0.0
80Conclusion,1,0.0
four-component,1,0.0
pratique,1,0.0
81098379,1,0.0
changesKnowledge,1,0.0
invasivesurgical,1,0.0
ethico-legal,1,0.0
packageswork,1,0.0
stevedores,1,0.0
surveyors,1,0.0
UK-REACH,1,0.0
describedDespite,1,0.0
laboratoryBased,1,0.0
TIIVL,1,0.0
auditable,1,0.0
34973724,1,0.0
105-134,1,0.0
46124655,1,0.0
COVID‐,1,0.0
881931,1,0.0
swabs1,1,0.0
790931,1,0.0
3226386,1,0.0
reverse‐,1,0.0
nAH1N1v,1,0.0
094-143,1,0.0
123-132,1,0.0
108-272,1,0.0
observedexpected,1,0.0
room-temperature,1,0.0
CHADS2VASc,1,0.0
dose-confirmation,1,0.0
symtoms,1,0.0
fatigued,1,0.0
Accommodating,1,0.0
Weakly,1,0.0
ischemia-guided,1,0.0
lytics,1,0.0
five-sample,1,0.0
nine-sample,1,0.0
non-intracranial,1,0.0
Accessioning,1,0.0
2900,1,0.0
3476,1,0.0
AOU,1,0.0
6266,1,0.0
subverting,1,0.0
APerth162009-clade,1,0.0
-LR,1,0.0
wondered,1,0.0
14299,1,0.0
5-75,1,0.0
provisioning,1,0.0
test-at-home,1,0.0
revenues,1,0.0
1kΩ,1,0.0
Bicycle,1,0.0
lambda-wave-like,1,0.0
384°C,1,0.0
factors-that,1,0.0
healthprotective,1,0.0
fearfulFearful,1,0.0
5-week-old,1,0.0
geophagia,1,0.0
GA20210,1,0.0
phospho-inositol,1,0.0
IgGIgMAntigen,1,0.0
IRVS,1,0.0
Dongyang,1,0.0
Tandem-Heart,1,0.0
forces-acute,1,0.0
cupboards,1,0.0
fibrilation,1,0.0
census-weighted,1,0.0
1998-2007,1,0.0
perniosis,1,0.0
biopsy-proven,1,0.0
institutionshospitals,1,0.0
pernio,1,0.0
mid-1950s,1,0.0
A-subtype,1,0.0
eccrine,1,0.0
peri-inflammatory,1,0.0
manufacturer-dependant,1,0.0
1Z0,1,0.0
epigenotyping,1,0.0
-659,1,0.0
histopathological-clinical,1,0.0
€100,1,0.0
less-established,1,0.0
stacks,1,0.0
stroke-,1,0.0
CRISPR-CRISPR,1,0.0
12a-based,1,0.0
forward-flexed,1,0.0
JIA,1,0.0
r-093,1,0.0
r035,1,0.0
two-control,1,0.0
or48,1,0.0
risk-adjustment,1,0.0
46003,1,0.0
nonbleeding,1,0.0
8500,1,0.0
immune-enhancement,1,0.0
73868,1,0.0
1330240,1,0.0
19567,1,0.0
689-782,1,0.0
inexpensively,1,0.0
Fc-fusion,1,0.0
16967,1,0.0
12284,1,0.0
gained--in,1,0.0
Patient-facing,1,0.0
dissection-related,1,0.0
Teruel,1,0.0
head-butt,1,0.0
severa,1,0.0
disengaged,1,0.0
confirm--as,1,0.0
enmeshed,1,0.0
stones,1,0.0
lipoid,1,0.0
orbit,1,0.0
electrons,1,0.0
Soviet-made,1,0.0
10000-40000,1,0.0
Murphy-Topel,1,0.0
NISN,1,0.0
plaqued,1,0.0
Certosa,1,0.0
Adinvira,1,0.0
Czechoslovak-made,1,0.0
concordancediscordance,1,0.0
PRO™,1,0.0
308218,1,0.0
Fenom,1,0.0
PlGF,1,0.0
significance--by,1,0.0
mild-moderately,1,0.0
2020Expert,1,0.0
D110,1,0.0
HCoVOC43,1,0.0
IgG2a-Fc,1,0.0
RTPCR-positive,1,0.0
prospection,1,0.0
symptom-alleviating,1,0.0
Slower,1,0.0
Fleming,1,0.0
101-197,1,0.0
231-391,1,0.0
man-to-man,1,0.0
insufficiencies,1,0.0
antibody-free,1,0.0
garden,1,0.0
CAHAIs,1,0.0
urologists,1,0.0
subject-to-subject,1,0.0
H-1,1,0.0
reninaldosterone,1,0.0
Doing,1,0.0
renally,1,0.0
methylcobalamin,1,0.0
oxocobalamin,1,0.0
bioluminescence-based,1,0.0
CAHAI,1,0.0
Chedoke,1,0.0
nanoluciferase,1,0.0
12-wk,1,0.0
2592,1,0.0
2809,1,0.0
3596,1,0.0
nonexperimental,1,0.0
analysis-in,1,0.0
Multi-Centre,1,0.0
Deterministic,1,0.0
supportive-educative,1,0.0
90301QALY,1,0.0
QuadrivalentTM,1,0.0
00058,1,0.0
Microautoradiography,1,0.0
125ISar1Ile8,1,0.0
phase-specific,1,0.0
4812,1,0.0
3690,1,0.0
3512,1,0.0
etcStudy,1,0.0
papersData,1,0.0
subheadings,1,0.0
30251,1,0.0
2019-nCoVResults,1,0.0
linger,1,0.0
LAIV3s,1,0.0
contactsConclusions,1,0.0
March-July,1,0.0
CONDOR,1,0.0
Arrival,1,0.0
127797,1,0.0
CHIT1,1,0.0
BHK-21,1,0.0
gradient-refocused,1,0.0
emblospheres,1,0.0
3976,1,0.0
4b,1,0.0
Lown-Wolff,1,0.0
micro-costing,1,0.0
≤31-55,1,0.0
H1-blockers,1,0.0
Tomas,1,0.0
Ulaanbaatar,1,0.0
UV-light,1,0.0
11191,1,0.0
Speedy,1,0.0
16291,1,0.0
IHA,1,0.0
adsorbent,1,0.0
absentism,1,0.0
multiformity,1,0.0
Vientiane,1,0.0
94-119,1,0.0
full-grain,1,0.0
Lancefield,1,0.0
silver-based,1,0.0
thalamo-sub-thalamic,1,0.0
InfluNet,1,0.0
secures,1,0.0
WST8,1,0.0
UTIs,1,0.0
II-induced,1,0.0
fibrosis-associated,1,0.0
popularization,1,0.0
single-multi-mode,1,0.0
coupler,1,0.0
SMFC,1,0.0
antibodies-modified,1,0.0
COVID‐191,1,0.0
D‐dimer,1,0.0
POC-tests,1,0.0
mesor,1,0.0
2010-June,1,0.0
GermanEuropean,1,0.0
Chon-Tuz,1,0.0
caves,1,0.0
Isareli,1,0.0
12282021-372021,1,0.0
24-day,1,0.0
507100000,1,0.0
del142-144,1,0.0
wwwics-shippingorg,1,0.0
Nsp6,1,0.0
Nsp11,1,0.0
web-application,1,0.0
ZN,1,0.0
LO,1,0.0
042-080,1,0.0
Collgroupp,1,0.0
SNHs,1,0.0
non-SNHs,1,0.0
I-values,1,0.0
HRSN,1,0.0
yearsand,1,0.0
30-May,1,0.0
worldMeasures,1,0.0
25in,1,0.0
patients94in,1,0.0
826-902,1,0.0
056-062,1,0.0
patients73in,1,0.0
Savings,1,0.0
17in,1,0.0
834-874,1,0.0
060-064,1,0.0
36935,1,0.0
was--132,1,0.0
nonobstructed,1,0.0
Hokumou,1,0.0
17481,1,0.0
keypoints,1,0.0
patientsHerpesviridae,1,0.0
patients--stratified,1,0.0
10-199,1,0.0
age-defined,1,0.0
CMVAmong,1,0.0
2257,1,0.0
Hui,1,0.0
2734and,1,0.0
cough2634,1,0.0
002-57,1,0.0
3334,1,0.0
history13,1,0.0
0002-063,1,0.0
1877,1,0.0
001-21,1,0.0
50-68,1,0.0
Grouped,1,0.0
-recommendations,1,0.0
probaby,1,0.0
181797,1,0.0
GPnurse,1,0.0
TIACVA,1,0.0
NVN,1,0.0
Menstrual-linked,1,0.0
institutionsThe,1,0.0
PAIA,1,0.0
peri-menstrually,1,0.0
36-hour,1,0.0
100000-1,1,0.0
1963--1972,1,0.0
stages-were,1,0.0
unbearable,1,0.0
0084-092,1,0.0
depriving,1,0.0
401-18,1,0.0
Glib-treated,1,0.0
xenon-blood-flow,1,0.0
above-cited,1,0.0
Piloting,1,0.0
HCoV-19,1,0.0
prospected,1,0.0
194-29,1,0.0
424-24,1,0.0
TDBH,1,0.0
neurodisability,1,0.0
infarct-to-risk,1,0.0
Place,1,0.0
nano-objects,1,0.0
5HD,1,0.0
5-hydroxydecanoate,1,0.0
Glib,1,0.0
077-087,1,0.0
074-092,1,0.0
HPD066-087,1,0.0
089-102,1,0.0
7001,1,0.0
4241days,1,0.0
HPD3174-5615days,1,0.0
423-18,1,0.0
5HD-treated,1,0.0
Okhotsk,1,0.0
104-114,1,0.0
AH1N1pmd09,1,0.0
124-599,1,0.0
Abashiri,1,0.0
Bihoro,1,0.0
recourses,1,0.0
dRPP,1,0.0
unreactive,1,0.0
estates,1,0.0
copymL,1,0.0
posterior-to-anterior,1,0.0
102-528,1,0.0
p069,1,0.0
capture-mark-recapture,1,0.0
orthotics,1,0.0
p00033,1,0.0
SeroPrevalence,1,0.0
SPARTA,1,0.0
over-ground,1,0.0
multi-joint,1,0.0
Goal-directed,1,0.0
actuator,1,0.0
recannalize,1,0.0
418-12,1,0.0
412-18,1,0.0
borderzones,1,0.0
GBM-adjacent,1,0.0
studiesAreas,1,0.0
Mid-term,1,0.0
A0,1,0.0
identifiedObservations,1,0.0
9127,1,0.0
3-item,1,0.0
9709,1,0.0
Abha,1,0.0
LiSat-11,1,0.0
24677,1,0.0
4003,1,0.0
anticoagulationantiplatelet,1,0.0
22-62,1,0.0
Inner-city,1,0.0
druG,1,0.0
SOS-TIA,1,0.0
EXPRESS,1,0.0
COURAGE,1,0.0
percardial,1,0.0
leukomalacia,1,0.0
14-365,1,0.0
Hypochlorous,1,0.0
state-sponsored,1,0.0
electrolyzed,1,0.0
regionalizing,1,0.0
proud,1,0.0
adult-,1,0.0
shearwater,1,0.0
titreThe,1,0.0
A2Asian57,1,0.0
context-Aware,1,0.0
NADH-dehydrogenase,1,0.0
student-centered,1,0.0
active-learning,1,0.0
pedagogies,1,0.0
antithrombothic,1,0.0
Longini,1,0.0
Dissimilarities,1,0.0
0-231,1,0.0
Elveback,1,0.0
17073,1,0.0
managemenT,1,0.0
angio-scintigraphy,1,0.0
strokebleed-related,1,0.0
Context-aware,1,0.0
coronography,1,0.0
rhabdomyolysis-induced,1,0.0
perservation,1,0.0
postangioplasty,1,0.0
routinary,1,0.0
cortexs,1,0.0
Redfield,1,0.0
barrier-related,1,0.0
7169,1,0.0
chlororhynchus,1,0.0
pediatric-based,1,0.0
workwhich,1,0.0
terrific,1,0.0
Head-Off,1,0.0
chanting,1,0.0
Sangay,1,0.0
hexarelin,1,0.0
Menlha,1,0.0
secretagogues,1,0.0
warding,1,0.0
feast,1,0.0
emulated,1,0.0
7919,1,0.0
iFlash®,1,0.0
TASH,1,0.0
Variances,1,0.0
MI-injured,1,0.0
Trevo®,1,0.0
ProVue,1,0.0
Eigen,1,0.0
prorating,1,0.0
IOC,1,0.0
phase1,1,0.0
Reusing,1,0.0
SaTScan,1,0.0
multi-pollutant,1,0.0
evidence-to-date,1,0.0
severely-critically,1,0.0
astrology,1,0.0
Dana,1,0.0
N178,1,0.0
intra-season,1,0.0
cultivars,1,0.0
component-resolved,1,0.0
β-035,1,0.0
Trichotomizing,1,0.0
Noons,1,0.0
SMPC,1,0.0
affectively,1,0.0
IAPS,1,0.0
Leonard,1,0.0
Crewmembers,1,0.0
Atlantica,1,0.0
HEX-dependent,1,0.0
MI-HEX,1,0.0
Bodytest,1,0.0
MMP-13,1,0.0
collagen-degrading,1,0.0
Re-Admission,1,0.0
OSCARE,1,0.0
Widescale,1,0.0
issues--eg,1,0.0
MI-VEH,1,0.0
Zhung,1,0.0
Dratsang,1,0.0
monastic,1,0.0
succinic,1,0.0
1975-1980,1,0.0
aglycovancomycin,1,0.0
rebalance,1,0.0
dose-escalation,1,0.0
self-confined,1,0.0
ELF-MFs,1,0.0
Affects,1,0.0
20739,1,0.0
concatenating,1,0.0
4-April,1,0.0
quasi-experimentally,1,0.0
markov-state,1,0.0
nurse-managed,1,0.0
bi-clustering,1,0.0
Information-Bottleneck,1,0.0
RhinovirusEnterovirus,1,0.0
anti-angiogenic,1,0.0
Substrates,1,0.0
decomposes,1,0.0
pronouncing,1,0.0
dynorphin-12,1,0.0
apelin-12,1,0.0
dynorphin-13,1,0.0
IFN-driven,1,0.0
httpsdoiorg101084jem20201241,1,0.0
loose-fitting,1,0.0
context-revealed,1,0.0
Four-hundred,1,0.0
CI-137,1,0.0
025-075,1,0.0
Yb169-labelled,1,0.0
GBM-peritumor,1,0.0
GBM-central,1,0.0
90-96,1,0.0
shelter-like,1,0.0
case-definitions,1,0.0
EuroDRG,1,0.0
lopinavir-ritonavir,1,0.0
207265,1,0.0
catabolite,1,0.0
anti-IL5,1,0.0
complement-triggered,1,0.0
ethylenediaminetetracetic,1,0.0
CI-45,1,0.0
radio-isotope,1,0.0
airmen,1,0.0
miR-124-3p,1,0.0
miR-16,1,0.0
124-351,1,0.0
257-3380,1,0.0
ultrashort,1,0.0
UTE-MRI,1,0.0
26-83,1,0.0
serial-reaction,1,0.0
CI451,1,0.0
Israelow,1,0.0
prime-induced,1,0.0
β-secretase,1,0.0
hemicorporeal,1,0.0
p38γ,1,0.0
strip-based,1,0.0
easy-readout,1,0.0
revivified,1,0.0
easy-read,1,0.0
9921,1,0.0
2020-008-01,1,0.0
2020IECZD01,1,0.0
PJ-NBEY-2020-009-01,1,0.0
202034,1,0.0
Coarctation,1,0.0
bronchoactive,1,0.0
ecostress,1,0.0
alpha-adrenoceptor,1,0.0
real-word,1,0.0
surgicall7y,1,0.0
coronaroventriculography,1,0.0
haemangioblastoma,1,0.0
substituents,1,0.0
ε4,1,0.0
aglycoristocetin,1,0.0
chain-substituted,1,0.0
cyclobutenedione,1,0.0
ε3ε4,1,0.0
p38β,1,0.0
FasL,1,0.0
BioNTechPfizers,1,0.0
atherothromboembolic,1,0.0
Selections,1,0.0
Non-pharmacologic,1,0.0
corticosteroid-long,1,0.0
ICS-LABA,1,0.0
ChAdOx1-nCov-19,1,0.0
placebono,1,0.0
179637,1,0.0
patientstheir,1,0.0
incontestable,1,0.0
under-treatmentscarce,1,0.0
VITATOPS,1,0.0
neurodysfunction,1,0.0
pre-apoptotic,1,0.0
micromolL,1,0.0
Legislative,1,0.0
2004-July,1,0.0
thrombolectomy,1,0.0
cadmium,1,0.0
HUG,1,0.0
COVIDs,1,0.0
tri-vessel,1,0.0
bivessel,1,0.0
monovessel,1,0.0
Dobutamin,1,0.0
369390,1,0.0
952004,1,0.0
so-defined,1,0.0
radioenzymatic,1,0.0
Epi-info,1,0.0
mRNACovid19,1,0.0
polyethylenglycols,1,0.0
Kerlan,1,0.0
LaBerge,1,0.0
chlorotic,1,0.0
Jeanne,1,0.0
JVIR,1,0.0
Corner,1,0.0
encapsidation,1,0.0
SLDMs,1,0.0
screeningcase-finding,1,0.0
swab-to-test,1,0.0
ischaemia-driven,1,0.0
liverinjury,1,0.0
Clonidine,1,0.0
hyper-coagulable,1,0.0
4107,1,0.0
vs28,1,0.0
0674,1,0.0
Woolcock,1,0.0
al56,1,0.0
Townley,1,0.0
al14,1,0.0
ex-asthmatics,1,0.0
perseverations,1,0.0
Naked,1,0.0
submersion,1,0.0
manifestations--20,1,0.0
Ruppert,1,0.0
Stanisław,1,0.0
45-36,1,0.0
60-265,1,0.0
75-516,1,0.0
75-18,1,0.0
Gen,1,0.0
pain--41,1,0.0
Marshal,1,0.0
manifestations--49,1,0.0
corticothalamic,1,0.0
manifestations--23,1,0.0
unoxygenated,1,0.0
84--anteroseptal,1,0.0
174--anterior,1,0.0
96--massive,1,0.0
18--anterior-apical,1,0.0
64--anterior,1,0.0
253--posterior,1,0.0
9--posterior-lateral,1,0.0
self-activation,1,0.0
56--anterior-posterior,1,0.0
06--focal,1,0.0
disorders--in,1,0.0
vs59,1,0.0
futureABSTRACT,1,0.0
0093,1,0.0
EMBase,1,0.0
Plasmacytoid,1,0.0
HBsAg,1,0.0
Snuff,1,0.0
criticalThe,1,0.0
market-potentially,1,0.0
surfacesinterfaces,1,0.0
Bonn,1,0.0
-02066,1,0.0
-09609,1,0.0
Solu-Medrol,1,0.0
-05837,1,0.0
Powder,1,0.0
987-998,1,0.0
Upjohn,1,0.0
TrueNAT,1,0.0
Site-specific,1,0.0
trialsABSTRACT,1,0.0
anachronism,1,0.0
geoepidemiology,1,0.0
mg4,1,0.0
QALY-weights,1,0.0
PARIS,1,0.0
Hypertention,1,0.0
healthallergy,1,0.0
905-982,1,0.0
791-894,1,0.0
3324,1,0.0
S1-N-terminal,1,0.0
4324,1,0.0
strangulations,1,0.0
strangled,1,0.0
homicide,1,0.0
34324,1,0.0
Monash,1,0.0
cyclopheron,1,0.0
2500000,1,0.0
51324,1,0.0
S1-receptor,1,0.0
5993,1,0.0
2102,1,0.0
rapid-tested,1,0.0
2933,1,0.0
2786,1,0.0
prozone,1,0.0
albuminALB,1,0.0
patients-a,1,0.0
Mildmoderate,1,0.0
γ-glutamyl,1,0.0
COVID-19-vaccinated,1,0.0
mRNA-BNT162b2,1,0.0
warmup,1,0.0
ipratroprium,1,0.0
hospital--Sliven,1,0.0
conceptualizations,1,0.0
Marcin,1,0.0
World-wide,1,0.0
Lenfant,1,0.0
désordre,1,0.0
199948No,1,0.0
psychosomatique,1,0.0
Ed,1,0.0
Privat-Toulouse,1,0.0
coughphlegm,1,0.0
sympatho-vagal,1,0.0
peer-review,1,0.0
destructiveness,1,0.0
Formulas,1,0.0
cross-language,1,0.0
Kreisler,1,0.0
crossings,1,0.0
media-mastoiditis,1,0.0
n69,1,0.0
Alphacoronavirus,1,0.0
persecution,1,0.0
pre-rupture,1,0.0
Truvian,1,0.0
519±525,1,0.0
testSerologic,1,0.0
curbed,1,0.0
zoonic,1,0.0
RR-4,1,0.0
parted,1,0.0
loss-of-target,1,0.0
documentedreported,1,0.0
peptid,1,0.0
Doubtlessly,1,0.0
Hat,1,0.0
thoracoscopythoracotomy,1,0.0
resiliency-related,1,0.0
25381,1,0.0
gossipiboma,1,0.0
6110,1,0.0
gossypiboma,1,0.0
misread,1,0.0
9519,1,0.0
cdcgovncidoddiseasesflufluvirushtm,1,0.0
httpwww,1,0.0
Constraining,1,0.0
JPAC,1,0.0
personnelcatheter,1,0.0
superventricular,1,0.0
monographic,1,0.0
aggressivity,1,0.0
objectal,1,0.0
fusional,1,0.0
blocking-up,1,0.0
separation-individuation,1,0.0
traumatisms,1,0.0
1792,1,0.0
syndromes-CoV,1,0.0
Wroczyński,1,0.0
Pulseless,1,0.0
187-348,1,0.0
Backgroundintroduction,1,0.0
233-fold,1,0.0
pneumoniaHere,1,0.0
162-336,1,0.0
8957,1,0.0
telomeres,1,0.0
107-267,1,0.0
UTH,1,0.0
8382,1,0.0
Lusaka,1,0.0
0956,1,0.0
255-fold,1,0.0
extrauterine,1,0.0
virus--all,1,0.0
validationThe,1,0.0
profilactic,1,0.0
quanlity,1,0.0
ChinaA,1,0.0
7-51,1,0.0
Mozołowki,1,0.0
repudiating,1,0.0
DrAndrzej,1,0.0
Contradicting,1,0.0
Glioblastoma,1,0.0
finger-nose,1,0.0
milieus,1,0.0
diseasedeath,1,0.0
n711,1,0.0
0–94,1,0.0
facsimile,1,0.0
3025,1,0.0
limited-flow,1,0.0
adaptation-driven,1,0.0
3-98,1,0.0
dipyridamole-echocardiography,1,0.0
128000,1,0.0
adultschildren,1,0.0
Optic,1,0.0
severedeceased,1,0.0
suboccipital,1,0.0
408493,1,0.0
4-weeks,1,0.0
singleness,1,0.0
weeksQOL,1,0.0
Inter-individual,1,0.0
body-builder,1,0.0
Abuse,1,0.0
01-60,1,0.0
106-177,1,0.0
108-202,1,0.0
biopsy-diagnosed,1,0.0
Wmin,1,0.0
Ventrex,1,0.0
apposite,1,0.0
Bio-Psycho-Social,1,0.0
examens,1,0.0
admits,1,0.0
pump-inhibitors,1,0.0
microaspired,1,0.0
MMFR25-75,1,0.0
Mid-expiratory,1,0.0
200-1200,1,0.0
aerolization,1,0.0
betareceptor,1,0.0
HbSOArab,1,0.0
synthetics,1,0.0
recordsABSTRACT,1,0.0
flagellin,1,0.0
paradoxicus,1,0.0
stridulous,1,0.0
reappearing,1,0.0
10-Meter,1,0.0
attenuatedamplified,1,0.0
hatched,1,0.0
MIND-IT,1,0.0
Eggslarvae,1,0.0
ENRICHD,1,0.0
redundancies,1,0.0
Pre-exercise,1,0.0
pig-derived,1,0.0
1215-,1,0.0
non-angiogenic,1,0.0
hind-limb,1,0.0
Grünenwald,1,0.0
9250,1,0.0
3859,1,0.0
preterms,1,0.0
radio-opacities,1,0.0
CYP3A5,1,0.0
CYP3A4,1,0.0
solidaristic,1,0.0
VISTA-Imaging,1,0.0
SLV,1,0.0
disease--is,1,0.0
DM1--Curschmann-Steinert,1,0.0
Spaggiari,1,0.0
17year,1,0.0
urea-for,1,0.0
C8-T1,1,0.0
Pirogoff,1,0.0
chondrosarcoma,1,0.0
fissural,1,0.0
adherences,1,0.0
rt-PA-,1,0.0
polygenetic,1,0.0
ALA-ACRC,1,0.0
studies-as,1,0.0
buffers-4,1,0.0
G1-G5,1,0.0
supervene,1,0.0
intra-ethnic,1,0.0
Paralysis,1,0.0
55ABSTRACT,1,0.0
proton-selective,1,0.0
underexploited,1,0.0
anti-stalk,1,0.0
138-327,1,0.0
10-94,1,0.0
131-412,1,0.0
Laryngoscopy,1,0.0
160-3682,1,0.0
Monophonic,1,0.0
investigatedObjective,1,0.0
aspirative,1,0.0
M2-specific,1,0.0
patientsMethod,1,0.0
septations,1,0.0
Empyema,1,0.0
CVHS,1,0.0
underfitResults,1,0.0
underfit,1,0.0
Trouser,1,0.0
D150,1,0.0
Shirt,1,0.0
Coin,1,0.0
-358,1,0.0
M2-targeted,1,0.0
Counterscreening,1,0.0
1094516,1,0.0
31224,1,0.0
beta2-adrenocepter,1,0.0
2000-2018,1,0.0
US-born,1,0.0
065-,1,0.0
043-206,1,0.0
atherosclerotic-non-CAE,1,0.0
079-212,1,0.0
Cineangiocardiography,1,0.0
028-078,1,0.0
sub-total,1,0.0
Stenoses,1,0.0
last-known-well-to-arrival,1,0.0
Rhone-Alps,1,0.0
10449,1,0.0
™,1,0.0
0114,1,0.0
061-214,1,0.0
1185,1,0.0
MedlineCENTRAL,1,0.0
comportment,1,0.0
Castellon,1,0.0
auto-admission,1,0.0
Borriana,1,0.0
Falles,1,0.0
CYP2C8,1,0.0
1926dose,1,0.0
3508,1,0.0
signifiant,1,0.0
Espline,1,0.0
Excalibur,1,0.0
cHA,1,0.0
Joysbio,1,0.0
Mologic,1,0.0
NowCheck,1,0.0
Immunodiffusion,1,0.0
RespiStrip,1,0.0
Standard-F,1,0.0
Standard-Q,1,0.0
Sure-Status,1,0.0
Inital,1,0.0
stalks,1,0.0
inferoposterio,1,0.0
describedWe,1,0.0
RIOS,1,0.0
Optimism,1,0.0
Authoritarian,1,0.0
immunebased,1,0.0
triphenyl-tetrazolium,1,0.0
low-powdered,1,0.0
amphibians,1,0.0
nonpowdered,1,0.0
18-21°C,1,0.0
ActiveXpress,1,0.0
uAbs,1,0.0
27824,1,0.0
5163,1,0.0
Allostatic,1,0.0
NCT00979589,1,0.0
Khon,1,0.0
Kaen,1,0.0
studyTrial,1,0.0
outbreak-prevention,1,0.0
102-150,1,0.0
CHANCE,1,0.0
aIAB,1,0.0
2015-2020,1,0.0
Non-disabling,1,0.0
microgramL,1,0.0
ABeijing3292H3N2,1,0.0
broth,1,0.0
solidified,1,0.0
still-unanswered,1,0.0
mock-up,1,0.0
professional-diagnosed,1,0.0
stroke-within,1,0.0
onset-as,1,0.0
IBV-,1,0.0
NMDA-receptor,1,0.0
TIV-,1,0.0
volumeforced,1,0.0
climate-based,1,0.0
25071,1,0.0
38232144,1,0.0
despair,1,0.0
developmentproduction,1,0.0
Non-Covid,1,0.0
neuroreparative,1,0.0
Sedentary,1,0.0
1872,1,0.0
cancer-stroke,1,0.0
Adversarial,1,0.0
SLCO1B1,1,0.0
9507,1,0.0
9940,1,0.0
9461,1,0.0
ABCC2,1,0.0
Stacked,1,0.0
less-costly,1,0.0
office-located,1,0.0
ABCB1,1,0.0
n9027,1,0.0
n4534,1,0.0
916dose,1,0.0
2300dose,1,0.0
1989dose,1,0.0
5205dose,1,0.0
CY2D6,1,0.0
meanmedian,1,0.0
Aker,1,0.0
StackNet-DenVIS,1,0.0
high-qualified,1,0.0
treatmentThis,1,0.0
psychotrauma,1,0.0
MAWI,1,0.0
p-NBT,1,0.0
offindingan,1,0.0
elastin,1,0.0
extrapericardial,1,0.0
4303,1,0.0
postpneumonic,1,0.0
infectiousinflammatory,1,0.0
storm-like,1,0.0
collectivism,1,0.0
premorbidly,1,0.0
taxing,1,0.0
052-064,1,0.0
commutability,1,0.0
population-residents,1,0.0
crystalline,1,0.0
andendovascular,1,0.0
sharpening,1,0.0
case-fatalities,1,0.0
queue,1,0.0
re-cover,1,0.0
Illa,1,0.0
genetic-based,1,0.0
gravidity,1,0.0
immundeficienty,1,0.0
∼70,1,0.0
Yai,1,0.0
88-year,1,0.0
Oscillococcinum®,1,0.0
mirror-image,1,0.0
149-270,1,0.0
valsalva,1,0.0
6069,1,0.0
9531,1,0.0
8281,1,0.0
322-379,1,0.0
anosmiahypogeusia,1,0.0
5-21,1,0.0
sustainment,1,0.0
180-240,1,0.0
microscopies,1,0.0
shuttles,1,0.0
-254,1,0.0
-256,1,0.0
-165,1,0.0
-132,1,0.0
-182,1,0.0
-153,1,0.0
music-movement,1,0.0
keynotes,1,0.0
Sulphasalazine,1,0.0
IFN-PADRE-RBD-Fc,1,0.0
3-open,1,0.0
2-mixture,1,0.0
well-populated,1,0.0
Austrias,1,0.0
SARS-CoV-2-the,1,0.0
Scrutiny,1,0.0
cost-relevant,1,0.0
Self-reliance,1,0.0
pathogens-combined,1,0.0
2907,1,0.0
rint,1,0.0
gradable,1,0.0
139-402,1,0.0
109-355,1,0.0
101-883,1,0.0
Interrupter,1,0.0
chimney,1,0.0
wood-smoke,1,0.0
indigeneous,1,0.0
Mam-speaking,1,0.0
hyposecreting,1,0.0
3840,1,0.0
Maya,1,0.0
Guatemalan,1,0.0
ABOH,1,0.0
chimneys,1,0.0
1-improved,1,0.0
de-clining,1,0.0
PACU,1,0.0
V1-4,1,0.0
V2-5,1,0.0
limbas,1,0.0
over-produced,1,0.0
macrophage-associated,1,0.0
VFL,1,0.0
BoM,1,0.0
waterECW,1,0.0
kgintracellular,1,0.0
season-long,1,0.0
ICW,1,0.0
Fellow,1,0.0
TFFM,1,0.0
kgin,1,0.0
TFM,1,0.0
ICS-naïve,1,0.0
quotuniform,1,0.0
diseasequot,1,0.0
re-recognized,1,0.0
Taiyang,1,0.0
Cree-Métis,1,0.0
Shaoyang,1,0.0
Yangming,1,0.0
Dayuan,1,0.0
Swampy,1,0.0
Xiaochaihu,1,0.0
egg-dependent,1,0.0
TBW,1,0.0
feasibly,1,0.0
chain-dependent,1,0.0
123-878,1,0.0
V3-6,1,0.0
social-epidemiological,1,0.0
under-prescription,1,0.0
2150,1,0.0
3172,1,0.0
4506,1,0.0
non-neural-type,1,0.0
Pooled-sample,1,0.0
35Ct,1,0.0
Over-prescription,1,0.0
022-083,1,0.0
Chiaris,1,0.0
spasm-induced,1,0.0
008-093,1,0.0
048-094,1,0.0
756843,1,0.0
CPplasma-based,1,0.0
httpsbitly2QqSKxT,1,0.0
EndMT,1,0.0
inter-angiographic,1,0.0
utility-based,1,0.0
clonotypes,1,0.0
BMR,1,0.0
HR-QOL,1,0.0
on-cell,1,0.0
HGal-1,1,0.0
stoichiometric,1,0.0
articlesPalliative,1,0.0
TPD,1,0.0
084-108,1,0.0
P044,1,0.0
088-109,1,0.0
SDE,1,0.0
geneticenvironmental,1,0.0
P067,1,0.0
086-166,1,0.0
057-131,1,0.0
P049,1,0.0
generalizabilityThis,1,0.0
determinative,1,0.0
DNBs,1,0.0
Lipoprotein-Associated,1,0.0
Phospholipase,1,0.0
A2Lp-PLA2,1,0.0
Lp-PLA2P,1,0.0
hsCRPP,1,0.0
NT-proBNPP,1,0.0
high-Lp-PLA2,1,0.0
careAn,1,0.0
Tremor,1,0.0
055Lp-PLA2003hsCRP0005NT-proBNP15843,1,0.0
Hemichorea-hemiballism,1,0.0
P077,1,0.0
083-128,1,0.0
085195,1,0.0
Khuzestan,1,0.0
MAPs,1,0.0
MSSA,1,0.0
biocargo,1,0.0
MAP-mediated,1,0.0
MAP-based,1,0.0
methicillin-susceptible,1,0.0
Shimokita,1,0.0
Kamikita,1,0.0
MAP-delivered,1,0.0
Sanpachi,1,0.0
Tosei,1,0.0
to-,1,0.0
streak,1,0.0
4114,1,0.0
Aomori,1,0.0
Stroke-3,1,0.0
p0001Four,1,0.0
point-source,1,0.0
4576,1,0.0
328909,1,0.0
Barcelonas,1,0.0
079-224,1,0.0
P028,1,0.0
malfunctions,1,0.0
montage,1,0.0
0771-0924,1,0.0
Bronchoprovocational,1,0.0
revascularising,1,0.0
chest-symptoms,1,0.0
prediabetes,1,0.0
Apply,1,0.0
427000,1,0.0
2005-2010,1,0.0
0625p0001,1,0.0
post-genome,1,0.0
Disentangling,1,0.0
persistant,1,0.0
alinetic,1,0.0
ASON,1,0.0
G-protein-coupled-receptor,1,0.0
multiserial,1,0.0
readdress,1,0.0
cross-classified,1,0.0
Rorrico,1,0.0
unjustifiably,1,0.0
atom,1,0.0
IgGM,1,0.0
anticorrelated,1,0.0
sialoglycans,1,0.0
galactose-binding,1,0.0
proteins--galectins,1,0.0
Anisotropic,1,0.0
thats,1,0.0
Jaspen,1,0.0
Cutoff19696ngml,1,0.0
coronary-care-unit,1,0.0
19696ngml,1,0.0
dexmedetomidine,1,0.0
03-04,1,0.0
haemoglobin-based,1,0.0
pentazocine,1,0.0
05-06,1,0.0
self-sample,1,0.0
22th,1,0.0
microscopy-based,1,0.0
maleic,1,0.0
Brownsville,1,0.0
radiographycal,1,0.0
Killip-classification,1,0.0
do-not-resuscitate-orders,1,0.0
prophecies,1,0.0
1986-1999,1,0.0
chemoprohylaxis,1,0.0
zamanavir,1,0.0
AIRIAP,1,0.0
TIMI-risk-score,1,0.0
shock-index,1,0.0
Psychophysiological,1,0.0
Subscale,1,0.0
4-category,1,0.0
TNDs,1,0.0
exterior,1,0.0
perquisite,1,0.0
variant3,1,0.0
glutamino-oxaloacetic,1,0.0
ciruclation,1,0.0
LDH5,1,0.0
TAVR-related,1,0.0
bicuspid,1,0.0
Nivgrip,1,0.0
200136155-163,1,0.0
Workloads,1,0.0
Radiol,1,0.0
vaccines12,1,0.0
regions-including,1,0.0
Freeman-Tukey,1,0.0
32-64,1,0.0
Durocher,1,0.0
arcsine,1,0.0
Khiat,1,0.0
0122,1,0.0
0275,1,0.0
4357,1,0.0
Labelle,1,0.0
pTK1A-TPA-SpikeA,1,0.0
296X,1,0.0
mid-sized,1,0.0
subchronic,1,0.0
1420,1,0.0
35-72,1,0.0
Shaoxing,1,0.0
detectable4-6,1,0.0
pubblica,1,0.0
Cervicocerebral,1,0.0
sport-associated,1,0.0
NMRCD,1,0.0
Detachment,1,0.0
Hulunbuir,1,0.0
355-crewman,1,0.0
infirmary,1,0.0
Thallium-20,1,0.0
vaccines1-3,1,0.0
vaccination3,1,0.0
stage78,1,0.0
B-N,1,0.0
single-epitope,1,0.0
bnt162b2,1,0.0
death1-4,1,0.0
treatmill,1,0.0
100-685,1,0.0
hamsters5-7,1,0.0
primates8-10,1,0.0
primates11-13,1,0.0
vessels-patient,1,0.0
HDL-associated,1,0.0
ESPLINE,1,0.0
EP-assisted,1,0.0
3981,1,0.0
therere,1,0.0
Ulcerations,1,0.0
Chymotrypsin-like,1,0.0
Heritability,1,0.0
monumental,1,0.0
helicases,1,0.0
anti-SARS-COV,1,0.0
anti-MERS-COV,1,0.0
down-titration,1,0.0
hyperresponsitivity,1,0.0
Minorities,1,0.0
aphthous,1,0.0
baroreceptive,1,0.0
Baroreflex,1,0.0
SyndromeSARS-CoVThese,1,0.0
PLSVC,1,0.0
CORONAVAC,1,0.0
forty-six-year-old,1,0.0
SPUTNIK,1,0.0
MODERNA,1,0.0
PFIZER,1,0.0
VAXZEVRIA,1,0.0
increaseddecreased,1,0.0
CovPCR,1,0.0
Songkhla,1,0.0
guidanceconsults,1,0.0
chronics,1,0.0
anti-SARS-CoV-2-agentThrough,1,0.0
29-65,1,0.0
330-660,1,0.0
Hugh,1,0.0
AH1N1California0409,1,0.0
McMillan,1,0.0
Achenbachs,1,0.0
6-11-year,1,0.0
pesetas,1,0.0
Ont,1,0.0
69295,1,0.0
noncompliers,1,0.0
1984-1988,1,0.0
time-use,1,0.0
57-194,1,0.0
6781,1,0.0
34-98,1,0.0
short-period,1,0.0
Raising,1,0.0
co-opt,1,0.0
ER-resident,1,0.0
follow-on,1,0.0
Socioeconomically,1,0.0
Fuego,1,0.0
2018-2020,1,0.0
Tierra,1,0.0
large-framed,1,0.0
comet-,1,0.0
topically,1,0.0
Tingli,1,0.0
alcune,1,0.0
MDN,1,0.0
-99,1,0.0
βadj,1,0.0
non-eligibility,1,0.0
570595,1,0.0
considerazioni,1,0.0
Tama,1,0.0
H3N2-positive,1,0.0
19908,1,0.0
1974-80,1,0.0
istruttive,1,0.0
sawdust,1,0.0
-126,1,0.0
prestandosi,1,0.0
Obeche,1,0.0
sembri,1,0.0
quanto,1,0.0
immediate-,1,0.0
lontano,1,0.0
January302020,1,0.0
meno,1,0.0
March2021,1,0.0
VARC-2,1,0.0
1918-1957,1,0.0
Mixture,1,0.0
lactulose,1,0.0
unsatisfactorily,1,0.0
proffered,1,0.0
Dazao,1,0.0
Xiefei,1,0.0
Weijing,1,0.0
Xuanbai,1,0.0
Chengqi,1,0.0
Xiaoxianxiong,1,0.0
immeasurably,1,0.0
userfriendly,1,0.0
Zhuye,1,0.0
CoronaPep,1,0.0
Shigao,1,0.0
Sha-shen,1,0.0
time-steps,1,0.0
Maidong,1,0.0
contriving,1,0.0
Liujunzi,1,0.0
V2R,1,0.0
rein,1,0.0
V1R,1,0.0
1881,1,0.0
ezetimibe,1,0.0
dysarthria-clumsy,1,0.0
1year,1,0.0
sequence-learning,1,0.0
è,1,0.0
questi,1,0.0
facilites,1,0.0
rappresentare,1,0.0
phosphoenolpyruvate,1,0.0
electron-accepting,1,0.0
grande,1,0.0
noncytotoxic,1,0.0
chloroquine-resistant,1,0.0
anticarcinogenic,1,0.0
chloroquine-like,1,0.0
0329,1,0.0
0747,1,0.0
C8626T,1,0.0
C18452T,1,0.0
può,1,0.0
CHCs,1,0.0
viable-virus,1,0.0
transmissionIMPORTANCE,1,0.0
Kong48397,1,0.0
Kong48697,1,0.0
Cancer-associated,1,0.0
si,1,0.0
trascorso,1,0.0
appena,1,0.0
hospitalizing,1,0.0
lanno,1,0.0
patient-medical,1,0.0
malate,1,0.0
chiamato,1,0.0
Labbinamento,1,0.0
All-In-One,1,0.0
Genbank,1,0.0
Cray,1,0.0
Multithreading,1,0.0
XMT,1,0.0
maggio,1,0.0
parallelization,1,0.0
H1N1H1N2,1,0.0
52111,1,0.0
Firenze,1,0.0
copackaged,1,0.0
nata,1,0.0
protospacer,1,0.0
sua,1,0.0
perché,1,0.0
misattribute,1,0.0
resentment,1,0.0
chiamata,1,0.0
Nightingale,1,0.0
unstated,1,0.0
nascita,1,0.0
bicentenario,1,0.0
circondata,1,0.0
immagine,1,0.0
Deprivation,1,0.0
cache,1,0.0
adenomas,1,0.0
Inotropic,1,0.0
Mediators,1,0.0
-0544,1,0.0
gene-driven,1,0.0
pathway-driven,1,0.0
asthma-annotated,1,0.0
-0578,1,0.0
ignorome,1,0.0
-0458,1,0.0
super-connectors,1,0.0
Il6,1,0.0
Sleepiness,1,0.0
chin,1,0.0
Il1ß,1,0.0
EOG,1,0.0
Cd4,1,0.0
Cd44,1,0.0
Stat1,1,0.0
Traf6,1,0.0
electrooculograms,1,0.0
electrocephalogram,1,0.0
Rela,1,0.0
Cadm1,1,0.0
Nr3c1,1,0.0
Prkcd,1,0.0
DVTs,1,0.0
Vwf,1,0.0
4-December,1,0.0
0430,1,0.0
691000,1,0.0
0451,1,0.0
ribonucleoproteins,1,0.0
orientational,1,0.0
corona-shaped,1,0.0
Delineating,1,0.0
Sparrow,1,0.0
26-57,1,0.0
4572555,1,0.0
Malcolm,1,0.0
Mitchell,1,0.0
2982098,1,0.0
Comprehension,1,0.0
Vocabulary,1,0.0
beta0,1,0.0
Labetalol,1,0.0
WIPPSI-R,1,0.0
nicardipine,1,0.0
subtypelineage,1,0.0
FluChip-8G,1,0.0
electrolytic,1,0.0
-0709,1,0.0
0760,1,0.0
non-REM,1,0.0
0405,1,0.0
interleukinIL-3,1,0.0
allergen-g,1,0.0
Erbb2,1,0.0
CF-asthma,1,0.0
HIRA-NSC,1,0.0
9304,1,0.0
Merseyside,1,0.0
110-195,1,0.0
uppermost,1,0.0
PPPs,1,0.0
PTBs,1,0.0
GBSs,1,0.0
134-204,1,0.0
079-398,1,0.0
027-090,1,0.0
papilledema,1,0.0
005-097,1,0.0
cyclohepatotifen,1,0.0
fence,1,0.0
antianaphylactic,1,0.0
propitiating,1,0.0
Mutagrip,1,0.0
Ivry,1,0.0
wayABSTRACT,1,0.0
Symptom-Score,1,0.0
immunoelectrophoresis,1,0.0
ultrasonicates,1,0.0
7576,1,0.0
monoids,1,0.0
sonicates,1,0.0
SAHs,1,0.0
3746,1,0.0
predated,1,0.0
well-advised,1,0.0
P06,1,0.0
mono-metameric,1,0.0
11--75,1,0.0
9120,1,0.0
control-tonsillectomy,1,0.0
36--81,1,0.0
cramps,1,0.0
five-hour,1,0.0
non-obstetric,1,0.0
SMR01,1,0.0
SSCA,1,0.0
cellsmicroL,1,0.0
discharge12,1,0.0
hyper-connectivity,1,0.0
Real‐time,1,0.0
α5,1,0.0
virus-directed,1,0.0
enzyme-inducers,1,0.0
non-enzyme-inducers,1,0.0
handicapping,1,0.0
negotiates,1,0.0
wildlifes,1,0.0
forests,1,0.0
deprives,1,0.0
DDP4,1,0.0
Sheriffs,1,0.0
paraesthesia,1,0.0
0893,1,0.0
30ies,1,0.0
Biermann,1,0.0
Maler,1,0.0
JM,1,0.0
BAD-related,1,0.0
V3r,1,0.0
HRMRI,1,0.0
microatheroma,1,0.0
ratesABSTRACT,1,0.0
free-recall,1,0.0
stress-rest,1,0.0
Caplan,1,0.0
meropenem,1,0.0
beta-1b,1,0.0
immunome,1,0.0
Atheromatous,1,0.0
ultrosono-cardiokymography,1,0.0
replicas,1,0.0
ultrasono-cardiotomography,1,0.0
EDD-ESD,1,0.0
echo-demonstrated,1,0.0
available-the,1,0.0
bulged,1,0.0
COVID-19-indected,1,0.0
PMDCOCM,1,0.0
deltaPCAQ,1,0.0
Brief-COPE-28,1,0.0
Reulbach,1,0.0
Bleich,1,0.0
Niculae,1,0.0
chiropractors,1,0.0
mid-to-late,1,0.0
G75V,1,0.0
Basedows,1,0.0
C1247F,1,0.0
Country-scale,1,0.0
1-Adamantanamine,1,0.0
0980,1,0.0
Kong68In,1,0.0
0938,1,0.0
Stăncioiu,1,0.0
world--and,1,0.0
ASSIA,1,0.0
180120,1,0.0
anticonvulsive,1,0.0
infiltrate-derived,1,0.0
Home-onset,1,0.0
Th22,1,0.0
averagepoor,1,0.0
PWUDsubstance,1,0.0
CCL-26,1,0.0
population--generally,1,0.0
crashes,1,0.0
treatmentrecovery,1,0.0
post-education,1,0.0
sino-nasal,1,0.0
2275-3000,1,0.0
AMQ,1,0.0
3628,1,0.0
265-fold,1,0.0
Economically,1,0.0
singlemost,1,0.0
0343,1,0.0
3529,1,0.0
BOD,1,0.0
hypoglycemiaiatrogenic,1,0.0
DWIperfusion-weighted,1,0.0
multicountry,1,0.0
0953-5536,1,0.0
3801,1,0.0
1110-13015,1,0.0
anti-DM,1,0.0
0-88,1,0.0
AH3N2Fujian41102,1,0.0
shred,1,0.0
15-6,1,0.0
2750-3400,1,0.0
AH3N2Fujian,1,0.0
widens,1,0.0
miR-107,1,0.0
miR-29a,1,0.0
miR-22,1,0.0
basketlike,1,0.0
Spike-2-ACE2,1,0.0
IgG2c,1,0.0
-0703,1,0.0
≥50000,1,0.0
Sniffin,1,0.0
Sticks,1,0.0
Hypogeusia,1,0.0
coronapp,1,0.0
post-completion,1,0.0
httpgiorgilabuniboitcoronannotator,1,0.0
9402,1,0.0
httpsgithubcomfedericogiorgigiorgilabtreemastercoronannotator,1,0.0
6661,1,0.0
16063,1,0.0
102-264,1,0.0
114-336,1,0.0
KNOWLEDGE,1,0.0
10000outcome,1,0.0
014-095,1,0.0
lower-middle,1,0.0
Amphiphile,1,0.0
Bank-defined,1,0.0
diacyl,1,0.0
effectivenesscost-benefit,1,0.0
lipid-modified,1,0.0
IGOOGLE,1,0.0
Spike-2,1,0.0
ELI-005,1,0.0
season-by-season,1,0.0
killer-cell,1,0.0
KIRs,1,0.0
BFlorida406,1,0.0
DIAS-2,1,0.0
feladata,1,0.0
dietetikus,1,0.0
HIPE,1,0.0
50458,1,0.0
2750,1,0.0
39408,1,0.0
136408,1,0.0
Gly407Ser,1,0.0
változásához,1,0.0
annak,1,0.0
állapotához,1,0.0
alkalmazkodik,1,0.0
azaz,1,0.0
Arg374,1,0.0
progresszív,1,0.0
individuális,1,0.0
esetben,1,0.0
étrend,1,0.0
függően,1,0.0
laborértékektől,1,0.0
társbetegségektől,1,0.0
súlyosságától,1,0.0
alapbetegség,1,0.0
határozza,1,0.0
difinitly,1,0.0
diéta,1,0.0
strokeDIAS-2,1,0.0
értékeinek,1,0.0
placenta-mediated,1,0.0
3903,1,0.0
Guidelines-Coronary,1,0.0
ACTION-Get,1,0.0
AR-G,1,0.0
valuesThe,1,0.0
coronavirus-,1,0.0
aspirational,1,0.0
ajánlása,1,0.0
tápszerek,1,0.0
szükség,1,0.0
állapotának,1,0.0
strokeDEDAS,1,0.0
unmethylated,1,0.0
motif-containing,1,0.0
452R,1,0.0
követése,1,0.0
483A,1,0.0
oktatása,1,0.0
kezelőszemélyzet,1,0.0
DNA-vaccine,1,0.0
hozzátartozó,1,0.0
DIAS,1,0.0
összeállítása,1,0.0
ABrisbane1007,1,0.0
Folate,1,0.0
Nitrous,1,0.0
orvos,1,0.0
targeted-treatments,1,0.0
Chickenpox,1,0.0
kóros,1,0.0
magas,1,0.0
amikor,1,0.0
szorul,1,0.0
akkor,1,0.0
Táplálásterápiára,1,0.0
rapidSTRIPE,1,0.0
szűrése,1,0.0
CPG,1,0.0
Checklist-17,1,0.0
eleme,1,0.0
non-WC,1,0.0
egyik,1,0.0
12-89,1,0.0
gyógyszerköltségeket,1,0.0
Patient-reported,1,0.0
emeli,1,0.0
együtt,1,0.0
jár,1,0.0
időtartamával,1,0.0
ENGLAND,1,0.0
hosszabb,1,0.0
BioLabs,1,0.0
MERS-CoV-DPP4,1,0.0
co-receptor,1,0.0
CD26,1,0.0
biztonságosan,1,0.0
encased,1,0.0
célértékeket,1,0.0
Varieties,1,0.0
eszközeit,1,0.0
módját,1,0.0
táplálásterápia,1,0.0
folyadékbevitel,1,0.0
tápanyag-,1,0.0
microchannels,1,0.0
AuAg,1,0.0
micronano-filter,1,0.0
fluidssecretions,1,0.0
kialakulásának,1,0.0
Myelin,1,0.0
Oligodendrocyte,1,0.0
anti-IL6,1,0.0
fedezhető,1,0.0
31-years-old,1,0.0
EBRS,1,0.0
non-significative,1,0.0
adolinium,1,0.0
latero-apical,1,0.0
táplálással,1,0.0
kockázata,1,0.0
Wright-Patterson,1,0.0
patient-controlled,1,0.0
KIR,1,0.0
2147,1,0.0
ergotamines,1,0.0
restrosternal,1,0.0
ergotamine,1,0.0
20-38,1,0.0
20-53,1,0.0
Event-based,1,0.0
Triptans,1,0.0
No-Stroke,1,0.0
Silent-Infarct,1,0.0
migraine-associated,1,0.0
Purported,1,0.0
tropical--subtropical,1,0.0
scandalous,1,0.0
distinctiveness,1,0.0
perceptually,1,0.0
fished,1,0.0
cinemas,1,0.0
mollusks,1,0.0
B1499,1,0.0
tissue-potentially,1,0.0
radiolucency,1,0.0
18-year-olds,1,0.0
under-described,1,0.0
missile,1,0.0
infundibulum,1,0.0
haemiplegic,1,0.0
weird,1,0.0
antigen-generic,1,0.0
isozymic,1,0.0
KIR3DS1,1,0.0
KIR2DS5,1,0.0
KIR2DL5,1,0.0
cB01,1,0.0
cB03,1,0.0
tB01,1,0.0
Euope,1,0.0
Runs,1,0.0
triphasic,1,0.0
autovenous,1,0.0
electrocardiographic-left,1,0.0
AB2,1,0.0
matrix-tensor,1,0.0
19815,1,0.0
sex-unspecific,1,0.0
Sokolow-Lyon,1,0.0
1599,1,0.0
cofounders,1,0.0
110-184,1,0.0
107-203,1,0.0
ageHR,1,0.0
131-247,1,0.0
066-159,1,0.0
UCN19,1,0.0
non-migratory,1,0.0
Pontine,1,0.0
mucus-forming,1,0.0
invital,1,0.0
AMPLAZER,1,0.0
drafts,1,0.0
bivariable,1,0.0
specificity-500,1,0.0
Attica,1,0.0
house-call,1,0.0
Voltages,1,0.0
386-614,1,0.0
734-900,1,0.0
399-642,1,0.0
700-894,1,0.0
421000,1,0.0
AVQ30,1,0.0
time-differential,1,0.0
smokingvaping,1,0.0
httpsbitly3qOcyNb,1,0.0
highland,1,0.0
Fianarantsoa,1,0.0
electrode-tissue,1,0.0
pivotally,1,0.0
Remarks,1,0.0
isolatesquarantines,1,0.0
renounce,1,0.0
hydroxycholoroquine,1,0.0
neuraxial,1,0.0
PCI-facility,1,0.0
physician-manned,1,0.0
digitization,1,0.0
excitation-bronchoconstriction,1,0.0
tegmentobasal,1,0.0
Postmortal,1,0.0
62-year-old-male,1,0.0
46-76,1,0.0
cut-off-point,1,0.0
dyslipidemiasmoking-and-typical,1,0.0
LCVA,1,0.0
hypertensiondiabetes-and-atypical,1,0.0
memberships,1,0.0
emergency--a,1,0.0
agonism,1,0.0
reactivity-rather,1,0.0
GLCCI1,1,0.0
voltage-gate,1,0.0
lied,1,0.0
Undetectable,1,0.0
prolyse,1,0.0
hypertensiondiabetes,1,0.0
dyslipidemiasmoking,1,0.0
deliberation,1,0.0
RV2,1,0.0
atopic-allergic,1,0.0
pseudo,1,0.0
STIP1,1,0.0
adrenoreceptor,1,0.0
logopedic,1,0.0
Lepeschkins,1,0.0
edema--5202,1,0.0
0751,1,0.0
AECG,1,0.0
cost-cautious,1,0.0
Ventriculograms,1,0.0
digitised,1,0.0
Outward,1,0.0
itineraries,1,0.0
Health-One,1,0.0
anesthesiological,1,0.0
paCO2,1,0.0
trans-hemispheric,1,0.0
Cordialin,1,0.0
Walls,1,0.0
Wrapp,1,0.0
SHT,1,0.0
sensitisations,1,0.0
gm-m,1,0.0
glutamateaspartate,1,0.0
2180,1,0.0
parametrized,1,0.0
respectively--1838,1,0.0
admission--3064,1,0.0
rare--816,1,0.0
2435,1,0.0
2671,1,0.0
Oskar,1,0.0
Baghdad,1,0.0
29-32,1,0.0
noxas,1,0.0
straitjackets,1,0.0
varnishes,1,0.0
eczema-dermatitis,1,0.0
alergogenius,1,0.0
resolutely,1,0.0
truest,1,0.0
“cocoon,1,0.0
vaccination”,1,0.0
disinfectious,1,0.0
certificated,1,0.0
schoolchildred,1,0.0
asthma--defined,1,0.0
neuroanatomist,1,0.0
dyspnoea--were,1,0.0
republic,1,0.0
Clear-cut,1,0.0
Particpation,1,0.0
CK-MM3,1,0.0
Abstention,1,0.0
exercis,1,0.0
CSF-suppressed,1,0.0
Toklus,1,0.0
myrmecologist,1,0.0
temperance,1,0.0
2243,1,0.0
3878,1,0.0
stepdown,1,0.0
1337,1,0.0
atopy-like,1,0.0
CDP,1,0.0
progressionregression,1,0.0
2961,1,0.0
autotraining,1,0.0
Kayei,1,0.0
Chow,1,0.0
Wheezers,1,0.0
HMI,1,0.0
microecology,1,0.0
Dosable,1,0.0
Gomes,1,0.0
Voksentoppen,1,0.0
posi-tive,1,0.0
dancing,1,0.0
Activate-Initiate-Monitor,1,0.0
underpredict,1,0.0
Enclosed,1,0.0
empowers,1,0.0
amelioratory,1,0.0
biologys,1,0.0
solid-fuel,1,0.0
χ²,1,0.0
marshal,1,0.0
ago-chiefly,1,0.0
relaxation-oriented,1,0.0
Niacin,1,0.0
1306,1,0.0
20-36,1,0.0
medicalsurgical,1,0.0
community-matched,1,0.0
972-1979,1,0.0
13-71,1,0.0
vitiae,1,0.0
minimal-invasive,1,0.0
nomograms,1,0.0
7124,1,0.0
Diisocyanate-occupational,1,0.0
diisocyanate-exposed,1,0.0
YNHH,1,0.0
8870,1,0.0
147-1190,1,0.0
statecounty,1,0.0
1022904,1,0.0
recombinogenic,1,0.0
139487,1,0.0
alignment-based,1,0.0
k-mer,1,0.0
bat-origin,1,0.0
255726,1,0.0
14958,1,0.0
bat-to-human,1,0.0
030-222,1,0.0
subsidiarity,1,0.0
sensitivty,1,0.0
4783,1,0.0
kinasesNF-kappaB,1,0.0
lt180,1,0.0
Accepted,1,0.0
2020ABSTRACTSevere,1,0.0
self-docking,1,0.0
antipathy,1,0.0
Partisanship,1,0.0
contact†,1,0.0
14-24,1,0.0
tamiflu,1,0.0
known-associated,1,0.0
phenothiazines,1,0.0
thioxanthenes,1,0.0
akathisias,1,0.0
neuroleptics,1,0.0
Yamagata88-like,1,0.0
Amphetamines,1,0.0
Victoria87-lineage,1,0.0
late-vaccinated,1,0.0
spur,1,0.0
ASR,1,0.0
Acceleration,1,0.0
ARDinfluenza,1,0.0
mathematical-statistical,1,0.0
NIHs,1,0.0
NIBIB,1,0.0
emancipation,1,0.0
gt,1,0.0
SCHB,1,0.0
p1-30001,1,0.0
minResults,1,0.0
infections1000,1,0.0
Cardiomyopathies,1,0.0
p1-20001,1,0.0
SCLT,1,0.0
p2-30520,1,0.0
p1-20020,1,0.0
leukapheresis,1,0.0
p2-30200,1,0.0
p1-20539,1,0.0
B-Cells,1,0.0
p2-30005,1,0.0
рlt0001Conclusion,1,0.0
1552,1,0.0
excerpts,1,0.0
oblast,1,0.0
2007-2017,1,0.0
2011-2017,1,0.0
р0044,1,0.0
Assessment-Insulin,1,0.0
60min,1,0.0
р0004,1,0.0
r0759,1,0.0
PCHB,1,0.0
allergy-induced,1,0.0
POCTRN,1,0.0
imidodiphosphonate,1,0.0
guidance†,1,0.0
demandconsumption,1,0.0
oxygentherapy,1,0.0
Azelastine,1,0.0
geno-endo-phenotypes,1,0.0
anesthesics,1,0.0
KiHAC,1,0.0
ac-sk,1,0.0
1988-1999,1,0.0
Neurologia,1,0.0
Neurochirurgia,1,0.0
Polska,1,0.0
Hokuriku,1,0.0
ischeamic,1,0.0
mill,1,0.0
Thromboses,1,0.0
Kinki,1,0.0
subtilisinkexin,1,0.0
multiple-marker,1,0.0
Type-2eosinophilic,1,0.0
strokeshemiplegia,1,0.0
Statin-induced,1,0.0
Multipurpose,1,0.0
gamma-cameras,1,0.0
Leadership,1,0.0
99mtechnetium-labelled,1,0.0
Hypokinetic,1,0.0
renovascular,1,0.0
endometrium,1,0.0
872-928,1,0.0
learning§,1,0.0
CDC-recommended,1,0.0
durign,1,0.0
objective-driven,1,0.0
moderate-sized,1,0.0
5-round,1,0.0
TIMP-1-2,1,0.0
MMP-2-9,1,0.0
R1-R5,1,0.0
January-September,1,0.0
self-susceptibility,1,0.0
R4,1,0.0
qualitive,1,0.0
Flexvent,1,0.0
acid-Schiff,1,0.0
Diff-Quik,1,0.0
foretells,1,0.0
QCT,1,0.0
CaW-related,1,0.0
8-1925,1,0.0
20G,1,0.0
59412400,1,0.0
detectionThe,1,0.0
ovaries,1,0.0
steroids-and,1,0.0
Immunotherapies,1,0.0
program--government,1,0.0
gaybisexual,1,0.0
egg-factory,1,0.0
workersABSTRACT,1,0.0
YETI,1,0.0
httpyetiprincetonedu,1,0.0
postjunctional,1,0.0
microgkgbody,1,0.0
≤2337,1,0.0
25285,1,0.0
beta₂-adrenergic,1,0.0
1985-1992,1,0.0
2239,1,0.0
benzoylecgonine,1,0.0
33285,1,0.0
phencyclidine,1,0.0
tranquilizer,1,0.0
yearABSTRACT,1,0.0
nonarrhythmogenic,1,0.0
Author,1,0.0
SIR-type,1,0.0
Krasnoyarsk,1,0.0
9-56,1,0.0
vortexing,1,0.0
behaviourally,1,0.0
saliva-soaked,1,0.0
nudge,1,0.0
33294,1,0.0
procrastinated,1,0.0
factory-powdered,1,0.0
dominantco-dominant,1,0.0
N9879,1,0.0
BZDRs,1,0.0
Goldsteins,1,0.0
155866,1,0.0
pancreas-specific,1,0.0
co-localization,1,0.0
epidemiological-virological,1,0.0
circulationResultsIndividuals,1,0.0
dominanceco-dominance,1,0.0
influenza-intensity,1,0.0
CI-28,1,0.0
79-96ConclusionsThese,1,0.0
egg-processing,1,0.0
anti-immigrant,1,0.0
low-priority,1,0.0
reluctantly,1,0.0
sceptically,1,0.0
Menlo,1,0.0
CardioKinetix,1,0.0
ParachuteTM,1,0.0
Blaming,1,0.0
coercive,1,0.0
Xuesaitong,1,0.0
cardiocyte,1,0.0
Multifunctional,1,0.0
user-entered,1,0.0
controlAimWe,1,0.0
Lower-income,1,0.0
blow-out,1,0.0
tearing,1,0.0
Disagreement,1,0.0
1heartjnl104172F1F1F1Figure,1,0.0
13090,1,0.0
76min,1,0.0
re-challenged,1,0.0
culls,1,0.0
Terms,1,0.0
CoV-RNA,1,0.0
intolerability,1,0.0
sliceacute,1,0.0
hemagglutinin-,1,0.0
envelops,1,0.0
Wives,1,0.0
Spouses,1,0.0
cross-referencing,1,0.0
18-years-old,1,0.0
community--each,1,0.0
Pregistry,1,0.0
17871,1,0.0
27475282,1,0.0
921412562,1,0.0
1180017054,1,0.0
magneto-encephalography,1,0.0
34212,1,0.0
41-80,1,0.0
Experienced,1,0.0
Biomedicine,1,0.0
remindalert,1,0.0
hospitalization-relevant,1,0.0
Ulster,1,0.0
018ABSTRACT,1,0.0
CK-geqm2,1,0.0
flow--pharmacologically,1,0.0
holders,1,0.0
1B1D,1,0.0
mechanically--may,1,0.0
hyper-induce,1,0.0
MIP1alpha,1,0.0
Receptors,1,0.0
deliberative,1,0.0
ideniify,1,0.0
flagship,1,0.0
forging,1,0.0
27-83,1,0.0
15-345,1,0.0
abortedABSTRACT,1,0.0
Antigen-presenting,1,0.0
Me,1,0.0
AHMPPIs,1,0.0
GridGroup,1,0.0
Mary,1,0.0
groupsMethodsWe,1,0.0
BackgroundUnderstanding,1,0.0
18617,1,0.0
74242,1,0.0
well-staffed,1,0.0
Judicious,1,0.0
762868,1,0.0
spread--are,1,0.0
humans--and,1,0.0
it’,1,0.0
plasmapheresisalthough,1,0.0
wed,1,0.0
pneumoniaNowadays,1,0.0
report-based,1,0.0
OrganisationWHOThis,1,0.0
2SARS‐CoV‐2,1,0.0
10384,1,0.0
intercerebral,1,0.0
de-air,1,0.0
Dispatcher,1,0.0
ACE2-,1,0.0
fusion-,1,0.0
Colaizzis,1,0.0
Pharmacopea,1,0.0
Insufflation,1,0.0
Sedentarism,1,0.0
myokines,1,0.0
GXV,1,0.0
outdoor-based,1,0.0
21-38,1,0.0
superstition,1,0.0
language-barrier,1,0.0
hapten,1,0.0
SMDs,1,0.0
-0766,1,0.0
-1173,1,0.0
myorelaxant,1,0.0
Ceruloplasmin,1,0.0
-0358,1,0.0
T-Test,1,0.0
Chi-Square,1,0.0
00026,1,0.0
dinitrophenyl,1,0.0
DNP,1,0.0
Jasani,1,0.0
staff-pattern,1,0.0
Pathol,1,0.0
441-448,1,0.0
phosphotungstic,1,0.0
caeruloplasmin,1,0.0
negativation,1,0.0
pre-albumin,1,0.0
C3b,1,0.0
009-011,1,0.0
anti-trypsin,1,0.0
analogue-to-digital,1,0.0
lure,1,0.0
Guanxin,1,0.0
AS03-adjuvants,1,0.0
102-144,1,0.0
Leptin,1,0.0
Na-K,1,0.0
tireless,1,0.0
panobinostat,1,0.0
dilational,1,0.0
manidipine,1,0.0
Unchanged,1,0.0
Antismoking,1,0.0
LY2835219,1,0.0
METHODOLOGY,1,0.0
ebastine,1,0.0
2428,1,0.0
bedaquiline,1,0.0
atovaquone,1,0.0
tubule,1,0.0
glomerulus,1,0.0
Hepatocytes,1,0.0
expensesObjective,1,0.0
timeMethods,1,0.0
programResults,1,0.0
SARS-CoV-2-ΔOrf7a-NLuc,1,0.0
005Conclusion,1,0.0
transfer-related,1,0.0
Z-drug,1,0.0
3570,1,0.0
091-174,1,0.0
Twitter-generated,1,0.0
self-employed,1,0.0
industrial-administrative,1,0.0
Karyotyping,1,0.0
1049122,1,0.0
504385,1,0.0
Coxian,1,0.0
443959,1,0.0
clot-dispersing,1,0.0
766666,1,0.0
98104,1,0.0
gamma-radiation,1,0.0
18157,1,0.0
19239,1,0.0
122-158,1,0.0
monosomy,1,0.0
Twitters,1,0.0
Workplaces,1,0.0
mammalianhuman,1,0.0
semi-virtual,1,0.0
anti-HLA,1,0.0
activation-related,1,0.0
IRB2020-04-0818,1,0.0
home-visit,1,0.0
RasRafMEKERK,1,0.0
iAEC2s,1,0.0
LNCaP,1,0.0
10·6,1,0.0
EPIISL513925,1,0.0
S-clade,1,0.0
Basiliximab,1,0.0
1634,1,0.0
m2000sprt,1,0.0
ALA348,1,0.0
oil-derived,1,0.0
ASP382,1,0.0
14729,1,0.0
ASP350,1,0.0
OPLS3,1,0.0
preventiontreatment,1,0.0
ArQL,1,0.0
180192,1,0.0
52-2013,1,0.0
107-160,1,0.0
Laird,1,0.0
hitches,1,0.0
cell-modification,1,0.0
non-oncogenic,1,0.0
Dersimonian,1,0.0
A2Port,1,0.0
A2England4272,1,0.0
Kong573,1,0.0
Fixed-line,1,0.0
self-defined,1,0.0
flame-bonded,1,0.0
bed-day,1,0.0
cropped,1,0.0
ORF3a-Q57H,1,0.0
PHE40,1,0.0
apace,1,0.0
AngioVac,1,0.0
spike-glycoconjugates,1,0.0
141022,1,0.0
Heparin-binding,1,0.0
surface-bound,1,0.0
151123,1,0.0
751075,1,0.0
74251175,1,0.0
inhalation-based,1,0.0
529±7years,1,0.0
conjunctivalids,1,0.0
Beli,1,0.0
Manastir,1,0.0
Nebraskan,1,0.0
vacuum-assisted,1,0.0
469410000,1,0.0
Well-Being,1,0.0
3838,1,0.0
6285,1,0.0
3352,1,0.0
005-091,1,0.0
WHO-5,1,0.0
Hue,1,0.0
PHE390,1,0.0
315-795,1,0.0
NTW,1,0.0
TLR2TLR3TLR4,1,0.0
world-approved,1,0.0
MyD88-dependentindependent,1,0.0
8566162,1,0.0
care-sensitive,1,0.0
computation-based,1,0.0
SilybinC,1,0.0
August-October,1,0.0
Wisconsin-Madison,1,0.0
PM-900,1,0.0
PM-400,1,0.0
Isopomiferin,1,0.0
6763,1,0.0
Lycopene,1,0.0
SilydianinB,1,0.0
10791,1,0.0
Silydianin,1,0.0
fiendishly,1,0.0
K1,1,0.0
cobble,1,0.0
K6,1,0.0
beloved,1,0.0
heroically,1,0.0
palpetion,1,0.0
careened,1,0.0
grimly,1,0.0
Groundhog,1,0.0
precordium,1,0.0
move-in,1,0.0
agammaglobulinemic,1,0.0
dorms,1,0.0
1971-75,1,0.0
143±96,1,0.0
173±106,1,0.0
easy-to-apply,1,0.0
cineangiocardiography,1,0.0
234±106,1,0.0
cineangiocardiographic,1,0.0
Kuopio,1,0.0
1987-1990,1,0.0
n34,1,0.0
Gaudio,1,0.0
211000yr,1,0.0
14404,1,0.0
25171,1,0.0
vaccine-side,1,0.0
single-ion,1,0.0
proteotyping,1,0.0
endoproteinase,1,0.0
CI105-119,1,0.0
CI107-117,1,0.0
pre-stimulation,1,0.0
1766,1,0.0
well-articulated,1,0.0
well-tried,1,0.0
ASMAB-I,1,0.0
HTVS,1,0.0
B11284,1,0.0
posterior-inferiors,1,0.0
n452,1,0.0
Pract,1,0.0
078-109,1,0.0
1-180,1,0.0
Granada,1,0.0
≤270,1,0.0
201412493,1,0.0
113-142,1,0.0
117-154,1,0.0
11-128,1,0.0
PCS4604,1,0.0
Self-reporting,1,0.0
resource-use,1,0.0
Transcardiac,1,0.0
9208,1,0.0
23-55,1,0.0
24-hour-old,1,0.0
Amur,1,0.0
non-Estonian,1,0.0
November-,1,0.0
189-279,1,0.0
NSAID-exacerbated,1,0.0
201-297,1,0.0
aspirincyclooxygenase-1,1,0.0
aspirin-tolerant,1,0.0
Penicillin-resistant,1,0.0
P03554,1,0.0
181-270,1,0.0
ease-of-use,1,0.0
Substitute,1,0.0
067-092,1,0.0
102-134,1,0.0
observed-over-expected,1,0.0
withdrawals,1,0.0
infectionsThe,1,0.0
withdrew,1,0.0
CTI,1,0.0
CARET,1,0.0
situationThe,1,0.0
HCSs,1,0.0
3436,1,0.0
coursework,1,0.0
cell-permeable,1,0.0
Final-year,1,0.0
platelet-aggregation,1,0.0
load-limited,1,0.0
-181,1,0.0
39oC,1,0.0
89-year-old,1,0.0
patient-triage,1,0.0
glutamatergic,1,0.0
P07689,1,0.0
079-137,1,0.0
uncoupled,1,0.0
PHER,1,0.0
non-simulated,1,0.0
B11214,1,0.0
6538-1778,1,0.0
125-year-old,1,0.0
Dominican-American,1,0.0
prenebulizer,1,0.0
45228±35772,1,0.0
32746±377pgml,1,0.0
postnebulizer,1,0.0
15-146,1,0.0
28609±17910,1,0.0
Penetration-Aspiration,1,0.0
Oxyhemoglobin,1,0.0
vestibule,1,0.0
viruses-in,1,0.0
mutations--which,1,0.0
D101G,1,0.0
pMEP,1,0.0
3-115,1,0.0
E298K,1,0.0
A198E,1,0.0
mice--herein,1,0.0
P1-N2,1,0.0
ACalifornia0409H1N1,1,0.0
N1-P1,1,0.0
pMEPs,1,0.0
walkjogging,1,0.0
volleyball,1,0.0
6-12-,1,0.0
12-24-hour,1,0.0
71st,1,0.0
Non-contact,1,0.0
4561-1598,1,0.0
R062,1,0.0
3613-7743,1,0.0
4592-8198,1,0.0
1000patient,1,0.0
571-10,1,0.0
595-10,1,0.0
350patient,1,0.0
R058,1,0.0
3753,1,0.0
Diskus™,1,0.0
Commonwealth,1,0.0
Psychopathology,1,0.0
1923,1,0.0
biallelic,1,0.0
homogenizer,1,0.0
semi-alkaline,1,0.0
pDCs,1,0.0
PDCs,1,0.0
pDC-mediated,1,0.0
3119,1,0.0
Extant,1,0.0
sex-biased,1,0.0
Bandura,1,0.0
equilbrium,1,0.0
antigen-,1,0.0
074±030,1,0.0
microcosting,1,0.0
non-overlapping,1,0.0
Blood-pressure,1,0.0
antiembolism,1,0.0
angioarchitectonic,1,0.0
microhistoangiographic,1,0.0
microangiograms,1,0.0
Virus-neutralizing,1,0.0
p0050,1,0.0
vessel-less,1,0.0
R5-R20,1,0.0
rumbling,1,0.0
LSA-derived,1,0.0
X5,1,0.0
Fres,1,0.0
2020beginning,1,0.0
ADuckSingapore-QF119-297,1,0.0
830000,1,0.0
3He,1,0.0
ADuckSing97,1,0.0
microfluidised,1,0.0
≤13,1,0.0
child-seasons,1,0.0
httplinkslwwcomEDEB859,1,0.0
urban-suburban-rural,1,0.0
poststratification,1,0.0
low-rank,1,0.0
Ag-Test,1,0.0
3401,1,0.0
Objectivehypothesis,1,0.0
199092,1,0.0
945000,1,0.0
440000,1,0.0
membraneless,1,0.0
cell-targeted,1,0.0
DISPLACE,1,0.0
Minimising,1,0.0
Deadly,1,0.0
1462,1,0.0
5731462,1,0.0
35-65-folds,1,0.0
Shelf-life,1,0.0
exaggerates,1,0.0
Pharmacopeia,1,0.0
scripting,1,0.0
browsers,1,0.0
Categorical,1,0.0
online-database,1,0.0
glycosidic,1,0.0
BMassachusetts022012-like,1,0.0
breakage,1,0.0
agent-host-environment,1,0.0
2712,1,0.0
Bromelain,1,0.0
testsmL,1,0.0
efficiency-corrected,1,0.0
liquid-liquid,1,0.0
FDA-orchestrated,1,0.0
post-epidemically,1,0.0
buccosalivary,1,0.0
panhemispheric,1,0.0
AENG33380,1,0.0
WONCA,1,0.0
oseltamivir--and,1,0.0
Radio-allergo-sorbent-test,1,0.0
Precipitations,1,0.0
DHBs,1,0.0
non-breastfeeding,1,0.0
drugs--zanamivir,1,0.0
65yr,1,0.0
13058,1,0.0
1274,1,0.0
all-age,1,0.0
5849,1,0.0
Lorenz,1,0.0
1770,1,0.0
xerostomia,1,0.0
intoxicated,1,0.0
collection-related,1,0.0
subtypespatterns,1,0.0
0014-0855,1,0.0
Wonderland,1,0.0
analogical,1,0.0
Short-axis,1,0.0
occurredOne,1,0.0
outbreakIt,1,0.0
dispnea,1,0.0
cholesterol-polyethylene,1,0.0
amphiphile,1,0.0
patients--poor,1,0.0
374-fold,1,0.0
worker–collected,1,0.0
MMP-28,1,0.0
metalloproteinase-28,1,0.0
Ingestants,1,0.0
RdRp-targeting,1,0.0
38514,1,0.0
275358,1,0.0
nitration,1,0.0
clinicaltherapy,1,0.0
21322,1,0.0
26885,1,0.0
30134,1,0.0
stress-dependent,1,0.0
ischemia45,1,0.0
Myogenic,1,0.0
childparental,1,0.0
Dolnoślaskie,1,0.0
576449,1,0.0
January-December,1,0.0
September-December,1,0.0
LLPS,1,0.0
PY-NLS,1,0.0
sequencing-,1,0.0
-0948,1,0.0
neckaches,1,0.0
stage-specific,1,0.0
octamer,1,0.0
post-adult,1,0.0
Pharmacoepidemiologic,1,0.0
Pericallosal,1,0.0
Beta-agonist,1,0.0
pericallosal,1,0.0
explorable,1,0.0
menaces,1,0.0
complicatedness,1,0.0
unskillful,1,0.0
Sungnam,1,0.0
Suwon-si,1,0.0
794-962,1,0.0
950-999,1,0.0
unauthorized,1,0.0
0908,1,0.0
-0898,1,0.0
ecogenetic,1,0.0
-0938,1,0.0
-0834,1,0.0
Appreciable,1,0.0
-0914,1,0.0
malevolent,1,0.0
SSEA-1,1,0.0
pancytokeratin,1,0.0
cytokeratin-18,1,0.0
COVID19SEROSpeed,1,0.0
aneurismectomy,1,0.0
amplification-,1,0.0
23Na-MR,1,0.0
31P-MR,1,0.0
assaychemiluminescence,1,0.0
Signify,1,0.0
collectivism-oriented,1,0.0
cross-European,1,0.0
playful,1,0.0
phosphoroselenaote,1,0.0
spinoff,1,0.0
biostability,1,0.0
occludin,1,0.0
205-791,1,0.0
436-668,1,0.0
30-67,1,0.0
WoS,1,0.0
death-sparing,1,0.0
chemostability,1,0.0
1918-January1919,1,0.0
excess-mortality,1,0.0
II-like,1,0.0
CD90,1,0.0
CD29,1,0.0
bioweaponry,1,0.0
biohazard,1,0.0
NLSs,1,0.0
bioethics,1,0.0
Breazzano,1,0.0
Multi-variate,1,0.0
287-295,1,0.0
879-1000,1,0.0
multi-state,1,0.0
2002-07,1,0.0
Laidlaw,1,0.0
Andrewes,1,0.0
compartments-the,1,0.0
Endosome,1,0.0
primes,1,0.0
proteins-histone,1,0.0
karyopherin-β2,1,0.0
kapβ2-uncoat,1,0.0
bc,1,0.0
torment,1,0.0
tubulin,1,0.0
inter-island,1,0.0
MEXT,1,0.0
proteasomal,1,0.0
unanchored,1,0.0
dynein,1,0.0
00004-,1,0.0
Californian,1,0.0
hemi-spheres,1,0.0
uni-variate,1,0.0
three-time,1,0.0
multi-point,1,0.0
CoVRapid,1,0.0
-0860,1,0.0
Vomiting,1,0.0
less-steep,1,0.0
fascination,1,0.0
re-examine,1,0.0
minipools,1,0.0
photoperiodic,1,0.0
human-induced,1,0.0
fitness-based,1,0.0
outcompeting,1,0.0
human-earth,1,0.0
RPHM,1,0.0
ddPCR-in,1,0.0
Tapei,1,0.0
Em,1,0.0
2·5,1,0.0
pregnancythe,1,0.0
GALTs,1,0.0
anti-BCoV,1,0.0
exfoliation,1,0.0
16-36,1,0.0
39-87,1,0.0
crepitus,1,0.0
nondistensible,1,0.0
102-123,1,0.0
112-533,1,0.0
photonics-based,1,0.0
Irgm1,1,0.0
decimeter,1,0.0
omentum-based,1,0.0
cell-supporting,1,0.0
Call-back,1,0.0
rs6421983,1,0.0
easily-modifiable,1,0.0
STC-GO,1,0.0
methodologys,1,0.0
Dhx58,1,0.0
4825,1,0.0
HLA-DRβ1,1,0.0
Cxcl10,1,0.0
Cxcl11,1,0.0
Zbp1,1,0.0
Ifit1,1,0.0
Ifih1,1,0.0
Aotus,1,0.0
Trim25,1,0.0
Mx2,1,0.0
DNA-genotyped,1,0.0
functionally-relevant,1,0.0
autoaggressive,1,0.0
Immunodepression,1,0.0
supersystems,1,0.0
Oas2,1,0.0
transcerebral,1,0.0
rs34481144-G,1,0.0
pestilence,1,0.0
self-adaptive,1,0.0
patholophysiologic,1,0.0
7-20,1,0.0
Yamashitas,1,0.0
Toyamas,1,0.0
VCGABSTRACT,1,0.0
radio-nuclide,1,0.0
food-pharma,1,0.0
attentivecognitive,1,0.0
LC-PUFA,1,0.0
Sufferers,1,0.0
unclean,1,0.0
Fu,1,0.0
5591,1,0.0
rationalizes,1,0.0
Xie,1,0.0
Qiu,1,0.0
anti-roles,1,0.0
Zao,1,0.0
double-edge,1,0.0
IgG-concentrations,1,0.0
strokelike,1,0.0
extra-fine-particle,1,0.0
coarse-particle,1,0.0
Implication,1,0.0
Cd274,1,0.0
well-balanced,1,0.0
HOLOGIC,1,0.0
Irf7,1,0.0
maedi-visna,1,0.0
ionizers,1,0.0
paratuberculosis,1,0.0
aerosolizers,1,0.0
prior-to-stroke,1,0.0
anchorage-independent,1,0.0
high-yielding,1,0.0
NO-reactivity,1,0.0
postsaline,1,0.0
pseudotuberculosis,1,0.0
leaderless,1,0.0
88-bed,1,0.0
anti-Bax,1,0.0
immunotyping,1,0.0
mitochondrias,1,0.0
most-prevalent,1,0.0
monoplanar,1,0.0
biplanar,1,0.0
Ventriculographic,1,0.0
air-ways,1,0.0
condemnation,1,0.0
dyspneal,1,0.0
trimming,1,0.0
nontumoral,1,0.0
nonsurgically,1,0.0
nosophobia,1,0.0
abdominalgia,1,0.0
cephalgia,1,0.0
Draw,1,0.0
Infection-control,1,0.0
05-18,1,0.0
05-22,1,0.0
Migrant,1,0.0
AgriSafe,1,0.0
Middle‐East,1,0.0
Farmworkers,1,0.0
5370000,1,0.0
343000,1,0.0
softness,1,0.0
3715,1,0.0
5137,1,0.0
corporative,1,0.0
cardiale,1,0.0
LDH2LDH1,1,0.0
surgicalcatheter,1,0.0
violates,1,0.0
N1N2,1,0.0
ltd,1,0.0
TOYOBO,1,0.0
Shimadzu,1,0.0
hypersthenic,1,0.0
Ampdirect™,1,0.0
nontrial,1,0.0
non-coincidence,1,0.0
MedPro,1,0.0
first-listed,1,0.0
42920,1,0.0
felismerésének,1,0.0
korai,1,0.0
government-funded,1,0.0
infarction-operation,1,0.0
Wessex,1,0.0
Ulm,1,0.0
T63,1,0.0
Egyértelművé,1,0.0
alakul,1,0.0
hatásaként,1,0.0
cerebralis,1,0.0
egyértelműen,1,0.0
testsday,1,0.0
time-decay,1,0.0
jellegzetessége,1,0.0
incubation-based,1,0.0
megítélését,1,0.0
tüdőgyulladások,1,0.0
62-162,1,0.0
medication-histories,1,0.0
same-sex,1,0.0
stroke-ot,1,0.0
helyezte,1,0.0
értelmezésbe,1,0.0
2005-2011,1,0.0
szükségessége,1,0.0
stroke-betegek,1,0.0
Government-funded,1,0.0
mix-and-read,1,0.0
tartózkodás,1,0.0
kiszáradással,1,0.0
health-care-provider,1,0.0
malnutritióval,1,0.0
ILIARI,1,0.0
hónapban,1,0.0
előrejelzője,1,0.0
66·6,1,0.0
független,1,0.0
protein-induced,1,0.0
kimenetelének,1,0.0
prokaryotes,1,0.0
állapota,1,0.0
ADPR,1,0.0
záloga,1,0.0
Macrodomain,1,0.0
mortalitásnak,1,0.0
kezelésnek,1,0.0
rövidebb,1,0.0
csökkentésének,1,0.0
pathogen-induced,1,0.0
szövődményszám,1,0.0
rehabilitációnak,1,0.0
eredményes,1,0.0
más,1,0.0
2418,1,0.0
multilinear,1,0.0
gyökeresen,1,0.0
Papain,1,0.0
jelentőségét,1,0.0
flavonol,1,0.0
1273-1784,1,0.0
aspiráció,1,0.0
néma,1,0.0
Felismerték,1,0.0
emergency-the,1,0.0
feltárták,1,0.0
faciobrachial,1,0.0
részletesen,1,0.0
colliculus,1,0.0
lemniscal,1,0.0
beleértve,1,0.0
trigeminothalamic,1,0.0
370000,1,0.0
httphttpscovid19whoint,1,0.0
kórokok,1,0.0
PurFlock,1,0.0
FLOQSwab,1,0.0
kutatásai,1,0.0
oka,1,0.0
több,1,0.0
Pur-Wraps,1,0.0
Pre-treatment,1,0.0
Chymotrypsin-Like,1,0.0
Elazig,1,0.0
One-hundred-forty-two,1,0.0
28-55,1,0.0
104-171,1,0.0
fogalma,1,0.0
CT-Scan,1,0.0
non-radiologists,1,0.0
WELL-KNOWN,1,0.0
AGENTS,1,0.0
rimantadin,1,0.0
NasopharyngealOropharyngeal,1,0.0
dropouts,1,0.0
NSP12-M755I,1,0.0
ORF8-V117F,1,0.0
Preinfarction,1,0.0
Non-obstructive,1,0.0
892-angina,1,0.0
szövődmény,1,0.0
halálos,1,0.0
Barnig,1,0.0
sokszor,1,0.0
magistraliter,1,0.0
well-anticoagulated,1,0.0
amely,1,0.0
hátterében,1,0.0
aspirációs,1,0.0
gyakran,1,0.0
3828,1,0.0
Levalbuterol,1,0.0
054±038,1,0.0
BSichuan3799-like,1,0.0
Javits,1,0.0
asanguineous,1,0.0
Vented,1,0.0
Nonvented,1,0.0
69586,1,0.0
042-070,1,0.0
43-68,1,0.0
54018,1,0.0
310100000,1,0.0
lEducation,1,0.0
360100000,1,0.0
Générale,1,0.0
Mutuelle,1,0.0
Femmes,1,0.0
1160100000,1,0.0
4700100000,1,0.0
Epidemiologique,1,0.0
educationcontrol,1,0.0
0307,1,0.0
up-skill,1,0.0
7335,1,0.0
8620,1,0.0
outpatient-visit,1,0.0
≤27,1,0.0
AMoscow,1,0.0
USNS,1,0.0
Hamar,1,0.0
Comfort,1,0.0
adsorption-precipitation,1,0.0
BSG,1,0.0
AGE-RAGE,1,0.0
adipocytokine,1,0.0
proteinspathways,1,0.0
COL-3,1,0.0
entinostat,1,0.0
mocetinostat,1,0.0
D484Y,1,0.0
post-rituximab,1,0.0
water-swallowing,1,0.0
51354865,1,0.0
9459,1,0.0
€75691,1,0.0
20800,1,0.0
6486,1,0.0
US713,1,0.0
bolstered,1,0.0
Airmen,1,0.0
YorkNew,1,0.0
4332,1,0.0
64th,1,0.0
2973,1,0.0
5405,1,0.0
21-79,1,0.0
1099-like,1,0.0
multi-user,1,0.0
APOE4,1,0.0
3070,1,0.0
Post-Stroke,1,0.0
payroll,1,0.0
motorbike,1,0.0
905-922,1,0.0
Acids,1,0.0
Nucleotides,1,0.0
gut⁻lung,1,0.0
Nucleosides,1,0.0
microbe-based,1,0.0
HGprt,1,0.0
Re-emergence,1,0.0
Effectiveness-Monitoring,1,0.0
Sanitary-Epidemiological,1,0.0
abounded,1,0.0
hypoxanthine-guanine,1,0.0
Lesch-Nyhan,1,0.0
backs-up,1,0.0
thedifferent,1,0.0
Nyhan,1,0.0
15733,1,0.0
Naviaux,1,0.0
1304-1313,1,0.0
Nguyen,1,0.0
glycosyl-phosphatidylinositol,1,0.0
NCT02272426,1,0.0
diabetesobesity,1,0.0
institutionResults,1,0.0
anti-necrotic,1,0.0
Surg25,1,0.0
078-120,1,0.0
Sign-specific,1,0.0
non-significantly,1,0.0
BCL-oriented,1,0.0
light-resistant,1,0.0
multigravid,1,0.0
thrombus-like,1,0.0
PMN-oriented,1,0.0
bee-,1,0.0
Virus-Infected,1,0.0
257-263,1,0.0
Photomed,1,0.0
17666,1,0.0
Sinyakov,1,0.0
nonlaser,1,0.0
light-irradiated,1,0.0
37-485,1,0.0
housing-may,1,0.0
strategies-including,1,0.0
challengingPublic,1,0.0
SARS-CoV-2Conclusions,1,0.0
Versionshort,1,0.0
abidol,1,0.0
Thienopirydines,1,0.0
QMI--induced,1,0.0
pre-exist,1,0.0
cathe-room,1,0.0
Alexanders,1,0.0
Toll-likereceptor8,1,0.0
webserver,1,0.0
Azevedo,1,0.0
C-ImmSimm,1,0.0
Soares,1,0.0
Cluspro,1,0.0
activator-treated,1,0.0
inspissation,1,0.0
viscid,1,0.0
Ramachandran,1,0.0
prosA,1,0.0
Galaxy,1,0.0
lateral-wall,1,0.0
PSIPRED,1,0.0
VaxiJenserver,1,0.0
MURs,1,0.0
AlgPredserver,1,0.0
LINKERS,1,0.0
ADJUVANTS,1,0.0
14-msec,1,0.0
24-msec,1,0.0
32-msec,1,0.0
84825,1,0.0
BCPred,1,0.0
NetCTL,1,0.0
THHelper,1,0.0
TCcytotoxic,1,0.0
Andréia,1,0.0
peptide-pulsed,1,0.0
gatekeepers,1,0.0
Introductionaims,1,0.0
CoV-229E,1,0.0
CoV-229E-infected,1,0.0
heartvessels,1,0.0
e-cardiology,1,0.0
do-not-resuscitate,1,0.0
ultraviolet-A,1,0.0
DNR,1,0.0
6-HB,1,0.0
six-helix,1,0.0
M158-66-specific,1,0.0
oligemic,1,0.0
CXCR3,1,0.0
antibody-FcγR,1,0.0
trombectomy,1,0.0
GP-attended,1,0.0
ratiofor,1,0.0
21-131,1,0.0
mgliter,1,0.0
two-tiered,1,0.0
111951,1,0.0
31121969,1,0.0
8905,1,0.0
antigen-monoclonal,1,0.0
tastebuds,1,0.0
anti-epileptogenic,1,0.0
cry,1,0.0
backwardness,1,0.0
State-of-the-art,1,0.0
morbilliformexanthems,1,0.0
infarctionnormal,1,0.0
three-mo,1,0.0
27-wk,1,0.0
frailest,1,0.0
converged,1,0.0
Vacek,1,0.0
Horne,1,0.0
neurofibromas,1,0.0
angiograph,1,0.0
LCEF,1,0.0
secretors,1,0.0
laser-Doppler,1,0.0
AShanghai1689,1,0.0
preventionists,1,0.0
BYamagata1689,1,0.0
PRO,1,0.0
7T,1,0.0
terminalia,1,0.0
GluCEST,1,0.0
non-lesional,1,0.0
intraorgan,1,0.0
N95PFF2,1,0.0
Allergenic,1,0.0
100242,1,0.0
259627,1,0.0
TSLP-WDR36,1,0.0
infringements,1,0.0
impellent,1,0.0
expressiveness,1,0.0
nonrepeating,1,0.0
ORM1-like,1,0.0
33-60,1,0.0
H1-specific,1,0.0
ORMDL3-GSDMB,1,0.0
IL1RL1-IL18R1,1,0.0
RAD50-IL13,1,0.0
ARegensburgD609H1N1,1,0.0
layout,1,0.0
nonneurogenic,1,0.0
HLA-DRDQ,1,0.0
week-lag,1,0.0
ACT®,1,0.0
Freeman,1,0.0
Tabulation,1,0.0
Meaning,1,0.0
30-57,1,0.0
18-57,1,0.0
corticalstriatal,1,0.0
50-57,1,0.0
basophilmast,1,0.0
PCIMaterial,1,0.0
211000,1,0.0
German-Austrian,1,0.0
osztályos,1,0.0
223000,1,0.0
279000,1,0.0
semipermissive,1,0.0
hoursweek,1,0.0
fájdalmak,1,0.0
bio-specific,1,0.0
értékelésére,1,0.0
Időszerű,1,0.0
átfogó,1,0.0
7-hydroxyl,1,0.0
összefoglalónkban,1,0.0
hangsúlyozzuk,1,0.0
fájdalomcsillapítók,1,0.0
COVID-19-fertőzéssel,1,0.0
HDA,1,0.0
összefüggő,1,0.0
fájdalommal,1,0.0
16-hexanediamine,1,0.0
ni,1,0.0
folyamatokban,1,0.0
Trichoplusia,1,0.0
High-five™,1,0.0
brochodilators,1,0.0
physicianpatient,1,0.0
liberalization,1,0.0
COVID-19-et,1,0.0
218000,1,0.0
ongoingA,1,0.0
215000,1,0.0
OR56,1,0.0
6168,1,0.0
fájdalom,1,0.0
6122,1,0.0
enyhítésére,1,0.0
fájdalomcsillapítási,1,0.0
lehetőség,1,0.0
55290,1,0.0
65168,1,0.0
rendelkezésre,1,0.0
kezdete,1,0.0
50122,1,0.0
115290,1,0.0
Iashvili,1,0.0
171000,1,0.0
foglalkoznunk,1,0.0
enyhítésével,1,0.0
176000,1,0.0
osztályon,1,0.0
műtéti,1,0.0
alkalmával,1,0.0
209000,1,0.0
hazaengedését,1,0.0
figyelmet,1,0.0
fordítanunk,1,0.0
infectology,1,0.0
Gniezno,1,0.0
pacifier,1,0.0
29-folds,1,0.0
ophthalmologic,1,0.0
Valentine,1,0.0
iron-vaccine,1,0.0
vitiligo-type,1,0.0
Hypopigmented,1,0.0
2--4-fold,1,0.0
6105,1,0.0
1757,1,0.0
pigmentary,1,0.0
vitiligo,1,0.0
knowledge-rich,1,0.0
conchae,1,0.0
shorthaired,1,0.0
mid‑term,1,0.0
short‑term,1,0.0
muzzle,1,0.0
anti‑COVID‑19,1,0.0
bounding,1,0.0
Harsh,1,0.0
ausculted,1,0.0
rounding,1,0.0
unexpended,1,0.0
SSI,1,0.0
retiform,1,0.0
vesiculobullous,1,0.0
32288-309,1,0.0
endocrinologic,1,0.0
Anatomy,1,0.0
intraregional,1,0.0
KOREAN,1,0.0
marshalled,1,0.0
diag-nostic,1,0.0
Chattogram,1,0.0
Dazhou,1,0.0
Three-generation,1,0.0
PC20-matched,1,0.0
2231,1,0.0
nonnewer,1,0.0
Fructose-16-diphosphate,1,0.0
radiographical,1,0.0
Split-Dalmatia,1,0.0
Anatomists,1,0.0
Challenging,1,0.0
auto-positive,1,0.0
Otoscopic,1,0.0
unlabored,1,0.0
easy-to-administer,1,0.0
MII,1,0.0
outposts,1,0.0
Rotuma,1,0.0
Jaliut,1,0.0
CMED,1,0.0
Yule,1,0.0
OR175,1,0.0
ritkábban,1,0.0
középsúlyos,1,0.0
loudest,1,0.0
hospital-specific,1,0.0
2052,1,0.0
893-912,1,0.0
coopted,1,0.0
SVV--a,1,0.0
dysfunction--is,1,0.0
gyrus--key,1,0.0
multisensory,1,0.0
network--and,1,0.0
91-98,1,0.0
41-45,1,0.0
125-975,1,0.0
1837405,1,0.0
interethnic,1,0.0
copies5μL,1,0.0
nonacute,1,0.0
non-LDI-caused,1,0.0
LDI-caused,1,0.0
wwwseaclinicalresearchorg,1,0.0
impregnation,1,0.0
acknowledgment,1,0.0
fixed-combination,1,0.0
odema,1,0.0
delatation,1,0.0
Immunochemically,1,0.0
postlockdown,1,0.0
ONCOCARE-COV,1,0.0
MTMBs,1,0.0
Venezuelas,1,0.0
DMTs-such,1,0.0
cells-have,1,0.0
immunodepressive,1,0.0
neuroglial,1,0.0
Colombian-Venezuelan,1,0.0
infection-prone,1,0.0
ORG-10172,1,0.0
trails,1,0.0
flee,1,0.0
Venezuelans,1,0.0
onset-to-imaging,1,0.0
postponedin,1,0.0
P00003,1,0.0
semi-urgent,1,0.0
GTH,1,0.0
46-year,1,0.0
epitomize,1,0.0
syncopes,1,0.0
sultamicillin,1,0.0
mexiletine,1,0.0
crackling,1,0.0
MTBMs,1,0.0
thump-version,1,0.0
non-VT,1,0.0
self-induced,1,0.0
broncho-vascular,1,0.0
előfordulhat,1,0.0
serous-desquamous,1,0.0
region-of-interest,1,0.0
citokinvihar,1,0.0
kritikus,1,0.0
amplicon-targeting,1,0.0
Test-part,1,0.0
Pegboard,1,0.0
Grooved,1,0.0
légzési,1,0.0
elégtelenséggel,1,0.0
társuló,1,0.0
Diffusivity,1,0.0
respirációs,1,0.0
diszfunkciós,1,0.0
többszervi,1,0.0
okoz,1,0.0
Mostanáig,1,0.0
részben,1,0.0
tünetmentesen,1,0.0
tünetekkel,1,0.0
Co-activation,1,0.0
zajlanak,1,0.0
14168,1,0.0
36122,1,0.0
OR91,1,0.0
szakaszában,1,0.0
1742,1,0.0
elszabadulása,1,0.0
molekuláinak,1,0.0
specialist-confirmed,1,0.0
influencer,1,0.0
Questionnaire-Form,1,0.0
Meanprepost22203187,1,0.0
Meanprepost27533020,1,0.0
Meanprepost24041086,1,0.0
Meanprepost132783,1,0.0
coronary-ventricular,1,0.0
bioptic,1,0.0
textiloma,1,0.0
costocervical,1,0.0
rim-like,1,0.0
domen-specific,1,0.0
jelátvivő,1,0.0
14655,1,0.0
pH1N12009v,1,0.0
Albany,1,0.0
koronavírusként,1,0.0
megismert,1,0.0
SARS-CoV-2-fertőzés,1,0.0
legsúlyosabb,1,0.0
szövődményeként,1,0.0
±69,1,0.0
±227,1,0.0
folyamatok,1,0.0
papular,1,0.0
exanthemas,1,0.0
program--designed,1,0.0
Pre-travel,1,0.0
linearised,1,0.0
structures-households,1,0.0
ahistorical,1,0.0
Leu472Phe,1,0.0
Isoptin,1,0.0
HydroxychloroquineCommunicated,1,0.0
residence-the,1,0.0
hot-point,1,0.0
Bisphosphonates,1,0.0
minority-notwithstanding,1,0.0
Augurix,1,0.0
780-1476,1,0.0
546-1044,1,0.0
67-75,1,0.0
24-44,1,0.0
076-289,1,0.0
adaptogen,1,0.0
027-213,1,0.0
corticosteroids--a,1,0.0
FDNY,1,0.0
hematologist-stroke,1,0.0
inflammationmutations,1,0.0
therapy-are,1,0.0
citalopram,1,0.0
TCAs,1,0.0
Pro462Ala,1,0.0
ecosocial,1,0.0
metabisulphide,1,0.0
kyphoscoliosis,1,0.0
BRONCHITIS,1,0.0
enterobacteriaceae,1,0.0
plasmalogens,1,0.0
beta-hemolytic,1,0.0
Plasmalogens,1,0.0
COMMUNITY,1,0.0
ACQUIRED,1,0.0
as--omics,1,0.0
activityprogression,1,0.0
PC20methacholine,1,0.0
semi-invasive,1,0.0
PNEUMONIA,1,0.0
apoH,1,0.0
incidence-rate,1,0.0
QuickVue-positive,1,0.0
RESISTANCES,1,0.0
nanoplatform,1,0.0
gorilla,1,0.0
UnResponsiveness,1,0.0
Th1-dominated,1,0.0
ACE2-interfering,1,0.0
GRAd,1,0.0
NCT04528641,1,0.0
glycoprotein-ACE2,1,0.0
safetysecurity,1,0.0
92-99,1,0.0
EXACERBATIONS,1,0.0
life-prolonging,1,0.0
afterothrombotic,1,0.0
105105,1,0.0
174-fold,1,0.0
anotherAntiviral,1,0.0
seasonThe,1,0.0
Assimilating,1,0.0
trigeminovascular,1,0.0
13-23,1,0.0
CTA-positive,1,0.0
175-fold,1,0.0
Spline,1,0.0
110-161,1,0.0
115-188,1,0.0
64-channel,1,0.0
boat,1,0.0
Erratic,1,0.0
Ganja,1,0.0
KG,1,0.0
smuggled,1,0.0
ganja,1,0.0
ventriculo-peritoneal,1,0.0
PM25-induced,1,0.0
Meta,1,0.0
GC-MS,1,0.0
MUC5AC,1,0.0
9655-100,1,0.0
seasonsConclusionThis,1,0.0
methodResultsThe,1,0.0
timesaving,1,0.0
musclelumen,1,0.0
56-82,1,0.0
hypodynamically,1,0.0
engineering-based,1,0.0
organ-on-a-chip,1,0.0
bioprinting,1,0.0
NEMC,1,0.0
bioreactor,1,0.0
BackgroundDuring,1,0.0
NorthEast,1,0.0
CM-free,1,0.0
copiesµL,1,0.0
104105,1,0.0
25-100,1,0.0
1145-3690,1,0.0
RT-qPCR-positive,1,0.0
0923,1,0.0
6637-100,1,0.0
forAimThis,1,0.0
7618-9988,1,0.0
9524,1,0.0
surveillanceMethodsQuestionnaires,1,0.0
9481-9997,1,0.0
9905,1,0.0
CHRONIC,1,0.0
xRCovid,1,0.0
Chinese-American,1,0.0
PDE4D,1,0.0
72-0-3-9,1,0.0
epimutations,1,0.0
0995-0999,1,0.0
0888-0972,1,0.0
1019-1091,1,0.0
1054,1,0.0
1035-3285,1,0.0
declined-meanwhile,1,0.0
HDL09,1,0.0
N-terminal-,1,0.0
P0035,1,0.0
1006-1195,1,0.0
Chinook,1,0.0
Triglyceride,1,0.0
subvalvular,1,0.0
relocating,1,0.0
procedure--papillary,1,0.0
elevation--in,1,0.0
coaptation,1,0.0
anti-nucleoprotein-based,1,0.0
Unbalanced,1,0.0
Icahn,1,0.0
hemagluttinin,1,0.0
pledges,1,0.0
BMSC-based,1,0.0
80-0-6-4,1,0.0
sigmaQ,1,0.0
R0665,1,0.0
NeuroVR,1,0.0
RRT-PCR,1,0.0
Integumentary,1,0.0
boomer,1,0.0
Solna,1,0.0
513441,1,0.0
Shallice,1,0.0
Burgess,1,0.0
Fortin,1,0.0
10577263,1,0.0
p034,1,0.0
r-014,1,0.0
mall-like,1,0.0
ncRNAomics,1,0.0
bought,1,0.0
35-176,1,0.0
p035,1,0.0
Patient-Directed,1,0.0
Khanty-Mansiysk,1,0.0
between-day,1,0.0
37-2-2-4,1,0.0
r014,1,0.0
02-186,1,0.0
drooled,1,0.0
rugby,1,0.0
21-48,1,0.0
20-February,1,0.0
ACUTE,1,0.0
managed-care,1,0.0
instrumentation-of,1,0.0
commute,1,0.0
Prohibition,1,0.0
anisoylated,1,0.0
Castilian,1,0.0
DeWood,1,0.0
Chazov,1,0.0
Bahamas,1,0.0
myeloperoxidase-based,1,0.0
neutrophil-dependent,1,0.0
321785,1,0.0
116-130,1,0.0
PRTN,1,0.0
229-359,1,0.0
nonlaboratory,1,0.0
obstetrician-gynecologist,1,0.0
Vegas,1,0.0
normopenic,1,0.0
PEWSS,1,0.0
Myocardia,1,0.0
2-chlorohexadecanal,1,0.0
EMPIRICAL,1,0.0
STRATEGY,1,0.0
SINUSITIS,1,0.0
peni-resistant,1,0.0
literature-the,1,0.0
TIMI-3B,1,0.0
tripartite,1,0.0
inpairing,1,0.0
intra-axial,1,0.0
1-FC,1,0.0
GAP-FC,1,0.0
Trochlear,1,0.0
Conv1-GAP,1,0.0
Postacute,1,0.0
MCFF-Net66-Conv1-GAP,1,0.0
9466,1,0.0
Noise,1,0.0
Swarm,1,0.0
endovascular-capable,1,0.0
Hedi,1,0.0
rid,1,0.0
Chaker,1,0.0
still-to-be,1,0.0
Plant-derived,1,0.0
bioactives,1,0.0
Preeclampsia-eclampsia,1,0.0
Resolving,1,0.0
Surrounding,1,0.0
Likert-type,1,0.0
liquidity,1,0.0
three-procedure,1,0.0
number-of-procedures-dependent,1,0.0
threating,1,0.0
Lopinavir-,1,0.0
Chloroquinine,1,0.0
anormal,1,0.0
RR066,1,0.0
resonance-,1,0.0
95CI059,1,0.0
anti-H1,1,0.0
FEV1MD010,1,0.0
95CI007,1,0.0
psycho-physiologic,1,0.0
tweaking,1,0.0
MD390,1,0.0
95CI186,1,0.0
MD024,1,0.0
c-kitplatelet-derived,1,0.0
95CI016,1,0.0
LIGHT,1,0.0
placeboOR071,1,0.0
indistinct,1,0.0
95CI058,1,0.0
post-BMSC,1,0.0
AMexico2009,1,0.0
anti-CD90,1,0.0
SPIO‑labeled,1,0.0
Buda,1,0.0
animalsgroup,1,0.0
superparamagnetism,1,0.0
leptomeningitis,1,0.0
tomography-perfusion,1,0.0
Bibliographies,1,0.0
-Feb,1,0.0
TDI-associated,1,0.0
Human-robot,1,0.0
62log10,1,0.0
RT-ddPCR-based,1,0.0
chip-scale,1,0.0
2000x,1,0.0
followability,1,0.0
Posttreatment,1,0.0
optically,1,0.0
electro-optofluidic,1,0.0
human-robot,1,0.0
ChiCTR2000038676,1,0.0
concurs,1,0.0
BAIPC,1,0.0
polyisocyanate,1,0.0
mold-release,1,0.0
time-weighted,1,0.0
Ultrasensitive,1,0.0
Empowerment,1,0.0
Δλmax,1,0.0
polyisocyanates,1,0.0
anti-Interleukin-5,1,0.0
hydrogen-bond,1,0.0
E-Mbase,1,0.0
Beharier,1,0.0
moribund,1,0.0
Minutes,1,0.0
RT-ddPCR-derived,1,0.0
7085,1,0.0
sepsisseptic,1,0.0
12687,1,0.0
europium,1,0.0
quick-acting,1,0.0
S33-S38,1,0.0
147162,1,0.0
Suppl,1,0.0
Exerc,1,0.0
8180,1,0.0
CMap,1,0.0
Connectivity,1,0.0
Damage-associated,1,0.0
027-188,1,0.0
14-dog,1,0.0
011-037,1,0.0
othersp,1,0.0
cSCS,1,0.0
YSTCS,1,0.0
pfumouse,1,0.0
Doppler-flow,1,0.0
C57BL6-congenic,1,0.0
destructed,1,0.0
inhibitor-binding,1,0.0
exspiratory,1,0.0
clusterization,1,0.0
postcardiopulmonary,1,0.0
prebypass,1,0.0
15540,1,0.0
GISC,1,0.0
Superparamagnetic,1,0.0
100min,1,0.0
pletismography,1,0.0
08959,1,0.0
08483-09460,1,0.0
08676,1,0.0
08054-09345,1,0.0
09283,1,0.0
08517-10117,1,0.0
adenosin-monophosphate,1,0.0
psychopharmacologic,1,0.0
00899,1,0.0
database-specific,1,0.0
D-tek,1,0.0
COVIDOT,1,0.0
porosity,1,0.0
excrement,1,0.0
sewage-polluted,1,0.0
semi-stochastic,1,0.0
subdues,1,0.0
Cryoglobulinaemia,1,0.0
non-maleficence,1,0.0
Epiaortic,1,0.0
beneficence,1,0.0
8‐year‐old,1,0.0
epidemic-season,1,0.0
efforts-an,1,0.0
MMPI-Saarbrücken,1,0.0
intersequence,1,0.0
CANHEART,1,0.0
N6,1,0.0
sex-age-standardized,1,0.0
2490-4674,1,0.0
3411,1,0.0
108-110,1,0.0
102-119,1,0.0
103-111,1,0.0
4735-11100,1,0.0
≈10,1,0.0
caregiver-child,1,0.0
independentassisted,1,0.0
Haematoma,1,0.0
nonprogressing,1,0.0
pouring,1,0.0
tray,1,0.0
Nervosität,1,0.0
aerosoling,1,0.0
hexachloroplatinate,1,0.0
FPI-scale,1,0.0
4-week-,1,0.0
Leukotriene-receptor,1,0.0
leukotriene-synthesis,1,0.0
human-to,1,0.0
222DGNVY,1,0.0
76-107,1,0.0
24-40,1,0.0
httpsars2evodatamonkeyorg,1,0.0
Mississippi80,1,0.0
individualsThe,1,0.0
353rd,1,0.0
6-7-year-olds,1,0.0
13-14-year-olds,1,0.0
Kabul,1,0.0
Purpose-We,1,0.0
Aichi181,1,0.0
Yamagata2681,1,0.0
offshoots,1,0.0
Fingerprinting,1,0.0
6-digit,1,0.0
in-house-made,1,0.0
HEF,1,0.0
craniofacial-dental-related,1,0.0
Unambiguous,1,0.0
oftransmssion,1,0.0
prosthodontic,1,0.0
28-month,1,0.0
19967,1,0.0
HA-D222G,1,0.0
HA-222DGN,1,0.0
S2Frag-ELISAs,1,0.0
S2Frag,1,0.0
-humans,1,0.0
intraspecies,1,0.0
offoreign,1,0.0
intrabotanic,1,0.0
nicking,1,0.0
dilates,1,0.0
prefered,1,0.0
strategical,1,0.0
WIS,1,0.0
Cloud,1,0.0
Breathprints,1,0.0
48-93,1,0.0
WDSD,1,0.0
Secure,1,0.0
Anonymised,1,0.0
vitreoretinal,1,0.0
SAIL,1,0.0
Databank,1,0.0
1256412,1,0.0
sketched,1,0.0
42779,1,0.0
Auto-Regressive,1,0.0
feasible--revascularization,1,0.0
type-subarachnoid,1,0.0
hemorrhage-did,1,0.0
and--if,1,0.0
Coeliac,1,0.0
offamily,1,0.0
ofpsychopathological,1,0.0
SARS-CoV-2-responsive,1,0.0
ENc-GC3,1,0.0
signposted,1,0.0
7073,1,0.0
triangel,1,0.0
AmpliSeq,1,0.0
3361,1,0.0
metapneumo,1,0.0
16287,1,0.0
21287,1,0.0
rhinovirusEnterovirus,1,0.0
51287,1,0.0
non-contributory,1,0.0
IABPC,1,0.0
119287,1,0.0
dealth,1,0.0
microaneurysms,1,0.0
paper--antigenic,1,0.0
viruses--recombination,1,0.0
viruses--epidemiological,1,0.0
acuteaccidental,1,0.0
viruses--the,1,0.0
23°C30RH,1,0.0
cross-responsive,1,0.0
person-level,1,0.0
EBOLA,1,0.0
co-adaptation,1,0.0
CoV-responsive,1,0.0
conformers,1,0.0
show-despite,1,0.0
cell-cellmatrix,1,0.0
125600,1,0.0
Judgement,1,0.0
ratio1,1,0.0
Juglans,1,0.0
olanchana,1,0.0
Multimodality,1,0.0
rightsided,1,0.0
bronchopathy,1,0.0
Clockwise,1,0.0
SVV-unimpaired,1,0.0
self-orientation,1,0.0
lateralisation,1,0.0
SSAPL-,1,0.0
Clinicoradiological,1,0.0
oscilloscopes,1,0.0
structural-function,1,0.0
socialization,1,0.0
individuation,1,0.0
spurts,1,0.0
Kaifeng,1,0.0
1783,1,0.0
analysisThe,1,0.0
1317-274,1,0.0
2535,1,0.0
magnetics,1,0.0
menstruate,1,0.0
maternalcaregiver,1,0.0
1900s,1,0.0
process2The,1,0.0
short-interfering,1,0.0
39-89,1,0.0
non-AH1N1pdm09,1,0.0
16-77,1,0.0
re-engineered,1,0.0
S2E128,1,0.0
19-28th,1,0.0
COVID-NOR-MIL,1,0.0
S2H97,1,0.0
functions1213,1,0.0
Single-stranded,1,0.0
neutralization8-11,1,0.0
sarbecoviruses4-7,1,0.0
Prosopis,1,0.0
escape1-3,1,0.0
undrugable,1,0.0
3year,1,0.0
strain-mapping,1,0.0
colour-coded,1,0.0
trialsEPI-2010,1,0.0
21-mer,1,0.0
serum-IgE,1,0.0
regionhas,1,0.0
Hormodendrum,1,0.0
juliflora,1,0.0
pipettes,1,0.0
82800,1,0.0
months-15,1,0.0
42800,1,0.0
S-1CDDP,1,0.0
inferius,1,0.0
membrum,1,0.0
cT3N1M0H1stage,1,0.0
CPT-11,1,0.0
S-1irinotecan,1,0.0
sigmoideus,1,0.0
cT4bN2M1P1stage,1,0.0
S-1cisplatin,1,0.0
Sidebar,1,0.0
mml,1,0.0
1969-72,1,0.0
Hitchcock,1,0.0
lost--to,1,0.0
paraphrase,1,0.0
infectious-infectious-recovered,1,0.0
susceptible-exposed,1,0.0
eternal,1,0.0
FIC,1,0.0
Sattler,1,0.0
sero-status,1,0.0
anti-failure,1,0.0
interdisciplinarity,1,0.0
exosome-mediated,1,0.0
CoV2-6C3,1,0.0
cT4aN1M0stage,1,0.0
NAAQS,1,0.0
64660,1,0.0
late-,1,0.0
41400,1,0.0
21400,1,0.0
28-44,1,0.0
P00096,1,0.0
angiographic-cardiac,1,0.0
Irregular,1,0.0
Algomenorrhea,1,0.0
algomenorrhea,1,0.0
nonneoplastic,1,0.0
CKpan,1,0.0
osteoclast-like,1,0.0
carcinoma-which,1,0.0
Childhood-ISAAC,1,0.0
PFO-a,1,0.0
birth-can,1,0.0
Coexistent,1,0.0
cavity-which,1,0.0
medius,1,0.0
cerebellaris,1,0.0
ⅡA,1,0.0
sulfonate,1,0.0
pedunculus,1,0.0
facioplegia,1,0.0
1139452,1,0.0
4243,1,0.0
mastoid,1,0.0
carfilzomib,1,0.0
emboilment,1,0.0
13452,1,0.0
smokersmoker,1,0.0
non-smokersmoker,1,0.0
1192-2035,1,0.0
Siamon,1,0.0
1061-2815,1,0.0
activeactive,1,0.0
expertly,1,0.0
Symposia,1,0.0
0625,1,0.0
0460-0832,1,0.0
0438-1009,1,0.0
0761,1,0.0
Keystone,1,0.0
0599-0952,1,0.0
7-4,1,0.0
heamorrhage,1,0.0
18-53,1,0.0
hemagglutnin,1,0.0
Useing,1,0.0
defets,1,0.0
recomendet,1,0.0
AH1NIv,1,0.0
AHonkong68,1,0.0
9077,1,0.0
arousal-related,1,0.0
mononucleotide-free,1,0.0
Oxofrd,1,0.0
10-49-year,1,0.0
azithromycin-the,1,0.0
-Angiotensin,1,0.0
125I-and,1,0.0
131I-labeled,1,0.0
IMID,1,0.0
C19-VH,1,0.0
inhibitors--will,1,0.0
antibodies-virus,1,0.0
FcR,1,0.0
sentinel-hospital-based,1,0.0
research--such,1,0.0
infectious-inflammatory,1,0.0
tRNA-derived,1,0.0
Cook-Medley,1,0.0
Estrogenprogestin,1,0.0
out-break,1,0.0
Within-host,1,0.0
mRNA-1273-vaccinated,1,0.0
-pair,1,0.0
mock-vaccinated,1,0.0
12850,1,0.0
tRNA-specific,1,0.0
1-methyladenosine,1,0.0
Kanta,1,0.0
werent,1,0.0
summerise,1,0.0
Maurizios,1,0.0
2009-August,1,0.0
eHCoVs,1,0.0
SLE-related,1,0.0
Expressing,1,0.0
ACCAHASCAI,1,0.0
2-receptors,1,0.0
untried,1,0.0
2300-5000,1,0.0
dystonic,1,0.0
promethazine,1,0.0
frontocentral,1,0.0
anticalcium,1,0.0
064002,1,0.0
globality,1,0.0
SMD95,1,0.0
291114,1,0.0
OR95,1,0.0
ISIWeb,1,0.0
Work-up,1,0.0
14-5,1,0.0
early-recognised,1,0.0
Maurizio,1,0.0
Vignola,1,0.0
superb,1,0.0
mcgkgdose,1,0.0
proudly,1,0.0
Radical,1,0.0
a-31-year-old,1,0.0
cardiac-trained,1,0.0
recordsResultsA,1,0.0
3101,1,0.0
SAMPLE,1,0.0
that-with,1,0.0
treatment-rhythm,1,0.0
rate-,1,0.0
fever-free,1,0.0
curatively,1,0.0
ATHENA,1,0.0
BackgroundPoint-of-care,1,0.0
2018AimTo,1,0.0
RSVMethodsSamples,1,0.0
seasonConclusionPositive,1,0.0
2021502e84-e89,1,0.0
post-delivery,1,0.0
OR415,1,0.0
pollution-exacerbated,1,0.0
15-114,1,0.0
redox-active,1,0.0
OR101,1,0.0
pollutant-mediated,1,0.0
1-102,1,0.0
p0009,1,0.0
arteriogrammes,1,0.0
19covid-19,1,0.0
thirty-year,1,0.0
exposure-induced,1,0.0
re-contamination,1,0.0
antigenes,1,0.0
6200,1,0.0
miasmatic,1,0.0
brain-lesioned,1,0.0
post-bacteriological,1,0.0
Mn-superoxide,1,0.0
ASQ-Confidence,1,0.0
ASQ-Need,1,0.0
individuated,1,0.0
ANPS-FEAR,1,0.0
ANPS-ANGER,1,0.0
fifth-leading,1,0.0
ANPS-SADNESS,1,0.0
cryosection,1,0.0
neuro-interventionalist,1,0.0
ANPS-SEEKING,1,0.0
alpha1-antitrypsin,1,0.0
18875,1,0.0
ANGER,1,0.0
GG167,1,0.0
SADNESS,1,0.0
6473,1,0.0
LCAP,1,0.0
leukocytapheresis,1,0.0
astonish,1,0.0
innoculation,1,0.0
13-25,1,0.0
subjects--calls,1,0.0
geography--to,1,0.0
05-278,1,0.0
spike-waves,1,0.0
broadly-effective,1,0.0
124-386,1,0.0
Inhibitory,1,0.0
1303,1,0.0
myoclonic-atonic,1,0.0
-33CT,1,0.0
debateWe,1,0.0
re-injection,1,0.0
008-687,1,0.0
Revelation,1,0.0
55-82,1,0.0
Historians,1,0.0
tachypneic,1,0.0
p0055,1,0.0
p0054,1,0.0
Lambda-cyhalothrin,1,0.0
33700,1,0.0
pyrethroid,1,0.0
004-174,1,0.0
syndrome-corona,1,0.0
esterases,1,0.0
30-kb,1,0.0
06-89,1,0.0
flu-types,1,0.0
6293,1,0.0
Open-access,1,0.0
rear-service,1,0.0
-421,1,0.0
non-perfusion,1,0.0
576100000,1,0.0
metapneumoviruses,1,0.0
LVO-strokes,1,0.0
mildly-symptomatic,1,0.0
182100000,1,0.0
BCMA,1,0.0
highrisk,1,0.0
Melioidosis,1,0.0
nonpoor,1,0.0
respectivelyConclusionEarly,1,0.0
Sharpe,1,0.0
Petrie,1,0.0
overextending,1,0.0
Weinman,1,0.0
cine-mode,1,0.0
parentsrsquo,1,0.0
villous,1,0.0
SwePASS,1,0.0
mediastinoabdominal,1,0.0
junctures,1,0.0
N150,1,0.0
embellishments,1,0.0
small-sample,1,0.0
virusResultsOne,1,0.0
virusMethodsWe,1,0.0
-400,1,0.0
Standardisation,1,0.0
XVIII-th,1,0.0
3073,1,0.0
4557,1,0.0
9636,1,0.0
Include,1,0.0
Diffusional,1,0.0
non-Gaussianity,1,0.0
neuro-pathologies,1,0.0
kurtoses,1,0.0
rKas,1,0.0
Hyppocrates,1,0.0
Oncologists,1,0.0
-403,1,0.0
Homes,1,0.0
Biases,1,0.0
198283,1,0.0
Oncologi,1,0.0
porters,1,0.0
qualifies,1,0.0
BackgroundSeasonal,1,0.0
Primari,1,0.0
dei,1,0.0
2011AimWe,1,0.0
Collegio,1,0.0
hypoakinetic,1,0.0
synchrotrons,1,0.0
065-086,1,0.0
blatantly,1,0.0
qijie,1,0.0
thoroughfare,1,0.0
sihai,1,0.0
interferon-and,1,0.0
leucocyte-produced,1,0.0
short-sequence,1,0.0
Sustainability,1,0.0
Masters,1,0.0
fusion-related,1,0.0
currentfuture,1,0.0
∼85,1,0.0
∼121,1,0.0
∼070,1,0.0
Non-smoking,1,0.0
Inpatients,1,0.0
median20,1,0.0
283655,1,0.0
vetted,1,0.0
h505,1,0.0
ventricular-developed,1,0.0
BVÖGD,1,0.0
Bundesländer,1,0.0
placebovaccine,1,0.0
vaccineno,1,0.0
Minocycline,1,0.0
Shenmen,1,0.0
studiedThe,1,0.0
Xinshu,1,0.0
€6578-8612,1,0.0
pharmaco-logy,1,0.0
Taqman™,1,0.0
109-500,1,0.0
Revista,1,0.0
ratio234,1,0.0
Steroid-resistant,1,0.0
-309,1,0.0
reproductibility,1,0.0
exacerbationpatient,1,0.0
dayspatient,1,0.0
€7472patient,1,0.0
€1410patient,1,0.0
Fengfu,1,0.0
€1082patient,1,0.0
Quartiles,1,0.0
interferon-negative,1,0.0
€564-1987,1,0.0
interferon-positive,1,0.0
€8554patient,1,0.0
€7411-10199,1,0.0
€8554patientyear,1,0.0
relativity,1,0.0
artifically,1,0.0
Baihui,1,0.0
year-at,1,0.0
calcium-antagonistic,1,0.0
echo-dobutamine,1,0.0
viral-mediated,1,0.0
misinform,1,0.0
pathogen’s,1,0.0
Adriano,1,0.0
Immunosorbent,1,0.0
20208CD013705,1,0.0
32845525,1,0.0
micro-aspirations,1,0.0
refluxing,1,0.0
semirecumbent,1,0.0
Enzyme-Linked,1,0.0
seamed,1,0.0
quarantineisolation,1,0.0
RNARNA,1,0.0
deterioriation,1,0.0
Kongzui,1,0.0
NLRC4,1,0.0
Normalizing,1,0.0
AIM2,1,0.0
community-use,1,0.0
speck-like,1,0.0
cleanouts,1,0.0
manholes,1,0.0
open-science,1,0.0
centre-stage,1,0.0
RecASC,1,0.0
populationbased,1,0.0
4´880000,1,0.0
somatostatin,1,0.0
anti-vaccinations,1,0.0
VVF,1,0.0
subunit-virion,1,0.0
disease-reducing,1,0.0
Interleukin-3,1,0.0
biosafety-related,1,0.0
Hebrew,1,0.0
VAX,1,0.0
COVID-VAX,1,0.0
AMSAN,1,0.0
HCS,1,0.0
Scheffes,1,0.0
Coagulopathy,1,0.0
26439,1,0.0
transabdominal-mediastinal,1,0.0
Pew,1,0.0
non-immunogenicity,1,0.0
target-to-non-target,1,0.0
Empagliflozin,1,0.0
ortumor,1,0.0
gastrin-releasing,1,0.0
αβ3,1,0.0
3-point,1,0.0
089-156,1,0.0
P026,1,0.0
134±37,1,0.0
065-093,1,0.0
Pharmacology,1,0.0
β-receptor,1,0.0
lentivirus-based,1,0.0
Screen®,1,0.0
virus-pairs,1,0.0
pfu25,1,0.0
backyardfree,1,0.0
McClellans,1,0.0
McClellan,1,0.0
rosuvastatin,1,0.0
MPLA-AddaVax,1,0.0
TRL4,1,0.0
immunotherapy-based,1,0.0
gray-level,1,0.0
cooccurrence,1,0.0
GLCM,1,0.0
under-testing,1,0.0
Cobas®6800,1,0.0
phenol-chloroform,1,0.0
AIVH7N9,1,0.0
00444,1,0.0
NODs,1,0.0
MAs,1,0.0
estrogen-based,1,0.0
progestogen-only,1,0.0
re-investigates,1,0.0
non-government,1,0.0
mite-allergic,1,0.0
T-cell-peptide,1,0.0
tropicalis,1,0.0
AMIA,1,0.0
Additions,1,0.0
multiple-lead,1,0.0
echocardiographs,1,0.0
intra-mural,1,0.0
0319,1,0.0
ChiCTR2000034825,1,0.0
repercutaneous,1,0.0
21-fold,1,0.0
0483,1,0.0
Positron-emission,1,0.0
hoursCardiovascular,1,0.0
Stroke-Units,1,0.0
Blomia,1,0.0
pyridostigmine,1,0.0
4CD,1,0.0
httpwwweissorg,1,0.0
representativity,1,0.0
47ABSTRACT,1,0.0
harmonise,1,0.0
3-terminus,1,0.0
osteolytic,1,0.0
reality--the,1,0.0
subgroups--differs,1,0.0
osteoclastogenesis,1,0.0
profits,1,0.0
RIDA®GENE,1,0.0
100-221,1,0.0
Q-wavenon-Q,1,0.0
INV,1,0.0
pSmad,1,0.0
sectionally,1,0.0
careless,1,0.0
Problem-Solving,1,0.0
Inventory-Revised,1,0.0
impulsive-careless,1,0.0
037-104,1,0.0
Proliferation,1,0.0
cyclin-dependant,1,0.0
015-142,1,0.0
teachable,1,0.0
Phylagen,1,0.0
Smads,1,0.0
now-available,1,0.0
reassortantrecombinant,1,0.0
planningpreparedness,1,0.0
ecologyzoonosis,1,0.0
bromodeoxyuridine,1,0.0
colliculi,1,0.0
Hyperactivation,1,0.0
homotopic,1,0.0
uploading,1,0.0
Medlines,1,0.0
80-fold,1,0.0
Cycline-dependent,1,0.0
3339,1,0.0
QIAstat-SARS-CoV-2,1,0.0
imaginable,1,0.0
THRrPTCA,1,0.0
5263,1,0.0
Dottering,1,0.0
factor--non-acceptance,1,0.0
Aintermediate,1,0.0
Texas-Bangkok,1,0.0
Straight,1,0.0
sulfiting,1,0.0
Nofer,1,0.0
Autophagy-dependent,1,0.0
autophagosome,1,0.0
Off-target,1,0.0
QIAstat-Dx®,1,0.0
autophagyvirophagy,1,0.0
clinical-imaging,1,0.0
980000,1,0.0
imagingfluid,1,0.0
6-point,1,0.0
hypercholesterinemia,1,0.0
broncho-,1,0.0
tissuetype,1,0.0
acylated,1,0.0
agentsABSTRACT,1,0.0
bell-shaped,1,0.0
electrocardiographic-clinical-pathological,1,0.0
PARS,1,0.0
100±37,1,0.0
Gb-3,1,0.0
17631,1,0.0
AMIThere,1,0.0
Activase,1,0.0
Recover,1,0.0
post‑infarction,1,0.0
197677,1,0.0
Widals,1,0.0
4696,1,0.0
6967,1,0.0
ARABSTRACT,1,0.0
AIarea,1,0.0
059-093,1,0.0
053-098,1,0.0
0586-092,1,0.0
STEMICompared,1,0.0
quadrantanopias,1,0.0
acid-enriched,1,0.0
low-Ca,1,0.0
atrial-femoral,1,0.0
acroparesthesias,1,0.0
groupgroup,1,0.0
angiokeratoma,1,0.0
snared,1,0.0
misrepresents,1,0.0
echocardiogrphic,1,0.0
figs,1,0.0
17741,1,0.0
unclearBy,1,0.0
openEHR,1,0.0
141±49,1,0.0
P040,1,0.0
sex-ethnic,1,0.0
stroke-493,1,0.0
onset-636,1,0.0
UW-414,1,0.0
P×interaction079,1,0.0
vectorcardiographically,1,0.0
1572,1,0.0
atherosclerotic-mediated,1,0.0
4750,1,0.0
n514,1,0.0
needs2,1,0.0
n8130,1,0.0
immunoblot,1,0.0
at-point-of-care,1,0.0
58-419,1,0.0
reusing,1,0.0
optokinetic,1,0.0
Extinction,1,0.0
Energetics,1,0.0
cell-penetration,1,0.0
buffy,1,0.0
economizing,1,0.0
r071,1,0.0
21432,1,0.0
0045Consequently,1,0.0
gram-equivalent,1,0.0
diagnosis-specific,1,0.0
counterpoise,1,0.0
hyperreaction,1,0.0
intravoxel,1,0.0
flupenthixol,1,0.0
toremifene,1,0.0
bosutinib,1,0.0
IVIM,1,0.0
trimeprazine,1,0.0
naively,1,0.0
PTI,1,0.0
anterior-lateral,1,0.0
Intent,1,0.0
TBARS,1,0.0
LHPs,1,0.0
bioochemical,1,0.0
HCQ-based,1,0.0
much-discussed,1,0.0
19days,1,0.0
airway-derived,1,0.0
commonalties,1,0.0
patints,1,0.0
tree-based,1,0.0
mortalitiy,1,0.0
30-39,1,0.0
postevent,1,0.0
anti-SARS2,1,0.0
CIP,1,0.0
Covid-19-positive,1,0.0
round-shaped,1,0.0
7289,1,0.0
macro-vasculopathy,1,0.0
globotriaosylceramide,1,0.0
semispinal,1,0.0
paresthesiae,1,0.0
pigs-have,1,0.0
models-ferrets,1,0.0
NEST-II,1,0.0
ut,1,0.0
CESD-10,1,0.0
N40,1,0.0
371-922,1,0.0
Davos,1,0.0
agoraphobia,1,0.0
multidomain,1,0.0
amantadines,1,0.0
Spirotel,1,0.0
low-avidity,1,0.0
6M,1,0.0
Unfamiliarity,1,0.0
indiscriminating,1,0.0
8765,1,0.0
81-86,1,0.0
nanoantagonists,1,0.0
DatabaseTCMSP,1,0.0
autoclaving,1,0.0
fend,1,0.0
34·3-41·7,1,0.0
38·1,1,0.0
77·8-82·5,1,0.0
subtleties,1,0.0
allude,1,0.0
80·2,1,0.0
9·4-13·0,1,0.0
hegemonic,1,0.0
11·2,1,0.0
Shenzhens,1,0.0
masculine,1,0.0
microcatheters,1,0.0
103μL,1,0.0
gluing,1,0.0
piercing,1,0.0
≥09,1,0.0
RObi-based,1,0.0
non-CCP,1,0.0
rituximabobinutuzumab,1,0.0
01to,1,0.0
RhD,1,0.0
523068,1,0.0
Lubbock,1,0.0
394470,1,0.0
24028,1,0.0
72·5,1,0.0
66·9-78·0,1,0.0
invincibility,1,0.0
Inhalations,1,0.0
d-1,1,0.0
Heterogenic,1,0.0
myeloablation,1,0.0
nonmedicamental,1,0.0
inflammatory-edematous,1,0.0
alpha-stimulating,1,0.0
alpha-stimulated,1,0.0
hygiene-based,1,0.0
whole-scale,1,0.0
course-10,1,0.0
mid-serious,1,0.0
Zala,1,0.0
000-768,1,0.0
-0372,1,0.0
questinnaire,1,0.0
previsit,1,0.0
-0875,1,0.0
atypicity,1,0.0
liked,1,0.0
disillusionment,1,0.0
Hyperdiagnosis,1,0.0
Ruling,1,0.0
MDIspacerface,1,0.0
4·7-5·9,1,0.0
16-17,1,0.0
Anti-SARS-CoV-2S,1,0.0
Kurtzberg,1,0.0
non-Hodgkin,1,0.0
a-NIHSS,1,0.0
A-E,1,0.0
EAGLE,1,0.0
CPSS1,1,0.0
ASMA-Undx,1,0.0
CPSS2,1,0.0
M1M2,1,0.0
Checkpoint,1,0.0
inhalation--along,1,0.0
6765-13632,1,0.0
3981-12370,1,0.0
5589-10204,1,0.0
aphasianeglect,1,0.0
agent--preferably,1,0.0
CT-evidence,1,0.0
NT-PBNP,1,0.0
5352-9492,1,0.0
B-type-natriuretic,1,0.0
Plasmatic,1,0.0
Definitely,1,0.0
non-intensive-care,1,0.0
entitles,1,0.0
mortality-morbidity,1,0.0
polarization-dependent,1,0.0
light-analyte,1,0.0
sNIHSS-1,1,0.0
Alexandra,1,0.0
sNIHSS-8,1,0.0
streptococus,1,0.0
bacterium-free,1,0.0
surgerys,1,0.0
Best-published,1,0.0
∼5000,1,0.0
005-11,1,0.0
department-initiated,1,0.0
Huzhou,1,0.0
004-05,1,0.0
AH7N9-positive,1,0.0
cases’,1,0.0
immunodepressed,1,0.0
unitsmm3,1,0.0
3I-SS,1,0.0
13-88,1,0.0
Parliament,1,0.0
12-102,1,0.0
derogation,1,0.0
periindex,1,0.0
GMO-based,1,0.0
n179,1,0.0
Cb,1,0.0
Einstein,1,0.0
Forgoing,1,0.0
Anecdotally,1,0.0
Joanne,1,0.0
non-HLA,1,0.0
28285700,1,0.0
WHO-sponsored,1,0.0
pyschosocial,1,0.0
112-219,1,0.0
regresses,1,0.0
-284,1,0.0
orotracheal,1,0.0
numberous,1,0.0
-203,1,0.0
137-199,1,0.0
Between-visit,1,0.0
bimodally,1,0.0
factor-analyzed,1,0.0
69-940,1,0.0
28-432,1,0.0
guidelines-driven,1,0.0
10-206,1,0.0
43-150,1,0.0
10-52,1,0.0
03-16,1,0.0
Convex,1,0.0
diagnosis-based,1,0.0
unheard,1,0.0
Hethcote,1,0.0
Levin,1,0.0
biomathematics,1,0.0
3322,1,0.0
arbiter,1,0.0
autocoids,1,0.0
metaloproteineases,1,0.0
031-092,1,0.0
Hippel-Lindau,1,0.0
3707,1,0.0
Extracting,1,0.0
101-564,1,0.0
integer-based,1,0.0
contain1,1,0.0
Relaxed,1,0.0
wave2,1,0.0
phylogeographical,1,0.0
rekindling,1,0.0
PM-dependent,1,0.0
miRNA146a,1,0.0
Arteritis,1,0.0
miRNA-499,1,0.0
non-anemic,1,0.0
post-quarantine,1,0.0
blends,1,0.0
phytoconstituents,1,0.0
astray,1,0.0
victim-focused,1,0.0
119min,1,0.0
hydrogen-deuterium,1,0.0
atheromata,1,0.0
15-57,1,0.0
0875-0933,1,0.0
626-822,1,0.0
caloricenergy,1,0.0
844-920,1,0.0
vaccine-conferred,1,0.0
6887A,1,0.0
Inducing,1,0.0
α-chain,1,0.0
8651A,1,0.0
blastx,1,0.0
IgG-antibodies,1,0.0
«ELISA-SARS-CoV-2-AT-G»,1,0.0
cromoglycic,1,0.0
«Vitrotest®,1,0.0
orthopnoea,1,0.0
imaging-and,1,0.0
14×109L,1,0.0
Vitrotest,1,0.0
«Anti-SARS-Cov-2,1,0.0
haematuria,1,0.0
MoscowThis,1,0.0
B180,1,0.0
MDRO,1,0.0
single-introduction,1,0.0
periprosthetic,1,0.0
micro-organizational,1,0.0
Polarization-based,1,0.0
banked,1,0.0
low-calorie,1,0.0
hyperferritinemia,1,0.0
Mid,1,0.0
23403A,1,0.0
32109-121,1,0.0
546-744,1,0.0
882-949,1,0.0
PCR-oligochromatographic,1,0.0
193-211,1,0.0
Aron,1,0.0
clarifyed,1,0.0
Schwartz,1,0.0
ocardial,1,0.0
110665-679,1,0.0
Kuznetsov,1,0.0
Piccardi,1,0.0
multiple-strain,1,0.0
25563G,1,0.0
33-54,1,0.0
biology-related,1,0.0
ally,1,0.0
servicesfacilities,1,0.0
prognose,1,0.0
etal,1,0.0
65964-982,1,0.0
AKumamoto3779,1,0.0
non-prevalent,1,0.0
bane,1,0.0
14408C,1,0.0
hCoV-19FinlandFIN-252020,1,0.0
14×,1,0.0
memrbane,1,0.0
Thin-walled,1,0.0
Ascaris-positive,1,0.0
attention-deficithyperactivity,1,0.0
asthmatics--had,1,0.0
number--17,1,0.0
interchangeability,1,0.0
liveinactivated,1,0.0
prologue,1,0.0
Ascaris-infested,1,0.0
Infestation,1,0.0
1880351,1,0.0
88-97,1,0.0
72-89,1,0.0
92-98,1,0.0
PHT,1,0.0
19571958,1,0.0
glycoform,1,0.0
MUC2,1,0.0
anti-hypersecretory,1,0.0
mucor,1,0.0
Humanities,1,0.0
criticizes,1,0.0
Managed-care,1,0.0
Falciparum,1,0.0
hyphae,1,0.0
thick-walled,1,0.0
immunogenically,1,0.0
Uppsala,1,0.0
Zaire,1,0.0
haematogenous,1,0.0
P2Y12-inhibitors,1,0.0
209-,1,0.0
1992-5,1,0.0
E-N-4-cyanobenzylidene-6-fluoro-3-hydroxypyrazine-2-carboxamide,1,0.0
Sone,1,0.0
38282,1,0.0
torsional,1,0.0
flatter,1,0.0
H5pp,1,0.0
level-ground,1,0.0
extrude,1,0.0
MCVE,1,0.0
SAMMPs,1,0.0
human-emerged,1,0.0
AU-enrichment,1,0.0
AU-richer,1,0.0
acenocumarole,1,0.0
000ml,1,0.0
Phytocomplexes,1,0.0
090-092,1,0.0
069-087,1,0.0
Time-series,1,0.0
killedinactivateddegenerated,1,0.0
ebolavirus,1,0.0
corkscrew,1,0.0
malaria-induced,1,0.0
Cyanorona-20,1,0.0
laminated,1,0.0
137-339,1,0.0
p0069,1,0.0
alveolopleural,1,0.0
fistulae,1,0.0
Pymol,1,0.0
Autodock,1,0.0
ClueGO,1,0.0
pre-seasonal,1,0.0
030-092,1,0.0
bronchofibroscopies,1,0.0
endoscopes,1,0.0
MCODE,1,0.0
interactionPPI,1,0.0
ACE2-rich,1,0.0
kidney-239T,1,0.0
component-targetquot,1,0.0
quotactive,1,0.0
mg-1,1,0.0
baits,1,0.0
HK-2,1,0.0
OMIM,1,0.0
recongnition,1,0.0
translocated,1,0.0
GeneCards,1,0.0
pseudovirions,1,0.0
componentsquercetin,1,0.0
p00007,1,0.0
β-sitosterol,1,0.0
1919-20,1,0.0
high-specificity,1,0.0
E-GEOD-58294,1,0.0
aberrance,1,0.0
iPAS,1,0.0
Cross-Validation,1,0.0
854-860,1,0.0
AUC10,1,0.0
MRMPI,1,0.0
16121,1,0.0
unkown,1,0.0
time-to-presentation,1,0.0
1934-5,1,0.0
MAPK3,1,0.0
1949-50,1,0.0
sudies,1,0.0
potatoes,1,0.0
metabisulphite,1,0.0
6215,1,0.0
5393,1,0.0
4932,1,0.0
sprinkled,1,0.0
1986-92,1,0.0
CASP3,1,0.0
Nodes,1,0.0
immunity-mediated,1,0.0
low-reactivity,1,0.0
ace,1,0.0
genesig,1,0.0
sympathomimetically,1,0.0
re-vaccinations,1,0.0
pCT-derived,1,0.0
cuboid,1,0.0
beta1-adrenergic,1,0.0
ETA-blockers,1,0.0
time-to-maximum,1,0.0
AT1-receptors,1,0.0
glmTmax,1,0.0
glmmulti,1,0.0
activation--could,1,0.0
proBNP-derived,1,0.0
tissue--probably,1,0.0
myofilaments,1,0.0
Triangle,1,0.0
Nutley,1,0.0
Slipping,1,0.0
claustrophobic,1,0.0
Sindacato,1,0.0
abates,1,0.0
Pediatri,1,0.0
Famiglia,1,0.0
2235,1,0.0
lt7,1,0.0
hologic,1,0.0
Microbiota,1,0.0
microbially,1,0.0
0587,1,0.0
lithography,1,0.0
monocarboxypeptidase,1,0.0
antihypertrophic,1,0.0
FDM,1,0.0
counterbalances,1,0.0
BRACE,1,0.0
inhibitorsARBs,1,0.0
RIE,1,0.0
etching,1,0.0
Obturating,1,0.0
Thrombosed,1,0.0
degeneratively-necrotically,1,0.0
metal-oxide-semiconductor,1,0.0
dl,1,0.0
nanoslot,1,0.0
1993-4,1,0.0
Chip-scale,1,0.0
code-specific,1,0.0
106215,1,0.0
120204,1,0.0
9920,1,0.0
84225,1,0.0
169-1812,1,0.0
103235,1,0.0
101-474,1,0.0
panther,1,0.0
PAI-I,1,0.0
nucleosidenucleotide,1,0.0
3737,1,0.0
LESYMAP,1,0.0
flow-weighted,1,0.0
85-Plus,1,0.0
TOF-,1,0.0
P07,1,0.0
PEF-derived,1,0.0
Collateralized,1,0.0
BMassachusetts22012,1,0.0
Identify-Isolate-Inform,1,0.0
AVictoria3612011H3N2--and,1,0.0
risk-stratified,1,0.0
virus--ACalifornia72009H1N1pdm09,1,0.0
bradykininmin,1,0.0
speciality,1,0.0
kininase,1,0.0
transferrable,1,0.0
2597,1,0.0
well-newborn,1,0.0
recently-emerged,1,0.0
uprising,1,0.0
televised,1,0.0
Setacci,1,0.0
Battocchio,1,0.0
Antidote,1,0.0
Wach,1,0.0
TOF-MRA,1,0.0
multi-area,1,0.0
language-critical,1,0.0
49893,1,0.0
hCoVhParaFlu,1,0.0
transmissiondisequilibrium,1,0.0
AgNO₃,1,0.0
-675-674insG,1,0.0
PAI-1--the,1,0.0
Keio,1,0.0
nonirritant,1,0.0
50-85,1,0.0
AWuhan35995-like,1,0.0
bioengineer,1,0.0
chemist,1,0.0
re-immunization,1,0.0
sparseness,1,0.0
15-71,1,0.0
re-transplantation,1,0.0
Etiopathological,1,0.0
egg-allergy,1,0.0
appraising,1,0.0
indexABSTRACT,1,0.0
infarct-avid-agent,1,0.0
radionuclide-based,1,0.0
20-131,1,0.0
Radionuclide-based,1,0.0
EPIC-Norfolk,1,0.0
infarctioncritical,1,0.0
1977-2006,1,0.0
Landspitali,1,0.0
interlocutor,1,0.0
Meier-Schroers,1,0.0
Hübel,1,0.0
Schulze-Hagen,1,0.0
caretreatment,1,0.0
variablesa,1,0.0
isovolume,1,0.0
9-min,1,0.0
Thogotovirus,1,0.0
Heartland,1,0.0
n＝99,1,0.0
n＝435,1,0.0
black-white,1,0.0
but＜70,1,0.0
n＝354,1,0.0
arsenic-containing,1,0.0
mLlogTCID50,1,0.0
bucket-handle,1,0.0
Agostoni,1,0.0
0179,1,0.0
0116,1,0.0
Physiol,1,0.0
arsenic-contaminated,1,0.0
SDF-1CXCR4,1,0.0
201179-1186,1,0.0
CXCR4,1,0.0
Dtsch,1,0.0
Arztebl,1,0.0
allery,1,0.0
moderate-size,1,0.0
Workflow,1,0.0
Biosystems™,1,0.0
TaqMan™,1,0.0
112891,1,0.0
chi2776419,1,0.0
wal,1,0.0
Inferolateral,1,0.0
3417,1,0.0
Sibenik-Knin,1,0.0
microstimulation,1,0.0
CFARFA,1,0.0
ELISPOT-based,1,0.0
cellsPBMCs,1,0.0
stimulationSIGNIFICANCE,1,0.0
reachinggrasping,1,0.0
32762834,1,0.0
subregion,1,0.0
encroaching,1,0.0
2020117389-95,1,0.0
relapsingremitting,1,0.0
related-symptoms,1,0.0
Int,1,0.0
08-24,1,0.0
scrotal,1,0.0
retroaortic,1,0.0
SDF-1αCXCL12,1,0.0
93·3,1,0.0
short-burst,1,0.0
56·25,1,0.0
fibroblast‑specific,1,0.0
FSP1,1,0.0
Vimentin,1,0.0
15O2-PET,1,0.0
stroke-onset,1,0.0
C15O-PET,1,0.0
15O2-,1,0.0
16HBE14o‑was,1,0.0
ORMDL3‑expressing,1,0.0
FSP‑1,1,0.0
16HBE,1,0.0
14o‑cells,1,0.0
Gd,1,0.0
Apexcardiograms,1,0.0
post-gadolinium,1,0.0
15O2,1,0.0
paradoxal,1,0.0
heartchest,1,0.0
rCMRO2,1,0.0
C15O2,1,0.0
57Co,1,0.0
ACG-assessed,1,0.0
Christs,1,0.0
Co-isotopes,1,0.0
Revaccination,1,0.0
rCMRO265,1,0.0
rCBF45,1,0.0
post-Gd,1,0.0
updown,1,0.0
501-2000,1,0.0
87·5,1,0.0
1416,1,0.0
Physiopathology,1,0.0
datum,1,0.0
feedback-plus-instruction,1,0.0
Warming,1,0.0
12-21,1,0.0
Freiburger,1,0.0
T-spherical,1,0.0
POPS,1,0.0
zero-inconsistency,1,0.0
Manas,1,0.0
SD2,1,0.0
non-CAS,1,0.0
MT-related,1,0.0
fuzzy-weighted,1,0.0
Orosomucoid‑like,1,0.0
factor‑β,1,0.0
aneurysm-complicated,1,0.0
Masson,1,0.0
Anot,1,0.0
EMT‑associated,1,0.0
Kyrgyzstan,1,0.0
Scientific™,1,0.0
chi22463,1,0.0
cuticle,1,0.0
AGT--AAT,1,0.0
Nardell,1,0.0
5149,1,0.0
ResearchGate,1,0.0
papulo-vesicular,1,0.0
purpuricpetechial,1,0.0
rebalancing,1,0.0
2003-March,1,0.0
Dermatologys,1,0.0
Kan,1,0.0
pre-Thrombolysis,1,0.0
103-61,1,0.0
47-102,1,0.0
DCAF1,1,0.0
CUL4-associated,1,0.0
DDB1-,1,0.0
time-contraction,1,0.0
viral-based,1,0.0
AdV,1,0.0
proteasomal-mediated,1,0.0
AAV-based,1,0.0
coronavirus-initiated,1,0.0
willingness-to-participate,1,0.0
improvisations,1,0.0
recored,1,0.0
2560,1,0.0
DK,1,0.0
cicatrised,1,0.0
Hodgson,1,0.0
alertscodes,1,0.0
2002110November,1,0.0
asthma--update,1,0.0
2cc,1,0.0
3cc,1,0.0
asthmaasthgdlnpdf,1,0.0
httpwwwnhlbinihgovguidelines,1,0.0
97-4051,1,0.0
hemidystonia,1,0.0
hyperhomocyteinemia,1,0.0
inhibitorsantirheumatic,1,0.0
8716,1,0.0
7684,1,0.0
studySample,1,0.0
53526,1,0.0
within-stratum,1,0.0
06-08,1,0.0
reappraised,1,0.0
Radonovich,1,0.0
LJ,1,0.0
12196,1,0.0
significantConclusions,1,0.0
21921,1,0.0
Martinello,1,0.0
adviceData,1,0.0
eosinophil-rich,1,0.0
650382819,1,0.0
P00000,1,0.0
Ser31Asn,1,0.0
1989-8,1,0.0
CSPSS,1,0.0
cilostazole,1,0.0
2916,1,0.0
re-entrant,1,0.0
79-yr-old,1,0.0
irregularunstable,1,0.0
regular-stable,1,0.0
lobbied,1,0.0
Poisoning,1,0.0
P0000003092,1,0.0
7278,1,0.0
P0005159,1,0.0
18459,1,0.0
1372-2186,1,0.0
045-107,1,0.0
024-083,1,0.0
2162-3347,1,0.0
664100000,1,0.0
877100000,1,0.0
752100000,1,0.0
005-096,1,0.0
103000,1,0.0
education-adjusted,1,0.0
non-neurogenic,1,0.0
1994-8,1,0.0
COVID-appropriate,1,0.0
ring-coupled,1,0.0
reinfarction--292,1,0.0
GTT--GCT,1,0.0
Val27Ala,1,0.0
Fast-track,1,0.0
insurance-covered,1,0.0
concomitance,1,0.0
SSHNL,1,0.0
microglia-mediated,1,0.0
case-passenger,1,0.0
0-071,1,0.0
1532,1,0.0
angina--458,1,0.0
mortality--0,1,0.0
mammoth,1,0.0
aneurysm--167,1,0.0
ICS-responsive,1,0.0
Th2–mediated,1,0.0
failure--208,1,0.0
--521,1,0.0
overtreated,1,0.0
multifacated,1,0.0
4341,1,0.0
HRP-conjugated,1,0.0
bead-capture,1,0.0
pipette,1,0.0
cummulative,1,0.0
stroke-to-magnetic,1,0.0
divalent,1,0.0
Harcourt,1,0.0
SeqCapExome,1,0.0
Exome,1,0.0
heterosubtype,1,0.0
nose-bronchus,1,0.0
North-West,1,0.0
non-COVID-19-free,1,0.0
Fernand,1,0.0
AstraZenecaOxfords,1,0.0
PURSUIT,1,0.0
khi2,1,0.0
day-mortality,1,0.0
Sinovacs,1,0.0
SST,1,0.0
dOr,1,0.0
observatory,1,0.0
RICO,1,0.0
farction,1,0.0
approachAreas,1,0.0
medicineExpert,1,0.0
swinehuman,1,0.0
well-classified,1,0.0
endotypization,1,0.0
magnetically,1,0.0
maemodynamic,1,0.0
MMB-based,1,0.0
64373,1,0.0
p-value-discovery,1,0.0
p-value-replication,1,0.0
molesassay,1,0.0
copies100,1,0.0
purple,1,0.0
SARS-CoV-2-urged,1,0.0
3·103,1,0.0
advantageously,1,0.0
micropollutants,1,0.0
Membrane-Bioreactors,1,0.0
responsible-that,1,0.0
copiesassay,1,0.0
UV-irradiated,1,0.0
thermophilic,1,0.0
SARS-CoV-2-based,1,0.0
Headway27,1,0.0
COVID-19Expert,1,0.0
thionicotinamide-adenine,1,0.0
oligoamnios,1,0.0
perfluocarbon,1,0.0
open-chested,1,0.0
greyhounds,1,0.0
Monastryl,1,0.0
10-05,1,0.0
Fluocarbon,1,0.0
rs151091899,1,0.0
Safely,1,0.0
1771,1,0.0
Basin,1,0.0
5·103,1,0.0
n47,1,0.0
3949,1,0.0
2648,1,0.0
departmenthospital,1,0.0
Liposome-aspirin-chitosan,1,0.0
nanoparticle-loaded,1,0.0
assertive,1,0.0
valvar,1,0.0
rhinovirus-C,1,0.0
AEBA,1,0.0
rRT,1,0.0
-PCR,1,0.0
Pre-outbreak,1,0.0
3184,1,0.0
80548,1,0.0
40year,1,0.0
614178,1,0.0
Sadar,1,0.0
Valuka,1,0.0
prescibed,1,0.0
Trishal,1,0.0
Ishhorganj,1,0.0
94644,1,0.0
H3N2ANew,1,0.0
52356,1,0.0
453082,1,0.0
7355,1,0.0
damped,1,0.0
eigenvalue,1,0.0
snap,1,0.0
Intrathecal,1,0.0
anti-cyclic,1,0.0
anti-CCP2,1,0.0
sc-after,1,0.0
0125-065,1,0.0
administration-intrathecal,1,0.0
growth-enhancing,1,0.0
swirling,1,0.0
Endocardial,1,0.0
1977-1984,1,0.0
26-68,1,0.0
endocardial-based,1,0.0
Dimensional,1,0.0
paclitaxel-coated,1,0.0
EGE,1,0.0
PCB,1,0.0
precontrast,1,0.0
Polyethyleneimine,1,0.0
Arg170Cys,1,0.0
2007-2016,1,0.0
nano-composite,1,0.0
extra-allergic,1,0.0
B-related,1,0.0
six-dimensional,1,0.0
sewerage,1,0.0
UV-Vis,1,0.0
subvert,1,0.0
capacitylog,1,0.0
isadrin,1,0.0
stereo,1,0.0
architectonics,1,0.0
neoteric,1,0.0
≤60,1,0.0
non-enrolment,1,0.0
nanotoxicity,1,0.0
nano-drug,1,0.0
nano-biotechnology,1,0.0
Pre-morbid,1,0.0
diagnosistreatment,1,0.0
thins,1,0.0
acids-based,1,0.0
minor-axis,1,0.0
typify,1,0.0
microprocessor-based,1,0.0
institution-based,1,0.0
Measurable,1,0.0
segmentABSTRACT,1,0.0
catabolized,1,0.0
LDH-1,1,0.0
4481,1,0.0
075-09,1,0.0
071-085,1,0.0
alpha-HBDH,1,0.0
unfitting,1,0.0
113137,1,0.0
non-applicability,1,0.0
viably,1,0.0
E119EV,1,0.0
2019-nCoVSARS-CoV-2,1,0.0
auto-end-expiratory,1,0.0
intermittentlyABSTRACT,1,0.0
V119,1,0.0
lipemia-clearing,1,0.0
dicoumarin,1,0.0
acid-specific,1,0.0
4289,1,0.0
1009--mild,1,0.0
self-tests,1,0.0
3005,1,0.0
23-1552,1,0.0
5206--with,1,0.0
803--with,1,0.0
-0277,1,0.0
298--with,1,0.0
0264,1,0.0
5803,1,0.0
1789,1,0.0
7210,1,0.0
6136,1,0.0
demobilization,1,0.0
pituitrin,1,0.0
httpsbitly3sI8e0Y,1,0.0
logPD20,1,0.0
redshifting,1,0.0
Kanazawa,1,0.0
ageConclusionIn,1,0.0
peritraumatic,1,0.0
belching,1,0.0
blurs,1,0.0
Informatic,1,0.0
mRNA-specific,1,0.0
cadherin-related,1,0.0
paperless,1,0.0
RUTA,1,0.0
Triveneto,1,0.0
2015s,1,0.0
sputumThere,1,0.0
recordedOf,1,0.0
COVID-19On,1,0.0
T1–T3,1,0.0
S100A12,1,0.0
A12,1,0.0
±15,1,0.0
DBMS,1,0.0
Oracle,1,0.0
Power-Builder,1,0.0
ECG-derived,1,0.0
neutrophil-platelet,1,0.0
activatorsregulators,1,0.0
Maradi,1,0.0
never-hospitalised,1,0.0
placebo-device,1,0.0
symptomscore,1,0.0
Ang-II,1,0.0
2114,1,0.0
5395,1,0.0
41285395,1,0.0
105-123,1,0.0
7445395,1,0.0
40295395,1,0.0
069-088,1,0.0
1219245,1,0.0
45225395,1,0.0
des-Arg9-bradykinin,1,0.0
amyloid-β,1,0.0
yangming,1,0.0
3623,1,0.0
shaoyang,1,0.0
elbows,1,0.0
BackgroundVeneto,1,0.0
pandemicAimThis,1,0.0
2020MethodsInformation,1,0.0
sex-stratified,1,0.0
non-sedimenting,1,0.0
cleaningdisinfection,1,0.0
calculatedResultsKey,1,0.0
thoroughness,1,0.0
91345,1,0.0
non-insular,1,0.0
steadfastness,1,0.0
httpwwwnhlbinihgovguidelinesasthmaindexhtm,1,0.0
HAinfluenza,1,0.0
ratio04,1,0.0
pro-social,1,0.0
Heberkinase,1,0.0
5-11-year-old,1,0.0
ST2,1,0.0
T-helper-type-2,1,0.0
EBT,1,0.0
nonimmunogenic,1,0.0
TCN-032,1,0.0
rN,1,0.0
rN1,1,0.0
rN2,1,0.0
shattered,1,0.0
rS-RBD,1,0.0
Conservation,1,0.0
9209,1,0.0
419455,1,0.0
benefitsThis,1,0.0
706710,1,0.0
wild-domesticated,1,0.0
Kinshasa,1,0.0
6563,1,0.0
4684,1,0.0
SARS-Cov-2ACE-2,1,0.0
angina--AHT,1,0.0
imaging-to-reperfusion,1,0.0
n61,1,0.0
pro-mandatory,1,0.0
51163,1,0.0
N19,1,0.0
4541,1,0.0
18334541,1,0.0
1634541,1,0.0
164-331,1,0.0
4172,1,0.0
68163,1,0.0
3129,1,0.0
N70,1,0.0
hadintended,1,0.0
N82,1,0.0
HCoV-positive,1,0.0
vaccination-friendly,1,0.0
5313,1,0.0
useable,1,0.0
HCoV-NL63HKU1,1,0.0
69-82,1,0.0
74-115-fold,1,0.0
AUSSR6179,1,0.0
treatability,1,0.0
retire,1,0.0
preventability,1,0.0
polisher,1,0.0
Threfore,1,0.0
1996-2000,1,0.0
SARS-CoV-2ACE-2,1,0.0
multi-real-time,1,0.0
ignites,1,0.0
15year,1,0.0
Host-IAV,1,0.0
mechanism--hemorrhagic,1,0.0
ischemic--and,1,0.0
Loesch,1,0.0
Squirrel,1,0.0
logger,1,0.0
Tigerstedts,1,0.0
0-272,1,0.0
legends,1,0.0
Zeon,1,0.0
ZEEK,1,0.0
frontrunner,1,0.0
basophase,1,0.0
standup,1,0.0
short-falls,1,0.0
self-assess,1,0.0
httpwwwH1N1ResponseCentercom,1,0.0
Skewing,1,0.0
httpwwwFlugov,1,0.0
Off-Site,1,0.0
wash-offs,1,0.0
unadverted,1,0.0
dynpnea,1,0.0
profitable,1,0.0
Gollblatts,1,0.0
Braun,1,0.0
10year,1,0.0
hyperaldosteronism,1,0.0
Ibuprofen,1,0.0
broncholysis,1,0.0
AKITA-device,1,0.0
theAsymptomatic,1,0.0
iNFfection,1,0.0
ARII,1,0.0
Cushman,1,0.0
n-387,1,0.0
n-154,1,0.0
5-13,1,0.0
Ondetti,1,0.0
Conn,1,0.0
puff,1,0.0
0554,1,0.0
0589,1,0.0
Rechstein,1,0.0
Tadeus,1,0.0
-0534,1,0.0
0678,1,0.0
0831,1,0.0
Tait,1,0.0
hazy,1,0.0
Page,1,0.0
Menéndez,1,0.0
reassuranceeducation,1,0.0
entertaining,1,0.0
cases-the,1,0.0
treatment--from,1,0.0
shed-showing,1,0.0
Google-forms,1,0.0
1500-2499,1,0.0
117-873,1,0.0
Vaudois,1,0.0
125-163,1,0.0
Universitaire,1,0.0
123-304,1,0.0
penalised,1,0.0
788-993,1,0.0
CSC-appropriate,1,0.0
727-995,1,0.0
13106,1,0.0
exercise-centred,1,0.0
ARB-treated,1,0.0
16103,1,0.0
bite-sized,1,0.0
29209,1,0.0
chunks,1,0.0
cryptogenetic,1,0.0
atrioseptal,1,0.0
111116,1,0.0
378100,1,0.0
stimulus-dependent,1,0.0
consequences--must,1,0.0
units-the,1,0.0
FDA-USA,1,0.0
ideals,1,0.0
intrapersonal,1,0.0
Recall,1,0.0
LDFR,1,0.0
-90,1,0.0
3D-BHCA,1,0.0
glucose-based,1,0.0
Mouthwash,1,0.0
Aimsintroduction,1,0.0
300-394,1,0.0
BSSR,1,0.0
4093,1,0.0
non-controllable,1,0.0
arm-hand,1,0.0
highest-priority,1,0.0
9387,1,0.0
gaming,1,0.0
tooth-brushing,1,0.0
RNAml,1,0.0
16×,1,0.0
venodilator,1,0.0
leak-resistant,1,0.0
brain-tickling,1,0.0
eatingdrinking,1,0.0
Bloodwork,1,0.0
abstruse,1,0.0
28100,1,0.0
dialyses,1,0.0
Médicale,1,0.0
00433,1,0.0
22338,1,0.0
3432,1,0.0
2413,1,0.0
Repeat-tested,1,0.0
infarctedhealthy,1,0.0
mmolKg,1,0.0
Magniscan,1,0.0
Gadolinium-DOTA,1,0.0
repeat-tested,1,0.0
single-tested,1,0.0
GPRC-NL,1,0.0
organ-supportive,1,0.0
single-test,1,0.0
Probes,1,0.0
machinal,1,0.0
-032,1,0.0
NPSsputum,1,0.0
Leconte,1,0.0
CHCSJ,1,0.0
Presse,1,0.0
Januário,1,0.0
Conde,1,0.0
Hospitalar,1,0.0
Ian,1,0.0
safetyefficacy,1,0.0
27377,1,0.0
equalizeABSTRACT,1,0.0
RevascularIZatiON,1,0.0
near-total,1,0.0
internalizes,1,0.0
electroshocks,1,0.0
inferolaterally,1,0.0
Beckman-Coulter,1,0.0
Low-pathogenic,1,0.0
hamagglutinins,1,0.0
stereochemical,1,0.0
manking,1,0.0
asubstitution,1,0.0
stimulus-event,1,0.0
psychosomatics,1,0.0
enables--through,1,0.0
infacrtion,1,0.0
logico-mathematical,1,0.0
micro-computed,1,0.0
extra-parenchymal,1,0.0
tumor-free,1,0.0
emotional-behavioral,1,0.0
recovery-rehabilitation,1,0.0
referral-to-hospital,1,0.0
right-,1,0.0
ptiO2laser,1,0.0
iodo14Cantipyrine,1,0.0
13-month,1,0.0
that-compared,1,0.0
Chiba,1,0.0
97-4053,1,0.0
platypnea-orthodeoxia,1,0.0
Matrix-M™,1,0.0
NVX-CoV2327,1,0.0
GARD,1,0.0
AIRWAYS,1,0.0
MeDALL,1,0.0
Facemasks,1,0.0
6464,1,0.0
mid-diastolic,1,0.0
5901-7028,1,0.0
4989-6154,1,0.0
6071,1,0.0
5498-6645,1,0.0
pacemapping,1,0.0
61-years-old,1,0.0
IgGNo,1,0.0
3080,1,0.0
1832,1,0.0
2268,1,0.0
anti-pathogenetic,1,0.0
lying-down,1,0.0
100-149,1,0.0
standing-up,1,0.0
109-601,1,0.0
Hyperthermia,1,0.0
age-brackets,1,0.0
Cynomolgus,1,0.0
152000,1,0.0
48-year,1,0.0
Iscoms,1,0.0
lancinating,1,0.0
Spino-,1,0.0
trigemino-thalamic,1,0.0
paleo-reticulothalamic,1,0.0
P000001,1,0.0
Bliss,1,0.0
124-39,1,0.0
1968-type,1,0.0
macroembolization,1,0.0
X-sizer,1,0.0
Projections,1,0.0
Mallinckrodt,1,0.0
perimyocarditis,1,0.0
insulinIGF-1,1,0.0
immuno-triaging,1,0.0
Morton,1,0.0
DEMMI,1,0.0
FACS-purified,1,0.0
VEGF-expressing,1,0.0
nude,1,0.0
multi-projection,1,0.0
FACS-based,1,0.0
biomedically,1,0.0
verbiage,1,0.0
Sangerwini,1,0.0
apprehensions,1,0.0
hypalgesic,1,0.0
unseparable,1,0.0
immunoallergologic,1,0.0
Benteng,1,0.0
Lahad,1,0.0
erithro,1,0.0
Octubre,1,0.0
Quirúrgico,1,0.0
Clínico,1,0.0
GRAVID,1,0.0
E164G,1,0.0
Datu,1,0.0
Kedahs,1,0.0
Tembok,1,0.0
CGS,1,0.0
soar,1,0.0
aVR-STE,1,0.0
challengers,1,0.0
liners,1,0.0
Non-communicable,1,0.0
tabling,1,0.0
responderhealthcare,1,0.0
Cardiac-gated,1,0.0
parliament,1,0.0
recommended-as-essential,1,0.0
httpwwwnhlbinihgovhealthproflungasthmapractgdehtm,1,0.0
humanitarianism,1,0.0
2020The,1,0.0
re-strategize,1,0.0
169379,1,0.0
predictive-value,1,0.0
Jammu,1,0.0
color-coding,1,0.0
liothyronine,1,0.0
Post-thoracotomy,1,0.0
22-25,1,0.0
Neuropathic,1,0.0
B0765,1,0.0
murine-adapted,1,0.0
P0036,1,0.0
B3738,1,0.0
3666,1,0.0
18-09,1,0.0
3294,1,0.0
24-1,1,0.0
thrombelastography,1,0.0
IV-induced,1,0.0
equilibrating,1,0.0
thrusting,1,0.0
1114632,1,0.0
162616,1,0.0
161-578,1,0.0
resident-seasons,1,0.0
entangling,1,0.0
zeroes,1,0.0
Curriers,1,0.0
21-d,1,0.0
calibrating,1,0.0
QSRchildren,1,0.0
adenocarcinomas,1,0.0
IADCs,1,0.0
2106,1,0.0
AtriClipTM,1,0.0
guide-lines,1,0.0
psychodiagnostical,1,0.0
diseaseExpert,1,0.0
T1c,1,0.0
therapyAreas,1,0.0
P0962,1,0.0
vaccinationThe,1,0.0
Polls,1,0.0
T2a,1,0.0
developedan,1,0.0
theRobert,1,0.0
P0364,1,0.0
1229-2665,1,0.0
0500,1,0.0
0439,1,0.0
Cavitary,1,0.0
WHORegional,1,0.0
challengesusing,1,0.0
evergreen,1,0.0
inflammaging,1,0.0
Flanagans,1,0.0
1953-1980,1,0.0
AtriCure,1,0.0
Mason,1,0.0
un-vaccinated,1,0.0
implementationcompliance,1,0.0
rebounds,1,0.0
casesExpert,1,0.0
Peer-reviewed,1,0.0
frustrated,1,0.0
ofSARS-CoV-2,1,0.0
careAreas,1,0.0
three-parameter,1,0.0
IPMs,1,0.0
IVT-mediated,1,0.0
Panchgani,1,0.0
Disembarked,1,0.0
first-admission,1,0.0
H1N1pdm09-related,1,0.0
Stimulus-response,1,0.0
476521,1,0.0
identity-based,1,0.0
1-83,1,0.0
53109257,1,0.0
sentinel-based,1,0.0
forgot,1,0.0
OPV,1,0.0
slurring,1,0.0
post-clip,1,0.0
QOLS,1,0.0
middle-high,1,0.0
stage10-120,1,0.0
strategies-enhanced,1,0.0
289650,1,0.0
188202,1,0.0
14202,1,0.0
174289,1,0.0
88289,1,0.0
27289,1,0.0
52nd,1,0.0
natures,1,0.0
10th-13th,1,0.0
repopulate,1,0.0
physiologyinstability,1,0.0
RdRps,1,0.0
time-profile,1,0.0
model-derived,1,0.0
122811,1,0.0
SOAR,1,0.0
26479,1,0.0
135067-156603,1,0.0
prestrike,1,0.0
pre-cerebral,1,0.0
145834,1,0.0
CI601518-644991,1,0.0
4M,1,0.0
623248,1,0.0
diseaseA,1,0.0
202641,1,0.0
1980-1982,1,0.0
Virocult®,1,0.0
Nothwithstanding,1,0.0
pathophysiologyNEW,1,0.0
Contour,1,0.0
19q13,1,0.0
exportation,1,0.0
13q31,1,0.0
1p31,1,0.0
logos,1,0.0
reinvigorating,1,0.0
182104,1,0.0
analogizing,1,0.0
antithrombogenic,1,0.0
dwellings,1,0.0
Edirne,1,0.0
enalaprilhydrochlorothiazide,1,0.0
nullify,1,0.0
small-scattered,1,0.0
full-pressure,1,0.0
77-year,1,0.0
46-51,1,0.0
pressure-limiting,1,0.0
resultsin,1,0.0
costaffordability,1,0.0
Izmir,1,0.0
Perm,1,0.0
33226,1,0.0
9616,1,0.0
54369,1,0.0
biogenetically,1,0.0
28-197,1,0.0
P0114,1,0.0
locationshotspots,1,0.0
156-796,1,0.0
n410,1,0.0
n402,1,0.0
SCAI,1,0.0
delayscomplicates,1,0.0
190000,1,0.0
2024-will,1,0.0
conferences-The,1,0.0
Tank,1,0.0
awards,1,0.0
Ralph,1,0.0
Award,1,0.0
reviewWe,1,0.0
market-led,1,0.0
treatment-specific,1,0.0
Kenton,1,0.0
lecturing,1,0.0
lidocain,1,0.0
unapologetically,1,0.0
Technologically,1,0.0
AIMs,1,0.0
Pre-Columbian,1,0.0
mial,1,0.0
349-842,1,0.0
astmathics,1,0.0
Illness-Like,1,0.0
v-miRNA-based,1,0.0
SR-center,1,0.0
synthetic-mimic,1,0.0
three-point,1,0.0
v-miRNA-N-28612,1,0.0
v-miRNA-N,1,0.0
point-score,1,0.0
non-psychologic,1,0.0
9527,1,0.0
MLSS,1,0.0
3617±1094,1,0.0
9599,1,0.0
76-92,1,0.0
2977,1,0.0
Balearic,1,0.0
3893,1,0.0
Pardridge,1,0.0
Interdepartmental,1,0.0
Lag,1,0.0
Ba-Omer,1,0.0
Requirements,1,0.0
bonfire,1,0.0
crab-induced,1,0.0
molluscs,1,0.0
re-consider,1,0.0
ethnography,1,0.0
Russel,1,0.0
Raceethnic,1,0.0
Hirsch,1,0.0
managementadministrative,1,0.0
29-710,1,0.0
medicaldental,1,0.0
nonindustrial,1,0.0
Irritant,1,0.0
TxA2,1,0.0
LTCF-residents,1,0.0
HSE,1,0.0
Executive-Health,1,0.0
well-predetermined,1,0.0
S1A,1,0.0
Adaltis,1,0.0
fuser,1,0.0
MOLgen-COVID-19,1,0.0
logics,1,0.0
β-actin,1,0.0
N-and,1,0.0
thrombotic-type,1,0.0
finalists,1,0.0
runners-up,1,0.0
genes-RNA-dependent,1,0.0
spares,1,0.0
myolysis,1,0.0
peptidergic,1,0.0
apical-septal,1,0.0
Orebro,1,0.0
punctured,1,0.0
polypharmacological,1,0.0
Cine-MRI,1,0.0
Hardware,1,0.0
Would,1,0.0
GARFIELD-AF,1,0.0
stall,1,0.0
P045,1,0.0
1285±38y,1,0.0
so-far,1,0.0
Chemography,1,0.0
human-readable,1,0.0
speciesgenera,1,0.0
36mm3,1,0.0
anti-aggregating,1,0.0
chemotypes,1,0.0
200030,1,0.0
aerosol-derived,1,0.0
-conducted,1,0.0
cine-angiography,1,0.0
counter-pressure,1,0.0
mid-and,1,0.0
TRTE,1,0.0
antiviral-sensitive,1,0.0
non-embryo,1,0.0
Sternotomy,1,0.0
Gastro-liver,1,0.0
HF-center,1,0.0
Distortion,1,0.0
35-47,1,0.0
433-4,1,0.0
2391505,1,0.0
Thachil1,1,0.0
coagulation‐fibrinolysis,1,0.0
11911505,1,0.0
neuro-inflammatory,1,0.0
Unmitigated,1,0.0
Pentraxin-3,1,0.0
Broncho‐alveolar,1,0.0
R5Hz,1,0.0
C-SCD,1,0.0
D‐dimers,1,0.0
Nonvascular,1,0.0
Vectocardiographic,1,0.0
MAIN,1,0.0
INFLUENZA,1,0.0
vectocardiogram,1,0.0
18-67,1,0.0
13-34,1,0.0
SURVEILLANCE,1,0.0
LondonEpidemiological,1,0.0
etcThe,1,0.0
Kong572Whenever,1,0.0
25-47,1,0.0
30-52,1,0.0
CCL24,1,0.0
8191505,1,0.0
CCL11,1,0.0
cestodiases,1,0.0
microstoma,1,0.0
non-HA,1,0.0
3594,1,0.0
Taenia,1,0.0
3864,1,0.0
saginata,1,0.0
3959,1,0.0
corti,1,0.0
lineatus,1,0.0
diagnostics-molecular,1,0.0
mesocestoidiasis,1,0.0
Population-scale,1,0.0
CHCI,1,0.0
07-32,1,0.0
Brompton,1,0.0
Harefield,1,0.0
otherâ€™s,1,0.0
Hub,1,0.0
Rivera,1,0.0
childhood-adolescence,1,0.0
non-querying,1,0.0
old-and,1,0.0
SRR,1,0.0
Inter-group,1,0.0
64-75,1,0.0
neuro-cardiac,1,0.0
non-ISC,1,0.0
42-61,1,0.0
77ABSTRACT,1,0.0
hantaviruses,1,0.0
hibernoma,1,0.0
perirenal,1,0.0
21±20,1,0.0
12±15,1,0.0
periaortic,1,0.0
Hibernomas,1,0.0
Slurring,1,0.0
antibody-testing,1,0.0
19±16,1,0.0
18±16,1,0.0
P032,1,0.0
side-to-side,1,0.0
studentfamily,1,0.0
R0422,1,0.0
prize,1,0.0
Edaravone,1,0.0
polydimethysiloxane-tetraethoxysilane,1,0.0
R0241,1,0.0
R0110,1,0.0
R0363,1,0.0
wash-in,1,0.0
FXII,1,0.0
Holy,1,0.0
Express-6,1,0.0
RdRphelicase,1,0.0
RdRp-P2-negative,1,0.0
Echo-CG,1,0.0
Otolaryngic,1,0.0
23-43,1,0.0
61841000,1,0.0
polymerizing,1,0.0
toxic-irritative,1,0.0
14-26,1,0.0
Geniposide,1,0.0
5829,1,0.0
iridoid,1,0.0
adequite,1,0.0
radioventriculography,1,0.0
fields--typical,1,0.0
119273,1,0.0
typingsubtyping,1,0.0
Gardenia,1,0.0
Russian-backbone,1,0.0
46723,1,0.0
13153,1,0.0
jasminoides,1,0.0
Ellis,1,0.0
Certainly,1,0.0
05-08100000,1,0.0
29120,1,0.0
77273,1,0.0
neuroendocrinology,1,0.0
bespeak,1,0.0
multilocularis,1,0.0
Kong2289-,1,0.0
410-411,1,0.0
430-438,1,0.0
BPAT,1,0.0
hard-copy,1,0.0
asthma-relieving,1,0.0
1734,1,0.0
health-care-related,1,0.0
Studies-2,1,0.0
5276565,1,0.0
itch,1,0.0
honeybee-collected,1,0.0
fungicidal,1,0.0
1-time,1,0.0
gene-editing,1,0.0
3297,1,0.0
birthweights,1,0.0
Chicagos,1,0.0
Mistiming,1,0.0
Atemwegsliga,1,0.0
TREATMENT,1,0.0
north-to-south,1,0.0
GUIDELINES,1,0.0
3121,1,0.0
dysbalanced,1,0.0
4461000,1,0.0
ICD-codes,1,0.0
year-long,1,0.0
105-157,1,0.0
school-children,1,0.0
CI46,1,0.0
Y-Chromosome,1,0.0
846-56,1,0.0
232-260,1,0.0
1x106,1,0.0
81-101,1,0.0
Post-training,1,0.0
2806,1,0.0
2242,1,0.0
swam,1,0.0
multivitamins,1,0.0
WPT,1,0.0
PR129,1,0.0
50-dimensional,1,0.0
LFT,1,0.0
200-300,1,0.0
Tarragona,1,0.0
n2672,1,0.0
n2524,1,0.0
synchronic,1,0.0
Alum-adjuvanted,1,0.0
PR149,1,0.0
orthetics,1,0.0
106-209,1,0.0
Kong2289,1,0.0
Draft,1,0.0
phospho-AMPK,1,0.0
avail,1,0.0
hospital-admitted,1,0.0
psycho-vegetative,1,0.0
Olson,1,0.0
Tc-99m-stannous,1,0.0
Achenbach,1,0.0
Peri-procedural,1,0.0
kinase-B,1,0.0
eubiosis,1,0.0
2minm2,1,0.0
1986871,1,0.0
Beclin1,1,0.0
4162,1,0.0
HbSC,1,0.0
Post-intervention,1,0.0
P≤0005,1,0.0
P≤0008,1,0.0
Sbeta,1,0.0
P≤0002,1,0.0
E-cigarette,1,0.0
69264,1,0.0
vaped,1,0.0
069-125,1,0.0
HbSbetao,1,0.0
3425,1,0.0
049-092,1,0.0
induced‐pancreatic,1,0.0
amalgamate,1,0.0
educational-scientific,1,0.0
less-effective,1,0.0
Photonics,1,0.0
anti-cholinergics,1,0.0
Heliox-driven,1,0.0
1--21,1,0.0
overseen,1,0.0
7950,1,0.0
immunosuppresive,1,0.0
amantadine-sensitive,1,0.0
-sensitive,1,0.0
WReN,1,0.0
OTR,1,0.0
asthma-attributed,1,0.0
recovery1,1,0.0
nedd,1,0.0
inaugurate,1,0.0
nonhomeless,1,0.0
credentialed,1,0.0
polarization-sensitive,1,0.0
5-84,1,0.0
asthmatic-type,1,0.0
stroke4-6,1,0.0
mortality34,1,0.0
finger-like,1,0.0
phenomenon2,1,0.0
endotypesphenotypes,1,0.0
phospho-ACC,1,0.0
inflences,1,0.0
population-dynamic,1,0.0
6666,1,0.0
0940,1,0.0
Panting,1,0.0
prep,1,0.0
-01,1,0.0
SARS-CoV-2England22020,1,0.0
intraschool,1,0.0
09-11,1,0.0
pricks,1,0.0
NCT02301299,1,0.0
EVICURE,1,0.0
21441,1,0.0
28832,1,0.0
health-led,1,0.0
Artania,1,0.0
risk--as,1,0.0
cost--of,1,0.0
Subtherapeutic,1,0.0
out-of-range,1,0.0
Recife,1,0.0
nonmislabelers,1,0.0
mislabelers,1,0.0
susceptible-exposed-infected-recovery,1,0.0
air-based,1,0.0
nonairways,1,0.0
Jak2-STAT3,1,0.0
H5N1-derived,1,0.0
2666,1,0.0
4-tert-butyliminomethyl,1,0.0
114-162,1,0.0
117-126,1,0.0
migraine-sufferer,1,0.0
023-086,1,0.0
novelBetacoronavirus,1,0.0
clamps,1,0.0
Watchman-FLX,1,0.0
Th1-mediated,1,0.0
posterior-lateral,1,0.0
extraparanchymal,1,0.0
destructing,1,0.0
benzene-13-disulfonate,1,0.0
8986,1,0.0
disufenton,1,0.0
rH5,1,0.0
study-I,1,0.0
sublaminal,1,0.0
Dubrovnik,1,0.0
8785,1,0.0
submicrogram,1,0.0
5715,1,0.0
4285,1,0.0
best-in-class,1,0.0
glucopyranosyl,1,0.0
pre-schoolchildren,1,0.0
Mislabeling,1,0.0
ETUS,1,0.0
SARS-CoV-2-3CLpro,1,0.0
Aspirin-exacerbated,1,0.0
AERD,1,0.0
state-of-arts,1,0.0
leadless,1,0.0
decrementally,1,0.0
∼22-31,1,0.0
2007-2013,1,0.0
hypercoagulant,1,0.0
ligand-specific,1,0.0
payload,1,0.0
endocervical,1,0.0
nanospheres,1,0.0
cytoreduction,1,0.0
frontal-temporal-parietal,1,0.0
44-years-old,1,0.0
70020,1,0.0
four-degree,1,0.0
five-degree,1,0.0
26150,1,0.0
8151,1,0.0
control-guided,1,0.0
036-28,1,0.0
08-125,1,0.0
controL,1,0.0
PC20--the,1,0.0
oro-nasal,1,0.0
Forests,1,0.0
103-310,1,0.0
3031,1,0.0
SARS-CoV-2-cysteine-like,1,0.0
ethnomedicinal,1,0.0
neurotization,1,0.0
Calcium-activated,1,0.0
52195,1,0.0
248250,1,0.0
meridian-collateral,1,0.0
WANG,1,0.0
Juyiand,1,0.0
247250,1,0.0
GCVFthermodilution,1,0.0
UK2,1,0.0
111-390,1,0.0
U90,1,0.0
3131,1,0.0
hyperadrenergic,1,0.0
sympatholytic,1,0.0
3133,1,0.0
kidney-tissue,1,0.0
idenitfy,1,0.0
provider-collected,1,0.0
swamped,1,0.0
32-223,1,0.0
126-321,1,0.0
Hymenolepis,1,0.0
cestodes,1,0.0
heatwave,1,0.0
événement,1,0.0
générale,1,0.0
intervenants,1,0.0
1984-1994,1,0.0
Complement-fixing,1,0.0
SSE,1,0.0
tant,1,0.0
RSE,1,0.0
risque,1,0.0
long-terme,1,0.0
conséquences,1,0.0
SSE674200,1,0.0
RSE1069,1,0.0
durables,1,0.0
MAD707,1,0.0
ARE247,1,0.0
psychiatriques,1,0.0
GM11-10463,1,0.0
développer,1,0.0
G45,1,0.0
probabilité,1,0.0
I61,1,0.0
reliés,1,0.0
20740,1,0.0
∼USD,1,0.0
Haemorrheological,1,0.0
Notre,1,0.0
2006-2010,1,0.0
relevé,1,0.0
portent,1,0.0
preovulatory,1,0.0
faille,1,0.0
BNT162b2-mediated,1,0.0
qu’il,1,0.0
proposons,1,0.0
rayon,1,0.0
d’une,1,0.0
porte,1,0.0
aucune,1,0.0
phenolguanidine-based,1,0.0
précisément,1,0.0
SARS-CoV-2-particularly,1,0.0
mensuel,1,0.0
croissance,1,0.0
révèle,1,0.0
juillet,1,0.0
janvier,1,0.0
entre,1,0.0
clinical-demographic,1,0.0
care-process,1,0.0
acute-stroke-phase,1,0.0
sommeilinsomnie,1,0.0
scientifiques,1,0.0
NOAF,1,0.0
traumatique,1,0.0
après,1,0.0
difficultés,1,0.0
temps,1,0.0
pMCA,1,0.0
steroid-inhaling,1,0.0
mean-sd,1,0.0
133-148,1,0.0
021-030,1,0.0
H-subtyped,1,0.0
ike-illness,1,0.0
5-30,1,0.0
RNA-cDNA,1,0.0
crRNA-Cas12a,1,0.0
Cl3Cr,1,0.0
cells-virus-Cl3Cr,1,0.0
H-anti-H,1,0.0
haemolyse,1,0.0
haemolysed,1,0.0
hybridized,1,0.0
phosphorylase-BB,1,0.0
angry,1,0.0
Hermann,1,0.0
DenseNet201,1,0.0
VGG16,1,0.0
ResNet152V2,1,0.0
rapid-prototyped,1,0.0
inflowoutflow,1,0.0
InceptionResNetV2,1,0.0
Racal,1,0.0
SER,1,0.0
Airstream,1,0.0
tragédies,1,0.0
peu,1,0.0
durant,1,0.0
deformability,1,0.0
Haematocrit,1,0.0
survenant,1,0.0
problèmes,1,0.0
prouvent,1,0.0
passées,1,0.0
Them,1,0.0
Nuremberg,1,0.0
WHOCIOMS,1,0.0
backsliding,1,0.0
RdRp-based,1,0.0
lors,1,0.0
AICAO,1,0.0
recueillies,1,0.0
données,1,0.0
little-known,1,0.0
Portuguese-language,1,0.0
Intra-individual,1,0.0
stentriever-based,1,0.0
turnout,1,0.0
Lahore,1,0.0
2628,1,0.0
agir,1,0.0
frequency-dependent,1,0.0
housings,1,0.0
R158G,1,0.0
2Yam-2-derived,1,0.0
inter-clade,1,0.0
Disease-,1,0.0
3Yam-3,1,0.0
leaner,1,0.0
aspartateaminotransferase,1,0.0
AY1,1,0.0
190-580,1,0.0
B161721,1,0.0
Sankey,1,0.0
201-758,1,0.0
140-299,1,0.0
lipoprotein-cholesterolcholesterol,1,0.0
sequence-acquisition,1,0.0
046-096,1,0.0
113-124,1,0.0
Signature,1,0.0
cigarettesd,1,0.0
124-267,1,0.0
V70F,1,0.0
116-195,1,0.0
subarrachnoid,1,0.0
W258L,1,0.0
A1146T,1,0.0
mid-density,1,0.0
Yam-3-derived,1,0.0
vaccinovigilance,1,0.0
1Vic-1,1,0.0
China-three-stage,1,0.0
1959-2009,1,0.0
Year-to-year,1,0.0
arcs,1,0.0
Prominence,1,0.0
monosensitized,1,0.0
boot,1,0.0
betalactam,1,0.0
anti-inflamatory,1,0.0
analgo-antipyretics,1,0.0
commercialised,1,0.0
Actigraph,1,0.0
46-86,1,0.0
Vic-1B,1,0.0
GT3X,1,0.0
Actical,1,0.0
pedometer,1,0.0
non-plegic,1,0.0
design-adjusted,1,0.0
Guilan,1,0.0
megacities,1,0.0
Vic-1A,1,0.0
Vic-1C,1,0.0
092-240,1,0.0
112-289,1,0.0
9-Plex,1,0.0
single-plex,1,0.0
cette,1,0.0
sidechain,1,0.0
traitement,1,0.0
ST-recovery,1,0.0
ST-trend,1,0.0
Subgrouped,1,0.0
respectively--time,1,0.0
reelevationrecovery,1,0.0
sa,1,0.0
l’insomnie,1,0.0
prévention,1,0.0
nécessaires,1,0.0
outils,1,0.0
hyperexcitable,1,0.0
d’autant,1,0.0
Stentys,1,0.0
terme,1,0.0
predilatation,1,0.0
individuel,1,0.0
psychologique,1,0.0
l’équilibre,1,0.0
sixth-month,1,0.0
Multi-frequency,1,0.0
protéger,1,0.0
afin,1,0.0
période,1,0.0
frequency-difference,1,0.0
portée,1,0.0
self-referenced,1,0.0
mutation-induced,1,0.0
41021-patient,1,0.0
28-year,1,0.0
8-Plex,1,0.0
20-Plex,1,0.0
prick-tests,1,0.0
dsease,1,0.0
ways—from,1,0.0
60nt,1,0.0
KUl,1,0.0
echo-LVH,1,0.0
IFN-modifying,1,0.0
interventive,1,0.0
briefed,1,0.0
HSP90,1,0.0
anti-cancers,1,0.0
drugvirus,1,0.0
PxxPxKR,1,0.0
122-127,1,0.0
90-beta,1,0.0
nondrinking,1,0.0
4098,1,0.0
10754,1,0.0
professionnels,1,0.0
tous,1,0.0
BNS1-HSP90β,1,0.0
16-21,1,0.0
etiopathogenetyc,1,0.0
ISIRV,1,0.0
v-NY-S,1,0.0
‘overshadowed’,1,0.0
blacksCaribbean,1,0.0
antibiotic-treated,1,0.0
IRAK4,1,0.0
TRAF6,1,0.0
asthma-especially,1,0.0
‘Spanish’,1,0.0
factors--ie,1,0.0
ischemia-associated,1,0.0
SNR,1,0.0
ao--influence,1,0.0
warranty,1,0.0
availably,1,0.0
pathogen-agnostic,1,0.0
182191,1,0.0
ASsessment,1,0.0
ANT6068-like,1,0.0
amyliodosis,1,0.0
456518,1,0.0
ASingapore157,1,0.0
≈69,1,0.0
byA,1,0.0
evolutionarypopulation-genetic,1,0.0
BWGIC,1,0.0
BIWAC,1,0.0
historiographical,1,0.0
Respimat,1,0.0
practitioner-friendly,1,0.0
Playne,1,0.0
deductions,1,0.0
plague-like,1,0.0
policing,1,0.0
war-weariness,1,0.0
morale,1,0.0
Naive,1,0.0
mRNA-immunized,1,0.0
‘dread’,1,0.0
politicisation,1,0.0
BavPat1,1,0.0
Mail,1,0.0
20-community,1,0.0
JSA,1,0.0
theoretically-based,1,0.0
systolic-diastolic,1,0.0
hemorhagic,1,0.0
Novo,1,0.0
Nordisk,1,0.0
NNF20SA0062874,1,0.0
TRIAL,1,0.0
Wilfred,1,0.0
LACUSC,1,0.0
biopolitical,1,0.0
‘forgotten’,1,0.0
1871,1,0.0
MVA-S,1,0.0
subverted,1,0.0
hemispheral,1,0.0
Human-disease,1,0.0
likely--massive,1,0.0
pathologicoanatomic,1,0.0
formulize,1,0.0
cabsence,1,0.0
aproblems,1,0.0
ddenial,1,0.0
self-amplification,1,0.0
fantasy,1,0.0
pathogen-negative,1,0.0
plasmaserum,1,0.0
noninbred,1,0.0
Lucca,1,0.0
infantspreschoolers,1,0.0
gavaged,1,0.0
acephalic,1,0.0
tapeworm,1,0.0
pinnatifida-derived,1,0.0
sequencing-phylogenetic,1,0.0
Undaria,1,0.0
Fucoidans,1,0.0
abdominal-acupuncture,1,0.0
PCR-amplified,1,0.0
body-acupuncture,1,0.0
scalp-acupuncture,1,0.0
high--46,1,0.0
ARCOS-IV,1,0.0
14-40,1,0.0
1984-1991,1,0.0
Webster,1,0.0
Diane,1,0.0
Hulse,1,0.0
TH1-biased,1,0.0
growth-restricted,1,0.0
VACV,1,0.0
Vaccinia,1,0.0
Lumenwall,1,0.0
contradictories,1,0.0
6000000,1,0.0
w6,1,0.0
Counties,1,0.0
influenza-virus-associated,1,0.0
Idiosyncratic,1,0.0
Monaldi,1,0.0
UTSIR,1,0.0
Subintensive,1,0.0
photo,1,0.0
underpressures,1,0.0
Coated-platelets,1,0.0
9-day,1,0.0
Coated-platelet,1,0.0
cimetidine-,1,0.0
Salvadorian,1,0.0
constructional,1,0.0
Owen’s,1,0.0
vagal-sympathetic,1,0.0
81-100,1,0.0
noradrenal,1,0.0
weight-bearing,1,0.0
re-parameterised,1,0.0
age-stratification,1,0.0
Romberg,1,0.0
ICMN,1,0.0
Infusions,1,0.0
58050,1,0.0
droplet-borne,1,0.0
hostpathogen,1,0.0
immunevirus,1,0.0
5848X-2362,1,0.0
0825,1,0.0
prereferral,1,0.0
pro-competition,1,0.0
Herfindahl-Hirschman,1,0.0
98061,1,0.0
School-B,1,0.0
Notch1,1,0.0
SASU,1,0.0
40-77,1,0.0
65-81,1,0.0
83-100,1,0.0
School-A,1,0.0
alcohol-stroke,1,0.0
bloom,1,0.0
-093,1,0.0
gallops,1,0.0
cross-complementing,1,0.0
Neurotrophins,1,0.0
177-983,1,0.0
GlnGln,1,0.0
124-543,1,0.0
ArgGln,1,0.0
112-313,1,0.0
ArgTrp,1,0.0
chrysogenum,1,0.0
106-366,1,0.0
Arg399Gln,1,0.0
Arg194Trp,1,0.0
PCE-induced,1,0.0
phonocardiographically,1,0.0
3-yr,1,0.0
SR-theophylline,1,0.0
all-hazards,1,0.0
PCE-exposed,1,0.0
mold-induced,1,0.0
kmph,1,0.0
reporducibility,1,0.0
guidances,1,0.0
Dd,1,0.0
cardiogenick,1,0.0
7th--10th,1,0.0
VPP,1,0.0
PU5-18,1,0.0
skills--results,1,0.0
022-096,1,0.0
uniaxially,1,0.0
athymic,1,0.0
perfusable,1,0.0
Presumed,1,0.0
prescriptionsfor,1,0.0
transmitter,1,0.0
Confinement,1,0.0
intensivecare,1,0.0
periextubation,1,0.0
Srl,1,0.0
openable,1,0.0
EAT,1,0.0
cautery,1,0.0
httpsyoutubegPkCi27tWo,1,0.0
Postpneumonectomy,1,0.0
layer--as,1,0.0
Coronavirus-,1,0.0
hydrofluoroalkanes--which,1,0.0
yet-to-be-identified,1,0.0
press’s,1,0.0
processes--goal,1,0.0
self-efficacy--that,1,0.0
Operant,1,0.0
imaginative,1,0.0
factors--unknown,1,0.0
dual-prong,1,0.0
mechanically-constrained,1,0.0
Cell-induced,1,0.0
non-producing,1,0.0
020-097,1,0.0
616-81,1,0.0
014-074,1,0.0
EUROIMMUN®,1,0.0
032-079,1,0.0
Abbott®,1,0.0
Vircell®,1,0.0
CMIAs,1,0.0
030-079,1,0.0
leaderboards,1,0.0
Workshops,1,0.0
PIPDeploys,1,0.0
co-entrapment,1,0.0
022-063,1,0.0
pre-vascularized,1,0.0
1577,1,0.0
1727,1,0.0
Mixed-effects,1,0.0
Patches,1,0.0
2010-2016,1,0.0
nontropical,1,0.0
G2964A,1,0.0
Takahashi,1,0.0
sample-to-assay,1,0.0
Z-scores,1,0.0
Reminding,1,0.0
Sialylated,1,0.0
Z-27321,1,0.0
10160,1,0.0
105-369,1,0.0
42277,1,0.0
10167,1,0.0
covariablesResults,1,0.0
132-535,1,0.0
281-623,1,0.0
180430,1,0.0
001Conclusions,1,0.0
NCT00794885,1,0.0
cystathionine-gamma-,1,0.0
lyase,1,0.0
410-688,1,0.0
cystathionine-beta-synthase,1,0.0
396779,1,0.0
self-consistency,1,0.0
06-37,1,0.0
50-year,1,0.0
fixation-off,1,0.0
scotosensitivity,1,0.0
n90187,1,0.0
work-day,1,0.0
8318,1,0.0
58250,1,0.0
Z-24431,1,0.0
000-58,1,0.0
162min,1,0.0
TOCA,1,0.0
244-467,1,0.0
-challenged,1,0.0
every\year,1,0.0
46-month,1,0.0
door-in-door-out,1,0.0
response-curves,1,0.0
Equivocally,1,0.0
Pretherapeutic,1,0.0
11-12-year-old,1,0.0
ratio203,1,0.0
1x,1,0.0
ten-day,1,0.0
-48,1,0.0
STEMI-like,1,0.0
provider-patient,1,0.0
OR438,1,0.0
DWIMRA,1,0.0
4689,1,0.0
HPLCmass,1,0.0
congenita,1,0.0
Dyskeratosis,1,0.0
concentrationsDesign,1,0.0
D3N4,1,0.0
Idévac,1,0.0
20327,1,0.0
876-1000,1,0.0
sanification,1,0.0
retrovirus-mediated,1,0.0
sample-2347,1,0.0
cGMP-certified,1,0.0
skipping,1,0.0
forwent,1,0.0
CBCR,1,0.0
Clearer,1,0.0
contraction-excitation,1,0.0
nonrefundable,1,0.0
rhinoscopy,1,0.0
5-22,1,0.0
CAD-induced,1,0.0
lysophosphatidylcholine,1,0.0
nulligravid,1,0.0
anovulatory,1,0.0
bloating,1,0.0
colpotomy,1,0.0
cul-de-sac,1,0.0
study--far,1,0.0
Conflicts,1,0.0
5-hydroxytriptamine,1,0.0
transvaginal,1,0.0
Thrombospondin-1,1,0.0
biologically-based,1,0.0
morning-PEF,1,0.0
FM15-1There,1,0.0
asthma817,1,0.0
γ-glutamyl-carnosine,1,0.0
isopeptide,1,0.0
Intradiaphragmatic,1,0.0
inventory-based,1,0.0
sample-155,1,0.0
ST-presentation,1,0.0
sample-802,1,0.0
60-138,1,0.0
moreABSTRACT,1,0.0
holdings,1,0.0
Polymerized,1,0.0
decontaminating,1,0.0
JGL2003,1,0.0
soiling,1,0.0
07-161,1,0.0
PIB,1,0.0
carnosinase,1,0.0
insuperable,1,0.0
ultra-selection,1,0.0
species-dependent,1,0.0
Immense,1,0.0
IDEPS,1,0.0
BPS,1,0.0
IDEPSs,1,0.0
NO-induced,1,0.0
extralobar,1,0.0
soup,1,0.0
β-alanyl-1-methyl-L-histidine,1,0.0
98-,1,0.0
51-80,1,0.0
anti-depressant,1,0.0
workbooks,1,0.0
low-suspicion,1,0.0
Non-PSCI,1,0.0
hiatal,1,0.0
polymyxin,1,0.0
retroperitoneale,1,0.0
2713,1,0.0
12days,1,0.0
infection-resistant,1,0.0
slime,1,0.0
infero-apico-lateral,1,0.0
prohibits,1,0.0
Color-Word,1,0.0
decentral,1,0.0
Papworth,1,0.0
proximity-labeling,1,0.0
category-specific,1,0.0
53948,1,0.0
70932,1,0.0
BHarbin794-like,1,0.0
18-10,1,0.0
11-11,1,0.0
21-14,1,0.0
1004°F,1,0.0
29-14,1,0.0
data-thinning,1,0.0
B-immobilized,1,0.0
angiofollicular,1,0.0
hypervascular,1,0.0
familiaris,1,0.0
taurus,1,0.0
Nose-lung,1,0.0
poles,1,0.0
fibrillated,1,0.0
HEV,1,0.0
non-extra-fine,1,0.0
Extra-fine,1,0.0
Sus,1,0.0
scrofa,1,0.0
CRCoV,1,0.0
Canis,1,0.0
3-5emsp14μm,1,0.0
Inclement,1,0.0
CpG-deficient,1,0.0
U-rich,1,0.0
Oktiabrsky,1,0.0
105-166,1,0.0
0972-0999,1,0.0
granulometry,1,0.0
Vence,1,0.0
inhomogeneities,1,0.0
19981571573-1577,1,0.0
04-222,1,0.0
Crit,1,0.0
Under-reporting,1,0.0
Mastocytosis,1,0.0
0800-1700,1,0.0
eightfold-reduced,1,0.0
ofsubsequent,1,0.0
spaniel,1,0.0
subculturing,1,0.0
H1N1--first,1,0.0
six-month-old,1,0.0
diarrhoeal,1,0.0
Molds,1,0.0
MLF,1,0.0
strain--named,1,0.0
immune-thrombotic,1,0.0
potassium-induced,1,0.0
clathrin-mediated,1,0.0
recedes,1,0.0
48-60,1,0.0
caveolae-dependent,1,0.0
CDE,1,0.0
clathrin-caveolae-independent,1,0.0
macropinocytosis,1,0.0
Fc-epsilon,1,0.0
freed,1,0.0
life-cycle,1,0.0
straw,1,0.0
75-143,1,0.0
Heartstring,1,0.0
54-93,1,0.0
Ct35,1,0.0
analysis-based,1,0.0
CAMs,1,0.0
sutural,1,0.0
Al-adjuvant,1,0.0
HAstrain,1,0.0
Rixensart,1,0.0
trivalent--vaccines,1,0.0
monovalent--instead,1,0.0
deoxyhaemoglobin,1,0.0
organicity,1,0.0
NHW,1,0.0
TBCT,1,0.0
KA,1,0.0
insufficiency--it,1,0.0
erythenatosus,1,0.0
cuirass,1,0.0
19-77,1,0.0
ischemical,1,0.0
techniques--as,1,0.0
but--probably,1,0.0
Ser447Ter,1,0.0
hyperintensive,1,0.0
uraemia-related,1,0.0
dialysis-related,1,0.0
pathophsyiology,1,0.0
269-315,1,0.0
dysfunctionional,1,0.0
Job,1,0.0
Haplotypes,1,0.0
NIMV,1,0.0
-050,1,0.0
17181,1,0.0
2955,1,0.0
8998,1,0.0
reteplase-treated,1,0.0
Dose-finding,1,0.0
9307,1,0.0
1974-1979,1,0.0
2C,1,0.0
1779,1,0.0
Immunotoxicological,1,0.0
transthyretin,1,0.0
Radiotracer,1,0.0
Postinterventionally,1,0.0
sparkling,1,0.0
99mTc-33-diphosphono-12-propanodicarboxylic,1,0.0
BOhio012005,1,0.0
Island032006,1,0.0
Perugini,1,0.0
Kandal,1,0.0
99m-Tc-hydroxydiphosphate,1,0.0
1151,1,0.0
4233,1,0.0
chooses,1,0.0
vaccinates,1,0.0
Overlooked,1,0.0
3157,1,0.0
17287,1,0.0
HFC,1,0.0
6445,1,0.0
non-BT-treated,1,0.0
massConclusions,1,0.0
-025,1,0.0
-161,1,0.0
exploredMeasurements,1,0.0
desmin,1,0.0
post-BT,1,0.0
Yushu,1,0.0
6914,1,0.0
responseMethods,1,0.0
importantObjectives,1,0.0
infract,1,0.0
1804,1,0.0
843637,1,0.0
2961507,1,0.0
1721316,1,0.0
4704474,1,0.0
antibody-coated,1,0.0
42459,1,0.0
8452983,1,0.0
clearant,1,0.0
13822,1,0.0
CLM,1,0.0
Castile-La,1,0.0
susceptible--infective--removed,1,0.0
configure,1,0.0
candidemia,1,0.0
cathepsin-L,1,0.0
INTegrelin,1,0.0
FranceWe,1,0.0
CoPanFlu,1,0.0
Holter-detected,1,0.0
Veklury,1,0.0
Transgenic,1,0.0
2497,1,0.0
weeksConclusionsThe,1,0.0
co-domination,1,0.0
PIV-3,1,0.0
seasonsResultsA,1,0.0
individuality,1,0.0
countriesMethodBased,1,0.0
stuttered,1,0.0
conditioning-induced,1,0.0
SwedenAimWe,1,0.0
dioxide-induced,1,0.0
reflexly,1,0.0
Pixel-by-pixel,1,0.0
JanssenJohnson,1,0.0
Astra-Zeneca,1,0.0
59-190,1,0.0
preocclusive,1,0.0
soya,1,0.0
CTAs,1,0.0
low-positive,1,0.0
factorsthe,1,0.0
45to,1,0.0
1999-2004,1,0.0
nsp15,1,0.0
glucose-regulated,1,0.0
absorption-extraction,1,0.0
Ultra-15,1,0.0
Amicon®,1,0.0
MgCl2,1,0.0
D-E,1,0.0
SARS-CoV-2coronavirus,1,0.0
menThe,1,0.0
combined-therapy,1,0.0
2004-2009,1,0.0
measure-wearable,1,0.0
vaccinationTherefore,1,0.0
cameras-to,1,0.0
1994-1999,1,0.0
5086,1,0.0
centersThe,1,0.0
Nakhichevan,1,0.0
asthmaWe,1,0.0
EID,1,0.0
seasonsMoreover,1,0.0
AH1-,1,0.0
AH3-positive,1,0.0
8487,1,0.0
NCDOH,1,0.0
condemned,1,0.0
inferior--in,1,0.0
Indicator,1,0.0
SHEA,1,0.0
SRN,1,0.0
028-237,1,0.0
-257,1,0.0
40-86,1,0.0
-019,1,0.0
centralisation,1,0.0
admissionsyear,1,0.0
Salivette,1,0.0
Chelex-100,1,0.0
Salivette®,1,0.0
14984,1,0.0
1598,1,0.0
centralising,1,0.0
SBP-DBP,1,0.0
15-4,1,0.0
40-5,1,0.0
58-3,1,0.0
33-7,1,0.0
myocardium-at-risk,1,0.0
non-fluorescent,1,0.0
myocytes-at-risk,1,0.0
60-75,1,0.0
HCWsto,1,0.0
Myers-Briggs,1,0.0
trials-only,1,0.0
452-fold,1,0.0
merge,1,0.0
anti-species,1,0.0
chores,1,0.0
Hospitalized50,1,0.0
atopic-related,1,0.0
diaphragmal,1,0.0
posterobasal--in,1,0.0
Kasai,1,0.0
down-trending,1,0.0
VaxArray,1,0.0
SeroAssay,1,0.0
Partilla,1,0.0
Slapak,1,0.0
outclasses,1,0.0
227E,1,0.0
synthetize,1,0.0
15-lead,1,0.0
911-fold,1,0.0
donor-matched,1,0.0
low-to-medium,1,0.0
nitroferricyanide,1,0.0
156-131,1,0.0
022-074,1,0.0
Ten-day,1,0.0
E227A,1,0.0
200T,1,0.0
repayment,1,0.0
hyperaemic,1,0.0
multisector,1,0.0
MBTI,1,0.0
0724,1,0.0
DFDs3,1,0.0
0596-0880,1,0.0
Constructing,1,0.0
methodology2,1,0.0
Checklands,1,0.0
cytototxic,1,0.0
myeloid-derived,1,0.0
are1,1,0.0
MIP-1A,1,0.0
exemplarMethod,1,0.0
MIP1B,1,0.0
uncertainObjective,1,0.0
modelsAsthma,1,0.0
expounding,1,0.0
abstractions,1,0.0
29-07,1,0.0
Rrs5and,1,0.0
lurch,1,0.0
38-10,1,0.0
16-45,1,0.0
bio-weaponised,1,0.0
globalisation,1,0.0
Santayana,1,0.0
2-5-yr-old,1,0.0
system4,1,0.0
notation,1,0.0
trombocytopenia,1,0.0
β-Eudesmol,1,0.0
15-3,1,0.0
pentobarbital,1,0.0
pre-ischaemic,1,0.0
5327,1,0.0
4079,1,0.0
OR2322,1,0.0
COVID-19The,1,0.0
1197-3298,1,0.0
coronavirusMolecular,1,0.0
SarmaHighlightsDetermine,1,0.0
4730,1,0.0
Digitoxigenin,1,0.0
diagramResults,1,0.0
2285,1,0.0
Crocin,1,0.0
disease…,1,0.0
lethargicas,1,0.0
1074-3462,1,0.0
Transurethral,1,0.0
findingConclusions,1,0.0
DFDs,1,0.0
non-Markovian,1,0.0
detrended,1,0.0
analysis-experimental,1,0.0
oxygennoninvasive,1,0.0
deaminates,1,0.0
Centralized,1,0.0
cepstral,1,0.0
7180,1,0.0
InfluenzaTB,1,0.0
translatability,1,0.0
β-hexosaminidase,1,0.0
Varied,1,0.0
anti-obstructiveanti-inflammatory,1,0.0
Alcaligenes,1,0.0
103-496,1,0.0
eccentricity,1,0.0
contrast-enhancement,1,0.0
Leishmania-endemic,1,0.0
critiquing,1,0.0
4A,1,0.0
self-worth,1,0.0
re-appraisals,1,0.0
thoracenteses,1,0.0
hallmarked,1,0.0
intrusions,1,0.0
Compassionate,1,0.0
angiotensin-modulating,1,0.0
re-PTCA,1,0.0
r-057,1,0.0
r055,1,0.0
400x104mm3,1,0.0
234-028,1,0.0
high-burden,1,0.0
WHO-designated,1,0.0
CCL4,1,0.0
area-based,1,0.0
123I-beta-methyl,1,0.0
trans-hiatal,1,0.0
race-related,1,0.0
iodophenyl,1,0.0
actic,1,0.0
prophy,1,0.0
A2Analysing,1,0.0
daysThe,1,0.0
99mTc-Tetrofosmin,1,0.0
103-114,1,0.0
207-224,1,0.0
NEULY,1,0.0
gliatiline,1,0.0
thicknessEAT-t,1,0.0
Kimballs,1,0.0
Brest,1,0.0
GHP,1,0.0
MDA5,1,0.0
myeloblast,1,0.0
medullar,1,0.0
paracentetic,1,0.0
neuroleucosis,1,0.0
myeloischemia,1,0.0
polychemotherapy,1,0.0
Pituitary,1,0.0
222-033,1,0.0
soilage,1,0.0
207-037,1,0.0
emindole,1,0.0
notoamide,1,0.0
preventableThrough,1,0.0
key-opinion-leaders,1,0.0
benzofpyrano43-bchromene,1,0.0
hand-off,1,0.0
radioactively,1,0.0
assented,1,0.0
actinomycetes,1,0.0
90-98,1,0.0
Optimistic,1,0.0
Reaxys®,1,0.0
craniovertebral,1,0.0
11162,1,0.0
ChEMBL,1,0.0
5276,1,0.0
genomeediting,1,0.0
DNA-enzymes,1,0.0
HypothesisProblem,1,0.0
widly,1,0.0
GIC,1,0.0
recen,1,0.0
cell-line,1,0.0
358±33,1,0.0
GIC581±73,1,0.0
all-time,1,0.0
beta-mannoside,1,0.0
bromoindole,1,0.0
186-019,1,0.0
209-041,1,0.0
subsignals,1,0.0
k-Nearest,1,0.0
245-040,1,0.0
Erythrocyte,1,0.0
bewilderment,1,0.0
212-015,1,0.0
225-020,1,0.0
001052,1,0.0
217-023,1,0.0
193-022,1,0.0
1erythrocyte,1,0.0
THRACE,1,0.0
000342,1,0.0
Stratify,1,0.0
Cardioverter-Defibrillator,1,0.0
2-erythrocyte,1,0.0
PROTECT-ICD,1,0.0
579-89,1,0.0
Australian-led,1,0.0
EPS,1,0.0
reckoned,1,0.0
DWIvolume,1,0.0
Cholesterol-lowering,1,0.0
seldomly,1,0.0
craniectomies,1,0.0
immunoinflammatory,1,0.0
sync,1,0.0
MEF59,1,0.0
pre-randomization,1,0.0
FEF25-755,1,0.0
expir,1,0.0
Anti-IgE-induced,1,0.0
anti-IgE-induced,1,0.0
non-endosomal,1,0.0
NIH-sponsored,1,0.0
dominant-hemisphere,1,0.0
Biorxiv,1,0.0
Experimentation,1,0.0
neuroplasticity-related,1,0.0
Grid-walking,1,0.0
microinjected,1,0.0
remainders,1,0.0
exercise-induce,1,0.0
LV-shHDAC2,1,0.0
AAV-CAG-EGFP-Cre,1,0.0
Ad-HDAC2-Flag,1,0.0
post-immune,1,0.0
duloxetine,1,0.0
serotonin-norepinephrine,1,0.0
fairground,1,0.0
Duloxetine,1,0.0
Disneyland,1,0.0
VGT,1,0.0
D614GIMPORTANCE,1,0.0
HKU5-related,1,0.0
method-nasopharyngeal,1,0.0
prevelance,1,0.0
45hours,1,0.0
2years,1,0.0
VRTI-related,1,0.0
size--a,1,0.0
tPAthrombectomy,1,0.0
25156,1,0.0
notThis,1,0.0
105757,1,0.0
DAWNdemonstrated,1,0.0
3646,1,0.0
YAKHY24CH2017,1,0.0
Pipistrellus,1,0.0
pachypus,1,0.0
Tylonycteris,1,0.0
24hours,1,0.0
HKU4-related,1,0.0
12511,1,0.0
abramus,1,0.0
19B-Sp1,1,0.0
19B-Sp2,1,0.0
MRCAs,1,0.0
19A-Sp1,1,0.0
19A-Sp2,1,0.0
Ryles,1,0.0
FEV1ABSTRACT,1,0.0
∼081,1,0.0
WeCoF,1,0.0
myelosis,1,0.0
cervicosternotomy,1,0.0
hydrocarbonate,1,0.0
treatmentchemoprophylaxis,1,0.0
phenomenon-asymptomatic,1,0.0
molecular-biological,1,0.0
ASingapore686,1,0.0
SEFs,1,0.0
direct-current,1,0.0
Low-voltage,1,0.0
self-motivated,1,0.0
Vcm,1,0.0
Cardio-electrophysiological,1,0.0
measures-vaccination,1,0.0
recoverytreatment,1,0.0
Self-Motivation,1,0.0
ε,1,0.0
ϕ,1,0.0
self-motivation,1,0.0
viruses--not,1,0.0
copiesg,1,0.0
copiesm3,1,0.0
1910-17,1,0.0
genomicantigenic,1,0.0
064-072,1,0.0
Vaquez-Osler,1,0.0
43-years-old,1,0.0
Q-DE-method,1,0.0
N°,1,0.0
attention--preferably,1,0.0
hospital--to,1,0.0
Cyclical,1,0.0
breathingSDB,1,0.0
old-old,1,0.0
halogen,1,0.0
π-bonds,1,0.0
A-60,1,0.0
pdb,1,0.0
A-60ABSTRACT,1,0.0
single-device,1,0.0
high-stress,1,0.0
PISA-method,1,0.0
7-chloro-4-aminoquinoline,1,0.0
HR035,1,0.0
013-099,1,0.0
DARE,1,0.0
HR149,1,0.0
067-331,1,0.0
techniques--proximal,1,0.0
TLKW,1,0.0
isovelocity,1,0.0
≈19,1,0.0
transatlantic,1,0.0
“Awareness,1,0.0
multi-disciplines,1,0.0
029-234,1,0.0
RSV-viruses,1,0.0
Liberte,1,0.0
Taxus,1,0.0
Select,1,0.0
Control-4,1,0.0
Questionnaire-Sydney,1,0.0
Cypher,1,0.0
-040,1,0.0
-016,1,0.0
Gabriel,1,0.0
Leung,1,0.0
Angus,1,0.0
pdm09H1N1,1,0.0
AMexico44822009,1,0.0
Nicoll,1,0.0
ANetherlands2192003,1,0.0
ED-pertinent,1,0.0
93-page,1,0.0
School-closure,1,0.0
AAnhui012013,1,0.0
survey-modeling,1,0.0
hobby,1,0.0
foreground,1,0.0
vieew,1,0.0
sume,1,0.0
effectives,1,0.0
zotarolimus-eluting,1,0.0
Endeavor,1,0.0
dimensioning,1,0.0
Nonpharmacological,1,0.0
antiquated,1,0.0
Nanoparticle,1,0.0
geneticsgenomics,1,0.0
antitachycardia,1,0.0
HR114,1,0.0
HR092,1,0.0
untouched,1,0.0
HR718,1,0.0
illness1-4,1,0.0
CTA-CS,1,0.0
contractionhyperresponsiveness,1,0.0
gradient-search,1,0.0
Practically,1,0.0
deacetylases,1,0.0
oligodendrogenesis,1,0.0
Exacerbation-prone,1,0.0
well-apposed,1,0.0
malapposed,1,0.0
thinnest,1,0.0
11512,1,0.0
N71120,1,0.0
n5897,1,0.0
substratified,1,0.0
rapid-result,1,0.0
definitionof,1,0.0
re-arranged,1,0.0
ασθμαινω,1,0.0
Changed,1,0.0
Comfortdiscomfort,1,0.0
submits,1,0.0
Inadequately-controlled,1,0.0
appropriately-equipped,1,0.0
187-259,1,0.0
acid-suppressive,1,0.0
inter-protocol,1,0.0
customarily,1,0.0
Moya-moya,1,0.0
coagulography,1,0.0
MRTCT,1,0.0
346±82,1,0.0
dorsa,1,0.0
ECG-synchronized,1,0.0
3K3A-activated,1,0.0
otaplimastat,1,0.0
Crema,1,0.0
nerinetide,1,0.0
enzyme-catalytic,1,0.0
058-260,1,0.0
0631,1,0.0
polypeptide-like,1,0.0
052-292,1,0.0
031-202,1,0.0
0715,1,0.0
≈700000,1,0.0
self-training,1,0.0
Mid-season,1,0.0
12-minute,1,0.0
circuit-class,1,0.0
398-41,1,0.0
captopril-treated,1,0.0
life-expectancy,1,0.0
Hawaiian,1,0.0
mamane,1,0.0
class-specific,1,0.0
flavescens,1,0.0
guidelinesConclusion,1,0.0
agreeagree,1,0.0
amphiregulin,1,0.0
pedometry,1,0.0
n90,1,0.0
angiography--dilatation,1,0.0
interleukin-25,1,0.0
Hermans,1,0.0
Flat,1,0.0
Cédric,1,0.0
93-715,1,0.0
Molsidomine,1,0.0
fibrinogenolytic,1,0.0
30-647,1,0.0
acyl-streptokinase,1,0.0
streptokinases,1,0.0
gasp,1,0.0
icosahedral,1,0.0
“Evaluation,1,0.0
2mA,1,0.0
SIR-like,1,0.0
double-peak,1,0.0
case-vac,1,0.0
1969-1970,1,0.0
Preepidemic,1,0.0
enclosing,1,0.0
non-military,1,0.0
Casablanca,1,0.0
2000-2014,1,0.0
36±7,1,0.0
Amnesia,1,0.0
MPZ,1,0.0
estrogen-progestin,1,0.0
reportedin,1,0.0
anti-aggregation,1,0.0
29-122,1,0.0
Prejudice,1,0.0
unsurpassed,1,0.0
butyrylcholinesterase,1,0.0
reptile,1,0.0
Ophiophagus,1,0.0
hannah,1,0.0
post-PDT,1,0.0
40-61,1,0.0
multi-sequence,1,0.0
epochs,1,0.0
CTC,1,0.0
IUliters,1,0.0
non-compacted,1,0.0
phosphatidyl-serine,1,0.0
externalized,1,0.0
SRBD-coated,1,0.0
geometries,1,0.0
peri-lesional,1,0.0
doctor’s,1,0.0
1992-2003,1,0.0
seesawed,1,0.0
ain,1,0.0
specialistic,1,0.0
20-511,1,0.0
Positivenegativeinvalid,1,0.0
problem-specific,1,0.0
typhimurium,1,0.0
Levitronix,1,0.0
Centrimag,1,0.0
amplificationdetection,1,0.0
small-government,1,0.0
oil-sealed,1,0.0
expertise-expensive,1,0.0
bag-based,1,0.0
Amplification-based,1,0.0
instantiation,1,0.0
locale-,1,0.0
combustible,1,0.0
anode,1,0.0
0479,1,0.0
cathode,1,0.0
Brabilla,1,0.0
Wei,1,0.0
6650,1,0.0
Pakistanis,1,0.0
Trudeau,1,0.0
Justin,1,0.0
initatives,1,0.0
DIV,1,0.0
self-timed,1,0.0
50s,1,0.0
2832,1,0.0
transvalvular,1,0.0
5841,1,0.0
NCT04636294,1,0.0
ratesThis,1,0.0
30851,1,0.0
dysfunctionMany,1,0.0
threshold-value,1,0.0
biotherapies,1,0.0
Noradrenalin,1,0.0
Malondialdehyde,1,0.0
SNRIs,1,0.0
oxidant-induced,1,0.0
Aldehydes,1,0.0
35-40°C,1,0.0
immunizes,1,0.0
Qin,1,0.0
Conservatively,1,0.0
Münster,1,0.0
detectors,1,0.0
U-,1,0.0
∼4μm,1,0.0
pre-terminally,1,0.0
∼04μm,1,0.0
extra-pleura,1,0.0
extra-pleural,1,0.0
thalamic-internal,1,0.0
convective,1,0.0
thalamic-occipital,1,0.0
pathogen-carrying,1,0.0
Respirable,1,0.0
Mulligan,1,0.0
60years,1,0.0
100000QALY,1,0.0
UHM,1,0.0
infarctpenumbral,1,0.0
63773QALY,1,0.0
practice--most,1,0.0
4784112,1,0.0
2516,1,0.0
7dose,1,0.0
reserve-guided,1,0.0
55dose,1,0.0
significant-approximately,1,0.0
reperfusion-related,1,0.0
Buschke,1,0.0
CI206,1,0.0
Catheter-directed,1,0.0
distinguishers,1,0.0
multicausal,1,0.0
lipid-rafts,1,0.0
family-members,1,0.0
Soroka,1,0.0
endocytotic,1,0.0
sialic-acids,1,0.0
non-headache,1,0.0
copym3,1,0.0
Voxel-wise,1,0.0
27-91,1,0.0
44-149,1,0.0
interception,1,0.0
12035,1,0.0
unlikelyvery,1,0.0
warping,1,0.0
self-paying,1,0.0
CI686,1,0.0
Come,1,0.0
2624,1,0.0
diagnostic-related,1,0.0
multi-tier,1,0.0
CI119,1,0.0
BritishIrish,1,0.0
65min,1,0.0
aVf,1,0.0
p018,1,0.0
trioxazine,1,0.0
disaggregants,1,0.0
orofaecal,1,0.0
fullness,1,0.0
infectionsIn,1,0.0
overtook,1,0.0
Fuyang,1,0.0
knobs,1,0.0
towel,1,0.0
Elisor,1,0.0
M-immunoglobulin,1,0.0
PREDICT,1,0.0
antistress,1,0.0
1477,1,0.0
Fluvastatin,1,0.0
FLARE,1,0.0
Lescol,1,0.0
ARMYDA,1,0.0
Psychopharmacological,1,0.0
hypothalamo-hypophysial-adrenal,1,0.0
Briguori,1,0.0
3941,1,0.0
p014,1,0.0
p010,1,0.0
p0098,1,0.0
7583,1,0.0
15491,1,0.0
high-touched,1,0.0
2889,1,0.0
APHLs,1,0.0
8238,1,0.0
Grounds,1,0.0
27597,1,0.0
Hypothalamic-Pituitary-,1,0.0
fibrillation-induced,1,0.0
CLOSURE,1,0.0
NMs,1,0.0
Command-Europe,1,0.0
Δ6970,1,0.0
Command-Pacific,1,0.0
1×108,1,0.0
2D-Echo,1,0.0
sexspecific,1,0.0
refered,1,0.0
non-IgE-dependent,1,0.0
Variety,1,0.0
low-pH-unstable,1,0.0
45nl,1,0.0
ion-binding,1,0.0
58nl,1,0.0
glutamic-oxaloacetic,1,0.0
6374,1,0.0
34237,1,0.0
158451,1,0.0
asthma-,1,0.0
AE-,1,0.0
n4731,1,0.0
MB-fraction,1,0.0
2675,1,0.0
preangioplasty,1,0.0
00379,1,0.0
Infarct-vessel,1,0.0
00320,1,0.0
obligues,1,0.0
repercusion,1,0.0
kallisto,1,0.0
valuing,1,0.0
repercussion,1,0.0
lenght,1,0.0
bustools,1,0.0
MEPS,1,0.0
DNIC-GSkg,1,0.0
vasodilative,1,0.0
HMSA,1,0.0
non-central,1,0.0
Nitroglycerine,1,0.0
micromolkg,1,0.0
40-min,1,0.0
11900,1,0.0
dinitrosyl,1,0.0
m396,1,0.0
CR3014,1,0.0
elbow-levers,1,0.0
DWMHs,1,0.0
responsefibrillation,1,0.0
WinglessIntegrase-1,1,0.0
121-192,1,0.0
antinomic,1,0.0
073-092,1,0.0
easy-to-recognize,1,0.0
559-797,1,0.0
707-985,1,0.0
IVT-treated,1,0.0
NOCA,1,0.0
epitheliums,1,0.0
courseResults,1,0.0
lymphocyte-controlled,1,0.0
IGEPAL,1,0.0
incineration,1,0.0
tons,1,0.0
requisitioned,1,0.0
1543959,1,0.0
3727,1,0.0
sicks,1,0.0
coronavirus-based,1,0.0
Virus-Based,1,0.0
indict,1,0.0
Acid-Based,1,0.0
war-boosted,1,0.0
DNAPEI,1,0.0
equalization,1,0.0
availableCOVID-19,1,0.0
doppler-echocardiography,1,0.0
74-133,1,0.0
DIRs,1,0.0
ventilator-related,1,0.0
Nonconventional,1,0.0
autosome,1,0.0
Pedigree,1,0.0
pedigrees,1,0.0
Piton™,1,0.0
agonic,1,0.0
angiographic-,1,0.0
micro-catheters,1,0.0
Handan,1,0.0
UNICORN,1,0.0
RBD-spike,1,0.0
anticongestive,1,0.0
risk-prediction,1,0.0
1968-76,1,0.0
post-IVT,1,0.0
ISTM,1,0.0
imatinib-treated,1,0.0
CCL6,1,0.0
gavages,1,0.0
kinase-mediated,1,0.0
ER-a,1,0.0
emulsions,1,0.0
pre-IVT,1,0.0
nano-in-microparticles,1,0.0
melittin-PEI,1,0.0
PVWMHs,1,0.0
ATCs,1,0.0
pituitrin-neoepinephrine-induced,1,0.0
Riboxin,1,0.0
Pairing,1,0.0
≥89,1,0.0
polyribosomes,1,0.0
pandemic-era,1,0.0
1204,1,0.0
macroergic,1,0.0
subtrial,1,0.0
BIT,1,0.0
15-point,1,0.0
restexercise,1,0.0
Dystextia,1,0.0
midgestational,1,0.0
symptom-lesion,1,0.0
fissures,1,0.0
Multivariate-adjusted,1,0.0
fluidAccording,1,0.0
Iberoamerican,1,0.0
Mustelidae,1,0.0
minks-to-human,1,0.0
human-to-minks,1,0.0
taps,1,0.0
Taps,1,0.0
lensesThe,1,0.0
Choral,1,0.0
A2A,1,0.0
Management-related,1,0.0
197-364,1,0.0
transferrin-polyethyleneimine,1,0.0
difficult-to-transfect,1,0.0
z-disks,1,0.0
277-447We,1,0.0
253-409,1,0.0
Telangiectatic,1,0.0
182-316,1,0.0
248-343,1,0.0
68-228,1,0.0
34-122,1,0.0
28-89,1,0.0
osteosarcomas,1,0.0
non-confrontational,1,0.0
radio-pathological,1,0.0
339-475,1,0.0
telangiectatic,1,0.0
VDS,1,0.0
414-556,1,0.0
BPPV,1,0.0
resultsClinical,1,0.0
casesSearch,1,0.0
combustion-derived,1,0.0
haemophilia,1,0.0
leukotriene-1,1,0.0
dipyridamole-handgrip,1,0.0
Rb-82,1,0.0
dd,1,0.0
rolling-out,1,0.0
Kölner,1,0.0
6-28,1,0.0
Oporto,1,0.0
symptoms--morning,1,0.0
2-propanol,1,0.0
Cologne,1,0.0
Tatra,1,0.0
eliminations,1,0.0
self-supporting,1,0.0
interdependencies,1,0.0
batched,1,0.0
N-Pep-12,1,0.0
VLDL-CVLDL-TG,1,0.0
VLDL-cholesterol,1,0.0
LDL-Capo-B,1,0.0
TCapo-B,1,0.0
comorbiditymultimorbidity,1,0.0
EHF-acupuncture,1,0.0
EHF,1,0.0
springing,1,0.0
apo-B,1,0.0
normolipidaemic,1,0.0
apo-D,1,0.0
A-II,1,0.0
role-modelling,1,0.0
Neuropsychologisches,1,0.0
Professions,1,0.0
Schlaganfall-Patienten,1,0.0
laboratory’s,1,0.0
reperfusion--facilitated,1,0.0
modulus,1,0.0
Youngs,1,0.0
toughness,1,0.0
Guineans,1,0.0
Troubling,1,0.0
29-month,1,0.0
subtoxic,1,0.0
diffuseness,1,0.0
“in,1,0.0
house”,1,0.0
Hydrogels,1,0.0
grated,1,0.0
1–4,1,0.0
Beta-Adrenergic,1,0.0
hypocortisolemia,1,0.0
Awas,1,0.0
Navapur,1,0.0
dos,1,0.0
donts,1,0.0
009-050,1,0.0
14-120,1,0.0
115-787,1,0.0
Interagency,1,0.0
A-I,1,0.0
feedback-loops,1,0.0
1080-9277,1,0.0
LDL-,1,0.0
serviceThe,1,0.0
childrenAdditionally,1,0.0
mid-60s,1,0.0
epidemicFrom,1,0.0
rigors,1,0.0
pain-variant,1,0.0
illnessWe,1,0.0
truncations,1,0.0
age-of-infection,1,0.0
discrete-time,1,0.0
bonafide,1,0.0
tract-isolated,1,0.0
RB1,1,0.0
E2F,1,0.0
immunoprofile,1,0.0
titered,1,0.0
Seronegativity,1,0.0
RNASeq,1,0.0
plasmaCP,1,0.0
SANI,1,0.0
nonfacility,1,0.0
facility-associated,1,0.0
Test-Second,1,0.0
Szummer,1,0.0
SA-binding,1,0.0
Impede,1,0.0
THRIVES,1,0.0
first-of-its,1,0.0
Nonparametric,1,0.0
VLDL-,1,0.0
ethylenediaminetetraacetic,1,0.0
multitasking,1,0.0
Test-Home,1,0.0
neurologically-healthy,1,0.0
home-dwelling,1,0.0
Self-generated,1,0.0
106-332,1,0.0
115-283,1,0.0
zinc-metalloproteases,1,0.0
beneficialharmful,1,0.0
costeffectiveness,1,0.0
under-usage,1,0.0
chelating,1,0.0
citrateEDTA,1,0.0
chelators,1,0.0
2346,1,0.0
Serosurveys,1,0.0
strokes-those,1,0.0
prothromboticinflammatory,1,0.0
GLU,1,0.0
TRG,1,0.0
hCoV-NL63,1,0.0
beneficialABSTRACT,1,0.0
29-February,1,0.0
PCI--involves,1,0.0
nontransplanted,1,0.0
macrophages-induced,1,0.0
httpwwwacponlineorgcollegepressroomas06pandemicpolicypdf,1,0.0
Barnitz,1,0.0
00019,1,0.0
BJ,1,0.0
non-randomly,1,0.0
Berkwits,1,0.0
tranylcypromine,1,0.0
butenafine,1,0.0
MSCE,1,0.0
Jeffrey,1,0.0
Ethacrynic,1,0.0
IQF,1,0.0
intramolecularly,1,0.0
right-lobe,1,0.0
inquest,1,0.0
coagulapathy,1,0.0
Bronson,1,0.0
Julie,1,0.0
Ake,1,0.0
Patricia,1,0.0
misdistribution,1,0.0
702015,1,0.0
Molly,1,0.0
Herbert,1,0.0
Periventricular,1,0.0
Case-Control,1,0.0
22843,1,0.0
38151,1,0.0
4-risk-indicators,1,0.0
Syndrome-2,1,0.0
syncitial,1,0.0
glycophosphopeptical,1,0.0
seasonILI,1,0.0
sinorhinitis,1,0.0
2003-2016,1,0.0
4756,1,0.0
risk-indicator,1,0.0
N12,1,0.0
Bice-Boxerman,1,0.0
P089,1,0.0
asthma-obesity,1,0.0
policy-level,1,0.0
Monophasic,1,0.0
hypoaesthesia,1,0.0
hemibody,1,0.0
Fischers,1,0.0
ventricle-posterior,1,0.0
Strausbourg,1,0.0
serodiscordant,1,0.0
hyposupply,1,0.0
radiculomedullary,1,0.0
country-to-country,1,0.0
POR,1,0.0
TNC-induced,1,0.0
Joel,1,0.0
cohabitants,1,0.0
Levine,1,0.0
r07,1,0.0
72-26,1,0.0
Mean-SD,1,0.0
17-76,1,0.0
Exosome,1,0.0
information-giving,1,0.0
tetraspanins,1,0.0
line-by-line,1,0.0
females15,1,0.0
Echoventriculography,1,0.0
males17,1,0.0
informatively,1,0.0
conversation-style,1,0.0
echoventriculography,1,0.0
pi3,1,0.0
GXD,1,0.0
Xiebai,1,0.0
radian,1,0.0
Gualou,1,0.0
SNLG,1,0.0
non-genomic,1,0.0
Beckers,1,0.0
Parent-child,1,0.0
inappetence,1,0.0
B1139,1,0.0
re-edited,1,0.0
JSPACI,1,0.0
ENCHANTED,1,0.0
IfSG,1,0.0
post-SAH,1,0.0
McGinn,1,0.0
McLean,1,0.0
Ashley,1,0.0
Matricellular,1,0.0
Starkweather,1,0.0
175-463,1,0.0
Frederick,1,0.0
Turton,1,0.0
13-31,1,0.0
Regents,1,0.0
bronchoalvelolar,1,0.0
underfilled,1,0.0
Condition,1,0.0
Anabolic,1,0.0
meningovasculitis,1,0.0
1991-2015,1,0.0
AKorea7702000,1,0.0
42190,1,0.0
ofthrombolysis,1,0.0
507573,1,0.0
SCAST,1,0.0
CHHIPS,1,0.0
COSSACS,1,0.0
NASHIP,1,0.0
Blot,1,0.0
thromboendarterectomy,1,0.0
DRI,1,0.0
375000,1,0.0
drawn-out,1,0.0
ICCUs,1,0.0
soundly-based,1,0.0
8728,1,0.0
chronicize,1,0.0
6302,1,0.0
polymorbid,1,0.0
moyamoya-like,1,0.0
9949,1,0.0
Unintentional,1,0.0
0366UL,1,0.0
0121UL,1,0.0
superselectively,1,0.0
LLOD,1,0.0
digesting,1,0.0
uricemia,1,0.0
uricosuria,1,0.0
86-6,1,0.0
ENDOSTROKE,1,0.0
savanna,1,0.0
thrombectomythrombolysis,1,0.0
httpsbitly2yWp3jb,1,0.0
comets,1,0.0
cubicles,1,0.0
sneezers-runners,1,0.0
sketching,1,0.0
city-county,1,0.0
overinterpret,1,0.0
PLAC,1,0.0
amplificons,1,0.0
platelet-endothelial,1,0.0
MEASUREMENTS,1,0.0
cubes,1,0.0
b-FGF,1,0.0
VOE,1,0.0
Hemolysis-driven,1,0.0
acute-on-chronic,1,0.0
arginine-nitric,1,0.0
Brevia,1,0.0
environ-mental,1,0.0
lymphocyte-to-neutrophil,1,0.0
MoAb,1,0.0
mortalityincluding,1,0.0
MoAbs,1,0.0
ill-is,1,0.0
n391,1,0.0
countermeasure-the,1,0.0
n138,1,0.0
Agrin,1,0.0
antiviral-,1,0.0
AChRs,1,0.0
antiallegic,1,0.0
PRI,1,0.0
closed-circuit,1,0.0
epsilon-caprolactone,1,0.0
hexamethylene,1,0.0
non-integrin,1,0.0
0383,1,0.0
0576,1,0.0
Reveal,1,0.0
00608,1,0.0
LINQ,1,0.0
respondable,1,0.0
deviationchord,1,0.0
SURPRISE,1,0.0
university-recommended,1,0.0
gastro-oesophagien,1,0.0
CHA2DS2-Vasc,1,0.0
sunny,1,0.0
hypoxia-ischemia,1,0.0
insignificatively,1,0.0
AWSN1933,1,0.0
flu-infected,1,0.0
mgkgdose,1,0.0
Caledonia201999,1,0.0
FAK-Y397,1,0.0
oseltamivir3-4,1,0.0
sucking,1,0.0
Convergent,1,0.0
75087,1,0.0
compulsive,1,0.0
ICAM-3-grabbing,1,0.0
liverlymph,1,0.0
1-converting,1,0.0
965-996,1,0.0
masticatory,1,0.0
Temporomandibular,1,0.0
single-referral,1,0.0
DRKS00021220,1,0.0
testingClinical,1,0.0
817-998,1,0.0
971-998,1,0.0
243245,1,0.0
765-955,1,0.0
4045,1,0.0
712-923,1,0.0
245248,1,0.0
0593,1,0.0
750-948,1,0.0
professional-collected,1,0.0
reactivates,1,0.0
40-ms,1,0.0
azimuth,1,0.0
3rd-degree,1,0.0
nonclear-cut,1,0.0
Morain,1,0.0
bigeminated,1,0.0
HIV-based,1,0.0
HWVM,1,0.0
enzyme-mediated,1,0.0
polylactic,1,0.0
Hey,1,0.0
n1057,1,0.0
M-Partigen,1,0.0
16-98,1,0.0
CTLA4-Ig,1,0.0
4-Ig,1,0.0
panic-feat,1,0.0
thrombus-aspirating,1,0.0
Wilcoxons,1,0.0
B7CD28,1,0.0
CTLA4-Igs,1,0.0
fitness-enhancing,1,0.0
worldwide-and,1,0.0
postflight,1,0.0
4288,1,0.0
ITDS,1,0.0
ITDSs,1,0.0
1996-2013,1,0.0
scoresworse,1,0.0
1perfect,1,0.0
Life-5,1,0.0
calicivirus,1,0.0
6-Dimension,1,0.0
distemper,1,0.0
02395,1,0.0
enzyme-labeled,1,0.0
n1210,1,0.0
Behringwerke,1,0.0
Global-IgE,1,0.0
stroke--MR,1,0.0
GROGs,1,0.0
bio-fuel,1,0.0
freezed,1,0.0
hours-delayed,1,0.0
1913,1,0.0
41298,1,0.0
age-shift,1,0.0
viremia-associated,1,0.0
Chita,1,0.0
evacuating,1,0.0
misrepresenting,1,0.0
adjudicate,1,0.0
multi-antiviral,1,0.0
REVASCAT--have,1,0.0
furs,1,0.0
TiO2-induced,1,0.0
38-year,1,0.0
2011-2018,1,0.0
1949-1986,1,0.0
endomiocardial,1,0.0
87-5,1,0.0
7-7,1,0.0
92-3,1,0.0
decedent,1,0.0
pulmonaryICU,1,0.0
CCoV-positive,1,0.0
T-E1-E2-E3-E4-T,1,0.0
unreplicated,1,0.0
Quantile,1,0.0
histochrome,1,0.0
Trans-mediastinal,1,0.0
scimitar,1,0.0
trans-mediastinal,1,0.0
Rhine,1,0.0
timesdelay,1,0.0
gammahydroxybutyrate,1,0.0
Recreational,1,0.0
stroke-care,1,0.0
SSB,1,0.0
Ro-52,1,0.0
AQP4-positive,1,0.0
Cautions,1,0.0
six-part,1,0.0
ORF7aΔ115,1,0.0
Recently-published,1,0.0
anti-immune,1,0.0
H5N1-,1,0.0
H7N7-,1,0.0
H9N2-,1,0.0
highly-specific,1,0.0
H2N2-viruses,1,0.0
transilluminator,1,0.0
uncapping,1,0.0
Proofman,1,0.0
071-092,1,0.0
075-098,1,0.0
GHB,1,0.0
377-434,1,0.0
Study-specific,1,0.0
differenceunadjusted,1,0.0
-0147,1,0.0
207-227,1,0.0
951-971,1,0.0
-0258,1,0.0
-0090,1,0.0
-0119,1,0.0
647-671,1,0.0
-0111,1,0.0
-0022,1,0.0
-0085,1,0.0
073-097,1,0.0
91-135,1,0.0
-0034,1,0.0
20-item,1,0.0
QLQ-Asthma,1,0.0
foreign-made,1,0.0
mobilityThe,1,0.0
symptomsThe,1,0.0
Russian-made,1,0.0
Maintained,1,0.0
514483,1,0.0
079-095,1,0.0
Alder,1,0.0
NCPP,1,0.0
GMA,1,0.0
clamped,1,0.0
Tasks,1,0.0
Vilnus,1,0.0
35-5,1,0.0
Nizhny,1,0.0
1977-1991,1,0.0
fourteen-year,1,0.0
71-84,1,0.0
15-307,1,0.0
88-91,1,0.0
SACAO,1,0.0
1-229,1,0.0
methodsplatforms,1,0.0
p24,1,0.0
BTI-Tn-5B1-4,1,0.0
iron-based,1,0.0
Faradaic,1,0.0
ZnO-NW,1,0.0
homolog-modeled,1,0.0
nanowires,1,0.0
public-transportation,1,0.0
YQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQ,1,0.0
polymerpathogen,1,0.0
pH-drop,1,0.0
FSPDGKPCTPPALNCYWPLNDYGFYTTTGIGYQ,1,0.0
chemically-diverse,1,0.0
154933,1,0.0
squad,1,0.0
MRCT,1,0.0
Lo-ROX,1,0.0
000017,1,0.0
QIAgen,1,0.0
RNAdvance,1,0.0
BloodViral,1,0.0
Pooling-Based,1,0.0
Mag-Bind,1,0.0
956-978,1,0.0
Bio-tek,1,0.0
751-855,1,0.0
FastVirus,1,0.0
qPCRBIO,1,0.0
unevaluated,1,0.0
avulsion,1,0.0
clerk,1,0.0
NEB,1,0.0
primer-probes,1,0.0
alpha-hydroxybutyric,1,0.0
creatin,1,0.0
70°C,1,0.0
90°C,1,0.0
infliximab,1,0.0
CL-3,1,0.0
httpsosfiouebvj,1,0.0
pgmgcr,1,0.0
snake-catching,1,0.0
R020,1,0.0
P-,1,0.0
architecturally-,1,0.0
democracies,1,0.0
Prevention-approved,1,0.0
tube-based,1,0.0
12-μL,1,0.0
preloaded,1,0.0
infarctees,1,0.0
over-crowded,1,0.0
Microchips,1,0.0
averagemedian±SD,1,0.0
nurse-recognized,1,0.0
27412±357,1,0.0
patient-herself,1,0.0
NC-CTs,1,0.0
PRMVSI,1,0.0
PRMCBV,1,0.0
PRMADC-,1,0.0
applicative,1,0.0
Presenters,1,0.0
Schoolboys,1,0.0
OR-56,1,0.0
Clearinghouse,1,0.0
Cork,1,0.0
silenced,1,0.0
ChIP,1,0.0
Sponsors,1,0.0
greenness,1,0.0
nucleobase,1,0.0
Adrenaline,1,0.0
iodine-based,1,0.0
Ayub,1,0.0
Abbottabad,1,0.0
Undeniably,1,0.0
earlyterm,1,0.0
cough-jet,1,0.0
prima,1,0.0
speeding-up,1,0.0
facie,1,0.0
propensities,1,0.0
Nafamostat,1,0.0
portraying,1,0.0
TOPSE,1,0.0
ARIA-EAACI-EuGMS,1,0.0
3-15100000,1,0.0
congential,1,0.0
lipometabolic,1,0.0
Strip,1,0.0
1hr,1,0.0
JATAYU,1,0.0
ultra-fractionated,1,0.0
osmotherapy,1,0.0
web-tool,1,0.0
trans-cleavage,1,0.0
GP-IIbIIIa-receptor,1,0.0
eventsmillion,1,0.0
newer-generation,1,0.0
dusting,1,0.0
-220,1,0.0
cell-density,1,0.0
ipsilateralcontralateral,1,0.0
SLM,1,0.0
moleculare,1,0.0
liposome-based,1,0.0
H1-antigens,1,0.0
dendrite,1,0.0
lacunosum,1,0.0
chikungunya,1,0.0
bunyaviruses,1,0.0
alternations,1,0.0
post-surgeries,1,0.0
ensheathing,1,0.0
Questionnaire™,1,0.0
742855,1,0.0
2591015,1,0.0
trans-synaptic,1,0.0
microfusion,1,0.0
Chengal,1,0.0
hardwood,1,0.0
boats,1,0.0
oligostilbenoids,1,0.0
quinones,1,0.0
111-524,1,0.0
asthma-screening,1,0.0
forestalling,1,0.0
RBD-encoding,1,0.0
home-management,1,0.0
5714,1,0.0
1971-89,1,0.0
cooperated,1,0.0
shading,1,0.0
scares,1,0.0
antenatally,1,0.0
mutator,1,0.0
1991-2002,1,0.0
AIIV-Moscow012009,1,0.0
HIN1swl,1,0.0
4048,1,0.0
rearing,1,0.0
conformation-dependent,1,0.0
p071,1,0.0
AH1N1swl,1,0.0
illiterates,1,0.0
literates,1,0.0
Hooghly,1,0.0
Singur,1,0.0
Hakimpur,1,0.0
5067,1,0.0
23587,1,0.0
5272,1,0.0
p089,1,0.0
p096,1,0.0
RRC,1,0.0
≤130,1,0.0
Yam-lineage,1,0.0
AUSSR024975,1,0.0
intensiveprolonged,1,0.0
trichinous,1,0.0
Jakafi,1,0.0
Actemra,1,0.0
Fulfilling,1,0.0
Kevzara,1,0.0
Anti-COVID,1,0.0
Ad5-nCoV,1,0.0
adduct,1,0.0
240-360,1,0.0
pharmacokinetically,1,0.0
12-85,1,0.0
n157,1,0.0
DP-EES,1,0.0
BP-SES,1,0.0
low-nanomolar,1,0.0
ISRCTN89951424,1,0.0
Arial,1,0.0
conciousness,1,0.0
RE-MI,1,0.0
pheno-endotype-specific,1,0.0
endotyped,1,0.0
2020-21,1,0.0
14-311,1,0.0
thin-strut,1,0.0
contradistinction,1,0.0
neurogenically,1,0.0
beta-adrenorecepor,1,0.0
291000,1,0.0
ATokyo175,1,0.0
reimmunization,1,0.0
anti-H3,1,0.0
monoreceptor,1,0.0
REALISE™,1,0.0
post-childhood,1,0.0
age-contact,1,0.0
Clinicalmethodological,1,0.0
northern-most,1,0.0
4754,1,0.0
b-3,1,0.0
year-1,1,0.0
64-channels,1,0.0
0254,1,0.0
non-deconvolved,1,0.0
ex-,1,0.0
Perfusion-weighted,1,0.0
0·41-0·86,1,0.0
immunodef,1,0.0
iciency,1,0.0
0·59,1,0.0
clinical-behavioral,1,0.0
1-80,1,0.0
EEG-RSNs,1,0.0
14818,1,0.0
Taylor123347,1,0.0
httptsbmssmeduprimeportal,1,0.0
unspecialized,1,0.0
authentication,1,0.0
111In99mTc,1,0.0
optical-based,1,0.0
99mTc-Sestamibi,1,0.0
studiesExpert,1,0.0
Post-therapeutic,1,0.0
benefice,1,0.0
non-engrafted,1,0.0
MI-areas,1,0.0
optimizationAreas,1,0.0
positive-inotropic,1,0.0
quasi-poisson,1,0.0
1-unit,1,0.0
rT-PA,1,0.0
studies4,1,0.0
PAQ,1,0.0
100-106,1,0.0
disease3,1,0.0
lethal2,1,0.0
Face-Arm-Speech-Time,1,0.0
IFN-gamma874AT,1,0.0
utensils,1,0.0
rapidly-shifting,1,0.0
874AT,1,0.0
lFN-y,1,0.0
labeled-BMSCs,1,0.0
experiency,1,0.0
858-2929,1,0.0
111In,1,0.0
PPCI-capable,1,0.0
depressionhopelessness,1,0.0
cholinergically,1,0.0
asthma-relevant,1,0.0
hart,1,0.0
Equipping,1,0.0
Omaha,1,0.0
386-390,1,0.0
self-blame,1,0.0
∼,1,0.0
self-attribution,1,0.0
self-reflection,1,0.0
PERI,1,0.0
PFA-100,1,0.0
US243-US321,1,0.0
US228-291,1,0.0
Self-help,1,0.0
volumekg-1,1,0.0
increase060,1,0.0
3-72,1,0.0
7-85,1,0.0
039-93,1,0.0
115-273,1,0.0
OR121,1,0.0
SensorMedics,1,0.0
caregiver--were,1,0.0
flash-scarcity,1,0.0
OT-2,1,0.0
Opentrons,1,0.0
QuickNavi™-COVID19,1,0.0
nontype,1,0.0
dysphonia,1,0.0
weight-of-evidence,1,0.0
lower-level,1,0.0
2006-October,1,0.0
prejudicial,1,0.0
continental-level,1,0.0
cell-inducing,1,0.0
polarising,1,0.0
stroketransitory,1,0.0
infarction-TIMI,1,0.0
Worst,1,0.0
candid,1,0.0
macrophage-dense,1,0.0
collagen-poor,1,0.0
Role-physical,1,0.0
Role-emotional,1,0.0
polarisation,1,0.0
091-117,1,0.0
092-113,1,0.0
098-120,1,0.0
118-181,1,0.0
single-allergen,1,0.0
whetted,1,0.0
2DS,1,0.0
Fluticasone,1,0.0
effusioncardiac,1,0.0
MDCTs,1,0.0
attributes--objective,1,0.0
EMQN,1,0.0
Rodgerss,1,0.0
IRL,1,0.0
1960-2014,1,0.0
Contextbackground,1,0.0
Unenhanced,1,0.0
asthma-exacerbations,1,0.0
recalibrated,1,0.0
reperfused-myocardial-infarction,1,0.0
marriages,1,0.0
grounded-theory,1,0.0
Post-pandemic,1,0.0
CPMs,1,0.0
caregivingreceiving,1,0.0
23Na-MRI,1,0.0
flavonoid,1,0.0
08582,1,0.0
TTC-staining,1,0.0
intermodality,1,0.0
hypoattenuated,1,0.0
Jalisco,1,0.0
scaring,1,0.0
11159,1,0.0
albuminous,1,0.0
non-PPCI,1,0.0
underreport,1,0.0
Huberet,1,0.0
6144,1,0.0
thalidomide,1,0.0
absurd,1,0.0
37350,1,0.0
control-group,1,0.0
Novaseq,1,0.0
MoVac-Flu,1,0.0
MoVac-COVID19S,1,0.0
elusory,1,0.0
Humour,1,0.0
coped,1,0.0
17800,1,0.0
anhydrase,1,0.0
Eustachian,1,0.0
5‑10,1,0.0
FPM,1,0.0
biglobular,1,0.0
Detected,1,0.0
semi-qualitative,1,0.0
mid-end,1,0.0
femto-,1,0.0
NextSeq,1,0.0
DRG-based,1,0.0
WAM,1,0.0
multiwayly,1,0.0
forbids,1,0.0
executors,1,0.0
worksheets,1,0.0
AH3N2Hong,1,0.0
wellknown,1,0.0
Prolongation,1,0.0
0636,1,0.0
over-fitting,1,0.0
P-terminal,1,0.0
IDSCNIIDhttpidscnihgojpindex-jhtml,1,0.0
in-lab,1,0.0
foretaste,1,0.0
antibodycytokine-based,1,0.0
20-20,1,0.0
overrun,1,0.0
preclinicalclinical,1,0.0
syndromeGBS,1,0.0
AH1N1USSR,1,0.0
48635,1,0.0
rhodopsin-like,1,0.0
83-85,1,0.0
Cytometric,1,0.0
assy,1,0.0
pH1N1Influenza,1,0.0
healthydisease,1,0.0
Clasdosporium,1,0.0
mid-size,1,0.0
unit-acquired,1,0.0
data-independent,1,0.0
al2020Phys,1,0.0
gas-blood,1,0.0
Biol17065010,1,0.0
Sunshine,1,0.0
AswineIowa151930,1,0.0
discretized,1,0.0
Kashan,1,0.0
countriesterritoriesareas,1,0.0
nonfarm,1,0.0
5300,1,0.0
classifiable,1,0.0
IAV-specific,1,0.0
developability,1,0.0
ab1-like,1,0.0
mediated-vaccine,1,0.0
hACE2-expressing,1,0.0
ACE2-adapted,1,0.0
extirpated,1,0.0
competed,1,0.0
Contradictory,1,0.0
stepsday,1,0.0
-1893,1,0.0
-511,1,0.0
-0035,1,0.0
full-size,1,0.0
≈146-230,1,0.0
10844,1,0.0
LTx,1,0.0
Supraglottitis,1,0.0
parainfluenzae,1,0.0
Rhythm-control,1,0.0
highAreas,1,0.0
125-580,1,0.0
28°C,1,0.0
Quantifiable,1,0.0
capacitive,1,0.0
prehospitally,1,0.0
nitrangin,1,0.0
positiveABSTRACT,1,0.0
Serfling-specified,1,0.0
Self-testing,1,0.0
performedExpert,1,0.0
5-64,1,0.0
Rattus,1,0.0
Pasteurella,1,0.0
VCap,1,0.0
H5N1-specific,1,0.0
immunocompetency,1,0.0
iead,1,0.0
patientâ€™s,1,0.0
largerly,1,0.0
rate-control,1,0.0
supraglottitis,1,0.0
multipathogenic,1,0.0
supraglottitisepiglottitis,1,0.0
multocida,1,0.0
polysensitized,1,0.0
overground,1,0.0
Mucous,1,0.0
outgrowing,1,0.0
N418,1,0.0
23-valent-pneumococcal,1,0.0
most-well,1,0.0
7295875,1,0.0
anti-VZV,1,0.0
stumps,1,0.0
thirdhand,1,0.0
computer-quantitated,1,0.0
MCA-occluding,1,0.0
radionuclide-gated,1,0.0
imitates,1,0.0
under-40s,1,0.0
dyslipoproteinaemia,1,0.0
malpractices,1,0.0
Cattella,1,0.0
falsifying,1,0.0
decennia,1,0.0
faking,1,0.0
non-resilient,1,0.0
heterophile,1,0.0
anti-animal,1,0.0
de-globalized,1,0.0
cross-antigens,1,0.0
N18,1,0.0
immuno-informatics,1,0.0
expecially,1,0.0
016-41,1,0.0
symptomaticasymptomatic,1,0.0
Epifactors,1,0.0
MOV10,1,0.0
Anaes,1,0.0
problemsIt,1,0.0
pseudomembranous,1,0.0
enterocolitis,1,0.0
Thebesian,1,0.0
3435,1,0.0
EP300,1,0.0
2416,1,0.0
22-41,1,0.0
characterological,1,0.0
Transcriptional,1,0.0
1900000,1,0.0
drug-based,1,0.0
ambassadors,1,0.0
co-normative,1,0.0
full-battery,1,0.0
Ambassador,1,0.0
StrokeSafe,1,0.0
lipolysis,1,0.0
strokes-chameleons,1,0.0
hundrded,1,0.0
304000,1,0.0
±162,1,0.0
vaccine-TLRs,1,0.0
Burnard,1,0.0
beneficerisk,1,0.0
SD121,1,0.0
LEADER,1,0.0
ABL1,1,0.0
Histomorphological,1,0.0
12116,1,0.0
810-250281,1,0.0
nodes-832,1,0.0
96-11586,1,0.0
spleen-715,1,0.0
trial-has,1,0.0
inhibitors-and,1,0.0
0-2899,1,0.0
PROactive,1,0.0
Pioglitazone,1,0.0
LPVRTV,1,0.0
Billroth,1,0.0
cryomassage,1,0.0
silvinite,1,0.0
impmin,1,0.0
well-expressed,1,0.0
immunocorrecive,1,0.0
spiroanalyzers,1,0.0
cardiohemodynamics,1,0.0
inodilator,1,0.0
Pharmacoeconomic,1,0.0
dobulamine,1,0.0
SUSTAIN-6,1,0.0
18-1952,1,0.0
interlimb,1,0.0
SKN-based,1,0.0
mean619,1,0.0
21-75,1,0.0
Waters,1,0.0
Antral,1,0.0
9429,1,0.0
sympathomemetic,1,0.0
sympathomemetrics,1,0.0
empathic,1,0.0
formulations-a,1,0.0
vaccine-have,1,0.0
Objects,1,0.0
seclusion,1,0.0
Bimanual,1,0.0
beta-adrenoreceptors,1,0.0
10-12-day,1,0.0
virus-driven,1,0.0
histone-like,1,0.0
hPAF1C-mediated,1,0.0
-atherosclerosis,1,0.0
FMEF,1,0.0
VII--a,1,0.0
VII-phospholipid,1,0.0
complex--in,1,0.0
allergo-immunological,1,0.0
RELA,1,0.0
hypogonadal,1,0.0
life-support,1,0.0
Viewer,1,0.0
18F-fluoro-deoxy-glucose,1,0.0
0·14-0·44,1,0.0
0·27,1,0.0
Nsp12P314L,1,0.0
autograft,1,0.0
oxygen-rich,1,0.0
19B501Y,1,0.0
20C655Y,1,0.0
Mutants,1,0.0
Mink,1,0.0
continental-wise,1,0.0
pisitive,1,0.0
high-to,1,0.0
low-transmission,1,0.0
treatmentThere,1,0.0
ps,1,0.0
groupsite,1,0.0
event-potentially,1,0.0
nature-early,1,0.0
NRCS,1,0.0
SSURGO,1,0.0
interview-administered,1,0.0
httpswwwcbligandorggvirus-ckb,1,0.0
better-targeted,1,0.0
sequencing-related,1,0.0
manuel,1,0.0
0·15,1,0.0
poultry-transmitted,1,0.0
myxoma-related,1,0.0
treadmill-based,1,0.0
cardiovascular-active,1,0.0
light-induced,1,0.0
near-UV,1,0.0
post-systolic,1,0.0
5-log,1,0.0
materialscompounds,1,0.0
alive-dead,1,0.0
6394,1,0.0
museum,1,0.0
Myxomas,1,0.0
metal-exposed,1,0.0
color-codes,1,0.0
wwwinhalatoriumcom,1,0.0
cobalt-conjugated,1,0.0
pictured,1,0.0
cobalt-specific,1,0.0
Tc-HDP,1,0.0
Therapy-I--DEFIANT,1,0.0
Nisoldipine,1,0.0
dihydroyridine,1,0.0
renin-aldosterone-angiotensin,1,0.0
enzyme-inhibitors,1,0.0
n172,1,0.0
32017,1,0.0
NGL,1,0.0
4-lead,1,0.0
TargetHunter,1,0.0
K716Q,1,0.0
K736G,1,0.0
highest-lowest,1,0.0
co-expansion,1,0.0
54K,1,0.0
beta-D-glucuronidase,1,0.0
highmountain,1,0.0
biphasic--increasing,1,0.0
high-mountain,1,0.0
MK-treated,1,0.0
3233,1,0.0
1594-3492,1,0.0
715-9,1,0.0
vRNAμL,1,0.0
Neurologys,1,0.0
GEECVSEN,1,0.0
Kakutanis,1,0.0
mock-,1,0.0
transcriptionreplication,1,0.0
nonivasive,1,0.0
star-shaped,1,0.0
branch-,1,0.0
line-shaped,1,0.0
Freshmen,1,0.0
Prostaglandins,1,0.0
flowhighest,1,0.0
V14I,1,0.0
hypokinesiaakinesia,1,0.0
DAKB-GPCRs,1,0.0
HTDocking,1,0.0
2698,1,0.0
7--86,1,0.0
viral-related,1,0.0
6--53,1,0.0
multi-cavity,1,0.0
steaming,1,0.0
sEA-affected,1,0.0
steamed,1,0.0
scanMRI,1,0.0
multiple-compound,1,0.0
1371000,1,0.0
Discharging,1,0.0
1051000,1,0.0
4270,1,0.0
TIARIND,1,0.0
reuses,1,0.0
pharmacology-target,1,0.0
knowledgebase,1,0.0
attackreversible,1,0.0
gdL-1,1,0.0
chemogenomics,1,0.0
herbal-marine,1,0.0
PCR-diagnosis,1,0.0
dobutamine-responsive,1,0.0
adenoid,1,0.0
tympanostomy-tube,1,0.0
OPSI,1,0.0
Hemorheological,1,0.0
99mTc-ECD-SPECT,1,0.0
4846,1,0.0
Extracorporal,1,0.0
7973,1,0.0
3957,1,0.0
Rita,1,0.0
3273,1,0.0
7671,1,0.0
hurricane,1,0.0
it--you,1,0.0
4343,1,0.0
60-plus,1,0.0
TIMI-4,1,0.0
flow-meter,1,0.0
SCSs,1,0.0
disease-modelling,1,0.0
designer,1,0.0
angered,1,0.0
Post-Splenectomy,1,0.0
hypoenhancement,1,0.0
hypo-enhancement,1,0.0
Neurosciences,1,0.0
health-services,1,0.0
Insurants,1,0.0
extracorporal,1,0.0
MTRH,1,0.0
Moi,1,0.0
101002wsbm129,1,0.0
repeatibility,1,0.0
Antimyocardium,1,0.0
Stereotypes,1,0.0
Perfume-,1,0.0
cologne-scented,1,0.0
Kinetic,1,0.0
WIREs,1,0.0
syncopenear-syncope,1,0.0
Min-Redundancy,1,0.0
429-445,1,0.0
Max-Relevance,1,0.0
reflux-induced,1,0.0
KNH,1,0.0
asthmaallergic,1,0.0
iso-capnic,1,0.0
Boruta,1,0.0
CDC-funded,1,0.0
hay-fever,1,0.0
65-80,1,0.0
79-85,1,0.0
dacron,1,0.0
Lipid-lowering,1,0.0
positivitynegativity,1,0.0
Strangulated,1,0.0
142227,1,0.0
Gram-positive,1,0.0
Time-motion,1,0.0
OPSI-inducing,1,0.0
219-494,1,0.0
28-32,1,0.0
1898,1,0.0
130-337,1,0.0
118-262,1,0.0
AH3N8,1,0.0
Susceptibility-weighted,1,0.0
autopsyproven,1,0.0
S-TP,1,0.0
Macrus,1,0.0
SARS-CoV-2-pandemic,1,0.0
SARS-CoV-2-carriers,1,0.0
mTORC2,1,0.0
pararadon,1,0.0
Khodzhaobigarm,1,0.0
mTORC1,1,0.0
3-K,1,0.0
incites,1,0.0
hyposensitizing,1,0.0
immunocorrective,1,0.0
spetal,1,0.0
ospital,1,0.0
Tir,1,0.0
Fermo,1,0.0
Aentricular,1,0.0
Māori,1,0.0
296471,1,0.0
7-33,1,0.0
damagerepair,1,0.0
meningitides,1,0.0
efficient--albeit,1,0.0
neglected--strategies,1,0.0
SIRV-type,1,0.0
PSS-risk,1,0.0
19978,1,0.0
ANanchang93395H3N2,1,0.0
AJohannesburg8296H1N1,1,0.0
nonatherogenic,1,0.0
effectspotentials,1,0.0
50-53,1,0.0
19-26,1,0.0
n376,1,0.0
CD9,1,0.0
communicator,1,0.0
Radiologically,1,0.0
wwwasrtorgstore,1,0.0
Demography,1,0.0
day-2,1,0.0
NNECDSG,1,0.0
cohort-based,1,0.0
vaccine-inherent,1,0.0
psychoanalytic,1,0.0
hypothesis-seeking,1,0.0
noninvasivity,1,0.0
OSIRIS,1,0.0
w-eks,1,0.0
Omura,1,0.0
algorithm-linear,1,0.0
e65,1,0.0
Sleep-wake,1,0.0
wavenumbers,1,0.0
SenseWear,1,0.0
γ-irradiated,1,0.0
priori-selected,1,0.0
Fourier-transform,1,0.0
superfast,1,0.0
antigen-test,1,0.0
ultrarapid,1,0.0
macrostructural,1,0.0
corticopontocerebellar,1,0.0
Neurodegeneration,1,0.0
mechanistic-neuroanatomical,1,0.0
agency-approved,1,0.0
pre-approved,1,0.0
pro-oxidative,1,0.0
peracetic,1,0.0
fluorescence-activated,1,0.0
emigrate,1,0.0
metallothionein,1,0.0
hypochlorous,1,0.0
HSPC-derived,1,0.0
stroke-Smith,1,0.0
GA-LDA,1,0.0
blood-CSF,1,0.0
apelin-novel,1,0.0
aspirinday,1,0.0
imperception,1,0.0
nieces,1,0.0
MMFR,1,0.0
recomposed,1,0.0
MMRF,1,0.0
secondForced,1,0.0
1278,1,0.0
IRAnon-IRA,1,0.0
haemorhhagic,1,0.0
minispirometer,1,0.0
cilostazolday,1,0.0
single-institution,1,0.0
Thd,1,0.0
Intimate,1,0.0
3460,1,0.0
Anantham,1,0.0
thn,1,0.0
Buteykos,1,0.0
paired-associate,1,0.0
1970-1973,1,0.0
touchscreen-based,1,0.0
overvaluing,1,0.0
hESCs,1,0.0
plexuses,1,0.0
SARS-Coronavirus,1,0.0
slur,1,0.0
STangiography,1,0.0
Senchenkova,1,0.0
conserves,1,0.0
Etanercept,1,0.0
TNF-alpha-blocking,1,0.0
immunology-based,1,0.0
nurtures,1,0.0
Goal-driven,1,0.0
600mg,1,0.0
24g,1,0.0
fraxiparine,1,0.0
plasmaphereses,1,0.0
rs1696718G,1,0.0
036year,1,0.0
rs16986718,1,0.0
RPGN,1,0.0
episodesyear,1,0.0
3658,1,0.0
upweighting,1,0.0
8283,1,0.0
Re-infection,1,0.0
perinuclear,1,0.0
road-connected,1,0.0
Overshoot,1,0.0
overshoot,1,0.0
195000,1,0.0
RVFPLVFP,1,0.0
listserv,1,0.0
4159,1,0.0
superintendent,1,0.0
Toxline,1,0.0
Kaur,1,0.0
Tsunoda,1,0.0
Peirce,1,0.0
Gavins,1,0.0
Metallothionein,1,0.0
rate-heart,1,0.0
mortalitysudden,1,0.0
Afterdark,1,0.0
Bios,1,0.0
Agricola,1,0.0
gordox,1,0.0
Ottawa-Carleton,1,0.0
76085,1,0.0
contrycal,1,0.0
12-2-fold,1,0.0
patient-to-HCP,1,0.0
HCP-to-HCP,1,0.0
enjoyable,1,0.0
non-wheelchair,1,0.0
Municipality,1,0.0
infectionSARI,1,0.0
2010-January,1,0.0
2012-March,1,0.0
10320,1,0.0
9-24,1,0.0
IL-23IL-17,1,0.0
epitopes-based,1,0.0
paraganglia,1,0.0
Locomotor,1,0.0
videotaping,1,0.0
rechallenge,1,0.0
BrdU-injected,1,0.0
coronaviruses2,1,0.0
group-2B,1,0.0
hyperlocomotor,1,0.0
Perfusion-diffusion,1,0.0
EPF,1,0.0
Escalating,1,0.0
PRRAR,1,0.0
countries-as,1,0.0
pandemic1-has,1,0.0
SARS-CoV-2-a,1,0.0
collagenization,1,0.0
2020-fewer,1,0.0
exudative-proliferative,1,0.0
scientific-sounding,1,0.0
interventionalist,1,0.0
Nissl,1,0.0
2793le,1,0.0
protein-carbohydrate,1,0.0
2337le,1,0.0
ai,1,0.0
polyelectrode,1,0.0
newly-divided,1,0.0
5-bromo-2-dexoyuridine,1,0.0
orB,1,0.0
08-61,1,0.0
organizationscommunities,1,0.0
soon-to-be-approved,1,0.0
sensationalizing,1,0.0
lightest,1,0.0
Bio-rad,1,0.0
IgAIgGIgM,1,0.0
I338V,1,0.0
S220T,1,0.0
Pre-intervention,1,0.0
P100S,1,0.0
case-control-study,1,0.0
SARS-CoV-2-vaccination,1,0.0
makingAimOur,1,0.0
45-95,1,0.0
SARS-CoV-2-vaccine,1,0.0
sero-epidemiology,1,0.0
20-99,1,0.0
-32-95,1,0.0
testConclusionUsing,1,0.0
p0106,1,0.0
Heparinised,1,0.0
controlsResultsIgG,1,0.0
groupThe,1,0.0
studiesMethodsWe,1,0.0
mass-gathering,1,0.0
NP-positive,1,0.0
-DWI-positivity-,1,0.0
moderate-to,1,0.0
SARS-CoV-2-containing,1,0.0
vistas,1,0.0
MIP-1,1,0.0
polyIC-stimulated,1,0.0
tetracosactrin,1,0.0
Baum,1,0.0
Alina,1,0.0
Kyratsous,1,0.0
Christos,1,0.0
transducing,1,0.0
Subclassification,1,0.0
dander-specific,1,0.0
proIL-1,1,0.0
danderpelt,1,0.0
ox,1,0.0
proIL-18,1,0.0
HLA-DRB10101,1,0.0
HLA-A0206,1,0.0
Sarcomere,1,0.0
non-allergenicity,1,0.0
DSVIV,1,0.0
viPR,1,0.0
invasivity,1,0.0
arrhythmogenicity,1,0.0
deepest,1,0.0
protein-enriched,1,0.0
BGCs,1,0.0
Bowmans,1,0.0
secretion-hand,1,0.0
19-402,1,0.0
144-310,1,0.0
798-993,1,0.0
564-910,1,0.0
genetic-environmental,1,0.0
038-043,1,0.0
057-064,1,0.0
opsonized,1,0.0
mid-1972,1,0.0
063-077,1,0.0
Lang,1,0.0
object-hand-mucous,1,0.0
RNF5,1,0.0
neutrophil-dominated,1,0.0
468000,1,0.0
5400,1,0.0
colliquative,1,0.0
PB1-RNF5-MAVS-NBR1,1,0.0
RIG-I-MAVS-mediated,1,0.0
ubiquitinated,1,0.0
hyposmiaanosmia,1,0.0
Lys461,1,0.0
Lys362,1,0.0
K27-linked,1,0.0
anginanon-ST-segment,1,0.0
fall-winter,1,0.0
over-50,1,0.0
Kong13512002,1,0.0
H5N1-NA,1,0.0
Immunotoxicity,1,0.0
Try347,1,0.0
spot-like,1,0.0
erodes,1,0.0
immunorehabilitation,1,0.0
late-reaction,1,0.0
SIL-2R,1,0.0
immunobiologic,1,0.0
Nonperioperative,1,0.0
nonperioperative,1,0.0
post-infection-although,1,0.0
2006-H5N1-NA,1,0.0
2009-H1N1-NA,1,0.0
AcalDuschanbe5571,1,0.0
2006-H5N1,1,0.0
sub-homogeneous,1,0.0
unduplicated,1,0.0
0796-0804,1,0.0
Willcox,1,0.0
bounded,1,0.0
Newfoundland,1,0.0
ACCFAHA,1,0.0
linearize,1,0.0
Kong-like,1,0.0
bulky,1,0.0
efforts--at,1,0.0
diagnostician,1,0.0
Suburban,1,0.0
TagPath,1,0.0
asthmaConclusion,1,0.0
total-,1,0.0
low-titer,1,0.0
all-comers,1,0.0
low-viral-titer,1,0.0
well-instructed,1,0.0
age-standard,1,0.0
689-156,1,0.0
factor-matched,1,0.0
143-962,1,0.0
3781,1,0.0
exoskeleton,1,0.0
best-accepted,1,0.0
14398,1,0.0
2004-2015Results,1,0.0
sebum-rich,1,0.0
Diseases-10,1,0.0
HO-17-17558,1,0.0
BECMethods,1,0.0
oath,1,0.0
Demodecidae,1,0.0
Pyemotidae,1,0.0
arthropod-coronavirus,1,0.0
infinity,1,0.0
BShizuoka52001,1,0.0
ABCDE,1,0.0
Dirac,1,0.0
daltons,1,0.0
FEV110,1,0.0
smoothed,1,0.0
SARS-cov-2,1,0.0
1741,1,0.0
EQ-5D-Y,1,0.0
Plasticity,1,0.0
cytoarchitectural,1,0.0
daytime-unwitnessed,1,0.0
patient-matched,1,0.0
sera-characteristics,1,0.0
nsp1-16,1,0.0
p6,1,0.0
p7a,1,0.0
p8ab,1,0.0
p9b,1,0.0
hetero-oligomeric,1,0.0
manifestations1–3,1,0.0
Covid‐2019,1,0.0
pattern-recognition,1,0.0
dyscrasia,1,0.0
visceromegaly,1,0.0
regionspatient,1,0.0
ABCD2-score,1,0.0
034-43,1,0.0
Sephadex,1,0.0
unimodality,1,0.0
G-200,1,0.0
205-2540,1,0.0
31-50,1,0.0
compacted,1,0.0
Meningococci,1,0.0
semiflow,1,0.0
Würzburg,1,0.0
Khamitov,1,0.0
toxigenic,1,0.0
ulcerans,1,0.0
unencapsulated,1,0.0
Omotuyi,1,0.0
96-120,1,0.0
DRV,1,0.0
stressExpert,1,0.0
166-1956,1,0.0
Chu,1,0.0
115-5560,1,0.0
goldminers,1,0.0
ST-SE,1,0.0
anterior-second,1,0.0
Hirschberg,1,0.0
postneonatal,1,0.0
Price,1,0.0
stimuliAreas,1,0.0
post-respiratory,1,0.0
itra-aortic,1,0.0
conterpulsation,1,0.0
populism,1,0.0
CEPs,1,0.0
drug-targets,1,0.0
agents1-5,1,0.0
B1618,1,0.0
viruses-particularly,1,0.0
variant-seemed,1,0.0
biomonitoring,1,0.0
hoof,1,0.0
zebras,1,0.0
conformal,1,0.0
orgasmic,1,0.0
vaccinetherapeutic,1,0.0
carbogen,1,0.0
182-392,1,0.0
dapsone,1,0.0
leprosy,1,0.0
leprosy-related,1,0.0
gangliosides,1,0.0
highly-pathogenic,1,0.0
Quinacrine,1,0.0
noncompetitive,1,0.0
Lancashire,1,0.0
Stephania,1,0.0
cepharantha,1,0.0
Hayata,1,0.0
6328,1,0.0
surfact,1,0.0
113mIn,1,0.0
stretchable,1,0.0
nano-neuroprotectants,1,0.0
Special-risk,1,0.0
Charter,1,0.0
four-parameter,1,0.0
concentration-,1,0.0
382-7384,1,0.0
99260,1,0.0
xTAG®,1,0.0
microgrammin,1,0.0
slowly-expanding,1,0.0
Non-detectable,1,0.0
Afew,1,0.0
Nano-neuroprotectants,1,0.0
caesium,1,0.0
63874,1,0.0
20-39-year-olds,1,0.0
ajacent,1,0.0
palpitation,1,0.0
Aikewei,1,0.0
6-yr,1,0.0
normocapnia,1,0.0
caesium-131,1,0.0
infarction--in,1,0.0
60-79,1,0.0
supercapacitors,1,0.0
LG-75,1,0.0
primal,1,0.0
CGNHCAU,1,0.0
post-inspiration,1,0.0
prednisoneprednisolone,1,0.0
pandemicH1N1,1,0.0
2-nt,1,0.0
November-19,1,0.0
ever-popular,1,0.0
community-university,1,0.0
sill,1,0.0
H1N1pre,1,0.0
well-synchronized,1,0.0
intervention-related,1,0.0
MiR-20a-5p,1,0.0
skip-and-resurgence,1,0.0
cause-oriented,1,0.0
autophagy-modulated,1,0.0
stepping-stones,1,0.0
sputum-IL-26,1,0.0
3-Methyladenine,1,0.0
autophagy-induced,1,0.0
non-stress,1,0.0
ATG7-modulated,1,0.0
Mpn,1,0.0
Compounded,1,0.0
COVid-19,1,0.0
angioinvasive,1,0.0
Fluview,1,0.0
Intralobar,1,0.0
His274Tyr,1,0.0
undetectably,1,0.0
apnea-associated,1,0.0
rhythmogenic,1,0.0
dysrhythmic,1,0.0
cardiovagal,1,0.0
gynecologist,1,0.0
mother-to-be,1,0.0
morphohistological,1,0.0
18-36,1,0.0
12-48,1,0.0
roentgenographically,1,0.0
16-53,1,0.0
12-91,1,0.0
4-channel,1,0.0
digest,1,0.0
MESAM,1,0.0
respiratory-disturbance-index,1,0.0
bodyHaving,1,0.0
441395,1,0.0
94h,1,0.0
500-1100,1,0.0
flanker,1,0.0
Gadolinium-based,1,0.0
late-enhancement,1,0.0
20717,1,0.0
ACEACE2,1,0.0
calculated--and,1,0.0
GNHCA,1,0.0
Tan,1,0.0
felis,1,0.0
reencountered,1,0.0
α-HL,1,0.0
Ras-mediated,1,0.0
α-hemolysin,1,0.0
non-polio,1,0.0
Wallinga,1,0.0
Teunis,1,0.0
permeabilization,1,0.0
mutationsmonth,1,0.0
FECV,1,0.0
lysophospholipids,1,0.0
FIPC,1,0.0
Calicivirus,1,0.0
detergentlike,1,0.0
phospholipases,1,0.0
18Fluorodesoxyglucose,1,0.0
FCV,1,0.0
Herpesvirus-1,1,0.0
FHV-1,1,0.0
Parvovirus,1,0.0
infantum,1,0.0
Anaplasma,1,0.0
petition,1,0.0
phagocytophilum,1,0.0
Toxoplasma,1,0.0
region-binding,1,0.0
hapten-carrier,1,0.0
51586∼74063,1,0.0
0802,1,0.0
3444-2218,1,0.0
FMSF,1,0.0
14-06,1,0.0
non-RT,1,0.0
gratification,1,0.0
Singaporeans,1,0.0
795CT,1,0.0
924CT,1,0.0
57-item,1,0.0
mutuality,1,0.0
FDG-avid,1,0.0
0857,1,0.0
0408-0876,1,0.0
subcentimeter,1,0.0
I-CVI,1,0.0
twenty-five-year,1,0.0
～100,1,0.0
S-CVI,1,0.0
0807,1,0.0
item-to-subscale,1,0.0
0513-0865,1,0.0
intersubscale,1,0.0
0195-0604,1,0.0
subscale-to-total,1,0.0
gondii,1,0.0
NTAGI,1,0.0
httpwwwlphfgovbeepidemio,1,0.0
short-termlong-term,1,0.0
nonaffected,1,0.0
05022020,1,0.0
16012020-19022020,1,0.0
Bethlehem,1,0.0
encircle,1,0.0
SRAS-CoV-2,1,0.0
ketorolac,1,0.0
anaphylactic-type,1,0.0
Bronchospastic-,1,0.0
melatonins,1,0.0
urinary-sulfatoxymelatonin,1,0.0
non-bronchodilator,1,0.0
N2NA,1,0.0
oscillator,1,0.0
chemokinescytokines,1,0.0
H3HA,1,0.0
co-evolving,1,0.0
microcosm,1,0.0
httpswwwaasldorgabout-aasldcovid-19-resources,1,0.0
94-95,1,0.0
12841,1,0.0
UTP,1,0.0
kinease,1,0.0
Syndrome-Coronavirus-2,1,0.0
NHC-monophosphate,1,0.0
two-doses,1,0.0
practiceIn,1,0.0
Hood,1,0.0
Dirks,1,0.0
petitioner,1,0.0
7-day12-month,1,0.0
ethicacy,1,0.0
deltaalpha,1,0.0
queuesor,1,0.0
discord,1,0.0
sleuth,1,0.0
deltathetaalphabeta,1,0.0
Sriyal,1,0.0
DTABR,1,0.0
award,1,0.0
strategiesGraphical,1,0.0
Robin,1,0.0
7692,1,0.0
exemplificative,1,0.0
Diesse,1,0.0
ELFA,1,0.0
bioMerieux,1,0.0
44-61,1,0.0
contaminant,1,0.0
BVA,1,0.0
redistributive,1,0.0
value-generating,1,0.0
patientsIn,1,0.0
microangiopathy-related,1,0.0
Tock,1,0.0
Culturing,1,0.0
thoracolaryngopelvic,1,0.0
igraph,1,0.0
P2P,1,0.0
Linker,1,0.0
pandemicsin,1,0.0
Unanswered,1,0.0
01-42,1,0.0
17-104,1,0.0
18-46,1,0.0
NetBox,1,0.0
logFC,1,0.0
15-97,1,0.0
GSE29111,1,0.0
GSE22229,1,0.0
KRSFIEDLLFNKV,1,0.0
COMIRB,1,0.0
20-1007,1,0.0
BioIngine,1,0.0
experimentally-validated,1,0.0
calibre-mass,1,0.0
disease-to-contralateral,1,0.0
5602,1,0.0
19726,1,0.0
Quiz,1,0.0
theta-band,1,0.0
3142,1,0.0
kyoto,1,0.0
LCK,1,0.0
actuations,1,0.0
LiverLearning,1,0.0
thrombo-embolisation,1,0.0
teletriage,1,0.0
complaintpresentation,1,0.0
3560,1,0.0
018-082,1,0.0
044-076,1,0.0
Manuscripts,1,0.0
case-to-case,1,0.0
hysterotomy,1,0.0
Renilla,1,0.0
cytopathic-effect-based,1,0.0
2-interferon,1,0.0
94-98,1,0.0
Duodenal,1,0.0
flop,1,0.0
sympathetically,1,0.0
teleological,1,0.0
CD8A,1,0.0
IL2,1,0.0
thwarts,1,0.0
HLA-DRA,1,0.0
HDM-sensitive,1,0.0
CD3D,1,0.0
CD247,1,0.0
4-9-year-old,1,0.0
presurgical,1,0.0
intra-procedural,1,0.0
36-day-old,1,0.0
Short-course,1,0.0
1231,1,0.0
Plt0001,1,0.0
immuen,1,0.0
abormally,1,0.0
imunity,1,0.0
headquartered,1,0.0
interferonopathies,1,0.0
5643,1,0.0
17-83,1,0.0
9545,1,0.0
7386,1,0.0
pseudoangiomatosis,1,0.0
6591,1,0.0
eruptive,1,0.0
ETI,1,0.0
4387,1,0.0
papular-purpuric,1,0.0
Hoechst-Roussel,1,0.0
Paraviral,1,0.0
acute-subacute,1,0.0
fill-finishing,1,0.0
Leptomeningeal,1,0.0
mundane,1,0.0
ICCs,1,0.0
reischemia,1,0.0
infarction-linked,1,0.0
CpG-GNP,1,0.0
landbased,1,0.0
end-distending,1,0.0
virusses,1,0.0
bright-blood,1,0.0
toured,1,0.0
T2-Weighted,1,0.0
Risk-based,1,0.0
concanavalin,1,0.0
FMLP,1,0.0
upshot,1,0.0
pastime,1,0.0
asthmogenicity,1,0.0
3-hydroxy-3-methylglutaryl-CoA,1,0.0
Västerbotten,1,0.0
Neurointerventional,1,0.0
burn-out,1,0.0
Riley,1,0.0
neuroradiology-specific,1,0.0
Whitcomb,1,0.0
Immunomodulating,1,0.0
187-400,1,0.0
homoeostatic,1,0.0
nanoparticle-CpG,1,0.0
2876,1,0.0
3406,1,0.0
Intra-procedural,1,0.0
pro-vasoconstrictive,1,0.0
percolating,1,0.0
Universidade,1,0.0
impatient,1,0.0
reanalyzing,1,0.0
inpatient-specific,1,0.0
Proteomics,1,0.0
gender-sensitive,1,0.0
Concentrating,1,0.0
3815,1,0.0
inter-alveolar,1,0.0
Cq-values,1,0.0
174-498-fold,1,0.0
amuscular,1,0.0
peri-venular,1,0.0
6185,1,0.0
Three-dimensionally,1,0.0
bronchoarterial,1,0.0
3DP,1,0.0
1-285,1,0.0
hyaluronate-based,1,0.0
OIFI,1,0.0
cryptococcosis,1,0.0
B-ultrasound,1,0.0
Mycormycosis,1,0.0
2087,1,0.0
CK-gm-eqm2,1,0.0
73280,1,0.0
Theyen,1,0.0
monothematic,1,0.0
elses,1,0.0
Stylistic,1,0.0
Seng,1,0.0
1Th2,1,0.0
rupture-related,1,0.0
time-trends,1,0.0
Kyunghee,1,0.0
Anseriformes,1,0.0
Charadriiformes,1,0.0
effectABSTRACT,1,0.0
35-year,1,0.0
feedings,1,0.0
paralinguistic,1,0.0
12909,1,0.0
Sperner,1,0.0
detangle,1,0.0
VirusMuT,1,0.0
Woods,1,0.0
anatomically-correct,1,0.0
httpsbigdbigaccnbiocodetoolsBT007081,1,0.0
factoring,1,0.0
non-influenza-related,1,0.0
exportations,1,0.0
7100000,1,0.0
Hartel,1,0.0
Schilling,1,0.0
35-93,1,0.0
Obitos,1,0.0
paracentesis,1,0.0
Verificação,1,0.0
RU-group,1,0.0
Pacritinib,1,0.0
Ergotamine,1,0.0
verity,1,0.0
Typhoon,1,0.0
Gln27Glu,1,0.0
polymorphisms-Arg16Gly,1,0.0
MFCD02180753,1,0.0
Clofazimine,1,0.0
Gly,1,0.0
populationNeither,1,0.0
attentuated,1,0.0
Abivertinib,1,0.0
Dasabuvir,1,0.0
Leuconicine,1,0.0
20ns,1,0.0
Non-PCR,1,0.0
Non-conventional,1,0.0
201-TL,1,0.0
Condorelli,1,0.0
NMIs,1,0.0
DiSTRIBuTE,1,0.0
Seen,1,0.0
subserosal,1,0.0
6351,1,0.0
IPFs,1,0.0
NPASS,1,0.0
Pubchem,1,0.0
word-verb,1,0.0
78-92,1,0.0
-45-94,1,0.0
Serviço,1,0.0
64-82,1,0.0
transculturation,1,0.0
HBOT-related,1,0.0
spokespersons,1,0.0
pharmaceuticalization,1,0.0
hegemony,1,0.0
On-Off,1,0.0
WHO-listed,1,0.0
HyberBaric,1,0.0
duplication,1,0.0
httpsbitly3mup0hS,1,0.0
disposing,1,0.0
nonneutralizing,1,0.0
N2-specific,1,0.0
actualized,1,0.0
provider-related,1,0.0
glycoproteins-haemagglutinin,1,0.0
1-92,1,0.0
state-designated,1,0.0
cranialis,1,0.0
polyneuritis,1,0.0
4182-3010,1,0.0
23-47,1,0.0
2501,1,0.0
Kruskall-Wallis,1,0.0
SCUs,1,0.0
9-11-year-old,1,0.0
1064838,1,0.0
dome-like,1,0.0
endomyocardium,1,0.0
ink,1,0.0
36754395,1,0.0
Holland,1,0.0
distracting,1,0.0
reckoner,1,0.0
laboured,1,0.0
-cost,1,0.0
phosphorylation-dependent,1,0.0
7234,1,0.0
protein-C,1,0.0
influenza-like-illnesses,1,0.0
157-173,1,0.0
non-work,1,0.0
spousessexual,1,0.0
IA--acute,1,0.0
zero-covid,1,0.0
136-625,1,0.0
118-259,1,0.0
IB--acute,1,0.0
IIA--acute,1,0.0
5-7-,1,0.0
post-TIA,1,0.0
Pharmacotherapeutic,1,0.0
musclederived,1,0.0
101-173,1,0.0
059-102,1,0.0
FLURESP,1,0.0
Thrombopoietin,1,0.0
-385,1,0.0
doxorubicin-induced,1,0.0
963100000,1,0.0
-486,1,0.0
nonprivate,1,0.0
-270,1,0.0
antagomiRs,1,0.0
geographics,1,0.0
1993-October,1,0.0
omits,1,0.0
child-raising,1,0.0
Patient-centred,1,0.0
provider-patientparent,1,0.0
AH1N1-infected,1,0.0
multidetermined,1,0.0
dyscontrol,1,0.0
387C,1,0.0
CD8-positive,1,0.0
Immunohistochemically,1,0.0
specifically-a,1,0.0
B--acute,1,0.0
Mann,1,0.0
114-185,1,0.0
likelycertain,1,0.0
FAE,1,0.0
context-dependent,1,0.0
para-infectious,1,0.0
consequentiality,1,0.0
vertebrogenic,1,0.0
intrahousehold,1,0.0
hematogenic,1,0.0
01201,1,0.0
snowmobile,1,0.0
30-55,1,0.0
computer-interpreted,1,0.0
mortality--have,1,0.0
time-savers--and,1,0.0
hospital-initiated,1,0.0
inhibitordiuretic,1,0.0
paramedic-initiated,1,0.0
DPO,1,0.0
nosogenic,1,0.0
bitherapy,1,0.0
perindoprilindapamide,1,0.0
ic700,1,0.0
specimenssamples,1,0.0
191-205,1,0.0
spleen-deficency,1,0.0
106-225,1,0.0
exalted,1,0.0
Rhône,1,0.0
preexposure,1,0.0
FEV1--measured,1,0.0
likelyvery,1,0.0
049-085,1,0.0
-2092,1,0.0
8695,1,0.0
39-43,1,0.0
HK,1,0.0
Whitney,1,0.0
GZ,1,0.0
self-serving,1,0.0
Alerting,1,0.0
familiarise,1,0.0
trasmural,1,0.0
vinca,1,0.0
fibreoscopy,1,0.0
Prednisolone,1,0.0
05-075,1,0.0
doubted,1,0.0
Bouin,1,0.0
Paraffin,1,0.0
immuno-peroxidasic,1,0.0
VFS,1,0.0
persistencesurvivability,1,0.0
multitiered,1,0.0
lympho-monocytic,1,0.0
-844GA,1,0.0
104-142,1,0.0
fortified,1,0.0
depression-like,1,0.0
Movement-Specific,1,0.0
non-recent,1,0.0
Overtreatment,1,0.0
baumanii,1,0.0
pseudomallei,1,0.0
Burkholderia,1,0.0
Blindly,1,0.0
single-year,1,0.0
strategy-clinical,1,0.0
Travel-associated,1,0.0
APHA,1,0.0
ACE2-Fc,1,0.0
secforced,1,0.0
OR370,1,0.0
CI110-1242,1,0.0
infectionWe,1,0.0
OR355,1,0.0
CI118-1067,1,0.0
OR434,1,0.0
CI173-1086,1,0.0
FEV1FVC106,1,0.0
CI102-111,1,0.0
Prevention-developed,1,0.0
reocclude,1,0.0
insulars,1,0.0
277-1305,1,0.0
pre-existingMERS-CoV,1,0.0
350-1822,1,0.0
httpsdoiorg102105AJPH2021306424,1,0.0
leftist,1,0.0
P0·02,1,0.0
Disinformation,1,0.0
1·6-1·7,1,0.0
case-information,1,0.0
Atila,1,0.0
iAMP,1,0.0
Coronavirus‐2,1,0.0
GS,1,0.0
flag,1,0.0
practice-wide,1,0.0
2021111101772-1775,1,0.0
132-2730,1,0.0
wraparound,1,0.0
High-intensity,1,0.0
10662,1,0.0
5575,1,0.0
2011-2014,1,0.0
nonworkers,1,0.0
polyoxometalate,1,0.0
17-22,1,0.0
levophase,1,0.0
Appearance,1,0.0
SDF-1,1,0.0
insulas,1,0.0
hydroxylase,1,0.0
CAn,1,0.0
Toluca,1,0.0
Eprosartan,1,0.0
2670,1,0.0
7243,1,0.0
COgnition,1,0.0
pharmacologically-induced,1,0.0
adequately-sized,1,0.0
ACTOR,1,0.0
clinical-angiographic,1,0.0
Losartan-based,1,0.0
Mid-Atlantic,1,0.0
n239,1,0.0
F2G,1,0.0
million-,1,0.0
wafarin,1,0.0
Formative,1,0.0
n1761,1,0.0
spirometer-controlled,1,0.0
PAI-1s,1,0.0
bomb,1,0.0
27100000,1,0.0
8336,1,0.0
14403,1,0.0
110100000,1,0.0
164ABSTRACT,1,0.0
HindIII,1,0.0
groups768,1,0.0
receptor-gamma,1,0.0
globule,1,0.0
SHI,1,0.0
Liddle,1,0.0
httpwwwnicdacza,1,0.0
reninlow,1,0.0
Chagasic,1,0.0
Rupture-prone,1,0.0
failure--the,1,0.0
incretin,1,0.0
glucoregulatory,1,0.0
suggesting--in,1,0.0
linagliptin,1,0.0
receptor-dependent,1,0.0
DMP-P,1,0.0
unentangled,1,0.0
cromione,1,0.0
broncho-dilator,1,0.0
pheasants,1,0.0
pigeon,1,0.0
Live-bird,1,0.0
eradicable,1,0.0
obfuscate,1,0.0
workflow-COVseq-which,1,0.0
Two-way,1,0.0
photocopies,1,0.0
unbiasedly,1,0.0
1287726,1,0.0
RDA,1,0.0
cruise-liner,1,0.0
nonconclusive,1,0.0
RIFLE,1,0.0
Midwives,1,0.0
TSL,1,0.0
CMR-derived,1,0.0
SureFast®,1,0.0
Kant,1,0.0
Descartes,1,0.0
eye-movement,1,0.0
assimilates,1,0.0
dogmatic,1,0.0
antidualism,1,0.0
VOG-HINTS,1,0.0
dualism,1,0.0
Cartesian,1,0.0
7ABSTRACT,1,0.0
Powdered,1,0.0
immunoradiometric,1,0.0
mores,1,0.0
5187,1,0.0
41-61,1,0.0
2006-20,1,0.0
terminator,1,0.0
favipiravir-resistant,1,0.0
pleuroscopy,1,0.0
Sensor,1,0.0
EB-CT,1,0.0
Electron-Beam,1,0.0
Platonist,1,0.0
moya-moya,1,0.0
high-fat,1,0.0
airliner,1,0.0
pre-date,1,0.0
to11,1,0.0
hypoxic-ischaemic,1,0.0
Cholinesterase,1,0.0
Sc-ACT,1,0.0
75-90,1,0.0
AGC,1,0.0
methylglutaryl,1,0.0
0016x,1,0.0
Slits,1,0.0
structure-to-function,1,0.0
overinflated,1,0.0
condition-associated,1,0.0
autosutures,1,0.0
Appalachian,1,0.0
encircled,1,0.0
Cartesianism,1,0.0
KApSR,1,0.0
Appalachia,1,0.0
color-mapped,1,0.0
misleadingly,1,0.0
ascetics,1,0.0
cemeteries,1,0.0
Mortuaries,1,0.0
inoperative,1,0.0
2004-2014,1,0.0
Immuno-allergic,1,0.0
00101,1,0.0
0064,1,0.0
Locating,1,0.0
time-reversal,1,0.0
diffusion-like,1,0.0
Rackemanns,1,0.0
64-slice,1,0.0
Reconsidering,1,0.0
calcifediol,1,0.0
forgone,1,0.0
mid-2008,1,0.0
320-slice,1,0.0
post-stenotic,1,0.0
Elecsys-S,1,0.0
geometrically,1,0.0
Rung-Kutta,1,0.0
Elecsys-N,1,0.0
Bimodal,1,0.0
costomediastinal,1,0.0
N-RBD,1,0.0
bi-phasic,1,0.0
68-105,1,0.0
deviationschord,1,0.0
0104,1,0.0
Rackeman,1,0.0
AMI-both,1,0.0
shuntogram,1,0.0
UK-B117,1,0.0
frightened,1,0.0
hurt,1,0.0
E484KK417N,1,0.0
homozygosity,1,0.0
SA-N501YK417NE484K,1,0.0
UK-N501Y,1,0.0
SA-B1351,1,0.0
non-fibrin,1,0.0
patient-group,1,0.0
time-spanABSTRACT,1,0.0
Speakers,1,0.0
Pfizer-BTN162b2,1,0.0
non-coronarogenic,1,0.0
10110,1,0.0
10010,1,0.0
00110,1,0.0
00100,1,0.0
00010,1,0.0
NCEP,1,0.0
Jenners,1,0.0
excursus,1,0.0
AMR-related,1,0.0
ESCACCFAHAWHF,1,0.0
Swineford,1,0.0
socio-behavioral,1,0.0
hypolipidaemic,1,0.0
36493,1,0.0
72284,1,0.0
0756,1,0.0
80-96,1,0.0
≈05,1,0.0
Post-vaccine,1,0.0
mixed-cell,1,0.0
microabscess,1,0.0
patients--particularly,1,0.0
non-ideal,1,0.0
Recuscitation,1,0.0
2000-2008,1,0.0
polyacrylamide,1,0.0
H3M,1,0.0
1970-1979,1,0.0
attractiveness,1,0.0
nonmetal,1,0.0
shard,1,0.0
Uniformity,1,0.0
3904,1,0.0
2003-2019,1,0.0
Malpractice,1,0.0
34-47,1,0.0
whisky,1,0.0
anticoagulantantiplatelet,1,0.0
TaiHao,1,0.0
fungal-related,1,0.0
0490,1,0.0
0464,1,0.0
0345,1,0.0
sit-to-stand,1,0.0
Allowance,1,0.0
104646,1,0.0
3431,1,0.0
22559,1,0.0
512214,1,0.0
three-year-old,1,0.0
non-English,1,0.0
subsegment,1,0.0
unknownThe,1,0.0
nondraining,1,0.0
apexcardiogram,1,0.0
B-positive,1,0.0
0347,1,0.0
mechanocardiographic,1,0.0
apex-carotis,1,0.0
2267,1,0.0
13398,1,0.0
phonocardiogram,1,0.0
anti-neuraminidases,1,0.0
administratively,1,0.0
event-study,1,0.0
procedure-dependent,1,0.0
fibrillaton,1,0.0
0124,1,0.0
eczema--was,1,0.0
methylxanthine,1,0.0
androgenic-anabolic,1,0.0
symptoms--nocturnal,1,0.0
-167,1,0.0
CBL,1,0.0
fractiles,1,0.0
referee,1,0.0
6050,1,0.0
VAV1,1,0.0
httpbiosoftkaistackr8080resourcesasthmappi,1,0.0
00024,1,0.0
antiplatelet-treated,1,0.0
Reno,1,0.0
SARS-CoV-2-strains,1,0.0
SARS-CoV-2-PCR-positive,1,0.0
3241092,1,0.0
37-week,1,0.0
non-advantages,1,0.0
½,1,0.0
CORE,1,0.0
MagMAX™,1,0.0
1792-2112,1,0.0
475-666,1,0.0
119-227,1,0.0
Strasbourg,1,0.0
194-284,1,0.0
non-nitrates,1,0.0
111-278,1,0.0
-69,1,0.0
substructure,1,0.0
power-law,1,0.0
benefit-to-cost,1,0.0
less-frequent,1,0.0
082-098,1,0.0
mid-2004,1,0.0
apart-one,1,0.0
Index-2010,1,0.0
B0,1,0.0
168-item,1,0.0
trans-fatty,1,0.0
056-151,1,0.0
86000,1,0.0
spatial-structural,1,0.0
mass-produce,1,0.0
non-US,1,0.0
Phenomenological,1,0.0
Rhineland-Palatinate,1,0.0
adolescent-caregiver,1,0.0
P0026,1,0.0
Eight-hundred-and-nineteen,1,0.0
creepy,1,0.0
world”,1,0.0
headed,1,0.0
“microbes,1,0.0
Dudley,1,0.0
Road,1,0.0
non-belonging,1,0.0
weaners,1,0.0
lively,1,0.0
271-fold,1,0.0
Caslav,1,0.0
Kutna,1,0.0
PHC-known,1,0.0
perfusion-fixed,1,0.0
highly-qualified,1,0.0
xxxx,1,0.0
Hora,1,0.0
Znojmo,1,0.0
BJOG,1,0.0
fa,1,0.0
post‐symptomatic,1,0.0
tality,1,0.0
Bupivacaine,1,0.0
pre‐,1,0.0
Prabhu,1,0.0
wave”,1,0.0
“second,1,0.0
cal,1,0.0
6mg,1,0.0
hemorrhoidectomy,1,0.0
butterfly,1,0.0
injures,1,0.0
x-lead--in,1,0.0
ELISAneutralization,1,0.0
463-fold,1,0.0
hokenjo,1,0.0
medication-usage,1,0.0
Japan-assume,1,0.0
Rodríguez-Morales,1,0.0
systemATs,1,0.0
ATs,1,0.0
DepressionPSD,1,0.0
pseudo-depressive,1,0.0
aprosody,1,0.0
66-113,1,0.0
light-microscopic,1,0.0
224-358,1,0.0
94000,1,0.0
7983,1,0.0
kgfmin,1,0.0
summa,1,0.0
penumbral-based,1,0.0
pCK-HGF-X7,1,0.0
cost-of-care,1,0.0
US15000-140000,1,0.0
MERTK,1,0.0
OpenTarget,1,0.0
network-clusters,1,0.0
GSE66360,1,0.0
MEGF10,1,0.0
FcRγ,1,0.0
CD3ζ,1,0.0
ACCURATE,1,0.0
y-lead,1,0.0
Influenza-specific,1,0.0
histolytic,1,0.0
coexpressing,1,0.0
Venoarterial,1,0.0
gainsaying,1,0.0
2146,1,0.0
Anumber,1,0.0
pseudo-chilblain,1,0.0
st-STEMI,1,0.0
unconfounded,1,0.0
respiralogy,1,0.0
hypophonia,1,0.0
Maculopapular,1,0.0
tofrom,1,0.0
tissutal,1,0.0
congener,1,0.0
YM150,1,0.0
IXa,1,0.0
intracoronaric,1,0.0
NAPc2,1,0.0
rS-complex,1,0.0
cohoused,1,0.0
within-cage,1,0.0
TH2-polarized,1,0.0
TH1-,1,0.0
Expressions,1,0.0
1968-1973,1,0.0
poetry,1,0.0
advisers,1,0.0
C-19,1,0.0
40HS,1,0.0
challenge-confirmed,1,0.0
H1-MRS,1,0.0
dual-positive,1,0.0
Antimicrobial,1,0.0
admssion,1,0.0
hemophilus,1,0.0
counterimmunoelectrophoresis,1,0.0
PAF3,1,0.0
Counterimmunoelectrophoresis,1,0.0
AF34,1,0.0
strokes12,1,0.0
isomers,1,0.0
ca-influenza,1,0.0
Sedating,1,0.0
Sotirios,1,0.0
Tsiodras,1,0.0
ex-smoking,1,0.0
subirritant,1,0.0
6x9x4cm3,1,0.0
Hydrochloric,1,0.0
antirust,1,0.0
ultra-portable,1,0.0
1542,1,0.0
httpsdoiorg1023641asha10257578,1,0.0
Brain-behavior,1,0.0
neurhormonal,1,0.0
iperkaliemia,1,0.0
Story,1,0.0
Aerosp,1,0.0
n915,1,0.0
4078,1,0.0
0025muM,1,0.0
underperformance,1,0.0
3955,1,0.0
autoradiographs,1,0.0
isquemia,1,0.0
10e3,1,0.0
BACKGROUNDOBJECTIVE,1,0.0
F2144,1,0.0
airmans,1,0.0
avionics,1,0.0
piston-powered,1,0.0
Airplane,1,0.0
Accesssup,1,0.0
Surveillance-Broadcast,1,0.0
Chi-squaredFisher,1,0.0
mishaps100000,1,0.0
Serve,1,0.0
asssay,1,0.0
seriousfatal,1,0.0
pandemic-period,1,0.0
genetic-material,1,0.0
referencing,1,0.0
Boyd,1,0.0
emergency-care,1,0.0
pMDI-administered,1,0.0
103-343,1,0.0
counter-productive,1,0.0
cerebrovascular-associated,1,0.0
1976---76,1,0.0
Postprandial,1,0.0
arthrosclerosis,1,0.0
meta-random,1,0.0
lung--to,1,0.0
Inflammatoric,1,0.0
Congolese,1,0.0
Brazzaville,1,0.0
injection-site,1,0.0
micelle,1,0.0
pingchuanning,1,0.0
ASichuan109,1,0.0
Lowered,1,0.0
HEK-293T,1,0.0
debunk,1,0.0
PVESSARS-CoV-2,1,0.0
incentivizing,1,0.0
3024,1,0.0
povidone,1,0.0
antisepsis,1,0.0
100-141,1,0.0
procedure-device-related,1,0.0
ABaoan512008,1,0.0
4545,1,0.0
hemodinamically,1,0.0
hystolytic,1,0.0
7803,1,0.0
cleavages,1,0.0
stiblenoids,1,0.0
glutaredoxin,1,0.0
Gel,1,0.0
Tryptic,1,0.0
stilbene,1,0.0
chymotryptic,1,0.0
digestions,1,0.0
C300S,1,0.0
resveratrol-protein,1,0.0
FGIDs,1,0.0
nanoseconds,1,0.0
stilbenoid,1,0.0
€23,1,0.0
€13,1,0.0
24months,1,0.0
53days,1,0.0
39days,1,0.0
BYamagatalineage,1,0.0
BVictoria0207,1,0.0
ACalifornia0704,1,0.0
Clinical-epidemiological,1,0.0
Puglia,1,0.0
21465,1,0.0
AUD1180575,1,0.0
trunkal,1,0.0
httpsdoiorg102105AJPH2021306435,1,0.0
20211776-1779,1,0.0
models-in,1,0.0
9056,1,0.0
Perform,1,0.0
inmmediate,1,0.0
Infarction-I,1,0.0
E-PWP,1,0.0
9210773779,1,0.0
clinical-functional-anatomical,1,0.0
Caceres,1,0.0
approaches-a,1,0.0
capsule-thalamic,1,0.0
super-ensemble,1,0.0
hemihypoesthesia,1,0.0
Bozeman,1,0.0
over-reporting,1,0.0
non-surveillance,1,0.0
Campimetric,1,0.0
Border-zone,1,0.0
complexThe,1,0.0
meta-ensemble,1,0.0
Supplementing,1,0.0
post-forecast,1,0.0
complexIn,1,0.0
outcry,1,0.0
SarmaHighlightsStilbenoid,1,0.0
Poetry,1,0.0
non-toilet,1,0.0
22250,1,0.0
anterior-medial,1,0.0
CD8T,1,0.0
hesitantly,1,0.0
cantonal,1,0.0
yearsResults,1,0.0
больных,1,0.0
RIRRs,1,0.0
341±78,1,0.0
58±07,1,0.0
9335,1,0.0
IgG4‑negative,1,0.0
moulded,1,0.0
thrombosisConclusion,1,0.0
Subacutechronic,1,0.0
Endocarditis,1,0.0
hailed,1,0.0
Intercountry,1,0.0
thromboendocarditis,1,0.0
rDWI,1,0.0
2-30,1,0.0
10×106-,1,0.0
brochures,1,0.0
55×107,1,0.0
pre-incubation,1,0.0
DTBT,1,0.0
Non-linear,1,0.0
TReg,1,0.0
T-cell-directed,1,0.0
inductionmodulation,1,0.0
OR724,1,0.0
CI1023-2668,1,0.0
9349,1,0.0
fourth-class,1,0.0
OR1652,1,0.0
8204,1,0.0
7192,1,0.0
7284,1,0.0
6083,1,0.0
never-diagnosed,1,0.0
OR162,1,0.0
CI458-1145,1,0.0
ten-year-old,1,0.0
TRegs,1,0.0
Clermont-Ferrand,1,0.0
OR163,1,0.0
Inconclusive,1,0.0
SWS,1,0.0
Non-demographic,1,0.0
hesitancyacceptance,1,0.0
humaninfluenza,1,0.0
COVID-19Material,1,0.0
478±134,1,0.0
hypertropic,1,0.0
echocardiographically-documented,1,0.0
Voxelwise,1,0.0
ventrocaudalis,1,0.0
asthma-10,1,0.0
regional-,1,0.0
health-screening,1,0.0
embarkation,1,0.0
LPS-RS,1,0.0
fibrin-IgG,1,0.0
Morens,1,0.0
JK,1,0.0
962-970,1,0.0
lipopolysaccharide-RS,1,0.0
preantibiotic,1,0.0
reproductions,1,0.0
∼250,1,0.0
pre-AMI,1,0.0
receptor-4,1,0.0
FDA-approval,1,0.0
inulin,1,0.0
Hyperplastic,1,0.0
1--significant,1,0.0
2a--ST,1,0.0
2b--normal,1,0.0
CoPP-preconditioning,1,0.0
wallapical,1,0.0
Coimmunostaining,1,0.0
25pts,1,0.0
CoPP-preconditioned,1,0.0
24pts,1,0.0
InAc-based,1,0.0
nanodelivery,1,0.0
antigen-loaded,1,0.0
Galens,1,0.0
national-,1,0.0
perimesencephalic,1,0.0
portae,1,0.0
nucleus-pulvinar,1,0.0
6581,1,0.0
6179,1,0.0
reçues,1,0.0
idées,1,0.0
Wepfers,1,0.0
writings,1,0.0
7941,1,0.0
13045,1,0.0
∼65-fold,1,0.0
yuan,1,0.0
Subsidies,1,0.0
Padua,1,0.0
1620-1695,1,0.0
recommencing,1,0.0
posterioanterior,1,0.0
NALTs,1,0.0
nasal-associated,1,0.0
0703,1,0.0
Posterioanterior,1,0.0
PLGA-NPs,1,0.0
Californians-suffer,1,0.0
Exhibit,1,0.0
three-bed,1,0.0
099-173,1,0.0
prescription-only,1,0.0
neural-based,1,0.0
polyomavirus,1,0.0
unproblematic,1,0.0
erythrovirus,1,0.0
hump,1,0.0
coronavirus-229E,1,0.0
Aorto-coronary,1,0.0
2ABSTRACT,1,0.0
narrow-band,1,0.0
0171,1,0.0
defeathering,1,0.0
caged,1,0.0
Trentino-Alto-Adige,1,0.0
7193880,1,0.0
ISTAT,1,0.0
self-governing,1,0.0
OED,1,0.0
eyedrop,1,0.0
liposome,1,0.0
ozonated-oil,1,0.0
Accessing,1,0.0
163-612,1,0.0
126-213,1,0.0
111-499,1,0.0
unfitness,1,0.0
underemphasized,1,0.0
1237,1,0.0
Arizona--as,1,0.0
washbasin,1,0.0
louver,1,0.0
fecal-derived,1,0.0
FH002C,1,0.0
zinc-aluminum,1,0.0
bisphosphonate-modified,1,0.0
Anyway,1,0.0
comanaging,1,0.0
acetylsalisylic,1,0.0
BESTICD,1,0.0
StriFK,1,0.0
40-day,1,0.0
group-related,1,0.0
thermographic,1,0.0
digitalised,1,0.0
areas--Chicago,1,0.0
plains,1,0.0
asthmaAreas,1,0.0
alternativesExpert,1,0.0
onset-to-admission,1,0.0
racesex-specific,1,0.0
small-area,1,0.0
1981-1985,1,0.0
3163,1,0.0
decision-based,1,0.0
SPREAD,1,0.0
OFRs,1,0.0
healeeed,1,0.0
fast-tracking,1,0.0
high-virulence,1,0.0
alveolar-interstitial,1,0.0
careMethods,1,0.0
fainter,1,0.0
listvideo,1,0.0
FOOD,1,0.0
Feed,1,0.0
processMethods,1,0.0
condensationResults,1,0.0
providersConclusions,1,0.0
Charles-Ferdinand,1,0.0
mitogenesis,1,0.0
hander,1,0.0
cognitive-emotional,1,0.0
pro-oxidants,1,0.0
darexaban,1,0.0
devils,1,0.0
betrixaban,1,0.0
novels,1,0.0
AZD0837,1,0.0
ROCKET,1,0.0
Ramuzs,1,0.0
Scavenging,1,0.0
blooming,1,0.0
11-17,1,0.0
Occupation,1,0.0
pharyngealnasal,1,0.0
monthsResults,1,0.0
17-15,1,0.0
39-24,1,0.0
p000001,1,0.0
5914,1,0.0
Gallus,1,0.0
gallus,1,0.0
domesticus,1,0.0
monthsConclusions,1,0.0
Coturnix,1,0.0
stacked-cage,1,0.0
two-peaked,1,0.0
naps,1,0.0
alfa-1b,1,0.0
Equations,1,0.0
dinner,1,0.0
x2513,1,0.0
x2604,1,0.0
2pm-4pm,1,0.0
6pm-8pm,1,0.0
thyroid-induced,1,0.0
flapping,1,0.0
phrasing,1,0.0
Haemagglutinin,1,0.0
audio-tape,1,0.0
46th2009,1,0.0
Atack,1,0.0
4589,1,0.0
100846,1,0.0
LI4,1,0.0
GB20,1,0.0
reintubation,1,0.0
0818,1,0.0
world-widely,1,0.0
SNV,1,0.0
countryarea,1,0.0
0791,1,0.0
httpswan-bioinfoshinyappsioGESS,1,0.0
SARS-CoV-2hCoV-19,1,0.0
0773,1,0.0
non-HA-based,1,0.0
0705,1,0.0
quantifiers,1,0.0
31610-5,1,0.0
microtitre,1,0.0
Shipment,1,0.0
30810-5,1,0.0
32310-5,1,0.0
WHF,1,0.0
Th2-low,1,0.0
less-defined,1,0.0
non-antigenic,1,0.0
ERLs,1,0.0
WHOCCs,1,0.0
core-RBD-specific,1,0.0
ST36,1,0.0
SP6,1,0.0
consensus-building,1,0.0
14-341,1,0.0
14-80,1,0.0
councils,1,0.0
9876,1,0.0
TSSD,1,0.0
population71610,1,0.0
n315,1,0.0
fortieth,1,0.0
nonscientific,1,0.0
rs333,1,0.0
posttests,1,0.0
resumes,1,0.0
biopolymer-mediated,1,0.0
FDH,1,0.0
Met-CCL5,1,0.0
CV23,1,0.0
protease-resistant,1,0.0
S4V,1,0.0
GV16,1,0.0
Met-CCL5-FDH,1,0.0
EX-HN-1,1,0.0
GB39,1,0.0
S4V-SDH,1,0.0
LI11,1,0.0
60775,1,0.0
16175,1,0.0
155-2567,1,0.0
auto-immunity,1,0.0
Qingre,1,0.0
Touxieearly,1,0.0
Xuanfei,1,0.0
Ergot,1,0.0
impregnated,1,0.0
7182,1,0.0
0975,1,0.0
H1N109-infected,1,0.0
0611,1,0.0
Shizuo,1,0.0
Fanghua,1,0.0
deficiencyquot,1,0.0
2290,1,0.0
quotdamp,1,0.0
4103,1,0.0
4795,1,0.0
screeningincluding,1,0.0
bioproduct,1,0.0
thrombocytopaenic,1,0.0
interdict,1,0.0
inflammatorykinin,1,0.0
close-to-normal,1,0.0
Two-channel,1,0.0
jirovecci,1,0.0
previously-P,1,0.0
Xuanxie,1,0.0
recannalization,1,0.0
iso-strain,1,0.0
Accounts,1,0.0
100981,1,0.0
1388,1,0.0
sociopsychological,1,0.0
Atlas,1,0.0
KASID,1,0.0
2-stimulation,1,0.0
moderates,1,0.0
Huayu,1,0.0
zero-margin,1,0.0
markups,1,0.0
concretization,1,0.0
Yangyinrecovery,1,0.0
Karasek,1,0.0
Yure,1,0.0
Cardioprotective,1,0.0
monotruncular,1,0.0
pluritruncular,1,0.0
islets,1,0.0
Jiunisevere,1,0.0
Huiyang,1,0.0
Gutuo,1,0.0
Kaibi,1,0.0
Feiremiddle,1,0.0
Work-stress,1,0.0
pneumoniae-induced,1,0.0
112-3077,1,0.0
jirovecii,1,0.0
auto-inhalation,1,0.0
cortex-claustrum-cingulate,1,0.0
motor-cognitive,1,0.0
1994-1998,1,0.0
behaviorslifestyle,1,0.0
4344,1,0.0
SciSearch,1,0.0
S-Linker,1,0.0
HR147,1,0.0
133-163,1,0.0
HR348,1,0.0
231-526,1,0.0
L-ferritin,1,0.0
H-ferritin,1,0.0
HR180,1,0.0
Internalization,1,0.0
family-caregivers,1,0.0
150-216,1,0.0
layouts,1,0.0
HR126,1,0.0
point-of-distribution,1,0.0
HR176,1,0.0
109-283,1,0.0
AFujian4112002H3N2-like,1,0.0
echotomographic,1,0.0
Low-moderate,1,0.0
ventro-dorsal,1,0.0
Frey,1,0.0
Randerath,1,0.0
eIF4E,1,0.0
32-bed,1,0.0
5-cap,1,0.0
classmate,1,0.0
Marsh,1,0.0
Holyoke,1,0.0
Dorothy,1,0.0
polyadenylated,1,0.0
eIF4F,1,0.0
re-operation,1,0.0
Far-Right,1,0.0
Far-Left,1,0.0
rift,1,0.0
CabAbstracts,1,0.0
Left-Right,1,0.0
Metaanalysis,1,0.0
accumulatively,1,0.0
kilogenome-equivalentl,1,0.0
0742,1,0.0
neuroemergency,1,0.0
Re-positivity,1,0.0
re-positivity,1,0.0
Affordance,1,0.0
1419,1,0.0
6955,1,0.0
Echotomography,1,0.0
time-sequence-dependent,1,0.0
105-1056,1,0.0
38-52,1,0.0
2x2,1,0.0
Less-invasive,1,0.0
2HCl,1,0.0
tilorone,1,0.0
besylate,1,0.0
chatbot-based,1,0.0
echolucency,1,0.0
RdRP-gene,1,0.0
neurodiagnostic,1,0.0
MutaPLEX®,1,0.0
Immundiagnostic,1,0.0
ICAO,1,0.0
interferon-mediated,1,0.0
nub,1,0.0
1-88,1,0.0
123-770,1,0.0
155-920,1,0.0
1498,1,0.0
319325,1,0.0
330-6790,1,0.0
N172,1,0.0
e28-e292,1,0.0
165-2086,1,0.0
103-715,1,0.0
e6-e245,1,0.0
infection-permissive,1,0.0
building-level,1,0.0
thioridazine,1,0.0
M-triggered,1,0.0
94512,1,0.0
33902,1,0.0
females2,1,0.0
or30,1,0.0
LAD-associated,1,0.0
anti-allergics,1,0.0
3079,1,0.0
northern-eastern,1,0.0
120-214,1,0.0
205-473,1,0.0
TAMI-9,1,0.0
161-319,1,0.0
cytotoxiceffective,1,0.0
ion-beam,1,0.0
FIBSEM,1,0.0
M-N,1,0.0
M-mediated,1,0.0
M-induced,1,0.0
positive-antigen,1,0.0
salifungin,1,0.0
psychoneurological,1,0.0
34-41,1,0.0
vortioxetine,1,0.0
fendiline,1,0.0
stimulation-assisted,1,0.0
TH17-type,1,0.0
19590,1,0.0
dual-hemispheric,1,0.0
malleability,1,0.0
highly-regarded,1,0.0
position-sensitive,1,0.0
intra-governmental,1,0.0
5245,1,0.0
tourismhospitality,1,0.0
positive-negative,1,0.0
brutality,1,0.0
amends,1,0.0
phase-separated,1,0.0
RNA-helicases,1,0.0
corporeal,1,0.0
editases,1,0.0
500-23,1,0.0
sadnessdepression,1,0.0
fibrin-monomeric,1,0.0
neurovasalar,1,0.0
ristomycin,1,0.0
up‐to‐date,1,0.0
world‐wide,1,0.0
allergy‐related,1,0.0
Tekhnologiya-Standart,1,0.0
Sulianti,1,0.0
Saroso,1,0.0
SS-IDH,1,0.0
Texas-MD,1,0.0
Middle-income,1,0.0
blood-transported,1,0.0
connectivity-based,1,0.0
CD3CD8IFNγ,1,0.0
rMVA-vaccinated,1,0.0
gloved,1,0.0
1470,1,0.0
Vegetative,1,0.0
tissular,1,0.0
range--that,1,0.0
AAY,1,0.0
MCH-II,1,0.0
8295,1,0.0
adiastoly,1,0.0
9251,1,0.0
107-460,1,0.0
Spike-M-N,1,0.0
Peri-operatively,1,0.0
task-evoked,1,0.0
Scour,1,0.0
Judgments,1,0.0
Phlegm,1,0.0
030-fold,1,0.0
021-043,1,0.0
HDS,1,0.0
patient-important,1,0.0
Dash,1,0.0
RO5,1,0.0
single-case,1,0.0
flanked,1,0.0
real-stimulation,1,0.0
assailed,1,0.0
24hrs,1,0.0
forearmed,1,0.0
groups-eg,1,0.0
Limerick,1,0.0
Intakes,1,0.0
Migratory,1,0.0
globalizing,1,0.0
mild-to-severe,1,0.0
days•,1,0.0
AH9,1,0.0
to-be,1,0.0
Laboratory-acquired,1,0.0
mitralism,1,0.0
22000microliter,1,0.0
petechia,1,0.0
vaccination•,1,0.0
4PD,1,0.0
post-stenting,1,0.0
daysPractice,1,0.0
physician-centred,1,0.0
disenchantment,1,0.0
1978--79,1,0.0
IIV3-SD,1,0.0
908000,1,0.0
INASC-40,1,0.0
pro-inflamatory,1,0.0
Bermejo-Martin,1,0.0
Madagascan,1,0.0
2-mA,1,0.0
ADMET,1,0.0
nsp13-L2,1,0.0
mAcm2,1,0.0
Ccm2,1,0.0
grooved,1,0.0
pegboard,1,0.0
nine-hole,1,0.0
t0,1,0.0
t1,1,0.0
actualize,1,0.0
avoidanceremoval,1,0.0
anti-thrombotics,1,0.0
nsp-13,1,0.0
Tabachnik,1,0.0
HOMO-LUMO,1,0.0
112-122,1,0.0
Levision,1,0.0
Sreenivasulu,1,0.0
INASC-85,1,0.0
Geubelle,1,0.0
pathway-from,1,0.0
outcomes-we,1,0.0
aspirating,1,0.0
rMVA-infected,1,0.0
supply--the,1,0.0
novelist,1,0.0
pharmacoeconomical,1,0.0
ampholytes,1,0.0
CIEF,1,0.0
ExPASy,1,0.0
intramediastinal,1,0.0
Asa,1,0.0
Fc-tag,1,0.0
low-stroke,1,0.0
age75,1,0.0
His-,1,0.0
transgenerational,1,0.0
Conjunctival,1,0.0
184-316,1,0.0
Orbital,1,0.0
AQHI,1,0.0
pivot,1,0.0
pro-asthmatic,1,0.0
auscultated,1,0.0
mass-like,1,0.0
IgGNC,1,0.0
1236,1,0.0
preanesthetic,1,0.0
beatsmin-1,1,0.0
NC-,1,0.0
SP-specific,1,0.0
SARS-CoV-2-recovered,1,0.0
ampholyte,1,0.0
bodyplethysmography,1,0.0
RBDFc,1,0.0
441-587,1,0.0
Psychology,1,0.0
Bonaparte,1,0.0
reduplicative,1,0.0
Pneumocystis,1,0.0
paramnesia,1,0.0
519-611,1,0.0
immediacy,1,0.0
hACE2His,1,0.0
confabulatory,1,0.0
Jamess,1,0.0
disintegrated,1,0.0
S1S2His,1,0.0
824-932,1,0.0
Residence-based,1,0.0
geo-referenced,1,0.0
SARS-associated,1,0.0
sorptive,1,0.0
730-837,1,0.0
S1His,1,0.0
3478,1,0.0
antibody-focused,1,0.0
illusive,1,0.0
736-988,1,0.0
RBDHis,1,0.0
ureteral,1,0.0
specific-IgE,1,0.0
KNichol,1,0.0
11-131,1,0.0
type-3,1,0.0
PDE-3,1,0.0
Endothelin,1,0.0
01512,1,0.0
Connect,1,0.0
Ashkenazi,1,0.0
Hussey,1,0.0
KRIT1,1,0.0
CECR1,1,0.0
COL3A1,1,0.0
11--17,1,0.0
COL4A2,1,0.0
COLGALT1,1,0.0
35--40,1,0.0
DrK,1,0.0
TREX1,1,0.0
285-375,1,0.0
silico-predicted,1,0.0
149-197,1,0.0
07-28,1,0.0
etc--but,1,0.0
progress--ie,1,0.0
replication-restricted,1,0.0
MVAs,1,0.0
and--critically--health,1,0.0
Open-ended,1,0.0
0-217,1,0.0
escitalopram,1,0.0
pre-domination,1,0.0
54-497,1,0.0
41-350,1,0.0
1995-2009,1,0.0
2·40·5,1,0.0
1·30·1,1,0.0
⩾75,1,0.0
fluid-derived,1,0.0
Mention,1,0.0
oscilloscope,1,0.0
Kahn,1,0.0
sclerotic,1,0.0
14-88,1,0.0
466-567,1,0.0
ultrafiltrationdiafiltration,1,0.0
RFP-positive,1,0.0
knots,1,0.0
complementopathies,1,0.0
convoy,1,0.0
mutiple,1,0.0
7658,1,0.0
complementopathy,1,0.0
Cross-protective,1,0.0
physiochemically,1,0.0
co-purification,1,0.0
protoporphyrin,1,0.0
c-kit,1,0.0
human-to-pig,1,0.0
exacerbants,1,0.0
variation--and,1,0.0
ST-element,1,0.0
Adjusted-dose,1,0.0
triggering--of,1,0.0
68000,1,0.0
lifecourse,1,0.0
well-acknowledged,1,0.0
Vilnius,1,0.0
theragnostic,1,0.0
coreAAR,1,0.0
histomorphologic,1,0.0
mid-morning,1,0.0
iodized,1,0.0
Priviledged,1,0.0
Organic,1,0.0
adipositas,1,0.0
Cannabidiol,1,0.0
anticoagulatory,1,0.0
335-fold,1,0.0
Likelihoods,1,0.0
injury-into-repair,1,0.0
228000,1,0.0
Time-consuming,1,0.0
nonparenteral,1,0.0
Prairie,1,0.0
Interplay,1,0.0
2019-2023,1,0.0
bi-regional,1,0.0
2071,1,0.0
ulterior,1,0.0
chi21,1,0.0
1967-2000,1,0.0
LPH,1,0.0
Atomoxteine,1,0.0
Paroxetine,1,0.0
Nisoxteine,1,0.0
multimethod,1,0.0
multiinformant,1,0.0
dialog,1,0.0
CCD-19Lu,1,0.0
hyperventilating,1,0.0
Sidestream,1,0.0
1335,1,0.0
neuro-rehabilitation,1,0.0
seroprevalance,1,0.0
DOB,1,0.0
diabetes-related,1,0.0
Odd,1,0.0
periprocedual,1,0.0
stress-responsive,1,0.0
Supratentorial,1,0.0
catus,1,0.0
Felis,1,0.0
thermoplasty-treated,1,0.0
lung-wide,1,0.0
NFI,1,0.0
insures,1,0.0
20-64-year-olds,1,0.0
SF-36-derived,1,0.0
videoconference-based,1,0.0
Lanarkshire,1,0.0
125-190,1,0.0
-32,1,0.0
cliniciansresearchers,1,0.0
1968ResultsInfluenza,1,0.0
pandemicMethodsWe,1,0.0
Beta-2,1,0.0
theophyline,1,0.0
Examination--Revised,1,0.0
ACE-R,1,0.0
extubate,1,0.0
areflexia,1,0.0
35-54-year-old,1,0.0
VQI,1,0.0
epidemicAimTo,1,0.0
Gordons,1,0.0
ego,1,0.0
timeseries,1,0.0
LSTMs,1,0.0
ngrams,1,0.0
beta-hydroxylase,1,0.0
the-state-of-the-art,1,0.0
Pleiotropic,1,0.0
-96,1,0.0
5·7,1,0.0
-133,1,0.0
STI--over,1,0.0
treatment-as,1,0.0
nine-to-twelve,1,0.0
myelosuppressive,1,0.0
Electroencephalogram,1,0.0
CHAMPS,1,0.0
Entropy,1,0.0
Home-Based,1,0.0
entropy-based,1,0.0
miRNAsmiR,1,0.0
mammographic,1,0.0
-29,1,0.0
elliptic,1,0.0
anthropospheres,1,0.0
38102,1,0.0
54041,1,0.0
I-REV,1,0.0
imprint-regulated,1,0.0
One-hundred-and-fifty-four,1,0.0
15-37,1,0.0
tyrosineDiscussionImprinting,1,0.0
35-54-year-olds,1,0.0
-277,1,0.0
imbricating,1,0.0
cost-effectivity,1,0.0
manmade,1,0.0
pre-test-post-test,1,0.0
7563,1,0.0
22-days,1,0.0
ozone-scavenging,1,0.0
critically-ill,1,0.0
pooled-sample,1,0.0
8‒14,1,0.0
987‒989,1,0.0
913‒100,1,0.0
lowand,1,0.0
cut-off-indices,1,0.0
Tactics,1,0.0
ASN,1,0.0
lesionspatient,1,0.0
copous,1,0.0
lipid-depleted,1,0.0
hydrothorax,1,0.0
6·5,1,0.0
cationically,1,0.0
9-22,1,0.0
N-2-hydroxypropyl-3-trimethylammonium,1,0.0
Operationalizing,1,0.0
Non-essential,1,0.0
proteinIMPORTANCE,1,0.0
anticoronavirals,1,0.0
contratility,1,0.0
coronaviruses-SARS-CoV-2,1,0.0
Anti-nucleocapsid,1,0.0
non-accidental,1,0.0
troposphere,1,0.0
non-incident,1,0.0
²clinical,1,0.0
multicolour,1,0.0
H7N9-specific,1,0.0
CD8CD4,1,0.0
imminence,1,0.0
²at,1,0.0
Stated,1,0.0
Zhanjiang,1,0.0
myoclonic,1,0.0
C1-C3,1,0.0
Mitoses,1,0.0
overexpenditure,1,0.0
Oxides,1,0.0
metaphase,1,0.0
micronuclei,1,0.0
Co-operation,1,0.0
Pneumo-23,1,0.0
Hiberix,1,0.0
e-mailed,1,0.0
body-odor,1,0.0
1969-82,1,0.0
66103,1,0.0
anencephalic,1,0.0
beacon,1,0.0
8947,1,0.0
6837,1,0.0
CoVID,1,0.0
tread-mill,1,0.0
renoprotection,1,0.0
gynaecomastiamastalgia,1,0.0
collider,1,0.0
Macro-epidemiology,1,0.0
E3-,1,0.0
1997--2003,1,0.0
distributed1000,1,0.0
immuno-compromise,1,0.0
still-unknown,1,0.0
E2b-,1,0.0
E1-,1,0.0
NCT04355936,1,0.0
25-19,1,0.0
ejecta,1,0.0
Gurwitz,1,0.0
disarm,1,0.0
IFN-regulated,1,0.0
ANTICOAGULATION,1,0.0
38-8,1,0.0
CHOICE,1,0.0
x109L,1,0.0
259±064,1,0.0
withliver,1,0.0
1889-1892,1,0.0
Relational,1,0.0
1-biased,1,0.0
tachyarrthythmia,1,0.0
Cushings,1,0.0
depositiontransmission,1,0.0
medium-caliber,1,0.0
Tone,1,0.0
51-65,1,0.0
practice-only,1,0.0
Myoelectric,1,0.0
mechanoenergetics,1,0.0
pressure--volume,1,0.0
harassmentinsult,1,0.0
co-evaluating,1,0.0
A2Singapore57,1,0.0
1968-9,1,0.0
Bubnoff,1,0.0
aldosterone-mediated,1,0.0
776157,1,0.0
Peptide-based,1,0.0
Lactic-co-Glycolic,1,0.0
Andreas,1,0.0
PLGA,1,0.0
cardiology-where,1,0.0
critics,1,0.0
Aldactone,1,0.0
RALES,1,0.0
EPHESUS,1,0.0
035-053,1,0.0
shame,1,0.0
cognitive-educational,1,0.0
posterspamphlets,1,0.0
vodka,1,0.0
AswEhime180,1,0.0
AswNagasaki189,1,0.0
EAC,1,0.0
80--95,1,0.0
pyracetam,1,0.0
cytochrom-C,1,0.0
0602,1,0.0
0795,1,0.0
ClyA-receptor,1,0.0
CRD42019135805,1,0.0
Socio-biological,1,0.0
sociobiological,1,0.0
ring-like,1,0.0
BBV,1,0.0
RBD-BBV,1,0.0
RBD-BBVs,1,0.0
55203,1,0.0
82203,1,0.0
Mesothelioma,1,0.0
67203,1,0.0
P53,1,0.0
116195,1,0.0
Superinfections,1,0.0
NF2,1,0.0
37203,1,0.0
AswHK174,1,0.0
rosette,1,0.0
Iporanga,1,0.0
DTNAx,1,0.0
angioplastied,1,0.0
ready-for-docking,1,0.0
DE-MSCT,1,0.0
pre-1990s,1,0.0
white--populations,1,0.0
Nsp15,1,0.0
NendoU,1,0.0
wwwdockthorlnccbr,1,0.0
the--predominantly,1,0.0
CAQ,1,0.0
Age-standardised,1,0.0
levels--personal,1,0.0
4837,1,0.0
016-063,1,0.0
111-7,1,0.0
225-2019,1,0.0
telephoned,1,0.0
141-609,1,0.0
105-547,1,0.0
ABayern795-like,1,0.0
equivalentsml,1,0.0
ABeijing26295-like,1,0.0
Staphyloccocus,1,0.0
ABayern0795,1,0.0
26203,1,0.0
128-fold,1,0.0
Structure-Based,1,0.0
thirteenth,1,0.0
201651582-587,1,0.0
LSAs,1,0.0
dimorphisms,1,0.0
1963The,1,0.0
Heq2Neq2,1,0.0
immune-endocrine,1,0.0
virusesPreliminary,1,0.0
subtypeStudies,1,0.0
manThe,1,0.0
businessman,1,0.0
Paraplegia,1,0.0
perfluorooctanoic,1,0.0
≥550,1,0.0
venetoclax,1,0.0
Brutons,1,0.0
PFOA-exposed,1,0.0
EDITORIAL,1,0.0
hepatotropism,1,0.0
treatment-naive,1,0.0
0001-0162,1,0.0
triagedifferential,1,0.0
cirrhosis-associated,1,0.0
howeverand,1,0.0
queen,1,0.0
300-sow,1,0.0
IC90,1,0.0
Posteroinferior,1,0.0
postero-septal,1,0.0
125-690,1,0.0
urinastatin,1,0.0
whiskey,1,0.0
brandy,1,0.0
bottled,1,0.0
carbonated,1,0.0
Borough,1,0.0
Deceitful,1,0.0
psychotraining,1,0.0
Teesside,1,0.0
mesenchaymal,1,0.0
non-deferrable,1,0.0
Maxillofacial,1,0.0
bloodless,1,0.0
194-450,1,0.0
Magna,1,0.0
10292,1,0.0
38-103,1,0.0
Graecia,1,0.0
Catanzaro,1,0.0
-Italy,1,0.0
post-Sputnik,1,0.0
VSV-G,1,0.0
3-170,1,0.0
nonneonatal,1,0.0
acidotic,1,0.0
polyamine,1,0.0
Modellers,1,0.0
monthsThe,1,0.0
3-5th,1,0.0
369423,1,0.0
3075,1,0.0
871577,1,0.0
375215,1,0.0
SNOMED,1,0.0
3703,1,0.0
1455,1,0.0
2287383,1,0.0
431403,1,0.0
351153,1,0.0
18573,1,0.0
15493,1,0.0
NVE,1,0.0
Senility,1,0.0
hospital-outcome,1,0.0
Prophylaxic,1,0.0
QS2,1,0.0
β2-receptor,1,0.0
hydroxybutyric,1,0.0
ArgArg,1,0.0
formTeasing,1,0.0
symptom-predominant,1,0.0
overlapA,1,0.0
Szent,1,0.0
Bio-Air,1,0.0
callateralization,1,0.0
infusion-transfusion,1,0.0
110-128,1,0.0
impulsiveness,1,0.0
Valuable,1,0.0
Location-specific,1,0.0
location-independent,1,0.0
geolocations,1,0.0
cells-based,1,0.0
geo-location,1,0.0
5182,1,0.0
asthmamorning,1,0.0
gettingreceiving,1,0.0
Yogyakarta,1,0.0
100-251,1,0.0
virus-infection,1,0.0
096-174,1,0.0
non-government-held,1,0.0
101-227,1,0.0
090-242,1,0.0
093-175,1,0.0
112-26,1,0.0
Repeating,1,0.0
2004-,1,0.0
E-sensitization,1,0.0
Intriguing,1,0.0
Gastroduodenofibroscopy,1,0.0
treatmentSeveral,1,0.0
János,1,0.0
polyamine-depleted,1,0.0
re-evaluations,1,0.0
mucocutanous,1,0.0
14-30,1,0.0
09-81,1,0.0
07-29,1,0.0
16-61,1,0.0
brushings,1,0.0
1769,1,0.0
333-533,1,0.0
Noncontact,1,0.0
Entrainment,1,0.0
14-67,1,0.0
macroreentry,1,0.0
2-hourly,1,0.0
Curves,1,0.0
Rush,1,0.0
industrial-scale,1,0.0
oubreaks,1,0.0
eastwards,1,0.0
aspirant,1,0.0
COPD-asthma,1,0.0
little-studied,1,0.0
non-PFA,1,0.0
CPKMB,1,0.0
scarcer,1,0.0
catastrophically,1,0.0
Lingual,1,0.0
curfewlockdown,1,0.0
nosebleed,1,0.0
NCT00884117,1,0.0
needlestick,1,0.0
agonistsOne,1,0.0
Montes,1,0.0
Claros,1,0.0
114-1134,1,0.0
GP-patient,1,0.0
0892-9102,1,0.0
Bettering,1,0.0
estulik,1,0.0
Sandos,1,0.0
monitoringThe,1,0.0
rehabilitationThe,1,0.0
earths,1,0.0
updatesImplications,1,0.0
Unconfirmed,1,0.0
classificationConclusions,1,0.0
lower-order,1,0.0
SeptemberOctober,1,0.0
2605,1,0.0
Pandemic-09-H1N1,1,0.0
PV-,1,0.0
10B,1,0.0
Tot-CK,1,0.0
S-creatine,1,0.0
doctorspublic,1,0.0
Newspapermagazine,1,0.0
KPMmin,1,0.0
Staub,1,0.0
non-meteorological,1,0.0
predictand,1,0.0
weathers,1,0.0
S-SE,1,0.0
NW,1,0.0
PCs,1,0.0
Anticipation,1,0.0
BARD,1,0.0
61m,1,0.0
infectiology,1,0.0
adjuvant-free,1,0.0
state-of-the,1,0.0
£147716086,1,0.0
depletion-of-persons,1,0.0
cost-adjusted,1,0.0
polygraphy,1,0.0
gene-by-gene,1,0.0
£194797133,1,0.0
EVT-treated,1,0.0
£47081047,1,0.0
components--rapid,1,0.0
£149048676,1,0.0
£58146171,1,0.0
£136650962,1,0.0
27550,1,0.0
airpressure,1,0.0
canonic,1,0.0
RBANS,1,0.0
IGG,1,0.0
886-968,1,0.0
NS5B,1,0.0
892-969,1,0.0
HCW-based,1,0.0
2813,1,0.0
104161460,1,0.0
1983-4,1,0.0
DC-shock,1,0.0
Giannina,1,0.0
phenyltriazolinones,1,0.0
Gaslini,1,0.0
post-CVA,1,0.0
front-loading,1,0.0
TF-FVIIa,1,0.0
-106,1,0.0
118098670,1,0.0
factor-factor,1,0.0
macrocyclic,1,0.0
2692,1,0.0
Marin,1,0.0
agreed-upon,1,0.0
23-26,1,0.0
tomographycomputed,1,0.0
24-June,1,0.0
eschewing,1,0.0
misidentify,1,0.0
859-938,1,0.0
procalcitonine,1,0.0
0934,1,0.0
self-cleavage,1,0.0
0889-0983,1,0.0
0003-0333,1,0.0
Hijacking,1,0.0
invader,1,0.0
decipherment,1,0.0
minutiae,1,0.0
16-189,1,0.0
ex-West,1,0.0
acid-particle,1,0.0
ear-nose-throat,1,0.0
oxides-ozone,1,0.0
RT-PCRMALDI-TOF,1,0.0
smoke-dust,1,0.0
15625,1,0.0
014-067,1,0.0
68008800,1,0.0
Cabinet,1,0.0
FETP-veterinarian,1,0.0
FETP-wildlife,1,0.0
1-step,1,0.0
non-H5N1,1,0.0
087-341,1,0.0
9269,1,0.0
101-112,1,0.0
hypertensive-associated,1,0.0
trombophilia,1,0.0
Vargas-Parada,1,0.0
Dédié,1,0.0
propranolol-induced,1,0.0
99mTc-RP-30A,1,0.0
forewarn,1,0.0
pneumothoraxes,1,0.0
maximises,1,0.0
obscuring,1,0.0
psRLS,1,0.0
psPLMS,1,0.0
kicks,1,0.0
diseases--of,1,0.0
asthmalike,1,0.0
Affording,1,0.0
TARRACO,1,0.0
possibility--for,1,0.0
ATSERS,1,0.0
Public-private,1,0.0
protein-,1,0.0
AUSSR9077H1N1,1,0.0
3338,1,0.0
19781979,1,0.0
45-year-old-female,1,0.0
hospitalisation--pulmonary,1,0.0
acenokumarol,1,0.0
163632044,1,0.0
926-1000,1,0.0
Puschkinsky,1,0.0
40aine,1,0.0
Collaborators,1,0.0
nonQ-wave,1,0.0
rate-lowering,1,0.0
compilations,1,0.0
immunoenzymometrically,1,0.0
httpwwwf1000medicinecom,1,0.0
flavour,1,0.0
ratio200,1,0.0
10-216,1,0.0
091-113,1,0.0
0-60,1,0.0
die-out,1,0.0
097-301,1,0.0
N91,1,0.0
andmediators,1,0.0
seemsmore,1,0.0
N109,1,0.0
6298,1,0.0
OR3308,1,0.0
1317-8311,1,0.0
occurin,1,0.0
OR3086,1,0.0
MRIPH,1,0.0
MRI-defined,1,0.0
1262-7545,1,0.0
strokesABSTRACT,1,0.0
INTERCEPT,1,0.0
heart-rate-lowering,1,0.0
“big,1,0.0
Alphavirus,1,0.0
CK-serum,1,0.0
complexing,1,0.0
eq,1,0.0
urogram,1,0.0
IGs,1,0.0
intrahepatic,1,0.0
portosystemic,1,0.0
Possis,1,0.0
Watershed,1,0.0
imagination,1,0.0
viruses-and,1,0.0
httpsdoiorg101148radiol2020200370,1,0.0
data”,1,0.0
Alteplase-treated,1,0.0
vitalize,1,0.0
cruising,1,0.0
24-September,1,0.0
TNK,1,0.0
multiplex-microbead,1,0.0
Simplate,1,0.0
dysphagics,1,0.0
Packed,1,0.0
bed-hours,1,0.0
27385,1,0.0
Passenger,1,0.0
protease-inhibitor,1,0.0
low-picomolar,1,0.0
Ratiometric,1,0.0
otolich-ocular,1,0.0
Direction-changing,1,0.0
-1162,1,0.0
-2969,1,0.0
≥93,1,0.0
direction-changing,1,0.0
-8363,1,0.0
Homma,1,0.0
asthma-rhinitis,1,0.0
smallholders,1,0.0
commingling,1,0.0
boars,1,0.0
host-encoded,1,0.0
miR-31-5p,1,0.0
miR-423-5p,1,0.0
miR-23a-3p,1,0.0
miR-195-5p,1,0.0
guideline-endorsed,1,0.0
de-emphasized,1,0.0
7099,1,0.0
swine-flu,1,0.0
immunotherapys,1,0.0
systemsCommunicated,1,0.0
IKHC,1,0.0
stent-retrievers,1,0.0
Plug-and-Play,1,0.0
1685,1,0.0
photoconjugated,1,0.0
in-sample,1,0.0
calibrator,1,0.0
TRAINET,1,0.0
coronaro-,1,0.0
ST-dominant,1,0.0
adapters,1,0.0
T-dominant,1,0.0
2019-NCoV,1,0.0
peripherally-derived,1,0.0
fortnight-from,1,0.0
clinically-confirmed,1,0.0
Speeding,1,0.0
CFTs,1,0.0
2-o-ribose,1,0.0
analyte-induced,1,0.0
bioluminescent,1,0.0
MOGON,1,0.0
presumable,1,0.0
mix-and-measure,1,0.0
paritaprevir,1,0.0
Immunodiagnostics,1,0.0
anti-HCV,1,0.0
Bukavu,1,0.0
surgery-treated,1,0.0
Macro-,1,0.0
Saint-Petersburg,1,0.0
AUS1300,1,0.0
OASIS,1,0.0
Antimicrob,1,0.0
December-March,1,0.0
7821,1,0.0
Soriano,1,0.0
Qatari,1,0.0
phaeochromocytoma,1,0.0
phylo-geo-network,1,0.0
EpiCov,1,0.0
episomes,1,0.0
proviruses,1,0.0
haplogroup,1,0.0
Haplogroup,1,0.0
tracheotomies,1,0.0
Covidex,1,0.0
virusbacteria,1,0.0
Status-metry,1,0.0
Wuppertal,1,0.0
WMW,1,0.0
22-218,1,0.0
biplan,1,0.0
patient-and,1,0.0
therapy-should,1,0.0
Hyppönen,1,0.0
antithrombins,1,0.0
200785860-868,1,0.0
taurines,1,0.0
sulfur-containing,1,0.0
2-aminoethanesulfonic,1,0.0
recoveriesThese,1,0.0
12-April,1,0.0
995-998,1,0.0
osmotically,1,0.0
Boyden,1,0.0
26265,1,0.0
wood-burning,1,0.0
fireplace,1,0.0
GeXP,1,0.0
pteronnysinus,1,0.0
AH6N5,1,0.0
homesOne,1,0.0
1457,1,0.0
Chemother,1,0.0
nifty,1,0.0
dicom,1,0.0
Blood-Brain,1,0.0
Metabolife,1,0.0
Ripped,1,0.0
Thermadrene,1,0.0
Shape-Fast,1,0.0
Patlak,1,0.0
ipratropiumbromid,1,0.0
00490,1,0.0
Taurine,1,0.0
Holick,1,0.0
2007357266-281,1,0.0
dwarfing,1,0.0
co-chairman,1,0.0
dollarsis,1,0.0
hypodynamia,1,0.0
0070,1,0.0
bio-molecular,1,0.0
liner,1,0.0
Necrotising,1,0.0
leucocidin,1,0.0
CA-MRSA,1,0.0
USA300,1,0.0
heuristics,1,0.0
tachykinin,1,0.0
0109-0976,1,0.0
resolvesAnalysis,1,0.0
Multivariant,1,0.0
1304-4759,1,0.0
1848-5624,1,0.0
Belgaum,1,0.0
Ganesh,1,0.0
3224,1,0.0
P0034,1,0.0
1504-3942,1,0.0
28-08-2009,1,0.0
YQD,1,0.0
detoxifcation,1,0.0
03-09-2009,1,0.0
0015-0319,1,0.0
laps,1,0.0
pleading,1,0.0
n302,1,0.0
RITA,1,0.0
30261,1,0.0
H-index,1,0.0
delisted,1,0.0
Foxs,1,0.0
Medal,1,0.0
awarded,1,0.0
BOYUM,1,0.0
-3H-dihydroalprenolol,1,0.0
Stanley,1,0.0
Rayner,1,0.0
JMDC,1,0.0
4540,1,0.0
Cardiology-American,1,0.0
uncleaved,1,0.0
53000,1,0.0
equids,1,0.0
NP56,1,0.0
----,1,0.0
State-of-the-Art,1,0.0
NP53,1,0.0
OWEA,1,0.0
dollarsperson,1,0.0
PSM,1,0.0
strainsclades,1,0.0
energised,1,0.0
disorders-namely,1,0.0
octopus,1,0.0
anti-HIV-1,1,0.0
glyco-epitope,1,0.0
29299,1,0.0
host-derived,1,0.0
3255,1,0.0
faultless,1,0.0
583-1188,1,0.0
intratubular,1,0.0
hypercellularity,1,0.0
178-366,1,0.0
hypocomplementemia,1,0.0
familiarized,1,0.0
infarctshematomasaneurysmsstenoses,1,0.0
Neuroanatomy,1,0.0
159-865,1,0.0
121-223,1,0.0
firefly,1,0.0
13095,1,0.0
FVBNJ,1,0.0
097-174,1,0.0
bias-adjusted,1,0.0
oropharynx-nasopharynx,1,0.0
lay-professional,1,0.0
collinearity,1,0.0
2437,1,0.0
Helps,1,0.0
intractions,1,0.0
gp120,1,0.0
case-only,1,0.0
Proof-of-concept,1,0.0
slow-wave,1,0.0
answer-out,1,0.0
clumsiness,1,0.0
Barré,1,0.0
Guillaín,1,0.0
UET-treated,1,0.0
or20,1,0.0
or15,1,0.0
Nurse-led,1,0.0
Caveolin-1,1,0.0
caveolar,1,0.0
coronavirus-borne,1,0.0
cav-1VEGF,1,0.0
MACI,1,0.0
stereometric,1,0.0
glycan-dependent,1,0.0
FcγRII,1,0.0
redefines,1,0.0
Water-Human-Data,1,0.0
PGT128,1,0.0
Nexus,1,0.0
PGT126,1,0.0
delve,1,0.0
pot,1,0.0
cardiomyopathy-from,1,0.0
unamplified,1,0.0
OR-may,1,0.0
male-specific,1,0.0
sry,1,0.0
5195-1975,1,0.0
jeoparized,1,0.0
multi-stream,1,0.0
Calling,1,0.0
oligos,1,0.0
MF59®,1,0.0
Fluad®,1,0.0
well-performed,1,0.0
morpholino,1,0.0
phosphorodiamidate,1,0.0
Report-3,1,0.0
G-FET,1,0.0
programmability,1,0.0
PAOP,1,0.0
conformation-stabilized,1,0.0
virus-mimicking,1,0.0
adjuvancy,1,0.0
forward-looking,1,0.0
nano-enabled,1,0.0
Criticism,1,0.0
AuNP-decorated,1,0.0
H1-15,1,0.0
nanosensing,1,0.0
171-09,1,0.0
Schellong,1,0.0
FEV01,1,0.0
government-imposed,1,0.0
Post-reperfusion,1,0.0
43-100,1,0.0
distancing-even,1,0.0
Arbitrary,1,0.0
48-293,1,0.0
splashes,1,0.0
0-285,1,0.0
0962-0984,1,0.0
0952,1,0.0
0930-0974,1,0.0
patience,1,0.0
wife-caregivers,1,0.0
couldnt,1,0.0
CoV-positive,1,0.0
temperature-stability,1,0.0
copiesuL,1,0.0
79-92,1,0.0
syngenic,1,0.0
213-17,1,0.0
104121,1,0.0
P00467,1,0.0
232-19,1,0.0
lattice,1,0.0
P00140,1,0.0
infectionCOVID-19,1,0.0
310-1057,1,0.0
Paulo37882,1,0.0
5068,1,0.0
readjustments,1,0.0
ISAAC--Poznań,1,0.0
K986,1,0.0
V987,1,0.0
K986P,1,0.0
V987P,1,0.0
video-questionnaire,1,0.0
modelIMPORTANCE,1,0.0
n347,1,0.0
2197,1,0.0
further-optimized,1,0.0
nontransmissible,1,0.0
Arbor660H2N2,1,0.0
Reversion,1,0.0
nonreactogenic,1,0.0
AWashington89780H3N2,1,0.0
ten-,1,0.0
pandemic-restricted,1,0.0
AScotland84074H3N2,1,0.0
AScotland80H3N2,1,0.0
13580,1,0.0
carotic,1,0.0
antiaggregating,1,0.0
PROGRESS-study,1,0.0
HA222,1,0.0
threa,1,0.0
Farming,1,0.0
0998,1,0.0
self-protecting,1,0.0
irremediably,1,0.0
taxonomically,1,0.0
lay-offs,1,0.0
furloughs,1,0.0
electropathophysiologic,1,0.0
twenty-first-century,1,0.0
mutant-infected,1,0.0
jumbled,1,0.0
-207,1,0.0
-296,1,0.0
medical-grade,1,0.0
listservs,1,0.0
34-question,1,0.0
-930,1,0.0
“Confined,1,0.0
review1,1,0.0
papers1,1,0.0
non‐peer,1,0.0
millennia,1,0.0
261-319100000,1,0.0
36249,1,0.0
in‐depth,1,0.0
55533,1,0.0
Ludvigsson,1,0.0
SoS,1,0.0
post-carotid,1,0.0
re-exploration,1,0.0
airway-specific,1,0.0
Secchi,1,0.0
B--75,1,0.0
A--65,1,0.0
LSPRWYFYY,1,0.0
equation-based,1,0.0
3-years,1,0.0
immunity-stimulating,1,0.0
crossreactivity,1,0.0
HLA-A29,1,0.0
encasing,1,0.0
WYFYYLGTGP,1,0.0
rhinopathy,1,0.0
Perennial,1,0.0
CSF-leaks,1,0.0
skullbase,1,0.0
WYFYYLGT,1,0.0
immunomonitoring,1,0.0
Broken,1,0.0
aero-digestive,1,0.0
nurses-particularly,1,0.0
197152,1,0.0
304644,1,0.0
699-719,1,0.0
Bechet,1,0.0
458-479,1,0.0
1023-1058,1,0.0
embellished,1,0.0
pathographies,1,0.0
HLA-A02,1,0.0
QD,1,0.0
1439,1,0.0
8-month,1,0.0
1982-Aug,1,0.0
JR-NET1,1,0.0
TNFAIP8-like,1,0.0
Lasting,1,0.0
TNFAIP8TIPE,1,0.0
DLSPRWYFYYLGTGP,1,0.0
TNF-α-induced,1,0.0
QLLPRWYFYYLGTGP,1,0.0
SCoV-DP15-specific,1,0.0
1-7MasR,1,0.0
DLSPRWYFYY,1,0.0
ACE-2Ang,1,0.0
ACEAng-IIAT-1r,1,0.0
democratizing,1,0.0
undergird,1,0.0
HLA-I-restricted,1,0.0
change-induced,1,0.0
SPRWYFYYL,1,0.0
near-catastrophy,1,0.0
Flowire,1,0.0
HLA-B07,1,0.0
HLA-B35,1,0.0
3475,1,0.0
mesodiastolic,1,0.0
3762,1,0.0
post-infectionvaccination,1,0.0
Irbid,1,0.0
cases3053,1,0.0
cases2147,1,0.0
Revman,1,0.0
3182,1,0.0
rhinicis,1,0.0
membrane-enclosed,1,0.0
eclipse,1,0.0
Isaac,1,0.0
violinist,1,0.0
infarct-causing,1,0.0
0239,1,0.0
4614,1,0.0
CTRC,1,0.0
proto-oncogene,1,0.0
tyrosine-protein,1,0.0
4454,1,0.0
EV-associated,1,0.0
plasma-related,1,0.0
Ad5-vectored,1,0.0
broncho-provocative,1,0.0
hNSE-immunoreactive,1,0.0
trimerized,1,0.0
3452,1,0.0
Gaza,1,0.0
ICU-COVID,1,0.0
2819,1,0.0
cases2769,1,0.0
Sun,1,0.0
worm,1,0.0
PER,1,0.0
overrated,1,0.0
avulsed,1,0.0
host-parasite,1,0.0
post-performance,1,0.0
WMFT-time,1,0.0
lasersonics,1,0.0
SIS-total,1,0.0
SIS-physical,1,0.0
25-42,1,0.0
Yat-sen,1,0.0
cases2002,1,0.0
BASP,1,0.0
Nd,1,0.0
susceptible-this,1,0.0
vancomycin-resistant,1,0.0
carbapenem-resistant,1,0.0
thrombus-containing,1,0.0
Coronavirus-19-related,1,0.0
cases1972,1,0.0
parapsilosis,1,0.0
Carbapenem-resistant,1,0.0
cases1552,1,0.0
N-antibody,1,0.0
SK986PV987P,1,0.0
protosystolic,1,0.0
two-RBD,1,0.0
crown-shape,1,0.0
ultramicroscopy,1,0.0
WERE,1,0.0
Full-genome,1,0.0
intimidating,1,0.0
PERSISTENT,1,0.0
SEVERE,1,0.0
anti-SARS‑CoV-2,1,0.0
threshhold,1,0.0
047ABSTRACT,1,0.0
CHARACTERISTICS,1,0.0
isradipine,1,0.0
characteristicsTHE,1,0.0
Microinjection,1,0.0
Precipitation,1,0.0
SANDOZ,1,0.0
REBRACO,1,0.0
patients--22,1,0.0
782-1057,1,0.0
2668-3652,1,0.0
HORP,1,0.0
3228-4120,1,0.0
8024-9950,1,0.0
heat-related,1,0.0
protodiastole,1,0.0
gradesThe,1,0.0
Transversely,1,0.0
macroreaction,1,0.0
NCT04368728,1,0.0
one-RBD,1,0.0
virus-entry,1,0.0
T-helper-1,1,0.0
IFNγCD8,1,0.0
N-S-specific,1,0.0
overstressed,1,0.0
82-182×,1,0.0
SARS-CoV-2-convalescent,1,0.0
USA1-3,1,0.0
shut-downs,1,0.0
NCT04380701,1,0.0
6941,1,0.0
104-239,1,0.0
review-type,1,0.0
carboxymethylene,1,0.0
polyphenylene,1,0.0
1815,1,0.0
microbicide,1,0.0
tracheabronchia,1,0.0
1693,1,0.0
antiarrythmics,1,0.0
phenazine,1,0.0
245-544,1,0.0
110-254,1,0.0
AUGE,1,0.0
1962-1963,1,0.0
AH3N2-dominant,1,0.0
bilobed,1,0.0
74-98,1,0.0
82-97,1,0.0
≤22,1,0.0
BCL6,1,0.0
PFKFB3,1,0.0
CRIP2,1,0.0
NSG1,1,0.0
TNFRSF21,1,0.0
Biochemica,1,0.0
Medix,1,0.0
Customs,1,0.0
Enforcement,1,0.0
Asias,1,0.0
interfaith,1,0.0
Actim,1,0.0
≥380°C,1,0.0
interferon-independent,1,0.0
incautious,1,0.0
bicarotid,1,0.0
hepatomegaly,1,0.0
coluric,1,0.0
Leucocytosis,1,0.0
9697,1,0.0
12542,1,0.0
Bulgarias,1,0.0
DNA-DNA,1,0.0
societalglobal,1,0.0
anemometer,1,0.0
stenosiscan,1,0.0
echocardiographic-guided,1,0.0
476740,1,0.0
8·5,1,0.0
assiduously,1,0.0
1·5,1,0.0
20·5,1,0.0
5·0,1,0.0
0·7,1,0.0
for-the,1,0.0
to-but,1,0.0
Kong3302001-,1,0.0
throughthe,1,0.0
Pyrosequencing,1,0.0
causeof,1,0.0
anti-gens,1,0.0
immuno-dominant,1,0.0
Unsatisfactory,1,0.0
misunderstands,1,0.0
95-100,1,0.0
61-89,1,0.0
3-61,1,0.0
activity-dependent,1,0.0
fatigability--but,1,0.0
pancreas-after-kidney,1,0.0
trabeculas,1,0.0
carnous,1,0.0
patho-physiology,1,0.0
proximities,1,0.0
1794-1848,1,0.0
Ackerknechts,1,0.0
Erwin,1,0.0
médical,1,0.0
207-222,1,0.0
dose-rate,1,0.0
airborne-mediated,1,0.0
Spallanzani,1,0.0
archéologie,1,0.0
clinique,1,0.0
Naissance,1,0.0
imporved,1,0.0
H1N1pdm-positive,1,0.0
occasionaly,1,0.0
Roper,1,0.0
Logan,1,0.0
Tierney,1,0.0
Non-Pharmaceutical,1,0.0
CAN-NPI,1,0.0
endocranial,1,0.0
sus-clinoïd,1,0.0
Insidious,1,0.0
transparenchymal,1,0.0
suppletive,1,0.0
Parathormone,1,0.0
profited,1,0.0
humours,1,0.0
cataractogenic,1,0.0
pacos,1,0.0
conformation-based,1,0.0
lineage-based,1,0.0
Galectins,1,0.0
β-galactosides,1,0.0
trabecula,1,0.0
terminalis,1,0.0
pre-cancerous,1,0.0
crista,1,0.0
Linnaeus,1,0.0
tumourigenesis,1,0.0
railings,1,0.0
Vicugna,1,0.0
Armand,1,0.0
preface,1,0.0
≈30,1,0.0
1800-1875,1,0.0
sintered,1,0.0
cross-hatch,1,0.0
financier,1,0.0
apoB-LDL,1,0.0
1950s-60s,1,0.0
Airborne-mediated,1,0.0
banker,1,0.0
1801-1867,1,0.0
significancy,1,0.0
firmer,1,0.0
AH1N1-dominant,1,0.0
RIQ,1,0.0
835000,1,0.0
N460K,1,0.0
oxatomide,1,0.0
132833,1,0.0
113679-152000,1,0.0
levocabastine,1,0.0
662-1046,1,0.0
214-336,1,0.0
H1-activation,1,0.0
tenuous,1,0.0
Getting,1,0.0
LLLT,1,0.0
multi-vessels,1,0.0
H2-,1,0.0
14865,1,0.0
3620,1,0.0
6479,1,0.0
4766,1,0.0
Followed-up,1,0.0
Spider-group,1,0.0
School-centered,1,0.0
FilterWire-group,1,0.0
3018,1,0.0
CAS-detected,1,0.0
angiographs,1,0.0
Mitigations,1,0.0
111154-132423,1,0.0
121782,1,0.0
articlesreviews,1,0.0
119-638,1,0.0
tsunamic,1,0.0
nevus,1,0.0
saltatory,1,0.0
PBSI,1,0.0
anti-retroviralanti-viral,1,0.0
DAVITs,1,0.0
1-37,1,0.0
5-35,1,0.0
anti-malarialanti-parasitic,1,0.0
Tenofovir,1,0.0
distractions,1,0.0
Operators,1,0.0
Contraint-induced,1,0.0
body-weight-supported,1,0.0
NOT,1,0.0
bodyaches,1,0.0
backache,1,0.0
house-holds,1,0.0
PUO,1,0.0
mortality-particularly,1,0.0
disease-that,1,0.0
reportsObservation,1,0.0
vaccinationConclusions,1,0.0
721-122,1,0.0
60-615,1,0.0
undertreating,1,0.0
2573,1,0.0
oxidatively,1,0.0
PLproC111S,1,0.0
fallouts,1,0.0
ubiquitin-specific,1,0.0
chain-breaking,1,0.0
phantasy,1,0.0
mantras,1,0.0
catamnestic,1,0.0
later--all,1,0.0
MRC5,1,0.0
lung-derived,1,0.0
pro-eosinophilic,1,0.0
virus-susceptible,1,0.0
metabolize,1,0.0
phenotypeendotype-specific,1,0.0
SalivaDirect,1,0.0
Qualtrics,1,0.0
CLIA-certified,1,0.0
statisticians,1,0.0
monkey-derived,1,0.0
States-based,1,0.0
end-users-those,1,0.0
for-so,1,0.0
ESPS-2,1,0.0
pilot-funded,1,0.0
methonitrate,1,0.0
008ABSTRACT,1,0.0
triatriatum,1,0.0
carbon-containing,1,0.0
Greenfields,1,0.0
54-35,1,0.0
93-17,1,0.0
peroxiredoxins,1,0.0
71-54,1,0.0
Peroxiredoxins,1,0.0
NHISS,1,0.0
Pre-event,1,0.0
exocytosisendocytosis,1,0.0
Bioinformation,1,0.0
organics,1,0.0
water-suspended,1,0.0
revascularise,1,0.0
congregates,1,0.0
httpsbigdbigaccnncov,1,0.0
Indore,1,0.0
Biorad,1,0.0
b-coronavirus,1,0.0
16000000,1,0.0
656000,1,0.0
inicipient,1,0.0
high-positive,1,0.0
Tib,1,0.0
36-41,1,0.0
irritated,1,0.0
chemosis,1,0.0
pseudomembranes,1,0.0
underfunctioning,1,0.0
anthranilic,1,0.0
N-34-dimethoxycinnamoyl,1,0.0
hypocarbia,1,0.0
Ineffectively,1,0.0
Pfizer-Biotech,1,0.0
drugsConclusion,1,0.0
Pfizer-Biontech,1,0.0
K699,1,0.0
CaseDescription,1,0.0
Pandemrix®,1,0.0
3227,1,0.0
angioplastystenting,1,0.0
Two-stage,1,0.0
EICMA,1,0.0
ECAs,1,0.0
Kentuckians,1,0.0
delayed-enhanced,1,0.0
biomembranes,1,0.0
DiaSorins,1,0.0
lods,1,0.0
manufacturer-recommended,1,0.0
nearterm,1,0.0
face-seal,1,0.0
hosiery,1,0.0
pandemic-specific,1,0.0
N-5,1,0.0
N5,1,0.0
HLA-binders,1,0.0
Strongly,1,0.0
8903,1,0.0
Fibrotic,1,0.0
WPW,1,0.0
SPEIA,1,0.0
9156,1,0.0
polyelectrolyte,1,0.0
6751,1,0.0
8059,1,0.0
9409,1,0.0
7384,1,0.0
8017,1,0.0
multimerization,1,0.0
drowning-related,1,0.0
polyelectrolytes,1,0.0
strand-displacement,1,0.0
daclizumab,1,0.0
mepoluzimab,1,0.0
unerring,1,0.0
β2-mimetics,1,0.0
levelsLpa,1,0.0
antimuscarinic,1,0.0
patient-caretaker,1,0.0
effectorpolyfunctional,1,0.0
patientsIMPORTANCE,1,0.0
preschizophrenic,1,0.0
5389,1,0.0
His-Purkinje,1,0.0
US1000,1,0.0
pressure-assisted,1,0.0
RNPT,1,0.0
tension-relief,1,0.0
PUs,1,0.0
between-reader,1,0.0
gluteus,1,0.0
maximus,1,0.0
target-derived,1,0.0
electrocadiographic,1,0.0
Three-vessel,1,0.0
spirometry-proven,1,0.0
Inherently,1,0.0
hospital-phase,1,0.0
BIS,1,0.0
Freemasons,1,0.0
Umuahia,1,0.0
scapegoated,1,0.0
AShanghai22013,1,0.0
Otherness,1,0.0
hemodiafiltration,1,0.0
n160,1,0.0
106-111,1,0.0
≥052,1,0.0
large-circulation,1,0.0
subterranean,1,0.0
sacrococcyx,1,0.0
within-reader,1,0.0
DigiWest,1,0.0
Dutch-born,1,0.0
A85,1,0.0
4726,1,0.0
A884,1,0.0
epidemic1,1,0.0
undersized,1,0.0
mesoscale-level,1,0.0
preschizophrenics,1,0.0
neuroVIISAS-framework,1,0.0
spatial-exploration,1,0.0
Fos,1,0.0
10630,1,0.0
Connectome,1,0.0
08874,1,0.0
hubness,1,0.0
Dawson,1,0.0
home-caged,1,0.0
Ambiguities,1,0.0
microcircuit,1,0.0
1926,1,0.0
Dix74176,1,0.0
setting-up,1,0.0
09508,1,0.0
1-page,1,0.0
in-the-field,1,0.0
Anthropac,1,0.0
EpiInfo,1,0.0
conticosteroids,1,0.0
SARS-Coronavirus-2,1,0.0
nanoparticle-formulated,1,0.0
fu,1,0.0
Xue,1,0.0
maximising,1,0.0
Farr,1,0.0
Erchen,1,0.0
re-examines,1,0.0
Masu,1,0.0
Dingchuan,1,0.0
qinglong,1,0.0
resetting,1,0.0
Xiao,1,0.0
patternsyndrome,1,0.0
Payers,1,0.0
TOTAL,1,0.0
virus-to-cell,1,0.0
surface-virus-cleaning,1,0.0
pig-,1,0.0
poultry-producing,1,0.0
KnowledgeSM,1,0.0
sero-epidemioligical,1,0.0
sequencestructure,1,0.0
intra-continental,1,0.0
enzyme-2ACE2,1,0.0
post-project,1,0.0
Wernicke,1,0.0
anti-K-vitamin,1,0.0
anti-platelets,1,0.0
HI-5,1,0.0
Multidose,1,0.0
recoverydischarge,1,0.0
indemnity,1,0.0
block-like,1,0.0
Myasthenia,1,0.0
Configuration,1,0.0
antiparkinsonian,1,0.0
eroding,1,0.0
ENE-COVID,1,0.0
antipathogenic,1,0.0
intrastate,1,0.0
6614,1,0.0
monovariate,1,0.0
155-449,1,0.0
ratio540,1,0.0
Shenqi,1,0.0
302-964,1,0.0
Shenge,1,0.0
Nomina,1,0.0
Anatomica,1,0.0
asymetric,1,0.0
clinicopathobiology,1,0.0
Buzhong,1,0.0
1985-1997,1,0.0
accelerator,1,0.0
dissent,1,0.0
FGD-free,1,0.0
high-path,1,0.0
nonsupplemented,1,0.0
placebo-acupunctures,1,0.0
parasympatholytic,1,0.0
weight-lifters,1,0.0
hobbiesprofessions,1,0.0
acupunctures,1,0.0
muMol1,1,0.0
koordinatornye,1,0.0
3-levels,1,0.0
026039,1,0.0
00056,1,0.0
0002900087,1,0.0
swimming-bath,1,0.0
2352,1,0.0
Work-associated,1,0.0
unpreventable,1,0.0
bronchodilatorscorticosteroids,1,0.0
11Cflumazenil,1,0.0
Para-medical,1,0.0
micrograph,1,0.0
SARS-Co-V,1,0.0
90-bed,1,0.0
40-54,1,0.0
Gerriets,1,0.0
expressible,1,0.0
stroke-mimics,1,0.0
frequent-flyers,1,0.0
64100000,1,0.0
uninterruptedly,1,0.0
46494,1,0.0
Aphylaxis,1,0.0
AH1N1S-OIV,1,0.0
VA-pneumonia,1,0.0
INFLUNET,1,0.0
21250,1,0.0
pre-project,1,0.0
Medicare-B,1,0.0
S-nitrosation,1,0.0
Transmissible,1,0.0
CIRI-IT,1,0.0
4882415,1,0.0
ethno-racial,1,0.0
NAP,1,0.0
5519917,1,0.0
S-nitrosated,1,0.0
4660601,1,0.0
NO-donor,1,0.0
Osijek,1,0.0
manikins,1,0.0
3000-4000,1,0.0
BBrisbane6008,1,0.0
50-64-y-old,1,0.0
videothoracoscopic,1,0.0
folk-devil,1,0.0
misdisagnosed,1,0.0
preauricular,1,0.0
saline-cooled,1,0.0
microvascularisation,1,0.0
Orders,1,0.0
QO,1,0.0
QOs,1,0.0
D10,1,0.0
sang,1,0.0
fortify,1,0.0
immunoprofiling,1,0.0
chorister,1,0.0
processor,1,0.0
9-36,1,0.0
99mTc-Imidodiphosphonate,1,0.0
response-nonresponse,1,0.0
paeople,1,0.0
Subdivision,1,0.0
Cipto,1,0.0
Mangunkusumo,1,0.0
multipotency,1,0.0
ascariasis,1,0.0
inhalan,1,0.0
Vague,1,0.0
epithelialendothelial,1,0.0
eosinophilsneutrophils,1,0.0
vascularmatrix-related,1,0.0
cell-like,1,0.0
137-412,1,0.0
100000-fold,1,0.0
alveolospheres,1,0.0
broadcaster,1,0.0
non-existence,1,0.0
cardiocentres,1,0.0
CRNT,1,0.0
NYCDOHMH,1,0.0
N50-CRNT,1,0.0
gcL,1,0.0
real-rime,1,0.0
plateauing,1,0.0
9-16,1,0.0
preconceived,1,0.0
messageone,1,0.0
BolognaEmilia,1,0.0
R-spondin-dependent,1,0.0
TurinPiedmont,1,0.0
techniquesABSTRACT,1,0.0
MilanLombardy,1,0.0
archipelago,1,0.0
S19P,1,0.0
K26R,1,0.0
Tinnitus,1,0.0
Gomera,1,0.0
sphere-based,1,0.0
146-675,1,0.0
Wnt-,1,0.0
post-radiofrequency,1,0.0
concerns-and,1,0.0
homogeneities,1,0.0
straddles,1,0.0
Transitioning,1,0.0
Chemscore,1,0.0
D-score,1,0.0
countMeasurements,1,0.0
Hexane,1,0.0
2-hexanone,1,0.0
nonanal,1,0.0
1-propanol,1,0.0
hexane,1,0.0
persulphate,1,0.0
acrylates,1,0.0
G-score,1,0.0
ADP-Ribose,1,0.0
NSP12-NSP8-NSP7,1,0.0
hystory,1,0.0
tn,1,0.0
source-transmitters,1,0.0
cérebraux,1,0.0
Monophosphate,1,0.0
T-cell-responses,1,0.0
Maternity,1,0.0
roomed-in,1,0.0
submaxillaries,1,0.0
room-in,1,0.0
152-1326,1,0.0
phenotypesMethods,1,0.0
lackingObjectives,1,0.0
patient-caregiver,1,0.0
rubidium-82,1,0.0
children-vaccinations,1,0.0
popliteal,1,0.0
24-months,1,0.0
inducting,1,0.0
benchmarking-graphs,1,0.0
stroke-treatment,1,0.0
Osterreich,1,0.0
sub-systems,1,0.0
Gesundheit,1,0.0
Stroke-Unit-Registry,1,0.0
unexamined,1,0.0
fluorine-18-fluoro-deoxyglucose,1,0.0
navigators,1,0.0
virusesIMPORTANCE,1,0.0
mmHG,1,0.0
congenic,1,0.0
scrutinize,1,0.0
P210L,1,0.0
µgL,1,0.0
K206R,1,0.0
S-Se,1,0.0
neuropathologies,1,0.0
non-radicals,1,0.0
sarcolemmal,1,0.0
inadvisability,1,0.0
Higher-risk,1,0.0
159-488,1,0.0
0231,1,0.0
country-missions,1,0.0
school-attending,1,0.0
Swift,1,0.0
SOP,1,0.0
subregional,1,0.0
Rounds,1,0.0
memories,1,0.0
multiple-regression,1,0.0
unskilled,1,0.0
nonmedically,1,0.0
Shuttle,1,0.0
gene-rating,1,0.0
230100000,1,0.0
fit-tested,1,0.0
patientsThere,1,0.0
-593,1,0.0
-827,1,0.0
-360,1,0.0
-2300,1,0.0
-2942,1,0.0
-1658,1,0.0
-110,1,0.0
8739,1,0.0
0062-0858,1,0.0
5937,1,0.0
EuroFlu,1,0.0
Wars,1,0.0
1421,1,0.0
event-driven,1,0.0
183-944,1,0.0
157-1839,1,0.0
112-327,1,0.0
Khorasan,1,0.0
713-166,1,0.0
pre-MEDLINE,1,0.0
co‐infection,1,0.0
Aspirated,1,0.0
polypoid,1,0.0
pedunculated,1,0.0
core-lab,1,0.0
test-and-treat,1,0.0
drips,1,0.0
-0137,1,0.0
-0983,1,0.0
ncRNA,1,0.0
circRNA,1,0.0
excitersensor,1,0.0
PLTs,1,0.0
Frequency-difference,1,0.0
Bermudas,1,0.0
winds--were,1,0.0
northeasterly,1,0.0
factors--namely,1,0.0
11540,1,0.0
Cross-country,1,0.0
nonpatient,1,0.0
nontransfused,1,0.0
reassemble,1,0.0
subtilisin,1,0.0
amyloliquefaciens,1,0.0
antiganglioside,1,0.0
curvacin,1,0.0
transparietal,1,0.0
curvatus,1,0.0
twenty-year,1,0.0
Guyana,1,0.0
preadolescents,1,0.0
heptavalent,1,0.0
Pneumococci,1,0.0
non-capsulated,1,0.0
sakacin,1,0.0
sakei,1,0.0
21-92,1,0.0
Unity,1,0.0
lactococcin,1,0.0
self-paced,1,0.0
Gb,1,0.0
coherences,1,0.0
desynchronizationsynchronization,1,0.0
6405,1,0.0
Moravian,1,0.0
manualized,1,0.0
animalhuman,1,0.0
carelaboratory,1,0.0
probiotics-derived,1,0.0
χ2176619,1,0.0
shuffling,1,0.0
intrasubject,1,0.0
individualising,1,0.0
near-cut-off,1,0.0
Clique,1,0.0
ultra-small,1,0.0
sixty-controls,1,0.0
betweennessχ2214186,1,0.0
19-95,1,0.0
pre-virology,1,0.0
ecobiology,1,0.0
BCI-monitored,1,0.0
ruining,1,0.0
BCIs,1,0.0
Quarantining,1,0.0
103-301,1,0.0
forced-expiratory,1,0.0
114-440,1,0.0
101-431,1,0.0
SDS-PAGE,1,0.0
111-280,1,0.0
nonworking,1,0.0
immunoblots,1,0.0
Invulnerability,1,0.0
hyperconcentrations,1,0.0
heparinotherapy,1,0.0
anoeuvrism,1,0.0
Stroke-Unit,1,0.0
54223,1,0.0
30222,1,0.0
93219,1,0.0
halve,1,0.0
74219,1,0.0
139224,1,0.0
200224,1,0.0
188229,1,0.0
201236,1,0.0
flow-chart,1,0.0
CHADS2CHA2DS2-VASc,1,0.0
2401200,1,0.0
directory,1,0.0
ileal,1,0.0
non-compensatory,1,0.0
hysterical,1,0.0
speechvocal,1,0.0
givenABSTRACT,1,0.0
1631,1,0.0
17804,1,0.0
19-31,1,0.0
6–15,1,0.0
mid-afternoon,1,0.0
nonmedication,1,0.0
00171,1,0.0
100000-125000,1,0.0
26221,1,0.0
137205,1,0.0
P065,1,0.0
patient-groups,1,0.0
allotted,1,0.0
BlackHispanic,1,0.0
nightearly,1,0.0
outbreaksIMPORTANCE,1,0.0
nimble,1,0.0
noncortical,1,0.0
opine,1,0.0
Sabará,1,0.0
predestined,1,0.0
P066,1,0.0
non-AR,1,0.0
surveillance-in,1,0.0
P096,1,0.0
zero-filling,1,0.0
Patmore,1,0.0
Jennings,1,0.0
Rivett,1,0.0
IndianAlaska,1,0.0
similar-size,1,0.0
Karlson,1,0.0
testing-changes,1,0.0
virulency,1,0.0
Bahian,1,0.0
Marco,1,0.0
Nitrate-induced,1,0.0
Epigallocatechin-3-gallate,1,0.0
Sternal,1,0.0
54-68,1,0.0
383812,1,0.0
hospitalizationintubation,1,0.0
1945071,1,0.0
Kingdom-to,1,0.0
Survey-a,1,0.0
COVID-19-dengue,1,0.0
dengue-COVID-19,1,0.0
Bencard,1,0.0
rate--from,1,0.0
8731,1,0.0
HBT,1,0.0
HFM,1,0.0
nonmigraineurs,1,0.0
Right-to-left,1,0.0
conditioner,1,0.0
ratesamong,1,0.0
vaccinationsData,1,0.0
Citing,1,0.0
GPCR-derived,1,0.0
014-033,1,0.0
Religiosity,1,0.0
A-strain,1,0.0
vaccine-prevented,1,0.0
Signaling,1,0.0
60-71,1,0.0
65-88,1,0.0
73-85,1,0.0
Aretaeus,1,0.0
ectopia,1,0.0
Cantrells,1,0.0
pentalogy,1,0.0
1509,1,0.0
≈50,1,0.0
129-171,1,0.0
refusalhesitation,1,0.0
criticable,1,0.0
paradoxial,1,0.0
Bacground,1,0.0
Cappadocia,1,0.0
judgments--in,1,0.0
learning-driven,1,0.0
theory--when,1,0.0
evidential,1,0.0
subadditivity--cue,1,0.0
atherosclerosis--or,1,0.0
decisive--as,1,0.0
redundancy--are,1,0.0
classification-learning,1,0.0
erode,1,0.0
NCT02355457,1,0.0
subadditivity,1,0.0
linear-discounting,1,0.0
diABZI,1,0.0
ABZI-based,1,0.0
AOD,1,0.0
reassesment,1,0.0
233-246,1,0.0
FAMHAP,1,0.0
Single-,1,0.0
three-gene,1,0.0
two-region,1,0.0
137-177,1,0.0
26715,1,0.0
115-190,1,0.0
278-281,1,0.0
0001607,1,0.0
pstratified,1,0.0
0014831,1,0.0
0001525,1,0.0
897-913,1,0.0
cross-immunoprotection,1,0.0
GGGSGGG,1,0.0
KK,1,0.0
polymer-subunit,1,0.0
polyoxidonium,1,0.0
110986,1,0.0
back-end,1,0.0
TEMH,1,0.0
397577,1,0.0
dilators,1,0.0
arteriolarvenular,1,0.0
32970,1,0.0
462-485,1,0.0
895-929,1,0.0
amino-transaminases,1,0.0
P0070,1,0.0
IVT-CEA,1,0.0
0-349,1,0.0
20-69,1,0.0
reinflated,1,0.0
recommenced,1,0.0
college-aged,1,0.0
Antigen-dependent,1,0.0
care-giving,1,0.0
IgG-mediated,1,0.0
complex-mediated,1,0.0
phospho-kinase,1,0.0
sociodemografic,1,0.0
multi-focal,1,0.0
circs,1,0.0
wound-healing,1,0.0
RT-PCR-specific,1,0.0
Kosice,1,0.0
talc,1,0.0
anesthesiasedation,1,0.0
self-organized,1,0.0
angiomatosis,1,0.0
single-region,1,0.0
kinky,1,0.0
thromboembolia,1,0.0
Stimulus-effect,1,0.0
amidobenzimidazole,1,0.0
provocational,1,0.0
SAb,1,0.0
SWCNT,1,0.0
Peroxynitrite,1,0.0
high-purity,1,0.0
LTC4D4E4,1,0.0
Nitrotyrosine,1,0.0
Jena,1,0.0
Re-establishing,1,0.0
gluten-free,1,0.0
non-dyslipidemia,1,0.0
hemiparesthesias,1,0.0
OR128,1,0.0
Antitransglutaminase,1,0.0
deamidated,1,0.0
110-121,1,0.0
gliadin,1,0.0
antineuronal,1,0.0
6897,1,0.0
encephalomyopathy,1,0.0
options-including,1,0.0
nosspecific,1,0.0
spike-receptor,1,0.0
post-ictus,1,0.0
thrombectomy-has,1,0.0
IRF3,1,0.0
microchimerism,1,0.0
SAb-functionalized,1,0.0
pathologooantomical,1,0.0
lipid-related,1,0.0
choices--and,1,0.0
systems--in,1,0.0
cell-adhesion,1,0.0
Analyst,1,0.0
gene-activating,1,0.0
cardioembolias,1,0.0
carbamazepine,1,0.0
familysocial,1,0.0
9632,1,0.0
199984,1,0.0
3335,1,0.0
extrapancreatic,1,0.0
1-lead,1,0.0
innumerous,1,0.0
Bipolar,1,0.0
stroke-volume,1,0.0
timeamplitude,1,0.0
minicomputer,1,0.0
50-msec,1,0.0
LAAOS,1,0.0
Appriva,1,0.0
1985-1998,1,0.0
Atritech,1,0.0
PROTECTion,1,0.0
httpsbitly3eUnl1R,1,0.0
Termination,1,0.0
1971-1975,1,0.0
JCH-K,1,0.0
0·033,1,0.0
0·5,1,0.0
non-value,1,0.0
-1·9,1,0.0
optimalOperations,1,0.0
ABAH1N1,1,0.0
procedure-associated,1,0.0
left-dominant,1,0.0
podium,1,0.0
structuralgenomic,1,0.0
symposia,1,0.0
Diligent,1,0.0
Canada-Centre,1,0.0
horse-racing,1,0.0
emergesABSTRACT,1,0.0
OAM,1,0.0
point-of-care-potential,1,0.0
labchip,1,0.0
glass-based,1,0.0
silicon-,1,0.0
httpsbitly2QNTqO0,1,0.0
Hospital-Al,1,0.0
light-transparent,1,0.0
heat-transferable,1,0.0
chip-type,1,0.0
themTechnology-enhanced,1,0.0
processesThe,1,0.0
beneficialGiven,1,0.0
14-70,1,0.0
recommendations--have,1,0.0
AMI-066,1,0.0
Buerger’s,1,0.0
inﬂuenza-associated,1,0.0
AMI-048,1,0.0
conﬁrmed,1,0.0
vailable,1,0.0
diltiazemplacebo,1,0.0
1522,1,0.0
2377,1,0.0
provider-recipient,1,0.0
13-16,1,0.0
edit-distance,1,0.0
preimplant,1,0.0
oligoclonal,1,0.0
fluorimetrically,1,0.0
3805,1,0.0
2810,1,0.0
RIAELISA,1,0.0
postimplant,1,0.0
heatmap,1,0.0
multifactorialfacetted,1,0.0
malady,1,0.0
assay-screening,1,0.0
Kandarah,1,0.0
Aspirindipyridamole,1,0.0
infarction--who,1,0.0
non-standard,1,0.0
monocytogenes,1,0.0
Vibrio,1,0.0
Yersinia,1,0.0
pestis,1,0.0
knowlesi,1,0.0
42530,1,0.0
anti-TB,1,0.0
anti-leprosy,1,0.0
anti-lyme,1,0.0
27240,1,0.0
anti-plague,1,0.0
anti-anthrax,1,0.0
drugsvaccine,1,0.0
1955-1988,1,0.0
CTRI,1,0.0
forerunners,1,0.0
immunizedvaccinated,1,0.0
KVGGNYNYL444-452,1,0.0
SVLYNSASF366-374,1,0.0
KRISNCVADYSVLYN356-370,1,0.0
unturned,1,0.0
Kanagawa176,1,0.0
DLCFTNVYADSFVI389-402,1,0.0
YRVVVLSFELLHA508-520,1,0.0
data-intensive,1,0.0
Listeria,1,0.0
Pylori,1,0.0
Heg2,1,0.0
chitinase-like,1,0.0
α-interferon,1,0.0
LVMIs,1,0.0
chitins,1,0.0
chitooligomers,1,0.0
Burch,1,0.0
Druin,1,0.0
Consulting,1,0.0
MCH-induced,1,0.0
MCH-PC20-FEV1,1,0.0
diethylcarbamazine,1,0.0
18-glycosyl-hydrolase,1,0.0
chitooligosaccharides,1,0.0
tetani,1,0.0
DOIhttpdxdoiorg107554eLife00299001,1,0.0
then-circulating,1,0.0
gratifying,1,0.0
chitin-containing,1,0.0
hydrolases,1,0.0
dysfunctionABSTRACT,1,0.0
V3R-V4R-V5R,1,0.0
1826,1,0.0
Neg2,1,0.0
leprae,1,0.0
perfringens,1,0.0
AMI-082,1,0.0
AMI-111,1,0.0
activationreactivation,1,0.0
54·8,1,0.0
plansfurther,1,0.0
2004-5,1,0.0
rebate,1,0.0
Cannulation,1,0.0
prenodal,1,0.0
2003-4,1,0.0
unfixed,1,0.0
acid-reacting,1,0.0
nzymes,1,0.0
Asystolia,1,0.0
apex-cardiography,1,0.0
after-exercise,1,0.0
Insulae,1,0.0
Frusemide,1,0.0
5005,1,0.0
AArizona80,1,0.0
Wuhan35395,1,0.0
5I,1,0.0
51·2,1,0.0
4½,1,0.0
60·2,1,0.0
normoperceivers,1,0.0
39·9,1,0.0
5·8,1,0.0
13·4,1,0.0
stage-oriented,1,0.0
Extravagant,1,0.0
eating-related,1,0.0
189470,1,0.0
categorizations,1,0.0
neovascularity,1,0.0
53-year-old-man,1,0.0
counterindications,1,0.0
ECG-registration,1,0.0
functional-diagnostic,1,0.0
parainfluenza-1,1,0.0
random-digit-dial,1,0.0
00236,1,0.0
self-reading,1,0.0
8133,1,0.0
169780,1,0.0
non-returnable,1,0.0
134950,1,0.0
asthma-wheezing,1,0.0
130180,1,0.0
6367,1,0.0
118150,1,0.0
persona,1,0.0
suffocating,1,0.0
102800,1,0.0
pangs,1,0.0
returnable,1,0.0
9410,1,0.0
56·0,1,0.0
hyperperceivers,1,0.0
Wrześniewski,1,0.0
89·1,1,0.0
non-specifity,1,0.0
1615,1,0.0
malunion,1,0.0
platting,1,0.0
GINAGOLD,1,0.0
lead-time,1,0.0
microplate,1,0.0
2003-September,1,0.0
nanoplasmonic,1,0.0
class≥III,1,0.0
non-union,1,0.0
infarction-126,1,0.0
Beta-adrenoceptor,1,0.0
AMI-128,1,0.0
slow-channel,1,0.0
fun,1,0.0
stimulus-bronchial,1,0.0
AMI-053,1,0.0
hyperresponsiveness-obstruction-symptoms,1,0.0
Pavord,1,0.0
Digitalisdiuretic,1,0.0
ischemiaABSTRACT,1,0.0
AMI-046,1,0.0
Differently,1,0.0
non-acceptation,1,0.0
3008,1,0.0
StrokeESUS,1,0.0
2193,1,0.0
inhibitors--in,1,0.0
85·0,1,0.0
65·7,1,0.0
57·5,1,0.0
7·9,1,0.0
18-52,1,0.0
mgdose,1,0.0
Bricanyl,1,0.0
revascularisaton,1,0.0
1·2-1·5,1,0.0
or80,1,0.0
organ-transplant,1,0.0
expire,1,0.0
geo-physical,1,0.0
IABP-dependent,1,0.0
hyperlipoproteinemia,1,0.0
22048,1,0.0
19490,1,0.0
5-7-year,1,0.0
survivers,1,0.0
2227,1,0.0
Macrofocal,1,0.0
17206,1,0.0
ontology-modeling,1,0.0
11004,1,0.0
death-rates,1,0.0
SFCE,1,0.0
dysimmune,1,0.0
attitudesConclusions,1,0.0
Study-Birth,1,0.0
worldwide-approved,1,0.0
decorates,1,0.0
6146,1,0.0
acetylcholine-related,1,0.0
MINOCA-using,1,0.0
definition-and,1,0.0
Composition,1,0.0
Gastro-Hepatology,1,0.0
S183P,1,0.0
D222GS183P,1,0.0
civilizations,1,0.0
E1B,1,0.0
caracterized,1,0.0
PCR-detection,1,0.0
immunoflourescence,1,0.0
inflenza,1,0.0
measuresHypothesis,1,0.0
Extraction-free,1,0.0
methodsAim,1,0.0
NHSMethodology,1,0.0
kitsResults,1,0.0
Berlin-Charité,1,0.0
disese-19,1,0.0
selectionoutcome,1,0.0
hvs,1,0.0
Cardiometrical,1,0.0
cardiometrical,1,0.0
hyperchloremia,1,0.0
pathway-targeted,1,0.0
1975-2004,1,0.0
counter-matched,1,0.0
Woman,1,0.0
WIC,1,0.0
soot,1,0.0
80-lead,1,0.0
fifth-year,1,0.0
practice-specific,1,0.0
practice-oriented,1,0.0
MICU,1,0.0
Anion,1,0.0
large-image,1,0.0
Acid-base,1,0.0
Non-anion,1,0.0
double-placebo,1,0.0
UKSA,1,0.0
WGCNA,1,0.0
GEne,1,0.0
GENIE3,1,0.0
16148,1,0.0
136028,1,0.0
0074,1,0.0
two-projection,1,0.0
desionsubjects,1,0.0
CFX96,1,0.0
Age-grouped,1,0.0
Quantabio,1,0.0
1·83-2·64,1,0.0
obtainedon,1,0.0
4425,1,0.0
ST-depressions,1,0.0
or-tachycardia,1,0.0
067-40,1,0.0
ehospital,1,0.0
100-fold-higher,1,0.0
Non-neurological,1,0.0
230-1874,1,0.0
108-486,1,0.0
nonsurgical-related,1,0.0
104-362,1,0.0
Fallots,1,0.0
115-127,1,0.0
tetralogy,1,0.0
truncus,1,0.0
arteriosus,1,0.0
102-109,1,0.0
DiGeorge,1,0.0
144-2511,1,0.0
151-1128,1,0.0
108-339,1,0.0
125-138,1,0.0
103-108,1,0.0
capitalise,1,0.0
less-recognized,1,0.0
conversational,1,0.0
practiceObjectives,1,0.0
qScript,1,0.0
CDC-accredited,1,0.0
primerprobes,1,0.0
tensing,1,0.0
Quantabio-CDC,1,0.0
n127,1,0.0
R209259Conclusion,1,0.0
Geilomo,1,0.0
non-polluted,1,0.0
themResults,1,0.0
sub-maximal,1,0.0
lncRNA-mediated,1,0.0
purged,1,0.0
mountainous,1,0.0
Blairs,1,0.0
63·4,1,0.0
45·4,1,0.0
0·14,1,0.0
1·75,1,0.0
1·29-2·4,1,0.0
flatbed,1,0.0
2·15,1,0.0
micro-neutralization,1,0.0
1·8-2·56,1,0.0
glucocorticoid-sparing,1,0.0
immunocorrecting,1,0.0
reaction-negative,1,0.0
hemidiaphragmatic,1,0.0
155-491,1,0.0
contributionIn,1,0.0
Diluted,1,0.0
31-item,1,0.0
foreheads,1,0.0
two-session,1,0.0
TCCSs,1,0.0
TNCCSs,1,0.0
CSNAT-Stroke,1,0.0
OSCARSS,1,0.0
carer-led,1,0.0
47-81,1,0.0
48-83,1,0.0
12-64,1,0.0
2-74,1,0.0
3-64,1,0.0
wwwlifegenese,1,0.0
apoptosis-modulating,1,0.0
covidcgorg,1,0.0
vista,1,0.0
CSP,1,0.0
frontloading,1,0.0
brusquely,1,0.0
virusesH5N1,1,0.0
17700000,1,0.0
ASichuan287H3N2,1,0.0
124-338,1,0.0
109-391,1,0.0
12080,1,0.0
ionometry,1,0.0
nuclear-absorption,1,0.0
TicagrelorPrasugrel,1,0.0
DANAMI-3,1,0.0
AGAs,1,0.0
ready-made,1,0.0
⩾60,1,0.0
Ultrasonic,1,0.0
082-099,1,0.0
058-085,1,0.0
49518,1,0.0
123I-metaiodobenzylguanidine,1,0.0
9-304,1,0.0
123I-MIBG,1,0.0
0146,1,0.0
0459,1,0.0
0379,1,0.0
793-912,1,0.0
proverb,1,0.0
Extra-pulmonary,1,0.0
-0903,1,0.0
142-300,1,0.0
Haematomas,1,0.0
low-454,1,0.0
capitonnage,1,0.0
creatininepleural,1,0.0
gammaglobulinemia,1,0.0
Attempted,1,0.0
1978-1981,1,0.0
discloser,1,0.0
neurotransmissions,1,0.0
Korber,1,0.0
help-intended,1,0.0
medium-to-long,1,0.0
echocardioscopy,1,0.0
Insufficiently,1,0.0
Vaginal,1,0.0
neof,1,0.0
IgG-immunoglobulin,1,0.0
≥106,1,0.0
near-collapse,1,0.0
412-941,1,0.0
windows-of-opportunity,1,0.0
submacular,1,0.0
subretinal,1,0.0
Amsler,1,0.0
non-influenzal,1,0.0
unheparinised,1,0.0
uronic,1,0.0
neighbour-neighbour,1,0.0
history-dependent,1,0.0
heparinised,1,0.0
hyperfunctional,1,0.0
health-care-acquired,1,0.0
subgranular,1,0.0
2-482R,1,0.0
ACE2-Ang-1-7-Mas,1,0.0
Homogeneous,1,0.0
multi-patches,1,0.0
probabilities-a,1,0.0
Non-ST-elevation,1,0.0
several-day-old,1,0.0
Indium-111-antimyosin,1,0.0
Ambiguity-averse,1,0.0
69-yr-old,1,0.0
systemRAS,1,0.0
≤600,1,0.0
counterregulatory,1,0.0
cavernosum,1,0.0
2-588V,1,0.0
safetyThe,1,0.0
spotlights,1,0.0
crowned,1,0.0
Lipoxin,1,0.0
catabasis,1,0.0
ILC,1,0.0
human-swine,1,0.0
guidelines-defined,1,0.0
oxprenolol,1,0.0
replication-enhancing,1,0.0
acidic-497R,1,0.0
1433,1,0.0
region-results,1,0.0
108-43958,1,0.0
Fabaceae,1,0.0
ischemicinfarcted,1,0.0
μPAD,1,0.0
patent-infarct,1,0.0
xenotransplant,1,0.0
VPCshour,1,0.0
proanti-inflammatory,1,0.0
hBMSC,1,0.0
covered-up,1,0.0
impure,1,0.0
konjo,1,0.0
precipitation-enhanced,1,0.0
Withania,1,0.0
shimaguni,1,0.0
somnifera,1,0.0
Dunal,1,0.0
culture-bound,1,0.0
Solanaceae,1,0.0
Thunb,1,0.0
Miers,1,0.0
Menispermaceae,1,0.0
Phyllanthus,1,0.0
emblica,1,0.0
Euphorbiaceae,1,0.0
Asparagus,1,0.0
racemosus,1,0.0
LUCAS®,1,0.0
Coolgard®-System,1,0.0
Rhine-Westphalia,1,0.0
unthrombolytic,1,0.0
Aviation,1,0.0
appoint,1,0.0
153-4494,1,0.0
stripes,1,0.0
evaluation-II,1,0.0
IVEBsThirty-eight,1,0.0
2016Patients,1,0.0
ARDSThe,1,0.0
phaseAn,1,0.0
no-Q,1,0.0
Single-factor,1,0.0
nonreperfusion,1,0.0
G153R,1,0.0
2519,1,0.0
4673,1,0.0
Multifactors,1,0.0
enzymesIVEBs,1,0.0
3849,1,0.0
noncausal,1,0.0
Lorraine,1,0.0
Vandoeuvre-les-Nancy,1,0.0
unpalatable,1,0.0
7904,1,0.0
Specialised,1,0.0
Liliaceae,1,0.0
Ocimum,1,0.0
Civil,1,0.0
sanctum,1,0.0
Radiation,1,0.0
Hemorrhages,1,0.0
Sequestration,1,0.0
synthetaseRNase,1,0.0
LZ,1,0.0
dsRNA-dependent,1,0.0
LLPC,1,0.0
FDC,1,0.0
extrafollicular,1,0.0
CPSF30,1,0.0
anti-IFN,1,0.0
DZ,1,0.0
dsRNA-NS1,1,0.0
bNAb,1,0.0
BCR,1,0.0
abbreviations,1,0.0
HeartMate-II,1,0.0
efficacyKey,1,0.0
COAD,1,0.0
ozone-depleting,1,0.0
vaguely,1,0.0
3926,1,0.0
intra-aortal,1,0.0
eletrocardiographic,1,0.0
46950,1,0.0
DEALE,1,0.0
SLPB,1,0.0
TFH,1,0.0
artherosclerotic,1,0.0
Countless,1,0.0
Lamiaceae,1,0.0
Meliaceae,1,0.0
∼10,1,0.0
atherotrombotic,1,0.0
Reporter,1,0.0
Analyte,1,0.0
RNA-Encoded,1,0.0
X10-23-mediated,1,0.0
preamplification,1,0.0
XNA-based,1,0.0
1997-2005,1,0.0
α-amino-3-hydroxy-5-methyl-4-isoxazole,1,0.0
Secular,1,0.0
Beta2-blockers,1,0.0
reviw,1,0.0
propertiesand,1,0.0
foccus,1,0.0
slums,1,0.0
Mugica,1,0.0
Padre,1,0.0
parkinsonian,1,0.0
Barrio,1,0.0
glyburide,1,0.0
05Compared,1,0.0
October--December,1,0.0
1101,1,0.0
102-257,1,0.0
Pfizer-BioNTechs,1,0.0
PacO2,1,0.0
non-susceptibility,1,0.0
betalactams,1,0.0
e-Consent,1,0.0
denomination,1,0.0
exsanguination,1,0.0
Cough-type,1,0.0
cough-type,1,0.0
minuscule,1,0.0
Generalisation,1,0.0
any-influenza,1,0.0
social-cognitive,1,0.0
totaly,1,0.0
Amplifying,1,0.0
τ044,1,0.0
d-NLR,1,0.0
τ052,1,0.0
τ054,1,0.0
203-362,1,0.0
Shewhart,1,0.0
133-180,1,0.0
N289,1,0.0
N321,1,0.0
121-869,1,0.0
FDA-Emergency,1,0.0
37706,1,0.0
lipohyaline,1,0.0
PSCI-ND,1,0.0
Pre-defined,1,0.0
reliefs,1,0.0
5-beat,1,0.0
S1S2S3,1,0.0
biologically-safe,1,0.0
indel,1,0.0
Hachinski,1,0.0
7782-8411,1,0.0
non-dementia,1,0.0
∼12,1,0.0
Apixiban,1,0.0
4891,1,0.0
caspase-independent,1,0.0
4491-5292,1,0.0
3205,1,0.0
Rivoroxaban,1,0.0
Over-consumption,1,0.0
dot-blot,1,0.0
2832-3579,1,0.0
first-episode,1,0.0
halflife,1,0.0
71-,1,0.0
E-Challenge,1,0.0
Necroptosis,1,0.0
500000--600000,1,0.0
111-729,1,0.0
Aktyubinsk,1,0.0
Ringer,1,0.0
hit-and-run,1,0.0
Asp222Gly,1,0.0
neuroblastoma,1,0.0
IAVWSN,1,0.0
222E,1,0.0
nonciliated,1,0.0
Misfolding,1,0.0
α2-3-linked,1,0.0
24-59,1,0.0
Nonsmokers,1,0.0
38326-338,1,0.0
LDH2,1,0.0
non-displaceable,1,0.0
partial-volume,1,0.0
γ-aminobutyric,1,0.0
alpha-lipoic,1,0.0
18-F-FMZ,1,0.0
F-18-Flumazenil,1,0.0
Antihemagglutinating,1,0.0
citizen-to-citizen,1,0.0
subcounty,1,0.0
Microdata,1,0.0
phone-based,1,0.0
67-81,1,0.0
decifering,1,0.0
17-56,1,0.0
22CI,1,0.0
prions-evoked,1,0.0
exenatide,1,0.0
desipramine,1,0.0
320±31,1,0.0
sex-subgroups,1,0.0
461±34,1,0.0
age-group65,1,0.0
3852,1,0.0
222±26,1,0.0
503±31,1,0.0
pro-survival,1,0.0
141727940,1,0.0
herculean,1,0.0
underlyin,1,0.0
08-29,1,0.0
HDIs,1,0.0
diacylated,1,0.0
CARDSTx,1,0.0
β-cell,1,0.0
Th2-dominant,1,0.0
11097,1,0.0
07-30,1,0.0
17-55,1,0.0
IAVWSN-specific,1,0.0
24-76,1,0.0
06-24,1,0.0
sitersquos,1,0.0
diagnosisscreening,1,0.0
organellar,1,0.0
immunityAbbreviation,1,0.0
treatment-resisting,1,0.0
“mega-trials”,1,0.0
“proof,1,0.0
concept”,1,0.0
httpsbitly3o0K9kl,1,0.0
IEES,1,0.0
late--in,1,0.0
NHLBIWorld,1,0.0
non-infection,1,0.0
bronchoobstructive,1,0.0
BOS,1,0.0
possiblity,1,0.0
spread-out,1,0.0
choir,1,0.0
Pai,1,0.0
spurring,1,0.0
abounds,1,0.0
ripe,1,0.0
Townhall,1,0.0
day-long,1,0.0
rebuts,1,0.0
F303S,1,0.0
TLR3-transfected,1,0.0
COCONEL,1,0.0
IndiaSouth,1,0.0
Profiles,1,0.0
Partition,1,0.0
Propagate,1,0.0
westside,1,0.0
Homocystinuria,1,0.0
Explanation,1,0.0
Snedelor,1,0.0
many-varied,1,0.0
maxKg,1,0.0
1994-,1,0.0
non-uptake,1,0.0
Proteobacteria-dominated,1,0.0
sero-type,1,0.0
Kyushu-,1,0.0
sero-types,1,0.0
isopleth,1,0.0
Prioritize,1,0.0
Firmicutes-,1,0.0
Knemometry,1,0.0
Pleurodesis,1,0.0
strangulated,1,0.0
6578,1,0.0
6-th,1,0.0
3000-3500,1,0.0
4000-7000,1,0.0
34-48,1,0.0
Actinobacteria-,1,0.0
STATnon-STAT,1,0.0
Thinking,1,0.0
EHI,1,0.0
joy,1,0.0
Equivalized,1,0.0
des-induced,1,0.0
radio-allergo-sorbent,1,0.0
-dynamic,1,0.0
vertiginous,1,0.0
Neu5Acα2-3Gal,1,0.0
Neu5Acα2-6Gal,1,0.0
clinical-,1,0.0
and-early,1,0.0
manfestations,1,0.0
benefit-pleasing,1,0.0
19-years,1,0.0
umbrella-like,1,0.0
boarding-school,1,0.0
BIntermediate,1,0.0
Nachtigall,1,0.0
engulfing,1,0.0
clocks,1,0.0
creatures,1,0.0
unutilized,1,0.0
leucotomy,1,0.0
delinquency,1,0.0
Realdiron,1,0.0
Reaferon-EC,1,0.0
September-October,1,0.0
credentialling,1,0.0
Th2-Th1,1,0.0
retrometabolic,1,0.0
barkers,1,0.0
zoological,1,0.0
IMPLICATIONS,1,0.0
hemagglutinin-glycan,1,0.0
PRACTICE,1,0.0
avian-adapted,1,0.0
trialsclinical,1,0.0
time-windows,1,0.0
shorter-length,1,0.0
beat-to-beat,1,0.0
LTα,1,0.0
lymphotoxin,1,0.0
Vasodilator,1,0.0
Asiatic,1,0.0
antigen-saving,1,0.0
NTproBNP,1,0.0
sickening,1,0.0
44512500,1,0.0
26385301,1,0.0
non-fluorinated,1,0.0
histofluorescence,1,0.0
Denervation,1,0.0
Norepinephrine,1,0.0
etabote,1,0.0
high-content-enabled,1,0.0
loteprednol,1,0.0
hyperhomocystinemia,1,0.0
Diseased,1,0.0
20-29-years,1,0.0
L-citrulline,1,0.0
Newman,1,0.0
SYRCLEs,1,0.0
-1870-2539,1,0.0
-1811-2409-1214,1,0.0
Cerruti,1,0.0
rapid-type,1,0.0
Sim,1,0.0
ESPED,1,0.0
Deutschland,1,0.0
621508-1512,1,0.0
6606,1,0.0
Erkrankungen,1,0.0
pädiatrische,1,0.0
Documentary,1,0.0
wakening,1,0.0
seltene,1,0.0
surgicalinvasive,1,0.0
Erhebungseinheit,1,0.0
1974-75,1,0.0
Train,1,0.0
Asthma-only,1,0.0
FeNO-based,1,0.0
nitrate-rich,1,0.0
sirolimus-stent,1,0.0
flow-ependent,1,0.0
ETs,1,0.0
Burk,1,0.0
Majestys,1,0.0
asynergynonasynergy-containing,1,0.0
lpericardium,1,0.0
1953,1,0.0
031-085,1,0.0
127-201,1,0.0
Pravda,1,0.0
117-171,1,0.0
surreptitiously,1,0.0
poisoned,1,0.0
113Sn-labelled,1,0.0
readministered,1,0.0
equalled,1,0.0
asynergicnonasynergic,1,0.0
Tahiti,1,0.0
57Co-,1,0.0
ngkgmin,1,0.0
nonasynergic,1,0.0
BYamagata-associated,1,0.0
Antiepileptic,1,0.0
nonstaff,1,0.0
redistributes,1,0.0
159-582,1,0.0
artillery,1,0.0
269-681,1,0.0
hammocks,1,0.0
diseases-related,1,0.0
confusedly,1,0.0
Q30,1,0.0
brand-new,1,0.0
dimorphism,1,0.0
r0366,1,0.0
mid-teens,1,0.0
Microneutralisation,1,0.0
23400,1,0.0
assumption--that,1,0.0
years--the,1,0.0
both-causing,1,0.0
hurling,1,0.0
squads,1,0.0
field-based,1,0.0
less-strong,1,0.0
look-and,1,0.0
field-test,1,0.0
Executives,1,0.0
physician-labelled,1,0.0
229568,1,0.0
0719,1,0.0
Regionalized,1,0.0
0269,1,0.0
Grazie,1,0.0
first-level,1,0.0
Q40,1,0.0
-0021,1,0.0
anger-in,1,0.0
upstreamregulation,1,0.0
Telemedical,1,0.0
multi-epitope-vaccine,1,0.0
15456,1,0.0
deadlock,1,0.0
rhinovirus-triggered,1,0.0
12mo,1,0.0
16mo,1,0.0
mauretanicus,1,0.0
Androctonus,1,0.0
femurs,1,0.0
Femoral,1,0.0
p0040,1,0.0
Belem,1,0.0
Scorpion,1,0.0
40836,1,0.0
whole-food,1,0.0
14156,1,0.0
18306,1,0.0
5965,1,0.0
patho-etiological,1,0.0
227346,1,0.0
entrusts,1,0.0
Tonsils,1,0.0
monotone,1,0.0
bedclothes,1,0.0
laundered,1,0.0
vacuum-cleaned,1,0.0
Decision-analytic,1,0.0
cholestatic,1,0.0
43-year-old-woman,1,0.0
single-agent,1,0.0
56--57,1,0.0
4728,1,0.0
Nembutal,1,0.0
3902,1,0.0
11-122,1,0.0
thermosensitivity,1,0.0
preserved-LVEF,1,0.0
AMoscow1798,1,0.0
Triglycerides,1,0.0
Deferring,1,0.0
1990-1995,1,0.0
crafting,1,0.0
Rufiji,1,0.0
parasitemia,1,0.0
wrists,1,0.0
wear-time,1,0.0
accelerometeric,1,0.0
nonstationarity,1,0.0
poultry-related,1,0.0
poultry-owning,1,0.0
Uninsured,1,0.0
endocarditis-related,1,0.0
bandwidths,1,0.0
Small-molecule,1,0.0
CRD42020205035,1,0.0
stead,1,0.0
non-trained,1,0.0
-1121,1,0.0
2-O,1,0.0
anticoagulant-naive,1,0.0
583-841,1,0.0
12-139,1,0.0
14870,1,0.0
Zanjan,1,0.0
QuickNavi-COVID19,1,0.0
mevalonate-dependent,1,0.0
raft,1,0.0
defection,1,0.0
Confidently,1,0.0
NCT00989716,1,0.0
S-Adenosylmethionine,1,0.0
tyrosinase,1,0.0
ISRCTN,1,0.0
4011,1,0.0
Euro-Qol-5D,1,0.0
DB03909,1,0.0
DB03186,1,0.0
ZINC000029416466,1,0.0
ZINC000026985532,1,0.0
ZINC000085537017,1,0.0
R80,1,0.0
Care-2,1,0.0
of-1283,1,0.0
RDVmAb,1,0.0
κ-means,1,0.0
2009-2018,1,0.0
Wards,1,0.0
compensates,1,0.0
Perceiving,1,0.0
intima-medial,1,0.0
pre-diabetic,1,0.0
PDM,1,0.0
NDM,1,0.0
perimetry,1,0.0
retinotopic,1,0.0
3263,1,0.0
fovea,1,0.0
patients--visual,1,0.0
patients--eg,1,0.0
125-187,1,0.0
straight-ahead,1,0.0
myocarditismyositis,1,0.0
bridge-to-transplantation,1,0.0
126-200,1,0.0
092-144,1,0.0
fasciotomies,1,0.0
multilimb,1,0.0
pan-myositis,1,0.0
Reassuringly,1,0.0
blood-retinal,1,0.0
magnetic-bead,1,0.0
labor-,1,0.0
arterialized,1,0.0
contact-free,1,0.0
Nasal-pharyngeal,1,0.0
Plasmaphereses,1,0.0
Bucheon,1,0.0
Soonchunhyang,1,0.0
masterful,1,0.0
AnshLabs,1,0.0
underpresentation,1,0.0
NovaTec,1,0.0
underpresented,1,0.0
borderline-elevated,1,0.0
anti-RoSjögrens,1,0.0
Lionex,1,0.0
ond,1,0.0
exhaustivity,1,0.0
132-237,1,0.0
Schistocyte,1,0.0
10l,1,0.0
sequeloe,1,0.0
temporo-occipito-parietal,1,0.0
textural,1,0.0
2905,1,0.0
athero-thrombotic,1,0.0
poststenotic,1,0.0
Christchurch-like,1,0.0
252-1020,1,0.0
9891,1,0.0
foolproof,1,0.0
apixaban--are,1,0.0
hypoxia-reperfusion,1,0.0
CTD,1,0.0
1461-2088,1,0.0
1088-1896,1,0.0
1011-1522,1,0.0
0788-1447,1,0.0
Wilcoxon-Mann-Whitneys,1,0.0
unchallenged,1,0.0
Substantiation,1,0.0
trichloramine,1,0.0
aeroallergen-specific,1,0.0
0-1818,1,0.0
062-098,1,0.0
kIUL,1,0.0
100-hr,1,0.0
119-167,1,0.0
070-141,1,0.0
107-272,1,0.0
038-375,1,0.0
20000000,1,0.0
040-172,1,0.0
074-135,1,0.0
Republics,1,0.0
107-241,1,0.0
non-myelinated,1,0.0
069-309,1,0.0
AV-drugs,1,0.0
890-1072,1,0.0
1792-2081,1,0.0
U-test,1,0.0
Inupiat,1,0.0
communiy,1,0.0
flu-vaccinated,1,0.0
reify,1,0.0
incarceration,1,0.0
neurophysiology,1,0.0
10-19-years,1,0.0
interventions-for,1,0.0
disuse,1,0.0
Protect,1,0.0
treadmills,1,0.0
ecosophic,1,0.0
Alaskas,1,0.0
non-ransmural,1,0.0
Seward,1,0.0
lonely,1,0.0
746000,1,0.0
system--the,1,0.0
phenomenologic,1,0.0
51-86,1,0.0
Postsurgery,1,0.0
31851,1,0.0
hepatopathies,1,0.0
Unstructured,1,0.0
warehouses,1,0.0
pandemicIMPORTANCE,1,0.0
065-220,1,0.0
OACs--dabigatran,1,0.0
107-196,1,0.0
ENzymes,1,0.0
ECg,1,0.0
PC1,1,0.0
THOracic,1,0.0
PC2,1,0.0
RIsk,1,0.0
diagnosisunderlying,1,0.0
unrecognizable,1,0.0
111-689,1,0.0
134-877,1,0.0
exteroceptive,1,0.0
8422,1,0.0
Proprioceptive,1,0.0
rehearsal,1,0.0
Triaging,1,0.0
investigationIMPORTANCE,1,0.0
host-microRNA-mediated,1,0.0
Rhinorrhoea,1,0.0
2586,1,0.0
resource-scarce,1,0.0
5148,1,0.0
899-958,1,0.0
555-778,1,0.0
OOB,1,0.0
915-983,1,0.0
PC1PC2,1,0.0
RITHOCGENE,1,0.0
cyclooxygenase-1,1,0.0
1033-3945,1,0.0
8185,1,0.0
5235,1,0.0
SiteMap,1,0.0
information-exchange,1,0.0
health-preserving,1,0.0
2456,1,0.0
Site-I,1,0.0
Okrugs,1,0.0
Volga,1,0.0
Unhealthy,1,0.0
Organiser,1,0.0
DBT,1,0.0
naso-ocular,1,0.0
-4712,1,0.0
fibrillar,1,0.0
Cefoperazone,1,0.0
-4584,1,0.0
Aerodigestive,1,0.0
Site-II,1,0.0
anti-LT,1,0.0
-10678,1,0.0
-9955,1,0.0
cys-LTs,1,0.0
DCCM,1,0.0
post-H1N1,1,0.0
manifestated,1,0.0
theinferior,1,0.0
cost-comparisons,1,0.0
anaphylatoxins,1,0.0
bewildering,1,0.0
2264,1,0.0
maximun,1,0.0
Chizhou,1,0.0
Torsade,1,0.0
2008a,1,0.0
SMIs,1,0.0
toolsalgorithms,1,0.0
therapiesThe,1,0.0
best-care,1,0.0
E1E3-defective,1,0.0
ΔE1E3,1,0.0
Ad5-HA1,1,0.0
drug-vaccine,1,0.0
multi-pronged,1,0.0
1923-1981,1,0.0
alumni,1,0.0
Materia,1,0.0
Stobhill,1,0.0
deidentified,1,0.0
case-negative,1,0.0
color-Doppler,1,0.0
790000,1,0.0
case-positive,1,0.0
0529,1,0.0
0356,1,0.0
0326,1,0.0
LSSF,1,0.0
Cas13acrRNA,1,0.0
light-up,1,0.0
LSSM-IgM,1,0.0
994-999,1,0.0
βeta‐CoVs,1,0.0
LSSF-IgG,1,0.0
38S,1,0.0
HSSM,1,0.0
HSSF,1,0.0
LPTs,1,0.0
LSSM,1,0.0
Lowry,1,0.0
C5C5a,1,0.0
Ai,1,0.0
Oblique,1,0.0
Specification,1,0.0
2000106S153-7,1,0.0
openABSTRACT,1,0.0
biopathology,1,0.0
ROX,1,0.0
20869,1,0.0
PCR-Fluorescence,1,0.0
C3C3aR,1,0.0
fifth-,1,0.0
gatekeeper,1,0.0
2016A,1,0.0
303-288,1,0.0
18-821,1,0.0
Booking,1,0.0
preclassify,1,0.0
atolls,1,0.0
20-21,1,0.0
Horizons,1,0.0
Kloner,1,0.0
cariporide,1,0.0
monophosphate-elevating,1,0.0
Migrants,1,0.0
AEngland26191,1,0.0
ABeijing35289,1,0.0
Non-replicating,1,0.0
mumoL,1,0.0
thermostabilized,1,0.0
specific-T,1,0.0
Allelic,1,0.0
R576IL-4Ralpha,1,0.0
Inhalable,1,0.0
gamma-producing,1,0.0
Reevaluating,1,0.0
hand-to-face,1,0.0
parent-based,1,0.0
Selinexor,1,0.0
student-based,1,0.0
23-which,1,0.0
5687,1,0.0
plaquebiofilm,1,0.0
APLA,1,0.0
Aircrew,1,0.0
113-163,1,0.0
14-48,1,0.0
276-752,1,0.0
inter-county,1,0.0
64-85,1,0.0
1993-1996,1,0.0
MORs,1,0.0
MOR,1,0.0
l09,1,0.0
114-163,1,0.0
women--an,1,0.0
115-162,1,0.0
33-55,1,0.0
110-157,1,0.0
77-14,1,0.0
safety-related,1,0.0
53-93,1,0.0
airline-internal,1,0.0
harmonised,1,0.0
Aeromedical,1,0.0
Re-evaluating,1,0.0
decisionmakers,1,0.0
race-SES,1,0.0
clinico-investigative,1,0.0
681-998,1,0.0
104-43,1,0.0
virus-including,1,0.0
wind-cold,1,0.0
Aequi2Quillota,1,0.0
cerovive,1,0.0
01-100,1,0.0
100-134,1,0.0
Flexor,1,0.0
Chile1985,1,0.0
Aequi2Santiago,1,0.0
1571,1,0.0
Chile1977,1,0.0
OAK,1,0.0
Aequi1Santiago,1,0.0
ENGAGE-AF,1,0.0
NORF1ab,1,0.0
Microinfarction,1,0.0
Murphy,1,0.0
Roderick,1,0.0
negativeclinically,1,0.0
Corriveau,1,0.0
Donna,1,0.0
Wilcock,1,0.0
Pre-SARS-CoV-2,1,0.0
POSTEMI,1,0.0
mid-coronary,1,0.0
NPS-negativeclinically,1,0.0
NPS-positive,1,0.0
activase,1,0.0
pollution-asthma,1,0.0
Chile1992,1,0.0
Proximity,1,0.0
0984,1,0.0
semi,1,0.0
shrinking,1,0.0
subtlety,1,0.0
cushion,1,0.0
non-evidence,1,0.0
Pneumonectomy,1,0.0
dislipemia,1,0.0
V9R,1,0.0
EID5002,1,0.0
insuline-dependent,1,0.0
2-O-methylated,1,0.0
Neurovirulence,1,0.0
2-O-methylation,1,0.0
sequesters,1,0.0
IOIBD,1,0.0
thiopurines,1,0.0
non-tertiary,1,0.0
HU-USP,1,0.0
laboratory-grown,1,0.0
Universitário,1,0.0
air-fluid,1,0.0
microphysiological,1,0.0
rel-evance,1,0.0
lung-qi,1,0.0
physician-verified,1,0.0
Light-up,1,0.0
deaerated,1,0.0
misrepresent,1,0.0
DISEASE-2019,1,0.0
CORONAVIRUS,1,0.0
patient-individualised,1,0.0
pET,1,0.0
mechanisms--namely,1,0.0
singlemultiple,1,0.0
19Communicated,1,0.0
rolled-out,1,0.0
1984-93,1,0.0
Masculinity,1,0.0
masculinityfemininity,1,0.0
d-transposition,1,0.0
neatly,1,0.0
US6338,1,0.0
US2107,1,0.0
half-closed,1,0.0
US223,1,0.0
US286,1,0.0
US54,1,0.0
US77,1,0.0
plaza,1,0.0
deathdisability,1,0.0
Titration,1,0.0
target-activated,1,0.0
exigent,1,0.0
area-to-area,1,0.0
susceptible-exposure-infected-recovery,1,0.0
Anxiety-depressive,1,0.0
antidepression,1,0.0
dEBC,1,0.0
non-T,1,0.0
RESTful,1,0.0
respiratorypulmonary,1,0.0
influenza-bacteria,1,0.0
CATIS,1,0.0
HHYWH,1,0.0
HYWWT,1,0.0
5864,1,0.0
fibrynolytic,1,0.0
polish,1,0.0
0-asymptomatic,1,0.0
OrganizationComorbid,1,0.0
neurobehavioural,1,0.0
inhibitors--promising,1,0.0
NCGMs,1,0.0
US86year,1,0.0
US55year,1,0.0
US32year,1,0.0
Iwata,1,0.0
Shimizu,1,0.0
US10year,1,0.0
NCGM,1,0.0
GMCSF,1,0.0
fly,1,0.0
deep-seated,1,0.0
bicycles,1,0.0
asymmetries,1,0.0
border-line,1,0.0
tract-related,1,0.0
107147,1,0.0
R--the,1,0.0
moment-generating,1,0.0
scalar-based,1,0.0
oxygenation-related,1,0.0
researchA,1,0.0
managementThe,1,0.0
North-of-France,1,0.0
NoF,1,0.0
450686,1,0.0
PRIST,1,0.0
additional-lead,1,0.0
pandemic--an,1,0.0
cardiac-output,1,0.0
twice-vaccinees,1,0.0
world--is,1,0.0
Person-Trip,1,0.0
EqHL,1,0.0
ASLN,1,0.0
Ibaragi,1,0.0
human-to-feline,1,0.0
buses,1,0.0
monoaetiology,1,0.0
subgroupABSTRACT,1,0.0
30854,1,0.0
reinitiate,1,0.0
S-Proteins,1,0.0
lung-related,1,0.0
waterfowl--both,1,0.0
yardstick,1,0.0
achived,1,0.0
birds--carry,1,0.0
447-3701,1,0.0
Februrary,1,0.0
289-18,1,0.0
72-895,1,0.0
incipiently,1,0.0
142-,1,0.0
cardiac-infarct,1,0.0
age-similar,1,0.0
Persisting,1,0.0
picture-word,1,0.0
Cluster-based,1,0.0
--Exercise,1,0.0
area-specific,1,0.0
--Multivessel,1,0.0
31902,1,0.0
problematical,1,0.0
non-disease,1,0.0
grown-up,1,0.0
34-99,1,0.0
Riuniti,1,0.0
peptoid,1,0.0
Ospedali,1,0.0
1992-2015,1,0.0
Laser-dissection,1,0.0
0664-0797,1,0.0
1095-13069,1,0.0
cross-references,1,0.0
41887,1,0.0
gears,1,0.0
1001-1751596,1,0.0
Gavi,1,0.0
shigella,1,0.0
0601-1200,1,0.0
1201-1800,1,0.0
NCoV,1,0.0
SERS-CoV,1,0.0
CoV-specific,1,0.0
Dental-care,1,0.0
spraysaliva,1,0.0
Tyvek,1,0.0
suits,1,0.0
sprayhoods,1,0.0
salmonella,1,0.0
dental-care,1,0.0
non-typhoid,1,0.0
poverty-associated,1,0.0
unincentivized,1,0.0
0727,1,0.0
7529481,1,0.0
0056-0654,1,0.0
domicile,1,0.0
4--5,1,0.0
Jersey1076,1,0.0
4019,1,0.0
AIowa1530,1,0.0
0065,1,0.0
medium-high,1,0.0
reinfarct,1,0.0
Counter-regulatory,1,0.0
hypothalamo-pituitary-adrenal,1,0.0
1-year-all-cause,1,0.0
counter-inflammatory,1,0.0
desalinated,1,0.0
0191,1,0.0
neurologiststroke,1,0.0
interobservers,1,0.0
echo-trained,1,0.0
99110,1,0.0
2124,1,0.0
initialize,1,0.0
Forecast,1,0.0
100000-person,1,0.0
1294-16722,1,0.0
262461,1,0.0
80513,1,0.0
kidney-related,1,0.0
cardiovascular-related,1,0.0
publicizing,1,0.0
Proforma,1,0.0
minished,1,0.0
Dipyridamol,1,0.0
clinical-epidemiologic,1,0.0
0710,1,0.0
end-diatrolic,1,0.0
hy,1,0.0
hypertrabeculationnoncompaction,1,0.0
96th,1,0.0
decapitated,1,0.0
sinistra,1,0.0
strokesembolisms,1,0.0
M2-blocker-resistant,1,0.0
NAI-susceptible,1,0.0
coronaris,1,0.0
background-subtracted,1,0.0
endocardialepicardial,1,0.0
post-stroke-depression,1,0.0
18-week,1,0.0
Arteria,1,0.0
Plan-Do-Study-Act,1,0.0
ventriculoarterial,1,0.0
Clerking,1,0.0
embologenically,1,0.0
transabdominal-transdiaphragmatic,1,0.0
I-meta-iodo-benzylguanidine,1,0.0
slices-thus,1,0.0
eventmiddle-income,1,0.0
Emam,1,0.0
D1D2,1,0.0
Take,1,0.0
non-implementation,1,0.0
imagesABSTRACT,1,0.0
99mTc-methoxyisobutyl-isonitrile,1,0.0
ML-derived,1,0.0
re-localizing,1,0.0
Thogoto,1,0.0
μgday,1,0.0
Tracheostomies,1,0.0
tibolone,1,0.0
28S,1,0.0
3760,1,0.0
13-36,1,0.0
homothallicus,1,0.0
zygomycosis,1,0.0
expert-supported,1,0.0
r047,1,0.0
detectably,1,0.0
self-employedMedical,1,0.0
11668,1,0.0
7720,1,0.0
115-fold,1,0.0
across-time,1,0.0
3948,1,0.0
F-fluorodeoxyglucose,1,0.0
selen,1,0.0
2438,1,0.0
Bloods,1,0.0
susceptible-exposed-infectiousasymptomatic-recovered,1,0.0
hemiparalysis,1,0.0
Runc,1,0.0
Rcon,1,0.0
White-matter,1,0.0
tangle,1,0.0
non-changeable,1,0.0
smoking--all,1,0.0
1969-77,1,0.0
Recalculation,1,0.0
packyear,1,0.0
1953-77,1,0.0
ACTRN12620000922976,1,0.0
anklearm,1,0.0
strokehypertension,1,0.0
Spot-testing,1,0.0
Suspicions,1,0.0
swipe,1,0.0
DETECT,1,0.0
misinterpretations,1,0.0
Wenzhou,1,0.0
0996,1,0.0
0996-1089,1,0.0
1020-1078,1,0.0
54822,1,0.0
lobeAlberta,1,0.0
methodsCUSUM,1,0.0
ScoreASPECTS,1,0.0
N-Acetylcysteine,1,0.0
bloodsAt,1,0.0
admissionThe,1,0.0
90-114,1,0.0
proforma,1,0.0
40-75,1,0.0
microfluorimetric,1,0.0
87-electrode,1,0.0
recreancy,1,0.0
Denshi,1,0.0
A-G,1,0.0
group-mean,1,0.0
patientsConclusion,1,0.0
arteryICAsign,1,0.0
treathealing,1,0.0
analysisData,1,0.0
2020Study,1,0.0
semi-susceptible,1,0.0
non-neonatal,1,0.0
hyperintensityFVHin,1,0.0
signSVSat,1,0.0
extracranial-LAA,1,0.0
intermediateexcellent,1,0.0
T2WIs,1,0.0
DWI-ASPECTS,1,0.0
nativity,1,0.0
Vast,1,0.0
Calu-1,1,0.0
173728,1,0.0
clinically-rated,1,0.0
dPdtP,1,0.0
ST-deviation,1,0.0
sinustachycardia,1,0.0
mirror-lake,1,0.0
715-1118,1,0.0
46-61,1,0.0
oxymeter,1,0.0
Opioid,1,0.0
Chronicle,1,0.0
bio-behaviors,1,0.0
Microthrombi,1,0.0
pylazolon,1,0.0
anti-emetics,1,0.0
endothelialitis,1,0.0
immuneinflammatory,1,0.0
panlobular,1,0.0
insult--to,1,0.0
microvesicular,1,0.0
dislipidemia,1,0.0
2756,1,0.0
hyper-coagulation,1,0.0
bio-chemistry,1,0.0
4097,1,0.0
entire-day,1,0.0
NODEP,1,0.0
tomorrows,1,0.0
Answering,1,0.0
Background160,1,0.0
services160,1,0.0
hemaglutinin,1,0.0
namely160,1,0.0
NOVELTY,1,0.0
227000,1,0.0
FMGsResults160,1,0.0
193000,1,0.0
areaMethods160,1,0.0
262000,1,0.0
careObjective160,1,0.0
122-693,1,0.0
Introduction160,1,0.0
reevent,1,0.0
Idarucizumab,1,0.0
inspirations,1,0.0
179-1356,1,0.0
036-352,1,0.0
Decotion,1,0.0
4F,1,0.0
infectionquottrial,1,0.0
quotpneumonia,1,0.0
syndromeMERS,1,0.0
syndromeSARS,1,0.0
unzip,1,0.0
6424,1,0.0
59798,1,0.0
FMG,1,0.0
brachycephaly,1,0.0
protrude1,1,0.0
adenopathies,1,0.0
peak-intensity,1,0.0
Heavily,1,0.0
cells2-6,1,0.0
peak-timing,1,0.0
membranes278,1,0.0
microscopy279-12,1,0.0
influenza-diagnosis,1,0.0
Östergötland,1,0.0
B117501YV1,1,0.0
Y501-RBD,1,0.0
P1501YV3,1,0.0
B1351501YV2,1,0.0
Orthologous,1,0.0
1--1,1,0.0
COG,1,0.0
OTUs,1,0.0
OTU45,1,0.0
OTU4,1,0.0
Bilophila,1,0.0
clinico-electrocardiographic,1,0.0
technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile,1,0.0
117-350,1,0.0
OTU330,1,0.0
BNT16b2,1,0.0
httpsbitly3n4vaXe,1,0.0
Stills,1,0.0
evaded,1,0.0
113930,1,0.0
ultrasonics,1,0.0
ingestioninhalation,1,0.0
High-technological,1,0.0
air-travel,1,0.0
Mandryka,1,0.0
blood-clotting,1,0.0
sanitarian-educational,1,0.0
3001,1,0.0
dressed,1,0.0
grooming,1,0.0
neuro-functional,1,0.0
cobbling,1,0.0
Cerebro-vascular,1,0.0
Riks-Stroke,1,0.0
traumatogenic,1,0.0
mammal-to-mammal,1,0.0
Roy,1,0.0
laboratory-testing,1,0.0
desalt,1,0.0
serum-time,1,0.0
denaturing,1,0.0
intergovernmental,1,0.0
virus-inactivating,1,0.0
establishments160,1,0.0
polyprotein-1ab,1,0.0
OTU338,1,0.0
Uliege,1,0.0
644-932,1,0.0
goal--brain,1,0.0
httpwwwstrokecenterorgtrials,1,0.0
repertory,1,0.0
rib-invasive,1,0.0
glycoproteinbased,1,0.0
narrows,1,0.0
Directors,1,0.0
LNP-loaded,1,0.0
double-checking,1,0.0
Arriving,1,0.0
Tuning,1,0.0
artery-terminus,1,0.0
02-03,1,0.0
09-64,1,0.0
ICA-terminus,1,0.0
innateadaptive,1,0.0
M2-inibitors,1,0.0
sporadicendemic,1,0.0
65-107,1,0.0
Sahara,1,0.0
tracheobronchites,1,0.0
osmiophilic,1,0.0
nonactive,1,0.0
viralstaphylococcal,1,0.0
BHA,1,0.0
Mediagnost,1,0.0
Novatec,1,0.0
atazanavirritonavir,1,0.0
Helpful,1,0.0
762021,1,0.0
Niño,1,0.0
covariations,1,0.0
7650,1,0.0
125-1454,1,0.0
0484,1,0.0
0258,1,0.0
0119,1,0.0
098-284,1,0.0
large-droplet,1,0.0
X-p,1,0.0
POCD,1,0.0
irrversible,1,0.0
colonialist,1,0.0
11750,1,0.0
hematologiconcologic,1,0.0
OST-r,1,0.0
196970,1,0.0
imperialism,1,0.0
low-and-middle-income,1,0.0
Yancheng,1,0.0
197576,1,0.0
realx2010world,1,0.0
Lymphoid-macrophage,1,0.0
actue,1,0.0
homeDiscussion160,1,0.0
worsing,1,0.0
non-biased,1,0.0
ensemble-independent,1,0.0
anti-disease,1,0.0
cell-culture,1,0.0
surgeryinfarction,1,0.0
POC-Ab,1,0.0
Vero-15,1,0.0
purifications,1,0.0
thickest,1,0.0
spurs,1,0.0
APR81934,1,0.0
disease--corrected,1,0.0
staff-to-patient,1,0.0
CONTROL,1,0.0
footnote,1,0.0
retroperfusion,1,0.0
Kimball,1,0.0
protozoa,1,0.0
ectoparasites,1,0.0
needsConclusion160,1,0.0
Hyoscyamine,1,0.0
Tamaridone,1,0.0
Rotiorinol-C,1,0.0
Scutifoliamide-A,1,0.0
patients8217,1,0.0
Ile-Val,1,0.0
AF-the,1,0.0
CHA2DS2VASc-AFBurden,1,0.0
Influvax,1,0.0
treatmentAreas,1,0.0
Fredericq,1,0.0
Leon,1,0.0
impracticality,1,0.0
Pieces,1,0.0
waxes,1,0.0
11-years,1,0.0
Schwabe-cycle,1,0.0
contextualised,1,0.0
Becton-Dickson,1,0.0
42-fold,1,0.0
2·53,1,0.0
PeNSE,1,0.0
ruptureavulsion,1,0.0
Wakayama,1,0.0
2·84,1,0.0
3·28,1,0.0
1·96,1,0.0
P4501A1,1,0.0
2·61,1,0.0
5·82,1,0.0
AHIN1pdm,1,0.0
35--fold,1,0.0
mNSS,1,0.0
104-425,1,0.0
109-368,1,0.0
BSL3-AFM,1,0.0
clonus,1,0.0
transurethal,1,0.0
interinstitutional,1,0.0
saved100,1,0.0
ecologyfacilitated,1,0.0
296-893,1,0.0
Smoke-Free,1,0.0
SFOA,1,0.0
ourbreaks,1,0.0
patios,1,0.0
HSU,1,0.0
respiratoru,1,0.0
heterogenically,1,0.0
3-70,1,0.0
preinfact,1,0.0
ST-segment-depression,1,0.0
3587,1,0.0
DGH,1,0.0
Douala,1,0.0
thickeners,1,0.0
nonconvulsive,1,0.0
TARS-CoV,1,0.0
chicken-egg-based,1,0.0
renaming,1,0.0
34953,1,0.0
cell-culture-based,1,0.0
bundled,1,0.0
199085834,1,0.0
collaboratives,1,0.0
laboratory-established,1,0.0
voivodships,1,0.0
μmolm2,1,0.0
tropospheric,1,0.0
Po,1,0.0
monsoon,1,0.0
Montgomery-Asberg,1,0.0
PDS,1,0.0
US25098,1,0.0
US18487,1,0.0
microcrystalline,1,0.0
US85157,1,0.0
US90052,1,0.0
SBHCs,1,0.0
Occasional,1,0.0
blood-related,1,0.0
8041,1,0.0
distrustMethods,1,0.0
per-patient,1,0.0
ICM-based,1,0.0
refusalResults,1,0.0
genderConclusion,1,0.0
Sub-states,1,0.0
Indecision,1,0.0
SBHC,1,0.0
SARSr-CoV-RaTG13,1,0.0
devolved,1,0.0
1817,1,0.0
limping,1,0.0
121988-3091988,1,0.0
reaction–confirmed,1,0.0
2203-24356,1,0.0
line-dependent,1,0.0
92611,1,0.0
27967-157254,1,0.0
375-448,1,0.0
611-688,1,0.0
PA-NEAConclusions,1,0.0
arabic,1,0.0
tunisian,1,0.0
smells,1,0.0
perfumes,1,0.0
educations,1,0.0
IRFs,1,0.0
injuriesillnesses,1,0.0
AH1N1pdm09-associated,1,0.0
HIF-1beta,1,0.0
HREs,1,0.0
HIF,1,0.0
autophagsomes,1,0.0
line-specific,1,0.0
VSVSARS-CoV-2,1,0.0
NCI-H1299,1,0.0
antibody-resistant,1,0.0
13279,1,0.0
escorted,1,0.0
escorting,1,0.0
832-975,1,0.0
pseudorandomized,1,0.0
Kingdoms,1,0.0
intrigued,1,0.0
000-001,1,0.0
HDRS,1,0.0
att,1,0.0
SIADH-related,1,0.0
AKrasnodar1013559,1,0.0
non-osmotic,1,0.0
PA-NEAMethods,1,0.0
Reclassification,1,0.0
838-947,1,0.0
EGG,1,0.0
WPAI-Asthma,1,0.0
PA-NEAResults,1,0.0
25-μL,1,0.0
freeze-dried,1,0.0
temperature-dependent,1,0.0
nonrepresentative,1,0.0
134-times,1,0.0
refereed,1,0.0
trek,1,0.0
Exercised-induced,1,0.0
120-148,1,0.0
over-reactors,1,0.0
6289,1,0.0
OTU35,1,0.0
dual-mutation,1,0.0
unincorporated,1,0.0
102188,1,0.0
3491,1,0.0
countries14,1,0.0
mortality56,1,0.0
severedifficult-to-treat,1,0.0
QUASR,1,0.0
Tricity,1,0.0
Gdańsk,1,0.0
Sopot,1,0.0
Gdynia,1,0.0
internist,1,0.0
storm-elevated,1,0.0
LAMP-Enabled,1,0.0
cells-and,1,0.0
damagefailure,1,0.0
particlesμL,1,0.0
32123,1,0.0
DIY,1,0.0
60-minute,1,0.0
beta-sheet,1,0.0
surfactant-replacement,1,0.0
surfactant-secreting,1,0.0
dizzy,1,0.0
V367,1,0.0
infections3,1,0.0
wand,1,0.0
pipette-free,1,0.0
CD-300,1,0.0
144-345,1,0.0
104-240,1,0.0
Sphingomonadaceae,1,0.0
OTU303,1,0.0
A-64077,1,0.0
Akkermansia,1,0.0
OTU9,1,0.0
MK-679,1,0.0
Dehumidifiers,1,0.0
coadjuvant,1,0.0
MK-571,1,0.0
SB205312ONO-1078,1,0.0
nasopharyngeal-specific,1,0.0
inflammatory-cell,1,0.0
hemispherectomy,1,0.0
studiesABSTRACT,1,0.0
Risch,1,0.0
22-24,1,0.0
swapped,1,0.0
higher-throughput,1,0.0
QUASR-modified,1,0.0
emergency1,1,0.0
engraved,1,0.0
literature2,1,0.0
subtler,1,0.0
V367FD614G,1,0.0
2000-2003,1,0.0
derivate,1,0.0
herpetic,1,0.0
multiformeConclusions,1,0.0
Neurotrophin-3,1,0.0
Abassia,1,0.0
followings,1,0.0
self-infection,1,0.0
well-pumping,1,0.0
incitement,1,0.0
counterfeiting,1,0.0
retrotransposon-mediated,1,0.0
CAQDAS,1,0.0
target-primed,1,0.0
ATLASti,1,0.0
retroposition,1,0.0
semi-normalcy,1,0.0
squareResults,1,0.0
data--is,1,0.0
profile--informed,1,0.0
prophylaxed,1,0.0
allergicimmune,1,0.0
1002-1287,1,0.0
measure0,1,0.0
scale0,1,0.0
H5N1-influenza,1,0.0
166-3906,1,0.0
9375,1,0.0
keratinised,1,0.0
seriesIntroduction,1,0.0
pro-arrhythmic,1,0.0
Misdiagnosed,1,0.0
Ranitidine,1,0.0
Inequitable,1,0.0
R20013,1,0.0
Dominance,1,0.0
SDO,1,0.0
R20028,1,0.0
R20077,1,0.0
R20225,1,0.0
⩾30,1,0.0
supercapsid,1,0.0
antero-middle,1,0.0
GRECogVASC,1,0.0
6367±106,1,0.0
3-T,1,0.0
Post-Traumatic,1,0.0
pandemy,1,0.0
Vasculaire,1,0.0
lÉvaluation,1,0.0
Réflexion,1,0.0
noninfective-allergic,1,0.0
Groupe,1,0.0
co-epidemics,1,0.0
non-thrombectomy-capable,1,0.0
disciplinary,1,0.0
battery-operated,1,0.0
hypothalamic-pituitary-adrenocortical,1,0.0
29265,1,0.0
microRNA-specific,1,0.0
time-sequential,1,0.0
fear-provoking,1,0.0
producibility,1,0.0
672000,1,0.0
1439100000,1,0.0
baculovirus-,1,0.0
bacteriophage-derived,1,0.0
iodine-bromine,1,0.0
453000,1,0.0
electroaerosols,1,0.0
Ust-Kachka,1,0.0
beklametasone,1,0.0
perspectiveness,1,0.0
3279100000,1,0.0
BA--neurorehabilitation,1,0.0
U133,1,0.0
nonoptimal,1,0.0
1791-1797,1,0.0
16045,1,0.0
Postprocedure,1,0.0
industry-,1,0.0
self-repair,1,0.0
Laying,1,0.0
Re-arranging,1,0.0
molecule-specific,1,0.0
cytokine-specific,1,0.0
miR-9,1,0.0
Scarlet,1,0.0
CovID-19,1,0.0
multi-organic,1,0.0
fraud,1,0.0
fairer,1,0.0
dysfunction-associated,1,0.0
sector-based,1,0.0
Martius,1,0.0
Ill-conceived,1,0.0
148-226,1,0.0
12405,1,0.0
H1N1-pandemic,1,0.0
10-seasons-period,1,0.0
CK1δεcofilin,1,0.0
31100000,1,0.0
per-case,1,0.0
77100000,1,0.0
1-pass,1,0.0
2131100000,1,0.0
PI3KδAktmTOR,1,0.0
JAK12-STAT15,1,0.0
p38MAPKJNK,1,0.0
Nrf2HDAC2c-Jun,1,0.0
GRβGRα,1,0.0
casein,1,0.0
43220,1,0.0
22469,1,0.0
CAVEI,1,0.0
avidin-biotin,1,0.0
google,1,0.0
9180000,1,0.0
aortal-coronary,1,0.0
stroke-preventive,1,0.0
Suppurativa,1,0.0
Hidradenitis,1,0.0
predeclaration,1,0.0
postdeclaration,1,0.0
P95,1,0.0
P10,1,0.0
P26,1,0.0
P08,1,0.0
sunstantial,1,0.0
suppurativa,1,0.0
lower-extremity,1,0.0
-0318,1,0.0
Aerosols,1,0.0
-0370,1,0.0
non-fQRS,1,0.0
host-like,1,0.0
PMIs,1,0.0
O-glycoproteomic,1,0.0
S-insect,1,0.0
ist,1,0.0
mortaliyt,1,0.0
adalimumab,1,0.0
non-living,1,0.0
16-bisphosphocholine-hexane,1,0.0
694aa,1,0.0
45223,1,0.0
APC-resistance,1,0.0
prognostics,1,0.0
3358,1,0.0
unscarred,1,0.0
peel-off,1,0.0
posthemorrhagic,1,0.0
Ventriculopleural,1,0.0
Potosi,1,0.0
Non-ischaemic,1,0.0
well-planned,1,0.0
Helper,1,0.0
A-549,1,0.0
Aggravation,1,0.0
non-labor-intensive,1,0.0
H12,1,0.0
subfragments,1,0.0
Lifesciences,1,0.0
CoreValve,1,0.0
Balkans,1,0.0
definitional,1,0.0
expeditionary,1,0.0
atomic-detailed,1,0.0
anti-SARS-CoV2,1,0.0
Atot,1,0.0
short-changed,1,0.0
cell-produced,1,0.0
h-shaking,1,0.0
understate,1,0.0
94±89,1,0.0
Naturopathy,1,0.0
134±128,1,0.0
11±10,1,0.0
freshness,1,0.0
50±48,1,0.0
22±11,1,0.0
71±78,1,0.0
Free-ranging,1,0.0
escapees,1,0.0
Nimbus,1,0.0
090-099,1,0.0
076-099,1,0.0
policies--,1,0.0
MVV,1,0.0
hears,1,0.0
elastica,1,0.0
interna,1,0.0
FEVFEC,1,0.0
3820,1,0.0
recanalizations,1,0.0
biosphere,1,0.0
droughts,1,0.0
photosynthesis,1,0.0
21-68,1,0.0
B5,1,0.0
01011992-31101993,1,0.0
Graphene,1,0.0
Erythron,1,0.0
Ligands,1,0.0
-active,1,0.0
Aptamers,1,0.0
timber,1,0.0
Hypertonic,1,0.0
morphium,1,0.0
microcyte,1,0.0
166282,1,0.0
IUday,1,0.0
sulfatealkyl,1,0.0
C9,1,0.0
patients--46,1,0.0
measuresConclusionCOVID-19,1,0.0
2019ResultsFacility-based,1,0.0
metaphylactic,1,0.0
quality-controlled,1,0.0
winterMethodsWe,1,0.0
antidiscrimination,1,0.0
offsetting,1,0.0
echographically,1,0.0
PEPPEVS,1,0.0
PEVS,1,0.0
patients--41,1,0.0
INYS,1,0.0
s-vortexing,1,0.0
AASMAtot,1,0.0
elute,1,0.0
1980s-illustrate,1,0.0
077085,1,0.0
Hexoprenaline,1,0.0
082089,1,0.0
Clenbuterol,1,0.0
atropinic,1,0.0
oxytropium,1,0.0
45-85,1,0.0
7400,1,0.0
1350-bed,1,0.0
40000µl,1,0.0
meperidine,1,0.0
41000µl,1,0.0
painkillers,1,0.0
loosing,1,0.0
Huntingtons,1,0.0
apomorphine-induced,1,0.0
2-bed,1,0.0
Rate-pressure,1,0.0
23620,1,0.0
20100,1,0.0
nitro-glycerin,1,0.0
anoxic-ischemic,1,0.0
carinae,1,0.0
sensomotor,1,0.0
074082,1,0.0
072082,1,0.0
examples-the,1,0.0
vaccine-reference,1,0.0
4074,1,0.0
min-shaking,1,0.0
258×104,1,0.0
Blood-Mononuclear,1,0.0
quadruplicate,1,0.0
prenatally,1,0.0
hypervolemic-hemodilution,1,0.0
salary,1,0.0
jour,1,0.0
H3N2-drift,1,0.0
H3N2-virus-drift,1,0.0
defecation-related,1,0.0
odor-based,1,0.0
disregards,1,0.0
dysrrhythmia,1,0.0
Pharmacopuncture,1,0.0
defecations,1,0.0
pharmacopuncture,1,0.0
066076,1,0.0
bronchioloalveolar,1,0.0
Prednisone,1,0.0
065075,1,0.0
detergent-inactivated,1,0.0
handwash,1,0.0
periodDespite,1,0.0
CRISP-AMI,1,0.0
1971-2002,1,0.0
unclearMethods,1,0.0
1821-1879,1,0.0
closed-state,1,0.0
K417,1,0.0
D467,1,0.0
N501,1,0.0
Adolphe,1,0.0
Spore,1,0.0
033-089,1,0.0
032-097,1,0.0
skin-prick-test-negative,1,0.0
Didymella,1,0.0
119-324,1,0.0
145-408,1,0.0
pseudo-aneurysms,1,0.0
nonvavular,1,0.0
LARIAT,1,0.0
COVID-19-causing,1,0.0
SentreHEART,1,0.0
Ultraseal,1,0.0
008-059,1,0.0
Cardia,1,0.0
Lifetech,1,0.0
Coherex,1,0.0
WaveCrest,1,0.0
027-089,1,0.0
Beaujon,1,0.0
17081,1,0.0
1855,1,0.0
Suspension,1,0.0
sportsmen,1,0.0
24606,1,0.0
19402,1,0.0
5204,1,0.0
co-diagnoses,1,0.0
situation-based,1,0.0
162-272,1,0.0
84-559,1,0.0
163-186,1,0.0
PGI-2,1,0.0
teamsthose,1,0.0
pre-coronavirus,1,0.0
pharmacognosia,1,0.0
Parisian,1,0.0
intergrating,1,0.0
fame,1,0.0
Anaemia,1,0.0
Gublers,1,0.0
Millard-Gubler,1,0.0
Millard,1,0.0
prolifically,1,0.0
disciples,1,0.0
1868,1,0.0
classicication,1,0.0
173-706,1,0.0
ngmLh,1,0.0
olympic,1,0.0
45±31,1,0.0
supplementscompounds,1,0.0
detoxicating,1,0.0
1740,1,0.0
two-tailed,1,0.0
-076,1,0.0
CFUμL,1,0.0
result-out,1,0.0
Co-assisted,1,0.0
RICCA,1,0.0
seroreactive,1,0.0
Serendipitous,1,0.0
°°°This,1,0.0
necrotic-,1,0.0
189-236,1,0.0
bicyclic,1,0.0
124-180,1,0.0
280-326,1,0.0
PetCO2,1,0.0
186-times,1,0.0
USOPTF,1,0.0
14916,1,0.0
noncomparable,1,0.0
Isles,1,0.0
resort-and-spa,1,0.0
Essentuki,1,0.0
immunityreducing,1,0.0
medicalsocioeconomic,1,0.0
interventionsThe,1,0.0
aetiology-specific,1,0.0
P00009,1,0.0
152-4697,1,0.0
1049-2396,1,0.0
P00282,1,0.0
1010-3047,1,0.0
269-44452,1,0.0
P00460,1,0.0
specifique,1,0.0
re-examining,1,0.0
1976-1992,1,0.0
506768,1,0.0
S477R,1,0.0
demonstrably,1,0.0
serene,1,0.0
IL-33-amphiregulin,1,0.0
non-pathological,1,0.0
N501T,1,0.0
Q493L,1,0.0
F486L,1,0.0
Exuberant,1,0.0
R403K,1,0.0
F490L,1,0.0
deterring,1,0.0
A475S,1,0.0
Asthmonia,1,0.0
6302018,1,0.0
14-segment,1,0.0
V-2,1,0.0
prevaccination-,1,0.0
postvaccination-paired,1,0.0
SARS-CoV-2infections,1,0.0
389solid,1,0.0
522We,1,0.0
ventral-head,1,0.0
shamNSCs,1,0.0
Hematoxylin-eosin,1,0.0
interleukin-3,1,0.0
infantility,1,0.0
B-agonist,1,0.0
Ther,1,0.0
dorsomedian,1,0.0
202143702-710,1,0.0
65years,1,0.0
2003-2014,1,0.0
TC-99m,1,0.0
not-subtyped,1,0.0
048-098,1,0.0
Horizon,1,0.0
adrenomedullin,1,0.0
sinus-aortic,1,0.0
rhinologic,1,0.0
Signa,1,0.0
paralimbic,1,0.0
connote,1,0.0
Immunologists,1,0.0
61--100,1,0.0
TOPSIS,1,0.0
n76,1,0.0
N-glycosites,1,0.0
n95,1,0.0
week-gestation,1,0.0
SPORTIF,1,0.0
Cammellia,1,0.0
5529,1,0.0
28176,1,0.0
3261,1,0.0
nonfluoroscopic,1,0.0
neuro-rehabilitational,1,0.0
PROMETHEE,1,0.0
praehospitalization,1,0.0
clinico-psychopathological,1,0.0
clinico-catamnestic,1,0.0
ganglia-thalamus-cortical,1,0.0
IMLamygdala,1,0.0
MTThippocampal,1,0.0
astheno-hypochondriac,1,0.0
9922,1,0.0
clinico-pathological,1,0.0
logico-probabilistic,1,0.0
relevances,1,0.0
character-disease,1,0.0
plasmosorption,1,0.0
3173,1,0.0
1012015,1,0.0
Ibustrin,1,0.0
Pekin,1,0.0
767-999,1,0.0
budgerigar,1,0.0
crypts,1,0.0
reinoculation,1,0.0
contrat,1,0.0
dystopian,1,0.0
108-352,1,0.0
denialism,1,0.0
SARS-CoV-2-its,1,0.0
spread-exacerbate,1,0.0
142-65,1,0.0
01May2020,1,0.0
sequence-modified,1,0.0
lipopolyplex,1,0.0
LPP,1,0.0
ClinicalKey,1,0.0
Epicor,1,0.0
Th1-polarized,1,0.0
pigtailed,1,0.0
nemestrina,1,0.0
macaque-specific,1,0.0
coregulated,1,0.0
moratorium,1,0.0
honours,1,0.0
AKumamoto2276,1,0.0
Hav4Nav1,1,0.0
AbudgerigarHokkaido177,1,0.0
possibile,1,0.0
CI468-67,1,0.0
CI515-81,1,0.0
95CI495-788,1,0.0
95CI45-546,1,0.0
YO-A,1,0.0
acyloxymethyl,1,0.0
ketone,1,0.0
nonprimed,1,0.0
drug-development,1,0.0
Age-dependent,1,0.0
technetium-99m-pyrophosphate,1,0.0
complement-,1,0.0
Hav7N2,1,0.0
ACTIVE-W,1,0.0
Idraparinux,1,0.0
signal-transduction,1,0.0
AS03AB-adjuvanted,1,0.0
≥36,1,0.0
transversed,1,0.0
17921,1,0.0
schizophrenias,1,0.0
NaK-ATPase,1,0.0
942-999,1,0.0
AduckHokkaido577,1,0.0
patients--acute,1,0.0
5677,1,0.0
accuracyperformance,1,0.0
prn,1,0.0
mannitol-induced,1,0.0
assesing,1,0.0
anti-immunoglobulins,1,0.0
Tuberculous,1,0.0
13-month-old,1,0.0
Especialidades,1,0.0
Médico,1,0.0
Siglo,1,0.0
EMIP,1,0.0
EEC,1,0.0
source-image,1,0.0
pitfalls©RSNA,1,0.0
inequivalence,1,0.0
Driven,1,0.0
Melody,1,0.0
SEIRS,1,0.0
No-Surgery-On-Site,1,0.0
thombus,1,0.0
nosologic,1,0.0
1418,1,0.0
1717,1,0.0
epoxyeicosatrienoic,1,0.0
oseltamivir-,1,0.0
p-value054,1,0.0
Ose-R,1,0.0
038-188,1,0.0
Fludase,1,0.0
longtime-circulating,1,0.0
resistance-causing,1,0.0
HUCB,1,0.0
pretreat,1,0.0
renovating,1,0.0
lunchtime,1,0.0
0599,1,0.0
Armonk,1,0.0
post-HCTCAR-T,1,0.0
Myeloablative,1,0.0
Donors,1,0.0
post-CAR-T,1,0.0
05-136,1,0.0
levamisole,1,0.0
decaris,1,0.0
amateur,1,0.0
Emax,1,0.0
micro-alterations,1,0.0
ABethesdaMM1H3N2,1,0.0
Preintervention,1,0.0
003-063,1,0.0
0242,1,0.0
scalings,1,0.0
Controle,1,0.0
Rinite,1,0.0
Alérgica,1,0.0
na,1,0.0
BahiaProAR,1,0.0
vancomycin,1,0.0
RT-fluorescence,1,0.0
Pakistans,1,0.0
Khyber,1,0.0
Pakhtunkhwa,1,0.0
Gilgit-Baltistan,1,0.0
137370,1,0.0
anti-leakage,1,0.0
1985-89,1,0.0
n439,1,0.0
1990-94,1,0.0
deathacute,1,0.0
infarctioncongestive,1,0.0
log-normalized,1,0.0
Sympathovagal,1,0.0
cryoinjured,1,0.0
Cryoinjury-induced,1,0.0
11-dioctadecyl-3333-tetramethylindocarbocyanine,1,0.0
percholate,1,0.0
DiI-positive,1,0.0
MSC-positive,1,0.0
upstroke,1,0.0
electrotonic,1,0.0
raceethnicitysex,1,0.0
raceethnicsex-related,1,0.0
Florida-Puerto,1,0.0
10481,1,0.0
birthdateyear,1,0.0
284-442,1,0.0
249-392,1,0.0
11-minute,1,0.0
clinically-significant,1,0.0
racialethnicsex,1,0.0
EMS-related,1,0.0
CPN,1,0.0
RHW,1,0.0
3-45-hour,1,0.0
€570,1,0.0
€491,1,0.0
charcoals,1,0.0
25-month,1,0.0
propanolol,1,0.0
P051,1,0.0
28884,1,0.0
n453,1,0.0
1995-99,1,0.0
n545,1,0.0
p0007,1,0.0
vascularize,1,0.0
5-yr,1,0.0
hyperoxic,1,0.0
dysmenorrhoea,1,0.0
menorrhagia,1,0.0
561-41,1,0.0
744-136,1,0.0
540-106,1,0.0
437-99,1,0.0
children-years,1,0.0
P019,1,0.0
14562,1,0.0
14282,1,0.0
8-31,1,0.0
-4-21,1,0.0
Hemopericardium,1,0.0
408480,1,0.0
146164,1,0.0
129156,1,0.0
418480,1,0.0
IONM,1,0.0
FXII-driven,1,0.0
antithrombosis,1,0.0
HERMES,1,0.0
-0229,1,0.0
0249,1,0.0
technetium-99m-sestamibi,1,0.0
213-223,1,0.0
Zarit,1,0.0
childrearing,1,0.0
HF-,1,0.0
BL-rTMS,1,0.0
Bayers,1,0.0
-014,1,0.0
-184,1,0.0
test-1,1,0.0
shot-1,1,0.0
putrefaction,1,0.0
27810000,1,0.0
28900000,1,0.0
DGR,1,0.0
pretending,1,0.0
cytokine-induced,1,0.0
anti-IL-2,1,0.0
pneumoniainfluenza-,1,0.0
73∙5,1,0.0
1∙4100000,1,0.0
9∙2100000,1,0.0
pneumoniainfluenza-coded,1,0.0
10∙0100000,1,0.0
86∙6100000,1,0.0
H5N1virus,1,0.0
unfulfilled,1,0.0
bioethical,1,0.0
Zhoushan,1,0.0
Suspicious,1,0.0
duckschickens,1,0.0
Peds,1,0.0
Congressional,1,0.0
AIQP,1,0.0
95-fold,1,0.0
13508,1,0.0
10027,1,0.0
hypokalamia,1,0.0
hyperkalamia,1,0.0
213818,1,0.0
193455,1,0.0
2363,1,0.0
552722,1,0.0
122181,1,0.0
3545,1,0.0
20364,1,0.0
2240,1,0.0
18327,1,0.0
sgRNA,1,0.0
intra-QRS,1,0.0
isoetherine,1,0.0
exercise-iduced,1,0.0
anti-alergic,1,0.0
infarctions-whether,1,0.0
hospital-is,1,0.0
clinical-autoptical,1,0.0
myocardials,1,0.0
coronavirus-strain,1,0.0
bat-termed,1,0.0
SARS-CoV-2-has,1,0.0
livestockpet,1,0.0
pollutions,1,0.0
reclaim,1,0.0
178669333892,1,0.0
428-449,1,0.0
α-26-sialyl,1,0.0
schoolchildren-based,1,0.0
antihyperlipidemic,1,0.0
automatized,1,0.0
Lambda,1,0.0
Miltenyi,1,0.0
H3N2-virus,1,0.0
HiNI,1,0.0
difference-vectors,1,0.0
post-ligation,1,0.0
McFee,1,0.0
prepathological,1,0.0
DNA-copies,1,0.0
DNA-probes,1,0.0
high-conservative,1,0.0
trans-septal,1,0.0
PTMC-related,1,0.0
nonuniversity,1,0.0
nationalcultural,1,0.0
subxiphoid-right,1,0.0
video-thoracoscopic,1,0.0
thymomas,1,0.0
Hyperosmotic,1,0.0
09-fold,1,0.0
tubing,1,0.0
PC20-MCH,1,0.0
2711,1,0.0
Lith-Gly,1,0.0
cold-increased,1,0.0
lithocholicglycine,1,0.0
sialyl-N-acetyl-D-lactosamines,1,0.0
IBVs,1,0.0
Cheonan,1,0.0
38-fold,1,0.0
auxological,1,0.0
QRS-complexes,1,0.0
causes-of-death,1,0.0
self-quarantines,1,0.0
standardWe,1,0.0
grammar,1,0.0
vaccine-manufacturing,1,0.0
17454250,1,0.0
UAEs,1,0.0
nonexistense,1,0.0
Slowed,1,0.0
arithmetic-pulmonary,1,0.0
1989-1999,1,0.0
AGuangzhou33399,1,0.0
interleukin-17,1,0.0
twenty-,1,0.0
non-Th2-driven,1,0.0
paper-sharing,1,0.0
graftspatient,1,0.0
hyperfibrinolysis,1,0.0
reexploration,1,0.0
Gadolinium,1,0.0
corrupted,1,0.0
DEMPOT,1,0.0
Decomposition,1,0.0
Hilbert-Huang,1,0.0
Hilbert,1,0.0
Riesz,1,0.0
miR-133b,1,0.0
xenosorption,1,0.0
Neglected,1,0.0
usedAt,1,0.0
immunrendszer,1,0.0
immunválaszának,1,0.0
szerológiai,1,0.0
irányuló,1,0.0
gyakorlatban,1,0.0
használatos,1,0.0
módszereket,1,0.0
azok,1,0.0
helyét,1,0.0
értékelésük,1,0.0
tudomány,1,0.0
állása,1,0.0
Belait,1,0.0
myocardium-related,1,0.0
bas,1,0.0
ECV,1,0.0
osteophyte,1,0.0
vespid,1,0.0
QSARs,1,0.0
ideality,1,0.0
Dissecting,1,0.0
PfizerBioNtech,1,0.0
interleukin-15,1,0.0
IP-10CXCL10,1,0.0
Beauchamp,1,0.0
Childress,1,0.0
malefic,1,0.0
doctrine,1,0.0
double-effect,1,0.0
1426,1,0.0
specifikus,1,0.0
kimutatására,1,0.0
NTDs,1,0.0
okozó,1,0.0
vakcináció,1,0.0
idők,1,0.0
folyamán,1,0.0
szakterületen,1,0.0
háttérbe,1,0.0
szorultak,1,0.0
felfrissítésük,1,0.0
sürgető,1,0.0
elengedhetetlen,1,0.0
része,1,0.0
pandémiával,1,0.0
megküzdésnek,1,0.0
diagnosztikai,1,0.0
vizsgálatok,1,0.0
eszközei,1,0.0
megfékezésének,1,0.0
emberi,1,0.0
szervezet,1,0.0
interakciójának,1,0.0
megértése,1,0.0
elengedhetetlenül,1,0.0
korrekt,1,0.0
gyógyászati,1,0.0
véleményalkotáshoz,1,0.0
Jelen,1,0.0
cikkünk,1,0.0
orvosi,1,0.0
gyakorlat,1,0.0
foglalja,1,0.0
nursemidwife,1,0.0
sub-dimension,1,0.0
agreeI,1,0.0
Voysey,1,0.0
non-conditional,1,0.0
1502,1,0.0
1047-2154,1,0.0
1297-2120,1,0.0
1334-2684,1,0.0
Unlocking,1,0.0
85∙2,1,0.0
anaes,1,0.0
7546,1,0.0
1990–1993,1,0.0
215–1562,1,0.0
196–625,1,0.0
1–6,1,0.0
053–129,1,0.0
05–6,1,0.0
first-in-first-out,1,0.0
replenished,1,0.0
merchandising,1,0.0
reservoir-εs,1,0.0
conduit-εe,1,0.0
contraction-strain,1,0.0
SD-T2P,1,0.0
PAF-patients,1,0.0
SD-TPS,1,0.0
occupation-based,1,0.0
31-52,1,0.0
wordsphrases,1,0.0
Mega,1,0.0
BJ94-like,1,0.0
3726,1,0.0
1793,1,0.0
all-stroke,1,0.0
Swab-negative,1,0.0
Clemens,1,0.0
202139799-111,1,0.0
33306989,1,0.0
protein-RNA,1,0.0
discredited,1,0.0
domestic-only,1,0.0
16·8-45·3,1,0.0
7·5-26·0,1,0.0
0·5-1·5,1,0.0
14·3-22·2,1,0.0
7·4-9·1,1,0.0
7·1-9·1,1,0.0
remodel-ing,1,0.0
inter-contact,1,0.0
13-163,1,0.0
oxidativeantioxidative,1,0.0
oral-fecal,1,0.0
GAMES-II,1,0.0
influenzaparainfluenza,1,0.0
colonizations,1,0.0
Chlamydiae,1,0.0
Mycoplasms,1,0.0
memorable,1,0.0
one-sided,1,0.0
Misery,1,0.0
17-224,1,0.0
14-89,1,0.0
27-578,1,0.0
körű,1,0.0
széles,1,0.0
sikeressége,1,0.0
multisensors,1,0.0
Hajj--the,1,0.0
Arabia--is,1,0.0
SCOHP,1,0.0
Lanzhou,1,0.0
UFO,1,0.0
batching,1,0.0
accessories,1,0.0
Mossad,1,0.0
evidence-supported,1,0.0
glycovariants,1,0.0
Cocultivation,1,0.0
CD11c,1,0.0
deglycosylation,1,0.0
exoglycosidases,1,0.0
line-based,1,0.0
family-specific,1,0.0
tetra-branched,1,0.0
H5N1-M2e-MAP,1,0.0
M2e-MAP,1,0.0
H5N1-M2e,1,0.0
SRS-A,1,0.0
work-out,1,0.0
mercurialization,1,0.0
medical-scientific,1,0.0
arcane,1,0.0
cycled,1,0.0
32-40,1,0.0
1SD,1,0.0
lobbies,1,0.0
httpsbitly3m8rjHL,1,0.0
2019-CoV,1,0.0
ventriography,1,0.0
Robertson,1,0.0
BAOs,1,0.0
patients1-3,1,0.0
origin4,1,0.0
post-thrombectomy,1,0.0
placement5-7,1,0.0
Alawieh,1,0.0
Surgeons1,1,0.0
Susceptible-Infected-Isolated-Recovered,1,0.0
SIIR,1,0.0
curveABSTRACT,1,0.0
submicrosecond,1,0.0
seam,1,0.0
Sub-Scales,1,0.0
originally-designed,1,0.0
asthma-discordant,1,0.0
sence,1,0.0
Kanpur,1,0.0
value875,1,0.0
value686,1,0.0
HealthCare-one,1,0.0
providers-implemented,1,0.0
multilingual,1,0.0
Liposomal,1,0.0
QS-21,1,0.0
ALFQ,1,0.0
RFN-ALFQ,1,0.0
SARS-CoV-like,1,0.0
undiagnostic,1,0.0
self-life,1,0.0
home-use,1,0.0
megoldások,1,0.0
crystallinity,1,0.0
5023,1,0.0
somatoform,1,0.0
under-educated,1,0.0
pathology-mostly,1,0.0
strokeSerinken,1,0.0
Karcioglu,1,0.0
2018334451-453,1,0.0
boundary-value,1,0.0
backstepping,1,0.0
Antigen-detection,1,0.0
koronavírus-betegség,1,0.0
COVID-19-pandémia,1,0.0
komoly,1,0.0
kihívás,1,0.0
elé,1,0.0
állította,1,0.0
mikrobiológiai,1,0.0
laboratóriumokat,1,0.0
interpretálásában,1,0.0
klinikumban,1,0.0
kollégákat,1,0.0
orvostudomány,1,0.0
specializált,1,0.0
világában,1,0.0
immunológiai,1,0.0
fertőző,1,0.0
betegségekkel,1,0.0
ismeretek,1,0.0
antimikrobás,1,0.0
non-permanent,1,0.0
non-tuberculosis,1,0.0
BCG-based,1,0.0
nitromapping,1,0.0
foregut,1,0.0
vasodilatating,1,0.0
treatment--thrombi,1,0.0
complications--16,1,0.0
Reocclusions,1,0.0
administration--10,1,0.0
lumen--the,1,0.0
clottingembolism,1,0.0
overreactivity,1,0.0
cerebro-vasculature,1,0.0
auto-regulatory,1,0.0
Admitting,1,0.0
arterila,1,0.0
case-specific,1,0.0
boldine,1,0.0
post-hyposensitized,1,0.0
Pollinex,1,0.0
elastin-derived,1,0.0
1997-2006,1,0.0
680607,1,0.0
609359,1,0.0
2827,1,0.0
2104,1,0.0
-87,1,0.0
KRT6A,1,0.0
CEACAM5,1,0.0
FOXA1,1,0.0
lomefloxacin,1,0.0
1674,1,0.0
13618,1,0.0
5989,1,0.0
Continue,1,0.0
4572,1,0.0
3648,1,0.0
3638,1,0.0
Crt,1,0.0
daylong,1,0.0
Naughton,1,0.0
puffsday,1,0.0
0-72,1,0.0
preception,1,0.0
brute-force,1,0.0
linearization,1,0.0
calcium-entry,1,0.0
Norovirus,1,0.0
GII4,1,0.0
Mucolyse™,1,0.0
Chelex©,1,0.0
Resin,1,0.0
0543,1,0.0
3097,1,0.0
AASSP,1,0.0
nonasthma-associated,1,0.0
NAASSP,1,0.0
2721,1,0.0
37755,1,0.0
5085,1,0.0
low1,1,0.0
breast-fed,1,0.0
CTCT,1,0.0
nightclub,1,0.0
Participant,1,0.0
”,1,0.0
6080,1,0.0
“Cutaneous,1,0.0
direction-dependent,1,0.0
ADCs,1,0.0
hypocoagulability,1,0.0
headlock,1,0.0
sIgADcommon,1,0.0
N-β-alanyl-1-methyl-L-histidine,1,0.0
Carnosine-stimulated,1,0.0
imidazole-containing,1,0.0
histidine-containing,1,0.0
nonhydrolized,1,0.0
histidine-containg,1,0.0
non-hydrolized,1,0.0
L-carnosine,1,0.0
neuro-humoral,1,0.0
8211234,1,0.0
2381,1,0.0
intersects,1,0.0
anti-Asian,1,0.0
health-namely,1,0.0
conditions-lead,1,0.0
co-residence,1,0.0
multigenerational,1,0.0
intersectionality-informed,1,0.0
IFNϒ,1,0.0
ACE2-mediated,1,0.0
nanotechnologys,1,0.0
piecing,1,0.0
sex-steroid,1,0.0
luteal,1,0.0
penumbra-modifying,1,0.0
certifies,1,0.0
non-certified,1,0.0
HGS,1,0.0
Pamplona,1,0.0
19-item,1,0.0
075-092,1,0.0
029-084,1,0.0
salons,1,0.0
ATS-DLD,1,0.0
40-72,1,0.0
bronchoconstructive,1,0.0
2152,1,0.0
geneticsgene-environment,1,0.0
interventionpreventiontherapeutics,1,0.0
OBJECT,1,0.0
large-territory,1,0.0
1624,1,0.0
post-DH,1,0.0
CI139-3066,1,0.0
133-847,1,0.0
CI110-7276,1,0.0
178-4705,1,0.0
158-1679,1,0.0
152-2088,1,0.0
102-172,1,0.0
106-1651,1,0.0
136-1644,1,0.0
061-434,1,0.0
0328,1,0.0
2928,1,0.0
delipidated,1,0.0
precharacterised,1,0.0
8087,1,0.0
video-survey,1,0.0
broad-acting,1,0.0
CoronaCheck,1,0.0
1555,1,0.0
NCT02060760,1,0.0
93-95,1,0.0
eGFR≥90,1,0.0
n722,1,0.0
57-61,1,0.0
eGFR30,1,0.0
40-41,1,0.0
51-57,1,0.0
27-42,1,0.0
15-32,1,0.0
2946,1,0.0
Simtomax®,1,0.0
electro-chemiluminescence,1,0.0
temporal-spatial,1,0.0
79-97,1,0.0
81-98,1,0.0
89-99,1,0.0
post-symptoms,1,0.0
86-100,1,0.0
iCAALL,1,0.0
ICON,1,0.0
patchplasty,1,0.0
HASI,1,0.0
self-measured,1,0.0
AASI,1,0.0
127×10-2,1,0.0
013×10-2,1,0.0
disfiguring,1,0.0
29-December,1,0.0
httpwwwcdcgovfluweeklyfluactivitysurvhtm,1,0.0
VSV-SARS-CoV-2,1,0.0
17-59,1,0.0
micro-RNA,1,0.0
505days,1,0.0
24days,1,0.0
602days,1,0.0
6-17months,1,0.0
Polymorphous,1,0.0
tozinameran-the,1,0.0
vaccine-in,1,0.0
IFN-γIL-2RIL-18IL-16IL-10,1,0.0
anti-PD1,1,0.0
pharmacovigillence,1,0.0
self-estimated,1,0.0
-0602,1,0.0
-0517,1,0.0
11327790,1,0.0
532340,1,0.0
pneumothoraxpneumomediastinum,1,0.0
httpsbitly3gZqA7Z,1,0.0
CAA159,1,0.0
CNJ176,1,0.0
Mich,1,0.0
thrombosis-occluded,1,0.0
TMVR,1,0.0
MitraClip,1,0.0
SMVR,1,0.0
victimisation,1,0.0
boycotting,1,0.0
25-hydroxylase,1,0.0
self-administrated,1,0.0
752-1401,1,0.0
619-1712,1,0.0
NAAT-based,1,0.0
falsepositive,1,0.0
Jin-Yin-Tan,1,0.0
meantimes,1,0.0
11240,1,0.0
persons-week,1,0.0
1748,1,0.0
65-item,1,0.0
8985,1,0.0
2010-2017,1,0.0
brush-based,1,0.0
L2-regularized,1,0.0
0994,1,0.0
contract-tracing,1,0.0
transcription-regulating,1,0.0
Sf9,1,0.0
TRS-dependent,1,0.0
polyA,1,0.0
template-switching,1,0.0
TRS-independent,1,0.0
three-site,1,0.0
7165,1,0.0
0·82,1,0.0
TAUNS,1,0.0
938-989,1,0.0
841-931,1,0.0
874-999,1,0.0
821-979,1,0.0
alarm-to-treatment,1,0.0
VSV-SARS-CoV,1,0.0
25-hydroxycholesterol,1,0.0
Bowel,1,0.0
Internalized,1,0.0
Biolimus,1,0.0
A9™-eluting,1,0.0
Stoughton,1,0.0
McKenzie,1,0.0
CMR-defined,1,0.0
resolution70,1,0.0
p0043,1,0.0
p036,1,0.0
A-derived,1,0.0
isothermally,1,0.0
naso-pharyngal,1,0.0
COVIDISC,1,0.0
NIVW,1,0.0
Guanxinshutong,1,0.0
GXST,1,0.0
CARASIL,1,0.0
HERNS,1,0.0
accompaniments,1,0.0
T2w-CMR,1,0.0
T2-weigthed,1,0.0
Alborz,1,0.0
Cochrans,1,0.0
088-111,1,0.0
066-093,1,0.0
60ies,1,0.0
70ies,1,0.0
dermatophytes,1,0.0
Editions,1,0.0
anterior-circulation,1,0.0
120bpm,1,0.0
regurgitant,1,0.0
mm-58,1,0.0
MIPs,1,0.0
embryonic-like,1,0.0
VSELs,1,0.0
extraembryonic,1,0.0
milk-derived,1,0.0
teratocarcinoma-derived,1,0.0
Ntera2D1,1,0.0
neuron-like,1,0.0
NT2N,1,0.0
c-mycERTAM,1,0.0
CTX0E03,1,0.0
notch-transfected,1,0.0
SB623,1,0.0
transplantable,1,0.0
antibody-like,1,0.0
rice-sized,1,0.0
MIP-based,1,0.0
MIP-endowed,1,0.0
potentiostat,1,0.0
unlocks,1,0.0
prestabilized,1,0.0
Relaxation-group,1,0.0
presession,1,0.0
code-based,1,0.0
2331175,1,0.0
Fabreceptor,1,0.0
Wuhan-related,1,0.0
worldwideThe,1,0.0
immunopathobiological,1,0.0
time-outcome,1,0.0
nonthoracic,1,0.0
respondent-defined,1,0.0
presently-available,1,0.0
You-Gui-Wan,1,0.0
rRNA-based,1,0.0
acetylcarnitine,1,0.0
norleucine,1,0.0
branched-chain,1,0.0
p-induced,1,0.0
mid-axillary,1,0.0
0-degree,1,0.0
telescope,1,0.0
padron,1,0.0
10th-postoperative,1,0.0
Electroconvulsive,1,0.0
double-balloon,1,0.0
costdeath,1,0.0
Enforced,1,0.0
Yellow,1,0.0
milliondeath,1,0.0
Cyclophilin,1,0.0
immunophilin,1,0.0
peptidyl-prolyl,1,0.0
cis-trans,1,0.0
tumorigenesis,1,0.0
Cyclosporin,1,0.0
CsA,1,0.0
CypA-dependent,1,0.0
Kuramoto,1,0.0
Ways,1,0.0
self-responsibility,1,0.0
extra-renal,1,0.0
bio-signatures,1,0.0
2009-February,1,0.0
Partner,1,0.0
PRKAR1A,1,0.0
2059,1,0.0
Wuhan-1,1,0.0
isolate-based,1,0.0
NTD-specific,1,0.0
Purifier,1,0.0
modality-dependent,1,0.0
Microorganisms,1,0.0
neuraxis,1,0.0
Sudans,1,0.0
canister,1,0.0
liberally,1,0.0
complex-related,1,0.0
R1A,1,0.0
hypertensive-hyperkinetic-coronary-active,1,0.0
Albuminuria,1,0.0
ngl,1,0.0
hypersympathetic,1,0.0
cryodamage,1,0.0
isolate-test-treat-trace,1,0.0
geo-prioritization,1,0.0
statesdistricts,1,0.0
human-centered,1,0.0
user-identified,1,0.0
to-go,1,0.0
Usability,1,0.0
Human-centered,1,0.0
homoeopathy,1,0.0
herbalism,1,0.0
1979-1985,1,0.0
SLIT-tablet,1,0.0
transmission-enhancing,1,0.0
moderate-quality,1,0.0
prison-associated,1,0.0
spice-derived,1,0.0
Hmox1,1,0.0
group-matched,1,0.0
09-35,1,0.0
27242,1,0.0
2092-354706,1,0.0
multiple-gated,1,0.0
45-month-old,1,0.0
2003–06,1,0.0
2008–10,1,0.0
37–45,1,0.0
34–44,1,0.0
7–30,1,0.0
49–67,1,0.0
18–65,1,0.0
17–34,1,0.0
high-voltage,1,0.0
20TBSA,1,0.0
Fracture,1,0.0
xeno-acellular,1,0.0
Eschar,1,0.0
Henoch-Schonlein,1,0.0
LIMIT,1,0.0
impactboth,1,0.0
Life-style,1,0.0
295272,1,0.0
23418,1,0.0
234180,1,0.0
16-October,1,0.0
neuromonitoring,1,0.0
mechanisms--as,1,0.0
Friesinger,1,0.0
Q-single-photon,1,0.0
SPECTCT,1,0.0
140-147,1,0.0
104-112,1,0.0
106-113,1,0.0
134-157,1,0.0
positive-AMI,1,0.0
negative-AMI,1,0.0
contentment,1,0.0
SCC1,1,0.0
WA1,1,0.0
Hu-1,1,0.0
lipothymic,1,0.0
multi-theory,1,0.0
SD--its,1,0.0
MTMs,1,0.0
-0464,1,0.0
type-specificity,1,0.0
antigensThis,1,0.0
agar-gel,1,0.0
seraWhile,1,0.0
CDs,1,0.0
near-breakdown,1,0.0
conditions--such,1,0.0
ischemia--and,1,0.0
energy-compromised,1,0.0
ascend,1,0.0
energy-depleted,1,0.0
years-163,1,0.0
honorably,1,0.0
NS-GP,1,0.0
multipliers,1,0.0
kindly,1,0.0
6094,1,0.0
year--transyears--reported,1,0.0
detrending,1,0.0
zero-amplitude,1,0.0
no-rhythm,1,0.0
transyear,1,0.0
magnetoperiodisms,1,0.0
unqualified,1,0.0
quindecadal,1,0.0
extraterrestrial,1,0.0
Magnetoperiodic,1,0.0
fore,1,0.0
fiction,1,0.0
FLA,1,0.0
Fragebogen,1,0.0
zur,1,0.0
Lebensqualität,1,0.0
bei,1,0.0
EuroQol,1,0.0
Ulcerative,1,0.0
99mTechnetium,1,0.0
under-detected,1,0.0
24-45,1,0.0
38-83,1,0.0
114192-624435,1,0.0
18491-95390,1,0.0
4915-27174,1,0.0
54-70,1,0.0
Yaneng,1,0.0
Daan,1,0.0
Genekey,1,0.0
physiotheraphy,1,0.0
specialist-in-training,1,0.0
NSMOH,1,0.0
min--the,1,0.0
hour--of,1,0.0
Dilatation,1,0.0
segmentsABSTRACT,1,0.0
NSP12,1,0.0
NSP14,1,0.0
Importations,1,0.0
clade-defining,1,0.0
therapyCorticosteroids,1,0.0
horseness,1,0.0
polyphonic,1,0.0
hemosiderin,1,0.0
0898,1,0.0
denoising,1,0.0
texture-feature,1,0.0
plaque-motion,1,0.0
cCT,1,0.0
1600-h,1,0.0
nanofluidic,1,0.0
Fluidigm,1,0.0
nL-range,1,0.0
Over-estimation,1,0.0
over-estimation,1,0.0
0658,1,0.0
0852,1,0.0
0441,1,0.0
71-85,1,0.0
ReperfusionOcclusion,1,0.0
DEMATEL,1,0.0
HERO-1,1,0.0
azobisformamide,1,0.0
Auto,1,0.0
multifunction,1,0.0
ADO,1,0.0
26-March,1,0.0
illnessesAccurate,1,0.0
horizonWe,1,0.0
RNAscope,1,0.0
receptorOverall,1,0.0
vasculotide,1,0.0
angiopoietin-like,1,0.0
sphingosine,1,0.0
1-phosphate,1,0.0
CCSF,1,0.0
NexStent,1,0.0
EndoTex,1,0.0
Cupertino,1,0.0
KIDIGO,1,0.0
anticoagulate,1,0.0
Iterative,1,0.0
arborisation,1,0.0
anterogradely,1,0.0
myosistis,1,0.0
preference-sensitive,1,0.0
newalternative,1,0.0
Brasilia,1,0.0
Cuenca,1,0.0
endotype-based,1,0.0
Decision-Making,1,0.0
Azobisformamide,1,0.0
nmolmLmin,1,0.0
sarcoid-type,1,0.0
amyloid-beta,1,0.0
RV1-V420,1,0.0
urgentists,1,0.0
Dioctophymosis,1,0.0
Dioctophyme,1,0.0
parasitizing,1,0.0
celiotomy,1,0.0
nephrectomy,1,0.0
dioctophymosis,1,0.0
6xHis-tagged,1,0.0
IgG-HPR,1,0.0
HPR,1,0.0
Bead,1,0.0
6xHis,1,0.0
diabetes-induced,1,0.0
noncaseating,1,0.0
nonsterol,1,0.0
heals,1,0.0
SET-NET,1,0.0
COVI-PREG,1,0.0
PAN-COVID,1,0.0
Neonatal-Perinatal,1,0.0
SONPM,1,0.0
CANCOVID-Preg,1,0.0
loin,1,0.0
Excision,1,0.0
patientdied,1,0.0
Bell,1,0.0
10565,1,0.0
G197-like,1,0.0
F98-like,1,0.0
PSRSSR,1,0.0
oxide-related,1,0.0
imitator,1,0.0
gummas,1,0.0
Kinlen,1,0.0
Kinlens,1,0.0
Armstrong,1,0.0
weight-appropriate,1,0.0
multi-centers,1,0.0
output-O2,1,0.0
Rostov,1,0.0
CoronaVIR,1,0.0
httpswebsiiitdeduinraghavacoronavir,1,0.0
currently-in-use,1,0.0
LQLPQGTTLPKGFYA,1,0.0
VILLNKHIDAYKTFPPTEPKKDKKKK,1,0.0
EITVATSRTLS,1,0.0
GKGQQQQGQTV,1,0.0
SELVIGAVILR,1,0.0
Superintendent,1,0.0
OSSE,1,0.0
facilities†,1,0.0
parents§,1,0.0
outbreaks¶,1,0.0
OMNIgene-GUT,1,0.0
Quick-RNA,1,0.0
MagMAX,1,0.0
ViralPathogen,1,0.0
QiaAMP,1,0.0
pre-beta,1,0.0
5-nucleotide,1,0.0
Syphilis,1,0.0
disordersFurther,1,0.0
P-PCI,1,0.0
Amyotrophic,1,0.0
redact,1,0.0
nonvirulent,1,0.0
heartlung,1,0.0
liverlung,1,0.0
Optometrists,1,0.0
riskseverity,1,0.0
Macrolide,1,0.0
Friedemanns,1,0.0
NHLS,1,0.0
193671,1,0.0
2761121,1,0.0
top-most,1,0.0
colorimetric-fluorescent,1,0.0
dual-mode,1,0.0
protein-conjugated,1,0.0
NBs,1,0.0
Inland,1,0.0
pollination,1,0.0
stirking,1,0.0
preseasonal,1,0.0
scattergram,1,0.0
desirableABSTRACT,1,0.0
Hairdresser-related,1,0.0
HICE,1,0.0
fluor,1,0.0
non-radiological,1,0.0
ИХА-COVID-19-IgM,1,0.0
immunochemiluminescent,1,0.0
CSMs,1,0.0
transpeptidase,1,0.0
1964-65,1,0.0
Migraineurs,1,0.0
aura-related,1,0.0
CMV-seropositive,1,0.0
computer-assigned,1,0.0
558759,1,0.0
around-,1,0.0
the-clock,1,0.0
oral-self,1,0.0
833-923,1,0.0
961-981,1,0.0
080-088,1,0.0
527-694,1,0.0
062-076,1,0.0
Performances,1,0.0
fluidize,1,0.0
Swine-origine,1,0.0
interstudy,1,0.0
transcription-real-time,1,0.0
22-49,1,0.0
08-12,1,0.0
07-16,1,0.0
Lumen,1,0.0
25-67,1,0.0
nonstent,1,0.0
self-portrait,1,0.0
Move,1,0.0
UENI,1,0.0
pharmacokineticspharmacodynamics,1,0.0
288-358,1,0.0
thromboinflammatory,1,0.0
corticosteroid-long-acting,1,0.0
late-differentiated,1,0.0
neo-antigen,1,0.0
Vaccine-specific,1,0.0
co-crystallized,1,0.0
theyve,1,0.0
Thoses,1,0.0
fumigation,1,0.0
impragnated,1,0.0
cigares,1,0.0
cigarets,1,0.0
Solanacées,1,0.0
exemple,1,0.0
Clérys,1,0.0
Exibards,1,0.0
Lability,1,0.0
complexABSTRACT,1,0.0
5-part,1,0.0
dimethylfumarate,1,0.0
61-78,1,0.0
fosfomycin,1,0.0
ibrutinib,1,0.0
saxagliptin,1,0.0
anti-AH1N1,1,0.0
anti-AH3N2,1,0.0
immunoresponse,1,0.0
2047,1,0.0
SEKISUI,1,0.0
BIOLINE,1,0.0
≤45,1,0.0
22994,1,0.0
ss-agonist,1,0.0
1000µL,1,0.0
hyporesponsiveness,1,0.0
75min,1,0.0
13min,1,0.0
Provider-directed,1,0.0
multiple-gene-copy,1,0.0
vascularized,1,0.0
angiogenetic,1,0.0
httpsbitly3gzqEik,1,0.0
Quervain,1,0.0
all-payer,1,0.0
harmlessness,1,0.0
hochuekkito,1,0.0
Hochu-ekki-to,1,0.0
HET,1,0.0
mestizo,1,0.0
haemopoietic,1,0.0
vaccinated--although,1,0.0
non-intubated,1,0.0
curettage,1,0.0
opticalchemiluminescence,1,0.0
smartphone-camera-based,1,0.0
nanogold-labelled,1,0.0
HRP-labelled,1,0.0
H2O2luminolenhancers,1,0.0
semi-quantification,1,0.0
IgA-LFIA,1,0.0
diagnosticprognostic,1,0.0
Bronchopulmonary,1,0.0
ovalbumin-preimmunized,1,0.0
innervating,1,0.0
fast-increasing,1,0.0
taxation,1,0.0
Patient-created,1,0.0
FcγRT,1,0.0
TMRPSS2,1,0.0
alternates,1,0.0
Laypersons,1,0.0
0-45,1,0.0
609714,1,0.0
942633,1,0.0
985184,1,0.0
978531,1,0.0
949225,1,0.0
935571,1,0.0
profitability,1,0.0
Spokane,1,0.0
Collectives,1,0.0
ambivalently,1,0.0
mongering,1,0.0
puppet,1,0.0
gravid,1,0.0
intestinalis,1,0.0
amniocentesis,1,0.0
Diffusion-perfusion,1,0.0
RApid,1,0.0
PerfusIon,1,0.0
imagingperfusion-weighted,1,0.0
tissueABSTRACT,1,0.0
Vittore,1,0.0
Buzzi,1,0.0
pediatricmaternal,1,0.0
procedures-with,1,0.0
urgentemergent,1,0.0
ones-between,1,0.0
pneumatosis,1,0.0
3367,1,0.0
Induced-sputum,1,0.0
Canaan,1,0.0
108689,1,0.0
2007-December,1,0.0
extra-urban,1,0.0
Ineligibility,1,0.0
mass-vaccinations,1,0.0
D501,1,0.0
Simpson,1,0.0
touch-screen,1,0.0
arteried,1,0.0
angiographis,1,0.0
myoaggressive,1,0.0
myoagressive,1,0.0
2002-2007,1,0.0
86-165,1,0.0
6311,1,0.0
Nit-Occlud®,1,0.0
exercise-enhanced,1,0.0
00001ABSTRACT,1,0.0
Selectively,1,0.0
vtiral,1,0.0
coronavirus2,1,0.0
functiion,1,0.0
non-acceptance,1,0.0
ascendancy,1,0.0
Unsettling,1,0.0
ambidexterity,1,0.0
resurrection,1,0.0
perturbate,1,0.0
envied,1,0.0
Uncertain,1,0.0
Postexercise,1,0.0
2D-echocardiogram,1,0.0
93952,1,0.0
oscillococcinum,1,0.0
14182310,1,0.0
outpaced,1,0.0
19414,1,0.0
hypermagnesemia,1,0.0
GINA-2005,1,0.0
broncho-dilating,1,0.0
protectionimmunity,1,0.0
antigen-adjuvant,1,0.0
glassware,1,0.0
platform-specific,1,0.0
vascular-risk,1,0.0
anaferon,1,0.0
aflubin,1,0.0
disintoxicational,1,0.0
Tonghua,1,0.0
3552,1,0.0
prognostical,1,0.0
43-49,1,0.0
009-015,1,0.0
004-011,1,0.0
36-42,1,0.0
periodicity-3,1,0.0
teflon,1,0.0
gasket,1,0.0
P-like,1,0.0
aortic-right-ventricular,1,0.0
sympatho-neuronal,1,0.0
sympatho-adrenal,1,0.0
FFCW,1,0.0
χ29,1,0.0
16738,1,0.0
CoronaCentral,1,0.0
8139,1,0.0
Maccabi,1,0.0
MHS,1,0.0
MidReC,1,0.0
postanesthesia,1,0.0
cyclooxygen-ase,1,0.0
en-masse,1,0.0
electrochemicalfluorescence,1,0.0
S-allyl,1,0.0
antilipoperoxidative,1,0.0
D0,1,0.0
47T,1,0.0
sulphitesthe,1,0.0
interagency,1,0.0
doctor-diagnosis,1,0.0
BennettTwin,1,0.0
Staffordshire,1,0.0
eighty-two,1,0.0
Yavarian,1,0.0
e74–e76,1,0.0
AssociationEuropean,1,0.0
µJcm2,1,0.0
2-log,1,0.0
Benefit-risk,1,0.0
avidin-biotin-horseradish,1,0.0
band-like,1,0.0
interrogating,1,0.0
microRNA-21phosphoinositide,1,0.0
3-kinasehistone,1,0.0
in-transit,1,0.0
perspectively,1,0.0
bradycardia-hypotension,1,0.0
acclimatisation,1,0.0
PARTICIPANTS,1,0.0
Chemoprophylactics,1,0.0
road-and-traffic,1,0.0
HERMETIZATION,1,0.0
DURING,1,0.0
TRANSPORTATION,1,0.0
DRAINING,1,0.0
PLEURAL,1,0.0
CAVITY,1,0.0
emphases,1,0.0
siloed,1,0.0
Ladakh,1,0.0
rejoining,1,0.0
Leh,1,0.0
phase-matched,1,0.0
End-of-life,1,0.0
18270,1,0.0
atorvastastin,1,0.0
071-099,1,0.0
Peculiar,1,0.0
sex-balanced,1,0.0
mediastinoscopic,1,0.0
subcarinal,1,0.0
pretracheal,1,0.0
incised,1,0.0
30o,1,0.0
thoracoscope,1,0.0
video-mediastinoscope,1,0.0
nostrils,1,0.0
httpscoronacentralai,1,0.0
microbiotas,1,0.0
194-238,1,0.0
LC-MAI,1,0.0
myeloperoxidase-DNA,1,0.0
Above-median,1,0.0
Depressiveness,1,0.0
imprisoned,1,0.0
detainees,1,0.0
MDCK-cells,1,0.0
AH3N2-,1,0.0
falsely-negative,1,0.0
Erythropoiesis-stimulating,1,0.0
ESAs,1,0.0
blood-product,1,0.0
TREAT,1,0.0
intracardia,1,0.0
All-Union,1,0.0
factor‑κB,1,0.0
BMS‑345541dimethyl,1,0.0
gene-deficient,1,0.0
NS-deficient,1,0.0
01-03,1,0.0
240000-480000,1,0.0
non-asynergy,1,0.0
Exhaustion,1,0.0
41-66,1,0.0
stress-testing,1,0.0
ciculation,1,0.0
officiallly,1,0.0
large-branch,1,0.0
visual-motor,1,0.0
usual-care,1,0.0
pifalls,1,0.0
vitamine,1,0.0
2981,1,0.0
524514,1,0.0
764218,1,0.0
YMCA,1,0.0
litresmin,1,0.0
non-uniformity,1,0.0
Progranulin,1,0.0
PGRN-deficient,1,0.0
alveolar-epithelial,1,0.0
segmentation-corrected,1,0.0
UNet-inspired,1,0.0
fourth-year,1,0.0
Shinjuku,1,0.0
TMWU,1,0.0
095-347,1,0.0
6752,1,0.0
00002-02,1,0.0
182-726,1,0.0
149-382,1,0.0
TWMU,1,0.0
deconvolute,1,0.0
complex-stability,1,0.0
epitope-HLA-binding,1,0.0
LACDPH,1,0.0
CAIR2,1,0.0
WGS-based,1,0.0
43127,1,0.0
10895,1,0.0
30801,1,0.0
SETTINGPATIENTS,1,0.0
Clamydia,1,0.0
05298,1,0.0
H3N3,1,0.0
subgroupings,1,0.0
Disadvantages,1,0.0
GS4104,1,0.0
thromboclasis,1,0.0
FBiH,1,0.0
Successfulness,1,0.0
Qingshan,1,0.0
Destrict,1,0.0
SARS‐CoV‐2‐infected,1,0.0
Large‐scale,1,0.0
re‐opened,1,0.0
3415,1,0.0
physician-recruited,1,0.0
AKUH,1,0.0
8226,1,0.0
30318,1,0.0
controlscase-1,1,0.0
106-152,1,0.0
Consensus-positive,1,0.0
consensus-positive,1,0.0
bioactivated,1,0.0
glutathione-S-transferases,1,0.0
CYP2A13,1,0.0
SOD3,1,0.0
LNPs-encapsulated,1,0.0
Fc-conjugated,1,0.0
luc,1,0.0
LNP-based,1,0.0
23-123,1,0.0
cell-virus,1,0.0
Herpesvirus,1,0.0
Dibutyryl,1,0.0
anti-acidic,1,0.0
GFI,1,0.0
0989,1,0.0
-124,1,0.0
SPB,1,0.0
osltamimivir,1,0.0
2791,1,0.0
sparingly,1,0.0
heterokaryon,1,0.0
telomerase-associated,1,0.0
hero,1,0.0
villain,1,0.0
NLRP3-dependent,1,0.0
double-average,1,0.0
disease-2,1,0.0
omegadNdS265,1,0.0
February-June,1,0.0
99Tcm-labelled,1,0.0
methoxy-isobutyl-isonitrile,1,0.0
re-distribution,1,0.0
firing,1,0.0
performance†,1,0.0
agreement§,1,0.0
833-994,1,0.0
patients¶,1,0.0
30-August,1,0.0
382x10-3,1,0.0
262x10-3,1,0.0
codon-substitution,1,0.0
06-55,1,0.0
timecourse,1,0.0
extortionate,1,0.0
postero-anterior,1,0.0
40-67,1,0.0
Clotting,1,0.0
lock-downs-May,1,0.0
2020-our,1,0.0
59-68,1,0.0
69-78,1,0.0
départements,1,0.0
acceleration-based,1,0.0
workshifts,1,0.0
hospitalized-based,1,0.0
17100000,1,0.0
materno-fetalneonatal,1,0.0
disordersprocedures,1,0.0
Samu,1,0.0
socio-structural,1,0.0
azithromycine,1,0.0
necropsied,1,0.0
outruled,1,0.0
asthma-symptom-free,1,0.0
asynegry,1,0.0
plastic-shafted,1,0.0
rayon-budded,1,0.0
232-227,1,0.0
factor-binding,1,0.0
1-2-g,1,0.0
Epimyocardial,1,0.0
epimyocardial,1,0.0
51-75,1,0.0
Devastating,1,0.0
22-39,1,0.0
specimen-pooling,1,0.0
currentpast,1,0.0
hemor,1,0.0
radio-grams,1,0.0
pleuro-mediastinal,1,0.0
41-65,1,0.0
infra-azygos,1,0.0
51-19,1,0.0
28-8,1,0.0
11-1,1,0.0
41-21,1,0.0
86-66,1,0.0
nipple,1,0.0
double-contour,1,0.0
sickle-like,1,0.0
ClinMicroNet,1,0.0
agic,1,0.0
074-094,1,0.0
incomparable,1,0.0
bifacial,1,0.0
Stockpiles,1,0.0
hyperlipidemias,1,0.0
7406,1,0.0
5194,1,0.0
1988-1993,1,0.0
chance-kappa,1,0.0
morphophysiological,1,0.0
12347,1,0.0
0226-07142020,1,0.0
c-statistics,1,0.0
073-080,1,0.0
Acquires,1,0.0
SOURCE,1,0.0
↓,1,0.0
user-specific,1,0.0
channelrhodopsin-2,1,0.0
allergyallergens,1,0.0
Sorghum,1,0.0
halopense,1,0.0
clarosporoides,1,0.0
tenuis,1,0.0
Viroporins,1,0.0
deregulating,1,0.0
FASTA,1,0.0
nonallergen,1,0.0
nontoxin,1,0.0
BRD2,1,0.0
BRD4,1,0.0
retrosternally,1,0.0
line--behind,1,0.0
abuts,1,0.0
infallible,1,0.0
hyperexpanded,1,0.0
4486,1,0.0
Rîmnicu,1,0.0
Vîlcea,1,0.0
meridional,1,0.0
sub-Carpathian,1,0.0
driveline,1,0.0
neonatology,1,0.0
Craniotomiescraniostomies,1,0.0
Congenital-acquired,1,0.0
TITAN,1,0.0
105-659,1,0.0
light-based,1,0.0
35-2013,1,0.0
DEVELOPER,1,0.0
101640,1,0.0
00323,1,0.0
114-497,1,0.0
dynamicity,1,0.0
QTRR,1,0.0
SARS-CoV-1-convalescent,1,0.0
angiotensin-receptor,1,0.0
unimpeded,1,0.0
postfibrinolytic,1,0.0
ASSENT-3,1,0.0
beta-CoVs,1,0.0
dia-lysis,1,0.0
23-item,1,0.0
asthenoadymanic,1,0.0
tocsoinfectious,1,0.0
babies--they,1,0.0
palatum,1,0.0
fissum,1,0.0
immune-prevention,1,0.0
ureter,1,0.0
accordant,1,0.0
Argentinas,1,0.0
Argentinean,1,0.0
mo-old,1,0.0
shock-induced,1,0.0
Anti-Nogo,1,0.0
re-innervation,1,0.0
pruned,1,0.0
surface-mapping,1,0.0
ESAi,1,0.0
020-128,1,0.0
P025,1,0.0
Complacency,1,0.0
acceptant,1,0.0
Myofiber,1,0.0
dilator--papaverine--could,1,0.0
00152,1,0.0
cineframes,1,0.0
00039,1,0.0
effort-induced,1,0.0
figues,1,0.0
R2099,1,0.0
Galton-Watson,1,0.0
contact-type,1,0.0
pre-control,1,0.0
antinociceptive,1,0.0
somnific,1,0.0
oligohydramnios,1,0.0
autogenous,1,0.0
GORE-TEX,1,0.0
seasons4,1,0.0
vaccine5,1,0.0
and6,1,0.0
electrocardiographie,1,0.0
intermixing,1,0.0
Τo,1,0.0
indicesMethods,1,0.0
post-ICSLABA,1,0.0
visitResults,1,0.0
Sialidase,1,0.0
02-fold,1,0.0
05-fold,1,0.0
82-fold,1,0.0
0001--and,1,0.0
conductance--r,1,0.0
85mm-3,1,0.0
1131,1,0.0
psychopathy,1,0.0
no-vaccine,1,0.0
DISCLOSURES,1,0.0
2019-nCoV-induced,1,0.0
Counting,1,0.0
Kit-8,1,0.0
high-expressing,1,0.0
e-6,1,0.0
064e-7,1,0.0
014e-6,1,0.0
061e-7,1,0.0
078e-7,1,0.0
042e-7,1,0.0
Salvianolic,1,0.0
350mm-3,1,0.0
098-099,1,0.0
099-100,1,0.0
079-080,1,0.0
091-092,1,0.0
105-109,1,0.0
100-100,1,0.0
068-069,1,0.0
074-076,1,0.0
precordially,1,0.0
Antonio-Lackland,1,0.0
interventionsAreas,1,0.0
fieldsExpert,1,0.0
prednisone-treated,1,0.0
00154,1,0.0
Suicidal,1,0.0
angioarchitecture,1,0.0
environments1,1,0.0
Cinecoronariography,1,0.0
Non-bacterial,1,0.0
non-heat,1,0.0
small-group,1,0.0
micrographia,1,0.0
pen-limb,1,0.0
accumulating--and,1,0.0
here--against,1,0.0
D9,1,0.0
post-bone,1,0.0
bronhioltis,1,0.0
macromolecule,1,0.0
dysbiotic,1,0.0
47291,1,0.0
60323,1,0.0
57349,1,0.0
76375,1,0.0
eventsABSTRACT,1,0.0
trialGap,1,0.0
pandemicMethodology,1,0.0
QuickGene-480,1,0.0
Kurabo,1,0.0
Logix,1,0.0
Myra,1,0.0
SystemsResults,1,0.0
9648-100,1,0.0
9652-100,1,0.0
deploymentConclusion,1,0.0
Microvolt,1,0.0
angiography--have,1,0.0
strategies--thrombolytic,1,0.0
13-81,1,0.0
ad5,1,0.0
GLF,1,0.0
H183N,1,0.0
62-64,1,0.0
absented,1,0.0
ITE,1,0.0
M2-31N,1,0.0
NS1-42S,1,0.0
PA-356R,1,0.0
PA-409N,1,0.0
AAQOL-D,1,0.0
60682,1,0.0
2186,1,0.0
theirtheir,1,0.0
SARS-Spike,1,0.0
39-49,1,0.0
4043,1,0.0
3643,1,0.0
stuff,1,0.0
Ji-Ji,1,0.0
signal-on,1,0.0
enzyme-based,1,0.0
23148,1,0.0
10148,1,0.0
diethyldithiocarbamate,1,0.0
Cu-chelating,1,0.0
antigen-sensitized,1,0.0
zinc-SOD,1,0.0
environment-specific,1,0.0
MTWA,1,0.0
populations2-4,1,0.0
rebleeding,1,0.0
Primorsky,1,0.0
Vaxzevria-Comirnaty,1,0.0
bacteriologically,1,0.0
3799,1,0.0
Cavitations,1,0.0
2823,1,0.0
lingula,1,0.0
5716,1,0.0
balls,1,0.0
patient-centeredness,1,0.0
co-repressor,1,0.0
deacetylase-2,1,0.0
adhesivenessaggregation,1,0.0
captivity,1,0.0
generaly,1,0.0
porphyria,1,0.0
Peanut,1,0.0
Niox,1,0.0
Outgrown,1,0.0
upper-respiratory,1,0.0
monthlyABSTRACT,1,0.0
EMIAT,1,0.0
SANOFI,1,0.0
re-working,1,0.0
hard-pressed,1,0.0
difficile-associated,1,0.0
CDAD,1,0.0
BSAC,1,0.0
hydrocephaly,1,0.0
Nimodipine,1,0.0
rehabilitation--was,1,0.0
duration--including,1,0.0
above-average,1,0.0
indemnified,1,0.0
Krai,1,0.0
37years,1,0.0
immunogram,1,0.0
participants--15,1,0.0
group--completed,1,0.0
CBT-AE,1,0.0
antipanic,1,0.0
MOMENTUM,1,0.0
MagLev,1,0.0
Markup,1,0.0
ClearCanvas,1,0.0
Enriched,1,0.0
Stroke-phenotyping,1,0.0
endsnbsp,1,0.0
internistic,1,0.0
postsymptomatic,1,0.0
thrombolysis-coronary,1,0.0
Extra-viral,1,0.0
Intra-viral,1,0.0
fragmentpeptides,1,0.0
First-in-Class,1,0.0
anti-N-protein,1,0.0
H1N1-negative,1,0.0
oneset,1,0.0
indapamid,1,0.0
sartanes,1,0.0
best-documented,1,0.0
Günzburg,1,0.0
39-fold,1,0.0
01-fold,1,0.0
NCT01226758,1,0.0
VUI201201,1,0.0
frewuency,1,0.0
maw,1,0.0
familly,1,0.0
ensnare,1,0.0
extracellularly,1,0.0
19-70,1,0.0
108390,1,0.0
4507,1,0.0
cardiac-derived,1,0.0
cells20,1,0.0
microL,1,0.0
adherens-type,1,0.0
Shengmai,1,0.0
public-,1,0.0
spike-DTH,1,0.0
fifties,1,0.0
vitaminsupplement,1,0.0
Indochina,1,0.0
antigen-rapid,1,0.0
nondialysis,1,0.0
non-CKD,1,0.0
Cécile,1,0.0
Viboud,1,0.0
peanuts,1,0.0
dependent-IgE-mediated,1,0.0
Acetylcholine-induced,1,0.0
Mathes,1,0.0
5228,1,0.0
abstained,1,0.0
metreologic,1,0.0
tovextrinsic,1,0.0
Kubos,1,0.0
foyer,1,0.0
Sensorimotor,1,0.0
SENSory,1,0.0
UPPer,1,0.0
SENSUPP,1,0.0
RAINBOW,1,0.0
Crowded,1,0.0
Pró-Saúde,1,0.0
4030,1,0.0
122-155,1,0.0
132-270,1,0.0
varsity,1,0.0
Collegiate,1,0.0
NCAA,1,0.0
Neurohormonal,1,0.0
protocole,1,0.0
stymied,1,0.0
SARS-CoV-2This,1,0.0
conditions--most,1,0.0
hypertension--thereby,1,0.0
monoamines,1,0.0
hypercortisolism,1,0.0
inter-ventricular,1,0.0
Goldsmith,1,0.0
Pilpel,1,0.0
3977100000,1,0.0
3515,1,0.0
sriteria,1,0.0
spectar,1,0.0
383500,1,0.0
484KV2,1,0.0
McKinsey,1,0.0
IntroductionSeasonal,1,0.0
conjoint,1,0.0
endorsements,1,0.0
antiviral-antibiotic,1,0.0
Facially,1,0.0
forced-choice,1,0.0
disgust,1,0.0
1981-1986,1,0.0
inverse-variance,1,0.0
Projection,1,0.0
2010s,1,0.0
066-079,1,0.0
061-077,1,0.0
059-074,1,0.0
Upstate,1,0.0
2D-imaging,1,0.0
2D-echocardiography,1,0.0
Pori,1,0.0
pre-implementation,1,0.0
eight-sample,1,0.0
heterovariant,1,0.0
Issuance,1,0.0
debacle,1,0.0
noncalcified,1,0.0
Positively,1,0.0
Anaphylaxis-A,1,0.0
RELEASE,1,0.0
DATE,1,0.0
PRIOR,1,0.0
VERSION,1,0.0
anti-BHV-1,1,0.0
Natto,1,0.0
137-282,1,0.0
2020371m4262,1,0.0
VAHNSI,1,0.0
1968Altogether,1,0.0
receptor-destroying,1,0.0
KIO4,1,0.0
C-65,1,0.0
strainSurveillance,1,0.0
Moravia,1,0.0
waist-thigh,1,0.0
waist-hip,1,0.0
10524,1,0.0
5063,1,0.0
Mulchandani,1,0.0
Taylor-Phillips,1,0.0
33177070,1,0.0
17-segments,1,0.0
41-63,1,0.0
ASydney597H3N2-like,1,0.0
calculatory,1,0.0
40-68,1,0.0
ANanchang93395-like,1,0.0
19961997-19992000,1,0.0
self-insured,1,0.0
early-acute,1,0.0
Kamphaeng,1,0.0
Phet,1,0.0
physican,1,0.0
pneumotachogram,1,0.0
non-elastic,1,0.0
125-year,1,0.0
Bader,1,0.0
hranhsuk,1,0.0
INMET,1,0.0
33proteins,1,0.0
72hpirespectivelyCompared,1,0.0
F-actin-capping,1,0.0
alpha-1CapZ-α1,1,0.0
aminotransferaseOATpolyrC-binding,1,0.0
1PCBP1and,1,0.0
5A-1eIF5Aproduced,1,0.0
acetylhydrolaseIb,1,0.0
betaPAFAH1B2in,1,0.0
H7N9-infection,1,0.0
largemobile,1,0.0
non-responsive,1,0.0
21732472,1,0.0
770866,1,0.0
semi-synthetic,1,0.0
Pre-influenza,1,0.0
n496,1,0.0
Cairns,1,0.0
n779,1,0.0
influenza-seropositive,1,0.0
AH1N1-specific,1,0.0
non-telestroke,1,0.0
stroke-specialist,1,0.0
nonSTEMI,1,0.0
SIVEPGRIPE,1,0.0
SIH,1,0.0
Informatics,1,0.0
DATASUS,1,0.0
LACEN-SE,1,0.0
infectionhpiThere,1,0.0
72hours,1,0.0
MALDI-TOF-MSMSat,1,0.0
Friends,1,0.0
EudraCT,1,0.0
2009-014716-35,1,0.0
RNA-interference,1,0.0
Dicer1-gene,1,0.0
IL17,1,0.0
IL1-β,1,0.0
short-wavelength,1,0.0
saying,1,0.0
goodbye,1,0.0
R-,1,0.0
lay-out,1,0.0
stroke-trained,1,0.0
Portuguese-American,1,0.0
Got,1,0.0
approaches2DDIGE,1,0.0
Shots,1,0.0
Inoculations,1,0.0
amendable,1,0.0
chronic-stage,1,0.0
httpsdoiorg1023641asha14669715,1,0.0
outbreak-whether,1,0.0
transmission--can,1,0.0
crosswalk,1,0.0
virusH1N1pdm09-infected,1,0.0
investigatedA549,1,0.0
H1N1pdm09influenza,1,0.0
infectionMOIof,1,0.0
0001The,1,0.0
Meteorology,1,0.0
reformulate,1,0.0
receptors-βδ,1,0.0
psychogenesis,1,0.0
Karkashov,1,0.0
rφ054,1,0.0
р0001,1,0.0
11023±537,1,0.0
14971±223,1,0.0
р001,1,0.0
rs029-041,1,0.0
Tribulus,1,0.0
terrestris,1,0.0
GC-MS-based,1,0.0
intresting,1,0.0
fibrynolytical,1,0.0
Almer,1,0.0
nonhematologic,1,0.0
non-CNS,1,0.0
1977-February,1,0.0
Kiev,1,0.0
monoetiological,1,0.0
black-to-white,1,0.0
STROKE,1,0.0
BELT,1,0.0
antismoking,1,0.0
virus-cytokine-trypsin,1,0.0
disorders-cytokine,1,0.0
diisopropylamine,1,0.0
dichloroacetate,1,0.0
l-carnitine,1,0.0
bezafibrate,1,0.0
proliferation-activated,1,0.0
ofMiolkovska-Dmitrova,1,0.0
OHE-HEED,1,0.0
Economics-Health,1,0.0
ΔIGF-I-q,1,0.0
desertic,1,0.0
WBP,1,0.0
T98G,1,0.0
SH-SY5Y,1,0.0
cat-to-human,1,0.0
avian-lineage,1,0.0
pre-mating,1,0.0
Staging,1,0.0
ΔPpl,1,0.0
153if,1,0.0
multi-lobar,1,0.0
ΔIGF-I,1,0.0
ΔIGF-I-quintiles,1,0.0
2970,1,0.0
Biosis,1,0.0
Necker,1,0.0
protein-driven,1,0.0
5-question,1,0.0
mesophilic,1,0.0
CFUm3,1,0.0
Chrysonilia,1,0.0
Geotrichum,1,0.0
Trichoderma,1,0.0
Thermoactinomyces,1,0.0
air-machines,1,0.0
garbage,1,0.0
anti-vitamin,1,0.0
Healthstar,1,0.0
infarctionOf,1,0.0
assistanceOf,1,0.0
75th‰,1,0.0
22-110,1,0.0
Non-sustained,1,0.0
Programming,1,0.0
-115,1,0.0
MEF50VC,1,0.0
-352,1,0.0
MEF60TLC,1,0.0
-616,1,0.0
-420,1,0.0
-577,1,0.0
Diuresis,1,0.0
ThermoFishers,1,0.0
69-70,1,0.0
ACATGT,1,0.0
283-333,1,0.0
9244-9992,1,0.0
6472-6995,1,0.0
8031,1,0.0
7976-8085,1,0.0
skin-tests,1,0.0
45965,1,0.0
pressurefractional,1,0.0
26-42,1,0.0
08-1,1,0.0
PICCO,1,0.0
-0852,1,0.0
oxygenatory,1,0.0
2-fluoro-2-deoxycytidine,1,0.0
difluoro,1,0.0
21-59,1,0.0
ANFIS-predicted,1,0.0
1637-600,1,0.0
httpsbitly2KJxAbp,1,0.0
MMCA,1,0.0
10E3,1,0.0
≥12yrs,1,0.0
nonpsychotic,1,0.0
Liberia,1,0.0
Sierra,1,0.0
Leone,1,0.0
absorbs,1,0.0
non-characteristic,1,0.0
1581,1,0.0
AstraZeneca-Oxford,1,0.0
Pfizer-,1,0.0
Caseous,1,0.0
ASIs,1,0.0
paired-comparison,1,0.0
measureABSTRACT,1,0.0
Resected,1,0.0
microns-thick,1,0.0
15420,1,0.0
n544,1,0.0
One-fourth,1,0.0
007-243,1,0.0
137-295,1,0.0
restructure,1,0.0
highest-volume,1,0.0
ASOR,1,0.0
Asthma-education,1,0.0
Mastery,1,0.0
precipitators,1,0.0
Neuro-Fuzzy,1,0.0
oxygenfraction,1,0.0
450-638,1,0.0
cmH2,1,0.0
325-375,1,0.0
bendrofluazide,1,0.0
23∶1,1,0.0
MONICAKORA,1,0.0
19992001,1,0.0
2034,1,0.0
1764-2334,1,0.0
1971-2570,1,0.0
1824-2403,1,0.0
consummation,1,0.0
transmited,1,0.0
Zombie-city,1,0.0
21s⁢t,1,0.0
disqualified,1,0.0
9852,1,0.0
scopolamine,1,0.0
hornet,1,0.0
Vespa,1,0.0
cabro,1,0.0
linnaeus,1,0.0
risk-time,1,0.0
delay60,1,0.0
matureas,1,0.0
Refine,1,0.0
Pay,1,0.0
epidemic-associated,1,0.0
anti-risk,1,0.0
neuroregenerative,1,0.0
choke,1,0.0
2206,1,0.0
pandemic-deniers,1,0.0
propagates,1,0.0
02-97,1,0.0
ComirnatyVaxzevria,1,0.0
4366,1,0.0
6521,1,0.0
670-21600,1,0.0
4-204,1,0.0
4-234,1,0.0
catheter-related,1,0.0
Roles,1,0.0
Astute,1,0.0
adenoviral-vector,1,0.0
symptomaticconfirmed,1,0.0
VaxzevriaComirnaty,1,0.0
905-981,1,0.0
410-577,1,0.0
775-982,1,0.0
-046,1,0.0
578-879,1,0.0
Contrastingly,1,0.0
sociocontextual,1,0.0
customizing,1,0.0
digestible,1,0.0
cost-containing,1,0.0
cognisant,1,0.0
gliogenesis,1,0.0
201679895-906,1,0.0
Cardio-respiratory,1,0.0
20bps,1,0.0
NASN,1,0.0
three-armed,1,0.0
10E6,1,0.0
P-RDT-positive,1,0.0
Panbio-COVID-19,1,0.0
cortisone-dependent,1,0.0
nanomedicinal,1,0.0
IPL-induced,1,0.0
GPX,1,0.0
GRD,1,0.0
Garlic,1,0.0
Intermediate-acting,1,0.0
cromogylcate,1,0.0
intermediate-acting,1,0.0
129528,1,0.0
13294,1,0.0
1716,1,0.0
anti-radical,1,0.0
newly-emergent,1,0.0
COVIA-19,1,0.0
28503,1,0.0
19-23,1,0.0
TH1-acquired,1,0.0
TH1TH2,1,0.0
SF-6D,1,0.0
post-consensus,1,0.0
tree-structured,1,0.0
Trees,1,0.0
Multi-Layer,1,0.0
Perceptron,1,0.0
ECHRS,1,0.0
post-minor,1,0.0
riskIn,1,0.0
WVS,1,0.0
2344B,1,0.0
thrusted,1,0.0
STING-activating,1,0.0
nanoformulation,1,0.0
Bourboule,1,0.0
475000,1,0.0
659000,1,0.0
1-regulated,1,0.0
NCCa-ATP,1,0.0
uncle,1,0.0
horror,1,0.0
Multimeric,1,0.0
1μg,1,0.0
adjuvanting,1,0.0
alum-3M-052,1,0.0
CK-isoenzymes,1,0.0
CK--MM,1,0.0
CK--MB,1,0.0
seiousness,1,0.0
shuttling,1,0.0
Ls,1,0.0
Dofetilide,1,0.0
Periarterial,1,0.0
milking,1,0.0
dyssynergies,1,0.0
physicalfunctional,1,0.0
joyful,1,0.0
7-December,1,0.0
diseaseendocarditis,1,0.0
operationallogistic,1,0.0
ever-spreading,1,0.0
pathomechanistic,1,0.0
agonist-mediated,1,0.0
14-38,1,0.0
over-interpretation,1,0.0
self-reaction,1,0.0
anticoagulations,1,0.0
HtrA,1,0.0
inflammation‑associated,1,0.0
cycle‑associated,1,0.0
histamine-challenge,1,0.0
Phadiatop-test,1,0.0
Reluctance,1,0.0
closely-matched,1,0.0
2017469e332-e335,1,0.0
00028,1,0.0
Fritillariae,1,0.0
thunbergii,1,0.0
TCMSP,1,0.0
OB,1,0.0
STITCH,1,0.0
Compound-disease-target,1,0.0
pelargonidin,1,0.0
PTGS1,1,0.0
ligand-target,1,0.0
Workgroup,1,0.0
CREW,1,0.0
syndromemyocardial,1,0.0
Marker-to-marker,1,0.0
D5S2011,1,0.0
D6S305,1,0.0
D9S286,1,0.0
D6S1574,1,0.0
D8S1769,1,0.0
D19S226,1,0.0
note-based,1,0.0
miR‑30c‑5p,1,0.0
miR‑21‑5p,1,0.0
alstrom,1,0.0
disodiumcromoglycate,1,0.0
esmolol,1,0.0
ultra-short-acting,1,0.0
Carlos,1,0.0
Font,1,0.0
Pupo,1,0.0
Tunas,1,0.0
Curative,1,0.0
platelet-inhibitor,1,0.0
thrombosisABSTRACT,1,0.0
microsurgery,1,0.0
1295,1,0.0
Melanie,1,0.0
Saville,1,0.0
effort-limited,1,0.0
cytokine‑cytokine,1,0.0
extramortality,1,0.0
cow-milk,1,0.0
hypersensitivities,1,0.0
natrium,1,0.0
Critical-care,1,0.0
672–677,1,0.0
limma,1,0.0
Interacting,1,0.0
GSE24519,1,0.0
GSE48060,1,0.0
toll‑like,1,0.0
ras‑related,1,0.0
C‑C,1,0.0
vegetable-based,1,0.0
4918,1,0.0
IMIR,1,0.0
religion-based,1,0.0
hypochloraemia,1,0.0
wheat-derived,1,0.0
alphabeta-gliadin,1,0.0
oat-derived,1,0.0
avenin,1,0.0
ribulose,1,0.0
bisphosphate,1,0.0
carboxylase,1,0.0
PISCR,1,0.0
VQVVN,1,0.0
PQQQF,1,0.0
employee-reported,1,0.0
Caring,1,0.0
Behaviors,1,0.0
appliedABSTRACT,1,0.0
non-detected,1,0.0
micro-macroangiopathy,1,0.0
intima⁻media,1,0.0
L-arginineADMA,1,0.0
L-arginineSDMA,1,0.0
ADMASDMA,1,0.0
Concordant,1,0.0
upcoding,1,0.0
Sonographers,1,0.0
PACT,1,0.0
1-sided,1,0.0
208-4322,1,0.0
003-072,1,0.0
11435,1,0.0
Hyponatraemia,1,0.0
PROMIS®,1,0.0
150-930,1,0.0
worseness,1,0.0
RacCSxxx,1,0.0
PAAPVA,1,0.0
PRRA,1,0.0
RmYN02RacCSxxx,1,0.0
6-nucleotide,1,0.0
12-nucleotide,1,0.0
RmYN02s,1,0.0
osteomyelitis,1,0.0
mastoiditis,1,0.0
visualizer,1,0.0
r097,1,0.0
Ind,1,0.0
ZPA,1,0.0
Cakovice,1,0.0
fibroses,1,0.0
iso-areal,1,0.0
asynchronic,1,0.0
isodivergencies,1,0.0
Sibutramine,1,0.0
anti-obesity,1,0.0
sibutramine-induced,1,0.0
protectionMETHODSA,1,0.0
Milliplex,1,0.0
NRESULTSThe,1,0.0
groupCONCLUSIONAntenatal,1,0.0
pregnancyFUNDINGIsrael,1,0.0
Weizmann,1,0.0
Fondazione,1,0.0
Krenter,1,0.0
Tizoxanide,1,0.0
dolutegravir,1,0.0
bioisosterism,1,0.0
Ti-2,1,0.0
Vagal,1,0.0
inhitor,1,0.0
incrementing,1,0.0
carotid-posterior,1,0.0
unassisted,1,0.0
stent-containing,1,0.0
cone,1,0.0
Post-treatment,1,0.0
virus-triggered,1,0.0
Tele-rehabilitation,1,0.0
48-hr,1,0.0
reorganised,1,0.0
4212,1,0.0
2581,1,0.0
10874212,1,0.0
H9N2-positive,1,0.0
12-leads,1,0.0
immortalization,1,0.0
severe-controlled,1,0.0
misled,1,0.0
Neutrophil-derived,1,0.0
azurocidin,1,0.0
CAP-37,1,0.0
ImmunoAssay,1,0.0
73643,1,0.0
Hanta,1,0.0
stocking,1,0.0
15-241,1,0.0
Spin-echo,1,0.0
httprimedorgrimedicaljournal-2017-06asp,1,0.0
Chemo-radiotherapy-induced,1,0.0
reproductively,1,0.0
mink-to-humans,1,0.0
BD-2,1,0.0
Ar-3,1,0.0
misinterpret,1,0.0
non-aerosol-generating,1,0.0
high-severity,1,0.0
aerosol-based,1,0.0
commit,1,0.0
white-tailed,1,0.0
ferret-to-ferret,1,0.0
pumas,1,0.0
gorillas,1,0.0
zoos,1,0.0
animals-to-humans,1,0.0
3-m,1,0.0
CHA2DS2-VA,1,0.0
province-level,1,0.0
VVLSFELL,1,0.0
H-2Kb,1,0.0
BDushanbe66,1,0.0
BLeningrad67,1,0.0
A2Moscow2165,1,0.0
krasnodar,1,0.0
67-8,1,0.0
63-168,1,0.0
october,1,0.0
412-48,1,0.0
756-788,1,0.0
sex-less,1,0.0
current-season,1,0.0
RPF75,1,0.0
RPF50,1,0.0
Ceremony,1,0.0
n966,1,0.0
n289,1,0.0
n677,1,0.0
generalmild,1,0.0
exercised-induced,1,0.0
Hyperlipidemias,1,0.0
POSCH,1,0.0
45150,1,0.0
10129,1,0.0
sniffles,1,0.0
Complemented,1,0.0
adenosyncytial,1,0.0
AJohannesburg,1,0.0
nano-coatings,1,0.0
IΙIIΙ,1,0.0
lab-on-a-chip,1,0.0
3818,1,0.0
Dipeptidyl,1,0.0
Ishikawa,1,0.0
intraesophageal,1,0.0
pH-metry,1,0.0
Diminution,1,0.0
electromanometry,1,0.0
superesophageal,1,0.0
metoclopramide,1,0.0
cerucal,1,0.0
sphincters,1,0.0
x03B22,1,0.0
acronyms,1,0.0
lagophthalmos,1,0.0
Severe-Acute-Respiratory-Syndrom-Corona-Virus-2,1,0.0
resorption-necrotic,1,0.0
me-,1,0.0
110-120,1,0.0
cost-control,1,0.0
spec-,1,0.0
trometrymass,1,0.0
recrui-,1,0.0
ted,1,0.0
squares-discriminant,1,0.0
OPLS-DA,1,0.0
vari-,1,0.0
Metaboanalyst,1,0.0
stearic,1,0.0
creased,1,0.0
mino-malonic,1,0.0
tabolism,1,0.0
mat,1,0.0
oxalic,1,0.0
L-threonine,1,0.0
syn-,1,0.0
dromes,1,0.0
COVID-secure,1,0.0
ARWMC,1,0.0
17-month-old,1,0.0
health-risk,1,0.0
overran,1,0.0
Sur,1,0.0
domiciles,1,0.0
1879047,1,0.0
RMS-V,1,0.0
burden-of-disease,1,0.0
ST-R,1,0.0
roll-off,1,0.0
anaphylaxic,1,0.0
HLA-A6601,1,0.0
G1124V,1,0.0
B44,1,0.0
hypoxaemic,1,0.0
insecticidal,1,0.0
MERS-CoV20-24,1,0.0
1m,1,0.0
technetium-99m-glucoheptonate,1,0.0
AShanghai1187H3N2,1,0.0
nomographic,1,0.0
Marquardts,1,0.0
Compact,1,0.0
five-to-one,1,0.0
on-,1,0.0
redeploying,1,0.0
2-October,1,0.0
68913,1,0.0
10265,1,0.0
Fanggan,1,0.0
herb-component-target,1,0.0
multi-directional,1,0.0
target-pathway,1,0.0
onset-ie,1,0.0
threshold-up,1,0.0
carbon-13,1,0.0
wheezinginaudible,1,0.0
wheezing-like,1,0.0
FW,1,0.0
F99,1,0.0
HLA-B4403,1,0.0
HLA-B4402,1,0.0
real--,1,0.0
COVID19Speed-Antigen,1,0.0
specimen-to-answer,1,0.0
SARS-CoV-2Research,1,0.0
studyConclusions,1,0.0
Dimethylarginine,1,0.0
dimethylaminohydrolase,1,0.0
horn,1,0.0
suboptimum,1,0.0
LNP-encapsulated,1,0.0
novelvariant,1,0.0
dysorientation,1,0.0
Trans-thoracic,1,0.0
nonduplicated,1,0.0
tubes-containing,1,0.0
275046,1,0.0
Fleischner,1,0.0
Non-black,1,0.0
resonators,1,0.0
double-tuned,1,0.0
H23,1,0.0
birdcage,1,0.0
-weighting,1,0.0
Duplicate,1,0.0
ultraearly,1,0.0
Walsh,1,0.0
Teijaro,1,0.0
30-December,1,0.0
Arterio-venous,1,0.0
hoursday,1,0.0
Inadequately,1,0.0
radiologically-guided,1,0.0
mechanism--spontaneous,1,0.0
150-250,1,0.0
measurements-RMSV,1,0.0
HFAV-provide,1,0.0
metionin,1,0.0
glycosites,1,0.0
populationweek,1,0.0
Easing,1,0.0
non-Covid-19,1,0.0
locationThe,1,0.0
yearWith,1,0.0
costIt,1,0.0
nonadjacent,1,0.0
parameters--a,1,0.0
worsening--are,1,0.0
post-ECMO,1,0.0
27619,1,0.0
49-69,1,0.0
curve--AUC,1,0.0
variantshas,1,0.0
risk-structured,1,0.0
2-16,1,0.0
NK-cell,1,0.0
IFN-c,1,0.0
angiotension-converting,1,0.0
Transitions,1,0.0
87994,1,0.0
Hemiballismus,1,0.0
78-year,1,0.0
CoronaVAC,1,0.0
34-fold,1,0.0
unfiltered,1,0.0
IFN-based,1,0.0
character--lysis,1,0.0
aminoacidic,1,0.0
genotoxic,1,0.0
Cytosorbents®,1,0.0
3D-TOF,1,0.0
infarction-concomitant,1,0.0
Starling,1,0.0
S-glycoproteins,1,0.0
infectivitysusceptibility,1,0.0
Apropos,1,0.0
Arthritis,1,0.0
unidentifiable,1,0.0
disease-derived,1,0.0
privates,1,0.0
apprentices,1,0.0
juniors,1,0.0
HAC,1,0.0
yearsABSTRACT,1,0.0
monotonic,1,0.0
Heian,1,0.0
influenza--Asian,1,0.0
fluH2N2,1,0.0
determinating,1,0.0
confection,1,0.0
standardizations,1,0.0
Itabashi,1,0.0
mild-pandemic,1,0.0
atrial-aortic,1,0.0
ventricular-aortic,1,0.0
ONAP,1,0.0
myeloleucosis,1,0.0
10-120,1,0.0
229-574,1,0.0
153-246,1,0.0
AORs,1,0.0
semaglutide,1,0.0
Surely,1,0.0
35-4,1,0.0
P0DTD2,1,0.0
P0DTD3,1,0.0
QMEANDisCo,1,0.0
ProQ3,1,0.0
Tunnel,1,0.0
tunneling,1,0.0
Rises,1,0.0
≤38,1,0.0
preventor,1,0.0
8987,1,0.0
DScore,1,0.0
5817,1,0.0
-1029,1,0.0
-10156,1,0.0
-5196,1,0.0
-6436,1,0.0
-975,1,0.0
-5943,1,0.0
treatmentCommunicated,1,0.0
Bioelectric,1,0.0
Assay-based,1,0.0
pre-immobilized,1,0.0
biomatrix,1,0.0
ease-of-handle,1,0.0
plug-and-apply,1,0.0
substandard,1,0.0
non-insulin,1,0.0
683-988,1,0.0
832-100,1,0.0
holdbacks,1,0.0
stale,1,0.0
one-shot,1,0.0
metabolizers,1,0.0
GARNET,1,0.0
23-41,1,0.0
Image-guided,1,0.0
SPectral,1,0.0
Achieved,1,0.0
SPLASH,1,0.0
AH1N1swine,1,0.0
bi-criteria,1,0.0
demographically-structured,1,0.0
rata,1,0.0
fuming,1,0.0
6-pool,1,0.0
lesser-explored,1,0.0
411726,1,0.0
27406,1,0.0
141320,1,0.0
365406,1,0.0
292365,1,0.0
36365,1,0.0
clarifier,1,0.0
50-55,1,0.0
cross-shift,1,0.0
Speckle-tracking,1,0.0
insonation,1,0.0
homogeneous-mixing,1,0.0
Multidetector,1,0.0
r0614,1,0.0
posology,1,0.0
importance3-5,1,0.0
PMIS‐TS2,1,0.0
Zn2,1,0.0
metalloproteome,1,0.0
diffusively,1,0.0
decays,1,0.0
Lévy,1,0.0
algebraically,1,0.0
tails,1,0.0
two-parameter,1,0.0
Neurology®,1,0.0
Karch,1,0.0
Thomas1,1,0.0
34907,1,0.0
149632,1,0.0
101-120,1,0.0
Sixty-second,1,0.0
opposite-wall,1,0.0
5920,1,0.0
majorities,1,0.0
AH1N1AH1N1pdm09,1,0.0
Spasticity,1,0.0
µs,1,0.0
dynamometer,1,0.0
stepsmin,1,0.0
bio-pathology,1,0.0
PEF-monitor,1,0.0
Embodied,1,0.0
NO-exchange,1,0.0
virus12,1,0.0
unexplainably,1,0.0
perspective1,1,0.0
PMIS‐TS,1,0.0
Silzone,1,0.0
60240,1,0.0
10535,1,0.0
PCS9832,1,0.0
55120,1,0.0
50110,1,0.0
3590,1,0.0
18400,1,0.0
misclassify,1,0.0
Bobath,1,0.0
relearn,1,0.0
perio,1,0.0
demolition,1,0.0
four-stage,1,0.0
Silzone-coated,1,0.0
Multi‐system,1,0.0
Cytotoxicity,1,0.0
32-93,1,0.0
3-48,1,0.0
CT-verification,1,0.0
191-398,1,0.0
148-179,1,0.0
110-160,1,0.0
AnginaNon-ST-Elevation,1,0.0
Non-ST-Segment,1,0.0
agebirth,1,0.0
7-56,1,0.0
nebulous,1,0.0
Mallineni,1,0.0
20H,1,0.0
Mandela,1,0.0
time-periods,1,0.0
data-which,1,0.0
washroom,1,0.0
stifles,1,0.0
Myocarditis-related,1,0.0
factorConclusion,1,0.0
damageWhat,1,0.0
humans•,1,0.0
pandemicWhat,1,0.0
involvement•,1,0.0
APNs,1,0.0
Responsibilities,1,0.0
AbstractThe,1,0.0
formol-killed,1,0.0
MR-based,1,0.0
preconditioning-like,1,0.0
triphosphate-sensitive,1,0.0
antipreconditioning,1,0.0
075-011,1,0.0
071-011,1,0.0
midportion,1,0.0
clinically-diagnosed,1,0.0
N95P2,1,0.0
illnesslaboratory-confirmed,1,0.0
non-fit-tested,1,0.0
maskrespirator,1,0.0
2012-2015,1,0.0
2048380,1,0.0
1096663,1,0.0
Parametric,1,0.0
over-represent,1,0.0
1704,1,0.0
MEK12,1,0.0
transcription-1,1,0.0
B-Type,1,0.0
regions-suggest,1,0.0
escape6-8,1,0.0
Nonmotor,1,0.0
automating,1,0.0
LOINC,1,0.0
Identifiers,1,0.0
Names,1,0.0
httpsclamputheducovidloincphp,1,0.0
piling,1,0.0
Prof,1,0.0
Arnon,1,0.0
Multimeric-001,1,0.0
M-001,1,0.0
ischemia-time,1,0.0
FCepsilonR1,1,0.0
cine-,1,0.0
LE-,1,0.0
pain-to-balloon,1,0.0
pain-to-balloon-time,1,0.0
pa2000Mar5811-10,1,0.0
subendothelium,1,0.0
229E-infected,1,0.0
over-relying,1,0.0
Tyrosine,1,0.0
Lyn,1,0.0
Lck,1,0.0
ZAP-70,1,0.0
Btk,1,0.0
nation-wise,1,0.0
Nepali,1,0.0
6p211-6p213,1,0.0
23-50,1,0.0
psychovegetative,1,0.0
anxious-hypochondriac,1,0.0
BirdFlu2009,1,0.0
IVIgs,1,0.0
NEX-DAS-181,1,0.0
NexBio,1,0.0
MVA-NP-M1,1,0.0
10-360,1,0.0
index--a,1,0.0
disturbance--and,1,0.0
epimyocardium,1,0.0
postrepolarization,1,0.0
IntroductionWe,1,0.0
Malin,1,0.0
Srivastava,1,0.0
Secunderabad,1,0.0
1967--72,1,0.0
1969--70,1,0.0
279-287,1,0.0
on-reserve,1,0.0
515-fold,1,0.0
500-530,1,0.0
off-reserve,1,0.0
preventionmanagement,1,0.0
humane,1,0.0
extrac-tion-free,1,0.0
levelsObjectives,1,0.0
controlsMethods,1,0.0
≤4-weeks,1,0.0
polymer-coated,1,0.0
bioabsorbable,1,0.0
Neich,1,0.0
Urologic,1,0.0
Forelimb,1,0.0
fingertip,1,0.0
Phocine,1,0.0
PhHV-1,1,0.0
ischaemia-modified,1,0.0
limitedMethodology,1,0.0
double-centered,1,0.0
Ferritin,1,0.0
1lymphocyte,1,0.0
0671platelets,1,0.0
1-specificity,1,0.0
0001Conclusion,1,0.0
hemograms,1,0.0
activities-including,1,0.0
Orbus,1,0.0
training-was,1,0.0
G6-pdm,1,0.0
G7-pdm,1,0.0
G6,1,0.0
6C,1,0.0
6D,1,0.0
G7,1,0.0
cell-extracellular,1,0.0
long-lasing,1,0.0
Xin,1,0.0
Jiang,1,0.0
disease-model,1,0.0
Cura,1,0.0
61±12,1,0.0
60±11,1,0.0
PNIPH,1,0.0
pareticnon-paretic,1,0.0
rs12212740,1,0.0
factor-β1,1,0.0
agonistic,1,0.0
innately,1,0.0
hypermobile,1,0.0
fluid-like,1,0.0
solid-like,1,0.0
jammed,1,0.0
jamming,1,0.0
dysmature,1,0.0
17-48,1,0.0
≤49,1,0.0
68-93,1,0.0
PCV13,1,0.0
QuebecThe,1,0.0
next-gen,1,0.0
materials-transfer,1,0.0
preceed,1,0.0
34-aminoacid,1,0.0
noncleaved,1,0.0
NP56--NP53,1,0.0
Np,1,0.0
kidney-liver,1,0.0
108-1197,1,0.0
122-771,1,0.0
122-757,1,0.0
hour-delayed,1,0.0
radio-angiographic,1,0.0
semeiotics,1,0.0
PyRadiomics,1,0.0
HRCTs,1,0.0
nCOVID,1,0.0
FRS-S,1,0.0
non-dominantdominant,1,0.0
ULResults,1,0.0
6733,1,0.0
useday,1,0.0
0302,1,0.0
Paretic,1,0.0
8730,1,0.0
p002Conclusions,1,0.0
antimitochondrial,1,0.0
extrahepatic,1,0.0
non-caregivers,1,0.0
17-185,1,0.0
visitations,1,0.0
AHA∕ASA,1,0.0
disesase,1,0.0
percent-predicted,1,0.0
aerosol-infected,1,0.0
IVF-conceived,1,0.0
18-26,1,0.0
evidentiary,1,0.0
PIAH,1,0.0
Wuerzburg,1,0.0
includin,1,0.0
diagn,1,0.0
California0709,1,0.0
epidemic-originating,1,0.0
non-neutral,1,0.0
tipically,1,0.0
PMRFs,1,0.0
brilliantly,1,0.0
TNF-associated,1,0.0
2995,1,0.0
hypo-akinesia,1,0.0
Ansan,1,0.0
Membrane-associated,1,0.0
pycnosis,1,0.0
vacuolization,1,0.0
Leakage,1,0.0
Cytopathic,1,0.0
inflammationAHR,1,0.0
SARS-CoV-2-dengue,1,0.0
Parkland,1,0.0
cosyntropin,1,0.0
hypophysitis,1,0.0
Enigma®,1,0.0
FluAB-RSV,1,0.0
Porton,1,0.0
Salisbury,1,0.0
955-994,1,0.0
96-996,1,0.0
972-999,1,0.0
NAVIGATE-ESUS,1,0.0
Reduplication,1,0.0
7523,1,0.0
7224,1,0.0
Dander,1,0.0
IABP-treated,1,0.0
SARAS-CoV-2,1,0.0
9991-100,1,0.0
9979-100,1,0.0
nt28144,1,0.0
QRS-loop,1,0.0
pulsated,1,0.0
63-72,1,0.0
albifrons,1,0.0
LT-alpha-Ncol,1,0.0
LT-alpha-Ncol1,1,0.0
LT-alpha-Ncol2,1,0.0
testingIn,1,0.0
latterMajor,1,0.0
weals,1,0.0
Molin,1,0.0
1858,1,0.0
Filarioidea,1,0.0
parasitize,1,0.0
Sapajus,1,0.0
Spix,1,0.0
Cebus,1,0.0
1812,1,0.0
OMV,1,0.0
Cebidae,1,0.0
Yavarí-Mirín,1,0.0
cebids,1,0.0
papillae,1,0.0
DswineOklahoma13142011,1,0.0
DOK,1,0.0
seven-plasmid-based,1,0.0
RGS-derived,1,0.0
E697K,1,0.0
L462F,1,0.0
IDVIMPORTANCE,1,0.0
OMVs,1,0.0
patter,1,0.0
nt8782,1,0.0
2895,1,0.0
Apnoea,1,0.0
pre-thrombotic,1,0.0
microclimate,1,0.0
reflex-segmental,1,0.0
stepped-care,1,0.0
bronchospasmic,1,0.0
401-515,1,0.0
RBDS1,1,0.0
Freunds,1,0.0
oligodeoxinucleotideAlum,1,0.0
polyepitopic,1,0.0
C56BL6J,1,0.0
104-3,1,0.0
CD8T-cell,1,0.0
S-derived,1,0.0
446-488,1,0.0
Flushing,1,0.0
pushpull,1,0.0
point-of-dispensing,1,0.0
LAUNCH,1,0.0
VACCINATION,1,0.0
PROGRAM,1,0.0
Push,1,0.0
Pull,1,0.0
PushPull,1,0.0
Actin,1,0.0
288-330,1,0.0
Européen,1,0.0
Pompidou,1,0.0
health-workers,1,0.0
past-infections,1,0.0
decimetric,1,0.0
Staged,1,0.0
electroacupuncture,1,0.0
GSNO-mediated,1,0.0
004-094,1,0.0
006-091,1,0.0
005-085,1,0.0
004-093,1,0.0
003-087,1,0.0
clinical-anamnestical,1,0.0
boi,1,0.0
pick-flow,1,0.0
Recker,1,0.0
nNOS-originated,1,0.0
redox-modulating,1,0.0
S-nitrosoglutathione,1,0.0
GSNO,1,0.0
nNOSperoxynitrite-associated,1,0.0
2284,1,0.0
PPLATL,1,0.0
microbiome-immune,1,0.0
COVID-19-microbiome-immune,1,0.0
microbiome-related,1,0.0
efficacious-without,1,0.0
re-discuss,1,0.0
vaccine-naïve,1,0.0
semi-close,1,0.0
15-75,1,0.0
toughly,1,0.0
29226,1,0.0
40-76,1,0.0
Personal-level,1,0.0
Philips,1,0.0
Gyroscan,1,0.0
Teslacon,1,0.0
element-free,1,0.0
isochoric,1,0.0
child-child,1,0.0
child-adult,1,0.0
nonphysician,1,0.0
Prototypic,1,0.0
unelucidated,1,0.0
furanthril,1,0.0
cases--of,1,0.0
arenot,1,0.0
hyptonics,1,0.0
reckon,1,0.0
fire-damp,1,0.0
topographic-anatomic,1,0.0
borderlines,1,0.0
inexorably,1,0.0
community-representative,1,0.0
4-June,1,0.0
5125,1,0.0
seroprevalence-to-case,1,0.0
Rodents,1,0.0
nonhaemorrhagic,1,0.0
construe,1,0.0
specificity-and,1,0.0
C-were,1,0.0
¬V,1,0.0
disconfirms,1,0.0
httpsfuncoupsbcsuse,1,0.0
genesproteins,1,0.0
redundancy-weighted,1,0.0
Galerkin,1,0.0
invariant-based,1,0.0
inchoate,1,0.0
under-supply,1,0.0
institutionABSTRACT,1,0.0
SARS-CoV-2To,1,0.0
ACE2-Spike,1,0.0
HCAbs,1,0.0
Camelidae,1,0.0
Nanobodies,1,0.0
pulmologists´,1,0.0
Cronbach´s,1,0.0
Spearman´s,1,0.0
two-factorial,1,0.0
one-factor,1,0.0
case-test,1,0.0
1-OR×100,1,0.0
chromatography-multiple,1,0.0
monitoring-mass,1,0.0
LC-MRM-MS-based,1,0.0
rAspN,1,0.0
Gender-related,1,0.0
butcheries,1,0.0
kitchens,1,0.0
Pre-challenge,1,0.0
Replication-incompetent,1,0.0
V3SWG,1,0.0
3912,1,0.0
Ad26-targeting,1,0.0
Ad26ZEBOV,1,0.0
MVA-BN-Filo,1,0.0
sociomedical,1,0.0
invalidization,1,0.0
orthology,1,0.0
FunCoups,1,0.0
Noguchi,1,0.0
NMIMR,1,0.0
touristic,1,0.0
252-286,1,0.0
Choi,1,0.0
Logsdon,1,0.0
≈319,1,0.0
cell-intrinsic,1,0.0
Astragaloside,1,0.0
astragalus,1,0.0
H1N1-triggered,1,0.0
autolysosomes,1,0.0
multi-spectral,1,0.0
SAE,1,0.0
ISLES,1,0.0
0968,1,0.0
2571,1,0.0
3667,1,0.0
clinicomorphological,1,0.0
Hecin,1,0.0
non-inactive,1,0.0
LateTIME,1,0.0
moderate-to-large,1,0.0
CCTRN,1,0.0
cells-to-placebo,1,0.0
≤045,1,0.0
mid-right,1,0.0
Influenza-Associated,1,0.0
phosholipases,1,0.0
Geographically-close,1,0.0
geographically-distant,1,0.0
Gardena,1,0.0
2244,1,0.0
postdating,1,0.0
intra-subtype,1,0.0
Baxcaspases,1,0.0
BeclinLC3,1,0.0
attachmententry,1,0.0
assemblyrelease,1,0.0
products-based,1,0.0
BackgroundInfluenza,1,0.0
rationalising,1,0.0
interventionsAimTo,1,0.0
settingsMethodsWe,1,0.0
dataResultsCompared,1,0.0
7590,1,0.0
8490,1,0.0
S331R,1,0.0
community-circulating,1,0.0
phylogenetically-distinct,1,0.0
metagenomeConclusionNanopore,1,0.0
Helton,1,0.0
the-counter,1,0.0
lionized,1,0.0
sculpting,1,0.0
non-cooperation,1,0.0
schoolnursery,1,0.0
schoolsnurseries,1,0.0
semi-intensive,1,0.0
NAI-resistant,1,0.0
2-layer,1,0.0
superdominant,1,0.0
HO-13-14054,1,0.0
near-death,1,0.0
Carnegie,1,0.0
1300-bed,1,0.0
methylprednisone,1,0.0
IDDs,1,0.0
last-mile,1,0.0
ultra-deep,1,0.0
gestational-age,1,0.0
hereditarycongenital,1,0.0
psychologicalemotional,1,0.0
conjoined,1,0.0
stratified-cluster-random,1,0.0
greenhouses,1,0.0
5420,1,0.0
10405420,1,0.0
103-149,1,0.0
109-144,1,0.0
planting,1,0.0
087-098,1,0.0
sidewall,1,0.0
069-096,1,0.0
073-099,1,0.0
043-084,1,0.0
1997-2001,1,0.0
42806,1,0.0
p-PCI,1,0.0
rosewood,1,0.0
joiner,1,0.0
sanded,1,0.0
polished,1,0.0
well-chosen,1,0.0
4901,1,0.0
1925105,1,0.0
ARAA,1,0.0
location-based,1,0.0
Susceptible-Latent-Infected-Recovered,1,0.0
group-successful,1,0.0
diaphragms,1,0.0
four-centre,1,0.0
3-37,1,0.0
days-53,1,0.0
neo-vascularization,1,0.0
days-23,1,0.0
131-372,1,0.0
2·2,1,0.0
14·6,1,0.0
41·3,1,0.0
23·6,1,0.0
4·0,1,0.0
0·3-7·6,1,0.0
storm-triggered,1,0.0
commendation,1,0.0
well-based,1,0.0
QiuckVue,1,0.0
Eosinophil-mediated,1,0.0
TFSO,1,0.0
deteoriorating,1,0.0
re-configured,1,0.0
easy-to-adapt,1,0.0
bronchial-airway-on-a-chip,1,0.0
bronchial-airway,1,0.0
airway-on-a-chip,1,0.0
bicaudate,1,0.0
proceduresThe,1,0.0
FFP2FFP3,1,0.0
bradyphrenia,1,0.0
miracle,1,0.0
medical-alone,1,0.0
territorywide,1,0.0
9811,1,0.0
9866,1,0.0
9726,1,0.0
Overweightobese,1,0.0
hypocoagulatory,1,0.0
Danang,1,0.0
39-56,1,0.0
60-240,1,0.0
minweek,1,0.0
30-150,1,0.0
fromCOVID-19,1,0.0
Granulocyte-colony,1,0.0
chainschannels,1,0.0
time-scaled,1,0.0
patientsviral,1,0.0
co-admission,1,0.0
isolatespatients,1,0.0
non-molecular,1,0.0
teasing,1,0.0
January-October,1,0.0
1535982,1,0.0
Klüver-Bucy,1,0.0
PVG,1,0.0
Ventroposterolateral,1,0.0
nucleus-VPL,1,0.0
McGills,1,0.0
NCT00469248,1,0.0
dyn,1,0.0
prognosis-validated,1,0.0
MosMedData,1,0.0
predator,1,0.0
metaheuristic,1,0.0
HuH7,1,0.0
cold-causing,1,0.0
Xiaochuangao,1,0.0
XAP,1,0.0
cyclodextrin-soluble,1,0.0
244000,1,0.0
nonimmunostimulatory,1,0.0
atheroprotective,1,0.0
CD163low,1,0.0
CD163high-Reflow,1,0.0
CD163low-Reflow,1,0.0
-049,1,0.0
bisbenzylisoquinoline,1,0.0
HEK293hACE2,1,0.0
N501YD614G,1,0.0
non-O-wave,1,0.0
501YV3,1,0.0
013-041,1,0.0
-dependent,1,0.0
pan-coronaviruses,1,0.0
sixty-eight,1,0.0
OSCE,1,0.0
Tyneside,1,0.0
variable--heart,1,0.0
partioning,1,0.0
PKR-mediated,1,0.0
enhanceosome,1,0.0
antagomiR,1,0.0
cotreatment,1,0.0
8860,1,0.0
CAMARADES,1,0.0
Trim-and-fill,1,0.0
dEfiniTion,1,0.0
Orientgene,1,0.0
asphixy,1,0.0
andperiwall,1,0.0
erythrocyte-rich,1,0.0
ferulas,1,0.0
vascular-type,1,0.0
postmyocarditic,1,0.0
membranotoxic,1,0.0
T7-phage,1,0.0
coiled-body,1,0.0
1NOLC1,1,0.0
His-pull-down,1,0.0
co-immunoprecipitation,1,0.0
Catalonian,1,0.0
meat-processing,1,0.0
segregating,1,0.0
2000-03,1,0.0
empiricism,1,0.0
Patient-provider,1,0.0
Guidelines-based,1,0.0
1959-73,1,0.0
northern-hemisphere,1,0.0
half-saturated,1,0.0
LDLHDL,1,0.0
15x,1,0.0
RNV-LVEF,1,0.0
motion-derived,1,0.0
nonstandardized,1,0.0
investigatedThe,1,0.0
Genrui,1,0.0
Zheihang,1,0.0
bioaccumulation,1,0.0
negative-predictive,1,0.0
interferometry,1,0.0
BLI,1,0.0
HEK293T-ACE2,1,0.0
52-year,1,0.0
Worksites,1,0.0
nonresidential,1,0.0
2020‒September,1,0.0
hard-metal-induced,1,0.0
22-September,1,0.0
reliever-only,1,0.0
past-year,1,0.0
nephelometric-based,1,0.0
positive-predictive,1,0.0
Cas-9,1,0.0
T-1824,1,0.0
2000-2009,1,0.0
Noncommunicable,1,0.0
therafter,1,0.0
Plata,1,0.0
biomaterial-based,1,0.0
psycho-clinical,1,0.0
function-based,1,0.0
under-study,1,0.0
steroid-requiring,1,0.0
age-predicted,1,0.0
sensitivityABSTRACT,1,0.0
133Xenon,1,0.0
indulant,1,0.0
INfarction,1,0.0
J-MINUET,1,0.0
AlphaLISA,1,0.0
angiographyPre-procedural,1,0.0
psychoneurogenic,1,0.0
infero-dorsal,1,0.0
EC-Graphic,1,0.0
22WABSTRACT,1,0.0
per-country,1,0.0
54357,1,0.0
DiaSorinThe,1,0.0
37-40,1,0.0
46-52,1,0.0
70-86,1,0.0
prevalence-to-incidence,1,0.0
45-157,1,0.0
CoPanFlu-Mali,1,0.0
Dioro,1,0.0
≥180,1,0.0
124-149,1,0.0
0-19-year,1,0.0
160-184,1,0.0
fruitless,1,0.0
consternation,1,0.0
single-disease,1,0.0
Bilirubin,1,0.0
Epi,1,0.0
oxyfedrine,1,0.0
fibrinogenic,1,0.0
mgkg-1d-1,1,0.0
Zooming,1,0.0
ΔCT,1,0.0
-6713,1,0.0
domineering,1,0.0
psychomatic,1,0.0
Arab-speaking,1,0.0
l-1,1,0.0
flowAntiplatelet,1,0.0
nonrecognition,1,0.0
patientsTaiwanese,1,0.0
methodThere,1,0.0
Dan,1,0.0
Xiong,1,0.0
03-fold,1,0.0
treatmentIHD,1,0.0
Lacunar-type,1,0.0
Macaque,1,0.0
extra-systole,1,0.0
201-400,1,0.0
401-800,1,0.0
CK-group,1,0.0
immune-efficacy,1,0.0
ST-changes,1,0.0
satisfactoryABSTRACT,1,0.0
nephelometric,1,0.0
Nowhere,1,0.0
CrRNAs,1,0.0
LFB,1,0.0
nonpositive,1,0.0
nonbypassed,1,0.0
graftABSTRACT,1,0.0
8060,1,0.0
celery,1,0.0
2423,1,0.0
AH1N1-induced,1,0.0
biolayer,1,0.0
pulldown,1,0.0
submolecular,1,0.0
coresidents,1,0.0
promise8,1,0.0
COVID-19910,1,0.0
UK11,1,0.0
Africa12,1,0.0
94-fold,1,0.0
103-124-fold,1,0.0
variants1314,1,0.0
counsellors,1,0.0
transmission--the,1,0.0
bottleneck--is,1,0.0
profileefficiency,1,0.0
VATT,1,0.0
identificationexclusion,1,0.0
PF4-ELISA,1,0.0
valerianate,1,0.0
camphor,1,0.0
Primitive,1,0.0
anti-pneumococcal,1,0.0
intraorganelle,1,0.0
ketitofen,1,0.0
RBs,1,0.0
0-073,1,0.0
009-056,1,0.0
024-106,1,0.0
023-084,1,0.0
accentuating,1,0.0
U0126,1,0.0
SB239063,1,0.0
p38alpha,1,0.0
development4-7,1,0.0
authorization1-3,1,0.0
poludanum,1,0.0
XXFXXM,1,0.0
besieged,1,0.0
unearthed,1,0.0
suburbanization,1,0.0
Community-Led,1,0.0
CLTS,1,0.0
0303,1,0.0
expediate,1,0.0
red-blood-cell,1,0.0
bed-care,1,0.0
cardiomiocytes,1,0.0
Genotype,1,0.0
Sry,1,0.0
XYwt,1,0.0
XYFXYM,1,0.0
LENS,1,0.0
reexposed,1,0.0
≈82,1,0.0
≈8400-12600,1,0.0
Pandemic-level,1,0.0
2795,1,0.0
746-180,1,0.0
176-643,1,0.0
core-not-too-large,1,0.0
13-3378,1,0.0
036-9529,1,0.0
core-clinical,1,0.0
double-blinding,1,0.0
-09,1,0.0
SP600125,1,0.0
hyporeactivity,1,0.0
featuresHere,1,0.0
Bach2-deficient,1,0.0
1-piperoylpiperidine,1,0.0
π-π,1,0.0
glucuronidation,1,0.0
HLA-DQ,1,0.0
gluten,1,0.0
SLEwho,1,0.0
perfusionist,1,0.0
least-cost,1,0.0
waterbird,1,0.0
human-mediated,1,0.0
cyber,1,0.0
r098,1,0.0
r043,1,0.0
37778,1,0.0
004-013,1,0.0
h24,1,0.0
under-equipped,1,0.0
single-hit,1,0.0
Ethnopharmacology,1,0.0
Alpinia,1,0.0
zerumbet,1,0.0
antihyperthyroidal,1,0.0
demoralisation,1,0.0
wide‐spread,1,0.0
malnutrition-induced,1,0.0
malnutrition-linked,1,0.0
4-72,1,0.0
Co-diagnosis,1,0.0
phenotypeThe,1,0.0
nigrum,1,0.0
Piper,1,0.0
kick-off,1,0.0
shallower,1,0.0
11872,1,0.0
looked-for,1,0.0
25-years,1,0.0
want--less,1,0.0
196-250,1,0.0
258-320,1,0.0
214-266,1,0.0
239-291,1,0.0
thirty-day,1,0.0
26-36,1,0.0
S816-G838,1,0.0
D839-F855,1,0.0
helix-turn-helix,1,0.0
Fine-needle,1,0.0
41-67,1,0.0
80-yr-old,1,0.0
genus-,1,0.0
species-specificity,1,0.0
cross-talking,1,0.0
KSMC,1,0.0
cross-exploration,1,0.0
minoritized,1,0.0
Transgender,1,0.0
bisexualpansexual,1,0.0
gaylesbian,1,0.0
Generic,1,0.0
Twentieth,1,0.0
Convenience,1,0.0
Diaphragms,1,0.0
score-based,1,0.0
stromelysin-1,1,0.0
Zoom®,1,0.0
Fetuin-A,1,0.0
fetuin-A,1,0.0
SEAIC,1,0.0
SEMERGEN,1,0.0
semFYC,1,0.0
SEMG,1,0.0
immunosuppressors,1,0.0
Viehmann-Wical,1,0.0
2021172355,1,0.0
vaccination-based,1,0.0
Etiopathogenesis,1,0.0
Livedo,1,0.0
antiplateletantithrombotic,1,0.0
4165,1,0.0
Transapical,1,0.0
METHOD,1,0.0
Brunnstrom,1,0.0
faktors,1,0.0
based-diagnosis,1,0.0
FNCAS9,1,0.0
editor-limited,1,0.0
Nonreplicating,1,0.0
clinal,1,0.0
frontrunning,1,0.0
Clickhaler,1,0.0
Innovata,1,0.0
Biomed,1,0.0
Albans,1,0.0
PIFs,1,0.0
Interatrial,1,0.0
Mers,1,0.0
deepnets,1,0.0
ERIC,1,0.0
férfi,1,0.0
nő,1,0.0
felvételre,1,0.0
életkorra,1,0.0
lakosra,1,0.0
vetített,1,0.0
prevalencia,1,0.0
20854,1,0.0
12961,1,0.0
eloszlást,1,0.0
tekintve,1,0.0
abszolút,1,0.0
felettiek,1,0.0
kivételével,1,0.0
korcsoportban,1,0.0
meghaladta,1,0.0
nőkét,1,0.0
igénybevétele,1,0.0
bizonyult,1,0.0
legfőbb,1,0.0
költségtényezőnek,1,0.0
162Suppl,1,0.0
Unloading,1,0.0
hypokinesia--the,1,0.0
allochiria--the,1,0.0
misperceives,1,0.0
EZs,1,0.0
allochiria,1,0.0
presential,1,0.0
deaggregate,1,0.0
micronized,1,0.0
6-years,1,0.0
non-suddenly,1,0.0
SARS-CoV-2-encoding,1,0.0
postcoronavirus,1,0.0
adjutant,1,0.0
Rachiplusia,1,0.0
nu,1,0.0
Suicide,1,0.0
hospital-stage,1,0.0
13·8,1,0.0
4·5,1,0.0
age-weighted,1,0.0
51·4,1,0.0
populationAreas,1,0.0
strategiesExpert,1,0.0
booster-dose,1,0.0
65-15,1,0.0
SerionVirion,1,0.0
Passing-Bablok,1,0.0
6197,1,0.0
reinterpreting,1,0.0
self-participation,1,0.0
interspersing,1,0.0
Subset,1,0.0
Prothrombin,1,0.0
10-years,1,0.0
health-gains,1,0.0
cost-offsets,1,0.0
Amplitude,1,0.0
lightday,1,0.0
photoperiod,1,0.0
Receptor-Binding,1,0.0
fully-closed,1,0.0
Pangolin-CoV,1,0.0
factors--elevated,1,0.0
CH5,1,0.0
Jogging,1,0.0
00651,1,0.0
71152,1,0.0
4597,1,0.0
5286,1,0.0
3333,1,0.0
inflammatory-fibroproliferative,1,0.0
134100000,1,0.0
12-sample,1,0.0
Progetto,1,0.0
CUORE,1,0.0
1983-2002,1,0.0
cholesterolhigh,1,0.0
Pangolin-CoVs,1,0.0
ratio--related,1,0.0
Population-wide,1,0.0
1996-January,1,0.0
non-anginous,1,0.0
46-60,1,0.0
eudaimonic,1,0.0
Investigated,1,0.0
2548,1,0.0
Grays,1,0.0
Dyads,1,0.0
sideline,1,0.0
plan-do-study-act,1,0.0
PDSA,1,0.0
9742,1,0.0
fő,1,0.0
belül,1,0.0
viperin-expressing,1,0.0
ethiopathogenese,1,0.0
therapeutists,1,0.0
psychotherapeutists,1,0.0
strokeObjective,1,0.0
BioRescue,1,0.0
Bosnia-Herzegovina,1,0.0
Supposedly,1,0.0
PresbyterianWeill,1,0.0
doctorally,1,0.0
fellowship-trained,1,0.0
CD4CD25,1,0.0
disproved,1,0.0
arboviral,1,0.0
domain-targeting,1,0.0
isotype-independent,1,0.0
Ramifications,1,0.0
Scarcely,1,0.0
1639,1,0.0
Above-normal,1,0.0
softer,1,0.0
tromethaminetrometamol,1,0.0
viricidal,1,0.0
povidone-iodine,1,0.0
99026,1,0.0
transmissibility†§,1,0.0
geographically¶,1,0.0
Named,1,0.0
B1351††,1,0.0
16-23,1,0.0
92--47,1,0.0
differenet,1,0.0
Neuro-psychical,1,0.0
assent,1,0.0
MMP3,1,0.0
self-patients,1,0.0
148067,1,0.0
4096,1,0.0
SIVswas,1,0.0
LuxembourgSera,1,0.0
inhibitionHI,1,0.0
antibodiestitre,1,0.0
H3N2SIV,1,0.0
ancestorsAVictoria375,1,0.0
Interleukin-5,1,0.0
rate692,1,0.0
soliciting,1,0.0
elevated-ST,1,0.0
exacerating,1,0.0
atherothrombogenesis,1,0.0
37213,1,0.0
hyperspatial,1,0.0
prequisite,1,0.0
dBs,1,0.0
IranDoc,1,0.0
RICeST,1,0.0
SID,1,0.0
Tau2,1,0.0
terpenes,1,0.0
benzoquinones,1,0.0
Estimator,1,0.0
RRE-90,1,0.0
IFN-inducible,1,0.0
AWSN33H1N1,1,0.0
keretén,1,0.0
viperin-knockout,1,0.0
jutó,1,0.0
prevalenciát,1,0.0
kiadásokat,1,0.0
korcsoportos,1,0.0
bontásban,1,0.0
egyes,1,0.0
típusokra,1,0.0
szívinfarktust,1,0.0
Betegségek,1,0.0
Nemzetközi,1,0.0
Osztályozásának,1,0.0
revíziója,1,0.0
I21-es,1,0.0
kódcsoporttal,1,0.0
azonosítottuk,1,0.0
szívinfarktusra,1,0.0
fordított,1,0.0
kiadása,1,0.0
61902,1,0.0
52463,1,0.0
2018-ban,1,0.0
kiadás,1,0.0
958-át,1,0.0
költségei,1,0.0
16032,1,0.0
59321,1,0.0
50276,1,0.0
képezték,1,0.0
ezen,1,0.0
főre,1,0.0
tekintetében,1,0.0
rendelkező,1,0.0
felelősek,1,0.0
viperin-deficient,1,0.0
szív-,1,0.0
érrendszeri,1,0.0
vezető,1,0.0
halálokok,1,0.0
szerepelnek,1,0.0
világszerte,1,0.0
összes,1,0.0
egyharmadáért,1,0.0
európai,1,0.0
halálozások,1,0.0
közel,1,0.0
feléért,1,0.0
Vizsgálatunk,1,0.0
kiadással,1,0.0
betegségteher,1,0.0
Adatok,1,0.0
módszerek,1,0.0
Adataink,1,0.0
Egészségbiztosítási,1,0.0
Alapkezelő,1,0.0
finanszírozási,1,0.0
adatbázisából,1,0.0
származnak,1,0.0
2018-as,1,0.0
évre,1,0.0
Meghatároztuk,1,0.0
betegszámokat,1,0.0
CAichi181,1,0.0
CMississippi80,1,0.0
T1-oligonucleotide,1,0.0
3565-15516,1,0.0
agnostically,1,0.0
Watchman™,1,0.0
amoeboid,1,0.0
glias,1,0.0
35800,1,0.0
0221-462,1,0.0
nucleotidic,1,0.0
3UTRs,1,0.0
CpG-loss-associated,1,0.0
transition-transversion,1,0.0
13NH13-PET,1,0.0
SI-upslopeglobal,1,0.0
-372-275,1,0.0
flowLV,1,0.0
Cic4,1,0.0
azide,1,0.0
Cic6,1,0.0
chloro,1,0.0
22-68,1,0.0
1-17-year,1,0.0
Insects,1,0.0
habited,1,0.0
synchronicity,1,0.0
New-York,1,0.0
8858,1,0.0
abnormalitiesABSTRACT,1,0.0
circumventing,1,0.0
transcription-plymerase,1,0.0
ΔΔCt,1,0.0
Affair,1,0.0
or70,1,0.0
statin-pretreatment,1,0.0
NYMC,1,0.0
non-ESUS,1,0.0
105-318,1,0.0
acupunture,1,0.0
pyschologic,1,0.0
LYS-Pro,1,0.0
113-116,1,0.0
resequenced,1,0.0
Ser249Pro,1,0.0
disease-association,1,0.0
016-087,1,0.0
hacking,1,0.0
1964-1965,1,0.0
15μg,1,0.0
X-179AH1N1,1,0.0
121-166,1,0.0
Greenflu-S™,1,0.0
87699097,1,0.0
579097,1,0.0
610-915,1,0.0
528-931,1,0.0
deleting,1,0.0
754-933,1,0.0
penalizing,1,0.0
West-African,1,0.0
compels,1,0.0
125-202,1,0.0
075-170,1,0.0
0565,1,0.0
2-∆∆Ct,1,0.0
425-489,1,0.0
stroke-were,1,0.0
copiestest,1,0.0
sharpen,1,0.0
Rich,1,0.0
SDG,1,0.0
gasping,1,0.0
relegates,1,0.0
down-to-up,1,0.0
highest-effect,1,0.0
preidentifying,1,0.0
time-lagged,1,0.0
tICA,1,0.0
Residues,1,0.0
distant-but-conserved,1,0.0
greately,1,0.0
WRA-like,1,0.0
in-bore,1,0.0
ADC-derived,1,0.0
spatiotemporally,1,0.0
417-778,1,0.0
10-unit,1,0.0
019-072,1,0.0
016-076,1,0.0
072-109,1,0.0
091-167,1,0.0
Phet0047,1,0.0
Nucleotide-binding,1,0.0
leucine-rich-containing,1,0.0
domain-containing-3,1,0.0
22182,1,0.0
Anomaly,1,0.0
alkanes,1,0.0
010-026,1,0.0
307-1121,1,0.0
fantastic,1,0.0
31384,1,0.0
-150,1,0.0
2532-15542,1,0.0
140-219,1,0.0
understandingsexperiences,1,0.0
Mindful,1,0.0
discursively,1,0.0
Attentive,1,0.0
Guardwire,1,0.0
9406,1,0.0
nonREM,1,0.0
SDCA,1,0.0
Ewings,1,0.0
voyage,1,0.0
159-1533,1,0.0
MacKenzie,1,0.0
Scherf,1,0.0
apologize,1,0.0
I290,1,0.0
recensed,1,0.0
2563,1,0.0
1827,1,0.0
fration,1,0.0
Ile,1,0.0
LL-37,1,0.0
Ck,1,0.0
EDTA-plasma,1,0.0
PRISMA-oriented,1,0.0
outpouching,1,0.0
INTERRSeCT-a,1,0.0
19881990,1,0.0
142-202,1,0.0
insignificance,1,0.0
pR71H,1,0.0
pP885S,1,0.0
DExDH-box,1,0.0
DDX58,1,0.0
Comilla,1,0.0
601AM-1200PM,1,0.0
33-93,1,0.0
primary-stroke,1,0.0
4775,1,0.0
VUI-NP13L-like,1,0.0
B191,1,0.0
cavitate,1,0.0
-ae,1,0.0
diminutive,1,0.0
lacus,1,0.0
Escalation,1,0.0
Year-round,1,0.0
magazine,1,0.0
shoud,1,0.0
Dimethyl,1,0.0
fumarate,1,0.0
DMF,1,0.0
neuro-protective,1,0.0
Diffusion-weightedimaging-fluid-attenuated,1,0.0
FLAIR-mismatch,1,0.0
llama-derived,1,0.0
5035,1,0.0
110-152,1,0.0
15416,1,0.0
18002359,1,0.0
12001759,1,0.0
507102,1,0.0
CMiyagi391,1,0.0
CMiyagi991,1,0.0
CMiyagi292,1,0.0
19801989,1,0.0
19811982,1,0.0
propertiesThe,1,0.0
Sepsis-Related,1,0.0
qSOFA,1,0.0
pLOS,1,0.0
1216285,1,0.0
31844,1,0.0
11957,1,0.0
57197,1,0.0
75790,1,0.0
06001159,1,0.0
27181,1,0.0
140876,1,0.0
3128,1,0.0
multi-transfused,1,0.0
barbers,1,0.0
10033000,1,0.0
single-epidemic,1,0.0
20685,1,0.0
19915,1,0.0
11339,1,0.0
8576,1,0.0
morning-dominant,1,0.0
00000559,1,0.0
118-166,1,0.0
169-243,1,0.0
4-log10,1,0.0
141-247,1,0.0
Shariati,1,0.0
bottles,1,0.0
asthma--use,1,0.0
bronchodilators--is,1,0.0
videofluroscopy,1,0.0
Neurogastroenterology,1,0.0
Motility,1,0.0
coder,1,0.0
arbitration,1,0.0
supervisor,1,0.0
preprocessed,1,0.0
non-infarcts,1,0.0
2444,1,0.0
35954,1,0.0
pronouncements,1,0.0
quests,1,0.0
social-based,1,0.0
bad-risk,1,0.0
non-concave,1,0.0
anti-T,1,0.0
plt001,1,0.0
epoch,1,0.0
time-intensive,1,0.0
melding,1,0.0
039-216,1,0.0
021-130,1,0.0
Massachussets,1,0.0
Rya,1,0.0
Göta,1,0.0
groupsexaminations,1,0.0
kilometres,1,0.0
PRAGUE-1,1,0.0
074-146,1,0.0
141-254,1,0.0
047-094,1,0.0
043-089,1,0.0
hyperintensitiy,1,0.0
123-318,1,0.0
109-240,1,0.0
Zabrze,1,0.0
analysers,1,0.0
OxCGRT,1,0.0
reimposition,1,0.0
self-capacity,1,0.0
074-157,1,0.0
058-145,1,0.0
stigmata,1,0.0
52217430,1,0.0
Hallingdal,1,0.0
Out-of-hours,1,0.0
remote-controlled,1,0.0
telemedicine-based,1,0.0
99Tc-HMPAO-labelled,1,0.0
over-the-wire,1,0.0
no-perfusion,1,0.0
transcoronary-applied,1,0.0
IslandMethods,1,0.0
oversampled,1,0.0
modeResults,1,0.0
31Conclusions,1,0.0
n79808293,1,0.0
womenmen,1,0.0
MRR,1,0.0
14118,1,0.0
gene-a,1,0.0
Baür,1,0.0
Bernstein,1,0.0
Intal-nasal--20,1,0.0
mg--in,1,0.0
Becotide--400,1,0.0
microgram--only,1,0.0
Dithiaden,1,0.0
RLO,1,0.0
144150,1,0.0
149150,1,0.0
SARS-CoV-2-SP-IgM,1,0.0
Swahili-speaking,1,0.0
conveyor,1,0.0
stoppers,1,0.0
dioctyl,1,0.0
households-of-people,1,0.0
29707,1,0.0
wiped,1,0.0
combinative,1,0.0
lipomaliposarcoma,1,0.0
self-designed,1,0.0
HAMD,1,0.0
paradigm-shifting,1,0.0
gt90,1,0.0
sub-questions,1,0.0
poisonous,1,0.0
gastroesophagography,1,0.0
scintiscanning,1,0.0
HAPN,1,0.0
evolution-by,1,0.0
recombinant-type,1,0.0
AktNF-kappaB,1,0.0
neuroangiographic,1,0.0
angiotensin-,1,0.0
FSH,1,0.0
Follicle,1,0.0
FYVE,1,0.0
Coiled-Coil,1,0.0
Adaptor,1,0.0
IFFS,1,0.0
Luteinizing,1,0.0
Leucine,1,0.0
Zipper,1,0.0
REDa,1,0.0
Reversetrascriptase,1,0.0
Solute,1,0.0
Carrier,1,0.0
Molecule,1,0.0
Testosterone,1,0.0
X-C,1,0.0
8244,1,0.0
alcohol-related,1,0.0
6078,1,0.0
pancreaticobiliary,1,0.0
sensity,1,0.0
MethecholoneMTCH,1,0.0
MTCH,1,0.0
25-54,1,0.0
26-607,1,0.0
558-831,1,0.0
629-983,1,0.0
-877,1,0.0
LAPN,1,0.0
Coronovideae,1,0.0
polymerization,1,0.0
Dressing,1,0.0
9308,1,0.0
off-set,1,0.0
cost-conscious,1,0.0
49135-141,1,0.0
lacquers,1,0.0
Peak-flow,1,0.0
SUVA,1,0.0
neuropharmacologic,1,0.0
Cuyahoga,1,0.0
redesigning,1,0.0
ganglias,1,0.0
semiovale,1,0.0
lenticulo-striatum,1,0.0
hemo-dynamically,1,0.0
heightens,1,0.0
eight-wk,1,0.0
8-39,1,0.0
andaffects,1,0.0
ofpregnancy,1,0.0
obstetricalcomplications,1,0.0
mostlyeither,1,0.0
non-complianceThe,1,0.0
DSM-IV-TR,1,0.0
4100-9,1,0.0
courseofacute,1,0.0
wereobserved,1,0.0
3325,1,0.0
non-RBBB,1,0.0
Sirtuins,1,0.0
12914,1,0.0
5939,1,0.0
13938,1,0.0
Caledonia20,1,0.0
≥44,1,0.0
≥07,1,0.0
44-point,1,0.0
pat,1,0.0
well-visit,1,0.0
Vaud,1,0.0
Fribourg,1,0.0
MONI-toring,1,0.0
timeABSTRACT,1,0.0
Locum,1,0.0
zeniths,1,0.0
136732,1,0.0
AWisconsin672005H3N2-like,1,0.0
99H1N1-like,1,0.0
7346,1,0.0
clinically-related,1,0.0
immune-differentiation,1,0.0
sub-typestrain,1,0.0
orthomxoviruses,1,0.0
9·01,1,0.0
Laotians,1,0.0
Streptoccocus,1,0.0
K16,1,0.0
anti-aggregate,1,0.0
11818,1,0.0
3377,1,0.0
9723,1,0.0
8661,1,0.0
unfoldsAbbreviations,1,0.0
reassuranceencouragement,1,0.0
Readjustment,1,0.0
mistargeting,1,0.0
neutrons,1,0.0
IgM-,1,0.0
caridopulmonary,1,0.0
Preemptive,1,0.0
joined-up,1,0.0
paramyxoviral,1,0.0
DiaSorin®,1,0.0
Euroimmun®,1,0.0
revaccinated,1,0.0
BHarbin,1,0.0
all-language,1,0.0
1271,1,0.0
Kerosene,1,0.0
Protein3M-052-SE,1,0.0
Protein-3M-052-SE,1,0.0
typesMethods,1,0.0
ResultsWe,1,0.0
7198,1,0.0
40-74,1,0.0
Nonfasting,1,0.0
78-110,1,0.0
beckon,1,0.0
rethrombus,1,0.0
AsthmaGlobal,1,0.0
non-specifically,1,0.0
optogenetics,1,0.0
growth-promoting,1,0.0
optogenetic,1,0.0
Optogenetically,1,0.0
olivary,1,0.0
heterotopias,1,0.0
forking,1,0.0
Axis,1,0.0
NCT03700853,1,0.0
consensual-,1,0.0
SLTs,1,0.0
625-78,1,0.0
Middlemore,1,0.0
anatomo-histopathological,1,0.0
reddish,1,0.0
S247N,1,0.0
tri-border,1,0.0
semi-logical,1,0.0
Charpin,1,0.0
bronchospasmodic,1,0.0
Fever-related,1,0.0
Immunizing,1,0.0
aqueduct,1,0.0
235000,1,0.0
mixed-design,1,0.0
13653,1,0.0
Linköping,1,0.0
10-99,1,0.0
crafts,1,0.0
dustiness,1,0.0
Rank,1,0.0
absencerestriction,1,0.0
intraerythrocytic,1,0.0
STem,1,0.0
NeuroloGy,1,0.0
STARTING,1,0.0
optogenetically,1,0.0
18mm,1,0.0
n275,1,0.0
haemoperitoneum,1,0.0
acetylsalicylate,1,0.0
Haute-garonne,1,0.0
one-compartment,1,0.0
37-107,1,0.0
46-303,1,0.0
diformazan,1,0.0
monogormazan,1,0.0
corpse,1,0.0
embolichemorrhagic,1,0.0
site-,1,0.0
pre-transplant,1,0.0
PubMedgov,1,0.0
dually-labeled,1,0.0
immunomagnetic,1,0.0
kilovoltage,1,0.0
air-soft,1,0.0
pulmonary-soft,1,0.0
pleural-azygos-esophageal,1,0.0
rs17216473,1,0.0
ViruSurf,1,0.0
multi-FASTA,1,0.0
CSV,1,0.0
Pages,1,0.0
zooming,1,0.0
severityvirulence,1,0.0
light-weight,1,0.0
httpgmqleuvirusviz,1,0.0
1456,1,0.0
1942,1,0.0
Backgound,1,0.0
Accountability,1,0.0
Portability,1,0.0
117-541,1,0.0
Minnesotans,1,0.0
Oppositional,1,0.0
Defiant,1,0.0
Deficit,1,0.0
centerChildrens,1,0.0
CenterinTehran,1,0.0
2017With,1,0.0
Disorders-IV,1,0.0
withsignificant,1,0.0
thecase,1,0.0
p08,1,0.0
attention-deficit,1,0.0
140-474,1,0.0
fighter,1,0.0
squatter,1,0.0
ICI-treated,1,0.0
Refining,1,0.0
exposomics,1,0.0
Phytohaemagglutinin,1,0.0
Preselected,1,0.0
September-mid-October,1,0.0
hepatopathy,1,0.0
apoprotein,1,0.0
biting,1,0.0
dispense,1,0.0
furtherance,1,0.0
well-reproducible,1,0.0
swine-variant,1,0.0
Sirtuin,1,0.0
sirtuins,1,0.0
MRRunadjusted,1,0.0
Trouillas,1,0.0
neurolysin,1,0.0
Agaricoglyceride,1,0.0
overexpress,1,0.0
catalytically,1,0.0
Over-expression,1,0.0
expiration-to-inspiration,1,0.0
mid-frequency,1,0.0
200-400,1,0.0
13-33,1,0.0
variance-weighted,1,0.0
68-136,1,0.0
16-91,1,0.0
-05-11,1,0.0
post-HAART,1,0.0
haemato-biochemical,1,0.0
IgMIgGIgA,1,0.0
two-tier,1,0.0
Donghua,1,0.0
Meikang,1,0.0
cha-racteristics,1,0.0
Clementine,1,0.0
Apriori,1,0.0
abidor,1,0.0
moxifloxacin,1,0.0
Qiangli,1,0.0
Pipa,1,0.0
glycyrrhizinate,1,0.0
diammonium,1,0.0
pantoprazole,1,0.0
002Authors,1,0.0
discussionMain,1,0.0
sirtuin-triggered,1,0.0
shamData,1,0.0
micro-emboli,1,0.0
Neuropsychiatry,1,0.0
post-arrival,1,0.0
Antineutrophil,1,0.0
Crescentic,1,0.0
anti-myeloperoxidase,1,0.0
anti-proteinase-3,1,0.0
flakes,1,0.0
time-relationship,1,0.0
Microlife,1,0.0
WatchBP,1,0.0
single-channel,1,0.0
One-time,1,0.0
STLT,1,0.0
LAmbere,1,0.0
Lariat,1,0.0
HSI,1,0.0
sub-acutely,1,0.0
U-shape,1,0.0
1890-1917,1,0.0
inter-strain,1,0.0
postentry,1,0.0
2005Objectives,1,0.0
strokeSearch,1,0.0
TrialsCENTRAL,1,0.0
MedicineDORCTIHM,1,0.0
articlesWe,1,0.0
handsearched,1,0.0
studiesSelection,1,0.0
post-admission,1,0.0
26924,1,0.0
6045,1,0.0
34102,1,0.0
Highlighted,1,0.0
interferometric,1,0.0
Quartz,1,0.0
Immunosensors,1,0.0
Plaques,1,0.0
faked,1,0.0
ADuckSingapore-QF119-397,1,0.0
httpsdrugdesignrikenjpFMODB,1,0.0
22-years,1,0.0
semi-and,1,0.0
para-influenza,1,0.0
conduction-rhythm,1,0.0
infarction--0,1,0.0
Oscour®,1,0.0
Kriging,1,0.0
non-Gaussian,1,0.0
70196-06515,1,0.0
00729,1,0.0
10813,1,0.0
large-medium,1,0.0
stroke-detection,1,0.0
GFFSM,1,0.0
voting,1,0.0
ERSATS,1,0.0
overdosage,1,0.0
57104,1,0.0
2868,1,0.0
108-154,1,0.0
113-266,1,0.0
Swine-influenza,1,0.0
travail,1,0.0
sécurité,1,0.0
HIF-1α-induced,1,0.0
7125,1,0.0
27205,1,0.0
33139,1,0.0
9475,1,0.0
PubMedMedline,1,0.0
HIVSARS-CoV-2,1,0.0
Synergetic,1,0.0
Constraint-Induced,1,0.0
massed,1,0.0
Modified-Constraint-Induced,1,0.0
m-CIMT,1,0.0
anti-thrombi,1,0.0
1α,1,0.0
hypoxia-related,1,0.0
pollutionirritants,1,0.0
cough-wind,1,0.0
gauze,1,0.0
non-woven,1,0.0
neuroprostheses,1,0.0
Inflammation--specifically,1,0.0
origin--has,1,0.0
vitro--aggregation,1,0.0
substances--have,1,0.0
Kossa-stained,1,0.0
patient-rated,1,0.0
observer-rated,1,0.0
impairmentyr,1,0.0
Beta-2-agonistsmonth,1,0.0
tutorials,1,0.0
Kissimmee,1,0.0
photoemission,1,0.0
hypercholesterolemics,1,0.0
season-dependent,1,0.0
biotropic,1,0.0
light--darkness,1,0.0
823626,1,0.0
40598,1,0.0
Lieque,1,0.0
Neiguan,1,0.0
Sanyinjiao,1,0.0
FEF75-85,1,0.0
FEF50,1,0.0
FEF75,1,0.0
nonstuctural,1,0.0
guanine-N7-methyltransferase,1,0.0
A59,1,0.0
N7-MTase-deficient,1,0.0
lethal-dose,1,0.0
N7-methyltransferase,1,0.0
1985-87,1,0.0
mass-production,1,0.0
feverfeverishness,1,0.0
Inverted,1,0.0
convexityABSTRACT,1,0.0
HMN19B,1,0.0
Henri,1,0.0
Mondor,1,0.0
multi-cohort,1,0.0
8748€quality-adjusted,1,0.0
30000€QALY,1,0.0
informatics-based,1,0.0
turning-points,1,0.0
2000--a,1,0.0
astronomic,1,0.0
CLMP,1,0.0
dysfunctions12,1,0.0
hemolytic-uremic,1,0.0
domesticities,1,0.0
multi-layered,1,0.0
structure-including,1,0.0
friendships,1,0.0
prioritises,1,0.0
IntroductionStandard,1,0.0
infectivityAimThe,1,0.0
virusMethodsUsing,1,0.0
synthesisedResultsOf,1,0.0
daysDiscussionFindings,1,0.0
2-this,1,0.0
003-071,1,0.0
Q-Gen,1,0.0
Wisconsinnorthern,1,0.0
100-the,1,0.0
Summarized,1,0.0
chr3p2131,1,0.0
proteinAngiotensin-converting,1,0.0
ACE2-dependent,1,0.0
Embryonic,1,0.0
53-3,1,0.0
P012,1,0.0
Dizzy,1,0.0
viruses-associated,1,0.0
nonbiologic,1,0.0
GSA,1,0.0
3043,1,0.0
Surveillance-based,1,0.0
better-off,1,0.0
exposed-unexposed,1,0.0
SARS-CoV-2•,1,0.0
induction•,1,0.0
Brandenburg,1,0.0
Mecklenburg-Vorpommern,1,0.0
Yonker,1,0.0
Gilboa,1,0.0
94731,1,0.0
77489,1,0.0
79398,1,0.0
81824,1,0.0
78804,1,0.0
Rheumatism,1,0.0
Ruhrgebiet,1,0.0
HG-U133A,1,0.0
hyperaggregahility,1,0.0
hydroproline,1,0.0
201314season,1,0.0
201415season,1,0.0
Immuno-corrective,1,0.0
Mildronate,1,0.0
hemopoiesis,1,0.0
Phrenic,1,0.0
pacers,1,0.0
I-107,1,0.0
3-5-year,1,0.0
I-110,1,0.0
4706,1,0.0
13-14-yr-old,1,0.0
10-category,1,0.0
discussedKey,1,0.0
ISG,1,0.0
sulfasalazine,1,0.0
attuned,1,0.0
Ultimate,1,0.0
context-fit,1,0.0
OMalleys,1,0.0
five-stage-process,1,0.0
Print,1,0.0
In-Process,1,0.0
Indexed,1,0.0
SportDiscus,1,0.0
Ebsco,1,0.0
1979-2020,1,0.0
14-56,1,0.0
microtrauma,1,0.0
sport-related,1,0.0
Lucilia,1,0.0
proguanil,1,0.0
anglers,1,0.0
parietaria,1,0.0
emanations,1,0.0
AGuinea,1,0.0
fowlHong,1,0.0
KongWF1099,1,0.0
ovo,1,0.0
electromechanic,1,0.0
60-year-olds,1,0.0
Dominating,1,0.0
HDLP,1,0.0
cross-examined,1,0.0
MoAs,1,0.0
NCT03499574,1,0.0
concurrent-,1,0.0
CIJ,1,0.0
related-quality,1,0.0
VivaDiag™,1,0.0
HangZhouChina,1,0.0
therfore,1,0.0
ComplementaryAlternative,1,0.0
allergy-intolerance,1,0.0
CAMS,1,0.0
kinesiology,1,0.0
leukocytotoxic,1,0.0
iridology,1,0.0
printers,1,0.0
midweek,1,0.0
morbility,1,0.0
etcetera,1,0.0
hyperploid,1,0.0
Cytoreductive,1,0.0
mlsystm2,1,0.0
gmsystm2,1,0.0
cardioplagia,1,0.0
Nonstroke,1,0.0
bruits,1,0.0
non-outbreak,1,0.0
019-034,1,0.0
023-038,1,0.0
014-025,1,0.0
016-029,1,0.0
low-birth,1,0.0
Cox-analysis,1,0.0
public-facing,1,0.0
housecleaning,1,0.0
Absorb,1,0.0
Immunocapture,1,0.0
fango,1,0.0
anti-nucleoprotein,1,0.0
inhibitors--remain,1,0.0
allergists-immunologists,1,0.0
N27770,1,0.0
Geological,1,0.0
USGS,1,0.0
non-dietary,1,0.0
Darwin,1,0.0
Harbour,1,0.0
factor-,1,0.0
non-network,1,0.0
Sublytic,1,0.0
253-40,1,0.0
409-43,1,0.0
Heat-inactivation,1,0.0
anti-C5a,1,0.0
390-31,1,0.0
417-51,1,0.0
384-23,1,0.0
276-50,1,0.0
379-45,1,0.0
nonidentifiable,1,0.0
cangrelor,1,0.0
VAERD,1,0.0
MA10,1,0.0
Whole-inactivated,1,0.0
heat-denatured,1,0.0
low-potency,1,0.0
saline-immunized,1,0.0
subprotective,1,0.0
deportation,1,0.0
adenylcyclase,1,0.0
PAF-liberation,1,0.0
T11-,1,0.0
TcPYP,1,0.0
Superficial,1,0.0
capsulo-lenticular,1,0.0
capsulo-thalamic,1,0.0
AgooseGuangdong11996,1,0.0
Dystonia,1,0.0
hemiballism,1,0.0
neuropathophysiological,1,0.0
intermediate-sized,1,0.0
pre-extracted,1,0.0
Umfrid,1,0.0
GSES,1,0.0
SASR,1,0.0
PSQI,1,0.0
SSRS,1,0.0
thrombolysisAreas,1,0.0
elderlyExpert,1,0.0
reagentsequipment,1,0.0
Green-based,1,0.0
jersey,1,0.0
1203,1,0.0
hospitalFor,1,0.0
Afibrinogenaemia,1,0.0
delta-sleep,1,0.0
Selye,1,0.0
disrhythmias,1,0.0
more-vulnerable,1,0.0
bocaviruses,1,0.0
13836,1,0.0
150998,1,0.0
5113628,1,0.0
Freeze,1,0.0
social-media,1,0.0
T4-,1,0.0
Leu8,1,0.0
Self-gated,1,0.0
artifact-free,1,0.0
cines,1,0.0
SENSE,1,0.0
Organization-World,1,0.0
Organization-International,1,0.0
infoveillance,1,0.0
Researchs,1,0.0
lower-respiratory,1,0.0
Roentgenpneumopolygraphy,1,0.0
redistributed,1,0.0
84-94,1,0.0
in-use,1,0.0
subsidization,1,0.0
spigelian,1,0.0
iconography,1,0.0
SOIVH1N1,1,0.0
4-5years,1,0.0
world-making,1,0.0
unapproachable,1,0.0
honed,1,0.0
rob,1,0.0
stadium,1,0.0
mega-clinics,1,0.0
1991-1992,1,0.0
-over,1,0.0
CXC,1,0.0
classes--including,1,0.0
pathways--have,1,0.0
AACE,1,0.0
Wilks,1,0.0
vertebroplasty,1,0.0
Sultanah,1,0.0
Bahiyah,1,0.0
Kedah,1,0.0
RT-PCRGap,1,0.0
biosafe,1,0.0
comparedAim,1,0.0
eNAT-,1,0.0
Murrieta,1,0.0
systemMethods,1,0.0
standardResults,1,0.0
P00022,1,0.0
P00012,1,0.0
casesConclusion,1,0.0
risk-area,1,0.0
RWMS,1,0.0
autoimmunitary,1,0.0
polimyositis,1,0.0
denominated,1,0.0
Baotou,1,0.0
V5-V6,1,0.0
Tall,1,0.0
73-87,1,0.0
fuzzily,1,0.0
µgkg,1,0.0
n56,1,0.0
p067,1,0.0
p085,1,0.0
SRMR,1,0.0
NNFI,1,0.0
chi2df,1,0.0
budesonide-formoterol,1,0.0
PI3K-δ-driven,1,0.0
in-between,1,0.0
Susceptible-Infected-Susceptible,1,0.0
170min,1,0.0
ergooxymetry,1,0.0
15-week,1,0.0
costovertebral,1,0.0
articulations,1,0.0
force-length,1,0.0
p85beta,1,0.0
400μL,1,0.0
expectorated,1,0.0
three-track,1,0.0
quintupling,1,0.0
Questionnaire-AQLQS,1,0.0
Three-year,1,0.0
ProteomeXchange,1,0.0
PXD019423,1,0.0
KFH,1,0.0
Hayward,1,0.0
single-session,1,0.0
procainamide,1,0.0
bretylium,1,0.0
stresses--including,1,0.0
responses--is,1,0.0
titters,1,0.0
diphasic,1,0.0
brady-dependent,1,0.0
AACEs,1,0.0
45-years-old,1,0.0
drugs--including,1,0.0
6707,1,0.0
Exposing,1,0.0
overtaken,1,0.0
httpsbitly36BzTaD,1,0.0
Midland,1,0.0
Mersey,1,0.0
lung-not,1,0.0
airway-vascularity,1,0.0
ultraviolet-irradiated,1,0.0
out-of-attack,1,0.0
Reinfusion,1,0.0
Nitrendipine,1,0.0
fibinolytic,1,0.0
sucessful,1,0.0
dysmotility,1,0.0
within-hospital,1,0.0
incalculable,1,0.0
causatory,1,0.0
Siemens-Elema,1,0.0
overreading,1,0.0
amantadine-,1,0.0
lac,1,0.0
partialcomplete,1,0.0
nationwid,1,0.0
nonhazardous,1,0.0
malfeasance,1,0.0
nanoscientists,1,0.0
showcase,1,0.0
interation,1,0.0
perceptualized,1,0.0
linage,1,0.0
Femur,1,0.0
1595-16,1,0.0
correctors,1,0.0
Spotlight,1,0.0
naringenin,1,0.0
esculetin,1,0.0
nimbin,1,0.0
withaferin,1,0.0
andrographolide,1,0.0
zingiberene,1,0.0
thebaine,1,0.0
magnolol,1,0.0
rosmarinic,1,0.0
Autosomal,1,0.0
macrophage-colony-stimulating,1,0.0
chi-fms,1,0.0
post-war,1,0.0
angiogenensis,1,0.0
baby-boom,1,0.0
hist,1,0.0
trial-excluded,1,0.0
hop,1,0.0
bronchconstriction,1,0.0
mesodermal,1,0.0
endodermal,1,0.0
ectodermal,1,0.0
MAPC-treated,1,0.0
MAPC-,1,0.0
BMC-treated,1,0.0
PDGF-BB,1,0.0
TGFbeta1,1,0.0
deceptively,1,0.0
111-08,1,0.0
beta2-adrenoreceptor,1,0.0
digs,1,0.0
life-limiting,1,0.0
Software-based,1,0.0
Hampshire,1,0.0
NHH,1,0.0
focal-neurological,1,0.0
blood-sensitive,1,0.0
seenOwing,1,0.0
co-chaired,1,0.0
Szucs,1,0.0
macroscopical,1,0.0
croupous,1,0.0
alveolis,1,0.0
carnification,1,0.0
tanatogenesis,1,0.0
pseudo-normalization,1,0.0
textual,1,0.0
pushback,1,0.0
haematemesis,1,0.0
gastritis,1,0.0
sanctions,1,0.0
Completely,1,0.0
40076,1,0.0
Mimics,1,0.0
cardiopaths,1,0.0
oxygen-saving,1,0.0
GCRs,1,0.0
GCRbeta,1,0.0
transactivating,1,0.0
GCRDNA,1,0.0
Wholesale,1,0.0
Hydrobiology,1,0.0
idella,1,0.0
9-12-year-olds,1,0.0
6-53,1,0.0
28-68,1,0.0
policy-relevant,1,0.0
ACPP,1,0.0
Opposition,1,0.0
politicization,1,0.0
free-rider,1,0.0
nuclei-enriched,1,0.0
detergent-free,1,0.0
Down-regulated,1,0.0
114-318,1,0.0
111-261,1,0.0
102-239,1,0.0
AMC,1,0.0
Ctenopharyngodon,1,0.0
overburdening,1,0.0
telecommuting,1,0.0
47-49,1,0.0
low-impact,1,0.0
DoH,1,0.0
PPR,1,0.0
022-029,1,0.0
August-7,1,0.0
300-332,1,0.0
Pendleton,1,0.0
565000,1,0.0
Carassius,1,0.0
crusian,1,0.0
censorship,1,0.0
design-activity,1,0.0
kappa-B,1,0.0
quasi-randomly,1,0.0
FVD,1,0.0
angiocoronarography,1,0.0
short-list,1,0.0
UK-MHPRA,1,0.0
JohnsonJanssen,1,0.0
vaccinotherapy,1,0.0
Théophile,1,0.0
Alajouanine,1,0.0
musician,1,0.0
Ravel,1,0.0
Valery,1,0.0
Larbaud,1,0.0
Paul-Elie,1,0.0
Gernez,1,0.0
1888-1948,1,0.0
poetic,1,0.0
spontaneity,1,0.0
151700,1,0.0
575400,1,0.0
49×10-3,1,0.0
single-penetrator,1,0.0
CWS-crescendo,1,0.0
Origins,1,0.0
COAST,1,0.0
US63,1,0.0
US250,1,0.0
Qv6,1,0.0
Cabrera,1,0.0
Pelican,1,0.0
7537,1,0.0
Anti-H7N9,1,0.0
transdiaphragm,1,0.0
unitless,1,0.0
VOI-based,1,0.0
CPTHAL,1,0.0
-0066-0027,1,0.0
00020042,1,0.0
Aliquots,1,0.0
18°C,1,0.0
26°C,1,0.0
-10°C,1,0.0
-30°C,1,0.0
Meuse,1,0.0
high-haemorrhagic,1,0.0
tele-expertised,1,0.0
perception-action,1,0.0
dry-powder,1,0.0
shorthair,1,0.0
botanicals,1,0.0
larch,1,0.0
arabinogalactan,1,0.0
Baptisia,1,0.0
Allium,1,0.0
Panax,1,0.0
senticosus,1,0.0
Andrographis,1,0.0
paniculata,1,0.0
DHEA,1,0.0
Workflows,1,0.0
blemished,1,0.0
vibrant,1,0.0
hPSC-CMshECs,1,0.0
cardiomyocyteendothelial,1,0.0
194-33,1,0.0
impotant,1,0.0
ministrokes,1,0.0
4947,1,0.0
caliper,1,0.0
post-IMA,1,0.0
¥7237month,1,0.0
¥1743557,1,0.0
¥8647069,1,0.0
¥3819861,1,0.0
¥9639844,1,0.0
antigen-encoding,1,0.0
Rabies,1,0.0
Self-amplifying,1,0.0
metric-based,1,0.0
large-data,1,0.0
dimension-reduced,1,0.0
dimension-reduction,1,0.0
t-distributed,1,0.0
t-SNE,1,0.0
best-suited,1,0.0
distanced-based,1,0.0
UMAP-assisted,1,0.0
65000,1,0.0
subhuman,1,0.0
extrahospitalary,1,0.0
intrahospitalary,1,0.0
perplexityWe,1,0.0
groupStroke,1,0.0
6150,1,0.0
differentProper,1,0.0
high-intensive,1,0.0
3-group,1,0.0
1-physical,1,0.0
1963-74,1,0.0
40-05,1,0.0
r063,1,0.0
Thyroxine,1,0.0
35-diiodothyropropionic,1,0.0
3-wk,1,0.0
volume-to-mass,1,0.0
Arteriolar,1,0.0
angiopoietin,1,0.0
EEGs,1,0.0
non-epileptiform,1,0.0
Lumbar,1,0.0
asthma--especially,1,0.0
Drug-doping,1,0.0
76925,1,0.0
physiologylung,1,0.0
Druze,1,0.0
Tel-Hashomer,1,0.0
kibbutz,1,0.0
firstborn,1,0.0
acquaintance,1,0.0
conditionsABSTRACT,1,0.0
charter,1,0.0
eosinophiles,1,0.0
researcher-reported,1,0.0
30-75,1,0.0
transcriptomic-,1,0.0
proteomic-informed,1,0.0
cholangiocarcinoma,1,0.0
niduses,1,0.0
sex-disaggregated,1,0.0
MrgD,1,0.0
sex-role,1,0.0
Cotard-like,1,0.0
erotomanic,1,0.0
neurofunctional,1,0.0
FortalezaCE,1,0.0
1997-2000,1,0.0
10-th,1,0.0
n1777,1,0.0
ISCO,1,0.0
067-137,1,0.0
154-589,1,0.0
158-496,1,0.0
clearcut,1,0.0
Microbes,1,0.0
Steve,1,0.0
Seattle-based,1,0.0
Schubert,1,0.0
90-person,1,0.0
Dripping,1,0.0
Pills,1,0.0
tuberculomas,1,0.0
equidensite,1,0.0
Cavernous,1,0.0
Cardiocerebrovascular,1,0.0
RCCVCs,1,0.0
Committee-Medical,1,0.0
IOC-MC,1,0.0
Alkaloids,1,0.0
heptapeptides,1,0.0
alamandine,1,0.0
Fregoli,1,0.0
paranoid,1,0.0
Delusion,1,0.0
HRG,1,0.0
more-efficient,1,0.0
2932,1,0.0
3051,1,0.0
cancer--bearing,1,0.0
EDRF,1,0.0
ECG-assessment,1,0.0
Pressures,1,0.0
over-distention,1,0.0
mainstem,1,0.0
bronchoesophageal,1,0.0
H-type,1,0.0
deviation-induced,1,0.0
postpneumonectomy,1,0.0
HRGs,1,0.0
adaptiveness,1,0.0
oligo-,1,0.0
handball,1,0.0
inflammationoedema,1,0.0
Lake-Louis,1,0.0
Spiroergometric,1,0.0
spiroergometry,1,0.0
5e-year,1,0.0
2ndto,1,0.0
determine-out,1,0.0
year-which,1,0.0
understand-and,1,0.0
predict-influenza,1,0.0
20265,1,0.0
online-based,1,0.0
7-d,1,0.0
kgm-2,1,0.0
OR1581,1,0.0
1212-2356,1,0.0
OR1659,1,0.0
1268-2170,1,0.0
OR3570,1,0.0
1825-6980,1,0.0
OR1957,1,0.0
1286-2979,1,0.0
OR17745,1,0.0
12271-25660,1,0.0
Alleviating,1,0.0
Shuangqiao,1,0.0
Chengde,1,0.0
SABALABA,1,0.0
Arg16,1,0.0
Crossing,1,0.0
animal-to-animal,1,0.0
polycardiographic,1,0.0
discordinated,1,0.0
slow-filling,1,0.0
fast-filling,1,0.0
Frank--Starling,1,0.0
viral-human,1,0.0
OMICs,1,0.0
Thromboplastin,1,0.0
acutely-ill,1,0.0
thrombophylaxis,1,0.0
Nekemte,1,0.0
NRH,1,0.0
Donation,1,0.0
OR1690,1,0.0
OR1409,1,0.0
Kong68-ts-1,1,0.0
OR24,1,0.0
Fick,1,0.0
Quadruplicate,1,0.0
0465,1,0.0
VH3-30,1,0.0
32D4,1,0.0
unhastened,1,0.0
slow-progressive,1,0.0
valuables,1,0.0
demandsupply,1,0.0
T2MIs,1,0.0
C-reactive-protein,1,0.0
activated-partial-thromboplastin-time,1,0.0
alanine-aminotransferase,1,0.0
aspartate-aminotransferase,1,0.0
723-794,1,0.0
0876-0955,1,0.0
child-friendly,1,0.0
stethoscopes,1,0.0
10dB,1,0.0
162100000week,1,0.0
0252,1,0.0
0267,1,0.0
Refresher,1,0.0
bullyingdepression,1,0.0
Twenty-year,1,0.0
silicose,1,0.0
vaccine-outcome,1,0.0
1995-1997,1,0.0
OR28,1,0.0
BORG-score,1,0.0
MRC-dyspnoea,1,0.0
silver-nanorod,1,0.0
1447,1,0.0
on-admission,1,0.0
002-094,1,0.0
Predictability,1,0.0
treatment-responsive,1,0.0
recentcomprehensive,1,0.0
normalising,1,0.0
irrefutably,1,0.0
contagion-minimizing,1,0.0
pathogen-prevalent,1,0.0
non-aggressive,1,0.0
bronchomotricity,1,0.0
10segments,1,0.0
malfunctioning,1,0.0
geneticepigenetic,1,0.0
empathy--the,1,0.0
state--is,1,0.0
infections-severe,1,0.0
H5N1-have,1,0.0
receptor-related,1,0.0
RANKLRANK,1,0.0
companys,1,0.0
7489,1,0.0
3589,1,0.0
2374,1,0.0
€149,1,0.0
€114,1,0.0
non-ARDS,1,0.0
ninth-most,1,0.0
glucometabolic,1,0.0
0206,1,0.0
Rho,1,0.0
SupSagS,1,0.0
arginases,1,0.0
easy-operation,1,0.0
Zang-organs,1,0.0
Neijing,1,0.0
Tunnels,1,0.0
spirits,1,0.0
Gan-spirit,1,0.0
Gan,1,0.0
plank,1,0.0
asthma-asthma,1,0.0
work-provides,1,0.0
IgE-associated,1,0.0
L-Arginine,1,0.0
semi-essential,1,0.0
electrobiological,1,0.0
Readout,1,0.0
serum-analysis,1,0.0
resolution-computed,1,0.0
sero-,1,0.0
micro-biological,1,0.0
dislocated,1,0.0
BE-FAST,1,0.0
categories--age,1,0.0
alkalemia,1,0.0
volume-pressure,1,0.0
time-velocity,1,0.0
Multilinear,1,0.0
monotonous,1,0.0
re-define,1,0.0
moycardial,1,0.0
IUmin,1,0.0
shades,1,0.0
seasonBoth,1,0.0
3034,1,0.0
17868,1,0.0
3688,1,0.0
sensor-modified,1,0.0
electrode-tethered,1,0.0
analyte-binding,1,0.0
chronoamperometry,1,0.0
drag,1,0.0
virus-detecting,1,0.0
probevirus,1,0.0
UTMs,1,0.0
Orf3a-G251V,1,0.0
flu-positive,1,0.0
non-antibiotic,1,0.0
Tg-suppressors,1,0.0
extraadrenal,1,0.0
adrenodeficiency,1,0.0
omplications,1,0.0
QtCRP,1,0.0
PCIin,1,0.0
allergoimmunological,1,0.0
plethysmographically,1,0.0
beta-2-mimetic,1,0.0
A₂B,1,0.0
A₃,1,0.0
A₁,1,0.0
reinterpretation,1,0.0
00070,1,0.0
echo-CG,1,0.0
12546,1,0.0
0054,1,0.0
commitment--are,1,0.0
Highly-motivated,1,0.0
ts-1,1,0.0
SGA-associated,1,0.0
SGA-related,1,0.0
Dysregulated,1,0.0
semiquantify,1,0.0
mlkg24,1,0.0
follies,1,0.0
millenium,1,0.0
spikeless,1,0.0
MT-providing,1,0.0
Synchronous,1,0.0
Eradication,1,0.0
cesarian,1,0.0
conterparts,1,0.0
credibility--which,1,0.0
normovolemia,1,0.0
patientsSeveral,1,0.0
practiceErythropoietin,1,0.0
Registrars,1,0.0
Cedar-Sinai,1,0.0
Alarmingly,1,0.0
47-52,1,0.0
‘weekend,1,0.0
effect’,1,0.0
‘confounding,1,0.0
severity’,1,0.0
galvanize,1,0.0
infighting,1,0.0
followingThe,1,0.0
seasonAnnual,1,0.0
science-informed,1,0.0
preferenceLive,1,0.0
April-2011,1,0.0
December-2012,1,0.0
smokingResults,1,0.0
-0489,1,0.0
-0570,1,0.0
-0409,1,0.0
decrementimpairment,1,0.0
-0729,1,0.0
-0844,1,0.0
-0613,1,0.0
-0031,1,0.0
-0047,1,0.0
-0029,1,0.0
eachConclusions,1,0.0
shelf-like,1,0.0
single-growth,1,0.0
encephalomyocarditis,1,0.0
Rpp30,1,0.0
Covid-19-negative,1,0.0
E-GUSB,1,0.0
ddRT-PCR,1,0.0
Bronchoscopic,1,0.0
airwaylung,1,0.0
evaluationsquantitative,1,0.0
oversimplifying,1,0.0
deconstruct,1,0.0
Masks,1,0.0
Emmentaler,1,0.0
black-or-white,1,0.0
populationMethods,1,0.0
Scenario-based,1,0.0
911000,1,0.0
knowingnot,1,0.0
LAIVThe,1,0.0
seasonAs,1,0.0
Repino,1,0.0
512--functional,1,0.0
383--FC,1,0.0
53--FC,1,0.0
5--FC,1,0.0
00-27,1,0.0
02-121,1,0.0
Merleau-Ponty,1,0.0
Pollio,1,0.0
figural,1,0.0
freedomunfreedom,1,0.0
gene-nutritional,1,0.0
Mission118,1,0.0
Videoconferencing,1,0.0
truefalse,1,0.0
nonpercutaneous,1,0.0
FoF,1,0.0
vortex,1,0.0
echocardiography-derived,1,0.0
VFM,1,0.0
Ram,1,0.0
devalued,1,0.0
Winchester,1,0.0
permafrost,1,0.0
Carolina118,1,0.0
York118,1,0.0
sub-classified,1,0.0
Chitotriosidase,1,0.0
live-vectored,1,0.0
Episode,1,0.0
reiterated,1,0.0
gerontologist,1,0.0
firsthand,1,0.0
Fighting,1,0.0
gerontologists,1,0.0
Catheterization,1,0.0
LSs,1,0.0
Vibrosphere,1,0.0
inpatientpartial,1,0.0
Tinitiai,1,0.0
mono-cell,1,0.0
oxygen-glucose,1,0.0
prothrombin-deficient,1,0.0
TMZ,1,0.0
Sadoff,1,0.0
Vandebosch,1,0.0
33882225,1,0.0
photo-documented,1,0.0
Fundus,1,0.0
electromagnetotherapy,1,0.0
Spirometer,1,0.0
Handi,1,0.0
FVCex,1,0.0
FEV1FVCex,1,0.0
MTU,1,0.0
500H,1,0.0
200-660,1,0.0
50-620,1,0.0
Gateshead,1,0.0
JNKs,1,0.0
single-aeroallergen,1,0.0
macroaspiration,1,0.0
field-transmitted,1,0.0
firstsecond,1,0.0
CK-MB-activity,1,0.0
redevelope,1,0.0
Levison,1,0.0
epidemic--and,1,0.0
general--and,1,0.0
Antigen-sparing,1,0.0
low-antigen,1,0.0
transcription‒polymerase,1,0.0
H1N1virus,1,0.0
homologic,1,0.0
looped,1,0.0
dendroaspis,1,0.0
In-field,1,0.0
0331000,1,0.0
constant-sized,1,0.0
Pepitope,1,0.0
cladessubclades,1,0.0
6B1A5,1,0.0
BVictoria-like,1,0.0
9481,1,0.0
6740,1,0.0
twice-yearly,1,0.0
Avirus,1,0.0
Diagnóstico,1,0.0
Referencia,1,0.0
Epidemiológica,1,0.0
theAgency,1,0.0
SINAPs,1,0.0
replete,1,0.0
CK-MB-type,1,0.0
biofilms,1,0.0
8566,1,0.0
beta‐coronaviruses,1,0.0
WL,1,0.0
Newark,1,0.0
Fractionated,1,0.0
CyC,1,0.0
theimpact,1,0.0
PKPD,1,0.0
kit-extracted,1,0.0
pre-boiled,1,0.0
risk-balance,1,0.0
1377000,1,0.0
orphanage,1,0.0
BLeningrad17986,1,0.0
Arbor186,1,0.0
B722,1,0.0
B724,1,0.0
B71288,1,0.0
ventroposterior,1,0.0
rostrolateral,1,0.0
Phosphocreatine,1,0.0
defibrillations,1,0.0
Eddy,1,0.0
Liew,1,0.0
1904-1917,1,0.0
1919-1927,1,0.0
rebounded,1,0.0
15-54,1,0.0
colonizing,1,0.0
flujometry,1,0.0
6123,1,0.0
ACE2-small,1,0.0
tropicalsubtropical,1,0.0
Neem,1,0.0
assemblyCommunicated,1,0.0
Cuiabá,1,0.0
Mato,1,0.0
Grosso,1,0.0
OttawaCanada,1,0.0
SARS-CoV2so,1,0.0
pub-med,1,0.0
SARS-coV2,1,0.0
numbersRo,1,0.0
worldhowever,1,0.0
MERStill,1,0.0
non-immersive,1,0.0
electrically-induced,1,0.0
543-545,1,0.0
child-completed,1,0.0
parentcaregiver-completed,1,0.0
typesA,1,0.0
Hygienic,1,0.0
Myth,1,0.0
FINSTROKE,1,0.0
apelinAPJ,1,0.0
Apelin‑13,1,0.0
CCVD--RI,1,0.0
non-diagnosed,1,0.0
them--healed,1,0.0
pathologoanatomical,1,0.0
Batlle,1,0.0
MB-type,1,0.0
immuno-precipitation,1,0.0
Phase3,1,0.0
Infectors,1,0.0
glycolyzed,1,0.0
side-specific,1,0.0
BMSs,1,0.0
non-seroconverter,1,0.0
seroconverters,1,0.0
non-seroconverters,1,0.0
SAL,1,0.0
≤34,1,0.0
7500Fast,1,0.0
NPMT,1,0.0
Georgias,1,0.0
PSD-defined,1,0.0
stroke-is,1,0.0
medial-temporal-lobe,1,0.0
Kurdish,1,0.0
asthma--prevalence,1,0.0
COV2,1,0.0
AMoscow1099H3N2,1,0.0
AMoscow1099H3N2-like,1,0.0
well-constructed,1,0.0
Dynamically,1,0.0
prioritizations,1,0.0
homoplasic,1,0.0
OECD,1,0.0
5975,1,0.0
10-9vs,1,0.0
10-6vs,1,0.0
-021,1,0.0
early-June,1,0.0
antiplasmin,1,0.0
alpha-2,1,0.0
Neu5Gc,1,0.0
Cas-Témoins,1,0.0
codon-optimized,1,0.0
UU,1,0.0
cautioning,1,0.0
-generated,1,0.0
42-72,1,0.0
Sestre,1,0.0
Milosrdnice,1,0.0
48--72,1,0.0
24-week,1,0.0
Paraoxonase,1,0.0
high-density-lipoprotein,1,0.0
hydrolyzing,1,0.0
GlnArg,1,0.0
lInfarctus,1,0.0
Mebus,1,0.0
Myocarde,1,0.0
Gln,1,0.0
192Arg,1,0.0
0295,1,0.0
0323,1,0.0
Susceptible-ExposedLatent-Infectious-Removed,1,0.0
Kullback-Leibler,1,0.0
best-case,1,0.0
16h,1,0.0
cytophilic,1,0.0
18557,1,0.0
1969-1976,1,0.0
mannose,1,0.0
37C,1,0.0
DSM-III,1,0.0
CK-activities,1,0.0
26-131,1,0.0
necrosis-distant,1,0.0
effect--oxygen,1,0.0
ata-air,1,0.0
auricles,1,0.0
McMaster-Asthma,1,0.0
Symptom-reporting,1,0.0
microcorrosion,1,0.0
neovessels,1,0.0
diagnosticated,1,0.0
Allergy-Clinic,1,0.0
Mg2pre-treatment,1,0.0
Legacy,1,0.0
Emanuel,1,0.0
inCOVID-19,1,0.0
Berotec,1,0.0
G-index,1,0.0
8769844,1,0.0
463745,1,0.0
clinical-statistical,1,0.0
infarctionWe,1,0.0
thamalusSubsequent,1,0.0
3934-3p,1,0.0
1307-3p,1,0.0
3691-3p,1,0.0
1468-5p,1,0.0
miR-related,1,0.0
miR-3691-3p,1,0.0
miR-3934-3p,1,0.0
miR-3334-3p,1,0.0
perinfarction,1,0.0
3H-uridine,1,0.0
3H-thymidine,1,0.0
Multi-voxel,1,0.0
102-112,1,0.0
partialed,1,0.0
dosecm3,1,0.0
Immunostaining,1,0.0
l-type,1,0.0
protein-positive,1,0.0
CD68-positive,1,0.0
alltrans,1,0.0
ATRA,1,0.0
25-51,1,0.0
24-52,1,0.0
Multisection,1,0.0
hemodinamics,1,0.0
time-attenuation,1,0.0
histoautoradiographic,1,0.0
damage--tissue,1,0.0
physician-centered,1,0.0
neuro-ophthalmological,1,0.0
beneficial--quickly,1,0.0
ASichuan,1,0.0
ALeningrad,1,0.0
protocol-directed,1,0.0
Low-dosage,1,0.0
tongxinluo,1,0.0
TXL,1,0.0
ambience,1,0.0
Armonia,1,0.0
oxygen-air,1,0.0
Serum-neutralizing,1,0.0
anthropometry,1,0.0
unstandardized,1,0.0
CD4-predominant,1,0.0
n65,1,0.0
handshaking,1,0.0
Self-Management,1,0.0
meta-review,1,0.0
RECURSIVE,1,0.0
tissue-protective,1,0.0
Cortico-cerebellar,1,0.0
HIV-1hepatitis,1,0.0
HIV-1-induced,1,0.0
12-weeks,1,0.0
AT1-receptor,1,0.0
2460,1,0.0
-receptor,1,0.0
1935-58,1,0.0
8635,1,0.0
5082,1,0.0
091-126,1,0.0
081-146,1,0.0
flow--via,1,0.0
grafting--improves,1,0.0
house-dust-mite-sensitive,1,0.0
Plasma-cell,1,0.0
non-neoplastic,1,0.0
SALUTE,1,0.0
JapanMethods,1,0.0
roll-in,1,0.0
36±16,1,0.0
30±11,1,0.0
ITT,1,0.0
parametrise,1,0.0
spongiotic,1,0.0
Anti-COVID-19,1,0.0
neurotechnologies,1,0.0
influenza-season,1,0.0
week-peak-periods,1,0.0
VESKA,1,0.0
influenza-strains,1,0.0
goal-centered,1,0.0
controlFENO,1,0.0
analysisWhen,1,0.0
0713-0805,1,0.0
0769,1,0.0
0706-0810,1,0.0
0590,1,0.0
0531-0653,1,0.0
0416-0567,1,0.0
p0482,1,0.0
respectivelyThe,1,0.0
atrioventicular,1,0.0
unseeably,1,0.0
internodal,1,0.0
supernormality,1,0.0
4-hourly,1,0.0
18457,1,0.0
FNEs,1,0.0
Corriere,1,0.0
Repubblica,1,0.0
TGCOM,1,0.0
23-year,1,0.0
hygroscopic,1,0.0
19-32,1,0.0
within-study,1,0.0
deviceprocedure,1,0.0
1974-1978,1,0.0
1719,1,0.0
widely-available,1,0.0
STEMIWe,1,0.0
KORMISix,1,0.0
KORMI,1,0.0
cohortWe,1,0.0
SVGE,1,0.0
CNE,1,0.0
Multicolour,1,0.0
Cytometry,1,0.0
sparsity-a,1,0.0
models-may,1,0.0
chemometrics,1,0.0
Clausen,1,0.0
Southam,1,0.0
EA-,1,0.0
delegation,1,0.0
813-100,1,0.0
high-viral-load,1,0.0
nasopharyngeal-positive,1,0.0
pre-amplification,1,0.0
microchamber-array,1,0.0
disembarkation,1,0.0
1-beta-d-ribofuranosyl-124-triazole-3-carboxamide,1,0.0
identical-appearing,1,0.0
atrialLA,1,0.0
NSTEAMI,1,0.0
suggestible,1,0.0
1144793,1,0.0
A688V,1,0.0
Δ680SPRRA684,1,0.0
QaHKG197-suggesting,1,0.0
KongG197,1,0.0
virus-AquailHong,1,0.0
r086,1,0.0
scramble,1,0.0
Adipokines,1,0.0
adipocytes,1,0.0
hovers,1,0.0
thromboxanes,1,0.0
8-Hours,1,0.0
Mike,1,0.0
Leavitt,1,0.0
Bushs,1,0.0
iodine-123,1,0.0
15-p-iodophenyl-3R,1,0.0
S-methylpentadecanoic,1,0.0
44-25,1,0.0
adverse-event,1,0.0
55-62,1,0.0
Triplex,1,0.0
COPAN,1,0.0
IRCCS,1,0.0
Sacro,1,0.0
Cuore,1,0.0
Don,1,0.0
9333,1,0.0
6805,1,0.0
9983,1,0.0
thawed,1,0.0
Sokolniky,1,0.0
164000,1,0.0
44-38,1,0.0
230000,1,0.0
6600,1,0.0
nonmyocyte,1,0.0
supramaximal,1,0.0
out-of-bag,1,0.0
PBMC-,1,0.0
NEC-,1,0.0
AEC-based,1,0.0
locus-locus,1,0.0
CDH6,1,0.0
RAPGEF3,1,0.0
neutrophilic-eosinophilic,1,0.0
unfurled,1,0.0
Reparation,1,0.0
neuro-therapeutic,1,0.0
five-needle,1,0.0
6-month-therapy,1,0.0
mg24,1,0.0
-192,1,0.0
-213,1,0.0
Organization-confirmed,1,0.0
sickunexpectedly,1,0.0
CBPs,1,0.0
Bibliographic,1,0.0
Simson,1,0.0
CIRC,1,0.0
Time-domain,1,0.0
0-200,1,0.0
80-ms,1,0.0
51-100,1,0.0
101-150,1,0.0
151-200,1,0.0
Spectrotemporal,1,0.0
PBMC-based,1,0.0
NEC-based,1,0.0
AEC-,1,0.0
Cocci,1,0.0
VO2peakABSTRACT,1,0.0
FRI,1,0.0
NO-based,1,0.0
13414,1,0.0
3509,1,0.0
tweeted,1,0.0
disappointment,1,0.0
Two-phased,1,0.0
accelerometer-derived,1,0.0
recanalise,1,0.0
42±33,1,0.0
2331,1,0.0
34±27years,1,0.0
20188,1,0.0
Epigenome-wide,1,0.0
χ²4215,1,0.0
P0040,1,0.0
38188,1,0.0
χ²7029,1,0.0
101188,1,0.0
χ²6099,1,0.0
Analytic,1,0.0
Grand-Duchy,1,0.0
Luxemburg,1,0.0
equipe,1,0.0
hypo-dysaminoacidemic,1,0.0
dysaminoacidemia,1,0.0
disease-oriented,1,0.0
51-200,1,0.0
long-submaximal,1,0.0
electrocardiographers,1,0.0
emphysematic,1,0.0
1317,1,0.0
angio-TDM,1,0.0
arterio-embolization,1,0.0
postdural,1,0.0
establishedwithout,1,0.0
0387-0651,1,0.0
nonplatelet,1,0.0
atherosclerosisthrombosis,1,0.0
Wegners,1,0.0
Manifest,1,0.0
cull,1,0.0
mink-virus,1,0.0
mink-derived,1,0.0
mink-viruses,1,0.0
HLA-W6,1,0.0
227600,1,0.0
209435,1,0.0
MoHP,1,0.0
QGIS,1,0.0
3108,1,0.0
Bagmati,1,0.0
≥54,1,0.0
CV-ECG,1,0.0
XYZ,1,0.0
D-ECG,1,0.0
polarcardiogram,1,0.0
Telemed,1,0.0
TC-ECG,1,0.0
TD-ECG,1,0.0
09100000,1,0.0
cavernomas,1,0.0
10100000,1,0.0
receptor-binding-domain,1,0.0
hemithoracic,1,0.0
ordinally,1,0.0
Weighting,1,0.0
Prick-testing,1,0.0
colophony-based,1,0.0
cored,1,0.0
reactins,1,0.0
needs-analysis,1,0.0
member--including,1,0.0
Formalized,1,0.0
1978-87,1,0.0
Matão,1,0.0
nonfrequent,1,0.0
spike-pseudotyped,1,0.0
recurrencemortality,1,0.0
VSV-based,1,0.0
N-seropositive,1,0.0
RBD-seropositive,1,0.0
N-based,1,0.0
time-difference,1,0.0
Home-monitoring,1,0.0
single-item,1,0.0
cardioheumatological,1,0.0
2--3,1,0.0
electroacrdiographic,1,0.0
C-4,1,0.0
protein-lipid,1,0.0
never-smoked,1,0.0
Δ685RSVA688,1,0.0
Δ680SPRRARSVA688,1,0.0
Δ680SPRRARSVAS689,1,0.0
INIHDII,1,0.0
1603,1,0.0
3547,1,0.0
3613,1,0.0
RVCL,1,0.0
mRNA‐1273,1,0.0
vector‐based,1,0.0
previousLy,1,0.0
anginaMI,1,0.0
rehabiLitation,1,0.0
Resumption,1,0.0
Anti-Nogo-A,1,0.0
movement-based,1,0.0
dealer,1,0.0
2065,1,0.0
1562,1,0.0
VGDF,1,0.0
challenge-positive,1,0.0
asthma-risk,1,0.0
breathing-related,1,0.0
site-directed,1,0.0
fallout,1,0.0
aortoenteric,1,0.0
antibody-naive,1,0.0
IL-2-,1,0.0
-06,1,0.0
CD8IFN-γIL-2-,1,0.0
CD45RA,1,0.0
CCR7-,1,0.0
lung-homing,1,0.0
7241,1,0.0
pre-disposition,1,0.0
etiological-pathological,1,0.0
catheterism,1,0.0
3056,1,0.0
Argentinian,1,0.0
IL-35GM-CSF,1,0.0
neutral-,1,0.0
epitopesIMPORTANCE,1,0.0
low-pH-induced-conformational,1,0.0
nonepitope,1,0.0
5346,1,0.0
10773,1,0.0
5904,1,0.0
9109,1,0.0
proceduresAreas,1,0.0
CDCExpert,1,0.0
Time-lapse,1,0.0
Qualification,1,0.0
ductus,1,0.0
venosus,1,0.0
tenterhooks,1,0.0
cousins,1,0.0
obligated,1,0.0
mystifying,1,0.0
effective-many,1,0.0
foams,1,0.0
toxicologically,1,0.0
SYNTHESIS,1,0.0
Embolectomy,1,0.0
chronicled,1,0.0
SOLITAIRE™TM,1,0.0
crossprotection,1,0.0
disease-targeted,1,0.0
64-157,1,0.0
incentivisation,1,0.0
sorghum,1,0.0
black-eye,1,0.0
peas,1,0.0
yams,1,0.0
squash,1,0.0
pumpkin,1,0.0
moringa,1,0.0
quantityintegrity,1,0.0
laboratory-specific,1,0.0
error-containing,1,0.0
receivers,1,0.0
location-aware,1,0.0
Acceptance-resignation,1,0.0
Dripps-American,1,0.0
Detsky,1,0.0
Eagles,1,0.0
Coopermans,1,0.0
LC-Q-TOFMS,1,0.0
Ala-Leu-Pro-Met-His-Ile-Arg,1,0.0
ALMPHIR,1,0.0
Ile-Pro-Ala-Val-Phe-Lys,1,0.0
IPAVFK,1,0.0
NSBHR,1,0.0
O2pulse,1,0.0
rateVO2max,1,0.0
interventionists,1,0.0
road-map,1,0.0
Charités,1,0.0
192000,1,0.0
millet,1,0.0
puzzled,1,0.0
cTBS,1,0.0
recurrence-reducing,1,0.0
Ascertainment,1,0.0
Kristian,1,0.0
Thygesen,1,0.0
Alpert,1,0.0
Lars,1,0.0
Rydén,1,0.0
Arthur,1,0.0
Garson,1,0.0
0752,1,0.0
0609,1,0.0
In-VitroCellular,1,0.0
SBW,1,0.0
ofcalcification,1,0.0
Berksons,1,0.0
praxisapraxia,1,0.0
φ,1,0.0
real-time-PCR,1,0.0
φ09,1,0.0
φ06,1,0.0
mghour,1,0.0
wolves,1,0.0
NIHLB,1,0.0
1282,1,0.0
31-329,1,0.0
identifed,1,0.0
risk--sometimes,1,0.0
lethal--is,1,0.0
MEDLINE-PubMed,1,0.0
167-80,1,0.0
4-179,1,0.0
P681del,1,0.0
4609,1,0.0
reimmunize,1,0.0
bronchoconstrictions,1,0.0
HAdV-3,1,0.0
NMDA-type,1,0.0
1-st,1,0.0
7-8th,1,0.0
3-4th,1,0.0
dysmetabolism,1,0.0
10-14th,1,0.0
BAFTA,1,0.0
age≥80,1,0.0
endeavored,1,0.0
SIDRIA-2,1,0.0
1314,1,0.0
SIDRIA,1,0.0
meningococcemia,1,0.0
canonically,1,0.0
platforms-mRNA,1,0.0
adjuvant-looking,1,0.0
GC-derived,1,0.0
post-IgE,1,0.0
whispering-gallery-mode,1,0.0
N-proteins,1,0.0
N-IgM,1,0.0
red-shifts,1,0.0
H-IgG,1,0.0
H-IgM,1,0.0
Stabilisation,1,0.0
hyposignal,1,0.0
1985-1991,1,0.0
Up-regulation,1,0.0
bulwark,1,0.0
milligram,1,0.0
Q677P,1,0.0
Culturally,1,0.0
particulate-arresting,1,0.0
registrated,1,0.0
immune-suppressive,1,0.0
V1-V6-DI-aVL,1,0.0
DII-DIII-aVF,1,0.0
druggene,1,0.0
nanogram,1,0.0
Anchoring,1,0.0
pentamer,1,0.0
638-73,1,0.0
102-44,1,0.0
00613,1,0.0
7aiORF1,1,0.0
0166,1,0.0
0152,1,0.0
Immunoinformatics,1,0.0
unannotated,1,0.0
uORFs,1,0.0
ORF9b40-48,1,0.0
Structure-based,1,0.0
ORF9b61-68,1,0.0
ORF9b65-69,1,0.0
ORF3c2-16,1,0.0
ORF3c3-17,1,0.0
ORF3c4-18,1,0.0
ORF3c14-22,1,0.0
clopidrogel,1,0.0
endocardiosis,1,0.0
60312,1,0.0
SEMF,1,0.0
n132,1,0.0
n164,1,0.0
n752,1,0.0
121-238,1,0.0
165-304,1,0.0
102-228,1,0.0
145-322,1,0.0
098-225,1,0.0
126-312,1,0.0
controls--all,1,0.0
years--prevalence,1,0.0
balloon-occluded,1,0.0
dual-source,1,0.0
iPSc-based,1,0.0
CXCR2,1,0.0
QRSD,1,0.0
nonattempted,1,0.0
Varimax,1,0.0
unobtainable,1,0.0
III-1-2,1,0.0
clammy,1,0.0
4731,1,0.0
South-west,1,0.0
398-493,1,0.0
age-bands,1,0.0
10-172,1,0.0
269-432,1,0.0
669-1040,1,0.0
70333,1,0.0
763±152,1,0.0
enoxacin-targeted,1,0.0
enoxacin-enhanced,1,0.0
12-96,1,0.0
natural-killer,1,0.0
Landmark,1,0.0
stroke-a,1,0.0
025-058,1,0.0
019-044,1,0.0
Prodromic,1,0.0
Hapten-induced,1,0.0
hapten-induced,1,0.0
gender-oriented,1,0.0
reformation,1,0.0
ExLA,1,0.0
DLA,1,0.0
L-A,1,0.0
prehemodialysis,1,0.0
DICER,1,0.0
DGE,1,0.0
blind-testing,1,0.0
worldwidely,1,0.0
H1N1-host,1,0.0
Plausible,1,0.0
post-severe,1,0.0
55-assisted,1,0.0
pneumoniae-associated,1,0.0
exduation,1,0.0
Baumannii,1,0.0
subsiding,1,0.0
recently-published,1,0.0
TACTICS,1,0.0
cells-dominant,1,0.0
CD4-positive,1,0.0
PI3K-targeted,1,0.0
57-92I29463,1,0.0
ankylosing,1,0.0
spondylitis,1,0.0
MultiLEIT,1,0.0
extensionadduction,1,0.0
229719,1,0.0
patters,1,0.0
15861,1,0.0
2054,1,0.0
peri-myocardial,1,0.0
Flash,1,0.0
Eurobarometer,1,0.0
Rogers,1,0.0
reflexivity,1,0.0
Educated,1,0.0
post-industrial,1,0.0
distrustful,1,0.0
formulary,1,0.0
3457,1,0.0
27496,1,0.0
1651,1,0.0
26984,1,0.0
1459,1,0.0
mite-impermeable,1,0.0
Genesig,1,0.0
1copy,1,0.0
DNA-Techonolgy,1,0.0
Ustar,1,0.0
Amplification-Real,1,0.0
DNA-technology,1,0.0
81-99I29296,1,0.0
91-95,1,0.0
cause-hospitalization,1,0.0
78-100I29780,1,0.0
Cyrillic,1,0.0
GSM,1,0.0
short-message,1,0.0
2724,1,0.0
1731,1,0.0
7763,1,0.0
7825,1,0.0
7888,1,0.0
0497,1,0.0
2857-1756,1,0.0
2314-1948,1,0.0
3779,1,0.0
-2214,1,0.0
-15-16,1,0.0
-12-16,1,0.0
-22-16,1,0.0
frontal-lenticulocapsular-pontine,1,0.0
Trasient,1,0.0
myoglobinaemia,1,0.0
226997,1,0.0
23-35,1,0.0
average-risk,1,0.0
-4-11,1,0.0
18336,1,0.0
co-organised,1,0.0
serological-based,1,0.0
Full-text,1,0.0
n1166,1,0.0
61-92I29528,1,0.0
belive,1,0.0
amplifiaction,1,0.0
inline,1,0.0
thromboelastography,1,0.0
28027100000,1,0.0
113100000,1,0.0
232100000,1,0.0
022011,1,0.0
112011,1,0.0
BBrisbane602008,1,0.0
KUNO-Kids,1,0.0
exaggeratedConclusion,1,0.0
Spike-Fc,1,0.0
downmodulates,1,0.0
drugsHerein,1,0.0
relacion,1,0.0
extra-cellular,1,0.0
wwwnycgov,1,0.0
htmldohhtmlcmhaindexhtml,1,0.0
publicprivate,1,0.0
Arteriosclerotic,1,0.0
valinevaline,1,0.0
plasmasera,1,0.0
BackgroundAcross,1,0.0
infectionMethodsWe,1,0.0
OPinpatient,1,0.0
EuropeResultsIn,1,0.0
33-40,1,0.0
22-31,1,0.0
32-50,1,0.0
27-40,1,0.0
31-34,1,0.0
21-27,1,0.0
352010-172011,1,0.0
per-sample,1,0.0
cfuml,1,0.0
Fluids1Of,1,0.0
Thromboelastography,1,0.0
so-approved,1,0.0
an-at,1,0.0
intermittent-obstructive,1,0.0
aphthous-like,1,0.0
USSC,1,0.0
MN-CBC,1,0.0
Worker,1,0.0
metalworking,1,0.0
compressors,1,0.0
Full-shift,1,0.0
3was,1,0.0
Metalworking,1,0.0
smash,1,0.0
Annealing,1,0.0
Document1p,1,0.0
extravagant,1,0.0
patients-those,1,0.0
2019-infected,1,0.0
obstetrician-gynecologists,1,0.0
respectfully,1,0.0
ProMedica,1,0.0
6313,1,0.0
0246,1,0.0
0472,1,0.0
Marginally,1,0.0
0741,1,0.0
antigenicgenetic,1,0.0
ze,1,0.0
winter-season,1,0.0
196869,1,0.0
57-10,1,0.0
orthostasis,1,0.0
6104,1,0.0
angstroms,1,0.0
High-yield,1,0.0
02-2,1,0.0
hydatidosis,1,0.0
refinery,1,0.0
electroplating,1,0.0
NH42PdCl4,1,0.0
-35,1,0.0
metal-induced,1,0.0
anti-seasonal,1,0.0
copayments,1,0.0
Lian-zhongs,1,0.0
Shousanli,1,0.0
Hegu,1,0.0
Sidu,1,0.0
Fenglong,1,0.0
Tengyue,1,0.0
Taichong,1,0.0
Xiangu,1,0.0
Zulinqi,1,0.0
Dazhong,1,0.0
Genjian,1,0.0
Zhaohai,1,0.0
Fuliu,1,0.0
solvent-based,1,0.0
force-fields,1,0.0
ratifying,1,0.0
interaction009,1,0.0
09-238,1,0.0
155-269,1,0.0
P055,1,0.0
polygenomic,1,0.0
thiols,1,0.0
v140SE,1,0.0
totalizing,1,0.0
5744,1,0.0
29-63,1,0.0
56-72,1,0.0
non-specified,1,0.0
pH-reflux,1,0.0
2-stimulant,1,0.0
triangulate,1,0.0
P015,1,0.0
P017,1,0.0
P038,1,0.0
075-123,1,0.0
P008,1,0.0
incentivized,1,0.0
nucleic-based,1,0.0
fraction-LAEF,1,0.0
DSM-III-R,1,0.0
Dolabchians,1,0.0
PATIENT,1,0.0
Iso,1,0.0
S1w,1,0.0
-angiotensin-converting,1,0.0
2128,1,0.0
101-141,1,0.0
137-222,1,0.0
maiden,1,0.0
Tr-,1,0.0
1959-1999,1,0.0
493-163,1,0.0
biogeochemical,1,0.0
Concrete,1,0.0
low-abundance,1,0.0
IP4-RdRP,1,0.0
IP4,1,0.0
16185,1,0.0
non-positive,1,0.0
mindbody,1,0.0
nonneurologists,1,0.0
discreet,1,0.0
Benton,1,0.0
Chattanooga,1,0.0
»True«,1,0.0
acetone-methanol,1,0.0
M-PER,1,0.0
non-denaturing,1,0.0
contralaterally,1,0.0
1259,1,0.0
explosives,1,0.0
sniffing,1,0.0
3290,1,0.0
K9,1,0.0
3134,1,0.0
fibrinolytic-treated,1,0.0
thienopyridine,1,0.0
sizedesign,1,0.0
survey-specific,1,0.0
RSImechanical,1,0.0
temperatureweather,1,0.0
misguided,1,0.0
self-medicating,1,0.0
injudicious,1,0.0
AH7N9-affected,1,0.0
QTD,1,0.0
infar-tion,1,0.0
Electrocardiagrams,1,0.0
embody,1,0.0
bunker,1,0.0
7885,1,0.0
4001,1,0.0
Deferred,1,0.0
strategyABSTRACT,1,0.0
coins,1,0.0
emitting,1,0.0
LEDs,1,0.0
UVC-exposure,1,0.0
multifractal,1,0.0
TFT,1,0.0
Hurst,1,0.0
Dombkowski,1,0.0
Hassan,1,0.0
Wasilevich,1,0.0
Zanconato,1,0.0
Meneghelli,1,0.0
Braga,1,0.0
Zacchello,1,0.0
Baraldi,1,0.0
thin-film-transistor,1,0.0
digital-microfluidics,1,0.0
aQdrop™,1,0.0
addressable,1,0.0
2-22,1,0.0
9-24ConclusionsLaboratory-confirmed,1,0.0
post-PA,1,0.0
325mg,1,0.0
Vigili,1,0.0
Fuoco,1,0.0
disease--namely,1,0.0
hyperresponsiveness--are,1,0.0
enzymeimmunoassay,1,0.0
Viol,1,0.0
101002jmv25728,1,0.0
physiologies,1,0.0
unbiasedstatistical,1,0.0
Hyperhomocysteinaemia,1,0.0
vaccinesadjuvants,1,0.0
employedABSTRACT,1,0.0
5600,1,0.0
8-16-year-old,1,0.0
Buddy,1,0.0
Hero,1,0.0
mutation-more,1,0.0
1ng,1,0.0
Phosphorus-31,1,0.0
food-dependent,1,0.0
research-investigating,1,0.0
deviceMethods,1,0.0
SocietyResults,1,0.0
08Conclusions,1,0.0
readjust,1,0.0
confimed,1,0.0
mammalians,1,0.0
Avians,1,0.0
Autoptic,1,0.0
Nazionale,1,0.0
Corpo,1,0.0
ISPESL,1,0.0
targetsAreas,1,0.0
websitesreference,1,0.0
AGREE,1,0.0
testslaboratory,1,0.0
httpswwwcrdyorkacukPROSPERO,1,0.0
CRD42019127822,1,0.0
Szabolcs-Szatmar-Bereg,1,0.0
Szabolcs-,1,0.0
Szatmár-Bereg,1,0.0
15-29,1,0.0
156-5187,1,0.0
fumeirritant,1,0.0
blankets,1,0.0
Two-tailed,1,0.0
CT-sensitivity,1,0.0
62694,1,0.0
Triage®,1,0.0
multimarker,1,0.0
D-Dimers,1,0.0
Matrix-Metalloproteinase-9,1,0.0
Multimarkerindex,1,0.0
MMX,1,0.0
fasten,1,0.0
1950-1975,1,0.0
IRAN,1,0.0
ware,1,0.0
ISAAC-written,1,0.0
6236,1,0.0
Childs,1,0.0
miosis,1,0.0
host-nation,1,0.0
happen-the,1,0.0
posteriorinferior,1,0.0
Neoteryx,1,0.0
electrochemiluminescence-based,1,0.0
now-a-days,1,0.0
well-growing,1,0.0
well-spreading,1,0.0
14117,1,0.0
1554,1,0.0
humble,1,0.0
IRAs,1,0.0
motoneurons,1,0.0
brain-stem,1,0.0
COVID-free,1,0.0
pre-triage,1,0.0
COVID-suspected,1,0.0
door-to-treatment,1,0.0
5945,1,0.0
neoplasma,1,0.0
rehabilitationeducation,1,0.0
EBBSP,1,0.0
rebirth,1,0.0
empathize,1,0.0
4849,1,0.0
4949,1,0.0
NECoV19,1,0.0
Zn-chitosan,1,0.0
Adju-Phos,1,0.0
NT70,1,0.0
14580,1,0.0
NT80,1,0.0
absorptive,1,0.0
fingerprick,1,0.0
Mataró,1,0.0
West-Nile,1,0.0
relivers,1,0.0
shortacting,1,0.0
anti-complement,1,0.0
Nord,1,0.0
T55S,1,0.0
V56F,1,0.0
E69R,1,0.0
G70del,1,0.0
coil➔helix,1,0.0
H-bonds,1,0.0
Tyr42,1,0.0
Tyr57,1,0.0
N145S,1,0.0
monkeypox,1,0.0
Minden,1,0.0
killers,1,0.0
zoonotics,1,0.0
Moderate-to-Severe,1,0.0
500-600,1,0.0
medicallegal,1,0.0
detailPurposeTo,1,0.0
humansMaterials,1,0.0
MethodsFifty-one,1,0.0
16-76,1,0.0
evaluatedResultsFifty,1,0.0
patientsConclusionPatients,1,0.0
pneumonia©,1,0.0
Nal,1,0.0
guidelinesconsensus,1,0.0
flu-considered,1,0.0
cerebello-parietal,1,0.0
248558,1,0.0
Heberden,1,0.0
antithesis,1,0.0
injury-vasospasm,1,0.0
injury-spasm,1,0.0
fight-flight,1,0.0
conservation-withdrawal,1,0.0
14444,1,0.0
≈9,1,0.0
Safer,1,0.0
21-54,1,0.0
13-30,1,0.0
56-96,1,0.0
microdissected,1,0.0
nonoperated,1,0.0
9613,1,0.0
15600,1,0.0
preoptic,1,0.0
supraoptic,1,0.0
subfornical,1,0.0
ceruleus,1,0.0
RCFs,1,0.0
tray-carrying,1,0.0
slow-stream,1,0.0
asthma-attack,1,0.0
college-age,1,0.0
Breathe,1,0.0
Dartmouth,1,0.0
125048,1,0.0
CeAD-related,1,0.0
pre-infarct,1,0.0
types--the,1,0.0
non-enhancement,1,0.0
mouthrinse,1,0.0
Trujillo,1,0.0
iFlash3000,1,0.0
within-laboratory,1,0.0
EP15-A3,1,0.0
no-antibody,1,0.0
froms,1,0.0
Bayley,1,0.0
influenza-virus-diseases,1,0.0
influenza-virus-strain,1,0.0
phospho,1,0.0
scalers,1,0.0
air-water,1,0.0
handpieces,1,0.0
peopleBesides,1,0.0
hypo-enhanced,1,0.0
Bernard,1,0.0
Graneek,1,0.0
34000,1,0.0
interrelatedness,1,0.0
antihistamine-containing,1,0.0
shock-resistive,1,0.0
A23T,1,0.0
AlgeriaEPIISL418241,1,0.0
AlgeriaEPIISL420037,1,0.0
T1004I,1,0.0
AlgeriaG37318-88492020EPIISL766863,1,0.0
Gadolinium-diethylenetriamine,1,0.0
42-03,1,0.0
3582233,1,0.0
drugexacerbated,1,0.0
r-0283,1,0.0
cerebrocardiovascular,1,0.0
Bi-variable,1,0.0
2327,1,0.0
univariated,1,0.0
16-352,1,0.0
16-134,1,0.0
seizure-free,1,0.0
queued,1,0.0
deliverable,1,0.0
decentralize,1,0.0
bioprocesses,1,0.0
professionalism,1,0.0
nationally-representative,1,0.0
3739,1,0.0
sequenation,1,0.0
microchip-based,1,0.0
58-year-old-man,1,0.0
interscapular,1,0.0
hypoattenuating,1,0.0
Turbohaler,1,0.0
graftingventricular,1,0.0
237828,1,0.0
Istituto,1,0.0
Superiore,1,0.0
34448,1,0.0
Khalid,1,0.0
1005±1268,1,0.0
3729±1297,1,0.0
4385±1177,1,0.0
p00198,1,0.0
concern†,1,0.0
2020-May,1,0.0
177044,1,0.0
host-acting,1,0.0
underdosing,1,0.0
needle-tipped,1,0.0
weightleft,1,0.0
263200,1,0.0
microns2,1,0.0
registrar,1,0.0
250625,1,0.0
002-003,1,0.0
non-prospective,1,0.0
sequencebased,1,0.0
H275Y-bearing,1,0.0
recruitement,1,0.0
inaptitude,1,0.0
TAMIS-II,1,0.0
DNA-assisted,1,0.0
1837,1,0.0
1775,1,0.0
n≥25,1,0.0
500mL,1,0.0
micronecrosis,1,0.0
stroke-none,1,0.0
woeful,1,0.0
opacification1,1,0.0
defect2,1,0.0
defect3,1,0.0
post-and,1,0.0
speacling,1,0.0
non-quantitative,1,0.0
reductionistic,1,0.0
three-center,1,0.0
1976--77,1,0.0
education-based,1,0.0
12-session,1,0.0
catharsis,1,0.0
Characterising,1,0.0
neuro-PASC,1,0.0
Humanity,1,0.0
feces-,1,0.0
sewage-derived,1,0.0
angioplastyPTCA,1,0.0
InfarctionTIMI,1,0.0
motionr,1,0.0
0558,1,0.0
reservemaxQcQn,1,0.0
PTCAr,1,0.0
0768,1,0.0
mother-to-newborn,1,0.0
preconditioning-based,1,0.0
STudy,1,0.0
ADenosine,1,0.0
IONA,1,0.0
postconditioning--in,1,0.0
sequences--is,1,0.0
quiescence,1,0.0
HK1,1,0.0
vest,1,0.0
Noted,1,0.0
self-regulation--that,1,0.0
behavior--individuals,1,0.0
patient-management,1,0.0
perfunctory,1,0.0
disability-related,1,0.0
pre-empting,1,0.0
NCT02560935,1,0.0
akenesia,1,0.0
Wuhans,1,0.0
prestratified,1,0.0
40-17,1,0.0
164-61,1,0.0
24-74,1,0.0
12-46,1,0.0
13-183,1,0.0
Pipeline,1,0.0
COVGAP,1,0.0
time-calibrated,1,0.0
83·6,1,0.0
68·2,1,0.0
C15324T,1,0.0
B1-C15324T,1,0.0
tri-national,1,0.0
returners,1,0.0
up-coming,1,0.0
NCT04351503,1,0.0
Illu,1,0.0
Aba,1,0.0
Bora,1,0.0
Buno,1,0.0
Bedelle,1,0.0
Creatinephosphokinase,1,0.0
Self-Perception,1,0.0
Punnett,1,0.0
Intercorrelations,1,0.0
principal-components,1,0.0
35601,1,0.0
nonlinearly,1,0.0
time-adjusted,1,0.0
9501,1,0.0
House-dust-mite,1,0.0
0156,1,0.0
self-renew,1,0.0
postmitotic,1,0.0
Tripoli,1,0.0
Libya,1,0.0
50-7143,1,0.0
des-Arg,1,0.0
937-bradykinin,1,0.0
kinin-kallikrein,1,0.0
immune-mechanisms,1,0.0
inflammationtissue-damage,1,0.0
cerebral-mediated,1,0.0
counterreactions,1,0.0
Posterior-wall,1,0.0
Bradycardic,1,0.0
typicality,1,0.0
pillow,1,0.0
Work-Exacerbated,1,0.0
pediatrician-pulmonologist,1,0.0
cruciferae,1,0.0
mustard,1,0.0
Cross-allergy,1,0.0
30-51,1,0.0
terrorists,1,0.0
Depth,1,0.0
dialed,1,0.0
blurring,1,0.0
segmentouter,1,0.0
maculopathy,1,0.0
real‑time,1,0.0
Everlywell,1,0.0
LapCorp,1,0.0
yellow-gold-stained,1,0.0
Allergen-avoidance,1,0.0
Renewed,1,0.0
mayhem,1,0.0
Qs,1,0.0
LDHQ72,1,0.0
LVef,1,0.0
life-events,1,0.0
influenza-morbidity,1,0.0
ILI-figures,1,0.0
season-years,1,0.0
proportionallyABSTRACT,1,0.0
quantometer,1,0.0
SEMQ,1,0.0
Logically,1,0.0
peristent,1,0.0
genotype-to-phenotype,1,0.0
parsimoniously,1,0.0
unremarked,1,0.0
boom-and-bust,1,0.0
SIRVA,1,0.0
bursa,1,0.0
2554,1,0.0
June-October,1,0.0
1911-1926,1,0.0
1987-1992,1,0.0
titer-mediated,1,0.0
ABrisbane592007H1N1,1,0.0
Rico81934H1N1,1,0.0
insertiondeletions,1,0.0
CPCs,1,0.0
neurosonography,1,0.0
13751,1,0.0
1-3481,1,0.0
1575,1,0.0
2-4000,1,0.0
3-3808,1,0.0
2185,1,0.0
1-2319,1,0.0
2-2615,1,0.0
3-2299,1,0.0
1449,1,0.0
Mumps,1,0.0
Macugen®,1,0.0
Onpattro®,1,0.0
transthyretin-coding,1,0.0
Suring,1,0.0
setting-specific,1,0.0
maximand,1,0.0
interconnective,1,0.0
Elmhurst,1,0.0
545-bed,1,0.0
45712,1,0.0
58828,1,0.0
45918,1,0.0
54743,1,0.0
451214,1,0.0
11647,1,0.0
528857,1,0.0
14538,1,0.0
452222,1,0.0
10842,1,0.0
high-pitched,1,0.0
hyper-glycemia,1,0.0
recognized-the,1,0.0
experimentally-infected,1,0.0
134-154,1,0.0
MRRadjusted,1,0.0
095-110,1,0.0
5224,1,0.0
74000,1,0.0
gritty,1,0.0
equalizes,1,0.0
PRACtical,1,0.0
ALLergy,1,0.0
1900-1919,1,0.0
9003,1,0.0
4890,1,0.0
naturally-infected,1,0.0
rank-order-correlation,1,0.0
done--recognizing,1,0.0
SARS-CoV-2-LIPS-N,1,0.0
nineth,1,0.0
admissiondischarge,1,0.0
needle-stick,1,0.0
Susceptible-Infectious-recovered,1,0.0
Perus,1,0.0
phenotype-directed,1,0.0
B1177,1,0.0
S898F,1,0.0
ΔY144,1,0.0
S162G,1,0.0
D1118H,1,0.0
polyphyletic,1,0.0
5098,1,0.0
dipyridamoleABSTRACT,1,0.0
28th-30th,1,0.0
Asthma-one,1,0.0
inter-provinces,1,0.0
pseudo-shift,1,0.0
MIOS,1,0.0
histamine-liberation,1,0.0
PERFECT,1,0.0
cytoplasmatic,1,0.0
postinfarctional,1,0.0
undemanding,1,0.0
Expectably,1,0.0
endurance-trained,1,0.0
chilhood,1,0.0
Camps,1,0.0
fellows-in-training,1,0.0
cheer-leadersFifty-four,1,0.0
Campers,1,0.0
questionaire,1,0.0
double-tested,1,0.0
Mimmunoglobulin,1,0.0
ambulatories,1,0.0
Sabin,1,0.0
2343708,1,0.0
Flue,1,0.0
Bakcuspun,1,0.0
Vaksigrip,1,0.0
pyodermia,1,0.0
parent-initiated,1,0.0
PIOCS,1,0.0
201-thallium,1,0.0
1st-2nd,1,0.0
2716100000,1,0.0
1276100000,1,0.0
112100000,1,0.0
-B1527,1,0.0
adults-is,1,0.0
control-ie,1,0.0
tinderbox,1,0.0
saddest,1,0.0
reimagine,1,0.0
682153-2162,1,0.0
4752,1,0.0
00217,1,0.0
haunts,1,0.0
cytoskeleton-related,1,0.0
yeast-derived,1,0.0
gender-age,1,0.0
HLA-A2501,1,0.0
-B4601,1,0.0
396100000,1,0.0
-C0102,1,0.0
-C0729,1,0.0
HLA-A0202,1,0.0
-B1503,1,0.0
-C1203,1,0.0
IL1R1,1,0.0
IL1RN,1,0.0
3p2131,1,0.0
9q342,1,0.0
risk-genes,1,0.0
J-40,1,0.0
J47,1,0.0
J44,1,0.0
salvation,1,0.0
Thiele,1,0.0
Zeymer,1,0.0
Carnosol,1,0.0
3055,1,0.0
Klebsiellapneumoniae,1,0.0
virus-like-particles,1,0.0
GFPΔN,1,0.0
N-expressing,1,0.0
intein-mediated,1,0.0
trans-splicing,1,0.0
salinomycin,1,0.0
tubeimoside,1,0.0
nigericin,1,0.0
Prevotella,1,0.0
melaninogenica,1,0.0
Streptobacillus,1,0.0
Porphyromonas,1,0.0
Granulicatella,1,0.0
elegans,1,0.0
Veillonella,1,0.0
dispar,1,0.0
Dazhui,1,0.0
Fengmen,1,0.0
factor-beta1,1,0.0
infec-tious,1,0.0
fatalitycase,1,0.0
double-inactivation,1,0.0
DNases,1,0.0
Wuzhi,1,0.0
sincere,1,0.0
6Y84,1,0.0
AutoDock-42,1,0.0
3081,1,0.0
counterintuitively,1,0.0
infections-all,1,0.0
Heberdens,1,0.0
r0910,1,0.0
beused,1,0.0
post-analytical,1,0.0
nCoV19,1,0.0
DCPR,1,0.0
audio-taped,1,0.0
Logotherapy,1,0.0
Existential,1,0.0
fate-,1,0.0
faith-related,1,0.0
hemiazygos,1,0.0
32486,1,0.0
rbl,1,0.0
piecemeal,1,0.0
mollify,1,0.0
uncritical,1,0.0
Technology-based,1,0.0
Taoyuan,1,0.0
Foggia,1,0.0
trimetasidine,1,0.0
unquantifiable,1,0.0
resonance-derived,1,0.0
brain-induced,1,0.0
interdependences,1,0.0
alpha-thalassaemia,1,0.0
Haemosiderosis,1,0.0
deferoxamine,1,0.0
erythrocytapheresis,1,0.0
MGLTools-156,1,0.0
Arjunglucoside-I,1,0.0
r-0133,1,0.0
-788,1,0.0
181-043,1,0.0
perinatally,1,0.0
single-event,1,0.0
httpsdoiorg1023641asha7849304,1,0.0
Creola,1,0.0
Sputa,1,0.0
Smears,1,0.0
A-B-C-D,1,0.0
Ranking,1,0.0
Montebello,1,0.0
-0183,1,0.0
-0238,1,0.0
0586,1,0.0
-0294,1,0.0
teleworking,1,0.0
STRIDE,1,0.0
sw2009,1,0.0
straightened,1,0.0
herniate,1,0.0
domain-like,1,0.0
viroporins,1,0.0
Neuroleptanalgesic,1,0.0
Reddy’s,1,0.0
Pharma,1,0.0
Immunologicals,1,0.0
Forums,1,0.0
H1N1pdm09-infected,1,0.0
puerperal,1,0.0
SPRING,1,0.0
261-022,1,0.0
LVWSI,1,0.0
384-95,1,0.0
Pseudomyxoma,1,0.0
Rosmanol,1,0.0
-799,1,0.0
trialsCommunicated,1,0.0
technologies-mobile,1,0.0
robotically,1,0.0
angiography-as,1,0.0
Surinamese-,1,0.0
Antillean,1,0.0
Ischemia-reperfusion,1,0.0
methylationacetylation,1,0.0
less-than-optimal,1,0.0
Advisors,1,0.0
recombinant-based,1,0.0
peritonei,1,0.0
359-63,1,0.0
mucopolysaccharides,1,0.0
cytoreductive,1,0.0
pressure-based,1,0.0
Cardiosurgery,1,0.0
1st-21st,1,0.0
Doppler-echocardiography,1,0.0
Kay,1,0.0
Medial-lateral,1,0.0
368-26,1,0.0
239-056,1,0.0
29-02,1,0.0
533-6,1,0.0
50-41,1,0.0
r0721,1,0.0
r0849,1,0.0
Neumann,1,0.0
reflowed,1,0.0
infectious-disease,1,0.0
280588,1,0.0
autosomally,1,0.0
16p131,1,0.0
underrate,1,0.0
aspartate-transaminase,1,0.0
four-weekly,1,0.0
myopic,1,0.0
microgg,1,0.0
allergen-impermeable,1,0.0
encasement,1,0.0
water-sealing,1,0.0
three-bottle,1,0.0
Extraction,1,0.0
dissuaded,1,0.0
heliox-driven,1,0.0
17million,1,0.0
200billion,1,0.0
Haemovigilance,1,0.0
JN,1,0.0
Aligarh,1,0.0
Hindus,1,0.0
gamma-irradiation,1,0.0
OZG-3861,1,0.0
SK-01,1,0.0
management--that,1,0.0
100-130,1,0.0
mmHg60-80,1,0.0
mmHg0133,1,0.0
LatinoHispanic,1,0.0
HFCWO-NPPV,1,0.0
expectorating,1,0.0
Ebelt,1,0.0
FJ,1,0.0
Ferenc,1,0.0
Olbrich,1,0.0
Hausleiter,1,0.0
Richardt,1,0.0
Hennersdorf,1,0.0
Empen,1,0.0
Fuernau,1,0.0
Desch,1,0.0
Eitel,1,0.0
Hambrecht,1,0.0
Fuhrmann,1,0.0
Böhm,1,0.0
Schneider,1,0.0
homingsurvival,1,0.0
Schuler,1,0.0
Werdan,1,0.0
3671287-1296,1,0.0
Repositioned,1,0.0
BCESs,1,0.0
AIBCESs,1,0.0
R0052,1,0.0
longum,1,0.0
R0033,1,0.0
R0071,1,0.0
P≤,1,0.0
bifidobacteria,1,0.0
APN-related,1,0.0
anesthesio-logist,1,0.0
kitsmethods,1,0.0
correlativity,1,0.0
malcoaptation,1,0.0
7176,1,0.0
hyper-methylation,1,0.0
valerate,1,0.0
from-and,1,0.0
in-a,1,0.0
retrievable-stent,1,0.0
scinitgrams,1,0.0
99mTc-stannous,1,0.0
multi-indexes,1,0.0
15-92,1,0.0
0950,1,0.0
0704,1,0.0
0660,1,0.0
0532,1,0.0
0596,1,0.0
0778,1,0.0
0592,1,0.0
2031,1,0.0
0967,1,0.0
7691013,1,0.0
Satomi,1,0.0
Mori,1,0.0
1970-1978,1,0.0
cRNAvRNA,1,0.0
inlfuenza,1,0.0
morphopathological,1,0.0
rehabilitation-dependent,1,0.0
hemorrhagia,1,0.0
n107,1,0.0
SPARKLE,1,0.0
thejeopardized,1,0.0
5-year-survival,1,0.0
BASIGIN,1,0.0
Josephs,1,0.0
Tampa,1,0.0
mid-2000s,1,0.0
analysisConclusion,1,0.0
givenThe,1,0.0
BMassachusetts,1,0.0
Divalent,1,0.0
effectThe,1,0.0
triumph,1,0.0
450229,1,0.0
6414,1,0.0
4997100000,1,0.0
2554100000,1,0.0
sounder,1,0.0
078ABSTRACT,1,0.0
socio-economy,1,0.0
7791,1,0.0
4483,1,0.0
17994,1,0.0
antimigraine,1,0.0
lomerizine,1,0.0
Alan,1,0.0
Glasper,1,0.0
sub-lineages,1,0.0
mV15,1,0.0
Idioventricular,1,0.0
beatshour,1,0.0
beathour,1,0.0
2430,1,0.0
0--14,1,0.0
nurtured,1,0.0
task-adaptive,1,0.0
7578,1,0.0
Croydon,1,0.0
Alkyl,1,0.0
carcinogen,1,0.0
males11,1,0.0
Interparental,1,0.0
Relatedness,1,0.0
Hopelessness,1,0.0
RSA--an,1,0.0
Triangulation,1,0.0
Insecure,1,0.0
Cov-2,1,0.0
152280,1,0.0
68102,1,0.0
not-yet-decided,1,0.0
82280,1,0.0
3582,1,0.0
fevermyalgiaheadache,1,0.0
AIRD-flares,1,0.0
pathogenically,1,0.0
Solid-organ,1,0.0
belatacept,1,0.0
Vax,1,0.0
Asociación,1,0.0
Vacunología,1,0.0
AEV,1,0.0
life-lasting,1,0.0
broader-spectrum,1,0.0
QLQ,1,0.0
pretrained,1,0.0
intra-domain,1,0.0
7744,1,0.0
KongA2,1,0.0
KRT25,1,0.0
P37510-5,1,0.0
P000095,1,0.0
PD20-based,1,0.0
Ig-like,1,0.0
blockaded,1,0.0
KIM1-derived,1,0.0
AP2,1,0.0
objected,1,0.0
interiorly,1,0.0
falciform,1,0.0
perihepatic,1,0.0
diaphragmatis,1,0.0
routs,1,0.0
alveolocapillary,1,0.0
2021506e242-e244,1,0.0
influenzahepatitis,1,0.0
congeners,1,0.0
322-1455,1,0.0
8967,1,0.0
binding-free,1,0.0
Anti-pneumoncoccal,1,0.0
un-remittent,1,0.0
hipertension,1,0.0
Electromechanic,1,0.0
HRV-infected,1,0.0
6-day-old,1,0.0
defibrase,1,0.0
1968-1972,1,0.0
0330,1,0.0
ths,1,0.0
20058,1,0.0
24516,1,0.0
associated-mortality,1,0.0
bronchosecretion,1,0.0
03-1,1,0.0
Atropine,1,0.0
H1-receptors,1,0.0
483-112,1,0.0
076-204,1,0.0
164-334,1,0.0
060-271,1,0.0
026-075,1,0.0
fevercoughmyalgia,1,0.0
Ga-FAPI-04,1,0.0
Ga-FAPI,1,0.0
concretely,1,0.0
oseltamivirzanamivir,1,0.0
hemostaseologyhemodynamics,1,0.0
HELLP-syndrome,1,0.0
C33T,1,0.0
Glycoproteins,1,0.0
α-13-galactose,1,0.0
PK-15,1,0.0
unattenuated,1,0.0
imperatively,1,0.0
cardionuclear,1,0.0
face-to,1,0.0
ICHD-III-beta,1,0.0
Morever,1,0.0
systemsWe,1,0.0
milrinone,1,0.0
deaths100000,1,0.0
8853986,1,0.0
NACG,1,0.0
Alpha-1-antitrypsin,1,0.0
6317,1,0.0
3674,1,0.0
16262,1,0.0
Hayashi,1,0.0
Non-cardiac,1,0.0
house-wife,1,0.0
joblessness,1,0.0
multifariously,1,0.0
--In,1,0.0
re-infarctionQ-wave,1,0.0
endopeptidases,1,0.0
proteinases,1,0.0
definitly,1,0.0
charging,1,0.0
VESD,1,0.0
03042020,1,0.0
Kong68-like,1,0.0
veno-veno-arterial,1,0.0
-08,1,0.0
unitsg,1,0.0
pandemicsIMPORTANCE,1,0.0
1918-when,1,0.0
H1N1-dominated,1,0.0
99m-tetrofosmin,1,0.0
Uneven,1,0.0
low-ventilation,1,0.0
non-mold,1,0.0
undiminished,1,0.0
rs72821893,1,0.0
nominally,1,0.0
bronchoconstrictionhypersecretion,1,0.0
before2,1,0.0
bat-SARS-like,1,0.0
domestication,1,0.0
eighty-seven,1,0.0
AWellington12004,1,0.0
Caledonia2099H1N1-like,1,0.0
AWellington,1,0.0
12004H3N2-like,1,0.0
pharmacotherapeutics,1,0.0
therapyThe,1,0.0
cornerstoneThe,1,0.0
infarctionThis,1,0.0
Chilaiditi,1,0.0
aerometric,1,0.0
excerbations,1,0.0
infectionsABSTRACT,1,0.0
contextually,1,0.0
expert-recommended,1,0.0
Low-Income,1,0.0
High-Income,1,0.0
cross-priming,1,0.0
B-F,1,0.0
Interrupting,1,0.0
ß-1a,1,0.0
Co-primary,1,0.0
treatment-eligible,1,0.0
α26,1,0.0
n1298,1,0.0
prothromobotic,1,0.0
levelsstatus,1,0.0
bat-SARS-like-CoV,1,0.0
431835,1,0.0
7885123,1,0.0
9110,1,0.0
oncolytic,1,0.0
noncellular,1,0.0
antivector,1,0.0
non-N-wave,1,0.0
N-NSTEMI,1,0.0
pinnacle,1,0.0
sine,1,0.0
qua,1,0.0
nod,1,0.0
precision-cut,1,0.0
reprograming,1,0.0
trapezoidal,1,0.0
5310,1,0.0
rkDNA-graphene,1,0.0
gasotransmitter,1,0.0
rkDNA-GO,1,0.0
21902,1,0.0
074-12,1,0.0
069-004,1,0.0
6893,1,0.0
082-008,1,0.0
Hypomagnesaemia,1,0.0
17-69,1,0.0
highest-reliability,1,0.0
life-styles,1,0.0
three-generation,1,0.0
fibroadenoma,1,0.0
rotten,1,0.0
convenes,1,0.0
veil,1,0.0
self-confidenceABSTRACT,1,0.0
MILIS,1,0.0
350-fold,1,0.0
E119VI,1,0.0
A-315675,1,0.0
unpropagated,1,0.0
mountaineer,1,0.0
unobstructed,1,0.0
non-arrhythmic,1,0.0
Occident,1,0.0
clinical-onset,1,0.0
serpiginous,1,0.0
pregnancyand,1,0.0
diedtwo,1,0.0
hemangioma,1,0.0
1712,1,0.0
2008-June,1,0.0
RRSD,1,0.0
low-LF,1,0.0
high-HF,1,0.0
grade-school,1,0.0
encephalpathy,1,0.0
nQ,1,0.0
-086,1,0.0
NHEFS,1,0.0
Camey,1,0.0
Ahern,1,0.0
Frasure-Smith,1,0.0
Ouagadougou,1,0.0
HA1-part,1,0.0
group-therapy,1,0.0
ATexas122007,1,0.0
Col1A1,1,0.0
c-Kit,1,0.0
3‒5,1,0.0
gm-Eqm2,1,0.0
6-13-year-old,1,0.0
1829,1,0.0
preview,1,0.0
Braşov,1,0.0
1969Altogether,1,0.0
recordedThe,1,0.0
Supplydemand,1,0.0
avoidably,1,0.0
7545,1,0.0
167545,1,0.0
Dear,1,0.0
rateFollowing,1,0.0
seasonal-epidemic,1,0.0
Nkx25,1,0.0
AGIHO,1,0.0
MEP-,1,0.0
dorsiflexor,1,0.0
biometrical,1,0.0
Solar,1,0.0
Hope-Simpsons,1,0.0
non-confirmed,1,0.0
Carceral,1,0.0
carceral,1,0.0
Clinic-based,1,0.0
eHealth,1,0.0
Mef2C,1,0.0
Gata4,1,0.0
non-O,1,0.0
Anti-A,1,0.0
Stavanger,1,0.0
Predi-COVID-H,1,0.0
branching-type,1,0.0
straight-type,1,0.0
carnae,1,0.0
mating,1,0.0
APintailAlberta11979,1,0.0
AWashington89780,1,0.0
300-fold,1,0.0
AWashington80,1,0.0
AMallard78,1,0.0
APintail79,1,0.0
BMI30,1,0.0
libitum,1,0.0
8-isoprostane,1,0.0
carbonyls,1,0.0
4-hydroxynonenal,1,0.0
adducts,1,0.0
Elixhauser,1,0.0
cross-neutralizes,1,0.0
negative-stain,1,0.0
complementarity-determining,1,0.0
stepped-up,1,0.0
screeningMethods,1,0.0
systemResults,1,0.0
notConclusion,1,0.0
combing,1,0.0
amplitude-based,1,0.0
aritcle,1,0.0
semiarid,1,0.0
5q31-33,1,0.0
soothing,1,0.0
75-year,1,0.0
shocking,1,0.0
B1620,1,0.0
Gabapentins,1,0.0
microcommunication,1,0.0
Q192R,1,0.0
L55M,1,0.0
thin-layer,1,0.0
revises,1,0.0
thiazolidinediones,1,0.0
TZDs,1,0.0
metabisulfite,1,0.0
Xofluza,1,0.0
influenzaPatients,1,0.0
affinity-mature,1,0.0
Evolved,1,0.0
Danio,1,0.0
Behind,1,0.0
rerio,1,0.0
Surveying,1,0.0
Jin,1,0.0
Ming,1,0.0
dynasty,1,0.0
postinterventions,1,0.0
drive-up,1,0.0
TDI-challenge,1,0.0
2D-DIGE,1,0.0
rocked,1,0.0
anchorage,1,0.0
carved,1,0.0
books-with,1,0.0
immunopharmacological,1,0.0
hypothesises,1,0.0
lungbody,1,0.0
H2OL,1,0.0
AQAP,1,0.0
30Kb,1,0.0
IFFANIAM,1,0.0
Lawton-Brody,1,0.0
Fried,1,0.0
FRAIL,1,0.0
Assessment-Short,1,0.0
Pro12Ala,1,0.0
C1431T,1,0.0
C-2821T,1,0.0
1994-2014,1,0.0
221684,1,0.0
0972-0977,1,0.0
0971-0974,1,0.0
Splenectomy,1,0.0
reformulating,1,0.0
perplexingly,1,0.0
reclining,1,0.0
intra-oesophageal,1,0.0
three-lead,1,0.0
hierarchial,1,0.0
QX,1,0.0
0105,1,0.0
0308,1,0.0
model-HBM,1,0.0
behavior-TPB,1,0.0
1497,1,0.0
Glaserian,1,0.0
life-giving,1,0.0
citrus,1,0.0
cruciferous,1,0.0
4156,1,0.0
adjacently,1,0.0
diencephalon,1,0.0
infections--viruses,1,0.0
cases--encephalopathy,1,0.0
determinantal,1,0.0
1867,1,0.0
0088,1,0.0
practice--at,1,0.0
mentalities,1,0.0
history-the,1,0.0
abnegation,1,0.0
overflowing,1,0.0
faiths,1,0.0
Prevalent,1,0.0
Apta-Jaeger,1,0.0
4900,1,0.0
pollen-affected,1,0.0
Correlates,1,0.0
305275,1,0.0
Vd,1,0.0
Overnight,1,0.0
double-catheter,1,0.0
pre-LAAO,1,0.0
single-antiplatelet,1,0.0
GCGR,1,0.0
eosinophil-predominant,1,0.0
Th17-mediated,1,0.0
neutrophil-predominant,1,0.0
phosphorylating,1,0.0
charetrestic,1,0.0
Ovalbumin-induced,1,0.0
furnishing,1,0.0
undercount,1,0.0
allergic-type,1,0.0
cromoglicate,1,0.0
predictable-in-time,1,0.0
chronobiologic,1,0.0
27810,1,0.0
74201,1,0.0
53170,1,0.0
44201,1,0.0
28170,1,0.0
37201,1,0.0
34170,1,0.0
090-138,1,0.0
082-210,1,0.0
069-402,1,0.0
043-149,1,0.0
beadcell-based,1,0.0
Spike-ACE2,1,0.0
Trachea,1,0.0
heman,1,0.0
subject-level,1,0.0
frailty-copula,1,0.0
Metropolis-Hastings,1,0.0
Sampler,1,0.0
enoxaparine,1,0.0
synergic,1,0.0
Punctuated,1,0.0
preimplantation,1,0.0
inhalerholding,1,0.0
activity--the,1,0.0
gamma-IFN,1,0.0
alpha-IFN,1,0.0
pronouncedly,1,0.0
vaccines--are,1,0.0
Vivalytic,1,0.0
Schnelltest,1,0.0
medicalscientific,1,0.0
politicallegal,1,0.0
Sentinelles,1,0.0
accross,1,0.0
pansinusitis,1,0.0
graphene-based,1,0.0
Spike-based,1,0.0
pVO2,1,0.0
anaerobe,1,0.0
spiroergometric,1,0.0
that--unlike,1,0.0
disease-dynamic,1,0.0
Gamaleia,1,0.0
fslv508,1,0.0
v60,1,0.0
FreeSurferv60,1,0.0
ipsi-and,1,0.0
contra-lesionally,1,0.0
ipsi-lesionally,1,0.0
Atrophy,1,0.0
complementarily,1,0.0
Convincing,1,0.0
CD10,1,0.0
CD62L,1,0.0
formyl,1,0.0
FlowSOM,1,0.0
over-,1,0.0
winding,1,0.0
mouse-model,1,0.0
defied,1,0.0
Raloxifene,1,0.0
non-apathetic,1,0.0
Erythematosus,1,0.0
31P-NMR,1,0.0
pre-ischemic,1,0.0
Simulation-based,1,0.0
stigmatizing,1,0.0
Thuja,1,0.0
occidentalis,1,0.0
thuja,1,0.0
plicata,1,0.0
Antiserum,1,0.0
arborvitae,1,0.0
Stress-induced,1,0.0
coinfect,1,0.0
ethylmethylhydroxypyridine,1,0.0
b-lipoproteins,1,0.0
nanoimmunoassay,1,0.0
ultralow-volume,1,0.0
27-67,1,0.0
1968-70,1,0.0
Alcoholic,1,0.0
Krebs-Henseleit,1,0.0
fallowed,1,0.0
23±31,1,0.0
97±24,1,0.0
95±23,1,0.0
VEBs,1,0.0
Gabapentin,1,0.0
concordant-positive,1,0.0
uncultured,1,0.0
Barthels,1,0.0
2010-September,1,0.0
cell-entry,1,0.0
receptor-utilizing,1,0.0
non-mammal,1,0.0
Conserving,1,0.0
low-probability,1,0.0
Primersprobes,1,0.0
geneprotein,1,0.0
automatedmanual,1,0.0
aortic-root,1,0.0
echogram,1,0.0
catheter-tip,1,0.0
manometer,1,0.0
pressure-dimension,1,0.0
10-114,1,0.0
apheresis-associated,1,0.0
autopsic,1,0.0
body-weight-support,1,0.0
visual-deprivation,1,0.0
GAITRite,1,0.0
step-time,1,0.0
step-length,1,0.0
UTHealth,1,0.0
radiation-monitoring,1,0.0
h⁻¹,1,0.0
EDTA-dependent,1,0.0
pseudothrombocytopenia,1,0.0
first-in-man,1,0.0
3258,1,0.0
29145,1,0.0
8263,1,0.0
Yemenite,1,0.0
-130,1,0.0
family-,1,0.0
person-seasons,1,0.0
presaging,1,0.0
sharpest,1,0.0
38-53,1,0.0
1965-1969,1,0.0
67-100,1,0.0
system-a,1,0.0
9427392,1,0.0
Kilians,1,0.0
coagglutination,1,0.0
biovar,1,0.0
201Tl-Cl,1,0.0
Restricted,1,0.0
MA15,1,0.0
1409,1,0.0
698±118,1,0.0
angioplastyballoon,1,0.0
translocate,1,0.0
κB,1,0.0
adrenomimetics,1,0.0
PER2,1,0.0
rs12363415,1,0.0
thrombus-removal,1,0.0
X-Sizer,1,0.0
Pro,1,0.0
Stryker,1,0.0
Kalamazoo,1,0.0
ev3,1,0.0
imperilled,1,0.0
-159,1,0.0
9235,1,0.0
-38,1,0.0
glucocorticoids-,1,0.0
MFs,1,0.0
cycles-dependent,1,0.0
example-geomagnetic,1,0.0
MF-mediated,1,0.0
Upto,1,0.0
climateecological,1,0.0
wrecking,1,0.0
fixedscreen,1,0.0
differentiable,1,0.0
nanostars,1,0.0
00048,1,0.0
μAμgmL-1,1,0.0
furtherly,1,0.0
nanosystem,1,0.0
doorway,1,0.0
COV19,1,0.0
250-800,1,0.0
FELTPs,1,0.0
case-hospitalization,1,0.0
pyrexial,1,0.0
≤349,1,0.0
287292,1,0.0
PurFlockTM,1,0.0
OmniSwabsTM,1,0.0
macroinfarct,1,0.0
antibodiesAbs,1,0.0
hyper-osmotic,1,0.0
297-125,1,0.0
n221,1,0.0
n355,1,0.0
0610,1,0.0
CPLP,1,0.0
00111,1,0.0
09754,1,0.0
pseudoparticles,1,0.0
cytokine-directed,1,0.0
period-September-October,1,0.0
1969-and,1,0.0
29-point,1,0.0
R-to-Q,1,0.0
R-to-S,1,0.0
spirometry-diagnosed,1,0.0
gasometry,1,0.0
subresponse,1,0.0
92-agonists,1,0.0
P2-agonist,1,0.0
anti-adhesive,1,0.0
hydrous,1,0.0
Chylothorax,1,0.0
Transudative,1,0.0
peritoneopleural,1,0.0
iodopovidone,1,0.0
safety-and,1,0.0
efficacy-of,1,0.0
government-supported,1,0.0
transfusion-specific,1,0.0
TTN,1,0.0
frecuency,1,0.0
interventionism,1,0.0
Throm-bolysis,1,0.0
Donabedians,1,0.0
Matthews,1,0.0
trainable,1,0.0
invariants,1,0.0
Tuberculosis-sick,1,0.0
sub-mucosa,1,0.0
re-activated,1,0.0
adjective,1,0.0
6785,1,0.0
Lowest,1,0.0
3921,1,0.0
Gynecologists,1,0.0
severity1,1,0.0
expedience,1,0.0
28-years-old,1,0.0
Herlyn,1,0.0
Wunderlich,1,0.0
anti-Mycobacterium,1,0.0
Murry,1,0.0
DCT,1,0.0
prevision,1,0.0
deficiences,1,0.0
recommand,1,0.0
eqlivalent,1,0.0
spike-immunized,1,0.0
biomarker-guided,1,0.0
323±118years,1,0.0
Cannabinoids,1,0.0
A97V-,1,0.0
A97V-RdRp,1,0.0
-241,1,0.0
-173,1,0.0
poodle,1,0.0
NF-kappaB-,1,0.0
magnetoreception,1,0.0
CLOCKBMAL1,1,0.0
yearlong,1,0.0
paroxetine,1,0.0
azodicarbonamide,1,0.0
rewired,1,0.0
Systems-level,1,0.0
sleep-awake,1,0.0
haemodinamic,1,0.0
20-713,1,0.0
40-180,1,0.0
80-430,1,0.0
P0192,1,0.0
5363,1,0.0
4276,1,0.0
1656,1,0.0
treatment--herbal,1,0.0
eaten,1,0.0
recommendation-abiding,1,0.0
Neuroprotectant,1,0.0
humans12,1,0.0
approaches-normobaric,1,0.0
α-phenyl-butyl-tert-nitrone,1,0.0
N-methyl-D-aspartic,1,0.0
MK801-in,1,0.0
Laser-speckle,1,0.0
dUTP,1,0.0
TUNEL-positive,1,0.0
circadian-like,1,0.0
necroptotic,1,0.0
MK801,1,0.0
stategy,1,0.0
Suture,1,0.0
intragroup,1,0.0
4402,1,0.0
complaintsIn,1,0.0
G3P2,1,0.0
Ig-M,1,0.0
toehold,1,0.0
nano-lantern,1,0.0
colorluminescence,1,0.0
PHAsed,1,0.0
NASBA-Translation,1,0.0
PHANTOM,1,0.0
Marginal,1,0.0
statistiscal,1,0.0
SARS-CoV-2Retrospective,1,0.0
studyData,1,0.0
abstractedData,1,0.0
anergy,1,0.0
disk-like,1,0.0
normoergy,1,0.0
Credo,1,0.0
Pte,1,0.0
skeletonised,1,0.0
user-interactive,1,0.0
1174,1,0.0
Team-based,1,0.0
247365,1,0.0
lesion-outcome,1,0.0
data-led,1,0.0
diffusor,1,0.0
cacetylsalicylic,1,0.0
160mm,1,0.0
RTAs,1,0.0
rhinoconjonctivitis,1,0.0
field-sensitive,1,0.0
-efficacy,1,0.0
AOhio776,1,0.0
nasotracheal,1,0.0
accords,1,0.0
eipiphenomena,1,0.0
84000,1,0.0
188000,1,0.0
360000,1,0.0
267000,1,0.0
Eight-five,1,0.0
Eilish,1,0.0
Jukes,1,0.0
unremarkably,1,0.0
nonvolume-averaged,1,0.0
29737453,1,0.0
endeavouring,1,0.0
adolescents2,1,0.0
season3,1,0.0
condition4,1,0.0
vaccinesa,1,0.0
AMichigan452015H1N1pdm09-like,1,0.0
ASingaporeINFIMH-16-00192016H3N2-like,1,0.0
Colorado602017-like,1,0.0
updatedb,1,0.0
Phuket30732013-like,1,0.0
lineage5,1,0.0
vaccines6,1,0.0
infants7,1,0.0
complications8,1,0.0
Cryptochrome,1,0.0
main-stream,1,0.0
lipocytes,1,0.0
Bamrasnaradura,1,0.0
454-781,1,0.0
dextroversion,1,0.0
perisulcular,1,0.0
angiogrpahy,1,0.0
007ABSTRACT,1,0.0
intermittent-dosing,1,0.0
double-occupancy,1,0.0
105-676,1,0.0
antacids,1,0.0
visually-read,1,0.0
Bioeksen,1,0.0
plate-based,1,0.0
Sigmoidal,1,0.0
241-275,1,0.0
003-091,1,0.0
centrepiece,1,0.0
297-3528,1,0.0
111-2882,1,0.0
vanish,1,0.0
persecutory,1,0.0
homicidal,1,0.0
superoanterior,1,0.0
arrestcardiogenic,1,0.0
Moderna®,1,0.0
SOTIRIA,1,0.0
Propedeutic,1,0.0
LAIKO,1,0.0
25-cm,1,0.0
Scope,1,0.0
Best-in-Practice,1,0.0
co-transplantation,1,0.0
thermosensitive,1,0.0
log-term,1,0.0
Flaviviridae,1,0.0
Flavaviridae,1,0.0
Rift,1,0.0
Phlebovirus,1,0.0
Bunyaviridae,1,0.0
Simplexviruses,1,0.0
Herpesviridae,1,0.0
3-CLpro,1,0.0
angiotensin-I,1,0.0
Henrik,1,0.0
1828-1906,1,0.0
playwright,1,0.0
poet,1,0.0
70th,1,0.0
Dead,1,0.0
Awaken,1,0.0
Edvard,1,0.0
Bull,1,0.0
1845-1925,1,0.0
biographic,1,0.0
1906,1,0.0
LMT-acute,1,0.0
resounding,1,0.0
Mini-Review,1,0.0
cauda,1,0.0
equina,1,0.0
GBS-like,1,0.0
Midwifery,1,0.0
third-year,1,0.0
Forest-Spring,1,0.0
Tick-Borne,1,0.0
Pneumoviridae,1,0.0
high-acuity,1,0.0
acclaimed,1,0.0
18113,1,0.0
pharmacokineticpharmacodynamic,1,0.0
neededThe,1,0.0
noncardiomyocyte,1,0.0
driftstrains,1,0.0
2004-2008,1,0.0
mitral-valve,1,0.0
12654,1,0.0
rate--especially,1,0.0
adults--during,1,0.0
80-312,1,0.0
salicylate-intoxicated,1,0.0
magnetism,1,0.0
Orthopneumovirus,1,0.0
trial-tests,1,0.0
hover,1,0.0
medical-,1,0.0
hailing,1,0.0
Blake,1,0.0
implausible,1,0.0
incentive-based,1,0.0
Orthopedic,1,0.0
transfusion-related,1,0.0
7760,1,0.0
non-binary,1,0.0
Coronavirus-1,1,0.0
broad--spectrum,1,0.0
repidly,1,0.0
mirage,1,0.0
adversary,1,0.0
purification-MS,1,0.0
Afterload,1,0.0
LaPlace,1,0.0
renunciation,1,0.0
1685100000,1,0.0
1590-1780100000,1,0.0
1893100000,1,0.0
1751-1780100000,1,0.0
1487100000,1,0.0
1360-1614100000,1,0.0
726100000,1,0.0
663-789100000,1,0.0
851100000,1,0.0
783-919100000,1,0.0
94100000,1,0.0
71-117100000,1,0.0
preventiontherapy,1,0.0
mercy,1,0.0
JBI,1,0.0
Trove,1,0.0
mixed-method,1,0.0
mechanical-reperfusion,1,0.0
IV-associated,1,0.0
1379690,1,0.0
836135,1,0.0
369868,1,0.0
310050,1,0.0
clinician-reported-diagnosed,1,0.0
289120,1,0.0
215610,1,0.0
ARI-related,1,0.0
Self-administration,1,0.0
populationConclusion,1,0.0
161100000,1,0.0
labeling-MS,1,0.0
FET-based,1,0.0
Lius,1,0.0
res-tricted,1,0.0
NACManchester,1,0.0
--especially,1,0.0
illnesses--,1,0.0
sensitivization-dependent,1,0.0
environment-dependent,1,0.0
treatment-dependent,1,0.0
illness-dependent,1,0.0
1995-2003,1,0.0
Stroke-incidence,1,0.0
087100000,1,0.0
SNOT-22Results,1,0.0
025100000,1,0.0
037100000,1,0.0
Agent-Based,1,0.0
licit,1,0.0
decongestant,1,0.0
portents,1,0.0
regrouped,1,0.0
Screenings,1,0.0
questionably,1,0.0
distracted,1,0.0
asthmaObjective,1,0.0
rino-sinusal,1,0.0
Sino-nasal,1,0.0
age-varying,1,0.0
bully,1,0.0
Giddiness,1,0.0
500×-os,1,0.0
Kórház,1,0.0
dolgozóin,1,0.0
adása,1,0.0
elemeztük,1,0.0
előfordulását,1,0.0
oltások,1,0.0
reakciókat,1,0.0
nukleokapszid,1,0.0
elleni,1,0.0
ellenanyag,1,0.0
szintjének,1,0.0
változását,1,0.0
közül,1,0.0
oltást,1,0.0
megelőzően,1,0.0
időszak,1,0.0
hónapjában,1,0.0
alakult,1,0.0
oltási,1,0.0
reakciók,1,0.0
enyhék,1,0.0
voltak,1,0.0
N-antitestek,1,0.0
küszöbértékindexe,1,0.0
mérve,1,0.0
2837,1,0.0
S-antitestek,1,0.0
8015,1,0.0
S-antitest-középértéke,1,0.0
Irgalmasrendi,1,0.0
Budai,1,0.0
igazolása,1,0.0
≈1,1,0.0
dysfunction-raised,1,0.0
Kussmaulls,1,0.0
11-dehydrothromboxane,1,0.0
11-DTB2,1,0.0
13-26,1,0.0
Sin,1,0.0
Nombre,1,0.0
monopoly,1,0.0
monikers,1,0.0
atmospheres,1,0.0
NHGRI-EBI,1,0.0
rs3184504,1,0.0
glycerolipid,1,0.0
log₁₀,1,0.0
immunogenitásának,1,0.0
time-inhomogeneous,1,0.0
Manchuria,1,0.0
generation-time,1,0.0
anatomo-angiographic,1,0.0
koronavírus,1,0.0
általános,1,0.0
gazdasági,1,0.0
krízist,1,0.0
idézett,1,0.0
megfigyeléses,1,0.0
mRNS-Pfizer-BioNTech-vakcina,1,0.0
hatásosságának,1,0.0
biztonságosságának,1,0.0
mintegy,1,0.0
emelkedést,1,0.0
blindsided,1,0.0
mutatott,1,0.0
Streptase,1,0.0
Broncholysin,1,0.0
Spofa,1,0.0
5210,1,0.0
5129,1,0.0
6-12-month,1,0.0
50160-167,1,0.0
Simon,1,0.0
Bolivar,1,0.0
preanalysis,1,0.0
prepossessing,1,0.0
Gyeonggi,1,0.0
4633,1,0.0
data-set,1,0.0
heteroscedasticity,1,0.0
preplaced,1,0.0
snares,1,0.0
pressure-induced,1,0.0
dyskinesis-infarct,1,0.0
artifitial,1,0.0
durnig,1,0.0
Platts-Mills,1,0.0
anwer,1,0.0
Colonoscopy,1,0.0
irretrievable,1,0.0
collegial,1,0.0
11-66,1,0.0
7700-79000,1,0.0
2005-2013,1,0.0
Herricks,1,0.0
cites,1,0.0
Strazhesko,1,0.0
csoportjában,1,0.0
ről,1,0.0
Uml-re,1,0.0
hatásosságát,1,0.0
terjedésének,1,0.0
megakadályozása,1,0.0
igazolja,1,0.0
Következtetések,1,0.0
időszakban,1,0.0
fertőzésen,1,0.0
S-antitest,1,0.0
emelkedése,1,0.0
mérsékelt,1,0.0
emelkedik,1,0.0
jelentős,1,0.0
Obraztsov,1,0.0
S-antitest-termelődést,1,0.0
16239,1,0.0
1551-1557,1,0.0
established-but,1,0.0
literally,1,0.0
profound-in,1,0.0
infectiousparainfectious,1,0.0
006ST,1,0.0
001ST,1,0.0
AMI-patient,1,0.0
lateral-flow-assay,1,0.0
India-wide,1,0.0
2279,1,0.0
79420,1,0.0
59086,1,0.0
7058,1,0.0
overrepresenting,1,0.0
18141,1,0.0
athero-stenotic,1,0.0
CASOD,1,0.0
SARS-CoV-2-antibody,1,0.0
pHCWs,1,0.0
2460092,1,0.0
2040611,1,0.0
2280247,1,0.0
10LV,1,0.0
6LV,1,0.0
8LV,1,0.0
5LV,1,0.0
first-vaccine-dose,1,0.0
patient-preference-sensitive,1,0.0
non-atheromatic,1,0.0
150-cavity,1,0.0
group-1,1,0.0
precampaign,1,0.0
Debre,1,0.0
Berhan,1,0.0
patient-identified,1,0.0
8-level,1,0.0
cigarette-smoking,1,0.0
q-wave,1,0.0
Coding,1,0.0
Children-Revised,1,0.0
Arithmetic,1,0.0
Spelling,1,0.0
Test-Revised,1,0.0
1643,1,0.0
CHQs,1,0.0
Susceptible§,1,0.0
funeral,1,0.0
conventially,1,0.0
SARS-CoV-2-causing,1,0.0
retrotransposon,1,0.0
pre-human,1,0.0
food-ingested,1,0.0
vector-carried,1,0.0
CHSA-,1,0.0
SUBJECTS,1,0.0
INTERVENTION,1,0.0
MEASURES,1,0.0
Well-understanding,1,0.0
treatmentsvaccines,1,0.0
genetic-related,1,0.0
high-reward,1,0.0
pharmaco-proteomic,1,0.0
Asp614Gly,1,0.0
74922,1,0.0
non-H1,1,0.0
H1r,1,0.0
Ala222Val,1,0.0
BLITZ-1,1,0.0
14-month,1,0.0
infarciton,1,0.0
laboratory-controlled,1,0.0
vegetatble,1,0.0
salads,1,0.0
aquaculture,1,0.0
vector-mediated,1,0.0
vending,1,0.0
multiple-treatments,1,0.0
N-nitroso,1,0.0
6-15-fold,1,0.0
autosomic,1,0.0
theobromine,1,0.0
acidophilic,1,0.0
manganese,1,0.0
Mn,1,0.0
Clustered,1,0.0
Regularly-Interspaced,1,0.0
Palindromic,1,0.0
IgA-,1,0.0
IgG-specific,1,0.0
manifolds,1,0.0
haunting,1,0.0
offsprings,1,0.0
Catheter-based,1,0.0
IV-tPa,1,0.0
pre-washout,1,0.0
overinfected,1,0.0
aerobiology,1,0.0
pathophysiobiology,1,0.0
Alternaria-induced,1,0.0
690±235,1,0.0
423±276,1,0.0
444±270,1,0.0
±284,1,0.0
non‑smokers,1,0.0
448±279,1,0.0
380±264,1,0.0
dizzinessweakness,1,0.0
non‑modifiable,1,0.0
Turner-Warwick,1,0.0
gallate,1,0.0
epigallocatechin,1,0.0
shoots,1,0.0
maleficence,1,0.0
25-300,1,0.0
-1185,1,0.0
-152,1,0.0
6294,1,0.0
1345-29457,1,0.0
P0019,1,0.0
6172,1,0.0
1235-3125,1,0.0
MES-positive,1,0.0
post-developmental,1,0.0
birthed,1,0.0
contended,1,0.0
medicineIn,1,0.0
unblinding,1,0.0
Camellia,1,0.0
active-controlled,1,0.0
trialsIt,1,0.0
84·9,1,0.0
84·7,1,0.0
66·5,1,0.0
60·1,1,0.0
58·1,1,0.0
18·4,1,0.0
5·1,1,0.0
0·0-6·7,1,0.0
31980,1,0.0
0·02,1,0.0
Genomics-led,1,0.0
Peridural,1,0.0
A23187,1,0.0
ionophore,1,0.0
NREM,1,0.0
Itching,1,0.0
pseudochilblain,1,0.0
1156-bed,1,0.0
vasculopathic,1,0.0
cross-study,1,0.0
otorhinolaryngologic,1,0.0
lipooligosaccharides,1,0.0
O-deacylation,1,0.0
anhydrous,1,0.0
hydrazine,1,0.0
22778,1,0.0
34164,1,0.0
L-glycero-D-manno-heptoses,1,0.0
3-deoxy-D-manno-octulosonic,1,0.0
diphosphorylated,1,0.0
phosphoethanolamine,1,0.0
N-acetylhexosamine,1,0.0
size-exclusion,1,0.0
12434,1,0.0
22158,1,0.0
heptose,1,0.0
trisaccharide,1,0.0
anhydro-KDO,1,0.0
beta-elimination,1,0.0
4-position,1,0.0
N-acetylglucosamine,1,0.0
sugars,1,0.0
seraplasma,1,0.0
snored,1,0.0
httpsqapecdceuropaeupublicextensionsCOVID-19COVID-19html,1,0.0
CT-alternative,1,0.0
redone,1,0.0
041-091,1,0.0
odds-ratio,1,0.0
132-390,1,0.0
therapyself-care,1,0.0
workphysical,1,0.0
interpersonalfamily,1,0.0
PSG,1,0.0
OSA-induced,1,0.0
polysomnogram,1,0.0
2008-2013,1,0.0
10138,1,0.0
4226,1,0.0
5912,1,0.0
19-39,1,0.0
119-402,1,0.0
Electrostatic,1,0.0
alpha7-nicotinic,1,0.0
HBEpC,1,0.0
httpsbitly3eJ5b35,1,0.0
Sero-conversion,1,0.0
Mx1-,1,0.0
BALB,1,0.0
A2G-Mx1,1,0.0
Mx-,1,0.0
changingcleaning,1,0.0
Syndecan-4,1,0.0
synd4-deficient,1,0.0
Westcott,1,0.0
natu-ral,1,0.0
non-rapid,1,0.0
cranio-mandibular,1,0.0
0130,1,0.0
cephalometric,1,0.0
uropoetic,1,0.0
MBT,1,0.0
-73,1,0.0
centThe,1,0.0
11195,1,0.0
stress-echocardiography,1,0.0
telephone-surveys,1,0.0
household-interviews,1,0.0
74-88,1,0.0
ratio88,1,0.0
IKKNF-kappaB,1,0.0
5mgkgday,1,0.0
mgkgtwice,1,0.0
all-community,1,0.0
0-case,1,0.0
10-case,1,0.0
bicycle-exercise,1,0.0
consider--from,1,0.0
France--antigenic,1,0.0
shear-induced,1,0.0
VWF--,1,0.0
VWF-encoding,1,0.0
GPIbalphaVWF,1,0.0
PLD1,1,0.0
80-250,1,0.0
nonfiltered,1,0.0
0181,1,0.0
0138,1,0.0
0240,1,0.0
15512,1,0.0
1996-2002,1,0.0
Mikulas,1,0.0
hemorrhaghic,1,0.0
Snoring,1,0.0
pharynxes,1,0.0
Müller,1,0.0
RdRPEN,1,0.0
RdRPNInternal,1,0.0
RdRPNIC,1,0.0
Kogenebiotech,1,0.0
FAMN,1,0.0
CY5IC,1,0.0
Hex,1,0.0
9462,1,0.0
9692,1,0.0
Heartmate,1,0.0
undergraduate-aged,1,0.0
Liptovsky,1,0.0
smoking--for,1,0.0
Tables,1,0.0
invadability,1,0.0
Lianhua-Qingwen,1,0.0
amygdalitis,1,0.0
wave-by-wave,1,0.0
population-age,1,0.0
Lobules,1,0.0
VIIb,1,0.0
Crus,1,0.0
misattribution,1,0.0
pitch,1,0.0
loudness,1,0.0
persons†,1,0.0
contacts¶,1,0.0
73-80,1,0.0
C1-2,1,0.0
Postischemic,1,0.0
factor-2,1,0.0
compaction,1,0.0
tabs,1,0.0
asymptomaticsymptomatic,1,0.0
pre-scientific,1,0.0
Apostle,1,0.0
evil,1,0.0
Codex,1,0.0
Calixtinus,1,0.0
xii,1,0.0
apostolic,1,0.0
immovable,1,0.0
infectees,1,0.0
thrombolyis,1,0.0
weeks-a,1,0.0
fractalkine,1,0.0
CX3CL1,1,0.0
neural-microglial,1,0.0
Trinidadian,1,0.0
Research-based,1,0.0
KCHS,1,0.0
socio-occupational,1,0.0
femtomolar,1,0.0
metasensor,1,0.0
squeeze,1,0.0
electrodynamics,1,0.0
ultranarrow,1,0.0
lineshapes,1,0.0
PAI,1,0.0
Self-reports,1,0.0
16PF,1,0.0
scents,1,0.0
nonregistration,1,0.0
247-393,1,0.0
tools--evidence-based,1,0.0
technology--to,1,0.0
intrapatient,1,0.0
4-quadrant,1,0.0
PIE,1,0.0
Proteases,1,0.0
PACMANS,1,0.0
2074,1,0.0
≤12,1,0.0
RNASE3,1,0.0
q24-q31,1,0.0
Bacteroicles,1,0.0
Proteus,1,0.0
biodata,1,0.0
Hyperperceivers,1,0.0
rRt-PCR,1,0.0
httpsbitly3aZUAPB,1,0.0
Hesed,1,0.0
H-coil,1,0.0
disruptor,1,0.0
whipped,1,0.0
cursory,1,0.0
--003,1,0.0
age-corrected,1,0.0
--30,1,0.0
organogram,1,0.0
doctorspecialist,1,0.0
terahertz,1,0.0
THz,1,0.0
quasi-infinite,1,0.0
Possessing,1,0.0
petrificate,1,0.0
Connective,1,0.0
AH5N1cases,1,0.0
4-slice,1,0.0
paucisymptomaticasymptomatic,1,0.0
antigenemia,1,0.0
skyline,1,0.0
B1221,1,0.0
1537,1,0.0
7441,1,0.0
S98F,1,0.0
0574,1,0.0
0276,1,0.0
0247,1,0.0
0815,1,0.0
0169,1,0.0
annexes,1,0.0
deep-vein,1,0.0
post-pathway,1,0.0
summiteer,1,0.0
trekker,1,0.0
MiniPAQLQ,1,0.0
Representatives,1,0.0
PHEP,1,0.0
awardee,1,0.0
coronarycircumflex,1,0.0
Mixovirus,1,0.0
VigiGripes,1,0.0
immunoturbidimetric,1,0.0
FluINsure,1,0.0
Intellivax,1,0.0
destiny,1,0.0
lurks,1,0.0
604674,1,0.0
-196-591,1,0.0
070-355,1,0.0
eradicatedas,1,0.0
health--that,1,0.0
case-a,1,0.0
Cambodias,1,0.0
Periodontology,1,0.0
Ludwig-Maximilians-University,1,0.0
LMU,1,0.0
Smoking-related,1,0.0
breathtaking,1,0.0
mankinds,1,0.0
background--a,1,0.0
immune-phenomena,1,0.0
ever-mutating,1,0.0
real‐life,1,0.0
NCBA,1,0.0
prometaphase,1,0.0
DG,1,0.0
ET-eligible,1,0.0
Life--optimally,1,0.0
GARCM,1,0.0
SARS-CoV-2-explicit,1,0.0
Chuetsu,1,0.0
Earthquake,1,0.0
subunit-vaccines,1,0.0
Virus-like-Particle,1,0.0
understatement,1,0.0
1961--before,1,0.0
unknown--apart,1,0.0
croplands,1,0.0
AMemphis1496,1,0.0
HA0--HA1HA2,1,0.0
virus-activating,1,0.0
low-detectible,1,0.0
Multiplication,1,0.0
150-min,1,0.0
105-110,1,0.0
pre-RIPerC,1,0.0
Leeuwen,1,0.0
Lind,1,0.0
Wijngaarden,1,0.0
climatized,1,0.0
allergen-free,1,0.0
infections2,1,0.0
1365,1,0.0
B1154,1,0.0
B1156,1,0.0
B1106,1,0.0
Huang,1,0.0
mecanism,1,0.0
Befelatanana,1,0.0
5541,1,0.0
3612,1,0.0
5022,1,0.0
7753,1,0.0
NIHSS8,1,0.0
MRS4,1,0.0
UNV,1,0.0
agro-ecological,1,0.0
AMoscow4502003,1,0.0
AMoscow5012011,1,0.0
AHamburg0509,1,0.0
GP1BA,1,0.0
Learys,1,0.0
-door,1,0.0
unfunded,1,0.0
GUSTO-IIB,1,0.0
PAMI-I,1,0.0
Ct≤29,1,0.0
F5,1,0.0
F2,1,0.0
FGAFGB,1,0.0
F7,1,0.0
F13A1,1,0.0
ITGB3ITGA2B,1,0.0
ITGA2,1,0.0
THBD,1,0.0
mcgdL,1,0.0
PZ,1,0.0
ANX5,1,0.0
MTR,1,0.0
CETP,1,0.0
ABCA1,1,0.0
CIII,1,0.0
apoa,1,0.0
PON123,1,0.0
LDLRLOX-1,1,0.0
genegene,1,0.0
antimediator,1,0.0
15750,1,0.0
reportsseries,1,0.0
BRT,1,0.0
low-to-middle-income,1,0.0
amotosalenUVA,1,0.0
groups1-7,1,0.0
refines,1,0.0
injurydisorders,1,0.0
evaluate-via,1,0.0
questionnaire-the,1,0.0
vaccinesmass,1,0.0
European-CDC,1,0.0
USA-CDC,1,0.0
Taiwan-CDC,1,0.0
coalescent-based,1,0.0
working-out,1,0.0
athopy,1,0.0
conditionings,1,0.0
leukotriens,1,0.0
tromboxanes,1,0.0
cytometer-friendly,1,0.0
Jurkat,1,0.0
huEGFRt,1,0.0
T2A,1,0.0
self-cleaving,1,0.0
double-staining,1,0.0
anti-EGFR,1,0.0
CBMSO,1,0.0
non-sinus,1,0.0
nonfailing,1,0.0
Heq1,1,0.0
Heq2,1,0.0
KentUnited,1,0.0
R‑value,1,0.0
Biontech,1,0.0
simple-advice,1,0.0
pre-retinal,1,0.0
BDA,1,0.0
offerings,1,0.0
test8,1,0.0
30-48-fold,1,0.0
studies9-11,1,0.0
Groupement,1,0.0
dExpertise,1,0.0
dInformation,1,0.0
Expertise,1,0.0
4382443,1,0.0
832443,1,0.0
3662218,1,0.0
71225,1,0.0
Syndrome-Coronavirus-1,1,0.0
cold-like,1,0.0
Spire,1,0.0
Principally,1,0.0
plc©,1,0.0
4259,1,0.0
bimaxillary,1,0.0
mandibular,1,0.0
genioplasty,1,0.0
1990-2010,1,0.0
thrombolysisHighlights,1,0.0
Terminology,1,0.0
neuro-disability,1,0.0
15841,1,0.0
insubsequent,1,0.0
glitch,1,0.0
Futhermore,1,0.0
PageRank-like,1,0.0
commutes,1,0.0
bi-directionally,1,0.0
rarest,1,0.0
electroencephalography-functional,1,0.0
areasApproachWe,1,0.0
areasMain,1,0.0
resultsOur,1,0.0
self-inhibitory,1,0.0
taskSignificanceTo,1,0.0
Step-care,1,0.0
enteropathy,1,0.0
Thiel-embalmed,1,0.0
non-anastomosing,1,0.0
Anastomoses,1,0.0
immunosuppressing,1,0.0
Infarct-avid,1,0.0
Hachim,1,0.0
Burbelo,1,0.0
anti-nucleocapsidN,1,0.0
lipooxygenase,1,0.0
Lipooxigenase-5,1,0.0
lipooxygenase-activating,1,0.0
protein-5,1,0.0
Sulfidopeptid,1,0.0
Technetium-99m-glucarate,1,0.0
six-carbon,1,0.0
dicarboxylic,1,0.0
glucarate,1,0.0
10729,1,0.0
tau-b,1,0.0
failuresuncertain,1,0.0
anti-malarialantibiotic,1,0.0
ObjectiveIn,1,0.0
Mihaljević,1,0.0
182IU,1,0.0
Fran,1,0.0
dif-,1,0.0
ferences,1,0.0
symp-,1,0.0
toms,1,0.0
low-dimensional,1,0.0
between-scatter,1,0.0
slump,1,0.0
Seaweed,1,0.0
foodstuff,1,0.0
fraction--by,1,0.0
6238,1,0.0
4208,1,0.0
exercise-wheezing,1,0.0
Under-recognition,1,0.0
integumentary,1,0.0
Hoffmann,1,0.0
angiotestin,1,0.0
IL-6-STAT3,1,0.0
Resilient,1,0.0
9-21,1,0.0
unrecognisable,1,0.0
NISSS,1,0.0
Nasopharyngealoropharyngeal,1,0.0
interchanged,1,0.0
pre-analytic,1,0.0
Low-throughput,1,0.0
EZ1,1,0.0
1-96,1,0.0
fluorochrome,1,0.0
hydroxychloroquineazithromycin,1,0.0
highly-touted,1,0.0
specificnon-specific,1,0.0
Mexico-specific,1,0.0
widows,1,0.0
rateespecially,1,0.0
Telematics,1,0.0
sends,1,0.0
telematics,1,0.0
unfrozen,1,0.0
±0019,1,0.0
0197,1,0.0
±006,1,0.0
sols,1,0.0
frogs,1,0.0
palates,1,0.0
ciliostasis,1,0.0
cute,1,0.0
Headteacher-reported,1,0.0
4026,1,0.0
saps,1,0.0
WWW,1,0.0
spaciously,1,0.0
supramolecular,1,0.0
Polymers,1,0.0
inhalationnebulization,1,0.0
CoV-2Covid-19,1,0.0
employability,1,0.0
workedweek,1,0.0
AimsIntroduction,1,0.0
procession,1,0.0
Altitude,1,0.0
elicitating,1,0.0
delirium294,1,0.0
pneumonia173,1,0.0
shock119,1,0.0
101-208,1,0.0
270596,1,0.0
140062,1,0.0
Mex214,1,0.0
US108,1,0.0
225497,1,0.0
116718,1,0.0
2769,1,0.0
Mex178,1,0.0
US9,1,0.0
TMMPRSS2,1,0.0
molecules-ie,1,0.0
acidsN-glycolylneuraminic,1,0.0
stables,1,0.0
117-294,1,0.0
edema203,1,0.0
102-167,1,0.0
160-329,1,0.0
015-071,1,0.0
349-715,1,0.0
126-447,1,0.0
325-844,1,0.0
126-575,1,0.0
group70,1,0.0
groupunder,1,0.0
group608,1,0.0
angioplasty286,1,0.0
success748,1,0.0
death236,1,0.0
knowl-,1,0.0
re-sampled,1,0.0
Västerås,1,0.0
existsin,1,0.0
20-MHz,1,0.0
460-466,1,0.0
480-487,1,0.0
490-491,1,0.0
490-492,1,0.0
494-496,1,0.0
MHI,1,0.0
POP,1,0.0
macromoleculeligand,1,0.0
airway-nervous,1,0.0
nodose,1,0.0
intra-airway,1,0.0
neutrally,1,0.0
Intra-airway,1,0.0
scn10a,1,0.0
isg15,1,0.0
matched-volume,1,0.0
sand,1,0.0
demystified,1,0.0
Dobutamine-induced,1,0.0
four-grade,1,0.0
59019,1,0.0
08961,1,0.0
05708,1,0.0
00369,1,0.0
Congruity,1,0.0
0·77,1,0.0
0·71,1,0.0
0·74,1,0.0
TMPRSS,1,0.0
pandemicExpert,1,0.0
implementedAreas,1,0.0
12052,1,0.0
90-90,1,0.0
64-77,1,0.0
77-87,1,0.0
60-60,1,0.0
curved,1,0.0
notched,1,0.0
24--96,1,0.0
allergen-carrying,1,0.0
starch,1,0.0
thunderstorm-asthma,1,0.0
Francs,1,0.0
Senegalese,1,0.0
33573,1,0.0
32614442,1,0.0
group-at-risk,1,0.0
78426,1,0.0
18839,1,0.0
4954635,1,0.0
19373172,1,0.0
8253246,1,0.0
96100,1,0.0
Ct≤30,1,0.0
15-56,1,0.0
Non-probability,1,0.0
3026,1,0.0
962Results,1,0.0
049Conclusions,1,0.0
Inborn,1,0.0
188-193,1,0.0
H5N1H9N2H7N7,1,0.0
102-25,1,0.0
aerosol-droplet,1,0.0
reawakening,1,0.0
Camperdown,1,0.0
Chikwawa,1,0.0
Gianturco,1,0.0
Roubin,1,0.0
nonelective,1,0.0
VDJ,1,0.0
VH3-53VH3-66,1,0.0
242-244,1,0.0
pseudo-,1,0.0
three-dose,1,0.0
RBD-vaccines,1,0.0
third-dose,1,0.0
myofibers,1,0.0
polymorphonucleosis,1,0.0
fuchsinorrhagia,1,0.0
Bochum,1,0.0
Help,1,0.0
volunteer-supported,1,0.0
helpers-a,1,0.0
partnership-based,1,0.0
GeSa,1,0.0
40-45,1,0.0
-0635,1,0.0
Influent,1,0.0
200-5000,1,0.0
membrane-vortex,1,0.0
NSarbeco,1,0.0
103-82,1,0.0
Tohoku,1,0.0
90-magnitude,1,0.0
interactional,1,0.0
IChildrens,1,0.0
earthbound,1,0.0
Center-Myocardial,1,0.0
20495,1,0.0
20722,1,0.0
22986,1,0.0
22400,1,0.0
PCR-testing,1,0.0
71111,1,0.0
99116,1,0.0
2341,1,0.0
211833,1,0.0
anneal,1,0.0
apicomplexan,1,0.0
SLC-SiOH,1,0.0
acrylic,1,0.0
pH1N1IFVA,1,0.0
H3N2IFVA,1,0.0
yamagataIFVB,1,0.0
victoriaIFVB,1,0.0
PREDAC-H1,1,0.0
trazodone,1,0.0
levodopa,1,0.0
neuromodulating,1,0.0
P2N95,1,0.0
face-shields,1,0.0
Hsien,1,0.0
Yung,1,0.0
Lai,1,0.0
castor,1,0.0
bean,1,0.0
soja,1,0.0
Switch,1,0.0
mmyocardial,1,0.0
angina-free,1,0.0
recatheterized,1,0.0
68-year,1,0.0
middle-apical,1,0.0
Anistreplase,1,0.0
c7E3,1,0.0
Impella™,1,0.0
0639,1,0.0
0565-0722,1,0.0
0527-0687,1,0.0
epidemics-and,1,0.0
dynamics-modellers,1,0.0
US-Russian,1,0.0
gastroenterological,1,0.0
mini-monograph,1,0.0
whom--that,1,0.0
likeliest,1,0.0
conditionClinical,1,0.0
prior-season,1,0.0
Prior-season,1,0.0
HIVSIDA,1,0.0
Resorting,1,0.0
Actor-Network,1,0.0
ANT,1,0.0
socio-technical,1,0.0
global-scale,1,0.0
Bruno,1,0.0
Latour,1,0.0
subtly,1,0.0
immunity--significantly,1,0.0
could--through,1,0.0
beensubstantially,1,0.0
bridled,1,0.0
Sterna,1,0.0
anaetheta,1,0.0
gannets,1,0.0
Sula,1,0.0
leucogaster,1,0.0
short-tailed,1,0.0
tenuirostris,1,0.0
-coronavirus‑1,1,0.0
SARS-CoV‑1,1,0.0
Yinghua,1,0.0
Pinggan,1,0.0
endow,1,0.0
spawn,1,0.0
Inspiringly,1,0.0
β-CoV-Bs,1,0.0
Tumpey,1,0.0
Fee-for-Service,1,0.0
FFS,1,0.0
45-day,1,0.0
CP-,1,0.0
«serious,1,0.0
treatments»,1,0.0
SARS-CoV2The,1,0.0
GKGDFRI,1,0.0
Gly353,1,0.0
Ile359,1,0.0
pseudovirion,1,0.0
Toehold,1,0.0
200251,1,0.0
Anous,1,0.0
RR-31-31,1,0.0
1-36,1,0.0
Wild-silk,1,0.0
wild-growing,1,0.0
oak,1,0.0
silkworms,1,0.0
Influenza-like-Illness,1,0.0
meditated,1,0.0
liver1,1,0.0
COVID-1923,1,0.0
subjects24,1,0.0
pathology23,1,0.0
httpsbitly372Xdhw,1,0.0
oropharyngeal-,1,0.0
nasopharyngeal-,1,0.0
anal-swabs,1,0.0
millilitres,1,0.0
OPNP,1,0.0
GMW,1,0.0
ERMs,1,0.0
transcribing,1,0.0
5533,1,0.0
8678,1,0.0
104-118,1,0.0
155-197,1,0.0
143-182,1,0.0
099-112,1,0.0
co-treatment,1,0.0
Citicoline,1,0.0
devided,1,0.0
Tabular,1,0.0
httpsdoiorg107937tcia20206c7y-gq39,1,0.0
NIfTI,1,0.0
groups--133,1,0.0
Kong14342002,1,0.0
thimerosal,1,0.0
mL-dose,1,0.0
mass-fabricated,1,0.0
tonifying,1,0.0
balloon-catheter,1,0.0
Locked-In,1,0.0
PD--time,1,0.0
DD--time,1,0.0
HD--time,1,0.0
PD--95,1,0.0
DD--20,1,0.0
HD--35,1,0.0
One-dose,1,0.0
expert-vetted,1,0.0
14-59,1,0.0
952-979,1,0.0
710-905,1,0.0
Anti-asthmatic,1,0.0
diferuloylmethane,1,0.0
rhizomes,1,0.0
longa,1,0.0
constant-volume,1,0.0
p00399,1,0.0
p00043,1,0.0
ORF9c,1,0.0
ORF3d,1,0.0
non-small,1,0.0
minutus,1,0.0
noddy,1,0.0
Acute-onset,1,0.0
23-sialyllactose,1,0.0
re-adapted,1,0.0
metalic,1,0.0
maneuveres,1,0.0
coronarygraphy,1,0.0
3221,1,0.0
subepicardiac,1,0.0
estimable,1,0.0
ELSIA,1,0.0
H-d,1,0.0
deltaF508,1,0.0
GOF-type,1,0.0
Nondetectable,1,0.0
26-h,1,0.0
Late-Presenting,1,0.0
Kona,1,0.0
host-to-host,1,0.0
od,1,0.0
Mayor,1,0.0
Fibrolipoma,1,0.0
fibrolipomas,1,0.0
eyelids,1,0.0
pseudostroke,1,0.0
Akershus,1,0.0
COSI,1,0.0
emulsion-based,1,0.0
rhythmological,1,0.0
Combine,1,0.0
Put,1,0.0
single-spin,1,0.0
Caxias,1,0.0
mass-produced,1,0.0
conical,1,0.0
129S6,1,0.0
syringe-needle,1,0.0
fixed-needle,1,0.0
operator-dependent,1,0.0
reinforcements,1,0.0
antiviral-based,1,0.0
Fluogen,1,0.0
Masovia,1,0.0
GeneFinder™-COVID-19-Plus-RealAmpKit,1,0.0
OSANG,1,0.0
eighty-one,1,0.0
proclaimed,1,0.0
worriers,1,0.0
It´s,1,0.0
cilengitide,1,0.0
purport,1,0.0
mESC,1,0.0
steroides,1,0.0
mantained,1,0.0
stabilitation,1,0.0
monitered,1,0.0
simptoms,1,0.0
4502,1,0.0
134-219,1,0.0
133-384,1,0.0
118-565,1,0.0
006-069,1,0.0
target-rich,1,0.0
jugulars,1,0.0
Sialic,1,0.0
23-SL-modified,1,0.0
wedge-tailed,1,0.0
Rico0834,1,0.0
appreciative,1,0.0
comor-bidity,1,0.0
pol-ymerase,1,0.0
conduct-ing,1,0.0
interferon-2b,1,0.0
propaga-tion,1,0.0
Levins,1,0.0
Feng,1,0.0
among-group,1,0.0
Nold,1,0.0
Jacquez,1,0.0
two-level,1,0.0
inter-generational,1,0.0
school-closures,1,0.0
“Spanish,1,0.0
“consensus”,1,0.0
Myxoviruses,1,0.0
Paramyxoviruses,1,0.0
NDV,1,0.0
Yucaipavirus,1,0.0
PVM,1,0.0
Nariva,1,0.0
bovinerespiratory,1,0.0
SV5,1,0.0
SV41,1,0.0
Asian57,1,0.0
ABEL42,1,0.0
ABEL,1,0.0
AFM1,1,0.0
IPTA,1,0.0
Catel,1,0.0
anti-G2B3A,1,0.0
hemisphereGap,1,0.0
glycocluster,1,0.0
common--and,1,0.0
treated--respiratory,1,0.0
forewarning,1,0.0
pandemic-2009,1,0.0
OPOs,1,0.0
lipokine,1,0.0
phage-to-yeast,1,0.0
PtY,1,0.0
ChiCTR2100042150,1,0.0
clinical-stage,1,0.0
of99mTc-MIBI18F-FDG-dual-isotope,1,0.0
DISA,1,0.0
infectionAim,1,0.0
noninfarcting,1,0.0
cobas6800Methodology,1,0.0
4223,1,0.0
situationally,1,0.0
oligosymptomatics,1,0.0
variablesstrategies,1,0.0
agegroups,1,0.0
thioldisulfide,1,0.0
TDR,1,0.0
survival-dependent,1,0.0
31-90,1,0.0
91-365,1,0.0
34866,1,0.0
5442,1,0.0
associated-with-thromboembolic-event,1,0.0
Spike-binding,1,0.0
pandemicepidemic,1,0.0
HO1,1,0.0
HIF-1α-positive,1,0.0
HIF-1α-negative,1,0.0
DP2kpHO1,1,0.0
Vasoactive,1,0.0
hemostimulating,1,0.0
automotive,1,0.0
€1044,1,0.0
€557549,1,0.0
€13024,1,0.0
€6956559,1,0.0
ceasing,1,0.0
bio-impedance,1,0.0
non-radiative,1,0.0
gradiometer,1,0.0
Frequency-Constrained,1,0.0
MMV,1,0.0
SBL,1,0.0
baseline-free,1,0.0
five-years,1,0.0
-ACE2,1,0.0
DB08248,1,0.0
DB02651,1,0.0
DB03714,1,0.0
DB14826,1,0.0
Administration-Emergency,1,0.0
lighted,1,0.0
2489,1,0.0
Fourty,1,0.0
syndrome-coronavirus‑2,1,0.0
factor-1α,1,0.0
Lipofectamine,1,0.0
Pima,1,0.0
polyethylenimine-25k,1,0.0
K-5,1,0.0
K-8,1,0.0
intrasubtypic,1,0.0
must-have,1,0.0
PEG-based,1,0.0
electrostatically,1,0.0
life-interfering,1,0.0
Eight-year,1,0.0
conservatively--560,1,0.0
39000000,1,0.0
neurological-,1,0.0
cardiac-,1,0.0
renal-related,1,0.0
hydroxychloroquine-a,1,0.0
beginning-were,1,0.0
transorbital,1,0.0
rtACS,1,0.0
REVIS,1,0.0
hemianopic,1,0.0
vision-related,1,0.0
EEG-spectra,1,0.0
sham-stimulation,1,0.0
toxicmetabolic,1,0.0
1875,1,0.0
Adrenergic,1,0.0
anti-RAGE,1,0.0
deoxycholate-conjugated,1,0.0
polyethylenimine-2k,1,0.0
RAGE-binding,1,0.0
womenIn,1,0.0
immunodefensive,1,0.0
neonateThe,1,0.0
thromboinflammation-mediated,1,0.0
Bladder,1,0.0
high-hit,1,0.0
scientometric,1,0.0
Sulfonylureas,1,0.0
9266,1,0.0
5301,1,0.0
-0027,1,0.0
-00032,1,0.0
re-assorted,1,0.0
personalizing,1,0.0
diagnostic-therapy-organizational,1,0.0
mid-2005,1,0.0
outsized,1,0.0
monotonically,1,0.0
perceptibly,1,0.0
11120microl,1,0.0
mlmin173,1,0.0
underusage,1,0.0
1994-95,1,0.0
nosocominal,1,0.0
Constitution,1,0.0
tetrahydrocannabinol,1,0.0
oromucosal,1,0.0
guessed,1,0.0
encephalitic,1,0.0
coasts,1,0.0
cropping,1,0.0
Geynisman,1,0.0
Bialkowski,1,0.0
sudomotor,1,0.0
Drug-drug,1,0.0
CAVE,1,0.0
4203,1,0.0
possibleThere,1,0.0
thrombovasculitis,1,0.0
influenza--H5N1,1,0.0
H7N9--has,1,0.0
CBF-blood,1,0.0
undertakes,1,0.0
N197,1,0.0
N65,1,0.0
non-RCT,1,0.0
SAPALDIA,1,0.0
11136,1,0.0
252AG,1,0.0
Precipitating,1,0.0
homeokinetic,1,0.0
SeLECT,1,0.0
99-166,1,0.0
ischaemi,1,0.0
Besat,1,0.0
segmentectomy,1,0.0
postcardiotomy-syndrome,1,0.0
cine-NMR,1,0.0
RIMAS,1,0.0
receptor-accessible,1,0.0
on-path,1,0.0
post-cocaine,1,0.0
natriuretric,1,0.0
BNP-associated,1,0.0
ischemically,1,0.0
2000106S144-52,1,0.0
CFIp,1,0.0
child-parent,1,0.0
notoriety,1,0.0
semipermeable,1,0.0
Prefectures,1,0.0
unchangeduncertain,1,0.0
scorings,1,0.0
741808,1,0.0
targetsdrugs,1,0.0
251815,1,0.0
6604,1,0.0
16904,1,0.0
mazowieckie,1,0.0
15431,1,0.0
14348,1,0.0
lubuskie,1,0.0
35825,1,0.0
lódzkie,1,0.0
infectionABSTRACT,1,0.0
poliomyelitis-like,1,0.0
9-year-olds,1,0.0
graders,1,0.0
80-99,1,0.0
care--the,1,0.0
NCT01473433,1,0.0
AdiFLAP,1,0.0
mi-AGTP,1,0.0
RealOpt-POD-v802,1,0.0
RealOpt-based,1,0.0
cytometers,1,0.0
biotin-streptavidin,1,0.0
biotin-conjugated,1,0.0
non-city,1,0.0
676were,1,0.0
Off,1,0.0
noncollagenouscollagenous,1,0.0
Audits,1,0.0
871234,1,0.0
MMR-vaccinated,1,0.0
Trial-Italy,1,0.0
HRCs,1,0.0
ice-hockey,1,0.0
overdiagnosing,1,0.0
multi-symptomatic,1,0.0
Alaskan,1,0.0
Sydney-New,1,0.0
Zealand-Sydney,1,0.0
axis-45,1,0.0
pepsin-insoluble,1,0.0
noncollagenous,1,0.0
points-of-entry,1,0.0
1991-1996,1,0.0
OLSA,1,0.0
stasus,1,0.0
350-500000,1,0.0
SwONT97,1,0.0
pig-to-pig,1,0.0
single-pill,1,0.0
ExT,1,0.0
eye-nose,1,0.0
305-310,1,0.0
variant-dominant,1,0.0
Augmenting,1,0.0
Bioanalytical,1,0.0
streptavidin-coated,1,0.0
6766,1,0.0
differIn,1,0.0
6176,1,0.0
8864,1,0.0
hostenvironment,1,0.0
defuzzification,1,0.0
confusable,1,0.0
intra-country,1,0.0
May-September,1,0.0
thoracoepigastric,1,0.0
Eu-luminescent,1,0.0
bioimaging,1,0.0
field-of-view,1,0.0
submillimeter,1,0.0
∼32,1,0.0
nanotheranostics,1,0.0
apneahypopnea,1,0.0
win-shiftwin-stay,1,0.0
Prefrontal,1,0.0
anxiety-like,1,0.0
impatient-care,1,0.0
ColdZyme®,1,0.0
nasopharyngolaryngoscopy,1,0.0
pre-visit,1,0.0
Separated,1,0.0
RASis,1,0.0
UAI,1,0.0
Cesarean,1,0.0
exercise-running,1,0.0
swimming-was,1,0.0
Biotelemetric,1,0.0
equate,1,0.0
httpswwwgisaidorg,1,0.0
beclouded,1,0.0
Phenotype-driven,1,0.0
storable,1,0.0
7172,1,0.0
long-term--care,1,0.0
groups--Group,1,0.0
Haemodynamically,1,0.0
H1-H13,1,0.0
evacuee,1,0.0
1534,1,0.0
chronic-phase,1,0.0
argatroban,1,0.0
CT3412,1,0.0
974-1000,1,0.0
949-998,1,0.0
0966-1000,1,0.0
Venter,1,0.0
Th2-expression,1,0.0
Schoub,1,0.0
Dial,1,0.0
rhetoric,1,0.0
20211116522-523,1,0.0
httpsdoiorg107196SAMJ2021v111i615740,1,0.0
Roberto,1,0.0
Río,1,0.0
SerologicDiagnostic,1,0.0
endproducts,1,0.0
APOEε2,1,0.0
impact-of-asthma,1,0.0
free-standing,1,0.0
barky,1,0.0
Stanton,1,0.0
Disis,1,0.0
Destroy,1,0.0
improverestore,1,0.0
Rosenbergs,1,0.0
situate,1,0.0
marginality,1,0.0
Tetrahydrofolate,1,0.0
Reductase,1,0.0
methylte,1,0.0
trahydrofolate,1,0.0
677th,1,0.0
MTHFR677TT,1,0.0
Transferrin,1,0.0
TRFE,1,0.0
2000-years,1,0.0
drug-testing,1,0.0
awake-onset,1,0.0
immune-relevant,1,0.0
per-site,1,0.0
coordinately,1,0.0
hypo-methylated,1,0.0
polycomb-group,1,0.0
FOXP2,1,0.0
HLA-DQB2,1,0.0
Chulalongkorn,1,0.0
6952,1,0.0
2945,1,0.0
186-485,1,0.0
PC35Gaw,1,0.0
DHR,1,0.0
rectify,1,0.0
co-led,1,0.0
1–3,1,0.0
2–7,1,0.0
35–59,1,0.0
protein-disrupting,1,0.0
volume1,1,0.0
increasement,1,0.0
teen-caregiver,1,0.0
symptom-days,1,0.0
peak-GOT,1,0.0
peak-LDH,1,0.0
-0655,1,0.0
-0713,1,0.0
STAY,1,0.0
134±08,1,0.0
imaging-fluid-attenuated,1,0.0
Laryngeal,1,0.0
gapless,1,0.0
S813I,1,0.0
Ns,1,0.0
A41V,1,0.0
A895V,1,0.0
CUS3,1,0.0
197000,1,0.0
Mid-April,1,0.0
thombolytic,1,0.0
osteocyte-derived,1,0.0
123-57,1,0.0
215-138,1,0.0
IJME,1,0.0
‒,1,0.0
Hua,1,0.0
Zhong,1,0.0
Indigenous-led,1,0.0
Radiofrequency,1,0.0
2014-April,1,0.0
RFA-ablated,1,0.0
neurodegenerationageing,1,0.0
training-induced,1,0.0
neuropharmacological,1,0.0
ethology,1,0.0
Semnan,1,0.0
36-item,1,0.0
widoweddivorced,1,0.0
seletive,1,0.0
infae,1,0.0
proteo-genomic,1,0.0
extragenic,1,0.0
IL-12-mediated,1,0.0
Bilbao,1,0.0
seacoast,1,0.0
paraparesis,1,0.0
man-ifestations,1,0.0
Chronical,1,0.0
side-biting,1,0.0
anaortic,1,0.0
primeval,1,0.0
calciﬁcation,1,0.0
tachyarrthythmias,1,0.0
T2-w,1,0.0
65-75,1,0.0
Doubled-Vascular,1,0.0
low-socioeconomic,1,0.0
Ole,1,0.0
340B,1,0.0
disease-state,1,0.0
paediatricdevelopmental,1,0.0
mentaladdictive,1,0.0
injurystroke,1,0.0
48-fold,1,0.0
Planetary,1,0.0
Boundary,1,0.0
Layer-PBL,1,0.0
January-30,1,0.0
agglomerated,1,0.0
isotype-specific,1,0.0
COVID-19-suspect,1,0.0
Multiple-target,1,0.0
assist-as-needed,1,0.0
RNAish,1,0.0
-2019,1,0.0
580000,1,0.0
Alinity™,1,0.0
4-600,1,0.0
reorganizing,1,0.0
26-19,1,0.0
SFlu,1,0.0
15-billion-a-year,1,0.0
congressional,1,0.0
S291-carrying,1,0.0
epsilon2-,1,0.0
epsilon4-carrying,1,0.0
X447-containing,1,0.0
123-1515,1,0.0
HRR,1,0.0
124-534,1,0.0
S447X,1,0.0
HDL-,1,0.0
redirection,1,0.0
IFN-λ3-treated,1,0.0
Tagliamonte,1,0.0
C3037T,1,0.0
24-question,1,0.0
Re-education,1,0.0
Microfluidic,1,0.0
nested-PCR,1,0.0
fluorescence-Based,1,0.0
multiplexer,1,0.0
Porous,1,0.0
Silicon,1,0.0
Nanowire,1,0.0
HAV,1,0.0
virus-bacterial,1,0.0
clpL,1,0.0
psaB,1,0.0
Mn2,1,0.0
ΔclpL,1,0.0
ΔpsaB,1,0.0
Coker,1,0.0
Cascio,1,0.0
Fooks,1,0.0
Van,1,0.0
Poel,1,0.0
Latham,1,0.0
Gowtage-Sequeria,1,0.0
smokelaparoscopic,1,0.0
long-recognized,1,0.0
Felids,1,0.0
non-domestic,1,0.0
mink-to-human-cat,1,0.0
C28144T,1,0.0
outfitted,1,0.0
TOCC,1,0.0
County-specific,1,0.0
shown2,1,0.0
Whole-Cell,1,0.0
Keenan,1,0.0
Jaffee,1,0.0
2012Dendritic,1,0.0
Mastelic-Gavillet,1,0.0
Gatti-Mays,1,0.0
2017Other,1,0.0
idiotype,1,0.0
anti-idiotype,1,0.0
Racotumomab,1,0.0
Vaxira,1,0.0
FDACancer,1,0.0
2020a,1,0.0
Bout,1,0.0
departmentinpatients,1,0.0
ampndash,1,0.0
Amisha,1,0.0
BREYANZI,1,0.0
TECARTUS,1,0.0
YESCARTA,1,0.0
IMLYGIC,1,0.0
KYMRIAH,1,0.0
PROVENGE,1,0.0
BioNTechamp39s,1,0.0
Maderno,1,0.0
ever-intriguing,1,0.0
eosinophil-depleting,1,0.0
1659,1,0.0
T8782C,1,0.0
C1059T,1,0.0
IFN-λ2-treated,1,0.0
G25563T,1,0.0
total-Ig,1,0.0
B-cell-,1,0.0
T-cell-stimulating,1,0.0
Micro-neutralisation,1,0.0
5763,1,0.0
5868,1,0.0
β-chain,1,0.0
alpha2-adrenergic,1,0.0
83-90,1,0.0
Cross-detection,1,0.0
A-5,1,0.0
B-6,1,0.0
C-6,1,0.0
D-5,1,0.0
gainfully,1,0.0
intervensions,1,0.0
iGLS,1,0.0
Contextual,1,0.0
Registry-based,1,0.0
NHIRD,1,0.0
nonatrial,1,0.0
0520,1,0.0
18-February-2020,1,0.0
72000,1,0.0
NetMHCpan,1,0.0
9-mer,1,0.0
iPred,1,0.0
A549-IFN-λ3,1,0.0
P00028,1,0.0
knowlegde,1,0.0
ovreview,1,0.0
114-189,1,0.0
S-groups,1,0.0
intervariability,1,0.0
Workforce,1,0.0
2017381361-1363,1,0.0
phenotypic-directed,1,0.0
AgooseGuangdong196,1,0.0
hepato-pancreato-biliary,1,0.0
Eurotransplant,1,0.0
rampaging,1,0.0
cookers,1,0.0
asthma-variable,1,0.0
obstruction-is,1,0.0
withstands,1,0.0
targetted,1,0.0
immuno-unbalance,1,0.0
sub-grouped,1,0.0
Spermatozoa,1,0.0
predictorThe,1,0.0
objectivized,1,0.0
deathAnxiety,1,0.0
HRRs,1,0.0
121-332,1,0.0
132-409,1,0.0
follow-upIn,1,0.0
Haddon,1,0.0
T-tests,1,0.0
non-statistically,1,0.0
incontrovertibly,1,0.0
SPECT-detected,1,0.0
second-largest,1,0.0
3419,1,0.0
impact-,1,0.0
multibasic,1,0.0
Anti-neuraminidase,1,0.0
broadens,1,0.0
LVMMs,1,0.0
110574,1,0.0
13157,1,0.0
42-79,1,0.0
Phase-1,1,0.0
phase-1,1,0.0
68240,1,0.0
phase-2,1,0.0
95189,1,0.0
Socio-economic,1,0.0
Exosomal,1,0.0
gene-modified,1,0.0
24–89,1,0.0
6–86,1,0.0
ventriculoplasty,1,0.0
drum-like,1,0.0
rightwards-leftwards,1,0.0
pushers,1,0.0
-78,1,0.0
modalityies,1,0.0
thalamo-parietal,1,0.0
somaesthetic,1,0.0
graviceptive,1,0.0
Tilts,1,0.0
erect,1,0.0
Δ-9-tetrahydrocannabinol,1,0.0
action-centered,1,0.0
cathepsin-mediated,1,0.0
CI12-93,1,0.0
nonbiomedical,1,0.0
11-74,1,0.0
SEC-HPLC,1,0.0
Yeast,1,0.0
48-64,1,0.0
AJapan3051957,1,0.0
Kong107399,1,0.0
AIndiana0811,1,0.0
KongG997,1,0.0
AchickenHong,1,0.0
KongSF401,1,0.0
AShanghai213,1,0.0
ANetherlands21903,1,0.0
brazilians,1,0.0
magnesemia,1,0.0
arrthythmias,1,0.0
RKAS-1,1,0.0
discrupted,1,0.0
Thursday,1,0.0
Tuesday,1,0.0
P-ECP,1,0.0
bilobar,1,0.0
piperacillin,1,0.0
tazobactam,1,0.0
long-term-,1,0.0
cardiac-rehabilitation,1,0.0
IEEE,1,0.0
Xplore,1,0.0
1992-1995,1,0.0
MSDB,1,0.0
21132,1,0.0
2006-2012,1,0.0
€18,1,0.0
Stem-,1,0.0
credentialing,1,0.0
AHK2132003,1,0.0
ATurkey655962006,1,0.0
QNG,1,0.0
low-high-highest-high-low,1,0.0
diffusions,1,0.0
attacksThe,1,0.0
TristaniaThe,1,0.0
aptamer-modified,1,0.0
bronchofiberoscopy,1,0.0
pre-certification,1,0.0
recombinase-polymerase-amplification,1,0.0
025-25,1,0.0
RT-real-time,1,0.0
RT-qPCR-mediated,1,0.0
labor-extensive,1,0.0
formamide,1,0.0
H1N1H3N2,1,0.0
ect,1,0.0
09-21,1,0.0
897-902,1,0.0
Age-of-asthma,1,0.0
2921,1,0.0
age-of-onset,1,0.0
matinal,1,0.0
24-68,1,0.0
methyltransferases,1,0.0
PRMTs,1,0.0
G3BP1,1,0.0
R95K,1,0.0
MEGA40,1,0.0
ClustalX183,1,0.0
nonobese,1,0.0
5-2,1,0.0
experianced,1,0.0
parentage,1,0.0
flu-illness,1,0.0
hand-agitated,1,0.0
poly-gelin,1,0.0
PTCRABSTRACT,1,0.0
κ07-09,1,0.0
κ01-06,1,0.0
observer-dependent,1,0.0
RMS-ratio,1,0.0
TMA-time,1,0.0
RAEV-ratio,1,0.0
disproportion,1,0.0
PTCAstent,1,0.0
2·0-fold,1,0.0
254100000,1,0.0
280100000,1,0.0
133100000,1,0.0
156100000,1,0.0
229100000,1,0.0
147100000,1,0.0
fungibles,1,0.0
pointof-care,1,0.0
ADF,1,0.0
Mini-log,1,0.0
creep,1,0.0
coinfer,1,0.0
2·5-,1,0.0
5-L,1,0.0
1-L,1,0.0
cGMPs,1,0.0
375-523,1,0.0
selfmanagement,1,0.0
well-contained,1,0.0
Basque,1,0.0
17260,1,0.0
22696,1,0.0
7178,1,0.0
socio-sanitary,1,0.0
neutrophileosinophil,1,0.0
cities--New,1,0.0
Connecticut--diverged,1,0.0
situates,1,0.0
non-unified,1,0.0
Pleurovenous,1,0.0
screeningsurveillance,1,0.0
re-pooling,1,0.0
bronchodilatorsreduction,1,0.0
3-2,1,0.0
AMIWe,1,0.0
monthsPatients,1,0.0
symptom-to-intervention,1,0.0
Preinterventional,1,0.0
infarction-0-flow,1,0.0
5399,1,0.0
822-35463,1,0.0
Lucknow,1,0.0
non-duplicated,1,0.0
n173,1,0.0
n163,1,0.0
pre-December,1,0.0
Underpinned,1,0.0
glimpses,1,0.0
IL-12IL-23,1,0.0
preteen,1,0.0
QTLs,1,0.0
Multi-Frequency,1,0.0
HASU,1,0.0
UCLH,1,0.0
emotionally-based,1,0.0
tightrope,1,0.0
push-pull,1,0.0
2359,1,0.0
concernedABSTRACT,1,0.0
thermometer-sales,1,0.0
Mobitz,1,0.0
data-all,1,0.0
Latinxs,1,0.0
Ilorin,1,0.0
interleukin-6R,1,0.0
Hesitance,1,0.0
extirpating,1,0.0
deterioate,1,0.0
beta-Blockers,1,0.0
antagonistsABSTRACT,1,0.0
SnapShot,1,0.0
1975-90,1,0.0
childbirths,1,0.0
1975-6,1,0.0
regressors,1,0.0
Heterologous,1,0.0
cytokine-producing,1,0.0
Abatacept,1,0.0
418-565,1,0.0
345-490,1,0.0
Rafsanjan,1,0.0
325-473,1,0.0
SHCS,1,0.0
STCS,1,0.0
∼500000,1,0.0
IAV-susceptible,1,0.0
NFkB-promoter,1,0.0
1991-1993,1,0.0
Climatology,1,0.0
1980-1990,1,0.0
Warm,1,0.0
oceanic,1,0.0
Apples,1,0.0
ResearchKit,1,0.0
6346,1,0.0
recognized-including,1,0.0
inflammatory-induced,1,0.0
COVID-19-convalescence,1,0.0
Shorthair,1,0.0
High-grade,1,0.0
non-Hodgkins,1,0.0
re-arrangements,1,0.0
euthanased,1,0.0
mAs,1,0.0
isonicotinate,1,0.0
British-German,1,0.0
17q12,1,0.0
Aiolos,1,0.0
GSDML,1,0.0
Ali-Ibne-Abi,1,0.0
Taleb,1,0.0
IFN-independent,1,0.0
cis,1,0.0
helper-2,1,0.0
non-cirrhotic,1,0.0
735-992,1,0.0
828-999,1,0.0
0963,1,0.0
0885-10,1,0.0
EPI-Info,1,0.0
9805,1,0.0
10957,1,0.0
8726,1,0.0
OctoberNovember,1,0.0
GEMedical,1,0.0
HiSpeedZXi,1,0.0
Drug-delivery,1,0.0
4h,1,0.0
2003-2007,1,0.0
co-authors,1,0.0
TD1,1,0.0
autopsy-studied,1,0.0
Mural,1,0.0
altherosclerotic,1,0.0
lodging,1,0.0
0-45h,1,0.0
FLAIR-negative,1,0.0
FLAIR-positive,1,0.0
diseaseMethods,1,0.0
pubmedorg,1,0.0
2152021,1,0.0
countriesExpert,1,0.0
Figueroa,1,0.0
N-mediated,1,0.0
methylarginine,1,0.0
Tudor,1,0.0
MiRs,1,0.0
innate-to-adaptive,1,0.0
well-cooked,1,0.0
test-elasticity,1,0.0
decomposed,1,0.0
PFO-mediated,1,0.0
nonparenchymal,1,0.0
sinusoidal-cell,1,0.0
shreds,1,0.0
3-million,1,0.0
mammalian-derived,1,0.0
FHMI-by-risk,1,0.0
goiters,1,0.0
topographically,1,0.0
wave--the,1,0.0
latrogenic,1,0.0
palliation,1,0.0
Deferral,1,0.0
parish,1,0.0
Dyfed,1,0.0
Anglia,1,0.0
Northumbria,1,0.0
inter-epidemic,1,0.0
N-acetylamino-235-trideoxy-23-difluoro-d-erythro-β-l-manno-2-nonulopyranosonic,1,0.0
Y406,1,0.0
deoxygenated,1,0.0
9-OH,1,0.0
last-well,1,0.0
-291,1,0.0
9297,1,0.0
24-756,1,0.0
intrasubgroup,1,0.0
FFU,1,0.0
Hilleman,1,0.0
metalloporphyrin,1,0.0
siderosis,1,0.0
flight-contact,1,0.0
CIbRIVM,1,0.0
Schiphol,1,0.0
T-705,1,0.0
over-aggressive,1,0.0
rectification,1,0.0
casework,1,0.0
chromatography-high-resolution,1,0.0
deuterated,1,0.0
ravished,1,0.0
Peloponnesian,1,0.0
onset-to-reperfusion,1,0.0
virus-like-particle,1,0.0
storm-induced,1,0.0
integrin-linked,1,0.0
ILK,1,0.0
poly-L-lysine,1,0.0
promisingly,1,0.0
ILK-engineered,1,0.0
Pristimerin,1,0.0
33-83,1,0.0
baculoviral,1,0.0
retrovirus,1,0.0
HERV,1,0.0
envelope-coated,1,0.0
baculovirus-based,1,0.0
2643,1,0.0
quantiles,1,0.0
nickle,1,0.0
Covid-19-related,1,0.0
Nonregular,1,0.0
complications--most,1,0.0
ammounted,1,0.0
Controlled-release,1,0.0
corticosteroid-induced,1,0.0
high-potency,1,0.0
sustained-action,1,0.0
sinusoid-left,1,0.0
sinusoid,1,0.0
sinusoid-coronary,1,0.0
interhemisphere,1,0.0
COV2T®,1,0.0
Centaur®,1,0.0
Dia-Pro,1,0.0
Kruskall,1,0.0
Wallis,1,0.0
225-281,1,0.0
9691-,1,0.0
9893,1,0.0
aspergillosisNinety-six,1,0.0
Mofid,1,0.0
evaluatedNineteen,1,0.0
mildpersistent,1,0.0
patientsOur,1,0.0
gene-editing-based,1,0.0
in-vitroin-vivo,1,0.0
in-utero,1,0.0
amylnitrate,1,0.0
approvalimplementation,1,0.0
Misidentification,1,0.0
Introductionbackground,1,0.0
drug-caused,1,0.0
（CCS）,1,0.0
haematology-oncology,1,0.0
Krasnoyarsk--325,1,0.0
Tynda--329,1,0.0
Anadyr--348,1,0.0
Stroke-case,1,0.0
Tynda,1,0.0
Anadyr,1,0.0
excessing,1,0.0
pressuregeomagnetic,1,0.0
Host-based,1,0.0
（SCD）,1,0.0
（including,1,0.0
infarction）,1,0.0
commissural,1,0.0
patencyABSTRACT,1,0.0
331125,1,0.0
diffuselarge,1,0.0
Umberto,1,0.0
035x1000mL,1,0.0
0680,1,0.0
Factoring,1,0.0
technietium,1,0.0
concertation,1,0.0
evidence-to-practice,1,0.0
cross-cutting,1,0.0
weak-spot,1,0.0
134-46,1,0.0
millionyear,1,0.0
040050049,1,0.0
non-compaction,1,0.0
10-years-olds,1,0.0
dendrimers,1,0.0
controllerreliever,1,0.0
Representation,1,0.0
AIRS-S,1,0.0
ED--discharge,1,0.0
hospitalization--after,1,0.0
85-100,1,0.0
counteraction,1,0.0
program--Prevention,1,0.0
low-burden,1,0.0
High-Dose®,1,0.0
kV,1,0.0
grouper,1,0.0
∼27,1,0.0
Talos,1,0.0
Arctica,1,0.0
Macrobrachium,1,0.0
rosenbergii,1,0.0
nodavirus,1,0.0
sub-3Å,1,0.0
TEMs,1,0.0
HDL-based,1,0.0
2942,1,0.0
CATHEPSINs,1,0.0
AhR,1,0.0
Daniloski,1,0.0
oxidativenitrosative,1,0.0
glycohydrolase,1,0.0
melastatin,1,0.0
trehalose,1,0.0
dictation,1,0.0
blindfolded,1,0.0
Afferent,1,0.0
5576999,1,0.0
semi-Markov,1,0.0
recollections,1,0.0
microwave-generated,1,0.0
QIAcube,1,0.0
RR19,1,0.0
28126,1,0.0
11761,1,0.0
Non-approved,1,0.0
8671,1,0.0
6316,1,0.0
6520,1,0.0
3422,1,0.0
287513685,1,0.0
23186686,1,0.0
unachievable,1,0.0
48-117,1,0.0
1384,1,0.0
nurse-based,1,0.0
syndrome--but,1,0.0
dripping,1,0.0
naso-bronchial,1,0.0
causable,1,0.0
ageenvironment,1,0.0
venerability,1,0.0
frequented,1,0.0
seasonal-influenza,1,0.0
FRagmin,1,0.0
InStability,1,0.0
flufenamic,1,0.0
mouthwashesgargles,1,0.0
trabeculations,1,0.0
shampoo,1,0.0
396-bp,1,0.0
345-bp,1,0.0
RdRP-amplified,1,0.0
Oppression,1,0.0
fluororadiographs,1,0.0
Bodyweight,1,0.0
thirty-two-year-old,1,0.0
localisable,1,0.0
Bokutoh,1,0.0
dead-on-arrival,1,0.0
DOA,1,0.0
non-DOA,1,0.0
AFAS,1,0.0
unter,1,0.0
renewable,1,0.0
hyperechogenic,1,0.0
posterolaterally,1,0.0
pre-moistened,1,0.0
fountain,1,0.0
receptacle,1,0.0
ordeals,1,0.0
37584,1,0.0
411e27-e32,1,0.0
Misericordia,1,0.0
Diseases-9,1,0.0
115-1046,1,0.0
147-901,1,0.0
1-103,1,0.0
aetiology-oriented,1,0.0
STT-wave,1,0.0
≥2690,1,0.0
2005-08,1,0.0
NA-specific,1,0.0
mouthwashgargle,1,0.0
Listerine,1,0.0
Listerine-like,1,0.0
Resting-state,1,0.0
bolus5,1,0.0
monastral,1,0.0
2350,1,0.0
1839,1,0.0
Th2-adaptive,1,0.0
hystero-hypochondriacal,1,0.0
WVA,1,0.0
rNP,1,0.0
Toxicologists,1,0.0
routined,1,0.0
2014-17,1,0.0
intermitting,1,0.0
pandemic-variant,1,0.0
arginine-glycine-aspartate,1,0.0
Integrins,1,0.0
virion-integrin,1,0.0
Patient-specific,1,0.0
VUI,1,0.0
SNpc,1,0.0
nigrostriatal,1,0.0
1387,1,0.0
08-20,1,0.0
Carraro,1,0.0
transcriptase-,1,0.0
65-82,1,0.0
offs,1,0.0
11924,1,0.0
primo-infection,1,0.0
bronchialbronchiolar,1,0.0
end-labelling,1,0.0
footballers,1,0.0
Technogenetics,1,0.0
CLIA-LIAISON®,1,0.0
ECLIA-Elecsys®,1,0.0
Euroimmune,1,0.0
IGM,1,0.0
ishemic,1,0.0
figuring,1,0.0
anti-hypertrophic,1,0.0
tissue-engineering,1,0.0
self-adhesive,1,0.0
Fe3-induced,1,0.0
dopamine-gelatin,1,0.0
GelDA,1,0.0
dopamine-functionalized,1,0.0
polypyrrole,1,0.0
DA-PPy,1,0.0
Schiff,1,0.0
HA-CHO,1,0.0
hydrazided,1,0.0
HHA,1,0.0
single-mode,1,0.0
HA-CHOHHA,1,0.0
GelDADA-PPy,1,0.0
MeV,1,0.0
early-passage,1,0.0
S203T,1,0.0
Excitingly,1,0.0
chorioamniotitis,1,0.0
intermediately,1,0.0
oseltamivir-based,1,0.0
swabsMethods,1,0.0
No10-35,1,0.0
No10-29,1,0.0
Reverse-transcriptase-polymerase-chain-reaction,1,0.0
performedResults,1,0.0
No1-29,1,0.0
No30-35,1,0.0
no132131,1,0.0
no21,1,0.0
9The,1,0.0
2288,1,0.0
03Conclusion,1,0.0
receptor-lipopolysaccharide,1,0.0
TLR-LPS,1,0.0
GLPSS,1,0.0
H3N2v-associated,1,0.0
hematochemical,1,0.0
Bonheur,1,0.0
LBCH,1,0.0
3879,1,0.0
watershedhypoperfusion,1,0.0
174700,1,0.0
32500,1,0.0
862-972,1,0.0
929-100,1,0.0
degrees-120,1,0.0
degrees-60,1,0.0
Poste,1,0.0
Visp,1,0.0
203T,1,0.0
disulphine,1,0.0
187000,1,0.0
X24073,1,0.0
resettlement,1,0.0
17-90,1,0.0
Endoluminal,1,0.0
tension-anxiety,1,0.0
depression-dejection,1,0.0
vigor-activity,1,0.0
test--cardiopulmonary,1,0.0
possible--before,1,0.0
thyrotropin,1,0.0
thyroxin,1,0.0
8085,1,0.0
7572,1,0.0
rythmical,1,0.0
eletrocardiogram,1,0.0
ABo,1,0.0
2760,1,0.0
Ph,1,0.0
1973--4,1,0.0
0--4,1,0.0
2126,1,0.0
0285,1,0.0
0224,1,0.0
22-80,1,0.0
Simulator,1,0.0
viral-load-based,1,0.0
loss-to-follow-up,1,0.0
micro-targeting,1,0.0
laptop,1,0.0
34670,1,0.0
native-born,1,0.0
down-trend,1,0.0
Jet,1,0.0
co-create,1,0.0
etiopathogenia,1,0.0
pretibial,1,0.0
arteriolopathies,1,0.0
Aldhous,1,0.0
discovers,1,0.0
CPRintubation,1,0.0
Oak,1,0.0
Ridge,1,0.0
Goggle,1,0.0
endo,1,0.0
Endo-diastolic,1,0.0
RMW,1,0.0
parentscaregivers,1,0.0
Influenza-attributed,1,0.0
Beclojet,1,0.0
Managerial,1,0.0
10674,1,0.0
8661-12687,1,0.0
2112-2964,1,0.0
5522,1,0.0
4834-6210,1,0.0
3793,1,0.0
3375-4211,1,0.0
24-31,1,0.0
30-43,1,0.0
44-68,1,0.0
dose-efficacy,1,0.0
hand-lung,1,0.0
Objecive,1,0.0
USVI,1,0.0
29713,1,0.0
Life-table,1,0.0
costophrenic,1,0.0
manpower-saving,1,0.0
PHASIFY™,1,0.0
NucliSENS®,1,0.0
easyMAG®,1,0.0
111120,1,0.0
108120,1,0.0
5360,1,0.0
4960,1,0.0
concoctions,1,0.0
Licorice,1,0.0
Gancao,1,0.0
Pinyin,1,0.0
cuisines,1,0.0
sweets,1,0.0
socialised,1,0.0
disease-a,1,0.0
Snakebites,1,0.0
neuromyopathies,1,0.0
Bothrops,1,0.0
jararaca,1,0.0
Reconcavo,1,0.0
Extra-respiratory,1,0.0
non-tobacco,1,0.0
high-titre,1,0.0
7945,1,0.0
065-092,1,0.0
075-102,1,0.0
062-089,1,0.0
loculated,1,0.0
system-of-care,1,0.0
ECC,1,0.0
embryo-,1,0.0
postregistration,1,0.0
Reflective,1,0.0
COVID-denialist,1,0.0
corrupt,1,0.0
elites,1,0.0
Lymphangio-MRI,1,0.0
contrast-enhancing,1,0.0
48711,1,0.0
12-day,1,0.0
practices†,1,0.0
B117s,1,0.0
dolantine,1,0.0
β-propiolactone-inactivated,1,0.0
fetotoxicity,1,0.0
diabetologists,1,0.0
Robustness,1,0.0
n420,1,0.0
parainfluenzavirus,1,0.0
DIFA,1,0.0
AWyoming32003-like,1,0.0
BJiangsu102003-like,1,0.0
intensiv,1,0.0
4049,1,0.0
1567,1,0.0
EURASPIRE,1,0.0
noninsulin-diabetes,1,0.0
Wouldnt,1,0.0
cardiodiabetic,1,0.0
074-100,1,0.0
Association-American,1,0.0
Adamantane-resistant,1,0.0
rea-ltime,1,0.0
sMMPi,1,0.0
cold-recombinant,1,0.0
recombining,1,0.0
Arbor166,1,0.0
cases--that,1,0.0
attacks--were,1,0.0
Wedge,1,0.0
20Fr,1,0.0
cannulas,1,0.0
US104,1,0.0
US164,1,0.0
non-taking,1,0.0
“Is,1,0.0
Carli,1,0.0
SYST-Eur,1,0.0
SYST-China,1,0.0
WHOInternational,1,0.0
thiazide-type,1,0.0
2307,1,0.0
021004,1,0.0
024004,1,0.0
040009,1,0.0
1305,1,0.0
6329,1,0.0
Between-group,1,0.0
canalization,1,0.0
unblocked,1,0.0
peinfarction,1,0.0
Sixty-seven-year-old,1,0.0
inter-provider,1,0.0
Spike-variants,1,0.0
SARS-CoV-2-Spike,1,0.0
seven-item,1,0.0
methological,1,0.0
SARS-CoV-2-spike-encoding,1,0.0
cocreation-based,1,0.0
TÜBİTAK,1,0.0
cocreation,1,0.0
immune-assays,1,0.0
116017,1,0.0
14933,1,0.0
€3047,1,0.0
€43129,1,0.0
ICTUSCARE,1,0.0
half-standardized,1,0.0
crescendo-course,1,0.0
enlist,1,0.0
C19-S-I-IFA,1,0.0
22-27,1,0.0
weaknessnumbness,1,0.0
ImmunoDiagnostics,1,0.0
Performed,1,0.0
arteririography,1,0.0
doulbe-radionuclide,1,0.0
still-viable,1,0.0
cold-spot,1,0.0
recently-infarcted,1,0.0
expert-review,1,0.0
Kalafong,1,0.0
currentprevious,1,0.0
SARS-CoV-Spike,1,0.0
a-specific,1,0.0
Hemo-vascular,1,0.0
meta,1,0.0
COVID-Net,1,0.0
IVIG-treated,1,0.0
∼2789,1,0.0
105558,1,0.0
£187682,1,0.0
Epi-aortic,1,0.0
Monetarised,1,0.0
102-1630,1,0.0
modified-Rankin,1,0.0
2-13,1,0.0
138-1159,1,0.0
128-1003,1,0.0
035-091,1,0.0
120-14080-90,1,0.0
J-,1,0.0
investigatedCurrently,1,0.0
dysprosody,1,0.0
stutter,1,0.0
reverting,1,0.0
rampantly,1,0.0
RBD-binding,1,0.0
199091,1,0.0
H3-AShanghai1688,1,0.0
H1-ATaiwan186,1,0.0
51-64,1,0.0
Patient-clinician,1,0.0
record-based,1,0.0
2004-14,1,0.0
sandstorm,1,0.0
eighty-six,1,0.0
COVIDNet-CT,1,0.0
five-category,1,0.0
immune-histochemical,1,0.0
CABP,1,0.0
score21,1,0.0
Z-9190,1,0.0
3266,1,0.0
2220,1,0.0
χ249614,1,0.0
χ224267,1,0.0
Plzen,1,0.0
141--16081--100,1,0.0
61--80min,1,0.0
Krichel,1,0.0
coauthors,1,0.0
post-immunisation,1,0.0
17-120,1,0.0
months-old,1,0.0
sero-susceptibility,1,0.0
swH3N2,1,0.0
ASydney51997,1,0.0
pre-immunisation,1,0.0
orf,1,0.0
transcription-insulated,1,0.0
RT-iiPCR,1,0.0
905-100,1,0.0
931-100,1,0.0
RT-3DE,1,0.0
866000,1,0.0
2562,1,0.0
2852,1,0.0
2662,1,0.0
2985,1,0.0
Lea,1,0.0
Xga,1,0.0
hyper-homocysteinemia,1,0.0
opinionated,1,0.0
Oligoryzomys,1,0.0
nigripes,1,0.0
Rodentia,1,0.0
Muridae,1,0.0
semideciduous,1,0.0
Misiones,1,0.0
odilae,1,0.0
amphids,1,0.0
microfilaria,1,0.0
sheathed,1,0.0
petteri,1,0.0
marsupials,1,0.0
indicated--pulmonary,1,0.0
Atherosclerosis-small,1,0.0
disease-cardiac,1,0.0
source-other,1,0.0
Inter-rater,1,0.0
0870,1,0.0
0860,1,0.0
proatrial,1,0.0
257000,1,0.0
481000,1,0.0
166-277,1,0.0
demographers,1,0.0
197-202,1,0.0
362-371,1,0.0
99Tcm,1,0.0
PyP,1,0.0
unremittent,1,0.0
allergistspulmonologists,1,0.0
C6T,1,0.0
R279Q,1,0.0
karma,1,0.0
hereof,1,0.0
biosensing-related,1,0.0
syndromeinfarct,1,0.0
myocarial,1,0.0
temporo-occipital,1,0.0
sit,1,0.0
Interferon-regulated,1,0.0
tetratricopeptide,1,0.0
IFIT2,1,0.0
vipirin,1,0.0
Gene-expression,1,0.0
Hindu,1,0.0
twice--4,1,0.0
intercorrelated,1,0.0
-C1562T,1,0.0
Attribution,1,0.0
30-62,1,0.0
32-70,1,0.0
Discover,1,0.0
Chlorine,1,0.0
32-yr,1,0.0
gonadotrophin,1,0.0
hormone-analogue,1,0.0
2019-2019-nCoV,1,0.0
Organiza,1,0.0
Dinkihaler,1,0.0
suicidesuicide,1,0.0
-T1702A,1,0.0
χ26267,1,0.0
2348,1,0.0
χ28616,1,0.0
31-60,1,0.0
Nut,1,0.0
476181,1,0.0
083-098,1,0.0
078-098,1,0.0
069-106,1,0.0
March‒October,1,0.0
10848,1,0.0
line‒associated,1,0.0
COVID-19‒positive,1,0.0
test-and-travel,1,0.0
low-neck,1,0.0
162020,1,0.0
Guangxi,1,0.0
Zhuang,1,0.0
conjunctivitis-related,1,0.0
1667±929,1,0.0
2019Chin,1,0.0
433-437,1,0.0
supra-,1,0.0
double-lumen,1,0.0
CO₂,1,0.0
waterbodies,1,0.0
soiled,1,0.0
4720,1,0.0
1441,1,0.0
5957,1,0.0
4327,1,0.0
diet--primarily,1,0.0
salt--was,1,0.0
agitatedanxious,1,0.0
sadderdepressive,1,0.0
Sjögren,1,0.0
chinine,1,0.0
C5b-9,1,0.0
hemo-vascular,1,0.0
observationally,1,0.0
fecal-viral-excreting,1,0.0
Stay†,1,0.0
school-wide,1,0.0
59552,1,0.0
events§,1,0.0
109752,1,0.0
student-days¶,1,0.0
189091,1,0.0
postwar,1,0.0
school-building,1,0.0
archaeology,1,0.0
196-514,1,0.0
reductionism,1,0.0
re-construct,1,0.0
postlytic,1,0.0
tepid,1,0.0
PRIMVAC,1,0.0
Castellón,1,0.0
22–39,1,0.0
58–63,1,0.0
37015,1,0.0
4326,1,0.0
120-158,1,0.0
073-118,1,0.0
108-185,1,0.0
membrane-,1,0.0
61-90,1,0.0
P0001and,1,0.0
Check™,1,0.0
133-362,1,0.0
071-191,1,0.0
040-055,1,0.0
062-194,1,0.0
0763,1,0.0
CV-1,1,0.0
JOYSBIO,1,0.0
Assure,1,0.0
NDFOS,1,0.0
ATGs,1,0.0
81-97,1,0.0
2092,1,0.0
lightheaded,1,0.0
HPAI-related,1,0.0
Immunisations,1,0.0
64E,1,0.0
Highly-pathogenic,1,0.0
polyDL-lactide-co-glycolide,1,0.0
PLGA-based,1,0.0
low-airborne,1,0.0
short-termed,1,0.0
re-consideration,1,0.0
bloodserum,1,0.0
levelaccording,1,0.0
6603,1,0.0
3213,1,0.0
7613,1,0.0
score20,1,0.0
Z-3928,1,0.0
112-241,1,0.0
11402,1,0.0
12023,1,0.0
Plateau,1,0.0
abulia,1,0.0
AH1N1v-associated,1,0.0
∼18-50,1,0.0
∼5,1,0.0
DNA-centric,1,0.0
PAIMS,1,0.0
INFR,1,0.0
mutagenicity,1,0.0
non-hERG,1,0.0
httpssars3dcom,1,0.0
GISSI-Avoidable,1,0.0
1217-1436,1,0.0
1001-1146,1,0.0
15-50,1,0.0
12514,1,0.0
opercular,1,0.0
Foix-Chavany-Marie,1,0.0
opercula,1,0.0
patients--48,1,0.0
patients--24,1,0.0
cent--were,1,0.0
patients--24--were,1,0.0
rest--10--between,1,0.0
febrility,1,0.0
tnine,1,0.0
syndrome--two,1,0.0
six--with,1,0.0
Cysteiny,1,0.0
n266,1,0.0
n171,1,0.0
placements,1,0.0
22-75,1,0.0
0-395,1,0.0
5291,1,0.0
483-87114,1,0.0
188369,1,0.0
7422-572604,1,0.0
strategiesWe,1,0.0
CFROverall,1,0.0
Tfh-mediated,1,0.0
Subepithelial-layer,1,0.0
subepithelial-layer,1,0.0
Thickness,1,0.0
Agrippal,1,0.0
IL-1βIL-1F2,1,0.0
TLR-2,1,0.0
TLR-7,1,0.0
TRL-2,1,0.0
TRL-4,1,0.0
TRL-7,1,0.0
downgrade,1,0.0
InfluSim,1,0.0
19500,1,0.0
Wide-spread,1,0.0
NI-resistant,1,0.0
5939234,1,0.0
367255,1,0.0
non-normative,1,0.0
appears-unlike,1,0.0
behavior-not,1,0.0
attributional,1,0.0
0-311,1,0.0
IgGII,1,0.0
n153,1,0.0
Musashino,1,0.0
Hemophagocytosis,1,0.0
aberrantly,1,0.0
immuno-stimulation,1,0.0
main-group,1,0.0
non-familial,1,0.0
laterocervical,1,0.0
Horner,1,0.0
SS-QOL,1,0.0
PEIPKGRG,1,0.0
dual-receptor,1,0.0
embolize,1,0.0
anti-T2,1,0.0
4759,1,0.0
3152,1,0.0
3617,1,0.0
300-651,1,0.0
-181-152,1,0.0
379-679,1,0.0
348-621,1,0.0
513-824,1,0.0
-574-608,1,0.0
Ablative,1,0.0
neurosurgeries,1,0.0
ablative,1,0.0
VANQWISH,1,0.0
construed,1,0.0
Marx,1,0.0
Pirogov,1,0.0
precoditions,1,0.0
alignment-free,1,0.0
three-base,1,0.0
F-measure,1,0.0
Kappa-scores,1,0.0
rekindled,1,0.0
WMF,1,0.0
pathogenesistransmission,1,0.0
RP-control,1,0.0
extractionpurification,1,0.0
inoculation-with,1,0.0
concentration-into,1,0.0
primerprobe-set,1,0.0
VTM-3941,1,0.0
VTM-4141,1,0.0
VTM-8181,1,0.0
high-attenuation,1,0.0
16760,1,0.0
14741,1,0.0
broncho,1,0.0
Mycology,1,0.0
interferon-α2a,1,0.0
glutaryl-Coenzyme-A,1,0.0
antilipidemic,1,0.0
Lipohyalinosis,1,0.0
Atheroma,1,0.0
12577,1,0.0
all-campus,1,0.0
Bates,1,0.0
40-y-old,1,0.0
extralimbic,1,0.0
10-yr-old,1,0.0
Immunosuppressive,1,0.0
64-year-olds,1,0.0
carency,1,0.0
radio-allergo-sorbent-test,1,0.0
excretions,1,0.0
mealtime,1,0.0
outperforming,1,0.0
eso-bronchial,1,0.0
oesofagus,1,0.0
esogastroscopy,1,0.0
ultrasound-virtual,1,0.0
ADP-ribosylhydrolase,1,0.0
ADP-ribose-1,1,0.0
QPLD,1,0.0
allocates,1,0.0
acceptor,1,0.0
well-adopt,1,0.0
Unlabelled,1,0.0
salivation,1,0.0
pharyngolaryngeal,1,0.0
beta-Blocker,1,0.0
Pretransplant,1,0.0
24275,1,0.0
131-257,1,0.0
137-277,1,0.0
151-293,1,0.0
104-293,1,0.0
043-092,1,0.0
048-097,1,0.0
salt-loaded,1,0.0
macrophagemicroglial,1,0.0
albumincreatinine,1,0.0
mgmg,1,0.0
small-molecular,1,0.0
5013-6083,1,0.0
81404,1,0.0
in-comparison,1,0.0
log-cubic,1,0.0
Roys,1,0.0
acarabose,1,0.0
triflusal,1,0.0
intersect,1,0.0
Vmax50,1,0.0
vested,1,0.0
1654100000,1,0.0
29713100000,1,0.0
40-99,1,0.0
32933,1,0.0
Moderated,1,0.0
retes,1,0.0
apartment,1,0.0
ferroconcrete,1,0.0
aluminum-framed,1,0.0
carpet,1,0.0
self-smoking,1,0.0
-031,1,0.0
-026,1,0.0
Potency,1,0.0
industry-wide,1,0.0
angiotencin,1,0.0
AH1v,1,0.0
AN1v,1,0.0
NVRL,1,0.0
non-related,1,0.0
disastolic,1,0.0
OSCTC,1,0.0
OSCTCs,1,0.0
dsmCRIPSR,1,0.0
7353,1,0.0
G614D164,1,0.0
μgg,1,0.0
over-preferred,1,0.0
4291,1,0.0
3014,1,0.0
lineal,1,0.0
X1,1,0.0
X3,1,0.0
Polygraphic,1,0.0
narrations,1,0.0
conflictual,1,0.0
antimetabolites,1,0.0
CD001187,1,0.0
well-discussed,1,0.0
metafor,1,0.0
44-94,1,0.0
crRNA--1,1,0.0
non-sulfated,1,0.0
dose-response-inhibition,1,0.0
v902,1,0.0
CalcuSyn,1,0.0
Biosoft,1,0.0
Carrageenan,1,0.0
toxiclethal,1,0.0
1968-1980,1,0.0
WvGS,1,0.0
COVID-19IMPORTANCE,1,0.0
ordinances,1,0.0
casirimabimdevimab,1,0.0
dsmCRISPR,1,0.0
coactivator,1,0.0
climacteric,1,0.0
PFAMQMAYRFNG,1,0.0
twenties,1,0.0
Elitech,1,0.0
T2HIGH,1,0.0
T2LOW,1,0.0
FFP2,1,0.0
Semaphorins,1,0.0
Ubiquitously,1,0.0
plexinD1,1,0.0
semaphorin,1,0.0
semaphorin3EplexinD1,1,0.0
neurodiagnostics,1,0.0
sympton-free,1,0.0
Tentacious,1,0.0
possibleto,1,0.0
postloads,1,0.0
R254,1,0.0
R229,1,0.0
T25-100,1,0.0
Thung,1,0.0
01-30,1,0.0
9-Hole,1,0.0
Stride,1,0.0
PRESPERO,1,0.0
CRD42016037106,1,0.0
custommune,1,0.0
QTGKIADYNYK,1,0.0
TEIYQASTPCNGVEG,1,0.0
LQSYGFQPT,1,0.0
IRGDEVRQIAPGQTGKIADYNYKLPD,1,0.0
FSQILPDPSKPSKRS,1,0.0
GeneFinder,1,0.0
I216T,1,0.0
S162N,1,0.0
1473,1,0.0
myoglobinemia,1,0.0
380-53,1,0.0
Wehn,1,0.0
195-47,1,0.0
41-6,1,0.0
Left-brain,1,0.0
two-handed,1,0.0
non-mirror,1,0.0
implementability,1,0.0
Executability,1,0.0
Decidability,1,0.0
balloon-mounted,1,0.0
navigable,1,0.0
nutritive,1,0.0
AH1N1pdm09-positive,1,0.0
suckling,1,0.0
arrhythmiaThe,1,0.0
developmentHigh-quality,1,0.0
testing-on-a-probe,1,0.0
RBD-coated,1,0.0
Cy5-Streptavidin-polysacharide,1,0.0
fluidics,1,0.0
TOP-TAb,1,0.0
TOP-SNAb,1,0.0
Saturday,1,0.0
multi-marker,1,0.0
44-77,1,0.0
26-73,1,0.0
membersvisitors,1,0.0
recentclose,1,0.0
ILIH1N1,1,0.0
anti-basigin,1,0.0
Less-frequent,1,0.0
2821103,1,0.0
Bauhins,1,0.0
duodenography,1,0.0
dose-capacity,1,0.0
ergonomic,1,0.0
Flutrade,1,0.0
dead-space,1,0.0
10-dose,1,0.0
Extrapolations,1,0.0
equal-tailed,1,0.0
CrIs,1,0.0
102950,1,0.0
sarilumab,1,0.0
proxalutamide,1,0.0
non-iatrogenic,1,0.0
nonencapsulated,1,0.0
ncHi,1,0.0
G2P2,1,0.0
weight-dependent,1,0.0
snack,1,0.0
cytopathologists,1,0.0
mucoviscidosis,1,0.0
upholstered,1,0.0
G11083T,1,0.0
G26144T,1,0.0
C14805T,1,0.0
reticulocyte,1,0.0
RH5,1,0.0
CmaxEC90,1,0.0
CmaxEC50,1,0.0
IHUMI-3,1,0.0
Mani,1,0.0
doxcycline,1,0.0
tet-notch4,1,0.0
Flk1,1,0.0
respecified,1,0.0
Tet-notch4,1,0.0
embryoid,1,0.0
uninduced,1,0.0
Dox-cells,1,0.0
therapy-Adler,1,0.0
Bystrup,1,0.0
Giovannone,1,0.0
Briley-Saebo,1,0.0
Kattman,1,0.0
Laflamme,1,0.0
non-photoactivated,1,0.0
W-Z,1,0.0
Fayad,1,0.0
Keller,1,0.0
Cerebellum,1,0.0
AICA,1,0.0
PICA,1,0.0
practices--yogasanas,1,0.0
kriyas--and,1,0.0
14-296,1,0.0
above-matched,1,0.0
known-onset,1,0.0
TorontoABSTRACT,1,0.0
non-photodynamic,1,0.0
RH5-basigin,1,0.0
plasmin-alpha,1,0.0
Mini-Mult,1,0.0
2-plasmin,1,0.0
treatment-it,1,0.0
malonylation,1,0.0
succinylation,1,0.0
glutarylation,1,0.0
heterogenity,1,0.0
cortisolaemia,1,0.0
charcteristics,1,0.0
glial-expressed,1,0.0
receptorstargets,1,0.0
Epicardial,1,0.0
VTs,1,0.0
Stroke-Canadian,1,0.0
Symbol-Digit,1,0.0
Modalities,1,0.0
23-2430,1,0.0
Sepsis-like,1,0.0
recanalizationreperfusion,1,0.0
RBD-Ferritin,1,0.0
RBD-mi3,1,0.0
60-mer,1,0.0
RBD-I53-50,1,0.0
120-mer,1,0.0
SpyTag-SpyCatcher,1,0.0
120-fold,1,0.0
sect,1,0.0
re-employed,1,0.0
DMP-,1,0.0
pre-clinically,1,0.0
DipHE,1,0.0
swabsaliva,1,0.0
LVPW,1,0.0
brainstem-,1,0.0
bathyphase,1,0.0
NATURE,1,0.0
Willey,1,0.0
ALPHA,1,0.0
BETA,1,0.0
GAMMA,1,0.0
Theta,1,0.0
20-bed,1,0.0
Foster,1,0.0
mid-apical,1,0.0
Reddy,1,0.0
q-RTPCR,1,0.0
Monocytes,1,0.0
Cosinor,1,0.0
death-related,1,0.0
dolichoectasia,1,0.0
1969-1983,1,0.0
parenchymatous,1,0.0
drift-variant,1,0.0
Victoria75,1,0.0
antigonists,1,0.0
solvent-accessible,1,0.0
anchor-locker,1,0.0
Y473-F490,1,0.0
G496-V503,1,0.0
nonanchoring,1,0.0
N450-F456,1,0.0
H1N1pdm-vaccinated,1,0.0
001-098,1,0.0
hypnosuggestive,1,0.0
026-070,1,0.0
-of,1,0.0
D239N,1,0.0
archeo-epidemiologic,1,0.0
1916-1922,1,0.0
influenza-July,1,0.0
1919-were,1,0.0
Ono,1,0.0
Pranlukast,1,0.0
Chrétien,1,0.0
Pledge,1,0.0
Elliott,1,0.0
unwieldy,1,0.0
orbitofrontal,1,0.0
bow,1,0.0
subaxial,1,0.0
tri-assortment,1,0.0
12089,1,0.0
12693068,1,0.0
1921269,1,0.0
9301346,1,0.0
2010-March,1,0.0
220523,1,0.0
infectiondeath,1,0.0
Identity,1,0.0
ACalifornia072009H1N1,1,0.0
07-26,1,0.0
06-17,1,0.0
0-06,1,0.0
S179N,1,0.0
K180T,1,0.0
ATianjinhedongSWL442011H1,1,0.0
362065,1,0.0
bedsize,1,0.0
diasthesis,1,0.0
polypous,1,0.0
Proclamation,1,0.0
heptamer,1,0.0
protein-aided,1,0.0
mHla,1,0.0
Windsor,1,0.0
Wave,1,0.0
IWK,1,0.0
1943421452,1,0.0
783180968,1,0.0
same-household,1,0.0
aortography,1,0.0
rhino-,1,0.0
laryngo-bronchial,1,0.0
physical-activity-related,1,0.0
knitting,1,0.0
Hospitalisations,1,0.0
non-progressing,1,0.0
arteriogrpahy,1,0.0
propagules,1,0.0
carotid-plaque,1,0.0
octreotide,1,0.0
histamine-PC20,1,0.0
Cockroft,1,0.0
IgE-allergen,1,0.0
Claiborne-Johnston,1,0.0
Chalela,1,0.0
Mission11918,1,0.0
embroidery,1,0.0
ATianjinjinnanSWL412011H1,1,0.0
ATianjinningheSWL492009H1,1,0.0
028-072,1,0.0
dihydroorotate,1,0.0
flap-like,1,0.0
kappa-light-chain-enhancer,1,0.0
Theranostics,1,0.0
Brewer,1,0.0
dirty,1,0.0
flies,1,0.0
transmediastinal,1,0.0
cardiac-penetrating,1,0.0
30100,1,0.0
caucasians,1,0.0
bradycardic,1,0.0
mechano-chronotropic,1,0.0
oleic,1,0.0
Al-Ain,1,0.0
railed,1,0.0
kinesthetic-,1,0.0
visual-dominant,1,0.0
healthy-controls,1,0.0
kinesthetic,1,0.0
pre-assessment,1,0.0
only-based,1,0.0
Tian,1,0.0
Nius,1,0.0
Nail,1,0.0
Microcirculation,1,0.0
082-097,1,0.0
5678,1,0.0
050-090,1,0.0
049-088,1,0.0
long-segment,1,0.0
transesophagical,1,0.0
RRT-requiring,1,0.0
not-withstanding,1,0.0
DHODH,1,0.0
temporality,1,0.0
self-degradative,1,0.0
allergen-driven,1,0.0
SS-OCT,1,0.0
micro-RNAs,1,0.0
ACE2-S-protein,1,0.0
patientsA,1,0.0
non-CCC,1,0.0
analyzedCCC,1,0.0
nonresolution,1,0.0
-blockers,1,0.0
trekking,1,0.0
5-28,1,0.0
inotropics,1,0.0
39-86,1,0.0
24-49,1,0.0
4-32,1,0.0
BROCA,1,0.0
waist-height,1,0.0
viral-cell,1,0.0
bilayered,1,0.0
micelles,1,0.0
15N,1,0.0
acyl,1,0.0
nitroxide,1,0.0
Polar,1,0.0
creatinine-kinase,1,0.0
instrumentation-based,1,0.0
IFCC,1,0.0
ampliconread,1,0.0
tangled,1,0.0
pain-door,1,0.0
door-needle,1,0.0
door-balloon,1,0.0
togheter,1,0.0
antibody-laden,1,0.0
transcribrial,1,0.0
Naegleria,1,0.0
fowleri,1,0.0
COVID-1,1,0.0
legionellosis,1,0.0
roles—sources,1,0.0
groups—as,1,0.0
out-of-the-home,1,0.0
penicillinresistant,1,0.0
Nicholson,1,0.0
“Pandemic,1,0.0
Plan”,1,0.0
httpwwwhhsgovnvpopandemicplan,1,0.0
medistinum,1,0.0
approch,1,0.0
defecationmicturition,1,0.0
toilet-related,1,0.0
Build-up,1,0.0
host-Influenza,1,0.0
Everolimus,1,0.0
Beclocort-Polfa,1,0.0
Bronchoscreen,1,0.0
thriceprior,1,0.0
intertwining,1,0.0
Holt,1,0.0
allergy-free,1,0.0
pleuropericardial,1,0.0
Holts,1,0.0
demolishing,1,0.0
ingenious,1,0.0
PwDs,1,0.0
MCAO90min,1,0.0
infarct±SEM,1,0.0
29±3,1,0.0
Ovariectomized,1,0.0
70±3,1,0.0
47±4,1,0.0
67±3,1,0.0
Iba1,1,0.0
JAB1,1,0.0
2-variable,1,0.0
inV1,1,0.0
3-variable,1,0.0
postolateral,1,0.0
37-year,1,0.0
predicativity,1,0.0
rivalries,1,0.0
touchstone,1,0.0
multilateralism,1,0.0
Solidarity,1,0.0
Economy,1,0.0
LAD-ligation,1,0.0
Rebuilding,1,0.0
Atg,1,0.0
virus-regulated,1,0.0
mop,1,0.0
Fido,1,0.0
markerbiomarker,1,0.0
DNMDNB,1,0.0
DNM-based,1,0.0
begging,1,0.0
eosinophile,1,0.0
exoserosis,1,0.0
epithalaxia,1,0.0
lightened,1,0.0
isosoratory,1,0.0
osteo-costochondromyelitis,1,0.0
quiddity,1,0.0
Undocumented,1,0.0
squat,1,0.0
nano-layer,1,0.0
optical-chemical,1,0.0
semi-experimental,1,0.0
Tarapacá,1,0.0
9961,1,0.0
9722,1,0.0
bordercustoms,1,0.0
frame-1,1,0.0
3N,1,0.0
influencers,1,0.0
influencer-driven,1,0.0
Comments,1,0.0
community-led,1,0.0
Dispatchers,1,0.0
AMCC,1,0.0
Arapahoe,1,0.0
two-route,1,0.0
rickets,1,0.0
osteomalacia,1,0.0
high-tech,1,0.0
-08050,1,0.0
caregiver-directed,1,0.0
2013-February,1,0.0
Neurowave,1,0.0
Haguenau,1,0.0
re-enroll,1,0.0
re-enrolled,1,0.0
re-enrollment,1,0.0
algebraic,1,0.0
Libman-Sacks,1,0.0
Villa,1,0.0
42953,1,0.0
19875,1,0.0
23078,1,0.0
077-095,1,0.0
070-082,1,0.0
tobacco-associated,1,0.0
systemMaterials,1,0.0
point-of,1,0.0
weekFindings,1,0.0
valuesConclusion,1,0.0
P300,1,0.0
neurosensory,1,0.0
epornitic,1,0.0
1524,1,0.0
pullet,1,0.0
Bolton,1,0.0
Visitation,1,0.0
meso-,1,0.0
microlevels,1,0.0
vacillating,1,0.0
spliced,1,0.0
dispensability,1,0.0
SFD,1,0.0
specialty-based,1,0.0
Vero-derived,1,0.0
MERS-CoV2012,1,0.0
SARS-CoV-22019,1,0.0
splitsubunit,1,0.0
Pre-contrast,1,0.0
pre-contrast,1,0.0
ABangkokH3N2,1,0.0
gateways,1,0.0
whom--and,1,0.0
outbreak--or,1,0.0
hoarding,1,0.0
Fedson,1,0.0
cries,1,0.0
Allens,1,0.0
300161,1,0.0
106-179,1,0.0
092-117,1,0.0
109-130,1,0.0
021-028,1,0.0
024-030,1,0.0
059-162,1,0.0
072-136,1,0.0
047-168,1,0.0
085-128,1,0.0
150300,1,0.0
pathomorphologic,1,0.0
applicator,1,0.0
Poznań,1,0.0
Prussian,1,0.0
ADunedin73,1,0.0
SARS-CoV-12003,1,0.0
OC431890,1,0.0
HKU5,1,0.0
2rectal,1,0.0
filers,1,0.0
cyclones,1,0.0
MERS-Cov,1,0.0
undercontrolled,1,0.0
TOPCAB,1,0.0
13500,1,0.0
cardioverterdefibrillator,1,0.0
normal-to-normal,1,0.0
373℃,1,0.0
screen-negative,1,0.0
periodSurgical,1,0.0
Neoadjuvant,1,0.0
NCCN,1,0.0
3unresectable,1,0.0
HKU4,1,0.0
esophagogastricjunction,1,0.0
EGJ,1,0.0
Transnasal,1,0.0
intubationpercutaneous,1,0.0
goggle,1,0.0
enterostomy,1,0.0
Thoroughly,1,0.0
infectioninflammation,1,0.0
Single-room,1,0.0
1894-plague,1,0.0
1918-AH1N1,1,0.0
SARS-related-CoVs,1,0.0
MERS-related,1,0.0
successors,1,0.0
Observers,1,0.0
121-297,1,0.0
kappas,1,0.0
E42,1,0.0
Y41H,1,0.0
Publicly,1,0.0
610-728,1,0.0
176-419,1,0.0
ex-workers,1,0.0
Westminster,1,0.0
5·3,1,0.0
removingrecanalizing,1,0.0
congressmen,1,0.0
counterarguments,1,0.0
deceive,1,0.0
ferritin-antibody,1,0.0
ferritin-haemagglutinin,1,0.0
Georgian,1,0.0
laboratory-instrumental,1,0.0
clinical-pathogenetic,1,0.0
hemoreologic,1,0.0
camouflaged,1,0.0
thebasis,1,0.0
resorting,1,0.0
164-285,1,0.0
stagnated,1,0.0
dawning,1,0.0
bronchoscopically,1,0.0
GKV-Modernisierungsgesetz,1,0.0
121-162,1,0.0
147-358,1,0.0
124-171,1,0.0
macrotis,1,0.0
erythaematosus,1,0.0
heparine,1,0.0
COVID-19–related,1,0.0
mirror-aided,1,0.0
H1N1pdmsH1N1,1,0.0
intra-virion,1,0.0
virus-epithelial,1,0.0
paients,1,0.0
n519,1,0.0
n518,1,0.0
062-152,1,0.0
p090,1,0.0
progesterone-only,1,0.0
progestagen,1,0.0
medical-diagnostic,1,0.0
2003-February,1,0.0
respondents’,1,0.0
7328,1,0.0
progress-would,1,0.0
accused,1,0.0
emergency-department,1,0.0
108-53,1,0.0
13-99,1,0.0
148-1001,1,0.0
107-809,1,0.0
myopathic,1,0.0
subtentorial,1,0.0
creatinemia,1,0.0
Nigerias,1,0.0
1821,1,0.0
8638,1,0.0
exercise-ECG,1,0.0
bromhexine,1,0.0
careplacebo,1,0.0
Ultrafast,1,0.0
uncompleted,1,0.0
petrol,1,0.0
four-specimen,1,0.0
9775,1,0.0
BACKGROUNDCirculating,1,0.0
samplesMETHODSA,1,0.0
comparisonsRESULTSCRISPR-augmented,1,0.0
resultsCONCLUSIONResults,1,0.0
infectionTRIAL,1,0.0
NCT04358211FUNDINGDepartment,1,0.0
sternocleidomastoid,1,0.0
SCM,1,0.0
vestibulum,1,0.0
VEMP,1,0.0
restenotic,1,0.0
macro-environment,1,0.0
custom-tailored,1,0.0
Endotype,1,0.0
theratype,1,0.0
precisionpersonalized,1,0.0
patomechanisms,1,0.0
uderdiagnosis,1,0.0
toracostomy,1,0.0
picardy,1,0.0
Aisne,1,0.0
Oise,1,0.0
Somme,1,0.0
medicalised,1,0.0
centABSTRACT,1,0.0
self-grown,1,0.0
MOB,1,0.0
Cilengitide,1,0.0
spleno-porto-mesenteric,1,0.0
EuropeConclusions,1,0.0
Cardioplegia,1,0.0
crossclamp,1,0.0
artery-specific,1,0.0
rennin-angiotensin,1,0.0
58×104,1,0.0
14×104,1,0.0
43×103,1,0.0
34×103,1,0.0
primaryjunior,1,0.0
asthma-oriented,1,0.0
policiespractices,1,0.0
veincerebral,1,0.0
small-bowel,1,0.0
RGD-binding,1,0.0
compound—,1,0.0
BFDBSC—can,1,0.0
compounds—FPBFDBSC,1,0.0
BFB-gallate—,1,0.0
effectsthan,1,0.0
BFDBSC,1,0.0
whearas,1,0.0
two—BFB-borneol,1,0.0
BFB-menthol—showed,1,0.0
inactivity-related,1,0.0
Rales,1,0.0
K403R,1,0.0
Arg-Gly-Asp,1,0.0
sectional-analytic,1,0.0
gadolinium-DTPA-enhanced,1,0.0
sideadverseundesirable,1,0.0
Amplatzer™,1,0.0
065ABSTRACT,1,0.0
catch-22,1,0.0
near-elimination,1,0.0
clinico-statistical,1,0.0
algetic,1,0.0
emergen-ce,1,0.0
inherits,1,0.0
hematologically,1,0.0
fibrinopeptid,1,0.0
electro-encephalographic,1,0.0
nightsmonth,1,0.0
over-generalization,1,0.0
136-146,1,0.0
20-27,1,0.0
74-113,1,0.0
synapse-associated,1,0.0
outgrowth-associated,1,0.0
PC12,1,0.0
free-serum,1,0.0
34-54,1,0.0
I559N,1,0.0
D641V,1,0.0
V729I,1,0.0
180110,1,0.0
radiopacity,1,0.0
releaser,1,0.0
4880,1,0.0
non-dipolar,1,0.0
Dipole,1,0.0
back-titration,1,0.0
astuprotimut-r,1,0.0
Vical,1,0.0
JNJ63623872,1,0.0
Amulet™,1,0.0
new-acquired,1,0.0
Opponents,1,0.0
materialize,1,0.0
chuankezhi,1,0.0
AUdon72,1,0.0
thioglycolate-treated,1,0.0
phagocytose,1,0.0
Connection,1,0.0
Cockeysville,1,0.0
BaxterBartels,1,0.0
Issaquah,1,0.0
Wash,1,0.0
S-033188,1,0.0
VCL-CB01,1,0.0
Lyon,1,0.0
IncDynPort,1,0.0
FP-01,1,0.0
FluGEM,1,0.0
Mucosis,1,0.0
protein-1-altered,1,0.0
Vivaldi,1,0.0
Biosciences,1,0.0
PentaStaph,1,0.0
plc,1,0.0
StaphVAX,1,0.0
Nabi,1,0.0
Biopharmaceuticals,1,0.0
tabulatedResults,1,0.0
vaccinesData,1,0.0
numbersThis,1,0.0
ultraviolet-induced,1,0.0
17-1064,1,0.0
11-82,1,0.0
three9,1,0.0
Cartridge,1,0.0
TGE,1,0.0
Lemierre,1,0.0
necrophorum,1,0.0
hindbrain,1,0.0
AGF,1,0.0
siphon,1,0.0
ARussia,1,0.0
dysphagiaaspiration,1,0.0
“severe,1,0.0
aquired,1,0.0
2019”,1,0.0
667–671,1,0.0
IAH,1,0.0
jfoxupmc-biosecurityorg,1,0.0
Ig-E-mediated,1,0.0
diagnostical,1,0.0
Gravitation,1,0.0
PF-05,1,0.0
fractionator,1,0.0
rheopolyglucin,1,0.0
APACI,1,0.0
CLT,1,0.0
AMI-indicative,1,0.0
SATIS-Stroke,1,0.0
PRR,1,0.0
acrimonious,1,0.0
infection-precipitated,1,0.0
Alarmin,1,0.0
heat-sterilized,1,0.0
worker-led,1,0.0
pathomorphologically,1,0.0
light-microscopical,1,0.0
enzyme-histochemically,1,0.0
1995-2010,1,0.0
Biphasic,1,0.0
groupAcute,1,0.0
well-founded,1,0.0
Atherothrombotic,1,0.0
CHARISMA,1,0.0
EuropeanAustralasian,1,0.0
ESPRIT,1,0.0
aspirindipyridamole,1,0.0
somatotropin,1,0.0
Re-elevation,1,0.0
milk-based,1,0.0
006-026,1,0.0
BACA,1,0.0
embodying,1,0.0
poisons,1,0.0
rRNAs,1,0.0
biotinylated,1,0.0
overhang,1,0.0
echocardiographicDoppler,1,0.0
droplet-PCR,1,0.0
disquiets,1,0.0
hypopsia,1,0.0
enervating,1,0.0
Schwann,1,0.0
trisodium,1,0.0
MHRAStudy,1,0.0
red-colored,1,0.0
BsmI,1,0.0
non-antigen-dependent,1,0.0
radiosurgical,1,0.0
isodose,1,0.0
4-mm,1,0.0
collimator,1,0.0
encephalomalacia,1,0.0
irradiation-based,1,0.0
shoreline,1,0.0
Phocidae,1,0.0
Otariidae,1,0.0
leakiness,1,0.0
DallasFort,1,0.0
679631,1,0.0
medihalers,1,0.0
infarction--including,1,0.0
Sørlandet,1,0.0
Arendal,1,0.0
immuno-deficient,1,0.0
poststress,1,0.0
ACCCORD,1,0.0
17114,1,0.0
ACCORD,1,0.0
125-135,1,0.0
HQoL,1,0.0
HA1-domain,1,0.0
BWisconsin012010-like,1,0.0
Northern-Hemisphere,1,0.0
EMAEuropean,1,0.0
2417,1,0.0
Haider,1,0.0
trans-neuronal,1,0.0
I212,1,0.0
risk-benefits,1,0.0
plus-strand,1,0.0
ebselen,1,0.0
oxidases,1,0.0
III-type,1,0.0
ratio246,1,0.0
161-376,1,0.0
ratio207,1,0.0
136-317,1,0.0
ratio045,1,0.0
021-097,1,0.0
ratio049,1,0.0
030-081,1,0.0
perceptionidentification,1,0.0
trivaccine-immunized,1,0.0
confabulations,1,0.0
amotivational,1,0.0
VERIPRO®,1,0.0
Env,1,0.0
20-hydroxy-5,1,0.0
14-eicosatetraenoic,1,0.0
HVE,1,0.0
PCU,1,0.0
gamma-glutamyltransferase,1,0.0
gamma-GT,1,0.0
non-contagious,1,0.0
echocarciographic,1,0.0
ice-pick,1,0.0
age-by-sex,1,0.0
coelom,1,0.0
length-based,1,0.0
reactants,1,0.0
nicotinism,1,0.0
75750,1,0.0
222750,1,0.0
2885,1,0.0
2564,1,0.0
2129,1,0.0
20922129,1,0.0
976-987,1,0.0
961961,1,0.0
11311168,1,0.0
957-977,1,0.0
0965,1,0.0
0954-0976,1,0.0
repeatedfurther,1,0.0
Examinee,1,0.0
2004-2016,1,0.0
158902,1,0.0
073-093,1,0.0
078-097,1,0.0
soda,1,0.0
066-087,1,0.0
070-090,1,0.0
ATexas185,1,0.0
100-mg,1,0.0
antiphosholipid,1,0.0
or75,1,0.0
BiomarkersImaging,1,0.0
individual-patient,1,0.0
n109,1,0.0
Pneumo-phthisiology,1,0.0
ropes,1,0.0
DGIDb,1,0.0
mobility-dependent,1,0.0
Appointment,1,0.0
Simplification,1,0.0
1970-1995,1,0.0
8-102,1,0.0
AH1N1B,1,0.0
alphahydroxybutyrate,1,0.0
04p0006,1,0.0
alphahydroxybutytrate,1,0.0
introspective,1,0.0
Non-SARS-CoV-2,1,0.0
past-COVID-19,1,0.0
blending,1,0.0
Bari,1,0.0
reprocess,1,0.0
CoVCoVs,1,0.0
coronaviruscoronaviruses,1,0.0
task-shifting,1,0.0
worker-years,1,0.0
pens,1,0.0
foodwater,1,0.0
8003,1,0.0
8004,1,0.0
Pfuml,1,0.0
CPE-based,1,0.0
A1812D,1,0.0
P1821S,1,0.0
neutralizationvirological,1,0.0
vaccinesantivirals,1,0.0
Mot,1,0.0
gmL,1,0.0
P0025,1,0.0
11-43,1,0.0
098-55,1,0.0
bail,1,0.0
Cricetidae,1,0.0
transatrial,1,0.0
Bashkortostan,1,0.0
unclearWe,1,0.0
usedSix,1,0.0
69990,1,0.0
Postantithrombotic,1,0.0
059-087,1,0.0
063-086,1,0.0
067-083,1,0.0
085-108,1,0.0
043-123,1,0.0
033-054,1,0.0
typeThe,1,0.0
qualitative-descriptive,1,0.0
17y,1,0.0
2014-December,1,0.0
caseness,1,0.0
6361-9388,1,0.0
9928,1,0.0
9851-9967,1,0.0
5503-8714,1,0.0
9959,1,0.0
9893-9986,1,0.0
409-431,1,0.0
OGDs,1,0.0
3-week-old,1,0.0
atopia,1,0.0
hazard-based,1,0.0
irritant-based,1,0.0
state-of-science,1,0.0
poly-specific,1,0.0
n196,1,0.0
141-339,1,0.0
15-1396,1,0.0
059-078,1,0.0
064-096,1,0.0
fiberoscope,1,0.0
intra-bronchial,1,0.0
2834,1,0.0
report2,1,0.0
BNT162b2-induced,1,0.0
effector-memory,1,0.0
002-292,1,0.0
001-028,1,0.0
Pcom,1,0.0
modes-of-action,1,0.0
pentane,1,0.0
time--at,1,0.0
year--must,1,0.0
endures,1,0.0
childfamily,1,0.0
Flusurvey,1,0.0
inferior--posterior--left,1,0.0
myocarditis-associated,1,0.0
ESPGHAN,1,0.0
2006-March,1,0.0
6355,1,0.0
Genova,1,0.0
physicians--syndromic,1,0.0
subfertility,1,0.0
100-384,1,0.0
IVFICSI,1,0.0
atlas-guided,1,0.0
Basketball,1,0.0
cortically,1,0.0
MI-based,1,0.0
brain-machine,1,0.0
conditioning-test,1,0.0
interstimulus,1,0.0
cytokinemia,1,0.0
injury-causing,1,0.0
6600000,1,0.0
animate,1,0.0
unanimate,1,0.0
infectuousness,1,0.0
authories,1,0.0
330000,1,0.0
25-74,1,0.0
DEFINITE,1,0.0
POSSIBLE,1,0.0
symptom-monitoring,1,0.0
countries2,1,0.0
20113,1,0.0
pandemic-fighting,1,0.0
inflammation-prone,1,0.0
bronchus-associated,1,0.0
iBALTs,1,0.0
CCL19,1,0.0
CXCL13,1,0.0
Atlas-to-scan,1,0.0
application-dependent,1,0.0
atlas-defined,1,0.0
faciliate,1,0.0
courseABSTRACT,1,0.0
daily--3,1,0.0
eukinetic,1,0.0
MinIONGridION,1,0.0
RSLAs,1,0.0
mediator-generating,1,0.0
Beneath,1,0.0
cooperates,1,0.0
practitioner-based,1,0.0
enpaneled,1,0.0
“long,1,0.0
COVID”,1,0.0
httpsbitly3y8n0Bt,1,0.0
disaggregate,1,0.0
117276,1,0.0
Xiangtan,1,0.0
astograph,1,0.0
years--2,1,0.0
Spotter,1,0.0
MOSA,1,0.0
OPCS,1,0.0
particle-like,1,0.0
metal-conjugates,1,0.0
Metal,1,0.0
complexes-,1,0.0
bismuth,1,0.0
duplex-unwinding,1,0.0
Q-RT-PCR,1,0.0
radioassay,1,0.0
Metal-conjugates,1,0.0
3Clike,1,0.0
atlas-quantified,1,0.0
scan-derived,1,0.0
ICSI,1,0.0
Topic,1,0.0
Model-A,1,0.0
EVT-centers,1,0.0
Model-B,1,0.0
drive-time,1,0.0
stroke-centers,1,0.0
Flipping,1,0.0
EVT-capable,1,0.0
lavendustin,1,0.0
downstroke,1,0.0
Prolonging,1,0.0
680000,1,0.0
Gene-disease,1,0.0
MI-related,1,0.0
drug-target-disease,1,0.0
contrifugation,1,0.0
SVCs,1,0.0
lentiviral-based,1,0.0
allergistsimmunologists,1,0.0
demographicpre-stroke,1,0.0
AdC68,1,0.0
Single-dose,1,0.0
18-28,1,0.0
2-63,1,0.0
1-75,1,0.0
Syrup,1,0.0
Regulators,1,0.0
admirable,1,0.0
antibody-discovery,1,0.0
IVFintracytoplasmic,1,0.0
trauma-models,1,0.0
EVT-center,1,0.0
stroke-treating,1,0.0
polyphasic,1,0.0
diseasesauthors,1,0.0
over-production,1,0.0
anti-proinflammatory,1,0.0
anti-infectious,1,0.0
accrual,1,0.0
envenomated,1,0.0
heart-disease,1,0.0
100--109,1,0.0
FDPS,1,0.0
104--110,1,0.0
Acceptable,1,0.0
36-55,1,0.0
8th-10th,1,0.0
regionallyABSTRACT,1,0.0
rs1143627,1,0.0
entrenching,1,0.0
THAWS,1,0.0
Unclear-Onset,1,0.0
TLCO,1,0.0
Interleukin-1A,1,0.0
Interleukin-1B,1,0.0
rs1304037,1,0.0
rs16347,1,0.0
rs17561,1,0.0
rs2071373,1,0.0
IL1A,1,0.0
rs1143623,1,0.0
rs3917345,1,0.0
tune,1,0.0
hyperparameters,1,0.0
Memetic,1,0.0
Crombachs,1,0.0
FDA-licensed,1,0.0
choriomeningitis,1,0.0
D414,1,0.0
Mycophenolic,1,0.0
self-reactivity,1,0.0
Fluctuation,1,0.0
ratioORC2,1,0.0
012-080,1,0.0
ORC4,1,0.0
014-097,1,0.0
apoliopoproteina,1,0.0
Cerebrospinal-fluid,1,0.0
2019-coronavirus,1,0.0
rejuvenate,1,0.0
infarctioninjury,1,0.0
000year,1,0.0
injuryinfarction,1,0.0
0435,1,0.0
densitytime,1,0.0
TDC-derived,1,0.0
Fluid-attenuated,1,0.0
take-off,1,0.0
hind,1,0.0
perceptiveness,1,0.0
system-integrated,1,0.0
pathogen-monitoring,1,0.0
small-volume,1,0.0
chip-integrated,1,0.0
withinbetween,1,0.0
Arenaviruses,1,0.0
atelectases,1,0.0
aerohematic,1,0.0
very-long-chain,1,0.0
stagesphases,1,0.0
research-in-humans,1,0.0
processesExamining,1,0.0
discoverybasic,1,0.0
miR-based,1,0.0
Bland-White-Garland,1,0.0
Localisation,1,0.0
022-059,1,0.0
033-093,1,0.0
e-health,1,0.0
Covod-19,1,0.0
pro-homeostatic,1,0.0
elovanoids,1,0.0
VLC-PUFA,1,0.0
CI057-075,1,0.0
ELV,1,0.0
disease-modifiable,1,0.0
fixes,1,0.0
mesentery,1,0.0
Fogartys,1,0.0
ERCHS,1,0.0
years-155,1,0.0
chi2516,1,0.0
n191,1,0.0
n110,1,0.0
076-092,1,0.0
95CI076-090,1,0.0
CI046-064,1,0.0
4408,1,0.0
inter-item,1,0.0
0-18-year-olds,1,0.0
varianceABSTRACT,1,0.0
Refractoriness,1,0.0
return-visits,1,0.0
virus-appeared,1,0.0
antipandemic,1,0.0
3829-7167,1,0.0
7300-9638,1,0.0
anti-SARS-CoV-2-IgG,1,0.0
8437,1,0.0
6646-9410,1,0.0
7641-9782,1,0.0
5938,1,0.0
4079-7578,1,0.0
4853-8268,1,0.0
4244,1,0.0
7649-9884,1,0.0
month-long,1,0.0
plexectomy,1,0.0
demostrated,1,0.0
disarrayed,1,0.0
floaters,1,0.0
ChADOx1,1,0.0
venogram,1,0.0
liasing,1,0.0
unsurvivable,1,0.0
HAIS,1,0.0
atrial-to-femoral,1,0.0
fresh-blood,1,0.0
pre-post,1,0.0
miRWalk,1,0.0
dynes,1,0.0
fall-off,1,0.0
M-shape,1,0.0
53-298,1,0.0
Neuroinvasion,1,0.0
intrahypothalamic,1,0.0
Hypothalamic,1,0.0
Ramphastos,1,0.0
2376,1,0.0
4887,1,0.0
air-filled,1,0.0
V-shaped,1,0.0
ischaemiaABSTRACT,1,0.0
redeveloped,1,0.0
0126,1,0.0
739-939,1,0.0
742-940,1,0.0
14-82,1,0.0
multi-wave,1,0.0
audit-feedback,1,0.0
ILBI,1,0.0
AOF,1,0.0
Goethe,1,0.0
Incorporated,1,0.0
Monde,1,0.0
boder,1,0.0
house-,1,0.0
Karen,1,0.0
uneducated,1,0.0
haematologists,1,0.0
1738,1,0.0
1205-1816,1,0.0
easesTo,1,0.0
19-60-year-olds,1,0.0
MADE,1,0.0
SLUCVD,1,0.0
corticosteroid-refractory,1,0.0
thirteen-year-old,1,0.0
TNF-A863C,1,0.0
TNF-A308G,1,0.0
TNF-A238G,1,0.0
IL1B-C511T,1,0.0
IL1B-C-31T,1,0.0
IL4-C590T,1,0.0
IL6-C174G,1,0.0
IL10A-1082G,1,0.0
IL10-A592C,1,0.0
distirbances,1,0.0
Excerpta,1,0.0
pressure-wire-,1,0.0
echocardiography-based,1,0.0
acceptanceConclusions,1,0.0
first-responders,1,0.0
Kohn,1,0.0
antiradical,1,0.0
23-101,1,0.0
12-78,1,0.0
20-117,1,0.0
goal-concordant,1,0.0
Hoffman,1,0.0
Goolishian,1,0.0
allopathy,1,0.0
Solapur,1,0.0
human-to-human-transmitted,1,0.0
cobra,1,0.0
Wausau,1,0.0
pressured,1,0.0
actualizes,1,0.0
thermotools,1,0.0
chest-Computed,1,0.0
Electrophoresis,1,0.0
CK-MM,1,0.0
Polypeptide,1,0.0
4-item,1,0.0
sNIHSS-4,1,0.0
greater-than-normal,1,0.0
Tens,1,0.0
osteopaths,1,0.0
NF1,1,0.0
anginanon-Q,1,0.0
myeloperaxidase,1,0.0
CD401,1,0.0
optimalization,1,0.0
fittest,1,0.0
elderlys,1,0.0
Withholding,1,0.0
20N,1,0.0
80S,1,0.0
20W,1,0.0
20E,1,0.0
Accuracies,1,0.0
Globe,1,0.0
stroke-miRNA,1,0.0
Rumors,1,0.0
4806299,1,0.0
318599,1,0.0
lighten,1,0.0
hyper-production,1,0.0
-associated,1,0.0
2005-6,1,0.0
MC-ventricular,1,0.0
tracheo-esophageal,1,0.0
technologys,1,0.0
IHD-patients,1,0.0
42-86,1,0.0
unattended,1,0.0
bilevel,1,0.0
BiPAP,1,0.0
Suggestive,1,0.0
endotheliitis,1,0.0
humeral,1,0.0
superantigen,1,0.0
respiratory-directed,1,0.0
post-Covid-19,1,0.0
coagulation-like,1,0.0
vaccinationStudy,1,0.0
macula,1,0.0
subsequentlyConclusions,1,0.0
0512,1,0.0
0620,1,0.0
peridomestic,1,0.0
bushy-tailed,1,0.0
woodrats,1,0.0
striped,1,0.0
skunks,1,0.0
cottontail,1,0.0
fox,1,0.0
black-tailed,1,0.0
racoons,1,0.0
human-wildlife,1,0.0
Subglottic,1,0.0
32584464,1,0.0
20206CD013652,1,0.0
11–80,1,0.0
0044Our,1,0.0
Glycine,1,0.0
gavestinel,1,0.0
disrespectful,1,0.0
finger-to-nose,1,0.0
P0467,1,0.0
62-41,1,0.0
58-61,1,0.0
P0771,1,0.0
aso,1,0.0
serological-immunological,1,0.0
152585,1,0.0
20–40,1,0.0
1–30,1,0.0
Takwoingi,1,0.0
23–87,1,0.0
AULSS7,1,0.0
Pedemontana,1,0.0
Vicenza,1,0.0
community-orientated,1,0.0
Delft,1,0.0
unhappy,1,0.0
IE1,1,0.0
asthma-smoking,1,0.0
Gel-filtration,1,0.0
UV-monitor,1,0.0
Fe2-induced,1,0.0
pathochemical,1,0.0
1613,1,0.0
2282,1,0.0
079-090,1,0.0
C-C-motif,1,0.0
trefoil,1,0.0
retinol-binding,1,0.0
chitinase-3-like,1,0.0
3215,1,0.0
serine-type,1,0.0
Guanajuato,1,0.0
23517,1,0.0
34154,1,0.0
asylum-seekers,1,0.0
landed,1,0.0
runes,1,0.0
Ags,1,0.0
lab-modified,1,0.0
extraocular,1,0.0
nasolacrimal,1,0.0
neoliberal,1,0.0
longings,1,0.0
5944-1303,1,0.0
6838-1769,1,0.0
fluorocein,1,0.0
non-collagenous,1,0.0
slippage,1,0.0
supraconducting,1,0.0
embalmed,1,0.0
METHODS-DESIGN,1,0.0
pro-atrial,1,0.0
creatinekinase,1,0.0
haemoglobine,1,0.0
transthoracal,1,0.0
pro-epidermal,1,0.0
lipocalin-2,1,0.0
PCa,1,0.0
impermeability,1,0.0
droplet-induced,1,0.0
population-mixing,1,0.0
1008-7467,1,0.0
drop-high,1,0.0
0448,1,0.0
0219-0919,1,0.0
0399,1,0.0
0219-0727,1,0.0
ENI,1,0.0
drop-low,1,0.0
OR5239,1,0.0
1271-21595,1,0.0
SBP-the,1,0.0
OR3797,1,0.0
1486-9697,1,0.0
1185-9683,1,0.0
supercontactors,1,0.0
Moderates,1,0.0
CHi,1,0.0
26-161,1,0.0
17-107,1,0.0
12-79,1,0.0
15-195,1,0.0
10-194,1,0.0
16-416,1,0.0
20-659,1,0.0
headspace,1,0.0
coronavirus-NL63,1,0.0
misassignment,1,0.0
ECG-Holter,1,0.0
Neurosonological,1,0.0
Org10172,1,0.0
119-893,1,0.0
non-lipidated,1,0.0
LC3-II,1,0.0
lipidated,1,0.0
PLP2-TM,1,0.0
TGEV,1,0.0
postsystolic,1,0.0
asthma-specialist,1,0.0
surveillance-Senegal,1,0.0
sites-in,1,0.0
doctorclinic,1,0.0
NiRAN,1,0.0
kinase-like,1,0.0
Brepocitinib,1,0.0
Decernotinib,1,0.0
Fasudil,1,0.0
Filgotinib,1,0.0
GSK2606414,1,0.0
Peficitinib,1,0.0
Ruxolitinib,1,0.0
Tofacitinib,1,0.0
Upadacitinib,1,0.0
Pamapimod,1,0.0
Ibrutinib,1,0.0
ITK,1,0.0
Rho-associated,1,0.0
FGFR2,1,0.0
TYK2,1,0.0
p38-MAPK,1,0.0
SYK,1,0.0
LC3-I,1,0.0
beclin,1,0.0
BECN1,1,0.0
bioreceptor,1,0.0
Believe,1,0.0
noyes,1,0.0
271-3657,1,0.0
sureyes,1,0.0
163-1463,1,0.0
138-1146,1,0.0
167-621,1,0.0
157-863,1,0.0
102-1645,1,0.0
premedical,1,0.0
proceding,1,0.0
pervenous,1,0.0
reagentless,1,0.0
appurtenance,1,0.0
Abbreviation,1,0.0
4ere,1,0.0
Francis-Davenport,1,0.0
Smorodintsev-Luzyanina,1,0.0
hyper-response,1,0.0
complement-induced,1,0.0
life-shortening,1,0.0
noncrepitant,1,0.0
neuroanatomicalneurobiological,1,0.0
obesity-,1,0.0
not-allergic-not-obese,1,0.0
allergic-not-obese,1,0.0
obese-not-allergic,1,0.0
allergic-and-obese,1,0.0
0·3-0·4,1,0.0
size-specific,1,0.0
environment-virus-host,1,0.0
mix-and-match,1,0.0
oro-esophageal,1,0.0
IOE,1,0.0
Xuanqiaoliyan,1,0.0
decotion,1,0.0
re-canalization,1,0.0
0106,1,0.0
0486,1,0.0
asia,1,0.0
HiN2,1,0.0
epidemiosurveillance,1,0.0
teenage-asthma,1,0.0
Byker,1,0.0
Grove,1,0.0
stars,1,0.0
Sellars,1,0.0
karaoke,1,0.0
T-shirts,1,0.0
quiz,1,0.0
5–10,1,0.0
REVEAL,1,0.0
opinion-,1,0.0
Snow,1,0.0
patients--intention,1,0.0
Finlands,1,0.0
Swedens,1,0.0
isopropyly,1,0.0
Amines,1,0.0
asthmatogens,1,0.0
Capturing,1,0.0
senegalese,1,0.0
crebrovascular,1,0.0
proportionnal,1,0.0
drunk,1,0.0
proficiency-testing,1,0.0
Proficiency-testing,1,0.0
Appraising,1,0.0
Calderon,1,0.0
Guardia,1,0.0
Multivitamin,1,0.0
etiopathophysiological,1,0.0
membrane-virus,1,0.0
Spikes,1,0.0
replica,1,0.0
fusogenic,1,0.0
dyadic,1,0.0
reconceptualize,1,0.0
binge-drinking,1,0.0
flacid,1,0.0
predate,1,0.0
BShangdong797,1,0.0
therapy--2,1,0.0
005--whereas,1,0.0
group--366,1,0.0
IFN-IIFN-III,1,0.0
Vit-D,1,0.0
vit-D,1,0.0
Landesnervenklinik,1,0.0
bactérial,1,0.0
encephalic,1,0.0
Royer,1,0.0
S-beta0,1,0.0
Vaccine-related,1,0.0
NUTS,1,0.0
influenza-containing,1,0.0
18-county,1,0.0
BHonk,1,0.0
super-potent,1,0.0
γ1,1,0.0
Quad,1,0.0
out-performs,1,0.0
3175,1,0.0
multispace,1,0.0
Delta-plus,1,0.0
Eta,1,0.0
welcomes,1,0.0
role-modeling,1,0.0
house-to-house,1,0.0
role-models,1,0.0
Denmarks,1,0.0
lobbying,1,0.0
Post-vaccination,1,0.0
2178,1,0.0
9233,1,0.0
receiveCOVID-19,1,0.0
Nationalities,1,0.0
SNNPR,1,0.0
9930,1,0.0
9754,1,0.0
Tigray,1,0.0
9704,1,0.0
Gambela,1,0.0
9542,1,0.0
non-farm,1,0.0
inhaledexhaled,1,0.0
co‐detected,1,0.0
HCoV‐HKU1,1,0.0
HCoV‐NL63,1,0.0
CD19-based,1,0.0
purplish,1,0.0
oedematous,1,0.0
15120,1,0.0
SS-A,1,0.0
Reactants,1,0.0
long-debated,1,0.0
slit-like,1,0.0
evaporating,1,0.0
rains,1,0.0
drought,1,0.0
tornadoes,1,0.0
h-bonds,1,0.0
2019-nCoVCommunicated,1,0.0
non-hematologic,1,0.0
HCoV‐OC43,1,0.0
vaccine-reported,1,0.0
cytopenia,1,0.0
rotatablator,1,0.0
Naul,1,0.0
high-containment,1,0.0
fixatives,1,0.0
2214,1,0.0
2793398,1,0.0
FBS,1,0.0
Cigarettes,1,0.0
Ca-antagonist,1,0.0
‐2,1,0.0
HCoV‐229E,1,0.0
DTN,1,0.0
lag-time,1,0.0
098-100,1,0.0
treatments-depends,1,0.0
mitigative,1,0.0
Wandering,1,0.0
Betacoronaviridae,1,0.0
reponding,1,0.0
non-judgmental,1,0.0
I-11,1,0.0
II-23,1,0.0
RRI,1,0.0
luminolo-dependent,1,0.0
Microlumat,1,0.0
96P,1,0.0
RGG,1,0.0
Brethold,1,0.0
96P-WMP,1,0.0
rri,1,0.0
subgrouping,1,0.0
playgroups,1,0.0
agent-specific,1,0.0
Mycobacterial,1,0.0
copathogen,1,0.0
aspects-all,1,0.0
palatine,1,0.0
EISN,1,0.0
weather-dependent,1,0.0
BSL-1,1,0.0
Garmisch-Partenkirchen,1,0.0
keynote,1,0.0
Heinrich,1,0.0
Mattle,1,0.0
trans-membrane,1,0.0
treatment-or,1,0.0
APACHE-II,1,0.0
ratio432,1,0.0
PAR-1,1,0.0
unreasonably,1,0.0
530348,1,0.0
Thrombin-Receptor,1,0.0
FDA-confirmed,1,0.0
outcome-driven,1,0.0
Zontivity®,1,0.0
Plavix®,1,0.0
Aggrenox®,1,0.0
etiologic-pathogenetic,1,0.0
yes-or-no,1,0.0
history-,1,0.0
flow-limited,1,0.0
pathogen-targeted,1,0.0
guesswork,1,0.0
asthma-evoked,1,0.0
panic-like,1,0.0
agerisk,1,0.0
patent-protected,1,0.0
radiolabelling,1,0.0
TechneCoat,1,0.0
goal-related,1,0.0
Quarterly,1,0.0
48003,1,0.0
Assocaitions,1,0.0
eugylcemia,1,0.0
Six-hundred,1,0.0
min6,1,0.0
max68,1,0.0
Brainin,1,0.0
Chamorro,1,0.0
Hacke,1,0.0
Didier,1,0.0
17-78,1,0.0
Cancer-related,1,0.0
SRaw,1,0.0
121-question,1,0.0
dedicate,1,0.0
Capabilities,1,0.0
Sampled,1,0.0
indifference,1,0.0
anosodiaphoria,1,0.0
euphoria,1,0.0
13-6,1,0.0
17-0,1,0.0
1-69,1,0.0
Gallopamil,1,0.0
10-ml,1,0.0
EiAi,1,0.0
nMPFR,1,0.0
800-ms,1,0.0
measuredABSTRACT,1,0.0
socioeconomics,1,0.0
arXiv,1,0.0
Lhasa,1,0.0
cardio-circulatory,1,0.0
thromoembolism,1,0.0
mucorales,1,0.0
202012,1,0.0
158in,1,0.0
proven-effective,1,0.0
anti-CCD,1,0.0
BMP-7-mediated,1,0.0
anti-fibrosis,1,0.0
protein-7,1,0.0
non-strokes,1,0.0
Hennerici,1,0.0
fat-saturated,1,0.0
T1WI,1,0.0
telestroke--a,1,0.0
patients--compared,1,0.0
47324,1,0.0
S1RBD,1,0.0
Syndrome-associated,1,0.0
q1-q3,1,0.0
49-73,1,0.0
-05838,1,0.0
-01507,1,0.0
0647,1,0.0
36-92,1,0.0
morphogenetic,1,0.0
12105,1,0.0
22105,1,0.0
shunt-related,1,0.0
OR0427,1,0.0
0228-0799,1,0.0
0438-0663,1,0.0
scotland,1,0.0
WoSSVC,1,0.0
huMAN,1,0.0
disprosodia,1,0.0
dysartria,1,0.0
stammering,1,0.0
somatosensory-evoked,1,0.0
Reef,1,0.0
ICPS,1,0.0
ZWOLLE,1,0.0
3356,1,0.0
2-h,1,0.0
wet-to-dry,1,0.0
mOsmL,1,0.0
PDCF,1,0.0
HEART-SENSE,1,0.0
personas,1,0.0
animated,1,0.0
multi-media,1,0.0
vividness,1,0.0
WMDs,1,0.0
4916,1,0.0
162-243,1,0.0
209-478,1,0.0
149-615,1,0.0
227-729,1,0.0
619000,1,0.0
nR,1,0.0
authenticity,1,0.0
leads-standard,1,0.0
lead-standard,1,0.0
1969-1985,1,0.0
12202,1,0.0
Arima,1,0.0
70-89,1,0.0
2716,1,0.0
pressure-rate-product,1,0.0
VPBsmin,1,0.0
IMT0684,1,0.0
0713,1,0.0
Halothane-anesthetized,1,0.0
Osmotherapy,1,0.0
Tagging,1,0.0
non-neuropsychological,1,0.0
strategy-making,1,0.0
tenure,1,0.0
professionalization,1,0.0
bureaucracy,1,0.0
Clinicopathological,1,0.0
seventeenth,1,0.0
multiattribute,1,0.0
Copper,1,0.0
MBR,1,0.0
Non-treated,1,0.0
co-analysis,1,0.0
F-specific,1,0.0
medication-specific,1,0.0
neuropsychologists,1,0.0
Generalizability,1,0.0
8400,1,0.0
ATBUTH,1,0.0
Bauchi,1,0.0
polycarbonate,1,0.0
PC-polydimethylsiloxane,1,0.0
epoxy,1,0.0
Europium,1,0.0
EuNPs,1,0.0
EuNP,1,0.0
signal-to-background,1,0.0
μENIA,1,0.0
1178,1,0.0
Discrete-time,1,0.0
1646,1,0.0
99295,1,0.0
STENTIM,1,0.0
21846,1,0.0
8-session,1,0.0
Misplacement,1,0.0
misrepresentations,1,0.0
pluralistic,1,0.0
navigates,1,0.0
13000-15000,1,0.0
purse,1,0.0
pseudoephedrine,1,0.0
ephedra,1,0.0
N4000,1,0.0
alpha-blocking,1,0.0
humans--H1N1,1,0.0
H1N2--and,1,0.0
704003,1,0.0
first-doses,1,0.0
6536,1,0.0
24100000,1,0.0
marcrofocal,1,0.0
Twenty-six81,1,0.0
Thirteen50,1,0.0
Seven538,1,0.0
5100,1,0.0
allergenPD15,1,0.0
levelbound,1,0.0
creatinkinase-isoenzyme,1,0.0
CK-MB-immunoinhibition,1,0.0
spuriously,1,0.0
CK-MB-activities,1,0.0
macro-CK-BB-emia,1,0.0
eight-session,1,0.0
TH1-TH2,1,0.0
0902,1,0.0
kdt,1,0.0
HEalth,1,0.0
HES-C,1,0.0
1478,1,0.0
106-183,1,0.0
104-160,1,0.0
189-305,1,0.0
209-303,1,0.0
066-096,1,0.0
070-089,1,0.0
099-141,1,0.0
369-540,1,0.0
decisiveness,1,0.0
verbalizing,1,0.0
54-484,1,0.0
optimism-adjusted,1,0.0
113-697,1,0.0
288-760,1,0.0
164-746,1,0.0
236-940,1,0.0
NIDDM,1,0.0
submicroscopic,1,0.0
process--left,1,0.0
dilation--is,1,0.0
ile105val,1,0.0
pro187ser,1,0.0
NADPHquinone,1,0.0
bootstrapped,1,0.0
0375,1,0.0
hinging,1,0.0
spring-summer,1,0.0
neurraminidase,1,0.0
Ninety194,1,0.0
1971-85,1,0.0
oxtriphylline,1,0.0
immune-selected,1,0.0
VSV-eGFP-SARS-CoV-2-S,1,0.0
Micro-aggregation,1,0.0
α2-adrenoreceptors,1,0.0
micro-aggregation,1,0.0
108-1203,1,0.0
105-286,1,0.0
250Approximately,1,0.0
mortalityThe,1,0.0
Asthma-specific,1,0.0
004-058,1,0.0
012-079,1,0.0
abuser,1,0.0
fibrointimal,1,0.0
azoles,1,0.0
population--school,1,0.0
children--which,1,0.0
ABeijing,1,0.0
35389,1,0.0
4-valent,1,0.0
W135,1,0.0
One-second,1,0.0
within-session,1,0.0
cocaine-mediated,1,0.0
privet,1,0.0
ORF3,1,0.0
Trans-complementation,1,0.0
57194,1,0.0
rampart,1,0.0
unshielded,1,0.0
enamored,1,0.0
lectinophagocytosis,1,0.0
toxin-insensitive,1,0.0
nonself,1,0.0
Darwinian,1,0.0
co-associations,1,0.0
Yaoundé,1,0.0
treat-,1,0.0
36-96,1,0.0
jelly,1,0.0
beeswax,1,0.0
applicableClass,1,0.0
eachABSTRACT,1,0.0
Black-white,1,0.0
2001-2006,1,0.0
Metered-dose,1,0.0
Honghu,1,0.0
6112,1,0.0
diagnostic-tactical,1,0.0
immune-modifier,1,0.0
debatted,1,0.0
before-,1,0.0
childrenparents,1,0.0
recounting,1,0.0
Institutionalized,1,0.0
desthiobiotin-modified,1,0.0
Cas13a-based,1,0.0
attomolar,1,0.0
2002-SARS-CoV,1,0.0
hard-won,1,0.0
complementation-derived,1,0.0
staff-visitor,1,0.0
Tc99m-sestamibi,1,0.0
fat-suppressed,1,0.0
hypotension-bradycardia,1,0.0
Umbilical,1,0.0
Delineation,1,0.0
NCT04422457,1,0.0
Surprising,1,0.0
titanate-zirconate,1,0.0
ESL,1,0.0
EDL-ESLEDL,1,0.0
reperfusionp,1,0.0
collor,1,0.0
alexia,1,0.0
Balints,1,0.0
declarative,1,0.0
Abulia,1,0.0
Disorientation,1,0.0
well-respected,1,0.0
fully-developed,1,0.0
Nonparticipation,1,0.0
Copies,1,0.0
overdistended,1,0.0
plugged,1,0.0
necropsies,1,0.0
provenance,1,0.0
dataevidence,1,0.0
serendipitous,1,0.0
1985-1990,1,0.0
fulminans,1,0.0
multi-consistency,1,0.0
depolarisations,1,0.0
n85,1,0.0
n135,1,0.0
necessaryThe,1,0.0
31–73,1,0.0
turbospin,1,0.0
T2-prepared,1,0.0
locker,1,0.0
T2-threshold,1,0.0
T1-threshold,1,0.0
pvaccine,1,0.0
pvaccination,1,0.0
39000,1,0.0
AIndia64272014,1,0.0
forbiddingly,1,0.0
PreventionUS,1,0.0
leukopenic,1,0.0
Scotland-wide,1,0.0
CI22–79,1,0.0
CoV229E,1,0.0
−104,1,0.0
Hib-Neisseria,1,0.0
Y-tetanus,1,0.0
HibMenCY,1,0.0
amortized,1,0.0
infectiosum,1,0.0
Sunlight,1,0.0
320-400,1,0.0
260-320,1,0.0
200-260,1,0.0
CoVHKU1,1,0.0
CoVNL63,1,0.0
CoVOC43,1,0.0
infliction,1,0.0
self-surveillance,1,0.0
macrophagesmonocytes,1,0.0
market-driven,1,0.0
p000009,1,0.0
p00061,1,0.0
p000036,1,0.0
universally-recognized,1,0.0
Concerned,1,0.0
revitalized,1,0.0
Miller-Fisher,1,0.0
GQ,1,0.0
1b-positive,1,0.0
Bickerstaffs,1,0.0
asthma-severity,1,0.0
Self-regulation,1,0.0
Tyr,1,0.0
Phe,1,0.0
Belgorod,1,0.0
moderate-persistent,1,0.0
unvarying,1,0.0
symptomsawakening,1,0.0
relieverrescue,1,0.0
stepping-down,1,0.0
architecturePrevious,1,0.0
CDKN2AB,1,0.0
SCIENCEDIRECT,1,0.0
work-associated,1,0.0
10198,1,0.0
9192,1,0.0
II-R,1,0.0
FSII-R,1,0.0
equips,1,0.0
p00018,1,0.0
p00173,1,0.0
34425-21096,1,0.0
GS4071,1,0.0
antihaemagglutinin,1,0.0
infection-to-delivery,1,0.0
675-962,1,0.0
and--in,1,0.0
smokers--vitamin,1,0.0
neuroinfluenza,1,0.0
noncoated,1,0.0
platelet-release,1,0.0
bioinformatics-driven,1,0.0
Betacoronavirus-like,1,0.0
polycystosis,1,0.0
Almeria,1,0.0
Ro64-0802,1,0.0
1311,1,0.0
157-094,1,0.0
last-day,1,0.0
n112,1,0.0
AH1N109v,1,0.0
Predominance,1,0.0
2759,1,0.0
2111,1,0.0
mono-infected,1,0.0
105-1925,1,0.0
SSAHOS,1,0.0
MenAfriVac,1,0.0
17D,1,0.0
rVSV-ZEBOV,1,0.0
00060,1,0.0
centre-based,1,0.0
language-based,1,0.0
lesioning,1,0.0
Analog,1,0.0
CARPS,1,0.0
cardiohumerospinal,1,0.0
cardio-intercostal,1,0.0
cardio-lumbosacral,1,0.0
solkoseryl,1,0.0
troxevasin,1,0.0
dibazol,1,0.0
galanthamine,1,0.0
proserin,1,0.0
nootropic,1,0.0
venotonic,1,0.0
immunoresponsiveness,1,0.0
Grodno,1,0.0
Belarus,1,0.0
badges,1,0.0
pre-stent,1,0.0
trigger-defined,1,0.0
150-mg,1,0.0
110-mg,1,0.0
CrCL,1,0.0
coronavirussevere,1,0.0
methods--electrocardiographic,1,0.0
biochemical--for,1,0.0
bronchoobturation,1,0.0
1773,1,0.0
oral-steroid,1,0.0
0013-0051,1,0.0
0025-0078,1,0.0
0024-0042,1,0.0
Fetuin,1,0.0
microgramsmL,1,0.0
05-mL,1,0.0
FABP,1,0.0
slider,1,0.0
touchscreen,1,0.0
BBR,1,0.0
isoquinoline,1,0.0
dosesmlrange,1,0.0
15-60,1,0.0
dosesml,1,0.0
CCHs,1,0.0
preallocated,1,0.0
preallocation,1,0.0
denture,1,0.0
xerostomic,1,0.0
rhombencephalitis,1,0.0
soon-to-be-available,1,0.0
CRISPRCas‑based,1,0.0
immunizationimmunotherapy,1,0.0
antigenicepitopic,1,0.0
myriads,1,0.0
Prototypes,1,0.0
Works,1,0.0
spinhaler,1,0.0
low-fidelity,1,0.0
mutation-introduced,1,0.0
Ribomunyl,1,0.0
Rosettes,1,0.0
Bronchial-,1,0.0
infectionsepsis,1,0.0
repeatsCas,1,0.0
peri,1,0.0
flumazenil,1,0.0
fluoromisonidazole,1,0.0
cross-check,1,0.0
Rohani,1,0.0
30₊6-40,1,0.0
307750,1,0.0
69764,1,0.0
1720-3900,1,0.0
≥9,1,0.0
targethome,1,0.0
megapascal,1,0.0
type-,1,0.0
13312,1,0.0
describedThirty-three,1,0.0
collectedThe,1,0.0
125The,1,0.0
collapses,1,0.0
interpreter,1,0.0
developed--and,1,0.0
article--a,1,0.0
4-step,1,0.0
confoundingmimicking,1,0.0
interpreters,1,0.0
Postintervention,1,0.0
≤8,1,0.0
8-20,1,0.0
fungal-sensitized,1,0.0
Saxonian,1,0.0
Contract,1,0.0
seven-fold,1,0.0
cross-checking,1,0.0
anonymisation,1,0.0
Ayatollah,1,0.0
home-monitoring,1,0.0
1553,1,0.0
146-480,1,0.0
HRQOLISP,1,0.0
Likert-graded,1,0.0
over-reperfusion,1,0.0
39-55,1,0.0
operationABSTRACT,1,0.0
inhaler-specific,1,0.0
One-on-one,1,0.0
pm-0600,1,0.0
107-361,1,0.0
142-439,1,0.0
132-415,1,0.0
lighter,1,0.0
323-546,1,0.0
426-858,1,0.0
Underrecognized,1,0.0
303-653,1,0.0
0-758,1,0.0
outcompete,1,0.0
reactivity--defined,1,0.0
aerosol--together,1,0.0
surviellance,1,0.0
ObstetricsMaternal,1,0.0
Manizales,1,0.0
PolyPHb,1,0.0
monoazide,1,0.0
chloride-based,1,0.0
re-occurring,1,0.0
surfing,1,0.0
Saxonians,1,0.0
holder,1,0.0
103€,1,0.0
43·1,1,0.0
toughest,1,0.0
real-or,1,0.0
onlinemobile,1,0.0
2622571,1,0.0
182359,1,0.0
DcoVA,1,0.0
cardiosurgery,1,0.0
OAS-like,1,0.0
grandmothers,1,0.0
grandfathers,1,0.0
constitutional-familial,1,0.0
bronchic,1,0.0
hyperergy,1,0.0
postuberculosis,1,0.0
suprainfected,1,0.0
JSSRS,1,0.0
radioangiography,1,0.0
radioangiographically,1,0.0
incoherence,1,0.0
TGF-b1,1,0.0
SMAD,1,0.0
Hypnotic,1,0.0
Ether,1,0.0
non-Asians,1,0.0
draw-backs,1,0.0
reticent,1,0.0
body-mind-spirit,1,0.0
sarpogrelate-based,1,0.0
TAPT,1,0.0
expensive--financially,1,0.0
transmission-preventing,1,0.0
young-,1,0.0
wide-spectrum,1,0.0
-26·8-74·5,1,0.0
3C3,1,0.0
supranormal,1,0.0
wheezer,1,0.0
KuL,1,0.0
0-180,1,0.0
kul,1,0.0
Litres,1,0.0
4388,1,0.0
Sones,1,0.0
Judkins,1,0.0
197477,1,0.0
period-prevalence,1,0.0
3-kinases,1,0.0
84-year,1,0.0
gamma-deficient,1,0.0
Blida,1,0.0
hemocorrection,1,0.0
ABAO,1,0.0
Unsolved,1,0.0
midazolam,1,0.0
acidA,1,0.0
9733,1,0.0
215-242,1,0.0
163-185,1,0.0
263-301,1,0.0
198-225,1,0.0
65-,1,0.0
64€,1,0.0
Clínic,1,0.0
diffusionperfusion-weighted,1,0.0
VIST,1,0.0
out-of-household,1,0.0
029-077,1,0.0
018-036,1,0.0
004-036,1,0.0
reoxygenating,1,0.0
oxygen-radical,1,0.0
hypercontracture,1,0.0
diabolical,1,0.0
mK-ATP,1,0.0
plasmacytapheresis,1,0.0
Inefficiency,1,0.0
Th-cell,1,0.0
Th1-cells,1,0.0
Cross-regulation,1,0.0
inflammationasthma,1,0.0
Memantine,1,0.0
α7-nAChR,1,0.0
httpsbitly2AZHiVg,1,0.0
azolo-adamantanes,1,0.0
triterpenes,1,0.0
benzimidazole,1,0.0
usnic,1,0.0
heterocyclic,1,0.0
virus-inhibiting,1,0.0
re-estimated,1,0.0
socio-historical,1,0.0
unrealistically,1,0.0
gravitation,1,0.0
nitrate-poor,1,0.0
015-042,1,0.0
024-070,1,0.0
ICC090,1,0.0
367-17,1,0.0
perfusion-weighted-diffusion-weighted,1,0.0
anti-hyperuricemic,1,0.0
post-graduate,1,0.0
2506,1,0.0
PRACTIC,1,0.0
Heather,1,0.0
IgG-detecting,1,0.0
RNA-persistence,1,0.0
frequents,1,0.0
obliterates,1,0.0
pro-atherogenetic,1,0.0
intranazally,1,0.0
AChickenKurganRussia0205,1,0.0
500-00,1,0.0
questions7,1,0.0
383-17,1,0.0
117-17,1,0.0
Cataract,1,0.0
Bentham,1,0.0
RhoRock,1,0.0
TGF-β1Smad,1,0.0
23-97,1,0.0
96-174,1,0.0
326-448,1,0.0
467-611,1,0.0
00275,1,0.0
indexrecurrent,1,0.0
neuroradiologically,1,0.0
constant-rate,1,0.0
pylori-bullfrog,1,0.0
Brno,1,0.0
Sixteen-,1,0.0
athma-specific,1,0.0
winter--spring,1,0.0
Diffusion-tensor,1,0.0
DC-SIGN,1,0.0
non-IAV,1,0.0
pre-incubated,1,0.0
Carcinoembryonic,1,0.0
CEACAM6,1,0.0
questionary,1,0.0
PHM,1,0.0
risk-recognition,1,0.0
5G-enabled,1,0.0
up-conversion,1,0.0
UCNPsmSiO2,1,0.0
IPTV,1,0.0
endows,1,0.0
motor-tracking,1,0.0
workshift,1,0.0
V2-4,1,0.0
theory-a,1,0.0
Caulophyllum,1,0.0
thalictroides,1,0.0
asthmawheezing,1,0.0
ISCOMATRIX,1,0.0
trademark,1,0.0
single-injection,1,0.0
62-year,1,0.0
crossmatch-compatible,1,0.0
vascular-cognitive,1,0.0
less-sensitive,1,0.0
mainline,1,0.0
Between-groups,1,0.0
Expressive,1,0.0
RBD-nanoparticles,1,0.0
phono-,1,0.0
rheoplethysmography,1,0.0
sphingolipidosis,1,0.0
excercised,1,0.0
35-86,1,0.0
infarction--most,1,0.0
14114,1,0.0
Neuro,1,0.0
reoperated,1,0.0
pneumopericardium,1,0.0
Center-based,1,0.0
Fundamentals-Revised,1,0.0
Taizhou,1,0.0
multibehavioral,1,0.0
yearsranging,1,0.0
illdead,1,0.0
caseswhite,1,0.0
q12,1,0.0
B-subunit,1,0.0
CTxB,1,0.0
pET-28,1,0.0
571000,1,0.0
herding,1,0.0
Precardiac,1,0.0
HLA-matched,1,0.0
HLA-haplotype-matched,1,0.0
diphtheria-tetanus-pertussis,1,0.0
beta-sympatholytics,1,0.0
medicament,1,0.0
9405,1,0.0
CRP-values,1,0.0
non-insurance-based,1,0.0
hearings,1,0.0
FDA-proposed,1,0.0
Carolina-Chapel,1,0.0
HO-17-18283,1,0.0
more-frequent,1,0.0
exacerbationsyear,1,0.0
4504,1,0.0
3102,1,0.0
2709,1,0.0
protein-16,1,0.0
couldn’t,1,0.0
Manens,1,0.0
Informants,1,0.0
EMTs,1,0.0
EMT-led,1,0.0
Akashi,1,0.0
Loopamp®,1,0.0
2019-SARSCoV-2,1,0.0
sunrise,1,0.0
sehour,1,0.0
sunset,1,0.0
Iftar,1,0.0
ICS±LABA,1,0.0
jurisprudence,1,0.0
Sehour,1,0.0
Islam,1,0.0
Quran,1,0.0
Percordial,1,0.0
insurance-based,1,0.0
temporarily-housed,1,0.0
478-59,1,0.0
outbreak-oriented,1,0.0
ACE2-encoding,1,0.0
concavity,1,0.0
BLASTn,1,0.0
Antibody-mediated,1,0.0
hives,1,0.0
polysorbates,1,0.0
anaphylactoids,1,0.0
not-IgE-mediated,1,0.0
Mildly,1,0.0
previously-well,1,0.0
DVS,1,0.0
Denizli,1,0.0
thrombo-embolus,1,0.0
underrecognised,1,0.0
NTs,1,0.0
AdipoGen,1,0.0
HUDSON-SHERLOCK,1,0.0
STOPCovid,1,0.0
low-copy,1,0.0
Cas13-based,1,0.0
Cardio-vascular,1,0.0
Penza,1,0.0
microaggregates,1,0.0
mismatch-based,1,0.0
500mm3,1,0.0
6359,1,0.0
1471,1,0.0
5845,1,0.0
student-run,1,0.0
48-lead,1,0.0
2-to-3-hourly,1,0.0
RBS,1,0.0
rs2275913,1,0.0
0791-0908,1,0.0
125-920,1,0.0
Granulation,1,0.0
cell-rich,1,0.0
stouter,1,0.0
Fas-mediated,1,0.0
GATA-4,1,0.0
sarcomeric,1,0.0
non-cellular,1,0.0
cell-driven,1,0.0
proof-of-efficacy,1,0.0
selectins,1,0.0
receptor-beta,1,0.0
lectin-F,1,0.0
intra-observer,1,0.0
coal-fired,1,0.0
counterfactual,1,0.0
Orthomyxovirus,1,0.0
SARS-CoV-2-like,1,0.0
chemoattractants,1,0.0
Potosí,1,0.0
barred,1,0.0
dives,1,0.0
sufferred,1,0.0
2568,1,0.0
1144-1819,1,0.0
3265-3824,1,0.0
731-1222,1,0.0
Corornaviridae,1,0.0
intrarater,1,0.0
P0033,1,0.0
resonancecomputed,1,0.0
pendrinDUOXperoxidase,1,0.0
G-152A,1,0.0
under-developed,1,0.0
rCVR,1,0.0
Hazardous,1,0.0
all-dielectric,1,0.0
silicon-on-insulator,1,0.0
nanorod,1,0.0
oligoDNAs,1,0.0
amolmL,1,0.0
1969-1979,1,0.0
relook,1,0.0
pendrinSLC26A4,1,0.0
hypothiocyanite,1,0.0
Pendrin,1,0.0
Prochaskas,1,0.0
Peroxidases,1,0.0
DUOX,1,0.0
Heme,1,0.0
infestations,1,0.0
Eat,1,0.0
rainbow,1,0.0
Beat,1,0.0
Temperate,1,0.0
2753,1,0.0
7955,1,0.0
3694,1,0.0
4796,1,0.0
peakABSTRACT,1,0.0
non-adjuvant,1,0.0
bothWe,1,0.0
7912,1,0.0
THATKA,1,0.0
superhydrophobic,1,0.0
SHPB,1,0.0
9999995,1,0.0
cube,1,0.0
∝,1,0.0
mN,1,0.0
reproliferation,1,0.0
MCM7,1,0.0
pneumoniae-infected,1,0.0
wwwgrouptextingcom,1,0.0
DFG,1,0.0
BMBF,1,0.0
Zuckerberg,1,0.0
DAF,1,0.0
FWF,1,0.0
Heath-funded,1,0.0
cost-effectivenessIn,1,0.0
perspectiveWe,1,0.0
67-177,1,0.0
significantRTMM,1,0.0
patientsThis,1,0.0
SPSS15,1,0.0
softwareRhinosinusitis,1,0.0
P0002Comparing,1,0.0
stage3,1,0.0
stage1,1,0.0
p0002The,1,0.0
Vo2peak,1,0.0
Ga-East,1,0.0
repelling,1,0.0
wettability,1,0.0
psycho-somatic,1,0.0
immunoprecipitate,1,0.0
170-226,1,0.0
350-410,1,0.0
590-643,1,0.0
311-352,1,0.0
280-340,1,0.0
1y,1,0.0
CIEDs,1,0.0
promp,1,0.0
stereology,1,0.0
RNAm,1,0.0
astroglial,1,0.0
peri-lesioned,1,0.0
Pco2,1,0.0
mimotopes,1,0.0
undeviating,1,0.0
558-569,1,0.0
627-638,1,0.0
S-binding,1,0.0
junctional-cytoskeletal,1,0.0
Zazzo,1,0.0
FMRIB,1,0.0
Toolbox,1,0.0
66±13,1,0.0
β-024,1,0.0
β-0241,1,0.0
PWC170,1,0.0
capacitymaximum,1,0.0
tension-frquency,1,0.0
04-06,1,0.0
transmissibility-presymptomatic,1,0.0
kappa0599,1,0.0
presentations-may,1,0.0
881896-1904,1,0.0
NAEPPs,1,0.0
-agonist,1,0.0
outbreak-control,1,0.0
livebirths,1,0.0
Arteriopathy-including,1,0.0
arteriopathies-might,1,0.0
Microelectrode,1,0.0
-242,1,0.0
synchronizing,1,0.0
unclearObjectives,1,0.0
5421,1,0.0
questionnaireMeasurements,1,0.0
-010,1,0.0
-006,1,0.0
-000,1,0.0
112654202,1,0.0
2496749,1,0.0
parallelism,1,0.0
BMIR,1,0.0
12163,1,0.0
virusesμL,1,0.0
nanowire,1,0.0
adenosines,1,0.0
uncontrolledpartly,1,0.0
controlledpartly,1,0.0
reevaluatedWe,1,0.0
kappa0511,1,0.0
7718,1,0.0
-695,1,0.0
125-676,1,0.0
29-518,1,0.0
gain-framed,1,0.0
reinvigoration,1,0.0
three-season,1,0.0
CCSs,1,0.0
carboxy-terminal,1,0.0
hydrolase-L1,1,0.0
UCH-L1,1,0.0
bio-assay,1,0.0
14085,1,0.0
Dyskinesias,1,0.0
hypo-akinetic,1,0.0
T732A,1,0.0
B11519,1,0.0
loss-framed,1,0.0
gain-loss,1,0.0
392883,1,0.0
CO-VID-19-related,1,0.0
Luleå,1,0.0
self-managers,1,0.0
beta-myosin,1,0.0
beta-MHC,1,0.0
masculinity,1,0.0
androgenic,1,0.0
sebum,1,0.0
alopecia,1,0.0
23-person,1,0.0
Readying,1,0.0
empirically-informed,1,0.0
Non-sentinel,1,0.0
para-aminomethylbenzoic,1,0.0
bronchoconstrictory,1,0.0
T-birdVSO2,1,0.0
sobering,1,0.0
Generals,1,0.0
1-44,1,0.0
1-71,1,0.0
stigmatisation,1,0.0
anti-receptor-binding,1,0.0
seramaternal,1,0.0
6471,1,0.0
079-127,1,0.0
097-130,1,0.0
073-120,1,0.0
081-116,1,0.0
Othering,1,0.0
ticked,1,0.0
platelet-fibrin,1,0.0
oesogastrectomy,1,0.0
coloplasty,1,0.0
Monod,1,0.0
exposuresensitization,1,0.0
109-141,1,0.0
long-rank,1,0.0
broad-scale,1,0.0
SARS-CoV-2-rtPCR,1,0.0
cOPNP,1,0.0
011-066,1,0.0
Endoplasmic,1,0.0
will-power,1,0.0
durably,1,0.0
regrettable,1,0.0
frequency--cyanosis,1,0.0
subendothelial,1,0.0
25-544,1,0.0
12-222,1,0.0
Splenosis,1,0.0
ehere,1,0.0
97-5,1,0.0
copositivity,1,0.0
brunch,1,0.0
automated-manual,1,0.0
isointerval,1,0.0
caudally,1,0.0
Thoroughbred,1,0.0
trot,1,0.0
canter,1,0.0
lobeline,1,0.0
4-6-fold,1,0.0
cryopreservative,1,0.0
autoimplants,1,0.0
NFEQ,1,0.0
Transbaikal,1,0.0
Viralbacterial,1,0.0
Enteroccocci,1,0.0
enterococcal,1,0.0
realists,1,0.0
PhysioNet,1,0.0
9728,1,0.0
9500,1,0.0
Backgrund,1,0.0
-0519,1,0.0
0579,1,0.0
53-321,1,0.0
findingspitfalls,1,0.0
sieving,1,0.0
dear,1,0.0
RSPC,1,0.0
mythology,1,0.0
typiques,1,0.0
embolie,1,0.0
pulmonaire,1,0.0
Et,1,0.0
n´est,1,0.0
qu´après,1,0.0
troisième,1,0.0
qu´il,1,0.0
positif,1,0.0
montre,1,0.0
l´intérêt,1,0.0
répéter,1,0.0
fois,1,0.0
également,1,0.0
considérer,1,0.0
scanographiques,1,0.0
comme,1,0.0
devant,1,0.0
induire,1,0.0
adéquate,1,0.0
Droplet-based,1,0.0
virus-was,1,0.0
Baguio,1,0.0
pulsed-xenon,1,0.0
PX-UV,1,0.0
dispersin,1,0.0
ICD10,1,0.0
onset-to-door-times,1,0.0
71010,1,0.0
retrouvait,1,0.0
reprises,1,0.0
négatif,1,0.0
généralisée,1,0.0
belies,1,0.0
invocations,1,0.0
2·13,1,0.0
-8·08,1,0.0
11·82,1,0.0
-0·70,1,0.0
10·50,1,0.0
Peels,1,0.0
BAV,1,0.0
subintensive,1,0.0
déclarée,1,0.0
Chine,1,0.0
s´est,1,0.0
aux,1,0.0
testé,1,0.0
Son,1,0.0
fait,1,0.0
prélèvements,1,0.0
naso-pharyngés,1,0.0
bien,1,0.0
spécifique,1,0.0
d´une,1,0.0
sensibilité,1,0.0
moindre,1,0.0
comparé,1,0.0
thoracique,1,0.0
rapportons,1,0.0
d´un,1,0.0
enzbling,1,0.0
GTA,1,0.0
LTV-1000,1,0.0
788±67,1,0.0
6-mo,1,0.0
whith,1,0.0
stadily,1,0.0
Extraesophageal,1,0.0
throught,1,0.0
4970,1,0.0
21-September,1,0.0
502-594,1,0.0
791-877,1,0.0
615-706,1,0.0
65-70,1,0.0
chromatography-high,1,0.0
Nontarget,1,0.0
nontarget,1,0.0
proof-of-the-concept,1,0.0
httpdiscoveryinformaticsuabeduPAGER-CoV,1,0.0
Annotated,1,0.0
gene-lists,1,0.0
PAG,1,0.0
co-membership,1,0.0
PAGER,1,0.0
14-15,1,0.0
Girard,1,0.0
Palkonyay,1,0.0
2008264975-7,1,0.0
prime-boosting,1,0.0
Jamaican,1,0.0
65-year,1,0.0
extra-polating,1,0.0
4-238,1,0.0
end-of-trial,1,0.0
0164,1,0.0
proteins-the,1,0.0
Vt,1,0.0
Prunella,1,0.0
SPG614,1,0.0
SCoV-2-SP-PVs,1,0.0
SCoV-2-SP,1,0.0
hCoV-19CanadaON-VIDO-012020,1,0.0
NhPVSuramin,1,0.0
SCoV2-SP-PVs,1,0.0
SP-pseudotyped,1,0.0
mRNA-vaccinated,1,0.0
Vaccination-induced,1,0.0
edema-to-normal,1,0.0
Lever,1,0.0
cell-and,1,0.0
7345-9428,1,0.0
eIND,1,0.0
arid,1,0.0
traffic-,1,0.0
non-traffic,1,0.0
two-pollutant,1,0.0
PM10-25,1,0.0
2019n-CoV,1,0.0
1359-396,1,0.0
3077,1,0.0
1702-4757,1,0.0
7151-10000,1,0.0
8525,1,0.0
8242-8769,1,0.0
scapula,1,0.0
LATF,1,0.0
tertiary-level,1,0.0
KDCA,1,0.0
moduleAll,1,0.0
propertiesMD,1,0.0
coulomb-SR,1,0.0
LJ-SR,1,0.0
1975-1995,1,0.0
2960,1,0.0
non-RSV,1,0.0
disease-perception,1,0.0
invigorating,1,0.0
Pi,1,0.0
DFIPRS,1,0.0
Maldives,1,0.0
time-shift,1,0.0
occlusionstenosis,1,0.0
brucellosis,1,0.0
httpswwwncbinlmnihgovresearchcoronavirus,1,0.0
symptom-onset-,1,0.0
door-to-balloon-inflation,1,0.0
stability-putting,1,0.0
JanssenJohnsonJohnson,1,0.0
CanSino,1,0.0
systematised,1,0.0
place-related,1,0.0
32-month,1,0.0
switchboard,1,0.0
polypathology,1,0.0
mediator-release,1,0.0
hygene,1,0.0
still-evolving,1,0.0
CoV-2These,1,0.0
receptorsTop,1,0.0
CoV-2All,1,0.0
Serosurvey,1,0.0
UDO,1,0.0
non-ketotic,1,0.0
H5N1-associated,1,0.0
identilfy,1,0.0
friability,1,0.0
ressources,1,0.0
dialling,1,0.0
66250,1,0.0
6440,1,0.0
86-124,1,0.0
57-92,1,0.0
72-109,1,0.0
bias-corrected,1,0.0
76-85,1,0.0
SarmaHighlightsCoronavirus,1,0.0
impairmentConclusion,1,0.0
carcinoembryonic,1,0.0
39840,1,0.0
Asbestosis,1,0.0
PIH,1,0.0
ultra-high-pressure,1,0.0
UHPLC-MS-based,1,0.0
20-hydroxy-leukotriene,1,0.0
18-epoxy-eicosatetraenoic,1,0.0
718-EpETE,1,0.0
insilico,1,0.0
maestro,1,0.0
Coumarin,1,0.0
259-281,1,0.0
502-544,1,0.0
38-120,1,0.0
SMAD4,1,0.0
preprogrammed,1,0.0
wristwatches,1,0.0
AR-DRG,1,0.0
AR-DRGs,1,0.0
resists,1,0.0
Emetine,1,0.0
collars,1,0.0
systematical,1,0.0
nonexacerbation,1,0.0
defecate,1,0.0
expel,1,0.0
Blancmange,1,0.0
sub-Sahara,1,0.0
extractiondetection,1,0.0
2690,1,0.0
identified-organelle,1,0.0
proteins-several,1,0.0
translation-associated,1,0.0
typology,1,0.0
1133,1,0.0
angiographymagnetic,1,0.0
30-November,1,0.0
32401,1,0.0
conducted†,1,0.0
grazing,1,0.0
noncartilaginous,1,0.0
rubric,1,0.0
Movats,1,0.0
pentachrome-stained,1,0.0
MEF2575,1,0.0
miR-449c,1,0.0
793-892,1,0.0
miR-34b,1,0.0
pre-training,1,0.0
minimizingself-confident,1,0.0
agro-industrial,1,0.0
Penicullium,1,0.0
February-September,1,0.0
paramyxovirus,1,0.0
Nonarteritic,1,0.0
Tyuya-Ashu,1,0.0
Favourable,1,0.0
AlCl3-induced,1,0.0
Aluminum,1,0.0
systolic-volume,1,0.0
speeches,1,0.0
5030866,1,0.0
2020-7,1,0.0
n-grams,1,0.0
Pericytes,1,0.0
1968-1977,1,0.0
STANDARDTM,1,0.0
humansimian,1,0.0
planing,1,0.0
PROMISs,1,0.0
situation-specific,1,0.0
centrality-based,1,0.0
proteaseantiprotease,1,0.0
TFs,1,0.0
intricated,1,0.0
3-node,1,0.0
Feed-Forward,1,0.0
hyperplasiametaplasia,1,0.0
mucusinflammation,1,0.0
lobules,1,0.0
122829,1,0.0
severityAim,1,0.0
JapanMethodology,1,0.0
testsResults,1,0.0
daysConclusion,1,0.0
4--8,1,0.0
myelofibrosis,1,0.0
tumour-like,1,0.0
hypertransfusion,1,0.0
anti-RdRP,1,0.0
Multigated,1,0.0
well-perfused,1,0.0
hyperres-,1,0.0
ponsiveness,1,0.0
remo-,1,0.0
delling,1,0.0
1600000,1,0.0
CMR-edema,1,0.0
not-so-new,1,0.0
sepsisshock,1,0.0
adrenocorticotropin,1,0.0
supraphysiological,1,0.0
Overactivation,1,0.0
hypercatabolic,1,0.0
Harris-Benedict,1,0.0
Background-,1,0.0
Color-coded,1,0.0
C-OCS,1,0.0
Mid-life,1,0.0
chest-pain,1,0.0
assaysGap,1,0.0
55-96,1,0.0
detoxify,1,0.0
studies67,1,0.0
983217,1,0.0
24386,1,0.0
Fundeni,1,0.0
29380,1,0.0
3775,1,0.0
4492,1,0.0
45-396,1,0.0
0803,1,0.0
060-090,1,0.0
levels12,1,0.0
virological3,1,0.0
syndromic4,1,0.0
WHO5,1,0.0
sciadopitysin,1,0.0
K145N,1,0.0
isoproternol,1,0.0
Tn-T,1,0.0
SDN-treated,1,0.0
computer-driven,1,0.0
Weber,1,0.0
Methodologic,1,0.0
north-westsouth-east,1,0.0
ingesta,1,0.0
Elektrocardiographic,1,0.0
eliscrepancy,1,0.0
ravages,1,0.0
AWyoming303,1,0.0
lysine-to-asparagine,1,0.0
5-day-lasting,1,0.0
redouble,1,0.0
ironically,1,0.0
re-outbreaks,1,0.0
countervailing,1,0.0
rtPA-treated,1,0.0
SARS-C0V-2,1,0.0
ovoid,1,0.0
mid-splenium,1,0.0
signal-intensity,1,0.0
hostviral,1,0.0
2006218-16,1,0.0
delimiting,1,0.0
intra-cellular,1,0.0
systems-injury,1,0.0
MLE,1,0.0
nondescript,1,0.0
Grasp,1,0.0
germvirus,1,0.0
prosthetics,1,0.0
Recirculation,1,0.0
contingence,1,0.0
apidly,1,0.0
victimised,1,0.0
onethird,1,0.0
drugrelated,1,0.0
groupPatients,1,0.0
U071Results,1,0.0
ipsilaterally,1,0.0
fluorine,1,0.0
dithio,1,0.0
CDG,1,0.0
monounsaturated,1,0.0
N405-419,1,0.0
N349-399,1,0.0
N229-269,1,0.0
93-like,1,0.0
subscore,1,0.0
23-85,1,0.0
15-35,1,0.0
anxietyconversion,1,0.0
MRIMR,1,0.0
Ci,1,0.0
0003ABSTRACT,1,0.0
intelligently,1,0.0
Beijing3292-like,1,0.0
85230,1,0.0
75239,1,0.0
BPanama4590-,1,0.0
BBeijing184,1,0.0
3178,1,0.0
antibody-detection,1,0.0
auto-AIF,1,0.0
co-amplify,1,0.0
144NEG,1,0.0
9931,1,0.0
9622-9998,1,0.0
984-100,1,0.0
electromyography-controlled,1,0.0
brace,1,0.0
phospholid,1,0.0
Lambda-like,1,0.0
Remitting,1,0.0
ODEs,1,0.0
CambodiaVietnam,1,0.0
MUFA,1,0.0
Painless,1,0.0
Anti-tuberculosis,1,0.0
immunotoxic,1,0.0
ergotropic,1,0.0
Anterolateral,1,0.0
interauricular,1,0.0
VR6,1,0.0
Sanborn,1,0.0
QTa,1,0.0
V4-V5,1,0.0
unipolars,1,0.0
Wp,1,0.0
QTac,1,0.0
VM,1,0.0
ambulance-administered,1,0.0
NL2631-I223R,1,0.0
Stent-assisted,1,0.0
TICI≥2b,1,0.0
90thday,1,0.0
stent-first,1,0.0
midget,1,0.0
antifoam,1,0.0
rast,1,0.0
allergen-mast,1,0.0
FLU-CIN,1,0.0
postreperfusion,1,0.0
thrombolytically,1,0.0
00025-001,1,0.0
pre-licensure,1,0.0
1600-2000,1,0.0
PSL,1,0.0
whitish,1,0.0
trophotropic,1,0.0
personalitys,1,0.0
MEF50-values,1,0.0
210-6885,1,0.0
chemically-induced,1,0.0
Era,1,0.0
enemas,1,0.0
H1N1v-,1,0.0
CRV-infected,1,0.0
Ariadnes,1,0.0
MINOCAs,1,0.0
Directigen™,1,0.0
AB®,1,0.0
103-385,1,0.0
004-097,1,0.0
203-943,1,0.0
120-6038,1,0.0
silo,1,0.0
CRISPRDx,1,0.0
106kg,1,0.0
Hemodyamics,1,0.0
4570,1,0.0
6742,1,0.0
heart-specific,1,0.0
water-clustered,1,0.0
high-concentration,1,0.0
Sandman,1,0.0
immunogenesis,1,0.0
phonotachooscillography,1,0.0
Francisella,1,0.0
novicida,1,0.0
T716I,1,0.0
studiíes,1,0.0
RBDMW06,1,0.0
Thrombectomy-Capable,1,0.0
humanizing,1,0.0
icSHAPE,1,0.0
Speedwell,1,0.0
ingenuity,1,0.0
Test-Children,1,0.0
CVLT-C,1,0.0
discriminability,1,0.0
0473,1,0.0
pAsp614Gly,1,0.0
5-log10,1,0.0
1-log10,1,0.0
100-µg,1,0.0
ECG-trigger,1,0.0
infarctionreperfusion,1,0.0
Stroke-EAST,1,0.0
min-max,1,0.0
90000-750000,1,0.0
150-1589,1,0.0
2-45,1,0.0
SITS-EAST,1,0.0
triumphant,1,0.0
system-coronavirus-2,1,0.0
Morrocan,1,0.0
headset,1,0.0
labstix,1,0.0
subfalcine,1,0.0
harmoniously,1,0.0
3kg200,1,0.0
4524,1,0.0
rations,1,0.0
cleaning-related,1,0.0
apoBapoA1,1,0.0
14820,1,0.0
TIV-vaccinated,1,0.0
destructively,1,0.0
Socio-Economics,1,0.0
under-investigational,1,0.0
COVID-19Flatten,1,0.0
SARS-CoV-antigen,1,0.0
multiply-mutated,1,0.0
initiations,1,0.0
Sham-operated,1,0.0
Cilazapril,1,0.0
delicately,1,0.0
hemorrhage-a,1,0.0
hypercarbic,1,0.0
Altmetrics,1,0.0
p095,1,0.0
15152,1,0.0
30000year,1,0.0
15151738,1,0.0
621121,1,0.0
breakneck,1,0.0
bet,1,0.0
treatments-,1,0.0
food-hypersensitive,1,0.0
acupuncture-treated,1,0.0
H19,1,0.0
longtime,1,0.0
severety,1,0.0
asthmasports,1,0.0
non-COVID-designated,1,0.0
polygeny,1,0.0
lentiviruses,1,0.0
cut-down,1,0.0
glucocorticoides,1,0.0
Terrapinns,1,0.0
FluGen,1,0.0
4296,1,0.0
Point-prevalence,1,0.0
Multi-echo,1,0.0
7-14-day,1,0.0
2SD,1,0.0
Marseille-4,1,0.0
S477,1,0.0
cheetah,1,0.0
12-15-year-old,1,0.0
wht,1,0.0
salt-spice,1,0.0
CONOCES,1,0.0
CNS-involvement,1,0.0
mRNA1273,1,0.0
HSPGs,1,0.0
splice,1,0.0
COVID-suspect,1,0.0
56-year,1,0.0
1938-1994,1,0.0
hemagglutinin-loaded,1,0.0
Within-individual,1,0.0
β-adrenergic,1,0.0
Segreto,1,0.0
Deigin,1,0.0
RaTG13-like,1,0.0
MP789-like,1,0.0
non-recombinant,1,0.0
strokes--221,1,0.0
37655,1,0.0
1910s,1,0.0
093-095,1,0.0
thiabendazole,1,0.0
Lima,1,0.0
APeru164199,1,0.0
APeru179899,1,0.0
Bayern795-like,1,0.0
Beijing26295-like,1,0.0
nos1,1,0.0
nos2,1,0.0
AATn-repeat,1,0.0
GM-CSFs,1,0.0
Reflux,1,0.0
ingrained,1,0.0
policys,1,0.0
CLP,1,0.0
Organoid,1,0.0
IBDs,1,0.0
easy-to-dose,1,0.0
monitoringfeedback,1,0.0
Reasonable,1,0.0
paged,1,0.0
cross-activity,1,0.0
multiple-center,1,0.0
9821,1,0.0
7954,1,0.0
8745,1,0.0
9686,1,0.0
headedness,1,0.0
areolar,1,0.0
owes,1,0.0
14F,1,0.0
TSC,1,0.0
rendelkezett,1,0.0
5-month-old,1,0.0
inflatable,1,0.0
Előzmény,1,0.0
adataira,1,0.0
hosszú,1,0.0
távú,1,0.0
kórlefolyására,1,0.0
vonatkozó,1,0.0
hazai,1,0.0
eddig,1,0.0
pilotidőszakában,1,0.0
rögzített,1,0.0
betegeknél,1,0.0
nagyrégiókban,1,0.0
későbbi,1,0.0
neve,1,0.0
január,1,0.0
centrumok,1,0.0
önkéntes,1,0.0
rögzítette,1,0.0
akik,1,0.0
írásban,1,0.0
hozzájárultak,1,0.0
klinikai,1,0.0
adataik,1,0.0
kezeléséhez,1,0.0
adatgyűjtés,1,0.0
Kutatásetikai,1,0.0
Bizottság,1,0.0
CaNS,1,0.0
tracts--by,1,0.0
Petrov,1,0.0
context--analysed,1,0.0
9615,1,0.0
One-half,1,0.0
histamine-1-receptor,1,0.0
RADs,1,0.0
disease-initiating,1,0.0
seven-level,1,0.0
popularize,1,0.0
GCP,1,0.0
⑤,1,0.0
90-110,1,0.0
HOT,1,0.0
classification--a,1,0.0
UDE,1,0.0
consecutives,1,0.0
kinesi,1,0.0
Well-confirmed,1,0.0
ISPs,1,0.0
Charges,1,0.0
cross-hemisphere,1,0.0
Unraveling,1,0.0
OVD,1,0.0
depressionanxiety,1,0.0
Generating,1,0.0
Coadministration,1,0.0
six-months,1,0.0
CMC,1,0.0
qualitative-quantitative,1,0.0
Attendance,1,0.0
engedélyével,1,0.0
populációban,1,0.0
overstimulation,1,0.0
szerepelt,1,0.0
16236,1,0.0
1438-1450,1,0.0
parahippocampus,1,0.0
ADCav,1,0.0
COPD-like,1,0.0
ugly,1,0.0
provokers,1,0.0
vHIT,1,0.0
aadditional,1,0.0
1889-90,1,0.0
age-pattern,1,0.0
cortico-ponto-cerebellar,1,0.0
MCPs,1,0.0
Bithermal,1,0.0
audiometry,1,0.0
horizontaltorsional,1,0.0
gaze-evoked,1,0.0
eye-position,1,0.0
metazoans,1,0.0
BLASTP,1,0.0
Tmprss2,1,0.0
TM-align,1,0.0
WISO,1,0.0
on-time,1,0.0
Paragangliomas,1,0.0
paragangliomas,1,0.0
and-if,1,0.0
available-ambiguous,1,0.0
undisputable,1,0.0
vannak,1,0.0
különbségek,1,0.0
prognózisában,1,0.0
szívműtét,1,0.0
feldolgozott,1,0.0
betegévre,1,0.0
vonatkoznak,1,0.0
amelyeket,1,0.0
Nyugat-,1,0.0
Közép-,1,0.0
hasonlítottunk,1,0.0
784-ánál,1,0.0
NSTEMI-betegek,1,0.0
516-ánál,1,0.0
katéteres,1,0.0
érmegnyitás,1,0.0
revascularisatiós,1,0.0
492-a,1,0.0
ellátásában,1,0.0
466-a,1,0.0
NSTEMI-csoportban,1,0.0
szakban,1,0.0
elvégzett,1,0.0
betegcsoportban,1,0.0
nemben,1,0.0
időpontjában,1,0.0
csökkentette,1,0.0
halálozást,1,0.0
régiók,1,0.0
különbözött,1,0.0
jobb,1,0.0
infarktusos,1,0.0
swineTaiwan731070,1,0.0
pet-associated,1,0.0
carrying-out,1,0.0
quarter-century-old,1,0.0
Samoan,1,0.0
contagionism,1,0.0
monocausalism,1,0.0
Anxieties,1,0.0
aircrafts,1,0.0
Air-Mobile,1,0.0
controlledAreas,1,0.0
agreedExpert,1,0.0
Resurgences,1,0.0
httpcovdbpopgeneticsnet,1,0.0
Antigen-induced,1,0.0
17938,1,0.0
1X108CFU,1,0.0
DBPC,1,0.0
T-2,1,0.0
108CFU,1,0.0
exaled,1,0.0
Aeroallergens,1,0.0
viruses4,1,0.0
vaccinations5,1,0.0
annually6,1,0.0
Ribosomal,1,0.0
40S,1,0.0
S3P,1,0.0
euthanatized,1,0.0
broncho-interstitial,1,0.0
Inaccurate,1,0.0
Detective,1,0.0
SIFT,1,0.0
Characterised,1,0.0
2392,1,0.0
sepsis-induced,1,0.0
coronaviruss,1,0.0
3237,1,0.0
≥34,1,0.0
Fomite,1,0.0
delbrueckii,1,0.0
bulgaricus,1,0.0
20-71,1,0.0
leftventricular,1,0.0
arming,1,0.0
antinflammatory,1,0.0
toxics,1,0.0
criterion-based,1,0.0
step--elimination,1,0.0
facilities--these,1,0.0
Biobanks,1,0.0
upload,1,0.0
preconfigured,1,0.0
10144,1,0.0
swallowed,1,0.0
half-broken,1,0.0
neck-chest-abdominal,1,0.0
pylorus,1,0.0
alligator-tooth,1,0.0
Peri-hematomal,1,0.0
Self-ratings,1,0.0
Couples,1,0.0
3-77,1,0.0
herbicides,1,0.0
antiparasites,1,0.0
endotoxins,1,0.0
PROVEAN,1,0.0
ws-SNPsGO,1,0.0
NSP12b,1,0.0
Non-uniform,1,0.0
rocuronium,1,0.0
atracurium,1,0.0
mivacurium,1,0.0
piggy,1,0.0
syb-type,1,0.0
teen-agers,1,0.0
hospices,1,0.0
long-termed,1,0.0
hipurgia,1,0.0
compulsory-duty,1,0.0
Accountancy,1,0.0
hyperpyretic,1,0.0
NAVY,1,0.0
HAIVEN,1,0.0
breath-omics,1,0.0
allergen-related,1,0.0
Human-severe,1,0.0
outcomes-it,1,0.0
irresponsible,1,0.0
super-emitters,1,0.0
self-confinement,1,0.0
inhibitorsThe,1,0.0
B-types,1,0.0
foal,1,0.0
sulfonamide,1,0.0
filly,1,0.0
mgHg,1,0.0
627K,1,0.0
signal-associated,1,0.0
Vecuronium,1,0.0
Sevoflurane,1,0.0
Halothane,1,0.0
metabisulphates,1,0.0
Neutral,1,0.0
inactivator,1,0.0
α-26-linked,1,0.0
nalmefene,1,0.0
YM,1,0.0
204352,1,0.0
140690-700e8,1,0.0
flow-related,1,0.0
Nonsevere,1,0.0
Constricted,1,0.0
impinged,1,0.0
depositions,1,0.0
Sulfites,1,0.0
metabisulphites,1,0.0
etomidate,1,0.0
STROBE,1,0.0
writing-up,1,0.0
-310,1,0.0
HA-D222N,1,0.0
PB2-E627K,1,0.0
NS1-T123V,1,0.0
children5,1,0.0
4272,1,0.0
6971,1,0.0
40-44,1,0.0
deathmyocardial,1,0.0
infarctionrevascularizationangina,1,0.0
Lidocaine,1,0.0
Ct≥34,1,0.0
Zixiao,1,0.0
Glycomics,1,0.0
photoelectron,1,0.0
breath-ing,1,0.0
volemic,1,0.0
tessutal,1,0.0
Gamaleyas,1,0.0
Fam,1,0.0
25-32,1,0.0
32-38,1,0.0
31-58,1,0.0
allografts,1,0.0
deceased-donor,1,0.0
interleukine-6,1,0.0
cross-regionally,1,0.0
hyposensitation,1,0.0
infuse,1,0.0
interatomic,1,0.0
discretely,1,0.0
PF14,1,0.0
NF55,1,0.0
lung-targeted,1,0.0
pDNA,1,0.0
therapies--ie,1,0.0
nitrodrivatives,1,0.0
calcium-antagonists--the,1,0.0
BackgroundEvidence,1,0.0
incompleteAimsThis,1,0.0
oseltamivirMethodsParticipants,1,0.0
analysisResultsThe,1,0.0
011-093,1,0.0
influenzaConclusionsOseltamivir,1,0.0
130000,1,0.0
sympathoexcitation,1,0.0
endocannabinoid,1,0.0
008-014,1,0.0
non-winter,1,0.0
intraoperability,1,0.0
httpisaregistriesorg,1,0.0
inclusivityopenness,1,0.0
SARS-CoV-2hepatitis,1,0.0
e-stim,1,0.0
Urokinase,1,0.0
clot-specific,1,0.0
11712,1,0.0
17187,1,0.0
12490,1,0.0
subsetting,1,0.0
MIsABSTRACT,1,0.0
2821-2849,1,0.0
085-162,1,0.0
marginated,1,0.0
Azygos-pleural,1,0.0
paraspinous,1,0.0
14±7,1,0.0
Multivariable-adjusted,1,0.0
69±10,1,0.0
131000,1,0.0
101000,1,0.0
91000,1,0.0
113-202,1,0.0
agesex-adjusted,1,0.0
113-193,1,0.0
socieoeconomic,1,0.0
Laser-scribed,1,0.0
XPS,1,0.0
proofing,1,0.0
50-500,1,0.0
microaxial,1,0.0
35Lmin,1,0.0
intravenous-inter-arterial,1,0.0
IV-IA,1,0.0
kringle,1,0.0
fractionate,1,0.0
praise,1,0.0
contig,1,0.0
enrichment-based,1,0.0
insulo-opercular,1,0.0
BTA,1,0.0
Isoprostanes,1,0.0
PG-like,1,0.0
prostane,1,0.0
isoprostane,1,0.0
F₂-isoprostane,1,0.0
D₂-,1,0.0
E₂-isoprostanes,1,0.0
F₂-isoprostanes,1,0.0
Live-attenuated,1,0.0
Interferon-beta,1,0.0
teriflunomide,1,0.0
fumarates,1,0.0
cell-depleting,1,0.0
ofatumumab,1,0.0
photovoice,1,0.0
Albacete,1,0.0
Galdakao,1,0.0
Oviedo,1,0.0
cardiac-assist,1,0.0
counter-shocks,1,0.0
sea-side,1,0.0
95confidence,1,0.0
Enjoyment,1,0.0
asset-based,1,0.0
devolution,1,0.0
subepidermal,1,0.0
A--55,1,0.0
B--70,1,0.0
prodromata,1,0.0
bowling,1,0.0
gateball,1,0.0
httpsbitly3gpBC75,1,0.0
challengingGuidelines,1,0.0
4°Cfor,1,0.0
7833,1,0.0
027–093,1,0.0
carried-out,1,0.0
thresholdCt,1,0.0
p031,1,0.0
proportion-positive,1,0.0
samplespotentially,1,0.0
less-focused,1,0.0
thereunder,1,0.0
strokestransitory,1,0.0
TH1-type,1,0.0
acid-human,1,0.0
PA-HSA,1,0.0
vasculitides,1,0.0
berry,1,0.0
asthma-prurigo,1,0.0
FKBP4,1,0.0
artery-associated,1,0.0
Implicit,1,0.0
Sociedad,1,0.0
-71·4,1,0.0
insults--such,1,0.0
ischemia--that,1,0.0
Silhouette,1,0.0
Tendency,1,0.0
homology-based,1,0.0
R203M,1,0.0
NSP2,1,0.0
F506L,1,0.0
S507C,1,0.0
Exon,1,0.0
Anaferon,1,0.0
children®,1,0.0
AC®,1,0.0
100-4800,1,0.0
microfoci,1,0.0
bestoptimal,1,0.0
RNA-RT-PCR,1,0.0
19-69,1,0.0
SARS-CoV-2-positives,1,0.0
Board-approved,1,0.0
1996-1998,1,0.0
4360,1,0.0
0-002,1,0.0
multiplex-type,1,0.0
«SEIMC,1,0.0
2016»,1,0.0
Microbiologists,1,0.0
Soria,1,0.0
20·7,1,0.0
67·1,1,0.0
-40·9,1,0.0
•Haloperidol,1,0.0
cineventriculographic,1,0.0
cineangiographically,1,0.0
four-channel,1,0.0
breeders,1,0.0
Orf9c,1,0.0
sigma-2,1,0.0
benzomorphan,1,0.0
protein-drug,1,0.0
NSP6-drug,1,0.0
•Inhibitors,1,0.0
•Antipsychotic,1,0.0
•Dextromethorphan,1,0.0
•These,1,0.0
infection-naive,1,0.0
31·9,1,0.0
hyperresponsivness,1,0.0
aer,1,0.0
Assessement,1,0.0
dose--PD20,1,0.0
CD69,1,0.0
CD66,1,0.0
CD81,1,0.0
PSIs,1,0.0
RAMI,1,0.0
AMIpicture,1,0.0
QS-wave,1,0.0
post-EVT,1,0.0
92·6,1,0.0
Melguizo,1,0.0
Enfermedades,1,0.0
ST--T,1,0.0
Infecciosasy,1,0.0
GWTG-Stroke,1,0.0
CONCLUSIONS-,1,0.0
first-grade,1,0.0
Anchorage,1,0.0
123651,1,0.0
exposure-effect,1,0.0
00097,1,0.0
refuses,1,0.0
116771,1,0.0
523194,1,0.0
5331,1,0.0
disables,1,0.0
hyperparathyroidism,1,0.0
99mTc-diphosphonate,1,0.0
biometeorological,1,0.0
investigator-determined,1,0.0
normoglycemia,1,0.0
repeatabilty,1,0.0
Bland,1,0.0
hyperrepsonsiveness,1,0.0
Genevas,1,0.0
enhancement-magnetic,1,0.0
signals--red,1,0.0
green--pediatricians,1,0.0
aggravators,1,0.0
twitchy,1,0.0
Consequentially,1,0.0
L-CDH,1,0.0
liver-to-thoracic,1,0.0
RESULTS-,1,0.0
BACKGROUND-,1,0.0
coumadin,1,0.0
tension--and,1,0.0
Microbiología,1,0.0
CNE-2Z,1,0.0
clathrin-,1,0.0
dynamin-dependent,1,0.0
10-68,1,0.0
tumorigenesis-2,1,0.0
Premonitory,1,0.0
Coinciding,1,0.0
Illustrated,1,0.0
behavior-modification,1,0.0
conjointly,1,0.0
Electromyography,1,0.0
EMG--a,1,0.0
EDR--a,1,0.0
к,1,0.0
response--biofeedback,1,0.0
nosologically,1,0.0
hypothalamopituitary,1,0.0
thromboticfibrinolytic,1,0.0
Fenton,1,0.0
•OH,1,0.0
t12-10-9s,1,0.0
Midlife,1,0.0
MIDUS,1,0.0
gamut,1,0.0
patientes,1,0.0
postintubation,1,0.0
More-severe,1,0.0
direct-PTCA,1,0.0
anxiety-related,1,0.0
Tanzanian,1,0.0
protocol-defined,1,0.0
incident-definite,1,0.0
Xa-specific,1,0.0
pentasaccharide,1,0.0
70-year,1,0.0
fear-appeal,1,0.0
threatlow,1,0.0
efficacylow,1,0.0
between-subjects,1,0.0
response-efficacy,1,0.0
longitidinal,1,0.0
RVPER,1,0.0
RVPFR,1,0.0
compliances,1,0.0
ck-levels,1,0.0
controlMethods,1,0.0
OLIN,1,0.0
32-92,1,0.0
0022Conclusions,1,0.0
NAHA,1,0.0
calibers,1,0.0
end-anastomosing,1,0.0
plowing,1,0.0
neuro-interventionist,1,0.0
Espírito,1,0.0
isolator,1,0.0
postarrival,1,0.0
7173,1,0.0
podding,1,0.0
years†,1,0.0
Influenza-for,1,0.0
tests-BD,1,0.0
dihydrate,1,0.0
software-generated,1,0.0
ascaris-endemic,1,0.0
transcriptases,1,0.0
heat-resistant,1,0.0
Thermotoga,1,0.0
petrophila,1,0.0
K4,1,0.0
Thermococcus,1,0.0
kodakarensis,1,0.0
KOD1,1,0.0
Thermus,1,0.0
uracil-DNA,1,0.0
glycosylase,1,0.0
UNG,1,0.0
cervix,1,0.0
EPM2AIP1,1,0.0
Papanicolaou,1,0.0
LBC,1,0.0
brain-saving,1,0.0
Counterbalancing,1,0.0
saddlebrown,1,0.0
grey60,1,0.0
lightgreen,1,0.0
darkred,1,0.0
lncRNAmRNA,1,0.0
lncRNA-mRNAs,1,0.0
RP11-847H182,1,0.0
KLHL28,1,0.0
SPRTN,1,0.0
5218,1,0.0
38059,1,0.0
P75,1,0.0
camper,1,0.0
prevous,1,0.0
significant--age,1,0.0
N2013,1,0.0
asparagine-to-glycine,1,0.0
chemistrybiology,1,0.0
lemniscus,1,0.0
thalamic-pain-like,1,0.0
P15,1,0.0
P1314,1,0.0
OTV-resistance,1,0.0
119V,1,0.0
292K,1,0.0
OTV-treated,1,0.0
treatment-naïve,1,0.0
274Y-containing,1,0.0
2336,1,0.0
anxiety-,1,0.0
depression-related,1,0.0
BALBcJ,1,0.0
7-57,1,0.0
N98,1,0.0
Labored,1,0.0
onceweek,1,0.0
inflammationLabored,1,0.0
P60,1,0.0
SERT,1,0.0
5Htr1a,1,0.0
corticotropin,1,0.0
Crhr1,1,0.0
Symptomatology,1,0.0
influenza--a,1,0.0
Stroke-TPI,1,0.0
SEREMI,1,0.0
AIDA,1,0.0
NCT00712101,1,0.0
TATORT,1,0.0
NCT01612312,1,0.0
Almeida,1,0.0
25μm,1,0.0
integer-valued,1,0.0
GARCH,1,0.0
heteroscedastic,1,0.0
integer-value,1,0.0
over-dispersion,1,0.0
Globalization,1,0.0
WHOannounced,1,0.0
august,1,0.0
Stroke-Thrombolytic,1,0.0
6171,1,0.0
0346,1,0.0
t233,1,0.0
IFNγ-based,1,0.0
CDEs,1,0.0
4-3,1,0.0
5-3,1,0.0
5-4,1,0.0
105-167,1,0.0
Multifactorial,1,0.0
stroke-in,1,0.0
dyslipidaemia-will,1,0.0
normoglycaemia,1,0.0
pucker,1,0.0
creeping,1,0.0
theophylline-sensitive,1,0.0
Comment,1,0.0
aura-like,1,0.0
pleasantly,1,0.0
MCP-1CCL2,1,0.0
CCR2,1,0.0
MCP-1-mediated,1,0.0
non-infarctive,1,0.0
non-East,1,0.0
Influenzas,1,0.0
non-transferred,1,0.0
90-180,1,0.0
180-360,1,0.0
asthmaA,1,0.0
revisionsThe,1,0.0
102-133,1,0.0
100-131,1,0.0
113-133,1,0.0
lifeAsthma,1,0.0
co-variables,1,0.0
38-349,1,0.0
three-state,1,0.0
VSS,1,0.0
147072,1,0.0
157126,1,0.0
75663,1,0.0
63753,1,0.0
BRL,1,0.0
strenghten,1,0.0
remoteruraldistrict,1,0.0
importanceAreas,1,0.0
sirolimus-,1,0.0
out-of-danger,1,0.0
Xe133,1,0.0
improvementimmunity,1,0.0
arrayed,1,0.0
usurped,1,0.0
re-targeted,1,0.0
monohemispheric,1,0.0
19-channel,1,0.0
contra-,1,0.0
CLH,1,0.0
ILH,1,0.0
Low-band,1,0.0
low-band,1,0.0
Diarylheptanoids,1,0.0
diphenylheptanoids,1,0.0
hitchhiking,1,0.0
counterpart--a,1,0.0
FluWeb,1,0.0
echogenicity,1,0.0
Crying-induced,1,0.0
ARTIs,1,0.0
48539872,1,0.0
1232791,1,0.0
150mmHg,1,0.0
neurofibrillary,1,0.0
tangles,1,0.0
assuages,1,0.0
vaccine---recommendations,1,0.0
2010--11,1,0.0
High-Dose,1,0.0
Cytokine-mediated,1,0.0
IL-1-related,1,0.0
PUBMEDMEDLINE,1,0.0
pregnancyExpert,1,0.0
Framing,1,0.0
interoperable,1,0.0
BAUmL,1,0.0
nonsensitized,1,0.0
001-104,1,0.0
httpsbitly38JaUmB,1,0.0
mid-201314,1,0.0
n431,1,0.0
n344,1,0.0
clinically-useful,1,0.0
inpatient-based,1,0.0
Inpatient-based,1,0.0
17921000,1,0.0
16961000,1,0.0
hundred-six,1,0.0
EBBx,1,0.0
titreor140,1,0.0
community-living,1,0.0
HIor40,1,0.0
neuramidinase,1,0.0
Q226I,1,0.0
lowpathogenicity,1,0.0
rcso2,1,0.0
CBVI,1,0.0
000067,1,0.0
Christchurch485-like,1,0.0
Amazingly,1,0.0
many-sided,1,0.0
antiplatelet-aggregating,1,0.0
monocellular,1,0.0
Bereavement,1,0.0
16-685,1,0.0
6769,1,0.0
aeration,1,0.0
salbutamol-induced,1,0.0
GNNs,1,0.0
GNN,1,0.0
graph-theory-based,1,0.0
neighborhood-based,1,0.0
20SD,1,0.0
four-view,1,0.0
bichromic,1,0.0
specificityABSTRACT,1,0.0
Diagnosticat,1,0.0
bacterialallergic,1,0.0
COIVD-19-associated,1,0.0
Plastic-adherent,1,0.0
BMC-secreted,1,0.0
IL-10-induced,1,0.0
soft-toy,1,0.0
IL-10-secreting,1,0.0
Sloan,1,0.0
Kettering,1,0.0
p028,1,0.0
p047,1,0.0
p019,1,0.0
nay,1,0.0
STABSTRACT,1,0.0
MGCBS,1,0.0
tow-,1,0.0
highly-conserved,1,0.0
electrically-heated,1,0.0
feather-bedding,1,0.0
4310,1,0.0
6550,1,0.0
Alsace-Lorraine,1,0.0
carnosic,1,0.0
meso-diencephalic,1,0.0
semicircular,1,0.0
canal,1,0.0
unsteadiness,1,0.0
HIR,1,0.0
0-777,1,0.0
1971-1977,1,0.0
ruinous,1,0.0
hemicorporal,1,0.0
polygon,1,0.0
homozygotous,1,0.0
alpha-thalassemia,1,0.0
42-60,1,0.0
acquaints,1,0.0
RTq-PCR,1,0.0
989-100,1,0.0
679-782,1,0.0
non-exhaustive,1,0.0
Guro,1,0.0
polyarthralgia,1,0.0
Arthralgia,1,0.0
Non-steroidal,1,0.0
Ug,1,0.0
053-086,1,0.0
048-082,1,0.0
084-149,1,0.0
115ABSTRACT,1,0.0
2-mm,1,0.0
antiwei,1,0.0
swaying,1,0.0
Midbrain,1,0.0
Swaying,1,0.0
20th-century,1,0.0
097-099,1,0.0
065-081,1,0.0
093-097,1,0.0
activiation,1,0.0
45-50th,1,0.0
T-V1,1,0.0
T-V6,1,0.0
185-187,1,0.0
vascular-brain,1,0.0
Jay,1,0.0
Gould,1,0.0
somewhere,1,0.0
source-subpopulation,1,0.0
disease-prone,1,0.0
pontomedullary,1,0.0
serum-cholesterol,1,0.0
case-fatality--which,1,0.0
1960s--may,1,0.0
Ecologic,1,0.0
auto-immune,1,0.0
Mimicry,1,0.0
9173,1,0.0
7days,1,0.0
149-260,1,0.0
147-253,1,0.0
I2135,1,0.0
0629,1,0.0
hypercholesterolaemic,1,0.0
berries,1,0.0
guava,1,0.0
Mulhouse,1,0.0
Bai,1,0.0
deducing,1,0.0
GeneFinderTM,1,0.0
0107,1,0.0
SanSure,1,0.0
ChAdOx1-nCOV,1,0.0
CovishieldTM,1,0.0
BBV-152,1,0.0
CovaxinTM,1,0.0
3272,1,0.0
electro-cardiographic,1,0.0
35-49,1,0.0
22-34,1,0.0
32-45,1,0.0
post-load,1,0.0
strains-severe,1,0.0
ganciclovir,1,0.0
acyclovir,1,0.0
interferon-β,1,0.0
LysGlu,1,0.0
Glu,1,0.0
21398,1,0.0
14401,1,0.0
Caldwell,1,0.0
LaSalle,1,0.0
non-rural,1,0.0
ACVIs,1,0.0
descriptivecomparative,1,0.0
acuteischemic,1,0.0
Haut-Rhin,1,0.0
Administering,1,0.0
Union-miscommunication,1,0.0
post-WWII,1,0.0
neurorehabilitationThis,1,0.0
alkalization,1,0.0
earthing,1,0.0
latecomer,1,0.0
pre-community-outbreak,1,0.0
80·5,1,0.0
P0·025,1,0.0
hPSC,1,0.0
hPSC-derived,1,0.0
Unpartnered,1,0.0
nurse-coached,1,0.0
validationfeedback,1,0.0
encouragementsupport,1,0.0
fundament,1,0.0
Non-systematically,1,0.0
Suez,1,0.0
dataStudy,1,0.0
criteriaData,1,0.0
synthesisResults,1,0.0
saliva-containing,1,0.0
splatter,1,0.0
universalize,1,0.0
kringing,1,0.0
concomittant,1,0.0
Summarising,1,0.0
Winston,1,0.0
Churchills,1,0.0
minister,1,0.0
resignation,1,0.0
24-fold,1,0.0
bereavement-related,1,0.0
risk-modifying,1,0.0
triples,1,0.0
hu-,1,0.0
vi-,1,0.0
rus,1,0.0
patholog-,1,0.0
ical,1,0.0
epithe-,1,0.0
lial,1,0.0
EuropeWe,1,0.0
non-OCS,1,0.0
±6,1,0.0
≥450,1,0.0
statusOf,1,0.0
effectsOur,1,0.0
Phases,1,0.0
emergencycompassionate,1,0.0
12-37,1,0.0
CG180,1,0.0
AHSN,1,0.0
antibiotic-producing,1,0.0
nephroureterotomy,1,0.0
benzylpenicilloyl,1,0.0
BPO,1,0.0
hyperventilated,1,0.0
turboinhaler,1,0.0
C1q-binding,1,0.0
anti-BPO-IgG,1,0.0
anti-BPO-IgE,1,0.0
CRB-65,1,0.0
Pneumococcus,1,0.0
entific,1,0.0
sci-,1,0.0
ritodrine,1,0.0
sub-nanomolar,1,0.0
bronchomalacia,1,0.0
Economics,1,0.0
finalizing,1,0.0
bata-2,1,0.0
inhibiters,1,0.0
Cantonal,1,0.0
scale-back,1,0.0
geo-data,1,0.0
ultra-cold,1,0.0
bronchidilators,1,0.0
aQua,1,0.0
nitroblue-tetrazolium,1,0.0
overdose,1,0.0
co-incubation,1,0.0
13826,1,0.0
corticosteroid-responsive,1,0.0
cortisol-induced,1,0.0
SMCs,1,0.0
Multi-Hit,1,0.0
Endocrine,1,0.0
Adult-Onset,1,0.0
cardiotopography,1,0.0
radiotopography,1,0.0
study--ten,1,0.0
individuals--eg,1,0.0
treatment--could,1,0.0
Rapids,1,0.0
AmpliQuick®,1,0.0
uncharacteristic,1,0.0
on-and-off,1,0.0
Bronchoalveolar-lavage,1,0.0
electrochemical-based,1,0.0
rucksack,1,0.0
sustained-handgrip,1,0.0
Charcot-Bouchard,1,0.0
PATS,1,0.0
CAPPP,1,0.0
NORDIL,1,0.0
ANBP2,1,0.0
communicability,1,0.0
Difficult-to-Treat,1,0.0
Bronchiale,1,0.0
Necessarily,1,0.0
mid-way,1,0.0
November-March,1,0.0
Kongs,1,0.0
subtropicaltropical,1,0.0
Sulphites,1,0.0
sulphite-sensitive,1,0.0
sensibilisation,1,0.0
Hydrometeorological,1,0.0
4038,1,0.0
strokes-196,1,0.0
-0016,1,0.0
Cominarty,1,0.0
faster-spreading,1,0.0
non-Jewish,1,0.0
unremittingly,1,0.0
histometric,1,0.0
necrobiotic,1,0.0
intrarenal,1,0.0
basket,1,0.0
shoppong,1,0.0
rhinorhea,1,0.0
0663-0871,1,0.0
Medisoft,1,0.0
HypAir,1,0.0
chemiluminescence-based,1,0.0
navigateaccess,1,0.0
5-HL,1,0.0
renin-aldosterone-angiotensin-system,1,0.0
uPA,1,0.0
Humana,1,0.0
153245,1,0.0
TKAs,1,0.0
2272,1,0.0
3824,1,0.0
2614-5406,1,0.0
0749,1,0.0
Glucagon,1,0.0
0628-0885,1,0.0
2020433e151-e158,1,0.0
lmin-1,1,0.0
helpfulABSTRACT,1,0.0
Avant,1,0.0
reciprocally,1,0.0
Self-protection,1,0.0
BA44,1,0.0
18756008,1,0.0
5713811,1,0.0
281010135,1,0.0
VF--primary,1,0.0
recurrent--are,1,0.0
difficult-to,1,0.0
Subarctic,1,0.0
vision-guided,1,0.0
350-406,1,0.0
antimetastatic,1,0.0
AgooseGuangdong96-like,1,0.0
GD96,1,0.0
1-comprised,1,0.0
2-comprised,1,0.0
employable,1,0.0
Traveling,1,0.0
COPD1,1,0.0
issue23,1,0.0
ACO1,1,0.0
secondard,1,0.0
Methodical,1,0.0
immune-response,1,0.0
attact,1,0.0
Phenazine,1,0.0
electron-acceptor,1,0.0
tetrazolium-reductase,1,0.0
diaphorase,1,0.0
KR,1,0.0
walkers,1,0.0
coronary-occlusion,1,0.0
enzymes--superoxide,1,0.0
staunch,1,0.0
3-factor,1,0.0
interprets,1,0.0
strain-selection,1,0.0
vaccine-selection,1,0.0
aFter,1,0.0
StrOke,1,0.0
straight-line,1,0.0
Nonhospitalized,1,0.0
Murrays,1,0.0
evasive,1,0.0
force-matching,1,0.0
0-3-Hz,1,0.0
vision-,1,0.0
aged≥65,1,0.0
2010-May,1,0.0
plan-do-check-act,1,0.0
aVOR,1,0.0
saccade,1,0.0
pontine-cerebellar,1,0.0
sanogenetic,1,0.0
insultology,1,0.0
Trade-offs,1,0.0
sonothrombosis,1,0.0
B11282,1,0.0
PaO2\FiO2,1,0.0
metereological,1,0.0
httpvirologicalorg,1,0.0
11132,1,0.0
characterizationclassification,1,0.0
7640,1,0.0
465-469,1,0.0
Formosan,1,0.0
Assoc,1,0.0
1123,1,0.0
sedimented,1,0.0
mass-spectrometric,1,0.0
Precious,1,0.0
Computational-based,1,0.0
SAFFO,1,0.0
2424,1,0.0
Cree,1,0.0
less-examined,1,0.0
555-4993,1,0.0
Adam,1,0.0
Hammer,1,0.0
anatomopathology,1,0.0
Biegański,1,0.0
Pawiński,1,0.0
Zdzisław,1,0.0
Dmochowski,1,0.0
Antoni,1,0.0
Gluziński,1,0.0
Marian,1,0.0
Franke,1,0.0
Latkowski,1,0.0
Szymonowicz,1,0.0
years--pharmacotherapy,1,0.0
A-29,1,0.0
B-35,1,0.0
C-53,1,0.0
Eq,1,0.0
8308,1,0.0
10554,1,0.0
1962-1972,1,0.0
Apicoseptal,1,0.0
surgical-treated,1,0.0
Colored,1,0.0
CERX-CQ3001,1,0.0
eight-colored,1,0.0
Stroke-prevention,1,0.0
Urged,1,0.0
00023,1,0.0
8254,1,0.0
23254,1,0.0
Salient,1,0.0
SICAS,1,0.0
NIHNIAID,1,0.0
allergistimmunologist,1,0.0
ADA,1,0.0
psycho-autonomic,1,0.0
adrenomedullary,1,0.0
asthenization,1,0.0
neuro-mental,1,0.0
disadaptation,1,0.0
hypochondriacal,1,0.0
Neurorepair,1,0.0
Magdeburg,1,0.0
microgliosis,1,0.0
transcriptase-loop,1,0.0
32254,1,0.0
NIEHS,1,0.0
Extramural,1,0.0
E-selection,1,0.0
P0,1,0.0
Frequencies,1,0.0
128Arg,1,0.0
307-1086,1,0.0
128Arginine,1,0.0
Ser128Arg,1,0.0
tallied,1,0.0
92254,1,0.0
55254,1,0.0
43254,1,0.0
LiTR,1,0.0
E-POL,1,0.0
post-monitoring,1,0.0
Callithrix,1,0.0
mate,1,0.0
cohabitating,1,0.0
Marmosets,1,0.0
11-year-old-girl,1,0.0
angioresonance,1,0.0
Pepitope-a,1,0.0
regions-for,1,0.0
410x,1,0.0
102679,1,0.0
63012,1,0.0
electro-mechanical,1,0.0
milk-coffee-like,1,0.0
naturally-induced,1,0.0
fade,1,0.0
theophyllinemia,1,0.0
CardioWest,1,0.0
enterocolic,1,0.0
dicumarol,1,0.0
Sisli,1,0.0
Hamidiye,1,0.0
Etfal,1,0.0
Cookie,1,0.0
Theft,1,0.0
lexical-semantic,1,0.0
postradiotherapy,1,0.0
hemiclaviculectomy,1,0.0
manubriectomy,1,0.0
tracheostoma,1,0.0
Gore-Tex,1,0.0
jacchus,1,0.0
bicycling,1,0.0
torr,1,0.0
LoE,1,0.0
MerciPenumbra,1,0.0
Ossong,1,0.0
pseudoacute,1,0.0
hyperkalemia-induced,1,0.0
pseudomyocardial,1,0.0
postage,1,0.0
0738-1000,1,0.0
dipyridamole-aspirine,1,0.0
eprosartan,1,0.0
receptor-inhibiting,1,0.0
immune-induced,1,0.0
cov,1,0.0
SARS-cov,1,0.0
Peroxisome,1,0.0
adipocyte,1,0.0
Upregulation,1,0.0
eMag,1,0.0
Discrepant,1,0.0
Cepheids,1,0.0
octatitanate,1,0.0
K2O·6TiO2,1,0.0
52-,1,0.0
65-week,1,0.0
TISMO-infused,1,0.0
mesotheliomas,1,0.0
non-variant,1,0.0
Germanys,1,0.0
doubtfulness,1,0.0
diabetes-associated,1,0.0
biorepositories,1,0.0
better-customized,1,0.0
mRNA-COVID-19,1,0.0
64-91,1,0.0
8696,1,0.0
6129,1,0.0
5217,1,0.0
6130,1,0.0
5652,1,0.0
7742,1,0.0
vs7391,1,0.0
bystander-initiated,1,0.0
phonocardiography,1,0.0
unforced,1,0.0
dAP,1,0.0
dPAP,1,0.0
CRISPRCas9-mediated,1,0.0
triple-line,1,0.0
TL-LFA,1,0.0
transcription-recombinase,1,0.0
9714,1,0.0
Hashimoto,1,0.0
factorssubtypes,1,0.0
Pre-infarction,1,0.0
3Ms,1,0.0
1995-March,1,0.0
company-sponsored,1,0.0
populationAlmost,1,0.0
acceptanceThe,1,0.0
LRIs,1,0.0
monitoringcontainment,1,0.0
resource-heavy,1,0.0
low-population,1,0.0
endotypes--has,1,0.0
TH2-low,1,0.0
TH2-high,1,0.0
78236,1,0.0
realigning,1,0.0
immunodiagnostics,1,0.0
simili,1,0.0
nanoLC-MSMS,1,0.0
ADETQALPQR,1,0.0
GFYAQGSR,1,0.0
MIDs,1,0.0
visualizations,1,0.0
VUM,1,0.0
Blouse,1,0.0
USAF,1,0.0
Brooks,1,0.0
AFB,1,0.0
Kolonel,1,0.0
inflammation--into,1,0.0
Corrado,1,0.0
100216–221,1,0.0
1974—The,1,0.0
3935,1,0.0
17081000,1,0.0
22711000,1,0.0
midshipmen,1,0.0
midshipman,1,0.0
8951000,1,0.0
England4272,1,0.0
30-DEM,1,0.0
current-day,1,0.0
voluntarism,1,0.0
damageimpairment,1,0.0
underevaluate,1,0.0
p0034,1,0.0
32867,1,0.0
PCA-related,1,0.0
87-97,1,0.0
Hospitality,1,0.0
aestheticians,1,0.0
AAFP,1,0.0
2081,1,0.0
2774,1,0.0
PANS,1,0.0
9987,1,0.0
9868,1,0.0
5827,1,0.0
random-digit-dialed,1,0.0
winterly,1,0.0
527-608,1,0.0
433-519,1,0.0
Subperiod,1,0.0
AStockholm182011H3N2,1,0.0
SAITR,1,0.0
2-6-a,1,0.0
formalizing,1,0.0
pre-specification,1,0.0
Prespecifying,1,0.0
Hochberg-Holm,1,0.0
presenter,1,0.0
effect-represented,1,0.0
segments-as,1,0.0
lesionbehavioural,1,0.0
centers--one,1,0.0
Barisal,1,0.0
stabilogram,1,0.0
stabilometric,1,0.0
Isiskate,1,0.0
solutionsAreas,1,0.0
890-1000,1,0.0
Ocrelizumab,1,0.0
PPMS,1,0.0
air-trapping,1,0.0
therapy--inhaled,1,0.0
sodium--as,1,0.0
129Cs,1,0.0
Observer,1,0.0
myocardiun,1,0.0
age-oriented,1,0.0
Immunotyping,1,0.0
Big,1,0.0
hypotheses-generating,1,0.0
yearsExpert,1,0.0
omnidirectional,1,0.0
Disclosure,1,0.0
prothromboticantifibrinolytic,1,0.0
t-PAPAI-1,1,0.0
fibrillationABSTRACT,1,0.0
LiCl,1,0.0
SkM,1,0.0
Wnt1gene,1,0.0
Wnt1,1,0.0
organophosphorous,1,0.0
costliness,1,0.0
infarction-remains,1,0.0
Thammasat,1,0.0
Post-CVA,1,0.0
Mitford,1,0.0
furo,1,0.0
r034,1,0.0
FRSCV,1,0.0
129-161,1,0.0
147-187,1,0.0
97-105,1,0.0
49-77,1,0.0
82-91,1,0.0
127-142,1,0.0
175-223,1,0.0
Cuiaba,1,0.0
38-59,1,0.0
venopathy,1,0.0
that-for,1,0.0
general-embolism,1,0.0
involved-is,1,0.0
swayed,1,0.0
defensiveness,1,0.0
Facilitators,1,0.0
culturallylinguistically,1,0.0
stressorssocial,1,0.0
conceptualisation,1,0.0
carpet-making,1,0.0
Alpha-amylase,1,0.0
orizae,1,0.0
floral,1,0.0
Ficus,1,0.0
Gypsophila,1,0.0
H7N9A,1,0.0
1987-97,1,0.0
r-020,1,0.0
mch,1,0.0
142-177,1,0.0
137-160,1,0.0
121-139,1,0.0
diseasesThe,1,0.0
volume-outcome,1,0.0
glucagon,1,0.0
corticotrophin,1,0.0
bombesin,1,0.0
vasointestinal,1,0.0
Darnell,1,0.0
Rockefeller,1,0.0
275x106,1,0.0
co-collected,1,0.0
3724,1,0.0
pods,1,0.0
medicine-led,1,0.0
COVIDCareHome,1,0.0
patientsICD-10-based,1,0.0
74589,1,0.0
vaccinationData,1,0.0
156803,1,0.0
8528,1,0.0
populationThe,1,0.0
HsTn,1,0.0
gender-neutral,1,0.0
2009-like,1,0.0
the--very,1,0.0
likely--scenario,1,0.0
e1e2,1,0.0
Ψ,1,0.0
macro-regions,1,0.0
self-filled,1,0.0
near-infrared-fluorescence,1,0.0
avidities,1,0.0
antibody-maturation,1,0.0
4867,1,0.0
1979-1981,1,0.0
CED,1,0.0
Europe-wide,1,0.0
Unobserved,1,0.0
kindred,1,0.0
airway-invasive,1,0.0
angio-invasive,1,0.0
miR-323,1,0.0
miR-491,1,0.0
miR-654,1,0.0
crudeness,1,0.0
74-122,1,0.0
47-87,1,0.0
83-185,1,0.0
devastate,1,0.0
Low-cost,1,0.0
fg⋅mL-1,1,0.0
HCoV-specific,1,0.0
3183,1,0.0
non-diseased,1,0.0
ARTerial,1,0.0
disease-Magnetic,1,0.0
SMART-MR,1,0.0
380↔2812,1,0.0
250↔640,1,0.0
Requirement,1,0.0
anticipatory-guidance,1,0.0
MAGPIX,1,0.0
7143,1,0.0
ELISA-positive,1,0.0
H1-H15,1,0.0
caspica,1,0.0
sphenoid,1,0.0
espoused,1,0.0
Auricle,1,0.0
0155,1,0.0
DCW,1,0.0
virus-infested,1,0.0
shieldsvisors,1,0.0
eyewear,1,0.0
Bogotás,1,0.0
political-institutional,1,0.0
spill-over,1,0.0
coryzal,1,0.0
Beta-2-transferrin,1,0.0
encephalocele,1,0.0
RsSHC014,1,0.0
Phoca,1,0.0
multiplexed-chimeric,1,0.0
CLEIA,1,0.0
geneticist,1,0.0
Radiography,1,0.0
Pool-testing,1,0.0
pool-testing,1,0.0
reperformed,1,0.0
Andaman,1,0.0
Nicobar,1,0.0
settler,1,0.0
Nicobarese,1,0.0
tribe,1,0.0
ill-suboptimal,1,0.0
9633,1,0.0
Hemoglobin,1,0.0
end-labeling,1,0.0
RNa,1,0.0
choriocapillaris,1,0.0
wasps,1,0.0
half-hour,1,0.0
reported58,1,0.0
Pan-American,1,0.0
42-63,1,0.0
decadal,1,0.0
conflicted,1,0.0
tissue-toxic,1,0.0
08-09,1,0.0
p07,1,0.0
premorbidity,1,0.0
adiuvant,1,0.0
pneumonitis-deficiencies,1,0.0
GATA2,1,0.0
IRF9,1,0.0
TLR3-have,1,0.0
boom,1,0.0
off‑label,1,0.0
immune‑checkpoint,1,0.0
death‑1,1,0.0
PD‑1PD,1,0.0
ligand-1,1,0.0
PD‑L1,1,0.0
anti‑tumoral,1,0.0
anti‑PD‑L1,1,0.0
non‑cancer,1,0.0
T‑cells,1,0.0
Cleaners,1,0.0
allergy-associated,1,0.0
Pasadena,1,0.0
Cyranose,1,0.0
AsianPacific,1,0.0
chymotrypsin-like,1,0.0
protease-inhibition,1,0.0
replication-inhibition,1,0.0
diclazuril,1,0.0
anti-protozoal,1,0.0
lenvatinib,1,0.0
serendipitously,1,0.0
Lenvatinib,1,0.0
broadly-acting,1,0.0
pazopanib,1,0.0
sunitinib,1,0.0
mechanism-of-action,1,0.0
361538,1,0.0
Acculturation,1,0.0
classificate,1,0.0
mutation-specific,1,0.0
httpswwwcdcgovcoronavirus2019-ncov,1,0.0
S-N501Y,1,0.0
S-E484K,1,0.0
S-H69-V70del,1,0.0
S-L450R,1,0.0
B1427429,1,0.0
B15261,1,0.0
1389,1,0.0
staving,1,0.0
2461,1,0.0
P4,1,0.0
Olfactive,1,0.0
precocultured,1,0.0
dUTP-biotin,1,0.0
Vircell-IgMA,1,0.0
22727,1,0.0
complications--including,1,0.0
pneumonia--cause,1,0.0
definition-based,1,0.0
Eminase,1,0.0
RNA‑polymerase,1,0.0
3C‑like,1,0.0
SARS‑coronavirus,1,0.0
non‑expensive,1,0.0
flebography,1,0.0
risk-informed,1,0.0
9509,1,0.0
noninfarcts,1,0.0
Trafermin,1,0.0
mucoadhesive,1,0.0
gellan,1,0.0
λ-carrageenan,1,0.0
sterically,1,0.0
LpPLA2,1,0.0
aged≤45,1,0.0
communitySee,1,0.0
httpwwwbiomedcentralcom1741-701510117,1,0.0
Hypertrophy,1,0.0
Risperidone,1,0.0
risperidone,1,0.0
treatment-decision,1,0.0
Pleasure,1,0.0
Hubeiin,1,0.0
11280,1,0.0
825731,1,0.0
transsternal,1,0.0
transclavicular,1,0.0
Metabolically,1,0.0
Retinol,1,0.0
Vircell-IgMIgA,1,0.0
psittaci,1,0.0
flow-cytometric,1,0.0
biorhythmic,1,0.0
Biorhythm,1,0.0
misreporting,1,0.0
settingsTo,1,0.0
strokeA,1,0.0
questionnaireEighteen,1,0.0
sensitivity-96,1,0.0
Fibrillary,1,0.0
Acidic,1,0.0
specificity-100,1,0.0
specificity-,1,0.0
obesity-associated,1,0.0
typesOur,1,0.0
imagingdiffusion-weighted,1,0.0
Well-standardized,1,0.0
isocyanate-sensitive,1,0.0
toluene-diisocyanate,1,0.0
isocyanate-related,1,0.0
exposure-type,1,0.0
Inside,1,0.0
colonized,1,0.0
myocardiosclerosis,1,0.0
Collegium,1,0.0
Medicum,1,0.0
enpowerment,1,0.0
58871,1,0.0
disjuncture,1,0.0
transferase-mediated,1,0.0
PR-interval,1,0.0
3rd-,1,0.0
4th-grade,1,0.0
dovetailed,1,0.0
asthmagenic,1,0.0
athmagenic,1,0.0
Manganese,1,0.0
Gd-containing,1,0.0
Gd-based,1,0.0
Appeared,1,0.0
regional-level,1,0.0
USA‒specific,1,0.0
disease‒related,1,0.0
March‒June,1,0.0
J501YV3,1,0.0
protein-related,1,0.0
bioprosthesis,1,0.0
aquaculture--the,1,0.0
Revolution--will,1,0.0
co-location,1,0.0
Lomudal,1,0.0
Placebo,1,0.0
king,1,0.0
emetics,1,0.0
bloodlettings,1,0.0
1782-1782,1,0.0
Ministers,1,0.0
NGO,1,0.0
105-574,1,0.0
SVS-,1,0.0
3rd-grade,1,0.0
radiopager,1,0.0
syntax,1,0.0
156176,1,0.0
176193,1,0.0
158176,1,0.0
128176,1,0.0
150176,1,0.0
161176,1,0.0
67176,1,0.0
101176,1,0.0
89176,1,0.0
112176,1,0.0
72176,1,0.0
58176,1,0.0
Emiratis,1,0.0
2212,1,0.0
candidate-predictors,1,0.0
phonology,1,0.0
family-provider,1,0.0
Nidovirales,1,0.0
replication-mediating,1,0.0
PR8-based,1,0.0
AEngland61107,1,0.0
E611PR8,1,0.0
weeksyear,1,0.0
mixedChronic,1,0.0
diseaseAreas,1,0.0
comorbidityExpert,1,0.0
IL-17F,1,0.0
hemiplegias,1,0.0
aphasias,1,0.0
transportrequirement,1,0.0
hemoglobin-oxygen,1,0.0
Stage-by-stage,1,0.0
AHK21203-like,1,0.0
stablished,1,0.0
Heartlands,1,0.0
BHH,1,0.0
bibasal,1,0.0
293-2870,1,0.0
Well-trained,1,0.0
endoscopic-related,1,0.0
PGD2-induced,1,0.0
DP-mediated,1,0.0
vasodilation-extravasation,1,0.0
PGD2-related,1,0.0
Senescence,1,0.0
Senescent,1,0.0
microcirculatures,1,0.0
Luks,1,0.0
Andrew,1,0.0
Grissom,1,0.0
Alt,1,0.0
119-127,1,0.0
2021-With,1,0.0
fibrinogen-alpha,1,0.0
fibrinogen-beta,1,0.0
fibrinogen-gamma,1,0.0
50-kb,1,0.0
times-to-inactivation,1,0.0
72327,1,0.0
or99,1,0.0
1--4,1,0.0
Parirenyatwa,1,0.0
CESI,1,0.0
AHK21303,1,0.0
-80°C,1,0.0
AHK21203,1,0.0
1979-88,1,0.0
1969-78,1,0.0
ICD8,1,0.0
Affecting,1,0.0
GASROS,1,0.0
curve60,1,0.0
clozapine,1,0.0
still-developing,1,0.0
case-matched,1,0.0
shadowed,1,0.0
cholesterol-absorption,1,0.0
ezetimide,1,0.0
Single-radial-immunodiffusion,1,0.0
contralesioned,1,0.0
9624,1,0.0
2000--2001,1,0.0
2002--2003,1,0.0
Frictional,1,0.0
Nm2,1,0.0
PCRTaqMan,1,0.0
numberrate,1,0.0
psoralen,1,0.0
morphea,1,0.0
SACAWG,1,0.0
serum-expanded,1,0.0
Supra-tentorial,1,0.0
infarctionNINDS-III,1,0.0
MRIor,1,0.0
3D-CTA,1,0.0
Zimbabweans,1,0.0
medicationsamantadine,1,0.0
18922,1,0.0
-098,1,0.0
ULTRASOUND,1,0.0
POTENTIAL,1,0.0
MECHANISM,1,0.0
SONOTHROMBOLYSIS,1,0.0
Augmentation,1,0.0
6-24h,1,0.0
envenomed,1,0.0
Coincidence,1,0.0
Genetical,1,0.0
reassortation,1,0.0
17462,1,0.0
5110,1,0.0
venosus-type,1,0.0
Tasmanian,1,0.0
WHO-defined,1,0.0
west-to-east,1,0.0
south-to-north,1,0.0
extra-European,1,0.0
WHO-developed,1,0.0
between-countries,1,0.0
variant†,1,0.0
CMS-certified,1,0.0
NHSN§,1,0.0
1-May,1,0.0
predominated¶,1,0.0
21-August,1,0.0
17407,1,0.0
700-788,1,0.0
33160,1,0.0
ROLE,1,0.0
mCIMT,1,0.0
20-1152,1,0.0
subcategorization,1,0.0
19535,1,0.0
skin-blister,1,0.0
Tijuana,1,0.0
EBP,1,0.0
--some,1,0.0
--however,1,0.0
bakerss,1,0.0
ICUCCU,1,0.0
Maharajgunj,1,0.0
Bir,1,0.0
Wolverhampton,1,0.0
Nobusawa,1,0.0
equivalences,1,0.0
pmMRI,1,0.0
12-128,1,0.0
gamma-angiography,1,0.0
bi-dimensional,1,0.0
bronchoprovocations,1,0.0
neuroscientific,1,0.0
readying,1,0.0
conditions-multilevel,1,0.0
behaviours-that,1,0.0
imaging--MRI,1,0.0
imaging--DWI,1,0.0
7589,1,0.0
115123,1,0.0
Co-pathogens,1,0.0
co-infective,1,0.0
p00161,1,0.0
p00469,1,0.0
DLVpulmonary,1,0.0
non-statistical,1,0.0
201469652-657,1,0.0
©2013,1,0.0
Implementations,1,0.0
00325,1,0.0
Alarms,1,0.0
reverse-vaccinology,1,0.0
nullomer,1,0.0
urgencies,1,0.0
radioisotopes,1,0.0
nitrate-treated,1,0.0
space-time，,1,0.0
systemHIS,1,0.0
3A,1,0.0
patients，,1,0.0
heat，,1,0.0
day，,1,0.0
hospitalization，,1,0.0
stasis，,1,0.0
drugs，,1,0.0
refreshing,1,0.0
urgent，,1,0.0
research，,1,0.0
theory，,1,0.0
patient-syndrome-drug-time-effective,1,0.0
dug,1,0.0
out，,1,0.0
Fowkes,1,0.0
Fulton,1,0.0
3395,1,0.0
Transcervical,1,0.0
Grandhi,1,0.0
Ribo,1,0.0
labyrinthine,1,0.0
reoriented,1,0.0
Peripartum,1,0.0
thigh-focused,1,0.0
subfebrile,1,0.0
bubbling,1,0.0
flowmetric,1,0.0
MEFR25,1,0.0
MEFR50--p,1,0.0
MEFR75--p,1,0.0
4421,1,0.0
gaze-holding,1,0.0
central-type,1,0.0
neuro-otologists,1,0.0
Healthcare-acquired,1,0.0
Jadkhav,1,0.0
patients1,1,0.0
stroke23,1,0.0
bail-out,1,0.0
republished,1,0.0
Sekhar,1,0.0
LN,1,0.0
Iwai,1,0.0
Bloom,1,0.0
1993334723-727,1,0.0
Griffin,1,0.0
Looby,1,0.0
2019117647-652,1,0.0
©The,1,0.0
calculus,1,0.0
gingivitis,1,0.0
aerated,1,0.0
Lara,1,0.0
1981-1984,1,0.0
3-35-fold,1,0.0
laboratory-verified,1,0.0
JMEI,1,0.0
ZA,1,0.0
Bashliaeva,1,0.0
Sumarokov,1,0.0
2-299,1,0.0
SDcord,1,0.0
httpwwwwhointinfluenzavaccinesplanen,1,0.0
GAPs,1,0.0
Medullary,1,0.0
Medulla,1,0.0
conglomerate,1,0.0
Drobeta,1,0.0
Turnu,1,0.0
Severin,1,0.0
Mehedinţi,1,0.0
fibrin-macrophagic,1,0.0
indwelling,1,0.0
DABI,1,0.0
random-mixing,1,0.0
outpatient-treated,1,0.0
platn,1,0.0
5-23,1,0.0
nephrotoxic,1,0.0
27-81,1,0.0
600years,1,0.0
4-164,1,0.0
SE-AZh,1,0.0
3-7-year-old,1,0.0
1983--first,1,0.0
Euroimmun-Anti-SARS-CoV-2-ELISA-IgAIgG,1,0.0
LASS,1,0.0
lectured,1,0.0
httpsdoiorg101016jscitotenv2020138704,1,0.0
deflated,1,0.0
ASMs,1,0.0
ceaseless,1,0.0
seroassays,1,0.0
neededWe,1,0.0
6658,1,0.0
n193,1,0.0
true-negatives,1,0.0
n1091,1,0.0
n5374,1,0.0
Roche-Elecsys-Anti-SARS-CoV-2,1,0.0
recomLine-RBD,1,0.0
VIRAMED-SARS-CoV-2-ViraChip,1,0.0
Mikrogen-recomLine-SARS-CoV-2-IgG,1,0.0
Euroimmun-anti-S1-IgG,1,0.0
772798,1,0.0
manufacturersoptimised,1,0.0
980978,1,0.0
855886,1,0.0
998997,1,0.0
-IgG,1,0.0
RT-PCR-positivity,1,0.0
Virus-neutralisation,1,0.0
Mikrogen-recomLine-RBD,1,0.0
GeneScriptcPassTM,1,0.0
11581,1,0.0
10-June,1,0.0
601-735,1,0.0
methoxy,1,0.0
Leiper,1,0.0
Diesing,1,0.0
Mansonella,1,0.0
Faust,1,0.0
Bain,1,0.0
Diagne,1,0.0
pitheciid,1,0.0
Pithecia,1,0.0
É,1,0.0
Geoffroy,1,0.0
Saint-Hilaire,1,0.0
Cacajao,1,0.0
calvus,1,0.0
ucayalii,1,0.0
Pitheciidae,1,0.0
Yavari-Mirin,1,0.0
iNfection,1,0.0
Indianapolis,1,0.0
COVID-like,1,0.0
Stay-at-Home,1,0.0
1970-73,1,0.0
1980-83,1,0.0
557-637,1,0.0
79-87,1,0.0
surmise,1,0.0
dye-loaded,1,0.0
nanoparticles-based,1,0.0
dodecyl,1,0.0
sulfate-polyacrylamide,1,0.0
12-63,1,0.0
overland,1,0.0
FWI,1,0.0
spectrographic,1,0.0
nanobiotechnology,1,0.0
sensitivespecific,1,0.0
Pediatric-specific,1,0.0
cortico-hypothalamic,1,0.0
oculosympathetic,1,0.0
50000000,1,0.0
1250000,1,0.0
health-systems,1,0.0
patientprovider,1,0.0
Multipotent,1,0.0
Lyte-A,1,0.0
transarterial,1,0.0
microsyringe,1,0.0
171-316,1,0.0
year’s,1,0.0
138-248,1,0.0
160-292,1,0.0
179-435,1,0.0
gaselectricity,1,0.0
rural-town-city,1,0.0
urbanicity,1,0.0
environmentallifestyle,1,0.0
trash,1,0.0
cans,1,0.0
sickbed,1,0.0
≈4,1,0.0
nucleoli,1,0.0
glomangiosarcomas,1,0.0
Polymersomes,1,0.0
glycol-b-polycaprolactone,1,0.0
RIPK2,1,0.0
mPEG-b-PCL,1,0.0
DREP-S,1,0.0
DREP-Secto,1,0.0
1-1-2005,1,0.0
12-31-2014,1,0.0
189471,1,0.0
108226,1,0.0
81245,1,0.0
58189,1,0.0
rEDV,1,0.0
Pattern-based,1,0.0
7895,1,0.0
maxingshigan-yinqiaosan,1,0.0
modernize,1,0.0
AH1AH3B,1,0.0
benzo-diazepines,1,0.0
5×105,1,0.0
eNOS-induced,1,0.0
Exercised,1,0.0
p-S1177-eNOS,1,0.0
p-T172-AMPK,1,0.0
L-NIO,1,0.0
non-exercise,1,0.0
peNOS,1,0.0
pAMPK,1,0.0
MA-SM,1,0.0
CTP-based,1,0.0
GENERIC,1,0.0
ABBOTT,1,0.0
ROCHE,1,0.0
DNA-launched,1,0.0
cfu,1,0.0
1x1011,1,0.0
anovel,1,0.0
diblock,1,0.0
copolymers,1,0.0
Coomassie,1,0.0
polymersomes,1,0.0
92-94,1,0.0
91-97,1,0.0
S-CK,1,0.0
Bangkokian,1,0.0
J10,1,0.0
J11,1,0.0
1995-2005,1,0.0
-h,1,0.0
Wadsworth,1,0.0
aglobal,1,0.0
pre-administered,1,0.0
19718030,1,0.0
728013,1,0.0
nonstationary,1,0.0
protein-heat,1,0.0
two-hybrid,1,0.0
17-N-allylamino-17-demethoxygeldanamycin,1,0.0
17AAG,1,0.0
NA-Hsp90,1,0.0
Infarct-like,1,0.0
bisphenol,1,0.0
diglycidyl,1,0.0
BADGE,1,0.0
867-66,1,0.0
nodosome-targeting,1,0.0
receptor-interacting,1,0.0
85593,1,0.0
chemoreceptor,1,0.0
low-SES,1,0.0
diesel-related,1,0.0
psycho-socioeconomic,1,0.0
Rabdomyolysis,1,0.0
broncholithiasis,1,0.0
nihilist,1,0.0
EMEA,1,0.0
protocolised,1,0.0
mainstone,1,0.0
intrarterial,1,0.0
ethiopathogeny,1,0.0
jjfoxupmcedu,1,0.0
8040,1,0.0
2x75,1,0.0
1-beta-D-Ribofuranosyl-124-triazole-3-carboxamide,1,0.0
disguised,1,0.0
PKUPH,1,0.0
non-nucleic,1,0.0
etiopathogeny,1,0.0
Morgantown,1,0.0
5141,1,0.0
3069,1,0.0
persulphates,1,0.0
vector-vaccinated,1,0.0
Kzyl-Orda,1,0.0
Al-OH,1,0.0
Cardioaortic,1,0.0
imaging-transthoracic,1,0.0
MRI-in,1,0.0
ASLRPL,1,0.0
PGP,1,0.0
better-understand,1,0.0
05331,1,0.0
14917,1,0.0
491-567,1,0.0
Structure,1,0.0
Epithelium,1,0.0
Endogenic,1,0.0
04822,1,0.0
00186,1,0.0
uta,1,0.0
09207,1,0.0
hoarse,1,0.0
ORF1abRdRp,1,0.0
4715L,1,0.0
-003757,1,0.0
-02876,1,0.0
automic,1,0.0
06389,1,0.0
regional-specific,1,0.0
2775,1,0.0
25-36,1,0.0
Ischemia-related,1,0.0
14-months,1,0.0
actine,1,0.0
allergen-sensitive,1,0.0
002-04,1,0.0
15-11,1,0.0
01-09,1,0.0
15-27,1,0.0
15-127,1,0.0
Salmeterol,1,0.0
1979--1980,1,0.0
alphaviruses,1,0.0
roubles,1,0.0
100-day-old,1,0.0
mmin,1,0.0
dwk,1,0.0
386-421min,1,0.0
9263,1,0.0
7448,1,0.0
Diphtheria,1,0.0
TDaP,1,0.0
angiocardioscintigraphy,1,0.0
Tc-99,1,0.0
620-113,1,0.0
virus-deactivating,1,0.0
venous-based,1,0.0
pandemic-like,1,0.0
40-fold,1,0.0
reimbursing,1,0.0
Badak,1,0.0
Baru,1,0.0
Anastomotic,1,0.0
in-Soult,1,0.0
men-with,1,0.0
3985,1,0.0
COVID-infected,1,0.0
anosmiadysgeusia,1,0.0
chest-first,1,0.0
Trauma-associated,1,0.0
Infu,1,0.0
nontriaged,1,0.0
flaviviruses,1,0.0
ACST-1,1,0.0
Trial-1,1,0.0
0·039,1,0.0
ventriculoatrial,1,0.0
apidemiological,1,0.0
httpswwwcovid19dataportalorg,1,0.0
visualisations,1,0.0
FAIR,1,0.0
Findable,1,0.0
Interoperable,1,0.0
US-Mexican,1,0.0
supine-standing-supine,1,0.0
002-05,1,0.0
005-015,1,0.0
015-05,1,0.0
psycho-behavioural,1,0.0
smokeABSTRACT,1,0.0
microcephaly,1,0.0
2·3,1,0.0
dysplastic,1,0.0
pectum,1,0.0
arched,1,0.0
hemi-arches,1,0.0
C7,1,0.0
sagittal-cleft,1,0.0
lippalate,1,0.0
odontoid,1,0.0
PTPN11,1,0.0
82·1,1,0.0
53·5,1,0.0
3·1,1,0.0
0·019,1,0.0
sequential-infection,1,0.0
338539,1,0.0
easy-to-read,1,0.0
Lazaruss,1,0.0
Nearing,1,0.0
Cold-adaptation,1,0.0
WHOUNICEF,1,0.0
riskbenefit-,1,0.0
120-510,1,0.0
sialyllactose,1,0.0
COA,1,0.0
DEGS,1,0.0
sCFR-is,1,0.0
heuristically,1,0.0
US-accelerated,1,0.0
high-acoustic-pressure,1,0.0
MB-enhanced,1,0.0
multi-session,1,0.0
NBHE,1,0.0
pMHC,1,0.0
neurosupplementation,1,0.0
IL-6RA,1,0.0
anti-IL-6,1,0.0
poly-porous,1,0.0
β-galactoside-binding,1,0.0
centralizing,1,0.0
Aquitaine,1,0.0
bacterialfungal,1,0.0
OSR,1,0.0
miR-196a2,1,0.0
rs11614913,1,0.0
miRNA-125b,1,0.0
HAA,1,0.0
stress-coping,1,0.0
Re-establishment,1,0.0
COVID-9,1,0.0
resonance-T1,1,0.0
btsDMARDs,1,0.0
abatacept,1,0.0
Rheumatologists,1,0.0
nidi,1,0.0
Weighing,1,0.0
irreproducible,1,0.0
2946013,1,0.0
58-83,1,0.0
AH1Npdm09,1,0.0
Aristotelian,1,0.0
multivalued-based,1,0.0
57000,1,0.0
ELSI-COVID-19,1,0.0
Precautionary,1,0.0
proceduralists,1,0.0
February-28-2020,1,0.0
June-14-2020,1,0.0
post-provocation,1,0.0
therapy--922,1,0.0
MedRix,1,0.0
3405,1,0.0
192-fold,1,0.0
p00040,1,0.0
Erythroblastic,1,0.0
sarcomatous,1,0.0
Fasenra™,1,0.0
BiVs,1,0.0
Excluded,1,0.0
microimaging,1,0.0
Diagnose,1,0.0
vivaciously,1,0.0
Controversially,1,0.0
Treatable,1,0.0
hypokalaemia,1,0.0
hypokalaemic,1,0.0
1695,1,0.0
complementarities,1,0.0
nonexercise,1,0.0
spike-glycoprotein,1,0.0
1036030,1,0.0
30806,1,0.0
subclonal,1,0.0
clinico-anamnestic,1,0.0
NKG2A,1,0.0
TIM-3,1,0.0
Criança,1,0.0
FMUSP,1,0.0
summited,1,0.0
Laboratorio,1,0.0
Informática,1,0.0
FEV1-forced,1,0.0
neuropsyquiatric,1,0.0
psiqyiatric,1,0.0
beeing,1,0.0
bacterias,1,0.0
arbovirus,1,0.0
Bacterias,1,0.0
neumoniae,1,0.0
Histoplasma,1,0.0
capsulatum,1,0.0
Winnipegs,1,0.0
infectionisolation,1,0.0
fingolimod,1,0.0
tc,1,0.0
ACTIVE,1,0.0
parasympathetic--vagus,1,0.0
behaviorlifestyle,1,0.0
subtopics,1,0.0
Intra-hospital,1,0.0
d90,1,0.0
minor-risk,1,0.0
agents-based,1,0.0
ill-posed,1,0.0
18-58,1,0.0
2007-2011,1,0.0
anti-infarction,1,0.0
Oxidation,1,0.0
reagented,1,0.0
immuno-infiltrative,1,0.0
hyperkrinia,1,0.0
electrocauterization,1,0.0
prehension,1,0.0
equally-sized,1,0.0
workspace,1,0.0
double-step,1,0.0
Bahia-Brazil,1,0.0
X-chromosomal,1,0.0
α-galactosidase,1,0.0
Beta-2-mimetics,1,0.0
chromolynglycate,1,0.0
non-pollen-allergens,1,0.0
physiopathogenic,1,0.0
unavoidably,1,0.0
inhalatant,1,0.0
anti-rheumatic,1,0.0
allergyanaphylaxis,1,0.0
waterproof,1,0.0
STREAM-study,1,0.0
TPH1,1,0.0
PCDHGC4,1,0.0
RIT1,1,0.0
HSP90AB1,1,0.0
OLMALINC,1,0.0
DNMT3A,1,0.0
STAP1,1,0.0
OAS2,1,0.0
Health-National,1,0.0
Wister,1,0.0
values-2,1,0.0
CCL1,1,0.0
29903bp,1,0.0
lipid-bilayer,1,0.0
Camostat,1,0.0
Amentoflavone,1,0.0
Scutellarein,1,0.0
indigotica,1,0.0
Nsp9,1,0.0
SwissDoc,1,0.0
intelligencemachine,1,0.0
respirability,1,0.0
midseptal,1,0.0
CD40-expressing,1,0.0
Vaccine-elicited,1,0.0
flour-exposed,1,0.0
chest-X,1,0.0
welder,1,0.0
infracted-artery,1,0.0
HPRT1,1,0.0
FGD5,1,0.0
LTBP1,1,0.0
A-H3,1,0.0
vogue,1,0.0
80-101,1,0.0
Wisc,1,0.0
Rey,1,0.0
GoodenoughMachouver,1,0.0
mcgml,1,0.0
Schlieper,1,0.0
449-455,1,0.0
nonimmunocompromised,1,0.0
capacity-enhancement,1,0.0
47XX21,1,0.0
ABangkok79,1,0.0
APhilippines283,1,0.0
ABelgium281,1,0.0
USH2A,1,0.0
APrague283,1,0.0
passage-independent,1,0.0
CDK20,1,0.0
TACC2,1,0.0
ORC5,1,0.0
NEK5,1,0.0
RFN34,1,0.0
BIRC3,1,0.0
NAA16,1,0.0
RNF13,1,0.0
MRPL37,1,0.0
CACNA1G,1,0.0
LAMA3,1,0.0
pharamacoinvasive,1,0.0
STrategic,1,0.0
micro-droplets,1,0.0
birth-cohort,1,0.0
893-928,1,0.0
938-978,1,0.0
96-161,1,0.0
229-487,1,0.0
499-597,1,0.0
3889,1,0.0
23533889,1,0.0
split-grade,1,0.0
nonsplit,1,0.0
RCM-mediated,1,0.0
ultradian,1,0.0
variational,1,0.0
PC15PtcO2,1,0.0
23458,1,0.0
3635,1,0.0
developingemerging,1,0.0
initially-exposed,1,0.0
COVID-only,1,0.0
Diverging,1,0.0
AI-powered,1,0.0
AI-enabled,1,0.0
IgEeosinophilic,1,0.0
Estrogenprogesterone,1,0.0
co-relationship,1,0.0
anti-ganglioside,1,0.0
anti-GQ1b,1,0.0
banknote,1,0.0
absorbent,1,0.0
long-persisting,1,0.0
932-957,1,0.0
376-473,1,0.0
359-455,1,0.0
recounted,1,0.0
1a-1,1,0.0
bronchodilatator,1,0.0
diagnosed--an,1,0.0
4-89,1,0.0
50-5,1,0.0
resistors,1,0.0
semi-recumbent,1,0.0
Sadly,1,0.0
dramatis,1,0.0
personae,1,0.0
odyssey,1,0.0
transcend,1,0.0
countriesstates,1,0.0
≈40,1,0.0
381-478,1,0.0
evangelical,1,0.0
thanking,1,0.0
exurbs,1,0.0
Gates,1,0.0
HealthStar,1,0.0
proponent,1,0.0
8220twindemia8221,1,0.0
haziness,1,0.0
torn,1,0.0
angioscopic,1,0.0
darkened,1,0.0
088-100,1,0.0
IgG-based,1,0.0
number-one,1,0.0
recruitingcompleted,1,0.0
19-928,1,0.0
2135,1,0.0
lbe,1,0.0
asthmaa,1,0.0
multimetastatic,1,0.0
Tako-tsubo,1,0.0
IFN-γ-release,1,0.0
Whole-blood-platform,1,0.0
uninfected-individuals,1,0.0
whole-blood-platform,1,0.0
recategorized,1,0.0
10149,1,0.0
8514,1,0.0
5038,1,0.0
2599,1,0.0
NCT04321421,1,0.0
workday,1,0.0
460-702,1,0.0
1993-2000,1,0.0
cca,1,0.0
Mantel-Cox,1,0.0
discussedNon-invasive,1,0.0
physiotherapies,1,0.0
logopedics,1,0.0
kick-started,1,0.0
go-to,1,0.0
CPK-BB,1,0.0
01-266,1,0.0
Shells,1,0.0
casesInfluenza,1,0.0
casesthree,1,0.0
neuro-otological,1,0.0
DWIMRI-negative,1,0.0
Nonobstetric,1,0.0
favipiravir-containing,1,0.0
2184,1,0.0
115-1151,1,0.0
sectored,1,0.0
visions,1,0.0
Cornerstones,1,0.0
well-educated,1,0.0
35-lead,1,0.0
elevation-mapping,1,0.0
length-of-stay,1,0.0
overheads,1,0.0
AU35942,1,0.0
10269,1,0.0
82152,1,0.0
AU51294,1,0.0
22849,1,0.0
110340,1,0.0
AU63298,1,0.0
78722,1,0.0
AU85395,1,0.0
147457,1,0.0
pneumonitisacute,1,0.0
65000000,1,0.0
observer-blinded,1,0.0
NCT04450004,1,0.0
tolerabilitysafety,1,0.0
CpG1018,1,0.0
27-85,1,0.0
post-infusion,1,0.0
58-78,1,0.0
ePlex®,1,0.0
cartridge-based,1,0.0
SDD,1,0.0
v-ATPase,1,0.0
harshly,1,0.0
Seamless,1,0.0
19-21th,1,0.0
IgE-RAST,1,0.0
coaxial,1,0.0
Flexible,1,0.0
extruding,1,0.0
spaghetti-like,1,0.0
fluoroscopically,1,0.0
2-26,1,0.0
Albumin,1,0.0
ALIAS,1,0.0
Phitsanulok,1,0.0
two-sample,1,0.0
mendelian,1,0.0
R363,1,0.0
1745,1,0.0
CRE,1,0.0
Facts,1,0.0
rural-dwelling,1,0.0
multitherapies,1,0.0
H5Nx,1,0.0
H5N5,1,0.0
2344b,1,0.0
GC-associated,1,0.0
FANN,1,0.0
nutritionist,1,0.0
single-response,1,0.0
adopters,1,0.0
poultry-handling,1,0.0
sequenced-based,1,0.0
53-8,1,0.0
AG-frailty,1,0.0
IMPDH,1,0.0
laryngopharyngitis,1,0.0
12331,1,0.0
2545,1,0.0
H1N1-Influenza,1,0.0
anisotrophy,1,0.0
SynCardia,1,0.0
JSCA-QOL,1,0.0
chelator,1,0.0
Gill,1,0.0
Peterson-Counting,1,0.0
PWP-CP,1,0.0
Peterson-Gap,1,0.0
PWP-CP-frailty,1,0.0
Cubans,1,0.0
PWP-GT-frailty,1,0.0
BIC,1,0.0
Cox-Snell,1,0.0
Z5,1,0.0
disruptiveness,1,0.0
disobedience,1,0.0
gene-sequencing,1,0.0
vaccines--including,1,0.0
hypersensitivity--have,1,0.0
flu-planning,1,0.0
Prepare,1,0.0
Revise,1,0.0
Dominicans,1,0.0
histamine-poor,1,0.0
traduction,1,0.0
anriaggregants,1,0.0
32°C,1,0.0
13-question,1,0.0
27095,1,0.0
229278,1,0.0
210229,1,0.0
15229,1,0.0
4229,1,0.0
3449,1,0.0
Environmentally,1,0.0
theory-,1,0.0
STand,1,0.0
exit-interview,1,0.0
8-weeks,1,0.0
NCT02980744,1,0.0
unencountered,1,0.0
Spurred,1,0.0
ill-conceived,1,0.0
EBSCOhost,1,0.0
IRBIS,1,0.0
РИНЦ,1,0.0
RISC,1,0.0
post-Soviet,1,0.0
PACI,1,0.0
LACI,1,0.0
diagnosticand,1,0.0
Incorporate,1,0.0
paninfluenza-specific,1,0.0
Objetive,1,0.0
hospitalizes,1,0.0
His-tagged,1,0.0
AH7N9-related,1,0.0
AH7N9-specific,1,0.0
3117,1,0.0
Gifu,1,0.0
CURB-65,1,0.0
Forecasting,1,0.0
±3·6,1,0.0
tangram,1,0.0
overprotective,1,0.0
self-sacrificing,1,0.0
non-objective,1,0.0
non-anxious,1,0.0
textbook-style,1,0.0
gastroepiploic,1,0.0
reawakened,1,0.0
adult-relapse,1,0.0
Meilahti,1,0.0
10-245,1,0.0
1281,1,0.0
rimu,1,0.0
Dacrydium,1,0.0
cupressinum,1,0.0
woodworking,1,0.0
Compression,1,0.0
mechanosensing,1,0.0
Work-aggravated,1,0.0
Rat230-20,1,0.0
Unit-Kenya,1,0.0
USAMRU-K,1,0.0
heart-valve,1,0.0
∼1-2,1,0.0
2112,1,0.0
109-fold,1,0.0
GS-CHO,1,0.0
30years,1,0.0
49-fold,1,0.0
dwarf,1,0.0
Kogia,1,0.0
breviceps,1,0.0
cross-sectioned,1,0.0
Kogiid,1,0.0
kogiid,1,0.0
physeterids,1,0.0
ziphiids,1,0.0
odontocetes,1,0.0
plesiomorphic,1,0.0
ROBIS,1,0.0
pro-hemorrhagic,1,0.0
factor-targeted,1,0.0
isocapneic,1,0.0
detectionquantification,1,0.0
modeling-based,1,0.0
Array,1,0.0
13324,1,0.0
2017-,1,0.0
Rhinovirusenterovirus,1,0.0
COH20G677H,1,0.0
20AEU2,1,0.0
smartphoneweb,1,0.0
mRNA-lipid,1,0.0
assault,1,0.0
Massaab,1,0.0
diferent,1,0.0
Avtandilov,1,0.0
Salbiyev,1,0.0
pygmy,1,0.0
Tursiops,1,0.0
dolphins,1,0.0
ofapoptosis,1,0.0
Ni-chelate,1,0.0
co-eluting,1,0.0
15189,1,0.0
Jacobian,1,0.0
multi-controller,1,0.0
Proportional-Integral,1,0.0
chattering,1,0.0
reduced-order,1,0.0
MATLAB®,1,0.0
Low-molecular-weight,1,0.0
heparinoid,1,0.0
dysplasiacardiomyopathy,1,0.0
enforces,1,0.0
sFas--marker,1,0.0
bottlenose,1,0.0
ofapoptosis--in,1,0.0
dismantling,1,0.0
MOL,1,0.0
BIOL,1,0.0
COBAS,1,0.0
16-43,1,0.0
17-44,1,0.0
5371,1,0.0
Congregate,1,0.0
FEV2,1,0.0
DDS,1,0.0
neurologystroke,1,0.0
Shallow-diving,1,0.0
January-June,1,0.0
ShSMCH,1,0.0
Suhrawardy,1,0.0
Dalmatian,1,0.0
Survey-36,1,0.0
hostile-angry,1,0.0
fearful-panicky,1,0.0
beta-028,1,0.0
beta-037,1,0.0
beta019,1,0.0
beta025,1,0.0
beta-017,1,0.0
beta-064,1,0.0
longing,1,0.0
reorientation,1,0.0
Autonomy,1,0.0
Anarchic,1,0.0
anarchic,1,0.0
2003-2015,1,0.0
subocclusion,1,0.0
unphysiological,1,0.0
re-computed,1,0.0
dual-antiplatelet,1,0.0
two-by-two,1,0.0
2500-3020,1,0.0
aerogenic,1,0.0
2006-11,1,0.0
232-434,1,0.0
325-828,1,0.0
1574,1,0.0
1084-2065,1,0.0
1837-3803,1,0.0
26-102,1,0.0
pre-war,1,0.0
Indo-Pacific,1,0.0
Shaheed,1,0.0
forward-deployed,1,0.0
post-approval,1,0.0
pre-marketing,1,0.0
microaspirations,1,0.0
vagally-transmitted,1,0.0
pH-recording,1,0.0
GER-specific,1,0.0
nAb-based,1,0.0
bacterialviral,1,0.0
42-66,1,0.0
45-97,1,0.0
27-97,1,0.0
15-91,1,0.0
42-68,1,0.0
32-91,1,0.0
Lurian,1,0.0
across-tasks,1,0.0
dyscoordination,1,0.0
age-equivalent,1,0.0
stuck-in-set,1,0.0
nonneurologic,1,0.0
0935,1,0.0
lactated,1,0.0
Ringers,1,0.0
German-speaking,1,0.0
ADSR,1,0.0
280000,1,0.0
Courtney,1,0.0
Smedley,1,0.0
Butler,1,0.0
713-1615,1,0.0
3420,1,0.0
articleExpert,1,0.0
Unavailability,1,0.0
platelet-like,1,0.0
operatives,1,0.0
ABCs,1,0.0
spotting,1,0.0
contaminate-controlling,1,0.0
attire,1,0.0
awesome,1,0.0
watchful,1,0.0
GMartino,1,0.0
Messina,1,0.0
subinsular,1,0.0
5188,1,0.0
flux-coated,1,0.0
fluorides,1,0.0
xylomannan,1,0.0
xylan,1,0.0
pectins,1,0.0
fucoidans,1,0.0
glucoarabinan,1,0.0
arabinoxylan,1,0.0
non-inbred,1,0.0
cristae,1,0.0
ARDS-their,1,0.0
ochraceus,1,0.0
voriconazole,1,0.0
ascorbate,1,0.0
dimethylamine,1,0.0
O-phosphocholine,1,0.0
methanol,1,0.0
lymphocyte-like,1,0.0
B-like,1,0.0
GP1R,1,0.0
Goodacre,1,0.0
780K,1,0.0
150K,1,0.0
66B,1,0.0
improvise,1,0.0
Latin-American,1,0.0
Iquique,1,0.0
Soderberghs,1,0.0
persuading,1,0.0
selflessness,1,0.0
tropes,1,0.0
scapegoating,1,0.0
139393,1,0.0
2000-08,1,0.0
Bradburn,1,0.0
cytotoxic-T-lymphocytes,1,0.0
3Mg,1,0.0
293-300,1,0.0
protocol-specified,1,0.0
supraunleveling,1,0.0
3h59-2h55min,1,0.0
Unmarried,1,0.0
3733,1,0.0
apples,1,0.0
pears,1,0.0
cabbages,1,0.0
challenge-mid,1,0.0
78-20,1,0.0
21-250,1,0.0
EEs,1,0.0
survi-ved,1,0.0
under-studied,1,0.0
monogenetic,1,0.0
embarks,1,0.0
mammoplasty,1,0.0
carcinoid,1,0.0
silicone,1,0.0
CIRN,1,0.0
NCT01517191,1,0.0
performedMethods,1,0.0
virusesResults,1,0.0
lineagesConclusions,1,0.0
34±05,1,0.0
18±03,1,0.0
lipid-enveloped,1,0.0
Nrf-2,1,0.0
cardiomodulation,1,0.0
fiercely,1,0.0
distrusting,1,0.0
Visuoconstructive,1,0.0
visuoconstructive,1,0.0
Saudis,1,0.0
Pteronyssinus,1,0.0
customs,1,0.0
Q-infarct,1,0.0
remeasured,1,0.0
non-embalmed,1,0.0
double-channel,1,0.0
gastroscope,1,0.0
2R,1,0.0
4R,1,0.0
4L,1,0.0
10083,1,0.0
BUSSR,1,0.0
ACaen,1,0.0
cerium,1,0.0
Norways,1,0.0
CT-equipped,1,0.0
telemedicine-guided,1,0.0
3G-based,1,0.0
audio-visual,1,0.0
head-chest,1,0.0
HCECG,1,0.0
RLECG,1,0.0
microgramskg-1min-1,1,0.0
positivityABSTRACT,1,0.0
Complementarily,1,0.0
consumption-based,1,0.0
110-130,1,0.0
Promisingly,1,0.0
AChile,1,0.0
β₂-adrenoceptor,1,0.0
β₂-adrenergic,1,0.0
desensitisation,1,0.0
AH7N9-infected,1,0.0
influenzaH5N1,1,0.0
ARDSacute,1,0.0
haemo-phagocytosis,1,0.0
stemness,1,0.0
PROTACs,1,0.0
Ubiquitin-proteasome,1,0.0
ubiquitination-independent,1,0.0
PA28γ,1,0.0
198182,1,0.0
child-bonding,1,0.0
11-34,1,0.0
AWuhan-like,1,0.0
immunophenotype,1,0.0
DUB,1,0.0
deISGylating,1,0.0
1121,1,0.0
itemized,1,0.0
7·7,1,0.0
10·1,1,0.0
14-,1,0.0
MI-IHH,1,0.0
sham-IHH,1,0.0
key-approach,1,0.0
ribavirine,1,0.0
BMPD,1,0.0
BMPD-analysis,1,0.0
3-80,1,0.0
primer-independent,1,0.0
RNA-replicable,1,0.0
RdRP-induced,1,0.0
disability-severity,1,0.0
omong,1,0.0
weblogs,1,0.0
Linguistic,1,0.0
H1N1-relevant,1,0.0
loneAF,1,0.0
non-Healthcare,1,0.0
low-to-very,1,0.0
Co-circulating,1,0.0
AH3N2Wuhan35995-like,1,0.0
AH3N2Sydney0597-like,1,0.0
ASydney-like,1,0.0
deubiquitinating,1,0.0
entrant,1,0.0
7634,1,0.0
35040,1,0.0
COP9,1,0.0
signalosome,1,0.0
CSN5-COX2,1,0.0
examination--including,1,0.0
vasculature--is,1,0.0
treatmentAdvanced,1,0.0
endovenous,1,0.0
treatedMoreover,1,0.0
approachHere,1,0.0
Acidification,1,0.0
osteoclast,1,0.0
3331,1,0.0
4398,1,0.0
Grass,1,0.0
Tween-ether,1,0.0
advisories,1,0.0
180-200,1,0.0
Microscopic,1,0.0
therapy-based,1,0.0
fraction-confirmed,1,0.0
PFO-RS,1,0.0
multinucleate,1,0.0
nms,1,0.0
syncytium,1,0.0
internalize,1,0.0
bi-arginine,1,0.0
costotransversectomy,1,0.0
extraneural,1,0.0
formate,1,0.0
butanone,1,0.0
Lipoproteins,1,0.0
140-350,1,0.0
Amber,1,0.0
elixir,1,0.0
1986-87,1,0.0
Landscape,1,0.0
anti-hyperlipidemic,1,0.0
Purity,1,0.0
μgμl,1,0.0
260280,1,0.0
Mag,1,0.0
LATE,1,0.0
haemmorrhagic,1,0.0
semi-shadow,1,0.0
inflamamation,1,0.0
peri-infract,1,0.0
8569,1,0.0
proxied,1,0.0
71-127,1,0.0
1455-25401,1,0.0
co-contracting,1,0.0
degree-of-freedom,1,0.0
EMG-assisted,1,0.0
erector,1,0.0
spinae,1,0.0
r081,1,0.0
r091,1,0.0
co-contract,1,0.0
CRD42020221827,1,0.0
Extracted,1,0.0
Mid-turbinate,1,0.0
4518,1,0.0
hostel-type,1,0.0
k-mean,1,0.0
14688-31353,1,0.0
RNAantisense,1,0.0
siRNAASO,1,0.0
linkerimmunodominant,1,0.0
Bioengineered,1,0.0
highly-sensitive,1,0.0
roadmaps,1,0.0
revolutionizing,1,0.0
35mgkg,1,0.0
tail-vein,1,0.0
gadopentetate,1,0.0
30527,1,0.0
19992-39288,1,0.0
193675,1,0.0
19745,1,0.0
CMI-2,1,0.0
895-3455,1,0.0
075-114,1,0.0
163-219,1,0.0
128-198,1,0.0
187-282,1,0.0
7033,1,0.0
ratio129,1,0.0
8534,1,0.0
9504,1,0.0
0797,1,0.0
diploma,1,0.0
attractively,1,0.0
CMI-1,1,0.0
virusess,1,0.0
100-260,1,0.0
phosphoproteins,1,0.0
12-22,1,0.0
Influenza-A-virus-specific,1,0.0
HLA-restricted,1,0.0
1977-82,1,0.0
influenza-A-virus,1,0.0
14-16-year-old,1,0.0
laboratorily,1,0.0
NA-sequences,1,0.0
secretary,1,0.0
bio-terror,1,0.0
50±12,1,0.0
typeThere,1,0.0
lung1,1,0.0
bronchiectasisSPSS250,1,0.0
SPSS250,1,0.0
PneumoniaCOVID-19,1,0.0
0819,1,0.0
correlatedThere,1,0.0
inflammationCT,1,0.0
nano-ultra,1,0.0
3316,1,0.0
157A,1,0.0
bacteraemia,1,0.0
Uludağ,1,0.0
Strength-Fatigue,1,0.0
CIS-Fatigue,1,0.0
BAI,1,0.0
Bundesliga,1,0.0
analyed,1,0.0
femals,1,0.0
ectopies,1,0.0
ST-T-wave,1,0.0
0812020,1,0.0
clinicoinstrumental,1,0.0
well-ventilated,1,0.0
4414,1,0.0
7715,1,0.0
blood-perfused,1,0.0
1689,1,0.0
opportunistically,1,0.0
52-101,1,0.0
176-214,1,0.0
population-standardized,1,0.0
110-189,1,0.0
remote-living,1,0.0
PCoVGXSARS-CoV-2,1,0.0
troponine,1,0.0
chronograms,1,0.0
19237,1,0.0
no-significant,1,0.0
Rhythmometric,1,0.0
statistically-significant,1,0.0
Acrophases,1,0.0
acrophases,1,0.0
conditionate,1,0.0
discussedABSTRACT,1,0.0
penicillin-sensitive,1,0.0
sulphidopeptide,1,0.0
33-52,1,0.0
8--12,1,0.0
3--4,1,0.0
ad-dress,1,0.0
codeliver,1,0.0
phosphopeptides,1,0.0
lipoprotein-a,1,0.0
program-,1,0.0
healthTab,1,0.0
case--In,1,0.0
mgdie,1,0.0
001--This,1,0.0
platelet-,1,0.0
synthaseNOS,1,0.0
urgently-needed,1,0.0
druggabillity,1,0.0
liganbility,1,0.0
6W4B,1,0.0
6VWW,1,0.0
6M3M,1,0.0
6VYO,1,0.0
theoric,1,0.0
lactobacilli,1,0.0
TS-1,1,0.0
copies·g-1,1,0.0
Two-compartment,1,0.0
dislikes,1,0.0
lateness,1,0.0
ischemiainjury,1,0.0
economicaL,1,0.0
WHO-ISH,1,0.0
8667,1,0.0
6933,1,0.0
16483,1,0.0
15083,1,0.0
1754946,1,0.0
anteroseptum,1,0.0
Cypriot,1,0.0
33567,1,0.0
affluence,1,0.0
Zingiberis,1,0.0
Sheba,1,0.0
Hashomer,1,0.0
WanFang,1,0.0
bitter,1,0.0
Fibrosum-Armeniacae,1,0.0
Fibrosum-Glycyrrhizae,1,0.0
Amarum-Glycyrrhizae,1,0.0
Semen-Armeniacae,1,0.0
Amarum-Gypsum,1,0.0
Herba-Zingiberis,1,0.0
Recens-Magnoliae,1,0.0
Radix-Armeniacae,1,0.0
Amarum-Scutellariae,1,0.0
Recens,1,0.0
persons-years,1,0.0
Magnoliae,1,0.0
Sphenantherae,1,0.0
Panacis,1,0.0
Quinquefolii,1,0.0
Sirius,1,0.0
Prevotellaceae,1,0.0
Clostridiaceae,1,0.0
SARS-CoV-2-S-transfected,1,0.0
SARS-CoV-2-SACE2,1,0.0
SARS-CoV-SACE2,1,0.0
SARS-CoV-S-mediated,1,0.0
Lifelines,1,0.0
n97,1,0.0
Designs,1,0.0
8978,1,0.0
iTRAQ-labeled,1,0.0
rehabilitator,1,0.0
immunoresistance,1,0.0
antigrip,1,0.0
10-days,1,0.0
Panther-Fusion™,1,0.0
00903,1,0.0
±00787,1,0.0
01400,1,0.0
±00953,1,0.0
00867,1,0.0
±00629,1,0.0
00805±00736,1,0.0
hilltribe,1,0.0
AWuhan35995H3N2,1,0.0
CF-,1,0.0
Squamous,1,0.0
non-ciliated,1,0.0
primer-mediated,1,0.0
5-modified,1,0.0
3-modified,1,0.0
Matrix-M1,1,0.0
15mgkg,1,0.0
100mgkg,1,0.0
Isoproterenol-induced,1,0.0
hydro,1,0.0
aortogram,1,0.0
255256,1,0.0
phosphoproteomic,1,0.0
Phosphopeptides,1,0.0
titania,1,0.0
Disappearance,1,0.0
wers,1,0.0
65-91,1,0.0
R153C,1,0.0
physiciannursing,1,0.0
rehabilitators,1,0.0
plasminogen-deficient,1,0.0
Plg,1,0.0
non-healing,1,0.0
gelatinolytic,1,0.0
wild-types,1,0.0
plasmin-mediated,1,0.0
4928,1,0.0
reinfarcted,1,0.0
Chung,1,0.0
inefficiencies,1,0.0
Albertans,1,0.0
1968-71,1,0.0
IgG-ELISA,1,0.0
lipid-associated,1,0.0
Inversely,1,0.0
SR-B1,1,0.0
metallocarboxypeptidase,1,0.0
testes,1,0.0
ADAM,1,0.0
ACEiARB,1,0.0
23266,1,0.0
1784293,1,0.0
10404,1,0.0
Kupferzell,1,0.0
2203,1,0.0
RT-PCR-positives,1,0.0
Starr,1,0.0
Takatsu,1,0.0
1119–1122,1,0.0
384Conclusions,1,0.0
soins,1,0.0
réadaptation,1,0.0
34-94,1,0.0
n99,1,0.0
108-429,1,0.0
009-099,1,0.0
reportStudy,1,0.0
Stomatology,1,0.0
pandemicData,1,0.0
oro-maxillofacial,1,0.0
itConclusions,1,0.0
HEp-2,1,0.0
Schad,1,0.0
Oro-Nasopharyngeal,1,0.0
ONS,1,0.0
trialling,1,0.0
documentable,1,0.0
African-admixed,1,0.0
Multiterritorial,1,0.0
single-territory,1,0.0
Annualized,1,0.0
053-24,1,0.0
rivaroxaban-assigned,1,0.0
aspirin-assigned,1,0.0
NCT02313909,1,0.0
mailing,1,0.0
incisor,1,0.0
hypomineralization,1,0.0
Sugar,1,0.0
strokeOur,1,0.0
Immunotherapeutics,1,0.0
EF--left,1,0.0
PJ,1,0.0
2320,1,0.0
2293,1,0.0
28-October,1,0.0
Self-specimen,1,0.0
PH1N12009v,1,0.0
Needle,1,0.0
macrovesicular,1,0.0
steatosis,1,0.0
elementary-aged,1,0.0
ofthe,1,0.0
3-chymotrypsin,1,0.0
α-glucosidases,1,0.0
influenza-control,1,0.0
repealed,1,0.0
Carollia,1,0.0
perspicillata,1,0.0
PR8-H18N11,1,0.0
33164,1,0.0
18131,1,0.0
intraventicular,1,0.0
stage--339,1,0.0
infarction--555,1,0.0
8273,1,0.0
8233,1,0.0
8229,1,0.0
056-085,1,0.0
HistCiteTM,1,0.0
mappingResults,1,0.0
Dhama,1,0.0
15·7,1,0.0
bites--particularly,1,0.0
complications--are,1,0.0
Cerastes,1,0.0
22000,1,0.0
infected-host,1,0.0
haematoxylin-eosin,1,0.0
acridine,1,0.0
SARS-CoV-2-mediating,1,0.0
non-fucosylated,1,0.0
antibody-neutralizing,1,0.0
Jiashen,1,0.0
JSP,1,0.0
Rhodamine,1,0.0
6G,1,0.0
Rh-6G,1,0.0
nanostar,1,0.0
GNS-based,1,0.0
distance-dependent,1,0.0
Rh-6G-attached,1,0.0
single-stand,1,0.0
GNS,1,0.0
aptamer-spike,1,0.0
particlesmL,1,0.0
GNSs,1,0.0
two-strategy,1,0.0
pay-off,1,0.0
SADS-CoV,1,0.0
99MTc,1,0.0
period--permanent,1,0.0
a-v,1,0.0
30-621,1,0.0
0-55,1,0.0
less-conserved,1,0.0
blueprints,1,0.0
virion-CD46,1,0.0
inservice,1,0.0
cerastes,1,0.0
vipers,1,0.0
toxin-induced,1,0.0
clinician-identified,1,0.0
sociodemographicsocioeconomic,1,0.0
Kawasakis-like,1,0.0
Harnessing,1,0.0
exosome-based,1,0.0
1116933,1,0.0
39807,1,0.0
RBDRsACE2,1,0.0
UKS,1,0.0
AIS-C,1,0.0
aircrew,1,0.0
HAdV-B,1,0.0
30--35th,1,0.0
continually-rising,1,0.0
load-rating,1,0.0
sum-total,1,0.0
2190,1,0.0
physician-community,1,0.0
0-162,1,0.0
Bangui,1,0.0
18294,1,0.0
4294,1,0.0
Mini-Asthma,1,0.0
Adenoviruses,1,0.0
receptor-screening,1,0.0
Cpneumoniae,1,0.0
LOGICAL,1,0.0
peripneumonia,1,0.0
IACE,1,0.0
bio-aerosols,1,0.0
plumbing,1,0.0
high-rise,1,0.0
Angels,1,0.0
n2819,1,0.0
Upscale,1,0.0
≥24,1,0.0
MIR-21,1,0.0
MiRNA,1,0.0
MiR-21,1,0.0
adherencenon-adherence,1,0.0
secondarytertiary,1,0.0
scalp-,1,0.0
body-acupoints,1,0.0
environmentclimate,1,0.0
TTI6,1,0.0
or24,1,0.0
NIHSS-,1,0.0
NIHSSadmission,1,0.0
NIHSS×100,1,0.0
P039,1,0.0
P933,1,0.0
84MCA,1,0.0
63MCA,1,0.0
-44MCA,1,0.0
P23,1,0.0
P035,1,0.0
P421,1,0.0
P043,1,0.0
Curbing,1,0.0
vasculotropic,1,0.0
angiotensin-converting-enzyme-2,1,0.0
8797,1,0.0
NH3,1,0.0
flow-metabolism,1,0.0
LBBBRBBB,1,0.0
LAHBLPHB,1,0.0
LAHB,1,0.0
LPHB,1,0.0
57980,1,0.0
005-001,1,0.0
Holberton,1,0.0
Antigua,1,0.0
273300,1,0.0
284300,1,0.0
7997,1,0.0
far-ultraviolet,1,0.0
neuro-pathophysiology,1,0.0
Epithelial-immune,1,0.0
2229,1,0.0
sero-surveying,1,0.0
Village,1,0.0
Organising,1,0.0
Josset,1,0.0
Plos,1,0.0
salivaoral,1,0.0
resources-limited,1,0.0
18-72,1,0.0
13-52,1,0.0
29-80,1,0.0
68-88,1,0.0
specialising,1,0.0
andAspergillusspecies,1,0.0
inspects,1,0.0
casesAspergillusspp,1,0.0
refresher,1,0.0
untruths,1,0.0
covidvaccine,1,0.0
Discouraged,1,0.0
Encouraged,1,0.0
6579,1,0.0
parody,1,0.0
7107,1,0.0
5789,1,0.0
encumber,1,0.0
SynCon-derived,1,0.0
2019-July,1,0.0
10-4-868,1,0.0
morbillivirus,1,0.0
Enterovirus,1,0.0
15-43,1,0.0
18FFluorodeoxyglucose,1,0.0
rest-,1,0.0
dobutamine-MRI,1,0.0
dobutaminekg,1,0.0
weightmin,1,0.0
3240,1,0.0
2540,1,0.0
coming-of-age,1,0.0
Rollout,1,0.0
Rollouts,1,0.0
23-46,1,0.0
31-46,1,0.0
37-64,1,0.0
occluded-artery,1,0.0
patent-,1,0.0
hemiaxis,1,0.0
005Conclusions,1,0.0
casesPneumocystisand,1,0.0
32Candidaspp,1,0.0
Mycotic,1,0.0
elucidatedObjectives,1,0.0
sphingolipid-associated,1,0.0
multiomic,1,0.0
dataMethods,1,0.0
COPSAC2010,1,0.0
palmitoyl-CoA,1,0.0
cohortMeasurements,1,0.0
sphingomyelins,1,0.0
phosphosphingolipids,1,0.0
sphinganine-1-phosphate,1,0.0
Lopinavirritonavir,1,0.0
Nonischemic,1,0.0
osteoprotective,1,0.0
extra-personal,1,0.0
asthmaeducation,1,0.0
Violence,1,0.0
sufferer,1,0.0
care-prophylactic,1,0.0
283--in,1,0.0
control--439,1,0.0
Summing,1,0.0
conclusionsABSTRACT,1,0.0
functionless,1,0.0
prognosisWith,1,0.0
4--6,1,0.0
0-691,1,0.0
eventspatient-year,1,0.0
006-029,1,0.0
Catharus,1,0.0
2-antiplasmin,1,0.0
LAD-related,1,0.0
mPOCTs,1,0.0
Constrictive,1,0.0
Perimyocardial,1,0.0
effusive-constrictive,1,0.0
flare-prone,1,0.0
anxiety-associated,1,0.0
47-57,1,0.0
15-26,1,0.0
non-TLP-treated,1,0.0
TLP-treated,1,0.0
presuming,1,0.0
control-placebo,1,0.0
Canarias,1,0.0
hyoid,1,0.0
breathers,1,0.0
≈25,1,0.0
Apodemus,1,0.0
chevrieri,1,0.0
Hypsugo,1,0.0
savii,1,0.0
Camelus,1,0.0
bactrianus,1,0.0
Nannospalax,1,0.0
galili,1,0.0
Galilee,1,0.0
Phyllostomus,1,0.0
discolor,1,0.0
dynamic-HRV,1,0.0
GBE,1,0.0
Biloba,1,0.0
BX51WI,1,0.0
ashore,1,0.0
VITT-associated,1,0.0
non-surviving,1,0.0
occlusion-induced,1,0.0
ketonemia,1,0.0
post-filament,1,0.0
flourish,1,0.0
Marrakech,1,0.0
tie,1,0.0
firemen,1,0.0
rescuers,1,0.0
questionnaire-derived,1,0.0
vessel-specific,1,0.0
BX,1,0.0
NCT02534701,1,0.0
collimated,1,0.0
dichroic,1,0.0
atypicals,1,0.0
small-center,1,0.0
Eric,1,0.0
2-arm,1,0.0
Embolus,1,0.0
Interlinked,1,0.0
CagesSOFIA,1,0.0
Microvention,1,0.0
61-77,1,0.0
19-103,1,0.0
2b3,1,0.0
spear-nosed,1,0.0
ustulatus,1,0.0
dose-AM,1,0.0
Swainsons,1,0.0
peroxidase-1,1,0.0
GPx1,1,0.0
A-class,1,0.0
CAPTIM,1,0.0
Wahlgren,1,0.0
frequency-modulated,1,0.0
magnetolaser,1,0.0
Toluene,1,0.0
CFY196,1,0.0
campared,1,0.0
immunesera,1,0.0
BMass66,1,0.0
134401,1,0.0
WorldGroup,1,0.0
or19,1,0.0
81505,1,0.0
10139,1,0.0
DWIPWIMRA,1,0.0
US871,1,0.0
US102,1,0.0
ODTS,1,0.0
Endotoxins,1,0.0
casesThe,1,0.0
2912,1,0.0
2338,1,0.0
rs2430561,1,0.0
rs1024611,1,0.0
AH1N1pdm09-infected,1,0.0
Alea,1,0.0
Pro198Leu,1,0.0
flow-induced,1,0.0
strokes39,1,0.0
206-238,1,0.0
thrush,1,0.0
mucopurulent,1,0.0
extrarespiratory,1,0.0
galliform,1,0.0
anseriform,1,0.0
polypharmacy-related,1,0.0
Leisure,1,0.0
105-242,1,0.0
2411,1,0.0
1993-1998,1,0.0
necrosis-free,1,0.0
nonprobability-based,1,0.0
Novelli,1,0.0
Scattered,1,0.0
1514,1,0.0
Nino,1,0.0
vaccinatum,1,0.0
Family-wide,1,0.0
Long-read,1,0.0
consensus-level,1,0.0
read-count,1,0.0
mother-characterized,1,0.0
individuation-is,1,0.0
CERNTRAL,1,0.0
45843,1,0.0
105-189,1,0.0
statistically-powered,1,0.0
FLENI,1,0.0
7d,1,0.0
antecubital,1,0.0
003-011,1,0.0
wide-angle,1,0.0
peribronchium,1,0.0
portioned,1,0.0
30th--35th,1,0.0
caliberfunction,1,0.0
microRNA-146a,1,0.0
3372,1,0.0
105-177,1,0.0
105-171,1,0.0
19853131027-30,1,0.0
toxin-producing,1,0.0
theorys,1,0.0
Arguing,1,0.0
premodern,1,0.0
vectorborne,1,0.0
aningal,1,0.0
pallor,1,0.0
atlas-based,1,0.0
aslant,1,0.0
Spoken,1,0.0
24-63,1,0.0
Cattells,1,0.0
Self-Analysis,1,0.0
lets,1,0.0
superego,1,0.0
agglomerate,1,0.0
patient-to-provider,1,0.0
Atuire,1,0.0
Atuires,1,0.0
Keisha,1,0.0
anti-IAVs,1,0.0
FoxO1,1,0.0
Poma,1,0.0
Pontoise,1,0.0
103-691,1,0.0
053-148,1,0.0
solids-of-revolution-inspired,1,0.0
Nanofiber,1,0.0
10×,1,0.0
Hard,1,0.0
drilling,1,0.0
cobalt--either,1,0.0
machining,1,0.0
size-limiting,1,0.0
transcutaneously,1,0.0
963-1000,1,0.0
849-992,1,0.0
84305,1,0.0
nest,1,0.0
improvementABSTRACT,1,0.0
under-diagnose,1,0.0
age-SD,1,0.0
322-243,1,0.0
virosome-formulated,1,0.0
Inflexal,1,0.0
Berna,1,0.0
Berne,1,0.0
Tupaia,1,0.0
belangeri,1,0.0
Tupaiidae,1,0.0
microecological,1,0.0
Refeeding,1,0.0
justice-oriented,1,0.0
Rays,1,0.0
scarlatiniform,1,0.0
sicken,1,0.0
suspected-COVID-19,1,0.0
3861,1,0.0
344891,1,0.0
43891,1,0.0
5656,1,0.0
504891,1,0.0
3423,1,0.0
305891,1,0.0
28891,1,0.0
558891,1,0.0
7914-8699,1,0.0
7907-8720,1,0.0
9671,1,0.0
9485-9804,1,0.0
9125,1,0.0
0814,1,0.0
0775-0854,1,0.0
poststudy,1,0.0
Stepped,1,0.0
vital-capacity,1,0.0
Histograms,1,0.0
16263,1,0.0
1836,1,0.0
14427,1,0.0
123-233,1,0.0
113-187,1,0.0
maresins,1,0.0
RIGOR,1,0.0
NIHNINDS,1,0.0
recoup,1,0.0
Corporations,1,0.0
Chiron,1,0.0
IFI27,1,0.0
disable,1,0.0
Showed,1,0.0
bi-annually,1,0.0
highest-yield,1,0.0
logistic-normal,1,0.0
QUADAS,1,0.0
head-to,1,0.0
NCAP,1,0.0
NCAP-specific,1,0.0
IFIT3,1,0.0
OASL,1,0.0
USP18,1,0.0
XAF1,1,0.0
EPSTI1,1,0.0
GSKs,1,0.0
0930,1,0.0
0914,1,0.0
0921,1,0.0
invasion-related,1,0.0
semirigid,1,0.0
transfat,1,0.0
TMW,1,0.0
adductor,1,0.0
polarographic,1,0.0
dog-rose,1,0.0
2005-2012,1,0.0
amending,1,0.0
Tommy,1,0.0
13N,1,0.0
LATEF--left,1,0.0
Rt-PA,1,0.0
37·9,1,0.0
ssRNAs,1,0.0
disequilibrated,1,0.0
anti-TGF-β,1,0.0
cutter,1,0.0
25-di-tert-amyl,1,0.0
dicyclohexylphthalate,1,0.0
mid-1980s,1,0.0
confiding,1,0.0
cooler,1,0.0
fan,1,0.0
Eppendorf®,1,0.0
r053,1,0.0
EIB-positive,1,0.0
EIB-negative,1,0.0
NEAT,1,0.0
Clinico-anamnestic,1,0.0
work--changes,1,0.0
COG-UK,1,0.0
conditions--cervical,1,0.0
hypertension--cause,1,0.0
73442-445,1,0.0
Langmack,1,0.0
Curr,1,0.0
Opin,1,0.0
Pulm,1,0.0
1613-18,1,0.0
Rhabdoviridae,1,0.0
Paramyxoviridae,1,0.0
288ww,1,0.0
40·2,1,0.0
33·0,1,0.0
EA--earlyatrial,1,0.0
2731,1,0.0
non-reversibility,1,0.0
COMPLEX,1,0.0
PATHOGENESIS,1,0.0
eosionophils,1,0.0
DIFFICULT,1,0.0
MANAGEMENT,1,0.0
TC2,1,0.0
Th2-derived,1,0.0
chemoattraction,1,0.0
6-11month,1,0.0
swine-,1,0.0
human-,1,0.0
chorioallantoic,1,0.0
diagnosticians,1,0.0
stroke-registers,1,0.0
Acquaviva-Casamassima,1,0.0
Aeolian,1,0.0
Belluno,1,0.0
LAquila,1,0.0
Trasimeno,1,0.0
74·6,1,0.0
72·3,1,0.0
76·6,1,0.0
67·3-82·6,1,0.0
9·9-19·6,1,0.0
1·6-4·0,1,0.0
1·2-17·7,1,0.0
1751,1,0.0
3601,1,0.0
30ww,1,0.0
abnomalities,1,0.0
Beclabuvir,1,0.0
α-ketoamide,1,0.0
Tumors,1,0.0
Qinghai,1,0.0
EVRFs,1,0.0
RF-IgM-positive,1,0.0
0371,1,0.0
RF-IgM,1,0.0
grinding,1,0.0
US-FDA,1,0.0
juxtaposes,1,0.0
rescheduling,1,0.0
metre,1,0.0
spectacles,1,0.0
optometric,1,0.0
non-work-related,1,0.0
NWRA,1,0.0
non-specificity,1,0.0
Polypharmacy,1,0.0
VALIANT,1,0.0
monthsAlthough,1,0.0
BJohannesburg3358,1,0.0
BSingapore364,1,0.0
varietiesAmong,1,0.0
A2Singapore157,1,0.0
A2England1264,1,0.0
A2USSR,1,0.0
Gor6265,1,0.0
A257,1,0.0
A264,1,0.0
A267Outbreaks,1,0.0
imagess,1,0.0
trueFISP,1,0.0
10℃,1,0.0
normalFive,1,0.0
HIE,1,0.0
GLN,1,0.0
HIS-related,1,0.0
receded,1,0.0
1500000mm3,1,0.0
Hyperaggregability,1,0.0
S100Annexin,1,0.0
1967-1978,1,0.0
levosalbutamol,1,0.0
cinetracheobronchography,1,0.0
expectedly,1,0.0
shockAll,1,0.0
litres,1,0.0
reimplant,1,0.0
108-117,1,0.0
graft-left,1,0.0
stereotactically,1,0.0
microinjection,1,0.0
163000,1,0.0
10-year-period,1,0.0
Creativity,1,0.0
58186,1,0.0
March-December,1,0.0
pandemic-hit,1,0.0
BW16,1,0.0
lag0,1,0.0
lag10,1,0.0
higher-magnitude,1,0.0
DEFINITION,1,0.0
CONTROVERSIAL,1,0.0
measuresclosures,1,0.0
microbiome-based,1,0.0
inertial-MMG,1,0.0
IABS,1,0.0
growth-suppressing,1,0.0
Hypoglycemia,1,0.0
hypoglycemia-induced,1,0.0
swung,1,0.0
tug,1,0.0
SIRT1,1,0.0
genetic-neurodevelopmental,1,0.0
hai,1,0.0
creatinines,1,0.0
333-405,1,0.0
non-delayers,1,0.0
Delayers,1,0.0
wether,1,0.0
millers,1,0.0
1916-1921,1,0.0
wars,1,0.0
or45,1,0.0
VIRGO,1,0.0
3572,1,0.0
Association-defined,1,0.0
≥150,1,0.0
pre-acute,1,0.0
121-155,1,0.0
Non-white,1,0.0
Infancy,1,0.0
cardioversionsdefibrillations,1,0.0
CPRABSTRACT,1,0.0
sub-components,1,0.0
handwrist,1,0.0
sensor-derived,1,0.0
ABangkok79-like,1,0.0
HospitalABSTRACT,1,0.0
80-87,1,0.0
andhemorrhagic,1,0.0
pseudoradial,1,0.0
synkinetic,1,0.0
aspirin-treated,1,0.0
wind-related,1,0.0
well-entrenched,1,0.0
11509,1,0.0
negetive,1,0.0
0764,1,0.0
0585-0998,1,0.0
ethnic-cultural,1,0.0
rhinopharingeal,1,0.0
MMG,1,0.0
malagasy,1,0.0
Enfants,1,0.0
embryonned,1,0.0
repartition,1,0.0
polyintricated,1,0.0
cell-degranulation,1,0.0
chromoglycat--DSCG,1,0.0
season--asthmatics,1,0.0
treatment--or,1,0.0
season--some,1,0.0
2019483e103-e109,1,0.0
Provides,1,0.0
mechanomyography,1,0.0
RNA-segments,1,0.0
Allergistsimmunologists,1,0.0
department--to,1,0.0
NF-kbeta,1,0.0
Resnet-50,1,0.0
VGG1,1,0.0
Dodecafluoropentane,1,0.0
Injections,1,0.0
05-1-h,1,0.0
Stained,1,0.0
5030,1,0.0
course--variant,1,0.0
fruste,1,0.0
4723,1,0.0
ingestant,1,0.0
Rowes,1,0.0
beef,1,0.0
soy-cake,1,0.0
sauce,1,0.0
spinach,1,0.0
carrot,1,0.0
reinstituted,1,0.0
chlortrimeton,1,0.0
≥28,1,0.0
developmentfunction,1,0.0
RBD-induced,1,0.0
August-17,1,0.0
Plam,1,0.0
Olympics-a,1,0.0
052-065,1,0.0
pre-Olympic,1,0.0
115-152,1,0.0
plans--one,1,0.0
AlexNet,1,0.0
LetNet-5,1,0.0
preventives,1,0.0
9614,1,0.0
HSEEP,1,0.0
ReportImprovement,1,0.0
AARIP,1,0.0
evacuators,1,0.0
sack,1,0.0
puntorifice,1,0.0
unseemly,1,0.0
Incorporation,1,0.0
PNs,1,0.0
killip,1,0.0
LVEFABSTRACT,1,0.0
-C,1,0.0
9591,1,0.0
KWPWYIWLGF1211-1220,1,0.0
37-90,1,0.0
14-epitope,1,0.0
8960,1,0.0
Stroma,1,0.0
Fibrinoid,1,0.0
interstice,1,0.0
anti-asthmatics,1,0.0
appendices,1,0.0
icelandic,1,0.0
Rescuing,1,0.0
hypoxy,1,0.0
peripheral-type,1,0.0
symptom-inducing,1,0.0
Lesion-NWU,1,0.0
neurocognition,1,0.0
steepest,1,0.0
indicatedABSTRACT,1,0.0
Durango,1,0.0
psychotypes,1,0.0
cycloidal,1,0.0
hysteroid,1,0.0
Hysteroid,1,0.0
psychotype,1,0.0
schizoid,1,0.0
ontologies,1,0.0
airway-wall,1,0.0
angioblastic,1,0.0
beta-1a,1,0.0
testing-phase,1,0.0
57927,1,0.0
Intervals,1,0.0
personals,1,0.0
vehicle-mounted,1,0.0
records-based,1,0.0
bed-disabling,1,0.0
influenza-vaccines,1,0.0
virus-vaccines,1,0.0
F1-Score,1,0.0
0883,1,0.0
cross-links,1,0.0
TH2-like,1,0.0
diapedesis,1,0.0
degranulate,1,0.0
asphyxiated,1,0.0
factions,1,0.0
self-sufficient,1,0.0
Tepehuanos,1,0.0
psychotypological,1,0.0
astenia,1,0.0
1977-1986,1,0.0
electrocardiology,1,0.0
Laboratory-Based,1,0.0
1998-2005,1,0.0
46000,1,0.0
product-limit,1,0.0
011-091,1,0.0
029-177,1,0.0
11806,1,0.0
12381,1,0.0
Mantel-Haenszel-Peto,1,0.0
082-126,1,0.0
G-protein-linked,1,0.0
PKG,1,0.0
full-,1,0.0
rapidly-spreading,1,0.0
lipophilicity,1,0.0
trickling,1,0.0
federally-mandated,1,0.0
Slow-progressive,1,0.0
primary-Influenza,1,0.0
Nonrespiratory,1,0.0
NSH,1,0.0
2000-person,1,0.0
nutriceutical,1,0.0
AVED,1,0.0
AVED1,1,0.0
AVED09,1,0.0
treatment-only,1,0.0
AVED06,1,0.0
Mestizos,1,0.0
LVEFRVEF,1,0.0
RAF-NOACs,1,0.0
Inferoseptal,1,0.0
mycomutacapitis,1,0.0
myco-root-black,1,0.0
artemisia,1,0.0
pollemo,1,0.0
allium,1,0.0
8470,1,0.0
dermotaphagoides,1,0.0
Contrasting,1,0.0
Lariboisière,1,0.0
Bicêtre,1,0.0
VKA-related,1,0.0
Nicardipine,1,0.0
LB-46,1,0.0
exhausting,1,0.0
Follow-up1,1,0.0
±1,1,0.0
Follow-up2,1,0.0
teleconference,1,0.0
Kostis,1,0.0
Jersey-Robert,1,0.0
Philip,1,0.0
Gorelick,1,0.0
Franz,1,0.0
Messerli,1,0.0
Lukes-Roosevelt,1,0.0
group--30,1,0.0
group--14,1,0.0
DT-E--wave,1,0.0
IVRT--isovolumic,1,0.0
Practicing,1,0.0
universitiescolleges,1,0.0
145-192,1,0.0
NEO,1,0.0
MIS-Cpediatric,1,0.0
mammalian-adaptive,1,0.0
1-20,1,0.0
CK-gram,1,0.0
4080,1,0.0
re-perfusion,1,0.0
interventionin,1,0.0
oxidated,1,0.0
hyperinsulinaemia,1,0.0
43-52,1,0.0
eco-planar,1,0.0
underwater,1,0.0
emotion-,1,0.0
PI-R,1,0.0
Monte-Carlo,1,0.0
conscientiousness,1,0.0
Nano,1,0.0
882069-2077,1,0.0
underdetected,1,0.0
ORION,1,0.0
Anti-leukotrienes,1,0.0
bisulfate,1,0.0
Rehabilitational,1,0.0
1500-2500,1,0.0
Disorders-3rd,1,0.0
A145,1,0.0
auras,1,0.0
Markov-chain,1,0.0
13-39,1,0.0
RAF,1,0.0
thirty-five,1,0.0
closed-ended,1,0.0
antibodies1,1,0.0
COV1001,1,0.0
I-IIa,1,0.0
trial2,1,0.0
29-fold,1,0.0
nsp7,1,0.0
deployments,1,0.0
nonglucocorticoid,1,0.0
antagonising,1,0.0
G-CSFR,1,0.0
sCD93,1,0.0
gluconate,1,0.0
Chlorhexidine,1,0.0
astonished,1,0.0
8700,1,0.0
3242,1,0.0
81000,1,0.0
Spillover,1,0.0
bush-trafficking,1,0.0
inter-human,1,0.0
Hardy,1,0.0
Confronting,1,0.0
pandemic—Workshop,1,0.0
27–29,1,0.0
438–442,1,0.0
Habitual,1,0.0
7·5,1,0.0
nw,1,0.0
guideline-defined,1,0.0
vaccine1-3,1,0.0
Radiocardiography,1,0.0
Madras,1,0.0
2006-May,1,0.0
nonill,1,0.0
Arteriogenesis,1,0.0
pro-angiogenic,1,0.0
10μm,1,0.0
OCT-guidance,1,0.0
hallucination,1,0.0
Pre-symptomatic,1,0.0
Nonuniform,1,0.0
noduliform,1,0.0
Stuckelberger,1,0.0
non-hospital-based,1,0.0
Investment,1,0.0
sputum-positive,1,0.0
SurveyMonkey,1,0.0
daysWe,1,0.0
Cross-tabulation,1,0.0
149-348,1,0.0
232-461,1,0.0
non-exercised,1,0.0
hyp-oxaemia,1,0.0
brain-lung,1,0.0
volume-time,1,0.0
cardiometric,1,0.0
diastasis,1,0.0
phase--left,1,0.0
enlightens,1,0.0
CCUIs,1,0.0
electroshock,1,0.0
aiim,1,0.0
satified,1,0.0
Bridging,1,0.0
pdm09-like,1,0.0
baseline§,1,0.0
regions¶,1,0.0
threshold††,1,0.0
activity§§,1,0.0
Globo,1,0.0
2012005,1,0.0
p28,1,0.0
enlightening,1,0.0
Marilda,1,0.0
Mendonça,1,0.0
Siqueira,1,0.0
15-bed,1,0.0
SRU,1,0.0
Givens,1,0.0
Lapé-Nixon,1,0.0
Clarke,1,0.0
58e01742-20,1,0.0
httpsdoiorg101128JCM01742-20,1,0.0
1991-1994,1,0.0
nonexpert,1,0.0
PC-related,1,0.0
nanoengineered,1,0.0
nano-gold-containing,1,0.0
collagen-based,1,0.0
nonintentional,1,0.0
hydrocarbon,1,0.0
foiecasting,1,0.0
2037,1,0.0
Genitourinary,1,0.0
illness†,1,0.0
NPC1-inhibiting,1,0.0
Niemann-Pick,1,0.0
Wedge-shaped,1,0.0
ATexas502012,1,0.0
BMassachusetts22012-like,1,0.0
endotypic,1,0.0
industrialoccupational,1,0.0
waterwastewater,1,0.0
12392,1,0.0
11243,1,0.0
12254,1,0.0
nonprocedure-related,1,0.0
noncryptogenic,1,0.0
p00003,1,0.0
periodABSTRACT,1,0.0
intraaxial,1,0.0
10-47,1,0.0
endo-lysosomal,1,0.0
Travel-related,1,0.0
Domestically,1,0.0
provinence,1,0.0
prevelant,1,0.0
Spike-receptor,1,0.0
httpswwwwhointhealth-topicscoronaviruslaboratory-diagnostics-for-novel-coronavirus,1,0.0
Dismissal,1,0.0
SDMS,1,0.0
inter-organizational,1,0.0
Mindray,1,0.0
00373,1,0.0
1-protease,1,0.0
EBOV,1,0.0
57-664,1,0.0
19-19,1,0.0
neurotonia,1,0.0
1-716,1,0.0
dateObjectives,1,0.0
137Measurements,1,0.0
40Conclusions,1,0.0
angio-MRI,1,0.0
stroke-burden,1,0.0
Angiopathy,1,0.0
afresh,1,0.0
die-offs,1,0.0
1Bordetellapertussisand,1,0.0
2Bordetella,1,0.0
pertussisoften,1,0.0
colonizes,1,0.0
pertussis-vaccinated,1,0.0
pertussis-based,1,0.0
pertussisand,1,0.0
allergicsensitization,1,0.0
nasopharyngealBordetella,1,0.0
pertussiscolonizing,1,0.0
subclinicalBordetella,1,0.0
pertussiscolonization,1,0.0
110-178,1,0.0
108-193,1,0.0
Ras-association,1,0.0
miR-125bRASSF1,1,0.0
virus-positivity,1,0.0
Myasnikov,1,0.0
bench-to-field,1,0.0
agriculturally,1,0.0
technique-focused,1,0.0
technique-derived,1,0.0
preimmunization,1,0.0
pro-fracture-healing,1,0.0
hemagglutinating-inhibiting,1,0.0
II0,1,0.0
III0,1,0.0
elbowed,1,0.0
youll,1,0.0
352357,1,0.0
162162,1,0.0
190195,1,0.0
4571,1,0.0
non-natives,1,0.0
obtainment,1,0.0
source-verified,1,0.0
basics-adherence,1,0.0
smoking-and,1,0.0
Todo,1,0.0
Corazón,1,0.0
Mexicano,1,0.0
Seguro,1,0.0
AsiaWorld-Expo,1,0.0
flight-associated,1,0.0
sprouted,1,0.0
Anti-vaccine,1,0.0
stern,1,0.0
Pociask,1,0.0
foodbeverage,1,0.0
backfill,1,0.0
quad,1,0.0
ESR-spectroscopy,1,0.0
14-19,1,0.0
05-ml,1,0.0
ionizationmass,1,0.0
plusmn,1,0.0
4144,1,0.0
4041,1,0.0
Ex-GF,1,0.0
microgliamacrophage,1,0.0
lymphocyte-deficient,1,0.0
lymphocyte-driven,1,0.0
contact-tracking,1,0.0
information-theoretic,1,0.0
behaviour-influenza,1,0.0
behaviour-disease,1,0.0
nationalregional,1,0.0
air-handling,1,0.0
20-November,1,0.0
21449,1,0.0
012--mean,1,0.0
infarct-sizing,1,0.0
unsedated,1,0.0
Tc-PP,1,0.0
Gastrostomy,1,0.0
studies-both,1,0.0
barium,1,0.0
Flanders,1,0.0
Dutch-speaking,1,0.0
AD-MSCs,1,0.0
sGeff,1,0.0
sWOB,1,0.0
experimentally-determined,1,0.0
19-56,1,0.0
closed-network,1,0.0
nonhypolipidemic,1,0.0
cononary,1,0.0
recolonized,1,0.0
germfree,1,0.0
Microbiome,1,0.0
122019,1,0.0
pan-coronary,1,0.0
Watertown,1,0.0
bench-marked,1,0.0
£251QALY,1,0.0
practitionners,1,0.0
14-14,1,0.0
173-584,1,0.0
28-27,1,0.0
4-polyanion,1,0.0
high-tension,1,0.0
hemodialyses,1,0.0
201TlCl,1,0.0
012014,1,0.0
two-to,1,0.0
Hemisphere-Argentina,1,0.0
progestogens,1,0.0
Desogestrel,1,0.0
Gestodene,1,0.0
Excessively,1,0.0
oxidantsantioxidants,1,0.0
jolted,1,0.0
chasing,1,0.0
magical,1,0.0
psycho-behavioral,1,0.0
Worrying,1,0.0
chlopidogrel,1,0.0
GPIIb-IIIa,1,0.0
haste,1,0.0
1991-1997,1,0.0
236623,1,0.0
530000-inhabitant,1,0.0
2012-November,1,0.0
biospecimen,1,0.0
metabolomics-based,1,0.0
1774,1,0.0
Moderately-Severe,1,0.0
infectionTwo,1,0.0
anti-spike-receptor,1,0.0
demographicsclinical,1,0.0
Anti-S-RBD,1,0.0
Anti-NCP,1,0.0
patientsn7,1,0.0
eotaxin-1,1,0.0
Terpenes,1,0.0
Supraventricular,1,0.0
focus-driven,1,0.0
foreshadows,1,0.0
Rehab-Compass,1,0.0
positive-result,1,0.0
annuallyResearch,1,0.0
influenzaResults,1,0.0
-406,1,0.0
Fluad®Conclusions,1,0.0
random-sampling,1,0.0
4010,1,0.0
bug,1,0.0
Amyloidosis,1,0.0
AbstractAIMS,1,0.0
CAESAR,1,0.0
n503,1,0.0
n382,1,0.0
georeferenced,1,0.0
shameli,1,0.0
malayanus,1,0.0
hyperventilate,1,0.0
Powered,1,0.0
non-universitary,1,0.0
alsacians,1,0.0
Self-Care,1,0.0
air–filtered,1,0.0
Hexapod,1,0.0
influenza-activity,1,0.0
antigenetic,1,0.0
7-26,1,0.0
113106,1,0.0
changesABSTRACT,1,0.0
CONCEPT,1,0.0
PLACE,1,0.0
Persuasion,1,0.0
acuminatus,1,0.0
well-crafted,1,0.0
1976-95,1,0.0
0-4-year,1,0.0
10-14-year,1,0.0
75-fold,1,0.0
Julien,1,0.0
Bogousslavsky,1,0.0
Bogousslavskys,1,0.0
disengagement,1,0.0
rumination,1,0.0
ACT™Childhood,1,0.0
CACT™,1,0.0
Haifa,1,0.0
nitroglycerin-treated,1,0.0
Managua,1,0.0
MN50,1,0.0
127-190,1,0.0
holograms,1,0.0
epi-phenomenon,1,0.0
Pancreatic,1,0.0
endoscopist,1,0.0
22462,1,0.0
10739,1,0.0
multidetector-row,1,0.0
coinhibitory,1,0.0
cell-defining,1,0.0
pre-Tfh,1,0.0
active-duty,1,0.0
mechanized,1,0.0
infantry,1,0.0
limited-resource,1,0.0
calculous,1,0.0
echoCG,1,0.0
tredmill,1,0.0
gall-bladder,1,0.0
biliferous,1,0.0
Chris,1,0.0
Alderman,1,0.0
editor-in-chief,1,0.0
grips,1,0.0
Val308,1,0.0
Gly548,1,0.0
Gln830,1,0.0
Glu843,1,0.0
renatured,1,0.0
Blotting,1,0.0
shearing,1,0.0
field-portable,1,0.0
drugsherbsvaccines,1,0.0
ANJ76,1,0.0
16-84,1,0.0
pH1N1-confirmed,1,0.0
5·9,1,0.0
2·7-9·1,1,0.0
ratio0,1,0.0
2·8,1,0.0
2·1-3·4,1,0.0
AH1H1,1,0.0
0685,1,0.0
S-spike,1,0.0
intruding,1,0.0
hale,1,0.0
hearty,1,0.0
counter-clockwise,1,0.0
beauty,1,0.0
HEALTH-RELATED,1,0.0
QUALITY,1,0.0
ADOLESCENTS,1,0.0
CHILDREN,1,0.0
initially-raised,1,0.0
Hotel,1,0.0
hotel-associated,1,0.0
guanylate-binding,1,0.0
hGBP1-mediated,1,0.0
wings,1,0.0
chemicalherbal,1,0.0
subjectspatients,1,0.0
Orodispersible,1,0.0
MicroRNA-4485,1,0.0
anti-osteoporosis,1,0.0
19-12,1,0.0
143-429,1,0.0
Rosa,1,0.0
p023,1,0.0
DECT,1,0.0
DECT-derived,1,0.0
texture-derived,1,0.0
derangementNEW,1,0.0
pseudo-allergic,1,0.0
psychogenic-induced,1,0.0
bronchopulmonal,1,0.0
use-related,1,0.0
parentscarers,1,0.0
Leriche,1,0.0
transulnar,1,0.0
Sojourns,1,0.0
Noncompaction,1,0.0
Garenne,1,0.0
565-581,1,0.0
1918post-1918,1,0.0
microdata,1,0.0
Garennes,1,0.0
age-overlap,1,0.0
Crowds,1,0.0
asthma-COPD-overlap,1,0.0
P0540,1,0.0
Work-relatedness,1,0.0
sagging,1,0.0
echocardiagraphy,1,0.0
electrocordiography,1,0.0
multispeciality,1,0.0
GuardWire,1,0.0
256-25,1,0.0
low-temperature,1,0.0
1999–2000,1,0.0
epidemics--pandemics,1,0.0
600mm3,1,0.0
premortally,1,0.0
2039,1,0.0
564630,1,0.0
193225,1,0.0
7615,1,0.0
Baddeley,1,0.0
Hitchs,1,0.0
3125,1,0.0
3870,1,0.0
1563,1,0.0
2509,1,0.0
nonsubspecialists,1,0.0
lysosome-dependent,1,0.0
5mgday,1,0.0
heterocycles,1,0.0
pharmaceutically,1,0.0
Aggravating,1,0.0
Serotonergic,1,0.0
effectuate,1,0.0
272-nm,1,0.0
UKFIMFAM,1,0.0
Approximation,1,0.0
Tucker,1,0.0
09220907,1,0.0
-68,1,0.0
FIMFAM,1,0.0
AH7N1,1,0.0
superstructure,1,0.0
case-histories,1,0.0
drug-dependent,1,0.0
reemphasizes,1,0.0
chlorofluorocarbon-free,1,0.0
hormonotherapy,1,0.0
Nogo-c,1,0.0
hypoxia-,1,0.0
Nogo-C-mediated,1,0.0
indigestion,1,0.0
00118,1,0.0
re-view,1,0.0
AH1N1virus,1,0.0
transtentorial,1,0.0
transforaminal,1,0.0
NOAK,1,0.0
Tc-sestamibi,1,0.0
1096,1,0.0
119-140,1,0.0
110-142,1,0.0
resource-challenged,1,0.0
backing,1,0.0
NCLS,1,0.0
post-trial,1,0.0
Phase-3,1,0.0
Argentinos,1,0.0
Pediatría,1,0.0
in12,1,0.0
Limulusamoebocyte,1,0.0
2697,1,0.0
162690,1,0.0
ngg,1,0.0
Valdecilla,1,0.0
Delivering,1,0.0
bronchodilator-responsive,1,0.0
C-ACTchildren,1,0.0
apoptosis-inducing,1,0.0
Huashi,1,0.0
ginger,1,0.0
lemon,1,0.0
neem,1,0.0
basil,1,0.0
italiano,1,0.0
Sopravvlvenza,1,0.0
nell,1,0.0
infarcto,1,0.0
mega-trials,1,0.0
Trandopril,1,0.0
ore,1,0.0
factor-related,1,0.0
public-good,1,0.0
tessellation,1,0.0
unstainable,1,0.0
SARS-CoV2-infected,1,0.0
hybridise,1,0.0
aerosolsThe,1,0.0
managementIt,1,0.0
motor-,1,0.0
cognition-related,1,0.0
chickenpox,1,0.0
GJIC,1,0.0
ZP123,1,0.0
Rotigaptide,1,0.0
nmolL,1,0.0
Thiessens,1,0.0
c-kit-positive,1,0.0
self-regenerative,1,0.0
tissue-engineered,1,0.0
223-1018,1,0.0
April-,1,0.0
18423,1,0.0
posses,1,0.0
tetrad,1,0.0
P-Ta,1,0.0
risk-versus-benefit,1,0.0
flyways,1,0.0
poultry-exposed,1,0.0
H16,1,0.0
beta-adrenoreactivity,1,0.0
DAP,1,0.0
Oxalotransaminase,1,0.0
histopathalogical,1,0.0
isoprenalin,1,0.0
asplenic,1,0.0
hyposplenic,1,0.0
94-year-old,1,0.0
≤-025,1,0.0
contenders,1,0.0
Vaccination-associated,1,0.0
information-dates,1,0.0
vaccine-should,1,0.0
diseasesMethods,1,0.0
scatterplot,1,0.0
751-795,1,0.0
120-293,1,0.0
172-432,1,0.0
113-551,1,0.0
103-216,1,0.0
Mesoexpiratory,1,0.0
pneumopathogens,1,0.0
629During,1,0.0
anterioseptal,1,0.0
whip-like,1,0.0
cracks,1,0.0
crack,1,0.0
Crack,1,0.0
Responde,1,0.0
microalgae,1,0.0
high-value,1,0.0
eigenspace,1,0.0
subbands,1,0.0
hypercute,1,0.0
SVMs,1,0.0
Datasets,1,0.0
anteriolateral,1,0.0
inferioposterio-lateral,1,0.0
epiweek,1,0.0
9958,1,0.0
ballism,1,0.0
athetosis,1,0.0
akathisia,1,0.0
AQUISITION,1,0.0
DEVELOPMENT,1,0.0
infl,1,0.0
uencing,1,0.0
KEYWORDS,1,0.0
time-step,1,0.0
ferriferrocyanide,1,0.0
FeCN63-4-,1,0.0
analysis1059,1,0.0
101-110,1,0.0
828-2980Conclusions,1,0.0
Oscillometry,1,0.0
dizzying,1,0.0
attenuations,1,0.0
liquidated,1,0.0
paO2,1,0.0
pa-vO2,1,0.0
penetrability,1,0.0
tamibarotene,1,0.0
Fc-modified,1,0.0
TVvideo,1,0.0
oralis,1,0.0
vestibules,1,0.0
Well-known,1,0.0
coactivation,1,0.0
Tsuchiura,1,0.0
Ibaraki,1,0.0
2607,1,0.0
rapid-test-confirmed,1,0.0
8-66,1,0.0
Exposome,1,0.0
exposomic,1,0.0
fungus-induced,1,0.0
intraepithelial,1,0.0
Bystander,1,0.0
H2N1,1,0.0
H2N3,1,0.0
Palpitations,1,0.0
differABSTRACT,1,0.0
P353,1,0.0
information--such,1,0.0
Flaws,1,0.0
G1P0,1,0.0
Mundialde,1,0.0
Organización,1,0.0
enfermedadque,1,0.0
pivoted,1,0.0
decidua,1,0.0
TBCA,1,0.0
conservative--early,1,0.0
active--TBCA,1,0.0
Cerebral-vascular,1,0.0
crescendo-decrescendo,1,0.0
Cheyne,1,0.0
Stokes,1,0.0
tipo,1,0.0
SARS-CoV-2del,1,0.0
síndrome,1,0.0
respiratorio,1,0.0
coronavirus2019,1,0.0
parte,1,0.0
fueron,1,0.0
descritos,1,0.0
primera,1,0.0
vezen,1,0.0
ciudad,1,0.0
Diciembre,1,0.0
de2019,1,0.0
Marzo,1,0.0
dispersión,1,0.0
mundialde,1,0.0
patógeno,1,0.0
condujo,1,0.0
declaraciónde,1,0.0
5-hydroxytryptaminergic,1,0.0
tantalizing,1,0.0
74-90,1,0.0
2432020,1,0.0
hyposplenism,1,0.0
Elaborate,1,0.0
Oldenberg,1,0.0
2084,1,0.0
boy-girl,1,0.0
1121000,1,0.0
1081000,1,0.0
721000,1,0.0
651000,1,0.0
alpha-maximin,1,0.0
weekend-extension,1,0.0
CNBG,1,0.0
sage,1,0.0
Sciencedirect,1,0.0
Scifinder,1,0.0
3190,1,0.0
3363,1,0.0
non-managerial,1,0.0
embarrassed,1,0.0
enalaprilat,1,0.0
elevationdepression,1,0.0
depolarize,1,0.0
circumnavigate,1,0.0
45-70,1,0.0
MedLine,1,0.0
1424,1,0.0
convulsive-like,1,0.0
fasciculation-like,1,0.0
jerky,1,0.0
demonstratedthat,1,0.0
non-extrafine,1,0.0
Gaz,1,0.0
disease-causes,1,0.0
changesthat,1,0.0
Reevaluation,1,0.0
ABSTARCT,1,0.0
person-,1,0.0
self-defence,1,0.0
theory-guided,1,0.0
1858-1919,1,0.0
assertions,1,0.0
worldview,1,0.0
bedrock,1,0.0
orthopedics,1,0.0
99mlday,1,0.0
territory-wide,1,0.0
Wuhan-Hu-1-related,1,0.0
countriesIMPORTANCE,1,0.0
stay-at-homeshelter-in-placeself-restraintlockdown,1,0.0
accomodation,1,0.0
November--April,1,0.0
bed-room,1,0.0
preceede,1,0.0
Belyakov,1,0.0
4147,1,0.0
e-mails,1,0.0
Hawalli,1,0.0
Al-Farwaniyah,1,0.0
Al-Jahra,1,0.0
doctor-recommended,1,0.0
authoritieshealthcare,1,0.0
pathogen-content,1,0.0
decerebrate,1,0.0
medias,1,0.0
banned,1,0.0
aconfirmed,1,0.0
arginines,1,0.0
neurovegetative,1,0.0
hyperbronchial,1,0.0
Daira,1,0.0
Chéraga,1,0.0
pleads,1,0.0
DMC,1,0.0
DSMB,1,0.0
Cortexin,1,0.0
StrongStep®SARS-CoV-2,1,0.0
IgMIgAIgG,1,0.0
monotest,1,0.0
0766,1,0.0
0706,1,0.0
KAB,1,0.0
2478,1,0.0
Enabling,1,0.0
R01,1,0.0
100-108,1,0.0
132-148,1,0.0
R-RQT,1,0.0
QTR-R,1,0.0
-04,1,0.0
ocurring,1,0.0
diming,1,0.0
RVP-PCR,1,0.0
sociologic,1,0.0
2021111101780-1783,1,0.0
httpsdoiorg102105AJPH2021306444,1,0.0
Acidosis,1,0.0
Lactic,1,0.0
self-similar,1,0.0
1972-1974,1,0.0
acommon,1,0.0
AMI-associated,1,0.0
interferon-γinterleukin-4,1,0.0
effificacy,1,0.0
allergen-specifific,1,0.0
inflflammatory,1,0.0
infifiltration,1,0.0
herbderived,1,0.0
anti-inflflammatory,1,0.0
33-66,1,0.0
stressogenic,1,0.0
61-item,1,0.0
Kaunas-Rotterdam,1,0.0
mortality-related,1,0.0
1525±0105,1,0.0
anticontamination,1,0.0
TCCSG,1,0.0
MSEC,1,0.0
policy-setting,1,0.0
Mississippis,1,0.0
2768,1,0.0
2013reported,1,0.0
susceptible-exposed-infectiousasymptomatic-removed,1,0.0
self-similarities,1,0.0
FDs,1,0.0
NIHss,1,0.0
Highuchi,1,0.0
1447±0092,1,0.0
19-68,1,0.0
deprive,1,0.0
re-,1,0.0
117-236,1,0.0
AppleWatch,1,0.0
province-wide,1,0.0
1578,1,0.0
5941100000,1,0.0
erupted,1,0.0
Unchecked,1,0.0
ketoprofen,1,0.0
Paraben,1,0.0
paraben,1,0.0
Arachidonic,1,0.0
aspirinABSTRACT,1,0.0
SEIADR,1,0.0
susceptible-exposed-infected-asymptomatic-documented-recovered,1,0.0
11123,1,0.0
08911,1,0.0
35736,1,0.0
20126,1,0.0
30672,1,0.0
Placentas,1,0.0
ErasmusMC,1,0.0
Fostering,1,0.0
myringotomy,1,0.0
Kilip,1,0.0
084-222,1,0.0
imagingDWIand,1,0.0
recoveryFLAIRmismatch,1,0.0
Angiojet,1,0.0
AngioJET,1,0.0
STENTing,1,0.0
taskforces,1,0.0
3752,1,0.0
intra-arterialmechanical,1,0.0
44-106,1,0.0
spinous,1,0.0
respi-,1,0.0
vestigate,1,0.0
PF4CXLC4,1,0.0
mim-,1,0.0
AKorea0109,1,0.0
cell-binding,1,0.0
1483,1,0.0
person-year,1,0.0
time-stamped,1,0.0
antacid,1,0.0
12-May,1,0.0
70-83,1,0.0
122-317,1,0.0
GINAGlobal,1,0.0
Respone,1,0.0
567-trihydroxyflavone,1,0.0
Baicalein,1,0.0
285-064,1,0.0
215-012,1,0.0
137-020,1,0.0
MSECT,1,0.0
G452RV3,1,0.0
B16173,1,0.0
P681R,1,0.0
RBD-EP,1,0.0
depressiveneurotic,1,0.0
Inititative,1,0.0
JETSTENT,1,0.0
230-682,1,0.0
automate,1,0.0
101-179,1,0.0
recoded,1,0.0
Attenuated,1,0.0
-137,1,0.0
semiurban,1,0.0
-762,1,0.0
taka,1,0.0
-219,1,0.0
Thoraco-myoplasty,1,0.0
bone-structure,1,0.0
CMO,1,0.0
post-morbid,1,0.0
butcher,1,0.0
uncooked,1,0.0
abattoir,1,0.0
ham,1,0.0
bacon,1,0.0
normalise,1,0.0
POCRT,1,0.0
Specialties,1,0.0
platelet-factor,1,0.0
FcRγIIA,1,0.0
pre-exposed,1,0.0
SARS-CoV-2-proteins,1,0.0
23848,1,0.0
Biplane,1,0.0
repellent,1,0.0
formaldehyde-preserved,1,0.0
cisterna,1,0.0
chyli,1,0.0
manouvre,1,0.0
Rref,1,0.0
Nsp13C541,1,0.0
14-18th,1,0.0
≈6,1,0.0
Stohr,1,0.0
Influenza-WHO,1,0.0
200229517,1,0.0
wetland,1,0.0
fielded,1,0.0
thimerosal-free,1,0.0
results--an,1,0.0
002--a,1,0.0
In-utero,1,0.0
passive-smoking,1,0.0
treatment-outcomes,1,0.0
shockABSTRACT,1,0.0
t-Student,1,0.0
Nsp13L504,1,0.0
150-407,1,0.0
holiday-related,1,0.0
≈12-13,1,0.0
≈20-30,1,0.0
Nsp2,1,0.0
SNAP2,1,0.0
S194L,1,0.0
S202N,1,0.0
Nsp12L314,1,0.0
Nsp13P504,1,0.0
Nsp13Y541,1,0.0
SpikeG614,1,0.0
Nsp12P314,1,0.0
followingcoronary,1,0.0
includeRescue,1,0.0
opt-in,1,0.0
Posterolateral,1,0.0
dysarthric,1,0.0
syptoms,1,0.0
suspition,1,0.0
Stanford-A,1,0.0
April-November,1,0.0
167754,1,0.0
bed-days,1,0.0
H1N1sw-positive,1,0.0
psycho-traumatic,1,0.0
ulcerous,1,0.0
psihosomatic,1,0.0
Socio,1,0.0
28213,1,0.0
£7035,1,0.0
£14371,1,0.0
9484,1,0.0
£6103,1,0.0
£5817,1,0.0
4945-6689,1,0.0
Belokurikha,1,0.0
bioadaptive,1,0.0
resourse,1,0.0
1550000,1,0.0
EndoU,1,0.0
dihydroxyphenyl,1,0.0
likeliness,1,0.0
4152,1,0.0
31892,1,0.0
ward-based,1,0.0
right-gaze-deviation,1,0.0
addmitted,1,0.0
hungarian,1,0.0
73-year-old-man,1,0.0
Post-PTCA,1,0.0
predictiveABSTRACT,1,0.0
225-525,1,0.0
cross-institutional,1,0.0
Anabolic-androgenic,1,0.0
bodybuilder,1,0.0
33-76,1,0.0
Heterogenous,1,0.0
brightest,1,0.0
myocardialskeletal,1,0.0
Scanwell,1,0.0
smart-phone,1,0.0
fascinate,1,0.0
quadrigeminy,1,0.0
sypmtos,1,0.0
Exercise-redistribution,1,0.0
list-mode,1,0.0
postsinus,1,0.0
Tertile,1,0.0
Inhospital,1,0.0
HEMS,1,0.0
Community-level,1,0.0
school-level,1,0.0
Hop,1,0.0
Acid-induced,1,0.0
capsaicin-sensitive,1,0.0
Protons,1,0.0
conjunctivae,1,0.0
Herniated,1,0.0
pulmonary-related,1,0.0
Monoacetylcurcumin,1,0.0
Microglia,1,0.0
bpy32,1,0.0
tetrahedral,1,0.0
DT-based,1,0.0
EEA,1,0.0
Pharmacovigilance,1,0.0
Justine,1,0.0
channelled,1,0.0
harbingers,1,0.0
agesex,1,0.0
vegetablefish,1,0.0
polyunsaturatedsaturated,1,0.0
-166,1,0.0
BABSTRACT,1,0.0
2927,1,0.0
AFOP,1,0.0
NHBECs,1,0.0
RVPs,1,0.0
cobas68008800,1,0.0
Protein-carbohydrate,1,0.0
carbohydrate-based,1,0.0
Scaffold,1,0.0
glycodrugs,1,0.0
Hartzler,1,0.0
7E3,1,0.0
angiopeptin,1,0.0
phasing,1,0.0
5785,1,0.0
adviser,1,0.0
Electricité,1,0.0
Ru,1,0.0
DNA-participated,1,0.0
Dependable,1,0.0
high-power,1,0.0
adipose-tissue-derived,1,0.0
ADMSCs,1,0.0
recovery-permissive,1,0.0
NAT1,1,0.0
coupons,1,0.0
40°N,1,0.0
nonporous,1,0.0
non-circadian,1,0.0
diffuser,1,0.0
5321,1,0.0
fluorescent-labeled,1,0.0
Cardiogenesis,1,0.0
explant,1,0.0
unilamellar,1,0.0
species-to,1,0.0
SAG,1,0.0
G26,1,0.0
intra-province,1,0.0
province-specific,1,0.0
constant-pH,1,0.0
metadynamics,1,0.0
glycosyl-enzyme,1,0.0
Asp151,1,0.0
NEAC,1,0.0
acetaldehyde-produced,1,0.0
government-recommended,1,0.0
indirecly,1,0.0
Hughes,1,0.0
enone,1,0.0
bio-activities,1,0.0
Rewards,1,0.0
0·84,1,0.0
lamin,1,0.0
lamins,1,0.0
473958,1,0.0
Biobank,1,0.0
14877,1,0.0
739-fold,1,0.0
213-fold,1,0.0
Late-life,1,0.0
disorders-especially,1,0.0
life-when,1,0.0
detractors,1,0.0
Norn,1,0.0
periacute,1,0.0
uninhibited,1,0.0
virus-targeting,1,0.0
Pitfalls,1,0.0
primary-secondary,1,0.0
Kyungpook,1,0.0
Chilgok,1,0.0
benzodiazepine-triggered,1,0.0
electrocoagulation,1,0.0
therapeuticsThe,1,0.0
implicationsIn,1,0.0
outpaces,1,0.0
abiding,1,0.0
CHIs,1,0.0
alternative-standard,1,0.0
exercise-reinjection,1,0.0
0826,1,0.0
prelamin,1,0.0
pGlu138Lys,1,0.0
c1824C,1,0.0
liposarcomas,1,0.0
ferret-reactive,1,0.0
ferret-specific,1,0.0
9814,1,0.0
9026,1,0.0
8347,1,0.0
9659,1,0.0
unread,1,0.0
Pathohistiological,1,0.0
Mimic,1,0.0
Chameleon,1,0.0
orolingual,1,0.0
mis-indicated,1,0.0
non-homogeneous,1,0.0
semilateral,1,0.0
pGly608Gly,1,0.0
honeymoon,1,0.0
big-wave,1,0.0
35-days,1,0.0
«diagnostic»,1,0.0
«therapeutic»,1,0.0
«verifying»,1,0.0
hsacirc0141720,1,0.0
thermoplastys,1,0.0
graphed,1,0.0
undeterred,1,0.0
inflammation-inducing,1,0.0
single-point,1,0.0
C36,1,0.0
0816,1,0.0
0·3,1,0.0
colourant,1,0.0
0·97,1,0.0
onset-late,1,0.0
Pre-PSA,1,0.0
behavior-change,1,0.0
students--an,1,0.0
under-served,1,0.0
disenfranchised,1,0.0
population--in,1,0.0
»076,1,0.0
067-085,1,0.0
105-fold,1,0.0
SARS2-Cov,1,0.0
otoscope,1,0.0
otorespiratory,1,0.0
otocough,1,0.0
Tuelwe,1,0.0
isotopoangiocardiographic,1,0.0
regionals,1,0.0
ful,1,0.0
n251,1,0.0
P0043,1,0.0
P0133,1,0.0
P0079,1,0.0
SARS-CoV-2The,1,0.0
demystifying,1,0.0
door-to-groin,1,0.0
curve093,1,0.0
curve088,1,0.0
Shielding,1,0.0
OMalley,1,0.0
high-fever,1,0.0
2003--2004,1,0.0
Ether-treated,1,0.0
2-54,1,0.0
Rambachan,1,0.0
Hubbard,1,0.0
RJ,1,0.0
ONE,1,0.0
e43491,1,0.0
NCT00059306,1,0.0
105000,1,0.0
0972-09995,1,0.0
0979-1008,1,0.0
0993-1013,1,0.0
0991-1013,1,0.0
3271,1,0.0
Méditerranée,1,0.0
co-pathogen,1,0.0
254502,1,0.0
subscript,1,0.0
connotes,1,0.0
tes,1,0.0
14-23,1,0.0
aquire,1,0.0
electrochemiluminiscence,1,0.0
445516,1,0.0
379516,1,0.0
18516,1,0.0
173498,1,0.0
87516,1,0.0
22502,1,0.0
Fisher´s,1,0.0
1971-2011,1,0.0
498222,1,0.0
1686,1,0.0
speedcoordination,1,0.0
deterrence,1,0.0
sensitivity12,1,0.0
Cromoglycate,1,0.0
anti-dust,1,0.0
anti-gas,1,0.0
helmets,1,0.0
re-structuring,1,0.0
moisteners,1,0.0
Directory,1,0.0
NaK,1,0.0
quality-adjusted-,1,0.0
‘vaccine,1,0.0
passports’,1,0.0
69-138,1,0.0
therapy-eventually,1,0.0
sedatives-can,1,0.0
IIbIIIa-targeted,1,0.0
chimokines,1,0.0
Nazareth,1,0.0
inuenza,1,0.0
MI-specific,1,0.0
33rd,1,0.0
ESPID,1,0.0
battled,1,0.0
Schizophyllum,1,0.0
suehirotake,1,0.0
basidiomycetous,1,0.0
AFS,1,0.0
industrially,1,0.0
extra-thalamic,1,0.0
medialanterior,1,0.0
3328,1,0.0
Medial,1,0.0
post-introduction,1,0.0
Re-admissions,1,0.0
134-209,1,0.0
Jutland,1,0.0
fax,1,0.0
contradicted,1,0.0
DHI,1,0.0
003ABSTRACT,1,0.0
PRObjective,1,0.0
PRMethods,1,0.0
224-386,1,0.0
219-374,1,0.0
unafraid,1,0.0
276-523,1,0.0
394-143,1,0.0
249-443,1,0.0
455Discussion,1,0.0
double-sandwich,1,0.0
Cross-reaction,1,0.0
8491,1,0.0
848-969,1,0.0
171171,1,0.0
640642,1,0.0
989-1000,1,0.0
α-diversity,1,0.0
riverside,1,0.0
neuromechanical,1,0.0
weight-control,1,0.0
1992-2013,1,0.0
CT-scans,1,0.0
CNNs,1,0.0
Grad-CAM,1,0.0
Fast-CAM,1,0.0
Marie-Paule,1,0.0
countries’,1,0.0
8806,1,0.0
tonsillectomyadenoidectomy,1,0.0
painvomiting,1,0.0
arbiters,1,0.0
Effort,1,0.0
wwwcovidhgecom,1,0.0
IFN-dependent,1,0.0
auto-Abs,1,0.0
X77,1,0.0
X77-MPro,1,0.0
web-oriented,1,0.0
Pharmit,1,0.0
top-ranking,1,0.0
His-41,1,0.0
Met-49,1,0.0
Cys-145,1,0.0
Met-165,1,0.0
Gln-189,1,0.0
MProCommunicated,1,0.0
and5,1,0.0
rehabilitations,1,0.0
χ28045,1,0.0
diedχ212121,1,0.0
neurointensivists,1,0.0
buckshot,1,0.0
intraparenchymatous,1,0.0
cicatrization,1,0.0
teased,1,0.0
CYamagata2681-related,1,0.0
cultureRT-PCR,1,0.0
25-month-old,1,0.0
Selvester-Wagner,1,0.0
semiquantitatively,1,0.0
56-64,1,0.0
UE23,1,0.0
20-years,1,0.0
20160,1,0.0
Physio-bank,1,0.0
Arif-Fayyaz,1,0.0
prune,1,0.0
Pruning,1,0.0
fearfulness,1,0.0
mis-diagnosis,1,0.0
FK-506,1,0.0
operator-independent,1,0.0
deserved,1,0.0
post-effort,1,0.0
multi-electrode,1,0.0
diamentoid,1,0.0
Kowarzyk,1,0.0
non-ipolarity,1,0.0
non-dipolarity,1,0.0
Migraines,1,0.0
theorised,1,0.0
Vasoconstrictors,1,0.0
leukodystrophy,1,0.0
definitions-current,1,0.0
cryoprecipitate,1,0.0
hyperconcentrates,1,0.0
bifasicular,1,0.0
D399,1,0.0
BtKY72,1,0.0
juxtacrine,1,0.0
HifB-HifD,1,0.0
ion-exchange,1,0.0
3209,1,0.0
non-consolidating,1,0.0
electrochemiluminescent,1,0.0
DBS-serum,1,0.0
tautological,1,0.0
overwork,1,0.0
076-097,1,0.0
NCI,1,0.0
stages-early,1,0.0
years-and,1,0.0
Gillim-Ross,1,0.0
inPLoS,1,0.0
cross-reacts,1,0.0
Services’,1,0.0
Contiguous,1,0.0
r089,1,0.0
9575-100,1,0.0
849-989,1,0.0
Agreeing,1,0.0
appellation,1,0.0
19th-century,1,0.0
thrived,1,0.0
response-to-treatment,1,0.0
antivenom,1,0.0
whole-IgG,1,0.0
caprylic,1,0.0
restrictive-obstructive,1,0.0
HifB-HifA,1,0.0
PapD,1,0.0
two-stranded,1,0.0
transportable,1,0.0
multicycle,1,0.0
UTOS,1,0.0
AswineIowa1530,1,0.0
Aswineowa1530,1,0.0
930000,1,0.0
MONItoring,1,0.0
presented--common,1,0.0
AKIN,1,0.0
4548,1,0.0
114Shock,1,0.0
Dec93,1,0.0
May94,1,0.0
Guam,1,0.0
Isomune-CK,1,0.0
subassemblies,1,0.0
Tandem-E,1,0.0
inter-correlated,1,0.0
stokeembolic,1,0.0
Strokeembolic,1,0.0
051-089,1,0.0
058-087,1,0.0
strokeembolic,1,0.0
053-077,1,0.0
046-128,1,0.0
067-078,1,0.0
quick-freeze,1,0.0
deep-etch,1,0.0
immunogold,1,0.0
mesenchymal-,1,0.0
Statusometry,1,0.0
TLLPAADLDDFSKQL,1,0.0
multiparametrical,1,0.0
co-express,1,0.0
33million,1,0.0
gold‐standard,1,0.0
Lassen,1,0.0
Jinan,1,0.0
Applanation,1,0.0
tonometry,1,0.0
p0125,1,0.0
1730-270,1,0.0
2121-529,1,0.0
p0179,1,0.0
236-16,1,0.0
207-25,1,0.0
p0219,1,0.0
Exercise-induce,1,0.0
FEV1after,1,0.0
DeltaFEV,1,0.0
242-23,1,0.0
259-40,1,0.0
p0744,1,0.0
4516,1,0.0
4840-1110,1,0.0
p0777,1,0.0
DeltaFEV1,1,0.0
61-3,1,0.0
57-5,1,0.0
54-5,1,0.0
52-7,1,0.0
393-407,1,0.0
570-bed,1,0.0
FET25-75,1,0.0
volume-1,1,0.0
E484D,1,0.0
time-dependency,1,0.0
mooted,1,0.0
amino-terminal,1,0.0
propeptide,1,0.0
procollagen,1,0.0
PIIINP,1,0.0
beta-Agonist,1,0.0
case-note,1,0.0
mo-16,1,0.0
self-antigen,1,0.0
suture-induced,1,0.0
Soetomo,1,0.0
D215Y,1,0.0
B16,1,0.0
involuntarily,1,0.0
B147,1,0.0
Red-blood-cell,1,0.0
T131K,1,0.0
R142K,1,0.0
R261Q,1,0.0
cross-lineage,1,0.0
trans-activational,1,0.0
GRγ,1,0.0
ECAS,1,0.0
ICASECAS,1,0.0
ACSPCS,1,0.0
OCFA,1,0.0
1428,1,0.0
ischemia-modified,1,0.0
A12A,1,0.0
deficiency-induced,1,0.0
700000mm3,1,0.0
SARS-CoV-induced,1,0.0
Thymus,1,0.0
cymbopogon,1,0.0
citratus,1,0.0
Rosmarinus,1,0.0
officinalis,1,0.0
TatTAR-RNA,1,0.0
lipophilic,1,0.0
Mucociliary,1,0.0
2-glycoprotein,1,0.0
10-month-old,1,0.0
132U,1,0.0
Bibliometric,1,0.0
quotidian,1,0.0
hebdomadal,1,0.0
1-peak,1,0.0
multi-peak,1,0.0
Cramers,1,0.0
Tochigi,1,0.0
hubris,1,0.0
1678,1,0.0
19516,1,0.0
100-151,1,0.0
096-151,1,0.0
nonmigrant,1,0.0
dysimmunity,1,0.0
old-aged,1,0.0
MS-associated,1,0.0
Retroviruses,1,0.0
oleoresins,1,0.0
Lippia,1,0.0
reshni,1,0.0
TLR-3,1,0.0
SaBio,1,0.0
65-90,1,0.0
CV-related,1,0.0
70-71,1,0.0
Superimposition,1,0.0
drugs--IFN,1,0.0
medical-and-biological,1,0.0
therapeutic-and-preventive,1,0.0
dsRNA-based,1,0.0
therapeutic-and-clinical,1,0.0
Non-randomized,1,0.0
VaxiJen,1,0.0
50S,1,0.0
PNAD-COVID19,1,0.0
Citrus,1,0.0
346181,1,0.0
Rao-Scott,1,0.0
coughsore,1,0.0
offlu,1,0.0
polyorgan,1,0.0
Th2-immune,1,0.0
telemedicines,1,0.0
kbp,1,0.0
IFN-α-inducible,1,0.0
epoxides,1,0.0
bergamot,1,0.0
lemongrass,1,0.0
lavender,1,0.0
HERVs,1,0.0
A1-S3-C1-O3,1,0.0
cosmetics,1,0.0
A1-S9-C0-O3,1,0.0
VV37,1,0.0
valinealanine,1,0.0
VA71,1,0.0
AA68,1,0.0
1903-1414,1,0.0
RR4423,1,0.0
RR1025,1,0.0
RR4490,1,0.0
endopoints,1,0.0
MTFHR,1,0.0
endopoint,1,0.0
Buxco,1,0.0
271-048,1,0.0
320-041,1,0.0
mentees,1,0.0
atop,1,0.0
μms,1,0.0
entrained,1,0.0
dipyridamoleaspirin,1,0.0
deltaHRchanges,1,0.0
deltaWR,1,0.0
deltaHRdeltaWR,1,0.0
personal-environmental,1,0.0
deficit-hyperactivity,1,0.0
influenza--like,1,0.0
124-1855,1,0.0
133-232,1,0.0
chemo-immunotherapy,1,0.0
BTK,1,0.0
II65,1,0.0
ID91,1,0.0
DD20,1,0.0
SD22,1,0.0
A1-A2-A3,1,0.0
2771,1,0.0
Chinese-developed,1,0.0
Jair,1,0.0
Bolsonaro-a,1,0.0
denier,1,0.0
critic,1,0.0
MVR,1,0.0
RT-PCR-detectable,1,0.0
PCR-detectable,1,0.0
inter-governmental,1,0.0
DIS41,1,0.0
score41,1,0.0
score32,1,0.0
8-53,1,0.0
SD15,1,0.0
chi2419,1,0.0
U340550,1,0.0
U211050,1,0.0
U113050,1,0.0
U118150,1,0.0
U198250,1,0.0
U291800,1,0.0
p03,1,0.0
communityhospital,1,0.0
kinked,1,0.0
Alhough,1,0.0
14-51,1,0.0
Immediate-type,1,0.0
glycols,1,0.0
prosurvival,1,0.0
quality-control,1,0.0
016-028,1,0.0
difficulttherapy-resistant,1,0.0
gas-exchange,1,0.0
patient-ventilator,1,0.0
synchronism,1,0.0
nonoccluded,1,0.0
enclose,1,0.0
intellectuals,1,0.0
outbuildings,1,0.0
LOGISTICS,1,0.0
IMPLEMENTATION,1,0.0
immuno-analytics,1,0.0
L314P,1,0.0
A222VL18F,1,0.0
httpgenomicslshtmacukimmuno,1,0.0
httpsgithubcomdan-ward-bioCOVID-immunoanalytics,1,0.0
1946-74,1,0.0
1964-75,1,0.0
1969-74,1,0.0
1968-74,1,0.0
sinuous,1,0.0
midsummer,1,0.0
Hanshin-Awaji,1,0.0
EQ,1,0.0
seismic,1,0.0
bicycle-ergometer,1,0.0
persuasion,1,0.0
99mTc-tetrofosmin,1,0.0
provincewide,1,0.0
019-026,1,0.0
017-021,1,0.0
nonexclusively,1,0.0
69-26,1,0.0
swines,1,0.0
echo-contrast,1,0.0
curls,1,0.0
α2-antiplasmin,1,0.0
Viikinmäki,1,0.0
pre-centrifuged,1,0.0
pellet-that,1,0.0
influent-as,1,0.0
1067,1,0.0
1697,1,0.0
quotion,1,0.0
57-14,1,0.0
83-16,1,0.0
76-16,1,0.0
265-605,1,0.0
stenosisthrombolysis,1,0.0
deltasdchord,1,0.0
249-105,1,0.0
067-065,1,0.0
NQMIs,1,0.0
alleging,1,0.0
quotations,1,0.0
Surawicz,1,0.0
Qwave,1,0.0
blizzard,1,0.0
postblizzard,1,0.0
Clades,1,0.0
imaging-assisted,1,0.0
07-14,1,0.0
399631,1,0.0
Polyethylene,1,0.0
2574,1,0.0
database-searches,1,0.0
Forde,1,0.0
e72–e73,1,0.0
neuropeptide-mediated,1,0.0
Nasalnasopharyngealthroat,1,0.0
de-convoluted,1,0.0
non-sigmoid,1,0.0
medical-record,1,0.0
69114,1,0.0
fetalneonatal,1,0.0
33-question,1,0.0
emailed,1,0.0
157674,1,0.0
23-61,1,0.0
3473,1,0.0
055-097,1,0.0
monointervention,1,0.0
083-178,1,0.0
032-084,1,0.0
066-131,1,0.0
10639,1,0.0
metabolizer,1,0.0
within-infarct,1,0.0
-SE,1,0.0
6873,1,0.0
002r,1,0.0
004r,1,0.0
12980,1,0.0
2577,1,0.0
Medline-,1,0.0
disbalance,1,0.0
n657,1,0.0
074-097,1,0.0
14-November,1,0.0
Work-release,1,0.0
state-run,1,0.0
low-security,1,0.0
Shenfu,1,0.0
verbalizations,1,0.0
IU1,1,0.0
arc-welding,1,0.0
award-winning,1,0.0
Tangará,1,0.0
BCTs,1,0.0
8230,1,0.0
Lymphocytopenia,1,0.0
physician-ordered,1,0.0
MONICA-PSYCHOSOCIAL,1,0.0
Marshfield,1,0.0
slowest,1,0.0
sporadic-yet,1,0.0
recognized-cases,1,0.0
hosts-wild,1,0.0
waterbirds-to,1,0.0
immunopathomechanisms,1,0.0
Maharaj,1,0.0
Chiang,1,0.0
Mai,1,0.0
late-October,1,0.0
SCORE,1,0.0
symptom-frequency,1,0.0
plunged,1,0.0
1535,1,0.0
Significative,1,0.0
history-making,1,0.0
trypsin-resistant,1,0.0
IDMS,1,0.0
freezethaw,1,0.0
Desiring,1,0.0
rebounding,1,0.0
COVID-PRESTO®,1,0.0
COVID-DUO®,1,0.0
rhinoscopic,1,0.0
tracheoscopy,1,0.0
Dirofilaria,1,0.0
Stroke-International,1,0.0
thromboprophylactic,1,0.0
291patients,1,0.0
048-217,1,0.0
-MOST,1,0.0
059-153,1,0.0
082-159,1,0.0
149-253,1,0.0
devicesAreas,1,0.0
bronchoscopes,1,0.0
servicesExpert,1,0.0
re-design,1,0.0
27345,1,0.0
35731,1,0.0
Cholestatic,1,0.0
hepatodepressive,1,0.0
absorptive-excretory,1,0.0
63-46,1,0.0
44-45,1,0.0
single-radial,1,0.0
HLA-A1101,1,0.0
1-November,1,0.0
HLA-A02402,1,0.0
Resumed,1,0.0
quits,1,0.0
February‒March,1,0.0
strokesOxygen,1,0.0
rehabilitationBefore,1,0.0
stokes,1,0.0
Chernobyl,1,0.0
Kievites,1,0.0
perfecting,1,0.0
3359,1,0.0
Anyang,1,0.0
neurokinin-1,1,0.0
Na-Ca2,1,0.0
Ach,1,0.0
lung-chest,1,0.0
propulsion,1,0.0
24-folds,1,0.0
-United,1,0.0
extractionhomogenization,1,0.0
CHADS2VASC,1,0.0
intervenes,1,0.0
chopped,1,0.0
48000,1,0.0
NS7a,1,0.0
ESGLKTIL,1,0.0
RYPANSIV,1,0.0
NVAITRAK,1,0.0
RRARSVAS,1,0.0
HLA-B0801,1,0.0
illness-during,1,0.0
307-891,1,0.0
411-92,1,0.0
201617season,1,0.0
extrapyramidal,1,0.0
north-south,1,0.0
well-done,1,0.0
chronic-degenerative,1,0.0
Constraint,1,0.0
VHS,1,0.0
BJx109,1,0.0
α23-Gal-linked,1,0.0
voluntary-based,1,0.0
Handicaps,1,0.0
ICIDH,1,0.0
Apdm,1,0.0
105-405,1,0.0
138-523,1,0.0
133-352,1,0.0
05-30,1,0.0
05-41,1,0.0
grayish,1,0.0
Reddish,1,0.0
Informatively,1,0.0
non-heparin-treated,1,0.0
preeclampsia-related,1,0.0
thermoscanners,1,0.0
homeopath,1,0.0
philosophies,1,0.0
Commonalities,1,0.0
Cross-examining,1,0.0
self-perceptions,1,0.0
Self-perception,1,0.0
paresthesia,1,0.0
SARS-CoV-2-infections,1,0.0
ionising,1,0.0
anticoagulants-,1,0.0
beak-shaped,1,0.0
morbity,1,0.0
social-health,1,0.0
objetctives,1,0.0
level-III,1,0.0
20211761333,1,0.0
Interpreted,1,0.0
center--,1,0.0
RC--,1,0.0
federal-state-wide,1,0.0
HesseGermany,1,0.0
2006-2015,1,0.0
20895,1,0.0
antagonists-treated,1,0.0
blocker-based,1,0.0
Crotty,1,0.0
constant-force,1,0.0
10s,1,0.0
64±14years,1,0.0
8-25days,1,0.0
62±10years,1,0.0
022⩽R2⩽072,1,0.0
P⩽00004,1,0.0
035⩽R2⩽052,1,0.0
P⩽00002,1,0.0
FINDINGS,1,0.0
40min,1,0.0
Radioisotope,1,0.0
355-809,1,0.0
008-022,1,0.0
P057,1,0.0
AITs,1,0.0
Solumbra,1,0.0
first-Pass,1,0.0
naturally-occurring,1,0.0
1974-78,1,0.0
pensionable,1,0.0
under-60-year-old,1,0.0
over-70-year-old,1,0.0
Binswangers,1,0.0
pseudotumour,1,0.0
01-18,1,0.0
H1N109-negative,1,0.0
Flongle,1,0.0
massively-parallel,1,0.0
8246,1,0.0
22173,1,0.0
EpiCoV™,1,0.0
1-47,1,0.0
15438G,1,0.0
non-minorities,1,0.0
prevention--including,1,0.0
therapies--results,1,0.0
SERVIS,1,0.0
fecally,1,0.0
work--occurring,1,0.0
aggressor,1,0.0
treated--has,1,0.0
Avenues,1,0.0
high-troughput,1,0.0
unceasingly,1,0.0
semiformal,1,0.0
UPP,1,0.0
nH1N1-specific,1,0.0
dual-type,1,0.0
arteriosclerosisintermittent,1,0.0
Haemoglobin,1,0.0
1192±207,1,0.0
68±212,1,0.0
9611,1,0.0
monomethoxypolyethylene,1,0.0
mPEG,1,0.0
Dp-challenge,1,0.0
symptomsmedication,1,0.0
Dp-specific,1,0.0
Gewerbliche,1,0.0
Berufsgenossenschaften,1,0.0
Type-I,1,0.0
Type-III,1,0.0
therapeutc,1,0.0
lowhigh,1,0.0
Conjunctive,1,0.0
17138-123,1,0.0
014-0,1,0.0
Meier,1,0.0
nefiracetam,1,0.0
estrogen-replacement,1,0.0
Kedzierski,1,0.0
2000-2013,1,0.0
easy-to-obtain,1,0.0
eicosatetraenoic,1,0.0
dyshythmia,1,0.0
PVCshr,1,0.0
pharmaceutical-grade,1,0.0
Disconnection,1,0.0
037-093,1,0.0
spiramycins,1,0.0
ester,1,0.0
COVID-3CL,1,0.0
March-3,1,0.0
EUROSENTINEL,1,0.0
EUROGEIG,1,0.0
EUROGROG,1,0.0
Prague,1,0.0
2-adrenoceptor-mediated,1,0.0
muscle-related,1,0.0
REasons,1,0.0
collides,1,0.0
storagehandling,1,0.0
redetection,1,0.0
Swine-flu,1,0.0
OPDemergency,1,0.0
Indira,1,0.0
Gandhi,1,0.0
Nagpur,1,0.0
2388,1,0.0
autopsy-proved,1,0.0
STONE,1,0.0
Benidipine,1,0.0
Sdiastolic,1,0.0
ABPM-630,1,0.0
1000-2000,1,0.0
0000-0600,1,0.0
146-256,1,0.0
129-219,1,0.0
140-255,1,0.0
phenethyl,1,0.0
Rutin,1,0.0
81801,1,0.0
glucocorticoid-mediated,1,0.0
adipic,1,0.0
non-irritant,1,0.0
Arequipa,1,0.0
Perú,1,0.0
Nitrites,1,0.0
Griess,1,0.0
1630,1,0.0
rotablation,1,0.0
Alair,1,0.0
workschoolother,1,0.0
lauded,1,0.0
utilityObjectives,1,0.0
baselineprerandomization,1,0.0
modelsMeasurements,1,0.0
70112,1,0.0
hsa-miR-155-5p,1,0.0
hsa-miR-532-5p,1,0.0
dexamethasone-induced,1,0.0
086Conclusions,1,0.0
administrative-managerial,1,0.0
cardiovascular-system,1,0.0
pre-infraction,1,0.0
teinted,1,0.0
2194,1,0.0
Zambon,1,0.0
Union-funded,1,0.0
VIRGIL,1,0.0
3CL-protease,1,0.0
swings,1,0.0
aetio-pathogenic,1,0.0
very-large,1,0.0
underfunding,1,0.0
P0·002,1,0.0
OR3·86,1,0.0
1·03,1,0.0
14·42,1,0.0
P0·045,1,0.0
Romanians,1,0.0
immunohystochemical,1,0.0
precutaneous,1,0.0
technique-latent,1,0.0
analysis-and,1,0.0
Measurement-based,1,0.0
pet-derived,1,0.0
semi-volatile,1,0.0
Obvious,1,0.0
ATVS,1,0.0
well-delineated,1,0.0
ionotropic,1,0.0
glucose225,1,0.0
117-283,1,0.0
175-508,1,0.0
170-489,1,0.0
305-980,1,0.0
079-088,1,0.0
physician-operated,1,0.0
computer-derived,1,0.0
Torontos,1,0.0
Hastingss,1,0.0
successor,1,0.0
Sheela,1,0.0
5·71,1,0.0
1·50,1,0.0
OR2·93,1,0.0
dephosphorylate,1,0.0
25-33°C,1,0.0
inflammatorynon-allergic,1,0.0
23aVF,1,0.0
reportimprovement,1,0.0
AARIPs,1,0.0
Perfusion-metabolism,1,0.0
thallium-201radio,1,0.0
beta-methyl-p-iodophenyl,1,0.0
CFV,1,0.0
Raye,1,0.0
donators,1,0.0
Ser226,1,0.0
dual-specificity,1,0.0
DUSP1,1,0.0
P0·03,1,0.0
FK506-binding,1,0.0
TNFα-induced,1,0.0
nuclearcytoplasmic,1,0.0
coimmunoprecipitated,1,0.0
GR-JNK1-DUSP4,1,0.0
immunoprecipitated,1,0.0
IP-DUSP4,1,0.0
Coimmunoprecipitation,1,0.0
Formoterol,1,0.0
dephosphorylation,1,0.0
OR1·97,1,0.0
1·05,1,0.0
3·69,1,0.0
Basrur,1,0.0
common-and,1,0.0
climber,1,0.0
harmful-ones,1,0.0
Furthering,1,0.0
effects-magnitude,1,0.0
outbreaks-remain,1,0.0
model-validation,1,0.0
out-of-sample,1,0.0
DSE-associated,1,0.0
testing-the,1,0.0
diagnosis-is,1,0.0
4-d,1,0.0
hypercubes,1,0.0
cardiac-marker,1,0.0
eight-item,1,0.0
145-961,1,0.0
health-maintenance,1,0.0
split-sample,1,0.0
16520,1,0.0
2251,1,0.0
highest-quality,1,0.0
CYP19A1,1,0.0
Orléans,1,0.0
935-999,1,0.0
PGC,1,0.0
AFujianH3N2,1,0.0
angiotensin-converting-enzymeACE-inhibitors,1,0.0
GUSTO-,1,0.0
AIRE-study,1,0.0
isoglycyrrhizinate,1,0.0
18-α,1,0.0
stereoisomer,1,0.0
Anyhow,1,0.0
sodiumcalcium,1,0.0
ednit,1,0.0
200-age,1,0.0
2012-nCoV,1,0.0
ß-CoV,1,0.0
A--patients,1,0.0
B--patients,1,0.0
C--patients,1,0.0
D--patients,1,0.0
K--control,1,0.0
substenotic,1,0.0
36-years-old,1,0.0
Ospedale,1,0.0
Martino,1,0.0
neuroreceptors,1,0.0
transanastomotic,1,0.0
immuno-hemolysis,1,0.0
monopril,1,0.0
pollinic,1,0.0
Nine-Hole,1,0.0
ARAT,1,0.0
Motion,1,0.0
AROM,1,0.0
care-cerebral,1,0.0
Respirometer,1,0.0
0372,1,0.0
0477,1,0.0
FVCpreFVC,1,0.0
luteinizing,1,0.0
Monopril,1,0.0
Ednit,1,0.0
16862,1,0.0
apprentice,1,0.0
haemophagocytic,1,0.0
aphorisms,1,0.0
1442,1,0.0
7562,1,0.0
4590,1,0.0
Biopsychosocial,1,0.0
001-081,1,0.0
CFUs,1,0.0
Lifes,1,0.0
SIRC,1,0.0
multi-stable,1,0.0
30-ms,1,0.0
Sequoia,1,0.0
sempervirens,1,0.0
Metasequoia,1,0.0
glyptostroboides,1,0.0
Juniperus,1,0.0
rigida,1,0.0
interendothelial,1,0.0
fluorescein-labelled,1,0.0
Danderyd,1,0.0
glucosides,1,0.0
podocyte,1,0.0
protein-to-creatine,1,0.0
gg,1,0.0
1787,1,0.0
Clerc,1,0.0
1726-1798,1,0.0
herniaCDH,1,0.0
gradational,1,0.0
Oceanic,1,0.0
Mishel,1,0.0
non-superspreaders,1,0.0
empirically-based,1,0.0
sad-blue,1,0.0
1911-1988,1,0.0
10500-2200,1,0.0
thrombo-occlusion,1,0.0
3-min,1,0.0
cruder,1,0.0
best-established,1,0.0
variability--that,1,0.0
FEV1--at,1,0.0
phone-internet,1,0.0
gray-scale,1,0.0
transferral,1,0.0
ACM,1,0.0
28-78,1,0.0
tired-drowsy,1,0.0
8787,1,0.0
machine-learned,1,0.0
hereon,1,0.0
on-par,1,0.0
life-stress,1,0.0
VTGTLC,1,0.0
VTGVC,1,0.0
Calcification,1,0.0
electron-beam,1,0.0
spotty,1,0.0
Front,1,0.0
sailors,1,0.0
50-day,1,0.0
396652,1,0.0
kahunas,1,0.0
83100000,1,0.0
jobexposure,1,0.0
tell-tale,1,0.0
PT14,1,0.0
PT19,1,0.0
occipitotemporal,1,0.0
MALDI-time,1,0.0
TOF-mass,1,0.0
ML-enhanced,1,0.0
post-varicella,1,0.0
hemmorrhage,1,0.0
4500000,1,0.0
sickling,1,0.0
Dyspnea-12,1,0.0
D-12,1,0.0
n1390,1,0.0
severeuncontrolled,1,0.0
H5N1-caused,1,0.0
entry--49,1,0.0
glm,1,0.0
PreCoV,1,0.0
and102,1,0.0
discordances,1,0.0
Dedifferentiation,1,0.0
dedifferentiated,1,0.0
175×145×135,1,0.0
osteosarcomatous,1,0.0
NAB2-STAT6,1,0.0
nasopharengealoropharengeal,1,0.0
75-min,1,0.0
maths,1,0.0
scratched,1,0.0
PT8,1,0.0
PT2,1,0.0
23×104,1,0.0
3months,1,0.0
two-antibody,1,0.0
Costly,1,0.0
deep-rooted,1,0.0
noninfluenzal,1,0.0
252271,1,0.0
Greencross,1,0.0
105300,1,0.0
Chuseok,1,0.0
Ulsan,1,0.0
Gyeongnam,1,0.0
school-targeted,1,0.0
5-Word,1,0.0
3-4weeks,1,0.0
mismatch-tolerant,1,0.0
87×106,1,0.0
1186,1,0.0
dMT,1,0.0
Rh-negative,1,0.0
Titre,1,0.0
N66S,1,0.0
anti-interferon,1,0.0
Tenon,1,0.0
angiotensin-17,1,0.0
data-fitted,1,0.0
BPCs,1,0.0
indicatorsTwenty-one,1,0.0
≥22,1,0.0
7±2,1,0.0
BiH,1,0.0
skin-to-muscle,1,0.0
transcription-free,1,0.0
mugml,1,0.0
memotine,1,0.0
1-p-methoxyphenoxymethyl-34-dihydroisoquinoline,1,0.0
virusConsistent,1,0.0
manTrials,1,0.0
drug-treated,1,0.0
231--391,1,0.0
101--197,1,0.0
testine,1,0.0
usuel,1,0.0
Oligo,1,0.0
long-amplicon,1,0.0
low-viral-load,1,0.0
5864345,1,0.0
17138300,1,0.0
3332329,1,0.0
HLA-bound,1,0.0
peptidomics,1,0.0
HLA-II,1,0.0
out-of-frame,1,0.0
daysnights,1,0.0
influents,1,0.0
multi-county,1,0.0
multi-month,1,0.0
age5064-127,1,0.0
Remain,1,0.0
Encourage,1,0.0
pleuromediastinal,1,0.0
4942,1,0.0
RAA,1,0.0
1-p-chlorophenoxymethyl-34-dihydroisoquinoline,1,0.0
component-target-pathway,1,0.0
repatriate,1,0.0
material-chemical,1,0.0
EACVI,1,0.0
Dexmedetomidine,1,0.0
Bcl‑2,1,0.0
caspase‑3,1,0.0
µgkgday,1,0.0
post‑myocardial,1,0.0
over‑activation,1,0.0
NOXs,1,0.0
sFr,1,0.0
circumspect,1,0.0
adventurous,1,0.0
milked,1,0.0
fibrillationAFin,1,0.0
systemsCHADS2,1,0.0
Nod-like,1,0.0
AIM2-like,1,0.0
Underutilization,1,0.0
non-nucleoside,1,0.0
quantitativeness,1,0.0
HISCL,1,0.0
SARS1-,1,0.0
MERS-S,1,0.0
serologicalimmunological,1,0.0
ante,1,0.0
hydrallazine,1,0.0
Flus,1,0.0
hypopharyngeal,1,0.0
Longmaining,1,0.0
Pharmacology-based,1,0.0
nets,1,0.0
TIMs,1,0.0
lipid-modifying,1,0.0
millions--and,1,0.0
polypnea,1,0.0
S-100beta,1,0.0
phenylpropanoid,1,0.0
361-052,1,0.0
158-015,1,0.0
257-028,1,0.0
P50122-024,1,0.0
289-029,1,0.0
P50154-027,1,0.0
340-076,1,0.0
mono-therapy,1,0.0
co-therapy,1,0.0
SQT,1,0.0
belief-based,1,0.0
pull-down-assisted,1,0.0
CRISPRCas12a-assisted,1,0.0
9512,1,0.0
cathertization,1,0.0
evaluation--including,1,0.0
patients--during,1,0.0
enzyme-confirmed,1,0.0
067-091,1,0.0
Trandolapril,1,0.0
059-098,1,0.0
severeresistant,1,0.0
066-113,1,0.0
collapseconsolidation,1,0.0
subprogramme,1,0.0
group-rehabilitation,1,0.0
exam-induced,1,0.0
midsemester,1,0.0
asthma--completed,1,0.0
43plus,1,0.0
deaths--every,1,0.0
cytocidal,1,0.0
virus--which,1,0.0
hematogeneous,1,0.0
heart--,1,0.0
predamaged,1,0.0
ten-minute,1,0.0
Association-Hawaii,1,0.0
Kapiolani,1,0.0
Manoa,1,0.0
Waianae,1,0.0
cephalospoins,1,0.0
38plus,1,0.0
haemagglutinate,1,0.0
students--healthy,1,0.0
nonmyelinated,1,0.0
scarceMETHODS,1,0.0
medicationsRESULTS,1,0.0
4826,1,0.0
1383,1,0.0
7893,1,0.0
mLsec,1,0.0
ACQ-5,1,0.0
yearCONCLUSION,1,0.0
allergist-immunologist,1,0.0
ACR’s,1,0.0
Musculoskeletal,1,0.0
Force’s,1,0.0
hysterectomized,1,0.0
Hysterectomy,1,0.0
angioembolisation,1,0.0
treatments-chemoprophylaxis,1,0.0
41-78,1,0.0
11-58,1,0.0
57-97,1,0.0
76-81,1,0.0
149-380,1,0.0
orangutans,1,0.0
lion,1,0.0
Groll,1,0.0
Thomsons,1,0.0
HAIs,1,0.0
Clinico,1,0.0
Christus,1,0.0
RS-UCCH,1,0.0
perception-based,1,0.0
prelearned,1,0.0
Authoratative,1,0.0
time-international,1,0.0
PT-INR,1,0.0
1-35,1,0.0
Profesor,1,0.0
Alejandro,1,0.0
Posadas,1,0.0
EW18-35,1,0.0
FLU-AH1N1pdm,1,0.0
FLU-B,1,0.0
patella,1,0.0
Stilianakis,1,0.0
Perelson,1,0.0
Hayden,1,0.0
68-87,1,0.0
patienthousehold,1,0.0
Nonalcoholic,1,0.0
remuneration,1,0.0
Dermcidin,1,0.0
isoform-2,1,0.0
dermcidin,1,0.0
scat,1,0.0
chard,1,0.0
108plateletsml,1,0.0
resensitized,1,0.0
SIR-based,1,0.0
CLSM,1,0.0
vibrations,1,0.0
hospitalized-acute,1,0.0
mass-based,1,0.0
VRI-induced,1,0.0
Emphysematous,1,0.0
satisfaction-based,1,0.0
preschooler,1,0.0
2218,1,0.0
2638,1,0.0
2513,1,0.0
andlowest,1,0.0
Appeals,1,0.0
PC6,1,0.0
HEROES-RECOVER,1,0.0
ABSTRACTSince,1,0.0
Gillams,1,0.0
campaignLocal,1,0.0
201913596-604,1,0.0
Oldest-old,1,0.0
863-873,1,0.0
deterministic-model,1,0.0
secondFVC,1,0.0
September-November,1,0.0
PREAMI,1,0.0
38750,1,0.0
295642,1,0.0
non-Latinx,1,0.0
Beta2,1,0.0
ICSfast,1,0.0
Crespo,1,0.0
Granulo-monocytoapheresis,1,0.0
H3N2Wisconsin,1,0.0
receptors-mediated,1,0.0
host-unique,1,0.0
non-passive,1,0.0
319-322,1,0.0
addenda,1,0.0
pseudocontinuous,1,0.0
Thungsong,1,0.0
Si,1,0.0
Thammarat,1,0.0
June-December,1,0.0
7700,1,0.0
0413,1,0.0
0173-0988,1,0.0
1230-5604,1,0.0
4475,1,0.0
1882-10644,1,0.0
logbook,1,0.0
Substituting,1,0.0
Judged,1,0.0
user-defined,1,0.0
callusumin,1,0.0
vegan,1,0.0
1947-2008,1,0.0
enzyme-conjugated,1,0.0
6-2,1,0.0
translucence,1,0.0
striations,1,0.0
myofibres,1,0.0
margination,1,0.0
SARS-CoV-2-driven,1,0.0
exhaustionA,1,0.0
20204912e532-e536,1,0.0
Vacuolar,1,0.0
V-ATPase,1,0.0
eNHEs,1,0.0
membrane-filtration,1,0.0
23385-399,1,0.0
anti-globulin,1,0.0
14352708,1,0.0
LncRNAs,1,0.0
Znfx1,1,0.0
deocclusion,1,0.0
277100000,1,0.0
20787510844,1,0.0
1044,1,0.0
2172078,1,0.0
102078,1,0.0
58612,1,0.0
53612,1,0.0
25217,1,0.0
22217,1,0.0
5299,1,0.0
sexualcardiac,1,0.0
PETT,1,0.0
RTF,1,0.0
3743,1,0.0
03743,1,0.0
Machine-Learning,1,0.0
LogitBoost,1,0.0
AdaboostM1,1,0.0
7069,1,0.0
6207,1,0.0
Allele,1,0.0
Lv,1,0.0
RdRpA97V,1,0.0
Clade-G,1,0.0
lubeluzole,1,0.0
041-088,1,0.0
101-713,1,0.0
concentration-effect,1,0.0
non-specialized,1,0.0
8743,1,0.0
1025-2822,1,0.0
0250,1,0.0
ig,1,0.0
acid-phosphatase,1,0.0
lipoperoxide,1,0.0
Neu,1,0.0
3169,1,0.0
Besançon,1,0.0
66-78,1,0.0
Russells,1,0.0
Viper,1,0.0
Daboia,1,0.0
exofocal,1,0.0
R-squared,1,0.0
0000135,1,0.0
unanesthetized,1,0.0
1029p-value,1,0.0
Spanish-Speaking,1,0.0
135000,1,0.0
sCD163,1,0.0
PCA-LDA,1,0.0
S1PR,1,0.0
EEAEuropean,1,0.0
EFTA,1,0.0
bacteriophage-like,1,0.0
067-154,1,0.0
P095,1,0.0
052-122,1,0.0
NCT01927549,1,0.0
45998,1,0.0
hospital-admitting,1,0.0
Sampling,1,0.0
patients--assuming,1,0.0
fibrinolysis--would,1,0.0
South-western,1,0.0
Madura,1,0.0
quinquennial,1,0.0
decennial,1,0.0
426-437,1,0.0
07-42,1,0.0
CK-B,1,0.0
re-visited,1,0.0
26642,1,0.0
SD614G,1,0.0
C14408,1,0.0
0000358,1,0.0
T2-,1,0.0
Co-registration,1,0.0
Weifang,1,0.0
ventilator-assisted,1,0.0
10-45,1,0.0
ex-traction,1,0.0
nonangiographic,1,0.0
reperfusion--a,1,0.0
activity--in,1,0.0
6ABSTRACT,1,0.0
suudenly,1,0.0
two-month-old,1,0.0
005-01,1,0.0
rates-of-influenza-related,1,0.0
55000,1,0.0
60500,1,0.0
178000,1,0.0
308000,1,0.0
propelling,1,0.0
Transcoronary,1,0.0
435588,1,0.0
CI-017,1,0.0
dynamically-determined,1,0.0
non-neurosurgery,1,0.0
1990-2000,1,0.0
Shexiang,1,0.0
Baoxin,1,0.0
Pharmacopoeia,1,0.0
M2-MCA,1,0.0
pre-EVT,1,0.0
Fibonacci,1,0.0
Cascade,1,0.0
Laskowitz,1,0.0
HepC,1,0.0
HepB,1,0.0
upper-arm,1,0.0
readout-segmented,1,0.0
mid-cavity,1,0.0
saponin,1,0.0
Phytolacca,1,0.0
esculenta,1,0.0
ipratromium,1,0.0
EPAC,1,0.0
parenchymal-and,1,0.0
Irreversibility,1,0.0
Demographical,1,0.0
MAEs,1,0.0
misidentified,1,0.0
CO-expression,1,0.0
type-C,1,0.0
1-amino,1,0.0
Unconstrained,1,0.0
Ideomotor,1,0.0
pantomime,1,0.0
VASQIP,1,0.0
FrankfurtMain,1,0.0
33-41,1,0.0
531-612,1,0.0
558-752,1,0.0
408-611,1,0.0
Expediting,1,0.0
data-dependent,1,0.0
EuropeanAmerican,1,0.0
479689,1,0.0
between-study,1,0.0
pseudo-asthmas,1,0.0
comprehends,1,0.0
Estate-leaders,1,0.0
03-233,1,0.0
substrain,1,0.0
Q675H,1,0.0
after-infection,1,0.0
MDI-based,1,0.0
Hyperreflective,1,0.0
GCL,1,0.0
wool,1,0.0
7855,1,0.0
4465,1,0.0
degree-prepared,1,0.0
40-82,1,0.0
60±12,1,0.0
was167-315×109L,1,0.0
78-152×109L,1,0.0
778-1152×109L,1,0.0
991-1593×109L,1,0.0
069-159×109L,1,0.0
058-086×109L,1,0.0
glutamic-pyruvic,1,0.0
140-3520,1,0.0
69-345,1,0.0
160-1620,1,0.0
331-4140,1,0.0
06-1000,1,0.0
groupthe,1,0.0
250-1810,1,0.0
48-259,1,0.0
150-400,1,0.0
C-reaction,1,0.0
146-204,1,0.0
165-172,1,0.0
20AEU1,1,0.0
B-cell-derived,1,0.0
IVC,1,0.0
0100h,1,0.0
0500h,1,0.0
altruistically,1,0.0
clinician-scientists,1,0.0
Saiseikai,1,0.0
low-uptake,1,0.0
Yes-associated,1,0.0
Organisations,1,0.0
BSTH,1,0.0
causeThese,1,0.0
load-5X,1,0.0
ST-4X,1,0.0
high-ranked,1,0.0
171-240,1,0.0
vaccine-TLR3,1,0.0
interchain,1,0.0
thermodynamically,1,0.0
time-pressured,1,0.0
EDICT,1,0.0
4391,1,0.0
13-190,1,0.0
14-150,1,0.0
21-1287,1,0.0
17-373,1,0.0
Arshad,1,0.0
Kanabar,1,0.0
183-218,1,0.0
128-525,1,0.0
t407,1,0.0
suspectedconfirmed,1,0.0
inter-tropical,1,0.0
Vaxigrip®,1,0.0
tumefactive,1,0.0
Nephrologists,1,0.0
frequently-used,1,0.0
Hematocrit,1,0.0
102-104,1,0.0
between-year,1,0.0
AGDPs,1,0.0
ungrounded,1,0.0
adenosine-5-monophosphate,1,0.0
bronchoprovocants,1,0.0
n6group,1,0.0
00625,1,0.0
29-years-old,1,0.0
ALSPAC,1,0.0
Hyalas,1,0.0
500-2,1,0.0
hyaluronidase-treated,1,0.0
regions-west,1,0.0
Closely,1,0.0
IL-1ra,1,0.0
recordability,1,0.0
R90C,1,0.0
domestically-infected,1,0.0
Narita,1,0.0
well-reflected,1,0.0
10462,1,0.0
41467,1,0.0
129-190,1,0.0
VaxigripTetra™,1,0.0
somaticaffective,1,0.0
nonperfusing,1,0.0
BRIMS,1,0.0
climatologically,1,0.0
sulodexide,1,0.0
micro-ecological,1,0.0
highly-neutralizing,1,0.0
poorly-neutralizing,1,0.0
full-fat,1,0.0
STAT6,1,0.0
IFNGR1,1,0.0
diseasecommon,1,0.0
politeness,1,0.0
N-terminally,1,0.0
Unspecific,1,0.0
Bidar,1,0.0
revasucularization,1,0.0
Benin-derived,1,0.0
stroke-attributable,1,0.0
stroke-management,1,0.0
Id-Vet,1,0.0
AAZ-LMB,1,0.0
Fasa,1,0.0
FaRMI,1,0.0
AUCmg,1,0.0
Sniffer,1,0.0
FebMarch,1,0.0
JuneJulyAug,1,0.0
pronged,1,0.0
medium-to-severe,1,0.0
Stopping,1,0.0
methemoglobin,1,0.0
SMAD-2,1,0.0
ATomsk132010,1,0.0
DMARD,1,0.0
NPCs,1,0.0
NPC,1,0.0
SSVMod,1,0.0
NIHSSMod,1,0.0
recalibrate,1,0.0
billion-atom,1,0.0
surmounted,1,0.0
Phosphokinase,1,0.0
SISPA,1,0.0
Illuminas,1,0.0
aspirinclopidogrel,1,0.0
heparinlow,1,0.0
heparindirect,1,0.0
3D-CTs,1,0.0
4DCTs,1,0.0
local-amplitude,1,0.0
Sentinel™,1,0.0
C-RAD,1,0.0
29±37,1,0.0
27±26,1,0.0
27±22,1,0.0
50±36,1,0.0
35±25,1,0.0
37±27,1,0.0
short-and,1,0.0
neural–mucosal,1,0.0
sensitisers,1,0.0
Chrome,1,0.0
likeminded,1,0.0
DGRh,1,0.0
necessary-especially,1,0.0
epithelialmesenchymal,1,0.0
non‐respiratory,1,0.0
Runge-Kutta-based,1,0.0
forward-backward,1,0.0
stimulations,1,0.0
Isoflurane,1,0.0
polysyndactyly,1,0.0
Bardet-Biedl,1,0.0
Ohasama,1,0.0
1-skewed,1,0.0
Ad26COV2S-vaccinated,1,0.0
rupture-prone,1,0.0
60-mm-long,1,0.0
201-item,1,0.0
interviewer-assisted,1,0.0
358-1324,1,0.0
278-998,1,0.0
Borderzone,1,0.0
psychosomatic-somatopsychic,1,0.0
--treatment,1,0.0
--information,1,0.0
--coping,1,0.0
--development,1,0.0
1965-9,1,0.0
populationNine,1,0.0
1960-4,1,0.0
characteristicsOral,1,0.0
persanality,1,0.0
monochorionic,1,0.0
mood-related,1,0.0
11140,1,0.0
Nanoscale,1,0.0
specificityisotype,1,0.0
arehospitable,1,0.0
egg-shaped,1,0.0
Survivor,1,0.0
austral,1,0.0
±174,1,0.0
2225,1,0.0
bed-occupation,1,0.0
hi-frequency,1,0.0
Neuropilin-1,1,0.0
lead-,1,0.0
VEGF-A-NRP-1,1,0.0
EG00229,1,0.0
VEGFR2,1,0.0
-539,1,0.0
-519,1,0.0
Hyperoxia,1,0.0
0411-0900,1,0.0
0880-0951,1,0.0
1041-1098,1,0.0
1180,1,0.0
1140-1221,1,0.0
0868-0926,1,0.0
positing,1,0.0
premised,1,0.0
Barbadian,1,0.0
hyperspecificity,1,0.0
Incontinentia,1,0.0
panINFLU,1,0.0
sINFLU,1,0.0
hydroxyvitamin,1,0.0
non-peptide,1,0.0
vain,1,0.0
agonist-induced,1,0.0
autacoids,1,0.0
tri-axial,1,0.0
Thoracolithiasis,1,0.0
gadolinium-diethylene-triamine,1,0.0
pseudo-infarct,1,0.0
4071,1,0.0
2389-4120,1,0.0
air-conditioned,1,0.0
bad-ventilated,1,0.0
market-leading,1,0.0
community-managed,1,0.0
8148,1,0.0
high-squat,1,0.0
deep-squat,1,0.0
transmissibilitysignal,1,0.0
knees,1,0.0
CXCL10CXCR3,1,0.0
Leg,1,0.0
body-weight,1,0.0
DESIGNMETHOD,1,0.0
week-103,1,0.0
201738387-392,1,0.0
non-pooled,1,0.0
first-round,1,0.0
near-optimal,1,0.0
injurys,1,0.0
Polymer-based,1,0.0
nanobiosensing,1,0.0
biodegradability,1,0.0
target-vessel,1,0.0
optimality,1,0.0
glaring,1,0.0
Activity-based,1,0.0
populationsThe,1,0.0
2170,1,0.0
3633,1,0.0
3340,1,0.0
5592,1,0.0
gas-phase,1,0.0
LAIV3,1,0.0
centrifuged,1,0.0
chi2093,1,0.0
A2Aichi268,1,0.0
P004Serological,1,0.0
troughs,1,0.0
2967,1,0.0
1448,1,0.0
Rudolf,1,0.0
1860s,1,0.0
miliary,1,0.0
Bouchard,1,0.0
agrégation,1,0.0
professorship,1,0.0
protégés,1,0.0
Gilles,1,0.0
Tourette,1,0.0
arthropathies,1,0.0
7-day-Holter,1,0.0
7-d-Holter,1,0.0
24-h-Holter,1,0.0
1994-2005,1,0.0
5-34-year,1,0.0
1959-79,1,0.0
5973,1,0.0
usages,1,0.0
infectible,1,0.0
pamidronate,1,0.0
Time-of-day,1,0.0
OBJECTIVECerebral,1,0.0
perfusion-dependent,1,0.0
populationMETHODSA,1,0.0
imagingRESULTSAt,1,0.0
recordedCONCLUSIONSCerebral,1,0.0
up-front,1,0.0
Rab,1,0.0
glycosylphosphatidylinositol,1,0.0
essentiality,1,0.0
Neuroradiological,1,0.0
haemodialysis--including,1,0.0
haemodialysis--seemed,1,0.0
antiC5a,1,0.0
pan-virus,1,0.0
asthma--persistence,1,0.0
others--remain,1,0.0
1972-92,1,0.0
Concussion,1,0.0
Swapping,1,0.0
nearness,1,0.0
280400,1,0.0
resurvey,1,0.0
inspecting,1,0.0
hmodynamic,1,0.0
EMSs,1,0.0
BloodNational,1,0.0
microNT,1,0.0
1977-9,1,0.0
fashions,1,0.0
SIGN,1,0.0
testspatient,1,0.0
easy-to-determine,1,0.0
underarm,1,0.0
Jebsen,1,0.0
JTHFT,1,0.0
2008-2011,1,0.0
Conflict,1,0.0
Aimshypothesis,1,0.0
Steno-2,1,0.0
10822013,1,0.0
eighty-five,1,0.0
dysuria,1,0.0
dislipidaemia,1,0.0
8118,1,0.0
5881,1,0.0
7529,1,0.0
5176,1,0.0
4824,1,0.0
7882,1,0.0
3765,1,0.0
5484,1,0.0
40000-50000,1,0.0
16000-20000,1,0.0
30000-40000,1,0.0
up-date,1,0.0
24-well,1,0.0
bayesian,1,0.0
VA-New,1,0.0
Harbor,1,0.0
Multimorbidities,1,0.0
201Tl-SPECT,1,0.0
ventriculographically,1,0.0
scintigram--among,1,0.0
Rob,1,0.0
5-52,1,0.0
placoid,1,0.0
epitheliopathy,1,0.0
APMPPE,1,0.0
oversimplifications,1,0.0
pneumococcus-influenza,1,0.0
multipathogen,1,0.0
cerebellum-brainstem,1,0.0
200453No,1,0.0
RR-61-40,1,0.0
BJilin202003,1,0.0
payoffs,1,0.0
Eastcott,1,0.0
Clamping,1,0.0
odorants,1,0.0
Hollenhorst,1,0.0
odds-ratios,1,0.0
snorers,1,0.0
intima-media-thickness,1,0.0
apneics,1,0.0
cerebri,1,0.0
noradrensine,1,0.0
non-apneic,1,0.0
allergenantigen,1,0.0
low-speed,1,0.0
Fragrances,1,0.0
fragranced,1,0.0
non-irritating,1,0.0
thrombopoietin,1,0.0
Thrombocytopenic,1,0.0
Purpura,1,0.0
14980,1,0.0
nonexertional,1,0.0
elavation,1,0.0
vasospastic-type,1,0.0
cohortMethods,1,0.0
RTIsResults,1,0.0
75665,1,0.0
6397,1,0.0
68733,1,0.0
1938759,1,0.0
1271457,1,0.0
149461,1,0.0
115927,1,0.0
1005-1247,1,0.0
1586,1,0.0
1197-2103,1,0.0
0001Conclusions,1,0.0
size-dependent,1,0.0
L-GOs,1,0.0
RhoA-ROCK-MLC,1,0.0
cytoskeleton-dependent,1,0.0
nanozipper,1,0.0
L-GO-adjuvanted,1,0.0
suprasternal,1,0.0
spreaded,1,0.0
administrate,1,0.0
performancs,1,0.0
QuidelUSA,1,0.0
Platelet-active,1,0.0
mid-phase,1,0.0
eosinophil-dependent,1,0.0
p046,1,0.0
113-160,1,0.0
RealAmp,1,0.0
ORF5,1,0.0
SarbecoV,1,0.0
interepisode,1,0.0
walker,1,0.0
Virus-induced,1,0.0
SEMICYUC,1,0.0
SingHealth,1,0.0
Polyclinics,1,0.0
nitrofurazone,1,0.0
hairpins,1,0.0
QuantaBio,1,0.0
Invitrogen,1,0.0
GeneFinder™,1,0.0
Osang,1,0.0
Sano,1,0.0
genesig®,1,0.0
Primerdesign,1,0.0
ViroReal®,1,0.0
Ingenetix,1,0.0
Fleiss-Kappa,1,0.0
58ABSTRACT,1,0.0
EPs,1,0.0
submedial,1,0.0
reobstructing,1,0.0
Well-recognized,1,0.0
microangiopathies,1,0.0
Sano-Kosei,1,0.0
131877,1,0.0
sod,1,0.0
60-Minutes,1,0.0
Pseudovirus,1,0.0
examinatory,1,0.0
justicidin,1,0.0
euphol,1,0.0
curine,1,0.0
Paul-Ehrlich-Society,1,0.0
vented-electric,1,0.0
Woburn,1,0.0
intrathoracically,1,0.0
sternotomies,1,0.0
informant-based,1,0.0
dementiamultidomain,1,0.0
load-stratified,1,0.0
CBCs,1,0.0
≤90,1,0.0
≤180×103μL,1,0.0
001μL,1,0.0
≥173,1,0.0
2304,1,0.0
91-583,1,0.0
CBC-based,1,0.0
oligosymptomatic,1,0.0
AVE,1,0.0
alacrity,1,0.0
experience-driven,1,0.0
Edelta,1,0.0
-uninfected,1,0.0
Rosenberg,1,0.0
Self-Esteem,1,0.0
investigator-developed,1,0.0
often-reported,1,0.0
glycyrrhetic,1,0.0
ethamidindole,1,0.0
Allegra,1,0.0
httpsmrcppu-covidbio,1,0.0
prevailingly,1,0.0
Giovanni,1,0.0
Dio,1,0.0
ectosomes,1,0.0
bi-layered,1,0.0
nanoassembly,1,0.0
biodegradation,1,0.0
reamberine,1,0.0
Airspace,1,0.0
phorbol,1,0.0
myristate,1,0.0
unaccustomed,1,0.0
apilimod,1,0.0
geriatric-related,1,0.0
fexofenadine,1,0.0
extra-esophageal,1,0.0
bronchspasm,1,0.0
Makefu,1,0.0
ABangkok179H3N3,1,0.0
axoxia,1,0.0
aortisc,1,0.0
postdilation,1,0.0
stifled,1,0.0
snap-frozen,1,0.0
self-regulatory,1,0.0
ﬁrst,1,0.0
ﬁnd,1,0.0
Atovaquone,1,0.0
pinning,1,0.0
A701V,1,0.0
Hes,1,0.0
N1-gene,1,0.0
salivatears,1,0.0
chromatography-laser-induced,1,0.0
photoacoustic,1,0.0
chemiluminiscence,1,0.0
aevit,1,0.0
hemocoagulation,1,0.0
strontium,1,0.0
nonspecialty,1,0.0
wooded,1,0.0
epidemically,1,0.0
non-caucasian,1,0.0
thrills,1,0.0
18514,1,0.0
Co-endemicity,1,0.0
SARS-CoV-2DV,1,0.0
anti-S1-RBD-SARS-CoV-2,1,0.0
disperses,1,0.0
Evaporation,1,0.0
coalesce,1,0.0
lamps,1,0.0
hospitalintensive,1,0.0
stayadmission,1,0.0
COVID-19-confirmed,1,0.0
V-20,1,0.0
6364,1,0.0
6452,1,0.0
4537,1,0.0
8077,1,0.0
high-capacity,1,0.0
Tears,1,0.0
biomarkersExpert,1,0.0
infectionsAreas,1,0.0
Hypertensives,1,0.0
structurefunction,1,0.0
StrokEDGE,1,0.0
2017-2020,1,0.0
1--occlusion,1,0.0
2--occlusion,1,0.0
3--subtotal,1,0.0
Proponents,1,0.0
rightsresponsibilities,1,0.0
Eightysix,1,0.0
most-widely,1,0.0
cardioselectivity,1,0.0
declineDespite,1,0.0
determinedISSYS,1,0.0
multi-omic,1,0.0
≤120,1,0.0
473864,1,0.0
N-delta-acetylornithine,1,0.0
d171241,1,0.0
tricosanoyl,1,0.0
d181230,1,0.0
epigenomic,1,0.0
smoking-associated,1,0.0
B-Ditcel,1,0.0
coagulogram,1,0.0
intermittency,1,0.0
fallaciously,1,0.0
A-D,1,0.0
5-bromodeoxyuridine,1,0.0
mastermixes,1,0.0
EN1,1,0.0
D253G,1,0.0
Orf1abN1,1,0.0
WAS,1,0.0
Address,1,0.0
Neuropediatric,1,0.0
0183100,1,0.0
motorsensory,1,0.0
hemisyndrome,1,0.0
535512,1,0.0
-0365,1,0.0
symptomaticcarotid,1,0.0
homolateral,1,0.0
strokethe,1,0.0
well-immunised,1,0.0
log-lank,1,0.0
1354,1,0.0
208-987,1,0.0
0537,1,0.0
≈400,1,0.0
AH1N1pdm09-negative,1,0.0
schoolchild,1,0.0
NO3,1,0.0
Levitan,1,0.0
Teiramaa,1,0.0
Mrazek,1,0.0
Steinhausen,1,0.0
chiropteran,1,0.0
upside,1,0.0
contactless,1,0.0
Microsampling,1,0.0
Wide-scale,1,0.0
051-056,1,0.0
LASSO,1,0.0
Shrinkage,1,0.0
anti-inference,1,0.0
Alien,1,0.0
time-equivalent,1,0.0
cerebellar-cortical,1,0.0
Peri-infarct,1,0.0
Seegene®,1,0.0
Invalid,1,0.0
2®,1,0.0
time-to-results,1,0.0
-0411,1,0.0
-0494,1,0.0
-0157,1,0.0
-0568,1,0.0
alpha2-agonists,1,0.0
bare-,1,0.0
suspecteddiagnosed,1,0.0
Odette,1,0.0
ON,1,0.0
provincially,1,0.0
OCCs,1,0.0
genomics-guided,1,0.0
syndromal,1,0.0
corticoparietal,1,0.0
well-differentiable,1,0.0
biotechnology-based,1,0.0
CRISPRCas-mediated,1,0.0
CRISPRCas13d,1,0.0
transitoy,1,0.0
Analagous,1,0.0
2014711311-1318,1,0.0
GuideLiner,1,0.0
intermedius,1,0.0
strainspecificity,1,0.0
1973--March,1,0.0
∼7,1,0.0
capillariesarterioles,1,0.0
refocus,1,0.0
immunosubdominant,1,0.0
Computer-based,1,0.0
physician-led,1,0.0
Airtopia,1,0.0
hyperesponsiveness,1,0.0
Modeler,1,0.0
STEM,1,0.0
wwweclipseorgstem,1,0.0
shook,1,0.0
Opening,1,0.0
Guiding,1,0.0
school-directed,1,0.0
handface,1,0.0
school-initiated,1,0.0
synergized,1,0.0
InterleukinIL-37,1,0.0
9-fold,1,0.0
7000-fold,1,0.0
microglia-macrophages,1,0.0
semiotics,1,0.0
MSKCC,1,0.0
African-descent,1,0.0
nonPSC,1,0.0
favourites,1,0.0
Smooth,1,0.0
BYamagata173,1,0.0
Immunoadsorption,1,0.0
ModernaNIAID,1,0.0
Chorea,1,0.0
mafodotin,1,0.0
belamaf,1,0.0
treatment-free,1,0.0
20979,1,0.0
015-020,1,0.0
AV-plane,1,0.0
short-haired,1,0.0
ovariohysterectomy,1,0.0
Talisman,1,0.0
Sabre,1,0.0
HMNZS,1,0.0
AustraliansNew,1,0.0
2888,1,0.0
2189,1,0.0
eradicates,1,0.0
102-year-old,1,0.0
rebellion,1,0.0
Survey-2003,1,0.0
Featuring,1,0.0
double-digit,1,0.0
TIA-s,1,0.0
hypophyseal-adrenal,1,0.0
one-stage,1,0.0
leisureliness,1,0.0
fisheries,1,0.0
manhood,1,0.0
drown,1,0.0
Weak,1,0.0
Hemichorea,1,0.0
ever-changing,1,0.0
85-698,1,0.0
54-535,1,0.0
47-552,1,0.0
QRS-vector,1,0.0
160-170,1,0.0
83911,1,0.0
antipyreticsanalgesics,1,0.0
bite-related,1,0.0
rats-stroke,1,0.0
overactivated,1,0.0
non-Maoris,1,0.0
∼15kDa,1,0.0
blood-stream,1,0.0
ICI-204219,1,0.0
35151,1,0.0
1915-1921,1,0.0
21334,1,0.0
1915-1925,1,0.0
Cobas®SARS-CoV-2,1,0.0
Aptima®,1,0.0
tachyarrhythmic,1,0.0
con-cordance,1,0.0
Network®,1,0.0
consents,1,0.0
extracorpereal,1,0.0
mycochemical,1,0.0
Inonotus,1,0.0
terpenoid,1,0.0
inonotusane,1,0.0
anti-Severe,1,0.0
10-39,1,0.0
Delineated,1,0.0
macroaggregates,1,0.0
deacylase,1,0.0
antagonises,1,0.0
1791,1,0.0
parascientific,1,0.0
featureobject,1,0.0
Polokwane,1,0.0
Limpopo,1,0.0
flush,1,0.0
toileta,1,0.0
Premedication,1,0.0
mishandling,1,0.0
scented,1,0.0
fresheners,1,0.0
racialethic,1,0.0
pirphotech,1,0.0
ultrasounding,1,0.0
MOG-antibody,1,0.0
viperin-previously,1,0.0
CDSCO,1,0.0
B11351,1,0.0
20201202,1,0.0
66-years,1,0.0
chef,1,0.0
Empowering,1,0.0
Adjustable,1,0.0
Complementing,1,0.0
TFAs,1,0.0
Initiative-Observational,1,0.0
asthmaclinically,1,0.0
HDAC11-depleted,1,0.0
genes-IFITM3,1,0.0
belantamab,1,0.0
Mabs,1,0.0
SMM,1,0.0
phase-mapping,1,0.0
hyperglycolysis,1,0.0
hyperglycolytic,1,0.0
OC-defined,1,0.0
OC-MRI,1,0.0
November--December,1,0.0
codominated,1,0.0
Zerem,1,0.0
12yo,1,0.0
c19631964dupAT,1,0.0
pIle382Met,1,0.0
OPA1,1,0.0
SLEstroke-like,1,0.0
tomography-based,1,0.0
xylazine,1,0.0
CD11,1,0.0
physician-defined,1,0.0
Roaring,1,0.0
Adventures,1,0.0
Puff,1,0.0
practice-changing,1,0.0
inflammation-,1,0.0
immune-associated,1,0.0
293i,1,0.0
CCID50,1,0.0
vaccine-immunized,1,0.0
anthropic,1,0.0
Bambarén,1,0.0
Alatrista,1,0.0
MdS,1,0.0
autoradiograms,1,0.0
μCikg,1,0.0
14C2-deoxyglucose,1,0.0
0925,1,0.0
eventABSTRACT,1,0.0
Wine,1,0.0
Picornaviridae,1,0.0
Regrettably,1,0.0
2322,1,0.0
imformation,1,0.0
Sleep-related,1,0.0
kitsreagents,1,0.0
biorepository,1,0.0
Extracta,1,0.0
Quibasa,1,0.0
Lucigen,1,0.0
assayskits,1,0.0
Mohammed,1,0.0
biotracer,1,0.0
universitary,1,0.0
blogging,1,0.0
electromyostimulation,1,0.0
PATRIARCH,1,0.0
Myorhythm-040,1,0.0
buttocks,1,0.0
WaSH,1,0.0
EOL,1,0.0
PCEOL,1,0.0
important-with,1,0.0
door-,1,0.0
to-door,1,0.0
Adan,1,0.0
2018332197-200,1,0.0
pleuroparenchymal,1,0.0
RNA-targeted,1,0.0
optics,1,0.0
digestionremoval,1,0.0
TIM4,1,0.0
Rab5,1,0.0
Rab7,1,0.0
AFAfl,1,0.0
reinfecting,1,0.0
self-assemble,1,0.0
Constraint-induced,1,0.0
Multi-modality,1,0.0
open-blinded,1,0.0
easy-to-collect,1,0.0
99MTc-PYP,1,0.0
well-orchestrated,1,0.0
vestibulopathy,1,0.0
moderate-altitude,1,0.0
2230,1,0.0
level7314,1,0.0
4-times,1,0.0
afternoonearly,1,0.0
thickeningdilatation,1,0.0
tree-in-bud,1,0.0
viscerum,1,0.0
16-48,1,0.0
176-1398,1,0.0
267-1457,1,0.0
24-134,1,0.0
s2m,1,0.0
∼102,1,0.0
structure-restrained,1,0.0
BCG-treated,1,0.0
Intranasally,1,0.0
Efferocytosis,1,0.0
Oronasopharyngeal,1,0.0
doubtless,1,0.0
anatomist,1,0.0
interface-assisted,1,0.0
sham-tDCS,1,0.0
A-infected,1,0.0
metabonomics,1,0.0
Pyrrolidine,1,0.0
dithiocarbamate,1,0.0
nordihydroguaiaretic,1,0.0
200049No,1,0.0
RR-31-38,1,0.0
Stro-3,1,0.0
1-28,1,0.0
discomfortable,1,0.0
cognitive-behaviour,1,0.0
9441,1,0.0
ProteinsPeptides,1,0.0
HDPs,1,0.0
brilacidin-a,1,0.0
HDPs-on,1,0.0
Brilacidin,1,0.0
stripping,1,0.0
2040,1,0.0
Scheimfplug,1,0.0
Slit-lamp,1,0.0
sclera,1,0.0
Muro,1,0.0
obfuscating,1,0.0
Correlational,1,0.0
subjective-objective,1,0.0
CYPs,1,0.0
Hospitalario,1,0.0
Nuclepore,1,0.0
clogging,1,0.0
4372,1,0.0
79-94,1,0.0
accentuates,1,0.0
chronicling,1,0.0
Dopplers,1,0.0
5869,1,0.0
MITRA,1,0.0
P0053,1,0.0
P0056,1,0.0
0062,1,0.0
OR046,1,0.0
P00230,1,0.0
glycolization,1,0.0
RBP,1,0.0
out-compete,1,0.0
Administered,1,0.0
illness-associated,1,0.0
community-minded,1,0.0
lament,1,0.0
Colo,1,0.0
Colorados,1,0.0
non-consecutive,1,0.0
V4-5,1,0.0
midanterolateral,1,0.0
co-ordinates,1,0.0
feeds,1,0.0
PRIAMHO,1,0.0
4405,1,0.0
4762,1,0.0
BIO,1,0.0
49±81,1,0.0
046-072,1,0.0
044-071,1,0.0
045-069,1,0.0
052-092,1,0.0
pseudo-continuous,1,0.0
pCASL,1,0.0
-89,1,0.0
trans-telephonic,1,0.0
8557768,1,0.0
565±1063,1,0.0
67±859,1,0.0
p0685,1,0.0
98±175,1,0.0
p0381,1,0.0
third-highest,1,0.0
Normalisation,1,0.0
side-effects--such,1,0.0
pneumonia--it,1,0.0
profiteering,1,0.0
Retired,1,0.0
expressionfunction,1,0.0
transcriptase-Polymerase,1,0.0
A-16,1,0.0
B-10,1,0.0
pause-dependent,1,0.0
prolongtion,1,0.0
cases10000,1,0.0
sub-endocardium,1,0.0
Agudo,1,0.0
unhomogeneous,1,0.0
shock--489,1,0.0
Soldering,1,0.0
infusive-transfusive,1,0.0
TamifluRelenza,1,0.0
BIPAR,1,0.0
corner-stones,1,0.0
Proteolytic,1,0.0
standardbaseline,1,0.0
physio-kinesiotherapy,1,0.0
spa-based,1,0.0
mixed-granulocytic,1,0.0
0828,1,0.0
0939,1,0.0
0844,1,0.0
Psychic,1,0.0
acutely-infarcted,1,0.0
65-67,1,0.0
115-86,1,0.0
175-147,1,0.0
183-91,1,0.0
acutely-ischemic,1,0.0
Pericardiocentesis,1,0.0
myeloblastin,1,0.0
11D,1,0.0
lymphocyte-,1,0.0
testisin,1,0.0
non-peptidic,1,0.0
Gaithersburg,1,0.0
Firule,1,0.0
vas,1,0.0
2-72,1,0.0
Autumn,1,0.0
А,1,0.0
VI-CVST,1,0.0
leucaemia,1,0.0
irons,1,0.0
depilatory,1,0.0
slaughtered,1,0.0
anti-slipping,1,0.0
cream,1,0.0
ballet,1,0.0
cello,1,0.0
MI-classification,1,0.0
149026,1,0.0
vaccinatedp,1,0.0
point-of-view,1,0.0
Illness-related,1,0.0
17-71y,1,0.0
lower-priority,1,0.0
protopathic,1,0.0
quality-of-care,1,0.0
Graphene-related,1,0.0
GRM-based,1,0.0
showcased,1,0.0
Foreseeing,1,0.0
war-torn,1,0.0
nsp78,1,0.0
nsp7s,1,0.0
EPI-DWI,1,0.0
Merrem,1,0.0
atrialfibrillation,1,0.0
ICMR-approved,1,0.0
asthmaAnswer,1,0.0
infarction--500,1,0.0
interinfarction,1,0.0
Inherited,1,0.0
meta-differences,1,0.0
n1218,1,0.0
n1602,1,0.0
7494,1,0.0
datetime,1,0.0
definedABSTRACT,1,0.0
research-sharing,1,0.0
chanches,1,0.0
analize,1,0.0
explaine,1,0.0
enviroment,1,0.0
aspirinNSAID,1,0.0
-class,1,0.0
area--length,1,0.0
39x,1,0.0
41x,1,0.0
EFV,1,0.0
0420,1,0.0
1125-2150,1,0.0
100-138,1,0.0
288-2669,1,0.0
diagnoseCase,1,0.0
15-day-old,1,0.0
mottling,1,0.0
conditionConclusion,1,0.0
Stroke-risk,1,0.0
non-time-consuming,1,0.0
FMC,1,0.0
2-month-old,1,0.0
meterological,1,0.0
Naso-esophageal,1,0.0
Onset-to-door,1,0.0
1297-7217,1,0.0
081-124,1,0.0
at-riskelderly,1,0.0
Pathomorphological,1,0.0
Vivid,1,0.0
hyperresponsiveness--a,1,0.0
JBs,1,0.0
patient--namely,1,0.0
severeresistent,1,0.0
non-symptom-based,1,0.0
sel-fassessed,1,0.0
multivariately,1,0.0
6154,1,0.0
019-055,1,0.0
046-082,1,0.0
037-103,1,0.0
1108-8011,1,0.0
smm2,1,0.0
0531,1,0.0
008-094,1,0.0
150-832,1,0.0
106-162,1,0.0
214-3409,1,0.0
134-737,1,0.0
46-528,1,0.0
12-200,1,0.0
over-65,1,0.0
One-person,1,0.0
Two-person,1,0.0
2980,1,0.0
meta-odds,1,0.0
063-082,1,0.0
Traits,1,0.0
four-to,1,0.0
Villagers,1,0.0
DENV-endemic,1,0.0
streptase,1,0.0
Neiserria,1,0.0
Non-infectious,1,0.0
ICU-admission,1,0.0
ventilator-use,1,0.0
TFC-MS,1,0.0
1300-1800,1,0.0
case-detection,1,0.0
SIDARTHE,1,0.0
model2,1,0.0
paces,1,0.0
298000,1,0.0
open-close,1,0.0
dispersive,1,0.0
161807,1,0.0
Minireview,1,0.0
bronkhoobstruktivny,1,0.0
If-blockers,1,0.0
COVID-19-pandemic,1,0.0
thrombocytropenia,1,0.0
adeno-vector,1,0.0
Ad26COV2-S,1,0.0
3-30-day,1,0.0
Settling,1,0.0
2364,1,0.0
andautologous,1,0.0
twice--before,1,0.0
1-km,1,0.0
RECOVERY,1,0.0
conflate,1,0.0
FENO-guided,1,0.0
six-fold,1,0.0
kpmmin-1,1,0.0
138175,1,0.0
Dys20,1,0.0
potectin,1,0.0
PDX,1,0.0
15-lipoxygenase,1,0.0
17S-HpDHA,1,0.0
17HDHA,1,0.0
Oxygenated,1,0.0
MEF75,1,0.0
62698,1,0.0
layover,1,0.0
28-43,1,0.0
Apps,1,0.0
937-1000,1,0.0
110-285,1,0.0
172-369,1,0.0
Susceptible-Infectious,1,0.0
postguideline,1,0.0
hematothorax,1,0.0
stent-implantation,1,0.0
Vasopressin,1,0.0
Baystate,1,0.0
H5NI,1,0.0
11-26,1,0.0
polyradiculoneuropathy,1,0.0
tiotrohium,1,0.0
SOLVD,1,0.0
Deteriorating,1,0.0
decannulated,1,0.0
diseaseWhat,1,0.0
FEV1reversibility,1,0.0
period1,1,0.0
quadratically,1,0.0
non-Thai,1,0.0
mvRNAs,1,0.0
intravesical,1,0.0
diastases,1,0.0
divarication,1,0.0
abdominis,1,0.0
myofascial,1,0.0
hydrometer,1,0.0
DCCT,1,0.0
WOSCOPS,1,0.0
risked,1,0.0
Berkhemer,1,0.0
201537211-20,1,0.0
90days,1,0.0
perfusion-imaging,1,0.0
Campbell,1,0.0
20153721009-18,1,0.0
20153721019-30,1,0.0
20153722285-95,1,0.0
8h,1,0.0
Jovin,1,0.0
3722296-306,1,0.0
Barrow,1,0.0
BRAT,1,0.0
clippings,1,0.0
Spetzler,1,0.0
obstruction•,1,0.0
function•,1,0.0
hesitancy-reluctance,1,0.0
obstructionWhat,1,0.0
MG772933,1,0.0
MG772934,1,0.0
62000,1,0.0
Wake-time-adjusted,1,0.0
frantic,1,0.0
gustation,1,0.0
1964-1974,1,0.0
asinfluenza,1,0.0
EAI,1,0.0
mediocolegal,1,0.0
examinedthough,1,0.0
287651,1,0.0
immuno-inhibition,1,0.0
fluorimetric,1,0.0
immuno-enzymological,1,0.0
infero-lateral-basal,1,0.0
malnourished,1,0.0
65-97,1,0.0
hypoproteinemia,1,0.0
PaO₂,1,0.0
PaCO₂,1,0.0
Ping-pong,1,0.0
rhythmical,1,0.0
saccadic,1,0.0
75-kg,1,0.0
covid19bioreproducibilityorg,1,0.0
expert-verified,1,0.0
wellpartly,1,0.0
FEV1Conclusion,1,0.0
JNS,1,0.0
2015123609-17,1,0.0
ISAT,1,0.0
Molyneux,1,0.0
anti-Xa,1,0.0
Pathozyme,1,0.0
ZstatFlu,1,0.0
formatted,1,0.0
many-fold,1,0.0
organlife-threatening,1,0.0
3140,1,0.0
non-autonomous,1,0.0
5279376,1,0.0
13042,1,0.0
arthalgia,1,0.0
pharyngodynia,1,0.0
aspirin-relieved,1,0.0
Interferes,1,0.0
«It,1,0.0
data»,1,0.0
relaunch,1,0.0
EBM-based,1,0.0
ebghit,1,0.0
Diabeteshyperglycemia-triggered,1,0.0
Kinsa,1,0.0
sells,1,0.0
Prices,1,0.0
Pricing,1,0.0
prizes,1,0.0
non-African-American,1,0.0
nAA,1,0.0
TwTtot,1,0.0
pitched,1,0.0
75300,1,0.0
176-fold,1,0.0
56-fold,1,0.0
ABCD3-I,1,0.0
2015385691-7,1,0.0
Yang,1,0.0
201577241-7,1,0.0
Diazepam,1,0.0
OBJECTIVESeveral,1,0.0
Ideal,1,0.0
MACMETHODSThe,1,0.0
methodsRESULTSOf,1,0.0
male-to-female,1,0.0
1814,1,0.0
0021CONCLUSIONSThe,1,0.0
GAClinical,1,0.0
NCT03036631,1,0.0
123Iiodophenylpentadecanoic,1,0.0
00406,1,0.0
15O-water,1,0.0
IPPA-viable,1,0.0
IPPA-SPECT-TI,1,0.0
0536,1,0.0
2635,1,0.0
Diagnóstica,1,0.0
109112,1,0.0
RT-PCRRAD,1,0.0
101108,1,0.0
2014-2017,1,0.0
adenosine-treated,1,0.0
00121,1,0.0
slowlier,1,0.0
Bat-SARS-like,1,0.0
Neighbor-joining,1,0.0
subgenera,1,0.0
166-319,1,0.0
SDI,1,0.0
PCR-CI,1,0.0
sub-epicardiac,1,0.0
cancer-free,1,0.0
Bnai,1,0.0
Zion,1,0.0
supportiveness,1,0.0
Supportiveness,1,0.0
1962-63,1,0.0
duringafter,1,0.0
overdoses,1,0.0
2004-January,1,0.0
CMRglu,1,0.0
subdomain,1,0.0
noradrenalin,1,0.0
pericostal,1,0.0
splint,1,0.0
immutable,1,0.0
Gln493,1,0.0
2019-nCoVs,1,0.0
Asn501,1,0.0
2019-nCoVIMPORTANCE,1,0.0
reiterative,1,0.0
AHRQ,1,0.0
2821,1,0.0
1088087,1,0.0
558-822,1,0.0
3385‰,1,0.0
1377-5394,1,0.0
62761,1,0.0
deducted,1,0.0
NZ378,1,0.0
4620,1,0.0
1972-86,1,0.0
254402,1,0.0
64-113,1,0.0
30-66,1,0.0
markers-eosinophil,1,0.0
protein-X-were,1,0.0
protein-X,1,0.0
5793,1,0.0
Presumptively,1,0.0
eastward,1,0.0
s-antigen,1,0.0
193-691,1,0.0
S-antibodies,1,0.0
1240-7820,1,0.0
NZ469,1,0.0
S-antibody,1,0.0
myoglobincarboanhydrase,1,0.0
MyoCAIII,1,0.0
nove,1,0.0
nonvaccination,1,0.0
NZ1,1,0.0
US05458,1,0.0
NZ142,1,0.0
NZ1778,1,0.0
NZ535,1,0.0
NZ6718,1,0.0
NZ4940,1,0.0
NZ104,1,0.0
242‰,1,0.0
non-SE,1,0.0
shift--the,1,0.0
Significance,1,0.0
brightness,1,0.0
3σslope,1,0.0
Dzungarian,1,0.0
Dwarf,1,0.0
40s,1,0.0
seeming,1,0.0
homocysteinemia,1,0.0
colchicine-a,1,0.0
rheumatism-may,1,0.0
COLCOT,1,0.0
adjustement,1,0.0
WCC,1,0.0
Folkmans,1,0.0
varimax,1,0.0
Problem-focused,1,0.0
Emotion-focused,1,0.0
Social-support,1,0.0
dandelion,1,0.0
clock-like,1,0.0
clinicl,1,0.0
p100,1,0.0
vectorcardiographical,1,0.0
electrocardiogramme,1,0.0
frequencyseverity,1,0.0
childrenyoung,1,0.0
onsetcomplicated,1,0.0
appendicial,1,0.0
perforationabscess,1,0.0
incidenceseverity,1,0.0
4-Methylumbelliferone,1,0.0
4-Methylumbelliferyl-N-acetyl-α-D-neuraminic,1,0.0
PBST,1,0.0
fullest,1,0.0
441123,1,0.0
11237285,1,0.0
E-positive,1,0.0
N2-negative,1,0.0
Recrudescence,1,0.0
July-November,1,0.0
GAD-2,1,0.0
1890s,1,0.0
pre-virological,1,0.0
nonchalant,1,0.0
invalidation,1,0.0
inflexible,1,0.0
thighs,1,0.0
MacSweeney,1,0.0
Tween-20,1,0.0
Love-Geffen,1,0.0
Say,1,0.0
Bellugi,1,0.0
Deaf,1,0.0
iconic,1,0.0
non-iconic,1,0.0
noun,1,0.0
verb,1,0.0
Sign,1,0.0
BSL,1,0.0
Smulevitch,1,0.0
11-oxalyldiimidazole,1,0.0
nanocomposite,1,0.0
AFIP,1,0.0
Rawalpindi,1,0.0
intraamniotic,1,0.0
electrical-based,1,0.0
fast-expanding,1,0.0
Aminu,1,0.0
4-min,1,0.0
occlusion4-min,1,0.0
omega-nitro-L-arginine,1,0.0
Non-COVID,1,0.0
T-follicular,1,0.0
interleukin-21,1,0.0
ICOS1,1,0.0
ICOS1-,1,0.0
IL-21-dependent,1,0.0
sulphuric,1,0.0
wideband,1,0.0
08202020,1,0.0
followirg-such,1,0.0
APhilippines1982,1,0.0
microinfarctions,1,0.0
SDSH,1,0.0
LGA,1,0.0
InterCert,1,0.0
Rhineland,1,0.0
TÜV,1,0.0
Rheinland,1,0.0
shouting,1,0.0
twice-passaged,1,0.0
Bromodeoxyuridine,1,0.0
Six-weeks,1,0.0
prestimulation,1,0.0
fast-detection,1,0.0
overlaid,1,0.0
DX,1,0.0
I120F,1,0.0
tachycard,1,0.0
X31,1,0.0
α23,1,0.0
GD1a,1,0.0
adhesion-strengthening,1,0.0
unbinding,1,0.0
ensemble-averaged,1,0.0
Ostelamivir,1,0.0
low-and-middle,1,0.0
hyperenhanced,1,0.0
Semistructured,1,0.0
Puducherry,1,0.0
favourite,1,0.0
bradycard,1,0.0
hyperlipidaemic,1,0.0
G15ST428I,1,0.0
quasi-experiment,1,0.0
ATigerHarbin012002,1,0.0
circulant,1,0.0
edges5,1,0.0
high-clustering,1,0.0
ePTFE,1,0.0
12F,1,0.0
embolizing,1,0.0
circaseptan,1,0.0
V1176F,1,0.0
B1X,1,0.0
B11X,1,0.0
B12-B13,1,0.0
enticed,1,0.0
amphetamine-induced,1,0.0
virus-membrane,1,0.0
21-year-olds,1,0.0
counterpartAntecedent,1,0.0
Renin-angiotensin-aldosterone,1,0.0
subgroupIn,1,0.0
follow-upWhether,1,0.0
Mold-infested,1,0.0
community-academic,1,0.0
Head-off,1,0.0
2007The,1,0.0
post-Katrina,1,0.0
postdisaster,1,0.0
disastersWe,1,0.0
Nano-based,1,0.0
nano-silver,1,0.0
7896,1,0.0
2902-21487,1,0.0
stitching,1,0.0
polybacterial,1,0.0
immunostimulator,1,0.0
Respivax,1,0.0
bronchospasmolytics,1,0.0
9285,1,0.0
mRNA-173,1,0.0
transpose,1,0.0
Transformants,1,0.0
10-8,1,0.0
MGTn916,1,0.0
Insertions,1,0.0
Transposon,1,0.0
hesitant-reluctant,1,0.0
4-grade,1,0.0
44-86,1,0.0
nonadaptive,1,0.0
sinking,1,0.0
Blast,1,0.0
hypohalite,1,0.0
Societys,1,0.0
Stewart,1,0.0
Nunn,1,0.0
vasovagal,1,0.0
0426,1,0.0
QTcwork-QTcrest,1,0.0
Robins,1,0.0
Breslow,1,0.0
boast,1,0.0
layered-surveillance,1,0.0
geolocalization,1,0.0
1974--1976,1,0.0
Clostridioides,1,0.0
nonregenerative,1,0.0
neuro-genesis,1,0.0
burgeon,1,0.0
allegations,1,0.0
participantsAlthough,1,0.0
N70718,1,0.0
n5617,1,0.0
nonuser,1,0.0
107-174,1,0.0
125-447,1,0.0
100-179,1,0.0
086-243,1,0.0
071-153,1,0.0
STAWASP,1,0.0
SLBs,1,0.0
hatchings,1,0.0
impelled,1,0.0
N203,1,0.0
influenza-vaccination,1,0.0
worker-immunization,1,0.0
case-definition,1,0.0
renal-transplant,1,0.0
unrecorded,1,0.0
coagulatory,1,0.0
syndrome--not,1,0.0
disease--which,1,0.0
pneumological,1,0.0
Pilates,1,0.0
rib-diaphragram,1,0.0
cicatrization-time,1,0.0
sperimental,1,0.0
imm,1,0.0
omogeneous,1,0.0
1-naphtol,1,0.0
no-invasive,1,0.0
Congregational,1,0.0
synagogues,1,0.0
masjids,1,0.0
medical-religious,1,0.0
trial-proven,1,0.0
glucocorticoids-induced,1,0.0
quasi-random,1,0.0
119-237,1,0.0
106-208,1,0.0
010-057,1,0.0
dose-,1,0.0
N140,1,0.0
Four-hundred-twelve,1,0.0
patient-risk,1,0.0
thirty-first,1,0.0
permissiveness,1,0.0
reisolates,1,0.0
Nested,1,0.0
uv-inactivated,1,0.0
fanned,1,0.0
Neurilemmomas,1,0.0
Intercostal,1,0.0
dull,1,0.0
benefits-averting,1,0.0
11M,1,0.0
design-if,1,0.0
ATaiwan86,1,0.0
Arbor86,1,0.0
student-weeks,1,0.0
Foix,1,0.0
31000,1,0.0
sinus-node,1,0.0
softenings,1,0.0
artherosclerosis,1,0.0
Pitié,1,0.0
Vulpian,1,0.0
Rochoux,1,0.0
Rostan,1,0.0
Durand-Fardel,1,0.0
Dechambre,1,0.0
Rokitansky,1,0.0
clinical-topographic,1,0.0
Déjerine,1,0.0
timing-dependent,1,0.0
polychromatic,1,0.0
31-79,1,0.0
argumentative,1,0.0
WaterLOGSY,1,0.0
Estudio,1,0.0
Epidemiológico,1,0.0
Poblacional,1,0.0
sobre,1,0.0
Accidente,1,0.0
EstEPA,1,0.0
Villegas,1,0.0
doctoral,1,0.0
Symbolic,1,0.0
Interactionism,1,0.0
2010-July,1,0.0
kriging,1,0.0
eco-epidemiological,1,0.0
disinfections,1,0.0
TJs,1,0.0
inter-relation,1,0.0
n1999,1,0.0
3109,1,0.0
drug-protein,1,0.0
httpscovirusccdrugs,1,0.0
transmissionvirus,1,0.0
forconstraints,1,0.0
wherewithal,1,0.0
determinationmodelling,1,0.0
granularities,1,0.0
tomographymagnetic,1,0.0
5146,1,0.0
07-114,1,0.0
NMR-based,1,0.0
aberration,1,0.0
1973-1976,1,0.0
Chapters,1,0.0
serendipity-based,1,0.0
RVIs,1,0.0
childadolescent,1,0.0
Sucrose,1,0.0
non-random,1,0.0
16-3,1,0.0
804000,1,0.0
78000,1,0.0
parietal-occipital,1,0.0
Pamphlets,1,0.0
ethylisopropylamiloride,1,0.0
EIPA-treatment,1,0.0
non-profit,1,0.0
artery--using,1,0.0
BCCG,1,0.0
ischaemia--can,1,0.0
Drawbacks,1,0.0
deltaN2,1,0.0
post-methacholine,1,0.0
actin-to-myosin,1,0.0
unsolvable,1,0.0
TRANSGRIPE1-2,1,0.0
retransplant,1,0.0
63-77,1,0.0
Over-protection,1,0.0
excising,1,0.0
equitably,1,0.0
Bedfordshire,1,0.0
dichorionic-diamniotic,1,0.0
2-day-old,1,0.0
HELLP,1,0.0
ΔORF7b,1,0.0
non-dihydropyridines,1,0.0
TRENT,1,0.0
SPRINT-I,1,0.0
DAVIT-I,1,0.0
DAVIT-II,1,0.0
groups-control,1,0.0
upraised,1,0.0
L452,1,0.0
T478,1,0.0
L452RT478K,1,0.0
HRM-based,1,0.0
46363,1,0.0
09278,1,0.0
02361,1,0.0
A‑kinase‑anchoring,1,0.0
ischemia‑reperfusion,1,0.0
Futuna,1,0.0
SA-galactose,1,0.0
alpha26SAalpha26Gal,1,0.0
SAalpha23Gal,1,0.0
NeuAc,1,0.0
N-glycolylneuraminic,1,0.0
NeuGc,1,0.0
NeuAcalpha26Gal,1,0.0
NeuAcalpha23Gal,1,0.0
lectin-binding,1,0.0
kindergartener,1,0.0
asthma-model,1,0.0
sham-acu-,1,0.0
ΔORF8,1,0.0
ΔORF7a,1,0.0
2019-4,1,0.0
ORF-deficient,1,0.0
IL-2CD48,1,0.0
nanovaccines-laden,1,0.0
maxim,1,0.0
adolescents--young,1,0.0
ProMED,1,0.0
ISID,1,0.0
EINet,1,0.0
multipoint,1,0.0
remodelling-related,1,0.0
beta-2-mimetrics,1,0.0
mastcell,1,0.0
stabilisators,1,0.0
unappreciable,1,0.0
20925,1,0.0
meta‑analyses,1,0.0
SARS‑CoV2,1,0.0
commemorated,1,0.0
collagen-fibre,1,0.0
Oscilloscope,1,0.0
best-managed,1,0.0
Aflunov,1,0.0
hoped-for,1,0.0
Coronavax,1,0.0
STW,1,0.0
Earth,1,0.0
79-year,1,0.0
EUL,1,0.0
-7a,1,0.0
-7b,1,0.0
u-,1,0.0
sing,1,0.0
attenu-,1,0.0
ating,1,0.0
missingness,1,0.0
42-82,1,0.0
SFV,1,0.0
HFV,1,0.0
Infarction-Thrombolysis,1,0.0
Aggrastat,1,0.0
ARIETTA,1,0.0
cell-sheets,1,0.0
SMBs,1,0.0
cases1000,1,0.0
HAVRI,1,0.0
mutationalvariant,1,0.0
hexamers-based,1,0.0
single-assay,1,0.0
early-identification,1,0.0
communitypopulation,1,0.0
glycomic,1,0.0
glycoproteomic,1,0.0
bisecting,1,0.0
GlcNAc,1,0.0
N-glycan,1,0.0
fucosylation,1,0.0
ALeningrad1341757,1,0.0
RE-SPECT,1,0.0
Etexilate,1,0.0
shock-state,1,0.0
358-503,1,0.0
11700-13700,1,0.0
1998-2013,1,0.0
55-69-year-old,1,0.0
39-72,1,0.0
4945,1,0.0
Yongyuth,1,0.0
evolution-resistant,1,0.0
autotransporter,1,0.0
jejunum,1,0.0
surface-expressed,1,0.0
vaccine-appropriate,1,0.0
face‐to‐face,1,0.0
onabotulinumtoxinA,1,0.0
injections1,1,0.0
SARS‐CoV2,1,0.0
gene‐related,1,0.0
malicious,1,0.0
healthcare-provider,1,0.0
hills,1,0.0
Yuthavong,1,0.0
SGTF1,1,0.0
productioncollagen,1,0.0
myoardial,1,0.0
BAT-CoV,1,0.0
3-plex,1,0.0
antigens-the,1,0.0
Nc,1,0.0
care-onset,1,0.0
case-comparison,1,0.0
20201,1,0.0
severity2,1,0.0
2245263,1,0.0
17452,1,0.0
1146534,1,0.0
IFN-γCD48,1,0.0
precompetitive,1,0.0
substratify,1,0.0
PbSAg2,1,0.0
LACBES®device,1,0.0
effectivenessMethods,1,0.0
ResultsLACBES®occluders,1,0.0
Endothelialization,1,0.0
LACBES®occluders,1,0.0
thermo-sensitive,1,0.0
9-95,1,0.0
11024-12048,1,0.0
Reassortants,1,0.0
visithospitalization,1,0.0
postinterventional,1,0.0
out-clinic,1,0.0
media-fueled,1,0.0
newness,1,0.0
semiautomated,1,0.0
isocyanate-based,1,0.0
superficially,1,0.0
6024,1,0.0
determinates,1,0.0
806±211,1,0.0
799±214,1,0.0
121-170,1,0.0
NCT02588664,1,0.0
SLHD,1,0.0
RACF,1,0.0
procalctinon,1,0.0
3460±1382,1,0.0
406±20,1,0.0
NIR-IIb,1,0.0
SCEsSCLs,1,0.0
eventslesions,1,0.0
near-real,1,0.0
pandemic-associated,1,0.0
2D-sketcher,1,0.0
trimmed,1,0.0
k21QA,1,0.0
C-ImmSim,1,0.0
position-specific,1,0.0
MImmunoglobulin,1,0.0
Max™,1,0.0
globin,1,0.0
glu-val,1,0.0
5°N,1,0.0
-35°S,1,0.0
2787,1,0.0
PI-,1,0.0
genomically,1,0.0
YnWm,1,0.0
n55,1,0.0
2260,1,0.0
Breakfast,1,0.0
192-item,1,0.0
095-098,1,0.0
094-098,1,0.0
HR094,1,0.0
089-099,1,0.0
EWARS,1,0.0
Dhr,1,0.0
loess,1,0.0
STL,1,0.0
TBATS,1,0.0
nanoprobe,1,0.0
QDs,1,0.0
sequence-confirmed,1,0.0
VCAM1,1,0.0
CRC,1,0.0
unimodal,1,0.0
EG2-positive,1,0.0
UCHL1,1,0.0
1995-2006,1,0.0
Neuromotor,1,0.0
Prognoses,1,0.0
myofibrillary,1,0.0
digitalis-treated,1,0.0
Readmitted,1,0.0
1021-1126,1,0.0
1426-3412,1,0.0
0444,1,0.0
0221-0894,1,0.0
Po2,1,0.0
23585,1,0.0
dog-exposed,1,0.0
wraps,1,0.0
data-derived,1,0.0
N159K,1,0.0
N173K,1,0.0
outgrew,1,0.0
NBT-test,1,0.0
215-age,1,0.0
CPJ,1,0.0
pre-occlusion,1,0.0
Prior-MI,1,0.0
qualifier,1,0.0
LAAs,1,0.0
extrahospital,1,0.0
intravitally,1,0.0
Post-introduction,1,0.0
uplift,1,0.0
ONOO-,1,0.0
mothed,1,0.0
Universally,1,0.0
cardioneurology,1,0.0
state-of,1,0.0
King68,1,0.0
distinguished-namely,1,0.0
periodFrom,1,0.0
enrollmentA,1,0.0
≥390°C,1,0.0
groupCOVID-19,1,0.0
manifestaions,1,0.0
tormented,1,0.0
mobilities,1,0.0
authorizationlisting,1,0.0
spilled,1,0.0
pneumonaie,1,0.0
rickettsia,1,0.0
Victoria-like,1,0.0
Pacemaker,1,0.0
caucasian,1,0.0
corticosteroidfast-onset,1,0.0
Papi,1,0.0
mid-30s,1,0.0
treatment--vis-á-vis,1,0.0
agents--in,1,0.0
2007-20008,1,0.0
Thombolysis,1,0.0
gasses,1,0.0
Nonreversible,1,0.0
systematism,1,0.0
millersbakers,1,0.0
intracisternal,1,0.0
Synergistic,1,0.0
Microtubules,1,0.0
hyperphosphorylated,1,0.0
multispecific,1,0.0
HCMC,1,0.0
20971-973,1,0.0
inferior-right,1,0.0
3-month-caring,1,0.0
transcortin,1,0.0
Anglo-Saxon,1,0.0
Department--Polyclinic,1,0.0
Iaşi--and,1,0.0
rhinobronchial,1,0.0
Wednesdays,1,0.0
Thursdays,1,0.0
Tuesdays,1,0.0
circannian,1,0.0
inquiry-driven,1,0.0
hone,1,0.0
prophecy,1,0.0
month-18,1,0.0
suspecteddefinite,1,0.0
wardintensive,1,0.0
wasdetected,1,0.0
mobilising,1,0.0
socio-cognitive,1,0.0
bibliographical,1,0.0
alarmist,1,0.0
STROKE-AF,1,0.0
CRD42015029251,1,0.0
22-43,1,0.0
fibrosis-mediated,1,0.0
existe,1,0.0
evidencia,1,0.0
creciente,1,0.0
ha,1,0.0
identificado,1,0.0
neurotropismo,1,0.0
sus,1,0.0
complicaciones,1,0.0
neurológicas,1,0.0
incluida,1,0.0
isquémica,1,0.0
escasamente,1,0.0
hemorragia,1,0.0
interleukin-33,1,0.0
19-38,1,0.0
IL-33-induced,1,0.0
autochthone,1,0.0
Child-generated,1,0.0
complier,1,0.0
CACE,1,0.0
12440,1,0.0
11170-13710,1,0.0
mis-,1,0.0
patient-infected,1,0.0
exposureinfection,1,0.0
mathematicians,1,0.0
6718,1,0.0
16-27,1,0.0
mobilise,1,0.0
shoemakers,1,0.0
VLA-4,1,0.0
Sanger-based,1,0.0
Tedlar,1,0.0
preconcentration,1,0.0
AMDIS,1,0.0
ELU,1,0.0
NIST,1,0.0
FIN,1,0.0
TDIMDI-induced,1,0.0
decision-maker,1,0.0
-2SDchordc,1,0.0
numberCN,1,0.0
-292,1,0.0
Farringtons,1,0.0
463-989,1,0.0
28-54,1,0.0
9364,1,0.0
Tromsø,1,0.0
Ertel,1,0.0
Tapping,1,0.0
Yeung,1,0.0
sunspotpandemic,1,0.0
un-binned,1,0.0
Sphenopalatine,1,0.0
laboratory-diagnosed,1,0.0
Placed,1,0.0
NADPH-dependent,1,0.0
oxygen-species-associated,1,0.0
pollen-associated,1,0.0
butadiene,1,0.0
tire,1,0.0
002-20,1,0.0
GC-mass,1,0.0
digging,1,0.0
late‑onset,1,0.0
ChAdOx1-SnCoV-19,1,0.0
Add,1,0.0
Maackia,1,0.0
amurensis,1,0.0
Actilyse,1,0.0
SNC,1,0.0
extra-SPC,1,0.0
intra-SPC,1,0.0
coconcomitant,1,0.0
T‑helper,1,0.0
non-Th2,1,0.0
asthma‑like,1,0.0
obesity‑associated,1,0.0
Inspectorate,1,0.0
Breath-exhaled,1,0.0
inspectorate,1,0.0
resistancehyperinsulinemia,1,0.0
nourished,1,0.0
Oncological,1,0.0
classifydetermine,1,0.0
Edinburg,1,0.0
142-item,1,0.0
intraculturally,1,0.0
interculturally,1,0.0
ethnocultural,1,0.0
hotcold,1,0.0
ethnomedical,1,0.0
exhales,1,0.0
Introducción,1,0.0
eosinophil-chemotactic,1,0.0
inventors,1,0.0
Tinetti,1,0.0
S-881-895,1,0.0
N-156-170,1,0.0
S235F,1,0.0
epitopesCONCLUSIONEpitope-resolved,1,0.0
formatsFUNDINGOntario,1,0.0
AMOSO,1,0.0
5401,1,0.0
one-hour,1,0.0
heterogeneity-focused,1,0.0
pheno-endotypes,1,0.0
unsophisticated,1,0.0
microglobulincreatinine,1,0.0
IgG1-IgG3,1,0.0
AMem171,1,0.0
protein-2,1,0.0
XYZ-leads,1,0.0
kappa035,1,0.0
Y-lead,1,0.0
York5501H3N2-like,1,0.0
AFujian41102H3N2-like,1,0.0
bronchially,1,0.0
IgE-inhibitor,1,0.0
One-Airway-One-Disease,1,0.0
AArizona82,1,0.0
facilitatorco-therapist,1,0.0
176±153,1,0.0
0556,1,0.0
mail-out,1,0.0
075-087,1,0.0
S-811-825,1,0.0
resolutionRESULTSWe,1,0.0
outcomeMETHODSUsing,1,0.0
dissipated,1,0.0
Lonicerae,1,0.0
Japonicae,1,0.0
Flos,1,0.0
Forsythiae,1,0.0
Astragali,1,0.0
Menthae,1,0.0
Haplocalycis,1,0.0
Houttuyniae,1,0.0
Folium,1,0.0
Rhei,1,0.0
Gardeniae,1,0.0
Platycodonis,1,0.0
COVID-197th,1,0.0
IFN-γ-induced,1,0.0
vaccinevaccine,1,0.0
proteinvirus-like,1,0.0
idealoptimal,1,0.0
acceptableminimal,1,0.0
stack,1,0.0
bleeding-risk,1,0.0
group-dynamic,1,0.0
rehabilitational,1,0.0
Organizstion,1,0.0
polysorbate,1,0.0
Recommendation,1,0.0
41000000,1,0.0
402-1559,1,0.0
011-02,1,0.0
573±129,1,0.0
posturography,1,0.0
0--2,1,0.0
TIME,1,0.0
positive-to-negative,1,0.0
negative-to-positive,1,0.0
Alamar,1,0.0
hedonics,1,0.0
Odour,1,0.0
CLES,1,0.0
Hyposmia,1,0.0
44-fold,1,0.0
136-fold,1,0.0
week-by-week,1,0.0
TAAR,1,0.0
GNE,1,0.0
nanomechatronics,1,0.0
newly-emerged,1,0.0
nanoplatforms,1,0.0
ACING,1,0.0
Hoyo,1,0.0
Manzanares,1,0.0
Rationed-exercise,1,0.0
thermophysiological,1,0.0
Klima-Michel,1,0.0
beta-agonists--effective,1,0.0
bronchodilators--are,1,0.0
36114,1,0.0
53114,1,0.0
Brazelton,1,0.0
Touchpoints,1,0.0
edematization,1,0.0
Sonazoid,1,0.0
286313,1,0.0
micro-simulation,1,0.0
Subtyping,1,0.0
3195,1,0.0
visualspatial,1,0.0
ICD-,1,0.0
CRT-,1,0.0
VAD-implantation,1,0.0
CBC-Diff,1,0.0
DxH,1,0.0
re-checked,1,0.0
6p21,1,0.0
Well-being,1,0.0
Short-form,1,0.0
multi-item,1,0.0
adultsMethods,1,0.0
vaccineResults,1,0.0
vaccineConclusion,1,0.0
49381,1,0.0
human‐to‐human,1,0.0
SARS‐nCoV,1,0.0
yr-old,1,0.0
12918,1,0.0
Hamiltons,1,0.0
takeaways,1,0.0
statice,1,0.0
fern,1,0.0
eucalyptus,1,0.0
Gypsophilia,1,0.0
panniculata,1,0.0
RTPCRs,1,0.0
332381,1,0.0
738-742,1,0.0
6LZG,1,0.0
throughputs,1,0.0
lesion-mapping,1,0.0
Alarming,1,0.0
poultry-keeping,1,0.0
dayto-day,1,0.0
less-positive,1,0.0
Craiova,1,0.0
Dolj,1,0.0
prevailling,1,0.0
etiopathogenically,1,0.0
17-50,1,0.0
1961-October,1,0.0
community--77,1,0.0
100000--the,1,0.0
09954,1,0.0
09949,1,0.0
policypublic,1,0.0
Splitting,1,0.0
defies,1,0.0
BGC,1,0.0
vaccinologists,1,0.0
5-to-40-year,1,0.0
Examiners,1,0.0
Metacognition,1,0.0
Self-Regulation,1,0.0
SRSI,1,0.0
Self-Awareness,1,0.0
SADI,1,0.0
Competency,1,0.0
PCRS,1,0.0
anterior-extensive,1,0.0
JUSTIFICATION,1,0.0
Annexins,1,0.0
k21,1,0.0
annexin-repertoires,1,0.0
0979,1,0.0
0876,1,0.0
0324,1,0.0
nature-inspired,1,0.0
optimizer,1,0.0
predators,1,0.0
RMSE,1,0.0
RMSRE,1,0.0
9859,1,0.0
9874,1,0.0
9595,1,0.0
6031,1,0.0
395194,1,0.0
21727,1,0.0
12979,1,0.0
ememrged,1,0.0
practioners,1,0.0
-vaccination,1,0.0
Anti-allergy,1,0.0
83-986,1,0.0
594-82,1,0.0
381-696,1,0.0
Multi-variable,1,0.0
47-132,1,0.0
Ego,1,0.0
tonsillopharyngitis,1,0.0
PWA,1,0.0
annexins,1,0.0
lymphocytesmonocytes,1,0.0
inferior-extensive,1,0.0
I--tall,1,0.0
II--significant,1,0.0
III--negativity,1,0.0
Low-flow,1,0.0
Diagniostic,1,0.0
414179,1,0.0
81848,1,0.0
332331,1,0.0
18440,1,0.0
15153,1,0.0
113802,1,0.0
marathons,1,0.0
half-marathons,1,0.0
AF03,1,0.0
hypodensities,1,0.0
Hypercoaguable,1,0.0
Naftidrofuryl,1,0.0
N90,1,0.0
mistrusted,1,0.0
decile,1,0.0
womb,1,0.0
Progesterone,1,0.0
uteruses,1,0.0
educability,1,0.0
Zambian,1,0.0
repolarization-related,1,0.0
theophyllins,1,0.0
nitrogram,1,0.0
He--80,1,0.0
O2--20,1,0.0
ADP-ribosyl,1,0.0
transferases,1,0.0
atretic,1,0.0
infarcti,1,0.0
Profiling,1,0.0
IFN-γ⁺,1,0.0
IV--ST,1,0.0
2-ΔCT,1,0.0
labor-intense,1,0.0
-IgA,1,0.0
079-092,1,0.0
2001-2,1,0.0
semi-enclosed,1,0.0
151350,1,0.0
-positive,1,0.0
gravely,1,0.0
glucose-producing,1,0.0
effectormemory,1,0.0
CD4⁺,1,0.0
GC-resistant,1,0.0
RNA-columns,1,0.0
25OHVD,1,0.0
bowls,1,0.0
instigation,1,0.0
Unpaywall,1,0.0
OpenRefine,1,0.0
5611,1,0.0
Bronze,1,0.0
stop-resume,1,0.0
Preemployment,1,0.0
4-78,1,0.0
hypoprothrombinemia,1,0.0
narrowingspatient,1,0.0
human-to-human-to-human,1,0.0
0424,1,0.0
244-1664,1,0.0
7713,1,0.0
cholelithiasis,1,0.0
Wells,1,0.0
FQHCs,1,0.0
CrescentCare,1,0.0
3366,1,0.0
programing,1,0.0
Paraneoplastic,1,0.0
paraneoplasic,1,0.0
quails,1,0.0
144-284,1,0.0
07-13,1,0.0
non-dihydropyridinic,1,0.0
SSc,1,0.0
SARS-CoV-21-4,1,0.0
47216,1,0.0
Nucleoside-modified,1,0.0
immune-suppressants,1,0.0
contraction-band,1,0.0
whole-mount,1,0.0
infarctednormal,1,0.0
leupeptin,1,0.0
Site-directed,1,0.0
multi-argininelysine,1,0.0
2n,1,0.0
00116,1,0.0
00092,1,0.0
4179,1,0.0
00158,1,0.0
0279,1,0.0
darker,1,0.0
124544,1,0.0
1970225,1,0.0
acronymed,1,0.0
1947-1956,1,0.0
heteroduplex,1,0.0
EXPAR,1,0.0
Deploying,1,0.0
RNA-to-DNA,1,0.0
RTF-EXPAR,1,0.0
132-1256,1,0.0
185-6074,1,0.0
131-1079,1,0.0
syndrome-coronaviruses-2,1,0.0
NCT00122980,1,0.0
hypercalcaemia,1,0.0
vasculo-,1,0.0
Khabarovsk,1,0.0
AH1N1v-influenza,1,0.0
exacted,1,0.0
£26,1,0.0
7695,1,0.0
6195,1,0.0
1863,1,0.0
106-275,1,0.0
needlescopic,1,0.0
Staple,1,0.0
candidacy-even,1,0.0
CElnhal,1,0.0
CEinhal,1,0.0
CEInhal,1,0.0
doses--very,1,0.0
Anti-lgE,1,0.0
vomit,1,0.0
obscures,1,0.0
83-104,1,0.0
short-cut,1,0.0
testsResultsQuarantine,1,0.0
quarantineno,1,0.0
83-95ConclusionThe,1,0.0
per-conditioning,1,0.0
REmote,1,0.0
RECAST-1,1,0.0
Hyperpolarised,1,0.0
xenon-129,1,0.0
--there,1,0.0
Controlateral,1,0.0
exploitable,1,0.0
controlateral,1,0.0
mRs,1,0.0
6970,1,0.0
lipidemia,1,0.0
Radiolabeled,1,0.0
5-triphenyltetrazolium,1,0.0
Hold,1,0.0
Meet,1,0.0
Assessors,1,0.0
2935,1,0.0
Liquid-phase,1,0.0
Time-resolved,1,0.0
triangulated,1,0.0
enquire,1,0.0
Kota,1,0.0
Bharu,1,0.0
Bahasa,1,0.0
2878,1,0.0
eraMethodsWe,1,0.0
2020AimTo,1,0.0
BackgroundTo,1,0.0
Biochemically,1,0.0
acupressure,1,0.0
≥64,1,0.0
NanoSign®,1,0.0
Mutagenesis,1,0.0
ADAR,1,0.0
Eunice,1,0.0
Shriver,1,0.0
drug-labeling,1,0.0
incumbent,1,0.0
child-weeks,1,0.0
heart-care,1,0.0
og,1,0.0
Ad26COV2-SVITT,1,0.0
neoplasmatic,1,0.0
270°,1,0.0
Decision-making,1,0.0
Descriptors,1,0.0
speech-voice-tight,1,0.0
groupn,1,0.0
41was,1,0.0
Q-Speak,1,0.0
patientsn,1,0.0
NRCP,1,0.0
fractionr,1,0.0
stoppage,1,0.0
commensurately,1,0.0
end-goal,1,0.0
180°,1,0.0
Impared,1,0.0
disappointed,1,0.0
NSAIDS,1,0.0
Exposome-Wide,1,0.0
tlirombolytic,1,0.0
2041,1,0.0
5-times,1,0.0
tri-annual,1,0.0
subconscious,1,0.0
r077-085,1,0.0
scintigrapic,1,0.0
OSH,1,0.0
NODS,1,0.0
DOCA,1,0.0
cortisol-glucocorticoid,1,0.0
hypotalamic,1,0.0
pre-menstrual,1,0.0
perimenopausal,1,0.0
hyperestrogenism,1,0.0
PGF2PGE2,1,0.0
initiationacceleration,1,0.0
Initiationacceleration,1,0.0
Asymmetrical,1,0.0
walking-related,1,0.0
lod,1,0.0
Radiologys,1,0.0
somatize,1,0.0
TIM-4,1,0.0
guideline-compliant,1,0.0
culprit-lesion,1,0.0
non-involuted,1,0.0
intracavernous,1,0.0
exposure-health,1,0.0
re-used,1,0.0
viropexis,1,0.0
analysied,1,0.0
135-158,1,0.0
field-workers,1,0.0
postdemonstration,1,0.0
adversely--either,1,0.0
licened,1,0.0
Age-old,1,0.0
Intralumenal,1,0.0
nonruptured,1,0.0
microhemorrhages,1,0.0
transection,1,0.0
Polypectomy,1,0.0
CLOTs,1,0.0
sTocking,1,0.0
6-122,1,0.0
nanomechanical,1,0.0
ACE2hi,1,0.0
hCoV-SARS-CoV-2,1,0.0
parameters-LDH,1,0.0
vs83,1,0.0
enzymopathy,1,0.0
G6PDdgroup,1,0.0
EVALUATION,1,0.0
e1000182,1,0.0
mortality--to,1,0.0
DAF-DAM,1,0.0
2019-new,1,0.0
24232429,1,0.0
826518,1,0.0
ACE2-expressed,1,0.0
exposome-health,1,0.0
ExWAS,1,0.0
underlaying,1,0.0
co-exposures,1,0.0
2CXCL2,1,0.0
Salviae,1,0.0
Miltiorrhizae,1,0.0
Croci,1,0.0
HD-IIV3,1,0.0
SD-IIV3,1,0.0
Graphing,1,0.0
prenotified,1,0.0
stroke-capable,1,0.0
MSC-mediated,1,0.0
cocultures,1,0.0
E1A,1,0.0
VEGF165,1,0.0
CREG-modified,1,0.0
aquaporin-4,1,0.0
non-colostrum,1,0.0
Novoshakhtinsk,1,0.0
153-167,1,0.0
Scant,1,0.0
Lombardima,1,0.0
electorcardiographic,1,0.0
3403,1,0.0
SEK,1,0.0
1914-1918,1,0.0
deteriortation,1,0.0
Example,1,0.0
CCDD,1,0.0
presently--or,1,0.0
future--form,1,0.0
8CXCL8,1,0.0
2PTGS2,1,0.0
prostaglandin-endoperoxide,1,0.0
genesDEGs,1,0.0
Deletion-Substitution-Addition,1,0.0
health-outcome,1,0.0
environment-asthma,1,0.0
recoverers,1,0.0
recovery-enhancing,1,0.0
Rico-,1,0.0
titrations,1,0.0
IIIB,1,0.0
strokeIS,1,0.0
gene-chip,1,0.0
GSE22255,1,0.0
InformationNCBI,1,0.0
sex-and,1,0.0
ontologyGO,1,0.0
1EGR1,1,0.0
gnomesKEGG,1,0.0
Complexity,1,0.0
ModuleMCODE,1,0.0
plug-in,1,0.0
platformCoremine,1,0.0
drug-active,1,0.0
ingredient-target,1,0.0
interleukin-17IL-17,1,0.0
kappaBNF-κB,1,0.0
factorTNF,1,0.0
domainNOD-like,1,0.0
DEGs-encoding,1,0.0
3IER3,1,0.0
Expedited,1,0.0
2906,1,0.0
δ-changes,1,0.0
vago-vagal,1,0.0
C4d,1,0.0
AD-MSC,1,0.0
lessons-learned,1,0.0
agreedagreed,1,0.0
EAC-RFC,1,0.0
blastogenic,1,0.0
phytohemagglutinin,1,0.0
antihemmagglutinin,1,0.0
40-97,1,0.0
046-163,1,0.0
041-120,1,0.0
2-62,1,0.0
27-50,1,0.0
thrombophylactic,1,0.0
pre-dispose,1,0.0
auto-regulation,1,0.0
19761977,1,0.0
2375,1,0.0
-hospital,1,0.0
SSNAP,1,0.0
-summaries,1,0.0
Bridgend,1,0.0
11-month,1,0.0
perverse,1,0.0
ovale-related,1,0.0
idiopatic,1,0.0
«red,1,0.0
softening»,1,0.0
Székely,1,0.0
blood-encrusted,1,0.0
55±02,1,0.0
50±01,1,0.0
capillary-free,1,0.0
non-ACS,1,0.0
Asking,1,0.0
049-102,1,0.0
paralysing,1,0.0
phase-wise,1,0.0
GoI,1,0.0
PETMRI,1,0.0
PEToptical,1,0.0
62-95,1,0.0
April-August,1,0.0
maximum-minimum,1,0.0
medially,1,0.0
cross-protect,1,0.0
Rendu-Osler-Weber,1,0.0
238±31,1,0.0
reagent-loaded,1,0.0
G894T,1,0.0
UAPNSTEMI,1,0.0
combats,1,0.0
anti-BNT162b2,1,0.0
post-switch,1,0.0
pre-switch,1,0.0
MIMethods,1,0.0
ResultsMI,1,0.0
n51,1,0.0
50±02,1,0.0
56±02,1,0.0
415±21,1,0.0
Pataki,1,0.0
PLC-PKC,1,0.0
httpsbcgscgithubioSARS2,1,0.0
Find,1,0.0
mid-2020,1,0.0
zoning,1,0.0
pneumoniaChest,1,0.0
Dosimetry,1,0.0
analyzedOn,1,0.0
0219,1,0.0
0073,1,0.0
mSvUld,1,0.0
Mantova,1,0.0
pre-angioplasty,1,0.0
Initiated,1,0.0
Agencys,1,0.0
Prohibited,1,0.0
chemodynamic,1,0.0
London-van,1,0.0
generically,1,0.0
biointernalization,1,0.0
PM-sorbed,1,0.0
chemodynamics,1,0.0
Backgroundand,1,0.0
22660,1,0.0
January-31,1,0.0
glycopolypeptide,1,0.0
23-185,1,0.0
1-38,1,0.0
ground-zero,1,0.0
ntEdit,1,0.0
GitHub,1,0.0
BCGSC,1,0.0
uncontrol,1,0.0
powerfulness,1,0.0
foramena,1,0.0
250-400,1,0.0
caesarian-derived,1,0.0
colostrum-deprived,1,0.0
epidermis,1,0.0
9625,1,0.0
4903,1,0.0
5-91,1,0.0
6044,1,0.0
deontological,1,0.0
disease-called,1,0.0
hand-in-hand,1,0.0
TEVAR,1,0.0
2-stimulants,1,0.0
tail-blood,1,0.0
beclometasone,1,0.0
Freer,1,0.0
sialo-sugar,1,0.0
decreasenormalisation,1,0.0
Disposal,1,0.0
0865,1,0.0
120uL,1,0.0
03026,1,0.0
vasculitis-related,1,0.0
questionnaires-an,1,0.0
BMQ,1,0.0
section-and,1,0.0
poly-ADP-ribose,1,0.0
LPS-induced,1,0.0
casei,1,0.0
Neurotic,1,0.0
capture-based,1,0.0
monochorionic-diamniotic,1,0.0
105100000,1,0.0
mn--40--,1,0.0
2283,1,0.0
rhDNase,1,0.0
short-action,1,0.0
ONO-1301-loaded,1,0.0
dl-lactic-co-glycolic,1,0.0
ONO-1301MS-treated,1,0.0
damge,1,0.0
Cheaper,1,0.0
paper-strip,1,0.0
low-sensitivity,1,0.0
8252,1,0.0
106∼467,1,0.0
162∼286,1,0.0
187∼369,1,0.0
179∼457,1,0.0
105∼211,1,0.0
133∼297,1,0.0
155∼414,1,0.0
147∼1172,1,0.0
0645,1,0.0
ventriculus,1,0.0
0297,1,0.0
7712,1,0.0
mean-fold,1,0.0
nonoral,1,0.0
COCs,1,0.0
BackgroundPoor,1,0.0
stressMethodsIn,1,0.0
Care-ILI-QoL,1,0.0
anonymity,1,0.0
subunit-vaccine,1,0.0
School-wide,1,0.0
influenza-dengue,1,0.0
DENV-1,1,0.0
Chacon,1,0.0
inﬂuenza,1,0.0
elevationor5,1,0.0
N131,1,0.0
frontal-executive,1,0.0
PATH,1,0.0
N385,1,0.0
Remediation,1,0.0
295776,1,0.0
541597,1,0.0
heavy-weighted,1,0.0
COVID-CTx,1,0.0
light-weighted,1,0.0
Depthwise,1,0.0
Separable,1,0.0
Dense,1,0.0
Convolution,1,0.0
convolutions,1,0.0
overfitting,1,0.0
TMPSSR2,1,0.0
like-cycles,1,0.0
bio-pharma,1,0.0
off-targeting,1,0.0
hyperhydrosis,1,0.0
exophthalmos,1,0.0
rRT-qPCR,1,0.0
handing,1,0.0
GRβ,1,0.0
TGFβ2,1,0.0
RT-PCRResultsPeak,1,0.0
146±23,1,0.0
RAM,1,0.0
pseudopandemic,1,0.0
9776,1,0.0
9760,1,0.0
9833,1,0.0
7942,1,0.0
hairy,1,0.0
Staphilococcus,1,0.0
Aerues,1,0.0
osentamyvir,1,0.0
19-40,1,0.0
vaccinoprophylaxis,1,0.0
20-65,1,0.0
Alignment,1,0.0
canyon,1,0.0
ASwitzerland88082002,1,0.0
human-swine-avian,1,0.0
eagle,1,0.0
Aquila,1,0.0
fasciata,1,0.0
81-93,1,0.0
48-57,1,0.0
506-673,1,0.0
eagles,1,0.0
Ruffin,1,0.0
Dolovich,1,0.0
Hargreave,1,0.0
19777503-13,1,0.0
Altounyans,1,0.0
modem,1,0.0
Kbps,1,0.0
electric-field,1,0.0
glucometers,1,0.0
adolescentsConclusionsThis,1,0.0
travel-induced,1,0.0
1972-2002,1,0.0
air-traffic,1,0.0
1984-2004,1,0.0
membraned,1,0.0
virally-infected,1,0.0
sub-micron,1,0.0
spike-expressing,1,0.0
NFC,1,0.0
spike-carrying,1,0.0
serum-derived,1,0.0
320test,1,0.0
Trajectories,1,0.0
field-induced,1,0.0
Intergovernmental,1,0.0
Iba-1,1,0.0
TMEM119,1,0.0
HFD-fed,1,0.0
Chow-fed,1,0.0
covert-like,1,0.0
1917-1918,1,0.0
membrane-embedded,1,0.0
oligomeric,1,0.0
40-amino-acid,1,0.0
non-compaction-a,1,0.0
recesses-is,1,0.0
destabilise,1,0.0
w50,1,0.0
z10,1,0.0
z-w,1,0.0
Normo-,1,0.0
Interactome,1,0.0
NS7b,1,0.0
52705,1,0.0
∈3,1,0.0
drug‐drug,1,0.0
23782,1,0.0
Vrchlabí,1,0.0
Kvasiny,1,0.0
5079,1,0.0
13h,1,0.0
pectoral-shoulder,1,0.0
Dartevelle,1,0.0
Grunenwald,1,0.0
manubrial-clavicular-chest,1,0.0
Manubrial,1,0.0
plating,1,0.0
PCR-RT,1,0.0
186486,1,0.0
56176,1,0.0
1999-2006,1,0.0
2149,1,0.0
2·0,1,0.0
1·4-3·0,1,0.0
1--the,1,0.0
2--the,1,0.0
3--the,1,0.0
4--the,1,0.0
5--the,1,0.0
10--the,1,0.0
RWR,1,0.0
Restart,1,0.0
Malawi-Liverpool-Wellcome,1,0.0
antinicotine,1,0.0
CF-MB,1,0.0
CKP,1,0.0
cebrovascular,1,0.0
non-whites,1,0.0
well-explained,1,0.0
poorfair,1,0.0
-187,1,0.0
0059,1,0.0
Fatebenefratelli,1,0.0
categorise,1,0.0
Swiecie,1,0.0
Allergologic,1,0.0
score--25,1,0.0
life-threat,1,0.0
inexperienced,1,0.0
tight-packed,1,0.0
JNJ-39758979,1,0.0
Otto,1,0.0
Leichtenstern,1,0.0
P00026,1,0.0
P00016,1,0.0
00018-00071,1,0.0
60-hour,1,0.0
0-hour,1,0.0
mild-to-moderately,1,0.0
NCT01749358,1,0.0
426-bed,1,0.0
open-labelled,1,0.0
7--the,1,0.0
Reactivity,1,0.0
infected-virus,1,0.0
memorizing,1,0.0
nonrevascularization,1,0.0
NCT00009243,1,0.0
RHSs,1,0.0
LHSs,1,0.0
equivalency,1,0.0
206728,1,0.0
Geocodification,1,0.0
countrywise,1,0.0
withdrawal-of-care,1,0.0
2003-SARS,1,0.0
year-2012,1,0.0
palm-civets,1,0.0
dromedary,1,0.0
attractor-source,1,0.0
386th,1,0.0
exponents,1,0.0
Viruss,1,0.0
sanitized,1,0.0
LCEs,1,0.0
y-z,1,0.0
y100,1,0.0
exposed-symptomatically,1,0.0
y-u,1,0.0
exposed-removed,1,0.0
y-v,1,0.0
exposed-virus,1,0.0
y-w,1,0.0
z-v,1,0.0
u-v,1,0.0
IVT-only,1,0.0
IV-tPA-treated,1,0.0
aortas,1,0.0
-259,1,0.0
euro14919,1,0.0
euro9731,1,0.0
euro4149,1,0.0
euro2706,1,0.0
ABrazil78H1N1,1,0.0
TGF,1,0.0
birthPregnant,1,0.0
Admitted,1,0.0
-surrounding,1,0.0
dyspena,1,0.0
study-animals,1,0.0
extentresolution,1,0.0
0404,1,0.0
trivialize,1,0.0
climactic,1,0.0
patientsObjective,1,0.0
exploredResults,1,0.0
eventsConclusion,1,0.0
AbbreviationsFEV1forced,1,0.0
secondATSAmerican,1,0.0
SocietyERSEuropean,1,0.0
SocietyACQAsthma,1,0.0
QuestionnaireICSinhaled,1,0.0
corticosteroidsOCSoral,1,0.0
corticosteroidsBTSBritish,1,0.0
SocietySIGNScottish,1,0.0
NetworkWAPwritten,1,0.0
materialized,1,0.0
Siaα2-3Galβ1-,1,0.0
4632,1,0.0
210121,1,0.0
xMAP,1,0.0
Gr,1,0.0
int,1,0.0
Aint,1,0.0
200655No,1,0.0
reemphasizing,1,0.0
2007--2008,1,0.0
XVE,1,0.0
preperitoneal,1,0.0
avain,1,0.0
ccs,1,0.0
Teflon,1,0.0
Chungpyesagan-tang,1,0.0
labortory,1,0.0
asessment,1,0.0
420-924,1,0.0
WI,1,0.0
ball-like,1,0.0
David-Komeda,1,0.0
nanometre,1,0.0
bio-,1,0.0
commercialisation,1,0.0
nanomedical,1,0.0
neurodegerative,1,0.0
nanomedine,1,0.0
nanotoxicology,1,0.0
IV-thrombolysis,1,0.0
IV-thrombolytics,1,0.0
GP-referred,1,0.0
cardiologistABSTRACT,1,0.0
ob,1,0.0
relativesfriends,1,0.0
backed-up,1,0.0
relocate,1,0.0
subdued,1,0.0
Medizinische,1,0.0
Wochenschrift,1,0.0
intra-institutional,1,0.0
Botucatu,1,0.0
hoarded,1,0.0
exploitative,1,0.0
brushnasal,1,0.0
GIPSE,1,0.0
guideline-generating,1,0.0
325-mg,1,0.0
or50,1,0.0
electronically-paced,1,0.0
ejected,1,0.0
self-preserving,1,0.0
Interleukin-37,1,0.0
mediator-driven,1,0.0
Nonasthmatics,1,0.0
post-accident,1,0.0
relinquishing,1,0.0
symptom-relevant,1,0.0
18558,1,0.0
102-154,1,0.0
104-203,1,0.0
055-194,1,0.0
0928,1,0.0
092-191,1,0.0
0127,1,0.0
0-20,1,0.0
cost-efficiency,1,0.0
1845683,1,0.0
best-performing,1,0.0
longer-acting,1,0.0
Eicosanoids,1,0.0
16-90,1,0.0
age-patterns,1,0.0
mechanism--whereby,1,0.0
companions--would,1,0.0
rubbing,1,0.0
Nondifferential,1,0.0
pericardiocenteses,1,0.0
aortacoronary,1,0.0
drowned,1,0.0
2825821,1,0.0
2709611,1,0.0
114840,1,0.0
568100,1,0.0
033100000,1,0.0
131100000,1,0.0
myelodysplasia,1,0.0
advantaged,1,0.0
Placement,1,0.0
water-electrolyte,1,0.0
impairmentrestriction,1,0.0
HEK-293,1,0.0
7781,1,0.0
16394,1,0.0
141-156,1,0.0
Guglielmi,1,0.0
detachable,1,0.0
10-day-old,1,0.0
Chronopharmacology,1,0.0
chronopharmacologic,1,0.0
LTFC,1,0.0
immunologist,1,0.0
9578,1,0.0
Time-dependent,1,0.0
44131,1,0.0
27151,1,0.0
113-177,1,0.0
leukocyte-derived,1,0.0
westernization,1,0.0
28-August,1,0.0
29-August,1,0.0
27-August,1,0.0
Geolocation,1,0.0
Luhe,1,0.0
Extrinsic,1,0.0
Diffusion-,1,0.0
Beclomethasone,1,0.0
microdissection,1,0.0
and--less,1,0.0
frequently--apical,1,0.0
postero-mesial,1,0.0
irrigates,1,0.0
necropsic,1,0.0
andMethods,1,0.0
electrogoniometer,1,0.0
MyotonePRO,1,0.0
aVr,1,0.0
2×,1,0.0
longer-lasting,1,0.0
SCTD,1,0.0
6366399,1,0.0
2248643,1,0.0
109361,1,0.0
Renin-Angiotensin,1,0.0
Cholesterol-rich,1,0.0
Football,1,0.0
NFLPA,1,0.0
gameplay,1,0.0
Midseason,1,0.0
nitroderivatives,1,0.0
swellingangioedema,1,0.0
Gasdermin,1,0.0
GSDMs,1,0.0
recognizably,1,0.0
Julian,1,0.0
Meningovascular,1,0.0
40-73,1,0.0
3144,1,0.0
37-57,1,0.0
29-54,1,0.0
54-84,1,0.0
multidiscipline,1,0.0
Lopinavir-interferon,1,0.0
α2b,1,0.0
nasopharynxoropharynx,1,0.0
bares,1,0.0
Conjugated,1,0.0
CLA,1,0.0
CD209L,1,0.0
TTSPs,1,0.0
thermolysin,1,0.0
3-phosphate,1,0.0
5-kinase,1,0.0
world-level,1,0.0
smelter,1,0.0
eleventh,1,0.0
120th,1,0.0
237844,1,0.0
long-livers,1,0.0
pigments,1,0.0
Multi-parameter,1,0.0
fluorescing,1,0.0
morbidity-associated,1,0.0
paralyzing,1,0.0
prognosesIn,1,0.0
10-5ABSTRACT,1,0.0
CHF-complicating,1,0.0
nitroglycerinangiotensin-converting,1,0.0
Over-reliance,1,0.0
allergeng,1,0.0
360th,1,0.0
Moines,1,0.0
17-August,1,0.0
9863,1,0.0
42-50,1,0.0
27-35,1,0.0
115-149,1,0.0
206-278,1,0.0
receptionistsmedical,1,0.0
workerscase,1,0.0
occupationalphysicalspeech,1,0.0
Superinfection,1,0.0
005-067,1,0.0
365-4967,1,0.0
Anturane,1,0.0
C-α,1,0.0
cyclist,1,0.0
0173,1,0.0
vigorous-intensity,1,0.0
Coxiella,1,0.0
Coxiella-like,1,0.0
Morans,1,0.0
0134,1,0.0
Sars,1,0.0
underimmunized,1,0.0
Lymphatic,1,0.0
USG-led,1,0.0
chartogram,1,0.0
Crawford,1,0.0
8x,1,0.0
well-tested,1,0.0
endocrine-immune,1,0.0
alginate,1,0.0
β-glucan,1,0.0
Sheng-mei-san,1,0.0
size-reducing,1,0.0
syndrometoxic,1,0.0
necrolysis,1,0.0
NCCHC,1,0.0
Pheochromocytoma,1,0.0
365°C,1,0.0
β-adrenoceptor,1,0.0
acid-derived,1,0.0
EP1-4,1,0.0
sub-centers,1,0.0
2851,1,0.0
3925331,1,0.0
2641,1,0.0
meagre,1,0.0
vaccinatedWhile,1,0.0
well-tailored,1,0.0
stupor,1,0.0
acetylcholineAC,1,0.0
pneumotaxography,1,0.0
sequencing-driven,1,0.0
Pre-test-post-test,1,0.0
multistage-cluster,1,0.0
governorate,1,0.0
Schoolteachers,1,0.0
AGKQA,1,0.0
Laënnec,1,0.0
punctuating,1,0.0
9193,1,0.0
P0021,1,0.0
parafascicular,1,0.0
201884926-930,1,0.0
campaignsThe,1,0.0
arisingfrom,1,0.0
Keyfindings,1,0.0
reifying,1,0.0
Datura,1,0.0
stramonium,1,0.0
nonpeer-reviewed,1,0.0
end-product,1,0.0
populationWhile,1,0.0
problem-free,1,0.0
groupsThe,1,0.0
emergenciesThe,1,0.0
cadre,1,0.0
salaried,1,0.0
Merck-1-Test,1,0.0
Laboratory-controlled,1,0.0
iLAMP,1,0.0
transmissivity,1,0.0
antibody-induced,1,0.0
400-450,1,0.0
arterio-,1,0.0
pleuro-pleural,1,0.0
Fractionation,1,0.0
DEAE-cellulose,1,0.0
molarity,1,0.0
Hexose,1,0.0
sulfate-rich,1,0.0
Panvax®,1,0.0
Parkville,1,0.0
early-mid-2009,1,0.0
15-µg,1,0.0
httpstoolkitsevereasthmaorgau,1,0.0
asthmaanxiety,1,0.0
SCAS,1,0.0
dot-probe,1,0.0
threat-,1,0.0
retardations,1,0.0
auscultate,1,0.0
immunocompromisedimmunosuppressed,1,0.0
infectionantiviral,1,0.0
animalspatients,1,0.0
75-bed,1,0.0
Choices,1,0.0
once-off,1,0.0
Authorised,1,0.0
immunisers,1,0.0
3458,1,0.0
curevaccine,1,0.0
neuro-invasive,1,0.0
laboratory-measurable,1,0.0
event-specific,1,0.0
AML-associated,1,0.0
P0585,1,0.0
P00166,1,0.0
un-,1,0.0
CDPs,1,0.0
CD23,1,0.0
decorate,1,0.0
legume,1,0.0
pea,1,0.0
monocot,1,0.0
snowdrop,1,0.0
relativeformal,1,0.0
monotonicity,1,0.0
Heart-,1,0.0
Berka,1,0.0
rehabilitatory,1,0.0
Bronchodilatator,1,0.0
ca-,1,0.0
non-temperature-sensitive,1,0.0
non-cold-adapted,1,0.0
ALeningrad1344757,1,0.0
ALeningrad13447ts181957H2N2,1,0.0
COMMANDER,1,0.0
Constituting,1,0.0
in-cell,1,0.0
icELISA-based,1,0.0
clinician-ordered,1,0.0
5-33,1,0.0
httpwwwflugovplanning-preparednessfederalpandemic-influenza-implementationpdf,1,0.0
hyposexuality,1,0.0
hypersexuality,1,0.0
homodimer,1,0.0
thermodynamics,1,0.0
0665,1,0.0
-0657,1,0.0
wwwginasthmaorg,1,0.0
Session,1,0.0
practice--was,1,0.0
pH1NI,1,0.0
hypoactive,1,0.0
ethos,1,0.0
person-focused,1,0.0
harmony,1,0.0
assemblyegress,1,0.0
PDZ-domain,1,0.0
GST-PDZ,1,0.0
PDZ,1,0.0
Zona,1,0.0
Occludens-1,1,0.0
formationintegrity,1,0.0
HTRF,1,0.0
E-ZO1,1,0.0
Prophylactictherapeutic,1,0.0
NITC,1,0.0
Mueller,1,0.0
3463,1,0.0
9073,1,0.0
Seventy-three23,1,0.0
2137908,1,0.0
CSSs,1,0.0
hemophagocytes,1,0.0
aBMT,1,0.0
loopQRS,1,0.0
co-sine,1,0.0
UPSIT,1,0.0
768000,1,0.0
homodimeric,1,0.0
1-point,1,0.0
Myeloid,1,0.0
Algel-IMDG,1,0.0
Algel,1,0.0
vo,1,0.0
unteered,1,0.0
race-matched,1,0.0
Västernorrland,1,0.0
VHEEP,1,0.0
6231,1,0.0
Referents,1,0.0
Mediating,1,0.0
rainfalls,1,0.0
Mets,1,0.0
often-accompanied,1,0.0
sewage-associated,1,0.0
sewage-contaminated,1,0.0
overflowed,1,0.0
non-dispersed,1,0.0
upgrades,1,0.0
under-researched,1,0.0
FPG,1,0.0
myonecrosis,1,0.0
discussants,1,0.0
Biennial,1,0.0
ASydney0597--APanama200799--AFujian41102--AWellington0104,1,0.0
ABayern0795--ABejing26295--ANew,1,0.0
all-transretinoic,1,0.0
blast-like,1,0.0
hypergranular,1,0.0
pro-inflammation,1,0.0
pleurocentesis,1,0.0
OSDs,1,0.0
paracancerous,1,0.0
137-30,1,0.0
highly-sophisticated,1,0.0
double-chamber,1,0.0
Chick,1,0.0
Ortholog,1,0.0
cell-type,1,0.0
HIPPO,1,0.0
mulch,1,0.0
77201,1,0.0
insists,1,0.0
leukotriene-receptor-antagonists,1,0.0
un-frequent,1,0.0
Ivory,1,0.0
Esafosfina,1,0.0
histologic-staining,1,0.0
86-year-patient,1,0.0
characteristics-eg,1,0.0
inflammation-are,1,0.0
Chains,1,0.0
neuro-otologic,1,0.0
peroral,1,0.0
cooccurring,1,0.0
northward,1,0.0
disseminator,1,0.0
ACTEIASI,1,0.0
healthbr,1,0.0
p00009,1,0.0
eighth-grade,1,0.0
ATS-NHLI,1,0.0
geohelminths,1,0.0
18-45-year-old,1,0.0
1907,1,0.0
surveillance-confirmed,1,0.0
14-64,1,0.0
immunopotentiators,1,0.0
Billions,1,0.0
anti-clot,1,0.0
mole-rat,1,0.0
Chrysemys,1,0.0
picta,1,0.0
euthermic,1,0.0
arctic,1,0.0
hypoxiaischemia,1,0.0
wheezeasthma,1,0.0
Society-National,1,0.0
Diamont,1,0.0
bronchoconstrict,1,0.0
sensor-based,1,0.0
eight-month-old,1,0.0
SARS-CoV-2-attributable,1,0.0
Reasoned,1,0.0
MDPI,1,0.0
Inorganic,1,0.0
polyphosphates,1,0.0
polyP,1,0.0
Sulfated,1,0.0
bromotyrosines,1,0.0
same-aged,1,0.0
renin-angiotension,1,0.0
ACEIARB,1,0.0
gold-immunochromatographic,1,0.0
CPC-MB,1,0.0
NAIs-resistant,1,0.0
199847No,1,0.0
RR-61-26,1,0.0
H1N-likelike,1,0.0
ABrazil78,1,0.0
beginners,1,0.0
telemetric,1,0.0
sportswomen,1,0.0
seocnd,1,0.0
touring,1,0.0
drop-outs,1,0.0
vestibulocochlear,1,0.0
busses,1,0.0
caspase-mediated,1,0.0
WHO-PREMISE,1,0.0
colonise,1,0.0
retro-nasal,1,0.0
988°F,1,0.0
UDOH,1,0.0
contacts†,1,0.0
factors§,1,0.0
PRs,1,0.0
regression¶,1,0.0
reflection-Fourier,1,0.0
lesser-known,1,0.0
8000000,1,0.0
Gangwon,1,0.0
Schofields,1,0.0
LUNS,1,0.0
drug-susceptible,1,0.0
psycosocial,1,0.0
ave,1,0.0
SNOMED-CT®,1,0.0
Kontron,1,0.0
M-7000,1,0.0
6-26,1,0.0
anterolateroposterior,1,0.0
interlocking,1,0.0
excavating,1,0.0
pleurodiaphragmatic,1,0.0
demo-graphics,1,0.0
hyperferritinaemia,1,0.0
≥500,1,0.0
5000mm3,1,0.0
13176,1,0.0
Infoway,1,0.0
LOINC®,1,0.0
largescale,1,0.0
informaticists,1,0.0
Pan-Canadian,1,0.0
REspiratory,1,0.0
STandards,1,0.0
INitiative,1,0.0
PRESTINE,1,0.0
175-month,1,0.0
typological,1,0.0
supplementations,1,0.0
championing,1,0.0
undimished,1,0.0
earthworm,1,0.0
overweightobesity,1,0.0
IAHS,1,0.0
fHLHpHLH,1,0.0
sHLH,1,0.0
208-297,1,0.0
TRPV1,1,0.0
K562,1,0.0
K562-based,1,0.0
S-protein-expressing,1,0.0
multiple-valent,1,0.0
United,1,0.0
Airways,1,0.0
geoenvironmental,1,0.0
Bangladesh-originated,1,0.0
Repository,1,0.0
Jalview,1,0.0
NSP2-3,1,0.0
NSP-12RdRp,1,0.0
NSP-13Helicase,1,0.0
S-Spike,1,0.0
N-Nucleocapsid,1,0.0
UM,1,0.0
UM-18,1,0.0
NSP9,1,0.0
NSP11,1,0.0
NSP7a,1,0.0
SR-rich,1,0.0
RDRP,1,0.0
Amantadine-,1,0.0
hospitalslaboratories,1,0.0
geotemporal,1,0.0
mid-late,1,0.0
12758251,1,0.0
150024987,1,0.0
desensitises,1,0.0
5monophosphte,1,0.0
neonatally,1,0.0
RDs,1,0.0
RWL,1,0.0
hypernoea,1,0.0
clinicalradiological,1,0.0
25841,1,0.0
restenosed,1,0.0
previously-detected,1,0.0
caseABSTRACT,1,0.0
coronary-infused,1,0.0
milieu-dependent,1,0.0
Londoners,1,0.0
hype,1,0.0
BIBSYS,1,0.0
Daycare,1,0.0
Pesquisa,1,0.0
future-oriented,1,0.0
Evandro,1,0.0
ChagasFundação,1,0.0
StudyCausative,1,0.0
etiology--arteriovenous,1,0.0
thrombocytopenias,1,0.0
thrombocytopathy,1,0.0
aplasias,1,0.0
antiphospholipoid,1,0.0
coagulate,1,0.0
bioequivalent,1,0.0
sub-basement,1,0.0
irritate,1,0.0
out-door,1,0.0
61-182,1,0.0
3177-4542,1,0.0
and55,1,0.0
populationepidemiological,1,0.0
11086,1,0.0
94311086,1,0.0
20710218,1,0.0
COVID-19dengue,1,0.0
infarctrelated,1,0.0
Vc,1,0.0
16046,1,0.0
13101,1,0.0
unstratified,1,0.0
1621,1,0.0
apex-cardiographically,1,0.0
psmaller,1,0.0
00000006,1,0.0
video-sharing,1,0.0
V2ST,1,0.0
18825,1,0.0
18393,1,0.0
heatingcooking,1,0.0
Oseltamivir-resistance,1,0.0
vaccine-activating,1,0.0
anti-polyethylene,1,0.0
vitrovivo,1,0.0
Expedient,1,0.0
research-based,1,0.0
Chemokines,1,0.0
Otago,1,0.0
pulmonological,1,0.0
bronchological,1,0.0
1-month-old,1,0.0
contending,1,0.0
4heparin,1,0.0
4T,1,0.0
infection1,1,0.0
superspread,1,0.0
sartan,1,0.0
isolationquarantine,1,0.0
SRIs,1,0.0
SRIABSTRACT,1,0.0
unpreparedness,1,0.0
neuro-biomechanical,1,0.0
corticalsubcortical,1,0.0
homecare,1,0.0
parentspatients,1,0.0
Envisioning,1,0.0
Maximizing,1,0.0
Proteinuria,1,0.0
available2‐5,1,0.0
Dysrhythmias,1,0.0
EEG-SEP,1,0.0
Contact-Confirming,1,0.0
pandemic-causing,1,0.0
lentivectors,1,0.0
27086,1,0.0
L323,1,0.0
supremacy,1,0.0
acupoint-application,1,0.0
timelier,1,0.0
SSNs,1,0.0
CNS-driven,1,0.0
131I,1,0.0
Hypothyroidism,1,0.0
utilities13,1,0.0
was57,1,0.0
TCR-T,1,0.0
httpsbitly3gjuqdU,1,0.0
27-54,1,0.0
28-67,1,0.0
24-104,1,0.0
31-69,1,0.0
115-166,1,0.0
minimal-to-no,1,0.0
pneumologyallergy,1,0.0
Kiddie-SADS,1,0.0
Moderatesevere,1,0.0
STAIC,1,0.0
anxiousdepression,1,0.0
littleno,1,0.0
responsive-,1,0.0
infection-severity,1,0.0
heat-map,1,0.0
responsive-purchased,1,0.0
disease-like,1,0.0
EuroQoL-5,1,0.0
Phase-SD,1,0.0
00057,1,0.0
MVTL,1,0.0
MVTl,1,0.0
hCoVs-SARS-CoV,1,0.0
SARS-CoV-2-briefly,1,0.0
290100000,1,0.0
minimally-biased,1,0.0
2-induced,1,0.0
intra-articular,1,0.0
1month,1,0.0
22-52,1,0.0
8467,1,0.0
large‑scale,1,0.0
3499,1,0.0
revue,1,0.0
IIL-4,1,0.0
IIL-9,1,0.0
long-axis-cut,1,0.0
25-60,1,0.0
Chapman,1,0.0
0192,1,0.0
0132,1,0.0
1988-1995,1,0.0
ventilationintubation,1,0.0
abuseinhalation,1,0.0
Alergológica-2005,1,0.0
3012,1,0.0
self-contraction,1,0.0
north‑European,1,0.0
swathes,1,0.0
NPCPAI,1,0.0
Mansehra,1,0.0
government-sponsored,1,0.0
Ardent,1,0.0
moored,1,0.0
Pacemakers,1,0.0
MR-imaging,1,0.0
Hyperdominant,1,0.0
hyperdominant,1,0.0
stent-based,1,0.0
2014-May,1,0.0
south‑European,1,0.0
128–376,1,0.0
40--55,1,0.0
microheterogeneity,1,0.0
qR,1,0.0
intermediate-size,1,0.0
leukotriene-modifying,1,0.0
estrogenic,1,0.0
Constipation,1,0.0
reportedWe,1,0.0
strokeAfter,1,0.0
1385,1,0.0
40-91,1,0.0
27-75,1,0.0
23-73Constipation,1,0.0
safety-data,1,0.0
re-stenosis,1,0.0
MP-ratio,1,0.0
stainings,1,0.0
cytospins,1,0.0
2019-,1,0.0
protein-replacement,1,0.0
nanoassemblies,1,0.0
multiround,1,0.0
core-shell-structured,1,0.0
in-vitro-transcribed,1,0.0
020-072,1,0.0
medication-taking,1,0.0
5727,1,0.0
Flight-related,1,0.0
non-flight-related,1,0.0
matted,1,0.0
DMDs,1,0.0
coagulum,1,0.0
non-Spanish,1,0.0
Re-examination,1,0.0
pantropically,1,0.0
cyberbullying,1,0.0
Machine-learning,1,0.0
kernels,1,0.0
heats,1,0.0
Microwave,1,0.0
BACKGROUNDː,1,0.0
capivasertib,1,0.0
quirks,1,0.0
Terengganu,1,0.0
one-carbon,1,0.0
stalling,1,0.0
07-25,1,0.0
catheterization-related,1,0.0
anticoagulation-related,1,0.0
cyberostracism,1,0.0
HA1-HA2,1,0.0
26-90,1,0.0
postherpetic,1,0.0
relive,1,0.0
fevipiravir,1,0.0
QUOSA,1,0.0
51-106,1,0.0
11-97,1,0.0
5-96,1,0.0
eligibilities,1,0.0
ER-based,1,0.0
antigen-test-based,1,0.0
influenza-like-illness-based,1,0.0
exhuming,1,0.0
pricked,1,0.0
midspinal,1,0.0
4996,1,0.0
comitees,1,0.0
PF-07304814,1,0.0
GC-376,1,0.0
CDI-45205,1,0.0
PF-07321332,1,0.0
ST-monitoring,1,0.0
unprecedent,1,0.0
non-physician,1,0.0
non-physicians,1,0.0
salt-soluble,1,0.0
albumins,1,0.0
globulins--cereal,1,0.0
alpha-amylasetrypsin,1,0.0
thaumatin-like,1,0.0
protein-as,1,0.0
salt-insoluble,1,0.0
prolamins,1,0.0
gliadins,1,0.0
glutenins,1,0.0
CBFV,1,0.0
beekeepers,1,0.0
melittin,1,0.0
Melittin,1,0.0
underexpression,1,0.0
phosphatidylinositol-34-bisphosphate,1,0.0
Unlock,1,0.0
Cardiovascular-Thoracic,1,0.0
Masterclass,1,0.0
August-July,1,0.0
5655,1,0.0
rational-based,1,0.0
underrated,1,0.0
Carolina11918,1,0.0
comitee,1,0.0
Covid-related,1,0.0
21st-century,1,0.0
S2k,1,0.0
DGN,1,0.0
AuthoritiesThe,1,0.0
H1N1flu,1,0.0
subcortical-cortical,1,0.0
LOT,1,0.0
health-relevant,1,0.0
LOTs,1,0.0
nation-states,1,0.0
propositions,1,0.0
HLA-class,1,0.0
class-II,1,0.0
HLA-DRB1,1,0.0
DBQ1,1,0.0
short-medium-term,1,0.0
SBs,1,0.0
popping-out,1,0.0
ratiox100,1,0.0
de-centralized,1,0.0
re-thinking,1,0.0
Metagenomic,1,0.0
2727,1,0.0
bellow,1,0.0
manufacturerdistributor,1,0.0
distributorsmanufacturers,1,0.0
performant,1,0.0
custodian,1,0.0
metoprolol-treated,1,0.0
low-mortality,1,0.0
populationABSTRACT,1,0.0
Trancatheter,1,0.0
tanslation,1,0.0
3-untranslated,1,0.0
miR-29c-mediated,1,0.0
Ad26COV2·S,1,0.0
JanssenJJ,1,0.0
liquorice,1,0.0
05-in,1,0.0
cinememory,1,0.0
replayed,1,0.0
osteoporotic,1,0.0
Cononaviridae,1,0.0
Electrolyte,1,0.0
hospitalizationre-hospitalization,1,0.0
25µm,1,0.0
university-age,1,0.0
sublinical,1,0.0
Immunohematology,1,0.0
20213733-43,1,0.0
poly-symptomatic,1,0.0
Reassorted,1,0.0
FluShuffle,1,0.0
FluResort,1,0.0
IL-4-receptor,1,0.0
Q576R,1,0.0
dispositionfollowup,1,0.0
Energetic,1,0.0
mycoplasmic,1,0.0
frequencyof,1,0.0
less-12,1,0.0
Spa,1,0.0
psycholeptics,1,0.0
psychoanaleptics,1,0.0
Legionnaires,1,0.0
CAN,1,0.0
cohortABSTRACT,1,0.0
probrain,1,0.0
Lemur,1,0.0
catta,1,0.0
2D-,1,0.0
time-motion,1,0.0
M-,1,0.0
cell-ASM,1,0.0
testkit,1,0.0
city-scale,1,0.0
11264,1,0.0
Camping,1,0.0
saviour,1,0.0
phototherapy,1,0.0
pathogen-centric,1,0.0
adhesion-,1,0.0
invasion-associated,1,0.0
TLR-,1,0.0
response-mediated,1,0.0
cocultured,1,0.0
response-,1,0.0
pathogen-mediated,1,0.0
testifies,1,0.0
suprachiasmatic,1,0.0
dysrythmias,1,0.0
differenciation,1,0.0
hypoexcitability,1,0.0
30-76GRADE,1,0.0
77-99GRADE,1,0.0
37-99,1,0.0
n484,1,0.0
8to,1,0.0
gp96,1,0.0
gp96-Ig,1,0.0
polyepitope-specific,1,0.0
protein-S,1,0.0
-specific,1,0.0
HLA-A21,1,0.0
1987-1998,1,0.0
14250,1,0.0
CONVINCE,1,0.0
Myths,1,0.0
uvKillsCovid19,1,0.0
UVdisinfection,1,0.0
tanning,1,0.0
man‐made,1,0.0
photo‐dimerisation,1,0.0
thymine,1,0.0
micro‐organisms,1,0.0
non‐viable,1,0.0
44260,1,0.0
valueABSTRACT,1,0.0
preextracorporeal,1,0.0
on-extracorporeal,1,0.0
accessioning,1,0.0
380000,1,0.0
Rast,1,0.0
HRTprick,1,0.0
testRast,1,0.0
farinaeABSTRACT,1,0.0
thenation-wide,1,0.0
cluster-wise,1,0.0
-wide,1,0.0
doi101093awx020,1,0.0
MKH,1,0.0
315±30,1,0.0
479±44,1,0.0
corticosteriods,1,0.0
1996-June,1,0.0
Introductions,1,0.0
46-day,1,0.0
Concluded,1,0.0
4092,1,0.0
4383,1,0.0
9982,1,0.0
stringy,1,0.0
mimicks,1,0.0
articleStroke,1,0.0
Gwalior,1,0.0
Disability-Adjusted,1,0.0
132-219,1,0.0
millilitre,1,0.0
-104,1,0.0
SRMC,1,0.0
SRMCs,1,0.0
subfractional,1,0.0
middle-size,1,0.0
50-120,1,0.0
agammaglobulinaemia,1,0.0
cerumen,1,0.0
psycheThe,1,0.0
Chambal,1,0.0
n474,1,0.0
pNS,1,0.0
16-85,1,0.0
fibrinolysis-treated,1,0.0
002-140,1,0.0
52-81,1,0.0
73-100,1,0.0
neuroprotectives,1,0.0
unexpensive,1,0.0
succinodehydrogenase,1,0.0
Vmyocardium,1,0.0
Vinfarct,1,0.0
VinfarctVmyocardium,1,0.0
swan,1,0.0
preimmunity,1,0.0
bat‐originated,1,0.0
simplot,1,0.0
analyses1,1,0.0
research2‐4,1,0.0
-August,1,0.0
Rosenmans,1,0.0
9074,1,0.0
00283,1,0.0
narrating,1,0.0
post-practice,1,0.0
whole-person,1,0.0
Montefiore,1,0.0
CLI,1,0.0
Killer,1,0.0
acid-dependent,1,0.0
orthologue,1,0.0
NCR1,1,0.0
2006-July,1,0.0
polyarthritis,1,0.0
bloodpool,1,0.0
Fab2,1,0.0
Europeenne-in,1,0.0
Cappariloside,1,0.0
ASST,1,0.0
Fatebenefratelli-Sacco,1,0.0
Nucleoside,1,0.0
β-d-N4-hydroxycytidine,1,0.0
terminators,1,0.0
Cryo-EM,1,0.0
RNA-bound,1,0.0
precatalytic,1,0.0
resistance-conferring,1,0.0
1999-2013,1,0.0
vulnerabilitys,1,0.0
Conformite,1,0.0
stateMethods,1,0.0
Indium-111,1,0.0
04132020,1,0.0
08272020,1,0.0
comparedResults,1,0.0
7213,1,0.0
1585,1,0.0
3470,1,0.0
3670,1,0.0
otherConclusion,1,0.0
promulgate,1,0.0
effectsadverse,1,0.0
8-49,1,0.0
0561,1,0.0
0388-0812,1,0.0
Nonhemorrhagic,1,0.0
alpha2-3,1,0.0
N417T,1,0.0
re-sponses,1,0.0
evoked-CBO,1,0.0
VDBP,1,0.0
GC-group,1,0.0
62089,1,0.0
25985,1,0.0
5–14,1,0.0
SARs-CoV-2–infected,1,0.0
sketchy,1,0.0
26-60,1,0.0
25-38,1,0.0
depression-anhedonia-would,1,0.0
45-min,1,0.0
Deconvolution,1,0.0
Laplacian,1,0.0
regionalisation,1,0.0
2016-W03,1,0.0
Brittany,1,0.0
BeijingSinopharm,1,0.0
analrectal,1,0.0
mother-infant,1,0.0
dualchamber,1,0.0
Rate-responsive,1,0.0
devvgrees,1,0.0
Lattice,1,0.0
779-992,1,0.0
833-999,1,0.0
085-096,1,0.0
KXG,1,0.0
663-946,1,0.0
activa-tion,1,0.0
revascu-larization,1,0.0
alpha2-3alpha2-6,1,0.0
flattens,1,0.0
reflux-provoked,1,0.0
tibia,1,0.0
antigravity,1,0.0
Platelet-to-lymphocyte,1,0.0
infarction-one,1,0.0
nondiabetic-the,1,0.0
angiographically-proven,1,0.0
voltagemaximal,1,0.0
QRS-T,1,0.0
widthlength,1,0.0
Hoffmans,1,0.0
17-45,1,0.0
non-differential,1,0.0
clinico-neurological,1,0.0
oxyproline,1,0.0
“bird,1,0.0
‘flu”,1,0.0
tabloids’,1,0.0
Hien,1,0.0
“most,1,0.0
when”,1,0.0
“predicament,1,0.0
proportions”,1,0.0
neuroprosthetic,1,0.0
ANISE,1,0.0
61232,1,0.0
payor,1,0.0
six-factor,1,0.0
Ramping,1,0.0
888-1000,1,0.0
077-091,1,0.0
ski-equipped,1,0.0
LC-130,1,0.0
139-357,1,0.0
OR--143,1,0.0
115-176,1,0.0
OR--126,1,0.0
-SARS-COV2,1,0.0
viral-encoded,1,0.0
Rep,1,0.0
subclassified,1,0.0
extreme-dipper,1,0.0
Rotation,1,0.0
endopeptidase,1,0.0
secretogogues,1,0.0
chronotherapeutic,1,0.0
neurobrucellosis,1,0.0
hypernatremic,1,0.0
consanguinity,1,0.0
GIB,1,0.0
NIH-NINDS,1,0.0
followed-by,1,0.0
observability,1,0.0
56-83,1,0.0
antigenicity-associated,1,0.0
3171,1,0.0
40-120,1,0.0
80-160,1,0.0
electrocardiotopograms,1,0.0
showering,1,0.0
stormy,1,0.0
cold-adaptation,1,0.0
OR--224,1,0.0
cellmicroliter,1,0.0
00062,1,0.0
49th,1,0.0
airlifted,1,0.0
fortune,1,0.0
cross-validating,1,0.0
MIDAS,1,0.0
transmitters-first,1,0.0
ACIP-recommended,1,0.0
individuals-first,1,0.0
children-first,1,0.0
HCV-infected,1,0.0
Huh-7,1,0.0
paragordonae,1,0.0
rMpg-RBD,1,0.0
mycobacteria,1,0.0
withour,1,0.0
150-1172,1,0.0
gastroinestinal,1,0.0
AnnalsAmerican,1,0.0
Eucomed,1,0.0
interventions--especially,1,0.0
cost-beneficial,1,0.0
leukocytesmicroliter,1,0.0
seventy-fold,1,0.0
OR--7518,1,0.0
889-63584,1,0.0
no-improvement,1,0.0
OR--778,1,0.0
251-2417,1,0.0
OR--420,1,0.0
ups,1,0.0
bandingABSTRACT,1,0.0
infarct-induced,1,0.0
8937,1,0.0
n82,1,0.0
recycle,1,0.0
sterilize,1,0.0
1408cases,1,0.0
737cases,1,0.0
infarction-23,1,0.0
wall-who,1,0.0
Hernández-Camba,1,0.0
academic-community,1,0.0
UEA-lectin,1,0.0
CD133,1,0.0
KDR,1,0.0
tubulogenic,1,0.0
Matrigel®,1,0.0
Fluorescence-activated,1,0.0
CD133CD34KDRCD45,1,0.0
OECs,1,0.0
questionnaire-diagnosed,1,0.0
Al-Furash,1,0.0
Al-Gafure,1,0.0
Pharmacoeconomics,1,0.0
N2MBW,1,0.0
ceMRI,1,0.0
Vectorcardiography,1,0.0
Savitzky-Golay,1,0.0
Stationary,1,0.0
minimum-redundancy-maximum-relevance,1,0.0
mRMR,1,0.0
class-oriented,1,0.0
168-145,1,0.0
BAT,1,0.0
balloon-anchoring,1,0.0
ST-wave,1,0.0
multivalency,1,0.0
alpha2-36,1,0.0
2x105,1,0.0
GCmass,1,0.0
LC-MS-based,1,0.0
miR-1260,1,0.0
-26a,1,0.0
-335,1,0.0
-576-3p,1,0.0
-628-3p,1,0.0
-664,1,0.0
Leyte,1,0.0
distributor,1,0.0
conduced,1,0.0
archcervical,1,0.0
Cas12a-linked,1,0.0
unlocking,1,0.0
144mgdL,1,0.0
here-presented,1,0.0
161173,1,0.0
palliating,1,0.0
anoikis,1,0.0
instinctive,1,0.0
restrictively,1,0.0
Free-living,1,0.0
starchsugar,1,0.0
Plastid,1,0.0
plastome,1,0.0
9914,1,0.0
pre-school-aged,1,0.0
psyschosomatic,1,0.0
reagents-lyophilized,1,0.0
82Rubidium-2-fluoro-2-desoxyglucose,1,0.0
unconditionally,1,0.0
foresight,1,0.0
biogenic,1,0.0
single-stroke-based,1,0.0
Contractility,1,0.0
pentamethylcyclopentadienyl,1,0.0
CpRh13-dicyclohexylimidazol-2-ylideneCl2,1,0.0
CpRhdipivaloylmethanatoCl,1,0.0
3960,1,0.0
non-rupture,1,0.0
Ruptures,1,0.0
non-expatriate,1,0.0
cause-dependent,1,0.0
391479,1,0.0
21-37,1,0.0
adenoviral-vectored,1,0.0
to--alternative,1,0.0
RALT,1,0.0
78-297,1,0.0
052-097,1,0.0
025-044,1,0.0
037-089,1,0.0
023-045,1,0.0
DSD,1,0.0
irritational,1,0.0
nonrecurring,1,0.0
MIRU,1,0.0
control-subjects,1,0.0
coronarangiography,1,0.0
myocardium--have,1,0.0
conditions--stunned,1,0.0
GPRD,1,0.0
interest-that,1,0.0
enzyme-expressing,1,0.0
desiccants,1,0.0
Gate,1,0.0
instantiate,1,0.0
Sheehan,1,0.0
Rated,1,0.0
curiously,1,0.0
24343,1,0.0
46657,1,0.0
outpatient-group,1,0.0
self-confident,1,0.0
ReadOXMIS,1,0.0
four-limb,1,0.0
ISO-SPREAD,1,0.0
oscillometric,1,0.0
Interankle,1,0.0
153-359,1,0.0
P0123,1,0.0
self-employment,1,0.0
Cepheid®,1,0.0
Fusion®,1,0.0
pan-Sarbecovirus,1,0.0
Cortisol,1,0.0
adenyl,1,0.0
cAMP-PDE,1,0.0
ciplar,1,0.0
nutrition-related,1,0.0
Kabeer,1,0.0
non-SARS-coronavirus,1,0.0
m3,1,0.0
LMCO,1,0.0
4971,1,0.0
5770,1,0.0
088-114,1,0.0
realising,1,0.0
Commodification,1,0.0
decolonial,1,0.0
frees,1,0.0
BMMSCs,1,0.0
UK-wide,1,0.0
infamously,1,0.0
off-guard,1,0.0
saccharin,1,0.0
FIT,1,0.0
r023-051,1,0.0
r-027,1,0.0
Laihe,1,0.0
Lyher,1,0.0
Kokan,1,0.0
9093827,1,0.0
471490,1,0.0
2019-Novel,1,0.0
14356,1,0.0
716659,1,0.0
370341,1,0.0
341±12,1,0.0
amassed,1,0.0
WINGSPAN,1,0.0
Liebeskind,1,0.0
pre-packaged,1,0.0
60-years-old,1,0.0
low-density-lipoprotein,1,0.0
12-99,1,0.0
10355,1,0.0
021-103,1,0.0
Taste,1,0.0
intercalated,1,0.0
outcome1,1,0.0
T6-T7,1,0.0
Dysphasia,1,0.0
proatheroscleroticprothrombotic,1,0.0
case-control-studies,1,0.0
V-Leiden,1,0.0
arg506gln,1,0.0
ACE-insertion-deletion,1,0.0
pooledABSTRACT,1,0.0
ineligibility,1,0.0
128677,1,0.0
talked-about,1,0.0
gynaecological,1,0.0
Neuroimmune,1,0.0
E-Gene,1,0.0
surety,1,0.0
Two-phase,1,0.0
14000Xg,1,0.0
SARs-COV-2,1,0.0
Lipid-Lowering,1,0.0
42448,1,0.0
chlorthalidone,1,0.0
agent--doxazosin,1,0.0
doxazosin,1,0.0
chlorthalidone-amlodipine,1,0.0
chlorthalidone-lisinopril,1,0.0
warm-blooded,1,0.0
17506,1,0.0
Inspector,1,0.0
late-November,1,0.0
littered,1,0.0
glimmer,1,0.0
cardiosphere-derived,1,0.0
permeate,1,0.0
otters,1,0.0
Localities,1,0.0
Naknek,1,0.0
Dillingham,1,0.0
Palmer,1,0.0
5933,1,0.0
FEF25-75FVC,1,0.0
-189,1,0.0
-297,1,0.0
-364,1,0.0
-93,1,0.0
-129,1,0.0
anti-vax,1,0.0
serotherapy,1,0.0
readdresses,1,0.0
orf4a,1,0.0
ERGIC,1,0.0
assembles,1,0.0
homopentameric,1,0.0
homodimers,1,0.0
homotetramers,1,0.0
PDZ-binding,1,0.0
29-amino-acid,1,0.0
single-passage,1,0.0
cation-selective,1,0.0
grail,1,0.0
chain-immobilized,1,0.0
corticoresistance,1,0.0
204966,1,0.0
non-expert,1,0.0
stun,1,0.0
Thoraxcenter,1,0.0
9799,1,0.0
papameters,1,0.0
Thb,1,0.0
0217,1,0.0
0234,1,0.0
XMVO2satPCW,1,0.0
lipid-stroke,1,0.0
R20997,1,0.0
rejections,1,0.0
184460,1,0.0
8360,1,0.0
inadapted,1,0.0
OrientGene,1,0.0
Allagology,1,0.0
usefullness,1,0.0
blepharospasm,1,0.0
thecoronavirus,1,0.0
host-specificity,1,0.0
mobilizer,1,0.0
cell-mobilizing,1,0.0
Jak-STAT,1,0.0
angiomyogenesis,1,0.0
Prestimulation,1,0.0
TLR4-related,1,0.0
knocked,1,0.0
037-401,1,0.0
55-91,1,0.0
21504,1,0.0
338-358,1,0.0
Pirfenidone,1,0.0
Nintedanib,1,0.0
conferees,1,0.0
Yakima,1,0.0
Pleurisy,1,0.0
vasectomy,1,0.0
States-Indiana,1,0.0
Connecticut-have,1,0.0
middle-school,1,0.0
8707,1,0.0
10037,1,0.0
8833,1,0.0
8083,1,0.0
radioiodinated,1,0.0
phenylpentadecanoic,1,0.0
filling-in,1,0.0
boiled,1,0.0
muddled,1,0.0
fallacies,1,0.0
12p13,1,0.0
NINJ2,1,0.0
earlier-onset,1,0.0
Sars-Cov2,1,0.0
splines,1,0.0
February-31st,1,0.0
52437,1,0.0
49213-55863,1,0.0
50979,1,0.0
50333-51425,1,0.0
KL-6,1,0.0
Subpleural,1,0.0
Inter-intra-lobular,1,0.0
875-920,1,0.0
Fundamentally,1,0.0
post-emergent,1,0.0
zoonotically,1,0.0
less-lethal,1,0.0
loom,1,0.0
Heterotypic,1,0.0
humoral-herd,1,0.0
surface-length,1,0.0
transaortic,1,0.0
racetrack,1,0.0
346-524,1,0.0
994-100,1,0.0
935-100,1,0.0
rRT-PCR-positive,1,0.0
point-counting,1,0.0
BinaxNOW-negative,1,0.0
best-recognized,1,0.0
accumulation-a,1,0.0
increase-of,1,0.0
CPSP-like,1,0.0
astrocyte-derived,1,0.0
subproject,1,0.0
7-28,1,0.0
bigemini,1,0.0
Recourse,1,0.0
Individualised,1,0.0
endothelium-platelets-vasomotricity,1,0.0
STAT1STAT2,1,0.0
October-31st,1,0.0
272-354,1,0.0
6435,1,0.0
95-124,1,0.0
35-57,1,0.0
HT18C6,1,0.0
HT18C6Ag,1,0.0
PAMAM,1,0.0
dendrimer-coated,1,0.0
SiQDsPAMAM,1,0.0
aminated,1,0.0
signal-off,1,0.0
pM-80,1,0.0
6555,1,0.0
32676,1,0.0
PAMAM-functionalized,1,0.0
SiQDs,1,0.0
maneuvre,1,0.0
StrokeEAPCIEBNI,1,0.0
neurointerventionist,1,0.0
Wenckebach-type,1,0.0
2nd-degree,1,0.0
Intracavitary,1,0.0
fascicles,1,0.0
Transcription--Polymerase,1,0.0
suceptibility,1,0.0
well-predicted,1,0.0
Impoverished,1,0.0
School-Based,1,0.0
SBAT,1,0.0
May20th,1,0.0
12419,1,0.0
5984,1,0.0
inertinanimate,1,0.0
482-12,1,0.0
Lutheran,1,0.0
Garcia,1,0.0
loco-regional,1,0.0
QTc-interval,1,0.0
133times,1,0.0
6120,1,0.0
061-157,1,0.0
HRPZyme,1,0.0
HARIOM,1,0.0
meldonium,1,0.0
disputing,1,0.0
barking,1,0.0
steeple,1,0.0
A-induced,1,0.0
Stridor,1,0.0
rota-rod,1,0.0
Gundersen,1,0.0
Garcias,1,0.0
post-hepatic,1,0.0
tegu,1,0.0
lizard,1,0.0
merianae,1,0.0
VLr,1,0.0
VLm,1,0.0
intracoelomic,1,0.0
striated,1,0.0
225328,1,0.0
8908QALY,1,0.0
8338QALY,1,0.0
22408QALY,1,0.0
structure-functional,1,0.0
metazoan,1,0.0
thicklip,1,0.0
ASSENT-2,1,0.0
carelessness,1,0.0
3226,1,0.0
1263,1,0.0
Kanagawa176-related,1,0.0
isolation-positive,1,0.0
seroevidence,1,0.0
phosphodiesterase-4,1,0.0
Abounding,1,0.0
tautologic,1,0.0
miR-26a,1,0.0
MiR-221,1,0.0
hyperproliferation,1,0.0
p21,1,0.0
p27,1,0.0
reckoning,1,0.0
Oppel,1,0.0
pressurepain,1,0.0
anginal-equivalent,1,0.0
hastily,1,0.0
nocere,1,0.0
Initiate,1,0.0
Unwarranted,1,0.0
convalesces,1,0.0
PCR-proven,1,0.0
non-AF-related,1,0.0
suicides,1,0.0
psychotherapists,1,0.0
scientificclinical,1,0.0
colliding,1,0.0
Refusal,1,0.0
Abolishment,1,0.0
cGAS,1,0.0
phenoendotype,1,0.0
Gabbana,1,0.0
Ricerca,1,0.0
corrente,1,0.0
Non-type,1,0.0
Non-T2-mediated,1,0.0
vaccines--whole,1,0.0
pyrogenic,1,0.0
institutionsABSTRACT,1,0.0
flit,1,0.0
cingulum,1,0.0
cEDA,1,0.0
eighties,1,0.0
T2-mediated,1,0.0
rtPAs,1,0.0
microsphere-determined,1,0.0
multi-targets,1,0.0
Dl-3-n-Butylphthalide,1,0.0
l-3-n-,1,0.0
Butylphthalide,1,0.0
Apium,1,0.0
graveolens,1,0.0
3-n-butylphthalide,1,0.0
dl-,1,0.0
antiinflammation,1,0.0
anti-thrombosis,1,0.0
high-field,1,0.0
pathology-determined,1,0.0
NMR-imaged,1,0.0
Ictus,1,0.0
toxicologist,1,0.0
shortageTRIAL,1,0.0
Permissible,1,0.0
reperfusion-thrombotic,1,0.0
Platforms,1,0.0
gastrectomy,1,0.0
remake,1,0.0
Rosario,1,0.0
FM147,1,0.0
R162,1,0.0
HK168,1,0.0
E4272,1,0.0
PCh173,1,0.0
prevale,1,0.0
gatekeeping,1,0.0
signposting,1,0.0
listened,1,0.0
Quick-relief,1,0.0
childhood-type,1,0.0
typeABSTRACT,1,0.0
Between-country,1,0.0
pandemicsIn,1,0.0
tided,1,0.0
Calcified,1,0.0
CCE,1,0.0
signature-encompassing,1,0.0
infections-across,1,0.0
xenon-CT,1,0.0
haemorrhage-sensitive,1,0.0
mortality4,1,0.0
Jaber,1,0.0
Al-Amiri,1,0.0
ACE-related,1,0.0
ar,1,0.0
Fibreoptic,1,0.0
pig-to-human,1,0.0
inducement,1,0.0
data-sharing,1,0.0
thoracal,1,0.0
30-61,1,0.0
PEG-,1,0.0
co-concentration,1,0.0
noncorticosteroid,1,0.0
EILDITPCSFGGVS,1,0.0
LEILDITPC,1,0.0
HLA-A0201,1,0.0
GROMACS,1,0.0
HLA-A0201peptide,1,0.0
14100000,1,0.0
sports-induced,1,0.0
Re-vaccination,1,0.0
13-14-year-old,1,0.0
Capivari,1,0.0
Baixo,1,0.0
rental,1,0.0
Ser49Gly,1,0.0
Arg389Gly,1,0.0
ADRB1,1,0.0
Pollard,1,0.0
Barker,1,0.0
1974British,1,0.0
Medicine31,1,0.0
292-297,1,0.0
vaccination—acceptance,1,0.0
NCT04387929FUNDINGDolce,1,0.0
doseCONCLUSIONOne,1,0.0
wrasse,1,0.0
trend00011,1,0.0
fatalnon-fatal,1,0.0
Log-linear,1,0.0
pseudoasthma,1,0.0
reconfigurations,1,0.0
Reconfiguration,1,0.0
Kampala,1,0.0
training-related,1,0.0
8-13-year-old,1,0.0
stoical,1,0.0
nonthreatening,1,0.0
cardiac-prone,1,0.0
15461,1,0.0
Sparking,1,0.0
assimilate,1,0.0
Riviera,1,0.0
837-915,1,0.0
918-1000,1,0.0
565-655,1,0.0
919-987,1,0.0
710-888,1,0.0
734-999,1,0.0
reinterviewed,1,0.0
variant-positive,1,0.0
gymnast,1,0.0
sports†,1,0.0
105year,1,0.0
236year,1,0.0
24year,1,0.0
77year,1,0.0
hospitalisednon-hospitalised,1,0.0
2008-2014,1,0.0
103-351,1,0.0
tetraphyllidean,1,0.0
Hemigymnus,1,0.0
melapterus,1,0.0
Lizard,1,0.0
4649,1,0.0
gnathiid,1,0.0
isopods,1,0.0
copepod,1,0.0
Hatschekia,1,0.0
hemigymni,1,0.0
digenean,1,0.0
Callohelmis,1,0.0
pichelinae,1,0.0
morphotypes,1,0.0
Parasite,1,0.0
145-182,1,0.0
-disability,1,0.0
box1,1,0.0
ideological,1,0.0
nonconcordance,1,0.0
4320,1,0.0
9780,1,0.0
CRP-levels,1,0.0
antiviral-therapy,1,0.0
Shingles,1,0.0
216431,1,0.0
167-213,1,0.0
117-170,1,0.0
157-196,1,0.0
Door-to-CT,1,0.0
trend00022,1,0.0
asymptomaticpaucisymptomatic,1,0.0
CA-125,1,0.0
handicap-outcomes,1,0.0
PQCI,1,0.0
DSI,1,0.0
Handicap-Outcomes,1,0.0
PQoL,1,0.0
Unaffected,1,0.0
trivialization,1,0.0
wishful,1,0.0
distractive,1,0.0
self-reconstructive,1,0.0
meaning-searching,1,0.0
000046,1,0.0
seventy-six,1,0.0
severityprogression,1,0.0
severityprogression12,1,0.0
corticosteroidsglucocorticoids,1,0.0
36-60,1,0.0
contrarily,1,0.0
271-421,1,0.0
356-50,1,0.0
2-Sympathomimetic,1,0.0
Three-week-old,1,0.0
OVA-sIgE,1,0.0
Into,1,0.0
QIIME,1,0.0
adult-like,1,0.0
butyrogenic,1,0.0
dosesMETHODSWe,1,0.0
symptomsRESULTSPostvaccine,1,0.0
disability-,1,0.0
ITP-enhanced,1,0.0
isotachophoresis,1,0.0
CoA-reductase,1,0.0
Anti-allergen,1,0.0
Olive,1,0.0
Mugwort,1,0.0
Birch,1,0.0
Timothy,1,0.0
2391,1,0.0
claims-derived,1,0.0
interventions--let,1,0.0
programs--have,1,0.0
0102,1,0.0
0793,1,0.0
attack-free,1,0.0
HMG,1,0.0
panoramic,1,0.0
Cas12-gRNA,1,0.0
JGCA,1,0.0
Minds,1,0.0
trinity,1,0.0
medico-surgical,1,0.0
oseltamivirin,1,0.0
population--Takotsubo,1,0.0
sportspersons,1,0.0
allowable,1,0.0
ergogenicity,1,0.0
khellin,1,0.0
single-dilution,1,0.0
fluorophore-quencher,1,0.0
cofocusing,1,0.0
Temperature-sensitive,1,0.0
Determinative,1,0.0
exposure-or,1,0.0
26-April,1,0.0
multi-colored,1,0.0
Computationally,1,0.0
derivative-free,1,0.0
baseline-,1,0.0
Scan,1,0.0
prejudice-based,1,0.0
bi-national,1,0.0
Resultant,1,0.0
gut-brain-lung,1,0.0
Middle-Income,1,0.0
damagemicrobial,1,0.0
trichotomy,1,0.0
35gmdl,1,0.0
≥35gmdl,1,0.0
mean±SD,1,0.0
302±012gmdl,1,0.0
448±050gmdl,1,0.0
525980,1,0.0
7800,1,0.0
101150,1,0.0
8920,1,0.0
20790,1,0.0
8320,1,0.0
4160,1,0.0
576±183,1,0.0
440±122,1,0.0
350gmdl,1,0.0
channel-antagonists,1,0.0
anti‑SARS‑CoV‑2,1,0.0
Immunochromatography,1,0.0
Interasma,1,0.0
pre-Kardiomobil,1,0.0
Manifesto,1,0.0
flavonolignan,1,0.0
immune-cytokine,1,0.0
-135061,1,0.0
-811,1,0.0
3768,1,0.0
biosamples,1,0.0
1452,1,0.0
acenocoumarin,1,0.0
tools--CURB-65,1,0.0
PMEWS,1,0.0
CAT--in,1,0.0
SOAP,1,0.0
iso-enzyme,1,0.0
re-initiation,1,0.0
CovXNets,1,0.0
gradient-based,1,0.0
COVIDNormal,1,0.0
COVIDViral,1,0.0
COVIDBacterial,1,0.0
COVIDnormalViralBacterial,1,0.0
httpsgithubcomPerceptron21CovXNet,1,0.0
Modal,1,0.0
commercializing,1,0.0
infectionsGraphical,1,0.0
ORV,1,0.0
head-and-neck,1,0.0
≈42,1,0.0
LNA,1,0.0
MOC,1,0.0
anti‑viral,1,0.0
treatmentmanagement,1,0.0
feto-maternal,1,0.0
nonMaoris,1,0.0
antiallergenics,1,0.0
Parainfluenzae,1,0.0
2741,1,0.0
Solu-cortef,1,0.0
laryngotracheobronchitis,1,0.0
stridors,1,0.0
Tracheotomy,1,0.0
crusts,1,0.0
stimulus-centered,1,0.0
body-centered,1,0.0
tri-part,1,0.0
Nanoluciferase,1,0.0
tags,1,0.0
fiscally,1,0.0
18970,1,0.0
CI102-177,1,0.0
evidence-adjusted,1,0.0
phenol,1,0.0
chloroform,1,0.0
GITCRNA,1,0.0
PCR-ready,1,0.0
NEUPSILIN,1,0.0
NEUPSILIN-Af,1,0.0
Radio-isotopic,1,0.0
melancholic,1,0.0
ASwitzerland33302017,1,0.0
ABrisbane022018,1,0.0
S91R,1,0.0
S181T,1,0.0
pillow-shaped,1,0.0
deseases,1,0.0
1958-1967,1,0.0
vesiculating,1,0.0
shock--13,1,0.0
13-1,1,0.0
pandemic-it,1,0.0
philosophers,1,0.0
Cliniques,1,0.0
universitaires,1,0.0
Saint-Luc,1,0.0
22-May,1,0.0
5200-248000,1,0.0
4800-504000,1,0.0
25000-425000,1,0.0
580000-3700000,1,0.0
coronary-A-behaviour,1,0.0
Fiberoptic,1,0.0
hydrocortisone-sodium,1,0.0
LEVEL,1,0.0
I38T,1,0.0
baloxavir-treated,1,0.0
Caribbean-Hispanic,1,0.0
Mestizo,1,0.0
1551095,1,0.0
double-peaked,1,0.0
intervention-timing,1,0.0
locationtype,1,0.0
supraglottic,1,0.0
Epiglottitis,1,0.0
acuta,1,0.0
Solucortef,1,0.0
theelimination,1,0.0
inchildren,1,0.0
BIOAIR,1,0.0
Registrya,1,0.0
Christianity,1,0.0
nationalists,1,0.0
hour-scale,1,0.0
time-consumption,1,0.0
LOQ,1,0.0
immunorecognition,1,0.0
immunopharmacology,1,0.0
4685,1,0.0
monitor-computer,1,0.0
KOMPAS-01,1,0.0
1915-22,1,0.0
1924-25,1,0.0
47-53,1,0.0
Preindustrialized,1,0.0
immunostimulant,1,0.0
Oligonucleotides,1,0.0
regulatory-type,1,0.0
antihypertension,1,0.0
tMCAo,1,0.0
synaptophysin,1,0.0
exude,1,0.0
high-sensitivityspecificity,1,0.0
lower-sensitivityspecificity,1,0.0
cough-generated,1,0.0
Deposition,1,0.0
TREVO,1,0.0
NVSN,1,0.0
2004--05,1,0.0
Teledentistry,1,0.0
permeated,1,0.0
nationalism-a,1,0.0
12±4,1,0.0
242020,1,0.0
COVID--19,1,0.0
millennials,1,0.0
Susceptible-Exposed-Infected-Removed,1,0.0
latently,1,0.0
unobservable,1,0.0
15-June,1,0.0
34-53,1,0.0
27-July,1,0.0
2286,1,0.0
30-42,1,0.0
15-December,1,0.0
15-23,1,0.0
atory,1,0.0
nCov,1,0.0
hospitalizationThe,1,0.0
45±16,1,0.0
case60,1,0.0
casethe,1,0.0
54±22,1,0.0
67±31,1,0.0
fever142,1,0.0
sputum108,1,0.0
cases72,1,0.0
fatigue23,1,0.0
cases15,1,0.0
anorexia20,1,0.0
42±22,1,0.0
lymphonpenia,1,0.0
remote-assistance,1,0.0
18973,1,0.0
mitogenic,1,0.0
2010secondary,1,0.0
speleo-,1,0.0
cave,1,0.0
Bystrá,1,0.0
coactions,1,0.0
scale-dependent,1,0.0
intra-seasonal,1,0.0
spatially-referenced,1,0.0
spatially-organized,1,0.0
endgame,1,0.0
courageously,1,0.0
433-893,1,0.0
274304,1,0.0
195086-402719,1,0.0
12469,1,0.0
8868-18306,1,0.0
1976-2001,1,0.0
odontoiatric,1,0.0
centimetres,1,0.0
otolaryngic,1,0.0
Kode,1,0.0
Technology-modified,1,0.0
C19-kodecytes,1,0.0
examinations--Holter,1,0.0
sparrows,1,0.0
pigeons,1,0.0
falcons,1,0.0
Low-pathogenicity,1,0.0
cook,1,0.0
transdermally,1,0.0
mmolliter,1,0.0
18-49-y-old,1,0.0
€94039,1,0.0
VA-TT,1,0.0
electrocardiotopographic,1,0.0
7--10,1,0.0
pump-driven,1,0.0
wall-suction,1,0.0
constitutionally,1,0.0
overinvolvement,1,0.0
mechanisms--neuro-hormonal,1,0.0
Cryopreservation,1,0.0
gonadotoxic,1,0.0
SARS-CoV-2-contamination,1,0.0
BGuangdong893,1,0.0
functionalpsychological,1,0.0
Influenza-coded,1,0.0
Haematology-Oncology,1,0.0
purposeobjective,1,0.0
human-coronaviruses,1,0.0
Ctl2-2018,1,0.0
Ctl-2018,1,0.0
HCoV-OC43-reactive,1,0.0
SIgM,1,0.0
polyreactive,1,0.0
salinity,1,0.0
trephinationWe,1,0.0
5A,1,0.0
41917,1,0.0
20982,1,0.0
trephination,1,0.0
20935,1,0.0
T202I,1,0.0
S200P,1,0.0
ASwitzerland80602017,1,0.0
Literature-based,1,0.0
solitus,1,0.0
Pavlov--,1,0.0
Plovdiv,1,0.0
hypercoagulemia,1,0.0
admitted--a,1,0.0
ITIS,1,0.0
postrandomization,1,0.0
’one,1,0.0
health’,1,0.0
nurse-driven,1,0.0
laser-cut,1,0.0
Cool,1,0.0
FlexAbility,1,0.0
Anam,1,0.0
hole-based,1,0.0
Non-irrigation,1,0.0
non-paroxysmal,1,0.0
5290,1,0.0
111539,1,0.0
11291,1,0.0
heartbase,1,0.0
near-field,1,0.0
non-contiguous,1,0.0
Wimmera,1,0.0
authorizing,1,0.0
electroimpedansometry,1,0.0
Grayling,1,0.0
2056,1,0.0
vehemently,1,0.0
mitis,1,0.0
reduced-sodium,1,0.0
cardiopathies,1,0.0
384-,1,0.0
nonrelevant,1,0.0
1990-92,1,0.0
logDRS,1,0.0
439-693,1,0.0
377-715,1,0.0
Bensons,1,0.0
rarefaction,1,0.0
31-45,1,0.0
17532,1,0.0
habitant,1,0.0
95-98,1,0.0
Recoveries,1,0.0
proactivity,1,0.0
298-461,1,0.0
post-angioplasty,1,0.0
206-422,1,0.0
Interleukin-8,1,0.0
16005,1,0.0
immunomodulatingimmunosuppressive,1,0.0
nonST,1,0.0
7428,1,0.0
chatting,1,0.0
relaying,1,0.0
syndrome-scoring,1,0.0
ColdHot-associated,1,0.0
cg10791966,1,0.0
hyposensibilisation,1,0.0
Producing,1,0.0
EAACIs,1,0.0
resent,1,0.0
airway-related,1,0.0
5718,1,0.0
Ciudad,1,0.0
Madero,1,0.0
Tamaulipas,1,0.0
theme--the,1,0.0
ceruloplasmic,1,0.0
isoenzyme-confirmed,1,0.0
1372,1,0.0
00003ABSTRACT,1,0.0
Ensuing,1,0.0
statim,1,0.0
near-sourced,1,0.0
NCT04338360,1,0.0
locally-evolving,1,0.0
onset-to-hospital,1,0.0
6282,1,0.0
genosensors,1,0.0
sestaMIBI,1,0.0
pre-lysis,1,0.0
-blocker,1,0.0
3923,1,0.0
DxCG,1,0.0
9-patient,1,0.0
1220545,1,0.0
manor,1,0.0
authorise,1,0.0
2780,1,0.0
dischargedeath,1,0.0
AMS,1,0.0
20--30,1,0.0
advisement,1,0.0
sex-by-hemisphere,1,0.0
locally-programmable,1,0.0
ll,1,0.0
108-135,1,0.0
125-194,1,0.0
121-313,1,0.0
121-371,1,0.0
139-333,1,0.0
SARS-CoV-2nCoV-19,1,0.0
CoronaHack,1,0.0
INFORM,1,0.0
4158-,1,0.0
4250,1,0.0
7520,1,0.0
allergist-immunologists,1,0.0
greater-than-zero,1,0.0
31389,1,0.0
cost-wise,1,0.0
frequency≥10,1,0.0
Nsp2T85I,1,0.0
proteinG204R,1,0.0
to4,1,0.0
ORF3aQ57HNsp2T85I,1,0.0
proteinR203KG204R,1,0.0
Nsp12P323LSpikeD614G,1,0.0
Nsp10,1,0.0
Concisely,1,0.0
armored,1,0.0
MS2-phage-based,1,0.0
Vector-PCRrv-2019-nCoV-RG,1,0.0
particles-based,1,0.0
Airway-related,1,0.0
virusThe,1,0.0
Australia342019,1,0.0
scartectomy,1,0.0
mid-face,1,0.0
frameshift,1,0.0
acetyl-salicic,1,0.0
postanalytical,1,0.0
virüs,1,0.0
cytokinesmediators,1,0.0
IL-38,1,0.0
GCSF,1,0.0
CCL3,1,0.0
MCSF,1,0.0
uncontrolled-adaptivehyperimmune,1,0.0
IL-1αIL-1β,1,0.0
CH3,1,0.0
endothelialvascular,1,0.0
2-factor,1,0.0
3-level,1,0.0
face-centred,1,0.0
PCDs,1,0.0
PAMI-1,1,0.0
PVFM,1,0.0
pathfinder,1,0.0
cEEG,1,0.0
primary-prevention,1,0.0
27-96,1,0.0
082-094,1,0.0
Q2,1,0.0
≥115,1,0.0
aetiopathology,1,0.0
endo-bronchial,1,0.0
hypertelorism,1,0.0
thumbs,1,0.0
uvula,1,0.0
N163,1,0.0
T144AI,1,0.0
T151K,1,0.0
Q213R,1,0.0
S214P,1,0.0
T176K,1,0.0
D69N,1,0.0
Q277R,1,0.0
N137K,1,0.0
N187K,1,0.0
E78KG,1,0.0
1A3-DEL,1,0.0
BWashington022009,1,0.0
K162,1,0.0
D164,1,0.0
facies,1,0.0
G129D,1,0.0
G133R,1,0.0
K136E,1,0.0
V180R,1,0.0
22647,1,0.0
319-387,1,0.0
133-168,1,0.0
105-165,1,0.0
106-133,1,0.0
anti-phospholipid,1,0.0
juxta-cortical,1,0.0
McDonald,1,0.0
Menieres,1,0.0
exaspiration,1,0.0
Fries,1,0.0
virusIn,1,0.0
stuffed,1,0.0
kinetically,1,0.0
α23-linked,1,0.0
biomarkerprotein,1,0.0
agents--ACE,1,0.0
PPARα,1,0.0
metformin--also,1,0.0
generics,1,0.0
≈20,1,0.0
scripts,1,0.0
organization-specific,1,0.0
month--group,1,0.0
ST-E,1,0.0
50-67,1,0.0
intrusive,1,0.0
nonintrusively,1,0.0
2004--2005,1,0.0
college-affiliated,1,0.0
organizations--the,1,0.0
Association--and,1,0.0
Listserv,1,0.0
leftover,1,0.0
tip-to-date,1,0.0
phenotype-genotype,1,0.0
diagrammatic,1,0.0
wheezingasthma,1,0.0
Tirilazad,1,0.0
spokespeople,1,0.0
shouldered,1,0.0
Opacification,1,0.0
interconversion,1,0.0
LP50,1,0.0
RTI-causing,1,0.0
Mesocricetus,1,0.0
10017,1,0.0
10002-10033,1,0.0
10044,1,0.0
10011-10077,1,0.0
Pneumotology,1,0.0
psychogenic-existential,1,0.0
microsocial,1,0.0
groupfamily,1,0.0
Gestalt,1,0.0
CFC,1,0.0
steroid-based,1,0.0
codon-pair,1,0.0
unitsmL,1,0.0
ibuprofen-sensitive,1,0.0
pruritis,1,0.0
cox,1,0.0
Dipping,1,0.0
chi2124,1,0.0
chi2135,1,0.0
chi2703,1,0.0
070-094,1,0.0
chi2770,1,0.0
38-75,1,0.0
life-threateningly,1,0.0
Menopausal,1,0.0
wavelet-based,1,0.0
pre-emergent,1,0.0
18-60-year,1,0.0
infarct-and,1,0.0
197172,1,0.0
exposome-matching,1,0.0
RIP,1,0.0
21Lmin,1,0.0
Di-isocyanates,1,0.0
practolol-treated,1,0.0
pretrial,1,0.0
antibody-conjugated,1,0.0
phase-shifted,1,0.0
cladding,1,0.0
antibody-immobilized,1,0.0
reusability,1,0.0
unperturbed,1,0.0
Technologists,1,0.0
ten-segment,1,0.0
rallies,1,0.0
practionners,1,0.0
Paracelsus,1,0.0
AGMT,1,0.0
NCT04351529,1,0.0
79-88,1,0.0
0-78,1,0.0
7-32,1,0.0
non-mutually,1,0.0
Designation,1,0.0
personalfamily,1,0.0
receptionists,1,0.0
Calls,1,0.0
waken,1,0.0
Mexico--1626,1,0.0
Ricia,1,0.0
drugs--Tamiflu,1,0.0
012L,1,0.0
Capsaicin,1,0.0
work-sensitizing,1,0.0
analgesics-induced,1,0.0
non-coronavirus,1,0.0
≥96,1,0.0
out-of-state,1,0.0
IR-induced,1,0.0
IPC-induced,1,0.0
gene-related,1,0.0
kinase-3β,1,0.0
tensin,1,0.0
mito-KATP,1,0.0
MPTP,1,0.0
Respondent-driven,1,0.0
RDS,1,0.0
webRDS,1,0.0
rtPA-induced,1,0.0
peroxidase-like,1,0.0
spectroscopically,1,0.0
Gendarmerie,1,0.0
IRCGN™,1,0.0
Covid-,1,0.0
Presto®,1,0.0
Wilkins,1,0.0
mending,1,0.0
omega,1,0.0
Nephropathy,1,0.0
strokemyocardial,1,0.0
infarctionvascular,1,0.0
5-y,1,0.0
Chimpanzee,1,0.0
1st-2018,1,0.0
serives,1,0.0
stakeholdersservice,1,0.0
vigil,1,0.0
UNDMT,1,0.0
5373,1,0.0
0241,1,0.0
＜,1,0.0
unleash,1,0.0
UCSF,1,0.0
Chimera,1,0.0
httpsdoiorg10110120200803234872,1,0.0
primedboosted,1,0.0
primedintranasally,1,0.0
intramuscular-alum-only,1,0.0
mucosally,1,0.0
Imperfections,1,0.0
are--in,1,0.0
Mage1140,1,0.0
SD235,1,0.0
Mage1125,1,0.0
SD81,1,0.0
neurofilament,1,0.0
sNfL,1,0.0
acLVO,1,0.0
spike-antibody,1,0.0
httpscov3dibbrumdedu,1,0.0
nonfollicular,1,0.0
pinhead-sized,1,0.0
pustulosis,1,0.0
Punch,1,0.0
subcorneal,1,0.0
Dermal,1,0.0
Chao1,1,0.0
phenotype-guided,1,0.0
perinatally-acquired,1,0.0
congenitally-,1,0.0
parametrically,1,0.0
developmentprocurement,1,0.0
comprehensible,1,0.0
simple-to-perform,1,0.0
biodefense,1,0.0
77years,1,0.0
58±1039,1,0.0
3600days,1,0.0
Exactly,1,0.0
9687,1,0.0
splatters,1,0.0
components-namely,1,0.0
high-velocity,1,0.0
formites,1,0.0
monochromatic,1,0.0
Fetuses,1,0.0
light-sheet,1,0.0
water-cooled,1,0.0
burr,1,0.0
operatory,1,0.0
EP-Covid19-Madrid,1,0.0
Regaining,1,0.0
ICUdied,1,0.0
129-314,1,0.0
092-499,1,0.0
chimeras,1,0.0
G139,1,0.0
R140,1,0.0
H5N2-N9,1,0.0
PrimerDesign,1,0.0
KH,1,0.0
refresh,1,0.0
parameterisation,1,0.0
Réalité,1,0.0
47-69,1,0.0
388746,1,0.0
376606,1,0.0
harbours,1,0.0
B1128Gamma,1,0.0
epicardially,1,0.0
volume-rendered,1,0.0
ISDN-group,1,0.0
Melaka,1,0.0
Kampar,1,0.0
Orthoreovirus,1,0.0
Reoviridae,1,0.0
orthoreoviruses,1,0.0
medicationABSTRACT,1,0.0
parasitism,1,0.0
parasite-free,1,0.0
antihelminthic,1,0.0
pandemics--we,1,0.0
characteristics--ie,1,0.0
nationss,1,0.0
FluAid,1,0.0
poignancy,1,0.0
nonstimulated,1,0.0
nonphagocytising,1,0.0
Bratislava,1,0.0
INT,1,0.0
vacations,1,0.0
intra-European,1,0.0
Immunodéprimées,1,0.0
VacciNation,1,0.0
AVNIR,1,0.0
RSVhMPV,1,0.0
beyond-genetics,1,0.0
12090,1,0.0
Carroll,1,0.0
2020–2021,1,0.0
therapy--dual,1,0.0
antiplateles,1,0.0
neuraminidase-optimized,1,0.0
HA-stem,1,0.0
lung-resident,1,0.0
circularized,1,0.0
hyperbranched,1,0.0
intercalation,1,0.0
signalnoise,1,0.0
narrowest,1,0.0
Ipsos,1,0.0
Derp,1,0.0
Absentees,1,0.0
SARSID,1,0.0
electromaps,1,0.0
examplative,1,0.0
radioligands,1,0.0
Kong1968,1,0.0
amantadine-dosed,1,0.0
placebo-dosed,1,0.0
379661,1,0.0
16428,1,0.0
1988-1997,1,0.0
hold-out,1,0.0
broad-brush,1,0.0
Chocolate,1,0.0
Kidneys,1,0.0
transition-state,1,0.0
22315,1,0.0
anticoncipients,1,0.0
exploratory-descriptive,1,0.0
Cachoeira,1,0.0
11100,1,0.0
18-90,1,0.0
sneezed,1,0.0
coughingsneezing,1,0.0
seven-month,1,0.0
Asthma-onset,1,0.0
ischemia-,1,0.0
SNAP-induced,1,0.0
donor-induced,1,0.0
chloride-independent,1,0.0
cyclophilin,1,0.0
Released,1,0.0
mucus--both,1,0.0
Antileukotriene,1,0.0
IVTEVT,1,0.0
bronchospasmogenic,1,0.0
non-isosmolar,1,0.0
2455,1,0.0
medieval,1,0.0
980-1025,1,0.0
sekteh,1,0.0
Canon,1,0.0
pyroptotic,1,0.0
Bcl-xL,1,0.0
infectionIMPORTANCE,1,0.0
≥29,1,0.0
routed,1,0.0
AFRI,1,0.0
antithrombinics,1,0.0
DNA-enzyme,1,0.0
state-the,1,0.0
state-that,1,0.0
64-multislice,1,0.0
dubutamine,1,0.0
retrofitted,1,0.0
what-if,1,0.0
deswabbing,1,0.0
high-leverage,1,0.0
water-to-N-acetylaspartate,1,0.0
80M,1,0.0
broadly-reactive,1,0.0
Unadjuvanted,1,0.0
epicardic,1,0.0
aerolizated,1,0.0
transmiocardic,1,0.0
viruses--bVictoria287,1,0.0
BYamagata1688--cocirculated,1,0.0
syst,1,0.0
diast,1,0.0
4725,1,0.0
vasospasm-induced,1,0.0
virus-Asian57,1,0.0
Russian77-are,1,0.0
immunoabsorbent,1,0.0
antihemophilic,1,0.0
A--those,1,0.0
B--those,1,0.0
Fusobacteria,1,0.0
Spirochetes,1,0.0
1405,1,0.0
1975-94,1,0.0
alloyed,1,0.0
working-days,1,0.0
Contentment,1,0.0
445-482,1,0.0
worker-tradesman,1,0.0
evidence-guided,1,0.0
Staying,1,0.0
Healthy-Asthma,1,0.0
Prepared™,1,0.0
spelling,1,0.0
studentcaregiver,1,0.0
IRDT-,1,0.0
sIE,1,0.0
412000,1,0.0
57786,1,0.0
hemostaseology,1,0.0
valve-related,1,0.0
descriptive-comparative,1,0.0
readable,1,0.0
AdministrationDepartment,1,0.0
user-friendliness,1,0.0
DoDVeterans,1,0.0
mTICI2b3,1,0.0
Guarani,1,0.0
0334,1,0.0
ACalifornia072009-like,1,0.0
BA-like,1,0.0
experimentum,1,0.0
naturae,1,0.0
cemented,1,0.0
microdiamonds,1,0.0
abrasive,1,0.0
In-vivo,1,0.0
140-337,1,0.0
50-person,1,0.0
998-999,1,0.0
983-993,1,0.0
self-attributed,1,0.0
6063,1,0.0
PAQLQcopyright,1,0.0
intraclass-correlation,1,0.0
8764,1,0.0
Dharavi,1,0.0
intravenous-tissue,1,0.0
107448,1,0.0
3292,1,0.0
five-point,1,0.0
polishing,1,0.0
3940,1,0.0
Colleman,1,0.0
MassARRAY,1,0.0
HaploView,1,0.0
block1-3,1,0.0
block3,1,0.0
0000015,1,0.0
T-C,1,0.0
C-T,1,0.0
siderophiline,1,0.0
microglobulin,1,0.0
subjectsparents,1,0.0
careABSTRACT,1,0.0
≈3,1,0.0
pollutantsirritants,1,0.0
100-160,1,0.0
non-athletes,1,0.0
CentralEastern,1,0.0
4-month-old,1,0.0
described--Angiocardiogram,1,0.0
ventricle--Thallium,1,0.0
Lavage,1,0.0
persons1,1,0.0
IRP,1,0.0
frugal,1,0.0
40-90,1,0.0
≥65-years-old,1,0.0
fascicularbundle,1,0.0
premortal,1,0.0
-120,1,0.0
-180,1,0.0
198207,1,0.0
60-89,1,0.0
3968,1,0.0
0186,1,0.0
VEGFR-2,1,0.0
httpsbitly3eQObIR,1,0.0
treatedcontrolled,1,0.0
anticorrosive,1,0.0
Irritative,1,0.0
6q,1,0.0
13q,1,0.0
well-directed,1,0.0
infusion--at,1,0.0
Ukghr--to,1,0.0
14000-17000,1,0.0
ASK-12,1,0.0
Starts,1,0.0
3341,1,0.0
phyllaemblicin,1,0.0
Ormond,1,0.0
Street,1,0.0
1990s-like,1,0.0
∼7100,1,0.0
anti-tussive,1,0.0
δ-viniferin,1,0.0
myricitrin,1,0.0
taiwanhomoflavone,1,0.0
lactucopicrin,1,0.0
15-oxalate,1,0.0
nympholide,1,0.0
afzelin,1,0.0
biorobin,1,0.0
Intrestingly,1,0.0
two-to-five-year,1,0.0
multi-target-directed,1,0.0
infectionCommunicated,1,0.0
73880,1,0.0
2803,1,0.0
wwwwhointinfluenza,1,0.0
190-392,1,0.0
9846,1,0.0
9785,1,0.0
souls,1,0.0
LFID,1,0.0
allergic-associated,1,0.0
AH1N1v-related,1,0.0
favorablyABSTRACT,1,0.0
16-39,1,0.0
IFRs,1,0.0
2445,1,0.0
tissue-compatible,1,0.0
PEACE-Retrospective,1,0.0
in-turn,1,0.0
E1261,1,0.0
1596°,1,0.0
stroke-damaged,1,0.0
multi-components,1,0.0
stroke-disrupted,1,0.0
capaity,1,0.0
Douban,1,0.0
dictators,1,0.0
11992,1,0.0
GC100,1,0.0
clininal,1,0.0
ionometer,1,0.0
Superactivation,1,0.0
Helping,1,0.0
D614GL18FA222V,1,0.0
D614GA222V,1,0.0
D614GS477N,1,0.0
VOC-20201201B117,1,0.0
D614G69-70delN439K,1,0.0
pseudovirus-neutralization,1,0.0
spike-encoding,1,0.0
DNA-immunized,1,0.0
DNA-elicited,1,0.0
protein-elicited,1,0.0
Multilineage-differentiating,1,0.0
stress-enduring,1,0.0
non-tumorigenic,1,0.0
Evaluative,1,0.0
day-wheeze,1,0.0
AH1N1-related,1,0.0
anti-oxidizing,1,0.0
39-52,1,0.0
56-69,1,0.0
59-87,1,0.0
14-36,1,0.0
Cabin,1,0.0
05-187,1,0.0
Embedded,1,0.0
15-h,1,0.0
non-centralized,1,0.0
overdosed,1,0.0
Simplistically,1,0.0
Gaze-evoked,1,0.0
nasoorofaryngeal,1,0.0
cranio-cerebral,1,0.0
Norton,1,0.0
graded-refractive-index,1,0.0
rod-based,1,0.0
10-microm,1,0.0
GRIN,1,0.0
lens-based,1,0.0
fps,1,0.0
first-reported,1,0.0
Contactevbcunj-jenade,1,0.0
beagle,1,0.0
single-thrombus,1,0.0
060mm,1,0.0
6h-DWI,1,0.0
half-twelve,1,0.0
pluripotency,1,0.0
quadrants,1,0.0
steroid-induced,1,0.0
desquamed,1,0.0
0648-1721,1,0.0
0401,1,0.0
0174-0922,1,0.0
anti-IDV,1,0.0
expiration--FEV1,1,0.0
flow--FEF,1,0.0
flow--PEF,1,0.0
two-question,1,0.0
unsupportive,1,0.0
Fibrinolytics,1,0.0
833-998,1,0.0
730-997,1,0.0
466-778,1,0.0
extensionreinfarction,1,0.0
QQL-EPM,1,0.0
within-individual,1,0.0
between-subject,1,0.0
ACQUIRE-2,1,0.0
NCT02640742,1,0.0
2015-based,1,0.0
insufficiently-controlled,1,0.0
poorly-controlled,1,0.0
STANDARD™,1,0.0
3369,1,0.0
two-allele,1,0.0
polygenicmultifactorial,1,0.0
Transventricular,1,0.0
reattachment,1,0.0
edge-to-edge,1,0.0
1025-2332,1,0.0
3335-7085,1,0.0
4861,1,0.0
5464,1,0.0
Desmoplastic,1,0.0
fibroblastoma,1,0.0
fibroma,1,0.0
desmoplastic,1,0.0
fibroblastomas,1,0.0
ECG-but,1,0.0
31-channel,1,0.0
antimetabolite,1,0.0
81173,1,0.0
7601,1,0.0
7316,1,0.0
8165,1,0.0
1842,1,0.0
National-,1,0.0
1133-2445,1,0.0
strokes-a,1,0.0
1944,1,0.0
equalized,1,0.0
male-biased,1,0.0
Preben,1,0.0
Magnus,1,0.0
Nasopharynx-Associated,1,0.0
Lymphoid,1,0.0
Periodontopathic,1,0.0
Morisky-Green,1,0.0
0965-0987,1,0.0
1187-2507,1,0.0
1664,1,0.0
EK1-based,1,0.0
intestine-derived,1,0.0
seepage,1,0.0
factors--in,1,0.0
DRG-like,1,0.0
episode-specific,1,0.0
factors--respiratory,1,0.0
treatment--which,1,0.0
compensable,1,0.0
sub-typing,1,0.0
pitutrin-isadrin,1,0.0
quinasopyrin,1,0.0
ischemia-involved,1,0.0
less-than-ideal,1,0.0
offing,1,0.0
Termed,1,0.0
microcontroller,1,0.0
Jiaxing,1,0.0
unrelieved,1,0.0
3-tiered,1,0.0
patternwhereas,1,0.0
Flaherty,1,0.0
Bussman,1,0.0
Yusuf,1,0.0
54672,1,0.0
ever-adulthood,1,0.0
pizzasalty,1,0.0
pies,1,0.0
dessert,1,0.0
ever-asthma,1,0.0
111-373,1,0.0
031-096,1,0.0
retinol,1,0.0
DRGs--that,1,0.0
chain-free,1,0.0
non-transsphenoidal,1,0.0
2-8°C,1,0.0
spleen-derived,1,0.0
unravels,1,0.0
IL-4IL-5,1,0.0
aggregation-induced,1,0.0
luminogens,1,0.0
AIEgen-based,1,0.0
photostability,1,0.0
chemicalbiological,1,0.0
reigns,1,0.0
1606,1,0.0
nonatheroslerotic,1,0.0
ZymeTx,1,0.0
Okla,1,0.0
Polaroid,1,0.0
High-Speed,1,0.0
Detector,1,0.0
2000-to-2001,1,0.0
00574,1,0.0
WelfareMHW,1,0.0
MHW,1,0.0
Individual-level,1,0.0
228735,1,0.0
224175,1,0.0
152-179,1,0.0
121-222,1,0.0
recurrence--especially,1,0.0
primarysecondaryrehabilitative,1,0.0
post-entry,1,0.0
perplex,1,0.0
≥4-point,1,0.0
sBP,1,0.0
0151,1,0.0
0263,1,0.0
inexistence,1,0.0
99Tcm-gluconate,1,0.0
BNDF,1,0.0
YLL,1,0.0
2012-2017,1,0.0
Radioisotopic,1,0.0
retroactive,1,0.0
pleuropericarditis,1,0.0
thrift,1,0.0
Japanese-American,1,0.0
Non-Communicable,1,0.0
oyt,1,0.0
pleung,1,0.0
jup,1,0.0
40-855,1,0.0
94-738,1,0.0
203-725,1,0.0
perdipine,1,0.0
mini-lesions,1,0.0
ladder,1,0.0
preappointment,1,0.0
Medium-containing,1,0.0
SMSemail,1,0.0
13-wk,1,0.0
4032,1,0.0
uptick,1,0.0
insipidus,1,0.0
infundibuloneurophysitis,1,0.0
mLday,1,0.0
person‐to‐person,1,0.0
4-parameter,1,0.0
enanthem,1,0.0
Imaging-Confirmed,1,0.0
RDICH,1,0.0
RDIS,1,0.0
deconstructed,1,0.0
adjoining,1,0.0
4322,1,0.0
dropletcontact,1,0.0
stroke-heart,1,0.0
2020-Feb,1,0.0
B11250,1,0.0
B1261,1,0.0
V2-V3,1,0.0
Respiratory-borne,1,0.0
HELEX®,1,0.0
0305-0999,1,0.0
954958,1,0.0
P0046,1,0.0
HELEX,1,0.0
009-062,1,0.0
device-,1,0.0
memory-like,1,0.0
2623231,1,0.0
AboriginalTorres,1,0.0
261403,1,0.0
95-137,1,0.0
51-84,1,0.0
4-61,1,0.0
pearlescent,1,0.0
enanthema,1,0.0
filaria-specific,1,0.0
MIP-2,1,0.0
MIP-1β,1,0.0
3578,1,0.0
deters,1,0.0
PKBAKT,1,0.0
2020-10,1,0.0
gallopamil-sensitive,1,0.0
calcium-calmodulin,1,0.0
PGC-1α,1,0.0
NRF-1,1,0.0
mt-TFA,1,0.0
mitochondria-dependent,1,0.0
Mikrogen,1,0.0
recomWell,1,0.0
Serion,1,0.0
Cleartest,1,0.0
reanalyzes,1,0.0
Prussia,1,0.0
8911,1,0.0
6325,1,0.0
029day,1,0.0
47-73,1,0.0
Bamford,1,0.0
Anti-S,1,0.0
05157,1,0.0
06010,1,0.0
24-point,1,0.0
0737,1,0.0
0653,1,0.0
0575,1,0.0
0666,1,0.0
3566,1,0.0
steroid-inducible,1,0.0
Protein-1,1,0.0
PDGF,1,0.0
non-fish,1,0.0
iiithe,1,0.0
39-83,1,0.0
careied,1,0.0
micro-Astrup,1,0.0
Radiometer,1,0.0
Compensated,1,0.0
self-contact,1,0.0
AsCas12a,1,0.0
DNA-RNA,1,0.0
conjectured,1,0.0
Szybio,1,0.0
1997-April,1,0.0
non-IFF,1,0.0
PRC,1,0.0
Platelet-derived,1,0.0
influenaz,1,0.0
interchangably,1,0.0
ASt,1,0.0
Petersburg4816,1,0.0
IL-12AIL-12B,1,0.0
rs2243115,1,0.0
IL-12B,1,0.0
rs3212227,1,0.0
00085,1,0.0
Imputation,1,0.0
endoleak,1,0.0
starved,1,0.0
Epidermal,1,0.0
131174,1,0.0
31162,1,0.0
life-stage,1,0.0
110-124,1,0.0
chromatography-tandem,1,0.0
Centrifugal,1,0.0
Micro-nano,1,0.0
0·77-0·90,1,0.0
0·64-0·96,1,0.0
0·99,1,0.0
sypmtomatic,1,0.0
commandeer,1,0.0
ipomoeassin,1,0.0
Sec61-mediated,1,0.0
agentsThis,1,0.0
anti-migratory,1,0.0
HCOT,1,0.0
PtCO2,1,0.0
Titrated,1,0.0
TOT,1,0.0
PtCO,1,0.0
shortchanged,1,0.0
Infarct-associated,1,0.0
67--44,1,0.0
infarcts--and,1,0.0
17--11,1,0.0
filariasis,1,0.0
elephantiasis,1,0.0
onchocerciasis,1,0.0
loiasis,1,0.0
filaria-driven,1,0.0
host-filaria,1,0.0
microfilariae,1,0.0
micronano-separation,1,0.0
2020-Dec,1,0.0
77-99,1,0.0
P0086,1,0.0
112-134,1,0.0
104-127,1,0.0
Largely,1,0.0
overhead,1,0.0
2825,1,0.0
systolicdiastolic,1,0.0
1538928,1,0.0
6833,1,0.0
089-062,1,0.0
068-090,1,0.0
P00007,1,0.0
054-073,1,0.0
087-101,1,0.0
Giving,1,0.0
88100000,1,0.0
CRx,1,0.0
metatranscriptomics,1,0.0
total-RNA-seq,1,0.0
NYC-distinctive,1,0.0
50821,1,0.0
Function-5,1,0.0
interest-based,1,0.0
Theorical,1,0.0
mmHq,1,0.0
185110,1,0.0
Prudence,1,0.0
14-47,1,0.0
Baltimore-Washington,1,0.0
Endocrinological,1,0.0
influenzaand,1,0.0
lung-,1,0.0
1330·000,1,0.0
not-infected,1,0.0
Gaulle,1,0.0
Aranui,1,0.0
Marquesas,1,0.0
boarded,1,0.0
two-year-old,1,0.0
Analogues,1,0.0
•Positive,1,0.0
Clinic•70,1,0.0
•The,1,0.0
Confounders,1,0.0
-61,1,0.0
dissective,1,0.0
eICA,1,0.0
D-D,1,0.0
reflux-triggered,1,0.0
self-transcribing,1,0.0
STARR-based,1,0.0
Assaying,1,0.0
IL-4-positive,1,0.0
Th1-dominant,1,0.0
test--regarding,1,0.0
decompensations,1,0.0
AACC,1,0.0
case-reporting,1,0.0
alternativeadditional,1,0.0
102-116,1,0.0
84-91,1,0.0
035-041,1,0.0
myocardical,1,0.0
neurologist-to-patient,1,0.0
149-4721,1,0.0
4·9,1,0.0
1081974,1,0.0
28359,1,0.0
3177,1,0.0
8052,1,0.0
świetokrzyskie,1,0.0
52579,1,0.0
warmifisko-mazurskie,1,0.0
68512,1,0.0
20101,1,0.0
132916,1,0.0
warmińsko-mazurskie,1,0.0
71352,1,0.0
8944,1,0.0
3–5,1,0.0
300000–500000,1,0.0
low-powered,1,0.0
V617F,1,0.0
CD-1,1,0.0
prime-only,1,0.0
immunity-including,1,0.0
immunity-against,1,0.0
degeneracy,1,0.0
neuro-displacement,1,0.0
neurocomputational,1,0.0
iScore,1,0.0
0·9,1,0.0
20·6,1,0.0
6·0,1,0.0
72·0,1,0.0
037-043,1,0.0
065-069,1,0.0
049-052,1,0.0
non-diabetes,1,0.0
TTP-naïve,1,0.0
underdiagnoses,1,0.0
populationsLilly,1,0.0
LY3819253,1,0.0
Technique,1,0.0
redistributing,1,0.0
micro-interventions,1,0.0
patient--in,1,0.0
Left-,1,0.0
better-studied,1,0.0
Turner-Warwicks,1,0.0
Cordoba,1,0.0
1986-June,1,0.0
reportings,1,0.0
transchromosomic,1,0.0
consensus-sequence,1,0.0
anti-M2e,1,0.0
NMA,1,0.0
semirural,1,0.0
non-SA,1,0.0
non-PDA,1,0.0
food-stuff,1,0.0
potentially-salvageable,1,0.0
Hemicraniectomy,1,0.0
differnce,1,0.0
aetiologically,1,0.0
antipodal,1,0.0
antithetical,1,0.0
down-regulate,1,0.0
caplacizumab,1,0.0
ADAMTS13-deficiency,1,0.0
infirmity,1,0.0
Biostroke,1,0.0
audiology,1,0.0
audiological,1,0.0
tympanometry,1,0.0
otoacoustic,1,0.0
TEOAE,1,0.0
TEOAEs,1,0.0
Septic,1,0.0
retiree,1,0.0
hopefulness,1,0.0
spiritual-care,1,0.0
cell-entry-inhibiting,1,0.0
thromboembolus-artery,1,0.0
lower-frequency,1,0.0
NCT00763217,1,0.0
autochtonous,1,0.0
decline-no-dementia,1,0.0
0950-0996,1,0.0
p0024,1,0.0
Aβ1-,1,0.0
whereupon,1,0.0
8-year-olds,1,0.0
self-examination,1,0.0
difference-in-differences,1,0.0
anterior-lateral-superior,1,0.0
B-Victoria,1,0.0
6481,1,0.0
9966,1,0.0
posttesting,1,0.0
COVID-19-afflicted,1,0.0
RATULS,1,0.0
Robot-Assisted,1,0.0
HA11-328C14SL157S,1,0.0
well-adjusted,1,0.0
tridimensional,1,0.0
gamma-ray,1,0.0
Dissolved,1,0.0
dextrose,1,0.0
retrocardiac,1,0.0
mTc,1,0.0
mTc--labelled,1,0.0
Krypton,1,0.0
Asthma-2007,1,0.0
most-frequent,1,0.0
diseases--allergic,1,0.0
dermatitis--in,1,0.0
ENT-specialists,1,0.0
ENT-specialist,1,0.0
class-IA,1,0.0
selectiveβ1-blocker,1,0.0
METOprolol,1,0.0
CARDioproteCtioN,1,0.0
InfarCtion,1,0.0
METOCARD-CNIC,1,0.0
medicosocial,1,0.0
142-671,1,0.0
infections--by,1,0.0
country--in,1,0.0
lognormal,1,0.0
HA1HA2,1,0.0
HA223-185C137S,1,0.0
membrane-interacting,1,0.0
mesh-covered,1,0.0
malappostion,1,0.0
homepage,1,0.0
DPP10,1,0.0
HAis,1,0.0
radioisotope-labeled,1,0.0
18-hour,1,0.0
afield,1,0.0
non-treatable,1,0.0
DISCUSSION,1,0.0
reconceptualisation,1,0.0
grandiose,1,0.0
nationalistic,1,0.0
6p,1,0.0
16q,1,0.0
17q,1,0.0
desintegrin,1,0.0
homeodomain,1,0.0
PubChems,1,0.0
bifurcated,1,0.0
GPRA,1,0.0
Kazal,1,0.0
SPINK5,1,0.0
RANTES-28CG,1,0.0
receptor-homologous,1,0.0
re545659,1,0.0
httpspubchemncbinlmnihgov,1,0.0
chemical-literature,1,0.0
Thieme,1,0.0
SpringerMaterials,1,0.0
Properties,1,0.0
WIPO,1,0.0
rHA1,1,0.0
C137S,1,0.0
disobstruct,1,0.0
C14S,1,0.0
Fehrenbach,1,0.0
psychotherapic,1,0.0
deviances,1,0.0
IsraelABSTRACT,1,0.0
Masovian,1,0.0
Rotational,1,0.0
RVAO,1,0.0
Bow,1,0.0
hunter,1,0.0
ligamentous,1,0.0
Doljevac,1,0.0
biapenem,1,0.0
ethambutol,1,0.0
Electrocardiographically,1,0.0
superconducting,1,0.0
findingABSTRACT,1,0.0
Administration-compliant,1,0.0
doff,1,0.0
encumbrance,1,0.0
Acclimatization,1,0.0
PAPRs,1,0.0
hydrolyzed,1,0.0
guar,1,0.0
PHGG,1,0.0
Nantes,1,0.0
corelate,1,0.0
lespace,1,0.0
souffle,1,0.0
post-preguidelines,1,0.0
Christine,1,0.0
arealeft,1,0.0
vetricular,1,0.0
TGFBR1,1,0.0
nonfusogenic,1,0.0
anti-HA1,1,0.0
anti-HA2,1,0.0
beta-actin,1,0.0
confess,1,0.0
déjà,1,0.0
vu,1,0.0
pandemic--Avian,1,0.0
Bow-tie,1,0.0
IRF7hi,1,0.0
IRF7lo,1,0.0
CHDR3,1,0.0
GSDMB,1,0.0
SMAD3,1,0.0
PILPN,1,0.0
reprograms,1,0.0
large-sample,1,0.0
bicep,1,0.0
non-linearly,1,0.0
stroke-impaired,1,0.0
study-quality,1,0.0
used-appropriately,1,0.0
appropriately-to,1,0.0
stoking,1,0.0
meat-packing,1,0.0
radio-immunologic,1,0.0
pneumallergens,1,0.0
distingusihed,1,0.0
iithe,1,0.0
ithe,1,0.0
coast-to,1,0.0
still-valid,1,0.0
chokepoints,1,0.0
corridors,1,0.0
Chokepoints,1,0.0
prophylax,1,0.0
distal-cerebral,1,0.0
treatment-modality,1,0.0
cat-owners,1,0.0
human-to-cat,1,0.0
unpremeditated,1,0.0
imprudence,1,0.0
incapability,1,0.0
Immunoglobulins,1,0.0
punches,1,0.0
pre-dilution,1,0.0
self-collectable,1,0.0
defended,1,0.0
Academia,1,0.0
afore,1,0.0
hypoteses,1,0.0
academicians,1,0.0
staunchest,1,0.0
defenders,1,0.0
oportunity,1,0.0
sOsmo,1,0.0
uOsmo,1,0.0
SI-ADH,1,0.0
hyposmolarity,1,0.0
hypertonicity,1,0.0
Twitter-based,1,0.0
triumphs,1,0.0
centuries-old,1,0.0
Ica,1,0.0
SAHLSIS,1,0.0
PTEN-induced,1,0.0
1PINK1Parkin,1,0.0
pollutantallergen-induced,1,0.0
in-vitro-diagnostic,1,0.0
076-089,1,0.0
change-so,1,0.0
overused-is,1,0.0
1984-1990,1,0.0
instrumental-variables,1,0.0
non-cases,1,0.0
18-87,1,0.0
29-June,1,0.0
4-terminal,1,0.0
syndromeInitial,1,0.0
4060,1,0.0
Gaussia,1,0.0
Gluc,1,0.0
-31,1,0.0
poured,1,0.0
quantitiesthus,1,0.0
Tianeptine,1,0.0
F-5-HT,1,0.0
PNEC,1,0.0
5-HT3,1,0.0
5-HT4,1,0.0
hyperparasympathetic,1,0.0
serotonin-induced,1,0.0
5-HT-terminals,1,0.0
Lviv,1,0.0
antivaccine,1,0.0
nonaction,1,0.0
Tweet,1,0.0
Routes,1,0.0
multi-racial,1,0.0
Asthmaasthma-like,1,0.0
thrombocytocrit,1,0.0
Bottlenecks,1,0.0
Immersed,1,0.0
Lossless,1,0.0
easier-to-deploy,1,0.0
Virushost,1,0.0
hospitality,1,0.0
Penguin,1,0.0
support-seeking,1,0.0
Patchy,1,0.0
fractionation,1,0.0
multi-hospital,1,0.0
pre-notification,1,0.0
stretcher,1,0.0
leagues,1,0.0
6511,1,0.0
4748,1,0.0
health-specific,1,0.0
Amantadin,1,0.0
NAls,1,0.0
readmit,1,0.0
ChILD,1,0.0
Cantonese,1,0.0
poorly-,1,0.0
bat-influenza,1,0.0
99100,1,0.0
685100,1,0.0
nearly-fatal,1,0.0
hyaline-vascular,1,0.0
nonatheromatous,1,0.0
22071,1,0.0
nucleophiles,1,0.0
diisocyanate-adducted,1,0.0
celldiisocyanate,1,0.0
340000,1,0.0
disease-,1,0.0
≈6699,1,0.0
nosebleeding,1,0.0
2153,1,0.0
Preterm,1,0.0
evolution1,1,0.0
non-integrative,1,0.0
LV-based,1,0.0
post-infarctional,1,0.0
borrows,1,0.0
012-038,1,0.0
Vitality,1,0.0
clinician-pathologist,1,0.0
164-209,1,0.0
remitting,1,0.0
counter-pandemic,1,0.0
Appearing,1,0.0
enzootics,1,0.0
clinical-therapeutic,1,0.0
Val,1,0.0
dAriège,1,0.0
1989-93,1,0.0
139-313,1,0.0
009-061,1,0.0
Dysregulations,1,0.0
NPSoropharyngeal,1,0.0
commutable,1,0.0
NSTEMI-nél,1,0.0
utánkövetésének,1,0.0
nap,1,0.0
Szívinfarktusra,1,0.0
utaló,1,0.0
panasz,1,0.0
reggel,1,0.0
jelentkezett,1,0.0
leggyakrabban,1,0.0
körül,1,0.0
találtak,1,0.0
gyakorisági,1,0.0
csúcsot,1,0.0
gyakoriság,1,0.0
szempontjából,1,0.0
eltérést,1,0.0
mutattak,1,0.0
incidenciát,1,0.0
találtunk,1,0.0
éven,1,0.0
belüli,1,0.0
mintázat,1,0.0
nemi,1,0.0
életkori,1,0.0
szerinti,1,0.0
konzisztens,1,0.0
legmagasabb,1,0.0
nyáron,1,0.0
legalacsonyabb,1,0.0
napokon,1,0.0
rögzítettük,1,0.0
Három,1,0.0
használtak,1,0.0
diurnalis,1,0.0
sportAlthough,1,0.0
exerciseinduced,1,0.0
prophylaxisForty-three,1,0.0
mite-proof,1,0.0
halálozásának,1,0.0
napi,1,0.0
ingadozása,1,0.0
adat,1,0.0
régóta,1,0.0
tárgya,1,0.0
általa,1,0.0
okozott,1,0.0
halálozásnak,1,0.0
vizsgálata,1,0.0
modelleket,1,0.0
esetszámú,1,0.0
válogatás,1,0.0
nélküli,1,0.0
betegcsoport,1,0.0
adatainak,1,0.0
elemzésével,1,0.0
szerzők,1,0.0
Regiszterben,1,0.0
regisztrált,1,0.0
dolgozták,1,0.0
többváltozós,1,0.0
általánosított,1,0.0
additív,1,0.0
STEMI-nél,1,0.0
többszempontos,1,0.0
tractionAreas,1,0.0
analízise,1,0.0
408495,1,0.0
55188,1,0.0
B--in,1,0.0
levels--in,1,0.0
stress-tests,1,0.0
electrocardiostimulation,1,0.0
fertility-related,1,0.0
Googles,1,0.0
10242020,1,0.0
1272021,1,0.0
71047,1,0.0
20756,1,0.0
26435,1,0.0
29437,1,0.0
52926,1,0.0
coinfecting,1,0.0
recombinations,1,0.0
117710,1,0.0
settingsThe,1,0.0
confinementThe,1,0.0
measuresGiven,1,0.0
trialing,1,0.0
non-CeAD-IS,1,0.0
workbook,1,0.0
Psycho-education,1,0.0
pre-sensitized,1,0.0
βCoV,1,0.0
phosphatidylethanolamine,1,0.0
lightly,1,0.0
93888,1,0.0
Łódzkie,1,0.0
1596920,1,0.0
fordult,1,0.0
azt,1,0.0
igazolta,1,0.0
itt,1,0.0
eltértek,1,0.0
napoknak,1,0.0
ugyanakkor,1,0.0
halálozásra,1,0.0
04542,1,0.0
halálozási,1,0.0
adatai,1,0.0
különböztek,1,0.0
00677,1,0.0
gyakrabban,1,0.0
reggeli,1,0.0
well-distinct,1,0.0
órákban,1,0.0
nagyobb,1,0.0
munkanapokon,1,0.0
16214,1,0.0
555-560,1,0.0
Women’s,1,0.0
NCT00920621,1,0.0
non-radioactive,1,0.0
Azan-Mallory,1,0.0
838-105,1,0.0
587-213,1,0.0
lunar,1,0.0
2704,1,0.0
TRPC,1,0.0
TRPV,1,0.0
Vanilloid,1,0.0
not-work,1,0.0
APOA2,1,0.0
rs5082,1,0.0
102-211,1,0.0
EG2,1,0.0
35-kg,1,0.0
EXCOR,1,0.0
delaysigns,1,0.0
examinedImmunosuppressed,1,0.0
COVID-19High,1,0.0
TANANARIVE,1,0.0
BVICTORIA287,1,0.0
AVICTORIA3688,1,0.0
peoplepeople,1,0.0
GEDIIB,1,0.0
NS-gene,1,0.0
HLA-A9,1,0.0
Th1Th1,1,0.0
08517,1,0.0
Rolling,1,0.0
2573605,1,0.0
701838,1,0.0
178562,1,0.0
strictness,1,0.0
sterilisers,1,0.0
self-revival,1,0.0
Q5,1,0.0
Quattrociocchi,1,0.0
Dietram,1,0.0
Scheufele,1,0.0
103-212,1,0.0
rs1333049,1,0.0
CDKN2BAS1,1,0.0
galactomannan,1,0.0
rewarm,1,0.0
Rectal,1,0.0
safeABSTRACT,1,0.0
Pentraxin,1,0.0
IL-17A-dominant,1,0.0
Yemeni,1,0.0
HA-the,1,0.0
infectionAlthough,1,0.0
non-Covid,1,0.0
SyrSpendⓇ,1,0.0
PH4,1,0.0
stability-indicating,1,0.0
5249,1,0.0
16221fewer,1,0.0
107-250,1,0.0
€34,1,0.0
€12852,1,0.0
mAb-based,1,0.0
mass-spectrometry,1,0.0
KIAA1462,1,0.0
rs3739998,1,0.0
119-245,1,0.0
105-240,1,0.0
LIG1,1,0.0
rs20579,1,0.0
106-417,1,0.0
ADAMDEC1,1,0.0
rs3765124,1,0.0
does-and,1,0.0
Spirograms,1,0.0
069-235,1,0.0
initail,1,0.0
corticosteroid-sparing,1,0.0
streptomycin-free,1,0.0
wheals,1,0.0
mid-2007,1,0.0
sinus-rhythm,1,0.0
Holter-ECG,1,0.0
mRS-grades,1,0.0
57±11years,1,0.0
NIHSS-score,1,0.0
Posthospitalization,1,0.0
double-umbrella,1,0.0
6645,1,0.0
8056,1,0.0
4717,1,0.0
2026,1,0.0
6--previous,1,0.0
artial,1,0.0
WHOQOL-BREF,1,0.0
neogenetic,1,0.0
ICAAC,1,0.0
CyNC,1,0.0
Cy,1,0.0
lid,1,0.0
polyspecific,1,0.0
n24398,1,0.0
ACIP-defined,1,0.0
genitovascular,1,0.0
Peru-Lima,1,0.0
Iquitos,1,0.0
DTCAs,1,0.0
preadolescence,1,0.0
cisapride,1,0.0
studiesseriestrials,1,0.0
EP15-A2,1,0.0
EP7-A2,1,0.0
CVs,1,0.0
Neu5Acα2-3Galβ1-4,1,0.0
Kupffers,1,0.0
constituencies,1,0.0
respiratorysyndrome,1,0.0
co-managing,1,0.0
haulers-now,1,0.0
Infiltration,1,0.0
MNCCD34,1,0.0
StemStromal,1,0.0
outcome-improving,1,0.0
MSCbased,1,0.0
2957,1,0.0
enterobacterial,1,0.0
2-methoxyisobutyl,1,0.0
000002,1,0.0
136-637,1,0.0
20-723,1,0.0
136-535,1,0.0
139-699,1,0.0
148-768,1,0.0
120-674,1,0.0
25-648,1,0.0
≧16,1,0.0
≧65,1,0.0
5345,1,0.0
roller,1,0.0
092-111,1,0.0
TRPM,1,0.0
recoils,1,0.0
2·38,1,0.0
1·52-3·73,1,0.0
CCCT,1,0.0
1·62,1,0.0
1·18-2·22,1,0.0
1·88,1,0.0
1·34-2·62,1,0.0
2·70,1,0.0
1·86-3·94,1,0.0
1·26,1,0.0
0·93-1·71,1,0.0
Botnía,1,0.0
Willemoes,1,0.0
adrenergic-blocking,1,0.0
optimises,1,0.0
Schéma,1,0.0
régional,1,0.0
dorganisation,1,0.0
sanitaire,1,0.0
boils,1,0.0
reoccurring,1,0.0
Keratin,1,0.0
MCMs,1,0.0
distill,1,0.0
Iatrogenic,1,0.0
PenicilliumAspergillus,1,0.0
Stachybotrys,1,0.0
MI‑related,1,0.0
2-year-olds,1,0.0
CTTT,1,0.0
1·32-2·13,1,0.0
1·68,1,0.0
neurosonology,1,0.0
Melastatin,1,0.0
TRPP,1,0.0
Polycystin,1,0.0
TRPML,1,0.0
Mucolipin,1,0.0
TRPA,1,0.0
Ankyrin,1,0.0
2009a,1,0.0
piggery,1,0.0
2009b,1,0.0
Holyoake,1,0.0
n460,1,0.0
Producers,1,0.0
grad,1,0.0
Methodologically,1,0.0
Bloodborne,1,0.0
Recruited,1,0.0
fibrocytosis,1,0.0
corticosteroid-insensitive,1,0.0
ACT-,1,0.0
Test20,1,0.0
non-BMTs,1,0.0
self-sufficiency,1,0.0
Alpenklinik,1,0.0
Oberjoch,1,0.0
EMbase,1,0.0
consecutiveness,1,0.0
ScreeLing,1,0.0
lubricates,1,0.0
stomata,1,0.0
075-103,1,0.0
TLVO,1,0.0
203100000,1,0.0
081-098,1,0.0
patientstroke,1,0.0
067-087,1,0.0
089-112,1,0.0
leaping,1,0.0
n182,1,0.0
failureABSTRACT,1,0.0
253pii2000045,1,0.0
angiografic,1,0.0
Homeless,1,0.0
total-creatine,1,0.0
nano-sized,1,0.0
ct,1,0.0
Paulo10-1182016,1,0.0
Paulo30322016,1,0.0
genome-typing,1,0.0
CJ,1,0.0
Lopez,1,0.0
19973491269-76,1,0.0
Bakey,1,0.0
Endovasc,1,0.0
199634,1,0.0
nontherapeutic,1,0.0
livereal-time,1,0.0
3DTTE,1,0.0
2DTTE,1,0.0
RPDB,1,0.0
074-105,1,0.0
scorepre-stroke,1,0.0
case-ascertainment,1,0.0
mid-lateral,1,0.0
hada,1,0.0
Val66Met,1,0.0
ESPro,1,0.0
1206,1,0.0
-4407,1,0.0
2233,1,0.0
input-output,1,0.0
as-planned,1,0.0
Computable,1,0.0
Equilibrium,1,0.0
Percentagecost,1,0.0
percentagecost,1,0.0
Cardiologist,1,0.0
Reader,1,0.0
86300,1,0.0
preestablished,1,0.0
Billion,1,0.0
patient-held,1,0.0
bronchointerstitial,1,0.0
heartworm,1,0.0
Eo,1,0.0
home-stay,1,0.0
II-3,1,0.0
vaccine-influenza,1,0.0
demonstratedABSTRACT,1,0.0
Lokomat,1,0.0
hemiparethic,1,0.0
survey-weighted,1,0.0
027-069,1,0.0
insulin-producing,1,0.0
glucose-induced,1,0.0
1992-2000,1,0.0
Type-II,1,0.0
2–6,1,0.0
intramusculary,1,0.0
peaks--has,1,0.0
--Eprosartan,1,0.0
cerebro-,1,0.0
2954,1,0.0
instance-based,1,0.0
⁓,1,0.0
6-24-h,1,0.0
2321b,1,0.0
Q591K,1,0.0
ignorant,1,0.0
self-disciplined,1,0.0
resigned,1,0.0
Y-G,1,0.0
PsychINFO,1,0.0
2442,1,0.0
schizophrenia-like,1,0.0
Twelve-year,1,0.0
Psychosis,1,0.0
sacrified,1,0.0
histoenzymatic,1,0.0
Sarcolemmal,1,0.0
commemoration,1,0.0
archeo-epidemiology,1,0.0
troves,1,0.0
RELEVANCE,1,0.0
NIH-funded,1,0.0
Pseudoaneurysm,1,0.0
7Suppl,1,0.0
Odense,1,0.0
gamechanger,1,0.0
Low-density,1,0.0
NCMJ,1,0.0
A-B-A,1,0.0
verbally,1,0.0
dry-erase,1,0.0
Contraindications,1,0.0
mdx,1,0.0
damageinfarction,1,0.0
pseudo-noise,1,0.0
fibrillationventricular,1,0.0
VFVT,1,0.0
isirv-Antiviral,1,0.0
novelpre-licensure,1,0.0
non-heritable,1,0.0
clamp-tolerant,1,0.0
Saibokutou,1,0.0
unemploymentABSTRACT,1,0.0
chain-binomial,1,0.0
0378,1,0.0
0205-0698,1,0.0
0091-0919,1,0.0
1011-28253,1,0.0
3922,1,0.0
sanitary-and-epidemiologic,1,0.0
epizootia,1,0.0
antiepizootic,1,0.0
poultry-farming,1,0.0
2109-nCoV,1,0.0
annal,1,0.0
Flawed,1,0.0
Politicians,1,0.0
6201,1,0.0
Quorum,1,0.0
Short-lasting,1,0.0
HbOC,1,0.0
OMP,1,0.0
217-1034,1,0.0
174-1107,1,0.0
ORMDL3GSDMB,1,0.0
Stromal,1,0.0
Lymphopoietin,1,0.0
TH2-asthma,1,0.0
MMP-12,1,0.0
Anti-MMP,1,0.0
anti-MMP,1,0.0
cut-,1,0.0
cut-scores,1,0.0
1973-78,1,0.0
spleniculi,1,0.0
2012-2016,1,0.0
Ipsilesional,1,0.0
anti-correlated,1,0.0
Stressful,1,0.0
Victims,1,0.0
929×10-3,1,0.0
146×10-2,1,0.0
523×10-3,1,0.0
110×10-2,1,0.0
8876,1,0.0
6017,1,0.0
Revolving,1,0.0
timeless,1,0.0
re,1,0.0
PRP-D,1,0.0
3-60,1,0.0
Phenocopy,1,0.0
8-French,1,0.0
Continuous-flow,1,0.0
CVAs-ischemic,1,0.0
hemorrhagic-were,1,0.0
hVAD,1,0.0
18-1460,1,0.0
Trinitrin,1,0.0
Webers,1,0.0
well-used,1,0.0
20·0,1,0.0
12·6,1,0.0
89·10,1,0.0
37·09,1,0.0
hugging,1,0.0
1095months,1,0.0
phenocopies,1,0.0
44months,1,0.0
rhinovirus-16,1,0.0
ofinfluenza,1,0.0
ofpandemic,1,0.0
ergo,1,0.0
Pollutant,1,0.0
afterdepolarizations,1,0.0
ischemiainfarction,1,0.0
asthma-derived,1,0.0
US2879,1,0.0
US1336,1,0.0
US2407,1,0.0
US6393,1,0.0
ABCS,1,0.0
Justus-Warren,1,0.0
leeway,1,0.0
self-proliferation,1,0.0
L-based,1,0.0
fluorophore-labeled,1,0.0
94-100,1,0.0
91-96,1,0.0
82-87,1,0.0
Armitage,1,0.0
chair-bound,1,0.0
SV-40,1,0.0
Hysteria,1,0.0
95-item,1,0.0
self-questionnaire,1,0.0
Drug-induced,1,0.0
range-iqr,1,0.0
4384,1,0.0
3384,1,0.0
22017-900,1,0.0
5671-110,1,0.0
7487-947,1,0.0
1036-339,1,0.0
12467,1,0.0
19796,1,0.0
39671,1,0.0
37515,1,0.0
9286,1,0.0
7738,1,0.0
6098,1,0.0
8788,1,0.0
5278,1,0.0
lipoprotein-C,1,0.0
lungheart,1,0.0
scintiangiography,1,0.0
First-day,1,0.0
anti-SSA,1,0.0
daratumumab,1,0.0
zidovudine,1,0.0
Surfaxin,1,0.0
immune-bridging,1,0.0
initialy,1,0.0
ophthalmicus,1,0.0
Herpetic,1,0.0
DW-MRI,1,0.0
AngioMRI,1,0.0
PLEX,1,0.0
Acyclovir,1,0.0
anti-double,1,0.0
anti-Sm,1,0.0
anti-cardiolipin,1,0.0
mishandle,1,0.0
Halitosis,1,0.0
7194,1,0.0
falsely-positive,1,0.0
frame-shift,1,0.0
lifesavingABSTRACT,1,0.0
9371,1,0.0
intragenera,1,0.0
Mex-CoV-6,1,0.0
preparers,1,0.0
shoppers,1,0.0
WebEx,1,0.0
kicking,1,0.0
vinegar,1,0.0
6667,1,0.0
outbreakof,1,0.0
mildness,1,0.0
Zotarolimus,1,0.0
spiking,1,0.0
Hsp,1,0.0
Hsp60,1,0.0
IgG-seropositive,1,0.0
IgG-negative,1,0.0
anti-Hsp60,1,0.0
anti-Hsp70,1,0.0
anti-Hsp90,1,0.0
anti-COVID-19-immunized,1,0.0
IA-IIB,1,0.0
Surgically,1,0.0
MOPP,1,0.0
involved-,1,0.0
extended-field,1,0.0
N417,1,0.0
N461,1,0.0
113-329,1,0.0
OR143,1,0.0
103-199,1,0.0
traffictruck,1,0.0
4444,1,0.0
Primary-care,1,0.0
multibreath,1,0.0
MBWLCI,1,0.0
transfer-polymerase,1,0.0
american,1,0.0
≈126,1,0.0
armour,1,0.0
measured--static,1,0.0
Self-induced,1,0.0
deterrents,1,0.0
expend,1,0.0
dualistic,1,0.0
TIA-S,1,0.0
1830s,1,0.0
1840s,1,0.0
identified-time,1,0.0
KNHANES,1,0.0
XGB,1,0.0
PROGNOSIS,1,0.0
BIOTECH,1,0.0
Larissa,1,0.0
Antihistamines,1,0.0
Althesin,1,0.0
Northwick,1,0.0
busiest,1,0.0
bexarotene,1,0.0
levan,1,0.0
immune-polarizing,1,0.0
754-bed,1,0.0
HSs,1,0.0
teleconnection,1,0.0
phenotype-defined,1,0.0
50-87,1,0.0
ischaemia-,1,0.0
pulmonary-cardiac,1,0.0
immune-boosting,1,0.0
methylglyoxal,1,0.0
chrysin,1,0.0
galangin,1,0.0
hesperidinin,1,0.0
Separating,1,0.0
X4-like,1,0.0
paralog,1,0.0
5LD50,1,0.0
α23-sialic,1,0.0
S228,1,0.0
α23-SA,1,0.0
L226G228,1,0.0
L226S228,1,0.0
Q226G228,1,0.0
-091,1,0.0
inconclusiveness,1,0.0
thrombosis-thrombolysis,1,0.0
Narcotics,1,0.0
metaprolol,1,0.0
precipate,1,0.0
overpower,1,0.0
protein-hACE-2,1,0.0
metal-organic,1,0.0
Extraction-based,1,0.0
Unheated,1,0.0
protocol-samples,1,0.0
μgμL,1,0.0
98°C,1,0.0
conducing,1,0.0
nonaspirin,1,0.0
outpatiently,1,0.0
VIl,1,0.0
14-95,1,0.0
antiremodeling,1,0.0
Isomagnetic,1,0.0
isomagnetic,1,0.0
22-26,1,0.0
Q226,1,0.0
supervisory,1,0.0
by18,1,0.0
non-perceptive,1,0.0
07-101,1,0.0
monomers,1,0.0
MinION-based,1,0.0
cross-detection,1,0.0
high-titered,1,0.0
transcriptsreaction,1,0.0
low-titered,1,0.0
capacityIMPORTANCE,1,0.0
stagnating,1,0.0
Spectrum,1,0.0
occlusionwhich,1,0.0
0·25,1,0.0
0·08-0·75,1,0.0
exacerbationIn,1,0.0
multi-centric,1,0.0
bronchia,1,0.0
H5N1-host,1,0.0
life-threats,1,0.0
LUSC19,1,0.0
LUSAC,1,0.0
LUSI,1,0.0
Plants,1,0.0
farmingtransient,1,0.0
biopharming,1,0.0
prevelence,1,0.0
women’s,1,0.0
inareases,1,0.0
hyprtension,1,0.0
SPPS,1,0.0
travel-network-based,1,0.0
non-dihydropyridine,1,0.0
inflows,1,0.0
follow-upABSTRACT,1,0.0
shuntPatients,1,0.0
CVAtransient,1,0.0
Antidiuresis,1,0.0
clinicoradiologic,1,0.0
trigger-induced,1,0.0
SHERLOCK-Covid,1,0.0
STOP-Covid,1,0.0
CRISPR-built,1,0.0
functioning--not,1,0.0
normalABSTRACT,1,0.0
lay-peoples,1,0.0
antiedematous,1,0.0
ANew-Caledonia2099,1,0.0
AFFINITY,1,0.0
non-cardiothoracic,1,0.0
illness-SARI,1,0.0
18-to-59-year,1,0.0
131-410,1,0.0
111-357,1,0.0
276-1328,1,0.0
128-583,1,0.0
128-919,1,0.0
175-640,1,0.0
008-037,1,0.0
011-081,1,0.0
anti-bacterial,1,0.0
cholesterol-coupled,1,0.0
EK1C4,1,0.0
27200,1,0.0
Suizhou,1,0.0
Se-deficient,1,0.0
AugustThe,1,0.0
family-focused,1,0.0
HIV-infection,1,0.0
fixated,1,0.0
CORADS-4,1,0.0
mad,1,0.0
agentsbut,1,0.0
1963-2011,1,0.0
yy,1,0.0
EPRs,1,0.0
Hegers,1,0.0
mixed-bag,1,0.0
better-known,1,0.0
Ga,1,0.0
100-800,1,0.0
Xiangyang,1,0.0
Iodides,1,0.0
60792,1,0.0
1977-1989,1,0.0
rhinocytological,1,0.0
vasodepressor,1,0.0
periarteriolar,1,0.0
resistance-artery,1,0.0
cardiovascular-disease,1,0.0
race-,1,0.0
era-matched,1,0.0
Se-enriched,1,0.0
Enshi,1,0.0
Shiyan,1,0.0
Non-diagnosis,1,0.0
susceptibility-reducing,1,0.0
hitherto-unknown,1,0.0
413000,1,0.0
Flinders,1,0.0
small-vessel-type,1,0.0
inflammatoryendothelial,1,0.0
unIt,1,0.0
MCA-ischemia,1,0.0
nonshunting,1,0.0
stady,1,0.0
Phospholipids,1,0.0
thinlayer,1,0.0
32-56,1,0.0
disembolism,1,0.0
membrano-destructive,1,0.0
drugeluting,1,0.0
mini-pig,1,0.0
low-attenuation,1,0.0
Streaking,1,0.0
half-term,1,0.0
clinician-reported,1,0.0
hundred-fourteen,1,0.0
dihydrofolate,1,0.0
C1008,1,0.0
folinic,1,0.0
leucovorin,1,0.0
Counteracting,1,0.0
MAPKERK,1,0.0
Vogt-Koyanagi-Harada,1,0.0
hyperfluorescent,1,0.0
Understandably,1,0.0
feverishly,1,0.0
potassiumsodium,1,0.0
7-21,1,0.0
62-99,1,0.0
post-symptom-onset,1,0.0
Orf7aIMPORTANCE,1,0.0
PlA1A2,1,0.0
GPIIIa,1,0.0
PlA2,1,0.0
or600,1,0.0
-236,1,0.0
-290,1,0.0
-320,1,0.0
cysteine-containing,1,0.0
FPL,1,0.0
55712,1,0.0
BAY,1,0.0
u9773,1,0.0
2-involved,1,0.0
40-96,1,0.0
tPa,1,0.0
post-operation,1,0.0
Atiya,1,0.0
PhD,1,0.0
physician-scientist,1,0.0
hookworm,1,0.0
SARSMERSSARS-2,1,0.0
single-author,1,0.0
ardent,1,0.0
antivax,1,0.0
CDSR,1,0.0
BioNTech-Pfizer,1,0.0
6423,1,0.0
iRMD,1,0.0
most-talked-about,1,0.0
quality-based,1,0.0
Francis,1,0.0
Ascorbic,1,0.0
125-OH2,1,0.0
Zinc-dependent,1,0.0
4150,1,0.0
1677,1,0.0
FUTURE,1,0.0
≥35,1,0.0
Med-Tx,1,0.0
Population-Based,1,0.0
PBIDS,1,0.0
wet-dry,1,0.0
Short-duration,1,0.0
ΔICP,1,0.0
day-of-the-week,1,0.0
Exponentially,1,0.0
EWMA,1,0.0
three-stage,1,0.0
Kanfer,1,0.0
Karoly,1,0.0
conceptualizing,1,0.0
3187,1,0.0
20-31,1,0.0
fusing,1,0.0
176-206,1,0.0
SRGGSQASSRSSSRSRNSSRNSTPGSSRGTS,1,0.0
102-110,1,0.0
traverses,1,0.0
IPH-induced,1,0.0
9664,1,0.0
Cascorbic,1,0.0
assisted-treating,1,0.0
prognosed,1,0.0
lexicon,1,0.0
Multistate,1,0.0
135399,1,0.0
8705,1,0.0
ACCFAHAESCWHF,1,0.0
hsTnT,1,0.0
forcibly,1,0.0
self-restraint,1,0.0
CoV-AbDab,1,0.0
publishedpatented,1,0.0
antibodynanobody,1,0.0
germline,1,0.0
Postinfarct,1,0.0
46-diamidino-2-phenylindole-labeled,1,0.0
peripartumpostpartum,1,0.0
200--250,1,0.0
Longyearbyen,1,0.0
Svalbard,1,0.0
Pole,1,0.0
Penetrating,1,0.0
Radar,1,0.0
graves,1,0.0
exhumation,1,0.0
Cooling,1,0.0
retro-perfusion,1,0.0
heat-exchange,1,0.0
epidemic-free,1,0.0
prepotent,1,0.0
1978--1981,1,0.0
Anti-Spike,1,0.0
Sonothrombolysis,1,0.0
Seroconversions,1,0.0
Kuskokwim,1,0.0
lipases,1,0.0
endonucleases,1,0.0
reperfusive,1,0.0
creatinin,1,0.0
circumferenceintrapleural,1,0.0
non-intestinal,1,0.0
mucosal-associated,1,0.0
MALT,1,0.0
extra-intestinal,1,0.0
sixgroup,1,0.0
partition,1,0.0
thymalin,1,0.0
T-activin,1,0.0
1-2weeks,1,0.0
65s,1,0.0
immunosenscence,1,0.0
27131,1,0.0
worldwide-the,1,0.0
supermarkets,1,0.0
freezer,1,0.0
791-187,1,0.0
262-215,1,0.0
340-850,1,0.0
145-475,1,0.0
SARS-CoV-2-pre-immunized,1,0.0
S-ELISpot,1,0.0
antithymocytes,1,0.0
DSAs,1,0.0
3-hydroxy-3-methylglutaryl-coenzyme,1,0.0
54981,1,0.0
Norwegians,1,0.0
ATACH-2,1,0.0
broncho-reactivity,1,0.0
thrombus-after,1,0.0
1981-90,1,0.0
MitoQ,1,0.0
3R,1,0.0
model--repair,1,0.0
replacement--for,1,0.0
rejuvenating,1,0.0
non-identified,1,0.0
Guo,1,0.0
Mi,1,0.0
JQ,1,0.0
Nie,1,0.0
Pharmacol,1,0.0
20202410208-18,1,0.0
33090430,1,0.0
Virally,1,0.0
connect-the-dots,1,0.0
Purinergic,1,0.0
FOSAs,1,0.0
Bafoussam,1,0.0
BRH,1,0.0
biosignatures,1,0.0
nonmajor,1,0.0
pre-morbidity,1,0.0
Vacuuming,1,0.0
hermetically,1,0.0
Washing,1,0.0
Tannic,1,0.0
de-naturing,1,0.0
011-017,1,0.0
Beam,1,0.0
monocenter,1,0.0
H5N1-like,1,0.0
differents,1,0.0
uncertains,1,0.0
3-channel,1,0.0
hiccup,1,0.0
Ativan,1,0.0
thorazine,1,0.0
non–ST-segment,1,0.0
Second-line,1,0.0
anaesthetics,1,0.0
Bruces,1,0.0
strokeThe,1,0.0
Manuscript,1,0.0
trials-Global,1,0.0
Syndromes-IIb,1,0.0
Infarction-patients,1,0.0
blood-tinged,1,0.0
hemosiderin-laden,1,0.0
lymphocyte-predominant,1,0.0
re-exacerbation,1,0.0
re-administration,1,0.0
MCC-135,1,0.0
Salvage,1,0.0
EVOLVE,1,0.0
primrose,1,0.0
neurodermatitis,1,0.0
phytotherapeutic,1,0.0
EBPP,1,0.0
UEMS,1,0.0
1838,1,0.0
non-diagnosis,1,0.0
Case-crossover,1,0.0
1·0-1·8,1,0.0
December2020,1,0.0
pandemicity,1,0.0
Nowwith,1,0.0
re-emphasizes,1,0.0
lulled,1,0.0
CoV‐2,1,0.0
re‐infection,1,0.0
TH2-lymphocytes,1,0.0
month12,1,0.0
HIV3-7,1,0.0
nonexistence,1,0.0
influenza-derived,1,0.0
myocardium-a,1,0.0
multiprotein,1,0.0
21210,1,0.0
1·5-3·4,1,0.0
20587,1,0.0
studies-one,1,0.0
non-fitters,1,0.0
Explained,1,0.0
non-susceptible,1,0.0
affinity-enhancing,1,0.0
B-00001,1,0.0
-00008,1,0.0
P-value0781,1,0.0
permutations,1,0.0
1·8,1,0.0
1·3-2·8,1,0.0
2·1,1,0.0
DT-as,1,0.0
infarction-dependent,1,0.0
116-,1,0.0
interferential,1,0.0
Narodowy,1,0.0
Fundusz,1,0.0
Zdrowia,1,0.0
asthmaic,1,0.0
Thermofisher,1,0.0
28932C,1,0.0
quieter,1,0.0
resigning,1,0.0
specialist-specific,1,0.0
swapping,1,0.0
P1427I,1,0.0
Y1464C,1,0.0
1969-1977,1,0.0
1969-1971,1,0.0
plurifascicular,1,0.0
unchangedly,1,0.0
calculators,1,0.0
-ORS,1,0.0
Score-,1,0.0
breakout,1,0.0
httpcovpimmtresin,1,0.0
manually-curated,1,0.0
epitope-HLA,1,0.0
binding-complex,1,0.0
in-built,1,0.0
cross-genome,1,0.0
High-Performance,1,0.0
high-complexity,1,0.0
top-100,1,0.0
13540,1,0.0
etidronate,1,0.0
alendronate,1,0.0
UNIPred,1,0.0
Basse,1,0.0
Normandie,1,0.0
twelfth,1,0.0
adequation,1,0.0
infarction-20,1,0.0
infarction-33,1,0.0
infarction-29,1,0.0
multi-resolution,1,0.0
community-community,1,0.0
protein-community,1,0.0
zoom,1,0.0
limited-size,1,0.0
UNIPred-Web,1,0.0
imbalance-aware,1,0.0
covishield,1,0.0
vertex-centric,1,0.0
meaningfulness,1,0.0
CoV-human,1,0.0
3610000,1,0.0
sedentariness,1,0.0
syndrome-Coronavirus-2,1,0.0
enzymeIt,1,0.0
GO-T,1,0.0
evasionsuppression,1,0.0
CoV-derived,1,0.0
Prostate-specific,1,0.0
antiinfarctual,1,0.0
92-year-old,1,0.0
Needless,1,0.0
RevMan51,1,0.0
369-504,1,0.0
OR074,1,0.0
2005231540-8,1,0.0
Fewlass,1,0.0
2005116397-407,1,0.0
6403,1,0.0
1998-2001,1,0.0
3166,1,0.0
broncho-dilators,1,0.0
function--elicited,1,0.0
infusion--in,1,0.0
49-70,1,0.0
kit-independent,1,0.0
1984-1987,1,0.0
immune-pathogenic,1,0.0
hypoxytherapy,1,0.0
form--in,1,0.0
expectorate,1,0.0
29--for,1,0.0
166--for,1,0.0
HGM-10,1,0.0
sub-massive,1,0.0
falsehoods,1,0.0
restated,1,0.0
1987-1994,1,0.0
post-divisional,1,0.0
Peirsman,1,0.0
FeNO-guided,1,0.0
categoric,1,0.0
70-103,1,0.0
11th-floor,1,0.0
trivalent-live,1,0.0
200415865-73,1,0.0
Adolesc,1,0.0
Georgetown,1,0.0
OR07,1,0.0
OR040,1,0.0
GM-CSFIL-4IL-5,1,0.0
dischargedAmong,1,0.0
8378,1,0.0
7432,1,0.0
01Compared,1,0.0
SHould,1,0.0
Coronaries,1,0.0
shocK,1,0.0
abdomen-pelvis,1,0.0
courts,1,0.0
Publics,1,0.0
expressly,1,0.0
heart-failure,1,0.0
nonemergencies,1,0.0
neurotransplantation,1,0.0
β2-AR,1,0.0
between-person,1,0.0
far-off,1,0.0
Postcoital,1,0.0
160-20090,1,0.0
n660,1,0.0
n666,1,0.0
non-ISH,1,0.0
hemorrhagicother,1,0.0
losartan-treated,1,0.0
inclusion-,1,0.0
group-structured,1,0.0
debilitates,1,0.0
effect-an,1,0.0
transgresses,1,0.0
inappropriateness,1,0.0
stereotyping,1,0.0
nonproximal,1,0.0
Qualitatively,1,0.0
cetyl,1,0.0
trimethylammonium,1,0.0
OH3,1,0.0
HI-test,1,0.0
lower-than-core,1,0.0
Thermotherapy,1,0.0
heat-based,1,0.0
Afflicted,1,0.0
overweightness,1,0.0
113-256,1,0.0
20-58,1,0.0
NCT01854047,1,0.0
200300,1,0.0
q2w,1,0.0
pre-BD,1,0.0
plaque-vulnerability,1,0.0
morality,1,0.0
Mommys,1,0.0
Biorepository,1,0.0
Taichung,1,0.0
ATaiwan186H1N1,1,0.0
eGFP,1,0.0
VSV-S,1,0.0
6092,1,0.0
54026,1,0.0
peer-reported,1,0.0
RMET,1,0.0
senescent,1,0.0
CUBS,1,0.0
RNA-sensing,1,0.0
2705,1,0.0
Sharjah,1,0.0
135-217,1,0.0
144-236,1,0.0
030-044,1,0.0
ACE2-highly,1,0.0
bucking,1,0.0
Submicron,1,0.0
resuspension,1,0.0
Supermicron,1,0.0
2048,1,0.0
Unclassified,1,0.0
Pirandello,1,0.0
renderings,1,0.0
wild-fire,1,0.0
Calvin,1,0.0
obese-asthma,1,0.0
health-management,1,0.0
prerupture,1,0.0
tumor-associated,1,0.0
replicons,1,0.0
co-registered,1,0.0
active-contour,1,0.0
coverage992,1,0.0
leakage052,1,0.0
PET-avid,1,0.0
obscurations,1,0.0
trans-signalling,1,0.0
Occluding,1,0.0
lipid-encapsulated,1,0.0
21-119,1,0.0
intervbal,1,0.0
788-975,1,0.0
764-964,1,0.0
502-747,1,0.0
Coronapass,1,0.0
Vector-Best,1,0.0
SCO,1,0.0
“intrinsic,1,0.0
rate”,1,0.0
Constitutive,1,0.0
NO-synthase,1,0.0
CATs,1,0.0
l-ornithine,1,0.0
awareness-attitude,1,0.0
Lignosus,1,0.0
soxhlet,1,0.0
CCR3,1,0.0
CCR8,1,0.0
PMCH,1,0.0
CCL22,1,0.0
CCR4,1,0.0
PRG2,1,0.0
FCER1A,1,0.0
CHIA,1,0.0
Cma1,1,0.0
Subsequeuntly,1,0.0
21-February,1,0.0
INTERACT-2,1,0.0
INTEnsive,1,0.0
MNASensitivity,1,0.0
SARS--CoV--2--IgG--EIA--BEST,1,0.0
CoronaPass,1,0.0
1917-27,1,0.0
18-104,1,0.0
28-116,1,0.0
21-51,1,0.0
18-43,1,0.0
prinzmetal,1,0.0
Anti-S-RBDs,1,0.0
D22-D36,1,0.0
D36-D111,1,0.0
low-middle-income,1,0.0
kinase-myocardial,1,0.0
dischargedConclusion,1,0.0
repiratory,1,0.0
Economos,1,0.0
catatonia,1,0.0
enzyme-,1,0.0
tardive,1,0.0
Clq-solubility,1,0.0
60-lead,1,0.0
111981,1,0.0
3181983,1,0.0
sneezes-coupled,1,0.0
influenza-leads,1,0.0
confusion--for,1,0.0
CT-assessed,1,0.0
algebra,1,0.0
keratitis,1,0.0
phacoemulsification,1,0.0
unecessary,1,0.0
hyperproteinemia,1,0.0
nedrocromil,1,0.0
domination,1,0.0
therapyCommunicated,1,0.0
deceiving,1,0.0
Burke,1,0.0
Lateropulsion,1,0.0
P5×10-5,1,0.0
Steel,1,0.0
Buchak,1,0.0
Eyal,1,0.0
Value-based,1,0.0
3o,1,0.0
middle-eastern,1,0.0
1669,1,0.0
663540,1,0.0
lineage-level,1,0.0
angiographyangioplasty,1,0.0
microsurgical,1,0.0
covdock,1,0.0
2020-1,1,0.0
Gromacs,1,0.0
20181,1,0.0
delavirdine,1,0.0
axetil,1,0.0
prevacid,1,0.0
-7217,1,0.0
-7202,1,0.0
-6519,1,0.0
-5765,1,0.0
-5425,1,0.0
-518,1,0.0
-5114,1,0.0
1397,1,0.0
newsletter,1,0.0
Strain-encoded,1,0.0
Large‑scale,1,0.0
cross-type,1,0.0
immunity-driven,1,0.0
Visitor,1,0.0
4-yr-old,1,0.0
immunity-as,1,0.0
system-plays,1,0.0
US-Ukraine,1,0.0
asthma--related,1,0.0
kyiv,1,0.0
resumed-walking,1,0.0
non‑ischemic,1,0.0
chow,1,0.0
CALTH,1,0.0
post‑MI,1,0.0
97258,1,0.0
interarterial,1,0.0
0024-0044,1,0.0
trifurcated,1,0.0
known-index,1,0.0
discrete-generation,1,0.0
child-to-child,1,0.0
01-02,1,0.0
Displacement,1,0.0
ENcoding,1,0.0
Stimulated,1,0.0
Echoes,1,0.0
strain-encoded,1,0.0
130300,1,0.0
anti-protease,1,0.0
semeiological,1,0.0
prevalance,1,0.0
electrogenetic,1,0.0
finest,1,0.0
subzones,1,0.0
AE-C,1,0.0
n220124,1,0.0
3-28,1,0.0
MED,1,0.0
Monoculture,1,0.0
MCAO-R,1,0.0
Josiah,1,0.0
Quincy,1,0.0
Chinatown,1,0.0
mid-2021,1,0.0
CIDRAP,1,0.0
divulgation,1,0.0
Barrys,1,0.0
ZINC20601870,1,0.0
ZINC00793735,1,0.0
wondering,1,0.0
AFinland474,1,0.0
FRCs,1,0.0
22-61,1,0.0
11-24,1,0.0
ipsilateral-contralateral,1,0.0
04-35,1,0.0
07-33,1,0.0
4239,1,0.0
five-12,1,0.0
160-182,1,0.0
antero-septal-apical,1,0.0
metabisulfites,1,0.0
Neuro-endocrine,1,0.0
Non-allergics,1,0.0
Transfusion-related,1,0.0
49-74,1,0.0
10-word,1,0.0
card-sorting,1,0.0
nonatherothrombotic,1,0.0
periarteritis,1,0.0
anterior--98,1,0.0
inferior--82,1,0.0
posterior--73,1,0.0
asynergy--80,1,0.0
dieseas,1,0.0
antiphospholid,1,0.0
arterialvenous,1,0.0
injuryacute,1,0.0
prohibitions,1,0.0
not-negligible,1,0.0
20-80,1,0.0
confederated,1,0.0
Glucosinolate,1,0.0
flavones,1,0.0
midwall,1,0.0
licensed-vaccines,1,0.0
considerate,1,0.0
furthermost,1,0.0
final-stage,1,0.0
Vaccine-promoting,1,0.0
non-heparin,1,0.0
Acute-stroke,1,0.0
Allergics,1,0.0
enlists,1,0.0
exarcebated,1,0.0
bIntroductionb,1,0.0
CREB-DNA,1,0.0
β-catenin,1,0.0
AMI--these,1,0.0
alterative,1,0.0
Midterm,1,0.0
Stroke-free,1,0.0
3-13,1,0.0
NECT,1,0.0
989-student,1,0.0
0-70,1,0.0
student-days,1,0.0
student-day,1,0.0
calcium-antagonist,1,0.0
ischaemics,1,0.0
entry-exit,1,0.0
108235,1,0.0
58116,1,0.0
66193,1,0.0
traffic-associated,1,0.0
74203,1,0.0
64125,1,0.0
0265,1,0.0
2008--09,1,0.0
April--September,1,0.0
END-definitions,1,0.0
RESLE,1,0.0
136mEqL,1,0.0
9-hour,1,0.0
unitICU,1,0.0
post-arterial,1,0.0
phosphorylates,1,0.0
kinase-3,1,0.0
Interethnic,1,0.0
Glycogen,1,0.0
Kliegman,1,0.0
Jenson,1,0.0
Eds,1,0.0
Saunders,1,0.0
1947-1972,1,0.0
biomarker-based,1,0.0
reconsiders,1,0.0
Polyphenols,1,0.0
vascular-,1,0.0
Bichat,1,0.0
566700,1,0.0
Fineberg,1,0.0
immunopriviliges,1,0.0
alternative--low-dose,1,0.0
Catheterangiography,1,0.0
inhaledingested,1,0.0
EMASE,1,0.0
CRD42020201461,1,0.0
ORsevere,1,0.0
128-190,1,0.0
ORmortality,1,0.0
115-346,1,0.0
153-281,1,0.0
085-290,1,0.0
110-179,1,0.0
267-528,1,0.0
asymptomatic-this,1,0.0
immune-depressed,1,0.0
Crosstalk,1,0.0
1198,1,0.0
1380,1,0.0
77-years-old,1,0.0
S-ASAT,1,0.0
T-tube,1,0.0
andrological,1,0.0
hemato-testicular,1,0.0
unmotivated,1,0.0
1949--1956,1,0.0
overexpressionhyperactivation,1,0.0
parentcarer,1,0.0
Non-stroke,1,0.0
appointing,1,0.0
Weakened,1,0.0
case-case,1,0.0
Gabrielle,1,0.0
deVeber,1,0.0
Anthony,1,0.0
operatively,1,0.0
pre-calculated,1,0.0
urothelial,1,0.0
Surveilans,1,0.0
Infeksi,1,0.0
Saluran,1,0.0
Pernafasan,1,0.0
Akut,1,0.0
Berat,1,0.0
consumer-grade,1,0.0
shafts,1,0.0
eluent,1,0.0
large-lumen,1,0.0
TASTE,1,0.0
NIs--zanamivir,1,0.0
Choledochotomy,1,0.0
burrowed,1,0.0
185KA,1,0.0
7623,1,0.0
306370,1,0.0
Fungi,1,0.0
4543,1,0.0
3679,1,0.0
formationIn,1,0.0
intra-species,1,0.0
Rhino-,1,0.0
351-1531,1,0.0
128-6613,1,0.0
mend,1,0.0
inside-out,1,0.0
Resister,1,0.0
CiNii,1,0.0
nonuniformity,1,0.0
24IUl,1,0.0
sigmaGEF,1,0.0
REF24,1,0.0
100GEF,1,0.0
GEF,1,0.0
REF,1,0.0
1313-15,1,0.0
counsellor,1,0.0
negotiator,1,0.0
problem-solver,1,0.0
avulsions,1,0.0
tele-consultation,1,0.0
Biliary,1,0.0
31mgdl,1,0.0
Behrman,1,0.0
Textbook,1,0.0
Alemzadeh,1,0.0
arisal,1,0.0
4mm,1,0.0
reactionsanaphylaxis,1,0.0
PEG-free,1,0.0
00020,1,0.0
confoundingbias,1,0.0
FXI,1,0.0
unconspicuous,1,0.0
anamnestically,1,0.0
laboratory-chemically,1,0.0
Issuing,1,0.0
pseudoinfarction,1,0.0
differential-diagnostically,1,0.0
-need,1,0.0
Hb-O2-dissociation,1,0.0
O2-need,1,0.0
polyetiologic,1,0.0
Bluish,1,0.0
coloration,1,0.0
tibial,1,0.0
dorsalis,1,0.0
pedis,1,0.0
whole-of-life,1,0.0
life-course,1,0.0
virus´s,1,0.0
Reportedly,1,0.0
patient´s,1,0.0
schools-asymptomatic,1,0.0
children-is,1,0.0
BinaxNOW™,1,0.0
Mohr,1,0.0
bronchial-pulmonary,1,0.0
smouldering,1,0.0
SASCQ,1,0.0
CoV-HKU1,1,0.0
immunoprobe,1,0.0
Tripterygium,1,0.0
wilfordii,1,0.0
Pudilan,1,0.0
Xiaoyan,1,0.0
Saponin,1,0.0
Xuebijing,1,0.0
worst-affected,1,0.0
retransplanted,1,0.0
medicinally,1,0.0
Anti-HA,1,0.0
H1-16,1,0.0
privatizations,1,0.0
epidemicsThe,1,0.0
hefty,1,0.0
uncared,1,0.0
Herewith,1,0.0
socio-health,1,0.0
cortisol-sensitive,1,0.0
Multidirectional,1,0.0
noninstitutional,1,0.0
13-60,1,0.0
31-91,1,0.0
Australia-as,1,0.0
1957-58In,1,0.0
highIn,1,0.0
smouldered,1,0.0
fluoroimmunoassay,1,0.0
interepidemical,1,0.0
Precedence,1,0.0
stem-progenitor,1,0.0
Randall,1,0.0
biblio-graphy,1,0.0
auto-isolation,1,0.0
-40-50,1,0.0
CharitéBerlin,1,0.0
57-69,1,0.0
25-35min,1,0.0
Schultes,1,0.0
warfarin-eligible,1,0.0
approvable,1,0.0
PREVIAL,1,0.0
Manitoban,1,0.0
Manitobans,1,0.0
Faecal-oral,1,0.0
GC·mL-1,1,0.0
PFU·mL-1,1,0.0
pppy,1,0.0
post-attack,1,0.0
anti‐severe,1,0.0
effects1,1,0.0
Malagasy,1,0.0
MoPH,1,0.0
district-community,1,0.0
hospital-including,1,0.0
1-154,1,0.0
SSRCEs,1,0.0
intravenousintra-arterial,1,0.0
behaviour-driven,1,0.0
biomarkers--meaning,1,0.0
Ira,1,0.0
Stravinsky,1,0.0
Igor,1,0.0
treatment-limiting,1,0.0
1970-1974,1,0.0
-43,1,0.0
fibrillation-associated,1,0.0
K-antagonist,1,0.0
fibrillation-stroke,1,0.0
nonsquamous,1,0.0
Habarovsk,1,0.0
Ocean76,1,0.0
AwhalePO1976,1,0.0
AswNew,1,0.0
Ocean1976,1,0.0
Nav2,1,0.0
β2-adrenoreceptor,1,0.0
receptor-alpha,1,0.0
Shebalin,1,0.0
template-dependent,1,0.0
phosphodiester,1,0.0
nonnucleoside,1,0.0
NNIs,1,0.0
Schnittke,1,0.0
1934-1998,1,0.0
amazingly,1,0.0
Schnittkes,1,0.0
composers,1,0.0
Benjamin,1,0.0
Britten,1,0.0
Langlais,1,0.0
Vissarion,1,0.0
oseltamivir--remind,1,0.0
Prehospitalization,1,0.0
bMaterials,1,0.0
quartz-crystal,1,0.0
418000,1,0.0
DNA-dependent,1,0.0
clemizole,1,0.0
monorden,1,0.0
tanespimycin,1,0.0
acetylursolic,1,0.0
hardwickiic,1,0.0
anthraquinones,1,0.0
ellagitannin,1,0.0
friedelanone,1,0.0
3-Chymotrypsin-like,1,0.0
2-O-ribose,1,0.0
nsp16,1,0.0
CK2alpha,1,0.0
5Y3E,1,0.0
6NUS,1,0.0
6JYT,1,0.0
2XYR,1,0.0
3VB6,1,0.0
Socio-behavioural,1,0.0
Uncommonly,1,0.0
Kossa,1,0.0
sanctioned,1,0.0
phisiological,1,0.0
conside,1,0.0
Monoparetic,1,0.0
monoparetic,1,0.0
artistry,1,0.0
painter-curators,1,0.0
7410000,1,0.0
non-labeling,1,0.0
re-ignited,1,0.0
spriometric,1,0.0
anti-miR-181a,1,0.0
nasopharyngealoral,1,0.0
negative-conversion,1,0.0
FLC,1,0.0
DWI-only,1,0.0
PCI-capable,1,0.0
2192,1,0.0
stamping-out,1,0.0
2002-2010,1,0.0
oil-emulsified,1,0.0
risk-,1,0.0
governmentality,1,0.0
individualfamily,1,0.0
scientificmedical,1,0.0
citizenship,1,0.0
aorta-to-coronary,1,0.0
artyery,1,0.0
methicillin-sensitive,1,0.0
methicillin,1,0.0
04-4,1,0.0
overshadows,1,0.0
erythrocytosis,1,0.0
user-centered,1,0.0
time-to-call,1,0.0
noncystic,1,0.0
concommitant,1,0.0
Wrights,1,0.0
univariant,1,0.0
purulence,1,0.0
temporal-occipital,1,0.0
hepatological,1,0.0
nonmusculoskeletal,1,0.0
R0183,1,0.0
E484R,1,0.0
G502P,1,0.0
K31,1,0.0
K353,1,0.0
S477NE484K,1,0.0
K417TE484KN501Y,1,0.0
SpikehACE2,1,0.0
5214,1,0.0
distinctness,1,0.0
76-yr-old,1,0.0
n862,1,0.0
Patna,1,0.0
8005,1,0.0
5429,1,0.0
4814,1,0.0
smokerstobacco,1,0.0
chewers,1,0.0
4733,1,0.0
1334,1,0.0
N29,1,0.0
audio-recordings,1,0.0
Dasatinib,1,0.0
BCR-ABL-positive,1,0.0
chromosome-positive,1,0.0
chylum,1,0.0
lymphoscintigraphy,1,0.0
stake,1,0.0
metachronous,1,0.0
limits--in,1,0.0
G476S,1,0.0
S443A,1,0.0
N440K,1,0.0
e-tools,1,0.0
alcohol-dependence,1,0.0
smoking-dependence,1,0.0
Impact-Responsive,1,0.0
sovereignty,1,0.0
importedlocal,1,0.0
Chatbots,1,0.0
chatbots,1,0.0
viral-vector,1,0.0
Mass-production,1,0.0
Vaccine-resistant,1,0.0
eight-to-ten,1,0.0
peri-implant,1,0.0
brainstorming,1,0.0
practicalwork-related,1,0.0
Spike-hACE2,1,0.0
CMDAimWe,1,0.0
testingMethodsWe,1,0.0
diagnosticsResultsBetween,1,0.0
199744,1,0.0
44161,1,0.0
non-POC,1,0.0
testsConclusionPOC,1,0.0
cardio-cardio,1,0.0
multivascular,1,0.0
IIbIIa,1,0.0
CAGB,1,0.0
3-hydroxy-3-methylglytaryl-coenzyme,1,0.0
HMGCoA,1,0.0
countriesregiongs,1,0.0
≈795000,1,0.0
weave,1,0.0
7884,1,0.0
epitranscriptomic,1,0.0
RR035,1,0.0
014-088,1,0.0
RR050,1,0.0
immunologic-mediated,1,0.0
7-September,1,0.0
MeCDC,1,0.0
wedding,1,0.0
SFHH,1,0.0
Paris-Public,1,0.0
APHP,1,0.0
muco-cutaneous,1,0.0
086-088,1,0.0
082-084,1,0.0
4-5-fold,1,0.0
MERS-CoV-,1,0.0
HKU1-specific,1,0.0
2021505e222-e226,1,0.0
113715,1,0.0
RP-SARS-CoV-2,1,0.0
LI-AD,1,0.0
LI-FD,1,0.0
LI-FA,1,0.0
Near-infrared,1,0.0
ALA,1,0.0
PVL-toxin,1,0.0
exotoxin,1,0.0
PVL-producing,1,0.0
Lubeck,1,0.0
methylome,1,0.0
miCLIP,1,0.0
RIP-seq,1,0.0
S1-mAb,1,0.0
EES,1,0.0
MSHS,1,0.0
20899,1,0.0
8928,1,0.0
1144-286,1,0.0
168-34,1,0.0
vaccine†,1,0.0
person-days§,1,0.0
5-d,1,0.0
self-adaptation,1,0.0
4-30,1,0.0
RCA-related,1,0.0
MSC-EVs,1,0.0
proteinsreaction,1,0.0
m6A-modified,1,0.0
ACE2-LFIA,1,0.0
non-antiphospholipid-related,1,0.0
deluged,1,0.0
hunker,1,0.0
histamine-2,1,0.0
Autoimmuneinflammatory,1,0.0
ChromaCode,1,0.0
HDPCR™,1,0.0
EMAG,1,0.0
8186,1,0.0
Félix-Guyon,1,0.0
Saint-Denis,1,0.0
N6-methyladenosine,1,0.0
post-initial,1,0.0
7484,1,0.0
water-resistant,1,0.0
specificitypositive,1,0.0
Gd-BOPTAdimeg,1,0.0
IR-EPI,1,0.0
GR-EPI,1,0.0
localizationof,1,0.0
AShantou9209,1,0.0
Double-immunostaining,1,0.0
Type-2,1,0.0
-low,1,0.0
near-endotype,1,0.0
T2-biomarker,1,0.0
20453,1,0.0
Siblings,1,0.0
099-175,1,0.0
139-241,1,0.0
WHO-coordinated,1,0.0
Orthos,1,0.0
transtelephonic,1,0.0
1367,1,0.0
EURopean,1,0.0
iNtolerant,1,0.0
telmisartan-treated,1,0.0
later-onset,1,0.0
topiramate,1,0.0
post-HI,1,0.0
Prenotification,1,0.0
139-177,1,0.0
P0096,1,0.0
guard,1,0.0
Cloth,1,0.0
gadolinium-BOPTAdimeglumine,1,0.0
recomendedfor,1,0.0
perlinterventional,1,0.0
053-134,1,0.0
996928,1,0.0
996906,1,0.0
980712,1,0.0
996925,1,0.0
WHOCenters,1,0.0
sub-branch,1,0.0
C20,1,0.0
oxygen-generating,1,0.0
cryogel-based,1,0.0
vaccine-driven,1,0.0
110-240,1,0.0
108-254,1,0.0
088-189,1,0.0
191-432,1,0.0
SAPPHIRE,1,0.0
170-422,1,0.0
phenomenon--denoted,1,0.0
interaction--suggests,1,0.0
stinging,1,0.0
lebrikizumab,1,0.0
pseudo-coloring,1,0.0
annotating,1,0.0
09307,1,0.0
09890,1,0.0
09792,1,0.0
Heatmaps,1,0.0
endatherectomy,1,0.0
CAVATAS,1,0.0
Paper-based,1,0.0
location-dependent,1,0.0
strokethromboembolism,1,0.0
neurocysticercosis,1,0.0
HIV-12,1,0.0
multiterritorial,1,0.0
obstructiveasthmatic,1,0.0
quantizer,1,0.0
color-encoded,1,0.0
chirrhosis,1,0.0
cereus,1,0.0
counter-fire,1,0.0
automaton,1,0.0
COMPACT,1,0.0
shockwave,1,0.0
itselfAccounting,1,0.0
quarterfirst,1,0.0
9525,1,0.0
DYNAmic,1,0.0
MOdule,1,0.0
DYNAMO,1,0.0
overlays,1,0.0
immune-specific,1,0.0
femtogram,1,0.0
aspects-physically,1,0.0
genera-,1,0.0
post-recovery,1,0.0
curatives,1,0.0
control-direct,1,0.0
discussions-namely,1,0.0
staple,1,0.0
Dyslipidaemia,1,0.0
cohortcross-sectional,1,0.0
HIV-RNA,1,0.0
740-888MBq,1,0.0
strokesthromboembolism,1,0.0
isonitrileMIBI,1,0.0
Concerted,1,0.0
leu-enkephalin,1,0.0
met-enkephalin,1,0.0
enkephalin,1,0.0
electron-microscopically,1,0.0
lanthanum,1,0.0
Lung-protective,1,0.0
N-acetyl-cysteine,1,0.0
Clinicalangiographic,1,0.0
0787-0961,1,0.0
onset-to-recanalization,1,0.0
0987-0999,1,0.0
years1-3,1,0.0
wheezers4,1,0.0
cases5,1,0.0
wheezers6,1,0.0
asthma7,1,0.0
4x10-4,1,0.0
5SARS-CoV-2,1,0.0
variantSARS-CoV-2,1,0.0
B11248lineage,1,0.0
connections-based,1,0.0
scenario-specific,1,0.0
setpoint-mediated,1,0.0
injury-specific,1,0.0
molecule-based,1,0.0
non-capsular,1,0.0
cRCT,1,0.0
technetium-99m-Hexakis-2-methoxyisobutyl,1,0.0
experimentaloutcome,1,0.0
clinicalanatomic,1,0.0
Circ,1,0.0
1665-1673,1,0.0
pre-campaign,1,0.0
AH1N1pdm09-specific,1,0.0
21656,1,0.0
5390,1,0.0
26-30,1,0.0
rice-based,1,0.0
mitral-leaflet,1,0.0
institution-wide,1,0.0
nonessentialelective,1,0.0
non-skiers,1,0.0
swabsHypothesis,1,0.0
RT-PCRAim,1,0.0
specimensMethodology,1,0.0
153165,1,0.0
888-967,1,0.0
150165,1,0.0
865-953,1,0.0
118126,1,0.0
894-979,1,0.0
122126,1,0.0
938-999,1,0.0
P09,1,0.0
861-100,1,0.0
521-908,1,0.0
daysConclusions,1,0.0
Anticytokine,1,0.0
ArchitectTM,1,0.0
diversionary,1,0.0
transcription-related,1,0.0
Knox,1,0.0
incubate,1,0.0
metropolises,1,0.0
cancer‑associated,1,0.0
NIPH,1,0.0
Budding,1,0.0
detachment-the,1,0.0
stickiness-is,1,0.0
modRNA,1,0.0
years-of-age,1,0.0
HeFH,1,0.0
TG-controlled,1,0.0
apheresis-experienced,1,0.0
transmissionSimulations,1,0.0
virusUse,1,0.0
Pseudotyped,1,0.0
re-entries,1,0.0
D‑Dimer,1,0.0
Parenteral,1,0.0
rTPA,1,0.0
low‑molecular‑weight,1,0.0
immune-targeted,1,0.0
Edmondson,1,0.0
Rothenberg,1,0.0
Gwaltney,1,0.0
Univ,1,0.0
22901,1,0.0
Amer,1,0.0
Epidem,1,0.0
480–486,1,0.0
1971—Monovalent,1,0.0
1968–1969,1,0.0
vouchers,1,0.0
voucher,1,0.0
1970-1977,1,0.0
tag-free,1,0.0
Nonselective,1,0.0
beta-blocker-induced,1,0.0
Q310,1,0.0
HA-Q310,1,0.0
2355853,1,0.0
164656,1,0.0
effectiveness--756,1,0.0
93993,1,0.0
Population-adjusted,1,0.0
87500,1,0.0
97500,1,0.0
oftentimes,1,0.0
Tape-recorded,1,0.0
asserting,1,0.0
Hopefulness,1,0.0
postMI,1,0.0
subdiagnostic,1,0.0
tension-type-like,1,0.0
14-41,1,0.0
12-35,1,0.0
11-27,1,0.0
11-48,1,0.0
02-08,1,0.0
relatively-safe,1,0.0
verapamil-related,1,0.0
active-control,1,0.0
SpyTagSpyCatcher,1,0.0
metastability,1,0.0
HR2-deleted,1,0.0
Electrically,1,0.0
lard,1,0.0
Malaya,1,0.0
Disparity,1,0.0
009-029,1,0.0
042-091,1,0.0
apportioning,1,0.0
GCN-based,1,0.0
homograft,1,0.0
bis-gadolinium,1,0.0
mesoporphyrins-enhanced,1,0.0
Up-till,1,0.0
up-till,1,0.0
one1,1,0.0
Force2,1,0.0
cosponsored,1,0.0
ODP,1,0.0
Shortcomings,1,0.0
sterol,1,0.0
Teamwork,1,0.0
self-swab,1,0.0
asymptomaticpauci-symptomatic,1,0.0
COVID-197,1,0.0
B∙1,1,0.0
angiotensin-1-receptor,1,0.0
efficacy-even,1,0.0
55-74,1,0.0
53-77,1,0.0
Solicited,1,0.0
nephrological,1,0.0
mineralization,1,0.0
atheronecrosis,1,0.0
glycine-capped,1,0.0
E2p,1,0.0
DT2,1,0.0
60-mers,1,0.0
Helsingborg,1,0.0
quide,1,0.0
field-tested,1,0.0
fundraising,1,0.0
Audiences,1,0.0
Announcements,1,0.0
hastening,1,0.0
JACS,1,0.0
integro-differential,1,0.0
hypoconnectivity,1,0.0
decelerations,1,0.0
CSTE,1,0.0
rate-limited,1,0.0
ECG-recordings,1,0.0
silhouettes,1,0.0
angio,1,0.0
hypo-akinesis,1,0.0
hormone-related,1,0.0
threat-first,1,0.0
H1N1-encouraged,1,0.0
CoV-2-related,1,0.0
Pesaro,1,0.0
Fano,1,0.0
codification,1,0.0
contractual,1,0.0
eCoV-specific,1,0.0
EARIP,1,0.0
FP7-funded,1,0.0
IJERPH,1,0.0
chrono-diagnosis,1,0.0
Chronobiological,1,0.0
childhood-ACT,1,0.0
Raffaele,1,0.0
S2GΔHR2-presenting,1,0.0
net-,1,0.0
HlN1,1,0.0
1177,1,0.0
Gh,1,0.0
Lupu,1,0.0
Medicine--Bucharest,1,0.0
2439,1,0.0
pyramidon,1,0.0
biseptol,1,0.0
exagerately,1,0.0
pt--house,1,0.0
After-Action,1,0.0
Elders,1,0.0
0253,1,0.0
1014-1018,1,0.0
1010-1013,1,0.0
1001-1004,1,0.0
Periaccess,1,0.0
SCoV2-PLpro,1,0.0
exergames,1,0.0
pleasurable,1,0.0
ACEAng-IIAT1recptor,1,0.0
hrACE2,1,0.0
difficult-asthma,1,0.0
Telephoning,1,0.0
Non-attendance,1,0.0
Tc99m-Sestamibi,1,0.0
Rosenbaum,1,0.0
righward,1,0.0
backward-directed,1,0.0
reperfusion30-s,1,0.0
73-90,1,0.0
middle-vital-capacity,1,0.0
V1-,1,0.0
415673,1,0.0
21-residue,1,0.0
S929T,1,0.0
S949F,1,0.0
D936,1,0.0
inter-monomer,1,0.0
R1185,1,0.0
rescuerecovery,1,0.0
RUCDR,1,0.0
Infinite,1,0.0
Rutgers,1,0.0
three-quarter-year,1,0.0
war-weary,1,0.0
Brunswickers,1,0.0
Empire,1,0.0
legitimizing,1,0.0
minted,1,0.0
masthead,1,0.0
nanoarchitectured,1,0.0
id,1,0.0
Non-human,1,0.0
infarct-risk,1,0.0
intersected,1,0.0
occlusion10-min,1,0.0
Wortmannin,1,0.0
infarct-sparing,1,0.0
months-24,1,0.0
vaccination-promotion,1,0.0
measures-and,1,0.0
CA-nonLTM,1,0.0
behavior-disease,1,0.0
companionship,1,0.0
MV-PCI,1,0.0
C-PCI,1,0.0
2011-July,1,0.0
BSC,1,0.0
respiratory-occupational,1,0.0
mills,1,0.0
anotherThe,1,0.0
modest-enough,1,0.0
SIR-S,1,0.0
T90,1,0.0
pH-based,1,0.0
CA-LTM,1,0.0
slight-to-fair,1,0.0
3289,1,0.0
nondiseased,1,0.0
aviculturists,1,0.0
crosslinking,1,0.0
bulking,1,0.0
MAPD,1,0.0
pregnancy--asthma,1,0.0
6324,1,0.0
Microbind,1,0.0
Affinity,1,0.0
Architect®,1,0.0
ANSH®,1,0.0
AESKULISA®,1,0.0
preconditionings,1,0.0
NIHNAEPP,1,0.0
fallacious,1,0.0
modelscolored,1,0.0
Mysterious,1,0.0
Case-Based,1,0.0
mutants-induced,1,0.0
AYn1,1,0.0
non-cell-based,1,0.0
HEK293ThACE2,1,0.0
peptides-treated,1,0.0
non-POS,1,0.0
nPOS,1,0.0
ILl,1,0.0
nose-pharingeal,1,0.0
remittance,1,0.0
announces,1,0.0
multicultural,1,0.0
teas,1,0.0
lobelia,1,0.0
pennyroyal,1,0.0
Ubiquitous,1,0.0
revolutional,1,0.0
123I-15-p-iodophenyl-3-RS-methylpentadecanoic,1,0.0
3×,1,0.0
3353,1,0.0
≈17-62,1,0.0
metabolomic-based,1,0.0
proteinogenic,1,0.0
non-proteinogenic,1,0.0
L-valine,1,0.0
DL-β-aminoisobutyric,1,0.0
ƴ-amino-n-butyric,1,0.0
Cardiologia,1,0.0
Brasileiros,1,0.0
Arquivos,1,0.0
verifyextend,1,0.0
Organ-to-organ,1,0.0
better-than-average,1,0.0
STP,1,0.0
electrocardiographic-gated,1,0.0
tetrofosmin,1,0.0
neglectful,1,0.0
Advocates,1,0.0
apples-to-oranges,1,0.0
usual-comparing,1,0.0
BaxBcl-2,1,0.0
pseudoseizures,1,0.0
CardioSEAL,1,0.0
reinstitution,1,0.0
Consiglio,1,0.0
infarcectomy,1,0.0
Gruber,1,0.0
137000,1,0.0
postprocessing,1,0.0
garner,1,0.0
periodsTo,1,0.0
multipatch,1,0.0
Inequalities,1,0.0
two-patch,1,0.0
diseasefree,1,0.0
disease-prevalent,1,0.0
factors--mainly,1,0.0
done--and,1,0.0
persits,1,0.0
lattice-gas,1,0.0
MedImpact,1,0.0
ramification,1,0.0
1557,1,0.0
9487,1,0.0
Honorary,1,0.0
Academician,1,0.0
1491,1,0.0
imidazolyl,1,0.0
ethanamide,1,0.0
pentandioic,1,0.0
ingavirin,1,0.0
interferon-a2b,1,0.0
viferon,1,0.0
ultrathin,1,0.0
research-generated,1,0.0
incontrovertible,1,0.0
preached,1,0.0
emphatic,1,0.0
Strep,1,0.0
Strep-tagged,1,0.0
tabled,1,0.0
clearanceHospitalized,1,0.0
confoundersThirty-four,1,0.0
13-21,1,0.0
013-09,1,0.0
016HCQ,1,0.0
multiagency,1,0.0
leukotrien,1,0.0
-apart,1,0.0
Neuropsychologic,1,0.0
colorimetricSERSfluorescence,1,0.0
femtomole,1,0.0
8507,1,0.0
9623,1,0.0
tachycardia-inducing,1,0.0
KNOWN,1,0.0
LBB,1,0.0
5963,1,0.0
irrefutable,1,0.0
Flare-ups,1,0.0
half-sisters,1,0.0
dopamine-beta-hydroxylase,1,0.0
50-day-old,1,0.0
low-birth-weight,1,0.0
persistencesurvival,1,0.0
23°C-25,1,0.0
drinking-water,1,0.0
hermeneutical,1,0.0
ostracized,1,0.0
ABOUT,1,0.0
Interventricular,1,0.0
TOPIC,1,0.0
52-65,1,0.0
51-71,1,0.0
Carefulness,1,0.0
under-utilisation,1,0.0
Liposarcoma,1,0.0
suryanamaskar,1,0.0
yogasana,1,0.0
dhyana,1,0.0
devotional,1,0.0
VOC-2020121,1,0.0
High-surgical-risk,1,0.0
Robinsons,1,0.0
24-July,1,0.0
EUA-cleared,1,0.0
tele-stroke,1,0.0
IFN-innate,1,0.0
bicyle,1,0.0
well-immunized,1,0.0
CNN-based,1,0.0
6040,1,0.0
5050,1,0.0
9881,1,0.0
9912,1,0.0
moinly,1,0.0
resectability,1,0.0
murmurs,1,0.0
MEDLINEEMBASE,1,0.0
RR173,1,0.0
157-190,1,0.0
RR163,1,0.0
134-199,1,0.0
RR135,1,0.0
124-146,1,0.0
RR110,1,0.0
102-118,1,0.0
or12,1,0.0
emission-computed,1,0.0
gamma-emitting,1,0.0
Conjugate,1,0.0
equiangular,1,0.0
multiple-level,1,0.0
backprojection,1,0.0
10--15,1,0.0
rms,1,0.0
hospicedeath,1,0.0
0-02,1,0.0
voided,1,0.0
oth,1,0.0
alpha-agonists,1,0.0
8251,1,0.0
3-56,1,0.0
LTRI,1,0.0
Uniquely,1,0.0
isochrones,1,0.0
2313,1,0.0
DSC,1,0.0
086±0074,1,0.0
66-96,1,0.0
ante-mortem,1,0.0
adrenergic-receptor,1,0.0
methacholine-sensitive,1,0.0
Scatchard,1,0.0
FEVFVC,1,0.0
ibuprophen,1,0.0
cold-air,1,0.0
non-AIDS,1,0.0
2515,1,0.0
Antiretroviral,1,0.0
post-ART,1,0.0
midchildhood,1,0.0
methyluracil,1,0.0
nucleinate,1,0.0
retabolil,1,0.0
phenabolil,1,0.0
hypereactive,1,0.0
amidopyrin,1,0.0
butadion,1,0.0
used--to,1,0.0
393-463,1,0.0
inciters,1,0.0
4095,1,0.0
5195,1,0.0
0196,1,0.0
0796,1,0.0
RNActive®,1,0.0
CureVac,1,0.0
NV,1,0.0
Tübingen,1,0.0
sequence-optimized,1,0.0
24·0,1,0.0
21·7-26·5,1,0.0
1·58-3·11,1,0.0
3·92,1,0.0
2·83-5·43,1,0.0
1·44,1,0.0
1·03-2·03,1,0.0
1·57,1,0.0
1·06-2·33,1,0.0
0·47,1,0.0
0·31-0·72,1,0.0
9·2-20·2,1,0.0
88·3,1,0.0
82·5-92·7,1,0.0
42·1,1,0.0
34·6-59·9,1,0.0
Cocaine-related,1,0.0
speedball,1,0.0
self-injection,1,0.0
Adequately,1,0.0
bi-weekly,1,0.0
2596,1,0.0
uniformed,1,0.0
d-136,1,0.0
Non-alcoholic,1,0.0
AKhabarovsk77,1,0.0
40380,1,0.0
asingle-center,1,0.0
NewYork,1,0.0
patientcycle,1,0.0
October2020,1,0.0
astrong,1,0.0
apositive,1,0.0
adocumented,1,0.0
unclearAbbreviations,1,0.0
sono,1,0.0
cryo,1,0.0
DataMart,1,0.0
2009–2012,1,0.0
bakeries,1,0.0
teller,1,0.0
ophthalmoscopes,1,0.0
phonopneumograph,1,0.0
745ABSTRACT,1,0.0
4805,1,0.0
4407,1,0.0
Baden-Württemberg,1,0.0
Child-to-child,1,0.0
FluMist®,1,0.0
Brisbane102007,1,0.0
anti-Bris59,1,0.0
prodigiosin,1,0.0
reorienting,1,0.0
pseudoneuritis,1,0.0
ORM-like,1,0.0
catalyzing,1,0.0
Deregulation,1,0.0
Chloroquines,1,0.0
mikroszkóp,1,0.0
felfedezése,1,0.0
tudjuk,1,0.0
szoros,1,0.0
közelségben,1,0.0
élő,1,0.0
egyedeknek,1,0.0
csupán,1,0.0
látható,1,0.0
élőhelyük,1,0.0
szemmel,1,0.0
érzékelhető,1,0.0
mikroorganizmusokat,1,0.0
megosztanak,1,0.0
fokban,1,0.0
adaptálódtak,1,0.0
gazdáikhoz,1,0.0
emberek,1,0.0
életterének,1,0.0
bővülésével,1,0.0
ezzel,1,0.0
párhuzamosan,1,0.0
állatok,1,0.0
élőhelyének,1,0.0
csökkenésével,1,0.0
állatfajok,1,0.0
kerülhetnek,1,0.0
veszélyes,1,0.0
közelségbe,1,0.0
middlehigh,1,0.0
Yamaguchi,1,0.0
Male-to-female,1,0.0
httpsbitly3e2GajO,1,0.0
long-established,1,0.0
（2019-nCoV）,1,0.0
wild-bird,1,0.0
live-captured,1,0.0
Halichoerus,1,0.0
grypus,1,0.0
Cod,1,0.0
64-125,1,0.0
12-146,1,0.0
150-245,1,0.0
337-664,1,0.0
foraging,1,0.0
microanatomical,1,0.0
leukemia-related,1,0.0
1461,1,0.0
approach--balloon,1,0.0
stents--might,1,0.0
eosinophil-mediated,1,0.0
antedate,1,0.0
549-554,1,0.0
nonanxious,1,0.0
Within-group,1,0.0
trapezius,1,0.0
APhilippines3412004,1,0.0
AThailand2712005,1,0.0
reassorting,1,0.0
post-CEA,1,0.0
stenostic,1,0.0
immunoelectronmicroscopy,1,0.0
pilot-study,1,0.0
perforin-positive,1,0.0
682-100,1,0.0
67103,1,0.0
‒211,1,0.0
‒760,1,0.0
---,1,0.0
Hopf,1,0.0
tota,1,0.0
infarct-PSD,1,0.0
Graduated,1,0.0
sTockings,1,0.0
upgradation,1,0.0
intra-muscular,1,0.0
intra-peritoneal,1,0.0
bona-fide,1,0.0
double-up,1,0.0
hemo-metabolic,1,0.0
Door,1,0.0
Unload,1,0.0
DTU-STEMI,1,0.0
pancreatic-based,1,0.0
maliciously,1,0.0
quantifiably,1,0.0
Epithelial-to-mesenchymal,1,0.0
ball-bearing,1,0.0
Ease,1,0.0
NOTCH,1,0.0
apparition,1,0.0
2764,1,0.0
810-100,1,0.0
881-100,1,0.0
29-95,1,0.0
5601,1,0.0
inchday,1,0.0
Pan-African,1,0.0
d-123,1,0.0
-122-034,1,0.0
d-081,1,0.0
-165004,1,0.0
T0-T16,1,0.0
d-155,1,0.0
-262-048,1,0.0
d-065,1,0.0
-168-037,1,0.0
Pro-,1,0.0
seric,1,0.0
CRD42017058107,1,0.0
Unpublished,1,0.0
Filling,1,0.0
Fahrenheit,1,0.0
cabazitaxel,1,0.0
-a,1,0.0
oropharyngealnares,1,0.0
SCA-related,1,0.0
hydroxycarbamide,1,0.0
mid-childhood,1,0.0
fibrils,1,0.0
fifth-generation,1,0.0
stroke-recurrence,1,0.0
anti-clotting,1,0.0
Outcome-specific,1,0.0
Scene,1,0.0
Copying,1,0.0
760-100,1,0.0
534-100,1,0.0
Perforin-positive,1,0.0
signal-to-cut-off,1,0.0
hemmorhaghic,1,0.0
Lochaber,1,0.0
Ross,1,0.0
Cromarty,1,0.0
1702,1,0.0
verus,1,0.0
observations-based,1,0.0
response--that,1,0.0
proclamation,1,0.0
Thoracopancreatic,1,0.0
57th,1,0.0
740835,1,0.0
183363,1,0.0
region-determinant,1,0.0
44th,1,0.0
46th,1,0.0
Shift,1,0.0
BY-2,1,0.0
MRI-detected,1,0.0
Chapidze,1,0.0
nomber,1,0.0
ECG-leads,1,0.0
collateralized,1,0.0
Incheon,1,0.0
Test-Treat-Track,1,0.0
Cup,1,0.0
Soccer,1,0.0
Perforin,1,0.0
quick-action,1,0.0
hemmorhagic,1,0.0
arterymiddle,1,0.0
cycleIMPORTANCE,1,0.0
lobularity,1,0.0
sero-reversion,1,0.0
OTA,1,0.0
Jämtland,1,0.0
Gävleborg,1,0.0
M235T,1,0.0
1989-1992,1,0.0
test-seeking,1,0.0
594000,1,0.0
cytometrically,1,0.0
May-Grünwald-Giemsa-stained,1,0.0
pyogranulomatous,1,0.0
histiocytosis,1,0.0
transudate,1,0.0
cytograms,1,0.0
nsp1s,1,0.0
Rotahaler,1,0.0
particualarly,1,0.0
cholesterolemia,1,0.0
energical,1,0.0
nonshortage,1,0.0
exterminate,1,0.0
LR-,1,0.0
RER,1,0.0
extractionsPCR,1,0.0
flourished,1,0.0
First-line,1,0.0
psychosthenic,1,0.0
nsp1-coding,1,0.0
következményes,1,0.0
mikrobaátadással,1,0.0
gazdában,1,0.0
poliovirus-induced,1,0.0
Widening,1,0.0
azygoesophageal,1,0.0
Paravertebral,1,0.0
clavicles,1,0.0
cardiologist-assisted,1,0.0
HN51,1,0.0
bron-,1,0.0
chospasm,1,0.0
Toxicmetabolic,1,0.0
analized,1,0.0
obstrucción,1,0.0
ARST,1,0.0
VCGF,1,0.0
QF,1,0.0
VCGH,1,0.0
QH,1,0.0
VCGS,1,0.0
PMRP,1,0.0
p30,1,0.0
re-analyzed,1,0.0
9503-9526,1,0.0
8372-9855,1,0.0
fase,1,0.0
non-replication,1,0.0
Obsidan,1,0.0
oralnasal,1,0.0
Nonparalytic,1,0.0
illness-The,1,0.0
disease-apparently,1,0.0
therepeutic,1,0.0
Higashi-Saitama,1,0.0
ICD-implantation,1,0.0
sickness-benefit,1,0.0
reflexotherapeutic,1,0.0
CNIRTM,1,0.0
well-apparent,1,0.0
120S94-S138,1,0.0
nightsmo,1,0.0
RMDs,1,0.0
seizure-related,1,0.0
H5N197,1,0.0
hyperinduces,1,0.0
hyperinduction,1,0.0
phosphatase-1,1,0.0
MKP-1,1,0.0
hyperinduced,1,0.0
19689,1,0.0
NCT02594488,1,0.0
Cusums,1,0.0
Cusum,1,0.0
19801,1,0.0
dissolvable,1,0.0
HDTs,1,0.0
rephrase,1,0.0
immunoprotective,1,0.0
non-thrombotic,1,0.0
non-travel-related,1,0.0
195758,1,0.0
influenza-exposure,1,0.0
implantable-cardioverter,1,0.0
NCT00673842,1,0.0
Postpolio,1,0.0
Started,1,0.0
177-566,1,0.0
SARS-dependent,1,0.0
158-754,1,0.0
027-437,1,0.0
027-097,1,0.0
025-096,1,0.0
025-092,1,0.0
unusable,1,0.0
EFPT-K,1,0.0
peptideN-terminal,1,0.0
whole-sample,1,0.0
password,1,0.0
casuistics,1,0.0
unconclusive,1,0.0
SAUA,1,0.0
successfuly,1,0.0
unsuccessfuly,1,0.0
H49Y,1,0.0
T573I,1,0.0
cepharanthine,1,0.0
affectations,1,0.0
drug-S,1,0.0
12-55,1,0.0
16-57,1,0.0
56380CS01,1,0.0
Testami,1,0.0
near-immediate,1,0.0
demonstrator,1,0.0
multi-channel,1,0.0
2G3G4G,1,0.0
satellites,1,0.0
115-761,1,0.0
-045,1,0.0
granulomotosis,1,0.0
AswineTexas4199-298-H3N2,1,0.0
590000,1,0.0
182020,1,0.0
lab-made,1,0.0
24-91,1,0.0
cephalic,1,0.0
cvp,1,0.0
enlisting,1,0.0
ACTH-4-10,1,0.0
course--5,1,0.0
atrialleft,1,0.0
vaccine-derived,1,0.0
Calibrating,1,0.0
VOC-targeted,1,0.0
Rico834-H1N1,1,0.0
diagnosable,1,0.0
virus-bacteria,1,0.0
ERE,1,0.0
impairmentdementia,1,0.0
Platyhelminthes,1,0.0
Chordata,1,0.0
metastats,1,0.0
Tetrahymena,1,0.0
thermophila,1,0.0
Candidatus,1,0.0
Zinderia,1,0.0
insecticola,1,0.0
47-fold,1,0.0
small-worldness,1,0.0
reflexotherapy,1,0.0
305-2669,1,0.0
mikroba,1,0.0
hozzájárulhatnak,1,0.0
evolúciós,1,0.0
környezeti,1,0.0
tudományok,1,0.0
szakemberei,1,0.0
globális,1,0.0
Egészség,1,0.0
keretében,1,0.0
célok,1,0.0
érdekében,1,0.0
összefogás,1,0.0
jegyében,1,0.0
tanulmány,1,0.0
állatorvos,1,0.0
humánorvos,1,0.0
szerzőpárosa,1,0.0
összefoglalja,1,0.0
ismereteket,1,0.0
vonatkozásában,1,0.0
szakma,1,0.0
érdemlegesek,1,0.0
lehetnek,1,0.0
Bemutatásra,1,0.0
kerül,1,0.0
eredete,1,0.0
természetes,1,0.0
mesterséges,1,0.0
állatfajokban,1,0.0
állati,1,0.0
koronavírusokkal,1,0.0
ökológiai,1,0.0
állatgyógyászat,1,0.0
humánorvoslás,1,0.0
néhány,1,0.0
eltérő,1,0.0
viselkedésével,1,0.0
járhat,1,0.0
Feltételezhetően,1,0.0
jelenség,1,0.0
vezetett,1,0.0
szindróma,1,0.0
kialakulásához,1,0.0
mely,1,0.0
2019-ben,1,0.0
jelent,1,0.0
először,1,0.0
emberekben,1,0.0
hónap,1,0.0
kíván,1,0.0
leforgása,1,0.0
milliókat,1,0.0
fertőzött,1,0.0
egész,1,0.0
világon,1,0.0
leküzdéséhez,1,0.0
újabb,1,0.0
járványok,1,0.0
megelőzéséhez,1,0.0
lehetséges,1,0.0
eszközt,1,0.0
használni,1,0.0
együttműködést,1,0.0
tapasztalatok,1,0.0
működésének,1,0.0
301-8468,1,0.0
megértéséhez,1,0.0
Dejguny,1,0.0
Dobskie,1,0.0
yeast-expressed,1,0.0
PUUV-positive,1,0.0
Carpathian,1,0.0
9155,1,0.0
8028,1,0.0
9268,1,0.0
8537,1,0.0
8293,1,0.0
9390,1,0.0
7777,1,0.0
8859,1,0.0
691780,1,0.0
672780,1,0.0
Babylonia,1,0.0
infranuclear,1,0.0
hemi-facial,1,0.0
Yorkers,1,0.0
fragment-mediated,1,0.0
revascularisatin,1,0.0
phlebotomists,1,0.0
OACD,1,0.0
foreign-antigen-specific,1,0.0
antigen-responsive,1,0.0
Diseases-,1,0.0
VIIIc,1,0.0
2742,1,0.0
495-15193,1,0.0
north-eastern,1,0.0
Fennoscandia,1,0.0
HFRS,1,0.0
process-from,1,0.0
ellene,1,0.0
védekezés,1,0.0
tökéletesítéséhez,1,0.0
Vepacel®,1,0.0
supra-regional,1,0.0
16358,1,0.0
arousals,1,0.0
mornings,1,0.0
dialy,1,0.0
valúes,1,0.0
over-estimators,1,0.0
treatmentvaccine,1,0.0
52-63,1,0.0
anti-GOF,1,0.0
Puumala,1,0.0
BER,1,0.0
NER,1,0.0
jointing,1,0.0
NHEJ,1,0.0
OGG1,1,0.0
Polβ,1,0.0
NEIL3,1,0.0
Gadd45b,1,0.0
DNA-PKs,1,0.0
6-wk,1,0.0
dPdtmax,1,0.0
pre-discharging,1,0.0
eighty-year,1,0.0
-226-046,1,0.0
-243-059,1,0.0
Nonapproved,1,0.0
Anisoylated,1,0.0
dietarylifestyle,1,0.0
yearsMethods,1,0.0
seasonResults,1,0.0
4185,1,0.0
44-71,1,0.0
-1130,1,0.0
32-69,1,0.0
8-67,1,0.0
46-78,1,0.0
-5332,1,0.0
-1140,1,0.0
-2468,1,0.0
32-78,1,0.0
36-78,1,0.0
22-58,1,0.0
childrenConclusion,1,0.0
Psychiatry,1,0.0
1379,1,0.0
ofwomen,1,0.0
casemix,1,0.0
Adamantane,1,0.0
M12,1,0.0
2003-2005,1,0.0
source-sink,1,0.0
Time-of-addition,1,0.0
particle-to-pfu,1,0.0
0244,1,0.0
2-specific,1,0.0
Post-transplant,1,0.0
threeABSTRACT,1,0.0
201336749–756,1,0.0
d-151,1,0.0
Cavender,1,0.0
2245-6451,1,0.0
wield,1,0.0
techniques-such,1,0.0
medicine-in,1,0.0
pharmaceutical-based,1,0.0
Guideline-directed,1,0.0
336919,1,0.0
21223,1,0.0
15882,1,0.0
3887,1,0.0
Slaskie,1,0.0
37182,1,0.0
AKorea77002,1,0.0
Hands-free,1,0.0
eyeglass,1,0.0
neurofacilitatory,1,0.0
n454,1,0.0
Ankle-foot,1,0.0
orthoses,1,0.0
3D-gait,1,0.0
muscle-activity,1,0.0
Ambulation,1,0.0
315000,1,0.0
noise-induced,1,0.0
IL-1Ra,1,0.0
macrofollicular,1,0.0
extemporaneous,1,0.0
Tx,1,0.0
Risk-factor,1,0.0
nucleoprotein-specific,1,0.0
SFUs,1,0.0
-0418,1,0.0
detectable-but,1,0.0
subcarinae,1,0.0
104ml,1,0.0
controlsSex,1,0.0
sigmoidal,1,0.0
ICD9-CM,1,0.0
8326,1,0.0
1217,1,0.0
high-72,1,0.0
1000-10000,1,0.0
5-lipogenase,1,0.0
mTurk,1,0.0
persistent-mild,1,0.0
persistent-moderate,1,0.0
persistent-severe,1,0.0
Intervuniversity,1,0.0
N-PET,1,0.0
histamine-HCl,1,0.0
Transcutaneous,1,0.0
44-15,1,0.0
peri-myocarditis,1,0.0
44-30,1,0.0
C-positive,1,0.0
decades-old,1,0.0
sexologic,1,0.0
erections,1,0.0
copulations,1,0.0
iohimbina,1,0.0
tendex,1,0.0
speman,1,0.0
50-ml,1,0.0
telemetered,1,0.0
vision-specific,1,0.0
cytidines,1,0.0
time-SARS-CoV-2-CMI,1,0.0
1500-3000,1,0.0
Pre,1,0.0
exo,1,0.0
phylogenetic-based,1,0.0
Calixto,1,0.0
García,1,0.0
hemaglutination,1,0.0
rivabirin,1,0.0
ninety-one,1,0.0
hypnotizability,1,0.0
31421,1,0.0
h-index,1,0.0
AVAILABILITY,1,0.0
Vision,1,0.0
IRIS,1,0.0
immunosuppressivebiological,1,0.0
cephalea,1,0.0
7480,1,0.0
24284660,1,0.0
6081432,1,0.0
5671432,1,0.0
40Conclusion,1,0.0
globally•,1,0.0
adults•,1,0.0
Thromboangiits,1,0.0
15730,1,0.0
1207-1211,1,0.0
4241,1,0.0
menwomen,1,0.0
IU25,1,0.0
3D-TOF-MRA,1,0.0
Consistency,1,0.0
well-published,1,0.0
within-person,1,0.0
EXPLORE,1,0.0
19823,1,0.0
19734,1,0.0
19812,1,0.0
Tablet,1,0.0
Malpositioning,1,0.0
single-view,1,0.0
acuteresolving,1,0.0
structure-mediated,1,0.0
twice-annual,1,0.0
CD14CD16,1,0.0
Imagery,1,0.0
radio-frequency,1,0.0
myomalacia,1,0.0
superbrilliant,1,0.0
SWCNTs,1,0.0
passivate,1,0.0
surface-immobilized,1,0.0
turn-on,1,0.0
334518,1,0.0
loosening,1,0.0
Weaker,1,0.0
89-96,1,0.0
78-82,1,0.0
responsesHEK,1,0.0
one-by-one,1,0.0
12352,1,0.0
Pangolin-CoV-2019,1,0.0
Bat-CoV-RaTG13,1,0.0
under-appreciation,1,0.0
ultrahigh-dose,1,0.0
50mgday,1,0.0
disintegrin-like,1,0.0
PLASMIC,1,0.0
FRETS-VWF73,1,0.0
588100000,1,0.0
206100000,1,0.0
559100000,1,0.0
Drummonds,1,0.0
omissions,1,0.0
tetrachoric,1,0.0
liminal,1,0.0
Health-based,1,0.0
Choline,1,0.0
26312,1,0.0
methyl-group,1,0.0
monocyteneutrophil,1,0.0
8943,1,0.0
3086,1,0.0
USP5,1,0.0
IQGAP1,1,0.0
TRIM28,1,0.0
Ubiquitination,1,0.0
by-means,1,0.0
areactive,1,0.0
31min,1,0.0
virusesObservational,1,0.0
29452,1,0.0
arrhythmiasABSTRACT,1,0.0
287-298,1,0.0
pts--3000000,1,0.0
43-44,1,0.0
Randomly,1,0.0
16264,1,0.0
3days,1,0.0
OR118,1,0.0
107-136,1,0.0
OR134,1,0.0
126-142,1,0.0
1-3days,1,0.0
OR142,1,0.0
128-158,1,0.0
OR106,1,0.0
093-113,1,0.0
vaccines-despite,1,0.0
development-must,1,0.0
viabilitythat,1,0.0
involved-the,1,0.0
five-times,1,0.0
T2-driven,1,0.0
biomarker-specific,1,0.0
asthma-school,1,0.0
22-66,1,0.0
pledgeted,1,0.0
2179,1,0.0
community-comprehensive,1,0.0
103µL,1,0.0
54--to,1,0.0
SKhour,1,0.0
pts--2000000,1,0.0
IUhour,1,0.0
mass-diagnostic,1,0.0
amplificationLAMP,1,0.0
hyperrectivity,1,0.0
8-981,1,0.0
OTD,1,0.0
revascularisable,1,0.0
non-critical,1,0.0
Post-thrombolysis,1,0.0
drugs179,1,0.0
-0270,1,0.0
phorbole,1,0.0
ether-PMA,1,0.0
hypochloride,1,0.0
meyloperoxidase,1,0.0
Schlaganfall,1,0.0
Gesellschaft,1,0.0
G-DRG,1,0.0
anti-spastic,1,0.0
marco-focal,1,0.0
virally-induced,1,0.0
secretly,1,0.0
p-MiniAQLQ,1,0.0
r-MiniAQLQ,1,0.0
targetoid,1,0.0
ligand-dependent,1,0.0
bucket,1,0.0
1993-2009,1,0.0
ILR,1,0.0
Ruapehu,1,0.0
urea-formaldehyde,1,0.0
buoyant,1,0.0
2019-early,1,0.0
oestrogen-induced,1,0.0
oestrogenic,1,0.0
NaKATPase,1,0.0
AUSSR9077H1N1-like,1,0.0
refrigeration-free,1,0.0
Hydrophilic,1,0.0
reversed-phase,1,0.0
hypotaurine,1,0.0
118-215,1,0.0
four--intensity,1,0.0
self-involvement,1,0.0
driving--had,1,0.0
one--the,1,0.0
Index--was,1,0.0
noncoxib,1,0.0
circuitries,1,0.0
disentangled,1,0.0
mega-units,1,0.0
brief-duration,1,0.0
23267,1,0.0
Network-Based,1,0.0
Signatures,1,0.0
LINCS,1,0.0
MEK,1,0.0
selumetinib,1,0.0
coagulationinflammation,1,0.0
Durations,1,0.0
dermatopathology,1,0.0
Jackson,1,0.0
ATexas177-like,1,0.0
Rocky,1,0.0
Cheyenne,1,0.0
re-isolated,1,0.0
virionsreaction,1,0.0
instrumentation-free,1,0.0
custom-designed,1,0.0
Werion,1,0.0
rightleft,1,0.0
00314,1,0.0
exercise-isoproterenol,1,0.0
E-1,1,0.0
sedentary-isoproterenol,1,0.0
Pp,1,0.0
neurologicneuropsychiatric,1,0.0
asthma-triggering,1,0.0
dextroamphetamine,1,0.0
deficithyperactivity,1,0.0
15-mg,1,0.0
XR,1,0.0
amphetamine-containing,1,0.0
highest-performing,1,0.0
transcription-loop,1,0.0
5-unit,1,0.0
083-093,1,0.0
syndrome--clinical,1,0.0
enunciated,1,0.0
moderate-dose,1,0.0
therapeutics--those,1,0.0
asthamticus,1,0.0
L25I,1,0.0
H75Q,1,0.0
H155T,1,0.0
Q156H,1,0.0
AFujian4112002-like,1,0.0
2171,1,0.0
AVictoria375H3N2-like,1,0.0
medicosurgical,1,0.0
beg,1,0.0
cytoxan,1,0.0
33378609,1,0.0
2075,1,0.0
abscessoscopy,1,0.0
hydropneumothorasx,1,0.0
clotted,1,0.0
reabscessoscopy,1,0.0
Revideothoracoscopies,1,0.0
hermetism,1,0.0
revideothoracoscopy,1,0.0
Whose,1,0.0
Discourse,1,0.0
recapture,1,0.0
Heaves-affected,1,0.0
neuroproctetive,1,0.0
intracarotid,1,0.0
MRI-assisted,1,0.0
℃,1,0.0
percutaenous,1,0.0
bedsideevent,1,0.0
diag-,1,0.0
nosis,1,0.0
prob-,1,0.0
inifluenza,1,0.0
neurointerventions,1,0.0
disclosures,1,0.0
IL-12p70,1,0.0
Standardbred,1,0.0
trotters,1,0.0
T16,1,0.0
2021384403-16,1,0.0
Essink,1,0.0
Sahly,1,0.0
ACCFAHAHRS,1,0.0
anti-neutrophilic,1,0.0
cANCA,1,0.0
open-lung,1,0.0
capillaritis,1,0.0
months-16,1,0.0
Brenner,1,0.0
3·3-3·7,1,0.0
bat-,1,0.0
pangolin-derived,1,0.0
2021-22,1,0.0
laryngotracheomalacia,1,0.0
whit,1,0.0
sacrifices,1,0.0
tachydysrhythmias,1,0.0
Baden,1,0.0
pre-MT,1,0.0
27-51,1,0.0
Polyps,1,0.0
hyperresponsivenes,1,0.0
nasal-bronchial,1,0.0
Postnasal,1,0.0
Sankoff,1,0.0
value-laden,1,0.0
non-experts,1,0.0
Graduate,1,0.0
ACGME,1,0.0
teen-age,1,0.0
expirate,1,0.0
micturition,1,0.0
transposable,1,0.0
Ca2ATPase,1,0.0
20937,1,0.0
children10,1,0.0
yearsadults,1,0.0
LAIV-pilot,1,0.0
non-supervised,1,0.0
clinician-led,1,0.0
1946-1999,1,0.0
100147,1,0.0
59558,1,0.0
5759,1,0.0
hypochondria,1,0.0
ResNet-18,1,0.0
ResNet-50,1,0.0
DenseNet-201,1,0.0
19825,1,0.0
non-consanguineous,1,0.0
encephalitis-like,1,0.0
rarefication,1,0.0
seroarcheologic,1,0.0
leukaraiosis,1,0.0
alpha-adducin,1,0.0
hydrofluoroalkane-beclomethasone,1,0.0
Mmirp-1,1,0.0
livingdead,1,0.0
37279,1,0.0
26784,1,0.0
2361,1,0.0
4893,1,0.0
32424,1,0.0
30935,1,0.0
AdC7-RBD-tr2-elicted,1,0.0
AdC7-RBD,1,0.0
AdC7-S,1,0.0
insolated,1,0.0
Laminar,1,0.0
tricolour,1,0.0
second-or,1,0.0
mid-LV,1,0.0
Expanders,1,0.0
rd,1,0.0
Osun,1,0.0
Matter,1,0.0
78509,1,0.0
62930,1,0.0
22842,1,0.0
177877,1,0.0
2566171,1,0.0
dumb-bell,1,0.0
RBD-tr2,1,0.0
solidliquid,1,0.0
downslope,1,0.0
rest-breathing,1,0.0
A-aDO2,1,0.0
Schistosomiasis,1,0.0
Schistosoma,1,0.0
depletionOVA,1,0.0
antigensOVA,1,0.0
Tn,1,0.0
TME,1,0.0
STICH,1,0.0
AdC7,1,0.0
tandem-repeat,1,0.0
44075,1,0.0
bed-bound,1,0.0
ostrich,1,0.0
44614,1,0.0
technician,1,0.0
195ABSTRACT,1,0.0
THCs,1,0.0
Gondar,1,0.0
R54G,1,0.0
T160A,1,0.0
K289R,1,0.0
K292R,1,0.0
V363VI,1,0.0
LR332R,1,0.0
α26-galactose,1,0.0
SAα26-Gal,1,0.0
8782,1,0.0
T8517C,1,0.0
28144,1,0.0
C251T,1,0.0
S84L,1,0.0
EPR-1,1,0.0
convene,1,0.0
5648,1,0.0
50-200,1,0.0
EMS-specific,1,0.0
oCcclusion,1,0.0
mRACE,1,0.0
Intrasubject,1,0.0
noncompartmental,1,0.0
Within-subject,1,0.0
3268,1,0.0
Inappropriately,1,0.0
7390,1,0.0
1790,1,0.0
happier,1,0.0
H163A,1,0.0
27009,1,0.0
22783,1,0.0
57624,1,0.0
21041,1,0.0
16934,1,0.0
11920,1,0.0
Occult,1,0.0
p081,1,0.0
p016,1,0.0
underrecognize,1,0.0
Inactivity,1,0.0
avails,1,0.0
load-burdened,1,0.0
E166A,1,0.0
miocardiac,1,0.0
His163,1,0.0
Glu166,1,0.0
physicial,1,0.0
percussions,1,0.0
vasoactivespasmogenic,1,0.0
eosinophilis,1,0.0
apoptosisABSTRACT,1,0.0
relaxation-breathing,1,0.0
apoB100,1,0.0
aldehyde-modified,1,0.0
H5N1avian,1,0.0
aetiopathophysiology,1,0.0
O-FT,1,0.0
AFortitude,1,0.0
247257,1,0.0
LC480,1,0.0
10685,1,0.0
9-April,1,0.0
levels--through,1,0.0
border-area,1,0.0
pre-retirement,1,0.0
VOORHORST,1,0.0
Migen,1,0.0
UVT,1,0.0
66x103,1,0.0
copyml,1,0.0
06971,1,0.0
Chilblain-like,1,0.0
Mina,1,0.0
FVH-diffusion-weighted,1,0.0
DWImismatch,1,0.0
1005-1058,1,0.0
14311,1,0.0
2670-76703,1,0.0
low-health-related,1,0.0
large-scaled,1,0.0
8-1234,1,0.0
8-1338,1,0.0
4-933,1,0.0
immunnomodulators,1,0.0
Wet,1,0.0
1-90,1,0.0
4-log,1,0.0
eosinophilsbasophils,1,0.0
ragweed-induced,1,0.0
ventricul,1,0.0
redifferentiation,1,0.0
12-57,1,0.0
shRNAs-treated,1,0.0
pressureABSTRACT,1,0.0
95CI091-130,1,0.0
702996,1,0.0
6651016,1,0.0
RR089,1,0.0
95CI063-125,1,0.0
person-day,1,0.0
Roche-sponsored,1,0.0
Oseltamivir-susceptible,1,0.0
seminiferous,1,0.0
17β-oestradiol,1,0.0
trioxide,1,0.0
WO3-based,1,0.0
light-responsive,1,0.0
photocatalyst-coated,1,0.0
logTCID50,1,0.0
logTCID50mL,1,0.0
lux,1,0.0
20℃,1,0.0
photocatalyst-coat,1,0.0
Immunoblotting,1,0.0
criminals,1,0.0
cross-agency,1,0.0
informationsharing,1,0.0
1·9,1,0.0
6·59,1,0.0
Wiihabilitation,1,0.0
NeuroAid®,1,0.0
phytomedicines,1,0.0
arginine-vasopressin,1,0.0
muscolar,1,0.0
spreadability,1,0.0
1915-1916,1,0.0
strove,1,0.0
Americana,1,0.0
housedust,1,0.0
preponderant,1,0.0
immune-suppressing,1,0.0
food-allergic,1,0.0
sulfating,1,0.0
tartrazine,1,0.0
monosodium,1,0.0
asthmaHowever,1,0.0
food-challenge,1,0.0
CAP-RAST,1,0.0
CAP-radioallergosorbent,1,0.0
fluoroenzyme,1,0.0
immunoasssay,1,0.0
decentralisation,1,0.0
glycoproteine,1,0.0
PCAIS,1,0.0
ACAIS,1,0.0
industryWork-related,1,0.0
Extra-cardiac,1,0.0
Abdala,1,0.0
system-particularly,1,0.0
care-to,1,0.0
Biocon,1,0.0
Marshaling,1,0.0
BioCubaFarma-the,1,0.0
conglomerate-and,1,0.0
Founded,1,0.0
powerhouse,1,0.0
Pax,1,0.0
visionary,1,0.0
Hitler,1,0.0
advertent,1,0.0
blindfold,1,0.0
Tactuo-motor,1,0.0
nonlateralised,1,0.0
nonneglect,1,0.0
right-biased,1,0.0
44000,1,0.0
azygus,1,0.0
robotic-assisted,1,0.0
1994-96,1,0.0
septicaemia,1,0.0
IE-related,1,0.0
ACSs-either,1,0.0
UAP-who,1,0.0
prepubertal,1,0.0
Adolf,1,0.0
blown,1,0.0
areessential,1,0.0
Hydrophobic,1,0.0
sedation-analgesia,1,0.0
isolationism,1,0.0
Admiral,1,0.0
Cary,1,0.0
Edith,1,0.0
Patient-physician,1,0.0
eve,1,0.0
unwavering,1,0.0
distanced,1,0.0
thwart,1,0.0
RR109,1,0.0
278875,1,0.0
488812,1,0.0
131-211,1,0.0
Pull-down,1,0.0
0614,1,0.0
Non-vasculitic,1,0.0
euglycemic,1,0.0
1970--71,1,0.0
1975--76,1,0.0
1973--74,1,0.0
catch-up-fatality,1,0.0
15--64,1,0.0
leaking,1,0.0
stapler,1,0.0
610000,1,0.0
variants-identified,1,0.0
£150,1,0.0
nearer,1,0.0
CG167,1,0.0
longside,1,0.0
httpwwwniceorgukCG167,1,0.0
httpwwwniceorgukCG95,1,0.0
httpwwwniceorgukCG94,1,0.0
httpwwwniceorgukCG48,1,0.0
trio,1,0.0
livestock-dependent,1,0.0
Wen,1,0.0
Xing,1,0.0
7698,1,0.0
1828,1,0.0
112-207,1,0.0
144-399,1,0.0
preincubation,1,0.0
Agglutinin,1,0.0
Germ,1,0.0
crècheschool,1,0.0
shM349,1,0.0
shM522,1,0.0
RIG-1,1,0.0
vagosympathetic,1,0.0
orthosympathetic,1,0.0
hypobronchial,1,0.0
NALF,1,0.0
syndrome-novel,1,0.0
cellsendothelial,1,0.0
anti-parasitic,1,0.0
physicalnonphysical,1,0.0
13-29,1,0.0
age-associative,1,0.0
TNAP,1,0.0
Wheat,1,0.0
AP-targeted,1,0.0
mortgage,1,0.0
defaults,1,0.0
sufficiencysupplementation,1,0.0
8000-fold,1,0.0
52247,1,0.0
150-fold,1,0.0
Zn-sufficiency,1,0.0
07893-06849,1,0.0
2308084-05658,1,0.0
26-,1,0.0
availabilities,1,0.0
Triticum,1,0.0
103-390,1,0.0
116-302,1,0.0
95CI107-236,1,0.0
140-762,1,0.0
121-358,1,0.0
ChinaDaily,1,0.0
DLNM,1,0.0
exposure-lag-response,1,0.0
visibilityA,1,0.0
12800,1,0.0
Flu-AIn,1,0.0
reclaiming,1,0.0
evidenceit,1,0.0
asthmadiagnosis,1,0.0
immu,1,0.0
nization,1,0.0
adop,1,0.0
ting,1,0.0
popula,1,0.0
tion,1,0.0
telligence,1,0.0
ducted,1,0.0
stra,1,0.0
tegies,1,0.0
penultimate,1,0.0
impo-sed,1,0.0
Nasopha-ryngeal,1,0.0
6-120,1,0.0
1691,1,0.0
Thalassemia,1,0.0
morbidity-heart,1,0.0
dysrhythmias-is,1,0.0
RR159,1,0.0
106-206,1,0.0
thirty-seven-year-old,1,0.0
treatmentrehabilitation,1,0.0
pandemic12,1,0.0
erythrograms,1,0.0
32-35°C,1,0.0
Recurring,1,0.0
0733,1,0.0
0675,1,0.0
Time-course,1,0.0
0863,1,0.0
5805,1,0.0
homogenisation,1,0.0
Inequities,1,0.0
dischargehome,1,0.0
Inequity,1,0.0
ninety-eight,1,0.0
spikeD614G,1,0.0
treatmentstherapies,1,0.0
Peripheral-type,1,0.0
clinico-radiologic,1,0.0
Drug-related,1,0.0
Energies,1,0.0
RANKIN,1,0.0
date-of-birth-,1,0.0
zipcode-matched,1,0.0
0-75,1,0.0
7-35,1,0.0
64mg,1,0.0
value-short,1,0.0
TLV-STEL,1,0.0
N50,1,0.0
CIMs,1,0.0
Eduardo,1,0.0
Ojito-Magaz,1,0.0
clause,1,0.0
testingIMPORTANCE,1,0.0
ventilationminute,1,0.0
anti-dysreactive,1,0.0
embalmers,1,0.0
embalming,1,0.0
300-year-old,1,0.0
mummies,1,0.0
resuscitation-promoting,1,0.0
nanoparticles-mediated,1,0.0
2867,1,0.0
2609,1,0.0
Exclusive,1,0.0
65-17,1,0.0
Colloidal,1,0.0
acid-positive,1,0.0
09756,1,0.0
09485-1000,1,0.0
8116-9685,1,0.0
9684,1,0.0
9517-9715,1,0.0
MVP,1,0.0
≤9,1,0.0
Liberation,1,0.0
lifeline,1,0.0
Client,1,0.0
turn-of-the-century,1,0.0
commensurable,1,0.0
microbe,1,0.0
no-jab,1,0.0
9596,1,0.0
3748,1,0.0
culture-grown,1,0.0
prescribable,1,0.0
unselective,1,0.0
2009-September,1,0.0
132140,1,0.0
132110,1,0.0
0281,1,0.0
0069,1,0.0
non-VA,1,0.0
vicissitudes,1,0.0
exudative-stage,1,0.0
SAalpha2-3Gal,1,0.0
copiescell,1,0.0
nonfinishers,1,0.0
anaerobically,1,0.0
ambulance-transported,1,0.0
-SP,1,0.0
alder,1,0.0
hazel,1,0.0
cyclotron,1,0.0
virusTo,1,0.0
proteins-explicit,1,0.0
antibodies-based,1,0.0
Friendly,1,0.0
II-Yoga,1,0.0
mi,1,0.0
Imperia,1,0.0
1960-1972,1,0.0
donor-,1,0.0
acceptor-labeled,1,0.0
no-job,1,0.0
Desaturation,1,0.0
allergen-reactive,1,0.0
stubborn,1,0.0
165-day,1,0.0
rehabilitee,1,0.0
datalicense,1,0.0
1-34,1,0.0
HAPI,1,0.0
noncorticosteroids,1,0.0
Caputo,1,0.0
Riemann-Liouville,1,0.0
Caputos,1,0.0
index--the,1,0.0
tamponage,1,0.0
voluminal,1,0.0
antiedemic,1,0.0
antiprostaglandin,1,0.0
Flunet,1,0.0
86-91,1,0.0
€51-€53,1,0.0
age-risk,1,0.0
Herniation,1,0.0
pericardioperitoneal,1,0.0
co-designed,1,0.0
Expenditures,1,0.0
cost-ineffective,1,0.0
providerspayers,1,0.0
insensitiveness,1,0.0
controlledresponding,1,0.0
alternativenovel,1,0.0
rheology-hemostasis,1,0.0
prerequsite,1,0.0
Sending,1,0.0
-valvular,1,0.0
2014†,1,0.0
Gyneonggi,1,0.0
retroinformation,1,0.0
presure,1,0.0
sleepinessfatigue,1,0.0
hypnotics,1,0.0
dopeminergic,1,0.0
modafinil,1,0.0
project-the,1,0.0
Hospital-Clínica,1,0.0
Guayaquil,1,0.0
26·3,1,0.0
16·5,1,0.0
CE-IVD-labeled,1,0.0
BIOSYNEX,1,0.0
LYHER,1,0.0
virusAn,1,0.0
Medakit,1,0.0
NG-BIOTECH,1,0.0
NG-Biotech,1,0.0
Guipry,1,0.0
BackgroundnbspCOVID-19,1,0.0
Coventry,1,0.0
Warwickshire,1,0.0
work-package,1,0.0
parnaparin,1,0.0
I-Treat,1,0.0
computerisation,1,0.0
inadequateABSTRACT,1,0.0
confected,1,0.0
humour,1,0.0
Chemosensory,1,0.0
MEDICC,1,0.0
Fance,1,0.0
outsourcing,1,0.0
undisclosing,1,0.0
SBNT,1,0.0
intolerent,1,0.0
MiBa,1,0.0
indicator-based,1,0.0
RAND-IAQL-12Using,1,0.0
stepOur,1,0.0
QoLThese,1,0.0
1-PCI,1,0.0
Lightcycler,1,0.0
Helminthic,1,0.0
10203,1,0.0
123-300,1,0.0
84-223,1,0.0
57-231,1,0.0
414-542,1,0.0
16-789,1,0.0
468-766,1,0.0
246-107,1,0.0
319-1495,1,0.0
non-public,1,0.0
∼80,1,0.0
LTB,1,0.0
influenzaA,1,0.0
Lin-Kou,1,0.0
WHOA,1,0.0
71158,1,0.0
76-93,1,0.0
storytelling,1,0.0
under-investigated,1,0.0
contexualised,1,0.0
coronaritis,1,0.0
nonpsychiatric,1,0.0
160-199,1,0.0
DBP90,1,0.0
DBP90,1,0.0
16569,1,0.0
19348,1,0.0
13285,1,0.0
8215,1,0.0
ambulance-treated,1,0.0
metyrapone,1,0.0
4815,1,0.0
endarteritis,1,0.0
leutic,1,0.0
lipoidosis,1,0.0
9-14,1,0.0
cushions,1,0.0
perivasal,1,0.0
arteriols,1,0.0
forsaken,1,0.0
Lockdowns,1,0.0
Betacorona,1,0.0
24182030,1,0.0
825798,1,0.0
JHU,1,0.0
∼79,1,0.0
nucleocapsids,1,0.0
1990-1992,1,0.0
ischemia--who,1,0.0
specificityClinical,1,0.0
Nanostructured,1,0.0
tissue-volume,1,0.0
molecularbiomarker,1,0.0
editorialists,1,0.0
on-Q,1,0.0
uni-multivariate,1,0.0
Transmyocardial,1,0.0
laser-induced,1,0.0
Laplaces,1,0.0
duplexed,1,0.0
A-,1,0.0
OIA,1,0.0
Biostar,1,0.0
Re-opening,1,0.0
RT-qPCRs,1,0.0
Spielbergers,1,0.0
BSI,1,0.0
oxidativenitrification,1,0.0
Lineages,1,0.0
Kenya-Tanzania,1,0.0
vindicated,1,0.0
attention-matched,1,0.0
non-dental,1,0.0
acceptabilitysatisfaction,1,0.0
glycan-array,1,0.0
four-building,1,0.0
121-day,1,0.0
Post-natal,1,0.0
latero-basal,1,0.0
Northland,1,0.0
Alia,1,0.0
Hebron,1,0.0
Chou,1,0.0
IgGIg,1,0.0
291-765,1,0.0
20023,1,0.0
drugRNA,1,0.0
nanotheragnostics,1,0.0
webbased,1,0.0
Ataxia,1,0.0
enrollments,1,0.0
Holistic,1,0.0
diffe-rentiation,1,0.0
Zangfu,1,0.0
therapyHDT,1,0.0
Capsules,1,0.0
Haoqin,1,0.0
Qingdan,1,0.0
Bath,1,0.0
Constellations,1,0.0
235-709,1,0.0
risk-inducing,1,0.0
Aetiology,1,0.0
CNS-injury,1,0.0
HA-based,1,0.0
Codon,1,0.0
tRNAs,1,0.0
Lam,1,0.0
alXiao,1,0.0
notebook,1,0.0
ACRO,1,0.0
835-998,1,0.0
VOMED,1,0.0
Coris-Bioconcept,1,0.0
shM22,1,0.0
U1-short,1,0.0
Aphasic,1,0.0
T1-hyperintense,1,0.0
-847,1,0.0
-861,1,0.0
-154,1,0.0
Hemosorption,1,0.0
Partnerships,1,0.0
SI-type,1,0.0
age-since-infection,1,0.0
infection-free,1,0.0
247583,1,0.0
€222,1,0.0
€191,1,0.0
€2656,1,0.0
€749,1,0.0
€120,1,0.0
€475,1,0.0
personsVirological,1,0.0
NYCs,1,0.0
7847465,1,0.0
way--using,1,0.0
analysis--different,1,0.0
hypoalbuminaemia,1,0.0
swellingoedema,1,0.0
OCW,1,0.0
rtpa,1,0.0
3-hours,1,0.0
tpa,1,0.0
Yonas,1,0.0
Pittsburg,1,0.0
non-contrasted,1,0.0
gyral,1,0.0
pan-necrosis,1,0.0
non-shared,1,0.0
depths,1,0.0
138-53,1,0.0
050-083,1,0.0
052-099,1,0.0
12-27,1,0.0
data-bank,1,0.0
18-22,1,0.0
kaifukuki-,1,0.0
Anxiety-induced,1,0.0
damage-inducing,1,0.0
hyperproductive,1,0.0
acarids,1,0.0
non-criteria,1,0.0
Anti-aggregant,1,0.0
35214,1,0.0
3278,1,0.0
κ038,1,0.0
Commun,1,0.0
Intell,1,0.0
2016403E340-E346,1,0.0
video-mediated,1,0.0
Rowley,1,0.0
s-2-4-bromo-biphenyl-4-sulfonylamino-3-methyl-butyric,1,0.0
PD200126,1,0.0
mgdaypo,1,0.0
Unoperated,1,0.0
Ivor,1,0.0
oesophagectomy,1,0.0
unceasing,1,0.0
fungicide,1,0.0
mls100,1,0.0
gmmin,1,0.0
BCI-supported,1,0.0
10-33,1,0.0
on-the-ground,1,0.0
inter-current,1,0.0
suis,1,0.0
sectionalcohort,1,0.0
modelsautopsy,1,0.0
reviewsmeta-analysis,1,0.0
Ophthalmic,1,0.0
AH1N1-09,1,0.0
civilian-defense,1,0.0
15-month-old,1,0.0
chest-wall,1,0.0
puncture-to-balloon,1,0.0
non-ELF-EMF,1,0.0
hemolysates,1,0.0
Bioelectromagnetics,1,0.0
38386-396,1,0.0
cornonavirus-1,1,0.0
cornonavirus-2,1,0.0
EBMP,1,0.0
qPCR-confirmed,1,0.0
outpatient-care,1,0.0
OAC-related,1,0.0
misperceived,1,0.0
polysegmental,1,0.0
T-cell-generated,1,0.0
TH2-related,1,0.0
lowgrade,1,0.0
byssinosis,1,0.0
1430-3884,1,0.0
Bundling,1,0.0
farct,1,0.0
above-background,1,0.0
hyperomocysteinemia,1,0.0
CAPHRI,1,0.0
mono-intervention,1,0.0
NG,1,0.0
2163,1,0.0
eight-three,1,0.0
Schultz-Cherry,1,0.0
non-steroids,1,0.0
0-001,1,0.0
Arrest-Specific,1,0.0
FWS,1,0.0
5-16,1,0.0
IADSA,1,0.0
cavernoma,1,0.0
pseudoxantoma,1,0.0
emotionality,1,0.0
first-choice,1,0.0
ness,1,0.0
Rigshospitalet,1,0.0
obesity-or,1,0.0
pollution-associated,1,0.0
department-focused,1,0.0
BSL4,1,0.0
poultry--with,1,0.0
spread--,1,0.0
countries--mainly,1,0.0
Asia--and,1,0.0
Pre-clinically,1,0.0
Rt-Ach,1,0.0
un-studied,1,0.0
devil,1,0.0
Teleconsultations,1,0.0
traumatization,1,0.0
recognisable,1,0.0
cordarone,1,0.0
Symptom-free,1,0.0
n118,1,0.0
77-192,1,0.0
nonpharmacologically,1,0.0
medication-free,1,0.0
epidemic-economic,1,0.0
Ambiguous,1,0.0
nonbattle,1,0.0
4629,1,0.0
31-fold,1,0.0
0830-0907,1,0.0
specifity,1,0.0
collaborator,1,0.0
education-related,1,0.0
AIB,1,0.0
LCA--in,1,0.0
RCA--in,1,0.0
re-studied,1,0.0
cmsec--in,1,0.0
ABH-induced,1,0.0
cardiometry,1,0.0
neurointervention,1,0.0
1975-1990,1,0.0
1--lymphoid,1,0.0
1--pollenosis,1,0.0
hypertoxic,1,0.0
SATURN,1,0.0
Lactating,1,0.0
paternalistic,1,0.0
throwback,1,0.0
sinusitisThree,1,0.0
methodb,1,0.0
bResultsb,1,0.0
113±21,1,0.0
126±25,1,0.0
p00008,1,0.0
OR436,1,0.0
176-1081,1,0.0
OR220,1,0.0
095-506,1,0.0
128-1036,1,0.0
105-1136,1,0.0
198-1991,1,0.0
bConclusionb,1,0.0
1AB,1,0.0
fluticasone250,1,0.0
therapyheartjnl10512960F1F1F1Figure,1,0.0
arrestThe,1,0.0
178×109,1,0.0
002-05×109,1,0.0
antineutrophil,1,0.0
QUESTION,1,0.0
arrestAggressive,1,0.0
diseasePrinzmetals,1,0.0
anginaLoeffler,1,0.0
endocarditisCoronary,1,0.0
group-effectiveness,1,0.0
2-yr,1,0.0
eosinophilsor2,1,0.0
Scale-revised,1,0.0
BTQ,1,0.0
teleconsultations,1,0.0
7-item,1,0.0
CI029,1,0.0
two-doctor,1,0.0
semi-rural,1,0.0
Shroshire,1,0.0
gas-chromatography,1,0.0
gotten,1,0.0
6-74,1,0.0
MEFV,1,0.0
PROFESS,1,0.0
20s,1,0.0
816884,1,0.0
4894,1,0.0
Pretest,1,0.0
five-known,1,0.0
protein-coding,1,0.0
α-helical,1,0.0
EU1,1,0.0
B1117,1,0.0
Fujirebio,1,0.0
9703,1,0.0
9769,1,0.0
9967,1,0.0
420000,1,0.0
9300000,1,0.0
2358,1,0.0
Receiver-operating-characteristics,1,0.0
non-VOCs,1,0.0
largest-ever,1,0.0
ICPC,1,0.0
CI123,1,0.0
non-Campus,1,0.0
Campuses,1,0.0
endolymphatic,1,0.0
BDI-II,1,0.0
FLUNET,1,0.0
Overlapping,1,0.0
November-February,1,0.0
pro-coagulative,1,0.0
ECMO-centre,1,0.0
Repopulating,1,0.0
cytokinesis,1,0.0
gene-mediated,1,0.0
Mainstream,1,0.0
ST-100,1,0.0
behaviourABSTRACT,1,0.0
Intrapulmonary,1,0.0
body-1,1,0.0
Barbados--3,1,0.0
Adoptive,1,0.0
Madinatul-Hujjaj,1,0.0
Tabung,1,0.0
Haji,1,0.0
symptoms†,1,0.0
midadulthood,1,0.0
≥25,1,0.0
back-to-back,1,0.0
poorlynot,1,0.0
poorno,1,0.0
throes,1,0.0
region--7,1,0.0
Tobago--5,1,0.0
141-385,1,0.0
SeraCare,1,0.0
intraday,1,0.0
Sturgis,1,0.0
arteriolopathy,1,0.0
1408‰,1,0.0
29-70,1,0.0
clinicoimmunological,1,0.0
Well-defined,1,0.0
B13,1,0.0
B21,1,0.0
B27,1,0.0
EcC,1,0.0
ExC,1,0.0
0·1,1,0.0
8–10,1,0.0
30–50,1,0.0
30-mm,1,0.0
39–104,1,0.0
286–410,1,0.0
10–52,1,0.0
2464,1,0.0
630–9638,1,0.0
TACS–PACS,1,0.0
331–1749,1,0.0
self-inoculation,1,0.0
GLOBOCAN,1,0.0
immuno-suppressant,1,0.0
non-medicamentous,1,0.0
4-to-5-year,1,0.0
13164,1,0.0
0858-20193,1,0.0
Tamil,1,0.0
CNB-conjugated,1,0.0
12H8,1,0.0
12H1,1,0.0
Inrecurrentgroup，,1,0.0
（270±164）UL］，,1,0.0
［（060±050）,1,0.0
（084±098）μgL］，,1,0.0
［（294±195）,1,0.0
（395±319）μgL］，,1,0.0
［（917±642）,1,0.0
（1428±1774）ngL］,1,0.0
（577±266）,1,0.0
（474±281）UL］,1,0.0
betweenrecurrentandnon-recurrentgroups,1,0.0
（all,1,0.0
P005）,1,0.0
（4）,1,0.0
glass，,1,0.0
CNB-based,1,0.0
Meanwhile，,1,0.0
（5）,1,0.0
images，,1,0.0
Allrecurrentpatients,1,0.0
pleotropic,1,0.0
proceded,1,0.0
cathetarization,1,0.0
transvascular,1,0.0
Starflex,1,0.0
embolic-thrombotic,1,0.0
LFIA-based,1,0.0
fragment-crystallizable,1,0.0
nanobead,1,0.0
ergotism,1,0.0
rally,1,0.0
（3647±3412）UL），,1,0.0
somewhat-curious,1,0.0
SICHs,1,0.0
15543,1,0.0
3065,1,0.0
cosmic,1,0.0
Forbush,1,0.0
Friday,1,0.0
Saturday-Sunday,1,0.0
mid-week,1,0.0
festivities,1,0.0
week-ends,1,0.0
electrified,1,0.0
Edge-network,1,0.0
TCGA,1,0.0
immunoenhancing,1,0.0
Mathods,1,0.0
cass,1,0.0
MOOSE,1,0.0
1398,1,0.0
128-172,1,0.0
148-190,1,0.0
128-151,1,0.0
13-β-d-glucan,1,0.0
cagocel,1,0.0
Urology,1,0.0
60--65,1,0.0
nonthrombus,1,0.0
1304×109L,1,0.0
1080×109L,1,0.0
≥8355,1,0.0
Butantan,1,0.0
pasteur,1,0.0
Butantan-sanofi,1,0.0
right-ventricular,1,0.0
thinly,1,0.0
err,1,0.0
dragging,1,0.0
N104,1,0.0
1446,1,0.0
am-9,1,0.0
squatted,1,0.0
trans-oesophageal,1,0.0
loath,1,0.0
social-medical,1,0.0
potentiator,1,0.0
Pelvic,1,0.0
Ficks,1,0.0
4939,1,0.0
fill-finish,1,0.0
20-72,1,0.0
102ABSTRACT,1,0.0
Hsu,1,0.0
Hsieh,1,0.0
627-647,1,0.0
vivo-reconstituted,1,0.0
transcription-activated,1,0.0
molecular-driven,1,0.0
angiographySWANbefore,1,0.0
thrombectomymiddle,1,0.0
occlusionwas,1,0.0
SWAN,1,0.0
direct-from-scene,1,0.0
［（268±208）,1,0.0
［（2260±1282）,1,0.0
illst,1,0.0
eight-hourly,1,0.0
43185,1,0.0
91109,1,0.0
108-781,1,0.0
042-65,1,0.0
differenceABSTRACT,1,0.0
PrimeDirect®,1,0.0
PrimeScript®RT-PCR,1,0.0
SANSURE®BIOTECH,1,0.0
3437,1,0.0
3337,1,0.0
pre-dialysis,1,0.0
nosology,1,0.0
Lleida,1,0.0
Origination,1,0.0
extrasystoli,1,0.0
NaeKe,1,0.0
CuZn-superoxide,1,0.0
PrPC-knockout,1,0.0
bird-flu,1,0.0
markers--the,1,0.0
flow--are,1,0.0
Transformational,1,0.0
crisiss,1,0.0
maelstrom,1,0.0
Greyhounds,1,0.0
Post-infarct,1,0.0
winter-like,1,0.0
haemotocrit,1,0.0
off-setting,1,0.0
46226,1,0.0
brushed,1,0.0
medico,1,0.0
malignantly,1,0.0
analyti,1,0.0
anybody,1,0.0
minichromosome,1,0.0
topoisomerase,1,0.0
Immunocytochemical,1,0.0
Topo,1,0.0
BP-related,1,0.0
target-organ,1,0.0
TOD,1,0.0
hypercreatinemia,1,0.0
pressure-related,1,0.0
whole-day,1,0.0
40-week-old,1,0.0
Downregulation,1,0.0
previous-generation,1,0.0
Tear,1,0.0
maculopathies,1,0.0
OSA-associated,1,0.0
Co-existent,1,0.0
Wheezes,1,0.0
gate-keeping,1,0.0
5238,1,0.0
242076,1,0.0
081-101,1,0.0
055-115,1,0.0
065-099,1,0.0
s-ECP,1,0.0
sucrose,1,0.0
thermally-induced,1,0.0
six-hourly,1,0.0
（3024±2320）UL］，,1,0.0
Methylprednisolone-sodium-acetate,1,0.0
（2）,1,0.0
2019-nCoVrecurrentpatients,1,0.0
positive，,1,0.0
type，,1,0.0
fever，,1,0.0
cough，,1,0.0
expectoration，,1,0.0
（573±282）,1,0.0
（3）,1,0.0
normal（all005,1,0.0
ngml）,1,0.0
ofrecurrentgroup,1,0.0
（151±171）,1,0.0
ngL，,1,0.0
ofnon-recurrentgroup,1,0.0
（63±78）,1,0.0
（t,1,0.0
3207，,1,0.0
0000）,1,0.0
［（617±24）,1,0.0
（604±241）×109L］，,1,0.0
lymphocyte［（159±052）,1,0.0
（132±064）×109L］，,1,0.0
［（1254±2820）,1,0.0
（2174±2563）mgL］，,1,0.0
［（3107±2872）,1,0.0
（3410±2216）mm1,1,0.0
h］，,1,0.0
［（2473±915）,1,0.0
（1）,1,0.0
CRP，,1,0.0
ESR，,1,0.0
from15,1,0.0
referees,1,0.0
investigation†,1,0.0
126§,1,0.0
contact¶,1,0.0
classmates,1,0.0
noncompeting,1,0.0
112-243,1,0.0
106-300,1,0.0
ofrecurrenceRNA,1,0.0
withoutrecurrence,1,0.0
Jinyintan,1,0.0
Quanzhou,1,0.0
females，,1,0.0
asrecurrence2019-nCoV,1,0.0
procalcitonin，,1,0.0
RNArecurrencepatients,1,0.0
collected，,1,0.0
situations，,1,0.0
symptoms，,1,0.0
2019-nCoVnon-recurrentgroup,1,0.0
innon-recurrentgroup,1,0.0
（χ²0800，P0371）,1,0.0
（57±21）,1,0.0
ofnon-recurrentgroup（53±17）,1,0.0
COVID-19recurrentgroup,1,0.0
83non-recurrentpatients,1,0.0
2019-nCoV，,1,0.0
IL-6，,1,0.0
anxiogenic,1,0.0
biapical,1,0.0
Certest,1,0.0
taurin,1,0.0
caregiver-generated,1,0.0
trend-analysis,1,0.0
immune-system,1,0.0
surmised,1,0.0
ordinalized,1,0.0
Crime,1,0.0
Dichotomous,1,0.0
non-birth,1,0.0
111-381,1,0.0
Autoregressive,1,0.0
aspired,1,0.0
adherenceThe,1,0.0
undemonstrated,1,0.0
ethnical,1,0.0
G1S,1,0.0
G2M,1,0.0
Spirography,1,0.0
Dneprodzerzhinsk,1,0.0
cell-only,1,0.0
polylactide-co-epsilon-caprolactone,1,0.0
actioncoping,1,0.0
heterozonal,1,0.0
arterivirus,1,0.0
Arteriviridae,1,0.0
phylogenomic,1,0.0
hp1hp2,1,0.0
hp2,1,0.0
screen-detected,1,0.0
Settings,1,0.0
TAU-60,1,0.0
phenilalkyl,1,0.0
«Severe,1,0.0
breath-holding,1,0.0
postantigen,1,0.0
0205-0062,1,0.0
0054-0016,1,0.0
antigenbemiparin,1,0.0
Muc5ac,1,0.0
low-anticoagulant,1,0.0
organizationally,1,0.0
phylogeographically,1,0.0
ecophylogenetically,1,0.0
100-years,1,0.0
ecophylogenetic,1,0.0
duck-swine-man,1,0.0
Holarctic,1,0.0
Anas,1,0.0
turkey-swine-man,1,0.0
self-sustained,1,0.0
inclusively,1,0.0
nonrecurrent,1,0.0
logic-gated,1,0.0
salivaIMPORTANCE,1,0.0
low-tech,1,0.0
dipsticks,1,0.0
copresence,1,0.0
high-surety,1,0.0
left-right,1,0.0
Vestfold,1,0.0
Rogaland,1,0.0
Nordland,1,0.0
43-year-old-scuba,1,0.0
Acetylsalicylic-acid,1,0.0
ASA-sensitive,1,0.0
JTpJT,1,0.0
TpeJTp,1,0.0
malrotation,1,0.0
Intra-operatively,1,0.0
ventilate,1,0.0
1-1000,1,0.0
foregone,1,0.0
conductedABSTRACT,1,0.0
WinterSTT,1,0.0
ds,1,0.0
ICLC,1,0.0
reprimand,1,0.0
betrayal,1,0.0
envy,1,0.0
Form-36,1,0.0
MOS,1,0.0
cephalgias,1,0.0
Rolandic,1,0.0
postcentral,1,0.0
ill-staffed,1,0.0
38000,1,0.0
wakeup,1,0.0
tenascin,1,0.0
Cmpd,1,0.0
PCW-170,1,0.0
SARS-COV-1,1,0.0
close-distance,1,0.0
On-field,1,0.0
peptide-antibody,1,0.0
bioconjugates,1,0.0
self-agency,1,0.0
follow‑up,1,0.0
post‑mortem,1,0.0
PALLAS,1,0.0
239-413,1,0.0
TpeJT,1,0.0
TpeQTp,1,0.0
TpeQT,1,0.0
quich,1,0.0
1-1059,1,0.0
single-bounded,1,0.0
n223,1,0.0
n64,1,0.0
intrusiveness,1,0.0
highThe,1,0.0
CSMost,1,0.0
settingSome,1,0.0
systemsMany,1,0.0
36-74,1,0.0
2652,1,0.0
090-33,1,0.0
30-31,1,0.0
COVID19-suspected,1,0.0
non-preconditioned,1,0.0
phenprocoumon,1,0.0
CHADS2-Score,1,0.0
INR2,1,0.0
anticoagulants--especially,1,0.0
antagonists--are,1,0.0
homemakers,1,0.0
06-134,1,0.0
09-108,1,0.0
6270,1,0.0
Brown-Norway,1,0.0
Heparins,1,0.0
SLF,1,0.0
B-94,1,0.0
5664,1,0.0
underinvestigated,1,0.0
268000,1,0.0
Weiss,1,0.0
900-1200,1,0.0
Best-fitting,1,0.0
reconfigured,1,0.0
httpsbitly3hCw5dq,1,0.0
disaster-type,1,0.0
perihematomal,1,0.0
person-based,1,0.0
b-,1,0.0
leukotriene-,1,0.0
G431,1,0.0
S514,1,0.0
3705,1,0.0
G496,1,0.0
F497,1,0.0
D355,1,0.0
Immunize,1,0.0
1406,1,0.0
¿young¿,1,0.0
¿old¿,1,0.0
372-653,1,0.0
heathcare,1,0.0
183-375,1,0.0
156-367,1,0.0
DiseasesNational,1,0.0
fibroelastomas,1,0.0
135-5802,1,0.0
barograms,1,0.0
Clalit,1,0.0
«Praxis»,1,0.0
QIs,1,0.0
casuistic,1,0.0
2000-2010,1,0.0
specificityinterference,1,0.0
broad-range,1,0.0
219220,1,0.0
250261,1,0.0
Fujita,1,0.0
Hamman‐Rich,1,0.0
101111j1750‐2659201200353x,1,0.0
Methylxanthines,1,0.0
anti-leukotriene,1,0.0
bent-tip,1,0.0
Transcerebral,1,0.0
AIDShuman,1,0.0
Praxis,1,0.0
Lpt,1,0.0
Rpt,1,0.0
Erroneous,1,0.0
Rpts,1,0.0
Lpts,1,0.0
subserves,1,0.0
praxic,1,0.0
H1N1infection,1,0.0
414-417,1,0.0
high-lights,1,0.0
Ventilator,1,0.0
500th,1,0.0
PFEs,1,0.0
decentralised,1,0.0
Fascicle,1,0.0
Henoch-Schönlein,1,0.0
173-662,1,0.0
7140±250,1,0.0
Redox,1,0.0
nitritenitrate,1,0.0
TEAC,1,0.0
Dismutase,1,0.0
ox-LDL,1,0.0
7028±203,1,0.0
CuZn-SOD,1,0.0
r0668,1,0.0
P00065,1,0.0
Moms2Moms,1,0.0
OR1-month,1,0.0
087-105,1,0.0
019-174,1,0.0
006-181,1,0.0
Eighteen-month,1,0.0
0108,1,0.0
V70,1,0.0
vehicles24,1,0.0
1999-May,1,0.0
convictions,1,0.0
Altruism,1,0.0
Two-Part,1,0.0
Five-Point,1,0.0
85of,1,0.0
AUC-value,1,0.0
ROC-analysis,1,0.0
2174-6875,1,0.0
120-297,1,0.0
express-micromethod,1,0.0
Turbidimetric,1,0.0
levies,1,0.0
splits,1,0.0
nonfibrin-specific,1,0.0
3200-6400,1,0.0
1-log,1,0.0
35-90,1,0.0
111-246,1,0.0
parlance,1,0.0
clock-regulated,1,0.0
reviewVaccine,1,0.0
adhesiolysis,1,0.0
hematologicalbiochemical,1,0.0
questioner,1,0.0
psychopharmaceutical,1,0.0
pan-regional,1,0.0
turbidimetric,1,0.0
galvanizing,1,0.0
rallying,1,0.0
Ms,1,0.0
Omni,1,0.0
rhythm-and-music,1,0.0
horse-riding,1,0.0
Zungs,1,0.0
SNU,1,0.0
point4,1,0.0
T232,1,0.0
gamma-05748,1,0.0
gamma-06015,1,0.0
alpha2-globulin,1,0.0
volition,1,0.0
marginalization,1,0.0
Cobas®8800,1,0.0
Keynes,1,0.0
CLIA-IgG,1,0.0
CLIA-RBD,1,0.0
LFIA-S,1,0.0
isotope-related,1,0.0
CLIAELISA,1,0.0
defibrogenating,1,0.0
100-1000000,1,0.0
random-digit-dialling,1,0.0
pre-peak,1,0.0
ultrasound-targeted,1,0.0
mEql,1,0.0
inter-groups,1,0.0
50-65,1,0.0
anginanon-ST,1,0.0
Tenerife,1,0.0
7132,1,0.0
7503,1,0.0
Canarian,1,0.0
35-43,1,0.0
liquor,1,0.0
Frontenac,1,0.0
Lennox,1,0.0
Addington,1,0.0
KFLA,1,0.0
once-a-day,1,0.0
Intentions,1,0.0
VAPF,1,0.0
early-career,1,0.0
Labs,1,0.0
CLIA-IgMG,1,0.0
ELISA-total,1,0.0
CLIA-based,1,0.0
drift-like,1,0.0
rife,1,0.0
Sums,1,0.0
Derived,1,0.0
Stability,1,0.0
Streptokinasi,1,0.0
miocardico,1,0.0
RESULTS--Anterior,1,0.0
infarction--SK,1,0.0
RV1-V6,1,0.0
2195,1,0.0
younger-age,1,0.0
15-30-year,1,0.0
after-stroke,1,0.0
bistable,1,0.0
96-99,1,0.0
Staircase,1,0.0
reintegrated,1,0.0
capacitance,1,0.0
diseases--it,1,0.0
rhinitics,1,0.0
3376,1,0.0
non-native,1,0.0
Metandi,1,0.0
mixed-model,1,0.0
86-9599,1,0.0
97-99,1,0.0
82-8999,1,0.0
71-8398,1,0.0
Biocentre,1,0.0
distressingly,1,0.0
ledipasvirsofosbuvir,1,0.0
gas-chromatographic,1,0.0
already-positive,1,0.0
microlevel,1,0.0
observables,1,0.0
G29540A,1,0.0
sociobehavioral,1,0.0
dashboard-like,1,0.0
Blanc,1,0.0
huqqa,1,0.0
dalda,1,0.0
desi,1,0.0
ghee,1,0.0
specifical,1,0.0
treatpeuthic,1,0.0
OX40,1,0.0
Seq,1,0.0
hACE2-Tg,1,0.0
pancoronavirus,1,0.0
cornoracy,1,0.0
Reperfusion-mediated,1,0.0
preparationsABSTRACT,1,0.0
prestige,1,0.0
68207-214,1,0.0
0-542,1,0.0
102-132,1,0.0
110-139,1,0.0
nuclear-powered,1,0.0
4779,1,0.0
interstices,1,0.0
5075Geneaid,1,0.0
curriculums,1,0.0
risk-increasing,1,0.0
HIHPCCs,1,0.0
E484K-harboring,1,0.0
unsafety,1,0.0
Besag,1,0.0
Mollié,1,0.0
BYM,1,0.0
R-INLA,1,0.0
702226,1,0.0
2005-2018,1,0.0
5509,1,0.0
lowest-risk,1,0.0
Fas-ligand-antagonizing,1,0.0
Fas-ligand,1,0.0
macrobleeds,1,0.0
headless,1,0.0
B12431,1,0.0
impacthigh,1,0.0
dichotomous-choice,1,0.0
14761,1,0.0
19665,1,0.0
climatology,1,0.0
role-model,1,0.0
group--29,1,0.0
group--25,1,0.0
similar--in,1,0.0
2-nd,1,0.0
ecodeterminated,1,0.0
deldel,1,0.0
1993-2008,1,0.0
Case-Mix,1,0.0
Purchasing,1,0.0
Harvoni,1,0.0
719-928,1,0.0
039-079,1,0.0
scanographic,1,0.0
Banteay,1,0.0
Meanchey,1,0.0
minibus,1,0.0
common-source,1,0.0
Preah,1,0.0
Sdach,1,0.0
Prey,1,0.0
Veng,1,0.0
Arlington,1,0.0
adjuvant-supplemented,1,0.0
Rethrombosis,1,0.0
hemorrheology,1,0.0
Thrombin,1,0.0
anticoagulationABSTRACT,1,0.0
119-page,1,0.0
pathohistological,1,0.0
antigentic,1,0.0
H0-H1Nav2,1,0.0
costresource,1,0.0
Vapac,1,0.0
backs,1,0.0
virus-causing,1,0.0
Jonathan,1,0.0
114-253,1,0.0
144-315,1,0.0
118-245,1,0.0
118-261,1,0.0
134-613,1,0.0
immuno-allergologic,1,0.0
Reeds,1,0.0
specimen-wise,1,0.0
7935,1,0.0
cripple,1,0.0
time-PCR,1,0.0
EXTRAzol,1,0.0
one-lung,1,0.0
gatheringsIMPORTANCE,1,0.0
interhost,1,0.0
Tc-99m-MIBI,1,0.0
11-30,1,0.0
660711,1,0.0
WY,1,0.0
48252,1,0.0
BACKGROUNDEstimates,1,0.0
2020METHODSParticipants,1,0.0
dried-blood,1,0.0
3678,1,0.0
assayRESULTSOverall,1,0.0
monthsCONCLUSIONQuantitative,1,0.0
vaccineFundingNational,1,0.0
2035114,1,0.0
3UL1TR001422-06S4,1,0.0
TR001422,1,0.0
TR002389,1,0.0
Dixon,1,0.0
P30,1,0.0
CA060553,1,0.0
Walder,1,0.0
Foundations,1,0.0
8982,1,0.0
153-360,1,0.0
036-084,1,0.0
velpatasvirsofosbuvir,1,0.0
warriors,1,0.0
3139,1,0.0
decision-theoretic,1,0.0
Y280G9,1,0.0
9-35,1,0.0
multiinstitution,1,0.0
AUBMC,1,0.0
2-years,1,0.0
UHS,1,0.0
spike-reactive,1,0.0
ratio×100,1,0.0
fetal-type,1,0.0
MSCTA,1,0.0
E-ALT,1,0.0
syndrome-children,1,0.0
re-emphasises,1,0.0
Electroimpulse,1,0.0
anti-arrhythic,1,0.0
hilurithamal,1,0.0
novocainamide,1,0.0
panangin,1,0.0
neighbourhoods,1,0.0
thrombohemostatic,1,0.0
ortholog,1,0.0
dimerisation,1,0.0
PP1AB,1,0.0
near-identical,1,0.0
purchasable,1,0.0
ledipasvir,1,0.0
Epclusa,1,0.0
8182,1,0.0
1286,1,0.0
nonhypertensives,1,0.0
0908-0993,1,0.0
well-implemented,1,0.0
intravalvular,1,0.0
sonomicrometer,1,0.0
Snares,1,0.0
commissure,1,0.0
elongates,1,0.0
avian-exposed,1,0.0
minimalize,1,0.0
insidiously,1,0.0
Destruction,1,0.0
36-month,1,0.0
0908-0995,1,0.0
0949,1,0.0
iFGF23,1,0.0
3036,1,0.0
hypertensionIn,1,0.0
assaysDuring,1,0.0
pgmL-increase,1,0.0
103-120,1,0.0
107-130,1,0.0
0001This,1,0.0
Preclinically,1,0.0
mMRI,1,0.0
TSR,1,0.0
motionABSTRACT,1,0.0
4245,1,0.0
1709,1,0.0
3823,1,0.0
2»,1,0.0
therefrom,1,0.0
Reentrant,1,0.0
ozone-damaging,1,0.0
supraphysiologic,1,0.0
Setaria,1,0.0
brocket,1,0.0
Mazama,1,0.0
Loreto,1,0.0
Filarial,1,0.0
cervid,1,0.0
Infarction-related,1,0.0
rhACE-2,1,0.0
httpsbitly3bsUKO2,1,0.0
021min,1,0.0
064min,1,0.0
0334min,1,0.0
seizure-induction,1,0.0
107166,1,0.0
3974,1,0.0
6892,1,0.0
64111,1,0.0
metapneumonia,1,0.0
bulbar,1,0.0
insulted,1,0.0
Scar,1,0.0
quality-assured,1,0.0
RECOVER,1,0.0
undertreat,1,0.0
laboratory-supported,1,0.0
virus-antigen,1,0.0
Technetium-99m-pyrophosphate,1,0.0
lubricant,1,0.0
breath-actuated,1,0.0
high‐risk,1,0.0
reperfusedhyperperfused,1,0.0
4·5100,1,0.0
Whitaker-Dowling,1,0.0
Youngner,1,0.0
1641200-1202,1,0.0
010-018,1,0.0
026-032,1,0.0
antitoxic,1,0.0
auto-immunization,1,0.0
Th1-Th2,1,0.0
compartment-specific,1,0.0
PGF2α,1,0.0
pro-abortive,1,0.0
not-so-subtle,1,0.0
sickle-related,1,0.0
clientpatient,1,0.0
locationssites,1,0.0
needs1–3,1,0.0
CNY,1,0.0
8352,1,0.0
2012-2018,1,0.0
1-1-1,1,0.0
14-94,1,0.0
04-52,1,0.0
ofpositive,1,0.0
maxi-,1,0.0
Vmore,1,0.0
VCO,1,0.0
recruitability,1,0.0
PAFiO2,1,0.0
VCO2,1,0.0
bio-availability,1,0.0
tridimensionality,1,0.0
chromatic,1,0.0
lamination,1,0.0
700111331,1,0.0
313625,1,0.0
pan-specific,1,0.0
janus,1,0.0
anteriography,1,0.0
graded-interval,1,0.0
kilopond-mmin,1,0.0
diagnosisOverall,1,0.0
47756433,1,0.0
9494775,1,0.0
5894775,1,0.0
00143,1,0.0
picoliters,1,0.0
75400,1,0.0
52200,1,0.0
98600,1,0.0
01042,1,0.0
302200,1,0.0
308600,1,0.0
influenza-laden,1,0.0
motor-visual,1,0.0
autophagy-coronavirus,1,0.0
Cataloging,1,0.0
AKTprotein,1,0.0
CGAS,1,0.0
GMP-AMP,1,0.0
ovarycell,1,0.0
EAV,1,0.0
EDEM1,1,0.0
single-incision,1,0.0
partialy,1,0.0
endothelialization,1,0.0
BTs,1,0.0
horseradish,1,0.0
HRP,1,0.0
0112,1,0.0
under-prescribed,1,0.0
pressed,1,0.0
curantil,1,0.0
CoV-2-,1,0.0
-vitro,1,0.0
Chromogranin,1,0.0
CaliforniaMethods,1,0.0
1085481,1,0.0
389Conclusions,1,0.0
BT-OAT,1,0.0
MIRACL,1,0.0
up-dated,1,0.0
GREACE,1,0.0
CHD-related,1,0.0
statin-associated,1,0.0
under-powered,1,0.0
Accepting,1,0.0
radio-isotopes,1,0.0
pathobiologically,1,0.0
2021508e315-e319,1,0.0
KE,1,0.0
591-690,1,0.0
696-786,1,0.0
77-892,1,0.0
908-984,1,0.0
1460,1,0.0
treatmentABSTRACT,1,0.0
A8560,1,0.0
SIR-derived,1,0.0
heavily-exposed,1,0.0
SnipSnip,1,0.0
single-SNP,1,0.0
rs13057866,1,0.0
non-genotyped,1,0.0
anchorpartner,1,0.0
rs13057866rs9622682,1,0.0
rs62236673rs2899292,1,0.0
rs2899292,1,0.0
lymphoblast,1,0.0
eQTL,1,0.0
contributable,1,0.0
cellex,1,0.0
Sulphate,1,0.0
down-sloping,1,0.0
0-45-1415-64,1,0.0
Hanzels,1,0.0
Woolf,1,0.0
α005,1,0.0
patient-care,1,0.0
Prolyse,1,0.0
locoregional,1,0.0
SSFP,1,0.0
frenzied,1,0.0
2631,1,0.0
avapritinib,1,0.0
ziprasidone,1,0.0
capmatinib,1,0.0
pexidartinib,1,0.0
7859,1,0.0
2779,1,0.0
100-,1,0.0
Unquestionably,1,0.0
electroanatomic,1,0.0
64-electrode,1,0.0
mini-basket,1,0.0
Biosci,1,0.0
unobtrusive,1,0.0
Questioning,1,0.0
≤95,1,0.0
neutrocyte,1,0.0
≥03,1,0.0
germinal-center,1,0.0
blunts,1,0.0
Multi-season,1,0.0
self-measurement,1,0.0
useddeveloped,1,0.0
crossregulation,1,0.0
developedsuggested,1,0.0
availableproposed,1,0.0
nanobased,1,0.0
EMD,1,0.0
lipopolysaccharides,1,0.0
SARS-genetic,1,0.0
CoV-2s,1,0.0
72-95,1,0.0
pharmacists-led,1,0.0
5th-14th,1,0.0
co-tests,1,0.0
9839,1,0.0
immunopathy,1,0.0
overlaying,1,0.0
AnH1N1,1,0.0
A21248,1,0.0
-51,1,0.0
trainingafter,1,0.0
self-appraisal,1,0.0
trial-and-error,1,0.0
SMsare,1,0.0
Vitreous,1,0.0
mutton,1,0.0
keratic,1,0.0
Tyndall,1,0.0
hyperreactivityABSTRACT,1,0.0
phlyctenular,1,0.0
keratoconjunctivitis,1,0.0
disinfectantsantiseptics,1,0.0
self-epistemic,1,0.0
himherself,1,0.0
self-EA,1,0.0
658667,1,0.0
5155,1,0.0
4755,1,0.0
9965,1,0.0
9872,1,0.0
9990,1,0.0
post-positive,1,0.0
medianmean,1,0.0
Indwelling,1,0.0
removals,1,0.0
113-1119,1,0.0
Yuzhong,1,0.0
elevators,1,0.0
Belmont,1,0.0
Kotses,1,0.0
3442,1,0.0
pro-forma,1,0.0
Citrobacter,1,0.0
RTi,1,0.0
Religion,1,0.0
unison,1,0.0
classificationMethods,1,0.0
CT-scanResults,1,0.0
elongated-containing,1,0.0
band-like-opacities-containing,1,0.0
increasedConclusions,1,0.0
Bovie,1,0.0
2807,1,0.0
lipoteichoic,1,0.0
LPS-binding,1,0.0
LPSLBP,1,0.0
koseri,1,0.0
weather-related,1,0.0
SADS,1,0.0
Ligand,1,0.0
IKKs,1,0.0
GRhistone,1,0.0
injuryARDS,1,0.0
clinically-focussed,1,0.0
diagnosis-centred,1,0.0
practice-centred,1,0.0
N-Acetyl-beta-D-glucosaminidase,1,0.0
spectrofluorimetric,1,0.0
1092-75,1,0.0
68-22,1,0.0
Lower-risk,1,0.0
alpha-mannosidase,1,0.0
ER-associated,1,0.0
LAMP1,1,0.0
thrombolized,1,0.0
BREATHE,1,0.0
Exercises,1,0.0
inhaledoral,1,0.0
one-year-cohort,1,0.0
13520,1,0.0
27-39,1,0.0
analyzedand,1,0.0
Ⅱin,1,0.0
muscleand,1,0.0
ruptureAll,1,0.0
ventilationand,1,0.0
therapyCRRTThree,1,0.0
repair1,1,0.0
ECMOCRRTand,1,0.0
IABPand,1,0.0
hospitalMeanwhile,1,0.0
AMIand,1,0.0
post-hospitalisation,1,0.0
TQ,1,0.0
sativas,1,0.0
Yonsei,1,0.0
YSR,1,0.0
Retavase-Thrombolysis,1,0.0
ER-TIMI,1,0.0
32-minute,1,0.0
partial-dose,1,0.0
megaunits,1,0.0
PATCAR,1,0.0
0-405,1,0.0
F2FB,1,0.0
DVDB,1,0.0
EasyMagRotorGene,1,0.0
Zileuton,1,0.0
RXXR,1,0.0
tumor-specific,1,0.0
IbABSTRACT,1,0.0
viabilitystability,1,0.0
ICD9,1,0.0
303673,1,0.0
1160-1189,1,0.0
E-value,1,0.0
5e-24,1,0.0
Heptad,1,0.0
QadirVID-19,1,0.0
Qadir,1,0.0
VID-19,1,0.0
Renormalization,1,0.0
KFABI,1,0.0
eRG,1,0.0
Coronavirys-2,1,0.0
Solitaire™,1,0.0
Seeker,1,0.0
Authoritative,1,0.0
Misunderstanding,1,0.0
medication-induced,1,0.0
Barnes-Jewish,1,0.0
late-April,1,0.0
EasyMag,1,0.0
RotorGene,1,0.0
KingFisher-ABI,1,0.0
fastDX,1,0.0
analogously,1,0.0
10470,1,0.0
PEP-FOLD3,1,0.0
Teacher,1,0.0
valvulopathies,1,0.0
Immunogenetic,1,0.0
clinicoimmunogenetic,1,0.0
Antigenes,1,0.0
Leepsilon,1,0.0
Kell-,1,0.0
Chickering,1,0.0
Kearns,1,0.0
dual-roadmap,1,0.0
to18,1,0.0
IPost,1,0.0
Shinshilla,1,0.0
kinase-signal,1,0.0
stroke-dedicated,1,0.0
9426,1,0.0
kg·m-2,1,0.0
ADP-stimulated,1,0.0
Km,1,0.0
diagnosisNEW,1,0.0
spiraled,1,0.0
volcano,1,0.0
Asama,1,0.0
Deteriorated,1,0.0
Ash,1,0.0
10microm,1,0.0
gm2,1,0.0
ash-induced,1,0.0
suppressors,1,0.0
functionhomeostasis,1,0.0
antiphospholipd,1,0.0
antiphospolipid,1,0.0
anti-β2-glycoprotein,1,0.0
Inasmuch,1,0.0
oxideNO,1,0.0
endothelinET,1,0.0
hyperreactivityBHR,1,0.0
“optimal”,1,0.0
httpsbitly2Mfp4on,1,0.0
homocystine,1,0.0
tetra-O-galloyl-β-D-glucose,1,0.0
saikosaponin,1,0.0
Silvestrol,1,0.0
scutellarein,1,0.0
guidefacilitate,1,0.0
counter-intuitively,1,0.0
Pharos,1,0.0
sword--characterised,1,0.0
coronary-computer,1,0.0
PTCA-induced,1,0.0
T1-uptake,1,0.0
43-46,1,0.0
008-024,1,0.0
password-protected,1,0.0
NeuMoDxTM,1,0.0
SimplexaTM,1,0.0
contentions,1,0.0
effort-related,1,0.0
Gaborone,1,0.0
Botswana,1,0.0
complaint-based,1,0.0
exporting,1,0.0
Heliquest,1,0.0
wheel,1,0.0
MCoV,1,0.0
MDs,1,0.0
nebulizations,1,0.0
continuous-perfusion,1,0.0
enamel,1,0.0
4081,1,0.0
2006-2013,1,0.0
Splanchnicectomies,1,0.0
superoinferior,1,0.0
crus,1,0.0
crural,1,0.0
passageway,1,0.0
hyperpnoea-induced,1,0.0
HIB,1,0.0
ipsi-lateral,1,0.0
aphasia-only,1,0.0
12±005‰,1,0.0
04±003‰,1,0.0
675±06,1,0.0
183±05,1,0.0
53±03,1,0.0
90±04,1,0.0
315±17-372±22,1,0.0
orthomyxo-,1,0.0
pre-engraftment,1,0.0
peritransplant,1,0.0
Hibernation,1,0.0
lesion-centric,1,0.0
dorsomedial,1,0.0
language-related,1,0.0
Naming,1,0.0
Gravity,1,0.0
42016039896,1,0.0
I248,1,0.0
Vps,1,0.0
CALCOCO2NDP52,1,0.0
coiled-coil,1,0.0
phagophores,1,0.0
PtdIns3K,1,0.0
PLP,1,0.0
pMEF,1,0.0
SKP2,1,0.0
SQSTM1,1,0.0
sequestosome,1,0.0
STING1,1,0.0
interactor,1,0.0
ULK1,1,0.0
unc-51,1,0.0
vacuolar,1,0.0
016-171,1,0.0
NHMRC,1,0.0
exhorted,1,0.0
immunopotentiator,1,0.0
nasopharyngeal-oropharyngeal,1,0.0
NOPS,1,0.0
Multi-Colored,1,0.0
single-sheet,1,0.0
AISF,1,0.0
Geldern,1,0.0
Informations,1,0.0
OR062,1,0.0
052-073,1,0.0
OR053,1,0.0
diffusivities,1,0.0
Nonlesioned,1,0.0
TMHMM,1,0.0
thalamocortical,1,0.0
1975-1997,1,0.0
Kawai,1,0.0
Fukutomi,1,0.0
pyrolysis,1,0.0
chronification,1,0.0
anti-T-helper,1,0.0
muscle-mediated,1,0.0
P-Q,1,0.0
careThe,1,0.0
agereason,1,0.0
Split-initiator,1,0.0
viral-exposure,1,0.0
60°C,1,0.0
viral-capsid,1,0.0
60Co,1,0.0
Implant,1,0.0
Protheses,1,0.0
subpectoral,1,0.0
Tat,1,0.0
VP22,1,0.0
wide-range,1,0.0
CellPPD,1,0.0
C2Pred,1,0.0
CPPred-RF,1,0.0
MLCPP,1,0.0
amphipathicity,1,0.0
protparam,1,0.0
pepcalc,1,0.0
APD3,1,0.0
LRs,1,0.0
diagnostic-accuracy,1,0.0
probe-free,1,0.0
Ultrasound-enhanced,1,0.0
10·5,1,0.0
56100,1,0.0
School-associated,1,0.0
Imported,1,0.0
1·41,1,0.0
1·43,1,0.0
clinico-biochemical,1,0.0
chlorine-soluble,1,0.0
hexose,1,0.0
glycoaminoglycane,1,0.0
oxyprolin,1,0.0
overunlevelling,1,0.0
completes,1,0.0
elinogrel,1,0.0
GolayMetaMiner,1,0.0
trans-synoptically,1,0.0
Chitosomes,1,0.0
hydrating,1,0.0
calorimetric,1,0.0
diffraction,1,0.0
Met-loaded,1,0.0
immunomics,1,0.0
10263,1,0.0
9257,1,0.0
AMI-onset,1,0.0
465915,1,0.0
21031,1,0.0
containment-based,1,0.0
Compulsory,1,0.0
